PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Serebryany, E; Yu, SH; Trauger, SA; Budnik, B; Shakhnovich, EI				Serebryany, Eugene; Yu, Shuhuai; Trauger, Sunia A.; Budnik, Bogdan; Shakhnovich, Eugene I.			Dynamic disulfide exchange in a crystallin protein in the human eye lens promotes cataract-associated aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lens; crystallin; cataract; disulfide; protein aggregation; protein misfolding; conformational intermediates; disulfide exchange; oxidoreductase; redox mechanism	GAMMA-D-CRYSTALLIN; AMYOTROPHIC-LATERAL-SCLEROSIS; ALPHA-A-CRYSTALLIN; POSTTRANSLATIONAL MODIFICATIONS; BOND FORMATION; IN-VITRO; PROTEOMIC ANALYSIS; GLOBULAR-PROTEINS; CYSTEINE RESIDUES; MASS-SPECTROMETRY	Increased light scattering in the eye lens due to aggregation of the long-lived lens proteins, crystallins, is the cause of cataract disease. Several mutations in the gene encoding human D-crystallin (HD) cause misfolding and aggregation. Cataract-associated substitutions at Trp(42) cause the protein to aggregate in vitro from a partially unfolded intermediate locked by an internal disulfide bridge, and proteomic evidence suggests a similar aggregation precursor is involved in age-onset cataract. Surprisingly, WT HD can promote aggregation of the W42Q variant while itself remaining soluble. Here, a search for a biochemical mechanism for this interaction has revealed a previously unknown oxidoreductase activity in HD. Using in vitro oxidation, mutational analysis, cysteine labeling, and MS, we have assigned this activity to a redox-active internal disulfide bond that is dynamically exchanged among HD molecules. The W42Q variant acts as a disulfide sink, reducing oxidized WT and forming a distinct internal disulfide that kinetically traps the aggregation-prone intermediate. Our findings suggest a redox hot potato competition among WT and mutant or modified polypeptides wherein variants with the lowest kinetic stability are trapped in aggregation-prone intermediate states upon accepting disulfides from more stable variants. Such reactions may occur in other long-lived proteins that function in oxidizing environments. In these cases, aggregation may be forestalled by inhibiting disulfide flow toward mutant or damaged polypeptides.	[Serebryany, Eugene; Shakhnovich, Eugene I.] Harvard Univ, Dept Chem & Chem Biol, 12 Oxford St, Cambridge, MA 02138 USA; [Yu, Shuhuai] Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi 214122, Jiangsu, Peoples R China; [Trauger, Sunia A.] Harvard Univ, Small Mol Mass Spectrometry Core Facil, Fac Arts & Sci, Cambridge, MA 02138 USA; [Budnik, Bogdan] Harvard Univ, Mass Spectrometry & Prote Resource Lab, Fac Arts & Sci, Cambridge, MA 02138 USA	Harvard University; Jiangnan University; Harvard University; Harvard University	Shakhnovich, EI (corresponding author), Harvard Univ, Dept Chem & Chem Biol, 12 Oxford St, Cambridge, MA 02138 USA.	shakhnovich@chemistry.harvard.edu	Budnik, Bogdan/AGG-8824-2022; Budnik, Bogdan/AAH-9987-2019	Budnik, Bogdan/0000-0003-3622-2003; 	National Institutes of Health [R01GM111955, F32GM126651]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM126651, R01GM111955] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health Grants R01GM111955 (to E. I. S.) and F32GM126651 (to E. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; Arolas JL, 2006, TRENDS BIOCHEM SCI, V31, P292, DOI 10.1016/j.tibs.2006.03.005; Bah A, 2016, J BIOL CHEM, V291, P6696, DOI 10.1074/jbc.R115.695056; Banerjee R, 2012, J BIOL CHEM, V287, P4397, DOI 10.1074/jbc.R111.287995; Bartlett AI, 2009, NAT STRUCT MOL BIOL, V16, P582, DOI 10.1038/nsmb.1592; Basak A, 2003, J MOL BIOL, V328, P1137, DOI 10.1016/S0022-2836(03)00375-9; Basilio D, 2014, NAT STRUCT MOL BIOL, V21, P456, DOI 10.1038/nsmb.2814; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; Boscia F, 2000, INVEST OPHTH VIS SCI, V41, P2461; CAREAGA CL, 1992, J MOL BIOL, V226, P1219, DOI 10.1016/0022-2836(92)91063-U; Chang JY, 2001, J BIOL CHEM, V276, P4845, DOI 10.1074/jbc.M005160200; Cherian-Shaw M, 1999, MOL CELL BIOCHEM, V199, P163, DOI 10.1023/A:1006906615469; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Clarke SG, 2013, TRENDS BIOCHEM SCI, V38, P243, DOI 10.1016/j.tibs.2013.02.004; Connors LH, 2007, BIOCHEMISTRY-US, V46, P14259, DOI 10.1021/bi7013773; Cook KM, 2013, ANTIOXID REDOX SIGN, V18, P1987, DOI 10.1089/ars.2012.4807; CREIGHTON TE, 1988, BIOESSAYS, V8, P57, DOI 10.1002/bies.950080204; de Graff AMR, 2016, STRUCTURE, V24, P329, DOI 10.1016/j.str.2015.11.006; Deis LN, 2014, STRUCTURE, V22, P1467, DOI 10.1016/j.str.2014.08.014; Derewenda U, 2009, BIOCHEMISTRY-US, V48, P8664, DOI 10.1021/bi900437z; Fan XJ, 2015, MOL CELL PROTEOMICS, V14, P3211, DOI 10.1074/mcp.M115.050948; Fass D, 2018, CHEM REV, V118, P293, DOI 10.1021/acs.chemrev.7b00123; Finley EL, 1998, PROTEIN SCI, V7, P2391, DOI 10.1002/pro.5560071116; Flaugh SL, 2006, J BIOL CHEM, V281, P30782, DOI 10.1074/jbc.M603882200; Flaugh SL, 2005, PROTEIN SCI, V14, P2030, DOI 10.1110/ps.051460505; Flaugh SL, 2005, PROTEIN SCI, V14, P571, DOI 10.1110/ps.041111405; Forman-Kay JD, 2013, STRUCTURE, V21, P1492, DOI 10.1016/j.str.2013.08.001; FRIEDBURG D, 1973, EXP EYE RES, V15, P173, DOI 10.1016/0014-4835(73)90116-4; Fuchs SM, 2011, CURR BIOL, V21, P53, DOI 10.1016/j.cub.2010.11.058; Garcia-Manyes S, 2016, J BIOL CHEM, V291, P4226, DOI 10.1074/jbc.M115.673871; GIBLIN FJ, 1995, EXP EYE RES, V60, P219, DOI 10.1016/S0014-4835(05)80105-8; Go YM, 2015, FREE RADICAL BIO MED, V84, P227, DOI 10.1016/j.freeradbiomed.2015.03.022; GOODSON RJ, 1990, BIO-TECHNOL, V8, P343, DOI 10.1038/nbt0490-343; Grad LI, 2014, PRION, V8, P33, DOI 10.4161/pri.27602; Hains PG, 2007, J PROTEOME RES, V6, P3935, DOI 10.1021/pr070138h; Hains PG, 2008, BBA-PROTEINS PROTEOM, V1784, P1959, DOI 10.1016/j.bbapap.2008.07.016; Hanson SRA, 1998, EXP EYE RES, V67, P301, DOI 10.1006/exer.1998.0530; Hoehenwarter W, 2006, AMINO ACIDS, V30, P369, DOI 10.1007/s00726-005-0283-9; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Horwich A, 2002, J CLIN INVEST, V110, P1221, DOI 10.1172/JCI200216781; Hua QX, 2002, BIOCHEMISTRY-US, V41, P14700, DOI 10.1021/bi0202981; Huang F, 2003, ANGEW CHEM INT EDIT, V42, P2269, DOI 10.1002/anie.200250684; Jakob U, 1999, CELL, V96, P341, DOI 10.1016/S0092-8674(00)80547-4; Ji FL, 2013, J BIOL CHEM, V288, P99, DOI 10.1074/jbc.M112.416354; Jones DP, 2010, J INTERN MED, V268, P432, DOI 10.1111/j.1365-2796.2010.02268.x; Karamanos TK, 2014, MOL CELL, V55, P214, DOI 10.1016/j.molcel.2014.05.026; KOBASHI K, 1968, BIOCHIM BIOPHYS ACTA, V158, P239, DOI 10.1016/0304-4165(68)90136-0; Kong FR, 2011, PROTEIN SCI, V20, P513, DOI 10.1002/pro.583; Kosinski-Collins MS, 2003, PROTEIN SCI, V12, P480, DOI 10.1110/ps.0225503; Lampi KJ, 2014, PROG BIOPHYS MOL BIO, V115, P21, DOI 10.1016/j.pbiomolbio.2014.02.004; Lapko VN, 2003, PROTEIN SCI, V12, P1762, DOI 10.1110/ps.0305403; Lapko VN, 2002, BIOCHEMISTRY-US, V41, P14645, DOI 10.1021/bi0267700; LOU MF, 1992, EXP EYE RES, V55, P889, DOI 10.1016/0014-4835(92)90015-K; Lou MF, 2003, PROG RETIN EYE RES, V22, P657, DOI 10.1016/S1350-9462(03)00050-8; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; Lu JL, 2001, BIOCHEMISTRY-US, V40, P13288, DOI 10.1021/bi0107647; Ma ZX, 1998, EXP EYE RES, V67, P21, DOI 10.1006/exer.1998.0482; MCDERMOTT M, 1991, BIOCHEMISTRY-US, V30, P8653, DOI 10.1021/bi00099a023; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Michael R, 2011, PHILOS T R SOC B, V366, P1278, DOI 10.1098/rstb.2010.0300; Mills IA, 2007, PROTEIN SCI, V16, P2427, DOI 10.1110/ps.072970207; Moran SD, 2013, BIOCHEMISTRY-US, V52, P6169, DOI 10.1021/bi4008353; Moreau KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037256; Moreau KL, 2012, TRENDS MOL MED, V18, P273, DOI 10.1016/j.molmed.2012.03.005; Moreau KL, 2009, J BIOL CHEM, V284, P33285, DOI 10.1074/jbc.M109.031344; Murzin AG, 2008, SCIENCE, V320, P1725, DOI 10.1126/science.1158868; Oka OBV, 2015, BIOCHEM J, V469, P279, DOI 10.1042/BJ20141423; OZAKI Y, 1987, J BIOL CHEM, V262, P15445; Quintanar L, 2016, ACS CHEM BIOL, V11, P263, DOI 10.1021/acschembio.5b00919; Ramkumar S, 2018, BBA-MOL BASIS DIS, V1864, P3595, DOI 10.1016/j.bbadis.2018.08.021; Robertson AD, 1997, CHEM REV, V97, P1251, DOI 10.1021/cr960383c; Ronzoni R, 2016, HUM MOL GENET, V25, P642, DOI 10.1093/hmg/ddv501; Sarsour EH, 2009, ANTIOXID REDOX SIGN, V11, P2985, DOI [10.1089/ars.2009.2513, 10.1089/ARS.2009.2513]; Schafheimer N, 2013, PHOTOCHEM PHOTOBIOL, V89, P1106, DOI 10.1111/php.12096; Serebryany E, 2016, J BIOL CHEM, V291, P19172, DOI 10.1074/jbc.M116.735977; Serebryany E, 2016, PROTEIN SCI, V25, P1115, DOI 10.1002/pro.2924; Serebryany E, 2015, J BIOL CHEM, V290, P11491, DOI 10.1074/jbc.M114.621581; Serebryany E, 2014, PROG BIOPHYS MOL BIO, V115, P32, DOI 10.1016/j.pbiomolbio.2014.05.002; Sevier CS, 2002, NAT REV MOL CELL BIO, V3, P836, DOI 10.1038/nrm954; Shang F, 2004, EXP EYE RES, V78, P1, DOI 10.1016/j.exer.2003.10.003; SIEZEN RJ, 1987, P NATL ACAD SCI USA, V84, P6088, DOI 10.1073/pnas.84.17.6088; SPECTOR A, 1978, P NATL ACAD SCI USA, V75, P3244, DOI 10.1073/pnas.75.7.3244; Su S, 2011, INVEST OPHTH VIS SCI, V52, P4182, DOI 10.1167/iovs.10-7094; Sweeney MHJ, 1998, EXP EYE RES, V67, P587, DOI 10.1006/exer.1998.0549; Takemoto LJ, 1996, BIOCHEM BIOPH RES CO, V223, P216, DOI 10.1006/bbrc.1996.0873; Takemoto LJ, 1997, CURR EYE RES, V16, P719, DOI 10.1076/ceyr.16.7.719.5055; Takemoto LJ, 1997, EXP EYE RES, V64, P609, DOI 10.1006/exer.1996.0247; Tessier PM, 2007, NATURE, V447, P556, DOI 10.1038/nature05848; THORNTON JM, 1981, J MOL BIOL, V151, P261, DOI 10.1016/0022-2836(81)90515-5; Toichi K, 2013, J BIOL CHEM, V288, P4970, DOI 10.1074/jbc.M112.414235; Trivedi MV, 2009, CURR PROTEIN PEPT SC, V10, P614, DOI 10.2174/138920309789630534; Truscott RJW, 2016, TRENDS BIOCHEM SCI, V41, P654, DOI 10.1016/j.tibs.2016.06.004; Walsh CT, 2005, ANGEW CHEM INT EDIT, V44, P7342, DOI 10.1002/anie.200501023; Wang BL, 2017, AGING CELL, V16, P244, DOI 10.1111/acel.12548; Wang BB, 2011, HUM MUTAT, V32, pE1939, DOI 10.1002/humu.21386; Wang Y, 2016, ELIFE, V5, DOI [10.7554/elife.17505, 10.7554/eLife.17505]; Woycechowsky KJ, 2000, CURR OPIN CHEM BIOL, V4, P533, DOI 10.1016/S1367-5931(00)00128-9; Woycechowsky KJ, 2003, BIOCHEMISTRY-US, V42, P5387, DOI 10.1021/bi026993q; Wride MA, 2011, PHILOS T R SOC B, V366, P1219, DOI 10.1098/rstb.2010.0324; Xin FX, 2012, BIOINFORMATICS, V28, P2905, DOI 10.1093/bioinformatics/bts541; YU NT, 1985, P NATL ACAD SCI USA, V82, P7965, DOI 10.1073/pnas.82.23.7965; Zougman A, 2014, PROTEOMICS, V14, P1006, DOI 10.1002/pmic.201300553	104	31	31	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2018	293	46					17997	18009		10.1074/jbc.RA118.004551	http://dx.doi.org/10.1074/jbc.RA118.004551			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HA6SG	30242128	hybrid, Green Published			2022-12-26	WOS:000450409500027
J	Sitthiyotha, T; Pichyangkura, R; Chunsrivirot, S				Sitthiyotha, Thassanai; Pichyangkura, Rath; Chunsrivirot, Surasak			Molecular dynamics provides insight into how N251A and N251Y mutations in the active site of Bacillus licheniformis RN-01 levansucrase disrupt production of long-chain levan	PLOS ONE			English	Article							SWISS-MODEL; FREE-ENERGY; CRYSTAL-STRUCTURE; MM-PBSA; SIMULATIONS; BINDING; PERFORMANCE; MM/PBSA; GENE; MM/GBSA	Produced by levansucrase, levan and levan oligosaccharides (GF(n)) have potential applications in food and pharmaceutical industries such as prebiotics, anti-tumor and anti-inflammatory agents. Previous study reported that Bacillus licheniformis RN-01 levansucrase could produce levan oligosaccharides and long-chain levan. However, its N251A and N251Y mutants could effectively produce short-chain oligosaccharides upto GF(3), but they could not produce long-chain levan. We hypothesized that these mutations probably reduced GF(3) binding affinity in levansucrase active site that contains fructosyl-Asp93 intermediate and caused GF(3) to be in an unfavorable orientation for transfructosylation; therefore, levansucrase could not effectively extend GF(3) by one fructosyl residue to produce GF(4) and subsequently long-chain levan. However, these mutations probably did not significantly reduce binding affinity or drastically change orientation of GF(2); therefore, levansucrase could still extend GF(2) to produce GF(3). Using this hypothesis, we employed molecular dynamics to investigate effects of these mutations on GF(2)/GF(3) binding in levansucrase active site. Our results reasonably support this hypothesis as N251A and N251Y mutations did not significantly reduce GF(2) binding affinity, as calculated by MM-GBSA technique and hydrogen bond occupations, or drastically change orientation of GF(2) in levansucrase active site, as measured by distance between atoms necessary for transfructosylation. However, these mutations drastically decreased GF(3) binding affinity and caused GF(3) to be in an unfavorable orientation for transfructosylation. Furthermore, the free energy decomposition and hydrogen bond occupation results suggest the importance of Arg255 in GF(2)/GF(3) binding in levansucrase active site. This study provides important and novel insight into the effects of N251A and N251Y mutations on GF(2)/GF(3) binding in levansucrase active site and how they may disrupt production of long-chain levan. This knowledge could be beneficial in designing levansucrase to efficiently produce levan oligosaccharides with desired length.	[Sitthiyotha, Thassanai; Pichyangkura, Rath; Chunsrivirot, Surasak] Chulalongkorn Univ, Fac Sci, Dept Biochem, Bangkok, Thailand; [Sitthiyotha, Thassanai; Chunsrivirot, Surasak] Chulalongkorn Univ, Fac Sci, Dept Biochem, Struct & Computat Biol Res Grp, Bangkok, Thailand	Chulalongkorn University; Chulalongkorn University	Chunsrivirot, S (corresponding author), Chulalongkorn Univ, Fac Sci, Dept Biochem, Bangkok, Thailand.; Chunsrivirot, S (corresponding author), Chulalongkorn Univ, Fac Sci, Dept Biochem, Struct & Computat Biol Res Grp, Bangkok, Thailand.	surasak.ch@chula.ac.th		Pichyangkura, Rath/0000-0003-2451-5941	Institute for the Promotion of Teaching Science and Technology (IPST) under the Research Fund for DPST Graduate with First Placement [07/2557]; Structural and Computational Biology Research Group, Special Task Force for Activating Research (STAR), Faculty of Science, Rachadaphiseksomphot Endowment Fund, Chulalongkorn University; Graduate School, Chulalongkorn University; Rachadaphiseksomphot Endowment Fund Part of the "Strengthen CU's Researcher's Project"; Ratchadaphiseksomphot Endowment Fund Part of the "Research Grant for New Scholar CU Researcher's Project," Chulalongkorn University [RGN_2558_002_01_23]; Thailand Research Fund [TRG5880222, IRG 5780008]	Institute for the Promotion of Teaching Science and Technology (IPST) under the Research Fund for DPST Graduate with First Placement; Structural and Computational Biology Research Group, Special Task Force for Activating Research (STAR), Faculty of Science, Rachadaphiseksomphot Endowment Fund, Chulalongkorn University; Graduate School, Chulalongkorn University(Chulalongkorn University); Rachadaphiseksomphot Endowment Fund Part of the "Strengthen CU's Researcher's Project"; Ratchadaphiseksomphot Endowment Fund Part of the "Research Grant for New Scholar CU Researcher's Project," Chulalongkorn University; Thailand Research Fund(Thailand Research Fund (TRF))	This research is supported by the Institute for the Promotion of Teaching Science and Technology (IPST) under the Research Fund for DPST Graduate with First Placement [Grant no. 07/2557 to SC] and Structural and Computational Biology Research Group, Special Task Force for Activating Research (STAR), Faculty of Science, Rachadaphiseksomphot Endowment Fund, Chulalongkorn University. TS was partially supported by the Scholarship from Graduate School, Chulalongkorn University to commemorate The Celebrations on the Auspicious Occasion of Her Royal Highness Princess Maha Chakri Sirindhorn's 5th Cycle (60th) Birthday. RP was partially supported by Rachadaphiseksomphot Endowment Fund Part of the "Strengthen CU's Researcher's Project." SC was also partially supported by the Ratchadaphiseksomphot Endowment Fund Part of the "Research Grant for New Scholar CU Researcher's Project," Chulalongkorn University [Grant no. RGN_2558_002_01_23] and the Thailand Research Fund [Grant no. TRG5880222 and IRG 5780008]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Arvidson SA, 2006, CARBOHYD POLYM, V65, P144, DOI 10.1016/j.carbpol.2005.12.039; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bryce RA, 2001, BIOPHYS J, V81, P1373, DOI 10.1016/S0006-3495(01)75793-1; Cao RY, 2012, J PHYS CHEM B, V116, P6087, DOI 10.1021/jp3010647; Case D.A., 2022, AMBER; Dal Bello F, 2001, SYST APPL MICROBIOL, V24, P232, DOI 10.1078/0723-2020-00033; Dennington R., 2016, GAUSSVIEW VERSION 6; Fadda E, 2010, DRUG DISCOV TODAY, V15, P596, DOI 10.1016/j.drudis.2010.06.001; Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005; Frisch M.J., 2009, GAUSSIAN 09 REVIS D0; GEIER G, 1993, PHYSIOL MOL PLANT P, V42, P387, DOI 10.1006/pmpp.1993.1029; Genheden S, 2015, EXPERT OPIN DRUG DIS, V10, P449, DOI 10.1517/17460441.2015.1032936; Gibson GR, 2004, NUTR RES REV, V17, P259, DOI 10.1079/NRR200479; Gotz AW, 2012, J CHEM THEORY COMPUT, V8, P1542, DOI 10.1021/ct200909j; Gohlke H, 2003, J MOL BIOL, V330, P891, DOI 10.1016/S0022-2836(03)00610-7; Goldman D, 2008, J BIOL CHEM, V283, P32209, DOI 10.1074/jbc.M805985200; Gonzalez-Garcinuno A, 2017, MICROB CELL FACT, V16, DOI 10.1186/s12934-017-0703-z; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Han J, 2016, APPL ENVIRON MICROB, V82, P1383, DOI 10.1128/AEM.02944-15; Han Y W, 1990, Adv Appl Microbiol, V35, P171, DOI 10.1016/S0065-2164(08)70244-2; Homann A, 2007, BIOCHEM J, V407, P189, DOI 10.1042/BJ20070600; Hou TJ, 2008, J MOL BIOL, V376, P1201, DOI 10.1016/j.jmb.2007.12.054; Hou TJ, 2011, J COMPUT CHEM, V32, P866, DOI 10.1002/jcc.21666; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; Kang FK, 2005, BBA-GENE STRUCT EXPR, V1727, P5, DOI 10.1016/j.bbaexp.2004.10.012; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kim KH, 2005, J COSMET SCI, V56, P395; Kim MG, 1998, BIOTECHNOL LETT, V20, P333, DOI 10.1023/A:1005310926399; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Le Grand S, 2013, COMPUT PHYS COMMUN, V184, P374, DOI 10.1016/j.cpc.2012.09.022; Li Y, 1997, BBA-GENE STRUCT EXPR, V1353, P203, DOI 10.1016/S0167-4781(97)00103-6; Liu JY, 2015, SCI REP-UK, V5, DOI 10.1038/srep12359; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Martinez-Fleites C, 2005, BIOCHEM J, V390, P19, DOI 10.1042/BJ20050324; Mena-Ulecia K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142774; Meng GY, 2003, NAT STRUCT BIOL, V10, P935, DOI 10.1038/nsb974; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; Nakapong S., 2011, THESIS; Niu YZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145219; Olarte-Avellaneda S, 2016, INTERDISCIP SCI, P1; Rairakhwada D, 2007, FISH SHELLFISH IMMUN, V22, P477, DOI 10.1016/j.fsi.2006.06.005; Rairakhwada D, 2010, J IND MICROBIOL BIOT, V37, P195, DOI 10.1007/s10295-009-0664-2; Rastelli G, 2010, J COMPUT CHEM, V31, P797, DOI 10.1002/jcc.21372; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; Seibel J, 2006, CARBOHYD RES, V341, P2335, DOI 10.1016/j.carres.2006.07.001; Singh PK, 2016, J MOL MODEL, V22, DOI 10.1007/s00894-016-2935-y; Song KB, 1998, ANN NY ACAD SCI, V864, P506, DOI 10.1111/j.1749-6632.1998.tb10369.x; Srikanth R, 2015, CARBOHYD POLYM, V120, P102, DOI 10.1016/j.carbpol.2014.12.003; STEINMETZ M, 1985, MOL GEN GENET, V200, P220, DOI 10.1007/BF00425427; Strube CP, 2011, J BIOL CHEM; Sun HY, 2014, PHYS CHEM CHEM PHYS, V16, P22035, DOI 10.1039/c4cp03179b; Swanson JMJ, 2004, BIOPHYS J, V86, P67, DOI 10.1016/S0006-3495(04)74084-9; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Virtanen SI, 2015, J MOL GRAPH MODEL, V62, P303, DOI 10.1016/j.jmgm.2015.10.012; Visnapuu T, 2011, J BIOTECHNOL, V155, P338, DOI 10.1016/j.jbiotec.2011.07.026; Wu XW, 2003, CHEM PHYS LETT, V381, P512, DOI 10.1016/j.cplett.2003.10.013; Wuerges J, 2015, J STRUCT BIOL, V191, P290, DOI 10.1016/j.jsb.2015.07.010; Xu L, 2013, J PHYS CHEM B, V117, P8408, DOI 10.1021/jp404160y; Ylilauri M, 2013, J CHEM INF MODEL, V53, P2626, DOI 10.1021/ci4002475; YORK DM, 1993, J CHEM PHYS, V99, P8345, DOI 10.1063/1.465608; Zuo ZC, 2016, SCI REP-UK, V6, DOI 10.1038/srep37584	65	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0204915	10.1371/journal.pone.0204915	http://dx.doi.org/10.1371/journal.pone.0204915			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3QJ	30278092	Green Published, Green Submitted, gold			2022-12-26	WOS:000446010200027
J	Donohue, JM; Guclu, H; Gellad, WF; Chang, CCH; Huskamp, HA; Choudhry, NK; Zhang, RX; Lo-Ciganic, WH; Junker, SP; Anderson, T; Richards-Shubik, S				Donohue, Julie M.; Guclu, Hasan; Gellad, Walid F.; Chang, Chung-Chou H.; Huskamp, Haiden A.; Choudhry, Niteesh K.; Zhang, Ruoxin; Lo-Ciganic, Wei-Hsuan; Junker, Stefanie P.; Anderson, Timothy; Richards-Shubik, Seth			Influence of peer networks on physician adoption of new drugs	PLOS ONE			English	Article							PATIENT-SHARING NETWORKS; PRIMARY-CARE; SOCIAL NETWORKS; DIFFUSION; BEHAVIOR; CENTRALITY; INNOVATION; CONTAGION; MEDICARE; DECISION	Although physicians learn about new medical technologies from their peers, the magnitude and source of peer influence is unknown. We estimate the effect of peer adoption of three first-in-class medications (dabigatran, sitigliptin, and aliskiren) on physicians' own adoption of those medications. We included 11,958 physicians in Pennsylvania prescribing anticoagulant, antidiabetic, and antihypertensive medications. We constructed 4 types of peer networks based on shared Medicare and Medicaid patients, medical group affiliation, hospital affiliation, and medical school/residency training. Instrumental variables analysis was used to estimate the causal effect of peer adoption (fraction of peers in each network adopting the new drug) on physician adoption (prescribing at least the median number prescriptions within 15 months of the new drug's introduction). We illustrate how physician network position can inform targeting of interventions to physicians by computing a social multiplier. Dabigatran was adopted by 25.2%, sitagliptin by 24.5% and aliskiren by 8.3% of physicians. A 10-percentage point increase in peer adoption in the patient-sharing network led to a 5.90% (SE = 1.50%, p<0.001) increase in physician adoption of dabigatran, 8.32% (SE = 1.51%, p<0.001) increase in sitagliptin, and 7.84% increase in aliskiren adoption (SE = 2.93%, p<0.001). Peer effects through shared hospital affiliation were positive but not significant, and medical group and training network effects were not reliably estimated. Physicians in the top decile of patient-sharing network peers were estimated to have nearly 2-fold stronger influence on their peers' adoption compared to physicians in the top decile of prescribing volume. Limitations include lack of detailed clinical information and pharmaceutical promotion, variables which may influence physician adoption but which are unlikely to bias our peer effect estimates. Peer adoption, especially by those with whom physicians share patients, strongly influenced physician adoption of new drugs. Our study shows the potential for using information on physician peer networks to improve technology diffusion.	[Donohue, Julie M.; Junker, Stefanie P.] Univ Pittsburgh, Dept Hlth Policy & Management, Grad Sch Publ Hlth, Pittsburgh, PA 15260 USA; [Guclu, Hasan] Istanbul Medeniyet Univ, Sch Engn & Nat Sci, Dept Stat, Istanbul, Turkey; [Guclu, Hasan] Istanbul Medeniyet Univ, Sch Med, Dept Biostat & Med Informat, Istanbul, Turkey; [Gellad, Walid F.] Univ Pittsburgh, Ctr Pharmaceut Policy & Prescribing, Hlth Policy Inst, Pittsburgh, PA USA; [Gellad, Walid F.; Chang, Chung-Chou H.] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15213 USA; [Gellad, Walid F.] Vet Affairs Pittsburgh Healthcare Syst, Ctr Hlth Equ Res & Promot, Pittsburgh, PA USA; [Chang, Chung-Chou H.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA USA; [Huskamp, Haiden A.] Harvard Univ, Harvard Med Sch, Dept Hlth Care Policy, Boston, MA 02115 USA; [Choudhry, Niteesh K.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA; [Choudhry, Niteesh K.] Harvard Med Sch, Boston, MA USA; [Zhang, Ruoxin] Permanente Med Grp Inc, Qual & Operat Support, Oakland, CA USA; [Lo-Ciganic, Wei-Hsuan] Univ Arizona, Coll Pharm, Dept Pharm Practice & Sci, Tucson, AZ 85721 USA; [Anderson, Timothy] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Richards-Shubik, Seth] Lehigh Univ, Coll Business & Econ, Dept Econ, Bethlehem, PA 18015 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Istanbul Medeniyet University; Istanbul Medeniyet University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Permanente Medical Groups; University of Arizona; University of California System; University of California San Francisco; Lehigh University	Donohue, JM (corresponding author), Univ Pittsburgh, Dept Hlth Policy & Management, Grad Sch Publ Hlth, Pittsburgh, PA 15260 USA.	jdonohue@pitt.edu	Guclu, Hasan/B-7080-2008	Guclu, Hasan/0000-0003-3582-9460; Donohue, Julie/0000-0003-2418-6017	National Heart, Lung, and Blood Institute [R01HL119246]; Permanente Medical Group, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119246] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Permanente Medical Group, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant from the National Heart, Lung, and Blood Institute (R01HL119246). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. One of our authors (RZ) is now employed by The Permanente Medical Group, Inc. She was employed solely by the University of Pittsburgh when the analyses for this manuscript were conducted. The Permanente Medical Group, Inc. provided support in the form of salary for author RZ when this work was submitted to PLOS ONE, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Altalib HH, 2017, EPILEPSY BEHAV, V73, P31, DOI 10.1016/j.yebeh.2017.05.026; Banerjee A, 2013, SCIENCE, V341, P363, DOI 10.1126/science.1236498; Barnett ML, 2012, MED CARE, V50, P152, DOI 10.1097/MLR.0b013e31822dcef7; Barnett ML, 2011, HEALTH SERV RES, V46, P1592, DOI 10.1111/j.1475-6773.2011.01262.x; Becker G., 2000, SOCIAL ECONOMICS; Bhatia T, 2011, INT J RES MARK, V28, P51, DOI 10.1016/j.ijresmar.2010.10.002; Blume L.E., 2011, HDB SOCIAL EC, V1B; BONACICH P, 1987, AM J SOCIOL, V92, P1170, DOI 10.1086/228631; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Casalino LP, 2015, MED CARE, V53, P534, DOI 10.1097/MLR.0000000000000365; Centola D, 2011, SCIENCE, V334, P1269, DOI 10.1126/science.1207055; Chambers D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041911; Christakis NA, 2010, CONTAGION PRESCRIBIN; COLEMAN J, 1957, SOCIOMETRY, V20, P253, DOI 10.2307/2785979; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Csardi ~ G, 2006, INTERJ COMP SYST, V1695; Davis D, 1999, JAMA-J AM MED ASSOC, V282, P867, DOI 10.1001/jama.282.9.867; Desai NR, 2012, AM J MED, V125, DOI 10.1016/j.amjmed.2011.07.033; Fattore G, 2009, HEALTH POLICY, V92, P141, DOI 10.1016/j.healthpol.2009.03.005; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Flodgren G, 2011, COCHRANE DATABASE SY, V8; Gaviria A, 2001, REV ECON STAT, V83, P257, DOI 10.1162/00346530151143798; Grimshaw JM, 2001, MED CARE, V39, pII2; Institute of Medicine, 2013, VARIATION HLTH CARE, DOI [10.17226/18393, DOI 10.17226/18393]; Iyengar R, 2011, MARKET SCI, V30, P195, DOI 10.1287/mksc.1100.0566; Kaiser Family Foundation, HLTH INS COV TOT POP; Kang CH, 2016, ARTIF INTELL, V239, P70, DOI 10.1016/j.artint.2016.06.008; Keating NL, 2007, J GEN INTERN MED, V22, P794, DOI 10.1007/s11606-007-0190-8; Keating NL, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djx009; Landon BE, 2012, JAMA-J AM MED ASSOC, V308, P265, DOI 10.1001/jama.2012.7615; Lewis JM, 2008, SOC SCI MED, V67, P280, DOI 10.1016/j.socscimed.2008.03.046; Liu QH, 2018, CHAOS INTERDISCIPLIN, V28; LOMAS J, 1991, JAMA-J AM MED ASSOC, V265, P2202, DOI 10.1001/jama.265.17.2202; Manchanda P, 2008, MARKET SCI, V27, P961, DOI 10.1287/mksc.1070.0354; MANSKI CF, 1993, REV ECON STUD, V60, P531, DOI 10.2307/2298123; Mascia D, 2011, SOC SCI MED, V72, P798, DOI 10.1016/j.socscimed.2010.12.011; McGettigan P, 2001, BRIT J CLIN PHARMACO, V51, P184; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Meltzer D, 2010, SOC SCI MED, V71, P1119, DOI 10.1016/j.socscimed.2010.05.012; Menchik DA, 2010, J HEALTH SOC BEHAV, V51, P137, DOI 10.1177/0022146510372231; Moen EL, 2016, HEALTH SERV OUTCOME, V16, P132, DOI 10.1007/s10742-016-0152-x; Moffitt R.A., 2001, SOCIAL DYNAMICS, P45; Morris ZS, 2011, J ROY SOC MED, V104, P510, DOI 10.1258/jrsm.2011.110180; Nair HS, 2010, J MARKETING RES, V47, P883, DOI 10.1509/jmkr.47.5.883; Neumann PJ, 2005, NEW ENGL J MED, V353, P1516, DOI 10.1056/NEJMsb050564; Norris S., 2010, DRUG CLASS REV DIREC; Pollack CE, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw330; Pollack CE, 2012, HEALTH SERV RES, V47, P380, DOI 10.1111/j.1475-6773.2011.01331.x; Prosser H, 2006, SOC SCI MED, V62, P1565, DOI 10.1016/j.socscimed.2005.08.035; Prosser H, 2003, FAM PRACT, V20, P61, DOI 10.1093/fampra/20.1.61; Scott J, 2005, ANN FAM MED, V3, P443, DOI 10.1370/afm.344; Smith M., 2013, BUSINESS MODELS RESP; SOUMERAI SB, 1990, JAMA-J AM MED ASSOC, V263, P549, DOI 10.1001/jama.263.4.549; Stock J., 2005, NBER TECHNICAL WORKI, P80; Valente TW, 2012, SCIENCE, V337, P49, DOI 10.1126/science.1217330; Valente TW, 1999, ANN AM ACAD POLIT SS, V566, P55, DOI 10.1177/0002716299566001005; Van den Bulte C, 2001, AM J SOCIOL, V106, P1409, DOI 10.1086/320819; Van Hoof TJ, 2015, AM HEALTH DRUG BENEF, V8, P414; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Wooldridge JM, 2010, ECONOMETRIC ANALYSIS OF CROSS SECTION AND PANEL DATA, 2ND EDITION, P1; Yeh JS, 2016, AM HEALTH DRUG BENEF, V9, P42; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317; Zheng K, 2010, J AM MED INFORM ASSN, V17, P328, DOI 10.1136/jamia.2009.000877	63	25	25	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204826	10.1371/journal.pone.0204826	http://dx.doi.org/10.1371/journal.pone.0204826			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV5EV	30273368	gold, Green Published, Green Submitted			2022-12-26	WOS:000446124700037
J	Mezghani, N; Mechmeche, I; Mitiche, A; Ouakrim, Y; de Guise, JA				Mezghani, Neila; Mechmeche, Imene; Mitiche, Amar; Ouakrim, Youssef; de Guise, Jacques A.			An analysis of 3D knee kinematic data complexity in knee osteoarthritis and asymptomatic controls	PLOS ONE			English	Article							CLASSIFIER DOMAINS; COMPETENCE; SYSTEM	Three-dimensional (3D) knee kinematic data, measuring flexion/extension, abduction/ adduction, and internal/external rotation angle variations during locomotion, provide essential information to diagnose, classify, and treat musculoskeletal knee pathologies. However, and so across genders, the curse of dimensionality, intra-class high variability, and interclass proximity make this data usually difficult to interpret, particularly in tasks such as knee pathology classification. The purpose of this study is to use data complexity analysis to get some insight into this difficulty. Using 3D knee kinematic measurements recorded from osteoarthritis and asymptomatic subjects, we evaluated both single feature complexity, where each feature is taken individually, and global feature complexity, where features are considered simultaneously. These evaluations afford a characterization of data complexity independent of the used classifier and, therefore, provide information as to the level of classification performance one can expect. Comparative results, using reference databases, reveal that knee kinematic data are highly complex, and thus foretell the difficulty of knee pathology classification.	[Mezghani, Neila; Ouakrim, Youssef] TELUQ Univ, LICEF Res Ctr, 5800 Rue St Denis, Montreal, PQ H2S 3L4, Canada; [Mechmeche, Imene; Mitiche, Amar] INRS Ctr Energie Mat & Telecommun, 800 Rue Gauchetiere West, Montreal, PQ H5A 1E4, Canada; [Mezghani, Neila; Ouakrim, Youssef; de Guise, Jacques A.] Ecole Technol Super, Ctr Rech CHUM, Lab Rech Imagerie & Orthopedie, 900 Rue St Denis, Montreal, PQ H2X 0A9, Canada	University of Quebec; Universite TELUQ; University of Quebec; Institut national de la recherche scientifique (INRS); Universite de Montreal; University of Quebec; Ecole de Technologie Superieure - Canada	Mezghani, N (corresponding author), TELUQ Univ, LICEF Res Ctr, 5800 Rue St Denis, Montreal, PQ H2S 3L4, Canada.; Mezghani, N (corresponding author), Ecole Technol Super, Ctr Rech CHUM, Lab Rech Imagerie & Orthopedie, 900 Rue St Denis, Montreal, PQ H2X 0A9, Canada.	neila.mezghani@teluq.ca			Natural Sciences and Engineering Research Council Grant [RGPIN-2015-03853]; Canada Research Chair on Biomedical Data Mining [950-231214]	Natural Sciences and Engineering Research Council Grant; Canada Research Chair on Biomedical Data Mining	This research was supported in part by the Natural Sciences and Engineering Research Council Grant (RGPIN-2015-03853) (http://www.nserc-crsng.gc.ca/professors-professeurs/rpp-pp/crd-rdc_eng.asp) and the Canada Research Chair on Biomedical Data Mining (950-231214) (http://www.chairs-chaires.gc.ca/home-accueil-eng.aspx) (NM).	Altman R, 2006, ARTHRITIS RHEUM, V29, P2512; Bensalma F, 2018, 20 BIENN M CAN SOC B; Bernado-Mansilla E, 2005, IEEE T EVOLUT COMPUT, V9, P82, DOI 10.1109/TEVC.2004.840153; Beynon MJ, 2006, IEEE T SYST MAN CY A, V36, P173, DOI 10.1109/TSMCA.2006.859098; Boivin K, 2006, GAIT POSTURE, V24, pS164, DOI [10.1016/j.gaitpost.2006.11.114, DOI 10.1016/J.GAITPOST.2006.11.114]; Bytyqi D, 2014, INT ORTHOP, V38, P1191, DOI 10.1007/s00264-014-2312-3; Chen J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10376-0; Clement J, 2018, GAIT POSTURE, V64, P198, DOI 10.1016/j.gaitpost.2018.06.024; Duda R.O., 2006, PATTERN CLASSIFICATI; FRIEDMAN JH, 1979, ANN STAT, V7, P697, DOI 10.1214/aos/1176344722; Fuentes A, 2011, ORTHOPAEDIC P, V93, P278; Gaudreault N, 2011, CLIN BIOMECH, V26, P284, DOI 10.1016/j.clinbiomech.2010.10.004; Hagemeister N, 2005, J BIOMECH, V38, P1926, DOI 10.1016/j.jbiomech.2005.05.013; Ho TK, 2006, ADV INFO KNOW PROC, P135; Ho TK, 2002, PATTERN ANAL APPL, V5, P102, DOI 10.1007/s100440200009; Ho TK, 1997, IEEE T PATTERN ANAL, V19, P1067, DOI 10.1109/34.625107; Hunter DJ, 2013, OSTEOARTHR CARTILAGE, V21, pS253, DOI 10.1016/j.joca.2013.02.524; Hunter DJ, 2009, THER ADV MUSCULOSKEL, V1, P35, DOI 10.1177/1759720X09342132; KOLMOGOROV AN, 1968, INT J COMPUT MATH, V2, P157, DOI 10.1080/00207166808803030; Lebourgeois F., 1996, Proceedings of the 13th International Conference on Pattern Recognition, P256, DOI 10.1109/ICPR.1996.547426; Li M., 2009, INTRO KOLMOGOROV COM; Lorena AC, 2015, LECT NOTES COMPUT SC, V9489, P158, DOI 10.1007/978-3-319-26532-2_18; Lustig S, 2012, KNEE SURG SPORT TR A, V20, P633, DOI 10.1007/s00167-011-1867-4; MACIEJOWSKI JM, 1979, AUTOMATICA, V15, P579, DOI 10.1016/0005-1098(79)90006-2; Mansilla EB, 2004, INT C PATT RECOG, P136, DOI 10.1109/ICPR.2004.1334026; Mechmeche I, 2016, IEEE ENG MED BIO, P884, DOI 10.1109/EMBC.2016.7590842; Medved V., 2000, MEASUREMENT HUMAN LO; Mezghani N, 2012, OSTEOARTHR CARTILAGE, V20, pS97, DOI 10.1016/j.joca.2012.02.102; Mezghani N, 2008, J MECH MED BIOL, V8, P45, DOI 10.1142/S0219519408002474; Mezghani N, 2008, IEEE T BIO-MED ENG, V55, P1230, DOI 10.1109/TBME.2007.905388; Mezghani N, 2017, J BIOMECH, V52, P106, DOI 10.1016/j.jbiomech.2016.12.022; Ouakrim Y, 2018, 20 BIENN M CAN SOC B; Sati M, 1997, Comput Aided Surg, V2, P108, DOI 10.1002/(SICI)1097-0150(1997)2:2<108::AID-IGS4>3.0.CO;2-3; Sharma L, 2001, JAMA-J AM MED ASSOC, V286, P188, DOI 10.1001/jama.286.2.188; SMITH SP, 1988, IEEE T PATTERN ANAL, V10, P757, DOI 10.1109/34.6789; Thorp LE, 2006, ARTHRITIS RHEUM, V54, P3842, DOI 10.1002/art.22247; Turcot K, 2008, ARCH PHYS MED REHAB, V89, P732, DOI 10.1016/j.apmr.2007.09.033; Wilson JLA, 2011, OSTEOARTHR CARTILAGE, V19, P186, DOI 10.1016/j.joca.2010.10.020	39	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0202348	10.1371/journal.pone.0202348	http://dx.doi.org/10.1371/journal.pone.0202348			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273346	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000446124700003
J	Garcia, LG; Pierce, GJ; Autret, E; Torres-Palenzuela, JM				Gonzalez Garcia, Laura; Pierce, Graham J.; Autret, Emmanuelle; Torres-Palenzuela, Jesus M.			Multi-scale habitat preference analyses for Azorean blue whales	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; BALAENOPTERA-MUSCULUS; MESOSCALE VARIABILITY; MARINE ANIMALS; NORTH-ATLANTIC; FIN WHALES; SEA; CETACEANS; WATERS; OCEAN	Blue whales are sighted every year around the Azores islands, which apparently provide an important seasonal foraging area. In this paper we aim to characterize habitat preferences and analyze the temporal distribution of blue whales around Sao Miguel Island. To do so, we applied Generalized Additive Models to an opportunistic cetacean occurrence dataset and remotely sensed environmental data on bathymetry, sea surface temperature, chlorophyll concentration and altimetry. We provide a brief description of the oceanography of the area, emphasizing its high spatio-temporal variability. In order to capture this dynamism, we used environmental data with two different spatial resolutions (low and high) and three different temporal resolutions (daily, weekly and monthly), thus accounting for both long-term oceanographic events such as the spring bloom, and shorter-term features such as eddies or fronts. Our results show that blue whales have a well-defined ecological niche around the Azores. They usually cross the archipelago from March to June and habitat suitability is highest in dynamic areas (with high Eddy Kinetic Energy) characterized by convergence or aggregation zones where productivity is enhanced. Multi-scale studies are useful to understand the ecological niche and habitat requirements of highly mobile species that can easily react to short-term changes in the environment.	[Gonzalez Garcia, Laura; Torres-Palenzuela, Jesus M.] Univ Vigo, Appl Phys Dept, Vigo, Spain; [Pierce, Graham J.] CSIC, Inst Invest Marinas, Vigo, Spain; [Pierce, Graham J.] Univ Aveiro, CESAM, Aveiro, Portugal; [Pierce, Graham J.] Univ Aveiro, Dept Biol, Aveiro, Portugal; [Autret, Emmanuelle] IFREMER, Lab Oceanog Phys & Spatiale, Brest, France	Universidade de Vigo; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM); Universidade de Aveiro; Universidade de Aveiro; Ifremer	Garcia, LG; Torres-Palenzuela, JM (corresponding author), Univ Vigo, Appl Phys Dept, Vigo, Spain.	lauragonzalez@uvigo.es; jesu@uvigo.es	Palenzuela, Jesus M Torres/AAB-1994-2019; Pierce, Graham/A-5404-2018	Palenzuela, Jesus M Torres/0000-0002-0629-0710; Pierce, Graham/0000-0002-4744-4501; AUTRET, Emmanuelle/0000-0002-0979-9192; Gonzalez Garcia, Laura/0000-0001-7353-0983	Applied Physics Department of the Universidad de Vigo (Spain); Conselleria de Cultura, Educacion e Ordenacion Universitaria, Xunta de Galicia [Modalidade B] [PRE/2013/409]; LabexMER	Applied Physics Department of the Universidad de Vigo (Spain); Conselleria de Cultura, Educacion e Ordenacion Universitaria, Xunta de Galicia [Modalidade B]; LabexMER	This work was supported by the Applied Physics Department of the Universidad de Vigo (Spain); a predoctoral grant from Conselleria de Cultura, Educacion e Ordenacion Universitaria, Xunta de Galicia [Modalidade B] (PRE/2013/409) for the Marine Science, Technology and Management (DOMAR) PhD Program (www.edu.xunta.gal/); and a grant from LabexMER action for young researchers in 2016 (https://www.labexmer.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, ECOLOGICAL NICHES GE; Bailey Helen, 2010, Endangered Species Research, V10, P93, DOI 10.3354/esr00239; Bailleul F, 2010, MAR ECOL PROG SER, V408, P251, DOI 10.3354/meps08560; Ballance LT, 2006, PROG OCEANOGR, V69, P360, DOI 10.1016/j.pocean.2006.03.013; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Bashmachnikov Igor, 2004, Arquipelago Boletim da Universidade dos Acores Ciencias Biologicas e Marinhas, P19; Becker E. A., 2012, Endangered Species Research, V16, P97, DOI 10.3354/esr00390; Becker EA, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8020149; Bivand R., 2013, APPL SPATIAL DATA AN, V2nd; Branch TA, 2007, MAMMAL REV, V37, P116, DOI 10.1111/j.1365-2907.2007.00106.x; Caldeira RMA, 2002, REMOTE SENS ENVIRON, V80, P336, DOI 10.1016/S0034-4257(01)00316-9; Caldeira RMA, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00037; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Canadas A, 2005, AQUAT CONSERV, V15, P495, DOI 10.1002/aqc.689; Canny J., 1987, READINGS COMPUTER VI, P184; Clarke R., 1981, International Whaling Commission Report of the Commission, V31, P607; Correia AM, 2015, J MARINE SYST, V143, P73, DOI 10.1016/j.jmarsys.2014.10.016; Cotte C, 2011, LIMNOL OCEANOGR, V56, P219, DOI 10.4319/lo.2011.56.1.0219; Dave AC, 2015, J GEOPHYS RES-OCEANS, V120, P3958, DOI 10.1002/2015JC010787; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Doniol-Valcroze Thomas, 2012, Endangered Species Research, V17, P255, DOI 10.3354/esr00427; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Esteban R, 2014, J MAR BIOL ASSOC UK, V94, P1317, DOI 10.1017/S002531541300091X; Evans PGH, 2004, MAMMAL REV, V34, P131, DOI 10.1046/j.0305-1838.2003.00027.x; Fernandez M, 2017, J BIOGEOGR, V44, P2816, DOI 10.1111/jbi.13080; Forney KA, 2015, ENDANGER SPECIES RES, V27, P1, DOI 10.3354/esr00632; Friedlaender AS, 2015, MAR MAMMAL SCI, V31, P345, DOI 10.1111/mms.12134; Godo OR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030161; Goncalves Joao M., 1996, Arquipelago Boletim da Universidade dos Acores Ciencias Biologicas e Marinhas, V14A, P57; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hasegawa D, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039743; Hastie T., 2009, UNSUPERVISED LEARNIN; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Hauser Donna D. W., 2006, Journal of Cetacean Research and Management, V8, P273; Hoyt E., 2005, DOLPHINS PORPOISES W; Hoyt E, MARINE MAMMAL PROTEC; Hupman K, 2015, NEW ZEAL J MAR FRESH, V49, P132, DOI 10.1080/00288330.2014.980278; Ingram SN, 2007, J MAR BIOL ASSOC UK, V87, P149, DOI 10.1017/S0025315407054884; Irvine LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102959; Lambert C, 2017, DEEP-SEA RES PT II, V141, P133, DOI 10.1016/j.dsr2.2016.06.011; Levy M, 2008, LECT NOTES PHYS, V744, P219, DOI 10.1007/978-3-540-75215-8_9; MacLeod CD, 2008, HYDROBIOLOGIA, V612, P21, DOI 10.1007/s10750-008-9491-0; Mannocci L, 2017, DIVERS DISTRIB, V23, P1098, DOI 10.1111/ddi.12609; Martinez A., 2017, FARO DE VIGO    1010; Marubini F, 2009, MAR ECOL PROG SER, V381, P297, DOI 10.3354/meps07893; Maxwell SM, 2015, MAR POLICY, V58, P42, DOI 10.1016/j.marpol.2015.03.014; Miller BS, 2015, ENDANGER SPECIES RES, V26, P257, DOI 10.3354/esr00642; Olsen Erik, 2009, Aquatic Mammals, V35, P313, DOI 10.1578/AM.35.3.2009.313; OLSON DB, 1985, J MAR RES, V43, P113, DOI 10.1357/002224085788437325; Olson PA, 2012, SC64SH8; Panigada S, 2008, REMOTE SENS ENVIRON, V112, P3400, DOI 10.1016/j.rse.2007.11.017; Panigada Simone, 2005, Journal of Cetacean Research and Management, V7, P137; Pascual A, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024633; Pebesma E.J., 2005, R NEWS, V5, P9; Perez FF, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2000JC000360; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Pike Daniel G., 2009, NAMMCO Scientific Publications, V7, P19; Prieto R, 2017, DEEP-SEA RES PT II, V141, P155, DOI 10.1016/j.dsr2.2016.07.015; Radosavljevic A, 2014, J BIOGEOGR, V41, P629, DOI 10.1111/jbi.12227; Ramp C, 2006, MAR ECOL PROG SER, V319, P287, DOI 10.3354/meps319287; Redfern JV, 2006, MAR ECOL PROG SER, V310, P271, DOI 10.3354/meps310271; Redfern JV, 2017, DIVERS DISTRIB, V23, P394, DOI 10.1111/ddi.12537; Reilly S. B., 2008, IUCN RED LIST THREAT, DOI [10. 2305/iucn. uk. 2008. rlts. t2477a9447146. en, DOI 10.2305/IUCN.UK.2008.RLTS.T2477A9447146.EN]; Reynolds RW, 2013, J CLIMATE, V26, P2514, DOI 10.1175/JCLI-D-12-00787.1; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rogerson P.A., 2001, STAT METHODS GEOGRAP; Sala I, 2016, J MARINE SYST, V154, P146, DOI 10.1016/j.jmarsys.2015.10.001; Santos MB, 2015, HYDROBIOLOGIA, V750, P13, DOI 10.1007/s10750-014-2164-2; Scales KL, 2017, ECOGRAPHY, V40, P210, DOI 10.1111/ecog.02272; Sears R, 2002, COSEWIC ASSESSMENT U; Sears R, 2005, 16 BIENN C BIOL MAR; Sigurjonsson J., 1990, REPORT INT WHALING C REPORT INT WHALING C, V40, P537; Sigurjonsson Johann, 1997, Journal of Northwest Atlantic Fishery Science, V22, P271; Silva Monica A., 2003, Aquatic Mammals, V29, P77, DOI 10.1578/016754203101024095; Silva MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076507; Silva MA, 2014, MAR BIOL RES, V10, P123, DOI 10.1080/17451000.2013.793814; Spyrakos E, 2011, HYDROBIOLOGIA, V670, P87, DOI 10.1007/s10750-011-0722-4; Tarling GA, 2003, LIMNOL OCEANOGR, V48, P2020, DOI 10.4319/lo.2003.48.5.2020; Tepsich P, 2014, MAR ECOL PROG SER, V508, P247, DOI 10.3354/meps10851; Torres LG, 2008, ECOL APPL, V18, P1702, DOI 10.1890/07-1455.1; Visser F, 2011, MAR ECOL PROG SER, V440, P267, DOI 10.3354/meps09349; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Zuur A.F., 2007, ANAL ECOLOGICAL DATA	84	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0201786	10.1371/journal.pone.0201786	http://dx.doi.org/10.1371/journal.pone.0201786			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265673	Green Published, Green Submitted, gold			2022-12-26	WOS:000446005500005
J	Teixeira, DL; Larrain, R; Hotzel, MJ				Lemos Teixeira, Dayane; Larrain, Rafael; Hotzel, Maria Jose			Are views towards egg farming associated with Brazilian and Chilean egg consumers' purchasing habits?	PLOS ONE			English	Article							WILLINGNESS-TO-PAY; ANIMAL-WELFARE; FOOD-ANIMALS; ATTITUDES; CITIZENS; MEAT; METAANALYSIS; INFORMATION; PERCEPTIONS; ORIGIN	In many industrialised countries, public rejection of intensive animal production systems has led to the development of legislation and industry actions that have resulted in significant changes in animal care at the farm level. However, little is known about the views of citizens from emerging countries regarding animal production. The aims of this study were to explore the views of Brazilian and Chilean consumers towards egg farming, and to investigate if these views are associated with participants' eggs purchasing habits and reported willingness to pay (WTP) more for eggs produced in the conditions they perceive as important. In an open question, participants (n = 716) were asked to describe an ideal egg production farm and explain their reasons. This was followed by closed questions asking egg purchasing habits, willingness to pay for eggs produced in the conditions they perceive as important and demographic information. Participants main concerns were with animal welfare, naturalness, hygiene, production, and ethical aspects, which many associated with improved health, sensory, and nutritional quality of the eggs. The views of participants towards an ideal egg production farm were associated, to some extent, with type of egg purchasing habits and WTP a premium for organic or free-range eggs. Our results suggest a demand for more natural, animal friendly egg production systems; furthermore, they indicate a disconnect between lay citizens' expectations and industry practices, given that intensive confined systems typically fail to supply many of the expected characteristics.	[Lemos Teixeira, Dayane; Larrain, Rafael] Pontificia Univ Catolica Chile, Fac Agron & Ingn Forestal, Dept Ciencias Anim, Santiago, Chile; [Lemos Teixeira, Dayane; Hotzel, Maria Jose] Univ Fed Santa Catarina, Dept Zootecnia & Desenvolvimento Rural, Lab Etol Aplicada, Florianopolis, SC, Brazil	Pontificia Universidad Catolica de Chile; Universidade Federal de Santa Catarina (UFSC)	Hotzel, MJ (corresponding author), Univ Fed Santa Catarina, Dept Zootecnia & Desenvolvimento Rural, Lab Etol Aplicada, Florianopolis, SC, Brazil.	maria.j.hotzel@ufsc.br	Hötzel, Maria José/H-6975-2014; Teixeira, Dayane/AAA-6807-2020; Teixeira, Dayane L/H-8640-2018	Hötzel, Maria José/0000-0003-1034-3202; Teixeira, Dayane/0000-0001-5063-7972; 	CNPq (National Council for Scientific and Technological Development, Brazil) [300131/2015-1]; Facultad de Agronomia e Ingenieria Forestal of the Pontificia Universidad Catolica de Chile; CNPq	CNPq (National Council for Scientific and Technological Development, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Facultad de Agronomia e Ingenieria Forestal of the Pontificia Universidad Catolica de Chile; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	DLT was awarded a Young Talent Fellowship (grant number 300131/2015-1) from CNPq (National Council for Scientific and Technological Development, Brazil) and a Postdoctoral Fellowship in Sustainable Agriculture from Facultad de Agronomia e Ingenieria Forestal of the Pontificia Universidad Catolica de Chile. MJH received support fromCNPq.	ABPA, 2016, PROD OV BRAS CREASC; Aerts S., 2013, ETHICS CONSUMPTION C, P172; Anderson EC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160424; [Anonymous], 2005, SPECIAL EUROBAROMETE; Appleby M. C., 2003, STATE ANIM, V2003, P159; Avicultura, 2016, CONS HUEV CHIL SUP 2; Avicultura Insdustrial, 2016, OP REST MCDONALD AM; Behrens JH, 2010, FOOD CONTROL, V21, P963, DOI 10.1016/j.foodcont.2009.07.018; Bejaei M, 2011, POULTRY SCI, V90, P1088, DOI 10.3382/ps.2010-01129; Benard M, 2013, J AGR ENVIRON ETHIC, V26, P1015, DOI 10.1007/s10806-013-9438-y; Bennett R, 1996, J AGR ECON, V47, P224, DOI 10.1111/j.1477-9552.1996.tb00686.x; Bokma-Bakker M.H., 2014, 714 LIV RES LEL, P1; Breidert C., 2006, INNOV MARK, V2, P8; Cardoso CS, 2017, ANIMALS-BASEL, V7, DOI 10.3390/ani7120089; Cardoso CS, 2016, J DAIRY SCI, V99, P1663, DOI 10.3168/jds.2015-9925; Centner TJ, 2010, J AGR ENVIRON ETHIC, V23, P469, DOI 10.1007/s10806-009-9225-y; Clark B, 2017, FOOD POLICY, V68, P112, DOI 10.1016/j.foodpol.2017.01.006; Clark B, 2016, J AGR ENVIRON ETHIC, V29, P455, DOI 10.1007/s10806-016-9615-x; Clarke N, 2017, VET REC, V180, DOI 10.1136/vr.104165; de Barcellos MD, 2011, INT J CONSUM STUD, V35, P391, DOI 10.1111/j.1470-6431.2010.00978.x; Duffy B, 2005, INT J MARKET RES, V47, P615, DOI 10.1177/147078530504700602; Elkhoraibi C, 2014, POULTRY SCI, V93, P2920, DOI 10.3382/ps.2014-04154; EMOL, 2016, HUEV GALL LIBR VAL P; Farnsworth V, 2016, BRIT J EDUC STUD, V64, P139, DOI 10.1080/00071005.2015.1133799; Fearne A., 1996, British Food Journal, V98, P7, DOI 10.1108/00070709610111269; Fraser D, 2006, ANIM WELFARE, V15, P93; Fraser D, 1997, ANIM WELFARE, V6, P187; Garnett T, 2013, SCIENCE, V341, P33, DOI 10.1126/science.1234485; Gaymard S, 2015, SOC INDIC RES, V120, P801, DOI 10.1007/s11205-014-0610-1; Goddard E., 2007, CONSUMER ATTITUDES W, P92; Grunert KG, 2018, MEAT SCI, V137, P123, DOI 10.1016/j.meatsci.2017.11.022; Guivant JS, 2015, PATHWAY SUSTAIN, P74; Harper G. C., 2002, British Food Journal, V104, P287, DOI 10.1108/00070700210425723; Heng Y, 2013, J AGR RESOUR ECON, V38, P418; Hotzel MJ, 2017, J DAIRY SCI, V100, P4150, DOI 10.3168/jds.2016-11933; Hotzel MJ, 2014, DILEMMAS IN ANIMAL WELFARE, P67, DOI 10.1079/9781780642161.0067; HSI, 2015, FAC SUA PART DIG NAO; Huberman AM, 1994, HDB QUALITATIVE RES, P643; Lagerkvist CJ, 2011, EUR REV AGRIC ECON, V38, P55, DOI 10.1093/erae/jbq043; Lassen J, 2006, LIVEST SCI, V103, P221, DOI 10.1016/j.livsci.2006.05.008; Lemos Teixeira Dayane, 2018, PLoS One, V13, pe0190671, DOI 10.1371/journal.pone.0190671; Lusk JL, 2010, SOC INDIC RES, V96, P551, DOI 10.1007/s11205-009-9492-z; Maria GA, 2006, LIVEST SCI, V103, P250, DOI 10.1016/j.livsci.2006.05.011; Miranda-de la Lama GC, 2017, MEAT SCI, V125, P106, DOI 10.1016/j.meatsci.2016.12.001; ODEPA, 2016, HUEV OF EST POL AGR; Pettersson IC, 2016, BRIT FOOD J, V118, P1979, DOI 10.1108/BFJ-02-2016-0065; Rollin Bernard E, 1995, FARM ANIMAL WELFARE; Sato P, 2017, ANIMALS, V7, DOI 10.3390/ani7080064; Savory CJ, 2004, ANIM WELFARE, V13, pS153; Schnettler B, 2009, FOOD QUAL PREFER, V20, P156, DOI 10.1016/j.foodqual.2008.07.006; Schnettler B, 2015, FOOD SCI TECH-BRAZIL, V35, P570, DOI 10.1590/1678-457X.6699; Steinfeld H, 2010, P NATL ACAD SCI USA, V107, P18237, DOI 10.1073/pnas.1012541107; Thorslund CAH, 2016, LIVEST SCI, V193, P58, DOI 10.1016/j.livsci.2016.09.007; Van Boeckel TP, 2017, SCIENCE, V357, P1350, DOI 10.1126/science.aao1495; von Keyserlingk MAG, 2013, J DAIRY SCI, V96, P5405, DOI 10.3168/jds.2012-6354; von Keyserlingk MAG, 2015, J AGR ENVIRON ETHIC, V28, P179, DOI 10.1007/s10806-014-9518-7; WATT Global Media, 2015, GLOB EGG CONS RIS WO; Yunes MC, 2017, ANIMALS-BASEL, V7, DOI 10.3390/ani7100075; Yunes MC, ANIMAL WELFARE	59	12	12	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0203867	10.1371/journal.pone.0203867	http://dx.doi.org/10.1371/journal.pone.0203867			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV3OT	30265672	gold, Green Published, Green Submitted			2022-12-26	WOS:000446005500012
J	Reverdy, A; Chen, Y; Hunter, E; Gozzi, K; Chai, YR				Reverdy, Alicyn; Chen, Yun; Hunter, Evan; Gozzi, Kevin; Chai, Yunrong			Protein lysine acetylation plays a regulatory role in Bacillus subtilis multicellularity	PLOS ONE			English	Article							A SYNTHETASE ACSA; BIOFILM FORMATION; STAPHYLOCOCCUS-AUREUS; GENE-EXPRESSION; HISTIDINE KINASE; SPORE FORMATION; COMPLEX; COENZYME; DEGU; INVOLVEMENT	Protein lysine acetylation is a post-translational modification that alters the charge, conformation, and stability of proteins. A number of genome-wide characterizations of lysine-acetylated proteins, or acetylomes, in bacteria have demonstrated that lysine acetylation occurs on proteins with a wide diversity of functions, including central metabolism, transcription, chemotaxis, and cell size regulation. Bacillus subtilis is a model organism for studies of sporulation, motility, cell signaling, and multicellular development (or biofilm formation). In this work, we investigated the role of global protein lysine acetylation in multicellular development in B. subtilis. We analyzed the B. subtilis acetylome under biofilm-inducing conditions and identified acetylated proteins involved in multicellularity, specifically, swarming and biofilm formation. We constructed various single and double mutants of genes known to encode enzymes involved in global protein lysine acetylation in B. subtilis. Some of those mutants showed a defect in swarming motility while others demonstrated altered biofilm phenotypes. Lastly, we picked two acetylated proteins known to be important for biofilm formation, YmcA (also known as RicA), a regulatory protein critical for biofilm induction, and GtaB, an UTP-glucose-1-phosphate uridylyltransferase that synthesizes a nucleotide sugar precursor for biosynthesis of exopolysaccharide, a key biofilm matrix component. We performed site-directed mutagenesis on the acetylated lysine codons in ymcA and gtaB, respectively, and assayed cells bearing those point mutants for biofilm formation. The mutant alleles of ymcA(K64R), gtaB(K89R), and gtaB(K191R) all demonstrated a severe biofilm defect. These results indicate the importance of acetylated lysine residues in both YmcA and GtaB. In summary, we propose that protein lysine acetylation plays a global regulatory role in B. subtilis multicellularity.	[Reverdy, Alicyn; Hunter, Evan; Gozzi, Kevin; Chai, Yunrong] Northeastern Univ, Dept Biol, Boston, MA 02115 USA; [Chen, Yun] Zhejiang Univ, Inst Biotechnol, Hangzhou, Zhejiang, Peoples R China; [Gozzi, Kevin] MIT, Dept Microbiol, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Northeastern University; Zhejiang University; Massachusetts Institute of Technology (MIT)	Chai, YR (corresponding author), Northeastern Univ, Dept Biol, Boston, MA 02115 USA.	y.chai@northeastern.edu	Chen, Yun/J-6959-2014	Chen, Yun/0000-0002-5663-2352; Gozzi, Kevin/0000-0002-1168-1425	National Science Foundation [MCB1651732]; National Natural Science Foundation of China [31301707]; Northeastern University	National Science Foundation(National Science Foundation (NSF)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Northeastern University	This work was supported in part by a grant from National Science Foundation (MCB1651732, https://www.nsf.gov) to Y. Chai. Y. Chen was supported by a grant from the National Natural Science Foundation of China (31301707, http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Yiyang Yu (Northeastern University) for construction of some of the strains used in this study. We also thank members of the Chai laboratory, especially Jennifer Greenwich, for helpful suggestions during the preparation of the manuscript. This work was supported in part by a grant from National Science Foundation (MCB1651732) to Y. Chai. Y. Chen was supported by a grant from the National Natural Science Foundation of China (31301707). KG was supported by a Provost Research Fund from Northeastern University.	Aguilar C, 2007, CURR OPIN MICROBIOL, V10, P638, DOI 10.1016/j.mib.2007.09.006; Archer NK, 2011, VIRULENCE, V2, P445, DOI 10.4161/viru.2.5.17724; Beauregard PB, 2013, P NATL ACAD SCI USA, V110, pE1621, DOI 10.1073/pnas.1218984110; Bernal V, 2014, NEW BIOTECHNOL, V31, P586, DOI 10.1016/j.nbt.2014.03.002; Branda SS, 2006, MOL MICROBIOL, V59, P1229, DOI 10.1111/j.1365-2958.2005.05020.x; Branda SS, 2004, J BACTERIOL, V186, P3970, DOI 10.1128/JB.186.12.3970-3979.2004; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; Caina JA, 2014, J PROTEOMICS, V97, P265, DOI 10.1016/j.jprot.2013.08.012; Cairns LS, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0410-z; Carabetta VJ, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00107-17; Carabetta VJ, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00005-16; Chai YR, 2012, MBIO, V3, DOI 10.1128/mBio.00184-12; Chan JM, 2014, J BACTERIOL, V196, P740, DOI 10.1128/JB.01217-13; Chen Y, 2015, MICROB CELL, V2, P406, DOI 10.15698/mic2015.10.233; Chen Y, 2015, MBIO, V6, DOI 10.1128/mBio.00392-15; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; DAHL MK, 1992, J BIOL CHEM, V267, P14509; DeLoughery A, 2016, MOL MICROBIOL, V99, P425, DOI 10.1111/mmi.13240; Diehl A, 2018, P NATL ACAD SCI USA, V115, P3237, DOI 10.1073/pnas.1718102115; Dimmer EC, 2012, NUCLEIC ACIDS RES, V40, pD565, DOI 10.1093/nar/gkr1048; Dubnau EJ, 2016, MOL MICROBIOL, V101, P606, DOI 10.1111/mmi.13411; ERRINGTON J, 1993, MICROBIOL REV, V57, P1; Erskine E, 2017, BIORXIV, DOI [10.1101/188995, DOI 10.1101/188995]; Gardner JG, 2008, J BACTERIOL, V190, P5132, DOI 10.1128/JB.00340-08; Gardner JG, 2006, J BACTERIOL, V188, P5460, DOI 10.1128/JB.00215-06; Gardner JG, 2009, J BACTERIOL, V191, P1749, DOI 10.1128/JB.01674-08; Gozzi K, 2017, NPJ BIOFILMS MICROBI, V3, DOI 10.1038/s41522-017-0016-3; GRUNDY FJ, 1993, J BACTERIOL, V175, P7348, DOI 10.1128/JB.175.22.7348-7355.1993; GRYCZAN TJ, 1978, J BACTERIOL, V134, P318, DOI 10.1128/JB.134.1.318-329.1978; Guan KL, 2011, TRENDS BIOCHEM SCI, V36, P108, DOI 10.1016/j.tibs.2010.09.003; Harshey RM, 2015, J MOL BIOL, V427, P3683, DOI 10.1016/j.jmb.2015.07.025; Hilbert DW, 2004, MICROBIOL MOL BIOL R, V68, P234, DOI 10.1128/MMBR.68.2.234-262.2004; Hobley L, 2013, P NATL ACAD SCI USA, V110, P13600, DOI 10.1073/pnas.1306390110; Hu LI, 2010, MOL MICROBIOL, V77, P15, DOI 10.1111/j.1365-2958.2010.07204.x; Kim D, 2013, PROTEOMICS, V13, P1726, DOI 10.1002/pmic.201200001; Kochanowski K, 2015, CURR OPIN MICROBIOL, V27, P10, DOI 10.1016/j.mib.2015.05.007; Kolodkin-Gal I, 2013, GENE DEV, V27, P887, DOI 10.1101/gad.215244.113; Kosono S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131169; Kuhn ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094816; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Liu L, 2016, SCI REP-UK, V6, DOI 10.1038/srep20108; Lopez D, 2009, P NATL ACAD SCI USA, V106, P280, DOI 10.1073/pnas.0810940106; Mader U, 2002, MOL GENET GENOMICS, V268, P455, DOI 10.1007/s00438-002-0774-2; Mordini S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085065; Mukherjee S, 2014, ANNU REV GENET, V48, P319, DOI 10.1146/annurev-genet-120213-092406; Ouidir T, 2015, PROTEOMICS, V15, P2152, DOI 10.1002/pmic.201500056; Post DMB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179621; Rajkovic A, 2016, J BIOL CHEM, V291, P10976, DOI 10.1074/jbc.M115.712091; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; Rybtke M, 2015, J MOL BIOL, V427, P3628, DOI 10.1016/j.jmb.2015.08.016; Schroeder JW, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.01085-13; Shemesh M, 2013, J BACTERIOL, V195, P2747, DOI 10.1128/JB.00028-13; Stanley NR, 2003, J BACTERIOL, V185, P1951, DOI 10.1128/JB.185.6.1951-1957.2003; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Tan IS, 2014, ENV MICROBIOL REP, V6, P212, DOI 10.1111/1758-2229.12130; Tanner AW, 2017, MOL MICROBIOL, V104, P837, DOI 10.1111/mmi.13667; Thoden JB, 2007, PROTEIN SCI, V16, P432, DOI 10.1110/ps.062626007; Tortosa P, 2000, MOL MICROBIOL, V35, P1110, DOI 10.1046/j.1365-2958.2000.01779.x; VARON D, 1993, J BACTERIOL, V175, P3964; Vlamakis H, 2013, NAT REV MICROBIOL, V11, P157, DOI 10.1038/nrmicro2960; Weinert BT, 2013, MOL CELL, V51, P265, DOI 10.1016/j.molcel.2013.06.003; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; YASBIN RE, 1974, J VIROL, V14, P1343, DOI 10.1128/JVI.14.6.1343-1348.1974; Zhang Y, 2014, SCI CHINA CHEM, V57, P732, DOI 10.1007/s11426-014-5100-4	64	21	22	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204687	10.1371/journal.pone.0204687	http://dx.doi.org/10.1371/journal.pone.0204687			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265683	Green Published, Green Submitted, gold			2022-12-26	WOS:000446005500044
J	Springer, YP; Johnson, PTJ				Springer, Yuri P.; Johnson, Pieter T. J.			Large-scale health disparities associated with Lyme disease and human monocytic ehrlichiosis in the United States, 2007-2013	PLOS ONE			English	Article							WEST-NILE-VIRUS; TICK-BORNE ENCEPHALITIS; SOCIOECONOMIC-FACTORS; AVAILABILITY; INFESTATION; WASHINGTON; MANAGEMENT; BALTIMORE; COUNTIES	Promoting health equity is a fundamental public health objective, yet health disparities remain largely overlooked in studies of vectorborne diseases, especially those transmitted by ticks. We sought to identify health disparities associated with Lyme disease and human monocytic ehrlichiosis, two of the most pervasive tickborne diseases within the United States. We used general linear mixed models to measure associations between county-level disease incidence and six variables representing racial/ethnic and socioeconomic characteristics of counties (percent white non-Hispanic; percent with a bachelors degree or higher; percent living below the poverty line; percent unemployed; percent of housing units vacant; per capita number of property crimes). Two ecological variables important to tick demography (percent forest cover; density of white-tailed deer) were included in secondary analyses to contextualize findings. Analyses included data from 2,695 counties in 37 states and the District of Columbia during 2007-2013. Each of the six variables was significantly associated with the incidence of one or both diseases, but the direction and magnitude of associations varied by disease. Results suggested that the incidence of Lyme disease was highest in counties with relatively higher proportions of white and more educated persons and lower poverty and crime rates; the incidence of human monocytic ehrlichiosis was highest in counties with relatively higher proportions of white and less educated persons, higher unemployment rates and lower crime rates. The percentage of housing units vacant was a strong positive predictor for both diseases with a magnitude of association comparable to those between incidence and the ecological variables. Our findings indicate that racial/ethnic and socioeconomic disparities in disease incidence appear to be epidemiologically important features of Lyme disease and human monocytic ehrlichiosis in the United States. Steps to mitigate encroachment of wild flora and fauna into areas with vacant housing might be warranted to reduce disease risk.	[Springer, Yuri P.] US Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA 30333 USA; [Johnson, Pieter T. J.] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Springer, Yuri P.] Venice Bike Fix, Venice, CA 90291 USA	Centers for Disease Control & Prevention - USA; University of Colorado System; University of Colorado Boulder	Springer, YP (corresponding author), US Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA 30333 USA.; Springer, YP (corresponding author), Venice Bike Fix, Venice, CA 90291 USA.	yurispringer@gmail.com		JOHNSON, PIETER/0000-0002-7997-5390; Springer, Yuri/0000-0001-9254-7203	U.S. Centers for Disease Control and Prevention as part of Epidemic Intelligence Service (EIS) fellowship program; David and Lucile Packard Foundation; National Science Foundation [DEB 1149308]; U.S. Centers for Disease Control and Prevention	U.S. Centers for Disease Control and Prevention as part of Epidemic Intelligence Service (EIS) fellowship program; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); National Science Foundation(National Science Foundation (NSF)); U.S. Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was funded by U.S. Centers for Disease Control and Prevention as part of financial support of the Epidemic Intelligence Service (EIS) fellowship program. There was no specific grant number associated with this work. PTJJ was supported by a fellowship from the David and Lucile Packard Foundation and funds from the National Science Foundation (DEB 1149308). The funders had no role in study design, data collection and analysis, or decision to publish. The funders reviewed the manuscript as part of preparation to publish, and the manuscript was cleared by the institutional review process.; This work was funded by U.S. Centers for Disease Control and Prevention. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of U.S. Centers for Disease Control and Prevention.	Adams K, 2010, QDMAS WHITETAIL REPO, P1; Adler NE, 2008, ANNU REV PUBL HEALTH, V29, P235, DOI 10.1146/annurev.publhealth.29.020907.090852; Askling HH, 2015, VACCINE, V33, P4962, DOI 10.1016/j.vaccine.2015.07.030; Bartlett-Healy K, 2011, INT J ENV RES PUB HE, V8, P1358, DOI 10.3390/ijerph8051358; Bates D, 2014, ARXIV14065823; Bayles BR, 2014, EPIDEMIOL INFECT, V142, P1911, DOI 10.1017/S0950268813002951; Becker B, 2014, INT J ENV RES PUB HE, V11, P3256, DOI 10.3390/ijerph110303256; CHAMBERS DM, 1986, J AM MOSQUITO CONTR, V2, P539; Dowling Z, 2013, J MED ENTOMOL, V50, P764, DOI 10.1603/ME12250; Dowling Z, 2013, ECOHEALTH, V10, P36, DOI 10.1007/s10393-013-0818-6; Eisen RJ, 2016, J MED ENTOMOL, V53, P349, DOI 10.1093/jme/tjv237; Elston DA, 2001, PARASITOLOGY, V122, P563, DOI 10.1017/S0031182001007740; Fiore Anthony E., 2011, Morbidity and Mortality Weekly Report, V60, P1; Godfrey ER, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-35; Gulachenski A, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8050491; Harrigan RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015437; Harrison XA, 2014, PEERJ, V2, DOI 10.7717/peerj.616; Heitman KN, 2016, AM J TROP MED HYG, V94, P52, DOI 10.4269/ajtmh.15-0540; Homer C, 2015, PHOTOGRAMM ENG REM S, V81, P345, DOI 10.14358/PERS.81.5.345; LaDeau SL, 2013, INT J ENV RES PUB HE, V10, P1505, DOI 10.3390/ijerph10041505; Liu H, 2011, SCI TOTAL ENVIRON, V409, P4235, DOI 10.1016/j.scitotenv.2011.07.012; Liu Y, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2068-x; Lockaby G, 2016, J VECTOR ECOL, V41, P232, DOI 10.1111/jvec.12218; Marder E, 2013, MMWR-MORBID MORTAL W, V62, P1; Murphree R, 2009, THESIS, P1; Nelson CA, 2015, EMERG INFECT DIS, V21, P1625, DOI 10.3201/eid2109.150417; Ozdenerol E, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-12; R Core Team, 2012, R LANG ENV STAT COMP; Raghavan RK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150180; Raghavan RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100850; Randolph SE, 2010, EUROSURVEILLANCE, V15, P24; Reisen WK, 2008, EMERG INFECT DIS, V14, P1747, DOI 10.3201/eid1411.080719; Reisen WK, 2010, ANNU REV ENTOMOL, V55, P461, DOI 10.1146/annurev-ento-112408-085419; REISEN WK, 1990, J MED ENTOMOL, V27, P356, DOI 10.1093/jmedent/27.3.356; Rios J, 2006, J AM MOSQUITO CONTR, V22, P254, DOI 10.2987/8756-971X(2006)22[254:DASAOW]2.0.CO;2; Rochlin I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023280; Ruiz MO, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-10; Springer YP, 2014, J MED ENTOMOL, V51, P342, DOI 10.1603/ME13115; Stefanoff P, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15040677; Stefanoff P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045511; Sumilo D, 2008, VACCINE, V26, P2580, DOI 10.1016/j.vaccine.2008.03.029; Sumilo D, 2008, REV MED VIROL, V18, P81, DOI 10.1002/rmv.566; Tedesco C, 2010, HEALTH PLACE, V16, P1188, DOI 10.1016/j.healthplace.2010.08.003; U.S. Department of Health and Human Services, 2000, HLTH PEOPL 2010 UND; U. S. Office of Management and Budget, 1974, A105 US OFF MAN BUDG, P1; Unlu I, 2011, PEST MANAG SCI, V67, P965, DOI 10.1002/ps.2140; Watson SC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174428	47	14	16	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204609	10.1371/journal.pone.0204609	http://dx.doi.org/10.1371/journal.pone.0204609			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30261027	Green Published, gold			2022-12-26	WOS:000445907400075
J	Stefani, GP; Marmett, B; Alves, JP; Moller, GB; Heck, TG; Frizzo, MN; Di Domenico, M; Motta, GA; Dal Lago, P; Nunes, RB; Rhoden, CR				Stefani, Giuseppe Potrick; Marmett, Bruna; Alves, Jadson Pereira; Moller, Gabriella Berwig; Heck, Thiago Gomes; Frizzo, Matias Nunes; Di Domenico, Marlise; Motta, Gabriela Almeida; Dal Lago, Pedro; Nunes, Ramiro Barcos; Rhoden, Claudia Ramos			Resistance training and L-arginine supplementation are determinant in genomic stability, cardiac contractility and muscle mass development in rats	PLOS ONE			English	Article								L-arginine supplementation has been related to increased maximum strength and improvement of hemodynamic parameters in several diseases. The aim of our study was to evaluate the effect of L-arginine supplementation and resistance training on muscle mass, hemodynamic function and DNA damage in healthy rats subjected to a low-arginine concentration diet. Twenty three Wistar rats (290-320g) were divided into 4 groups: Sedentary (SED-Arg, n = 6), Sedentary+Arg (SED+Arg, n = 6), Resistance Training (RT-Arg, n = 5), Resistance Training+Arg (RT+Arg, n = 6). Trained animals performed resistance training protocol in a squat apparatus adapted for rats (4 sets of 10-12 repetitions, 90s of interval, 4x/week, 65-75% of One Maximum Repetition, for 8 weeks). Comet assay was performed to measure DNA damage in leukocytes. The resistance training induced higher muscle mass in trained groups. The L-arginine supplementation increased both gastrocnemius and left ventricle to body mass ratio and increased left ventricle contractility without changing hemodynamic variables. The SED+Arg group showed higher concentration of extracellular heat shock protein 72 (eHSP72) and total testosterone, as well as lower uric acid concentration in blood versus SED-Arg group. The administration of isolated L-arginine supplementation and its association with resistance training promoted less damage in leukocytes DNA. In conclusion, the L-arginine supplementation showed synergistic effect with resistance training regarding leukocyte genomic stability in a low-L-arginine diet scenario.	[Stefani, Giuseppe Potrick; Marmett, Bruna; Alves, Jadson Pereira; Moller, Gabriella Berwig; Dal Lago, Pedro; Nunes, Ramiro Barcos] Fed Univ Hlth Sci Porto Alegre UFCSPA, Lab Expt Physiol, Porto Alegre, RS, Brazil; [Stefani, Giuseppe Potrick; Moller, Gabriella Berwig; Dal Lago, Pedro; Nunes, Ramiro Barcos] Fed Univ Hlth Sci Porto Alegre UFCSPA, Grad Program Rehabil Sci, Porto Alegre, RS, Brazil; [Marmett, Bruna; Di Domenico, Marlise; Motta, Gabriela Almeida; Rhoden, Claudia Ramos] Fed Univ Hlth Sci Porto Alegre UFCSPA, Lab Air Pollut, Porto Alegre, RS, Brazil; [Heck, Thiago Gomes; Frizzo, Matias Nunes] Northwestern Reg Univ State Rio Grande Do Sul UNI, Res Grp Physiol, Post Grad Program Comprehens Hlth Care, Ijui, RS, Brazil	Universidade Federal de Ciencias da Saude de Porto Alegre; Universidade Federal de Ciencias da Saude de Porto Alegre; Universidade Federal de Ciencias da Saude de Porto Alegre	Stefani, GP (corresponding author), Fed Univ Hlth Sci Porto Alegre UFCSPA, Lab Expt Physiol, Porto Alegre, RS, Brazil.; Stefani, GP (corresponding author), Fed Univ Hlth Sci Porto Alegre UFCSPA, Grad Program Rehabil Sci, Porto Alegre, RS, Brazil.	gpotrick@gmail.com	Marmett, Bruna/ABD-6243-2020; Dal Lago, Pedro/AAM-9136-2020; Heck, Thiago Gomes/D-2251-2011; Dal Lago, Pedro/K-4414-2013; Möller, Gabriella Berwig/AAQ-6448-2020; Stefani, Giuseppe Potrick/D-4561-2014	Marmett, Bruna/0000-0002-2982-0323; Dal Lago, Pedro/0000-0001-9907-7689; Heck, Thiago Gomes/0000-0002-1242-5423; Dal Lago, Pedro/0000-0001-9907-7689; Möller, Gabriella Berwig/0000-0001-5354-0551; Stefani, Giuseppe Potrick/0000-0001-5492-4530; frizzo, matias/0000-0001-5578-4656	CAPES, Brasilia, Brazil; CNPq, Brasilia, Brazil; PROAP/UFCSPA, Porto Alegre, Brazil	CAPES, Brasilia, Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq, Brasilia, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PROAP/UFCSPA, Porto Alegre, Brazil	This work was supported by grants from the following: CAPES and CNPq, Brasilia, Brazil, and PROAP/UFCSPA, Porto Alegre, Brazil (http://www.capes.gov.br/; http://www.ufcspa.edu.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asea Alexzander, 2006, Current Immunology Reviews, V2, P209, DOI 10.2174/157339506778018514; Azqueta A, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00288; Barcelos GT, 2017, METABOLISM, V76, P1, DOI 10.1016/j.metabol.2017.06.009; Boger RH, 2014, ALTERNATIVE THERAPIE; Brevik A, 2011, CELL BIOCHEM FUNCT, V29, P36, DOI 10.1002/cbf.1715; Brown MB, 2017, PULM CIRC, V8, DOI 10.1177/2045893217743966; Calderwood SK, 2007, FEBS LETT, V581, P3689, DOI 10.1016/j.febslet.2007.04.044; Cash SW, 2014, J PHYS ACT HEALTH, V11, P770, DOI 10.1123/jpah.2012-0278; CASTILLO L, 1994, METABOLISM, V43, P114, DOI 10.1016/0026-0495(94)90166-X; Chen QS, 2018, BRIT J PHARMACOL, V175, P1279, DOI 10.1111/bph.13828; Cook MD, 2013, J HUM HYPERTENS, V27, P388, DOI 10.1038/jhh.2012.48; Cruzat VF, 2014, J INT SOC SPORT NUTR, V11, DOI 10.1186/s12970-014-0061-8; do Nascimento MA, 2017, CLIN NUTR ESPEN, V22, P43, DOI 10.1016/j.clnesp.2017.09.001; Glennon-Alty L, 2018, FREE RADICAL BIO MED, V125, P25, DOI 10.1016/j.freeradbiomed.2018.03.049; Heck TG, 2017, CELL STRESS CHAPERON, V22, P271, DOI 10.1007/s12192-017-0771-3; Heck TG, 2011, CELL BIOCHEM FUNCT, V29, P215, DOI 10.1002/cbf.1739; Hensen SMM, 2012, CELL STRESS CHAPERON, V17, P743, DOI 10.1007/s12192-012-0347-1; Huang CC, 2008, EXP GERONTOL, V43, P571, DOI 10.1016/j.exger.2008.03.002; Huang CC, 2009, CHINESE J PHYSIOL, V52, P306, DOI 10.4077/CJP.2009.AMH068; Kim SW, 2004, J NUTR, V134, P625, DOI 10.1093/jn/134.3.625; Konca K, 2003, MUTAT RES-GEN TOX EN, DOI [10.1016/81383-5718(02)00251-6, DOI 10.1016/81383-5718(02)00251-6]; Krause M, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/249205; Lakshmikuttyamma A, 2006, INT J MOL MED; Le Moal E, 2017, ANTIOXID REDOX SIGN, V27, P276, DOI 10.1089/ars.2016.6782; Marsh JD, 1998, CIRCULATION, V98, P256, DOI 10.1161/01.CIR.98.3.256; Melo SFS, 2018, INT J MED SCI, V15, P403, DOI 10.7150/ijms.23150; Miki A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196570; Moura CS, 2017, FOOD FUNCT, V8, P3228, DOI [10.1039/c7fo00465f, 10.1039/C7FO00465F]; Nakad R, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00147; Ozsoy M, 2011, HPB SURG, DOI [10.1155/2011/306069, DOI 10.1155/2011/306069]; Petry ER, 2015, INT J SPORT NUTR EXE, DOI [10.1123/ijsnern.2014-013125202991, DOI 10.1123/IJSNERN.2014-013125202991]; Petry ER, 2014, LIFE SCI, DOI [10.101641fs.2013.11.009, DOI 10.1016/J.LFFS.2013.11.009]; Scholer CM, 2016, MOL CELL BIOCHEM, V421, P111, DOI 10.1007/s11010-016-2791-1; SETH P, 1994, BLOOD, V84, P2741; Shan LL, 2013, J APPL PHYSIOL, V115, P1146, DOI 10.1152/japplphysiol.00225.2013; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Soci UPR, 2011, PHYSIOL GENOMICS, V43, P665, DOI 10.1152/physiolgenomics.00145.2010; Stefani GP, 2014, J INT SOC SPORT NUTR, V11, DOI 10.1186/1550-2783-11-11; Steinbacher P, 2015, BIOMOLECULES, V5, P356, DOI 10.3390/biom5020356; Suzuki J, 2006, J PHYSL SCI; TAMAKI T, 1992, MED SCI SPORT EXER, V24, P881; Tan B, 2009, AMINO ACIDS, DOI [10.1007/s00726-008-5148-0, DOI 10.1007/S00726-008-5148-0]; Tan B, 2010, AMINO ACIDS, V38, P1227, DOI 10.1007/s00726-009-0334-8; Wang YF, 2001, IMMUNITY, V15, P971, DOI 10.1016/S1074-7613(01)00242-4; Wax B, 2012, J INT SOC SPORT NUTR, V9, DOI 10.1186/1550-2783-9-17; Wu GY, 2013, AMINO ACIDS, V44, P1107, DOI 10.1007/s00726-012-1444-2; Yao K, 2008, J NUTR, V138, P867, DOI 10.1093/jn/138.5.867	47	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204858	10.1371/journal.pone.0204858	http://dx.doi.org/10.1371/journal.pone.0204858			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30261076	Green Submitted, gold, Green Published			2022-12-26	WOS:000445907400109
J	Chen, Q; Hartman, CA; Haavik, J; Harro, J; Klungsoyr, K; Hegvik, TA; Wanders, R; Ottosen, C; Dalsgaard, S; Faraone, SV; Larsson, H				Chen, Qi; Hartman, Catharina A.; Haavik, Jan; Harro, Jaanus; Klungsoyr, Kari; Hegvik, Tor-Arne; Wanders, Rob; Ottosen, Caecilie; Dalsgaard, Soren; Faraone, Stephen, V; Larsson, Henrik			Common psychiatric and metabolic comorbidity of adult attention-deficit/hyperactivity disorder: A population-based cross-sectional study	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; DSM-IV; ADHD; PREVALENCE; ASSOCIATION; SYMPTOMS; SMOKING; OBESITY; METAANALYSIS; ANXIETY	Attention-deficit/hyperactivity disorder (ADHD) is often comorbid with other psychiatric conditions in adults. Yet, less is known about its relationship with common metabolic disorders and how sex and ageing affect the overall comorbidity patterns of adult ADHD. We aimed to examine associations of adult ADHD with several common psychiatric and metabolic conditions. Through the linkage of multiple Swedish national registers, 5,551,807 adults aged 18 to 64 years and living in Sweden on December 31, 2013 were identified and assessed for clinical diagnoses of adult ADHD, substance use disorder (SUD), depression, bipolar disorder, anxiety, type 2 diabetes mellitus (T2DM), and hypertension. Logistic regression models and regression standardization method were employed to obtain estimates of prevalence, prevalence difference (PD), and prevalence ratio (PR). All comorbid conditions of interest were more prevalent in adults with ADHD (3.90% to 44.65%) than in those without (0.72% to 4.89%), with the estimated PRs being over nine for psychiatric conditions (p < 0.001) and around two for metabolic conditions (p < 0.001). Sex differences in the prevalence of comorbidities were observed among adults with ADHD. Effect modification by sex was detected on the additive scale and/or multiplicative scale for the associations of adult ADHD with all comorbidities. ADHD remained associated with all comorbidities in older adults aged 50 to 64 when all conditions were assessed from age 50 onwards. The comorbidity patterns of adult ADHD underscore the severity and clinical complexity of the disorder. Clinicians should remain vigilant for a wide range of psychiatric and metabolic problems in ADHD affected adults of all ages and both sexes.	[Chen, Qi; Hegvik, Tor-Arne; Larsson, Henrik] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Hartman, Catharina A.; Wanders, Rob] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands; [Haavik, Jan] Haukeland Hosp, Div Psychiat, Bergen, Norway; [Haavik, Jan; Hegvik, Tor-Arne; Faraone, Stephen, V] Univ Bergen, KG Jebsen Ctr Neuropsychiat Disorders, Dept Biomed, Bergen, Norway; [Harro, Jaanus] Univ Tartu, Dept Psychol, Div Neuropsychopharmacol, Tartu, Estonia; [Klungsoyr, Kari] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Klungsoyr, Kari] Norwegian Inst Publ Hlth, Div Mental & Phys Hlth, Bergen, Norway; [Ottosen, Caecilie; Dalsgaard, Soren] Aarhus Univ, Natl Ctr Register Based Res, Aarhus, Denmark; [Ottosen, Caecilie; Dalsgaard, Soren] Lundbeck Fdn Initiat Integrat Psychiat Res, iPSYCH, Aarhus, Denmark; [Dalsgaard, Soren] Hosp Telemark, Dept Child & Adolescent Psychiat, Kragero, Norway; [Faraone, Stephen, V] SUNY Upstate Med Univ, Dept Psychiat, Syracuse, NY 13210 USA; [Faraone, Stephen, V] SUNY Upstate Med Univ, Dept Neurosci, Syracuse, NY 13210 USA; [Faraone, Stephen, V] SUNY Upstate Med Univ, Dept Physiol, Syracuse, NY 13210 USA; [Larsson, Henrik] Orebro Univ, Sch Med Sci, Orebro, Sweden	Karolinska Institutet; University of Groningen; University of Bergen; Haukeland University Hospital; University of Bergen; University of Tartu; University of Bergen; Norwegian Institute of Public Health (NIPH); Aarhus University; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); Telemark Hospital Trust; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Orebro University	Chen, Q (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.	qi.chen@ki.se	Harro, Jaanus/W-4939-2017; Dalsgaard, Søren/AAA-4475-2020; Larsson, Henrik/GYD-5161-2022; Klungsøyr, Kari/ABC-6147-2020; Haavik, Jan/ABE-1535-2020; Faraone, Stephen/AAE-7334-2019	Harro, Jaanus/0000-0002-4484-2096; Dalsgaard, Søren/0000-0003-4659-0969; Klungsøyr, Kari/0000-0003-2482-1690; Faraone, Stephen/0000-0002-9217-3982; Chen, Qi/0000-0002-4602-4388	Shire International GmbH; Swedish Research Council [2014-3831]; Swedish Initiative for Research on Microdata in the Social And Medical Sciences (SIMSAM) [340-2013-5867]; European Union [667302, 602805, 728018]; K.G. Jebsen Centre for Research on Neuropsychiatric Disorders, University of Bergen, Bergen, Norway; National Institute of Mental Health [5R01MH101519, U01 MH109536-01]; Aarhus University Foundation [AUFF-E-2015-FLS-8-61]; Novo Nordisk Foundation [NNF 22018]	Shire International GmbH; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Initiative for Research on Microdata in the Social And Medical Sciences (SIMSAM); European Union(European Commission); K.G. Jebsen Centre for Research on Neuropsychiatric Disorders, University of Bergen, Bergen, Norway; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Aarhus University Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This work was supported by Shire International GmbH. Although employees of the Sponsor were involved in the editing and fact checking of information, the content of this manuscript, the design of the work, the interpretation of the data, and the decision to submit the manuscript for publication was made by the authors independently. This work was also supported by the Swedish Research Council (grant #2014-3831), the Swedish Initiative for Research on Microdata in the Social And Medical Sciences (SIMSAM) framework (grant #340-2013-5867), the European Union's Horizon 2020 research and innovation programme (grant #667302). Dr. Faraone also receives support from the K.G. Jebsen Centre for Research on Neuropsychiatric Disorders, University of Bergen, Bergen, Norway, the European Union's Seventh Framework Programme for research, technological development and demonstration (grant #602805), the European Union's Horizon 2020 research and innovation programme under grant agreements (grant #728018), and National Institute of Mental Health (grant #5R01MH101519 and U01 MH109536-01). Dr. Dalsgaard also receives support from Aarhus University Foundation Associate Professor Starting Grant (grant #AUFF-E-2015-FLS-8-61) and the Novo Nordisk Foundation (grant #NNF 22018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Asherson P, 2016, LANCET PSYCHIAT, V3, P568, DOI 10.1016/S2215-0366(16)30032-3; BIEDERMAN J, 1994, PSYCHIAT RES, V53, P13, DOI 10.1016/0165-1781(94)90092-2; Biederman J, 2004, BIOL PSYCHIAT, V55, P692, DOI 10.1016/j.biopsych.2003.12.003; Chen HJ, 2013, PEDIATR RES, V73, P492, DOI 10.1038/pr.2013.5; Chen Q, 2017, J CHILD PSYCHOL PSYC, V58, P711, DOI 10.1111/jcpp.12686; Donev R, 2010, ADHD-ATTEND DEFICIT, V2, P257, DOI 10.1007/s12402-010-0038-7; Faraone SV, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.20; Faraone SV, 2013, CLIN THER, V35, P1778, DOI 10.1016/j.clinthera.2013.09.005; Faraone SV, 2012, AM J PSYCHIAT, V169, P1256, DOI 10.1176/appi.ajp.2012.12010087; Fuemmeler BF, 2011, INT J OBESITY, V35, P852, DOI 10.1038/ijo.2010.214; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Guldberg-Kjar T, 2013, INT PSYCHOGERIATR, V25, P667, DOI 10.1017/S1041610212002050; Hodgkins Paul, 2011, Prim Care Companion CNS Disord, V13, DOI 10.4088/PCC.10m01030; Instanes JT, 2018, J ATTEN DISORD, V22, P203, DOI 10.1177/1087054716669589; Jacob CP, 2007, EUR ARCH PSY CLIN N, V257, P309, DOI 10.1007/s00406-007-0722-6; Jain R, 2011, J AM ACAD CHILD PSY, V50, P171, DOI 10.1016/j.jaac.2010.11.005; Jiang SZ, 2016, EXP THER MED, V12, P2395, DOI 10.3892/etm.2016.3667; Joseph N, 2015, J ATTEN DISORD, V19, P915, DOI 10.1177/1087054713510354; Kessler RC, 2006, AM J PSYCHIAT, V163, P716, DOI 10.1176/appi.ajp.163.4.716; Klassen LJ, 2010, J AFFECT DISORDERS, V124, P1, DOI 10.1016/j.jad.2009.06.036; Knol MJ, 2012, INT J EPIDEMIOL, V41, P514, DOI 10.1093/ije/dyr218; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Ludvigsson JF, 2016, EUR J EPIDEMIOL, V31, P125, DOI 10.1007/s10654-016-0117-y; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Luman M, 2010, NEUROSCI BIOBEHAV R, V34, P744, DOI 10.1016/j.neubiorev.2009.11.021; McClernon FJ, 2008, ANN NY ACAD SCI, V1141, P131, DOI 10.1196/annals.1441.016; McGough JJ, 2005, AM J PSYCHIAT, V162, P1621, DOI 10.1176/appi.ajp.162.9.1621; McIntosh D, 2009, NEUROPSYCH DIS TREAT, V5, P137; Michielsen M, 2013, J AFFECT DISORDERS, V148, P220, DOI 10.1016/j.jad.2012.11.063; Michielsen M, 2012, BRIT J PSYCHIAT, V201, P298, DOI 10.1192/bjp.bp.111.101196; Mick E, 2013, EUR NEUROPSYCHOPHARM, V23, P534, DOI 10.1016/j.euroneuro.2012.06.011; Nielsen PR, 2017, J AM ACAD CHILD PSY, V56, P234, DOI 10.1016/j.jaac.2016.12.010; Paloyelis Y, 2010, NEUROPSYCHOPHARMACOL, V35, P2414, DOI 10.1038/npp.2010.124; Philipp-Wiegmann F, 2016, EUR ARCH PSY CLIN N, V266, P367, DOI 10.1007/s00406-015-0644-7; Roy A, 2014, J CLIN PSYCHIAT, V75, pE108, DOI 10.4088/JCP.13m08648; Sagvolden T, 2009, NEUROPHARMACOLOGY, V57, P619, DOI 10.1016/j.neuropharm.2009.08.004; Simon V, 2009, BRIT J PSYCHIAT, V194, P204, DOI 10.1192/bjp.bp.107.048827; Sjolander A, 2016, EUR J EPIDEMIOL, V31, P563, DOI 10.1007/s10654-016-0157-3; Spencer TJ, 2014, J NERV MENT DIS, V202, P725, DOI 10.1097/NMD.0000000000000191; van de Glind G, 2014, DRUG ALCOHOL DEPEN, V134, P158, DOI 10.1016/j.drugalcdep.2013.09.026; van Hulzen KJE, 2017, BIOL PSYCHIAT, V82, P634, DOI 10.1016/j.biopsych.2016.08.040; Virdis A, 2010, CURR PHARM DESIGN, V16, P2518, DOI 10.2174/138161210792062920; Willcutt E, 2012, NEUROTHERAPEUTICS, V9, P490, DOI 10.1007/s13311-012-0135-8; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654	46	84	84	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2018	13	9							e0204516	10.1371/journal.pone.0204516	http://dx.doi.org/10.1371/journal.pone.0204516			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV3NB	30256837	Green Published, Green Submitted, gold			2022-12-26	WOS:000446000200052
J	Noble, JC; Meredith, D; Lane, RP				Noble, J. C.; Meredith, Diane; Lane, Robert P.			Frequent and biased odorant receptor (OR) re-selection in an olfactory placode-derived cell line	PLOS ONE			English	Article							GENE-EXPRESSION; SINGLE-CELL; EPITHELIUM; RNA; CHOICE; MOUSE; NEURONS; TRANSCRIPTOMES; NEUROGENESIS; PROTEINS	We previously characterized a clonal olfactory placode-derived cell line (OP6) as a model system for studying odorant receptor (OR) choice, where individual OP6 cells, similar to olfactory sensory neurons in vivo, transcribe one allele ("monoallelic") of one OR gene ("monogenic"). The OP6 cell line provides a unique opportunity to investigate intrinsic properties of OR regulation that cannot easily be investigated in vivo. First, whereas OR-expressing cells in vivo are post-mitotic, OP6 cells are immortalized, raising interesting questions about the stability of epigenetic states associated with OR selection/silencing as OP6 cells progress through the cell cycle. Second, OP6 cells have been isolated away from extrinsic developmental cues, and therefore, any long-term OR selection biases are likely to arise from intrinsic epigenetic states that persist in the absence of developmental context. In this study, we investigated OR re-selection frequency and selection biases within clonal OP6 cell populations. We found no evidence of OR stability through the cell cycle: our results were most consistent with OR re-selection events transpiring at least once per cell division, suggesting that chromatin states associated with OR selection in this system might not be maintained in the subsequent generation. In contrast, we found strong evidence for OR selection biases maintained over prolonged culturing across a diverse set of OP6 cell lineages, suggesting the persistence of intrinsic epigenetic states that advantage some OR loci over others. Together, our data suggest that in the absence of instructive cues, intrinsic epigenetic states influencing OR eligibility, but not those determining OR choice, might persist through the cell cycle.	[Noble, J. C.; Meredith, Diane; Lane, Robert P.] Wesleyan Univ, Dept Mol Biol & Biochem, Middletown, CT 06457 USA	Wesleyan University	Lane, RP (corresponding author), Wesleyan Univ, Dept Mol Biol & Biochem, Middletown, CT 06457 USA.	rlane@wesleyan.edu			National Institutes of Health [R01-DC002167]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002167] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institutes of Health, R01-DC002167 (https://grants.nih.gov/grants/funding/r01.htm) to RL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdus-Saboor I, 2016, CURR BIOL, V26, P1083, DOI 10.1016/j.cub.2016.02.039; Brooks MJ, 2011, MOL VIS, V17, P3034; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Burke KS, 2017, ACS CENTRAL SCI, V3, P425, DOI 10.1021/acscentsci.7b00048; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Clark MB, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000625; Clowney EJ, 2012, CELL, V151, P724, DOI 10.1016/j.cell.2012.09.043; Dalton RP, 2013, CELL, V155, P321, DOI 10.1016/j.cell.2013.09.033; Eerdunfu, 2017, NEURAL DEV, V12, DOI 10.1186/s13064-017-0079-0; Fu GK, 2014, P NATL ACAD SCI USA, V111, P1891, DOI 10.1073/pnas.1323732111; Hanchate NK, 2015, SCIENCE, V350, P1251, DOI 10.1126/science.aad2456; Huard JMT, 1998, J COMP NEUROL, V400, P469; Illing N, 2002, MOL CELL NEUROSCI, V20, P225, DOI 10.1006/mcne.2002.1106; Islam S, 2014, NAT METHODS, V11, P163, DOI [10.1038/NMETH.2772, 10.1038/nmeth.2772]; Islam S, 2011, GENOME RES, V21, P1160, DOI 10.1101/gr.110882.110; Iwema CL, 2003, J COMP NEUROL, V459, P209, DOI 10.1002/cne.10583; Kilinc S, 2016, MOL CELL NEUROSCI, V74, P58, DOI 10.1016/j.mcn.2016.03.001; Kilinc S, 2014, NUCLEUS-AUSTIN, V5, P318, DOI 10.4161/nucl.29343; KOSHIMOTO H, 1992, NEUROREPORT, V3, P521, DOI 10.1097/00001756-199206000-00017; KOSHIMOTO H, 1994, NEUROSCI LETT, V169, P73, DOI 10.1016/0304-3940(94)90359-X; Krolewski RC, 2013, J COMP NEUROL, V521, P833, DOI 10.1002/cne.23204; Lewcock JW, 2004, P NATL ACAD SCI USA, V101, P1069, DOI 10.1073/pnas.0307986100; Low VF, 2017, NEUROSCIENCE, V344, P167, DOI 10.1016/j.neuroscience.2016.12.044; Lyons DB, 2014, CELL REP, V9, P884, DOI 10.1016/j.celrep.2014.10.001; Marinov GK, 2014, GENOME RES, V24, P496, DOI 10.1101/gr.161034.113; Markenscoff-Papadimitriou E, 2014, CELL, V159, P543, DOI 10.1016/j.cell.2014.09.033; McClintock Timothy S, 2015, ChemoSense, V16, P3; McClintock TS, 2010, CHEM SENSES, V35, P447, DOI 10.1093/chemse/bjq041; Monahan K, 2017, ELIFE, V6, DOI 10.7554/elife.28620.001; Monahan K, 2015, ANNU REV CELL DEV BI, V31, P721, DOI 10.1146/annurev-cellbio-100814-125308; Nickell MD, 2012, J COMP NEUROL, V520, P2608, DOI 10.1002/cne.23052; Nicolay DJ, 2006, CELL MOL NEUROBIOL, V26, P803, DOI 10.1007/s10571-006-9058-4; Pathak N, 2009, J NEUROCHEM, V108, P486, DOI 10.1111/j.1471-4159.2008.05780.x; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Rodriguez-Gil DJ, 2015, P NATL ACAD SCI USA, V112, P5821, DOI 10.1073/pnas.1417955112; Rodriguez-Gil DJ, 2010, J NEUROSCI, V30, P10067, DOI 10.1523/JNEUROSCI.1776-10.2010; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Serizawa S, 2000, NAT NEUROSCI, V3, P687, DOI 10.1038/76641; Shykind BM, 2004, CELL, V117, P801, DOI 10.1016/j.cell.2004.05.015; Tan LZ, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156639; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Vyas RN, 2017, MOL CELL NEUROSCI, V82, P1, DOI 10.1016/j.mcn.2017.04.005; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800; Zhang XM, 2004, GENOMICS, V83, P802, DOI 10.1016/j.ygeno.2003.10.009	45	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2018	13	9							e0204604	10.1371/journal.pone.0204604	http://dx.doi.org/10.1371/journal.pone.0204604			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3NB	30256852	Green Submitted, Green Published, gold			2022-12-26	WOS:000446000200056
J	Peju, M; Deroux, A; Pelloux, H; Bouillet, L; Epaulard, O				Peju, Martin; Deroux, Alban; Pelloux, Herve; Bouillet, Laurence; Epaulard, Olivier			Hypereosinophilia: Biological investigations and etiologies in a French metropolitan university hospital, and proposed approach for diagnostic evaluation	PLOS ONE			English	Article							RETURNING TRAVELERS; EOSINOPHILIA	Objectives We aimed to evaluate the usefulness of biological investigations in cases of eosinophilia in our area (French Alps). Methods We retrospectively included all adult patients attending the infectious disease and internal medicine units between 2009 and 2015 with eosinophilia >= 1 G/l. Results We identified 298 cases (129 women and 169 men). In 139 patients, eosinophilia had not been addressed. In the 159 others, the cause of eosinophilia was identified in 118 (74.2%). The main identified causes at the time were drug reactions (24.5%, mostly beta-lactams and allopurinol), infectious diseases (17.0%), vasculitis (8.2%), autoimmune diseases (6.9%), and malignant diseases (6.2%). In patients with a skin rash, eosinophilia was significantly more often investigated, and a diagnosis significantly more often made. Helminthosis were mainly diagnosed in tropical travelers (18/24) excepting toxocariasis (3 non-travelers). Stool examination for helminthosis was positive in 5/76 patients (6.6%) (all tropical travelers); 391 helminth serologies were performed in 91 patients, with 7.9% being positive (all but 3 positive cases were travelers). Anti-neutrophil cytoplasmic antibodies (ANCA) were positive in 26/112 patients (23.2%), with 9 cases of vasculitis identified. Conclusions Drug-related eosinophilia is the main etiology. Search for helminthosis is not recommended among non-travelers (excepting toxocariasis). ANCA should be performed early so as not to overlook vasculitis.	[Peju, Martin; Epaulard, Olivier] Ctr Hosp Univ Grenoble Alpes, Infect Dis Unit, Grenoble, France; [Peju, Martin; Pelloux, Herve; Epaulard, Olivier] Univ Grenoble Alpes, Federat Infectiol Multidisciplinaire Arc Alpin, Grenoble, France; [Deroux, Alban; Bouillet, Laurence] Ctr Hosp Univ Grenoble Alpes, Internal Med Unit, Grenoble, France; [Pelloux, Herve] Ctr Hosp Univ Grenoble Alpes, Parasitol Mycol Lab, Grenoble, France; [Pelloux, Herve] Univ Grenoble Alpes, Grenoble, France	CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Epaulard, O (corresponding author), Ctr Hosp Univ Grenoble Alpes, Infect Dis Unit, Grenoble, France.; Epaulard, O (corresponding author), Univ Grenoble Alpes, Federat Infectiol Multidisciplinaire Arc Alpin, Grenoble, France.	OEpaulard@chu-grenoble.fr	Pelloux, Hervé/M-7132-2014; Epaulard, Olivier/AHD-4798-2022; DEROUX, Alban/AGN-3318-2022	Pelloux, Hervé/0000-0001-5727-5441; DEROUX, Alban/0000-0002-9098-7368; Peju, Martin/0000-0002-2761-3531				Andersen CL, 2013, AM J HEMATOL, V88, P843, DOI 10.1002/ajh.23515; Brigden M, 1997, ARCH PATHOL LAB MED, V121, P963; Brigden ML, 1999, POSTGRAD MED, V105, P193, DOI 10.3810/pgm.1999.03.638; Brigden ML, 1999, POSTGRAD MED, V105, P207, DOI [DOI 10.3810/PGM.1999.03.638, 10.3810/pgm.1999.03.638]; Centre national de reference des syndromes hypere A osinophiliques (CEREO), DIAGN ASS HYP; Chappuis Samuel, 2013, Rev Med Suisse, V9, P819; Checkley AM, 2010, J INFECTION, V60, P1, DOI 10.1016/j.jinf.2009.11.003; Kardaun SH, 2013, BRIT J DERMATOL, V169, P1071, DOI 10.1111/bjd.12501; Meltzer E, 2008, AM J TROP MED HYG, V78, P702, DOI 10.4269/ajtmh.2008.78.702; Pardo J, 2006, EMERG INFECT DIS, V12, P1587, DOI 10.3201/eid1210.060102; Ridings Herb, 2006, JAAPA, V19, P34; Roufosse F, 2010, J ALLERGY CLIN IMMUN, V126, P39, DOI 10.1016/j.jaci.2010.04.011; Sade K, 2007, EUR J INTERN MED, V18, P196, DOI 10.1016/j.ejim.2006.09.031; Savini H, 2012, EMC MALADIES INFECTI, V9, P1; Schulte C, 2002, CLIN INFECT DIS, V34, P407, DOI 10.1086/338026; Sims H, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2670	16	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2018	13	9							e0204468	10.1371/journal.pone.0204468	http://dx.doi.org/10.1371/journal.pone.0204468			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3NB	30256812	Green Published, Green Submitted, gold			2022-12-26	WOS:000446000200047
J	Gabbia, D; Pozzo, L; Zigiotto, G; Roverso, M; Sacchi, D; Dalla Pozza, A; Carrara, M; Bogialli, S; Floreani, A; Guido, M; De Martin, S				Gabbia, Daniela; Pozzo, Luisa; Zigiotto, Giorgia; Roverso, Marco; Sacchi, Diana; Dalla Pozza, Arianna; Carrara, Maria; Bogialli, Sara; Floreani, Annarosa; Guido, Maria; De Martin, Sara			Dexamethasone counteracts hepatic inflammation and oxidative stress in cholestatic rats via CAR activation	PLOS ONE			English	Article							PREGNANE-X-RECEPTOR; CONSTITUTIVE ANDROSTANE RECEPTOR; NF-KAPPA-B; BILE-ACIDS; INTRAHEPATIC CHOLESTASIS; MEDIATED INDUCTION; IN-VITRO; EXPRESSION; LIVER; HEPATOCYTES	Glucocorticoids (GCs) are currently used for the therapeutic management of cholestatic diseases, but their use and molecular mechanism remain controversial. The aims of this study were 1) to assess the therapeutic effect of a 2-week treatment with the GC dexamethasone on hepatic damage in bile duct-ligated rats; 2) to investigate its effect on the activation of the nuclear receptors (NRs) pregnane X receptor (PXR), constitutive androstane receptor (CAR) and GC receptor (GR), and NF-kappa B, as well as on oxidative stress and bile acid (BA) hepatic composition. Cholestasis was induced by ligation of bile duct (BDL animals) in 16 male Wistar-Kyoto rats, and eight of them were daily treated by oral gavage with 0.125 mg/ml/kg DEX for 14 days. Eight Sham-operated rats were used as controls. Severity of cholestasis was assessed histologically and on plasma biochemical parameters. The nuclear expression of NF-kappa B (p65), GR, PXR and CAR was measured in hepatic tissue by Western Blot. Oxidative stress was evaluated by measuring malondialdehyde, carbonylated proteins, GHS and ROS content in rat livers. LC-MS was used to measure the plasma and liver concentration of 7 BAs. Histological findings and a significant drop in several markers of inflammation (p65 nuclear translocation, mRNA expressions of TNF-alpha, IL-1 beta, IL-6) showed that DEX treatment reversed cholestasis-induced inflammation, and similar results have been obtained with oxidative stress markers. The nuclear expression of p65 and CAR were inversely correlated, with the latter increasing significantly after DEX treatment (p<0.01 vs vehicle). Hepatic BA levels tended to drop in the untreated cholestatic rats, whereas they were similar to those of healthy rats in DEX-treated animals. Plasma BAs decreased significantly in DEX-treated animals with respect to untreated cholestatic rats. In conclusion, DEX reduces inflammation and oxidative stress in BDL rats, and probably CAR is responsible for this effect. Therefore, this NR represents a promising pharmacological target for managing cholestatic and inflammatory liver diseases.	[Gabbia, Daniela; Zigiotto, Giorgia; Dalla Pozza, Arianna; Carrara, Maria; De Martin, Sara] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Padua, Italy; [Pozzo, Luisa] CNR, Inst Agr Biol & Biotechnol, Pisa, Italy; [Roverso, Marco; Bogialli, Sara] Univ Padua, Dept Chem Sci, Padua, Italy; [Sacchi, Diana; Guido, Maria] Univ Padua, Dept Med, Gen Pathol & Cytopathol Unit, Padua, Italy; [Floreani, Annarosa] Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, Italy	University of Padua; Consiglio Nazionale delle Ricerche (CNR); University of Padua; University of Padua; University of Padua	De Martin, S (corresponding author), Univ Padua, Dept Pharmaceut & Pharmacol Sci, Padua, Italy.	sara.demartin@unipd.it	Gabbia, Daniela/J-9984-2019; Roverso, Marco/ABE-1580-2020; bogialli, sara/AAA-9818-2021; De Martin, Sara/AAC-7396-2022	Gabbia, Daniela/0000-0003-2247-8227; bogialli, sara/0000-0002-9152-3602; De Martin, Sara/0000-0001-6398-8237; Pozzo, Luisa/0000-0001-7530-7814; Roverso, Marco/0000-0003-1264-8878	University of Padova [CPDA138721/13]; Gilead Inc. (Gilead Fellowship)	University of Padova; Gilead Inc. (Gilead Fellowship)	This work was supported by grants from the University of Padova (CPDA138721/13 to SDM), and Gilead Inc. (Gilead Fellowship 2015 to SDM). The funders did not have any role in the study design, data collection and analysis, and in the decision to publish, or preparation of the manuscript.	Adcock IM, 2001, PULM PHARMACOL THER, V14, P211, DOI 10.1006/pupt.2001.0283; Aricha R, 2011, J AUTOIMMUN, V36, P135, DOI 10.1016/j.jaut.2010.12.001; Assenat E, 2006, EUR J CANCER, V42, P785, DOI 10.1016/j.ejca.2006.01.005; Beigneux AP, 2002, BIOCHEM BIOPH RES CO, V293, P145, DOI 10.1016/S0006-291X(02)00196-1; Benz C, 1998, J HEPATOL, V28, P99, DOI 10.1016/S0168-8278(98)80208-0; Beytut E, 2018, J TRACE ELEM MED BIO, V45, P131, DOI 10.1016/j.jtemb.2017.10.005; Browne R W, 1998, Methods Mol Biol, V108, P347; Castellani G, 2016, CYTOKINE, V88, P136, DOI 10.1016/j.cyto.2016.09.003; Chirulli V, 2005, LIFE SCI, V76, P2535, DOI 10.1016/j.lfs.2004.09.042; Colin TS, 2018, EXP MOL PATHOL, V104, P1, DOI 10.1016/j.yexmp.2017.11.012; Courtois A, 1999, FEBS LETT, V459, P381, DOI 10.1016/S0014-5793(99)01295-8; De Martin S, 2014, DRUG METAB DISPOS, V42, P1617, DOI 10.1124/dmd.114.058511; Faubion WA, 1999, J CLIN INVEST, V103, P137, DOI 10.1172/JCI4765; Fleige S, 2006, BIOTECHNOL LETT, V28, P1601, DOI 10.1007/s10529-006-9127-2; Floreani M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061983; Gabbia D, 2017, WORLD J GASTROENTERO, V23, P7519, DOI 10.3748/wjg.v23.i42.7519; Geenes V, 2015, EUR J OBSTET GYN R B, V189, P59, DOI 10.1016/j.ejogrb.2015.03.020; Ghosal A, 1996, ARCH BIOCHEM BIOPHYS, V332, P153, DOI 10.1006/abbi.1996.0327; Guido M, 2018, LIVER INT, V38, P1770, DOI 10.1111/liv.13718; Heck S, 1997, EMBO J, V16, P4698, DOI 10.1093/emboj/16.15.4698; Hu YY, 2015, EUR REV MED PHARMACO, V19, P3181; Barrasa JI, 2011, APOPTOSIS, V16, P1054, DOI 10.1007/s10495-011-0633-x; Ito K, 2001, J BIOL CHEM, V276, P30208, DOI 10.1074/jbc.M103604200; Kim EK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181183; KOUNTOURAS J, 1984, BRIT J EXP PATHOL, V65, P305; Kubitz R, 1999, GASTROENTEROLOGY, V116, P401, DOI 10.1016/S0016-5085(99)70138-1; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Masubuchi N, 2016, CHEM-BIOL INTERACT, V255, P83, DOI 10.1016/j.cbi.2015.08.016; Mercier Y, 2004, MEAT SCI, V66, P467, DOI 10.1016/S0309-1740(03)00135-9; Mork LM, 2016, J CLIN EXP HEPATOL, V6, P87, DOI 10.1016/j.jceh.2016.01.007; Niknahad H, 2017, RENAL FAILURE, V39, P745, DOI 10.1080/0886022X.2017.1399908; Nissen RM, 2000, GENE DEV, V14, P2314, DOI 10.1101/gad.827900; Palatini P, 2016, WORLD J GASTROENTERO, V22, P1260, DOI 10.3748/wjg.v22.i3.1260; Pascussi JM, 2000, MOL PHARMACOL, V58, P1441, DOI 10.1124/mol.58.6.1441; Pascussi JM, 2000, BIOCHEM BIOPH RES CO, V274, P707, DOI 10.1006/bbrc.2000.3219; Schoneveld OJLM, 2004, BBA-GENE STRUCT EXPR, V1680, P114, DOI 10.1016/j.bbaexp.2004.09.004; Seljeskog E, 2006, CLIN BIOCHEM, V39, P947, DOI 10.1016/j.clinbiochem.2006.03.012; Tag CG, 2015, JOVE-J VIS EXP, DOI 10.3791/52438; Teng S, 2005, J PHARMACOL EXP THER, V312, P841, DOI 10.1124/jpet.104.076141; Terevinto A, 2010, MEAT SCI, V84, P706, DOI 10.1016/j.meatsci.2009.11.007; Trauner M, 1998, NEW ENGL J MED, V339, P1217, DOI 10.1056/NEJM199810223391707; Turncliff RZ, 2004, DRUG METAB DISPOS, V32, P834, DOI 10.1124/dmd.32.8.834; Yan L, 2017, MOL PHARMACOL, V92, P113, DOI 10.1124/mol.117.108225; Yang TT, 2017, J STEROID BIOCHEM, V172, P69, DOI 10.1016/j.jsbmb.2017.05.015; Zhang Y, 2013, GASTROENT RES PRACT, V2013, DOI 10.1155/2013/490731	45	35	36	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2018	13	9							e0204336	10.1371/journal.pone.0204336	http://dx.doi.org/10.1371/journal.pone.0204336			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU9BO	30252871	Green Published, gold, Green Submitted			2022-12-26	WOS:000445639700044
J	Whitehead, ABR; Butcher, GD; Walden, HS; Duque, V; Cruz, M; Hernandez, JA				Whitehead, Ashley B. R.; Butcher, Gary D.; Walden, Heather S.; Duque, Viviana; Cruz, Marilyn; Hernandez, Jorge A.			Burden of exposure to infectious bursal disease virus, infectious bronchitis virus, Newcastle disease virus, Mycoplasma gallisepticum, and intestinal parasites in introduced broiler chickens on the Galapagos	PLOS ONE			English	Article							PATHOGENS; BIRDS	Diseases in introduced broilers can possibly spill over to wild birds on the Galapagos. Knowledge about the current burden of exposure to pathogens in broilers on the Galapagos is very limited. The objective of the study reported here was to measure the burden of exposure to infectious bursal disease virus (IBDV), infectious bronchitis virus (IBV), Newcastle disease virus (NDV), Mycoplasma gallisepticum (MG), and intestinal parasites in a sample of broiler chickens on 13 farms on Santa Cruz Island and San Cristobal Island in July 2017. Blood serum samples were tested for detection of antibodies to IBDV, IBV, NDV, and MG by using an IDEXX Enzyme-linked Immunosorbent Assay. In addition, fecal samples and pen bedding environmental samples were processed and analyzed for diagnosis of intestinal parasite eggs under a compound light microscope. The frequency of seropositive broilers to IBDV was 74/130 or 56% (95% CI = 48, 65%), to IBV was 27/130 or 20% (14, 28%), and to NDV was 1/130 or 0.7% (0.1, 4%). All broilers tested negative to MG antibodies. Eimeria spp. infection was common in study broilers. Finally, we observed interaction between broiler chickens and wild birds (finches) inside broiler pens, as well as the presence of backyard chickens inside property limits of study farms. This study produced evidence that exposure to IBDV, IBV, and intestinal parasites in broilers on Santa Cruz Island and San Cristobal Island is important. Study results are relevant because (i) they provide new baseline data on the burden of exposure to avian pathogens in broiler farms, (ii) justify the need to verify standard operating procedures in hatcheries that supply (non-vaccinated) day-old chicks to the Galapagos and (iii) to implement enhanced biosecurity standards on broiler chicken farms to mitigate risk of disease transmission between broilers, backyard poultry, and wild birds on the Galapagos.	[Whitehead, Ashley B. R.; Butcher, Gary D.; Walden, Heather S.; Hernandez, Jorge A.] Univ Florida, Coll Vet Med, Gainesville, FL 32611 USA; [Duque, Viviana; Cruz, Marilyn] Agencia Regulac & Control Bioseguridad & Cuarente, Santa Cruz, Galapagos, Ecuador; [Hernandez, Jorge A.] Univ Florida, Ctr Latin Amer Studies, Gainesville, FL 32611 USA; [Hernandez, Jorge A.] Univ Florida, Coll Publ Hlth & Hlth Profess, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Hernandez, JA (corresponding author), Univ Florida, Coll Vet Med, Gainesville, FL 32611 USA.; Hernandez, JA (corresponding author), Univ Florida, Ctr Latin Amer Studies, Gainesville, FL 32611 USA.; Hernandez, JA (corresponding author), Univ Florida, Coll Publ Hlth & Hlth Profess, Gainesville, FL 32611 USA.	hernandezja@ufl.edu	Whitehead, Ashley/GZG-5062-2022	Hernandez, Jorge A./0000-0002-3096-4762	Galapagos Biosecurity Agency; WildAid; University of Florida Center for Latin American Studies; University of Florida College of Veterinary Medicine	Galapagos Biosecurity Agency; WildAid; University of Florida Center for Latin American Studies; University of Florida College of Veterinary Medicine(University of Florida)	This research was funded in part by the Galapagos Biosecurity Agency; WildAid; and University of Florida's Center for Latin American Studies and College of Veterinary Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AusVet Animal Health Services, 2015, CALC CONF LIM POP PR; Block SS, 1991, DIS POULTRY, P167; Cannon RM, 2001, PREV VET MED, V49, P141, DOI 10.1016/S0167-5877(01)00184-2; Deem SL, 2012, ANIM CONSERV, V15, P73, DOI 10.1111/j.1469-1795.2011.00489.x; Eimeria Yabsley M., 2008, PARASITIC DIS WILD B, P161; Gottdenker NL, 2005, BIOL CONSERV, V126, P429, DOI 10.1016/j.biocon.2005.06.025; LINDSAY DS, 1988, AM J VET RES, V49, P1412; Prescott JF, 2016, AVIAN PATHOL, V45, P288, DOI 10.1080/03079457.2016.1139688; Soos C, 2008, AUK, V125, P445, DOI 10.1525/auk.2008.06235; Teeter RG, 2008, 23 WORLDS POULTR C B; Zajac AM., 2012, VET CLIN PARASITOLOG, V8th Edition, DOI [10.5402/2013/468163, DOI 10.5402/2013/468163]	11	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2018	13	9							e0203658	10.1371/journal.pone.0203658	http://dx.doi.org/10.1371/journal.pone.0203658			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3MI	30248128	Green Published, gold, Green Submitted			2022-12-26	WOS:000445998100010
J	Kozma, MT; Schmidt, M; Ngo-Vu, H; Sparks, SD; Senatore, A; Derby, CD				Kozma, Mihika T.; Schmidt, Manfred; Ngo-Vu, Hanh; Sparks, Shea D.; Senatore, Adriano; Derby, Charles D.			Chemoreceptor proteins in the Caribbean spiny lobster, Panulirus argus: Expression of Ionotropic Receptors, Gustatory Receptors, and TRP channels in two chemosensory organs and brain	PLOS ONE			English	Article							MOSQUITO ANOPHELES-GAMBIAE; CARCINUS-MAENAS CRUSTACEA; FUNNEL-CANAL ORGANS; ANTENNULAR PROJECTIONS; CAMPANIFORM SENSILLA; GLUTAMATE RECEPTORS; SENSORY INNERVATION; HOMARUS-AMERICANUS; OLFACTORY MIDBRAIN; ODORANT RECEPTORS	The spiny lobster, Panulirus argus, has two classes of chemosensilla representing "olfaction" and "distributed chemoreception," as is typical for decapod crustaceans. Olfactory sensilla are found exclusively on antennular lateral flagella and are innervated only by olfactory receptor neurons (ORNs) that project into olfactory lobes organized into glomeruli in the brain. Distributed chemoreceptor sensilla are found on all body surfaces including the antennular lateral flagella (LF) and walking leg dactyls (dactyls), and are innervated by both chemoreceptor neurons (CRNs) and mechanoreceptor neurons that project into somatotopically organized neuropils. Here, we examined expression of three classes of chemosensory genes in transcriptomes of the LF (with ORNs and CRNs), dactyls (with only CRNs), and brain of P. argus: Ionotropic Receptors (IRs), which are related to ionotropic glutamate receptors and found in all protostomes including crustaceans; Gustatory Receptors (GRs), which are ionotropic receptors that are abundantly expressed in insects but more restricted in crustaceans; and Transient Receptor Potential (TRP) channels, a diverse set of sensorchannels that include several chemosensors in diverse animals. We identified 108 IRs, one GR, and 18 homologues representing all seven subfamilies of TRP channels. The number of IRs expressed in the LF is far greater than in dactyls, possibly reflecting the contribution of receptor proteins associated with the ORNs beyond those associated with CRNs. We found co-receptor IRs (IR8a, IR25a, IR76b, IR93a) and conserved IRs (IR21a, IR40a) in addition to the numerous divergent IRs in the LF, dactyl, and brain. Immunocytochemistry showed that IR25a is expressed in ORNs, CRNs, and a specific type of cell located in the brain near the olfactory lobes. While the function of IRs, TRP channels, and the GR was not explored, our results suggest that P. argus has an abundance of diverse putative chemoreceptor proteins that it may use in chemoreception.	[Kozma, Mihika T.; Schmidt, Manfred; Ngo-Vu, Hanh; Sparks, Shea D.; Derby, Charles D.] Georgia State Univ, Neurosci Inst, Atlanta, GA 30303 USA; [Senatore, Adriano] Univ Toronto Mississauga, Dept Biol, Mississauga, ON, Canada	University System of Georgia; Georgia State University; University of Toronto; University Toronto Mississauga	Kozma, MT (corresponding author), Georgia State Univ, Neurosci Inst, Atlanta, GA 30303 USA.	mtottempudi1@gsu.edu		Kozma, Mihika/0000-0002-4474-4138	Georgia State University's Brains AMP; Behavior program; Georgia State University's 2CI Neurogenomics program, Center for Neuromics, and Neuroscience Institute	Georgia State University's Brains AMP; Behavior program; Georgia State University's 2CI Neurogenomics program, Center for Neuromics, and Neuroscience Institute	This study was funded by a seed grant from the Georgia State University's Brains & Behavior program. Mihika T. Kozma was supported by fellowships from Georgia State University's 2CI Neurogenomics program, Center for Neuromics, and Neuroscience Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuin L, 2011, NEURON, V69, P44, DOI 10.1016/j.neuron.2010.11.042; Ache BW, 2002, CRUSTACEAN EXPERIMENTAL SYSTEMS IN NEUROBIOLOGY, P189; Aggio JF, 2008, J EXP MAR BIOL ECOL, V363, P28, DOI 10.1016/j.jembe.2008.06.008; Albertin CB, 2015, NATURE, V524, P220, DOI 10.1038/nature14668; Arenas OM, 2017, NAT NEUROSCI, V20, P1686, DOI 10.1038/s41593-017-0005-0; Atema Jelle, 1995, P313, DOI 10.1016/B978-012247570-2/50035-9; Bandell M, 2007, CURR OPIN NEUROBIOL, V17, P490, DOI 10.1016/j.conb.2007.07.014; Barnea G, 2004, SCIENCE, V304, P1468, DOI 10.1126/science.1096146; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2015, TRENDS ECOL EVOL, V30, P590, DOI 10.1016/j.tree.2015.07.009; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; BLAUSTEIN DN, 1993, J NEUROSCI, V13, P2821; Bobkov YV, 2010, J EXP BIOL, V213, P1417, DOI 10.1242/jeb.037234; Bobkov YV, 2005, J NEUROPHYSIOL, V93, P1372, DOI 10.1152/jn.00990.2004; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; BRAUNIG P, 1982, J NEUROBIOL, V13, P413, DOI 10.1002/neu.480130504; BRAUNIG P, 1980, NATURE, V283, P768, DOI 10.1038/283768a0; Breithaupt T., 2010, CHEM COMMUNICATION C; Brochtrup A, 2011, CURR OPIN NEUROBIOL, V21, P85, DOI 10.1016/j.conb.2010.11.001; Minh BQ, 2013, MOL BIOL EVOL, V30, P1188, DOI 10.1093/molbev/mst024; Cate HS, 2002, J COMP NEUROL, V442, P293, DOI 10.1002/cne.10106; Cate HS, 2001, CELL TISSUE RES, V304, P439, DOI 10.1007/s004410100377; Chen C, 2015, NATURE, V527, P516, DOI 10.1038/nature16148; Chipman AD, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1002005; Colbert HA, 1997, J NEUROSCI, V17, P8259; Corey EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060551; Croset V, 2016, SCI REP-UK, V6, DOI 10.1038/srep34871; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; Cummins SF, 2009, J EXP BIOL, V212, P2036, DOI 10.1242/jeb.026427; Cummins SF, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-28; Derby CD, 2014, NERVOUS SYSTEMS CONT, P263; Derby CD, 2016, CHEM SENSES, V41, P381, DOI 10.1093/chemse/bjw057; Egekwu N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102667; Elmore T, 2001, INSECT BIOCHEM MOLEC, V31, P791, DOI 10.1016/S0965-1748(00)00184-3; Enjin A, 2016, CURR BIOL, V26, P1352, DOI 10.1016/j.cub.2016.03.049; EVANS PD, 1975, BRAIN RES, V90, P340, DOI 10.1016/0006-8993(75)90317-0; Eyun SI, 2017, MOL BIOL EVOL, V34, P1838, DOI 10.1093/molbev/msx147; Finn RD, 2017, NUCLEIC ACIDS RES, V45, pD190, DOI 10.1093/nar/gkw1107; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Fox AN, 2001, P NATL ACAD SCI USA, V98, P14693, DOI 10.1073/pnas.261432998; Frank DD, 2017, CURR BIOL, V27, P2381, DOI 10.1016/j.cub.2017.06.077; Freeman EG, 2015, CURR OPIN NEUROBIOL, V34, P140, DOI 10.1016/j.conb.2015.06.001; Fukushima N, 2009, J NEUROCHEM, V109, P683, DOI 10.1111/j.1471-4159.2009.06013.x; Galizia CG., 2010, NEUROBIOLOGY OLFACTI, V35, P70, DOI [10.1201/9781420071993, DOI 10.1201/9781420071993-C2, 10.1201/9781420071993-c2, DOI 10.1201/9781420071993]; Ganguly A, 2017, CELL REP, V18, P737, DOI 10.1016/j.celrep.2016.12.071; Garm A, 2006, J MORPHOL, V267, P464, DOI 10.1002/jmor.10417; GLEESON RA, 1989, COMP BIOCHEM PHYS C, V92, P413, DOI 10.1016/0742-8413(89)90076-5; GNATZY W, 1984, ZOOMORPHOLOGY, V104, P11, DOI 10.1007/BF00312166; Gohl Thomas, 2006, Invertebrate Neuroscience, V6, P13, DOI 10.1007/s10158-005-0012-9; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Groh KC, 2014, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00266; Groh-Lunow Katrin C, 2014, Front Cell Neurosci, V8, P448, DOI 10.3389/fncel.2014.00448; GRUNERT U, 1988, CELL TISSUE RES, V251, P95, DOI 10.1007/BF00215452; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; HATT H, 1994, P NATL ACAD SCI USA, V91, P6264, DOI 10.1073/pnas.91.14.6264; Herbst C, 1916, ARCH ENTWICKLUNG ORG, V42, P407, DOI 10.1007/BF02161599; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Hollins B, 2003, J COMP NEUROL, V455, P125, DOI 10.1002/cne.10489; Hussain A, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002454; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Joseph RM, 2015, TRENDS GENET, V31, P683, DOI 10.1016/j.tig.2015.09.005; Kalyaanamoorthy S, 2017, NAT METHODS, V14, P587, DOI [10.1038/NMETH.4285, 10.1038/nmeth.4285]; Kamio M, 2014, J EXP BIOL, V217, P1286, DOI 10.1242/jeb.099051; Kang K, 2010, NATURE, V464, P597, DOI 10.1038/nature08848; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kem WR, 2001, HYDROBIOLOGIA, V456, P221, DOI 10.1023/A:1013063726807; Kenny NJ, 2015, GENOME BIOL EVOL, V7, P1280, DOI 10.1093/gbe/evv070; Knecht ZA, 2017, ELIFE, V6, DOI 10.7554/eLife.26654; Knecht ZA, 2016, ELIFE, V5, DOI 10.7554/eLife.17879; Krishnan A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093048; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104; Kwon Y, 2010, CURR BIOL, V20, P1672, DOI 10.1016/j.cub.2010.08.016; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Lenz PH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088589; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li WZ, 2001, BIOINFORMATICS, V17, P282, DOI 10.1093/bioinformatics/17.3.282; Ling F, 2014, J NEUROSCI, V34, P7148, DOI 10.1523/JNEUROSCI.0649-14.2014; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Malacostraca Schmidt M., 2015, STRUCTURE EVOLUTION, P529; Matsuura H, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-228; Mayer ML, 2011, STRUCTURE, V19, P1370, DOI 10.1016/j.str.2011.08.009; Mayer ML, 2006, J NEUROSCI, V26, P2852, DOI 10.1523/JNEUROSCI.0123-06.2005; Mayer ML, 2004, ANNU REV PHYSIOL, V66, P161, DOI 10.1146/annurev.physiol.66.050802.084104; McGrath LL, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2373-3; MELLON D, 1990, ADV LIF SCI, P49; MELLON D, 1990, J COMP NEUROL, V296, P253, DOI 10.1002/cne.902960205; Missbach C, 2015, CHEM SENSES, V40, P615, DOI 10.1093/chemse/bjv050; Missbach C, 2014, ELIFE, V3, DOI 10.7554/eLife.02115; Miyamoto T, 2012, CELL, V151, P1113, DOI 10.1016/j.cell.2012.10.024; Mombaerts P, 2006, ANNU REV CELL DEV BI, V22, P713, DOI 10.1146/annurev.cellbio.21.012804.093915; Montell C, 2013, CURR BIOL, V23, pR929, DOI 10.1016/j.cub.2013.09.026; Murthy VN, 2011, ANNU REV NEUROSCI, V34, P233, DOI 10.1146/annurev-neuro-061010-113738; Ni L, 2016, ELIFE, V5, DOI 10.7554/eLife.13254; Ni LN, 2013, NATURE, V500, P580, DOI 10.1038/nature12390; Nordstrom KJV, 2011, MOL BIOL EVOL, V28, P2471, DOI 10.1093/molbev/msr061; Northcutt AJ, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3215-z; Nunez-Acuna G, 2016, AQUACULTURE, V451, P99, DOI 10.1016/j.aquaculture.2015.09.001; Nunez-Acuna G, 2014, EXP PARASITOL, V145, P99, DOI 10.1016/j.exppara.2014.08.003; Penalva-Arana DC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-79; Peng GD, 2015, MOL PHYLOGENET EVOL, V84, P145, DOI 10.1016/j.ympev.2014.06.016; Pezier A, 2009, J NEUROPHYSIOL, V101, P1151, DOI 10.1152/jn.90903.2008; Pitts RJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40297; Roberts RE, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3793-4; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Robertson HM, 2015, CHEM SENSES, V40, P609, DOI 10.1093/chemse/bjv046; Rytz R, 2013, INSECT BIOCHEM MOLEC, V43, P888, DOI 10.1016/j.ibmb.2013.02.007; Saina M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7243; Sarajlic S, 2016, PROCEEDINGS OF XSEDE16: DIVERSITY, BIG DATA, AND SCIENCE AT SCALE, DOI 10.1145/2949550.2952770; Schachtner J, 2005, ARTHROPOD STRUCT DEV, V34, P257, DOI 10.1016/j.asd.2005.04.003; Schmidt M, 1996, J COMP PHYSIOL A, V178, P579, DOI 10.1007/BF00227374; SCHMIDT M, 1984, CELL TISSUE RES, V237, P81; SCHMIDT M, 1992, J COMP NEUROL, V318, P277, DOI 10.1002/cne.903180305; SCHMIDT M, 1992, J COMP NEUROL, V318, P291, DOI 10.1002/cne.903180306; Schmidt M, 2005, J EXP BIOL, V208, P233, DOI 10.1242/jeb.01357; Schmidt M, 1996, J COMP PHYSIOL A, V178, P605, DOI 10.1007/BF00227375; SCHMIDT M, 1990, J MORPHOL, V204, P335, DOI 10.1002/jmor.1052040311; Schmidt M, 2001, J NEUROBIOL, V48, P181, DOI 10.1002/neu.1050; Schmidt M., 2014, NATURAL HIST CRUSTAC, V3; Schmidt M, 1989, J COMP PHYSIOL A, V166, DOI [10.1007/bf00193467, DOI 10.1007/BF00193467]; Schmidt M, 2006, CELL TISSUE RES, V325, P369, DOI 10.1007/s00441-006-0163-y; Schmidt M, 2011, J COMP NEUROL, V519, P2283, DOI 10.1002/cne.22657; Schmidt M, 2011, CHEMICAL COMMUNICATION IN CRUSTACEANS, P123, DOI 10.1007/978-0-387-77101-4_7; Schram FR, 2012, NATURAL HIST CRUSTAC, V1, P1; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Silbering AF, 2011, J NEUROSCI, V31, P13357, DOI 10.1523/JNEUROSCI.2360-11.2011; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; SPENCER M, 1986, CELL TISSUE RES, V245, P69; Stensmyr MC, 2005, CURR BIOL, V15, P116, DOI 10.1016/j.cub.2004.12.069; Stepanyan R, 2004, CHEM SENSES, V29, P179, DOI 10.1093/chemse/bjh023; Steullet P, 2000, J NEUROSCI, V20, P3282, DOI 10.1523/JNEUROSCI.20-09-03282.2000; Strotmann J, 2004, J NEUROSCI, V24, P7754, DOI 10.1523/JNEUROSCI.2588-04.2004; Tadesse T, 2011, DEV NEUROBIOL, V71, P316, DOI 10.1002/dneu.20862; Thomas JH, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-42; Thorne N, 2008, J COMP NEUROL, V506, P548, DOI 10.1002/cne.21547; Trifinopoulos J, 2016, NUCLEIC ACIDS RES, V44, pW232, DOI 10.1093/nar/gkw256; Upadhyay A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13135; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Venkatachalam K, 2014, HANDB EXP PHARMACOL, V223, P937, DOI 10.1007/978-3-319-05161-1_9; Vosshall LB, 2001, CHEM SENSES, V26, P207, DOI 10.1093/chemse/26.2.207; WALLACE BG, 1974, BRAIN RES, V74, P349, DOI 10.1016/0006-8993(74)90590-3; Wang KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025890; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Waterhouse Robert M, 2018, Mol Biol Evol, V35, P543, DOI 10.1093/molbev/msx319; Wicher D., 2017, CHEMORECEPTORS EVOLU, P245; Xiang Y, 2010, NATURE, V468, P921, DOI 10.1038/nature09576; Yoshida T, 2006, NAT CHEM BIOL, V2, P596, DOI 10.1038/nchembio821; Zbinden M, 2017, CHEM SENSES, V42, P319, DOI 10.1093/chemse/bjx007; Zhang YLV, 2013, SCIENCE, V340, P1334, DOI 10.1126/science.1234133; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3; Zufall F., 2016, CHEMOSENSORY TRANSDU	153	29	29	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2018	13	9							e0203935	10.1371/journal.pone.0203935	http://dx.doi.org/10.1371/journal.pone.0203935			45	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU5MM	30240423	Green Submitted, Green Published, gold			2022-12-26	WOS:000445329700014
J	Garland-Kuntz, EE; Vago, FS; Sieng, M; Van Camp, M; Chakravarthy, S; Blaine, A; Corpstein, C; Jiang, W; Lyon, AM				Garland-Kuntz, Elisabeth E.; Vago, Frank S.; Sieng, Monita; Van Camp, Michelle; Chakravarthy, Srinivas; Blaine, Arryn; Corpstein, Clairissa; Jiang, Wen; Lyon, Angeline M.			Direct observation of conformational dynamics of the PH domain in phospholipases CE and may contribute to subfamily-specific roles in regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Phospholipase C; signal transduction; conformational change; calcium; structural biology; phosphatidylinositol lipid; signaling protein; second messenger; PKC	PLECKSTRIN HOMOLOGY DOMAIN; ANGLE SCATTERING DATA; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; BIOLOGICAL MACROMOLECULES; CRYSTAL-STRUCTURE; MEMBRANE-BINDING; TERMINAL REGION; BETA; EPSILON; ACTIVATION	Phospholipase C (PLC) enzymes produce second messengers that increase the intracellular Ca2+ concentration and activate protein kinase C (PKC). These enzymes also share a highly conserved arrangement of core domains. However, the contributions of the individual domains to regulation are poorly understood, particularly in isoforms lacking high-resolution information, such as PLCE. Here, we used small-angle X-ray scattering (SAXS), EM, and functional assays to gain insights into the molecular architecture of PLCE, revealing that its PH domain is conformationally dynamic and essential for activity. We further demonstrate that the PH domain of PLC exhibits similar dynamics in solution that are substantially different from its conformation observed in multiple previously reported crystal structures. We propose that this conformational heterogeneity contributes to subfamily-specific differences in activity and regulation by extracellular signals.	[Garland-Kuntz, Elisabeth E.; Sieng, Monita; Van Camp, Michelle; Blaine, Arryn; Corpstein, Clairissa; Lyon, Angeline M.] Purdue Univ, Dept Chem, 560 Oval Dr, W Lafayette, IN 47907 USA; [Vago, Frank S.; Jiang, Wen; Lyon, Angeline M.] Purdue Univ, Dept Biol Sci, 560 Oval Dr, W Lafayette, IN 47907 USA; [Chakravarthy, Srinivas] Argonne Natl Lab, Adv Photon Source, Sector 18ID, Biophys Collaborat Access Team,IIT, Lemont, IL 60439 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Illinois Institute of Technology; United States Department of Energy (DOE); Argonne National Laboratory	Lyon, AM (corresponding author), Purdue Univ, Dept Chem, 560 Oval Dr, W Lafayette, IN 47907 USA.; Lyon, AM (corresponding author), Purdue Univ, Dept Biol Sci, 560 Oval Dr, W Lafayette, IN 47907 USA.	lyonam@purdue.edu	jiang, wen/GYI-9662-2022	Lyon, Angeline/0000-0001-7501-0148	DOE Office of Science [DE-AC02-06CH11357]; NIGMS, National Institutes of Health (NIH) [9 P41 GM103622]; NIGMS, NIH [1S10OD018090-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL141076] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103622] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018090] Funding Source: NIH RePORTER	DOE Office of Science(United States Department of Energy (DOE)); NIGMS, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank A. V. Smrcka (University of Michigan) for the R. norvegicus PLC epsilon cDNA and technical and editorial advice. We thank J. Tesmer (Purdue University) and M. Tantama (Purdue University) for helpful discussions. This research used resources of the Advanced Photon Source, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357. This project was supported by NIGMS, National Institutes of Health (NIH), Grant 9 P41 GM103622. Use of the Pilatus 3 1M detector was provided by NIGMS, NIH, Grant 1S10OD018090-01.	Bunney TD, 2006, MOL CELL, V21, P495, DOI 10.1016/j.molcel.2006.01.008; CAMPS M, 1992, EUR J BIOCHEM, V206, P821, DOI 10.1111/j.1432-1033.1992.tb16990.x; CIFUENTES ME, 1993, J BIOL CHEM, V268, P11586; Drin G, 2006, BIOCHEMISTRY-US, V45, P5712, DOI 10.1021/bi052317n; Dusaban SS, 2013, P NATL ACAD SCI USA, V110, P3609, DOI 10.1073/pnas.1217355110; Essen LO, 1996, NATURE, V380, P595, DOI 10.1038/380595a0; Feng JW, 2005, BIOCHEMISTRY-US, V44, P2577, DOI 10.1021/bi0482607; Filtz TM, 2009, FASEB J, V23, P3564, DOI 10.1096/fj.09-133983; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; Garcia P, 1995, BIOCHEMISTRY-US, V34, P16228, DOI 10.1021/bi00049a039; Ghosh Mousumi, 2003, V237, P67; Glukhova A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7250; Gresset Aurelie, 2012, Subcell Biochem, V58, P61, DOI 10.1007/978-94-007-3012-0_3; Grubb DR, 2015, J MOL CELL CARDIOL, V84, P95, DOI 10.1016/j.yjmcc.2015.04.016; Guo YJ, 2003, J BIOL CHEM, V278, P29995, DOI 10.1074/jbc.M301438200; Han DS, 2011, MOL PHARMACOL, V80, P434, DOI 10.1124/mol.111.073403; Harden TK, 2009, J LIPID RES, V50, pS243, DOI 10.1194/jlr.R800045-JLR200; Hicks SN, 2008, MOL CELL, V31, P383, DOI 10.1016/j.molcel.2008.06.018; Hopkins JB, 2017, J APPL CRYSTALLOGR, V50, P1545, DOI 10.1107/S1600576717011438; Hudson BN, 2017, BIOCHEMISTRY-US, V56, P5604, DOI 10.1021/acs.biochem.7b00547; Ilkaeva O, 2002, J BIOL CHEM, V277, P4294, DOI 10.1074/jbc.M109612200; Jezyk MR, 2006, NAT STRUCT MOL BIOL, V13, P1135, DOI 10.1038/nsmb1175; Jin TG, 2001, J BIOL CHEM, V276, P30301, DOI 10.1074/jbc.M103530200; Kadamur G, 2016, J BIOL CHEM, V291, P11394, DOI 10.1074/jbc.M116.723940; Kadamur G, 2013, ANNU REV PHYSIOL, V75, P127, DOI 10.1146/annurev-physiol-030212-183750; Kelley GG, 2004, BIOCHEM J, V378, P129, DOI 10.1042/BJ20031370; Kelley GG, 2001, EMBO J, V20, P743, DOI 10.1093/emboj/20.4.743; Kim CG, 1996, J BIOL CHEM, V271, P21187, DOI 10.1074/jbc.271.35.21187; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Korasick DA, 2018, PROTEIN SCI, V27, P814, DOI 10.1002/pro.3376; Lyon AM, 2014, STRUCTURE, V22, P1844, DOI 10.1016/j.str.2014.10.008; Lyon AM, 2013, MOL PHARMACOL, V84, P488, DOI 10.1124/mol.113.087403; Lyon AM, 2013, NAT STRUCT MOL BIOL, V20, P355, DOI 10.1038/nsmb.2497; Lyon AM, 2011, NAT STRUCT MOL BIOL, V18, P999, DOI 10.1038/nsmb.2095; Madukwe JC, 2018, J BIOL CHEM, V293, P6387, DOI 10.1074/jbc.RA118.002354; Mezzasalma TM, 2007, J BIOMOL SCREEN, V12, P418, DOI 10.1177/1087057106297984; Mylonas E, 2007, J APPL CRYSTALLOGR, V40, pS245, DOI 10.1107/S002188980700252X; Oestreich EA, 2007, J BIOL CHEM, V282, P5488, DOI 10.1074/jbc.M608495200; Oestreich EA, 2009, J BIOL CHEM, V284, P1514, DOI 10.1074/jbc.M806994200; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; PARK DG, 1993, J BIOL CHEM, V268, P3710; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Runnels LW, 1996, BIOCHEMISTRY-US, V35, P16824, DOI 10.1021/bi961606w; Scheres SHW, 2016, METHOD ENZYMOL, V579, P125, DOI 10.1016/bs.mie.2016.04.012; Seifert JP, 2008, J BIOL CHEM, V283, P29690, DOI 10.1074/jbc.M805038200; Seifert JP, 2006, METHOD ENZYMOL, V406, P260, DOI 10.1016/S0076-6879(06)06019-8; Seifert JP, 2004, J BIOL CHEM, V279, P47992, DOI 10.1074/jbc.M407111200; Singer AU, 2002, NAT STRUCT BIOL, V9, P32, DOI 10.1038/nsb731; Skou S, 2014, NAT PROTOC, V9, P1727, DOI 10.1038/nprot.2014.116; Smrcka AV, 2015, J CARDIOVASC PHARM, V65, P203, DOI 10.1097/FJC.0000000000000195; Smrcka AV, 2012, CELL SIGNAL, V24, P1333, DOI 10.1016/j.cellsig.2012.01.009; SMRCKA AV, 1993, J BIOL CHEM, V268, P9667; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Trewhella J, 2017, ACTA CRYSTALLOGR D, V73, P710, DOI 10.1107/S2059798317011597; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Waldo GL, 2010, SCIENCE, V330, P974, DOI 10.1126/science.1193438; Wing MR, 2001, J BIOL CHEM, V276, P48257, DOI 10.1074/jbc.C100574200; Zhang LH, 2013, CELL, V153, P216, DOI 10.1016/j.cell.2013.02.047; Zhang LH, 2011, J BIOL CHEM, V286, P23012, DOI 10.1074/jbc.M111.231993; Zhang W, 2001, J BIOL CHEM, V276, P2503, DOI 10.1074/jbc.M003562200	65	5	5	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2018	293	45					17477	17490		10.1074/jbc.RA118.003656	http://dx.doi.org/10.1074/jbc.RA118.003656			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ9EI	30242131	Green Published, hybrid			2022-12-26	WOS:000449799000014
J	Gilberti, M; Baruffini, E; Donnini, C; Dallabona, C				Gilberti, Micol; Baruffini, Enrico; Donnini, Claudia; Dallabona, Cristina			Pathological alleles of MPV17 modeled in the yeast Saccharomyces cerevisiae orthologous gene SYM1 reveal their inability to take part in a high molecular weight complex	PLOS ONE			English	Article							MITOCHONDRIAL-DNA DEPLETION; HUMAN-DISEASE; PROTEIN; DEFECTS; ENCODES; REPLICATION; MUTATIONS; CHANNEL	Mitochondrial DNA depletion syndromes (MDDS) are a genetically and clinically heterogeneous group of human diseases caused by mutations in nuclear genes and characterized by a severe reduction in mitochondrial DNA (mtDNA) copy number leading to impaired energy production in affected tissues and organs. Mutations in the MPV17 gene, whose role is still elusive, were described as cause of the hepatocerebral form of MDDS and Navajo neuro-hepathopathy. The high degree of conservation observed between MPV17 and its yeast homolog SYM1 made the latter a good model for the study of the pathology. Here, we used Saccharomyces cerevisiae to elucidate the molecular consequences of seven MPV17 missense mutations identified in patients and localized in different protein domains. The phenotypic analysis of the appropriate sym1 mutant strains created demonstrated deleterious effect for all mutations regarding OXPHOS metabolism and mtDNA stability. We deepened the pathogenic effect of the mutations by investigating whether they prevented the correct protein localization into the mitochondria or affected the stability of the proteins. All the Sym1 mutant proteins correctly localized into the mitochondria and only one mutation predominantly affects protein stability. All the other mutations compromised the formation of the high molecular weight complex of unknown composition, previously identified both in yeast, cell cultures and mouse tissues, as demonstrated by the consistent fraction of the Sym1 mutant proteins found free or in not fully assembled complex, strengthening its role as protein forming part of a high molecular weight complex.	[Gilberti, Micol; Baruffini, Enrico; Donnini, Claudia; Dallabona, Cristina] Univ Parma, Dept Chem Life Sci & Environm Sustainabil, Parma, Italy	University of Parma	Donnini, C (corresponding author), Univ Parma, Dept Chem Life Sci & Environm Sustainabil, Parma, Italy.	claudia.donnini@unipr.it	Baruffini, Enrico/AAL-2608-2020; Baruffini, Enrico/C-1057-2015; Donnini, Claudia/B-5548-2015	Baruffini, Enrico/0000-0002-8280-7849; Baruffini, Enrico/0000-0002-8280-7849; Donnini, Claudia/0000-0002-4901-2358; DALLABONA, Cristina/0000-0003-4397-9143	Telethon Foundation [GGP15041]	Telethon Foundation(Fondazione Telethon)	This work was supported by Telethon Foundation GGP15041 (www.telethon.it).	Antonenkov VD, 2015, J BIOL CHEM, V290, P13840, DOI 10.1074/jbc.M114.608083; Baruffini E, 2010, METHODS, V51, P426, DOI 10.1016/j.ymeth.2010.02.023; BONNEAUD N, 1991, YEAST, V7, P609, DOI 10.1002/yea.320070609; Bottani E, 2014, MOL THER, V22, P10, DOI 10.1038/mt.2013.230; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Copeland WC, 2012, CRIT REV BIOCHEM MOL, V47, P64, DOI 10.3109/10409238.2011.632763; Dallabona C, 2010, HUM MOL GENET, V19, P1098, DOI 10.1093/hmg/ddp581; El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017; El-Hattab AW, 2010, MOL GENET METAB, V99, P300, DOI 10.1016/j.ymgme.2009.10.003; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Glick BS, 1995, METHOD ENZYMOL, V260, P213, DOI 10.1016/0076-6879(95)60139-2; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Karadimas CL, 2006, AM J HUM GENET, V79, P544, DOI 10.1086/506913; KARASAWA M, 1993, HUM MOL GENET, V2, P1829, DOI 10.1093/hmg/2.11.1829; Krauss J, 2013, BIOL OPEN, V2, P703, DOI 10.1242/bio.20135132; Lodi T, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00106; Lollgen S, 2015, BIOL CHEM, V396, P13, DOI 10.1515/hsz-2014-0198; Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5; Reinhold R, 2012, MOL CELL BIOL, V32, P5009, DOI 10.1128/MCB.00843-12; Rokka A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005090; Rosa ID, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005779; Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765; Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017; Trott A, 2004, EUKARYOT CELL, V3, P620, DOI 10.1128/EC.3.3.620-631.2004; Zeviani M, 1997, MOL HUM REPROD, V3, P133, DOI 10.1093/molehr/3.2.133	26	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0205014	10.1371/journal.pone.0205014	http://dx.doi.org/10.1371/journal.pone.0205014			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273399	gold, Green Published, Green Submitted			2022-12-26	WOS:000446124700058
J	Ma, MH; Liang, SD				Ma, Minghui; Liang, Shidong			An optimization approach for freeway network coordinated traffic control and route guidance	PLOS ONE			English	Article							VARIABLE-SPEED LIMITS; PREDICTIVE CONTROL; MOTORWAY NETWORKS; CONTROL SCHEME; CONGESTION; EMISSIONS; WAVES	Traffic congestion in freeway network is a prevalent transportation problem and leads to a strong degradation of freeway network facilities. This paper proposes a new coordinated optimization approach for freeway network, aiming to relieve the traffic congestion in freeway network equipped with the coordinated traffic controllers. The challenge is how to solve the problem between the traffic control goals of each path and those of the network. In this paper, the bi-level programming theory is used to address this problem. More exactly, in the path level, the optimal control model is designed to relieve congestion in each path of the test network. Furthermore, in the network level, the optimal model considers the traffic equilibrium and cost optimization. The efficiency of the proposed approach is tested on a well-known traffic network calibrated by the field test data of freeway network. The results show that the proposed approach has positive effects in balancing traffic load and improving the service level of freeway networks.	[Ma, Minghui] Shanghai Univ Engn Sci, Automobile Engn Coll, Shanghai, Peoples R China; [Liang, Shidong] Univ Shanghai Sci & Technol, Business Sch, Shanghai, Peoples R China	Shanghai University of Engineering Science; University of Shanghai for Science & Technology	Liang, SD (corresponding author), Univ Shanghai Sci & Technol, Business Sch, Shanghai, Peoples R China.	sdliang@hotmail.com		Liang, Shidong/0000-0002-2191-6187	Shanghai Youth Teacher Training Assistance Scheme [ZZGCD16025, ZZslg18013]; National Natural Science Foundation of China [71801153, 71801149]	Shanghai Youth Teacher Training Assistance Scheme; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Research was supported by Shanghai Youth Teacher Training Assistance Scheme (ZZGCD16025, ZZslg18013), National Natural Science Foundation of China (Grant NO. 71801153), and National Natural Science Foundation of China (Grant NO. 71801149). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Aty M, 2017, TRANSP RES PROC, V27, P577, DOI 10.1016/j.trpro.2017.12.061; Carlson RC, 2014, TRANSPORT RES C-EMER, V46, P209, DOI 10.1016/j.trc.2014.05.017; Habtemichael FG, 2013, TRANSPORT RES REC, P7, DOI 10.3141/2386-02; Hadiuzzaman M, 2013, CAN J CIVIL ENG, V40, P46, DOI 10.1139/cjce-2012-0101; Han Y, 2017, TRANSPORT RES C-EMER, V77, P405, DOI 10.1016/j.trc.2017.02.009; Hasanpour MZ, 2017, ENG TECHNOL APPL SCI, V7, P1535; Hegyi A, 2003, TRANSPORT RES REC, P167, DOI 10.3141/1852-21; Hellinga B, 2011, J TRANSP ENG, V137, P260, DOI 10.1061/(ASCE)TE.1943-5436.0000214; Heydecker BG, 2011, TRANSPORT RES C-EMER, V19, P206, DOI 10.1016/j.trc.2010.05.008; Jamshidnejad A., 2017, IEEE T CONTR SYST T, VPP, P1; Karimi A, 2004, P AMER CONTR CONF, P5533; Kotsialos A, 2002, IEEE T INTELL TRANSP, V3, P282, DOI 10.1109/TITS.2002.806804; Kotsialos A, 2001, TRANSPORT RES REC, P55; Kotsialos A, 2002, TRANSPORT RES C-EMER, V10, P65, DOI 10.1016/S0968-090X(01)00005-5; Li ZB, 2014, ACCIDENT ANAL PREV, V72, P134, DOI 10.1016/j.aap.2014.06.018; Liu M, 2016, INT J MODERN PHYS C, V27; Ma M, 2016, T I MEASUREMENT CONT; Ma M, 2015, MATH PROBL ENG, V2015, P1; Messmer A., 1990, TRAF C ENG CONTROL, V31, P466, DOI DOI 10.1007/978-1-4419-6142-611; Pasquale C, 2017, TRANSPORT RES C-EMER, V80, P384, DOI 10.1016/j.trc.2017.04.007; Pasquale C, 2016, IFAC PAPERSONLINE, V49, P329, DOI 10.1016/j.ifacol.2016.07.055; Wang YB, 2000, TRAFFIC AND TRANSPORTATION STUDIES, P642; Yang XF, 2013, PROCD SOC BEHV, V96, P2362, DOI 10.1016/j.sbspro.2013.08.265	24	6	6	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204255	10.1371/journal.pone.0204255	http://dx.doi.org/10.1371/journal.pone.0204255			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265696	Green Published, Green Submitted, gold			2022-12-26	WOS:000446005500022
J	Chithrameenal, K; Alagarasan, G; Raveendran, M; Robin, S; Meena, S; Ramanathan, A; Ramalingam, J				Chithrameenal, Kannan; Alagarasan, Ganesh; Raveendran, Muthurajan; Robin, Sabariappan; Meena, Suresh; Ramanathan, Ayyasamy; Ramalingam, Jegadeesan			Genetic enhancement of phosphorus starvation tolerance through marker assisted introgression of OsPSTOL1 gene in rice genotypes harbouring bacterial blight and blast resistance	PLOS ONE			English	Article							ORYZA-SATIVA L.; BASMATI RICE; PHOSPHATE ACQUISITION; CONFERRING RESISTANCE; REPEAT PROTEIN; SELECTION; EFFICIENCY; VARIETY; IDENTIFICATION; IMPROVEMENT	Phosphorus (P), an essential macronutrient, is a prerequisite for various plant-growth mechanisms including root establishment/development, early/late vegetative stage development and reproductive stage development. Rice (Oryza sativa) is very sensitive to P starvation. Most cultivated genotypes have poor tolerance levels to P deficiency and consequently the grain yield is severely affected by P starvation. Since P deficiency of soils is a major concern of rice production areas, it is necessary to develop new cultivars with enhanced P tolerance. This is also an expectation of farmers and the Agriculture ministry of southern states of India where rice cultivation is intensive. Our objective was to introgress the phosphorus starvation tolerance (OsPSTOL1) gene through marker-assisted backcross breeding (MABB) in to two intermediate genetic stocks of popular local-varieties namely, ASD 16 and ADT 43 which harbour bacterial blight and blast resistance (R) genes. To delve into the P starvation phenotypic effect, we have generated a set of four backcross inbred lines (BILs) with enhanced P starvation tolerance. The developed BILs showed altered root architecture pattern and greater root surface area with increased P uptake, confirming their adaptability to P deficient soil conditions. Further, a correlation between root traits and low/high P conditions indicates the function of introgressed OsPSTOL1 in BILs. The enhanced root characteristics, therefore, enabled the plants to access and effectively absorb available nutrients from soil. In summary, the unique features of the OsPSTOL1 BILs with bacterial blight and blast resistance can aid varietal development suitable for cultivation in P deficient soils.	[Chithrameenal, Kannan; Alagarasan, Ganesh; Raveendran, Muthurajan; Ramalingam, Jegadeesan] Tamil Nadu Agr Univ, Ctr Plant Mol Biol & Biotechnol, Coimbatore, Tamil Nadu, India; [Robin, Sabariappan; Ramanathan, Ayyasamy] Tamil Nadu Agr Univ, Dept Rice, Ctr Plant Breeding & Genet, Coimbatore, Tamil Nadu, India; [Meena, Suresh] Tamil Nadu Agr Univ, Dept Soil Sci & Agr Chem, Coimbatore, Tamil Nadu, India	Tamil Nadu Agricultural University; Tamil Nadu Agricultural University; Tamil Nadu Agricultural University	Ramalingam, J (corresponding author), Tamil Nadu Agr Univ, Ctr Plant Mol Biol & Biotechnol, Coimbatore, Tamil Nadu, India.	ramalingam.j@tnau.ac.in	J, Ramalingam/AAC-2253-2021	Suresh, Meena/0000-0003-4856-8562; J, Ramalingam/0000-0002-0887-8286; Ganesh, Alagarasan/0000-0003-4255-5023; Muthurajan, Raveendran/0000-0002-8803-7662	Department of Science and Technology, Government of India (GoI) through DST Women Scientist WOS-A program [SR/WOS-A/LS-146/2014]; Biotechnology Information System (BTIS), DBT - GoI; Biotechnology Information System (BTIS), DBT-GoI	Department of Science and Technology, Government of India (GoI) through DST Women Scientist WOS-A program; Biotechnology Information System (BTIS), DBT - GoI; Biotechnology Information System (BTIS), DBT-GoI	This study was funded by Department of Science and Technology, Government of India (GoI) through DST Women Scientist WOS-A program (No. SR/WOS-A/LS-146/2014) to KC and Biotechnology Information System (BTIS), DBT - GoI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the Department of Science and Technology, Government of India (GoI) for supporting the research through DST Women Scientist WOS-A program (No. SR/WOS-A/LS-146/2014) and Biotechnology Information System (BTIS), DBT-GoI for financial assistance. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript. This study was part of the Ph.D. research work of the first author, K.C. We acknowledge Mr. Jothi Basu for assistance in root system architecture studies.	Amudhan R., 2009, THESIS; Balachiranjeevi CH, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0348-8; Chaithra L. T, 2017, THESIS; Chen S, 2011, THEOR APPL GENET, V122, P1331, DOI 10.1007/s00122-011-1534-7; Chin JH, 2010, THEOR APPL GENET, V120, P1073, DOI 10.1007/s00122-009-1235-7; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Divya B, 2014, EUPHYTICA, V200, P61, DOI 10.1007/s10681-014-1146-9; Dokku P, 2013, BIOTECHNOL LETT, V35, P1339, DOI 10.1007/s10529-013-1212-8; Dokku P, 2013, EUPHYTICA, V192, P87, DOI 10.1007/s10681-013-0878-2; Ellur RK, 2016, PLANT SCI, V242, P330, DOI 10.1016/j.plantsci.2015.08.020; Galkovskyi T, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-116; Gamuyao R, 2012, NATURE, V488, P535, DOI 10.1038/nature11346; Ganpatrao W. S, 2011, THESIS; Gopalakrishnan S, 2008, PLANT BREEDING, V127, P131, DOI 10.1111/j.1439-0523.2007.01458.x; Guo LB, 2014, RICE SCI, V21, P65, DOI 10.1016/S1672-6308(13)60174-2; Gupta R., 2012, THESIS; Haefele SM, 2005, PLANT SOIL, V270, P57, DOI 10.1007/s11104-004-1131-5; Hasan BR., 1996, CROPS, V10, P4; Heuer S, 2017, PLANT J, V90, P868, DOI 10.1111/tpj.13423; Hittalmani S, 2000, THEOR APPL GENET, V100, P1121, DOI 10.1007/s001220051395; Hossain MF, 2005, FIELD CROP RES, V93, P94, DOI 10.1016/j.fcr.2004.09.017; Huyen L. T. N., 2012, American Journal of Plant Sciences, V3, P981, DOI 10.4236/ajps.2012.37116; IRRI, 2002, STANDARD EVALUATION, V4, P15; Jones B. J., 1990, SOIL TESTING PLANT A; Joseph M, 2004, MOL BREEDING, V13, P377, DOI 10.1023/B:MOLB.0000034093.63593.4c; KAUFFMAN HE, 1973, PLANT DIS REP, V57, P537; Kaushik P, 2004, BIORESOURCE TECHNOL, V94, P203, DOI 10.1016/j.biortech.2003.10.033; Khush G. S., 1989, BACTERIAL BLIGHT RIC, P207; Kim SM, 2015, THEOR APPL GENET, V128, P1933, DOI 10.1007/s00122-015-2557-2; Kumar A, 2014, J EXP BOT, V65, P6265, DOI 10.1093/jxb/eru363; Lin F, 2007, GENETICS, V177, P1871, DOI 10.1534/genetics.107.080648; Magalhaes JV, 2017, PLANT MACRONUTRIENT USE EFFICIENCY: MOLECULAR AND GENOMIC PERSPECTIVES IN CROP PLANTS, P123, DOI 10.1016/B978-0-12-811308-0.00007-7; MCCOUCH SR, 1994, RICE BLAST DISEASE, P167; MEW TW, 1993, PLANT DIS, V77, P5, DOI 10.1094/PD-77-0005; MEW TW, 1987, ANNU REV PHYTOPATHOL, V25, P359, DOI 10.1146/annurev.py.25.090187.002043; Mukherjee A, 2014, J GENET, V93, P683, DOI 10.1007/s12041-014-0424-6; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Neelam K, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00509; OGAWA T, 1993, JARQ-JPN AGR RES Q, V27, P71; Ou SH., 1985, RICE DIS, P61; Perumalsamy S, 2010, PLANT BREEDING, V129, P400, DOI 10.1111/j.1439-0523.2009.01705.x; Perumalsamy S, 2008, THESIS; Piper C.S., 1966, SOIL PLANT ANAL; Poli Yugandhar, 2017, Australian Journal of Crop Science, V11, P548, DOI 10.21475/ajcs.17.11.05.p372; Pradhan SK, 2015, RICE, V8, DOI 10.1186/s12284-015-0051-8; Qu SH, 2006, GENETICS, V172, P1901, DOI 10.1534/genetics.105.044891; Raghothama KG, 2005, PLANT SOIL, V274, P37, DOI 10.1007/s11104-004-2005-6; Rai AK, 2011, J PLANT BIOCHEM BIOT, V20, P55, DOI 10.1007/s13562-010-0026-1; Rohlf F.J., 1993, NTSYS PC; Rose TJ, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00444; Roumen E, 1997, EUR J PLANT PATHOL, V103, P363, DOI 10.1023/A:1008697728788; Sakthivel K, 2017, PLANT BREEDING, V136, P357, DOI 10.1111/pbr.12472; Sakulkoo W, 2018, SCIENCE, V359, P1399, DOI 10.1126/science.aaq0892; Shanmugam T. R., 2006, Agricultura Tropica et Subtropica, V39, P194; Singh VK, 2012, FIELD CROP RES, V128, P8, DOI 10.1016/j.fcr.2011.12.003; Suh JP, 2013, RICE, V6, DOI 10.1186/1939-8433-6-5; Sundaram RM, 2008, EUPHYTICA, V160, P411, DOI 10.1007/s10681-007-9564-6; Sundaram Raman M., 2009, Biotechnology Journal, V4, P400, DOI 10.1002/biot.200800310; Tyagi W, 2017, PROTOPLASMA, V254, P725, DOI 10.1007/s00709-016-0986-7; van Berloo R, 1999, J HERED, V90, P328, DOI 10.1093/jhered/90.2.328; Wang GL, 2017, SCIENCE, V355, P906, DOI 10.1126/science.aam9517; Wissuwa M, 1998, THEOR APPL GENET, V97, P777, DOI 10.1007/s001220050955; Wissuwa M, 2002, THEOR APPL GENET, V105, P890, DOI 10.1007/s00122-002-1051-9; Wissuwa M, 2001, PLANT SOIL, V237, P275, DOI 10.1023/A:1013385620875; Wissuwa M, 2009, PLANT SOIL, V321, P409, DOI 10.1007/s11104-008-9693-2; Wu P, 2013, CURR OPIN PLANT BIOL, V16, P205, DOI 10.1016/j.pbi.2013.03.002; YOSHIDA S, 1976, P471; Yumnam JS, 2017, PLANT GENET RESOUR-C, V15, P221, DOI 10.1017/S1479262115000544; Zhang Y., 2017, PLANT GROWTH REGULAT, P1	69	13	13	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204144	10.1371/journal.pone.0204144	http://dx.doi.org/10.1371/journal.pone.0204144			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30260973	Green Published, Green Submitted, gold			2022-12-26	WOS:000445907400027
J	Veach, RA; Wilson, MH				Veach, Ruth Ann; Wilson, Matthew H.			CRISPR/Cas9 engineering of a KIM-1 reporter human proximal tubule cell linee	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; MOLECULE-1 KIM-1; EPITHELIAL-CELLS; BIOMARKERS; NUCLEASES	We used the CRISPR/Cas9 system to knock-in reporter transgenes at the kidney injury molecule-1 (KIM-1) locus and isolated human proximal tubule cell (HK-2) clones. PCR verified targeted knock-in of the luciferase and eGFP reporter at the KIM-1 locus. HK-2-KIM-1 reporter cells responded to various stimuli including hypoxia, cisplatin, and high glucose, indicative of upregulation of KIM-1 expression. We attempted using CRISPR/Cas9 to also engineer the KIM-1 reporter in telomerase-immortalized human RPTEC cells. However, these cells demonstrated an inability to undergo homologous recombination at the target locus. KIM-1-reporter human proximal tubular cells could be valuable tools in drug discovery for molecules inhibiting kidney injury. Additionally, our gene targeting strategy could be used in other cell lines to evaluate the biology of KIM-1 in vitro or in vivo.	[Veach, Ruth Ann; Wilson, Matthew H.] US Dept Vet Affairs, Nashville, TN 37228 USA; [Veach, Ruth Ann; Wilson, Matthew H.] Vanderbilt Univ, Med Ctr, Div & Nephrol & Hypertens, Dept Med, 221 Kirkland Hall, Nashville, TN 37235 USA; [Wilson, Matthew H.] Vanderbilt Univ, Dept Pharmacol, 221 Kirkland Hall, Nashville, TN 37235 USA	US Department of Veterans Affairs; Vanderbilt University; Vanderbilt University	Wilson, MH (corresponding author), US Dept Vet Affairs, Nashville, TN 37228 USA.; Wilson, MH (corresponding author), Vanderbilt Univ, Med Ctr, Div & Nephrol & Hypertens, Dept Med, 221 Kirkland Hall, Nashville, TN 37235 USA.; Wilson, MH (corresponding author), Vanderbilt Univ, Dept Pharmacol, 221 Kirkland Hall, Nashville, TN 37235 USA.	matthew.wilson@vanderbilt.edu		Veach, Ruth Ann/0000-0003-0038-8802	National Institutes of Health [R01 DK093660]; Department of Veterans Affairs [BX002190, BX004258]; Cell and Genome Engineering Core of the Vanderbilt O'Brien Kidney Center (National Institutes of Health) [P30 DK114809]; Vanderbilt Center for Kidney Disease; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK114809, R01DK093660] Funding Source: NIH RePORTER; Veterans Affairs [I01BX004258, I01BX002190] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); Cell and Genome Engineering Core of the Vanderbilt O'Brien Kidney Center (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Center for Kidney Disease; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by grants from the National Institutes of Health R01 DK093660 and Department of Veterans Affairs BX002190 and BX004258 to MHW. This work was also supported by the Cell and Genome Engineering Core of the Vanderbilt O'Brien Kidney Center (National Institutes of Health P30 DK114809) and the Vanderbilt Center for Kidney Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; de Caestecker M, 2015, J AM SOC NEPHROL, V26, P2905, DOI 10.1681/ASN.2015070832; Gou R, 2016, CELL PHYSIOL BIOCHEM, V38, P2479, DOI 10.1159/000445598; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Ichimura T, 2004, AM J PHYSIOL-RENAL, V286, pF552, DOI 10.1152/ajprenal.00285.2002; Ichimura T, 1998, J BIOL CHEM, V273, P4135, DOI 10.1074/jbc.273.7.4135; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Kokura K, 2016, J GENE MED, V18, P273, DOI 10.1002/jgm.2925; Koyner JL, 2010, CLIN J AM SOC NEPHRO, V5, P2154, DOI 10.2215/CJN.00740110; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lin QZ, 2014, AM J PHYSIOL-RENAL, V306, pF885, DOI 10.1152/ajprenal.00331.2013; Miyagi A, 2016, J AM SOC NEPHROL, V27, P2940, DOI 10.1681/ASN.2016020146; Morizane R, 2017, NAT PROTOC, V12, DOI 10.1038/nprot.2016.170; RYAN MJ, 1994, KIDNEY INT, V45, P48, DOI 10.1038/ki.1994.6; Vaidya VS, 2010, NAT BIOTECHNOL, V28, P478, DOI 10.1038/nbt.1623; Wieser M, 2008, AM J PHYSIOL-RENAL, V295, pF1365, DOI 10.1152/ajprenal.90405.2008; Yang L, 2015, J CLIN INVEST, V125, P1620, DOI 10.1172/JCI75417	19	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204487	10.1371/journal.pone.0204487	http://dx.doi.org/10.1371/journal.pone.0204487			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30260998	gold, Green Published, Green Submitted			2022-12-26	WOS:000445907400059
J	Willmes, M; Ransom, KM; Lewis, LS; Denney, CT; Glessner, JJG; Hobbs, JA				Willmes, Malte; Ransom, Katherine M.; Lewis, Levi S.; Denney, Christian T.; Glessner, Justin J. G.; Hobbs, James A.			IsoFishR: An application for reproducible data reduction and analysis of strontium isotope ratios (Sr-87/Sr-86) obtained via laser-ablation MC-ICP-MS	PLOS ONE			English	Article							PLASMA-MASS-SPECTROMETRY; SR-ISOTOPE; SPATIAL-RESOLUTION; GEOLOGICAL-MATERIALS; IOLITE FREEWARE; TOOTH ENAMEL; R PACKAGE; CARBONATES; ELEMENTS; SCRIPT	The IsoFishR application is a data reduction and analysis tool for laser-ablation strontium isotope data, following common best practices and providing reliable and reproducible results. Strontium isotope ratios (Sr-87/Sr-86) are a powerful geochemical tracer commonly applied in a wide range of scientific fields and laser-ablation inductively coupled mass spectrometry is considered the method of choice to obtain spatially resolved Sr-87/Sr-86 isotope ratios from a variety of sample materials. However, data reduction and analyses methods are variable between different research groups and research communities limiting reproducibility between studies. IsoFishR provides a platform to standardize these methods and can be used for both spot and time-resolved line transects. Furthermore, it provides advanced data analysis tools and filters for outlier removal, noise reduction, and visualization of time resolved data. The application can be downloaded from GitHub (https://github.com/MalteWillmes/IsoFishR) and the source code is available, encouraging future development and evolution of this software.	[Willmes, Malte; Ransom, Katherine M.; Lewis, Levi S.; Denney, Christian T.; Hobbs, James A.] Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA; [Ransom, Katherine M.] Univ Calif Davis, Dept Land Air & Water Dept, Davis, CA USA; [Glessner, Justin J. G.] Univ Calif Davis, Interdisciplinary Ctr Plasma Mass Spectrometry, Davis, CA USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Willmes, M (corresponding author), Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA.	mwillmes@ucdavis.edu	Willmes, Malte/J-3710-2015	Willmes, Malte/0000-0001-8734-5324; Lewis, Levi/0000-0002-9664-9386	Delta Science Program [1167]; California Department of Water Resources [4600011196]; Solano County Water Agency	Delta Science Program; California Department of Water Resources; Solano County Water Agency	Funding disclosure: Parts of this study were funded by the Delta Science Program under Grant No. (1167) to Malte Willmes. The contents of this material do not necessarily reflect the views and policies of the Delta Stewardship Council, nor does mention of trade names or commercial products constitute endorsement or recommendation for use. Kathrine Ransom was funded from the California Department of Water Resources contract #4600011196 to James Hobbs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Julie Griffin, Rachel Fichman, Mackenzie Gilliam, James Chhor, and Brian Healey for testing the application and providing helpful comments. We would also like to thank Chris Donohoe for his important work on the original strontium otolith method excel-macro. The Chinook salmon otoliths were collected by the Biotelemetry lab at UC Davis as part of an ongoing research project funded by the Solano County Water Agency. Finally, we would like to acknowledge the reviewers and the editor for providing valuable feedback which improved the quality of this manuscript.	[Anonymous], 2017, QDOAS VERSION 32 SO; ARROWSMITH P, 1987, ANAL CHEM, V59, P1437, DOI 10.1021/ac00137a014; Attali D., 2017, COLOURPICKER COLOUR; Beard BL, 2000, J FORENSIC SCI, V45, P1049; Belli R, 2017, GEOCHIM COSMOCHIM AC, V199, P247, DOI 10.1016/j.gca.2016.10.024; Benson A, 2013, J ARCHAEOL SCI, V40, P2991, DOI 10.1016/j.jas.2013.02.028; Bentley RA, 2006, J ARCHAEOL METHOD TH, V13, P135, DOI 10.1007/s10816-006-9009-x; Brennan SR, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400124; Chang W., 2017, SHINY WEB APPL FRAME; Chang W., 2018, SHINYDASHBOARD CREAT; CHRISTENSEN JN, 1995, EARTH PLANET SC LETT, V136, P79, DOI 10.1016/0012-821X(95)00181-6; Davidson J, 2001, EARTH PLANET SC LETT, V184, P427, DOI 10.1016/S0012-821X(00)00333-2; De Laeter JR, 2003, PURE APPL CHEM, V75, P683, DOI 10.1351/pac200375060683; Faure G., 2005, ISOTOPES PRINCIPLES, VThird; Fox M, 2017, CHEM GEOL, V467, P30, DOI 10.1016/j.chemgeo.2017.07.001; Hobson KA, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P273, DOI 10.1007/978-90-481-3354-3_13; Horstwood MSA, 2008, GEOCHIM COSMOCHIM AC, V72, P5659, DOI 10.1016/j.gca.2008.08.016; Irrgeher J, 2016, SPECTROCHIM ACTA B, V125, P31, DOI 10.1016/j.sab.2016.09.008; Kelly S, 2005, TRENDS FOOD SCI TECH, V16, P555, DOI 10.1016/j.tifs.2005.08.008; Killick R, 2014, J STAT SOFTW, V58, P1; Lewis J, 2014, CHEM GEOL, V390, P173, DOI 10.1016/j.chemgeo.2014.10.021; Longerich HP, 1996, J ANAL ATOM SPECTROM, V11, P899, DOI 10.1039/ja9961100899; McArthur JM, 2001, J GEOL, V109, P155, DOI 10.1086/319243; Mischel SA, 2017, RAPID COMMUN MASS SP, V31, P1079, DOI 10.1002/rcm.7895; Mokadem F, 2015, EARTH PLANET SC LETT, V415, P111, DOI 10.1016/j.epsl.2015.01.036; Muller W, 2016, J ANAL ATOM SPECTROM, V31, P259, DOI 10.1039/c5ja00311c; Paton C, 2011, J ANAL ATOM SPECTROM, V26, P2508, DOI 10.1039/c1ja10172b; Paul B, 2012, J ANAL ATOM SPECTROM, V27, P700, DOI 10.1039/c2ja10383d; Perrier V, 2018, SHINYWIDGETS CUSTOM; Pozebon D, 2014, J ANAL ATOM SPECTROM, V29, P2204, DOI 10.1039/c4ja00250d; R Core Team, 2018, R LANG ENV STAT COMP; Rittner M, 2012, COMPUT GEOSCI-UK, V42, P152, DOI 10.1016/j.cageo.2011.07.016; Robinson D., 2018, BROOM CONVERT STAT A; Rosman KJR, 1998, PURE APPL CHEM, V70, P217, DOI 10.1351/pac199870010217; Sanborn M, 2003, J ANAL ATOM SPECTROM, V18, P1231, DOI 10.1039/b302513f; Simonetti A, 2008, ARCHAEOMETRY, V50, P371, DOI 10.1111/j.1475-4754.2007.00351.x; Sirot C, 2017, METHODS ECOL EVOL, V8, P1659, DOI 10.1111/2041-210X.12822; Slovak NM, 2012, HDB ENV ISOTOPE GEOC, DOI [10.1007/978-3-642-10637-8, DOI 10.1007/978-3-642-10637-8]; Solari LA, 2011, REV MEX CIENC GEOL, V28, P83; Voerkelius S, 2010, FOOD CHEM, V118, P933, DOI 10.1016/j.foodchem.2009.04.125; VOGEL JC, 1990, NATURE, V346, P747, DOI 10.1038/346747a0; Vroon PZ, 2008, ANAL BIOANAL CHEM, V390, P465, DOI 10.1007/s00216-007-1742-9; Willmes M, 2016, J ARCHAEOL SCI, V70, P102, DOI 10.1016/j.jas.2016.04.017; Wood S.N., 2017, GEN ADDITIVE MODELS; Woodhead J, 2005, J ANAL ATOM SPECTROM, V20, P22, DOI 10.1039/b412730g; Woodhead JD, 2007, GEOSTAND GEOANAL RES, V31, P331; Wortham BE, 2017, EARTH PLANET SC LETT, V463, P310, DOI 10.1016/j.epsl.2017.01.034; Xie Y., 2018, **DATA OBJECT**; Zeileis A, 2005, J STAT SOFTW, V14; Zhang L, 2018, RAPID COMMUN MASS SP, V32, P105, DOI 10.1002/rcm.8011	50	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204519	10.1371/journal.pone.0204519	http://dx.doi.org/10.1371/journal.pone.0204519			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30261018	Green Submitted, Green Published, gold			2022-12-26	WOS:000445907400063
J	Mehanna, N; Mohamed, N; Wordofa, M; Abera, D; Mesfin, A; Wolde, M; Desta, K; Tsegaye, A; Taye, B				Mehanna, Nezar; Mohamed, Nader; Wordofa, Moges; Abera, Dessie; Mesfin, Abiyot; Wolde, Mistire; Desta, Kassu; Tsegaye, Aster; Taye, Bineyam			Allergy-related disorders (ARDs) among Ethiopian primary school-aged children: Prevalence and associated risk factors	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; ATOPIC-DERMATITIS; CHILDHOOD ASTHMA; SYMPTOMS; RHINITIS; URBAN; RHINOCONJUNCTIVITIS; WHEEZE; ECZEMA; SENSITIZATION	Background There has been a noticeable increase in the prevalence of allergy-related disorders (ARDs) in the modern era. Urbanization is believed to be a major environmental risk factor for the onset of ARDs but data from low-to middle-income countries is limited. Objective Our purpose was to assess the prevalence of ARDs and atopy among a population of rural Ethiopian school children and identify environmental and lifestyle factors associated with such disorders. Methods We performed a cross-sectional study on 541 school-children. An interviewer-led questionnaire administered to the mothers of each participant provided information on demographic and lifestyle variables. Questions on allergic disease symptoms were based on the International Study of Asthma and Allergies in Children (ISAAC) core allergy and environmental questionnaire. Skin prick test for common allergens German cockroach (Blattella germanica) and dust mite (Dermatophagoides) was performed to define atopy. Multiple logistic regression analyses were performed to determine the odds ratio between ARDs and atopy with specific environmental and lifestyle habits. Results 541 children responded to the survey questions: the majority of participants were female (60.3%) and aged 10-15 years-old. The prevalence of any ARD was 27%, while the rates of ever-having eczema, rhinitis, and wheeze was found to be 16.8%, 9.6%, and 8.6% respectively. Only 3.6% (19 school-children) tested positive for any skin sensitization. Analysis of associated factors for ARDs found that a family history of allergic disorders (AOR: 2.80; p-value<0.01), use of insecticides (AOR: 2.05; p-value<0.01), and wearing open-toed shoes (AOR: 2.19; p-value = 0.02) were all significantly associated factors. Insecticide use, river-bathing, and infection with intestinal parasites were found to be significantly associated factors for atopy. Other potential risk factors such as frequent use of soap, bacterial infection, and household crowding had no statistical significance. Conclusion Our study suggests that the prevalence of skin sensitization and ARDs in rural populations of developing countries is still relatively low. We identified several possible risk factors for further investigation. Overall, the significance of identified risk factors appears to indicate that genetic predisposition and exposure to environmental pollution are more important to the etiology of ARDs and atopy than specific lifestyle behaviors.	[Mehanna, Nezar; Mohamed, Nader; Taye, Bineyam] Colgate Univ, Dept Biol, Hamilton, NY 13346 USA; [Wordofa, Moges; Abera, Dessie; Mesfin, Abiyot; Wolde, Mistire; Desta, Kassu; Tsegaye, Aster] Addis Ababa Univ, Dept Med Lab Sci, Addis Ababa, Ethiopia	Colgate University; Addis Ababa University	Taye, B (corresponding author), Colgate Univ, Dept Biol, Hamilton, NY 13346 USA.	btaye@colgate.edu	Tsegaye, Aster/AAH-7028-2020	Tsegaye, Aster/0000-0002-9026-4629; Abera, Dessie/0000-0003-1067-4511; Mohamed, Nader/0000-0001-9877-5717	Colgate University research council	Colgate University research council	Colgate University research council funded the study. The views expressed are those of the author(s) and not necessarily those of Colgate University or the Addis Ababa University Collage of Health Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully thank the mothers and children at each school who generously provided information, and the project data collectors and the laboratory technicians for their commitment during the fieldwork. Colgate University research council funded the study. The views expressed are those of the author(s) and not necessarily those of Colgate University or the Addis Ababa University College of Health Sciences. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Abera Kumie, 2002, Ethiopian Journal of Health Development, V16, P303; Ait-Khaled N, 2007, ALLERGY, V62, P247, DOI 10.1111/j.1398-9995.2007.01325.x; Amberbir A, 2014, CLIN EXP ALLERGY, V44, P563, DOI 10.1111/cea.12289; Anandan C, 2010, ALLERGY, V65, P152, DOI 10.1111/j.1398-9995.2009.02244.x; Arathimos R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176293; Asher I, 2014, INT J TUBERC LUNG D, V18, P1269, DOI 10.5588/ijtld.14.0170; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; Blanc PD, 2006, EUR RESPIR J, V27, P85, DOI 10.1183/09031936.06.00061205; Braback L, 2005, EUR RESPIR J, V26, P1064, DOI 10.1183/09031936.05.00022105; Chatzi L, 2007, OCCUP ENVIRON MED, V64, P417, DOI 10.1136/oem.2006.029835; Chereches-Panta Paraschiva, 2011, Maedica (Bucur), V6, P10; Devereux G, 2005, J ALLERGY CLIN IMMUN, V115, P1109, DOI 10.1016/j.jaci.2004.12.1139; Gehring U, 2010, AM J RESP CRIT CARE, V181, P596, DOI 10.1164/rccm.200906-0858OC; Haileamlak A, 2005, J ALLERGY CLIN IMMUN, V115, P370, DOI 10.1016/j.jaci.2004.10.024; Hailu S, 2003, PEDIATR PULM, V35, P427, DOI 10.1002/ppul.10215; Hamid F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067064; Herrant M, 2015, ALLERGY ASTHMA CL IM, V11, DOI 10.1186/s13223-015-0090-0; Hoppin JA, 2017, ENVIRON HEALTH PERSP, V125, P535, DOI 10.1289/EHP315; Jie Y, 2013, REV ENVIRON CONTAM T, V226, P33, DOI 10.1007/978-1-4614-6898-1_2; Kim BK, 2016, ALLERGOL INT, V65, P186, DOI 10.1016/j.alit.2015.11.002; Lule SA, 2017, PEDIAT ALLERG IMM-UK, V28, P377, DOI 10.1111/pai.12719; Nutten S, 2015, ANN NUTR METAB, V66, P8, DOI 10.1159/000370220; Pawankar R., 2011, WORLD ALLERGY ORG WA; Pearce N, 2007, THORAX, V62, P758, DOI 10.1136/thx.2006.070169; Peroni DG, 2003, CLIN EXP ALLERGY, V33, P1349, DOI 10.1046/j.1365-2222.2003.01766.x; Perzanowski MS, 2002, J PEDIATR-US, V140, P582, DOI 10.1067/mpd.2002.122937; Purvis DJ, 2005, BRIT J DERMATOL, V152, P742, DOI 10.1111/j.1365-2133.2005.06540.x; Rodriguez A, 2017, BMJ OPEN RESPIR RES, V4, DOI 10.1136/bmjresp-2017-000205; Rodriguez A, 2011, THORAX, V66, P1043, DOI 10.1136/thoraxjnl-2011-200225; Rutkowski K, 2014, POSTEP DERM ALERGOL, V31, P77, DOI 10.5114/pdia.2014.40936; Scrivener S, 2001, LANCET, V358, P1493, DOI 10.1016/S0140-6736(01)06579-5; Strachan David P., 2000, Thorax, V55, pS2, DOI 10.1136/thorax.55.suppl_1.S2; Taye B, 2015, CLIN EXP ALLERGY, V45, P882, DOI 10.1111/cea.12404; Timm S, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13010093; 김영휘, 2011, [Allergy Asthma & Respiratory Diseases, 알레르기 천식 호흡기질환], V21, P165; Viinanen A, 2005, ALLERGY, V60, P1370, DOI 10.1111/j.1398-9995.2005.00877.x; Weinberg EG, 2000, J ALLERGY CLIN IMMUN, V105, P224, DOI 10.1016/S0091-6749(00)90069-1; Xu F, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13060537; Yazdanbakhsh M, 2002, SCIENCE, V296, P490, DOI 10.1126/science.296.5567.490; Yemaneberhan H, 2004, CLIN EXP ALLERGY, V34, P779, DOI 10.1111/j.1365-2222.2004.1946.x; Yemaneberhan H, 1997, LANCET, V350, P85, DOI 10.1016/S0140-6736(97)01151-3; Zar HJ, 2007, PEDIAT ALLERG IMM-UK, V18, P560, DOI 10.1111/j.1399-3038.2007.00554.x	44	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2018	13	9							e0204521	10.1371/journal.pone.0204521	http://dx.doi.org/10.1371/journal.pone.0204521			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU9BO	30252916	Green Published, gold, Green Submitted			2022-12-26	WOS:000445639700058
J	Valdes, A; Zhao, HX; Pettersson, U; Lind, SB				Valdes, Alberto; Zhao, Hongxing; Pettersson, Ulf; Lind, Sara Bergstrom			Time-resolved proteomics of adenovirus infected cells	PLOS ONE			English	Article							RNA EXPRESSION LEVELS; QUANTITATIVE-PROTEOMICS; MASS-SPECTROMETRY; MESSENGER-RNA; GENE-EXPRESSION; PROTEIN-KINASE; TRANSCRIPTION FACTOR; SIGNALING PATHWAY; CELLULAR-PROTEINS; IMMUNE-RESPONSE	Viral infections cause large problems in the world and deeper understanding of the disease mechanisms is needed. Here we present an analytical strategy to investigate the host cell protein changes during human adenovirus type 2 (HAdV-C2 or Ad2) infection of lung fibro-blasts by stable isotope labelling of amino acids in cell culture (SILAC) and nanoLC-MS/MS. This work focuses on early phase of infection (6 and 12 h post-infection (hpi)) but the data is combined with previously published late phase (24 and 36 hpi) proteomics data to produce a time series covering the complete infection. As many as 2169 proteins were quantitatively monitored from 6 to 36 hpi, while some proteins were time-specific. After applying different filter criteria, 2027 and 2150 proteins were quantified at 6 and 12 hpi and among them, 431 and 544 were significantly altered at the two time points. Pathway analysis showed that the De novo purine and pyrimidine biosynthesis, Glycolysis and Cytoskeletal regulation by Rho GTPase pathways were activated early during infection while inactivation of the Integrin signalling pathway started between 6 and 12 hpi. Moreover, upstream regulator analysis predicted MYC to be activated with time of infection and protein and RNA data for genes controlled by this transcription factor showed good correlation, which validated the use of protein data for this prediction. Among the identified phosphorylation sites, a group related to glycolysis and cytoskeletal reorganization were up-regulated during infection. The results show specific aspects on how the host cell proteins, the final products in the genetic information flow, are influenced by Ad2 infection, which would be overlooked if only knowledge derived from mRNA data is considered.	[Valdes, Alberto; Lind, Sara Bergstrom] Uppsala Univ, Dept Chem BMC Analyt Chem, Uppsala, Sweden; [Zhao, Hongxing; Pettersson, Ulf] Uppsala Univ, Rudbeck Lab, Dept Immunol Genet & Pathol, Beijer Lab,Sci Life Lab, Uppsala, Sweden	Uppsala University; Uppsala University	Lind, SB (corresponding author), Uppsala Univ, Dept Chem BMC Analyt Chem, Uppsala, Sweden.	sara.lind@kemi.uu.se	Lind, Sara Bergstrom/D-3723-2013; Valdés, Alberto/C-3454-2019	Lind, Sara Bergstrom/0000-0002-9510-3816; Valdés, Alberto/0000-0002-7901-5816	Ake Wiberg Foundation [M14-0127]; Magnus Bergvall Foundation [2015-01200, 2016-01675]; Carl Trygger Foundation [CST 15:57]; Clas Groschinsky memory foundation [M1603, M1742]; Kjell and Marta Beijer Foundation	Ake Wiberg Foundation; Magnus Bergvall Foundation; Carl Trygger Foundation; Clas Groschinsky memory foundation; Kjell and Marta Beijer Foundation	This work was supported by Ake Wiberg Foundation (SBL, M14-0127), Magnus Bergvall Foundation (SBL, 2015-01200, 2016-01675), Carl Trygger Foundation (SBL, CST 15:57), Clas Groschinsky memory foundation (SBL, M1603, M1742) and Kjell and Marta Beijer Foundation (UP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; ARANY Z, 1995, NATURE, V374, P81, DOI 10.1038/374081a0; BAGCHI S, 1990, CELL, V62, P659, DOI 10.1016/0092-8674(90)90112-R; Bosshard F, 2013, APPL ENVIRON MICROB, V79, P1325, DOI 10.1128/AEM.03457-12; BOYD JM, 1994, CELL, V79, P341, DOI 10.1016/0092-8674(94)90202-X; Boyer J, 1999, VIROLOGY, V263, P307, DOI 10.1006/viro.1999.9866; Cetin S, 2004, J BIOL CHEM, V279, P24592, DOI 10.1074/jbc.M313620200; Chahrour O, 2015, J PHARMACEUT BIOMED, V113, P2, DOI 10.1016/j.jpba.2015.04.013; Chen CC, 2009, INT J BIOCHEM CELL B, V41, P771, DOI 10.1016/j.biocel.2008.07.025; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; De Koning TJ, 2003, BIOCHEM J, V371, P653, DOI 10.1042/BJ20021785; Evans VC, 2012, NAT METHODS, V9, P1207, DOI [10.1038/nmeth.2227, 10.1038/NMETH.2227]; Firat-Karalar EN, 2011, CURR OPIN CELL BIOL, V23, P4, DOI 10.1016/j.ceb.2010.10.007; Flint J, 1997, ANNU REV GENET, V31, P177, DOI 10.1146/annurev.genet.31.1.177; Granberg F, 2005, VIROLOGY, V343, P236, DOI 10.1016/j.virol.2005.08.023; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P310, DOI 10.1074/mcp.M400219-MCP200; Han JH, 1996, GENE DEV, V10, P461, DOI 10.1101/gad.10.4.461; Hartman ZC, 2007, VIROLOGY, V358, P357, DOI 10.1016/j.virol.2006.08.041; Heldin CH, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-97; Jandova J, 2012, CELL BIOCHEM FUNCT, V30, P687, DOI 10.1002/cbf.2853; Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070; Kallsten M, 2017, VIROLOGY, V511, P240, DOI 10.1016/j.virol.2017.08.032; Kandasamy RK, 2016, NPJ SYST BIOL APPL, V2, DOI 10.1038/npjsba.2016.27; Kawasaki T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00461; Kireeva ML, 1998, J BIOL CHEM, V273, P3090, DOI 10.1074/jbc.273.5.3090; Kostenko S, 2009, CELL MOL LIFE SCI, V66, P3289, DOI 10.1007/s00018-009-0086-3; Koussounadis A, 2015, SCI REP-UK, V5, DOI 10.1038/srep10775; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Kulej K, 2017, MOL CELL PROTEOMICS, V16, pS92, DOI 10.1074/mcp.M116.065987; Lam YW, 2010, MOL CELL PROTEOMICS, V9, P117, DOI 10.1074/mcp.M900338-MCP200; Lane AN, 2015, NUCLEIC ACIDS RES, V43, P2466, DOI 10.1093/nar/gkv047; Lau E, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.15; Lee WH, 2010, TOXICOLOGY, V278, P224, DOI 10.1016/j.tox.2010.02.005; Li E, 1998, J VIROL, V72, P8806, DOI 10.1128/JVI.72.11.8806-8812.1998; Liu N, 2008, PROTEOMICS, V8, P1851, DOI 10.1002/pmic.200700757; Liu YS, 2016, CELL, V165, P535, DOI 10.1016/j.cell.2016.03.014; Lohr K, 2003, J VIROL, V77, P7936, DOI 10.1128/JVI.77.14.7936-7944.2003; Luo YZ, 2017, SCI REP-UK, V7, DOI 10.1038/srep41191; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; McBride AA, 2017, MOL CELL PROTEOMICS, V16, pS65, DOI 10.1074/mcp.O116.065201; Nemerow GR, 1999, MICROBIOL MOL BIOL R, V63, P725, DOI 10.1128/MMBR.63.3.725-734.1999; NOBES CD, 1995, J CELL SCI, V108, P225; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Park SK, 2009, NAT METHODS, V6, P184, DOI 10.1038/nmeth0309-184; Park SS, 2012, J PROTEOMICS, V75, P3720, DOI 10.1016/j.jprot.2012.04.035; Querido E, 2001, GENE DEV, V15, P3104, DOI 10.1101/gad.926401; Saito Y, 2001, MOL CELL BIOL, V21, P6387, DOI 10.1128/MCB.21.19.6387-6394.2001; Sharma V, 2014, BIOCHEM BIOPH RES CO, V453, P220, DOI 10.1016/j.bbrc.2014.06.021; Shen S, 2014, BIOCHEM BIOPH RES CO, V450, P538, DOI 10.1016/j.bbrc.2014.06.008; Shevchenko A, 2000, METH MOL B, V146, P1, DOI 10.1385/1-59259-045-4:1; Shi-Wen X, 2008, CYTOKINE GROWTH F R, V19, P133, DOI 10.1016/j.cytogfr.2008.01.002; Sundberg C, 1996, J CELL BIOL, V132, P741, DOI 10.1083/jcb.132.4.741; Tan HY, 2017, IMMUNITY, V46, P488, DOI 10.1016/j.immuni.2017.02.010; Terry LJ, 2012, P NATL ACAD SCI USA, V109, P3071, DOI 10.1073/pnas.1200494109; Thai M, 2014, CELL METAB, V19, P694, DOI 10.1016/j.cmet.2014.03.009; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Thompson JA, 2012, J VIROL ANTIVIR RES, V1, P1; Tong XM, 2009, CURR OPIN GENET DEV, V19, P32, DOI 10.1016/j.gde.2009.01.002; Troutman TD, 2012, CELL CYCLE, V11, P3559, DOI 10.4161/cc.21572; Tworkowski KA, 2008, P NATL ACAD SCI USA, V105, P6103, DOI 10.1073/pnas.0802095105; Vadlamudi RK, 2002, NAT CELL BIOL, V4, P681, DOI 10.1038/ncb838; Valdes A, 2017, MOL CELL PROTEOMICS, V16, P8, DOI 10.1074/mcp.M116.061481; Viruses He B, 2006, CELL DEATH DIFFER, V13, P393, DOI [10.1038/sj.cdd.4401833, DOI 10.1038/SJ.CDD.4401833]; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; Wold W S, 1995, Curr Top Microbiol Immunol, V199 ( Pt 1), P237; Woodhouse SD, 2010, HEPATOLOGY, V52, P443, DOI 10.1002/hep.23733; WU BJ, 1986, MOL CELL BIOL, V6, P2994, DOI 10.1128/MCB.6.8.2994; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Yates JR, 2009, ANNU REV BIOMED ENG, V11, P49, DOI 10.1146/annurev-bioeng-061008-124934; YEW PR, 1992, NATURE, V357, P82, DOI 10.1038/357082a0; ZAMANIAN M, 1992, EMBO J, V11, P2603, DOI 10.1002/j.1460-2075.1992.tb05325.x; Zeisel MB, 2005, J IMMUNOL, V174, P7393, DOI 10.4049/jimmunol.174.11.7393; Zhao HX, 2007, VIROLOGY, V363, P357, DOI 10.1016/j.virol.2007.02.013; Zhao HX, 2017, J PROTEOME RES, V16, P872, DOI 10.1021/acs.jproteome.6b00834; Zhao HX, 2016, VIROLOGY, V492, P242, DOI 10.1016/j.virol.2016.02.017; Zhao HX, 2015, VIROLOGY, V478, P99, DOI 10.1016/j.virol.2015.01.033; Zhao HX, 2012, VIROLOGY, V424, P115, DOI 10.1016/j.virol.2011.12.006; Zhao HX, 2003, J VIROL, V77, P11006, DOI 10.1128/JVI.77.20.11006-11015.2003; Zhu JG, 2007, J VIROL, V81, P3170, DOI 10.1128/JVI.02192-06	83	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2018	13	9							e0204522	10.1371/journal.pone.0204522	http://dx.doi.org/10.1371/journal.pone.0204522			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU9BO	30252905	Green Published, gold, Green Submitted			2022-12-26	WOS:000445639700059
J	Etbaigha, F; Willms, AR; Poljak, Z				Etbaigha, Fatima; Willms, Allan R.; Poljak, Zvonimir			An SEIR model of influenza A virus infection and reinfection within a farrow-to-finish swine farm	PLOS ONE			English	Article							MATHEMATICAL-MODEL; TRANSMISSION; PIGS; HERDS; H1N1; VACCINATION; ANTIBODIES; IMPACT	Influenza A virus (IAV) in swine is a pathogen that causes a threat to the health as well as to the production of swine. Moreover, swine can spread this virus to other species including humans. The virus persists in different types of swine farms as evident in a number of studies. The core objectives of this study are (i) to analyze the dynamics of influenza infection of a farrow-to-finish swine farm, (ii) to explore the reinfection at the farm level, and finally (iii) to examine the effectiveness of two control strategies: vaccination and reduction of indirect contact. The analyses are conducted using a deterministic Susceptible-Exposed-Infectious-Recovered (SEIR) model. Simulation results show that the disease is maintained in gilts and piglets because of new susceptible pigs entering the population on a weekly basis. A sensitivity analysis shows that the results are not sensitive to variation in the parameters. The results of the reinfection simulation indicate that the virus persists in the entire farm. The control strategies studied in this work are not successful in eliminating the virus within the farm.	[Etbaigha, Fatima; Willms, Allan R.] Univ Guelph, Dept Math & Stat, Guelph, ON N1G 2W1, Canada; [Poljak, Zvonimir] Univ Guelph, Dept Populat Med, Guelph, ON N1G 2W1, Canada	University of Guelph; University of Guelph	Etbaigha, F (corresponding author), Univ Guelph, Dept Math & Stat, Guelph, ON N1G 2W1, Canada.	fetbaigh@uoguelph.ca		Willms, Allan/0000-0003-3502-5163	Ministry of Higher Education and scientific research, Libya	Ministry of Higher Education and scientific research, Libya	This work was supported by Ministry of Higher Education and scientific research, Libya.	Allerson M, 2013, VACCINE, V31, P500, DOI 10.1016/j.vaccine.2012.11.023; Bisen P.S., 2013, EMERGING EPIDEMICS M; Brown IH, 2000, VET MICROBIOL, V74, P29, DOI 10.1016/S0378-1135(00)00164-4; Cador C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163672; Dorjee S, 2013, ZOONOSES PUBLIC HLTH, V60, P383, DOI 10.1111/zph.12010; Easterday B, 1992, DIS SWINE SWINE INFL; Evans CM, 2010, PREV VET MED, V93, P248, DOI 10.1016/j.prevetmed.2009.11.001; GRENFELL BT, 1990, AM J VET RES, V51, P156; Holck J, 2003, PORCINE REPROD RESP, P51; Ivanek R, 2004, J FOOD PROTECT, V67, P2403, DOI 10.4315/0362-028X-67.11.2403; Kothalawala H, 2006, VET QUART, V28, P45, DOI 10.1080/01652176.2006.9695207; Loeffen WLA, 2003, VET IMMUNOL IMMUNOP, V92, P23, DOI 10.1016/S0165-2427(03)00019-9; Loeffen WLA, 2003, VET MICROBIOL, V91, P295, DOI 10.1016/S0378-1135(02)00306-1; Markowska-Daniel I, 2011, VET IMMUNOL IMMUNOP, V142, P81, DOI 10.1016/j.vetimm.2011.03.019; McCaw M, FIELD EXPERIENCES DI; Mughini-Gras L, 2014, PLOS CURRENTS, V7; Olsen CW, 2002, VIRUS RES, V85, P199, DOI 10.1016/S0168-1702(02)00027-8; Olsen CW, 2000, ARCH VIROL, V145, P1399, DOI 10.1007/s007050070098; Pitzer VE, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0138; Pojak Z, 2008, PREV VET MED, V83, P24, DOI 10.1016/j.prevetmed.2007.05.025; Poljak Z, 2008, CAN J VET RES, V72, P7; Pulliam JRC, 2012, J R SOC INTERFACE, V9, P89, DOI 10.1098/rsif.2011.0223; Reynolds Jennifer J H, 2014, PLoS One, V9, pe106177, DOI 10.1371/journal.pone.0106177; Romagosa A, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-120; Rothkotter HJ, 2002, HUM EXP TOXICOL, V21, P533, DOI 10.1191/0960327102ht293oa; Takemae N, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-537; Torremorell M, 2012, TRANSBOUND EMERG DIS, V59, P68, DOI 10.1111/j.1865-1682.2011.01300.x; Van Reeth K, 2001, VACCINE, V19, P4479, DOI 10.1016/S0264-410X(01)00206-7; Van Reeth K, 2008, INFLUENZA OTHER RESP, V2, P99, DOI 10.1111/j.1750-2659.2008.00043.x; Vincent AL, 2008, ADV VIRUS RES, V72, P127, DOI 10.1016/S0065-3527(08)00403-X; Weng L, 2016, PREV VET MED, V134, P58, DOI 10.1016/j.prevetmed.2016.09.018; White LA, 2017, PREV VET MED, V138, P55, DOI 10.1016/j.prevetmed.2016.12.013	32	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2018	13	9							e0202493	10.1371/journal.pone.0202493	http://dx.doi.org/10.1371/journal.pone.0202493			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3MI	30248106	Green Published, gold, Green Submitted			2022-12-26	WOS:000445998100005
J	Hu, CC; Katerelos, M; Choy, SW; Crossthwaite, A; Walker, SP; Pell, G; Lee, M; Cook, N; Mount, PF; Paizis, K; Power, DA				Hu, Chih-Chiang; Katerelos, Marina; Choy, Suet-Wan; Crossthwaite, Amy; Walker, Susan P.; Pell, Gabrielle; Lee, Mardiana; Cook, Natasha; Mount, Peter F.; Paizis, Kathy; Power, David A.			Pre-eclampsia is associated with altered expression of the renal sodium transporters NKCC2, NCC and ENaC in urinary extracellular vesicles	PLOS ONE			English	Article							ANGIOTENSIN-ALDOSTERONE SYSTEM; ACTIVATED PROTEIN-KINASE; CHLORIDE COTRANSPORTER; HYPERTENSIVE DISORDERS; CL-COTRANSPORTER; EXOSOMES; AMPK; PHOSPHORYLATION; EXCRETION; PREGNANCY	Pre-eclampsia is a hypertensive disorder of pregnancy characterised by hypertension and sodium retention by the kidneys. To identify changes in sodium uptake proteins in the tubules of the distal nephron, we studied their expression in urinary extracellular vesicles or exosomes (uEVs). Urine was collected from women with pre-eclampsia or during normal pregnancy, and from healthy non-pregnant controls. uEVs were isolated by centrifugation and analyzed by Western blot. Expression, proteolytic cleavage and phosphorylation was determined by densitometric analysis normalized to the exosome marker CD9. Results showed a significant increase in phosphorylation of the activating S130 site in NKCC2, the drug target for frusemide, in women with pre-eclampsia compared with normal pregnant women. Phosphorylation of the activating sites T101/105 in NKCC2 was similar but the activating T60 site in NCC, the drug target for thiazide diuretics, showed significantly less phosphorylation in pre-eclampsia compared with normal pregnancy. Expression of the larger forms of the a subunit of ENaC, the drug target for amiloride, was significantly greater in pre-eclampsia, with more fragmentation of they subunit. The differences observed are predicted to increase the activity of NKCC2 and ENaC while reducing that of NCC. This will increase sodium reabsorption, and so contribute to hypertension in pre-eclampsia.	[Hu, Chih-Chiang; Walker, Susan P.] Univ Melbourne, Melbourne Med Sch, Parkville, Vic, Australia; [Katerelos, Marina; Mount, Peter F.; Power, David A.] Austin Hlth, Inst Breathing & Sleep IBAS, Kidney Lab, Heidelberg, Vic, Australia; [Choy, Suet-Wan; Crossthwaite, Amy; Lee, Mardiana; Mount, Peter F.; Paizis, Kathy; Power, David A.] Austin Hlth, Dept Nephrol, Heidelberg, Vic, Australia; [Choy, Suet-Wan; Crossthwaite, Amy; Walker, Susan P.; Pell, Gabrielle; Paizis, Kathy] Mercy Hosp Women, Heidelberg, Vic, Australia; [Crossthwaite, Amy; Lee, Mardiana; Mount, Peter F.; Power, David A.] Univ Melbourne, Dept Med, Parkville, Vic, Australia; [Cook, Natasha] Univ Melbourne, Obstet & Gynecol, Parkville, Vic, Australia	University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Institute for Breathing & Sleep (IBAS); Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne	Power, DA (corresponding author), Austin Hlth, Inst Breathing & Sleep IBAS, Kidney Lab, Heidelberg, Vic, Australia.; Power, DA (corresponding author), Austin Hlth, Dept Nephrol, Heidelberg, Vic, Australia.; Power, DA (corresponding author), Univ Melbourne, Dept Med, Parkville, Vic, Australia.	david.power@austin.org.au	Power, David/L-4387-2019; Power, David/AAM-6012-2021	Power, David/0000-0003-3983-0581; Lee, Mardiana/0000-0002-0124-0845; Hu, Chih-Chiang/0000-0002-0912-278X; Choy, Suet-Wan/0000-0001-5838-7779				Andersen H, 2015, NEPHROL DIAL TRANSPL, V30, P781, DOI 10.1093/ndt/gfu402; BROWN MA, 1988, AM J OBSTET GYNECOL, V159, P297, DOI 10.1016/S0002-9378(88)80071-1; Brown MA, 1997, CLIN EXP HYPERTENS, V19, P713, DOI 10.3109/10641969709083181; Buhl KB, 2012, HYPERTENSION, V60, P1346, DOI 10.1161/HYPERTENSIONAHA.112.198879; Cook N, 2009, AM J PHYSIOL-RENAL, V296, pF801, DOI 10.1152/ajprenal.90372.2008; Corbetta S, 2015, NEPHROL DIAL TRANSPL, V30, P621, DOI 10.1093/ndt/gfu362; Davies M, 2014, AM J PHYSIOL-RENAL, V307, pF96, DOI 10.1152/ajprenal.00524.2013; Davies MRP, 2015, KIDNEY BLOOD PRESS R, V40, P509, DOI 10.1159/000368527; Esteva-Font C, 2010, NEPHRON PHYSIOL, V114, pP25, DOI 10.1159/000274468; Fraser SA, 2007, BIOCHEM J, V405, P85, DOI 10.1042/BJ20061850; Fraser SA, 2013, AM J PHYSIOL-RENAL, V305, pF679, DOI 10.1152/ajprenal.00407.2012; Gimenez I, 2005, AM J PHYSIOL-RENAL, V289, pF1341, DOI 10.1152/ajprenal.00214.2005; Gunaratne R, 2010, P NATL ACAD SCI USA, V107, P15653, DOI 10.1073/pnas.1007424107; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Lowe SA, 2015, AUST NZ J OBSTET GYN, V55, P11, DOI 10.1111/ajo.12253; Magee L, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004351.pub3; Mathivanan S, 2009, PROTEOMICS, V9, P4997, DOI 10.1002/pmic.200900351; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Nielsen MR, 2017, PFLUG ARCH EUR J PHY, V469, P1107, DOI 10.1007/s00424-017-1977-z; Passero CJ, 2008, J BIOL CHEM, V283, P36586, DOI 10.1074/jbc.M805676200; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Qi Y, 2016, J AM SOC NEPHROL, V27, P646, DOI 10.1681/ASN.2014111137; Richardson C, 2008, J CELL SCI, V121, P3293, DOI 10.1242/jcs.029223; Richardson C, 2008, J CELL SCI, V121, P675, DOI 10.1242/jcs.025312; Richardson C, 2011, J CELL SCI, V124, P789, DOI 10.1242/jcs.077230; Salih M, 2016, AM J PHYSIOL-RENAL, V310, pF796, DOI 10.1152/ajprenal.00463.2015; Salih M, 2016, CURR OPIN NEPHROL HY, V25, P67, DOI 10.1097/MNH.0000000000000192; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Svenningsen P, 2011, CURR OPIN NEPHROL HY, V20, P529, DOI 10.1097/MNH.0b013e328348bcc7; Terker AS, 2016, KIDNEY INT, V89, P127, DOI 10.1038/ki.2015.289; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tranquilli AL, 2014, PREGNANCY HYPERTENS, V4, P97, DOI [10.1016/j.preghy.2014.02.001, 10.1016/j.preghy.2014.04.007, 10.1016/j.preghy.2014.04.017]; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329; van der Lubbe N, 2012, HYPERTENSION, V60, P741, DOI 10.1161/HYPERTENSIONAHA.112.198135; Wolley MJ, 2017, J AM SOC NEPHROL, V28, P56, DOI 10.1681/ASN.2015111221; Zachar RM, 2015, J AM SOC NEPHROL, V26, P95, DOI 10.1681/ASN.2013111173	38	20	20	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2018	13	9							e0204514	10.1371/journal.pone.0204514	http://dx.doi.org/10.1371/journal.pone.0204514			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3MI	30248150	gold, Green Published			2022-12-26	WOS:000445998100047
J	Bonney, PJ; Malladi, S; Boender, GJ; Weaver, JT; Ssematimba, A; Halvorson, DA; Cardona, CJ				Bonney, Peter J.; Malladi, Sasidhar; Boender, Gert Jan; Weaver, J. Todd; Ssematimba, Amos; Halvorson, David A.; Cardona, Carol J.			Spatial transmission of H5N2 highly pathogenic avian influenza between Minnesota poultry premises during the 2015 outbreak	PLOS ONE			English	Article							VIRUS-INFECTION; UNITED-STATES; RISK-FACTORS; EPIDEMIC; CHICKENS; TURKEYS; SPREAD; MODEL; FOOT	The spatial spread of highly pathogenic avian influenza (HPAI) H5N2 during the 2015 outbreak in the U.S. state of Minnesota was analyzed through the estimation of a spatial transmission kernel, which quantifies the infection hazard an infectious premises poses to an uninfected premises some given distance away. Parameters were estimated using a maximum likelihood method for the entire outbreak as well as for two phases defined by the daily number of newly detected HPAI-positive premises. The results indicate both a strong dependence of the likelihood of transmission on distance and a significant distance-independent component of outbreak spread for the overall outbreak. The results further suggest that HPAI spread differed during the later phase of the outbreak. The estimated spatial transmission kernel was used to compare the Minnesota outbreak with previous HPAI outbreaks in the Netherlands and Italy to contextualize the Minnesota transmission kernel results and make additional inferences about HPAI transmission during the Minnesota outbreak. Lastly, the spatial transmission kernel was used to identify high risk areas for HPAI spread in Minnesota. Risk maps were also used to evaluate the potential impact of an early marketing strategy implemented by poultry producers in a county in Minnesota during the outbreak, with results providing evidence that the strategy was successful in reducing the potential for HPAI spread.	[Bonney, Peter J.; Malladi, Sasidhar; Ssematimba, Amos; Halvorson, David A.; Cardona, Carol J.] Univ Minnesota, Dept Vet & Biomed Sci, Secure Food Syst Team, St Paul, MN 55108 USA; [Boender, Gert Jan] Wageningen Univ, Wageningen Biovet Res, Dept Bacteriol & Epidemiol, Lelystad, Netherlands; [Boender, Gert Jan] Res Ctr, Lelystad, Netherlands; [Weaver, J. Todd] USDA, Ctr Epidemiol & Anim Hlth, Sci Technol & Anal Serv, Vet Serv,Anim & Plant Hlth Inspect Serv, Ft Collins, CO USA; [Ssematimba, Amos] Gulu Univ, Fac Sci, Dept Math, Gulu, Uganda	University of Minnesota System; University of Minnesota Twin Cities; Wageningen University & Research; United States Department of Agriculture (USDA)	Bonney, PJ (corresponding author), Univ Minnesota, Dept Vet & Biomed Sci, Secure Food Syst Team, St Paul, MN 55108 USA.	bonne213@umn.edu	Ssematimba, Amos/S-3217-2019	Ssematimba, Amos/0000-0002-5407-2478	United States Department of Agriculture, Animal Plant Health Inspection Service, Veterinary Services [14-9208-0365CA]; University of Minnesota [14-9208-0365CA]	United States Department of Agriculture, Animal Plant Health Inspection Service, Veterinary Services; University of Minnesota(University of Minnesota System)	This work was completed under the cooperative agreement between the United States Department of Agriculture, Animal Plant Health Inspection Service, Veterinary Services and the University of Minnesota for risk assessments to support national preparedness planning for animal health emergencies (14-9208-0365CA). Authors who received this funding include PB, SM, AS, DH, and CC. The funders reviewed the manuscript prior to publication.	Akaike H., 2011, INT ENCY STAT SCI, P25, DOI DOI 10.1007/978-3-642-04898-2_110; Aldous EW, 2010, AVIAN PATHOL, V39, P265, DOI 10.1080/03079457.2010.492825; Baquero OS, 2016, GGSN N SYMBOLS SCALE; Beard C. W., 1984, Proceedings of the United States Animal Health Association, V88, P462; Bertran K, 2016, VET RES, V47, DOI 10.1186/s13567-016-0401-6; Boender GJ, 2007, PLOS COMPUT BIOL, V3, P704, DOI 10.1371/journal.pcbi.0030071; Boender GJ, 2014, VET RES, V45, DOI 10.1186/s13567-014-0075-x; Boender GJ, 2010, EPIDEMICS-NETH, V2, P36, DOI 10.1016/j.epidem.2010.03.001; Bos MEH, 2009, PREV VET MED, V88, P278, DOI 10.1016/j.prevetmed.2008.12.003; Burnham KP., 2002, MODEL SELECTION MULT, V2, P70; Busani L, 2009, VET J, V181, P171, DOI 10.1016/j.tvjl.2008.02.013; Capua I, 2000, AVIAN PATHOL, V29, P289, DOI 10.1080/03079450050118403; DeJesus E, 2016, VIROLOGY, V499, P52, DOI 10.1016/j.virol.2016.08.036; Dorigatti I, 2010, EPIDEMICS-NETH, V2, P29, DOI 10.1016/j.epidem.2010.01.002; Garber L, 2016, AVIAN DIS, V60, P460, DOI 10.1637/11351-121715-Reg; Halvorson DA, 2009, REV SCI TECH OIE, V28, P359, DOI 10.20506/rst.28.1.1866; Hayama Y, 2013, PREV VET MED, V112, P183, DOI 10.1016/j.prevetmed.2013.08.010; McQuiston JH, 2005, JAVMA-J AM VET MED A, V226, P767, DOI 10.2460/javma.2005.226.767; Miller P.J., 2013, DIS POULTRY, V5th ed., P89; NARAYAN O, 1969, ARCH GES VIRUSFORSCH, V26, P149, DOI 10.1007/BF01241184; Nash JC, 2014, J STAT SOFTW, V60, P1; Nash JC, 2011, J STAT SOFTW, V43, P1; R Core Team, 2013, R LANG ENV STAT COMP; Rorres C, 2011, AVIAN DIS, V55, P35, DOI 10.1637/9429-061710-Reg.1; Savill Nicholas J, 2006, BMC Vet Res, V2, P3, DOI 10.1186/1746-6148-2-3; Spackman E, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0890-6; Ssematimba A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040929; Ster IC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000502; Ster IC, 2009, EPIDEMICS-NETH, V1, P21, DOI 10.1016/j.epidem.2008.09.001; Stoute S, 2016, AVIAN DIS, V60, P688, DOI 10.1637/11314-110615-Case.1; Torchetti MK, 2014, NOVEL EURASIAN HIGHL; U.S. Department of Agriculture; Animal and Plant Health Inspection Service; Surveillance P and Response Services; Veterinary Services, 2016, FIN REP 2014 2015 OU; U.S. Department of Agriculture APHIS Veterinary Services, 2015, EP OTH AN HPAI AFF P; U.S. Department of Agriculture APHIS Veterinary Services, 2016, FY2016 HPAI RESP REA; Weaver JT, 2016, AVIAN DIS, V60, P132, DOI 10.1637/11108-042415-Reg; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wolfram Research I, 2014, MATHEMATICA; Wood JP, 2010, ENVIRON SCI TECHNOL, V44, P7515, DOI 10.1021/es1016153	38	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2018	13	9							e0204262	10.1371/journal.pone.0204262	http://dx.doi.org/10.1371/journal.pone.0204262			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU5MM	30240402	Green Published, gold, Green Submitted			2022-12-26	WOS:000445329700034
J	Pardo, R; Vila, M; Cervela, L; de Marco, M; Gama-Perez, P; Gonzalez-Franquesa, A; Statuto, L; Vilallonga, R; Simo, R; Garcia-Roves, PM; Villena, JA				Pardo, Rosario; Vila, Maria; Cervela, Luis; de Marco, Marina; Gama-Perez, Pau; Gonzalez-Franquesa, Alba; Statuto, Lucia; Vilallonga, Ramon; Simo, Rafael; Garcia-Roves, Pablo M.; Villena, Josep A.			Calorie restriction prevents diet-induced insulin resistance independently of PGC-1-driven mitochondrial biogenesis in white adipose tissue	FASEB JOURNAL			English	Article						oxidative metabolism; adipocytes; glucose homeostasis; mitochondria	TRANSCRIPTIONAL CONTROL; PGC-1 COACTIVATORS; SKELETAL-MUSCLE; WEIGHT-LOSS; FAT DIET; INFLAMMATION; MICE; METABOLISM; OBESITY; EXPRESSION	Calorie restriction (CR) exerts remarkable, beneficial effects on glucose homeostasis by mechanisms that are not fully understood. Given the relevance of white adipose tissue (WAT) in glucose homeostasis, we aimed at identifying the main cellular processes regulated in WAT in response to CR in a pathologic context of obesity. For this, a gene-expression profiling study was first conducted in mice fed ad libitum or subjected to 40% CR. We found that the gene network related to mitochondria was the most highly upregulated in WAT by CR. To study the role that increased mitochondrial biogenesis plays on glucose homeostasis following CR, we generated a mouse model devoid of the coactivators peroxisome proliferator-activated receptor coactivator 1 (PGC-1) and PGC-1 specifically in adipocytes. Our results show that mice lacking PGC-1s in adipocytes are unable to increase mitochondrial biogenesis in WAT upon CR. Despite a blunted induction of mitochondrial biogenesis in response to calorie deprivation, mice lacking adipose PGC-1s still respond to CR by improving their glucose homeostasis. Our study demonstrates that PGC-1 coactivators are major regulators of CR-induced mitochondrial biogenesis in WAT and that increased mitochondrial biogenesis and oxidative function in adipose tissue are not required for the improvement of glucose homeostasis mediated by CR.Pardo, R., Vila, M., Cervela, L., de Marco, M., Gama-Perez, P., Gonzalez-Franquesa, A., Statuto, L., Vilallonga, R., Simo, R., Garcia-Roves, P. M., Villena, J. A. Calorie restriction prevents diet-induced insulin resistance independently of PGC-1-driven mitochondrial biogenesis in white adipose tissue.	[Pardo, Rosario; Vila, Maria; Cervela, Luis; de Marco, Marina; Statuto, Lucia; Vilallonga, Ramon; Villena, Josep A.] Univ Autonoma Barcelona, Lab Metab & Obes, Barcelona, Spain; [Simo, Rafael] Univ Autonoma Barcelona, Vall dHebron Inst Recerca, Unit Diabet & Metab, Barcelona, Spain; [Gama-Perez, Pau; Gonzalez-Franquesa, Alba; Garcia-Roves, Pablo M.] Univ Barcelona, Hosp Llobregat, Inst Invest Biomed Bellvitge, Dept Physiol Sci, Barcelona, Spain; [Vilallonga, Ramon] Vall dHebron Univ Hosp, European Accreditat Council Bariatr Surg, Ctr Excellence, Metab & Bariatr Surg Unit, Barcelona, Spain; [Simo, Rafael; Villena, Josep A.] Inst Salud Carlos III, Ctr Invest Biomed Red Diabet & Enfermedades Metab, Barcelona, Spain; [Gonzalez-Franquesa, Alba] Univ Copenhagen, Novo Nordisk Ctr Basic Metab Res, Copenhagen, Denmark	Autonomous University of Barcelona; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Hospital Universitari Vall d'Hebron; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III; University of Copenhagen	Villena, JA (corresponding author), Vall dHebron Inst Recerca, Unit Diabet & Metab, Lab Metab & Obes, Passeig Vall dHebron 119-129, Barcelona 08035, Spain.	josep.villena@vhir.org	Roves, Pablo Garcia/A-7113-2015; Gonzalez-Franquesa, Alba/G-1691-2015; Vilà-Rovira, Maria/GLT-6460-2022; , VILALLONGA/AAO-5437-2020; Cervela Cardona, Luis Manuel/AAP-3192-2021; Garcia-Roves, Pablo M./X-4585-2018	Gonzalez-Franquesa, Alba/0000-0001-9081-753X; Villena, Josep A/0000-0002-2200-2985; Simo Canonge, Rafael/0000-0003-0475-3096; Cervela Cardona, Luis Manuel/0000-0002-7293-4473; Garcia-Roves, Pablo M./0000-0002-8371-2067	Ministerio de Economia y competitividad (MINECO/FEDER; Spain) [SAF2011-23886, SAF2012-39484]; Instituto de Salud Carlos III (ISCIII) [PI15/00701]	Ministerio de Economia y competitividad (MINECO/FEDER; Spain); Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission)	The authors thank Anastasia Kralli (Johns Hopkins University, Baltimore, MD, USA) for the Ppargc1a<SUP>flox/flox</SUP> and Ppargc1b<SUP>flox/flox</SUP> mice and helpful discussions. This work was supported by Grants SAF2011-23886 and SAF2012-39484 from Ministerio de Economia y competitividad (MINECO/FEDER; Spain) to J.A.V. and Grant PI15/00701 from Instituto de Salud Carlos III (ISCIII) to P.M.G.-R. The authors declare no conflicts of interest.	Barger JL, 2017, AGING CELL, V16, P750, DOI 10.1111/acel.12608; Barquissau V, 2018, CELL REP, V22, P1079, DOI 10.1016/j.celrep.2017.12.102; Boden G, 2005, DIABETES, V54, P880, DOI 10.2337/diabetes.54.3.880; Bogacka I, 2005, DIABETES, V54, P1392, DOI 10.2337/diabetes.54.5.1392; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Bruce CR, 2003, J CLIN ENDOCR METAB, V88, P5444, DOI 10.1210/jc.2003-030791; Canto Carles, 2015, Curr Protoc Mouse Biol, V5, P135, DOI 10.1002/9780470942390.mo140061; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Eguchi J, 2011, CELL METAB, V13, P249, DOI 10.1016/j.cmet.2011.02.005; Enguix N, 2013, MOL METAB, V2, P215, DOI 10.1016/j.molmet.2013.05.004; Fabbiano S, 2016, CELL METAB, V24, P434, DOI 10.1016/j.cmet.2016.07.023; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Finley LWS, 2012, P NATL ACAD SCI USA, V109, P2931, DOI 10.1073/pnas.1115813109; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Hamann A, 1996, ENDOCRINOLOGY, V137, P21, DOI 10.1210/en.137.1.21; Hancock CR, 2011, FASEB J, V25, P785, DOI 10.1096/fj.10-170415; Henegar C, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r14; Higami Y, 2003, FASEB J, V17, P415, DOI 10.1096/fj.03-0678fje; HIMMSHAGEN J, 1985, INT J OBESITY, V9, P17; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; International Diabetes Federation, 2015, IDF DIABETES ATLAS; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Kelly TJ, 2009, J BIOL CHEM, V284, P19945, DOI 10.1074/jbc.M109.015164; Khan T, 2009, MOL CELL BIOL, V29, P1575, DOI 10.1128/MCB.01300-08; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lasheras J, 2016, MOL CELL ENDOCRINOL, V430, P77, DOI 10.1016/j.mce.2016.04.004; Lopez-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Meydani SN, 2016, AGING-US, V8, P1416, DOI 10.18632/aging.100994; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nedergaard J, 2013, BBA-MOL CELL BIOL L, V1831, P943, DOI 10.1016/j.bbalip.2013.01.009; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Pardo R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026989; Park CY, 2017, BIOCHEM BIOPH RES CO, V490, P636, DOI 10.1016/j.bbrc.2017.06.090; Pasarica M, 2009, J CLIN ENDOCR METAB, V94, P5155, DOI 10.1210/jc.2009-0947; Pellegrinelli V, 2016, DIABETOLOGIA, V59, P1075, DOI 10.1007/s00125-016-3933-4; Pope BD, 2016, TRENDS CELL BIOL, V26, P745, DOI 10.1016/j.tcb.2016.05.005; REAVEN E, 1983, DIABETES, V32, P175, DOI 10.2337/diabetes.32.2.175; Reilly SM, 2017, NAT REV ENDOCRINOL, V13, P633, DOI 10.1038/nrendo.2017.90; Rong JX, 2007, DIABETES, V56, P1751, DOI 10.2337/db06-1135; ROTHWELL NJ, 1982, BIOSCIENCE REP, V2, P543, DOI 10.1007/BF01314214; Sun K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4485; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; VILLARROYA F, 1986, BIOSCIENCE REP, V6, P669, DOI 10.1007/BF01114762; Villena JA, 2007, P NATL ACAD SCI USA, V104, P1418, DOI 10.1073/pnas.0607696104; Villena JA, 2015, FEBS J, V282, P647, DOI 10.1111/febs.13175; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Wetter TJ, 1999, AM J PHYSIOL-ENDOC M, V276, pE728; Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752; Zamora M, 2014, CURR PHARM DESIGN, V20, P5527, DOI 10.2174/1381612820666140306102514	55	16	17	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2343	2358		10.1096/fj.201800310R	http://dx.doi.org/10.1096/fj.201800310R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30277821	Green Submitted			2022-12-26	WOS:000457296600065
J	Zhan, J; Jia, HS; Semchenko, EA; Bian, YQ; Zhou, AM; Li, ZX; Yang, YD; Wang, JH; Sarkar, S; Totsika, M; Blanchard, H; Jen, FEC; Ye, QZ; Haselhorst, T; Jennings, MP; Seib, KL; Zhou, YQ				Zhan, Jian; Jia, Husen; Semchenko, Evgeny A.; Bian, Yunqiang; Zhou, Amy M.; Li, Zhixiu; Yang, Yuedong; Wang, Jihua; Sarkar, Sohinee; Totsika, Makrina; Blanchard, Helen; Jen, Freda E. -C.; Ye, Qizhuang; Haselhorst, Thomas; Jennings, Michael P.; Seib, Kate L.; Zhou, Yaoqi			Self-derived structure-disrupting peptides targeting methionine aminopeptidase in pathogenic bacteria: a new strategy to generate antimicrobial peptides	FASEB JOURNAL			English	Article						antibiotic resistance; Neisseria gonorrhoeae; Escherichia coli; protein-specific denaturation	PROTEIN SECONDARY STRUCTURE; PARTICLE MESH EWALD; ESCHERICHIA-COLI; IDENTIFICATION; INHIBITION; POTENTIALS; PREDICTION; RESISTANCE; STABILITY; FORCE	Bacterial infection is one of the leading causes of death in young, elderly, and immune-compromised patients. The rapid spread of multi-drug-resistant (MDR) bacteria is a global health emergency and there is a lack of new drugs to control MDR pathogens. We describe a heretofore-unexplored discovery pathway for novel antibiotics that is based on self-targeting, structure-disrupting peptides. We show that a helical peptide, KFF-EcH3, derived from the Escherichia coli methionine aminopeptidase can disrupt secondary and tertiary structure of this essential enzyme, thereby killing the bacterium (including MDR strains). Significantly, no detectable resistance developed against this peptide. Based on a computational analysis, our study predicted that peptide KFF-EcH3 has the strongest interaction with the structural core of the methionine aminopeptidase. We further used our approach to identify peptide KFF-NgH1 to target the same enzyme from Neisseria gonorrhoeae. This peptide inhibited bacterial growth and was able to treat a gonococcal infection in a human cervical epithelial cell model. These findings present an exciting new paradigm in antibiotic discovery using self-derived peptides that can be developed to target the structures of any essential bacterial proteins.Zhan, J., Jia, H., Semchenko, E. A., Bian, Y., Zhou, A. M., Li, Z., Yang, Y., Wang, J., Sarkar, S., Totsika, M., Blanchard, H., Jen, F. E.-C., Ye, Q., Haselhorst, T., Jennings, M. P., Seib, K. L., Zhou, Y. Self-derived structure-disrupting peptides targeting methionine aminopeptidase in pathogenic bacteria: a new strategy to generate antimicrobial peptides.	[Zhan, Jian; Jia, Husen; Semchenko, Evgeny A.; Yang, Yuedong; Blanchard, Helen; Jen, Freda E. -C.; Haselhorst, Thomas; Jennings, Michael P.; Seib, Kate L.; Zhou, Yaoqi] Griffith Univ, Inst Glyc, Parklands Dr, Southport, Qld 4222, Australia; [Bian, Yunqiang; Wang, Jihua; Zhou, Yaoqi] Dezhou Univ, Shandong Key Lab Biophys, Inst Biophys, Dezhou, Peoples R China; [Zhou, Amy M.] Queensland Acad Hlth Sci, Southport, Qld, Australia; [Li, Zhixiu; Zhou, Yaoqi] Indiana Univ Purdue Univ, Indiana Univ, Sch Informat, Indianapolis, IN 46202 USA; [Sarkar, Sohinee; Totsika, Makrina] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Sch Biomed Sci, Brisbane, Qld, Australia; [Ye, Qizhuang] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Ye, Qizhuang] Shenzhen Univ, Sch Med, Shenzhen, Peoples R China	Griffith University; Dezhou University; Indiana University System; Indiana University-Purdue University Indianapolis; Queensland University of Technology (QUT); Indiana University System; Indiana University Bloomington; Shenzhen University	Zhou, YQ (corresponding author), Griffith Univ, Inst Glyc, Parklands Dr, Southport, Qld 4222, Australia.	yaoqi.zhou@griffith.edu.au	Haselhorst, Thomas/A-5066-2015; Zhou, Yaoqi/B-3284-2009; Jennings, Michael P/G-4822-2013; Li, Zhixiu/AAK-4021-2021; Blanchard, Helen/A-4681-2009; Seib, Kate L/B-4670-2015; Yang, Yuedong/C-9394-2009; Jian, Zhan/AAM-2759-2021; Totsika, Makrina/A-8993-2011	Haselhorst, Thomas/0000-0002-3373-8680; Zhou, Yaoqi/0000-0002-9958-5699; Jennings, Michael P/0000-0002-1027-4684; Blanchard, Helen/0000-0003-3372-5027; Seib, Kate L/0000-0002-7094-3528; Yang, Yuedong/0000-0002-6782-2813; Jian, Zhan/0000-0003-0856-2385; Li, Zhixiu/0000-0002-2924-9120; Semchenko, Evgeny/0000-0002-5188-7946; Totsika, Makrina/0000-0003-2468-0293; Sarkar, Sohinee/0000-0001-9364-1920	National Institute of General Medical Sciences of the U.S. National Institutes of Health [R01GM085003]; National Health and Medical Research Council of Australia [1059775, 1121629, 1069370, 1071659, 1045235, 1138466]; National Natural Science Foundation of China [61271378, 61671107, 61540025]; Taishan Scholars Program of the Shandong Province of China	National Institute of General Medical Sciences of the U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Taishan Scholars Program of the Shandong Province of China	The authors acknowledge support from the National Institute of General Medical Sciences of the U.S. National Institutes of Health under award number R01GM085003 and National Health and Medical Research Council of Australia Grants 1059775 (to Y.Z.), 1121629 (to Y.Z., K.L.S., T.H., H.B., and Y.Y), 1069370 (to M.T.), and 1071659 (to M.P.J.), and Fellowships 1045235 (to K.L.S.) and 1138466 (to M.P.J.); National Natural Science Foundation of China Grants 61271378, 61671107, and 61540025 (to J.W.); and the Taishan Scholars Program of the Shandong Province of China. The authors also gratefully acknowledge the use of the High Performance Computing Cluster "Gowonda" to complete this research. This research/project was undertaken with the aid of the research cloud resources provided by the Queensland Cyber Infrastructure Foundation (QCIF). The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.	[Anonymous], 2012, Drug Discov Today Technol, V9, pe1, DOI 10.1016/j.ddtec.2011.07.006; Arya T, 2015, J MED CHEM, V58, P2350, DOI 10.1021/jm501790e; Azzarito V, 2013, NAT CHEM, V5, P161, DOI [10.1038/nchem.1568, 10.1038/NCHEM.1568]; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bonomi M, 2009, COMPUT PHYS COMMUN, V180, P1961, DOI 10.1016/j.cpc.2009.05.011; Broglia RA, 2008, CURR OPIN STRUC BIOL, V18, P60, DOI 10.1016/j.sbi.2007.10.004; Caldarini M, 2009, PROTEINS, V74, P390, DOI 10.1002/prot.22161; CDC, 2013, ANTIBIOTIC RESISTANC; Cresci GA, 2015, NUTR CLIN PRACT, V30, P734, DOI 10.1177/0884533615609899; Croxen MA, 2010, NAT REV MICROBIOL, V8, P26, DOI 10.1038/nrmicro2265; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; Edwards JL, 2016, CRIT REV MICROBIOL, V42, P928, DOI 10.3109/1040841X.2015.1105782; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; French GL, 2006, J ANTIMICROB CHEMOTH, V58, P1107, DOI 10.1093/jac/dkl393; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Guilhelmelli F, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00353; Hashimoto M, 2005, MOL MICROBIOL, V55, P137, DOI 10.1111/j.1365-2958.2004.04386.x; Herring CD, 2004, J BACTERIOL, V186, P2673, DOI 10.1128/JB.186.9.2673-2681.2004; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Holm T, 2006, NAT PROTOC, V1, P1001, DOI 10.1038/nprot.2006.174; Hrobowski YM, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-49; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Laio A, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/12/126601; Lee TT, 2015, NAT MATER, V14, P352, DOI [10.1038/nmat4157, 10.1038/NMAT4157]; Lewis K, 2013, NAT REV DRUG DISCOV, V12, P371, DOI 10.1038/nrd3975; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Ling LL, 2015, NATURE, V517, P455, DOI 10.1038/nature14098; London N, 2010, PROTEINS, V78, P3140, DOI 10.1002/prot.22785; Louis-Jeune C, 2012, PROTEINS, V80, P374, DOI 10.1002/prot.23188; Lu JP, 2010, J MED CHEM, V53, P1329, DOI 10.1021/jm901624n; Lushniak BD, 2014, PUBLIC HEALTH REP, V129, P314, DOI 10.1177/003335491412900402; Matulis D, 2005, BIOCHEMISTRY-US, V44, P5258, DOI 10.1021/bi048135v; Otvos L, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00062; Patel JB, 2015, 25 INFORMATIONAL SUP; RODERICK SL, 1993, BIOCHEMISTRY-US, V32, P3907, DOI 10.1021/bi00066a009; Simon MD, 2014, CHEMBIOCHEM, V15, P713, DOI 10.1002/cbic.201300796; Tan XX, 2005, ANTIMICROB AGENTS CH, V49, P3203, DOI 10.1128/AAC.49.8.3203-3207.2005; Totsika M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026578; Unemo M, 2009, J ANTIMICROB CHEMOTH, V63, P1142, DOI 10.1093/jac/dkp098; White TR, 2011, NAT CHEM BIOL, V7, P810, DOI 10.1038/nchembio.664; Yang YD, 2008, PROTEIN SCI, V17, P1212, DOI 10.1110/ps.033480.107; Yao J, 1997, FEBS LETT, V419, P285, DOI 10.1016/S0014-5793(97)01474-9; Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002	44	4	4	1	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2095	2104		10.1096/fj.201700613RR	http://dx.doi.org/10.1096/fj.201700613RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30260702	Green Published			2022-12-26	WOS:000457296600046
J	Choi, Y; Yang, HJ				Choi, Youngchol; Yang, Hyun Jong			On-demand route discovery in a unicast manner	PLOS ONE			English	Article							WIRELESS AD-HOC; RANDOM FORWARDING GERAF; SENSOR NETWORKS; OVERHEAD	While having high bandwidth-efficiency, the ad-hoc on-demand distance vector (AODV) routing protocol suffers from high signaling overhead due to route request (RREQ) messages flooding, especially when the node density and the number of connections are increased. In order to resolve this broadcast storm problem of the AODV in a high node density mobile ad-hoc network, we propose a geographical on-demand route discovery scheme. Assuming a known location of the destination, the RREQ of the proposed routing protocol is propagated in a unicast manner by employing a novel parsing mechanism for possible duplicate RREQs. The routing overhead of the proposed routing protocol is greatly robust to the node density change. We derive the node density required for the proposed routing protocol to keep the same connectivity as the AODV under the circumstance where the nodes are uniformly distributed. In addition, we present an imaginary destination consideration method to incorporate the uncertainty of the destination's location due to mobility. Computer simulations show that the proposed scheme enables the RREQ propagation to cover 95% of the one-hop communication area centered at the originally known location of the destination without sacrificing the unicast feature.	[Choi, Youngchol] Korea Res Inst Ships & Ocean Engn, Marine ICT Res Div, Daejeon 34103, South Korea; [Yang, Hyun Jong] UNIST, Sch Elect & Comp Engn, Ulsan 44919, South Korea	Korea Research Institute of Ships & Ocean Engineering; Ulsan National Institute of Science & Technology (UNIST)	Yang, HJ (corresponding author), UNIST, Sch Elect & Comp Engn, Ulsan 44919, South Korea.	hjyang@unist.ac.kr	Yang, Hyun Jong/A-4696-2019	Yang, Hyun Jong/0000-0002-0717-3794	National R&D Project "Development of marine RF based ad-hoc network for ship"; National R&D Project "Development of wide-area underwater mobile communication systems" - Ministry of Oceans and Fisheries, Korea [PMS3792, PMS3930]; MSIT (Ministry of Science and ICT), Korea, under the ITRC (Information Technology Research Center) [IITP-2018-2017-0-01635]; IITP grant - Korea government (MSIT) [2018-0-00958]	National R&D Project "Development of marine RF based ad-hoc network for ship"; National R&D Project "Development of wide-area underwater mobile communication systems" - Ministry of Oceans and Fisheries, Korea; MSIT (Ministry of Science and ICT), Korea, under the ITRC (Information Technology Research Center); IITP grant - Korea government (MSIT)	This work was supported by grants from National R&D Projects "Development of marine RF based ad-hoc network for ship" and "Development of wide-area underwater mobile communication systems" funded by Ministry of Oceans and Fisheries, Korea (PMS3792, PMS3930), by the MSIT (Ministry of Science and ICT), Korea, under the ITRC (Information Technology Research Center) support program (IITP-2018-2017-0-01635) supervised by the IITP (Institute for Information & communications Technology Promotion), and by the IITP grant funded by the Korea government (MSIT) (No. 2018-0-00958, Development of joint Electrical/Mechanical Drone Beamforming based on Target Detection and Precise Attitude Control). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from National R&DProjects "Development of marine RF based ad-hoc network for ship" and "Development of wide-area underwater mobile communication systems" funded by Ministry of Oceans and Fisheries, Korea(PMS3792, PMS3930), by the MSIT(Ministry of Science and ICT), Korea, under the ITRC(Information Technology Research Center) support program(IITP-2018-2017-0-01635) supervised by the IITP(Institute for Information & communications Technology Promotion), and by the IITP grant funded by the Korea government(MSIT) (No. 2018-0-00958, Development of joint Electrical/Mechanical Drone Beamforming based on Target Detection and Precise Attitude Control).	Akyildiz I. F., 2005, Ad Hoc Networks, V3, P257, DOI 10.1016/j.adhoc.2005.01.004; Alotaibi E, 2012, COMPUT NETW, V56, P940, DOI 10.1016/j.comnet.2011.10.011; An K, 2016, INT J E-NAVIG MARIT, V4, P13, DOI 10.1016/j.enavi.2016.06.002; [Anonymous], M18421 ITUR; [Anonymous], M13715 ITUR; [Anonymous], 2013, PTC13INFO16 CPG; Belding-Royer E., 2003, RFC3561 AD HOC ON DE; Beraldi R., 2006, Ad Hoc Networks, V4, P547, DOI 10.1016/j.adhoc.2005.06.004; Beraldi R, 2008, AD HOC NETW, V6, P79, DOI 10.1016/j.adhoc.2006.08.002; Boukerche A, 2011, COMPUT NETW, V55, P3032, DOI 10.1016/j.comnet.2011.05.010; Breton D, 2016, INT J E-NAVIG MARIT, V4, P23, DOI 10.1016/j.enavi.2016.06.003; Campolo C, 2015, VEH COMMUN, V2, P158, DOI 10.1016/j.vehcom.2015.06.002; Colagrosso M, 2004, ICWN'04 & PCC'04, VOLS, 1 AND 2, PROCEEDINGS, P924; Cui JH, 2006, IEEE NETWORK, V20, P12; Dubois-Ferriere H., 2003, P 4 ACM INT S MOBILE, P257, DOI DOI 10.1145/778415.778446; Gao W, 2015, IEEE T MOBILE COMPUT, V14, P714, DOI 10.1109/TMC.2014.2333756; Giust F, 2015, IEEE COMMUN MAG, V53, P142, DOI 10.1109/MCOM.2015.7010527; Gorrieri A, 2016, IEEE T MOBILE COMPUT, V15, P2706, DOI 10.1109/TMC.2015.2508804; Haas ZJ, 2006, IEEE ACM T NETWORK, V14, P479, DOI 10.1109/TNET.2006.876186; Hartenstein H, 2008, IEEE COMMUN MAG, V46, P164, DOI 10.1109/MCOM.2008.4539481; Johnson D. B., 1996, DYNAMIC SOURCE ROUTI; Kang C. G., 2006, P IEEE INT S WIR PER; Ko YB, 2000, WIREL NETW, V6, P307, DOI 10.1023/A:1019106118419; Kwon TJ, 2003, P IEEE, V91, P1210, DOI 10.1109/JPROC.2003.814920; Li F, 2007, IEEE VEH TECHNOL MAG, V2, P12, DOI 10.1109/MVT.2007.912927; Li XY, 2005, MOBILE NETW APPL, V10, P61, DOI 10.1023/B:MONE.0000048546.90440.0d; Nikolov M, 2015, IEEE T MOBILE COMPUT, V14, P1530, DOI 10.1109/TMC.2014.2356466; Partan J., 2006, P 1 ACM INT WORKSH U, P11; Perkins C. E., 1994, Computer Communication Review, V24, P234, DOI 10.1145/190809.190336; Perkins CE, 1999, WMCSA '99, SECOND IEEE WORKSHOP ON MOBILE COMPUTING SYSTEMS AND APPLICATIONS, PROCEEDINGS, P90, DOI 10.1109/MCSA.1999.749281; Qayyum A, 2000, MULTIPOINT RELAYING; Reina DG, 2015, AD HOC NETW, V25, P263, DOI 10.1016/j.adhoc.2014.10.001; Shin K, 2015, IEEE COMMUN MAG, V53, P118, DOI 10.1109/MCOM.2015.7010524; Sozer EM, 2000, IEEE J OCEANIC ENG, V25, P72, DOI 10.1109/48.820738; Sze-Yao Ni, 1999, MobiCom'99. Proceedings of Fifth Annual ACM/IEEE International Conference on Mobile Computing and Networking, P151; Wang Y., 2015, P INT C COMP NETW CO; Williams B., 2002, MOBIHOC 2002. Proceedings of the Third ACM International Symposium on Mobile Ad Hoc Networking and Computing, P194, DOI 10.1145/513800.513825; Yoo H, 2015, IEEE T MOBILE COMPUT, V14, P1490, DOI 10.1109/TMC.2014.2359664; Zhang XM, 2013, IEEE T MOBILE COMPUT, V12, P424, DOI 10.1109/TMC.2011.277; Zhang XM, 2011, IEEE T VEH TECHNOL, V60, P3473, DOI 10.1109/TVT.2011.2158865; Zhang X, 2014, 2014 AUSTRALASIAN TELECOMMUNICATION NETWORKS AND APPLICATIONS CONFERENCE (ATNAC), P23, DOI 10.1109/ATNAC.2014.7020868; Zhu C., 2004, P IEEE CONS COMM NET; Zorzi M, 2003, IEEE T MOBILE COMPUT, V2, P337, DOI 10.1109/TMC.2003.1255648; Zorzi M, 2003, IEEE T MOBILE COMPUT, V2, P349, DOI 10.1109/TMC.2003.1255650	44	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204555	10.1371/journal.pone.0204555	http://dx.doi.org/10.1371/journal.pone.0204555			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273378	gold, Green Published, Green Submitted			2022-12-26	WOS:000446124700025
J	Moketla, MB; Wadley, AL; Kamerman, P; Rosa, DD				Moketla, Marvin Blessings; Wadley, Antonia L.; Kamerman, Peter; Rosa, Debra de Assis			Pharmacogenetic variation influences sensory neuropathy occurrence in Southern Africans treated with stavudine-containing antiretroviral therapy	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE INHIBITORS; RIBONUCLEOTIDE REDUCTASE; GENETIC-VARIANTS; RISK-FACTORS; HIV PATIENTS; POPULATION; POLYMORPHISMS; MUTATIONS; TRANSPORT; TOXICITY	Background The use of the HIV antiretroviral drug stavudine (d4T), a thymidine analogue, is associated with the development of mitochondrial toxicities such as sensory neuropathy (SN). Genetic variation in genes relating to d4T transport and metabolism, as well as genetic variation in the thymidine synthesis pathway, could influence occurrence of d4T-related toxicity. Methods We examined this hypothesis in a cohort of HIV-positive South African adults exposed to d4T, including 143 cases with SN and 120 controls without SN. Ten SNPs in four genes associated with stavudine transport, and 16 SNPs in seven genes of the thymidine synthesis / phosphorylation pathway were genotyped using Agena mass spectrometry methods. Associations between sensory neuropathy and genetic variants were evaluated using PLINK by univariate and multivariable analyses. Result Age and height were significantly associated with SN occurrence. Using logistic regression with age and height as covariates, and uncorrected empirical p-values, genetic variation in SLC28A1, SAMHD1, MTHFR and RRM2B was associated with SN in South Africans using d4T. Conclusion Variation in genes relating to d4T transport and metabolism, as well as genetic variation in the thymidine synthesis pathway may influence occurrence of d4T-related SN. These data PLOS contribute to the characterisation of African pharmacogenetic variation and its role in adverse response to antiretroviral therapy.	[Moketla, Marvin Blessings; Rosa, Debra de Assis] Univ Witwatersrand, Fac Sci, Sch Mol & Cell Biol, Johannesburg, South Africa; [Wadley, Antonia L.; Kamerman, Peter] Univ Witwatersrand, Fac Hlth Sci, Sch Physiol, Brain Funct Res Grp, Johannesburg, South Africa; [Kamerman, Peter] Curtin Univ, Fac Hlth Sci, Sch Pharm & Biomed Sci, Perth, WA, Australia	University of Witwatersrand; University of Witwatersrand; Curtin University	Rosa, DD (corresponding author), Univ Witwatersrand, Fac Sci, Sch Mol & Cell Biol, Johannesburg, South Africa.	Debbie.deassisrosa@wits.ac.za	Wadley, Antonia/CAJ-1596-2022	Kamerman, Peter/0000-0002-3103-5295; de Assis Rosa, Debra/0000-0002-9342-2661	National Research Foundation of South Africa [91513]	National Research Foundation of South Africa(National Research Foundation - South Africa)	This work was funded by the National Research Foundation of South Africa (unrated researchers programme), grant no 91513 to DdAR, www.nrf.ac.za. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Amie SM, 2013, J BIOL CHEM, V288, P20683, DOI 10.1074/jbc.M113.472159; Andrade CH, 2011, BRAZ J PHARM SCI, V47, P209, DOI 10.1590/S1984-82502011000200003; [Anonymous], 2010, NAT ANT TREATM GUID; [Anonymous], 2004, NAT ANT TREATM GUID; Ballana E, 2014, ANTIMICROB AGENTS CH, V58, P4804, DOI 10.1128/AAC.03145-14; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Boulle A, 2007, ANTIVIR THER, V12, P753; Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040; Cano-Soldado P, 2012, MED RES REV, V32, P428, DOI 10.1002/med.20221; Chan LMS, 2004, EUR J PHARM SCI, V21, P25, DOI 10.1016/j.ejps.2003.07.003; Cherry CL, 2005, NEUROLOGY, V65, P1778, DOI 10.1212/01.wnl.0000187119.33075.41; Coon S, 2012, AIDS RES HUM RETROV, V28, P1565, DOI [10.1089/AID.2012.0039, 10.1089/aid.2012.0039]; Dandara C, 2011, PHARMACOGENOMICS, V12, P1663, DOI [10.2217/PGS.11.106, 10.2217/pgs.11.106]; de Filippo C, 2012, P ROY SOC B-BIOL SCI, V279, P3256, DOI 10.1098/rspb.2012.0318; Domingo P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067035; Domingo P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057347; ELLEDGE SJ, 1992, TRENDS BIOCHEM SCI, V17, P119, DOI 10.1016/0968-0004(92)90249-9; Errasti-Murugarren E, 2010, PHARMACOGENOMICS, V11, P809, DOI [10.2217/pgs.10.70, 10.2217/PGS.10.70]; Gabriel Stacey, 2009, Curr Protoc Hum Genet, VChapter 2, DOI 10.1002/0471142905.hg0212s60; Goullee H, 2016, J NEUROVIROL, V22, P508, DOI 10.1007/s13365-015-0421-4; Johnson JA, 2003, TRENDS GENET, V19, P660, DOI 10.1016/j.tig.2003.09.008; Kamerman PR, 2012, CURR PAIN HEADACHE R, V16, P226, DOI 10.1007/s11916-012-0257-z; Kampira E, 2013, JAIDS-J ACQ IMM DEF, V63, P647, DOI 10.1097/QAI.0b013e3182968ea5; Kerb R, 2009, LANCET INFECT DIS, V9, P760, DOI 10.1016/S1473-3099(09)70320-2; Kis O, 2010, TRENDS PHARMACOL SCI, V31, P22, DOI 10.1016/j.tips.2009.10.001; Kroetz DL, 2010, CLIN PHARMACOL THER, V87, P109, DOI 10.1038/clpt.2009.226; Maritz J, 2010, MUSCLE NERVE, V41, P599, DOI 10.1002/mus.21535; Menezes CN, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-244; Michaud V, 2012, PHARMACOL REV, V64, P803, DOI 10.1124/pr.111.005553; Miller S. A., 1998, NUCLEIC ACIDS RES, V16, P215, DOI DOI 10.1093/NAR/16.3.1215; Minuesa G, 2011, PHARMACOL THERAPEUT, V132, P268, DOI 10.1016/j.pharmthera.2011.06.007; Molina-Arcas M, 2009, CURR VASC PHARMACOL, V7, P426, DOI 10.2174/157016109789043892; Njuguna C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063596; Pastor-Anglada M, 2005, VIRUS RES, V107, P151, DOI 10.1016/j.virusres.2004.11.005; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rampazzo C, 2010, MUTAT RES-GEN TOX EN, V703, P2, DOI 10.1016/j.mrgentox.2010.06.002; Scholtz CL, 2002, SAMJ S AFR MED J, V92, P464; Selvaraj S, 2014, CLIN PHARMACOL THER, V96, P110, DOI 10.1038/clpt.2014.64; Sinxadi PZ, 2013, AIDS RES HUM RETROV, V29, P1031, DOI [10.1089/aid.2012.0373, 10.1089/AID.2012.0373]; Tekola-Ayele F, 2015, PHARMACOGENOMICS J, V15, P101, DOI 10.1038/tpj.2014.39; van der Put NMJ, 1998, AM J HUM GENET, V62, P1044, DOI 10.1086/301825; Volberding PA, 2010, LANCET, V376, P49, DOI 10.1016/S0140-6736(10)60676-9; Wadley AL, 2013, MOL IMMUNOL, V55, P197, DOI 10.1016/j.molimm.2013.02.002; Wadley AL, 2015, EUR J HUM GENET, V23, P363, DOI 10.1038/ejhg.2014.104; Wadley AL, 2011, J PAIN SYMPTOM MANAG, V41, P700, DOI 10.1016/j.jpainsymman.2010.07.006; Warnich Louise, 2011, Current Pharmacogenomics & Personalized Medicine, V9, P191	47	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204111	10.1371/journal.pone.0204111	http://dx.doi.org/10.1371/journal.pone.0204111			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273369	Green Published, gold, Green Submitted			2022-12-26	WOS:000446124700015
J	Patterson, JA; Nippita, T; Randall, DA; Irving, DO; Ford, JB				Patterson, Jillian A.; Nippita, Tanya; Randall, Deborah A.; Irving, David O.; Ford, Jane B.		Obstet Transfusion Steering Grp	Outcomes of subsequent pregnancy following obstetric transfusion in a first birth	PLOS ONE			English	Article							SEVERE POSTPARTUM HEMORRHAGE; BLOOD-TRANSFUSION; RISK-FACTORS; RECURRENCE; ALLOIMMUNIZATION; VALIDATION; ANTIBODIES; PLACENTA; COHORT; CELL	Background Increasing rates of postpartum haemorrhage and obstetric transfusion mean that more women are entering subsequent pregnancies with a history of blood transfusion. This study investigates subsequent pregnancy outcomes of women with a prior obstetric red cell transfusion, compared to women without a transfusion. Methods All women with a first pregnancy resulting in a liveborn singleton infant of at least 20 weeks gestation delivering in hospitals in New South Wales, Australia, between 2003 and 2012 were included in the study, with followup for second births until June 2015. Linked hospital and births data were used to identify women with a transfusion and/or postpartum haemorrhage in their first birth, time to second pregnancy and adverse birth outcomes (including transfusion, postpartum haemorrhage and severe morbidity) in their subsequent birth. Results There were 358,384 singleton births to primiparous women, with 1.4% receiving an obstetric blood transfusion. Sixty-three percent of women had at least one subsequent birth. The relative risk (RR) of requiring a transfusion in a second birth was 4.9 (95% CI 4.1,6.1) for women with a previous transfusion compared with women without. The risk (RR) of severe morbidity in a second birth was 4.1 times higher (95% CI 2.2,7.4) for those receiving a transfusion without haemorrhage in their first birth compared with women with neither haemorrhage nor transfusion. Conclusion It is important to consider a woman's history of transfusion and/or haemorrhage as part of her obstetric history to ensure management in a manner that minimises risk in subsequent pregnancies.	[Patterson, Jillian A.; Nippita, Tanya; Randall, Deborah A.; Ford, Jane B.] Kolling Inst, Northern Sydney Local Hlth Dist, Clin & Populat Perinatal Hlth Res, St Leonards, NSW, Australia; [Patterson, Jillian A.; Nippita, Tanya; Randall, Deborah A.; Ford, Jane B.] Univ Sydney, Northern Clin Sch, St Leonards, NSW, Australia; [Nippita, Tanya] Royal North Shore Hosp, Dept Obstet & Gynaecol, Northern Sydney Local Hlth Dist, St Leonards, NSW, Australia; [Irving, David O.] Australian Red Cross Blood Serv, Res & Dev, Sydney, NSW, Australia	University of Sydney; Kolling Institute of Medical Research; University of Sydney; Royal North Shore Hospital; Australian Red Cross Blood Service	Patterson, JA (corresponding author), Kolling Inst, Northern Sydney Local Hlth Dist, Clin & Populat Perinatal Hlth Res, St Leonards, NSW, Australia.; Patterson, JA (corresponding author), Univ Sydney, Northern Clin Sch, St Leonards, NSW, Australia.	jillian.patterson@sydney.edu.au	Patterson, Jillian/A-7384-2015; Irving, David/AAS-9892-2021; Peek, Michael/D-5991-2016	Peek, Michael/0000-0001-6055-5129; Patterson, Jillian/0000-0002-9888-9818; Randall, Deborah/0000-0002-5075-0227	Australian National Health and Medical Research Centre (NHMRC) [1094822]; Australian Research Council Future Fellowship [120100069]	Australian National Health and Medical Research Centre (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Future Fellowship(Australian Research Council)	This work was supported by an Australian National Health and Medical Research Centre (NHMRC) Partnership grant (#1094822; https://www.nhmrc.gov.au/). JF is supported by an Australian Research Council Future Fellowship (#120100069; http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ananth CV, 2017, AM J OBSTET GYNECOL, V217, P167, DOI 10.1016/j.ajog.2017.04.016; Baldwin HJ, 2017, ACTA OBSTET GYN SCAN, V96, P1373, DOI 10.1111/aogs.13201; Chen JS, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-68; Copen C.E., 2015, NATL VITAL STAT REPO, V64, P1; Dajak S, 2013, BLOOD TRANSFUS-ITALY, V11, P528, DOI 10.2450/2013.0193-12; Egbor M, 2012, BEST PRACT RES CL OB, V26, P119, DOI 10.1016/j.bpobgyn.2011.10.004; Ford JB, 2007, MED J AUSTRALIA, V187, P391, DOI 10.5694/j.1326-5377.2007.tb01308.x; Ford JB, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0788-5; Ford JB, 2013, AUST HEALTH REV, V37, P495, DOI 10.1071/AH12017; Ford JB, 2012, MATERN CHILD HLTH J, V16, P1542, DOI 10.1007/s10995-011-0919-1; Fullerton G, 2013, BJOG-INT J OBSTET GY, V120, P621, DOI 10.1111/1471-0528.12120; Gardosi J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f108; Gottvall K, 2002, BJOG-INT J OBSTET GY, V109, P254, DOI 10.1111/j.1471-0528.2002.01200.x; Holm C, 2012, BJOG-INT J OBSTET GY, V119, P596, DOI 10.1111/j.1471-0528.2011.03267.x; James AH, 2008, J WOMENS HEALTH, V17, P1279, DOI 10.1089/jwh.2007.0605; Knight M, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-55; Koelewijn JM, 2009, BJOG-INT J OBSTET GY, V116, P655, DOI 10.1111/j.1471-0528.2008.01984.x; Kramer MS, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.07.007; Lain SJ, 2008, AUST NZ J OBSTET GYN, V48, P481, DOI 10.1111/j.1479-828X.2008.00910.x; Liumbruno GM, 2010, BLOOD TRANSFUS-ITALY, V8, P8, DOI 10.2450/2009.0108-09; Mehrabadi A, 2014, J OBSTET GYNAECOL CA, V36, P21, DOI 10.1016/S1701-2163(15)30680-0; National Blood Authority, 2015, PAT BLOOD MAN GUID M; Oberg AS, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.10.872; Pal M, 2015, PATHOLOGY, V47, P151, DOI 10.1097/PAT.0000000000000225; Patterson JA, 2015, VOX SANG, V108, P37, DOI 10.1111/vox.12186; Patterson JA, 2014, OBSTET GYNECOL, V123, P126, DOI 10.1097/AOG.0000000000000054; Prick BW, 2014, BJOG-INT J OBSTET GY, V121, P1005, DOI 10.1111/1471-0528.12531; Rn L, 2013, ACTA OBSTET GYN SCAN, V92, P210, DOI [10.1111/aogs.12034, DOI 10.1111/AOGS.12034]; Roberts CL, 2008, MED CARE, V46, P786, DOI 10.1097/MLR.0b013e318178eae4; Roberts CL, 2012, AUST NZ J OBSTET GYN, V52, P483, DOI 10.1111/j.1479-828X.2012.01470.x; Roberts CL, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-7; Seeho SK, AM J OBSTET GYNECOLO; Smith Heather M, 2013, Immunohematology, V29, P127; The Royal Australian and New Zealand College of Obstetricians and Gynaecologists, 2016, MAN POSTP HAEM PPH; Thompson JF, 2011, AUST NZ J OBSTET GYN, V51, P365, DOI 10.1111/j.1479-828X.2011.01317.x; Wikkelso AJ, 2014, J MATERN-FETAL NEO M, V27, P1661, DOI 10.3109/14767058.2013.872095	36	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0203195	10.1371/journal.pone.0203195	http://dx.doi.org/10.1371/journal.pone.0203195			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265674	gold, Green Published, Green Submitted			2022-12-26	WOS:000446005500006
J	Jeremias, HF; Lousa, D; Hollmann, A; Coelho, AC; Baltazar, CS; Seixas, JD; Marques, AR; Santos, NC; Romao, CC; Soares, CM				Jeremias, Helia F.; Lousa, Diana; Hollmann, Axel; Coelho, Ana C.; Baltazar, Carla S.; Seixas, Joao D.; Marques, Ana R.; Santos, Nuno C.; Romao, Carlos C.; Soares, Claudio M.			Study of the interactions of bovine serum albumin with a molybdenum(II) carbonyl complex by spectroscopic and molecular simulation methods	PLOS ONE			English	Article							MONOXIDE-RELEASING MOLECULES; CRYSTAL-STRUCTURE; CO-RMS; BINDING; FLUORESCENCE; INCLUSION; DRUGS	Therapy with inhaled carbon monoxide (CO) is being tested in human clinical trials, yet the alternative use of prodrugs, CO-Releasing Molecules (CORMs), is conceptually advantageous. These molecules are designed to release carbon monoxide in specific tissues, in response to some locally expressed stimulus, where CO can trigger a cytoprotective response. The design of such prodrugs, mostly metal carbonyl complexes, must consider their ADMET profiles, including their interaction with transport plasma proteins. However, the molecular details of this interaction remain elusive. To shed light into this matter, we focused on the CORM prototype [Mo(eta(5)-Cp)(CH2COOH)(CO)(3)] (ALF414) and performed a detailed molecular characterization of its interaction with bovine serum albumin (BSA), using spectroscopic and computational methods. The experimental results show that ALF414 partially quenches the intrinsic fluorescence of BSA without changing its secondary structure. The interaction between BSA and ALF414 follows a dynamic quenching mechanism, indicating that no stable complex is formed between the protein Trp residues and ALF414. The molecular dynamics simulations are in good agreement with the experimental results and confirm the dynamic and unspecific character of the interaction between ALF414 and BSA. The simulations also provide important insights into the nature of the interactions of this CORM prototype with BSA, which are dominated by hydrophobic contacts, with a contribution from hydrogen bonding. This kind of information is useful for future CORM design.	[Jeremias, Helia F.; Lousa, Diana; Coelho, Ana C.; Baltazar, Carla S.; Romao, Carlos C.; Soares, Claudio M.] Univ Nova Lisboa, ITQB NOVA, Inst Tecnol Quim & Biol Antonio Xavier, Oeiras, Portugal; [Hollmann, Axel; Santos, Nuno C.] Univ Lisbon, Inst Med Mol, Fac Med, Lisbon, Portugal; [Seixas, Joao D.; Marques, Ana R.; Romao, Carlos C.] Alfama Lda, Inst Biol Expt & Tecnol, Oeiras, Portugal	Universidade Nova de Lisboa; Universidade de Lisboa	Romao, CC; Soares, CM (corresponding author), Univ Nova Lisboa, ITQB NOVA, Inst Tecnol Quim & Biol Antonio Xavier, Oeiras, Portugal.; Romao, CC (corresponding author), Alfama Lda, Inst Biol Expt & Tecnol, Oeiras, Portugal.	ccr@itqb.unl.pt; claudio@itqb.unl.pt	Soares, Claudio M/E-2675-2012; Lousa, Diana/S-7808-2016; Santos, Nuno/N-7248-2013	Soares, Claudio M/0000-0003-1154-556X; Lousa, Diana/0000-0002-2309-0980; Santos, Nuno/0000-0002-0580-0475; Hollmann, Axel/0000-0002-8060-2997	Fundacao para a Ciencia e a Tecnologia, Portugal [PTDC/QUI-BIQ/117799/2010, Pest-OE/EQB/LA0004/2011]; FEDER funds through COMPETE2020 - Programa Operacional Competitividade e Internacionalizacao (POCI) [LISBOA-01-0145-FEDER-007660]; FCT - Fundacao para a Ci00EAncia e a Tecnologia; FCT [SFRH/BPD/92537, SFRH/BPD/92537/2013, SFRH/BPD/70163/2010]; Alfama Lda; ITQB institutional funds; FCT - Fundacao para a Ciencia e a Tecnologia, Portugal [PTDC/QUI-BIQ/117799/2010, Pest-OE/EQB/LA0004/2011]; FEDER funds through COMPETE2020-Programa Operacional Competitividade e Internacionalizacao (POCI) [LISBOA-01-0145-FEDER-007660]; FCT - Fundacao para a Ciencia e a Tecnologia; Fundação para a Ciência e a Tecnologia [PTDC/QUI-BIQ/117799/2010] Funding Source: FCT	Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); FEDER funds through COMPETE2020 - Programa Operacional Competitividade e Internacionalizacao (POCI); FCT - Fundacao para a Ci00EAncia e a Tecnologia; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Alfama Lda; ITQB institutional funds; FCT - Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); FEDER funds through COMPETE2020-Programa Operacional Competitividade e Internacionalizacao (POCI); FCT - Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology); Fundação para a Ciência e a Tecnologia	This work was financially supported by Fundacao para a Ciencia e a Tecnologia, Portugal, through projects PTDC/QUI-BIQ/117799/2010 and Pest-OE/EQB/LA0004/2011. This work was also financially supported by Project LISBOA-01-0145-FEDER-007660 (Microbiologia Molecular, Estrutural e Celular) funded by FEDER funds through COMPETE2020 - Programa Operacional Competitividade e Internacionalizacao (POCI) and by national funds through FCT - Fundacao para a Ci00EAncia e a Tecnologia. DL was supported by FCT post-doc fellowship SFRH/BPD/92537 The funder Alfama Lda, owned by Alfama Inc. provided support in the form of salaries for authors [CCR, JDS, ARM] as well as costs for the chemistry [JDS] and biological research [ARM] and initial spectroscopic research at IMM (NCS, AH]. JDS and ARM left Alfama Lda in 2011 when it closed all research activities. CCR resumed his academic position at ITQB in July 2011 and remained as probono manager of Alfama Lda and Board member of Alfama Inc until it was acquired by Proterris Inc in 2017, becoming Proterris (Portugal) Lda. This research was continued at ITQB [CCR, ACC, HFJ spectroscopy; CMS, DL, HFJ, CSB, computational studies] and IMM [NCS, AH, spectroscopic studies] using existing ALF414 stock samples and exclusively financed by Fundacao para a Ciencia e a Tecnologia, Portugal [project PTDC/QUI-BIQ/117799/2010 and Pest-OE/EQB/LA0004/2011] as well as ITQB institutional funds. Since 2011 neither Alfama Lda nor Proterris Inc played any further financial, scientific or commercial role in this research, which was carried out at the academic level with specific. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was financially supported by FCT - Fundacao para a Ciencia e a Tecnologia, Portugal, through projects PTDC/QUI-BIQ/117799/2010 and Pest-OE/EQB/LA0004/2011. This work was also financially supported by Project LISBOA-01-0145-FEDER-007660 (Microbiologia Molecular, Estrutural e Celular) funded by FEDER funds through COMPETE2020-Programa Operacional Competitividade e Internacionalizacao (POCI) and by national funds through FCT - Fundacao para a Ciencia e a Tecnologia. DL was supported by FCT post-doc fellowship SFRH/BPD/92537/2013. ACC was supported by FCT post-doc fellowship SFRH/BPD/70163/2010.	Adler AJ, 1973, CIRCULAR DICHROISM O, P675; ARIYARAT.JK, 1969, J CHEM SOC A, P1309, DOI 10.1039/j19690001309; Baptista AM, 1999, BIOPHYS J, V76, P2978, DOI 10.1016/S0006-3495(99)77452-7; Baptista AM, 2001, J PHYS CHEM B, V105, P293, DOI 10.1021/jp002763e; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bertucci C, 2002, CURR MED CHEM, V9, P1463, DOI 10.2174/0929867023369673; Binkley SL, 2010, CHEM COMMUN, V46, P1203, DOI 10.1039/b923688k; Braga SS, 2006, INORG CHIM ACTA, V359, P4757, DOI 10.1016/j.ica.2006.03.017; Chaves-Ferreira M, 2015, ANGEW CHEM INT EDIT, V54, P1172, DOI 10.1002/anie.201409344; Curry S, 1998, NAT STRUCT BIOL, V5, P827, DOI 10.1038/1869; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dorr M, 2014, CURR OPIN CHEM BIOL, V19, P76, DOI 10.1016/j.cbpa.2014.01.005; Fairlamb IJS, 2007, DALTON T, P3603, DOI 10.1039/b707377a; Garcia-Gallego S, 2014, ANGEW CHEM INT EDIT, V53, P9712, DOI 10.1002/anie.201311225; Ghosh S, 2015, J PHYS CHEM B, V119, P7804, DOI 10.1021/acs.jpcb.5b00965; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Heinemann SH, 2014, CHEM COMMUN, V50, P3644, DOI 10.1039/c3cc49196j; HERMANS J, 1984, BIOPOLYMERS, V23, P1513, DOI 10.1002/bip.360230807; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hewison L, 2010, DALTON T, V39, P8967, DOI 10.1039/c0dt00203h; Hu YJ, 2005, J MOL STRUCT, V750, P174, DOI 10.1016/j.molstruc.2005.04.032; Jiang XJ, 2015, CHEM-EUR J, V21, P13065, DOI 10.1002/chem.201501348; Kautz AC, 2016, DALTON T, V45, P18045, DOI 10.1039/c6dt03515a; Kim HP, 2006, ANNU REV PHARMACOL, V46, P411, DOI 10.1146/annurev.pharmtox.46.120604.141053; LEHRER SS, 1971, BIOCHEMISTRY-US, V10, P3254, DOI 10.1021/bi00793a015; Lovering F, 2009, J MED CHEM, V52, P6752, DOI 10.1021/jm901241e; Marques AR, 2012, ORGANOMETALLICS, V31, P5810, DOI 10.1021/om300360c; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Motterlini R, 2010, NAT REV DRUG DISCOV, V9, P728, DOI 10.1038/nrd3228; Otterbein LE, 2009, RESP CARE, V54, P925, DOI 10.4187/002013209793800394; Patra M, 2012, CHEMBIOCHEM, V13, P1232, DOI 10.1002/cbic.201200159; Peters Jr. T., 1995, ALL ALBUMIN BIOCH GE; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Razavet M, 2007, CHEM COMMUN, P2805, DOI 10.1039/b703887a; Romao CC, 2012, CHEM SOC REV, V41, P3571, DOI 10.1039/c2cs15317c; Ryter SW, 2004, BIOESSAYS, V26, P270, DOI 10.1002/bies.20005; Santos NC, 1998, BIOCHEMISTRY-US, V37, P8674, DOI 10.1021/bi9803933; Santos-Silva T, 2011, J AM CHEM SOC, V133, P1192, DOI 10.1021/ja108820s; Scapens D, 2007, DALTON T, P4962, DOI 10.1039/b704832g; Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9; Seixas JD, 2013, DALTON T, V42, P5985, DOI 10.1039/c2dt32174b; Steiger C, 2017, EUR J PHARM BIOPHARM, V118, P3, DOI 10.1016/j.ejpb.2016.11.002; Szabo C, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000721; Timerbaev AR, 2006, CHEM REV, V106, P2224, DOI 10.1021/cr040704h; Wu LY, 2005, PHARMACOL REV, V57, P585, DOI 10.1124/pr.57.4.3; Yamasaki K, 2013, BBA-GEN SUBJECTS, V1830, P5435, DOI 10.1016/j.bbagen.2013.05.005; Yang F, 2014, INT J MOL SCI, V15, P3580, DOI 10.3390/ijms15033580; Zhang WQ, 2011, ORGANOMETALLICS, V30, P4643, DOI 10.1021/om200495h; Zobi F, 2012, DALTON T, V41, P370, DOI 10.1039/c1dt10649j	50	10	10	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204624	10.1371/journal.pone.0204624	http://dx.doi.org/10.1371/journal.pone.0204624			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30261022	Green Published, Green Submitted, gold			2022-12-26	WOS:000445907400082
J	Kang, H; Graybill, PM; Fleetwood, S; Boreyko, JB; Jung, S				Kang, Hosung; Graybill, Philip M.; Fleetwood, Sara; Boreyko, Jonathan B.; Jung, Sunghwan			Seasonal changes in morphology govern wettability of Katsura leaves	PLOS ONE			English	Article							SUPER-HYDROPHOBIC SURFACES; SOLID-SURFACES; WATER; SUPERHYDROPHOBICITY; CONTAMINATION; ABSCISSION; CAPACITY; NEEDLES; LOTUS	Deciduous broad-leaf trees survive and prepare for winter by shedding their leaves in fall. During the fall season, a change in a leaf's wettability and its impact on the leaf-fall are not well understood. In this study, we measure the surface morphology and wettability of Katsura leaves from the summer to winter, and reveal how leaf structural changes lead to wettability changes. The averaged contact angle of leaves decreases from 147 degrees to 124 degrees while the contact-angle hysteresis significantly increases by about 35 degrees, which are attributed to dehydration and erosion of nano-wax. Due to such wettability changes, fall brown leaves support approximately 17 times greater water volume than summer leaves.	[Kang, Hosung; Boreyko, Jonathan B.; Jung, Sunghwan] Virginia Tech, Dept Biomed Engn & Mech, Blacksburg, VA 24061 USA; [Graybill, Philip M.] Virginia Tech, Dept Mech Engn, Blacksburg, VA 24061 USA; [Fleetwood, Sara] Virginia Tech, Dept Mat Sci & Engn, Blacksburg, VA 24061 USA; [Jung, Sunghwan] Cornell Univ, Dept Biol & Environm Engn, Ithaca, NY 14853 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Cornell University	Jung, S (corresponding author), Virginia Tech, Dept Biomed Engn & Mech, Blacksburg, VA 24061 USA.; Jung, S (corresponding author), Cornell Univ, Dept Biol & Environm Engn, Ithaca, NY 14853 USA.	sunnyjsh@cornell.edu	Graybill, Philip M/K-7651-2017; Boreyko, Jonathan B./GXW-2443-2022	Graybill, Philip M/0000-0002-2057-7478; Boreyko, Jonathan B./0000-0003-0344-5868; Fleetwood, Sara/0000-0001-9692-6833				Addicott F.T, 1982, ABSCISSION; Barthlott W, 1997, PLANTA, V202, P1, DOI 10.1007/s004250050096; Blacksburg Weather Forecast Office, 2017, ANN CLIM REP BLACKSB; Boreyko JB, 2011, LANGMUIR, V27, P7502, DOI 10.1021/la201587u; Cassie ABD, 1944, T FARADAY SOC, V40, P0546, DOI 10.1039/tf9444000546; Chien H, 1992, CERCIDIPHYLLUM JAPON; CLARK JB, 1975, PLANT PHYSIOL, V55, P407, DOI 10.1104/pp.55.2.407; Dressaire E, 2016, SOFT MATTER, V12, P200, DOI 10.1039/c5sm02246k; Feng L, 2002, ADV MATER, V14, P1857, DOI 10.1002/adma.200290020; Fernandez V, 2014, PLANT SOIL, V384, P7, DOI 10.1007/s11104-014-2052-6; Franks PJ, 2007, PLANT PHYSIOL, V143, P78, DOI 10.1104/pp.106.089367; FURMIDGE CG, 1962, J COLL SCI IMP U TOK, V17, P309, DOI 10.1016/0095-8522(62)90011-9; Gart S, 2015, PHYS REV APPL, V3, DOI 10.1103/PhysRevApplied.3.044019; Holder CD, 2017, HYDROLOG SCI J, V62, P182, DOI 10.1080/02626667.2016.1217414; Klamerus-Iwan A, 2018, ATMOS POLLUT RES, V9, P455, DOI 10.1016/j.apr.2017.11.006; Klamerus-Iwan A, 2018, J HYDROL, V559, P534, DOI 10.1016/j.jhydrol.2018.02.032; KOZLOWSKI TT, 1976, WATER DEFICITS PLANT, V4, P191, DOI DOI 10.1016/B978-0-12-424154-1.50011-5; LEOPOLD AC, 1961, SCIENCE, V134, P1727, DOI 10.1126/science.134.3492.1727; Marmur A, 2004, LANGMUIR, V20, P3517, DOI 10.1021/la036369u; McHale G, 2004, LANGMUIR, V20, P10146, DOI 10.1021/la0486584; Neinhuis C, 1997, ANN BOT-LONDON, V79, P667, DOI 10.1006/anbo.1997.0400; Neinhuis C, 1998, NEW PHYTOL, V138, P91, DOI 10.1046/j.1469-8137.1998.00882.x; Pallardy S.G., 2010, PHYSL WOODY PLANTS; Papierowska E, 2018, TREES-STRUCT FUNCT, V32, P1253, DOI 10.1007/s00468-018-1707-y; Park KC, 2012, ACS NANO, V6, P3789, DOI 10.1021/nn301112t; REICOSKY DA, 1978, PLANT PHYSIOL, V62, P101, DOI 10.1104/pp.62.1.101; RUBINSTEIN B, 1964, Q REV BIOL, V39, P356, DOI 10.1086/404326; SEXTON R, 1982, ANNU REV PLANT PHYS, V33, P133, DOI 10.1146/annurev.pp.33.060182.001025; Soto D, 2014, SOFT MATTER, V10, P4929, DOI 10.1039/c4sm00513a; Vasileiou T, 2016, P NATL ACAD SCI USA, V113, P13307, DOI 10.1073/pnas.1611631113; Verho T, 2012, P NATL ACAD SCI USA, V109, P10210, DOI 10.1073/pnas.1204328109; Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024; Zwieniecki MA, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0535	33	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0202900	10.1371/journal.pone.0202900	http://dx.doi.org/10.1371/journal.pone.0202900			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30260963	Green Submitted, Green Published, gold			2022-12-26	WOS:000445907400007
J	Li, Y; Li, JQ; Gao, LH; Tian, YQ				Li, Yang; Li, Juanqi; Gao, Lihong; Tian, Yongqiang			Irrigation has more influence than fertilization on leaching water quality and the potential environmental risk in excessively fertilized vegetable soils	PLOS ONE			English	Article							PHOSPHORUS MINERALIZATION; NITROGEN-BALANCE; SYSTEM; GROWTH; GREENHOUSE; MANAGEMENT; CHINA; TEMPERATURE; CALCIUM; PROFILE	Excessive fertilization is a common agricultural practice that often negatively influence soil and environmental quality in intensive vegetable production systems in China. To reduce negative effects of excessive fertilization, current studies generally focused on fertilizer management but not irrigation. In this study, we investigated the effects of fertilization and irrigation on soil properties, leaching water characteristics, plant growth, cucumber yield, irrigation water use efficiency (IWUE) and partial factor productivity of nitrogen (PFPN) in a double cropping system. The treatments included (i) conventional irrigation with conventional N fertilization (IcNc), (ii) optimal irrigation with conventional N fertilization (IoNc), (iii) conventional irrigation with optimal N fertilization (IcNo), and (iv) optimal irrigation with optimal N fertilization (IoNo). In general, fertilization merely influenced concentrations of nitrate (NO3-), phosphorus (P) and potassium (K), but did not affect most leaching water characteristics. In contrast, irrigation influenced pH, EC and concentrations of P, K, Ca, Mg, Na and Cu. Cumulative leached amounts of NO3-, P, K, Ca, Mg, Na, Fe, Cu and Zn were significantly decreased by optimal irrigation as compared to conventional irrigation under same fertilization conditions, but not by optimal fertilization as compared to conventional fertilization under same irrigation conditions. The leachate volume was strongly positively correlated with cumulative leached amounts of all tested elements, and these relationships were obviously influenced by irrigation but not fertilization. The IoNo treatment significantly increased both IWUE and PFPN as compared to the IcNc treatment. However, the IcNo treatment only enhanced PFPN, while the IoNc treatment improved IWUE, when compared to the IcNc treatment. Our results suggested that irrigation has more influence than fertilization on leaching water quality and that the optimal irrigation combined with optimal fertilization was efficient in reducing the potential environmental risk caused by excessive fertilization in intensive vegetable production systems.	[Li, Yang; Gao, Lihong; Tian, Yongqiang] China Agr Univ, Beijing Key Lab Growth & Dev Regulat Protected Ve, Beijing, Peoples R China; [Li, Yang; Li, Juanqi] Henan Agr Univ, Coll Hort, Zhengzhou, Henan, Peoples R China	China Agricultural University; Henan Agricultural University	Gao, LH; Tian, YQ (corresponding author), China Agr Univ, Beijing Key Lab Growth & Dev Regulat Protected Ve, Beijing, Peoples R China.	gaolh@cau.edu.cn; tianyq1984@cau.edu.cn			Special Fund for the National Key Research and Development Program of China [2016YED201003]; key projects of the Chinese Ministry of Science and Technology [2015BAD23B01-4]; earmarked fund for China Agriculture Research System [CARS-25]	Special Fund for the National Key Research and Development Program of China; key projects of the Chinese Ministry of Science and Technology; earmarked fund for China Agriculture Research System	Funding was provided by the Special Fund for the National Key Research and Development Program of China (2016YED201003 to LG), the key projects of the Chinese Ministry of Science and Technology (2015BAD23B01-4) and the earmarked fund for China Agriculture Research System (CARS-25 to LG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the Special Fund for the National Key Research and Development Program of China (2016YED201003), the key projects of the Chinese Ministry of Science and Technology (2015BAD23B01-4) and the earmarked fund for China Agriculture Research System (CARS-25) for their financial supports. We also grateful to reviewers for their valuable comments and suggestions in manuscript preparation.	Agostini F, 2010, SUSTAIN AGR REV, V4, P147, DOI 10.1007/978-90-481-8741-6_6; Alfaro MA, 2004, SOIL USE MANAGE, V20, P182, DOI 10.1079/SUM2004249; Bayer A, 2014, ACTA HORTIC, V1034, P477, DOI 10.17660/ActaHortic.2014.1034.59; Bayer A, 2015, HORTSCIENCE, V50, P994, DOI 10.21273/HORTSCI.50.7.994; Bremner J. M., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P595; Cabello MJ, 2009, AGR WATER MANAGE, V96, P866, DOI 10.1016/j.agwat.2008.11.006; Chen Q, 2004, NUTR CYCL AGROECOSYS, V69, P51, DOI 10.1023/B:FRES.0000025293.99199.ff; Chen Q, 2005, CHINA VEGETABLES, V54, P70; de Kroon H, 2005, NEW PHYTOL, V166, P73, DOI 10.1111/j.1469-8137.2004.01310.x; de Ruijter FJ, 2007, NUTR CYCL AGROECOSYS, V77, P155, DOI 10.1007/s10705-006-9051-9; FARE DC, 1994, HORTSCIENCE, V29, P1514, DOI 10.21273/HORTSCI.29.12.1514; Fortune S, 2005, PLANT SOIL, V269, P99, DOI 10.1007/s11104-004-1659-4; Gao LH, 2010, HORTTECHNOLOGY, V20, P626, DOI 10.21273/HORTTECH.20.3.626; Gao YA, 2015, SCI HORTIC-AMSTERDAM, V186, P190, DOI 10.1016/j.scienta.2015.02.026; Girotto E, 2013, NUTR CYCL AGROECOSYS, V95, P115, DOI 10.1007/s10705-013-9552-2; Grierson PF, 1999, BIOL FERT SOILS, V28, P244, DOI 10.1007/s003740050489; Han K, 2015, J ENVIRON QUAL, V44, P560, DOI 10.2134/jeq2014.08.0326; Hodge A, 2006, J EXP BOT, V57, P401, DOI 10.1093/jxb/eri280; Houba VJG, 2000, COMMUN SOIL SCI PLAN, V31, P1299, DOI 10.1080/00103620009370514; Hvistendahl M, 2010, SCIENCE, V327, P801, DOI 10.1126/science.327.5967.801; Jalota SK, 2006, AGR WATER MANAGE, V84, P137, DOI 10.1016/j.agwat.2006.02.003; Ju XT, 2006, ENVIRON POLLUT, V143, P117, DOI 10.1016/j.envpol.2005.11.005; Liang XH, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0091801, 10.1371/journal.pone.0086975]; Matsuo N, 2009, PLANT PROD SCI, V12, P514, DOI 10.1626/pps.12.514; Migliaccio KW, 2010, AGR WATER MANAGE, V97, P1452, DOI 10.1016/j.agwat.2010.04.012; Min J, 2012, AGR WATER MANAGE, V111, P53, DOI 10.1016/j.agwat.2012.05.003; Min J, 2011, PEDOSPHERE, V21, P464, DOI 10.1016/S1002-0160(11)60148-3; Noe GB, 2013, ECOSYSTEMS, V16, P75, DOI 10.1007/s10021-012-9597-0; OLSEN STERLING R., 1954, U S DEPT AGRIC CIRC, V939, P1; Paramasivam S, 2000, SOIL SCI, V165, P343, DOI 10.1097/00010694-200004000-00005; Pei XB, 2002, J INTEGR AGR, V1, P1246; Quinones A, 2007, AGR ECOSYST ENVIRON, V122, P399, DOI 10.1016/j.agee.2007.02.004; da Silva VDR, 2009, SCI HORTIC-AMSTERDAM, V120, P467, DOI 10.1016/j.scienta.2008.12.005; SCHAFF BE, 1982, SOIL SCI SOC AM J, V46, P521, DOI 10.2136/sssaj1982.03615995004600030015x; SHARPLEY AN, 1987, ADV AGRON, V41, P297, DOI 10.1016/S0065-2113(08)60807-X; Shi WM, 2009, NUTR CYCL AGROECOSYS, V83, P73, DOI 10.1007/s10705-008-9201-3; Song XZ, 2009, CR BIOL, V332, P385, DOI 10.1016/j.crvi.2008.11.005; Thompson RB, 2007, AGR WATER MANAGE, V89, P261, DOI 10.1016/j.agwat.2007.01.013; Tian YQ, 2016, SCI TOTAL ENVIRON, V544, P251, DOI 10.1016/j.scitotenv.2015.11.091; Tian YQ, 2010, NUTR CYCL AGROECOSYS, V88, P429, DOI 10.1007/s10705-010-9367-3; Valdemarsen T, 2015, BIOGEOSCIENCES, V12, P1765, DOI 10.5194/bg-12-1765-2015; Vitousek PM, 2009, SCIENCE, V324, P1519, DOI 10.1126/science.1170261; [汪建飞 Wang Jianfei], 2005, [土壤通报, Journal of Soil Science], V36, P708; Wang XZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155298; Yu HaiYing, 2010, Scientia Agricultura Sinica, V43, P514; YU JQ, 2016, CHINA VEGETABLES, V9, P18; Zheng JS, 2018, NUTR CYCL AGROECOSYS, V112, P197, DOI 10.1007/s10705-018-9939-1; Zhu ZL, 2002, NUTR CYCL AGROECOSYS, V63, P117, DOI 10.1023/A:1021107026067	48	39	40	9	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204570	10.1371/journal.pone.0204570	http://dx.doi.org/10.1371/journal.pone.0204570			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30261079	Green Published, gold, Green Submitted			2022-12-26	WOS:000445907400069
J	Wang, GY; Chen, B; Du, HS; Zhang, FL; Zhang, HY; Wang, YQ; He, HJ; Geng, SS; Zhang, XF				Wang, Guoyun; Chen, Bin; Du, Heshan; Zhang, Fenglan; Zhang, Haiying; Wang, Yaqin; He, Hongju; Geng, Sansheng; Zhang, Xiaofen			Genetic mapping of anthocyanin accumulation-related genes in pepper fruits using a combination of SLAF-seq and BSA	PLOS ONE			English	Article							CAPSICUM-ANNUUM; ARABIDOPSIS-THALIANA; LINKAGE MAP; BIOSYNTHESIS; GENOME; EXPRESSION; IDENTIFICATION; SEQUENCE; MARKERS; ENZYME	Anthocyanins have significant functions in stress tolerance in pepper (Capsicum annuum L.) and also benefit human health. Nevertheless, the key structural genes and regulatory genes involved in anthocyanin accumulation in pepper fruits are still not well understood and fine mapped. For the present study, 383 F-2 plants from a cross between the green-fruited C. annuum line Z5 and the purple-fruited line Z6 was developed. Two separate bulked DNA pools were constructed with DNAs extracted from either 37 plants with high anthocyanin content or from 18 plants with no anthocyanin. A combination of specific-locus amplified fragment sequencing (SLAF-seq) and bulked segregant analysis (BSA) was used to identify candidates for regions associated with anthocyanin accumulation. We identified a total of 127,004 high-quality single nucleotide polymorphism (SNP) markers, and detected 1674 high-quality SNP markers associated with anthocyanin accumulation. Three candidate anthocyanin-associated regions including the intervals from 12.48 to 20.00 Mb, from 54.67 to 56.59 Mb, and from 192.17 to 196.82 Mb were identified within a 14.10-Mb interval on chromosome 10 containing 126 candidate genes. Based on their annotations, we identified 12 candidate genes that are predicted to be associated with anthocyanin expression. The present results provide an efficient strategy for genetic mapping of and valuable insights into the genetic mechanisms of anthocyanin accumulation in pepper fruit, and allow us to clone and functionally analyze the genes that influence anthocyanin accumulation in this species.	[Wang, Guoyun; Chen, Bin; Du, Heshan; Zhang, Fenglan; Zhang, Haiying; Wang, Yaqin; He, Hongju; Geng, Sansheng; Zhang, Xiaofen] Minist Agr, Beijing Vegetable Res Ctr, Beijing Acad Agr & Forestry Sci, Key Lab Biol & Genet Improvement Hort Crops North, Beijing, Peoples R China	Beijing Academy of Agriculture & Forestry; Ministry of Agriculture & Rural Affairs	Geng, SS; Zhang, XF (corresponding author), Minist Agr, Beijing Vegetable Res Ctr, Beijing Acad Agr & Forestry Sci, Key Lab Biol & Genet Improvement Hort Crops North, Beijing, Peoples R China.	gengsansheng@nercv.org; zhangxiaofen@nercv.org			Construction Program of Science and Technology Innovation Capability of Beijing Academy of Agriculture and Forestry ScienceS [KJCX2018042]; Innovation Ability Construction Project of Beijing Academy of Agriculture and Forestry Sciences [KJCX20170102-14]; National Key R D Plan [2016YFD0101700]	Construction Program of Science and Technology Innovation Capability of Beijing Academy of Agriculture and Forestry ScienceS; Innovation Ability Construction Project of Beijing Academy of Agriculture and Forestry Sciences; National Key R D Plan	Construction Program of Science and Technology Innovation Capability of Beijing Academy of Agriculture and Forestry ScienceS (KJCX2018042), Innovation Ability Construction Project of Beijing Academy of Agriculture and Forestry Sciences (KJCX20170102-14) and National Key R & D Plan (2016YFD0101700).	Abe A, 2012, NAT BIOTECHNOL, V30, P174, DOI 10.1038/nbt.2095; Aguilar-Barragan A, 2014, BIOL PLANTARUM, V58, P567, DOI 10.1007/s10535-014-0427-4; Alexa A., 2019, TOPGO ENRICHMENT ANA; Aza-Gonzalez C, 2013, BIOL PLANTARUM, V57, P49, DOI 10.1007/s10535-012-0265-1; Barchi L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043740; Baudry A, 2004, PLANT J, V39, P366, DOI 10.1111/j.1365-313X.2004.02138.x; Ben Chaim A, 2003, GENOME, V46, P1, DOI [10.1139/g02-096, 10.1139/G02-096]; Borovsky Y, 2004, THEOR APPL GENET, V109, P23, DOI 10.1007/s00122-004-1625-9; Borovsky Y, 2011, THEOR APPL GENET, V123, P657, DOI 10.1007/s00122-011-1615-7; Chen W, 2015, THEOR APPL GENET, V128, P539, DOI 10.1007/s00122-014-2452-2; Chen X, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-346; Cheng JW, 2016, SCI REP-UK, V6, DOI 10.1038/srep33293; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; De Jong WS, 2004, THEOR APPL GENET, V108, P423, DOI 10.1007/s00122-003-1455-1; DESHPANDE RAMCHANDRA BALWANT, 1933, INDIAN JOUR AGRIC SCI, V3, P219; Fekih R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068529; Frary A, 2014, EUPHYTICA, V197, P211, DOI 10.1007/s10681-013-1060-6; FULTON TM, 1995, PLANT MOL BIOL REP, V13, P207, DOI 10.1007/BF02670897; Geng XX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147580; Gonzalez A, 2008, PLANT J, V53, P814, DOI 10.1111/j.1365-313X.2007.03373.x; Gould K. S., 2006, Flavonoids: chemistry, biochemistry and applications, P397; Griesser M, 2008, PLANT PHYSIOL, V146, P1528, DOI 10.1104/pp.107.114280; Gunderson KL, 2005, NAT GENET, V37, P549, DOI 10.1038/ng1547; Guo GJ, 2017, THEOR APPL GENET, V130, P41, DOI 10.1007/s00122-016-2790-3; Hamilton JMU, 2003, BIOCHEM J, V370, P57, DOI 10.1042/BJ20021125; Hill JT, 2013, GENOME RES, V23, P687, DOI 10.1101/gr.146936.112; Jeong HS, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0417-z; Kang BC, 2001, THEOR APPL GENET, V102, P531, DOI 10.1007/s001220051678; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim J, 2017, PLANT METHODS, V13, DOI 10.1186/s13007-016-0151-5; Kim S, 2014, NAT GENET, V46, P270, DOI 10.1038/ng.2877; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Lamy S, 2007, J CELL BIOCHEM, V100, P100, DOI 10.1002/jcb.21023; Lee J, 2005, J AOAC INT, V88, P1269; Li B, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1086; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JG, 2011, AFR J BIOTECHNOL, V10, P8267; Li ST, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.27522; Lightbourn GJ, 2007, J AM SOC HORTIC SCI, V132, P824, DOI 10.21273/JASHS.132.6.824; Lim SH, 2016, PLANT CELL REP, V35, P641, DOI 10.1007/s00299-015-1909-3; Lu HF, 2014, THEOR APPL GENET, V127, P1491, DOI 10.1007/s00122-014-2313-z; Luo J, 2007, PLANT J, V50, P678, DOI 10.1111/j.1365-313X.2007.03079.x; Mahasuk P, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0435-5; MARRS KA, 1995, NATURE, V375, P397, DOI 10.1038/375397a0; Mathews H, 2003, PLANT CELL, V15, P1689, DOI 10.1105/tpc.012963; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Morita Y, 2005, PLANT J, V42, P353, DOI 10.1111/j.1365-313X.2005.02383.x; PETERSON PA, 1959, GENETICS, V44, P407; Rao GU, 2003, THEOR APPL GENET, V106, P1457, DOI 10.1007/s00122-003-1204-5; Reddy MK, 2005, J AGR FOOD CHEM, V53, P9268, DOI 10.1021/jf051399j; Sadilova E, 2006, Z NATURFORSCH C, V61, P527; Schreiber G, 2012, THEOR APPL GENET, V124, P295, DOI 10.1007/s00122-011-1705-6; Sheehan H, 2016, NAT GENET, V48, P159, DOI 10.1038/ng.3462; Shi MZ, 2010, PLANTA, V231, P1385, DOI 10.1007/s00425-010-1142-9; Sugita T, 2005, BREEDING SCI, V55, P287, DOI 10.1270/jsbbs.55.287; Sugita T, 2013, MOL BREEDING, V31, P909, DOI 10.1007/s11032-013-9844-x; Suh Y, 2005, MUTAT RES-FUND MOL M, V573, P41, DOI 10.1016/j.mrfmmm.2005.01.005; Sun XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058700; Takagi H, 2013, PLANT J, V74, P174, DOI 10.1111/tpj.12105; Unno H, 2007, J BIOL CHEM, V282, P15812, DOI 10.1074/jbc.M700638200; Vogt T, 1999, PLANT J, V19, P509, DOI 10.1046/j.1365-313X.1999.00540.x; Wang JE, 2013, EUR J PLANT PATHOL, V136, P625, DOI 10.1007/s10658-013-0193-8; Xu FF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122206; Xu XM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151401; Xu XW, 2015, SCI REP-UK, V5, DOI 10.1038/srep15829; Zhang H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148150; Zhang HB, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-29; Zhang Q, 2012, BIOL PLANTARUM, V56, P97, DOI 10.1007/s10535-012-0022-5; Zhang XF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194071; Zhang YC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144356; Zhang Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135430; Zhang Z, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00500; Zhao XX, 2016, SCI REP-UK, V6, DOI 10.1038/srep29345; Zhou P, 2016, INT J GENOMICS, V2016, DOI 10.1155/2016/2095195	74	16	20	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204690	10.1371/journal.pone.0204690	http://dx.doi.org/10.1371/journal.pone.0204690			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30261055	Green Published, gold, Green Submitted			2022-12-26	WOS:000445907400089
J	Ron, SR; Duellman, WE; Caminer, MA; Pazmino, D				Ron, Santiago R.; Duellman, William E.; Caminer, Marcel A.; Pazmino, Diana			Advertisement calls and DNA sequences reveal a new species of Scinax (Anura: Hylidae) on the Pacific lowlands of Ecuador	PLOS ONE			English	Article							COMPLEX ANURA; FROGS ANURA; PHYLOGENY; PHYLOGEOGRAPHY; DIVERSITY; TREEFROGS; AMPLIFICATION; BIODIVERSITY; SYSTEMATICS; PRIMERS	Scinax is a speciose genus of Neotropical hylid frogs. We describe a new species from western Ecuador (elevations between 0 and 1207 m) using morphology, vocalizations, and DNA sequences. We also present a new phylogeny for Scinax based on mitochondrial DNA genes 12S rRNA, Cytochrome Oxidase sub-unit I, Cytochrome B, 16S rRNA, NADH dehydrogenase subunit 1, and adjacent tRNAs. The new species, Scinax tsachila sp. nov. was previously confused with S. quinquefasciatus, a morphologically similar sympatric species. They differ by having markedly different advisement calls, distinct skin texture in the dorsum, and different bone coloration. The new species is sister to S. elaeochroa, a species that differs in advertisement call and color pattern. We provide an updated species account for Scinax quinquefasciatus and a redescription of its holotype.	[Ron, Santiago R.; Caminer, Marcel A.; Pazmino, Diana] Pontificia Univ Catolica Ecuador, Museo Zool, Escuela Biol, Quito, Ecuador; [Duellman, William E.] Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA; [Pazmino, Diana] James Cook Univ, Coll Sci & Engn, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld, Australia; [Pazmino, Diana] Univ San Francisco Quito, Galapagos Sci Ctr, Galapagos, Ecuador	Pontificia Universidad Catolica del Ecuador; University of Kansas; James Cook University	Ron, SR (corresponding author), Pontificia Univ Catolica Ecuador, Museo Zool, Escuela Biol, Quito, Ecuador.	santiago.r.ron@gmail.com	Ron, Santiago/J-4203-2019; Rodríguez, Marcel Adrián Caminer/I-1687-2019	Ron, Santiago/0000-0001-6300-9350; Rodríguez, Marcel Adrián Caminer/0000-0002-5827-7462	Secretaria Nacional de Educacion Superior, Ciencia, Tecnologia e Innovacion del Ecuador SENESCYT (Arca de Noe initiative); Pontificia Universidad CatoAlica del Ecuador of the Direccion General Academica (DGA) department	Secretaria Nacional de Educacion Superior, Ciencia, Tecnologia e Innovacion del Ecuador SENESCYT (Arca de Noe initiative); Pontificia Universidad CatoAlica del Ecuador of the Direccion General Academica (DGA) department	Field and laboratory work were funded by grants from the Secretaria Nacional de Educacion Superior, Ciencia, Tecnologia e Innovacion del Ecuador SENESCYT (Arca de Noe initiative; SRR and Omar Torres principal investigators), and a grant from Pontificia Universidad CatoAlica del Ecuador of the Direccion General Academica (DGA) department for SRR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Galvis A, 2018, BIOTA COLOMBIANA, V19; AmphibiaWeb, 2018, AMPHIBIAWEB INF AMPH; Bell RC, 2012, J BIOGEOGR, V39, P1733, DOI 10.1111/j.1365-2699.2012.02708.x; Bolanos Federico, 2008, P92; Brusquetti F, 2014, ZOOL J LINN SOC-LOND, V171, P783, DOI 10.1111/zoj.12148; Caminer MA, 2014, ZOOKEYS, P1, DOI 10.3897/zookeys.370.6291; Carnaval ACOQ, 2002, INTEGR COMP BIOL, V42, P913, DOI 10.1093/icb/42.5.913; Catenazzi A, 2015, ANNU REV ENV RESOUR, V40, P91, DOI 10.1146/annurev-environ-102014-021358; Cisneros-Heredia DF, 2018, SOC ECOL INTERACT GA, P95, DOI 10.1007/978-3-319-67177-2_7; Darst CR, 2004, MOL PHYLOGENET EVOL, V31, P462, DOI 10.1016/j.ympev.2003.09.003; Duellman W., 1993, OCCASIONAL PAPER MUS, V153, P1; Duellman W. E., 1966, University of Kansas Publications of the Museum of Natural History, V17, P263; DUELLMAN W E, 1973, Herpetologica, V29, P219; DUELLMAN W E, 1971, Herpetologica, V27, P212; Duellman W.E., 1970, Monograph Mus nat Hist Univ Kans, V1, P1; Duellman WE, 2005, COPEIA, P526, DOI 10.1643/CH-05-019R; Duellman WE, 2001, HYLID FROGS MIDDLE A; Duellman William E., 2007, Phyllomedusa, V6, P119; Duellman WE, 2016, ZOOTAXA, V4104, P1, DOI 10.11646/zootaxa.4104.1.1; Duellman WE, 2014, ZOOTAXA, V3768, P159, DOI 10.11646/zootaxa.3768.2.4; Faivovich J, 2005, B AM MUS NAT HIST, P6, DOI 10.1206/0003-0090(2005)294[0001:SROTFF]2.0.CO;2; Faivovich J, 2004, MOL PHYLOGENET EVOL, V32, P938, DOI 10.1016/j.ympev.2004.03.008; Ferrao M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165679; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fouquet A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001109; Fouquet A, 2007, MOL PHYLOGENET EVOL, V43, P567, DOI 10.1016/j.ympev.2006.12.006; Fouquet A, 2012, BIOL J LINN SOC, V106, P356, DOI 10.1111/j.1095-8312.2012.01871.x; Fouquet A, 2012, SYST BIOL, V61, P461, DOI 10.1093/sysbio/syr130; Fowler H. W., 1913, Proceedings of the Academy of Natural Sciences of Philadelphia, V65; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; Goebel AM, 1999, MOL PHYLOGENET EVOL, V11, P163, DOI 10.1006/mpev.1998.0538; Guarnizo CE, 2012, HERPETOLOGICA, V68, P523, DOI 10.1655/HERPETOLOGICA-D-10-00038; Heinicke MP, 2007, P NATL ACAD SCI USA, V104, P10092, DOI 10.1073/pnas.0611051104; Hutter Carl R., 2012, Zootaxa, V3257, P1; *IUCN, 2001, RED LIST CAT VERS 3; Jansen M, 2011, ZOOL SCR, V40, P567, DOI 10.1111/j.1463-6409.2011.00498.x; Jimenez-Uzcategui G, 2016, C DARWIN FDN GALAPAG; Jimenez-Uzcategui G, 2007, STATUS INTRO VERTEBR, P136; Jungfer KH, 2013, ZOOL SCR, V42, P351, DOI 10.1111/zsc.12015; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lynch JD, 2004, DIVERSIDAD BIOTICA 4, P633; Maddison W. P, 2014, MESQUITE MODULAR SYS; Ortega-Andrade HM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143392; McDiarmid R. W., 1994, MEASURING MONITORING; Ministerio de Ambiente del Ecuador, 2012, LINEA BASE DEFORESTA; Ministerio de Ambiente del Ecuador, 2013, SIST CLASS EC EC CON; Moen DS, 2009, EVOLUTION, V63, P195, DOI 10.1111/j.1558-5646.2008.00538.x; Moravec Jiri, 2009, South American Journal of Herpetology, V4, P9, DOI 10.2994/057.004.0102; MYERS C W, 1982, American Museum Novitates, P1; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Paez-Vacas MI, 2010, ZOOTAXA, P1; Ron S. J. M., 2011, AMPHIBIAN BIOL, P129; Ron SR, 2010, ZOOTAXA, P25, DOI 10.11646/zootaxa.2606.1.2; Ron SR, 2012, ZOOKEYS, P1, DOI 10.3897/zookeys.229.3580; Ron SR, 2006, MOL PHYLOGENET EVOL, V39, P392, DOI 10.1016/j.ympev.2005.11.022; Ron SR, 2018, ANFIBIOS ECUADOR; Ruiz-Carranza Pedro M., 1996, Revista de la Academia Colombiana de Ciencias Exactas Fisicas y Naturales, V20, P365; Salducci MD, 2005, CR BIOL, V328, P1009, DOI 10.1016/j.crvi.2005.07.005; Salducci MD, 2002, CR BIOL, V325, P141, DOI 10.1016/S1631-0691(02)01423-3; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SAS Institute, 2010, US GUID VERS 9; Savage J.M., 2002, AMPHIBIANS REPTILES; Schulze A, 2015, ZOOTAXA, V4016, P1, DOI 10.11646/zootaxa.4016.1.1; Simmons J.E., 2002, HERPETOLOGICAL CIRCU, V31, P1; TAYLOR EDWARD H., 1958, UNIV KANSAS SCI BULL, V39, P3; Wiens JJ, 2005, SYST BIOL, V54, P719, DOI 10.1080/10635150500234625; Wiens JJ, 2010, MOL PHYLOGENET EVOL, V55, P871, DOI 10.1016/j.ympev.2010.03.013; Zwickl D. J, 2006, GENETIC ALGORITHM AP	70	11	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2018	13	9							e0203169	10.1371/journal.pone.0203169	http://dx.doi.org/10.1371/journal.pone.0203169			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3NB	30256795	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000446000200013
J	Billeci, L; Marino, D; Insana, L; Vatti, G; Varanini, M				Billeci, Lucia; Marino, Daniela; Insana, Laura; Vatti, Giampaolo; Varanini, Maurizio			Patient-specific seizure prediction based on heart rate variability and recurrence quantification analysis	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; ATRIAL-FIBRILLATION; EPILEPTIC SEIZURES; ILAE COMMISSION; EEG; CHILDREN; ECG; METAANALYSIS; SERIES; STATES	Epilepsy is often associated with modifications in autonomic nervous system, which usually precede the onset of seizures of several minutes. Thus, there is a great interest in identifying these modifications enough time in advance to prevent a dangerous effect and to intervene. In addition, these changes can be a risk factor for epileptic patients and can increase the possibility of death. Notably autonomic changes associated to seizures are highly depended of seizure type, localization and lateralization. The aim of this study was to develop a patient-specific approach to predict seizures using electrocardiogram (ECG) features. Specifically, from the RR series, both time and frequency variables and features obtained by the recurrence quantification analysis were used. The algorithm was applied in a dataset of 15 patients with 38 different types of seizures. A feature selection step, was used to identify those features that were more significant in discriminating preictal and interictal phases. A preictal interval of 15 minutes was selected. A support vector machine (SVM) classifier was then built to classify preictal and interictal phases. First, a classifier was set up to classify preictal and interictal segments of each patient and an average sensibility of 89.06% was obtained, with a number of false positive per hour (FP/h) of 0.41. Then, in those patients who had at least 3 seizures, a double-cross-validation approach was used to predict unseen seizures on the basis of a training on previous ones. The results were quite variable according to seizure type, achieving the best performance in patients with more stereotypical seizure. The results of the proposed approach show that it is feasible to predict seizure in advance, considering patient-specific, and possible seizure specific, characteristics.	[Billeci, Lucia; Varanini, Maurizio] Natl Res Council Italy, CNR, Inst Clin Physiol, Pisa, Italy; [Marino, Daniela; Insana, Laura; Vatti, Giampaolo] Univ Siena, Dept Med Surg & Neurosci, Siena, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); University of Siena	Billeci, L (corresponding author), Natl Res Council Italy, CNR, Inst Clin Physiol, Pisa, Italy.	lucia.billeci@ifc.cnr.it	Marino, Daniela/AAP-1043-2021; Billeci, Lucia/J-2667-2016; Varanini, Maurizio/B-7945-2015	Marino, Daniela/0000-0003-0688-4495; Billeci, Lucia/0000-0002-5487-0277; Varanini, Maurizio/0000-0001-8489-3560	Bando FAS Salute Sviluppo Toscana 2014-PANACEE Project [6247]	Bando FAS Salute Sviluppo Toscana 2014-PANACEE Project(Regione Toscana)	This study was supported by Bando FAS Salute Sviluppo Toscana 2014-PANACEE Project (No. 6247). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya UR, 2013, KNOWL-BASED SYST, V45, P147, DOI 10.1016/j.knosys.2013.02.014; Acharya UR, 2011, INT J NEURAL SYST, V21, P199, DOI 10.1142/S0129065711002808; Baumgartner C, 1998, J NUCL MED, V39, P978; Behbahani S., 2013, ADV BIORES, V4, P50; Behbahani S, 2016, TECHNOL HEALTH CARE, V24, P795, DOI 10.3233/THC-161225; Behbahani S, 2013, ANATOL J CARDIOL, V13, P797, DOI 10.5152/akd.2013.237; Billeci L, 2017, COMPUT CARDIOL, P44; Carrara M, 2015, PHYSIOL MEAS, V36, P1873, DOI 10.1088/0967-3334/36/9/1873; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Costa RP, 2008, KNOWLEDGE BASED INTE, P5178; ECKMANN JP, 1987, EUROPHYS LETT, V4, P973, DOI 10.1209/0295-5075/4/9/004; Engel J, 2008, EPILEPSY COMPREHENSI; EPSTEIN MA, 1992, NEUROLOGY, V42, P50, DOI 10.1212/WNL.42.1.50; Fiest KM, 2017, NEUROLOGY, V88, P296, DOI 10.1212/WNL.0000000000003509; Fisher RS, 2017, EPILEPSIA, V58, P522, DOI 10.1111/epi.13670; Friedman J. H., 1994, STAT NEURAL NETWORKS, P1; Fujiwara K, 2016, IEEE T BIO-MED ENG, V63, P1321, DOI 10.1109/TBME.2015.2512276; Ghaderyan P, 2014, J NEUROSCI METH, V232, P134, DOI 10.1016/j.jneumeth.2014.05.019; Gomes RL, 2018, J SPORT MED PHYS FIT, V58, P998, DOI 10.23736/S0022-4707.17.06922-5; Greene BR, 2007, CLIN NEUROPHYSIOL, V118, P1348, DOI 10.1016/j.clinph.2007.02.015; Harnod T, 2008, SEIZURE-EUR J EPILEP, V17, P297, DOI 10.1016/j.seizure.2007.09.002; Hoyos-Osorio K, 2016, SYMP IMAG SIG PROC A; Jacoby A, 2007, EPILEPSIA, V48, P6, DOI 10.1111/j.1528-1167.2007.01391.x; Jansen K, 2010, SEIZURE-EUR J EPILEP, V19, P455, DOI 10.1016/j.seizure.2010.07.008; Jansen K, 2013, EPILEPSY BEHAV, V29, P72, DOI 10.1016/j.yebeh.2013.06.030; Jette N, 2017, NEUROLOGY, V89, P641, DOI 10.1212/WNL.0000000000004206; KATZ MJ, 1988, COMPUT BIOL MED, V18, P145, DOI 10.1016/0010-4825(88)90041-8; Kerem DH, 2005, MED BIOL ENG COMPUT, V43, P230, DOI 10.1007/BF02345960; Kharbouch A, 2011, EPILEPSY BEHAV, V22, pS29, DOI 10.1016/j.yebeh.2011.08.031; Kolsal E, 2014, SEIZURE-EUR J EPILEP, V23, P357, DOI 10.1016/j.seizure.2014.01.025; Kwan P, 2010, EPILEPSIA, V51, P1069, DOI 10.1111/j.1528-1167.2009.02397.x; Lake DE, 2011, AM J PHYSIOL-HEART C, V300, pH319, DOI 10.1152/ajpheart.00561.2010; Langan Y, 2000, J NEUROL NEUROSUR PS, V68, P211, DOI 10.1136/jnnp.68.2.211; Le Van Quyen M, 2001, LANCET, V357, P183, DOI 10.1016/S0140-6736(00)03591-1; Leutmezer F, 2003, EPILEPSIA, V44, P348, DOI 10.1046/j.1528-1157.2003.34702.x; Litt B, 2002, CURR OPIN NEUROL, V15, P173, DOI 10.1097/00019052-200204000-00008; Lotufo PA, 2012, EPILEPSIA, V53, P272, DOI 10.1111/j.1528-1167.2011.03361.x; Marwan N, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.026702; May O, 2011, ACTA DIABETOL, V48, P55, DOI 10.1007/s00592-010-0222-4; Mayer H, 2004, NEUROLOGY, V63, P324, DOI 10.1212/01.WNL.0000129830.72973.56; Melo HM, 2018, ANN NONINVASIVE ELEC; Moghim N, 2014, SEIZURE, V23, P357, DOI [10.1016/j.seizure.2014.01.025, DOI 10.1016/J.SEIZURE.2014.01.025]; Moghim N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099334; Moghimi N, 2013, CURR CARDIOL REP, V15, DOI 10.1007/s11886-013-0424-9; Moridani MK, 2017, BRATISL MED J, V118, P3, DOI 10.4149/BLL_2017_001; Ngamga EJ, 2016, PHYS LETT A, V380, P1419, DOI 10.1016/j.physleta.2016.02.024; Noachtar S, 2009, EPILEPSY BEHAV, V15, P22, DOI 10.1016/j.yebeh.2009.02.035; Park Y, 2011, EPILEPSIA, V52, P1761, DOI 10.1111/j.1528-1167.2011.03138.x; Pavei J, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00765; Ponnusamy A, 2012, EPILEPSIA, V53, P1314, DOI 10.1111/j.1528-1167.2012.03518.x; Ponnusamy A, 2011, EPILEPSY BEHAV, V22, P685, DOI 10.1016/j.yebeh.2011.08.020; Raiesdana S, 2009, COMPUT BIOL MED, V39, P1073, DOI 10.1016/j.compbiomed.2009.09.001; Shoeb A. H., 2010, P 27 INT C INT C MAC, P975, DOI DOI 10.0RG/PAPERS/; Shoeb A, 2009, IEEE ENG MED BIO, P4202, DOI 10.1109/IEMBS.2009.5333790; Sun RR, 2008, MED ENG PHYS, V30, P1105, DOI 10.1016/j.medengphy.2008.01.008; Tang YC, 2009, IEEE T SYST MAN CY B, V39, P281, DOI 10.1109/TSMCB.2008.2002909; Toth V, 2010, EUR J NEUROL, V17, P780, DOI 10.1111/j.1468-1331.2009.02939.x; Vapnik V., 1998, STAT LEARNING THEORY; Varanini M, 2014, PHYSIOL MEAS, V35, P1607, DOI 10.1088/0967-3334/35/8/1607; Varanini M, 1998, COMPUT CARDIOL, P25; WEBBER CL, 1994, J APPL PHYSIOL, V76, P965, DOI 10.1152/jappl.1994.76.2.965; Weinand ME, 1997, J NEUROSURG, V86, P226, DOI 10.3171/jns.1997.86.2.0226	62	36	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2018	13	9							e0204339	10.1371/journal.pone.0204339	http://dx.doi.org/10.1371/journal.pone.0204339			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU9BO	30252915	Green Submitted, gold, Green Published			2022-12-26	WOS:000445639700046
J	Wang, M; Li, XJ; Wang, SZ; Wang, GD; Zhang, JT				Wang, Ming; Li, Xiujun; Wang, Shengzhong; Wang, Guodong; Zhang, Jitao			Patterns and controls of temperature sensitivity of soil respiration in a meadow steppe of the Songnen Plain, Northeast China	PLOS ONE			English	Article							SEASONAL-VARIATIONS; ORGANIC-CARBON; VEGETATION TYPES; Q(10); DEPENDENCE; MOISTURE; FOREST; DECOMPOSITION; ECOSYSTEMS; COMPONENTS	Quantifying the temporal and spatial patterns of temperature sensitivity (Q(10)) of soil respiration (Rs) as well as its controlling factors is critical to reveal the response the soil ecological processes to global warming and improve carbon budget estimations at a regional scale. The seasonal and annual variations in the temperature response of Rs were assessed during the two growing seasons in 2011 and 2012 in four different vegetation sites in a meadow steppe of the Songnen Plain, China. The Q(10) values across all sites exhibited significant seasonal variations with a minimum value (1.81-2.34) occurring during summer and a peak value (3.82-4.54) occurring in either spring or autumn. The mean seasonal Q(10) values showed no significant differences among the four different vegetation types. On the annual scale, however, the Chloris virgata site had significantly higher annual Q(10) values (3.67-4.22) than the other three community sites in 2011 and 2012 and over the two years (2.01-3.67), indicating that the response of the Rs to climate warming may vary with vegetation type. The soil temperature and moisture had interactive effects on the variations of Q(10) values. Soil temperature was the dominant factor influencing Q(10) values, while soil moisture was an additional contributor to the variations of Q(10). Due to the significant temporal and spatial variations in soil respiration response to temperature, acclimation of Rs to temperature variation should be taken into account in forecasting future terrestrial carbon cycle and its feedback to global warming.	[Wang, Ming; Wang, Shengzhong] Northeast Normal Univ, Inst Peat & Mire Res, State Environm Protect Key Lab Wetland Ecol & Veg, Changchun, Jilin, Peoples R China; [Wang, Ming; Li, Xiujun; Wang, Guodong; Zhang, Jitao] Chinese Acad Sci, Northeast Inst Geog & Agroecol, Key Lab Wetland Ecol & Environm, Changchun, Jilin, Peoples R China; [Wang, Ming; Wang, Shengzhong] Jilin Prov Key Lab Wetland Ecol Proc & Environm C, Changchun, Jilin, Peoples R China	Northeast Normal University - China; Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS	Wang, GD (corresponding author), Chinese Acad Sci, Northeast Inst Geog & Agroecol, Key Lab Wetland Ecol & Environm, Changchun, Jilin, Peoples R China.	wanggd@iga.ac.cn	li, xiu/GXV-1745-2022		National Natural Science Foundation of China [41620104005, 41501090]; National Key Research and Development Program of China [2016YFC0500407]; Science Foundation for Youths of Jilin Province [20180520099JH]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Science Foundation for Youths of Jilin Province	This study was supported by the National Natural Science Foundation of China (Grant No. 41620104005, 41501090 received by GW), the National Key Research and Development Program of China (2016YFC0500407 received by MW), the Science Foundation for Youths of Jilin Province (20180520099JH received by MW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkin O. K., 2000, VVolume 9, P153; Boone RD, 1998, NATURE, V396, P570, DOI 10.1038/25119; Bouwman AF, 1998, BIOL FERT SOILS, V27, P219; Chen BY, 2010, SOIL BIOL BIOCHEM, V42, P1735, DOI 10.1016/j.soilbio.2010.06.010; Chen H, 2005, J INTEGR PLANT BIOL, V47, P1288, DOI 10.1111/j.1744-7909.2005.00211.x; Chen QS, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003538; Chen ZZ, 2000, CHINA TYPICAL GRASSL, P228; Davidson EA, 2006, GLOBAL CHANGE BIOL, V12, P154, DOI 10.1111/j.1365-2486.2005.01065.x; Davidson EA, 1998, GLOBAL CHANGE BIOL, V4, P217, DOI 10.1046/j.1365-2486.1998.00128.x; Deng L, 2013, CATENA, V110, P1, DOI 10.1016/j.catena.2013.06.016; Deng W, 2006, BACKGROUND REGIONAL, P31; Edenhofer O., 2014, CONTRIBUTION WORKING; [耿鹏飞 Geng Pengfei], 2016, [林业科学, Scientia Silvae Sinicae], V52, P140; Gershenson A, 2009, GLOBAL CHANGE BIOL, V15, P176, DOI 10.1111/j.1365-2486.2008.01827.x; Giardina CP, 2000, NATURE, V404, P858, DOI 10.1038/35009076; Han MG, 2018, EUR J SOIL BIOL, V85, P36, DOI 10.1016/j.ejsobi.2018.01.001; Hursh A, 2017, GLOBAL CHANGE BIOL, V23, P2090, DOI 10.1111/gcb.13489; Janssens IA, 2003, GLOBAL CHANGE BIOL, V9, P911, DOI 10.1046/j.1365-2486.2003.00636.x; Kirschbaum MUF, 2006, SOIL BIOL BIOCHEM, V38, P2510, DOI 10.1016/j.soilbio.2006.01.030; Lal R, 1998, ADV SOIL S, P365; Lellei-Kovacs E, 2011, EUR J SOIL BIOL, V47, P247, DOI 10.1016/j.ejsobi.2011.05.004; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Lu R, 1999, METHODS SOIL AGR CHE; Mahecha MD, 2011, SCIENCE, V331, P1265, DOI 10.1126/science.1197033; Meyer N, 2018, GLOBAL BIOGEOCHEMICA, V32; Montagnoli A, 2014, EUR J FOREST RES, V133, P957, DOI 10.1007/s10342-014-0814-6; POTTER CS, 1993, GLOBAL BIOGEOCHEM CY, V7, P811, DOI 10.1029/93GB02725; RAICH JW, 1991, ECOL APPL, V1, P399, DOI 10.2307/1941899; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; Rayment MB, 2000, SOIL BIOL BIOCHEM, V32, P35, DOI 10.1016/S0038-0717(99)00110-8; Running S.W., 1993, SCALING PHYSL PROCES, P141, DOI DOI 10.1016/B978-0-12-233440-5.50014-2; Sampson DA, 2007, GLOBAL CHANGE BIOL, V13, P2008, DOI 10.1111/j.1365-2486.2007.01414.x; Schimel J., 2001, GLOBAL BIOGEOCHEM CY, P177, DOI [10.1016/b978-012631260-7/50015-7, DOI 10.1016/B978-012631260-7/50015-7]; Schlesinger WH, 1998, BIOGEOCHEMISTRY, V42, P169, DOI 10.1023/A:1005939924434; Schlesinger WH, 2000, BIOGEOCHEMISTRY, V48, P7, DOI 10.1023/A:1006247623877; Sun QQ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195400; Thornley JHM, 2001, ANN BOT-LONDON, V87, P591, DOI 10.1006/anbo.2001.1372; Wang CK, 2006, GLOBAL CHANGE BIOL, V12, P2103, DOI 10.1111/j.1365-2486.2006.01234.x; Wang M, 2015, J PLANT ECOL, V8, P51, DOI 10.1093/jpe/rtu006; Wang W, 2009, GLOBAL PLANET CHANGE, V67, P20, DOI 10.1016/j.gloplacha.2008.12.011; Wang XG, 2008, AUST J SOIL RES, V46, P727, DOI 10.1071/SR07223; Wang XH, 2010, SOIL BIOL BIOCHEM, V42, P1728, DOI 10.1016/j.soilbio.2010.06.008; Wen XF, 2006, AGR FOREST METEOROL, V137, P166, DOI 10.1016/j.agrformet.2006.02.005; WEST NE, 1994, ARID SOIL RES REHAB, V8, P307, DOI 10.1080/15324989409381408; Xu M, 2001, GLOBAL BIOGEOCHEM CY, V15, P687, DOI 10.1029/2000GB001365; Yan JX, 2013, CLEAN-SOIL AIR WATER, V41, P680, DOI 10.1002/clen.201200591; Yang C, 2018, EUR J SOIL BIOL, V86, P42, DOI 10.1016/j.ejsobi.2018.03.001; Yu SQ, 2017, SCI TOTAL ENVIRON, V607, P160, DOI 10.1016/j.scitotenv.2017.06.194; Yuste JC, 2004, GLOBAL CHANGE BIOL, V10, P161, DOI 10.1111/j.1529-8817.2003.00727.x; Zan CS, 2001, AGR ECOSYST ENVIRON, V86, P135, DOI 10.1016/S0167-8809(00)00273-5; Zheng ZM, 2009, SOIL BIOL BIOCHEM, V41, P1531, DOI 10.1016/j.soilbio.2009.04.013; Zhou W, 2014, PLOS ONE, V3	52	1	1	6	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2018	13	9							e0204053	10.1371/journal.pone.0204053	http://dx.doi.org/10.1371/journal.pone.0204053			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3MI	30248117	gold, Green Published, Green Submitted			2022-12-26	WOS:000445998100022
J	Hsieh, IH; Chen, SC; Liu, JW				Hsieh, I-Hui; Chen, Ssc-Chen; Liu, Jia-Wei			Binaural localization of musical pitch using interaural time differences in congenital amusia	PLOS ONE			English	Article							AUDITORY PERIPHERY; PHASE SENSITIVITY; MONTREAL BATTERY; ABSOLUTE MEMORY; COMPUTER-MODEL; TONE-DEAFNESS; VIRTUAL PITCH; DISCRIMINATION; PERCEPTION; DEFICITS	Naturally occurring sounds are routinely periodic. The ability to phase-lock to such periodicity facilitates pitch perception and interaural time differences (ITDs) determination in binaural localization. We examined whether deficient pitch processing in individuals with congenital amusia (tone deafness) is accompanied by impaired ability to lateralize musical pitch at auditory periphery and memorize the location of pitch at the working memory level. If common mechanisms subserve processing of temporal-fine-structure based pitch and ITDs, then deficient processing of one feature should impair performance on the other. Thus, we measured ITD discrimination thresholds using an adaptive-tracking procedure for lateralizing musical tone pairs separated by different semitone intervals. Amusic individuals exhibited normal ITD thresholds comparable to those of matched controls, which were not affected by concurrent pitch changes. For working memory tasks, the amusic group performed significantly worse than matched controls in probed pitch recall, irrespective of the complexity level of concurrent variations along the ITD dimension of the melodic sequence. Interestingly, despite normal peripheral ITD thresholds, amusic individuals performed worse than controls in recalling probed locations of tones within a sequence of musical notes originating from different ITD simulated locations. Findings suggest that individuals with congenital amusia are unimpaired in temporal fine-structure encoding to determine the location of musical pitch based on binaural ITD information at the auditory periphery. However, working memory for a sequence of sounds' ITD-dependent spatial location is here shown to be impaired and dissociated from the pitch feature of sounds at the working memory level.	[Hsieh, I-Hui; Chen, Ssc-Chen; Liu, Jia-Wei] Natl Cent Univ, Inst Cognit Neurosci, Taoyuan, Jhongli County, Taiwan	National Central University	Hsieh, IH (corresponding author), Natl Cent Univ, Inst Cognit Neurosci, Taoyuan, Jhongli County, Taiwan.	ihuihsieh@gmail.com		Hsieh, I-Hui/0000-0003-4001-4274	Ministry of Science and Technology-Taiwan [MOST-98-2410-H-008-081 MY3, MOST-106-2410-H-008-039-MY2]	Ministry of Science and Technology-Taiwan(Ministry of Science and Technology, Taiwan)	The work is funded by the Ministry of Science and Technology-Taiwan (Grant# MOST-98-2410-H-008-081 MY3 and MOST-106-2410-H-008-039-MY2) to IH. (https://www.most.gov.tw/) The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alain C, 2001, P NATL ACAD SCI USA, V98, P12301, DOI 10.1073/pnas.211209098; Albouy P, 2016, SCI REP-UK, V6, DOI 10.1038/srep18861; Albouy P, 2013, BRAIN, V136, P1639, DOI 10.1093/brain/awt082; Ayotte J, 2002, BRAIN, V125, P238, DOI 10.1093/brain/awf028; Bella SD, 2009, J ACOUST SOC AM, V126, P414, DOI 10.1121/1.3132504; Bernstein LR, 2001, J NEUROSCI RES, V66, P1035, DOI 10.1002/jnr.10103; BERZ WL, 1995, MUSIC PERCEPT, V12, P353; Brown AD, 2012, HEARING RES, V291, P52, DOI 10.1016/j.heares.2012.06.002; Cousineau M, 2015, NEUROPSYCHOLOGIA, V66, P293, DOI 10.1016/j.neuropsychologia.2014.11.031; Douglas KM, 2007, NAT NEUROSCI, V10, P915, DOI 10.1038/nn1925; Drayna D, 2001, SCIENCE, V291, P1969, DOI 10.1126/science.291.5510.1969; Foxton JM, 2006, BRAIN COGNITION, V62, P24, DOI 10.1016/j.bandc.2006.03.005; Foxton JM, 2004, BRAIN, V127, P801, DOI 10.1093/brain/awh105; Frieler K, 2013, MUSIC SCI, V17, P334, DOI 10.1177/1029864913493802; Furukawa S, 2013, ADV EXP MED BIOL, V787, P91, DOI 10.1007/978-1-4614-1590-9_11; Gosselin N, 2015, CORTEX, V71, P171, DOI 10.1016/j.cortex.2015.06.022; Gosselin N, 2009, ANN NY ACAD SCI, V1169, P270, DOI 10.1111/j.1749-6632.2009.04762.x; Grothe B, 1998, J NEUROSCI, V18, P6608; Guerard K, 2013, MEM COGNITION, V41, P378, DOI 10.3758/s13421-012-0275-4; Hartmann WM, 2013, ADV EXP MED BIOL, V787, P239, DOI 10.1007/978-1-4614-1590-9_27; Henry MJ, 2013, MUSIC PERCEPT, V30, P480, DOI 10.1525/MP.2013.30.5.480; Henry MJ, 2010, MUSIC PERCEPT, V27, P413, DOI 10.1525/mp.2010.27.5.413; Hyde KL, 2004, PSYCHOL SCI, V15, P356, DOI 10.1111/j.0956-7976.2004.00683.x; Hyde KL, 2007, J NEUROSCI, V27, P13028, DOI 10.1523/JNEUROSCI.3039-07.2007; Hyde KL, 2006, BRAIN, V129, P2562, DOI 10.1093/brain/awl204; Hyde KL, 2011, CEREB CORTEX, V21, P292, DOI 10.1093/cercor/bhq094; Jiang CM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08005-x; Jiang CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079216; JORIS PX, 1992, J ACOUST SOC AM, V91, P215, DOI 10.1121/1.402757; Kaiser J, 2003, NEUROSCIENTIST, V9, P475, DOI 10.1177/1073858403259137; Kaiser J, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00613; LEVITIN DJ, 1994, PERCEPT PSYCHOPHYS, V56, P414, DOI 10.3758/BF03206733; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Liu B., 2010, J UNCERTAIN SYST, V4, P163; Loui P, 2009, J NEUROSCI, V29, P10215, DOI 10.1523/JNEUROSCI.1701-09.2009; Mandell J, 2007, RESTOR NEUROL NEUROS, V25, P323; MEDDIS R, 1991, J ACOUST SOC AM, V89, P2866, DOI 10.1121/1.400725; MEDDIS R, 1991, J ACOUST SOC AM, V89, P2883, DOI 10.1121/1.400726; Moore BC, 2012, INTRO PSYCHOL HEARIN; Oxenham AJ, 2012, J NEUROSCI, V32, P13335, DOI 10.1523/JNEUROSCI.3815-12.2012; Peretz I, 2003, ANN NY ACAD SCI, V999, P58, DOI 10.1196/annals.1284.006; Peretz I, 2002, NEURON, V33, P185, DOI 10.1016/S0896-6273(01)00580-3; Peretz I, 2007, AM J HUM GENET, V81, P582, DOI 10.1086/521337; Peretz I, 2017, EUR J HUM GENET, V25, P625, DOI 10.1038/ejhg.2017.15; Peretz I, 2016, TRENDS COGN SCI, V20, P857, DOI 10.1016/j.tics.2016.09.002; Peretz I, 2013, PSYCHOLOGY OF MUSIC, THIRD EDITION, P551, DOI 10.1016/B978-0-12-381460-9.00013-4; Pfeifer J, 2015, FRONT HUM NEUROSCI, V9, DOI [10.3389/tnhum.2015.00161, 10.3389/fnhum.2015.00161]; Pfeuty M, 2010, ATTEN PERCEPT PSYCHO, V72, P763, DOI 10.3758/APP.72.3.763; Phillips-Silver J, 2013, COGN NEUROPSYCHOL, V30, P311, DOI 10.1080/02643294.2013.863183; SABERI K, 1995, J ACOUST SOC AM, V98, P1803, DOI 10.1121/1.413379; Tillmann B, 2015, Handb Clin Neurol, V129, P589, DOI 10.1016/B978-0-444-62630-1.00033-0; Tillmann B, 2016, BRAIN RES, V1640, P251, DOI 10.1016/j.brainres.2015.10.035; Tillmann B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010173; TOBIAS JV, 1959, J ACOUST SOC AM, V31, P1591, DOI 10.1121/1.1907664; Vuvan DT, 2018, BEHAV RES METHODS, V50, P662, DOI 10.3758/s13428-017-0892-8; Vuvan DT, 2015, CORTEX, V69, P186, DOI 10.1016/j.cortex.2015.05.002; WEISS TF, 1988, HEARING RES, V33, P175, DOI 10.1016/0378-5955(88)90030-5; WETHERILL GB, 1965, BRIT J MATH STAT PSY, V18, P1, DOI 10.1111/j.2044-8317.1965.tb00689.x; Whiteford KL, 2018, CORTEX, V103, P164, DOI 10.1016/j.cortex.2018.03.012; Williamson VJ, 2011, BRAIN COGNITION, V76, P70, DOI 10.1016/j.bandc.2011.02.016; Williamson VJ, 2010, ADV COGN PSYCHOL, V6, P15, DOI 10.2478/v10053-008-0073-5; Williamson VJ, 2010, MEMORY, V18, P657, DOI 10.1080/09658211.2010.501339; Wright BA, 2001, P NATL ACAD SCI USA, V98, P12307, DOI 10.1073/pnas.211220498	63	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2018	13	9							e0204397	10.1371/journal.pone.0204397	http://dx.doi.org/10.1371/journal.pone.0204397			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GU5MM	30240453	gold, Green Published, Green Submitted			2022-12-26	WOS:000445329700045
J	Keefer, ML; Clabough, TS; Jepson, MA; Johnson, EL; Peery, CA; Caudill, CC				Keefer, Matthew L.; Clabough, Tami S.; Jepson, Michael A.; Johnson, Eric L.; Peery, Christopher A.; Caudill, Christopher C.			Thermal exposure of adult Chinook salmon and steelhead: Diverse behavioral strategies in a large and warming river system	PLOS ONE			English	Article							MIGRATING SOCKEYE-SALMON; LIFE-HISTORY DIVERSITY; COLUMBIA RIVER; PACIFIC SALMON; CLIMATE-CHANGE; FRASER-RIVER; ONCORHYNCHUS-NERKA; WATER TEMPERATURE; PRESPAWN MORTALITY; SUMMER STEELHEAD	Rising river temperatures in western North America have increased the energetic costs of migration and the risk of premature mortality in many Pacific salmon (Oncorhynchus spp.) populations. Predicting and managing risks for these populations requires data on acute and cumulative thermal exposure, the spatio-temporal distribution of adverse conditions, and the potentially mitigating effects of cool-water refuges. In this study, we paired radiotelemetry with archival temperature loggers to construct continuous, spatially-explicit thermal histories for 212 adult Chinook salmon (O. tshawytscha) and 200 adult steelhead (O. mykiss). The fish amassed -500,000 temperature records (30-min intervals) while migrating through 470 kilometers of the Columbia and Snake rivers en route to spawning sites in Idaho, Oregon, and Washington. Spring- and most summer-run Chinook salmon migrated before river temperatures reached annual highs; their body temperatures closely matched ambient temperatures and most had thermal maxima in the lower Snake River. In contrast, many individual fall-run Chinook salmon and most steelhead had maxima near thermal tolerance limits (20-22 degrees C) in the lower Columbia River. High temperatures elicited extensive use of thermal refuges near tributary confluences, where body temperatures were similar to 2-10 degrees C cooler than the adjacent migration corridor. Many steelhead used refuges for weeks or more whereas salmon use was typically hours to days, reflecting differences in spawn timing. Almost no refuge use was detected in a similar to 260-km reach where a thermal migration barrier may more frequently develop in future warmer years. Within population, cumulative thermal exposure was strongly positively correlated (0.88 <= r <= 0.98) with migration duration and inconsistently associated (-0.28 <= r <= 0.09) with migration date. All four populations have likely experienced historically high mean and maximum temperatures in recent years. Expected responses include population-specific shifts in migration phenology, increased reliance on patchily-distributed thermal refuges, and natural selection favoring temperature tolerant phenotypes.	[Keefer, Matthew L.; Clabough, Tami S.; Jepson, Michael A.; Johnson, Eric L.; Peery, Christopher A.; Caudill, Christopher C.] Univ Idaho, Dept Fish & Wildlife Sci, Moscow, ID 83843 USA; [Johnson, Eric L.] Idaho Dept Fish & Game, Eagle Fish Genet Lab, Eagle, ID USA; [Peery, Christopher A.] US Army, Corps Engineers, NWW Operat Div, Walla Walla, WA USA	Idaho; University of Idaho; United States Department of Defense; United States Army; U.S. Army Corps of Engineers	Keefer, ML (corresponding author), Univ Idaho, Dept Fish & Wildlife Sci, Moscow, ID 83843 USA.	mkeefer@uidaho.edu	Caudill, Christopher C/M-7906-2014	Caudill, Christopher C/0000-0002-7129-8620; Keefer, Matthew/0000-0002-4264-2576	University of Idaho Open Access Publishing Fund, U.S. Army Corps of Engineers, Portland and Walla Walla Districts; U.S. Environmental Protection Agency	University of Idaho Open Access Publishing Fund, U.S. Army Corps of Engineers, Portland and Walla Walla Districts; U.S. Environmental Protection Agency(United States Environmental Protection Agency)	University of Idaho Open Access Publishing Fund, U.S. Army Corps of Engineers, Portland and Walla Walla Districts, http://www.nwp.usace.army.mil/, http://www.nww.usace.army.mil/Contact/; U.S. Environmental Protection Agency, https://www.epa.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Principal investigators for the original study were T. Bjornn (University of Idaho [UI]) and L. Stuehrenberg (National Marine Fisheries Service [NMFS]). Many people assisted with the field work and data compilation for this study. We thank R. Ringe, S. Lee, C. Boggs, and D. Queampts (UI) for tagging fish; K. Tolotti, G. Naughton, K. Traylor, C. Morat T. Dick, and M. Morasch (UI) for maintaining telemetry sites and downloading receivers; B. Burke, K. Frick, and A. Matter (NMFS) for administering the database in Seattle; and D. Joosten, C. Williams, and C. Nauman (UI) for coding the raw telemetry data. This study was funded by the U.S. Army Corps of Engineers (USACE), Portland and Walla Walla Districts, with assistance provided by R. Kalamasz, M. Langeslay, M. Shutters and K. Zelch; the staff at Lower Granite Dam and the other USACE dams also provided invaluable support. Additional funding was provided by the U.S. Environmental Protection Agency, with assistance provided by J. Palmer, D. Keenan, and J. Carlin and administrative support from A. King (Tetra Tech).	Alerstam T, LONG DISTANCE MIGRAT; Anderson JH, 2010, MOL ECOL, V19, P2562, DOI 10.1111/j.1365-294X.2010.04652.x; Anderson JJ, 2009, ECOL APPL, V19, P1989, DOI 10.1890/08-0477.1; Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; Angilletta MJ, 2008, EVOL APPL, V1, P286, DOI 10.1111/j.1752-4571.2008.00032.x; Armstrong JB, 2016, CONSERV PHYSIOL, V4, DOI 10.1093/conphys/cow039; Asch RG, 2015, P NATL ACAD SCI USA, V112, pE4065, DOI 10.1073/pnas.1421946112; Battin J, 2007, P NATL ACAD SCI USA, V104, P6720, DOI 10.1073/pnas.0701685104; Beamish RJ, 2004, T AM FISH SOC, V133, P1163, DOI 10.1577/T03-170.1; Benda SE, 2015, T AM FISH SOC, V144, P1159, DOI 10.1080/00028487.2015.1073621; Berger J, 2004, CONSERV BIOL, V18, P320, DOI 10.1111/j.1523-1739.2004.00548.x; BERMAN CH, 1991, J FISH BIOL, V39, P301, DOI 10.1111/j.1095-8649.1991.tb04364.x; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Bourret SL, 2016, REV FISH BIOL FISHER, V26, P375, DOI 10.1007/s11160-016-9432-3; Bowerman T, 2018, T AM FISH SOC, V147, P31, DOI 10.1002/tafs.10022; Bowerman T, 2016, FISHERIES, V41, P738, DOI 10.1080/03632415.2016.1245993; Brannon EL, 2004, REV FISH SCI, V12, P99, DOI 10.1080/10641260490280313; Braun DC, 2013, ECOL EVOL, V3, P1727, DOI 10.1002/ece3.555; Brett J.R., 1995, P3; Brown RS, 2006, T AM FISH SOC, V135, P281, DOI 10.1577/T05-223.1; Busby PJ, 1996, NMFSNWFSC27 NOAA; Campbell MR, 2012, T AM FISH SOC, V141, P1310, DOI 10.1080/00028487.2012.690816; Carlson SM, 2008, EVOL APPL, V1, P222, DOI 10.1111/j.1752-4571.2008.00025.x; Carruth LL, 2002, INTEGR COMP BIOL, V42, P574, DOI 10.1093/icb/42.3.574; Caudill CC, 2007, CAN J FISH AQUAT SCI, V64, P979, DOI 10.1139/F07-065; Caudill CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085586; Cook CB, 2006, PNNL15532; Cooke SJ, 2006, ECOLOGY, V87, P1575, DOI 10.1890/0012-9658(2006)87[1575:MBOIMI]2.0.CO;2; Cooke SJ, 2016, COMP BIOCHEM PHYS A, V202, P23, DOI 10.1016/j.cbpa.2016.03.022; Cooke SJ, 2012, PHILOS T R SOC B, V367, P1757, DOI 10.1098/rstb.2012.0022; Copeland T, 2017, N AM J FISH MANAGE, V37, P395, DOI 10.1080/02755947.2016.1264506; Crossin GT, 2008, CAN J ZOOL, V86, P127, DOI 10.1139/Z07-122; Crozier LG, 2008, EVOL APPL, V1, P252, DOI 10.1111/j.1752-4571.2008.00033.x; Crozier LG, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1965; Crozier LG, 2014, EVOL APPL, V7, P68, DOI 10.1111/eva.12135; Crozier LG, 2011, AM NAT, V178, P755, DOI 10.1086/662669; Dickerson BR, 2005, ECOLOGY, V86, P347, DOI 10.1890/03-625; Dingle H, 2007, BIOSCIENCE, V57, P113, DOI 10.1641/B570206; Dolan BP, 2016, FISH SHELLFISH IMMUN, V48, P136, DOI 10.1016/j.fsi.2015.11.015; Donaldson MR, 2009, CAN J ZOOL, V87, P480, DOI 10.1139/Z09-032; Eliason EJ, 2016, J FISH BIOL, V88, P359, DOI 10.1111/jfb.12790; Eliason EJ, 2011, SCIENCE, V332, P109, DOI 10.1126/science.1199158; Farrell AP, 2008, PHYSIOL BIOCHEM ZOOL, V81, P697, DOI 10.1086/592057; Fenkes M, 2016, COMP BIOCHEM PHYS A, V193, P11, DOI 10.1016/j.cbpa.2015.11.012; Goniea TM, 2006, T AM FISH SOC, V135, P408, DOI 10.1577/T04-113.1; Groves Phillip A., 1999, North American Journal of Fisheries Management, V19, P912, DOI 10.1577/1548-8675(1999)019&lt;0912:SHUBFC&gt;2.0.CO;2; Gustafson RG, 2007, CONSERV BIOL, V21, P1009, DOI 10.1111/j.1523-1739.2007.00693.x; Hanson KC, 2008, PHYSIOL BIOCHEM ZOOL, V81, P255, DOI 10.1086/529460; Hardie DC, 2010, ENVIRON REV, V18, P1, DOI 10.1139/A09-014; Hayes DB, 2014, RIVER RES APPL, V30, P1110, DOI 10.1002/rra.2719; Healey M.C., 1991, PACIFIC SALMON LIFE, P313; Healey M, 2011, CAN J FISH AQUAT SCI, V68, P718, DOI [10.1139/F11-010, 10.1139/f2011-010]; Hendry AP, 1999, CAN J ZOOL, V77, P1663, DOI 10.1139/cjz-77-11-1663; Hendry AP, 2005, MOL ECOL, V14, P901, DOI 10.1111/j.1365-294X.2005.02480.x; Hendry AP, 2004, ECOL FRESHW FISH, V13, P185, DOI 10.1111/j.1600-0633.2004.00045.x; Hendry AP, 2004, P ROY SOC B-BIOL SCI, V271, P259, DOI 10.1098/rspb.2003.2600; Hess JE, 2016, ICES J MAR SCI, V73, P2606, DOI 10.1093/icesjms/fsw138; Hess MA, 2016, ICES J MAR SCI, V73, P2616, DOI 10.1093/icesjms/fsw120; High B, 2006, T AM FISH SOC, V135, P519, DOI 10.1577/T04-224.1; Hilborn R, 2003, P NATL ACAD SCI USA, V100, P6564, DOI 10.1073/pnas.1037274100; Hinch SG, 2012, J FISH BIOL, V81, P576, DOI 10.1111/j.1095-8649.2012.03360.x; Hinch SG, 2000, CAN J FISH AQUAT SCI, V57, P2470, DOI 10.1139/cjfas-57-12-2470; Hyatt K.D., 2003, CANADIAN WATER RESOU, V28, P689, DOI DOI 10.4296/CWRJ2804689; Isaak DJ, 2012, CLIMATIC CHANGE, V113, P499, DOI 10.1007/s10584-011-0326-z; Isaak DJ, 2018, T AM FISH SOC, V147, P566, DOI 10.1002/tafs.10059; Jeffries KM, 2014, EVOL APPL, V7, P286, DOI 10.1111/eva.12119; Jepson MA, 2010, N AM J FISH MANAGE, V30, P72, DOI 10.1577/M08-078.1; Johnson EL, 2005, T AM FISH SOC, V134, P1213, DOI 10.1577/T04-116.1; Johnson EL, 2007, RIVER RES APPL, V23, P963, DOI 10.1002/rra.1019; Jonsson B, 2009, J FISH BIOL, V75, P2381, DOI 10.1111/j.1095-8649.2009.02380.x; Kammerer BD, 87242 US GEOL SURV; Karvonen A, 2010, INT J PARASITOL, V40, P1483, DOI 10.1016/j.ijpara.2010.04.015; Katz J, 2013, ENVIRON BIOL FISH, V96, P1169, DOI 10.1007/s10641-012-9974-8; Keefer ML, 2008, ECOL FRESHW FISH, V17, P136, DOI 10.1111/j.1600-0633.2007.00267.x; Keefer ML, 2010, ECOL FRESHW FISH, V19, P361, DOI 10.1111/j.1600-0633.2010.00418.x; Keefer ML, 2008, T AM FISH SOC, V137, P1120, DOI 10.1577/T07-008.1; Keefer ML, 2008, N AM J FISH MANAGE, V28, P81, DOI 10.1577/M07-011.1; Keefer ML, 2016, ECOL FRESHW FISH, V25, P599, DOI 10.1111/eff.12238; Keefer ML, 2015, J THERM BIOL, V48, P11, DOI 10.1016/j.jtherbio.2014.12.002; Keefer ML, 2014, REV FISH BIOL FISHER, V24, P333, DOI 10.1007/s11160-013-9334-6; Keefer ML, 2009, CAN J FISH AQUAT SCI, V66, P1734, DOI 10.1139/F09-131; Keefer ML, 2005, CAN J FISH AQUAT SCI, V62, P930, DOI 10.1139/F04-246; Keefer ML, 2004, N AM J FISH MANAGE, V24, P1145, DOI 10.1577/M03-170.1; Keefer ML, 2004, T AM FISH SOC, V133, P1413, DOI 10.1577/T03-223.1; King HR, 2007, J FISH BIOL, V70, P190, DOI 10.1111/j.1095-8649.2006.01295.x; Kovach RP, 2015, GLOBAL CHANGE BIOL, V21, P1821, DOI 10.1111/gcb.12829; Kovach RP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053807; Lee CG, 2003, J EXP BIOL, V206, P3239, DOI 10.1242/jeb.00547; Manhard CV, 2017, CAN J FISH AQUAT SCI, V74, P1519, DOI 10.1139/cjfas-2017-0028; Mantua N, 2010, CLIMATIC CHANGE, V102, P187, DOI 10.1007/s10584-010-9845-2; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Marlier ME, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa8fde; Martins EG, 2011, GLOBAL CHANGE BIOL, V17, P99, DOI 10.1111/j.1365-2486.2010.02241.x; Mathes MT, 2010, CAN J FISH AQUAT SCI, V67, P70, DOI 10.1139/F09-158; Matter AL, 2003, N AM J FISH MANAGE, V23, P967, DOI 10.1577/M02-019; Mccullough DA, 2009, REV FISH SCI, V17, P90, DOI 10.1080/10641260802590152; Moore JW, 2014, J ANIM ECOL, V83, P1035, DOI 10.1111/1365-2656.12212; Morbey YE, 2005, AM NAT, V166, P556, DOI 10.1086/491720; Mote PW, 2005, B AM METEOROL SOC, V86, P39, DOI 10.1175/BAMS-86-1-39; Myers JM, NMFSNWFSC35 NOAA FIS; Naik PK, 2011, J HYDROL, V404, P259, DOI 10.1016/j.jhydrol.2011.04.035; National Marine Fisheries Service, 2011, FED REGISTER, V76, P50448; Naughton GP, MAR FRESHW RES; Newell JC, 2005, CAN J ZOOL, V83, P1232, DOI 10.1139/Z05-113; Nielsen JL, 2011, ENVIRON BIOL FISH, V96, P1187; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Quinn TP, 2016, CAN J FISH AQUAT SCI, V73, P1015, DOI 10.1139/cjfas-2015-0345; Quinn TP, 1996, ECOLOGY, V77, P1151, DOI 10.2307/2265584; Quinn TP, 2004, REV FISH BIOL FISHER, V14, P421, DOI 10.1007/s11160-005-0802-5; Quinn TP, 2000, EVOLUTION, V54, P1372, DOI 10.1111/j.0014-3820.2000.tb00569.x; Rand PS, 2006, T AM FISH SOC, V135, P655, DOI 10.1577/T05-023.1; Reed TE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020380; Reed TE, 2011, CONSERV BIOL, V25, P56, DOI 10.1111/j.1523-1739.2010.01552.x; Richter A, 2005, REV FISH SCI, V13, P23, DOI 10.1080/10641260590885861; Robards MD, 2002, T AM FISH SOC, V131, P523, DOI 10.1577/1548-8659(2002)131<0523:TMTOAS>2.0.CO;2; Salinger DH, 2006, T AM FISH SOC, V135, P188, DOI 10.1577/T04-181.1; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; Scholz NL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028013; Schreck CB, 2010, GEN COMP ENDOCR, V165, P549, DOI 10.1016/j.ygcen.2009.07.004; Strange JS, 2012, T AM FISH SOC, V141, P1622, DOI 10.1080/00028487.2012.716010; Strange JS, 2010, T AM FISH SOC, V139, P1091, DOI 10.1577/T09-171.1; Thompson LC, 2012, J WATER RES PLAN MAN, V138, P465, DOI 10.1061/(ASCE)WR.1943-5452.0000194; Tillotson MD, 2017, FISH RES, V188, P138, DOI 10.1016/j.fishres.2016.12.013; Torgersen CE, 1999, ECOL APPL, V9, P301, DOI 10.1890/1051-0761(1999)009[0301:MTRASH]2.0.CO;2; Wade AA, 2013, J APPL ECOL, V50, P1093, DOI 10.1111/1365-2664.12137; Wagner GN, 2005, CAN J FISH AQUAT SCI, V62, P2124, DOI 10.1139/F05-126; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Waples RS, 2008, EVOL APPL, V1, P189, DOI 10.1111/j.1752-4571.2008.00023.x; Waples RS, 2004, EVOLUTION, V58, P386, DOI 10.1111/j.0014-3820.2004.tb01654.x; Wilcove DS, 2008, PLOS BIOL, V6, P1361, DOI 10.1371/journal.pbio.0060188; Wobus C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147242; Wu H, 2012, WATER RESOUR RES, V48, DOI 10.1029/2012WR012082; Yearsley JR, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR007629; Young JL, 2006, CAN J FISH AQUAT SCI, V63, P1067, DOI 10.1139/F06-014	134	23	23	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2018	13	9							e0204274	10.1371/journal.pone.0204274	http://dx.doi.org/10.1371/journal.pone.0204274			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU5MM	30240404	Green Submitted, Green Published, gold			2022-12-26	WOS:000445329700036
J	Kojima, M; Nakajima, I; Arakawa, A; Mikawa, S; Matsumoto, T; Uenishi, H; Nakamura, Y; Taniguchi, M				Kojima, Misaki; Nakajima, Ikuyo; Arakawa, Aisaku; Mikawa, Satoshi; Matsumoto, Toshimi; Uenishi, Hirohide; Nakamura, Yuki; Taniguchi, Masaaki			Differences in gene expression profiles for subcutaneous adipose, liver, and skeletal muscle tissues between Meishan and Landrace pigs with different backfat thicknesses	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; LIPID-METABOLISM; BODY-COMPOSITION; GROWTH; IDENTIFICATION; QTL; POPULATION; DEPOSITION; LIVESTOCK; SYSTEM	Backfat thickness is one of the most important traits of commercially raised pigs. Meishan pigs are renowned for having thicker backfat than Landrace pigs. To examine the genetic factors responsible for the differences, we first produced female crossbred pig lines by mating Landrace (L) x Large White (W) x Duroc (D) females (LWD) with Landrace (L) or Meishan (M) boars (i.e., LWD x L = LWDL for Landrace offspring and LWD x M = LWDM for the Meishan offspring). We confirmed that LWDM pigs indeed had a thicker backfat than LWDL pigs. Next, we performed gene expression microarray analysis in both genetic lines to examine differentially expressed genes (DEGs) in energy metabolism-related tissues, subcutaneous adipose (fat), liver, and longissimus dorsi muscle tissues. We analyzed the annotation of DEGs (2-fold cutoff) to functionally categorize them by Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathways. The number of DEGs in muscle tissues of both lines was much less than that in fat and liver tissues, indicating that DEGs in muscle tissues may not contribute much to differences in backfat thickness. In contrast, several genes related to muscle (in fat tissue) and lipid metabolism (in liver tissue) were more upregulated in LWDM pigs than LWDL pigs, indicating that those DEGs might be responsible for differences in backfat thickness. The different genome-wide gene expression profiles in the fat, liver, and muscle tissues between genetic lines can provide useful information for pig breeders.	[Kojima, Misaki; Arakawa, Aisaku; Mikawa, Satoshi; Taniguchi, Masaaki] Natl Agr & Food Res Org NARO, Anim Genome Unit, Inst Livestock & Grassland Sci, Tsukuba, Ibaraki, Japan; [Nakajima, Ikuyo] Natl Agr & Food Res Org NARO, Meat Qual Res Unit, Inst Livestock & Grassland Sci, Tsukuba, Ibaraki, Japan; [Matsumoto, Toshimi; Uenishi, Hirohide] Natl Agr & Food Res Org NARO, Anim Bioregulat Unit, Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan; [Nakamura, Yuki] Natl Agr & Food Res Org NARO, Insect Genome Res Unit, Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan; [Nakamura, Yuki] RIKEN, Bio Resource Ctr, Japan Collect Microorganisms, Tsukuba, Ibaraki, Japan	National Agriculture & Food Research Organization - Japan; National Agriculture & Food Research Organization - Japan; National Agriculture & Food Research Organization - Japan; National Agriculture & Food Research Organization - Japan; RIKEN	Taniguchi, M (corresponding author), Natl Agr & Food Res Org NARO, Anim Genome Unit, Inst Livestock & Grassland Sci, Tsukuba, Ibaraki, Japan.	masaakit@affrc.go.jp	TANIGUCHI, Masaaki/I-2564-2019	TANIGUCHI, Masaaki/0000-0001-8194-3577; KOJIMA, MISAKI/0000-0002-1921-8160	Ministry of Agriculture Forestry and Fisheries [AGB2003]	Ministry of Agriculture Forestry and Fisheries(Ministry of Agriculture Forestry & Fisheries - Japan)	This work was supported by Ministry of Agriculture Forestry and Fisheries, AGB2003 (http://www.affrc.maff.go.jp/docs/e/index.htm) to SM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Artemenko Y, 2005, J CELL PHYSIOL, V204, P646, DOI 10.1002/jcp.20314; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chen CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-448; de Koning DJ, 1999, GENETICS, V152, P1679; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; FOLCH J, 1957, J BIOL CHEM, V226, P497; Goh DLM, 2002, MOL GENET METAB, V76, P172, DOI 10.1016/S1096-7192(02)00037-9; Gondret F, 2012, J ANIM BREED GENET, V129, P316, DOI 10.1111/j.1439-0388.2011.00965.x; Grygiel-Gorniak B, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-17; Herault F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096491; Hu ZL, 2016, NUCLEIC ACIDS RES, V44, pD827, DOI 10.1093/nar/gkv1233; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jing F, 2013, MOL CELL ENDOCRINOL, V378, P23, DOI 10.1016/j.mce.2012.03.005; Kim S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120073; Kojima M, 2016, DRUG METAB PHARMACOK, V31, P185, DOI 10.1016/j.dmpk.2016.02.001; Kojima M, 2014, DRUG METAB PHARMACOK, V29, P192, DOI 10.2133/dmpk.DMPK-13-RG-086; Legault C, 1985, J Reprod Fertil Suppl, V33, P151; Ma JW, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-46; Matsumoto T, 2012, ANIM GENET, V43, P535, DOI 10.1111/j.1365-2052.2011.02310.x; Mercade A, 2006, ANIM GENET, V37, P219, DOI 10.1111/j.1365-2052.2006.01436.x; Nafikov RA, 2007, J NUTR, V137, P702, DOI 10.1093/jn/137.3.702; Nakajima I, 2003, BIOCHEM BIOPH RES CO, V309, P702, DOI 10.1016/j.bbrc.2003.08.057; Nakajima I, 2011, ANIM SCI J, V82, P144, DOI 10.1111/j.1740-0929.2010.00810.x; Nguyen P, 2008, J ANIM PHYSIOL AN N, V92, P272, DOI 10.1111/j.1439-0396.2007.00752.x; Nobusue H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4368; Ponsuksili S, 2007, PHYSIOL GENOMICS, V29, P267, DOI 10.1152/physiolgenomics.00178.2006; Quintanilla R, 2011, J ANIM SCI, V89, P2963, DOI 10.2527/jas.2011-3974; Rohrer GA, 1998, J ANIM SCI, V76, P2247; Ron M, 2007, ANIM GENET, V38, P429, DOI 10.1111/j.1365-2052.2007.01640.x; Rothschild MF, 2007, INT J BIOL SCI, V3, P192; Ruhl R, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005213; Sato S, 2003, J ANIM SCI, V81, P2938; Sellner EM, 2007, J ANIM SCI, V85, P3148, DOI 10.2527/jas.2007-0291; Soma Y, 2011, J ANIM SCI, V89, P601, DOI 10.2527/jas.2010-3119; Taniguchi M, 2014, MOL BIOL REP, V41, P1081, DOI 10.1007/s11033-013-2954-z; Vaziri C, 1996, J BIOL CHEM, V271, P13642, DOI 10.1074/jbc.271.23.13642; Vincent A, 2012, PHYSIOL GENOMICS, V44, P1116, DOI 10.1152/physiolgenomics.00098.2012; Wada Y, 2000, ANIM GENET, V31, P376, DOI 10.1046/j.1365-2052.2000.00696.x; Walling GA, 1998, ANIM GENET, V29, P415, DOI 10.1046/j.1365-2052.1998.296360.x; Wayne ML, 2002, P NATL ACAD SCI USA, V99, P14903, DOI 10.1073/pnas.222549199; WHITE BR, 1995, J ANIM SCI, V73, P738; Xing K, 2016, SCI REP-UK, V6, DOI 10.1038/srep23219; YU K, 1995, J BIOL CHEM, V270, P23975, DOI 10.1074/jbc.270.41.23975	44	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2018	13	9							e0204135	10.1371/journal.pone.0204135	http://dx.doi.org/10.1371/journal.pone.0204135			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU5MM	30240433	Green Published, gold, Green Submitted			2022-12-26	WOS:000445329700027
J	Choi, EK; Nguyen, TT; Iwase, S; Seo, YA				Choi, Eun-Kyung; Trang-Tiffany Nguyen; Iwase, Shigeki; Seo, Young Ah			Ferroportin disease mutations influence manganese accumulation and cytotoxicity	FASEB JOURNAL			English	Article						manganese transport; manganese toxicity; iron metabolism	IRON TRANSPORTER FERROPORTIN; FUNCTIONAL-ANALYSIS; HEREDITARY HEMOCHROMATOSIS; INTRACELLULAR TRAFFICKING; MOLECULAR-BASIS; PARKINSONISM; SLC30A10; PROTEIN; EFFLUX; EXPRESSION	Hemochromatosis is a frequent genetic disorder, characterized by the accumulation of excess iron across tissues. Mutations in the FPN1 gene, encoding a cell surface iron exporter [ferroportin (Fpn)], are responsible for hemochromatosis type 4, also known as ferroportin disease. Recently, Fpn has been implicated in the regulation of manganese (Mn), another essential nutrient required for numerous cellular enzymes. However, the roles of Fpn in Mn regulation remain ill-defined, and the impact of disease mutations on cellular Mn levels is unknown. Here, we provide evidence that Fpn can export Mn from cells into extracellular space. Fpn seems to play protective roles in Mn-induced cellular toxicity and oxidative stress. Finally, disease mutations interfere with the role of Fpn in controlling Mn levels as well as the stability of Fpn. These results define the function of Fpn as an exporter of both iron and Mn and highlight the potential involvement of Mn dysregulation in ferroportin disease.Choi, E.-K., Nguyen, T.-T., Iwase, S., Seo, Y. A. Ferroportin disease mutations influence manganese accumulation and cytotoxicity.	[Choi, Eun-Kyung; Trang-Tiffany Nguyen; Seo, Young Ah] Univ Michigan, Sch Publ Hlth, Dept Nutr Sci, 3850 SPH I,1415 Washington Hts, Ann Arbor, MI 48109 USA; [Iwase, Shigeki] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Seo, YA (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Nutr Sci, 3850 SPH I,1415 Washington Hts, Ann Arbor, MI 48109 USA.	youngseo@umich.edu	Seo, Young Ah/AAT-5022-2020; Iwase, Shigeki/J-8294-2019	Seo, Young Ah/0000-0003-3884-0665; Iwase, Shigeki/0000-0003-2280-7422	U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences Grant [K99/R00 ES024340]; University of Michigan Protein Folding Disease Initiative grant; NIH National Institute of Neurological Disorders and Stroke [R01 NS089896]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R00ES024340, P30ES017885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS089896] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences Grant; University of Michigan Protein Folding Disease Initiative grant; NIH National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Dr. Marianne Wessling-Resnick (Harvard School of Public Health, Boston, MA, USA) for providing insightful suggestions for the manuscript. This work was supported by the U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences Grant K99/R00 ES024340 (to Y.A.S.), University of Michigan Protein Folding Disease Initiative grant (to Y.A.S.), and NIH National Institute of Neurological Disorders and Stroke Grant R01 NS089896 (to S.I.). The authors declare no conflicts of interest.	Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; Arden KE, 2003, GUT, V52, P1215, DOI 10.1136/gut.52.8.1215; Aschemeyer S, 2018, BLOOD, V131, P899, DOI 10.1182/blood-2017-05-786590; BIEDLER JL, 1973, CANCER RES, V33, P2643; Bosomworth HJ, 2012, METALLOMICS, V4, P771, DOI 10.1039/c2mt20088k; Callebaut I, 2014, HUM MOL GENET, V23, P4479, DOI 10.1093/hmg/ddu160; Chen P, 2015, J NEUROCHEM, V134, P601, DOI 10.1111/jnc.13170; Choi EK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21464-0; Corradini E, 2005, BLOOD CELL MOL DIS, V35, P315, DOI 10.1016/j.bcmd.2005.07.010; Cunat S, 2007, CLIN CHEM, V53, P2060, DOI 10.1373/clinchem.2007.090605; De Domenico I, 2005, P NATL ACAD SCI USA, V102, P8955, DOI 10.1073/pnas.0503804102; Detivaud L, 2013, HUM MUTAT, V34, P1529, DOI 10.1002/humu.22396; DeWitt MR, 2013, BIOCHEM BIOPH RES CO, V432, P1, DOI 10.1016/j.bbrc.2013.01.058; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Fernandes A, 2009, BLOOD, V114, P437, DOI 10.1182/blood-2008-03-146134; Goncalves AS, 2006, BIOCHEM J, V396, P265, DOI 10.1042/BJ20051682; Guilarte TR, 2010, ENVIRON HEALTH PERSP, V118, P1071, DOI [10.1289/ehp.0901748, 10.1590/S1413-81232011001200028]; Hetet G, 2003, BLOOD, V102, P1904, DOI 10.1182/blood-2003-02-0439; Horning KJ, 2015, ANNU REV NUTR, V35, P71, DOI 10.1146/annurev-nutr-071714-034419; Kawabata H, 1999, J BIOL CHEM, V274, P20826, DOI 10.1074/jbc.274.30.20826; Le Gac G, 2013, HUM MUTAT, V34, P1371, DOI 10.1002/humu.22369; Leyva-Illades D, 2014, J NEUROSCI, V34, P14079, DOI 10.1523/JNEUROSCI.2329-14.2014; Li JJ, 2015, CELL SYST, V1, P361, DOI 10.1016/j.cels.2015.11.002; Li XL, 2013, BIOMETALS, V26, P941, DOI 10.1007/s10534-013-9670-y; Liu XB, 2005, BLOOD CELL MOL DIS, V35, P33, DOI 10.1016/j.bcmd.2005.04.005; Lok CY, 2009, BLOOD, V114, P20, DOI 10.1182/blood-2009-01-199109; Madejczyk MS, 2012, BBA-BIOMEMBRANES, V1818, P651, DOI 10.1016/j.bbamem.2011.12.002; McCarthy RC, 2015, CELL MOL LIFE SCI, V72, P709, DOI 10.1007/s00018-014-1771-4; McCarthy RC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089003; McDonald CJ, 2011, J HEPATOL, V54, P538, DOI 10.1016/j.jhep.2010.07.048; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; McKie AT, 2004, PFLUG ARCH EUR J PHY, V447, P801, DOI 10.1007/s00424-003-1102-3; Milatovic D, 2009, TOXICOL APPL PHARM, V240, P219, DOI 10.1016/j.taap.2009.07.004; Mitchell CJ, 2014, AM J PHYSIOL-CELL PH, V306, pC450, DOI 10.1152/ajpcell.00348.2013; Mukhopadhyay S, 2010, MOL BIOL CELL, V21, P1282, DOI 10.1091/mbc.E09-11-0985; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nishito Y, 2016, J BIOL CHEM, V291, P14773, DOI 10.1074/jbc.M116.728014; Njajou OT, 2002, BLOOD CELL MOL DIS, V29, P439, DOI 10.1006/bcmd.2002.0581; Pietrangelo A, 2006, BLOOD CELL MOL DIS, V37, P192, DOI 10.1016/j.bcmd.2006.08.007; Pietrangelo A, 2017, HAEMATOLOGICA, V102, P1972, DOI 10.3324/haematol.2017.170720; Pietrangelo A, 2011, SEMIN LIVER DIS, V31, P302, DOI 10.1055/s-0031-1286061; Powell LW, 2016, LANCET, V388, P706, DOI 10.1016/S0140-6736(15)01315-X; Qiao B, 2012, CELL METAB, V15, P918, DOI 10.1016/j.cmet.2012.03.018; Quadri M, 2012, AM J HUM GENET, V90, P467, DOI 10.1016/j.ajhg.2012.01.017; Racette BA, 2001, NEUROLOGY, V56, P8, DOI 10.1212/WNL.56.1.8; Rice AE, 2009, J MOL BIOL, V386, P717, DOI 10.1016/j.jmb.2008.12.063; Rosmorduc O, 2008, GASTROEN CLIN BIOL, V32, P321, DOI 10.1016/j.gcb.2008.01.030; Schimanski LM, 2005, BLOOD, V105, P4096, DOI 10.1182/blood-2004-11-4502; Seo YA, 2016, BIOCHEM J, V473, P4243, DOI 10.1042/BCJ20160674; Seo YA, 2016, BIOMETALS, V29, P147, DOI 10.1007/s10534-015-9904-2; Seo YA, 2015, FASEB J, V29, P2726, DOI 10.1096/fj.14-262592; Seo YA, 2013, NEUROTOXICOLOGY, V38, P67, DOI 10.1016/j.neuro.2013.06.002; Seo YA, 2011, AM J PHYSIOL-CELL PH, V300, pC1479, DOI 10.1152/ajpcell.00420.2010; Seo YA, 2010, PHYSIOL GENOMICS, V42A, P219, DOI 10.1152/physiolgenomics.00137.2010; Sham RL, 2005, BLOOD CELL MOL DIS, V34, P157, DOI 10.1016/j.bcmd.2004.12.002; Sham RL, 2009, BLOOD, V114, P493, DOI 10.1182/blood-2009-04-216226; Stanwood GD, 2009, J NEUROCHEM, V110, P378, DOI 10.1111/j.1471-4159.2009.06145.x; Tuschl K, 2012, AM J HUM GENET, V90, P457, DOI 10.1016/j.ajhg.2012.01.018; Wallace DF, 2010, AM J PHYSIOL-CELL PH, V298, pC75, DOI 10.1152/ajpcell.00621.2008; Wu LJC, 2004, BRAIN RES, V1001, P108, DOI 10.1016/j.brainres.2003.10.066; Wu ZF, 2014, MOL NEUROBIOL, V50, P986, DOI 10.1007/s12035-014-8675-z; Yin ZB, 2010, J NEUROCHEM, V112, P1190, DOI 10.1111/j.1471-4159.2009.06534.x; Zhu Y, 2007, NEUROCHEM INT, V50, P507, DOI 10.1016/j.neuint.2006.10.010	65	16	16	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2228	2240		10.1096/fj.201800831R	http://dx.doi.org/10.1096/fj.201800831R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30247984	Green Submitted, Green Published			2022-12-26	WOS:000457296600056
J	Kim, S; Lee, KS; Choi, S; Kim, J; Lee, DK; Park, M; Park, W; Kim, TH; Hwang, JY; Won, MH; Lee, H; Ryoo, S; Ha, KS; Kwon, YG; Kim, YM				Kim, Suji; Lee, Kyu-Sun; Choi, Seunghwan; Kim, Joohwan; Lee, Dong-Keon; Park, Minsik; Park, Wonjin; Kim, Tae-Hoon; Hwang, Jong Yun; Won, Moo-Ho; Lee, Hansoo; Ryoo, Sungwoo; Ha, Kwon-Soo; Kwon, Young-Guen; Kim, Young-Myeong			NF-kappa B-responsive miRNA-31-5p elicits endothelial dysfunction associated with preeclampsia via down-regulation of endothelial nitric-oxide synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; TNF-ALPHA; HYPERTENSION; EXPRESSION; EXOSOMES; CELLS; WOMEN; MICRORNA-335; PREGNANCY; PROTEINS	Inflammatory cytokines, including tumor necrosis factor-alpha (TNF alpha), were elevated in patients with cardiovascular diseases and are also considered as crucial factors in the pathogenesis of preeclampsia; however, the underlying pathogenic mechanism has not been clearly elucidated. This study provides novel evidence that TNF alpha leads to endothelial dysfunction associated with hypertension and vascular remodeling in preeclampsia through down-regulation of endothelial nitric-oxide synthase (eNOS) by NF-kappa B-dependent biogenesis of microRNA (miR)-31-5p, which targets eNOS mRNA. In this study, we found that miR-31-5p was up-regulated in sera from patients with preeclampsia and in human endothelial cells treated with TNF alpha. TNF alpha-mediated induction of miR-31-5p was blocked by an NF-kappa B inhibitor and NF-kappa B p65 knockdown but not by mitogen- activated protein kinase (MAPK) and phosphatidylinositol 3-kinase inhibitors, indicating that NF-kappa B is essential for biogenesis of miR-31-5p. The treatment of human endothelial cells with TNF alpha or miR-31-5p mimics decreased endothelial nitricoxide synthase (eNOS) mRNA stability without affecting eNOS promoter activity, resulting in inhibition of eNOS expression and NO/cGMP production through blocking of the functional activity of the eNOSmRNA3'-UTR. Moreover, TNF alpha and miR-31-5p mimic evoked endothelial dysfunction associated with defects in angiogenesis, trophoblastic invasion, and vasorelaxation in an ex vivo cultured model of human placental arterial vessels, which are typical features of preeclampsia. These results suggest that NF-kappa B-responsive miR-31-5p elicits endothelial dysfunction, hypertension, and vascular remodeling via post-transcriptional down-regulation ofeNOSand is a molecular risk factor in the pathogenesis and development of preeclampsia.	[Kim, Suji; Lee, Kyu-Sun; Choi, Seunghwan; Kim, Joohwan; Lee, Dong-Keon; Park, Minsik; Park, Wonjin; Kim, Tae-Hoon; Ha, Kwon-Soo; Kim, Young-Myeong] Kangwon Natl Univ, Sch Med, Dept Mol & Cellular Biochem, Chunchon 24341, Gangwon Do, South Korea; [Hwang, Jong Yun] Kangwon Natl Univ, Sch Med, Dept Obstet & Gynecol, Chunchon 24341, Gangwon Do, South Korea; [Won, Moo-Ho] Kangwon Natl Univ, Sch Med, Dept Neurobiol, Chunchon 24341, Gangwon Do, South Korea; [Lee, Hansoo; Ryoo, Sungwoo] Kangwon Natl Univ, Coll Nat Sci, Dept Biol, Chunchon 24341, Gangwon Do, South Korea; [Kwon, Young-Guen] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul 03722, South Korea	Kangwon National University; Kangwon National University; Kangwon National University; Kangwon National University; Yonsei University	Kim, YM (corresponding author), Kangwon Natl Univ, Sch Med, Dept Mol & Cellular Biochem, Chunchon 24341, Gangwon Do, South Korea.	ymkim@kangwon.ac.kr	Ha, Kwon-Soo/AAU-4417-2020	Ha, Kwon-Soo/0000-0002-4219-1787	National Research Foundation of Korea (NRF) [2016M3A9B6903103]; Korea Government (MSIP)	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea Government (MSIP)	This work was supported by National Research Foundation of Korea (NRF) Grant 2016M3A9B6903103 funded by the Korea Government (MSIP). The authors declare that they have no conflicts of interest with the contents of this article.	Alexander BT, 2002, AM J HYPERTENS, V15, P170, DOI 10.1016/S0895-7061(01)02255-5; BAYLIS C, 1992, J CLIN INVEST, V90, P278, DOI 10.1172/JCI115849; Cartwright JE, 2005, EXP CELL RES, V304, P328, DOI 10.1016/j.yexcr.2004.11.013; Choi S, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.193; Conrad KP, 1998, AM J REPROD IMMUNOL, V40, P102; Cuhlmann S, 2011, CIRC RES, V108, P950, DOI 10.1161/CIRCRESAHA.110.233841; de Jager SCA, 2017, EUR J PHARMACOL, V816, P129, DOI 10.1016/j.ejphar.2017.09.012; Diejomaoh MFE, 2003, GYNECOL OBSTET INVES, V56, P197, DOI 10.1159/000074452; Dong QG, 1997, ARTERIOSCL THROM VAS, V17, P1599, DOI 10.1161/01.ATV.17.8.1599; Fichtlscherer S, 2001, CIRCULATION, V104, P3023, DOI 10.1161/hc5001.101749; Fu QZ, 2015, INT J MOL MED, V36, P1417, DOI 10.3892/ijmm.2015.2355; Gangwar RS, 2018, AM J HYPERTENS, V31, P150, DOI 10.1093/ajh/hpx197; Henderson JT, 2014, ANN INTERN MED, V161, P613, DOI [10.7326/L14-5020-4, 10.7326/L14-5020-5]; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Jiang F, 2015, MOL MED REP, V12, P5383, DOI 10.3892/mmr.2015.4018; Kim J, 2017, FREE RADICAL BIO MED, V104, P185, DOI 10.1016/j.freeradbiomed.2017.01.010; Laresgoiti-Servitje E, 2013, J LEUKOCYTE BIOL, V94, P247, DOI 10.1189/jlb.1112603; Lee KS, 2014, BIOCHEM BIOPH RES CO, V448, P101, DOI 10.1016/j.bbrc.2014.04.079; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Li F, 2012, J AM SOC NEPHROL, V23, P652, DOI 10.1681/ASN.2011040369; Li HG, 2002, NITRIC OXIDE-BIOL CH, V7, P132, DOI 10.1016/S1089-8603(02)00127-1; Li Y, 2016, REPROD SCI, V23, P1402, DOI 10.1177/1933719116641760; Liu XJ, 2011, J BIOL CHEM, V286, P42371, DOI 10.1074/jbc.M111.261065; Luppi P, 2006, AM J REPROD IMMUNOL, V56, P135, DOI 10.1111/j.1600-0897.2006.00386.x; Marin V, 2001, J IMMUNOL METHODS, V254, P183, DOI 10.1016/S0022-1759(01)00408-2; Martinez EC, 2017, J MOL CELL CARDIOL, V112, P27, DOI 10.1016/j.yjmcc.2017.08.013; Moore MJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9864; Nazari-Jahantigh M, 2012, J CLIN INVEST, V122, P4190, DOI 10.1172/JCI61716; Pankratz F, 2018, CIRC RES, V122, P417, DOI 10.1161/CIRCRESAHA.117.311428; Peracoli JC, 2007, AM J REPROD IMMUNOL, V57, P177, DOI 10.1111/j.1600-0897.2006.00455.x; Rudic RD, 1998, J CLIN INVEST, V101, P731, DOI 10.1172/JCI1699; Salomon C, 2017, J CLIN ENDOCR METAB, V102, P3182, DOI 10.1210/jc.2017-00672; Sarker S, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-204; Shaamash AH, 2000, INT J GYNECOL OBSTET, V68, P207, DOI 10.1016/S0020-7292(99)00213-1; Shah TJ, 2007, AM J OBSTET GYNECOL, V196, P48, DOI 10.1016/j.ajog.2006.08.038; Sladek SM, 1997, AM J PHYSIOL-REG I, V272, pR441, DOI 10.1152/ajpregu.1997.272.2.R441; Sunderland NS, 2011, CYTOKINE, V56, P192, DOI 10.1016/j.cyto.2011.06.003; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tian FJ, 2014, CARDIOVASC RES, V103, P100, DOI 10.1093/cvr/cvu070; Vargas A, 2014, FASEB J, V28, P3703, DOI 10.1096/fj.13-239053; Vaughan JE, 2012, HYPERTENS PREGNANCY, V31, P243, DOI 10.3109/10641955.2011.642436; Walford G, 2003, J THROMB HAEMOST, V1, P2112, DOI 10.1046/j.1538-7836.2003.00345.x; Yan S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8652; Yentrapalli R, 2017, INT J RADIAT BIOL, V93, P569, DOI 10.1080/09553002.2017.1294772; Zhai DS, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.03.022	45	54	58	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2018	293	49					18989	19000		10.1074/jbc.RA118.005197	http://dx.doi.org/10.1074/jbc.RA118.005197			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NY	30279269	Green Published, hybrid			2022-12-26	WOS:000458467400014
J	Lee, SM; Ha, DH; Han, SH				Lee, Sang Min; Ha, Doo Hoe; Han, Soo Hong			Differential sonographic features of the extensor pollicis longus tendon rupture and other finger tendons rupture in the setting of hand and wrist trauma	PLOS ONE			English	Article							MUSCULOSKELETAL ULTRASONOGRAPHY; ULTRASOUND EVALUATION; DISTAL RADIUS; ANATOMY; DIAGNOSIS; INJURY; TEARS; CT	Purpose To investigate the difference between sonographic findings in extensor pollicis longus tendons rupture and other finger tendons rupture in patients sustaining hand and wrist trauma. Methods Twenty-four patients who presented with signs and symptoms clinically suspicious for tendon injury and surgically confirmed tendon rupture were included in this study. We analyzed 6 sonographic features: discontinuity of the tendon, pseudomass formation, decreased echogenicity of the tendon, retraction of the ruptured tendon, fluid collection within the tendon sheath, and the motion of the tendon. We compared the sonographic features of ruptured extensor pollicis longus tendons with the other ruptured finger tendons. Results Discontinuity of the tendon was the most common sonographic findings and retraction of the ruptured tendon was the second most common findings. Fourteen of 16 cases with a dynamic study on sonography showed loss of normal motion of the tendon. Pseudomass formation was the second most common feature in ruptured extensor pollicis longus tendons, in contrast to the other ruptured finger tendons (p < 0.05). Conclusion Using ultrasonography, detection of discontinuity of the tendon, retraction of the ruptured tendon, and limitation of tendon motion could be very helpful for diagnosing a tendon rupture in hand and wrist trauma. Pseudomass formation could be more specific for diagnosing extensor pollicis longus tendon ruptures compared with other finger tendons.	[Lee, Sang Min; Ha, Doo Hoe] CHA Univ, Sch Med, CHA Bundang Med Ctr, Dept Radiol, Seongnam, South Korea; [Han, Soo Hong] CHA Univ, Sch Med, CHA Bundang Med Ctr, Dept Orthoped, Seongnam, South Korea	Pochon Cha University; Pochon Cha University	Lee, SM (corresponding author), CHA Univ, Sch Med, CHA Bundang Med Ctr, Dept Radiol, Seongnam, South Korea.	smlee@cha.ac.kr		Lee, Sang Min/0000-0002-1331-0214				Bianchi S, 2005, SKELETAL RADIOL, V34, P500, DOI 10.1007/s00256-005-0956-1; Bjorkman A, 2004, SCAND J PLAST RECONS, V38, P32, DOI 10.1080/02844310310013046; CHHEM RK, 1994, RADIOL CLIN N AM, V32, P275; Cvitanic OA, 2007, AM J ROENTGENOL, V189, P1190, DOI 10.2214/AJR.07.2281; De Maeseneer M, 2005, AM J ROENTGENOL, V184, P175, DOI 10.2214/ajr.184.1.01840175; Dezfuli B, 2016, ANN PLAS SURG, V76, P187, DOI 10.1097/SAP.0000000000000524; Fessell DP, 1998, RADIOGRAPHICS, V18, P325, DOI 10.1148/radiographics.18.2.9536481; FORNAGE BD, 1988, RADIOL CLIN N AM, V26, P87; Gitto S, 2018, J ULTRAS MED, V37, P51, DOI 10.1002/jum.14313; HOVE LM, 1994, ACTA ORTHOP SCAND, V65, P199, DOI 10.3109/17453679408995434; Jacobson JA, 1998, ORTHOP CLIN N AM, V29, P135, DOI 10.1016/S0030-5898(05)70010-9; Klauser A, 1999, AM J SPORT MED, V27, P733, DOI 10.1177/03635465990270060801; Lee DH, 2000, J HAND SURG-AM, V25A, P236, DOI 10.1053/jhsu.2000.jhsu25a0236; Mattox R, 2017, J ULTRASOUND, V20, P237, DOI 10.1007/s40477-016-0223-4; Nanno M, 2015, J NIPPON MED SCH, V82, P220, DOI 10.1272/jnms.82.220; Owers KL, 2007, J HAND SURG-BRIT EUR, V32E, P467, DOI 10.1016/j.jhsb.2006.11.021; Parellada AJ, 2007, SKELETAL RADIOL, V36, P203, DOI 10.1007/s00256-006-0238-6; Rockwell WB, 2000, PLAST RECONSTR SURG, V106, P1592, DOI 10.1097/00006534-200012000-00024; Santiago FR, 2008, EUR J RADIOL, V66, P112, DOI 10.1016/j.ejrad.2007.05.007; Sharma P., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P181; Soni P, 2009, PLAST RECONSTR SURG, V123, pE52, DOI [10.1097/PRS.0b013e318197b692, 10.1097/01.prs.0000345599.95343.2a]; Sunagawa T, 2003, J COMPUT ASSIST TOMO, V27, P169, DOI 10.1097/00004728-200303000-00012; VANHOLSBEECK M, 1992, RADIOL CLIN N AM, V30, P907; VONSCHROEDER HP, 1995, J HAND SURG-AM, V20A, P27, DOI 10.1016/S0363-5023(05)80053-X	24	1	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0205111	10.1371/journal.pone.0205111	http://dx.doi.org/10.1371/journal.pone.0205111			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3QJ	30278069	Green Published, Green Submitted, gold			2022-12-26	WOS:000446010200039
J	Medeiros, FS; Martins, AES; Gomes, RG; de Oliveira, SAV; Welkovic, S; Maruza, M; Menezes, MLB; Ximenes, RAD; Diniz, GTN; Donadi, EA; Lucena-Silva, N				Medeiros, Fernanda Silva; Silva Martins, Albert Eduardo; Gomes, Renan Garcia; Vieira de Oliveira, Savio Augusto; Welkovic, Stefan; Maruza, Magda; Bezerra Menezes, Maria Luiza; de Alencar Ximenes, Ricardo Arraes; Nunes Diniz, George Tadeu; Donadi, Eduardo Antonio; Lucena-Silva, Norma			Variation sites at the HLA-G 3 ' untranslated region confer differential susceptibility to HIV/HPV co-infection and aneuploidy in cervical cell	PLOS ONE			English	Article							LEUKOCYTE ANTIGEN-G; TO-CHILD TRANSMISSION; HUMAN-PAPILLOMAVIRUS; G POLYMORPHISMS; HPV INFECTION; G EXPRESSION; G GENE; CANCER; RISK; ASSOCIATION	Post-transcriptional regulatory elements associated with transcript degradation or transcript instability have been described at the 3' untranslated region (3'UTR) of the HLA-G gene. Considering that HPV infection and aneuploidy, which causes gene instability, are associated with cervical cell malignancy, as well as the fact that HIV infection and HLA-G may modulate the immune response, the present study aimed to compare the frequencies of HLA-G 3'UTR polymorphic sites (14-base pair insertion/deletion, +3142C/G, and +3187A/G) between 226 HIV+ women co-infected (n = 82) or not with HPV (n = 144) and 138 healthy women. We also evaluated the relationship between those HLA-G 3'UTR variants and aneuploidy in cervical cells. HPV types and HLA-G polymorphisms were determined by PCR and sequencing of cervical samples DNA. Aneuploidy in cervical cell was measured by flow cytometry. The HLA-G 3'UTR 14-bp ins/del was not associated with either HIV nor HIV/ HPV co-infection. The +3142G allele (p= 0.049) and +3142GG genotype (p = 0.047) were overrepresented in all HIV-infected women. On the other hand, the +3187G allele (p = 0.028) and the +3187GG genotype (p = 0.026) predominated among healthy women. The +3142G (p = 0.023) and +3187A (p = 0.003) alleles were associated with predisposition to HIV infection, irrespective of the presence or not of HIV/HPV co-infection. The diplotype formed by the combination of the +3142CX (CC or CG) and +3187AA genotype conferred the highest risk for aneuploidy in cervical cell induced by HPV. The HLA-G 3'UTR +3142 and +3187variants conferred distinct susceptibility to HIV infection and aneuploidy.	[Medeiros, Fernanda Silva; Silva Martins, Albert Eduardo; Gomes, Renan Garcia; Vieira de Oliveira, Savio Augusto; Lucena-Silva, Norma] Fundacao Oswaldo Cruz, Aggeu Magalhaes Inst, Dept Immunol, Lab Immunogenet, Recife, PE, Brazil; [Welkovic, Stefan] Univ Pernambuco, Integrated Hlth Ctr Amaury de Medeiros CISAM, Recife, PE, Brazil; [Maruza, Magda] Hlth Secretariat Pernambuco, Hosp Correia Picanco, Recife, PE, Brazil; [Bezerra Menezes, Maria Luiza] Univ Pernambuco UPE, Fac Med Sci, Maternal & Child Dept, Recife, PE, Brazil; [de Alencar Ximenes, Ricardo Arraes] Fed Univ Pernambuco UFPE, Dept Trop Med, Recife, PE, Brazil; [Nunes Diniz, George Tadeu] Aggeu Magalhaes Inst, Dept Publ Hlth, Lab Computat Methods, Recife, PE, Brazil; [Donadi, Eduardo Antonio] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Med, Ribeirao Preto, Brazil; [Lucena-Silva, Norma] IMIP Hosp, Pediat Oncol Serv, Recife, PE, Brazil	Fundacao Oswaldo Cruz; Universidade de Pernambuco (UPE); Universidade de Pernambuco (UPE); Universidade Federal de Pernambuco; Universidade de Sao Paulo	Lucena-Silva, N (corresponding author), Fundacao Oswaldo Cruz, Aggeu Magalhaes Inst, Dept Immunol, Lab Immunogenet, Recife, PE, Brazil.; Lucena-Silva, N (corresponding author), IMIP Hosp, Pediat Oncol Serv, Recife, PE, Brazil.	norma.lucena@hotmail.com	Lucena-Silva, Norma/AAH-9437-2019; donadi, eduardo/H-7080-2013	Garcia Gomes, Renan/0000-0003-4950-7614; donadi, eduardo/0000-0002-9457-9601	Brazilian Health Ministry Project DECIT-FINEP [1299-13;401700/2015-1]; CAPES Project PROCAD [88881-068436/2014-09]; Foundation for Science and Technology of the State of Pernambuco (FACEPE) [PROEP-APQ16804.01/15, IBPG-0849-4.01/16]; Brazilian National Council for Scientific and Technological Development (CNPq) [310364/2015-9, 304931/2014.1]	Brazilian Health Ministry Project DECIT-FINEP; CAPES Project PROCAD(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Foundation for Science and Technology of the State of Pernambuco (FACEPE)(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)); Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from: (1) Brazilian Health Ministry Project DECIT-FINEP #1299-13;401700/2015-1; (2) CAPES Project PROCAD #88881-068436/2014-09; (3) Foundation for Science and Technology of the State of Pernambuco (FACEPE), grant PROEP-APQ16804.01/15 and award #IBPG-0849-4.01/16 to F.S.M.; (4) Brazilian National Council for Scientific and Technological Development (CNPq), Award #310364/2015-9 to N.L.-S. and #304931/2014.1 to E.A.D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham AG, 2013, JAIDS-J ACQ IMM DEF, V62, P405, DOI 10.1097/QAI.0b013e31828177d7; Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004; Ananworanich J, 2015, J VIRUS ERAD, V1, P30; Rodriguez JA, 2012, PATHOBIOLOGY, V79, P72, DOI 10.1159/000334089; Baricordi Olavio R., 2008, Inflammation & Allergy Drug Targets, V7, P67, DOI 10.2174/187152808785107615; Bortolotti D, 2014, TISSUE ANTIGENS, V83, P113, DOI 10.1111/tan.12281; Carosella ED, 2008, BLOOD, V111, P4862, DOI 10.1182/blood-2007-12-127662; Carosella ED, 2011, IMMUNOL LETT, V138, P22, DOI 10.1016/j.imlet.2011.02.011; Castelli EC, 2010, GENES IMMUN, V11, P134, DOI 10.1038/gene.2009.74; Crosbie EJ, 2013, LANCET, V382, P889, DOI 10.1016/S0140-6736(13)60022-7; da Silva GK, 2014, INFECT GENET EVOL, V21, P418, DOI 10.1016/j.meegid.2013.12.013; de Albuquerque RS, 2016, HUM IMMUNOL, V77, P358, DOI 10.1016/j.humimm.2016.02.001; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Donadi EA, 2011, CELL MOL LIFE SCI, V68, P369, DOI 10.1007/s00018-010-0580-7; Dong DD, 2010, REPROD SCI, V17, P718, DOI 10.1177/1933719110369183; Ferguson R, 2012, INT J CANCER, V131, pE312, DOI 10.1002/ijc.27356; Ferguson R, 2011, HUM IMMUNOL, V72, P337, DOI 10.1016/j.humimm.2011.01.010; Garbuglia AR, 2012, J CLIN VIROL, V54, P141, DOI 10.1016/j.jcv.2012.02.013; Gimenes F, 2014, BBA-REV CANCER, V1846, P576, DOI 10.1016/j.bbcan.2014.10.004; Hong HA, 2015, INFECT GENET EVOL, V30, P147, DOI 10.1016/j.meegid.2014.12.021; Huang JH, 2010, J VIROL, V84, P10784, DOI 10.1128/JVI.01292-10; Hviid TVF, 2004, IMMUNOGENETICS, V56, P135, DOI 10.1007/s00251-004-0673-2; Lajoie J, 2010, HUM IMMUNOL, V71, P182, DOI 10.1016/j.humimm.2009.11.007; Larsen MH, 2013, J INFECT DIS, V207, P903, DOI 10.1093/infdis/jis924; Li T, 2015, MOL GENET GENOMICS, V290, P1235, DOI 10.1007/s00438-014-0985-3; Lucena-Silva N, 2013, MOL GENET GENOM MED, V1, P123, DOI 10.1002/mgg3.14; Lucena-Silva N, 2012, TISSUE ANTIGENS, V79, P272, DOI 10.1111/j.1399-0039.2012.01842.x; Lucena-Silva N, 2013, J RHEUMATOL, V40, P1104, DOI 10.3899/jrheum.120814; MANOS MM, 1989, CANCER CEL, V7, P209; Lozano JM, 2009, VIRAL IMMUNOL, V22, P463, DOI 10.1089/vim.2009.0041; Martelli-Palomino G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071742; Melsheimer P, 2004, CLIN CANCER RES, V10, P3059, DOI 10.1158/1078-0432.CCR-03-0565; Metcalfe S, 2013, HUM IMMUNOL, V74, P1610, DOI 10.1016/j.humimm.2013.08.279; Murdaca G, 2009, CLIN IMMUNOL, V133, P238, DOI 10.1016/j.clim.2009.08.002; Naucler P, 2011, J GEN VIROL, V92, P2784, DOI 10.1099/vir.0.034298-0; Porto IOP, 2015, MOL IMMUNOL, V65, P230, DOI 10.1016/j.molimm.2015.01.030; Rocha-Brischiliari SC, 2014, INFECT AGENTS CANCER, V9, DOI 10.1186/1750-9378-9-6; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Schneider ML, 1998, ATLAS DIAGNOSTICO DI, P165; Segat L, 2014, TISSUE ANTIGENS, V83, P161, DOI 10.1111/tan.12296; Silva ID, 2013, HUM IMMUNOL, V74, P452, DOI 10.1016/j.humimm.2012.11.025; Martins AES, 2014, MEM I OSWALDO CRUZ, V109, P738, DOI 10.1590/0074-0276140070; Martins AES, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104801; Simoes RT, 2009, MODERN PATHOL, V22, P1075, DOI 10.1038/modpathol.2009.67; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan Z, 2007, AM J HUM GENET, V81, P829, DOI 10.1086/521200; Xu HH, 2014, TISSUE ANTIGENS, V84, P216, DOI 10.1111/tan.12359; Yang YC, 2014, EUR J CANCER, V50, P469, DOI 10.1016/j.ejca.2013.10.018; Yie SM, 2008, MOL HUM REPROD, V14, P649, DOI 10.1093/molehr/gan059; Yoon BS, 2007, INT J GYNECOL OBSTET, V98, P48, DOI 10.1016/j.ijgo.2007.03.041	50	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0204679	10.1371/journal.pone.0204679	http://dx.doi.org/10.1371/journal.pone.0204679			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3QJ	30278059	Green Published, Green Submitted, gold			2022-12-26	WOS:000446010200020
J	Almeer, RS; El-Khadragy, MF; Abdelhabib, S; Moneim, AEA				Almeer, Rafa S.; El-Khadragy, Manal F.; Abdelhabib, Semlali; Moneim, Ahmed E. Abdel			Ziziphus spina-christi leaf extract ameliorates schistosomiasis liver granuloma, fibrosis, and oxidative stress through downregulation of fibrinogenic signaling in mice	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; MATRIX METALLOPROTEINASES; MANSONI INFECTION; GROWTH-FACTOR; L. WILLD; PROTECTS; EXPRESSION; APOPTOSIS; INJURY; TISSUE	Schistosomiasis is a widespread parasitic infection that affects humans, as well as wild and domestic animals. It ranks second after malaria, with a significant health and socio-economic impact in the developing countries. The objective of this study was to assess the anti-schistosomal impact of Ziziphus spina-christi leaf extract (ZLE) on Schistosoma mansoni-induced liver fibrosis in CD-1 Swiss male albino mice. S. mansoni infection was achieved by dipping of mouse tails in schistosomal cercariae. ZLE treatment was initiated at 46 days post-infection by administering a dose of the extract on a daily basis for 10 consecutive days. S. mansoni infection resulted in liver granuloma and fibrosis, with a drastic elevation in liver function factors, nitric oxide, and lipid peroxidation, which were associated with a reduction in glutathione content and substantial inhibition of antioxidant enzyme activities compared to those of the control. Induction of hepatic granuloma, oxidative stress, and fibrosis in the liver was controlled by ZLE administration, which also produced inhibition of matrix metalloproteinase-9, alpha-smooth muscle actin, transforming growth factor-beta, and tissue inhibitors of metalloproteinases expressions. In addition, the S. mansoni-infected group exhibited an increase in Box and caspase-3 levels and a decrease in Bcl-2 level. However, treatment with ZLE mainly mitigated apoptosis in the liver. Thus, the findings of this study revealed that Ziziphus spina-christi had anti-apoptotic, anti-fibrotic, antioxidant, and protective effects on S. mansoni-induced liver wounds. The benefits of Ziziphus spina-christi extract on S. mansoni were partly partially mediated by enhancing anti-fibrinogenic and nuclear factor erythroid 2-related factor 2 (Nrf2) pathways.	[Almeer, Rafa S.; El-Khadragy, Manal F.] King Saud Univ, Coll Sci, Dept Zool, Riyadh, Saudi Arabia; [El-Khadragy, Manal F.; Moneim, Ahmed E. Abdel] Helwan Univ, Fac Sci, Dept Zool & Entomol, Cairo, Egypt; [Abdelhabib, Semlali] King Saud Univ, Coll Sci, Dept Biochem, Genome Res Chair, Riyadh, Saudi Arabia	King Saud University; Egyptian Knowledge Bank (EKB); Helwan University; King Saud University	Almeer, RS (corresponding author), King Saud Univ, Coll Sci, Dept Zool, Riyadh, Saudi Arabia.; Moneim, AEA (corresponding author), Helwan Univ, Fac Sci, Dept Zool & Entomol, Cairo, Egypt.	ralmeer@ksu.edu.sa; aest1977@hotmail.com	Semlali, Abdelhabib/AAP-7043-2020; Moneim, Ahmed E. Abdel/C-7461-2012	Semlali, Abdelhabib/0000-0002-1643-0377; Moneim, Ahmed E. Abdel/0000-0002-2654-2591	Deanship of Scientific Research at King Saud University [R6-17-03-55]	Deanship of Scientific Research at King Saud University(King Saud University)	The authors extend their sincere appreciation to the Deanship of Scientific Research at King Saud University for its funding of this work through the Research Project No. R6-17-03-55.	Abdel Moneim AE, 2013, CNS NEUROL DISORD DR; Adenowo AF, 2015, BRAZ J INFECT DIS, V19, P196, DOI 10.1016/j.bjid.2014.11.004; AEBI H, 1984, METHOD ENZYMOL, V105, P121; Aguiar DD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167135; Al-Olayan EM, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1389-1; Al-Olayan E, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/381413; Almeer RS, 2018, FOOD CHEM TOXICOL, V115, P49, DOI 10.1016/j.fct.2018.03.002; Aly HF, 2013, PARASITOL INT, V62, P380, DOI 10.1016/j.parint.2013.04.002; Amin A, 2009, FOOD CHEM TOXICOL, V47, P2111, DOI 10.1016/j.fct.2009.05.038; Anthony BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068479; Benammar C, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-54; de Oliveira RB, 2013, INT J PARASITOL, V43, P371, DOI 10.1016/j.ijpara.2012.12.006; Dkhil MA, 2018, INFLAMMOPHARMACOLOGY, V26, P779, DOI 10.1007/s10787-017-0439-8; Dkhil MA, 2018, BIOMED PHARMACOTHER, V102, P64, DOI 10.1016/j.biopha.2018.03.032; Dkhil MA, 2014, PAK J ZOOL, V46, P763; Dooley S, 2012, CELL TISSUE RES, V347, P245, DOI 10.1007/s00441-011-1246-y; Du WD, 1999, WORLD J GASTROENTERO, V5, P397; Duarte S, 2015, MATRIX BIOL, V44-46, P147, DOI 10.1016/j.matbio.2015.01.004; El-Lakkany NM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-9; Elaloui M, 2017, NAT PROD RES, V31, P1209, DOI 10.1080/14786419.2016.1226830; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Fabre V, 2011, J INFECT DIS, V203, P707, DOI 10.1093/infdis/jiq099; Factor VM, 1998, J BIOL CHEM, V273, P15846, DOI 10.1074/jbc.273.25.15846; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Hamada T, 2008, HEPATOLOGY, V47, P186, DOI 10.1002/hep.21922; Hams E, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00089; Han HX, 2013, PARASITOL INT, V62, P100, DOI 10.1016/j.parint.2012.09.008; Kadioglu O, 2016, PHYTOMEDICINE, V23, P293, DOI 10.1016/j.phymed.2016.01.004; Khandoga A, 2006, J LEUKOCYTE BIOL, V79, P1295, DOI 10.1189/jlb.0805468; Lee EF, 2014, TRENDS PARASITOL, V30, P75, DOI 10.1016/j.pt.2013.12.005; Lee EF, 2011, P NATL ACAD SCI USA, V108, P6999, DOI 10.1073/pnas.1100652108; Li L, 2015, PARASITOLOGY, V142, P341, DOI 10.1017/S0031182014001115; Liang YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023908; Liu Y, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00116; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lundy SK, 2001, INFECT IMMUN, V69, P271, DOI 10.1128/IAI.69.1.271-280.2001; Michel CG, 2011, J ETHNOPHARMACOL, V133, P53, DOI 10.1016/j.jep.2010.09.001; Moneim AEA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158965; Nabavi SF, 2016, CRIT REV CL LAB SCI, V53, P293, DOI 10.3109/10408363.2015.1129530; Naik SR, 2007, LIVER INT, V27, P393, DOI 10.1111/j.1478-3231.2007.01463.x; NISHIKIMI M, 1972, BIOCHEM BIOPH RES CO, V46, P849, DOI 10.1016/S0006-291X(72)80218-3; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Parola M, 2001, J HEPATOL, V35, P297, DOI 10.1016/S0168-8278(01)00142-8; Pearce EJ, 2005, PARASITE IMMUNOL, V27, P265, DOI 10.1111/j.1365-3024.2005.00765.x; Pradere JP, 2013, HEPATOLOGY, V58, P1461, DOI 10.1002/hep.26429; REITMAN S, 1957, AM J CLIN PATHOL, V28, P56, DOI 10.1093/ajcp/28.1.56; Shaker Y, 2014, J CLIN TRANSL HEPATO, V2, P212, DOI 10.14218/JCTH.2014.00018; de Almeida LMS, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/9521349; Singh KP, 2004, IMMUNOLOGY, V111, P343, DOI 10.1111/j.0019-2805.2004.01817.x; Sobhy MMK, 2018, EXP PARASITOL, V185, P115, DOI 10.1016/j.exppara.2018.01.013; Stetler-Stevenson WG, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.127re6; Wang M, 2014, FREE RADICAL BIO MED, V71, P109, DOI 10.1016/j.freeradbiomed.2014.03.015; Wang Q, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00377-4; WHO, 2014, WHO TECH REP SER; Xu WH, 2008, LAB INVEST, V88, P1068, DOI 10.1038/labinvest.2008.75; Zhu DD, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0640-9	57	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204923	10.1371/journal.pone.0204923	http://dx.doi.org/10.1371/journal.pone.0204923			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273397	Green Published, Green Submitted, gold			2022-12-26	WOS:000446124700048
J	Januszek, R; Dziewierz, A; Siudak, Z; Rakowski, T; Dudek, D; Bartus, S				Januszek, Rafal; Dziewierz, Artur; Siudak, Zbigniew; Rakowski, Tomasz; Dudek, Dariusz; Bartus, Stanislaw			Chronic obstructive pulmonary disease and periprocedural complications in patients undergoing percutaneous coronary interventions	PLOS ONE			English	Article							VASCULAR COMPLICATIONS; MORTALITY; ARTERY; COPD	Background The relationship between chronic obstructive pulmonary disease (COPD) and periprocedural complications of percutaneous coronary interventions (PCIs) is influenced by several factors. We aimed to investigate the association between COPD, its complication type and rate in patients undergoing PCI. Methods Data were prospectively collected using the Polish Cardiovascular Intervention Society national registry (ORPKI) on all PCIs performed in Poland between January 2015 and December 2016. COPD was present in 5,594 of the 221,187 patients undergoing PCI. We assessed the frequency and predictors of periprocedural complications in PCI. Results Patients with COPD were elder individuals (70.3 +/- 9.9 vs. 67 +/- 10.8 years; p < 0.05). We noted 145 (2.6%) periprocedural complications in the COPD group and 4,121 (1.9%) in the non-COPD group (p < 0.001). The higher incidence of periprocedural complications in the COPD patients was mainly attributed to cardiac arrest (p = 0.001), myocardial infarctions (p = 0.002) and no-reflows (p < 0.001). COPD was not an independent predictor of all periprocedural complications. On the other hand, COPD was found to be an independent predictor of increased no-reflow risk (odds ratio [OR] 1.447, 95% CI 1.085-1.929; p = 0.01), and at the same time, of decreased risk of periprocedural allergic reactions (OR 0.117, 95% CI 0.016-0.837; p = 0.03). Conclusions In conclusion, periprocedural complications of PCIs are more frequent in patients with COPD. COPD is an independent positive predictor of no-reflow and a negative predictor of periprocedural allergic reactions.	[Januszek, Rafal; Dziewierz, Artur; Rakowski, Tomasz; Dudek, Dariusz; Bartus, Stanislaw] Univ Hosp, Dept Cardiol & Cardiovasc Intervent 2, Krakow, Poland; [Dziewierz, Artur; Rakowski, Tomasz; Dudek, Dariusz; Bartus, Stanislaw] Jagiellonian Univ, Dept Cardiol 2, Med Coll, Krakow, Poland; [Siudak, Zbigniew] Jan Kochanowski Univ Humanities & Sci, Fac Med & Hlth Sci, Kielce, Poland; [Dudek, Dariusz] Jagiellonian Univ, Dept Intervent Cardiol, Med Coll, Krakow, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University; Jan Kochanowski University; Jagiellonian University; Collegium Medicum Jagiellonian University	Bartus, S (corresponding author), Univ Hosp, Dept Cardiol & Cardiovasc Intervent 2, Krakow, Poland.; Bartus, S (corresponding author), Jagiellonian Univ, Dept Cardiol 2, Med Coll, Krakow, Poland.	stanislaw.bartus@uj.edu.pl	Rakowski, Tomasz/AFV-5238-2022; Januszek, Rafał/AFK-5634-2022	Rakowski, Tomasz/0000-0001-6478-6186; Siudak, Zbigniew/0000-0002-8033-3977; Januszek, Rafal/0000-0002-6591-1919; Bartus, Stanislaw/0000-0003-4508-3551				Ahmed B, 2009, CIRC-CARDIOVASC INTE, V2, P423, DOI 10.1161/CIRCINTERVENTIONS.109.860494; ALESSANDRI C, 1994, THROMB HAEMOSTASIS, V72, P343; Applegate RJ, 2008, JACC-CARDIOVASC INTE, V1, P317, DOI 10.1016/j.jcin.2008.03.013; de Miguel-Diez J, 2015, INT J CHRONIC OBSTR, V10, DOI 10.2147/COPD.S92614; Dziewierz A, 2009, KARDIOL POL, V67, P115; Enriquez JR, 2011, CHEST, V140, P604, DOI 10.1378/chest.10-2644; Gayed M, 2017, INT HEART J, V58, P180, DOI 10.1536/ihj.16-083; Hadi HAR, 2010, CLIN CARDIOL, V33, P228, DOI 10.1002/clc.20751; Januszek R, 2018, CATHETER CARDIO INTE, V92, pE278, DOI 10.1002/ccd.27372; Januszek R, 2018, POL ARCH INTERN MED, V128, P195, DOI 10.20452/pamw.4237; Januszek R, 2018, POL ARCH INTERN MED, V128, P24, DOI 10.20452/pamw.4145; Mehta SK, 2009, CIRC-CARDIOVASC INTE, V2, P222, DOI 10.1161/CIRCINTERVENTIONS.108.846741; Montalescot G, 2011, INT J CARDIOL, V150, P79, DOI 10.1016/j.ijcard.2010.02.077; Mukherjee B, 2017, J CLIN DIAGN RES, V11, pBC19, DOI 10.7860/JCDR/2017/25933.10667; Nishiyama K, 2010, INT J CARDIOL, V143, P178, DOI 10.1016/j.ijcard.2009.02.010; Raherison C, 2009, EUR RESPIR REV, V18, P213, DOI 10.1183/09059180.00003609; Sidney S, 2005, CHEST, V128, P2068, DOI 10.1378/chest.128.4.2068; Siudak Z, 2017, EUROINTERVENTION, V13, P843, DOI 10.4244/EIJ-D-17-00078; Sung Pei-Hsun, 2013, Biomed J, V36, P274, DOI 10.4103/2319-4170.113373; Zhang M, 2016, MATH PROBL ENG, V2016, DOI 10.1155/2016/1395701	20	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204257	10.1371/journal.pone.0204257	http://dx.doi.org/10.1371/journal.pone.0204257			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273363	Green Submitted, Green Published, gold			2022-12-26	WOS:000446124700017
J	Robles-Bykbaev, Y; Tarrio-Saavedra, J; Quintana-Pita, S; Diaz-Prado, S; Saban, FJG; Naya, S				Robles-Bykbaev, Yaroslava; Tarrio-Saavedra, Javier; Quintana-Pita, Sara; Diaz-Prado, Silvia; Garcia Saban, Francisco Javier; Naya, Salvador			Statistical degradation modelling of Poly(D,L-lactide-co-glycolide) copolymers for bioscaffold applications	PLOS ONE			English	Article							GENERALIZED LOGISTIC FUNCTION; BIODEGRADABLE POLYMERS; PLGA MICROSPHERES; IN-VITRO; SCAFFOLDS; KINETICS; FABRICATION; DELIVERY; PLA; RELEASE	This methodology permits to simulate the performance of different Poly(D,L-lactide-co-glycolide) copolymer formulations (PDLGA) in the human body, to identify the more influencing variables on hydrolytic degradation and, thus, to estimate biopolymer degradation level. The PDLGA characteristic degradation trends, caused by hydrolysis processes, have been studied to define their future biomedical applications as dental scaffolds. For this purpose, the mass loss, pH, glass transition temperature (T-g) and absorbed water mass of the different biopolymers have been obtained from samples into a phosphate-buffered saline solution (PBS) with initial pH of 7.4, at 37 degrees C (human body conditions). The mass loss has been defined as the variable that characterize the biopolymer degradation level. Its dependence relationship with respect to time, pH and biopolymer formulation has been modelled using statistical learning tools. Namely, generalized additive models (GAM) and nonlinear mixed effects regression with logistic and asymptotic functions have been applied. GAM model provides information about the relevant variables and the parametric functions that relate mass loss, pH and time. Mixed effects are introduced to model and estimate the degradation properties, and to compare the PDLGA biopolymer populations. The degradation path for each polymer formulation has been estimated and compared with respect to the others for helping to use the proper polymer for each specific medical application, performing selection criteria. It was found that the mass loss differences in PDLGA copolymers are strongly related with the way the pH decay versus time, due to carboxylic acid groups formation. This may occur in those environments in which the degradation products remain relatively confined with the non degraded mass. This is the case emulated with the present experimental procedure. The results show that PDLGA polymers degradation degree, in terms of half life and degradation rate, is increasing when acid termination is included, when DL-lactide molar ratio is reduced, decreasing the midpoint viscosity, or when glycolide is not included.	[Robles-Bykbaev, Yaroslava; Diaz-Prado, Silvia] Univ A Coruna, Dept Med, SERGAS, Inst Invest Biomed A Coruna INIBIC,CHUAC, La Coruna, Spain; [Robles-Bykbaev, Yaroslava] Univ Politecn Salesiana, GIIATa, Cuenca, Ecuador; [Tarrio-Saavedra, Javier; Naya, Salvador] Univ A Coruna, Escola Politecn Super, Dept Matemat, Grp MODES, Ferrol, Spain; [Tarrio-Saavedra, Javier; Naya, Salvador] Univ A Coruna, CITIC, La Coruna, Spain; [Quintana-Pita, Sara; Garcia Saban, Francisco Javier] DevelopBiosystem SL, Cedeira, Spain; [Naya, Salvador] ITMATI, Santiago De Compostela, Spain	Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC); Universidad Politecnica Salesiana; Universidade da Coruna; Universidade da Coruna	Tarrio-Saavedra, J (corresponding author), Univ A Coruna, Escola Politecn Super, Dept Matemat, Grp MODES, Ferrol, Spain.; Tarrio-Saavedra, J (corresponding author), Univ A Coruna, CITIC, La Coruna, Spain.	jtarrio@udc.es	DÍAZ-PRADO, SILVIA MARIA/ABH-6665-2020; Naya, Salvador/F-7405-2014; Robles-Bykbaev, Yaroslava/Y-6019-2019; Tarrío-Saavedra, Javier/K-9077-2017	DÍAZ-PRADO, SILVIA MARIA/0000-0001-9776-2180; Naya, Salvador/0000-0003-4931-9859; Robles-Bykbaev, Yaroslava/0000-0003-3177-8344; Tarrío-Saavedra, Javier/0000-0002-9584-127X	Xunta de Galicia (Centro Singular de Investigacion de Galicia accreditation) [ED431G/01 2016-2019]; Xunta de Galicia (Grupos de Referencia Competitiva) [ED431C2016-015]; MINECO [MTM2014-52876-R]; European Union (European Regional Development Fund - ERDF); Ecuador's Secretaria Nacional de Educacion Superior, Ciencia, Tecnologia e Innovacion (SENESCYT); Inditex-UDC International Doctoral School Grant; DevelopBiosystem SL	Xunta de Galicia (Centro Singular de Investigacion de Galicia accreditation); Xunta de Galicia (Grupos de Referencia Competitiva)(Xunta de Galicia); MINECO(Spanish Government); European Union (European Regional Development Fund - ERDF); Ecuador's Secretaria Nacional de Educacion Superior, Ciencia, Tecnologia e Innovacion (SENESCYT); Inditex-UDC International Doctoral School Grant; DevelopBiosystem SL	The research of Salvador Naya and Javier Tarrio-Saavedra has been partially supported by the Xunta de Galicia (Centro Singular de Investigacion de Galicia accreditation [ED431G/01 2016-2019] and Grupos de Referencia Competitiva [ED431C2016-015]) and by the MINECO [Grant MTM2014-52876-R]. These grants are cofunded by the European Union (European Regional Development Fund - ERDF). The research of Yaroslava Robles has been supported by the Ecuador's Secretaria Nacional de Educacion Superior, Ciencia, Tecnologia e Innovacion (SENESCYT) and Inditex-UDC International Doctoral School Grant for pre-doctoral students. Francisco Javier Garcia Saban and Sara Quintana-Pita are employed by DevelopBiosystem SL. DevelopBiosystem SL provided support in the form of salaries for J.G.S and S.Q.P. authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author	Akl MA, 2016, J DRUG DELIV SCI TEC, V32, P10, DOI 10.1016/j.jddst.2016.01.007; Anderson JM, 2012, ADV DRUG DELIVER REV, V64, P72, DOI 10.1016/j.addr.2012.09.004; Ballester JJ, 2011, BIOMATERIALES SUSTIT; Breche Q, 2016, POLYM DEGRAD STABIL, V131, P145, DOI 10.1016/j.polymdegradstab.2016.07.014; Carral-Couce L, 2017, P I MECH ENG M-J ENG, V231, P600, DOI 10.1177/1475090216677130; Carreno JM, 2016, VACCINE, V34, P4263, DOI 10.1016/j.vaccine.2016.05.036; Chen YH, 2011, ACTA BIOMATER, V7, P1140, DOI 10.1016/j.actbio.2010.09.038; Chew SA, 2016, J BIOMED MATER RES A, V104, P1202, DOI 10.1002/jbm.a.35657; Cristallini C, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/7176154; Elamanchili P, 2004, VACCINE, V22, P2406, DOI 10.1016/j.vaccine.2003.12.032; Escobar, 1998, STAT METHODS RELIABI; Francisco-Fernandez M, 2017, J THERM ANAL CALORIM, V127, P499, DOI 10.1007/s10973-016-5917-5; Francisco-Fernandez M, 2015, J THERM ANAL CALORIM, V120, P541, DOI 10.1007/s10973-014-4260-y; Ghorbani F, 2016, MAT SCI ENG C-MATER, V69, P208, DOI 10.1016/j.msec.2016.06.079; Han X, 2017, WOODH PUBL SER BIOM, V117, P427, DOI 10.1016/B978-0-08-100372-5.00015-5; Hastie TJ, 2011, ELEMENTS STAT LEARNI; Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421; Hoque M. E., 2012, REGENERATIVE RES, V1, P58; Idaszek J, 2016, POLYM DEGRAD STABIL, V124, P119, DOI 10.1016/j.polymdegradstab.2015.12.020; Janeiro-Arocas J, 2016, J MECH BEHAV BIOMED, V63, P456, DOI 10.1016/j.jmbbm.2016.07.014; Ji YH, 2017, J BIOMED MATER RES A, V105, P1593, DOI 10.1002/jbm.a.35962; Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002; Kaur MAS, 2008, POLY DL LACTIDE CO G; Lazzari S, 2014, POLYM DEGRAD STABIL, V110, P80, DOI 10.1016/j.polymdegradstab.2014.08.012; Li H., 2016, ABU DHABI INT PET EX, P1, DOI [10.2118/183215-MS, DOI 10.2118/183215-MS]; Meneses A, 2016, SPRINGER P MATH STAT, V175, P211, DOI 10.1007/978-3-319-41582-6_15; Nikkola L, 2015, EUR J MED RES, V20, DOI 10.1186/s40001-015-0145-1; Parisi O.I., 2015, ADV POLYM MED, P1; Pinheiro J., 2018, NLME LINEAR NONLINEA; Pinheiro J.C., 2000, STAT COMPUTING; PITT C G, 1987, Journal of Controlled Release, V4, P283, DOI 10.1016/0168-3659(87)90020-4; Rios-Fachal M, 2014, J THERM ANAL CALORIM, V116, P1141, DOI 10.1007/s10973-013-3623-0; Ronkko S, 2011, OPHTHALMIC RES, V46, P55, DOI 10.1159/000322996; Samami H., 2016, WOODHEAD PUBLISHING, P45; Sandino C, 2008, J BIOMECH, V41, P1005, DOI 10.1016/j.jbiomech.2007.12.011; Schliecker G, 2003, BIOMATERIALS, V24, P3835, DOI 10.1016/S0142-9612(03)00243-6; Tarrio-Saaavedra J, 2008, POLYM DEGRAD STABIL, V93, P2133, DOI 10.1016/j.polymdegradstab.2008.08.006; Tarrio-Saavedra J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169866; Tarrio-Saavedra J, 2015, J THERM ANAL CALORIM, V122, P1203, DOI 10.1007/s10973-015-5083-1; Tarrio-Saavedra J, 2014, J THERM ANAL CALORIM, V118, P1253, DOI 10.1007/s10973-014-3887-z; Thavornyutikarn B, 2014, PROG BIOMATER, V3, P61, DOI 10.1007/s40204-014-0026-7; Tyler B, 2016, ADV DRUG DELIVER REV, V107, P163, DOI 10.1016/j.addr.2016.06.018; Tzeng SY, 2016, J CONTROL RELEASE, V233, P101, DOI 10.1016/j.jconrel.2016.05.012; Upson SJ, 2016, MAT SCI ENG C-MATER, V69, P470, DOI 10.1016/j.msec.2016.06.012; Valenzuela LM, 2016, INT J BIOMATER, V2016, DOI 10.1155/2016/6273414; Vyazovkin S, 2011, THERMOCHIM ACTA, V520, P1, DOI 10.1016/j.tca.2011.03.034; Wang LM, 2016, APPL NANOBIOMATER, V4, P241, DOI 10.1016/B978-0-323-42862-0.00008-0; Wood S.N., 2017, GEN ADDITIVE MODELS; Zeng L, 2016, IIE TRANS, V48, P16, DOI 10.1080/0740817X.2015.1019164; Zhao W, 2016, MAT SCI ENG C-MATER, V59, P1181, DOI 10.1016/j.msec.2015.11.026	50	10	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204004	10.1371/journal.pone.0204004	http://dx.doi.org/10.1371/journal.pone.0204004			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273349	Green Published, Green Submitted, gold			2022-12-26	WOS:000446124700012
J	Frolov, AO; Malysheva, MN; Ganyukova, AI; Yurchenko, V; Kostygov, AY				Frolov, Alexander O.; Malysheva, Marina N.; Ganyukova, Anna I.; Yurchenko, Vyacheslav; Kostygov, Alexei Y.			Obligate development of Blastocrithidia papi (Trypanosomatidae) in the Malpighian tubules of Pyrrhocoris apterus (Hemiptera) and coordination of host-parasite life cycles	PLOS ONE			English	Article							LYGAEUS-PANDURUS HEMIPTERA; AL 1971 TRYPANOSOMATIDAE; BUG TRIATOMA-INFESTANS; INSECT TRYPANOSOMATIDS; ONCOPELTUS-FASCIATUS; SP-N; LEPTOMONAS; ULTRASTRUCTURE; TRANSMISSION; LYGAEIDAE	Blastocrithidia papi is a unique trypanosomatid in that its life cycle is synchronized with that of its host, and includes an obligate stage of development in Malpighian tubules (MTs). This occurs in firebugs, which exited the winter diapause. In the short period, preceding the mating of overwintered insects, the flagellates penetrate MTs of the host, multiply attached to the epithelial surface with their flagella, and start forming cyst-like amastigotes (CLAs) in large agglomerates. By the moment of oviposition, a large number of CLAs are already available in the rectum. They are discharged on the eggs' surface with feces, used for transmission of bugs' symbiotic bacteria, which are compulsorily engulfed by the newly hatched nymphs along with the CLAs. The obligate development of B. papi in MTs is definitely linked to the life cycle synchronization. The absence of peristalsis allow the trypanosomatids to accumulate and form dense CLA-forming subpopulations, whereas the lack of peritrophic structures facilitates the extensive discharge of CLAs directly into the hindgut lumen. The massive release of CLAs associated with oviposition is indispensable for maximization of the infection efficiency at the most favorable time point.	[Frolov, Alexander O.; Malysheva, Marina N.; Ganyukova, Anna I.] Russian Acad Sci, Zool Inst, St Petersburg, Russia; [Yurchenko, Vyacheslav; Kostygov, Alexei Y.] Univ Ostrava, Life Sci Res Ctr, Fac Sci, Ostrava, Czech Republic; [Yurchenko, Vyacheslav] Czech Acad Sci, Inst Parasitol, Biol Ctr, Ceske Budejovice, Budweis, Czech Republic; [Yurchenko, Vyacheslav] Sechenov Univ, Martsinovsky Inst Med Parasitol Trop & Vector Bor, Moscow, Russia	Russian Academy of Sciences; Zoological Institute of the Russian Academy of Sciences; University of Ostrava; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Sechenov First Moscow State Medical University	Kostygov, AY (corresponding author), Univ Ostrava, Life Sci Res Ctr, Fac Sci, Ostrava, Czech Republic.	aleksei.kostygov@osu.cz	Kostygov, Alexei Y/D-3931-2015; Frolov, Alexander/AAP-9475-2020; Yurchenko, Vyacheslav/E-4532-2013; Frolov, Alexander O./P-3414-2015	Kostygov, Alexei Y/0000-0002-1516-437X; Frolov, Alexander/0000-0003-1444-3104; Yurchenko, Vyacheslav/0000-0003-4765-3263; 	Russian Science Foundation [14-14-00621]; European Regional Funds [OPVVV 16_019/0000759]; Grant Agency of the Czech Republic [18-15962S]	Russian Science Foundation(Russian Science Foundation (RSF)); European Regional Funds; Grant Agency of the Czech Republic(Grant Agency of the Czech Republic)	This work was supported by the Russian Science Foundation (rscf.ru) grant 14-14-00621 (material collection, TEM and SEM analyses of a host-parasite relationships, and experiments with life cycle of parasites) to AOF, MNM, AIG, and AYK, and European Regional Funds (www.msmt.cz/ strukturalni-fondy-1/vyzvy-op-vvv), project OPVVV 16_019/0000759 and the Grant Agency of the Czech Republic (gacr.cz) grant 18-15962S (light microscopy and statistical analyses) to VY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butenko A, 2018, CURR GENOMICS, V19, P150, DOI 10.2174/1389202918666170815143331; CLEVELAND LR, 1957, J PROTOZOOL, V4, P168, DOI 10.1111/j.1550-7408.1957.tb02504.x; Codreanu R., 1930, CR Acad Sci Paris, V190, P1154; CODREANU RADU, 1934, ANN PROTISTOLOGIE, V4, P181; Desportes I, 2013, GREGARINES EARLY BRA; Dias FD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108746; DOGIEL VA, 1966, GEN PARASITOLOGY; FREVERT U, 1988, J ULTRA MOL STRUCT R, V99, P124, DOI 10.1016/0889-1605(88)90048-1; Frolov A. O., 2014, Parazitologiya (St. Petersburg), V48, P461; Frolov A.O., 1995, Tsitologiya, V37, P539; Frolov AO, 2017, EUR J PROTISTOL, V57, P85, DOI 10.1016/j.ejop.2016.10.007; Frolov AO, 2016, EUR J PROTISTOL, V52, P1, DOI 10.1016/j.ejop.2015.08.002; Frolov Alexander O., 1995, Tsitologiya, V37, P1072; FROLOV AO, 1987, ZOOL ZH, V66, P5; FROLOV AO, 1991, TSITOLOGIYA+, V33, P55; GIBBS AJ, 1950, PARASITOLOGY, V40, P322, DOI 10.1017/S0031182000018199; GOLIKOVA M. N., 1963, ACTA PROTOZOOLOGICA, V1, P31; Halberg KA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11266; Hollar L, 1998, J EUKARYOT MICROBIOL, V45, P293, DOI 10.1111/j.1550-7408.1998.tb04539.x; Jaskowska E, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004484; Kaltenpoth M, 2009, FEMS MICROBIOL ECOL, V69, P373, DOI 10.1111/j.1574-6941.2009.00722.x; Kostygov A.Yu., 2007, Parazitologiya (St. Petersburg), V41, P126; Kostygov AY, 2014, PROTIST, V165, P594, DOI 10.1016/j.protis.2014.07.001; Kozminsky E, 2015, PROTIST, V166, P551, DOI 10.1016/j.protis.2015.08.004; LIPA JERZY J., 1966, ACTA PROTOZOOL, V4, P19; Lukes J, 2018, TRENDS PARASITOL, V34, P466, DOI 10.1016/j.pt.2018.03.002; Malysheva M N, 2006, Tsitologiia, V48, P723; Maslov DA, 2019, PARASITOLOGY, V146, P1, DOI 10.1017/S0031182018000951; Maslov DA, 2013, TRENDS PARASITOL, V29, P43, DOI 10.1016/j.pt.2012.11.001; Maslov DA, 2010, J EUKARYOT MICROBIOL, V57, P177, DOI 10.1111/j.1550-7408.2009.00464.x; MCGHEE RB, 1980, MICROBIOL REV, V44, P140, DOI 10.1128/MMBR.44.1.140-173.1980; MCGHEE RB, 1962, J PROTOZOOL, V9, P488, DOI 10.1111/j.1550-7408.1962.tb02660.x; MEHLHORN H, 1979, TROPENMED PARASITOL, V30, P289; Merzlyak E, 2001, J EUKARYOT MICROBIOL, V48, P161, DOI 10.1111/j.1550-7408.2001.tb00298.x; Caicedo AM, 2011, MEM I OSWALDO CRUZ, V106, P301, DOI 10.1590/S0074-02762011000300008; Molyneux DH, 1983, BIOL TRYPANOSOMA LEI, Vxi; Neresheimer Eugen, 1907, Archiv fuer Protistenkunde Jena Suppl, V1; Nowlin N., 1922, Journal of Parasitology Urbana, V8, P153, DOI 10.2307/3271231; PENG PL, 1981, J PROTOZOOL, V28, P116, DOI 10.1111/j.1550-7408.1981.tb02814.x; PODLIPAEV SA, 1987, PARAZITOLOGIYA+, V21, P545; Podlipaev SA, 1990, CATALOGUE WORLD FAUN; REDUTH D, 1988, PARASITOL RES, V74, P301, DOI 10.1007/BF00539449; Romeiro A, 2000, J EUKARYOT MICROBIOL, V47, P208, DOI 10.1111/j.1550-7408.2000.tb00040.x; ROWTON ED, 1981, J PROTOZOOL, V28, P297, DOI 10.1111/j.1550-7408.1981.tb02854.x; Schaub G A, 1988, Mem Inst Oswaldo Cruz, V83 Suppl 1, P622, DOI 10.1590/S0074-02761988000500075; SCHAUB GA, 1988, PARASITOL RES, V75, P88, DOI 10.1007/BF00932706; SCHAUB GA, 1989, J PROTOZOOL, V36, P171, DOI 10.1111/j.1550-7408.1989.tb01067.x; SCHAUB GA, 1994, PARASITOL TODAY, V10, P463, DOI 10.1016/0169-4758(94)90155-4; SCHAUB GA, 1981, T ROY SOC TROP MED H, V75, P168, DOI 10.1016/0035-9203(81)90057-2; SCHAUB GA, 1989, ANN TROP MED PARASIT, V83, P215, DOI 10.1080/00034983.1989.11812335; SMIRNOFF WA, 1970, J INVERTEBR PATHOL, V16, P187, DOI 10.1016/0022-2011(70)90059-5; Takata CSA, 1996, EUR J PROTISTOL, V32, P90, DOI 10.1016/S0932-4739(96)80043-5; TIESZEN K, 1985, Z PARASITENKD, V71, P179, DOI 10.1007/BF00926268; TIESZEN KL, 1989, J PARASITOL, V75, P441, DOI 10.2307/3282603; TIESZEN KL, 1989, PARASITOLOGY, V98, P395, DOI 10.1017/S0031182000061473; Vickerman K., 1976, P35; Votypka J, 2014, KENTOMONAS GEN N NEW; Votypka J, 2015, TRENDS PARASITOL, V31, P460, DOI 10.1016/j.pt.2015.06.015; WALLACE FG, 1966, EXP PARASITOL, V18, P124, DOI 10.1016/0014-4894(66)90015-4; Wessenberg H., 1961, University of California Publications in Zoology, V61, P315; Wichterman R, 1937, J MORPHOL, V60, P563, DOI 10.1002/jmor.1050600212; Yurchenko VY, 2008, PROTIST, V159, P99, DOI 10.1016/j.protis.2007.07.003	62	14	15	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204467	10.1371/journal.pone.0204467	http://dx.doi.org/10.1371/journal.pone.0204467			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30261003	Green Submitted, Green Published, gold			2022-12-26	WOS:000445907400055
J	Rezapour, A; Jahangiri, R; Olyaeemanesh, A; Kalaghchi, B; Nouhi, M; Nahvijou, A				Rezapour, Aziz; Jahangiri, Reza; Olyaeemanesh, Alireza; Kalaghchi, Bita; Nouhi, Mojtaba; Nahvijou, Azin			The economic burden of oral cancer in Iran	PLOS ONE			English	Article							COST-OF-ILLNESS; INCIDENCE RATES; NECK CANCERS; HEAD; DIAGNOSIS; EPIDEMIOLOGY; CAVITY; CARE	Background Cancer is one of the leading causes of death in the world, among which, oral cancer is associated with significant morbidity, and low survival. A large part of the budget allocated to health care is attributed to cancer. In this study we aim to estimate the economic burden of oral cancer in Iran for the year 2014. Methods In this study, we generated a prevalence-based estimate of the cost-of-illness of oral cancer in Iran. A societal perspective was used for this study, in which the direct costs and productivity losses of oral cancer cases in 2014 were estimated. The human capital approach was adopted for estimating productivity losses. Several data sources contributed to this study, including national cancer registry reports, hospital records, occupational data, and interviews with experts. Result Nearly 53% of patients were diagnosed in an advanced stage of oral cancer. The economic burden of oral cancer was $64,245,173 most of which (50%) was attributed to productivity losses. The direct medical cost accounted for 42% of the estimated total cost. Treatment expenses for advanced stages were five times higher than the early stages ($10,532 vs. $2,225). Conclusion The economic burden of oral cancer is high in Iran. Planning an early detection and screening program for oral cancer may potentially decrease health care costs, morbidity, and mortality.	[Rezapour, Aziz] Iran Univ Med Sci, Hlth Management & Econ Res Ctr, Tehran, Iran; [Jahangiri, Reza] Iran Univ Med Sci, Sch Hlth Management & Informat Sci, Dept Hlth Econ, Tehran, Iran; [Olyaeemanesh, Alireza; Nouhi, Mojtaba] Univ Tehran Med Sci, Hlth Equ Res Ctr, Tehran, Iran; [Olyaeemanesh, Alireza] Univ Tehran Med Sci, Natl Inst Hlth Res, Tehran, Iran; [Kalaghchi, Bita] Univ Tehran Med Sci, Radiat Oncol Res Ctr, Tehran, Iran; [Nahvijou, Azin] Univ Tehran Med Sci, Canc Inst, Canc Res Ctr, Tehran, Iran	Iran University of Medical Sciences; Iran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences	Jahangiri, R (corresponding author), Iran Univ Med Sci, Sch Hlth Management & Informat Sci, Dept Hlth Econ, Tehran, Iran.; Nahvijou, A (corresponding author), Univ Tehran Med Sci, Canc Inst, Canc Res Ctr, Tehran, Iran.	reza.jahan67@gmail.com; azin.nahvijou@gmail.com	Olyaeemanesh, Alireza/ABB-8563-2020; Nahvijou, Azin/AAL-4117-2020	Nahvijou, Azin/0000-0003-1973-7638; nouhi, mojtaba/0000-0002-4466-8403	Iran university of medical sciences; cancer research center of cancer institute of Iran (Sohrabi cancer charity) [97-02-202-39593]	Iran university of medical sciences; cancer research center of cancer institute of Iran (Sohrabi cancer charity)	This work is funded by Iran university of medical sciences. Additionally, this project has been conducted by a grant from cancer research center of cancer institute of Iran (Sohrabi cancer charity, Grant No: 97-02-202-39593). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadzadeh Nahal, 2017, Med J Islam Repub Iran, V31, P78, DOI 10.14196/mjiri.31.78; [Anonymous], IR ANN NAT CANC REG; Armour B. S., 2005, Morbidity and Mortality Weekly Report, V54, P625; Asmarian NS, 2013, ASIAN PAC J CANCER P, V14, P11, DOI 10.7314/APJCP.2013.14.1.11; Bray F, 2013, INT J CANCER, V132, P1133, DOI 10.1002/ijc.27711; Chaturvedi AK, 2013, J CLIN ONCOL, V31, P4550, DOI 10.1200/JCO.2013.50.3870; Clabaugh G, 2008, VALUE HEALTH, V11, P13, DOI 10.1111/j.1524-4733.2007.00210.x; Daroudi A, 2014, REV METHODS ESTIMATI, P349; Daroudi R, 2015, IRAN J PUBLIC HEALTH, V44, P12; Dedhia RC, 2011, LARYNGOSCOPE, V121, P952, DOI 10.1002/lary.21412; Epstein JD, 2008, HEAD NECK-J SCI SPEC, V30, P178, DOI 10.1002/hed.20670; Esmaelbeigi F, 2014, ARCH IRAN MED, V17, P253, DOI 014174/AIM.007; Ferlay J, 2014, GLOBOCAN 2012 V1 0 C, V11; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Finkelstein Eric, 2003, Expert Rev Pharmacoecon Outcomes Res, V3, P367, DOI 10.1586/14737167.3.4.367; Han S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-196; Hanly P, 2015, INT J CANCER, V136, pE136, DOI 10.1002/ijc.29105; Hasoumi Mojtaba, 2014, Mater Sociomed, V26, P339, DOI 10.5455/msm.2014.26.339-342; Jamshidi S, 2012, J MASH DENT SCH, P23; Jo C, 2014, CLIN MOL HEPATOL, V20, P327, DOI 10.3350/cmh.2014.20.4.327; Kakoei S, 2009, SHIRAZ UNIV DENT J, V10, P234; Klussmann JP, 2013, CLINICOECONOMIC OUTC, V5, P203, DOI 10.2147/CEOR.S43393; Larg A, 2011, PHARMACOECONOMICS, V29, P653, DOI 10.2165/11588380-000000000-00000; Mahmoudifar F, 2011, J NURSING MIDWIFERY, V9, P367; Marur S, 2008, MAYO CLIN PROC, V83, P489, DOI 10.4065/83.4.489; Medina JE, 2016, ORAL CAVITY CANC CAN, P3; Menzin Joseph, 2007, Curr Opin Otolaryngol Head Neck Surg, V15, P68, DOI 10.1097/MOO.0b013e328017f669; Ministry of Cooperation Labour and Social Welfare, 2014, LAB MARK INF SYST 20; Ministry of Health and Medical Education, 2014, BOOK REL VAL HEALTHC; Mohebbi E, 2018, BASIC CLIN CANC RES, V9; Motallebinejad M, 2007, J MASHHAD DENT SCH, V30, P309; Naghavi M., 2008, IRAN J EPIDEMIOL, V4, P1; Nahvijou A, 2014, ASIAN PAC J CANCER P, V15, P8209, DOI 10.7314/APJCP.2014.15.19.8209; Pearce AM, 2015, APPL HEALTH ECON HEA, V13, P359, DOI 10.1007/s40258-015-0155-8; Pfister DG, 2015, J NATL COMPR CANC NE, V13, P847, DOI 10.6004/jnccn.2015.0102; Quer M, 2001, Acta Otorrinolaringol Esp, V52, P201; Rad M., 2008, J KERMAN U MED SCI, V15, P363; Sargeran K, 2008, BRIT J ORAL MAX SURG, V46, P187, DOI 10.1016/j.bjoms.2007.11.004; Segel J, 2006, COST OF ILLNESS STUD; Shiva A, 2014, J MAZANDARAN U MED S, V24, P164; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Speight PM, 2006, HEALTH TECHNOL ASSES, V10, P1; Subramanian S, 2009, B WORLD HEALTH ORGAN, V87, P198, DOI 10.2471/BLT.08.053231; Vahdatimanesh Z, 2017, MED J ISLAMIC REPUBL, V31, P768; Waldfahrer F, 1999, HNO, V47, P957, DOI 10.1007/s001060050475; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; World Health Organization, 2009, WHO GUID ID EC CONS; World Health Organization, 2014, WORLD HLTH STAT 2014; Zavras A, 2002, BMC PUBLIC HEALTH, V2, DOI 10.1186/1471-2458-2-12; Zendehdel K, 2010, IMPROVING QUALITY 1, P42; Zendehdel K, 2010, IMPROVING QUALITY 2	51	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0203059	10.1371/journal.pone.0203059	http://dx.doi.org/10.1371/journal.pone.0203059			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30260976	Green Submitted, gold, Green Published			2022-12-26	WOS:000445907400008
J	Eijsvoogel, NG; Hendriks, BMF; Willigers, JL; Martens, B; Carati, LF; Horehledova, B; Kietselaer, BLJH; Crijns, HJGM; Wildberger, JE; Das, M				Eijsvoogel, Nienke G.; Hendriks, Babs M. F.; Willigers, Jef L.; Martens, Bibi; Carati, Luc F.; Horehledova, Barbora; Kietselaer, Bastiaan L. J. H.; Crijns, Harry J. G. M.; Wildberger, Joachim E.; Das, Marco			Personalization of injection protocols to the individual patient's blood volume and automated tube voltage selection (ATVS) in coronary CTA	PLOS ONE			English	Article							COMPUTED TOMOGRAPHIC ANGIOGRAPHY; RADIATION-DOSE REDUCTION; CONTRAST ENHANCEMENT; IMAGE QUALITY; BODY-WEIGHT; RADIOLOGY; SOCIETY; RISK	Purpose The aim was to assess personalised contrast media (CM) protocols-based on patient's blood volume (BV) and automated tube voltage selection (ATVS)-in coronary computed tomography angiography (CCTA). Methods A total of 114 consecutive patients received an ECG-triggered or ECG-gated helical scan on a 3rd -generation dual-source CT with 70-120kV (ATVS) and 330mAs(qual.ref.) CM was adapted to BV, scan time (s) and kV. Image quality (IQ) was assessed in a 17-segment coronary model using attenuation values (HU), contrast-to-noise (CNR), signal-to-noise ratio (SNR) (objective IQ) and a Likert scale (subjective IQ: 1 = poor/2 = sufficient/3 = good/4 = excellent). ig Results Patient distribution was: n = 60 for 70kV, n = 37 80kV and n = 17 90kV. Mean BV was 5.4 +/- 0.6L for men and 4.1 +/- 0.6L for women. Mean CM volume (300 mg l/mL) and flow rate were: 30.9 +/- 6.4mL and 3.3 +/- 0.5mL/s (70kV); 40.8 +/- 7.1mL and 4.5 +/- 0.6mL/s (80kV); 53.6 +/- 8.6mL and 5.7 +/- 0.6mL/s (90kV). Overall mean HU was >300HU in 98.2% (112/114) of patients. Overall mean attenuation was below 300HU in two scans (70kV) due to late scan timing. Of 1.661 segments, 95.4% was assessable. Mean CNR was 14 +/- 4(70kV), 13 +/- 3(80kV) and 14 +/- 4(90kV); mean SNR was 10 +/- 2(both 70kV+80kV) and 9 +/- 2(90kV). Objective IQ was comparable between kV settings, protocols and sex. Subjective IQ was diagnostic in all scans and excellent-sufficient in 95.4% of segments. Conclusions Personalisation of CCTA CM injection protocols to BV and ATVS is a promising technique to tailor CM administration to the individual patient, while maintaining diagnostic IQ.	[Eijsvoogel, Nienke G.; Hendriks, Babs M. F.; Willigers, Jef L.; Martens, Bibi; Carati, Luc F.; Horehledova, Barbora; Kietselaer, Bastiaan L. J. H.; Wildberger, Joachim E.; Das, Marco] Maastricht Univ, Dept Radiol & Nucl Med, Med Ctr, Maastricht, Netherlands; [Eijsvoogel, Nienke G.; Hendriks, Babs M. F.; Martens, Bibi; Horehledova, Barbora; Kietselaer, Bastiaan L. J. H.; Crijns, Harry J. G. M.; Wildberger, Joachim E.] Maastricht Univ, Med Ctr, CARIM Sch Cardiovasc Dis, Maastricht, Netherlands; [Kietselaer, Bastiaan L. J. H.; Crijns, Harry J. G. M.] Maastricht Univ, Med Ctr, Dept Cardiol, Maastricht, Netherlands; [Das, Marco] Helios Kliniken Duisburg, Dept Diagnost & Intervent Radiol, Duisburg, Germany	Maastricht University; Maastricht University; Maastricht University	Eijsvoogel, NG (corresponding author), Maastricht Univ, Dept Radiol & Nucl Med, Med Ctr, Maastricht, Netherlands.; Eijsvoogel, NG (corresponding author), Maastricht Univ, Med Ctr, CARIM Sch Cardiovasc Dis, Maastricht, Netherlands.	nienke.eijsvoogel@mumc.nl		Wildberger, Joachim/0000-0002-4810-6854; Martens, Bibi/0000-0003-3105-6640; Hendriks, Babs/0000-0001-9163-337X	Philips; Siemens; Bayer; Cook; AGFA; GE; BRACCO	Philips; Siemens(Siemens AG); Bayer(Bayer AG); Cook; AGFA; GE; BRACCO	MD receives institutional grants from Philips, Siemens and Bayer and personal fees (speakers bureau) from Cook, Siemens and Bayer. JEW reports institutional research grants from Philips, AGFA, GE, BRACCO, Siemens and Bayer and personal fees (speakers bureau) from Siemens and Bayer. The specific roles of these authors are articulated in the 'author contributions' section. The funders did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas MK, 2004, JAMA-J AM MED ASSOC, V292, P1462, DOI 10.1001/jama.292.12.1462; Austen W G, 1975, Circulation, V51, P5; Aycock RD, 2018, ANN EMERG MED, V71, P44, DOI 10.1016/j.annemergmed.2017.06.041; Bae KT, 2004, RADIOLOGY, V231, P732, DOI 10.1148/radiol.2313030497; Bae KT, 2008, AM J ROENTGENOL, V190, P777, DOI 10.2214/AJR.07.2765; Bae KT, 2010, RADIOLOGY, V256, P32, DOI 10.1148/radiol.10090908; Becker CR, 2003, INVEST RADIOL, V38, P690, DOI 10.1097/01.rli.0000084886.44676.e4; Budoff MJ, 2008, J AM COLL CARDIOL, V52, P1724, DOI 10.1016/j.jacc.2008.07.031; Cademartiri Filippo, 2006, AJR Am J Roentgenol, V187, pW430, DOI 10.2214/AJR.05.1406; Funama Y, 2005, RADIOLOGY, V237, P905, DOI 10.1148/radiol.2373041643; Goldstein JA, 2011, J AM COLL CARDIOL, V58, P1414, DOI 10.1016/j.jacc.2011.03.068; Hendel RC, 2006, J AM COLL CARDIOL, V48, P1475, DOI 10.1016/j.jacc.2006.07.003; Huda W, 2000, RADIOLOGY, V217, P430, DOI 10.1148/radiology.217.2.r00nv35430; Johnson TRC, 2007, J COMPUT ASSIST TOMO, V31, P265, DOI 10.1097/01.rct.0000236421.35761.7a; Kok M, 2016, EUR J RADIOL, V85, P1068, DOI 10.1016/j.ejrad.2016.03.022; Kok M, 2015, AM J ROENTGENOL, V205, P1332, DOI 10.2214/AJR.14.13957; Leber AW, 2003, HEART, V89, P633, DOI 10.1136/heart.89.6.633; Mahesh M, 2009, MDCT PHYS BASICS TEC; Meijboom WB, 2008, J AM COLL CARDIOL, V52, P2135, DOI 10.1016/j.jacc.2008.08.058; Mihl C, 2016, EUR J RADIOL, V85, P830, DOI 10.1016/j.ejrad.2015.12.031; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; NADLER SB, 1962, SURGERY, V51, P224; Nakayama Y, 2005, RADIOLOGY, V237, P945, DOI 10.1148/radiol.2373041655; Nijssen EC, 2017, LANCET, V389, P1312, DOI 10.1016/S0140-6736(17)30057-0; Roffi M, 2016, EUR HEART J, V37, P267, DOI 10.1093/eurheartj/ehv320; Thomsen HS, 2006, EUR J RADIOL, V60, P307, DOI 10.1016/j.ejrad.2006.06.020; Williams MC, 2014, THORAX, V69, P718, DOI 10.1136/thoraxjnl-2012-203151	28	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2018	13	9							e0203682	10.1371/journal.pone.0203682	http://dx.doi.org/10.1371/journal.pone.0203682			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3NB	30256835	Green Published, gold, Green Submitted			2022-12-26	WOS:000446000200024
J	Tietze, A; Nielsen, A; Mikkelsen, IK; Hansen, MB; Obel, A; Ostergaard, L; Mouridsen, K				Tietze, Anna; Nielsen, Anne; Mikkelsen, Irene Klaerke; Hansen, Mikkel Bo; Obel, Annette; Ostergaard, Leif; Mouridsen, Kim			Bayesian modeling of Dynamic Contrast Enhanced MRI data in cerebral glioma patients improves the diagnostic quality of hemodynamic parameter maps	PLOS ONE			English	Article							DCE-MRI; RECURRENT GLIOBLASTOMA; BOLUS TRACKING; BLOOD-VOLUME; DSC-MRI; PERFUSION; PERMEABILITY; QUANTIFICATION; CANCER	Purpose The purpose of this work is to investigate if the curve-fitting algorithm in Dynamic Contrast Enhanced (DCE) MRI experiments influences the diagnostic quality of calculated parameter maps. Material and methods We compared the Levenberg-Marquardt (LM) and a Bayesian method (BM) in DCE data of 42 glioma patients, using two compartmental models (extended Toft's and 2-compartment-exchange model). Logistic regression and an ordinal linear mixed model were used to investigate if the image quality differed between the curve-fitting algorithms and to quantify if image quality was affected for different parameters and algorithms. The diagnostic performance to discriminate between high-grade and low-grade gliomas was compared by applying a Wilcoxon signed-rank test (statistical significance p>0.05). Two neuroradiologists assessed different qualitative imaging features. Results Parameter maps based on BM, particularly those describing the blood-brain barrier, were superior those based on LM. The image quality was found to be significantly improved (p<0.001) for BM when assessed through independent clinical scores. In addition, given a set of clinical scores, the generating algorithm could be predicted with high accuracy (area under the receiver operating characteristic curve between 0.91 and 1). Using linear mixed models, image quality was found to be improved when applying the 2-compartment-exchange model compared to the extended Toft's model, regardless of the underlying fitting algorithm. Tumor grades were only differentiated reliably on plasma volume maps when applying BM. The curve-fitting algorithm had, however, no influence on grading when using parameter maps describing the blood-brain barrier. Conclusion The Bayesian method has the potential to increase the diagnostic reliability of Dynamic Contrast Enhanced parameter maps in brain tumors. In our data, images based on the 2-compartment-exchange model were superior to those based on the extended Toft's model.	[Tietze, Anna] Charite Univ Med Berlin, Free Univ Berlin, Humboldt Univ Berlin, Berlin, Germany; [Tietze, Anna] Berlin Inst Hlth, Berlin, Germany; [Tietze, Anna; Nielsen, Anne; Mikkelsen, Irene Klaerke; Hansen, Mikkel Bo; Ostergaard, Leif; Mouridsen, Kim] Aarhus Univ, Ctr Functionally Integrat Neurosci, Clin Inst, Aarhus, Denmark; [Obel, Annette; Ostergaard, Leif] Aarhus Univ Hosp, Dept Neuroradiol, Aarhus, Denmark	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Aarhus University; Aarhus University	Tietze, A (corresponding author), Charite Univ Med Berlin, Free Univ Berlin, Humboldt Univ Berlin, Berlin, Germany.; Tietze, A (corresponding author), Berlin Inst Hlth, Berlin, Germany.; Tietze, A (corresponding author), Aarhus Univ, Ctr Functionally Integrat Neurosci, Clin Inst, Aarhus, Denmark.	anna.tietze@charite.de	Tietze, Anna/H-3333-2018; Østergaard, Leif/A-9281-2008; Hansen, Mikkel B/A-5899-2009; Ostergaard, Lars/AAA-3020-2020	Tietze, Anna/0000-0002-2601-9055; Østergaard, Leif/0000-0003-2930-6997; Hansen, Mikkel B/0000-0002-8619-1519; Ostergaard, Lars/0000-0003-2459-0511; Ostergaard, Lars/0000-0002-7619-605X	Danish Ministry of Science, Technology and Innovation's University Investment Grant [902063]; Central Region Denmark Research Grant [1-45-72-4-09]; Lundbeckfonden [R151-2013-14167]; Danmarks Grundforskningsfonden; German Research Foundation (DFG); Open Access Publication Fund of Charite - UniversitaEtsmedizin Berlin	Danish Ministry of Science, Technology and Innovation's University Investment Grant; Central Region Denmark Research Grant; Lundbeckfonden(Lundbeckfonden); Danmarks Grundforskningsfonden; German Research Foundation (DFG)(German Research Foundation (DFG)); Open Access Publication Fund of Charite - UniversitaEtsmedizin Berlin	This work was supported by: Anna Tietze: Danish Ministry of Science, Technology and Innovation's University Investment Grant, Number 902063, https://ufm.dk/en; Central Region Denmark Research Grant, Number 1-45-72-4-09, https://www.rm.dk/sundhed/faginfo/forskning/region-midtjyllands-sundhedsvidenskabelige-forskningsfond/; Lundbeckfonden, Number R151-2013-14167, https://www.lundbeckfonden.com/. Irene Klaerke Mikkelsen: Danish Ministry of Science, Technology and Innovation's University Investment Grant, Number 902063, https://ufm.dk/en; Lundbeckfonden, Number R151-2013-14167, https://www.lundbeckfonden.com/. Mikkel Bo Hansen: Danish Ministry of Science, Technology and Innovation's University Investment Grant, Number 902063, https://ufm.dk/en. Kim Mouridsen: Danish Ministry of Science, Technology and Innovation's University Investment Grant, Number 902063, https://ufm.dk/en; Lundbeckfonden, Number R151-2013-14167, https://www.lundbeckfonden.com/; Danmarks Grundforskningsfonden, http://dg.dk/en/. Leif Ostergaard: Danish Ministry of Science, Technology and Innovation's University Investment Grant, Number 902063, https://ufm.dk/en; Danmarks Grundforskningsfonden, http://dg.dk/en/. We acknowledge support from the German Research Foundation (DFG) and the Open Access Publication Fund of Charite - UniversitaEtsmedizin Berlin.	Ahearn TS, 2005, PHYS MED BIOL, V50, pN85, DOI 10.1088/0031-9155/50/9/N02; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Bisdas S, 2011, ACAD RADIOL, V18, P575, DOI 10.1016/j.acra.2011.01.018; Boutelier T, 2012, IEEE T MED IMAGING, V31, P1381, DOI 10.1109/TMI.2012.2189890; Demidenko E, 2004, WILEY SERIES PROBABI; Dikaios N, 2017, COMPUT MED IMAG GRAP, V56, P1, DOI 10.1016/j.compmedimag.2017.01.003; Hastie T., 2008, ELEMENTS STAT LEARNI; Heye AK, 2014, NEUROIMAGE-CLIN, V6, P262, DOI 10.1016/j.nicl.2014.09.002; Ingrisch M, 2012, INVEST RADIOL, V47, P252, DOI 10.1097/RLI.0b013e31823bfc97; Kudo K, 2014, MAGN RESON MED SCI, V13, P45, DOI 10.2463/mrms.2013-0085; Larsson HBW, 2009, MAGN RESON MED, V62, P1270, DOI 10.1002/mrm.22136; Li X, 2014, MAGN RESON MED, V71, P1592, DOI 10.1002/mrm.24782; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; Mouridsen K, 2006, NEUROIMAGE, V33, P570, DOI 10.1016/j.neuroimage.2006.06.015; Mouridsen K, 2014, J CEREBR BLOOD F MET, V34, P1511, DOI 10.1038/jcbfm.2014.111; Nael K, 2015, AM J NEURORADIOL, V36, P710, DOI 10.3174/ajnr.A4184; O'Connor JPB, 2007, BRIT J CANCER, V96, P189, DOI 10.1038/sj.bjc.6603515; Ostergaard L, 2005, J MAGN RESON IMAGING, V22, P710, DOI 10.1002/jmri.20460; Parker GJM, 2006, MAGN RESON MED, V56, P993, DOI 10.1002/mrm.21066; PATLAK CS, 1985, J CEREBR BLOOD F MET, V5, P584, DOI 10.1038/jcbfm.1985.87; Quarles CC, 2009, PHYS MED BIOL, V54, P5749, DOI 10.1088/0031-9155/54/19/006; Schmid VJ, 2006, IEEE T MED IMAGING, V25, P1627, DOI 10.1109/TMI.2006.884210; Sommer JC, 2014, J R STAT SOC C-APPL, V63, P695, DOI 10.1111/rssc.12057; Sommer JC, 2014, STAT MED, V33, P1029, DOI 10.1002/sim.5997; Sorensen AG, 2009, CANCER RES, V69, P5296, DOI 10.1158/0008-5472.CAN-09-0814; Sourbron SP, 2012, PHYS MED BIOL, V57, pR1, DOI 10.1088/0031-9155/57/2/R1; Sourbron S, 2009, MAGN RESON MED, V62, P205, DOI 10.1002/mrm.22005; Thomas AA, 2015, J NEURO-ONCOL, V125, P183, DOI 10.1007/s11060-015-1893-z; Tietze A, 2015, NEURORADIOLOGY, V57, P561, DOI 10.1007/s00234-015-1502-z; Tofts PS, 1997, JMRI-J MAGN RESON IM, V7, P91, DOI 10.1002/jmri.1880070113	30	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2018	13	9							e0202906	10.1371/journal.pone.0202906	http://dx.doi.org/10.1371/journal.pone.0202906			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3NB	30256797	Green Published, gold, Green Submitted			2022-12-26	WOS:000446000200007
J	Angioni, MM; Piga, M; Paladini, F; Lai, S; Erre, GL; Roils, A; Cauli, A; Fiorillo, MT; Passiu, G; Carcassi, C; Sorrentino, R; Mathieu, A				Angioni, Maria Maddalena; Piga, Matteo; Paladini, Fabiana; Lai, Sara; Erre, Gian Luca; Roils, Alberto; Cauli, Alberto; Fiorillo, Maria Teresa; Passiu, Giuseppe; Carcassi, Carlo; Sorrentino, Rosa; Mathieu, Alessandro			AIF-1 gene does not confer susceptibility to Behcet's disease: Analysis of extended haplotypes in Sardinian population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INFLAMMATORY FACTOR-I; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MHC CLASS-I; GEOGRAPHICAL-PERSPECTIVES; LOCI; POLYMORPHISMS; IL23R-IL12RB2; METAANALYSIS; MACROPHAGES	Background Behcets disease (BD) is a polygenic immune-mediated disorder characterized by a close association with the HLA-B*51 allele. The HLA region has a strong linkage disequilibrium (LD) and carries several genetic variants (e.g. MIC-A, TNF-alpha genes) identified as associated to BD because of their LD with HLA-B*51. In fact, the HLA-B*51 is inherited as part of extended HLA haplotypes which are well preserved in patients with BD. Sardinian population is highly differentiated from other Mediterranean populations because of a distinctive genetic structure with very highly preserved HLA haplotypes. Patients and methods In order to identify other genes of susceptibility to BD within the HLA region we investigated the distribution of human Allograft Inflammatory Factor-1 (AIF-1) gene variants among BD patients and healthy controls from Sardinia. Six (rs2736182; rs2259571; rs2269475; rs2857597; rs13195276; rs4711274) AIF-1 single nucleotide polymorphisms (SNPs) and related extended haplotypes have been investigated as well as their LD within the HLA region and with HLA-B*51. Overall, 64 BD patients, 43 HLA-B*51 positive healthy controls (HC) and 70 random HC were enrolled in the study. Results HLA-B*51 was the only allele with significantly higher frequency (p(c) = 0.0021) in BD patients (40.6%) than in HC (9.8%). The rs2259571(T) AIF-1 variant had a significantly reduced phenotypic, but not allelic frequency in BD patients (72.1%; p(c) = 0.014) compared to healthy population (91.3%). That was likely due to the LD between HLA-B*51 and rs2259571(G) (p(c) = 9E-5), even though the rs2259571(G) distribution did not significantly differ between BD patients and HC. Conclusion No significant difference in distribution of AIF-1 SNPs haplotypes was observed between BD patients and HC and between HLA-B*51 positive BD patients and HLA-B*51 positive HC. Taken together, these results suggest that AIF-1 gene is not associated with susceptibility to BD in Sardinia.	[Angioni, Maria Maddalena; Piga, Matteo; Roils, Alberto; Cauli, Alberto; Mathieu, Alessandro] Univ Cagliari, Chair Rheumatol & Rheumatol Unit, Cagliari, Italy; [Angioni, Maria Maddalena; Piga, Matteo; Roils, Alberto; Cauli, Alberto; Mathieu, Alessandro] AOU Cagliari, Cagliari, Italy; [Paladini, Fabiana; Fiorillo, Maria Teresa; Sorrentino, Rosa] Sapienza Univ Rome, Dept Biol & Biotechnol C Darwin, Rome, Italy; [Lai, Sara; Carcassi, Carlo] Univ Cagliari, Chair Med Genet, Cagliari, Italy; [Erre, Gian Luca; Passiu, Giuseppe] Univ Sassari, Chair Rheumatol & Rheumatol Unit, Sassari, Italy; [Erre, Gian Luca; Passiu, Giuseppe] AOU Sassari, Sassari, Italy	University of Cagliari; University of Cagliari; Sapienza University Rome; University of Cagliari; University of Sassari	Piga, M (corresponding author), Univ Cagliari, Chair Rheumatol & Rheumatol Unit, Cagliari, Italy.; Piga, M (corresponding author), AOU Cagliari, Cagliari, Italy.	matteopiga@unica.it	ANGIONI, MARIA MADDALENA/K-3766-2019; Sorrentino, Rosa/G-5472-2012; Erre, Gian Luca/C-7907-2017; LAI, SARA/GXV-2963-2022	Sorrentino, Rosa/0000-0002-9632-2383; Erre, Gian Luca/0000-0001-6818-7666; Paladini, Fabiana/0000-0003-1040-452X; Lai, Sara/0000-0002-8040-0631; FIORILLO, Maria Teresa/0000-0002-6859-5851; Piga, Matteo/0000-0002-1126-8315				Ahmad T, 2003, ARTHRITIS RHEUM, V48, P807, DOI 10.1002/art.10815; Alkassab F, 2007, RHEUMATOLOGY, V46, P1248, DOI 10.1093/rheumatology/kem057; Cavalli-Sforza LL, 1996, HIST GEOGRAPHY HUMAN; CONTU L, 1992, TISSUE ANTIGENS, V40, P165, DOI 10.1111/j.1399-0039.1992.tb02041.x; de Menthon M, 2009, ARTHRIT CARE RES, V61, P1287, DOI 10.1002/art.24642; Direskeneli H, 2006, RHEUMATOLOGY, V45, P1461, DOI 10.1093/rheumatology/kel329; Erre GL, 2015, CLIN EXP RHEUMATOL, V33, pS72; Grateau G, 2013, NAT REV RHEUMATOL, V9, P624, DOI 10.1038/nrrheum.2013.101; Gul A, 2001, ARTHRITIS RHEUM, V44, P239, DOI 10.1002/1529-0131(200101)44:1<239::AID-ANR31>3.0.CO;2-X; Hughes T, 2013, NAT GENET, V45, P319, DOI 10.1038/ng.2551; Kirino Y, 2013, NAT GENET, V45, P202, DOI 10.1038/ng.2520; Mizuki N, 2010, NAT GENET, V42, P703, DOI 10.1038/ng.624; Nishimura M, 2003, HUM IMMUNOL, V64, P302, DOI 10.1016/S0198-8859(02)00799-1; OHNO S, 1982, ARCH OPHTHALMOL-CHIC, V100, P1455; Ombrello MJ, 2014, P NATL ACAD SCI USA, V111, P8867, DOI 10.1073/pnas.1406575111; Ozturk O, 2017, GENES IMMUN, V18, P28, DOI 10.1038/gene.2016.46; Pawlik A, 2008, TISSUE ANTIGENS, V72, P171, DOI 10.1111/j.1399-0039.2008.01086.x; Piga M, 2014, CLIN EXP RHEUMATOL, V32, pS123; Piga M, 2012, CLIN EXP RHEUMATOL, V30, pS51; Piga M, 2011, RHEUMATOLOGY, V50, P299, DOI 10.1093/rheumatology/keq331; Remmers EF, 2010, NAT GENET, V42, P698, DOI 10.1038/ng.625; Schluesener HJ, 1999, ACTA NEUROPATHOL, V97, P119, DOI 10.1007/s004010050964; Storch MK, 2002, BRAIN PATHOL, V12, P287; Takeuchi M, 2017, NAT GENET, V49, P438, DOI 10.1038/ng.3786; Verity DH, 1999, TISSUE ANTIGENS, V54, P213, DOI 10.1034/j.1399-0039.1999.540301.x; Zhang J, 2016, SCI REP-UK, V6, DOI 10.1038/srep21033; Zhao YY, 2013, CELL IMMUNOL, V284, P75, DOI 10.1016/j.cellimm.2013.07.008	27	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2018	13	9							e0204250	10.1371/journal.pone.0204250	http://dx.doi.org/10.1371/journal.pone.0204250			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU9BO	30252881	Green Published, gold, Green Submitted			2022-12-26	WOS:000445639700037
J	Rostamian, M; Bahrami, F; Niknam, HM				Rostamian, Mosayeb; Bahrami, Fariborz; Niknam, Hamid M.			Vaccination with whole-cell killed or recombinant leishmanial protein and toll-like receptor agonists against Leishmania tropica in BALB/c mice	PLOS ONE			English	Article							CUTANEOUS LEISHMANIASIS; PROTECTIVE IMMUNITY; METACYCLIC PROMASTIGOTES; VISCERAL LEISHMANIASIS; C57BL/6 MICE; MURINE MODEL; ADJUVANTS; INFECTION; VACCINES; INTERLEUKIN-10	One strategy to control leishmaniasis is vaccination with potent antigens alongside suitable adjuvants. The use of toll-like receptor (TLR) agonists as adjuvants is a promising approach in Leishmania vaccine research. Leishmania (L.) tropica is among the less-investigated Leishmania species and a causative agent of cutaneous and sometimes visceral leishmaniasis with no approved vaccine against it. In the present study, we assessed the adjuvant effects of a TLR4 agonist, monophosphoryl lipid A (MPL) and a TLR7/8 agonist, R848 beside two different types of Leishmania vaccine candidates; namely, whole-cell soluble L. tropica antigen (SLA) and recombinant L. tropica stress-inducible protein-1 (LtSTI1). BALB/c mice were vaccinated three times by the antigens (SLA or LtSTI1) with MPL or R848 and then were challenged by L. tropica. Delayed-type hypersensitivity (DTH), parasite load, disease progression and cytokines (IL-10 and IFN-gamma) responses were assessed. In general compared to SLA, application of LtSTI1 resulted in higher DTH, higher IFN-gamma response and lower lymph node parasite load. Also compared to R848, MPL as an adjuvant resulted in higher DTH and lower lymph node parasite load. Although, no outstanding ability for SLA and R848 in evoking immune responses of BALB/c mice against L. tropica infection could be observed, our data suggest that LtSTI1 and MPL have a better potential to control L. tropica infection and could be pursued for the development of effective vaccination strategies.	[Rostamian, Mosayeb] Kermanshah Univ Med Sci, Nosocomial Infect Res Ctr, Kermanshah, Iran; [Bahrami, Fariborz; Niknam, Hamid M.] Pasteur Inst Iran, Immunol Dept, Tehran, Iran	Kermanshah University of Medical Sciences; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran	Niknam, HM (corresponding author), Pasteur Inst Iran, Immunol Dept, Tehran, Iran.	hamid.m.niknam@gmail.com	Bahrami, Fariborz/AAU-9648-2021; rostamian, mosayeb/L-7885-2019; Bahrami, Fariborz/J-7123-2017	Bahrami, Fariborz/0000-0001-9561-415X; rostamian, mosayeb/0000-0002-1071-7019; Bahrami, Fariborz/0000-0001-9561-415X; /0000-0001-9338-4266	Pasteur Institute of Iran; Iran National Science Foundation [93035899]	Pasteur Institute of Iran; Iran National Science Foundation(Iran National Science Foundation (INSF))	To pursue this study, M. Rostamian was supported by a Ph.D. scholarship from Pasteur Institute of Iran. This research was also financially supported by Iran National Science Foundation (http://en.insf.org/)(project 93035899). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CF, 2008, J IMMUNOL, V180, P4090, DOI 10.4049/jimmunol.180.6.4090; Ausubel F. M., 2002, SHORT PROTOCOLS MOL; BASTIEN P, 1992, EXP PARASITOL, V75, P433, DOI 10.1016/0014-4894(92)90256-A; BOGDAN C, 1993, ANN NY ACAD SCI, V685, P713, DOI 10.1111/j.1749-6632.1993.tb35934.x; Bohannon JK, 2013, SHOCK, V40, P451, DOI 10.1097/SHK.0000000000000042; Campos-Neto A, 2001, INFECT IMMUN, V69, P4103, DOI 10.1128/IAI.69.6.4103-4108.2001; Coler RN, 2005, TRENDS PARASITOL, V21, P244, DOI 10.1016/j.pt.2005.03.006; DEROSSELL RA, 1987, PARASITE IMMUNOL, V9, P105, DOI 10.1111/j.1365-3024.1987.tb00492.x; Di Pasquale A, 2015, VACCINES-BASEL, V3, P320, DOI 10.3390/vaccines3020320; Dos-Santos ALA, 2016, EXP PARASITOL, V167, P67, DOI 10.1016/j.exppara.2016.05.005; Gillespie PM, 2016, VACCINE, V34, P2992, DOI 10.1016/j.vaccine.2015.12.071; Girginkardesler N, 2001, J PARASITOL, V87, P1177, DOI 10.1645/0022-3395(2001)087[1177:CLIIBC]2.0.CO;2; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Jacobson RL, 2003, FOLIA PARASIT, V50, P241, DOI 10.14411/fp.2003.042; Lira R, 1998, EXP PARASITOL, V89, P331, DOI 10.1006/expr.1998.4283; Liu SG, 1997, CLIN BIOCHEM, V30, P455, DOI 10.1016/S0009-9120(97)00049-0; Luo Y, 2001, Curr Protoc Immunol, VChapter 4, DOI 10.1002/0471142735.im0405s55; Mahmoudzadeh-Niknam H, 2004, SCAND J LAB ANIM SCI, V31, P201; Mahmoudzadeh-Niknam H, 2011, IRAN J PARASITOL, V6, P41; Mahmoudzadeh-Niknam Hamid, 2007, Korean Journal of Parasitology, V45, P247, DOI 10.3347/kjp.2007.45.4.247; Mahmoudzadeh-Niknam Hamid, 2007, Korean Journal of Parasitology, V45, P103, DOI 10.3347/kjp.2007.45.2.103; Mahmoudzadeh-Niknam H, 2013, KOREAN J PARASITOL, V51, P69, DOI 10.3347/kjp.2013.51.1.69; Mahmoudzadeh-Niknam H, 2011, EXP PARASITOL, V127, P448, DOI 10.1016/j.exppara.2010.10.008; Mendonca SCF, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1777-x; Mutiso JM, 2010, J BIOMED RES, V24, P16, DOI 10.1016/S1674-8301(10)60004-8; O'Garra A, 2007, NAT REV IMMUNOL, V7, P425, DOI 10.1038/nri2097; Peters NC, 2012, J IMMUNOL, V189, P4832, DOI 10.4049/jimmunol.1201676; Peters NC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000484; Qian C, 2013, ANN NY ACAD SCI, V1283, P67, DOI 10.1111/j.1749-6632.2012.06786.x; Reed SG, 2013, NAT MED, V19, P1597, DOI 10.1038/nm.3409; Ronet C, 2010, J IMMUNOL, V184, P886, DOI 10.4049/jimmunol.0901114; Rostamian M, 2017, MOL IMMUNOL, V91, P202, DOI 10.1016/j.molimm.2017.09.010; Rostamian M, 2017, J MICROBIOL IMMUNOL, V50, P160, DOI 10.1016/j.jmii.2015.05.007; Sacks D, 2004, IMMUNOL REV, V201, P225, DOI 10.1111/j.0105-2896.2004.00185.x; Sacks David L, 2015, Curr Protoc Immunol, V108, DOI 10.1002/0471142735.im1902s108; SCOTT P, 1987, J IMMUNOL, V139, P221; Shargh VH, 2012, VACCINE, V30, P3957, DOI 10.1016/j.vaccine.2012.03.040; Shokri M, 2016, MOL IMMUNOL, V76, P108, DOI 10.1016/j.molimm.2016.06.010; Simonian MH, 1996, CURRENT PROTOCOLS MO; Spath GF, 2001, EXP PARASITOL, V99, P97, DOI 10.1006/expr.2001.4656; Srivastava S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1553-y; Svobodova M, 2003, MICROBES INFECT, V5, P471, DOI 10.1016/S1286-4579(03)00066-2; Thakur A, 2015, PARASITOL INT, V64, P70, DOI 10.1016/j.parint.2014.10.003; Tomai MA, 2007, EXPERT REV VACCINES, V6, P835, DOI 10.1586/14760584.6.5.835; van Griensven J, 2010, LANCET INFECT DIS, V10, P184, DOI 10.1016/S1473-3099(10)70011-6; Vasilakos JP, 2013, EXPERT REV VACCINES, V12, P809, DOI 10.1586/14760584.2013.811208; Weirather JL, 2011, J CLIN MICROBIOL, V49, P3892, DOI 10.1128/JCM.r00764-11; WHO, 2010, WHO TECH REP SER, V949, P1	48	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2018	13	9							e0204491	10.1371/journal.pone.0204491	http://dx.doi.org/10.1371/journal.pone.0204491			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3MI	30248142	gold, Green Published, Green Submitted			2022-12-26	WOS:000445998100044
J	Song, I; Kang, Y; Lee, YK; Myung, SC; Ko, K				Song, Ilchan; Kang, YangJoo; Lee, Young Koung; Myung, Soon-Chul; Ko, Kisung			Endoplasmic reticulum retention motif fused to recombinant anti-cancer monoclonal antibody (mAb) CO17-1A affects mAb expression and plant stress response	PLOS ONE			English	Article							COLORECTAL-CANCER; PROTEIN; ARABIDOPSIS	The endoplasmic reticulum (ER) is the main site of protein synthesis, folding, and secretion to other organelles. The capacity of the ER to process proteins is limited, and excessive accumulation of unfolded and misfolded proteins can induce ER stress, which is associated with plant diseases. Here, a transgenic Arabidopsis system was established to express anticancer monoclonal antibodies (mAbs) that recognize the tumor-associated antigen GA7332. Monoclonal antibody (mAb) CO17-1A recognize a tumor-associated epitope expressed on the colorectal cancer cell surface. The ER retention Lys-Asp-Glu-Leu (KDEL) motif sequence was added to the C-terminus of the heavy chain to retain anti-colorectal cancer mAbs in the ER, consequently boosting mAb production. Agrobacterium-mediated floral dip transformation was used to generate T-1 transformants, and homozygous T-4 seeds obtained from transgenic Arabidopsis plants expressing anti-colorectal cancer mAbs were used to confirm the physiological effects of KDEL tagging. Germination rates were not significantly different between both plants expressing mAb CO without KDEL mAb CO (CO plant) and mAb CO with KDEL mAb COK (COK plant). However, COK plants primary root lengths were shorter than those of CO plants and non-transgenic Arabidopsis plants in in vitro media. Most ER stress-related genes, with the exception of bZIP28 and IRE1 a, were upregulated in COK plants compared to CO plants. Western blot and SDS-PAGE analyses showed that COK plants exhibited up to five times higher expression and mAb amounts than plants. Enhanced expression in mAb COK plants was confirmed by immunohistochemical analyses. mAb COK was distributed across most of the area of leaf tissues, whereas mAb CO was mainly distributed in extracellular areas. Surface plasmon resonance analyses revealed that mAb CO and mAb COK possessed equivalent or slightly better binding activities to antigen EpCAM compared to a commercially available parental antibody. N-glycosylation analysis showed that mAb CO had plant specific residues whereas mAb COK mainly showed an oligo-mannose N-glycan structure without the plant specific glycan residues. In this study, the reduction of plant growth and biomass induced by ER retention signal peptide might be only in in vitro conditions, and thus should be carefully considered for the initial screening for transgenic lines on culture media. Taken together, nevertheless the fusion of ER retention signal peptide is an effective approach for enhancing the yields of recombinant proteins in vivo.	[Song, Ilchan; Kang, YangJoo] Chung Ang Univ, Coll Med, Dept Pathol, Seoul, South Korea; [Song, Ilchan; Ko, Kisung] Chung Ang Univ, Coll Med, Dept Med, Seoul, South Korea; [Lee, Young Koung] Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA; [Myung, Soon-Chul] Chung Ang Univ, Coll Med, Dept Urol, Seoul, South Korea; [Lee, Young Koung] Wonkwang Univ, Div Biol Sci, Iksan, South Korea; [Lee, Young Koung] Wonkwang Univ, Res Inst Glycosci, Iksan, South Korea	Chung Ang University; Chung Ang University Hospital; Chung Ang University; Chung Ang University Hospital; Cold Spring Harbor Laboratory; Chung Ang University; Chung Ang University Hospital; Wonkwang University; Wonkwang University	Ko, K (corresponding author), Chung Ang Univ, Coll Med, Dept Med, Seoul, South Korea.	ksko@cau.ac.kr			Korean Rural Development Administration [PJ0134372018]; National Research Foundation of Korea - Korean Government (MEST) [NRF-2017R1A2A2A0569788]	Korean Rural Development Administration(Rural Development Administration (RDA), Republic of Korea); National Research Foundation of Korea - Korean Government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government)	This research was supported by a grant (Code#PJ0134372018) from the Korean Rural Development Administration and National Research Foundation of Korea Grant funded by the Korean Government (MEST) (NRF-2017R1A2A2A0569788).	CHOMCZYNSKI P, 1995, BIOTECHNIQUES, V19, P942; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Deng Y, 2013, INT J MOL SCI, V14, P8188, DOI 10.3390/ijms14048188; Eichmann R, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00200; Han SJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-179; Han SS, 2017, EBIOMEDICINE, V20, P61, DOI 10.1016/j.ebiom.2017.05.025; Kang YJ, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00274; Kim DS, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01037; Kim DS, 2015, PLANT BIOTECHNOL REP, V9, P361, DOI 10.1007/s11816-015-0373-4; Ko K, 2008, MOL CELLS, V25, P494; Ko Kisung, 2014, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V33, P192, DOI 10.1089/mab.2014.0049; Koornneef M, 2010, PLANT J, V61, P909, DOI 10.1111/j.1365-313X.2009.04086.x; Lee J, 2014, J BIOL CHEM, V289, P1203, DOI 10.1074/jbc.R113.534743; Lee JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068772; Liu JX, 2010, PLANT CELL, V22, P2930, DOI 10.1105/tpc.110.078154; Liu LJ, 2011, CELL RES, V21, P957, DOI 10.1038/cr.2010.181; Lu Z, 2012, BIOMED RES INT, V2012; Moussavou G, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/306164; Okamoto T, 2003, PLANT PHYSIOL, V132, P1892, DOI 10.1104/pp.103.021147; Ozgur R, 2014, J EXP BOT, V65, P1377, DOI 10.1093/jxb/eru034; Park SR, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01040; Roy G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183694; Sanderson TH, 2015, INT J MOL SCI, V16, P7133, DOI 10.3390/ijms16047133; So Y, 2013, PLANT CELL TISS ORG, V113, P41, DOI 10.1007/s11240-012-0249-z; Song I, 2015, HORTIC ENVIRON BIOTE, V56, P123, DOI 10.1007/s13580-015-0097-y; Tajima H, 2008, BIOCHEM BIOPH RES CO, V374, P242, DOI 10.1016/j.bbrc.2008.07.021; Tariq K, 2016, CANCER BIOL MED, V13, P120, DOI 10.28092/j.issn.2095-3941.2015.0103; Yamamoto K, 2003, J BIOL CHEM, V278, P34525, DOI 10.1074/jbc.M304188200; Yang ZT, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004243; Zalevsky J, 2010, NAT BIOTECHNOL, V28, P157, DOI 10.1038/nbt.1601; Zhang LR, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00293	31	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2018	13	9							e0198978	10.1371/journal.pone.0198978	http://dx.doi.org/10.1371/journal.pone.0198978			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3MI	30248125	gold, Green Published, Green Submitted			2022-12-26	WOS:000445998100002
J	Ma, YH; Zhang, QQ; Zhang, QF; He, HQ; Chen, Z; Zhao, Y; Wei, D; Kong, MG; Huang, Q				Ma, Yuhan; Zhang, Qianqian; Zhang, Qifu; He, Huaqi; Chen, Zhu; Zhao, Yan; Wei, Da; Kong, Mingguang; Huang, Qing			Improved production of polysaccharides in Ganoderma lingzhi mycelia by plasma mutagenesis and rapid screening of mutated strains through infrared spectroscopy	PLOS ONE			English	Article							FED-BATCH FERMENTATION; IN-VITRO MUTAGENESIS; MEDICINAL MUSHROOM; SUBMERGED CULTURE; ATRUM POLYSACCHARIDE; ENHANCED PRODUCTION; LUCIDUM; ACID; MUTANTS; OVEREXPRESSION	As a traditional Chinese medicine, Ganoderma lingzhi has attracted increasing attention for both scientific research and medical application. In this work, in order to improve the production of polysaccharides from an original wide-type (WT) strain (named "RWY-0") of Ganoderma lingzhi, we applied atmospheric-pressure dielectric barrier discharge (DBD) nonthermal plasma to the protoplasts of RWY-0 for mutagenesis treatment. Through a randomly amplified polymorphic DNA (RAPD) assay, at least 10 mutagenic strains were confirmed. They also showed different mycelium characteristics in terms of shape, color, size and biomass in liquid fermentation. The mutant strains were examined by infrared spectroscopy, and based on the established near-infrared (NIR) quantification model, the polysaccharide contents in these mutants were quantitatively evaluated. As a result, we found that the Ganoderma polysaccharide contents in some of the mutant strains were significantly changed compared with that of the original WT strain. The polysaccharide content of RWY-1 G. lingzhi was considerably higher than that of the WT strain, with an increase of 25.6%. Thus, this preliminary work demonstrates the extension of the plasma mutagenesis application in acquiring polysaccharide-enhanced Ganoderma lingzhi mutants and shows the usefulness of NIR spectroscopy in the rapid screening of mutagenic strains for other important ingredients.	[Ma, Yuhan; Zhang, Qianqian; Zhang, Qifu; Chen, Zhu; Huang, Qing] Chinese Acad Sci, Key Lab High Magnet Field & Ion Beam Phys Biol, Key Lab Environm Toxicol & Pollut Control Technol, Inst Tech Biol & Agr Engn,Hefei Inst Phys Sci, Hefei, Anhui, Peoples R China; [Ma, Yuhan; Zhang, Qianqian; Zhang, Qifu; Chen, Zhu; Huang, Qing] Univ Sci & Technol China, Hefei, Anhui, Peoples R China; [Ma, Yuhan; He, Huaqi; Zhao, Yan; Wei, Da] Anhui Sci & Technol Univ, Coll Life & Hlth Sci, Fengyang, Peoples R China; [Kong, Mingguang] Chinese Acad Sci, Inst Solid State Phys, Hefei Inst Phys Sci, Hefei, Anhui, Peoples R China	Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Anhui Science & Technology University; Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS	Huang, Q (corresponding author), Chinese Acad Sci, Key Lab High Magnet Field & Ion Beam Phys Biol, Key Lab Environm Toxicol & Pollut Control Technol, Inst Tech Biol & Agr Engn,Hefei Inst Phys Sci, Hefei, Anhui, Peoples R China.; Huang, Q (corresponding author), Univ Sci & Technol China, Hefei, Anhui, Peoples R China.	huangq@ipp.ac.cn		chen, zhu/0000-0002-9974-0716; Huang, Qing/0000-0002-8884-2063	National Natural Science Foundation of China [11475217, 11635013, 11775272]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA08040107]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This research was supported by the National Natural Science Foundation of China (11475217, 11635013, 11775272 to QH) and the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA08040107 to QH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barakat MN, 2011, AUST J CROP SCI, V5, P214; Barakat MN, 2010, AFR J AGR RES, V5, P748; Cao S, 2017, BIORESOURCE TECHNOL, V244, P1400, DOI 10.1016/j.biortech.2017.05.039; Chen Y, 2017, FOOD SCI, P112; Committee NP., 2015, PHARM PEOPL REP CHIN, V1, P188; Cote G, 1999, SOME STRUCTURAL FEAT, P656; de Ana F, 2017, ARCH DIS CHILD, V102, P27, DOI [10.1016/j.biortech.2011.06.043, DOI 10.1016/J.BIORTECH.2011.06.043]; Dwivedi S, 2017, J GENETIC ENG BIOTEC; Galichet A, 1999, MONITORING MODIFICAT; HAMELIN C, 1974, MUTAT RES, V24, P271; Ikehata H, 2011, J RADIAT RES, V52, P115, DOI 10.1269/jrr.10175; Ji SL, 2015, INT J MED MUSHROOMS, V17, P435, DOI 10.1615/IntJMedMushrooms.v17.i5.30; Lackmann JW, 2014, APPL MICROBIOL BIOT, V98, P6205, DOI 10.1007/s00253-014-5781-9; LHERAULT P, 1984, MOL GEN GENET, V197, P472, DOI 10.1007/BF00329945; Li G, 2001, Wei Sheng Wu Xue Bao, V41, P229; Li HJ, 2016, J BIOTECHNOL, V217, P132, DOI 10.1016/j.jbiotec.2015.11.011; Li WJ, 2017, J AGR FOOD CHEM, V65, P348, DOI 10.1021/acs.jafc.6b04888; Li X, 2016, BIORESOURCES, V11, P9047, DOI 10.15376/biores.11.4.9047-9058; Li-Chan ECY, 2006, HDB VIBRATIONAL SPEC, P4326; Liu AD, 2009, CHEM RES CHINESE U, V25, P487; Liu J, 2016, APPL SPECTROSCOPY, V70; Liu JH, 2016, LETT APPL MICROBIOL, V62, P185, DOI 10.1111/lam.12531; Liu JH, 2016, PHYCOLOGIA, V55, P650, DOI 10.2216/16-14.1; Liu X, 2017, FOOD SCI BIOTECHNOL, V26, P707, DOI 10.1007/s10068-017-0080-8; Lowry SR, 2006, AUTOMATED SPECTRAL S; Lv XC, 2016, INT J BIOL MACROMOL, V86, P28, DOI 10.1016/j.ijbiomac.2016.01.048; Ma YH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18422-7; Melin AM, 2001, ARCH BIOCHEM BIOPHYS, V394, P265, DOI 10.1006/abbi.2001.2533; NORRIS KH, 1961, IRE T BIOMED ELECTR, VBME8, P153, DOI 10.1109/TBMEL.1961.4322890; Ottenheim C, 2018, BIORESOUR BIOPROCESS, V5, DOI 10.1186/s40643-018-0200-1; Papinutti L, 2010, BIORESOURCE TECHNOL, V101, P1941, DOI 10.1016/j.biortech.2009.09.076; Peng R, 2016, BIOTECHNOL BIOTEC EQ, V30, P381, DOI 10.1080/13102818.2015.1133254; Ren A, 2010, BIORESOURCE TECHNOL, V101, P6785, DOI 10.1016/j.biortech.2010.03.118; Sargowo D, 2017, INDONES BIOMED J, V9, P153, DOI 10.18585/inabj.v9i3.298; Sha ChunYan, 2018, Genomics and Applied Biology, V37, P16; Shao YN, 2015, SPECTROCHIM ACTA A, V140, P431, DOI 10.1016/j.saa.2015.01.018; Siwulski M, 2017, EUR FOOD RES TECHNOL, V243, P1555, DOI 10.1007/s00217-017-2864-8; Tang YJ, 2009, BIORESOURCE TECHNOL, V100, P1852, DOI 10.1016/j.biortech.2008.10.005; Tang YJ, 2003, ENZYME MICROB TECH, V32, P478, DOI 10.1016/S0141-0229(02)00338-1; Tang YJ, 2002, BIOTECHNOL LETT, V24, P1023, DOI 10.1023/A:1015677313598; Tang YJ, 2002, ENZYME MICROB TECH, V31, P20, DOI 10.1016/S0141-0229(02)00066-2; Twardowski T, 2015, TRENDS BIOTECHNOL, V33, P1, DOI 10.1016/j.tibtech.2014.11.006; United States Pharmacopoeia 39-National Formulary 34, 2016, US PHARM GAN LUC FRU; Upton R, 2011, AMERICAN HERBAL PHARMACOPOEIA(R): BOTANICAL PHARMACOGNOSY - MICROSCOPIC CHARACTERIZATION OF BOTANICAL MEDICINES, P1, DOI 10.1201/b10413; Wang CL, 2014, APPL MICROBIOL BIOT, V98, P9389, DOI 10.1007/s00253-014-6027-6; Wang JG, 2009, J AGR FOOD CHEM, V57, P10565, DOI 10.1021/jf902597w; Wang JinFeng, 2017, Southwest China Journal of Agricultural Sciences, V30, P26; Wang XZ, 2009, J PEANUT SCI, P5; Wei ZH, 2016, BIOPROC BIOSYST ENG, V39, P37, DOI 10.1007/s00449-015-1480-x; Wu QZ, 2017, RSC ADV, V7, P45093, DOI 10.1039/c7ra08087e; Xiang QD, 2017, J AGR FOOD CHEM, V65, P5306, DOI 10.1021/acs.jafc.7b01763; Xiao C, 2017, J ETHNOPHARMACOL, V196, P47, DOI 10.1016/j.jep.2016.11.044; Xu JW, 2015, BIOPROC BIOSYST ENG, V38, P399, DOI 10.1007/s00449-014-1279-1; Xue Z, 2014, CIESC J; Yolmeh M, 2017, BIOCATAL AGR BIOTECH, V10, P285, DOI 10.1016/j.bcab.2017.04.007; [余增亮 Yu ZengLiang], 2012, [科学通报, Chinese Science Bulletin], V57, P883; Zeng P, 2018, J CELLULAR MOL MED, P1; Zhang YS, 2017, INT J BIOL MACROMOL, V98, P398, DOI 10.1016/j.ijbiomac.2017.01.071; Zhao B, 2018, APPL MICROBIOL BIOT, V102, P2351, DOI 10.1007/s00253-018-8756-4; Zhao W, 2011, BIORESOURCE TECHNOL, V102, P8185, DOI 10.1016/j.biortech.2011.06.043; Zhao YP, 2017, ZHEJIANG J INTEGRATE, V9, P760; Zhu LW, 2008, PROCESS BIOCHEM, V43, P1359, DOI 10.1016/j.procbio.2008.08.003	62	12	14	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2018	13	9							e0204266	10.1371/journal.pone.0204266	http://dx.doi.org/10.1371/journal.pone.0204266			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU5MM	30240407	Green Published, Green Submitted, gold			2022-12-26	WOS:000445329700035
J	Singh, AK; Fechtner, S; Chourasia, M; Sicalo, J; Ahmed, S				Singh, Anil K.; Fechtner, Sabrina; Chourasia, Mukesh; Sicalo, Jerry; Ahmed, Salahuddin			Critical role of IL-1 in IL-1-induced inflammatory responses: cooperation with NF-Bp65 in transcriptional regulation	FASEB JOURNAL			English	Article						rheumatoid arthritis; synovial fibroblasts; nuclear factor B; signal transduction	INTERLEUKIN-1-ALPHA; IL-1-BETA; ACTIVATION; IL-1-ALPHA; MECHANISM; SUPPRESSION; EXPRESSION; PRECURSOR; PATHWAYS; PROMOTER	The IL-1 cytokines are considered among the first family of cytokines that orchestrate acute and chronic inflammatory diseases. Both IL-1 and IL-1 are members of the IL-1 family; however, their distinct roles in the inflammatory processes remain poorly understood. We explored the role of IL-1 in IL-1-activated signaling pathways causing synovial inflammation in rheumatoid arthritis (RA). Using synovial fibroblasts isolated from RA joints, we found that IL-1 significantly stimulated IL-1 expression, which was selectively inhibited by blocking the NF-B pathway. Knockdown of IL-1 using small interfering RNA abolished IL-1-induced pro-IL-1 and pro-IL-1 expression and suppressed inflammation. Native and chromatin immunoprecipitation studies showed that IL-1 cooperates in NF-Bp65 binding to the distal region of IL-1 promoter and to the proximal region of IL-1 promoter upstream of the transcription start site to stabilize their gene transcription. Molecular dynamics simulation of IL-1 or IL-1 binding to IL-1 receptor showed distinct interaction sites that corroborate with the ability of IL-1 to differentially activate phosphorylation of signaling proteins compared with IL-1. Our study highlights the importance of IL-1 in mediating IL-1-induced inflammation in addition to maintaining its expression and providing a rationale for targeting IL-1 to minimize the role of IL-1 in inflammatory diseases like RA.Singh, A. K., Fechtner, S., Chourasia, M., Sicalo, J., Ahmed, S. Critical role of IL-1 in IL-1-induced inflammatory responses: cooperation with NF-Bp65 in transcriptional regulation.	[Singh, Anil K.; Fechtner, Sabrina; Sicalo, Jerry; Ahmed, Salahuddin] Washington State Univ, Coll Pharm, Dept Pharmaceut Sci, SPBS Room 411,412 E Spokane Falls Blvd, Spokane, WA 99210 USA; [Chourasia, Mukesh] Amity Univ, Amity Inst Biotechnol, Ctr Computat Biol & Bioinformat, Noida, India; [Ahmed, Salahuddin] Univ Washington, Sch Med, Div Rheumatol, Seattle, WA USA	Washington State University; Amity University Noida; University of Washington; University of Washington Seattle	Ahmed, S (corresponding author), Washington State Univ, Coll Pharm, Dept Pharmaceut Sci, SPBS Room 411,412 E Spokane Falls Blvd, Spokane, WA 99210 USA.	salah.ahmed@wsu.edu	Chourasia, Mukesh/ABI-6012-2020; Singh, Anil K/H-6225-2019; Chourasia, Mukesh/S-3976-2016	Singh, Anil K/0000-0002-4102-2420; Fechtner, Sabrina/0000-0001-5931-4600; Chourasia, Mukesh/0000-0002-4565-5348	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR-063104]; Washington State University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063104] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Washington State University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank the Cooperative Human Tissue Network (CHTN) and National Disease Research Interchange (NDRI) for providing RA and NL synovial tissues. This work was supported by the U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases (Grant AR-063104 to S.A.), and Start-Up Funds from Washington State University (to S.A.). The authors declare no conflicts of interest.	Ahmed S, 2008, P NATL ACAD SCI USA, V105, P14692, DOI 10.1073/pnas.0802675105; Bersudsky M, 2014, GUT, V63, P598, DOI 10.1136/gutjnl-2012-303329; Bottini N, 2013, NAT REV RHEUMATOL, V9, P24, DOI 10.1038/nrrheum.2012.190; Buryskova M, 2004, J BIOL CHEM, V279, P4017, DOI 10.1074/jbc.M306342200; Busso N, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2952; CARRUTH LM, 1991, J BIOL CHEM, V266, P12162; CLINTON SK, 1991, AM J PATHOL, V138, P1005; Di Paolo NC, 2016, NAT IMMUNOL, V17, P906, DOI 10.1038/ni.3503; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Fichorova RN, 2001, J INFECT DIS, V184, P418, DOI 10.1086/322047; Gabay C, 2010, NAT REV RHEUMATOL, V6, P232, DOI 10.1038/nrrheum.2010.4; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Genovese MC, 2009, ARTHRITIS RHEUM, V60, P317, DOI 10.1002/art.24264; HISCOTT J, 1993, MOL CELL BIOL, V13, P6231, DOI 10.1128/MCB.13.10.6231; Huber MD, 2007, J CELL BIOL, V179, P583, DOI 10.1083/jcb.200710156; Jhang JJ, 2015, CELL MOL IMMUNOL, V12, P424, DOI 10.1038/cmi.2014.65; Jones DS, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aal1601; KAVITA U, 1995, J BIOL CHEM, V270, P27758, DOI 10.1074/jbc.270.46.27758; Kim EY, 2018, FASEB J, V32, P6174, DOI 10.1096/fj.201800425R; Lamacchia C, 2013, CYTOKINE, V63, P135, DOI 10.1016/j.cyto.2013.04.010; Lopez-Castejon G, 2011, CYTOKINE GROWTH F R, V22, P189, DOI 10.1016/j.cytogfr.2011.10.001; Luheshi NM, 2009, TRAFFIC, V10, P16, DOI 10.1111/j.1600-0854.2008.00840.x; Moldovan F, 2000, OSTEOARTHR CARTILAGE, V8, P186, DOI 10.1053/joca.1999.0289; Mori N, 1996, BLOOD, V87, P3410, DOI 10.1182/blood.V87.8.3410.bloodjournal8783410; MOSLEY B, 1987, J BIOL CHEM, V262, P2941; Ogata S, 2007, J DENT RES, V86, P186, DOI 10.1177/154405910708600215; Ren XM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00864-2; Rider P, 2013, SEMIN IMMUNOL, V25, P430, DOI 10.1016/j.smim.2013.10.005; Rider P, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00290; RISTIMAKI A, 1994, J BIOL CHEM, V269, P11769; Singh AK, 2016, ARTHRITIS RHEUMATOL, V68, P347, DOI 10.1002/art.39447; Singh AK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009912; Umekawa T, 2003, NEPHROL DIAL TRANSPL, V18, P664, DOI 10.1093/ndt/gfg140; Vollmer S, 2017, BIOCHEM J, V474, P2027, DOI 10.1042/BCJ20170097; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; WESSENDORF JHM, 1993, J BIOL CHEM, V268, P22100; Xia YY, 1999, MOL CELL BIOL, V19, P7688; Yaron M, 1999, OSTEOARTHR CARTILAGE, V7, P272, DOI 10.1053/joca.1998.0201; Zhu QZ, 2015, MUTAT RES-FUND MOL M, V776, P16, DOI 10.1016/j.mrfmmm.2015.01.005	39	17	19	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2526	2536		10.1096/fj.201801513R	http://dx.doi.org/10.1096/fj.201801513R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30272996	Green Published			2022-12-26	WOS:000457296600079
J	Kuhnle, S; Martinez-Noel, G; Leclere, F; Hayes, SD; Harper, JW; Howley, PM				Kuhnle, Simone; Martinez-Noel, Gustavo; Leclere, Flavien; Hayes, Sebastian D.; Harper, J. Wade; Howley, Peter M.			Angelman syndrome-associated point mutations in the Zn2+-binding N-terminal (AZUL) domain of UBE3A ubiquitin ligase inhibit binding to the proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autism; proteasome; estrogen receptor; Wnt signaling; E3 ubiquitin ligase; Angelman syndrome; AZUL domain; E6AP; PSMD4; UBE3A	HUMAN-PAPILLOMAVIRUS TYPE-16; PROTEIN-DEGRADATION; DEVELOPMENTAL DELAY; MULTIUBIQUITIN CHAIN; E6 ONCOPROTEIN; 26S PROTEASOME; AUTISM; E6-AP; COMPLEX; MODEL	Deregulation of the HECT ubiquitin ligase UBE3A/E6AP has been implicated in Angelman syndrome as well as autism spectrum disorders. We and others have previously identified the 26S proteasome as one of the major UBE3A-interacting protein complexes. Here, we characterize the interaction of UBE3A and the proteasomal subunit PSMD4 (Rpn10/S5a). We map the interaction to the highly conserved Zn2+-binding N-terminal (AZUL) domain of UBE3A, the integrity of which is crucial for binding to PSMD4. Interestingly, two Angelman syndrome point mutations that affect the AZUL domain show an impaired ability to bind PSMD4. Although not affecting the ubiquitin ligase or the estrogen receptor -mediated transcriptional regulation activities, these AZUL domain mutations prevent UBE3A from stimulating the Wnt/-catenin signaling pathway. Taken together, our data indicate that impaired binding to the 26S proteasome and consequential deregulation of Wnt/-catenin signaling might contribute to the functional defect of these mutants in Angelman syndrome.	[Kuhnle, Simone; Martinez-Noel, Gustavo; Leclere, Flavien; Howley, Peter M.] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Hayes, Sebastian D.; Harper, J. Wade] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Hayes, Sebastian D.] Agios Pharmaceut, 88 Sidney St, Cambridge, MA 02139 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Agios Pharmaceuticals	Howley, PM (corresponding author), Harvard Med Sch, Dept Microbiol & Immunobiol, NRB, Rm 950,77 Ave Louis Pasteur, Boston, MA 02115 USA.	peter_howley@hms.harvard.edu		Kuhnle, Simone/0000-0001-9382-3142; Howley, Peter/0000-0002-8668-9579; HAYES, SEBASTIAN/0000-0002-2383-9461	National Institutes of Health [R35CA197262, AG011085]; German Research Foundation (Deutsche Forschungsgemeinschaft) Scholarship [KU 3196/2-1]; NATIONAL CANCER INSTITUTE [R35CA197262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation (Deutsche Forschungsgemeinschaft) Scholarship(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants R35CA197262 (to P. M. H) and AG011085 (to J. W. H.) and German Research Foundation (Deutsche Forschungsgemeinschaft) Scholarship Grant KU 3196/2-1 (to S. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altun M, 2010, J BIOL CHEM, V285, P39597, DOI 10.1074/jbc.M110.129718; ANGELMAN H, 1965, DEV MED CHILD NEUROL, V7, P681; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Besche HC, 2014, EMBO J, V33, P1159, DOI 10.1002/embj.201386906; Chang CY, 1999, MOL CELL BIOL, V19, P8226; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Cheron G, 2005, NEUROSCIENCE, V130, P631, DOI 10.1016/j.neuroscience.2004.09.013; Cooper EM, 2004, J BIOL CHEM, V279, P41208, DOI 10.1074/jbc.M401302200; Demsar J, 2013, J MACH LEARN RES, V14, P2349; DiAntonio A, 2004, ANNU REV NEUROSCI, V27, P223, DOI 10.1146/annurev.neuro.27.070203.144317; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; Fang P, 1999, HUM MOL GENET, V8, P129, DOI 10.1093/hmg/8.1.129; Fonseca R, 2006, NEURON, V52, P239, DOI 10.1016/j.neuron.2006.08.015; Fu HY, 1998, J BIOL CHEM, V273, P1970, DOI 10.1074/jbc.273.4.1970; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Hall JM, 1999, ENDOCRINOLOGY, V140, P5566, DOI 10.1210/en.140.12.5566; Harlalka GV, 2013, J MED GENET, V50, P65, DOI 10.1136/jmedgenet-2012-101367; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hogart A, 2010, NEUROBIOL DIS, V38, P181, DOI 10.1016/j.nbd.2008.08.011; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P4918, DOI 10.1128/MCB.13.8.4918; HUIBREGTSE JM, 1991, EMBO J, V10, P4129, DOI 10.1002/j.1460-2075.1991.tb04990.x; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Jacobson AD, 2014, MOL BIOL CELL, V25, P1824, DOI 10.1091/mbc.E13-10-0585; Karpova A, 2006, J NEUROSCI, V26, P4949, DOI 10.1523/JNEUROSCI.4573-05.2006; Kish-Trier E, 2013, ANNU REV BIOPHYS, V42, P29, DOI 10.1146/annurev-biophys-083012-130417; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Kleijnen MF, 2000, MOL CELL, V6, P409, DOI 10.1016/S1097-2765(00)00040-X; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kredel S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004391; Kremers GJ, 2007, BIOCHEMISTRY-US, V46, P3775, DOI 10.1021/bi0622874; Kuhnle S, 2013, P NATL ACAD SCI USA, V110, P8888, DOI 10.1073/pnas.1302792110; Kuhnle S, 2011, J BIOL CHEM, V286, P19410, DOI 10.1074/jbc.M110.205211; Kumar S, 1999, J BIOL CHEM, V274, P18785, DOI 10.1074/jbc.274.26.18785; Kwan V, 2016, J NEURODEV DISORD, V8, DOI 10.1186/s11689-016-9176-3; Lamesch P, 2007, GENOMICS, V89, P307, DOI 10.1016/j.ygeno.2006.11.012; Lee SY, 2014, CELL MOL LIFE SCI, V71, P2747, DOI 10.1007/s00018-013-1526-7; Lemak A, 2011, J BIOMOL NMR, V51, P185, DOI 10.1007/s10858-011-9552-y; Li L, 2006, J BIOL CHEM, V281, P1978, DOI 10.1074/jbc.M508545200; Lichtig H, 2010, VIROLOGY, V396, P47, DOI 10.1016/j.virol.2009.10.011; Lossie AC, 2001, J MED GENET, V38, P834, DOI 10.1136/jmg.38.12.834; Mabb AM, 2011, TRENDS NEUROSCI, V34, P293, DOI 10.1016/j.tins.2011.04.001; Malzac P, 1998, AM J HUM GENET, V62, P1353, DOI 10.1086/301877; Martinez-Noel G, 2018, J MOL BIOL, V430, P1024, DOI 10.1016/j.jmb.2018.01.021; Martinez-Noel G, 2012, MOL CELL BIOL, V32, P3095, DOI 10.1128/MCB.00201-12; Martinez-Zapien D, 2016, NATURE, V529, P541, DOI 10.1038/nature16481; Miura K, 2002, NEUROBIOL DIS, V9, P149, DOI 10.1006/nbdi.2001.0463; Moncla A, 1999, EUR J HUM GENET, V7, P131, DOI 10.1038/sj.ejhg.5200258; Mueller O Thomas, 2008, Hum Genet, V124, P304; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Nawaz Z, 1999, MOL CELL BIOL, V19, P1182; Noor A, 2015, HUM MUTAT, V36, P689, DOI 10.1002/humu.22800; PHELPS WC, 1991, J VIROL, V65, P6922, DOI 10.1128/JVI.65.12.6922-6930.1991; Puffenberger EG, 2012, HUM MUTAT, V33, P1639, DOI 10.1002/humu.22237; Ramamoorthy Sivapriya, 2008, Nucl Recept Signal, V6, pe006, DOI 10.1621/nrs.06006; Ronchi VP, 2014, J BIOL CHEM, V289, P1033, DOI 10.1074/jbc.M113.517805; Rougeulle C, 1997, NAT GENET, V17, P14, DOI 10.1038/ng0997-14; Sadikovic B, 2014, HUM MUTAT, V35, P1407, DOI 10.1002/humu.22687; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; SCHEFFNER M, 1992, J VIROL, V66, P5100, DOI 10.1128/JVI.66.8.5100-5105.1992; Schiffman M, 2005, VIROLOGY, V337, P76, DOI 10.1016/j.virol.2005.04.002; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; Sominsky S, 2014, VIROLOGY, V468, P510, DOI 10.1016/j.virol.2014.09.007; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Subbaiah VK, 2016, ONCOGENE, V35, P2062, DOI 10.1038/onc.2015.268; Tai HC, 2008, NAT REV NEUROSCI, V9, P826, DOI 10.1038/nrn2499; Tai HC, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/fnmol.2010.00012; Tan MJA, 2012, P NATL ACAD SCI USA, V109, pE1473, DOI 10.1073/pnas.1205991109; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Tomaic V, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.572; Tomaic V, 2013, VIROLOGY, V446, P389, DOI 10.1016/j.virol.2013.08.016; Uchiki T, 2009, J BIOL CHEM, V284, P12622, DOI 10.1074/jbc.M900556200; Wang QH, 2005, J MOL BIOL, V348, P727, DOI 10.1016/j.jmb.2005.03.007; Williams CA, 2006, AM J MED GENET A, V140A, P413, DOI 10.1002/ajmg.a.31074; WILLIAMS CA, 1995, AM J MED GENET, V56, P237, DOI 10.1002/ajmg.1320560224; Wu Y, 2008, P NATL ACAD SCI USA, V105, P12399, DOI 10.1073/pnas.0805291105; Yamamoto Y, 1997, GENOMICS, V41, P263, DOI 10.1006/geno.1997.4617; Yi JJ, 2007, PHARMACOL REV, V59, P14, DOI 10.1124/pr.59.1.4; Yi JJ, 2017, J BIOL CHEM, V292, P12503, DOI 10.1074/jbc.M117.788448; Yi JJ, 2015, CELL, V162, P795, DOI 10.1016/j.cell.2015.06.045; Zanier K, 2013, SCIENCE, V339, P694, DOI 10.1126/science.1229934	85	21	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18387	18399		10.1074/jbc.RA118.004653	http://dx.doi.org/10.1074/jbc.RA118.004653			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30257870	hybrid, Green Published			2022-12-26	WOS:000451375200029
J	Ndeh, D; Munoz, JM; Cartmell, A; Bulmer, D; Wills, C; Henrissat, B; Gray, J				Ndeh, Didier; Munoz, Jose Munoz; Cartmell, Alan; Bulmer, David; Wills, Corinne; Henrissat, Bernard; Gray, Joseph			The human gut microbe Bacteroides thetaiotaomicron encodes the founding member of a novel glycosaminoglycan-degrading polysaccharide lyase family PL29	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chondroitin sulfate; hyaluronan; hyaluronate lyase; carbohydrate metabolism; bacterial metabolism; polysaccharide; CAZymes; cell surface enzyme; glycosaminoglycan degradation; human gut microbiota; PL29	CHONDROITIN SULFATE; STERCORIS HJ-15; PROTEOGLYCANS; BACTERIUM; SYMBIONT; GLYCAN; GROWTH; ABC; OLIGOSACCHARIDES; TETRASACCHARIDES	Glycosaminoglycans (GAGs) and GAG-degrading enzymes have wide-ranging applications in the medical and biotechnological industries. The former are also an important nutrient source for select species of the human gut microbiota (HGM), a key player in host-microbial interactions. How GAGs are metabolized by the HGM is therefore of interest and has been extensively investigated in the model human gut microbe Bacteroides thetaiotaomicron. The presence of as-yet uncharacterized GAG-inducible genes in its genome and of related species, however, is testament to our incomplete understanding of this process. Nevertheless, it presents a potential opportunity for the discovery of additional GAG-degrading enzymes. Here, we investigated a gene of unknown function (BT_3328) from the chondroitin sulfate (CS) utilization locus of B. thetaiotaomicron. NMR and UV spectroscopic assays revealed that it encodes a novel polysaccharide lyase (PL), hereafter referred to as BtCDH, reflecting its source (B. thetaiotaomicron (Bt)) and its ability to degrade the GAGs CS, dermatan sulfate (DS), and hyaluronic acid (HA). When incubated with HA, BtCDH generated a series of unsaturated HA sugars, including (4,5)UA-GlcNAc, (4,5)UA-GlcNAc-GlcA-GlcNac, (4,5)UA-[GlcNAc-GlcA](2)-GlcNac, and (4,5)UA-[GlcNAc-GlcA](3)-GlcNac, as end products and hence was classed as endo-acting. A combination of genetic and biochemical assays revealed that BtCDH localizes to the cell surface of B. thetaiotaomicron where it enables extracellular GAG degradation. BtCDH homologs were also detected in several other HGM species, and we therefore propose that it represents the founding member of a new polysaccharide lyase family (PL29). The current discovery also contributes new insights into CS metabolism by the HGM.	[Ndeh, Didier; Cartmell, Alan; Bulmer, David; Gray, Joseph] Newcastle Univ, Inst Cell & Mol Biosci, Med Sch, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Munoz, Jose Munoz] Northumbria Univ, Dept Appl Sci, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England; [Bulmer, David] Newcastle Univ, Med Sch, Bioimaging Unit, William Leech Bldg, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Wills, Corinne] Sch Nat & Environm Sci, Bedson Bldg,Kings Rd, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Henrissat, Bernard] Aix Marseille Univ, CNRS, Architecture & Fonct Macromol Biol, F-13288 Marseille, France; [Henrissat, Bernard] INRA, Architecture & Fonct Macromol Biol USC1408, F-13288 Marseille, France; [Henrissat, Bernard] King Abdulaziz Univ, Dept Biol Sci, Jeddah 23218, Saudi Arabia	Newcastle University - UK; Northumbria University; Newcastle University - UK; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; INRAE; King Abdulaziz University	Ndeh, D (corresponding author), Newcastle Univ, Inst Cell & Mol Biosci, Med Sch, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	Didier.Ndeh@newcastle.ac.uk	Henrissat, Bernard/J-2475-2012; Munoz-Munoz, Jose/G-3506-2016	Henrissat, Bernard/0000-0002-3434-8588; Ndeh, Didier/0000-0001-7875-1638; Gray, Joseph/0000-0003-2338-0301; Bulmer, David/0000-0003-0157-9790; Cartmell, Alan/0000-0002-5512-249X; Munoz-Munoz, Jose/0000-0003-0010-948X	European Union's Seventh Framework Program Grant FP/2007/2013; European Research Council [322820]	European Union's Seventh Framework Program Grant FP/2007/2013; European Research Council(European Research Council (ERC)European Commission)	This work was supported by the European Union's Seventh Framework Program Grant FP/2007/2013 and European Research Council Grant Agreement 322820. The authors declare that they have no conflicts of interest with the contents of this article.	Vazquez JA, 2013, MAR DRUGS, V11, P747, DOI 10.3390/md11030747; Cartmell A, 2017, P NATL ACAD SCI USA, V114, P7037, DOI 10.1073/pnas.1704367114; CHENG QO, 1995, J BACTERIOL, V177, P3721, DOI 10.1128/jb.177.13.3721-3727.1995; DAVIDSON S, 1990, J BIOL CHEM, V265, P12324; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Desai MS, 2016, CELL, V167, P1339, DOI 10.1016/j.cell.2016.10.043; Elmabrouk ZH, 2011, PROTEINS, V79, P965, DOI 10.1002/prot.22938; Gama CI, 2006, NAT CHEM BIOL, V2, P467, DOI 10.1038/nchembio810; Gill S, 2010, ANAT REC, V293, P968, DOI 10.1002/ar.21094; Hamai A, 1997, J BIOL CHEM, V272, P9123; Han WJ, 2014, J BIOL CHEM, V289, P27886, DOI 10.1074/jbc.M114.590752; Hong SW, 2002, EUR J BIOCHEM, V269, P2934, DOI 10.1046/j.1432-1033.2002.02967.x; Huckerby TN, 2001, EUR J BIOCHEM, V268, P1181, DOI 10.1046/j.1432-1327.2001.01948.x; Iozzo RV, 2011, J CELL MOL MED, V15, P1013, DOI 10.1111/j.1582-4934.2010.01236.x; Kim SH, 2011, J ENDOCRINOL, V209, P139, DOI 10.1530/JOE-10-0377; Koropatkin NM, 2008, STRUCTURE, V16, P1105, DOI 10.1016/j.str.2008.03.017; Kusche-Gullberg M, 2003, CURR OPIN STRUC BIOL, V13, P605, DOI 10.1016/j.sbi.2003.08.002; Larsbrink J, 2014, NATURE, V506, P498, DOI 10.1038/nature12907; Lemmnitzer K, 2016, ANAL METHODS-UK, V8, P8483, DOI 10.1039/c6ay02531e; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Malavaki CJ, 2008, ANAL BIOCHEM, V374, P213, DOI 10.1016/j.ab.2007.11.006; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Muthusamy A, 2004, GLYCOBIOLOGY, V14, P635, DOI 10.1093/glycob/cwh077; Ndeh D, 2018, FEMS MICROBIOL REV, V42, P146, DOI 10.1093/femsre/fuy002; Ndeh D, 2017, NATURE, V544, P65, DOI 10.1038/nature21725; Pomin VH, 2018, PHARMACEUTICALS-BASE, V11, DOI 10.3390/ph11010027; Pudlo NA, 2015, MBIO, V6, DOI 10.1128/mBio.01282-15; Raghavan V, 2015, J BACTERIOL, V197, P1538, DOI 10.1128/JB.00010-15; Raghavan V, 2014, MOL MICROBIOL, V93, P1010, DOI 10.1111/mmi.12714; Rani A, 2016, J MOL CATAL B-ENZYM, V134, P215, DOI 10.1016/j.molcatb.2016.11.001; Shaya D, 2008, BIOCHEMISTRY-US, V47, P6650, DOI 10.1021/bi800353g; Shim KW, 2008, PROTEIN EXPRES PURIF, V58, P222, DOI 10.1016/j.pep.2007.11.014; Silva C, 2015, ANAL CHIM ACTA, V885, P207, DOI 10.1016/j.aca.2015.05.034; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Terrapon N, 2015, BIOINFORMATICS, V31, P647, DOI 10.1093/bioinformatics/btu716; Tuncil YE, 2017, MBIO, V8, DOI [10.1128/mBio.01068-17, 10.1128/mbio.01068-17]; Ulmer JE, 2014, J BIOL CHEM, V289, P24289, DOI 10.1074/jbc.M114.573303; Wight Thomas N., 1992, Current Opinion in Cell Biology, V4, P793, DOI 10.1016/0955-0674(92)90102-I	38	19	20	3	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2018	293	46					17906	17916		10.1074/jbc.RA118.004510	http://dx.doi.org/10.1074/jbc.RA118.004510			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HA6SG	30262663	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000450409500020
J	Godfrey, TC; Wildman, BJ; Beloti, MM; Kemper, AG; Ferraz, EP; Roy, B; Rehan, M; Afreen, LH; Kim, E; Lengner, CJ; Hassan, Q				Godfrey, Tanner C.; Wildman, Benjamin J.; Beloti, Marcio M.; Kemper, Austin G.; Ferraz, Emanuela P.; Roy, Bhaskar; Rehan, Mohammad; Afreen, Lubana H.; Kim, Eddy; Lengner, Christopher J.; Hassan, Quamarul			The microRNA-23a cluster regulates the developmental HoxA cluster function during osteoblast differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bone; osteoblast; epigenetics; microRNA (miRNA); gene regulation; Bone epigenetics; H3K27 acetylation; HoxA cluster; miR-23a cluster; osteoblast differentiation; homeobox; transcription factor	MESENCHYMAL STEM-CELLS; BONE-FORMATION; MESSENGER-RNA; OSTEOGENIC DIFFERENTIATION; HOMEOTIC TRANSFORMATIONS; TARGETED DISRUPTIONS; LINEAGE COMMITMENT; COMPOUND MUTANTS; LIMB DEVELOPMENT; AXIAL SKELETON	MicroRNAs (miRs) and Hox transcription factors have decisive roles in postnatal bone formation and homeostasis. In silico analysis identified extensive interaction between HOXA cluster mRNA and microRNAs from the miR-23a cluster. However, Hox regulation by the miR-23a cluster during osteoblast differentiation remains undefined. We examined this regulation in preosteoblasts and in a novel miR-23a cluster knockdown mouse model. Overexpression and knockdown of the miR-23a cluster in preosteoblasts decreased and increased, respectively, the expression of the proteins HOXA5, HOXA10, and HOXA11; these proteins' mRNAs exhibited significant binding with the miR-23a cluster miRNAs, and miRNA 3-UTR reporter assays confirmed repression. Importantly, during periods correlating with development and differentiation of bone cells, we found an inverse pattern of expression between HoxA factors and members of the miR-23a cluster. HOXA5 and HOXA11 bound to bone-specific promoters, physically interacted with transcription factor RUNX2, and regulated bone-specific genes. Depletion of HOXA5 or HOXA11 in preosteoblasts also decreased cellular differentiation. Additionally, stable overexpression of the miR-23a cluster in osteoblasts decreased the recruitment of HOXA5 and HOXA11 to osteoblast gene promoters, significantly inhibiting histone H3 acetylation. Heterozygous miR-23a cluster knockdown female mice (miR-23a Cl-WT/ZIP) had significantly increased trabecular bone mass when compared with WT mice. Furthermore, miR-23a cluster knockdown in calvarial osteoblasts of these mice increased the recruitment of HOXA5 and HOXA11, with a substantial enrichment of promoter histone H3 acetylation. Taken together, these findings demonstrate that the miR-23a cluster is required for maintaining stage-specific HoxA factor expression during osteogenesis.	[Godfrey, Tanner C.; Wildman, Benjamin J.; Kemper, Austin G.; Roy, Bhaskar; Rehan, Mohammad; Afreen, Lubana H.; Kim, Eddy; Hassan, Quamarul] Univ Alabama Birmingham, Sch Dent, Dept Oral & Maxillofacial Surg, RNA Biol & Epigenet Lab, Birmingham, AL 35294 USA; [Beloti, Marcio M.; Ferraz, Emanuela P.] Univ Sao Paulo, Sch Dent Ribeirao Preto, BR-14040904 Ribeirao Preto, SP, Brazil; [Lengner, Christopher J.] Univ Penn, Sch Vet Med, Dept Biomed Sci, Philadelphia, PA 19104 USA; [Lengner, Christopher J.] Univ Penn, Inst Regenerat Med, Philadelphia, PA 19104 USA	University of Alabama System; University of Alabama Birmingham; Universidade de Sao Paulo; University of Pennsylvania; University of Pennsylvania	Hassan, Q (corresponding author), Sch Dent, Inst Oral Hlth Res, Dept Oral & Maxillofacial Surg, 1919 7th Ave S, Birmingham, AL 35233 USA.	hassank@uab.edu	Ferraz, Emanuela/J-9441-2012	Ferraz, Emanuela/0000-0001-6833-4865	NIAMS, National Institutes of Health [1R01AR069578]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR069578] Funding Source: NIH RePORTER	NIAMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIAMS, National Institutes of Health, Grant 1R01AR069578. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Alexander R, 2011, EXPERT OPIN THER TAR, V15, P623, DOI 10.1517/14728222.2011.561317; Alexander T, 2009, ANNU REV CELL DEV BI, V25, P431, DOI 10.1146/annurev.cellbio.042308.113423; Bae YJ, 2012, HUM MOL GENET, V21, P2991, DOI 10.1093/hmg/dds129; Bazzini AA, 2012, SCIENCE, V336, P233, DOI 10.1126/science.1215704; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Boulet AM, 2002, DEV BIOL, V249, P96, DOI 10.1006/dbio.2002.0755; Brend T, 2003, DEVELOPMENT, V130, P2717, DOI 10.1242/dev.00471; Buchholz F, 1998, NAT BIOTECHNOL, V16, P657, DOI 10.1038/nbt0798-657; Carapuco M, 2005, GENE DEV, V19, P2116, DOI 10.1101/gad.338705; CONDIE BG, 1994, NATURE, V370, P304, DOI 10.1038/370304a0; DAVIS AP, 1995, NATURE, V375, P791, DOI 10.1038/375791a0; Di Leva G, 2010, TRENDS MOL MED, V16, P257, DOI 10.1016/j.molmed.2010.04.001; Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691; Duboule D, 2007, DEVELOPMENT, V134, P2549, DOI 10.1242/dev.001065; Favier B, 1996, DEVELOPMENT, V122, P449; Gaur T, 2010, DEV BIOL, V340, P10, DOI 10.1016/j.ydbio.2010.01.008; Gindin Y, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00233; Gordon JAR, 2010, MOL CELL BIOL, V30, P3531, DOI 10.1128/MCB.00889-09; Grunhagen J, 2015, J BONE MINER RES, V30, P796, DOI 10.1002/jbmr.2412; Hassan MQ, 2007, MOL CELL BIOL, V27, P3337, DOI 10.1128/MCB.01544-06; Hassan MQ, 2015, BONE, V81, P746, DOI 10.1016/j.bone.2015.05.026; Hassan MQ, 2012, J BIOL CHEM, V287, P42084, DOI 10.1074/jbc.M112.377515; Hassan MQ, 2010, P NATL ACAD SCI USA, V107, P19879, DOI 10.1073/pnas.1007698107; Hassan MQ, 2006, J BIOL CHEM, V281, P40515, DOI 10.1074/jbc.M604508200; Hassan MQ, 2004, MOL CELL BIOL, V24, P9248, DOI 10.1128/MCB.24.20.9248-9261.2004; Heair HM, 2015, MOL CELL BIOL, V35, P3116, DOI 10.1128/MCB.00093-15; HORAN GSB, 1995, GENE DEV, V9, P1667, DOI 10.1101/gad.9.13.1667; Hornstein E, 2005, NATURE, V438, P671, DOI 10.1038/nature04138; Iliopoulos D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003740; Inose H, 2009, P NATL ACAD SCI USA, V106, P20794, DOI 10.1073/pnas.0909311106; JEANNOTTE L, 1993, GENE DEV, V7, P2085, DOI 10.1101/gad.7.11.2085; Kapinas K, 2010, J BIOL CHEM, V285, P25221, DOI 10.1074/jbc.M110.116137; Kato RB, 2014, J CELL PHYSIOL, V229, P1690, DOI 10.1002/jcp.24614; Kobayashi T, 2008, P NATL ACAD SCI USA, V105, P1949, DOI 10.1073/pnas.0707900105; KOSTIC D, 1994, MECH DEVELOP, V46, P231, DOI 10.1016/0925-4773(94)90073-6; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Leucht P, 2008, DEVELOPMENT, V135, P2845, DOI 10.1242/dev.023788; Li H, 2015, CELL DEATH DIFFER, V22, P1935, DOI 10.1038/cdd.2015.99; Li T, 2016, INT J BIOCHEM CELL B, V72, P55, DOI 10.1016/j.biocel.2016.01.004; Li XK, 2010, NAT REV NEUROSCI, V11, P329, DOI 10.1038/nrn2739; Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105; Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200; Lian JB, 2012, NAT REV ENDOCRINOL, V8, P212, DOI 10.1038/nrendo.2011.234; Lipsky PE, 2010, NAT REV RHEUMATOL, V6, P179, DOI [10.1038/nrrheum.2010.50, 10.1038/nrrheum.2009.266, 10.1038/nrrheum.2009.270, 10.1038/nrrheum.2010.38, 10.1038/nrrheum.2010.112]; Liu N, 2010, DEV CELL, V18, P510, DOI 10.1016/j.devcel.2010.03.010; Liu P, 2016, SCI REP-UK, V6, DOI 10.1038/srep32112; Mansfield JH, 2012, CURR TOP DEV BIOL, V99, P31, DOI 10.1016/B978-0-12-387038-4.00002-1; Mei W, 2005, BIOCHEM BIOPH RES CO, V328, P651, DOI 10.1016/j.bbrc.2004.11.067; Mizoguchi F, 2010, J CELL BIOCHEM, V109, P866, DOI 10.1002/jcb.22228; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Nelson CE, 1996, DEVELOPMENT, V122, P1449; O'Carroll D, 2007, GENE DEV, V21, P1999, DOI 10.1101/gad.1565607; Ortega FJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009022; Qin YW, 2017, J BIOL CHEM, V292, P11021, DOI 10.1074/jbc.M116.770941; Rijli FM, 1997, CURR OPIN GENET DEV, V7, P481, DOI 10.1016/S0959-437X(97)80074-3; Rux DR, 2017, J BONE MINER RES, V32, P1750, DOI 10.1002/jbmr.3166; Rux DR, 2017, DEV DYNAM, V246, P310, DOI 10.1002/dvdy.24482; Salsi V, 2006, J BIOL CHEM, V281, P1992, DOI 10.1074/jbc.M510900200; Salsi V, 2008, DEV BIOL, V317, P497, DOI 10.1016/j.ydbio.2008.02.048; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Taylor Sarah E B, 2014, Bonekey Rep, V3, P585, DOI 10.1038/bonekey.2014.80; Wei JW, 2012, J CELL BIOL, V197, P509, DOI 10.1083/jcb.201201057; Weilner S, 2015, BONE, V79, P43, DOI 10.1016/j.bone.2015.05.027; Williams AH, 2009, CURR OPIN CELL BIOL, V21, P461, DOI 10.1016/j.ceb.2009.01.029; Woltering JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001396; Wu QX, 2012, J BIOL CHEM, V287, P25173, DOI 10.1074/jbc.M112.362053; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yekta S, 2008, NAT REV GENET, V9, P789, DOI 10.1038/nrg2400; Zeng HC, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15000; Zhang LA, 2011, CELL STEM CELL, V8, P294, DOI 10.1016/j.stem.2011.01.014; Zhang Y, 2011, P NATL ACAD SCI USA, V108, P9863, DOI 10.1073/pnas.1018493108	72	26	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2018	293	45					17646	17660		10.1074/jbc.RA118.003052	http://dx.doi.org/10.1074/jbc.RA118.003052			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ9EI	30242124	Green Published, hybrid			2022-12-26	WOS:000449799000027
J	den Drijver, E; Verweij, JJ; Verhulst, C; Oome, S; Soer, J; Willemsen, I; Schrauwen, EJA; Kluytmans-van den Bergh, MFQ; Kluytmans, JAJW				den Drijver, Evert; Verweij, Jaco J.; Verhulst, Carlo; Oome, Stijn; Soer, Joke; Willemsen, Ina; Schrauwen, Eefje J. A.; Kluytmans-van den Bergh, Marjolein F. Q.; Kluytmans, Jan A. J. W.			Decline in AmpC beta-lactamase-producing Escherichia coli in a Dutch teaching hospital (2013-2016)	PLOS ONE			English	Article							EXTENDED-SPECTRUM; MOLECULAR CHARACTERIZATION; RISK-FACTORS; CTX-M; PREVALENCE; ENTEROBACTERIACEAE; COLONIZATION; EPIDEMIOLOGY; INFECTIONS; MICROARRAY	Objective The objective of this study is to determine the prevalence of rectal carriage of plasmid- and chromosome-encoded AmpC beta-lactamase-producing Escherichia coli and Klebsiella spp. in patients in a Dutch teaching hospital between 2013 and 2016. Methods Between 2013 and 2016, hospital-wide yearly prevalence surveys were performed to determine the prevalence of AmpC beta-lactamase-producing E. coli and Klebsiella spp. rectal carriage. Rectal swabs were taken and cultured using an enrichment broth and selective agar plates. All E. coli and Klebsiella spp. isolates were screened for production of AmpC beta-lactamase using phenotypic confirmation tests and for the presence of plasmid-encoded AmpC (pAmpC) genes. E. coli isolates were screened for chromosome-encoded AmpC (cAmpC) promoter/attenuator alterations. Results Fifty (2.4%) of 2,126 evaluable patients were identified as rectal carrier of AmpC beta-lactamase-producing E. coll. No carriage of AmpC beta-lactamase producing Klebsiella spp. was found. Nineteen (0.9%) patients harboured isolates with pAmpC genes and 30 (1,4%) patients harboured isolates with cAmpC promoter/attenuator alterations associated with AmpC beta-lactamase overproduction. For one isolate, no pAmpC genes or cAmpC promotor/attenuator alterations could be identified. During the study period, a statistically significant decline in the prevalence of rectal carriage with E. coil with cAmpC promotor/attenuator alterations was found (p = 0.012). The prevalence of pAmpC remained stable over the years. Conclusions The prevalence of rectal carriage of AmpC-producing E. coli and Klebsiella spp. in patients in Dutch hospitals is low and a declining trend was observed for E. coli with cAmpC promotor/attenuator alterations.	[den Drijver, Evert; Verhulst, Carlo; Oome, Stijn; Soer, Joke; Willemsen, Ina; Schrauwen, Eefje J. A.; Kluytmans-van den Bergh, Marjolein F. Q.; Kluytmans, Jan A. J. W.] Amphia Hosp, Lab Microbiol & Infect Control, Breda, Netherlands; [den Drijver, Evert; Verweij, Jaco J.; Kluytmans, Jan A. J. W.] Elisabeth TweeSteden Hosp, Lab Med Microbiol & Immunol, Tilburg, Netherlands; [Oome, Stijn; Soer, Joke; Schrauwen, Eefje J. A.] AVANS Univ Appl Sci, Avans Acad Technol Hlth & Environm, Breda, Netherlands; [Kluytmans-van den Bergh, Marjolein F. Q.] Amphia Hosp, Amphia Acad Infect Dis Fdn, Breda, Netherlands; [Kluytmans-van den Bergh, Marjolein F. Q.; Kluytmans, Jan A. J. W.] Univ Utrecht, Julius Ctr Hlth Sci & Primary Care, UMC Utrecht, Utrecht, Netherlands	Amphia Hospital; Elisabeth-TweeSteden Ziekenhuis (ETZ); Amphia Hospital; Utrecht University	den Drijver, E (corresponding author), Amphia Hosp, Lab Microbiol & Infect Control, Breda, Netherlands.; den Drijver, E (corresponding author), Elisabeth TweeSteden Hosp, Lab Med Microbiol & Immunol, Tilburg, Netherlands.	e.dendrijver@etz.nl	van den Bergh, Marjolein Kluytmans -/A-7267-2016	van den Bergh, Marjolein Kluytmans -/0000-0002-6576-6408; Verweij, Jaco J./0000-0001-8553-931X				Alonso N, 2016, INT J ANTIMICROB AG, V47, P62, DOI 10.1016/j.ijantimicag.2015.10.007; Bogaerts P, 2016, INT J ANTIMICROB AG, V48, P189, DOI 10.1016/j.ijantimicag.2016.05.006; Corvec S, 2002, ANTIMICROB AGENTS CH, V46, P3265, DOI 10.1128/AAC.46.10.3265-3267.2002; Cunningham SA, 2016, J CLIN MICROBIOL, V54, P1368, DOI 10.1128/JCM.03302-15; Cuzon G, 2012, J ANTIMICROB CHEMOTH, V67, P1865, DOI 10.1093/jac/dks156; Dierikx CM, 2012, J ANTIMICROB CHEMOTH, V67, P1368, DOI 10.1093/jac/dks049; Garrido A, 2014, MICROB DRUG RESIST, V20, P301, DOI 10.1089/mdr.2013.0109; Hordijk J, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00242; Hordijk J, 2013, J ANTIMICROB CHEMOTH, V68, P1970, DOI 10.1093/jac/dkt132; Huijbers PMC, 2014, J ANTIMICROB CHEMOTH, V69, P2669, DOI 10.1093/jac/dku178; Husickova V, 2012, BIOMED PAP, V156, P348, DOI 10.5507/bp.2012.039; Ingram PR, 2011, J MED MICROBIOL, V60, P715, DOI 10.1099/jmm.0.029140-0; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Jorgensen RL, 2010, J ANTIMICROB CHEMOTH, V65, P460, DOI 10.1093/jac/dkp484; Kluytmans JAJW, 2013, CLIN INFECT DIS, V56, P478, DOI 10.1093/cid/cis929; Kluytmans-van den Bergh MFQ, 2015, J CLIN MICROBIOL, V53, P2709, DOI 10.1128/JCM.01251-15; Koningstein M, 2015, J PEDIAT INF DIS SOC, V4, pE93, DOI 10.1093/jpids/piv042; Livermore DM, 2007, J ANTIMICROB CHEMOTH, V59, P165, DOI 10.1093/jac/dkl483; Mulvey MR, 2005, ANTIMICROB AGENTS CH, V49, P358, DOI 10.1128/AAC.49.1.358-365.2005; Nourrisson C, 2015, EUR J CLIN MICROBIOL, V34, P975, DOI 10.1007/s10096-014-2305-6; Park MJ, 2013, ANN LAB MED, V33, P353, DOI 10.3343/alm.2013.33.5.353; Pascual V, 2016, EUR J CLIN MICROBIOL, V35, P1997, DOI 10.1007/s10096-016-2752-3; Pascual V, 2015, J ANTIMICROB CHEMOTH, V70, P899, DOI 10.1093/jac/dku468; Philippon A, 2002, ANTIMICROB AGENTS CH, V46, P1, DOI 10.1128/AAC.46.1.1-11.2002; Reuland EA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0113033; Rodriguez-Bano J, 2012, J INFECTION, V64, P176, DOI 10.1016/j.jinf.2011.11.016; Savelkoul PHM, 1999, J CLIN MICROBIOL, V37, P3083, DOI 10.1128/JCM.37.10.3083-3091.1999; Tracz DM, 2007, FEMS MICROBIOL LETT, V270, P265, DOI 10.1111/j.1574-6968.2007.00672.x; Ulstad CR, 2016, ANTIMICROB RESIST IN, V5, DOI 10.1186/s13756-016-0156-x; van Hoek AHAM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129085; Veldman K. T, 2016, MARAN 2016 MONITORIN; Willemsen I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141765	32	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204864	10.1371/journal.pone.0204864	http://dx.doi.org/10.1371/journal.pone.0204864			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273375	Green Published, gold, Green Submitted			2022-12-26	WOS:000446124700044
J	Esculier, JF; Krowchuk, NM; Li, LC; Taunton, JE; Hunt, MA				Esculier, Jean-Francois; Krowchuk, Natasha M.; Li, Linda C.; Taunton, Jack E.; Hunt, Michael A.			What are the perceptions about running and knee joint health among the public and healthcare practitioners in Canada?	PLOS ONE			English	Article							PHYSICAL-ACTIVITY GUIDELINES; OLDER-ADULTS; OSTEOARTHRITIS; HIP; EXERCISE; PEOPLE; ASSOCIATION; COMMUNITY; PAIN	Objectives To evaluate the perceptions of the general public and healthcare practitioners (HCP) in Canada about the relationship between running and knee joint health, and to explore HCP's usual recommendations to runners with knee osteoarthritis (KOA). Methods Non-runners and runners (with and without KOA) and HCP completed an online survey regarding the safety of running for knee joint health. HCP also provided information related to usual clinical recommendations. Proportions of agreement were compared between non-runners and runners. Results A total of 114 non-runners, 388 runners and 329 HCP completed the survey. Overall, running was perceived as detrimental for the knee joint by 13.1% of the general public, while 25.9% were uncertain. More uncertainty was reported regarding frequent (33.9%) and long-distance (43.6%) running. Statistical analyses revealed greater proportions of non-runners perceiving running negatively compared with runners. Overall, 48.4% believed that running in the presence of KOA would lead to disease progression, while 53.1% believed running would lead to premature arthroplasty. In HCP, 8.2%, 9.1% and 22.2% perceived that running in general, running frequently, or running long-distances are risk factors for KOA, respectively. 37.1% and 2.7% of HCP typically recommended patients with KOA to modify their running training or to quit running, respectively. Conclusion High rates of uncertainty among the general public and HCP in Canada outline the need for further studies about running and knee joint health. Filling knowledge gaps will help inform knowledge translation strategies to better orientate the general public and HCP about the safety of running for knee joint health.	[Esculier, Jean-Francois; Krowchuk, Natasha M.; Li, Linda C.; Hunt, Michael A.] Univ British Columbia, Fac Med, Dept Phys Therapy, Vancouver, BC, Canada; [Li, Linda C.] Arthrit Res Canada, Richmond, BC, Canada; [Taunton, Jack E.] Univ British Columbia, Fac Med, Dept Family Med, Vancouver, BC, Canada	University of British Columbia; Arthritis Research Canada; University of British Columbia	Hunt, MA (corresponding author), Univ British Columbia, Fac Med, Dept Phys Therapy, Vancouver, BC, Canada.	michael.hunt@ubc.ca	Li, Linda C./P-8485-2015	Li, Linda C./0000-0001-6280-0511; Hunt, Michael/0000-0002-8648-1591	Canadian Institutes of Health Research; Michael Smith Foundation for Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	Any funding secured is limited to scholarship or salary support from the Canadian Institutes of Health Research and the Michael Smith Foundation for Health Research. The funders had no role in any aspect of the study	Abramson SB, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2655; Alentorn-Geli E, 2017, J ORTHOP SPORT PHYS, V47, P373, DOI 10.2519/jospt.2017.7137; Bombardier C., 2011, IMPACT ARTHRITIS CAN; Bricca A, 2018, BR J SPORTS MED; Fransen M, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004376.pub3; Gay C, 2017, JOINT BONE SPINE; Hansen P, 2012, PM&R, V4, pS117, DOI 10.1016/j.pmrj.2012.02.011; Hespanhol LC, 2015, SPORTS MED, V45, P1455, DOI 10.1007/s40279-015-0359-y; Holden MA, 2012, ARTHRIT CARE RES, V64, P1554, DOI 10.1002/acr.21700; Jinks C, 2016, OSTEOARTHR CARTILAGE, V24, pS186, DOI 10.1016/j.joca.2016.01.365; Li LC, 2011, J RHEUMATOL, V38, P2230, DOI 10.3899/jrheum.110264; Lo GH, 2018, CLIN RHEUMATOL; Lo GH, 2017, ARTHRIT CARE RES, V69, P183, DOI 10.1002/acr.22939; Macintyre JG, 1991, CLIN J SPORT MED, V1, P81, DOI DOI 10.1097/00042752-199104000-00002; Miller RH, 2017, EXERC SPORT SCI REV, V45, P87, DOI 10.1249/JES.0000000000000105; Nelson AE, 2014, SEMIN ARTHRITIS RHEU, V43, P701, DOI 10.1016/j.semarthrit.2013.11.012; Nicolson PJA, 2018, ARTHRIT CARE RES, V70, P388, DOI 10.1002/acr.23297; Ponzio DY, 2018, J BONE JOINT SURG AM, V100, P131, DOI 10.2106/JBJS.16.01071; Semanik PA, 2012, PM&R, V4, pS37, DOI 10.1016/j.pmrj.2012.02.015; Stubbs B, 2015, CLIN REHABIL, V29, P80, DOI 10.1177/0269215514538069; Szabo A, 2013, PSYCHOL HEALTH MED, V18, P251, DOI 10.1080/13548506.2012.701755; Taunton JE, 2002, BRIT J SPORT MED, V36, P95, DOI 10.1136/bjsm.36.2.95; Timmins KA, 2017, AM J SPORT MED, V45, P1447, DOI 10.1177/0363546516657531; Wallis JA, 2013, OSTEOARTHR CARTILAGE, V21, P1648, DOI 10.1016/j.joca.2013.08.003; Warburton DER, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-39; Williams PT, 2013, MED SCI SPORT EXER, V45, P1292, DOI 10.1249/MSS.0b013e3182885f26	26	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204872	10.1371/journal.pone.0204872	http://dx.doi.org/10.1371/journal.pone.0204872			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273410	Green Submitted, Green Published, gold			2022-12-26	WOS:000446124700045
J	Li, YX; Huang, JB; Yan, Y; Liang, JJ; Liang, QK; Lu, YY; Zhao, L; Li, HF				Li, Yunxia; Huang, Jinbing; Yan, Yuan; Liang, Jingjing; Liang, Qiankun; Lu, Yanyu; Zhao, Li; Li, Hongfang			Preventative effects of resveratrol and estradiol on streptozotocin-induced diabetes in ovariectomized mice and the related mechanisms	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; INSULIN-RESISTANCE; OXIDATIVE STRESS; VASCULAR RESPONSIVENESS; HOMA-IR; GLUCOSE; MUSCLE; HYPERGLYCEMIA; PROTECTION; SECRETION	Resveratrol, a non-flavonoid polyphenolic compound, is structurally and functionally similar to estrogen and has drawn great attention for its potentially beneficial effects on diabetes. However, it is not known whether it shares the same protective effect against diabetes as estrogen and the underlying mechanisms. The aim of the present study was to investigate the protective effects of phytoestrogen resveratrol and exogenous 17 beta-estradiol against streptozotocin (STZ)-induced type 1 diabetes. Female mice were ovariectomized (OVX) and chronically injected with different concentrations of resveratrol (0.1, 1 or 10 mg/kg) and 17 beta-estradiol (0.01, 0.1 or 1 mg/kg) subcutaneously for 4 weeks, and the levels of blood glucose, plasma insulin, plasma antioxidant capacity, the changes of pancreatic islet cells and the expressions of glucose transporter 4 (GLUT4), insulin receptor substrate 1 (IRS-1) and phosphorylation of extracellular signal-regulated kinase (p-ERK) were detected. Resveratrol and 17 beta-estradiol significantly inhibited the increase of the blood glucose level and the rise of plasma malondialdehyde in STZ-induced diabetic mice, improved the levels of plasma antioxidant capacity and plasma insulin, protected the pancreatic islet cells, and increased the expressions of GLUT4 and IRS-1, but decreased p-ERK expression in skeletal muscle and myocardial tissue. The results suggest that resveratrol or 17 beta-estradiol shows obvious protection against STZ-induced diabetes in OVX mice, the mechanisms probably involve their ameliorating antioxidant activities and islet function, promoting muscle glucose uptake and inhibiting the expression of p-ERK.	[Li, Yunxia; Huang, Jinbing; Yan, Yuan; Liang, Jingjing; Liang, Qiankun; Zhao, Li; Li, Hongfang] Lanzhou Univ, Coll Basic Med, Dept Physiol, Lanzhou, Gansu, Peoples R China; [Lu, Yanyu] Lanzhou Univ, Funct Lab Coll Basic Med, Lanzhou, Gansu, Peoples R China; [Li, Hongfang] Key Lab Preclin Study New Drugs Gansu Prov, Lanzhou, Gansu, Peoples R China	Lanzhou University; Lanzhou University	Li, HF (corresponding author), Lanzhou Univ, Coll Basic Med, Dept Physiol, Lanzhou, Gansu, Peoples R China.; Li, HF (corresponding author), Key Lab Preclin Study New Drugs Gansu Prov, Lanzhou, Gansu, Peoples R China.	lihf@lzu.edu.cn			Administration of Traditional Chinese Medicine of Gansu Province [GZK-2015-238]	Administration of Traditional Chinese Medicine of Gansu Province	Funding was provided by the Administration of Traditional Chinese Medicine of Gansu Province (grant # GZK-2015-238) to HL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Acconcia F, 2017, MOL CELL ENDOCRINOL, V457, P3, DOI 10.1016/j.mce.2016.10.033; Alvim RO, 2015, AN ACAD BRAS CIENC, V87, P351, DOI 10.1590/0001-3765201520140225; ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; Arrick DM, 2011, AM J PHYSIOL-HEART C, V301, pH696, DOI 10.1152/ajpheart.00312.2011; Ates O, 2007, J CLIN NEUROSCI, V14, P256, DOI 10.1016/j.jocn.2005.12.010; Borissova AM, 2002, GYNECOL ENDOCRINOL, V16, P67, DOI 10.1080/713602987; Briaud I, 2003, DIABETES, V52, P974, DOI 10.2337/diabetes.52.4.974; Brussaard HE, 1997, ARTERIOSCL THROM VAS, V17, P324, DOI 10.1161/01.ATV.17.2.324; Carlson CJ, 2003, DIABETES, V52, P634, DOI 10.2337/diabetes.52.3.634; Catanuto P, 2009, 17 BETA ESTRADIOL TA, V75, P1194, DOI [10.1038/ki.2009.69, DOI 10.1038/KI.2009.69]; Catanuto Paola, 2017, Curr Trends Endocinol, V9, P19; Cetkovic-Cvrlje M, 2017, J IMMUNOTOXICOL, V14, P160, DOI 10.1080/1547691X.2017.1334722; Chang CC, 2012, CHINESE J PHYSIOL, V55, P192, DOI [10.4077/CJP.2011.BAA012, 10.4077/CJP.2012.BAA012]; Chen KH, 2011, AM J PHYSIOL-ENDOC M, V301, pE853, DOI 10.1152/ajpendo.00048.2011; Chi TC, 2007, LIFE SCI, V80, P1713, DOI 10.1016/j.lfs.2007.02.002; Choi J, 2018, NUTRIENTS, V10, DOI 10.3390/nu10010051; Barros RPD, 2008, MOL CELL ENDOCRINOL, V295, P24, DOI 10.1016/j.mce.2008.07.008; Deng JY, 2008, DIABETES, V57, P1814, DOI 10.2337/db07-1750; Do GM, 2012, MOL NUTR FOOD RES, V56, P1282, DOI 10.1002/mnfr.201200067; Ekladous D, 2008, CLIN EXP PHARMACOL P, V35, P971, DOI 10.1111/j.1440-1681.2008.04944.x; FRODIN M, 1995, J BIOL CHEM, V270, P7882, DOI 10.1074/jbc.270.14.7882; Gencoglu H, 2015, INT J FOOD SCI NUTR, V66, P314, DOI 10.3109/09637486.2014.1003534; Kara A, 2014, GYNECOL ENDOCRINOL, V30, P226, DOI 10.3109/09513590.2013.864270; Li HF, 2006, PHYSIOL RES, V55, P365, DOI 10.33549/physiolres.930826; Mossmann M, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0085-5; Nadal A, 2009, MOL CELL ENDOCRINOL, V304, P63, DOI 10.1016/j.mce.2009.02.016; Nakhjavani M, 2014, J DIABETES METAB DIS, V13, DOI 10.1186/s40200-014-0102-5; Negi G, 2011, J PINEAL RES, V50, P124, DOI 10.1111/j.1600-079X.2010.00821.x; Opara EC, 2002, J R SOC PROMO HEALTH, V122, P28, DOI 10.1177/146642400212200112; Ordonez P, 2008, J STEROID BIOCHEM, V111, P287, DOI 10.1016/j.jsbmb.2008.07.001; Palsamy P, 2008, BIOMED PHARMACOTHER, V62, P598, DOI 10.1016/j.biopha.2008.06.037; Palsamy P, 2011, BBA-MOL BASIS DIS, V1812, P719, DOI 10.1016/j.bbadis.2011.03.008; Prasannarong M, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-28; Rahavi H, 2017, J IMMUNOTOXICOL, V14, P160; Roghani M, 2010, PHYTOTHER RES, V24, pS148, DOI 10.1002/ptr.3032; Santos RS, 2017, BIOL SEX DIFFER, V8, DOI 10.1186/s13293-017-0151-9; Schindler CE, 2014, AM J PHYSIOL-REG I, V307, pR434, DOI 10.1152/ajpregu.00123.2014; Shen KP, 2018, KAOHSIUNG J MED SCI, V34, P142, DOI 10.1016/j.kjms.2017.11.003; Silan C, 2008, BIOL PHARM BULL, V31, P897, DOI 10.1248/bpb.31.897; Stenbit AE, 1997, NAT MED, V3, P1096, DOI 10.1038/nm1097-1096; Stubbins RE, 2012, EUR J NUTR, V51, P861, DOI 10.1007/s00394-011-0266-4; Su HC, 2006, AM J PHYSIOL-ENDOC M, V290, pE1339, DOI 10.1152/ajpendo.00487.2005; Szkudelska K, 2010, EUR J PHARMACOL, V635, P1, DOI 10.1016/j.ejphar.2010.02.054; Szkudelski T, 2015, BBA-MOL BASIS DIS, V1852, P1145, DOI 10.1016/j.bbadis.2014.10.013; Tang Q, 2015, DRUG DISCOV THER, V9, P380, DOI 10.5582/ddt.2015.01207; Vogel H, 2013, HORM METAB RES, V45, P430, DOI 10.1055/s-0032-1331700; Wang M, 2018, J DIABETES INVEST, V9, P762, DOI 10.1111/jdi.12775; Wang Q, 2008, DIABETOLOGIA, V51, P1202, DOI 10.1007/s00125-008-1026-8; Wang WZ, 2016, NAT MED, V22, P54, DOI 10.1038/nm.3983; Whitcroft Sovra, 2011, Menopause Int, V17, P24, DOI 10.1258/mi.2011.011003; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; Yan CF, 2016, MOL ENDOCRINOL, V30, P600, DOI 10.1210/me.2015-1277; Yoh K, 2008, GENES CELLS, V13, P1159, DOI 10.1111/j.1365-2443.2008.01234.x; Yoshihara E, 2016, CELL METAB, V23, P622, DOI 10.1016/j.cmet.2016.03.005; Zhang JY, 2012, DIABETES RES CLIN PR, V97, P474, DOI 10.1016/j.diabres.2012.02.029; Zhou YQ, 2015, GASTROENT RES PRACT, V2015, DOI 10.1155/2015/506390	57	14	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204499	10.1371/journal.pone.0204499	http://dx.doi.org/10.1371/journal.pone.0204499			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273360	gold, Green Published, Green Submitted			2022-12-26	WOS:000446124700024
J	Pollini, S; Di Pilato, V; Landini, G; Di Maggio, T; Cannatelli, A; Sottotetti, S; Cariani, L; Aliberti, S; Blasi, F; Sergio, F; Rossolini, GM; Pallecchi, L				Pollini, Simona; Di Pilato, Vincenzo; Landini, Giulia; Di Maggio, Tiziana; Cannatelli, Antonio; Sottotetti, Samantha; Cariani, Lisa; Aliberti, Stefano; Blasi, Francesco; Sergio, Francesco; Rossolini, Gian Maria; Pallecchi, Lucia			In vitro activity of N-acetylcysteine against Stenotrophomonas maltophilia and Burkholderia cepacia complex grown in planktonic phase and biofilm	PLOS ONE			English	Article							LUNG TRANSPLANTATION; CYSTIC-FIBROSIS; RESISTANCE; INFECTION; PATHOGENS; MODEL	Stenotrophomonas maltophilia and Burkholderia cepacia complex (Bcc) have been increasingly recognized as relevant pathogens in hospitalized, immunocompromised and cystic fibrosis (CF) patients. As a result of complex mechanisms, including biofilm formation and multidrug resistance phenotype, S. maltophilia and Bcc respiratory infections are often refractory to therapy, and have been associated with a worse outcome in CF patients. Here we demonstrate for the first time that N-acetylcysteine (NAC), a mucolytic agent with antioxidant and anti-inflammatory properties, may exhibit antimicrobial and antibiofilm activity against these pathogens. The antimicrobial and antibiofilm activity of high NAC concentrations, potentially achievable by topical administration, was tested against a collection of S. maltophilia (n = 19) and Bcc (n = 19) strains, including strains from CF patients with acquired resistance traits. Minimum Inhibitory Concentrations (MICs) and Minimum Bactericidal Concentrations (MBCs) ranged from 16 to 32 mg/ml and from 32 to >32 mg/ml, respectively. Sub-MIC concentrations (i.e., 0.25 x MIC) slowed down the growth kinetics of most strains. In time-kill assays, 2-day-old biofilms were more affected than planktonic cultures, suggesting a specific antibiofilm activity of NAC against these pathogens. Indeed, a dose- and time-dependent antibiofilm activity of NAC against most of the S. maltophilia and Bcc strains tested was observed, with a sizable antibiofilm activity observed also at 0.5 and 1 x MIC NAC concentrations. Furthermore, at those concentrations, NAC was also shown to significantly inhibit biofilm formation with the great majority of tested strains.	[Pollini, Simona; Di Pilato, Vincenzo; Rossolini, Gian Maria] Univ Florence, Dept Expt & Clin Med, Florence, Italy; [Landini, Giulia; Di Maggio, Tiziana; Cannatelli, Antonio; Pallecchi, Lucia] Univ Siena, Dept Med Biotechnol, Siena, Italy; [Sottotetti, Samantha; Cariani, Lisa] Osped Maggiore Policlin, Cyst Fibrosis Microbiol Lab, IRCCS Fdn Ca Granda, Milan, Italy; [Aliberti, Stefano; Blasi, Francesco] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy; [Aliberti, Stefano; Blasi, Francesco] Osped Maggiore Policlin, IRCCS Fdn Ca Granda, Internal Med Dept, Resp Unit, Milan, Italy; [Aliberti, Stefano; Blasi, Francesco] Osped Maggiore Policlin, IRCCS Fdn Ca Granda, Reg Adult Cyst Fibrosis Ctr, Milan, Italy; [Sergio, Francesco] Zambon SpA, Global Resp Med Affairs, Bresso, Italy; [Rossolini, Gian Maria] Florence Careggi Univ Hosp, Clin Microbiol & Virol Unit, Florence, Italy	University of Florence; University of Siena; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico; Zambon; University of Florence; Azienda Ospedaliero Universitaria Careggi	Pallecchi, L (corresponding author), Univ Siena, Dept Med Biotechnol, Siena, Italy.	lucia.pallecchi@unisi.it	Aliberti, Stefano/K-9115-2016; Pollini, Simona/D-1709-2017; Aliberti, Stefano/AAL-8032-2021; Pallecchi, Lucia/S-7193-2018; Di Pilato, Vincenzo/K-1182-2018; Blasi, Francesco/O-5885-2017	Aliberti, Stefano/0000-0002-0090-4531; Aliberti, Stefano/0000-0002-0090-4531; Pallecchi, Lucia/0000-0001-7999-5140; Di Pilato, Vincenzo/0000-0002-5863-5805; Blasi, Francesco/0000-0002-2285-9970	Zambon S.p.A.	Zambon S.p.A.	This work was funded by a research grant from Zambon S.p.A. FS is employed at Corporate Respiratory Medical Affairs, Zambon S.p.A. Zambon S.p.A. provided support in the form of salary for author FS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the "author contributions" section.	Abbott IJ, 2015, SEMIN RESP CRIT CARE, V36, P99, DOI 10.1055/s-0034-1396929; Amaral EP, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0872-7; Bach E, 2017, PATHOG DIS, V75, DOI 10.1093/femspd/ftx076; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Barsky EE, 2017, PEDIATR PULM, V52, P1276, DOI 10.1002/ppul.23781; Blasi F, 2016, RESP MED, V117, P190, DOI 10.1016/j.rmed.2016.06.015; Chang YT, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00893; Chiew AL, 2016, BRIT J CLIN PHARMACO, V81, P471, DOI 10.1111/bcp.12789; CLSI, 1999, M26A CLIN LAB STAND; Domenech M, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.01992-16; Eroshenko D, 2017, MICROB PATHOGENESIS, V105, P145, DOI 10.1016/j.micpath.2017.02.030; Esposito A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01590; Ferris RA, 2016, J CLIN MICROBIOL, V54, P631, DOI 10.1128/JCM.02861-15; Gautam V, 2015, EXPERT REV ANTI-INFE, V13, P629, DOI 10.1586/14787210.2015.1025056; Goswami M, 2010, ANTIMICROB AGENTS CH, V54, P3529, DOI 10.1128/AAC.00710-10; Harrison JJ, 2010, NAT PROTOC, V5, P1236, DOI 10.1038/nprot.2010.71; Landini G, 2016, ANTIMICROB AGENTS CH, V60, P7513, DOI 10.1128/AAC.01334-16; Lewis ERG, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw070; Mata AF, 2013, PEDIATRICS, V132, pE1418, DOI 10.1542/peds.2013-0912; Parkins MD, 2015, J CYST FIBROS, V14, P293, DOI 10.1016/j.jcf.2015.03.012; Payne GW, 2005, APPL ENVIRON MICROB, V71, P3917, DOI 10.1128/AEM.71.7.3917-3927.2005; Rodriguez-Beltran J, 2015, ANTIMICROB AGENTS CH, V59, P3246, DOI 10.1128/AAC.00017-15; SAMBROOK J, 2000, MOL CLONING LAB MANU; Samuni Y, 2013, BBA-GEN SUBJECTS, V1830, P4117, DOI 10.1016/j.bbagen.2013.04.016; Scoffone VC, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01592; Snell G, 2017, J CYST FIBROS, V16, P553, DOI 10.1016/j.jcf.2017.06.008; Volgers C, 2017, FEMS MICROBIOL LETT, V364, DOI 10.1093/femsle/fnx087; Wang RB, 2018, CLIN TRANSPLANT, V32, DOI 10.1111/ctr.13236; Waters V, 2013, J CYST FIBROS, V12, P482, DOI 10.1016/j.jcf.2012.12.006; Zhao TM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-140	31	22	22	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0203941	10.1371/journal.pone.0203941	http://dx.doi.org/10.1371/journal.pone.0203941			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273348	Green Published, gold			2022-12-26	WOS:000446124700009
J	Doyle, AM; Floyd, S; Baisley, K; Orindi, B; Kwaro, D; Mthiyane, TN; Muuo, S; Shahmanesh, M; Ziraba, A; Birdthistle, I				Doyle, Aoife M.; Floyd, Sian; Baisley, Kathy; Orindi, Benedict; Kwaro, Daniel; Mthiyane, Thandiwe N.; Muuo, Sheru; Shahmanesh, Maryam; Ziraba, Abdhalah; Birdthistle, Isolde			Who are the male sexual partners of adolescent girls and young women? Comparative analysis of population data in three settings prior to DREAMS roll-out	PLOS ONE			English	Article							AGE-DISPARATE RELATIONSHIPS; HIV-INFECTION; SOUTH-AFRICA; LIKOMA ISLAND; RISK; PREVALENCE; PROFILE; ACQUISITION; EPIDEMICS; BEHAVIOR	Background The DREAMS (Determined Resilient Empowered AIDS-free, Mentored and Safe) Partnership aims to reduce HIV incidence among adolescent girls and young women (AGYW,15-24y) with a core package of evidence-based interventions. Some interventions, including voluntary HIV counselling and testing and circumcision, will be targeted at the male sexual partners of AGYW. A priority of DREAMS is to characterise the male partners for effective targeting. Methods Using population-based data (2010-2015) in three DREAMS impact evaluation settings in Kenya and South Africa, we describe the demographic characteristics and sexual behaviour of male partners reported by AGYW, and the characteristics of males who report sexual activity with AGYW. Results In all settings, over 90% of recent male partners reported by AGYW were aged <35 years. Median ages of spousal and non-spousal partners were 29 and 23 years respectively in uMkhanyakude (rural South Africa) and 21 and 20 years respectively in Nairobi (urban Kenya). Most males reporting an AGYW partner had never been married (89%) and many were in school (39%). Most male partners reported only 1 AGYW partner in the past year; in Gem (rural Kenya) and Nairobi 25%-29% reported 2+(AGYW or older female) partners. Concurrent partners were reported by 16% of male partners in Gem and 3-4% in uMkhanyakude. Two thirds of male partners in Gem reported testing for HIV in the past 6 months and under half in uMkhanyakude reported testing for HIV in the past year. Almost all (96%) partners in Nairobi were circumcised, compared to 45% in Gem and 43% in uMkhanyakude. Conclusions With almost all AGYW's sexual partners aged 15-34 years, this is an appropriate target group for DREAMS interventions. Encouraging young men to reduce their number of partners and concurrency, and uptake prevention and treatment services such as HIV testing, circumcision and ART is crucial in the effort to reduce HIV among both AGYW and young men.	[Doyle, Aoife M.; Floyd, Sian; Baisley, Kathy] London Sch Hyg & Trop Med, Dept Infect Dis, MRC Trop Epidemiol Grp, London, England; [Baisley, Kathy; Mthiyane, Thandiwe N.; Shahmanesh, Maryam] African Hlth Res Inst, Kwa Zulu, South Africa; [Orindi, Benedict; Muuo, Sheru; Ziraba, Abdhalah] African Populat & Hlth Res Ctr, Nairobi, Kenya; [Orindi, Benedict] Katholieke Univ Leuven, Leuven, Belgium; [Kwaro, Daniel] Kenya Govt Med Res Ctr, Gem, Siaya County, Kenya; [Shahmanesh, Maryam] UCL, London, England; [Birdthistle, Isolde] London Sch Hyg & Trop Med, Dept Populat Hlth, London, England	University of London; London School of Hygiene & Tropical Medicine; African Population & Health Research Centre; KU Leuven; Kenya Medical Research Institute; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine	Doyle, AM (corresponding author), London Sch Hyg & Trop Med, Dept Infect Dis, MRC Trop Epidemiol Grp, London, England.	aoife.doyle@lshtm.ac.uk	Ziraba, Abdhalah/T-3707-2019; Doyle, Aoife/AAX-3525-2020	Doyle, Aoife/0000-0002-3305-7738; Kwaro, Daniel/0000-0002-0929-8072; Orindi, Benedict/0000-0002-4601-7890; Ziraba, Abdhalah/0000-0002-3417-6536; Shahmanesh, Maryam/0000-0001-7129-8535	Wellcome Trust [082384/Z/07/Z, GR 07830 M]; Bill and Melinda Gates Foundation [OPP1136774]	Wellcome Trust(Wellcome TrustEuropean Commission); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Africa Health Research Institute is supported by a grant from the Wellcome Trust (082384/Z/07/Z). The Transitions-To-Adulthood study was part of a larger project on Urbanization, Poverty and Health Dynamics, that was funded by the Wellcome Trust (Grant Number GR 07830 M). The impact evaluation of DREAMS, including these analyses for baseline data, is funded by the Bill and Melinda Gates Foundation (OPP1136774). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akullian A, 2017, AIDS, V31, P1755, DOI [10.1097/QAD.0000000000001553, 10.1097/qad.0000000000001553]; Balkus JE, 2015, JAIDS-J ACQ IMM DEF, V70, P212, DOI 10.1097/QAI.0000000000000715; Beauclair R, 2016, SCI REP-UK, V6, DOI 10.1038/srep36121; Beguy D, 2015, INT J EPIDEMIOL, V44, P462, DOI 10.1093/ije/dyu251; Beguy D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101034; Biraro S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055060; de Oliveira T, 2017, LANCET HIV, V4, pE41, DOI 10.1016/S2352-3018(16)30186-2; Doyle AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182567; Evans M, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.21310; Glynn JR, 2001, AIDS, V15, pS51, DOI 10.1097/00002030-200108004-00006; Hallman Kelly P S, 2016, ASERT METHOD REVEALS; Harling G, 2017, BMC MED RES METHODOL, V17, DOI 10.1186/s12874-017-0403-8; Harling G, 2014, JAIDS-J ACQ IMM DEF, V66, P443, DOI 10.1097/QAI.0000000000000198; Helleringer S, 2007, AIDS, V21, P2323, DOI 10.1097/QAD.0b013e328285df98; Hewett PC, 2004, SEX TRANSM INFECT, V80, P43, DOI 10.1136/sti.2004.013250; Hosegood V, 2009, DEMOGR RES, V20, P279, DOI 10.4054/DemRes.2009.20.13; Iwuji CC, 2018, LANCET HIV, V5, pE116, DOI 10.1016/S2352-3018(17)30205-9; Kripke K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156776; Larmarange J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123345; Madise NJ, 2012, HEALTH PLACE, V18, P1144, DOI 10.1016/j.healthplace.2012.04.003; Mah TL, 2010, AIDS BEHAV, V14, P11, DOI 10.1007/s10461-008-9433-x; Mah TL, 2010, AIDS BEHAV, V14, P25, DOI 10.1007/s10461-009-9617-z; Mathur S, 2015, JAIDS-J ACQ IMM DEF, V69, P75, DOI 10.1097/QAI.0000000000000539; Maughan-Brown B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159162; Mavedzenge SN, 2011, J ADOLESCENT HEALTH, V49, P559, DOI 10.1016/j.jadohealth.2011.02.012; McGrath N, 2015, LANCET HIV, V2, pE252, DOI 10.1016/S2352-3018(15)00045-4; Nnko S, 2004, SOC SCI MED, V59, P299, DOI 10.1016/j.socscimed.2003.10.031; Odhiambo FO, 2012, INT J EPIDEMIOL, V41, P977, DOI 10.1093/ije/dys108; PEPFAR, 2015, PREV HIV AD GIRLS YO; Pettifor AE, 2004, AIDS, V18, P1435, DOI 10.1097/01.aids.0000131338.61042.b8; Phillips AE, 2010, INT J EPIDEMIOL, V39, P1541, DOI 10.1093/ije/dyq114; Plummer ML, 2011, LEXINGTON BOOKS, V2011; Program TD, 2015, DHS MOD QUEST PHAS 7; Reniers G, 2016, INT J EPIDEMIOL, V45, P83, DOI 10.1093/ije/dyv343; Rositch AF, 2012, INT J STD AIDS, V23, P468, DOI 10.1258/ijsa.2012.011361; Schaefer R, 2017, AIDS, V31, P1461, DOI [10.1097/qad.0000000000001506, 10.1097/QAD.0000000000001506]; Statistics KNBo, 2009, POP HOUS CHAR KENYA; Swartzendruber A, 2013, SEX TRANSM DIS, V40, P372, DOI 10.1097/OLQ.0b013e318283d2c9; Tanser F, 2008, INT J EPIDEMIOL, V37, P956, DOI 10.1093/ije/dym211; Tanser F, 2011, LANCET, V378, P247, DOI 10.1016/S0140-6736(11)60779-4; UNAIDS, 2016, GET FAST TRACK LIFE; WHO, 2017, GLOB ACC ACT HLTH AD	42	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0198783	10.1371/journal.pone.0198783	http://dx.doi.org/10.1371/journal.pone.0198783			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV3OT	30265667	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000446005500001
J	Middendorf, M; Wieseke, N				Middendorf, Martin; Wieseke, Nicolas			A strict upper bound for the partition distance and the cluster distance of phylogenetic trees for each fixed pair of topological trees	PLOS ONE			English	Article								For each given pair of (rooted or unrooted) topological trees with the same number of leaves a strict upper bound is shown for the tree partition distance (also called symmetric difference metric and Robinson-Foulds distance)-in case of unrooted trees-and for the cluster distance (also called Robinson-Foulds distance)-in case of rooted trees-of corresponding phylogenetic trees. In particular, it is shown that there exist assignments of labels (e.g., species) to the leaves of both topological tree where each label is assigned to exactly one leaf in each tree such that: i) in the unrooted case, the tree partition distance between the corresponding phylogenetic trees equals the number of internal edges in both trees minus the number of nodes with degree 2 in both trees, ii) in the rooted case, the cluster distance between any two corresponding phylogenetic trees equals the number of internal edges in both trees minus the number of nodes with degree 2 in both trees, and iii) the values in (i) and (ii) are also the maximum values with respect to all possible assignments. The shown strict worst case bounds are needed as normalization factor to compute a normalized version of the respective tree partition metrics.	[Middendorf, Martin; Wieseke, Nicolas] Univ Leipzig, Fac Math & Comp Sci, Swarm Intelligence & Complex Syst Grp, Leipzig, Germany	Leipzig University	Middendorf, M (corresponding author), Univ Leipzig, Fac Math & Comp Sci, Swarm Intelligence & Complex Syst Grp, Leipzig, Germany.	middendorf@informatik.uni-leipzig.de	Middendorf, Martin/AAF-6805-2019	Middendorf, Martin/0000-0002-5426-1092				Bogdanowicz D, 2012, EVOL BIOINFORM, V8, P475, DOI 10.4137/EBO.S9657; Bourque M., 1978, THESIS; Bryant D, 2009, IEEE ACM T COMPUT BI, V6, P420, DOI 10.1109/TCBB.2009.32; Geoghegan JL, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006215; Gorecki P., 2012, LECT NOTES COMPUTER, V7292, P115; Guillerme T, 2016, MOL PHYLOGENET EVOL, V94, P146, DOI 10.1016/j.ympev.2015.08.023; HENDY MD, 1984, SIAM J APPL MATH, V44, P1054, DOI 10.1137/0144075; Ho SYW, 2015, MOL ECOL RESOUR, V15, P688, DOI 10.1111/1755-0998.12320; Kupczok A, 2010, ALGORITHM MOL BIOL, V5, DOI 10.1186/1748-7188-5-37; PENNY D, 1985, SYST ZOOL, V34, P75, DOI 10.2307/2413347; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; Robinson DF, 1979, LECT NOTES MATH, V748, P119, DOI DOI 10.1007/BFB0102678; Steel M. A., 1988, SIAM J DISCRETE MATH, V1, P541, DOI DOI 10.1137/0401050; STEEL MA, 1993, SYST BIOL, V42, P126, DOI 10.2307/2992536; Weyenberg G, 2016, ENCY EVOLUTIONARY BI, V3, P285	15	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204907	10.1371/journal.pone.0204907	http://dx.doi.org/10.1371/journal.pone.0204907			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265723	Green Published, Green Submitted, gold			2022-12-26	WOS:000446005500054
J	Hankel, J; Popp, J; Meemken, D; Zeiger, K; Beyerbach, M; Taube, V; Klein, G; Visscher, C				Hankel, Julia; Popp, Johanna; Meemken, Diana; Zeiger, Katrin; Beyerbach, Martin; Taube, Venja; Klein, Guenter; Visscher, Christian			Influence of lauric acid on the susceptibility of chickens to an experimental Campylobacter jejuni colonisation	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; PALM KERNEL; THERMOPHILIC CAMPYLOBACTER; INTESTINAL COLONIZATION; BROILER-CHICKENS; RISK-ASSESSMENT; ORGANIC-ACIDS; CAPRYLIC-ACID; COCONUT OILS; INFECTION	Among the organic acids, lauric acid has shown a high level of in vitro activity against Campylobacter jejuni. The prevalence and intensity of C. jejuni excretion at slaughter often becomes lower with increasing age. In higher-aged broilers on organic farms which often use other breeds, in turn, the prevalence of C. jejuni is sometimes higher at slaughter. The question then arises as to whether a diet with higher lauric acid concentrations, the age alone or the genetic breed might have an effect in the spread and intensity of an experimental C. jejuni infection in vivo. Therefore, two complete diets with or without 2% lauric acid from palm kernel fatty acids were offered to 450 chickens (ten subgroups a 15 birds, repetitions: n = 3) of two broiler and two layer breeds (Ross 308, Hubbard JA 757, Lohmann Dual and Lohmann Brown-Classic). All breeds were reared for 42 days, Lohmann Brown-Classic also for about 98 days. Twenty-one days before dissection, three seeder birds per subgroup were orally infected with a 1 mL inoculum of C. jejuni (4.46 +/- 0.35 log(10) CFU/mL). Qualitative detection of C. jejuni in cloacal swabs was performed at days 2, 4, 7, 14 after inoculation and at dissection in all birds. Quantitative detection was performed on excreta samples of seeder birds at days 2, 11 and 17 after experimental challenge and on caecal samples of all birds at dissection. Two days after experimental inoculation, C. jejuni prevalence was higher in control birds without lauric acid supplementation (48.9% vs. 39.6%; P = 0.0462). Depending on age, two days after inoculation the C. jejuni prevalence in young Lohmann Brown Classic chickens was significantly lower (37.8% vs. 61.1%) whereas at dissection it was higher (99% vs. 67%). At day 2 after inoculation C. jejuni counts in the excreta of young Lohmann Brown-Classic were lower in comparison to those in old ones (log(10) CFU/g: 3.30 +/- 2.68 vs. 5.24 +/- 1.56). Eleven (log(10) CFU/g: 5.14 +/- 1.13 vs. 4.16 +/- 0.82) and 17 days after inoculatioin (logioCFU/g: 3.77 +/- 2.02 vs. 1.72 +/- 1.87) it was the reverse situation. At dissection, the carriage of C. jejuni in caecal content was higher in younger than in older birds (log(10) CFU/g: 8.57 +/- 0.46 vs. 6.66 +/- 1.43). An effect of genetic breed on C. jejuni prevalence was seen at dissection, this being lowest in Lohmann Dual chickens (91% vs. 98.9% in other breeds). At d 17 after challenge, C. jejunicounts in the excreta of young Lohmann Brown-Classic were lower in comparison to Ross 308 and Hubbard JA 757 (logio CFU/g: 3.77 +/- 2.02 vs. 5.21 +/- 0.85 and 5.62 +/- 0.90). Lohmann Dual chickens showed an intermediary excretion, this being only significant lower compared to Hubbard JA 757 (log(10) CFU/g: 4.31 +/- 0.89). In summary, the effect of lauric acid is limited to the initial phase after experimental inoculation. A higher age at infection seems to lead to a more rapid limitation of the infection. The excretion of C. jejuni appears to decrease more rapidly in layer breeds than in broiler lines after experimental inoculation.	[Hankel, Julia; Visscher, Christian] Univ Vet Med Hannover, Inst Anim Nutr, Hannover, Germany; [Popp, Johanna; Meemken, Diana; Zeiger, Katrin; Klein, Guenter] Univ Vet Med Hannover, Inst Food Qual & Food Safety, Hannover, Germany; [Meemken, Diana] Free Univ Berlin, Inst Food Safety & Food Hyg, Berlin, Germany; [Beyerbach, Martin] Univ Vet Med Hannover, Inst Biometry Epidemiol & Informat Proc, Hannover, Germany; [Taube, Venja] BEST 3 Gefluegelernaehrung GmbH, Twistringen, Germany	University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; Free University of Berlin; University of Veterinary Medicine Hannover, Foundation	Visscher, C (corresponding author), Univ Vet Med Hannover, Inst Anim Nutr, Hannover, Germany.	christian.visscher@tiho-hannover.de		Hankel, Julia/0000-0002-4347-3161	University of Veterinary Medicine Hannover, Foundation; Deutsche Forschungsgemeinschaft; Ahrberg-Foundation	University of Veterinary Medicine Hannover, Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ahrberg-Foundation	C.F. Visscher, J. Popp, D. Meemken got the grant representative for the University of Veterinary Medicine Hannover, Foundation. The Ahrberg-Foundation provided support in the form of salaries for authors [J.H.; K.Z.], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This publication was supported by Deutsche Forschungsgemeinschaft and University of Veterinary Medicine Hannover, Foundation within the funding programme Open Access Publishing. The specific roles of these authors are articulated in the 'author contributions' section. V.T. is an employee of the BEST 3 Gefluegelernaehrung GmbH, Germany. The BEST 3 Gefluegelernaehrung GmbH provided support in the form of salaries for authors [V.T.], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. For the investigations the resources at the University of Veterinary Medicine Hannover, Foundation were used. Reagents, materials and other analysis tools were funded by the Ahrberg-Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Ahrberg-Foundation for the financial support of the investigations.; This publication was supported by Deutsche Forschungsgemeinschaft and University of Veterinary Medicine Hannover, Foundation within the funding programme Open Access Publishing.	Abd El-Wahab A, 2013, POULTRY SCI, V92, P629, DOI 10.3382/ps.2012-02614; BEERY JT, 1988, APPL ENVIRON MICROB, V54, P2365, DOI 10.1128/AEM.54.10.2365-2370.1988; Bouwknegt M, 2004, PREV VET MED, V62, P35, DOI 10.1016/j.prevetmed.2003.09.003; Boyd Y, 2005, IMMUNOGENETICS, V57, P248, DOI 10.1007/s00251-005-0790-6; CAVE NAG, 1982, POULTRY SCI, V61, P1147, DOI 10.3382/ps.0611147; Colles FM, 2009, ENVIRON MICROBIOL, V11, P258, DOI 10.1111/j.1462-2920.2008.01773.x; Coward C, 2008, APPL ENVIRON MICROB, V74, P3857, DOI 10.1128/AEM.02835-07; Cox NA, 2009, POULTRY SCI, V88, P2449, DOI 10.3382/ps.2009-00195; de los Santos FS, 2009, POULTRY SCI, V88, P61, DOI 10.3382/ps.2008-00228; Devleesschauwer B, 2017, CAMPYLOBACTER: FEATURES, DETECTION, AND PREVENTION OF FOODBORNE DISEASE, P27, DOI 10.1016/B978-0-12-803623-5.00002-2; Evans SJ, 2000, PREV VET MED, V46, P209, DOI 10.1016/S0167-5877(00)00143-4; EVANS SJ, 1992, VET REC, V131, P574; Fanatico AC, 2007, POULTRY SCI, V86, P2245, DOI 10.1093/ps/86.10.2245; GfE, 1999, REC EN NUTR SUPPL LA; GLUNDER G, 1995, BERL MUNCH TIERARZTL, V108, P101; Guerin MT, 2010, POULTRY SCI, V89, P1070, DOI 10.3382/ps.2009-00213; Han ZF, 2016, GUT PATHOG, V8, DOI 10.1186/s13099-016-0133-1; Han ZF, 2016, DEV COMP IMMUNOL, V62, P58, DOI 10.1016/j.dci.2016.04.020; Hanel I, 2008, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, V51, P1347, DOI 10.1007/s00103-008-0705-4; HARRIS NV, 1986, AM J PUBLIC HEALTH, V76, P407, DOI 10.2105/AJPH.76.4.407; Havelaar AH, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001923; Hermans D, 2010, POULTRY SCI, V89, P1144, DOI 10.3382/ps.2010-00717; Heuer OE, 2001, LETT APPL MICROBIOL, V33, P269, DOI 10.1046/j.1472-765X.2001.00994.x; Hovorkova P, 2015, FOODBORNE PATHOG DIS, V12, P712, DOI 10.1089/fpd.2015.1978; HUGDAHL MB, 1988, INFECT IMMUN, V56, P1560, DOI 10.1128/IAI.56.6.1560-1566.1988; Humphrey S, 2014, MBIO, V5, DOI 10.1128/mBio.01364-14; Jansen W, 2014, J APPL MICROBIOL, V116, P1676, DOI 10.1111/jam.12490; Kaakoush NO, 2015, CLIN MICROBIOL REV, V28, P687, DOI 10.1128/CMR.00006-15; Kirk MD, 2015, PLOS MED, V12, DOI [10.1371/journal.pmed.1001921, 10.1371/journal.pmed.1001940]; Lawes JR, 2012, EPIDEMIOL INFECT, V140, P1725, DOI 10.1017/S0950268812000982; LEPAGE G, 1986, J LIPID RES, V27, P114; Li X, 2008, POULTRY SCI, V87, P1742, DOI 10.3382/ps.2008-00136; Luangtongkum T, 2006, APPL ENVIRON MICROB, V72, P3600, DOI 10.1128/AEM.72.5.3600-3607.2006; Makela P, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3129; Middelkoop K. van, 2002, World Poultry, V18, P20; Molatova Z, 2010, FOLIA MICROBIOL, V55, P215, DOI 10.1007/s12223-010-0031-8; Montagne L, 2004, NUTR REV, V62, P105, DOI [10.1301/nr.2004.mar.105-114, 10.1111/j.1753-4887.2004.tb00031.x]; Nandi S, 2005, ENZYME MICROB TECH, V36, P725, DOI 10.1016/j.enzmictec.2004.12.016; Naumann C., 2012, BIOCHEMISCHE UNTERSU; Nauta MJ, 2016, MICROB RISK ANAL, V2-3, P68, DOI 10.1016/j.mran.2016.02.001; Newell DG, 2003, APPL ENVIRON MICROB, V69, P4343, DOI 10.1128/AEM.69.8.4343-4351.2003; Northcutt JK, 2003, POULTRY SCI, V82, P169, DOI 10.1093/ps/82.1.169; Ratert C, 2015, AVIAN DIS, V59, P74, DOI 10.1637/10890-062414-Reg; RECK RA, 1985, J AM OIL CHEM SOC, V62, P355, DOI 10.1007/BF02541405; Reich F, 2008, INT J FOOD MICROBIOL, V127, P116, DOI 10.1016/j.ijfoodmicro.2008.06.018; Robyn J, 2013, POULTRY SCI, V92, P1408, DOI 10.3382/ps.2012-02863; Romero-Barrios P, 2013, FOOD CONTROL, V29, P343, DOI 10.1016/j.foodcont.2012.05.043; Rosenquist H, 2006, INT J FOOD MICROBIOL, V108, P226, DOI 10.1016/j.ijfoodmicro.2005.12.007; Rosenquist H, 2003, INT J FOOD MICROBIOL, V83, P87, DOI 10.1016/S0168-1605(02)00317-3; SCHOENI JL, 1992, APPL ENVIRON MICROB, V58, P664, DOI 10.1128/AEM.58.2.664-670.1992; SKIRROW MB, 1977, BRIT MED J, V2, P9, DOI 10.1136/bmj.2.6078.9; SKIRROW MB, 1991, INT J FOOD MICROBIOL, V12, P9, DOI 10.1016/0168-1605(91)90044-P; Stern NJ, 2003, J FOOD PROTECT, V66, P1557, DOI 10.4315/0362-028X-66.9.1557; STERN NJ, 1995, POULTRY SCI, V74, P937, DOI 10.3382/ps.0740937; STERN NJ, 1990, AVIAN DIS, V34, P602, DOI 10.2307/1591251; Udayamputhoor RS, 2003, CAN J VET RES, V67, P204; van der Most PJ, 2011, FUNCT ECOL, V25, P74, DOI 10.1111/j.1365-2435.2010.01800.x; Van Deun K, 2008, AVIAN PATHOL, V37, P379, DOI 10.1080/03079450802216603; Van Deun K, 2008, VET MICROBIOL, V130, P285, DOI 10.1016/j.vetmic.2007.11.027; van Gerwe T, 2010, VET MICROBIOL, V143, P314, DOI 10.1016/j.vetmic.2009.11.029; Vervuert I, 2005, J ANIM PHYSIOL AN N, V89, P140, DOI 10.1111/j.1439-0396.2005.00534.x; Weber R, 2014, BERL MUNCH TIERARZTL, V127, P257, DOI 10.2376/0005-9366-127-257; WELKOS SL, 1984, J MED MICROBIOL, V18, P233, DOI 10.1099/00222615-18-2-233; YOUNG FVK, 1983, J AM OIL CHEM SOC, V60, P374, DOI 10.1007/BF02543521; Young KT, 2007, NAT REV MICROBIOL, V5, P665, DOI 10.1038/nrmicro1718; Zeiger K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175693	66	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204483	10.1371/journal.pone.0204483	http://dx.doi.org/10.1371/journal.pone.0204483			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30261072	Green Published, gold, Green Submitted			2022-12-26	WOS:000445907400058
J	Jabbari, M; Fakheri, BA; Aghnoum, R; Nezhad, NM; Ataei, R				Jabbari, Mitra; Fakheri, Barat Ali; Aghnoum, Reza; Nezhad, Nafiseh Mahdi; Ataei, Reza			GWAS analysis in spring barley (Hordeum vulgare L.) for morphological traits exposed to drought	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; GENOME-WIDE ASSOCIATION; LINKAGE DISEQUILIBRIUM; POPULATION-STRUCTURE; COMPLEX TRAITS; WILD BARLEY; GENETIC DISSECTION; TERMINAL DROUGHT; STRESS TOLERANCE; POWDERY MILDEW	Association analysis based on linkage disequilibrium has become a common and powerful approach for detection of QTLs underlying complex agronomic traits including drought tolerance. To determine marker/trait association, 148 modern European spring barley cultivars were evaluated under drought stress. Associations of morphological traits with AFLP/SSR markers were investigated based on the mixed linear model using the TASSEL(3.0). Population structure was estimated using various methods including Bayesian clustering model by STRUCTURE software, PCoA analysis, NJ dendrogram and Hierarchical Clustering. Linkage disequilibrium patterns were explored among the whole genome and each chromosome separately. All the analysis for population structure divided the population into two subgroups. Linkage disequilibrium analysis showed that by increasing genetic distance, LD decreases. Totally, 167 significant marker trait associations were found which delineated into 65 QTLs in both treatments. Two stable QTLs on 5H at 86.880 cM were detected for Internode Length and on 3H at 126.421 cM for flag leaf length in drought stress treatment. Fourteen QTLs were co-localized with previously reported QTLs and others were novel. The results indicate that these putative genomic regions contain genes that have pleiotropic effects on morphological traits in drought condition.	[Jabbari, Mitra; Fakheri, Barat Ali; Nezhad, Nafiseh Mahdi] Univ Zabol, Fac Agr, Dept Plant Breeding & Biotechnol, Zabol, Sistan & Baluch, Iran; [Aghnoum, Reza] AREEO, Khorasan Razavi Agr & Nat Resources Res & Educ Ct, Seed & Plant Improvement Res Dept, Mashhad, Iran; [Ataei, Reza] AREEO, Seed & Plant Improvement Inst, Karaj, Iran		Jabbari, M (corresponding author), Univ Zabol, Fac Agr, Dept Plant Breeding & Biotechnol, Zabol, Sistan & Baluch, Iran.	Jabbari.mitra2@gmail.com	fakheri, barat ali/AAH-8039-2020	Ataei, Reza/0000-0002-6320-0662; jabbari, mitra/0000-0003-4316-4489				Aghnoum R, 2010, MOL PLANT MICROBE IN, V23, P91, DOI 10.1094/MPMI-23-1-0091; Ahmad MQ, 2014, INT J AGRIC BIOL, V16, P862; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bates B.C., 2008, TECHNICAL PAPER INTE, DOI DOI 10.1016/J.JMB.2010.08.039; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Buckler ES, 2006, CURR OPIN PLANT BIOL, V9, P172, DOI 10.1016/j.pbi.2006.01.013; Burke JM, 2007, CURR OPIN GENET DEV, V17, P525, DOI 10.1016/j.gde.2007.09.003; Caldwell KS, 2006, GENETICS, V172, P557, DOI 10.1534/genetics.104.038489; Chan EKF, 2010, GENETICS, V185, P991, DOI 10.1534/genetics.109.108522; Chen C. X., 2011, Journal of Plant Sciences, V6, P66, DOI 10.3923/jps.2011.66.76; Chen GX, 2010, GENET RESOUR CROP EV, V57, P85, DOI 10.1007/s10722-009-9453-z; Close TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-582; Collins NC, 2008, PLANT PHYSIOL, V147, P469, DOI 10.1104/pp.108.118117; Comadran J, 2011, THEOR APPL GENET, V122, P1363, DOI 10.1007/s00122-011-1537-4; del Pozo A, 2012, ANN APPL BIOL, V160, P157, DOI 10.1111/j.1744-7348.2011.00528.x; Devlin B, 2004, NAT GENET, V36, P1129, DOI 10.1038/ng1104-1129; Druka A, 2011, PLANT PHYSIOL, V155, P617, DOI 10.1104/pp.110.166249; Ersoz E.S., 2007, GENOMICS ASSISTED CR, P97, DOI DOI 10.1007/978-1-4020-6295-7_5; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Fan Y, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1243-8; Ferrio JP, 2011, CABI CLIM CHANGE SER, V2, P1, DOI 10.1079/9781845936808.0001; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Francia E, 2005, PLANT CELL TISS ORG, V82, P317, DOI 10.1007/s11240-005-2387-z; Franckowiak J.D., 1997, BARLEY GENET NEWSL, V26, P9; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Griffin TJ, 2000, TRENDS BIOTECHNOL, V18, P77, DOI 10.1016/S0167-7799(99)01401-8; Grunewald TGP, 2015, NAT GENET, V47, P1073, DOI 10.1038/ng.3363; Gulcher J, 2012, COLD SPRING HARB PRO, V4, P425; Gupta PK, 2005, PLANT MOL BIOL, V57, P461, DOI 10.1007/s11103-005-0257-z; Gupta Pushpendra Kumar, 2007, Journal of Zhejiang University-Science B, V8, P807, DOI 10.1631/jzus.2007.B0807; Gyenis L, 2007, GENOME, V50, P714, DOI 10.1139/G07-054; Hall D, 2010, BRIEF FUNCT GENOMICS, V9, P157, DOI 10.1093/bfgp/elp048; Haseneyer G, 2010, PLANT BREEDING, V129, P271, DOI 10.1111/j.1439-0523.2009.01725.x; Inostroza L, 2009, MOL BREEDING, V23, P365, DOI 10.1007/s11032-008-9239-6; Jacobsen SE, 2012, FIELD CROP RES, V128, P34, DOI 10.1016/j.fcr.2011.12.001; Kalladan R, 2013, MOL BREEDING, V32, P71, DOI 10.1007/s11032-013-9853-9; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kraakman ATW, 2006, MOL BREEDING, V17, P41, DOI 10.1007/s11032-005-1119-8; Kraakman ATW, 2004, GENETICS, V168, P435, DOI 10.1534/genetics.104.026831; Krill AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009958; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Liu LP, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0187-y; Lobell DB, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/1/014002; Maccaferri M, 2005, MOL BREEDING, V15, P271, DOI 10.1007/s11032-004-7012-z; Maccaferri M, 2011, J EXP BOT, V62, P409, DOI 10.1093/jxb/erq287; Malosetti M, 2011, THEOR APPL GENET, V122, P1605, DOI 10.1007/s00122-011-1558-z; Malysheva-Otto LV, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-6; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Mansour E, 2014, MOL BREEDING, V33, P249, DOI 10.1007/s11032-013-9946-5; MELCHINGER AE, 1994, CROP SCI, V34, P1191, DOI 10.2135/cropsci1994.0011183X003400050009x; Mora F, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0264-y; Murchie EH, 2009, NEW PHYTOL, V181, P532, DOI 10.1111/j.1469-8137.2008.02705.x; Naz T, 2012, PAK J BOT, V44, P1467; Ochieng JW, 2007, AFR J BIOTECHNOL, V6, P650; Pasam RK, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-16; Peterhansel C, 2008, PHOTOCHEM PHOTOBIOL, V84, P1317, DOI 10.1111/j.1751-1097.2008.00427.x; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK, 2010, DOCUMENTATION STRUCT; Rafalski JA, 2010, CURR OPIN PLANT BIOL, V13, P174, DOI 10.1016/j.pbi.2009.12.004; Rostoks N, 2006, P NATL ACAD SCI USA, V103, P18656, DOI 10.1073/pnas.0606133103; Roy JK, 2010, MOL BREEDING, V26, P243, DOI 10.1007/s11032-010-9402-8; Sanguineti MC, 2007, ANN APPL BIOL, V151, P291, DOI 10.1111/j.1744-7348.2007.00198.x; Sato K, 2009, THEOR APPL GENET, V119, P613, DOI 10.1007/s00122-009-1071-9; Schmalenbach I, 2008, THEOR APPL GENET, V117, P1093, DOI 10.1007/s00122-008-0847-7; Semenov MA, 2009, J EXP BOT, V60, P2791, DOI 10.1093/jxb/erp164; Setter TL, 2011, J EXP BOT, V62, P701, DOI 10.1093/jxb/erq308; Soutar D., 2011, INTRO GENSTAT WINDOW; Stich B, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-94; Stracke S, 2007, GENETICS, V175, P805, DOI 10.1534/genetics.106.063800; Tondelli A, 2006, THEOR APPL GENET, V112, P445, DOI 10.1007/s00122-005-0144-7; Wang JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090144; Wehner GG, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0524-3; Wenzl P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-206; Wojcik-Jagla M, 2013, THEOR APPL GENET, V126, P3021, DOI 10.1007/s00122-013-2190-x; Yu JM, 2006, CURR OPIN BIOTECH, V17, P155, DOI 10.1016/j.copbio.2006.02.003; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang LY, 2009, THEOR APPL GENET, V119, P43, DOI 10.1007/s00122-009-1015-4; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhou GF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133161; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089; Zoric M, 2012, GENETICA, V140, P259, DOI 10.1007/s10709-012-9677-2	84	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204952	10.1371/journal.pone.0204952	http://dx.doi.org/10.1371/journal.pone.0204952			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30261061	Green Submitted, Green Published, gold			2022-12-26	WOS:000445907400115
J	Ravarotto, V; Carraro, G; Pagnin, E; Bertoldi, G; Simioni, F; Maiolino, G; Martinato, M; Landini, L; Davis, PA; Calo, LA				Ravarotto, Verdiana; Carraro, Gianni; Pagnin, Elisa; Bertoldi, Giovanni; Simioni, Francesca; Maiolino, Giuseppe; Martinato, Matteo; Landini, Linda; Davis, Paul A.; Calo, Lorenzo A.			Oxidative stress and the altered reaction to it in Fabry disease: A possible target for cardiovascular-renal remodeling?	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; ENZYME REPLACEMENT THERAPY; RHO-KINASE-ACTIVITY; HYPERTENSIVE PATIENTS; GITELMANS SYNDROMES; MECHANISMS; PROTEIN; GLOBOTRIAOSYLCERAMIDE; INFLAMMATION; CROSSTALK	Background Fabry disease is characterized by deficient expression/activity of alpha-GalA with consequent lysosomal accumulation in various organs of its substrate Gb3. Despite enzyme replacement therapy, Fabry disease progresses with serious myocardial, cerebral and renal manifestations. Gb3 accumulation may induce oxidative stress (OxSt), production of inflammatory cytokines and reduction of nitric oxide, which may impact on Fabry disease's clinical manifestations. Methods OxSt status was characterized in 10 patients compared with 10 healthy subjects via protein expression of p22 phox, subunit of NADH/NADPH oxidase, (Western blot), Heme oxygenase (HO)-1 levels (ELISA), antioxidant/anti-inflammatory, lipid peroxidation as malondialdehyde (MDA) production (colorimetric assay), phosphorylation state of Extracellular Signal Regulated Kinase (ERK) 1/2 and Myosin Phosphatase Target Protein (MYPT)-1 (Western blot), marker of Rho kinase activation, both involved in OxSt signaling. Cardiac left ventricular (LV) mass was also evaluated (M-mode echocardiography). Results LV mass was higher in Fabry's males (123.72 +/- 2.03 SEMg/m(2)) and females (132.09 +/- 6.72 g/m(2)). p22(phox) expression was also higher in patients (1.04 +/- 0.09 d.u. vs 0.54 +/- 0.05 d.u. p<0.01) as well as MDA levels (54.51 +/- 3.97 vs 30.05 +/- 7.11 nmol/mL p = 0.01) while HO-1 was reduced (8.84 +/- 0.79 vs 14.03 +/- 1.23 ng/mL, p<0.02). MYPT-1's phosphorylation was increased in patients (0.52 +/- 0.11 d.u. vs 0.03 +/- 0.08 d.u., p<0.01) while phosphorylation of ERK1/2 was reduced (0.91 +/- 0.08 d.u. vs 1.53 +/- 0.17 d.u., p = 0.004). Conclusions This study documents OxSt activation and the altered reaction to it in Fabry patients. Cardiac remodeling, Rho kinase signaling activation and reduction of protective HO-1 might suggest that, in addition to enzyme replacement therapy, OxSt inhibition by either pharmacological or nutritional measures, is likely to prove useful for the prevention/treatment of Fabry patients' cardiovascular-renal remodeling.	[Ravarotto, Verdiana; Carraro, Gianni; Pagnin, Elisa; Bertoldi, Giovanni; Simioni, Francesca; Calo, Lorenzo A.] Univ Padua, Dept Med, Nephrol, Padua, Italy; [Maiolino, Giuseppe] Univ Padua, Dept Med, Hypertens, Padua, Italy; [Martinato, Matteo] Padua Univ Hosp, Clin Res Unit, Padua, Italy; [Landini, Linda] Med Affairs Sanofi Genzyme, Milan, Italy; [Davis, Paul A.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA	University of Padua; University of Padua; University of Padua; Azienda Ospedaliera - Universita di Padova; Sanofi-Aventis; Genzyme Corporation; University of California System; University of California Davis	Calo, LA (corresponding author), Univ Padua, Dept Med, Nephrol, Padua, Italy.	renzcalo@unipd.it	Ravarotto, Verdiana/AAH-5150-2021; Bertoldi, Giovanni/AAS-9315-2020; Calò, Lorenzo/AAC-9123-2019; Martinato, Matteo/D-2951-2019	Bertoldi, Giovanni/0000-0001-6498-6671; Martinato, Matteo/0000-0001-8875-1738; Ravarotto, Verdiana/0000-0002-9393-9791; landini, luigi/0000-0002-2534-2651; maiolino, giuseppe/0000-0001-6050-1155	Sanofi Genzyme; DOR fund	Sanofi Genzyme(Sanofi-AventisGenzyme Corporation); DOR fund	This study was supported in part by an unrestricted grant from Sanofi Genzyme and by an institutional DOR fund to L.A.C. There was no additional external funding received for this study. Linda Landini is employed by Sanofi-Genzyme. The funder provided support in the form of salaries for author L.L., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the 'author contributions' section	Ayala A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/360438; Biancini GB, 2012, BBA-MOL BASIS DIS, V1822, P226, DOI 10.1016/j.bbadis.2011.11.001; Biancini GB, 2016, CLIN CHIM ACTA, V461, P41, DOI 10.1016/j.cca.2016.07.016; Calo LA, 2015, J ENDOCRINOL INVEST, V38, P711, DOI 10.1007/s40618-015-0249-z; Calo LA, 2007, J HYPERTENS, V25, P259, DOI 10.1097/HJH.0b013e328010d4d2; Calo LA, 2016, LIFE SCI, V148, P80, DOI 10.1016/j.lfs.2016.02.019; Calo LA, 2014, J HYPERTENS, V32, P2109, DOI 10.1097/HJH.0000000000000321; Calo LA, 2014, CLIN NUTR, V33, P437, DOI 10.1016/j.clnu.2013.06.010; Calo LA, 2014, J HYPERTENS, V32, P331, DOI 10.1097/HJH.0000000000000075; Choi JY, 2016, BIOCHEM BIOPH RES CO, V470, P907, DOI 10.1016/j.bbrc.2016.01.152; Gabrielli L, 2014, AM J HYPERTENS, V27, P838, DOI 10.1093/ajh/hpt234; Germain DP, 2016, NEW ENGL J MED, V375, P545, DOI 10.1056/NEJMoa1510198; Germain DP, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-30; Girotti AW, 1998, J LIPID RES, V39, P1529; Harrison D, 2003, AM J CARDIOL, V91, p7A; Hilgers KF, 2002, J HYPERTENS, V20, P593, DOI 10.1097/00004872-200204000-00010; Kim S, 2000, PHARMACOL REV, V52, P11; Kim YM, 2011, ANTIOXID REDOX SIGN, V14, P137, DOI 10.1089/ars.2010.3153; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Locatelli F, 2003, NEPHROL DIAL TRANSPL, V18, P1272, DOI 10.1093/ndt/gfg074; Marchesoni CL, 2010, J PEDIATR-US, V156, P828, DOI 10.1016/j.jpeds.2010.02.012; McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1775, DOI 10.1089/ars.2006.8.1775; Nath KA, 2001, KIDNEY INT, V59, P106, DOI 10.1046/j.1523-1755.2001.00471.x; Noma K, 2012, J CARDIOL, V60, P1, DOI 10.1016/j.jjcc.2012.03.005; Rombach SM, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-47; Shu LM, 2014, KIDNEY INT, V86, P58, DOI 10.1038/ki.2013.520; Sirker A, 2007, AM J NEPHROL, V27, P649, DOI 10.1159/000109148; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Yasunari K, 2002, HYPERTENSION, V39, P777, DOI 10.1161/hy0302.104670	29	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204618	10.1371/journal.pone.0204618	http://dx.doi.org/10.1371/journal.pone.0204618			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30261035	gold, Green Submitted, Green Published			2022-12-26	WOS:000445907400079
J	Zhou, Y; Jiao, SW; Li, NN; Grace, J; Yang, M; Lu, C; Geng, XM; Zhu, XW; Zhang, L; Lei, GC				Zhou, Yan; Jiao, Shengwu; Li, Nana; Grace, John; Yang, Meng; Lu, Cai; Geng, Xuemeng; Zhu, Xinwei; Zhang, Li; Lei, Guangchun			Impact of plateau pikas (Ochotona curzoniae) on soil properties and nitrous oxide fluxes on the Qinghai-Tibetan Plateau	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; ALPINE MEADOWS; ORGANIC-MATTER; LITTORAL-ZONE; N2O EMISSIONS; CARBON; METHANE; CASTS	This paper demonstrates the impact of an endemic fossorial animal, plateau pika (Ochotona curzoniae), on soil properties and N2O flux at the Zoige Wetland. Pika burrow and control sites without disturbance by pika were selected to measure the soil water content, bulk density, soil organic matter (SOM), NH4-N content and NO3-N content in August 2012. N2O fluxes were measured with static opaque chambers at these sites in June and August 2012. Pika burrowing altered soil aeration by transferring deeper soil to the surface and by constructing underground burrows, which significantly increased bulk density, and reduced soil water content, SOM and NH4-N content at 0-10 cm and 10-20 cm soil depth. N2O flux had a significant correlation with bulk density, SOM and NH4-N content. Pika burrowing significantly influenced N2O flux by increasing N2O flux at the control site from near zero to 0.063 +/- 0.011 mg m(-2) h(-1). Our findings described how pika burrowing influences the soil traits and significantly increases the principal greenhouse gas N2O emission. As plateau pika was commonly considered as a pest, our findings give a novel clue to effectively manage populations of plateau pika on the Qinghai-Tibet Plateau from the perspective of greenhouse gas emission.	[Zhou, Yan] Nanjing Forestry Univ, Coll Biol & Environm, Southern Modern Forestry Collaborat Innovat Ctr, Nanjing, Jiangsu, Peoples R China; [Zhou, Yan; Jiao, Shengwu; Li, Nana; Yang, Meng; Lu, Cai; Geng, Xuemeng; Lei, Guangchun] Beijing Forestry Univ, Sch Nat Conservat, Beijing, Peoples R China; [Jiao, Shengwu] Chinese Acad Forestry, Res Inst Subtrop Forestry, Fuyang, Peoples R China; [Grace, John] Univ Edinburgh, Sch Geosci, Edinburgh, Midlothian, Scotland; [Zhu, Xinwei; Zhang, Li] Aba Prefecture Res Inst Forestry Sci & Technol, Aba, Peoples R China	Nanjing Forestry University; Beijing Forestry University; Chinese Academy of Forestry; Research Institute of Subtropical Forestry, CAF; University of Edinburgh	Lei, GC (corresponding author), Beijing Forestry Univ, Sch Nat Conservat, Beijing, Peoples R China.	leiguangchunbjfu@gmail.com	Guangchun, Lei/ABC-8081-2021; Grace, John/N-9280-2013	Zhou, Yan/0000-0003-1774-7402	China National Forestry Public Welfare Fund [200804005]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	China National Forestry Public Welfare Fund; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This research was supported by China National Forestry Public Welfare Fund (No. 200804005) and Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Audet J, 2013, ECOL ENG, V57, P170, DOI 10.1016/j.ecoleng.2013.04.021; Brown JR, 2012, BIOGEOCHEMISTRY, V109, P85, DOI 10.1007/s10533-011-9655-2; Burgos M, 2015, SCI TOTAL ENVIRON, V503, P179, DOI 10.1016/j.scitotenv.2014.06.038; Chen H, 2011, ENVIRON MONIT ASSESS, V182, P545, DOI 10.1007/s10661-011-1896-y; Chen H, 2009, ATMOS ENVIRON, V43, P4995, DOI 10.1016/j.atmosenv.2009.07.001; Davidson AD, 2012, FRONT ECOL ENVIRON, V10, P477, DOI 10.1890/110054; Du YG, 2008, PLANT SOIL, V311, P245, DOI 10.1007/s11104-008-9727-9; ELLIOTT PW, 1991, BIOL FERT SOILS, V11, P24, DOI 10.1007/BF00335829; Hartmann DL, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P159; Heincke M, 1999, NUTR CYCL AGROECOSYS, V55, P133, DOI 10.1023/A:1009842011599; Hogan B. W., 2010, THESIS; Huang XY, 2013, CHEM ECOL, V29, P529, DOI 10.1080/02757540.2013.790382; HUDSON BD, 1994, J SOIL WATER CONSERV, V49, P189; Kurek P, 2014, ECOL RES, V29, P1, DOI 10.1007/s11284-013-1094-1; Lan T, 2013, PLANT SOIL, V371, P611, DOI 10.1007/s11104-013-1721-1; Lavelle P, 1997, EUR J SOIL BIOL, V33, P159; Li Wenjing, 2006, Acta Theriologica Sinica, V26, P331; Lipiec J, 2015, SOIL TILL RES, V145, P55, DOI 10.1016/j.still.2014.08.010; Liu Wei, 2010, Acta Theriologica Sinica, V30, P35; Liu YS, 2013, PLANT SOIL, V366, P491, DOI 10.1007/s11104-012-1442-x; Lu X, 2005, OBSERVATION METHODS; Lubbers IM, 2013, NAT CLIM CHANGE, V3, P187, DOI [10.1038/NCLIMATE1692, 10.1038/nclimate1692]; Luo Yand, 2006, SOIL RESP ENV; Martin Greg, 2003, Ecological Management & Restoration, V4, P114, DOI 10.1046/j.1442-8903.2003.00145.x; Myhre G. D., 2013, CLIMATE CHANGE 2013, DOI [10.1017/c bo9781107415324.018, DOI 10.1017/CBO9781107415324.018]; Qin Y, 2015, ECOL ENG, V84, P287, DOI 10.1016/j.ecoleng.2015.09.012; Qu JP, 2013, MAMM BIOL, V78, P68, DOI 10.1016/j.mambio.2012.09.005; Semenov MV, 2010, EURASIAN SOIL SCI+, V43, P541, DOI 10.1134/S1064229310050078; Smith AT, 1999, ANIM CONSERV, V2, P235, DOI 10.1111/j.1469-1795.1999.tb00069.x; Smith AT, 2018, INTEGRATIVE ZOOLOGY; Sun FeiDa, 2010, Journal of Arid Land Resources and Environment, V24, P181; Tan X, 2007, SOIL TILL RES, V93, P77, DOI 10.1016/j.still.2006.03.017; Wei XH, 2007, CHINESE GEOGR SCI, V17, P75, DOI 10.1007/s11769-007-0075-0; Yang M, 2015, BIOGEOSCIENCES, V12, P4711, DOI 10.5194/bg-12-4711-2015; Yoshihara Y, 2010, PLANT ECOL, V206, P211, DOI 10.1007/s11258-009-9636-x; Yu C, 2017, GEODERMA, V307, P98, DOI 10.1016/j.geoderma.2017.07.041; Zhang R. Z., 1999, ZOOGEOGRAPHY CHINA; Zhang W, 2014, SOIL BIOL BIOCHEM, V71, P105, DOI 10.1016/j.soilbio.2014.01.005; Zhou Huakun, 2005, Grassland Science, V51, P191, DOI 10.1111/j.1744-697X.2005.00028.x; Zhou MH, 2017, GLOBAL CHANGE BIOL, V23, P4068, DOI 10.1111/gcb.13648; Zhou Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115542	41	5	5	10	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0203691	10.1371/journal.pone.0203691	http://dx.doi.org/10.1371/journal.pone.0203691			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30260971	Green Submitted, Green Published, gold			2022-12-26	WOS:000445907400014
J	Dong, W; Liu, XJ; Li, DL; Gao, TX; Song, YG				Dong, Wei; Liu, Xijiang; Li, Donglei; Gao, Tianxue; Song, Yuguang			Transcriptional profiling reveals that a MYB transcription factor MsMYB4 contributes to the salinity stress response of alfalfa	PLOS ONE			English	Article							MEDICAGO-SATIVA L.; SALT-STRESS; GENE-EXPRESSION; RNA-SEQ; TOLERANCE; WHEAT; BIOSYNTHESIS	MYB transcription factors are important regulators of the plant response to abiotic stress. Their participation in the salinity stress of the key forage legume species alfalfa (Medicago sativa) was investigated here by comparing the transcriptomes of the two cultivars Dryland (DL) and Sundory (SD), which differed with respect to their ability to tolerate salinity stress. When challenged by the stress, DL plants were better able than SD ones to scavenge reactive oxygen species. A large number of genes encoding transcription regulators, signal transducers and proteins involved in both primary and secondary metabolism were differentially transcribed in the two cultivars, especially when plants were subjected to salinity stress. The set of induced genes included 17 MYB family of transcription factors, all of which were subsequently isolated. The effect of constitutively expressing these genes on the salinity tolerance expressed by Arabidopsis thaliana was investigated. The introduction of MsMYB4 significantly increased the plants' salinity tolerance in an abscisic acid-dependent manner. A sub-cellular localization experiment and a transactivation assay indicated that MsMYB4 was deposited in the nucleus and was able to activate transcription in yeast. Based on this information, we propose that the MsMYB4 products is likely directly involved in alfalfa's response to salinity stress.	[Dong, Wei; Liu, Xijiang; Li, Donglei; Gao, Tianxue; Song, Yuguang] Qufu Normal Univ, Sch Life Sci, Qufu, Shandong, Peoples R China	Qufu Normal University	Song, YG (corresponding author), Qufu Normal Univ, Sch Life Sci, Qufu, Shandong, Peoples R China.	SYG-0423@163.com		Yuguang, Song/0000-0003-3132-6639	National Natural Science Foundation of China [31501328, 31300220]; Natural Science Foundation of Shandong [ZR2015JL012]; Postdoctoral Science Foundation of China [2014M550366]; Science and Technology Project of the Qufu Normal University [XKJ201320]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong(Natural Science Foundation of Shandong Province); Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); Science and Technology Project of the Qufu Normal University	This project was supported by the National Natural Science Foundation of China (grant nos. 31501328, 31300220); the Natural Science Foundation of Shandong (ZR2015JL012); the Postdoctoral Science Foundation of China (2014M550366), and the Science and Technology Project of the Qufu Normal University (XKJ201320). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An YM, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00931; Behr M, 2015, INT J MOL SCI, V16, P16104, DOI 10.3390/ijms160716104; Chao YH, 2009, MOL BIOL REP, V36, P2315, DOI 10.1007/s11033-009-9450-5; Choudhury FK, 2017, PLANT J, V90, P856, DOI 10.1111/tpj.13299; Cominelli E, 2005, CURR BIOL, V15, P1196, DOI 10.1016/j.cub.2005.05.048; Du H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037463; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Feller A, 2011, PLANT J, V66, P94, DOI 10.1111/j.1365-313X.2010.04459.x; Feng CP, 2004, PLANT SCI, V167, P1099, DOI 10.1016/j.plantsci.2004.06.014; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo R, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0546-x; Haga N, 2007, DEVELOPMENT, V134, P1101, DOI 10.1242/dev.02801; Ismail AM, 2017, ANNU REV PLANT BIOL, V68, P405, DOI 10.1146/annurev-arplant-042916-040936; Kang YH, 2009, PLANT CELL, V21, P1080, DOI 10.1105/tpc.108.063180; Kim JH, 2013, J PLANT PHYSIOL, V170, P1461, DOI 10.1016/j.jplph.2013.05.011; Kumar V, 2018, PLANT CELL REP, V37, P61, DOI 10.1007/s00299-017-2210-4; Lei YT, 2018, BMC PLANT BIOL, V18, DOI 10.1186/s12870-018-1250-4; Lei YT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181589; Liao Y, 2008, CELL RES, V18, P1047, DOI 10.1038/cr.2008.280; Liu WX, 2016, PLANT CELL REP, V35, P561, DOI 10.1007/s00299-015-1903-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu WJ, 2014, PLANT PHYSIOL BIOCH, V76, P17, DOI 10.1016/j.plaphy.2013.12.013; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Paul D, 2014, AGRON SUSTAIN DEV, V34, P737, DOI 10.1007/s13593-014-0233-6; Postnikova OA, 2013, PLANT CELL PHYSIOL, V54, P1041, DOI 10.1093/pcp/pct056; Qiu NW, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091953; Radovic J., 2009, Biotechnology in Animal Husbandry, V25, P465; Shelton D, 2012, PLANT PHYSIOL, V159, P531, DOI 10.1104/pp.112.194753; Shu YJ, 2017, GENET MOL BIOL, V40, P824, DOI [10.1590/1678-4685-gmb-2017-0053, 10.1590/1678-4685-GMB-2017-0053]; Song YG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041274; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; Stracke R, 2007, PLANT J, V50, P660, DOI 10.1111/j.1365-313X.2007.03078.x; Surget-Groba Y, 2010, GENOME RES, V20, P1432, DOI 10.1101/gr.103846.109; Tohge T, 2018, PHYTOCHEM REV, V17, P279, DOI 10.1007/s11101-017-9531-3; Vaidyanathan H, 2003, PLANT SCI, V165, P1411, DOI 10.1016/j.plantsci.2003.08.005; Wang BaoPing, 2013, Acta Agrestia Sinica, V21, P1124; Wang T, 2015, PLANT PHYSIOL, V169, P1027, DOI 10.1104/pp.15.00962; Wang YX, 2013, MOL BIOL REP, V40, P6451, DOI 10.1007/s11033-013-2760-7; Wang YJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192382; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Yu YH, 2017, BIOCHEM BIOPH RES CO, V491, P642, DOI 10.1016/j.bbrc.2017.07.150; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0; Zhu N, 2015, PLANT SCI, V236, P146, DOI 10.1016/j.plantsci.2015.03.023	44	19	22	4	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2018	13	9							e0204033	10.1371/journal.pone.0204033	http://dx.doi.org/10.1371/journal.pone.0204033			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU9BO	30252877	Green Published, gold, Green Submitted			2022-12-26	WOS:000445639700025
J	Huang, CLC; Wu, MP; Ho, CH; Wang, O				Huang, Charles Lung-Cheng; Wu, Ming-Ping; Ho, Chung-Han; Wang, Jhi-Joung			Risks of treated anxiety, depression, and insomnia among nurses: A nationwide longitudinal cohort study	PLOS ONE			English	Article							HEALTH-CARE; FEMALE NURSES; WORK STRESS; SHIFT WORK; SYMPTOMS; SEEKING; SOMATIZATION; BARRIERS; BURNOUT; USAGE	The high level of occupational stress and burnout among nurses can lead to insomnia, anxiety, and depression. However, the actual risks for healthcare-seeking for these stress-related mental health problems among nurses are still unclear. The aim of this study was to explore the risks and influencing factors of treated anxiety, depression, and insomnia among nurses. We used claims data obtained from the 2010 National Health Insurance Research Database (NHIRD) in Taiwan. Hospital nurses who had at least 3 coded ambulatory care claims or 1 inpatient claim with a principal diagnosis of anxiety, depression, or insomnia were identified. A cohort of 46,120 nurses and 92,240 matched controls were included. All the study subjects were followed up until the onset of any of the aforementioned outcomes, death, or the end of 2012. Results showed that the adjusted hazard ratios (HRs) for treated anxiety, depression, and insomnia among all the nurses were 0.91 (95% CI, 0.88-0.95), 0.59 (95% CI, 0.55-0.63), and 1.43 (95% CI, 1.38-1.48), respectively. Furthermore, the risks of these psychiatric problems in healthcare-seeking nurses were affected by age, gender, hospital level, and job tenure. Our findings suggest that hospital nurses have lower hazards of treated anxiety and depression than the general population, although they have a higher hazard of treated insomnia. There may be undertreatment in some subgroups of nurses with different demographic and working characteristics.	[Huang, Charles Lung-Cheng] Chi Mei Med Ctr, Dept Psychiat, Tainan, Taiwan; [Huang, Charles Lung-Cheng] Chia Nan Univ Pharm & Sci, Dept Social Work, Tainan, Taiwan; [Wu, Ming-Ping] Chi Mei Med Ctr, Dept Obstet & Gynecol, Div Urogynecol & Pelv Floor Reconstruct, Tainan, Taiwan; [Wu, Ming-Ping] Chia Nan Univ Pharm & Sci, Ctr Gen Educ, Tainan, Taiwan; [Ho, Chung-Han] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Ho, Chung-Han; Wang, Jhi-Joung] Chia Nan Univ Pharm & Sci, Dept Hosp & Hlth Care Adm, Tainan, Taiwan	Chi Mei Hospital; Chia Nan University of Pharmacy & Science; Chi Mei Hospital; Chia Nan University of Pharmacy & Science; Chi Mei Hospital; Chia Nan University of Pharmacy & Science	Huang, CLC (corresponding author), Chi Mei Med Ctr, Dept Psychiat, Tainan, Taiwan.; Huang, CLC (corresponding author), Chia Nan Univ Pharm & Sci, Dept Social Work, Tainan, Taiwan.	psychidr@gmail.com		Ho, Chung-Han/0000-0001-5925-8477	Chi Mei Foundation Hospital, Tainan, Taiwan [CMFHR10270]	Chi Mei Foundation Hospital, Tainan, Taiwan	This work was supported in part by grants CMFHR10270 from Chi Mei Foundation Hospital, Tainan, Taiwan (http://www.chimei.org.tw/main/cmh_department/top/54000_index.html) (M-PW). The sponsor had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the article.	Anbazhagan Surekha, 2016, Indian J Occup Environ Med, V20, P35, DOI 10.4103/0019-5278.183842; Cares A, 2015, SUBST ABUS, V36, P59, DOI 10.1080/08897077.2014.933725; Chen PJ, 2017, SLEEP MED, V38, P122, DOI 10.1016/j.sleep.2017.07.016; Cheung T, 2015, INT J ENV RES PUB HE, V12, P11072, DOI 10.3390/ijerph120911072; Chiang YM, 2012, HEALTH POLICY, V108, P149, DOI 10.1016/j.healthpol.2012.08.027; Chou LP, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004185; Futenma K, 2015, SLEEP MED, V16, P604, DOI 10.1016/j.sleep.2014.11.018; Galbraith ND, 2014, NURS FORUM, V49, P171, DOI 10.1111/nuf.12066; Halter Margaret J, 2004, J Psychosoc Nurs Ment Health Serv, V42, P42; Hernandez SHA, 2016, NURS RES, V65, P481, DOI 10.1097/NNR.0000000000000182; Hsieh ML, 2011, NURS HEALTH SCI, V13, P468, DOI 10.1111/j.1442-2018.2011.00641.x; Huang CLC, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001323; Johnson J, 2017, J ADV NURS, V73, P1667, DOI 10.1111/jan.13251; Jung HS, 2016, WORK, V54, P93, DOI 10.3233/WOR-162283; Karanikola MNK, 2016, REV ESC ENFERM USP, V50, P800, DOI [10.1590/S0080-623420160000600013, 10.1590/s0080-623420160000600013]; Khamisa N, 2013, INT J ENV RES PUB HE, V10, P2214, DOI 10.3390/ijerph10062214; KLEINMAN AM, 1977, SOC SCI MED, V11, P3, DOI 10.1016/0037-7856(77)90138-X; Lee HY, 2016, J NURS MANAGE, V24, P192, DOI 10.1111/jonm.12298; Li SC, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010829; Lin HS, 2010, J CLIN NURS, V19, P2342, DOI 10.1111/j.1365-2702.2010.03216.x; Lin TC, 2016, J CLIN NURS, V25, P1120, DOI 10.1111/jocn.13119; Michie S, 2003, OCCUP ENVIRON MED, V60, P3, DOI 10.1136/oem.60.1.3; Park SC, 2015, AUST NZ J PSYCHIAT, V49, P833, DOI 10.1177/0004867415579464; Parker G, 2001, AM J PSYCHIAT, V158, P857, DOI 10.1176/appi.ajp.158.6.857; Portela LF, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/820610; Roberts RK, 2014, REHABIL NURS, V39, P62, DOI 10.1002/rnj.97; Sang E, 2018, INT J MENT HEALTH NU, V27, P400, DOI 10.1111/inm.12334; Shen SH, 2016, NURS HEALTH SCI, V18, P223, DOI 10.1111/nhs.12257; Silva MT, 2014, REV BRAS PSIQUIATR, V36, P262, DOI 10.1590/1516-4446-2013-1294; Stein MB, 2015, NEW ENGL J MED, V373, P2059, DOI 10.1056/NEJMcp1502514; Tsai K, 2017, INT J OCCUP SAF ERGO, V23, P127, DOI 10.1080/10803548.2016.1248604; Wang SM, 2015, ARCH PSYCHIAT NURS, V29, P64, DOI 10.1016/j.apnu.2014.10.002; Weiss B, 2009, J CONSULT CLIN PSYCH, V77, P987, DOI 10.1037/a0016779; Yazdanshenas Ghazwin Manijeh, 2016, Iran J Psychiatry, V11, P120; Yen S, 2000, J CONSULT CLIN PSYCH, V68, P993, DOI 10.1037/0022-006X.68.6.993	35	33	35	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2018	13	9							e0204224	10.1371/journal.pone.0204224	http://dx.doi.org/10.1371/journal.pone.0204224			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GU9BO	30252873	gold, Green Published, Green Submitted			2022-12-26	WOS:000445639700035
J	Malik, D; Kaul, D				Malik, Deepti; Kaul, Deepak			Human cellular mitochondrial remodelling is governed by miR-2909 RNomics	PLOS ONE			English	Article							IMMUNE-RESPONSE; GENE-EXPRESSION; MTORC1; UCP2; METABOLISM; ASSAY; P53	Background There exists a general recognition of the fact that mitochondrial remodelling as a result of aerobic glycolysis ensures human somatic cells to revert to a more primitive-form exhibiting stem-like phenotype. The present study is an attempt to demonstrate that miR-2909 RNo-mics within human peripheral blood mononuclear cells (PBMCs) has the inherent capacity to re-program these cells to exhibit mitochondrial remodelling paralleled by aerobic glycolysis together with intracellular lipid inclusions. Such re-programmed PBMCs also expressed genes having ability to sustain their de-differentiation state and survival. Material and methods Human PBMCs were programed to ectopically express miR-2909. Expression levels of genes including glucose transporter-1 (Glut-1), hexokinase (HK), hypoxia inducia factor-1 (HIF-1 alpha), c-Myc, p53, mechanistic target of rapamycin complex (mTORC1), polycombcomplex protein (Bmi-1), Notch, Nanog, Tie-2, Oct-4, CD59, p53, CD34, B-cell lymphoma-2 (Bcl2), sterol regulatory element-binding protein2 (SREBP2), peroxisome proliferator-activated receptor gamma (PPAR.) nuclear respiratory factor 1 (NRF1), mitochondrial transcription factor A (Tfam), peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1 alpha) within miR-2909 expression vector transfected human PBMCs as well as PBMCs transfected with control vector containing scrambled sequence after 48h post-transfection using RT-qPCR and cellular ultrastructural features induced by miR-2909 ectopic expression were observed using transmission electron microscopy and morphometric analysis of an electron micrograph. Results Ectopic expression of miR-2909 within human PBMCs resulted in their reprogramming into stem-like phenotype indicated by mitochondrial globular shaped coupled with cristae-poor morphology. Nuclear to cytoplasmic ratio (N/C), quantification of ATP levels, GSSG/GSH ratio, mitochondrial cytochrome c oxidase activity, secreted lactate concentrations, activity of antioxidant enzymes, levels of esterified cholesterol and triglycerides and flow-cytometric detection of apoptosis confirmed the compromised nature of mitochondrial function induced by ectopic miR-2909 expression in human PBMCs. Conclusion Based upon these results we propose that AATF gene-encoded miR-2909 may act as an epigenetic switch for cellular aerobic-glycolysis to ensure de-differentiation.	[Malik, Deepti; Kaul, Deepak] Postgrad Inst Med Educ & Res, Mol Biol Unit, Expt Med & Biotechnol, Chandigarh, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Kaul, D (corresponding author), Postgrad Inst Med Educ & Res, Mol Biol Unit, Expt Med & Biotechnol, Chandigarh, India.	dkaul_24@hotmail.com			Department of Science and Technology (DST) under their Women Scientists Scheme-A (WOS-A scheme) New Delhi (India)	Department of Science and Technology (DST) under their Women Scientists Scheme-A (WOS-A scheme) New Delhi (India)	The study was supported by the funds provided by Department of Science and Technology (DST) under their Women Scientists Scheme-A (WOS-A scheme) New Delhi (India).	BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; Delmastro-Greenwood MM, 2013, AM J CLIN EXP IMMUNO, V2, P30; Dolgin E., 2009, NATURE REPORTS STEM; Dong DW, 2015, GENOM DATA, V6, P99, DOI 10.1016/j.gdata.2015.07.031; Han JB, 2018, PROTEIN CELL, V9, P145, DOI 10.1007/s13238-017-0409-3; Hasty P, 2013, CELL CYCLE, V12, P20, DOI 10.4161/cc.22912; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Kaul D., 2017, J ANTIVIR ANTIRETROV, V9, P2; Kaul D., 2016, CELLULAR MOL MED, V2, P1; Kaul D, 2015, BLOOD CELL MOL DIS, V55, P89, DOI 10.1016/j.bcmd.2015.05.001; Kaul D, 2015, BLOOD CELL MOL DIS, V54, P342, DOI 10.1016/j.bcmd.2015.01.009; Kaul D, 2015, MOL IMMUNOL, V64, P210, DOI 10.1016/j.molimm.2014.11.018; KONO Y, 1978, ARCH BIOCHEM BIOPHYS, V186, P189, DOI 10.1016/0003-9861(78)90479-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laplante M, 2013, J CELL SCI, V126, P1713, DOI 10.1242/jcs.125773; Lezzi S, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00141; Li YF, 2006, J BIOENERG BIOMEMBR, V38, P283, DOI 10.1007/s10863-006-9052-z; Malik D, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-175; Pecqueur C, 2009, IUBMB LIFE, V61, P762, DOI 10.1002/iub.188; Puzio-Kuter Anna M, 2011, Genes Cancer, V2, P385, DOI 10.1177/1947601911409738; Rayat CS, 2016, AUSTIN J PATHOL LAB, V3, P1016; Rigoglio NN, 2012, CURRENT MICROSCOPY C, P309; Sambrook J., 2006, CSH PROTOC; Sapan CV, 1999, BIOTECHNOL APPL BIOC, V29, P99; Sharma S, 2015, FORENSIC SCI INT, V247, pE21, DOI 10.1016/j.forsciint.2014.12.008; Shrikant PA, 2016, J IMMUNOL S, V196, DOI [10.4049/jimmunol.1501704, DOI 10.4049/JIMMUNOL.1501704]; Singh Rama, 2012, Int J Evol Biol, V2012, P191495, DOI 10.1155/2012/191495; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; Vozza A, 2014, P NATL ACAD SCI USA, V111, P960, DOI 10.1073/pnas.1317400111; Williams JR, 2008, B WORLD HEALTH ORGAN, V86, P650, DOI 10.2471/BLT.08.050955; Wu DL, 2011, JOVE-J VIS EXP, DOI 10.3791/3357; Wylie A, 2014, ELIFE, V3, DOI 10.7554/eLife.01530; Xu XL, 2013, CELL METAB, V18, P325, DOI 10.1016/j.cmet.2013.06.005; Zhang J, 2011, EMBO J, V30, P4860, DOI 10.1038/emboj.2011.401	34	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2018	13	9							e0203614	10.1371/journal.pone.0203614	http://dx.doi.org/10.1371/journal.pone.0203614			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU9BO	30252847	Green Published, gold, Green Submitted			2022-12-26	WOS:000445639700009
J	Essmann, CL; Ryan, KR; Elmr, M; Bryon-Dodd, K; Porter, A; Vaughan, A; McMullan, R; Nurrish, S				Essmann, Clara L.; Ryan, Katie R.; Elmr, Muna; Bryon-Dodd, Kimberley; Porter, Andrew; Vaughan, Andrew; McMullan, Rachel; Nurrish, Stephen			Activation of RHO-1 in cholinergic motor neurons competes with dopamine signalling to control locomotion	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; NEUROTRANSMITTER RELEASE; C.-ELEGANS; TRANSPORTER TRAFFICKING; MONOAMINE TRANSPORTERS; SYNAPTIC LOCALIZATION; UNC-31 CAPS; GENE; PATHWAY; ENDOCYTOSIS	The small GTPase RhoA plays a crucial role in the regulation of neuronal signalling to generate behaviour. In the developing nervous system RhoA is known to regulate the actin cytoskeleton, however the effectors of RhoA-signalling in adult neurons remain largely unidentified. We have previously shown that activation of the RhoA ortholog (RHO-1) in C. elegans cholinergic motor neurons triggers hyperactivity of these neurons and loopy locomotion with exaggerated body bends. This is achieved in part through increased diacylglycerol (DAG) levels and the recruitment of the synaptic vesicle protein UNC-13 to synaptic release sites, however other pathways remain to be identified. Dopamine, which is negatively regulated by the dopamine re-uptake transporter (DAT), has a central role in modulating locomotion in both humans and C. elegans. In this study we identify a new pathway in which RHO-1 regulates locomotory behaviour by repressing dopamine signalling, via DAT-1, linking these two pathways together. We observed an upregulation of dat-1 expression when RHO-1 is activated and show that loss of DAT-1 inhibits the loopy locomotion phenotype caused by RHO-1 activation. Reducing dopamine signalling in dat-1 mutants through mutations in genes involved in dopamine synthesis or in the dopamine receptor DOP-1 restores the ability of RHO-1 to trigger loopy locomotion in dat-1 mutants. Taken together, we show that negative regulation of dopamine signalling via DAT-1 is necessary for the neuronal RHO-1 pathway to regulate locomotion.	[Essmann, Clara L.; Ryan, Katie R.; Elmr, Muna; Bryon-Dodd, Kimberley; Porter, Andrew; Vaughan, Andrew; McMullan, Rachel; Nurrish, Stephen] UCL, MRC Lab Mol Cell Biol, London, England; [Essmann, Clara L.; Elmr, Muna] UCL, Dept Comp Sci, Malet Pl Engn Bldg, London, England; [Ryan, Katie R.] Univ Arkansas Med Sci, Myeloma Inst, Little Rock, AR 72205 USA; [Porter, Andrew] Univ Manchester, Canc Res UK Manchester Inst, Manchester, Lancs, England; [McMullan, Rachel] Open Univ, Dept Life Hlth & Chem Sci, Walton Hall, Milton Keynes, Bucks, England; [Nurrish, Stephen] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA	MRC Laboratory Molecular Biology; University of London; University College London; University of London; University College London; University of Arkansas System; University of Arkansas Medical Sciences; Cancer Research UK; University of Manchester; Open University - UK; Harvard University; Massachusetts General Hospital	Essmann, CL (corresponding author), UCL, MRC Lab Mol Cell Biol, London, England.; Essmann, CL (corresponding author), UCL, Dept Comp Sci, Malet Pl Engn Bldg, London, England.	c.essmann@ucl.ac.uk	McMullan, Rachel/ABJ-3519-2022; Porter, Andrew/GWU-8628-2022	McMullan, Rachel/0000-0003-2677-8016; Ryan, Katie/0000-0003-0488-5603; Porter, Andrew/0000-0002-3353-7002	ALTF [1511-2010]; NIH Office of Research Infrastructure Programs [P40 OD010440];  [MC_U122665004];  [MC_UU12018/8]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER; MRC [MC_U122665004] Funding Source: UKRI	ALTF; NIH Office of Research Infrastructure Programs; ; ; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by MC_U122665004 and MC_UU12018/8 https://mrc.ukri.org/funding/, ALTF 1511-2010 http://www.embo.org/funding-awards/fellowships/long-term-fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Richard Poole, Arantza Barrios, QueeLim Ch'ng, Alison Lloyd, and Julie Pitcher for comments on the manuscript. We also thank Julie Pitcher for her support of CLE and KRR. We thank Randy Blakely, Daniel Chase, and Oliver Hobert for plasmids and/or strains, Patricia de Winter at qStandard for her unflagging enthusiasm for this project, Janos Kriston-Vizi for help with bio-informatics, and members of the Schafer lab for help with setting up the worm tracker. Some strains were provided by the CGC, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440).	Allen AT, 2011, GENETICS, V188, P579, DOI 10.1534/genetics.111.128512; Bermingham DP, 2017, J NEUROSCI, V37, P9288, DOI 10.1523/JNEUROSCI.1582-17.2017; Bhattacharya R, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004584; Bigelow H, 2009, NAT METHODS, V6, P549, DOI 10.1038/nmeth.f.260; BRENNER S, 1974, GENETICS, V77, P71; Carvelli L, 2004, P NATL ACAD SCI USA, V101, P16046, DOI 10.1073/pnas.0403299101; Charlie NK, 2006, GENETICS, V172, P943, DOI 10.1534/genetics.105.049577; Chase D. L., 2007, WORMBOOK ONLINE REV, P1, DOI [10.1895/wormbook.1.132.1, DOI 10.1895/WORMBOOK.1.132.1]; Chase DL, 2004, NAT NEUROSCI, V7, P1096, DOI 10.1038/nn1316; Chen R, 2010, FUTUR NEUROL, V5, P123, DOI 10.2217/FNL.09.76; CHEN WN, 1994, J BIOL CHEM, V269, P32394; Cheng PL, 2011, NEURON, V69, P231, DOI 10.1016/j.neuron.2010.12.021; Dalpe G, 2004, DEVELOPMENT, V131, P2073, DOI 10.1242/dev.01063; de Bono M, 2002, NATURE, V419, P899, DOI 10.1038/nature01169; Diana G, 2007, P NATL ACAD SCI USA, V104, P636, DOI 10.1073/pnas.0610059104; Doitsidou M, 2013, GENE DEV, V27, P1391, DOI 10.1101/gad.217224.113; Erikson KM, 2000, J NUTR, V130, P2831, DOI 10.1093/jn/130.11.2831; Erion R, 2016, ELIFE, V5, DOI 10.7554/eLife.13552; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Felling RJ, 2011, J NEUROSCI, V31, P12387, DOI 10.1523/JNEUROSCI.0150-11.2011; Flames N, 2009, NATURE, V458, P885, DOI 10.1038/nature07929; Gainetdinov RR, 2003, ANNU REV PHARMACOL, V43, P261, DOI 10.1146/annurev.pharmtox.43.050802.112309; Garcia-Morales V, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002153; Gowrishankar R, 2014, NEUROCHEM INT, V73, P42, DOI 10.1016/j.neuint.2013.10.016; Guo G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009352; Hardaway JA, 2012, G3-GENES GENOM GENET, V2, P961, DOI 10.1534/g3.112.003533; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; Hiley E, 2006, EMBO J, V25, P5884, DOI 10.1038/sj.emboj.7601458; Hu ZT, 2011, NEURON, V71, P92, DOI 10.1016/j.neuron.2011.04.021; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jayanthi LD, 1998, MOL PHARMACOL, V54, P601; Jiang HB, 2004, J BIOL CHEM, V279, P54380, DOI 10.1074/jbc.M409282200; Jones SR, 1999, NAT NEUROSCI, V2, P649, DOI 10.1038/10204; Jospin M, 2007, CURR BIOL, V17, P1595, DOI 10.1016/j.cub.2007.08.036; Kasri NN, 2011, NEURON, V72, P300, DOI 10.1016/j.neuron.2011.09.001; Kim K., 2009, NEW DESIGN METHOD DU, P1, DOI [10.1895/wormbook.1.142.1, DOI 10.1895/WORMBOOK.1.142.1]; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Kurian MA, 2009, J CLIN INVEST, V119, P1595, DOI 10.1172/JCI39060; Matsumoto Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105435; McDonald PW, 2007, J NEUROSCI, V27, P14216, DOI 10.1523/JNEUROSCI.2992-07.2007; McDonald PW, 2006, CELL MOL NEUROBIOL, V26, P593, DOI 10.1007/s10571-006-9003-6; McMullan R, 2006, GENE DEV, V20, P65, DOI 10.1101/gad.359706; McMullan R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002530; McMullan R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017265; Melikian HE, 2004, PHARMACOL THERAPEUT, V104, P17, DOI 10.1016/j.pharmthera.2004.07.006; Nelson LS, 1998, SCIENCE, V281, P1686, DOI 10.1126/science.281.5383.1686; Nieoullon A, 2003, CURR OPIN NEUROL, V16, pS3, DOI 10.1097/00019052-200312002-00002; Nurrish S, 1999, NEURON, V24, P231, DOI 10.1016/S0896-6273(00)80835-1; Perez-Mansilla B, 2009, ADV GENET, V65, P145, DOI 10.1016/S0065-2660(09)65004-5; Pilpel Y, 2004, EUR J NEUROSCI, V19, P3151, DOI 10.1111/j.0953-816X.2004.03380.x; Powell AD, 2012, J PHYSIOL-LONDON, V590, DOI 10.1113/jphysiol.2011.219907; RITZ MC, 1987, SCIENCE, V237, P1219, DOI 10.1126/science.2820058; Robinson SB, 2017, MOL CELL NEUROSCI, V78, P41, DOI 10.1016/j.mcn.2016.11.011; Roe D L, 1997, J Hist Neurosci, V6, P291; Sanyal S, 2004, EMBO J, V23, P473, DOI 10.1038/sj.emboj.7600057; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Schmitt KC, 2010, ANN NY ACAD SCI, V1187, P316, DOI 10.1111/j.1749-6632.2009.05148.x; Shao LW, 2016, CELL RES, V26, P1182, DOI 10.1038/cr.2016.118; Shi LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043091; Sieburth D, 2007, NAT NEUROSCI, V10, P49, DOI 10.1038/nn1810; Speese S, 2007, J NEUROSCI, V27, P6150, DOI 10.1523/JNEUROSCI.1466-07.2007; Spencer AG, 2001, P NATL ACAD SCI USA, V98, P13132, DOI 10.1073/pnas.241504098; Steven R, 2005, GENE DEV, V19, P2016, DOI 10.1101/gad.1319905; SULSTON J, 1975, J COMP NEUROL, V163, P215, DOI 10.1002/cne.901630207; Sulzer D, 2005, PROG NEUROBIOL, V75, P406, DOI 10.1016/j.pneurobio.2005.04.003; Swant J, 2011, J BIOL CHEM, V286, P43933, DOI 10.1074/jbc.M111.241232; Taoufiq Z, 2013, J NEUROSCI, V33, P12099, DOI 10.1523/JNEUROSCI.0730-13.2013; Topalidou I, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007032; Topalidou I, 2017, GENETICS, V206, P265, DOI 10.1534/genetics.116.198820; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Vaughan RA, 2013, TRENDS PHARMACOL SCI, V34, P489, DOI 10.1016/j.tips.2013.07.005; Vidal-Gadea A, 2011, P NATL ACAD SCI USA, V108, P17504, DOI 10.1073/pnas.1108673108; Vidal-Gadea Andres G., 2012, Communicative & Integrative Biology, V5, P440; Wheeler DS, 2015, P NATL ACAD SCI USA, V112, pE7138, DOI 10.1073/pnas.1511670112; Yemini Eviatar, 2011, Cold Spring Harb Protoc, V2011, P1480, DOI 10.1101/pdb.prot067009; Yemini E, 2013, NAT METHODS, V10, P877, DOI [10.1038/NMETH.2560, 10.1038/nmeth.2560]; Zallen JA, 2000, MOL BIOL CELL, V11, P3177, DOI 10.1091/mbc.11.9.3177; Zhao Y, 2013, PHARMACOGENOMICS, V14, P1481, DOI 10.2217/pgs.13.141	78	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2018	13	9							e0204057	10.1371/journal.pone.0204057	http://dx.doi.org/10.1371/journal.pone.0204057			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU5MM	30240421	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000445329700021
J	Mana-Capelli, S; McCollum, D				Mana-Capelli, Sebastian; McCollum, Dannel			Angiomotins stimulate LATS kinase autophosphorylation and act as scaffolds that promote Hippo signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Hippo pathway; LATS (Warts; Wts); mechanotransduction; cell signaling; Yes-associated protein (YAP); protein kinase; mammalian sterile 20-like kinase 1 (MST1); mammalian sterile 20-like kinase 2 (MST2); Salvador (Sav); scaffold protein; AMOT; angiomotin; MOB1; SAV1	F-ACTIN; FAMILY PROTEINS; PATHWAY; YAP; DROSOPHILA; PHOSPHORYLATION; ACTIVATION; COMPLEX; BINDING; GROWTH	The Hippo pathway controls cell proliferation, differentiation, and survival by regulating the Yes-associated protein (YAP) transcriptional coactivator in response to various stimuli, including the mechanical environment. The major YAP regulators are the LATS1/2 kinases, which phosphorylate and inhibit YAP. LATS1/2 are activated by phosphorylation on a hydrophobic motif (HM) outside of the kinase domain by MST1/2 and other kinases. Phosphorylation of the HM motif then triggers autophosphorylation of the kinase in the activation loop to fully activate the kinase, a process facilitated by MOB1. The angiomotin family of proteins (AMOT, AMOTL1, and AMOTL2) bind LATS1/2 and promote its kinase activity and YAP phosphorylation through an unknown mechanism. Here we show that angiomotins increase Hippo signaling through multiple mechanisms. We found that, by binding LATS1/2, SAV1, and YAP, angiomotins function as a scaffold that connects LATS1/2 to both its activator SAV1-MST1 and its target YAP. Deletion of all three angiomotins reduced the association of LATS1 with SAV1-MST1 and decreased MST1/2-mediated LATS1/2-HM phosphorylation. Angiomotin deletion also reduced LATS1/2's ability to associate with and phosphorylate YAP. In addition, we found that angiomotins have an unexpected function along with MOB1 to promote autophosphorylation of LATS1/2 on the activation loop motif independent of HM phosphorylation. These results indicate that angiomotins enhance Hippo signaling by stimulating LATS1/2 autophosphorylation and by connecting LATS1/2 with both its activator SAV1-MST1/2 and its substrate YAP.	[Mana-Capelli, Sebastian; McCollum, Dannel] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	McCollum, D (corresponding author), Univ Massachusetts, Sch Med, 364 Plantat St, Worcester, MA 01605 USA.	dannel.mccollum@umassmed.edu			National Institutes of Health [RO1 GM058406]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058406] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant RO1 GM058406 (to D. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adler JJ, 2013, P NATL ACAD SCI USA, V110, P17368, DOI 10.1073/pnas.1308236110; Bae SJ, 2017, ELIFE, V6, DOI [10.7554/eLife.30278.001, 10.7554/eLife.30278]; Cairns L, 2018, J BIOL CHEM, V293, P5532, DOI 10.1074/jbc.RA117.000923; Callus BA, 2006, FEBS J, V273, P4264, DOI 10.1111/j.1742-4658.2006.05427.x; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Chan SW, 2013, J BIOL CHEM, V288, P37296, DOI 10.1074/jbc.M113.527598; Chan SW, 2011, J BIOL CHEM, V286, P7018, DOI 10.1074/jbc.C110.212621; Couzens AL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004712; Dai XM, 2013, J BIOL CHEM, V288, P34041, DOI 10.1074/jbc.M113.518019; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Feng XD, 2014, CANCER CELL, V25, P831, DOI 10.1016/j.ccr.2014.04.016; Fernandez BG, 2011, DEVELOPMENT, V138, P2337, DOI 10.1242/dev.063545; Guo C, 2007, CURR BIOL, V17, P700, DOI 10.1016/j.cub.2007.02.055; Hainer SJ, 2015, GENE DEV, V29, P362, DOI 10.1101/gad.253534.114; Hergovich A, 2006, BIOCHEM BIOPH RES CO, V345, P50, DOI 10.1016/j.bbrc.2006.03.244; Hirate Y, 2013, CURR BIOL, V23, P1181, DOI 10.1016/j.cub.2013.05.014; Hoa L, 2016, CELL SIGNAL, V28, P488, DOI 10.1016/j.cellsig.2016.02.012; Hwang E, 2007, P NATL ACAD SCI USA, V104, P9236, DOI 10.1073/pnas.0610716104; Jagannathan R, 2016, MOL CELL BIOL, V36, P2526, DOI 10.1128/MCB.00136-16; Kawahara M, 2008, BLOOD, V112, P3856, DOI 10.1182/blood-2007-09-111773; Kim MJ, 2016, EMBO REP, V17, P64, DOI 10.15252/embr.201540809; Leung CY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3251; Li YJ, 2015, CELL RES, V25, P801, DOI 10.1038/cr.2015.69; Liu CY, 2010, J BIOL CHEM, V285, P37159, DOI 10.1074/jbc.M110.152942; Ma HH, 2012, MOL CELL PROTEOMICS, V11, P501, DOI 10.1074/mcp.O111.016246; Mana-Capelli S, 2014, MOL BIOL CELL, V25, P1676, DOI 10.1091/mbc.E13-11-0701; Meng ZP, 2016, GENE DEV, V30, P1, DOI 10.1101/gad.274027.115; Meng ZP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9357; Moleirinho S, 2017, ELIFE, V6, DOI 10.7554/eLife.23966; Ni LS, 2015, GENE DEV, V29, P1416, DOI 10.1101/gad.264929.115; Oka T, 2008, J BIOL CHEM, V283, P27534, DOI 10.1074/jbc.M804380200; Paramasivam M, 2011, MOL BIOL CELL, V22, P3725, DOI 10.1091/mbc.E11-04-0300; Plouffe SW, 2016, MOL CELL, V64, P993, DOI 10.1016/j.molcel.2016.10.034; Sansores-Garcia L, 2011, EMBO J, V30, P2325, DOI 10.1038/emboj.2011.157; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987; Wang WQ, 2011, J BIOL CHEM, V286, P4364, DOI 10.1074/jbc.C110.205401; Yi CL, 2011, CANCER CELL, V19, P527, DOI 10.1016/j.ccr.2011.02.017; Yin F, 2013, CELL, V154, P1342, DOI 10.1016/j.cell.2013.08.025; Zanconato F, 2016, CANCER CELL, V29, P783, DOI 10.1016/j.ccell.2016.05.005; Zhang JM, 2008, CANCER RES, V68, P2789, DOI 10.1158/0008-5472.CAN-07-6205; Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zheng YG, 2015, DEV CELL, V34, P642, DOI 10.1016/j.devcel.2015.08.014	47	40	42	5	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18230	18241		10.1074/jbc.RA118.004187	http://dx.doi.org/10.1074/jbc.RA118.004187			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30266805	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000451375200017
J	Wang, J; Shen, T; Zhu, WQ; Dou, LY; Gu, H; Zhang, LL; Yang, ZY; Chen, HY; Zhou, Q; Sanchez, ER; Field, LJ; Mayo, LD; Xie, ZW; Xiao, DY; Lin, X; Shou, WN; Yong, WD				Wang, Jun; Shen, Tao; Zhu, Wuqiang; Dou, Longyu; Gu, Hao; Zhang, Lingling; Yang, Zhenyun; Chen, Hanying; Zhou, Qi; Sanchez, Edwin R.; Field, Loren J.; Mayo, Lindsey D.; Xie, Zhongwen; Xiao, Deyong; Lin, Xia; Shou, Weinian; Yong, Weidong			Protein phosphatase 5 and the tumor suppressor p53 down-regulate each other's activities in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						p53; cancer; gene knockout; protein serine; threonine phosphatase (PSP); protein phosphorylation; protein phosphatase 5; transcriptional regulation; tumorigenesis; posttranslational regulation; cell stress	NEGATIVE FEEDBACK-REGULATION; WILD-TYPE P53; GLUCOCORTICOID-RECEPTOR; INDUCED PHOSPHORYLATION; IONIZING-RADIATION; OXIDATIVE STRESS; DIRECT BINDING; ACTS UPSTREAM; DNA-BINDING; ACTIVATION	Protein phosphatase 5 (PP5), a serine/threonine phosphatase, has a wide range of biological functions and exhibits elevated expression in tumor cells. We previously reported that pp5-deficient mice have altered ataxia-telangiectasia mutated (ATM)-mediated signaling and function. However, this regulation was likely indirect, as ATM is not a known PP5 substrate. In the current study, we found that pp5-deficient mice are hypersensitive to genotoxic stress. This hypersensitivity was associated with the marked up-regulation of the tumor suppressor tumor protein p53 and its downstream targets cyclin-dependent kinase inhibitor 1A (p21), MDM2 proto-oncogene (MDM2), and phosphatase and tensin homolog (PTEN) in pp5-deficient tissues and cells. These observations suggested that PP5 plays a role in regulating p53 stability and function. Experiments conducted with p53(+/-)pp5(+/-) or p53(+/-)pp5(-/-) mice revealed that complete loss of PP5 reduces tumorigenesis in the p53(+/-) mice. Biochemical analyses further revealed that PP5 directly interacts with and dephosphorylates p53 at multiple serine/threonine residues, resulting in inhibition of p53-mediated transcriptional activity. Interestingly, PP5 expression was significantly up-regulated in p53-deficient cells, and further analysis of pp5 promoter activity revealed that p53 strongly represses PP5 transcription. Our results suggest a reciprocal regulatory interplay between PP5 and p53, providing an important feedback mechanism for the cellular response to genotoxic stress.	[Wang, Jun; Dou, Longyu; Gu, Hao; Zhang, Lingling; Yong, Weidong] Chinese Acad Med Sci, Inst Lab Anim Sci, Comparat Med Ctr, Beijing 100021, Peoples R China; [Zhu, Wuqiang; Yang, Zhenyun; Chen, Hanying; Zhou, Qi; Field, Loren J.; Mayo, Lindsey D.; Shou, Weinian; Yong, Weidong] Indiana Univ Sch Med, Dept Pediat, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Wang, Jun; Xie, Zhongwen] Anhui Agr Univ, Sch Life Sci, Hefei 230036, Anhui, Peoples R China; [Shen, Tao; Lin, Xia] Baylor Coll Med, DeBakey Dept Surg, Houston, TX 77030 USA; [Sanchez, Edwin R.] Univ Toledo, Coll Med, Dept Physiol & Pharmacol, Toledo, OH 43614 USA; [Xiao, Deyong] Fountain Valley Inst Life Sci, Dalian 116023, Peoples R China; [Xiao, Deyong] Fountain Valley Biomed Technol Co, Dalian 116023, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Indiana University System; Indiana University Bloomington; Anhui Agricultural University; Baylor College of Medicine; University System of Ohio; University of Toledo	Yong, WD (corresponding author), Chinese Acad Med Sci, Inst Lab Anim Sci, Comparat Med Ctr, Beijing 100021, Peoples R China.; Shou, WN; Yong, WD (corresponding author), Indiana Univ Sch Med, Dept Pediat, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA.	wshou@iu.edu; wyong@cnilas.org	zhang, lingling/HDM-2189-2022		Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences [CIFMS2017-I2M-3-015]; National Natural Science Foundation of China [NSFC81272273, NSFC31571207]; National Institutes of Health [R01HL181092, P01HL134599]; Fountain Valley Life Science Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL132927, P01HL134599] Funding Source: NIH RePORTER	Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fountain Valley Life Science Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences Grant CIFMS2017-I2M-3-015, National Natural Science Foundation of China Grants NSFC81272273 (to W. Y.) and NSFC31571207 (to Z. X.), National Institutes of Health Grants R01HL181092 and P01HL134599 (to W. S.), and the Fountain Valley Life Science Fund (to D. X.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ali A, 2004, GENE DEV, V18, P249, DOI 10.1101/gad.1176004; Amable L, 2011, J BIOL CHEM, V286, P40413, DOI 10.1074/jbc.M111.244053; Ashcroft M, 1999, MOL CELL BIOL, V19, P1751; Atiye J, 2005, GENE CHROMOSOME CANC, V42, P158, DOI 10.1002/gcc.20120; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; BARTON GJ, 1994, EUR J BIOCHEM, V220, P225, DOI 10.1111/j.1432-1033.1994.tb18618.x; Chen MX, 1997, FEBS LETT, V400, P136, DOI 10.1016/S0014-5793(96)01427-5; Choi J, 2002, MOL CELL BIOL, V22, P1094, DOI 10.1128/MCB.22.4.1094-1105.2002; Crescenzi E, 2013, J BIOL CHEM, V288, P16212, DOI 10.1074/jbc.M112.435149; CUMMINGS J, 1991, EUR J CANCER, V27, P532, DOI 10.1016/0277-5379(91)90209-V; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; Dai C, 2010, TRENDS MOL MED, V16, P528, DOI 10.1016/j.molmed.2010.09.002; Dean DA, 2001, BMC CELL BIOL, V2, DOI 10.1186/1471-2121-2-6; DONEHOWER LA, 1995, GENE DEV, V9, P882, DOI 10.1101/gad.9.7.882; Dumble Melissa L, 2003, Methods Mol Biol, V234, P29; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Feldmeyer L, 2007, CURR BIOL, V17, P1140, DOI 10.1016/j.cub.2007.05.074; Fiscella M, 1997, P NATL ACAD SCI USA, V94, P6048, DOI 10.1073/pnas.94.12.6048; FISCELLA M, 1993, ONCOGENE, V8, P1519; Freie B, 2003, BLOOD, V102, P4146, DOI 10.1182/blood-2003-03-0971; Golden T, 2008, CANCER METAST REV, V27, P169, DOI 10.1007/s10555-008-9125-z; Golden T, 2008, BBA-MOL BASIS DIS, V1782, P259, DOI 10.1016/j.bbadis.2008.01.004; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hemann MT, 2004, P NATL ACAD SCI USA, V101, P9333, DOI 10.1073/pnas.0403286101; Hemann MT, 2003, NAT GENET, V33, P396, DOI 10.1038/ng1091; Hinds TD, 2011, J BIOL CHEM, V286, P42911, DOI 10.1074/jbc.M111.311662; Johnson RA, 2001, J BIOL CHEM, V276, P27716, DOI 10.1074/jbc.C100121200; Kang H, 2001, BIOCHEMISTRY-US, V40, P10485, DOI 10.1021/bi010999i; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Li DWC, 2006, ONCOGENE, V25, P3006, DOI 10.1038/sj.onc.1209334; Li LW, 2000, J BIOL CHEM, V275, P2410, DOI 10.1074/jbc.275.4.2410; LIU LF, 1989, ANNU REV BIOCHEM, V58, P351, DOI 10.1146/annurev.bi.58.070189.002031; Luo KT, 2017, EMBO J, V36, P1434, DOI 10.15252/embj.201695669; Mayo LD, 2005, J BIOL CHEM, V280, P25953, DOI 10.1074/jbc.M503026200; McKay BC, 1998, ONCOGENE, V17, P545, DOI 10.1038/sj.onc.1201963; McKenzie L, 2010, CELL CYCLE, V9, P4200, DOI 10.4161/cc.9.20.13532; McVean M, 2000, CARCINOGENESIS, V21, P633, DOI 10.1093/carcin/21.4.633; Meek DW, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000950; Messner DJ, 2006, J CELL BIOCHEM, V99, P241, DOI 10.1002/jcb.20919; Mi J, 2009, MOL CANCER THER, V8, P135, DOI 10.1158/1535-7163.MCT-08-0457; Morita K, 2001, EMBO J, V20, P6028, DOI 10.1093/emboj/20.21.6028; Munugalavadla V, 2007, BLOOD, V110, P1612, DOI 10.1182/blood-2006-10-053058; Oberoi J, 2016, P NATL ACAD SCI USA, V113, P9009, DOI 10.1073/pnas.1603059113; Pazdrak K, 2016, J IMMUNOL, V197, P3782, DOI 10.4049/jimmunol.1601029; PU Y, 1995, J APPL TOXICOL, V15, P477, DOI 10.1002/jat.2550150609; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Ryan KM, 2001, CURR OPIN CELL BIOL, V13, P332, DOI 10.1016/S0955-0674(00)00216-7; Sakurai T, 2008, CANCER CELL, V14, P156, DOI 10.1016/j.ccr.2008.06.016; SCHEIDTMANN KH, 1991, MOL CELL BIOL, V11, P1996, DOI 10.1128/MCB.11.4.1996; Schmitt CA, 2002, CANCER CELL, V1, P289, DOI 10.1016/S1535-6108(02)00047-8; Sekine Y, 2012, MOL CELL, V48, P692, DOI 10.1016/j.molcel.2012.09.018; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Sluss HK, 2004, MOL CELL BIOL, V24, P976, DOI 10.1128/MCB.24.3.976-984.2004; St Clair S, 2004, MOL CELL, V16, P725; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Takekawa M, 2000, EMBO J, V19, P6517, DOI 10.1093/emboj/19.23.6517; TAKENAKA I, 1995, J BIOL CHEM, V270, P5405, DOI 10.1074/jbc.270.10.5405; Thompson T, 2004, J BIOL CHEM, V279, P53015, DOI 10.1074/jbc.M410233200; Urban G, 2001, J BIOL CHEM, V276, P27638, DOI 10.1074/jbc.M103512200; Venkatachalam S, 1998, EMBO J, V17, P4657, DOI 10.1093/emboj/17.16.4657; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; von Kriegsheim A, 2006, NAT CELL BIOL, V8, P1011, DOI 10.1038/ncb1465; Wechsler T, 2004, P NATL ACAD SCI USA, V101, P1247, DOI 10.1073/pnas.0307765100; Woo RA, 1998, NATURE, V394, P700, DOI 10.1038/29343; Yang ZY, 2009, MOL CELL BIOL, V29, P4376, DOI 10.1128/MCB.01330-08; Yang ZC, 2006, MOL ENDOCRINOL, V20, P2682, DOI 10.1210/me.2006-0024; Yong WD, 2007, J BIOL CHEM, V282, P14690, DOI 10.1074/jbc.C700019200; Zhang J, 2005, MOL CELL BIOL, V25, P9910, DOI 10.1128/MCB.25.22.9910-9919.2005; Zhang Y, 2009, J BIOL CHEM, V284, P24542, DOI 10.1074/jbc.M109.021469; Zhu WQ, 2009, CIRCULATION, V119, P99, DOI 10.1161/CIRCULATIONAHA.108.799700; Zuo Z, 1998, J BIOL CHEM, V273, P12250, DOI 10.1074/jbc.273.20.12250	72	8	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18218	18229		10.1074/jbc.RA118.004256	http://dx.doi.org/10.1074/jbc.RA118.004256			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30262665	Green Published, hybrid			2022-12-26	WOS:000451375200016
J	Patel, MP; Hu, LY; Brown, CA; Sun, ZZ; Adamski, CJ; Stojanoski, V; Sankaran, B; Prasad, BVV; Palzkill, T				Patel, Meha P.; Hu, Liya; Brown, Cameron A.; Sun, Zhizeng; Adamski, Carolyn J.; Stojanoski, Vlatko; Sankaran, Banumathi; Prasad, B. V. Venkataram; Palzkill, Timothy			Synergistic effects of functionally distinct substitutions in -lactamase variants shed light on the evolution of bacterial drug resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						drug resistance; enzyme kinetics; enzyme catalysis; protein evolution; protein structure; protein stability; protein drug interaction; conformational change; antibiotic resistance; -lactamase	TEM-1 BETA-LACTAMASE; ESCHERICHIA-COLI; ACTIVE-SITE; CRYSTALLOGRAPHIC STRUCTURE; CEFTAZIDIME RESISTANCE; ANTIBIOTIC-RESISTANCE; MOLECULAR REPLACEMENT; GLOBAL SUPPRESSOR; CRYSTAL-STRUCTURE; CLONED GENES	The CTX-M -lactamases have emerged as the most widespread extended-spectrum -lactamases (ESBLs) in Gram-negative bacteria. These enzymes rapidly hydrolyze cefotaxime, but not the related cephalosporin, ceftazidime. ESBL variants have evolved, however, that provide enhanced ceftazidime resistance. We show here that a natural variant at a nonactive site, i.e. second-shell residue N106S, enhances enzyme stability but reduces catalytic efficiency for cefotaxime and ceftazidime and decreases resistance levels. However, when the N106S variant was combined with an active-site variant, D240G, that enhances enzyme catalytic efficiency, but decreases stability, the resultant double mutant exhibited higher resistance levels than predicted on the basis of the phenotypes of each variant. We found that this epistasis is due to compensatory effects, whereby increased stability provided by N106S overrides its cost of decreased catalytic activity. X-ray structures of the variant enzymes in complex with cefotaxime revealed conformational changes in the active-site loop spanning residues 103-106 that were caused by the N106S substitution and relieve steric strain to stabilize the enzyme, but also alter contacts with cefotaxime and thereby reduce catalytic activity. We noted that the 103-106 loop conformation in the N106S-containing variants is different from that of WT CTX-M but nearly identical to that of the non-ESBL, TEM-1 -lactamase, having a serine at the 106 position. Therefore, residue 106 may serve as a switch that toggles the conformations of the 103-106 loop. When it is serine, the loop is in the non-ESBL, TEM-like conformation, and when it is asparagine, the loop is in a CTX-M-like, cefotaximase-favorable conformation.	[Patel, Meha P.] Baylor Coll Med, Interdept Grad Program Translat Biol & Mol Med, Houston, TX 77030 USA; [Hu, Liya; Adamski, Carolyn J.; Stojanoski, Vlatko; Prasad, B. V. Venkataram; Palzkill, Timothy] Baylor Coll Med, Verna Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Patel, Meha P.; Brown, Cameron A.; Sun, Zhizeng; Adamski, Carolyn J.; Stojanoski, Vlatko; Palzkill, Timothy] Baylor Coll Med, Dept Pharmacol & Chem Biol, Houston, TX 77030 USA; [Sankaran, Banumathi] Lawrence Berkeley Natl Lab, Dept Mol Biophys & Integrated Bioimaging, Berkeley Ctr Struct Biol, Berkeley, CA 94720 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Palzkill, T (corresponding author), One Baylor Plaza, Houston, TX 77030 USA.	timothyp@bcm.edu		Brown, Cameron/0000-0002-8886-1328	NIGMS from the National Institutes of Health [P30 GM124169-01]; Department of Energy Office of Science User Facility [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032956] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM124169] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021832] Funding Source: NIH RePORTER	NIGMS from the National Institutes of Health; Department of Energy Office of Science User Facility(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Hiram Gilbert for discussions and comments on the manuscript. The ALS-ENABLE beamlines are supported in part by NIGMS Grant P30 GM124169-01 from the National Institutes of Health. The Advanced Light Source is a Department of Energy Office of Science User Facility under Contract No. DE-AC02-05CH11231.	Adamski CJ, 2015, BIOCHEMISTRY-US, V54, P447, DOI 10.1021/bi501195g; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; AMANN E, 1983, GENE, V25, P167, DOI 10.1016/0378-1119(83)90222-6; Bar-Even A, 2015, BIOCHEMISTRY-US, V54, P4969, DOI 10.1021/acs.biochem.5b00621; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Blomberg R, 2013, NATURE, V503, P418, DOI 10.1038/nature12623; Bonnet R, 2001, ANTIMICROB AGENTS CH, V45, P2269, DOI 10.1128/AAC.45.8.2269-2275.2001; Bonnet R, 2004, ANTIMICROB AGENTS CH, V48, P1, DOI 10.1128/AAC.48.1.1-14.2004; Bonomo Robert A, 2017, Cold Spring Harb Perspect Med, V7, DOI 10.1101/cshperspect.a025239; Brereton AE, 2016, PROTEIN SCI, V25, P926, DOI 10.1002/pro.2883; Brown NG, 2010, J MOL BIOL, V404, P832, DOI 10.1016/j.jmb.2010.10.008; Campbell E, 2016, NAT CHEM BIOL, V12, P944, DOI [10.1038/NCHEMBIO.2175, 10.1038/nchembio.2175]; Canton R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00110; Chellapa GD, 2015, PROTEINS, V83, P1687, DOI 10.1002/prot.24854; Chen Y, 2005, J MOL BIOL, V348, P349, DOI 10.1016/j.jmb.2005.02.010; D'Andrea MM, 2013, INT J MED MICROBIOL, V303, P305, DOI 10.1016/j.ijmm.2013.02.008; Dellus-Gur E, 2015, J MOL BIOL, V427, P2396, DOI 10.1016/j.jmb.2015.05.011; Delmas J, 2006, ANTIMICROB AGENTS CH, V50, P731, DOI 10.1128/AAC.50.2.731-738.2006; Delmas J, 2010, J MOL BIOL, V400, P108, DOI 10.1016/j.jmb.2010.04.062; Doucet N, 2007, PROTEINS, V69, P340, DOI 10.1002/prot.21485; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FONZE E, 1995, ACTA CRYSTALLOGR D, V51, P682, DOI 10.1107/S0907444994014496; Gonzalez MM, 2016, MOL BIOL EVOL, V33, P1768, DOI 10.1093/molbev/msw052; Hart KM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12965; Huang WZ, 1997, P NATL ACAD SCI USA, V94, P8801, DOI 10.1073/pnas.94.16.8801; JELSCH C, 1993, PROTEINS, V16, P364, DOI 10.1002/prot.340160406; Jimenez-Oses G, 2014, NAT CHEM BIOL, V10, P431, DOI 10.1038/nchembio.1503; Perez-Llarena FJ, 2011, ANTIMICROB AGENTS CH, V55, P4361, DOI 10.1128/AAC.00298-11; Kimura S, 2004, ANTIMICROB AGENTS CH, V48, P1454, DOI 10.1128/AAC.48.5.1454-1460.2004; Lim D, 2001, NAT STRUCT BIOL, V8, P848, DOI 10.1038/nsb1001-848; Livermore DM, 2006, TRENDS MICROBIOL, V14, P413, DOI 10.1016/j.tim.2006.07.008; Marciano DC, 2008, J MOL BIOL, V384, P151, DOI 10.1016/j.jmb.2008.09.009; Mehta SC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004949; MOBASHERY S, 1986, J BIOL CHEM, V261, P7879; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Novais A, 2008, ANTIMICROB AGENTS CH, V52, P2377, DOI 10.1128/AAC.01658-07; Otten R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03562-9; Palzkill T, 2018, FRONT MOL BIOSCI, V5, DOI 10.3389/fmolb.2018.00016; Patel MP, 2017, BIOCHEMISTRY-US, V56, P3443, DOI 10.1021/acs.biochem.7b00176; Patel MP, 2015, ANTIMICROB AGENTS CH, V59, P6741, DOI 10.1128/AAC.00618-15; Perez F, 2007, CURR OPIN PHARMACOL, V7, P459, DOI 10.1016/j.coph.2007.08.003; Petrosino J, 1999, J BIOL CHEM, V274, P2394, DOI 10.1074/jbc.274.4.2394; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PRATT RF, 1986, J AM CHEM SOC, V108, P5328, DOI 10.1021/ja00277a044; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; Scholtz J. M., 1989, PROTEIN STRUCTURE PR; Shimamura T, 2002, J BIOL CHEM, V277, P46601, DOI 10.1074/jbc.M207884200; Sideraki V, 2001, P NATL ACAD SCI USA, V98, P283, DOI 10.1073/pnas.011454198; Strynadka NCJ, 1996, NAT STRUCT BIOL, V3, P290, DOI 10.1038/nsb0396-290; STRYNADKA NCJ, 1992, NATURE, V359, P700, DOI 10.1038/359700a0; Strynadka NCJ, 1996, NAT STRUCT BIOL, V3, P688, DOI 10.1038/nsb0896-688; Studer RA, 2014, P NATL ACAD SCI USA, V111, P2223, DOI 10.1073/pnas.1310811111; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Tokuriki N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000002; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vandavasi VG, 2016, J MED CHEM, V59, P474, DOI 10.1021/acs.jmedchem.5b01215; Wang XJ, 2002, J MOL BIOL, V320, P85, DOI 10.1016/S0022-2836(02)00400-X; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xiao H, 2015, P NATL ACAD SCI USA, V112, P6961, DOI 10.1073/pnas.1507741112; Yang G, 2016, BIOCHEMISTRY-US, V55, P4583, DOI 10.1021/acs.biochem.6b00561	61	11	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2018	293	46					17971	17984		10.1074/jbc.RA118.003792	http://dx.doi.org/10.1074/jbc.RA118.003792			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HA6SG	30275013	Green Published, hybrid			2022-12-26	WOS:000450409500025
J	Korenblum, D				Korenblum, Daniel			Laplacian mixture modeling for network analysis and unsupervised learning on graphs	PLOS ONE			English	Article								Laplacian mixture models identify overlapping regions of influence in unlabeled graph and network data in a scalable and computationally efficient way, yielding useful low-dimensional representations. By combining Laplacian eigenspace and finite mixture modeling methods, they provide probabilistic or fuzzy dimensionality reductions or domain decompositions for a variety of input data types, including mixture distributions, feature vectors, and graphs or networks. Provable optimal recovery using the algorithm is analytically shown for a nontrivial class of cluster graphs. Heuristic approximations for scalable high-performance implementations are described and empirically tested. Connections to PageRank and community detection in network analysis demonstrate the wide applicability of this approach. The origins of fuzzy spectral methods, beginning with generalized heat or diffusion equations in physics, are reviewed and summarized. Comparisons to other dimensionality reduction and clustering methods for challenging unsupervised machine learning problems are also discussed.	[Korenblum, Daniel] Nanobio Md, Res Div, San Francisco, CA 10001 USA		Korenblum, D (corresponding author), Nanobio Md, Res Div, San Francisco, CA 10001 USA.	d@nanobio.md		Korenblum, Daniel/0000-0002-8539-4445				Azran A., 2006, IEEE COMPUTER VISION, V1, P190, DOI DOI 10.1109/CVPR.2006.289; Banushkina P, 2005, LECT NOTES COMPUT SC, V3695, P208; Belkin M, 2003, NEURAL COMPUT, V15, P1373, DOI 10.1162/089976603321780317; Bett DK, 2015, IEEE INT C BIOINFORM, P1614, DOI 10.1109/BIBM.2015.7359917; Bishop Christopher M., 2006, PATTERN RECOGNITION; Chung, 1997, SPECTRAL GRAPH THEOR, DOI DOI 10.1090/CBMS/092; Chung F., 1998, J COMB, V6, P163; Dmitriev N., 1945, C R DOKL ACAD SCI UR, V49, P159; Everitt B S, 1996, Stat Methods Med Res, V5, P107, DOI 10.1177/096228029600500202; Fasshauer G., 2007, MESHFREE APPROXIMATI; FIEDLER M, 1973, CZECH MATH J, V23, P298; Gleich DF, 2015, SIAM REV, V57, P321, DOI 10.1137/140976649; Gould S, 2014, LECT NOTES COMPUT SC, V8689, P632, DOI 10.1007/978-3-319-10590-1_41; Guo JM, 2007, COMPUT MATH APPL, V54, P709, DOI 10.1016/j.camwa.2007.02.009; Heath JR, 2015, P NATL ACAD SCI USA, V112, P14436, DOI 10.1073/pnas.1515202112; Kondor R.I., 2002, P 19 INT C MACHINE L, P315; Korenblum D, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.056704; KRAMER HP, 1959, ANN MATH STAT, V30, P149, DOI 10.1214/aoms/1177706367; Lancichinetti A, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.066122; MAAS C, 1987, Z ANGEW MATH MECH, V67, pT428; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; McAuliffe JD, 2006, STAT COMPUT, V16, P5, DOI 10.1007/s11222-006-5196-2; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Ng AY, 2002, ADV NEUR IN, V14, P849; Nie F., 2010, ADV NEURAL INFORM PR, V23, DOI DOI 10.1007/978-3-319-10690-8_12; Nie FP, 2010, IEEE T IMAGE PROCESS, V19, P1921, DOI 10.1109/TIP.2010.2044958; Pardalos P. M., 1993, Annals of Operations Research, V43, P87, DOI 10.1007/BF02024487; PARDALOS PM, 1994, J GLOBAL OPTIM, V4, P117, DOI 10.1007/BF01096719; Parter SV., 1962, J MATH ANAL APPL, V4, P102, DOI [10.1016/0022-247X(62)90032-X, DOI 10.1016/0022-247X(62)90032-X]; Patil A, 2011, NUCLEIC ACIDS RES, V39, pD744, DOI 10.1093/nar/gkq897; Pearson K., 1894, Philosophical Transactions, V185a, P71, DOI 10.1098/rsta.1894.0003; Risken H., 1989, FOKKER PLANCK EQUATI, DOI [10.1007/978-3-642-61544-3, DOI 10.1007/978-3-642-61544-3, 10.1007/978-3-642-61544-3_4]; Ronan T, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad1932; ROWLINSON P, 1990, B LOND MATH SOC, V22, P209, DOI 10.1112/blms/22.3.209; Schiebinger G, 2015, ANN STAT, V43, P819, DOI 10.1214/14-AOS1283; Shalloway D, 1996, J CHEM PHYS, V105, P9986, DOI 10.1063/1.472830; Shamir R, 2004, DISCRETE APPL MATH, V144, P173, DOI 10.1016/j.dam.2004.01.007; Shi T, 2009, ANN STAT, V37, P3960, DOI 10.1214/09-AOS700; Smola AJ, 2003, LECT NOTES ARTIF INT, V2777, P144, DOI 10.1007/978-3-540-45167-9_12; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Wang R, 2017, IEEE T IMAGE PROCESS, V26, P5019, DOI 10.1109/TIP.2017.2726188; White BS, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056705; Yang J, 2015, KNOWL INF SYST, V42, P181, DOI 10.1007/s10115-013-0693-z	43	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204096	10.1371/journal.pone.0204096	http://dx.doi.org/10.1371/journal.pone.0204096			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273384	Green Published, Green Submitted, gold			2022-12-26	WOS:000446124700014
J	Sagadevan, S; Chowdhury, ZZ; Bin Johan, MR; Khan, AA; Aziz, FA; Rafique, RF; Hoque, ME				Sagadevan, Suresh; Chowdhury, Zaira Zaman; Bin Johan, Mohd Rafie; Khan, Ali A.; Aziz, Fauziah Abdul; Rafique, Rahman F.; Hoque, Md Enamul			A facile hydrothermal approach for catalytic and optical behavior of tin oxide- graphene (SnO2/G) nanocomposite	PLOS ONE			English	Article							POLLUTANT SOOT; NANOPARTICLES; GRAPHITE; DEGRADATION; NANOSHEETS; PERFORMANCE; COMPOSITE; GROWTH; FILMS; TIO2	A cost-effective, facile hydrothermal approach was made for the synthesis of SnO2/graphene (Gr) nano-composites. XRD diffraction spectra clearly confirmed the presence of tetragonal crystal system of SnO2 which was maintaining its structure in both pure and composite materials' matrix. The stretching and bending vibrations of the functional groups were analyzed using FTIR analysis. FESEM images illustrated the surface morphology and the texture of the synthesized sample. HRTEM images confirmed the deposition of SnO2 nanoparticles over the surface of graphene nano-sheets. Raman Spectroscopic analysis was carried out to confirm the in-plane blending of SnO2 and graphene inside the composite matrix. The photocatalytic performance of the synthesized sample under UV irradiation using methylene blue dye was observed. Incorporation of grapheme into the SnO2 sample had increased the photocatalytic activity compared with the pure SnO2 sample. The electrochemical property of the synthesized sample was evaluated.	[Sagadevan, Suresh] AMET Univ, Ctr Nanotechnol, Madras, Tamil Nadu, India; [Sagadevan, Suresh; Aziz, Fauziah Abdul] Natl Def Univ Malaysia, Ctr Def Fdn Studies, Dept Phys, Kuala Lumpur, Malaysia; [Chowdhury, Zaira Zaman; Bin Johan, Mohd Rafie; Khan, Ali A.] Univ Malaya, Nanotechnol & Catalysis Res Ctr, Kuala Lumpur, Malaysia; [Rafique, Rahman F.] Rutgers State Univ, Rutgers Cooperat Extens Water Resources Program, New Brunswick, NJ USA; [Hoque, Md Enamul] Mil Inst Sci & Technol MIST Mirpur Cantonment, Dept Biomed Engn, Dhaka, Bangladesh	Universiti Pertahanan Nasional Malaysia; Universiti Malaya; Rutgers State University New Brunswick	Sagadevan, S (corresponding author), AMET Univ, Ctr Nanotechnol, Madras, Tamil Nadu, India.; Sagadevan, S (corresponding author), Natl Def Univ Malaysia, Ctr Def Fdn Studies, Dept Phys, Kuala Lumpur, Malaysia.; Chowdhury, ZZ (corresponding author), Univ Malaya, Nanotechnol & Catalysis Res Ctr, Kuala Lumpur, Malaysia.	drsureshnano@gmail.com; zaira.chowdhury76@gmail.com	JOHAN, MOHD RAFIE/B-9106-2010; Rafique, Rahman Faizur/AAE-5229-2020; chowdhury, zaira zaman/B-3016-2017; Chowdhury, Zaira Zaman/R-7276-2016; Sagadevan, Suresh/ABF-3381-2021; Hoque, Enamul/L-9825-2017; Abdul Aziz, Fauziah/C-3374-2011	JOHAN, MOHD RAFIE/0000-0003-1133-9977; Rafique, Rahman Faizur/0000-0002-1186-4061; chowdhury, zaira zaman/0000-0001-7788-8747; Chowdhury, Zaira Zaman/0000-0001-7788-8747; Hoque, Enamul/0000-0003-0393-6771; Abdul Aziz, Fauziah/0000-0003-0773-4990; Sagadevan, Suresh/0000-0003-0393-7344; Sagadevan, Suresh/0000-0003-2779-6339	University Malaya, Malaysia [RP044C-17AET, RP044D-17AET]; Ministry of Higher Education under the Niche Research Grant Scheme (NRGS) [NRGS/2013/UPNM/PK/P1]	University Malaya, Malaysia; Ministry of Higher Education under the Niche Research Grant Scheme (NRGS)	This work has been conducted under the grants RP044C-17AET and RP044D-17AET of University Malaya, Malaysia to Z.C. The authors F.A and S.S would like to acknowledge the financial support provided by The Ministry of Higher Education under the Niche Research Grant Scheme (NRGS) NRGS/2013/UPNM/PK/P1.	Abergel DSL, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2768625; Baek S, 2011, RSC ADV, V1, P1687, DOI 10.1039/c1ra00797a; Berger C, 2004, J PHYS CHEM B, V108, P19912, DOI 10.1021/jp040650f; Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109; Cozzoli PD, 2004, J AM CHEM SOC, V126, P3868, DOI 10.1021/ja0395846; Dresselhaus MS, 2002, ADV PHYS, V51, P1, DOI [10.1080/00018730110113644, 10.1080/00018738100101367]; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Hirata M, 2004, CARBON, V42, P2929, DOI 10.1016/j.carbon.2004.07.003; Hou CY, 2011, CARBON, V49, P47, DOI 10.1016/j.carbon.2010.08.040; Khare P, 2018, ACS SUSTAIN CHEM ENG, V6, P579, DOI 10.1021/acssuschemeng.7b02929; Kim H, 2010, NANO RES, V3, P813, DOI 10.1007/s12274-010-0050-4; Kumar M, 2017, VACUUM, V146, P517, DOI 10.1016/j.vacuum.2017.03.002; Kumar M, 2016, PLASMONICS, V11, P261, DOI 10.1007/s11468-015-0044-x; Kumar M, 2015, SCRIPTA MATER, V105, P46, DOI 10.1016/j.scriptamat.2015.04.030; Kumar M, 2014, PLASMONICS, V9, P129, DOI 10.1007/s11468-013-9605-z; Kumar M, 2011, J APPL PHYS, V109, DOI 10.1063/1.3555593; Kumar M, 2009, PHYS STATUS SOLIDI B, V246, P2232, DOI 10.1002/pssb.200844464; Li FH, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/45/455602; Li J, 2012, MATER LETT, V78, P106, DOI 10.1016/j.matlet.2012.03.013; Li ZS, 2013, ENERG ENVIRON SCI, V6, P347, DOI 10.1039/c2ee22618a; Meng XB, 2011, J MATER CHEM, V21, P12321, DOI 10.1039/c1jm11511a; Mishra YK, 2018, MATER TODAY, V21, P631, DOI 10.1016/j.mattod.2017.11.003; Muhulet A, 2018, MATER TODAY ENERGY, V9, P154, DOI 10.1016/j.mtener.2018.05.002; Naebe M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04375; Nair RR, 2008, SCIENCE, V320, P1308, DOI 10.1126/science.1156965; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Paek SM, 2009, NANO LETT, V9, P72, DOI 10.1021/nl802484w; Pan XY, 2013, J PHYS CHEM C, V117, P17996, DOI 10.1021/jp4064802; Park SK, 2012, J MATER CHEM, V22, P2520, DOI 10.1039/c1jm14199f; Ramachandran R, 2014, RSC ADV, V4, P21151, DOI 10.1039/c4ra01515k; Sagadevan S, 2018, J MATER SCI-MATER EL, V29, P9099, DOI 10.1007/s10854-018-8937-z; Sagadevan S, 2018, MATER RES EXPRESS, V5, DOI 10.1088/2053-1591/aab173; Sagadevan S, 2017, MATER RES EXPRESS, V4, DOI 10.1088/2053-1591/aa9a8c; Sagadevan S, 2017, J MATER SCI-MATER EL, V28, P17193, DOI 10.1007/s10854-017-7648-1; Sagadevan S, 2017, J ALLOY COMPD, V728, P645, DOI 10.1016/j.jallcom.2017.09.061; Sagadevan S, 2017, J MATER SCI-MATER EL, V28, P7892, DOI 10.1007/s10854-017-6488-3; Seema H, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/35/355705; Singh A, 2017, ACS SUSTAIN CHEM ENG, V5, P8860, DOI 10.1021/acssuschemeng.7b01645; Singh V, 2011, PROG MATER SCI, V56, P1178, DOI 10.1016/j.pmatsci.2011.03.003; Smazna D., NANOSCALE, V10, P1, DOI [10.1039/x0xx00000x, DOI 10.1039/X0XX00000X]; Stankovich S, 2007, CARBON, V45, P1558, DOI 10.1016/j.carbon.2007.02.034; Stankovich S, 2006, NATURE, V442, P282, DOI 10.1038/nature04969; Talebian N, 2010, THIN SOLID FILMS, V518, P2210, DOI 10.1016/j.tsf.2009.07.135; Tripathi KM, 2018, SUSTAIN MATER TECHNO, V16, P1, DOI 10.1016/j.susmat.2018.01.001; Tripathi KM, 2017, ACS SUSTAIN CHEM ENG, V5, P2906, DOI 10.1021/acssuschemeng.6b01937; Tripathi KM, 2016, ACS SUSTAIN CHEM ENG, V4, P6399, DOI 10.1021/acssuschemeng.6b01045; Tran TS, 2017, MATER RES BULL, V96, P395, DOI 10.1016/j.materresbull.2017.04.012; Wang F, 2008, SCIENCE, V320, P206, DOI 10.1126/science.1152793; Wang W, 2018, RSC ADV, V8, P2410, DOI 10.1039/c7ra12455d; Xiong ZG, 2010, CHEM COMMUN, V46, P6099, DOI 10.1039/c0cc01259a; Xu MW, 2007, J SOLID STATE ELECTR, V11, P1101, DOI 10.1007/s10008-006-0246-4; Xu M, 2007, J PHYS CHEM C, V111, P19141, DOI 10.1021/jp076730b; Zhang JT, 2011, J MATER CHEM, V21, P3634, DOI 10.1039/c0jm03827j; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235; Zhou XZ, 2009, J PHYS CHEM C, V113, P10842, DOI 10.1021/jp903821n; Zhu YQ, 2013, RSC ADV, V3, P11860, DOI 10.1039/c3ra41863d	56	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0202694	10.1371/journal.pone.0202694	http://dx.doi.org/10.1371/journal.pone.0202694			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273344	gold, Green Published, Green Submitted			2022-12-26	WOS:000446124700005
J	Sobhkhez, M; Krasnov, A; Robertsen, B				Sobhkhez, Mehrdad; Krasnov, Aleksei; Robertsen, Borre			Transcriptome analyses of Atlantic salmon muscle genes induced by a DNA vaccine against salmonid alphavirus, the causative agent of salmon pancreas disease (PD)	PLOS ONE			English	Article							HEMATOPOIETIC NECROSIS VIRUS; ALDRICH-SYNDROME PROTEIN; AFFINITY IGG RECEPTOR; CLASS-II GENES; INTERFERON-GAMMA; INFLAMMATORY DISEASE; RAINBOW-TROUT; EXPRESSION; INDUCTION; CHEMOKINES	Salmonid alphavirus (SAV) is the causative agent of pancreas disease (PD) in farmed Atlantic salmon. A previous study showed that vaccination of pre-smolt salmon with a plasmid encoding the structural polypeptide of SAV gave protection against infection and development of PD accompanied by production of antibodies against the virus. In the present work we analyzed transcript responses in the muscle to vaccination with this plasmid (here named pSAV). The purpose was to shed light on how pSAV might initiate adaptive immune responses in the fish. The work was based on microarray and reverse transcription quantitative PCR analyses of muscle at the injection site 7 days after vaccination. The results showed that pSAV and pcDNA3.3 had similar abilities to up-regulate type I IFN stimulated genes. In contrast, pSAV caused higher up-regulation of IFN gamma and several IFN gamma inducible genes. Compared to pcDNA3.3, pSAV also gave larger increase in transcripts of marker genes for B-cells, T-cells and antigen presenting cells (APCs), which suggest attraction and role of these cells in the adaptive immune responses elicited by pSAV. Moreover, pSAV caused a stronger up-regulation of the chemokine CXCL10 and the proinflammatory cytokines IL-1 beta and TNF alpha, which may explain attraction of lymphocytes and APCs. The present work shows that the expression profile of genes resulting from vaccination with pSAV is different from the expression profiles obtained previously by vaccination of salmonids with DNA vaccines against infectious salmon anemia virus and infectious hematopoietic necrosis virus.	[Sobhkhez, Mehrdad; Robertsen, Borre] UiT Arctic Univ Norway, Norwegian Coll Fishery Sci, Tromso, Norway; [Krasnov, Aleksei] Nofima As, Norwegian Inst Food Fisheries & Aquaculture Res, AS, Norway	UiT The Arctic University of Tromso; Nofima	Robertsen, B (corresponding author), UiT Arctic Univ Norway, Norwegian Coll Fishery Sci, Tromso, Norway.	borre.robertsen@uit.no			Aquaculture programme of the Research Council of Norway [254907/E40]; NOFIMA AS; Research Council of Norway; Ministry of Trade, Industry and Fisheries; Norwegian Seafood Research Fund (FHF)	Aquaculture programme of the Research Council of Norway; NOFIMA AS(Nofima); Research Council of Norway(Research Council of Norway); Ministry of Trade, Industry and Fisheries; Norwegian Seafood Research Fund (FHF)	Borre Robertsen received funding from the Aquaculture programme of the Research Council of Norway (https://www.forskningsradet.no/en/Home_page/1177315753906), grant no. 254907/E40. NOFIMA AS (https://nofima.no/en/research/) provided support in the form of salaries for author AK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. NOFIMA AS is a non-profit research institution supported by grants from the following sources: The Research Council of Norway; The Ministry of Trade, Industry and Fisheries; The Norwegian Seafood Research Fund (FHF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarca-Heidemann K, 2002, IMMUNOL LETT, V83, P197, DOI 10.1016/S0165-2478(02)00104-9; Ai KT, 2018, FISH SHELLFISH IMMUN, V72, P31, DOI 10.1016/j.fsi.2017.10.042; AKI M, 1994, J BIOCHEM, V115, P257, DOI 10.1093/oxfordjournals.jbchem.a124327; Alenghat FJ, 2012, J CELL SCI, V125, P5535, DOI 10.1242/jcs.111260; Anderson ED, 1996, MOL MAR BIOL BIOTECH, V5, P114; Barnes BJ, 2002, MOL CELL BIOL, V22, P5721, DOI 10.1128/MCB.22.16.5721-5740.2002; Bergan V, 2010, MOL IMMUNOL, V47, P2005, DOI 10.1016/j.molimm.2010.04.015; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Chang CJ, 2017, J FISH DIS, V40, P1775, DOI 10.1111/jfd.12644; Chang CJ, 2015, VACCINE, V33, P2442, DOI 10.1016/j.vaccine.2015.03.093; Chang CJ, 2014, VACCINE, V32, P4695, DOI 10.1016/j.vaccine.2014.05.059; Choi NM, 2011, CURR OPIN IMMUNOL, V23, P81, DOI 10.1016/j.coi.2010.09.007; Hallen LC, 2007, J INTERF CYTOK RES, V27, P675, DOI 10.1089/jir.2007.0021; Hultqvist M, 2005, CELL IMMUNOL, V233, P97, DOI 10.1016/j.cellimm.2005.04.008; Kloetzel PM, 2001, NAT REV MOL CELL BIO, V2, P179, DOI 10.1038/35056572; Krasnov A, 2011, COMP BIOCHEM PHYS D, V6, P31, DOI 10.1016/j.cbd.2010.04.006; Kutzler MA, 2008, NAT REV GENET, V9, P776, DOI 10.1038/nrg2432; Ma WL, 1997, J BIOL CHEM, V272, P16585, DOI 10.1074/jbc.272.26.16585; McCarthy MK, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00021; Morley Sharon Celeste, 2012, Int J Cell Biol, V2012, P935173, DOI 10.1155/2012/935173; Orange JS, 2002, P NATL ACAD SCI USA, V99, P11351, DOI 10.1073/pnas.162376099; Paun A, 2007, BIOCHIMIE, V89, P744, DOI 10.1016/j.biochi.2007.01.014; PEARSE RN, 1991, P NATL ACAD SCI USA, V88, P11305, DOI 10.1073/pnas.88.24.11305; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Purcell MK, 2006, MOL IMMUNOL, V43, P2089, DOI 10.1016/j.molimm.2005.12.005; Salonius K, 2007, CURR OPIN INVEST DR, V8, P635; Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; SEGAL AW, 1992, BIOCHEM J, V284, P781, DOI 10.1042/bj2840781; SINGER DS, 1990, CRIT REV IMMUNOL, V10, P235; Sobhkhez M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188456; Stirnweiss A, 2010, J IMMUNOL, V184, P5179, DOI 10.4049/jimmunol.0902264; Sun BJ, 2011, J VIROL, V85, P9188, DOI 10.1128/JVI.00319-11; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Traxler GS, 1999, DIS AQUAT ORGAN, V38, P183, DOI 10.3354/dao038183; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Tsuboi S, 2006, J IMMUNOL, V176, P6576, DOI 10.4049/jimmunol.176.11.6576; Turner MD, 2014, BBA-MOL CELL RES, V1843, P2563, DOI 10.1016/j.bbamcr.2014.05.014; van den Elsen PJ, 1998, IMMUNOL TODAY, V19, P308, DOI 10.1016/S0167-5699(98)01287-0; van der Poel CE, 2011, J IMMUNOL, V186, P2699, DOI 10.4049/jimmunol.1003526; Vestal DJ, 2011, J INTERF CYTOK RES, V31, P89, DOI 10.1089/jir.2010.0102	41	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204924	10.1371/journal.pone.0204924	http://dx.doi.org/10.1371/journal.pone.0204924			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273392	Green Published, gold, Green Submitted			2022-12-26	WOS:000446124700049
J	Fan, HC; Chen, CY; Hsu, YC; Chou, RH; Teng, CLJ; Chiu, CH; Hsu, CY; Muo, CH; Chang, MY; Chang, KH				Fan, Hueng-Chuen; Chen, Chiu-Ying; Hsu, Yi-Chao; Chou, Ruey-Hwang; Teng, Chieh-Lin Jerry; Chiu, Chun-Hsiang; Hsu, Chung Y.; Muo, Chih-Hsin; Chang, Mei-Yin; Chang, Kuang-Hsi			Increased risk of incident nasopharyngeal carcinoma with exposure to air pollution	PLOS ONE			English	Article							BREAST-CANCER; EPIDEMIOLOGY; NITROSAMINES; CONSUMPTION; SHANGHAI; WORKERS	Background Nasopharyngeal carcinoma (NPC) is a race-specific malignancy. The nasal cavity is the main entry point for air pollutants or poisonous gases into the human body. However, the risk of NPC in populations exposed to air pollution remains unknown. Methods We combined data from the Taiwan Air Quality Monitoring Database (TAQMD) and the Longitudinal Health Insurance Database (LHID) to assess the risk of NPC in a population exposed to air pollution. Results Multivariate analysis revealed positive trends for the association between the risk of NPC and exposure to air pollution. After adjusting for potential covariates, the risk of developing NPC increased with the increase in nitrogen dioxide (NO2) and fine particulate matter (PM2.5) exposure concentrations from 1.39 to 2.28 and 2.01 to 1.97, respectively, compared to the risks at the lowest concentration levels. Conclusions We identified a significant risk of NPC in a population exposed to air pollution. However, this study had several limitations. Moreover, additional experimental and clinical studies on the associations between environmental factors and NPC risk are warranted.	[Fan, Hueng-Chuen; Chang, Kuang-Hsi] Tungs Taichung Metroharbor Hosp, Dept Med Res, Taichung, Taiwan; [Fan, Hueng-Chuen] Tungs Taichung Metroharbor Hosp, Dept Med Res, Dept Pediat, Taichung, Taiwan; [Fan, Hueng-Chuen; Chang, Kuang-Hsi] Jen Teh Jr Coll Med Nursing & Management, Dept Rehabil, Miaoli, Taiwan; [Chen, Chiu-Ying] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Hsu, Yi-Chao] Mackay Med Coll, Inst Biomed Sci, New Taipei, Taiwan; [Chou, Ruey-Hwang; Hsu, Chung Y.; Chang, Kuang-Hsi] China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan; [Chou, Ruey-Hwang] China Med Univ, Ctr Mol Med, Taichung, Taiwan; [Chou, Ruey-Hwang] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Teng, Chieh-Lin Jerry] Taichung Vet Gen Hosp, Dept Med, Div Hematol Med Oncol, Taichung, Taiwan; [Teng, Chieh-Lin Jerry] Tunghai Univ, Dept Life Sci, Taichung, Taiwan; [Teng, Chieh-Lin Jerry] Chung Shan Med Univ, Dept Med, Taichung, Taiwan; [Chiu, Chun-Hsiang] Triserv Gen Hosp, Natl Def Med Ctr, Dept Internal Med, Div Infect Dis & Trop Med, Taipei, Taiwan; [Chiu, Chun-Hsiang] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei, Taiwan; [Muo, Chih-Hsin] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Chang, Mei-Yin] Fooyin Univ, Sch Med & Hlth Sci, Dept Med Lab Sci & Biotechnol, Kaohsiung, Taiwan	Tungs' Taichung MetroHarbor Hospital; Tungs' Taichung MetroHarbor Hospital; China Medical University Taiwan; Mackay Medical College; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan; Taichung Veterans General Hospital; Tunghai University; Chung Shan Medical University; National Defense Medical Center; Tri-Service General Hospital; National Yang Ming Chiao Tung University; China Medical University Taiwan; China Medical University Hospital - Taiwan; Fooyin University	Chang, KH (corresponding author), Tungs Taichung Metroharbor Hosp, Dept Med Res, Taichung, Taiwan.; Chang, KH (corresponding author), Jen Teh Jr Coll Med Nursing & Management, Dept Rehabil, Miaoli, Taiwan.; Chang, KH (corresponding author), China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan.	kuanghsichang@gmail.com	Teng, Chieh-Lin Jerry/AAC-7441-2020; Chou, Ruey-Hwang/K-8541-2013; Hsu, Yi-Chao/AAK-7478-2021	Teng, Chieh-Lin Jerry/0000-0001-9744-0368; Chou, Ruey-Hwang/0000-0002-2297-2180; Chang, Kuang Hsi/0000-0002-4453-0068	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105-TDU-B-212-133019]; China Medical University Hospital; Academia Sinica Taiwan Biobank; Stroke Biosignature Project [BM104010092]; NRPB Stroke Clinical Trial Consortium [MOST 103-2325B-039 -006]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan from the Ministry of Education of Taiwan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital; Academia Sinica Taiwan Biobank; Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan from the Ministry of Education of Taiwan	This study was supported in part by the Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019); China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Biosignature Project (BM104010092); the NRPB Stroke Clinical Trial Consortium (MOST 103-2325B-039 -006); the Tseng-Lien Lin Foundation, Taichung, Taiwan; the Taiwan Brain Disease Foundation, Taipei, Taiwan; the Katsuzo and Kiyo Aoshima Memorial Funds, Japan; and the CMU under the Aim for Top University Plan from the Ministry of Education of Taiwan. (CMU is China Medical University; NRPB is National Research Program for Biopharmaceuticals.)	Bourouba M, 2015, CYTOKINE, V74, P157, DOI 10.1016/j.cyto.2015.04.003; Bradshaw PT, 2016, EPIDEMIOLOGY, V27, P6, DOI 10.1097/EDE.0000000000000394; Busson P, 2004, TRENDS MICROBIOL, V12, P356, DOI 10.1016/j.tim.2004.06.005; Chang ET, 2006, CANCER EPIDEM BIOMAR, V15, P1765, DOI 10.1158/1055-9965.EPI-06-0353; Chang KH, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000733; Chang KH, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001485; Chang KH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103078; Chang KH, 2014, AGE, V36, P967, DOI 10.1007/s11357-013-9608-x; Chen RW, 2015, ONCOTARGETS THER, V8, P2835, DOI 10.2147/OTT.S90430; Cheng YJ, 1999, CANCER CAUSE CONTROL, V10, P201, DOI 10.1023/A:1008893109257; Database NHIR, 2015, TAIWAN; Enoch MA, 2002, AM FAM PHYSICIAN, V65, P441; Fashi M, 2015, IRAN J CANCER PREV, V8, DOI 10.17795/ijcp2333; Feng BJ, 2009, BRIT J CANCER, V101, P1207, DOI 10.1038/sj.bjc.6605281; Hamra GB, 2015, ENVIRON HEALTH PERSP, V123, P1107, DOI 10.1289/ehp.1408882; Ho CK, 1999, OCCUP ENVIRON MED, V56, P426, DOI 10.1136/oem.56.6.426; Huang WY, 2015, CLIN OTOLARYNGOL, V40, P327, DOI 10.1111/coa.12371; Li PY, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1895-4; Li W, 2006, OCCUP ENVIRON MED, V63, P39, DOI 10.1136/oem.2005.021709; Lin JH, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1902-9; Lourembam Deepak Singh, 2015, Asian Pac J Cancer Prev, V16, P4927; Miller BA, 2002, AM J EPIDEMIOL, V155, P534, DOI 10.1093/aje/155.6.534; Murphy BA, 2015, J CLIN ONCOL, V33, P3314, DOI 10.1200/JCO.2015.61.3836; Ni L, 2015, FRONT PHYSIOL, V6, DOI [10.3339/fphys.2015.00294, 10.3389/fphys.2015.00294]; Panasevich S, 2009, OCCUP ENVIRON MED, V66, P747, DOI 10.1136/oem.2008.043471; Parkin WSL, 1997, IARC PUBL, Vi-xxxiv, P1; Pauwels RA, 2004, LANCET, V364, P613, DOI 10.1016/S0140-6736(04)16855-4; Polesel J, 2013, CANCER CAUSE CONTROL, V24, P1157, DOI 10.1007/s10552-013-0195-z; Shen ZC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121420; Song HN, 2016, CANCER RES TREAT, V48, P789, DOI 10.4143/crt.2015.062; Tseng CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131911; Ward MH, 2000, INT J CANCER, V86, P603, DOI 10.1002/(SICI)1097-0215(20000601)86:5&lt;603::AID-IJC1&gt;3.0.CO;2-H; Xie SH, 2014, ENVIRON MOL MUTAGEN, V55, P751, DOI 10.1002/em.21894; Yu MC, 2002, SEMIN CANCER BIOL, V12, P421, DOI 10.1016/S1044579X02000858; YU MC, 1990, INT J CANCER, V45, P1033, DOI 10.1002/ijc.2910450609; Yuan JM, 2000, INT J CANCER, V85, P364, DOI 10.1002/(SICI)1097-0215(20000201)85:3&lt;364::AID-IJC12&gt;3.0.CO;2-C; Zhang Y, 2015, ENVIRON TOXICOL; ZHENG YM, 1994, BRIT J CANCER, V69, P508, DOI 10.1038/bjc.1994.92; ZOU XN, 1994, INT J CANCER, V59, P155, DOI 10.1002/ijc.2910590202	39	15	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204568	10.1371/journal.pone.0204568	http://dx.doi.org/10.1371/journal.pone.0204568			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265690	gold, Green Published, Green Submitted			2022-12-26	WOS:000446005500037
J	Voolstra, O; Strauch, L; Mayer, M; Huber, A				Voolstra, Olaf; Strauch, Lisa; Mayer, Matthias; Huber, Armin			Functional characterization of the three Drosophila retinal degeneration C (RDGC) protein phosphatase isoforms	PLOS ONE			English	Article							IN-VIVO; RHODOPSIN; APOPTOSIS; PHOSPHORYLATION; PHOTORECEPTORS; ENCODES; CHANNEL; OPSIN; STATE; GENE	Drosophila retinal degeneration C (RDGC) is the founding member of the PPEF family of protein phosphatases. RDGC mediates dephosphorylation of the visual pigment rhodopsin and the TRP ion channel. From the rdgC locus, three protein isoforms, termed RDGC-S, -M, and -L, with different N-termini are generated. Due to fatty acylation, RDGC-M and -L are attached to the plasma membrane while RDGC-S is soluble. To assign physiological roles to these RDGC isoforms, we constructed flies that express various combinations of RDGC protein isoforms. Expression of the RDGC-L isoform alone did not fully prevent rhodopsin hyperphosphorylation and resulted in impaired photoreceptor physiology and in decelerated TRP dephosphorylation at Ser936. However, expression of RDGC-L alone as well as RDGC-S/M was sufficient to prevent degeneration of photoreceptor cells which is a hallmark of the rdgC null mutant. Membrane-attached RDGC-M displayed higher activity of TRP dephosphorylation than the soluble isoform RDGC-S. Taken together, in vivo activities of RDGC splice variants are controlled by their N-termini.	[Voolstra, Olaf; Strauch, Lisa; Mayer, Matthias; Huber, Armin] Univ Hohenheim, Inst Physiol, Dept Biochem, Stuttgart, Germany	University Hohenheim	Voolstra, O (corresponding author), Univ Hohenheim, Inst Physiol, Dept Biochem, Stuttgart, Germany.	olaf.voolstra@uni-hohenheim.de	Huber, Armin/GYU-6322-2022					ADAMUS G, 1991, VISION RES, V31, P17, DOI 10.1016/0042-6989(91)90069-H; Alloway PG, 2000, NEURON, V28, P129, DOI 10.1016/S0896-6273(00)00091-X; Bentrop J, 1997, EMBO J, V16, P1600, DOI 10.1093/emboj/16.7.1600; Chorna-Ornan I, 2005, J CELL BIOL, V171, P143, DOI 10.1083/jcb.200503014; Davidson FF, 1998, NATURE, V391, P587, DOI 10.1038/35385; DOLPH PJ, 1993, SCIENCE, V260, P1910, DOI 10.1126/science.8316831; FRANCESCHINI N, 1971, KYBERNETIK, V9, P159, DOI 10.1007/BF02215177; Gratz SJ, 2013, FLY, V7, P249, DOI 10.4161/fly.26566; Katz B, 2009, FRONT CELL NEUROSCI, V3, DOI 10.3389/neuro.03.002.2009; Kiselev A, 2000, NEURON, V28, P139, DOI 10.1016/S0896-6273(00)00092-1; Lee SJ, 2001, NEURON, V32, P1097, DOI 10.1016/S0896-6273(01)00538-4; Montini E, 1997, HUM MOL GENET, V6, P1137, DOI 10.1093/hmg/6.7.1137; OTOUSA JE, 1985, CELL, V40, P839, DOI 10.1016/0092-8674(85)90343-5; Port F, 2014, P NATL ACAD SCI USA, V111, pE2967, DOI 10.1073/pnas.1405500111; Sherman PM, 1997, P NATL ACAD SCI USA, V94, P11639, DOI 10.1073/pnas.94.21.11639; Shieh BH, 2014, J BIOL CHEM, V289, P18526, DOI 10.1074/jbc.M114.571224; STEELE F, 1990, NEURON, V4, P883, DOI 10.1016/0896-6273(90)90141-2; STEELE FR, 1992, CELL, V69, P669, DOI 10.1016/0092-8674(92)90230-A; Strauch L, 2018, FEBS LETT, V592, P2403, DOI 10.1002/1873-3468.13163; Venken KJT, 2011, NAT METHODS, V8, P737, DOI 10.1038/nmeth.1662; Vinos J, 1997, SCIENCE, V277, P687, DOI 10.1126/science.277.5326.687; Voolstra O, 2017, J NEUROSCI, V37, P4213, DOI 10.1523/JNEUROSCI.3670-16.2017; Voolstra O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073787; Voolstra O, 2010, J BIOL CHEM, V285, P14275, DOI 10.1074/jbc.M110.102053	24	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204933	10.1371/journal.pone.0204933	http://dx.doi.org/10.1371/journal.pone.0204933			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265717	Green Published, gold, Green Submitted			2022-12-26	WOS:000446005500056
J	Budan, F; Szigeti, K; Weszl, M; Horvath, I; Balogh, E; Kanaan, R; Berenyi, K; Lacza, Z; Mathe, D; Gyongyi, Z				Budan, Ferenc; Szigeti, Krisztian; Weszl, Miklos; Horvath, Ildiko; Balogh, Erika; Kanaan, Reem; Berenyi, Karoly; Lacza, Zsombor; Mathe, Domokos; Gyongyi, Zoltan			Novel radiomics evaluation of bone formation utilizing multimodal (SPECT/X-ray CT) in vivo imaging	PLOS ONE			English	Article							MODELS; BANK; BIOMATERIALS; DISEASE; REPAIR	Although an extensive research is being undertaken, the ideal bone graft and evaluation method of the bone formation draw still a warranted attention. The purpose of this study was to develop a novel multimodal radiomics evaluation method, utilizing X-ray computed tomography (CT) and single photon emission computed tomography (SPECT) with Tc-99m-Methyl diphosphonate (Tc-99m-MDP) tracer. These modalities are intended to provide quantitative data concerning the mineral bone density (after evaluation it is referred to as opacity) and the osteoblast activity, at the same time. The properties of bone formation process within poly (methyl methacrylate)-based bone cement graft (PMMA) was compared to that of albumin coated, sterilized, antigen-extracted freeze-dried human bone grafts (HLBC), in caudal vertebrae (C5) of rats. The animals were scanned at 3 and 8 weeks after surgery. In both groups, the mean opacity increased, while the mean Tc-99m-MDP activity decreased. The later parameter was significant (n = 4, p = 0.002) only in HLBC group. The linear regression analysis of PMMA-treated group variables (mean opacity increase; mean Tc-99m-MDP activity decrease), revealed a negative correlation with the medium strength (r = 0.395, p = 0.605). Whereas, it showed strong positive correlation when HLBC group variables were analyzed (r = 0.772, p = 0.012). These results indicate that using HLBC grafts is advantageous in terms of the osteoblast activity and bone vascularization over PMMA cement. Using this regression analysis method, we were able to distinguish characteristics that otherwise could not be distinguished by a regular data analysis. Hence, we propose utilizing this novel method in preclinical tests, and in clinical monitoring of bone healing, in order to improve diagnosis of bone-related diseases.	[Budan, Ferenc; Balogh, Erika; Kanaan, Reem; Berenyi, Karoly; Gyongyi, Zoltan] Univ Pecs, Med Sch, Dept Publ Hlth Med, Pecs, Hungary; [Budan, Ferenc] MedProDevelop, Pecs, Hungary; [Szigeti, Krisztian; Weszl, Miklos; Horvath, Ildiko; Mathe, Domokos] Semmelweis Univ, Dept Biophys & Radiat Biol, Budapest, Hungary; [Weszl, Miklos; Lacza, Zsombor] Corvinus Univ Budapest, Dept Hlth Econ, Budapest, Hungary; [Weszl, Miklos] Semmelweis Univ, Inst Clin Expt Res, Budapest, Hungary; [Mathe, Domokos] CROmed Translat Res Ctr, Budapest, Hungary	University of Pecs; Semmelweis University; Corvinus University Budapest; Semmelweis University	Gyongyi, Z (corresponding author), Univ Pecs, Med Sch, Dept Publ Hlth Med, Pecs, Hungary.	zoltan.gyongyi@aok.pte.hu	Gyöngyi, Zoltán/B-6433-2014; Budán, Ferenc/AAW-1481-2020	Gyöngyi, Zoltán/0000-0001-9330-9119; Mathe, Domokos/0000-0001-7343-0413; Budan, Ferenc/0000-0003-1562-9496; Berenyi, Karoly/0000-0001-5886-1311	MedProDevelop Center; CROmed Translational Research Center	MedProDevelop Center; CROmed Translational Research Center	The authors received no specific funding for this work. Ferenc Budan is employed by MedProDevelop. Domokos Mathe is employed by CROmed Translational Research Centers. MedProDevelop and CROmed Translational Research Centers provided support in the form of salaries for authors [FB and DM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aberg J, 2011, INT J BIOMATER, V2011, DOI 10.1155/2011/232574; Albrektsson T, 2001, EUR SPINE J, V10, pS96, DOI 10.1007/s005860100282; ASPENBERG P, 1990, ACTA ORTHOP SCAND, V61, P546, DOI 10.3109/17453679008993579; Blazsek J, 2009, PATHOL ONCOL RES, V15, P567, DOI 10.1007/s12253-009-9156-y; CHAMBERS TJ, 1993, BONE MINER, V20, P167, DOI 10.1016/S0169-6009(08)80025-6; Chen FM, 2016, PROG POLYM SCI, V53, P86, DOI 10.1016/j.progpolymsci.2015.02.004; Chiu R, 2010, J ORTHOP RES, V28, P571, DOI 10.1002/jor.21035; Chopra A, 2004, MOL IMAGING CONTRAST; Coles ME, 1995, SCA C, P9513; ELLENDER G, 1988, J ANAT, V158, P173; Feeman TG, 2010, MATH MED IMAGING BEG, DOI [10.1007/978-3-319-22665-1, DOI 10.1007/978-3-319-22665-1]; FITZGERALD TA, 1983, J MED PRIMATOL, V12, P138; FOGELMAN I, 1978, J NUCL MED, V19, P270; Gupta AK, 2016, INDIAN J ORTHOP, V50, P427, DOI 10.4103/0019-5413.185609; Hartung T, 2010, ALTEX-ALTERN ANIM EX, V27, P285; Huber FX, 2006, J HAND SURG-BRIT EUR, V31B, P298, DOI 10.1016/j.jhsb.2005.12.006; KANISHI D, 1993, ORAL SURG ORAL MED O, V75, P239, DOI 10.1016/0030-4220(93)90100-I; Kon E, 2010, INJURY, V41, P693, DOI 10.1016/j.injury.2009.11.014; Lewis G, 2009, J APPL BIOMATER BIOM, V7, P90; Nunamaker DM, 1998, CLIN ORTHOP RELAT R, pS56; PELLER PJ, 1993, RADIOGRAPHICS, V13, P715, DOI 10.1148/radiographics.13.4.8356264; Renaud M, 2016, TISSUE ENG PART C-ME, V22, P125, DOI 10.1089/ten.tec.2015.0187; Roach P, 2007, J MATER SCI-MATER M, V18, P1263, DOI 10.1007/s10856-006-0064-3; Sheikh Z., 2013, DENT BIOMATERIALS PR; Sheikh Z., 2017, BIOMATER RES, V21, P9, DOI [10.1186/s40824-017-0095-5 28593053, DOI 10.1186/S40824-017-0095-5]; Sullivan MP, 2014, BONE JOINT J, V96B, P569, DOI 10.1302/0301-620X.96B5.33606; Szigeti K, 2018, CONTRAST MEDIA MOL I, DOI 10.1155/2018/2023604; Szigeti K, 2016, BMC MED IMAGING, V16, DOI 10.1186/s12880-016-0118-z; THOREN K, 1995, CLIN ORTHOP RELAT R, P232; Vaishya Raju, 2013, J Clin Orthop Trauma, V4, P157, DOI 10.1016/j.jcot.2013.11.005; Weszl M, 2012, J ORTHOP RES, V30, P489, DOI 10.1002/jor.21527	31	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2018	13	9							e0204423	10.1371/journal.pone.0204423	http://dx.doi.org/10.1371/journal.pone.0204423			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU9BO	30252902	Green Published, Green Submitted, gold			2022-12-26	WOS:000445639700050
J	Fasbender, L; Yanez-Serrano, AM; Kreuzwieser, J; Dubbert, D; Werner, C				Fasbender, Lukas; Yanez-Serrano, Ana Maria; Kreuzwieser, Juergen; Dubbert, David; Werner, Christiane			Real-time carbon allocation into biogenic volatile organic compounds (BVOCs) and respiratory carbon dioxide (CO2) traced by PTR-TOF-MS, (CO2)-C-13 laser spectroscopy and C-13-pyruvate labelling	PLOS ONE			English	Article							LEAF-RESPIRED CO2; ISOTOPIC COMPOSITION; MASS-SPECTROMETRY; DIURNAL-VARIATION; GAS-EXCHANGE; BIOSYNTHESIS; EMISSIONS; LIGHT; ISOPRENE; TEMPERATURE	Our understanding of biogenic volatile organic compound (BVOC) emissions improved substantially during the last years. Nevertheless, there are still large uncertainties of processes controlling plant carbon investment into BVOCs, of some biosynthetic pathways and their linkage to CO2 decarboxylation at central metabolic branching points. To shed more light on carbon partitioning during BVOC biosynthesis, we used an innovative approach combining delta(CO2)-C-13 laser spectroscopy, high-sensitivity proton-transfer-reaction time-of-flight mass spectrometry and a multiple branch enclosure system in combination with position-specific C-13-metabolite labelling. Feeding experiments with position-specific C-13-labelled pyruvate, a central metabolite of BVOC synthesis, enabled online detection of carbon partitioning into C-13-BVOCs and respiratory (CO2)-C-13. Measurements of trace gas emissions of the Mediterranean shrub Halimium halimifolium revealed a broad range of emitted BVOCs. In general, [2-13C]-PYR was rapidly incorporated into emitted acetic acid, methyl acetate, toluene, cresol, trimethylbenzene, ethylphenol, monoterpenes and sesquiterpenes, indicating de novo BVOC biosynthesis of these compounds. In contrast, [1-13C]-pyruvate labelling substantially increased (CO2)-C-13 emissions in the light indicating C1-decarboxylation. Similar labelling patterns of methyl acetate and acetic acid suggested tightly connected biosynthetic pathways and, furthermore, there were hints of possible biosynthesis of benzenoids via the MEP-pathway. Overall, substantial CO2 emission from metabolic branching points during de novo BVOC biosynthesis indicated that decarboxylation of [1-13C]-pyruvate, as a non-mitochondrial source of CO2, seems to contribute considerably to daytime CO2 release from leaves. Our approach, combining synchronised BVOC and CO2 measurements in combination with position-specific labelling opens the door for real-time analysis tracing metabolic pathways and carbon turnover under different environmental conditions, which may enhance our understanding of regulatory mechanisms in plant carbon metabolism and BVOC biosynthesis.	[Fasbender, Lukas; Yanez-Serrano, Ana Maria; Kreuzwieser, Juergen; Dubbert, David; Werner, Christiane] Albert Ludwigs Univ Freiburg, Fac Environm & Nat Resources, Inst Forest Sci, Ecosyst Physiol, Freiburg, Germany	University of Freiburg	Fasbender, L (corresponding author), Albert Ludwigs Univ Freiburg, Fac Environm & Nat Resources, Inst Forest Sci, Ecosyst Physiol, Freiburg, Germany.	lukas.fasbender@cep.uni-freiburg.de	Werner, Christiane/AAO-9976-2021; yañez serrano, ana/Z-6147-2019; Werner, Christiane/B-2948-2009	Werner, Christiane/0000-0002-7676-9057; yañez serrano, ana/0000-0001-6408-5961; Werner, Christiane/0000-0002-7676-9057	European Research Council (ERC) Project VOCO2 [647008]	European Research Council (ERC) Project VOCO2(European Research Council (ERC))	This work was supported by the European Research Council (ERC) Project VOCO2 (647008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affek HP, 2003, PLANT PHYSIOL, V131, P1727, DOI 10.1104/pp.102.012294; Arigoni D, 1997, P NATL ACAD SCI USA, V94, P10600, DOI 10.1073/pnas.94.20.10600; Atkin O. K., 2000, VVolume 9, P153; Barradas MCD, 1999, FOLIA GEOBOT, V34, P189, DOI 10.1007/BF02913395; Brilli F, 2014, ATMOS ENVIRON, V97, P54, DOI 10.1016/j.atmosenv.2014.08.007; BROOKS A, 1985, PLANTA, V165, P397, DOI 10.1007/BF00392238; Cappellin L, 2012, ENVIRON SCI TECHNOL, V46, P2283, DOI 10.1021/es203985t; Castelyn HD, 2015, AUSTRALAS PLANT PATH, V44, P245, DOI 10.1007/s13313-014-0336-1; DELWICHE CF, 1993, PLANT CELL ENVIRON, V16, P587, DOI 10.1111/j.1365-3040.1993.tb00907.x; Dudareva N, 2000, PLANT PHYSIOL, V122, P627, DOI 10.1104/pp.122.3.627; Dudareva N, 2006, CRIT REV PLANT SCI, V25, P417, DOI 10.1080/07352680600899973; Dudareva N, 2013, NEW PHYTOL, V198, P16, DOI 10.1111/nph.12145; Duhl T. R., 2007, BIOGEOSCI DISCUSS, V4, P3987; Effmert U, 2008, PLANT PHYSIOL, V146, P1996, DOI 10.1104/pp.107.112326; Fares S, 2012, ENVIRON POLLUT, V169, P258, DOI 10.1016/j.envpol.2012.01.030; Federico V, 2015, SCI REP-UK, V5, DOI 10.1038/srep12629; Feussner I, 2002, ANNU REV PLANT BIOL, V53, P275, DOI 10.1146/annurev.arplant.53.100301.135248; Filella I, 2006, NEW PHYTOL, V169, P135, DOI 10.1111/j.1469-8137.2005.01570.x; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Ghirardo A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017393; Ghirardo A, 2010, PLANT CELL ENVIRON, V33, P781, DOI 10.1111/j.1365-3040.2009.02104.x; Graus M, 2004, PLANT PHYSIOL, V135, P1967, DOI 10.1104/pp.104.043240; Graus M, 2010, J AM SOC MASS SPECTR, V21, P1037, DOI 10.1016/j.jasms.2010.02.006; Hansen U, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003853; Heiden AC, 1999, GEOPHYS RES LETT, V26, P1283, DOI 10.1029/1999GL900220; Heiden AC, 2003, J ATMOS CHEM, V45, P143, DOI 10.1023/A:1024069605420; Hemmerlin A, 2003, J BIOL CHEM; Jardine K, 2012, PHOTOSYNTH RES, V113, P321, DOI 10.1007/s11120-012-9746-5; Jardine K, 2014, PLANT CELL ENVIRON, V37, P414, DOI 10.1111/pce.12164; Jardine KJ, 2010, ENVIRON SCI TECHNOL, V44, P2454, DOI 10.1021/es903544p; Jordan A, 2009, INT J MASS SPECTROM, V286, P122, DOI 10.1016/j.ijms.2009.07.005; Karl T, 2002, PLANT CELL ENVIRON, V25, P1121, DOI 10.1046/j.1365-3040.2002.00889.x; Karl TG, 2007, ATMOS CHEM PHYS, V7, P5883, DOI 10.5194/acp-7-5883-2007; Kaser L, 2013, ATMOS CHEM PHYS, V13, P2893, DOI 10.5194/acp-13-2893-2013; Kesselmeier J, 1999, J ATMOS CHEM, V33, P23, DOI 10.1023/A:1006127516791; Kreuzwieser J, 1999, J EXP BOT, V50, P757, DOI 10.1093/jexbot/50.335.757; Kreuzwieser J, 2002, NEW PHYTOL, V156, P171, DOI 10.1046/j.1469-8137.2002.00516.x; Lehmann MM, 2016, PLANT BIOLOGY, V18, P776, DOI 10.1111/plb.12464; Lehmann MM, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00739; Lichtenthaler HK, 1999, ANNU REV PLANT PHYS, V50, P47, DOI 10.1146/annurev.arplant.50.1.47; LIEDVOGEL B, 1982, PLANT PHYSIOL, V69, P897, DOI 10.1104/pp.69.4.897; Lindinger W, 1997, PLASMA SOURCES SCI T, V6, P111, DOI 10.1088/0963-0252/6/2/004; Loreto F, 2001, AUST J PLANT PHYSIOL, V28, P1103; MACDONALD RC, 1993, PLANT PHYSIOL, V102, P173, DOI 10.1104/pp.102.1.173; May B, 2013, PHYTOCHEMISTRY, V95, P135, DOI 10.1016/j.phytochem.2013.07.021; MCGARVEY DJ, 1995, PLANT CELL, V7, P1015, DOI 10.1105/tpc.7.7.1015; Mikoviny T, 2010, ATMOS MEAS TECH, V3, P537, DOI 10.5194/amt-3-537-2010; Misztal PK, 2015, SCI REP-UK, V5, DOI 10.1038/srep12064; Muller M, 2013, CHEMOMETR INTELL LAB, V127, P158, DOI 10.1016/j.chemolab.2013.06.011; Owen SM, 2002, ATMOS ENVIRON, V36, P3147, DOI 10.1016/S1352-2310(02)00235-2; Papaefthimiou D, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00035; Penuelas J, 2001, CHEMOSPHERE, V45, P237, DOI 10.1016/S0045-6535(00)00572-5; Peperkorn R, 2005, FUNCT PLANT BIOL, V32, P933, DOI 10.1071/FP04197; POULOSE AJ, 1978, ARCH BIOCHEM BIOPHYS, V187, P307, DOI 10.1016/0003-9861(78)90039-5; Priault P, 2009, NEW PHYTOL, V181, P400, DOI 10.1111/j.1469-8137.2008.02665.x; Rohmer M, 1996, J AM CHEM SOC, V118, P2564, DOI 10.1021/ja9538344; Romano A, 2018, J MASS SPECTROM, V53, P287, DOI 10.1002/jms.4063; Sallaud C, 2009, PLANT CELL, V21, P301, DOI 10.1105/tpc.107.057885; Schnitzler JP, 2004, PLANT PHYSIOL, V135, P152, DOI 10.1104/pp.103.037374; Schuh G, 1997, J ATMOS CHEM, V27, P291, DOI 10.1023/A:1005850710257; Shalit M, 2003, PLANT PHYSIOL, V131, P1868, DOI 10.1104/pp.102.018572; Sharkey TD, 2017, PLANT CELL ENV; Sweetlove LJ, 2013, PLANT CELL ENVIRON, V36, P1631, DOI 10.1111/pce.12105; Sweetlove LJ, 2010, TRENDS PLANT SCI, V15, P462, DOI 10.1016/j.tplants.2010.05.006; Tcherkez G, 2008, P NATL ACAD SCI USA, V105, P797, DOI 10.1073/pnas.0708947105; Tcherkez G, 2017, NEW PHYTOL, V216, P986, DOI 10.1111/nph.14816; Thekedar B, 2009, J BREATH RES, V3, DOI 10.1088/1752-7155/3/2/027007; Titzmann T, 2010, INT J MASS SPECTROM, V295, P72, DOI 10.1016/j.ijms.2010.07.009; von Hartungen E, 2004, INT J MASS SPECTROM, V239, P243, DOI 10.1016/j.ijms.2004.09.009; VONCAEMMERER S, 1981, PLANTA, V153, P376, DOI 10.1007/BF00384257; Wegener F, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00609; Wegener F, 2015, FUNCT PLANT BIOL, V42, P620, DOI 10.1071/FP14152; Wegener F, 2010, FUNCT PLANT BIOL, V37, P849, DOI 10.1071/FP09224; Wehr R, 2016, NATURE, V534, P680, DOI 10.1038/nature17966; Werner C, 2011, BIOGEOSCIENCES, V8, P2437, DOI 10.5194/bg-8-2437-2011; Werner C, 2007, RAPID COMMUN MASS SP, V21, P1352, DOI 10.1002/rcm.2970; Werner C, 2009, RAPID COMMUN MASS SP, V23, P2428, DOI 10.1002/rcm.4036; Yanez-Serrano AM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25056-w	78	23	23	6	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2018	13	9							e0204398	10.1371/journal.pone.0204398	http://dx.doi.org/10.1371/journal.pone.0204398			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU9BO	30252899	Green Submitted, Green Published, gold			2022-12-26	WOS:000445639700049
J	DiPerna, S; Hoogenboom, M; Noonan, S; Fabricius, K				DiPerna, Stephanie; Hoogenboom, Mia; Noonan, Sam; Fabricius, Katharina			Effects of variability in daily light integrals on the photophysiology of the corals Pachyseris speciosa and Acropora millepora	PLOS ONE			English	Article							GREAT-BARRIER-REEF; STYLOPHORA-PISTILLATA; PHOTOSYSTEM-II; CHLOROPHYLL FLUORESCENCE; BUILDING CORALS; PHOTOSYNTHESIS; PHOTOPROTECTION; PHOTOACCLIMATION; PHOTOBIOLOGY; PIGMENTS	Phototrophic sessile organisms, such as reef corals, adjust their photosynthetic apparatus to optimize the balance of light capture versus protection in response to variable light availability (photoacclimation). In shallow marine environments, daily light integrals (DLI) can vary severalfold in response to water clarity and clouds. This laboratory study investigated the responses of two coral species to fluctuations in DLI. Corals were exposed to four contrasting DLI treatments: 'highlight' (potentially photoinhibiting conditions, 32 mol photons m(-2) d(-1)), 'lowlight' (potentially lightlimiting conditions, 6 mol photons m(-2) d(-1)), and two ` variable light' treatments that alternated between high and low conditions every 5 days. In the variable treatments, the shadetolerant coral Pachyseris speciosa displayed cycles of rapid declines in maximum quantum yield during highlight and subsequent recoveries during lowlight, showing photoacclimation at a time scale of 3 +/- 5 days. In contrast, the shallowwater coral Acropora millepora showed slow (> 20 days) photoacclimation, and minimal changes in photosynthetic yields despite contrasting light exposure. However, growth (change in buoyant weight) in A. millepora was significantly slower under variable light, and even more so under lowlight conditions, compared with highlight conditions. The responses of yields in P. speciosa match their preference for lowlight environments, but suggest a vulnerability to even short periods of highlight exposure. In contrast, A. millepora had better tolerance of highlight conditions, however its slow photoacclimatory responses limit its growth under low and variable conditions. The study shows contrasting photoacclimatory responses in variable light environments, which is important to identify and understand as many coastal and midshelf reefs are becoming increasingly more turbid, and may experience higher variability in light availability.	[DiPerna, Stephanie; Hoogenboom, Mia] James Cook Univ, Coll Sci & Engn, Townsville, Qld, Australia; [Hoogenboom, Mia] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia; [Noonan, Sam; Fabricius, Katharina] Australian Inst Marine Sci, Townsville, Qld, Australia	James Cook University; James Cook University; Australian Institute of Marine Science	DiPerna, S (corresponding author), James Cook Univ, Coll Sci & Engn, Townsville, Qld, Australia.	stephanie.diperna@my.jcu.au	Hoogenboom, Mia O/D-3664-2012; Fabricius, Katharina/F-1759-2010	Hoogenboom, Mia O/0000-0003-3709-6344; DiPerna, Stephanie/0000-0001-9795-3817; Noonan, Sam/0000-0002-0392-6197; Fabricius, Katharina/0000-0001-7671-4358	Australian Government's National Environmental Science Program - Tropical Water Quality Hub (NESP Project) [2.3.1]; Australian Marine Institute of Marine Science, Australia	Australian Government's National Environmental Science Program - Tropical Water Quality Hub (NESP Project); Australian Marine Institute of Marine Science, Australia	This study was funded by the Australian Government's National Environmental Science Program - Tropical Water Quality Hub (NESP Project 2.3.1), and the Australian Marine Institute of Marine Science, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambarsari I, 1997, MAR ECOL PROG SER, V159, P303, DOI 10.3354/meps159303; Anning T, 2000, LIMNOL OCEANOGR, V45, P1807, DOI 10.4319/lo.2000.45.8.1807; Anthony KRN, 2006, MAR ECOL PROG SER, V319, P111, DOI 10.3354/meps319111; Anthony KRN, 2004, LIMNOL OCEANOGR, V49, P2201, DOI 10.4319/lo.2004.49.6.2201; Anthony KRN, 2003, FUNCT ECOL, V17, P246, DOI 10.1046/j.1365-2435.2003.00731.x; Anthony KRN, 2003, OECOLOGIA, V134, P23, DOI 10.1007/s00442-002-1095-1; Bainbridge SJ, 2017, J OPER OCEANOGR, V10, P16, DOI 10.1080/1755876X.2017.1290863; Bessell-Browne P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11783-z; BRADSHAW A. D., 1965, ADVANCE GENET, V13, P115, DOI 10.1016/S0065-2660(08)60048-6; Brodersen KE, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0997; Brown BE, 2002, J EXP MAR BIOL ECOL, V277, P129, DOI 10.1016/S0022-0981(02)00305-2; Brown BE, 1999, CORAL REEFS, V18, P99; Brown BE, 2000, MAR ECOL PROG SER, V195, P117, DOI 10.3354/meps195117; Browne NK, 2014, MAR ECOL PROG SER, V502, P129, DOI 10.3354/meps10714; CHALKER BE, 1983, J EXP MAR BIOL ECOL, V73, P37, DOI 10.1016/0022-0981(83)90004-7; CULLEN JJ, 1988, J PLANKTON RES, V10, P1039, DOI 10.1093/plankt/10.5.1039; DAVIES PS, 1989, MAR BIOL, V101, P389; DeVantier LM, 2006, CORAL REEFS, V25, P329, DOI 10.1007/s00338-006-0115-8; Dimier C, 2009, LIMNOL OCEANOGR, V54, P823, DOI 10.4319/lo.2009.54.3.0823; Dove SG, 2008, PLANT CELL ENVIRON, V31, P1523, DOI 10.1111/j.1365-3040.2008.01852.x; Dubinsky Z, 2009, AQUAT MICROB ECOL, V56, P163, DOI 10.3354/ame01345; EDMUNDS PJ, 1988, CORAL REEFS, V7, P7, DOI 10.1007/BF00301975; Erftemeijer PLA, 2012, MAR POLLUT BULL, V64, P1737, DOI 10.1016/j.marpolbul.2012.05.008; Fabricius KE, 2014, MAR POLLUT BULL, V84, P191, DOI 10.1016/j.marpolbul.2014.05.012; Falkowski P.G., 2007, AQUATIC PHOTOSYNTHES; FALKOWSKI PG, 1981, NATURE, V289, P172, DOI 10.1038/289172a0; Frade PR, 2008, CORAL REEFS, V27, P913, DOI 10.1007/s00338-008-0406-3; Frade PR, 2008, LIMNOL OCEANOGR, V53, P2711, DOI 10.4319/lo.2008.53.6.2711; Gattuso JP, 2006, BIOGEOSCIENCES, V3, P489, DOI 10.5194/bg-3-489-2006; GENTY B, 1987, PLANT PHYSIOL, V83, P360, DOI 10.1104/pp.83.2.360; Gorbunov MY, 2001, LIMNOL OCEANOGR, V46, P75, DOI 10.4319/lo.2001.46.1.0075; Hennige SJ, 2009, CORAL REEFS, V28, P179, DOI 10.1007/s00338-008-0444-x; Hennige SJ, 2008, MAR ECOL PROG SER, V369, P77, DOI 10.3354/meps07612; Hill R, 2014, CORAL REEFS, V33, P1101, DOI 10.1007/s00338-014-1188-4; Hoegh-Guldberg O, 1999, MAR ECOL PROG SER, V183, P73, DOI 10.3354/meps183073; Hoogenboom MO, 2008, ECOLOGY, V89, P1144, DOI 10.1890/07-1272.1; Iglesias-Prieto R, 2004, P ROY SOC B-BIOL SCI, V271, P1757, DOI 10.1098/rspb.2004.2757; IGLESIASPRIETO R, 1994, MAR ECOL PROG SER, V113, P163, DOI 10.3354/meps113163; JASSBY AD, 1976, LIMNOL OCEANOGR, V21, P540, DOI 10.4319/lo.1976.21.4.0540; Kaniewska P, 2011, J PHYCOL, V47, P846, DOI 10.1111/j.1529-8817.2011.01021.x; Kayanne H, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002400; Kirk J.T.O., 1994, LIGHT PHOTOSYNTHESIS; Langlois LA, 2014, MAR ECOL PROG SER, V508, P149, DOI 10.3354/meps10836; Lesser MP, 2010, ECOLOGY, V91, P990, DOI 10.1890/09-0313.1; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; MALLIN MA, 1992, LIMNOL OCEANOGR, V37, P54, DOI 10.4319/lo.1992.37.1.0054; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Middlebrook R, 2012, J EXP MAR BIOL ECOL, V432, P64, DOI 10.1016/j.jembe.2012.07.005; Mishra Y, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-6; Muir PR, 2015, SCIENCE, V348, P1135, DOI 10.1126/science.1259911; Mumby PJ, 2008, CONSERV BIOL, V22, P941, DOI 10.1111/j.1523-1739.2008.00933.x; Muscatine L, 1990, ROLE SYMBIOTIC ALGAE, P75; Niyogi KK, 1997, P NATL ACAD SCI USA, V94, P14162, DOI 10.1073/pnas.94.25.14162; Perkins RG, 2006, MAR BIOL, V149, P703, DOI 10.1007/s00227-005-0222-z; Piniak GA, 2008, ESTUAR COAST SHELF S, V77, P56, DOI 10.1016/j.ecss.2007.08.023; Piniak GA, 2007, MAR ENVIRON RES, V64, P456, DOI 10.1016/j.marenvres.2007.04.001; Reynolds JM, 2008, P NATL ACAD SCI USA, V105, P13674, DOI 10.1073/pnas.0805187105; Ritchie RJ, 2008, PHOTOSYNTHETICA, V46, P115, DOI 10.1007/s11099-008-0019-7; Roth MS, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00422; Roth MS, 2010, J EXP BIOL, V213, P3644, DOI 10.1242/jeb.040881; Salih A, 2000, NATURE, V408, P850, DOI 10.1038/35048564; SCHLICHTING CD, 1986, ANNU REV ECOL SYST, V17, P667, DOI 10.1146/annurev.es.17.110186.003315; Shick JM, 1996, GLOBAL CHANGE BIOL, V2, P527, DOI 10.1111/j.1365-2486.1996.tb00065.x; Shick JM, 1999, LIMNOL OCEANOGR, V44, P1667, DOI 10.4319/lo.1999.44.7.1667; Six C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001341; Smith EG, 2013, CORAL REEFS, V32, P463, DOI 10.1007/s00338-012-0994-9; Titlyanov EA, 2001, J EXP MAR BIOL ECOL, V263, P211, DOI 10.1016/S0022-0981(01)00309-4; Veal CJ, 2010, LIMNOL OCEANOGR-METH, V8, P241, DOI 10.4319/lom.2010.8.241; Vermeij MJA, 2002, MAR ECOL PROG SER, V233, P105, DOI 10.3354/meps233105; Wangpraseurt D, 2014, LIMNOL OCEANOGR, V59, P917, DOI 10.4319/lo.2014.59.3.0917; Warner ME, 2006, LIMNOL OCEANOGR, V51, P1887, DOI 10.4319/lo.2006.51.4.1887; Warner ME, 1999, P NATL ACAD SCI USA, V96, P8007, DOI 10.1073/pnas.96.14.8007; Weeks S, 2012, REMOTE SENS-BASEL, V4, P3781, DOI 10.3390/rs4123781; Yentsch CS, 2002, J EXP MAR BIOL ECOL, V268, P171, DOI 10.1016/S0022-0981(01)00379-3	74	16	16	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2018	13	9							e0203882	10.1371/journal.pone.0203882	http://dx.doi.org/10.1371/journal.pone.0203882			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU5MM	30240397	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000445329700011
J	Tateyama, M; Kubo, Y				Tateyama, Michihiro; Kubo, Yoshihiro			Gi/o-coupled muscarinic receptors co-localize with GIRK channel for efficient channel activation	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; RECTIFYING POTASSIUM CHANNELS; HETEROTRIMERIC G-PROTEINS; DELTA-OPIOID RECEPTORS; K+-CHANNEL; ATRIAL MYOCYTES; KIR3 CHANNELS; LIVING CELLS; SUBUNITS; SPECIFICITY	G protein-gated inwardly rectifying K+ (GIRK) channel regulates cellular excitability upon activation of Gi/o-coupled receptors. In Gi/o-coupled muscarinic M2R, the intracellular third loop (i3) is known as a key domain for Gi/o coupling, because replacement of i3 of Gq-coupled muscarinic M1R with that of M2R enables the chimeric receptor (MC9) to activate the GIRK channel. In the present study, we showed that MC9, but not M1R, co-localizes with the GIRK channel and G alpha(i1) by Forster resonance energy transfer (FRET) analysis. When M1R was forced to stay adjacent to the channel through ligation with short linkers, M1R activated the GIRK channel. FRET analysis further suggested that the efficacy of channel activation is correlated with the linker length between M1R and the GIRK channel. The results show that co-localization is an important factor for activating the GIRK channel. In contrast, for MC9 and M2R, the GIRK channel was activated even when they were connected by long linkers, suggesting the formation of a molecular complex even in the absence of a linker. We also observed that replacement of 13 amino acid residues at the N-terminal end of i3 of MC9 with those of M1R impaired the co-localization with the GIRK channel as well as channel activation. These results show that localization of the receptor near the GIRK channel is a key factor in efficiently activating the channel and that the N-terminal end of i3 of M2R plays an important role in co-localization.	[Tateyama, Michihiro; Kubo, Yoshihiro] Natl Inst Physiol Sci, Dept Mol & Cellular Physiol, Div Biophys & Neurobiol, Okazaki, Aichi, Japan; [Tateyama, Michihiro; Kubo, Yoshihiro] SOKENDAI, Sch Life Sci, Dept Physiol Sci, Hayama, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Graduate University for Advanced Studies - Japan	Tateyama, M (corresponding author), Natl Inst Physiol Sci, Dept Mol & Cellular Physiol, Div Biophys & Neurobiol, Okazaki, Aichi, Japan.; Tateyama, M (corresponding author), SOKENDAI, Sch Life Sci, Dept Physiol Sci, Hayama, Japan.	tateyama@nips.ac.jp		Kubo, Yoshihiro/0000-0001-6707-0837	Japan Society for the Promotion of Science [17K08557, 17H04021]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported partly by research grants from the Japan Society for the Promotion of Science to Michihiro Tateyama (17K08557) and Yoshihiro Kubo(17H04021).	Audet N, 2008, J BIOL CHEM, V283, P15078, DOI 10.1074/jbc.M707941200; Ben-Chaim Y, 2006, NATURE, V444, P106, DOI 10.1038/nature05259; Berlin S, 2011, J BIOL CHEM, V286, P33223, DOI 10.1074/jbc.M111.271056; BRAUN AP, 1992, PFLUG ARCH EUR J PHY, V421, P431, DOI 10.1007/BF00370253; Clancy SM, 2005, MOL CELL NEUROSCI, V28, P375, DOI 10.1016/j.mcn.2004.10.009; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; Fowler CE, 2007, J PHYSIOL-LONDON, V580, P51, DOI 10.1113/jphysiol.2006.123216; Gleitsman KR, 2009, AM J PHYSIOL-CELL PH, V297, pC290, DOI 10.1152/ajpcell.00647.2008; Hein P, 2005, EMBO J, V24, P4106, DOI 10.1038/sj.emboj.7600870; Hein P, 2006, J BIOL CHEM, V281, P33345, DOI 10.1074/jbc.M606713200; ITO H, 1992, J GEN PHYSIOL, V99, P961, DOI 10.1085/jgp.99.6.961; Kobrinsky E, 2000, NAT CELL BIOL, V2, P507, DOI 10.1038/35019544; Kobrinsky E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005587; Koike-Tani M, 2005, J PHYSIOL-LONDON, V564, P489, DOI 10.1113/jphysiol.2004.079285; Kostenis E, 1997, BIOCHEMISTRY-US, V36, P1487, DOI 10.1021/bi962554d; KUBO T, 1988, FEBS LETT, V241, P119, DOI 10.1016/0014-5793(88)81043-3; Lavine N, 2002, J BIOL CHEM, V277, P46010, DOI 10.1074/jbc.M205035200; Leaney JL, 2001, J PHYSIOL-LONDON, V534, P367, DOI 10.1111/j.1469-7793.2001.00367.x; Lei WB, 2001, J BIOL CHEM, V276, P16720, DOI 10.1074/jbc.M100207200; LIM NF, 1995, J GEN PHYSIOL, V105, P421, DOI 10.1085/jgp.105.3.421; LIU J, 1995, P NATL ACAD SCI USA, V92, P11642, DOI 10.1073/pnas.92.25.11642; Luscher C, 2010, NAT REV NEUROSCI, V11, P301, DOI 10.1038/nrn2834; Mase Y, 2012, J BIOL CHEM, V287, P19537, DOI 10.1074/jbc.M112.353888; Nobles M, 2005, P NATL ACAD SCI USA, V102, P18706, DOI 10.1073/pnas.0504778102; Peleg S, 2002, NEURON, V33, P87, DOI 10.1016/S0896-6273(01)00567-0; Richard-Lalonde M, 2013, MOL PHARMACOL, V83, P416, DOI 10.1124/mol.112.081950; Riven I, 2006, NEURON, V51, P561, DOI 10.1016/j.neuron.2006.08.017; Rusinova R, 2007, J BIOL CHEM, V282, P34019, DOI 10.1074/jbc.M704928200; Schwarzer S, 2010, J BIOL CHEM, V285, P27817, DOI 10.1074/jbc.M110.103598; Slesinger PA, 1997, P NATL ACAD SCI USA, V94, P12210, DOI 10.1073/pnas.94.22.12210; Sungkaworn T, 2017, NATURE, V550, P543, DOI 10.1038/nature24264; Tateyama M, 2016, EUR J PHARMACOL, V788, P122, DOI 10.1016/j.ejphar.2016.06.025; Tateyama M, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.134; Tateyama M, 2013, NEUROPHARMACOLOGY, V65, P173, DOI 10.1016/j.neuropharm.2012.10.006; van der Wal J, 2001, J BIOL CHEM, V276, P15337, DOI 10.1074/jbc.M007194200; Wellner-Kienitz MC, 2001, J BIOL CHEM, V276, P37347, DOI 10.1074/jbc.M106234200; Whorton MR, 2013, NATURE, V498, P190, DOI 10.1038/nature12241	37	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2018	13	9							e0204447	10.1371/journal.pone.0204447	http://dx.doi.org/10.1371/journal.pone.0204447			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU5MM	30240440	Green Published, Green Submitted, gold			2022-12-26	WOS:000445329700051
J	Haraguchi, H; Hirota, Y; Saito-Fujita, T; Tanaka, T; Shimizu-Hirota, R; Harada, M; Akaeda, S; Hiraoka, T; Matsuo, M; Matsumoto, L; Hirata, T; Koga, K; Wada-Hiraike, O; Fujii, T; Osuga, Y				Haraguchi, Hirofumi; Hirota, Yasushi; Saito-Fujita, Tomoko; Tanaka, Tomoki; Shimizu-Hirota, Ryoko; Harada, Miyuki; Akaeda, Shun; Hiraoka, Takehiro; Matsuo, Mitsunori; Matsumoto, Leona; Hirata, Tetsuya; Koga, Kaori; Wada-Hiraike, Osamu; Fujii, Tomoyuki; Osuga, Yutaka			Mdm2-p53-SF1 pathway in ovarian granulosa cells directs ovulation and fertilization by conditioning oocyte quality	FASEB JOURNAL			English	Article						infertility; oocyte maturation; cumulus granulosa; cell-oocyte complex	HYALURONIC-ACID SYNTHESIS; STEROIDOGENIC FACTOR-1; EMBRYONIC LETHALITY; MDM2-DEFICIENT MICE; CUMULUS EXPANSION; ONCOPROTEIN MDM2; FEMALE FERTILITY; OXIDATIVE STRESS; PRETERM BIRTH; MOUSE	Functions of tumor suppressor p53 and its negative regulator mouse double minute 2 homolog (Mdm2) in ovarian granulosa cells remain to be elucidated, and the current study aims at clarifying this issue. Mice with Mdm2 deficiency in ovarian granulosa cells [Mdm2-loxP/progesterone receptor (Pgr)-Cre mice] were infertile as a result of impairment of oocyte maturation, ovulation, and fertilization, and those with Mdm2/p53 double deletion in granulosa cells (Mdm2-loxP/p53-loxP/Pgr-Cre mice) showed normal fertility, suggesting that p53 induction in the ovarian granulosa cells is detrimental to ovarian function by disturbing oocyte quality. Another model of Mdm2 deletion in ovarian granulosa cells (Mdm2-loxP/anti-Mullerian hormone type 2 receptor-Cre mice) also showed subfertility as a result of the failure of ovulation and fertilization, indicating critical roles of ovarian Mdm2 in ovulation and fertilization. Mdm2-p53 pathway in cumulus granulosa cells transcriptionally controlled an orphan nuclear receptor steroidogenic factor 1 (SF1), a key regulator of ovarian function. Importantly, MDM2 and SF1 levels in human cumulus granulosa cells were positively associated with the outcome of oocyte maturation and fertilization in patients undergoing infertility treatment. These findings suggest that the Mdm2-p53-SF1 axis in ovarian cumulus granulosa cells directs ovarian function by affecting their neighboring oocyte quality.Haraguchi, H., Hirota, Y., Saito-Fujita, T., Tanaka, T., Shimizu-Hirota, R., Harada, M., Akaeda, S., Hiraoka, T., Matsuo, M., Matsumoto, L., Hirata, T., Koga, K., Wada-Hiraike, O., Fujii, T., Osuga, Y. Mdm2-p53-SF1 pathway in ovarian granulosa cells directs ovulation and fertilization by conditioning oocyte quality.	[Haraguchi, Hirofumi; Hirota, Yasushi; Saito-Fujita, Tomoko; Tanaka, Tomoki; Harada, Miyuki; Akaeda, Shun; Hiraoka, Takehiro; Matsuo, Mitsunori; Matsumoto, Leona; Hirata, Tetsuya; Koga, Kaori; Wada-Hiraike, Osamu; Fujii, Tomoyuki; Osuga, Yutaka] Univ Tokyo, Grad Sch Med, Dept Obstet & Gynecol, Tokyo, Japan; [Hirota, Yasushi] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Saitama, Japan; [Hirota, Yasushi] Japan Agcy Med Res & Dev, Precursory Res Innovat Med Care, Tokyo, Japan; [Shimizu-Hirota, Ryoko] Keio Univ, Sch Med, Ctr Prevent Med, Dept Internal Med, Tokyo, Japan	University of Tokyo; Japan Science & Technology Agency (JST); Keio University	Hirota, Y (corresponding author), Univ Tokyo, Grad Sch Med, Dept Obstet & Gynecol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	yhirota-tky@umin.ac.jp	Hirota, Yasushi/AAD-8713-2020; Koga, Kaori/ABA-5601-2020	Hirota, Yasushi/0000-0003-0241-9780; Koga, Kaori/0000-0002-5057-4120; Hirata, Tetsuya/0000-0002-9975-6208	Precursory Research for Embryonic Science and Technology (PRESTO), Japan Society for the Promotion of Science [16H04679, 16H05469, 16K15700, 16K15701, 15H04979, 15K10660, 17K16833, 16K10668, 17H06640, 15K15597, 18K19601, 18K19600, 18H02943, 18K09284]; Takeda Science Foundation; Japan Agency for Medical Research and Development-Precursory Research for Innovative Medical Care (AMED-PRIME) [JP17gm5910010]	Precursory Research for Embryonic Science and Technology (PRESTO), Japan Society for the Promotion of Science; Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Agency for Medical Research and Development-Precursory Research for Innovative Medical Care (AMED-PRIME)(Japan Agency for Medical Research and Development (AMED))	The authors thank Dr. Francesco J. DeMayo (National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA) and Dr. John P. Lydon (Baylor College of Medicine, Houston, TX, USA) for providing Pgr-Cre mice, the National Cancer Institute for providing p53-loxP and Mdm2-loxP mice, Dr. Richard Behringer (The University of Texas MD Anderson Cancer Center, Houston, TX, USA) for providing Amhr2-Cre mice, and Dr. Toshihiro Nakajima (Tokyo Medical University, Tokyo, Japan) for providing a p53-expression plasmid. This work was supported by Precursory Research for Embryonic Science and Technology (PRESTO), Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research (JSPS KAKENHI; Grants16H04679, 16H05469, 16K15700, 16K15701, 15H04979, 15K10660, 17K16833, 16K10668, 17H06640, 15K15597, 18K19601, 18K19600, 18H02943, and 18K09284), Japan Agency for Medical Research and Development-Precursory Research for Innovative Medical Care (AMED-PRIME; JP17gm5910010), and Takeda Science Foundation. The authors declare no conflicts of interest.	Agarwal A, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-49; Ahima RS, 2009, NAT MED, V15, P996, DOI 10.1038/nm0909-996; BUCCIONE R, 1990, DEV BIOL, V138, P16, DOI 10.1016/0012-1606(90)90172-F; Burnum KE, 2012, ENDOCRINOLOGY, V153, P4568, DOI 10.1210/en.2012-1335; Cha J, 2013, J CLIN INVEST, V123, P4063, DOI 10.1172/JCI70098; Chan Y, 2016, GYNECOL ENDOCRINOL, V32, P136, DOI 10.3109/09513590.2015.1092515; Coticchio G, 2015, HUM REPROD UPDATE, V21, P427, DOI 10.1093/humupd/dmv011; Deng WB, 2016, J CLIN INVEST, V126, P2941, DOI 10.1172/JCI87715; Denissenko MF, 1996, SCIENCE, V274, P430, DOI 10.1126/science.274.5286.430; Edson MA, 2009, ENDOCR REV, V30, P624, DOI 10.1210/er.2009-0012; Egashira M, 2017, ENDOCRINOLOGY, V158, P2344, DOI 10.1210/en.2016-1886; EPPIG JJ, 1981, BIOL REPROD, V25, P191, DOI 10.1095/biolreprod25.1.191; EPPIG JJ, 1979, NATURE, V281, P483, DOI 10.1038/281483a0; EPPIG JJ, 1983, DEV BIOL, V100, P39, DOI 10.1016/0012-1606(83)90198-7; FIELD JK, 1991, BRIT J CANCER, V64, P573, DOI 10.1038/bjc.1991.352; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fouchecourt S, 2016, CELL DEATH DIFFER, V23, P521, DOI 10.1038/cdd.2015.120; Harada M, 2015, GYNECOL ENDOCRINOL, V31, P783, DOI 10.3109/09513590.2015.1062862; Haraguchi H, 2014, MOL ENDOCRINOL, V28, P1108, DOI 10.1210/me.2014-1097; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hirota Y, 2011, P NATL ACAD SCI USA, V108, P18073, DOI 10.1073/pnas.1108180108; Hirota Y, 2010, J CLIN INVEST, V120, P803, DOI 10.1172/JCI40051; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Hosokawa K, 1998, ENDOCRINOLOGY, V139, P4688, DOI 10.1210/en.139.11.4688; Huang ZW, 2012, CURR PHARM DESIGN, V18, P310, DOI 10.2174/138161212799040439; Jamin SP, 2002, NAT GENET, V32, P408, DOI 10.1038/ng1003; Jeyasuria P, 2004, MOL ENDOCRINOL, V18, P1610, DOI 10.1210/me.2003-0404; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Jorgez CJ, 2004, MOL ENDOCRINOL, V18, P953, DOI 10.1210/me.2003-0301; Kang HJ, 2009, P NATL ACAD SCI USA, V106, P9761, DOI 10.1073/pnas.0904280106; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kugu K, 1998, CELL DEATH DIFFER, V5, P67, DOI 10.1038/sj.cdd.4400316; Livera G, 2016, FEBS LETT, V590, P2566, DOI 10.1002/1873-3468.12275; Lourenco D, 2009, NEW ENGL J MED, V360, P1200, DOI 10.1056/NEJMoa0806228; LUNA RMD, 1995, NATURE, V378, P203; Makrigiannakis A, 2000, J CLIN ENDOCR METAB, V85, P449, DOI 10.1210/jc.85.1.449; Meirow D, 2001, HUM REPROD UPDATE, V7, P535, DOI 10.1093/humupd/7.6.535; Mendrysa SM, 2003, MOL CELL BIOL, V23, P462, DOI 10.1128/MCB.23.2.462-473.2003; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; Pasquali Renato, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P482, DOI 10.1097/MED.0b013e3282f1d6cb; Pelusi C, 2008, BIOL REPROD, V79, P1074, DOI 10.1095/biolreprod.108.069435; Practice Committee of the American Society for Reproductive Medicine, 2006, Fertil Steril, V86, pS248; Practice Committee of the American Society for Reproductive Medicine, 2006, Fertil Steril, V86, pS172; Richards Joanne S, 2010, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-642-02062-9_1; Richards JS, 2005, MOL CELL ENDOCRINOL, V234, P75, DOI 10.1016/j.mce.2005.01.004; Robker RL, 2000, P NATL ACAD SCI USA, V97, P4689, DOI 10.1073/pnas.080073497; Ruder EH, 2009, CURR OPIN OBSTET GYN, V21, P219, DOI 10.1097/GCO.0b013e32832924ba; Rui X, 2008, ENDOCRINOLOGY, V149, P3668, DOI 10.1210/en.2008-0203; SALUSTRI A, 1985, BIOL REPROD, V33, P229, DOI 10.1095/biolreprod33.1.229; Sbisa E, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S1-S20; Shukla KK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076959; Soyal SM, 2005, GENESIS, V41, P58, DOI 10.1002/gene.20098; Takahashi N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11252-7; VANDERHYDEN BC, 1990, DEV BIOL, V140, P307, DOI 10.1016/0012-1606(90)90081-S; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Yamasaki S, 2007, EMBO J, V26, P113, DOI 10.1038/sj.emboj.7601490	58	16	17	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2610	2620		10.1096/fj.201801401R	http://dx.doi.org/10.1096/fj.201801401R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30260703				2022-12-26	WOS:000457296600086
J	Li, WT; Luo, QQ; Wang, B; Chen, X; Yan, XJ; Qiu, HY; Chen, SL				Li, Wen-Ting; Luo, Qing-Qing; Wang, Bo; Chen, Xin; Yan, Xiu-Juan; Qiu, Hong-Yi; Chen, Sheng-Liang			Bile acids induce visceral hypersensitivity via mucosal mast cell-to-nociceptor signaling that involves the farnesoid X receptor/nerve growth factor/transient receptor potential vanilloid 1 axis	FASEB JOURNAL			English	Article						pain processing; IBS; p38 MAPK; NF-B	IRRITABLE-BOWEL-SYNDROME; COLONIC TRANSIT; EXPRESSION; NGF; INFLAMMATION; ACTIVATION; NEURONS; PREVALENCE; DISORDERS; EXCRETION	Increased colonic bile acid (BA) exposure, frequent in diarrhea-predominant irritable bowel syndrome (IBS-D), can affect gut function. Nerve growth factor (NGF) is implicated in the development of visceral hypersensitivity (VH). In this study, we tested the hypothesis that BAs cause VH via mucosal mast cell (MMC)-to-nociceptor signaling, which involves the farnesoid X receptor (FXR)/NGF/transient receptor potential vanilloid (TRPV)1 axis. BAs were intracolonically administered to rats for 15 d. Visceral sensitivity to colorectal distention and colonic NGF expression were examined. BAs caused VH, an effect that involved MMC-derived NGF and was accompanied by enhanced TRPV1 expression in the dorsal root ganglia. Anti-NGF treatment and TRPV1 antagonism inhibited BA-induced VH. BAs induced NGF mRNA and protein expression and release in cultured mast cells. Colonic supernatants from patients with IBS-D with elevated colonic BA content transcriptionally induced NGF expression. In FXR-/- mice, visceral sensitivity and colonic NGF expression were unaltered after BA treatment. Pharmacological antagonism and FXR silencing suppressed BA-induced NGF expression and release in mast cells. Mitogen-activated protein kinase kinase (MKK) 3/6/p38 MAPK/NF-B signaling was mechanistically responsible for FXR-mediated NGF expression and secretion. The findings show an MMC-dependent and FXR-mediated pronociceptive effect of BAs and identify the BA/FXR/NGF/TRPV1 axis as a key player in MMC-to-neuron communication during pain processing in IBS.Li, W.-T., Luo, Q.-Q., Wang, B., Chen, X., Yan, X.-J., Qiu, H.-Y., Chen, S.-L. Bile acids induce visceral hypersensitivity via mucosal mast cell-to-nociceptor signaling that involves the farnesoid X receptor/nerve growth factor/transient receptor potential vanilloid 1 axis.	[Li, Wen-Ting; Luo, Qing-Qing; Wang, Bo; Chen, Xin; Yan, Xiu-Juan; Qiu, Hong-Yi; Chen, Sheng-Liang] Shanghai Jiao Tong Univ, Shanghai Inst Digest Dis, Sch Med, Div Gastroenterol & Hepatol,Renji Hosp, 145 Middle Shandong Rd, Shanghai 200001, Peoples R China	Shanghai Jiao Tong University	Chen, SL (corresponding author), Shanghai Jiao Tong Univ, Shanghai Inst Digest Dis, Sch Med, Div Gastroenterol & Hepatol,Renji Hosp, 145 Middle Shandong Rd, Shanghai 200001, Peoples R China.	slchenmd@hotmail.com	Shen, Nan/AGK-6807-2022		National Natural Science Foundation of China [81670484, 81470812, 81270463, 81500412]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Grants 81670484, 81470812, 81270463, and 81500412 from the National Natural Science Foundation of China (to S.-L.C. and X.-J.Y.). The authors declare no conflicts of interest.	Al-Chaer ED, 2000, GASTROENTEROLOGY, V119, P1276, DOI 10.1053/gast.2000.19576; Bajor A, 2015, GUT, V64, P84, DOI 10.1136/gutjnl-2013-305965; Bajor A, 2010, SCAND J GASTROENTERO, V45, P645, DOI 10.3109/00365521003702734; Bampton PA, 2002, AM J PHYSIOL-GASTR L, V282, pG443, DOI 10.1152/ajpgi.00194.2001; Bannwarth B, 2014, DRUGS, V74, P619, DOI 10.1007/s40265-014-0208-6; Barreau F, 2004, GASTROENTEROLOGY, V127, P524, DOI 10.1053/j.gastro.2004.05.019; Camilleri M, 2014, AM J GASTROENTEROL, V109, P1621, DOI 10.1038/ajg.2014.215; Camilleri M, 2012, NEW ENGL J MED, V367, P1626, DOI 10.1056/NEJMra1207068; Carey LM, 2016, MOL PAIN, V12, DOI 10.1177/1744806916649192; Cenac N, 2010, GUT, V59, P481, DOI 10.1136/gut.2009.192567; Coelho A, 2015, BRIT J PHARMACOL, V172, P1691, DOI 10.1111/bph.12958; Cortez DM, 2007, AM J PHYSIOL-HEART C, V293, pH3356, DOI 10.1152/ajpheart.00928.2007; Dothel G, 2015, GASTROENTEROLOGY, V148, P1002, DOI 10.1053/j.gastro.2015.01.042; Drossman DA, 2016, GASTROENTEROLOGY, V150, P1257, DOI 10.1053/j.gastro.2016.03.035; Guerrero-Alba R, 2017, GUT, V66, P2121, DOI 10.1136/gutjnl-2016-311456; He JL, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0427-9; Ji RR, 2002, NEURON, V36, P57, DOI 10.1016/S0896-6273(02)00908-X; Lee CG, 2012, GASTROENTEROLOGY, V142, P1206, DOI 10.1053/j.gastro.2012.01.007; Lee J, 2010, J BIOL CHEM, V285, P12604, DOI 10.1074/jbc.M109.094524; Lee KN, 2016, GASTROENT RES PRACT, V2016, DOI 10.1155/2016/2031480; LEON A, 1994, P NATL ACAD SCI USA, V91, P3739, DOI 10.1073/pnas.91.9.3739; Lieu T, 2014, BRIT J PHARMACOL, V171, P1156, DOI 10.1111/bph.12426; Lovell RM, 2012, CLIN GASTROENTEROL H, V10, P712, DOI 10.1016/j.cgh.2012.02.029; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; MEKHJIAN HS, 1971, J CLIN INVEST, V50, P1569, DOI 10.1172/JCI106644; MEKHJIAN HS, 1979, DIGEST DIS SCI, V24, P545, DOI 10.1007/BF01489324; Natarajan K, 1996, P NATL ACAD SCI USA, V93, P9090, DOI 10.1073/pnas.93.17.9090; Peleman C, 2017, CLIN GASTROENTEROL H, V15, P720, DOI 10.1016/j.cgh.2016.11.012; QUIST RG, 1991, GASTROENTEROLOGY, V101, P446, DOI 10.1016/0016-5085(91)90024-F; Ridlon JM, 2014, CURR OPIN GASTROEN, V30, P332, DOI 10.1097/MOG.0000000000000057; Serna H, 2006, J PHARMACOL EXP THER, V319, P1104, DOI 10.1124/jpet.106.104620; Shin A, 2013, CLIN GASTROENTEROL H, V11, P1270, DOI 10.1016/j.cgh.2013.04.020; Shutov LP, 2016, J NEUROSCI, V36, P5055, DOI 10.1523/JNEUROSCI.3249-15.2016; Slattery SA, 2015, ALIMENT PHARM THER, V42, P3, DOI 10.1111/apt.13227; Sun Y, 2004, GUT, V53, P362, DOI 10.1136/gut.2003.015867; Tam SY, 1997, BLOOD, V90, P1807, DOI 10.1182/blood.V90.5.1807; Traub RJ, 2008, GASTROENTEROLOGY, V135, P2075, DOI 10.1053/j.gastro.2008.08.051; Veenstra TD, 1998, BIOCHEMISTRY-US, V37, P5988, DOI 10.1021/bi972965+; Wang Lina, 2014, Cells, V3, P662, DOI 10.3390/cells3030662; Xu XJ, 2017, ALIMENT PHARM THER, V45, P100, DOI 10.1111/apt.13848; Zhu WG, 2007, MOL CELL NEUROSCI, V34, P689, DOI 10.1016/j.mcn.2007.01.005	41	28	31	2	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2435	2450		10.1096/fj.201800935RR	http://dx.doi.org/10.1096/fj.201800935RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30260705				2022-12-26	WOS:000457296600072
J	Kendra, JA; Advani, VM; Chen, B; Briggs, JW; Zhu, JY; Bress, HJ; Pathy, SM; Dinman, JD				Kendra, Joseph A.; Advani, Vivek M.; Chen, Bin; Briggs, Joseph W.; Zhu, Jinyi; Bress, Hannah J.; Pathy, Sushrut M.; Dinman, Jonathan D.			Functional and structural characterization of the chikungunya virus translational recoding signals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						alphavirus; RNA; chemical modification; molecular dynamics; chikungunya virus; antiviral treatment; programmed frameshift; recoding; RNA secondary structure; TCR signal	SELECTIVE 2'-HYDROXYL ACYLATION; OPAL TERMINATION CODON; RNA STRUCTURE-ANALYSIS; MURINE LEUKEMIA-VIRUS; SINGLE NUCLEOTIDE RESOLUTION; PRIMER EXTENSION SHAPE; STOP CODON; VERTICAL TRANSMISSION; SINDBIS VIRUS; MOSAIC-VIRUS	Climate change and human globalization have spurred the rapid spread of mosquito-borne diseases to naive populations. One such emerging virus of public health concern is chikungunya virus (CHIKV), a member of the Togaviridae family, genus Alphavirus. CHIKV pathogenesis is predominately characterized by acute febrile symptoms and severe arthralgia, which can persist in the host long after viral clearance. CHIKV has also been implicated in cases of acute encephalomyelitis, and its vertical transmission has been reported. Currently, no FDA-approved treatments exist for this virus. Recoding elements help expand the coding capacity in many viruses and therefore represent potential therapeutic targets in antiviral treatments. Here, we report the molecular and structural characterization of two CHIKV translational recoding signals: a termination codon read-through (TCR) element located between the nonstructural protein 3 and 4 genes and a programmed -1 ribosomal frameshift (-1 PRF) signal located toward the 3 end of the CHIKV 6K gene. Using Dual-Luciferase and immunoblot assays in HEK293T and U87MG mammalian cell lines, we validated and genetically characterized efficient TCR and -1 PRF. Analyses of RNA chemical modification data with selective 2-hydroxyl acylation and primer extension (SHAPE) assays revealed that CHIKV -1 PRF is stimulated by a tightly structured, triple-stem hairpin element, consistent with previous observations in alphaviruses, and that the TCR signal is composed of a single large multibulged hairpin element. These findings illuminate the roles of RNA structure in translational recoding and provide critical information relevant for design of live-attenuated vaccines against CHIKV and related viruses.	[Kendra, Joseph A.; Advani, Vivek M.; Chen, Bin; Briggs, Joseph W.; Dinman, Jonathan D.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Advani, Vivek M.; Zhu, Jinyi; Bress, Hannah J.; Pathy, Sushrut M.] Univ Maryland, Year Innovat & Res Experience Program 1, College Pk, MD 20742 USA; [Advani, Vivek M.] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Hale Bldg Transformat Med,60 Fenwood Rd, Boston, MA 02115 USA; [Briggs, Joseph W.] US FDA, Div Microbiol Devices CDRH VIR1, Off Vitro Diagnost & Radiol Hlth, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Harvard University; Brigham & Women's Hospital; US Food & Drug Administration (FDA)	Dinman, JD (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA.	dinman@umd.edu	Kendra, Joseph/AAA-1844-2020; Advani, Vivek/L-1827-2019	Advani, Vivek/0000-0002-0584-8989; Dinman, Jonathan/0000-0002-2402-9698; Kendra, Joseph/0000-0001-5886-7377	Defense Threat Reduction Agency [HDTRA1-13-1-0005]; NIGMS, National Institutes of Health (NIH) [R01 GM117177]; NHLBI, NIH [R01HL119439]; First-year Innovation and Research Experience (FIRE) Program at University of Maryland, College Park; Howard Hughes Medical Institute/University of Maryland College Park; NIH Institutional Training Grant [2T32AI051967-06A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI051967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM117177] Funding Source: NIH RePORTER	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); NIGMS, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); First-year Innovation and Research Experience (FIRE) Program at University of Maryland, College Park; Howard Hughes Medical Institute/University of Maryland College Park; NIH Institutional Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Defense Threat Reduction Agency Grant HDTRA1-13-1-0005; NIGMS, National Institutes of Health (NIH) Grant R01 GM117177; NIH Institutional Training Grant 2T32AI051967-06A1 (to J. A. K.); NHLBI, NIH Grant R01HL119439 (to J. W. B.); and the First-year Innovation and Research Experience (FIRE) Program at University of Maryland, College Park (to V. M. A.). Part of this work was made possible by an undergraduate fellowship from the Howard Hughes Medical Institute/University of Maryland College Park (to J. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adamson CS, 2003, VIROLOGY, V314, P488, DOI 10.1016/S0042-6822(03)00485-9; Atkins GJ., 2013, ISRN VIROL, V2013, P1, DOI [10.5402/2013/861912, DOI 10.5402/2013/861912]; Atkins JF, 2016, NUCLEIC ACIDS RES, V44, P7007, DOI 10.1093/nar/gkw530; Bandeira AC, 2016, IDCases, V5, P57, DOI 10.1016/j.idcr.2016.07.008; Barry JK, 2002, P NATL ACAD SCI USA, V99, P11133, DOI 10.1073/pnas.162223099; Belew AT, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-339; BRIERLEY I, 1995, J GEN VIROL, V76, P1885, DOI 10.1099/0022-1317-76-8-1885; Brizzi K, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0561-1; Cardona-Correa SE, 2017, REV CHIL PEDIATR-CHI, V88, P285, DOI 10.4067/S0370-41062017000200015; Chandak NH, 2009, NEUROL INDIA, V57, P177, DOI 10.4103/0028-3886.51289; Chung BYW, 2010, J MOL BIOL, V397, P448, DOI 10.1016/j.jmb.2010.01.044; Csibra E, 2014, J VIROL, V88, P10364, DOI 10.1128/JVI.00898-14; DINMAN JD, 1992, J VIROL, V66, P3669, DOI 10.1128/JVI.66.6.3669-3676.1992; Dinman JD, 1998, TRENDS BIOTECHNOL, V16, P190, DOI 10.1016/S0167-7799(97)01167-0; Dinman JD, 2012, WIRES RNA, V3, P661, DOI 10.1002/wrna.1126; Doma MK, 2006, NATURE, V440, P561, DOI 10.1038/nature04530; Firth AE, 2011, NUCLEIC ACIDS RES, V39, P6679, DOI 10.1093/nar/gkr224; Firth AE, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-108; Gao F, 2016, NUCLEIC ACIDS RES, V44, P878, DOI 10.1093/nar/gkv1241; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gorchakov R, 2012, J VIROL, V86, P6084, DOI 10.1128/JVI.06449-11; Gould EA, 2009, T ROY SOC TROP MED H, V103, P109, DOI 10.1016/j.trstmh.2008.07.025; Green L, 2015, J GEN VIROL, V96, P3411, DOI 10.1099/jgv.0.000284; JACKS T, 1990, CURR TOP MICROBIOL, V157, P93; Jacobs JL, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh157; Jones JE, 2017, MBIO, V8, DOI 10.1128/mBio.01456-17; Kendra JA, 2017, J VIROL, V91, DOI 10.1128/JVI.01766-16; Kuhlmann MM, 2016, J VIROL, V90, P8575, DOI 10.1128/JVI.01129-16; LEMM JA, 1990, J VIROL, V64, P3001, DOI 10.1128/JVI.64.6.3001-3011.1990; LI GP, 1989, J VIROL, V63, P1326, DOI 10.1128/JVI.63.3.1326-1337.1989; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Lopinski JD, 2000, MOL CELL BIOL, V20, P1095, DOI 10.1128/MCB.20.4.1095-1103.2000; Loughran G, 2017, RNA, V23, P1285, DOI 10.1261/rna.061051.117; Melian EB, 2010, J VIROL, V84, P1641, DOI 10.1128/JVI.01979-09; Melton JV, 2002, J BIOL CHEM, V277, P46923, DOI 10.1074/jbc.M207847200; Merino EJ, 2005, J AM CHEM SOC, V127, P4223, DOI 10.1021/ja043822v; Moomau C, 2016, J BIOL CHEM, V291, P15788, DOI 10.1074/jbc.M116.735613; Myles KM, 2006, J VIROL, V80, P4992, DOI 10.1128/JVI.80.10.4992-4997.2006; Napthine S, 2003, EMBO J, V22, P3941, DOI 10.1093/emboj/cdg365; Newburn LR, 2015, VIROLOGY, V479, P434, DOI 10.1016/j.virol.2015.02.032; Newburn LR, 2014, VIROLOGY, V450, P258, DOI 10.1016/j.virol.2013.12.006; Nicholson BL, 2014, NAT REV MICROBIOL, V12, P493, DOI 10.1038/nrmicro3288; Njenga MK, 2008, J GEN VIROL, V89, P2754, DOI 10.1099/vir.0.2008/005413-0; Parisien M, 2008, NATURE, V452, P51, DOI 10.1038/nature06684; Patterson J, 2016, WEST J EMERG MED, V17, P671, DOI 10.5811/westjem.2016.9.30904; Paul CP, 2001, J MOL BIOL, V310, P987, DOI 10.1006/jmbi.2001.4801; Plant EP, 2005, PLOS BIOL, V3, P1012, DOI 10.1371/journal.pbio.0030172; Plant EP, 2005, NUCLEIC ACIDS RES, V33, P1825, DOI 10.1093/nar/gki329; Plant EP, 2013, VIRUSES-BASEL, V5, P279, DOI 10.3390/v5010279; Plant EP, 2010, J VIROL, V84, P4330, DOI 10.1128/JVI.02480-09; Ramsey J, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9080228; Ramsey J, 2017, J VIROL, V91, DOI 10.1128/JVI.02000-16; Ross R., 1956, J HYG LOND, V54, P177, DOI DOI 10.1017/S0022172400044442; Sahadeo N, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004199; Schuller AP, 2018, NAT REV MOL CELL BIO, V19, P526, DOI 10.1038/s41580-018-0011-4; Shehu-Xhilaga M, 2001, J VIROL, V75, P1834, DOI 10.1128/JVI.75.4.1834-1841.2001; Smola MJ, 2015, NAT PROTOC, V10, P1643, DOI 10.1038/nprot.2015.103; Snyder JE, 2013, J VIROL, V87, P8511, DOI 10.1128/JVI.00449-13; SOMOGYI P, 1993, MOL CELL BIOL, V13, P6931, DOI 10.1128/MCB.13.11.6931; STRAUSS EG, 1983, P NATL ACAD SCI-BIOL, V80, P5271, DOI 10.1073/pnas.80.17.5271; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Tajima Y, 2011, VIROLOGY, V417, P169, DOI 10.1016/j.virol.2011.05.012; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; Yactayo S, 2016, J INFECT DIS, V214, pS441, DOI 10.1093/infdis/jiw390; Zadeh JN, 2011, J COMPUT CHEM, V32, P170, DOI 10.1002/jcc.21596	66	13	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2018	293	45					17536	17545		10.1074/jbc.RA118.005606	http://dx.doi.org/10.1074/jbc.RA118.005606			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ9EI	30242123	Green Published, hybrid			2022-12-26	WOS:000449799000018
J	Hoover, KC				Hoover, Kara C.			Intragenus (Homo) variation in a chemokine receptor gene (CCR5)	PLOS ONE			English	Article							WEST-NILE-VIRUS; GENOME SEQUENCE; INFECTIOUS-DISEASE; HIV-1 INFECTION; FUSION COFACTOR; CLIMATE-CHANGE; EVOLUTION; NEANDERTHAL; RESISTANCE; ORIGIN	Humans have a comparatively higher rate of more polymorphisms in regulatory regions of the primate CCR5 gene, an immune system gene with both general and specific functions. This has been interpreted as allowing flexibility and diversity of gene expression in response to varying disease loads. A broad expression repertoire is useful to humans-the only globally distributed primate-due to our unique adaptive pattern that increased pathogen exposure and disease loads (e.g., sedentism, subsistence practices). The main objective of the study was to determine if the previously observed human pattern of increased variation extended to other members of our genus, Homo. The data for this study are mined from the published genomes of extinct hominins (four Neandertals and two Denisovans), an ancient human (Ust'-Ishim), and modern humans (1000 Genomes). An average of 15 polymorphisms per individual were found in human populations (with a total of 262 polymorphisms). There were 94 polymorphisms identified across extinct Homo (an average of 13 per individual) with 41 previously observed in modern humans and 53 novel polymorphisms (32 in Denisova and 21 in Neandertal). Neither the frequency nor distribution of polymorphisms across gene regions exhibit significant differences within the genus Homo. Thus, humans are not unique with regards to the increased frequency of regulatory polymorphisms and the evolution of variation patterns across CCR5 gene appears to have originated within the genus. A broader evolutionary perspective on regulatory flexibility may be that it provided an advantage during the transition to confrontational foraging (and later hunting) that altered human-environment interaction as well as during migration to Eurasia and encounters with novel pathogens.	[Hoover, Kara C.] Univ Alaska Fairbanks, Dept Anthropol, Fairbanks, AK 99775 USA; [Hoover, Kara C.] Univ Alaska Fairbanks, Biochem & Mol Biol, Fairbanks, AK 99775 USA	University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks	Hoover, KC (corresponding author), Univ Alaska Fairbanks, Dept Anthropol, Fairbanks, AK 99775 USA.; Hoover, KC (corresponding author), Univ Alaska Fairbanks, Biochem & Mol Biol, Fairbanks, AK 99775 USA.	kchoover@alaska.edu		Hoover, Kara C./0000-0001-6394-930X				Abi-Rached L, 2011, SCIENCE, V334, P89, DOI 10.1126/science.1209202; Abrantes J, 2011, CONSERV GENET, V12, P325, DOI 10.1007/s10592-009-9990-1; Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Alkhatib G, 1997, NATURE, V388, P238, DOI 10.1038/40789; Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Angelici, 2016, PROBLEMATIC WILDLIFE, P507, DOI [10.1007/978-3-319-22246-2_24, DOI 10.1007/978-3-319-22246-2_24]; BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97; Berens AJ, 2017, HUM BIOL OCEANIA, V89; Brantingham PJ, 1998, J ANTHROPOL ARCHAEOL, V17, P327, DOI 10.1006/jaar.1998.0326; Briggs AW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1163; Brinkworth JF, 2017, HUM BIOL, V89, P47, DOI 10.13110/humanbiology.89.1.03; Carmo CR, 2006, IMMUNOGENETICS, V58, P494, DOI 10.1007/s00251-006-0095-4; Carrington M, 1997, AM J HUM GENET, V61, P1261, DOI 10.1086/301645; Castellano S, 2014, P NATL ACAD SCI USA, V111, P6666, DOI 10.1073/pnas.1405138111; Chen MF, 2017, P NATL ACAD SCI USA, V114, P8089, DOI 10.1073/pnas.1620664114; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Dabney J, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012567; de Heinzelin J, 1999, SCIENCE, V284, P625; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Deng HK, 1997, NATURE, V388, P296, DOI 10.1038/40894; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Diamond MS, 2006, TRENDS MICROBIOL, V14, P287, DOI 10.1016/j.tim.2006.05.004; Dominguez-Rodrigo M, 2003, EVOL ANTHROPOL, V12, P275, DOI 10.1002/evan.10119; Dominguez-Rodrigo M, 2002, J WORLD PREHIST, V16, P1, DOI 10.1023/A:1014507129795; Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Dudley JP, 2015, ECOHEALTH, V12, P713, DOI 10.1007/s10393-015-1036-1; Essig A, 2014, J BIOL CHEM, V289, P34953, DOI 10.1074/jbc.M114.599878; Esteves PJ, 2007, INT J IMMUNOGENET, V34, P321, DOI 10.1111/j.1744-313X.2007.00716.x; Farzan M, 1997, J EXP MED, V186, P405, DOI 10.1084/jem.186.3.405; Fu QM, 2014, NATURE, V514, P445, DOI 10.1038/nature13810; Galvani AP, 2003, P NATL ACAD SCI USA, V100, P15276, DOI 10.1073/pnas.2435085100; Gittelman RM, 2016, CURR BIOL, V26, P3375, DOI 10.1016/j.cub.2016.10.041; Glass WG, 2006, J EXP MED, V203, P35, DOI 10.1084/jem.20051970; Hardy BL, 2010, QUATERNARY SCI REV, V29, P662, DOI 10.1016/j.quascirev.2009.11.016; Hardy K, 2016, ANTIQUITY, V90, P1373, DOI 10.15184/aqy.2016.134; Hardy K, 2017, SCI NAT-HEIDELBERG, V104, DOI 10.1007/s00114-016-1420-x; Hardy K, 2012, NATURWISSENSCHAFTEN, V99, P617, DOI 10.1007/s00114-012-0942-0; Holmes EC, 2001, BIOL REV, V76, P239, DOI 10.1017/S1464793101005668; Hoover KC, 2016, WIRES CLIM CHANGE, V7, P283, DOI 10.1002/wcc.382; Hu Y, 2015, BIORXIV; Huang YX, 1996, NAT MED, V2, P1240, DOI 10.1038/nm1196-1240; Huerta-Sanchez E, 2014, NATURE, V512, P194, DOI 10.1038/nature13408; Hummel S, 2005, GENES IMMUN, V6, P371, DOI 10.1038/sj.gene.6364172; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Karlsson EK, 2014, NAT REV GENET, V15, P379, DOI 10.1038/nrg3734; Lalueza-Fox C, 2007, SCIENCE, V318, P1453, DOI 10.1126/science.1147417; Liao F, 1997, J EXP MED, V185, P2015, DOI 10.1084/jem.185.11.2015; Lim JK, 2008, J INFECT DIS, V197, P262, DOI 10.1086/524691; Limborska SA, 2002, HUM HERED, V53, P49, DOI 10.1159/000048605; LIVINGSTONE FB, 1958, AM ANTHROPOL, V60, P533, DOI 10.1525/aa.1958.60.3.02a00110; Marciniak S, 2017, NAT REV GENET, V18, DOI 10.1038/nrg.2017.65; Mecsas J, 2004, NATURE, V427, P606, DOI 10.1038/427606a; Mendez FL, 2013, MOL BIOL EVOL, V30, P798, DOI 10.1093/molbev/mst004; Mendez FL, 2012, AM J HUM GENET, V91, P265, DOI 10.1016/j.ajhg.2012.06.015; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Moleon M, 2014, BIOSCIENCE, V64, P394, DOI 10.1093/biosci/biu034; Mossoun A, 2017, J VIROL, V91, DOI [10.1128/JVI.02479-16, 10.1128/jvi.02479-16]; Mummidi S, 2000, J BIOL CHEM, V275, P18946, DOI 10.1074/jbc.M000169200; Mummidi S, 1997, J BIOL CHEM, V272, P30662, DOI 10.1074/jbc.272.49.30662; Niemitz C, 2010, NATURWISSENSCHAFTEN, V97, P241, DOI 10.1007/s00114-009-0637-3; Novembre J, 2005, PLOS BIOL, V3, P1954, DOI 10.1371/journal.pbio.0030339; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Olalde I, 2014, NATURE, V507, P225, DOI 10.1038/nature12960; Perelygin AA, 2008, J HERED, V99, P500, DOI 10.1093/jhered/esn029; Pimenoff VN, 2017, MOL BIOL EVOL, V34, P4, DOI 10.1093/molbev/msw214; Prufer K, 2017, SCIENCE, V358, P655, DOI 10.1126/science.aao1887; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Quintana-Murci L, 2016, CR BIOL, V339, P278, DOI 10.1016/j.crvi.2016.04.005; Racimo F, 2017, MOL BIOL EVOL, V34, P296, DOI 10.1093/molbev/msw216; Racimo F, 2015, NAT REV GENET, V16, P359, DOI 10.1038/nrg3936; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Ribeiro Ieda P., 2005, Infection Genetics and Evolution, V5, P271, DOI 10.1016/j.meegid.2004.07.009; Richards MP, 2000, P NATL ACAD SCI USA, V97, P7663, DOI 10.1073/pnas.120178997; Sabeti PC, 2005, PLOS BIOL, V3, P1963, DOI 10.1371/journal.pbio.0030378; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Samson M, 1996, BIOCHEMISTRY-US, V35, P3362, DOI 10.1021/bi952950g; Sankararaman S, 2014, NATURE, V507, P354, DOI 10.1038/nature12961; Schroder KEE, 2003, ANN BEHAV MED, V26, P76, DOI 10.1207/S15324796ABM2602_02; SHIPMAN P, 1981, CURR ANTHROPOL, V22, P257, DOI 10.1086/202663; Slon V, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700186; Stephens JC, 1998, AM J HUM GENET, V62, P1507, DOI 10.1086/301867; Steve AM, 2017, ECOHEALTH, V14, P100, DOI 10.1007/s10393-016-1202-0; Temme S, 2014, J BIOL CHEM, V289, P639, DOI 10.1074/jbc.M113.515767; Van Vliet N, 2017, ETHNOBIOL CONSERV, V6, DOI 10.15451/ec2017-04-6.3-1-45; Vazquez-Salat N, 2007, GENOMICS, V90, P213, DOI 10.1016/j.ygeno.2007.04.009; Vernot B, 2016, SCIENCE, V352, P235, DOI 10.1126/science.aad9416; Weyrich LS, 2017, NATURE, V544, P357, DOI 10.1038/nature21674; Winder IC, 2015, J HUM EVOL, V87, P48, DOI 10.1016/j.jhevol.2015.07.002; Zhang YW, 1999, MOL BIOL EVOL, V16, P1145, DOI 10.1093/oxfordjournals.molbev.a026205; Zhang YW, 2003, MOL BIOL EVOL, V20, P1722, DOI 10.1093/molbev/msg198; Zimmerman PA, 1997, MOL MED, V3, P23, DOI 10.1007/BF03401665	93	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0204989	10.1371/journal.pone.0204989	http://dx.doi.org/10.1371/journal.pone.0204989			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3QJ	30278065	Green Submitted, Green Published, gold			2022-12-26	WOS:000446010200031
J	Ansaripour, A; Zendehdel, K; Tadayon, N; Sadeghi, F; Uyl-de Groot, CA; Redekop, WK				Ansaripour, Amir; Zendehdel, Kazem; Tadayon, Niki; Sadeghi, Fatemeh; Uyl-de Groot, Carin A.; Redekop, W. Ken			Use of data-mining to support real-world cost analyses: An example using HER2-positive breast cancer in Iran	PLOS ONE			English	Article							ADJUVANT CHEMOTHERAPY; TRASTUZUMAB; TRIAL	Introduction Patient registries play an important role in obtaining real-world evidence of the cost-effectiveness of treatments. However, their implementation is costly and sometimes infeasible in many middle-income countries (MICs). We explored the combination of data-mining and a large claims database to estimate the direct healthcare costs of HER2-positive breast cancer (BC) treatment in Iran and the fraction of total costs from trastuzumab use. Method We performed a retrospective analysis of claims data from the Iran Social Security Organization, a health insurer which covers approximately 50%(-40 million) of the Iranian population, in the period of 21/03/2011-20/03/2014. A data-mining algorithm using R software and validated using patient dossiers in the Cancer Research Center identified 1295 patients and divided them into the three main HER2-positive breast cancer stages (early, loco-regional and advanced). A payer perspective was used to calculate the absolute and relative direct costs of healthcare services associated with the treatment of HER2-positive breast cancer in the public and private healthcare systems. Results The number of women totaled 802 (early), 125 (loco-regional) and 218 (advanced). The mean age[SD] was 45[10], 46[10] and 48[10] years, respectively, while mean follow-up in all stages was approximately one year. Average costs of direct healthcare care in early, loco-regional and advanced stages were (sic)11,796 (95%CI: (sic)9,356-(sic)12,498), (sic)8,253 (95% CI: (sic)6,843-(sic)10,002), and (sic)17,742 (95%CI: (sic)15,720-(sic)19,505), respectively. Trastuzumab accounted for the largest share of total costs in all three stages (range: 53-76%). Conclusion Wherever comprehensive patient registries are infeasible or costly, real-world costs can be estimated through claims databases and data-mining strategies. Using this method, real-world costs have been estimated in Iran. The stage-specific cost estimates derived from this study can be used to perform real-world cost-effectiveness analyses of therapies for HER2-positive BC and support healthcare financing decisions.	[Ansaripour, Amir; Uyl-de Groot, Carin A.; Redekop, W. Ken] Erasmus Univ, Erasmus Sch Hlth Policy & Management, Rotterdam, Netherlands; [Zendehdel, Kazem; Sadeghi, Fatemeh] Univ Tehran Med Sci, Canc Res Ctr, Canc Inst Iran, Tehran, Iran; [Tadayon, Niki] Shahid Beheshti Univ Med Sci, Shohadaye Tajrish Med Ctr, Dept Gen & Vasc Surg, Tehran, Iran	Erasmus University Rotterdam; Tehran University of Medical Sciences; Shahid Beheshti University Medical Sciences	Ansaripour, A (corresponding author), Erasmus Univ, Erasmus Sch Hlth Policy & Management, Rotterdam, Netherlands.	ansaripour@eshpm.eur.nl	Ansaripour, Amir/AAI-5719-2021; tadayon, niki/AAZ-3631-2020; Redekop, Ken/AAA-2423-2020	Ansaripour, Amir/0000-0002-9298-6393; tadayon, niki/0000-0001-9431-4411; Zendehdel, Kazem/0000-0002-0269-4945; Redekop, Ken/0000-0001-9538-4083				[Anonymous], 2016, NEWS REPORT PHYS PRI; [Anonymous], 2016, GLOBOCAN 2012; Ansaripour A, 2016, J Cancer Policy, V9, P8, DOI 10.1016/j.jcpo.2016.05.005; Ansaripour Amir, 2014, Value Health Reg Issues, V3, P174, DOI 10.1016/j.vhri.2014.04.010; CRNN, 2012, GUID PRESCR TRAST PR; Daroudi R, 2015, IRAN J PUBLIC HEALTH, V44, P1225; Davari M, 2013, INT J PREVENTIVE MED, V4, P748; Drummond MF, 2015, METHODS EC EVALUATIO, V4th; Freitas AA., 2013, DISCOVERY DATA MININ; Gradishar Wj, 2014, NCCN CLIN PRACTICE G; Iran Social Security Organization, 1392 IR SOC SEC ORG; Iranian Government, 2013, DET DIAGN THER SERV; Jazayeri SB, 2015, CANCER EPIDEMIOL, V39, P519, DOI 10.1016/j.canep.2015.04.016; Larose DT., 2004, ANONYMOUS DISCOVERIN, P180; Larose DT., 2004, DISCOVERING KNOWLEDG, P147; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Mousavi SM, 2007, BREAST J, V13, P383, DOI 10.1111/j.1524-4741.2007.00446.x; Paik S, 2000, J NATL CANCER I, V92, P1991, DOI 10.1093/jnci/92.24.1991; Parsa M, 2015, IRAN J PUBLIC HEALTH, V44, P79; Pivot X, 2013, LANCET ONCOL, V14, P741, DOI 10.1016/S1470-2045(13)70225-0; R Core Team, 2013, R LANG ENV STAT COMP; Smith I, 2007, LANCET, V369, P29, DOI 10.1016/S0140-6736(07)60028-2; SSO, GEN STAT REP SOC SEC; Vera-Llonch M, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-250; Vostakolaei FA, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/517976; World Health Organization, 2016, BREAST CANC PREV CON; World Health Organization, 2006, GUID MAN BREAST CANC	27	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0205079	10.1371/journal.pone.0205079	http://dx.doi.org/10.1371/journal.pone.0205079			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273393	Green Published, Green Submitted, gold			2022-12-26	WOS:000446124700063
J	Loiselle, AR; de Kleine, E; van Dijk, P; Jansonius, NM				Loiselle, Allison R.; de Kleine, Emile; van Dijk, Pim; Jansonius, Nomdo M.			Noninvasive intracranial pressure assessment using otoacoustic emissions: An application in glaucoma	PLOS ONE			English	Article							CEREBROSPINAL-FLUID PRESSURE; OPEN-ANGLE GLAUCOMA; MENIERES-DISEASE; HYPERTENSION; POSTURE	The theory that glaucoma patients have a lower intracranial pressure (ICP) than healthy subjects is a controversial one. The aim of this study was to assess ICP noninvasively by determining the relationship between distortion product otoacoustic emission (DPOAE) phase and body position and to compare this relationship between patients with primary open angle glaucoma (POAG), patients with normal tension glaucoma (NTG), and controls. The relationship was also calibrated using published data regarding invasive measurements of ICP versus body position. DPOAEs were measured in 30 controls and 32 glaucoma patients (17 POAG, 15 NTG) at the following body positions (assuming 90 degrees as upright): 45, 30, 20, 10, 0 (supine), -10, and -20 degrees. DPOAE phase had a clear, nonlinear relationship with body position. The mean DPOAE phase shifts between the two most extreme body positions (45 to -20 degrees) were 73.6, 80.7, and 66.3 degrees for healthy, POAG, and NTG, respectively (P = 0.73), and the groups showed the same, nonlinear behaviour. This indicates that there is no evidence that glaucoma patients have a reduced ICP. When calibrated with invasive data, ICP and DPOAE phase were linearly related over an ICP of 3 mmHg. This suggests that, more broadly, DPOAEs could be used in the future to monitor changes in ICP in a clinical setting and to measure dynamic changes in ICP such as diurnal fluctuations or changes induced by certain medications.	[Loiselle, Allison R.; Jansonius, Nomdo M.] Univ Groningen, Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands; [Loiselle, Allison R.; de Kleine, Emile; van Dijk, Pim; Jansonius, Nomdo M.] Univ Groningen, Grad Sch Med Sci, Res Sch Behav & Cognit Neurosci, Groningen, Netherlands; [de Kleine, Emile; van Dijk, Pim] Univ Groningen, Univ Med Ctr Groningen, Dept Otorhinolaryngol Head & Neck Surg, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Jansonius, NM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands.; Jansonius, NM (corresponding author), Univ Groningen, Grad Sch Med Sci, Res Sch Behav & Cognit Neurosci, Groningen, Netherlands.	n.m.jansonius@umcg.nl	Van Dijk, Pim/E-8019-2010; de Kleine, Emile/P-2350-2014	Van Dijk, Pim/0000-0002-8023-7571; Loiselle, Allison/0000-0003-2686-0634; de Kleine, Emile/0000-0001-9525-3032; Jansonius, Nomdo/0000-0002-6495-6568	European Union (EU) Horizon 2020 [661883]; Uitzicht [2015-11]	European Union (EU) Horizon 2020; Uitzicht	This study was funded by the European Union (EU) Horizon 2020 grant No 661883 European Glaucoma Research Training Program (EGRET) and by Uitzicht grant No 2015-11 (ANVVB, Glaucoomfonds, LSBS, Novartisfonds, Oogfonds, Stichting Blinden-Penning). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBECK MJ, 1991, J NEUROSURG, V74, P597, DOI 10.3171/jns.1991.74.4.0597; Avan P, 2011, HEARING RES, V277, P88, DOI 10.1016/j.heares.2011.03.006; Berdahl JP, 2008, OPHTHALMOLOGY, V115, P763, DOI 10.1016/j.ophtha.2008.01.013; Berdahl JP, 2008, INVEST OPHTH VIS SCI, V49, P5412, DOI 10.1167/iovs.08-2228; Bershad EM, 2014, NEUROSURGERY, V75, P445, DOI 10.1227/NEU.0000000000000449; Buki B, 2000, HEARING RES, V140, P202, DOI 10.1016/S0378-5955(99)00202-6; Casson RJ, 2012, CLIN EXP OPHTHALMOL, V40, P341, DOI 10.1111/j.1442-9071.2012.02773.x; Chaaban MR, 2013, INT FORUM ALLERGY RH, V3, P718, DOI 10.1002/alr.21188; CHAPMAN PH, 1990, NEUROSURGERY, V26, P181, DOI 10.1227/00006123-199002000-00001; de Kleine E, 2000, J ACOUST SOC AM, V107, P3308, DOI 10.1121/1.429403; Flammer J, 2013, EPMA J, V4, DOI 10.1186/1878-5085-4-14; Gallina P, 2018, J NEUROSURG, V129, P1078, DOI 10.3171/2017.5.JNS163062; Gerenton G, 2015, HEARING RES, V327, P199, DOI 10.1016/j.heares.2015.07.016; GUCER G, 1978, J NEUROSURG, V49, P256, DOI 10.3171/jns.1978.49.2.0256; Heeg GP, 2005, ACTA OPHTHALMOL SCAN, V83, P46, DOI 10.1111/j.1600-0420.2005.00423.x; Jonas JB, 2015, PROG BRAIN RES, V221, P33, DOI 10.1016/bs.pbr.2015.06.002; Kemp DT, 2002, BRIT MED BULL, V63, P223, DOI 10.1093/bmb/63.1.223; Linden C, 2018, OPHTHALMOLOGY, V125, P361, DOI 10.1016/j.ophtha.2017.09.022; MORGAN WH, 1995, INVEST OPHTH VIS SCI, V36, P1163; Pircher A, 2017, ACTA OPHTHALMOL, V95, pE524, DOI 10.1111/aos.13302; PROBST R, 1991, J ACOUST SOC AM, V89, P2027, DOI 10.1121/1.400897; Ren RJ, 2010, OPHTHALMOLOGY, V117, P259, DOI 10.1016/j.ophtha.2009.06.058; Smith SV, 2017, HEADACHE, V57, P1303, DOI 10.1111/head.13144; Voss SE, 2010, HEARING RES, V263, P43, DOI 10.1016/j.heares.2010.03.003; Williams MA, 2016, AEROSP MED HUM PERF, V87, P844, DOI 10.3357/AMHP.4572.2016	25	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204939	10.1371/journal.pone.0204939	http://dx.doi.org/10.1371/journal.pone.0204939			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273407	Green Submitted, Green Published, gold			2022-12-26	WOS:000446124700052
J	Tam, J; Hoffmann, T; Fischer, S; Bornstein, S; Grassler, J; Noack, B				Tam, Jonathan; Hoffmann, Thomas; Fischer, Sabine; Bornstein, Stefan; Graessler, Juergen; Noack, Barbara			Obesity alters composition and diversity of the oral microbiota in patients with type 2 diabetes mellitus independently of glycemic control	PLOS ONE			English	Article							HUMAN GUT MICROBIOME; PERIODONTAL-DISEASE; INFLAMMATION; DEFINITIONS; ASSOCIATION; SENSITIVITY; GENETICS; DATABASE; HEALTH; WOMEN	Background and objective The involvement of the oral microbiota as a possible link between periodontitis, type 2 diabetes mellitus and obesity is still not well understood. The objective of the study was to investigate if glycemic control and obesity play a role in modulating the composition and diversity of the oral microbial ecology. Material and methods A cohort of patients with type 2 diabetes mellitus (n = 18) was recruited. Participants demonstrating improved glycemic control after 3 months (n = 6) were included in a second examination. A full mouth examination was performed to estimate periodontitis severity followed by sample collection (subgingival plaque and saliva). Generation of large sequence libraries was performed using the high-throughput Illumina MiSeq sequencing platform. Results The majority of participants (94.4%, n = 17) presented with moderate or severe forms of periodontitis. Differences in microbial composition and diversity between obese (BMI >= 30 kg/m(2)) and non-obese (BMI < 30 kg/m(2)) groups were statistically significant. Cross-sectional and longitudinal approaches failed to reveal statistically significant associations between HbA(1c) level and species composition or diversity. Conclusions Obesity was significantly associated with the oral microbial composition. The impact of glycemic control on oral microbiota, however, could not be assured statistically.	[Tam, Jonathan; Hoffmann, Thomas; Noack, Barbara] Tech Univ Dresden, Med Fac Carl Gustav Carus, Dept Periodontol, Dresden, Germany; [Fischer, Sabine; Bornstein, Stefan; Graessler, Juergen] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept & Outpatient Dept Med 3, Dresden, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Noack, B (corresponding author), Tech Univ Dresden, Med Fac Carl Gustav Carus, Dept Periodontol, Dresden, Germany.	barbara.noack@uniklinikum-dresden.de		Graessler, Juergen/0000-0003-3619-8517	Open Access Publication Funds of the SLUB/TU Dresden	Open Access Publication Funds of the SLUB/TU Dresden	The authors acknowledge support by the Open Access Publication Funds of the SLUB/TU Dresden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Arimatsu K, 2014, SCI REP-UK, V4, DOI 10.1038/srep04828; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Casagrande SS, 2013, DIABETES CARE, V36, P2271, DOI 10.2337/dc12-2258; Casarin RCV, 2013, J PERIODONTAL RES, V48, P30, DOI 10.1111/j.1600-0765.2012.01498.x; Chaffee BW, 2010, J PERIODONTOL, V81, P1708, DOI 10.1902/jop.2010.100321; Chapple ILC, 2013, J CLIN PERIODONTOL, V40, pS106, DOI [10.1111/jcpe.12077, 10.1902/jop.2013.1340011]; Chen T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq013; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Crommen S, 2018, GENES-BASEL, V9, DOI 10.3390/genes9010010; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fadrosh DW, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-6; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Ganesan SM, 2017, ISME J, V11, P2075, DOI 10.1038/ismej.2017.73; Goodson JM, 2009, J DENT RES, V88, P519, DOI 10.1177/0022034509338353; Graessler J, 2013, PHARMACOGENOMICS J, V13, P514, DOI 10.1038/tpj.2012.43; Hajishengallis G, 2012, MOL ORAL MICROBIOL, V27, P409, DOI 10.1111/j.2041-1014.2012.00663.x; Hall MW, 2017, NPJ BIOFILMS MICROBI, V3, DOI 10.1038/s41522-016-0011-0; Hinkle D. E., 2003, APPL STAT BEHAV SCI, P109; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Kodukula K, 2017, BIORESEARCH OPEN ACC, V6, P123, DOI 10.1089/biores.2017.0020; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lin HP, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031286, 10.1371/journal.pone.0035240]; Lin SW, 2015, OBESITY, V23, P862, DOI 10.1002/oby.21020; Maciel SS, 2016, J CLIN PERIODONTOL, V43, P1003, DOI 10.1111/jcpe.12634; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Nakajima M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134234; Noack B, 2013, J PERIODONTOL, V84, P614, DOI 10.1902/jop.2012.120062; Page RC, 2007, J PERIODONTOL, V78, P1387, DOI 10.1902/jop.2007.060264; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Polak D, 2018, J CLIN PERIODONTOL, V45, P150, DOI 10.1111/jcpe.12803; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shungin D, 2015, INT J EPIDEMIOL, V44, P638, DOI 10.1093/ije/dyv075; Silva-Boghossian CM, 2018, J PERIODONTOL, V89, P186, DOI 10.1002/JPER.17-0236; Talbott K, 1976, J PREV DENT, V4, P28; Taylor John J, 2013, J Periodontol, V84, pS113, DOI [10.1111/jcpe.12059, 10.1902/jop.2013.134005]; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Tonetti MS, 2005, J CLIN PERIODONTOL, V32, P210, DOI 10.1111/j.1600-051X.2005.00822.x; Tsuda A, 2015, CLIN TRANSL GASTROEN, V6, DOI 10.1038/ctg.2015.20; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Wang BH, 2017, ENGINEERING, V3, P71, DOI 10.1016/J.ENG.2017.01.008; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Xiong YM, 2004, P NATL ACAD SCI USA, V101, P1045, DOI 10.1073/pnas.2637002100; Yoav Benjamini, 2001, Behavioural Brain Research, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Zhou M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061516	51	40	43	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204724	10.1371/journal.pone.0204724	http://dx.doi.org/10.1371/journal.pone.0204724			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273364	Green Published, Green Submitted, gold			2022-12-26	WOS:000446124700033
J	Menendez-Ortiz, A; Feregrino-Uribe, C; Garcia-Hernandez, JJ				Menendez-Ortiz, Alejandra; Feregrino-Uribe, Claudia; Juan Garcia-Hernandez, Jose			Self-recovery scheme for audio restoration using auditory masking	PLOS ONE			English	Article							FRAGILE WATERMARKING; DIGITAL AUDIO; AUTHENTICATION; TRANSFORM	Self-recovery schemes identify and restore tampering, using as a reference a compressed representation of a signal embedded into itself. In addition, audio self-recovery must comply with a transparency threshold, adequate for applications such as on-line music distribution or speech transmission. In this manuscript, an audio self-recovery scheme is proposed. Auditory masking properties of the signals are used to determine the frequencies that better mask the embedding distortion. Frequencies in the Fourier domain are mapped to the intDCT domain for embedding and extraction of reference bits for signal restoration. The contribution of this work is the use of auditory masking properties for the frequency selection and the mapping to the intDCT domain. Experimental results demonstrate that the proposed scheme satisfies a threshold of -2 ODG, suitable for audio applications. The efficacy of the scheme, in terms of its restoration capabilities, is also shown.	[Menendez-Ortiz, Alejandra; Feregrino-Uribe, Claudia] INAOE, Comp Sci Dept, Luis Enrique Erro 1, Puebla 72840, Mexico; [Juan Garcia-Hernandez, Jose] IPN, Ctr Invest & Estudios Avanzados, Unidad Tamaulipas, Km 5-5 Carr Cd Victoria Solo La Marina, Cd Victoria 87130, Tamps, Mexico; [Menendez-Ortiz, Alejandra] Ctr Invest Matemat AC, Guanajuato, Mexico	Instituto Nacional de Astrofisica, Optica y Electronica	Garcia-Hernandez, JJ (corresponding author), IPN, Ctr Invest & Estudios Avanzados, Unidad Tamaulipas, Km 5-5 Carr Cd Victoria Solo La Marina, Cd Victoria 87130, Tamps, Mexico.	jjuan@tamps.cinvestav.mx	Garcia-Hernandez, Jose Juan/E-8633-2010; Feregrino, Claudia/AAW-2607-2021	Garcia-Hernandez, Jose Juan/0000-0002-1249-5413; 	PRODEP-SEP; CONACY [PDCPN2013- 01-216689, PDCPN2017-01-5814, 351601]	PRODEP-SEP; CONACY	This work was supported by PRODEP-SEP and CONACY under grants PDCPN2013- 01-216689, PDCPN2017-01-5814, and Ph.D. scholarship No. 351601. There was no additional external funding received for this study.	Bartolini F, 2001, P IEEE, V89, P1403, DOI 10.1109/5.959338; Bravo-Solorio S, 2012, IEEE IMAGE PROC, P2197, DOI 10.1109/ICIP.2012.6467330; Bravo-Solorio S, 2012, IEEE INT WORKS INFOR, P217, DOI 10.1109/WIFS.2012.6412652; Celik MU, 2002, PROC SPIE, V4675, P531, DOI 10.1117/12.465311; Chen Q, 2013, LECT NOTES COMPUTER, V7809, P395, DOI [10.1007/978-3-642-40099-5_33, DOI 10.1007/978-3-642-40099-533]; Cvejic N., 2008, DIGITAL AUDIO WATERM; Dortmund University, 2005, MUS AUD BENCHM DAT S; Fan MQ, 2013, INT J COMPUT MATH, V90, P2588, DOI 10.1080/00207160.2013.805752; Fridrich J, 2002, PROC SPIE, V4675, P691, DOI 10.1117/12.465330; FRIDRICH J, 1999, S CONT SEC DAT HID D, P1; Gomez E, 2002, INT TEL S D ITS2002, P1; Gouyon F., 2006, BALLROOM DATASET; Hassan A.M., 2009, WORLD ACAD SCI ENG T, V2009, P69; He HJ, 2012, IEEE T INF FOREN SEC, V7, P185, DOI 10.1109/TIFS.2011.2162950; Huang HB, 2004, 2004 IEEE INTERNATIONAL CONFERENCE ON ACOUSTICS, SPEECH, AND SIGNAL PROCESSING, VOL IV, PROCEEDINGS, P177; Hung KL, 2007, LECT NOTES COMPUT SC, V4610, P333; Garcia-Hernandez JJ, 2013, MIDWEST SYMP CIRCUIT, P1375, DOI 10.1109/MWSCAS.2013.6674912; Lin Y., 2015, AUDIO WATERMARK COMP; Liu ZH, 2017, MULTIMED TOOLS APPL, V76, P12481, DOI 10.1007/s11042-016-3664-z; Lu C., 2004, MULTIMEDIA SECURITY, DOI [10.5860/choice.42-2260, DOI 10.5860/CHOICE.42-2260]; Luo X, 2014, WUHAN UNIV J NAT SCI, V19, P497, DOI [DOI 10.1007/s11859-014-1044-y, 10.1007/s11859-014-1044-y]; Menendez-Ortiz A, 2017, INVENTORS ASSIGNEE S; Menendez-Ortiz A, 2018, AUDIO DATABASE SELF, V1, DOI [10.7910/DVN/ZXW0NP, DOI 10.7910/DVN/ZXW0NP]; Menendez-Ortiz A, 2017, MULTIMED TOOLS APPL, V76, P14197, DOI 10.1007/s11042-016-3783-6; Mobasseri B. G., 2000, Proceedings International Conference on Information Technology: Coding and Computing (Cat. No.PR00540), P68, DOI 10.1109/ITCC.2000.844185; Newton H., 2011, POINTS VIEW MUSIC CE, V1, P1; NFSTC, 2010, SIMPL GUID FOR AUD V; Owen M., 2007, PRACTICAL SIGNAL PRO; Sarreshtedari S, 2015, IEEE-ACM T AUDIO SPE, V23, P1917, DOI 10.1109/TASLP.2015.2456431; Shi YJ, 2013, OPTIK, V124, P3827, DOI 10.1016/j.ijleo.2012.11.078; Steinebach M, 2003, EURASIP J APPL SIG P, V2003, P1001, DOI 10.1155/S1110865703304081; Thiede T, 2000, J AUDIO ENG SOC, V48, P3; Wang HX, 2010, SCI CHINA INFORM SCI, V53, P619, DOI 10.1007/s11432-010-0058-0; Wang S. M., 2007, SE CULTURE, V5, P12, DOI DOI 10.1016/j.engappai.2007.05.012; Xu TT, 2009, LECT NOTES COMPUT SC, V5879, P1281; Zhang XP, 2011, IEEE T IMAGE PROCESS, V20, P485, DOI 10.1109/TIP.2010.2066981; Zhang XP, 2008, IEEE T MULTIMEDIA, V10, P1490, DOI 10.1109/TMM.2008.2007334; Zhu X, 2007, SIGNAL PROCESS-IMAGE, V22, P515, DOI 10.1016/j.image.2007.03.004	38	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204442	10.1371/journal.pone.0204442	http://dx.doi.org/10.1371/journal.pone.0204442			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265725	Green Published, Green Submitted, gold			2022-12-26	WOS:000446005500033
J	Subedi, D; Vijay, AK; Kohli, GS; Rice, SA; Willcox, M				Subedi, Dinesh; Vijay, Ajay Kumar; Kohli, Gurjeet Singh; Rice, Scott A.; Willcox, Mark			Association between possession of ExoU and antibiotic resistance in Pseudomonas aeruginosa	PLOS ONE			English	Article							III SECRETION SYSTEM; REAL-TIME-PCR; FLUOROQUINOLONE RESISTANCE; MEXAB-OPRM; ANTIMICROBIAL RESISTANCE; MICROBIAL KERATITIS; TOPOISOMERASE-IV; CYSTIC-FIBROSIS; EFFLUX PUMPS; RISK-FACTORS	Virulent strains of Pseudomonas aeruginosa are often associated with an acquired cytotoxic protein, exoenzyme U (ExoU) that rapidly destroys the cell membranes of host cells by its phospholipase activity. Strains possessing the exoU gene are predominant in eye infections and are more resistant to antibiotics. Thus, it is essential to understand treatment options for these strains. Here, we have investigated the resistance profiles and genes associated with resistance for fluoroquinolone and beta-lactams. A total of 22 strains of P. aeruginosa from anterior eye infections, microbial keratitis (MK), and the lungs of cystic fibrosis (CF) patients were used. Based on whole genome sequencing, the prevalence of the exoU gene was 61.5% in MK isolates whereas none of the CF isolates possessed this gene. Overall, higher antibiotic resistance was observed in the isolates possessing exoU. Of the exoUstrains, all except one were resistant to fluoroquinolones, 100% were resistant to beta-lactams. 75% had mutations in quinolone resistance determining regions (T81I gyrA and/or S87L parC) which correlated with fluoroquinolone resistance. In addition, exoUstrains had mutations at K76Q, A110T, and V126E in ampC, Q155I and V356I in ampR and E114A, G283E, and M288R in mexR genes that are associated with higher beta-lactamase and efflux pump activities. In contrast, such mutations were not observed in the strains lacking exoU. The expression of the ampC gene increased by up to nine-fold in all eight exoUstrains and the ampR was upregulated in seven exoUstrains compared to PAO1. The expression of mexR gene was 1.4 to 3.6 fold lower in 75% of exoUstrains. This study highlights the association between virulence traits and antibiotic resistance in pathogenic P. aeruginosa.	[Subedi, Dinesh; Vijay, Ajay Kumar; Willcox, Mark] Univ New South Wales, Sch Optometry & Vis Sci, Sydney, NSW, Australia; [Kohli, Gurjeet Singh; Rice, Scott A.] Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, Singapore, Singapore; [Rice, Scott A.] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore; [Rice, Scott A.] Univ Technol Sydney, Ithree Inst, Sydney, NSW, Australia	University of New South Wales Sydney; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of Technology Sydney	Subedi, D (corresponding author), Univ New South Wales, Sch Optometry & Vis Sci, Sydney, NSW, Australia.	d.subedi@unsw.edu.au	Vijay, Ajay Kumar/AAF-7460-2020; Subedi, Dinesh/R-1686-2017; Rice, Scott/A-6084-2019; Vijay, Ajay Kumar/M-2194-2017	Vijay, Ajay Kumar/0000-0002-8248-6379; Subedi, Dinesh/0000-0002-1357-9520; Rice, Scott/0000-0002-9486-2343; Vijay, Ajay Kumar/0000-0002-8248-6379; willcox, mark/0000-0003-3842-7563	National Research Foundation Singapore; Ministry of Education; Nanyang Technological University; National University of Singapore	National Research Foundation Singapore(National Research Foundation, Singapore); Ministry of Education; Nanyang Technological University(Nanyang Technological University); National University of Singapore(National University of Singapore)	The authors would like to acknowledge the Singapore Centre for Environmental Life Sciences Engineering (SCELSE), whose research is supported by the National Research Foundation Singapore, Ministry of Education, Nanyang Technological University and National University of Singapore, under its Research Centre of Excellence Programme. Sequencing of DNA was carried out with the help of Daniela Moses and Stephan Schuster using the sequencing facilities at SCELSE. We are also thankful to UNSW high performance computing facility KATANA for providing us cluster for data analysis.	Adewoye L, 2002, J BACTERIOL, V184, P4308, DOI 10.1128/JB.184.15.4308-4312.2002; Agnello M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01591; Agnello M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042973; Akasaka T, 2001, ANTIMICROB AGENTS CH, V45, P2263, DOI 10.1128/AAC.45.8.2263-2268.2001; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Berrazeg M, 2015, ANTIMICROB AGENTS CH, V59, P6248, DOI 10.1128/AAC.00825-15; Berthelot P, 2003, J INFECT DIS, V188, P512, DOI 10.1086/377000; Borkar DS, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-54; Bradbury RS, 2010, J MED MICROBIOL, V59, P881, DOI 10.1099/jmm.0.018283-0; Bruchmann S, 2013, ANTIMICROB AGENTS CH, V57, P1361, DOI 10.1128/AAC.01581-12; Cho HH, 2014, ANN LAB MED, V34, P286, DOI 10.3343/alm.2014.34.4.286; Choudhury D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149156; Choy MH, 2008, J MED MICROBIOL, V57, P1539, DOI 10.1099/jmm.0.2008/003723-0; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Clinical and Laboratory Standard Institute (CLSI), 2012, METH DIL ANT SUSC TE, V32; CLSI, 2012, M100S22 CLSI, V32; Ding CY, 2016, INT J INFECT DIS, V49, P119, DOI 10.1016/j.ijid.2016.06.014; Dumas JL, 2006, FEMS MICROBIOL LETT, V254, P217, DOI 10.1111/j.1574-6968.2005.00008.x; EUCAST The European Committee on Antimicrobial Susceptibility Testing, 2021, BREAKP TABL INT MICS; Silva KDFD, 2017, BURNS, V43, P137, DOI 10.1016/j.burns.2016.07.002; FinckBarbancon V, 1997, MOL MICROBIOL, V25, P547, DOI 10.1046/j.1365-2958.1997.4891851.x; Fleiszig SMJ, 1997, INFECT IMMUN, V65, P579, DOI 10.1128/IAI.65.2.579-586.1997; Fleiszig Suzanne M. J., 1998, CLAO Journal, V24, P41; Garey KW, 2008, J CHEMOTHERAPY, V20, P714, DOI 10.1179/joc.2008.20.6.714; Georgescu M, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1396-3; Green M, 2008, CORNEA, V27, P22, DOI 10.1097/ICO.0b013e318156caf2; Hauser AR, 2009, NAT REV MICROBIOL, V7, P654, DOI 10.1038/nrmicro2199; Hauser AR, 2002, CRIT CARE MED, V30, P521, DOI 10.1097/00003246-200203000-00005; Heidary Zohreh, 2016, Acta Med Iran, V54, P201; Hirose K, 2002, ANTIMICROB AGENTS CH, V46, P3249, DOI 10.1128/AAC.46.10.3249-3252.2002; Hocquet D, 2003, ANTIMICROB AGENTS CH, V47, P1887, DOI 10.1128/AAC.47.6.1887-1894.2003; Hsu DI, 2005, J ANTIMICROB CHEMOTH, V55, P535, DOI 10.1093/jac/dki026; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Keay L, 2008, CLIN EXP OPHTHALMOL, V36, P209, DOI 10.1111/j.1442-9071.2008.01722.x; Kulasekara BR, 2006, J BACTERIOL, V188, P4037, DOI 10.1128/JB.02000-05; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Laxminarayan R, 2016, LANCET, V387, P168, DOI 10.1016/S0140-6736(15)00474-2; Lee JK, 2005, INT J ANTIMICROB AG, V25, P290, DOI 10.1016/j.ijantimicag.2004.11.012; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Ling JM, 2003, ANTIMICROB AGENTS CH, V47, P3567, DOI 10.1128/AAC.47.11.3567-3573.2003; Masuda N, 2000, ANTIMICROB AGENTS CH, V44, P3322, DOI 10.1128/AAC.44.12.3322-3327.2000; Mitov I, 2010, BRAZ J MICROBIOL, V41, P588, DOI 10.1590/S1517-83822010000300008; Park MH, 2017, AURIS NASUS LARYNX, V44, P258, DOI 10.1016/j.anl.2016.07.005; Poole K, 2005, J ANTIMICROB CHEMOTH, V56, P20, DOI 10.1093/jac/dki171; Poole K, 2001, J MOL MICROB BIOTECH, V3, P255; Richards MJ, 1999, CRIT CARE MED, V27, P887, DOI 10.1097/00003246-199905000-00020; Saito K, 1999, FEMS MICROBIOL LETT, V179, P67, DOI 10.1016/S0378-1097(99)00394-8; Sato H, 2003, EMBO J, V22, P2959, DOI 10.1093/emboj/cdg290; Sawa T, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0668-9; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Stewart RMK, 2011, J CLIN MICROBIOL, V49, P993, DOI 10.1128/JCM.02036-10; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Tam VH, 2007, CLIN MICROBIOL INFEC, V13, P413, DOI 10.1111/j.1469-0691.2006.01674.x; Tingpej P, 2007, J CLIN MICROBIOL, V45, P1697, DOI 10.1128/JCM.02364-06; Tran QT, 2011, FOODBORNE PATHOG DIS, V8, P451, DOI 10.1089/fpd.2010.0687; Vaez Hamid, 2014, Adv Biomed Res, V3, P117, DOI 10.4103/2277-9175.133183; Walker SE, 2013, METHOD ENZYMOL, V530, P337, DOI 10.1016/B978-0-12-420037-1.00019-1; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Wolfgang MC, 2003, P NATL ACAD SCI USA, V100, P8484, DOI 10.1073/pnas.0832438100; Wong-Beringer A, 2008, CLIN MICROBIOL INFEC, V14, P330, DOI 10.1111/j.1469-0691.2007.01939.x; Yahr TL, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 6, THIRD EDITION, P704, DOI 10.1007/0-387-30746-x_22; Yamaguchi S, 2014, J INFECT CHEMOTHER, V20, P407, DOI 10.1016/j.jiac.2014.02.007	63	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204936	10.1371/journal.pone.0204936	http://dx.doi.org/10.1371/journal.pone.0204936			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265709	Green Published, gold			2022-12-26	WOS:000446005500057
J	Teter, J; Yeh, S; Khanna, M; Berndes, G				Teter, Jacob; Yeh, Sonia; Khanna, Madhu; Berndes, Goren			Water impacts of US biofuels: Insights from an assessment combining economic and biophysical models	PLOS ONE			English	Article							BIOENERGY CROPS; BIOMASS PRODUCTION; USE EFFICIENCY; CLIMATE-CHANGE; FOOTPRINT; QUALITY; SWITCHGRASS; MISCANTHUS; LCA; CONSUMPTION	Biofuels policies induce land use changes (LUC), including cropland expansion and crop switching, and this in turn alters water and soil management practices. Policies differ in the extent and type of land use changes they induce and therefore in their impact on water resources. We quantify and compare the spatially varying water impacts of biofuel crops stemming from LUC induced by two different biofuels policies by coupling a biophysical model with an economic model to simulate the economically viable mix of crops, land uses, and crop management choices under alternative policy scenarios. We assess the outputs of an economic model with a high-resolution crop-water model for major agricultural crops and potential cellulosic feedstocks in the US to analyze the impacts of three alternative policy scenarios on water balances: a counterfactual 'no-biofuels policy' (BAU) scenario, a volumetric mandate (Mandate) scenario, and a clean fuel-intensity standard (CFS) scenario incentivizing fuels based on their carbon intensities. While both biofuel policies incentivize more biofuels than in the counterfactual, they differ in the mix of corn ethanol and advanced biofuels from miscanthus and switchgrass (more corn ethanol in Mandate and more cellulosic biofuels in CFS). The two policies differ in their impact on irrigated acreage, irrigation demand, groundwater use and runoff. Net irrigation requirements increase 0.7% in Mandate and decrease 3.8% in CFS, but in both scenarios increases are concentrated in regions of Kansas and Nebraska that rely upon the Ogallala aquifer for irrigation water. Our study illustrates the importance of accounting for the overall LUC and shifts in agricultural production and management practices in response to policies when assessing the water impacts of biofuels.	[Teter, Jacob] Int Energy Agcy, Sustainable Technol Outlooks, Paris, France; [Yeh, Sonia; Berndes, Goren] Chalmers Univ Technol, Dept Space Earth & Environm, Gothenburg, Sweden; [Khanna, Madhu] Univ Illinois, Dept Agr & Consumer Econ, Urbana, IL USA; [Khanna, Madhu] Univ Illinois, DOE Ctr Adv Bioenergy & Bioprod Innovat, Urbana, IL USA	Chalmers University of Technology; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Teter, J (corresponding author), Int Energy Agcy, Sustainable Technol Outlooks, Paris, France.	jacob.TETER@iea.org	Yeh, Sonia/Q-3632-2017	Yeh, Sonia/0000-0002-4852-1177	California Energy Commission; Sustainable Transportation Energy Pathways (STEPS) program at the Institute of Transportation Studies, UC Davis; National Center for Sustainable Transportation; DOE Center for Advanced Bioenergy and Bioproducts Innovation (U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research) [DE-SC0018420]	California Energy Commission; Sustainable Transportation Energy Pathways (STEPS) program at the Institute of Transportation Studies, UC Davis; National Center for Sustainable Transportation; DOE Center for Advanced Bioenergy and Bioproducts Innovation (U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research)(United States Department of Energy (DOE))	The authors were funded by the California Energy Commission and the Sustainable Transportation Energy Pathways (STEPS) program at the Institute of Transportation Studies, UC Davis, as well as a dissertation grant from the National Center for Sustainable Transportation, for funding the research (JT, SY). Madhu Khanna is grateful for funding provided by the DOE Center for Advanced Bioenergy and Bioproducts Innovation (U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research under Award Number DE-SC0018420). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RG, 2005, J IRRIG DRAIN ENG, V131, P2, DOI 10.1061/(ASCE)0733-9437(2005)131:1(2); [Anonymous], 2010, EN INF ADM; Argonne National Laboratory, 2015, WAT AN TOOL EN RES V; Arnold J, 1994, SWAT SOIL WATER ASSE; Barton B, 2014, WATER CLIMATE RISKS; Boulay A-M, 2017, INT J LIFE CYCLE ASS; Boulay AM, 2015, INT J LIFE CYCLE ASS, V20, P577, DOI 10.1007/s11367-015-0869-8; Cai H, 2013, APPL ENERG, V111, P644, DOI 10.1016/j.apenergy.2013.05.023; Casler MD, 2012, SWITCHGRASS GREEN EN; Chen XG, 2014, J ENVIRON ECON MANAG, V67, P241, DOI 10.1016/j.jeem.2013.09.006; Chiu YW, 2012, ENVIRON SCI TECHNOL, V46, P9155, DOI 10.1021/es3002162; Chiu YW, 2009, ENVIRON SCI TECHNOL, V43, P2688, DOI 10.1021/es8031067; Christopher KW, 2017, ENVIRON RES LETT, V12; Cibin R, 2016, GCB BIOENERGY; Cibin R, 2016, GCB BIOENERGY, V8, P837, DOI 10.1111/gcbb.12307; Deb D, 2015, WATER-SUI, V7, P3283, DOI 10.3390/w7073283; Dominguez-Faus R, 2009, ENVIRON SCI TECHNOL, V43, P3005, DOI 10.1021/es802162x; Dominguez-Faus R, 2013, ENVIRON SCI TECHNOL, V47, P6030, DOI 10.1021/es400435n; Economic NRCCo Production EIoIB, 2011, REN ELOLB REN FUEL S; EIA, 2009, MONTHL BIOD PROD REP; Emmenegger MF, 2011, INT J LIFE CYCLE ASS, V16, P869, DOI 10.1007/s11367-011-0327-1; Engel B, 2010, BIOFUELS-UK, V1, P463, DOI 10.4155/BFS.10.17; Environment and Climate Change Canada, 2017, CLEAN FUEL STAND DIS; Feng KS, 2011, ECON SYST RES, V23, P371, DOI 10.1080/09535314.2011.638276; Fingerman KR, 2011, BIOFUEL BIOPROD BIOR, V5, P375, DOI 10.1002/bbb.294; Fingerman KR, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/1/014020; Gerbens-Leenes PW, 2012, GLOBAL ENVIRON CHANG, V22, P764, DOI 10.1016/j.gloenvcha.2012.04.001; Gerbens-Leenes PW, 2009, ECOL ECON, V68, P1052, DOI 10.1016/j.ecolecon.2008.07.013; Gerbens-Leenes W, 2011, ENERG ENVIRON SCI, V4, P2658, DOI 10.1039/c1ee01187a; Hamilton SK, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/6/064015; Han WG, 2012, COMPUT ELECTRON AGR, V84, P111, DOI 10.1016/j.compag.2012.03.005; Hertel T, 2013, AGR ECON-BLACKWELL, V44, P129, DOI 10.1111/agec.12057; Holgate TC, 2016, INT ENERGY CONVERS; Hoogeveen J, 2009, IRRIG DRAIN, V58, pS148, DOI 10.1002/ird.479; Housh M, 2015, ENVIRON SCI TECHNOL, V49, P11932, DOI 10.1021/acs.est.5b02712; Huang H, ECONOMETRIC ANAL US; Huang HX, 2013, ENERG POLICY, V56, P5, DOI 10.1016/j.enpol.2012.06.002; Hudiburg TW, 2016, NAT ENERGY, V1, DOI 10.1038/NENERGY.2015.5; Johnson R, 2008 FARM BILL MAJOR; Khanna M, 2012, CLIMATE CHANGE EC, V3; Khanna M, 2012, ANNU REV RESOUR ECON, V4, P160, DOI 10.1146/annurev-resource-110811-114523; Khanna M, 2011, AM J AGR ECON, V93, P473, DOI 10.1093/ajae/aaq119; King CW, 2008, ENVIRON SCI TECHNOL, V42, P7866, DOI 10.1021/es800367m; Kiniry J.R., 2008, NEW RES BIOFUELS, P1; Lark TJ, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/4/044003; Le PVV, 2011, P NATL ACAD SCI USA, V108, P15085, DOI 10.1073/pnas.1107177108; Lee J, 2012, GCB BIOENERGY, V4, P521, DOI 10.1111/j.1757-1707.2011.01140.x; Lienden vA, 2010, BIOFUEL SCENARIOS WA; Love BJ, 2011, BIOMASS BIOENERG, V35, P2200, DOI 10.1016/j.biombioe.2011.02.041; McIsaac GF, 2010, J ENVIRON QUAL, V39, P1790, DOI 10.2134/jeq2009.0497; Mishra GS, 2011, ENVIRON SCI TECHNOL, V45, P4563, DOI 10.1021/es104145m; Mu Q., 2013, ALGORITHM THEORETICA; Mu QZ, 2011, REMOTE SENS ENVIRON, V115, P1781, DOI 10.1016/j.rse.2011.02.019; Mueller H, 2015, REMOTE SENS ENVIRON, V156, P490, DOI 10.1016/j.rse.2014.10.014; NASS, 2010, NASS AGR HDB NUMB, V628; NASS U, 2008, FARM RANCH IRR SURV; Ng TL, 2010, ENVIRON SCI TECHNOL, V44, P7138, DOI 10.1021/es9039677; Parajuli P. B., 2013, J SUSTAINABLE BIOENE, V3, P202, DOI [10.4236/jsbs.2013.33028, DOI 10.4236/JSBS.2013.33028]; Parish ES, 2012, BIOFUEL BIOPROD BIOR, V6, P58, DOI 10.1002/bbb.342; Pfister S, 2017, ECOL INDIC, V72, P352, DOI 10.1016/j.ecolind.2016.07.051; R Core Team, 2013, R LANG ENV STAT COMP; Reitsma KD, 2016, AGRON J, V108, P266, DOI 10.2134/agronj2015.0288; RFA, 2017, IND STAT; Schaible G., 2012, USDA ERS EC INFORM B, V99; Scherer L, 2015, ENVIRON SCI TECHNOL, V49, P4971, DOI 10.1021/acs.est.5b00429; Scown CD, 2011, ENVIRON SCI TECHNOL, V45, P2541, DOI 10.1021/es102633h; Smith CM, 2013, J ENVIRON QUAL, V42, P219, DOI 10.2134/jeq2012.0210; Sophocleous M, 2010, HYDROGEOL J, V18, P559, DOI 10.1007/s10040-009-0540-1; Ssegane H, 2015, BIOMASS BIOENERG, V80, P179, DOI 10.1016/j.biombioe.2015.04.012; Teter J., 2015, AGR WATER USE IMPACT; VanLoocke A, 2016, GCB BIOENERGY; VanLoocke A, 2012, AGR FOREST METEOROL, V164, P82, DOI 10.1016/j.agrformet.2012.05.016; Wagner KL, 2017, J CONTEMP WAT RES ED, V162, P1, DOI 10.1111/j.1936-704X.2017.03255.x; Wallander S, 2011, USDA ERS EC INFORM B; Wang WW, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/11/114019; WatkinsJr DW, 2015, ENVIRON MANAGE, P1; Williams J. R., 1995, Computer models of watershed hydrology., P909; Wright CK, 2013, P NATL ACAD SCI USA, V110, P4134, DOI 10.1073/pnas.1215404110; Wu M, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR011809; Wu M, 2009, ENVIRON MANAGE, V44, P981, DOI 10.1007/s00267-009-9370-0; Wu YP, 2012, BIOMASS BIOENERG, V36, P182, DOI 10.1016/j.biombioe.2011.10.030; Yeh S, 2012, UCDITSRR1210; Yeh S, 2012, UCDITSRR1211; Yeh S, 2016, ENERG POLICY, V97, P220, DOI 10.1016/j.enpol.2016.07.029; Yeh S, 2013, ENERG POLICY, V56, P1, DOI 10.1016/j.enpol.2013.01.008; Yeh S, 2011, BIOFUEL BIOPROD BIOR, V5, P361, DOI 10.1002/bbb.308; Yi FJ, 2014, GCB BIOENERGY, V6, P672, DOI 10.1111/gcbb.12075; Zeri M, 2013, J GEOPHYS RES-BIOGEO, V118, P581, DOI 10.1002/jgrg.20052; Zhuang QL, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/015020; Zilberman D, 2013, AM J AGR ECON, V95, P1332, DOI 10.1093/ajae/aat038	90	4	4	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204298	10.1371/journal.pone.0204298	http://dx.doi.org/10.1371/journal.pone.0204298			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV3OT	30265704	Green Published, Green Submitted, gold			2022-12-26	WOS:000446005500027
J	Dennison, KL; Chack, AC; Hickman, MP; Harenda, QE; Shull, JD				Dennison, Kirsten L.; Chack, Aaron C.; Hickman, Maureen Peters; Harenda, Quincy Eckert; Shull, James D.			Ept7, a quantitative trait locus that controls estrogen-induced pituitary lactotroph hyperplasia in rat, is orthologous to a locus in humans that has been associated with numerous cancer types and common diseases	PLOS ONE			English	Article							INDUCED MAMMARY-CANCER; PROLACTIN GENE-TRANSCRIPTION; FEMALE TRANSSEXUAL PATIENT; SPRAGUE-DAWLEY RATS; CROSS-SEX HORMONES; X ACI INTERCROSS; BROWN-NORWAY RAT; BREAST-CANCER; TUMOR-GROWTH; CONTROLLING SUSCEPTIBILITY	Pituitary adenoma is a common intracranial neoplasm that is observed in approximately 10% of unselected individuals at autopsy. Prolactin-producing adenomas, i.e., prolactinomas, comprise approximately 50% of all pituitary adenomas and represent the most common class of pituitary tumor. Multiple observations suggest that estrogens may contribute to development of prolactinoma; however, direct evidence for a causal role of estrogens in prolactinoma etiology is lacking. Rat models of estrogen-induced prolactinoma have been utilized extensively to identify the factors, pathways and processes that are involved in pituitary tumor development. The objective of this study was to localize to high resolution Ept7 (Estrogen-induced pituitary tumor), a quantitative trait locus (QTL) that controls lactotroph responsiveness to estrogens and was mapped to rat chromosome 7 (RNO7) in an intercross between BN and ACI rats. Data presented and discussed herein localize the Ept7 causal variant(s) to a 1.91 Mb interval of RNO7 that contains two protein coding genes, A1bg and Myc, and Pvt1, which yields multiple non-protein coding transcripts of unknown function. The Ept7 orthologous region in humans is located at 8q24.21 and has been linked in genome wide association studies to risk of 8 distinct epithelial cancers, including breast, ovarian, and endometrial cancers; 3 distinct types of B cell lymphoma; multiple inflammatory and autoimmune diseases; and orofacial cleft defects. In addition, the Ept7 locus in humans has been associated with variation in normal hematologic and development phenotypes, including height. Functional characterization of Ept7 should ultimately enhance our understanding of the genetic etiology of prolactinoma and these other diseases.	[Dennison, Kirsten L.; Chack, Aaron C.; Hickman, Maureen Peters; Harenda, Quincy Eckert; Shull, James D.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Oncol, McArdle Lab Canc Res, Madison, WI 53706 USA; [Shull, James D.] Univ Wisconsin, Sch Med & Publ Hlth, Carbone Canc Ctr, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Shull, JD (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Oncol, McArdle Lab Canc Res, Madison, WI 53706 USA.; Shull, JD (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Carbone Canc Ctr, Madison, WI 53706 USA.	shull@oncology.wisc.edu		Shull, James/0000-0003-4537-5159	National Institutes of Health, National Cancer Institute [R01-CA077876, R01-CA204320, P30-CA014520]; Susan G. Komen Breast Cancer Foundation [KG081343]; NATIONAL CANCER INSTITUTE [R01CA077876, R01CA204320, P30CA014520] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by grants R01-CA077876 (J.D. Shull, PI), R01-CA204320 (J. D. Shull, PI), and P30-CA014520 from the National Institutes of Health, National Cancer Institute; and grant KG081343 (J.D. Shull, PI) from the Susan G. Komen Breast Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasiadou E, 2018, NAT REV CANCER, V18, P5, DOI 10.1038/nrc.2017.99; [Anonymous], 2011, GUIDE CARE USE LAB A; Asa SL, 2009, ANNU REV PATHOL-MECH, V4, P97, DOI 10.1146/annurev.pathol.4.110807.092259; ASSCHEMAN H, 1988, CLIN ENDOCRINOL, V28, P583, DOI 10.1111/j.1365-2265.1988.tb03849.x; Bunck Mathijs C, 2009, BMJ Case Rep, V2009, DOI 10.1136/bcr.02.2009.1589; Carramusa L, 2007, J CELL PHYSIOL, V213, P511, DOI 10.1002/jcp.21133; Carroll PA, 2018, FRONT MED-PRC, V12, P412, DOI 10.1007/s11684-018-0650-z; Casanueva FF, 2006, CLIN ENDOCRINOL, V65, P265, DOI 10.1111/j.1365-2265.2006.02562.x; Chahal HS, 2010, TRENDS ENDOCRIN MET, V21, P419, DOI 10.1016/j.tem.2010.02.007; Cheng THT, 2016, NAT GENET, V48, P667, DOI 10.1038/ng.3562; CHERNAVSKY AC, 1993, NEUROL RES, V15, P339; Cho SW, 2018, CELL, V173, P1398, DOI 10.1016/j.cell.2018.03.068; Colao A, 2011, NAT REV ENDOCRINOL, V7, P267, DOI 10.1038/nrendo.2011.37; Colletti JA, 2014, G3-GENES GENOM GENET, V4, P1385, DOI 10.1534/g3.114.011163; Cunha FS, 2015, ANDROLOGIA, V47, P680, DOI 10.1111/and.12317; Dennison KL, 2015, ENDOCR-RELAT CANCER, V22, P239, DOI 10.1530/ERC-14-0539; Ding LN, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-573; Drinkwater NR., 2018, MSTAT VERSION 6 4 2; Dworakowska D, 2009, BEST PRACT RES CL EN, V23, P525, DOI 10.1016/j.beem.2009.05.004; Fujimoto N, 2009, J STEROID BIOCHEM, V115, P75, DOI [10.1016/j.jsbmb.2004.12.016, 10.1016/j.jsbmb.2004.02.006]; Garcia-Malpartida K, 2010, FERTIL STERIL, V94, DOI 10.1016/j.fertnstert.2010.01.076; Goffin V, 2002, ANNU REV PHYSIOL, V64, P47, DOI 10.1146/annurev.physiol.64.081501.131049; GOOREN LJG, 1988, J CLIN ENDOCR METAB, V66, P444, DOI 10.1210/jcem-66-2-444; Gooren LJ, 2008, J CLIN ENDOCR METAB, V93, P19, DOI 10.1210/jc.2007-1809; Gorski J, 1997, PROG CLIN BIOL RES, V396, P233; Gould KA, 2005, MAMM GENOME, V16, P854, DOI 10.1007/s00335-005-0070-7; Gould KA, 2004, GENETICS, V168, P2113, DOI 10.1534/genetics.104.033878; Gould KA, 2006, MAMM GENOME, V17, P451, DOI 10.1007/s00335-005-0183-z; HOLTZMAN S, 1979, CANCER RES, V39, P779; Huppi K, 2008, MOL CANCER RES, V6, P212, DOI 10.1158/1541-7786.MCR-07-0105; Jerry DJ, 2018, MAMM GENOME, V29, P24, DOI 10.1007/s00335-018-9741-z; KOVACS K, 1994, ARCH PATHOL LAB MED, V118, P562; Kurz SG, 2008, ENDOCRINOLOGY, V149, P3850, DOI 10.1210/en.2008-0173; Kurz SG, 2014, MAMM GENOME, V25, P244, DOI 10.1007/s00335-014-9504-4; Laulederkind SJF, 2013, BRIEF BIOINFORM, V14, P520, DOI 10.1093/bib/bbt007; LIEBERMAN ME, 1982, ADV EXP MED BIOL, V138, P151; Melmed S, 2011, NAT REV ENDOCRINOL, V7, P257, DOI 10.1038/nrendo.2011.40; Michailidou K, 2017, NATURE, V551, P92, DOI 10.1038/nature24284; Michailidou K, 2015, NAT GENET, V47, P373, DOI 10.1038/ng.3242; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Molitch ME, 2017, JAMA-J AM MED ASSOC, V317, P516, DOI 10.1001/jama.2016.19699; Molitch ME, 2006, ENDOCRIN METAB CLIN, V35, P99, DOI 10.1016/j.ecl.2005.09.011; Mueller A, 2008, EUR J ENDOCRINOL, V159, P197, DOI 10.1530/EJE-08-0289; Nigam R, 2013, PHYSIOL GENOMICS, V45, P809, DOI 10.1152/physiolgenomics.00065.2013; Paci P, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-83; Pandey J, 2005, MAMM GENOME, V16, P865, DOI 10.1007/s00335-005-0071-6; Pandey J, 2004, CARCINOGENESIS, V25, P1829, DOI 10.1093/carcin/bgh192; Phelan CM, 2017, NAT GENET, V49, P680, DOI 10.1038/ng.3826; Sarkar DK, 2006, FRONT HORM RES, V35, P32, DOI 10.1159/000094307; Sarkar Dipak K., 1998, Frontiers in Bioscience, V3, pD934; Schaffer BS, 2006, CANCER RES, V66, P7793, DOI 10.1158/0008-5472.CAN-06-0143; Schaffer BS, 2013, CANCER PREV RES, V6, P59, DOI 10.1158/1940-6207.CAPR-12-0346-T; Sclafani RV, 2001, MOL CELL ENDOCRINOL, V176, P145, DOI 10.1016/S0303-7207(01)00401-4; Serri O, 1996, J CLIN ENDOCR METAB, V81, P3177, DOI 10.1210/jc.81.9.3177; ShawBruha CM, 1996, BRAIN RES BULL, V40, P33, DOI 10.1016/0361-9230(96)00004-4; Shull JD, 2007, MAMM GENOME, V18, P657, DOI 10.1007/s00335-007-9052-2; SHULL JD, 1990, MOL PHARMACOL, V37, P215; SHULL JD, 1987, J STEROID BIOCHEM, V26, P451, DOI 10.1016/0022-4731(87)90055-0; SHULL JD, 1986, VITAM HORM, V43, P197; Spady TJ, 1999, ENDOCRINOLOGY, V140, P2828, DOI 10.1210/en.140.6.2828; Spady TJ, 1999, J NUTR, V129, p587S, DOI 10.1093/jn/129.2.587S; Spady TJ, 1999, ENDOCRINE, V11, P217, DOI 10.1385/ENDO:11:3:217; STONE JP, 1979, CANCER RES, V39, P773; Strecker TE, 2005, GENETICS, V169, P2189, DOI 10.1534/genetics.104.039370; SZIJAN I, 1992, HORM METAB RES, V24, P154, DOI 10.1055/s-2007-1003283; Tachibana M, 2006, EXP ANIM TOKYO, V55, P91, DOI 10.1538/expanim.55.91; Tong YG, 2012, ENDOCRINOLOGY, V153, P3679, DOI 10.1210/en.2012-1056; Tseng YY, 2014, NATURE, V512, P82, DOI 10.1038/nature13311; Wendell DL, 1996, P NATL ACAD SCI USA, V93, P8112, DOI 10.1073/pnas.93.15.8112; Wendell DL, 2000, MAMM GENOME, V11, P855, DOI 10.1007/s003350010168; Wendell DL, 1997, MAMM GENOME, V8, P823, DOI 10.1007/s003359900586; Wendell DL, 2002, MAMM GENOME, V13, P664, DOI 10.1007/s00335-002-2183-6; WIKLUND J, 1981, ENDOCRINOLOGY, V109, P1708, DOI 10.1210/endo-109-5-1708; WIKLUND J, 1981, ENDOCRINOLOGY, V109, P1700, DOI 10.1210/endo-109-5-1700; WIKLUND JA, 1982, ENDOCRINOLOGY, V111, P1140, DOI 10.1210/endo-111-4-1140; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098	76	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204727	10.1371/journal.pone.0204727	http://dx.doi.org/10.1371/journal.pone.0204727			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30261014	gold, Green Published, Green Submitted			2022-12-26	WOS:000445907400096
J	Fujishiro, K; Needham, BL; Landsbergis, PA; Seeman, T; Jenny, NS; Roux, AVD				Fujishiro, Kaori; Needham, Belinda L.; Landsbergis, Paul A.; Seeman, Teresa; Jenny, Nancy Swords; Roux, Ana V. Diez			Selected occupational characteristics and change in leukocyte telomere length over 10 years: The Multi-Ethnic Study of Atherosclerosis (MESA)	PLOS ONE			English	Article							O-ASTERISK-NET; CARDIOVASCULAR-DISEASE; SOCIOECONOMIC-STATUS; HEALTH RESEARCH; JOB CONTROL; AGE; WORK; EPIDEMIOLOGY; EXPOSURE; RISK	Telomere length (TL) is considered as a marker of cell senescence, but factors influencing the rate of TL attrition are not well understood. While one previous study reported the association of occupation and TL, many subsequent studies have failed to find the association. This may be due to heterogeneity within the samples and cross-sectional designs. This longitudinal study examines two occupational characteristics, occupational complexity and hazardous conditions, as predictors of TL attrition in gender-and race/ethnicity-stratified analysis. Leukocyte TL (expressed as T/S ratio) was measured twice over a 10-year period in a multi-racial sample (n = 914). Linear mixed effect models were used to estimate TL attrition associated with occupational complexity and hazardous conditions. Analysis was stratified by gender and race/ethnicity (white, African American, and Latino) and controlled for baseline age, baseline TL, and time since baseline. Higher occupational complexity was associated with slower rates of TL attrition only among white men. Hazardous conditions were not associated with TL attrition for any gender-and-race/ethnicity stratified group. Occupational complexity may influence TL attrition, but the different findings for white men and other groups suggest that a more comprehensive framework is needed to better understand the potential link between occupational characteristics and biological aging.	[Fujishiro, Kaori] NIOSH, Div Surveillance Hazard Evaluat & Field Studies, Cincinnati, OH 45226 USA; [Needham, Belinda L.] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Needham, Belinda L.] Univ Michigan, Ctr Social Epidemiol & Populat Hlth, Ann Arbor, MI 48109 USA; [Landsbergis, Paul A.] Suny Downstate Med Ctr, Dept Environm & Occupat Hlth Sci, Brooklyn, NY 11203 USA; [Seeman, Teresa] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; [Jenny, Nancy Swords] Univ Vermont, Dept Pathol, Burlington, VT 05405 USA; [Roux, Ana V. Diez] Drexel Univ, Dornsife Sch Publ Hlth, Dept Epidemiol & Biostat, Philadelphia, PA 19104 USA	Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University of California System; University of California Los Angeles; University of Vermont; Drexel University	Fujishiro, K (corresponding author), NIOSH, Div Surveillance Hazard Evaluat & Field Studies, Cincinnati, OH 45226 USA.	kfujishiro@cdc.gov		Needham, Belinda/0000-0001-5939-2027; Fujishiro, Kaori/0000-0003-1743-625X	National Heart, Lung, and Blood Institute [HHSN268201500003I, N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168, N01-HC-95169]; NCATS [UL1-TR-000040, UL1-TR-001079, UL1-TR-001420]; UCLA Older Americans Independence Center, NIH/NIA [P30AG028748]; USC/UCLA Biodemography Center through a P30 grant from the NIA [P30AG017265];  [R01HL076831];  [R01HL101161]; NATIONAL INSTITUTE ON AGING [P30AG017265, P30AG028748] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); UCLA Older Americans Independence Center, NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); USC/UCLA Biodemography Center through a P30 grant from the NIA; ; ; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by contracts HHSN268201500003I, N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168 and N01-HC-95169 from the National Heart, Lung, and Blood Institute, and by grants UL1-TR-000040, UL1-TR-001079, and UL1-TR-001420 from NCATS. The MESA Stress Study was supported by R01HL076831 and R01HL101161 (PI: Ana DiezRoux). Work was also partially supported by funding from the UCLA Older Americans Independence Center, NIH/NIA Grant P30AG028748, and the USC/UCLA Biodemography Center through a P30 grant from the NIA (P30AG017265). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahola K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040186; Allison PD, 2009, FIXED EFFECT REGRESS; Altonji J, 1999, HDB LABOR EC C, V3C, P3143, DOI DOI 10.1016/S1573-4463(99)30039-0; [Anonymous], 2015, LAB FORC CHAR RAC ET; Artazcoz L, 2007, J EPIDEMIOL COMMUN H, V61, P39, DOI 10.1136/jech.2007.059774; Aviv A, 2009, AM J EPIDEMIOL, V169, P323, DOI 10.1093/aje/kwn338; Berglund K, 2016, AGING-US, V8, P1398, DOI 10.18632/aging.100995; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; Broer L, 2013, EUR J HUM GENET, V21, P1163, DOI 10.1038/ejhg.2012.303; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chen W, 2011, J GERONTOL A-BIOL, V66, P312, DOI 10.1093/gerona/glq223; Cherkas LF, 2006, AGING CELL, V5, P361, DOI 10.1111/j.1474-9726.2006.00222.x; Cifuentes M, 2010, AM J IND MED, V53, P898, DOI 10.1002/ajim.20846; Epel ES, 2009, AGING-US, V1, P81; Fallick B., 2004, FINANCE EC DISCUSSIO; Fitzpatrick AL, 2007, AM J EPIDEMIOL, V165, P14, DOI [10.1093/aje/kw346, 10.1093/aje/kwj346]; Fujishiro K, 2017, SSM-POPUL HLTH, V3, P497, DOI 10.1016/j.ssmph.2017.05.010; Fujishiro K, 2013, OCCUP ENVIRON MED, V70, P552, DOI 10.1136/oemed-2012-101296; Hadden WC, 2004, SOC SCI RES, V33, P64, DOI 10.1016/S0049-089X(03)00039-5; Hollister M, 2011, ANNU REV SOCIOL, V37, P305, DOI 10.1146/annurev-soc-081309-150042; KOHN ML, 1978, AM J SOCIOL, V84, P24, DOI 10.1086/226739; Lin J, 2010, J IMMUNOL METHODS, V352, P71, DOI 10.1016/j.jim.2009.09.012; Marmot MG, 1997, LANCET, V350, P235, DOI 10.1016/S0140-6736(97)04244-X; Masi S, 2014, EUR HEART J, V35, P3296, DOI 10.1093/eurheartj/ehu226; Meyer JD, 2014, AM J IND MED, V57, P587, DOI 10.1002/ajim.22255; Needham BL, 2013, SOC SCI MED, V85, P1, DOI 10.1016/j.socscimed.2013.02.023; Nordfjall K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000375; Pool LR, 2016, NEUROLOGY, V86, P1386, DOI 10.1212/WNL.0000000000002569; Revesz D, 2016, PSYCHONEUROENDOCRINO, V67, P153, DOI 10.1016/j.psyneuen.2016.02.007; Robertson T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041805; Sanders JL, 2012, J GERONTOL A-BIOL, V67, P409, DOI 10.1093/gerona/glr173; Schooler C, 1999, PSYCHOL AGING, V14, P483, DOI 10.1037/0882-7974.14.3.483; Shiels PG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022521; Sorenson O, 2016, AM SOCIOL REV, V81, P900, DOI 10.1177/0003122416656360; Steptoe A, 2011, BRAIN BEHAV IMMUN, V25, P1292, DOI 10.1016/j.bbi.2011.04.010; Tomaskovic-Devey D, 2005, AM J SOCIOL, V111, P58, DOI 10.1086/431779	37	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204704	10.1371/journal.pone.0204704	http://dx.doi.org/10.1371/journal.pone.0204704			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV2HB	30261026	gold, Green Submitted, Green Published			2022-12-26	WOS:000445907400094
J	Peer, N; Balakrishna, Y; de Villiers, A; Naidoo, P				Peer, Nasheeta; Balakrishna, Yusentha; de Villiers, Anniza; Naidoo, Pamela			Differential associations of cardio-metabolic diseases by population group, gender and adiposity in South Africa	PLOS ONE			English	Article							CORONARY HEART-DISEASE; RISK-FACTORS; ETHNIC-DIFFERENCES; INSULIN SENSITIVITY; CAPE PENINSULA; HYPERTENSION; PREVALENCE; COMMUNITY; PEOPLE	Aims To describe the distribution and examine the associations of diabetes, hypertension and hypercholesterolaemia across and within population groups, gender and body mass index (BMI) categories. Methods This national cross-sectional study was conducted in 2013 among >= 18-year-old black African, coloured, white and Indian adults self-selected for screening. Data collection included self-reported behavioural risk factors and clinical measurements comprising blood pressure, anthropometry and point-of-care random blood glucose and cholesterol assessments. Results Among the 7711 participants, 2488 men and 5223 women, the prevalence of diabetes and hypertension increased by BMI category across population groups. Compared with white men and women, black African men (odds ratio: 2.66, 95% confidence interval: 1.70-4.16) and women (2.10, 1.49-2.96), coloured men (2.28, 1.44-3.60) and women (2.15, 1.52-3.05) and Indian men (4.38, 2.65-7.26) and women (3.64, 2.50-5.32) were significantly more likely to have diabetes. The odds for hypertension were significantly higher only in coloured men compared with white men (1.37, 1.02-1.83), while it was significantly higher in black African, coloured and Indian women compared with white women. The odds for hypercholesterolaemia were significantly lower in black African men (0.64, 0.49-0.84) and women (0.52, 0.43-0.62) compared with white men and women, and significantly higher in Indian men (1.47, 1.05-2.08) compared with white men. Black African women compared with their male counterparts were less likely to have diabetes (0.64, 0.460-0.89). Black African (0.66, 0.54-.082), coloured (0.65, 0.50-0.84) and white (0.69, 0.53-0.88) women were significantly less likely to have hypertension compared with their male counterparts. The odds for hypercholesterolaemia were higher in coloured (1.44, 1.16-1.80) and white (1.47, 1.18-1.84) women compared with their counterparts. Conclusions The cardio-metabolic diseases of diabetes, hypertension and hypercholesterolaemia were differentially associated with population groups and gender in South Africa. The insights obtained highlight the need for multi-disciplinary targeted management approaches in high-risk populations.	[Peer, Nasheeta] South African Med Res Council, Noncommunicable Dis Res Unit, Durban, South Africa; [Peer, Nasheeta] Univ Cape Town, Dept Med, Cape Town, South Africa; [Balakrishna, Yusentha] South African Med Res Council, Biostat Unit, Durban, South Africa; [de Villiers, Anniza] South African Med Res Council, Noncommunicable Dis Res Unit, Cape Town, South Africa; [Naidoo, Pamela] Heart & Stroke Fdn South Africa, Cape Town, South Africa; [Naidoo, Pamela] Stellenbosch Univ, Cape Town, South Africa	South African Medical Research Council; University of Cape Town; South African Medical Research Council; South African Medical Research Council; Stellenbosch University	Peer, N (corresponding author), South African Med Res Council, Noncommunicable Dis Res Unit, Durban, South Africa.; Peer, N (corresponding author), Univ Cape Town, Dept Med, Cape Town, South Africa.	nasheeta.peer@mrc.ac.za	De Villiers, Anniza/GQB-3288-2022	Peer, Nasheeta/0000-0003-2131-8344; Balakrishna, Yusentha/0000-0001-6449-3260	National Lottery Board of South Africa; Pharma Dynamics	National Lottery Board of South Africa; Pharma Dynamics	The HSFSA received funding from the National Lottery Board of South Africa and Pharma Dynamics to conduct their screening programme in 2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo J, 2007, HYPERTENSION, V50, P1012, DOI 10.1161/HYPERTENSIONAHA.107.093336; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Berger GMB, 2000, S AFR MED J, V90, P164; Bilen O, 2016, WORLD J CARDIOL, V8, P247, DOI 10.4330/wjc.v8.i3.247; Cappuccio FP, 1997, J HUM HYPERTENS, V11, P571, DOI 10.1038/sj.jhh.1000516; Department of Health, 1999, S AFR DEM HLTH SURV; Fuentes R, 2000, J HYPERTENS, V18, P521, DOI 10.1097/00004872-200018050-00003; Gasevic D, 2015, CAN J CARDIOL, V31, P1169, DOI 10.1016/j.cjca.2015.06.017; Gavin JR, 1997, DIABETES CARE, V20, P1183; Goedecke JH, 2017, DIABETES RES CLIN PR, V123, P87, DOI 10.1016/j.diabres.2016.11.017; Goedecke JH, 2016, DIABETES RES CLIN PR, V122, P207, DOI 10.1016/j.diabres.2016.11.005; Hsu WC, 2015, DIABETES CARE, V38, P150, DOI 10.2337/dc14-2391; Kaze AD, 2017, J HYPERTENS, V35, P1345, DOI 10.1097/HJH.0000000000001345; Kodama K, 2013, DIABETES CARE, V36, P1789, DOI 10.2337/dc12-1235; Kurian AK, 2007, ETHNIC DIS, V17, P143; LEE JWR, 2011, DIABETES CARE, V34, P353, DOI DOI 10.2337/dc10-0746; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Motala AA, 2008, DIABETES CARE, V31, P1783, DOI 10.2337/dc08-0212; Norman R, 2007, SAMJ S AFR MED J, V97, P708; Oelofse A, 1996, S AFR MED J, V86, P162; Peer N., 2013, EUR J PREV CARDIOL; Peer N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078567; Pereira M, 2009, J HYPERTENS, V27, P963, DOI 10.1097/HJH.0b013e3283282f65; Rush EC, 2009, BRIT J NUTR, V102, P632, DOI 10.1017/S0007114508207221; Sarki AM, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001959; Seedat Y K, 1996, Ethn Health, V1, P349; SEEDAT YK, 1990, S AFR MED J, V78, P447; SEFTEL HC, 1993, S AFR MED J, V83, P891; Sliwa K, 2012, CARDIOVASC J AFR, V23, P389, DOI 10.5830/CVJA-2012-036; South African Medical Association and Lipid and Atherosclerosis Society of Southern Africa Working Group, 2000, S AFR MED J 2, V90, P76; Statistics South Africa, 2013, MID POP EST 2013; Statistics South Africa, 2017, S AFR DEM HLTH SURV; Steyn K, 1996, E AFR MED J, V73, P758; van Rooyen JM, 2000, J HUM HYPERTENS, V14, P779, DOI 10.1038/sj.jhh.1001098; Wang EJ, 2011, DIABETES RES CLIN PR, V93, P248, DOI 10.1016/j.diabres.2011.05.025; WHO, 2000, OB PREV MAN GLOB EP; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1	37	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0202899	10.1371/journal.pone.0202899	http://dx.doi.org/10.1371/journal.pone.0202899			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30260983	gold, Green Published, Green Submitted			2022-12-26	WOS:000445907400006
J	Kalinowski, M; Gradzki, Z; Jarosz, L; Adaszek, L				Kalinowski, Marcin; Gradzki, Zbigniew; Jarosz, Lukasz; Adaszek, Lukasz			Molecular analysis of the chromosomal 16S rRNA gene and vapA plasmid gene of Polish field strains of R-equi	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISMS; NUCLEIC-ACID AMPLIFICATION; VIRULENT RHODOCOCCUS-EQUI; 17-KILODALTON ANTIGENS; PATHOGENICITY ISLAND; INFECTED FOALS; HORSE; DIAGNOSIS; SOIL; DNA	Rhodococcus equi (R. hoagii) is an opportunistic pathogen commonly found in foals up to 6 months old and animal environment. The R. equi genome contains genetically stable chromosomal DNA and an 80-90 kb plasmid containing vapA gene, responsible for virulence. Most reports from around the world focus on the determination of R. equiplasmid profiles. Few studies have attempted to determine differences in nucleotide sequences between virulent strains of R. equi isolated from foals and breeding environment. The aim of the study was to perform a molecular analysis of a fragment of the chromosomal gene encoding the 16S rRNA subunit and the vapA plasmid gene of virulent R. equi strains isolated on Polish studs from foals and from the breeding environment of horses. The sequencing method was used to compare the primary structure of fragments of the chromosomal and plasmid DNA of the virulent R. equistrains. The sequences of 22 clinical and 18 environmental R. equi isolates were compared with the sequences of the gene fragments of reference strains available in the NCBI GenBank database. All sequenced 16S rRNA amplicons of Polish field strains were identical and showed 99.5% similarity to the four randomly selected sequences of this gene fragment in the GenBank database. The results confirm that fragments of the 16S rRNA gene of R. equi strains are highly conserved and do not undergo variation in field conditions. Analysis of the sequencing results for the vapA gene fragment of the strains used in our study revealed two polymorphic variants and clear differences between the sequences of strains isolated from foals and from soil samples. Presumably, R. equi strains present in the breeding environment are more exposed than clinical strains to adverse external factors. This may result in changes in the DNA sequence due to natural selection.	[Kalinowski, Marcin] Univ Life Sci Lublin, Fac Vet Med, Dept Epizootiol, Lublin, Poland; Univ Life Sci Lublin, Fac Vet Med, Clin Infect Dis, Lublin, Poland	University of Life Sciences in Lublin; University of Life Sciences in Lublin	Kalinowski, M (corresponding author), Univ Life Sci Lublin, Fac Vet Med, Dept Epizootiol, Lublin, Poland.	marcin.kalinowski@up.lublin.pl	Kalinowski, Marcin/AAQ-3950-2020; Gradzki, Zbigniew/R-6589-2018	Kalinowski, Marcin/0000-0003-4769-5471; Adaszek, Lukasz/0000-0003-0261-2695; Jarosz, Lukasz/0000-0002-4914-1758; Gradzki, Zbigniew/0000-0002-5390-3225				Bell KS, 1996, LETT APPL MICROBIOL, V23, P72, DOI 10.1111/j.1472-765X.1996.tb00033.x; Coenye T, 2003, ENVIRON MICROBIOL, V5, P719, DOI 10.1046/j.1462-2920.2003.00471.x; Coulson GB, 2015, INFECT IMMUN, V83, P3137, DOI 10.1128/IAI.00230-15; Coulson GB, 2010, INFECT IMMUN, V78, P3323, DOI 10.1128/IAI.00081-10; Darraj M, 2017, J INFECT PUBLIC HEAL, V10, P224, DOI 10.1016/j.jiph.2016.05.001; Duquesne F, 2010, FEMS MICROBIOL LETT, V311, P76, DOI 10.1111/j.1574-6968.2010.02070.x; Giguere S, 1999, INFECT IMMUN, V67, P3548; Giguere S, 2011, J VET INTERN MED, V25, P1221, DOI 10.1111/j.1939-1676.2011.00804.x; Gradzki Z, 2011, B VET I PULAWY, V55, P619; Gradzki Z, 2011, MED WETER, V67, P327; Kampfer P, 2014, INT J SYST EVOL MICR, V64, P755, DOI 10.1099/ijs.0.053322-0; Kalinowski M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152887; Kalinowski M, 2013, MED WETER, V69, P139; Letek M, 2008, J BACTERIOL, V190, P5797, DOI 10.1128/JB.00468-08; Letek M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001145; Makrai L, 2002, VET MICROBIOL, V88, P377, DOI 10.1016/S0378-1135(02)00157-8; Meijer WG, 2004, VET RES, V35, P383, DOI 10.1051/vetres:2004024; Muscatello G, 2007, EQUINE VET J, V39, P470, DOI 10.2746/042516407X209217; Pilares L, 2010, J CLIN MICROBIOL, V48, P1904, DOI 10.1128/JCM.01730-09; PRESCOTT JF, 1991, CLIN MICROBIOL REV, V4, P20, DOI 10.1128/CMR.4.1.20-34.1991; Rahal K, 1999, REV MED VET-TOULOUSE, V150, P349; Rofe AP, 2017, MICROBIOLOGYOPEN, V6, DOI 10.1002/mbo3.416; Sanz MG, 2015, VET IMMUNOL IMMUNOP, V164, P10, DOI 10.1016/j.vetimm.2015.01.004; Sellon DC, 1997, AM J VET RES, V58, P1232; Sellon DC, 2001, J CLIN MICROBIOL, V39, P1289, DOI 10.1128/JCM.39.4.1289-1293.2001; Son WG, 2006, J VET MED SCI, V68, P249, DOI 10.1292/jvms.68.249; Takai S, 1999, J CLIN MICROBIOL, V37, P3417, DOI 10.1128/JCM.37.10.3417-3420.1999; TAKAI S, 1991, J CLIN MICROBIOL, V29, P439, DOI 10.1128/JCM.29.3.439-443.1991; TAKAI S, 1991, INFECT IMMUN, V59, P4056, DOI 10.1128/IAI.59.11.4056-4060.1991; Takai S, 2003, J VET MED SCI, V65, P1313, DOI 10.1292/jvms.65.1313; Takai S, 2001, J VET DIAGN INVEST, V13, P489, DOI 10.1177/104063870101300606; Takai S, 2001, ONDERSTEPOORT J VET, V68, P105; Takai S, 2000, INFECT IMMUN, V68, P6840, DOI 10.1128/IAI.68.12.6840-6847.2000; Topino S, 2010, AIDS PATIENT CARE ST, V24, P211, DOI 10.1089/apc.2009.0248; Vazquez-Boland JA, 2013, VET MICROBIOL, V167, P9, DOI 10.1016/j.vetmic.2013.06.016; von Bargen K, 2009, FEMS MICROBIOL REV, V33, P870, DOI 10.1111/j.1574-6976.2009.00181.x; Willingham-Lane JM, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00186-16; Witkowski L, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-0954-2; Yamshchikov AV, 2010, LANCET INFECT DIS, V10, P350, DOI 10.1016/S1473-3099(10)70068-2; Zietek-Barszcz A, 2009, B VET I PULAWY, V53, P345	40	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2018	13	9							e0204024	10.1371/journal.pone.0204024	http://dx.doi.org/10.1371/journal.pone.0204024			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU9BO	30252885	Green Published, Green Submitted, gold			2022-12-26	WOS:000445639700023
J	Oh, ES; Blennow, K; Bigelow, GE; Inouye, SK; Marcantonio, ER; Neufeld, KJ; Rosenberg, PB; Troncoso, JC; Wang, NY; Zetterberg, H; Sieber, FE; Lyketsos, CG				Oh, Esther S.; Blennow, Kaj; Bigelow, George E.; Inouye, Sharon K.; Marcantonio, Edward R.; Neufeld, Karin J.; Rosenberg, Paul B.; Troncoso, Juan C.; Wang, Nae-Yuh; Zetterberg, Henrik; Sieber, Frederick E.; Lyketsos, Constantine G.			Abnormal CSF amyloid-beta 42 and tau levels in hip fracture patients without dementia	PLOS ONE			English	Article							ALZHEIMER-DISEASE; OLDER-ADULTS; ASSOCIATION; IMPAIRMENT; PREVALENCE; BIOMARKERS; PATHOLOGY; DECLINE; FALLS; RISK	Background There is strong association of Alzheimer's disease (AD) pathology with gait disorder and falls in older adults without dementia. The goal of the study was to examine the prevalence and severity of AD pathology in older adults without dementia who fall and sustain hip fracture. Methods Cerebrospinal fluid (CSF) was obtained from 168 hip fracture patients. CSF A beta 42/40 ratio, p-tau, and t-tau measures were dichotomized into normal vs. abnormal, and categorized according to the A/T/N classification. Results Among the hip fracture patients, 88.6% of the cognitively normal (Clinical Dementia Rating-CDR 0; n = 70) and 98.8% with mild cognitive impairment (CDR 0.5; n = 81) fell in the abnormal biomarker categories by the A/T/N classification. Conclusions A large proportion of older hip fracture patients have CSF evidence of AD pathology. Preoperative determination of AD biomarkers may play a crucial role in identifying persons without dementia who have underlying AD pathology in perioperative settings.	[Oh, Esther S.; Wang, Nae-Yuh] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Oh, Esther S.; Bigelow, George E.; Neufeld, Karin J.; Rosenberg, Paul B.; Lyketsos, Constantine G.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Oh, Esther S.; Troncoso, Juan C.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Blennow, Kaj; Zetterberg, Henrik] Univ Gothenburg, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Clin Neurochem Lab,Sahlgrenska Acad, Molndal, Sweden; [Inouye, Sharon K.; Marcantonio, Edward R.] Harvard Med Sch, Boston, MA USA; [Inouye, Sharon K.; Marcantonio, Edward R.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Inouye, Sharon K.; Marcantonio, Edward R.] Hebrew SeniorLife, Aging Brain Ctr, Boston, MA USA; [Wang, Nae-Yuh] Johns Hopkins Univ, Dept Biostat, Sch Med, Baltimore, MD 21205 USA; [Wang, Nae-Yuh] Johns Hopkins Univ, Dept Epidemiol, Sch Med, Baltimore, MD USA; [Zetterberg, Henrik] UCL Inst Neurol, Dept Mol Neurosci, Queen Sq, London, England; [Zetterberg, Henrik] UCL, UK Dementia Res Inst, London, England; [Sieber, Frederick E.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Gothenburg; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Hebrew SeniorLife; Johns Hopkins University; Johns Hopkins University; University of London; University College London; University of London; University College London; Johns Hopkins University	Oh, ES (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.; Oh, ES (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA.; Oh, ES (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.	eoh9@jhmi.edu	Marcantonio, Edward R/U-3929-2017; Inouye, Sharon/R-7216-2019	Marcantonio, Edward R/0000-0002-2911-4250; Wang, Nae-Yuh/0000-0001-6513-9730; Neufeld, Karin/0000-0002-2395-1883	Johns Hopkins Institute for Clinical and Translational Research (ICTR) [5KL2RR025006]; National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH) [UL1 TR 001079]; NIA/NIH [1K23AG043504, RO1 AG033615, P50 AG005146, R24AG054259, K07AG041835]; Rosalinde and Arthur Gilbert Foundation/AFAR New Investigator Award in Alzheimer's disease; Roberts Gift Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001079] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005146, R24AG054259, R01AG033615, K23AG043504, K07AG041835] Funding Source: NIH RePORTER	Johns Hopkins Institute for Clinical and Translational Research (ICTR); National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIA/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Rosalinde and Arthur Gilbert Foundation/AFAR New Investigator Award in Alzheimer's disease; Roberts Gift Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Research grants were obtained from the following: This study was supported by 5KL2RR025006 [Johns Hopkins Institute for Clinical and Translational Research (ICTR) which is funded in part by Grant Number UL1 TR 001079 from the National Center for Advancing Translational Sciences (NCATS) a component of the National Institutes of Health (NIH)] (E0), 1K23AG043504, RO1 AG033615 (NIA/NIH) (FS, KN), P50 AG005146 (CL), R24AG054259 (NIA/NIH) (SKI, EM), K07AG041835 (NIA/NIH) (SKI), the Rosalinde and Arthur Gilbert Foundation/AFAR New Investigator Award in Alzheimer's disease (EO), and the Roberts Gift Fund (EO). Swedish and European Research Councils (HZ), UK Dementia Research Institute (HZ), and Swedish State Support for Clinical Research (HZ). The funding sources did not have any involvement in study design; the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.	Alzheimer's Association, 2017, ALZHEIMERS DEMENT, V13, P325, DOI [DOI 10.1016/J.JALZ.2017.02.001, 10.1016/j.jalz.2017.02.001]; Bentler SE, 2009, AM J EPIDEMIOL, V170, P1290, DOI 10.1093/aje/kwp266; Buchman AS, 2013, NEUROLOGY, V80, P2055, DOI 10.1212/WNL.0b013e318294b462; Centers for Disease Control and Prevention (CDC), 1996, MMWR-MORBID MORTAL W, V45, P877; De Meyer G, 2010, ARCH NEUROL-CHICAGO, V67, P949, DOI 10.1001/archneurol.2010.179; del Campo N, 2016, NEUROLOGY, V86, P36, DOI 10.1212/WNL.0000000000002235; GRISSO JA, 1991, NEW ENGL J MED, V324, P1326, DOI 10.1056/NEJM199105093241905; Hansson O, 2006, LANCET NEUROL, V5, P228, DOI 10.1016/S1474-4422(06)70355-6; Hurd MD, 2013, NEW ENGL J MED, V368, P1326, DOI 10.1056/NEJMsa1204629; Idland AV, 2017, J ALZHEIMERS DIS, V55, P371, DOI 10.3233/JAD-160461; Jack CR, 2016, NEUROLOGY, V87, P539, DOI 10.1212/WNL.0000000000002923; Jack CR, 2017, LANCET NEUROL, V16, P435, DOI 10.1016/S1474-4422(17)30077-7; Janelidze S, 2016, ANN CLIN TRANSL NEUR, V3, P154, DOI 10.1002/acn3.274; Jansen WJ, 2015, JAMA-J AM MED ASSOC, V313, P1924, DOI 10.1001/jama.2015.4668; JORM AF, 1994, PSYCHOL MED, V24, P145, DOI 10.1017/S003329170002691X; Li TJ, 2017, CLIN TRIALS, V14, P299, DOI 10.1177/1740774516687253; Loskutova N, 2010, J ALZHEIMERS DIS, V20, P313, DOI 10.3233/JAD-2010-1364; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Palmqvist S, 2015, NEUROLOGY, V85, P1240, DOI 10.1212/WNL.0000000000001991; Schirinzi T, 2018, J ALZHEIMERS DIS, V64, P525, DOI 10.3233/JAD-171166; Sieber FE, 2018, JAMA SURG; Stark SL, 2013, NEUROLOGY, V81, P437, DOI 10.1212/WNL.0b013e31829d8599; Stevens JA, 2013, OSTEOPOROSIS INT, V24, P2725, DOI 10.1007/s00198-013-2375-9; Tian Q, 2017, J GERONTOL A-BIOL, V72, P716, DOI 10.1093/gerona/glw183; Tolppanen AM, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0383-2; Wennberg AMV, 2017, J AM GERIATR SOC, V65, P792, DOI 10.1111/jgs.14670; Wennberg AMV, 2017, DEMENT GERIATR COGN, V43, P128, DOI 10.1159/000456541; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593	28	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2018	13	9							e0204695	10.1371/journal.pone.0204695	http://dx.doi.org/10.1371/journal.pone.0204695			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GU9BO	30252906	Green Published, Green Submitted, gold			2022-12-26	WOS:000445639700068
J	Green, A; Chadwick, MA; Jones, PJS				Green, Alix; Chadwick, Michael A.; Jones, Peter J. S.			Variability of UK seagrass sediment carbon: Implications for blue carbon estimates and marine conservation management	PLOS ONE			English	Article							POSIDONIA-OCEANICA; ORGANIC-MATTER; BALTIC SEA; MEADOWS; STORAGE; ECOSYSTEMS; HABITAT; STOCKS; SINK; BEDS	Seagrass meadows provide a multitude of ecosystem services, including a capacity to sequester carbon dioxide (CO2) within their sediments. Seagrass research in the UK is lacking and there is no published data on sediment carbon (C) within UK seagrass meadows. We sampled 13 Zostera marina meadows along the southwest coast of the UK to assess the variability in their sedimentary organic carbon (OC) stocks. The study sites were considered representative of sub-tidal Z marina meadows in the UK, spanning a gradient of sheltered to exposed sites, varying in formation, size and density, but found along the same latitudinal gradient. OC stocks (C-stocks) integrated across 100cm depth profiles were similar among all sites (98.01 +/- 2.15 to 140.24 +/- 10.27 Mg C ha(-1)), apart from at Drakes Island, which recorded an unusually high C-stock (380.07 +/- 17.51 Mg C ha(-1)) compared to the rest of the region. The total standing stock of C in the top 100cm of the surveyed seagrass meadows was 66,337 t C, or the equivalent of 10,512 individual UK people's CO2 emissions per year. This figure is particularly significant relative to the seagrass area, which totalled 549.79 ha. Using estimates of seagrass cover throughout the UK and recent UK C trading values we approximate that the monetary value of the UK's seagrass standing C stock is between 2.6 pound million and 5.3 pound million. The C stock of the UK's seagrass meadows represent one of the largest documented C stocks within Europe and are, therefore, of important ecosystem service value. The research raises questions concerning the reliability of using global or regional data as a proxy for local seagrass C stock estimates and adds to a growing body of literature that is looking to understand the mechanisms of seagrass C storage. When taken with the fact that seagrass meadows are an important habitat for commercially important and endangered species in the UK, along with their declining health and cover, this research supports the need for more robust conservation strategies for UK seagrass habitats.	[Green, Alix; Jones, Peter J. S.] UCL, Dept Geog, London, England; [Chadwick, Michael A.] Kings Coll London, Dept Geog, London, England	University of London; University College London; University of London; King's College London	Green, A (corresponding author), UCL, Dept Geog, London, England.	alix.green.15@ucl.ac.uk	Jones, Peter JS/C-3322-2008; Chadwick, Michael/ABF-6431-2020	Jones, Peter JS/0000-0001-8479-3607; Chadwick, Michael/0000-0003-4891-4357	Natural Environmental Research Council [NE/L002485/1]	Natural Environmental Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by the Natural Environmental Research Council [AG grant number NE/L002485/1 to AG] (https://nerc.ukri.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell-James J., 2011, UNSWLJ, V2016, P1583; Bertelli CM, 2014, MAR POLLUT BULL, V83, P425, DOI 10.1016/j.marpolbul.2013.08.011; Blott SJ, 2001, EARTH SURF PROC LAND, V26, P1237, DOI 10.1002/esp.261; Burdige DJ, 2007, CHEM REV, V107, P467, DOI 10.1021/cr050347q; Collins K.J., 2010, INT J SOC UNDERWATER, V29, P117, DOI DOI 10.3723/UT.29.117; Dahl M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167493; Davidson DM, 1998, OVERVIEW DYNAMICS SE, V1; Davison DM, 1998, OVERVIEW DYNAMICS SE; DEAN WE, 1974, J SEDIMENT PETROL, V44, P242; Defra, 2016, CONS PROP 2 TRANCH M; Department of Agriculture Environment and Rural Affairs, 2018, DRAFT MAR PLAN NO IR; Department of Energy and Climate Change (DECC), 2011, BRIEF GUID CARB VAL; Duarte CM, 2013, NAT CLIM CHANGE, V3, P961, DOI [10.1038/nclimate1970, 10.1038/NCLIMATE1970]; Duarte CM, 2013, OCEAN COAST MANAGE, V83, P32, DOI 10.1016/j.ocecoaman.2011.09.001; Foden J, 2010, WATER FRAMEWORK DIRE; FONSECA MS, 1992, ESTUAR COAST SHELF S, V35, P565, DOI 10.1016/S0272-7714(05)80039-3; Fourqurean JW, 2012, NAT GEOSCI, V5, P505, DOI 10.1038/ngeo1477; Garcias-Bonet N, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00340; Garrard SL, 2014, MAR POLLUT BULL, V86, P138, DOI 10.1016/j.marpolbul.2014.07.032; Garrick-Maidment N, 2010, SEAHORSE TAGGING PRO, DOI [10.1017/S175526721000062X, DOI 10.1017/S175526721000062X]; Hemminga M.A., 2000, SEAGRASS ECOLOGY, DOI [10.1017/CBO9780511525551, DOI 10.1017/CBO9780511525551]; Hendriks IE, 2008, MAR ECOL PROG SER, V356, P163, DOI 10.3354/meps07316; Hiscock K., 2005, REPORT GAUGE HLTH UK; Howard J., 2014, COASTAL BLUE CARBON; Howard JL, 2018, LIMNOL OCEANOGR, V63, P160, DOI 10.1002/lno.10621; Jackson EL, 2001, OCEANOGR MAR BIOL, V39, P269; Jankowska E, 2016, J GEOPHYS RES-BIOGEO, V121, P2918, DOI 10.1002/2016JG003424; Johannessen SC, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/11/113001; Jones BL, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150596; Kennedy H, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2010GB003848; Kerr J., 2017, INTRO ENERGY CLIMATE; Laffoley D., 2009, MANAGEMENT NATURAL C; Lavery PS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073748; Luisetti T, 2013, MAR POLLUT BULL, V71, P101, DOI 10.1016/j.marpolbul.2013.03.029; Maddock A, 2008, UK BIODIVERSITY ACTI; Mateo MA, 1997, ESTUAR COAST SHELF S, V44, P103, DOI 10.1006/ecss.1996.0116; Mcleod E, 2011, FRONT ECOL ENVIRON, V9, P552, DOI 10.1890/110004; Miyajima T, 2015, GLOBAL BIOGEOCHEM CY, V29, P397, DOI 10.1002/2014GB004979; MMO. ENVIRONMENTAL PROTECTION LICENSING (MARINE) MARINE POLLUTION, 2011, MAR LIC EX ACT ORD 2; Nellemann C., 2009, BLUE CARBON RAPID RE; Nordlund LM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163091; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Pendleton L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043542; Rohr ME, 2016, BIOGEOSCIENCES, V13, P6139, DOI 10.5194/bg-13-6139-2016; Samper-Villarreal J, 2016, LIMNOL OCEANOGR, V61, DOI [10.1002/lno.10241, DOI 10.1002/LNO.10241]; Santisteban JI, 2004, J PALEOLIMNOL, V32, P287, DOI 10.1023/B:JOPL.0000042999.30131.5b; Serrano O, 2016, SCI REP-UK, V6, DOI 10.1038/srep23193; Serrano O, 2012, GEODERMA, V185, P26, DOI 10.1016/j.geoderma.2012.03.020; Short F.T., 2010, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2010.e.T153538A45166753.RLTS.T153538A4516675.en., DOI 10.2305/IUCN.UK.2010.E]; Simberloff D, 1998, BIOL CONSERV, V83, P247, DOI 10.1016/S0006-3207(97)00081-5; SMITH SV, 1981, SCIENCE, V211, P838, DOI 10.1126/science.211.4484.838; Unsworth RKF, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01309	52	19	20	15	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2018	13	9							e0204431	10.1371/journal.pone.0204431	http://dx.doi.org/10.1371/journal.pone.0204431			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3MI	30248130	Green Submitted, Green Published, gold			2022-12-26	WOS:000445998100040
J	Grimaldi, M; Stillitano, I; Amodio, G; Santoro, A; Buonocore, M; Moltedo, O; Remondelli, P; D'Ursi, AM				Grimaldi, Manuela; Stillitano, Ilaria; Amodio, Giuseppina; Santoro, Angelo; Buonocore, Michela; Moltedo, Ornella; Remondelli, Paolo; D'Ursi, Anna Maria			Structural basis of antiviral activity of peptides from MPER of FIV gp36	PLOS ONE			English	Article							FELINE IMMUNODEFICIENCY VIRUS; TRANSMEMBRANE GLYCOPROTEIN; ENTRY INHIBITORS; NMR-SPECTROSCOPY; MEMBRANE-FUSION; TYPE-1 GP41; CELL ENTRY; IN-VITRO; HIV; ECTODOMAIN	Feline immunodeficiency virus (FIV) is a naturally occurring Lentivirus causing acquired immunodeficiency syndrome in felines. It is considered a useful non-primate model to study HIV infection, and to test anti-HIV vaccine. Similarly to HIV, FIV enters cells via a mechanism involving a surface glycoprotein named gp36. C8 is a short synthetic peptide corresponding to the residues (770)WEDWVGWI(777) of gp36 membrane proximal external region (MPER). It elicits antiviral activity by inhibiting the fusion of the FIV and host cell membrane. C8 is endowed with evident membrane binding property, inducing alteration of the phospholipid bilayer and membrane fusion. The presence and the position of tryptophan residues in C8 are important for antiviral activity: the C8 derivative C6a, obtained by truncating the N-terminal (WE771)-W-770 residues, exhibits conserved antiviral activity, while the C8 derivative C6b, derived from the truncation of the C-terminal (WI777)-W-776, is nearly inactive. To elucidate the structural factors that induce the different activity profiles of C6a and C6b, in spite of their similarity, we investigated the structural behaviour of the two peptides in membrane mimicking environments. Conformational data on the short peptides C6a and C6b, matched to those of their parent peptide C8, allow describing a pharmacophore model of antiviral fusion inhibitors. This includes the essential structural motifs to design new simplified molecules overcoming the pharmacokinetic and high cost limitations affecting the antiviral entry inhibitors that currently are in therapy.	[Grimaldi, Manuela; Stillitano, Ilaria; Santoro, Angelo; Buonocore, Michela; Moltedo, Ornella; D'Ursi, Anna Maria] Univ Salerno, Dept Pharm, Fisciano, SA, Italy; [Amodio, Giuseppina; Remondelli, Paolo] Univ Salerno, Dept Med & Surg, Baronissi, SA, Italy	University of Salerno; University of Salerno	D'Ursi, AM (corresponding author), Univ Salerno, Dept Pharm, Fisciano, SA, Italy.	dursi@unisa.it	Santoro, Angelo/ABB-8087-2020; D'Ursi, Anna M/E-8557-2016; Remondelli, Paolo/X-7805-2019; Grimaldi, Manuela/AAQ-2981-2020; Amodio, Giuseppina/J-8755-2018	Santoro, Angelo/0000-0002-9690-907X; D'Ursi, Anna M/0000-0001-6814-8472; Amodio, Giuseppina/0000-0001-8971-8964; Buonocore, Michela/0000-0003-1189-1729; REMONDELLI, Paolo/0000-0002-3698-3497	Instruct-ERIC RD Award [APPID 300]	Instruct-ERIC RD Award	The authors acknowledge the support and the use of resources of Instruct-ERIC. This work would not have been possible without the financial support of the Instruct-ERIC R&D Award APPID 300.; This work would not have been possible without the financial support of the Instruct-ERIC R&D Award APPID 300.	Aghokeng AF, 2010, INFECT GENET EVOL, V10, P386, DOI 10.1016/j.meegid.2009.04.014; Amodio G, 2016, CELL BIOL TOXICOL, V32, P285, DOI 10.1007/s10565-016-9335-z; Badani H, 2014, BBA-BIOMEMBRANES, V1838, P2180, DOI 10.1016/j.bbamem.2014.04.015; Bar S, 2004, J VIROL, V78, P811, DOI 10.1128/JVI.78.2.811-820.2004; Barbato G, 2003, J MOL BIOL, V330, P1101, DOI 10.1016/S0022-2836(03)00611-9; Basu A, 2014, J VIROL, V88, P1447, DOI 10.1128/JVI.01225-13; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; BENDINELLI M, 1995, CLIN MICROBIOL REV, V8, P87, DOI 10.1128/CMR.8.1.87; Burkhard MJ, 2003, CURR HIV RES, V1, P15, DOI 10.2174/1570162033352101; Case D. A., 2002, AMBER 7; Cheng G, 2008, P NATL ACAD SCI USA, V105, P3088, DOI 10.1073/pnas.0712380105; Cooper DA, 2004, LANCET INFECT DIS, V4, P426, DOI 10.1016/S1473-3099(04)01058-8; D'Errico G, 2009, EUR BIOPHYS J BIOPHY, V38, P873, DOI [10.1007/s00249-009-0454-9, 10.1007/S00249-009-0454-9]; D'Ursi AM, 2006, CHEMBIOCHEM, V7, P774, DOI 10.1002/cbic.200500390; De Rosa M, 2013, EUR J MED CHEM, V69, P779, DOI 10.1016/j.ejmech.2013.09.035; Doms RW, 2000, J CELL BIOL, V151, pF9, DOI 10.1083/jcb.151.2.F9; Dufau I, 2000, TETRAHEDRON LETT, V41, P6063, DOI 10.1016/S0040-4039(00)01007-8; Elder JH, 2010, CURR HIV RES, V8, P73, DOI 10.2174/157016210790416389; Fasano D, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0410-7; Frey SCS, 2001, J VIROL, V75, P5433, DOI 10.1128/JVI.75.11.5433-5440.2001; Giannecchini S, 2004, VIROLOGY, V320, P156, DOI 10.1016/j.virol.2003.12.001; Glannecchini S, 2003, J VIROL, V77, P3724, DOI 10.1128/JVI.77.6.3724-3733.2003; Goddard T.D., 2004, SPARKY 3; Grimaldi M, 2010, BIOORGAN MED CHEM, V18, P7985, DOI 10.1016/j.bmc.2010.09.033; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Guntert Peter, 2004, Methods Mol Biol, V278, P353; He YX, 2008, J BIOL CHEM, V283, P11126, DOI 10.1074/jbc.M800200200; Hrobowski YM, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-49; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; KAISER E, 1970, ANAL BIOCHEM, V34, P595, DOI 10.1016/0003-2697(70)90146-6; LEE J, 2017, J VIROL, V91; Luttge BG, 2010, VET IMMUNOL IMMUNOP, V134, P3, DOI 10.1016/j.vetimm.2009.10.003; Mannhold R., 2006, BIONMR DRUG RES; Maselko M, 2011, CURR HIV RES, V9, P1, DOI 10.2174/157016211794582605; Matthews T, 2004, NAT REV DRUG DISCOV, V3, P215, DOI 10.1038/nrd1331; Merlino A, 2012, J PHYS CHEM B, V116, P401, DOI 10.1021/jp204781a; Oliva R, 2015, BBA-BIOMEMBRANES, V1848, P510, DOI 10.1016/j.bbamem.2014.10.017; PANCINO G, 1995, J VIROL, V69, P2110, DOI 10.1128/JVI.69.4.2110-2118.1995; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; PIANTINI U, 1982, J AM CHEM SOC, V104, P6800, DOI 10.1021/ja00388a062; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Ranieri R, 2018, CELL DEATH DIFFER, V25, P353, DOI 10.1038/cdd.2017.165; Rizvi SMD, 2013, EXCLI J, V12, P831; Salzwedel K, 1999, J VIROL, V73, P2469, DOI 10.1128/JVI.73.3.2469-2480.1999; Scrima M, 2014, BBA-BIOMEMBRANES, V1838, P1010, DOI 10.1016/j.bbamem.2013.12.010; Serres PF, 2000, CR ACAD SCI III-VIE, V323, P1019, DOI 10.1016/S0764-4469(00)01277-4; Suarez T, 2000, FEBS LETT, V477, P145, DOI 10.1016/S0014-5793(00)01785-3; Thomas CJ, 2011, J BIOL CHEM, V286, P6192, DOI 10.1074/jbc.M110.196428; Troyer JL, 2005, J VIROL, V79, P8282, DOI 10.1128/JVI.79.13.8282-8294.2005; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770; Williams A B, 1997, J Assoc Nurses AIDS Care, V8, P26, DOI 10.1016/S1055-3290(97)80011-8; Wuthrich K, 1986, EUR NEWSL, V17, P11, DOI [10.1051/epn/19861701011, DOI 10.1051/EPN/19861701011]; Yeni P, 2006, J HEPATOL, V44, pS100, DOI 10.1016/j.jhep.2005.11.021; Yi HA, 2016, CURR HIV RES, V14, P283, DOI 10.2174/1570162X14999160224103908; Zerbe O., 2003, BIONMR DRUG RES METH; Zhang HT, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-136; Zwick MB, 2004, NAT MED, V10, P133, DOI 10.1038/nm0204-133	61	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2018	13	9							e0204042	10.1371/journal.pone.0204042	http://dx.doi.org/10.1371/journal.pone.0204042			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU5MM	30240422	gold, Green Published, Green Submitted			2022-12-26	WOS:000445329700020
J	Kubota, K; Nakano, M; Kobayashi, E; Mizue, Y; Chikenji, T; Otani, M; Nagaishi, K; Fujimiya, M				Kubota, Kenta; Nakano, Masako; Kobayashi, Eiji; Mizue, Yuka; Chikenji, Takako; Otani, Miho; Nagaishi, Kanna; Fujimiya, Mineko			An enriched environment prevents diabetes-induced cognitive impairment in rats by enhancing exosomal miR-146a secretion from endogenous bone marrow-derived mesenchymal stem cells	PLOS ONE			English	Article							EXTRACELLULAR VESICLES; ALZHEIMERS-DISEASE; MEMORY DEFICITS; HIPPOCAMPUS; ACTIVATION; BRAIN; MICRORNA-146A; ASTROCYTES; MELLITUS; DEMENTIA	Increasing evidence suggests that an enriched environment (EE) ameliorates cognitive impairment by promoting repair of brain damage. However, the mechanisms by which this occurs have not been determined. To address this issue, we investigated whether an EE enhanced the capability of endogenous bone marrow-derived mesenchymal stem/stromal cells (BM-MSCs) to prevent hippocampal damage due to diabetes by focusing on miRNA carried in BM-MSC-derived exosomes. In diabetic streptozotocin (STZ) rats housed in an EE (STZ/EE), cognitive impairment was significantly reduced, and both neuronal and astroglial damage in the hippocampus was alleviated compared with STZ rats housed in conventional cages (STZ/CC). BM-MSCs isolated from STZ/CC rats had functional and morphological abnormalities that were not detected in STZ/EE BM-MSCs. The miR-146a levels in exosomes in conditioned medium of cultured BM-MSCs and serum from STZ/CC rats were decreased compared with non-diabetic rats, and the level was restored in STZ/EE rats. Thus, the data suggest that increased levels of miR-146a in sera were derived from endogenous BM-MSCs in STZ/EE rats. To examine the possibility that increased miR-146a in serum may exert anti-inflammatory effects on astrocytes in diabetic rats, astrocytes transfected with miR-146a were stimulated with advanced glycation end products (AGES) to mimic diabetic conditions. The expression of IRAK1, NF-kappa B, and tumor necrosis factor-alpha was significantly higher in AGE-stimulated astrocytes, and these factors were decreased in miR-146a-transfected astrocytes. These results suggested that EEs stimulate up-regulation of exosomal miR-146a secretion by endogenous BM-MSCs, which exerts anti-inflammatory effects on damaged astrocytes and prevents diabetes-induced cognitive impairment.	[Kubota, Kenta; Nakano, Masako; Kobayashi, Eiji; Mizue, Yuka; Chikenji, Takako; Otani, Miho; Nagaishi, Kanna; Fujimiya, Mineko] Sapporo Med Univ, Dept Anat, Sch Med, Sapporo, Hokkaido, Japan; [Kubota, Kenta] Hokkaido Chitose Rehabil Univ, Dept Phys Therapy, Chitose, Hokkaido, Japan	Sapporo Medical University	Fujimiya, M (corresponding author), Sapporo Med Univ, Dept Anat, Sch Med, Sapporo, Hokkaido, Japan.	fujimiya@sapmed.ac.jp		Kubota, Kenta/0000-0003-1176-1991	JSPS KAKENHI Grant [JP16K19317]; LEOC Co.	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); LEOC Co.	This study was supported by JSPS KAKENHI Grant Number JP16K19317 and LEOC Co. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R, 2014, BBA-MOL BASIS DIS, V1842, P1313, DOI 10.1016/j.bbadis.2014.05.007; Baldeon RL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115209; Bao Y, 2015, CELL PHYSIOL BIOCHEM, V36, P2366, DOI 10.1159/000430199; Beauquis J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013993; Bhatt K, 2016, J AM SOC NEPHROL, V27, P2277, DOI 10.1681/ASN.2015010111; Bian SY, 2014, J MOL MED, V92, P387, DOI 10.1007/s00109-013-1110-5; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Bruno S, 2016, EUR J PHARMACOL, V790, P83, DOI 10.1016/j.ejphar.2016.06.058; Cao WY, 2014, BEHAV BRAIN RES, V265, P76, DOI 10.1016/j.bbr.2014.02.022; Chang TC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126537; Clare L., 2003, COCHRANE DB SYST REV, V4, P1, DOI [https://doi.org/10.1002/14651858.CD003260, DOI 10.1002/14651858.CD003260]; Coleman E, 2004, GLIA, V48, P166, DOI 10.1002/glia.20068; Del Arco A, 2007, BEHAV BRAIN RES, V176, P267, DOI 10.1016/j.bbr.2006.10.006; Diniz LP, 2012, J BIOL CHEM, V287, P41432, DOI 10.1074/jbc.M112.380824; During Matthew J., 2006, Current Alzheimer Research, V3, P29, DOI 10.2174/156720506775697133; Elbana AM, 2015, INT J STEM CELLS, V8, P146, DOI 10.15283/ijsc.2015.8.2.146; Fares RP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053888; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Gong PP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081747; Gutierrez-Fernandez M, 2012, J CELL MOL MED, V16, P2280, DOI 10.1111/j.1582-4934.2012.01575.x; Habibi F, 2016, ADV PHARM BULL, V6, P99, DOI 10.15171/apb.2016.015; Hutchison ER, 2013, GLIA, V61, P1018, DOI 10.1002/glia.22483; Iyer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044789; Jung CKE, 2014, CEREB CORTEX, V24, P377, DOI 10.1093/cercor/bhs317; Kang K, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/659890; Kim JM, 2012, CELL PHYSIOL BIOCHEM, V30, P49, DOI 10.1159/000339045; Klaissle P, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-132; Li SM, 2013, NEURON, V77, P929, DOI 10.1016/j.neuron.2012.12.040; Li Y, 2014, GLIA, V62, P1, DOI 10.1002/glia.22585; Ma S, 2014, CELL DEATH DIFFER, V21, P216, DOI 10.1038/cdd.2013.158; Min LJ, 2012, HYPERTENSION, V59, P1079, DOI 10.1161/HYPERTENSIONAHA.112.192401; Morrison JH, 2012, NAT REV NEUROSCI, V13, P240, DOI 10.1038/nrn3200; Nagaishi K, 2016, SCI REP-UK, V6, DOI 10.1038/srep34842; Nagaishi K, 2014, HEPATOLOGY, V59, P1816, DOI 10.1002/hep.26975; Nagayach A, 2014, METAB BRAIN DIS, V29, P747, DOI 10.1007/s11011-014-9562-z; Nahid MA, 2009, J BIOL CHEM, V284, P34590, DOI 10.1074/jbc.M109.056317; Nakano M, 2016, SCI REP-UK, V6, DOI 10.1038/srep24805; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Ohta H, 1997, NEUROSCIENCE, V79, P1039, DOI 10.1016/S0306-4522(97)00037-7; Olmos G, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/861231; Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937; Piazza F, 2014, METAB BRAIN DIS, V29, P93, DOI 10.1007/s11011-013-9467-2; Piazza FV, 2011, BEHAV BRAIN RES, V217, P16, DOI 10.1016/j.bbr.2010.09.017; Pusic KM, 2016, CELL MOL NEUROBIOL, V36, P313, DOI 10.1007/s10571-015-0269-4; Rabins P, 1997, AM J PSYCHIAT, V154, P1; Revsin Y, 2005, BRAIN RES, V1038, P22, DOI 10.1016/j.brainres.2004.12.032; Saba R, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00578; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schulte-Herbruggen O, 2007, INT J DEV NEUROSCI, V25, P387, DOI 10.1016/j.ijdevneu.2007.05.010; Sethe S, 2006, AGEING RES REV, V5, P91, DOI 10.1016/j.arr.2005.10.001; Singh VP, 2014, KOREAN J PHYSIOL PHA, V18, P1, DOI 10.4196/kjpp.2014.18.1.1; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Son H, 2015, BRAIN RES, V1602, P32, DOI 10.1016/j.brainres.2014.12.055; Thery Clotilde, 2011, F1000 Biol Rep, V3, P15, DOI 10.3410/B3-15; Ti DD, 2016, SCI CHINA LIFE SCI, V59, P1305, DOI 10.1007/s11427-016-0240-4; Turinetto V, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071164; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Wang L, 2014, NEUROSCIENCE, V259, P155, DOI 10.1016/j.neuroscience.2013.11.057; Wyles CC, 2015, CLIN ORTHOP RELAT R, V473, P1155, DOI 10.1007/s11999-014-3925-y; Xin HQ, 2013, STEM CELLS, V31, P2737, DOI 10.1002/stem.1409; Xu JW, 2012, DIABETES, V61, P2906, DOI 10.2337/db12-0145; Yan JL, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.002238; Zhou GX, 2013, DEMENT GER COGN D EX, V3, P39, DOI 10.1159/000348349	63	35	40	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2018	13	9							e0204252	10.1371/journal.pone.0204252	http://dx.doi.org/10.1371/journal.pone.0204252			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU5MM	30240403	Green Published, gold, Green Submitted			2022-12-26	WOS:000445329700033
J	Kullmann, JAP; Hayes, S; Pamphlett, R				Kullmann, Jane Alana Parkin; Hayes, Susan; Pamphlett, Roger			Is psychological stress a predisposing factor for amyotrophic lateral sclerosis (ALS)? An online international case-control study of premorbid life events, occupational stress, resilience and anxiety	PLOS ONE			English	Article							RATING-SCALE; RISK; ASSOCIATION; PERSONALITY; EVOLUTION; SYMPTOMS; GENDER; ONSET	Psychological stress has been suggested to be relevant to the pathogenesis of neurodegenerative disorders, possibly via the generation of oxygen free radicals. We therefore sought to determine whether people with amyotrophic lateral sclerosis (ALS) had been subjected to more potentially stressful life events or occupations than controls, and whether they had differences in resilience or trait anxiety that would moderate their responses to these stressors. An online anonymous multilingual questionnaire was used to collect data on significant life events from people with and without ALS, using items from a modified Social Readjustment Rating Scale and from self-described significant events, which were combined to create a Life Events Inventory. Inventory scores were subdivided into 0-20 years and 21-40 years age ranges, and for the preceding 2, 5 and 10 years. Respondents also rated levels of stress experienced during different occupations. Resilience was measured using the Connor-Davidson Resilience Scale, and trait anxiety with a modified Geriatric Anxiety Inventory. Scores were compared using non-parametric statistics. Data from 400 ALS (251 male, 149 female) and 450 control (130 male, 320 female) respondents aged 40 years and over showed that Life Events Inventory scores were similar in male ALS respondents and controls, but lower in female ALS respondents than female controls for the preceding 5-year and 10-year periods. Occupational stress did not differ between ALS respondents and controls. Both male and female ALS respondents had higher resilience scores than controls. Anxiety scores did not differ between ALS and control groups. In conclusion, people with ALS reported no raised levels of potentially stressful premorbid life events or occupational stress, and did not have reduced levels of resilience, or increased levels of anxiety, that would augment the deleterious effects of stressors. On the contrary, ALS respondents had higher resilience than controls, though this conclusion relies on ALS respondents recalling their premorbid status. These results do not support the hypothesis that psychological stress from significant life events or occupational stress plays a role in the pathogenesis of ALS.	[Kullmann, Jane Alana Parkin; Pamphlett, Roger] Univ Sydney, Discipline Pathol, Stacey Motor Neuron Dis Lab, Brain & Mind Ctr, Sydney, NSW, Australia; [Hayes, Susan] Univ Sydney, Sydney Med Sch, Forens Psychol, Sydney, NSW, Australia; [Pamphlett, Roger] Royal Prince Alfred Hosp, Dept Neuropathol, Sydney, NSW, Australia	University of Sydney; University of Sydney; University of Sydney	Pamphlett, R (corresponding author), Univ Sydney, Discipline Pathol, Stacey Motor Neuron Dis Lab, Brain & Mind Ctr, Sydney, NSW, Australia.; Pamphlett, R (corresponding author), Royal Prince Alfred Hosp, Dept Neuropathol, Sydney, NSW, Australia.	Roger.Pamphlett@sydney.edu.au		Hayes, Susan/0000-0001-7612-9116; Pamphlett, Roger/0000-0003-3326-7273; Parkin Kullmann, Jane Alana/0000-0001-5768-1941	Aimee Stacey Memorial and Ignacy Burnett Bequests	Aimee Stacey Memorial and Ignacy Burnett Bequests	RP is supported by the Aimee Stacey Memorial and Ignacy Burnett Bequests.	Artemiadis AK, 2011, NEUROEPIDEMIOLOGY, V36, P109, DOI 10.1159/000323953; Aschbacher K, 2013, PSYCHONEUROENDOCRINO, V38, P1698, DOI 10.1016/j.psyneuen.2013.02.004; Black CN, 2017, PSYCHONEUROENDOCRINO, V80, P56, DOI 10.1016/j.psyneuen.2017.03.003; Brown RH, 2017, NEW ENGL J MED, V377, P1602, DOI [10.1038/nrdp.2017.85, 10.1056/NEJMra1603471, 10.1056/NEJMc1710379, 10.1016/S0140-6736(17)31287-4, 10.1016/S0140-6736(10)61156-7, 10.1038/nrdp.2017.71]; Chio A, 1999, J NEUROL, V246, P1; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Dohrenwend BP, 2006, PSYCHOL BULL, V132, P477, DOI 10.1037/0033-2909.132.3.477; Feder A, 2009, NAT REV NEUROSCI, V10, P446, DOI 10.1038/nrn2649; Gallagher S, 2018, INT J PSYCHOPHYSIOL, V126, P52, DOI 10.1016/j.ijpsycho.2018.02.009; Herrman H, 2011, CAN J PSYCHIAT, V56, P258, DOI 10.1177/070674371105600504; Ho SC, 2017, MENOPAUSE, V24, P180, DOI 10.1097/GME.0000000000000734; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; Jalilianhasanpour R, 2018, J PSYCHOSOM RES, V107, P55, DOI 10.1016/j.jpsychores.2018.02.005; Johansson L, 2010, BRAIN, V133, P2217, DOI 10.1093/brain/awq116; Kullmann JAP, 2015, JMIR RES PROTOC, V4, DOI 10.2196/resprot.4840; Kuraszkiewicz B, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00220; Le Moal M, 2007, PSYCHONEUROENDOCRINO, V32, pS3, DOI 10.1016/j.psyneuen.2007.03.019; Lovera J, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0398-4; Maattanen I, 2015, J HEALTH PSYCHOL, V20, P1445, DOI 10.1177/1359105313513049; Maier A, 2012, AMYOTROPH LATERAL SC, V13, P210, DOI 10.3109/17482968.2011.633268; Marquez-Gonzalez M, 2012, INT PSYCHOGERIATR, V24, P137, DOI 10.1017/S1041610211001505; MASUDA M, 1978, PSYCHOSOM MED, V40, P236, DOI 10.1097/00006842-197805000-00006; Matud MP, 2004, PERS INDIV DIFFER, V37, P1401, DOI 10.1016/j.paid.2004.01.010; McCombe PA, 2010, GENDER MED, V7, P557, DOI 10.1016/j.genm.2010.11.010; Mehl T, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.599; Monroe SM, 2008, ANNU REV CLIN PSYCHO, V4, P33, DOI 10.1146/annurev.clinpsy.4.022007.141207; Okamoto K, 2009, ANN EPIDEMIOL, V19, P359, DOI 10.1016/j.annepidem.2009.01.015; Osorio C, 2017, BEHAV MED, V43, P307, DOI 10.1080/08964289.2016.1170661; Pachana NA, 2007, INT PSYCHOGERIATR, V19, P103, DOI 10.1017/S1041610206003504; Pamphlett Roger, 2013, Acta Neuropathol Commun, V1, P13, DOI 10.1186/2051-5960-1-13; Saul A, 2017, MULT SCLER J, V23, P1000, DOI 10.1177/1352458516667566; Scully JA, 2000, EDUC PSYCHOL MEAS, V60, P864, DOI 10.1177/00131640021970952; SELYE H, 1973, AM SCI, V61, P692; Steinberg KM, 2015, AMYOTROPH LAT SCL FR, V16, P385, DOI 10.3109/21678421.2015.1040029; Sugama S, 2016, BRAIN BEHAV IMMUN, V51, P39, DOI 10.1016/j.bbi.2015.08.015; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Wu G, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00010; Young PE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182638	38	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2018	13	9							e0204424	10.1371/journal.pone.0204424	http://dx.doi.org/10.1371/journal.pone.0204424			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GU5MM	30240431	Green Submitted, gold, Green Published			2022-12-26	WOS:000445329700048
J	Yi, G; Kim, JS; Park, JE; Shin, H; Yu, SH; Park, S; Huh, JH				Yi, Gibum; Kim, June-Sik; Park, Jeong Eun; Shin, Hosub; Yu, Seung Hwa; Park, Suhyung; Huh, Jin Hoe			MYB1 transcription factor is a candidate responsible for red root skin in radish (Raphanus sativus L.)	PLOS ONE			English	Article							ANTHOCYANIN BIOSYNTHESIS	Root skin color is one of the economically important traits in radish (Raphanus sativus), and the pigmentation in red skin varieties is largely attributable to anthocyanin accumulation. Pelargonidin was found as a major anthocyanin pigment accumulated in the sub-epidermal layer of red radish roots. In the 20 F-2 population generated from the F-1 with red root skins, root skins with red and white colors segregated in a 3:1 ratio. Additionally, a test cross between a red F-3 individual and a white skin individual gave rise to 1:1 segregation of red and white, indicating that the root skin color of radish is determined by a single locus and red color is dominant over white. We performed association mapping for root skin color using SNPs obtained from RNA-seq analysis. Segregation analysis on the 152 F-3 test-cross population revealed an RsMyb1 transcription factor as a candidate gene to determine root skin color. A PCR marker based on the polymorphism within 2 kb of RsMyb1 was developed and tested on 12 and 152 individuals from F-2 and F-3 test cross populations, respectively, and red and white root skin colors were completely distinguished corresponding to the genotypes. Expression levels of RsMyb1 in red or purple root cultivars were significantly higher than in white root cultivars. These findings suggest that RsMyb1 is a crucial determinant for anthocyanin biosynthesis in radish roots, and the molecular marker developed in this study will be useful for marker-assisted selection for red skin individuals at early seedling stages.	[Yi, Gibum; Kim, June-Sik; Park, Jeong Eun; Shin, Hosub; Huh, Jin Hoe] Seoul Natl Univ, Dept Plant Sci, Plant Genom & Breeding Inst, Seoul, South Korea; [Yi, Gibum; Kim, June-Sik; Park, Jeong Eun; Shin, Hosub; Huh, Jin Hoe] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea; [Yu, Seung Hwa; Huh, Jin Hoe] Seoul Natl Univ, Interdisciplinary Program Agr Genom, Seoul, South Korea; [Park, Suhyung] Rural Dev Adm, Dept Hort Crop Res, Natl Inst Hort & Herbal Sci, Jeonju, South Korea; [Kim, June-Sik] RIKEN, Ctr Sustainable Resource Sci, Tsukuba, Ibaraki, Japan	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); National Institute of Horticultural & Herbal Science (NIHHS), Republic of Korea; Rural Development Administration (RDA), Republic of Korea; RIKEN	Huh, JH (corresponding author), Seoul Natl Univ, Dept Plant Sci, Plant Genom & Breeding Inst, Seoul, South Korea.; Huh, JH (corresponding author), Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea.; Huh, JH (corresponding author), Seoul Natl Univ, Interdisciplinary Program Agr Genom, Seoul, South Korea.	huhjh@snu.ac.kr	Kim, June-Sik/R-6474-2017	Kim, June-Sik/0000-0002-4703-609X; Shin, Hosub/0000-0001-6488-8430; Yi, Gibum/0000-0002-7630-1892	Golden Seed Project, Ministry for Food, Agriculture, Forestry, and Fisheries [213002041SBO20]; Next-Generation BioGreen 21 Program by the Rural Development Administration, Republic of Korea [PJ011203]	Golden Seed Project, Ministry for Food, Agriculture, Forestry, and Fisheries; Next-Generation BioGreen 21 Program by the Rural Development Administration, Republic of Korea	This study was supported by the grants from the Golden Seed Project (project no. 213002041SBO20, www.mafra.go.kr, JH), Ministry for Food, Agriculture, Forestry, and Fisheries, and the Next-Generation BioGreen 21 Program (project no. PJ011203, www.rda.go.kr, JH) provided by the Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124497; Browning BL, 2016, AM J HUM GENET, V98, P116, DOI 10.1016/j.ajhg.2015.11.020; CONE KC, 1993, PLANT CELL, V5, P1795, DOI 10.1105/tpc.5.12.1795; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Frost HB, 1923, GENETICS, V8, P0116; Giusti MM, 1996, J FOOD SCI, V61, P322, DOI 10.1111/j.1365-2621.1996.tb14186.x; Gonzalez A, 2008, PLANT J, V53, P814, DOI 10.1111/j.1365-313X.2007.03373.x; HARBORNE JB, 1964, HEREDITY, V19, P505, DOI 10.1038/hdy.1964.57; Heine GF, 2004, J BIOL CHEM, V279, P37878, DOI 10.1074/jbc.M405166200; Jeong YM, 2016, THEOR APPL GENET, V129, P1357, DOI 10.1007/s00122-016-2708-0; Jin WM, 2016, PLANT BIOTECHNOL J, V14, P2120, DOI 10.1111/pbi.12568; Jung CS, 2009, THEOR APPL GENET, V120, P45, DOI 10.1007/s00122-009-1158-3; Kitashiba H, 2014, DNA RES, V21, P481, DOI 10.1093/dnares/dsu014; Lim SH, 2016, PLANT CELL REP, V35, P641, DOI 10.1007/s00299-015-1909-3; Lin LZ, 2011, J AGR FOOD CHEM, V59, P6616, DOI 10.1021/jf200571a; Lippert C, 2011, NAT METHODS, V8, P833, DOI [10.1038/nmeth.1681, 10.1038/NMETH.1681]; Mitsui Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep10835; Park NI, 2011, J AGR FOOD CHEM, V59, P2356, DOI 10.1021/jf200020b; Schwinn KE, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01865; Tatebe T., 1938, JAP J GENET, V14, P39; Tatsuzawa F, 2008, DYES PIGMENTS, V79, P83, DOI 10.1016/j.dyepig.2008.01.009; Uphof JCT, 1924, GENETICS, V9, P0292; Vivarelli F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150913; YARNELL SH, 1956, BOT REV, V22, P81, DOI 10.1007/BF02872468; Yi G, 2016, J AGR FOOD CHEM, V64, P61, DOI 10.1021/acs.jafc.5b04575; Zhong Silin, 2011, Cold Spring Harb Protoc, V2011, P940, DOI 10.1101/pdb.prot5652	27	13	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2018	13	9							e0204241	10.1371/journal.pone.0204241	http://dx.doi.org/10.1371/journal.pone.0204241			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU5MM	30240413	Green Published, Green Submitted, gold			2022-12-26	WOS:000445329700032
J	Yoshida, K; Kita, Y; Tokuoka, SM; Hamano, F; Yamazaki, M; Sakimura, K; Kano, M; Shimizu, T				Yoshida, Kenji; Kita, Yoshihiro; Tokuoka, Suzumi M.; Hamano, Fumie; Yamazaki, Maya; Sakimura, Kenji; Kano, Masanobu; Shimizu, Takao			Monoacylglycerol lipase deficiency affects diet-induced obesity, fat absorption, and feeding behavior in CB1 cannabinoid receptor-deficient mice	FASEB JOURNAL			English	Article						metabolic syndrome; satiety; adipose tissue; liver; intestine	GLUCAGON-LIKE PEPTIDE-1; FOOD-INTAKE; MOLECULAR REGULATION; PROTECTS MICE; ENERGY; RESISTANCE; LIPOLYSIS; INSULIN; CHOLESTEROL; SENSITIVITY	Excess energy intake causes obesity, which leads to insulin resistance and various other complications of metabolic syndrome, including diabetes, atherosclerosis, dyslipidemia, and nonalcoholic fatty liver disease. Although recent studies have depicted altered lipid metabolism as an underlying feature, the detailed mechanisms are still unclear. Here we describe a possible role in high-fat diet (HFD)-induced obesity for monoacylglycerol lipase (MGL), an enzyme that is also known to hydrolyze the endocannabinoid 2-arachidonoylglycerol in brain. MGL-deficient [MGL-knockout (KO)] mice fed a HFD gained less body weight than wild-type mice and were protected from insulin resistance and hepatic steatosis. Food intake and energy expenditure were not altered in MGL-KO mice, but blood triglyceride levels after oral olive oil gavage were suppressed, indicating a role for MGL in intestinal fat absorption. Experiments with cannabinoid receptor type 1 (CB1)/MGL double-KO mice revealed that these phenotypes may include mechanisms that are independent of CB1-receptor-mediated endocannabinoid functions. We also noted that MGL-KO mice had less preference for HFD over normal chow diet. Oral but not intraperitoneal lipid administration strongly suppressed the appetites of MGL-KO and CB1/MGL double-KO mice, but not of wild-type and CB1-KO mice. Appetite suppression was reversed by vagotomy, suggesting involvement of MGL in the gut-brain axis regulation of appetite. Our results provide mechanistic insights of MGL's role in diet-induced obesity, lipid metabolic disorder, and regulation of appetite.Yoshida, K., Kita, Y., Tokuoka, S. M., Hamano, F., Yamazaki, M., Sakimura, K., Kano, M., Shimizu, T. Monoacylglycerol lipase deficiency affects diet-induced obesity, fat absorption, and feeding behavior in CB1 cannabinoid receptor-deficient mice.	[Yoshida, Kenji; Kita, Yoshihiro; Tokuoka, Suzumi M.; Hamano, Fumie; Shimizu, Takao] Univ Tokyo, Dept Lipid, Tokyo, Japan; [Kita, Yoshihiro; Hamano, Fumie] Univ Tokyo, Life Sci Core Facil, Tokyo, Japan; [Kano, Masanobu] Univ Tokyo, Dept Neurophysiol, Grad Sch Med, Tokyo, Japan; [Kano, Masanobu] Univ Tokyo, Int Res Ctr Neurointelligence WPI IRCN, UTIAS, Tokyo, Japan; [Hamano, Fumie; Shimizu, Takao] Natl Ctr Global Hlth & Med, Dept Lipid Signaling, Tokyo, Japan; [Yamazaki, Maya; Sakimura, Kenji] Niigata Univ, Dept Cellular Neurobiol, Brain Res Inst, Niigata, Japan; [Yamazaki, Maya] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA	University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; National Center for Global Health & Medicine - Japan; Niigata University; University of California System; University of California San Francisco	Kita, Y (corresponding author), Univ Tokyo, Dept Lipid, Grad Sch Med, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	kita@m.u-tokyo.ac.jp	Yamazaki, Maya/C-6952-2012; Shimizu, Takao/AAV-7052-2021	Kano, Masanobu/0000-0002-0725-3292	Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) [15K08296, 16H06276, 25000015, 24229003]; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF))	The authors thank J. Aoki and K. Kano (Tohoku University, Sendai, Japan) for technical assistance with mouse vagotomy. The authors also thank W. Valentine (National Center for Global Health and Medicine, Tokyo, Japan) and A. Kobayashi (The University of Tokyo) for critical reading and technical assistance, respectively, as well as other laboratory members for valuable discussions. This work was supported, in part, by Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research (KAKENHI) Grants 15K08296 (to Y.K.), 16H06276 (to K.S.), 25000015 (to M.K.), and 24229003 (to T.S.), and Takeda Science Foundation (to T.S.). CB<INF>1</INF>-KO mice were kindly provided by A. Zimmer (University of Bonn, Bonn, Germany). The authors declare no conflicts of interest.	Abbott CR, 2005, BRAIN RES, V1044, P127, DOI 10.1016/j.brainres.2005.03.011; Agudo J, 2010, DIABETOLOGIA, V53, P2629, DOI 10.1007/s00125-010-1894-6; Bederman IR, 2006, AM J PHYSIOL-ENDOC M, V290, pE1048, DOI 10.1152/ajpendo.00340.2005; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Botham KM, 2013, PROG LIPID RES, V52, P446, DOI 10.1016/j.plipres.2013.06.001; Castro-Perez J, 2011, J LIPID RES, V52, P159, DOI 10.1194/jlr.D009787; Chanda PK, 2010, MOL PHARMACOL, V78, P996, DOI 10.1124/mol.110.068304; Chon SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043962; Derbenev AV, 2016, SEMIN IMMUNOPATHOL, V38, P397, DOI 10.1007/s00281-015-0529-x; Douglass JD, 2015, J LIPID RES, V56, P1153, DOI 10.1194/jlr.M058586; EDWARDS GL, 1986, AM J PHYSIOL, V251, pR971, DOI 10.1152/ajpregu.1986.251.5.R971; Ertunc ME, 2016, J LIPID RES, V57, P2099, DOI 10.1194/jlr.R066514; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Hankir MK, 2017, CELL METAB, V25, P335, DOI 10.1016/j.cmet.2016.12.006; Hansen KB, 2011, J CLIN ENDOCR METAB, V96, pE1409, DOI 10.1210/jc.2011-0647; Harada K, 2003, AM J PHYSIOL-ENDOC M, V285, pE1182, DOI 10.1152/ajpendo.00259.2003; Hashimotodani Y, 2007, J NEUROSCI, V27, P1211, DOI 10.1523/JNEUROSCI.4159-06.2007; Hibuse T, 2005, P NATL ACAD SCI USA, V102, P10993, DOI 10.1073/pnas.0503291102; Jung KM, 2012, CELL METAB, V15, P299, DOI 10.1016/j.cmet.2012.01.021; Kentish SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135892; Kita Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133663; Koda S, 2005, ENDOCRINOLOGY, V146, P2369, DOI 10.1210/en.2004-1266; Lauffer LM, 2009, DIABETES, V58, P1058, DOI 10.2337/db08-1237; LEE JS, 1960, AM J PHYSIOL, V199, P238, DOI 10.1152/ajplegacy.1960.199.2.238; Lo Verme J, 2005, CELL MOL LIFE SCI, V62, P708, DOI 10.1007/s00018-004-4494-0; Neeland IJ, 2018, CIRCULATION, V137, P1391, DOI 10.1161/CIRCULATIONAHA.117.029617; Nelson DW, 2014, J BIOL CHEM, V289, P17338, DOI 10.1074/jbc.M114.555961; Nielsen TS, 2014, J MOL ENDOCRINOL, V52, pR199, DOI 10.1530/JME-13-0277; Nomura DK, 2011, SCIENCE, V334, P809, DOI 10.1126/science.1209200; Osuga J, 2000, P NATL ACAD SCI USA, V97, P787, DOI 10.1073/pnas.97.2.787; Palmer RK, 2013, CURR TOP MED CHEM, V13, P247; Petrosino S, 2016, BRIT J PHARMACOL, V173, P1154, DOI 10.1111/bph.13084; Quarta C, 2010, CELL METAB, V11, P273, DOI 10.1016/j.cmet.2010.02.015; Rachdaoui N, 2009, MOL CELL PROTEOMICS, V8, P2653, DOI 10.1074/mcp.M900026-MCP200; Richey JM, 2017, CURR DIABETES REP, V17, DOI 10.1007/s11892-017-0924-x; Schlosburg JE, 2010, NAT NEUROSCI, V13, P1113, DOI 10.1038/nn.2616; Schmitz K, 2016, INT J OBESITY, V40, P366, DOI 10.1038/ijo.2015.169; SCHOTZ MC, 1957, AM J PHYSIOL, V188, P399, DOI 10.1152/ajplegacy.1957.188.2.399; Schwartz GJ, 2008, CELL METAB, V8, P281, DOI 10.1016/j.cmet.2008.08.005; Skibicka KP, 2013, CURR OPIN PHARMACOL, V13, P977, DOI 10.1016/j.coph.2013.09.004; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Taschler U, 2015, BRIT J PHARMACOL, V172, P4419, DOI 10.1111/bph.13224; Taschler U, 2011, J BIOL CHEM, V286, P17467, DOI 10.1074/jbc.M110.215434; Trillou CR, 2004, INT J OBESITY, V28, P640, DOI 10.1038/sj.ijo.0802583; Uchigashima M, 2011, J NEUROSCI, V31, P7700, DOI 10.1523/JNEUROSCI.5665-10.2011; Verty ANA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140592; Vujic N, 2017, ONCOTARGET, V8, P33122, DOI 10.18632/oncotarget.16529; Yen CLE, 2015, J LIPID RES, V56, P489, DOI 10.1194/jlr.R052902; Yen CLE, 2009, NAT MED, V15, P442, DOI 10.1038/nm.1937; Zhang XY, 2016, CELL PHYSIOL BIOCHEM, V40, P1175, DOI 10.1159/000453171; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780; Zygmunt PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081618	53	17	17	2	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2484	2497		10.1096/fj.201801203R	http://dx.doi.org/10.1096/fj.201801203R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30265576				2022-12-26	WOS:000457296600076
J	Zheng, W; Wang, KR; Sun, YJ; Kuo, SM				Zheng, Wei; Wang, Kairui; Sun, Yijun; Kuo, Shiu-Ming			Dietary or supplemental fermentable fiber intake reduces the presence of Clostridium XI in mouse intestinal microbiota: The importance of higher fecal bacterial load and density	PLOS ONE			English	Article							DIFFICILE INFECTION; GUT MICROBIOTA; COLONIZATION RESISTANCE; INULIN; OLIGOSACCHARIDES; TRANSPLANTATION; RECURRENCE; SEQUENCES; PROFILES; THERAPY	Objectives Clostridium difficile infection is a public health concern. C. difficile was found in healthy human intestine as a member of Clostridium XI. Because soluble fermentable fiber ingestion affects intestinal microbiota, we used fiber-containing diets to determine the intestinal microbial condition that could reduce the presence of Clostridium XI. Methods Newly weaned male mice were assigned to three published diets: Control AIN-93G purified diet with only poorly fermented cellulose; Control plus 5% purified fermentable fiber inulin; Chow with wheat, soybean and corn that provide a mixture of unpurified dietary fibers. Methods were developed to quantify 24-hour fecal microbial load and microbial DNA density. The relative abundance of bacterial genera and the bacterial diversity were determined through 16S rRNA sequence-based fecal microbiota analysis. Results Mice adjusted food intake to maintain the same energy intake and body weight under these three moderate-fat (7% w:w) diets. Chow-feeding led to higher food intake but also higher 24-h fecal output. Chow-feeding and 1-8 wk ingestion of inulin-supplemented diet increased daily fecal microbial load and density along with lowering the prevalence of Clostridium XI to undetectable. Clostridium XI remained undetectable until 4 weeks after the termination of inulin-supplemented diet. Fermentable fiber intake did not consistently increase probiotic genera such as Bifidobacterium or Lactobacillus. Chow feeding, but not inulin supplementation, increased the bacterial diversity. Conclusions Increase fecal microbial load/density upon fermentable fiber ingestion is associated with a lower and eventually undetectable presence of Clostridium XI. Higher bacterial diversity or abundance of particular genera is not apparently essential. Future studies are needed to see whether this observation can be translated into the reduction of C. difficile at the species level in at-risk populations.	[Zheng, Wei; Sun, Yijun] Univ Buffalo, Dept Comp Sci & Engn, Buffalo, NY USA; [Wang, Kairui; Kuo, Shiu-Ming] Univ Buffalo, Dept Exercise & Nutr Sci, Buffalo, NY 14260 USA; [Sun, Yijun] Univ Buffalo, Dept Microbiol & Immunol, Buffalo, NY USA; [Sun, Yijun] Univ Buffalo, Dept Biostat, Buffalo, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Kuo, SM (corresponding author), Univ Buffalo, Dept Exercise & Nutr Sci, Buffalo, NY 14260 USA.	smkuo@buffalo.edu			University at Buffalo; National Institute of Health [NIH 1R01AI125982-01, NIH 1R01DE024523]	University at Buffalo; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding sources include University at Buffalo, and National Institute of Health through the following two grant support: NIH 1R01AI125982-01 (YJS); NIH 1R01DE024523-01(YJS).	Adlerberth I, 2014, J CLIN MICROBIOL, V52, P173, DOI 10.1128/JCM.01701-13; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Borgia G, 2015, EXPERT OPIN BIOL TH, V15, P1001, DOI 10.1517/14712598.2015.1045872; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carroll IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046953; Cock PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/nar/gkp1137; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; Dantes R, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv113; Dapa T, 2013, J BACTERIOL, V195, P545, DOI 10.1128/JB.01980-12; David LA, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-7-r89; Drenowatz C, 2015, ADV NUTR, V6, P592, DOI 10.3945/an.115.008615; Perez-Cobas AE, 2015, ANTIBIOTICS-BASEL, V4, P337, DOI 10.3390/antibiotics4030337; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Ghaffarzadegan T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157427; Giel JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008740; Hopkins MJ, 2003, APPL ENVIRON MICROB, V69, P1920, DOI 10.1128/AEM.69.4.1920-1927.2003; Hsieh YH, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01643; Kirk RE, 2013, EXPERIMENTAL DESIGN, P154; KOCH AL, 1970, ANAL BIOCHEM, V38, P252, DOI 10.1016/0003-2697(70)90174-0; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Koleva PT, 2012, BRIT J NUTR, V108, P1633, DOI 10.1017/S0007114511007203; Konstantinov SR, 2003, FEMS MICROBIOL ECOL, V43, P225, DOI 10.1111/j.1574-6941.2003.tb01062.x; Kuo SM, 2018, CURR DEV NUTR, V2, DOI 10.3945/cdn.117.001180; Kuo SM, 2014, J NUTR, V144, P245, DOI 10.3945/jn.113.185249; Kuo SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060270; Kuo SM, 2004, J NUTR, V134, P2216; Liu TW, 2016, J NUTR, V146, P949, DOI 10.3945/jn.115.227504; Lopetuso LR, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-23; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ma GK, 2017, ANN INTERN MED, V167, P152, DOI [10.7326/M16-2733, 10.7326/m16-2733]; Mai V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052876; Masso-Welch PA, 2012, IMMUNOL INVEST, V41, P521, DOI 10.3109/08820139.2012.684193; Matsumoto K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175406; McClane B. A., 2006, Gram-positive pathogens, P703; McGill CR, 2016, FOOD NUTR RES, V60, DOI 10.3402/fnr.v60.29977; Myint H, 2017, ANIM SCI J; Myllyluoma E, 2007, DIGEST LIVER DIS, V39, P516, DOI 10.1016/j.dld.2007.02.015; Myllyluoma E, 2005, ALIMENT PHARM THER, V21, P1263, DOI 10.1111/j.1365-2036.2005.02448.x; Navarro D, 2018, J ANIM SCI; Niness KR, 1999, J NUTR, V129, p1402S, DOI 10.1093/jn/129.7.1402S; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Paul HA, 2016, SCI REP-UK, V6, DOI 10.1038/srep20683; Penders J, 2005, FEMS MICROBIOL LETT, V243, P141, DOI 10.1016/j.femsle.2004.11.052; Peretz A, 2016, CURR MED CHEM, V23, P4442, DOI 10.2174/0929867323666161028162018; Razik R, 2016, AM J GASTROENTEROL, V111, P1141, DOI 10.1038/ajg.2016.187; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Roberfroid MB, 2005, BRIT J NUTR, V93, pS13, DOI 10.1079/BJN20041350; Shahinas D, 2012, MBIO, V3, DOI 10.1128/mBio.00338-12; So D, 2018, AM J CLIN NUTR, V107, P965, DOI 10.1093/ajcn/nqy041; Sorg JA, 2010, J BACTERIOL, V192, P4983, DOI 10.1128/JB.00610-10; Sullivan KM, 2010, ANN PHARMACOTHER, V44, P352, DOI 10.1345/aph.1M351; Surawicz CM, 2013, AM J GASTROENTEROL, V108, P478, DOI 10.1038/ajg.2013.4; Swanson KS, 2001, J ANIM SCI, V79, P919; Tschudin-Sutter S, 2014, PEDIATR INFECT DIS J, V33, P414, DOI 10.1097/INF.0000000000000108; Umu OCO, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0078-5; Vandeputte D, 2017, NATURE, V551, P507, DOI 10.1038/nature24460; Weingarden AR, 2014, AM J PHYSIOL-GASTR L, V306, pG310, DOI 10.1152/ajpgi.00282.2013; Yu YJ, 2008, CANCER EPIDEM BIOMAR, V17, P455, DOI 10.1158/1055-9965.EPI-07-2515; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593; Zhang LH, 2015, ANAEROBE, V34, P1, DOI 10.1016/j.anaerobe.2015.03.008; Zheng W, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0110-9	62	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0205055	10.1371/journal.pone.0205055	http://dx.doi.org/10.1371/journal.pone.0205055			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3QJ	30278071	Green Submitted, Green Published, gold			2022-12-26	WOS:000446010200037
J	Kalkowski, L; Malysz-Cymborska, I; Golubczyk, D; Janowski, M; Holak, P; Milewska, K; Kedziorek, D; Adamiak, Z; Maksymowicz, W; Walczak, P				Kalkowski, Lukasz; Malysz-Cymborska, Izabela; Golubczyk, Dominika; Janowski, Miroslaw; Holak, Piotr; Milewska, Kamila; Kedziorek, Dorota; Adamiak, Zbigniew; Maksymowicz, Wojciech; Walczak, Piotr			MRI-guided intracerebral convection-enhanced injection of gliotoxins to induce focal demyelination in swine	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; BRAIN; DELIVERY; CELLS; ENCEPHALOMYELITIS; REMYELINATION; MONKEYS; LESIONS; RESCUE; TISSUE	Demyelinating disorders such as multiple sclerosis (MS) or transverse myelitis are devastating neurological conditions with no effective cure. Prevention of myelin loss or restoration of myelin are key for successful therapy. To investigate the disease and develop cures animal models with good clinical relevance are essential. The goal of the current study was to establish a model of focal demyelination in the brain of domestic pig using MRI-guided gliotoxin delivery. The rationale for developing a new myelin disease model in the domestic pig was based on the fact that the brain in pigs is anatomically and histologically much more similar to that of humans compared to the rodent brain. For MRI-assisted gliotoxin injection, eight 30 kg pigs were subjected to treatment with lysolecithin (20, 30 mg/ml); or with ethidium bromide (0.0125, 0.05, 0.2 mg/ml). Animals were placed in an MRI scanner for intraparenchymal targeting of gliotoxin into the corona radiata (250 mu l over 1 h), with real-time monitoring of toxin distribution on T1 scans and monitoring of lesion evolution over seven days using both T1 and T2 scans. After the last MRI, animals were transcardially perfused and brains were processed for histological and immunofluorescent analysis. Gadolinium-enhanced T1 MRI during injection demonstrated biodistribution of the contrast (as a surrogate marker for toxin distribution) and its diffusion through the brain parenchyma. Lesion induction was confirmed on T2-weighted MRI and histopathology, thus enabling the establishment of optimal doses of gliotoxins. To conclude, MRI-guided focal demyelination in swine is accurate and provides real-time confirmation of gliotoxin, thus facilitating placement of focal lesions with high precision. This new model of focal demyelination can be used for further investigation and development of novel therapeutic approaches.	[Kalkowski, Lukasz; Malysz-Cymborska, Izabela; Golubczyk, Dominika; Milewska, Kamila; Maksymowicz, Wojciech; Walczak, Piotr] Univ Warmia & Mazury, Fac Med Sci, Dept Neurol & Neurosurg, Olsztyn, Poland; [Janowski, Miroslaw] Polish Acad Sci, Mossakowski Med Res Ctr, NeuroRepair Dept, Warsaw, Poland; [Janowski, Miroslaw; Kedziorek, Dorota; Walczak, Piotr] Johns Hopkins Univ, Sch Med, Cellular Imaging Sect, Inst Cell Engn, Baltimore, MD 21218 USA; [Janowski, Miroslaw; Kedziorek, Dorota; Walczak, Piotr] Johns Hopkins Univ, Sch Med, Dept Radiol & Radiol Sci, Div Russell H Morgan, Baltimore, MD 21218 USA; [Holak, Piotr; Adamiak, Zbigniew] Univ Warmia & Mazury, Fac Vet Med, Dept Surg & Radiol, Olsztyn, Poland	University of Warmia & Mazury; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; Johns Hopkins University; Johns Hopkins University; University of Warmia & Mazury	Walczak, P (corresponding author), Univ Warmia & Mazury, Fac Med Sci, Dept Neurol & Neurosurg, Olsztyn, Poland.; Walczak, P (corresponding author), Johns Hopkins Univ, Sch Med, Cellular Imaging Sect, Inst Cell Engn, Baltimore, MD 21218 USA.; Walczak, P (corresponding author), Johns Hopkins Univ, Sch Med, Dept Radiol & Radiol Sci, Div Russell H Morgan, Baltimore, MD 21218 USA.	pwalczak@mri.jhu.edu	Adamiak, Zbigniew/ABG-6173-2020; adamiak, zbigniew/ABD-4580-2021	Adamiak, Zbigniew/0000-0001-8350-0198; Walczak, Piotr/0000-0002-3733-3322; Malysz-Cymborska, Izabela/0000-0003-4192-6726; Golubczyk, Dominika/0000-0001-5692-6329; Janowski, Miroslaw/0000-0001-5261-7975; Holak, Piotr/0000-0002-2050-1959	National Institutes of Health [R01 NS091100, R01 NS091110, R01 NS076573, 2017-MSCRFD-3942]; Narodowe Centrum Badan i Rozwoju [1/233209/12/NCBIR/2015]; National Center for Research and Development [1/2352773/19/NCBR/2016, 12-/EuroNanoMed/2016]; NIH/NINDS [R01NS091110, R01NS091100, R01NS076573]; NIH [MSCRFD-3942]; National Centre for Research and Development [1/2352773/19/NCBR/2016, 12-/EuroNanoMed/2016, STRATEGMED1/233205/12/NCBR/2015]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076573, R01NS091100, R01NS091110] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Narodowe Centrum Badan i Rozwoju(National Centre for Research & Development, Poland); National Center for Research and Development(National Centre for Research & Development, Poland); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Centre for Research and Development(National Centre for Research & Development, Poland); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health- R01 NS091100; Piotr Walczak is reciever, National Institutes of Health- R01 NS091110; Piotr Walczak is reciever, National Institutes of Health- R01 NS076573; Piotr Walczak is reciever, Narodowe Centrum Badan i Rozwoju-Strategmed 1/233209/12/NCBIR/2015; Piotr Walczak is reciever, National Institutes of Health - 2017-MSCRFD-3942, National Center for Research and Development - Strategmed 1/2352773/19/NCBR/2016, National Center for Research and Development - Strategmed 12-/EuroNanoMed/2016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by NIH/NINDS (R01NS091110, R01NS091100, R01NS076573), NIH (MSCRFD-3942), National Centre for Research and Development (STRATEGMED1/233205/12/NCBR/2015, 1/2352773/19/NCBR/2016, 12-/EuroNanoMed/2016). The authors have declared that no competing interests exist.	Bankiewicz KS, 2000, EXP NEUROL, V164, P2, DOI 10.1006/exnr.2000.7408; Baxter AG, 2007, NAT REV IMMUNOL, V7, P904, DOI 10.1038/nri2190; Bieber AJ, 2003, ANN NEUROL, V53, P680, DOI 10.1002/ana.10578; Blakemore WF, 2008, CURR TOP MICROBIOL, V318, P193; BOBO RH, 1994, P NATL ACAD SCI USA, V91, P2076, DOI 10.1073/pnas.91.6.2076; Denic Aleksandar, 2011, Pathophysiology, V18, P21, DOI 10.1016/j.pathophys.2010.04.004; Ding D, 2010, J NEURO-ONCOL, V98, P1, DOI 10.1007/s11060-009-0046-7; Felix B, 1999, BRAIN RES BULL, V49, P1, DOI 10.1016/S0361-9230(99)00012-X; Gorelik M, 2012, RADIOLOGY, V265, P175, DOI 10.1148/radiol.12112212; HALL SM, 1972, J CELL SCI, V10, P535; Holm IE, 2016, J PATHOL, V238, P267, DOI 10.1002/path.4654; Janowski M, 2016, J CEREBR BLOOD F MET, V36, P569, DOI 10.1177/0271678X15615875; Kalincik T, 2015, NEUROEPIDEMIOLOGY, V44, P199, DOI 10.1159/000382130; Kantorovich S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080606; Kerr DA, 2002, CURR OPIN NEUROL, V15, P339, DOI 10.1097/00019052-200206000-00019; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Lyczek A, 2017, EXP NEUROL, V291, P74, DOI 10.1016/j.expneurol.2017.02.005; Merkler D, 2006, BRAIN, V129, P1972, DOI 10.1093/brain/awl135; Milo R, 2014, AUTOIMMUN REV, V13, P518, DOI 10.1016/j.autrev.2014.01.012; Nduom EK, 2012, J NEUROSURG, V117, P1150, DOI 10.3171/2012.9.JNS12506; Nichols NL, 2013, NEUROSCIENCE, V229, P77, DOI 10.1016/j.neuroscience.2012.10.066; Qin HM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169656; Rivers TM, 1933, J EXP MED, V58, P39, DOI 10.1084/jem.58.1.39; Samaranch L, 2016, GENE THER, V23, P393, DOI 10.1038/gt.2015.87; Sampson John H, 2006, Neurosurg Focus, V20, pE14, DOI 10.3171/foc.2006.20.4.9; Sirianni RW, 2014, BIOCONJUGATE CHEM, V25, P2157, DOI 10.1021/bc500315j; Walczak P, 2011, GLIA, V59, P499, DOI 10.1002/glia.21119; Windrem MS, 2008, CELL STEM CELL, V2, P553, DOI 10.1016/j.stem.2008.03.020; Yin D, 2013, CANCER GENE THER, V20, P336, DOI 10.1038/cgt.2013.25	29	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204650	10.1371/journal.pone.0204650	http://dx.doi.org/10.1371/journal.pone.0204650			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273376	gold, Green Submitted, Green Published			2022-12-26	WOS:000446124700030
J	Niwa, H; Ozawa, R; Kurahashi, Y; Kumamoto, T; Nakanishi, Y; Okumura, K; Matsuda, I; Ishida, Y; Hirota, S; Shinohara, H				Niwa, Hirotaka; Ozawa, Rie; Kurahashi, Yasunori; Kumamoto, Tsutomu; Nakanishi, Yasutaka; Okumura, Koichi; Matsuda, Ikuo; Ishida, Yoshinori; Hirota, Seiichi; Shinohara, Hisashi			The eCura system as a novel indicator for the necessity of salvage surgery after non-curative ESD for gastric cancer: A case-control study	PLOS ONE			English	Article							ENDOSCOPIC SUBMUCOSAL DISSECTION; RISK-FACTORS; RESECTION; CRITERIA; OUTCOMES; JAPAN	Endoscopic submucosal dissection (ESD) for early gastric cancer does not always lead to complete cancer resection. The aim of this study was to determine indicators for cancer residue (CR) status in cases of non-curative ESD. We analyzed 47 cases of non-curative ESD followed by salvage surgery and collected data regarding the rates of CR, which included both local CR and lymph node metastasis (LNM). To elucidate the risk factors for CR status, we compared the CR positive and the CR negative groups among surgical specimens according to the following variables obtained from ESD findings: tumor location, tumor size, depth of invasion, lympho-vascular invasion, histological margin, and histological diagnosis. The eCura system, which is an LNM risk scoring system, was also applied and scores were calculated in each case as follows: 3 points for lymphatic invasion and 1 point each for tumor size >30 mm, positive vertical margin, venous invasion, and submucosal invasion >= 500 mu m. There were 9 (19%) CR positive cases, which included 6 cases of local CR and 4 cases of LNM; no cancer was detected in over 80% of the patients. The eCura scoring system was the only significant factor for CR status: the higher the eCura score, the greater the CR positivity (p = 0.0128). In particular, all patients in the low-risk group (score = 0-1 point) had no CR. Although no cancer recurrence was observed during a median follow-up of 4 years, 2 patients died of pneumonia. In conclusion, the eCura system might make it possible to select appropriate cases for salvage surgery.	[Niwa, Hirotaka; Ozawa, Rie; Kurahashi, Yasunori; Kumamoto, Tsutomu; Nakanishi, Yasutaka; Okumura, Koichi; Ishida, Yoshinori; Shinohara, Hisashi] Hyogo Coll Med, Dept Surg, Nishinomiya, Hyogo, Japan; [Matsuda, Ikuo; Hirota, Seiichi] Hyogo Coll Med, Dept Surg Pathol, Nishinomiya, Hyogo, Japan	Hyogo College of Medicine; Hyogo College of Medicine	Niwa, H (corresponding author), Hyogo Coll Med, Dept Surg, Nishinomiya, Hyogo, Japan.	hironiwa@hyo-med.ac.jp			JSPS KAKENHI [16H05399]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 16H05399. No additional external or internal funding was received for this study other than this grant.	Choi JY, 2015, SURG ENDOSC, V29, P1842, DOI 10.1007/s00464-014-3874-2; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Eom BW, 2017, GASTROINTEST ENDOSC, V85, P155, DOI 10.1016/j.gie.2016.07.036; Gotoda T, 2006, J GASTROENTEROL, V41, P929, DOI 10.1007/s00535-006-1954-3; Hatta W, 2018, GASTRIC CANCER, V21, P481, DOI 10.1007/s10120-017-0769-7; Hatta W, 2017, AM J GASTROENTEROL, V112, P874, DOI 10.1038/ajg.2017.95; Hatta W, 2017, J GASTROENTEROL, V52, P175, DOI 10.1007/s00535-016-1210-4; Ito H, 2018, SURG ENDOSC, V32, P196, DOI 10.1007/s00464-017-5659-x; Japanese Gastr Canc Assoc, 2021, GASTRIC CANCER, V24, P1, DOI [10.1007/s10120-020-01042-y, 10.1007/s10120-016-0622-4]; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Kim ER, 2015, BRIT J SURG, V102, P1394, DOI 10.1002/bjs.9873; Lee JH, 2013, PATHOL RES PRACT, V209, P314, DOI 10.1016/j.prp.2013.02.014; McCall MD, 2016, WORLD J GASTROENTERO, V22, P1101, DOI 10.3748/wjg.v22.i3.1101; Takizawa K, 2013, GASTRIC CANCER, V16, P531, DOI 10.1007/s10120-012-0220-z; Tanabe S, 2017, GASTRIC CANCER, V20, P834, DOI 10.1007/s10120-017-0699-4; Tanabe S, 2017, GASTRIC CANCER, V20, pS45, DOI 10.1007/s10120-016-0664-7; Tomita T, 2012, J GASTROEN HEPATOL, V27, P1441, DOI 10.1111/j.1440-1746.2012.07144.x; Toyokawa T, 2016, SURG ENDOSC, V30, P2404, DOI 10.1007/s00464-015-4491-4; Toyokawa T, 2015, EXP THER MED, V9, P1209, DOI 10.3892/etm.2015.2265; Yamada T, 2014, GASTRIC CANCER, V17, P692, DOI 10.1007/s10120-013-0323-1; Zozumi M, 2010, J CLIN PATHOL, V63, P904, DOI 10.1136/jcp.2010.078980	21	13	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204039	10.1371/journal.pone.0204039	http://dx.doi.org/10.1371/journal.pone.0204039			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273388	Green Submitted, Green Published, gold			2022-12-26	WOS:000446124700013
J	Jarman, SK; Haney, AM; Valdez, GR				Jarman, Sorscha K.; Haney, Alison M.; Valdez, Glenn R.			Kappa opioid regulation of depressive-like behavior during acute withdrawal and protracted abstinence from ethanol	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; ANXIETY-LIKE BEHAVIOR; DEPENDENT RATS; ENHANCED RESPONSIVENESS; RECEPTOR ANTAGONIST; ANIMAL-MODEL; ALCOHOL; EXPOSURE; DRINKING; ACTIVATION	The dynorphin/kappa opioid receptor (DYN/KOR) system appears to be a key mediator of the behavioral effects of chronic exposure to alcohol. Although KOR opioid receptor antagonists have been shown to decrease stress-related behaviors in animal models during acute ethanol withdrawal, the role of the DYN/KOR system in regulating long-term behavioral changes following protracted abstinence from ethanol is not well understood. The objective of the current study was to further explore the role of the DYN/KOR system in regulating stress-related behavioral changes associated with acute withdrawal and protracted abstinence from ethanol. More specifically, the present experiments sought to examine the ability of the KOR antagonist norbinaltorphimine (nor-BNI) to reverse depressive-like behavior in the forced swim test in rats exposed to chronic ethanol.In the first experiment, rats were fed an ethanol or control liquid diet for 28-30 days, and then 24 hours after removal of the diet, were exposed to inescapable swim stress. Immediately following this procedure, rats were injected with nor-BNI (20 mg/kg) or saline and then tested 24 hours later in the forced swim test. A second experiment used a similar procedure to examine the effects of nor-BNI on behavioral changes during protracted abstinence in rats tested in the forced swim test 3 weeks after exposure to the ethanol liquid diet procedure. Ethanol-dependent rats showed increased immobility, which is thought to indicate a depressive-like state, when examined during acute withdrawal and protracted abstinence compared to controls, an effect attenuated by nor-BNI. These results suggest that the DYN/KOR system plays role in mediating both short- and long-term behavioral changes associated with depression following chronic alcohol exposure.	[Jarman, Sorscha K.; Haney, Alison M.; Valdez, Glenn R.] Grand Valley State Univ, Dept Psychol, Allendale, MI 49401 USA; [Haney, Alison M.] Purdue Univ, Dept Psychol, W Lafayette, IN 47907 USA	Grand Valley State University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Valdez, GR (corresponding author), Grand Valley State Univ, Dept Psychol, Allendale, MI 49401 USA.	valdezg@gvsu.edu		Valdez, Glenn/0000-0001-8337-1760; Haney, Alison/0000-0002-4257-4593	National Institute on Alcohol Abuse and Alcoholism [R15 AA018213]; Center for Scholarly and Creative Excellence at Grand Valley State University; Grand Valley State University TRIO McNair Scholars Program	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Center for Scholarly and Creative Excellence at Grand Valley State University; Grand Valley State University TRIO McNair Scholars Program	This work was supported by R15 AA018213 from the National Institute on Alcohol Abuse and Alcoholism (GRV), the Center for Scholarly and Creative Excellence at Grand Valley State University (GRV), and the Grand Valley State University TRIO McNair Scholars Program (GRV, SKJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RI, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00045; Annis HM, 1998, ADDICT BEHAV, V23, P127, DOI 10.1016/S0306-4603(97)00024-5; BEGLEITER H, 1979, DRUG ALCOHOL DEPEN, V4, P353, DOI 10.1016/0376-8716(79)90019-X; Bruchas MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008528; Carr GV, 2010, NEUROPSYCHOPHARMACOL, V35, P752, DOI 10.1038/npp.2009.183; CLONINGER CR, 1987, SCIENCE, V236, P410, DOI 10.1126/science.2882604; Cottone P, 2009, PSYCHONEUROENDOCRINO, V34, P38, DOI 10.1016/j.psyneuen.2008.08.010; DESOTO CB, 1989, ALCOHOL CLIN EXP RES, V13, P693; ENDOH T, 1992, ARCH INT PHARMACOD T, V316, P30; Gillett K, 2013, ALCOHOL, V47, P359, DOI 10.1016/j.alcohol.2013.05.001; Harshberger E, 2016, J ADDICT, DOI [10.1155/2016/1084235, DOI 10.1155/2016/1084235]; HERSHON HI, 1977, J STUD ALCOHOL, V38, P953, DOI 10.15288/jsa.1977.38.953; Holleran KM, 2016, NEUROPSYCHOPHARMACOL, V41, P2062, DOI 10.1038/npp.2016.3; JACKISCH R, 1986, J NEUROCHEM, V46, P1802; Kissler JL, 2016, NEUROPSYCHOPHARMACOL, V41, P560, DOI 10.1038/npp.2015.183; Laorden ML, 2000, ENDOCRINOLOGY, V141, P1366, DOI 10.1210/en.141.4.1366; Macey DJ, 1996, ALCOHOL, V13, P163, DOI 10.1016/0741-8329(95)02030-6; Mague SD, 2003, J PHARMACOL EXP THER, V305, P323, DOI 10.1124/jpet.102.046433; Nealey KA, 2011, NEUROPHARMACOLOGY, V61, P35, DOI 10.1016/j.neuropharm.2011.02.012; Pang TY, 2013, EUR J NEUROSCI, V37, P1803, DOI 10.1111/ejn.12195; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Rasmussen DD, 2001, ALCOHOL CLIN EXP RES, V25, P999, DOI 10.1097/00000374-200107000-00008; Reyes BAS, 2008, J COMP NEUROL, V508, P663, DOI 10.1002/cne.21683; Ribeiro-Carvalho A, 2011, BEHAV BRAIN RES, V221, P282, DOI 10.1016/j.bbr.2011.03.014; Roberts AJ, 2000, NEUROPSYCHOPHARMACOL, V22, P581, DOI 10.1016/S0893-133X(99)00167-0; ROELOFS SMGJ, 1985, ALCOHOL, V2, P501, DOI 10.1016/0741-8329(85)90123-5; Rorick-Kehn LM, 2014, NEUROPHARMACOLOGY, V77, P131, DOI 10.1016/j.neuropharm.2013.09.021; ROTH KA, 1983, SCIENCE, V219, P189, DOI 10.1126/science.6129700; Schank JR, 2012, ADDICT BIOL, V17, P634, DOI 10.1111/j.1369-1600.2012.00455.x; Schulteis G, 1996, ALCOHOL CLIN EXP RES, V20, P164, DOI 10.1111/j.1530-0277.1996.tb01060.x; South T, 2012, PHYSIOL BEHAV, V105, P1052, DOI 10.1016/j.physbeh.2011.11.019; Valdez GR, 2007, J PHARMACOL EXP THER, V323, P525, DOI 10.1124/jpet.107.125484; Valdez GR, 2012, PHARMACOL BIOCHEM BE, V102, P44, DOI 10.1016/j.pbb.2012.03.019; Valdez GR, 2002, ALCOHOL CLIN EXP RES, V26, P1494, DOI 10.1097/01.ALC.0000033120.51856.F0; Valdez GR, 2003, ALCOHOL, V29, P55, DOI 10.1016/S0741-8329(03)00020-X; Valdez GR, 2004, ALCOHOL CLIN EXP RES, V28, P865, DOI 10.1097/01.ALC.0000128222.29875.40; Walker BM, 2010, ADDICT BIOL, V16; Walker BM, 2008, NEUROPSYCHOPHARMACOL, V33, P643, DOI 10.1038/sj.npp.1301438; Walker BM, 2012, ALCOHOL, V46, P359, DOI 10.1016/j.alcohol.2011.10.006; Walker BM, 2010, ALCOHOL, V44, P487, DOI 10.1016/j.alcohol.2010.06.006; Zorrilla EP, 2001, PSYCHOPHARMACOLOGY, V158, P374, DOI 10.1007/s002130100773	41	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0205016	10.1371/journal.pone.0205016	http://dx.doi.org/10.1371/journal.pone.0205016			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265734	Green Published, gold			2022-12-26	WOS:000446005500061
J	Kaur, H; Badaruddoza, B; Bains, V; Kaur, A				Kaur, Harjit; Badaruddoza, Badaruddoza; Bains, Veena; Kaur, Anupam			Genetic association of ADIPOQ gene variants (-3971A > G and+276G > T) with obesity and metabolic syndrome in North Indian Punjabi population	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; BODY-MASS INDEX; ADIPONECTIN GENE; INSULIN-RESISTANCE; APM1 GENE; PLASMA ADIPONECTIN; PROXIMAL PROMOTER; WAIST/HIP RATIO; COMMON VARIANTS; RISK-FACTORS	Background and aims At present obesity and metabolic syndrome (MetS) in India are the most challenging health problems. It is also well accepted that obesity is a significant risk factor for the development of metabolic syndrome and other degenerative diseases. Many studies have reported that single-nucleotide polymorphisms (SNPs) of the adiponectin (ADIPOQ) gene have been associated with obesity and its related disorders. Here, we aimed to investigate the association of two intronic variants in ADIPOQ gene, -3971A>G (rs822396) and +276G>T (rs1501299) with obesity and metabolic syndrome. Methods Biochemical and anthropometric measurements were obtained from a total of 550 unrelated subjects (obese = 250 and non-obese = 300) of North Indian Punjabi population. Genotyping for the intron variants were performed by polymerase chain reaction based restriction fragment length polymorphism (PCR-RFLP) methods. After genotyping, as a quality control measure 10% of the samples for each polymorphism were confirmed by Sanger Sequencing method. The distributions of genotypic and allelic frequencies among obese and non-obese groups were compared by chi-square test and the corresponding risk was calculated using binary logistic regression. The effects of multiple testing were controlled by applying Bonferroni corrections. Results All the anthropometric and biochemical parameters except triglycerides (TG) and very low-density lipoproteins cholesterol (VLDL-C) have shown significant association with both GG and TT genotypes of -3971A>G (rs822396) and +276G>T (rs1501299) polymorphisms respectively. The frequencies of GG (-3971A>G) and TT (+276G>T) genotypes were higher among obese cases (p = 0.008 and p = 0.035 respectively). However, no significant association was found between allelic frequencies of ADIPOQ rs822396 and obesity, whereas the 16 association of ADIPOQ rs1501299 attenuated and became marginally significant after Bonferroni correction (p>0.025). Both the variant genotypes of ADIPOQ gene polymorphisms (-3971GG and +276TT) significantly increased the risk of development of obesity (OR: 1.52, p = 0.03; OR: 1.58, p = 0.04 respectively) and MetS (OR: 1.42, p = 0.03; OR: 1.57, p = 0.01 respectively) in the present population, after adjusting the various covariates. The G-T haplotype model (possessing -3971G and +276T alleles) was shown to provide similar to 3 fold risk towards the obesity susceptibility (OR: 2.69, p = 0.009) and MetS risk (OR: 2.73, p = 0.009) and the association persisted after adjusting for different confounding variables. Conclusion The present study has confirmed that ADIPOQ -3971A>G (rs822396) and +276G>T (rs1501299) polymorphism may be clinically helpful to estimate obesity and MetS risk in North Indian Punjabi population.	[Kaur, Harjit; Badaruddoza, Badaruddoza; Bains, Veena; Kaur, Anupam] Guru Nanak Dev Univ, Dept Human Genet, Amritsar, Punjab, India	Guru Nanak Dev University	Badaruddoza, B (corresponding author), Guru Nanak Dev Univ, Dept Human Genet, Amritsar, Punjab, India.	doza13@yahoo.co.in		, Badaruddoza/0000-0002-8082-1356	University Grants Commission (UGC), New Delhi, under General Development Assistance Scheme during XIIth plan [3-1/2012 (SU)-1]	University Grants Commission (UGC), New Delhi, under General Development Assistance Scheme during XIIth plan	The present work was funded by University Grants Commission (UGC), New Delhi, under General Development Assistance Scheme during XIIth plan (Grant No. F.No.3-1/2012 (SU)-1).	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Apalasamy YD, 2014, MOL BIOL REP, V41, P2917, DOI 10.1007/s11033-014-3147-0; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Badaruddoza, 2015, J ADV RES, V6, P739, DOI 10.1016/j.jare.2014.04.002; Badaruddoza, 2009, ANTHROPOL ANZ, V67, P111, DOI 10.1127/0003-5548/2009/0014; Badaruddoza, 2014, EGYPT J APPL SCI, V2, P13, DOI [10.1016/J.EJBAS.2014.11.002, DOI 10.1016/J.EJBAS.2014.11.002]; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Berthier MT, 2005, J LIPID RES, V46, P237, DOI 10.1194/jlr.M400135-JLR200; Bouatia-Naji N, 2006, DIABETES, V55, P545, DOI 10.2337/diabetes.55.02.06.db05-0971; Boumaiza I, 2012, GENET TEST MOL BIOMA, V16, P726, DOI 10.1089/gtmb.2011.0324; Boumaiza I, 2011, METAB SYNDR RELAT D, V9, P419, DOI 10.1089/met.2011.0035; Chauhan G, 2010, DIABETES, V59, P2068, DOI 10.2337/db09-1386; Cheong MY, 2011, YONSEI MED J, V52, P20, DOI 10.3349/ymj.2011.52.1.20; Comuzzie AG, 2001, J CLIN ENDOCR METAB, V86, P4321, DOI 10.1210/jc.86.9.4321; Cross DS, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-51; Cummings DE, 2003, ANNU REV MED, V54, P453, DOI 10.1146/annurev.med.54.101601.152403; Deepa M, 2009, EUR J CLIN NUTR, V63, P259, DOI 10.1038/sj.ejcn.1602920; Dolley G, 2008, INT J OBESITY, V32, P669, DOI 10.1038/sj.ijo.0803773; Filippi E, 2005, J MOL MED, V83, P711, DOI 10.1007/s00109-005-0667-z; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gable DR, 2006, ATHEROSCLEROSIS, V188, P231, DOI 10.1016/j.atherosclerosis.2006.02.010; Gotoda T, 1997, HUM MOL GENET, V6, P869, DOI 10.1093/hmg/6.6.869; Gu HF, 2004, DIABETES, V53, pS31, DOI 10.2337/diabetes.53.2007.S31; Gupta V, 2012, GENET TEST MOL BIOMA, V16, P948, DOI 10.1089/gtmb.2012.0051; Hara K, 2002, DIABETES, V51, P536, DOI 10.2337/diabetes.51.2.536; Heid IM, 2006, DIABETES, V55, P375, DOI 10.2337/diabetes.55.02.06.db05-0747; Henneman P, 2008, J MED GENET, V45, P572, DOI 10.1136/jmg.2008.058388; Hivert MF, 2008, DIABETES, V57, P3353, DOI 10.2337/db08-0700; Hu FB, 2004, DIABETES, V53, P209, DOI 10.2337/diabetes.53.1.209; Jang Y, 2005, AM J CLIN NUTR, V82, P760, DOI 10.1093/ajcn/82.4.760; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kalnina I, 2009, P LAV ACAD SCI, V63, P174, DOI [10.2478/v10046-009-0046-1, DOI 10.2478/V10046-009-0046-1]; Kang ES, 2005, DIABETES CARE, V28, P1139, DOI 10.2337/diacare.28.5.1139; Karmelic I, 2012, ARCH MED RES, V43, P145, DOI 10.1016/j.arcmed.2012.02.004; Krizova J, 2008, PHYSIOL RES, V57, P539, DOI 10.33549/physiolres.931195; Li P, 2015, EUR J CLIN NUTR, V69, P62, DOI 10.1038/ejcn.2014.152; Lu HY, 2007, DIABETES METAB SYND, V1, P259, DOI 10.1016/j.dsx.2007.09.008; Luke A, 2003, DIABETES, V52, P1284, DOI 10.2337/diabetes.52.5.1284; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Matsubara M, 2002, EUR J ENDOCRINOL, V147, P173, DOI 10.1530/eje.0.1470173; Menzaghi C, 2002, DIABETES, V51, P2306, DOI 10.2337/diabetes.51.7.2306; Misra A, 2009, J Assoc Physicians India, V57, P163; Mohammadzadeh Ghorban, 2016, Iranian Biomedical Journal, V20, P152, DOI 10.7508/ibj.2016.03.004; MOHAN V, 1986, DIABETOLOGIA, V29, P235, DOI 10.1007/BF00454882; Mohan V, 2004, J Assoc Physicians India, V52, P95; Mtiraoui N, 2012, DIABETES RES CLIN PR, V97, P290, DOI 10.1016/j.diabres.2012.02.015; Mullican DR, 2009, DIABETES CARE, V32, P1870, DOI 10.2337/dc09-0328; Newell Astrid, 2007, Prev Chronic Dis, V4, pA31; Ogundele OE., 2018, EGYPT J MED HUM GENE, V19, P123, DOI [DOI 10.1016/J.EJMHG.2017.08.005, 10.1016/j.ejm-hg.2017.08.005]; Okamoto Y, 2006, CLIN SCI, V110, P267, DOI 10.1042/CS20050182; Organization WH, 1998, WELLB MEAS PRIM HLTH; Pischon T, 2007, OBESITY, V15, P2051, DOI 10.1038/oby.2007.244; Poitou C, 2005, OBES SURG, V15, P11, DOI 10.1381/0960892052993431; Prakash J, 2015, INT J PREVENTIVE MED, V6, DOI 10.4103/2008-7802.154773; Prakash J, 2011, ANN HUM BIOL, V38, P760, DOI 10.3109/03014460.2011.614278; Qiao LP, 2005, DIABETES, V54, P1744, DOI 10.2337/diabetes.54.6.1744; Ramya K, 2013, GENE, V532, P253, DOI 10.1016/j.gene.2013.09.012; Rohde K, 2015, GENES NUTR, V10, DOI 10.1007/s12263-014-0449-8; Rosmond R, 2000, J CLIN ENDOCR METAB, V85, P3126, DOI 10.1210/jc.85.9.3126; Salmenniemi U, 2005, J CLIN ENDOCR METAB, V90, P4216, DOI 10.1210/jc.2004-2289; Schwartz MW, 2017, ENDOCR REV, V38, P267, DOI 10.1210/er.2017-00111; Snehalatha C, 2003, DIABETES CARE, V26, P1380, DOI 10.2337/diacare.26.5.1380; Stumvoll M, 2002, DIABETES, V51, P37, DOI 10.2337/diabetes.51.1.37; Tanko LB, 2005, OBES RES, V13, P2113, DOI 10.1038/oby.2005.262; Toy WC, 2011, J DIABETES METAB, V2, DOI 10.4172/2155-6156.1000152; Vasseur F, 2002, HUM MOL GENET, V11, P2607, DOI 10.1093/hmg/11.21.2607; Vazquez G, 2007, EPIDEMIOL REV, V29, P115, DOI 10.1093/epirev/mxm008; Vimaleswaran KS, 2008, HUM GENET, V123, P599, DOI 10.1007/s00439-008-0506-8; Wakai K, 2013, OBESITY, V21, P2413, DOI 10.1002/oby.20316; Warodomwichit D, 2009, OBESITY, V17, P510, DOI 10.1038/oby.2008.583; Yang WS, 2007, AM J CLIN NUTR, V86, P509, DOI 10.1093/ajcn/86.2.509; Yang WS, 2006, J MOL MED, V84, P112, DOI 10.1007/s00109-005-0011-7; Yang WS, 2003, J MOL MED-JMM, V81, P428, DOI 10.1007/s00109-002-0409-4; Yu ZB, 2012, OBESITY, V20, P396, DOI 10.1038/oby.2011.148; Zaki ME, 2014, INT J PHARM PHARM SC, V6, P226, DOI [10.1016/J.EJMHG.2017.08.005, DOI 10.1016/J.EJMHG.2017.08.005]	75	10	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204502	10.1371/journal.pone.0204502	http://dx.doi.org/10.1371/journal.pone.0204502			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265726	Green Published, gold, Green Submitted			2022-12-26	WOS:000446005500036
J	Kavunga-Membo, H; Nkwembe, E; Simulundu, E; Karhemere, S; Babakazo, P; Manya, L; Kabamba, J; Okitolonda, E; Ahuka-Mundeke, S; Muyembe, JJ				Kavunga-Membo, Hugo; Nkwembe, Edith; Simulundu, Edgar; Karhemere, Stomy; Babakazo, Pelagie; Manya, Leonie; Kabamba, Joelle; Okitolonda, Emile; Ahuka-Mundeke, Steve; Muyembe, Jean Jacques			Epidemiology of circulating human influenza viruses from the Democratic Republic of Congo, 2015	PLOS ONE			English	Article							SEASONAL INFLUENZA; SOUTH-AFRICA; SURVEILLANCE; NEURAMINIDASE; ALGORITHM; ILLNESS; BURDEN; KENYA; H1N1	Introduction The establishment of the influenza sentinel surveillance system in Kinshasa, Bas Congo, Maniema, Katanga, and Kasai Provinces allowed generation of important data on the molecular epidemiology of human influenza viruses circulating in the Democratic Republic of Congo (DRC). However, some challenges still exist, including the need for extending the influenza surveillance to more provinces. This study describes the pattern of influenza virus circulating in DRC during 2015. Methodology Nasopharyngeal swabs were collected from January to December 2015 from outpatients with influenza-like illness (ILI) and in all hospitalized patients with Severe Acute Respiratory Infection (SARI). Molecular analysis was done to determine influenza type and subtype at the National Reference Laboratory (NRL) in Kinshasa using real time reverse transcription-polymerase chain reaction (rRT-PCR). Analysis of antiviral resistance by enzyme inhibition assay and nucleotide sequencing was performed by the Collaborating center in the USA (CDC, Atlanta). Results Out of 2,376 nasopharyngeal swabs collected from patients, 218 (9.1%) were positive for influenza virus. Among the positive samples, 149 were characterized as influenza virus type A (Flu A), 67 as type B (Flu B) and 2 mixed infections (Flu A and B). Flu A subtypes detected were H3N2 and H1N1. The Yamagata strain of Flu B was detected among patients in the country. Individuals aged between 5 and 14 years accounted for the largest age group affected by influenza virus. All influenza viruses detected were found to be sensitive to antiviral drugs such as oseltamivar, zanamivir, peramivir and laninamivar. Conclusion The present study documented the possible involvement of both circulation of Flu A and B viruses in human respiratory infection in certain DRC provinces during 2015. This study emphasises the need to extend the influenza surveillance to other provinces for a better understanding of the epidemiology of influenza in DRC. It is envisioned that such a system would lead to improved disease control and patient management.	[Kavunga-Membo, Hugo; Nkwembe, Edith; Karhemere, Stomy; Ahuka-Mundeke, Steve; Muyembe, Jean Jacques] INRB, Dept Virol, Kinshasa, DEM REP CONGO; [Kavunga-Membo, Hugo; Simulundu, Edgar] Univ Zambia, Sch Vet Med, Dept Dis Control, Lusaka, Zambia; [Babakazo, Pelagie; Okitolonda, Emile] Univ Kinshasa UNIKIN, Ecole Sante Publ, Kinshasa, DEM REP CONGO; [Manya, Leonie; Kabamba, Joelle] Minist Sante Publ, Direct Lutte Malad, Kinshasa, DEM REP CONGO	Institute Nacional de Recherche Biomedical; University of Zambia; Universite de Kinshasa	Kavunga-Membo, H (corresponding author), INRB, Dept Virol, Kinshasa, DEM REP CONGO.; Kavunga-Membo, H (corresponding author), Univ Zambia, Sch Vet Med, Dept Dis Control, Lusaka, Zambia.	hugokavunga@gmail.com	Simulundu, Edgar/H-7331-2019; Babakazo, Pelagie/GLR-3170-2022; Babakazo, PÃ©lagie/Y-5453-2019	Simulundu, Edgar/0000-0001-9423-0816; 				[Anonymous], 2008, Wkly Epidemiol Rec, V83, P366; [Anonymous], 2008, Wkly Epidemiol Rec, V83, P81; [Anonymous], 2016, INFL DIV REP; Barakat A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024579; Beckett CG, 2004, CLIN INFECT DIS, V39, P443, DOI 10.1086/422314; Besselaar TG, 2008, EMERG INFECT DIS, V14, P1809, DOI 10.3201/eid1411.080958; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; Gachara G, 2006, J CLIN VIROL, V35, P117, DOI 10.1016/j.jcv.2005.10.004; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Gessner BD, 2011, LANCET INFECT DIS, V11, P223, DOI 10.1016/S1473-3099(11)70008-1; Hillman MR, 2002, VACCINE, V20, P3068, DOI 10.1016/S0264-410X(02)00254-2; Hirve S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153003; Kamps BS, 2006, PREISER J INFLUENZA; Katz MA, 2012, J INFECT DIS, V206, pS53, DOI 10.1093/infdis/jis530; McAnerney JM, 2012, J INFECT DIS, V206, pS153, DOI 10.1093/infdis/jis575; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Njouom R, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-56; POTIER M, 1979, ANAL BIOCHEM, V94, P287, DOI 10.1016/0003-2697(79)90362-2; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shepard SS, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3030-6; STUDIER JA, 1988, MOL BIOL EVOL, V5, P729; Tamfum JJM, 2012, J INFECT DIS, V206, pS36, DOI 10.1093/infdis/jis537; Theo A, 2012, J INFECT DIS, V206, pS173, DOI 10.1093/infdis/jis599; Wetherall NT, 2003, J CLIN MICROBIOL, V41, P742, DOI 10.1128/JCM.41.2.742-750.2003; Zhou Bin, 2012, Methods Mol Biol, V865, P175, DOI 10.1007/978-1-61779-621-0_11	25	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0203995	10.1371/journal.pone.0203995	http://dx.doi.org/10.1371/journal.pone.0203995			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265699	gold, Green Published, Green Submitted			2022-12-26	WOS:000446005500014
J	Wang, XS; Zhang, HH; Chen, Y				Wang, Xiushan; Zhang, Hehu; Chen, Ying			Research on maize canopy center recognition based on nonsignificant color difference segmentation	PLOS ONE			English	Article							MACHINE VISION; AUTOMATED CROP; VEGETATION; ALGORITHM; IMAGES; SVM	Weed control is a substantial challenge in field management. A better weed control method at an earlier growth stage is important for increasing yields. As a promising weed control technique, intelligent weeding based on machine vision can avoid the harm of chemical weeding. For machine vision, it is critical to extract and segment crops from their background. However, there is still no optimal solution for object tracking with occlusion under a similar color background. In this study, it was found that the gray distribution of a maize canopy follows the gradient law. Therefore, the recognition method based on the HLS-SVM (HLS color space and Support Vector Machine) and on the grayscale gradient was developed. First, the HLS color space was used to detect the maize canopy. Second, the SVM method was used to segment the central region of the maize canopy. Finally, the maize canopy center was identified according to the gradient law. The results showed that the average segmentation time was 0.49 s, the average segmentation quality was 87.25%, and the standard deviation of the segmentation was 3.57%. The average recognition rate of the center position was 93.33%. This study provided a machine vision method for intelligent weeding agricultural equipment as well as a theoretical reference for further agricultural machine vision research.	[Wang, Xiushan; Zhang, Hehu] Henan Agr Univ, Coll Mech & Elect Engn, Dept Elect Engn, Zhengzhou, Henan, Peoples R China; [Chen, Ying] Henan Agr Univ, Coll Humanities & Law, Zhengzhou, Henan, Peoples R China	Henan Agricultural University; Henan Agricultural University	Zhang, HH (corresponding author), Henan Agr Univ, Coll Mech & Elect Engn, Dept Elect Engn, Zhengzhou, Henan, Peoples R China.	henauzhh@163.com	zhang, hehu/AAT-8931-2020; Zhang, Hehu/AAN-5588-2021	Zhang, Hehu/0000-0003-0862-0506	National Natural Science Foundation of China [U1204524]; Henan province science and technology key project [172102210302]; Henan college key scientific research project [18A416002]; Development of key technologies for electrically driven inter robot weeding robot based on machine vision technology [KF1607]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Henan province science and technology key project; Henan college key scientific research project; Development of key technologies for electrically driven inter robot weeding robot based on machine vision technology	This research is supported by the following projects: the National Natural Science Foundation of China (Grant: U1204524), the Henan province science and technology key project (Grant: 172102210302), the Henan college key scientific research project (Grant: 18A416002), and the Development of key technologies for electrically driven inter robot weeding robot based on machine vision technology (KF1607).; This research is supported by the following projects: the National Natural Science Foundation of China (Grant: U1204524), the Henan province science and technology key project (Grant: 172102210302), the Henan college key scientific research project (Grant: 18A416002), and the Development of key technologies for electrically driven inter robot weeding robot based on machine vision technology (KF1607). The project team heartily expresses their full thanks to above units.	Abbasgholipour M, 2011, EXPERT SYST APPL, V38, P3671, DOI 10.1016/j.eswa.2010.09.023; Bai XF, 2016, NEURAL COMPUT APPL, V27, P45, DOI 10.1007/s00521-013-1544-2; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cordill C, 2011, BIOSYST ENG, V110, P247, DOI 10.1016/j.biosystemseng.2011.07.007; Eizentals P, 2017, SPR PROC ADV ROBOT, V1, P433, DOI 10.1007/978-3-319-50115-4_38; Eyre MD, 2011, EUR J AGRON, V34, P153, DOI 10.1016/j.eja.2011.01.001; Guo W, 2013, COMPUT ELECTRON AGR, V96, P58, DOI 10.1016/j.compag.2013.04.010; Hague T, 2006, PRECIS AGRIC, V7, P21, DOI 10.1007/s11119-005-6787-1; Huang YJ, 2010, COMPUT ELECTRON AGR, V70, P42, DOI 10.1016/j.compag.2009.08.011; Hunt E. Raymond Jr, 2005, Precision Agriculture, V6, P359, DOI 10.1007/s11119-005-2324-5; Kataoka T, 2003, IEEE ASME INT C ADV, P1079, DOI 10.1109/aim.2003.1225492; Kondo N., 2009, ENG AGR ENV FOOD, V2, P60, DOI DOI 10.1016/S1881-8366(09)80017-7; Kovac J, 2003, IEEE REGION 8 EUROCON 2003, VOL B, PROCEEDINGS, P144; Lapin M, 2014, NEURAL NETWORKS, V53, P95, DOI 10.1016/j.neunet.2014.02.002; Li N, 2015, INT J AGR BIOL ENG, V8, P20, DOI 10.3965/j.ijabe.20150806.1932; Pena JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077151; Meyer GE, 2004, COMPUT ELECTRON AGR, V42, P161, DOI 10.1016/j.compag.2003.08.002; Meyer GE, 2008, COMPUT ELECTRON AGR, V63, P282, DOI 10.1016/j.compag.2008.03.009; Moghaddam PA, 2016, COMPUT ELECTRON AGR, V122, P133, DOI 10.1016/j.compag.2016.01.025; Najman L, 2010, MATH MORPHOLOGY, P3, DOI [10.1002/9781118600788.ch1, DOI 10.1002/9781118600788.CH1]; Nuss ET, 2010, COMPR REV FOOD SCI F, V9, P417, DOI 10.1111/j.1541-4337.2010.00117.x; Wali SB, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/250461; Wu TF, 2010, P IEEE COMP SOC C CO, V2, P2301, DOI [10.1016/j.visres.2004.04.006, DOI 10.1016/J.VISRES.2004.04.006]; Zhang JS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195223; Zhao JD, 2017, J ADV TRANSPORT, DOI 10.1155/2017/6458495; Zheng LY, 2009, COMPUT ELECTRON AGR, V65, P93, DOI 10.1016/j.compag.2008.08.002	26	2	2	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0202366	10.1371/journal.pone.0202366	http://dx.doi.org/10.1371/journal.pone.0202366			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30261517	gold, Green Published, Green Submitted			2022-12-26	WOS:000445907400003
J	Darici, O; Temeltas, H; Kuo, AD				Darici, Osman; Temeltas, Hakan; Kuo, Arthur D.			Optimal regulation of bipedal walking speed despite an unexpected bump in the road	PLOS ONE			English	Article							PASSIVE DYNAMIC WALKING; HYBRID ZERO DYNAMICS; TO-STEP TRANSITIONS; MECHANICAL WORK; UNEVEN TERRAIN; HUMAN LEG; ENERGETICS; STABILIZATION; WALKERS; MODEL	Bipedal locomotion may occur over imperfect surfaces with bumps or other features that disrupt steady gait. An unexpected bump in the road is generally expected to slow down most types of locomotion. On wheels, speed may be regained quite readily with "cruise control" performed in continuous time. But legged locomotion is less straightforward, because the stance leg may be under-actuated, and the continuous-time dynamics are periodically disrupted by discrete ground contact events. Those events may also afford good control opportunities, albeit subject to the delay between discrete opportunities. The regulation of walking speed should ideally use these opportunities to compensate for lost time, and with good economy if possible. However, the appropriate control strategy is unknown. Here we present how to restore speed and make up for time lost going over a bump in the road, through discrete, once-per-step control. We use a simple dynamic walking model to determine the optimal sequence of control actions-pushing off from the leg at the end of each stance phase-for fast response or best economy. A two-step, deadbeat sequence is the fastest possible response, and reasonably economical. Slower responses over more steps are more economical overall, but a bigger difference is that they demand considerably less peak power. A simple, reactive control strategy can thus compensate for an unexpected bump, with explicit trade-offs in time and work. Control of legged locomotion is not as straightforward as with wheels, but discrete control actions also allow for effective and economical reactions to imperfect terrain.	[Darici, Osman; Kuo, Arthur D.] Univ Calgary, Fac Kinesiol, Calgary, AB, Canada; [Darici, Osman; Temeltas, Hakan] Istanbul Tech Univ, Fac Elect & Elect Eng, Istanbul, Turkey	University of Calgary; Istanbul Technical University	Darici, O (corresponding author), Univ Calgary, Fac Kinesiol, Calgary, AB, Canada.; Darici, O (corresponding author), Istanbul Tech Univ, Fac Elect & Elect Eng, Istanbul, Turkey.	osman.darici1@ucalgary.ca	Kuo, Arthur/L-3359-2013; Temeltas, Hakan/N-9248-2013	Kuo, Arthur/0000-0001-5233-9709; darici, osman/0000-0001-6217-5656; Temeltas, Hakan/0000-0002-3016-0027	U.S. Department of Defense [W81XWH-09-2-0142]; Office of Naval Research (ETOWL); National Institutes of Health [AG0308]; Defense Advanced Research Projects Agency (M3 Atlas Program); University of Calgary	U.S. Department of Defense(United States Department of Defense); Office of Naval Research (ETOWL); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Advanced Research Projects Agency (M3 Atlas Program); University of Calgary	U.S. Department of Defense (W81XWH-09-2-0142), http://cdmrp.army.mil/ Office of Naval Research (ETOWL), https://www.onr.navy.mi National Institutes of Health (AG0308), https://www.nih.gov/ Defense Advanced Research Projects Agency (M3 Atlas Program), https://www.darpa.mil/ The Dr. Benno Nigg Chair at University of Calgary The Canada Research Chair program, http://www.chairs-chaires.gc.ca/home-accueil-eng.aspx The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk PG, 2009, J EXP BIOL, V212, P2668, DOI 10.1242/jeb.027581; Bauby CE, 2000, J BIOMECH, V33, P1433, DOI 10.1016/S0021-9290(00)00101-9; Bhounsule PA, 2012, ADAPTIVE MOBILE ROBOTICS, P441; Byl K, 2008, IEEE INT CONF ROBOT, P1258, DOI 10.1109/ROBOT.2008.4543376; Doke J, 2005, J EXP BIOL, V208, P439, DOI 10.1242/jeb.01408; Doke J, 2007, J EXP BIOL, V210, P2390, DOI 10.1242/jeb.02782; Donelan JM, 2002, J EXP BIOL, V205, P3717; Donelan JM, 2002, J BIOMECH, V35, P117, DOI 10.1016/S0021-9290(01)00169-5; Fukunaga T, 2001, P ROY SOC B-BIOL SCI, V268, P229, DOI 10.1098/rspb.2000.1361; Gomes M, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.032901; Grieve D.W., 1968, BIOMED ENG, V3, P119; Hobbelen DGE, 2009, INT J HUM ROBOT, V6, P93, DOI 10.1142/S0219843609001632; KAJITA S, 1991, 1991 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION, VOLS 1-3, P1405, DOI 10.1109/ROBOT.1991.131811; Kerimoglu D, 2015, PROCEEDINGS OF THE 17TH INTERNATIONAL CONFERENCE ON ADVANCED ROBOTICS (ICAR), P351, DOI 10.1109/ICAR.2015.7251479; Kuo AD, 2007, IEEE ROBOT AUTOM MAG, V14, P18, DOI 10.1109/MRA.2007.380653; Kuo AD, 1999, INT J ROBOT RES, V18, P917, DOI 10.1177/02783649922066655; Kuo AD, 2001, J BIOMECH ENG-T ASME, V123, P264, DOI 10.1115/1.1372322; Kuo AD, 2005, EXERC SPORT SCI REV, V33, P88, DOI 10.1097/00003677-200504000-00006; Kuo AD, 2002, J BIOMECH ENG-T ASME, V124, P113, DOI 10.1115/1.1427703; Manchester IR, 2011, INT J ROBOT RES, V30, P265, DOI 10.1177/0278364910395339; MCGEER T, 1990, INT J ROBOT RES, V9, P62, DOI 10.1177/027836499000900206; McGeer T., 1990, Proceedings 1990 IEEE International Conference on Robotics and Automation (Cat. No.90CH2876-1), P1640, DOI 10.1109/ROBOT.1990.126245; Panizzolo FA, 2017, J EXP BIOL, V220, P4169, DOI 10.1242/jeb.161158; Pratt J, 1998, IEEE INT CONF ROBOT, P2014, DOI 10.1109/ROBOT.1998.680611; Safa AT, 2015, NONLINEAR DYNAM, V81, P2127, DOI 10.1007/s11071-015-2130-1; Saglam CO, 2018, SPR PROC ADV ROBOT, V3, P235, DOI 10.1007/978-3-319-60916-4_14; Sreenath K, 2011, INT J ROBOT RES, V30, P1170, DOI 10.1177/0278364910379882; Voloshina AS, 2013, J EXP BIOL, V216, P3963, DOI 10.1242/jeb.081711; Westervelt ER, 2003, IEEE T AUTOMAT CONTR, V48, P42, DOI 10.1109/TAC.2002.806653; Wisse M, 2005, IEEE T ROBOT, V21, P393, DOI 10.1109/TRO.2004.838030; Wisse M., 2005, INT J HUM ROBOT, V2, P459; Wu AR, 2016, J EXP BIOL, V219, P3106, DOI 10.1242/jeb.137356; Zelik KE, 2014, J THEOR BIOL, V346, P75, DOI 10.1016/j.jtbi.2013.12.014	33	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2018	13	9							e0204205	10.1371/journal.pone.0204205	http://dx.doi.org/10.1371/journal.pone.0204205			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3NB	30256825	Green Submitted, Green Published, gold			2022-12-26	WOS:000446000200039
J	Machado, ML; Arantes, LP; Gubert, P; Zamberlan, DC; da Silva, TC; da Silveira, TL; Boligon, A; Soares, FAA				Machado, Marina Lopes; Arantes, Leticia Priscilla; Gubert, Priscila; Zamberlan, Daniele Coradini; da Silva, Thayanara Cruz; da Silveira, Tassia Limana; Boligon, Aline; Antunes Soares, Felix Alexandre			Ilex paraguariensis modulates fat metabolism in Caenorhabditis elegans through purinergic system (ADOR-1) and nuclear hormone receptor (NHR-49) pathways	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; GREEN TEA; LIFE-SPAN; CATECHIN-POLYPHENOLS; ENERGY-EXPENDITURE; PHENOLIC-COMPOUNDS; AQUEOUS EXTRACT; LIPID DROPLETS; CAFFEINE; THERMOGENESIS	Ilex paraguariensis is a well-known plant that is widely consumed in South America, primarily as a drink called mate. Mate is described to have stimulant and medicinal properties. Considering the potential anti-lipid effects of I. paraguariensis infusion, we used an extract of this plant as a possible modulator of fat storage to control lipid metabolism in worms. Herein, the I. paraguariensis-dependent modulation of fat metabolism in Caenorhabditis elegans was investigated. C. elegans were treated with I. paraguariensis aqueous extract (1 mg/ml) from L1 larvae stage until adulthood, to simulate the primary form of consumption. Expression of adipocyte triglyceride lipase 1 (ATGL-1) and heat shock protein 16.2, lipid accumulation through C1-BODIPY-C12 (BODIPY) lipid staining, behavioral parameters, body length, total body energy expenditure and overall survival were analyzed. Total body energy expenditure was determined by the oxygen consumption rate in N2, nuclear hormone receptor knockout, nhr-49(nr2041), and adenosine receptor knockout, ador-1(ox489) strains. Ilex paraguariensis extract increased ATG L-1 expression 20.06% and decreased intestinal BODIPY fat staining 63.36%, compared with the respective control group, without affecting bacterial growth and energetic balance, while nhr-49 (nr2041) and ador-1(ox489) strains blocked the worm fat loss. In addition, I. paraguariensis increased the oxygen consumption in N2 worms, but not in mutant strains, increased N2 worm survival following juglone exposure, and did not alter hsp-16.2 expression. We demonstrate for the first time that I. paraguariensis can decrease fat storage and increase body energy expenditure in worms. These effects depend on the purinergic system (ADOR-1) and NHR-49 pathways. Ilex paraguariensis upregulated the expression of ATG L-1 to modulate fat metabolism. Furthermore, our data corroborates with other	[Machado, Marina Lopes; Arantes, Leticia Priscilla; Zamberlan, Daniele Coradini; da Silva, Thayanara Cruz; da Silveira, Tassia Limana; Antunes Soares, Felix Alexandre] Univ Fed Santa Maria, Dept Bioquim & Biol Mol, Programa Posgrad Ciencias Biol Bioquim Toxicol, Santa Maria, RS, Brazil; [Gubert, Priscila] Univ Fed Oeste Bahia, Ctr Ciencias Biol & Saude, Campus Reitor Edgard Santos, Barreiras, BA, Brazil; [Boligon, Aline] Univ Fed Santa Maria, Dept Farm Ind, Lab Pesquisa Fitoquim, Santa Maria, RS, Brazil	Universidade Federal de Santa Maria (UFSM); Universidade Federal do Oeste da Bahia; Universidade Federal de Santa Maria (UFSM)	Soares, FAA (corresponding author), Univ Fed Santa Maria, Dept Bioquim & Biol Mol, Programa Posgrad Ciencias Biol Bioquim Toxicol, Santa Maria, RS, Brazil.	felix@ufsm.br	Machado, Marina/AAI-6743-2020; Soares, Félix AA/K-7611-2012; Soares, Félix/AAE-6251-2020; Gubert, Priscila/ABC-1059-2020; Arantes, Leticia/AEC-9028-2022	Machado, Marina/0000-0001-7425-3316; Soares, Félix AA/0000-0002-6453-7902; Soares, Félix/0000-0002-6453-7902; Gubert, Priscila/0000-0002-3598-8050; Limana Da Silveira, Tassia/0000-0002-3947-1550; Arantes, Leticia/0000-0001-7091-0067	"Programa de Apoio a Nucleos Emergentes" (PRONEM) [16/25510000248-7]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES-PROEX) [23038.005848/2018-31, 0737/2018]	"Programa de Apoio a Nucleos Emergentes" (PRONEM); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES-PROEX)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The financial support for this study was provided by "Programa de Apoio a Nucleos Emergentes" (PRONEM) [grant number 16/25510000248-7] to FAAS and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES-PROEX) [Process: 23038.005848/2018-31, grant number 0737/2018]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas SR, 2014, FOOD CHEM, V147, P10, DOI 10.1016/j.foodchem.2013.09.113; Abdollahi M, 2003, MIDDLE E PHARM, V11, P6; Arantes LP, 2014, IND CROP PROD, V62, P265, DOI 10.1016/j.indcrop.2014.08.038; Arcari DP, 2011, MOL CELL ENDOCRINOL, V335, P110, DOI 10.1016/j.mce.2011.01.003; Arcari DP, 2009, OBESITY, V17, P2127, DOI 10.1038/oby.2009.158; Argyropoulos G, 2002, J APPL PHYSIOL, V92, P2187, DOI 10.1152/japplphysiol.00994.2001; ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759; Bastos D.H.M., 2007, MED AROMATIC PLANT S, V1, P37; Belza A, 2009, EUR J CLIN NUTR, V63, P57, DOI 10.1038/sj.ejcn.1602901; BLUM J, 1983, ARCH BIOCHEM BIOPHYS, V222, P35, DOI 10.1016/0003-9861(83)90499-X; Boligon AA, 2013, ACTA PHYSIOL PLANT, V35, P2229, DOI 10.1007/s11738-013-1259-0; Bonomo LDF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089933; BRACCO D, 1995, AM J PHYSIOL-ENDOC M, V269, pE671, DOI 10.1152/ajpendo.1995.269.4.E671; Bracesco N, 2011, J ETHNOPHARMACOL, V136, P378, DOI 10.1016/j.jep.2010.06.032; BRENNER S, 1974, GENETICS, V77, P71; Bridi JC, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00220; Brooks KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007545; Brunton L, 2014, GOODMAN GILMANS MANU, V5th; Chamoli M, 2014, AGING CELL, V13, P641, DOI 10.1111/acel.12218; de Jong WW, 1998, INT J BIOL MACROMOL, V22, P151, DOI 10.1016/S0141-8130(98)00013-0; Debas HT, 2006, COMPLEMENTARY ALTERN; Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101; DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44; Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040; Elle IC, 2010, FEBS LETT, V584, P2183, DOI 10.1016/j.febslet.2010.03.046; Filip R, 2000, NUTR RES, V20, P1437, DOI 10.1016/S0271-5317(00)80024-X; Filip R, 2001, FITOTERAPIA, V72, P774, DOI 10.1016/S0367-326X(01)00331-8; Filip R, 1998, PHYTOTHER RES, V12, P129, DOI 10.1002/(SICI)1099-1573(199803)12:2&lt;129::AID-PTR191&gt;3.0.CO;2-1; Frayn Keith N, 2009, METABOLIC REGULATION; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Gilbert B, 2003, CURR MED CHEM, V10, P13, DOI 10.2174/0929867033368583; Goh GYS, 2018, AGING CELL, V17, DOI 10.1111/acel.12743; GONZALEZ A, 1993, J ETHNOPHARMACOL, V39, P217, DOI 10.1016/0378-8741(93)90040-C; Gorjanovic S, 2012, J AGR FOOD CHEM, V60, P9573, DOI 10.1021/jf302375t; Haldi J, 1941, J NUTR, V21, P307, DOI 10.1093/jn/21.3.307; Harpaz Eynav, 2017, Journal of Basic and Clinical Physiology and Pharmacology, V28, P1, DOI 10.1515/jbcpp-2016-0090; Hasani-Ranjbar S, 2009, WORLD J GASTROENTERO, V15, P3073, DOI 10.3748/wjg.15.3073; Higgins HL, 1915, J PHARMACOL EXP THER, V7, P1; Huang C, 2004, P NATL ACAD SCI USA, V101, P8084, DOI 10.1073/pnas.0400848101; Jacobson Kenneth A, 2009, Handb Exp Pharmacol, P1, DOI 10.1007/978-3-540-89615-9_1; Jones KT, 2009, DIS MODEL MECH, V2, P224, DOI 10.1242/dmm.001933; Kahkonen MP, 1999, J AGR FOOD CHEM, V47, P3954, DOI 10.1021/jf990146l; Kang JG, 2012, DIABETES METAB J, V36, P13, DOI 10.4093/dmj.2012.36.1.13; Kubagawa HM, 2006, NAT CELL BIOL, V8, P1143, DOI 10.1038/ncb1476; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Migliori ML, 2011, PHYSIOL BEHAV, V103, P315, DOI 10.1016/j.physbeh.2011.01.026; Lima ME, 2014, INT J ENV RES PUB HE, V11, P10091, DOI 10.3390/ijerph111010091; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lodish H., 2000, OXIDATION GLUCOSE FA, V4th; Mak HY, 2006, NAT GENET, V38, P363, DOI 10.1038/ng1739; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; MILLER DS, 1974, P NUTR SOC, V33, pA28; Mosimann ALP, 2006, BIOFACTORS, V26, P59, DOI 10.1002/biof.5520260106; Mullaney BC, 2009, BBA-MOL CELL BIOL L, V1791, P474, DOI 10.1016/j.bbalip.2008.12.013; Narbonne P, 2009, NATURE, V457, P210, DOI 10.1038/nature07536; NEHLIG A, 1992, BRAIN RES REV, V17, P139, DOI 10.1016/0165-0173(92)90012-B; O'Rourke EJ, 2009, CELL METAB, V10, P430, DOI 10.1016/j.cmet.2009.10.002; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Pi-Sunyer FX, 2004, NUTR REV, V62, pS120, DOI 10.1111/j.1753-4887.2004.tb00081.x; Ranjan M, 2013, FREE RADICAL BIO MED, V63, P381, DOI 10.1016/j.freeradbiomed.2013.05.025; Rates SMK, 2001, TOXICON, V39, P603, DOI 10.1016/S0041-0101(00)00154-9; Riedel A, 2012, FOOD FUNCT, V3, P955, DOI 10.1039/c2fo30053b; Salgueiro WG, 2017, FREE RADICAL BIO MED, V110, P133, DOI 10.1016/j.freeradbiomed.2017.05.020; SCHAFER WR, 1995, NATURE, V375, P73, DOI 10.1038/375073a0; Schinella GR, 2000, BIOCHEM BIOPH RES CO, V269, P357, DOI 10.1006/bbrc.2000.2293; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Shen PY, 2017, J MED FOOD, V20, P887, DOI 10.1089/jmf.2016.0179; Sun QC, 2016, J MED FOOD, V19, P427, DOI 10.1089/jmf.2015.0133; Tsalik EL, 2003, J NEUROBIOL, V56, P178, DOI 10.1002/neu.10245; Van Gilst MR, 2005, PLOS BIOL, V3, P301, DOI 10.1371/journal.pbio.0030053; WAGNER H, 1993, J ETHNOPHARMACOL, V38, P105, DOI 10.1016/0378-8741(93)90004-O; Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430; Watts JL, 2003, GENETICS, V163, P581; Waypa GB, 2016, MOL ASPECTS MED, V47-48, P76, DOI 10.1016/j.mam.2016.01.002; Williamson EM, 2001, PHYTOMEDICINE, V8, P401, DOI 10.1078/0944-7113-00060; WORMBASE, 2017, ADOR 1 GENE; Yilmaz LS, 2014, TRENDS GENET, V30, P496, DOI 10.1016/j.tig.2014.07.010; Zamberlan DC, 2014, NEUROSCIENCE, V278, P40, DOI 10.1016/j.neuroscience.2014.07.068	78	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2018	13	9							e0204023	10.1371/journal.pone.0204023	http://dx.doi.org/10.1371/journal.pone.0204023			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU9BO	30252861	Green Published, gold, Green Submitted			2022-12-26	WOS:000445639700022
J	Chellaiah, MA; Majumdar, S; Aljohani, H				Chellaiah, Meenakshi A.; Majumdar, Sunipa; Aljohani, Hanan			Peptidomimetic inhibitors of L-plastin reduce the resorptive activity of osteoclast but not the bone forming activity of osteoblasts in vitro	PLOS ONE			English	Article							PROTEIN L-PLASTIN; CD44 SURFACE EXPRESSION; MATRIX DEGRADATION; CANCER CELLS; SRC KINASE; INTEGRIN; ACTIVATION; PHOSPHORYLATION; MIGRATION; ADHESION	Sealing ring formation is a requirement for osteoclast function. We have recently identified the role of an actin-bundling protein L-plastin in the assembly of nascent sealing zones (NSZs) at the early phase of sealing ring formation in osteoclasts. TNF-alpha signaling regulates this actin assembly by the phosphorylation of L-plastin on serine -5 and -7 residues at the amino-terminal end. These NSZs function as a core for integrin localization and coordinating integrin signaling required for maturation into fully functional sealing rings. Our goal is to elucidate the essential function of L-plastin phosphorylation in actin bundling, a process required for NSZs formation. The present study was undertaken to determine whether targeting serine phosphorylation of cellular L-plastin would be the appropriate approach to attenuate the formation of NSZs. Our approach is to use TAT-fused small molecular weight amino-terminal L-plastin peptides (10 amino acids) containing phospho- Ser-5 and Ser-7. We used peptides unsubstituted (P1) and substituted (P2- P4) at serine-to-alanine residues. Immunoblotting, actin staining, and dentine resorption analyses were done to determine cellular L-plastin phosphorylation, NSZ or sealing ring formation, and osteoclast function, respectively. Immunoblotting for bone formation markers, Alizarin red staining and alkaline phosphatase activity assay have been done to determine the effect of peptides on the mineralization process mediated by osteoblasts. Transduction of unsubstituted (P1) and substituted peptides at either Serine 5 or Serine 7 with Alanine (P3 and P4) demonstrated variable inhibitory effects on the phosphorylation of cellular L-plastin protein. Peptide P1 reduces the following processes substantially: 1) cellular L-plastin phosphorylation; 2) formation of nascent sealing zones and sealing rings; 3) bone resorption. Substitution of both Serine-5 and -7 with Alanine (P2) had no effects on the inhibitory activities described above. Furthermore, either the L-plastin (P1-P5) or (P6) control peptides had a little or no impact on the a) assembly/disassembly of podosomes and migration of osteoclasts; b) mineralization process mediated by osteoblasts in vitro. Small molecular weight peptidomimetics of L-plastin inhibits bone resorption by osteoclasts via attenuation of NSZ and sealing ring formation but not bone formation by osteoblasts in vitro. The L-plastin may be a valuable therapeutic target to treat and prevent diseases associated with bone loss without affecting bone formation.	[Chellaiah, Meenakshi A.; Majumdar, Sunipa; Aljohani, Hanan] Univ Maryland, Sch Dent, Dept Oncol & Diagnost Sci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Chellaiah, MA (corresponding author), Univ Maryland, Sch Dent, Dept Oncol & Diagnost Sci, Baltimore, MD 21201 USA.	mchellaiah@umaryland.edu		Chellaiah, Meenakshi/0000-0001-6572-1106	National Institute of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases [5R01AR066044]	National Institute of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by a research grant to MAC from the National Institute of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases (5R01AR066044) to MAC.	Al Tanoury Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009210; ARPIN M, 1994, J CELL BIOL, V127, P1995, DOI 10.1083/jcb.127.6.1995; Babb SG, 1997, CELL MOTIL CYTOSKEL, V37, P308; BLAVIER L, 1995, J CELL SCI, V108, P3649; BRETSCHER A, 1986, METHOD ENZYMOL, V134, P24; Chellaiah M, 2000, J CELL BIOL, V148, P665, DOI 10.1083/jcb.148.4.665; Chellaiah M, 1996, MOL BIOL CELL, V7, P743, DOI 10.1091/mbc.7.5.743; Chellaiah M, 1998, J BIOL CHEM, V273, P11908, DOI 10.1074/jbc.273.19.11908; Chellaiah MA, 2006, EUR J CELL BIOL, V85, P311, DOI 10.1016/j.ejcb.2006.01.008; Chellaiah MA, 2000, J BIOL CHEM, V275, P11993, DOI 10.1074/jbc.275.16.11993; Chellaiah MA, 2003, CALCIFIED TISSUE INT, V72, P197, DOI 10.1007/s00223-002-1025-6; Chellaiah MA, 2003, J BIOL CHEM, V278, P29086, DOI 10.1074/jbc.M211074200; Chellaiah MA, 2007, J BIOL CHEM, V282, P10104, DOI 10.1074/jbc.M608957200; Chellaiah MA, 2009, J CELL PHYSIOL, V220, P382, DOI 10.1002/jcp.21777; Chen H, 2003, IMMUNITY, V19, P95, DOI 10.1016/S1074-7613(03)00172-9; De Clercq S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078108; Delanote V, 2005, ACTA PHARMACOL SIN, V26, P769, DOI 10.1111/j.1745-7254.2005.00145.x; Desai B, 2008, J BIOL CHEM, V283, P13856, DOI 10.1074/jbc.M709401200; Duong Le T., 1998, Frontiers in Bioscience, V3, pD757; Duong LT, 1999, J BONE MINER METAB, V17, P1, DOI 10.1007/s007740050055; Fahiminiya S, 2014, J BONE MINER RES, V29, P1805, DOI 10.1002/jbmr.2208; Foran E, 2006, INT J CANCER, V118, P2098, DOI 10.1002/ijc.21593; Freeley M, 2012, J IMMUNOL, V188, P6357, DOI 10.4049/jimmunol.1103242; Fuller K, 2006, ENDOCRINOLOGY, V147, P1979, DOI 10.1210/en.2005-1340; Fuller K, 2002, ENDOCRINOLOGY, V143, P1108, DOI 10.1210/en.143.3.1108; Gupta A, 2003, J BONE MINER RES, V18, P669, DOI 10.1359/jbmr.2003.18.4.669; Janji B, 2006, J CELL SCI, V119, P1947, DOI 10.1242/jcs.02874; Jones SL, 1998, P NATL ACAD SCI USA, V95, P9331, DOI 10.1073/pnas.95.16.9331; Jones SL, 1996, J BIOL CHEM, V271, P14623, DOI 10.1074/jbc.271.24.14623; Lebart MC, 2004, BIOCHEMISTRY-US, V43, P2428, DOI 10.1021/bi030151p; Li N, 2016, ASIAN J ANDROL, V18, P716, DOI 10.4103/1008-682X.166583; Lin CS, 1998, DNA CELL BIOL, V17, P1041, DOI 10.1089/dna.1998.17.1041; Ma T, 2010, J BIOL CHEM, V285, P29911, DOI 10.1074/jbc.M109.099697; Ma Tao, 2008, J Mol Signal, V3, P4, DOI 10.1186/1750-2187-3-4; MIYAUCHI A, 1991, J BIOL CHEM, V266, P20369; Miyazaki T, 2004, J BIOL CHEM, V279, P17660, DOI 10.1074/jbc.M311032200; Morley SC, 2013, IMMUNOL REV, V256, P48, DOI 10.1111/imr.12102; Morley SC, 2010, J IMMUNOL, V184, P3628, DOI 10.4049/jimmunol.0903851; Nakamura I, 1999, J CELL SCI, V112, P3985; NAMBA Y, 1992, J BIOCHEM-TOKYO, V112, P503, DOI 10.1093/oxfordjournals.jbchem.a123929; Otsuka M, 2001, BIOCHEM BIOPH RES CO, V289, P876, DOI 10.1006/bbrc.2001.6047; Saltel F, 2008, EUR J CELL BIOL, V87, P459, DOI 10.1016/j.ejcb.2008.01.001; Samanna V, 2007, J CELL PHYSIOL, V213, P710, DOI 10.1002/jcp.21137; Sato T, 1997, J CELL SCI, V110, P589; SHIBATA M, 1993, J LEUKOCYTE BIOL, V54, P1; Teitelbaum SL, 2011, ANN NY ACAD SCI, V1240, P14, DOI 10.1111/j.1749-6632.2011.06283.x; Wang J, 2001, J BIOL CHEM, V276, P14474, DOI 10.1074/jbc.M007324200; Wang J, 1999, J BIOL CHEM, V274, P24349, DOI 10.1074/jbc.274.34.24349; ZAMBONINZALLONE A, 1988, J BONE MINER RES, V3, P517	49	16	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2018	13	9							e0204209	10.1371/journal.pone.0204209	http://dx.doi.org/10.1371/journal.pone.0204209			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3MI	30248139	gold, Green Published, Green Submitted			2022-12-26	WOS:000445998100027
J	Legris, E; Galvin, J; Roux, S; Gomot, M; Aoustin, JM; Marx, M; He, SM; Bakhos, D				Legris, Elsa; Galvin, John; Roux, Sylvie; Gomot, Marie; Aoustin, Jean-Marie; Marx, Mathieu; He, Shuman; Bakhos, David			Cortical reorganization after cochlear implantation for adults with single-sided deafness	PLOS ONE			English	Article							AUDITORY-EVOKED-POTENTIALS; UNILATERAL HEARING-LOSS; SOUND SOURCE LOCALIZATION; EVENT-RELATED POTENTIALS; BONE-ANCHORED HEARING; SIGNAL AMPLIFICATION; SPEECH-PERCEPTION; BINAURAL HEARING; RESPONSES; CHILDREN	Background Adults with single sided deafness (SSD) have lost binaural function, which limits sound source localization, speech understanding in noise, and quality of life. For SSD patients, restoration of bilateral auditory input is possible only with a cochlear implant (CI). In this study, cortical auditory evoked potentials (CAEPs) and behavioral performance were measured in left-implanted (SSD-CI-L) and right-implanted (SSD-CI-R) patients before and after cochlear implantation. We hypothesized that improvements in behavioral performance would be accompanied by changes in CAEPs after cochlear implantation. Design Prospective longitudinal study. Setting Tertiary referral center. Method Nine right-handed adult SSD CI patients participated in the study. CAEPs were recorded before cochlear implantation and at 6 and 12 months post-implantation. CAEPs were elicited using speech stimuli (/ba/) delivered in sound field at 70 dBA. Global field power (GFP) latency and amplitude were calculated for P1, N1 and P2 peaks at each test session. CAEP were analyzed at frontocentral (Cz) and temporal (P7, P8, T7 and T8) and mastoid electrodes (M1 and M2) contralateral to the CI ear. Behavioral measures (sentence recognition in noise, with and without spatial cues) were collected at the same test sessions as for CAEPs. Speech performance and CAEPs were also measured in a control group of normal-hearing (NH) subjects. Results While increased N1 amplitude was observed in the scalp potential maps for GFP and Cz for SSD-CI-L patients after implantation, the changes were not statistically significant. Peak CAEP amplitude at electrodes to contralateral to the CI ear increased after cochlear implantation for all SSD-CI patients, but significant increases were observed only for mastoid sites. Peak latencies for some components at temporal and mastoid sites remained significantly longer than for the NH control group, even after cochlear implantation. For SSD-CI-R patients, P2 peak amplitude for baseline GFP and Cz was significantly lower than for the NH control group. A significant improvement for speech understanding in noise was observed at 12 months post-implantation when speech was presented to the CI ear and noise to the non-implanted ear. Conclusion After cochlear implantation, speech understanding significantly improved when speech and noise were spatially separated. The increased N1 amplitude for SSD-CI-L patients and the increased bilateral activation for all SSD-CI patients may reflect cortical reorganization and restoration of binaural function after one year of experience with the CI. However, because of the limited number of SSD patients, significant changes in cortical activity after cochlear implantation were often difficult to observe.	[Legris, Elsa; Roux, Sylvie; Gomot, Marie; Bakhos, David] Univ Francois Rabelais Tours, CHRU Tours, UMR S1253, Tours, France; [Legris, Elsa; Aoustin, Jean-Marie; Bakhos, David] Ear Nose & Throat Dept, Tours, France; [Galvin, John] House Ear Res Inst, Los Angeles, CA USA; [Marx, Mathieu] Ear Nose & Throat Dept, Toulouse, France; [He, Shuman] Ohio State Univ, Dept Otolaryngol Head & Neck Surg, Columbus, OH 43210 USA	CHU Tours; House Research Institute; University System of Ohio; Ohio State University	Legris, E (corresponding author), Univ Francois Rabelais Tours, CHRU Tours, UMR S1253, Tours, France.; Legris, E (corresponding author), Ear Nose & Throat Dept, Tours, France.	legris.elsa@gmail.com	Roux, Sylvie/N-5655-2016; Gomot, Marie/N-3135-2016; Bakhos, David/P-5827-2016	Gomot, Marie/0000-0003-1747-5806; Bakhos, David/0000-0003-1417-5082; Elsa, Legris/0000-0001-5458-4644				Aguera PE, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/158970; Arndt S, 2017, HNO, V65, P98, DOI 10.1007/s00106-016-0297-5; Bakhos D, 2012, INT J PEDIATR OTORHI, V76, P1627, DOI 10.1016/j.ijporl.2012.07.034; Bilecen D, 2000, NEUROLOGY, V54, P765, DOI 10.1212/WNL.54.3.765; Cabral F, 2016, INT ARCH OTORHINOLAR, V20, P69, DOI 10.1055/s-0035-1559586; Canete Oscar M, 2017, Cochlear Implants Int, V18, P335, DOI 10.1080/14670100.2017.1373499; Ceponiene R, 2008, CLIN NEUROPHYSIOL, V119, P1560, DOI 10.1016/j.clinph.2008.03.005; Ceponiene R, 2005, PSYCHOPHYSIOLOGY, V42, P391, DOI 10.1111/j.1469-8986.2005.00305.x; CONNOLLY JF, 1985, PSYCHOPHYSIOLOGY, V22, P87, DOI 10.1111/j.1469-8986.1985.tb01564.x; Crowley KE, 2004, CLIN NEUROPHYSIOL, V115, P732, DOI 10.1016/j.clinph.2003.11.021; Debener S, 2008, PSYCHOPHYSIOLOGY, V45, P20, DOI 10.1111/j.1469-8986.2007.00610.x; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Deprez H, 2014, EUR SIGNAL PR CONF, P1995; Dorman MF, 2016, AUDIOL NEURO-OTOL, V21, P127, DOI 10.1159/000444740; Firszt JB, 2012, EAR HEARING, V33, P521, DOI 10.1097/AUD.0b013e31824b9dfc; Fournier J.E., 1951, AUDIOM TRIE VOCALE E; Fujiki N, 1998, NEUROREPORT, V9, P3129, DOI 10.1097/00001756-199810050-00002; Giardina CK, 2014, CURR SURG REP, V2, DOI 10.1007/s40137-014-0075-9; Gordon KA, 2005, NEUROREPORT, V16, P2041, DOI 10.1097/00001756-200512190-00015; Groenen P, 1996, Audiol Neurootol, V1, P112; Hanss J, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-23; Kelly AS, 2005, CLIN NEUROPHYSIOL, V116, P1235, DOI 10.1016/j.clinph.2005.02.011; Khosla D, 2003, JARO-J ASSOC RES OTO, V4, P235, DOI 10.1007/s10162-002-3014-x; Kitterick PT, 2015, AUDIOL NEURO-OTOL, V20, P79, DOI 10.1159/000380753; KNIGHT RT, 1980, ELECTROEN CLIN NEURO, V50, P112, DOI 10.1016/0013-4694(80)90328-4; KNIGHT RT, 1988, ELECTROEN CLIN NEURO, V70, P499, DOI 10.1016/0013-4694(88)90148-4; Kral A, 2007, BRAIN RES REV, V56, P259, DOI 10.1016/j.brainresrev.2007.07.021; Kral A, 2013, BRAIN, V136, P180, DOI 10.1093/brain/aws305; KRAUS N, 1995, EAR HEARING, V16, P19, DOI 10.1097/00003446-199502000-00003; LEHMANN D, 1980, ELECTROEN CLIN NEURO, V48, P609, DOI 10.1016/0013-4694(80)90419-8; Leterme G, 2015, AUDIOL NEURO-OTOL, V20, P251, DOI 10.1159/000381329; Lieu JEC, 2010, PEDIATRICS, V125, pE1348, DOI 10.1542/peds.2009-2448; Lin LM, 2006, OTOL NEUROTOL, V27, P172, DOI 10.1097/01.mao.0000196421.30275.73; Lippe S, 2009, NEUROSCIENCE, V164, P1108, DOI 10.1016/j.neuroscience.2009.07.066; Lister JJ, 2011, INT J AUDIOL, V50, P211, DOI 10.3109/14992027.2010.526967; McCallum W. C., 1979, HUMAN EVOKED POTENTI, P235, DOI [DOI 10.1007/978-1-4684-3483-5_16, 10.1007/978-1-4684-3483-5_16]; Mertens G, 2016, CLIN OTOLARYNGOL, V41, P511, DOI 10.1111/coa.12555; Michel CM, 2004, CLIN NEUROPHYSIOL, V115, P2195, DOI 10.1016/j.clinph.2004.06.001; MOORE DR, 1991, AUDIOLOGY, V30, P125; Moore DR, 2004, SPR HDB AUD, V23, P96; MOORE DR, 1990, SEMIN PERINATOL, V14, P294; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; Niparko JK, 2003, OTOL NEUROTOL, V24, P73, DOI 10.1097/00129492-200301000-00015; Penfield W, 1954, EPILEPSY FUNCTIONAL; PERRAULT N, 1984, ELECTROEN CLIN NEURO, V59, P177, DOI 10.1016/0168-5597(84)90058-3; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; Petersen B, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00007; Polonenko MJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17129-z; Ponton CW, 2001, HEARING RES, V154, P32, DOI 10.1016/S0378-5955(01)00214-3; Ponton CW, 1996, EAR HEARING, V17, P430, DOI 10.1097/00003446-199610000-00009; REALE RA, 1987, DEV BRAIN RES, V34, P281, DOI 10.1016/0165-3806(87)90215-X; Roman S, 2005, HEARING RES, V201, P10, DOI 10.1016/j.heares.2004.08.021; Ross DS, 2010, EAR HEARING, V31, P126, DOI 10.1097/AUD.0b013e3181bb69db; Sandmann P, 2015, CLIN NEUROPHYSIOL, V126, P594, DOI 10.1016/j.clinph.2014.06.029; Scheffler K, 1998, CEREB CORTEX, V8, P156, DOI 10.1093/cercor/8.2.156; Shafer VL, 2011, CLIN NEUROPHYSIOL, V122, P1137, DOI 10.1016/j.clinph.2010.10.046; Sharma A, 2016, OTOL NEUROTOL, V37, pE26, DOI 10.1097/MAO.0000000000000904; Sharma Mridula, 2004, J Am Acad Audiol, V15, P616, DOI 10.3766/jaaa.15.9.3; Singh S, 2004, EAR HEARING, V25, P598, DOI 10.1097/00003446-200412000-00008; SKRANDIES W, 1990, Brain Topography, V3, P137, DOI 10.1007/BF01128870; SPRENG M, 1979, SCAND AUDIOL, P211; Tavora-Vieira D, 2015, EAR HEARING, V36, pE93, DOI 10.1097/AUD.0000000000000130; VASAMA JP, 1995, HEARING RES, V87, P132, DOI 10.1016/0378-5955(95)00086-J; VAUGHAN HG, 1970, ELECTROEN CLIN NEURO, V28, P360, DOI 10.1016/0013-4694(70)90228-2; Vermeire K, 2009, AUDIOL NEURO-OTOL, V14, P163, DOI 10.1159/000171478; Vidal J, 2005, NEUROSCI LETT, V378, P145, DOI 10.1016/j.neulet.2004.12.022; Wagner M, 2017, J SPEECH LANG HEAR R, V60, P2105, DOI 10.1044/2017_JSLHR-H-16-0056; Wedekind A, 2018, NEUROREPORT, V29, P408, DOI 10.1097/WNR.0000000000000984; Wong DDE, 2009, IEEE T BIO-MED ENG, V56, P2851, DOI 10.1109/TBME.2009.2029239; WOOD CC, 1982, ELECTROEN CLIN NEURO, V54, P25, DOI 10.1016/0013-4694(82)90228-0; Yang M, 2014, HEARING RES, V316, P37, DOI 10.1016/j.heares.2014.07.006; Zeitler DM, 2015, OTOL NEUROTOL, V36, P1467, DOI 10.1097/MAO.0000000000000841; [张功成 Zhang Gongcheng], 2014, [天然气工业, Natural Gas Industry], V34, P11	73	15	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2018	13	9							e0204402	10.1371/journal.pone.0204402	http://dx.doi.org/10.1371/journal.pone.0204402			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV3MI	30248131	gold, Green Submitted, Green Published			2022-12-26	WOS:000445998100036
J	Rheuban, JE; Doney, SC; Cooley, SR; Hart, DR				Rheuban, Jennie E.; Doney, Scott C.; Cooley, Sarah R.; Hart, Deborah R.			Projected impacts of future climate change, ocean acidification, and management on the US Atlantic sea scallop (Placopecten magellanicus) fishery	PLOS ONE			English	Article							ARGOPECTEN-IRRADIANS; PECTEN-MAXIMUS; SURVIVAL; LARVAL	Ocean acidification has the potential to significantly impact both aquaculture and wildcaught mollusk fisheries around the world. In this work, we build upon a previously published integrated assessment model of the US Atlantic Sea Scallop (Placopecten magellanicus) fishery to determine the possible future of the fishery under a suite of climate, economic, biological, and management scenarios. We developed a 4x4x4x4 hypercube scenario framework that resulted in 256 possible combinations of future scenarios. The study highlights the potential impacts of ocean acidification and management for a subset of future climate scenarios, with a high CO2 emissions case (RCP8.5) and lower CO2 emissions and climate mitigation case (RCP4.5). Under RCP4.5 and the highest impact and management scenario, ocean acidification has the potential to reduce sea scallop biomass by approximately 13% by the end of century; however, the lesser impact scenarios cause very little change. Under RCP8.5, sea scallop biomass may decline by more than 50% by the end of century, leading to subsequent declines in industry landings and revenue. Management-set catch limits improve the outcomes of the fishery under both climate scenarios, and the addition of a 10% area closure increases future biomass by more than 25% under the highest ocean acidification impacts. However, increased management still does not stop the projected long-term decline of the fishery under ocean acidification scenarios. Given our incomplete understanding of acidification impacts on P. magellanicus, these declines, along with the high value of the industry, suggest population-level effects of acidification should be a clear research priority. Projections described in this manuscript illustrate both the potential impacts of ocean acidification under a business-as-usual and a moderately strong climate-policy scenario. We also illustrate the importance of fisheries management targets in improving the longterm outcome of the P. magellanicus fishery under potential global change.	[Rheuban, Jennie E.; Doney, Scott C.] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; [Doney, Scott C.] Univ Virginia, Dept Environm Sci, Clark Hall, Charlottesville, VA 22903 USA; [Cooley, Sarah R.] Ocean Conservancy, Washington, DC USA; [Hart, Deborah R.] Northeast Fisheries Sci Ctr, Woods Hole, MA USA	Woods Hole Oceanographic Institution; University of Virginia	Rheuban, JE (corresponding author), Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA.	jrheuban@whoi.edu	Cooley, Sarah R/K-7373-2012; Hart, Deborah/E-6917-2016; Doney, Scott C/F-9247-2010	Cooley, Sarah R/0000-0002-1034-0653; Doney, Scott C/0000-0002-3683-2437; Hart, Deborah/0000-0002-0406-0751	NOAA [NA12NOS4780145]; WestWind Foundation	NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); WestWind Foundation	This study was funded by the NOAA Grant # NA12NOS4780145 (www.noaa.gov) and by the WestWind Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by NOAA Grant NA12NOS4780145 (www.noaa.gov) and the WestWind Foundation and utilized data collected by the NOAA's Northeast Fisheries Science Center as part of an ongoing mission to monitor and assess the Northeast Continental Shelf ecosystem. Data attributed to NEFSC Oceanography was downloaded from http://www.nefsc.noaa.gov/epd/ocean/MainPage/.	Andersen S, 2013, BIOGEOSCIENCES, V10, P6161, DOI 10.5194/bg-10-6161-2013; [Anonymous], 2015, ANN EN OUTL 2015 PRO; Barton A, 2012, LIMNOL OCEANOGR, V57, P698, DOI 10.4319/lo.2012.57.3.0698; Bopp L, 2013, BIOGEOSCIENCES, V10, P6225, DOI 10.5194/bg-10-6225-2013; Brand A. R., 2006, SCALLOPS BIOL ECOLOG, V35, P651; Cooley SR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124145; Cooley SR, 2012, FISH FISH, V13, P182, DOI 10.1111/j.1467-2979.2011.00424.x; Cooley SR, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/2/024007; Feely RA, 2009, OCEANOGRAPHY, V22, P36, DOI 10.5670/oceanog.2009.95; Gilbert CS, 2010, PROG OCEANOGR, V87, P37, DOI 10.1016/j.pocean.2010.09.021; Gledhill DK, 2015, OCEANOGRAPHY, V28, P182, DOI 10.5670/oceanog.2015.41; Gobler CJ, 2017, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00282; Hare JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146756; Hart DR, 2006, N AM J FISH MANAGE, V26, P490, DOI 10.1577/M04-116.1; Hart DR, 2013, ICES J MAR SCI, V70, P591, DOI 10.1093/icesjms/fss204; Hennen DR, 2012, J SHELLFISH RES, V31, P1133, DOI 10.2983/035.031.0424; Kroeker KJ, 2014, BIOL BULL-US, V226, P211, DOI 10.1086/BBLv226n3p211; Kroeker KJ, 2013, GLOBAL CHANGE BIOL, V19, P1884, DOI 10.1111/gcb.12179; Kroeker KJ, 2011, P NATL ACAD SCI USA, V108, P14515, DOI 10.1073/pnas.1107789108; Lagos NA, 2016, AQUACULT ENV INTERAC, V8, P357, DOI 10.3354/aei00183; MACDONALD BA, 1985, MAR ECOL PROG SER, V25, P295, DOI 10.3354/meps025295; Moss R., 2008, NEW SCENARIOS ANAL E; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; National Oceanic and Atmospheric Administration, 2006, MAGN STEV FISH CONS; New England Fishery Management Council, 2012, FRAM 24 SCALL FMP FR; Northeast Fisheries Science Centre (NEFSC), 2010, 50 NE REG STOCK ASS; Northeast Fisheries Science Centre (NEFSC), 2014, 59 NE REG STOCK ASS; Punt AE, 2014, ECOL MODEL, V285, P39, DOI 10.1016/j.ecolmodel.2014.04.017; Ramajo L, 2016, GLOBAL CHANGE BIOL, V22, P2025, DOI 10.1111/gcb.13179; Riahi K, 2017, GLOBAL ENVIRON CHANG, V42, P153, DOI 10.1016/j.gloenvcha.2016.05.009; Sanders MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074118; Schalkhausser B, 2014, MAR BIOL, V161, P2819, DOI 10.1007/s00227-014-2548-x; Schalkhausser B, 2013, MAR BIOL, V160, P1995, DOI 10.1007/s00227-012-2057-8; Sunday JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022881; Tai TC, 2018, ECOL MODEL, V385, P1, DOI 10.1016/j.ecolmodel.2018.07.007; Thomson AM, 2011, CLIMATIC CHANGE, V109, P77, DOI 10.1007/s10584-011-0151-4; U. S. National Marine Fisheries Service, 2016, COMM LAND; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0152-3, 10.1007/s10584-011-0157-y]; White MM, 2014, MAR ECOL PROG SER, V498, P173, DOI 10.3354/meps10621; White MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061065	40	20	22	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2018	13	9							e0203536	10.1371/journal.pone.0203536	http://dx.doi.org/10.1371/journal.pone.0203536			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU5MM	30240399	Green Published, Green Submitted, gold			2022-12-26	WOS:000445329700007
J	Sipos, D; Ursu, K; Dan, A; Herczeg, D; Eszterbauer, E				Sipos, Dora; Ursu, Krisztina; Dan, Adam; Herczeg, David; Eszterbauer, Edit			Susceptibility-related differences in the quantity of developmental stages of Myxobolus spp. (Myxozoa) in fish blood	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; WHIRLING DISEASE; RAINBOW-TROUT; PSEUDODISPAR GORBUNOVA; CYPRINUS-CARPIO; SALMO-TRUTTA; COMMON CARP; CEREBRALIS; MYXOSPOREA; SPHAEROSPORA	Here, we investigated the early development of two closely related myxozoan parasites, the highly pathogenic Myxobolus cerebralis, the causative agent of the whirling disease in sal-monids, and Myxobolus pseudodispar, a common, non-pathogenic parasite of cyprinids. The aim of our study was to examine under in vivo laboratory conditions whether fish blood is involved in the intrapiscine development of the two parasite species and investigate if there is dissimilarity between the parasite infection intensity in blood and if it varies in terms of host susceptibility and parasite pathogenicity. Highly susceptible, less susceptible and non-susceptible hosts were involved. Blood samples were taken 1 day, 1 week and 1 month post exposure to M. cerebralis and M. pseudodispar, respectively. The prevalence and infection intensity was estimated by parasite-specific quantitative real-time PCR. Although previous findings assumed that M. cerebralis might escape from host immune system by migrating via peripheral nerves, our experimental results demonstrated that M. cerebralis is present in blood during the early stage of intrapiscine development. For the non-pathogenic M. pseudodispar, the highest infection prevalence was found in the original host, common roach Rutilus rutilus, whereas the highest infection intensity was detected in rudd Scardinius erythrophthalmus, a "dead-end" host of the parasite. The presence of M. pseudodispar developmental stages in the blood of both susceptible and non-susceptible cyprinids suggests that the susceptibility differences remain hidden during the early stage of infection. Our findings supply further evidence that host specificity is not determined during the early, intrapiscine development involving the vascular system. Furthermore, we found remarkable differences in the infection dynamics of the two parasite species examined, possibly due to their distinct pathogenicity or variations in adaptive capabilities to immune components in host blood.	[Sipos, Dora; Herczeg, David; Eszterbauer, Edit] Hungarian Acad Sci, Ctr Agr Res, Inst Vet Med Res, Budapest, Hungary; [Ursu, Krisztina; Dan, Adam] NFCSO, Vet Diagnost Directorate, Budapest, Hungary	Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Hungarian Veterinary Medical Research Institute	Eszterbauer, E (corresponding author), Hungarian Acad Sci, Ctr Agr Res, Inst Vet Med Res, Budapest, Hungary.	eszterbauer.edit@agrar.mta.hu	Herczeg, Dávid/AAW-1574-2021; Herczeg, Dávid/Y-4735-2019; Dán, Ádám/G-6018-2012	Herczeg, Dávid/0000-0001-5098-961X; Dán, Ádám/0000-0001-7849-7721; Eszterbauer, Edit/0000-0002-4612-0898	National Research, Development and Innovation Fund of Hungary [K112301]	National Research, Development and Innovation Fund of Hungary	The study has been implemented with the support provided from the National Research, Development and Innovation Fund of Hungary, financed under the K112301 funding scheme. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, LANG ENV STAT COMP; Bali K., 2015, THESIS; Bartosova-Sojkova P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194042; BASKA F, 1988, DIS AQUAT ORGAN, V5, P23, DOI 10.3354/dao005023; BASKA F, 1987, ACTA VET HUNG, V35, P251; Bjork SJ, 2010, INT J PARASITOL, V40, P1087, DOI 10.1016/j.ijpara.2010.03.005; Chaidir L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052001; Eiras JC, 2005, SYST PARASITOL, V61, P1, DOI 10.1007/s11230-004-6343-9; Eiras JC, 2014, SYST PARASITOL, V88, P11, DOI 10.1007/s11230-014-9484-5; El-Matbouli M, 1999, DIS AQUAT ORGAN, V35, P1, DOI 10.3354/dao035001; ELMATBOULI M, 1995, J FISH BIOL, V46, P919, DOI 10.1111/j.1095-8649.1995.tb01397.x; Eszterbauer E., 2015, MYXOZOAN EVOLUTION E, P175, DOI [10.1007/978-3-319-14753-6_10, DOI 10.1007/978-3-319-14753-6_10]; Eszterbauer E, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0744-2; Fetherman ER, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096954; Fetherman ER, 2012, DIS AQUAT ORGAN, V102, P97, DOI 10.3354/dao02543; Forro B, 2016, FOLIA PARASIT, V63, DOI 10.14411/fp.2016.019; Garver KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146229; Gilad O, 2004, DIS AQUAT ORGAN, V60, P179, DOI 10.3354/dao060179; Hartigan A, 2016, SCI REP-UK, V6, DOI 10.1038/srep39093; Hedrick RP, 1999, DIS AQUAT ORGAN, V37, P173, DOI 10.3354/dao037173; Hedrick RP, 2003, DIS AQUAT ORGAN, V55, P37, DOI 10.3354/dao055037; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Herczeg D, 2017, ACTA VET HUNG, V65, P517, DOI 10.1556/004.2017.050; HOFFMAN G L, 1990, Journal of Aquatic Animal Health, V2, P30, DOI 10.1577/1548-8667(1990)002&lt;0030:MCAWCO&gt;2.3.CO;2; Holzer AS, 2013, PARASITOLOGY, V140, P46, DOI 10.1017/S0031182012001175; Kallert D.M., 2015, MYXOZOAN EVOLUTION E, P235, DOI DOI 10.1007/978-3-319-14753-6_13; Kallert DM, 2011, INT J PARASITOL, V41, P271, DOI 10.1016/j.ijpara.2010.09.012; Kallert DM, 2009, DIS AQUAT ORGAN, V84, P123, DOI 10.3354/dao02034; Kallert DM, 2012, FISH SHELLFISH IMMUN, V33, P969, DOI 10.1016/j.fsi.2012.08.012; Kallert DM, 2005, PARASITOLOGY, V131, P609, DOI 10.1017/S0031182005008383; Kelley GO, 2004, J VET DIAGN INVEST, V16, P202, DOI 10.1177/104063870401600305; Lom J, 2006, FOLIA PARASIT, V53, P1, DOI 10.14411/fp.2006.001; Lom J., 1992, DEV AQUACULTURE FISH; Marton S, 2012, J FISH DIS, V35, P303, DOI 10.1111/j.1365-2761.2012.01347.x; Molnar K, 2002, J FISH DIS, V25, P643, DOI 10.1046/j.1365-2761.2002.00409.x; Molnar K, 2006, DIS AQUAT ORGAN, V73, P49, DOI 10.3354/dao073049; Molnar K, 2015, MYXOZOAN EVOLUTION E, P295, DOI DOI 10.1007/978-3-319-14753-6_16; Molnar K, 2010, PARASITOL RES, V107, P1137, DOI 10.1007/s00436-010-1982-z; Sarker S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178687; Steinbach Elwell LC, 2009, WHIRLING DIS US SUMM; Szekely C, 2001, J FISH DIS, V24, P461, DOI 10.1046/j.1365-2761.2001.00324.x; WHIPPS C. M., 2015, MYXOZOAN EVOLUTION E, P85, DOI [10.1007/978-3-319-14753-6_5, DOI 10.1007/978-3-319-14753-6_5]; WOLF K, 1984, SCIENCE, V225, P1449, DOI 10.1126/science.225.4669.1449	43	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2018	13	9							e0204437	10.1371/journal.pone.0204437	http://dx.doi.org/10.1371/journal.pone.0204437			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU5MM	30240456	Green Submitted, Green Published, gold			2022-12-26	WOS:000445329700050
J	El Masry, MS; Chaffee, S; Das Ghatak, P; Mathew-Steiner, SS; Das, A; Higuita-Castro, N; Roy, S; Anani, RA; Sen, CK				El Masry, Mohamed S.; Chaffee, Scott; Das Ghatak, Piya; Mathew-Steiner, Shomita S.; Das, Amitava; Higuita-Castro, Natalia; Roy, Sashwati; Anani, Raafat A.; Sen, Chandan K.			Stabilized collagen matrix dressing improves wound macrophage function and epithelialization	FASEB JOURNAL			English	Article						antimicrobial peptides; ECM; scaffold; biofilm; cytokines	ANTIMICROBIAL PEPTIDES; EQUINE PERICARDIUM; SKIN; INNATE; INFLAMMATION; CYTOKINE; IMMUNITY; EXPRESSION; REPAIR; BETA-DEFENSIN-2	Decellularized matrices of biologic tissue have performed well as wound care dressings. Extracellular matrix-based dressings are subject to rapid degradation by excessive protease activity at the wound environment. Stabilized, acellular, equine pericardial collagen matrix (sPCM) wound care dressing is flexible cross-linked proteolytic enzyme degradation resistant. sPCM was structurally characterized utilizing scanning electron and atomic force microscopy. In murine excisional wounds, sPCM was effective in mounting an acute inflammatory response. Postwound inflammation resolved rapidly, as indicated by elevated levels of IL-10, arginase-1, and VEGF, and lowering of IL-1 and TNF-. sPCM induced antimicrobial proteins S100A9 and -defensin-1 in keratinocytes. Adherence of Pseudomonas aeruginosa and Staphylococcus aureus on sPCM pre-exposed to host immune cells in vivo was inhibited. Excisional wounds dressed with sPCM showed complete closure at d 14, while control wounds remained open. sPCM accelerated wound re-epithelialization. sPCM not only accelerated wound closure but also improved the quality of healing by increased collagen deposition and maturation. Thus, sPCM is capable of presenting scaffold functionality during the course of wound healing. In addition to inducing endogenous antimicrobial defense systems, the dressing itself has properties that minimize biofilm formation. It mounts robust inflammation, a process that rapidly resolves, making way for wound healing to advance.El Masry, M. S., Chaffee, S., Das Ghatak, P., Mathew-Steiner, S. S., Das, A., Higuita-Castro, N., Roy, S., Anani, R. A., Sen, C. K. Stabilized collagen matrix dressing improves wound macrophage function and epithelialization.	[El Masry, Mohamed S.; Das Ghatak, Piya; Mathew-Steiner, Shomita S.; Das, Amitava; Roy, Sashwati; Sen, Chandan K.] Indiana Univ Sch Med, Indiana Ctr Regenerat Med & Engn, Comprehens Wound Ctr, Dept Surg,IUH, Indianapolis, IN 46202 USA; [El Masry, Mohamed S.; Chaffee, Scott; Das Ghatak, Piya; Mathew-Steiner, Shomita S.; Das, Amitava; Higuita-Castro, Natalia; Roy, Sashwati; Sen, Chandan K.] Ohio State Univ, Dept Surg, Wexner Med Ctr, Columbus, OH 43210 USA; [El Masry, Mohamed S.; Anani, Raafat A.] Zagazig Univ, Dept Plast & Reconstruct Surg, Zagazig, Egypt	Indiana University System; Indiana University Bloomington; University System of Ohio; Ohio State University; Egyptian Knowledge Bank (EKB); Zagazig University	Sen, CK (corresponding author), Indiana Univ Sch Med, 975 W Walnut St,Med Res Lib Bldg,Suite 454, Indianapolis, IN 46202 USA.	cksen@iu.edu	MATHEW-STEINER, SHOMITA S/AAE-8041-2022; El Masry, Mohamed S/J-4691-2017; Das, Amitava/AAJ-5682-2020	El Masry, Mohamed S/0000-0002-2686-1509; DAS, AMITAVA/0000-0003-4307-562X; Mathew-Steiner, Shomita/0000-0002-7730-9140	U.S. National Institutes of Health [GM077185, GM069589, NR013898, NR015676, DK076566]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK114718, U01DK119099, R56DK076566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR015676, R01NR013898] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	The authors thank Dr. B. Deng (Center for Electron Microscopy and Analysis College of Engineering, The Ohio State University) for her assistance with light microscopy studies on sPCM. This work was supported by U.S. National Institutes of Health Grants GM077185 and GM069589 (National Institute of General Medical Sciences), NR013898 and NR015676 (National Institute of Nursing Research), and DK076566 (National Institute of Diabetes and Digestive and Kidney Diseases). This work was supported, in part, by an unrestricted gift from Harbor MedTech (Irvine, CA, USA). The authors declare no conflicts of interest.	Achterberg VF, 2014, J INVEST DERMATOL, V134, P1862, DOI 10.1038/jid.2014.90; Alexander JH, 2012, J AM PODIAT MED ASSN, V102, P352, DOI 10.7547/1020352; Anderson Kristin, 2012, J Am Coll Clin Wound Spec, V4, P84, DOI 10.1016/j.jccw.2014.03.001; Autengruber A, 2012, EUR J MICROBIOL IMMU, V2, P112, DOI 10.1556/EuJMI.2.2012.2.3; Awad H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047569; Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003; Barki KG, 2019, ANN SURG, V269, P756, DOI 10.1097/SLA.0000000000002504; Boateng JS, 2008, J PHARM SCI-US, V97, P2892, DOI 10.1002/jps.21210; Bosanquet DC, 2014, WOUND REPAIR REGEN, V22, P143, DOI 10.1111/wrr.12149; Braff MH, 2005, J INVEST DERMATOL, V124, P394, DOI 10.1111/j.0022-202X.2004.23443.x; Brancato SK, 2011, AM J PATHOL, V178, P19, DOI 10.1016/j.ajpath.2010.08.003; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Broughton G, 2006, PLAST RECONSTR SURG, V117, p6S, DOI 10.1097/01.prs.0000225429.76355.dd; Chen HW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28842-8; Chung PY, 2017, J MICROBIOL IMMUNOL, V50, P405, DOI 10.1016/j.jmii.2016.12.005; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Das A, 2016, J IMMUNOL, V196, P5089, DOI 10.4049/jimmunol.1502270; Das A, 2015, AM J PATHOL, V185, P2596, DOI 10.1016/j.ajpath.2015.06.001; Dhivya S, 2015, BIOMEDICINE-TAIWAN, V5, P24, DOI 10.7603/s40681-015-0022-9; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Edwards H, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-86; Efron PA, 2004, J BURN CARE REHABIL, V25, P149, DOI 10.1097/01.BCR.0000111766.97335.34; Elgharably H, 2014, WOUND REPAIR REGEN, V22, P720, DOI 10.1111/wrr.12229; Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8; Fleck Cynthia A, 2007, Adv Skin Wound Care, V20, P256, DOI 10.1097/01.ASW.0000269310.00145.e2; Fleischli JG, 2009, J AM PODIAT MED ASSN, V99, P301, DOI 10.7547/0980301; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Ghatak S, 2015, MOL THER, V23, P1201, DOI 10.1038/mt.2015.65; Gjodsbol Kristine, 2006, Int Wound J, V3, P225, DOI 10.1111/j.1742-481X.2006.00159.x; Gniadecki R, 2001, EXP DERMATOL, V10, P71, DOI 10.1034/j.1600-0625.2001.010002071.x; Grant CA, 2012, ACTA BIOMATER, V8, P4123, DOI 10.1016/j.actbio.2012.06.042; Guani-Guerra E, 2010, CLIN IMMUNOL, V135, P1, DOI 10.1016/j.clim.2009.12.004; Guo JJ, 2010, J SURG RES, V159, P503, DOI 10.1016/j.jss.2008.09.018; Held M, 2015, WOUNDS, V27, P123; Higuita-Castro N, 2014, J APPL PHYSIOL, V117, P1231, DOI 10.1152/japplphysiol.00752.2013; Howard OMZ, 2002, J EXP MED, V196, P781, DOI 10.1084/jem.20020186; Hsu Kenneth, 2009, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V8, P290; Huang LC, 2007, ANTIMICROB AGENTS CH, V51, P3853, DOI 10.1128/AAC.01317-06; HURME T, 1991, LAB INVEST, V64, P76; IRETON JE, 2013, PRS GLOB OPEN, V1, DOI DOI 10.1097/GOX.0B013E31828FF9F4; Isomaki P, 1996, ARTHRITIS RHEUM-US, V39, P386, DOI 10.1002/art.1780390306; Izadpanah A, 2005, J AM ACAD DERMATOL, V52, P381, DOI 10.1016/j.jaad.2004.08.026; Jarbrink K, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0329-y; Jayakumar R, 2011, BIOTECHNOL ADV, V29, P322, DOI 10.1016/j.biotechadv.2011.01.005; Joo HS, 2012, CHEM BIOL, V19, P1503, DOI 10.1016/j.chembiol.2012.10.022; Kadler KE, 1996, BIOCHEM J, V316, P1; Khanna S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009539; Kimball A, 2018, ARTERIOSCL THROM VAS, V38, P1102, DOI 10.1161/ATVBAHA.118.310703; Kirschner N, 2012, EXP DERMATOL, V21, P171, DOI 10.1111/j.1600-0625.2011.01431.x; Lai YP, 2009, TRENDS IMMUNOL, V30, P131, DOI 10.1016/j.it.2008.12.003; Lebeaux D, 2014, MICROBIOL MOL BIOL R, V78, P510, DOI 10.1128/MMBR.00013-14; Lim SY, 2011, ANTIOXID REDOX SIGN, V15, P2235, DOI 10.1089/ars.2010.3641; Lin SL, 2009, J IMMUNOL, V183, P6733, DOI 10.4049/jimmunol.0901473; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; McDonald PP, 1999, J IMMUNOL, V163, P6164; Menke NB, 2007, CLIN DERMATOL, V25, P19, DOI 10.1016/j.clindermatol.2006.12.005; Mirza RE, 2015, CYTOKINE, V71, P409, DOI 10.1016/j.cyto.2014.09.005; Moore Z, 1997, World Ir Nurs, V5, P15; Morrison G, 2002, INFECT IMMUN, V70, P3053, DOI 10.1128/IAI.70.6.3053-3060.2002; Moser C, 2002, INFECT IMMUN, V70, P3068, DOI 10.1128/IAI.70.6.3068-3072.2002; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mulder G, 2009, WOUNDS, V21, P254; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Murray PJ, 2005, P NATL ACAD SCI USA, V102, P8686, DOI 10.1073/pnas.0500419102; Nataraj C, 2007, WOUNDS, V19, P148; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Oren A, 2003, EXP MOL PATHOL, V74, P180, DOI 10.1016/S0014-4800(02)00023-0; Ortega-Gomez A, 2013, EMBO MOL MED, V5, P661, DOI 10.1002/emmm.201202382; Perumal S, 2008, P NATL ACAD SCI USA, V105, P2824, DOI 10.1073/pnas.0710588105; Ramachandran P, 2012, P NATL ACAD SCI USA, V109, pE3186, DOI 10.1073/pnas.1119964109; Ramos-e-Silva M, 2002, CLIN DERMATOL, V20, P715, DOI 10.1016/S0738-081X(02)00298-5; Roy S, 2014, J PATHOL, V233, P331, DOI 10.1002/path.4360; Rubin RH, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-171; Sebastian A, 2011, WOUND REPAIR REGEN, V19, P693, DOI 10.1111/j.1524-475X.2011.00736.x; Seif-Naraghi SB, 2010, TISSUE ENG PT A, V16, P2017, DOI [10.1089/ten.tea.2009.0768, 10.1089/ten.TEA.2009.0768]; Shah Jayesh B, 2011, J Am Col Certif Wound Spec, V3, P65, DOI 10.1016/j.jcws.2012.04.002; Sheridan RL, 2001, BURNS, V27, P92, DOI 10.1016/S0305-4179(00)00076-0; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Strasser S, 2007, BIOCHEM BIOPH RES CO, V354, P27, DOI 10.1016/j.bbrc.2006.12.114; Strecker-McGraw MK, 2007, EMERG MED CLIN N AM, V25, P1, DOI 10.1016/j.emc.2006.12.002; Taylor PR, 2003, IMMUNITY, V19, P2, DOI 10.1016/S1074-7613(03)00178-X; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; VIEIRA P, 1991, P NATL ACAD SCI USA, V88, P1172, DOI 10.1073/pnas.88.4.1172; WILLIAMS BR, 1978, J BIOL CHEM, V253, P6578; Wolf M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00213; Xue ML, 2015, ADV WOUND CARE, V4, P119, DOI 10.1089/wound.2013.0485; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Yang D, 2001, CELL MOL LIFE SCI, V58, P978, DOI 10.1007/PL00000914; Yates CC, 2012, BIRTH DEFECTS RES C, V96, P325, DOI 10.1002/bdrc.21024; Yazdanpanah L, 2015, WORLD J DIABETES, V6, P37, DOI 10.4239/wjd.v6.i1.37; Zdrenghea MT, 2015, REV MED VIROL, V25, P33, DOI 10.1002/rmv.1817; Zelen CM, 2015, INT WOUND J, V12, P724, DOI 10.1111/iwj.12395; Zheng MH, 2005, J BIOMED MATER RES B, V73B, P61, DOI 10.1002/jbm.b.30170	94	30	30	4	34	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2144	2155		10.1096/fj.201800352R	http://dx.doi.org/10.1096/fj.201800352R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30260708	Green Published			2022-12-26	WOS:000457296600050
J	Helmke, A; Casper, J; Nordlohne, J; David, S; Haller, H; Zeisberg, EM; von Vietinghoff, S				Helmke, Alexandra; Casper, Janis; Nordlohne, Johannes; David, Sascha; Haller, Hermann; Zeisberg, Elisabeth M.; von Vietinghoff, Sibylle			Endothelial-to-mesenchymal transition shapes the atherosclerotic plaque and modulates macrophage function	FASEB JOURNAL			English	Article						endothelium; disturbed flow; hypoxia; macrophage lipid uptake	APOPTOTIC CELL ACCUMULATION; HIGH-DENSITY-LIPOPROTEINS; PRIMARY CILIA; INFLAMMATION; MONOCYTES; RECEPTOR; DIFFERENTIATION; CONTRIBUTES; RECRUITMENT; DYSFUNCTION	Endothelial cells can acquire a mesenchymal phenotype upon irritation [endothelial-to-mesenchymal transition (EndMT)]. Macrophages accumulate in the atherosclerotic plaque. This study addressed whether macrophages modulate EndMT and delineated a reciprocal effect of EndMT on macrophage functions in atherosclerosis. In atherosclerotic murine and human aortas, endothelial cells with mesenchymal markers were elevated by confocal microscopy and flow cytometric analysis. Increased EndMT master transcription factor Snai1 expression and extracellular matrix are consistent with enhanced EndMT in this condition. Hypoxia was detected in individual aortic EndMT cells in vivo and rapidly induced a similar EndMT phenotype in vitro. As a novel inducer of EndMT, macrophages, which are abundant in the atherosclerotic lesions, enhance mesothelial marker expression during coculture in vitro. In the reverse relationship, EndMT altered endothelial colony-stimulating factor expression. Functionally, EndMT cell-conditioned media attenuated macrophage proliferation, antigen-presenting cell marker expression, and TNF- production in response to oxidized LDL but increased oxidized LDL uptake and scavenger receptor expression. These experiments demonstrate that macrophages promote partial EndMT. In turn, EndMT cells modulate macrophage phenotype and lipid uptake. Our data suggest that EndMT shapes macrophage and endothelial cell phenotypes, thus affecting internal atherosclerotic plaque in addition to surface structure.Helmke, A., Casper, J., Nordlohne, J., David, S., Haller, H., Zeisberg, E. M., von Vietinghoff, S. Endothelial-to-mesenchymal transition shapes the atherosclerotic plaque and modulates macrophage function.	[Helmke, Alexandra; Casper, Janis; Nordlohne, Johannes; David, Sascha; Haller, Hermann; von Vietinghoff, Sibylle] Hannover Med Sch, Dept Internal Med, Div Nephrol & Hypertens, Hannover, Germany; [Zeisberg, Elisabeth M.] Univ Med Ctr Gottingen, Dept Cardiol & Pneumol, Gottingen, Germany; [Zeisberg, Elisabeth M.] German Ctr Cardiovasc Res DZHK, Partner Site Gottingen, Gottingen, Germany	Hannover Medical School; University of Gottingen; German Centre for Cardiovascular Research	von Vietinghoff, S (corresponding author), Hannover Med Sch, Dept Nephrol & Hypertens, OE 6840,Carl Neuberg Str 1, D-30625 Hannover, Germany.	vonvietinghoff.sibylle@mh-hannover.de	Zeisberg, Elisabeth/ABG-4970-2021; David, Sascha/AAL-6909-2021	Nordlohne, Alexandra/0000-0002-6177-0637	Bundesministerium fur Bildung und Forschung [Deutsches Zentrum fur Herz- und Kreislauferkrankungen (DZHK)]; Deutsche Forschungsgemeinschaft	Bundesministerium fur Bildung und Forschung [Deutsches Zentrum fur Herz- und Kreislauferkrankungen (DZHK)]; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors acknowledge support of the Imaging and Flow Cytometry Sorting Core Facilities at Hannover Medical School, and also thank Martina Flechsig and Yvonne Nicolai for expert technical work. The authors acknowledge the Department of Pathology at Hannover Medical School for cooperation for acquisition of patient samples. This work was supported by Bundesministerium fur Bildung und Forschung [Deutsches Zentrum fur Herz- und Kreislauferkrankungen (DZHK)] to E.Z. and S.v.V., and Deutsche Forschungsgemeinschaft to S.D., H.H., and S.v.V. The authors declare no conflicts of interest.	Ait-Oufella H, 2008, ARTERIOSCL THROM VAS, V28, P1429, DOI 10.1161/ATVBAHA.108.169078; Akhtar S, 2015, HYPERTENSION, V66, P1220, DOI 10.1161/HYPERTENSIONAHA.115.05886; Boulanger CM, 2016, ARTERIOSCL THROM VAS, V36, pE26, DOI 10.1161/ATVBAHA.116.306940; Bryan MT, 2014, ARTERIOSCL THROM VAS, V34, P2199, DOI 10.1161/ATVBAHA.114.303424; Cahill PA, 2016, ATHEROSCLEROSIS, V248, P97, DOI 10.1016/j.atherosclerosis.2016.03.007; Cai BS, 2017, J CLIN INVEST, V127, P564, DOI 10.1172/JCI90520; Chen PY, 2015, J CLIN INVEST, V125, P4514, DOI 10.1172/JCI82719; Chen PY, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005504; Cheng SL, 2013, ARTERIOSCL THROM VAS, V33, P1679, DOI 10.1161/ATVBAHA.113.300647; Chinetti-Gbaguidi G, 2015, NAT REV CARDIOL, V12, P10, DOI 10.1038/nrcardio.2014.173; Dinsmore C, 2016, EMBO REP, V17, P156, DOI 10.15252/embr.201541019; Dong L, 2016, J AM SOC NEPHROL, V27, P1753, DOI 10.1681/ASN.2015050540; Doran AC, 2017, J CLIN INVEST, V127, P4075, DOI 10.1172/JCI94735; Draude G, 2000, AM J PHYSIOL-HEART C, V278, pH1042, DOI 10.1152/ajpheart.2000.278.4.H1042; Drechsler M, 2015, ARTERIOSCL THROM VAS, V35, P1050, DOI 10.1161/ATVBAHA.114.304649; Egorova AD, 2011, CIRC RES, V108, P1093, DOI 10.1161/CIRCRESAHA.110.231860; Evrard SM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11853; Feng S, 2017, ARTERIOSCL THROM VAS, V37, P2087, DOI 10.1161/ATVBAHA.117.309249; Franck G, 2017, CIRC RES, V121, P31, DOI 10.1161/CIRCRESAHA.117.310694; Ge SW, 2013, CIRC RES, V113, P965, DOI 10.1161/CIRCRESAHA.113.301934; Hansson GK, 2015, J INTERN MED, V278, P483, DOI 10.1111/joim.12406; He HH, 2012, BLOOD, V120, P3152, DOI 10.1182/blood-2012-04-422758; Jakubzick C, 2013, IMMUNITY, V39, P599, DOI 10.1016/j.immuni.2013.08.007; Kim M, 2013, INT J RADIAT BIOL, V89, P356, DOI 10.3109/09553002.2013.763193; Koltsova EK, 2013, CURR OPIN LIPIDOL, V24, P371, DOI 10.1097/MOL.0b013e328363d298; Koltsova EK, 2012, J CLIN INVEST, V122, P3114, DOI 10.1172/JCI61758; Kwak BR, 2014, EUR HEART J, V35, P3013, DOI 10.1093/eurheartj/ehu353; Libby P, 2016, J AM COLL CARDIOL, V67, P1091, DOI 10.1016/j.jacc.2015.12.048; Mahmoud MM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03532-z; Mahmoud MM, 2016, CIRC RES, V119, P450, DOI 10.1161/CIRCRESAHA.116.308870; Medici D, 2012, SEMIN CANCER BIOL, V22, P379, DOI 10.1016/j.semcancer.2012.04.004; Medici D, 2010, NAT MED, V16, P1400, DOI 10.1038/nm.2252; Moonen JRAJ, 2015, CARDIOVASC RES, V108, P377, DOI 10.1093/cvr/cvv175; Randolph GJ, 1998, SCIENCE, V282, P480, DOI 10.1126/science.282.5388.480; Retzlaff J, 2017, SCI REP-UK, V7, DOI 10.1038/srep44113; Rieder F, 2011, AM J PATHOL, V179, P2660, DOI 10.1016/j.ajpath.2011.07.042; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sanchez-Duffhues G, 2015, ARTERIOSCL THROM VAS, V35, P616, DOI 10.1161/ATVBAHA.115.305268; Spillmann F, 2015, ARTERIOSCL THROM VAS, V35, P1774, DOI 10.1161/ATVBAHA.115.305887; Tarling EJ, 2013, CURR OPIN LIPIDOL, V24, P138, DOI 10.1097/MOL.0b013e32835da122; Thorp E, 2008, ARTERIOSCL THROM VAS, V28, P1421, DOI 10.1161/ATVBAHA.108.167197; van Meeteren LA, 2012, CELL TISSUE RES, V347, P177, DOI 10.1007/s00441-011-1222-6; Westerterp M, 2014, CIRC RES, V114, P157, DOI 10.1161/CIRCRESAHA.114.300738; Westhorpe CLV, 2012, EXP MOL PATHOL, V93, P220, DOI 10.1016/j.yexmp.2012.03.014; Witztum JL, 2005, J CLIN INVEST, V115, P2072, DOI 10.1172/JCI26130; Witztum JL, 2014, ANNU REV PATHOL-MECH, V9, P73, DOI 10.1146/annurev-pathol-020712-163936; Wu D, 2017, ELIFE, V6; Wu KQ, 2017, AM J PATHOL, V187, P2102, DOI 10.1016/j.ajpath.2017.05.014; Xu XB, 2015, J BIOL CHEM, V290, P16653, DOI 10.1074/jbc.M115.636944; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zuckerman SH, 2001, ATHEROSCLEROSIS, V155, P79, DOI 10.1016/S0021-9150(00)00540-2	51	25	25	1	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2278	2289		10.1096/fj.201801238R	http://dx.doi.org/10.1096/fj.201801238R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30260706				2022-12-26	WOS:000457296600060
J	Kim, HS; Kim, Y; Lim, MJ; Park, YG; Park, SI; Sohn, J				Kim, Hee Suk; Kim, Yongjin; Lim, Min Jae; Park, Yun-Gyu; Park, Serk In; Sohn, Jeongwon			The p38-activated ER stress-ATF6 axis mediates cellular senescence	FASEB JOURNAL			English	Article						NBR1; NADPH oxidase; oxidative stress; p53; Ras	ENDOPLASMIC-RETICULUM STRESS; P38 MAPK; PREMATURE SENESCENCE; UP-REGULATION; ACTIVATION; KINASE; CELLS; APOPTOSIS; AUTOPHAGY; INHIBITION	The importance of proteostasis in preventing cellular senescence has been well recognized. However, the exact mechanism by which the loss of proteostasis or endoplasmic reticulum (ER) stress induces cellular senescence remains unclear. We report that ER stress mediates cellular senescence through the activating transcription factor (ATF)6 branch of the unfolded protein response (UPR). Cellular senescence was induced by the abrogation of neighbor of breast cancer (BRCA)1 gene (NBR1). NBR1 abrogation-induced senescence was p53 dependent and observed in both transformed and nontransformed human cell lines: MCF-7, Caki-1, and MRC-5. NBR1 bound to p38 MAPK, preferentially to an active form, and upon NBR1 abrogation, the activity of p38 increased. NADPH oxidase was activated in turn by p38, and the resulting oxidative stress triggered ER stress. It was found that ER stress mediated cellular senescence through the UPR sensor ATF6. Knockdown of ATF6 prevented senescence, whereas ATF6 overexpression triggered it. The transcriptional activity of ATF6 was important. The ER stress-ATF6 axis also mediated cellular senescence induced by H-RasV12 overexpression and UV irradiation, suggesting a common role of this axis in senescence induction. In summary, we presented an evidence for the novel role of the ER stress-ATF6 axis in cellular senescence.Kim, H. S., Kim, Y., Lim, M. J., Park, Y.-G., Park, S. I., Sohn, J. The p38-activated ER stress-ATF6 axis mediates cellular senescence.	[Kim, Hee Suk; Kim, Yongjin; Lim, Min Jae; Park, Yun-Gyu; Park, Serk In; Sohn, Jeongwon] Korea Univ, Dept Biochem & Mol Biol, Coll Med, Moonsook Med Hall,73 Inchon Ro, Seoul 02841, South Korea; [Kim, Hee Suk; Kim, Yongjin; Lim, Min Jae; Park, Yun-Gyu; Park, Serk In; Sohn, Jeongwon] Korea Inst Mol Med & Nutr, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine)	Sohn, J (corresponding author), Korea Univ, Dept Biochem & Mol Biol, Coll Med, Moonsook Med Hall,73 Inchon Ro, Seoul 02841, South Korea.	biojs@korea.ac.kr	Park, Serk In/D-2840-2011; cioffi, federica/AAB-8161-2019	Park, Serk In/0000-0001-8643-5096; cioffi, federica/0000-0002-1530-8556; Sohn, Jeongwon/0000-0003-2395-458X	National Research Foundation of Korea (NRF) - Korean Government [NRF-2014R1A1A2058003]; Korea University Executive Vice President for Medical Affairs [K1723221]	National Research Foundation of Korea (NRF) - Korean Government; Korea University Executive Vice President for Medical Affairs	This work was supported by the National Research Foundation of Korea (NRF) funded by the Korean Government (Grant NRF-2014R1A1A2058003 to J.S.), and the Korea University Executive Vice President for Medical Affairs (Grant K1723221 to J.S.). The authors declare no conflicts of interest.	Barascu A, 2012, EMBO J, V31, P1080, DOI 10.1038/emboj.2011.492; Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817; Chen HS, 2015, MOL CELL, V59, P719, DOI 10.1016/j.molcel.2015.07.011; Corazzari M, 2015, CELL DEATH DIFFER, V22, P946, DOI 10.1038/cdd.2014.183; Daido S, 2005, CANCER RES, V65, P4368, DOI 10.1158/0008-5472.CAN-04-4202; Denoyelle C, 2006, NAT CELL BIOL, V8, P1053, DOI 10.1038/ncb1471; Deosaran E, 2013, J CELL SCI, V126, P939, DOI 10.1242/jcs.114819; Dorr JR, 2013, NATURE, V501, P421, DOI 10.1038/nature12437; Druelle C, 2016, ONCOTARGET, V7, P67699, DOI 10.18632/oncotarget.11505; Dufey E, 2015, SEMIN CANCER BIOL, V33, P40, DOI 10.1016/j.semcancer.2015.04.003; Feaver RE, 2008, ARTERIOSCL THROM VAS, V28, P1534, DOI 10.1161/ATVBAHA.108.167999; Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69; Haq R, 2002, CANCER RES, V62, P5076; Hitomi J, 2004, NEUROSCI LETT, V357, P127, DOI 10.1016/j.neulet.2003.12.080; Hong EH, 2010, J BIOL CHEM, V285, P1283, DOI 10.1074/jbc.M109.058628; Iwasa H, 2003, GENES CELLS, V8, P131, DOI 10.1046/j.1365-2443.2003.00620.x; Karali E, 2014, MOL CELL, V54, P559, DOI 10.1016/j.molcel.2014.03.022; Kim HD, 2013, J BIOL CHEM, V288, P28743, DOI 10.1074/jbc.M113.499053; Kim HS, 2016, INT J CANCER, V138, P1432, DOI 10.1002/ijc.29879; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Kraft C, 2010, NAT CELL BIOL, V12, P836, DOI 10.1038/ncb0910-836; Kwong J, 2009, J BIOL CHEM, V284, P11237, DOI 10.1074/jbc.M808327200; Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006; Li B, 2015, BBA-MOL BASIS DIS, V1852, P805, DOI 10.1016/j.bbadis.2015.01.010; Lin HK, 2010, NATURE, V464, P374, DOI 10.1038/nature08815; Liu J, 2014, CELL SIGNAL, V26, P110, DOI 10.1016/j.cellsig.2013.10.002; Luo Y, 2011, EXP GERONTOL, V46, P860, DOI 10.1016/j.exger.2011.07.005; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Mardakheh FK, 2009, J CELL BIOL, V187, P265, DOI 10.1083/jcb.200905118; Matos L, 2015, J GERONTOL A-BIOL, V70, P924, DOI 10.1093/gerona/glu129; Nicke B, 2005, MOL CELL, V20, P673, DOI 10.1016/j.molcel.2005.10.038; Pedruzzi E, 2004, MOL CELL BIOL, V24, P10703, DOI 10.1128/MCB.24.24.10703-10717.2004; Pluquet O, 2015, AM J PHYSIOL-CELL PH, V308, pC415, DOI 10.1152/ajpcell.00334.2014; Ranganathan AC, 2006, CANCER RES, V66, P1702, DOI 10.1158/0008-5472.CAN-05-3092; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; Schewe DM, 2008, P NATL ACAD SCI USA, V105, P10519, DOI 10.1073/pnas.0800939105; Su DM, 2011, BIOCHEM J, V433, P333, DOI 10.1042/BJ20100404; Sun PQ, 2007, CELL, V128, P295, DOI 10.1016/j.cell.2006.11.050; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Teodoro T, 2012, AM J PHYSIOL-CELL PH, V302, pC992, DOI 10.1152/ajpcell.00160.2011; Wang WP, 2002, MOL CELL BIOL, V22, P3389, DOI 10.1128/MCB.22.10.3389-3403.2002; Whitehouse CA, 2010, P NATL ACAD SCI USA, V107, P12913, DOI 10.1073/pnas.0913058107; Xu YX, 2014, TRENDS BIOCHEM SCI, V39, P268, DOI 10.1016/j.tibs.2014.04.004; Yosef R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11190; Zhang SS, 2003, CIRC RES, V93, P1026, DOI 10.1161/01.RES.0000104084.88317.91; Zhu BK, 2014, J BIOL CHEM, V289, P20102, DOI 10.1074/jbc.M114.551069	48	26	27	3	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2422	2434		10.1096/fj.201800836R	http://dx.doi.org/10.1096/fj.201800836R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30260700				2022-12-26	WOS:000457296600071
J	Clifton-Brown, JC; Senior, H; Purdy, SJ; Horsnell, R; Lankamp, B; Muennekhoff, AK; Virk, D; Guillemois, E; Chetty, V; Cookson, A; Girdwood, S; Clifton-Brown, G; Tan, MLMC; Awty-Carroll, D; Bentley, AR				Clifton-Brown, John C.; Senior, Hannah; Purdy, Sarah J.; Horsnell, Richard; Lankamp, Bernd; Mueennekhoff, Ann-Katrin; Virk, Daljit; Guillemois, Estelle; Chetty, Vera; Cookson, Alan; Girdwood, Sarah; Clifton-Brown, Gabi; Tan, Mei Lie M. C.; Awty-Carroll, Danny; Bentley, Alison R.			Investigating the potential of novel non-woven fabrics for efficient pollination control in plant breeding	PLOS ONE			English	Article							SEED YIELD; ARABIDOPSIS-THALIANA; HIGH-TEMPERATURE; POLLEN DEVELOPMENT; HARVEST INDEX; WHEAT; SIZE; BAGS; HYBRIDIZATION; SWITCHGRASS	Plant breeding is achieved through the controlled self- or cross-pollination of individuals and typically involves isolation of floral parts from selected parental plants. Paper, cellulose or synthetic materials are used to avoid self pollination or cross contamination. Low seed set limits the rate of breeding progress and increases costs. We hypothesized that a novel 'non-woven' fabric optimal for both pollination and seed set in multiple plant species could be developed. After determining the baseline pollen characteristics and usage requirements we established iterative three phase development and biological testing. This determined (1) that white fabric gave superior seed return and informed the (2) development of three non-woven materials using different fibre and layering techniques. We tested their performance in selfing and hybridisation experiments recording differences in performance by material type within species. Finally we (3) developed further advanced fabrics with increased air permeability and tested biological performance. An interaction between material type and species was observed and environmental decoupling investigated, showing that the non-woven fabrics had superior water vapour transmission and temperature regulation compared to controls. Overall, non-woven fabrics outperformed existing materials for both pollination and seed set and we found that different materials can optimize species-specific, rather than species-generic performance.	[Clifton-Brown, John C.; Purdy, Sarah J.; Cookson, Alan; Girdwood, Sarah; Clifton-Brown, Gabi; Awty-Carroll, Danny] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales; [Senior, Hannah; Virk, Daljit] PBS Int, Scarborough, England; [Horsnell, Richard; Bentley, Alison R.] NIAB, John Bingham Lab, Cambridge, England; [Lankamp, Bernd; Mueennekhoff, Ann-Katrin] KWS SAAT SE, Einbeck, Germany; [Guillemois, Estelle; Chetty, Vera] Nonwovens Innovat & Res Inst Ltd, Leeds, W Yorkshire, England; [Tan, Mei Lie M. C.] CreaNova Consultancy, Munden, Germany	Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS)	Bentley, AR (corresponding author), NIAB, John Bingham Lab, Cambridge, England.	alison.bentley@niab.com	Clifton-Brown, John/AAE-8154-2022; Awty-Carroll, Danny/AAR-4866-2020	Clifton-Brown, John/0000-0001-6477-5452; Awty-Carroll, Danny/0000-0001-5855-0775	InnovateUK (via Agri-Tech Early-Stage Feasibility Project) [131893]; UK Biotechnology and Biological Sciences Research Council [BBSRC: IBERS BB/N0071X/1, NIAB BB/N004752/1]; InnovateUK; BBSRC; Biotechnology and Biological Sciences Research Council [BB/N00471X/1] Funding Source: researchfish; BBSRC [BBS/E/C/000I0280, BB/N00471X/1, BB/N004752/1] Funding Source: UKRI	InnovateUK (via Agri-Tech Early-Stage Feasibility Project); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); InnovateUK(UK Research & Innovation (UKRI)Innovate UK); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by InnovateUK (via Agri-Tech Early-Stage Feasibility Project 131893) with the academic partners receiving funding from the UK Biotechnology and Biological Sciences Research Council (BBSRC: IBERS BB/N0071X/1; NIAB BB/N004752/1). The funders (InnovateUK and BBSRC) did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The commercial participants (PBS International, KWS SAAT SE, Nonwovens Innovation & Research Institute Ltd & CreaNova Consultancy) primarily contributed staff time as a matched contribution to InnovateUK funding. The objective of InnovateUK Agri-Tech funding is to catalyse public-private partnerships including commercially relevant R&D as described in this paper.	Adhikari L, 2015, BIOENERG RES, V8, P380, DOI 10.1007/s12155-014-9528-3; Alonso-Blanco C, 1999, P NATL ACAD SCI USA, V96, P4710, DOI 10.1073/pnas.96.8.4710; BALL ST, 1992, CROP SCI, V32, P1155, DOI 10.2135/cropsci1992.0011183X003200050019x; Bentley AR, 2014, THEOR APPL GENET, V127, P2619, DOI 10.1007/s00122-014-2403-y; Brewbaker HE, 1934, J AGRIC RES, V48, P0323; Bridgwater FE, 1998, FOREST CHRON, V74, P185, DOI 10.5558/tfc74185-2; CHHABRA N, 1978, ANN BOT-LONDON, V42, P1109, DOI 10.1093/oxfordjournals.aob.a085551; CHOWDHURY SI, 1978, AUST J AGR RES, V29, P205, DOI 10.1071/AR9780205; Clifton-Brown J, 2017, GCB BIOENERGY, V9, P6, DOI 10.1111/gcbb.12357; Demirel N, 2006, CROP PROT, V25, P1062, DOI 10.1016/j.cropro.2006.01.009; Du Pont, 1986, TYV HOUS MAT SPEC IN; Edlund AF, 2004, PLANT CELL, V16, pS84, DOI 10.1105/tpc.015800; Elwell AL, 2011, PLANT CELL ENVIRON, V34, P291, DOI 10.1111/j.1365-3040.2010.02243.x; FOSTER CA, 1970, EUPHYTICA, V19, P61, DOI 10.1007/BF01904667; FOSTER CA, 1968, EUPHYTICA, V17, P102; Gitz D. C., 2015, American Journal of Plant Sciences, V6, P265, DOI 10.4236/ajps.2015.62030; Gitz D.C., 2013, AM J PLANT SCI, V4, P571, DOI [10.4236/ajps.2013.43074, DOI 10.4236/AJPS.2013.43074]; Goins GD, 1997, J EXP BOT, V48, P1407, DOI 10.1093/jxb/48.7.1407; Harsant J, 2013, J EXP BOT, V64, P2971, DOI 10.1093/jxb/ert142; Jensen E, 2011, GCB BIOENERGY, V3, P387, DOI 10.1111/j.1757-1707.2011.01097.x; JURADO E, 1992, J ECOL, V80, P407, DOI 10.2307/2260686; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; KNIGHT R, 1966, EUPHYTICA, V15, P374, DOI 10.1007/BF00022182; Kumar RR, 2014, J PLANT BIOCHEM BIOT, V23, P293, DOI 10.1007/s13562-013-0214-x; LEISHMAN MR, 1994, J ECOL, V82, P249, DOI 10.2307/2261293; MCADAM NJ, 1987, PLANT BREEDING, V98, P178, DOI 10.1111/j.1439-0523.1987.tb01113.x; Muller F, 2016, PLANT REPROD, V29, P107, DOI 10.1007/s00497-016-0282-x; PICKERING RA, 1982, EUPHYTICA, V31, P439, DOI 10.1007/BF00021661; Prasad PVV, 2006, AGR FOREST METEOROL, V139, P237, DOI 10.1016/j.agrformet.2006.07.003; R Core Team, 2013, R LANG ENV STAT COMP; Simmonds J, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0191-9; Van Daele I, 2012, PLANT BIOTECHNOL J, V10, P488, DOI 10.1111/j.1467-7652.2012.00687.x; Vogel KP, 2014, CROP SCI, V54, P1621, DOI 10.2135/cropsci2013.09.0647; Windham GL, 2007, PHYTOPARASITICA, V35, P277, DOI 10.1007/BF02981161; Yun HG, 2017, MYCOBIOLOGY, V45, P192, DOI [10.5941/myco.2017.45.3.192, 10.5941/MYCO.2017.45.3.192]	35	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204728	10.1371/journal.pone.0204728	http://dx.doi.org/10.1371/journal.pone.0204728			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265713	Green Published, Green Submitted, gold			2022-12-26	WOS:000446005500047
J	Faber, H; van Soest, AJ; Kistemaker, DA				Faber, Herre; van Soest, Arthur J.; Kistemaker, Dinant A.			Inverse dynamics of mechanical multibody systems: An improved algorithm that ensures consistency between kinematics and external forces	PLOS ONE			English	Article							OPTIMIZATION; SIMULATIONS; MOMENTS; WALKING; GAIT; LEG	Inverse dynamics is a technique in which measured kinematics and, possibly, external forces are used to calculate net joint torques in a rigid body linked segment model. However, kinematics and forces are usually not consistent due to incorrect modelling assumptions and measurement errors. This is commonly resolved by introducing 'residual forces and torques' which compensate for this problem, but do not exist in reality. In this study a constrained optimization algorithm is proposed that finds the kinematics that are mechanically consistent with measured external forces and mimic the measured kinematics as closely as possible. The algorithm was tested on datasets containing planar kinematics and ground reaction forces obtained during human walking at three velocities (0.8 m/s, 1.25 and 1.8 m/s). Before optimization, the residual force and torque were calculated for a typical example. Both showed substantial values, indicating the necessity of developing a mechanically consistent algorithm. The proposed optimization algorithm converged to a solution in which the residual forces and torques were zero, without changing the ground reaction forces and with only minor changes to the measured kinematics. When using a rigid body approach, our algorithm ensures a consistent description of forces and kinematics, thereby improving the validity of calculated net joint torque and power values.	[Faber, Herre; van Soest, Arthur J.; Kistemaker, Dinant A.] Vrije Univ Amsterdam, Fac Behav & Movement Sci, Dept Human Movement Sci, Amsterdam Movement Sci, Amsterdam, Netherlands; [Faber, Herre] Hague Univ Appl Sci, Fac Hlth Nutr & Sports, The Hague, Netherlands	Vrije Universiteit Amsterdam	Faber, H (corresponding author), Vrije Univ Amsterdam, Fac Behav & Movement Sci, Dept Human Movement Sci, Amsterdam Movement Sci, Amsterdam, Netherlands.; Faber, H (corresponding author), Hague Univ Appl Sci, Fac Hlth Nutr & Sports, The Hague, Netherlands.	h.faber@hhs.nl			Nederlandse Organisatie voor Wetenschappelijk Onderzoek [023.006.090]; HORIZON 2020, The EU Framework Programme for Research and Innovation [H2020-MSCA-IF-665457]	Nederlandse Organisatie voor Wetenschappelijk Onderzoek(Netherlands Organization for Scientific Research (NWO)European Commission); HORIZON 2020, The EU Framework Programme for Research and Innovation	Funded by Nederlandse Organisatie voor Wetenschappelijk Onderzoek. Url: https://www.nwo.nl/. Grant number: 023.006.090. HORIZON 2020, The EU Framework Programme for Research and Innovation. Url: https://ec.europa.eu/programmes/horizon2020/en. Grant number: H2020-MSCA-IF-665457.	Cahouet V, 2002, J BIOMECH, V35, P1507, DOI 10.1016/S0021-9290(02)00176-8; CHAO EY, 1973, J BIOMECH, V6, P497, DOI 10.1016/0021-9290(73)90008-0; De Groote F, 2008, J BIOMECH, V41, P3390, DOI 10.1016/j.jbiomech.2008.09.035; Delp SL, 2007, IEEE T BIO-MED ENG, V54, P1940, DOI 10.1109/TBME.2007.901024; Elftman H, 1939, AM J PHYSIOL, V125, P339, DOI 10.1152/ajplegacy.1939.125.2.339; Fluit R, 2014, J BIOMECH, V47, P2321, DOI 10.1016/j.jbiomech.2014.04.030; Hatze H, 2002, J BIOMECH, V35, P109, DOI 10.1016/S0021-9290(01)00158-0; Kingma I, 1996, HUM MOVEMENT SCI, V15, P833, DOI 10.1016/S0167-9457(96)00034-6; Kuo AD, 1998, J BIOMECH ENG-T ASME, V120, P148, DOI 10.1115/1.2834295; Mazza C, 2004, ANN BIOMED ENG, V32, P764, DOI 10.1023/B:ABME.0000030241.26857.75; Remy CD, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3005148; Riemer R, 2008, J BIOMECH, V41, P1503, DOI 10.1016/j.jbiomech.2008.02.011; Riemer R, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3005155; Thelen DG, 2006, J BIOMECH, V39, P1107, DOI 10.1016/j.jbiomech.2005.02.010; van den Bogert AJ, 2008, COMPUT METHOD BIOMEC, V11, P3, DOI 10.1080/10255840701550865; van Soest AJ, P 15 C ISB JYV; VAUGHAN CL, 1982, J BIOMECH ENG-T ASME, V104, P38, DOI 10.1115/1.3138301; Winter D., 1990, BIOMECHANICS MOTOR C, V2nd	18	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204575	10.1371/journal.pone.0204575	http://dx.doi.org/10.1371/journal.pone.0204575			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265727	Green Published, gold, Green Submitted			2022-12-26	WOS:000446005500038
J	Marencakova, J; Maly, T; Sugimoto, D; Gryc, T; Zahalka, F				Marencakova, Jitka; Maly, Tomas; Sugimoto, Dai; Gryc, Tomas; Zahalka, Frantisek			Foot typology, body weight distribution, and postural stability of adolescent elite soccer players: A 3-year longitudinal study	PLOS ONE			English	Article							UNIPEDAL STANCE; INJURIES; STRENGTH; PERFORMANCE; AGE; ASYMMETRIES; BREAK; ANKLE; ARCH	Objective The unique foot morphology and distinctive functions facilitate complex tasks and strategies such as standing, walking, and running. In those weight-bearing activities, postural stability (PS) plays an important role. Correlations among foot type, PS, and other musculoskeletal problems that increase sport injury risk are known. However, long-term associations among the foot type, the PS, and body weight (BW) distribution are lacking. Thus, the purpose of this study was to longitudinally identify changes in foot morphology, PS, and symmetry in BW distribution during adolescence among elite male soccer players. Methods Thirty-five Czech elite male soccer players (age, 15.49 +/- 0.61 years; BW, 64.11 +/- 6.16 kg; body height, 174.62 +/- 5.71 cm) underwent foot type, PS, and BW distribution measurements during 3 consecutive years (T1, T2, T3). The Chippaux-Smirak index (CSI), BW distribution, and centre of pressure (COP) displacement (total traveled way [TTW]) of each player for the preferred (PL) and non-preferred leg (NL) were acquired. Repeated-measures analysis of variance (RM ANOVA), Bonferroni's post hoc tests, and partial eta-squared (eta(2)(p)) coefficient were used for investigating the effect of time on selected variables and effect size evaluation. Results Statistically significant effect of time on CSI values (PL: F-2,F-68 = 5.08, p < 0.01, eta(2)(p) = 0.13 and NL: F-2,F-68 = 10.87, p < 0.01, eta(2)(p) = 0.24) and COP displacement values (PL: F-2,F-68 = 5.07, p < 0.01, eta(2)(p) = 0.13; NL: F-2,F-68 = 3.53, p <0.05, eta(2)(p) = 0.09) for both legs over 3-years period was identified. Furthermore, the Bonferroni's post hoc analysis revealed a significant improvement of PS values in the PL (TTWT1 = 1617.11 +/- 520.22 mm vs. TTWT2 = 1405.29 +/- 462.76, p < 0.05; and between TTWT1 = 1617.11 +/- 520.22 mm vs. TTWT3 = 1370.46 +/- 373.94, p < 0.05). Only BW distribution parameter showed no significant differences, although that slightly improved over time. Conclusions We observed changes in foot typology, PS, and BW distribution in young elite male soccer players during 3 consecutive years. Results demonstrated that changes in PS and body weight distribution under the high-load sport conditions during adolescence may improve with aging, except for foot morphology. Therefore, foot morphology should be carefully monitored to minimize sport injury risk in professional young soccer players during adolescence. Further research is necessary to determine more clear associations between these parameters, soccer-related injuries, and sport performances.	[Marencakova, Jitka; Maly, Tomas; Gryc, Tomas; Zahalka, Frantisek] Charles Univ Prague, Fac Phys Educ & Sport, Sport Res Ctr, Prague, Czech Republic; [Sugimoto, Dai] Childrens Hosp Boston, Orthoped Ctr, Boston, MA USA; [Sugimoto, Dai] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Sugimoto, Dai] Harvard Med Sch, Dept Orthopaed Surg, Boston, MA USA	Charles University Prague; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Maly, T (corresponding author), Charles Univ Prague, Fac Phys Educ & Sport, Sport Res Ctr, Prague, Czech Republic.	maly@ftvs.cuni.cz	Maly, Tomas/AAK-2224-2021; Marenčáková, Jitka/D-9406-2017; Maly, Tomas/R-1147-2017; Gryc, Tomáš/E-3827-2017	Maly, Tomas/0000-0001-5439-6766; Marenčáková, Jitka/0000-0003-1981-818X; Maly, Tomas/0000-0001-5439-6766; Gryc, Tomáš/0000-0002-6793-6490	GACR [16-21791 S]; Czech Science Foundation [GACR 16-21791 S]; Charles University, Prague, Czech Republic [UNCE/HUM/032]	GACR(Grant Agency of the Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic); Charles University, Prague, Czech Republic(Czech Republic Government)	This study was supported by GACR 16-21791 S and UNCE/HUM/032: 1) GACR 16-21791 S was supported by Czech Science Foundation (Applicant Tomas Maly, Ph.D.); 2) UNCE/HUM/032 was supported by Charles University, Prague, Czech Republic (Applicant Prof. Frantisek Zahalka, Ph.D.).	Beynnon BD, 2002, J ATHL TRAINING, V37, P376; Billis E, 2007, FOOT, V17, P65, DOI DOI 10.1016/J.FOOT.2006.09.005; Cheng PT, 2001, ARCH PHYS MED REHAB, V82, P1650, DOI 10.1053/apmr.2001.26256; DeSilva JM, 2015, AM J PHYS ANTHROPOL, V156, P543, DOI 10.1002/ajpa.22699; DeSilva JM, 2013, AM J PHYS ANTHROPOL, V151, P495, DOI 10.1002/ajpa.22287; Dvorak J, 2008, F MARC MANUAL FOTBAL; Dvorak R, 2000, REHAB FYZ LEK, V3, P102; Earls J., 2014, BORN WALK MYOFASCIAL; Ekstrand J, 2011, BRIT J SPORT MED, V45, P553, DOI 10.1136/bjsm.2009.060582; EKSTRAND J, 1983, MED SCI SPORT EXER, V15, P267, DOI 10.1249/00005768-198315030-00014; Fousekis K, 2010, J SPORT SCI MED, V9, P364; Gill SV, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0554-5; Gill SV, 2014, BIOMED RES INT, V2014, P1; Haendlmayer KT., 2009, ORTHOPAEDICS TRAUMA, V23, P395; Harrison P.L., 2010, INDIAN J PHYSIOTHER, V4, P21; Harriss DJ, 2015, INT J SPORTS MED, V36, P1121, DOI 10.1055/s-0035-1565186; Inklaar H, 1996, INT J SPORTS MED, V17, P229, DOI 10.1055/s-2007-972837; Junge Astrid, 2004, Sports Med, V34, P929, DOI 10.2165/00007256-200434130-00004; Kapteyn T S, 1983, Agressologie, V24, P321; Kaufman KR, 1999, AM J SPORT MED, V27, P585, DOI 10.1177/03635465990270050701; Klementa J., 1987, SOMATOMETRIE NOHY; KNAPIK JJ, 1991, AM J SPORT MED, V19, P76, DOI 10.1177/036354659101900113; Le Gall F, 2006, AM J SPORT MED, V34, P928, DOI 10.1177/0363546505283271; Lin YC, 2010, J SPORT REHABIL, V19, P21, DOI 10.1123/jsr.19.1.21; Mala L, 2017, ACTA KINESIOL, V11, P101; Maly T, 2018, INT J SPORTS MED, V39, P297, DOI 10.1055/s-0043-123648; Maly T, 2016, INT J MORPHOL, V34, P1339, DOI 10.4067/S0717-95022016000400027; Maly T, 2015, OPEN MED-WARSAW, V10, P224, DOI 10.1515/med-2015-0034; Marencakova J, 2016, ACTA GYMNICA, V46, P74, DOI 10.5507/ag.2016.004; Onodera Andrea Naomi, 2008, Foot (Edinb), V18, P142, DOI 10.1016/j.foot.2008.03.003; Paillard T, 2006, J ATHL TRAINING, V41, P172; Philippaerts RM, 2006, J SPORT SCI, V24, P221, DOI 10.1080/02640410500189371; Queen RM, 2007, FOOT ANKLE INT, V28, P456, DOI 10.3113/FAI.2007.0456; Queen RM, 2009, GAIT POSTURE, V29, P582, DOI 10.1016/j.gaitpost.2008.12.010; Scott G, 2007, GAIT POSTURE, V26, P68, DOI 10.1016/j.gaitpost.2006.07.009; Smith EP, 2018, J CLIN SPORT PSYCHOL, P1; TIBERIO D, 1988, PHYS THER, V68, P1840, DOI 10.1093/ptj/68.12.1840; TROPP H, 1984, MED SCI SPORT EXER, V16, P64; Villarroya MA, 2009, EUR J PEDIATR, V168, P559, DOI 10.1007/s00431-008-0789-8; Wong P, 2005, BRIT J SPORT MED, V39, P473, DOI 10.1136/bjsm.2004.015511; Wright WG, 2012, J NEUROPHYSIOL, V107, P1513, DOI 10.1152/jn.00256.2011	41	2	2	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204578	10.1371/journal.pone.0204578	http://dx.doi.org/10.1371/journal.pone.0204578			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265689	Green Submitted, Green Published, gold			2022-12-26	WOS:000446005500039
J	Moravcova, S; Pacesova, D; Melkes, B; Kyclerova, H; Spisska, V; Novotny, J; Bendova, Z				Moravcova, Simona; Pacesova, Dominika; Melkes, Barbora; Kyclerova, Hana; Spisska, Veronika; Novotny, Jiri; Bendova, Zdenka			The day/night difference in the circadian clock's response to acute lipopolysaccharide and the rhythmic Stat3 expression in the rat suprachiasmatic nucleus	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; MESSENGER-RNA LEVELS; REV-ERB-ALPHA; TNF-ALPHA; GENE-EXPRESSION; PARAVENTRICULAR NUCLEUS; BIOLOGICAL CLOCK; PHASE-SHIFTS; MOUSE; RECEPTOR	The circadian clock in the suprachiasmatic nucleus (SCN) regulates daily rhythms in physiology and behaviour and is an important part of the mammalian homeostatic system. Previously, we have shown that systemic inflammatory stimulation with lipopolysaccharide (LPS) induced the daytime-dependent phosphorylation of STAT3 in the SCN. Here, we demonstrate the LPS-induced Stat3 mRNA expression in the SCN and show also the circadian rhythm in Stat3 expression in the SCN, with high levels during the day. Moreover, we examined the effects of LPS (1mg/kg), applied either during the day or the night, on the rhythm in locomotor activity of male Wistar rats. We observed that recovery of normal locomotor activity patterns took longer when the animals were injected during the night. The clock genes Pert, Per2and Nr1d1, and phosphorylation of kinases ERK1/2 and GSK3 beta are sensitive to external cues and function as the molecular entry for external signals into the circadian clockwork. We also studied the immediate changes in these clock genes expressions and the phosphorylation of ERK1/2 and GSK3 beta in the suprachiasmatic nucleus in response to daytime or night-time inflammatory stimulation. We revealed mild and transient changes with respect to the controls. Our data stress the role of STAT3 in the circadian clock response to the LPS and provide further evidence of the interaction between the circadian clock and immune system.	[Moravcova, Simona; Pacesova, Dominika; Melkes, Barbora; Kyclerova, Hana; Spisska, Veronika; Novotny, Jiri; Bendova, Zdenka] Charles Univ Prague, Fac Sci, Dept Physiol, Prague, Czech Republic; [Moravcova, Simona; Pacesova, Dominika; Bendova, Zdenka] Natl Inst Mental Hlth, Dept Sleep Med & Chronobiol, Klecany, Czech Republic	Charles University Prague; National Institute of Mental Health - Czech Republic	Bendova, Z (corresponding author), Charles Univ Prague, Fac Sci, Dept Physiol, Prague, Czech Republic.; Bendova, Z (corresponding author), Natl Inst Mental Hlth, Dept Sleep Med & Chronobiol, Klecany, Czech Republic.	zdenka.bendova@natur.cuni.cz	Novotny, Jiri/B-2163-2012; Bendová, Zdeňka/GSE-1065-2022; Melkes, Barbora/AAL-5349-2020; Pačesová, Dominika/N-3885-2017; Bendová, Zdenka/T-7733-2019; Míková, Hana/AAB-8201-2020; Bendová, Zdeňka/J-5045-2014; Benediktova, Simona/N-3888-2017	Novotny, Jiri/0000-0002-6372-0131; Bendová, Zdeňka/0000-0002-2693-2143; Pačesová, Dominika/0000-0002-7359-5135; Bendová, Zdenka/0000-0002-2693-2143; Míková, Hana/0000-0003-0151-9042; Bendová, Zdeňka/0000-0002-2693-2143; Benediktova, Simona/0000-0002-0959-8673	Charles University Grant Agency [361115]; Czech Science Foundation [18-08423S]; MEYS under the NPU I programme [LO1611]	Charles University Grant Agency; Czech Science Foundation(Grant Agency of the Czech Republic); MEYS under the NPU I programme	This work was supported by Charles University Grant Agency no. 361115 (SM); by the Czech Science Foundation, contract grant number 18-08423S (ZB), and by institutional project no. LO1611 with financial support from the MEYS under the NPU I programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama M, 1999, J NEUROSCI, V19, P1115; Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Albrecht U, 2012, NEURON, V74, P246, DOI 10.1016/j.neuron.2012.04.006; Bendova Z, 2012, NEUROCHEM INT, V61, P43, DOI 10.1016/j.neuint.2012.04.016; Beurel E, 2008, J BIOL CHEM, V283, P21934, DOI 10.1074/jbc.M802481200; Beurel E, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-9; Beynon AL, 2010, CHRONOBIOL INT, V27, P1546, DOI 10.3109/07420528.2010.501927; Bhattacharya A, 2013, J NEUROSCI, V33, P8035, DOI 10.1523/JNEUROSCI.4682-12.2013; Castanon-Cervantes O, 2010, J IMMUNOL, V185, P5796, DOI 10.4049/jimmunol.1001026; Cavadini G, 2007, P NATL ACAD SCI USA, V104, P12843, DOI 10.1073/pnas.0701466104; Cervena K, 2015, J MOL NEUROSCI, V56, P371, DOI 10.1007/s12031-015-0563-0; Ceyzeriat K, 2016, NEUROSCIENCE, V330, P205, DOI 10.1016/j.neuroscience.2016.05.043; Chen CC, 1999, MOL PHARMACOL, V55, P481; Damm J, 2013, NEUROPHARMACOLOGY, V71, P98, DOI 10.1016/j.neuropharm.2013.03.014; Duhart JM, 2016, NEUROPHARMACOLOGY, V108, P373, DOI 10.1016/j.neuropharm.2016.05.005; Duhart JM, 2013, J IMMUNOL, V191, P4656, DOI 10.4049/jimmunol.1300450; Dziema H, 2003, EUR J NEUROSCI, V17, P1617, DOI 10.1046/j.1460-9568.2003.02592.x; Fukuhara C, 2001, NEUROSCI LETT, V314, P119, DOI 10.1016/S0304-3940(01)02304-7; Gibbs JE, 2012, P NATL ACAD SCI USA, V109, P582, DOI 10.1073/pnas.1106750109; Green HF, 2012, NEUROCHEM INT, V61, P666, DOI 10.1016/j.neuint.2012.07.003; Guerrero-Vargas NN, 2014, J NEUROIMMUNOL, V273, P22, DOI 10.1016/j.jneuroim.2014.05.012; Hahnova K, 2016, CHRONOBIOL INT, V33, P141, DOI 10.3109/07420528.2015.1120741; HART BL, 1988, NEUROSCI BIOBEHAV R, V12, P123, DOI 10.1016/S0149-7634(88)80004-6; Horikawa K, 2000, J NEUROSCI, V20, P5867, DOI 10.1523/JNEUROSCI.20-15-05867.2000; Iitaka C, 2005, J BIOL CHEM, V280, P29397, DOI 10.1074/jbc.M503526200; Leone MJ, 2012, CHRONOBIOL INT, V29, P715, DOI 10.3109/07420528.2012.682681; Kalsbeek A, 2012, CHRONOBIOL INT, V29, P835, DOI 10.3109/07420528.2012.699123; Kiessling S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11297-8; Kurabayashi N, 2006, CHRONOBIOL INT, V23, P129, DOI 10.1080/07420520500464478; Leone MJ, 2006, J NEUROSCI RES, V84, P1521, DOI 10.1002/jnr.21042; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu DG, 2016, EXP CELL RES, V341, P54, DOI 10.1016/j.yexcr.2016.01.009; Marpegan L, 2005, J NEUROIMMUNOL, V160, P102, DOI 10.1016/j.jneuroim.2004.11.003; Mateju K, 2009, EUR J NEUROSCI, V29, P490, DOI 10.1111/j.1460-9568.2009.06609.x; Maywood ES, 1999, P NATL ACAD SCI USA, V96, P15211, DOI 10.1073/pnas.96.26.15211; Moravcova S, 2016, J NEUROSCI RES, V94, P99, DOI 10.1002/jnr.23673; Morin LP, 2007, J BIOL RHYTHM, V22, P3, DOI 10.1177/0748730406296749; Obrietan K, 1998, NAT NEUROSCI, V1, P693, DOI 10.1038/3695; Okada K, 2008, J SURG RES, V145, P5, DOI 10.1016/j.jss.2007.01.010; Osland TM, 2011, J PSYCHOPHARMACOL, V25, P924, DOI 10.1177/0269881110379508; Pacesova D, 2015, BRIT J PHARMACOL, V172, P3638, DOI 10.1111/bph.13152; Paladino N, 2014, CHRONOBIOL INT, V31, P668, DOI 10.3109/07420528.2014.886588; Paladino N, 2010, J NEUROIMMUNOL, V225, P62, DOI 10.1016/j.jneuroim.2010.04.015; Petrzilka S, 2009, J BIOL RHYTHM, V24, P283, DOI 10.1177/0748730409336579; Rawadi G, 1998, J IMMUNOL, V160, P1330; Reischl S, 2011, FEBS LETT, V585, P1393, DOI 10.1016/j.febslet.2011.02.038; Rummel C, 2016, BRAIN BEHAV IMMUN, V54, P1, DOI 10.1016/j.bbi.2015.09.003; Sadki A, 2007, NEUROBIOL AGING, V28, P296, DOI 10.1016/j.neurobiolaging.2005.12.007; Sanada K, 2004, GENES CELLS, V9, P697, DOI 10.1111/j.1356-9597.2004.00758.x; Sanada K, 2002, J BIOL CHEM, V277, P267, DOI 10.1074/jbc.M107850200; Sarafian TA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009532; Sato S, 2014, SCI WORLD J, DOI 10.1155/2014/685854; Sato S, 2014, J IMMUNOL, V192, P407, DOI 10.4049/jimmunol.1301982; Shearman LP, 1997, NEURON, V19, P1261, DOI 10.1016/S0896-6273(00)80417-1; Singru PS, 2008, ENDOCRINOLOGY, V149, P2283, DOI 10.1210/en.2007-1478; Sotak M, 2011, AM J PHYSIOL-GASTR L, V301, pG1066, DOI 10.1152/ajpgi.00256.2011; Svobodova I, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00192; Takahashi S, 2001, ENDOCRINOLOGY, V142, P4910, DOI 10.1210/en.142.11.4910; Wachulec M, 1997, J BIOL RHYTHM, V12, P226, DOI 10.1177/074873049701200304; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818	60	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0199405	10.1371/journal.pone.0199405	http://dx.doi.org/10.1371/journal.pone.0199405			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265676	Green Published, Green Submitted, gold			2022-12-26	WOS:000446005500002
J	Abouelkhair, MA; Bemis, DA; Giannone, RJ; Frank, LA; Kania, SA				Abouelkhair, Mohamed A.; Bemis, David A.; Giannone, Richard J.; Frank, Linda A.; Kania, Stephen A.			Characterization of a leukocidin identified in Staphylococcus pseudintermedius	PLOS ONE			English	Article							PHAGE SEARCH TOOL; KLUYVEROMYCES-LACTIS; HUMAN NEUTROPHILS; AUREUS VACCINE; RESISTANT; LEUKOTOXINS; LEUCOCIDIN; ANTIBODIES; BACTERIA; PHAST	Bacterial infections from Staphylococcus pseudintermedius are the most common cause of skin infections (pyoderma) affecting dogs. Two component pore-forming leukocidins are a family of potent toxins secreted by staphylococci and consist of S (slow) and F (fast) components. They impair the innate immune system, the first line of defense against these pathogens. Seven different leukocidins have been characterized in Staphylococcus aureus, some of which are host and cell specific. Through genome sequencing and analysis of the S. pseudintermedius secretome using liquid chromatography mass spectrometry we identified two proteins, named "LukS-I" and "LukF-I", encoded on a degenerate prophage contained in the genome of S. pseudintermedius isolates. Phylogenetic analysis of LukS-I components in comparison to the rest of the leukocidin family showed that LukS-I was most closely related to S. intermedius LukS-I, S. aureus LukE and LukP, whereas LukF-I was most similar to S. intermedius LukF-I S. aureus gamma hemolysin subunit B. The killing effect of recombinant S. pseudintermedius LukS-I and LukF-I on canine polymorphonuclear leukocytes was determined using a flow cytometry cell permeability assay. The cytotoxic effect occurred only when the two recombinant proteins were combined. Engineered mutant versions of the two-component pore-forming leukocidins, produced through amino acids substitutions at selected points, were not cytotoxic. Anti-Luk-I produced in dogs against attenuated proteins reduced the cytotoxic effect of native canine leukotoxin which highlights the importance of Luk-I as a promising component in a vaccine against canine S. pseudintermedius infections.	[Abouelkhair, Mohamed A.; Bemis, David A.; Kania, Stephen A.] Univ Tennessee, Coll Vet Med, Dept Biomed & Diagnost Sci, Knoxville, TN 37996 USA; [Abouelkhair, Mohamed A.] Univ Sadat City, Dept Bacteriol Mycol & Immunol, Fac Vet Med, Menoufia, Egypt; [Giannone, Richard J.] Oak Ridge Natl Lab, Biol Mass Spectrometry, Chem Sci Div, Oak Ridge, TN USA; [Frank, Linda A.] Univ Tennessee, Coll Vet Med, Dept Small Anim Clin Sci, Knoxville, TN USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; Egyptian Knowledge Bank (EKB); University of Sadat City; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Kania, SA (corresponding author), Univ Tennessee, Coll Vet Med, Dept Biomed & Diagnost Sci, Knoxville, TN 37996 USA.	skania@utk.edu	Abouelkhair, Mohamed/AAA-4665-2020; Kania, Stephen/ABF-6920-2021; Giannone, Richard/ABC-8247-2020	Abouelkhair, Mohamed/0000-0003-0109-6000; Giannone, Richard/0000-0001-8551-0138; Frank, Linda/0000-0002-7726-8297; Kania, Stephen/0000-0002-4490-7347	Egyptian Cultural and Educational Bureau, Washington DC; University of Tennessee, Center of Excellence in Livestock Diseases and Human Health	Egyptian Cultural and Educational Bureau, Washington DC(Egyptian Cultural & Educational Bureau); University of Tennessee, Center of Excellence in Livestock Diseases and Human Health	This research was supported by the Egyptian Cultural and Educational Bureau, Washington DC (to MAA) and University of Tennessee, Center of Excellence in Livestock Diseases and Human Health (to SAK, DAB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari RP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137874; Arndt D, 2016, NUCLEIC ACIDS RES, V44, pW16, DOI 10.1093/nar/gkw387; Bagnoli F, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00016; Begier E, 2017, VACCINE, V35, P1132, DOI 10.1016/j.vaccine.2017.01.024; Cheung GYC, 2012, EXPERT OPIN THER TAR, V16, P601, DOI 10.1517/14728222.2012.682573; Colussi PA, 2005, APPL ENVIRON MICROB, V71, P7092, DOI 10.1128/AEM.71.11.7092-7098.2005; Daum RS, 2012, CLIN INFECT DIS, V54, P560, DOI 10.1093/cid/cir828; Descloux S, 2008, J CLIN MICROBIOL, V46, P1818, DOI 10.1128/JCM.02255-07; DuMont AL, 2013, P NATL ACAD SCI USA, V110, P10794, DOI 10.1073/pnas.1305121110; DuMont AL, 2013, INFECT IMMUN, V81, P1830, DOI 10.1128/IAI.00095-13; Holman J. D., 2012, CURR PROTOC BIOINFOR, V13, P17, DOI [DOI 10.1002/0471250953.BI1317S37, 10.1002/0471250953.bi1317s37]; Karauzum H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065384; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Koop G, 2017, SCI REP-UK, V7, DOI 10.1038/srep40660; Lochner A, 2011, APPL ENVIRON MICROB, V77, P4042, DOI 10.1128/AEM.02811-10; Loffler B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000715; Moodley A, 2014, VET MICROBIOL, V171, P337, DOI 10.1016/j.vetmic.2014.02.008; Perreten V, 2010, J ANTIMICROB CHEMOTH, V65, P1145, DOI 10.1093/jac/dkq078; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Platko JD, 2008, PROTEIN EXPRES PURIF, V57, P57, DOI 10.1016/j.pep.2007.08.013; PREVOST G, 1995, FEBS LETT, V376, P135, DOI 10.1016/0014-5793(95)01260-9; Read JD, 2007, APPL ENVIRON MICROB, V73, P5088, DOI 10.1128/AEM.02253-06; Solyman SM, 2013, J CLIN MICROBIOL, V51, P306, DOI 10.1128/JCM.02421-12; van Ooyen AJJ, 2006, FEMS YEAST RES, V6, P381, DOI 10.1111/j.1567-1364.2006.00049.x; Videla R, 2018, MICROB DRUG RESIST, V24, P83, DOI 10.1089/mdr.2016.0250; Vrieling M, 2015, MBIO, V6, DOI 10.1128/mBio.00335-15; Vrieling M, 2016, SCI REP-UK, V6, DOI 10.1038/srep37759; Wass MN, 2010, NUCLEIC ACIDS RES, V38, pW469, DOI 10.1093/nar/gkq406; Weese JS, 2010, VET MICROBIOL, V140, P418, DOI 10.1016/j.vetmic.2009.01.039; WOODIN AM, 1959, BIOCHEM J, V73, P225, DOI 10.1042/bj0730225; WOODIN AM, 1960, BIOCHEM J, V75, P158, DOI 10.1042/bj0750158; Xu Q, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501254; Yoong P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9125; Yoong P, 2013, CURR OPIN MICROBIOL, V16, P63, DOI 10.1016/j.mib.2013.01.012; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	37	15	15	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204450	10.1371/journal.pone.0204450	http://dx.doi.org/10.1371/journal.pone.0204450			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30261001	Green Submitted, gold, Green Published			2022-12-26	WOS:000445907400052
J	Furukawa, Y; Lim, C; Tosha, T; Yoshida, K; Hagai, T; Akiyama, S; Watanabe, S; Nakagome, K; Shiro, Y				Furukawa, Yoshiaki; Lim, Carolyn; Tosha, Takehiko; Yoshida, Koki; Hagai, Tomoaki; Akiyama, Shuji; Watanabe, Shoji; Nakagome, Kenta; Shiro, Yoshitsugu			Identification of a novel zinc-binding protein, C1orf123, as an interactor with a heavy metal-associated domain	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE 1; COPPER CHAPERONE ATX1; SECONDARY STRUCTURE; TERMINAL DOMAIN; CU(I); METALLOCHAPERONES; ACTIVATION; MATURATION; MUTANTS; SPECTRA	Heavy metal-associated (HMA) domains bind metal ions at its Cys-x-x-Cys (CxxC) motif and constitute an intracellular network for trafficking of metal ions for utilization and detoxification. We thus expect that novel metalloproteins can be identified by screening proteins interacting with a HMA domain. In this study, we performed yeast two-hybrid screening of the human proteome and found an uncharacterized protein encoded as open reading frame 123 in chromosome 1 (C1orf123) that can interact specifically with the HMA domain of a copper chaperone for superoxide dismutase (CCSdI). Our X-ray structural analysis of C1orf123 further revealed that it binds a Zn2+ ion in a tetrahedral coordination with four thiolate groups from two conserved CxxC motifs. For the interaction between C1orf123 and CCSdI, the CxxC motifs in both C1orf123 and CCSdI were required, implying metal-mediated interaction through the CxxC motifs. Notably, C1orf123 did not interact with several other HMA domains containing CxxC motifs, supporting high specificity in the interaction between C1orf123 and CCSdI. Based upon these results, we further discuss functional and structural significance of the interaction between C1orf123 and CCS.	[Furukawa, Yoshiaki; Lim, Carolyn; Yoshida, Koki; Hagai, Tomoaki; Nakagome, Kenta] Keio Univ, Dept Chem, Yokohama, Kanagawa, Japan; [Tosha, Takehiko] RIKEN SPring 8 Ctr, Sayo, Hyogo, Japan; [Akiyama, Shuji] NINS, Inst Mol Sci, Res Ctr Integrat Mol Syst CIMoS, Okazaki, Aichi, Japan; [Akiyama, Shuji] SOKENDAI Grad Univ Adv Studies, Dept Funct Mol Sci, Okazaki, Aichi, Japan; [Watanabe, Shoji] Doshisha Univ, Grad Sch Brain Sci, Kyoto, Japan; [Shiro, Yoshitsugu] Univ Hyogo, Grad Sch Life Sci, Ako, Hyogo, Japan	Keio University; RIKEN; National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); Graduate University for Advanced Studies - Japan; Doshisha University; University of Hyogo	Furukawa, Y (corresponding author), Keio Univ, Dept Chem, Yokohama, Kanagawa, Japan.	furukawa@chem.keio.ac.jp	Furukawa, Yoshiaki/F-2871-2014; Tosha, Takehiko/AAR-2404-2020	Furukawa, Yoshiaki/0000-0002-1918-372X; Tosha, Takehiko/0000-0002-8971-0759; AKIYAMA, Shuji/0000-0002-7184-189X	Japan Society for the Promotion of Science [16H04768, 17H05705, 18H04564]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-Aid 16H04768 for Scientific Research (B) (to YF) and 17H05705, 18H04564 for Scientific Research on Innovative Areas (to YF) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen S, 2012, BIOCHEMISTRY-US, V51, P1439, DOI 10.1021/bi201370r; Arnesano F, 2002, GENOME RES, V12, P255, DOI 10.1101/gr.196802; Arnesano F, 2001, J BIOL CHEM, V276, P41365, DOI 10.1074/jbc.M104807200; Badarau A, 2013, CHEM COMMUN, V49, P8000, DOI 10.1039/c3cc42709a; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Banci L, 2006, NAT CHEM BIOL, V2, P367, DOI 10.1038/nchembio797; Banci L, 2013, CHEMBIOCHEM, V14, P1839, DOI 10.1002/cbic.201300042; Boal AK, 2009, CHEM REV, V109, P4760, DOI 10.1021/cr900104z; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; DiDonato M, 1997, BBA-MOL BASIS DIS, V1360, P3, DOI 10.1016/S0925-4439(96)00064-6; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fetherolf MM, 2017, J BIOL CHEM, V292, P12025, DOI 10.1074/jbc.M117.775981; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Fukuoka M, 2017, J INORG BIOCHEM, V175, P208, DOI 10.1016/j.jinorgbio.2017.07.036; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Holmes MA, 2006, ACTA CRYSTALLOGR F, V62, P180, DOI 10.1107/S1744309106005847; Kahra D, 2016, BIOPHYS J, V110, P95, DOI 10.1016/j.bpj.2015.11.016; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Kirby K, 2008, J BIOL CHEM, V283, P35393, DOI 10.1074/jbc.M807131200; Laitaoja M, 2013, INORG CHEM, V52, P10983, DOI 10.1021/ic401072d; Lamb AL, 1999, NAT STRUCT BIOL, V6, P724; Ma Z, 2009, CHEM REV, V109, P4644, DOI 10.1021/cr900077w; O'Halloran TV, 2000, J BIOL CHEM, V275, P25057, DOI 10.1074/jbc.R000006200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; Schmidt PJ, 2000, J BIOL CHEM, V275, P33771, DOI 10.1074/jbc.M006254200; Schmidt PJ, 1999, J BIOL CHEM, V274, P23719, DOI 10.1074/jbc.274.34.23719; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Van Dongen EMWM, 2006, J AM CHEM SOC, V128, P10754, DOI 10.1021/ja0610030; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; Xiao ZG, 2002, CHEM COMMUN, P588, DOI 10.1039/b111180a; Yu J, 2010, BIOINFORMATICS, V26, P46, DOI 10.1093/bioinformatics/btp599	37	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204355	10.1371/journal.pone.0204355	http://dx.doi.org/10.1371/journal.pone.0204355			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30260988	Green Published, Green Submitted, gold			2022-12-26	WOS:000445907400039
J	Bellwald, S; Balasubramaniam, R; Nagler, M; Burri, MS; Fischer, SDA; Hakim, A; Dobrocky, T; Yu, YN; Scalzo, F; Heldner, MR; Wiest, R; Mono, ML; Sarikya, H; El-Koussy, M; Mordasini, P; Fischer, U; Schroth, G; Gralla, J; Mettle, HP; Arnold, M; Liebeskind, D; Jung, S				Bellwald, Sebastian; Balasubramaniam, Rupashani; Nagler, Michael; Burri, Meret S.; Fischer, Samuel D. A.; Hakim, Arsany; Dobrocky, Tomas; Yu, Yannan; Scalzo, Fabien; Heldner, Mirjam R.; Wiest, Roland; Mono, Marie-Luise; Sarikya, Hakan; El-Koussy, Marwan; Mordasini, Pasquale; Fischer, Urs; Schroth, Gerhard; Gralla, Jan; Mettle, Heinrich P.; Arnold, Marcel; Liebeskind, David; Jung, Simon			Association of anemia and hemoglobin decrease during acute stroke treatment with infarct growth and clinical outcome	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; SEVERE ISOVOLEMIC ANEMIA; INTRAARTERIAL THROMBOLYSIS; CEREBRAL AUTOREGULATION; ARTERY-OCCLUSION; HEMODILUTION; INCREASES; PARAMETERS; DILUTION; IMPACT	Background and purpose Anemia is associated with worse outcome in stroke, but the impact of anemia with intravenous thrombolysis or endovascular therapy has hardly been delineated. The aim of this study was to analyze the role of anemia on infarct evolution and outcome after acute stroke treatment. Methods 1158 patients from Bern and 321 from Los Angeles were included. Baseline data and 3 months outcome assessed with the modified Rankin Scale were recorded prospectively. Baseline DWI lesion volumes were measured in 345 patients and both baseline and final infarct volumes in 180 patients using CT or MRI. Multivariable and linear regression analysis were used to determine predictors of outcome and infarct growth. Results 712 patients underwent endovascular treatment and 446 intravenous thrombolysis. Lower hemoglobin at baseline, at 24h, and nadir until day 5 predicted poor outcome (OR 1.150-1.279) and higher mortality (OR 1.131-1.237) independently of treatment. Decrease of hemoglobin after hospital arrival, mainly induced by hemodilution, predicted poor outcome and had a linear association with final infarct volumes and the amount and velocity of infarct growth. Infarcts of patients with newly observed anemia were twice as large as infarcts with normal hemoglobin levels. Conclusion Anemia at hospital admission and any hemoglobin decrease during acute stroke treatment affect outcome negatively, probably by enlarging and accelerating infarct growth. Our results indicate that hemodilution has an adverse effect on penumbral evolution. Whether hemoglobin decrease in acute stroke could be avoided and whether this would improve outcome would need to be studied prospectively.	[Bellwald, Sebastian; Balasubramaniam, Rupashani; Burri, Meret S.; Fischer, Samuel D. A.; Heldner, Mirjam R.; Mono, Marie-Luise; Sarikya, Hakan; Fischer, Urs; Mettle, Heinrich P.; Arnold, Marcel; Jung, Simon] Univ Bern, Bern Univ Hosp, Inselspital, Dept Neurol, Bern, Switzerland; [Balasubramaniam, Rupashani; Hakim, Arsany; Dobrocky, Tomas; Wiest, Roland; El-Koussy, Marwan; Mordasini, Pasquale; Schroth, Gerhard; Gralla, Jan] Univ Bern, Bern Univ Hosp, Inselspital, Univ Inst Diagnost & Intervent Neuroradiol, Bern, Switzerland; [Nagler, Michael] Univ Bern, Bern Univ Hosp, Inselspital, Dept Haematol, Bern, Switzerland; [Nagler, Michael] Univ Bern, Bern Univ Hosp, Inselspital, Cent Haematol Lab, Bern, Switzerland; [Nagler, Michael] Univ Bern, Dept Clin Res, Bern, Switzerland; [Yu, Yannan; Scalzo, Fabien; Liebeskind, David; Jung, Simon] Univ Calif Los Angeles, Neurovasc Imaging Res Core, Los Angeles, CA 90095 USA; [Yu, Yannan; Scalzo, Fabien; Liebeskind, David; Jung, Simon] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Jung, S (corresponding author), Univ Bern, Bern Univ Hosp, Inselspital, Dept Neurol, Bern, Switzerland.; Jung, S (corresponding author), Univ Calif Los Angeles, Neurovasc Imaging Res Core, Los Angeles, CA 90095 USA.; Jung, S (corresponding author), Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA.	simon.jung@insel.ch	Hakim, Arsany/I-2505-2019; Mordasini, Pasquale/H-8321-2015; Scalzo, Fabien/AAM-6328-2020; Nagler, Michael/H-6715-2019	Hakim, Arsany/0000-0001-9431-1069; Scalzo, Fabien/0000-0001-9755-8104; Nagler, Michael/0000-0003-4319-2367; Fischer, Urs/0000-0003-0521-4051; Heldner, Mirjam R/0000-0002-3594-2159	Swiss Heart Foundation	Swiss Heart Foundation	This study was funded by the Swiss Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aries MJH, 2010, STROKE, V41, P2697, DOI 10.1161/STROKEAHA.110.594168; Atkins ER, 2010, CEREBROVASC DIS, V29, P228, DOI 10.1159/000267845; Barlas RS, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003019; Chang TS, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000103.pub2; de Aguilar-Nascimento JE, 2012, WORLD J SURG, V36, P2776, DOI 10.1007/s00268-012-1756-0; Dexter F, 1997, BRIT J ANAESTH, V79, P346, DOI 10.1093/bja/79.3.346; Gilgen MD, 2015, STROKE, V46, P2510, DOI 10.1161/STROKEAHA.115.010250; Grathwohl KW, 1996, SOUTHERN MED J, V89, P51, DOI 10.1097/00007611-199601000-00008; GROSS JB, 1983, ANESTHESIOLOGY, V58, P277, DOI 10.1097/00000542-198303000-00016; Hatamian H, 2014, IRAN J NEUROL, V13, P237; Homi HM, 2004, ANESTH ANALG, V99, P974, DOI 10.1213/01.ane.0000131504.90754.d0; Jung S, 2013, BRAIN, V136, P3554, DOI 10.1093/brain/awt246; Jung S, 2012, STROKE, V43, P1584, DOI 10.1161/STROKEAHA.111.645358; Jung S, 2011, STROKE, V42, P1946, DOI 10.1161/STROKEAHA.110.606038; Karadibak K, 2002, EUR J ANAESTH, V19, P330, DOI 10.1017/S0265021502000534; Kase CS, 2001, NEUROLOGY, V57, P1603, DOI 10.1212/WNL.57.9.1603; Kellert L, 2014, J CRIT CARE, V29, P236, DOI 10.1016/j.jcrc.2013.11.008; Kellert L, 2012, CEREBROVASC DIS EXTR, V2, P99, DOI 10.1159/000343731; Kellert L, 2011, STROKE, V42, P2832, DOI 10.1161/STROKEAHA.110.606665; Kimberly WT, 2013, NEUROLOGY, V80, P719, DOI 10.1212/WNL.0b013e31828250ff; Kimberly WT, 2011, CEREBROVASC DIS EXTR, V1, P44, DOI 10.1159/000328219; Lasek-Bal A, 2015, NEUROL NEUROCHIR POL, V49, P107, DOI 10.1016/j.pjnns.2015.03.001; Lelubre C, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1321-6; Li ZZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep26636; Lobo DN, 2001, CLIN SCI, V101, P173, DOI 10.1042/CS20000316; Luedi R, 2014, J NEUROL, V261, P1622, DOI 10.1007/s00415-014-7401-0; Park YH, 2013, STROKE, V44, P3220, DOI 10.1161/STROKEAHA.113.002672; Reasoner DK, 1996, ANESTH ANALG, V82, P61, DOI 10.1097/00000539-199601000-00011; Sico JJ, 2013, J STROKE CEREBROVASC, V22, P271, DOI 10.1016/j.jstrokecerebrovasdis.2011.09.003; Weiskopf RB, 1998, JAMA-J AM MED ASSOC, V279, P217, DOI 10.1001/jama.279.3.217; Weiskopf RB, 2000, ANESTHESIOLOGY, V92, P1646, DOI 10.1097/00000542-200006000-00023	31	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2018	13	9							e0203535	10.1371/journal.pone.0203535	http://dx.doi.org/10.1371/journal.pone.0203535			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3NB	30256814	Green Published, Green Submitted, gold			2022-12-26	WOS:000446000200018
J	Kaida, K; Iwaki, S				Kaida, Kosuke; Iwaki, Sunao			Hearing own or other's name has different effects on monotonous task performance	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; SLEEPINESS; ATTENTION; DISTRACTION; MIND	We examined the effect of hearing two types of self-relevant words, one's own name and the name of others, on vigilant attention, arousal, and subjective sleepiness during performing the Psychomotor Vigilance Test (PVT). Participants performed the PVT under three experimental conditions, (a) hearing own full name (high self-relevant condition), (b) hearing other's name (low self- relevant condition) and (c) the control condition with no stimuli. Participants heard the names every 20 sec. Self-relevance was assessed before the experiment using the self-relevance scale. The results of the behavioral effects are relatively small and not consistently supported by all of the performance indicators. A tentative conclusion, based on the overall pattern of results, is that (1) arousal increased by hearing a name, regardless of its self-relevance, and (2) hearing less self-relevant stimuli such as other's name had a distractive effect on ongoing task performance, although it increased arousal, being aware that further experiments are urgently necessary.	[Kaida, Kosuke; Iwaki, Sunao] Natl Inst Adv Ind Sci & Technol, Automot Human Factors Res Ctr, Tsukuba, Ibaraki, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Kaida, K (corresponding author), Natl Inst Adv Ind Sci & Technol, Automot Human Factors Res Ctr, Tsukuba, Ibaraki, Japan.	kaida-kosuke@umin.ac.jp	Kaida, Kosuke/A-9979-2017; Iwaki, Sunao/B-1079-2011	Kaida, Kosuke/0000-0002-8975-4794; Iwaki, Sunao/0000-0002-7123-7203				AKERSTEDT T, 1990, INT J NEUROSCI, V52, P29, DOI 10.3109/00207459008994241; Basner M, 2011, SLEEP, V34, P581, DOI 10.1093/sleep/34.5.581; Berti S, 2003, EUR J NEUROSCI, V17, P1119, DOI 10.1046/j.1460-9568.2003.02527.x; Coull JT, 1998, PROG NEUROBIOL, V55, P343, DOI 10.1016/S0301-0082(98)00011-2; Cycowicz YM, 1998, BRAIN COGNITION, V36, P30, DOI 10.1006/brcg.1997.0955; FOX JG, 1972, APPL ERGON, V3, P202, DOI 10.1016/0003-6870(72)90101-9; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; ISHIHARA K, 1986, JPN J PSYCHOL, V57, P87, DOI 10.4992/jjpsy.57.87; Kaida K, 2006, CLIN NEUROPHYSIOL, V117, P1574, DOI 10.1016/j.clinph.2006.03.011; Kaida K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194065; Langner R, 2010, ACTA PSYCHOL, V133, P64, DOI 10.1016/j.actpsy.2009.10.001; NAATANEN R, 1990, BEHAV BRAIN SCI, V13, P201, DOI 10.1017/S0140525X00078407; Parmentier FBR, 2010, COGNITION, V115, P504, DOI 10.1016/j.cognition.2010.03.002; POULTON EC, 1979, PSYCHOL REV, V86, P361, DOI 10.1037/0033-295X.86.4.361; REQUIN J, 1973, Q J EXP PSYCHOL, V25, P344, DOI 10.1080/14640747308400355; SanMiguel I, 2010, EUR J COGN PSYCHOL, V22, P481, DOI 10.1080/09541440902930994; Smallwood J, 2006, PSYCHOL BULL, V132, P946, DOI 10.1037/0033-2909.132.6.946; Stawarczyk D, 2016, J EXP PSYCHOL HUMAN, V42, P1587, DOI 10.1037/xhp0000254; Steinborn MB, 2017, PSYCHOL RES-PSYCH FO, V81, P1135, DOI 10.1007/s00426-016-0810-1; Steinborn MB, 2018, PSYCHOL ASSESSMENT, V30, P339, DOI 10.1037/pas0000482; Steinborn MB, 2011, ACTA PSYCHOL, V136, P405, DOI 10.1016/j.actpsy.2011.01.008; Wetzel N, 2012, J EXP PSYCHOL HUMAN, V38, P664, DOI 10.1037/a0025856; Wetzel N, 2011, BIOL PSYCHOL, V86, P39, DOI 10.1016/j.biopsycho.2010.10.005	23	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2018	13	9							e0203966	10.1371/journal.pone.0203966	http://dx.doi.org/10.1371/journal.pone.0203966			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV3NB	30256823	Green Published, Green Submitted, gold			2022-12-26	WOS:000446000200032
J	Warner, DR; Liu, HL; Dastidar, SG; Warner, JB; Prodhan, MAI; Yin, XM; Zhang, X; Feldstein, AE; Gao, B; Prough, RA; McClain, CJ; Kirpich, IA				Warner, Dennis R.; Liu, Huilin; Dastidar, Shubha Ghosh; Warner, Jeffrey B.; Prodhan, Md Aminul Islam; Yin, Xinmin; Zhang, Xiang; Feldstein, Ariel E.; Gao, Bin; Prough, Russell A.; McClain, Craig J.; Kirpich, Irina A.			Ethanol and unsaturated dietary fat induce unique patterns of hepatic omega-6 and omega-3 PUFA oxylipins in a mouse model of alcoholic liver disease	PLOS ONE			English	Article							SOLUBLE EPOXIDE HYDROLASE; ENDOPLASMIC-RETICULUM STRESS; OXIDIZED LIPID PRODUCTS; NONALCOHOLIC STEATOHEPATITIS; ADIPOSE-TISSUE; MACROPHAGE ACTIVATION; INSULIN-RESISTANCE; ACID-METABOLISM; AMNIOTIC-FLUID; SATURATED FAT	Alcoholic liver disease (ALD), a significant health problem, progresses through the course of several pathologies including steatosis, steatohepatitis, fibrosis, and cirrhosis. There are no effective FDA-approved medications to prevent or treat any stages of ALD, and the mechanisms involved in ALD pathogenesis are not well understood. Bioactive lipid metabolites play a crucial role in numerous pathological conditions, as well as in the induction and resolution of inflammation. Herein, a hepatic lipidomic analysis was performed on a mouse model of ALD with the objective of identifying novel metabolic pathways and lipid mediators associated with alcoholic steatohepatitis, which might be potential novel biomarkers and therapeutic targets for the disease. We found that ethanol and dietary unsaturated, but not saturated, fat caused elevated plasma ALT levels, hepatic steatosis and inflammation. These pathologies were associated with increased levels of bioactive lipid metabolites generally involved in pro-inflammatory responses, including 13-hydroxy-octadecadienoic acid, 9,10- and 12,13-dihydroxy-octadecenoic acids, 5-, 8-, 9-, 11-, 15-hydroxy-eicosatetraenoic acids, and 8,9- and 11,12-dihydroxy-eicosatrienoic acids, in parallel with an increase in proresolving mediators, such as lipoxin A4, 18-hydroxy-eicosapentaenoic acid, and 10S,17S-dihydroxy-docosahexaenoic acid. Elucidation of alterations in these lipid metabolites may shed new light into the molecular mechanisms underlying ALD development/progression, and be potential novel therapeutic targets.	[Warner, Dennis R.; Liu, Huilin; Dastidar, Shubha Ghosh; Warner, Jeffrey B.; Prough, Russell A.; McClain, Craig J.; Kirpich, Irina A.] Univ Louisville, Dept Med, Div Gastroenterol Hepatol & Nutr, Louisville, KY 40292 USA; [Liu, Huilin] Jilin Univ, Coll Life Sci, Changchun, Jilin, Peoples R China; [Warner, Jeffrey B.; McClain, Craig J.; Kirpich, Irina A.] Univ Louisville, Sch Med, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA; [Prodhan, Md Aminul Islam; Yin, Xinmin; Zhang, Xiang] Univ Louisville, Dept Chem, Louisville, KY 40292 USA; [Zhang, Xiang; Prough, Russell A.; McClain, Craig J.; Kirpich, Irina A.] Univ Louisville, Sch Med, Alcohol Ctr, Louisville, KY 40292 USA; [Zhang, Xiang; Prough, Russell A.; McClain, Craig J.; Kirpich, Irina A.] Univ Louisville, Hepatobiol & Toxicol Program, Louisville, KY 40292 USA; [Feldstein, Ariel E.] Univ Calif San Diego, Dept Pediat, Div Gastroenterol, San Diego, CA 92103 USA; [Gao, Bin] NIAAA, Lab Liver Dis, NIH, Bethesda, MD USA; [McClain, Craig J.] Robley Rex Vet Med Ctr, Louisville, KY USA	University of Louisville; Jilin University; University of Louisville; University of Louisville; University of Louisville; University of Louisville; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Kirpich, IA (corresponding author), Univ Louisville, Dept Med, Div Gastroenterol Hepatol & Nutr, Louisville, KY 40292 USA.; Kirpich, IA (corresponding author), Univ Louisville, Sch Med, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA.; Kirpich, IA (corresponding author), Univ Louisville, Sch Med, Alcohol Ctr, Louisville, KY 40292 USA.; Kirpich, IA (corresponding author), Univ Louisville, Hepatobiol & Toxicol Program, Louisville, KY 40292 USA.	i0kirp01@louisville.edu	Russell A, Prough/AAH-5907-2020	Prough, Russell/0000-0001-8901-8490	NIH [R01 AA024102-01A1, U01AA022489, 1U01AA021901-01, 1U01AA021893-01, R01AA023681]; Department of Veterans Affairs [I01BX000350]; National Institute on Alcohol Abuse and Alcoholism; National Institute on Aging; Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health [P20GM113226]; National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health [P50AA024337]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM113226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA022489, R01AA024102, R01AA023681, P50AA024337] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002996] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health; National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Veterans Affairs(US Department of Veterans Affairs)	The work presented in this study was supported by NIH grants R01 AA024102-01A1 (IAK), U01AA022489 (AEF, CJM), 1U01AA021901-01 (CJM), 1U01AA021893-01 (CJM), R01AA023681 (CJM), the Department of Veterans Affairs I01BX000350 (CJM), and the Intramural Programs of the National Institute on Alcohol Abuse and Alcoholism and National Institute on Aging (CER). Research reported in this publication was supported by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant number P20GM113226 (CJM), and the National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health under Award Number P50AA024337 (CJM). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambade A, 2014, J HEPATOL, V61, P903, DOI 10.1016/j.jhep.2014.05.024; Bertola A, 2013, NAT PROTOC, V8, P627, DOI 10.1038/nprot.2013.032; Bettaieb A, 2013, J BIOL CHEM, V288, P14189, DOI 10.1074/jbc.M113.458414; Blasbalg TL, 2011, AM J CLIN NUTR, V93, P950, DOI 10.3945/ajcn.110.006643; Chen GZ, 2015, AM J PHYSIOL-ENDOC M, V308, pE97, DOI 10.1152/ajpendo.00366.2014; Chen P, 2009, FEBS LETT, V583, P3478, DOI 10.1016/j.febslet.2009.10.004; Chiamvimonvat N, 2007, J CARDIOVASC PHARM, V50, P225, DOI 10.1097/FJC.0b013e3181506445; Dai MY, 2017, SCI REP-UK, V7, DOI 10.1038/srep46743; Deol P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12624-9; Fang X, 2006, AM J PHYSIOL-HEART C, V290, pH55, DOI 10.1152/ajpheart.00427.2005; Feldstein AE, 2010, J LIPID RES, V51, P3046, DOI 10.1194/jlr.M007096; Fleming I, 2014, PHARMACOL REV, V66, P1106, DOI 10.1124/pr.113.007781; Frazier Thomas H, 2011, Therap Adv Gastroenterol, V4, P63, DOI 10.1177/1756283X10378925; Gabbs M, 2015, ADV NUTR, V6, P513, DOI 10.3945/an.114.007732; Gilroy DW, 2016, P NATL ACAD SCI USA, V113, pE3240, DOI 10.1073/pnas.1521453113; GOETZL EJ, 1980, J IMMUNOL, V125, P1789; Greene JF, 2000, CHEM RES TOXICOL, V13, P217, DOI 10.1021/tx990162c; Gutierrez-Juarez R, 2006, J CLIN INVEST, V116, P1686, DOI 10.1172/JCI26991; Harris TR, 2015, TOXICOL APPL PHARM, V286, P102, DOI 10.1016/j.taap.2015.03.022; HAYAKAWA M, 1986, BIOCHEM BIOPH RES CO, V137, P424, DOI 10.1016/0006-291X(86)91227-1; Ki SH, 2010, HEPATOLOGY, V52, P1291, DOI 10.1002/hep.23837; Kirpich I, 2013, ALCOHOL CLIN EXP RES, V37, P1920, DOI 10.1111/acer.12172; Kirpich I, 2012, ALCOHOL CLIN EXP RES, V36, P1578, DOI 10.1111/j.1530-0277.2012.01751.x; Kirpich IA, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6010001; Kirpich IA, 2016, AM J PATHOL, V186, P765, DOI 10.1016/j.ajpath.2015.11.017; Kirpich IA, 2012, ALCOHOL CLIN EXP RES, V36, P835, DOI 10.1111/j.1530-0277.2011.01673.x; Kirpich IA, 2011, J NUTR BIOCHEM, V22, P38, DOI 10.1016/j.jnutbio.2009.11.009; Kumar N, 2016, SCI REP-UK, V6, DOI 10.1038/srep31649; Lazic M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107658; Lefevre L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7801; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Li Q, 2013, ALCOHOL CLIN EXP RES, V37, P587, DOI 10.1111/acer.12013; LIEBER CS, 1967, J CLIN INVEST, V46, P1451, DOI 10.1172/JCI105637; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039165; Loomba R, 2015, J LIPID RES, V56, P185, DOI 10.1194/jlr.P055640; Lopez-Vicario C, 2016, EUR J PHARMACOL, V785, P133, DOI 10.1016/j.ejphar.2015.03.092; Lopez-Vicario C, 2015, P NATL ACAD SCI USA, V112, P536, DOI 10.1073/pnas.1422590112; Maddipati KR, 2016, J LIPID RES, V57, P1906, DOI 10.1194/jlr.P069096; Maddipati KR, 2016, FASEB J, V30, P3296, DOI 10.1096/fj.201600583R; Maddipati KR, 2014, FASEB J, V28, P4835, DOI 10.1096/fj.14-254383; Maddipati KR, 2011, PROSTAG OTH LIPID M, V94, P59, DOI 10.1016/j.prostaglandins.2011.01.003; Martinez-Clemente M, 2010, HEPATOLOGY, V51, P817, DOI 10.1002/hep.23463; Moghaddam MF, 1996, BBA-GEN SUBJECTS, V1290, P327, DOI 10.1016/0304-4165(96)00037-2; Morisseau C, 2005, ANNU REV PHARMACOL, V45, P311, DOI 10.1146/annurev.pharmtox.45.120403.095920; Morisseau C, 2013, ANNU REV PHARMACOL, V53, P37, DOI 10.1146/annurev-pharmtox-011112-140244; NANJI AA, 1993, AM J PATHOL, V142, P367; Nanji AA, 2013, ALCOHOL CLIN EXP RES, V37, P31, DOI 10.1111/j.1530-0277.2012.01838.x; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; Norris PC, 2014, P NATL ACAD SCI USA, V111, P12746, DOI 10.1073/pnas.1404372111; Oltman CL, 1998, CIRC RES, V83, P932; OZAWA T, 1988, BIOCHEM BIOPH RES CO, V152, P1310, DOI 10.1016/S0006-291X(88)80428-5; Puri P, 2016, J LIPID RES, V57, P1017, DOI 10.1194/jlr.M066175; Puri P, 2009, HEPATOLOGY, V50, P1827, DOI 10.1002/hep.23229; Raszeja-Wyszomirska J, 2012, PROSTAG OTH LIPID M, V99, P51, DOI 10.1016/j.prostaglandins.2012.06.001; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Ronis MJJ, 2004, J NUTR, V134, P904, DOI 10.1093/jn/134.4.904; Ryan AD, 2010, CURR OPIN PHARMACOL, V10, P166, DOI 10.1016/j.coph.2010.02.005; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Sisemore MF, 2001, ARCH BIOCHEM BIOPHYS, V392, P32, DOI 10.1006/abbi.2001.2434; Snyder NW, 2015, CHEM-BIOL INTERACT, V234, P144, DOI 10.1016/j.cbi.2014.10.029; Thompson DA, 2007, J BIOSCIENCES, V32, P279, DOI 10.1007/s12038-007-0028-x; Totani Y, 2000, EUR RESPIR J, V15, P75, DOI 10.1183/09031936.00.15107500; Wang CJ, 2017, BRIT J PHARMACOL, V174, P2358, DOI 10.1111/bph.13844; Warner DR, 2017, AM J PATHOL, V187, P2232, DOI 10.1016/j.ajpath.2017.06.008; Wei XL, 2015, J PROTEOME RES, V14, P4050, DOI 10.1021/acs.jproteome.5b00596; Yang LL, 2010, J BIOL CHEM, V285, P22211, DOI 10.1074/jbc.M110.119982; You M, 2002, J BIOL CHEM, V277, P29342, DOI 10.1074/jbc.M202411200; You M, 2008, J NUTR, V138, P497, DOI 10.1093/jn/138.3.497; Zein CO, 2012, HEPATOLOGY, V56, P1291, DOI 10.1002/hep.25778; Zhang WL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02759-0; Zhang XY, 2017, P NATL ACAD SCI USA, V114, P3181, DOI 10.1073/pnas.1700172114; Zhong W, 2013, AM J PHYSIOL-GASTR L, V305, pG919, DOI 10.1152/ajpgi.00226.2013	74	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2018	13	9							e0204119	10.1371/journal.pone.0204119	http://dx.doi.org/10.1371/journal.pone.0204119			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3NB	30256818	Green Published, gold, Green Submitted			2022-12-26	WOS:000446000200036
J	Muthiah, A; Angulo, MS; Walker, NN; Keller, SR; Lee, JK				Muthiah, Annamalai; Angulo, Morgan S.; Walker, Natalie N.; Keller, Susanna R.; Lee, Jae K.			Biologically anchored knowledge expansion approach uncovers KLF4 as a novel insulin signaling regulator	PLOS ONE			English	Article							GLUT4 TRANSLOCATION; NETWORKS; EXPRESSION; GENE; DIFFERENTIATION; RECEPTOR; SYSTEMS; MODEL; MICE; FAT	One of the biggest challenges in analyzing high throughput omics data in biological studies is extracting information that is relevant to specific biological mechanisms of interest while simultaneously restricting the number of false positive findings. Due to random chances with numerous candidate targets and mechanisms, computational approaches often yield a large number of false positives that cannot easily be discerned from relevant biological findings without costly, and often infeasible, biological experiments. We here introduce and apply an integrative bioinformatics approach, Biologically Anchored Knowledge Expansion (BAKE), which uses sequential statistical analysis and literature mining to identify highly relevant network genes and effectively removes false positive findings. Applying BAKE to genomic expression data collected from mouse (Mus musculus) adipocytes during insulin resistance progression, we uncovered the transcription factor Krueppel-like Factor 4 (KLF4) as a regulator of early insulin signaling. We experimentally confirmed that KLF4 controls the expression of two key insulin signaling molecules, the Insulin Receptor Substrate 2 (IRS2) and Tuberous Sclerosis Complex 2 (TSC2).	[Muthiah, Annamalai; Lee, Jae K.] Univ Virginia, Dept Syst & Informat Engn, Charlottesville, VA 22903 USA; [Angulo, Morgan S.] Univ Virginia, Med Ctr, Dept Surg, Charlottesville, VA USA; [Walker, Natalie N.; Keller, Susanna R.] Univ Virginia, Dept Med, Div Endocrinol & Metab, Charlottesville, VA 22903 USA; [Lee, Jae K.] H Lee Moffitt Canc Ctr & Res Inst, Dept Biostat & Bioinformat, Tampa, FL 33612 USA; [Lee, Jae K.] Univ Virginia, Sch Med, Dept Publ Hlth Sci, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia; H Lee Moffitt Cancer Center & Research Institute; University of Virginia	Lee, JK (corresponding author), Univ Virginia, Dept Syst & Informat Engn, Charlottesville, VA 22903 USA.; Keller, SR (corresponding author), Univ Virginia, Dept Med, Div Endocrinol & Metab, Charlottesville, VA 22903 USA.; Lee, JK (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Biostat & Bioinformat, Tampa, FL 33612 USA.; Lee, JK (corresponding author), Univ Virginia, Sch Med, Dept Publ Hlth Sci, Charlottesville, VA 22908 USA.	srk4b@virginia.edu; jae.lee@bms.com			National Heart, Lung, and Blood Institute [R01 HL081690]; University of Virginia School of Medicine	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of Virginia School of Medicine	This research was supported by the National Heart, Lung, and Blood Institute (R01 HL081690 to JKL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The SPC algorithm code was obtained from Dr. Eytan Domany, Department of Physics of Complex Systems, Weizmann Institute of Science (Rehovot, Israel). Questions regarding the execution of SPC clustering with the appropriate shell script were kindly answered by Dr. Assif Yitzhaky, a close associate of Dr. Eytan Domany. We would also like to thank Alyson Prorock and Dr. Yongde Bao in the DNA Sciences Core at the University of Virginia for performing the gene chip analysis of adipocyte RNA samples using the Affimetrix microarray system. The DNA Sciences Core is supported by the University of Virginia School of Medicine. We are grateful to Dr. Gary K. Owens at the University of Virginia for providing us with adipose tissue samples from the conditional KLF4 knockout mice and to Dr. Katherine Holcomb at the University of Virginia for assisting with the writing of BAKE's programming code.	Altay G, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-132; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Blatt M, 1996, PHYS REV LETT, V76, P3251, DOI 10.1103/PhysRevLett.76.3251; Bruning JC, 1997, CELL, V88, P561, DOI 10.1016/S0092-8674(00)81896-6; Butte A J, 2000, Pac Symp Biocomput, P418; Califano A, 2012, NAT GENET, V44, P841, DOI 10.1038/ng.2355; Chen Y, 2012, DIABETOLOGIA, V55, P2533, DOI 10.1007/s00125-012-2594-1; Cheung KJ, 2007, CELL METAB, V5, P115, DOI 10.1016/j.cmet.2007.01.005; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; de la Fuente A, 2004, BIOINFORMATICS, V20, P3565, DOI 10.1093/bioinformatics/bth445; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Fittschen M, 2015, NEUROGENETICS, V16, P181, DOI 10.1007/s10048-015-0441-5; Friedman N, 2004, SCIENCE, V303, P799, DOI 10.1126/science.1094068; Galkina EV, 2012, ARTERIOSCL THROM VAS, V32, P247, DOI 10.1161/ATVBAHA.111.240358; Haibe-Kains B, 2012, NUCLEIC ACIDS RES, V40, pD866, DOI 10.1093/nar/gkr1050; Hase T, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003361; Huynh-Thu VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012776; Klip A, 2014, AM J PHYSIOL-CELL PH, V306, pC879, DOI 10.1152/ajpcell.00069.2014; Lansey MN, 2012, AM J PHYSIOL-ENDOC M, V303, pE1273, DOI 10.1152/ajpendo.00316.2012; Lebre S, 2012, METHODS MOL BIOL, V802, P199, DOI 10.1007/978-1-61779-400-1_13; Liao JC, 2003, P NATL ACAD SCI USA, V100, P15522, DOI 10.1073/pnas.2136632100; Lopez-Miranda J, 2007, J MOL MED, V85, P209, DOI 10.1007/s00109-006-0138-1; Luo WJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-467; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Meyer PE, 2007, EURASIP J BIOINFORM, DOI 10.1155/2007/79879; Mitsuuchi Y, 1999, ONCOGENE, V18, P4891, DOI 10.1038/sj.onc.1203080; Modica S, 2009, GUT, V58, P1250, DOI 10.1136/gut.2008.158386; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Reshef DN, 2011, SCIENCE, V334, P1518, DOI 10.1126/science.1205438; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Schreyer SA, 2002, AM J PHYSIOL-ENDOC M, V282, pE207, DOI 10.1152/ajpendo.2002.282.1.E207; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Sul HS, 2009, MOL ENDOCRINOL, V23, P1717, DOI 10.1210/me.2009-0160; Sze KL, 2008, J CELL PHYSIOL, V214, P334, DOI 10.1002/jcp.21201; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Toni T, 2010, BIOINFORMATICS, V26, P104, DOI 10.1093/bioinformatics/btp619; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Someren EP, 2006, BIOINFORMATICS, V22, P477, DOI 10.1093/bioinformatics/bti816; Veiga DFT, 2007, GENET MOL RES, V6, P730; Villaverde AF, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0505; Yang YB, 2014, OBESITY, V22, P2147, DOI 10.1002/oby.20811; Yeung KY, 2011, P NATL ACAD SCI USA, V108, P19436, DOI 10.1073/pnas.1116442108; Yoshida T, 2008, CIRC RES, V102, P1548, DOI 10.1161/CIRCRESAHA.108.176974; Zhang HH, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006189, 10.1371/journal.pone.0007826]; Zoppoli P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-154	51	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2018	13	9							e0204100	10.1371/journal.pone.0204100	http://dx.doi.org/10.1371/journal.pone.0204100			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU5MM	30240435	Green Submitted, gold, Green Published			2022-12-26	WOS:000445329700025
J	Hsu, PC; Gopinath, RK; Hsueh, YA; Shieh, SY				Hsu, Pei-Ching; Gopinath, Rajaneesh Karimpurath; Hsueh, Yi-An; Shieh, Sheau-Yann			CHK2-mediated regulation of PARP1 in oxidative DNA damage response	ONCOGENE			English	Article							POLY ADP-RIBOSE; POLY(ADP-RIBOSE) POLYMERASE-1; CHK2 ACTIVATION; PROTEIN-KINASE; PHOSPHORYLATION; BINDING; CHECKPOINT; DOMAINS; REPAIR; XRCC1	Poly(ADP-ribose) polymerase 1 (PARP1) is a DNA damage sensor, which upon activation, recruits downstream proteins by poly(ADP-ribosyl)ation (PARylation). However, it remains largely unclear how PARP1 activity is regulated. Interestingly, the data obtained through this study revealed that PARP1 was co-immunoprecipitated with checkpoint kinase 2 (CHK2), and the interaction was increased after oxidative DNA damage. Moreover, CHK2 depletion resulted in a reduction in overall PARylation. To further explore the functional relationship between PARP1 and CHK2, this study employed H2O2 to induce an oxidative DNA damage response in cells. Here, we showed that CHK2 and PARP1 interact in vitro and in vivo through the CHK2 SCD domain and the PARP1 BRCT domain. Furthermore, CHK2 stimulates the PARylation activity of PARP1 through CHK2-dependent phosphorylation. Consequently, the impaired repair associated with PARP1 depletion could be rescued by re-expression of wild-type PARP1 and the phospho-mimic but not the phospho-deficient mutant. Mechanistically, we showed that CHK2-dependent phosphorylation of PARP1 not only regulates its cellular localization but also promotes its catalytic activity and its interaction with XRCC1. These findings indicate that CHK2 exerts a multifaceted impact on PARP1 in response to oxidative stress to facilitate DNA repair and to maintain cell survival.	[Hsu, Pei-Ching; Shieh, Sheau-Yann] Natl Def Med Ctr, Grad Inst Life Sci, Taipei 114, Taiwan; [Hsu, Pei-Ching; Gopinath, Rajaneesh Karimpurath; Hsueh, Yi-An; Shieh, Sheau-Yann] Acad Sinica, Inst Biomed Sci, 128 Sec 2,Acad Rd, Taipei 115, Taiwan	National Defense Medical Center; Academia Sinica - Taiwan	Shieh, SY (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei 114, Taiwan.; Shieh, SY (corresponding author), Acad Sinica, Inst Biomed Sci, 128 Sec 2,Acad Rd, Taipei 115, Taiwan.	sy88@ibms.sinica.edu.tw	Shieh, Sheau-Yann/N-9512-2018; Karimpurath Gopinath, Rajaneesh/AHA-8714-2022; KARIMPURATH GOPINATH, RAJANEESH/H-3933-2016	Shieh, Sheau-Yann/0000-0002-5351-4430; KARIMPURATH GOPINATH, RAJANEESH/0000-0003-1554-4310	Academia Sinica, Taiwan	Academia Sinica, Taiwan(Academia Sinica - Taiwan)	We are grateful to the Proteomic Core at Institute of Biomedical Sciences for the assistance with the identification of the PARP1 phosphorylation sites. This work was supported by funding from Academia Sinica, Taiwan to S-YS.	Ahn JY, 2002, J BIOL CHEM, V277, P19389, DOI 10.1074/jbc.M200822200; Altmeyer M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9088; Anderson VE, 2011, CANCER RES, V71, P463, DOI 10.1158/0008-5472.CAN-10-1252; Bahassi EM, 2006, MUTAT RES-FUND MOL M, V596, P166, DOI 10.1016/j.mrfmmm.2005.12.002; Barkauskaite E, 2015, MOL CELL, V58, P935, DOI 10.1016/j.molcel.2015.05.007; BAUER PI, 1992, BIOCHEM BIOPH RES CO, V187, P730, DOI 10.1016/0006-291X(92)91256-P; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Breslin C, 2015, NUCLEIC ACIDS RES, V43, P6934, DOI 10.1093/nar/gkv623; Brunyanszki A, 2014, MOL PHARMACOL, V86, P450, DOI 10.1124/mol.114.094318; Buscemi G, 2006, MOL CELL BIOL, V26, P7832, DOI 10.1128/MCB.00534-06; Chaudhuri AR, 2017, NAT REV MOL CELL BIO, V18, P610, DOI 10.1038/nrm.2017.53; Chaudhuri AR, 2016, NATURE, V535, P382, DOI 10.1038/nature18325; Chou WC, 2015, CARCINOGENESIS, V36, P832, DOI 10.1093/carcin/bgv079; Chou WC, 2008, EMBO J, V27, P3140, DOI 10.1038/emboj.2008.229; Du Y, 2016, NAT MED, V22, P194, DOI 10.1038/nm.4032; El-Khamisy SF, 2003, NUCLEIC ACIDS RES, V31, P5526, DOI 10.1093/nar/gkg761; Gagne JP, 2009, J PROTEOME RES, V8, P1014, DOI 10.1021/pr800810n; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Hassa PO, 2005, J BIOL CHEM, V280, P40450, DOI 10.1074/jbc.M507553200; Hegde ML, 2012, PROG MOL BIOL TRANSL, V110, P123, DOI 10.1016/B978-0-12-387665-2.00006-7; Helleday T, 2011, MOL ONCOL, V5, P387, DOI 10.1016/j.molonc.2011.07.001; Hong RX, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2754-7; Hu YD, 2014, CANCER DISCOV, V4, P1430, DOI 10.1158/2159-8290.CD-13-0891; Kauppinen TM, 2006, P NATL ACAD SCI USA, V103, P7136, DOI 10.1073/pnas.0508606103; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Langelier MF, 2012, SCIENCE, V336, P728, DOI 10.1126/science.1216338; Li M, 2013, GENE DEV, V27, P1752, DOI 10.1101/gad.226357.113; Loeffler PA, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-37; Lord CJ, 2016, NAT REV CANCER, V16, P110, DOI 10.1038/nrc.2015.21; Lord CJ, 2013, NAT MED, V19, P1381, DOI 10.1038/nm.3369; Mansoorabadi SO, 2014, BIOCHEMISTRY-US, V53, P1779, DOI 10.1021/bi401439n; Martin N, 2009, EMBO J, V28, P3534, DOI 10.1038/emboj.2009.279; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Meehan Robert S, 2016, Gynecol Oncol Res Pract, V3, P3, DOI 10.1186/s40661-016-0024-7; Messner S, 2009, FASEB J, V23, P3978, DOI 10.1096/fj.09-137695; Muthurajan UM, 2014, P NATL ACAD SCI USA, V111, P12752, DOI 10.1073/pnas.1405005111; Noren Hooten N, 2011, J BIOL CHEM, V286, P44679, DOI 10.1074/jbc.M111.255869; Panieri E, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.105; Pascal JM, 2015, DNA REPAIR, V32, P10, DOI 10.1016/j.dnarep.2015.04.008; Perina D, 2014, DNA REPAIR, V23, P4, DOI 10.1016/j.dnarep.2014.05.003; Pleschke JM, 2000, J BIOL CHEM, V275, P40974, DOI 10.1074/jbc.M006520200; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Ryu H, 2010, J BIOL CHEM, V285, P14415, DOI 10.1074/jbc.M109.074583; Shang FQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151845; Sonnenblick A, 2015, NAT REV CLIN ONCOL, V12, P27, DOI 10.1038/nrclinonc.2014.163; Stolz A, 2011, CLIN CANCER RES, V17, P401, DOI 10.1158/1078-0432.CCR-10-1215; Tan YJ, 2007, MOL CELL BIOL, V27, P1007, DOI 10.1128/MCB.01068-06; Vyas S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5426; Vyas S, 2014, NAT REV CANCER, V14, P502, DOI 10.1038/nrc3748; Wright RHG, 2012, GENE DEV, V26, P1972, DOI 10.1101/gad.193193.112; Xu XZ, 2002, MOL CELL BIOL, V22, P4419, DOI 10.1128/MCB.22.12.4419-4432.2002; Yeh YH, 2009, ONCOGENE, V28, P1366, DOI 10.1038/onc.2008.477; Zannini L, 2014, J MOL CELL BIOL, V6, P442, DOI 10.1093/jmcb/mju045; Zhang F, 2015, CELL REP, V13, P678, DOI 10.1016/j.celrep.2015.09.040; Zhang S, 2007, CELL DEATH DIFFER, V14, P1001, DOI 10.1038/sj.cdd.4402088; Zhao H, 2008, CELL CYCLE, V7, P1490, DOI 10.4161/cc.7.10.5963	56	12	12	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 21	2019	38	8					1166	1182		10.1038/s41388-018-0506-7	http://dx.doi.org/10.1038/s41388-018-0506-7			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HM1XR	30254210				2022-12-26	WOS:000459249800002
J	Kordon, MM; Szczurek, A; Berniak, K; Szelest, O; Solarczyk, K; Tworzydlo, M; Wachsmann-Hogiu, S; Vaahtokari, A; Cremer, C; Pederson, T; Dobrucki, JW				Kordon, Magdalena M.; Szczurek, Aleksander; Berniak, Krzysztof; Szelest, Oskar; Solarczyk, Kamil; Tworzydlo, Magdalena; Wachsmann-Hogiu, Sebastian; Vaahtokari, Anne; Cremer, Christoph; Pederson, Thoru; Dobrucki, Jurek W.			PML-like subnuclear bodies, containing XRCC1, juxtaposed to DNA replication-based single-strand breaks	FASEB JOURNAL			English	Article						DNA damage; PML nuclear bodies; superresolution microscopy	ORIGIN RECOGNITION COMPLEX; LIGASE III-ALPHA; DAMAGE RESPONSE; POLY(ADP-RIBOSE) POLYMERASE; EXCISION-REPAIR; VISIBLE-LIGHT; BRCT DOMAIN; PROTEIN; PARP-1; INTERACTS	DNA lesions induce recruitment and accumulation of various repair factors, resulting in formation of discrete nuclear foci. Using superresolution fluorescence microscopy as well as live cell and quantitative imaging, we demonstrate that X-ray repair cross-complementing protein 1 (XRCC1), a key factor in single-strand break and base excision repair, is recruited into nuclear bodies formed in response to replication-related single-strand breaks. Intriguingly, these bodies are assembled immediately in the vicinity of these breaks and never fully colocalize with replication foci. They are structurally organized, containing canonical promyelocytic leukemia (PML) nuclear body protein SP100 concentrated in a peripheral layer, and XRCC1 in the center. They also contain other factors, including PML, poly(ADP-ribose) polymerase 1 (PARP1), ligase III, and origin recognition complex subunit 5. The breast cancer 1 and -2 C terminus domains of XRCC1 are essential for formation of these repair foci. These results reveal that XRCC1-contaning foci constitute newly recognized PML-like nuclear bodies that accrete and locally deliver essential factors for repair of single-strand DNA breaks in replication regions.Kordon, M. M., Szczurek, A., Berniak, K., Szelest, O., Solarczyk, K., Tworzydo, M., Wachsmann-Hogiu, S., Vaahtokari, A., Cremer, C., Pederson, T., Dobrucki, J. W. PML-like subnuclear bodies, containing XRCC1, juxtaposed to DNA replication-based single-strand breaks.	[Kordon, Magdalena M.; Szczurek, Aleksander; Berniak, Krzysztof; Szelest, Oskar; Solarczyk, Kamil; Dobrucki, Jurek W.] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Cell Biophys, Gronostajowa 7, PL-30387 Krakow, Poland; [Tworzydlo, Magdalena] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Phys Biochem, Krakow, Poland; [Szczurek, Aleksander; Cremer, Christoph] Inst Mol Biol, Superresolut Microscopy Grp, Mainz, Germany; [Wachsmann-Hogiu, Sebastian] Univ Calif Davis, Dept Pathol & Lab Med, Davis, CA 95616 USA; [Vaahtokari, Anne] Canc Res UK, Francis Crick Inst, London, England; [Pederson, Thoru] Univ Massachusetts, Med Sch, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; [Wachsmann-Hogiu, Sebastian] McGill Univ, Dept Bioengn, Montreal, PQ, Canada; [Vaahtokari, Anne] Univ Calgary, Arnie Charbonneau Canc Inst, Hlth Sci Ctr, Calgary, AB, Canada	Jagiellonian University; Jagiellonian University; Institute of Molecular Biology (IMB); University of California System; University of California Davis; Cancer Research UK; Francis Crick Institute; University of Massachusetts System; University of Massachusetts Worcester; McGill University; University of Calgary; University of Manitoba; Children's Hospital Research Institute of Manitoba	Dobrucki, JW (corresponding author), Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Cell Biophys, Gronostajowa 7, PL-30387 Krakow, Poland.	jerzy.dobrucki@uj.edu.pl		Dobrucki, Jerzy/0000-0002-4432-1522	Polish Ministry of Science and Higher Education; Polish National Science Centre (NCN) [2013/09/N/NZ3/00203, 2013/11/B/NZ3/00189, 2017/27/B/NZ3/01065]; Jagiellonian University; U.S. National Institutes of Health, National Institute on Drug Abuse [U01 DA-040588]; National Science Centre [DEC-2015/16/T/NZ3/00157]; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA040588] Funding Source: NIH RePORTER	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Polish National Science Centre (NCN); Jagiellonian University; U.S. National Institutes of Health, National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Science Centre(National Science Centre, Poland); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank J. Drukaa for providing primary cultures of human fibroblasts, M. Dziedzicka-Wasylewska for making the molecular biology facilities in her laboratory available, and M. Rak and Z. Madeja (all from Jagiellonian University) for their support in transfection procedures of human fibroblasts (all from Jagiellonian University). The authors also thank B. Stillman (Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA) for providing the vectors encoding EYFP-ORC1 and EYFP-ORC5, V. Schreiber (Institut de Recherche de l'Ecole de Biotechnologie de Strasbourg, Illkirch, France) for providing the vector encoding GFP-PARP1, and M. Szklarczyk (freelance graphic designer) for help with computer graphics. The Faculty of Biochemistry, Biophysics, and Biotechnology, Jagiellonian University is a partner within the Leading National Research Centre (KNOW) supported by the Polish Ministry of Science and Higher Education. This work was supported by Polish National Science Centre (NCN) (2013/09/N/NZ3/00203 to M.M.K., 2013/11/B/NZ3/00189 to J.W.D., and 2017/27/B/NZ3/01065 to J.W.D.). M.M.K. was a recipient of a Society-Environment-Technologies (SET) doctoral studentship from Jagiellonian University and a doctoral studentship awarded by the National Science Centre (DEC-2015/16/T/NZ3/00157). T.P. was partially supported by U.S. National Institutes of Health, National Institute on Drug Abuse Grant U01 DA-040588 with P. Kaufman (University of Massachusetts Medical School). M.M.K., K.S., and J.W.D. declare a potential conflict of interest associated with an invention (patent application pending) relating to a method of ultrasensitive detection of single- and double-stranded DNA breaks. The remaining authors declare no conflicts of interest.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Almeida KH, 2007, DNA REPAIR, V6, P695, DOI 10.1016/j.dnarep.2007.01.009; Beernink PT, 2005, J BIOL CHEM, V280, P30206, DOI 10.1074/jbc.M502155200; Berniak K, 2013, CYTOM PART A, V83, P913, DOI 10.1002/cyto.a.22327; Bischof O, 2001, J CELL BIOL, V153, P367, DOI 10.1083/jcb.153.2.367; Breslin C, 2015, NUCLEIC ACIDS RES, V43, P6934, DOI 10.1093/nar/gkv623; Caldecott KW, 1996, NUCLEIC ACIDS RES, V24, P4387, DOI 10.1093/nar/24.22.4387; CALDECOTT KW, 1994, MOL CELL BIOL, V14, P68, DOI 10.1128/MCB.14.1.68; Caldecott KW, 1995, NUCLEIC ACIDS RES, V23, P4836, DOI 10.1093/nar/23.23.4836; Carbone R, 2002, ONCOGENE, V21, P1633, DOI 10.1038/sj.onc.1205227; Conlan LA, 2004, ONCOGENE, V23, P307, DOI 10.1038/sj.onc.1207119; Cuneo MJ, 2011, NUCLEIC ACIDS RES, V39, P7816, DOI 10.1093/nar/gkr419; Dillin A, 1997, GENETICS, V147, P1053; El-Khamisy SF, 2003, NUCLEIC ACIDS RES, V31, P5526, DOI 10.1093/nar/gkg761; Fan JS, 2004, NUCLEIC ACIDS RES, V32, P2193, DOI 10.1093/nar/gkh556; FOX CA, 1995, GENE DEV, V9, P911, DOI 10.1101/gad.9.8.911; Godon C, 2008, NUCLEIC ACIDS RES, V36, P4454, DOI 10.1093/nar/gkn403; Hanssen-Bauer A, 2012, DNA REPAIR, V11, P357, DOI 10.1016/j.dnarep.2012.01.001; Hodges M, 1998, AM J HUM GENET, V63, P297, DOI 10.1086/301991; Hoischen C, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00125; Huber A, 2004, DNA REPAIR, V3, P1103, DOI 10.1016/j.dnarep.2004.06.002; Jusuk I, 2015, SCI REP-UK, V5, DOI 10.1038/srep14075; KOKEN MHM, 1994, EMBO J, V13, P1073, DOI 10.1002/j.1460-2075.1994.tb06356.x; Kubota Y, 2003, DNA REPAIR, V2, P407, DOI 10.1016/S1568-7864(02)00242-2; Kubota Y, 1996, EMBO J, V15, P6662, DOI 10.1002/j.1460-2075.1996.tb01056.x; Lan L, 2004, P NATL ACAD SCI USA, V101, P13738, DOI 10.1073/pnas.0406048101; Lang M, 2010, J CELL SCI, V123, P392, DOI 10.1242/jcs.053496; Leonhardt H, 2000, J CELL BIOL, V149, P271, DOI 10.1083/jcb.149.2.271; Madeja Z, 2007, ACTA BIOCHIM POL, V54, P873, DOI 10.18388/abp.2007_3191; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; Misteli T, 2009, NAT REV MOL CELL BIO, V10, P243, DOI 10.1038/nrm2651; Mortusewicz O, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-81; Muratani M, 2002, NAT CELL BIOL, V4, P106, DOI 10.1038/ncb740; Nash RA, 1997, BIOCHEMISTRY-US, V36, P5207, DOI 10.1021/bi962281m; Ozaydin B, 2010, MOL CELL BIOL, V30, P626, DOI 10.1128/MCB.00614-09; Parsons JL, 2010, DNA REPAIR, V9, P835, DOI 10.1016/j.dnarep.2010.04.008; Pleschke JM, 2000, J BIOL CHEM, V275, P40974, DOI 10.1074/jbc.M006520200; Schreiber V, 2002, J BIOL CHEM, V277, P23028, DOI 10.1074/jbc.M202390200; Seker H, 2003, ONCOGENE, V22, P1620, DOI 10.1038/sj.onc.1206140; Shore D, 2001, CURR BIOL, V11, pR816, DOI 10.1016/S0960-9822(01)00493-6; Solarczyk KJ, 2016, DNA REPAIR, V37, P12, DOI 10.1016/j.dnarep.2015.10.006; Solarczyk KJ, 2012, DNA REPAIR, V11, P996, DOI 10.1016/j.dnarep.2012.09.008; Sternsdorf T, 1997, IMMUNOBIOLOGY, V198, P307, DOI 10.1016/S0171-2985(97)80051-4; Strom CE, 2011, DNA REPAIR, V10, P961, DOI 10.1016/j.dnarep.2011.07.004; Suter B, 2004, GENETICS, V167, P579, DOI 10.1534/genetics.103.024851; Szczurek AT, 2014, NUCLEUS-PHILA, V5, P331, DOI 10.4161/nucl.29564; Taylor RM, 2000, MOL CELL BIOL, V20, P735, DOI 10.1128/MCB.20.2.735-740.2000; Taylor RM, 2002, MOL CELL BIOL, V22, P2556, DOI 10.1128/MCB.22.8.2556-2563.2002; Taylor RM, 1998, CURR BIOL, V8, P877, DOI 10.1016/S0960-9822(07)00350-8; Verdaasdonk JS, 2014, METHOD CELL BIOL, V123, P347, DOI 10.1016/B978-0-12-420138-5.00019-7; Wei LZ, 2013, J CELL SCI, V126, P4414, DOI 10.1242/jcs.128272; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7; Xu ZX, 2003, MOL CELL BIOL, V23, P4247, DOI 10.1128/MCB.23.12.4247-4256.2003; Ying SM, 2016, CANCER RES, V76, P1078, DOI 10.1158/0008-5472.CAN-15-0608; Zhang XD, 1998, EMBO J, V17, P6404, DOI 10.1093/emboj/17.21.6404; Zhang Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128555; Zou YF, 2008, NUCLEIC ACIDS RES, V36, P5189, DOI 10.1093/nar/gkn465	57	5	5	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2301	2313		10.1096/fj.201801379R	http://dx.doi.org/10.1096/fj.201801379R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30260704	Green Published			2022-12-26	WOS:000457296600062
J	Shen, C; Liu, YH; Yu, HJ; Gulbranson, DR; Kogut, I; Bilousova, G; Zhang, C; Stowell, MHB; Shen, JS				Shen, Chong; Liu, Yinghui; Yu, Haijia; Gulbranson, Daniel R.; Kogut, Igor; Bilousova, Ganna; Zhang, Chen; Stowell, Michael H. B.; Shen, Jingshi			The N-peptide-binding mode is critical to Munc18-1 function in synaptic exocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane fusion; membrane reconstitution; membrane function; SNARE proteins; organelle; membrane proteins; vesicle transport; exocytosis; SM protein; synaptic transmission; Munc18; N-peptide	MEMBRANE-FUSION; TERMINAL PEPTIDE; VESICLE DOCKING; SNARE; SYNTAXIN; PROTEIN; ACTIVATION; MECHANISMS; MUTATIONS; CELLS	Sec1/Munc18 (SM) proteins promote intracellular vesicle fusion by binding to N-ethylmaleimide-sensitive factor attachment protein receptors (SNAREs). A key SNARE-binding mode of SM proteins involves the N-terminal peptide (N-peptide) motif of syntaxin, a SNARE subunit localized to the target membrane. In in vitro membrane fusion assays, inhibition of N-peptide motif binding previously has been shown to abrogate the stimulatory function of Munc18-1, a SM protein involved in synaptic exocytosis in neurons. The physiological role of the N-peptide-binding mode, however, remains unclear. In this work, we addressed this key question using a clogged Munc18-1 protein, in which an ectopic copy of the syntaxin N-peptide motif was directly fused to Munc18-1. We found that the ectopic N-peptide motif blocks the N-peptide-binding pocket of Munc18-1, preventing the latter from binding to the native N-peptide motif on syntaxin-1. In a reconstituted system, we observed that clogged Munc18-1 is defective in promoting SNARE zippering. When introduced into induced neuronal cells (iN cells) derived from human pluripotent stem cells, clogged Munc18-1 failed to mediate synaptic exocytosis. As a result, both spontaneous and evoked synaptic transmission was abolished. These genetic findings provide direct evidence for the crucial role of the N-peptide-binding mode of Munc18-1 in synaptic exocytosis. We suggest that clogged SM proteins will also be instrumental in defining the physiological roles of the N-peptide-binding mode in other vesicle-fusion pathways.	[Shen, Chong; Liu, Yinghui; Yu, Haijia; Gulbranson, Daniel R.; Stowell, Michael H. B.; Shen, Jingshi] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Liu, Yinghui; Yu, Haijia] Nanjing Normal Univ, Jiangsu Key Lab Mol & Med Biotechnol, Coll Life Sci, Nanjing 210023, Jiangsu, Peoples R China; [Kogut, Igor; Bilousova, Ganna] Univ Colorado, Dept Dermatol, Sch Med, Aurora, CO 80045 USA; [Kogut, Igor; Bilousova, Ganna] Univ Colorado, Charles C Gates Ctr Regenerat Med, Sch Med, Aurora, CO 80045 USA; [Zhang, Chen] Capital Med Univ, Sch Basic Med Sci, Beijing 100069, Peoples R China	University of Colorado System; University of Colorado Boulder; Nanjing Normal University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Capital Medical University	Yu, HJ; Shen, JS (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.; Yu, HJ (corresponding author), Nanjing Normal Univ, Jiangsu Key Lab Mol & Med Biotechnol, Coll Life Sci, Nanjing 210023, Jiangsu, Peoples R China.	haijiayu@gmail.com; jingshi.shen@colorado.edu	Gulbranson, Daniel/AAE-4338-2020; Gulbranson, Daniel/AAE-4807-2020; Yu, Haijia/GXV-5159-2022	Yu, Haijia/0000-0002-7193-8034; STOWELL, MICHAEL/0000-0001-7250-1419	National Basic Research Program of China [2017YFA0105201]; National Science Foundation of China [31871425, 31670842]; National Institutes of Health [GM126960, DK095367]; University of Colorado seed grant; American Heart Association predoctoral fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI135473] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095367, R56DK095367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM126960] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RF1AG061829] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Colorado seed grant; American Heart Association predoctoral fellowship(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Basic Research Program of China Grant 2017YFA0105201 and National Science Foundation of China Grant 31670842 (both to C. Z.), National Science Foundation of China Grant 31871425 (to H. Y.), National Institutes of Health Grants GM126960 and DK095367 (both to J. S.), a University of Colorado seed grant (to J. S.), and an American Heart Association predoctoral fellowship (to D. R. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahfeldt T, 2012, NAT CELL BIOL, V14, P209, DOI 10.1038/ncb2411; Baker RW, 2016, NAT REV MOL CELL BIO, V17, P465, DOI 10.1038/nrm.2016.65; Baker RW, 2015, SCIENCE, V349, P1111, DOI 10.1126/science.aac7906; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; Bracher A, 2002, EMBO J, V21, P6114, DOI 10.1093/emboj/cdf608; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Burkhardt P, 2008, EMBO J, V27, P923, DOI 10.1038/emboj.2008.37; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; ELFERINK LA, 1989, J BIOL CHEM, V264, P11061; Ellena JF, 2009, P NATL ACAD SCI USA, V106, P20306, DOI 10.1073/pnas.0908317106; Furgason MLM, 2009, P NATL ACAD SCI USA, V106, P14303, DOI 10.1073/pnas.0902976106; Gao Y, 2012, SCIENCE, V337, P1340, DOI 10.1126/science.1224492; GARCIA EP, 1994, P NATL ACAD SCI USA, V91, P2003, DOI 10.1073/pnas.91.6.2003; Gulbranson DR, 2017, P NATL ACAD SCI USA, V114, pE8224, DOI 10.1073/pnas.1712176114; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; Hu SH, 2007, P NATL ACAD SCI USA, V104, P8773, DOI 10.1073/pnas.0701124104; Jackson MB, 2006, ANNU REV BIOPH BIOM, V35, P135, DOI 10.1146/annurev.biophys.35.040405.101958; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jewell JL, 2011, J CELL BIOL, V193, P185, DOI 10.1083/jcb.201007176; Johnson JR, 2009, BIOCHEM J, V418, P73, DOI 10.1042/BJ20081956; Kondo T, 2013, CELL STEM CELL, V12, P487, DOI 10.1016/j.stem.2013.01.009; Lai Y, 2017, NEURON, V95, P591, DOI 10.1016/j.neuron.2017.07.004; Lee YK, 2014, METHOD ENZYMOL, V538, P35, DOI 10.1016/B978-0-12-800280-3.00003-7; Lobingier BT, 2014, ELIFE, V3, DOI 10.7554/eLife.02272; Ma C, 2013, SCIENCE, V339, P421, DOI 10.1126/science.1230473; Ma L, 2015, ELIFE, V4, DOI 10.7554/eLife.09580; Malintan NT, 2009, J BIOL CHEM, V284, P21637, DOI 10.1074/jbc.M109.013508; McEwen JM, 2008, MOL BIOL CELL, V19, P3836, DOI 10.1091/mbc.E08-02-0160; Meijer M, 2012, EMBO J, V31, P2156, DOI 10.1038/emboj.2012.72; Munch AS, 2016, J NEUROSCI, V36, P6881, DOI 10.1523/JNEUROSCI.0007-16.2016; NOVICK P, 1979, P NATL ACAD SCI USA, V76, P1858, DOI 10.1073/pnas.76.4.1858; OYLER GA, 1989, J CELL BIOL, V109, P3039, DOI 10.1083/jcb.109.6.3039; Parisotto D, 2012, J BIOL CHEM, V287, P31041, DOI 10.1074/jbc.M112.386805; Park S, 2016, MOL BIOL CELL, V27, P669, DOI 10.1091/mbc.E15-09-0638; Patzke C, 2015, J CLIN INVEST, V125, P3560, DOI 10.1172/JCI78612; PEVSNER J, 1994, P NATL ACAD SCI USA, V91, P1445, DOI 10.1073/pnas.91.4.1445; Rao LJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02636-4; Rathore SS, 2010, P NATL ACAD SCI USA, V107, P22399, DOI 10.1073/pnas.1012997108; Reese C, 2005, NATURE, V436, P410, DOI 10.1038/nature03722; Rizo J, 2015, ANNU REV BIOPHYS, V44, P339, DOI 10.1146/annurev-biophys-060414-034057; Rizo J, 2012, ANNU REV CELL DEV BI, V28, P279, DOI 10.1146/annurev-cellbio-101011-155818; Rodkey TL, 2008, MOL BIOL CELL, V19, P5422, DOI 10.1091/mbc.E08-05-0538; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Shen C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9852; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Shen JS, 2010, J CELL BIOL, V190, P55, DOI 10.1083/jcb.201003148; Shin YK, 2013, P NATL ACAD SCI USA, V110, P14116, DOI 10.1073/pnas.1313749110; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; SUDHOF TC, 1989, NEURON, V2, P1475, DOI 10.1016/0896-6273(89)90193-1; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Ungar D, 2003, ANNU REV CELL DEV BI, V19, P493, DOI 10.1146/annurev.cellbio.19.110701.155609; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Weimer RM, 2003, NAT NEUROSCI, V6, P1023, DOI 10.1038/nn1118; Wickner W, 2010, ANNU REV CELL DEV BI, V26, P115, DOI 10.1146/annurev-cellbio-100109-104131; Xu H, 2011, P NATL ACAD SCI USA, V108, P17325, DOI 10.1073/pnas.1113888108; Yamaguchi T, 2002, DEV CELL, V2, P295, DOI 10.1016/S1534-5807(02)00125-9; Yu HJ, 2018, P NATL ACAD SCI USA, V115, pE8421, DOI 10.1073/pnas.1802645115; Yu HJ, 2016, P NATL ACAD SCI USA, V113, P4362, DOI 10.1073/pnas.1517259113; Yu HJ, 2015, J AM CHEM SOC, V137, P12873, DOI 10.1021/jacs.5b08306; Yu HJ, 2013, P NATL ACAD SCI USA, V110, pE3271, DOI 10.1073/pnas.1311232110; Zhang YS, 2013, NEURON, V78, P785, DOI 10.1016/j.neuron.2013.05.029; Zhou P, 2013, NEURON, V80, P470, DOI 10.1016/j.neuron.2013.09.010; Zhou P, 2013, EMBO J, V32, P159, DOI 10.1038/emboj.2012.307	66	4	4	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18309	18317		10.1074/jbc.RA118.005254	http://dx.doi.org/10.1074/jbc.RA118.005254			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30275014	Green Published, hybrid			2022-12-26	WOS:000451375200022
J	Hayashi, Y; Nemoto-Sasaki, Y; Matsumoto, N; Hama, K; Tanikawa, T; Oka, S; Saeki, T; Kumasaka, T; Koizumi, T; Arai, S; Wada, I; Yokoyama, K; Sugiura, T; Yamashita, A				Hayashi, Yasuhiro; Nemoto-Sasaki, Yoko; Matsumoto, Naoki; Hama, Kotaro; Tanikawa, Takashi; Oka, Saori; Saeki, Tadaaki; Kumasaka, Tatsuya; Koizumi, Takanori; Arai, Seisuke; Wada, Ikuo; Yokoyama, Kazuaki; Sugiura, Takayuki; Yamashita, Atsushi			Complex formation of sphingomyelin synthase 1 with glucosylceramide synthase increases sphingomyelin and decreases glucosylceramide levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						sphingolipid; ceramide; dimerization; Golgi; protein domain; fusion protein; glucosylceramide synthase (GCS); lipid metabolism; sphingomyelin synthase 1 (SMS1); sterile -motif (SAM) domain	BIMOLECULAR FLUORESCENCE COMPLEMENTATION; GLYCOSPHINGOLIPID SYNTHESIS; ENDOPLASMIC-RETICULUM; LIVING CELLS; SAM DOMAIN; EXPRESSION CLONING; LIPID MICRODOMAINS; PLASMA-MEMBRANE; CERAMIDE; GOLGI	Sphingolipids, including sphingomyelin (SM) and glucosylceramide (GlcCer), are generated by the addition of a polar head group to ceramide (Cer). Sphingomyelin synthase 1 (SMS1) and glucosylceramide synthase (GCS) are key enzymes that catalyze the conversion of Cer to SM and GlcCer, respectively. GlcCer synthesis has been postulated to occur mainly in cis-Golgi, and SM synthesis is thought to occur in medial/trans-Golgi; however, SMS1 and GCS are known to partially co-localize in cisternae, especially in medial/trans-Golgi. Here, we report that SMS1 and GCS can form a heteromeric complex, in which the N terminus of SMS1 and the C terminus of GCS are in close proximity. Deletion of the N-terminal sterile -motif of SMS1 reduced the stability of the SMS1-GCS complex, resulting in a significant reduction in SM synthesis in vivo. In contrast, chemical-induced heterodimerization augmented SMS1 activity, depending on an increase in the amount and stability of the complex. Fusion of the SMS1 N terminus to the GCS C terminus via linkers of different lengths increased SM synthesis and decreased GlcCer synthesis in vivo. These results suggest that formation of the SMS1-GCS heteromeric complex increases SM synthesis and decreases GlcCer synthesis. Importantly, this regulation of relative Cer levels by the SMS1-GCS complex was confirmed by CRISPR/Cas9-mediated knockout of SMS1 or GCS combined with pharmacological inhibition of Cer transport protein in HEK293T cells. Our findings suggest that complex formation between SMS1 and GCS is part of a critical mechanism controlling the metabolic fate of Cer in the Golgi.	[Hayashi, Yasuhiro; Nemoto-Sasaki, Yoko; Matsumoto, Naoki; Hama, Kotaro; Tanikawa, Takashi; Oka, Saori; Saeki, Tadaaki; Kumasaka, Tatsuya; Koizumi, Takanori; Yokoyama, Kazuaki; Sugiura, Takayuki; Yamashita, Atsushi] Teikyo Univ, Fac Pharma Sci, Tokyo 1738605, Japan; [Arai, Seisuke; Wada, Ikuo] Fukushima Med Univ, Sch Med, Inst Biomed Sci, Dept Cell Sci, Fukushima, Fukushima 9601295, Japan	Teikyo University; Fukushima Medical University	Yamashita, A (corresponding author), Teikyo Univ, Fac Pharma Sci, Itabashi Ku, Kaga 2-11-1, Tokyo 1738605, Japan.	ayamashi@pharm.teikyo-u.ac.jp			Japan Society for the Promotion of Science [15K18868, 18K06635, 15K07946]; Japan Foundation for Applied Enzymology; Science Research Promotion Fund from the Japan Private School Promotion Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Foundation for Applied Enzymology; Science Research Promotion Fund from the Japan Private School Promotion Foundation	This work was supported in part by Grant-in-Aid for Young Scientists (B) 15K18868 (to Y. H.) and Grants-in-Aid for Scientific Research (C) 18K06635 (to Y. H.) and 15K07946 (to A. Y.) from the Japan Society for the Promotion of Science. This work was also supported in part by funds from the Japan Foundation for Applied Enzymology (to Y. H.) and by the Science Research Promotion Fund from the Japan Private School Promotion Foundation (to Y. H., K. H., K. Y., and A. Y.). The authors declare that they have no conflicts of interest with the contents of this article.	Akiyama M, 2017, J DERMATOL SCI, V88, P3, DOI 10.1016/j.jdermsci.2017.06.002; Aviv T, 2003, NAT STRUCT BIOL, V10, P614, DOI 10.1038/nsb956; Ballou Lisa M, 2008, J Chem Biol, V1, P27, DOI 10.1007/s12154-008-0003-5; Barrera FN, 2003, J BIOL CHEM, V278, P46878, DOI 10.1074/jbc.M307846200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Cabukusta B, 2017, SCI REP-UK, V7, DOI 10.1038/srep41290; Chu BB, 2015, CELL, V161, P291, DOI 10.1016/j.cell.2015.02.019; Contreras FX, 2005, BIOPHYS J, V88, P348, DOI 10.1529/biophysj.104.050690; Contreras FX, 2003, J BIOL CHEM, V278, P37169, DOI 10.1074/jbc.M303206200; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; Fukasawa M, 1999, J CELL BIOL, V144, P673, DOI 10.1083/jcb.144.4.673; Futerman AH, 2005, TRENDS CELL BIOL, V15, P312, DOI 10.1016/j.tcb.2005.04.006; FUTERMAN AH, 1991, BIOCHEM J, V280, P295, DOI 10.1042/bj2800295; Goni FM, 2006, BBA-BIOMEMBRANES, V1758, P1902, DOI 10.1016/j.bbamem.2006.09.011; Halter D, 2007, J CELL BIOL, V179, P101, DOI 10.1083/jcb.200704091; Hammond GRV, 2012, SCIENCE, V337, P727, DOI 10.1126/science.1222483; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hayashi Y, 2017, J BIOL CHEM, V292, P1122, DOI 10.1074/jbc.M116.746602; Hayashi Y, 2014, J BIOL CHEM, V289, P30842, DOI 10.1074/jbc.M114.574285; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; Ichikawa S, 1996, P NATL ACAD SCI USA, V93, P4638, DOI 10.1073/pnas.93.10.4638; Ishibashi Y, 2018, BIOCHEM BIOPH RES CO, V499, P1011, DOI 10.1016/j.bbrc.2018.04.039; Ishibashi Y, 2013, BBA-MOL CELL BIOL L, V1831, P1475, DOI 10.1016/j.bbalip.2013.06.001; JECKEL D, 1992, J CELL BIOL, V117, P259, DOI 10.1083/jcb.117.2.259; Karginov AV, 2010, NAT BIOTECHNOL, V28, P743, DOI 10.1038/nbt.1639; Kim CA, 2003, TRENDS BIOCHEM SCI, V28, P625, DOI 10.1016/j.tibs.2003.11.001; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Kiyokawa E, 2005, J BIOL CHEM, V280, P24072, DOI 10.1074/jbc.M502244200; Klayman LM, 2017, J BIOL CHEM, V292, P1773, DOI 10.1074/jbc.M116.750430; Lamour NF, 2007, J LIPID RES, V48, P1293, DOI 10.1194/jlr.M700083-JLR200; Li E, 2012, BBA-BIOMEMBRANES, V1818, P183, DOI 10.1016/j.bbamem.2011.08.031; Marks DL, 1999, J BIOL CHEM, V274, P451, DOI 10.1074/jbc.274.1.451; Marks DL, 2001, J BIOL CHEM, V276, P26492, DOI 10.1074/jbc.M102612200; Mitsutake S, 2007, BIOCHEM BIOPH RES CO, V359, P622, DOI 10.1016/j.bbrc.2007.05.160; Mitsutake S, 2013, VITAM HORM, V91, P271, DOI 10.1016/B978-0-12-407766-9.00012-2; Mitsutake S, 2011, J BIOL CHEM, V286, P28544, DOI 10.1074/jbc.M111.255646; Nagaya H, 2002, MOL BIOL CELL, V13, P302, DOI 10.1091/mbc.01-05-0255; Ozalp C, 2005, DRUG METAB DISPOS, V33, P1382, DOI 10.1124/dmd.105.005538; Qiao F, 2004, CELL, V118, P163, DOI 10.1016/j.cell.2004.07.010; Qiao Feng, 2005, Sci STKE, V2005, pre7, DOI 10.1126/stke.2862005re7; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rietveld A, 1998, BBA-REV BIOMEMBRANES, V1376, P467, DOI 10.1016/S0304-4157(98)00019-7; Sprong H, 2001, J CELL BIOL, V155, P369, DOI 10.1083/jcb.200106104; Tafesse FG, 2007, J BIOL CHEM, V282, P17537, DOI 10.1074/jbc.M702423200; Vacaru AM, 2009, J CELL BIOL, V185, P1013, DOI 10.1083/jcb.200903152; van Blitterswijk WJ, 2003, BIOCHEM J, V369, P199, DOI 10.1042/BJ20021528; Wurch T, 1998, BIOTECHNOL TECH, V12, P653, DOI 10.1023/A:1008848517221; Yamaoka S, 2004, J BIOL CHEM, V279, P18688, DOI 10.1074/jbc.M401205200; Yang W, 2008, J BIOL CHEM, V283, P8643, DOI 10.1074/jbc.M709824200; Yasuda S, 2003, J BIOL CHEM, V278, P4176, DOI 10.1074/jbc.M209602200; Yasuda S, 2001, J BIOL CHEM, V276, P43994, DOI 10.1074/jbc.M104884200; Yeang C, 2008, BBA-MOL CELL BIOL L, V1781, P610, DOI 10.1016/j.bbalip.2008.07.002	54	14	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2018	293	45					17505	17522		10.1074/jbc.RA118.002048	http://dx.doi.org/10.1074/jbc.RA118.002048			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ9EI	30242129	hybrid, Green Published			2022-12-26	WOS:000449799000016
J	Konboon, M; Bani-Yaghoub, M; Pithua, PO; Rhee, N; Aly, SS				Konboon, Malinee; Bani-Yaghoub, Majid; Pithua, Patrick O.; Rhee, Noah; Aly, Sharif S.			A nested compartmental model to assess the efficacy of paratuberculosis control measures on US dairy farms	PLOS ONE			English	Article							AVIUM SUBSP-PARATUBERCULOSIS; LINKED IMMUNOSORBENT ASSAYS; POLYMERASE-CHAIN-REACTION; JOHNES-DISEASE; MYCOBACTERIUM-PARATUBERCULOSIS; REPRODUCTION NUMBERS; INFECTED COWS; CATTLE; HERDS; SENSITIVITY	Paratuberculosis, also known as Johne's disease (JD), is a chronic contagious disease, caused by Mycobacterium avium subsp. paratuberculosis (MAP). The disease is incurable, fatal and causes economic losses estimated to exceed 200 million dollars to the U.S. dairy industry annually. Several preventive and control measures have been recommended; however, only a few of these measures have been validated empirically. Using a nested compartmental (NC) modeling approach, the main objective of this research was to identify the best combination of control and preventive measures that minimizes the prevalence and incidence of JD and the risk of MAP occurrence in a dairy herd. The NC model employs both MAP transmission estimates and data on pen movement of cattle on a dairy to quantify the effectiveness of control and preventive measures. To obtain reasonable ranges of parameter values for between-pen movements, the NC model was fitted to the movement data of four typical California dairy farms. Using the estimated ranges of the movement parameters and those of JD from previous research, the basic reproduction number was calculated to measure the risk of MAP occurrence in each pen environment as well as the entire dairy. Although the interventions evaluated by the NC model were shown to reduce the infection, no single measure alone was capable of eradicating the infection. The numerical simulations suggest that a combination of test and cull with more frequent manure removal is the most effective method in reducing incidence, prevalence and the risk of MAP occurrence. Other control measures such as limiting calf-adult cow contacts, raising calves in a disease-free herd or colostrum management were less effective.	[Konboon, Malinee; Bani-Yaghoub, Majid; Rhee, Noah] Univ Missouri, Dept Math & Stat, Kansas City, MO 64110 USA; [Pithua, Patrick O.] Univ Missouri, Coll Vet Med, Dept Vet Med & Surg, Columbia, MO 65211 USA; [Pithua, Patrick O.] Virginia Maryland Coll Vet Med, Dept Populat Hlth Sci, Blacksburg, VA USA; [Aly, Sharif S.] Univ Calif Davis, Vet Med Teaching & Res Ctr, Sch Vet Med, Tulare, CA USA; [Aly, Sharif S.] Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA	University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Columbia; University of California System; University of California Davis; University of California System; University of California Davis	Konboon, M (corresponding author), Univ Missouri, Dept Math & Stat, Kansas City, MO 64110 USA.	mk880@mail.umkc.edu	Pithua, Patrick/J-2426-2013; Aly, Sharif S./J-6586-2019	Pithua, Patrick/0000-0002-2817-5772; Aly, Sharif S./0000-0003-0330-5013				Aly SS, 2014, INT J APPL RES VET M, V12, P1; Aly SS, 2015, J DAIRY SCI, V98, P1805, DOI 10.3168/jds.2014-8759; Aly SS, 2012, J VET DIAGN INVEST, V24, P821, DOI 10.1177/1040638712452107; Aly SS, 2005, JAVMA-J AM VET MED A, V227, P450, DOI 10.2460/javma.2005.227.450; Angelidou E, 2016, PREV VET MED, V124, P102, DOI 10.1016/j.prevetmed.2015.12.011; Aranaz A, 2006, VET RES, V37, P593, DOI 10.1051/vetres:2006021; Ayele WY, 2004, VET MICROBIOL, V103, P209, DOI 10.1016/j.vetmic.2004.07.011; Bani-Yaghoub M, 2012, EPIDEMIOL INFECT, V140, P542, DOI 10.1017/S0950268811000604; Bani-Yaghoub M, 2012, J BIOL DYNAM, V6, P923, DOI 10.1080/17513758.2012.693206; Bolton MW, 2011, J DAIRY SCI, V94, P4669, DOI 10.3168/jds.2011-4158; Brito BP, 2014, JAVMA-J AM VET MED A, V244, P582, DOI 10.2460/javma.244.5.582; Cho J, 2013, CAN J AGR ECON, V61, P583, DOI 10.1111/j.1744-7976.2012.01270.x; Chowell G., 2009, MATH STAT ESTIMATION, DOI [10.1007/978-90-481-2313-1, DOI 10.1007/978-90-481-2313-1]; Collins M, 2010, WHAT IS JOHNES DIS W; Crossley BM, 2005, VET MICROBIOL, V107, P257, DOI 10.1016/j.vetmic.2005.01.017; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Espejo LA, 2013, AM J VET RES, V74, P1304, DOI 10.2460/ajvr.74.10.1304; Gautam R, 2014, EPIDEMIOL INFECT, V142, P1034, DOI 10.1017/S0950268813001805; Groenendaal H, 2008, JAVMA-J AM VET MED A, V233, P1852, DOI 10.2460/javma.233.12.1852; Heffernan C, 2008, VACCINE, V26, P2433, DOI 10.1016/j.vaccine.2008.02.045; KETTERER PJ, 1981, AUST VET J, V57, P61, DOI 10.1111/j.1751-0813.1981.tb00445.x; Kohler H, 2001, J VET MED B, V48, P185, DOI 10.1046/j.1439-0450.2001.00443.x; LARSEN AB, 1956, AM J VET RES, V17, P549; Lovell R, 1944, J COMP PATHOL, V54, P120, DOI DOI 10.1016/S0368-1742(44)80013-3; Lu Z, 2008, J THEOR BIOL, V254, P135, DOI 10.1016/j.jtbi.2008.05.008; Lu Z, 2013, PREV VET MED, V110, P335, DOI 10.1016/j.prevetmed.2013.01.006; Lu Z, 2013, PREV VET MED, V108, P148, DOI 10.1016/j.prevetmed.2012.08.001; Magombedze G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076636; Martcheva M, 2015, VET RES, V46, DOI 10.1186/s13567-015-0190-3; Massaro T, 2013, J BIOL SYST, V21, DOI 10.1142/S021833901340010X; Mitchell RM, 2015, PREV VET MED, V118, P215, DOI 10.1016/j.prevetmed.2014.12.009; Nielsen SS, 2006, J DAIRY SCI, V89, P4557, DOI 10.3168/jds.S0022-0302(06)72505-X; Pithua P, 2009, J AM VET MED ASSOC, V234; Pithua P, 2011, JAVMA-J AM VET MED A, V238, P94, DOI 10.2460/javma.238.1.94; Sorge US, 2013, VET MICROBIOL, V164, P383, DOI 10.1016/j.vetmic.2013.02.021; STREETER RN, 1995, AM J VET RES, V56, P1322; Sweeney RW, 2012, J VET INTERN MED, V26, P1239, DOI 10.1111/j.1939-1676.2012.01019.x; SWEENEY RW, 1992, AM J VET RES, V53, P477; Sweeney RW, 1996, VET CLIN N AM-FOOD A, V12, P305, DOI 10.1016/S0749-0720(15)30408-4; Tijdschr DT, 1977, PRODUCTIVE LIFE SPAN, V102, P739; Tiwari A, 2006, CAN VET J, V47, P874; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Whitlock RH, 2005, ESTIMATION PARAMETER; Whittington RJ, 2009, VET J, V179, P60, DOI 10.1016/j.tvjl.2007.08.023	44	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0203190	10.1371/journal.pone.0203190	http://dx.doi.org/10.1371/journal.pone.0203190			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3QJ	30278041	Green Published, Green Submitted, gold			2022-12-26	WOS:000446010200005
J	van Keulen, D; Pouwer, MG; Pasterkamp, G; van Gool, AJ; Gelpke, MDS; Princen, HMG; Tempel, D				van Keulen, Danielle; Pouwer, Marianne G.; Pasterkamp, Gerard; van Gool, Alain J.; Gelpke, Maarten D. Sollewijn; Princen, Hans M. G.; Tempel, Dennie			Inflammatory cytokine oncostatin M induces endothelial activation in macro- and microvascular endothelial cells and in APOE*3Leiden.CETP mice	PLOS ONE			English	Article							NF-KAPPA-B; IN-VIVO; RHEUMATOID-ARTHRITIS; TNF-ALPHA; EARLY ATHEROSCLEROSIS; GROWTH-FACTOR; CANCER-CELLS; EXPRESSION; ADHESION; DISEASE	Aims Endothelial activation is involved in many chronic inflammatory diseases, such as atherosclerosis, and is often initiated by cytokines. Oncostatin M (OSM) is a relatively unknown cytokine that has been suggested to play a role in both endothelial activation and atherosclerosis. We comprehensively investigated the effect of OSM on endothelial cell activation from different vascular beds and in APOE*3Leiden.CETP mice. Methods and results Human umbilical vein endothelial cells, human aortic endothelial cells and human microvascular endothelial cells cultured in the presence of OSM express elevated MCP-1, IL-6 and ICAM-1 mRNA levels. Human umbilical vein endothelial cells and human aortic endothelial cells additionally expressed increased VCAM-1 and E-selectin mRNA levels. Moreover, ICAM-1 membrane expression is increased as well as MCP-1, IL-6 and E-selectin protein release. A marked increase was observed in STAT1 and STAT3 phosphorylation indicating that the JAK/STAT pathway is involved in OSM signaling. OSM signals through the LIF receptor alfa (LIFR) and the OSM receptor (OSMR). siRNA knockdown of the LIFR and the OSMR revealed that simultaneous knockdown is necessary to significantly reduce MCP-1 and IL-6 secretion, VCAM-1 and E-selectin shedding and STAT1 and STAT3 phosphorylation after OSM stimulation. Moreover, OSM administration to APOE*3Leiden.CETP mice enhances plasma E-selectin levels and increases ICAM-1 expression and monocyte adhesion in the aortic root area. Furthermore, 11-6 mRNA expression was elevated in the aorta of OSM treated mice. Conclusion OSM induces endothelial activation in vitro in endothelial cells from different vascular beds through activation of the JAK/STAT cascade and in vivo in APOE*3Leiden.CETP mice. Since endothelial activation is an initial step in atherosclerosis development, OSM may play a role in the initiation of atherosclerotic lesion formation.	[van Keulen, Danielle; Pasterkamp, Gerard; Tempel, Dennie] Univ Med Ctr Utrecht, Lab Expt Cardiol, Utrecht, Netherlands; [van Keulen, Danielle; Pasterkamp, Gerard; Tempel, Dennie] Univ Med Ctr Utrecht, Lab Clin Chem & Haematol, Utrecht, Netherlands; [van Keulen, Danielle; Tempel, Dennie] Quorics BV, Rotterdam, Netherlands; [van Keulen, Danielle; Pouwer, Marianne G.; Princen, Hans M. G.] TNO Metab Hlth Res, Gaubius Lab, Leiden, Netherlands; [Pouwer, Marianne G.] Leiden Univ, Dept Cardiol, Med Ctr, Leiden, Netherlands; [van Gool, Alain J.] TNO Microbiol & Syst Biol, Zeist, Netherlands; [van Gool, Alain J.] Radboudumc, Nijmegen, Netherlands; [Gelpke, Maarten D. Sollewijn] Mol Profiling Consulting, London, England	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Netherlands Organization Applied Science Research; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Netherlands Organization Applied Science Research; Radboud University Nijmegen	Tempel, D (corresponding author), Univ Med Ctr Utrecht, Lab Expt Cardiol, Utrecht, Netherlands.; Tempel, D (corresponding author), Univ Med Ctr Utrecht, Lab Clin Chem & Haematol, Utrecht, Netherlands.; Tempel, D (corresponding author), Quorics BV, Rotterdam, Netherlands.	d.tempel@umcutrecht.nl	Princen, Hans MG/AID-9392-2022	Princen, Hans MG/0000-0002-7206-1596; van Gool, Alain/0000-0003-0010-5286	European Union Seventh Framework Programme (FP7/2007-2013) [602936]; Quorics B.V; Molecular Profiling Consulting	European Union Seventh Framework Programme (FP7/2007-2013); Quorics B.V; Molecular Profiling Consulting	This work was supported by the European Union Seventh Framework Programme (FP7/2007-2013) [grant number 602936] (CarTarDis project). https://ec.europa.eu/research/health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Quorics B.V provided support in the form of salaries for authors DVK and DT, and Molecular Profiling Consulting provided salary for MDSG but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aird WC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006429; Albasanz-Puig A, 2011, ATHEROSCLEROSIS, V216, P292, DOI 10.1016/j.atherosclerosis.2011.02.003; Amin MA, 2010, ANN RHEUM DIS, V69, P2204, DOI 10.1136/ard.2009.127241; BROWN TJ, 1991, J IMMUNOL, V147, P2175; BROWN TJ, 1987, J IMMUNOL, V139, P2977; Camare C, 2017, REDOX BIOL, V12, P18, DOI 10.1016/j.redox.2017.01.007; Collins RG, 2000, J EXP MED, V191, P189, DOI 10.1084/jem.191.1.189; Cross A, 2004, ARTHRITIS RHEUM-US, V50, P1430, DOI 10.1002/art.20166; Dewey FE, 2017, NEW ENGL J MED, V377, P211, DOI 10.1056/NEJMoa1612790; Dumas A, 2012, J CELL MOL MED, V16, P1274, DOI 10.1111/j.1582-4934.2011.01412.x; Esashi E, 2009, EUR J IMMUNOL, V39, P1664, DOI 10.1002/eji.200839149; Falk E, 2006, J AM COLL CARDIOL, V47, pC7, DOI 10.1016/j.jacc.2005.09.068; Foglia B, 2017, DIGEST LIVER DIS, V49, pE5, DOI 10.1016/j.dld.2017.01.013; Fossey SL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-125; Gosling J, 1999, J CLIN INVEST, V103, P773, DOI 10.1172/JCI5624; Hadi HAR, 2005, VASC HEALTH RISK MAN, V1, P183; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Hui W, 1997, ANN RHEUM DIS, V56, P184, DOI 10.1136/ard.56.3.184; Jing YY, 2011, CANCER INVEST, V29, P485, DOI 10.3109/07357907.2011.597812; Kang SA, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2366-2; Kapoor D, 2014, ATHEROSCLEROSIS, V237, P623, DOI 10.1016/j.atherosclerosis.2014.10.009; Kevil CG, 2001, AM J PHYSIOL-CELL PH, V281, pC1442, DOI 10.1152/ajpcell.2001.281.5.C1442; Kim I, 2000, JBC PAPERS; Kisucka J, 2008, CIRC RES, V103, P598, DOI 10.1161/CIRCRESAHA.108.174870; Kuhnast S, 2014, J LIPID RES, V55, P2103, DOI 10.1194/jlr.M051326; Landlinger C, 2017, EUR HEART J, V38, P2499, DOI 10.1093/eurheartj/ehx260; Langenkamp E, 2009, CELL TISSUE RES, V335, P205, DOI 10.1007/s00441-008-0642-4; Mako V, 2010, CYTOM PART A, V77A, P962, DOI 10.1002/cyto.a.20952; McDonald AI, 2018, CELL STEM CELL, V23, P210, DOI 10.1016/j.stem.2018.07.011; Modur V, 1997, J CLIN INVEST, V100, P158, DOI 10.1172/JCI119508; Modur V, 1997, J CLIN INVEST, V100, P2752, DOI 10.1172/JCI119821; Morel JCM, 2001, J BIOL CHEM, V276, P37069, DOI 10.1074/jbc.M103574200; Mosley B, 1996, J BIOL CHEM, V271, P32635, DOI 10.1074/jbc.271.51.32635; Mudau M, 2012, CARDIOVASC J AFR, V23, DOI 10.5830/CVJA-2011-068; Natarelli L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05065-z; Okane CM, 2008, EUR J IMMUNOL, V38, P1321, DOI 10.1002/eji.200737855; PIGOTT R, 1992, BIOCHEM BIOPH RES CO, V187, P584, DOI 10.1016/0006-291X(92)91234-H; Pradeep AR, 2010, BIOMARKERS, V15, P277, DOI 10.3109/13547500903573209; PUGIN J, 1993, J EXP MED, V178, P2193, DOI 10.1084/jem.178.6.2193; Rajashekhar G, 2006, J VASC RES, V43, P193, DOI 10.1159/000090949; Rajendran P, 2013, INT J BIOL SCI, V9, P1057, DOI 10.7150/ijbs.7502; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Reddy VS, 2011, J CELL PHYSIOL, V226, P3303, DOI 10.1002/jcp.22676; Rega G, 2007, ARTERIOSCL THROM VAS, V27, P1587, DOI 10.1161/ATVBAHA.107.143081; Reynolds HR, 2010, ATHEROSCLEROSIS, V210, P569, DOI 10.1016/j.atherosclerosis.2009.12.007; Ruprecht K, 2001, J NEUROPATH EXP NEUR, V60, P1087, DOI 10.1093/jnen/60.11.1087; Rychli K, 2010, J THROMB HAEMOST, V8, P596, DOI 10.1111/j.1538-7836.2010.03741.x; Sandoo A, 2010, OPEN CARDIOVASC MED, V4, P302, DOI 10.2174/1874192401004010302; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Schnittker D, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/317503; Scott DW, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000263; Shi N, 2014, J BIOMED RES, V28, P40, DOI 10.7555/JBR.28.20130130; Stamatiou R, 2012, ISRN Inflamm, V2012, P731472, DOI 10.5402/2012/731472; Sugaya M, 2006, J IMMUNOL, V177, P7665, DOI 10.4049/jimmunol.177.11.7665; Szmitko PE, 2003, CIRCULATION, V108, P1917, DOI 10.1161/01.CIR.0000089190.95415.9F; Tenger C, 2005, ARTERIOSCL THROM VAS, V25, P791, DOI 10.1161/01.ATV.0000153516.02782.65; Tokuhira M, 2000, ARTHRITIS RHEUM, V43, P1122, DOI 10.1002/1529-0131(200005)43:5<1122::AID-ANR23>3.0.CO;2-7; Vasse M, 1999, ARTERIOSCL THROM VAS, V19, P1835, DOI 10.1161/01.ATV.19.8.1835; Wang Q, 2002, AM J RESP CRIT CARE, V166, P872, DOI 10.1164/rccm.2201007; Weiss TW, 2011, ANTICANCER RES, V31, P3273; West NR, 2017, NAT MED, V23, P579, DOI 10.1038/nm.4307; WILDER RL, 1991, J CELL BIOCHEM, V45, P162, DOI 10.1002/jcb.240450207; Wu KK, 1996, ANNU REV MED, V47, P315; Zhang X, 2017, J LIPID RES, V58, P895, DOI 10.1194/jlr.M074112; Zhang YZ, 2014, J MOL CELL CARDIOL, V72, P85, DOI 10.1016/j.yjmcc.2014.02.012; Zhao WW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13072-1; ZWAGINGA JJ, 1990, ARTERIOSCLEROSIS, V10, P49, DOI 10.1161/01.ATV.10.1.49	67	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204911	10.1371/journal.pone.0204911	http://dx.doi.org/10.1371/journal.pone.0204911			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273401	Green Published, gold			2022-12-26	WOS:000446124700047
J	Wong, DPW; Ng, MY; Leung, JY; Boh, BK; Lim, EC; Tan, SH; Lim, S; Seah, WH; Hu, CZW; Ho, BC; Ng, DHP; Hagen, T				Wong, Daphne Pei Wen; Ng, Mei Ying; Leung, Jia Yu; Boh, Boon Kim; Lim, Ee Chien; Tan, Shi Hua; Lim, Shuying; Seah, Wen Hui; Hu, Christine Zhiwen; Ho, Boon Chuan; Ng, Daphne Hui Ping; Hagen, Thilo			Regulation of the NRF2 transcription factor by andrographolide and organic extracts from plant endophytes	PLOS ONE			English	Article							ANTIOXIDANT RESPONSE ELEMENT; COVALENT MODIFICATION; STRESS-RESPONSE; OXYGENASE 1; KEAP1; ACTIVATION; PROTEIN; CELLS; UBIQUITINATION; INFLAMMATION	The transcription factor NF-E2 Related Factor-2 (NRF2) is an important drug target. Activation of NRF2 has chemopreventive effects in cancer and exerts beneficial effects in a number of diseases, including neurodegenerative diseases, inflammatory diseases, hepatosteatosis, obesity and insulin resistance. Hence, there have been great efforts to discover and characterize novel NRF2 activators. One reported NRF2 activator is the labdane diterpenoid andrographolide. In this study, we identified the mechanism through which andrographolide activates NRF2. We showed that andrographolide inhibits the function of KEAP1, a protein that together with CUL3 and RBX1 forms an E3 ubiquitin ligase that polyu-biquitinates NRF2. Andrographolide partially inhibits the interaction of KEAP1 with CUL3 in a manner dependent on Cys151 in KEAP1. This suggests that andrographolide forms Michael acceptor dependent adducts with Cys151 in KEAP1 in vivo, leading to inhibition of NRF2 ubiquitination and consequently accumulation of the transcription factor. Interestingly, we also showed that at higher concentrations andrographolide increases NRF2 protein expression in a Cys151 independent, but likely KEAP1 dependent manner, possibly through modification of other Cys residues in KEAP1. In this study we also screened secondary metabolites produced by endophytes isolated from non-flowering plants for NRF2-inducing properties. One of the extracts, ORX 41, increased both NRF2 protein expression and transcriptional activity markedly. These results suggest that endophytes isolated from non-flowering or other plants may be a good source of novel NRF2 inducing compounds.	[Wong, Daphne Pei Wen; Ng, Mei Ying; Leung, Jia Yu; Boh, Boon Kim; Lim, Ee Chien; Tan, Shi Hua; Lim, Shuying; Seah, Wen Hui; Hu, Christine Zhiwen; Hagen, Thilo] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore, Singapore; [Tan, Shi Hua] Natl Heart Ctr Singapore, Singapore, Singapore; [Ho, Boon Chuan] Natl Pk Board, Singapore Bot Gardens, Herbarium, Singapore, Singapore; [Ng, Daphne Hui Ping] Nanyang Technol Univ, Sch Civil & Environm Engn, Singapore, Singapore	National University of Singapore; National Heart Centre Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Hagen, T (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore, Singapore.; Ng, DHP (corresponding author), Nanyang Technol Univ, Sch Civil & Environm Engn, Singapore, Singapore.	daphneng@ntu.edu.sg; daphneng@ntu.edu.sg; bchth@nus.edu.sg	Ho, Boon-Chuan/ABC-5638-2021	Ho, Boon-Chuan/0000-0003-0530-775X				Baird L, 2013, P NATL ACAD SCI USA, V110, P15259, DOI 10.1073/pnas.1305687110; Baird L, 2013, BIOCHEM BIOPH RES CO, V433, P58, DOI 10.1016/j.bbrc.2013.02.065; Bascom-Slack CA, 2012, SCIENCE, V338, P485, DOI 10.1126/science.1215227; Chapla VM, 2014, MOLECULES, V19, P6597, DOI 10.3390/molecules19056597; Chew EH, 2007, J BIOL CHEM, V282, P17032, DOI 10.1074/jbc.M701153200; Cleasby A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098896; COOPERDRIVER G, 1977, SCIENCE, V198, P1260, DOI 10.1126/science.198.4323.1260; Dhakshinamoorthy S, 2004, J BIOL CHEM, V279, P20096, DOI 10.1074/jbc.M312492200; Eggler AL, 2009, BIOCHEM J, V422, P171, DOI 10.1042/BJ20090471; Ichikawa T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008391; Kansanen E, 2011, J BIOL CHEM, V286, P14019, DOI 10.1074/jbc.M110.190710; Li XC, 2014, TURK J BIOCHEM, V39, P30, DOI 10.5505/tjb.2014.65882; Lim JCW, 2012, CLIN EXP PHARMACOL P, V39, P300, DOI 10.1111/j.1440-1681.2011.05633.x; Norhajar Eswani, 2010, Journal of Agricultural Science (Toronto), V2, P189; Rachakonda G, 2008, CHEM RES TOXICOL, V21, P705, DOI 10.1021/tx700302s; Revathi R., 2013, PTERID RES, V2, P1; Stefanson AL, 2014, NUTRIENTS, V6, P3777, DOI 10.3390/nu6093777; Taguchi K, 2011, GENES CELLS, V16, P123, DOI 10.1111/j.1365-2443.2010.01473.x; Tan WSD, 2017, BIOCHEM PHARMACOL, V139, P71, DOI 10.1016/j.bcp.2017.03.024; Trivedi P.C., 2009, MED PLANTS UTILISATI; Wang XJ, 2008, TOXICOL APPL PHARM, V230, P383, DOI 10.1016/j.taap.2008.03.003; WHO, WHO MON SEL MED PLAN, P12; Wong DPW, 2010, EUR J PHARMACOL, V643, P188, DOI 10.1016/j.ejphar.2010.06.040; Wong SY, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0723-3; Xia YF, 2004, J IMMUNOL, V173, P4207, DOI 10.4049/jimmunol.173.6.4207; Yang CH, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081638; Yen TL, 2016, TRANSL RES, V170, P57, DOI 10.1016/j.trsl.2015.12.002; Yuan YL, 2012, FITOTERAPIA, V83, P1506, DOI 10.1016/j.fitote.2012.08.018; Zakaria ZA, 2011, AFR J BIOTECHNOL, V10, P273; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zhao J, 2011, MINI-REV MED CHEM, V11, P159, DOI 10.2174/138955711794519492	32	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204853	10.1371/journal.pone.0204853	http://dx.doi.org/10.1371/journal.pone.0204853			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273379	Green Published, gold			2022-12-26	WOS:000446124700042
J	Dehiya, V; Thomas, J; Sael, L				Dehiya, Vasundhara; Thomas, Jaya; Sael, Lee			Impact of structural prior knowledge in SNV prediction: Towards causal variant finding in rare disease	PLOS ONE			English	Article							MISSENSE MUTATIONS; SOMATIC MUTATIONS; PROTEIN FUNCTION; TOOL; P53; ANNOTATION; DISCOVERY; SERVER; EXOMES; SIFT	Can structural information of proteins generate essential features for predicting the deleterious effect of a single nucleotide variant (SNV) independent of the known existence of the SNV in diseases? In this work, we answer the question by examining the performance of features generated from prior knowledge with the goal towards determining the pathogenic effect of rare variants in rare disease. We take the approach of prioritizing SNV loci focusing on protein structure-based features. The proposed structure-based features are generated from geometric, physical, chemical, and functional properties of the variant loci and structural neighbors of the loci utilizing multiple homologous structures. The performance of the structure-based features alone, trained on 80% of HumVar-HumDiv combination (HumVD-train) and tested on 20% of HumVar-HumDiv (HumVD-test), ClinVar and ClinVar rare variant rare disease (ClinVarRVRD) datasets, showed high levels of discernibility in determining the SNV's pathogenic or benign effects on patients. Combined structure- and sequence-based features generated from prior knowledge on a random forest model further improved the F scores to 0.84 (HumVD-test), 0.75 (ClinVar), and 0.75 (ClinVarRVRD). Including features based on the difference between wild-type in addition to the features based on loci information increased the F score slightly more to 0.90 (HumVD-test), 0.78 (ClinVar), and 0.76 (ClinVarRVRD). The empirical examination and high F scores of the results based on loci information alone suggest that location of SNV plays a primary role in determining functional impact of mutation and that structure-based features can help enhance the prediction performance.	[Dehiya, Vasundhara; Thomas, Jaya] State Univ New York Korea, Dept Comp Sci, Incheon, South Korea; [Dehiya, Vasundhara; Thomas, Jaya] SUNY Stony Brook, Dept Comp Sci, Stony Brook, NY 11794 USA; [Sael, Lee] Seoul Natl Univ, Dept Comp Sci & Engn, Seoul, South Korea	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Seoul National University (SNU)	Sael, L (corresponding author), Seoul Natl Univ, Dept Comp Sci & Engn, Seoul, South Korea.	saellee@snu.ac.kr	Sael, Lee/AAD-9185-2021	Sael, Lee/0000-0002-9066-5756	Basic Science Research Program through the National Research Foundation of Korea [2015R1C1A2A01055739, 2018R1A1A3A04079531]	Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea)	LS was supported by Basic Science Research Program through the National Research Foundation of Korea (2015R1C1A2A01055739, 2018R1A1A3A04079531).	Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aken BL, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw093; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Boycott KM, 2013, NAT REV GENET, V14, P681, DOI 10.1038/nrg3555; Bullock AN, 2000, ONCOGENE, V19, P1245, DOI 10.1038/sj.onc.1203434; Carter H, 2009, CANCER RES, V69, P6660, DOI 10.1158/0008-5472.CAN-09-1133; Chial H, 2008, NAT ED, V1, P63; Choi Y, 2015, BIOINFORMATICS, V31, P2745, DOI 10.1093/bioinformatics/btv195; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; de Vrueh R, 2013, 619 WHO; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Global Genes, 2017, RAR DIS FACTS STAT; Gress A, 2016, NUCLEIC ACIDS RES, V44, pW463, DOI 10.1093/nar/gkw364; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Jagadeesh KA, 2016, NAT GENET, V48, P1581, DOI 10.1038/ng.3703; Joerger AC, 2006, P NATL ACAD SCI USA, V103, P15056, DOI 10.1073/pnas.0607286103; Kapustin Y, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-20; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Lo YS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116347; Lwin TZ, 2007, J MOL BIOL, V373, P1334, DOI 10.1016/j.jmb.2007.07.080; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Pi J, 2013, INT J MOL SCI, V14, P20635, DOI 10.3390/ijms141020635; Quesada V, 2012, NAT GENET, V44, P47, DOI 10.1038/ng.1032; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Sael L, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S2-S7; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Shi JX, 2014, NAT GENET, V46, P482, DOI 10.1038/ng.2941; Shihab HA, 2015, BIOINFORMATICS, V31, P1536, DOI 10.1093/bioinformatics/btv009; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Witten I. H., 2016, MORGAN KAUFMANN, DOI 10.1016%2Fb978-0-12-804291-5.00024-6; Worth CL, 2011, NUCLEIC ACIDS RES, V39, pW215, DOI 10.1093/nar/gkr363; Yan XJ, 2011, NAT GENET, V43, P309, DOI 10.1038/ng.788; Zhang F, 2013, ARCH BIOCHEM BIOPHYS, V535, P120, DOI 10.1016/j.abb.2013.03.005	42	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204101	10.1371/journal.pone.0204101	http://dx.doi.org/10.1371/journal.pone.0204101			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265692	Green Submitted, Green Published, gold			2022-12-26	WOS:000446005500018
J	Fullwood, RA; Low, GM; Chase, EP; Grasley, M; Beal, SS; McCrary, IM; Daniels, CW; Ingersoll, K; Berges, BK				Fullwood, R. Amy; Low, Gregory M.; Chase, Emily P.; Grasley, Meagan; Beal, Soren S.; McCrary, Ian M.; Daniels, Christian W.; Ingersoll, Kayleigh; Berges, Bradford K.			The Kaposi's sarcoma-associated herpesvirus viral interleukin 6 gene affects metastasis and expression of B cell markers in a murine xenograft model	PLOS ONE			English	Article							PRIMARY EFFUSION LYMPHOMA; ACTIVATION; DISEASE; CD30; PROLIFERATION; LATENCY; GROWTH; IL-6; HIV	Kaposi's sarcoma-associated herpesvirus (KSHV) is a cancer-causing virus in humans, primarily affecting AIDS patients. KSHV causes a range of cancers including Kaposi's sarcoma, pleural effusion lymphoma and multicentric Castleman's disease. Current methods available for treating these cancers are relatively ineffective, and new targets for therapy are needed. The KSHV viral homolog of interleukin-6 gene (vIL-6) may play a significant role in tumor development and may serve as a new anti-cancer target, but its role in tumor formation is only partially understood. Here, a novel animal model was used to study how vIL-6 affects tumor development. Highly immune-deficient Rag2(-/-)yc(-/-) mice were transplanted with an immortalized human B cell line (BJAB) harboring either wild-type (WT) KSHV or a mutant strain lacking vIL-6 Delta vIL-6). Solid tumors developed and total tumor mass and the number of tumors were characterized. The vIL-6 gene had no significant impact on tumor mass, but significantly more tumors were detected when vIL-6 was present. Significant differences in expression of B cell markers in cells from extracted tumors were detected based upon the presence of vIL-6. B cell markers in tumor cells were also compared to the same cell type in culture, prior to xenotransplantation; B cell markers were mostly downregulated during tumor formation and these changes did not differ based upon the presence of vIL-6. The only marker that significantly increased in expression during tumor development was CD30. Tumor blood vessels were quantified to determine if more angiogenesis occurred with vIL-6-expressing virus, but there was no significant difference. These data indicate that vIL-6 plays a role in KSHV tumor formation in B cells in vivo. Further investigation into how vIL-6 manipulates CD30 expression may shed insight into KSHV oncogenesis, and may identify how vIL-6 can be targeted.	[Fullwood, R. Amy; Low, Gregory M.; Chase, Emily P.; Grasley, Meagan; Beal, Soren S.; McCrary, Ian M.; Daniels, Christian W.; Ingersoll, Kayleigh; Berges, Bradford K.] Brigham Young Univ, Dept Microbiol & Mol Biol, Provo, UT 84602 USA	Brigham Young University	Berges, BK (corresponding author), Brigham Young Univ, Dept Microbiol & Mol Biol, Provo, UT 84602 USA.	brad.berges@gmail.com	McCrary, Ian/HGB-1627-2022	Chase, Emily/0000-0003-4379-4552; Ingersoll Omdahl, Kayleigh/0000-0003-0255-5547; Berges, Bradford/0000-0003-0711-576X	Simmons Center for Cancer Research Fellowship; Brigham Young University Office of Research and Creative Activities award	Simmons Center for Cancer Research Fellowship; Brigham Young University Office of Research and Creative Activities award	RAF was supported by a Simmons Center for Cancer Research Fellowship. GML was supported by a Brigham Young University Office of Research and Creative Activities award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki Y, 1999, BLOOD, V93, P4034, DOI 10.1182/blood.V93.12.4034.412k38_4034_4043; Areste C, 2009, TRENDS MICROBIOL, V17, P119, DOI 10.1016/j.tim.2008.12.001; Carbone A, 2009, BLOOD, V113, P1213, DOI 10.1182/blood-2008-09-180315; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chatterjee M, 2002, SCIENCE, V298, P1432, DOI 10.1126/science.1074883; Chen DM, 2014, J VIROL, V88, P1025, DOI 10.1128/JVI.02830-13; Chen DM, 2009, J VIROL, V83, P722, DOI 10.1128/JVI.01517-08; Chen L, 2005, J VIROL, V79, P14383, DOI 10.1128/JVI.79.22.14383-14391.2005; Chen L, 2007, VIROLOGY, V359, P425, DOI 10.1016/j.virol.2006.09.044; Chiarle R, 1999, CLIN IMMUNOL, V90, P157, DOI 10.1006/clim.1998.4636; Cornaby C, 2016, J GEN VIROL, V97, P543, DOI 10.1099/jgv.0.000370; Cousins E, 2013, J VIROL, V87, P10816, DOI 10.1128/JVI.02047-13; DERIE MA, 1989, CELL IMMUNOL, V118, P368, DOI 10.1016/0008-8749(89)90385-7; Gasperini P, 2008, J LEUKOCYTE BIOL, V84, P994, DOI 10.1189/jlb.1107777; Giffin L, 2015, MBIO, V6, DOI 10.1128/mBio.01499-15; Jones KD, 1999, BLOOD, V94, P2871; Klein U, 2003, BLOOD, V101, P4115, DOI 10.1182/blood-2002-10-3090; Knowles DM, 2003, HEMATOL ONCOL CLIN N, V17, P785, DOI 10.1016/S0889-8588(03)00050-9; Lebbe Celeste, 2009, V146, P169, DOI 10.1007/978-0-387-78574-5_15; Mir SS, 2000, BLOOD, V96, P4307; Nador RG, 1996, BLOOD, V88, P645, DOI 10.1182/blood.V88.2.645.bloodjournal882645; Pellat-Deceunynck C, 2004, BLOOD CELL MOL DIS, V32, P293, DOI 10.1016/j.bcmd.2003.12.001; Picchio GR, 1997, VIROLOGY, V238, P22, DOI 10.1006/viro.1997.8822; Sakakibara S, 2011, J INTERF CYTOK RES, V31, P791, DOI 10.1089/jir.2011.0043; Sanchez Freddy M, 2013, Methods Mol Biol, V1031, P19, DOI 10.1007/978-1-62703-481-4_2; Staber PB, 2006, LEUKEMIA RES, V30, P343, DOI 10.1016/j.leukres.2005.08.010; Sullivan RJ, 2008, CLIN INFECT DIS, V47, P1209, DOI 10.1086/592298; Suthaus J, 2012, BLOOD, V119, P5173, DOI 10.1182/blood-2011-09-377705; Uldrick TS, 2010, CLIN INFECT DIS, V51, P350, DOI 10.1086/654798	29	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204947	10.1371/journal.pone.0204947	http://dx.doi.org/10.1371/journal.pone.0204947			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265712	Green Published, Green Submitted, gold			2022-12-26	WOS:000446005500058
J	Schiffner, I; Fuhrmann, P; Reimann, J; Wiltschko, R				Schiffner, Ingo; Fuhrmann, Patrick; Reimann, Juliane; Wiltschko, Roswitha			Behavioural traits of individual homing pigeons, Columba livia f. domestica, in their homing flights	PLOS ONE			English	Article							ROUTE LOYALTY; PILOTAGE; CUES; HOME	Homing tracks of two groups of pigeons, Columba livia f. domestica, were analyzed in view of difference between individual birds and correlations between characteristic variables, looking at the initial phase while the pigeons were still at the release site, and the homing phase separately. Individual birds differed significantly in their flying speed during the initial phase, and one pigeon tended to stay longer at the release site than the others. There were no significant differences in steadiness and efficiency, indicating that all pigeons homed equally well. Differences in correlation dimension, a variable reflecting the complexity of the navigational process, reflect differences in the use of navigational information, with one bird apparently using less complex information than others. The flying speed during the initial phase was positively correlated with the flying speed during the homing phase. During the homing phase, the steadiness of flight and the efficiency of homing were closely correlated, and both tended to be positively correlated with the correlation dimension, suggesting that birds that use more complex navigational information home more efficiently.	[Schiffner, Ingo; Fuhrmann, Patrick; Reimann, Juliane; Wiltschko, Roswitha] JW Goethe Univ Frankfurt, Fachbereich Biowissensch, Biol, Max von Laue Str 13, Frankfurt, Germany; [Schiffner, Ingo] Hebrew Univ Jerusalem, Dept Ecol Evolut & Behav, Jerusalem, Israel; [Schiffner, Ingo] Bangor Univ, Sch Biol Sci, Bangor, Gwynedd, Wales	Goethe University Frankfurt; Hebrew University of Jerusalem; Bangor University	Schiffner, I; Wiltschko, R (corresponding author), JW Goethe Univ Frankfurt, Fachbereich Biowissensch, Biol, Max von Laue Str 13, Frankfurt, Germany.; Schiffner, I (corresponding author), Hebrew Univ Jerusalem, Dept Ecol Evolut & Behav, Jerusalem, Israel.; Schiffner, I (corresponding author), Bangor Univ, Sch Biol Sci, Bangor, Gwynedd, Wales.	i.schiffner@bangor.ac.uk; Wiltschko@bio.uni-frankfurt.de	Schiffner, Ingo/M-5114-2018	Schiffner, Ingo/0000-0003-0044-1677	Deutsche Forschungsgemeinschaft [WI988/7-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funded by the Deutsche Forschungsgemeinschaft by grant number WI988/7-2 to R. Wiltschko.; Our work was supported by the Deutsche Forschungsgemeinschaft through grant Wi988/7-2 to R.W.)	Armstrong C, 2008, ORIENTATION NAVIGATI; Beason RC, 2015, J COMP PHYSIOL A, V201, P961, DOI 10.1007/s00359-015-1027-2; Biro D, 2006, J NAVIGATION, V59, P43, DOI 10.1017/S0373463305003541; Biro D, 2002, J EXP BIOL, V205, P3833; Biro D, 2004, P NATL ACAD SCI USA, V101, P17440, DOI 10.1073/pnas.0406984101; EXNER S, 1883, SITZUNGSBERICHTE AKA, V102, P318; Fuller E, 1984, VERH DTSCH ZOOL GES, V77, P245; Gagliardo A, 2006, J EXP BIOL, V209, P2888, DOI 10.1242/jeb.02313; GRASSBERGER P, 1983, PHYS REV LETT, V50, P346, DOI 10.1103/PhysRevLett.50.346; Guilford T, 2004, J THEOR BIOL, V227, P25, DOI 10.1016/j.jtbi.2003.07.003; Keeton W.T., 1974, Advances Study Behav, V5, P47, DOI 10.1016/S0065-3454(08)60020-0; Kramer G., 1954, Verhandlungen der Deutschen Zoologischen Gesellschaft, V1951, P172; Mann R, 2011, J R SOC INTERFACE, V8, P210, DOI 10.1098/rsif.2010.0301; Mann RP, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2013.0885; MATTHEWS GVT, 1951, J EXP BIOL, V28, P508; Meade J, 2005, P ROY SOC B-BIOL SCI, V272, P17, DOI 10.1098/rspb.2004.2873; Reynaud G, 1900, BIRD LORE, V2, P101; Reynaud G, 1900, BIRD LORE, V2, P141; Schiffner I, 2016, J COMP PHYSIOL A, V202, P869, DOI 10.1007/s00359-016-1127-7; Schiffner I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112439; Schiffner I, 2013, ANIM BEHAV, V86, P291, DOI 10.1016/j.anbehav.2013.05.018; Schiffner I, 2011, J THEOR BIOL, V291, P42, DOI 10.1016/j.jtbi.2011.09.009; Schiffner I, 2011, NATURWISSENSCHAFTEN, V98, P575, DOI 10.1007/s00114-011-0802-3; Schiffner I, 2009, NATURWISSENSCHAFTEN, V96, P251, DOI 10.1007/s00114-008-0476-7; Steiner I, 2000, PHYSIOL BEHAV, V71, P589, DOI 10.1016/S0031-9384(00)00409-1; Takens F, 1981, DYNAMICAL SYSTEMS TU, P366, DOI [10.1007/BFb0091924, DOI 10.1007/BFB0091924]; von Hunerbein K, 2000, NATURWISSENSCHAFTEN, V87, P278, DOI 10.1007/s001140050721; von Hunerbein K., 1997, C P GNSS, VII, P561; Walcott C, 2005, INTEGR COMP BIOL, V45, P574, DOI 10.1093/icb/45.3.574; Wiltschko R, 2018, MOVEBANK DATA REPOSI, DOI [10.5441/001/1.pk8g6s2h, DOI 10.5441/001/1.PK8G6S2H]; Wiltschko R, 2007, ANIM BEHAV, V74, P1229, DOI 10.1016/j.anbehav.2007.01.028; Wiltschko R, 2009, AUK, V126, P717, DOI 10.1525/auk.2009.11009; Wobbrock JO, 2011, 29TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P143, DOI 10.1145/1978942.1978963	33	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0201291	10.1371/journal.pone.0201291	http://dx.doi.org/10.1371/journal.pone.0201291			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30260962	Green Submitted, Green Published, gold			2022-12-26	WOS:000445907400001
J	Pereira, PHC; Macedo, CH; Nunes, JDCC; Marangoni, LFD; Bianchin, A				Cipresso Pereira, Pedro Henrique; Henrique Macedo, Claudio; Nunes, Jose de Anchieta C. C.; de Barros Marangoni, Laura Fernandes; Bianchin, Adalto			Effects of depth on reef fish communities: Insights of a "deep refuge hypothesis" from Southwestern Atlantic reefs	PLOS ONE			English	Article							CORAL-REEFS; STYLOPHORA-PISTILLATA; HIGH DIVERSITY; CLIMATE-CHANGE; ASSEMBLAGES; GRADIENT; OCEAN; ACQUISITION; RESILIENCE; STRATEGIES	Deeper reefs are often considered to be less susceptible to local and global disturbances, such as overfishing, pollution and climate change, compared to shallow reefs and therefore could act as refugia for shallow water species. Hence, the interest on deeper reefs has happened at a time when shallow reefs are undergoing unprecedented changes. Here we investigated the hypothesis that fish community differed from shallow to deeper reefs due to factors apart from habitat structure and quality and therefore discuss for the first-time insights of a "deep refuge hypothesis" from Brazilian reefs. We collected data on fish community, benthic community and physiological conditions of two coral species on shallow (< 6 m) and deep reefs (> 25 m). No significant difference on substratum composition was observed comparing sites and depths. Additionally, physiological data on corals also showed similar oxidative status and growth conditions when comparing the two-coral species in shallow and deep reefs. Conversely, our study demonstrated strong differences on reef fish communities in terms of abundance, species richness, trophic groups, size classes and groups of interest when comparing shallow and deeper reefs. Fish abundance was 2-fold higher and species richness was up to 70% higher on deeper reefs. Also, a significant difference was observed comparing trophic groups of reef fish. Macrocarnivore, Mobile invertebrate feeders, Planktivores, Sessile Invertebrates Feeders and Roving Herbivores were more abundant on deeper reefs. On the other hand, Territorialist Herbivores almost exclusively dominated shallow reefs. Strong differences were also observed comparing the abundance of reef fish groups of interest and their respective size classes between shallow and deeper reefs. Ornamental, Great Herbivores and Groupers showed clear differences, with higher abundances being observed in deeper reefs. Considering size classes, larger individuals (> 15 cm) of Great Herbivores, Groupers and Snapper were uniquely recorded at deeper reefs. Additionally, individuals with > 30 cm were recorded almost exclusively on deeper reefs for all the analyzed groups of interest. Our findings suggest that fishing pressure on the target species may be attenuated on deeper reefs, and these regions may therefore be considered as areas of refuge from shallow water impacts. Therefore, the likely potential for deeper reefs protect species from natural or anthropogenic disturbances increases the attention of marine conservation planning and resource management on including deeper reefs in protected areas.	[Cipresso Pereira, Pedro Henrique; Henrique Macedo, Claudio] Univ Fed Pernambuco UFPE, Dept Oceanog, Recife, PE, Brazil; [Cipresso Pereira, Pedro Henrique; Henrique Macedo, Claudio] Projeto Conservacao Recife, Reef Conservat Project, Recife, PE, Brazil; [Nunes, Jose de Anchieta C. C.] Univ Fed Bahia, LEB, Salvador, BA, Brazil; [de Barros Marangoni, Laura Fernandes; Bianchin, Adalto] Univ Fed Rio Grande, Inst Oceanog, Programa Posgrad Oceanog Biol, Rio Grande, RS, Brazil; [Bianchin, Adalto] Univ Fed Rio Grande, Inst Ciencias Biol, Rio Grande, RS, Brazil	Universidade Federal de Pernambuco; Universidade Federal da Bahia; Universidade Federal do Rio Grande; Universidade Federal do Rio Grande	Pereira, PHC (corresponding author), Univ Fed Pernambuco UFPE, Dept Oceanog, Recife, PE, Brazil.; Pereira, PHC (corresponding author), Projeto Conservacao Recife, Reef Conservat Project, Recife, PE, Brazil.	pedro.pereira@my.jcu.edu.au	Marangoni, Laura Fernandes de Barros/CSI-8557-2022; Bianchini, Adalto/C-5384-2013	Bianchini, Adalto/0000-0002-7627-7650; Fernandes de Barros Marangoni, Laura/0000-0002-8826-7126; Rodrigues Macedo, Claudio Henrique/0000-0003-2970-3052	Rufford Small Grants [RSG 1230.5]; Mohamed Bin Zayed Species Conservation [MBZ 536-2]; Conservation Leadership Program (CLP); APA Costa dos Corais; Universidade Federal de Pernambuco (UFPE)	Rufford Small Grants; Mohamed Bin Zayed Species Conservation; Conservation Leadership Program (CLP); APA Costa dos Corais; Universidade Federal de Pernambuco (UFPE)	Financial and logistical support from Rufford Small Grants (RSG 1230.5), Mohamed Bin Zayed Species Conservation (MBZ 536-2), Conservation Leadership Program (CLP), APA Costa dos Corais and Universidade Federal de Pernambuco (UFPE).	Aguilar-Perera A, 2008, ESTUAR COAST SHELF S, V76, P378, DOI 10.1016/j.ecss.2007.07.016; ANDERSON M. J., 2007, PERMANOVA PRIMER GUI; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Aschenbrenner A, 2015, J APPL ICHTHYOL, V31, P57, DOI 10.1111/jai.12633; Asher J, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00098; Bellwood DR, 2003, ECOL LETT, V6, P281, DOI 10.1046/j.1461-0248.2003.00432.x; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bellwood DR, 2011, P ROY SOC LOND B BIO, V16; Bongaerts P, 2010, CORAL REEFS, V29, P309, DOI 10.1007/s00338-009-0581-x; Bongaerts P, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602373; BOUCHONNAVARO Y, 1981, J EXP MAR BIOL ECOL, V55, P145, DOI 10.1016/0022-0981(81)90108-8; Brokovich E, 2008, MAR ECOL PROG SER, V371, P253, DOI 10.3354/meps07591; BURNS LD, 1985, OPER RES, V33, P469, DOI 10.1287/opre.33.3.469; Campbell SJ, 2006, FISH RES, V79, P75, DOI 10.1016/j.fishres.2005.12.015; CHAN KM, 1986, ANAL BIOCHEM, V157, P375, DOI 10.1016/0003-2697(86)90640-8; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Crandall JB, 2016, J EXP MAR BIOL ECOL, V474, P133, DOI 10.1016/j.jembe.2015.10.010; Marangoni LFD, 2017, MAR ENVIRON RES, V130, P248, DOI 10.1016/j.marenvres.2017.08.002; DeMartini Edward E., 2015, P135; dos Santos HF, 2015, SCI REP-UK, V5, DOI 10.1038/srep18268; Downs C.A., 2005, TECHNIQUES AQUATIC T, VVolume 2, P181; Edmunds PJ, 2002, CORAL REEFS, V21, P193, DOI 10.1007/s00338-002-0214-0; Einbinder S, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00195; Einbinder S, 2009, MAR ECOL PROG SER, V381, P167, DOI 10.3354/meps07908; Ellison AM, 2004, AM J BOT, V91, P1930, DOI 10.3732/ajb.91.11.1930; Ezzat L, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00102; Fiske CH, 1925, J BIOL CHEM, V66, P375; Fitzpatrick BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039634; Fonseca JD, 2017, AQUAT TOXICOL, V190, P121, DOI 10.1016/j.aquatox.2017.07.002; Francini RB, 2008, AQUAT CONSERV, V18, P1166, DOI 10.1002/aqc.966; Froese R., 2012, FISHBASE; Gattuso JP, 2006, BIOGEOSCIENCES, V3, P489, DOI 10.5194/bg-3-489-2006; Gibran FZ, 2012, NEOTROP ICHTHYOL, V10, P369, DOI 10.1590/S1679-62252012005000013; Glynn PW, 1996, GLOBAL CHANGE BIOL, V2, P495, DOI 10.1111/j.1365-2486.1996.tb00063.x; Goldstein ED, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1542; Hill J., 2004, METHODS ECOLOGICAL M, DOI DOI 10.1017/CBO9781107415324.004; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 2015, REVIVING OCEAN EC CA, P60; Holstein DM, 2016, CORAL REEFS, V35, P23, DOI 10.1007/s00338-015-1339-2; Hughes TP, 2018, SCIENCE, V359, P80, DOI 10.1126/science.aan8048; Hughes TP, 2017, NATURE, V543, P373, DOI 10.1038/nature21707; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Humann P., 2002, REEF CREATURE IDENTI; Jackson JBC, 2008, P NATL ACAD SCI USA, V105, P11458, DOI 10.1073/pnas.0802812105; Jones RJ, 1997, MAR ECOL PROG SER, V149, P163, DOI 10.3354/meps149163; Kahng SE, 2014, CURR OPIN ENV SUST, V7, P72, DOI 10.1016/j.cosust.2013.11.019; Lesser MP, 2009, J EXP MAR BIOL ECOL, V375, P1, DOI 10.1016/j.jembe.2009.05.009; Lindeman KC, 2000, B MAR SCI, V66, P929; Lindfield SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092628; MacDonald C, 2016, MAR ECOL PROG SER, V561, P217, DOI 10.3354/meps11953; Marques JA, 2017, CORAL REEFS, V36, P489, DOI 10.1007/s00338-017-1547-z; Mass T, 2007, MAR ECOL PROG SER, V334, P93, DOI 10.3354/meps334093; McCook LJ, 2009, CORAL REEFS, V28, P353, DOI 10.1007/s00338-008-0463-7; McDonald JH, 2009, HDB BIOL STAT, P173; Meirelles PM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130084; Miranda RJ, 2016, MAR BIOL, V163, DOI 10.1007/s00227-016-2819-9; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; Morato T, 2006, FISH FISH, V7, P24, DOI 10.1111/j.1467-2979.2006.00205.x; Nir O, 2011, CORAL REEFS, V30, P1089, DOI 10.1007/s00338-011-0801-z; Oakes KD, 2003, AQUAT TOXICOL, V63, P447, DOI 10.1016/S0166-445X(02)00204-7; Olavo G, 2011, AQUAT CONSERV, V21, P199, DOI 10.1002/aqc.1174; Papastamatiou YP, 2015, MAR ECOL PROG SER, V521, P155, DOI 10.3354/meps11110; Pereira PHC, 2016, PEERJ, V4, DOI 10.7717/peerj.2536; Pinheiro HT, 2016, CORAL REEFS, V35, P139, DOI 10.1007/s00338-015-1381-0; Pinheiro HT, 2011, J FISH BIOL, V79, P1984, DOI 10.1111/j.1095-8649.2011.03138.x; Prazeres M, 2015, P ROY SOC B, VB282, P2014; Prazeres MD, 2011, J EXP MAR BIOL ECOL, V407, P116, DOI 10.1016/j.jembe.2011.07.015; Prazeres MF, J FORAMINIFERAL RES, V2, P56; Riegl B, 2003, INT J EARTH SCI, V92, P520, DOI 10.1007/s00531-003-0328-9; Rocha LA, 2001, J BIOGEOGR, V30, P1161; Rosa MR, 2016, CORAL REEFS, V35, P113, DOI 10.1007/s00338-015-1368-x; Ruppert JLW, 2018, GLOBAL CHANGE BIOL, V24, pE67, DOI 10.1111/gcb.13882; Schmidt C, 2011, LIMNOL OCEANOGR, V56, P1587, DOI 10.4319/lo.2011.56.5.1587; Simon T, 2016, J FISH BIOL, V89, P990, DOI 10.1111/jfb.12967; Simon T, 2013, MAR ENVIRON RES, V90, P55, DOI 10.1016/j.marenvres.2013.05.012; Slattery M, 2011, CELL, V147, P1270, DOI 10.1016/j.cell.2011.10.053; Smith TB, 2016, GLOBAL CHANGE BIOL, V22, P2756, DOI 10.1111/gcb.13175; Tenggardjaja KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115493; Turner JA, 2017, ICES J MAR SCI, V74, P2309, DOI 10.1093/icesjms/fsx085; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Ziegler DV, 2015, AGING CELL, V14, P1, DOI 10.1111/acel.12287	82	26	26	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2018	13	9							e0203072	10.1371/journal.pone.0203072	http://dx.doi.org/10.1371/journal.pone.0203072			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3NB	30256788	Green Published, Green Submitted, gold			2022-12-26	WOS:000446000200009
J	Alt, JA; Lee, WY; Davis, BM; Savage, JR; Kennedy, TP; Prestwich, GD; Pulsipher, A				Alt, Jeremiah A.; Lee, Won Yong; Davis, Brock M.; Savage, Justin R.; Kennedy, Thomas P.; Prestwich, Glenn D.; Pulsipher, Abigail			A synthetic glycosaminoglycan reduces sinonasal inflammation in a murine model of chronic rhinosinusitis	PLOS ONE			English	Article							NASAL POLYPS; EPITHELIAL-CELLS; EOSINOPHIL; AIRWAY; HEPARIN; HYALURONAN; DISEASE; ASTHMA; MOUSE; SINUS	Chronic rhinosinusitis (CRS) is characterized by sustained mucosal inflammation, impaired mucociliary clearance, loss of cilia and epithelial barrier breakdown, and tissue remodeling. Certain glycosaminoglycans inhibit various inflammatory mediators, suppress bacterial growth, and provide important functions in mucosal tissue repair and mucociliary clearance. Herein, we evaluated the effects of a synthetic glycosaminoglycan, GM-1111, on the clinical signs and inflammatory tissue changes associated with CRS in mice. CRS was generated by repeated intranasal applications of Aspergillus fumigatus (A. fumigatus) extracts over 4 weeks. Mice were then intranasally administered GM-1111 (600 mu g per dose, 5 times a week) or vehicle (phosphate buffered saline, PBS) for an additional 4 weeks while still being given A. fumigatus extracts to maintain a chronic inflammatory environment with acute exacerbations. Clinical signs indicative of sinonasal inflammation were recorded throughout the study. After 9 weeks, whole blood and sinonasal tissues were harvested for hematological, histological, and biochemical examination. The clinical signs, white blood cell counts, tissue markers of sinonasal inflammation, and histological changes caused by A. fumigatus extract administration were compared to the healthy (PBS vehicle) and GM-1111-treated groups (n = 12 per treatment group). Compared to vehicle-treated animals, animals treated with GM-1111 demonstrated significant reductions in clinical signs (p<0.05), degenerative tissue changes, goblet cell hyperplasia, inflammatory cell infiltration (p<0.01), innate immunity-(tlr2, tlr4, myd88, il1b, tnfa, il6, and il12) and adaptive immunity-associated (ccl11, ccl24, ccl5, il4, il5, and il13) cytokine gene expression (p<0.05 to p<0.0001) in sinonasal tissues, and serum IgE levels (p<0.01). Our data suggest that GM-1111 significantly reduces local and systemic effects of CRS-associated sinonasal inflammation.	[Alt, Jeremiah A.; Davis, Brock M.; Pulsipher, Abigail] Univ Utah, Sch Med, Dept Surg, Rhinol Sinus & Skull Base Surg Program,Div Head &, Salt Lake City, UT 84112 USA; [Lee, Won Yong; Savage, Justin R.; Kennedy, Thomas P.; Prestwich, Glenn D.; Pulsipher, Abigail] GlycoMira Therapeut Inc, Salt Lake City, UT 84108 USA; [Kennedy, Thomas P.] Tulane Univ, Sch Med, Pulm Dis Crit Care & Environm Med, 1430 Tulane Ave, New Orleans, LA 70112 USA; [Prestwich, Glenn D.] Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA; [Prestwich, Glenn D.] Univ Utah, Ctr Therapeut Biomat, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Tulane University; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Pulsipher, A (corresponding author), Univ Utah, Sch Med, Dept Surg, Rhinol Sinus & Skull Base Surg Program,Div Head &, Salt Lake City, UT 84112 USA.; Pulsipher, A (corresponding author), GlycoMira Therapeut Inc, Salt Lake City, UT 84108 USA.	abigail.pulsipher@utah.edu		Lee, Won Yong/0000-0001-7915-1829; Alt, Jeremiah/0000-0003-0560-5028	National Institute of Allergy and Infectious Diseases [R43 AI126987]; Flight Attendant Medical Research Institute [CIA160008]; National Institute of Dental and Craniofacial Research [R44 DE024024]; University of Utah Program in Personalized Health; National Center for Advancing Translational Sciences [KL2TR001065]; GlycoMira Therapeutics, Inc.; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001065] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R43AI126987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R44DE024024] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Flight Attendant Medical Research Institute; National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); University of Utah Program in Personalized Health; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); GlycoMira Therapeutics, Inc.; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by grants awarded from the National Institute of Allergy and Infectious Diseases (R43 AI126987 to AP, JAA, GDP: https://www.niaid.nih.gov/); Flight Attendant Medical Research Institute (CIA160008 to JAA: http://www.famri.org/intro/); National Institute of Dental and Craniofacial Research (R44 DE024024 to WYL: https://www.nidcr.nih.gov/); and University of Utah Program in Personalized Health and the National Center for Advancing Translational Sciences (KL2TR001065 to JAA: https://medicine.utah.edu/ccts/). GlycoMira Therapeutics, Inc. provided support in the form of salaries for WYL, JRS, and AP but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbadi A, 2016, J BIOL CHEM, V291, P1448, DOI 10.1074/jbc.M115.704288; Al Suleimani YM, 2008, PULM PHARMACOL THER, V21, P340, DOI 10.1016/j.pupt.2007.08.004; Amarasekera M, 2011, ASIA PAC ALLERGY, V1, P12, DOI 10.5415/apallergy.2011.1.1.12; Antunes MB, 2009, IMMUNOL ALLERGY CLIN, V29, P631, DOI 10.1016/j.iac.2009.07.004; Baba S, 2017, ANN ALLERG ASTHMA IM, V119, P120, DOI 10.1016/j.anai.2017.05.019; Bachert C, 2016, J ALLER CL IMM-PRACT, V4, P621, DOI 10.1016/j.jaip.2016.05.004; Bachert C, 2014, WORLD ALLERGY ORGAN, V7, DOI 10.1186/1939-4551-7-25; Bhattacharyya N, 2010, LARYNGOSCOPE, V120, P635, DOI 10.1002/lary.20777; Biswas K, 2017, RHINOLOGY, V55, P59, DOI 10.4193/Rhino16.201; Chai LYA, 2011, MICROBES INFECT, V13, P151, DOI 10.1016/j.micinf.2010.10.005; Denzler KL, 2000, J IMMUNOL, V165, P5509, DOI 10.4049/jimmunol.165.10.5509; Dong Z, 2005, AM J RHINOL, V19, P236, DOI 10.1177/194589240501900303; Gevaert P, 2006, J ALLERGY CLIN IMMUN, V118, P1133, DOI 10.1016/j.jaci.2006.05.031; Gevaert P, 2011, J ALLERGY CLIN IMMUN, V128, P989, DOI 10.1016/j.jaci.2011.07.056; Hascall V, 2015, ESSENTIALS GLYCOBIOL; Hirsch AG, 2017, ALLERGY, V72, P274, DOI 10.1111/all.13042; Jacob A, 2006, LARYNGOSCOPE, V116, P558, DOI 10.1097/01.MLG.0000202085.23454.2F; Jacobsen EA, 2008, J EXP MED, V205, P699, DOI 10.1084/jem.20071840; Jia MH, 2014, AM J RHINOL ALLERGY, V28, pE115, DOI 10.2500/ajra.2014.28.4030; Johnson Z, 2005, CYTOKINE GROWTH F R, V16, P625, DOI 10.1016/j.cytogfr.2005.04.006; Jura-Szoltys E, 2011, KARDIOL POL, V69, P817; Kennedy JL, 2013, AM J RHINOL ALLERGY, V27, P367, DOI 10.2500/ajra.2013.27.3906; Ledson M, 2001, EUR RESPIR J, V17, P36, DOI 10.1183/09031936.01.17100360; Lee JJ, 2012, J ALLERGY CLIN IMMUN, V130, P572, DOI 10.1016/j.jaci.2012.07.025; Lee Stella, 2011, Curr Infect Dis Rep, V13, P159, DOI 10.1007/s11908-011-0166-z; Liang Jonathan, 2013, Curr Otorhinolaryngol Rep, V1, P51; Lindsay R, 2006, OTOLARYNG HEAD NECK, V134, P724, DOI 10.1016/j.otohns.2005.11.048; Liu Tao, 2006, J Huazhong Univ Sci Technolog Med Sci, V26, P63; London NR, 2016, LARYNSCOPE INVESTIG, V1, P49, DOI 10.1002/lio2.21; Manzanares D, 2007, AM J RESP CELL MOL, V37, P160, DOI 10.1165/rcmb.2006-0413OC; Nakagawa T, 1998, ACTA OTO-LARYNGOL, P205; National Research Council (U.S.). Committee for the Update of the Guide for the Care and Use of Laboratory Animals Institute for Laboratory Animal Research (U.S.) National Academies Press (U.S.), 2011, GUIDE CARE USE LAB A; Oottamasathien S, 2011, J UROLOGY, V186, P1684, DOI 10.1016/j.juro.2011.03.099; Orlandi RR, 2016, INT FORUM ALLERGY RH, V6, pS22, DOI 10.1002/alr.21695; Pakdaman MN, 2011, IMMUNOL INVEST, V40, P767, DOI 10.3109/08820139.2011.596876; Philpott C, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006680; Prestwich G, 2010, 20Patent, Patent No. [13/575069, 13575069]; Pulsipher A, 2017, INT FORUM ALLERGY RH, V7, P177, DOI 10.1002/alr.21865; Rao NV, 2010, AM J PHYSIOL-CELL PH, V299, pC97, DOI 10.1152/ajpcell.00009.2010; Rudmik L, 2013, INT FORUM ALLERGY RH, V3, P281, DOI 10.1002/alr.21096; Savage JR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157310; Schleimer RP, 2017, J ALLERGY CLIN IMMUN, V139, P1752, DOI 10.1016/j.jaci.2017.04.010; Schleimer RP, 2017, ANNU REV PATHOL-MECH, V12, P331, DOI 10.1146/annurev-pathol-052016-100401; Schuh JM, 2013, METHODS MOL BIOL, V1032, P173, DOI 10.1007/978-1-62703-496-8_14; Sha Q, 2004, AM J RESP CELL MOL, V31, P358, DOI 10.1165/rcmb.2003-0388OC; Shah SA, 2016, J INFLAMM-LOND, V13, DOI 10.1186/s12950-016-0121-8; Simon HU, 1997, J IMMUNOL, V158, P3902; Smith KA, 2017, CURR OPIN ALLERGY CL, V17, P5, DOI 10.1097/ACI.0000000000000329; Smith TL, 2010, OTOLARYNG HEAD NECK, V142, P55, DOI 10.1016/j.otohns.2009.10.009; Sok John C, 2007, Clin Allergy Immunol, V19, P69; Souza-Fernandes AB, 2006, CRIT CARE, V10, DOI 10.1186/cc5069; Stevens WW, 2015, J ALLERGY CLIN IMMUN, V136, P1442, DOI 10.1016/j.jaci.2015.10.009; Tomassen P, 2016, J ALLERGY CLIN IMMUN, V137, P1449, DOI 10.1016/j.jaci.2015.12.1324; Treuting P, 2017, COMP ANATOMY HIST MO; Turino GM, 2003, AM J RESP CRIT CARE, V167, P1169, DOI 10.1164/rccm.200205-449PP; Vancheri C, 2001, J ALLERGY CLIN IMMUN, V108, P703, DOI 10.1067/mai.2001.118785; Wang X, 2015, INT J CLIN EXP PATHO, V8, P1199; Yildiz-Pekoz A, 2017, J AEROSOL MED PULM D, V30, P143, DOI 10.1089/jamp.2015.1273; Zhang JX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016658	59	7	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2018	13	9							e0204709	10.1371/journal.pone.0204709	http://dx.doi.org/10.1371/journal.pone.0204709			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU9BO	30252910	gold, Green Published, Green Submitted			2022-12-26	WOS:000445639700069
J	Kriechbaum, SD; Wiedenroth, CB; Keller, T; Wolter, JS; Ajnwojner, R; Peters, K; Haas, MA; Roller, FC; Breithecker, A; Rieth, AJ; Guth, S; Rolf, A; Bandorski, D; Hamm, CW; Mayer, E; Liebetrau, C				Kriechbaum, Steffen D.; Wiedenroth, Christoph B.; Keller, Till; Wolter, Jan Sebastian; Ajnwojner, Ruth; Peters, Karina; Haas, Moritz A.; Roller, Fritz C.; Breithecker, Andreas; Rieth, Andreas J.; Guth, Stefan; Rolf, Andreas; Bandorski, Dirk; Hamm, Christian W.; Mayer, Eckhard; Liebetrau, Christoph			Dynamics of high-sensitivity cardiac troponin T during therapy with balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension	PLOS ONE			English	Article							BRAIN NATRIURETIC PEPTIDE; ENDARTERECTOMY; ASSOCIATION; SEVERITY; MARKER	Aims Balloon pulmonary angioplasty (BPA) is an interventional treatment modality for inoperable chronic thromboembolic pulmonary hypertension (CTEPH). Therapy monitoring, based on non-invasive biomarkers, is a clinical challenge. This post-hoc study aimed to assess dynamics of high-sensitivity cardiac troponin T (hs-cTnT) as a marker for myocardial damage and its relation to N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels as a marker for cardiac wall stress. Methods and results This study included 51 consecutive patients who underwent BPA treatment and completed a 6-month follow-up (6-MFU) between 3/2014 and 3/2017. Biomarker measurement was performed consecutively prior to each BPA and at 6-MFU. In total, the 51 patients underwent an average of 5 BPA procedures. The 6-month survival rate was 96.1%. The baseline (BL) meanPAP (39.5 +/- 12.1mmHg) and PVR (515.8 +/- 219.2dynxsecxcm(-5)) decreased significantly within the 6-MFU (meanPAP: 32.6 +/- 12.6mmHg, P<0.001; PVR: 396.9 +/- 182.6dynxsecxcm(-5), P<0.001). At BL, the median hs-cTnT level was 11 (IQR 6-16) ng/L and the median NT-proBNP level was 820 (IQR 153-1872) ng/L. The levels of both biomarkers decreased steadily after every BPA, showing the first significant difference after the first procedure. Within the 6-MFU, hs-cTnT levels (7 [IQR 5-12] ng/L; P<0.001) and NT-proBNP levels (159 [IQR 84-464] ng/l; P<0.001) continued to decrease. The hs-cTnT levels correlated with the PVR (r(rs) = 0.42; p = 0.005), the meanPAP (r(rs) = 0.32; p = 0.029) and the NT-proBNP (r(rs) = 0.51; p<0.001) levels at BL. Conclusion Non-invasive biomarker measurement provides valuable evidence for the decreasing impairment of myocardial function and structure during BPA therapy. Changes in hs-cTNT levels are suggestive for a reduction in ongoing myocardial damage.	[Kriechbaum, Steffen D.; Keller, Till; Wolter, Jan Sebastian; Ajnwojner, Ruth; Peters, Karina; Haas, Moritz A.; Rieth, Andreas J.; Rolf, Andreas; Hamm, Christian W.; Liebetrau, Christoph] German Ctr Cardiovasc Res DZHK, Dept Cardiol, Kerckhoff Heart & Thorax Ctr, Partner Site Rhine Main, Frankfurt, Germany; [Wiedenroth, Christoph B.; Guth, Stefan; Mayer, Eckhard] Kerckhoff Heart & Thorax Ctr, Dept Thorac Surg, Bad Nauheim, Germany; [Roller, Fritz C.] Liebig Univ Giessen, Dept Radiol, Giessen, Germany; [Breithecker, Andreas] Gesundheitszentrum Wetterau, Dept Radiol, Bad Nauheim, Germany; [Rolf, Andreas; Hamm, Christian W.; Liebetrau, Christoph] Justus Liebig Univ Giessen, Div Cardiol, Med Clin 1, Giessen, Germany; [Bandorski, Dirk] Justus Liebig Univ Giessen, Dept Internal Med, Div Pulmonol, Giessen, Germany	German Centre for Cardiovascular Research; Kerckhoff Clinic; Kerckhoff Clinic; Justus Liebig University Giessen; Justus Liebig University Giessen	Kriechbaum, SD (corresponding author), German Ctr Cardiovasc Res DZHK, Dept Cardiol, Kerckhoff Heart & Thorax Ctr, Partner Site Rhine Main, Frankfurt, Germany.	s.kriechbaum@kerckhoff-klinik.de	Bandorski, Dirk/GSO-2966-2022; Rolf, Andreas/ABH-4255-2020	Bandorski, Dirk/0000-0001-5341-5195; 				Andreassen AK, 2013, HEART, V99, P1415, DOI 10.1136/heartjnl-2012-303549; Delcroix M, 2016, CIRCULATION, V133, P859, DOI 10.1161/CIRCULATIONAHA.115.016522; Feinstein JA, 2001, CIRCULATION, V103, P10; Fine NM, 2013, CIRC-CARDIOVASC IMAG, V6, P711, DOI 10.1161/CIRCIMAGING.113.000640; Galie N, 2016, EUR HEART J, V37, P67, DOI 10.1093/eurheartj/ehv317; Giannitsis E, 2013, NAT REV CARDIOL, V10, P623, DOI 10.1038/nrcardio.2013.129; Giannitsis E, 2009, HERZ, V34, P600, DOI 10.1007/s00059-009-3306-6; Haeck MLA, 2012, CIRC-CARDIOVASC IMAG, V5, P628, DOI 10.1161/CIRCIMAGING.111.971465; Jagodzinski A, 2017, CLIN CHEM, V63, P1877, DOI 10.1373/clinchem.2017.275289; Kataoka M, 2012, CIRC-CARDIOVASC INTE, V5, P756, DOI 10.1161/CIRCINTERVENTIONS.112.971390; Kimura M, 2017, CAN J CARDIOL, V33, P463, DOI 10.1016/j.cjca.2016.12.003; Kriechbaum SD, 2017, J HEART LUNG TRANSPL; Lang IM, 2013, EUR RESPIR J, V41, P462, DOI 10.1183/09031936.00049312; Liebetrau C, 2014, CLIN CHIM ACTA, V429, P34, DOI 10.1016/j.cca.2013.11.017; Matthews DT, 2016, PULM CIRC, V6, P145, DOI 10.1086/686011; Mizoguchi H, 2012, CIRC-CARDIOVASC INTE, V5, P748, DOI 10.1161/CIRCINTERVENTIONS.112.971077; Muller DWM, 2016, EUROINTERVENTION, V12, pX35, DOI 10.4244/EIJV12SXA8; Ogo T, 2015, CURR OPIN PULM MED, V21, P425, DOI 10.1097/MCP.0000000000000188; Olsson KM, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.02409-2016; Park KC, 2017, CARDIOVASC RES, V113, P1708, DOI 10.1093/cvr/cvx183; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Reesink HJ, 2007, ANN THORAC SURG, V84, P537, DOI 10.1016/j.athoracsur.2007.04.006; Roffi M, 2016, EUR HEART J, V37, P267, DOI 10.1093/eurheartj/ehv320; Surie S, 2012, INTERACT CARDIOV TH, V15, P973, DOI 10.1093/icvts/ivs415; Torbicki A, 2003, CIRCULATION, V108, P844, DOI 10.1161/01.CIR.0000084544.54513.E2; van der Linden N, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005703; Velez-Martinez M, 2013, AM J CARDIOL, V111, P1812, DOI 10.1016/j.amjcard.2013.02.036; Volkers M, 2013, BMC PULM MED, V13, DOI 10.1186/1471-2466-13-28; Wiedenroth C, PULMONARY CIRCULATIO, V1; Wiedenroth CB, 2016, J HEART LUNG TRANSPL, V35, P591, DOI 10.1016/j.healun.2015.10.030; Wilkens H, 2016, DEUT MED WOCHENSCHR, V141, pS62, DOI 10.1055/s-0042-114529	31	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2018	13	9							e0204683	10.1371/journal.pone.0204683	http://dx.doi.org/10.1371/journal.pone.0204683			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU9BO	30252896	Green Submitted, Green Published, gold			2022-12-26	WOS:000445639700067
J	da Silva, LLS; Fawzi, WW; Cardoso, MA				Santos da Silva, Lara Livia; Fawzi, Wafaie Wahib; Cardoso, Marly Augusto		ENFAC Working Grp	Factors associated with anemia in young children in Brazil	PLOS ONE			English	Article							IRON-DEFICIENCY; RISK-FACTORS; PREVALENCE; INFECTIONS; HEALTH; SUPPLEMENTATION; UNDERNUTRITION; INFANTS	Background Anemia is recognized as a major public health problem in childhood, especially in children under 24 months of age. Despite improvements in public health strategies to prevent and control anemia in Brazilian young children in the last decade, few studies have assessed the predictors for this condition in primary health care. Thus, this study aimed to assess the associated factors of anemia in young children who visited primary public health care facilities in Brazil. Methods A cross-sectional study was conducted with 520 children aged 11 to 15 months who visited the primary health care in four Brazilian cities. Anemia was defined as hemoglobin concentration < 110 g/L in venous blood samples. Multilevel Poisson regression models were used to describe the associations between anemia and independent variables. Results The frequency of anemia was 23.1%. A higher frequency was observed in children who live with more than one other child younger than 5 years in the house (Prevalence Ratio [PR] 1.47; 95% Confidence Interval [CI] 1.01- 2.14), who started to receive fruits and vegetables after 8 months of age (PR 1.92; 95% CI 1.19-3.10), who were stunted (PR 2.44; 95% CI 1.32-4.50), who were hospitalized at least once in their life (PR 1.55; 95% CI 1.03-2.33) and who were in the lower tertile of serum folate concentration (PR 2.24; 95% CI 1.30-3.85). Conclusions Inadequate complementary feeding practices and morbidity were the main predictors for anemia in early childhood in this population. Improvements in current strategies to promote healthy complementary feeding along with better control of morbidities are recommended to reduce anemia in Brazilian young children.	[Santos da Silva, Lara Livia; Cardoso, Marly Augusto; ENFAC Working Grp] Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, Sao Paulo, SP, Brazil; [Fawzi, Wafaie Wahib] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA	Universidade de Sao Paulo; Harvard University; Harvard T.H. Chan School of Public Health	Cardoso, MA (corresponding author), Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, Sao Paulo, SP, Brazil.	marlyac@usp.br	Cardoso, Marly Augusto/B-8010-2013	Cardoso, Marly Augusto/0000-0003-0973-3908	Brazilian National Counsel of Technological and Scientific Development, CNPq [552747/2011-4]; CNPq [200487/2015-9]; CAPES	Brazilian National Counsel of Technological and Scientific Development, CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Funding This study was funded by the Brazilian National Counsel of Technological and Scientific Development, CNPq (Grant no. 552747/2011-4). LLSS received Sandwich Doctorate scholarship from the CNPq (Grant number 200487/2015-9) and doctoral scholarship from CAPES. The views expressed in the present article are those of the authors and not necessarily those of any funding agencies or others whose support is acknowledged. The funders had no role in the design and analysis of the study or in the writing of this article.	ALLEN L, 1997, IMPROVING IRON STATU; Allen LH, 2002, J NUTR, V132, p813S, DOI 10.1093/jn/132.4.813S; [Anonymous], 2001, IRON DEFICIENCY ANAE; Azeredo CM, 2010, REV SAUDE PUBL, V44, P230, DOI 10.1590/S0034-89102010000200002; Balarajan Y, 2011, LANCET, V378, P2123, DOI 10.1016/S0140-6736(10)62304-5; Black MM, 2011, NUTR REV, V69, pS64, DOI 10.1111/j.1753-4887.2011.00435.x; Brasil, 2009, PESQUISA NACL DEMOGR; Zanin FHC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139555; Cardoso MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151097; Cardoso MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036341; Silla LMD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068805; Vieira RCD, 2018, PUBLIC HEALTH NUTR, V21, P868, DOI 10.1017/S1368980017003238; Vieira RCD, 2010, REV NUTR, V23, P433, DOI 10.1590/S1415-52732010000300011; Davidsson L, 2003, J NUTR, V133, p1560S, DOI 10.1093/jn/133.5.1560S; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; De-Regil LM, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009085.pub2; Doniec K, 2018, LANCET, V392, P731, DOI 10.1016/S0140-6736(18)30853-5; Friedman JF, 2005, TRENDS PARASITOL, V21, P386, DOI 10.1016/j.pt.2005.06.006; JANSSON LT, 1986, PEDIATR INFECT DIS J, V5, P424, DOI 10.1097/00006454-198607000-00009; Jonker FAM, 2014, J INFECTION, V69, pS23, DOI 10.1016/j.jinf.2014.08.007; Kotecha Prakash V, 2011, Indian J Community Med, V36, P8, DOI 10.4103/0970-0218.80786; Kumar A, 2008, PEDIATRICS, V121, pE673, DOI 10.1542/peds.2007-1986; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Molla Eshetu, 2018, BMC Res Notes, V11, P585, DOI 10.1186/s13104-018-3679-9; Mujica-Coopman MF, 2015, FOOD NUTR BULL, V36, pS119, DOI 10.1177/0379572115585775; Oliveira BRG, 2010, REV BRAS EPIDEMIOL, V13, P1; Silva DG, 2007, J PEDIAT-BRAZIL, V83, P149, DOI [10.1590/S0021-75572007000200009, 10.2223/JPED.1603]; Stevens GA, 2013, LANCET GLOB HEALTH, V1, pE16, DOI 10.1016/S2214-109X(13)70001-9; Stoltzfus RJ., 2004, COMP QUANTIFICATION, pp. 163; Thurnham DI, 2010, AM J CLIN NUTR, V92, P546, DOI 10.3945/ajcn.2010.29284; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Victora CG, 2011, LANCET, V377, P1863, DOI 10.1016/S0140-6736(11)60138-4; Villalpando S, 2006, ANN NUTR METAB, V50, P506, DOI 10.1159/000098142; WHO Expert Committee on Physical Status: the Use and Interpretation of Anthropometry (1993: Geneva S Organization WH, 1995, PHYS STAT US INT ANT; WHO Guideline, 2016, US MULT MICR POW POI; Woldie H, 2015, J NUTR METAB, V2015, DOI 10.1155/2015/928632; World Health Organization, 2011, SER FERR CONC ASS IR; World Health Organization, 2015, GLOB PREV AN 2011; Zhao A, 2012, AM J TROP MED HYG, V87, P306, DOI 10.4269/ajtmh.2012.11-0660	39	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2018	13	9							e0204504	10.1371/journal.pone.0204504	http://dx.doi.org/10.1371/journal.pone.0204504			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU9BO	30252898	Green Published, Green Submitted, gold			2022-12-26	WOS:000445639700055
J	Tavares, DD; Salgado, VR; Miranda, JC; Mesquite, PRR; Rodrigues, FD; Barral-Netto, M; de Andrade, JB; Barral, A				Tavares, Diva da Silva; Salgado, Vanessa Riesz; Miranda, Jose Carlos; Mesquite, Paulo R. R.; Rodrigues, Frederico de Medeiros; Barral-Netto, Manoel; de Andrade, Jailson Bittencourt; Barral, Aldina			Attraction of phlebotomine sandflies to volatiles from skin odors of individuals residing in an endemic area of tegumentary leishmaniasis	PLOS ONE			English	Article							GAS CHROMATOGRAPHY/MASS SPECTROMETRY; SAND FLIES DIPTERA; LUTZOMYIA-LONGIPALPIS; AEDES-AEGYPTI; VIANNIA BRAZILIENSIS; ORGANIC-COMPOUNDS; MOSQUITOS; CAPTURE; IDENTIFICATION; PSYCHODIDAE	Background Many studies have investigated what could attract insects of medical importance and a crucial role has lately been attributed to human skin odors. Most of these researches have been concerned with mosquitoes, e.g., vectors of dengue and malaria. Little is known about volatile organic compounds (VOCs) from human skin odors and their effects on leishmania vectors. Objective The present study aimed to identify the VOCs from human skin that can be attractive to female anthropophilic phlebotomine sandflies. Results Forty-two VOCs were identified from skin odors of 33 male volunteers, seven of which were tested in wind tunnel assays employing field-captured phlebotomine sandflies (75.4% identified as Lutzomyia intermedia). Hexane and (E)-oct-3-en-1-ol (octenol) were used as negative and positive controls, respectively. 2-Phenylacetaldehyde (hereafter called phenylacetaldehyde), 6-methylhept-5-en-2-one (also known as sulcatone), nonadecane and icosane were found to activate female phlebotomine sandflies, but only phenylacetaldehyde, 6-methylhepten-5-en-2-one and icosane elicited attraction responses. Conclusions These results suggest that phenylacetaldehyde, 6-methylhepten-5-en-2-one and icosane may be suitable candidates for attractiveness experimentation in the field which can be an important tool to develop strategies concerning human beings protection against phlebotomine sandflies bites and consequently against leishmaniasis.	[Tavares, Diva da Silva; Salgado, Vanessa Riesz; Miranda, Jose Carlos; Barral-Netto, Manoel; Barral, Aldina] Inst Goncalo Moniz Fiocruz, Salvador, BA, Brazil; [Tavares, Diva da Silva; Barral-Netto, Manoel; Barral, Aldina] Univ Fed Bahia UFBA, Fac Med, Salvador, BA, Brazil; [Tavares, Diva da Silva] Ctr Univ Christus UNICHRISTUS, Fac Med, Fortaleza, Ceara, Brazil; [Mesquite, Paulo R. R.; Rodrigues, Frederico de Medeiros; de Andrade, Jailson Bittencourt] Univ Fed Bahia UFBA, Inst Quim, Salvador, BA, Brazil; [Barral-Netto, Manoel; Barral, Aldina] Inst Nacl Ciencia & Tecnol Invest Imunol iii INCT, Salvador, BA, Brazil; [de Andrade, Jailson Bittencourt] INCT EA, Salvador, BA, Brazil	Universidade Federal da Bahia; Universidade Federal da Bahia	Tavares, DD; Barral, A (corresponding author), Inst Goncalo Moniz Fiocruz, Salvador, BA, Brazil.; Tavares, DD; Barral, A (corresponding author), Univ Fed Bahia UFBA, Fac Med, Salvador, BA, Brazil.; Tavares, DD (corresponding author), Ctr Univ Christus UNICHRISTUS, Fac Med, Fortaleza, Ceara, Brazil.; Barral, A (corresponding author), Inst Nacl Ciencia & Tecnol Invest Imunol iii INCT, Salvador, BA, Brazil.	divest.bio@gmail.com; abarral@bahia.fiocruz.br	de Andrade, Jailson B./V-2437-2019; Barral, Aldina/B-4191-2009; Barral-Netto, Manoel/B-3904-2009; Miranda, Jose/HCI-6099-2022	de Andrade, Jailson B./0000-0001-5269-4866; Barral, Aldina/0000-0002-7177-464X; Barral-Netto, Manoel/0000-0002-5823-7903; Mesquita, Paulo R. R./0000-0003-3187-3800; Salgado, Vanessa Riesz/0000-0002-6650-6501	FAPESB [2582/2013]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq	FAPESB(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was funded by FAPESB (http://www.fapesb.ba.gov.br/), grant number 2582/2013 to JCM. DT received a doctoral scholarship from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (http://www.cnpq.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ampuero J, 2006, REV SOC BRAS MED TRO, V39, P22, DOI 10.1590/S0037-86822006000100004; Andrade AJ, 2008, MEM I OSWALDO CRUZ, V103, P337, DOI 10.1590/S0074-02762008000400004; Bernier UR, 2015, J AM MOSQUITO CONTR, V31, P63, DOI 10.2987/14-6452R.1; Bernier UR, 2002, J AM MOSQUITO CONTR, V18, P186; Bernier UR, 2000, ANAL CHEM, V72, P747, DOI 10.1021/ac990963k; Birkett MA, 2004, MED VET ENTOMOL, V18, P313, DOI 10.1111/j.0269-283X.2004.00528.x; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; Costa JML, 2005, GAZ MED BAHIA, V75, P13; de Oliveira LS, 2008, J CHROMATOGR B, V875, P392, DOI 10.1016/j.jchromb.2008.09.028; Dormont L, 2013, J CHEM ECOL, V39, P569, DOI 10.1007/s10886-013-0286-z; Gallagher M, 2008, BRIT J DERMATOL, V159, P780, DOI 10.1111/j.1365-2133.2008.08748.x; Geier M, 2002, P INT C URB PESTS 20, P37; Goulart TM, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1035-7; HAMILTON JGC, 1994, MED VET ENTOMOL, V8, P375, DOI 10.1111/j.1365-2915.1994.tb00101.x; Jhumur US, 2007, ARTHROPOD-PLANT INTE, V1, P245, DOI 10.1007/s11829-007-9022-3; Jirmanus L, 2012, AM J TROP MED HYG, V86, P426, DOI 10.4269/ajtmh.2012.11-0378; Kohoutova D, 2012, BEHAV ECOL SOCIOBIOL, V66, P569, DOI 10.1007/s00265-011-1305-0; Kong HH, 2012, J INVEST DERMATOL, V132, P933, DOI 10.1038/jid.2011.417; Leal HM, 2017, SCI REP, V7, P1, DOI [10.1038/s41598-016-0028-x, DOI 10.1038/S41598-016-0028-X]; Lewnard JA, 2014, PLOS NEGLECT TROP D, V8, P1; Logan JG, 2008, J CHEM ECOL, V34, P308, DOI 10.1007/s10886-008-9436-0; Magalhaes-Junior Jairo Torres, 2014, Parasit Vectors, V7, P60, DOI 10.1186/1756-3305-7-60; Magalhaes JT, 2014, ANAL BIOANAL CHEM, V406, P6691, DOI 10.1007/s00216-014-8103-2; McBride SC, 2011, CURR BIOL, V26, pR41; Menger DJ, 2014, MED VET ENTOMOL, V28, P407, DOI 10.1111/mve.12061; Miranda JC, 2002, MEM I OSWALDO CRUZ, V97, P185, DOI 10.1590/S0074-02762002000200006; Pinto MC, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-210; Pinto MC, 2001, MED VET ENTOMOL, V15, P132, DOI 10.1046/j.1365-2915.2001.00294.x; Prada PA, 2010, ANAL METHODS-UK, V2, P470, DOI 10.1039/b9ay00239a; Pugedo H, 2005, REV SOC BRAS MED TRO, V38, P70, DOI 10.1590/S0037-86822005000100017; Rebollar-Tellez EA, 1999, PHYSIOL ENTOMOL, V24, P220, DOI 10.1046/j.1365-3032.1999.00133.x; Santos J B, 2000, Cad Saude Publica, V16, P701; SCHLEIN Y, 1995, J MED ENTOMOL, V32, P882, DOI 10.1093/jmedent/32.6.882; Smallegange C, 2011, TRENDS PARASITOL, V30, P1; Stulp G, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028991, 10.1371/journal.pone.0020497]; Verhulst NO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015829; Verhulst NO, 2010, FEMS MICROBIOL ECOL, V74, P1, DOI 10.1111/j.1574-6941.2010.00908.x; Xue RY, 2008, RAPID COMMUN MASS SP, V22, P1181, DOI 10.1002/rcm.3466; Young D. G., 1994, Guide to the identification and geographic distribution of Lutzomyia sand flies in Mexico, the West Indies, Central and South America (Diptera: Psychodidae).; Zhang XD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124680	40	10	10	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2018	13	9							e0203989	10.1371/journal.pone.0203989	http://dx.doi.org/10.1371/journal.pone.0203989			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3MI	30248113	Green Published, Green Submitted, gold			2022-12-26	WOS:000445998100016
J	Vrijen, C; van Roekel, E; Oldehinkel, AJ				Vrijen, Charlotte; van Roekel, Eeske; Oldehinkel, Albertine J.			Alpha-amylase reactivity and recovery patterns in anhedonic young adults performing a tandem skydive	PLOS ONE			English	Article							MAJOR DEPRESSIVE DISORDER; PSYCHOLOGICAL STRESS; DIURNAL COURSE; CORTISOL; ANXIETY; DETERMINANTS; RESPONSES; ASSOCIATIONS; ADOLESCENTS; STATE	Background Anhedonia (loss of pleasure) is characterized by low responsiveness to rewards and, by virtue of being one of the two core symptoms of depression, by altered responses to stress. We investigated the effect of an acute stress experience (i.e., a tandem skydive) that was expected to elicit both intense fear and intense euphoria in a sample of anhedonic young adults. Objective (1) To examine individual differences in alpha-amylase reactivity to and recovery from a tandem skydive in anhedonic young adults; (2) to investigate whether trait depressive and anxiety problems, trait positive affect (PA), i.e., level of pleasure and reward responsiveness, and state anxiety, PA and self-esteem prior to the skydive were associated with alpha-amylase reactivity and recovery patterns; (3) to investigate whether alpha-amylase reactivity and recovery patterns were associated with pre-to post-jump changes in state anxiety, PA, and self-esteem. Method Participants were 61 individuals with persistent anhedonia (Mage = 21.38, 78.7% female), who filled out a baseline questionnaire at the start of the study, and momentary questionnaires (3 times per day) before and after the tandem skydive. Alpha-amylase was measured at four time points by means of salivettes (2 before and 2 after the skydive). Results Alpha-amylase reactivity and recovery patterns were highly similar across individuals, although mean levels varied greatly. No associations were found between any of the trait and state measures and reactivity and recovery. Only state self-esteem was affected by the reactivity and recovery patterns, in that individuals who showed high reactivity and low recovery experienced decreases in self-esteem after the skydive. Conclusions Alpha-amylase patterns following a tandem skydive in anhedonic individuals are highly similar to patterns previously found in healthy individuals. Although replication is warranted, our findings tentatively suggest that a strong stress response that cannot be downregulated well predicts a decrease in self-esteem.	[Vrijen, Charlotte; van Roekel, Eeske; Oldehinkel, Albertine J.] Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands; [van Roekel, Eeske] Tilburg Univ, Dept Dev Psychol, Tilburg, Netherlands	University of Groningen; Tilburg University	Vrijen, C (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands.	c.vrijen@umcg.nl	van Roekel, Eeske/E-7889-2012; Vrijen, Charlotte/R-3839-2019	van Roekel, Eeske/0000-0002-0829-8089; Vrijen, Charlotte/0000-0001-5144-7863	VICI grant from the Netherlands Organization for Scientific Research NWO [Vici 016.001/002]	VICI grant from the Netherlands Organization for Scientific Research NWO(Netherlands Organization for Scientific Research (NWO))	This project has been financially supported by a VICI grant (Vici 016.001/002) from the Netherlands Organization for Scientific Research NWO (www.nwo.nl), which was granted to AJO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach TM, 2003, MANUAL ASEBA ADULT F; Adam EK, 2011, BIOL PSYCHOL, V88, P170, DOI 10.1016/j.biopsycho.2011.07.007; Allwood MA, 2011, BIOL PSYCHOL, V88, P57, DOI 10.1016/j.biopsycho.2011.06.008; Alpers GW, 2008, J ANXIETY DISORD, V22, P591, DOI 10.1016/j.janxdis.2007.05.008; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Berghorst LH, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00133; Bogdan R, 2006, BIOL PSYCHIAT, V60, P1147, DOI 10.1016/j.biopsych.2006.03.037; Booij SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131002; Bosch JA, 2011, PSYCHONEUROENDOCRINO, V36, P449, DOI 10.1016/j.psyneuen.2010.12.019; Buchanan TW, 1999, PSYCHONEUROENDOCRINO, V24, P227, DOI 10.1016/S0306-4530(98)00078-X; Burke HM, 2005, PSYCHONEUROENDOCRINO, V30, P846, DOI 10.1016/j.psyneuen.2005.02.010; CELSI RL, 1993, J CONSUM RES, V20, P1, DOI 10.1086/209330; Chatterton RT, 1997, J CLIN ENDOCR METAB, V82, P2503, DOI 10.1210/jc.82.8.2503; Corral-Frias NS, 2016, PSYCHONEUROENDOCRINO, V66, P205, DOI 10.1016/j.psyneuen.2016.01.012; Gerra G, 2000, NEUROPSYCHOBIOLOGY, V42, P82, DOI 10.1159/000026677; Hare OA, 2013, PHYSIOL BEHAV, V118, P40, DOI 10.1016/j.physbeh.2013.05.011; IBM Corp. Released, 2017, IBM SPSS STAT WIND V; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lorentz K, 1998, CLIN CHEM LAB MED, V36, P185, DOI 10.1515/CCLM.1998.034; Marchand A, 2016, PSYCHONEUROENDOCRINO, V66, P65, DOI 10.1016/j.psyneuen.2016.01.005; Masselink M, DOMAINS PLEASURE SCA; Meyer VJ, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00138; Nater UM, 2009, PSYCHONEUROENDOCRINO, V34, P486, DOI 10.1016/j.psyneuen.2009.01.014; Nater UM, 2007, PSYCHONEUROENDOCRINO, V32, P392, DOI 10.1016/j.psyneuen.2007.02.007; Noto Y, 2005, ANESTH ANALG, V101, P1873, DOI 10.1213/01.ANE.0000184196.60838.8D; Oldehinkel AJ, 2011, PSYCHOPHYSIOLOGY, V48, P441, DOI 10.1111/j.1469-8986.2010.01118.x; Out D, 2013, PSYCHONEUROENDOCRINO, V38, P367, DOI 10.1016/j.psyneuen.2012.06.013; Porcelli AJ, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00157; Price IR, 2005, PERS INDIV DIFFER, V38, P1203, DOI 10.1016/j.paid.2004.08.003; R Core Team, 2021, R LANGUAGE ENV STAT; Rector NA, 1997, PERS INDIV DIFFER, V23, P799, DOI 10.1016/S0191-8869(97)00095-0; Rohleder N, 2009, PSYCHONEUROENDOCRINO, V34, P469, DOI 10.1016/j.psyneuen.2008.12.004; Salomon K, 2009, HEALTH PSYCHOL, V28, P157, DOI 10.1037/a0013001; Schumacher S, 2013, PSYCHONEUROENDOCRINO, V38, P729, DOI 10.1016/j.psyneuen.2013.02.003; Takahashi T, 2005, NEUROENDOCRINOL LETT, V26, P351; Takai N, 2004, ARCH ORAL BIOL, V49, P963, DOI 10.1016/j.archoralbio.2004.06.007; Tanaka Y, 2012, PROG NEURO-PSYCHOPH, V36, P220, DOI 10.1016/j.pnpbp.2011.10.005; Treadway MT, 2011, NEUROSCI BIOBEHAV R, V35, P537, DOI 10.1016/j.neubiorev.2010.06.006; Van den Berg I, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00239; van Roekel E, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0880-z; Veen G, 2012, INT J PSYCHOPHYSIOL, V84, P33, DOI 10.1016/j.ijpsycho.2012.01.005; Wickham H, 2017, GRAMMAR DATA MANIPUL; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilke C.O., 2017, cowplot: Streamlined plot theme and plot annotations for ``ggplot2''. R package version 0.8.0; Wingenfeld K, 2010, BIOL PSYCHOL, V85, P179, DOI 10.1016/j.biopsycho.2010.04.005; Yorbik O, 2016, PSYCHIAT RES, V235, P148, DOI 10.1016/j.psychres.2015.11.021	46	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2018	13	9							e0204556	10.1371/journal.pone.0204556	http://dx.doi.org/10.1371/journal.pone.0204556			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV3MI	30248153	Green Published, gold, Green Submitted			2022-12-26	WOS:000445998100052
J	Han, RF; Khakid, M; Juan, JX; Huang, DF				Han, Ruifeng; Khakid, Muhammad; Juan, Jiaxiang; Huang, Danfeng			Exogenous glycine inhibits root elongation and reduces nitrate-N uptake in pak choi (Brassica campestris ssp Chinensis L.)	PLOS ONE			English	Article							AMINO-ACIDS; ARABIDOPSIS-THALIANA; ETHYLENE PRODUCTION; INORGANIC NITROGEN; UPTAKE KINETICS; SOIL SOLUTIONS; WHEAT PLANTS; L-GLUTAMATE; GROWTH; L.	Nitrogen (N) supply, including NO3--N and organic N in the form of amino acids can influence the morphological attributes of plants. For example, amino acids contribute to plant nutrition; however, the effects of exogenous amino acids on NO3--N uptake and root morphology have received little attention. In this study, we evaluated the effects of exogenous glycine (Gly) on root growth and NO3--N uptake in pak choi (Brassica campestris ssp. Chinensis L.). Addition of Gly to NO3--N agar medium or hydroponic solution significantly decreased pak choi seedling root length; these effects of Gly on root morphology were not attributed to the proportion of N supply derived from Gly. When pak choi seedlings were exposed to mixtures of Gly and NO3--N in hydroponic culture, Gly significantly reduced (NO3-)-N-15-N uptake but significantly increased the number of root tips per unit root length, root activity and (NO3-)-N-15-N uptake rate per unit root length. In addition, N-15-Gly was taken up into the plants. In contrast to absorbed NO3--N, which was mostly transported to the shoots, a larger proportion of absorbed Gly was retained in the roots. Exogenous Gly enhanced root 1-aminocyclopropane-1-carboxylic acid synthase (ACS) and oxidase (ACO) activities and ethylene production. The ethylene antagonists aminoethoxyvinylglycine (0.5 mu M AVG) and silver nitrate (10 mu M AgNO3) partly reversed Gly-induced inhibition of primary root elongation on agar plates and increased the NO3--N uptake rate under hydroponic conditions, indicating exogenous Gly exerts these effects at least partly by enhancing ethylene production in roots. These findings suggest Gly substantially affects root morphology and N uptake and provide new information on the specific responses elicited by organic N sources.	[Han, Ruifeng; Khakid, Muhammad; Juan, Jiaxiang; Huang, Danfeng] Shanghai Jiao Tong Univ, Sch Agr & Biol, Dept Plant Sci, Shanghai, Peoples R China; [Han, Ruifeng; Khakid, Muhammad; Juan, Jiaxiang; Huang, Danfeng] Minist Agr, Key Lab Urban Agr South, Shanghai, Peoples R China	Shanghai Jiao Tong University; Ministry of Agriculture & Rural Affairs	Huang, DF (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Biol, Dept Plant Sci, Shanghai, Peoples R China.; Huang, DF (corresponding author), Minist Agr, Key Lab Urban Agr South, Shanghai, Peoples R China.	hdf@sjtu.edu.cn			earmarked fund for Shanghai Modern Leafvegetable industry Technology Research System [201802]; Science and Technology Commission of Shanghai Municipality [16391901700]	earmarked fund for Shanghai Modern Leafvegetable industry Technology Research System; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This research was supported in part by the earmarked fund for Shanghai Modern Leafvegetable industry Technology Research System (Grant No. 201802) to RH and DH, and the Science and Technology Commission of Shanghai Municipality (Project No. 16391901700) to DH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai LQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156188; Bonner CA, 1996, PLANT SCI, V113, P43, DOI 10.1016/0168-9452(95)04284-9; Caba JM, 1998, PLANT CELL ENVIRON, V21, P87, DOI 10.1046/j.1365-3040.1998.00242.x; Cambui CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019211; Cao XC, 2013, SOIL BIOL BIOCHEM, V62, P13, DOI 10.1016/j.soilbio.2013.02.018; Chen GuiLin, 2002, Agricultural Sciences in China, V1, P444; De Gernier H, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00070; Dominguez-May AV, 2013, J AM SOC HORTIC SCI, V138, P433, DOI 10.21273/JASHS.138.6.433; Forde BG, 2014, CURR OPIN PLANT BIOL, V21, P30, DOI 10.1016/j.pbi.2014.06.004; Forde BG, 2014, J EXP BOT, V65, P779, DOI 10.1093/jxb/ert335; Ge TD, 2009, ENVIRON EXP BOT, V66, P357, DOI 10.1016/j.envexpbot.2009.05.004; Gifford ML, 2008, P NATL ACAD SCI USA, V105, P803, DOI 10.1073/pnas.0709559105; Gioseffi E, 2012, BIOGEOSCIENCES, V9, P1509, DOI 10.5194/bg-9-1509-2012; Gruffman L, 2014, TREE PHYSIOL, V34, P205, DOI 10.1093/treephys/tpt121; Guo QQ, 2017, PLANT GROWTH REGUL, V83, P83, DOI 10.1007/s10725-017-0285-0; Hu LL, 2015, SCI HORTIC-AMSTERDAM, V186, P143, DOI 10.1016/j.scienta.2015.02.020; Hu YM, 2017, PLANTA, V245, P467, DOI 10.1007/s00425-017-2651-6; Iqbal N, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00475; Iqbal N, 2015, J PLANT PHYSIOL, V178, P84, DOI 10.1016/j.jplph.2015.02.006; Iqbal N, 2013, PLANT PHYSIOL BIOCH, V73, P128, DOI 10.1016/j.plaphy.2013.09.011; Iqbal N, 2011, J EXP BOT, V62, P4955, DOI 10.1093/jxb/err204; Islam E, 2007, J HAZARD MATER, V147, P806, DOI 10.1016/j.jhazmat.2007.01.117; Jamtgard S, 2010, SOIL BIOL BIOCHEM, V42, P2325, DOI 10.1016/j.soilbio.2010.09.011; Jones DL, 2002, SOIL BIOL BIOCHEM, V34, P1893, DOI 10.1016/S0038-0717(02)00203-1; Kaack K, 2014, J PLANT NUTR, V37, P1148, DOI 10.1080/01904167.2013.868484; Khan MIR, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00927; Kim TH, 2010, J PLANT BIOL, V53, P45, DOI 10.1007/s12374-009-9084-0; Krouk G, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r123; LeBlanc AG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065351; Leblanc A, 2008, PLANT PHYSIOL, V146, P1928, DOI 10.1104/pp.107.109363; Liu XS, 2016, SCI HORTIC-AMSTERDAM, V204, P8, DOI 10.1016/j.scienta.2016.02.037; Liu XQ, 2007, ACTA AGR SCAND B-S P, V57, P167, DOI 10.1080/09064710600914277; Luo JK, 2006, PLANT SOIL, V282, P291, DOI 10.1007/s11104-005-6094-7; Ma QX, 2016, SCI REP-UK, V6, DOI 10.1038/srep21200; Mobini M, 2014, SCI HORTIC-AMSTERDAM, V176, P232, DOI 10.1016/j.scienta.2014.07.014; Ohlund J, 2004, TREE PHYSIOL, V24, P1397; Princi MP, 2016, PLANT PHYSIOL BIOCH, V109, P9, DOI 10.1016/j.plaphy.2016.08.023; Robinson D, 2005, ECOL STU AN, V181, P43; Saiz-Fernandez I, 2015, J PLANT PHYSIOL, V173, P120, DOI 10.1016/j.jplph.2014.06.018; Song SW, 2016, COMMUN SOIL SCI PLAN, V47, P1372, DOI 10.1080/00103624.2016.1178279; Soper FM, 2011, FUNCT PLANT BIOL, V38, P788, DOI 10.1071/FP11077; Stoelken G, 2010, TREE PHYSIOL, V30, P1118, DOI 10.1093/treephys/tpq050; Tang YF, 2013, PLANT PHYSIOL BIOCH, V70, P14, DOI 10.1016/j.plaphy.2013.04.027; Thornton B, 2005, PLANT CELL ENVIRON, V28, P813, DOI 10.1111/j.1365-3040.2005.01332.x; Thornton B, 2007, J EXP BOT, V58, P1581, DOI 10.1093/jxb/erl294; Tian QY, 2009, NEW PHYTOL, V184, P918, DOI 10.1111/j.1469-8137.2009.03004.x; Vidal EA, 2013, P NATL ACAD SCI USA, V110, P12840, DOI 10.1073/pnas.1310937110; Vidmar JJ, 2000, PLANT PHYSIOL, V123, P307, DOI 10.1104/pp.123.1.307; Walch-Liu P, 2008, PLANT J, V54, P820, DOI 10.1111/j.1365-313X.2008.03443.x; Walch-Liu P, 2006, PLANT CELL PHYSIOL, V47, P1045, DOI 10.1093/pcp/pcj075; Wang HJ, 2007, PEDOSPHERE, V17, P595, DOI 10.1016/S1002-0160(07)60070-8; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Wang XL, 2013, SOIL SCI PLANT NUTR, V59, P237, DOI 10.1080/00380768.2013.770722; Wang XL, 2015, J PLANT NUTR SOIL SC, V178, P768, DOI 10.1002/jpln.201400587; Wang XL, 2014, PLANT PHYSIOL BIOCH, V75, P96, DOI 10.1016/j.plaphy.2013.12.012; Xiaochuang C, 2015, SCI HORTIC-AMSTERDAM, V186, P247, DOI 10.1016/j.scienta.2015.02.010; Yu Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep18888; Zhang HM, 1999, P NATL ACAD SCI USA, V96, P6529, DOI 10.1073/pnas.96.11.6529; Zhang HM, 1998, SCIENCE, V279, P407, DOI 10.1126/science.279.5349.407; Zheng DC, 2013, PLANT CELL ENVIRON, V36, P1328, DOI 10.1111/pce.12062; Zheng SL, 2016, J AGR SCI TECH-IRAN, V18, P399	62	10	11	7	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2018	13	9							e0204488	10.1371/journal.pone.0204488	http://dx.doi.org/10.1371/journal.pone.0204488			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU5MM	30240454	gold, Green Submitted, Green Published			2022-12-26	WOS:000445329700055
J	Kim, H; Kim, S; Yoon, SH				Kim, Hanseol; Kim, Sinyeon; Yoon, Sung Ho			Metabolic network reconstruction and phenome analysis of the industrial microbe, Escherichia coli BL21 (DE3)	PLOS ONE			English	Article							B STRAINS REL606; GENOME-SCALE MODELS; GENE; K-12; PATHWAYS; ORGANIZATION; MICROARRAYS; CULTIVATION; EXPRESSION; SEQUENCES	Escherichia coli BL21(DE3) is an industrial model microbe for the mass-production of bio-products such as biofuels, biorefineries, and recombinant proteins. However, despite its important role in scientific research and biotechnological applications, a high-quality metabolic network model for metabolic engineering is yet to be developed. Here, we present the comprehensive metabolic network model of E. coli BL21(DE3), named iHK1487, based on the latest genome reannotation and phenome analysis. The metabolic model consists of 1,164 unique metabolites, 2,701 metabolic reactions, and 1,487 genes. The model was validated and improved by comparing the simulation results with phenome data from phenotype microarray tests. Previous transcriptome profile data was incorporated during model reconstruction, and flux prediction was simulated using the model. iHK1487 was simulated to explore the metabolic features of BL21(DE3) such as broad spectrum amino acid utilization and enhanced flux through the upper glycolytic pathway and TCA cycle. iHK1487 will contribute to systematic understanding of cellular physiology and metabolism of E. coli BL21 (DE3) and highlight its biotechnological applications.	[Kim, Hanseol; Kim, Sinyeon; Yoon, Sung Ho] Konkuk Univ, Dept Biosci & Biotechnol, Seoul, South Korea	Konkuk University	Yoon, SH (corresponding author), Konkuk Univ, Dept Biosci & Biotechnol, Seoul, South Korea.	syoon@konkuk.ac.kr		KIM, SINYEON/0000-0002-3987-910X; Yoon, Sung Ho/0000-0003-0171-944X; Kim, Hanseol/0000-0002-0201-329X	National Research Foundation (NRF) of the Republic of Korea [2012M1A2A2026559]; Bio and Medical Technology Development Program [2018M3A9F3021968]; Ministry of Agriculture, Food, and Rural Affairs through the Strategic Initiative for Microbiomes in Agriculture and Food [918012-4]	National Research Foundation (NRF) of the Republic of Korea; Bio and Medical Technology Development Program; Ministry of Agriculture, Food, and Rural Affairs through the Strategic Initiative for Microbiomes in Agriculture and Food	This work was supported by the National Research Foundation (NRF) of the Republic of Korea through the Technology Development Program to Solve Climate Changes on Systems Metabolic Engineering for Biorefineries [2012M1A2A2026559] and Bio and Medical Technology Development Program [2018M3A9F3021968]; and by the Ministry of Agriculture, Food, and Rural Affairs through the Strategic Initiative for Microbiomes in Agriculture and Food [918012-4]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren R, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002980; Akesson M, 2004, METAB ENG, V6, P285, DOI 10.1016/j.ymben.2003.12.002; Andreishcheva EN, 2006, GENE, V384, P113, DOI 10.1016/j.gene.2006.07.020; [Anonymous], CURR OPIN BIOTECH, V24, P1116, DOI [10.1016/j.copbio.2013.02.003, DOI 10.1016/J.COPBIO.2013.02.003]; Aon JC, 2008, APPL ENVIRON MICROB, V74, P950, DOI 10.1128/AEM.01790-07; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Blazier AS, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00299; Bochner BR, 2009, FEMS MICROBIOL REV, V33, P191, DOI 10.1111/j.1574-6976.2008.00149.x; Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501; Browning DF, 2013, MOL MICROBIOL, V87, P939, DOI 10.1111/mmi.12144; Caspi R, 2017, NUCL ACIDS RES; Caspi R, 2016, NUCLEIC ACIDS RES, V44, pD471, DOI 10.1093/nar/gkv1164; CASTANO I, 1992, MOL MICROBIOL, V6, P2733, DOI 10.1111/j.1365-2958.1992.tb01450.x; Cvetkovic A, 2010, NATURE, V466, P779, DOI 10.1038/nature09265; Daegelen P, 2009, J MOL BIOL, V394, P634, DOI 10.1016/j.jmb.2009.09.022; Ebrahim A, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-74; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Feist AM, 2009, NAT REV MICROBIOL, V7, P129, DOI 10.1038/nrmicro1949; Ginsburg H, 2009, TRENDS PARASITOL, V25, P37, DOI 10.1016/j.pt.2008.08.012; Golby P, 1999, J BACTERIOL, V181, P1238, DOI 10.1128/JB.181.4.1238-1248.1999; Golby P, 1998, J BACTERIOL, V180, P6586, DOI 10.1128/JB.180.24.6586-6596.1998; HALPERN YS, 1961, J GEN MICROBIOL, V26, P175, DOI 10.1099/00221287-26-2-175; Han MJ, 2008, J BIOMED BIOTECHNOL, DOI 10.1155/2008/735101; Hayashi K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100049; Henry CS, 2010, NAT BIOTECHNOL, V28, P977, DOI 10.1038/nbt.1672; Herrera G, 2002, CYTOMETRY, V49, P62, DOI 10.1002/cyto.10148; Huergo LF, 2015, MICROBIOL MOL BIOL R, V79, P419, DOI 10.1128/MMBR.00038-15; Ishii N, 2007, SCIENCE, V316, P593, DOI 10.1126/science.1132067; Jeong H, 2009, J MOL BIOL, V394, P644, DOI 10.1016/j.jmb.2009.09.052; KADNER RJ, 1978, J BACTERIOL, V136, P1050, DOI 10.1128/JB.136.3.1050-1057.1978; Keseler IM, 2013, NUCLEIC ACIDS RES, V41, pD605, DOI 10.1093/nar/gks1027; Kim S, 2017, NUCLEIC ACIDS RES, V45, P5285, DOI 10.1093/nar/gkx228; King ZA, 2016, NUCLEIC ACIDS RES, V44, pD515, DOI 10.1093/nar/gkv1049; Kleefeld A, 2009, J BIOL CHEM, V284, P265, DOI 10.1074/jbc.M807856200; LEGRAIN C, 1972, EUR J BIOCHEM, V27, P93, DOI 10.1111/j.1432-1033.1972.tb01814.x; Long CP, 2017, METAB ENG, V44, P100, DOI 10.1016/j.ymben.2017.09.012; LULI GW, 1990, APPL ENVIRON MICROB, V56, P1004, DOI 10.1128/AEM.56.4.1004-1011.1990; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; Marolda CL, 1999, MICROBIOL-UK, V145, P2485, DOI 10.1099/00221287-145-9-2485; MASTERS PS, 1981, J BACTERIOL, V147, P805, DOI 10.1128/JB.147.3.805-819.1981; McCloskey D, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.18; Meier S, 2012, CHEMBIOCHEM, V13, P308, DOI 10.1002/cbic.201100654; Monk J, 2014, NAT BIOTECHNOL, V32, P447, DOI 10.1038/nbt.2870; Monk JM, 2017, NAT BIOTECHNOL, V35, P904, DOI 10.1038/nbt.3956; Monk JM, 2016, CELL SYST, V3, P238, DOI 10.1016/j.cels.2016.08.013; Monk JM, 2013, P NATL ACAD SCI USA, V110, P20338, DOI 10.1073/pnas.1307797110; Negrete A, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-75; Nicoloff H, 2013, MOL MICROBIOL, V90, P1233, DOI 10.1111/mmi.12429; O'Brien EJ, 2015, CELL, V161, P971, DOI 10.1016/j.cell.2015.05.019; Orth JD, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.65; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Pereira MP, 2004, BIOCHEMISTRY-US, V43, P11802, DOI 10.1021/bi048866v; Phue JN, 2005, BIOTECHNOL BIOENG, V90, P805, DOI 10.1002/bit.20478; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; Puchalka J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000210; Reed JL, 2006, P NATL ACAD SCI USA, V103, P17480, DOI 10.1073/pnas.0603364103; Reed JL, 2003, J BACTERIOL, V185, P2692, DOI 10.1128/JB.185.9.2692-2699.2003; REILING HE, 1985, J BIOTECHNOL, V2, P191, DOI 10.1016/0168-1656(85)90038-0; Reitzer L., 2005, ECOSAL PLUS, V1; Riley M, 2006, NUCLEIC ACIDS RES, V34, P1, DOI 10.1093/nar/gkj405; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Serres MH, 2001, GENOME BIOL 2 RESEAR; Simeonidis E, 2015, J IND MICROBIOL BIOT, V42, P327, DOI 10.1007/s10295-014-1576-3; Son YJ, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-52; Studier FW, 2009, J MOL BIOL, V394, P653, DOI 10.1016/j.jmb.2009.09.021; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; Vaas LAI, 2013, BIOINFORMATICS, V29, P1823, DOI 10.1093/bioinformatics/btt291; van Heeswijk WC, 2013, MICROBIOL MOL BIOL R, V77, P628, DOI 10.1128/MMBR.00025-13; Vitkin E, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r111; Vivek-Ananth RP, 2016, BIOSYSTEMS, V147, P1, DOI 10.1016/j.biosystems.2016.06.001; Waegeman H, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-70; Wang YH, 2005, BIOTECHNOL PROGR, V21, P1401, DOI 10.1021/bp050048m; Yoon SH, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-5-r37; Yoon SH, 2009, SYSTEMS BIOLOGY AND BIOTECHNOLOGY OF ESCHERICHIA COLI, P1, DOI 10.1007/978-1-4020-9394-4_1; Zhou L, 2003, J BACTERIOL, V185, P4956, DOI 10.1128/JB.185.16.4956-4972.2003	76	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2018	13	9							e0204375	10.1371/journal.pone.0204375	http://dx.doi.org/10.1371/journal.pone.0204375			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU5MM	30240424	gold, Green Published, Green Submitted			2022-12-26	WOS:000445329700044
J	Nadai, C; Lemos, WJF; Favaron, F; Giacomini, A; Corich, V				Nadai, Chiara; Lemos, Wilson Jose Fernandes, Jr.; Favaron, Francesco; Giacomini, Alessio; Corich, Viviana			Biocontrol activity of Starmerella bacillaris yeast against blue mold disease on apple fruit and its effect on cider fermentation	PLOS ONE			English	Article							SYNONYM CANDIDA-ZEMPLININA; PENICILLIUM-EXPANSUM GROWTH; SACCHAROMYCES-CEREVISIAE; BIOLOGICAL-CONTROL; BOTRYTIS-CINEREA; TORULASPORA-DELBRUECKII; ALCOHOLIC FERMENTATION; POSTHARVEST DISEASES; PATULIN ACCUMULATION; WINE FERMENTATIONS	The reduction of chemical fungicides in agriculture has led to the use of microorganisms as biocontrol agents. Starmerella bacillaris is a non-Saccharomyces yeast associated with overripe and botrytized grape berries microbiota. Its use has been proposed for wine fermentation because of yeast fructophilic character and high glycerol production. Recently, S. bacillaris has been demonstrated to possess antifungal activity against Botrytis cinerea on the grape. Penicillium expansum is the pathogen responsible for the blue mold rot, the most important postharvest disease of apples. These fruits are the raw material of the cider, an alcoholic beverage commonly produced using S. cerevisiae starter cultures. In this study 14 S. bacillaris strains have been studied to evaluate their postharvest antifungal activity against P. expansum on apples. Moreover, the fermentation performances in apple juice of these non-Saccharomyces strains were tested, both in single-strain fermentation and in sequential fermentation, together with S. cerevisiae. Four S. bacillaris strains, able to significantly decrease blue mold rot symptoms and to increase glycerol content during fermentation have been selected to improve apple and cider quality.	[Nadai, Chiara; Giacomini, Alessio; Corich, Viviana] Univ Padua, Dept Agron Food Nat Resources Anim & Environm DAF, Legnaro, Italy; [Nadai, Chiara; Giacomini, Alessio; Corich, Viviana] Univ Padua, Interdept Ctr Res Viticulture & Enol CIRVE, Conegliano, Italy; [Lemos, Wilson Jose Fernandes, Jr.] Univ Verona, Dept Biotechnol, Verona, Italy; [Favaron, Francesco] Univ Padua, Dept Land Environm Agr & Forestry TESAF, Legnaro, Italy	University of Padua; University of Padua; University of Verona; University of Padua	Giacomini, A (corresponding author), Univ Padua, Dept Agron Food Nat Resources Anim & Environm DAF, Legnaro, Italy.; Giacomini, A (corresponding author), Univ Padua, Interdept Ctr Res Viticulture & Enol CIRVE, Conegliano, Italy.	alessio.giacomini@unipd.it	Corich, Viviana/HDN-5095-2022; Lemos, Wilson/AAE-7297-2020; Giacomini, Alessio/D-5912-2017	Giacomini, Alessio/0000-0003-4124-0142; FAVARON, FRANCESCO/0000-0002-9167-8823; Jose Fernandes Lemos Junior, Wilson/0000-0002-5912-6148; Nadai, Chiara/0000-0003-4499-8653	CAPES Coordenacao de Aperfeicoamento de Pessoal de Novel Superior; MIUR (Ministero dell'Istruzione, dell'Universita e della Ricerca) [60A08/3022/15]	CAPES Coordenacao de Aperfeicoamento de Pessoal de Novel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); MIUR (Ministero dell'Istruzione, dell'Universita e della Ricerca)(Ministry of Education, Universities and Research (MIUR))	The research financial support was provided by CAPES Coordenacao de Aperfeicoamento de Pessoal de Novel Superior and MIUR Ex 60% (Ministero dell'Istruzione, dell'Universita e della Ricerca) (Grant No. 60A08/3022/15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin S.S., 2017, INT J CURR RES BIOSC, V4, P20, DOI [10.20546/ijcrbp.2017.401.004, DOI 10.20546/IJCRBP.2017.401.004]; Baraldi E, 2003, PLANT PATHOL, V52, P362, DOI 10.1046/j.1365-3059.2003.00861.x; Barreira MJ, 2010, FOOD CHEM, V121, P653, DOI 10.1016/j.foodchem.2009.12.085; Bautista-Ba?os S., 2006, POSTHARVEST DECAY, P189, DOI DOI 10.1016/B978-0-12-411552-1.00006-5; Belda I, 2015, APPL MICROBIOL BIOT, V99, P1911, DOI 10.1007/s00253-014-6197-2; Bely M, 2013, ALCOHOL LEVEL REDUCT, P33; Beretta B, 2000, FOOD ADDIT CONTAM, V17, P399, DOI 10.1080/026520300404815; Bilbao A, 1997, LETT APPL MICROBIOL, V24, P37, DOI 10.1046/j.1472-765X.1997.00340.x; Bokulich NA, 2014, P NATL ACAD SCI USA, V111, pE139, DOI 10.1073/pnas.1317377110; Bokulich NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066437; Bovo B, 2011, J APPL MICROBIOL, V111, P382, DOI 10.1111/j.1365-2672.2011.05060.x; Bovo B, 2016, INT J FOOD MICROBIOL, V236, P56, DOI 10.1016/j.ijfoodmicro.2016.07.022; Bovo B, 2011, ANN MICROBIOL, V61, P117, DOI 10.1007/s13213-010-0106-4; Domizio P, 2014, FOOD MICROBIOL, V43, P5, DOI 10.1016/j.fm.2014.04.005; Droby S, 2002, PHYTOPATHOLOGY, V92, P393, DOI 10.1094/PHYTO.2002.92.4.393; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; Englezos V, 2018, APPL ENVIRON MICROB, V84, DOI [10.1128/AEM.00797-18, 10.1128/aem.00797-18]; Englezos V, 2016, APPL MICROBIOL BIOT, V100, P5515, DOI 10.1007/s00253-016-7413-z; Englezos V, 2015, INT J FOOD MICROBIOL, V199, P33, DOI 10.1016/j.ijfoodmicro.2015.01.009; Escribano-Viana R, 2018, J SCI FOOD AGR, V98, P4517, DOI 10.1002/jsfa.8977; European Commission (EC), 2006, OFFICIAL J EUROPEAN; Lemos WJF, 2017, GENOME ANNOUNCEMENTS, V5, DOI [10.1128/genomeA.00788-17, 10.1128/genomea.00788-17]; Gawel R, 2007, AUST J GRAPE WINE R, V13, P38, DOI 10.1111/j.1755-0238.2007.tb00070.x; Flores MG, 2017, INT J FOOD MICROBIOL, V249, P9, DOI 10.1016/j.ijfoodmicro.2017.02.018; Haidar R, 2016, PHYTOPATHOL MEDITERR, V55, P301, DOI 10.14601/Phytopathol_Mediterr-18079; Junior WJFL, 2017, GENOME ANNOUNCEMENTS, V5, DOI [10.1128/genomeA.00224-17, 10.1128/genomea.00224-17]; Jurick WM, 2010, PHYTOPATHOLOGY, V100, P42, DOI 10.1094/PHYTO-100-1-0042; Lemos WJ, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01249; Lima G, 2011, POSTHARVEST BIOL TEC, V60, P164, DOI 10.1016/j.postharvbio.2010.12.010; Magyar I, 2011, FOOD MICROBIOL, V28, P94, DOI 10.1016/j.fm.2010.08.011; Milanovic V, 2013, INT J FOOD MICROBIOL, V161, P240, DOI 10.1016/j.ijfoodmicro.2012.12.019; Moake MM, 2005, COMPR REV FOOD SCI F, V4, P8, DOI 10.1111/j.1541-4337.2005.tb00068.x; MoraleS H, 2008, INT J FOOD MICROBIOL, V122, P61, DOI 10.1016/j.ijfoodmicro.2007.11.056; Morales H, 2010, FOOD CONTROL, V21, P953, DOI 10.1016/j.foodcont.2009.12.016; Morrissey WF, 2004, J APPL MICROBIOL, V97, P647, DOI 10.1111/j.1365-2672.2004.02354.x; Nadai C, 2016, APPL MICROBIOL BIOT, V100, P797, DOI 10.1007/s00253-015-7169-x; Nardi T, 2006, FEMS MICROBIOL LETT, V264, P168, DOI 10.1111/j.1574-6968.2006.00450.x; Nunes C, 2012, EUR J PLANT PATHOL, V133, P181, DOI 10.1007/s10658-011-9919-7; Parafati L, 2015, FOOD MICROBIOL, V47, P85, DOI 10.1016/j.fm.2014.11.013; Rantsiou K, 2012, APPL ENVIRON MICROB, V78, P1987, DOI 10.1128/AEM.06768-11; Reddy KRN, 2010, TOXIN REV, V29, P3, DOI 10.3109/15569541003598553; Sharma RR, 2009, BIOL CONTROL, V50, P205, DOI 10.1016/j.biocontrol.2009.05.001; Sipiczki M, 2003, INT J SYST EVOL MICR, V53, P2079, DOI 10.1099/ijs.0.02649-0; Soden A., 2000, Australian Journal of Grape and Wine Research, V6, P21, DOI 10.1111/j.1755-0238.2000.tb00158.x; Spadaro D, 2002, POSTHARVEST BIOL TEC, V24, P123, DOI 10.1016/S0925-5214(01)00172-7; Taillandier P, 2014, WORLD J MICROB BIOT, V30, P1959, DOI 10.1007/s11274-014-1618-z; Teuber R, 2011, BRIT FOOD J, V113, P900, DOI 10.1108/00070701111148423; TUKEY JW, 1949, BIOMETRICS, V5, P99, DOI 10.2307/3001913; Varela C, 2017, YEAST, V34, P111, DOI 10.1002/yea.3219; Varela C, 2016, APPL MICROBIOL BIOT, V100, P9861, DOI 10.1007/s00253-016-7941-6; Vero S, 2002, POSTHARVEST BIOL TEC, V26, P91, DOI 10.1016/S0925-5214(01)00199-5; Wang CX, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01156; Wang CX, 2014, INT J FOOD MICROBIOL, V191, P1, DOI 10.1016/j.ijfoodmicro.2014.08.014; Wang HX, 2015, J FOOD SCI, V80, pM1850, DOI 10.1111/1750-3841.12946; Wei JP, 2017, RSC ADV, V7, P44766, DOI 10.1039/c7ra08234g; Xu Y, 2006, J IND MICROBIOL BIOT, V33, P192, DOI 10.1007/s10295-005-0051-6; Ye MQ, 2014, FEMS YEAST RES, V14, P873, DOI 10.1111/1567-1364.12175; Zouaoui N, 2015, FOOD CONTROL, V51, P356, DOI 10.1016/j.foodcont.2014.09.048	58	23	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2018	13	9							e0204350	10.1371/journal.pone.0204350	http://dx.doi.org/10.1371/journal.pone.0204350			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU5MM	30240411	Green Published, gold, Green Submitted			2022-12-26	WOS:000445329700042
J	Arima, K; Ohmuraya, M; Miyake, K; Koiwa, M; Uchihara, T; Izumi, D; Gao, F; Yonemura, A; Bu, LK; Okabe, H; Imai, K; Hashimoto, D; Baba, Y; Chikamoto, A; Yamashita, Y; Furukawa, T; Araki, K; Baba, H; Ishimoto, T				Arima, Kota; Ohmuraya, Masaki; Miyake, Keisuke; Koiwa, Mayu; Uchihara, Tomoyuki; Izumi, Daisuke; Gao, Feng; Yonemura, Atsuko; Bu, Luke; Okabe, Hirohisa; Imai, Katsunori; Hashimoto, Daisuke; Baba, Yoshifumi; Chikamoto, Akira; Yamashita, Yo-ichi; Furukawa, Toru; Araki, Kimi; Baba, Hideo; Ishimoto, Takatsugu			Inhibition of 15-PGDH causes Kras-driven tumor expansion through prostaglandin E2-ALDH1 signaling in the pancreas	ONCOGENE			English	Article							TRANS-RETINOIC ACID; CANCER STEM-CELLS; ENGINEERED MOUSE MODELS; 15-HYDROXYPROSTAGLANDIN DEHYDROGENASE; DOWN-REGULATION; SUPPRESSOR; INFLAMMATION; TARGET; ROLES	The accumulation of prostaglandin E2 (PGE(2)) during chronic inflammation has been implicated in the progression of several cancers. Cyclooxygenase is the key synthesizing enzyme of PGE(2), although the degradation enzyme 15-ydroxyprostaglandin dehydrogenase (15-PGDH) has received considerable attention recently. We investigated the molecular mechanisms of pancreatic ductal adenocarcinoma (PDAC) progression via 15-PGDH downregulation. Here, we found that 15-PGDH expression was inversely correlated with ALDH1, an important cancer stem cell-associated marker indicative of poor prognosis in humans. Moreover, we demonstrated that pharmacological inhibition of 15-PGDH enhanced CYP26A1 expression, leading to depletion of all-trans retinoic acid (ATRA) and expansion of the ALDH1-positive subset in both human PDAC cells and tumor cells of Kras(LSL-G12D/+); Ptfla(Cre/+) (KC) mice. Furthermore, genetic deletion of 15-Pgdh in KC mice showed PGE(2) accumulation and ATRA depletion in the pancreas, resulting in PDAC with high levels of Aldh1 and Ki-67. Finally, ATRA replacement suppressed 15-PGDH inhibition-induced tumor progression in KC mice, and ATRA treatment attenuated Aldh1 activity in tumor cells isolated from the pancreas of 15-Pgdh(-/-) KC mice. These findings provide evidence that 15-PGDH inhibition enhances KRAS-driven tumor progression via ATRA depletion in the pancreas. Therefore, ATRA replacement could be a potential strategy for PDAC treatment.	[Arima, Kota; Miyake, Keisuke; Uchihara, Tomoyuki; Izumi, Daisuke; Gao, Feng; Yonemura, Atsuko; Bu, Luke; Okabe, Hirohisa; Imai, Katsunori; Hashimoto, Daisuke; Baba, Yoshifumi; Chikamoto, Akira; Yamashita, Yo-ichi; Baba, Hideo; Ishimoto, Takatsugu] Kumamoto Univ, Grad Sch Med Sci, Dept Gastroenterol Surg, Kumamoto, Japan; [Arima, Kota; Miyake, Keisuke; Koiwa, Mayu; Uchihara, Tomoyuki; Ishimoto, Takatsugu] Kumamoto Univ, Int Res Ctr Med Sci, Kumamoto, Japan; [Ohmuraya, Masaki] Hyogo Coll Med, Dept Genet, Nishinomiya, Hyogo, Japan; [Furukawa, Toru] Tohoku Univ, Grad Sch Med, Dept Histopathol, Sendai, Miyagi, Japan; [Araki, Kimi] Kumamoto Univ, Inst Resource Dev & Anal, Kumamoto, Japan	Kumamoto University; Kumamoto University; Hyogo College of Medicine; Tohoku University; Kumamoto University	Baba, H; Ishimoto, T (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Gastroenterol Surg, Kumamoto, Japan.; Ishimoto, T (corresponding author), Kumamoto Univ, Int Res Ctr Med Sci, Kumamoto, Japan.	hdobaba@kumamoto-u.ac.jp; taka1516@kumamoto-u.ac.jp	Hashimoto, Daisuke/AAE-7134-2020; Ishimoto, Takatsugu/AAP-1356-2020; Furukawa, Toru/AAF-5596-2021	Ishimoto, Takatsugu/0000-0003-1852-1835; Furukawa, Toru/0000-0002-1083-2324	Japan Society for the Promotion of Science KAKENHI [16H06257, 16K15595, 17K16570, 17K16571]; Pancreas Research Foundation of Japan; Kanae Foundation for the Promotion of Medical Science; Yasuda Medical Foundation; Shinnihon Foundation of Advanced Medical Treatment Research;  [201860083]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Pancreas Research Foundation of Japan(Pancreas Research Foundation of Japan); Kanae Foundation for the Promotion of Medical Science; Yasuda Medical Foundation; Shinnihon Foundation of Advanced Medical Treatment Research; 	We are grateful to Dr. David A. Tuveson (Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA) for providing the Kras<SUP>LSL-G12D</SUP> mice and to Dr. Sanford D. Markowitz (Department of Medicine, Case Western Reserve University, Cleveland, OH, USA) for their kind advice about establishing 15-Pgdh<SUP>-/-</SUP>mice. This work was supported, in part, by the Japan Society for the Promotion of Science KAKENHI (Grant Numbers 16H06257, 16K15595, 17K16570, and 17K16571), Grant-in-Aid for JSPS Research Fellows (Grant Numbers Y201860083), the Pancreas Research Foundation of Japan, the Kanae Foundation for the Promotion of Medical Science, the Yasuda Medical Foundation and the Shinnihon Foundation of Advanced Medical Treatment Research.	Altucci L, 2001, NAT REV CANCER, V1, P181, DOI 10.1038/35106036; Arima K, 2018, CANCER SCI, V109, P462, DOI 10.1111/cas.13467; Baumgart S, 2013, GUT, V62, P310, DOI 10.1136/gutjnl-2011-301008; Chen Z, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1794-8; Chronopoulos A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12630; Coggins KG, 2002, NAT MED, V8, P91, DOI 10.1038/nm0202-91; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Fu ZQ, 2017, CANCER LETT, V410, P68, DOI 10.1016/j.canlet.2017.09.019; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Guerra C, 2013, MOL ONCOL, V7, P232, DOI 10.1016/j.molonc.2013.02.002; Harris SG, 2002, TRENDS IMMUNOL, V23, P144, DOI 10.1016/S1471-4906(01)02154-8; Hashimoto M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11315; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hruban RH, 2006, CANCER RES, V66, P95, DOI 10.1158/0008-5472.CAN-05-2168; Huang GS, 2008, CANCER RES, V68, P5040, DOI 10.1158/0008-5472.CAN-07-6575; Ishimoto T, 2017, GASTROENTEROLOGY, V153, P191, DOI 10.1053/j.gastro.2017.03.046; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; Jayson GC, 2014, LANCET, V384, P1376, DOI 10.1016/S0140-6736(13)62146-7; Kane MA, 2008, ANAL CHEM, V80, P1702, DOI 10.1021/ac702030f; Kochel TJ, 2016, BREAST CANCER-BASIC, V10, P61, DOI 10.4137/BCBCR.S38529; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li CW, 2011, GASTROENTEROLOGY, V141, P2218, DOI 10.1053/j.gastro.2011.08.009; Loo TM, 2017, CANCER DISCOV, V7, P522, DOI 10.1158/2159-8290.CD-16-0932; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Mashiko D, 2013, SCI REP-UK, V3, DOI 10.1038/srep03355; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Mehdawi LM, 2016, MOL ONCOL, V10, P1415, DOI 10.1016/j.molonc.2016.07.011; Nelson CH, 2013, CURR TOP MED CHEM, V13, P1402; Nguyen PH, 2016, ONCOGENE, V35, P5619, DOI 10.1038/onc.2016.87; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Oshima H, 2011, GASTROENTEROLOGY, V140, P596, DOI 10.1053/j.gastro.2010.11.007; Rasheed ZA, 2010, JNCI-J NATL CANCER I, V102, P340, DOI 10.1093/jnci/djp535; Rothwell PM, 2011, OBSTET GYNECOL SURV, V66, P222, DOI 10.1097/OGX.0b013e318225cec2; Ryan DP, 2014, NEW ENGL J MED, V371, P1039, DOI 10.1056/NEJMra1404198; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Swanton C, 2016, NEW ENGL J MED, V374, P1864, DOI 10.1056/NEJMra1504688; Taki K, 2016, ONCOGENE, V35, P2407, DOI 10.1038/onc.2015.294; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Wei S, 2015, NAT MED, V21, P457, DOI 10.1038/nm.3839; Wolf I, 2006, CANCER RES, V66, P7818, DOI 10.1158/0008-5472.CAN-05-4368; Young MJ, 2015, CARCINOGENESIS, V36, P498, DOI 10.1093/carcin/bgv018; Zhang YY, 2015, SCIENCE, V348, DOI 10.1126/science.aaa2340; Zhao D, 2014, J CLIN INVEST, V124, P5453, DOI 10.1172/JCI76611	45	12	13	0	10	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 21	2019	38	8					1211	1224		10.1038/s41388-018-0510-y	http://dx.doi.org/10.1038/s41388-018-0510-y			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HM1XR	30250298				2022-12-26	WOS:000459249800005
J	Leclerc, J; Garandeau, D; Pandiani, C; Gaudel, C; Bille, K; Nottet, N; Garcia, V; Colosetti, P; Pagnotta, S; Bahadoran, P; Tondeur, G; Mograbi, B; Dalle, S; Caramel, J; Levade, T; Ballotti, R; Andrieu-Abadie, N; Bertolotto, C				Leclerc, Justine; Garandeau, David; Pandiani, Charlotte; Gaudel, Celine; Bille, Karine; Nottet, Nicolas; Garcia, Virginie; Colosetti, Pascal; Pagnotta, Sophie; Bahadoran, Philippe; Tondeur, Garance; Mograbi, Baharia; Dalle, Stephane; Caramel, Julie; Levade, Thierry; Ballotti, Robert; Andrieu-Abadie, Nathalie; Bertolotto, Corine			Lysosomal acid ceramidase ASAH1 controls the transition between invasive and proliferative phenotype in melanoma cells	ONCOGENE			English	Article							TRANSCRIPTION FACTOR; CONFERS RESISTANCE; GENE-EXPRESSION; HIGH-THROUGHPUT; MITF; PATHWAY; SWITCH; PREDISPOSES; METABOLISM; MUTATION	Phenotypic plasticity and subsequent generation of intratumoral heterogeneity underly key traits in malignant melanoma such as drug resistance and metastasis. Melanoma plasticity promotes a switch between proliferative and invasive phenotypes characterized by different transcriptional programs of which MITF is a critical regulator. Here, we show that the acid ceramidase ASAH1, which controls sphingolipid metabolism, acted as a rheostat of the phenotypic switch in melanoma cells. Low ASAH1 expression was associated with an invasive behavior mediated by activation of the integrin alphavbeta5-FAK signaling cascade. In line with that, human melanoma biopsies revealed heterogeneous staining of ASAH1 and low ASAH1 expression at the melanoma invasive front. We also identified ASAH1 as a new target of MITF, thereby involving MITF in the regulation of sphingolipid metabolism. Together, our findings provide new cues to the mechanisms underlying the phenotypic plasticity of melanoma cells and identify new anti-metastatic targets.	[Leclerc, Justine; Pandiani, Charlotte; Gaudel, Celine; Bille, Karine; Bahadoran, Philippe; Ballotti, Robert; Bertolotto, Corine] Univ Cote dAzur, Inserm U1065, Biol & Pathol Melanocytes, Equipe Labellisee ARC 2015,Team 1,C3M, Nice, France; [Garandeau, David; Nottet, Nicolas] Univ Cote dAzur, Inserm U1065, C3M, Nice, France; [Garcia, Virginie; Levade, Thierry; Andrieu-Abadie, Nathalie] Univ Toulouse III, Sphingolipids Metab Cell Death & Tumor Progress, Team 4, Inserm,UMR1037,CRCT, Toulouse, France; [Colosetti, Pascal] INSA Lyon, INRA1397, INSERM U1060, CarMeN Lab, Lyon, France; [Pagnotta, Sophie] Univ Cote dAzur, Ctr Commun Microscop Appl, Nice, France; [Bahadoran, Philippe] CHU NICE, Dept Dermatol, Nice, France; [Tondeur, Garance; Dalle, Stephane; Caramel, Julie] Univ Lyon, Inserm, U1052, CNRS 5286,Equipe Labeillsee Ligue Canc, Lyon, France; [Mograbi, Baharia] INSERM ERI21, EA 4319, F-06107 Nice, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm)	Bertolotto, C (corresponding author), Univ Cote dAzur, Inserm U1065, Biol & Pathol Melanocytes, Equipe Labellisee ARC 2015,Team 1,C3M, Nice, France.	bertolot@unice.fr	Mograbi, Baharia/N-5531-2018; GARCIA, Virginie/W-8313-2019; BALLOTTI, Robert/F-8825-2013; Andrieu-Abadie, Nathalie/N-6793-2013; Bertolotto, Corine/AAF-6634-2021; Colosetti, Pascal/ABH-4585-2020; Dalle, Stephane/E-4552-2018; Carmen, Team2/Y-7383-2019; Mograbi, Baharia/Q-7953-2019	GARCIA, Virginie/0000-0002-9761-7036; Andrieu-Abadie, Nathalie/0000-0003-2698-1970; Bertolotto, Corine/0000-0001-6971-7753; Dalle, Stephane/0000-0002-3423-4548; Carmen, Team2/0000-0001-9867-5724; Leclerc, Justine/0000-0003-3793-458X; BALLOTTI, Robert/0000-0002-7322-4908; Caramel, Julie/0000-0002-8883-918X; Lab, Carmen/0000-0002-5935-3236; Colosetti, Pascal/0000-0002-5848-6053; Nottet, Nicolas/0000-0002-8699-6747	INCA [INCA_10573]; la Ligue Nationale contre le Cancer; Inserm, La Societe Francaise de Dermatologie	INCA(Institut National du Cancer (INCA) France); la Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Inserm, La Societe Francaise de Dermatologie	This work was supported by Inserm, La Societe Francaise de Dermatologie, and by a grant from INCA (INCA_10573). CP is a fellowship from la Ligue Nationale contre le Cancer. The authors thank Dr. M Sewer (San Diego, USA) for providing the ASAH1 promoter vector. WM3912, WM8, WM3928 and WM3918 human melanoma cell lines were a kind gift from H Meenhard and G Zhang (Wistar melanoma Institute, Philadelphia, USA).	Bedia C, 2007, CHEMBIOCHEM, V8, P642, DOI 10.1002/cbic.200600533; Bertolotto C, 2011, NATURE, V480, P94, DOI 10.1038/nature10539; Bonet C, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw340; Bonet C, 2012, J BIOL CHEM, V287, P29887, DOI 10.1074/jbc.M112.371682; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Canel M, 2013, J CELL SCI, V126, P393, DOI 10.1242/jcs.100115; Caramel J, 2013, CANCER CELL, V24, P466, DOI 10.1016/j.ccr.2013.08.018; Carreira S, 2006, GENE DEV, V20, P3426, DOI 10.1101/gad.406406; Cheli Y, 2012, ONCOGENE, V31, P2461, DOI 10.1038/onc.2011.425; Cheli Y, 2011, ONCOGENE, V30, P2307, DOI 10.1038/onc.2010.598; Cheli Y, 2010, PIGM CELL MELANOMA R, V23, P27, DOI 10.1111/j.1755-148X.2009.00653.x; Cheng JC, 2013, J CLIN INVEST, V123, P4344, DOI 10.1172/JCI64791; Colombino M, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-117; Currie E, 2013, CELL METAB, V18, P153, DOI 10.1016/j.cmet.2013.05.017; Desch A, 2012, AM J PATHOL, V181, P693, DOI 10.1016/j.ajpath.2012.04.012; Don AS, 2014, BIOMOLECULES, V4, P315, DOI 10.3390/biom4010315; Elojeimy S, 2007, MOL THER, V15, P1259, DOI 10.1038/sj.mt.6300167; Falletta P, 2017, GENE DEV, V31, P18, DOI 10.1101/gad.290940.116; Fane ME, 2017, EBIOMEDICINE, V16, P63, DOI 10.1016/j.ebiom.2017.01.013; Ferlinz K, 2001, J BIOL CHEM, V276, P35352, DOI 10.1074/jbc.M103066200; Ganapathy-Kanniappan S, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-152; Giuliano S, 2010, CANCER RES, V70, P3813, DOI 10.1158/0008-5472.CAN-09-2913; Goodall J, 2008, CANCER RES, V68, P7788, DOI 10.1158/0008-5472.CAN-08-1053; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; Haq R, 2013, CANCER CELL, V23, P302, DOI 10.1016/j.ccr.2013.02.003; Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491; Johannessen CM, 2013, NATURE, V504, P138, DOI 10.1038/nature12688; Kemper K, 2015, EMBO MOL MED, V7, P1104, DOI 10.15252/emmm.201404914; Konieczkowski DJ, 2014, CANCER DISCOV, V4, P816, DOI 10.1158/2159-8290.CD-13-0424; Lai M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07606-w; Larribere L, 2005, GENE DEV, V19, P1980, DOI 10.1101/gad.335905; Lucki N, 2009, BBA-MOL CELL BIOL L, V1791, P706, DOI 10.1016/j.bbalip.2009.03.005; Lucki NC, 2011, J BIOL CHEM, V286, P19399, DOI 10.1074/jbc.M110.195826; Mahdy AEM, 2009, MOL THER, V17, P430, DOI 10.1038/mt.2008.281; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Morad SAF, 2013, NAT REV CANCER, V13, P51, DOI 10.1038/nrc3398; Muller J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6712; Ohanna M, 2018, GENE DEV, V32, P448, DOI 10.1101/gad.305854.117; Ohanna M, 2011, GENE DEV, V25, P1245, DOI 10.1101/gad.625811; Ohanna M, 2013, ONCOTARGET, V4, P2212, DOI 10.18632/oncotarget.1143; Paillerets BBD, 2014, EUR J CELL BIOL, V93, P71, DOI 10.1016/j.ejcb.2013.10.002; Park JH, 2006, BBA-BIOMEMBRANES, V1758, P2133, DOI 10.1016/j.bbamem.2006.08.019; Pinner S, 2009, CANCER RES, V69, P7969, DOI 10.1158/0008-5472.CAN-09-0781; Rambow F, 2015, CELL REP, V13, P840, DOI 10.1016/j.celrep.2015.09.037; Realini N, 2016, J BIOL CHEM, V291, P2422, DOI 10.1074/jbc.M115.666909; Reinhardt J, 2017, CANCER RES, V77, P4697, DOI 10.1158/0008-5472.CAN-17-0395; Riesenberg S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9755; Ruckhaberle E, 2009, CLIMACTERIC, V12, P502, DOI 10.3109/13697130902939913; Sanger N, 2015, MOL ONCOL, V9, P58, DOI 10.1016/j.molonc.2014.07.016; Shtraizent N, 2008, J BIOL CHEM, V283, P11253, DOI 10.1074/jbc.M709166200; Strub T, 2011, ONCOGENE, V30, P2319, DOI 10.1038/onc.2010.612; Truman JP, 2014, BBA-MOL CELL BIOL L, V1841, P1174, DOI 10.1016/j.bbalip.2013.12.013; Van Allen EM, 2014, PROSTATE CANCER P D, V17, P23, DOI 10.1038/pcan.2013.37; Vazquez F, 2013, CANCER CELL, V23, P287, DOI 10.1016/j.ccr.2012.11.020; Verfaillie A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7683; Vesuna F, 2008, BIOCHEM BIOPH RES CO, V367, P235, DOI 10.1016/j.bbrc.2007.11.151; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Walkley SU, 2009, BBA-MOL CELL RES, V1793, P726, DOI 10.1016/j.bbamcr.2008.11.014; Wang F, 1999, CANCER RES, V59, P6185; WARBURG O, 1956, SCIENCE, V124, P269; Webster MR, 2015, PIGM CELL MELANOMA R, V28, P184, DOI 10.1111/pcmr.12330; Widmer DS, 2012, PIGM CELL MELANOMA R, V25, P343, DOI 10.1111/j.1755-148X.2012.00986.x; Yokoyama S, 2011, NATURE, V480, P99, DOI 10.1038/nature10630; Zhou J, 2012, AM J HUM GENET, V91, P5, DOI 10.1016/j.ajhg.2012.05.001	64	24	24	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 21	2019	38	8					1282	1295		10.1038/s41388-018-0500-0	http://dx.doi.org/10.1038/s41388-018-0500-0			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HM1XR	30254208	Green Submitted			2022-12-26	WOS:000459249800010
J	Yu, WW; Ding, J; He, M; Chen, Y; Wang, RH; Han, ZW; Xing, EZ; Zhang, CT; Yeh, SY				Yu, Weiwei; Ding, Jie; He, Maio; Chen, Yuan; Wang, Ronghao; Han, Zhenwei; Xing, Emily Z.; Zhang, Cuntai; Yeh, Shuyuan			Estrogen receptor beta promotes the vasculogenic mimicry (VM) and cell invasion via altering the lncRNA-MALAT1/miR-145-5p/NEDD9 signals in lung cancer	ONCOGENE			English	Article							LONG NONCODING RNA; EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR PROGRESSION; CERVICAL-CANCER; GROWTH-FACTOR; IN-VITRO; EXPRESSION; METASTASIS; MALAT1; ADENOCARCINOMA	While estrogen receptor beta (ER beta) may impact the progression of non-small cell lung cancer (NSCLC), its linkage to alteration of the vasculogenic mimicry (VM) formation to influence the NSCLC cell invasion remains unclear. Here, we analyzed immunohistochemistry data from NSCLC tissues and found that ER beta-positive NSCLC female patients had worse survival outcomes than those of ER beta-negative NSCLC female patients. In vitro studies using multiple NSCLC cell lines also revealed that ER beta could increase the VM formation and cell invasion. Molecular mechanism dissection suggested that ER beta could increase the lncRNA-MALAT1 (MALAT1) expression via directly binding to the estrogen response elements (EREs) located on the promoter of MALAT1, which could then lead to (i) suppressing the miR145-5p and (ii) increasing the NEDD9 protein expression as miR145-5p can directly target the 3'-UTR of NEDD9-mRNA. A preclinical study using the in vivo mouse model further confirmed the in vitro cell lines data. Together, results from the above studies demonstrated that ER beta can promote NSCLC VM formation and cell invasion via altering the ER beta/MALAT1/miR145-5p/NEDD9 signaling. Targeting this newly identified signaling pathway with small molecules may help the development of novel therapies to better suppress the NSCLC metastasis.	[Yu, Weiwei; Chen, Yuan; Zhang, Cuntai] Huazhong Univ Sci & Technol, Gen Dept, Tongji Hosp, Tongji Med Coll, Wuhan, Hubei, Peoples R China; [Yu, Weiwei; Ding, Jie; He, Maio; Chen, Yuan; Wang, Ronghao; Han, Zhenwei; Xing, Emily Z.; Zhang, Cuntai; Yeh, Shuyuan] Univ Rochester, Med Ctr, Dept Urol, George Whipple Lab Canc Res, Rochester, NY 14642 USA; [Yu, Weiwei; Ding, Jie; He, Maio; Chen, Yuan; Wang, Ronghao; Han, Zhenwei; Xing, Emily Z.; Zhang, Cuntai; Yeh, Shuyuan] Univ Rochester, Med Ctr, Dept Pathol, George Whipple Lab Canc Res, Rochester, NY 14642 USA	Huazhong University of Science & Technology; University of Rochester; University of Rochester	Zhang, CT (corresponding author), Huazhong Univ Sci & Technol, Gen Dept, Tongji Hosp, Tongji Med Coll, Wuhan, Hubei, Peoples R China.; Zhang, CT; Yeh, SY (corresponding author), Univ Rochester, Med Ctr, Dept Urol, George Whipple Lab Canc Res, Rochester, NY 14642 USA.; Zhang, CT; Yeh, SY (corresponding author), Univ Rochester, Med Ctr, Dept Pathol, George Whipple Lab Canc Res, Rochester, NY 14642 USA.	ctzhang0425@163.com; shuyuan_yeh@URMC.Rochester.edu	Wang, Ronghao/AAV-9769-2021		George Whipple Professorship Endowment	George Whipple Professorship Endowment	This work was partially supported by George Whipple Professorship Endowment. We thank Karen Wolf for assistance in manuscript preparation.	Aiello A, 2016, SCI REP-UK, V6, DOI 10.1038/srep38414; [Anonymous], 1996, J Cell Biochem Suppl, V24, P1; Belani CP, 2007, LUNG CANCER, V55, P15, DOI 10.1016/j.lungcan.2006.09.008; CASERO RA, 1986, BIOCHEM BIOPH RES CO, V134, P572, DOI 10.1016/S0006-291X(86)80458-2; Chen Y, 2016, CELL PHYSIOL BIOCHEM, V38, P2194, DOI 10.1159/000445575; Chiang YY, 2014, ONCOL REP, V31, P597, DOI 10.3892/or.2013.2867; Choi I, 2001, MOL CELL ENDOCRINOL, V181, P139, DOI 10.1016/S0303-7207(01)00492-0; Coelho AL, 2017, ONCOTARGET, V8, P39795, DOI 10.18632/oncotarget.7794; Cui D, 2016, TUMOR BIOL, V37, P4127, DOI 10.1007/s13277-015-4261-x; Ding Y, 2012, ONCOGENE, V31, P2899, DOI 10.1038/onc.2011.467; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Hammoud Z, 2008, ENDOCR-RELAT CANCER, V15, P475, DOI 10.1677/ERC-08-0002; Hartman J, 2012, STEROIDS, V77, P1262, DOI 10.1016/j.steroids.2012.07.002; He JB, 2016, SCI REP-UK, V6, DOI 10.1038/srep20586; Hu HB, 2016, LUNG CANCER, V97, P87, DOI 10.1016/j.lungcan.2016.04.017; Huang NS, 2016, ONCOTARGET, V7, P37957, DOI 10.18632/oncotarget.9364; HUDGEL DW, 1979, AM REV RESPIR DIS, V120, P393; Jiang T, 2017, CLIN LUNG CANCER, V18, P421, DOI 10.1016/j.cllc.2016.12.012; Jin YJ, 2014, INT J CANCER, V134, P2294, DOI 10.1002/ijc.28568; Kiyohara C, 2010, GENDER MED, V7, P381, DOI 10.1016/j.genm.2010.10.002; Kushner PJ, 2000, J STEROID BIOCHEM, V74, P311, DOI 10.1016/S0960-0760(00)00108-4; Li YW, 2016, CANCER BIOL THER, V17, P272, DOI 10.1080/15384047.2016.1139242; Liu JH, 2017, FRONT BIOSCI-LANDMRK, V22, P66, DOI 10.2741/4472; Liu MJ, 2016, ONCOL REP, V36, P1679, DOI 10.3892/or.2016.4909; Liu RL, 2015, INT J BIOL MACROMOL, V81, P491, DOI 10.1016/j.ijbiomac.2015.08.016; Liu SK, 2016, TUMOR BIOL, V37, P633, DOI 10.1007/s13277-015-3732-4; Lother SA, 2013, HORM CANCER-US, V4, P270, DOI 10.1007/s12672-013-0149-7; Lu HZ, 2016, TUMOR BIOL, V37, P1683, DOI 10.1007/s13277-015-3946-5; Lu RJ, 2014, J CANCER RES CLIN, V140, P387, DOI 10.1007/s00432-013-1577-z; Lu Y, 2016, ONCOTARGETS THER, V9, P3077, DOI 10.2147/OTT.S102658; Luo J, 2014, TUMOR BIOL, V35, P11541, DOI 10.1007/s13277-014-2442-7; Luo Z, 2015, INT J CLIN EXP MED, V8, P8686; Ma LH, 2016, TRANSL LUNG CANCER R, V5, P202, DOI 10.21037/tlcr.2016.04.04; Maniotis AJ, 1999, AM J PATHOL, V155, P739, DOI 10.1016/S0002-9440(10)65173-5; Marquez-Garban DC, 2009, ANN NY ACAD SCI, V1155, P194, DOI 10.1111/j.1749-6632.2009.04116.x; Monica V, 2012, CLIN LUNG CANCER, V13, P416, DOI 10.1016/j.cllc.2012.03.006; Morimoto K, 2014, PROSTATE, V74, P901, DOI 10.1002/pros.22809; Nelson AW, 2017, MOL CELL ENDOCRINOL, V440, P138, DOI 10.1016/j.mce.2016.11.016; Nie FQ, 2015, MOL CANCER THER, V14, P268, DOI 10.1158/1535-7163.MCT-14-0492; Nose N, 2011, LUNG CANCER, V71, P350, DOI 10.1016/j.lungcan.2010.06.009; Onn A, 2003, CLIN CANCER RES, V9, P5532; Prensner JR, 2011, CANCER DISCOV, V1, P391, DOI 10.1158/2159-8290.CD-11-0209; Qiu MT, 2014, TUMOR BIOL, V35, P5375, DOI 10.1007/s13277-014-1700-z; Rodriguez-Lara V, 2017, ENDOCR RES, V42, P219, DOI 10.1080/07435800.2017.1292526; Rousseau B, 2015, SCI REP-UK, V5, DOI 10.1038/srep10356; Safe S, 2001, VITAM HORM, V62, P231, DOI 10.1016/S0083-6729(01)62006-5; Shagisultanova E, 2015, GENE, V567, P1, DOI 10.1016/j.gene.2015.04.086; Shen LQ, 2015, J NEURO-ONCOL, V121, P101, DOI 10.1007/s11060-014-1613-0; Shi ZM, 2017, ONCOGENE, V36, P2577, DOI 10.1038/onc.2016.414; Siegfried JM, 2014, SEMIN ONCOL, V41, P5, DOI 10.1053/j.seminoncol.2013.12.009; Skjefstad K, 2016, STEROIDS, V113, P5, DOI 10.1016/j.steroids.2016.05.008; Slowikowski BK, 2017, MOL BIOL REP, V44, P35, DOI 10.1007/s11033-016-4086-8; Wan L, 2016, MOL CANCER THER, V15, P1082, DOI 10.1158/1535-7163.MCT-15-0707; Wang JZ, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3151-6; Wang R, 2011, LUNG CANCER, V74, P188, DOI 10.1016/j.lungcan.2011.04.009; Wang XY, 2015, J BIOL CHEM, V290, P3925, DOI 10.1074/jbc.M114.596866; Weitsman GE, 2006, BREAST CANCER RES TR, V100, P23, DOI 10.1007/s10549-006-9229-5; Wu CT, 2005, HUM PATHOL, V36, P1108, DOI 10.1016/j.humpath.2005.08.003; Wu WJ, 2007, MOL CANCER THER, V6, P471, DOI 10.1158/1535-7163.MCT-06-0416; Wu XL, 2012, J CELL BIOCHEM, V113, P711, DOI 10.1002/jcb.23443; Wu Y, 2015, ONCOTARGET, V6, P9160, DOI 10.18632/oncotarget.3247; Xia WJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep16901; Yao LL, 2016, J CELL MOL MED, V20, P1673, DOI 10.1111/jcmm.12862; Zhang CG, 2017, EUR REV MED PHARMACO, V21, P115; Zhang GF, 2009, MOL ENDOCRINOL, V23, P146, DOI 10.1210/me.2008-0431; Zhao GF, 2012, MOL ENDOCRINOL, V26, P1304, DOI 10.1210/me.2012-1028; Zhu LC, 2015, PATHOL ONCOL RES, V21, P1259, DOI 10.1007/s12253-015-9960-5	67	72	73	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 21	2019	38	8					1225	1238		10.1038/s41388-018-0463-1	http://dx.doi.org/10.1038/s41388-018-0463-1			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HM1XR	30250297				2022-12-26	WOS:000459249800006
J	Yang, X; Xu, WT; Huang, KL; Zhang, BY; Wang, HM; Zhang, XQ; Gong, LJ; Luo, YB; He, XY				Yang, Xuan; Xu, Wentao; Huang, Kunlun; Zhang, Boyang; Wang, Haomiao; Zhang, Xueqin; Gong, Lijing; Luo, Yunbo; He, Xiaoyun			Precision toxicology shows that troxerutin alleviates ochratoxin A-induced renal lipotoxicity	FASEB JOURNAL			English	Article						lipidomics; brown adipose activity; chronic kidney disease; energy metabolism; RNA-seq	FATTY-ACID OXIDATION; CHRONIC KIDNEY-DISEASE; LIPID-METABOLISM; CELL-DEATH; GENE-EXPRESSION; DNA-DAMAGE; RNA-SEQ; PROTEIN; CERAMIDE; STRESS	Lipotoxicity is the most common cause of severe kidney disease, with few treatment options available today. Precision toxicology can improve detection of subtle intracellular changes in response to exogenous substrates; thus, it facilitates in-depth research on bioactive molecules that may interfere with the onset of certain diseases. In the current study, troxerutin significantly relieved nephrotoxicity, increased endurance, and improved systemic energy metabolism and renal inflammation in OTA-induced nephrotic mice. Lipidomics showed that troxerutin effectively reduced the levels of triglycerides, phosphatidylcholines, and phosphatidylethanolamines in nephropathy. The mechanism was partly attributable to troxerutin in alleviating the aberrantly up-regulated expression of sphingomyelinase, the cystic fibrosis transmembrane conductance regulator, and chloride channel 2. Renal tubular epithelial cells, the main site of toxin-induced accumulation of lipids in the kidney, were subjected to transcriptomic profiling, which uncovered several metabolic factors relevant to aberrant lipid and lipoprotein metabolism. Our work provides new insights into the molecular features of toxin-induced lipotoxicity in renal tubular epithelial cells in vivo and demonstrates the function of troxerutin in alleviating OTA-induced nephrosis and associated systemic energy metabolism disorders.Yang, X., Xu, W., Huang, K., Zhang, B., Wang, H., Zhang, X., Gong, L., Luo, Y., He, X. Precision toxicology shows that troxerutin alleviates ochratoxin A-induced renal lipotoxicity.	[Yang, Xuan; Xu, Wentao; Huang, Kunlun; Zhang, Boyang; Wang, Haomiao; Zhang, Xueqin; Luo, Yunbo; He, Xiaoyun] China Agr Univ, Coll Food Sci & Nutr Engn, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, 17 Qinghua Donglu, Beijing 100083, Peoples R China; [Xu, Wentao; Huang, Kunlun] Beijing Lab Food Qual & Safety, Beijing, Peoples R China; [Gong, Lijing] Beijing Sport Univ, China Acad Sport & Hlth Sci, Beijing, Peoples R China; [Luo, Yunbo; He, Xiaoyun] Minist Agr, Key Lab Safety Assessment Genetically Modified Or, Beijing, Peoples R China	China Agricultural University; Beijing Sport University; Ministry of Agriculture & Rural Affairs	He, XY (corresponding author), China Agr Univ, Coll Food Sci & Nutr Engn, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, 17 Qinghua Donglu, Beijing 100083, Peoples R China.	hexiaoyun@cau.edu.cn	Zhang, Boyang/AAG-4852-2020	Zhang, Boyang/0000-0003-2210-3572; Kunlun, Huang/0000-0002-2350-5859	Genetically Modified Organisms Breeding Major Projects of China [2016ZX08011-005]	Genetically Modified Organisms Breeding Major Projects of China	The authors thank Kai Gao and Xudong Shi (Institute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences) for their assistance with PET-CT, and Shanghai ProfLeader Biotechnology Co., Ltd. for assistance with lipidomics. This work was supported by Genetically Modified Organisms Breeding Major Projects of China Grant 2016ZX08011-005. The authors declare no conflicts of interest.	Ahmad A, 2017, FASEB J, V31, P771, DOI 10.1096/fj.201600618R; Argaud L, 2004, AM J PHYSIOL-HEART C, V286, pH246, DOI 10.1152/ajpheart.00638.2003; Banga A, 2011, FASEB J, V25; BENNETT MJ, 1993, CLIN CHEM, V39, P897; Bobulescu IA, 2010, CURR OPIN NEPHROL HY, V19, P393, DOI 10.1097/MNH.0b013e32833aa4ac; Bol EK, 2016, FOOD CHEM TOXICOL, V89, P85, DOI 10.1016/j.fct.2016.01.013; Cantaluppi V, 2008, J AM SOC NEPHROL, V19, P1904, DOI 10.1681/ASN.2007111209; Carraro-Lacroix LR, 2010, CELL PHYSIOL BIOCHEM, V26, P563, DOI 10.1159/000322324; Chen W, 2017, FEBS J, V284, P1070, DOI [10.1111/febs.14038, 10.1111/febs.]; Cheung WW, 2014, J AM SOC NEPHROL, V25, P119, DOI 10.1681/ASN.2013040432; Chondronikola M, 2016, CELL METAB, V23, P1200, DOI 10.1016/j.cmet.2016.04.029; Chu EPF, 2017, MOL IMMUNOL, V82, P19, DOI 10.1016/j.molimm.2016.12.007; Clement LC, 2011, NAT MED, V17, P117, DOI 10.1038/nm.2261; COHENFORTERRE L, 1984, BIOCHIM BIOPHYS ACTA, V801, P138, DOI 10.1016/0304-4165(84)90222-8; Cuppoletti J, 2015, FASEB J, V29; Cuppoletti J, 2014, AM J PHYSIOL-CELL PH, V307, pC479, DOI 10.1152/ajpcell.00077.2014; de Vries APJ, 2014, LANCET DIABETES ENDO, V2, P417, DOI 10.1016/S2213-8587(14)70065-8; Devenny JJ, 2012, OBESITY, V20, P1645, DOI 10.1038/oby.2012.59; Ding Y, 2014, J AM SOC NEPHROL, V25, P2835, DOI 10.1681/ASN.2013101068; Dionisi-Vici C, 2016, J INHERIT METAB DIS, V39, P689, DOI 10.1007/s10545-016-9956-7; Domijan AM, 2007, MOL NUTR FOOD RES, V51, P1147, DOI 10.1002/mnfr.200700079; Drewa G, 1998, NEOPLASMA, V45, P266; Dumitru CA, 2006, ONCOGENE, V25, P5612, DOI 10.1038/sj.onc.1209568; Eckardt KU, 2013, LANCET, V382, P158, DOI 10.1016/S0140-6736(13)60439-0; Eguchi Y, 2011, J GASTROENTEROL, V46, P70, DOI 10.1007/s00535-010-0340-3; Eknoyan Garabed, 2007, Curr Diab Rep, V7, P449, DOI 10.1007/s11892-007-0076-5; Ernandez T, 2009, KIDNEY INT, V76, P262, DOI 10.1038/ki.2009.142; Falkevall A, 2017, CELL METAB, V25, P713, DOI 10.1016/j.cmet.2017.01.004; Fan SH, 2009, INT IMMUNOPHARMACOL, V9, P91, DOI 10.1016/j.intimp.2008.10.008; Fernandez-Salas E, 2002, MOL CELL BIOL, V22, P3610, DOI 10.1128/MCB.22.11.3610-3620.2002; Fidaleo M, 2008, EXP TOXICOL PATHOL, V59, P391, DOI 10.1016/j.etp.2007.11.011; Freedman BI, 2013, AM J KIDNEY DIS, V62, P1165, DOI 10.1053/j.ajkd.2013.05.024; Geetha R, 2015, MOL CELL BIOCHEM, V407, P263, DOI 10.1007/s11010-015-2474-3; Gennari A, 2004, J BIOCHEM MOL TOXIC, V18, P43, DOI 10.1002/jbt.20006; Ghosh S, 2016, METHODS MOL BIOL, V1374, P339, DOI 10.1007/978-1-4939-3167-5_18; Gin H, 2000, DIABETES METAB, V26, P45; Gobe GC, 2003, SEMIN NEPHROL, V23, P416, DOI 10.1016/S0270-9295(03)00085-8; Grande MT, 2009, NAT REV NEPHROL, V5, P319, DOI 10.1038/nrneph.2009.74; Herman-Edelstein M, 2014, J LIPID RES, V55, P561, DOI 10.1194/jlr.P040501; Heuer JG, 2017, AM J PHYSIOL-RENAL, V312, pF951, DOI 10.1152/ajprenal.00443.2016; Heussner AH, 2007, TOXICOL IN VITRO, V21, P72, DOI 10.1016/j.tiv.2006.08.007; Hibi D, 2013, TOXICOLOGY, V304, P92, DOI 10.1016/j.tox.2012.12.005; Honke K, 2002, P NATL ACAD SCI USA, V99, P4227, DOI 10.1073/pnas.032068299; Jennings-Gee JE, 2010, TOXINS, V2, P1428, DOI 10.3390/toxins2061428; Jiang Y, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00270; Kang HM, 2015, NAT MED, V21, P37, DOI 10.1038/nm.3762; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kirk Rebecca, 2013, Nat Rev Nephrol, V9, P627, DOI 10.1038/nrneph.2013.194; Kumar A, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0003-8; Kume S, 2007, J AM SOC NEPHROL, V18, P2715, DOI 10.1681/ASN.2007010089; Kuroda K, 2015, TOXICOL SCI, V144, P65, DOI 10.1093/toxsci/kfu267; Lang PA, 2007, NAT MED, V13, P164, DOI 10.1038/nm1539; LEAF A, 1973, CIRCULATION, V48, P455, DOI 10.1161/01.CIR.48.3.455; Lee SJ, 2017, BIOCHEM BIOPH RES CO, V493, P34, DOI 10.1016/j.bbrc.2017.09.082; Lee ZH, 2000, MOL BRAIN RES, V75, P237, DOI 10.1016/S0169-328X(99)00304-6; LeonS FE, 1996, LANCET, V348, P1039, DOI 10.1016/S0140-6736(05)64974-4; Lepenies J, 2011, NEPHRON CLIN PRACT, V119, pC97, DOI 10.1159/000324765; Levin Adeera, 2017, Lancet, V390, P1888, DOI 10.1016/S0140-6736(17)30788-2; Li SY, 2012, AM J PHYSIOL-RENAL, V303, pF437, DOI 10.1152/ajprenal.00111.2012; Lidell ME, 2010, NAT REV ENDOCRINOL, V6, P319, DOI 10.1038/nrendo.2010.64; Lu J, 2013, J IMMUNOL, V190, P3466, DOI 10.4049/jimmunol.1202862; Lunyera J, 2016, CLIN J AM SOC NEPHRO, V11, P379, DOI 10.2215/CJN.07500715; Macdonald JH, 2012, AM J KIDNEY DIS, V60, P930, DOI 10.1053/j.ajkd.2012.06.021; Marumo T, 2015, J AM SOC NEPHROL, V26, P2388, DOI 10.1681/ASN.2014070665; Mas S, 2017, NEFROLOGIA, V37, P229, DOI [10.1016/j.nefro.2017.01.011, 10.1016/j.nefroe.2017.06.004]; Mattu S, 2016, J HEPATOL, V64, P891, DOI 10.1016/j.jhep.2015.11.029; Mezzani A, 2003, AM HEART J, V145, P1102, DOI 10.1016/S0002-8703(03)00100-5; Mitchell NJ, 2017, FOOD CHEM TOXICOL, V100, P265, DOI 10.1016/j.fct.2016.12.037; Mohammedi K, 2016, METABOLISM, V65, P12, DOI 10.1016/j.metabol.2015.10.004; Nangaku M, 2013, AM J PHYSIOL-RENAL, V305, pF977, DOI 10.1152/ajprenal.00385.2013; Newberry EP, 2006, HEPATOLOGY, V44, P1191, DOI 10.1002/hep.21369; Panat NA, 2016, FOOD CHEM, V194, P32, DOI 10.1016/j.foodchem.2015.07.078; Perazella MA, 2010, AM J KIDNEY DIS, V55, P399, DOI 10.1053/j.ajkd.2009.10.046; Persu A, 2000, J AM SOC NEPHROL, V11, P2285, DOI 10.1681/ASN.V11122285; Petrache I, 2005, NAT MED, V11, P491, DOI 10.1038/nm1238; Pfohl-Leszkowicz A, 2007, MOL NUTR FOOD RES, V51, P61, DOI 10.1002/mnfr.200600137; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Ramirez-Camacho I, 2016, BBA-MOL BASIS DIS, V1862, P1955, DOI 10.1016/j.bbadis.2016.07.021; Raucci FJ, 2010, CARDIOVASC RES, V86, P55, DOI 10.1093/cvr/cvp399; Rewers M, 2016, LANCET, V387, P2340, DOI 10.1016/S0140-6736(16)30507-4; ROUSER G, 1969, LIPIDS, V4, P599, DOI 10.1007/BF02531047; Sauvant C, 2003, Mycotoxin Res, V19, P118, DOI 10.1007/BF02942949; Sauvant C, 2005, CELL PHYSIOL BIOCHEM, V15, P125, DOI 10.1159/000083660; Sauvant C, 2005, MOL NUTR FOOD RES, V49, P31, DOI 10.1002/mnfr.200400020; Schmelzer C, 2010, MOL NUTR FOOD RES, V54, P805, DOI 10.1002/mnfr.200900155; Shapiro H, 2011, NAT REV NEPHROL, V7, P110, DOI 10.1038/nrneph.2010.156; Shukla SK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04469-z; Siddarth M, 2014, CHEMOSPHERE, V96, P174, DOI 10.1016/j.chemosphere.2013.10.029; Souza-Menezes J, 2009, Biophys Rev, V1, P3, DOI 10.1007/s12551-008-0002-3; Stachurska A, 2013, MOL NUTR FOOD RES, V57, P504, DOI 10.1002/mnfr.201200456; Szeto HH, 2016, KIDNEY INT, V90, P997, DOI 10.1016/j.kint.2016.06.013; Thomas NS, 2017, EUR J NUTR, V56, P2353, DOI 10.1007/s00394-016-1275-0; Tolonen N, 2009, DIABETOLOGIA, V52, P2522, DOI 10.1007/s00125-009-1541-2; Townsend DM, 2003, J AM SOC NEPHROL, V14, P1, DOI 10.1097/01.ASN.0000042803.28024.92; Vergara L, 2002, J AM SOC NEPHROL, V13, p546A; Wang ZW, 2005, DIABETES, V54, P2328, DOI 10.2337/diabetes.54.8.2328; Wanigasuriya KP, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-32; Webster AC, 2017, LANCET, V389, P1238, DOI 10.1016/S0140-6736(16)32064-5; WHITTAM R, 1964, NATURE, V203, P720, DOI 10.1038/203720a0; Wu HJ, 2017, KIDNEY INT, V92, P1334, DOI 10.1016/j.kint.2017.06.033; Yang XA, 2017, TOXICOLOGY, V382, P75, DOI 10.1016/j.tox.2017.03.009; Zhang BY, 2017, ARCH TOXICOL, V91, P2539, DOI 10.1007/s00204-017-1971-4; Zhang BY, 2014, J PROTEOMICS, V101, P154, DOI 10.1016/j.jprot.2014.02.017; Zhang HY, 2009, NEPHROLOGY, V14, P302, DOI 10.1111/j.1440-1797.2008.01072.x; Zhang LP, 2013, CELL METAB, V18, P368, DOI 10.1016/j.cmet.2013.07.012; Zhang LX, 2016, NEW ENGL J MED, V375, P905, DOI 10.1056/NEJMc1602469; Zhang ZF, 2014, BIOCHEM PHARMACOL, V91, P74, DOI 10.1016/j.bcp.2014.07.002; Zhang ZF, 2009, J AGR FOOD CHEM, V57, P7731, DOI 10.1021/jf9012357; Zhou MX, 2015, EXP THER MED, V10, P1265, DOI 10.3892/etm.2015.2711; Zigdon H, 2013, J BIOL CHEM, V288, P4947, DOI 10.1074/jbc.M112.402719	111	19	19	3	28	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2212	2227		10.1096/fj.201800742R	http://dx.doi.org/10.1096/fj.201800742R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30247986				2022-12-26	WOS:000457296600055
J	Ye, Q; Trivedi, M; Zhang, YT; Bohlke, M; Alsulimani, H; Chang, J; Maher, T; Deth, R; Kim, J				Ye, Qi; Trivedi, Malav; Zhang, Yiting; Bohlke, Mark; Alsulimani, Helal; Chang, JuOae; Maher, Timothy; Deth, Richard; Kim, Jonghan			Brain iron loading impairs DNA methylation and alters GABAergic function in mice	FASEB JOURNAL			English	Article						epigenetics; hemochromatosis; HFE; anxiety; oxidative stress	INCREASED OXIDATIVE STRESS; HEREDITARY HEMOCHROMATOSIS; HFE GENE; EXPRESSION; ACCUMULATION; MANGANESE; GABA; DEFICIENCY; METABOLISM; MECHANISMS	Iron deficiency is closely associated with altered GABA metabolism and affective behavior. While mutation in the hemochromatosis (HFE) gene disrupts iron homeostasis and promotes oxidative stress that increases the risk of neurodegeneration, it is largely unknown whether HFE mutation modifies GABAergic homeostasis and emotional behavior. The goal of our study was to investigate the impact of HFE on GABAergic neurochemistry and redox-epigenetic regulation in the brain using H67D HFE-mutant mice that recapitulates the H63D-HFE mutation in humans. H67D mice displayed elevated redox-active iron levels in the brain by 32% compared to age-matched wild-type mice. Moreover, the H67D brain had increased isoprostane and decreased glutathione, indicating elevated oxidative stress. Additionally, the H67D brain had decreased global methylation and attenuated DNA methyltransferase (DNMT) activity. Direct addition of iron to purified DNMT in vitro decreased enzyme activity in a concentration-dependent manner. Last, H67D mice exhibited decreased anxiety-like behavior, which was associated with increased expression of the GABA(A) receptor 2 subunits by 93%, and these changes were also observed in H67D mice fed a low-iron diet. Taken together, our results suggest a putative role of HFE in regulating labile iron status in the brain, and mutation in H67D perturbs redox-methylation status, contributing to GABAergic dysfunction.Ye, Q., Trivedi, M., Zhang, Y., Bohlke, M., Alsulimani, H., Chang, J., Maher, T., Deth, R., Kim, J. Brain iron loading impairs DNA methylation and alters GABAergic function in mice.	[Ye, Qi; Zhang, Yiting; Alsulimani, Helal; Chang, JuOae; Kim, Jonghan] Northeastern Univ, Dept Pharmaceut Sci, 360 Huntington Ave,148TF, Boston, MA 02115 USA; [Trivedi, Malav; Deth, Richard] Nova Southeastern Univ, Dept Pharmaceut Sci, Ft Lauderdale, FL 33314 USA; [Bohlke, Mark; Maher, Timothy] Massachusetts Coll Pharm & Hlth Sci MCPHS Univ, Dept Pharmaceut Sci, Boston, MA USA	Northeastern University; Nova Southeastern University	Kim, J (corresponding author), Northeastern Univ, Dept Pharmaceut Sci, 360 Huntington Ave,148TF, Boston, MA 02115 USA.	j.kim@neu.edu	Alsulimani, Helal/AAS-6328-2021; Deth, Richard/AFV-2608-2022	Alsulimani, Helal/0000-0002-2717-4452	U.S. National Institutes of Health, National Institute of Environmental Health Sciences [K99/R00 ES017781]; Northeastern University	U.S. National Institutes of Health, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Northeastern University	The authors are grateful to M. Han (Northeastern University) for help during animal experiments, and P. Paydary and P. Larese-Casanova (Northeastern University) for help with ICP-MS analysis. This work was supported, in part, by U.S. National Institutes of Health, National Institute of Environmental Health Sciences Grant K99/R00 ES017781 (to J.K.) and a Northeastern University TIER1 Interdisciplinary grant (to J.K.). The authors declare no conflicts of interest.	Abdolmaleky HM, 2006, HUM MOL GENET, V15, P3132, DOI 10.1093/hmg/ddl253; Acosta-Cabronero J, 2016, J NEUROSCI, V36, P364, DOI 10.1523/JNEUROSCI.1907-15.2016; Ali-Rahmani F, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00165; Archer T, 2007, NEUROCHEM RES, V32, P1625, DOI 10.1007/s11064-007-9358-1; Asada H, 1997, P NATL ACAD SCI USA, V94, P6496, DOI 10.1073/pnas.94.12.6496; Aziz A, 2006, MOL CELL BIOL, V26, P6808, DOI 10.1128/MCB.00245-06; Bartzokis G, 2010, J ALZHEIMERS DIS, V20, P333, DOI 10.3233/JAD-2010-1368; Batra Jyoti, 2002, Indian J Clin Biochem, V17, P108, DOI 10.1007/BF02867982; BEARD JL, 1993, NUTR REV, V51, P157, DOI 10.1111/j.1753-4887.1993.tb03096.x; Beard JL, 2007, J NUTR, V137, P1176, DOI 10.1093/jn/137.5.1176; Bianco LE, 2008, J NEUROCHEM, V106, P205, DOI 10.1111/j.1471-4159.2008.05358.x; Bishop GM, 2011, NEUROTOX RES, V19, P443, DOI 10.1007/s12640-010-9195-x; Bradley LA, 1998, J MED SCREEN, V5, P34, DOI 10.1136/jms.5.1.34; Brambilla P, 2003, MOL PSYCHIATR, V8, P721, DOI 10.1038/sj.mp.4001362; Caceres JA, 2012, EMERG MED CLIN N AM, V30, P771, DOI 10.1016/j.emc.2012.06.003; Cai YQ, 2006, J NEUROSCI RES, V84, P255, DOI 10.1002/jnr.20884; Chang J, 2014, TOX RESEARCH, V30, P267, DOI 10.5487/TR.2014.30.4.267; Chattopadhyaya B, 2007, NEURON, V54, P889, DOI 10.1016/j.neuron.2007.05.015; Chauhan NB, 2014, RESTOR NEUROL NEUROS, V32, P337, DOI 10.3233/RNN-130354; Cyr AR, 2011, ANTIOXID REDOX SIGN, V15, P551, DOI 10.1089/ars.2010.3492; Dahl C, 2011, CLIN CHIM ACTA, V412, P831, DOI 10.1016/j.cca.2011.02.013; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Edden RAE, 2012, ARCH GEN PSYCHIAT, V69, P750, DOI 10.1001/archgenpsychiatry.2011.2280; Erikson KM, 2000, J NUTR, V130, P2831, DOI 10.1093/jn/130.11.2831; Erikson KM, 2001, PHARMACOL BIOCHEM BE, V69, P409, DOI 10.1016/S0091-3057(01)00563-9; Esposito BP, 2003, BLOOD, V102, P2670, DOI 10.1182/blood-2003-03-0807; Farina M, 2013, NEUROCHEM INT, V62, P575, DOI 10.1016/j.neuint.2012.12.006; Fitsanakis VA, 2009, NEUROTOX RES, V15, P167, DOI 10.1007/s12640-009-9017-1; Garton T, 2016, STROKE VASC NEUROL, V1, P172, DOI 10.1136/svn-2016-000042; Grayson DR, 2013, NEUROPSYCHOPHARMACOL, V38, P138, DOI 10.1038/npp.2012.125; Han MR, 2016, J NEUROCHEM, V138, P918, DOI 10.1111/jnc.13717; Han M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120609; Hanson EH, 2001, AM J EPIDEMIOL, V154, P193, DOI 10.1093/aje/154.3.193; Heidari M, 2016, MOL PSYCHIATR, V21, P1599, DOI 10.1038/mp.2015.192; Hodgson N, 2013, J ALZHEIMERS DIS, V36, P197, DOI 10.3233/JAD-130101; James SJ, 2004, AM J CLIN NUTR, V80, P1611, DOI 10.1093/ajcn/80.6.1611; Kash SF, 1997, P NATL ACAD SCI USA, V94, P14060, DOI 10.1073/pnas.94.25.14060; Kim J, 2014, J NUTR BIOCHEM, V25, P1101, DOI 10.1016/j.jnutbio.2014.07.003; Klengel T, 2014, NEUROPHARMACOLOGY, V80, P115, DOI 10.1016/j.neuropharm.2014.01.013; Koziol MJ, 2016, NAT STRUCT MOL BIOL, V23, P24, DOI 10.1038/nsmb.3145; Kruszewski M, 2003, MUTAT RES-FUND MOL M, V531, P81, DOI 10.1016/j.mrfmmm.2003.08.004; Lee WJ, 2005, MOL PHARMACOL, V68, P1018, DOI 10.1124/mol.104.008367; Lertratanangkoon K, 1997, CANCER LETT, V120, P149, DOI 10.1016/S0304-3835(97)00300-5; Li Dan, 1998, Hokkaido Journal of Medical Science, V73, P215; Liu WH, 2008, NEUROSCI LETT, V432, P13, DOI 10.1016/j.neulet.2007.11.054; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Garcia-Gimenez JL, 2017, FREE RADICAL BIO MED, V112, P36, DOI 10.1016/j.freeradbiomed.2017.07.008; Lydiard RB, 2003, J CLIN PSYCHIAT, V64, P21; MILMAN N, 1991, DAN MED BULL, V38, P385; Mittal Rama Devi, 2003, Indian J Clin Biochem, V18, P111, DOI 10.1007/BF02867677; Montuschi P, 2004, FASEB J, V18, P1791, DOI 10.1096/fj.04-2330rev; Nakai T, 2014, NEUROCHEM INT, V74, P74, DOI 10.1016/j.neuint.2014.06.009; Nandar W, 2013, BBA-MOL BASIS DIS, V1832, P729, DOI 10.1016/j.bbadis.2013.02.009; Nandar W, 2011, J NUTR, V141, p729S, DOI 10.3945/jn.110.130351; Nuss P, 2015, NEUROPSYCH DIS TREAT, V11, P165, DOI 10.2147/NDT.S58841; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Oshiro S, 2000, BBA-MOL BASIS DIS, V1502, P405, DOI 10.1016/S0925-4439(00)00065-X; Pilsner JR, 2010, MOL ECOL, V19, P307, DOI 10.1111/j.1365-294X.2009.04452.x; Pleau JM, 2001, BIOCHEM BIOPH RES CO, V283, P843, DOI 10.1006/bbrc.2001.4884; Pogribny IP, 2013, INT J ONCOL, V42, P1822, DOI 10.3892/ijo.2013.1855; Pulliam JF, 2003, AM J MED GENET B, V119B, P48, DOI 10.1002/ajmg.b.10069; Qian Y, 2015, CELL SIGNAL, V27, P934, DOI 10.1016/j.cellsig.2015.01.017; Ramsey AJ, 1996, J BIOL CHEM, V271, P24395, DOI 10.1074/jbc.271.40.24395; Rasmussen KD, 2016, GENE DEV, V30, P733, DOI 10.1101/gad.276568.115; Raud S, 2009, NEUROSCI LETT, V460, P138, DOI 10.1016/j.neulet.2009.05.054; Ravindran CRM, 2005, NEUROCHEM INT, V46, P313, DOI 10.1016/j.neuint.2004.10.004; Raz E, 2011, AM J NEURORADIOL, V32, P1851, DOI 10.3174/ajnr.A2637; Roy CN, 2002, J CELL PHYSIOL, V190, P218, DOI 10.1002/JCP.10056; Salvador Gabriela A, 2010, Int J Alzheimers Dis, V2011, P720658, DOI 10.4061/2011/720658; Santos D, 2012, TOXICOLOGY, V292, P90, DOI 10.1016/j.tox.2011.11.017; Schipper HM, 2004, AGEING RES REV, V3, P265, DOI 10.1016/j.arr.2004.02.001; Serata D., 2012, GEN HOSP PSYCHIAT, V34; Shen XM, 1998, CHEM RES TOXICOL, V11, P824, DOI 10.1021/tx980036t; Tarale P, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2548792; Thomas C, 2009, REDOX REP, V14, P102, DOI 10.1179/135100009X392566; TORRANCE J D, 1968, South African Journal of Medical Sciences, V33, P9; Trivedi M, 2014, MOL PHARMACOL, V85, P747, DOI 10.1124/mol.114.091728; Unger EL, 2008, J NUTR, V138, P2487, DOI 10.3945/jn.108.095224; Urrutia P, 2013, J NEUROCHEM, V126, P541, DOI 10.1111/jnc.12244; Veeraiah P, 2014, BIOL PSYCHIAT, V76, P231, DOI 10.1016/j.biopsych.2013.09.024; Wu H, 2014, CELL, V156, P45, DOI 10.1016/j.cell.2013.12.019; Yao B, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01195-y; Ye Q, 2016, METALLOMICS, V8, P618, DOI 10.1039/c6mt00080k; Ye Q, 2015, ENVIRON TOXICOL PHAR, V40, P333, DOI 10.1016/j.etap.2015.06.016; Zhang CG, 2014, PROTEIN CELL, V5, P750, DOI 10.1007/s13238-014-0083-7; Zhang YT, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3849087	87	17	18	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2460	2471		10.1096/fj.201801116RR	http://dx.doi.org/10.1096/fj.201801116RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30277817	Green Published			2022-12-26	WOS:000457296600074
J	Petes, C; Mintsopoulos, V; Finnen, RL; Banfield, BW; Gee, K				Petes, Carlene; Mintsopoulos, Victoria; Finnen, Renee L.; Banfield, Bruce W.; Gee, Katrina			The effects of CD14 and IL-27 on induction of endotoxin tolerance in human monocytes and macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inflammation; cytokine action; Toll-like receptor 4 (TLR4); lipopolysaccharide (LPS); NF-B; CD14; endotoxin tolerance; interleukin-27 (IL-27); monocytes; macrophages	NECROSIS-FACTOR-ALPHA; KAPPA-B; IRAK-M; UP-REGULATION; IL-12 FAMILY; INFLAMMATORY RESPONSES; SIGNAL-TRANSDUCTION; NEGATIVE REGULATION; TLR4 ENDOCYTOSIS; RECEPTOR CD14	Upon repeated exposure to endotoxin or lipopolysaccharide (LPS), myeloid cells enter a refractory state called endotoxin tolerance as a homeostatic mechanism. In innate immune cells, LPS is recognized by co-receptors Toll-like receptor 4 (TLR4) and CD-14 to initiate an inflammatory response for subsequent cytokine production. One such cytokine, interleukin (IL)-27, is produced by myeloid cells in response to bacterial infection. In monocytes, IL-27 has proinflammatory functions such as up-regulating TLR4 expression for enhanced LPS-mediated cytokine production; alternatively, IL-27 induces inhibitory functions in activated macrophages. This study investigated the effects of IL-27 on the induction of endotoxin tolerance in models of human monocytes compared with macrophages. Our data demonstrate that IL-27 inhibits endotoxin tolerance by up-regulating cell surface TLR4 expression and soluble CD14 production to mediate stability of the surface LPS-TLR4-CD14 complex in THP-1 cells. In contrast, elevated basal expression of membrane-bound CD14 in phorbol 12-myristate 13-acetate (PMA)-THP-1 cells, primary monocytes, and primary macrophages may promote CD14-mediated endocytosis and be responsible for the preservation of an endotoxin-tolerized state in the presence of IL-27. Overall, the efficacy of IL-27 in inhibiting endotoxin tolerance in human THP-1 monocytes and PMA-THP-1 macrophages is affected by membrane-bound and soluble CD14 expression.	[Petes, Carlene; Mintsopoulos, Victoria; Finnen, Renee L.; Banfield, Bruce W.; Gee, Katrina] Queens Univ, Dept Biomed & Mol Sci, 18 Stuart St,Botterell Hall 738, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Gee, K (corresponding author), Queens Univ, Dept Biomed & Mol Sci, 18 Stuart St,Botterell Hall 738, Kingston, ON K7L 3N6, Canada.	kgee@queensu.ca		Gee, Katrina/0000-0002-7535-2882	Natural Sciences and Engineering Research Council of Canada (NSERC) [342168, 418719]; Ontario Graduate Scholarship; Dr. Robert John Wilson graduate fellowship; NSERC; NSERC undergraduate student research award; Canadian Institutes of Health Research [93804]; Canada Foundation for Innovation [16389]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Graduate Scholarship(Ontario Graduate Scholarship); Dr. Robert John Wilson graduate fellowship; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC undergraduate student research award(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	This work was supported by Grants 342168 (to K. G.) and 418719 (to B. W. B.) from the Natural Sciences and Engineering Research Council of Canada (NSERC). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by an Ontario Graduate Scholarship, a Dr. Robert John Wilson graduate fellowship, and an NSERC postgraduate supplement D (PGS D).; Supported by an NSERC undergraduate student research award.; Supported by Operating Grant 93804 from the Canadian Institutes of Health Research and Grant 16389 from the Canada Foundation for Innovation.	AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244; Baer M, 1998, MOL CELL BIOL, V18, P5678, DOI 10.1128/MCB.18.10.5678; BAZIL V, 1991, J IMMUNOL, V147, P1567; Biswas S. K., 2012, IMMUNOSUPPRESSION RO, P21; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; BUFLER P, 1995, EUR J IMMUNOL, V25, P604, DOI 10.1002/eji.1830250244; Cao J, 2014, THORAX, V69, P926, DOI 10.1136/thoraxjnl-2014-205777; Carmody RJ, 2007, SCIENCE, V317, P675, DOI 10.1126/science.1142953; Cavaillon JM, 2006, CRIT CARE, V10, DOI 10.1186/cc5055; Cavaillon JM, 2003, J ENDOTOXIN RES, V9, P101, DOI 10.1179/096805103125001487; Chen J, 2010, P NATL ACAD SCI USA, V107, P19438, DOI 10.1073/pnas.1007816107; Chen RF, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-340; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; d'Almeida SM, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1178025; del Fresno C, 2007, J ENDOTOXIN RES, V13, P39, DOI 10.1177/0968051907078623; Deng JC, 2006, J CLIN INVEST, V116, P2532, DOI 10.1172/JCI28054; Deschner J, 2003, ARCH MICROBIOL, V179, P430, DOI 10.1007/s00203-003-0548-1; Draisma A, 2009, CRIT CARE MED, V37, P1261, DOI 10.1097/CCM.0b013e31819c3c67; El Gazzar M, 2007, J BIOL CHEM, V282, P26857, DOI 10.1074/jbc.M704584200; Escoll P, 2003, BIOCHEM BIOPH RES CO, V311, P465, DOI 10.1016/j.bbrc.2003.10.019; Finberg RW, 2004, J ENDOTOXIN RES, V10, P413, DOI 10.1179/096805104225006273; Fitzgerald KA, 2004, MICROBES INFECT, V6, P1361, DOI 10.1016/j.micinf.2004.08.015; Gee Katrina, 2009, Inflammation & Allergy Drug Targets, V8, P40; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Guzzo C, 2012, J IMMUNOL, V188, P864, DOI 10.4049/jimmunol.1101912; Guzzo C, 2010, J BIOL CHEM, V285, P24404, DOI 10.1074/jbc.M110.112599; Hibbert L, 2003, J INTERF CYTOK RES, V23, P513, DOI 10.1089/10799900360708632; Holscher C, 2005, J IMMUNOL, V174, P3534, DOI 10.4049/jimmunol.174.6.3534; Huber R, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/9570129; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Italiani P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00514; Ivashkiv LB, 2011, EUR J IMMUNOL, V41, P2477, DOI 10.1002/eji.201141783; Iyer SS, 2010, J IMMUNOL, V185, P6599, DOI 10.4049/jimmunol.1002041; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kalliolias GD, 2008, J IMMUNOL, V180, P6325, DOI 10.4049/jimmunol.180.9.6325; Kalliolias GD, 2010, J IMMUNOL, V185, P7047, DOI 10.4049/jimmunol.1001290; Kamakura M, 2006, BIOCHEM BIOPH RES CO, V349, P1372, DOI 10.1016/j.bbrc.2006.09.004; Karimi Y, 2017, CYTOKINE, V95, P7, DOI 10.1016/j.cyto.2017.01.017; Kim D, 2014, MOL IMMUNOL, V57, P210, DOI 10.1016/j.molimm.2013.09.009; Kitchens RL, 2003, J LIPID RES, V44, P2339, DOI 10.1194/jlr.M300228-JLR200; Kitchens RL, 2001, J CLIN INVEST, V108, P485, DOI 10.1172/JCI200113139; Kox M, 2011, CRIT CARE MED, V39, P1866, DOI 10.1097/CCM.0b013e3182190d5d; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Lin YW, 2016, J INNATE IMMUN, V8, P97, DOI 10.1159/000433539; Lopez-Collazo E, 2013, CRIT CARE, V17, DOI 10.1186/cc13110; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Molle C, 2007, J IMMUNOL, V178, P7607, DOI 10.4049/jimmunol.178.12.7607; Nomura F, 2000, J IMMUNOL, V164, P3476, DOI 10.4049/jimmunol.164.7.3476; Park SH, 2011, NAT IMMUNOL, V12, P607, DOI 10.1038/ni.2043; Pearl JE, 2004, J IMMUNOL, V173, P7490, DOI 10.4049/jimmunol.173.12.7490; PEDRON T, 1995, J IMMUNOL, V155, P1460; Pena OM, 2011, J IMMUNOL, V186, P7243, DOI 10.4049/jimmunol.1001952; Petes C, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00256; Petes C, 2017, J LEUKOCYTE BIOL, V102, P83, DOI 10.1189/jlb.3A0316-098R; Pflanz S, 2004, J IMMUNOL, V172, P2225, DOI 10.4049/jimmunol.172.4.2225; Porta C, 2009, P NATL ACAD SCI USA, V106, P14978, DOI 10.1073/pnas.0809784106; Rackov G, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00493; Rajaiah R, 2015, P NATL ACAD SCI USA, V112, P8391, DOI 10.1073/pnas.1424980112; Rinchai D, 2012, EUR J IMMUNOL, V42, P3280, DOI 10.1002/eji.201242526; Ruckerl D, 2006, IMMUNOBIOLOGY, V211, P427, DOI 10.1016/j.imbio.2006.05.008; Santucci MB, 2003, INT IMMUNOPHARMACOL, V3, P1657, DOI 10.1016/S1567-5769(03)00202-9; Scicluna BP, 2012, CRIT CARE, V16, DOI 10.1186/cc11893; Shalova IN, 2015, IMMUNITY, V42, P484, DOI 10.1016/j.immuni.2015.02.001; Shapouri-Moghaddam A, 2018, J CELL PHYSIOL, V233, P6425, DOI 10.1002/jcp.26429; Shen H, 2008, J IMMUNOL, V181, P1849, DOI 10.4049/jimmunol.181.3.1849; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Shin HJ, 2007, MOL CELLS, V24, P119; Shive CL, 2015, AIDS, V29, P1263, DOI 10.1097/QAD.0000000000000735; Shuto T, 2005, BIOCHEM BIOPH RES CO, V338, P1402, DOI 10.1016/j.bbrc.2005.10.102; Sly LM, 2004, IMMUNITY, V21, P227, DOI 10.1016/j.immuni.2004.07.010; Takeda A, 2003, J IMMUNOL, V170, P4886, DOI 10.4049/jimmunol.170.10.4886; Tanimura N, 2008, BIOCHEM BIOPH RES CO, V368, P94, DOI 10.1016/j.bbrc.2008.01.061; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; van 't Veer C, 2007, J IMMUNOL, V179, P7110, DOI 10.4049/jimmunol.179.10.7110; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; Wang N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00614; Wertz IE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003350; West MA, 2008, J TRAUMA, V65, P893, DOI 10.1097/TA.0b013e3181877fde; Wheeler DS, 2008, SHOCK, V30, P267, DOI 10.1097/shk.0b013e318162c190; Wong HR, 2013, SHOCK, V40, P382, DOI 10.1097/SHK.0b013e3182a67632; Wong KL, 2012, IMMUNOL RES, V53, P41, DOI 10.1007/s12026-012-8297-3; Wu XH, 2015, INT J IMMUNOPATH PH, V28, P351, DOI 10.1177/0394632015593228; Wynick C, 2016, J INTERF CYTOK RES, V36, P477, DOI 10.1089/jir.2015.0134; Xie CL, 2016, INT J MOL MED, V38, P148, DOI 10.3892/ijmm.2016.2583; Xiong YB, 2011, J LEUKOCYTE BIOL, V90, P1141, DOI 10.1189/jlb.0611273; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yang JY, 2014, BIOMARK RES, V2, DOI 10.1186/2050-7771-2-1; Zanoni I, 2017, IMMUNITY, V47, P697, DOI 10.1016/j.immuni.2017.09.010; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051; Zhang GL, 2000, J ENDOTOXIN RES, V6, P453, DOI 10.1179/096805100101532414; Ziegler-Heitbrock L, 2001, J ENDOTOXIN RES, V7, P219, DOI 10.1177/09680519010070030401; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558; ZIEGLERHEITBROCK HWL, 1994, J BIOL CHEM, V269, P17001	93	13	14	3	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2018	293	45					17631	17645		10.1074/jbc.RA118.003501	http://dx.doi.org/10.1074/jbc.RA118.003501			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ9EI	30242126	Green Published, hybrid			2022-12-26	WOS:000449799000026
J	Li, J; Duan, R; Zhang, YY; Zhao, X; Cheng, YX; Chen, YX; Yuan, JG; Li, H; Zhang, JP; Chu, L; Xia, DY; Zhao, SM				Li, Jun; Duan, Ran; Zhang, Yingying; Zhao, Xin; Cheng, Yanxin; Chen, Yongxue; Yuan, Jinge; Li, Hong; Zhang, Jianping; Chu, Li; Xia, Dengyun; Zhao, Senming			Beta-adrenergic activation induces cardiac collapse by aggravating cardiomyocyte contractile dysfunction in bupivacaine intoxication	PLOS ONE			English	Article							STANDARD-DOSE EPINEPHRINE; CARDIORESPIRATORY RESPONSE; INTRAVENOUS BUPIVACAINE; ROPIVACAINE; RESUSCITATION; ARREST; DEPRESSION; TOXICITY; RATS; DOGS	In order to determine the role of the adrenergic system in bupivacaine-induced cardiotoxicity, a series of experiments were performed. In an animal experiment, male Sprague-Dawley (SD) rats under chloral hydrate anesthesia received intravenous bupivacaine, followed by an intravenous injection of adrenalin or isoprenalin, and the electrocardiogram (ECG), left ventricular systolic pressure (LVSP), left ventricular end-diastolic pressure (LVEDP), the maximum rate of rise of left ventricular pressure (+dP/dtmax) and the maximum rate of pressure decrease (-dP/dtmax) were continually monitored. In a cellular experiment, freshly isolated adult SD rat ventricular myocytes were perfused with bupivacaine at different concentrations in the presence or absence of isoprenalin, with or without esmolol. The percentage of the sarcomere shortening (bl% peak h), departure velocity (dep v) of sarcomere shortening and time to 50% of the peak speed of myocyte contraction (Tp50) was assessed by a video-based edge-detection system. In an additional experiment, Swiss mice pretreated with saline, isoprenalin, esmolol or dexmedetomidine received bupivacaine to determine the 50% lethal dose (LD50) of bupivacaine. Electron microscopy of myocardial mitochondria was performed to assess damage of these structures. To test mitochondrial reactive oxygen species (ROS) production, freshly isolated SD rat ventricular myocytes were incubated with bupivacaine in the presence of isoprenalin, with or without esmolol. First, our results showed that bupivacaine significantly reduced the LVSP and +dP/dtmax, as well as enhanced the LVEDP and -dP/dtmax (P < 0.05, vs. control, and vs. baseline). Adrenalin and isoprenalin induced a further reduction of LVSP and +dP/dtmax (P < 0.05, vs. before adrenalin or isoprenalin delivery, and vs. control). Second, bupivacaine induced a dose-dependent cardiomyocyte contractile depression. While 5.9 mu mol/L or 8.9 mu mol/L of bupivacaine resulted in no change, 30.0 mu mol/L of bupivacaine prolonged the Tp50 and reduced the bl% peak h and dep v (P < 0.05, vs. control and vs. baseline). Isoprenalin aggravated the bupivacaine-induced cardiomyocyte contractile depression, significantly prolonging the Tp50 (P < 0.05, vs. bupivacaine alone) and reducing the dep v (P < 0.05, vs. bupivacaine alone). Third, esmolol and dexmedetomidine significantly enhanced, while isoprenalin significantly reduced, the LD50 of bupivacaine in mice. Fourth, bupivacaine led to significant mitochondrial swelling, and the extent of myocardial mitochondrial swelling in isoprenalin-pretreated mice was significantly higher than that compared with mice pretreated with saline, as reflected by the higher mitochondrial damage score (P< 0.01). Meanwhile, esmolol pretreatment significantly reduced the mitochondrial damage score (P < 0.01). Fifth, bupivacaine significantly increased the ROS in freshly isolated cardiomyocytes, and added isoprenalin induced a further enhancement of ROS production (P< 0.05, vs. bupivacaine alone). Added esmolol significantly decreased ROS production (P < 0.05, vs. bupivacaine + isoprenalin). Our results suggest that bupivacaine depressed cardiac automaticity, conductivity and contractility, but the predominant effect was contractile dysfunction which resulted from the disruption of mitochondrial energy metabolism. beta-adrenergic activation aggravated the cellular metabolism disorder and therefore contractile dysfunction.	[Li, Jun; Duan, Ran; Cheng, Yanxin; Li, Hong; Zhao, Senming] Hebei Med Univ, Pain Med Ctr, Hosp 3, Shijiazhuang, Hebei, Peoples R China; [Zhang, Yingying; Xia, Dengyun] Hebei North Univ, Dept Anesthesiol, Zhangjiakou, Hebei, Peoples R China; [Zhao, Xin] Hebei Med Univ, Hepatopathy Dept, Hosp 3, Shijiazhuang, Hebei, Peoples R China; [Chen, Yongxue; Yuan, Jinge] Handan Ctr Hosp, Dept Anesthesiol, Handan, Hebei, Peoples R China; [Zhang, Jianping; Chu, Li] Hebei Univ Chinese Med, Dept Pharmacol, Shijiazhuang, Hebei, Peoples R China	Hebei Medical University; Hebei North University; Hebei Medical University; Hebei University of Chinese Medicine	Zhao, SM (corresponding author), Hebei Med Univ, Pain Med Ctr, Hosp 3, Shijiazhuang, Hebei, Peoples R China.	senming63@163.com						Ali B, 2007, ANN INTERN MED, V147, P171, DOI 10.7326/0003-4819-147-3-200708070-00006; Berg RA, 1996, CRIT CARE MED, V24, P1695, DOI 10.1097/00003246-199610000-00016; BERG RA, 1994, CRIT CARE MED, V22, P282, DOI 10.1097/00003246-199402000-00020; BERNARDS CM, 1989, ANESTHESIOLOGY, V71, P711, DOI 10.1097/00000542-198911000-00014; BERNARDS CM, 1991, ANESTHESIOLOGY, V74, P89, DOI 10.1097/00000542-199101000-00015; Cela O, 2010, MITOCHONDRION, V10, P487, DOI 10.1016/j.mito.2010.05.005; Cho HS, 2000, ANESTH ANALG, V91, P1096, DOI 10.1097/00000539-200011000-00010; CLARKSON CW, 1985, ANESTHESIOLOGY, V62, P396, DOI 10.1097/00000542-198504000-00006; El-Tantawy WH, 2014, J PHYSIOL BIOCHEM, V70, P33, DOI 10.1007/s13105-013-0277-0; ELEDJAM JJ, 1989, ANESTH ANALG, V69, P732; Groban L, 2001, ANESTH ANALG, V92, P37; HASSELSTROM LJ, 1984, ANESTH ANALG, V63, P1053; HEAVNER JE, 1995, ANESTH ANALG, V80, P1134, DOI 10.1097/00000539-199506000-00011; Hiller N, 2013, ANESTH ANALG, V116, P83, DOI 10.1213/ANE.0b013e31826c8095; Huske C, 2016, BRAIN RES, V1642, P364, DOI 10.1016/j.brainres.2016.04.019; ISENBERG G, 1982, PFLUG ARCH EUR J PHY, V395, P6, DOI 10.1007/BF00584963; Joshi MS, 2000, ANAL CELL PATHOL, V21, P41, DOI 10.1155/2000/201406; KINNEY WW, 1991, CAN J ANAESTH, V38, P533, DOI 10.1007/BF03007595; Krenek P, 2009, EUR J HEART FAIL, V11, P140, DOI 10.1093/eurjhf/hfn026; Kulier AH, 1996, ANESTH ANALG, V83, P62, DOI 10.1097/00000539-199607000-00011; Mather LE, 2001, DRUGS, V61, P333, DOI 10.2165/00003495-200161030-00002; Mikusova A, 2009, CAN J PHYSIOL PHARM, V87, P641, DOI [10.1139/Y09-053, 10.1139/y09-053]; ORSER B, 1992, CAN J ANAESTH, V39, P407, DOI 10.1007/BF03009066; Reinikainen M, 2003, ACTA ANAESTH SCAND, V47, P904, DOI 10.1034/j.1399-6576.2003.00188.x; Sandberg KL, 2013, ACTA PAEDIATR, V102, P391, DOI 10.1111/apa.12151; Schwoerer AP, 2015, ANESTH ANALG, V120, P1226, DOI 10.1213/ANE.0000000000000646; Sztark F, 1998, ANESTHESIOLOGY, V88, P1340, DOI 10.1097/00000542-199805000-00026; TAKAHASHI S, 1994, PHARMACOL TOXICOL, V75, P119, DOI 10.1111/j.1600-0773.1994.tb00334.x; Vandycke C, 2000, RESUSCITATION, V45, P161, DOI 10.1016/S0300-9572(00)00188-X; Yu XQ, 1996, BIOL NEONATE, V69, P146, DOI 10.1159/000244290	30	3	3	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0203602	10.1371/journal.pone.0203602	http://dx.doi.org/10.1371/journal.pone.0203602			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273351	gold, Green Published, Green Submitted			2022-12-26	WOS:000446124700007
J	Radowsky, JS; Neely, R; Forsberg, JA; Lisboa, FA; Dente, CJ; Elster, EA; Crane, NJ				Radowsky, Jason S.; Neely, Romon; Forsberg, Jonathan A.; Lisboa, Felipe A.; Dente, Christopher J.; Elster, Eric A.; Crane, Nicole J.			Preclosure spectroscopic differences between healed and dehisced traumatic wounds	PLOS ONE			English	Article							IMAGING TECHNOLOGIES; TISSUE OXYGENATION; MODEL; WAR; ENHANCEMENT; REFLECTANCE; EXPRESSION; BIOMARKERS; INFECTION; FAILURE	Background The complexity and severity of traumatic wounds in military and civilian trauma demandsimproved wound assessment, before, during, and after treatment. Here, we explore the potential of 3 charge-coupled device (3CCD) imaging values to distinguish between traumatic wounds that heal following closure and those that fail. Previous studies demonstrate that normalized 3CCD imaging values exhibit a high correlation with oxygen saturation and allow for comparison of values between diverse clinical settings, including utilizing different equipment and lighting. Methods We screened 119 patients at Walter Reed National Military Medical Center and at Grady Memorial Hospital with at least one traumatic extremity wound of >= 75 cm(2). We collected images of each wound during each debridement surgery for a total of 66 patients. An inhouse written computer application selected a region of interest in the images, separated the pixel color values, calculated relative values, and normalized them. We followed patients until the enrolled wounds were surgically closed, quantifying the number of wounds that dehisced (defined as wound failure or infection requiring return to the operating room after closure) or healed. Results Wound failure occurred in 20% (19 of 96) of traumatic wounds. Normalized intensity values for patients with wounds that healed successfully were, on average, significantly different from values for patients with wounds that failed (p <= 0.05). Simple thresholding models and partial least squares discriminant analysis models performed poorly. However, a hierarchical cluster analysis model created with 17 variables including 3CCD data, wound surface area, and time from injury predicts wound failure with 76.9% sensitivity, 76.5% specificity, 76.6% accuracy, and a diagnostic odds ratio of 10.8 (95% confidence interval: 2.645.9). Conclusions Imaging using 3CCD technology may provide a non-invasive and cost-effective method of aiding surgeons in deciding if wounds are ready for closure and could potentially decrease the number of required debridements and hospital days. The process may be automated to provide real-time feedback in the operating room and clinic. The low cost and small size of the cameras makes this technology attractive for austere and shipboard environments where space and weight are at a premium.	[Radowsky, Jason S.; Neely, Romon; Lisboa, Felipe A.; Elster, Eric A.; Crane, Nicole J.] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA; [Radowsky, Jason S.; Neely, Romon; Lisboa, Felipe A.; Elster, Eric A.; Crane, Nicole J.] Walter Reed Natl Mil Med Ctr, USUHS Walter Reed Surg, Bethesda, MD 20889 USA; [Forsberg, Jonathan A.] Walter Reed Natl Mil Med Ctr, USUHS Walter Reed Surg, Orthopaed, Bethesda, MD USA; [Forsberg, Jonathan A.] Johns Hopkins Univ, Orthopaed, Baltimore, MD USA; [Lisboa, Felipe A.; Elster, Eric A.; Crane, Nicole J.] Naval Med Res Ctr, Regenerat Med Dept, Silver Spring, MD USA; [Lisboa, Felipe A.; Dente, Christopher J.; Elster, Eric A.] Uniformed Serv Univ Hlth Sci, Surg Crit Care Initiat, Bethesda, MD 20814 USA; [Dente, Christopher J.] Emory Univ, Sch Med, Dept Surg, Atlanta, GA 30322 USA; [Dente, Christopher J.] Grady Mem Hosp, Trauma Surg Crit Care, Atlanta, GA USA	Uniformed Services University of the Health Sciences - USA; Walter Reed National Military Medical Center; Walter Reed National Military Medical Center; Johns Hopkins University; Naval Medical Research Center (NMRC); Uniformed Services University of the Health Sciences - USA; Emory University	Radowsky, JS (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA.	jason.radowsky@gmail.com	Radowsky, Jason/ABX-5157-2022; Elster, Eric/ABG-6091-2021	Elster, Eric/0000-0002-0981-2748	Department of Defense's Defense Health Program - Joint Program Committee 6 / Combat Casualty Care [USUHS HT9404-13-1-0032, HU0001-15-2-0001]; USAMRAA Peer Reviewed Orthopaedic Research Program award [W81XWH-10-2-0162]; USAMRAA award [W81XWH-13-2-0039];  [602115HP.3720.001.A1015];  [604115HP.4640.001.A1268]	Department of Defense's Defense Health Program - Joint Program Committee 6 / Combat Casualty Care; USAMRAA Peer Reviewed Orthopaedic Research Program award; USAMRAA award; ; 	Research activities leading to the development of this manuscript were funded by the Department of Defense's Defense Health Program - Joint Program Committee 6 / Combat Casualty Care (USUHS HT9404-13-1-0032 and HU0001-15-2-0001). Additionally, this work was supported/funded by work unit numbers 602115HP.3720.001.A1015 and 604115HP.4640.001.A1268. Funding Support includes USAMRAA Peer Reviewed Orthopaedic Research Program award W81XWH-10-2-0162 and USAMRAA award W81XWH-13-2-0039. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2017, J SURG RES, V209, P174, DOI 10.1016/j.jss.2016.09.017; Anghel Ersilia L, 2016, Surg Technol Int, V28, P58; Crane NJ, 2008, J AM COLL SURGEONS, V206, P1159, DOI 10.1016/j.jamcollsurg.2008.01.013; Crane NJ, 2007, APPL SPECTROSC, V61, P797, DOI 10.1366/000370207781540204; Crane NJ, 2010, J UROLOGY, V184, P1279, DOI 10.1016/j.juro.2010.06.010; Crane Nicole J, 2008, BMC Surg, V8, P8, DOI 10.1186/1471-2482-8-8; Forsberg JA, 2015, EBIOMEDICINE, V2, P1235, DOI 10.1016/j.ebiom.2015.07.022; Forsberg JA, 2014, CLIN ORTHOP RELAT R, V472, P2845, DOI 10.1007/s11999-014-3694-7; Forsberg JA, 2008, J BONE JOINT SURG AM, V90A, P580, DOI 10.2106/JBJS.G.00265; Grootveld M., 2015, ROYAL SOC CHEM, P1; Hahm G, 2011, PLAST RECONSTR SURG, V127, p21S, DOI 10.1097/PRS.0b013e3181fbe291; Hawksworth JS, 2009, ANN SURG, V250, P1002, DOI 10.1097/SLA.0b013e3181b248d9; Helling TS, 1998, ANN SURG, V228, P173, DOI 10.1097/00000658-199808000-00005; Irvine JM, 2014, ANAL TEMPORAL DYNAMI, DOI [10.1117/12.2043958, DOI 10.1117/12.2043958]; Jayachandran M, 2016, ADV WOUND CARE, V5, P349, DOI 10.1089/wound.2015.0678; Kaiser M, 2011, BURNS, V37, P377, DOI 10.1016/j.burns.2010.11.012; Lundy Jonathan B, 2010, J Intensive Care Med, V25, P156, DOI 10.1177/0885066609359588; Luthra R, 2013, PROC SPIE, V8574, DOI 10.1117/12.2000467; Millendez MB, 2012, J PEDIATR SURG, V47, P142, DOI 10.1016/j.jpedsurg.2011.10.033; Paul DW, 2015, WOUND REPAIR REGEN, V23, P149, DOI 10.1111/wrr.12262; Polfer EM, 2014, CLIN ORTHOP RELAT R, V472, P2978, DOI 10.1007/s11999-014-3586-x; Radowsky JS, 2015, SURG INFECT, V16, P526, DOI 10.1089/sur.2013.124; Radowsky JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137430; Reisman WM, 2016, MIL MED, V181, P111, DOI 10.7205/MILMED-D-14-00689; Schreiber MA, 2008, J TRAUMA, V64, pS118, DOI 10.1097/TA.0b013e318160869d; Sen CK, 2016, PLAST RECONSTR SURG, V138, p119S, DOI 10.1097/PRS.0000000000002654; Sowa MG, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.9.091304; Stojadinovic A, 2010, J MULTIDISCIP HEALTH, V3, P125; Thomas EV, 2003, J CHEMOMETR, V17, P653, DOI 10.1002/cem.833; Utz ER, 2010, J SURG RES, V159, P633, DOI 10.1016/j.jss.2009.08.021; VANDERVOET H, 1994, CHEMOMETR INTELL LAB, V25, P313, DOI 10.1016/0169-7439(94)85050-X	31	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204453	10.1371/journal.pone.0204453	http://dx.doi.org/10.1371/journal.pone.0204453			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30261011	Green Submitted, Green Published, gold			2022-12-26	WOS:000445907400053
J	Wetmore, JB; Li, SY; Yan, H; Xu, HR; Peng, Y; Sinsakul, MV; Liu, JN; Gilbertson, DT				Wetmore, James B.; Li, Suying; Yan, Heng; Xu, Hairong; Peng, Yi; Sinsakul, Marvin, V; Liu, Jiannong; Gilbertson, David T.			Predialysis anemia management and outcomes following dialysis initiation: A retrospective cohort analysis	PLOS ONE			English	Article							DOPPS PRACTICE MONITOR; 3RD NATIONAL-HEALTH; HEMODIALYSIS-PATIENTS; EPOETIN-ALPHA; DARBEPOETIN ALPHA; HEMATOCRIT VALUES; CARE UPDATE; MORTALITY; HEMOGLOBIN; ASSOCIATION	Whether and how anemia treatment with erythropoiesis stimulating agents (ESAs) before hemodialysis initiation may be associated with lower mortality after dialysis initiation is unknown. We compared all-cause and cardiovascular mortality in two groups of patients who experienced distinct anemia treatment patterns with ESAs before and after hemodialysis initiation. This retrospective cohort analysis included patients initiating hemodialysis April 1, 2012-June 30, 2013, identified from United States Renal Data System end-stage renal disease (ESRD) and pre-ESRD files. Patients treated with ESAs before and after hemodialysis initiation who maintained Hb >= 9.0 g/dL throughout (comparator group, n = 3662) were compared with patients with Hb < 9.0 g/dL before hemodialysis initiation (with or without ESAs) whose levels increased with ESAs after hemodialysis initiation (referent group, n = 4461). Cox proportional hazards models were used to calculate the hazard ratio of all-cause and cardiovascular mortality after hemodialysis initiation. Of 20,454 patients, 4855 (23.7%) had Hb < 9.0 g/dL upon hemodialysis initiation; of these 4855, 26.6% received ESAs before initiation. Comparator group Hb levels increased from 8.2 +/- 0.8 mg/dL upon initiation to 10.9 +/- 1.2 with ESAs afterward. Comparator patients were more likely than referent patients to be younger (76.3 +/- 6.7 versus 77.2 +/- 6.9 years), male (51.5% versus 49.8%), and black (24.6% versus 18.6%). Risk of all-cause mortality was lower for the comparator group versus the referent group at 3 (HR 0.83, 95% CI 0.68-1.00, P = 0.052), 6 (0.86, 0.74-1.00, P = 0.047), and 12 (0.88, 0.78-0.99, P = 0.036) months. The pattern was similar for cardiovascular mortality. Hb >= 9.0 with ESAs before and after hemodialysis initiation was generally associated with lower post-initiation all-cause and cardiovascular mortality compared with predialysis Hb < 9.0 g/dL in patients whose Hb levels subsequently improved with ESAs after hemodialysis initiation.	[Wetmore, James B.; Li, Suying; Yan, Heng; Peng, Yi; Liu, Jiannong; Gilbertson, David T.] Minneapolis Med Res Fdn Inc, Chron Dis Res Grp, Minneapolis, MN 55404 USA; [Wetmore, James B.] Univ Minnesota, Hennepin Cty Med Ctr, Div Nephrol, Minneapolis, MN 55415 USA; [Xu, Hairong; Sinsakul, Marvin, V] AstraZeneca, Gaithersburg, MD USA	Minneapolis Medical Research Foundation; Hennepin County Medical Center; University of Minnesota System; University of Minnesota Twin Cities; AstraZeneca	Wetmore, JB (corresponding author), Minneapolis Med Res Fdn Inc, Chron Dis Res Grp, Minneapolis, MN 55404 USA.; Wetmore, JB (corresponding author), Univ Minnesota, Hennepin Cty Med Ctr, Div Nephrol, Minneapolis, MN 55415 USA.	James.Wetmore@hcmed.org		Wetmore, James/0000-0003-1380-8597	AstraZeneca, Inc., Wilmington, Delaware	AstraZeneca, Inc., Wilmington, Delaware	This work was supported by a research contract from AstraZeneca, Inc., Wilmington, Delaware. The funder provided salary support for the academic investigators (JBW, SL, HY, YP, JL, and DTG) to conduct the analysis. HX and MVS, employees of AstraZeneca, provided insights into study design and the preparation of the manuscript, and so are included as coauthors as per ICMJE guidelines, but did not influence the decision to publish, which was solely the domain of the academic authors.	Astor BC, 2002, ARCH INTERN MED, V162, P1401, DOI 10.1001/archinte.162.12.1401; Berns Jeffrey S, 2007, Semin Dial, V20, P277, DOI 10.1111/j.1525-139X.2007.00290.x; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; Bradbury BD, 2008, AM J KIDNEY DIS, V51, P62, DOI 10.1053/j.ajkd.2007.09.015; Bradbury BD, 2009, CLIN J AM SOC NEPHRO, V4, P630, DOI 10.2215/CJN.03580708; Collins AJ, 2001, J AM SOC NEPHROL, V12, P2465, DOI 10.1681/ASN.V12112465; Daza JC, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011122.pub2; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; ESCHBACH JW, 1989, NEW ENGL J MED, V321, P158, DOI 10.1056/NEJM198907203210305; Foley RN, 2014, KIDNEY INT, V86, P392, DOI 10.1038/ki.2014.15; Foley RN, 2009, PEDIATR NEPHROL, V24, P2279, DOI 10.1007/s00467-009-1123-z; Freburger JK, 2012, AM J MED, V125, P906, DOI 10.1016/j.amjmed.2012.03.011; Fuller DS, 2013, AM J KIDNEY DIS, V62, P1213, DOI 10.1053/j.ajkd.2013.09.006; Hahn D, 2014, COCHRANE DB SYST REV, V5; Hsu CY, 2002, J AM SOC NEPHROL, V13, P504, DOI 10.1681/ASN.V132504; Icardi A, 2013, NEPHROL DIAL TRANSPL, V28, P1672, DOI 10.1093/ndt/gft021; Kausz AT, 2005, AM J KIDNEY DIS, V45, P136, DOI 10.1053/j.ajkd.2004.08.042; Levin A, 2007, NEPHROL DIAL TRANSPL, V22, P309, DOI 10.1093/ndt/gfl824; Locatelli F, 2004, NEPHROL DIAL TRANSPL, V19, P121, DOI 10.1093/ndt/gfg458; Ma JZ, 1999, J AM SOC NEPHROL, V10, P610; Miskulin DC, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-264; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Singh AK, 2008, SEMIN DIALYSIS, V21, P1, DOI 10.1111/j.1525-139X.2007.00329.x; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Teehan G, 2011, ANEMIA, V2011, DOI 10.1155/2011/623673; Weiner DE, 2013, AM J KIDNEY DIS, V62, P1217, DOI 10.1053/j.ajkd.2013.10.006; Wilhelm-Leen ER, 2015, AM J KIDNEY DIS, V66, P69, DOI 10.1053/j.ajkd.2014.12.012; Winkelmayer WC, 2010, SEMIN DIALYSIS, V23, P486, DOI 10.1111/j.1525-139X.2010.00768.x; Xue JL, 2002, AM J KIDNEY DIS, V40, P1153, DOI 10.1053/ajkd.2002.36861	29	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2018	13	9							e0203767	10.1371/journal.pone.0203767	http://dx.doi.org/10.1371/journal.pone.0203767			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3NB	30256836	Green Published, Green Submitted, gold			2022-12-26	WOS:000446000200026
J	Kranz, MB; Voss, MW; Cooke, GE; Banducci, SE; Burzynska, AZ; Kramer, AF				Kranz, Michael B.; Voss, Michelle W.; Cooke, Gillian E.; Banducci, Sarah E.; Burzynska, Agnieszka Z.; Kramer, Arthur F.			The cortical structure of functional networks associated with age-related cognitive abilities in older adults	PLOS ONE			English	Article							RESTING-STATE NETWORKS; HUMAN CEREBRAL-CORTEX; SURFACE-AREA; INDIVIDUAL-DIFFERENCES; CARDIORESPIRATORY FITNESS; EXECUTIVE FUNCTIONS; ANTERIOR INSULA; WORKING-MEMORY; DEFAULT MODE; BRAIN	Age and cortical structure are both associated with cognition, but characterizing this relationship remains a challenge. A popular approach is to use functional network organization of the cortex as an organizing principle for post-hoc interpretations of structural results. In the current study, we introduce two complimentary approaches to structural analyses that are guided by a-priori functional network maps. Specifically, we systematically investigated the relationship of cortical structure (thickness and surface area) of distinct functional networks to two cognitive domains sensitive to age-related decline thought to rely on both common and distinct processes (executive function and episodic memory) in older adults. We quantified the cortical structure of individual functional network's predictive ability and spatial extent (i.e., number of significant regions) with cognition and its mediating role in the age cognition relationship. We found that cortical thickness, rather than surface area, predicted cognition across the majority of functional networks. The default mode and somatomotor network emerged as particularly important as they appeared to be the only two networks to mediate the age-cognition relationship for both cognitive domains. In contrast, thickness of the salience network predicted executive function and mediated the age-cognition relationship for executive function. These relationships remained significant even after accounting for global cortical thickness. Quantifying the number of regions related to cognition and mediating the age-cognition relationship yielded similar patterns of results. This study provides a potential approach to organize and describe the apparent widespread regional cortical structural relationships with cognition and age in older adults.	[Kranz, Michael B.; Banducci, Sarah E.; Kramer, Arthur F.] Univ Illinois, Dept Psychol, Urbana, IL 61801 USA; [Kranz, Michael B.; Cooke, Gillian E.; Banducci, Sarah E.; Kramer, Arthur F.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Voss, Michelle W.] Univ Iowa, Dept Psychol & Brain Sci, Iowa City, IA USA; [Burzynska, Agnieszka Z.] Colorado State Univ, Dept Human Dev & Family Studies, Mol Cellular & Integrat Neurosci, Ft Collins, CO 80523 USA; [Kramer, Arthur F.] Northeastern Univ, Dept Psychol, Boston, MA 02115 USA; [Kramer, Arthur F.] Northeastern Univ, Dept Mech & Ind Engn, Boston, MA 02115 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Iowa; Colorado State University; Northeastern University; Northeastern University	Kranz, MB (corresponding author), Univ Illinois, Dept Psychol, Urbana, IL 61801 USA.; Kranz, MB (corresponding author), Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA.	mbkranz@illinois.edu	Kramer, Arthur/AAB-2937-2019; burzynska, agnieszka/ACX-5166-2022	Kramer, Arthur/0000-0001-5870-2724	National Institute on Aging (NIA) grant [R01 AG036682]	National Institute on Aging (NIA) grant	This work was supported by the National Institute on Aging (NIA) grant (R01 AG036682) awarded to Dr. Arthur Kramer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN PL, 1988, J EXP PSYCHOL GEN, V117, P288, DOI 10.1037/0096-3445.117.3.288; Alexander-Bloch A, 2013, NAT REV NEUROSCI, V14, P322, DOI 10.1038/nrn3465; Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; [Anonymous], 1997, WAIS 3; Bettcher BM, 2016, NEUROPSYCHOLOGIA, V85, P100, DOI 10.1016/j.neuropsychologia.2016.03.001; Betzel RF, 2014, NEUROIMAGE, V102, P345, DOI 10.1016/j.neuroimage.2014.07.067; Boot WR, 2010, ACTA PSYCHOL, V135, P349, DOI 10.1016/j.actpsy.2010.09.005; Braver TS, 2010, CURR OPIN NEUROBIOL, V20, P242, DOI 10.1016/j.conb.2010.03.002; Buckner RL, 2004, NEURON, V44, P195, DOI 10.1016/j.neuron.2004.09.006; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Burzynska AZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120315; Burzynska AZ, 2012, HUM BRAIN MAPP, V33, P1607, DOI 10.1002/hbm.21311; Cabeza R., 2016, COGNITIVE NEUROSCIEN; Chen ZJ, 2008, CEREB CORTEX, V18, P2374, DOI 10.1093/cercor/bhn003; Chen ZJ, 2011, NEUROIMAGE, V56, P235, DOI 10.1016/j.neuroimage.2011.01.010; Choi YY, 2008, J NEUROSCI, V28, P10323, DOI 10.1523/JNEUROSCI.3259-08.2008; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Colcombe SJ, 2005, PSYCHOL AGING, V20, P363, DOI 10.1037/0882-7974.20.3.363; Colcombe SJ, 2006, J GERONTOL A-BIOL, V61, P1166, DOI 10.1093/gerona/61.11.1166; Cole MW, 2013, NAT NEUROSCI, V16, P1348, DOI 10.1038/nn.3470; Colom R, 2013, NEUROIMAGE, V72, P143, DOI 10.1016/j.neuroimage.2013.01.032; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Delis D, 1997, CALIFORNIA VERBAL LE; Dickerson BC, 2009, NEUROBIOL AGING, V30, P432, DOI 10.1016/j.neurobiolaging.2007.07.022; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Duncan J, 2000, SCIENCE, V289, P457, DOI 10.1126/science.289.5478.457; Efron B., 1994, INTRO BOOTSTRAP; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Ferreira LK, 2016, CEREB CORTEX, V26, P3851, DOI 10.1093/cercor/bhv190; Finn ES, 2015, NAT NEUROSCI, V18, P1664, DOI 10.1038/nn.4135; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fjell AM, 2015, P NATL ACAD SCI USA, V112, P15462, DOI 10.1073/pnas.1508831112; Fjell AM, 2015, CEREB CORTEX, V25, P26, DOI 10.1093/cercor/bht201; Fjell AM, 2013, J NEUROSCI, V33, P8237, DOI 10.1523/JNEUROSCI.5506-12.2013; Freeman SH, 2008, J NEUROPATH EXP NEUR, V67, P1205, DOI 10.1097/NEN.0b013e31818fc72f; Friedman NP, 2017, CORTEX, V86, P186, DOI 10.1016/j.cortex.2016.04.023; Garrett DD, 2015, P NATL ACAD SCI USA; Geerligs L, 2014, NEUROIMAGE, V91, P52, DOI 10.1016/j.neuroimage.2014.01.029; Greenwood PM, 2005, NEUROPSYCHOLOGY, V19, P199, DOI 10.1037/0894-4105.19.2.199; Gunning-Dixon FM, 2003, NEUROPSYCHOLOGIA, V41, P1929, DOI 10.1016/S0028-3932(03)00129-5; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Head D, 2008, NEUROPSYCHOLOGY, V22, P491, DOI 10.1037/0894-4105.22.4.491; Hedden T, 2004, NAT REV NEUROSCI, V5, P87, DOI 10.1038/nrn1323; Hedden T, 2016, CEREB CORTEX, V26, P1388, DOI 10.1093/cercor/bhu238; Hogstrom LJ, 2013, CEREB CORTEX, V23, P2521, DOI 10.1093/cercor/bhs231; HORN JL, 1966, J EDUC PSYCHOL, V57, P253, DOI 10.1037/h0023816; Hosseini SMH, 2013, NEUROIMAGE, V78, P402, DOI 10.1016/j.neuroimage.2013.04.032; Kane MJ, 2007, J EXP PSYCHOL LEARN, V33, P615, DOI 10.1037/0278-7393.33.3.615; Kirchhoff BA, 2014, NEUROIMAGE, V90, P326, DOI 10.1016/j.neuroimage.2013.12.052; KIRCHNER WK, 1958, J EXP PSYCHOL, V55, P352, DOI 10.1037/h0043688; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; KRAMER AF, 1994, PSYCHOL AGING, V9, P491, DOI 10.1037/0882-7974.9.4.491; Kramer AF, 2001, ADV PSYCHOL, V133, P293; McGinnis SM, 2011, BRAIN TOPOGR, V24, P279, DOI 10.1007/s10548-011-0198-6; Mckinney W., 2010, P PYTH SCI C, P51, DOI DOI 10.25080/MAJORA-92BF1922-00A; Monti JM, 2015, J COGNITIVE NEUROSCI, V27, P234, DOI 10.1162/jocn_a_00717; Nelson SM, 2010, BRAIN STRUCT FUNCT, V214, P669, DOI 10.1007/s00429-010-0260-2; Onoda K, 2012, J COGNITIVE NEUROSCI, V24, P2186, DOI 10.1162/jocn_a_00269; Park H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171803; Power JD, 2013, NEURON, V79, P798, DOI 10.1016/j.neuron.2013.07.035; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Razlighi QR, 2017, CEREB CORTEX, V27, P3586, DOI 10.1093/cercor/bhw179; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Reiter K, 2015, J INT NEUROPSYCH SOC, V21, P757, DOI 10.1017/S135561771500079X; Rosenberg MD, 2016, NAT NEUROSCI, V19, P165, DOI 10.1038/nn.4179; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Salthouse TA, 2005, NEUROPSYCHOLOGY, V19, P532, DOI 10.1037/0894-4105.19.4.532; Salthouse TA, 2004, INTELLIGENCE, V32, P541, DOI 10.1016/j.intell.2004.07.003; Salthouse TA, 2003, J EXP PSYCHOL GEN, V132, P566, DOI 10.1037/0096-3445.132.4.566; Salthouse TA, 2015, NEUROBIOL AGING, V36, P3020, DOI 10.1016/j.neurobiolaging.2015.08.011; Salthouse TA, 2011, PSYCHOL BULL, V137, P753, DOI 10.1037/a0023262; Sanabria-Diaz G, 2010, NEUROIMAGE, V50, P1497, DOI 10.1016/j.neuroimage.2010.01.028; Schnack HG, 2015, CEREB CORTEX, V25, P1608, DOI 10.1093/cercor/bht357; Schultz AP, 2017, J NEUROSCI, V37, P4323, DOI 10.1523/JNEUROSCI.3263-16.2017; Shapira-Lichter I, 2013, P NATL ACAD SCI USA, V110, P4950, DOI 10.1073/pnas.1209888110; Shen XL, 2017, NAT PROTOC, V12, P506, DOI 10.1038/nprot.2016.178; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Sowell ER, 2007, CEREB CORTEX, V17, P1550, DOI 10.1093/cercor/bhl066; Sporns O, 2016, ANNU REV PSYCHOL, V67, P613, DOI 10.1146/annurev-psych-122414-033634; Storsve AB, 2014, J NEUROSCI, V34, P8488, DOI 10.1523/JNEUROSCI.0391-14.2014; Sun FW, 2016, J NEUROSCI, V36, P9659, DOI 10.1523/JNEUROSCI.1492-16.2016; Touroutoglou A, 2012, NEUROIMAGE, V60, P1947, DOI 10.1016/j.neuroimage.2012.02.012; Van Petten C, 2004, NEUROPSYCHOLOGIA, V42, P1313, DOI 10.1016/j.neuropsychologia.2004.02.009; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; Voss MW, 2016, NEUROIMAGE, V131, P113, DOI 10.1016/j.neuroimage.2015.10.044; Voss MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078345; Voss MW, 2010, NEUROPSYCHOLOGIA, V48, P1394, DOI 10.1016/j.neuropsychologia.2010.01.005; Vuoksimaa E, 2015, CEREB CORTEX, V25, P2127, DOI 10.1093/cercor/bhu018; Walhovd KB, 2016, P NATL ACAD SCI USA, V113, P9357, DOI 10.1073/pnas.1524259113; Watson PD, 2013, HIPPOCAMPUS, V23, P570, DOI 10.1002/hipo.22115; Westlye LT, 2011, CEREB CORTEX, V21, P345, DOI 10.1093/cercor/bhq101; White T, 2010, BRAIN COGNITION, V72, P36, DOI 10.1016/j.bandc.2009.10.009; Williams VJ, 2017, NEUROIMAGE, V146, P1084, DOI 10.1016/j.neuroimage.2016.10.033; Winkler AM, 2012, NEUROIMAGE, V61, P1428, DOI 10.1016/j.neuroimage.2012.03.026; Wood KN, 2016, FRONT AGING NEUROSCI, V8, DOI [10.3389/fnacji.2016.00155, 10.3389/fnagi.2016.00155]; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011	99	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2018	13	9							e0204280	10.1371/journal.pone.0204280	http://dx.doi.org/10.1371/journal.pone.0204280			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GU5MM	30240409	Green Published, Green Submitted, gold			2022-12-26	WOS:000445329700037
J	Plytycz, B; Bigaj, J; Panz, T; Grzmil, P				Plytycz, Barbara; Bigaj, Janusz; Panz, Tomasz; Grzmil, Pawel			Asymmetrical hybridization and gene flow between Eisenia andrei and E. fetida lumbricid earthworms	PLOS ONE			English	Article							FLUORESCENCE; REGENERATION; FOETIDA; DNA; CELOMOCYTES; OLIGOCHAETA; CADMIUM; AGENTS	Uniformly pigmented Eisenia andrei (Ea) and striped E. fetida (Ef) lumbricid earthworms are hermaphrodites capable of self-fertilization, cross-fertilization, and asymmetrical hybridization. The latter was detected by genotyping of F1 and F2 progeny of the controlled Ea+Ef pairs by species-specific sequences of maternal mitochondrial COI genes and maternal/paternal nuclear S28 rRNA genes. Among F1 offspring there were self-fertilized Ea (aAA), Ef (fFF), and cross-fertilized fertile Ea-derived hybrids (aAF); the latter mated with Ea and gave new generation of Ea and hybrids, while mated with Ef gave Ea, Ef, Ea-derived hybrids and sterile Ef-derived hybrids (fFA). Coelomic fluid of Ea exhibits unique fluorescence spectra called here the M-fluorescence considered as a molecular biomarker of this species. Since similar fluorescence was detected also in some Ef (hypothetical hybrids?), the aim of present investigations was to identify the M-positive earthworms among families genotyped previously. It was assumed that factor/s responsible for metabolic pathways leading to production of undefined yet M-fluorophore might be encoded/controlled by alleles of hypothetical nuclear gene of Eisenia sp. segregating independently from species-specific S28 rRNA nuclear genes, where 'MM' or 'Mm' alleles determine M-positivity while 'mm' alleles determine M-negative phenotypes. Spectra of M-fluorescence were detected in all 10 Ea (aAAMM) and 19 Ea-derived hybrids (aAFMm), three of four Ef-derived hybrids (fFAMm) and one 'atypical' Ef (fFFMm) among 13 Ef earthworms. Among progeny of 'atypical' M-positive Ef (fFFMm) reappeared 'typical' M-negative Ef (fFFmm), confirming such hypothesis. Alternatively, the M-fluorescence might be dependent on unknown gene products of vertically-transmitted Ea-specific symbiotic bacteria sexually transferred to the Ef partner. Hypotheses of intrinsic and external origin of M-fluorescence might complement each other. The presence/absence of M-fluorophore does not correspond with body pigmentation patterns; Ef-characteristic banding appeared in posterior parts of hybrids body. In conclusion, Ea/Ef hybridization may serve for further studies on bi-directional gene flow.	[Plytycz, Barbara; Bigaj, Janusz] Jagiellonian Univ, Inst Zool & Biomed Res, Dept Evolutionary Immunol, Krakow, Poland; [Panz, Tomasz] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Grzmil, Pawel] Jagiellonian Univ, Inst Zool & Biomed Res, Dept Genet & Evolut, Krakow, Poland	Jagiellonian University; Jagiellonian University; Jagiellonian University	Plytycz, B (corresponding author), Jagiellonian Univ, Inst Zool & Biomed Res, Dept Evolutionary Immunol, Krakow, Poland.	Barbara.plytycz@uj.edu.pl	Panz, Tomasz/AAN-4799-2021	Plytycz, Barbara/0000-0002-3869-500X; Panz, Tomasz/0000-0002-1800-7863; Grzmil, Pawel/0000-0001-9780-2007	National Science Centre, POLAND [2016/23/B/NZ8/00748]; Ministry of Science and Higher Education POLAND [K/ZDS/005405]	National Science Centre, POLAND(National Science Centre, Poland); Ministry of Science and Higher Education POLAND(Ministry of Science and Higher Education, Poland)	Investigations are financially supported by the National Science Centre, POLAND (2016/23/B/NZ8/00748) and Ministry of Science and Higher Education POLAND (K/ZDS/005405). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript".	Albani JR, 2003, PHOTOCHEM PHOTOBIOL, V78, P599, DOI 10.1562/0031-8655(2003)078<0599:FFOEFA>2.0.CO;2; Bundy JG, 2002, FEBS LETT, V521, P115, DOI 10.1016/S0014-5793(02)02854-5; Davidson SK, 2013, MOL PHYLOGENET EVOL, V67, P188, DOI 10.1016/j.ympev.2012.12.005; Davidson SK, 2010, ENVIRON MICROBIOL, V12, P2277, DOI 10.1111/j.1462-2920.2010.02231.x; Cosin DJD, 2011, SOIL BIOL, V24, P69, DOI 10.1007/978-3-642-14636-7_5; Dominguez J, 2005, PEDOBIOLOGIA, V49, P81, DOI 10.1016/j.pedobi.2004.08.005; Dominguez J, 2003, PEDOBIOLOGIA, V47, P530, DOI 10.1078/0031-4056-00224; Elvira C, 1996, PEDOBIOLOGIA, V40, P377; Hadjmohamadi MR, 2008, SPECTROCHIM ACTA A, V70, P358, DOI 10.1016/j.saa.2007.10.029; Hoekstra LA, 2013, GENETICS, V195, P1129, DOI 10.1534/genetics.113.154914; Hu XL, 2018, CURR TOP MED CHEM, V18, P114, DOI 10.2174/1568026618666171215101158; Hu XL, 2017, CURR TOP MED CHEM, V17, P3219, DOI 10.2174/1568026618666171215100326; Keni RS, 2015, EUR J MED CHEM, V100, P257, DOI 10.1016/j.ejmech.2015.06.017; Kjeldsen KU, 2012, GENOME BIOL EVOL, V4, P307, DOI 10.1093/gbe/evs014; Lund MB, 2010, ENVIRON MICROBIOL, V12, P2142, DOI 10.1111/j.1462-2920.2009.02084.x; Luo S-M, 2013, J GENET GENOMICS, V30, P539; Ma H, 2016, CELL METAB, V24, P283, DOI 10.1016/j.cmet.2016.06.012; Noh SJ, 2011, PHARMACOL BIOCHEM BE, V100, P73, DOI 10.1016/j.pbb.2011.07.018; Noh SJ, 2011, PHARMACOL BIOCHEM BE, V98, P150, DOI 10.1016/j.pbb.2010.12.014; Otomo PV, 2009, B ENVIRON CONTAM TOX, V82, P261, DOI 10.1007/s00128-008-9585-4; Perez-Losada M, 2005, PEDOBIOLOGIA, V49, P317, DOI 10.1016/j.pedobi.2005.02.004; Plytycz B, 2016, ISJ-INVERT SURVIV J, V13, P315; Plytycz B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191711; REINECKE AJ, 1991, BIOL FERT SOILS, V11, P295, DOI 10.1007/BF00335851; Rochfort S, 2017, EUR J SOIL BIOL, V78, P17, DOI 10.1016/j.ejsobi.2016.11.008; Rombke J, 2016, APPL SOIL ECOL, V104, P3, DOI 10.1016/j.apsoil.2015.02.010; Rorat A, 2017, COMP BIOCHEM PHYS C, V203, P39, DOI 10.1016/j.cbpc.2017.10.002; Rorat A, 2014, J EXP ZOOL PART A, V321, P28, DOI 10.1002/jez.1834; Santocki M, 2016, FOLIA BIOL-KRAKOW, V64, P121, DOI 10.3409/fb64_2.121; Santocki M, 2016, APPL SOIL ECOL, V104, P163, DOI 10.1016/j.apsoil.2015.08.022; Sato M, 2013, BBA-MOL CELL RES, V1833, P1979, DOI 10.1016/j.bbamcr.2013.03.010; SHEPPARD P S, 1988, P83; Swiderska B, 2017, DEV COMP IMMUNOL, V67, P404, DOI 10.1016/j.dci.2016.08.011; Takacs V, 2016, FOLIA BIOL-KRAKOW, V64, P275, DOI 10.3409/fb64_4.275; Thacker SM, 2008, J THROMB HAEMOST, V6, P1445, DOI 10.1111/j.1538-7836.2008.03074.x; Thakur A, 2015, EUR J MED CHEM, V101, P476, DOI 10.1016/j.ejmech.2015.07.010; Viana F, 2018, FEMS MICROBIOL ECOL, V94, DOI 10.1093/femsec/fix178; Zhang CY, 2017, DEVELOPMENT, V144, P2490, DOI 10.1242/dev.151951	38	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2018	13	9							e0204469	10.1371/journal.pone.0204469	http://dx.doi.org/10.1371/journal.pone.0204469			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU5MM	30240427	gold, Green Published, Green Submitted			2022-12-26	WOS:000445329700053
J	Sturrock, HJW; Woolheater, K; Bennett, AF; Andrade-Pacheco, R; Midekisa, A				Sturrock, Hugh J. W.; Woolheater, Katelyn; Bennett, Adam F.; Andrade-Pacheco, Ricardo; Midekisa, Alemayehu			Predicting residential structures from open source remotely enumerated data using machine learning	PLOS ONE			English	Article							BUILDING TYPE; CLASSIFICATION; ENSEMBLE	Having accurate maps depicting the locations of residential buildings across a region benefits a range of sectors. This is particularly true for public health programs focused on delivering services at the household level, such as indoor residual spraying with insecticide to help prevent malaria. While open source data from OpenStreetMap (OSM) depicting the locations and shapes of buildings is rapidly improving in terms of quality and completeness globally, even in settings where all buildings have been mapped, information on whether these buildings are residential, commercial or another type is often only available for a small subset. Using OSM building data from Botswana and Swaziland, we identified buildings for which 'type' was indicated, generated via on the ground observations, and classified these into two classes, "sprayable" and "not-sprayable". Ensemble machine learning, using building characteristics such as size, shape and proximity to neighbouring features, was then used to form a model to predict which of these 2 classes every building in these two countries fell into. Results show that an ensemble machine learning approach performed marginally, but statistically, better than the best individual model and that using this ensemble model we were able to correctly classify >86% (using independent test data) of structures correctly as sprayable and not-sprayable across both countries.	[Sturrock, Hugh J. W.; Bennett, Adam F.; Andrade-Pacheco, Ricardo; Midekisa, Alemayehu] Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94143 USA; [Woolheater, Katelyn] Clinton Hlth Access Initiat, Boston, MA USA	University of California System; University of California San Francisco	Sturrock, HJW (corresponding author), Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94143 USA.	hugh.sturrock@ucsf.edu		Sturrock, Hugh/0000-0002-0029-3101; Midekisa, Alemayehu/0000-0003-2558-6952	Bill and Melinda Gates Foundation [OPP1132900, OPP1089413, OPP1116450, OPP1158299]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was funded by grants from the Bill and Melinda Gates Foundation, Numbers OPP1132900, OPP1089413, OPP1116450 and OPP1158299 (https://www.gatesfoundation.org) to HJWS, KW, AFB, RAP and AM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; HJWS, KW, AFB, RAP and AM are funded by grants from the Bill and Melinda Gates Foundation (Numbers OPP1132900, OPP1089413, OPP1116450 and OPP1158299).	Arbib MA., 2003, HDB BRAIN THEORY NEU; Arnold BF, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005616; Awrangjeb M, 2010, ISPRS J PHOTOGRAMM, V65, P457, DOI 10.1016/j.isprsjprs.2010.06.001; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cho SB, 2007, APPL INTELL, V26, P243, DOI 10.1007/s10489-006-0020-4; Davies MM, 2016, INT J BIOSTAT, V12, P179, DOI 10.1515/ijb-2014-0060; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; Hastie T., 1986, STAT SCI, V1, P297; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Jin XY, 2005, EURASIP J APPL SIG P, V2005, P2196, DOI 10.1155/ASP.2005.2196; Kamanga A, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0831-z; Koc-San D, 2014, J APPL REMOTE SENS, V8, DOI 10.1117/1.JRS.8.083694; Lu ZY, 2014, LANDSCAPE URBAN PLAN, V130, P134, DOI 10.1016/j.landurbplan.2014.07.005; Meir R, 1995, ADV NEURAL INFORM PR; Midekisa A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184926; Pinchoff J, 2016, MALARIA J, V15, DOI 10.1186/s12936-015-1073-9; Polikar R, 2012, ENSEMBLE MACHINE LEARNING: METHODS AND APPLICATIONS, P1, DOI 10.1007/978-1-4419-9326-7_1; Todorovski L, 2003, MACH LEARN, V50, P223, DOI 10.1023/A:1021709817809; Van der Laan M., 2007, STAT APPL GENETICS M, V6; WOLPERT DH, 1992, NEURAL NETWORKS, V5, P241, DOI 10.1016/S0893-6080(05)80023-1; Xie JF, 2017, IEEE J-STARS, V10, P3515, DOI 10.1109/JSTARS.2017.2686422; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	25	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2018	13	9							e0204399	10.1371/journal.pone.0204399	http://dx.doi.org/10.1371/journal.pone.0204399			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU5MM	30240429	Green Published, gold, Green Submitted			2022-12-26	WOS:000445329700046
J	Huang, X; Wang, XN; Yuan, XD; Wu, WY; Lobie, PE; Wu, ZS				Huang, Xing; Wang, Xiao-nan; Yuan, Xiao-dong; Wu, Wen-yong; Lobie, Peter E.; Wu, Zhengsheng			XIAP facilitates breast and colon carcinoma growth via promotion of p62 depletion through ubiquitination-dependent proteasomal degradation	ONCOGENE			English	Article							APOPTOSIS PROTEINS; SIGNALING ADAPTER; AUTOPHAGY; CANCER; INHIBITOR; TUMORIGENESIS; BECLIN-1	X-linked inhibitor of apoptosis protein (XIAP) possesses a critical role in promotion of cell survival and maintenance of cellular homeostasis. In cancer, elevated XIAP expression has been associated with malignancy, poor prognosis, and treatment resistance. However, the underlying mechanisms of these effects remain unclear. XIAP has previously been proposed to promote tumor growth through suppression of autophagy. In this study, we examined the expression of XIAP and p62, two critical mediators of autophagy, in breast and colon cancer. We observed a negative correlation between XIAP and p62 expression in normal and cancer tissues of breast and colon, and that the ratio of XIAP and p62 expression determines the cancer phenotype. In vitro, we observed that XIAP interacted with p62 and also that XIAP depletion resulted in increased expression of p62. XIAP functioned as an ubiquitination E3 ligase towards p62 and suppressed p62 expression through ubiquitin-proteasomal degradation. Furthermore, XIAP enhanced cancer cell proliferation, viability, and colony formation in vitro via suppression of p62. In addition, we demonstrated that XIAP-enhanced tumor growth is dependent on depletion of p62 in vivo. Herein, we have therefore delineated a novel mechanism by which XIAP contributes to development and progression of breast and colon carcinoma.	[Huang, Xing] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Key Lab Precis Diag & Treatment Hepatobiliary & P, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Xiao-nan; Yuan, Xiao-dong; Wu, Zhengsheng] Anhui Med Univ, Dept Pathol, Hefei 230032, Anhui, Peoples R China; [Huang, Xing] Southeast Univ, Inst Life Sci, Key Lab Dev Genes & Human Dis, Nanjing 210096, Jiangsu, Peoples R China; [Wu, Wen-yong] Anhui Med Univ, Dept Gen Surg, Affiliated Hosp 1, Hefei 230032, Anhui, Peoples R China; [Lobie, Peter E.] Tsinghua Univ, Tsinghua Berkeley Shenzhen Inst, Shenzhen, Guangdong, Peoples R China	Zhejiang University; Anhui Medical University; Southeast University - China; Anhui Medical University; Tsinghua University	Huang, X (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Key Lab Precis Diag & Treatment Hepatobiliary & P, Hangzhou 310003, Zhejiang, Peoples R China.; Wu, ZS (corresponding author), Anhui Med Univ, Dept Pathol, Hefei 230032, Anhui, Peoples R China.; Huang, X (corresponding author), Southeast Univ, Inst Life Sci, Key Lab Dev Genes & Human Dis, Nanjing 210096, Jiangsu, Peoples R China.	dr.huangxing@foxmail.com; woozson@yahoo.com	黄, 星/AAB-2241-2019	黄, 星/0000-0002-8886-2777; Wu, Zhengsheng/0000-0002-6616-2745	National Natural Science Foundation of China [81502975, 81472493, 81572305]; China Postdoctoral Science Foundation [2016T90413, 2015M581693]; Jiangsu Planned Projects for Postdoctoral Research Funds [1501002A]; Fundamental Research Funds for the Central Universities [2242016R20027, 2242016K41045]; Anhui provincial academic and technical leader reserve candidate [2016H074]; Key Program of Outstanding Young Talents in Higher Education Institutions of Anhui [gxyqZD2016046]; Shenzhen Development and Reform Commission Subject Construction Project [[2017]1434]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Jiangsu Planned Projects for Postdoctoral Research Funds; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Anhui provincial academic and technical leader reserve candidate; Key Program of Outstanding Young Talents in Higher Education Institutions of Anhui; Shenzhen Development and Reform Commission Subject Construction Project	We deeply thank Dr. Bert Vogelstein (Johns Hopkins University) for XIAP<SUP>-/-</SUP> HCT116 and XIAP<SUP>-/-</SUP> DLD1 cell lines, Dr. Noboru Mizushima (The University of Tokyo) for Atg5<SUP>-/-</SUP> MEF cell lines, and Dr. Tao Zhu (University of Science & Technology of China) for breast cell lines. Especially, the author Xing Huang would like to express deepest thanks to Dr. Mian Wu (University of Science & Technology of China) for the technological training and ideological inspiration in his lab. This work was supported by grants from National Natural Science Foundation of China (81502975, 81472493, and 81572305), and China Postdoctoral Science Foundation (2016T90413 and 2015M581693). The research was funded in part by Jiangsu Planned Projects for Postdoctoral Research Funds (1501002A), Fundamental Research Funds for the Central Universities (2242016R20027 and 2242016K41045), Anhui provincial academic and technical leader reserve candidate (#2016H074), Key Program of Outstanding Young Talents in Higher Education Institutions of Anhui (#gxyqZD2016046) and the Shenzhen Development and Reform Commission Subject Construction Project ([2017]1434).	Amin MB, 2017, CA-CANCER J CLIN, V67, P93, DOI 10.3322/caac.21388; Duran A, 2008, CANCER CELL, V13, P343, DOI 10.1016/j.ccr.2008.02.001; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; Eskelinen EL, 2009, BBA-MOL CELL RES, V1793, P664, DOI 10.1016/j.bbamcr.2008.07.014; Fulda S, 2014, CLIN CANCER RES, V20, P289, DOI 10.1158/1078-0432.CCR-13-0227; Gao C, 2010, NAT CELL BIOL, V12, P781, DOI 10.1038/ncb2082; Holcik M, 2001, APOPTOSIS, V6, P253, DOI 10.1023/A:1011379307472; Holcik M, 2001, NAT REV MOL CELL BIO, V2, P550, DOI 10.1038/35080103; Huang X, 2013, EMBO J, V32, P2204, DOI 10.1038/emboj.2013.133; Hung TH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012202; Hunter AM, 2007, APOPTOSIS, V12, P1543, DOI 10.1007/s10495-007-0087-3; Ichimura Y, 2010, SEMIN IMMUNOPATHOL, V32, P431, DOI 10.1007/s00281-010-0220-1; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Komatsu M, 2011, AUTOPHAGY, V7, P1088, DOI 10.4161/auto.7.9.16474; Kong DK, 2010, MOL BIOL CELL, V21, P1335, DOI 10.1091/mbc.E09-09-0818; LaCasse EC, 2008, ONCOGENE, V27, P6252, DOI 10.1038/onc.2008.302; Lee HM, 2011, J IMMUNOL, V186, P1248, DOI 10.4049/jimmunol.1001954; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Linares JF, 2011, MOL CELL BIOL, V31, P105, DOI 10.1128/MCB.00620-10; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Merlo P, 2013, EMBO J, V32, P2187, DOI 10.1038/emboj.2013.152; Morselli E, 2009, BBA-MOL CELL RES, V1793, P1524, DOI 10.1016/j.bbamcr.2009.01.006; Moscat J, 2016, CELL, V167, P606, DOI 10.1016/j.cell.2016.09.030; Moscat J, 2012, TRENDS BIOCHEM SCI, V37, P230, DOI 10.1016/j.tibs.2012.02.008; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Pandey V, 2010, ENDOCRINOLOGY, V151, P909, DOI 10.1210/en.2009-0979; Puissant A, 2012, AM J CANCER RES, V2, P397; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Rosenfeldt MT, 2011, CARCINOGENESIS, V32, P955, DOI 10.1093/carcin/bgr031; Schlafli AM, 2015, EUR J HISTOCHEM, V59, P137, DOI 10.4081/ejh.2015.2481; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Wu WY, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0108-3	32	21	22	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 28	2019	38	9					1448	1460		10.1038/s41388-018-0513-8	http://dx.doi.org/10.1038/s41388-018-0513-8			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HN1KL	30275562				2022-12-26	WOS:000459945800006
J	Zhu, ZQ; Chung, YM; Sergeeva, O; Kepe, V; Berk, M; Li, JN; Ko, HK; Li, ZF; Petro, M; DiFilippo, FP; Lee, Z; Sharifi, N				Zhu, Ziqi; Chung, Yoon-Mi; Sergeeva, Olga; Kepe, Vladimir; Berk, Michael; Li, Jianneng; Ko, Hyun-Kyung; Li, Zhenfei; Petro, Marianne; DiFilippo, Frank P.; Lee, Zhenghong; Sharifi, Nima			Loss of dihydrotestosterone-inactivation activity promotes prostate cancer castration resistance detectable by functional imaging	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						steroid; steroid hormone receptor; steroidogenesis; metabolism; metabolic regulation; androgen; uridine 5'-diphospho-glucuronosyltransferase (UDP-glucuronosyltransferase); castration-resistant prostate cancer; nuclear medicine; PET; prostate cancer	ANDROGEN RECEPTOR; UDP-GLUCURONOSYLTRANSFERASES; TESTOSTERONE; GLUCURONIDATION; PROGRESSION; ABIRATERONE; METASTASIS; EXPRESSION	Androgens such as testosterone and dihydrotestosterone are a critical driver of prostate cancer progression. Cancer resistance to androgen deprivation therapies ensues when tumors engage metabolic processes that produce sustained androgen levels in the tissue. However, the molecular mechanisms involved in this resistance process are unclear, and functional imaging modalities that predict impending resistance are lacking. Here, using the human LNCaP and C4-2 cell line models of prostate cancer, we show that castration treatment-sensitive prostate cancer cells that normally have an intact glucuronidation pathway that rapidly conjugates and inactivates dihydrotestosterone and thereby limits androgen signaling, become glucuronidation deficient and resistant to androgen deprivation. Mechanistically, using CRISPR/Cas9-mediated gene ablation, we found that loss of UDP glucuronosyltransferase family 2 member B15 (UGT2B15) and UGT2B17 is sufficient to restore free dihydrotestosterone, sustained androgen signaling, and development of castration resistance. Furthermore, loss of glucuronidation enzymatic activity was also detectable with a nonsteroid glucuronidation substrate. Of note, glucuronidation-incompetent cells and the resultant loss of intracellular conjugated dihydrotestosterone were detectable in vivo by F-18-dihydrotestosterone PET. Together, these findings couple a mechanism with a functional imaging modality to identify impending castration resistance in prostate cancers.	[Zhu, Ziqi; Chung, Yoon-Mi; Berk, Michael; Li, Jianneng; Ko, Hyun-Kyung; Li, Zhenfei; Petro, Marianne; Sharifi, Nima] Cleveland Clin, Genitourinary Malignancies Res Ctr, Dept Canc Biol, Lerner Res Inst, Cleveland, OH 44195 USA; [Kepe, Vladimir; DiFilippo, Frank P.] Cleveland Clin, Dept Nucl Med, Imaging Inst, Cleveland, OH 44195 USA; [Sharifi, Nima] Cleveland Clin, Dept Urol, Glickman Urol & Kidney Inst, Cleveland, OH 44195 USA; [Sharifi, Nima] Cleveland Clin, Taussig Canc Inst, Dept Hematol & Oncol, Cleveland, OH 44195 USA; [Sergeeva, Olga; Lee, Zhenghong] Case Western Reserve Univ, Dept Radiol, Cleveland, OH 44124 USA; [Lee, Zhenghong] Case Western Reserve Univ, Biomed Engn, Cleveland, OH 44124 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Case Western Reserve University	Sharifi, N (corresponding author), Cleveland Clin, Genitourinary Malignancies Res Ctr, Dept Canc Biol, Lerner Res Inst, Cleveland, OH 44195 USA.; Sharifi, N (corresponding author), Cleveland Clin, Dept Urol, Glickman Urol & Kidney Inst, Cleveland, OH 44195 USA.; Sharifi, N (corresponding author), Cleveland Clin, Taussig Canc Inst, Dept Hematol & Oncol, Cleveland, OH 44195 USA.	sharifn@ccf.org	Sergeeva, Olga/AAE-1869-2019; Zhu, Ziqi/B-5063-2014; Berk, Michael/M-7891-2013	Zhu, Ziqi/0000-0001-8066-2052; Berk, Michael/0000-0002-5554-6946; Li, Zhenfei/0000-0001-6520-431X	Howard Hughes Medical Institute Physician-Scientist Early Career Award; Prostate Cancer Foundation Challenge Award; National Institutes of Health NCI [R01CA168899, R01CA172382, R01CA190289]; NCI [5R01CA204373]; Congressionally Directed Medical Research Programs, Prostate Cancer Research Program Award [PC141550]; NATIONAL CANCER INSTITUTE [R01CA190289, R01CA168899, R01CA172382, R01CA204373] Funding Source: NIH RePORTER	Howard Hughes Medical Institute Physician-Scientist Early Career Award(Howard Hughes Medical Institute); Prostate Cancer Foundation Challenge Award; National Institutes of Health NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Congressionally Directed Medical Research Programs, Prostate Cancer Research Program Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Howard Hughes Medical Institute Physician-Scientist Early Career Award and a Prostate Cancer Foundation Challenge Award (to N. S.), National Institutes of Health NCI Grants R01CA168899, R01CA172382, and R01CA190289 (to N. S.), NCI Grant 5R01CA204373 (to Z. L.), and Congressionally Directed Medical Research Programs, Prostate Cancer Research Program Award PC141550 (to Z. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Asim M, 2008, ONCOGENE, V27, P3596, DOI 10.1038/sj.onc.1211016; Attard G, 2016, LANCET, V387, P70, DOI 10.1016/S0140-6736(14)61947-4; Bao BY, 2008, PROSTATE, V68, P839, DOI 10.1002/pros.20749; Barbier O, 2008, BEST PRACT RES CL EN, V22, P259, DOI 10.1016/j.beem.2008.01.001; Beltran H, 2016, NAT MED, V22, P298, DOI 10.1038/nm.4045; Carreira S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009448; Chang KH, 2013, CELL, V154, P1074, DOI 10.1016/j.cell.2013.07.029; Chang KH, 2011, P NATL ACAD SCI USA, V108, P13728, DOI 10.1073/pnas.1107898108; Dai C, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a030452; Feldman JL, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.4_suppl.56; Fizazi K, 2017, NEW ENGL J MED, V377, P352, DOI 10.1056/NEJMoa1704174; Fraser M, 2017, NATURE, V541, P359, DOI 10.1038/nature20788; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Gillessen S, 2018, EUR UROL, V73, P178, DOI 10.1016/j.eururo.2017.06.002; Harmon SA, 2017, J CLIN ONCOL, V35, P2829, DOI 10.1200/JCO.2017.72.2348; Huggins C, 1941, CANCER RES, V1, P293; James ND, 2017, NEW ENGL J MED, V377, P338, DOI 10.1056/NEJMoa1702900; Krueckl SL, 2004, CANCER RES, V64, P8620, DOI 10.1158/0008-5472.CAN-04-2446; Larson SM, 2004, J NUCL MED, V45, P366; Li JN, 2017, ELIFE, V6, DOI 10.7554/eLife.20183; Li ZF, 2016, NATURE, V533, P547, DOI 10.1038/nature17954; Li ZF, 2015, NATURE, V523, P347, DOI 10.1038/nature14406; LIU AJ, 1992, J MED CHEM, V35, P2113, DOI 10.1021/jm00089a024; Montgomery RB, 2008, CANCER RES, V68, P4447, DOI 10.1158/0008-5472.CAN-08-0249; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Romanel A, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac9511; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sarkar S, 2014, ONCOGENE, V33, P26, DOI 10.1038/onc.2012.561; Sten T, 2009, DRUG METAB DISPOS, V37, P417, DOI 10.1124/dmd.108.024844; TEPHLY TR, 1994, DRUG METAB DISPOS, V22, P713; THALMANN GN, 1994, CANCER RES, V54, P2577; Titus MA, 2005, CLIN CANCER RES, V11, P4653, DOI 10.1158/1078-0432.CCR-05-0525; Turgeon D, 2001, ENDOCRINOLOGY, V142, P778, DOI 10.1210/en.142.2.778; Watson PA, 2015, NAT REV CANCER, V15, P701, DOI 10.1038/nrc4016; Wu JB, 2017, CANCER CELL, V31, P368, DOI 10.1016/j.ccell.2017.02.003	36	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2018	293	46					17829	17837		10.1074/jbc.RA118.004846	http://dx.doi.org/10.1074/jbc.RA118.004846			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HA6SG	30262668	Green Published, hybrid			2022-12-26	WOS:000450409500014
J	Armitage, AD; Lysoe, E; Nellist, CF; Lewis, LA; Cano, LM; Harrison, RJ; Brurberg, MB				Armitage, Andrew D.; Lysoe, Erik; Nellist, Charlotte F.; Lewis, Laura A.; Cano, Liliana M.; Harrison, Richard J.; Brurberg, May B.			Bioinformatic characterisation of the effector repertoire of the strawberry pathogen Phytophthora cactorum	PLOS ONE			English; English	Article							COMBINED TRANSMEMBRANE TOPOLOGY; SIGNAL PEPTIDE PREDICTION; HIDDEN MARKOV MODEL; GENETIC-VARIATION; RXLR EFFECTORS; PARTIAL RESISTANCE; PROTEIN FUNCTION; METHYL-BROMIDE; SILVER BIRCH; WEB SERVER	The oomycete pathogen Phytophthora cactorum causes crown rot, a major disease of cultivated strawberry. We report the draft genome of P. cactorum isolate 10300, isolated from symptomatic Fragaria x ananassa tissue. Our analysis revealed that there are a large number of genes encoding putative secreted effectors in the genome, including nearly 200 RxLR domain containing effectors, 77 Crinklers (CRN) grouped into 38 families, and numerous apoplastic effectors, such as phytotoxins (PcF proteins) and necrosis inducing proteins. As in other Phytophthora species, the genomic environment of many RxLR and CRN genes differed from core eukaryotic genes, a hallmark of the two-speed genome. We found genes homologous to known Phytophthora infestans avirulence genes including Avr1, Avr3b, Avr4, Avrblb1 and AvrSmira2 indicating effector sequence conservation between Phytophthora species of Glade 1a and Glade 1 c. The reported P. cactorum genome sequence and associated annotations represent a comprehensive resource for avirulence gene discovery in other Phytophthora species from Glade 1 and, will facilitate effector informed breeding strategies in other crops.	[Armitage, Andrew D.; Nellist, Charlotte F.; Lewis, Laura A.; Harrison, Richard J.] NIAB EMR, Kent, England; [Lysoe, Erik; Brurberg, May B.] Norwegian Inst Bioecon Res NIBIO, Div Biotechnol & Plant Hlth, As, Norway; [Cano, Liliana M.] Univ Florida, UF IFAS Indian River Res & Educ Ctr, Ft Pierce, FL USA; [Cano, Liliana M.] Sainsbury Lab, Norwich, Norfolk, England; [Brurberg, May B.] Norwegian Univ Life Sci NMBU, Dept Plant Sci, As, Norway	Norwegian Institute of Bioeconomy Research; State University System of Florida; University of Florida; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Norwegian University of Life Sciences	Harrison, RJ (corresponding author), NIAB EMR, Kent, England.	richard.harrison@emr.ac.uk	Brurberg, May Bente/HFI-2864-2022; Lysøe, Erik/AAJ-8894-2020; Cano, Liliana M/O-7041-2016; Harrison, Richard/E-3169-2015	Cano, Liliana M/0000-0002-7996-4181; Lysoe, Erik/0000-0001-5204-2577; Harrison, Richard/0000-0002-3307-3519; Nellist, Charlotte F/0000-0002-7453-3710; Armitage, Andrew/0000-0002-0610-763X	BBSRC [BB/K017071/1, BB/K017071/2]; strategic NIBIO project	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); strategic NIBIO project	AA, CFN, LAL and RJH were funded by BBSRC grant BB/K017071/1 and BB/K017071/2, https://bbsrc.ukri.org/research/grants/grants/AwardDetails.aspx? FundingReference=BB/K017071/1 and https://bbsrc.ukri.org/research/grants/grants/AwardDetails.aspx?FundingReference=BB/K017071/2. MB, EL and sequencing costs were financed by a strategic NIBIO project (basic funding).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amaro TMMM, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00099; Anderson RG, 2015, MOL PLANT MICROBE IN, V28, P1063, DOI 10.1094/MPMI-01-15-0022-CR; Antanaviciute L, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-203; Armstrong MR, 2005, P NATL ACAD SCI USA, V102, P7766, DOI 10.1073/pnas.0500113102; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Bhat RG, 2006, PLANT DIS, V90, P161, DOI 10.1094/PD-90-0161; Bhattacharjee Souvik, 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020050; Blackman LM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-785; Bouwmeester K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001327; Brunner F, 2002, EMBO J, V21, P6681, DOI 10.1093/emboj/cdf667; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Champouret N, 2009, MOL PLANT MICROBE IN, V22, P1535, DOI 10.1094/MPMI-22-12-1535; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Chen XR, 2018, MOL GENET GENOMICS, V293, P541, DOI 10.1007/s00438-017-1400-7; Chen XR, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-980; Chen XR, 2011, CURR GENET, V57, P297, DOI 10.1007/s00294-011-0348-0; Daccord N, 2017, NAT GENET, V49, P1099, DOI 10.1038/ng.3886; Damasceno CMB, 2008, MOL PLANT MICROBE IN, V21, P820, DOI 10.1094/MPMI-21-6-0820; Davik J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137746; De Cal A, 2004, PLANT DIS, V88, P210, DOI 10.1094/PDIS.2004.88.2.210; Denoyes-Rothan B, 2004, ACTA HORTIC, P147, DOI 10.17660/ActaHortic.2004.663.19; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dong SM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005704; Dong SM, 2015, CURR OPIN GENET DEV, V35, P57, DOI 10.1016/j.gde.2015.09.001; Dong SM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002353; Du Y, 2015, PLANT PHYSIOL, V169, P1975, DOI 10.1104/pp.15.01169; Eikemo H, 2010, HORTSCIENCE; Emms DM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0721-2; Erwin DC, 1996, PHYTOPHTHORA DIS WOR; Fankhauser N, 2005, BIOINFORMATICS, V21, P1846, DOI 10.1093/bioinformatics/bti299; Feng BZ, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-126; Fennimore SA, 2008, CALIF AGR, V62, P62, DOI 10.3733/ca.v062n02p62; Franceschetti M, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00066-16, 10.1128/mmbr.00066-16]; Fry WE, 2015, PHYTOPATHOLOGY, V105, P966, DOI 10.1094/PHYTO-01-15-0005-FI; Gijzen M, 2006, PHYTOCHEMISTRY, V67, P1800, DOI 10.1016/j.phytochem.2005.12.008; Gilroy EM, 2011, NEW PHYTOL, V191, P763, DOI 10.1111/j.1469-8137.2011.03736.x; Gottlieb D, 1978, PHYTOPATHOLOGY; Grenville-Briggs LJ, 2017, GENOM DATA, V12, P155, DOI 10.1016/j.gdata.2017.05.010; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Hantula J, 1997, MYCOL RES, V101, P565, DOI 10.1017/S0953756296002900; Hantula J, 2000, MYCOL RES, V104, P1062, DOI 10.1017/S0953756200002999; Hirakawa H, 2014, DNA RES, V21, P169, DOI 10.1093/dnares/dst049; Hoff KJ, 2016, BIOINFORMATICS, V32, P767, DOI 10.1093/bioinformatics/btv661; Huang L, 2018, NUCLEIC ACIDS RES, V46, pD516, DOI 10.1093/nar/gkx894; Jiang RHY, 2008, P NATL ACAD SCI USA, V105, P4874, DOI 10.1073/pnas.0709303105; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Jupe J, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r63; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kamoun S, 2003, EUKARYOT CELL, V2, P191, DOI 10.1128/EC.2.2.191-199.2003; Kamoun S, 1997, MOL PLANT MICROBE IN, V10, P13, DOI 10.1094/MPMI.1997.10.1.13; Kamoun S, 2006, ANNU REV PHYTOPATHOL, V44, P41, DOI 10.1146/annurev.phyto.44.070505.143436; Kamoun S, 2015, MOL PLANT PATHOL, V16, P413, DOI 10.1111/mpp.12190; Kong GH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005139; Kourelis J, 2018, PLANT CELL, V30, P285, DOI 10.1105/tpc.17.00579; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lamour KH, 2012, MOL PLANT MICROBE IN, V25, P1350, DOI 10.1094/MPMI-02-12-0028-R; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lilja A, 1998, EUR J PLANT PATHOL, V104, P529, DOI 10.1023/A:1008644804415; Martin FN, 2014, FUNGAL GENET BIOL, V66, P19, DOI 10.1016/j.fgb.2014.02.006; Nellist C. F., 2018, BIORXIV, DOI [10.1101/249573, DOI 10.1101/249573]; Oh SK, 2009, PLANT CELL, V21, P2928, DOI 10.1105/tpc.109.068247; Orsomando G, 2001, J BIOL CHEM, V276, P21578, DOI 10.1074/jbc.M101377200; Orsomando G, 2011, PROTEIN SCI, V20, P2047, DOI 10.1002/pro.742; Rajput NA, 2015, PLANT CELL PHYSIOL, V56, P2423, DOI 10.1093/pcp/pcv164; Rietman H, 2012, MOL PLANT MICROBE IN, V25, P910, DOI 10.1094/MPMI-01-12-0010-R; Robinson SM, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00797; Shaw DV, 2008, PLANT PATHOL, V57, P210, DOI 10.1111/j.1365-3059.2007.01773.x; Shaw DV, 2006, J AM SOC HORTICULTUR; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Sperisen P, 2005, PLOS COMPUT BIOL, V1, P492, DOI 10.1371/journal.pcbi.0010063; Stam R, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00387; Stam R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059517; Stanke M, 2005, NUCLEIC ACIDS RES, V33, pW465, DOI 10.1093/nar/gki458; Stensvand A., 1999, Bulletin OEPP, V29, P155, DOI 10.1111/j.1365-2338.1999.tb00809.x; Sugimoto T, 2011, BREEDING SCI, V61, P511, DOI 10.1270/jsbbs.61.511; Testa AC, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1344-4; Thines M, 2010, CURR OPIN PLANT BIOL, V13, P427, DOI 10.1016/j.pbi.2010.04.001; Thomas R, 2007, PLANT PHYSIOL, V144, P299, DOI 10.1104/pp.106.091090; Thomidis T, 2003, AUST J EXP AGR, V43, P99, DOI 10.1071/EA01203; Thomidis T, 2001, PHYTOPARASITICA, V29, P47, DOI 10.1007/BF02981813; Tian MY, 2007, PLANT PHYSIOL, V143, P364, DOI 10.1104/pp.106.090050; Tian MY, 2005, PLANT PHYSIOL, V138, P1785, DOI 10.1104/pp.105.061226; Torto TA, 2003, GENOME RES, V13, P1675, DOI 10.1101/gr.910003; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; van Poppel PMJA, 2008, MOL PLANT MICROBE IN, V21, P1460, DOI 10.1094/MPMI-21-11-1460; Vega-Sanchez ME, 2005, PHYSIOL MOL PLANT P, V66, P175, DOI 10.1016/j.pmpp.2005.07.001; Wawra S, 2017, PLANT CELL, V29, P1184, DOI 10.1105/tpc.16.00552; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Win J, 2007, PLANT CELL, V19, P2349, DOI 10.1105/tpc.107.051037; Win J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002400; Winnenburg R, 2006, NUCLEIC ACIDS RES, V34, pD459, DOI 10.1093/nar/gkj047; WOOD SG, 1978, BIOCHEM J, V170, P355, DOI 10.1042/bj1700355; Xu RQ, 2008, J BACTERIOL, V190, P343, DOI 10.1128/JB.00978-07	97	17	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0202305	10.1371/journal.pone.0202305	http://dx.doi.org/10.1371/journal.pone.0202305			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3QJ	30278048	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000446010200002
J	Dance, KM; Rooker, JR; Shipley, JB; Dance, MA; Wells, RJD				Dance, Kaylan M.; Rooker, Jay R.; Shipley, J. Brooke; Dance, Michael A.; Wells, R. J. David			Feeding ecology of fishes associated with artificial reefs in the northwest Gulf of Mexico	PLOS ONE			English	Article							TRIGGERFISH BALISTES-CAPRISCUS; SNAPPER LUTJANUS-CAMPECHANUS; STABLE-ISOTOPE ANALYSES; RED SNAPPER; GRAY TRIGGERFISH; NORTHEASTERN GULF; TROPHIC ECOLOGY; NATURAL REEFS; FOOD WEBS; HABITAT COMPLEXITY	The feeding ecology of two reef fishes associated with artificial reefs in the northwest Gulf of Mexico (GoM) was examined using gut contents and natural stable isotopes. Reefs were divided into three regions (east, central, west) across an east to west gradient of increasing reef complexity and salinity. Gray triggerfish (Balistes capriscus) primarily consumed reef-associated prey (xanthid crabs, bivalves, barnacles) and pelagic gastropods, while red snapper (Lutjanus campechanus) diets were mainly comprised of non-reef prey (stomato-pods, fishes, portunid crabs). Natural stable isotopes of carbon (delta C-13), nitrogen (delta N-15), and sulfur (delta S-34) were measured in consumer muscle tissue as well as potential primary producers. Gray triggerfish occupied a lower trophic position than red snapper, with lower delta C-13 and delta N-15 values across all size classes and regions, and generally higher delta S-34 values. Red snapper had a smaller range of stable isotope values and corrected standard ellipse areas across all size classes and regions, indicating a smaller isotopic niche. Contribution estimates of particulate organic matter (26 to 54%) and benthic microalgae (BMA, 47 to 74%) for both species were similar, with BMA contributions greater across all three size classes (juveniles, sub-adults, adults) of red snapper and all but the juvenile size class for gray triggerfish. Species gut contents and stable isotopes differed by region, with fishes consuming more crabs in the east region and more gastropods in the central and west regions. delta C-13 and delta N-15 values generally decreased from east to west, while delta S-34 increased across this gradient. Results highlight species-specific feeding differences associated with artificial reefs, where gray triggerfish may be more dependent on the reef structure for foraging opportunities. In addition, results offer further information on the integral role of BMA in primary production at nearshore artificial reefs.	[Dance, Kaylan M.; Rooker, Jay R.; Dance, Michael A.; Wells, R. J. David] Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA; [Rooker, Jay R.; Wells, R. J. David] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA; [Shipley, J. Brooke] Artificial Reef Program, Texas Pk & Wildlife Dept, Austin, TX USA; [Dance, Michael A.] Louisiana State Univ, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA	Texas A&M University System; Texas A&M University System; Texas A&M University College Station; Louisiana State University System; Louisiana State University	Dance, KM (corresponding author), Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA.	kaylandance@gmail.com	Shipley, Brooke/T-3045-2019		Texas Parks and Wildlife Departments Artificial Reef Program [443017]	Texas Parks and Wildlife Departments Artificial Reef Program	This work was funded by the Texas Parks and Wildlife Departments Artificial Reef Program (Award #443017) to RJDW and JRR. Funding agency website: https://tpwd.texas.gov/landwater/water/habitats/artificial_reef/. The funders, with exception of the named author, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis DT, 2016, N AM J FISH MANAGE, V36, P131, DOI 10.1080/02755947.2015.1084406; Addis DT, 2013, FISH RES, V147, P349, DOI 10.1016/j.fishres.2013.07.011; Ahlbeck I, 2012, CAN J FISH AQUAT SCI, V69, P1184, DOI [10.1139/F2012-051, 10.1139/f2012-051]; Ajemian MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126354; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; [Anonymous], 2016, 43 SEDAR; Baine M, 2001, OCEAN COAST MANAGE, V44, P241, DOI 10.1016/S0964-5691(01)00048-5; Ballard Sarah E., 2012, Gulf and Caribbean Research, V24, P31; Becker A, 2017, ICES J MAR SCI, V74, P277, DOI 10.1093/icesjms/fsw133; Boecklen WJ, 2011, ANNU REV ECOL EVOL S, V42, P411, DOI 10.1146/annurev-ecolsys-102209-144726; Bohnsack J.A., 1991, P61; BOHNSACK JA, 1985, B MAR SCI, V37, P11; Bortone SA, 1998, ITAL J ZOOL, V65, P265, DOI 10.1080/11250009809386830; Bretz F., 2016, MULTIPLE COMP USING; Brickhill MJ, 2005, J FISH BIOL, V67, P53, DOI 10.1111/j.0022-1112.2005.00915.x; Burt J, 2009, CORAL REEFS, V28, P663, DOI 10.1007/s00338-009-0500-1; Charbonnel E, 2002, ICES J MAR SCI, V59, pS208, DOI 10.1006/jmsc.2002.1263; Clarke K. R., 2015, PRIMER V7 USER MANUA; Creach V, 1997, ESTUAR COAST SHELF S, V44, P599, DOI 10.1006/ecss.1996.0147; Cresson P, 2014, MAR ECOL PROG SER, V509, P15, DOI 10.3354/meps10866; Daigle ST, 2013, MAR COAST FISH, V5, P53, DOI 10.1080/19425120.2013.774301; Dance MA, 2011, B MAR SCI, V87, P301, DOI 10.5343/bms.2010.1040; Fischer AJ, 2004, FISH B-NOAA, V102, P593; France RL, 1995, LIMNOL OCEANOGR, V40, P1310, DOI 10.4319/lo.1995.40.7.1310; FRAZER TK, 1991, B MAR SCI, V48, P159; Frisch AJ, 2014, MAR BIOL, V161, P61, DOI 10.1007/s00227-013-2315-4; FRY B, 1988, LIMNOL OCEANOGR, V33, P1182, DOI 10.4319/lo.1988.33.5.1182; Fry B, 2007, STABLE ISOTOPE ECOLO; Gallaway BJ, 2009, REV FISH SCI, V17, P48, DOI 10.1080/10641260802160717; Gelman A., 1992, BAYESIAN STAT, V4, P625; Goldman SF, 2016, FISH B-NOAA, V114, P317, DOI 10.7755/FB.114.3.5; Gregalis KC, 2012, T AM FISH SOC, V141, P1453, DOI 10.1080/00028487.2012.703154; Grossman GD, 1997, FISHERIES, V22, P17, DOI 10.1577/1548-8446(1997)022<0017:DARIRF>2.0.CO;2; Guzzo MM, 2013, BIOL INVASIONS, V15, P1695, DOI 10.1007/s10530-012-0401-z; Herbig JL, 2016, FISHERIES MANAG ECOL, V23, P418, DOI 10.1111/fme.12190; Herzka SZ, 2000, CAN J FISH AQUAT SCI, V57, P137, DOI 10.1139/cjfas-57-1-137; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hussey NE, 2014, ECOL LETT, V17, P239, DOI 10.1111/ele.12226; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Jackson MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031757; Jaxion-Harm J, 2015, N AM J FISH MANAGE, V35, P86, DOI 10.1080/02755947.2014.982332; Karnauskas M, 2017, MAR COAST FISH, V9, P50, DOI 10.1080/19425120.2016.1255684; Koeck B, 2014, AQUAT BIOL, V20, P219, DOI 10.3354/ab00561; Kulaw DH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172360; KURZ RC, 1995, B MAR SCI, V56, P150; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; Lindberg WJ, 1997, FISHERIES, V22, P10; LINDQUIST DG, 1994, B MAR SCI, V55, P308; Lingo ME, 2006, ENVIRON BIOL FISH, V76, P71, DOI 10.1007/s10641-006-9009-4; Lombardi LRA, SEDAR43WP102015; Macreadie PI, 2011, FRONT ECOL ENVIRON, V9, P455, DOI 10.1890/100112; McCawley Jessica R., 2006, Gulf of Mexico Science, V24, P14; Melville AJ, 2003, OECOLOGIA, V136, P499, DOI 10.1007/s00442-003-1302-8; Michener RH, 2007, ECOL METHOD CONCEPT, P238, DOI 10.1002/9780470691854.ch9; Moncreiff CA, 2001, MAR ECOL PROG SER, V215, P93, DOI 10.3354/meps215093; Morey SL, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001674; Moriarty PE, 2017, CAN J FISH AQUAT SCI, V74, P168, DOI 10.1139/cjfas-2016-0149; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Pinkas L, 1970, FISH B, V152, P10; Plumlee JD, 2016, MAR ECOL PROG SER, V550, P163, DOI 10.3354/meps11723; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Rooker JR, 2004, ESTUAR COAST SHELF S, V59, P653, DOI 10.1016/j.ecss.2003.11.009; SCHOENER TW, 1968, ECOLOGY, V49, P704, DOI 10.2307/1935534; SHAFFER JP, 1986, J AM STAT ASSOC, V81, P826, DOI 10.2307/2289016; Shipp RL, 2009, REV FISH SCI, V17, P41, DOI 10.1080/10641260802104244; Simmons CM, 2011, T AM FISH SOC, V140, P14, DOI 10.1080/00028487.2011.545002; Simonsen KA, 2015, ENVIRON BIOL FISH, V98, P811, DOI 10.1007/s10641-014-0317-9; Sluis MZ, 2013, ENVIRON TOXICOL CHEM, V32, P434, DOI 10.1002/etc.2077; Stephane C, 2009, J APPL ECOL, V46, P443; Stock B.C., 2013, MIXSIAR GUI USER MAN; Streich MK, 2016, ECOLOGY RED SNAPPER; Strelcheck AJ, 2005, B MAR SCI, V77, P425; Sutton SG, 2007, OCEAN COAST MANAGE, V50, P829, DOI 10.1016/j.ocecoaman.2007.01.003; Szedlmayer ST, 2004, FISH B-NOAA, V102, P366; Tarnecki JH, 2015, MAR COAST FISH, V7, P135, DOI 10.1080/19425120.2015.1020402; Tessier A, 2015, HYDROBIOLOGIA, V753, P1, DOI 10.1007/s10750-015-2213-5; Tolan JM, 2007, ESTUAR COAST SHELF S, V72, P247, DOI 10.1016/j.ecss.2006.10.018; VOSE FE, 1994, B MAR SCI, V55, P1316; Wang XC, 2004, MAR CHEM, V89, P241, DOI 10.1016/j.marchem.2004.02.014; Wells RJD, 2008, MAR ECOL PROG SER, V361, P213, DOI 10.3354/meps07425; [No title captured]	82	20	20	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0203873	10.1371/journal.pone.0203873	http://dx.doi.org/10.1371/journal.pone.0203873			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3QJ	30278043	Green Submitted, Green Published, gold			2022-12-26	WOS:000446010200007
J	Huang, FF; Wang, ZH; Zhang, JG; Du, WW; Su, C; Jiang, HR; Jia, XF; Ouyang, YF; Wang, Y; Li, L; Zhang, B; Wang, HJ				Huang, Feifei; Wang, Zhihong; Zhang, Jiguo; Du, Wenwen; Su, Chang; Jiang, Hongru; Jia, Xiaofang; Ouyang, Yifei; Wang, Yun; Li, Li; Zhang, Bing; Wang, Huijun			Dietary calcium intake and food sources among Chinese adults in CNTCS	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; HEALTH; DAIRY; RISK; NUTRIENTS; ENERGY; TRENDS; WOMEN	Background Calcium is one of the essential micronutrients in the human body and is well-known for its important role in keeping bones and teeth healthy. However, calcium deficiency is a very common nutritional problem in the world and especially in China. The aim of this research was to determine the dietary calcium intake of Chinese adults and the corresponding food sources based on data from the 2015 China Nutritional Transition Cohort Study. Methods We obtained dietary data from Chinese adults ages 18 to 64 years in 15 provinces, autonomous regions, and municipalities using 3 consecutive days combined with the household weighing method. We used the China Food Composition (book 1, 2nd edition) to calculate the calcium intake from each food category. We regarded the percentage of participants with a calcium intake median below the estimated average requirement as the level of calcium inadequacy in the overall population. Results We divided the participants into 2 age groups, 18-49 years and 50-64 years, which included 6,630 and 5,307 participants, respectively. The groups' dietary calcium intake medians were 324.8 milligrams per day (mg/d) and 332.7 mg/d, respectively, and the calcium inadequacies were 92.9% and 96.0%, correspondingly. The median calcium intake for the whole study population was 328.3 mg/d, and the inadequacy was 94.3%, which improved with higher education, income, and urbanization levels. The main food sources of dietary calcium among the study population were vegetables, legumes, and cereals, which contributed 30.2%, 16.7%, and 14.6%, respectively. Milk and dairy products contributed 6.7% to the study population but varied with the urbanization level to 15.0%, 6.1%, 6.3%, and 2.0% in urban, suburban, county, and rural areas, respectively. Conclusion These findings highlight the importance of nutrition education and intervention for Chinese adults to improve their dietary structures and increase milk and dairy products intake to consume adequate calcium.	[Huang, Feifei; Wang, Zhihong; Zhang, Jiguo; Du, Wenwen; Su, Chang; Jiang, Hongru; Jia, Xiaofang; Ouyang, Yifei; Wang, Yun; Li, Li; Zhang, Bing; Wang, Huijun] Chinese Ctr Dis Control & Prevent, Natl Inst Nutr & Hlth, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention	Wang, HJ (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Nutr & Hlth, Beijing, Peoples R China.	wanghj@ninh.chinacdc.cn			Ministry of Finance of the people's Republic of China [13103110700015005]	Ministry of Finance of the people's Republic of China	Financial support was provided by Ministry of Finance of the people's Republic of China (No. 13103110700015005). The website about this fund is not available. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aidong L, 2012, ACTA NUTRIMENTA SINI, V34, P10; Barr SI, 2002, J AM DIET ASSOC, V102, P780, DOI 10.1016/S0002-8223(02)90177-X; Barr SI, 2006, APPL PHYSIOL NUTR ME, V31, P66, DOI [10.1139/h05-020, 10.1139/H05-020]; Bolland Mark J, 2011, BMJ, V342, pd2040, DOI 10.1136/bmj.d2040; Dubuisson C, 2010, BRIT J NUTR, V103, P1035, DOI 10.1017/S0007114509992625; Fan YiOu, 2012, Acta Nutrimenta Sinica, V34, P15; Feifei H, 2018, ACTA NUTRIMENTA SINI; Food and Drug Administration HHS, 2008, Fed Regist, V73, P56477; Jile C, 2016, MONITORING NUTR HLTH, P37; Koyama T, 2017, ASIA PAC J CLIN NUTR, V26, P837, DOI 10.6133/apjcn.072016.11; Manios Y, 2015, NUTRIENTS, V7, P1841, DOI 10.3390/nu7031841; Mensink GBM, 2013, BRIT J NUTR, V110, P755, DOI 10.1017/S000711451200565X; Murphy SP, 2002, PUBLIC HEALTH NUTR, V5, P843, DOI 10.1079/PHN2002389; Murphy SP, 2008, ASIA PAC J CLIN NUTR, V17, P299; Nicklas TA, 2009, J AM COLL NUTR, V28, p73S, DOI 10.1080/07315724.2009.10719807; Nutrition C. S. O, 2013, CHIN DIET REF INT, P31; O'Neil CE, 2012, NUTRIENTS, V4, P2097, DOI 10.3390/nu4122097; Oh JM, 2017, NUTR METAB CARDIOVAS, V27, P1152, DOI 10.1016/j.numecd.2017.10.005; Olza J, 2017, NUTRIENTS, V9, DOI 10.3390/nu9020168; Paik JM, 2014, OSTEOPOROSIS INT, V25, P2047, DOI 10.1007/s00198-014-2732-3; Popkin BM, 2010, INT J EPIDEMIOL, V39, P1435, DOI 10.1093/ije/dyp322; Quann EE, 2015, NUTR J, V14, DOI 10.1186/s12937-015-0057-5; Serra-Majem L, 2007, PUBLIC HEALTH NUTR, V10, P1354, DOI 10.1017/S1368980007000961; Strohle A, 2015, CLIMACTERIC, V18, P702, DOI 10.3109/13697137.2015.1016419; Talaei M, 2017, J NUTR, V147, P235, DOI 10.3945/jn.116.238485; Wang HJ, 2017, NUTRIENTS, V9, DOI 10.3390/nu9040397; [王美辰 Wang Meichen], 2017, [营养学报, Acta Nutrimenta Sinica], V39, P332; Xiao Q, 2013, JAMA INTERN MED, V173, P639, DOI 10.1001/jamainternmed.2013.3283; Yuexin Y, CHINA FOOD COMPOSITI, V1, P3	29	24	27	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0205045	10.1371/journal.pone.0205045	http://dx.doi.org/10.1371/journal.pone.0205045			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273413	Green Published, Green Submitted, gold			2022-12-26	WOS:000446124700062
J	Onodera, Y; Teramura, T; Takehara, T; Itokazu, M; Mori, T; Fukuda, K				Onodera, Yuta; Teramura, Takeshi; Takehara, Toshiyuki; Itokazu, Maki; Mori, Tatsufumi; Fukuda, Kanji			Inflammation-associated miR-155 activates differentiation of muscular satellite cells	PLOS ONE			English	Article							MUSCLE STEM-CELL; BINDING-PROTEIN BETA; SKELETAL-MUSCLE; BONE-MARROW; MICRORNA EXPRESSION; SELF-RENEWAL; ADULT; PROLIFERATION; QUIESCENCE; NICHE	Tissue renewal and muscle regeneration largely rely on the proliferation and differentiation of muscle stem cells called muscular satellite cells (MuSCs). MuSCs are normally quiescent, but they are activated in response to various stimuli, such as inflammation. Activated MuSCs proliferate, migrate, differentiate, and fuse to form multinucleate myofibers. Meanwhile, inappropriate cues for MuSC activation induce premature differentiation and bring about stem cell loss. Recent studies revealed that stem cell regulation is disrupted in various aged tissues. We found that the expression of microRNA (miR)-155, which is an inflammation-associated miR, is upregulated in MuSCs of aged muscles, and this upregulation activates the differentiation process through suppression of C/ebp beta, which is an important molecule for maintaining MuSC self-renewal. We also found that Notch1 considerably repressed miR-155 expression, and loss of Notch1 induced miR-155 overexpression. Our findings suggest that miR-155 can act as an activator of muscular differentiation and might be responsible for accelerating aging-associated premature differentiation of MuSCs.	[Onodera, Yuta; Teramura, Takeshi; Takehara, Toshiyuki; Fukuda, Kanji] Kindai Univ, Inst Adv Clin Med, Div Cell Biol Regenerat Med, Fac Med, Osaka, Japan; [Itokazu, Maki; Fukuda, Kanji] Kindai Univ, Dept Rehabil Med, Fac Med, Osaka, Japan; [Mori, Tatsufumi] Kindai Univ, Life Sci Res Inst, Osaka, Japan	Kindai University (Kinki University); Kindai University (Kinki University); Kindai University (Kinki University)	Teramura, T (corresponding author), Kindai Univ, Inst Adv Clin Med, Div Cell Biol Regenerat Med, Fac Med, Osaka, Japan.	teramura@med.kindai.ac.jp	Itokazu, Maki/T-9417-2019; Teramura, Takeshi/ELU-7591-2022	Itokazu, Maki/0000-0002-6349-6571; Teramura, Takeshi/0000-0002-5310-4749	JSPS KAKENHI Grant [16K01484, 17K01487]	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 16K01484 (KF) and 17K01487 (MI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernet JD, 2014, NAT MED, V20, P265, DOI 10.1038/nm.3465; Blau HM, 2015, NAT MED, V21, P854, DOI 10.1038/nm.3918; Blaya D, 2018, HEPATOLOGY, V68, P691, DOI 10.1002/hep.29833; Brohl D, 2012, DEV CELL, V23, P469, DOI 10.1016/j.devcel.2012.07.014; Buck M, 2001, MOL CELL, V8, P807, DOI 10.1016/S1097-2765(01)00374-4; Carlson ME, 2009, EMBO MOL MED, V1, P381, DOI 10.1002/emmm.200900045; Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen JF, 2010, J CELL BIOL, V190, P867, DOI 10.1083/jcb.200911036; Chen WY, 2017, SCI REP-UK, V7, DOI 10.1038/srep41159; Cheung TH, 2012, NATURE, V482, P524, DOI 10.1038/nature10834; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Costamagna D, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/805172; Crist CG, 2009, P NATL ACAD SCI USA, V106, P13383, DOI 10.1073/pnas.0900210106; Dedkov EI, 2003, CELL TISSUE RES, V311, P401, DOI 10.1007/s00441-002-0686-9; Ding SJ, 2017, CELL DEATH DISCOV, V3, DOI 10.1038/cddiscovery.2017.3; Dodson S, 2011, ANNU REV MED, V62, P265, DOI 10.1146/annurev-med-061509-131248; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; Elton TS, 2013, GENE, V532, P1, DOI 10.1016/j.gene.2012.12.009; Fry CS, 2015, NAT MED, V21, P76, DOI 10.1038/nm.3710; Fu DC, 2015, J BIOL CHEM, V290, P10200, DOI 10.1074/jbc.M115.638577; Harrison EB, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00228; Kuang S, 2008, TRENDS MOL MED, V14, P82, DOI 10.1016/j.molmed.2007.12.004; LaBarge MA, 2002, CELL, V111, P589, DOI 10.1016/S0092-8674(02)01078-4; Li ZH, 2014, NAT REV DRUG DISCOV, V13, P622, DOI 10.1038/nrd4359; Liu L, 2015, NAT PROTOC, V10, P1612, DOI 10.1038/nprot.2015.110; Liu N, 2008, GENE DEV, V22, P3242, DOI 10.1101/gad.1738708; Marchildon F, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.4; Marchildon F, 2012, STEM CELLS, V30, P2619, DOI 10.1002/stem.1248; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; MUSARO A, 1995, EXP CELL RES, V221, P241, DOI 10.1006/excr.1995.1372; Nie M, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.165; O'Rourke JR, 2007, DEV BIOL, V311, P359, DOI 10.1016/j.ydbio.2007.08.032; Obora K, 2017, SCI REP-UK, V7, DOI 10.1038/srep43604; Onodera Y, 2017, AGING CELL, V16, P1369, DOI 10.1111/acel.12680; Park S, 2013, IMMUNOL INVEST, V42, P179, DOI 10.3109/08820139.2012.717328; Rozo M, 2016, NAT MED, V22, P889, DOI 10.1038/nm.4116; Seok HY, 2011, J BIOL CHEM, V286, P35339, DOI 10.1074/jbc.M111.273276; Shefer G, 2006, DEV BIOL, V294, P50, DOI 10.1016/j.ydbio.2006.02.022; Sousa-Victor P, 2014, NATURE, V506, P316, DOI 10.1038/nature13013; Sredni Simone T., 2011, Frontiers in Genetics, V2, P49, DOI 10.3389/fgene.2011.00049; Taulli R, 2009, J CLIN INVEST, V119, P2366, DOI 10.1172/JCI38075; Van Roosbroeck K, 2017, CLIN CANCER RES, V23, P2891, DOI 10.1158/1078-0432.CCR-16-1025; Verdijk LB, 2014, AGE, V36, P545, DOI 10.1007/s11357-013-9583-2; Wagers AJ, 2005, CELL, V122, P659, DOI 10.1016/j.cell.2005.08.021; Walston J, 2008, J GERONTOL A-BIOL, V63, P391, DOI 10.1093/gerona/63.4.391; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Wang L, 2014, CELL STEM CELL, V15, P51, DOI 10.1016/j.stem.2014.04.021; Woodbury ME, 2015, J NEUROSCI, V35, P9764, DOI 10.1523/JNEUROSCI.4790-14.2015; Yue F, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14328; Zhai LL, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.128	51	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204860	10.1371/journal.pone.0204860	http://dx.doi.org/10.1371/journal.pone.0204860			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273359	Green Submitted, Green Published, gold			2022-12-26	WOS:000446124700043
J	Sajid, A; Lusvarghi, S; Chufan, EE; Ambudkar, SV				Sajid, Andaleeb; Lusvarghi, Sabrina; Chufan, Eduardo E.; Ambudkar, Suresh, V			Evidence for the critical role of transmembrane helices 1 and 7 in substrate transport by human P-glycoprotein (ABCB1)	PLOS ONE			English	Article							DRUG-BINDING POCKET; MULTIDRUG-RESISTANCE; ATP HYDROLYSIS; CATALYTIC CYCLE; MAMMALIAN-CELLS; INHIBITION; RESIDUES; POLYSPECIFICITY; EXPRESSION; CANCER	P-glycoprotein (P-gp) is an ABC transporter that exports many amphipathic or hydrophobic compounds, including chemically and functionally dissimilar anticancer drugs, from cells. To understand the role of transmembrane helices (TMH) 1 and 7 in drug-binding and transport, we selected six residues from both TMH1 (V53, 159, I60, L65, M68 and F72) and TMH7 (V713,I719,I720, Q725, F728 and F732); and substituted them with alanine by gene synthesis to generate a variant termed "TMH1,7 mutant P-gp". The expression and function of TMH1,7 mutant P-gp with twelve mutations was characterized using the BacMam baculovirus-HeLa cell expression system. The expression and conformation of TMH1,7 mutant P-gp was not altered by the introduction of the twelve mutations, as confirmed by using the human P-gp-specific antibodies UIC2, MRK16 and 4E3. We tested 25 fluorescently-labeled substrates and found that only three substrates, NBD-cyclosporine A, Rhod-2-AM and X-Rhod-1-AM were transported by the TMH1,7 mutant. The basal ATPase activity of TMH1,7 mutant P-gp was lower (40-50%) compared to wild-type (WT) P-gp, despite similar level of expression. Although most of the substrates modulate ATPase activity of P-gp, the activity of TMH1,7 mutant transporter was not significantly modulated by any of the tested substrates. Docking of selected substrates in homology models showed comparable docking scores for the TMH1,7 mutant and WT P-gp, although the binding conformations were different. Both the ATPase assay and in silico docking analyses suggest that the interactions with residues in the drug-binding pocket are altered as a consequence of the mutations. We demonstrate that it is possible to generate a variant of P-gp with a loss of broad substrate specificity and propose that TMH1 and TMH7 play a critical role in the drug efflux function of this multidrug transporter.	[Sajid, Andaleeb; Lusvarghi, Sabrina; Chufan, Eduardo E.; Ambudkar, Suresh, V] NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bldg 37, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ambudkar, SV (corresponding author), NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bldg 37, Bethesda, MD 20892 USA.	ambudkar@mail.nih.gov	Sajid, Andaleeb/AAI-2960-2020	Sajid, Andaleeb/0000-0001-6248-4985; Ambudkar, Suresh/0000-0002-2639-4955; Lusvarghi, Sabrina/0000-0003-1793-0450	National Institutes of Health, the National Cancer Institute, Center for Cancer Research [ZIA BC010030]; NATIONAL CANCER INSTITUTE [ZIABC010030] Funding Source: NIH RePORTER	National Institutes of Health, the National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded by the Intramural Research Program of the National Institutes of Health, the National Cancer Institute, Center for Cancer Research (project #ZIA BC010030).	Alam A, 2018, P NATL ACAD SCI USA, V115, pE1973, DOI 10.1073/pnas.1717044115; Ambudkar SV, 2006, EUR J PHARM SCI, V27, P392, DOI 10.1016/j.ejps.2005.10.010; Ambudkar SV, 2006, FEBS LETT, V580, P1049, DOI 10.1016/j.febslet.2005.12.051; Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; Ambudkar SV, 1998, METHOD ENZYMOL, V292, P504; Bienert S, 2017, NUCLEIC ACIDS RES, V45, pD313, DOI 10.1093/nar/gkw1132; Callaghan R, 2014, DRUG METAB DISPOS, V42, P623, DOI 10.1124/dmd.113.056176; Cascorbi I, 2011, HANDB EXP PHARMACOL, V201, P261, DOI 10.1007/978-3-642-14541-4_6; Chufan EE, 2016, BIOCHEM PHARMACOL, V101, P40, DOI 10.1016/j.bcp.2015.12.007; Chufan EE, 2015, ADV CANCER RES, V125, P71, DOI 10.1016/bs.acr.2014.10.003; Chufan EE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082463; Dey S, 1997, P NATL ACAD SCI USA, V94, P10594, DOI 10.1073/pnas.94.20.10594; Egido E, 2015, MOL PHARMACEUT, V12, P4026, DOI 10.1021/acs.molpharmaceut.5b00463; Esser L, 2017, J BIOL CHEM, V292, P446, DOI 10.1074/jbc.M116.755884; Frank GA, 2016, MOL PHARMACOL, V90, P35, DOI 10.1124/mol.116.104190; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Gutmann DAP, 2010, TRENDS BIOCHEM SCI, V35, P36, DOI 10.1016/j.tibs.2009.07.009; Housman G, 2014, CANCERS, V6, P1769, DOI 10.3390/cancers6031769; Janson G, 2017, BIOINFORMATICS, V33, P444, DOI 10.1093/bioinformatics/btw638; Kerr KM, 2001, J BIOL CHEM, V276, P8657, DOI 10.1074/jbc.M010044200; Kim Y, 2018, SCIENCE, V359, P915, DOI 10.1126/science.aar7389; Li JZ, 2014, PROTEIN SCI, V23, P34, DOI 10.1002/pro.2387; Li MJ, 2018, J BIOL CHEM, V293, P6297, DOI 10.1074/jbc.RA118.002190; Loo TW, 2007, J BIOL CHEM, V282, P32043, DOI 10.1074/jbc.M706175200; Loo TW, 2006, BIOCHEM J, V399, P351, DOI 10.1042/BJ20060715; Loo TW, 2006, BIOCHEM J, V396, P537, DOI 10.1042/BJ20060012; Loo TW, 2003, J BIOL CHEM, V278, P39706, DOI 10.1074/jbc.M308559200; Loo TW, 2005, BIOCHEMISTRY-US, V44, P10250, DOI 10.1021/bi050705j; Loo TW, 2003, J BIOL CHEM, V278, P20449, DOI 10.1074/jbc.C300154200; Loo TW, 1997, J BIOL CHEM, V272, P31945, DOI 10.1074/jbc.272.51.31945; Loo TW, 2001, J BIOL CHEM, V276, P14972, DOI 10.1074/jbc.M100407200; Loo TW, 2000, J BIOL CHEM, V275, P39272, DOI 10.1074/jbc.M007741200; Loo TW, 1996, J BIOL CHEM, V271, P15414, DOI 10.1074/jbc.271.26.15414; LOO TW, 1994, J BIOL CHEM, V269, P28683; Lugo MR, 2005, BIOCHEMISTRY-US, V44, P14020, DOI 10.1021/bi0511179; Martinez L, 2014, FEBS J, V281, P673, DOI 10.1111/febs.12613; Okochi E, 1997, LEUKEMIA, V11, P1119, DOI 10.1038/sj.leu.2400658; Pan LR, 2015, SCI REP-UK, V5, DOI 10.1038/srep07880; Pluchino KM, 2016, BIOCHEMISTRY-US, V55, P1010, DOI 10.1021/acs.biochem.5b01064; Pluchino KM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136396; Ramachandra M, 1998, BIOCHEMISTRY-US, V37, P5010, DOI 10.1021/bi973045u; Ritchie TK, 2011, J BIOL CHEM, V286, P39489, DOI 10.1074/jbc.M111.284554; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; SARKADI B, 1992, J BIOL CHEM, V267, P4854; Sauna ZE, 2002, BIOCHEMISTRY-US, V41, P13989, DOI 10.1021/bi026626e; Shukla S, 2011, CURR DRUG TARGETS, V12, P621, DOI 10.2174/138945011795378540; Shukla S, 2012, DRUG METAB DISPOS, V40, P304, DOI 10.1124/dmd.111.042721; Strouse JJ, 2013, ANAL BIOCHEM, V437, P77, DOI 10.1016/j.ab.2013.02.018; Szewczyk P, 2015, ACTA CRYSTALLOGR D, V71, P732, DOI 10.1107/S1399004715000978; Szollosi D, 2018, BBA-BIOMEMBRANES, V1860, P818, DOI 10.1016/j.bbamem.2017.10.028; THIEBAUT F, 1987, P NATL ACAD SCI USA, V84, P7735, DOI 10.1073/pnas.84.21.7735; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vahedi S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30984-8; Vahedi S, 2017, BIOCHEM PHARMACOL, V143, P53, DOI 10.1016/j.bcp.2017.07.014; Ward AB, 2013, P NATL ACAD SCI USA, V110, P13386, DOI 10.1073/pnas.1309275110; Yuan SG, 2016, STRUCTURE, V24, P2041, DOI 10.1016/j.str.2016.11.012	56	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204693	10.1371/journal.pone.0204693	http://dx.doi.org/10.1371/journal.pone.0204693			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265721	gold, Green Submitted, Green Published			2022-12-26	WOS:000446005500045
J	Yen, PS; Amraoui, F; Rua, AV; Failloux, AB				Yen, Pei-Shi; Amraoui, Fadila; Rua, Anubis Vega; Failloux, Anna-Bella			Aedes aegypti mosquitoes from Guadeloupe (French West Indies) are able to transmit yellow fever virus	PLOS ONE			English	Article							VECTOR COMPETENCE; DENGUE; CHIKUNGUNYA; ALBOPICTUS; DIPTERA; ISLANDS	The recent yellow fever epidemic in Brazil has raised the concern of outbreaks in neighboring countries, particularly in the Caribbean region where the vector Aedes aegypti is predominant. This threat comes from the past when in the Americas, this disease caused devastating urban epidemics. We report the vector competence of Ae. aegypti from Guadeloupe for yellow fever virus by determining different parameters describing virus infection, dissemination, and transmission. The results indicate that Ae. aegypti Guadeloupe are susceptible to yellow fever virus with viral particles detected in mosquito saliva at 14 and 21 days post-infection. Local authorities and more broadly, international organizations should maintain the active surveillance of Aedes mosquitoes and the spreading of human cases from South America.	[Yen, Pei-Shi; Amraoui, Fadila; Failloux, Anna-Bella] Inst Pasteur, Dept Virol, Unit Arboviruses & Insect Vectors, Paris, France; [Rua, Anubis Vega] Inst Pasteur Guadeloupe, Environm & Hlth Unit, Lab Vector Control Res, Les Abymes, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Yen, PS (corresponding author), Inst Pasteur, Dept Virol, Unit Arboviruses & Insect Vectors, Paris, France.	pei-shi.yen@pasteur.fr		Yen, Pei-Shi/0000-0002-2113-7394	French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" [ANR-10-LABX-62-IBEID]; FEDER - European Union; Guadeloupe Region, Programme Operationnel FEDER-Guadeloupe-Conseil Regional [2015-FED-192]; Institut Pasteur; National Health Research Institutes in Taiwan	French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases"(French National Research Agency (ANR)); FEDER - European Union(European Commission); Guadeloupe Region, Programme Operationnel FEDER-Guadeloupe-Conseil Regional; Institut Pasteur(European Commission); National Health Research Institutes in Taiwan(National Health Research Institutes - Taiwan)	ABF was funded by French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" (grant noANR-10-LABX-62-IBEID); AVR was funded by FEDER grant that financed by the European Union and Guadeloupe Region, Programme Operationnel FEDER-Guadeloupe-Conseil Regional 2014-2020 (Grant number 2015-FED-192). P-SY was supported by the Institut Pasteur and the National Health Research Institutes in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, Rev Panam Salud Publica, V1, P68; Barrett ADT, 2007, ANNU REV ENTOMOL, V52, P209, DOI 10.1146/annurev.ento.52.110405.091454; Bryan CS, 2004, INFECT DIS CLIN N AM, V18, P275, DOI 10.1016/j.idc.2004.01.007; Cathey JT, 2014, T ROY SOC TROP MED H, V108, P252, DOI 10.1093/trstmh/tru043; Couto-Lima D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05186-3; Vasconcelos PFD, 2010, REV SAUDE PUBL, V44, P1144, DOI 10.1590/S0034-89102010005000046; Daudens-Vaysse E, 2016, EUROSURVEILLANCE, V21, P11, DOI 10.2807/1560-7917.ES.2016.21.28.30285; Dorleans F, 2018, AM J TROP MED HYG, V98, P1819, DOI 10.4269/ajtmh.16-0719; Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895; Ellis BR, 2012, T ROY SOC TROP MED H, V106, P387, DOI 10.1016/j.trstmh.2012.02.007; Goindin D, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0254-x; GOODYEAR JD, 1978, B HIST MED, V52, P5; Gustave J, 1996, B SOC PATHOL EXOT, V89, P143; Gustave J, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/249524; Johnson BW, 2002, T ROY SOC TROP MED H, V96, P611, DOI 10.1016/S0035-9203(02)90326-3; Jupp PG, 2002, T ROY SOC TROP MED H, V96, P493, DOI 10.1016/S0035-9203(02)90417-7; Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646; Larrieu S, 2014, ACTA TROP, V131, P37, DOI 10.1016/j.actatropica.2013.11.023; Lourenco-de-Oliveira R, 2002, MEM I OSWALDO CRUZ, V97, P437, DOI 10.1590/S0074-02762002000300031; Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030; Mousson L, 2005, GENET RES, V86, P1, DOI 10.1017/S0016672305007627; Pan American Health Organization (PAHO), 2018, EP UPD YELL FEV; Pastorino BAM, 2008, VIRUS RES, V131, P293, DOI 10.1016/j.virusres.2007.09.009; Payne AF, 2006, J VIROL METHODS, V134, P183, DOI 10.1016/j.jviromet.2006.01.003; van den Hurk AF, 2011, AM J TROP MED HYG, V85, P446, DOI 10.4269/ajtmh.2011.11-0061; Vasconcelos PFC, 1999, DENGUE B, V23, P11; Vazeille M, 2013, VECTOR-BORNE ZOONOT, V13, P37, DOI 10.1089/vbz.2012.0982	27	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204710	10.1371/journal.pone.0204710	http://dx.doi.org/10.1371/journal.pone.0204710			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265716	Green Published, gold, Green Submitted			2022-12-26	WOS:000446005500046
J	Guerreiro, EM; Vestad, B; Steffensen, LA; Aass, HCD; Saeed, M; Ovstebo, R; Costea, DE; Galtung, HK; Soland, TM				Guerreiro, Eduarda M.; Vestad, Beate; Steffensen, Lilly Alice; Aass, Hans Christian D.; Saeed, Muhammad; Ovstebo, Reidun; Costea, Daniela Elena; Galtung, Hilde Kanli; Soland, Tine M.			Efficient extracellular vesicle isolation by combining cell media modifications, ultrafiltration, and size-exclusion chromatography	PLOS ONE			English	Article							EXOSOMES; CULTURE; MICROVESICLES; TRACKING; GROWTH; SERA; RNAS	Extracellular vesicles (EVs) are a heterogeneous population of biological particles released by cells. They represent an attractive source of potential biomarkers for early detection of diseases such as cancer. However, it is critical that sufficient amounts of EVs can be isolated and purified in a robust and reproducible manner. Several isolation methods that seem to produce distinct populations of vesicles exist, making data comparability difficult. While some methods induce cellular stress that may affect both the quantity and function of the EVs produced, others involve expensive reagents or equipment unavailable for many laboratories. Thus, there is a need for a standardized, feasible and cost-effective method for isolation of EVs from cell culture supernatants. Here we present the most common obstacles in the production and isolation of small EVs, and we suggest a combination of relatively simple strategies to avoid these. Three distinct cell lines were used (human oral squamous cell carcinoma (PE/CA-PJ49/E10)), pancreatic adenocarcinoma (BxPC3), and a human melanoma brain metastasis (H3). The addition of 1% exosome-depleted FBS to Advanced culture media enabled for reduced presence of contaminating bovine EVs while still ensuring an acceptable cell proliferation and low cellular stress. Cells were gradually adapted to these new media. Furthermore, using the Integra CELLine AD1000 culture flask we increased the number of cells and thereby EVs in 3D-culture. A combination of ultrafiltration with different molecular weight cut-offs and size-exclusion chromatography was further used for the isolation of a heterogeneous population of small EVs with low protein contamination. The EVs were characterized by nanoparticle tracking analysis, immunoaffinity capture, flow cytometry, Western blot and transmission electron microscopy. We successfully isolated a significant amount of small EVs compatible with exosomes from three distinct cell lines in order to demonstrate reproducibility with cell lines of different origin. The EVs were characterized as CD9 positive with a size between 60-140 nm. We conclude that this new combination of methods is a robust and improved strategy for the isolation of EVs, and in particular small EVs compatible with exosomes, from cell culture media without the use of specialized equipment such as an ultracentrifuge.	[Guerreiro, Eduarda M.; Saeed, Muhammad; Galtung, Hilde Kanli; Soland, Tine M.] Univ Oslo, Inst Oral Biol, Fac Dent, Oslo, Norway; [Vestad, Beate; Steffensen, Lilly Alice; Aass, Hans Christian D.; Ovstebo, Reidun] Oslo Univ Hosp, Dept Med Biochem, Blood Cell Res Grp, Oslo, Norway; [Saeed, Muhammad] Univ Oslo, Inst Oral Biol, Electron Microscopy Lab, Oslo, Norway; [Costea, Daniela Elena] Univ Bergen, Ctr Canc Biomarkers CCBio, Bergen, Norway; [Costea, Daniela Elena] Univ Bergen, Gade Lab Pathol, Dept Clin Med, Bergen, Norway; [Costea, Daniela Elena] Haukeland Hosp, Dept Pathol, Bergen, Norway; [Soland, Tine M.] Oslo Univ Hosp, Dept Pathol, Oslo, Norway; [Vestad, Beate] Oslo Univ Hosp, Rikshosp, Internal Med Res Inst, Oslo, Norway; [Vestad, Beate] Univ Oslo, Inst Clin Med, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo	Soland, TM (corresponding author), Univ Oslo, Inst Oral Biol, Fac Dent, Oslo, Norway.; Soland, TM (corresponding author), Oslo Univ Hosp, Dept Pathol, Oslo, Norway.	t.m.soland@odont.uio.no	Søland, Tine/AAQ-4859-2021; Galtung, Hilde/ABD-9199-2020; Costea, Daniela Elena/AAB-9705-2020	Soland, Tine Merete/0000-0003-1687-3247; Costea, Daniela-Elena/0000-0001-7673-0358	Tannlegeundervisningens fond; Faculty of Dentistry, University of Oslo; Nansenfondet; Research Council of Norway through its Centers of Excellence funding scheme [223250]	Tannlegeundervisningens fond; Faculty of Dentistry, University of Oslo; Nansenfondet; Research Council of Norway through its Centers of Excellence funding scheme	This work received support from Tannlegeundervisningens fond (EG, HKG, TMS); https://unifor.no; Faculty of Dentistry, University of Oslo (HKG, TMS); https://www.odont.uio.no; Nansenfondet (HKG, TMS); http://www.nansenfondet.no; and The Research Council of Norway through its Centers of Excellence funding scheme, project number 223250 (DEC); https://www.forskningsradet.no/en/Home_page/1177315753906. This research has been funded by "Tannlegeundervisningens fond" (Eduarda M. Guerreiro, Hilde Galtung, Tine M. Soland), Faculty of Dentistry, University of Oslo (Hilde Galtung, Tine M. Soland), Nansenfondet (Hilde Galtung, Tine M. Soland), and the Research Council of Norway through its Centers of Excellence funding scheme, project number 223250 (Daniela Elena Costea).	Aqrawi LA, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1228-x; Azmi AS, 2013, CANCER METAST REV, V32, P623, DOI 10.1007/s10555-013-9441-9; Baranyai T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145686; BARNES D, 1980, CELL, V22, P649, DOI 10.1016/0092-8674(80)90540-1; Bellingham SA, 2012, NUCLEIC ACIDS RES, V40, P10937, DOI 10.1093/nar/gks832; Benedikter BJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15717-7; Boing AN, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.23430; Brinton LT, 2015, CELL MOL LIFE SCI, V72, P659, DOI 10.1007/s00018-014-1764-3; BUTLER M, 1989, J BIOTECHNOL, V12, P97, DOI 10.1016/0168-1656(89)90009-6; Butler M, 2005, APPL MICROBIOL BIOT, V68, P283, DOI 10.1007/s00253-005-1980-8; Eitan E, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.26373; EL Andaloussi S, 2013, NAT REV DRUG DISCOV, V12, P348, DOI 10.1038/nrd3978; Francis GL, 2010, CYTOTECHNOLOGY, V62, P1, DOI 10.1007/s10616-010-9263-3; Gamez-Valero A, 2016, SCI REP-UK, V6, DOI 10.1038/srep33641; Garcia NA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138849; Gardiner C, 2016, J EXTRACELL VESICLES, V5, DOI 10.3402/jev.v5.32945; Hessvik NP, 2018, CELL MOL LIFE SCI, V75, P193, DOI 10.1007/s00018-017-2595-9; Hong CS, 2016, J EXTRACELL VESICLES, V5, DOI 10.3402/jev.v5.29289; Kim JW, 2005, CLIN CANCER RES, V11, P1010; Konoshenko MY, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/8545347; Kornilov R, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2017.1422674; KW P., 2015, TRANSL BIOMED, V6, P1, DOI DOI 10.21767/2172-0479.100018; Levin VA, 2010, J PROTEOME RES, V9, P179, DOI 10.1021/pr900392b; Linares R, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.29509; Lobb RJ, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27031; Lotvall J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.26913; Maas SLN, 2017, TRENDS CELL BIOL, V27, P172, DOI 10.1016/j.tcb.2016.11.003; Mitchell JP, 2008, J IMMUNOL METHODS, V335, P98, DOI 10.1016/j.jim.2008.03.001; Mol EA, 2017, NANOMED-NANOTECHNOL, V13, P2061, DOI 10.1016/j.nano.2017.03.011; Muller L, 2014, J IMMUNOL METHODS, V411, P55, DOI 10.1016/j.jim.2014.06.007; NEUMANNOVA V, 1995, IN VITRO CELL DEV-AN, V31, P625; Nordin JZ, 2015, NANOMED-NANOTECHNOL, V11, P879, DOI 10.1016/j.nano.2015.01.003; Pirkmajer S, 2011, AM J PHYSIOL-CELL PH, V301, pC272, DOI 10.1152/ajpcell.00091.2011; Raimondo F, 2011, PROTEOMICS, V11, P709, DOI 10.1002/pmic.201000422; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Roma-Rodrigues C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/179486; Shelke GV, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24783; Smyth T, 2015, J CONTROL RELEASE, V199, P145, DOI 10.1016/j.jconrel.2014.12.013; Sun L, 2014, ACTA PHARMACOL SIN, V35, P381, DOI 10.1038/aps.2013.166; Sundstrom T, 2013, CANCER RES, V73, P2445, DOI 10.1158/0008-5472.CAN-12-3514; Szatanek R, 2015, INT J MOL MED, V36, P11, DOI 10.3892/ijmm.2015.2194; Taylor DD, 2015, METHODS, V87, P3, DOI 10.1016/j.ymeth.2015.02.019; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Trebak M, 1999, J IMMUNOL METHODS, V230, P59, DOI 10.1016/S0022-1759(99)00122-2; Vader P, 2014, TRENDS MOL MED, V20, P385, DOI 10.1016/j.molmed.2014.03.002; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Van Deun J, 2017, NAT METHODS, V14, P228, DOI 10.1038/nmeth.4185; Vestad B, 2017, J EXTRACELL VESICLES, V6, P1, DOI 10.1080/20013078.2017.1344087; Vojtech L, 2014, NUCLEIC ACIDS RES, V42, P7290, DOI 10.1093/nar/gku347; Xu R, 2016, J CLIN INVEST, V126, P1152, DOI 10.1172/JCI81129; Zabeo D, 2017, J EXTRACELL VESICLES, V6, DOI 10.1080/20013078.2017.1329476	51	68	70	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204276	10.1371/journal.pone.0204276	http://dx.doi.org/10.1371/journal.pone.0204276			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30260987	Green Published, gold, Green Submitted			2022-12-26	WOS:000445907400031
J	Dumont, S; Bykova, NV; Khaou, A; Besserour, Y; Dorval, M; Rivoal, J				Dumont, Sebastien; Bykova, Natalia, V; Khaou, Alexia; Besserour, Yasmine; Dorval, Maude; Rivoal, Jean			Arabidopsis thaliana alcohol dehydrogenase is differently affected by several redox modifications	PLOS ONE			English	Article							CYTOSOLIC GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; PROTEIN S-GLUTATHIONYLATION; OXIDATIVE STRESS; HYDROGEN-PEROXIDE; METABOLIC ENZYMES; PLANT-RESPONSES; NITRIC-OXIDE; NO LEVELS; HYPOXIA; NITROSYLATION	In plant cells, many stresses, including low oxygen availability, result in a higher production of reactive oxygen species (ROS) and reactive nitrogen species (RNS). These molecules can lead to redox-dependent post-translational modification of proteins Cys residues. Here, we studied the effect of different redox modifications on alcohol dehydrogenase (ADH) from Arabidopsis thaliana. ADH catalyzes the last step of the ethanol fermentation pathway used by plants to cope with energy deficiency during hypoxic stress. Arabidopsis suspension cell cultures showed decreased ADH activity upon exposure to H2O2, but not to the thiol oxidizing agent diamide. We purified recombinant ADH and observed a significant decrease in the enzyme activity by treatments with H2O2 and diethylamine NONOate (DEA/NO). Treatments leading to the formation of a disulfide bond between ADH and glutathione (protein S-glutathionylation) had no negative effect on the enzyme activity. LC-MS/MS analysis showed that Cys47 and Cys243 could make a stable disulfide bond with glutathione, suggesting redox sensitivity of these residues. Mutation of ADH Cys47 to Ser caused an almost complete loss of the enzyme activity while the Cys243 to Ser mutant had increased specific activity. Incubation of ADH with NAD(+) or NADH prevented inhibition of the enzyme by H2O2 or DEA/NO. These results suggest that binding of ADH with its cofactors may limit availability of Cys residues to redox modifications. Our study demonstrates that ADH from A. thaliana is subject to different redox modifications. Implications of ADH sensitivity to ROS and RNS during hypoxic stress conditions are discussed.	[Dumont, Sebastien; Khaou, Alexia; Besserour, Yasmine; Dorval, Maude; Rivoal, Jean] Univ Montreal, Inst Rech Biol Vegetale, Montreal, PQ, Canada; [Bykova, Natalia, V] Agr & Agri Food Canada, Morden Res & Dev Ctr, Morden, MB, Canada	Universite de Montreal; Agriculture & Agri Food Canada	Rivoal, J (corresponding author), Univ Montreal, Inst Rech Biol Vegetale, Montreal, PQ, Canada.	jean.rivoal@umontreal.ca	Rivoal, Jean/J-6544-2014	Rivoal, Jean/0000-0002-8991-0566	Discovery Grant from the National Science and Engineering Research Council of Canada [RGPIN 227271]; Agriculture and Agri-Food Canada Agri-Innovation [J-001356]; Fonds de Recherche du Quebec - Nature et Technologies; National Science and Engineering Research Council of Canada	Discovery Grant from the National Science and Engineering Research Council of Canada; Agriculture and Agri-Food Canada Agri-Innovation(Agriculture & Agri Food Canada); Fonds de Recherche du Quebec - Nature et Technologies; National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a Discovery Grant from the National Science and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp) to JR (grant number RGPIN 227271), and by Agriculture and Agri-Food Canada (http://www.agr.gc.ca) Agri-Innovation funding to NVB (AAFC project J-001356). SD was supported by a graduate fellowship from the Fonds de Recherche du Quebec - Nature et Technologies and YB received an Undergraduate Student Research Award from the National Science and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akter S, 2015, MOL CELL PROTEOMICS, V14, P1183, DOI 10.1074/mcp.M114.046896; ANDREWS DL, 1993, PLANT PHYSIOL, V101, P407, DOI 10.1104/pp.101.2.407; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Bailey-Serres J, 2008, ANNU REV PLANT BIOL, V59, P313, DOI 10.1146/annurev.arplant.59.032607.092752; BaileySerres J, 1996, PLANT PHYSIOL, V112, P685, DOI 10.1104/pp.112.2.685; Barford D, 2004, CURR OPIN STRUC BIOL, V14, P679, DOI 10.1016/j.sbi.2004.09.012; Bedhomme M, 2012, BIOCHEM J, V445, P337, DOI 10.1042/BJ20120505; Biemelt S, 2000, PLANT CELL ENVIRON, V23, P135, DOI 10.1046/j.1365-3040.2000.00542.x; Borisjuk L, 2004, PLANT BIOLOGY, V6, P375, DOI 10.1055/s-2004-817908; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bucciarelli T, 2009, BBA-PROTEINS PROTEOM, V1794, P563, DOI 10.1016/j.bbapap.2008.12.009; Chang R, 2012, PLANT MOL BIOL, V78, P109, DOI 10.1007/s11103-011-9850-5; Charles RL, 2007, MOL CELL PROTEOMICS, V6, P1473, DOI 10.1074/mcp.M700065-MCP200; Chen FF, 2015, BIOCHIMIE, V108, P33, DOI 10.1016/j.biochi.2014.10.023; Cole SR, 2012, J AM SOC MASS SPECTR, V23, P310, DOI 10.1007/s13361-011-0300-z; CROW JP, 1995, BIOCHEMISTRY-US, V34, P3544, DOI 10.1021/bi00011a008; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; Dixon DP, 2005, PLANT PHYSIOL, V138, P2233, DOI 10.1104/pp.104.058917; Dordas C, 2004, PLANTA, V219, P66, DOI 10.1007/s00425-004-1212-y; Dordas C, 2003, PLANT J, V35, P763, DOI 10.1046/j.1365-313X.2003.01846.x; Dorion S, 2005, PLANT SCI, V168, P183, DOI 10.1016/j.plantsci.2004.07.029; Dumont S, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01942; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Fares A, 2011, BIOCHEM BIOPH RES CO, V416, P331, DOI 10.1016/j.bbrc.2011.11.036; Foyer CH, 2009, ANTIOXID REDOX SIGN, V11, P861, DOI 10.1089/ars.2008.2177; Fukao T, 2004, TRENDS PLANT SCI, V9, P449, DOI 10.1016/j.tplants.2004.07.005; Gergel D, 1996, BIOCHEMISTRY-US, V35, P16186, DOI 10.1021/bi962043r; Hancock JT, 2005, PLANT PHYSIOL BIOCH, V43, P828, DOI 10.1016/j.plaphy.2005.07.012; Igamberdiev AU, 2004, J EXP BOT, V55, P2473, DOI 10.1093/jxb/erh272; Ismond KP, 2003, PLANT PHYSIOL, V132, P1292, DOI 10.1104/pp.103.022244; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Kato H, 2013, PHYSIOL PLANTARUM, V148, P371, DOI 10.1111/j.1399-3054.2012.01684.x; Klok EJ, 2002, PLANT CELL, V14, P2481, DOI 10.1105/tpc.004747; KOSOWER NS, 1995, METHOD ENZYMOL, V251, P123, DOI 10.1016/0076-6879(95)51116-4; Kumutha D, 2009, BIOL PLANTARUM, V53, P75, DOI 10.1007/s10535-009-0011-5; Marsolais F, 2010, J PROTEOMICS, V73, P1587, DOI 10.1016/j.jprot.2010.03.013; Martinez-Ruiz A, 2007, CARDIOVASC RES, V75, P220, DOI 10.1016/j.cardiores.2007.03.016; McCall KA, 2000, ANAL BIOCHEM, V284, P307, DOI 10.1006/abio.2000.4706; McDonagh B, 2009, J PROTEOMICS, V72, P677, DOI 10.1016/j.jprot.2009.01.023; Meitha K, 2015, ANN BOT-LONDON, V116, P703, DOI 10.1093/aob/mcv123; Men L, 2007, J PROTEOME RES, V6, P216, DOI 10.1021/pr0603809; Michelet L, 2008, J BIOL CHEM, V283, P21571, DOI 10.1074/jbc.M802331200; Moller IM, 2007, ANNU REV PLANT BIOL, V58, P459, DOI 10.1146/annurev.arplant.58.032806.103946; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; PARK JW, 1988, BIOCHEM BIOPH RES CO, V152, P916, DOI 10.1016/S0006-291X(88)80127-X; Peng HP, 2001, PLANT PHYSIOL, V126, P742, DOI 10.1104/pp.126.2.742; PERATA P, 1993, PLANT SCI, V93, P1, DOI 10.1016/0168-9452(93)90029-Y; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; Queval G, 2007, ANAL BIOCHEM, V363, P58, DOI 10.1016/j.ab.2007.01.005; Rauk A, 1998, J AM CHEM SOC, V120, P8848, DOI 10.1021/ja9807789; RICARD B, 1989, PLANT MOL BIOL, V12, P131, DOI 10.1007/BF00020498; RIVOAL J, 1989, PLANT PHYSIOL BIOCH, V27, P43; ROBERTS JKM, 1984, P NATL ACAD SCI-BIOL, V81, P3379, DOI 10.1073/pnas.81.11.3379; Sambrook J, 1989, MOL CLONING, DOI [10.1007/BF00020498, DOI 10.1007/BF00020498]; Shi HT, 2017, PLANT SCI, V262, P24, DOI 10.1016/j.plantsci.2017.05.013; SHIMOMURA S, 1983, PLANT PHYSIOL, V71, P736, DOI 10.1104/pp.71.4.736; Strommer J, 2011, PLANT J, V66, P128, DOI 10.1111/j.1365-313X.2010.04458.x; Sweetlove LJ, 2002, PLANT J, V32, P891, DOI 10.1046/j.1365-313X.2002.01474.x; Tripathy BC, 2012, PLANT SIGNAL BEHAV, V7, P1621, DOI 10.4161/psb.22455; van der Linde K, 2011, PLANT PHYSIOL BIOCH, V49, P946, DOI 10.1016/j.plaphy.2011.06.009; van Dongen JT, 2015, ANNU REV PLANT BIOL, V66, P345, DOI 10.1146/annurev-arplant-043014-114813; Vergara R, 2012, J EXP BOT, V63, P4123, DOI 10.1093/jxb/ers094; Wilson ID, 2008, PLANT CELL ENVIRON, V31, P622, DOI 10.1111/j.1365-3040.2007.01761.x; Yamazaki D, 2004, PLANT CELL PHYSIOL, V45, P18, DOI 10.1093/pcp/pch019; Zaffagnini M, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00450; Zaffagnini M, 2013, J BIOL CHEM, V288, P22777, DOI 10.1074/jbc.M113.475467; Zaffagnini M, 2012, ANTIOXID REDOX SIGN, V16, P567, DOI 10.1089/ars.2011.4255	67	16	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2018	13	9							e0204530	10.1371/journal.pone.0204530	http://dx.doi.org/10.1371/journal.pone.0204530			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU9BO	30252897	Green Submitted, Green Published, gold			2022-12-26	WOS:000445639700060
J	Marques, AR; Forde, H; Revie, CW				Marques, Ana Rita; Forde, Henny; Revie, Crawford W.			Time-series clustering of cage-level sea lice data	PLOS ONE			English	Article							FAST SIMILARITY SEARCH; ATLANTIC SALMON; FARMS; AQUACULTURE; DATABASES; ABUNDANCE	Sea lice Lepeophtheirus salmonis (Kroyer) are a major ectoparasite affecting farmed Atlantic salmon in most major salmon producing regions. Substantial resources are applied to sea lice control and the development of new technologies towards this end. Identifying and understanding how sea lice population patterns vary among cages on a salmon farm can be an important step in the design and analysis of any sea lice control strategy. Norway's intense monitoring efforts have provided salmon farmers and researchers with a wealth of sea lice infestation data. A frequently registered parameter is the number of adult female sea lice per cage. These time-series data can be analysed descriptively, the similarity between time-series quantified, so that groups and patterns can be identified among cages, using clustering algorithms capable of handling such dynamic data. We apply such algorithms to investigate the pattern of female sea lice counts among cages for three Atlantic salmon farms in Norway. A series of strategies involving a combination of distance measures and prototypes were explored and cluster evaluation was performed using cluster validity indices. Repeated agreement on cluster membership for different combinations of distance and centroids was taken to be a strong indicator of clustering while the stability of these results reinforced this likelihood. Though drivers behind clustering are not thoroughly investigated here, it appeared that fish weight at time of stocking and other management practices were strongly related to cluster membership. In addition to these internally driven factors it is also possible that external sources of infestation may drive patterns of sea lice infestation in groups of cages; for example, those most proximal to an external source. This exploratory method proved useful as a pattern discovery tool for cages in salmon farms.	[Marques, Ana Rita; Revie, Crawford W.] Univ Prince Edward Isl, Atlantic Atlant Vet Coll, Dept Hlth Management, Ctr Vet & Epidemiol Res, Charlottetown, PE, Canada; [Forde, Henny] Masoval Fiskeoppdrett AS, Sistranda, Norway	University of Prince Edward Island	Marques, AR (corresponding author), Univ Prince Edward Isl, Atlantic Atlant Vet Coll, Dept Hlth Management, Ctr Vet & Epidemiol Res, Charlottetown, PE, Canada.	amarques@upei.ca	Revie, Crawford/B-5002-2011	Revie, Crawford/0000-0002-5018-0340; Marques, Ana/0000-0002-1508-3246				Aghabozorgi S, 2015, INFORM SYST, V53, P16, DOI 10.1016/j.is.2015.04.007; [Anonymous], IMPUTETS TIME SERIES; Arbelaitz O, 2013, PATTERN RECOGN, V46, P243, DOI 10.1016/j.patcog.2012.07.021; Bui Cong Giao, 2016, Vietnam Journal of Computer Science, V3, P181, DOI 10.1007/s40595-016-0062-4; Chan FKP, 2003, IEEE T KNOWL DATA EN, V15, P686, DOI 10.1109/TKDE.2003.1198399; Costello MJ, 2009, J FISH DIS, V32, P115, DOI 10.1111/j.1365-2761.2008.01011.x; Cuturi M, 2017, P ICASSP, P413; Cuturi M., 2011, REV LIT ARTS AM, P929; Engle CR, 2017, J WORLD AQUACULT SOC, V48, P227, DOI 10.1111/jwas.12423; Faloutsos C., 1994, SIGMOD Record, V23, P419, DOI 10.1145/191843.191925; Grontvedt R, 2015, 2 I NORW VET; Hastie T., 2009, UNSUPERVISED LEARNIN; Hayward CJ, 2011, SALMON LICE: AN INTEGRATED APPROACH TO UNDERSTANDING PARASITE ABUNDANCE AND DISTRIBUTION, P1; Heuch PA, 2005, AQUACULTURE, V246, P79, DOI 10.1016/j.aquaculture.2004.12.027; Heuch PA, 2011, AQUACULTURE, V320, P149, DOI 10.1016/j.aquaculture.2011.05.002; Hornik K, CLUE CLUSTER ENSEMBL; Johnson SC, 2004, ZOOL STUD, V43, P229; Jones AC, 2015, FISH FISH, V16, P668, DOI 10.1111/faf.12086; Keogh E, 1997, PROC INT C TOOLS ART, P578, DOI 10.1109/TAI.1997.632306; Keogh EJ, 2000, LECT NOTES ARTIF INT, V1805, P122, DOI 10.1007/3-540-45571-x_14; Liao TW, 2005, PATTERN RECOGN, V38, P1857, DOI 10.1016/j.patcog.2005.01.025; Liu YJ, 2014, PREV VET MED, V117, P469, DOI 10.1016/j.prevetmed.2014.08.018; Liu YJ, 2011, MAR POLICY, V35, P413, DOI 10.1016/j.marpol.2010.11.007; Mardones FO, 2009, DIS AQUAT ORGAN, V84, P105, DOI 10.3354/dao02040; Marques AR, 2016, PREV VET MED, V463, P37; McKenzie E, 2004, AQUAC RES, V35, P764, DOI 10.1111/j.1365-2109.2004.01099.x; Mizutani E, 2016, MECH ENG SEM TOK MET; Moritz MS, TITLE TIME SERIES MI; Petitjean F, 2011, PATTERN RECOGN, V44, P678, DOI 10.1016/j.patcog.2010.09.013; Qian Chen, 2012, 2012 11th International Conference on Information Sciences, Signal Processing and their Applications (ISSPA), P1272, DOI 10.1109/ISSPA.2012.6310488; R Development Core Team, 2017, R LANG ENV STAT COMP; Ratanamahatana A, 2004, 3RD WORKSHOP MINING; Ratanamahatana CA, 2004, SIAM PROC S, P11; Regjeringen, 2017, NEW RUL LOUS LIM SPR; Revie C., 2009, SEA LICE WORKING GRO; Revie CW, 2007, PREV VET MED, V81, P135, DOI 10.1016/j.prevetmed.2007.04.004; Revie CW, 2005, J FISH BIOL, V66, P773, DOI 10.1111/j.0022-1112.2005.00642.x; Sarda-Espinosa A, DTWCLUST TIME SERIES; Sarda-Espinosa A, 2017, COMP TIME SERIES CLU; Solsvik T., 2017, NORWAY INTRO NEW SAL; Stien LH, 2016, AQUACULTURE, V458, P29, DOI 10.1016/j.aquaculture.2016.02.014	41	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2018	13	9							e0204319	10.1371/journal.pone.0204319	http://dx.doi.org/10.1371/journal.pone.0204319			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU9BO	30252874	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000445639700042
J	Rosenberg, R; Bono, MS; Braganza, S; Vaishnav, C; Karnik, R; Hart, AJ				Rosenberg, Ron; Bono, Michael S., Jr.; Braganza, Soumya; Vaishnav, Chintan; Karnik, Rohit; Hart, A. John			In-field determination of soil ion content using a handheld device and screen-printed solid-state ion-selective electrodes	PLOS ONE			English	Article							POTENTIOMETRIC SENSORS; CONDUCTING POLYMER; CARBON NANOTUBES; CONTACT; TRANSDUCER; MANAGEMENT; IONOPHORE; MEMBRANE	Small-holding farmers in the developing world suffer from sub-optimal crop yields because they lack a soil diagnostic system that is affordable, usable, and actionable. This paper details the fabrication and characterization of an integrated point-of-use soil-testing system, comprised of disposable ion-selective electrode strips and a handheld electrochemical reader. Together, the strips and reader transduce soil ion concentrations into to an alphanumeric output that can be communicated via text message to a central service provider offering immediate, customized fertilizer advisory. The solid-state ion-selective electrode (SS-ISE) strips employ a two-electrode design with screen-printable carbon nanotube ink serving as the electrical contacts for the working and reference electrodes. The working electrode comprises a plasticizer-free butyl acrylate ion-selective membrane (ISM), doped with an ion-selective ionophore and lipophilic salt. Meanwhile, the reference electrode includes a screen-printed silver-silver chloride ink and a polyvinyl-butyral membrane, which is doped with sodium chloride for stable reference potentials. As a proof of concept, potassium-selective electrodes are studied, given potassium's essential role in plant growth and reproduction. The ISE-based system is reproducibly manufactured to yield a Nernstian response with a sub-micromolar detection limit (pK(+) of 5.18 +/- 0.08) and near-Nernstian sensitivity (61 mV/decade) in the presence of a 0.02 M strontium chloride extraction solution. Analysis of soil samples using the printed electrodes and reader yielded a correlation coefficient of R-2 = 0.89 with respect to values measured via inductively coupled plasma atomic emission spectroscopy (ICP-AES). The reliable performance of this system is encouraging toward its deployment for soil nutrient management in resource-limited environments.	[Rosenberg, Ron; Bono, Michael S., Jr.; Karnik, Rohit; Hart, A. John] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Braganza, Soumya] MIT, Technol & Publ Policy Program, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Vaishnav, Chintan] MIT, Sloan Sch Management, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Hart, AJ (corresponding author), MIT, Dept Mech Engn, Cambridge, MA 02139 USA.	ajhart@mit.edu	Vaishnav, Chintan/AAH-7717-2021; Hart, A. John/A-9027-2010	Vaishnav, Chintan/0000-0002-1153-8880; Hart, A. John/0000-0002-7372-3512; Bono, Michael/0000-0002-6969-1300	Tata Center for Technology and Design at MIT; Tata Trusts; National Science Foundation [DMR-1419807]	Tata Center for Technology and Design at MIT; Tata Trusts; National Science Foundation(National Science Foundation (NSF))	This research was supported by the Tata Center for Technology and Design at MIT (https://tatacenter.mit.edu/programs/), which was funded with generous support from the Tata Trusts. Soil analysis via ICP-AES made use of the MRSEC Shared Experimental Facilities at MIT, supported by the National Science Foundation under award number DMR-1419807. The Tata Trusts and National Science Foundation had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Tata Center for Technology and Design at MIT, which was funded with generous support from the Tata Trusts. Soil analysis via ICP-AES made use of the MRSEC Shared Experimental Facilities at MIT, supported by the National Science Foundation under award number DMR-1419807. We also thank Dr. Rob Stoner and Dr. Nevan Hanumara of the MIT Tata Center, who not only advised the project on an individual level but also supported a community of students and postdocs interested in technology for development; as well as Naveen Jha (Deshpande Center) and Malavika Chauhan (Himmotthan Foundation), who provided valuable insight and interaction with potential end users of soil testing technology in India. To that end, we would like to especially thank the hundreds of farmers who took precious time out of their day for us, who opened their doors warmly with openness and endless chai, and who offered invaluable, honest feedback on our prototypes. Finally, Prof. Yang Shao-Horn's Electrochemical Energy Laboratory group, particularly Nir Pour and Chris Bachman, were invaluable in providing both their electrochemistry expertise and access to the glove box and potentiostat used in this study.	Amemiya S, 2003, ANAL CHEM, V75, P3329, DOI 10.1021/ac026471g; Ammann D., 1986, ION SELECTIVE MICROE, V1, DOI [10.1007/978-3-642-52507-0, DOI 10.1007/978-3-642-52507-0]; Bakker E, 2005, TRAC-TREND ANAL CHEM, V24, P199, DOI 10.1016/j.trac.2005.01.003; Bakker E, 2008, J BRAZIL CHEM SOC, V19, P621, DOI 10.1590/S0103-50532008000400003; Bank, 2007, WORLD DEV REPORT 200; Bobacka J, 2006, ELECTROANAL, V18, P7, DOI 10.1002/elan.200503384; Borthakur A, 2013, CURR SCI INDIA, V105, P587; Braganza S., 2016, POINT OF USE SOIL DI, DOI [10.1142/S2339547816500011, DOI 10.1142/S2339547816500011]; CADOGAN A, 1992, ANAL CHEM, V64, P2496, DOI 10.1021/ac00045a007; Chen XP, 2011, P NATL ACAD SCI USA, V108, P6399, DOI 10.1073/pnas.1101419108; Chierotti MR, 2012, SUPRAMOL CHEM MOL NA, P4014, DOI [10.1002/9780470661345.smc010, DOI 10.1002/9780470661345.SMC010]; Chumbimuni-Torres KY, 2006, ANAL CHEM, V78, P1318, DOI 10.1021/ac050749y; Crespo GA, 2008, ANAL CHEM, V80, P1316, DOI 10.1021/ac071156l; Crespo GA, 2009, ANAL CHEM, V81, P676, DOI 10.1021/ac802078z; Debye P, 1923, PHYS Z, V24, P185; Dryden MDM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140349; Fibbioli M, 2000, ELECTROANAL, V12, P1286, DOI 10.1002/1521-4109(200011)12:16<1286::AID-ELAN1286>3.0.CO;2-Q; Glendenning C. J., 2010, REV AGR EXTENSION IN, P1; Gugerty M.K., 2011, EVANS SCH REV, V1, P56, DOI DOI 10.7152/ESR.V1I1.12249; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; HAVLIN JL, 1999, SOIL FERTILITY FERTI, P1; HIRATA H, 1970, ANAL CHIM ACTA, V51, P209, DOI 10.1016/S0003-2670(01)95708-3; Hu JB, 2016, TRAC-TREND ANAL CHEM, V76, P102, DOI 10.1016/j.trac.2015.11.004; Kalba K, 2008, INT J COMMUN-US, V2, P631; Kienzle J., 2013, MECHANIZATION RURAL, V20; Kogan M, 1998, ANNU REV ENTOMOL, V43, P243, DOI 10.1146/annurev.ento.43.1.243; Lai CZ, 2009, J SOLID STATE ELECTR, V13, P123, DOI 10.1007/s10008-008-0579-2; Lan WJ, 2014, ANAL CHEM, V86, P9548, DOI 10.1021/ac5018088; Le C, 2010, ENVIRON MANAGE, V45, P662, DOI 10.1007/s00267-010-9440-3; Macca C, 1996, ANAL CHIM ACTA, V321, P1, DOI 10.1016/0003-2670(95)00545-5; Martinez AW, 2010, ANAL CHEM, V82, P3, DOI 10.1021/ac9013989; Maxwell EJ, 2013, MRS BULL, V38, P309, DOI 10.1557/mrs.2013.56; Mensah ST, 2014, ANAL CHEM, V86, P7269, DOI 10.1021/ac501470p; Michalska A, 2004, ANAL CHIM ACTA, V523, P97, DOI 10.1016/j.aca.2004.07.020; Mikhelson KN, 2013, LECT NOTES CHEM, P97; Parker B.L., 2008, GREENHOUSE MANAGERS; Rius-Ruiz FX, 2011, ANAL BIOANAL CHEM, V399, P3613, DOI 10.1007/s00216-011-4689-9; Rowe AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023783; Smolka M, 2017, PRECIS AGRIC, V18, P152, DOI 10.1007/s11119-016-9452-y; van der Ploeg JD, 2012, DEV CHANGE, V43, P439, DOI 10.1111/j.1467-7660.2012.01761.x; Vanamo U, 2014, ELECTROCHIM ACTA, V122, P316, DOI 10.1016/j.electacta.2013.10.134; Vazquez M, 2002, SENSOR ACTUAT B-CHEM, V82, P7, DOI 10.1016/S0925-4005(01)00983-2; Wang C, 2017, SCI REP, V7, DOI [10.1038/s41598-017-00035-9, DOI 10.1038/S41598-017-00035-9]; Yamada K, 2017, LAB CHIP, V17, P1206, DOI 10.1039/c6lc01577h; Zheng X., 2004, GLOBAL BIOGEOCHEM CY, V18	45	13	13	6	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2018	13	9							e0203862	10.1371/journal.pone.0203862	http://dx.doi.org/10.1371/journal.pone.0203862			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU9BO	30252859	Green Submitted, Green Published, gold			2022-12-26	WOS:000445639700015
J	Dravet-Gounot, P; Torchin, H; Goffinet, F; Aubelle, MS; El Ayoubi, M; Lefevre, C; Jarreau, PH; Zana-Taieb, E				Dravet-Gounot, Pauline; Torchin, Heloise; Goffinet, Francois; Aubelle, Marie-Stephanie; El Ayoubi, Mayass; Lefevre, Claire; Jarreau, Pierre-Henri; Zana-Taieb, Elodie			Bronchopulmonary dysplasia in neonates born to mothers with preeclampsia: Impact of small for gestational age	PLOS ONE			English	Article							FETAL-GROWTH RESTRICTION; CHRONIC LUNG-DISEASE; PRETERM INFANTS; ANGIOGENIC FACTORS; BIRTH-WEIGHT; PREMATURITY; MORBIDITY; MORTALITY; SURVIVAL; OUTCOMES	Background and objectives Small for gestational age and preeclampsia have both been described as risk factors for bronchopulmonary dysplasia in preterm neonates, but their respective role in the occurrence of bronchopulmonary dysplasia is debated. We evaluated the relation between small for gestational age and bronchopulmonary dysplasia in neonates born to mothers with preeclampsia. We hypothesized that low birth weight is still associated with bronchopulmonary dysplasia in this homogeneous population. Methods Retrospective single-center cohort study including 141 neonates born between 24 and 30 weeks' gestation to mothers with preeclampsia. The main outcome measure was moderate to severe bronchopulmonary dysplasia at 36 weeks' postmenstrual age. Neonates born small for gestational age (birthweight < 10th percentile on the AUDIPOG curves) were compared to those with appropriate birthweight for gestational age by bivariable analyses and logistic regression models, estimating odds ratios (ORs) and 95% confidence intervals (CIs). Results Bronchopulmonary dysplasia rates were 61.5% (32/52) and 27.4% (20/73) for small for gestational age and appropriate birthweight for gestational age neonates (p < .001). On adjustment for gestational age and other confounding factors, the risk of moderate to severe bronchopulmonary dysplasia was greater for small for gestational age than appropriate birthweight for gestational age neonates (adjusted OR = 5.9, 95% CI [2.2-15.4]), as was the composite outcome death or moderate to severe bronchopulmonary dysplasia (adjusted OR = 4.7, 95% CI [1.9-11.3]). Conclusions Small for gestational age was associated with bronchopulmonary dysplasia in very preterm neonates born to mothers with preeclampsia.	[Dravet-Gounot, Pauline; Torchin, Heloise; Aubelle, Marie-Stephanie; El Ayoubi, Mayass; Lefevre, Claire; Jarreau, Pierre-Henri; Zana-Taieb, Elodie] Hop Cochin, AP HP, Maternite Port Royal, Serv Med & Reanimat Neonatales, Paris, France; [Dravet-Gounot, Pauline; Torchin, Heloise; Goffinet, Francois; Aubelle, Marie-Stephanie; El Ayoubi, Mayass; Lefevre, Claire; Jarreau, Pierre-Henri; Zana-Taieb, Elodie] Maternite Port Royal, DHU Risques & Grossesse, Paris, France; [Torchin, Heloise; Goffinet, Francois; El Ayoubi, Mayass; Jarreau, Pierre-Henri] INSERM, U1153, Paris, France; [Goffinet, Francois] Hop Cochin, Maternite Port Royal, AP HP, Serv Gynecol Obstetr, Paris, France; [Zana-Taieb, Elodie] INSERM, U1141, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Dravet-Gounot, P (corresponding author), Hop Cochin, AP HP, Maternite Port Royal, Serv Med & Reanimat Neonatales, Paris, France.; Dravet-Gounot, P (corresponding author), Maternite Port Royal, DHU Risques & Grossesse, Paris, France.	pauline.dravet@aphp.fr	Torchin, Héloise/AAM-5170-2020	Torchin, Héloise/0000-0003-4699-5384; DRAVET, Pauline/0000-0002-7070-5239				Abman SH, 2001, AM J RESP CRIT CARE, V164, P1755, DOI 10.1164/ajrccm.164.10.2109111c; Alahakoon TI, 2014, J MATERN-FETAL NEO M, V27, P1854, DOI 10.3109/14767058.2014.880882; Aucott Susan W, 2004, J Perinatol, V24, P435; Baraldi E, 2007, NEW ENGL J MED, V357, P1946, DOI 10.1056/NEJMra067279; Baud O, 2016, LANCET, V387, P1827, DOI 10.1016/S0140-6736(16)00202-6; BELL MJ, 1978, NEW ENGL J MED, V298, P281; Durrmeyer X, 2012, J PEDIATR-US, V160, P578, DOI 10.1016/j.jpeds.2011.09.025; Ehrenkranz RA, 2005, PEDIATRICS, V116, P1353, DOI 10.1542/peds.2005-0249; Eriksson L, 2014, PEDIATR PULM, V49, P665, DOI 10.1002/ppul.22881; Gagliardi L, 2013, PEDIATR RES, V73, P794, DOI 10.1038/pr.2013.52; Garite TJ, 2004, AM J OBSTET GYNECOL, V191, P481, DOI 10.1016/j.ajog.2004.01.036; Hall D, 2003, J TROP PEDIATRICS, V49, P178, DOI 10.1093/tropej/49.3.178; Hansen AR, 2010, J PEDIATR-US, V156, P532, DOI 10.1016/j.jpeds.2009.10.018; Hasan J, 2009, PEDIATRICS, V123, P1541, DOI 10.1542/peds.2008-1670; Hines D, 2017, ACTA PAEDIATR, V106, P366, DOI 10.1111/apa.13672; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Lal MK, 2003, PEDIATRICS, V111, P483, DOI 10.1542/peds.111.3.483; Mamelle N., 1996, Journal de Gynecologie Obstetrique et Biologie de la Reproduction, V25, P61; Nanjo S, 2017, J OBSTET GYNAECOL RE, V43, P1805, DOI 10.1111/jog.13452; Nobile S, 2017, EUR J PEDIATR, V176, P1083, DOI 10.1007/s00431-017-2957-1; Ozkan H, 2012, J MATERN-FETAL NEO M, V25, P2681, DOI 10.3109/14767058.2012.708371; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Qiu XM, 2012, AM J PERINAT, V29, P87, DOI 10.1055/s-0031-1295647; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Reiss Irwin, 2003, Archives of Gynecology and Obstetrics, V269, P40, DOI 10.1007/s00404-003-0486-9; Soliman N, 2017, AM J PERINAT, V34, P585, DOI 10.1055/s-0036-1594017; Soudee S, 2014, NEONATOLOGY, V106, P304, DOI 10.1159/000360842; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Tang JR, 2012, AM J PHYSIOL-LUNG C, V302, pL36, DOI 10.1152/ajplung.00294.2011; Thebaud B, 2005, CIRCULATION, V112, P2477, DOI 10.1161/CIRCULATIONAHA.105.541524; Thebaud B, 2007, AM J RESP CRIT CARE, V175, P978, DOI 10.1164/rccm.200611-1660PP; Torchin H, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2163; Tsatsaris V, 2010, Ann Fr Anesth Reanim, V29, pe13, DOI 10.1016/j.annfar.2010.02.011; Vatten LJ, 2012, ACTA OBSTET GYN SCAN, V91, P1388, DOI 10.1111/j.1600-0412.2012.01516.x; Walsh Michele C, 2003, J Perinatol, V23, P451, DOI 10.1038/sj.jp.7210963; Wang A, 2009, PHYSIOLOGY, V24, P147, DOI 10.1152/physiol.00043.2008; Weller K, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0023931, 10.1371/journal.pone.0026937]; Yamakawa T, 2016, EARLY HUM DEV, V92, P7, DOI 10.1016/j.earlhumdev.2015.10.019; Yen TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075168; Zeitlin J, 2010, J PEDIATR-US, V157, P733, DOI 10.1016/j.jpeds.2010.05.002	40	11	12	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2018	13	9							e0204498	10.1371/journal.pone.0204498	http://dx.doi.org/10.1371/journal.pone.0204498			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3MI	30248159	gold, Green Published, Green Submitted			2022-12-26	WOS:000445998100045
J	Marinda, PA; Genschick, S; Khayeka-Wandabwa, C; Kiwanuka-Lubinda, R; Thilsted, SH				Marinda, Pamela A.; Genschick, Sven; Khayeka-Wandabwa, Christopher; Kiwanuka-Lubinda, Rebecca; Thilsted, Shakuntala H.			Dietary diversity determinants and contribution of fish to maternal and under-five nutritional status in Zambia	PLOS ONE			English	Article							SUGAR-SWEETENED BEVERAGES; CHILDHOOD OVERWEIGHT; FOOD-CONSUMPTION; OBESITY; CHILDREN; AQUACULTURE; PREVALENCE; BANGLADESH; SECURITY; ETHIOPIA	Background This study examines socio-economic determinants of food consumption patterns amongst women of reproductive age and children aged 6-59 months from urban poor settlements of Lusaka and their implications for nutritional status. Particular emphasis was placed on the role of fish in their diets and nutritional status. Methods A cross-sectional survey design was applied, in which 714 mother-child dyads, with children aged 6-59 months were enrolled. A three-stage randomized cluster sampling approach was applied. Results The mean dietary diversity score among children aged 6-23 and 24-59 months was 2.98 (+/- 1.27) and 3.478 (+/- 1.07), respectively. In children aged 6-23 months, there was a significant difference in their nutritional status, based on fish consumption (chi(2) = 10.979, df = 2, p = 0.004). Children from poorer households consumed mostly small fish (Kapenta). The quantity of fish consumed by children was significantly associated with stunting in both age groups, odds ratio = 0.947 (95% CI: 0.896, 1.000) for children aged 6-23 months and odds ratio = 1.038 (95% CI: 1.006, 1.072) for children aged 24-59 months old. Other significant risk factors for stunting in children aged 6-23 months were the child's age, mother's body mass index, access to treated water and child morbidity. Child's age, mother's educational level and wealth status were determinants of dietary diversity in children aged 6-59 months as shown by the Poisson regression. Conclusion Nutritional status of children aged 6-23 months is associated with fish consumption, with children consuming fish less likely to be stunted. Small fish (Kapenta) is an animal-source food that is particularly important in the diet of children in urban poor households in Zambia and contributes to better nutritional outcomes. As all small fish stem from capture fisheries, sustainable one health environmental integration, monitoring and management strategies are desirable.	[Marinda, Pamela A.] Univ Zambia, Sch Agr Sci, Dept Food Sci & Nutr, Lusaka, Zambia; [Genschick, Sven] WorldFish, Lusaka, Zambia; [Khayeka-Wandabwa, Christopher] Tianjin Univ, Hlth Sci Platform, SPST, Tianjin, Nankai District, Peoples R China; [Kiwanuka-Lubinda, Rebecca] Univ Zambia, Sch Agr Sci, Dept Agr Econ & Extens, Lusaka, Zambia; [Thilsted, Shakuntala H.] WorldFish, George Town, Malaysia	University of Zambia; CGIAR; Worldfish; Tianjin University; University of Zambia; CGIAR; Worldfish	Marinda, PA (corresponding author), Univ Zambia, Sch Agr Sci, Dept Food Sci & Nutr, Lusaka, Zambia.	ayiera@yahooco.uk		Thilsted, Shakuntala/0000-0002-4041-1651; Genschick, Sven/0000-0003-2630-4822	Federal Ministry for Economic Cooperation and Development, Germany; German Federal Ministry for Economic Cooperation and Development (BMZ) through the Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ) [81170271]	Federal Ministry for Economic Cooperation and Development, Germany; German Federal Ministry for Economic Cooperation and Development (BMZ) through the Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ)	This study was made possible with financial support from the Federal Ministry for Economic Cooperation and Development, Germany. Funding for this study was provided to WorldFish by the German Federal Ministry for Economic Cooperation and Development (BMZ) through the Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ). The funding contract number is 81170271.	Ali D, 2013, J NUTR, V143, P2015, DOI 10.3945/jn.113.175182; Appelhans BM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1160; Arimond M, 2004, J NUTR, V134, P2579, DOI 10.1093/jn/134.10.2579; Bethell C, 2009, PEDIATRICS, V123, pS277, DOI 10.1542/peds.2008-2780F; Birch LL, 2001, PEDIATR CLIN N AM, V48, P893, DOI 10.1016/S0031-3955(05)70347-3; Bouhlal S, 2015, APPETITE, V84, P154, DOI 10.1016/j.appet.2014.09.024; Chikobola M.M., 2016, MOD EC, V7, P567, DOI [10.4236/me.2016.75062, DOI 10.4236/ME.2016.75062]; Consensus C, 2012, 3 COP CONS OUTC DOC; Cordova A., 2009, INSIGHTS SERIES; Darapheak Chau, 2013, Int Arch Med, V6, P29, DOI 10.1186/1755-7682-6-29; de Seligny J, 2010, STAT WORLD FISH AQ 2; Della Torre SB, 2016, J ACAD NUTR DIET, V116, P638, DOI 10.1016/j.jand.2015.05.020; Department of Maternal and Child Health and Community Health Ministry of Health PRC, 2009, CHILD GROWTH STAND I; FAO, 2016, STATE WORLD FISH AQ; FAO F, 2016, MIN DIET DIV WOM GUI; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Filmer D., 1998, ESTIMATING WEALTH EF; Genschick S, 2018, AQUACULTURE, V492, P280, DOI 10.1016/j.aquaculture.2018.03.052; Hautvast JLA, 1999, EUR J CLIN NUTR, V53, P50, DOI 10.1038/sj.ejcn.1600676; Herrador Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133435; Hoffman D, 2017, J HEALTH POPUL NUTR, V36, DOI 10.1186/s41043-017-0095-z; Horton S., 2009, GLOBAL CRISES GLOBAL, P305, DOI DOI 10.1017/CBO9780511807633.007; Horton S, 2008, CHALLENGE HUNGER MAL, P3; Hu FB, 2013, OBES REV, V14, P606, DOI 10.1111/obr.12040; Jansen PW, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-130; Kawarazuka N, 2011, PUBLIC HEALTH NUTR, V14, P1927, DOI 10.1017/S1368980011000814; Kimani-Murage EW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129943; Kimani-Murage EW, 2011, J URBAN HEALTH, V88, P282, DOI 10.1007/s11524-010-9491-z; Lovelace S, 2015, MATERN CHILD NUTR, V11, P870, DOI 10.1111/mcn.12028; Malik VS, 2006, AM J CLIN NUTR, V84, P274; Matanda DJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161221; McDermott J, 2015, FOOD SECUR, V7, P593, DOI 10.1007/s12571-015-0462-9; Micklesfield LK, 2013, CARDIOVASC J AFR, V24, P369, DOI 10.5830/CVJA-2013-069; Mudenda HG, 2009, ASSESSMENT NATL AQUA; Musuka C. G., 2013, International Journal of Fisheries and Aquaculture, V5, P295; Mwase I, 2016, J TROP PEDIATRICS, V62, P46, DOI 10.1093/tropej/fmv071; Nti Christina Antwiwaa, 2008, Nutr Res Pract, V2, P93, DOI 10.4162/nrp.2008.2.2.93; Office CS, 2014, ZAMB DEM HLTH SURV 2; Olack B, 2011, J HEALTH POPUL NUTR, V29, P357, DOI 10.3329/jhpn.v29i4.8451; Preston EC, 2015, REV PANAM SALUD PUBL, V38, P472; Rah JH, 2010, EUR J CLIN NUTR, V64, P1393, DOI 10.1038/ejcn.2010.171; Ro Zambia, 2011, 6 NAT DEV PLAN ZAMB; Smith L. C., 2007, INT FOOD POLICY RES; Team S-UNRT, 2010, ROADM SCAL NUTR SUN; Thilsted S., 2012, POTENTIAL NUTR RICH; Thilsted SH, 2016, FOOD POLICY, V61, P126, DOI 10.1016/j.foodpol.2016.02.005; Tveteras S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036731; United Nations Children's Fund (UNICEF), 2003, STRAT RED MAT CHILD; WHO, 2016, GLOB DAT BOD MASS IN; WHO U USAID F AED U, 2010, IND ASS INF YOUNG CH; Workicho A, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3861-8; World Health Organization, 2010, IND ASS INF YOUNG CH; Zukiewicz-Sobczak W, 2014, ANN AGR ENV MED, V21, P590, DOI 10.5604/12321966.1120608	53	30	30	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2018	13	9							e0204009	10.1371/journal.pone.0204009	http://dx.doi.org/10.1371/journal.pone.0204009			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3MI	30248126	Green Submitted, Green Published, gold			2022-12-26	WOS:000445998100019
J	Rankin, EEW; Knowlton, JL; Gruner, DS; Flaspohler, DJ; Giardina, CP; Leopold, DR; Buckardt, A; Pitt, WC; Fukami, T				Rankin, Erin E. Wilson; Knowlton, Jessie L.; Gruner, Daniel S.; Flaspohler, David J.; Giardina, Christian P.; Leopold, Devin R.; Buckardt, Anna; Pitt, William C.; Fukami, Tadashi			Vertical foraging shifts in Hawaiian forest birds in response to invasive rat removal	PLOS ONE			English	Article							WESTERN MAUNA-KEA; FOOD-CHAIN LENGTH; SPECIES RICHNESS; CANOPY STRUCTURE; OCEANIC ISLAND; FEEDING GUILDS; ECOSYSTEM SIZE; NICHE SHIFT; ECOLOGY; FRAGMENTATION	Worldwide, native species increasingly contend with the interacting stressors of habitat fragmentation and invasive species, yet their combined effects have rarely been examined. Direct negative effects of invasive omnivores are well documented, but the indirect effects of resource competition or those caused by predator avoidance are unknown. Here we isolated and examined the independent and interactive effects of invasive omnivorous Black rats (Rattus rattus) and forest fragment size on the interactions between avian predators and their arthropod prey. Our study examines whether invasive omnivores and ecosystem fragment size impact: 1) the vertical distribution of arthropod species composition and abundance, and 2) the vertical profile of foraging behaviors of five native and two non-native bird species found in our study system. We predicted that the reduced edge effects and greater structural complexity and canopy height of larger fragments would limit the total and proportional habitat space frequented by rats and thus limit their impact on both arthropod biomass and birds' foraging behavior. We experimentally removed invasive omnivorous Black rats across a 100-fold (0.1 to 12 ha) size gradient of forest fragments on Hawaii Island, and paired foraging observations of forest passerines with arthropod sampling in the 16 rat-removed and 18 control fragments. Rat removal was associated with shifts in the vertical distribution of arthropod biomass, irrespective of fragment size. Bird foraging behavior mirrored this shift, and the impact of rat removal was greater for birds that primarily eat fruit and insects compared with those that consume nectar. Evidence from this model study system indicates that invasive rats indirectly alter the feeding behavior of native birds, and consequently impact multiple trophic levels. This study suggests that native species can modify their foraging behavior in response to invasive species removal and presumably arrival through behavioral plasticity.	[Rankin, Erin E. Wilson; Gruner, Daniel S.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Knowlton, Jessie L.; Flaspohler, David J.; Buckardt, Anna] Michigan Technol Univ, Sch Forest Resources & Environm Sci, Houghton, MI 49931 USA; [Giardina, Christian P.] US Forest Serv, Inst Pacific Isl Forestry, USDA, Hilo, HI USA; [Leopold, Devin R.; Fukami, Tadashi] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Pitt, William C.] Smithsonian Inst, Smithsonian Conservat Biol Inst, Front Royal, VA USA; [Rankin, Erin E. Wilson] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Knowlton, Jessie L.] Wheaton Coll, Dept Biol, Norton, MA 02766 USA	University System of Maryland; University of Maryland College Park; Michigan Technological University; United States Department of Agriculture (USDA); United States Forest Service; Stanford University; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; University of California System; University of California Riverside	Rankin, EEW (corresponding author), Univ Maryland, Dept Entomol, College Pk, MD 20742 USA.; Rankin, EEW (corresponding author), Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.	e.wilson.rankin@gmail.com	Rankin, Erin E Wilson/J-7044-2014; Giardina, Christian P/C-3120-2011; Rankin, Erin E. Wilson/AAX-1670-2020; Fukami, Tadashi/A-2934-2010; Gruner, Daniel Stephen/A-5166-2010; Wilson Rankin, E E/GLS-9381-2022	Rankin, Erin E Wilson/0000-0001-7741-113X; Giardina, Christian P/0000-0002-3431-5073; Rankin, Erin E. Wilson/0000-0001-7741-113X; Fukami, Tadashi/0000-0001-5654-4785; Gruner, Daniel Stephen/0000-0002-3153-4297; Wilson Rankin, E E/0000-0001-7741-113X	National Science Foundation [DEB-1020412, DEB-1020007, DEB-1240774, DEB-1019928]; Stanford University; Michigan Technological University; USDA Forest Service Institute of Pacific Islands Forestry	National Science Foundation(National Science Foundation (NSF)); Stanford University(Stanford University); Michigan Technological University; USDA Forest Service Institute of Pacific Islands Forestry(United States Department of Agriculture (USDA)United States Forest Service)	Funding was provided by the National Science Foundation (DEB-1020412 to T. Fukami, C. P. Giardina; DEB-1020007 to D. S. Gruner; DEB-1240774 to D. S. Gruner and DEB-1019928 to D. J. Flaspohler), the Terman Fellowship of Stanford University to T. Fukami, and the Michigan Technological University Summer Undergraduate Research Fellowship program. The USDA Forest Service Institute of Pacific Islands Forestry provided funding support for implementation and maintenance of the larger study and for some of the resighting work. Any use of trade, firm, or product names is for descriptive purposes only and does not imply endorsement by the U.S. Government. None of the funders had any input into the content of the manuscript. None of the funders required their approval of the manuscript before submission or publication.	AMARASEKARE P, 1993, CONSERV BIOL, V7, P316, DOI 10.1046/j.1523-1739.1993.07020316.x; AMARASEKARE P, 1994, J MAMMAL, V75, P24, DOI 10.2307/1382233; Armstrong DP, 2014, CONSERV BIOL, V28, P713, DOI 10.1111/cobi.12256; Atkinson I.A.E., 1985, International Council for Bird Preservation Technical Publication, P35; ATKINSON IAE, 1977, PAC SCI, V31, P109; BALDWIN PAUL H., 1953, UNIV CALIFORNIA PUBL ZOOL, V52, P285; Banko Paul C., 2009, P159; Banko PC, 2002, J BIOGEOGR, V29, P789, DOI 10.1046/j.1365-2699.2002.00724.x; Banko PC, 2015, HCSU066 HAW COOP STU; Barton K, 2018, MUMIN MULTIMODEL INF; Bates D., 2013, LME4 LINEAR MIXED EF; Berryman AA, 2006, OIKOS, V115, P192, DOI 10.1111/j.0030-1299.2006.15188.x; Bregman TP, 2014, BIOL CONSERV, V169, P372, DOI 10.1016/j.biocon.2013.11.024; Burke DM, 1998, AUK, V115, P96, DOI 10.2307/4089115; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Camp RJ, 2014, CONDOR, V116, P97, DOI 10.1650/CONDOR-13-089.1; CANADAY CL, 1987, CAN ENTOMOL, V119, P1101, DOI 10.4039/Ent1191101-12; CLARK DA, 1982, ECOLOGY, V63, P763, DOI 10.2307/1936797; Cole F. Russell, 2000, Pacific Science, V54, P313; Courchamp F, 2003, BIOL REV, V78, P347, DOI 10.1017/S1464793102006061; Crisol-Martinez E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150159; De Rosario-Martinez H., 2015, PHIA POSTHOC INTERAC; Denno Robert F., 2005, P211; Denslow JS, 2003, ANN MO BOT GARD, V90, P119, DOI 10.2307/3298531; Didham RK, 2007, TRENDS ECOL EVOL, V22, P489, DOI 10.1016/j.tree.2007.07.001; Didham RK, 2005, TRENDS ECOL EVOL, V20, P470, DOI 10.1016/j.tree.2005.07.006; Diehl S, 2001, ECOLOGY, V82, P2977, DOI 10.1890/0012-9658(2001)082[2977:IPSFEO]2.0.CO;2; Drever MC, 1998, CAN FIELD NAT, V112, P676; Ehrenfeld JG, 2000, ECOLOGY, V81, P600, DOI [10.1890/0012-9658(2000)081, DOI 10.1890/0012-9658(2000)081]; Flaspohler DJ, 2010, BIOL CONSERV, V143, P280, DOI 10.1016/j.biocon.2009.10.009; Franks A., 2014, MERUTILS R; Freed LA, 2009, CURR BIOL, V19, P1736, DOI 10.1016/j.cub.2009.08.044; Gray MA, 2007, CONSERV BIOL, V21, P133, DOI 10.1111/j.1523-1739.2006.00557.x; Gruner DS, 2004, ECOLOGY, V85, P3010, DOI 10.1890/04-0020; Gruner DS, 2003, REGRESSIONS LENGTH W; Guisan A, 2014, TRENDS ECOL EVOL, V29, P260, DOI 10.1016/j.tree.2014.02.009; Hagar JC, 2007, WILSON J ORNITHOL, V119, P533, DOI 10.1676/06-056.1; Hanna C, 2014, ECOLOGY, V95, P1622, DOI 10.1890/13-1276.1; Harrington LA, 2009, ECOLOGY, V90, P1207, DOI 10.1890/08-0302.1; Holdaway Richard N., 1999, P189; Kier G, 2009, P NATL ACAD SCI USA, V106, P9322, DOI 10.1073/pnas.0810306106; King RS, 1998, WETLANDS, V18, P100, DOI 10.1007/BF03161448; Klose K, 2012, FRESHWATER BIOL, V57, P526, DOI 10.1111/j.1365-2427.2011.02721.x; Knowlton JL, 2017, J AVIAN BIOL, V48, P921, DOI 10.1111/jav.00924; Kovach T., 2012, DETERMINANTS AVIAN D; Kuznetsova A., 2013, LMERTEST TESTS RANDO; Latta SC, 1996, CONDOR, V98, P595, DOI 10.2307/1369572; Levy S, 2003, BIOSCIENCE, V53, P694, DOI 10.1641/0006-3568(2003)053[0691:GTDOHI]2.0.CO;2; Lindsey Gerald D., 2009, P274; Losos JB, 2004, NATURE, V432, P505, DOI 10.1038/nature03039; MACARTHUR RH, 1958, ECOLOGY, V39, P599, DOI 10.2307/1931600; Manhaes MA, 2015, BRAZ J BIOL, V75, pS176, DOI 10.1590/1519-6984.09114; Maron JL, 2006, ECOL MONOGR, V76, P3, DOI 10.1890/05-0496; Martin JL, 2000, CONSERV BIOL, V14, P1452, DOI 10.1046/j.1523-1739.2000.99190.x; Martinson HM, 2014, ECOL LETT, V17, P1178, DOI 10.1111/ele.12305; Massaro M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002331; Miller JR, 2000, ECOL APPL, V10, P1732, DOI 10.2307/2641235; O'Dowd DJ, 2003, ECOL LETT, V6, P812, DOI 10.1046/j.1461-0248.2003.00512.x; Pitt WC, 1999, EVOL ECOL, V13, P499, DOI 10.1023/A:1006792726166; Polis GA, 2000, TRENDS ECOL EVOL, V15, P473, DOI 10.1016/S0169-5347(00)01971-6; Poole A., 1998, BIRDS N AM; Post DM, 2000, NATURE, V405, P1047, DOI 10.1038/35016565; POULIN B, 1994, BIOTROPICA, V26, P187, DOI 10.2307/2388808; Preston DL, 2012, ECOLOGY, V93, P1254, DOI 10.1890/11-1821.1; R Core Team, 2018, R LANG ENV STAT COMP; RALPH CJ, 1995, CONDOR, V97, P729, DOI 10.2307/1369181; Rayner MJ, 2007, P NATL ACAD SCI USA, V104, P20862, DOI 10.1073/pnas.0707414105; Razeng E, 2012, EMU, V112, P149, DOI 10.1071/MU11099; Ribon R, 2003, CONSERV BIOL, V17, P1827, DOI 10.1111/j.1523-1739.2003.00377.x; Robinson SK, 1998, AUK, V115, P1; Schmitz OJ, 2007, ECOLOGY, V88, P2415, DOI 10.1890/06-0937.1; Schmitz OJ, 2010, ECOL LETT, V13, P1199, DOI 10.1111/j.1461-0248.2010.01511.x; Schoener T.W., 1986, P91; Sheppard SK, 2005, FUNCT ECOL, V19, P751, DOI 10.1111/j.1365-2435.2005.01041.x; Shiels AB, 2014, PAC SCI, V68, P145, DOI 10.2984/68.2.1; Shiels AB, 2013, BIOL INVASIONS, V15, P1037, DOI 10.1007/s10530-012-0348-0; STONE PA, 1994, CONSERV BIOL, V8, P569, DOI 10.1046/j.1523-1739.1994.08020569.x; Strauss SY, 2006, ECOL LETT, V9, P354, DOI 10.1111/j.1461-0248.2005.00874.x; Sugihara Robert T., 1997, Pacific Science, V51, P189; Symondson WOC, 2002, MOL ECOL, V11, P627, DOI 10.1046/j.1365-294X.2002.01471.x; Takimoto G, 2008, ECOLOGY, V89, P3001, DOI 10.1890/07-1990.1; Tennessen JB, 2016, ANIM BEHAV, V114, P53, DOI 10.1016/j.anbehav.2016.01.021; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Thompson J, 2007, PLANT ECOL, V192, P289, DOI 10.1007/s11258-007-9318-5; Tingley R, 2014, P NATL ACAD SCI USA, V111, P10233, DOI 10.1073/pnas.1405766111; Tolson PJ, 1988, CRITICAL HABITAT PRE; Towns DR, 2006, BIOL INVASIONS, V8, P863, DOI 10.1007/s10530-005-0421-z; Turner MG, 2005, ANNU REV ECOL EVOL S, V36, P319, DOI 10.1146/annurev.ecolsys.36.102003.152614; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; Vafidis JO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159933; Vafidis JO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113665; Vander Werf E.A., 2011, Occasional Papers of the IUCN Species Survival Commission, V42, P124; Vandermeer J, 2006, BIOSCIENCE, V56, P967, DOI 10.1641/0006-3568(2006)56[967:OPABM]2.0.CO;2; VanderWerf EA, 2001, J FIELD ORNITHOL, V72, P448, DOI 10.1648/0273-8570-72.3.448; VanderWerf Eric A., 2002, Pacific Conservation Biology, V8, P73; Vanderwerf EA, 2012, CONSERV BIOL, V26, P905, DOI 10.1111/j.1523-1739.2012.01877.x; Vaughn NR, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00235.1; Vaughn NR, 2014, ECOL APPL, V24, P1638, DOI 10.1890/13-1568.1; Vaughn NR, 2013, INT J REMOTE SENS, V34, P7464, DOI 10.1080/2150704X.2013.820003; Vitousek P.M, 1990, ENVIRON MANAGE, P183, DOI [10.1007/978-1-4612-4018-1_17, DOI 10.1007/978-1-4612-4018-1_17]; Wardle DA, 2009, ECOLOGY, V90, P452, DOI 10.1890/08-0097.1; Wilson EE, 2010, ECOLOGY, V91, P3294, DOI 10.1890/09-1187.1; Wilson EE, 2011, TRENDS ECOL EVOL, V26, P129, DOI 10.1016/j.tree.2010.12.011; Woodworth Bethany L., 2009, P194	104	5	5	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2018	13	9							e0202869	10.1371/journal.pone.0202869	http://dx.doi.org/10.1371/journal.pone.0202869			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3MI	30248110	Green Published, Green Submitted, gold			2022-12-26	WOS:000445998100007
J	Aoki, S; Murata, H; Nakakura, S; Nakao, Y; Matsuura, M; Kiuchi, Y; Asaoka, R				Aoki, Shuichiro; Murata, Hiroshi; Nakakura, Shunsuke; Nakao, Yoshitaka; Matsuura, Masato; Kiuchi, Yoshiaki; Asaoka, Ryo			Correlation between elastic energy stored in an eye and visual field progression in glaucoma	PLOS ONE			English	Article							CORNEAL BIOMECHANICAL PROPERTIES; OCULAR HYPERTENSION TREATMENT; INTRAOCULAR-PRESSURE; IN-VIVO; LAMINA-CRIBROSA; RISK-FACTOR; HYSTERESIS; THICKNESS; PARAMETERS; REDUCTION	Purpose To investigate whether the elastic energy stored in an eyeball at highest concavity (highest concavity energy; HCE), calculated with Corivs ST (CST, OCULUS), correlates with glaucomatous visual field (VF) progression. Methods 108 eyes from 70 primary open angle-glaucoma patients were studied. The HCE was calculated using CST parameters. For each eye, the mean total deviation (mTD) of the 52 test points in the 24-2 Humphrey Field Analyzer test pattern was calculated and the mTD progression rate was determined from eight reliable VFs. Eyes were subdivided into: subgroups with low- or high-whole eye motion maximal length (WEM-d) and subgroups with short- or long-time taken to reach WEM-d (WEM-t), as measured with CST. The associations between mTD progression rate and HCE and other ocular/systemic parameters including age, Goldmann applanation tonometry based-intraocular pressure [GAT-IOP], and corneal hysteresis [CH] from the Ocular Response Analyzer (ORA (R) , Reichert) were investigated using the linear mixed model. The optimal model to describe mTD progression rate was selected from all possible combinations according to the second order bias corrected Akaike Information Criterion index. Results Optimal models to describe mTD progression rate included: CH in the model for all eyes, age and HCE in the model for the WEM-d low group, HCE in the model for the WEM-t short group, mean GAT-IOP in the model for the WEM-d high group, and age in the model for the WEM-t long-group. Conclusions HCE was associated with glaucomatous VF progression in eyes with minimal whole eye motion (low WEM-d and WEM-t subgroups).	[Aoki, Shuichiro; Murata, Hiroshi; Matsuura, Masato; Asaoka, Ryo] Univ Tokyo, Dept Ophthalmol, Tokyo, Japan; [Aoki, Shuichiro] Sapporo City Gen Hosp, Dept Ophthalmol, Sapporo, Hokkaido, Japan; [Nakakura, Shunsuke] Saneikai Tsukazaki Hosp, Dept Ophthalmol, Himeji, Hyogo, Japan; [Nakao, Yoshitaka; Kiuchi, Yoshiaki] Hiroshima Univ, Dept Ophthalmol & Visual Sci, Hiroshima, Japan; [Matsuura, Masato] Kitasato Univ, Sch Allied Hlth Sci, Dept Rehabil, Orthop & Visual Sci, Sagamihara, Kanagawa, Japan	University of Tokyo; Sapporo City General Hospital; Hiroshima University; Kitasato University	Asaoka, R (corresponding author), Univ Tokyo, Dept Ophthalmol, Tokyo, Japan.	rasaoka-tky@umin.ac.jp		Kiuchi, Yoshiaki/0000-0003-1915-1864; Nakao, Yoshitaka/0000-0003-1280-2791	Ministry of Education, Culture, Sports, Science, and Technology of Japan [17K11418]; Japan Science and Technology Agency (JST) CREST [JPMJCR1304]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency (JST) CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This work was supported by Grant 17K11418 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and Japan Science and Technology Agency (JST) CREST JPMJCR1304, URL: http://www.mext.go.jp/. This grant was given for R.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhamad TA, 2011, ACTA OPHTHALMOL, V89, pE443, DOI 10.1111/j.1755-3768.2011.02150.x; Alward WL, 1998, AM J OPHTHALMOL, V126, P498; Ambrosio R, 2013, REV BRAS OFTALMOL, V72, P99, DOI 10.1590/S0034-72802013000200005; Anderson Douglas R, 2003, Curr Opin Ophthalmol, V14, P86; Araie Makoto, 2011, Nippon Ganka Gakkai Zasshi, V115, P213; Bengtsson B, 2009, ARCH OPHTHALMOL-CHIC, V127, P1610, DOI 10.1001/archophthalmol.2009.297; Burnham K P, 2003, MODEL SELECT MULTIMO; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Chee RI, 2013, AM J OPHTHALMOL, V155, P983, DOI 10.1016/j.ajo.2013.01.005; COLEMAN DJ, 1969, ARCH OPHTHALMOL-CHIC, V82, P637; Congdon NG, 2006, AM J OPHTHALMOL, V141, P868, DOI 10.1016/j.ajo.2005.12.007; De Moraes CGV, 2012, J GLAUCOMA, V21, P209, DOI 10.1097/IJG.0b013e3182071b92; De Moraes CGV, 2011, ARCH OPHTHALMOL-CHIC, V129, P562, DOI 10.1001/archophthalmol.2011.72; Deol M, 2015, CURR OPIN OPHTHALMOL, V26, P96, DOI 10.1097/ICU.0000000000000130; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; Dupps WJ, 2007, J CATARACT REFR SURG, V33, P1499, DOI 10.1016/j.jcrs.2007.07.008; Fujino Y, 2016, INVEST OPHTH VIS SCI, V57, P2012, DOI 10.1167/iovs.15-19046; Garway-Heath DF, 2015, LANCET, V385, P1295, DOI 10.1016/S0140-6736(14)62111-5; Gordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Heijl A, 2013, ACTA OPHTHALMOL, V91, P406, DOI 10.1111/j.1755-3768.2012.02492.x; Hirasawa K, 2017, TRANSL VIS SCI TECHN, V6, DOI 10.1167/tvst.6.3.18; HOLMIN C, 1982, ACTA OPHTHALMOL, V60, P267; Ishii K, 2013, CLIN EXP OPHTHALMOL, V41, P6, DOI 10.1111/j.1442-9071.2012.02830.x; Joda AA, 2016, COMPUT METHOD BIOMEC, V19, P943, DOI 10.1080/10255842.2015.1077515; Johnstone M, 2011, EXP EYE RES, V92, P318, DOI 10.1016/j.exer.2011.03.011; Jonas JB, 2005, INVEST OPHTH VIS SCI, V46, P1275, DOI 10.1167/iovs.04-0851; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Kenny E, 2014, PHYSIOL MEAS, V35, P1229, DOI 10.1088/0967-3334/35/7/1229; Koprowski R, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-150; KRAKAU CET, 1985, ACTA OPHTHALMOL, V63, P19; Lanzagorta-Aresti A, 2017, BRIT J OPHTHALMOL, V101, P290, DOI 10.1136/bjophthalmol-2015-307428; LASCARATOS G, 2014, INVEST OPHTH VIS SCI, V0055; Luce D., 2006, REICHERT OPHTHALMIC; MALLOWS CL, 1973, TECHNOMETRICS, V15, P661, DOI 10.2307/1267380; Matsuura M, 2017, SCI REPORTS, V7; Matsuura M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176380; Medeiros FA, 2006, J GLAUCOMA, V15, P364, DOI 10.1097/01.ijg.0000212268.42606.97; Medeiros FA, 2013, OPHTHALMOLOGY, V120, P1533, DOI 10.1016/j.ophtha.2013.01.032; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Narayanaswamy A, 2011, ARCH OPHTHALMOL-CHIC, V129, P429, DOI 10.1001/archophthalmol.2011.60; Perez-Bartolome F., 2016, STREAMEVOLV ECML PKD, P1, DOI 1080/08820538.2016.1208763; Roberts CJ, 2014, J CATARACT REFR SURG, V40, P862, DOI 10.1016/j.jcrs.2014.04.019; Roberts CJ, 2014, J CATARACT REFR SURG, V40, P929, DOI 10.1016/j.jcrs.2014.04.011; Ryle JP, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.2.027004; Singh K, 2011, INVEST OPHTH VIS SCI, V52, P8927, DOI 10.1167/iovs.11-7854; Spry PGD, 2000, INVEST OPHTH VIS SCI, V41, P2192; Susanna CN, 2018, AM J OPHTHALMOL, V187, P148, DOI 10.1016/j.ajo.2017.12.018; Taketani Y, 2015, INVEST OPHTH VIS SCI, V56, P4076, DOI 10.1167/iovs.14-16341; Tibshirani RJ, 2012, ANN STAT, V40, P1198, DOI 10.1214/12-AOS1003; Uysal BS, 2016, J NEURO-OPHTHALMOL, V36, P285, DOI 10.1097/WNO.0000000000000406; Van Veldhuisen PC, 2000, AM J OPHTHALMOL, V130, P429; Vellara HR, 2015, INVEST OPHTH VIS SCI, V56, P6941, DOI 10.1167/iovs.15-17396; Wang XF, 2016, INVEST OPHTH VIS SCI, V57, P5825, DOI 10.1167/iovs.16-20560; Wells AP, 2008, INVEST OPHTH VIS SCI, V49, P3262, DOI 10.1167/iovs.07-1556; Yazgan S, 2015, CURR EYE RES, V40, P470, DOI 10.3109/02713683.2014.930157	56	4	4	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2018	13	9							e0204451	10.1371/journal.pone.0204451	http://dx.doi.org/10.1371/journal.pone.0204451			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU5MM	30240430	gold, Green Published, Green Submitted			2022-12-26	WOS:000445329700052
J	Kim, H; Kwon, D; Yoon, SH; Kim, H; Park, CM; Goo, JM; Jeon, YK; Ahn, SY				Kim, Heekyung; Kwon, Dohee; Yoon, Soon Ho; Kim, Hyungjin; Park, Chang Min; Goo, Jin Mo; Jeon, Yoon Kyung; Ahn, Su Yeon			Bronchovascular injury associated with clinically significant hemoptysis after CT-guided core biopsy of the lung: Radiologic and histopathologic analysis	PLOS ONE			English	Article							TRANSTHORACIC NEEDLE-BIOPSY; MASSIVE HEMOPTYSIS; RISK-FACTORS; COMPLICATIONS; NODULES; EXPERIENCE; MANAGEMENT; PNEUMOTHORAX; DISCHARGE; ACCURACY	Objective To evaluate bronchovascular injuries as the causative occurrence for clinically significant hemoptysis after percutaneous transthoracic needle biopsy (PTNB). Materials and methods We included 111 consecutive patients who experienced hemoptysis after cone beam CT (CBCT)-guided PTNB from January 2014 through January 2017. Clinically significant hemoptysis was defined as hemoptysis causing hemodynamic instability or oxygen desaturation greater than 10% of baseline. The lesion characteristics were evaluated on CT images. The penetration of bronchovascular structures along the trajectory of the introducer needle and potential penetration at the firing of the biopsy gun were assessed on CBCT images. The cutting injury of bronchovascular structures was histopathologically assessed in biopsy specimens. The associated factors for clinically significant hemoptysis were assessed using logistic regression analyses. Results Seventeen patients (15.3%; 95% CI, 9.7%-23.2%) had clinically significant hemoptysis. On univariate analysis, the open bronchus sign (P = .004), nodule consistency (P = .012), potential penetration of a pulmonary vessel or bronchus 1 mm or larger at firing (P = .008 and P = .038, respectively), and a cutting injury of a pulmonary vessel 1 mm or larger (P = .007) or a bronchial structure (P = .041) were associated with clinically significant hemoptysis. Multivariate analysis found the following significant associated factors: potential penetration of a pulmonary vessel 1 mm or larger at firing (OR, 3.874; 95% CI, 1.072-13.997; P = .039) and cutting injury of a pulmonary vessel 1 mm or larger (OR, 6.920; 95% CI, 1.728-27.711; P = .006) or a bronchial structure (OR 4.604; 95% CI, 1.194-17.755; P = .027). Conclusion Potential penetration and cutting injury of bronchovascular structures 1mm or larger at firing were independently associated with clinically significant hemoptysis after PTNB.	[Kim, Heekyung; Yoon, Soon Ho; Kim, Hyungjin; Park, Chang Min; Goo, Jin Mo; Ahn, Su Yeon] Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea; [Kwon, Dohee; Jeon, Yoon Kyung] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul, South Korea; [Yoon, Soon Ho; Park, Chang Min; Goo, Jin Mo] Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Yoon, SH (corresponding author), Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea.; Yoon, SH (corresponding author), Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea.	yshoka@gmail.com	Yoon, Soon Ho/AAL-1640-2020	Yoon, Soon Ho/0000-0002-3700-0165; Park, Chang Min/0000-0003-1884-3738; Goo, Jin Mo/0000-0003-1791-7942				Choi JW, 2012, AM J ROENTGENOL, V199, pW322, DOI 10.2214/AJR.11.7576; Dennie CJ, 2001, RADIOLOGY, V219, P247, DOI 10.1148/radiology.219.1.r01ap11247; Hakanson E, 2002, BRIT J ANAESTH, V88, P291, DOI 10.1093/bja/88.2.291; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Heck SL, 2006, EUR RADIOL, V16, P1387, DOI 10.1007/s00330-006-0152-2; Heerink WJ, 2017, EUR RADIOL, V27, P138, DOI 10.1007/s00330-016-4357-8; Hwang EJ, 2017, EUROPEAN RADIOLOGY, P1; Ibrahim WH, 2008, EUR RESPIR J, V32, P1131, DOI 10.1183/09031936.00080108; Jin KN, 2010, EUR RADIOL, V20, P2108, DOI 10.1007/s00330-010-1783-x; Lee SM, 2017, EUR RADIOL, V27, P5119, DOI 10.1007/s00330-017-4917-6; Lee SM, 2014, RADIOLOGY, V271, P291, DOI 10.1148/radiol.13131265; Lordan JL, 2003, THORAX, V58, P814, DOI 10.1136/thorax.58.9.814; MILNER LB, 1979, AM J ROENTGENOL, V132, P280, DOI 10.2214/ajr.132.2.280; Murphy JM, 2001, WORLD J SURG, V25, P373, DOI 10.1007/s002680020388; Raju S, 2017, CHEST, V151, P1356, DOI 10.1016/j.chest.2016.12.033; Sevransky J, 2009, CURR OPIN CRIT CARE, V15, P234, DOI 10.1097/MCC.0b013e32832b70e5; Song YS, 2013, AM J ROENTGENOL, V200, P1014, DOI 10.2214/AJR.12.8931; Tai R, 2016, RADIOLOGY, V279, P287, DOI 10.1148/radiol.2015150381; Viera AJ, 2005, FAM MED, V37, P360; Wiener RS, 2011, ANN INTERN MED, V155, P137, DOI 10.7326/0003-4819-155-3-201108020-00003; Yeow KM, 2004, CHEST, V126, P748, DOI 10.1378/chest.126.3.748; Yeow KM, 2001, J VASC INTERV RADIOL, V12, P1305, DOI 10.1016/S1051-0443(07)61556-5; Yoon HJ, 2012, RADIOLOGY, V265, P939, DOI 10.1148/radiol.12112613	23	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2018	13	9							e0204064	10.1371/journal.pone.0204064	http://dx.doi.org/10.1371/journal.pone.0204064			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU5MM	30240441	Green Published, gold, Green Submitted			2022-12-26	WOS:000445329700022
J	Chiang, YJ; Liao, WT; Ho, KC; Wang, SH; Chen, YG; Ho, CL; Huang, SF; Shih, LY; Yang-Yen, HF; Yen, JJY				Chiang, Yun-Jung; Liao, Wei-Ting; Ho, Kun-Chin; Wang, Shih-Hao; Chen, Yu-Guang; Ho, Ching-Liang; Huang, Shiu-Feng; Shih, Lee-Yung; Yang-Yen, Hsin-Fang; Yen, Jeffrey Jong-Young			CBAP modulates Akt-dependent TSC2 phosphorylation to promote Rheb-mTORC1 signaling and growth of T-cell acute lymphoblastic leukemia	ONCOGENE			English	Article							TUBEROUS SCLEROSIS; TSC1-TSC2 COMPLEX; LYSOSOMAL RECRUITMENT; MTOR; TARGET; PTEN; APOPTOSIS; INACTIVATION; INTEGRATION; DOWNSTREAM	High-frequency relapse remains a clinical hurdle for complete remission of T-cell acute lymphoblastic leukemia (T-ALL) patients, with heterogeneous dysregulated signaling profiles-including of Raf-MEK-ERK and Akt-mTORC1-S6K signaling pathways-recently being implicated in disease outcomes. Here we report that GM-CSF/IL-3/IL-5 receptor common beta-chain-associated protein (CBAP) is highly expressed in human T-ALL cell lines and many primary tumor tissues and is required to bolster leukemia cell proliferation in tissue culture and for in vivo leukemogenesis in a xenograft mouse model. Downregulation of CBAP markedly restrains expansion of leukemia cells and alleviates disease aggravation of leukemic mice. Transcriptomic profiling and molecular biological analyses suggest that CBAP acts upstream of Ras and Rac1, and functions as a modulator of both Raf-MEK-ERK and Akt-mTORC1 signaling pathways to control leukemia cell growth. Specifically, CBAP facilitated Akt-dependent TSC2 phosphorylation in cell-based assays and in vitro analysis, decreased lysosomal localization of TSC2, and elevated Rheb-GTP loading and subsequent activation of mTORC1 signaling. Taken together, our findings reveal a novel oncogenic contribution of CBAP in T-ALL leukemic cells, in addition to its original proapoptotic function in cytokine-dependent cell lines and primary hematopoietic cells, by demonstrating its functional role in the regulation of Akt-TSC2-mTORC1 signaling for leukemia cell proliferation. Thus, CBAP represents a novel therapeutic target for many types of cancers and metabolic diseases linked to PI3K-Akt-mTORC1 signaling.	[Chiang, Yun-Jung; Liao, Wei-Ting; Ho, Kun-Chin; Wang, Shih-Hao; Yen, Jeffrey Jong-Young] Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan; [Chen, Yu-Guang; Ho, Ching-Liang] Natl Def Med Ctr, Div Hematol Oncol, Dept Internal Med, Triserv Gen Hosp, Taipei 11490, Taiwan; [Huang, Shiu-Feng] Natl Hlth Res Inst, Inst Mol & Genom Med, Miaoli 35053, Taiwan; [Shih, Lee-Yung] Chang Gung Univ, Chang Gung Mem Hosp Linkou, Div Hematol Oncol, Dept Internal Med,Coll Med, Taoyuan 33305, Taiwan; [Yang-Yen, Hsin-Fang] Acad Sinica, Inst Mol Biol, Taipei 11529, Taiwan	Academia Sinica - Taiwan; National Defense Medical Center; Tri-Service General Hospital; National Health Research Institutes - Taiwan; Chang Gung Memorial Hospital; Chang Gung University; Academia Sinica - Taiwan	Yen, JJY (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan.	bmjyen@ibms.sinica.edu.tw	Yang-Yen, Hsin-Fang/ABA-5808-2021; Yen, Jeffrey Jong-Young/Q-5134-2018	Yang-Yen, Hsin-Fang/0000-0001-9048-4800; Yen, Jeffrey Jong-Young/0000-0001-6299-1995; Chiang, Yun-Jung/0000-0001-5024-8977	Ministry of Science and Technology, Taiwan [NSC102-2320-B001-007-MY3, MOST105-2320-B-001-012-MY3]; Tri-Service General Hospital [TSGH-106-01-34, MOST103-2811-B-001-090, MOST105-2811-B-001-044]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Tri-Service General Hospital	We thank Dr. Richard Lin at Stony Brook University Medical Center for his careful reading of the manuscript and his suggestions. We thank the National Center for Genome Medicine, National RNAi Core Facility, and the Molecular and Genetic Imaging Core of the Taiwan Mouse Clinic for their technical support. This work was supported by grants from the Ministry of Science and Technology, Taiwan to JJYY (NSC102-2320-B001-007-MY3 and MOST105-2320-B-001-012-MY3), and was partly supported by Tri-Service General Hospital (TSGH-106-01-34). YJC is supported by postdoctoral fellowships MOST103-2811-B-001-090 and MOST105-2811-B-001-044.	Bilanges B, 2007, MOL CELL BIOL, V27, P5746, DOI 10.1128/MCB.02136-06; Blackburn JS, 2014, CANCER CELL, V25, P366, DOI 10.1016/j.ccr.2014.01.032; Cai SL, 2006, J CELL BIOL, V173, P279, DOI 10.1083/jcb.200507119; Chiang YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061761; Chiarini F, 2010, CANCER RES, V70, P8097, DOI 10.1158/0008-5472.CAN-10-1814; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Demetriades C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10662; Demetriades C, 2014, CELL, V156, P786, DOI 10.1016/j.cell.2014.01.024; Dennis MD, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005103; Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763; Dibble CC, 2012, MOL CELL, V47, P535, DOI 10.1016/j.molcel.2012.06.009; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Gokbuget N, 2012, BLOOD, V120, P2032, DOI 10.1182/blood-2011-12-399287; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Gutierrez A, 2009, BLOOD, V114, P647, DOI 10.1182/blood-2009-02-206722; Ho KC, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.474; Hoshii T, 2014, J BIOCHEM, V156, P73, DOI 10.1093/jb/mvu037; Huang JX, 2008, MOL CELL BIOL, V28, P4104, DOI 10.1128/MCB.00289-08; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Jotta PY, 2010, LEUKEMIA, V24, P239, DOI 10.1038/leu.2009.209; Kao CJ, 2008, ONCOGENE, V27, P1397, DOI 10.1038/sj.onc.1210778; Keeshan K, 2006, CANCER CELL, V10, P401, DOI 10.1016/j.ccr.2006.09.012; Keeshan K, 2010, BLOOD, V116, P4948, DOI 10.1182/blood-2009-10-247361; Kuchta K, 2009, NUCLEIC ACIDS RES, V37, P7701, DOI 10.1093/nar/gkp854; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lin KR, 2007, J BIOL CHEM, V282, P21962, DOI 10.1074/jbc.M701663200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lonetti A, 2015, ONCOTARGET, V6, P10399, DOI 10.18632/oncotarget.3295; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Menon S, 2014, CELL, V156, P771, DOI 10.1016/j.cell.2013.11.049; Nikolaidis N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000204; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Roti G, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00170; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Silva A, 2008, J CLIN INVEST, V118, P3762, DOI 10.1172/JCI34616; Silverman LB, 1999, CANCER-AM CANCER SOC, V85, P1395, DOI 10.1002/(SICI)1097-0142(19990315)85:6<1395::AID-CNCR25>3.0.CO;2-2; Stofega Mary, 2006, V332, P269; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; Wermuth PJ, 2005, BLOOD, V105, P1222, DOI 10.1182/blood-2004-03-0802; You MJ, 2015, AM J CLIN PATHOL, V144, P411, DOI 10.1309/AJCPMF03LVSBLHPJ; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	44	7	8	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 28	2019	38	9					1432	1447		10.1038/s41388-018-0507-6	http://dx.doi.org/10.1038/s41388-018-0507-6			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HN1KL	30266989	hybrid, Green Published			2022-12-26	WOS:000459945800005
J	Pai, VC; Hsu, CC; Chan, TS; Liao, WY; Chuu, CP; Chen, WY; Li, CR; Lin, CY; Huang, SP; Chen, LT; Tsai, KK				Pai, Vincent C.; Hsu, Chung-Chi; Chan, Tze-Sian; Liao, Wen-Ying; Chuu, Chih-Pin; Chen, Wei-Yu; Li, Chi-Rong; Lin, Ching-Yu; Huang, Shu-Pin; Chen, Li-Tzong; Tsai, Kelvin K.			ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-beta-catenin signaling	ONCOGENE			English	Article							PLANAR CELL POLARITY; TUMOR; MARKER; METASTASIS; EXPRESSION; PATHWAY; SOX9; IDENTIFICATION; ELEVATION; RECEPTOR	Recurrent and hormone-refractory prostate cancer (PCA) exhibits aggressive behaviors while current therapeutic approaches show little effect of prolonging the survival of patients with PCA. Thus, a deeper understanding of the patho-molecular mechanisms underlying the disease progression in PCA is crucial to identify novel diagnostic and/or therapeutic targets to improve the outcome of patients. Recent evidence suggests that activation of Wnt signaling in cancer stem cells (CSCs) contributes to cancer progression in malignant tumors. Here, we report that a novel Wnt co-activator ASPM (abnormal spindle-like microcephaly associated) maintains the prostate CSC subpopulation by augmenting the Wnt-beta-catenin signaling in PCA. ASPM expression is incrementally upregulated in primary and metastatic PCA, implicating its potential role in PCA progression. Consistently, downregulation of ASPM expression pronouncedly attenuated the proliferation, colony formation, and the invasive behavior of PCA cells, and dramatically reduced the number of ALDH(+) CSCs and inhibited cancer stemness and tumorigenicity. Mechanistically, ASPM interacts with disheveled-3 (Dvl-3), a cardinal upstream regulator of canonical Wnt signaling, and inhibits its proteasome-dependent degradation, thereby increasing its protein stability and enabling the Wnt-induced beta-catenin transcriptional activity in PCA cells. In keeping with the role of ASPM as a CSC-regulator, ASPM co-localizes with ALDH in PCA tissues and its expression exhibits high intra-tumoral heterogeneity. The proportion of high-ASPM-expressing cells in the tumor inversely correlates with the relapse-free survival of PCA patients. Collectively, our data points to ASPM as a novel oncoprotein and an essential regulator of Wnt signaling and cancer stemness in PCA, which has important clinical and therapeutic significance.	[Pai, Vincent C.; Hsu, Chung-Chi; Chan, Tze-Sian; Tsai, Kelvin K.] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei 11031, Taiwan; [Hsu, Chung-Chi; Chan, Tze-Sian; Tsai, Kelvin K.] Taipei Med Univ, Wan Fang Hosp, Dept Internal Med, Lab Adv Mol Therapeut,Div Gastroenterol, Taipei 11696, Taiwan; [Pai, Vincent C.; Liao, Wen-Ying; Chen, Li-Tzong; Tsai, Kelvin K.] Natl Hlth Res Inst, Natl Inst Canc Res, Zhunan 35053, Miaoli County, Taiwan; [Chuu, Chih-Pin; Lin, Ching-Yu] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan 35053, Miaoli County, Taiwan; [Chen, Wei-Yu] Taipei Med Univ, Wan Fang Hosp, Dept Pathol, Taipei 11696, Taiwan; [Li, Chi-Rong] Minist Hlth & Welf, Dept Teaching & Res, Taichung Hosp, Taichung 40343, Taiwan; [Huang, Shu-Pin] Kaohsiung Med Univ, Dept Urol, Chung Ho Mem Hosp, Kaohsiung 80756, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan; Taipei Medical University; Taipei Municipal WanFang Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Tsai, KK (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei 11031, Taiwan.; Tsai, KK (corresponding author), Taipei Med Univ, Wan Fang Hosp, Dept Internal Med, Lab Adv Mol Therapeut,Div Gastroenterol, Taipei 11696, Taiwan.; Tsai, KK (corresponding author), Natl Hlth Res Inst, Natl Inst Canc Res, Zhunan 35053, Miaoli County, Taiwan.	tsaik@tmu.edu.tw	Lin, Ching Yu/AAN-9581-2020	Lin, Ching Yu/0000-0001-9041-5653; Li, Chi-Rong/0000-0002-0314-8284; Tsai, Kelvin/0000-0002-1612-2868	Ministry of Science and Technology [MOST 104-2314-B-400-022, MOST 105-2314-B-400-018, MOST 105-2314-B-400-003]; Taipei Medical University [DP2-107-21121-C-04]; Ministry of Health and Welfare grant [MOHW107-TDU-B-212-114020]; National Health Research Institutes intramural grant [CA-106-PP-09]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Taipei Medical University; Ministry of Health and Welfare grant; National Health Research Institutes intramural grant	Supported in part by Ministry of Science and Technology grants MOST 104-2314-B-400-022, MOST 105-2314-B-400-018 (KKT), MOST 105-2314-B-400-003 (L-TC), Taipei Medical University grant DP2-107-21121-C-04 (KKT), Ministry of Health and Welfare grant MOHW107-TDU-B-212-114020 (KKT) and National Health Research Institutes intramural grant CA-106-PP-09 (KKT).	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Arensman MD, 2014, ONCOGENE, V33, P899, DOI 10.1038/onc.2013.23; Bikeye SNN, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-1; Bill-Axelson A, 2005, NEW ENGL J MED, V352, P1977, DOI 10.1056/NEJMoa043739; Bisson I, 2009, CELL RES, V19, P683, DOI 10.1038/cr.2009.43; Bruning-Richardson A, 2011, BRIT J CANCER, V104, P1602, DOI 10.1038/bjc.2011.117; Buchman JJ, 2011, GENE DEV, V25, P1909, DOI 10.1101/gad.16830211; BUDWITNOVOTNY DA, 1986, CANCER RES, V46, P5419; Capecchi MR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9763; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Fish JL, 2006, P NATL ACAD SCI USA, V103, P10438, DOI 10.1073/pnas.0604066103; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Gilligan T, 2002, UROLOGY, V60, P94, DOI 10.1016/S0090-4295(02)01583-2; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Gray RS, 2011, DEV CELL, V21, P120, DOI 10.1016/j.devcel.2011.06.011; Hellerstedt BA, 2002, CA-CANCER J CLIN, V52, P154, DOI 10.3322/canjclin.52.3.154; Jiang K, 2017, NAT CELL BIOL, V19, P480, DOI 10.1038/ncb3511; Keller ET, 2001, CANCER METAST REV, V20, P333, DOI 10.1023/A:1015599831232; Kouprina N, 2005, HUM MOL GENET, V14, P2155, DOI 10.1093/hmg/ddi220; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li T, 2010, LAB INVEST, V90, P234, DOI 10.1038/labinvest.2009.127; Lin SY, 2008, CLIN CANCER RES, V14, P4814, DOI 10.1158/1078-0432.CCR-07-5262; Liu C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14270; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; Ma F, 2016, J CLIN INVEST, V126, P1745, DOI 10.1172/JCI78815; Major MB, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.2000037; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Nandana S, 2017, CANCER RES, V77, P1331, DOI 10.1158/0008-5472.CAN-16-0497; Narimatsu M, 2009, CELL, V137, P295, DOI 10.1016/j.cell.2009.02.025; Oskarsson T, 2011, NAT MED, V17, P867, DOI 10.1038/nm.2379; Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Richardson GD, 2004, J CELL SCI, V117, P3539, DOI 10.1242/jcs.01222; Schneider JA, 2018, MOL CELL ENDOCRINOL, V462, P3, DOI 10.1016/j.mce.2017.02.008; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; Thomsen MK, 2010, CANCER RES, V70, P979, DOI 10.1158/0008-5472.CAN-09-2370; van den Hoogen C, 2010, CANCER RES, V70, P5163, DOI 10.1158/0008-5472.CAN-09-3806; van der Voet M, 2009, NAT CELL BIOL, V11, P269, DOI 10.1038/ncb1834; Vange P, 2015, J PATHOL, V237, P447, DOI 10.1002/path.4591; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wang HY, 2007, CANCER RES, V67, P528, DOI 10.1158/0008-5472.CAN-06-1672; Wang WY, 2013, GASTROENTEROLOGY, V145, P1110, DOI 10.1053/j.gastro.2013.07.040; Xie JJ, 2017, INT UROL NEPHROL, V49, P817, DOI 10.1007/s11255-017-1545-7; Yokoyama NN, 2014, AM J CLIN EXP UROL, V2, P27; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	49	62	65	1	11	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 21	2019	38	8					1340	1353		10.1038/s41388-018-0497-4	http://dx.doi.org/10.1038/s41388-018-0497-4			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HM1XR	30266990				2022-12-26	WOS:000459249800014
J	Kosztelnik, M; Kurucz, A; Papp, D; Jones, E; Sigmond, T; Barna, J; Traka, MH; Lorincz, T; Szarka, A; Banhegyi, G; Vellai, T; Korcsmaros, T; Kapuy, O				Kosztelnik, Monika; Kurucz, Anita; Papp, Diana; Jones, Emily; Sigmond, Timea; Barna, Janos; Traka, Maria H.; Lorincz, Tamas; Szarka, Andras; Banhegyi, Gabor; Vellai, Tibor; Korcsmaros, Tamas; Kapuy, Orsolya			Suppression of AMPK/aak-2 by NRF2/SKN-1 down-regulates autophagy during prolonged oxidative stress	FASEB JOURNAL			English	Article						AMPK; prolonged stress; aging; C; elegans; network	TRANSCRIPTION FACTOR NRF2; SIGNALING PATHWAY; CELL-DEATH; P62 LINKS; PROTEIN; AMPK; GENE; LONGEVITY; SKN-1; DEGRADATION	NF-E2-related factor 2 (NRF2) transcription factor has a fundamental role in cell homeostasis maintenance as one of the master regulators of oxidative and electrophilic stress responses. Previous studies have shown that a regulatory connection exists between NRF2 and autophagy during reactive oxygen species-generated oxidative stress. The aim of the present study was to investigate how autophagy is turned off during prolonged oxidative stress, to avoid overeating and destruction of essential cellular components. AMPK is a key cellular energy sensor highly conserved in eukaryotic organisms, and it has an essential role in autophagy activation at various stress events. Here the role of human AMPK and its Caenorhabditis elegans counterpart AAK-2 was explored upon oxidative stress. We investigated the regulatory connection between NRF2 and AMPK during oxidative stress induced by tert-butyl hydroperoxide (TBHP) in HEK293T cells and C. elegans. Putative conserved NRF2/protein skinhead-1 binding sites were found in AMPK/aak-2 genes by in silico analysis and were later confirmed experimentally by using EMSA. After addition of TBHP, NRF2 and AMPK showed a quick activation; AMPK was later down-regulated, however, while NRF2 level remained high. Autophagosome formation and Unc-51-like autophagy activating kinase 1 phosphorylation were initially stimulated, but they returned to basal values after 4 h of TBHP treatment. The silencing of NRF2 resulted in a constant activation of AMPK leading to hyperactivation of autophagy during oxidative stress. We observed the same effects in C. elegans demonstrating the conservation of this self-defense mechanism to save cells from hyperactivated autophagy upon prolonged oxidative stress. We conclude that NRF2 negatively regulates autophagy through delayed down-regulation of the expression of AMPK upon prolonged oxidative stress. This regulatory connection between NRF2 and AMPK may have an important role in understanding how autophagy is regulated in chronic human morbidities characterized by oxidative stress, such as neurodegenerative diseases, certain cancer types, and in metabolic diseases.Kosztelnik, M., Kurucz, A., Papp, D., Jones, E., Sigmond, T., Barna, J., Traka, M. H., Lorincz, T., Szarka, A., Banhegyi, G., Vellai, T., Korcsmaros, T., Kapuy, O. Suppression of AMPK/aak-2 by NRF2/SKN-1 down-regulates autophagy during prolonged oxidative stress.	[Kosztelnik, Monika; Papp, Diana; Sigmond, Timea; Barna, Janos; Vellai, Tibor; Korcsmaros, Tamas] Eotvos Lorand Univ, Dept Genet, Budapest, Hungary; [Kurucz, Anita; Banhegyi, Gabor; Kapuy, Orsolya] Semmelweis Univ, Hungarian Acad Sci, Dept Med Chem Mol Biol & Pathobiochem, Budapest, Hungary; [Banhegyi, Gabor] Semmelweis Univ, Hungarian Acad Sci, Pathobiochem Res Grp, Budapest, Hungary; [Jones, Emily; Korcsmaros, Tamas] Quadram Inst, Gut Hlth & Microbes, Norwich, Norfolk, England; [Traka, Maria H.] Quadram Inst, Food Innovat & Hlth, Norwich, Norfolk, England; [Jones, Emily; Korcsmaros, Tamas] Earlham Inst, Norwich Res Pk, Norwich NR4 7UZ, Norfolk, England; [Lorincz, Tamas; Szarka, Andras] Budapest Univ Technol & Econ, Dept Appl Biotechnol & Food Sci, Lab Biochem & Mol Biol, Budapest, Hungary	Eotvos Lorand University; Hungarian Academy of Sciences; Semmelweis University; Hungarian Academy of Sciences; Semmelweis University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Earlham Institute; Budapest University of Technology & Economics	Korcsmaros, T (corresponding author), Earlham Inst, Norwich Res Pk, Norwich NR4 7UZ, Norfolk, England.; Kapuy, O (corresponding author), Semmelweis Univ, Dept Med Chem Mol Biol & Pathobiochem, Tuzolto Utca 37-47, H-1094 Budapest, Hungary.	tamas.korcsmaros@earlham.ac.uk; kapuy.orsolya@med.semmelweis-univ.huu	Barna, Janos/AAM-9432-2020; Lőrincz, Tamás/AAA-3847-2022; Sigmond, Tímea/J-9819-2018; Kosztelnik, Monika/AAZ-6485-2021; Vellai, Tibor/AAG-2154-2020; Korcsmaros, Tamas/C-3526-2015	Lőrincz, Tamás/0000-0003-1762-4007; Sigmond, Tímea/0000-0002-1985-428X; Kosztelnik, Monika/0000-0001-6735-3597; Barna, Janos/0000-0002-9242-0939; Korcsmaros, Tamas/0000-0003-1717-996X	Earlham Institute; Quadram Institute; Biotechnological and Biosciences Research Council [BB/J004529/1, BB/P016774/1, BB/J004545/1]; Baron Munchausen Program of the Department of Medical Chemistry, Molecular Biology and Pathobiochemistry of Semmelweis University; New National Excellence Program of the Ministry of Human Capacities [UNKP-17-4-III-SE-75]; National Research, Development and Innovation Office [K112696, K124813, K123752]; European Cooperation in Science and Technology (COST) Action [PROTEOSTASIS BM1307]; Hungarian Scientific Research Fund (OTKA) [NK78012]; MEDinPROT Protein Science Research Synergy Program [Hungarian Academy of Sciences (MTA)]; Competitive Central-Hungarian Operational Program [VEKOP-2.3.2-16-2017-00014]; MTA-Eotvos Lorand Tudomanyegyetem (MTA-ELTE) Genetics Research Group [01062]; BBSRC [BBS/E/F/000PR10347, BBS/E/F/00044500, BBS/E/F/000PR10355, BBS/E/T/000PR9819] Funding Source: UKRI	Earlham Institute(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Quadram Institute(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnological and Biosciences Research Council; Baron Munchausen Program of the Department of Medical Chemistry, Molecular Biology and Pathobiochemistry of Semmelweis University; New National Excellence Program of the Ministry of Human Capacities; National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary); European Cooperation in Science and Technology (COST) Action(European Cooperation in Science and Technology (COST)); Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); MEDinPROT Protein Science Research Synergy Program [Hungarian Academy of Sciences (MTA)]; Competitive Central-Hungarian Operational Program; MTA-Eotvos Lorand Tudomanyegyetem (MTA-ELTE) Genetics Research Group; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Computational Biology Fellowship (to T.K.) from the Earlham Institute in partnership with the Quadram Institute, and strategically supported by the Biotechnological and Biosciences Research Council (BB/J004529/1, BB/P016774/1, BB/J004545/1). O.K. was supported by the Baron Munchausen Program of the Department of Medical Chemistry, Molecular Biology and Pathobiochemistry of Semmelweis University, and by the UNKP-17-4-III-SE-75 New National Excellence Program of the Ministry of Human Capacities. O.K., A.S., and G.B. were supported by the National Research, Development and Innovation Office (K112696, K124813 and K123752). This article is based upon work from European Cooperation in Science and Technology (COST) Action (PROTEOSTASIS BM1307). This work was supported by the the Hungarian Scientific Research Fund (OTKA; Grant NK78012), the MEDinPROT Protein Science Research Synergy Program [provided by the Hungarian Academy of Sciences (MTA)], and the Competitive Central-Hungarian Operational Program (VEKOP-2.3.2-16-2017-00014). T.V. is supported by the MTA-Eotvos Lorand Tudomanyegyetem (MTA-ELTE) Genetics Research Group (01062). The authors declare no conflicts of interest.	Aschner M., 2016, CURR PROTOC TOXICOL, V69, P12; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; Bjedov I, 2010, CELL METAB, V11, P35, DOI 10.1016/j.cmet.2009.11.010; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Blackwell TK, 2015, FREE RADICAL BIO MED, V88, P290, DOI 10.1016/j.freeradbiomed.2015.06.008; BLACKWELL TK, 1994, SCIENCE, V266, P621, DOI 10.1126/science.7939715; BOWERMAN B, 1992, CELL, V68, P1061, DOI 10.1016/0092-8674(92)90078-Q; Brdlik CM, 2014, METHOD ENZYMOL, V539, P89, DOI 10.1016/B978-0-12-420120-0.00007-4; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Chen XP, 2012, NEURAL REGEN RES, V7, P376, DOI 10.3969/j.issn.1673-5374.2012.05.009; Choe KP, 2009, MOL CELL BIOL, V29, P2704, DOI 10.1128/MCB.01811-08; Cichoz-Lach H, 2014, WORLD J GASTROENTERO, V20, P8082, DOI 10.3748/wjg.v20.i25.8082; Denton D, 2015, IMMUNOL CELL BIOL, V93, P35, DOI 10.1038/icb.2014.85; Dinkova-Kostova AT, 2010, ARCH BIOCHEM BIOPHYS, V501, P116, DOI 10.1016/j.abb.2010.03.019; Essick EE, 2010, OXID MED CELL LONGEV, V3, P168, DOI 10.4161/oxim.3.3.12106; Filomeni G, 2015, CELL DEATH DIFFER, V22, P377, DOI 10.1038/cdd.2014.150; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fulda S, 2015, ONCOGENE, V34, P5105, DOI 10.1038/onc.2014.458; Fulda Simone, 2010, Int J Cell Biol, V2010, P370835, DOI 10.1155/2010/370835; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Geillinger KE, 2014, BBA-GEN SUBJECTS, V1840, P1747, DOI 10.1016/j.bbagen.2013.12.026; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; He H, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.533; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; Jaramillo MC, 2013, GENE DEV, V27, P2179, DOI 10.1101/gad.225680.113; Jiang T, 2015, FREE RADICAL BIO MED, V88, P199, DOI 10.1016/j.freeradbiomed.2015.06.014; Jing D, 2003, PROTEOMICS, V3, P1172, DOI 10.1002/pmic.200300438; Joo MS, 2016, MOL CELL BIOL, V36, P1931, DOI 10.1128/MCB.00118-16; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kansanen E, 2013, REDOX BIOL, V1, P45, DOI 10.1016/j.redox.2012.10.001; Kapuy O, 2014, FEBS OPEN BIO, V4, P704, DOI 10.1016/j.fob.2014.07.006; Kim GH, 2015, EXP NEUROBIOL, V24, P325, DOI 10.5607/en.2015.24.4.325; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kubisch J, 2013, SEMIN CANCER BIOL, V23, P252, DOI 10.1016/j.semcancer.2013.06.009; Lee HJ, 2008, J BIOL CHEM, V283, P14988, DOI 10.1074/jbc.M709115200; Lennicke C, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0118-6; Li S, 2015, INT J MOL SCI, V16, P26087, DOI 10.3390/ijms161125942; Liu WJ, 2016, CELL MOL BIOL LETT, V21, DOI 10.1186/s11658-016-0031-z; Liu XM, 2011, AM J PHYSIOL-HEART C, V300, pH84, DOI 10.1152/ajpheart.00749.2010; Loos B, 2014, AUTOPHAGY, V10, P2087, DOI 10.4161/15548627.2014.973338; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Navarro-Yepes J, 2014, ANTIOXID REDOX SIGN, V21, P66, DOI 10.1089/ars.2014.5837; Oliveira RP, 2009, AGING CELL, V8, P524, DOI 10.1111/j.1474-9726.2009.00501.x; Onken B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008758; Pajares M, 2016, AUTOPHAGY, V12, P1902, DOI 10.1080/15548627.2016.1208889; Palmisano N. J., 2016, COLD SPRING HARB PRO, V2016; Palmisano N. J., 2016, COLD SPRING HARB PRO, V2016; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Papp D, 2012, FEBS LETT, V586, P1795, DOI 10.1016/j.febslet.2012.05.016; Parzych KR, 2014, ANTIOXID REDOX SIGN, V20, P460, DOI 10.1089/ars.2013.5371; Rao VA, 2010, J BIOL CHEM, V285, P34447, DOI 10.1074/jbc.M110.133579; Rochette L, 2014, BBA-GEN SUBJECTS, V1840, P2709, DOI 10.1016/j.bbagen.2014.05.017; RUSH GF, 1985, TOXICOL APPL PHARM, V78, P473, DOI 10.1016/0041-008X(85)90255-8; Salminen A, 2012, AGEING RES REV, V11, P230, DOI 10.1016/j.arr.2011.12.005; Salmon' TB, 2004, NUCLEIC ACIDS RES, V32, P3712, DOI 10.1093/nar/gkh696; Scherz-Shouval R, 2011, TRENDS BIOCHEM SCI, V36, P30, DOI 10.1016/j.tibs.2010.07.007; Staab TA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003354; Tangvarasittichai S, 2015, WORLD J DIABETES, V6, P456, DOI 10.4239/wjd.v6.i3.456; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Toth ML, 2008, AUTOPHAGY, V4, P330, DOI 10.4161/auto.5618; Turei D, 2015, AUTOPHAGY, V11, P155, DOI 10.4161/15548627.2014.994346; Turei D, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/737591; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; Wu LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063799; Zhang B, 2013, J AGR FOOD CHEM, V61, P8765, DOI 10.1021/jf4012399; Zhang H, 2015, AUTOPHAGY, V11, P9, DOI 10.1080/15548627.2014.1003478; ZHANG L, 2016, OXID MED CELL LONGEV, V2016, DOI DOI 10.1155/2016/3897250; Zhao ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019456	75	26	27	0	26	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2372	2387		10.1096/fj.201800565RR	http://dx.doi.org/10.1096/fj.201800565RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30277819	hybrid, Green Published			2022-12-26	WOS:000457296600067
J	Poli, G; Sarchielli, E; Guasti, D; Benvenuti, S; Ballerini, L; Mazzanti, B; Armignacco, R; Cantini, G; Lulli, M; Chortis, V; Arlt, W; Romagnoli, P; Vannelli, GB; Mannelli, M; Luconi, M				Poli, Giada; Sarchielli, Erica; Guasti, Daniele; Benvenuti, Susanna; Ballerini, Lara; Mazzanti, Benedetta; Armignacco, Roberta; Cantini, Giulia; Lulli, Matteo; Chortis, Vasileios; Arlt, Wiebke; Romagnoli, Paolo; Vannelli, Gabriella Barbara; Mannelli, Massimo; Luconi, Michaela			Human fetal adrenal cells retain age-related stem- and endocrine-differentiation potential in culture	FASEB JOURNAL			English	Article						steroidogenesis; organoid; embryonic development; adrenal cortex; chromaffin	EXTRACELLULAR-MATRIX; GROWTH-FACTORS; ORGANOIDS; CORTEX; MOUSE; IDENTIFICATION; PROLIFERATION; BIOLOGY	The adrenal gland is a multiendocrine organ with a steroidogenic mesenchymal cortex and an inner catecholamine-producing medulla of neuroendocrine origin. After embryonic development, this plastic organ undergoes a functional postnatal remodeling. Elucidating these complex processes is pivotal for understanding the early bases of functional endocrine disorders and tumors affecting the mature gland. We developed an in vitro human adrenal cell model derived from fetal adrenal specimens at different gestational ages, consisting of neuroendocrine and cortical components and expressing the zona and functional markers of the original fetal organ. These cortical and neuroendocrine progenitor cells retain in vitro an intrinsic gestational-age-related differentiation and functional program. In vitro these cells spontaneously form 3-dimensional structure organoids with a structure similar to the fetal gland. The organoids show morphofunctional features and adrenal steroidogenic factor, steroid acute regulatory, cytochrome-P450-17A1, dosage-sensitive, sex-reversal, adrenal hypoplasia-critical region on chromosome X protein , NOTCH1, and nephroblastoma overexpressed/cysteine-rich protein 61/connective tissue growth factor/nephroblastoma overexpressed gene-3; stem (BMI1, nestin); and chromaffin (chromogranin A, tyrosine hydroxylase) markers similar to those of the populations of origin. This in vitro human adrenal system represents a unique but preliminar model for investigating the pathophysiological processes underlying physiologic adrenal remodeling and pathologic alterations involved in organ hypo- and hyperplasia and cancer.Poli, G., Sarchielli, E., Guasti, D., Benvenuti, S., Ballerini, L., Mazzanti, B., Armignacco, R., Cantini, G., Lulli, M., Chortis, V., Arlt, W., Romagnoli, P., Vannelli, G. B., Mannelli, M., Luconi, M. Human fetal adrenal cells retain age-related stem- and endocrine-differentiation potential in culture.	[Poli, Giada; Benvenuti, Susanna; Armignacco, Roberta; Cantini, Giulia; Mannelli, Massimo; Luconi, Michaela] Univ Florence, Endocrinol Unit, Florence, Italy; [Lulli, Matteo] Univ Florence, Dept Expt & Clin Biomed Sci, Gen Pathol Unit, Florence, Italy; [Sarchielli, Erica; Guasti, Daniele; Romagnoli, Paolo; Vannelli, Gabriella Barbara] Univ Florence, Histol & Embryol Unit, Florence, Italy; [Ballerini, Lara; Mazzanti, Benedetta] Univ Florence, Dept Expt & Clin Med, Haematol Unit, Florence, Italy; [Chortis, Vasileios; Arlt, Wiebke] Univ Birmingham, IMSR, Birmingham, W Midlands, England	University of Florence; University of Florence; University of Florence; University of Florence; University of Birmingham	Luconi, M (corresponding author), Univ Florence, Dept Expt & Clin Biomed Sci Mario Serio, Endocrinol Unit, Viale Pieraccini 6, I-50139 Florence, Italy.	michaela.luconi@unifi.it	Cantini, Giulia/K-7626-2016; Romagnoli, Paolo/AAJ-9636-2020; Luconi, Michaela/W-9522-2019; Lulli, Matteo/J-8623-2016; Arlt, Wiebke/B-6310-2009	Luconi, Michaela/0000-0001-5186-064X; Lulli, Matteo/0000-0002-8528-4094; Arlt, Wiebke/0000-0001-5106-9719; CANTINI, GIULIA/0000-0002-9159-9199; DANIELE, GUASTI/0000-0002-2856-6829	Seventh Framework Program (FP7/2007-2013) Grant ENS@T-Cancer [259735]; Associazione Italiana Ricerca sul Cancro (AIRC) Investigator Grant [IG2015-17691]; MRC [G0900567, G0801473] Funding Source: UKRI	Seventh Framework Program (FP7/2007-2013) Grant ENS@T-Cancer; Associazione Italiana Ricerca sul Cancro (AIRC) Investigator Grant(Fondazione AIRC per la ricerca sul cancro); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research received funding from the Seventh Framework Program (FP7/2007-2013) Grant 259735 ENS@T-Cancer, and was supported by Associazione Italiana Ricerca sul Cancro (AIRC) Investigator Grant IG2015-17691 (to M.L.). The authors declare no conflicts of interest.	Battista MC, 2005, J CLIN ENDOCR METAB, V90, P5426, DOI 10.1210/jc.2005-0666; Beaujean D, 2003, EXP NEUROL, V184, P348, DOI 10.1016/j.expneurol.2003.07.007; Broutier L, 2016, NAT PROTOC, V11, P1724, DOI 10.1038/nprot.2016.097; Caroccia B, 2010, ENDOCRINOLOGY, V151, P1375, DOI 10.1210/en.2009-1243; Chamoux E, 2005, BRAZ J MED BIOL RES, V38, P1495, DOI 10.1590/S0100-879X2005001000006; Chamoux E, 2002, J CLIN ENDOCR METAB, V87, P1819, DOI 10.1210/jc.87.4.1819; Chamoux E, 2001, J CLIN ENDOCR METAB, V86, P2090, DOI 10.1210/jc.86.5.2090; Del Valle Ignacio, 2017, Wellcome Open Res, V2, P25, DOI 10.12688/wellcomeopenres.11253.2; Di Franco A, 2016, STEM CELLS, V34, P1679, DOI 10.1002/stem.2336; Doghman M, 2007, J CLIN ENDOCR METAB, V92, P3253, DOI 10.1210/jc.2007-0342; Ehrhart-Bornstein M, 2010, CELL MOL NEUROBIOL, V30, P1417, DOI 10.1007/s10571-010-9571-3; Fatehullah A, 2016, NAT CELL BIOL, V18, P246, DOI 10.1038/ncb3312; Goto M, 2006, J CLIN INVEST, V116, P953, DOI 10.1172/JCI25091; Guasti L, 2011, MOL CELL ENDOCRINOL, V336, P117, DOI 10.1016/j.mce.2010.11.010; HAASEMATTHIAS, 2011, ENDOCR DEV, V20, P28; Hassan-Smith ZK, 2015, J CLIN ENDOCR METAB, V100, P2673, DOI 10.1210/jc.2015-1516; Huang CCJ, 2010, ENDOCRINOLOGY, V151, P1119, DOI 10.1210/en.2009-0814; Huch M, 2015, DEVELOPMENT, V142, P3113, DOI 10.1242/dev.118570; Ishimoto H, 2011, ENDOCR REV, V32, P317, DOI 10.1210/er.2010-0001; Ito M, 1997, MOL CELL BIOL, V17, P1476, DOI 10.1128/MCB.17.3.1476; Ivell R., 2017, ENDOCRINOLOGY TESTIS, P1; JESSELL TM, 1988, NEURON, V1, P3, DOI 10.1016/0896-6273(88)90204-8; Kretzschmar K, 2016, DEV CELL, V38, P590, DOI 10.1016/j.devcel.2016.08.014; Lebbe M, 2017, ENDOCRINOLOGY, V158, P1474, DOI 10.1210/en.2016-1851; Lerario AM, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00052; Lumb R, 2015, DEV GROWTH DIFFER, V57, P146, DOI 10.1111/dgd.12189; Mesiano S, 1997, ENDOCR REV, V18, P378, DOI 10.1210/er.18.3.378; Parlato R, 2009, ENDOCRINOLOGY, V150, P1775, DOI 10.1210/en.2008-1107; Parviainen H, 2007, MOL CELL ENDOCRINOL, V265, P17, DOI 10.1016/j.mce.2006.12.033; Penny MK, 2017, MOL CELL ENDOCRINOL, V445, P42, DOI 10.1016/j.mce.2016.12.005; Ratcliffe J, 2003, J CLIN ENDOCR METAB, V88, P3272, DOI 10.1210/jc.2003-022056; Sicard F, 2007, P NATL ACAD SCI USA, V104, P2007, DOI 10.1073/pnas.0610898104; Simunovic M, 2017, DEVELOPMENT, V144, P976, DOI 10.1242/dev.143529; Spencer SJ, 1999, J CLIN ENDOCR METAB, V84, P1110, DOI 10.1210/jc.84.3.1110; Steenblock C, 2017, MOL CELL ENDOCRINOL, V441, P156, DOI 10.1016/j.mce.2016.09.011; Terada T, 2015, MICROSC RES TECHNIQ, V78, P59, DOI 10.1002/jemt.22445; Walczak EM, 2015, NAT REV ENDOCRINOL, V11, P14, DOI 10.1038/nrendo.2014.166; Wood MA, 2011, MOL CELL ENDOCRINOL, V336, P206, DOI 10.1016/j.mce.2010.11.012; Xing Y, 2017, DEVELOPMENT, V144, P3798, DOI 10.1242/dev.150516; Xing YW, 2015, ENDOCRIN METAB CLIN, V44, P243, DOI 10.1016/j.ecl.2015.02.001; Ziegler CG, 2008, ENDOCRINOLOGY, V149, P320, DOI 10.1210/en.2007-0645	41	19	22	1	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2263	2277		10.1096/fj.201801028RR	http://dx.doi.org/10.1096/fj.201801028RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30247985				2022-12-26	WOS:000457296600059
J	Zhu, ED; Zhang, JJ; Li, YC; Yuan, HR; Zhou, J; Wang, BL				Zhu, Endong; Zhang, Juanjuan; Li, Yachong; Yuan, Hairui; Zhou, Jie; Wang, Baoli			Long noncoding RNA Plnc1 controls adipocyte differentiation by regulating peroxisome proliferator-activated receptor	FASEB JOURNAL			English	Article						adipogenesis; DNA methylation; obesity	ADIPOSE-TISSUE; GENE; ADIPOGENESIS; EXPRESSION; LNCRNA; OBESITY; PROMOTES; BINDING; ALPHA; GAMMA	Detailed understanding of molecular mechanisms controlling adipogenesis is of great importance to identify new targets for treating obesity. Emerging evidence suggests that long noncoding RNAs (lncRNAs) may play a pivotal role in adipogenesis. Here, we have identified a novel lncRNA, Plnc1, which is transcribed from a position approximate to 25,000 bp upstream of the peroxisome proliferator-activated receptor 2 (PPAR-2) gene. Plnc1 is abundantly expressed in adipose tissue, and obese mice have higher Plnc1 expression in adipose tissue than nonobese mice. Plnc1 was induced in established adipogenic lines ST2, 3T3-L1, and C3H10T1/2 as well as in bone marrow stromal cells (BMSCs) after adipogenic treatment. Plnc1 knockdown blocked differentiation of ST2 cells and BMSCs into mature adipocytes, along with the reduction of PPAR-, CCAAT/enhancer binding protein-, and adipocyte protein 2. Conversely, overexpression of Plnc1 promoted ST2 cells and BMSCs to fully differentiate. Mechanism studies revealed that Plnc1 could reduce the methylation level of CpG region in the PPAR-2 promoter and enhance the transcriptional activity of the promoter and thereby increase PPAR-2 transcription. Our study suggests that Plnc1 promotes adipogenic differentiation through controlling the key adipogenic transcription factor PPAR- and highlights the potential of Plnc1 as a target for new therapies to control metabolic disorders like obesity.Zhu, E., Zhang, J., Li, Y., Yuan, H., Zhou, J., Wang, B. Long noncoding RNA Plnc1 controls adipocyte differentiation by regulating peroxisome proliferator-activated receptor .	[Zhu, Endong; Zhang, Juanjuan; Yuan, Hairui; Zhou, Jie; Wang, Baoli] Tianjin Med Univ, Minist Hlth, Key Lab Hormones & Dev, Tianjin, Peoples R China; [Zhu, Endong; Zhang, Juanjuan; Yuan, Hairui; Zhou, Jie; Wang, Baoli] Tianjin Med Univ, Tianjin Metab Dis Hosp, Tianjin Key Lab Metab Dis, Tianjin, Peoples R China; [Zhu, Endong; Zhang, Juanjuan; Yuan, Hairui; Zhou, Jie; Wang, Baoli] Tianjin Med Univ, Tianjin Inst Endocrinol, Tianjin, Peoples R China; [Li, Yachong] Tianjin Med Univ, Stomatol Hosp, Dept Endodont, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Wang, BL (corresponding author), Tianjin Med Univ, Inst Endocrinol, Tianjin Key Lab Metab Dis, 22 Qi Xiang Tai Rd, Tianjin 300070, Peoples R China.	blwang@tmu.edu.cn	Zhang, Juan/GRX-2638-2022		National Natural Science Foundation of China [81501846, 81601864, 81672116, 81472040]; Tianjin Municipal Natural Science Foundation [18JCZDJC32200, 18JCQNJC12900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Municipal Natural Science Foundation(Natural Science Foundation of Tianjin)	This work was supported by Grants 81501846 (to E.Z.), 81601864 (to H.Y.), and 81672116 and 81472040 (to B.W.) from the National Natural Science Foundation of China. This work was also partially supported by Tianjin Municipal Natural Science Foundation Grants 18JCZDJC32200 and 18JCQNJC12900. The authors declare no conflicts of interest.	Ali AT, 2013, EUR J CELL BIOL, V92, P229, DOI 10.1016/j.ejcb.2013.06.001; Arsenijevic T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037517; Bhupathiraju SN, 2016, CIRC RES, V118, P1723, DOI 10.1161/CIRCRESAHA.115.306825; Bianchessi V, 2017, ANAL BIOCHEM, V519, P84, DOI 10.1016/j.ab.2016.12.016; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Carninci P, 1999, METHOD ENZYMOL, V303, P19; Carninci P, 2000, GENOME RES, V10, P1617, DOI 10.1101/gr.145100; Chen J, 2017, INT J OBESITY, V41, P299, DOI 10.1038/ijo.2016.189; Cooper DR, 2014, GENES-BASEL, V5, P1050, DOI 10.3390/genes5041050; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; Divoux A, 2014, OBESITY, V22, P1781, DOI 10.1002/oby.20793; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; FREYTAG SO, 1994, GENE DEV, V8, P1654, DOI 10.1101/gad.8.14.1654; Fujiki K, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-38; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Guil S, 2012, NAT STRUCT MOL BIOL, V19, P1068, DOI 10.1038/nsmb.2428; Knoll M, 2015, NAT REV ENDOCRINOL, V11, P151, DOI 10.1038/nrendo.2014.229; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Linhart HG, 2001, P NATL ACAD SCI USA, V98, P12532, DOI 10.1073/pnas.211416898; Liu S, 2014, J BIOL CHEM, V289, P13000, DOI 10.1074/jbc.M114.564658; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louro R, 2009, GENOMICS, V93, P291, DOI 10.1016/j.ygeno.2008.11.009; Luo LP, 2016, J ENDOCRINOL, V231, pR77, DOI 10.1530/JOE-16-0211; Ma LN, 2013, RNA BIOL, V10, P925, DOI 10.4161/rna.24604; Marchese FP, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1348-2; Pang WJ, 2013, J CELL BIOCHEM, V114, P2500, DOI 10.1002/jcb.24595; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Sarjeant K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008417; Sun L, 2013, P NATL ACAD SCI USA, V110, P3387, DOI 10.1073/pnas.1222643110; Sun Q., 2017, TRENDS GENET; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wang L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt006; Wang LJ, 2015, CELL RES, V25, P335, DOI 10.1038/cr.2015.21; Wei SJ, 2016, CELL MOL LIFE SCI, V73, P2079, DOI 10.1007/s00018-016-2169-2; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Xiao TF, 2015, STEM CELL REP, V5, P856, DOI 10.1016/j.stemcr.2015.09.007; Xu B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014199; Zhang JF, 2004, P NATL ACAD SCI USA, V101, P10703, DOI 10.1073/pnas.0403652101; Zhao XY, 2015, TRENDS BIOCHEM SCI, V40, P586, DOI 10.1016/j.tibs.2015.08.002; Zhou J, 2017, FASEB J, V31, P1939, DOI 10.1096/fj.201600975RR; Zhu ED, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106049; Zhu ED, 2018, J MOL ENDOCRINOL, V60, P225, DOI 10.1530/JME-17-0183; ZHU YJ, 1995, P NATL ACAD SCI USA, V92, P7921, DOI 10.1073/pnas.92.17.7921	46	32	38	1	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2396	2408		10.1096/fj.201800739RRR	http://dx.doi.org/10.1096/fj.201800739RRR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30277818				2022-12-26	WOS:000457296600069
J	Fernandez-Zapata, J; Perez-Castano, R; Aranda, J; Colizzi, F; Polanco, MC; Orozco, M; Padmanabhan, S; Elias-Arnanz, M				Fernandez-Zapata, Jesus; Perez-Castano, Ricardo; Aranda, Juan; Colizzi, Francesco; Carmen Polanco, Maria; Orozco, Modesto; Padmanabhan, S.; Elias-Arnanz, Montserrat			Plasticity in oligomerization, operator architecture, and DNA binding in the mode of action of a bacterial B-12-based photoreceptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adenosylcobalamin (AdoCbl); photoreceptor; protein-DNA interaction; bacterial signal transduction; bacterial transcription; oxidative stress; Bacillus megaterium; CarH; light sensor; photoregulation; Spx	CRYSTAL-STRUCTURE; STRUCTURAL MECHANISM; MYXOCOCCUS-XANTHUS; OXIDATIVE-STRESS; GENE-REGULATION; PROTEIN; FAMILY; INACTIVATION; PARAMETERS; EXPRESSION	Newly discovered bacterial photoreceptors called CarH sense light by using 5-deoxyadenosylcobalamin (AdoCbl). They repress their own expression and that of genes for carotenoid synthesis by binding in the dark to operator DNA as AdoCbl-bound tetramers, whose light-induced disassembly relieves repression. High-resolution structures of Thermus thermophilus CarH(Tt) have provided snapshots of the dark and light states and have revealed a unique DNA-binding mode whereby only three of four DNA-binding domains contact an operator comprising three tandem direct repeats. To gain further insights into CarH photoreceptors and employing biochemical, spectroscopic, mutational, and computational analyses, here we investigated CarH(Bm) from Bacillus megaterium. We found that apoCarH(Bm), unlike monomeric apoCarH(Tt), is an oligomeric molten globule that forms DNA-binding tetramers in the dark only upon AdoCbl binding, which requires a conserved W-X-9-EH motif. Light relieved DNA binding by disrupting CarH(Bm) tetramers to dimers, rather than to monomers as with CarH(Tt). CarH(Bm) operators resembled that of CarH(Tt), but were larger by one repeat and overlapped with the -35 or -10 promoter elements. This design persisted in a six-repeat, multipartite operator we discovered upstream of a gene encoding an Spx global redox-response regulator whose photoregulated expression links photooxidative and general redox responses in B. megaterium. Interestingly, CarH(Bm) recognized the smaller CarH(Tt) operator, revealing an adaptability possibly related to the linker bridging the DNA- and AdoCbl-binding domains. Our findings highlight a remarkable plasticity in the mode of action of B-12-based CarH photoreceptors, important for their biological functions and development as optogenetic tools.	[Fernandez-Zapata, Jesus; Padmanabhan, S.] CSIC, Inst Quim Fis Rocasolano, E-28006 Madrid, Spain; [Perez-Castano, Ricardo; Carmen Polanco, Maria; Elias-Arnanz, Montserrat] Univ Murcia, Dept Genet & Microbiol, CSIC,Fac Biol, Unidad Asociada,Inst Quim Fis Rocasolano,Area Gen, E-30100 Murcia, Spain; [Aranda, Juan; Colizzi, Francesco; Orozco, Modesto] Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Barcelona, Spain; [Aranda, Juan; Colizzi, Francesco; Orozco, Modesto] Joint BSC IRB Res Program Computat Biol, Baldiri Reixac 10-12, Barcelona 08028, Spain; [Orozco, Modesto] Univ Barcelona, Dept Biochem & Biomed, E-08028 Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); University of Murcia; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona	Padmanabhan, S (corresponding author), CSIC, Inst Quim Fis Rocasolano, E-28006 Madrid, Spain.; Elias-Arnanz, M (corresponding author), Univ Murcia, Dept Genet & Microbiol, CSIC,Fac Biol, Unidad Asociada,Inst Quim Fis Rocasolano,Area Gen, E-30100 Murcia, Spain.	padhu@iqfr.csic.es; melias@um.es	Padmanabhan, S./E-8943-2017; Moratalla, Juan Aranda/A-6888-2016; Moratalla, Juan Aranda/G-3376-2017; Elias-Arnanz, Montserrat/H-4707-2015; Polanco, Maria Carmen/H-5571-2015	Moratalla, Juan Aranda/0000-0001-9385-4651; Moratalla, Juan Aranda/0000-0001-9385-4651; Padmanabhan, S./0000-0002-8772-0152; Elias-Arnanz, Montserrat/0000-0003-1980-3092; Perez-Castano, Ricardo/0000-0003-3220-4297; Fernandez-Zapata, Jesus/0000-0002-7686-5591; Polanco, Maria Carmen/0000-0002-5968-5791; Orozco Lopez, Modesto/0000-0002-8608-3278; Colizzi, Francesco/0000-0001-5601-1452	Ministerio de Economia y Competitividad-Spain - European Union Fondo Europeo de Desarrollo Regional (FEDER) funds [BFU2015-67968-C2-1-P, BFU2015-67968-C2-2-P, BIO2015-64802-R]; Juan de la Cierva; European Research Council grant ERC SimDNA; European Union Marie Curie fellowship; Fundacion Seneca-Spain [19429/PI/14]	Ministerio de Economia y Competitividad-Spain - European Union Fondo Europeo de Desarrollo Regional (FEDER) funds; Juan de la Cierva(Instituto de Salud Carlos III); European Research Council grant ERC SimDNA(European Research Council (ERC)); European Union Marie Curie fellowship(European Commission); Fundacion Seneca-Spain(Fundacion Seneca)	This work was supported by Ministerio de Economia y Competitividad-Spain Grants BFU2015-67968-C2-1-P co-financed with the European Union Fondo Europeo de Desarrollo Regional (FEDER) funds (to M. E.-A.), BFU2015-67968-C2-2-P (to S. P.), and BIO2015-64802-R (to M. O.), and Ph.D. fellowships (to J. F.-Z and R. P.-C.), a Juan de la Cierva contract (to J. A.), the European Research Council grant ERC SimDNA (to M. O.), a European Union Marie Curie fellowship (to F. C.), and Fundacion Seneca-Spain Grant 19429/PI/14 (to M. E.-A.). The authors declare that they have no conflicts of interest with the contents of this article.	Baldwin RL, 2013, CURR OPIN STRUC BIOL, V23, P4, DOI 10.1016/j.sbi.2012.11.004; Barendt S, 2013, MICROBIOLOGYOPEN, V2, P695, DOI 10.1002/mbo3.109; Biedendieck R, 2011, METHOD ENZYMOL, V500, P165, DOI 10.1016/B978-0-12-385118-5.00010-4; Birukou I, 2014, NUCLEIC ACIDS RES, V42, P2774, DOI 10.1093/nar/gkt1215; Case DA, 2014, AMBER 14; Chatelle C, 2018, ACS SYNTH BIOL, V7, P1349, DOI 10.1021/acssynbio.7b00450; CRAIG ML, 1995, BIOCHEMISTRY-US, V34, P15624, DOI 10.1021/bi00048a004; Diez AI, 2013, EUR BIOPHYS J BIOPHY, V42, P463, DOI 10.1007/s00249-013-0897-x; DRENNAN CL, 1994, SCIENCE, V266, P1669, DOI 10.1126/science.7992050; Elias-Arnanz M, 2011, CURR OPIN MICROBIOL, V14, P128, DOI 10.1016/j.mib.2010.12.009; Flock T, 2014, CURR OPIN STRUC BIOL, V26, P62, DOI 10.1016/j.sbi.2014.05.007; Fuxreiter M, 2011, TRENDS BIOCHEM SCI, V36, P415, DOI 10.1016/j.tibs.2011.04.006; Gallego-Garcia A, 2017, SCI REP-UK, V7, DOI 10.1038/srep43240; Gao YF, 2017, P NATL ACAD SCI USA, V114, P12560, DOI 10.1073/pnas.1716721114; Garcia-Moreno D, 2009, J BACTERIOL, V191, P3108, DOI 10.1128/JB.01737-08; Glaeser J, 2011, ADV MICROB PHYSIOL, V58, P141, DOI 10.1016/B978-0-12-381043-4.00004-0; GOTO Y, 1989, BIOCHEMISTRY-US, V28, P945, DOI 10.1021/bi00429a004; Grubmuller H, 1996, SCIENCE, V271, P997, DOI 10.1126/science.271.5251.997; Heldwein EEZ, 2001, NATURE, V409, P378, DOI 10.1038/35053138; Iniesta AA, 2012, J BACTERIOL, V194, P5875, DOI 10.1128/JB.01110-12; Ivani I, 2016, NAT METHODS, V13, P55, DOI [10.1038/NMETH.3658, 10.1038/nmeth.3658]; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jost M, 2015, NATURE, V526, P536, DOI 10.1038/nature14950; Jost M, 2015, BIOCHEMISTRY-US, V54, P3231, DOI 10.1021/acs.biochem.5b00416; Kainrath S, 2017, ANGEW CHEM INT EDIT, V56, P4608, DOI 10.1002/anie.201611998; Kutta RJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8907; Li ZR, 2009, ANNU REV PLANT BIOL, V60, P239, DOI 10.1146/annurev.arplant.58.032806.103844; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Ortiz-Guerrero JM, 2011, P NATL ACAD SCI USA, V108, P7565, DOI 10.1073/pnas.1018972108; Meiser P, 2006, P NATL ACAD SCI USA, V103, P19128, DOI 10.1073/pnas.0606039103; Moglich A, 2010, ANNU REV PLANT BIOL, V61, P21, DOI 10.1146/annurev-arplant-042809-112259; Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001; Newberry KJ, 2004, J BIOL CHEM, V279, P20356, DOI 10.1074/jbc.M400960200; Newberry KJ, 2005, P NATL ACAD SCI USA, V102, P15839, DOI 10.1073/pnas.0506592102; Padmanabhan S, 2017, ANNU REV BIOCHEM, V86, P485, DOI 10.1146/annurev-biochem-061516-044500; Palczewski K, 2012, J BIOL CHEM, V287, P1612, DOI 10.1074/jbc.R111.301150; Park DM, 2014, MBIO, V5, DOI 10.1128/mBio.01684-14; Perez-Marin MC, 2008, MOL MICROBIOL, V67, P804, DOI 10.1111/j.1365-2958.2007.06086.x; Philips SJ, 2015, SCIENCE, V349, P877, DOI 10.1126/science.aaa9809; Purcell EB, 2008, CURR OPIN MICROBIOL, V11, P168, DOI 10.1016/j.mib.2008.02.014; Rohl CA, 1997, BIOCHEMISTRY-US, V36, P8435, DOI 10.1021/bi9706677; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Schmid F. Z., 1997, PROTEIN STRUCTURE PR, P261; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; Takano H, 2015, J BACTERIOL, V197, P2301, DOI 10.1128/JB.02528-14; Takano H, 2011, J BACTERIOL, V193, P2451, DOI 10.1128/JB.01125-10; vanLeeuwen HC, 1997, EMBO J, V16, P2043, DOI 10.1093/emboj/16.8.2043; Vuzman D, 2012, MOL BIOSYST, V8, P47, DOI 10.1039/c1mb05273j; Vuzman D, 2010, BIOPHYS J, V99, P1202, DOI 10.1016/j.bpj.2010.06.007; Wang R, 2017, P NATL ACAD SCI USA, V114, P5912, DOI 10.1073/pnas.1621350114; Watanabe S, 2008, P NATL ACAD SCI USA, V105, P4121, DOI 10.1073/pnas.0709188105; WEBER G, 1964, J BIOL CHEM, V239, P1415; WITTCHEN KD, 1995, APPL MICROBIOL BIOT, V42, P871, DOI 10.1007/s002530050345; Ziegelhoffer EC, 2009, NAT REV MICROBIOL, V7, P856, DOI 10.1038/nrmicro2237; Zuber P, 2009, ANNU REV MICROBIOL, V63, P575, DOI 10.1146/annurev.micro.091208.073241	55	8	8	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2018	293	46					17888	17905		10.1074/jbc.RA118.004838	http://dx.doi.org/10.1074/jbc.RA118.004838			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HA6SG	30262667	Green Published, hybrid			2022-12-26	WOS:000450409500019
J	McCartney, CSE; Ye, QL; Campbell, RL; Davies, PL				McCartney, Christian-Scott E.; Ye, Qilu; Campbell, Robert L.; Davies, Peter L.			Insertion sequence 1 from calpain-3 is functional in calpain-2 as an internal propeptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calpain; cysteine protease; muscular dystrophy; protease inhibitor; structure-function; protein engineering; calpain-2; calpain-3; p94; calpastatin; insertion sequence 1 (IS1); propeptide; p94; calpain inhibitor; limb-girdle muscular dystrophy; protease	MUSCLE-SPECIFIC CALPAIN; GIRDLE MUSCULAR-DYSTROPHY; HAND CA2+-BINDING PROTEINS; CALCIUM-DEPENDENT PROTEASE; SKELETAL-MUSCLE; EF-HAND; ACTIVE-SITE; MU-CALPAIN; ECCENTRIC EXERCISE; CRYSTAL-STRUCTURE	Calpains are intracellular, calcium-activated cysteine proteases. Calpain-3 is abundant in skeletal muscle, where its mutation-induced loss of function causes limb-girdle muscular dystrophy type 2A. Unlike the small subunit-containing calpain-1 and -2, the calpain-3 isoform homodimerizes through pairing of its C-terminal penta-EF-hand domain. It also has two unique insertion sequences (ISs) not found in the other calpains: IS1 within calpain-3's protease core and IS2 just prior to the penta-EF-hand domain. Production of either native or recombinant full-length calpain-3 to characterize the function of these ISs is challenging. Therefore, here we used recombinant rat calpain-2 as a stable surrogate and inserted IS1 into its equivalent position in the protease core. As it does in calpain-3, IS1 occupied the catalytic cleft and restricted the enzyme's access to substrate and inhibitors. Following activation by Ca2+, IS1 was rapidly cleaved by intramolecular autolysis, permitting the enzyme to freely accept substrate and inhibitors. The surrogate remained functional until extensive intermolecular autoproteolysis inactivated the enzyme, as is typical of calpain-2. Although the small-molecule inhibitors E-64 and leupeptin limited intermolecular autolysis of the surrogate, they did not block the initial intramolecular cleavage of IS1, establishing its role as a propeptide. Surprisingly, the large-molecule calpain inhibitor, calpastatin, completely blocked enzyme activity, even with IS1 intact. We suggest that calpastatin is large enough to oust IS1 from the catalytic cleft and take its place. We propose an explanation for why calpastatin can inhibit calpain-2 bearing the IS1 insertion but cannot inhibit WT calpain-3.	[McCartney, Christian-Scott E.; Ye, Qilu; Campbell, Robert L.; Davies, Peter L.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Davies, PL (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada.	daviesp@queensu.ca		Davies, Peter/0000-0002-8026-7818; Campbell, Robert/0000-0002-5473-5876	Canadian Institutes of Health Research Grant [MOP74681]	Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant MOP74681. The authors declare that they have no conflicts of interest with the contents of this article.	Beckmann JS, 2008, NEUROMUSCULAR DISORD, V18, P913, DOI 10.1016/j.nmd.2008.08.005; Betts R, 2004, BIOCHEMISTRY-US, V43, P2596, DOI 10.1021/bi0359832; Betts R, 2003, J BIOL CHEM, V278, P7800, DOI 10.1074/jbc.M208350200; Branca D, 1999, EUR J BIOCHEM, V265, P839, DOI 10.1046/j.1432-1327.1999.00817.x; Campbell RL, 2012, BIOCHEM J, V447, P335, DOI 10.1042/BJ20120921; Chou JS, 2011, BBA-PROTEINS PROTEOM, V1814, P864, DOI 10.1016/j.bbapap.2011.04.007; Cohen N, 2006, PROTEOMICS, V6, P6075, DOI 10.1002/pmic.200600199; CONG JY, 1989, J BIOL CHEM, V264, P10096; CRAWFORD C, 1987, BIOCHEM J, V248, P579, DOI 10.1042/bj2480579; Croall DE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-218; Cuerrier D, 2006, BIOCHEMISTRY-US, V45, P7446, DOI 10.1021/bi060425j; Cuerrier D, 2005, J BIOL CHEM, V280, P40632, DOI 10.1074/jbc.M506870200; Cuerrier D, 2007, J BIOL CHEM, V282, P9600, DOI 10.1074/jbc.M610372200; De Tullio R, 2003, BIOCHEM J, V375, P689, DOI 10.1042/BJ20030706; DEMARTINO GN, 1986, J BIOL CHEM, V261, P2047; Diaz BEG, 2006, BIOCHEMISTRY-US, V45, P3714, DOI 10.1021/bi051917j; Diaz BG, 2004, J BIOL CHEM, V279, P27656, DOI 10.1074/jbc.M313290200; Elce JS, 2000, METH MOL B, V144, P47; ELCE JS, 1995, PROTEIN ENG, V8, P843, DOI 10.1093/protein/8.8.843; EMORI Y, 1988, J BIOL CHEM, V263, P2364; Fanin M, 2007, J MED GENET, V44, P38, DOI 10.1136/jmg.2006.044859; Fanin M, 2004, HUM MUTAT, V24, P52, DOI 10.1002/humu.20058; Fanin M, 2003, AM J PATHOL, V163, P1929, DOI 10.1016/S0002-9440(10)63551-1; Fanin M, 2015, MUSCLE NERVE, V52, P163, DOI 10.1002/mus.24682; Federici C, 1999, ARCH BIOCHEM BIOPHYS, V363, P237, DOI 10.1006/abbi.1998.1091; Fukiage C, 2002, J BIOL CHEM, V277, P20678, DOI 10.1074/jbc.M200697200; Garnham CP, 2009, BIOCHEMISTRY-US, V48, P3457, DOI 10.1021/bi900130u; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; GRAHAMSIEGENTHALER K, 1994, J BIOL CHEM, V269, P30457; Guyon JR, 2003, MUSCLE NERVE, V28, P472, DOI 10.1002/mus.10465; Hanna RA, 2008, NATURE, V456, P409, DOI 10.1038/nature07451; Hanna RA, 2007, FEBS LETT, V581, P2894, DOI 10.1016/j.febslet.2007.05.035; Hauerslev S, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-43; Hosfield CM, 1999, EMBO J, V18, P6880, DOI 10.1093/emboj/18.24.6880; Jia ZC, 2001, BIOPHYS J, V80, P2590, DOI 10.1016/S0006-3495(01)76229-7; Kanzaki K, 2017, J APPL PHYSIOL, V122, P396, DOI 10.1152/japplphysiol.00270.2016; Kanzaki K, 2014, J MUSCLE RES CELL M, V35, P179, DOI 10.1007/s10974-014-9378-9; KAWASAKI H, 1989, J BIOCHEM, V106, P274, DOI 10.1093/oxfordjournals.jbchem.a122844; Kinbara K, 1998, BIOCHEM PHARMACOL, V56, P415; Kinbara K, 1998, BIOCHEM J, V335, P589, DOI 10.1042/bj3350589; Kiss R, 2008, BIOCHEMISTRY-US, V47, P6936, DOI 10.1021/bi800201a; Kramerova I, 2004, HUM MOL GENET, V13, P1373, DOI 10.1093/hmg/ddh153; Kramerova I, 2007, BBA-MOL BASIS DIS, V1772, P128, DOI 10.1016/j.bbadis.2006.07.002; Labeit S, 1997, CIRC RES, V80, P290, DOI 10.1161/01.RES.80.2.290; Li QS, 2006, BIOCHEMISTRY-US, V45, P701, DOI 10.1021/bi052077b; Ma H, 1998, INVEST OPHTH VIS SCI, V39, P454; Maki M, 2002, BBA-PROTEINS PROTEOM, V1600, P51, DOI 10.1016/S1570-9639(02)00444-2; Maki M, 2012, FEBS J, V279, P1414, DOI 10.1111/j.1742-4658.2012.08560.x; Moldoveanu T, 2004, J MOL BIOL, V343, P1313, DOI 10.1016/j.jmb.2004.09.016; Moldoveanu T, 2004, J BIOL CHEM, V279, P6106, DOI 10.1074/jbc.M310460200; Moldoveanu T, 2001, BBA-PROTEIN STRUCT M, V1545, P245, DOI 10.1016/S0167-4838(00)00286-7; Moldoveanu T, 2002, CELL, V108, P649, DOI 10.1016/S0092-8674(02)00659-1; Moldoveanu T, 2008, NATURE, V456, P404, DOI 10.1038/nature07353; Murphy RM, 2006, AM J PHYSIOL-CELL PH, V290, pC116, DOI 10.1152/ajpcell.00291.2005; Murphy RM, 2007, J APPL PHYSIOL, V103, P926, DOI 10.1152/japplphysiol.01422.2006; Murphy RM, 2011, J APPL PHYSIOL, V111, P1448, DOI 10.1152/japplphysiol.00441.2011; Murphy RM, 2010, CLIN EXP PHARMACOL P, V37, P385, DOI 10.1111/j.1440-1681.2009.05310.x; Murphy RM, 2009, J APPL PHYSIOL, V106, P2068, DOI 10.1152/japplphysiol.00239.2009; Murphy RM, 2009, J BIOL CHEM, V284, P7811, DOI 10.1074/jbc.M808655200; Nakamura Y, 1999, EXP EYE RES, V69, P155, DOI 10.1006/exer.1998.0686; Ono Y, 2004, J BIOL CHEM, V279, P2761, DOI 10.1074/jbc.M308789200; Ono Yasuko, 2007, Biotechnology Journal, V2, P565, DOI 10.1002/biot.200700018; Ono Y, 2006, J BIOL CHEM, V281, P18519, DOI 10.1074/jbc.M601029200; Ono Y, 2016, NAT REV DRUG DISCOV, V15, P854, DOI 10.1038/nrd.2016.212; Ono Y, 2015, DATA BRIEF, V5, P366, DOI 10.1016/j.dib.2015.09.021; Ono Y, 2016, BIOCHIMIE, V122, P169, DOI 10.1016/j.biochi.2015.09.010; Ono Y, 2012, BBA-PROTEINS PROTEOM, V1824, P224, DOI 10.1016/j.bbapap.2011.08.005; Pantoja-Melendez CA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170280; Partha SK, 2014, FEBS J, V281, P3138, DOI 10.1111/febs.12849; Piluso G, 2005, J MED GENET, V42, P686, DOI 10.1136/jmg.2004.028738; Qian J, 2008, J MED CHEM, V51, P5264, DOI 10.1021/jm800045t; Ravulapalli R, 2005, BIOCHEM J, V388, P585, DOI 10.1042/BJ20041821; Ravulapalli R, 2009, FEBS J, V276, P973, DOI 10.1111/j.1742-4658.2008.06833.x; Rey MA, 2002, FEBS LETT, V532, P401, DOI 10.1016/S0014-5793(02)03722-5; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; SORIMACHI H, 1990, BIOL CHEM H-S, V371, P171; SORIMACHI H, 1989, J BIOL CHEM, V264, P20106; SORIMACHI H, 1993, J BIOL CHEM, V268, P10593; Sorimachi H, 1995, J BIOL CHEM, V270, P31158, DOI 10.1074/jbc.270.52.31158; Strobl S, 2000, P NATL ACAD SCI USA, V97, P588, DOI 10.1073/pnas.97.2.588; SUZUKI K, 1991, BIOMED BIOCHIM ACTA, V50, P483; TAKANO E, 1988, BIOCHEMISTRY-US, V27, P1964, DOI 10.1021/bi00406a024; Taveau M, 2003, MOL CELL BIOL, V23, P9127, DOI 10.1128/MCB.23.24.9127-9135.2003; Thompson VF, 2003, BBA-PROTEINS PROTEOM, V1648, P140, DOI 10.1016/S1570-9639(03)00115-8; Wendt A, 2004, BIOL CHEM, V385, P465, DOI 10.1515/BC.2004.054; Ye QL, 2018, J BIOL CHEM, V293, P4056, DOI 10.1074/jbc.RA117.001097; YOSHIMURA N, 1983, J BIOL CHEM, V258, P8883	87	5	5	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2018	293	46					17716	17730		10.1074/jbc.RA118.004803	http://dx.doi.org/10.1074/jbc.RA118.004803			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HA6SG	30254072	Green Published, hybrid			2022-12-26	WOS:000450409500005
J	Martin-Frances, L; Martinon-Torres, M; de Pinillos, MM; Garcia-Campos, C; Modesto-Mata, M; Zanolli, C; Rodriguez, L; de Castro, JMB				Martin-Frances, Laura; Martinon-Torres, Maria; Martinez de Pinillos, Marina; Garcia-Campos, Cecilia; Modesto-Mata, Mario; Zanolli, Clement; Rodriguez, Laura; Bermudez de Castro, Jose Maria			Tooth crown tissue proportions and enamel thickness in Early Pleistocene Homo antecessor molars (Atapuerca, Spain)	PLOS ONE			English	Article							GEOMETRIC MORPHOMETRIC-ANALYSIS; DENTAL DEVELOPMENTAL PATTERN; PALEOLITHIC HUMAN REMAINS; BRIEF COMMUNICATION; MIDDLE PLEISTOCENE; MODERN HUMANS; GRAN DOLINA; ENDOSTRUCTURAL CHARACTERIZATION; MORPHOLOGICAL DESCRIPTION; HUMAN SETTLEMENT	Tooth crown tissue proportions and enamel thickness distribution are considered reliable characters for inferring taxonomic identity, phylogenetic relationships, dietary and behavioural adaptations in fossil and extant hominids. While most Pleistocene hominins display variations from thick to hyper-thick enamel, Neanderthals exhibit relatively thinner. However, the chronological and geographical origin for the appearance of this typical Neanderthal condition is still unknown. The European late Early Pleistocene species Homo antecessor (Gran Dolina-TD6 site, Sierra de Atapuerca) represents an opportunity to investigate the appearance of the thin condition in the fossil record. In this study, we aim to test the hypothesis if H. antecessor molars approximates the Neanderthal condition for tissue proportions and enamel thickness. To do so, for the first time we characterised the molar inner structural organization in this Early Pleistocene hominin taxon (n = 17) and compared it to extinct and extant populations of the genus Homo from African, Asian and European origin (n = 355). The comparative sample includes maxillary and mandibular molars belonging to H. erectus, East and North African Homo, European Middle Pleistocene Homo, Neanderthals, and fossil and extant H. sapiens. We used high-resolution images to investigate the endostructural configuration of TD6 molars (tissue proportions, enamel thickness and distribution). TD6 permanent molars tend to exhibit on average thick absolute and relative enamel in 2D and 3D estimates, both in the complete crown and the lateral enamel. This condition is shared with the majority of extinct and extant hominin sample, except for Neanderthals and some isolated specimens. However, while the total crown percentage of dentine in TD6 globally resembles the low modern values, the lateral crown percentage of dentine tends to be much higher, closer to the Neanderthal signal. Similarly, the H. antecessormolar enamel distribution maps reveal a relative distribution pattern that is more similar to the Neanderthal condition (with the thickest enamel more spread at the periphery of the occlusal basin) rather than that of other fossil specimens and modern humans (with thicker cuspal enamel). Future studies on European Middle Pleistocene populations will provide more insights into the evolutionary trajectory of the typical Neanderthal dental structural organization.	[Martin-Frances, Laura] Univ Bordeaux, CNRS, MCC, PACEA,UMR 5199, F-33615 Pessac, France; [Martin-Frances, Laura; Martinon-Torres, Maria; Martinez de Pinillos, Marina; Garcia-Campos, Cecilia; Modesto-Mata, Mario; Bermudez de Castro, Jose Maria] Ctr Nacl Invest Evoluc Humana, Burgos, Spain; [Martinon-Torres, Maria; Martinez de Pinillos, Marina; Garcia-Campos, Cecilia; Modesto-Mata, Mario; Bermudez de Castro, Jose Maria] UCL, Anthropol Dept, London, England; [Zanolli, Clement] Univ Toulouse III Paul Sabatier, UMR CNRS 5288, Lab AMIS, Toulouse, France; [Rodriguez, Laura] Univ Burgos, Lab Evoluc Humana, Dept Ciencias Hist & Geog, Edificio I D I, Burgos, Spain; [Rodriguez, Laura] Univ Isabel I, Fac Ciencias Salud, Burgos, Spain	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux; Centro Nacional de Investigacion de La Evolucion Humana (CENIEH); University of London; University College London; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universidad de Burgos	Martin-Frances, L (corresponding author), Univ Bordeaux, CNRS, MCC, PACEA,UMR 5199, F-33615 Pessac, France.; Martin-Frances, L (corresponding author), Ctr Nacl Invest Evoluc Humana, Burgos, Spain.	lauramartinfrancesmf@gmail.com	Rodriguez, Laura/AAO-4864-2020; de Pinillos, Marina Martínez/N-7595-2019; Garcia-Campos, Cecilia/L-3757-2016; Martínez de Pinillos, Marina/D-9631-2018; Rodriguez, Laura/H-4774-2015	Rodriguez, Laura/0000-0002-5090-1582; de Pinillos, Marina Martínez/0000-0002-8035-337X; Garcia-Campos, Cecilia/0000-0002-0310-6973; Martínez de Pinillos, Marina/0000-0002-8035-337X; Rodriguez, Laura/0000-0002-5090-1582; Bermudez de Castro, Jose Maria/0000-0003-1314-3273; Martin-Frances Martin de la Fuente, Laura/0000-0001-5853-5014; Zanolli, Clement/0000-0002-5617-1613	Ministerio de Economia y Competitividad (MINECO) [CGL2015-65387-C3-3-P]; British Academy [PM160019]; French State in the frame of the "Investments for the future" Programme IdEx Bordeaux [ANR-10-IDEX-03-02]; Leakey Foundation; IdEx Post-Doctoral Research Grant; Fundacion Atapuerca; Junta de Castilla y Leon - European Social Funds through the Consejeria de Educacion [BOCYL-D-02102014-14]; Junta de Castilla y Leon - European Social Funds through the Consejeria de Educacion	Ministerio de Economia y Competitividad (MINECO); British Academy; French State in the frame of the "Investments for the future" Programme IdEx Bordeaux; Leakey Foundation; IdEx Post-Doctoral Research Grant; Fundacion Atapuerca; Junta de Castilla y Leon - European Social Funds through the Consejeria de Educacion; Junta de Castilla y Leon - European Social Funds through the Consejeria de Educacion	This study was part of the Ministerio de Economia y Competitividad (MINECO), project CGL2015-65387-C3-3-P (JMBdC). This study received financial support from the British Academy (International Partnership and Mobility Scheme PM160019), the French State in the frame of the "Investments for the future" Programme IdEx Bordeaux, reference ANR-10-IDEX-03-02 (LM-F) and the Leakey Foundation through the personal support of Gordon Getty (2013) and Dub Crook (2014-2017) (MM-T). LM-F is beneficiary of an IdEx Post-Doctoral Research Grant, MMdP is beneficiary of a Fundacion Atapuerca Post-Doctoral Research Grant. CG-C and MMdP have a predoctoral contract of the Junta de Castilla y Leon (BOCYL-D-02102014-14) co-financed by the European Social Funds through the Consejeria de Educacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge all members of the Atapuerca Research Team for their dedication and effort. To Pilar Fernandez Colon and Elena Lacasa Marquina, from the CENIEH Conservation and Restoration Laboratory for their work with the conservation of the specimens. The authors are grateful to Dr. Priscilla Bayle (PACEA Lab. Universite A de Bordeaux, France) for her valuable comments and scientific discussion that greatly improved the study and to Dr. Santos (PACEA Lab. Universite A de Bordeaux, France) for his advice and discussion for the statistic analysis. Moreover, the authors are grateful to Dr. Tanya Smith (Griffith University, Australia) for kindly providing part of the modern human data. We also acknowledge The Leakey Foundation through the personal support of Gordon Getty (2013) and Dub Crook (2014-2017) to one of the authors (MM-T). L MF is a beneficiary of IdEx Post-Doctoral Research Grant, MM-P is beneficiary of a Fundacion Atapuerca Post-Doctoral Research Grant, whereas CG and MM have Predoctoral contracts of the Junta de Castilla y Leon financed by European Social Funds through the Consejeria de Educacion. Part of this research was done at the ICTS-Cenieh and with the collaboration of CENIEH staff. Thanks to the Conservation and Restauration area for the manipulation of the TD6 sample and the Microscopy lab for the mCT.	Arnaud J, 2016, QUATERN INT, V425, P437, DOI 10.1016/j.quaint.2016.09.009; Arnold LJ, 2015, QUATERN INT, V389, P167, DOI 10.1016/j.quaint.2014.08.010; Arsuaga JL, 1999, NATURE, V399, P255, DOI 10.1038/20430; Bailey SE, 2011, AM J PHYS ANTHROPOL, V145, P505, DOI 10.1002/ajpa.21468; Bayle P., 2017, PEOPLE PALOMAS NEAND, P115; Bayle P, SPY CAVE 125 YEARS M; Bayle P, 2009, AM J PHYS ANTHROPOL, V138, P493, DOI 10.1002/ajpa.21000; Bayle P, 2009, J HUM EVOL, V56, P66, DOI 10.1016/j.jhevol.2008.09.002; Been E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03025-z; Benazzi S, 2014, AM J PHYS ANTHROPOL, V153, P305, DOI 10.1002/ajpa.22421; Benazzi S, 2013, AM J PHYS ANTHROPOL, V152, P300, DOI 10.1002/ajpa.22355; Berger GW, 2008, J HUM EVOL, V55, P300, DOI 10.1016/j.jhevol.2008.02.012; de Castro JMB, 2017, EVOL ANTHROPOL, V26, P157, DOI 10.1002/evan.21540; de Castro JMB, 2016, QUATERNARY SCI REV, V153, P51, DOI 10.1016/j.quascirev.2016.10.010; de Castro JMB, 2012, AM J PHYS ANTHROPOL, V147, P604, DOI 10.1002/ajpa.22020; Bermudez-de-Castro JM, 2017, QUATERN INT, V433, P22, DOI 10.1016/j.quaint.2015.03.049; Buti L, 2017, J HUM EVOL, V113, P162, DOI 10.1016/j.jhevol.2017.08.009; Carbonell E, 1999, J HUM EVOL, V37, P313, DOI 10.1006/jhev.1999.0282; Carretero JM, 1999, J HUM EVOL, V37, P459, DOI 10.1006/jhev.1999.0342; Cuenca-Bescos G, 2010, QUATERN INT, V212, P109, DOI 10.1016/j.quaint.2009.06.007; de Castro JMB, 1999, J HUM EVOL, V37, P523, DOI 10.1006/jhev.1999.0323; Dean C, 2001, NATURE, V414, P628, DOI 10.1038/414628a; deCastro JMB, 1997, SCIENCE, V276, P1392; Duval M, 2018, QUAT GEOCHRONOL, V47, P120, DOI 10.1016/j.quageo.2018.05.001; Falgueres C, 1999, J HUM EVOL, V37, P343, DOI 10.1006/jhev.1999.0326; Goldberg Michel, 2011, Front Biosci (Elite Ed), V3, P711, DOI 10.2741/e281; Gomez-Robles A, 2007, J HUM EVOL, V53, P272, DOI 10.1016/j.jhevol.2007.02.002; Gomez-Robles A, 2015, J HUM EVOL, V82, P34, DOI 10.1016/j.jhevol.2015.02.013; Gomez-Robles A, 2013, P NATL ACAD SCI USA, V110, P18196, DOI 10.1073/pnas.1302653110; Gomez-Robles A, 2012, J HUM EVOL, V63, P512, DOI 10.1016/j.jhevol.2012.06.002; Gomez-Robles A, 2011, J HUM EVOL, V61, P688, DOI 10.1016/j.jhevol.2011.09.004; Grine FE, 2005, AM J PHYS ANTHROPOL, V126, P14, DOI 10.1002/ajpa.10277; Grine FE, 2002, S AFR J SCI, V98, P503; Kono RT, 2004, ANTHROPOL SCI, V112, P121, DOI 10.1537/ase.03106; Kupczik K, 2010, J HUM EVOL, V59, P525, DOI 10.1016/j.jhevol.2010.05.009; Le Luyer M, 2015, REDUCTION DENTS HUMA; Lieberman DE, 2011, EVOLUTION HUMAN HEAD; Lucas PW, 2008, J ANAT, V212, P486, DOI 10.1111/j.1469-7580.2008.00877.x; Macchiarelli R., 2013, ANTHR PERSPECTIVES T, P250, DOI DOI 10.1017/CBO9780511984464.011; Macchiarelli R, 2006, NATURE, V444, P748, DOI 10.1038/nature05314; Margherita C, 2017, J HUM EVOL, V113, P83, DOI 10.1016/j.jhevol.2017.07.011; Margherita C, 2016, J HUM EVOL, V93, P120, DOI 10.1016/j.jhevol.2016.01.007; Castro JMB, 2013, QUATERNARY SCI REV, V76, P53, DOI 10.1016/j.quascirev.2013.06.023; MARTIN L, 1985, NATURE, V314, P260, DOI 10.1038/314260a0; Martin LB, 1983, RELATIONSHIPS LATE M; Martinez de Pinillos M., 2017, THESIS; de Pinillos MM, 2014, CR PALEVOL, V13, P205, DOI 10.1016/j.crpv.2013.10.008; Martinon-Torres M, 2007, P NATL ACAD SCI USA, V104, P13279, DOI 10.1073/pnas.0706152104; Martinon-Torres M, 2014, CR PALEVOL, V13, P223, DOI 10.1016/j.crpv.2013.12.002; Martinon-Torres M, 2012, J HUM EVOL, V62, P7, DOI 10.1016/j.jhevol.2011.08.007; Maureille B, 2001, PALEO, V13, P183, DOI DOI 10.4000/PALEO.1043; Meyer M, 2016, NATURE, V531, P504, DOI 10.1038/nature17405; MOLNAR S, 1971, AM J PHYS ANTHROPOL, V34, P175, DOI 10.1002/ajpa.1330340204; Olejniczak AJ, 2008, BIOL LETTERS, V4, P406, DOI 10.1098/rsbl.2008.0223; Olejniczak AJ, 2005, S AFR J SCI, V101, P219; Olejniczak AJ, 2008, J HUM EVOL, V55, P12, DOI 10.1016/j.jhevol.2007.11.004; Pablos A, 2017, QUATERN INT, V433, P103, DOI 10.1016/j.quaint.2015.08.044; Pablos A, 2012, J HUM EVOL, V63, P610, DOI 10.1016/j.jhevol.2012.06.008; Pares JM, 2013, J ARCHAEOL SCI, V40, P4586, DOI 10.1016/j.jas.2013.06.013; Scolan HF, 2012, B MEMOIRES SOC ANTHR, V24; Skinner MM, 2016, J HUM EVOL, V93, P63, DOI 10.1016/j.jhevol.2016.01.010; Skinner MM, 2015, J HUM EVOL, V85, P35, DOI 10.1016/j.jhevol.2015.03.012; Skinner MM, 2010, AM J PHYS ANTHROPOL, V142, P157, DOI 10.1002/ajpa.21248; Smith TM, 2006, ARCH ORAL BIOL, V51, P974, DOI 10.1016/j.archoralbio.2006.04.012; Smith TM, 2007, P NATL ACAD SCI USA, V104, P20220, DOI 10.1073/pnas.0707051104; Smith TM, 2008, AM J PHYS ANTHROPOL, V136, P237, DOI 10.1002/ajpa.20796; Smith TM, 2012, J HUM EVOL, V62, P395, DOI 10.1016/j.jhevol.2011.12.004; Smith Tanya M., 2009, Paleoanthropology, V2009, P117; Suwa G, 2005, ANTHROPOL SCI, V113, P273, DOI 10.1537/ase.050118; Toussaint M, 2010, J HUM EVOL, V58, P56, DOI 10.1016/j.jhevol.2009.09.006; Vialet A, 2010, CR PALEVOL, V9, P331, DOI 10.1016/j.crpv.2010.07.017; Weber GW, 2011, VIRTUAL ANTHROPOLOGY: GUIDE TO A NEW INTERDISCIPLINARY FIELD, P1, DOI 10.1007/978-3-211-49347-2; Xing S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114265; Zanolli C, PLOSONE; Zanolli C, 2018, J HUM EVOL, V116, P1, DOI 10.1016/j.jhevol.2017.11.002; Zanolli C, 2017, CR PALEVOL, V16, P702, DOI 10.1016/j.crpv.2017.05.002; Zanolli C, 2015, AM J PHYS ANTHROPOL, V157, P666, DOI 10.1002/ajpa.22748; Zanolli C, 2015, AM J PHYS ANTHROPOL, V156, P148, DOI 10.1002/ajpa.22611; Zanolli C, 2014, J HUM EVOL, V74, P96, DOI 10.1016/j.jhevol.2014.04.005; Zanolli C, 2013, CR PALEVOL, V12, P293, DOI 10.1016/j.crpv.2013.06.004	80	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0203334	10.1371/journal.pone.0203334	http://dx.doi.org/10.1371/journal.pone.0203334			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV7VQ	30281589	Green Published, gold, Green Submitted			2022-12-26	WOS:000446342400019
J	Bottino, FD; Gardinali, NR; Salvador, SBS; Figueiredo, AS; Cysne, LB; Francisco, JS; de Oliveira, JM; Machado, MP; Pinto, MA				Bottino, Fernanda de Oliveira; Gardinali, Noemi Rovaris; Salamene Salvador, Sarah Beatrizv; Figueiredo, Andreza Soriano; Cysne, Lynn Barwick; Francisco, Juliane Siqueira; de Oliveira, Jaqueline Mendes; Machado, Marcelo Pelajo; Pinto, Marcelo Alves			Cynomolgus monkeys (Macaca fascicularis) experimentally and naturally infected with hepatitis E virus: The bone marrow as a possible new viral target	PLOS ONE			English	Article							KIDNEY-TRANSPLANT RECIPIENTS; STEM-CELL TRANSPLANTATION; APLASTIC-ANEMIA; TACROLIMUS; TRANSMISSION; GENOTYPE; CAMELS; DONOR; JAPAN; RISK	Hepatitis E virus (HEV) transmission through infected blood and blood products has already been described. However, little is known about the bone marrow (BM) as source of HEV infection. Our study aimed to investigate the presence of HEV antigen (Ag) and histological changes in BM of cynomolgus monkeys (Macaca fascicularis) experimentally and naturally infected with HEV. Four cynomolgus monkeys with acute, and two with chronic hepatitis E - after immunosuppressive therapy with tacrolimus - were compared with one colony-bred animal naturally infected. Both, natural and experimental infections were characterized by anti-HEV IgG seroconversion detected by ELISA, and viral RNA isolation confirmed by RT-qPCR and qualitative nested RT-PCR. BM biopsies were collected from all animals, submitted to histology and indirect immunofluorescence techniques and observed, respectively, by light and confocal microscopy. The HEV Ag-fluorescent-labeled cells were detected from BM biopsies obtained from three monkeys with acute and one with chronic hepatitis E, and also from the naturally infected monkey. In the experimentally infected animals with acute hepatitis, HEV Ag detection occurred at 160 days post-infection, even after viral clearance in serum, feces, and liver. Double-stranded RNA, a replicative marker, was detected in BM cells from both acute and chronically infected animals. Major histological findings included vacuolization in mononuclear and endosteal cells, an absence of organized inflammatory infiltrates, and also some fields suggesting displasic focal BM disease. These findings support the hypothesis of BM cells as secondary target sites of HEV persistence. Further experimental studies should be carried out to confirm the assumption of HEV transmission through BM transplantation.	[Bottino, Fernanda de Oliveira; Gardinali, Noemi Rovaris; Salamene Salvador, Sarah Beatrizv; Figueiredo, Andreza Soriano; de Oliveira, Jaqueline Mendes; Pinto, Marcelo Alves] Fundacao Oswaldo Cruz, Oswaldo Cruz Inst, Lab Technol Dev Virol, Rio De Janeiro, Brazil; [Cysne, Lynn Barwick] Fundacao Oswaldo Cruz, Inst Sci & Technol Biomodels, Rio De Janeiro, Brazil; [Francisco, Juliane Siqueira; Machado, Marcelo Pelajo] Fundacao Oswaldo Cruz, Oswaldo Cruz Inst, Lab Pathol, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Bottino, FD; Pinto, MA (corresponding author), Fundacao Oswaldo Cruz, Oswaldo Cruz Inst, Lab Technol Dev Virol, Rio De Janeiro, Brazil.	fernanda_bottino4@hotmail.com; marcelop@ioc.fiocruz.br	Pinto, Marcelo Alves/ABA-3312-2020; Machado, Marcelo Pelajo/I-5359-2012; Figueiredo, Andreza/O-3096-2019; Pinto, Marcelo/G-7503-2012	Figueiredo, Andreza/0000-0002-4222-223X; Pinto, Marcelo/0000-0003-3462-7277; de Oliveira, Jaqueline/0000-0002-6759-4574; de Oliveira Bottino, Fernanda/0000-0002-6682-9845	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [302367/2014-4]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Support was provided by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), grants awarded to MAP (302367/2014-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R, 2001, J INFECT DIS, V184, P1380, DOI 10.1086/324376; [Anonymous], HEP E; da Silva SGC, 2016, TRANSFUS MED HEMOTH, V43, P137, DOI 10.1159/000441910; Dalton HR, 2018, COLD SPRING HARB PER; Danesi R, 2004, TRANSPL P, V36, P703, DOI 10.1016/j.transproceed.2004.03.016; de Carvalho LG, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-495; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Duarte D, 2018, CELL STEM CELL, V22, P64, DOI 10.1016/j.stem.2017.11.006; Frange P, 2015, J INFECTION, V71, P141, DOI 10.1016/j.jinf.2015.02.008; Galan-Diez Marta, 2017, Curr Mol Biol Rep, V3, P53, DOI 10.1007/s40610-017-0055-9; Gardinali NR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174070; Griffin SP, 2016, PROG TRANSPLANT, V26, P314, DOI 10.1177/1526924816667950; Halac U, 2012, J PEDIATR-US, V160, P871, DOI 10.1016/j.jpeds.2012.01.028; Huang FF, 2002, J CLIN MICROBIOL, V40, P1326, DOI 10.1128/JCM.40.4.1326-1332.2002; Jaber M, 2014, BONE MARROW TRANSPL, V49, P857, DOI 10.1038/bmt.2014.27; Jothikumar N, 2006, J VIROL METHODS, V131, P65, DOI 10.1016/j.jviromet.2005.07.004; Kamar N, 2008, N ENGL J MED; Kamar N, 2011, GASTROENTEROLOGY, V140, P1481, DOI 10.1053/j.gastro.2011.02.050; Kannegieter NM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170806; Kannegieter NM, 2016, THER DRUG MONIT, V38, P280, DOI 10.1097/FTD.0000000000000264; Kawatani T, 2001, EUR J HAEMATOL, V67, P45, DOI 10.1034/j.1600-0609.2001.067001045.x; Kinugasa F, 2008, J PHARMACOL SCI, V108, P529, DOI 10.1254/jphs.08142FP; Koenecke C, 2014, BONE MARROW TRANSPL, V49, P159, DOI 10.1038/bmt.2013.148; le Coutre P, 2009, GUT, V58, P699, DOI 10.1136/gut.2008.165571; Matthews KA, 2015, COMPARATIVE MED, V65, P352; Mayer P., 1903, Z WISSENSCHAFTLICHE, V20; Meng XJ, 2010, VET MICROBIOL, V140, P256, DOI 10.1016/j.vetmic.2009.03.017; Mirazo S, 2014, HEPATIC MED-EVID RES, V6, P45, DOI 10.2147/HMER.S63417; O'Donghaile D, 2017, BONE MARROW TRANSPL, V52, P1471, DOI 10.1038/bmt.2017.163; Pischke S, 2016, J HEPATOL; Pischke S, 2016, CLIN INFECT DIS, V63, P569, DOI 10.1093/cid/ciw309; Purdy MA, 2017, J GEN VIROL, V98, P2645, DOI 10.1099/jgv.0.000940; Rauff B, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-87; Rivero-Juarez A, 2017, CLIN INFECT DIS, V64, P964, DOI 10.1093/cid/cix004; Safadi R, 2001, BONE MARROW TRANSPL, V27, P183, DOI 10.1038/sj.bmt.1702749; Shah SAR, 2012, J CLIN VIROL, V54, P96, DOI 10.1016/j.jcv.2012.02.002; Son KN, 2015, J VIROL, V89, P9383, DOI 10.1128/JVI.01299-15; Takahashi M, 2014, VIRUS RES, V180, P59, DOI 10.1016/j.virusres.2013.12.014; Tatapudi VS, 2018, CASE REP NEPHROL DIA, V8, P10, DOI 10.1159/000486158; Teshale EH, 2010, CLIN INFECT DIS, V51, P328, DOI 10.1086/653943; Versluis J, 2013, BLOOD, V122, P1079, DOI 10.1182/blood-2013-03-492363; Wang YJ, 2014, GASTROENTEROLOGY, V146, P1775, DOI 10.1053/j.gastro.2014.02.036; Weiler-Normann C, 2018, Z GASTROENTEROL, V56, P51, DOI 10.1055/s-0043-121737; Woo PCY, 2016, EMERG INFECT DIS, V22, P2219, DOI 10.3201/eid2212.160979; Woo PCY, 2014, EMERG INFECT DIS, V20, P1044, DOI 10.3201/eid2006.140140; Woolson KL, 2014, ALIMENT PHARM THER, V40, P1282, DOI 10.1111/apt.12986; Yamamoto H, 2012, EMERG INFECT DIS, V18, P2032, DOI 10.3201/eid1812.120884; Zylberman M, MEDICINA B AIRES, V75, P175	48	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0205039	10.1371/journal.pone.0205039	http://dx.doi.org/10.1371/journal.pone.0205039			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3QJ	30278075	Green Submitted, Green Published, gold			2022-12-26	WOS:000446010200035
J	In, HJ; Lim, H; Lee, JA; Lee, SR; Jin, YB; Jeong, KJ; Hyeon, JY; Yoo, JS; Lee, JW; Choi, YK; Lee, SW				In, Hyun Ju; Lim, Heeji; Lee, Jung-Ah; Lee, Sang-Rae; Jin, Yeung Bae; Jeong, Kang-Jin; Hyeon, Ji-Yeon; Yoo, Jung Sik; Lee, June-Woo; Choi, Young Ki; Lee, Sang-Won			Enhanced neutralizing antibody response induced by inactivated enterovirus 71 in cynomolgus monkeys	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; POLIO ERADICATION; NEWBORN MICE; DOUBLE-BLIND; PHASE-I; VACCINE; INFECTION; SAFETY; IMMUNOGENICITY; TAIWAN	Enterovirus 71 (EV71) is a major etiological agent of various public health issues, particularly in the Asia-Pacific region. EV71 causes hand-foot-and-mouth disease (HFMD) and is associated with serious neurological disorders in young children. A formalin-inactivated EV71 candidate vaccine (KCDC-HFMDV1-EV71) based on the C4 subgenotype was previously developed and confirmed to be a potential candidate vaccine for prevention of EV71 infection in mice. In this study, an inactivated EV71 vaccine was used for analysis of long-term immunogenicity and efficacy in cynomolgus monkeys, a common nonhuman primate model. The vaccine was immunized three times at 0, 4, and 8 weeks with either 20-mu g doses of EV71 candidate vaccine formulated with aluminum hydroxide gel adjuvant or phosphate-buffered saline as a control. The group immunized with the inactivated EV71 showed significantly increased EV71-specific antibody and serum neutralizing antibody titers at 3 weeks after vaccination and maintained these elevated titers until the end of the experiment (54 weeks after vaccination). The sera from vaccinated cynomolgus monkeys showed a crossreactive neutralizing antibody response to the heterologous subtype of EV71 (B1-4, C1, and C2). These findings suggest that the inactivated EV71 candidate vaccine may be a potential vaccine candidate and valuable tool for the control of HFMD.	[In, Hyun Ju; Lim, Heeji; Lee, Jung-Ah; Hyeon, Ji-Yeon; Yoo, Jung Sik; Lee, June-Woo; Lee, Sang-Won] Ctr Dis Control & Prevent, Natl Res Inst Hlth, Div Vaccine Res, Cheongju, Chungcheongbuk, South Korea; [In, Hyun Ju; Lim, Heeji; Choi, Young Ki] Chungbuk Natl Univ, Coll Med & Med Res Inst, Cheongju, Chungcheongbuk, South Korea; [Lee, Sang-Rae; Jin, Yeung Bae; Jeong, Kang-Jin] Korea Res Inst Biosci & Biotechnol, Natl Primate Res Ctr, Cheongju, Chungcheongbuk, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Infectious Disease; Chungbuk National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Lee, SW (corresponding author), Ctr Dis Control & Prevent, Natl Res Inst Hlth, Div Vaccine Res, Cheongju, Chungcheongbuk, South Korea.	epilsw@korea.kr	IN, HYUN JU/A-5623-2017	IN, HYUN JU/0000-0002-7783-4877	Korea National Institute of Health [NIH4800-4859-300]	Korea National Institute of Health	This study was supported by grant from the Korea National Institute of Health (Grant no. NIH4800-4859-300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arita M, 2007, J VIROL, V81, P9386, DOI 10.1128/JVI.02856-06; Cardosa MJ, 2003, EMERG INFECT DIS, V9, P461; Chang LY, 2006, PEDIATR RES, V60, P466, DOI 10.1203/01.pdr.0000238247.86041.19; Chang LY, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.6.e88; Cheng A, 2013, VACCINE, V31, P2471, DOI 10.1016/j.vaccine.2013.03.015; Chong P, 2012, HUM VACC IMMUNOTHER, V8, P1775, DOI 10.4161/hv.21739; Chou AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079783; Chung CY, 2010, VACCINE, V28, P6951, DOI 10.1016/j.vaccine.2010.08.052; Chung YC, 2008, VACCINE, V26, P1855, DOI 10.1016/j.vaccine.2008.01.058; Diamanti E, 1998, VACCINE, V16, P940, DOI 10.1016/S0264-410X(98)80025-X; Dong CH, 2011, VACCINE, V29, P6269, DOI 10.1016/j.vaccine.2011.06.044; Dowdle WR, 2003, REV MED VIROL, V13, P277, DOI 10.1002/rmv.401; Foo DGW, 2007, MICROBES INFECT, V9, P1299, DOI 10.1016/j.micinf.2007.06.002; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Huang SW, 2011, EXP BIOL MED, V236, P899, DOI 10.1258/ebm.2010.010233; In HJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178259; Li YP, 2012, VACCINE, V30, P3295, DOI 10.1016/j.vaccine.2012.03.010; Lim PY, 2015, VACCINE, V33, P6017, DOI 10.1016/j.vaccine.2015.05.108; Lin TY, 2003, EMERG INFECT DIS, V9, P291, DOI 10.3201/eid0903.020285; Lin YL, 2012, VACCINE, V30, P1305, DOI 10.1016/j.vaccine.2011.12.081; Lin YW, 2009, EXP BIOL MED, V234, P1166, DOI 10.3181/0903-RM-116; Liu CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106756; Lum LCS, 1998, J PEDIATR-US, V133, P795, DOI 10.1016/S0022-3476(98)70155-6; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Wagner BG, 2008, B MATH BIOL, V70, P253, DOI 10.1007/s11538-007-9255-4; Wang YF, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-31; Wu CN, 2001, VACCINE, V20, P895, DOI 10.1016/S0264-410X(01)00385-1; Yang F, 2009, J CLIN MICROBIOL, V47, P2351, DOI 10.1128/JCM.00563-09; Yip Cyril C Y, 2013, Emerg Health Threats J, V6, P19780, DOI 10.3402/ehtj.v6i0.19780; Yip CCY, 2010, ARCH VIROL, V155, P1413, DOI 10.1007/s00705-010-0722-0; Zhang YJ, 2015, CURR CHIN ECON REPOR, P33, DOI 10.1007/978-3-662-46205-8_2; Zhou XB, 2013, HUM VACC IMMUNOTHER, V9, P1430, DOI 10.4161/hv.24395; Zhu FC, 2013, LANCET, V381, P2024, DOI 10.1016/S0140-6736(13)61049-1	34	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0202552	10.1371/journal.pone.0202552	http://dx.doi.org/10.1371/journal.pone.0202552			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3QJ	30278051	Green Published, gold, Green Submitted			2022-12-26	WOS:000446010200003
J	Ford, K; Latic, N; Slavic, S; Zeitz, U; Dolezal, M; Andrukhov, O; Erben, RG; Andrukhova, O				Ford, Kristopher; Latic, Nejla; Slavic, Svetlana; Zeitz, Ute; Dolezal, Marlies; Andrukhov, Oleh; Erben, Reinhold G.; Andrukhova, Olena			Lack of vitamin D signalling per se does not aggravate cardiac functional impairment induced by myocardial infarction in mice	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; PARATHYROID-HORMONE LEVELS; D-RECEPTOR; PRIMARY HYPERPARATHYROIDISM; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; D SUPPLEMENTATION; D DEFICIENCY; ARTERIAL STIFFNESS; CONTROLLED-TRIAL	Epidemiological studies have linked vitamin D deficiency to an increased incidence of myocardial infarction and support a role for vitamin D signalling in the pathophysiology of myocardial infarction. Vitamin D deficiency results in the development of secondary hyperparathyroidism, however, the role of secondary hyperparathyroidism in the pathophysiology of myocardial infarction is not known. Here, we aimed to explore further the secondary hyperparathyroidism independent role of vitamin D signalling in the pathophysiology of myocardial infarction by inducing experimental myocardial infarction in 3-month-old, male, wild-type mice and in mice lacking a functioning vitamin D receptor. In order to prevent secondary hyperparathyroidism in vitamin D receptor mutant mice, all mice were maintained on a rescue diet enriched with calcium, phosphorus, and lactose. Surprisingly, survival rate, cardiac function as measured by echocardiography and intra-cardiac catheterisation and cardiomyocyte size were indistinguishable between normocalcaemic vitamin D receptor mutant mice and wild-type controls, 2 and 8 weeks post-myocardial infarction. In addition, the myocardial infarction-induced inflammatory response was similar in vitamin D receptor mutants and wild-type mice, as evidenced by a comparable upregulation in cardiac interleukin-1-beta and tumor-necrosis-factor-alpha mRNA abundance and similar elevations in circulating interleukin-1-beta and tumor-necrosis-factor-alpha. Our data suggest that the lack of vitamin D signalling in normocalcaemic vitamin D receptor mutants has no major detrimental effect on cardiac function and outcome post-myocardial infarction. Our study may have important clinical implications because it suggests that the secondary hyperparathyroidism induced by vitamin D deficiency, rather than the lack of vitamin D signalling per se, may negatively impact cardiac function post-myocardial infarction.	[Ford, Kristopher; Latic, Nejla; Slavic, Svetlana; Zeitz, Ute; Dolezal, Marlies; Erben, Reinhold G.; Andrukhova, Olena] Univ Vet Med Vienna, Dept Biomed Sci, Vienna, Austria; [Andrukhov, Oleh] Med Univ Vienna, Sch Dent, Div Conservat Dent & Periodontol, Vienna, Austria	University of Veterinary Medicine Vienna; Medical University of Vienna	Erben, RG (corresponding author), Univ Vet Med Vienna, Dept Biomed Sci, Vienna, Austria.	Reinhold.Erben@vetmeduni.ac.at	Andrukhov, Oleh/H-9851-2018; Erben, Reinhold/AAG-8007-2020	Andrukhov, Oleh/0000-0002-0485-2142; Erben, Reinhold/0000-0003-0801-6958; Latic, Nejla/0000-0001-5635-5175	Austrian Science Fund [FWF P 26534-B13]	Austrian Science Fund(Austrian Science Fund (FWF))	This work was supported by a grant from the Austrian Science Fund (FWF P 26534-B13) to Olena Andrukhova.	Adams JS, 2012, ARCH BIOCHEM BIOPHYS, V523, P95, DOI 10.1016/j.abb.2012.02.016; Almqvist EG, 2002, SURGERY, V132, P1126, DOI 10.1067/msy.2002.128692; AMANN K, 1994, J AM SOC NEPHROL, V4, P1814; AMANN K, 1995, NEPHROL DIAL TRANSPL, V10, P2043; Andrukhova O, 2014, MOL ENDOCRINOL, V28, P53, DOI 10.1210/me.2013-1252; [Anonymous], 2017, R LANG ENV STAT COMP; Autier P, 2007, ARCH INTERN MED, V167, P1730, DOI 10.1001/archinte.167.16.1730; Avenell A, 2012, J CLIN ENDOCR METAB, V97, P614, DOI 10.1210/jc.2011-1309; Azizieh F, 2016, J INFLAMM RES, V9, P51, DOI 10.2147/JIR.S103298; Bae S, 2013, J APPL PHYSIOL, V114, P979, DOI 10.1152/japplphysiol.01506.2012; Bikdeli B, 2012, CIRC-CARDIOVASC QUAL, V5, P580, DOI 10.1161/CIRCOUTCOMES.111.964072; Bikle DD, 2014, CHEM BIOL, V21, P319, DOI 10.1016/j.chembiol.2013.12.016; BOGIN E, 1981, J CLIN INVEST, V67, P1215, DOI 10.1172/JCI110137; BOGIN E, 1982, MINER ELECTROL METAB, V7, P151; Bouillon Roger, 2014, Bonekey Rep, V3, P480, DOI 10.1038/bonekey.2013.214; Calton EK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141770; Cannell JJ, 2014, DERM-ENDOCRINOL, V6, DOI 10.4161/19381980.2014.983401; Carroll WW, 2016, INT FORUM ALLERGY RH, V6, P605, DOI 10.1002/alr.21704; Chen S, 2008, HYPERTENSION, V52, P1106, DOI 10.1161/HYPERTENSIONAHA.108.119602; Chen SC, 2011, CIRCULATION, V124, P1838, DOI 10.1161/CIRCULATIONAHA.111.032680; CRAN, 2015, VIS PAIR COMP; CRAN, 2017, LEAST SQUAR MEANS VE; Dadabhai AS, 2017, WORLD J HEPATOL, V9, P278, DOI 10.4254/wjh.v9.i5.278; DOMINICZAK AF, 1990, CLIN SCI, V78, P127, DOI 10.1042/cs0780127; Erben RG, 2002, MOL ENDOCRINOL, V16, P1524, DOI 10.1210/me.16.7.1524; Fraser WD, 2009, LANCET, V374, P145, DOI 10.1016/S0140-6736(09)60507-9; Gardner DG, 2013, AM J PHYSIOL-REG I, V305, pR969, DOI 10.1152/ajpregu.00322.2013; GUILLEN I, 1995, AM J PHYSIOL-REG I, V269, pR229, DOI 10.1152/ajpregu.1995.269.2.R229; Gunta SS, 2013, NAT REV NEPHROL, V9, P337, DOI 10.1038/nrneph.2013.74; Gurantz D, 2005, J MOL CELL CARDIOL, V38, P505, DOI 10.1016/j.yjmcc.2004.12.015; Hsia J, 2007, CIRCULATION, V115, P846, DOI 10.1161/CIRCULATIONAHA.106.673491; Kamycheva E, 2004, EUR J CARDIOV PREV R, V11, P69, DOI 10.1097/01.hjr.0000114706.27531.01; Kendrick J, 2011, ADV CHRONIC KIDNEY D, V18, P113, DOI 10.1053/j.ackd.2010.12.003; Khalili H, 2012, CLIN RES CARDIOL, V101, P321, DOI 10.1007/s00392-011-0394-0; LAFFERTY FW, 1981, ARCH INTERN MED, V141, P1761, DOI 10.1001/archinte.141.13.1761; Lee JH, 2011, AM J CARDIOL, V107, P1636, DOI 10.1016/j.amjcard.2011.01.048; LEMIRE JM, 1995, J STEROID BIOCHEM, V53, P599, DOI 10.1016/0960-0760(95)00106-A; Li YC, 1998, ENDOCRINOLOGY, V139, P4391, DOI 10.1210/en.139.10.4391; Manousaki D, 2016, CIRC-CARDIOVASC GENE, V9, P349, DOI 10.1161/CIRCGENETICS.116.001396; MCCARTHY DM, 1984, LANCET, V1, P78; Meems LMG, 2012, J STEROID BIOCHEM, V132, P282, DOI 10.1016/j.jsbmb.2012.06.004; Milazzo V, 2017, WORLD J CARDIOL, V9, P14, DOI 10.4330/wjc.v9.i1.14; Nappi S, 2000, CARDIOLOGY, V93, P229, DOI 10.1159/000007031; Ni W, 2014, HYPERTENSION, V64, DOI 10.1161/HYPERTENSIONAHA.114.03971; Nuzzo V, 2002, EUR J ENDOCRINOL, V147, P453, DOI 10.1530/eje.0.1470453; Oliveira Gustavo B F, 2015, Front Cardiovasc Med, V2, P32, DOI 10.3389/fcvm.2015.00032; Park CW, 1999, AM J KIDNEY DIS, V33, P73, DOI 10.1016/S0272-6386(99)70260-X; Piovesan A, 1999, CLIN ENDOCRINOL, V50, P321, DOI 10.1046/j.1365-2265.1999.00651.x; Saleh FN, 2003, EUR HEART J, V24, P2054, DOI 10.1016/j.ehj.2003.09.010; Sandmann S, 2006, BLOOD PRESSURE, V15, P116, DOI 10.1080/08037050600586593; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schocken DD, 2008, CIRCULATION, V117, P2544, DOI 10.1161/CIRCULATIONAHA.107.188965; Simpson RU, 2007, J STEROID BIOCHEM, V103, P521, DOI 10.1016/j.jsbmb.2006.12.098; Simpson RU, 2011, CIRCULATION, V124, P1808, DOI 10.1161/CIRCULATIONAHA.111.061234; Snijder MB, 2007, J INTERN MED, V261, P558, DOI 10.1111/j.1365-2796.2007.01778.x; STEFENELLI T, 1990, AM HEART J, V120, P590, DOI 10.1016/0002-8703(90)90016-Q; Stefenelli T, 1997, J CLIN ENDOCR METAB, V82, P106, DOI 10.1210/jc.82.1.106; Takagawa J, 2007, J APPL PHYSIOL, V102, P2104, DOI 10.1152/japplphysiol.00033.2007; Tishkoff DX, 2008, ENDOCRINOLOGY, V149, P558, DOI 10.1210/en.2007-0805; Turner NA, 2007, CARDIOVASC RES, V76, P81, DOI 10.1016/j.cardiores.2007.06.003; Turner NA, 2009, AM J PHYSIOL-HEART C, V297, pH1117, DOI 10.1152/ajpheart.00372.2009; VAITKEVICIUS PV, 1993, CIRCULATION, V88, P1456, DOI 10.1161/01.CIR.88.4.1456; van Ballegooijen AJ, 2013, AM HEART J, V165, P655, DOI 10.1016/j.ahj.2013.02.014; Wang L, 2010, ANN INTERN MED, V152, P315, DOI 10.7326/0003-4819-152-5-201003020-00010; Willett AM, 2005, P NUTR SOC, V64, P193, DOI 10.1079/PNS2005420; Witham MD, 2013, INT J CARDIOL, V167, P745, DOI 10.1016/j.ijcard.2012.03.054; YANG SL, 1993, ARCH BIOCHEM BIOPHYS, V303, P98, DOI 10.1006/abbi.1993.1260; Yin K, 2014, J INFLAMM RES, V7, P69, DOI 10.2147/JIR.S63898	68	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204803	10.1371/journal.pone.0204803	http://dx.doi.org/10.1371/journal.pone.0204803			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273386	Green Submitted, gold, Green Published			2022-12-26	WOS:000446124700036
J	Ding, ZF; Jin, M; Ren, Q				Ding, Zhengfeng; Jin, Min; Ren, Qian			Transcriptome analysis of Macrobrachium rosenbergii intestines under the white spot syndrome virus and poly (I:C) challenges	PLOS ONE			English	Article							RNA-SEQ; WSSV; SPLICEOSOME; TOOL	Intestine is a primary site of the white spot syndrome virus (WSSV) infection in most crustaceans. To date, little is known about its role in the anti-viral immune response in the freshwater prawn Macrobrachium rosenbergii. In this study, next-generation sequencing was employed to investigate the M. rosenbergii intestine transcriptomes following WSSV or poly I:C challenges. A total of 41.06 M, 39.58 M and 47.00 M clean reads were generated and assembled into 65,340, 71,241 and 70,614 transcripts from the negative control group (NG), WSSV challenge group (WG) and poly I:C treatment group (PG) respectively. Based on homology searches, functional annotation with 7 databases (NR, NT, GO, COG, KEGG, Swissprot and Interpro) for 88,412 transcripts was performed. After WSSV or poly (I:C) challenge, the numbers of up-regulated differentially expressed genes (DEGs) were greater than the down-regulated DEGs. Gene Ontology (GO) classification of the DEGs also distributed similarly, with the same top 10 annotations and were all assigned to the signaling pathways, including spliceosome, Rap1 signaling pathway, proteoglycans, PI3K-Akt signaling pathway, ECM receptor interaction. Results could contribute to a better understanding of the intestinal immune response to viral pathogens.	[Ding, Zhengfeng] Jiangsu Second Normal Univ, Coll Life Sci & Chem, Inst Aquat Biol, Nanjing, Jiangsu, Peoples R China; [Ding, Zhengfeng] Jiangsu Second Normal Univ, Coll Life Sci & Chem, Jiangsu Key Lab Biofunct Mol, Nanjing, Jiangsu, Peoples R China; [Jin, Min] SOA, State Key Lab Breeding Base Marine Genet Resource, Inst Oceanog 3, Xiamen, Peoples R China; [Ren, Qian] Coinnovat Ctr Marine Bioind Technol Jiangsu Prov, Lianyungang, Peoples R China; [Ren, Qian] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Aquat Crustacean Dis, Nanjing, Jiangsu, Peoples R China	Jiangsu Second Normal University; Jiangsu Second Normal University; State Oceanic Administration; Nanjing Normal University	Ren, Q (corresponding author), Coinnovat Ctr Marine Bioind Technol Jiangsu Prov, Lianyungang, Peoples R China.; Ren, Q (corresponding author), Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Aquat Crustacean Dis, Nanjing, Jiangsu, Peoples R China.	renqian0402@126.com			Natural Sciences Foundation of Jiangsu Province [BK20171406]; Natural Science Fund of Colleges and Universities in Jiangsu Province [16KJA180005, 16KJB180006]; innovation of agricultural science [CX (17) 2008]; project for aquaculture of Jiangsu Province [Y2016-29, Y2017-28]; China Scholarship Council	Natural Sciences Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Natural Science Fund of Colleges and Universities in Jiangsu Province; innovation of agricultural science; project for aquaculture of Jiangsu Province; China Scholarship Council(China Scholarship Council)	This work was supported by grants from Natural Sciences Foundation of Jiangsu Province (BK20171406), Natural Science Fund of Colleges and Universities in Jiangsu Province (16KJA180005, 16KJB180006), innovation of agricultural science (CX (17) 2008), project for aquaculture of Jiangsu Province (Y2016-29, Y2017-28) and China Scholarship Council (2018).	Baranski M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085413; Bonami JR, 2011, J INVERTEBR PATHOL, V106, P131, DOI 10.1016/j.jip.2010.09.007; Cao J, 2017, FISH SHELLFISH IMMUN, V67, P27, DOI 10.1016/j.fsi.2017.05.059; Citarasu T, 2010, AQUACULT INT, V18, P403, DOI 10.1007/s10499-009-9253-7; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Ding ZF, 2017, AQUAC RES, V48, P2528, DOI 10.1111/are.13089; Ding ZF, 2015, J VIROL METHODS, V220, P49, DOI 10.1016/j.jviromet.2015.04.011; Du Z., 2016, SCI REP, V6; Du ZQ, 2017, GENET MOL BIOL, V40, P168, DOI [10.1590/1678-4685-GMB-2016-0133, 10.1590/1678-4685-gmb-2016-0133]; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Green TJ, 2013, FISH SHELLFISH IMMUN, V35, P382, DOI 10.1016/j.fsi.2013.04.051; Jung HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028492; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Li CZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049711; Li M, 2014, DEV COMP IMMUNOL, V46, P231, DOI 10.1016/j.dci.2014.04.014; Li ZP, 2016, J VIROL, V90, P842, DOI 10.1128/JVI.02357-15; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Oidtmann B, 2011, TRANSBOUND EMERG DIS, V58, P469, DOI 10.1111/j.1865-1682.2011.01231.x; Rao R, 2016, J INVERTEBR PATHOL, V136, P10, DOI 10.1016/j.jip.2016.01.002; Santos CA, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00298; Shen HS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110548; Su MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004196; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Verma AK, 2017, FISH SHELLFISH IMMUN, V67, P141, DOI 10.1016/j.fsi.2017.06.007; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wu JL, 2001, DIS AQUAT ORGAN, V47, P129, DOI 10.3354/dao047129; Yang L, 2007, MOL CELL, V27, P861, DOI 10.1016/j.molcel.2007.09.003; Yu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087218; Zhang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047038; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031	31	11	11	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204626	10.1371/journal.pone.0204626	http://dx.doi.org/10.1371/journal.pone.0204626			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265693	Green Submitted, Green Published, gold			2022-12-26	WOS:000446005500041
J	Adams, AAY; Lardner, B; Knox, AJ; Reed, RN				Adams, Amy A. Yackel; Lardner, Bjorn; Knox, Adam J.; Reed, Robert N.			Inferring the absence of an incipient population during a rapid response for an invasive species	PLOS ONE			English	Article							SUCCESSFUL ERADICATION; BROWN TREESNAKES; MANAGEMENT; GUAM; UNCERTAINTY; ELICITATION; EXTINCTION; KNOWLEDGE; DESIGN; MODELS	Successful eradication of invasives is facilitated by early detection and prompt onset of control. However, realizing or verifying that a colonization has occurred is difficult for cryptic species especially at low population densities. Responding to the capture or unconfirmed sighting of a cryptic invasive species, and the associated effort to determine if it indicates an incipient (small, localized) population or merely a lone colonizer, is costly and cannot continue indefinitely. However, insufficient detection effort risks erroneously concluding the species is not present, allowing the population to increase in size and expand its range. Evidence for an incipient population requires detection of >= 1 individual; its absence, on the other hand, must be inferred probabilistically. We use an actual rapid response incident and species-specific detection estimates tied to a known density to calculate the amount of effort (with non-sequential detections) necessary to assert, with a pre-defined confidence, that invasive brown treesnakes are absent from the search area under a wide range of hypothetical population densities. We illustrate that the amount of effort necessary to declare that a species is absent is substantial and increases with decreased individual detection probability, decreased density, and increased level of desired confidence about its absence. Such survey investment would be justified where the cost savings due to early detection are large. Our Poisson-based model application will allow managers to make informed decisions about how long to continue detection efforts, should no additional detections occur, and suggests that effort to do so is significantly higher than previously thought. While our model application informs how long to search to infer absence of an incipient population of brown treesnakes, the approach is sufficiently general to apply to other invasive species if density-dependent detection estimates are known or reliable surrogate estimates are available.	[Adams, Amy A. Yackel; Reed, Robert N.] US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO 80526 USA; [Lardner, Bjorn] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Knox, Adam J.] US Geol Survey, Brown Treesnake Project, Dededo, GU USA; [Knox, Adam J.] Maui Invas Species Comm, Makawao, HI USA	United States Department of the Interior; United States Geological Survey; Colorado State University; United States Department of the Interior; United States Geological Survey	Adams, AAY (corresponding author), US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO 80526 USA.	yackela@usgs.gov		Yackel Adams, Amy/0000-0002-7044-8447	U.S. Geological Survey; Office of Insular Affairs	U.S. Geological Survey(United States Geological Survey); Office of Insular Affairs	Funded by U.S. Geological Survey, Dr. Amy Yackel Adams. Office of Insular Affairs, Dr. Amy Yackel Adams. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LWJ, 2005, BIOL INVASIONS, V7, P1003, DOI 10.1007/s10530-004-3123-z; Barrett S, 2010, ENVIRON ECOL STAT, V17, P503, DOI 10.1007/s10651-009-0113-4; Beachy J, 2011, SUCCESSFUL CONTROL I; Boakes EH, 2015, METHODS ECOL EVOL, V6, P678, DOI 10.1111/2041-210X.12365; Brockerhoff EG, 2006, FOREST ECOL MANAG, V228, P234, DOI 10.1016/j.foreco.2006.02.046; Choy SL, 2009, ECOLOGY, V90, P265, DOI 10.1890/07-1886.1; Christy MT, 2010, J APPL ECOL, V47, P106, DOI 10.1111/j.1365-2664.2009.01753.x; Dorcas ME, 2012, P NATL ACAD SCI USA, V109, P2418, DOI 10.1073/pnas.1115226109; Ellison G. N., 2004, PRIMER ECOLOGICAL ST; Essl F, 2011, P NATL ACAD SCI USA, V108, P203, DOI 10.1073/pnas.1011728108; GREEN RH, 1993, ECOL APPL, V3, P351, DOI 10.2307/1941837; Guillera-Arroita G, 2014, ECOL EVOL, V4, P1751, DOI 10.1002/ece3.1056; Hauser Cindy, 2009, Plant Protection Quarterly, V24, P94; Henke SE, 1998, J HERPETOL, V32, P112, DOI 10.2307/1565489; Hill JE, 2015, MANAG BIOL INVASION, V6, P311, DOI 10.3391/mbi.2015.6.3.11; Hodgkins Jo, 2012, Conservation Evidence, V9, P63; Interior USDo, 2016, SAF AM LANDS WAT INV; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Johnson FA, 2017, ECOL ECON, V137, P83, DOI 10.1016/j.ecolecon.2017.03.004; Keefer J, 2014, EARLY DETECTION INVA; Kery M, 2002, J WILDLIFE MANAGE, V66, P330, DOI 10.2307/3803165; Knox A., 2015, HERPETOLOGICAL REV, V46, P61; Kraus F, 2010, J NAT CONSERV, V18, P135, DOI 10.1016/j.jnc.2009.07.001; Lardner B, 2007, P INT S; MacKenzie DI, 2005, ECOLOGY, V86, P1101, DOI 10.1890/04-1060; Martin TG, 2012, CONSERV BIOL, V26, P29, DOI 10.1111/j.1523-1739.2011.01806.x; Maxwell BD, 2012, INVAS PLANT SCI MANA, V5, P178, DOI 10.1614/IPSM-D-11-00022.1; Moga CI, 2008, USING SPECIES DETECT, P61; Moore AH, 2014, PLOS ONE, V9, P1; Nafus MG, 2018, RESTOR ECOL, V26, P331, DOI 10.1111/rec.12559; Pearse AT, 2008, J WILDLIFE MANAGE, V72, P808, DOI 10.2193/2007-274; Ramsey DSL, 2011, NEW ZEAL J ECOL, V35, P163; Regan TJ, 2006, ECOL LETT, V9, P759, DOI 10.1111/j.1461-0248.2006.00920.x; Richmond JQ, 2015, BIOL INVASIONS, V17, P337, DOI 10.1007/s10530-014-0733-y; Rodda GH, 2007, PAC SCI, V61, P307, DOI 10.2984/1534-6188(2007)61[307:BAIOPI]2.0.CO;2; Rodda GH, 2007, J WILDLIFE MANAGE, V71, P656, DOI 10.2193/2005-742; Rout TM, 2014, ANIM CONSERV, V17, P125, DOI 10.1111/acv.12065; Rout TM, 2009, J APPL ECOL, V46, P782, DOI 10.1111/j.1365-2664.2009.01678.x; SAVIDGE JA, 1987, ECOLOGY, V68, P660, DOI 10.2307/1938471; Savidge JA, 2011, NEW ZEAL J ECOL, V35, P174; Siers SR, ECOL EVOL; Simberloff D, 2009, BIOL INVASIONS, V11, P149, DOI 10.1007/s10530-008-9317-z; Simberloff Daniel, 2013, Elementa-Science of the Anthropocene, V1, P000008, DOI 10.12952/journal.elementa.000008; Solow A, 2008, J APPL ECOL, V45, P424, DOI 10.1111/j.1365-2664.2007.01446.x; Stanford J, 2007, P INT S; Stohlgren TJ, 2010, RISK ANAL, V30, P224, DOI 10.1111/j.1539-6924.2009.01343.x; Tyrrell CL, 2009, J APPL ECOL, V46, P128, DOI 10.1111/j.1365-2664.2008.01591.x; Wiewel AS, 2009, PAC SCI, V63, P205, DOI 10.2984/049.063.0204; Will DJ, 2014, WILDLIFE RES, V41, P499, DOI 10.1071/WR13178; Yemshanov D, 2015, CABI INVASIVE SER, V7, P206, DOI 10.1079/9781780643946.0206; Zonneveld C, 2003, CONSERV BIOL, V17, P476, DOI 10.1046/j.1523-1739.2003.01516.x	51	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204302	10.1371/journal.pone.0204302	http://dx.doi.org/10.1371/journal.pone.0204302			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30260994	gold, Green Published, Green Submitted			2022-12-26	WOS:000445907400033
J	Cautela, JM; Mannocci, A; Reggiani, C; Persechino, F; Ferrari, F; Rossi, E; Passini, E; Bellini, P; Meleti, M; Rowan, SW; Magnoni, C				Cautela, Jennifer Marchetti; Mannocci, Alice; Reggiani, Camilla; Persechino, Flavia; Ferrari, Federica; Rossi, Elena; Passini, Erika; Bellini, Pierantonio; Meleti, Marco; Rowan, Sara Wertzberger; Magnoni, Cristina			Identifying the factors that influence surgeon's compliance with excisional margins of non-melanoma skin cancer	PLOS ONE			English	Article							BASAL-CELL CARCINOMA; GUIDELINE-SUBCOMMITTEE; RISK-FACTORS; MANAGEMENT; EXPLANATION; DIAGNOSIS	The rising incidence of Non Melanoma Skin Cancers (NMSC) leads to a high number of surgical procedures worldwide. The strict compliance with international guidelines with regard to excisional margins may help decrease the number of re-excision procedures and reduce the risk of NMSC recurrence. The aim of this study was to investigate the prevalence of excisional margins as recommended by the European Academy of Dermatology and Venereology (EADV) and the European Dermatology Forum (EDF) guidelines, and the factors (demographic or clinical) that influence surgeons' compliance with these guidelines. This was a prevalence study looking at surgical excisions of NMSCs performed over a period of 2 years (2011 - 2012). A sample size of 1669 patients was considered. Definition of excisional margins recommended by the international guidelines (EADV and EDF) were used as point of reference for the analysis. Tumor and histologic specimen size were calculated ex vivo by 5 different pathologists. The size of skin specimens was measured with a major axis and a minor axis. The same was done for the tumor present on the skin specimens. The differences between the major and minor axes of surgical specimen and tumor were calculated. These differences were subsequently divided by two, hypothesizing that the lesion had the same distance from the margins of the surgical specimen. The differences obtained were named ''Delta'' , the formulas applied being the following: Delta major = (major axis specimen-major axis tumor)/2; Delta minor = (minor axis specimen-minor axis tumor)/2. Results show a significant statistical difference, associated with factors such as: age of the patient, anatomical localization of the tumor, histological diagnosis, and surgeons' experience. The identification of these factors sheds light on clinicians' practice and decision-making regarding excisional margins. Hopefully a higher level of adherence to the guidelines can be achieved in the future.	[Cautela, Jennifer Marchetti; Reggiani, Camilla; Persechino, Flavia; Ferrari, Federica; Rossi, Elena; Passini, Erika; Magnoni, Cristina] Modena & Reggio Emilia Univ, Dept Dermatol, Head & Neck Skin Canc Serv, Modena, Italy; [Mannocci, Alice] Sapienza Univ, Dept Publ Hlth & Infect Dis, Rome, Italy; [Bellini, Pierantonio] Modena & Reggio Emilia Univ, Unit Maxillofacial Surg, Dept Head & Neck Surg, Modena, Italy; [Meleti, Marco] Univ Parma, Unit Dent, Dept Med & Surg, Parma, Italy	Universita di Modena e Reggio Emilia; Sapienza University Rome; Universita di Modena e Reggio Emilia; University of Parma	Mannocci, A (corresponding author), Sapienza Univ, Dept Publ Hlth & Infect Dis, Rome, Italy.	alice.mannocci@uniroma1.it	Bellini, Pierantonio/B-1939-2017	Bellini, Pierantonio/0000-0002-0195-141X; MELETI, Marco/0000-0002-9111-3224; Passini, Erica/0000-0001-8824-0604; Rossi, Elena/0000-0002-6077-7052; persechino, flavia/0000-0001-7476-0326; Mannocci, Alice/0000-0002-8527-6940				Andreassi A, 2005, CLIN DERMATOL, V23, P332, DOI 10.1016/j.clindermatol.2004.07.024; Blasco-Morente G, 2015, J CUTAN PATHOL, V42, P253, DOI 10.1111/cup.12401; Bonerandi JJ, 2011, J EUR ACAD DERMATOL, V25, P1, DOI 10.1111/j.1468-3083.2011.04296.x; Braakhuis BJM, 2003, CANCER RES, V63, P1727; Brantsch KD, 2008, LANCET ONCOL, V9, P713, DOI 10.1016/S1470-2045(08)70178-5; DESILVA SP, 1985, J SURG ONCOL, V28, P72, DOI 10.1002/jso.2930280117; Donaldson MR, 2011, SEMIN CUTAN MED SURG, V30, P3, DOI 10.1016/j.sder.2011.01.002; Eisemann N, 2014, J INVEST DERMATOL, V134, P43, DOI 10.1038/jid.2013.304; Gilman Sander, 1999, MAKING BODY BEAUTIFU; Haas A, 1998, CUTANEOUS ONCOLOGY P, P998; Hajjaj FM, 2010, J ROY SOC MED, V103, P178, DOI 10.1258/jrsm.2010.100104; Hughes L, 2016, ANN SURG ONCOL, V23, pS656, DOI 10.1245/s10434-016-5602-8; Keith DJ, 2017, CLIN EXP DERMATOL, V42, P46, DOI 10.1111/ced.12990; Khan AA, 2013, J PLAST RECONSTR AES, V66, P467, DOI 10.1016/j.bjps.2012.12.016; Leiter Ulrike, 2014, Adv Exp Med Biol, V810, P120; Mahe I, 2016, J THROMB HAEMOST, V14, P2107, DOI 10.1111/jth.13483; Morche J, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0376-4; Nagore E, 2003, J EUR ACAD DERMATOL, V17, P167, DOI 10.1046/j.1468-3083.2003.00535.x; Ranchod M., 2010, INTRAOPERATIVE CONSU; Robinson J, 1996, BIOPSY TECHNIQUES AT; Sarwer DB, 2003, SEMIN CUTAN MED SURG, V22, P79, DOI 10.1053/sder.2003.50014; Soueid A, 2009, J PLAST RECONSTR AES, V62, pE500, DOI 10.1016/j.bjps.2008.04.067; Sterry W, 2006, EUR J DERMATOL, V16, P467, DOI 10.1684/ejd.2006.0035; Stratigos A, 2015, EUR J CANCER, V51, P1989, DOI 10.1016/j.ejca.2015.06.110; Trakatelli M, 2014, EUR J DERMATOL, V24, P312, DOI 10.1684/ejd.2014.2271; Turrentine FE, 2006, J AM COLL SURGEONS, V203, P865, DOI 10.1016/j.jamcollsurg.2006.08.026; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; VERBRUGGE LM, 1981, MED CARE, V19, P609, DOI 10.1097/00005650-198106000-00005	28	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204330	10.1371/journal.pone.0204330	http://dx.doi.org/10.1371/journal.pone.0204330			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30261075	Green Published, gold, Green Submitted			2022-12-26	WOS:000445907400037
J	Nanda, GG; Kumar, MV; Pradhan, L; Padhy, B; Sundaray, S; Das, S; Alone, DP				Nanda, Gargi Gouranga; Kumar, Malloji Vinay; Pradhan, Laxmipriya; Padhy, Biswajit; Sundaray, Satabdi; Das, Sujata; Alone, Debasmita Pankaj			rs4246215 is targeted by hsa-miR1236 to regulate FEN1 expression but is not associated with Fuchs' endothelial corneal dystrophy	PLOS ONE			English	Article							BASE EXCISION-REPAIR; EYE CARE CENTER; DNA-DAMAGE; MISSENSE MUTATIONS; GENETIC-VARIANTS; SOUTH-INDIA; CANCER RISK; POLYMORPHISMS; KERATOPLASTY; PREVALENCE	Fuchs' Endothelial Corneal Dystrophy (FECD) is a genetically complex disorder that affects individuals above 40 years of age; molecular pathogenesis of its associated genes is poorly understood. This study aims at assessing the association of flap endonuclease 1 (FEN1) polymorphisms, c.-69G>A (rs174538) and c.4150G>T (rs4246215) with FECD. Comet assay analysis reaffirmed that endogenous DNA damage was greater in FECD individuals. However, genetic analysis in 79 FECD patients and 234 unrelated control individuals prove that both the FEN1 polymorphisms, c.-69G>A (rs174538) and c.4150G>T (rs4246215), failed to show any genetic association with the FECD disease phenotype. In silico analysis and luciferase reporter assay identified 'G' allele of the 3'UTR located FEN1 polymorphism c.4150G>T as the target for binding of hsa-miR-1236-3p. This study indicates that although FEN1 polymorphisms, c.-69G>A (rs174538) and c.4150G>T (rs4246215) are not genetically associated with FECD, its transcript regulation reported in other diseases such as lung cancer which are genetically associated by rs4246215 could be mediated through miRNA, hsa-miR-1236-3p.	[Nanda, Gargi Gouranga; Kumar, Malloji Vinay; Pradhan, Laxmipriya; Padhy, Biswajit; Alone, Debasmita Pankaj] Natl Inst Sci Educ & Res NISER Bhubaneswar, HBNI, Sch Biol Sci, PO Bhimpur Padanpur, Khurja, Odisha, India; [Sundaray, Satabdi; Das, Sujata] LV Prasad Eye Inst, SMTC Campus, Bhubaneswar, Odisha, India	Homi Bhabha National Institute; National Institute of Science Education & Research (NISER); L. V. Prasad Eye Institute	Alone, DP (corresponding author), Natl Inst Sci Educ & Res NISER Bhubaneswar, HBNI, Sch Biol Sci, PO Bhimpur Padanpur, Khurja, Odisha, India.; Das, S (corresponding author), LV Prasad Eye Inst, SMTC Campus, Bhubaneswar, Odisha, India.	sujata.abani@gmail.com; debasmita@niser.ac.in	Alone, Debasmita Pankaj/AAH-1127-2020; Padhy, Biswajit/AAT-2848-2021	Alone, Debasmita Pankaj/0000-0003-4809-925X; Padhy, Biswajit/0000-0002-8165-6727	National Institute of Science Education and Research (NISER; Khurda, Odisha, India); Department of Atomic Energy (Mumbai, Maharashtra, India); Indian Council of Medical Research (Ansari Nagar, New Delhi, India) [5/4/6/03/Oph./2015-NCD-II]; University Grants Commission; NISER	National Institute of Science Education and Research (NISER; Khurda, Odisha, India); Department of Atomic Energy (Mumbai, Maharashtra, India); Indian Council of Medical Research (Ansari Nagar, New Delhi, India); University Grants Commission(University Grants Commission, India); NISER	Instruments and lab setting was funded and provided by Intramural support from National Institute of Science Education and Research (NISER; Khurda, Odisha, India), Department of Atomic Energy (Mumbai, Maharashtra, India) (DPA). Consumables were funded by Indian Council of Medical Research, from the Project no. 5/4/6/03/Oph./2015-NCD-II (Ansari Nagar, New Delhi, India) (DPA). Research scholarships were funded by University Grants Commission and NISER. Research fellowships from the University Grants Commission (GGN) and NISER (MVK, BP, LP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshari NA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14898; Baratz KH, 2010, NEW ENGL J MED, V363, P1016, DOI 10.1056/NEJMoa1007064; Biswas S, 2001, HUM MOL GENET, V10, P2415, DOI 10.1093/hmg/10.21.2415; Chen YD, 2013, J NEURO-ONCOL, V111, P145, DOI 10.1007/s11060-012-1007-0; Czarny P, 2013, MOL BIOL REP, V40, P2977, DOI 10.1007/s11033-012-2369-2; Fuchs E, 1910, GRAEFES ARCH CLIN EX, V76, P478, DOI DOI 10.1007/BF01986362; Guo ZG, 2010, NAT CHEM BIOL, V6, P766, DOI [10.1038/NCHEMBIO.422, 10.1038/nchembio.422]; Kitagawa K, 2002, OPHTHALMIC RES, V34, P135, DOI 10.1159/000063656; Klungland A, 1999, MOL CELL, V3, P33, DOI 10.1016/S1097-2765(00)80172-0; KRACHMER JH, 1978, ARCH OPHTHALMOL-CHIC, V96, P2036, DOI 10.1001/archopht.1978.03910060424004; Liu CL, 2016, INVEST OPHTH VIS SCI, V57, P2319, DOI 10.1167/iovs.16-19097; Liu L, 2012, CARCINOGENESIS, V33, P119, DOI 10.1093/carcin/bgr250; Liu Y, 2005, J BIOL CHEM, V280, P3665, DOI 10.1074/jbc.M412922200; Lv Z, 2014, GENE, V538, P42, DOI 10.1016/j.gene.2014.01.025; Mehta JS, 2008, INVEST OPHTH VIS SCI, V49, P184, DOI 10.1167/iovs.07-0847; Mohamed A, 2014, ASIA-PAC J OPHTHALMO, V3, P207, DOI 10.1097/APO.0b013e3182a75304; Myles S, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-22; Nanda GG, 2014, INVEST OPHTH VIS SCI, V55, P7674, DOI 10.1167/iovs.14-15297; Pandrowala H, 2004, CORNEA, V23, P541, DOI 10.1097/01.ico.0000126324.58884.b9; Ren HT, 2015, MOL CLIN ONCOL, V3, P1347, DOI 10.3892/mco.2015.617; Riazuddin SA, 2012, AM J HUM GENET, V90, P533, DOI 10.1016/j.ajhg.2012.01.013; Riazuddin SA, 2010, HUM MUTAT, V31, P1261, DOI 10.1002/humu.21356; Riazuddin SA, 2009, INVEST OPHTH VIS SCI, V50, P5667, DOI 10.1167/iovs.09-3764; Vedana G, 2016, CLIN OPHTHALMOL, V10, P321, DOI 10.2147/OPTH.S83467; Vithana EN, 2008, HUM MOL GENET, V17, P656, DOI 10.1093/hmg/ddm337; Wojcik KA, 2014, INT J MOL SCI, V15, P14786, DOI 10.3390/ijms150814786; Wojcik Katarzyna A, 2013, Klin Oczna, V115, P317; Yang M, 2009, HUM MUTAT, V30, P1320, DOI 10.1002/humu.21060; Zoega GM, 2006, OPHTHALMOLOGY, V113, P565, DOI 10.1016/j.ophtha.2005.12.014	29	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204278	10.1371/journal.pone.0204278	http://dx.doi.org/10.1371/journal.pone.0204278			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30260965	Green Submitted, Green Published, gold			2022-12-26	WOS:000445907400032
J	Rollm, JV; Ota-Arakaki, JS; Ferreira, EVM; Figliolino, GAM; Ivanaga, I; Vieira, EB; Fonseca, AXC; Messina, CMS; Costa, CM; Neder, JA; Nery, LE; Ramos, RP				Rollm, Joao Victor; Ota-Arakaki, Jaquelina Sonoe; Ferreira, Eloara V. M.; Figliolino, Gabriela A. M.; Ivanaga, Ivan; Vieira, Elaine Brito; Fonseca, Angelo X. C.; Messina, Carolina M. S.; Costa, Camila Melo; Alberto Neder, J.; Nery, Luiz Eduardo; Ramos, Roberta Pulcheri			Inspiratory muscle weakness contributes to exertional dyspnea in chronic thromboembolic pulmonary hypertension	PLOS ONE			English	Article							INTERNATIONAL PROSPECTIVE REGISTRY; ARTERIAL-HYPERTENSION; EXERCISE CAPACITY; REFERENCE VALUES; OXIDATIVE-STRESS; CYCLE ERGOMETRY; ENDARTERECTOMY; VENTILATION; MECHANISMS; MANAGEMENT	Determination of potentially-reversible factors contributing to exertional dyspnea remains an unmet clinical need in chronic thromboembolic pulmonary hypertension (CTEPH). Therefore, we aimed to evaluate the influence of inspiratory muscle weakness (IMW) on exercise capacity and dyspnea during effort in patients with CTEPH. We performed a prospective cross-sectional study that included thirty-nine consecutive patients with CTEPH (48 +/- 15 yrs, 61% female) confirmed by right heart catheterization that underwent an incremental cardiopulmonary exercise test, 6-minute walk test and maximum inspiratory pressure (MIP) measurement. MIP < 70%(pred) was found in 46% of patients. On a multiple linear regression analysis, MIP was independently associated with 6MWD and <(V)over dot>O-2 (PEAK). Patients with MIP < 70% presented greater Delta(V)over dot>E/Delta(V)over dot>CO2 than those with MIP >= 70%. Additionally, they also presented stronger sensations of dyspnea throughout exercise, even when adjusted for ventilation. At rest and at different levels of exercise, mean inspiratory flow (V-T/T-I) was significantly higher in patients with MIP < 70%. In conclusion, IMW is associated with a rapid increase of dyspnea, higher inspiratory load and poor exercise capacity in patients with CTEPH.	[Rollm, Joao Victor; Ota-Arakaki, Jaquelina Sonoe; Ferreira, Eloara V. M.; Figliolino, Gabriela A. M.; Ivanaga, Ivan; Vieira, Elaine Brito; Fonseca, Angelo X. C.; Messina, Carolina M. S.; Costa, Camila Melo; Alberto Neder, J.; Nery, Luiz Eduardo; Ramos, Roberta Pulcheri] Univ Fed Sao Paulo Unifesp, Dept Med, Pulm Circulat Grp, Div Resp Dis, Sao Paulo, SP, Brazil; [Rollm, Joao Victor; Ota-Arakaki, Jaquelina Sonoe; Ferreira, Eloara V. M.; Figliolino, Gabriela A. M.; Ivanaga, Ivan; Vieira, Elaine Brito; Fonseca, Angelo X. C.; Messina, Carolina M. S.; Costa, Camila Melo; Alberto Neder, J.; Nery, Luiz Eduardo; Ramos, Roberta Pulcheri] Univ Fed Sao Paulo Unifesp, Dept Med, Pulm Funct & Exercise Physiol Unit, Div Resp Dis, Sao Paulo, SP, Brazil; [Alberto Neder, J.] Queens Univ, Lab Clin Exercise Physiol, Resp & Crit Care Div, Dept Med, Kingston, ON, Canada	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Queens University - Canada	Ota-Arakaki, JS (corresponding author), Univ Fed Sao Paulo Unifesp, Dept Med, Pulm Circulat Grp, Div Resp Dis, Sao Paulo, SP, Brazil.; Ota-Arakaki, JS (corresponding author), Univ Fed Sao Paulo Unifesp, Dept Med, Pulm Funct & Exercise Physiol Unit, Div Resp Dis, Sao Paulo, SP, Brazil.	jaqueota@gmail.com	Ferreira, Eloara V M/ABA-4719-2021; Nery, Luiz E/C-3194-2015; ivanaga, ivan/M-5729-2019; Ota-Arakaki, Jaquelina Sonoe/D-6500-2014	Ferreira, Eloara V M/0000-0002-3291-6473; Ota-Arakaki, Jaquelina Sonoe/0000-0002-5350-7679; Ivanaga, Ivan Teruaki/0000-0003-4827-7474	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Grant [16/18497-7]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Grant	This research was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Grant #16/18497-7 to RPR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich TK, 2002, AM J RESP CRIT CARE, V166, P548, DOI 10.1164/rccm.166.4.518; Aslan GK, 2018, CLIN RESPIR J, V12, P699, DOI 10.1111/crj.12582; Bonderman D, 2007, CIRCULATION, V115, P2153, DOI 10.1161/CIRCULATIONAHA.106.661041; Bowers R, 2004, AM J RESP CRIT CARE, V169, P764, DOI 10.1164/rccm.200301-147OC; Ciarka A, 2010, AM J RESP CRIT CARE, V181, P1269, DOI 10.1164/rccm.200912-1856OC; Condliffe R, 2008, AM J RESP CRIT CARE, V177, P1122, DOI 10.1164/rccm.200712-1841OC; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; de Man FS, 2011, AM J RESP CRIT CARE, V183, P1411, DOI 10.1164/rccm.201003-0354OC; Delcroix M, 2016, CIRCULATION, V133, P859, DOI 10.1161/CIRCULATIONAHA.115.016522; Dube BP, 2016, J CLIN MED, V5, DOI 10.3390/jcm5120113; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Ghio S, 2014, EUR RESPIR J, V43, P1403, DOI 10.1183/09031936.00195313; Hurdman J, 2012, EUR RESPIR J, V39, P945, DOI 10.1183/09031936.00078411; Iwase T, 2001, HEART, V86, P188, DOI 10.1136/heart.86.2.188; Kabitz HJ, 2008, CLIN SCI, V114, P165, DOI 10.1042/CS20070238; Madani MM, 2012, ANN THORAC SURG, V94, P97, DOI 10.1016/j.athoracsur.2012.04.004; Manders E, 2016, AM J PHYSIOL-LUNG C, V311, pL20, DOI 10.1152/ajplung.00113.2016; Manders E, 2015, EUR RESPIR J, V46, P832, DOI 10.1183/13993003.02052-2014; Mayer E, 2011, J THORAC CARDIOV SUR, V141, P702, DOI 10.1016/j.jtcvs.2010.11.024; Meyer FJ, 2005, EUR RESPIR J, V25, P125, DOI 10.1183/09031936.04.00095804; Naeije R, 2005, EUR RESPIR J, V25, P6, DOI 10.1183/09031936.04.00121004; Neder JA, 1999, EUR RESPIR J, V14, P1304, DOI 10.1183/09031936.99.14613049; Neder JA, 1999, BRAZ J MED BIOL RES, V32, P719, DOI 10.1590/S0100-879X1999000600007; Neder JA, 2001, AM J RESP CRIT CARE, V164, P1481, DOI 10.1164/ajrccm.164.8.2103007; O'Donnell DE, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00082; O'Donnell DE, 2009, RESP PHYSIOL NEUROBI, V167, P116, DOI 10.1016/j.resp.2009.01.010; Parshall MB, 2012, AM J RESP CRIT CARE, V185, P435, DOI 10.1164/rccm.201111-2042ST; Pepke-Zaba J, 2016, ANN AM THORAC SOC, V13, pS248, DOI 10.1513/AnnalsATS.201512-802AS; Pepke-Zaba J, 2011, CIRCULATION, V124, P1973, DOI 10.1161/CIRCULATIONAHA.110.015008; Pereira Carlos Alberto de Castro, 2007, J. bras. pneumol., V33, P397, DOI 10.1590/S1806-37132007000400008; Petrucci L, 2007, Eura Medicophys, V43, P147; Potus F, 2014, AM J RESP CRIT CARE, V190, P318, DOI 10.1164/rccm.201402-0383OC; Rabinovitch M, 2014, CIRC RES, V115, P165, DOI 10.1161/CIRCRESAHA.113.301141; Reesink HJ, 2007, J THORAC CARDIOV SUR, V133, P510, DOI 10.1016/j.jtcvs.2006.10.020; Reis GS, 2013, PULM CIRC, V3, P856, DOI 10.1086/674764; Rodrigues A, 2017, CHEST, V152, P32, DOI 10.1016/j.chest.2016.11.045; Soon E, 2010, CIRCULATION, V122, P921, DOI 10.1161/CIRCULATIONAHA.109.933762; van der Plas MN, 2010, ANN THORAC SURG, V89, P347, DOI 10.1016/j.athoracsur.2009.08.001; Weatherald J, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.00860-2017; Weatherald J, 2017, ANN AM THORAC SOC, V14, pS84, DOI 10.1513/AnnalsATS.201610-788FR; Whipp B. J., 2011, HDB PHYSL RESP SYSTE, DOI [10.1002/cphy.cp030334, DOI 10.1002/CPHY.CP030334]; Zhang JH, 2016, AM J EMERG MED, V34, P212, DOI 10.1016/j.ajem.2015.10.028	42	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204072	10.1371/journal.pone.0204072	http://dx.doi.org/10.1371/journal.pone.0204072			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30260970	gold, Green Published, Green Submitted			2022-12-26	WOS:000445907400023
J	Zhao, JF; Zhan, X; Jiang, YQ; Xu, JW				Zhao, Junfang; Zhan, Xin; Jiang, Yueqing; Xu, Jingwen			Variations in climatic suitability and planting regionalization for potato in northern China under climate change	PLOS ONE			English	Article							LAND-USE; CROP; YIELD; TEMPERATURE; EFFICIENCY; IMPACTS; QUALITY; GROWTH; WHEAT; SOIL	Investigating the variations in crop climatic suitability and planting regionalization can provide scientific evidence for ensuring food security under climate change. In this study, variations in climatic suitability and planting regionalization for the potato in northern China were investigated based on daily data from 1965 to 2014 collected at 321 agro-meteorological observation stations located throughout the region. Northern China was divided into three areas, including Northwest China, North China and Northeast China. The agricultural climatic suitability theory and the fuzzy mathematics method were applied. The potato growth seasons were divided into threestages: from sowing to emergence, from emergence to flowering and from flowering to maturity. The comprehensive climatic suitabilityindex (C), which varied from 0 to 1, was established to evaluate the effects of climate change on potato planting. The results showed that, from 1965 to 2014, the C value in the study area increased 0.002 every ten years over the past 50 years with an average of 0.706, benefitting potato growth in the vast area of northern China. Nonetheless, precipitation was found to be the main climatic factor restricting potato growth in northern China. For spatial distribution, the C value showed a gradually declining trend from east to west, decreasing westward and southward over the past 50 years. For the growth season, the C value varied during different potato growth stages over the past 50 years. The C value increased during the sowing-emergence stage and decreased during the emergence-flowering stage and the flowering-maturity stage. The decreased C during the later growth stages would directly affect the quality and yield of the potato, mainly because the flowering-maturity stage was associated with potato tuber enlargement and starch accumulation. Variations in potato planting regionalization in northern China over the past 50 years were evident. Climate change was more beneficial to potato cultivation in northeast China where the highly suitable areas had clearly expanded. However, potato cultivation was most negatively affected in northwest China where the middle suitable areas had receded. Our findings have important implications for improving climate change impact studies and agricultural production to cope with ongoing climate change.	[Zhao, Junfang; Zhan, Xin] Chinese Acad Meteorol Sci, State Key Lab Severe Weather, Beijing, Peoples R China; [Zhan, Xin; Xu, Jingwen] Sichuan Agr Univ, Coll Resources, Chengdu, Sichuan, Peoples R China; [Jiang, Yueqing] Natl Meteorol Ctr, Beijing, Peoples R China	Chinese Academy of Meteorological Sciences (CAMS); Chinese Academy of Sciences; Sichuan Agricultural University	Zhao, JF (corresponding author), Chinese Acad Meteorol Sci, State Key Lab Severe Weather, Beijing, Peoples R China.	zhaojfcams@163.com	xu, jing/GRR-8698-2022		National Key Research and Development Program of China [2017YFA0603004]; Chinese Academy of Meteorological Sciences Basic Research Funds [2017R001, 2017Z004]; National Non-profit Research Foundation for Meteorology [GYHY201506016]	National Key Research and Development Program of China; Chinese Academy of Meteorological Sciences Basic Research Funds; National Non-profit Research Foundation for Meteorology	This work was supported by the National Key Research and Development Program of China (2017YFA0603004), the Chinese Academy of Meteorological Sciences Basic Research Funds (2017R001, 2017Z004) and the National Non-profit Research Foundation for Meteorology (GYHY201506016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen R. G., 1998, FAO Irrigation and Drainage Paper; [Anonymous], 2014, CHIN STAT YB 2014; [Anonymous], 2014, EVALUATION EFFECT AD; Caubel J, 2015, AGR FOREST METEOROL, V207, P94, DOI 10.1016/j.agrformet.2015.02.005; Cicatelli A, 2014, SCI TOTAL ENVIRON, V493, P1025, DOI 10.1016/j.scitotenv.2014.05.122; Daccache A, 2011, AGR FOREST METEOROL, V151, P1641, DOI 10.1016/j.agrformet.2011.06.018; Dong ZQ, 2016, ECOL INDIC, V69, P571, DOI 10.1016/j.ecolind.2016.04.010; El Baroudy AA, 2016, CATENA, V140, P96, DOI 10.1016/j.catena.2015.12.010; Geerts S, 2006, AGR FOREST METEOROL, V139, P399, DOI 10.1016/j.agrformet.2006.08.018; Guo W, 2014, J ARID METEOROLOGY, V32, P516; He YB, 2017, J INTEGR AGR, V16, P1520, DOI [10.1016/S2095-3119(16)61627-1, 10.1016/s2095-3119(16)61627-1]; Hijmans RJ, 2003, AM J POTATO RES, V80, P271, DOI 10.1007/BF02855363; Holman IP, 2017, AGR SYST, V151, P126, DOI 10.1016/j.agsy.2016.12.001; Holzkamper A, 2013, AGR FOREST METEOROL, V168, P149, DOI 10.1016/j.agrformet.2012.09.004; IPCC, 2014, CLIMATE CHANGE IMPAC; Kaiser DP, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL016057; Lobell DB, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/1/014002; Luo ZZ, 2013, AGR CLIMATE REGIONAL; Miao Bai-ling, 2015, Yingyong Shengtai Xuebao, V26, P278; Miglietta F, 1998, GLOBAL CHANGE BIOL, V4, P163, DOI 10.1046/j.1365-2486.1998.00120.x; Moniruzzaman S, 2015, ECOL ECON, V118, P90, DOI 10.1016/j.ecolecon.2015.07.012; Nguyen TT, 2011, AGR SCI CHINA, V10, P275, DOI 10.1016/S1671-2927(11)60005-9; Olesen JE, 2011, EUR J AGRON, V34, P96, DOI 10.1016/j.eja.2010.11.003; Olesen JE, 2002, EUR J AGRON, V16, P239, DOI 10.1016/S1161-0301(02)00004-7; Opena GB, 1991, AGRON J, V91, P426; Stalham MA, 2007, J AGR SCI-CAMBRIDGE, V145, P295, DOI 10.1017/S0021859607006867; [唐红艳 Tang Hongyan], 2010, [干旱地区农业研究, Agricultural Research in the Arid Areas], V28, P158; Tang JZ, 2018, AGR FOREST METEOROL, V256, P283, DOI 10.1016/j.agrformet.2018.03.022; Vinten AJA, 2014, SCI TOTAL ENVIRON, V468, P93, DOI 10.1016/j.scitotenv.2013.07.086; Wang C. L., 2015, IMPACTS CLIMATE CHAN; Wei TY, 2014, SCI TOTAL ENVIRON, V499, P133, DOI 10.1016/j.scitotenv.2014.08.035; Xiao GJ, 2013, AGR ECOSYST ENVIRON, V181, P108, DOI 10.1016/j.agee.2013.09.019; Xie KY, 2012, SCI HORTIC-AMSTERDAM, V134, P20, DOI 10.1016/j.scienta.2011.11.034; Xu GP, 2016, PROCEDIA ENVIRON SCI, V31, P668, DOI 10.1016/j.proenv.2016.02.123; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X; Zhao JF, 2005, AGR ECOSYST ENVIRON, V202, P178; Zhao JF, 2016, SCI TOTAL ENVIRON, V573, P965, DOI 10.1016/j.scitotenv.2016.08.195; [朱新玉 Zhu Xinyu], 2012, [地理研究, Geographical Research], V31, P1479	38	5	6	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0203538	10.1371/journal.pone.0203538	http://dx.doi.org/10.1371/journal.pone.0203538			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30260968	gold, Green Published, Green Submitted			2022-12-26	WOS:000445907400012
J	Davies, T; Cowley, A; Bennie, J; Leyshon, C; Inger, R; Carter, H; Robinson, B; Duffy, J; Casalegno, S; Lambert, G; Gaston, K				Davies, Thomas; Cowley, Andrew; Bennie, Jon; Leyshon, Catherine; Inger, Richard; Carter, Hazel; Robinson, Beth; Duffy, James; Casalegno, Stefano; Lambert, Gwladys; Gaston, Kevin			Popular interest in vertebrates does not reflect extinction risk and is associated with bias in conservation investment	PLOS ONE			English	Article							NOAHS-ARK BEAUTIFUL; BIODIVERSITY CONSERVATION; ENVIRONMENTAL GOVERNANCE; FLAGSHIPS; UMBRELLAS; SCIENCE; TRENDS	The interrelationship between public interest in endangered species and the attention they receive from the conservation community is the 'flywheel' driving much effort to abate global extinction rates. Yet big international conservation non-governmental organisations have typically focused on the plight of a handful of appealing endangered species, while the public remains largely unaware of the majority. We quantified the existence of bias in popular interest towards species, by analysing global internet search interest in 36,873 vertebrate taxa. Web search interest was higher for mammals and birds at greater risk of extinction, but this was not so for fish, reptiles and amphibians. Our analysis reveals a global bias in popular interest towards vertebrates that is undermining incentives to invest financial capital in thousands of species threatened with extinction. Raising the popular profile of these lesser known endangered and critically endangered species will generate clearer political and financial incentives for their protection.	[Davies, Thomas] Bangor Univ, Sch Ocean Sci, Menai Bridge, Anglesey, Wales; [Davies, Thomas; Bennie, Jon; Leyshon, Catherine] Univ Exeter, Ctr Geog Environm & Soc, Penryn, Cornwall, England; [Davies, Thomas; Cowley, Andrew; Inger, Richard; Carter, Hazel; Robinson, Beth; Duffy, James; Casalegno, Stefano; Gaston, Kevin] Univ Exeter, Environm & Sustainabil Inst, Penryn, Cornwall, England; [Lambert, Gwladys] Natl Marine Fisheries Serv, Alaska Fisheries Sci Ctr, Seattle, WA USA	Bangor University; University of Exeter; University of Exeter; National Oceanic Atmospheric Admin (NOAA) - USA	Davies, T (corresponding author), Bangor Univ, Sch Ocean Sci, Menai Bridge, Anglesey, Wales.; Davies, T (corresponding author), Univ Exeter, Ctr Geog Environm & Soc, Penryn, Cornwall, England.; Davies, T (corresponding author), Univ Exeter, Environm & Sustainabil Inst, Penryn, Cornwall, England.	Thomas.Davies@bangor.ac.uk	Davies, Thomas W/H-8103-2013; Duffy, James/L-9027-2019	Davies, Thomas W/0000-0002-4673-9893; Duffy, James/0000-0001-7971-3924; Leyshon, Catherine/0000-0003-0850-9226; Gaston, Kevin J./0000-0002-7235-7928	Natural Environment Research Council [NEC05173]	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the Natural Environment Research Council [grant number NEC05173 awarded to TWD].	Andelman SJ, 2000, P NATL ACAD SCI USA, V97, P5954, DOI 10.1073/pnas.100126797; Armitage D, 2012, CONSERV LETT, V5, P245, DOI 10.1111/j.1755-263X.2012.00238.x; Bennett NJ, 2017, BIOL CONSERV, V205, P93, DOI 10.1016/j.biocon.2016.10.006; Correia RA, 2017, ECOL INDIC, V78, P549, DOI 10.1016/j.ecolind.2017.03.052; Correia RA, 2016, PEERJ, V4, DOI 10.7717/peerj.1728; Corson C, 2010, ANTIPODE, V42, P576, DOI 10.1111/j.1467-8330.2010.00764.x; De Vos JM, 2015, CONSERV BIOL, V29, P452, DOI 10.1111/cobi.12380; Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817; Douglas LR, 2014, BIODIVERS CONSERV, V23, P979, DOI 10.1007/s10531-014-0647-0; International Telecommunications Union, 2016, INF COMM TECHN FACTS; Internet World Stats, 2016, INT WORLD US LANG; Jepson P, 2005, ENVIRON SCI POLICY, V8, P515, DOI 10.1016/j.envsci.2005.06.006; Ladle RJ, 2016, FRONT ECOL ENVIRON, V14, P270, DOI 10.1002/fee.1260; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Macdonald EA, 2015, GLOB ECOL CONSERV, V3, P851, DOI 10.1016/j.gecco.2015.04.006; Miller JR, 2005, TRENDS ECOL EVOL, V20, P430, DOI 10.1016/j.tree.2005.05.013; Nghiem LTP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152802; Preis T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01684; Proulx R, 2014, CONSERV BIOL, V28, P44, DOI 10.1111/cobi.12131; Roberge JM, 2014, BIODIVERS CONSERV, V23, P715, DOI 10.1007/s10531-014-0629-2; Roll U, 2016, BIOL CONSERV, V204, P42, DOI 10.1016/j.biocon.2016.03.037; Saunders CD., 2003, HUM ECOL REV, V10, P137; Schultz PW, 2011, CONSERV BIOL, V25, P1080, DOI 10.1111/j.1523-1739.2011.01766.x; Seddon PJ, 2005, ANIM CONSERV, V8, P51, DOI 10.1017/S1367943004001799; Seifter A, 2010, GEOSPATIAL HEALTH, V4, P135, DOI 10.4081/gh.2010.195; Simberloff D, 1998, BIOL CONSERV, V83, P247, DOI 10.1016/S0006-3207(97)00081-5; Small Ernest, 2012, Biodiversity (Ottawa), V13, P37, DOI 10.1080/14888386.2012.659443; Small Ernest, 2011, BIODIVERSITY-OTTAWA, V12, P232, DOI 10.1080/14888386.2011.642663; Smith RJ, 2012, CONSERV LETT, V5, P205, DOI 10.1111/j.1755-263X.2012.00229.x; Soriano-Redondo A, 2017, BIOL CONSERV, V206, P304, DOI 10.1016/j.biocon.2016.11.031; United Nations, 2014, STESASERA352 UN; Verissimo D., 2013, CONSERV EVIDENCE, V10, P29; Verissimo D, 2014, CONSERV LETT, V7, P263, DOI 10.1111/conl.12070; Verissimo D, 2011, CONSERV LETT, V4, P1, DOI 10.1111/j.1755-263X.2010.00151.x; Wilson JRU, 2007, FRONT ECOL ENVIRON, V5, P409, DOI 10.1890/060077.01; Wright AJ, 2015, OCEAN COAST MANAGE, V115, P41, DOI 10.1016/j.ocecoaman.2015.06.029	36	36	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2018	13	9							e0203694	10.1371/journal.pone.0203694	http://dx.doi.org/10.1371/journal.pone.0203694			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3NB	30256838	Green Submitted, gold, Green Published			2022-12-26	WOS:000446000200025
J	Bisconti, AV; Devoto, M; Venturelli, M; Bryner, R; Olfert, IM; Chantler, PD; Esposito, F				Bisconti, Angela Valentina; Devoto, Michela; Venturelli, Massimo; Bryner, Randall; Olfert, I. Mark; Chantler, Paul D.; Esposito, F.			Respiratory muscle training positively affects vasomotor response in young healthy women	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; FLOW-MEDIATED DILATION; INCREASES CYCLING ENDURANCE; BRACHIAL-ARTERY; BLOOD-PRESSURE; ENDOTHELIAL DYSFUNCTION; CARDIOVASCULAR-DISEASE; SYMPATHOVAGAL BALANCE; ULTRASOUND ASSESSMENT; SHEAR-STRESS	Vasomotor response is related to the capacity of the vessel to maintain vascular tone within a narrow range. Two main control mechanisms are involved: the autonomic control of the sympathetic neural drive (global control) and the endothelial smooth cells capacity to respond to mechanical stress by releasing vasoactive factors (peripheral control). The aim of this study was to evaluate the effects of respiratory muscle training (RMT) on vasomotor response, assessed by flow-mediated dilation (FMD) and heart rate variability, in young healthy females. The hypothesis was that RMT could enhance the balance between sympathetic and parasympathetic neural drive and reduce vessel shear stress. Thus, twenty-four women were randomly assigned to either RMT or SHAM group. Maximal inspiratory mouth pressure and maximum voluntary ventilation were utilized to assess the effectiveness of the RMT program, which consisted of three sessions of isocapnic hyperventilation/week for eight weeks, (twenty-four training sessions). Heart rate variability assessed autonomic balance, a global factor regulating the vasomotor response. Endothelial function was determined by measuring brachial artery vasodilation normalized by shear rate (%FMD/SR). After RMT, but not SHAM, maximal inspiratory mouth pressure and maximum voluntary ventilation increased significantly (+31% and +16%, respectively). Changes in heart rate variability were negligible in both groups. Only RMT exhibited a significant increase in % FMD/SR (+45%; p < 0.05). These data suggest a positive effect of RMT on vasomotor response that may be due to a reduction in arterial shear stress, and not through modulation of sympatho-vagal balance.	[Bisconti, Angela Valentina; Devoto, Michela; Venturelli, Massimo; Esposito, F.] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy; [Venturelli, Massimo] Univ Verona, Dept Neurosci Biomed & Movement Sci, Verona, Italy; [Bryner, Randall; Olfert, I. Mark; Chantler, Paul D.] West Virginia Univ, Sch Med, Div Exercise Physiol, Morgantown, WV USA; [Esposito, F.] IRCCS, Galeazzi Orthoped Inst, Milan, Italy	University of Milan; University of Verona; West Virginia University; IRCCS Istituto Ortopedico Galeazzi	Bisconti, AV (corresponding author), Univ Milan, Dept Biomed Sci Hlth, Milan, Italy.	angela.bisconti@unimi.it	BISCONTI, ANGELA VALENTINA/AAM-3509-2021; Esposito, Fabio/E-9340-2011; Venturelli, Massimo/AAQ-4613-2020	BISCONTI, ANGELA VALENTINA/0000-0003-0156-2593; Esposito, Fabio/0000-0002-4420-2611; Venturelli, Massimo/0000-0002-2469-8787				Atkinson G, 2013, J HYPERTENS, V31, P287, DOI 10.1097/HJH.0b013e32835b8164; Badrov MB, 2016, EUR J APPL PHYSIOL, V116, P1289, DOI 10.1007/s00421-016-3366-2; Bellenger CR, 2016, SPORTS MED, V46, P1461, DOI 10.1007/s40279-016-0484-2; Birk GK, 2012, J APPL PHYSIOL, V112, P1653, DOI 10.1152/japplphysiol.01489.2011; Camm AJ, 1996, CIRCULATION, V93, P1043; CELERMAJER DS, 1992, LANCET, V340, P1111, DOI 10.1016/0140-6736(92)93147-F; Chen X, 2015, EXP THER MED, V10, P2311, DOI 10.3892/etm.2015.2784; Chiappa GR, 2008, J AM COLL CARDIOL, V51, P1663, DOI 10.1016/j.jacc.2007.12.045; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; Dall'Ago P, 2006, J AM COLL CARDIOL, V47, P757, DOI 10.1016/j.jacc.2005.09.052; Donoghue D, 2009, J REHABIL MED, V41, P343, DOI 10.2340/16501977-0337; DUBOIS AB, 1956, J CLIN INVEST, V35, P322, DOI 10.1172/JCI103281; Esposito F, 2010, RESP PHYSIOL NEUROBI, V173, P115, DOI 10.1016/j.resp.2010.07.008; Esposito F, 2010, EUR J APPL PHYSIOL, V110, P219, DOI 10.1007/s00421-010-1487-6; Esposito F, 2010, RESP PHYSIOL NEUROBI, V170, P268, DOI 10.1016/j.resp.2010.02.004; Faghy MA, 2016, EUR J SPORT SCI, V16, P585, DOI 10.1080/17461391.2015.1071878; Feairheller DL, 2014, J CLIN HYPERTENS, V16, P504, DOI 10.1111/jch.12328; Ferreira JB, 2013, INT J CARDIOL, V166, P61, DOI 10.1016/j.ijcard.2011.09.069; Green DJ, 2008, J APPL PHYSIOL, V105, P766, DOI 10.1152/japplphysiol.01028.2007; Green DJ, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a029819; Green DJ, 2009, EXERC SPORT SCI REV, V37, P196, DOI 10.1097/JES.0b013e3181b7b6e3; Harris RA, 2010, HYPERTENSION, V55, P1075, DOI 10.1161/HYPERTENSIONAHA.110.150821; He F, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00486; Hepburn H, 2005, EUR J APPL PHYSIOL, V94, P681, DOI 10.1007/s00421-005-1355-y; Joyner MJ, 2009, J PHYSIOL-LONDON, V587, P5551, DOI 10.1113/jphysiol.2009.179432; Maiorana A, 2000, AM J PHYSIOL-HEART C, V279, pH1999, DOI 10.1152/ajpheart.2000.279.4.H1999; Markov G, 2001, EUR J APPL PHYSIOL, V85, P233, DOI 10.1007/s004210100450; Milicevic G, 2005, COLLEGIUM ANTROPOL, V29, P295; Mosca L, 2011, CIRCULATION, V124, P2145, DOI 10.1161/CIRCULATIONAHA.110.968792; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Naylor LH, 2005, J APPL PHYSIOL, V98, P2311, DOI 10.1152/japplphysiol.01047.2004; Naylor LH, 2011, AM J PHYSIOL-HEART C, V300, pH664, DOI 10.1152/ajpheart.00985.2010; Niebauer J, 1996, J AM COLL CARDIOL, V28, P1652, DOI 10.1016/S0735-1097(96)00393-2; Okamoto T, 2011, EUR J APPL PHYSIOL, V111, P743, DOI 10.1007/s00421-010-1702-5; Puricel S, 2016, INT J CARDIOL, V202, P525, DOI 10.1016/j.ijcard.2015.09.085; Pyke KE, 2005, J PHYSIOL-LONDON, V568, P357, DOI 10.1113/jphysiol.2005.089755; Sandoo A, 2010, OPEN CARDIOVASC MED, V4, P302, DOI 10.2174/1874192401004010302; Schafer A, 2013, INT J CARDIOL, V166, P15, DOI 10.1016/j.ijcard.2012.03.119; Spengler CM, 1999, EUR J APPL PHYSIOL O, V79, P299, DOI 10.1007/s004210050511; Stein PK, 1997, AM J CARDIOL, V80, P302, DOI 10.1016/S0002-9149(97)00350-0; Stuessi C, 2001, EUR J APPL PHYSIOL, V84, P582, DOI 10.1007/s004210100408; Szocs K, 2004, GEN PHYSIOL BIOPHYS, V23, P265; Tarvainen MP, 2014, COMPUT METH PROG BIO, V113, P210, DOI 10.1016/j.cmpb.2013.07.024; Thijssen DHJ, 2011, ACTA PHYSIOL, V201, P427, DOI 10.1111/j.1748-1716.2010.02213.x; Thijssen DHJ, 2014, J APPL PHYSIOL, V116, P1300, DOI 10.1152/japplphysiol.00110.2014; Thijssen DHJ, 2011, AM J PHYSIOL-HEART C, V300, pH2, DOI 10.1152/ajpheart.00471.2010; Thompson PD, 2003, CIRCULATION, V107, P3109, DOI 10.1161/01.CIR.0000075572.40158.77; Tinken TM, 2010, HYPERTENSION, V55, P312, DOI 10.1161/HYPERTENSIONAHA.109.146282; Uehata A, 1997, Vasc Med, V2, P87; Umetani K, 1998, J AM COLL CARDIOL, V31, P593, DOI 10.1016/S0735-1097(97)00554-8; Verges S, 2009, RESP PHYSIOL NEUROBI, V169, P282, DOI 10.1016/j.resp.2009.09.005; Voss A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118308; Widlansky ME, 2003, J AM COLL CARDIOL, V42, P1149, DOI 10.1016/S0735-1097(03)00994-X; Wilson C, 2016, J PHYSIOL-LONDON, V594, P7267, DOI 10.1113/JP272927; Wray DW, 2013, HYPERTENSION, V62, P345, DOI 10.1161/HYPERTENSIONAHA.113.01578; Ylitalo A, 1999, AM J CARDIOL, V83, P885, DOI 10.1016/S0002-9149(98)01067-4; Zuo L, 2015, ACTA PHYSIOL, V213, P700, DOI 10.1111/apha.12410	57	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2018	13	9							e0203347	10.1371/journal.pone.0203347	http://dx.doi.org/10.1371/journal.pone.0203347			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU9BO	30252845	Green Published, Green Submitted, gold			2022-12-26	WOS:000445639700006
J	Kim, WK; Kim, BJ; Ryu, IH; Kim, JK; Kim, SW				Kim, Wook Kyum; Kim, Bong Jun; Ryu, Ik-Hee; Kim, Jin Kook; Kim, Sun Woong			Corneal epithelial and stromal thickness changes in myopic orthokeratology and their relationship with refractive change	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; OVERNIGHT ORTHOKERATOLOGY; LENS WEAR; EYES; ABERRATIONS; LASIK	Purpose To investigate topographic changes in corneal epithelial thickness (CET) and stromal thickness following orthokeratology (OK) and to determine associated factors affecting refractive changes. Methods This study investigated the topographic changes in CET and stromal thickness in 60 myopic eyes that were fitted with OK lenses. CET and stromal thickness were obtained using spectral-domain optical coherence tomography (OCT) before and after OK lens wear. Changes in refractive error and corneal topography data were obtained. The correlation between refractive change and corneal thickness change, and various refractive, lens, and topographic parameters were analyzed using simple regression analysis. Results Mean refractive error changed by 1.75 +/- 0.79 diopters (D). The mean CET of the center zone (2 mm in diameter), paracenter (2 to 5 mm annular ring: 1 to 2.5 mm from center), and mid-periphery (5 to 6 mm annular ring: 2.5 to 3 mm from center) changed by -8.4, -1.4, and +2.7 mu m, respectively, after OK lens wear. There was an increase of 2.0, 3.3, and 3.9 mu m, respectively, in the center, paracenter, and mid-periphery of the stroma. A larger refractive correction was associated with a flatter base curve of the lens, larger decrease in the central epithelium, and smaller treatment diameter in corneal topography. Conclusion OK lenses caused the central corneal epithelium to thin while the mid-peripheral epithelium and stroma became thicker. Refractive changes during OK are associated with changes in central epithelial thickness, while stromal changes did not contribute significantly.	[Kim, Wook Kyum; Ryu, Ik-Hee; Kim, Jin Kook] B & VIIT Eye Ctr, Seoul, South Korea; [Kim, Bong Jun; Kim, Sun Woong] Yonsei Univ, Dept Ophthalmol, Wonju Coll Med, Wonju, Gangwon Do, South Korea	Yonsei University	Kim, SW (corresponding author), Yonsei Univ, Dept Ophthalmol, Wonju Coll Med, Wonju, Gangwon Do, South Korea.	eyedockim@yonsei.ac.kr						Alharbi A, 2005, INVEST OPHTH VIS SCI, V46, P2334, DOI 10.1167/iovs.04-1162; Alharbi A, 2003, INVEST OPHTH VIS SCI, V44, P2518, DOI 10.1167/iovs.02-0680; Chen CN, 2013, INVEST OPHTH VIS SCI, V54, P6510, DOI 10.1167/iovs.13-12527; Cho P, 2012, INVEST OPHTH VIS SCI, V53, P7077, DOI 10.1167/iovs.12-10565; Choo Jennifer D, 2008, Cont Lens Anterior Eye, V31, P29, DOI 10.1016/j.clae.2007.07.002; Hiraoka T, 2005, AM J OPHTHALMOL, V139, P429, DOI 10.1016/j.ajo.2004.10.006; Hiraoka T, 2012, INVEST OPHTH VIS SCI, V53, P3913, DOI 10.1167/iovs.11-8453; Hiraoka T, 2009, J CATARACT REFR SURG, V35, P1918, DOI 10.1016/j.jcrs.2009.06.018; Kakita T, 2011, INVEST OPHTH VIS SCI, V52, P2170, DOI 10.1167/iovs.10-5485; Kanellopoulos AJ, 2013, CORNEA, V32, P1493, DOI 10.1097/ICO.0b013e3182a15cee; Kim BJ, 2016, CORNEA, V35, P1078, DOI 10.1097/ICO.0000000000000850; Li F, 2016, EYE CONTACT LENS, V42, P141, DOI 10.1097/ICL.0000000000000132; Li Y, 2012, OPHTHALMOLOGY, V119, P2425, DOI 10.1016/j.ophtha.2012.06.023; Lian Y, 2013, INVEST OPHTH VIS SCI, V54, P691, DOI 10.1167/iovs.12-10263; Liu YM, 2016, EYE CONTACT LENS, V42, P35, DOI 10.1097/ICL.0000000000000219; Ma XJ, 2013, CORNEA, V32, P1544, DOI 10.1097/ICO.0b013e3182a7f39d; Maseedupally V, 2013, OPTOMETRY VISION SCI, V90, P1249, DOI 10.1097/OPX.0000000000000039; MUNNERLYN CR, 1988, J CATARACT REFR SURG, V14, P46, DOI 10.1016/S0886-3350(88)80063-4; Nieto-Bona A, 2011, CURR EYE RES, V36, P895, DOI 10.3109/02713683.2011.593723; Nieto-Bona A, 2011, CORNEA, V30, P646, DOI 10.1097/ICO.0b013e31820009bc; Ryu IH, 2017, J REFRACT SURG, V33, P250, DOI 10.3928/1081597X-20170111-01; Swarbrick HA, 1998, OPTOMETRY VISION SCI, V75, P791, DOI 10.1097/00006324-199811000-00019; Swarbrick Helen A, 2004, Eye Contact Lens, V30, P181, DOI 10.1097/01.ICL.0000140221.41806.6E; Wang JH, 2003, INVEST OPHTH VIS SCI, V44, P4742, DOI 10.1167/iovs.03-0239	24	23	26	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2018	13	9							e0203652	10.1371/journal.pone.0203652	http://dx.doi.org/10.1371/journal.pone.0203652			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU9BO	30252857	gold, Green Submitted, Green Published			2022-12-26	WOS:000445639700010
J	Gao, XL; Abdelkarim, H; Albee, LJ; Volkman, BF; Gaponenko, V; Majetschak, M				Gao, Xianlong; Abdelkarim, Hazem; Albee, Lauren J.; Volkman, Brian F.; Gaponenko, Vadim; Majetschak, Matthias			Partial agonist activity of alpha(1)-adrenergic receptor antagonists for chemokine (C-X-C motif) receptor 4 and atypical chemokine receptor 3	PLOS ONE			English	Article							PROSTATE-CANCER INCIDENCE; ALPHA-1-ADRENOCEPTOR ANTAGONISTS; BETA-ARRESTIN; BLADDER-CANCER; CXCR7; PATHOGENESIS; ACTIVATION; REDUCTION; PRAZOSIN; LIGAND	We observed in PRESTO-Tango beta-arrestin recruitment assays that the alpha(1)-adrenergic receptor (AR) antagonist prazosin activates chemokine (C-X-C motif) receptor (CXCR)4. This prompted us to further examine this unexpected pharmacological behavior. We screened a panel of 14 alpha(1/2)- and beta(1/2/3)-AR antagonists for CXCR4 and atypical chemokine receptor (ACKR)3 agonist activity in PRESTO-Tango assays against the cognate agonist CXCL12. We observed that multiple alpha(1)-AR antagonists activate CXCR4 (CXCL12 = prazosin = cyclazosin > doxazosin) and ACKR3 (CXCL12 = prazosin = cyclazosin > alfuzosin = doxazosin = phentolamine > terazosin = silodosin = tamsulosin). The two strongest CXCR4/ACKR3 activators, prazosin and cyclazosin, were selected for a more detailed evaluation. We found that the drugs dose-dependently activate both receptors in beta-arrestin recruitment assays, stimulate ERK1/2 phosphorylation in HEK293 cells overexpressing each receptor, and that their effects on CXCR4 could be inhibited with AMD3100. Both alpha(1)-AR antagonists induced significant chemical shift changes in the (HC)-H-1-C-13-heteronuclear single quantum correlation spectrum of CXCR4 and ACKR3 in membranes, suggesting receptor binding. Furthermore, prazosin and cyclazosin induced internalization of endogenous CXCR4/ACKR3 in human vascular smooth muscle cells (hVSMC). While these drugs did not in induce chemotaxis in hVSMC, they inhibited CXCL12-induced chemotaxis with high efficacy and potency (IC50: prazosin-4.5 nM, cyclazosin 11.6 pM). Our findings reveal unexpected pharmacological properties of prazosin, cyclazosin, and likely other alpha(1)-AR antagonists. The results of the present study imply that prazosin and cyclazosin are biased or partial CXCR4/ACKR3 agonists, which function as potent CXCL12 antagonists. Our findings could provide a mechanistic basis for previously observed anti-cancer properties of alpha(1)-AR antagonists and support the concept that prazosin could be re-purposed for the treatment of disease processes in which CXCR4 and ACKR3 are thought to play significant pathophysiological roles, such as cancer metastases or various autoimmune pathologies.	[Gao, Xianlong; Majetschak, Matthias] Univ S Florida, Morsani Coll Med, Dept Surg, Tampa, FL 33620 USA; [Abdelkarim, Hazem; Gaponenko, Vadim] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL USA; [Albee, Lauren J.] Loyola Univ, Chicago Stritch Sch Med, Dept Surg, Burn & Shock Trauma Res Inst, Maywood, IL 60153 USA; [Volkman, Brian F.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA	State University System of Florida; University of South Florida; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Loyola University Chicago; Medical College of Wisconsin	Majetschak, M (corresponding author), Univ S Florida, Morsani Coll Med, Dept Surg, Tampa, FL 33620 USA.	majetschak@health.usf.edu	Volkman, Brian F./ABE-7312-2020; Volkman, Brian F./ABE-7306-2020; Gaponenko, Vadim/K-9729-2019	Volkman, Brian F./0000-0002-6681-5179; Volkman, Brian F./0000-0002-6681-5179; Gaponenko, Vadim/0000-0002-7891-9223	National Institute of General Medical Sciences of the National Institutes of Health [R01GM107495]; National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health [R21AA025750]; NATIONAL CANCER INSTITUTE [R01CA135341, R01CA188427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107495] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number R01GM107495 and by the National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health under Award Number R21AA025750. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abraham SJ, 2009, J BIOMOL NMR, V43, P239, DOI 10.1007/s10858-009-9306-2; Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Albee LJ, 2018, OPEN BIOL, V8, DOI 10.1098/rsob.170207; Albee LJ, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006575; Batty M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081339; Benning CM, 2002, CANCER RES, V62, P597; Bilbro J, 2013, ANTICANCER RES, V33, P4695; Busillo JM, 2007, BBA-BIOMEMBRANES, V1768, P952, DOI 10.1016/j.bbamem.2006.11.002; Chapman N, 2010, J HYPERTENS, V28, P1796, DOI 10.1097/HJH.0b013e32833b912c; Cheng YH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187949; COFFMAN JD, 1990, CARDIOVASC DRUG THER, V4, P45, DOI 10.1007/BF00053426; Debnath B, 2013, THERANOSTICS, V3, P47, DOI 10.7150/thno.5376; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eby JM, 2017, MOL CELL BIOCHEM, V434, P143, DOI 10.1007/s11010-017-3044-7; Evans AE, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060971; Forbes A, 2016, PROSTATE, V76, P757, DOI 10.1002/pros.23167; Gao XL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21096-4; Goupil E, 2015, J BIOL CHEM, V290, P3137, DOI 10.1074/jbc.M114.631119; Gravel S, 2010, J BIOL CHEM, V285, P37939, DOI 10.1074/jbc.C110.147470; Harris AM, 2007, J UROLOGY, V178, P2176, DOI 10.1016/j.juro.2007.06.043; Kalatskaya I, 2009, MOL PHARMACOL, V75, P1240, DOI 10.1124/mol.108.053389; Kroeze WK, 2015, NAT STRUCT MOL BIOL, V22, P362, DOI 10.1038/nsmb.3014; Kufareva I, 2014, P NATL ACAD SCI USA, V111, pE5363, DOI 10.1073/pnas.1417037111; LAROCHELLE P, 1982, HYPERTENSION, V4, P93, DOI 10.1161/01.HYP.4.1.93; Martin FM, 2008, GENE THER MOL BIOL, V12B, P253; Nazari A, 2017, INT J CLIN ONCOL, V22, P991, DOI 10.1007/s10147-017-1187-x; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Raskind MA, 2018, NEW ENGL J MED, V378, P507, DOI 10.1056/NEJMoa1507598; Saha A, 2017, CANCER RES, V77, P5158, DOI [10.1158/0008-5472.CAN-17-0284, 10.1158/0008-5472.can-17-0284]; Saini V, 2011, J BIOL CHEM, V286, P33466, DOI 10.1074/jbc.M111.233742; Saini V, 2010, J BIOL CHEM, V285, P15566, DOI 10.1074/jbc.M110.103408; Scala S, 2015, CLIN CANCER RES, V21, P4278, DOI 10.1158/1078-0432.CCR-14-0914; Tripathi A, 2015, P NATL ACAD SCI USA, V112, pE1659, DOI 10.1073/pnas.1417564112; Wang JH, 2008, J BIOL CHEM, V283, P4283, DOI 10.1074/jbc.M707465200; Yamada D, 2013, INT J UROL, V20, P1220, DOI 10.1111/iju.12156; Yoshiki H, 2014, BRIT J PHARMACOL, V171, P4890, DOI 10.1111/bph.12813	36	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2018	13	9							e0204041	10.1371/journal.pone.0204041	http://dx.doi.org/10.1371/journal.pone.0204041			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3MI	30248140	Green Submitted, gold, Green Published			2022-12-26	WOS:000445998100021
J	Ioannou, CC; Madirolas, G; Brammer, FS; Rapley, HA; de Polavieja, GG				Ioannou, Christos C.; Madirolas, Gabriel; Brammer, Faith S.; Rapley, Hannah A.; de Polavieja, Gonzalo G.			Adolescents show collective intelligence which can be driven by a geometric mean rule of thumb	PLOS ONE			English	Article							GROUP-PERFORMANCE; DECISION-MAKING; REPRESENTATIONS; JUDGMENT	How effective groups are in making decisions is a long-standing question in studying human and animal behaviour. Despite the limited social and cognitive abilities of younger people, skills which are often required for collective intelligence, studies of group performance have been limited to adults. Using a simple task of estimating the number of sweets in jars, we show in two experiments that adolescents at least as young as 11 years old improve their estimation accuracy after a period of group discussion, demonstrating collective intelligence. Although this effect was robust to the overall distribution of initial estimates, when the task generated positively skewed estimates, the geometric mean of initial estimates gave the best fit to the data compared to other tested aggregation rules. A geometric mean heuristic in consensus decision making is also likely to apply to adults, as it provides a robust and well-performing rule for aggregating different opinions. The geometric mean rule is likely to be based on an intuitive logarithmic-like number representation, and our study suggests that this mental number scaling may be beneficial in collective decisions.	[Ioannou, Christos C.] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Madirolas, Gabriel] CSIC, Inst Cajal, Madrid, Spain; [Madirolas, Gabriel; de Polavieja, Gonzalo G.] Champalimaud Ctr Unknown, Champalimaud Res, Lisbon, Portugal; [Brammer, Faith S.; Rapley, Hannah A.] Univ Bath, Dept Psychol, Bath, Avon, England	University of Bristol; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); Fundacao Champalimaud; University of Bath	Ioannou, CC (corresponding author), Univ Bristol, Sch Biol Sci, Bristol, Avon, England.	c.cioannou@bristol.ac.uk	Madirolas, Gabriel/AAB-1998-2021; Madirolas, Gabriel/AAA-3753-2021	Madirolas, Gabriel/0000-0002-4526-4507; Ioannou, Christos/0000-0002-9739-889X	NERC [NE/K009370/1]; Fundacao para a Ciencia e Tecnologia [PTDC/NEU-SCC/0948/2014]; Champalimaud Foundation;  [BFU2013-49512-EXP];  [BFU2012-33448];  [BES-2013-33448]; NERC [NE/P012639/1] Funding Source: UKRI	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Champalimaud Foundation; ; ; ; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	CCI was supported by a NERC Independent Research Fellowship NE/K009370/1, and GGP by BFU2013-49512-EXP, BFU2012-33448 (with predoctoral contract BES-2013-33448 to GM), Fundacao para a Ciencia e Tecnologia PTDC/NEU-SCC/0948/2014 and Champalimaud Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Choudhury S, 2006, SOC COGN AFFECT NEUR, V1, P165, DOI 10.1093/scan/nsl024; Cohen DJ, 2014, DEV PSYCHOL, V50, P1640, DOI 10.1037/a0035901; Dehaene S, 1998, TRENDS NEUROSCI, V21, P355, DOI 10.1016/S0166-2236(98)01263-6; Engel D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115212; FRENCH DC, 1977, J EXP CHILD PSYCHOL, V24, P1, DOI 10.1016/0022-0965(77)90015-7; GIGLIOTTI RJ, 1988, SMALL GROUP BEHAV, V19, P273, DOI 10.1177/104649648801900207; Hastie R, 2005, PSYCHOL REV, V112, P494, DOI 10.1037/0033-295X.112.2.494; Hoffman AC, 2016, TOB CONTROL, V25, pii32, DOI 10.1136/tobaccocontrol-2016-053192; Inhelder B, 1958, GROWTH LOGICAL THINK; Ioannou CC, 2017, BEHAV PROCESS, V141, P141, DOI 10.1016/j.beproc.2016.10.005; Kao AB, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2018.0130; Kerr NL, 2004, ANNU REV PSYCHOL, V55, P623, DOI 10.1146/annurev.psych.55.090902.142009; Krause S, 2011, ANIM BEHAV, V81, P941, DOI 10.1016/j.anbehav.2010.12.018; Kutnick P, 2008, LEARN INSTR, V18, P83, DOI 10.1016/j.learninstruc.2006.12.002; Laan A, 2017, FRONT ROBOT AI, V4, DOI 10.3389/frobt.2017.00056; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; Lorenz J, 2011, P NATL ACAD SCI USA, V108, P9020, DOI 10.1073/pnas.1008636108; Madirolas G, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004594; Minson JA, 2012, PSYCHOL SCI, V23, P219, DOI 10.1177/0956797611429132; North A.C., 2000, EDUC PSYCHOL-US, V20, P389, DOI [10.1080/01443410020016635, DOI 10.1080/01443410020016635]; PIAGET J, 1972, HUM DEV, V15, P1, DOI 10.1159/000271225; Recchia HE, 2010, SOC DEV, V19, P838, DOI 10.1111/j.1467-9507.2009.00567.x; Siegler RS, 2003, PSYCHOL SCI, V14, P237, DOI 10.1111/1467-9280.02438; SLAVIN RE, 1980, REV EDUC RES, V50, P315, DOI 10.3102/00346543050002315; Smith MK, 2009, SCIENCE, V323, P122, DOI 10.1126/science.1165919; SNIEZEK JA, 1989, ORGAN BEHAV HUM DEC, V43, P1, DOI 10.1016/0749-5978(89)90055-1; Soll JB, 2009, J EXP PSYCHOL LEARN, V35, P780, DOI 10.1037/a0015145; Steinberg L, 2005, TRENDS COGN SCI, V9, P69, DOI 10.1016/j.tics.2004.12.005; Toyokawa W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095789; Woolley AW, 2010, SCIENCE, V330, P686, DOI 10.1126/science.1193147	31	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2018	13	9							e0204462	10.1371/journal.pone.0204462	http://dx.doi.org/10.1371/journal.pone.0204462			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV3MI	30248154	Green Submitted, Green Published, gold			2022-12-26	WOS:000445998100043
J	van Gemst, JJ; Kouwenberg, M; Rops, ALWMM; van Kuppevelt, TH; Berden, JH; Rabelink, TJ; Loeven, MA; van der Vlag, J				van Gemst, J. J.; Kouwenberg, M.; Rops, A. L. W. M. M.; van Kuppevelt, T. H.; Berden, J. H.; Rabelink, T. J.; Loeven, M. A.; van der Vlag, J.			Differential binding of chemokines CXCL1, CXCL2 and CCL2 to mouse glomerular endothelial cells reveals specificity for distinct heparan sulfate domains	PLOS ONE			English	Article							GLYCOSAMINOGLYCANS; PROTEOGLYCANS; MURINE; OLIGOMERIZATION; GLOMERULONEPHRITIS; MODULATION; EXPRESSION; ANTIBODIES; KC	Introduction Proliferative glomerulonephritis manifests in a range of renal diseases and is characterized by the influx of inflammatory cells into the glomerulus. Heparan sulfate (HS) is an important (co-)receptor for binding of chemokines, cytokines and leukocytes to the endothelial glycocalyx, a thick glycan layer that covers the inside of blood vessels. During glomerulonephritis, HS in the glomerular endothelial glycocalyx plays a central role in chemokine presentation and oligomerization, and in binding of selectins and integrins expressed by leukocytes. We hypothesize that distinct endothelial HS domains determine the binding of different chemokines. In this study we evaluated the interaction of three pro-inflammatory chemokines (CXCL1, CXCL2 and CCL2) with mouse glomerular endothelial cells (mGEnC-1) in ELISA in competition with different HS preparations and anti-HS single chain variable fragment (scFv) antibodies specific for distinct HS domains. Results HS appeared to be the primary ligand mediating chemokine binding to the glomerular endothelial glycocalyx in vitro. We found differential affinities of CXCL1, CXCL2 and CCL2 for HS in isolated mGEnC-1 glycocalyx, heparan sulfate from bovine kidney or low molecular weight heparin in competition ELISAs using mGEnC-1 as a substrate, indicating that chemokine binding is affected by the domain structure of the different HS preparations. Blocking of specific HS domains with anti-HS scFv antibodies revealed a domain-specific interaction of the tested chemokines to HS on mGEnC-1. Furthermore, chemokines did not compete for the same binding sites on mGEnC-1. Conclusion CXCL1, CXCL2 and CCL2 binding to the glomerular endothelial glycocalyx appears differentially mediated by specific HS domains. Our findings may therefore contribute to the development of HS-based treatments for renal and possibly other inflammatory diseases specifically targeting chemokine-endothelial cell interactions.	[van Gemst, J. J.; Kouwenberg, M.; Rops, A. L. W. M. M.; Berden, J. H.; Loeven, M. A.; van der Vlag, J.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Nephrol, Nijmegen, Netherlands; [van Kuppevelt, T. H.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Biochem, Nijmegen, Netherlands; [Rabelink, T. J.] Leiden Univ, Dept Nephrol, Med Ctr, Leiden, Netherlands; [Rabelink, T. J.] Leiden Univ, Einthoven Lab Vasc Med, Med Ctr, Leiden, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van der Vlag, J (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Nephrol, Nijmegen, Netherlands.	Johan.vanderVlag@radboudumc.nl	Rabelink, Ton J./A-5316-2008; Kouwenberg, Margreet/P-8827-2015; Van der Vlag, Johan/E-4636-2010	Rabelink, Ton J./0000-0001-6780-5186; Kouwenberg, Margreet/0000-0003-1992-920X; Van der Vlag, Johan/0000-0001-7843-5918; Berden, Jo/0000-0002-3562-9445	Dutch Kidney Foundation [CP 09.03, LSHM16058-SGF]; PPP Allowance; Radboud university medical center; NWO ZonMw AGIKO [92003567]	Dutch Kidney Foundation; PPP Allowance; Radboud university medical center; NWO ZonMw AGIKO	This study was supported by the Dutch Kidney Foundation, consortium grant CP 09.03 (GLYCOREN), consortium grant LSHM16058-SGF (GLYCOTREAT), a collaboration project financed by the PPP Allowance made available by Top Sector Life Sciences & Health to the Dutch Kidney Foundation to stimulate public-private partnerships, the Radboud university medical center (PhD project grant) and NWO ZonMw AGIKO 92003567.	Besbas N, 2004, PEDIATR NEPHROL, V19, P864, DOI 10.1007/s00467-004-1522-0; BOZIC CR, 1994, J BIOL CHEM, V269, P29355; Brown HJ, 2007, J AM SOC NEPHROL, V18, P1732, DOI 10.1681/ASN.2006060634; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; Call DR, 2001, SHOCK, V15, P278, DOI 10.1097/00024382-200115040-00005; Couser WG, 1998, NEPHROL DIAL TRANSPL, V13, P10, DOI 10.1093/ndt/13.suppl_1.10; Couser WG, 1999, LANCET, V353, P1509, DOI 10.1016/S0140-6736(98)06195-9; Dennissen MABA, 2002, J BIOL CHEM, V277, P10982, DOI 10.1074/jbc.M104852200; Elhadj S, 2002, J CELL BIOCHEM, V86, P239, DOI 10.1002/jcb.10226; Ellyard JI, 2007, J BIOL CHEM, V282, P15238, DOI 10.1074/jbc.M608046200; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Handel TM, 2005, ANNU REV BIOCHEM, V74, P385, DOI 10.1146/annurev.biochem.72.121801.161747; Heinzelmann M, 1999, AM J KIDNEY DIS, V34, P384, DOI 10.1016/S0272-6386(99)70375-6; Hoogewerf AJ, 1997, BIOCHEMISTRY-US, V36, P13570, DOI 10.1021/bi971125s; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; Johnson Z, 2005, CYTOKINE GROWTH F R, V16, P625, DOI 10.1016/j.cytogfr.2005.04.006; Johnson Z, 2004, J IMMUNOL, V173, P5776, DOI 10.4049/jimmunol.173.9.5776; Kuschert GSV, 1999, BIOCHEMISTRY-US, V38, P12959, DOI 10.1021/bi990711d; Li S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104107; Li S, 2010, J LEUKOCYTE BIOL, V88, P1017, DOI 10.1189/jlb.1109724; Massena S, 2010, BLOOD, V116, P1924, DOI 10.1182/blood-2010-01-266072; OQUENDO P, 1989, J BIOL CHEM, V264, P4133; Parish CR, 2006, NAT REV IMMUNOL, V6, P633, DOI 10.1038/nri1918; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Rops AL, 2008, KIDNEY INT, V73, P52, DOI 10.1038/sj.ki.5002573; Rops AL, 2007, KIDNEY INT, V72, P1204, DOI 10.1038/sj.ki.5002514; Rops AL, 2004, KIDNEY INT, V66, P2193, DOI 10.1111/j.1523-1755.2004.66009.x; Rops ALWMM, 2004, KIDNEY INT, V65, P768, DOI 10.1111/j.1523-1755.2004.00451.x; Rops AL, 2007, NEPHROL DIAL TRANSPL, V22, P1891, DOI 10.1093/ndt/gfm194; Rops AL, 2007, NEPHROL DIAL TRANSPL, V22, P1070, DOI 10.1093/ndt/gfl801; Rops ALWMM, 2014, KIDNEY INT, V86, P932, DOI 10.1038/ki.2014.115; Stasikowska O, 2007, MED SCI MONITOR, V13, pRA31; Taylor KR, 2006, FASEB J, V20, P9, DOI 10.1096/fj.05-4682rev; TEKAMPOLSON P, 1990, J EXP MED, V172, P911, DOI 10.1084/jem.172.3.911; Thompson R, 2011, ANAL BIOCHEM, V413, P114, DOI 10.1016/j.ab.2011.02.013; van de Westerlo EMA, 2002, BLOOD, V99, P2427, DOI 10.1182/blood.V99.7.2427; van Gemst JJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167336; van Kuppevelt TH, 1998, J BIOL CHEM, V273, P12960, DOI 10.1074/jbc.273.21.12960; Wagner L, 1998, NATURE, V391, P908, DOI 10.1038/36129; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Wijnhoven TJM, 2006, AM J KIDNEY DIS, V48, P250, DOI 10.1053/j.ajkd.2006.05.003; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	42	11	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2018	13	9							e0201560	10.1371/journal.pone.0201560	http://dx.doi.org/10.1371/journal.pone.0201560			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3MI	30248108	Green Published, gold			2022-12-26	WOS:000445998100004
J	Sbrissa, D; Naisan, G; Ikonomov, OC; Shisheva, A				Sbrissa, Diego; Naisan, Ghassan; Ikonomov, Ognian C.; Shisheva, Assia			Apilimod, a candidate anticancer therapeutic, arrests not only PtdIns(3,5)P-2 but also PtdIns5P synthesis by PIKfyve and induces bafilomycin A1-reversible aberrant endomembrane dilation	PLOS ONE			English	Article							FACTOR RECEPTOR TRAFFICKING; IL-12/IL-23 INHIBITOR; H+-ATPASE; PHOSPHATIDYLINOSITOL 3-PHOSPHATE; DEGRADATIVE PATHWAY; MAMMALIAN ORTHOLOG; PHOSPHATE KINASE; CELL MORPHOLOGY; EARLY ENDOSOMES; PLANT-CELLS	PIKfyve, an evolutionarily conserved kinase synthesizing PtdIns5P and PtdIns(3,5)P-2, is crucial for mammalian cell proliferation and viability. Accordingly, PIKfyve inhibitors are now in clinical trials as anti-cancer drugs. Among those, apilimod is the most promising, yet its potency to inhibit PIKfyve and affect endomembrane homeostasis is only partially characterized. We demonstrate here for the first time that apilimod powerfully inhibited in vitro synthesis of PtdIns5P along with that of PtdIns(3,5)P-2. HPLC-based resolution of intracellular phosphoinositides (Pis) revealed that apilimod triggered a marked reduction of both lipids in the context of intact cells. Notably, there was also a profound rise in PtdIns3P resulting from arrested PtdIns3P consumption for PtdIns(3,5)P-2 synthesis. As typical for PIKfyve inhibition and the concomitant PtdIns(3,5)P-2 reduction, apilimod induced the appearance of dilated endomembrane structures in the form of large translucent cytoplasmic vacuoles. Remarkably, bafilomycin A1 (BafA1) fully reversed the aberrant cell phenotype back to normal and completely precluded the appearance of cytoplasmic vacuoles when added prior to apilimod. Inspection of the PI profiles ruled out restoration of the reduced PtdIns(3,5)P-2 pool as a molecular mechanism underlying BafA1 rescue. Rather, we found that BafA1 markedly attenuated the PtdIns3P elevation under PIKfyve inhibition. This was accompanied by profoundly decreased endosomal recruitment of fusogenic EEA1. Together, our data demonstrate that apilimod inhibits not only PtdIns(3,5)P-2 but also PtdIns5P synthesis and that the cytoplasmic vacuolization triggered by the inhibitor is precluded or reversed by BafA1 through a mechanism associated, in part, with reduction in both PtdIns3P levels and EEA1 membrane recruitment.	[Sbrissa, Diego; Naisan, Ghassan; Ikonomov, Ognian C.; Shisheva, Assia] Wayne State Univ, Dept Psychol, Sch Med, 71 W Warren Ave, Detroit, MI 48202 USA; [Naisan, Ghassan] Univ West Virginia, Sch Osteopath Med, Lewisburg, WV USA	Wayne State University	Shisheva, A (corresponding author), Wayne State Univ, Dept Psychol, Sch Med, 71 W Warren Ave, Detroit, MI 48202 USA.	ashishev@med.wayne.edu		Shisheva, Assia/0000-0002-9148-5255	Department of Defense [W81XWH-17-1-0060]; American Diabetes Association [BS-13-161]; National Institutes of Health [DK58058]	Department of Defense(United States Department of Defense); American Diabetes Association(American Diabetes Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was supported by the following: AS, W81XWH-17-1-0060, Department of Defense, https://www.defense.gov; AS, BS-13-161, American Diabetes Association, http://www.diabetes.org; and AS, DK58058, National Institutes of Health, https://www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backer JM, 2008, BIOCHEM J, V410, P1, DOI 10.1042/BJ20071427; Baird AM, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00162; Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; Billich A, 2007, IDRUGS, V10, P53; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Cai XM, 2013, CHEM BIOL, V20, P912, DOI 10.1016/j.chembiol.2013.05.010; Cao CH, 2008, MOL BIOL CELL, V19, P3334, DOI 10.1091/mbc.E08-04-0367; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Compton LM, 2016, AM J PHYSIOL-CELL PH, V311, pC366, DOI 10.1152/ajpcell.00104.2016; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; DROBAK BK, 1988, PLANT PHYSIOL, V87, P217, DOI 10.1104/pp.87.1.217; Fogarty K, 2017, ASSAY DRUG DEV TECHN, V15, P210, DOI 10.1089/adt.2017.790; Gayle S, 2017, BLOOD, V129, P1768, DOI 10.1182/blood-2016-09-736892; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Hammond GR, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a027938; Hammond TG, 1998, J MEMBRANE BIOL, V162, P157, DOI 10.1007/s002329900353; Harb W., 2017, PATIENTS RELAPSED RE; Hayakawa N, 2014, BIOORGAN MED CHEM, V22, P3021, DOI 10.1016/j.bmc.2014.03.036; Ho CY, 2015, J BIOL CHEM, V290, P9919, DOI 10.1074/jbc.M114.613984; Ho CY, 2012, TRAFFIC, V13, P1, DOI 10.1111/j.1600-0854.2011.01246.x; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; Ikonomov OC, 2003, MOL BIOL CELL, V14, P4581, DOI 10.1091/mbc.E03-04-0222; Ikonomov OC, 2002, J BIOL CHEM, V277, P9206, DOI 10.1074/jbc.M108750200; Ikonomov OC, 2001, J BIOL CHEM, V276, P26141, DOI 10.1074/jbc.M101722200; Ikonomov OC, 2006, AM J PHYSIOL-CELL PH, V291, pC393, DOI 10.1152/ajpcell.00019.2006; Ikonomov OC, 2015, BBA-MOL CELL RES, V1853, P1240, DOI 10.1016/j.bbamcr.2015.01.008; Ikonomov OC, 2011, J BIOL CHEM, V286, P13404, DOI 10.1074/jbc.M111.222364; Ikonomov OC, 2009, J BIOL CHEM, V284, P35794, DOI 10.1074/jbc.M109.037515; Ikonomov OC, 2009, BIOCHEM BIOPH RES CO, V382, P566, DOI 10.1016/j.bbrc.2009.03.063; Jefferies HBJ, 2008, EMBO REP, V9, P164, DOI 10.1038/sj.embor.7401155; Kim J, 2007, CANCER RES, V67, P9229, DOI 10.1158/0008-5472.CAN-07-1333; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Krausz S, 2012, ARTHRITIS RHEUM-US, V64, P1750, DOI 10.1002/art.34339; Krishna S, 2016, DEV CELL, V38, P536, DOI 10.1016/j.devcel.2016.08.001; Lawe DC, 2002, J BIOL CHEM, V277, P8611, DOI 10.1074/jbc.M109239200; Maltese WA, 2014, AM J PATHOL, V184, P1630, DOI 10.1016/j.ajpath.2014.02.028; Marceau F, 2012, TOXICOL APPL PHARM, V259, P1, DOI 10.1016/j.taap.2011.12.004; Mauvezin C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8007; Maxson ME, 2014, J CELL SCI, V127, P4987, DOI 10.1242/jcs.158550; Merz AJ, 2015, P NATL ACAD SCI USA, V112, P8, DOI 10.1073/pnas.1422280112; Morris JB, 2000, FEBS LETT, V475, P57, DOI 10.1016/S0014-5793(00)01625-2; Murray DH, 2016, NATURE, V537, P107, DOI 10.1038/nature19326; Naufer A, 2018, J CELL BIOL, V217, P329, DOI 10.1083/jcb.201702179; Niebuhr K, 2002, EMBO J, V21, P5069, DOI 10.1093/emboj/cdf522; Raiborg C, 2013, FEBS J, V280, P2730, DOI 10.1111/febs.12116; Rameh LE, 1997, NATURE, V390, P192, DOI 10.1038/36621; Rutherford AC, 2006, J CELL SCI, V119, P3944, DOI 10.1242/jcs.03153; Sands BE, 2010, INFLAMM BOWEL DIS, V16, P1209, DOI 10.1002/ibd.21159; Sano O, 2016, FEBS LETT, V590, P1576, DOI 10.1002/1873-3468.12195; Sbrissa D, 2005, J BIOL CHEM, V280, P7883, DOI 10.1074/jbc.M412729200; Sbrissa D, 1999, J BIOL CHEM, V274, P21589, DOI 10.1074/jbc.274.31.21589; Sbrissa D, 2004, MOL CELL BIOL, V24, P10437, DOI 10.1128/MCB.24.23.10437-10447.2004; Sbrissa D, 2002, J BIOL CHEM, V277, P47276, DOI 10.1074/jbc.M207576200; Sbrissa D, 2007, J BIOL CHEM, V282, P23878, DOI 10.1074/jbc.M611678200; Sbrissa D, 2012, AM J PHYSIOL-CELL PH, V303, pC436, DOI 10.1152/ajpcell.00105.2012; Shah ZH, 2013, FEBS J, V280, P6295, DOI 10.1111/febs.12543; Shisheva A, 2001, CELL BIOL INT, V25, P1201, DOI 10.1006/cbir.2001.0803; Shisheva A, 1999, MOL CELL BIOL, V19, P623; Shisheva A, 2008, CELL BIOL INT, V32, P591, DOI 10.1016/j.cellbi.2008.01.006; Shisheva A, 2008, AM J PHYSIOL-ENDOC M, V295, pE536, DOI 10.1152/ajpendo.90353.2008; Shisheva A, 2015, BIOESSAYS, V37, P267, DOI 10.1002/bies.201400129; Shisheva A, 2013, ARCH BIOCHEM BIOPHYS, V538, P171, DOI 10.1016/j.abb.2013.07.023; Shisheva A, 2012, CURR TOP MICROBIOL, V362, P127, DOI 10.1007/978-94-007-5025-8_7; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Takasuga S, 2013, P NATL ACAD SCI USA, V110, P1726, DOI 10.1073/pnas.1213212110; Tronchere H, 2017, EMBO MOL MED, V9, P770, DOI 10.15252/emmm.201607096; Vicinanza M, 2015, MOL CELL, V57, P219, DOI 10.1016/j.molcel.2014.12.007; Wada Y, 2007, BLOOD, V109, P1156, DOI 10.1182/blood-2006-04-019398	68	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2018	13	9							e0204532	10.1371/journal.pone.0204532	http://dx.doi.org/10.1371/journal.pone.0204532			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU5MM	30240452	Green Submitted, Green Published, gold			2022-12-26	WOS:000445329700060
J	Hu, Y; French, SW; Chau, T; Liu, HX; Sheng, LL; Wei, F; Stondell, J; Garcia, JC; Du, YL; Bowlus, CL; Wan, YJY				Hu, Ying; French, Samuel W.; Chau, Thinh; Liu, Hui-Xin; Sheng, Lili; Wei, Fang; Stondell, Jesse; Garcia, Juan C.; Du, Yanlei; Bowlus, Christopher L.; Wan, Yu-Jui Yvonne			RAR acts as both an upstream regulator and downstream effector of miR-22, which epigenetically regulates NUR77 to induce apoptosis of colon cancer cells	FASEB JOURNAL			English	Article						nuclear receptor; protein deacetylase; butyrate; propionate; short-chain fatty acid	ORPHAN RECEPTOR TR3; BILE-ACID; RETINOIC ACID; HEPATOCELLULAR-CARCINOMA; HISTONE DEACETYLASE-1; NUCLEAR EXPORT; VITAMIN-D; PROLIFERATION; EXPRESSION; MICRORNA-22	This study investigates the mechanism and consequences of microRNA-22 (miR-22) induction. Our data revealed for the first time that retinoic acid (RA) and histone deacetylase (HDAC) inhibitors, including short-chain fatty acids and suberanilohydroxamic acid (SAHA), could individually or in combination induce miR-22. This induction was mediated via RA receptor (RAR) binding to a direct repeat 5 (DR5) motif. In addition, we uncovered HDAC1 as a novel miR-22 target. In an miR-22-dependent manner, HDAC inhibitors and RA reduced HDAC1, HDAC4, and sirtuin 1 (SIRT1), which were involved in chromatin remodeling of the RAR and nerve growth factor IB (NUR77). Thus, HDAC inhibitors and RA-induced miR-22 resulted in simultaneous induction of cytoplasmic RAR and NUR77, leading to apoptosis of colon cancer cells. In mice, miR-22 and its inducers inhibited the growth of xenograft colon cancer. Moreover, tumor size reduction was accompanied by elevated miR-22, NUR77, and RAR and by reduced HDACs. In human colon polyps and adenocarcinomas, miR-22 and RAR were consistently reduced, which was associated with elevated HDAC1, HDAC4, and SIRT1 in colon adenocarcinomas. Results from this study revealed a novel anticancer mechanism of RAR viamiR-22 induction to epigenetically regulate itself and NUR77, providing a promising cancer treatment modality using miR-22 and its inducers.Hu, Y., French, S. W., Chau, T., Liu, H.-X., Sheng, L., Wei, F., Stondell, J., Garcia, J. C., Du, Y., Bowlus, C. L., Wan, Y.-J. Y. RAR acts as both an upstream regulator and downstream effector of miR-22, which epigenetically regulates NUR77 to induce apoptosis of colon cancer cells.	[Hu, Ying; Chau, Thinh; Liu, Hui-Xin; Sheng, Lili; Wan, Yu-Jui Yvonne] Univ Calif, Davis Hlth Syst, Dept Med Pathol & Lab Med, Room 3400B,4645 Second Ave,Res Bldg 3, Sacramento, CA 95817 USA; [Stondell, Jesse; Garcia, Juan C.; Bowlus, Christopher L.] Univ Calif, Davis Hlth Syst, Div Gastroenterol, Sacramento, CA USA; [French, Samuel W.] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA USA; [Wei, Fang; Du, Yanlei] First Municipal Peoples Hosp Guangzhou, Guangzhou Med Coll, Dept Gastroenterol & Hepatol, Guangzhou, Guangdong, Peoples R China	University of California System; University of California Los Angeles; Guangzhou Medical University; South China University of Technology	Wan, YJY (corresponding author), Univ Calif, Davis Hlth Syst, Dept Med Pathol & Lab Med, Room 3400B,4645 Second Ave,Res Bldg 3, Sacramento, CA 95817 USA.	yjywan@ucdavis.edu	; Bowlus, Christopher/N-9276-2016	Liu, Hui-Xin/0000-0002-8981-9981; Bowlus, Christopher/0000-0002-3906-6811	U.S. National Institutes of Health (NIH) National Cancer Institute [R01CA222490]; Science Translation and Innovative Research (STAIR) Grant; National Natural Science Foundation of China [81772572]; NATIONAL CANCER INSTITUTE [U01CA179582, R01CA222490] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Science Translation and Innovative Research (STAIR) Grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Dr. Prasant Kumar Jena and Nidhi Nagar (University of California, Davis Health System) for their assistance in preparation of this manuscript. This study was supported by U.S. National Institutes of Health (NIH) National Cancer Institute Grant R01CA222490 (to Y.-J.Y.W.); a Science Translation and Innovative Research (STAIR) Grant (to Y.-J.Y.W.); and National Natural Science Foundation of China Grant 81772572 (to Y.D.). The authors declare no conflicts of interest.	Alvarez-Diaz S, 2012, HUM MOL GENET, V21, P2157, DOI 10.1093/hmg/dds031; Bushue N, 2010, ADV DRUG DELIVER REV, V62, P1285, DOI 10.1016/j.addr.2010.07.003; Cao XH, 2004, MOL CELL BIOL, V24, P9705, DOI 10.1128/MCB.24.22.9705-9725.2004; Chen B, 2015, CANCER LETT, V356, P410, DOI 10.1016/j.canlet.2014.09.028; Ding L, 2015, ACTA PHARM SIN B, V5, P135, DOI 10.1016/j.apsb.2015.01.004; Dokmanovic M, 2007, MOL CANCER RES, V5, P981, DOI 10.1158/1541-7786.MCR-07-0324; Gudas LJ, 2011, J CELL PHYSIOL, V226, P322, DOI 10.1002/jcp.22417; Han YH, 2006, ONCOGENE, V25, P2974, DOI 10.1038/sj.onc.1209358; He YQ, 2014, AM J PHYSIOL-GASTR L, V307, pG205, DOI 10.1152/ajpgi.00105.2014; Hedrick E, 2017, MOL CELL BIOL, V37; Hu Y, 2015, MOL CANCER RES, V13, P281, DOI 10.1158/1541-7786.MCR-14-0230; Hu Y, 2013, BIOCHEM PHARMACOL, V85, P1007, DOI 10.1016/j.bcp.2013.01.023; Huang BH, 2005, CELL DEATH DIFFER, V12, P395, DOI 10.1038/sj.cdd.4401567; Huang ZP, 2013, CIRC RES, V112, P1234, DOI 10.1161/CIRCRESAHA.112.300682; Joyce SA, 2014, P NATL ACAD SCI USA, V111, P7421, DOI 10.1073/pnas.1323599111; Kang SA, 2010, BIOCHEM PHARMACOL, V80, P867, DOI 10.1016/j.bcp.2010.04.026; Kolluri SK, 2003, MOL CELL BIOL, V23, P8651, DOI 10.1128/MCB.23.23.8651-8667.2003; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Lee SO, 2014, MOL CANCER RES, V12, P527, DOI 10.1158/1541-7786.MCR-13-0567; Lee SO, 2010, CANCER RES, V70, P6824, DOI 10.1158/0008-5472.CAN-10-1992; Li TG, 2015, CURR OPIN GASTROEN, V31, P159, DOI 10.1097/MOG.0000000000000156; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; Ling B, 2012, J CANCER RES CLIN, V138, P1355, DOI 10.1007/s00432-012-1194-2; Lionetti M, 2009, GENE CHROMOSOME CANC, V48, P521, DOI 10.1002/gcc.20660; Liu HX, 2016, ONCOTARGET, V7, P1096, DOI 10.18632/oncotarget.6665; Maran RRM, 2009, J PHARMACOL EXP THER, V328, P469, DOI 10.1124/jpet.108.145409; Minucci S, 1997, P NATL ACAD SCI USA, V94, P11295, DOI 10.1073/pnas.94.21.11295; Modica S, 2008, CANCER RES, V68, P9589, DOI 10.1158/0008-5472.CAN-08-1791; Moll UM, 2006, ONCOGENE, V25, P4725, DOI 10.1038/sj.onc.1209601; Niu YD, 2017, HEPATOLOGY, V65, P893, DOI 10.1002/hep.28924; Pant K, 2017, REDOX BIOL, V12, P340, DOI 10.1016/j.redox.2017.03.006; Quint K, 2011, VIRCHOWS ARCH, V459, P129, DOI 10.1007/s00428-011-1103-0; Rikimaru T, 2007, ONCOLOGY-BASEL, V72, P69, DOI 10.1159/000111106; Saeed A, 2017, BBA-MOL CELL BIOL L, V1862, P496, DOI 10.1016/j.bbalip.2017.01.007; Schilderink R, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00226; Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007; Sun J, 2017, CLIN TRANSL GASTROEN, V8, DOI 10.1038/ctg.2017.31; Tang HL, 2013, CANCER LETT, V340, P72, DOI 10.1016/j.canlet.2013.06.027; Tenga A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148433; Thorne J, 2008, P NUTR SOC, V67, P115, DOI 10.1017/S0029665108006964; Touma SE, 2005, CLIN CANCER RES, V11, P3558, DOI 10.1158/1078-0432.CCR-04-1155; Tsuchiya N, 2011, CANCER RES, V71, P4628, DOI 10.1158/0008-5472.CAN-10-2475; Tsuei J, 2014, EXP BIOL MED, V239, P1489, DOI 10.1177/1535370214538743; Wang CG, 2011, J STEROID BIOCHEM, V123, P91, DOI 10.1016/j.jsbmb.2010.12.003; Wang JY, 2017, INT J ONCOL, V50, P345, DOI 10.3892/ijo.2016.3811; Wang LG, 2009, AM J TRANSL RES, V1, P62; Wu H, 2011, FASEB J, V25, P192, DOI 10.1096/fj.10-166462; Xiong J, 2010, ONCOGENE, V29, P4980, DOI 10.1038/onc.2010.241; Xiong JH, 2010, FEBS J, V277, P1684, DOI 10.1111/j.1742-4658.2010.07594.x; Yamakuchi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020291; Yang F, 2015, J BIOL CHEM, V290, P6507, DOI 10.1074/jbc.M114.620369; Yang F, 2014, BIOCHEM PHARMACOL, V91, P483, DOI 10.1016/j.bcp.2014.08.018; Yang H, 2011, BIOCHEM PHARMACOL, V81, P910, DOI 10.1016/j.bcp.2011.01.005; Yang H, 2011, HEPATOLOGY, V53, P865, DOI 10.1002/hep.24101; Yang QQ, 2015, ONCOL REP, V34, P1771, DOI 10.3892/or.2015.4167; Yao LM, 2012, CARCINOGENESIS, V33, P301, DOI 10.1093/carcin/bgr287; Zhan Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050013; Zhang J, 2010, BRIT J CANCER, V103, P1215, DOI 10.1038/sj.bjc.6605895	58	9	9	1	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2314	2326		10.1096/fj.201801390R	http://dx.doi.org/10.1096/fj.201801390R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30252536	Green Published			2022-12-26	WOS:000457296600063
J	Mafakheri, S; Florke, RR; Kanngiesser, S; Hartwig, S; Espelage, L; De Wendt, C; Schonberger, T; Hamker, N; Lehr, S; Chadt, A; Al-Hasani, H				Mafakheri, Samaneh; Floerke, Ralf R.; Kanngiesser, Sibylle; Hartwig, Sonja; Espelage, Lena; De Wendt, Christian; Schoenberger, Tina; Hamker, Nele; Lehr, Stefan; Chadt, Alexandra; Al-Hasani, Hadi			AKT and AMP-activated protein kinase regulate TBC1D1 through phosphorylation and its interaction with the cytosolic tail of insulin-regulated aminopeptidase IRAP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Type 2 diabetes; skeletal muscle; glucose transporter type 4 (GLUT4); glucose transport; insulin; Rab10; RabGAPs	MOUSE SKELETAL-MUSCLE; STIMULATED GLUT4 TRANSLOCATION; PHOSPHOTYROSINE-BINDING DOMAIN; GLUCOSE-TRANSPORT; AS160; CONTRACTION; SUBSTRATE; TRAFFICKING; ADIPOCYTES; EXERCISE	In skeletal muscle, the Rab GTPase-activating (GAP) protein TBC1D1 is phosphorylated by AKT and AMP-activated protein kinase (AMPK) in response to insulin and muscle contraction. Genetic ablation of Tbc1d1 or mutation of distinct phosphorylation sites impairs intracellular GLUT4 retention and GLUT4 traffic, presumably through alterations of the activation state of downstream Rab GTPases. Previous studies have focused on characterizing the C-terminal GAP domain of TBC1D1 that lacks the known phosphorylation sites, as well as putative regulatory domains. As a result, it has been unclear how phosphorylation of TBC1D1 would regulate its activity. In the present study, we have expressed, purified, and characterized recombinant full-length TBC1D1 in Sf9 insect cells via the baculovirus system. Full-length TBC1D1 showed RabGAP activity toward GLUT4-associated Rab8a, Rab10, and Rab14, indicating similar substrate specificity as the truncated GAP domain. However, the catalytic activity of the full-length TBC1D1 was markedly higher than that of the GAP domain. Although in vitro phosphorylation of TBC1D1 by AKT or AMPK increased 14-3-3 binding, it did not alter the intrinsic RabGAP activity. However, we found that TBC1D1 interacts through its N-terminal PTB domains with the cytoplasmic domain of the insulin-regulated aminopeptidase, a resident protein of GLUT4 storage vesicles, and this binding is disrupted by phosphorylation of TBC1D1 by AKT or AMPK. In summary, our findings suggest that other regions outside the GAP domain may contribute to the catalytic activity of TBC1D1. Moreover, our data indicate that recruitment of TBC1D1 to GLUT4-containing vesicles and not its GAP activity is regulated by insulin and contraction-mediated phosphorylation.	[Mafakheri, Samaneh; Floerke, Ralf R.; Kanngiesser, Sibylle; Hartwig, Sonja; Espelage, Lena; De Wendt, Christian; Schoenberger, Tina; Hamker, Nele; Lehr, Stefan; Chadt, Alexandra; Al-Hasani, Hadi] Heinrich Heine Univ, Med Fac, Inst Clin Biochem & Pathobiochem, German Diabet Ctr,Leibniz Ctr Diabet Res, D-40225 Dusseldorf, Germany; [Mafakheri, Samaneh; Floerke, Ralf R.; Hartwig, Sonja; Espelage, Lena; De Wendt, Christian; Lehr, Stefan; Chadt, Alexandra; Al-Hasani, Hadi] German Ctr Diabet Res DZD, D-85764 Munich, Germany	Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf	Al-Hasani, H (corresponding author), German Diabet Ctr, Inst Clin Biochem & Pathobiochem, Hennekamp 65, D-40225 Dusseldorf, Germany.	hadi.al-hasani@ddz.uni-duesseldorf.de		Eickelschulte, Samaneh/0000-0002-8040-8393	Deutsche Forschungsgemeinschaft [AL452/4, SFB1116]; EFSD/Lilly European Diabetes Research Program	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EFSD/Lilly European Diabetes Research Program	This work was supported in part by Deutsche Forschungsgemeinschaft Grants AL452/4 and SFB1116 and the EFSD/Lilly European Diabetes Research Program (to H. A.). The authors declare that they have no conflicts of interest with the contents of this article.	Al-Hasani H, 1998, J BIOL CHEM, V273, P17504, DOI 10.1074/jbc.273.28.17504; An D, 2010, DIABETES, V59, P1358, DOI 10.2337/db09-1266; Baer K, 2005, BBA-GEN SUBJECTS, V1725, P340, DOI 10.1016/j.bbagen.2005.04.002; Bruss MD, 2005, DIABETES, V54, P41, DOI 10.2337/diabetes.54.1.41; Cartee G, 2015, DIABETOLOGIA, V58, P19, DOI 10.1007/s00125-014-3395-5; Chadt A, 2008, NAT GENET, V40, P1354, DOI 10.1038/ng.244; Chen SA, 2008, BIOCHEM J, V409, P449, DOI 10.1042/BJ20071114; Chen Y, 2012, J CELL BIOL, V198, P545, DOI 10.1083/jcb.201111091; Eguez L, 2005, CELL METAB, V2, P263, DOI 10.1016/j.cmet.2005.09.005; Jessen N, 2011, AM J PHYSIOL-ENDOC M, V301, pE164, DOI 10.1152/ajpendo.00042.2011; Jordens I, 2010, MOL BIOL CELL, V21, P2034, DOI 10.1091/mbc.E10-02-0158; Kane S, 2005, BIOCHEM BIOPH RES CO, V335, P175, DOI 10.1016/j.bbrc.2005.07.056; Karunanithi S, 2014, MOL BIOL CELL, V25, P3059, DOI 10.1091/mbc.E14-06-1060; Koumanov F, 2011, J BIOL CHEM, V286, P16574, DOI 10.1074/jbc.M111.226092; Kramer HF, 2007, DIABETES, V56, P2854, DOI 10.2337/db07-0681; Larance M, 2005, J BIOL CHEM, V280, P37803, DOI 10.1074/jbc.M503897200; Mafakheri S, 2018, BIOCHEM SOC T, V46, P683, DOI 10.1042/BST20170479; Meyre D, 2008, HUM MOL GENET, V17, P1798, DOI 10.1093/hmg/ddn070; Miinea CP, 2005, BIOCHEM J, V391, P87, DOI 10.1042/BJ20050887; Pan XJ, 2006, NATURE, V442, P303, DOI 10.1038/nature04847; Park SY, 2011, J BIOL CHEM, V286, P18130, DOI 10.1074/jbc.M110.217323; Park S, 2012, BMB REP, V45, P360, DOI 10.5483/BMBRep.2012.45.6.030; Parvaresch S, 2002, FEBS LETT, V532, P357, DOI 10.1016/S0014-5793(02)03708-0; Peck GR, 2006, MOL ENDOCRINOL, V20, P2576, DOI 10.1210/me.2005-0476; Peck GR, 2009, J BIOL CHEM, V284, P30016, DOI 10.1074/jbc.M109.035568; Pehmoller C, 2009, AM J PHYSIOL-ENDOC M, V297, pE665, DOI 10.1152/ajpendo.00115.2009; Rak A, 2000, EMBO J, V19, P5105, DOI 10.1093/emboj/19.19.5105; Ramm G, 2006, J BIOL CHEM, V281, P29174, DOI 10.1074/jbc.M603274200; Reed SE, 2013, J CELL SCI, V126, P1931, DOI 10.1242/jcs.104307; Richardson TG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063897; Roach WG, 2007, BIOCHEM J, V403, P353, DOI 10.1042/BJ20061798; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Sano H, 2011, J BIOL CHEM, V286, P16541, DOI 10.1074/jbc.C111.228908; Stone S, 2006, HUM MOL GENET, V15, P2709, DOI 10.1093/hmg/ddl204; Szekeres F, 2012, AM J PHYSIOL-ENDOC M, V303, pE524, DOI 10.1152/ajpendo.00605.2011; Taylor EB, 2008, J BIOL CHEM, V283, P9787, DOI 10.1074/jbc.M708839200; Thomas EC, 2018, BIOCHEM J, V475, P2969, DOI 10.1042/BCJ20180475; Treebak JT, 2014, J PHYSIOL-LONDON, V592, P351, DOI 10.1113/jphysiol.2013.266338; Vichaiwong K, 2010, BIOCHEM J, V431, P311, DOI 10.1042/BJ20101100; Will E, 2001, J BIOL CHEM, V276, P12135, DOI 10.1074/jbc.M011451200; Woo JR, 2017, INT J BIOL MACROMOL, V103, P965, DOI 10.1016/j.ijbiomac.2017.05.119; Zhou M, 2007, ANAL CHEM, V79, P7603, DOI 10.1021/ac071584r; Zhou Z, 2017, FEBS LETT, V591, P88, DOI 10.1002/1873-3468.12509	43	21	21	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2018	293	46					17853	17862		10.1074/jbc.RA118.005040	http://dx.doi.org/10.1074/jbc.RA118.005040			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HA6SG	30275018	Green Published, hybrid			2022-12-26	WOS:000450409500016
J	Odenwald, MA; Choi, W; Kuo, WT; Singh, G; Sailer, A; Wang, YT; Shen, L; Fanning, AS; Turner, JR				Odenwald, Matthew A.; Choi, Wangsun; Kuo, Wei-Ting; Singh, Gurminder; Sailer, Anne; Wang, Yitang; Shen, Le; Fanning, Alan S.; Turner, Jerrold R.			The scaffolding protein ZO-1 coordinates actomyosin and epithelial apical specializations in vitro and in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; cell adhesion; cell polarity; cell surface; cytoskeleton; intestinal epithelium; myosin; PDZ domain; tight junction; brush border; community border; microvilli; apical specialization	LIGHT-CHAIN KINASE; MEMBRANE-PERMEANT PEPTIDE; ZONULA OCCLUDENS-1 AND-2; TIGHT JUNCTION BARRIER; ACTIN-BINDING REGION; 2,3-BUTANEDIONE MONOXIME; CELL-SHAPE; MYOSIN; OCCLUDIN; LOCALIZATION	Polarized epithelia assemble into sheets that compartmentalize organs and generate tissue barriers by integrating apical surfaces into a single, unified structure. This tissue organization is shared across organs, species, and developmental stages. The processes that regulate development and maintenance of apical epithelial surfaces are, however, undefined. Here, using an intestinal epithelial-specific knockout (KO) mouse and cultured epithelial cells, we show that the tight junction scaffolding protein zonula occludens-1 (ZO-1) is essential for development of unified apical surfaces in vivo and in vitro. We found that U5 and GuK domains of ZO-1 are necessary for proper apical surface assembly, including organization of microvilli and cortical F-actin; however, direct interactions with F-actin through the ZO-1 actin-binding region (ABR) are not required. ZO-1 lacking the PDZ1 domain, which binds claudins, rescued apical structure in ZO-1-deficient epithelia, but not in cells lacking both ZO-1 and ZO-2, suggesting that heterodimerization with ZO-2 restores PDZ1-dependent ZO-1 interactions that are vital to apical surface organization. Pharmacologic F-actin disruption, myosin II motor inhibition, or dynamin inactivation restored apical epithelial structure in vitro and in vivo, indicating that ZO-1 directs epithelial organization by regulating actomyosin contraction and membrane traffic. We conclude that multiple ZO-1-mediated interactions contribute to coordination of epithelial actomyosin function and genesis of unified apical surfaces.	[Odenwald, Matthew A.; Singh, Gurminder; Sailer, Anne; Wang, Yitang; Shen, Le; Turner, Jerrold R.] Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Shen, Le] Univ Chicago, Dept Surg, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Choi, Wangsun; Kuo, Wei-Ting; Singh, Gurminder; Turner, Jerrold R.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Choi, Wangsun; Kuo, Wei-Ting; Singh, Gurminder; Turner, Jerrold R.] Harvard Med Sch, Boston, MA 02115 USA; [Fanning, Alan S.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA	University of Chicago; University of Chicago; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill	Turner, JR (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, 77 Ave Louis Pasteur,BHNRB 730, Boston, MA 02115 USA.	jrturner@bwh.harvard.edu	Wang, Yuan/HHC-1520-2022; Wang, Yanbo/HFZ-8018-2022; wang, yan/GSE-6489-2022; Turner, Jerrold/H-1502-2019; Wang, Yin/HCI-9352-2022; wangwangwang, yuanyaun/HHN-6432-2022; wang, yi/GVT-8516-2022	Shen, Le/0000-0002-4367-5476; Kuo, Wei-Ting/0000-0002-1230-0014	NIDDK, National Institutes of Health (NIH) [F30DK103511, R01DK61931, R01DK68271]; NICHD, NIH [T32HD007009]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061931, F30DK103511, R01DK068271] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIDDK, National Institutes of Health (NIH), Grants F30DK103511 (to M. A. O.) and R01DK61931 and R01DK68271 (to J. R. T.) and NICHD, NIH, Grant T32HD007009 (to M. A. O.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALLEN TD, 1976, NATURE, V264, P545, DOI 10.1038/264545a0; Balda MS, 2003, J CELL BIOL, V160, P423, DOI 10.1083/jcb.200210020; Barfod ET, 2011, MOL BIOL CELL, V22, P634, DOI 10.1091/mbc.E10-06-0514; Barth AIM, 1997, J CELL BIOL, V136, P693, DOI 10.1083/jcb.136.3.693; Bryant DM, 2010, NAT CELL BIOL, V12, P1035, DOI 10.1038/ncb2106; Buschmann MM, 2013, MOL BIOL CELL, V24, P3056, DOI 10.1091/mbc.E12-09-0688; Carisey AF, 2018, CURR BIOL, V28, P489, DOI 10.1016/j.cub.2017.12.044; Chen J, 2008, EMBO J, V27, P2113, DOI 10.1038/emboj.2008.138; Choi W, 2016, J CELL BIOL, V213, P243, DOI 10.1083/jcb.201506115; Chua J, 2009, P NATL ACAD SCI USA, V106, P20770, DOI 10.1073/pnas.0909812106; Clayburgh DR, 2005, J CLIN INVEST, V115, P2702, DOI 10.1172/JCI24970; COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2; CRAMER LP, 1995, J CELL BIOL, V131, P179, DOI 10.1083/jcb.131.1.179; Crawley SW, 2014, CELL, V157, P433, DOI 10.1016/j.cell.2014.01.067; Dietz ML, 2006, J BIOL CHEM, V281, P20542, DOI 10.1074/jbc.M512463200; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Eisenhoffer GT, 2012, NATURE, V484, P546, DOI 10.1038/nature10999; Etournay R, 2007, J CELL SCI, V120, P2838, DOI 10.1242/jcs.002568; Fanning AS, 2012, MOL BIOL CELL, V23, P577, DOI 10.1091/mbc.E11-09-0791; Fanning AS, 2009, ANN NY ACAD SCI, V1165, P113, DOI 10.1111/j.1749-6632.2009.04440.x; Fanning AS, 2002, FASEB J, V16, P1835, DOI 10.1096/fj.02-0121fje; Fernandez-Gonzalez R, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2101pe78; FURUSE M, 1994, J CELL BIOL, V127, P1617, DOI 10.1083/jcb.127.6.1617; Giepmans BNG, 1998, CURR BIOL, V8, P931, DOI 10.1016/S0960-9822(07)00375-2; Grosse AS, 2011, DEVELOPMENT, V138, P4423, DOI 10.1242/dev.065789; Ikenouchi J, 2007, J CELL BIOL, V176, P779, DOI 10.1083/jcb.200612080; Itoh M, 1997, J CELL BIOL, V138, P181, DOI 10.1083/jcb.138.1.181; Jaffe AB, 2008, J CELL BIOL, V183, P625, DOI 10.1083/jcb.200807121; Katsuno T, 2008, MOL BIOL CELL, V19, P2465, DOI 10.1091/mbc.E07-12-1215; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; Lee CS, 2010, J CELL BIOL, V190, P663, DOI 10.1083/jcb.201003057; Lee JY, 2010, CURR BIOL, V20, P253, DOI 10.1016/j.cub.2009.12.021; Limouze J, 2004, J MUSCLE RES CELL M, V25, P337, DOI 10.1007/s10974-004-6060-7; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Marchiando AM, 2011, GASTROENTEROLOGY, V140, P1208, DOI 10.1053/j.gastro.2011.01.004; Marchiando AM, 2010, J CELL BIOL, V189, P111, DOI 10.1083/jcb.200902153; Martin AC, 2014, DEVELOPMENT, V141, P1987, DOI 10.1242/dev.102228; Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522; McConnell RE, 2009, J CELL BIOL, V185, P1285, DOI 10.1083/jcb.200902147; McNeil E, 2006, MOL BIOL CELL, V17, P1922, DOI 10.1091/mbc.E05-07-0650; Nighot M, 2017, AM J PATHOL, V187, P2698, DOI 10.1016/j.ajpath.2017.08.005; Odenwald MA, 2017, J CELL SCI, V130, P243, DOI 10.1242/jcs.188185; Ostap EM, 2002, J MUSCLE RES CELL M, V23, P305, DOI 10.1023/A:1022047102064; Owens SE, 2005, PHARM RES-DORDR, V22, P703, DOI 10.1007/s11095-005-2584-9; Papadopulos A, 2017, MOL CELL NEUROSCI, V84, P93, DOI 10.1016/j.mcn.2017.05.006; Park RJ, 2013, J CELL SCI, V126, P5305, DOI 10.1242/jcs.138578; Plageman TF, 2011, DEVELOPMENT, V138, P5177, DOI 10.1242/dev.067868; Rodgers LS, 2013, J CELL SCI, V126, P1565, DOI 10.1242/jcs.113399; Rodriguez-Fraticelli AE, 2015, NAT CELL BIOL, V17, P241, DOI 10.1038/ncb3106; Rojas R, 2001, MOL BIOL CELL, V12, P2257, DOI 10.1091/mbc.12.8.2257; Roland JT, 2011, P NATL ACAD SCI USA, V108, P2789, DOI 10.1073/pnas.1010754108; Rosenblatt J, 2001, CURR BIOL, V11, P1847, DOI 10.1016/S0960-9822(01)00587-5; Saw TB, 2017, NATURE, V544, P212, DOI 10.1038/nature21718; Sawyer JM, 2010, DEV BIOL, V341, P5, DOI 10.1016/j.ydbio.2009.09.009; SELLIN LC, 1994, PHARMACOL TOXICOL, V74, P305, DOI 10.1111/j.1600-0773.1994.tb01365.x; Shashikanth N, 2017, COMPR PHYSIOL, V7, P1497, DOI 10.1002/cphy.c170003; Shen L, 2005, MOL BIOL CELL, V16, P3919, DOI 10.1091/mbc.E04-12-1089; Shen L, 2008, J CELL BIOL, V181, P683, DOI 10.1083/jcb.200711165; Shen L, 2006, J CELL SCI, V119, P2095, DOI 10.1242/jcs.02915; SIEGMAN MJ, 1994, J MUSCLE RES CELL M, V15, P457, DOI 10.1007/BF00122119; Sourisseau T, 2006, MOL CELL BIOL, V26, P2387, DOI 10.1128/MCB.26.6.2387-2398.2006; Spadaro D, 2017, CURR BIOL, V27, P3783, DOI 10.1016/j.cub.2017.11.014; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Surviladze Z., 2010, PROBE REPORTS NIH MO; Tran DT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10098; Turner JR, 1997, AM J PHYSIOL-CELL PH, V273, pC1378, DOI 10.1152/ajpcell.1997.273.4.C1378; Tyska MJ, 2005, MOL BIOL CELL, V16, P2443, DOI 10.1091/mbc.E04-12-1116; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Van Itallie CM, 2009, MOL BIOL CELL, V20, P3930, DOI 10.1091/mbc.E09-04-0320; Vogel GF, 2015, J CELL BIOL, V211, P587, DOI 10.1083/jcb.201506112; Xiao F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021527; Yeaman C, 2004, J CELL SCI, V117, P559, DOI 10.1242/jcs.00893; Yon C, 2005, J BIOL CHEM, V280, P27412, DOI 10.1074/jbc.M501393200; Yu ASL, 2005, AM J PHYSIOL-CELL PH, V288, pC1231, DOI 10.1152/ajpcell.00581.2004; Yu D, 2010, P NATL ACAD SCI USA, V107, P8237, DOI 10.1073/pnas.0908869107; Yu HYE, 2007, MOL BIOL CELL, V18, P4096, DOI 10.1091/mbc.E06-11-0993; Zemljic-Harpf AE, 2014, J CELL SCI, V127, P1104, DOI 10.1242/jcs.143743; Zihni C, 2017, NAT CELL BIOL, V19, P1049, DOI 10.1038/ncb3592; Zihni C, 2014, J CELL BIOL, V204, P111, DOI 10.1083/jcb.201304064; Zolotarevsky Y, 2002, GASTROENTEROLOGY, V123, P163, DOI 10.1053/gast.2002.34235	80	43	43	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2018	293	45					17317	17335		10.1074/jbc.RA118.003908	http://dx.doi.org/10.1074/jbc.RA118.003908			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ9EI	30242130	hybrid, Green Published			2022-12-26	WOS:000449799000002
J	Weismiller, HA; Murphy, R; Wei, GH; Ma, BY; Nussinov, R; Margittai, M				Weismiller, Hilary A.; Murphy, Rachel; Wei, Guanghong; Ma, Buyong; Nussinov, Ruth; Margittai, Martin			Structural disorder in four-repeat Tau fibrils reveals a new mechanism for barriers to cross-seeding of Tau isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Tau protein (Tau); amyloid; conformational change; Alzheimer disease; tauopathy; electron paramagnetic resonance (EPR); fibril; protein aggregation; prion; protein structure; seeding barrier	PAIRED HELICAL FILAMENTS; PROGRESSIVE SUPRANUCLEAR PALSY; AMYLOID FIBRILS; ALPHA-SYNUCLEIN; NEUROFIBRILLARY TANGLES; CASPASE-CLEAVAGE; PRION STRAINS; PROTEIN-TAU; MUTANT-TAU; MUTATIONS	The intracellular deposition of fibrils composed of the microtubule-associated protein Tau is a characteristic feature of Alzheimer's disease (AD) and other fatal neurodegenerative disorders collectively known as tauopathies. Short Tau fibrils spread intracerebrally through transfer between interconnected neurons. Once taken up by a recipient cell, Tau fibrils recruit Tau monomers onto their ends. Based on the number of microtubule-binding repeats, there are two distinct groups of Tau isoforms: three-repeat (3R) Tau and four-repeat (4R) Tau. In AD, all Tau isoforms are deposited, whereas in other tauopathies, only 3R or 4R Tau isoforms are deposited. The molecular basis for these isoform-specific depositions is poorly understood, although conformation-based cross-seeding barriers are key. Here, we used sedimentation assays, EPR spectroscopy, and other structural readouts to better understand the cross-seeding barriers of 4R Tau fibrils. We observed that fibrils formed from truncated Tau (K18), but not full-length Tau (htau40), exhibit a barrier that inhibits 3R Tau recruitment. Investigating an array of differently sized fragments, we found that the Tau C terminus modulates the cross-seeding barrier and that the N terminus plays a synergistic role. Two disease-associated Tau variants, P301S and P301L, also established strong cross-seeding barriers. EPR analysis indicated that fibrils seeded with truncated and mutated Tau, but not htau40, are structurally disordered in the second half of repeat four and onward. These findings suggest that the disorder in this region diminishes the ability of 4R Tau fibrils to recruit 3R Tau monomers, revealing a new mechanism for Tau cross-seeding barriers.	[Weismiller, Hilary A.; Murphy, Rachel; Margittai, Martin] Univ Denver, Dept Chem & Biochem, 2190 East Iliff Ave, Denver, CO 80208 USA; [Wei, Guanghong] Fudan Univ, Dept Phys, State Key Lab Surface Phys, Key Lab Computat Phys Sci,Minist Educ,Collaborat, Shanghai 200433, Peoples R China; [Ma, Buyong; Nussinov, Ruth] NCI, Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, NIH, Frederick, MD 21702 USA; [Nussinov, Ruth] Tel Aviv Univ, Sackler Inst Mol Med, Sackler Sch Med, Dept Human Genet & Mol Med, IL-69978 Tel Aviv, Israel	University of Denver; Fudan University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Tel Aviv University; Sackler Faculty of Medicine	Margittai, M (corresponding author), Univ Denver, Dept Chem & Biochem, 2190 East Iliff Ave, Denver, CO 80208 USA.	martin.margittai@du.edu	Margittai, Martin/D-5039-2014; Ma, Buyong/F-9491-2011	Margittai, Martin/0000-0003-1903-5927; Ma, Buyong/0000-0002-7383-719X; Wei, Guanghong/0000-0001-5814-3328; Nussinov, Ruth/0000-0002-8115-6415	Federal funds from the Frederick National Laboratory for Cancer Research, National Institutes of Health [HHSN261200800001E]; Intramural Research Program of National Institutes of Health, Frederick National Lab, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG051833] Funding Source: NIH RePORTER	Federal funds from the Frederick National Laboratory for Cancer Research, National Institutes of Health; Intramural Research Program of National Institutes of Health, Frederick National Lab, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Drs. S. S. Eaton and G. R. Eaton for technical support on the DEER measurements and Dr. M. R. Holden for help in the collection of EM images. This project was also supported by Federal funds from the Frederick National Laboratory for Cancer Research, National Institutes of Health under contract HHSN261200800001E. Further support was provided by the Intramural Research Program of National Institutes of Health, Frederick National Lab, Center for Cancer Research.	Aoyagi H, 2007, J BIOL CHEM, V282, P20309, DOI 10.1074/jbc.M611876200; Ayers JI, 2018, BIOL PSYCHIAT, V83, P337, DOI 10.1016/j.biopsych.2017.04.003; Bedrood S, 2012, J BIOL CHEM, V287, P5235, DOI 10.1074/jbc.M111.327817; Berliner L. J., 2000, BIOLOGICAL MAGNETIC; BERLINER LJ, 1982, ANAL BIOCHEM, V119, P450, DOI 10.1016/0003-2697(82)90612-1; Berriman J, 2003, P NATL ACAD SCI USA, V100, P9034, DOI 10.1073/pnas.1530287100; Bibow S, 2011, ANGEW CHEM INT EDIT, V50, P11520, DOI 10.1002/anie.201105493; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Carmel G, 1996, J BIOL CHEM, V271, P32789, DOI 10.1074/jbc.271.51.32789; Chen M, 2007, J BIOL CHEM, V282, P24970, DOI 10.1074/jbc.M700368200; Clavaguera F, 2013, P NATL ACAD SCI USA, V110, P9535, DOI 10.1073/pnas.1301175110; CLEVELAND DW, 1977, J MOL BIOL, V116, P227, DOI 10.1016/0022-2836(77)90214-5; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Collinge J, 2016, NATURE, V539, P217, DOI 10.1038/nature20415; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Delacourte A, 1996, J NEUROPATH EXP NEUR, V55, P159, DOI 10.1097/00005072-199602000-00004; Dinkel PD, 2015, BIOCHEMISTRY-US, V54, P4731, DOI 10.1021/acs.biochem.5b00453; Dinkel PD, 2011, BIOCHEMISTRY-US, V50, P4330, DOI 10.1021/bi2004685; Falcon B, 2018, NATURE, V561, P137, DOI 10.1038/s41586-018-0454-y; Falcon B, 2015, J BIOL CHEM, V290, P1049, DOI 10.1074/jbc.M114.589309; Fichou Y, 2018, CHEM COMMUN, V54, P4573, DOI 10.1039/c8cc01355a; Fitzpatrick AWP, 2017, NATURE, V547, P185, DOI 10.1038/nature23002; FLAMENT S, 1991, ACTA NEUROPATHOL, V81, P591, DOI 10.1007/BF00296367; Gamblin TC, 2003, P NATL ACAD SCI USA, V100, P10032, DOI 10.1073/pnas.1630428100; Ghetti B, 2015, NEUROPATH APPL NEURO, V41, P24, DOI 10.1111/nan.12213; GOEDERT M, 1992, NEURON, V8, P159, DOI 10.1016/0896-6273(92)90117-V; GOEDERT M, 1990, EMBO J, V9, P4225, DOI 10.1002/j.1460-2075.1990.tb07870.x; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Goedert M, 2017, ANNU REV NEUROSCI, V40, P189, DOI 10.1146/annurev-neuro-072116-031153; Gross A, 1999, BIOCHEMISTRY-US, V38, P10324, DOI 10.1021/bi990856k; Guo JL, 2016, J EXP MED, V213, P2635, DOI 10.1084/jem.20160833; GUSTKE N, 1994, BIOCHEMISTRY-US, V33, P9511, DOI 10.1021/bi00198a017; Hasegawa M, 1999, FEBS LETT, V443, P93, DOI 10.1016/S0014-5793(98)01696-2; Iijima M, 1999, NEUROREPORT, V10, P497, DOI 10.1097/00001756-199902250-00010; Irwin DJ, 2016, ANN NEUROL, V79, P272, DOI 10.1002/ana.24559; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Jeschke G, 2000, BIO MAGN RE, V19, P493; Jeschke G, 2012, ANNU REV PHYS CHEM, V63, P419, DOI 10.1146/annurev-physchem-032511-143716; Karyagina I, 2011, BIOPHYS J, V101, pL1, DOI 10.1016/j.bpj.2011.05.052; KSIEZAKREDING H, 1994, AM J PATHOL, V145, P1496; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Margittai M, 2004, P NATL ACAD SCI USA, V101, P10278, DOI 10.1073/pnas.0401911101; Margittai M, 2006, J BIOL CHEM, V281, P37820, DOI 10.1074/jbc.M605336200; Margittai M, 2008, Q REV BIOPHYS, V41, P265, DOI 10.1017/S0033583508004733; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Meyer V, 2016, J BIOL CHEM, V291, P12271, DOI 10.1074/jbc.M116.715557; Meyer V, 2014, BIOCHEMISTRY-US, V53, P5804, DOI 10.1021/bi501050g; Meyer V, 2014, ANGEW CHEM INT EDIT, V53, P1590, DOI 10.1002/anie.201308473; MILOV AD, 1981, FIZ TVERD TELA+, V23, P975; Miyasaka T, 2001, J NEUROPATH EXP NEUR, V60, P872, DOI 10.1093/jnen/60.9.872; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Narasimhan S, 2017, J NEUROSCI, V37, P11406, DOI 10.1523/JNEUROSCI.1230-17.2017; Pastor P, 2001, ANN NEUROL, V49, P263, DOI 10.1002/1531-8249(20010201)49:2<263::AID-ANA50>3.0.CO;2-K; Pornsuwan S, 2013, ANGEW CHEM INT EDIT, V52, P10290, DOI 10.1002/anie.201304747; Puoti G, 1999, NEUROLOGY, V53, P2173, DOI 10.1212/WNL.53.9.2173; Qiang W, 2017, NATURE, V541, P217, DOI 10.1038/nature20814; Quinn JP, 2018, J ALZHEIMERS DIS, V63, P13, DOI 10.3233/JAD-170959; Rissman RA, 2004, J CLIN INVEST, V114, P121, DOI 10.1172/JCI200420640; Ros R, 2005, ARCH NEUROL-CHICAGO, V62, P1444, DOI 10.1001/archneur.62.9.1444; Saito Y, 2004, J NEUROPATH EXP NEUR, V63, P911, DOI 10.1093/jnen/63.9.911; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; SCHWEERS O, 1994, J BIOL CHEM, V269, P24290; Siddiqua A, 2010, J BIOL CHEM, V285, P37920, DOI 10.1074/jbc.M110.185728; Siddiqua A, 2012, J AM CHEM SOC, V134, P10271, DOI 10.1021/ja303498q; Strang KH, 2018, J BIOL CHEM, V293, P2408, DOI 10.1074/jbc.M117.815357; Taniguchi-Watanabe S, 2016, ACTA NEUROPATHOL, V131, P267, DOI 10.1007/s00401-015-1503-3; von Bergen M, 2001, J BIOL CHEM, V276, P48165, DOI 10.1074/jbc.M105196200; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Williams DR, 2007, BRAIN, V130, P1566, DOI 10.1093/brain/awm104; Yoshida H, 2002, J NEUROCHEM, V80, P548, DOI 10.1046/j.0022-3042.2001.00729.x; Yu X, 2012, J BIOL CHEM, V287, P14950, DOI 10.1074/jbc.M112.340794; Zhang ZT, 2014, NAT MED, V20, P1254, DOI 10.1038/nm.3700	74	26	26	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2018	293	45					17336	17348		10.1074/jbc.RA118.005316	http://dx.doi.org/10.1074/jbc.RA118.005316			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ9EI	30242125	hybrid, Green Published			2022-12-26	WOS:000449799000003
J	Chen, YM; Tu, YK; Yu, HW; Chiu, TY; Chiang, TL; Chen, DR; Chang, RE				Chen, Ya-Mei; Tu, Yu-Kang; Yu, Hsiao-Wei; Chiu, Tzu-Ying; Chiang, Tung-Liang; Chen, Duan-Rung; Chang, Ray-E			Leisure time activities as mediating variables in functional disability progression: An application of parallel latent growth curve modeling	PLOS ONE			English	Article							LATE-LIFE DISABILITY; OLDER-ADULTS; PHYSICAL-ACTIVITY; UNITED-STATES; FOLLOW-UP; TRENDS; AGE; TRAJECTORIES; PREVALENCE; MORTALITY	Objectives The aims of this study were to investigate (1) whether and (2) the extent to which Taiwanese older adults' leisure time activity (LTA) trajectories mediated the potential association between their sociodemographic factors and their functional disability trajectories. Methods Longitudinal data from four waves of the Taiwan Longitudinal Study on Aging (TLSA), collected between 1996 and 2007, were used for analysis (N = 3,429). Parallel-process latent growth curve modeling was adopted to evaluate the process by which LTA mediated between sociodemographic factors (age, gender, education, self-rated health, comorbidities, and depression) and the outcome process of functional disabilities. Results When mediated by baseline level of LTA, five sociodemographic factors-age, gender, education level, self-rated health, and number of comorbidities-had significant and negative mediating effects on baseline or change in functional disability, thus improving disability outcomes. However, four of the sociodemographic factors (age, education level, and number of comorbidities), when mediated through the rate of change in LTA, were found to have significant and positive mediating effects, which increased disability levels. The proportion of effects mediated by the LTA trajectory ranged from 0% to 194%. Discussion The large proportion of effects mediated through the LTA process underlines the importance of LTA to public health policy and health programs for older adults. The study's findings shed light on how to better target populations of older adults to promote an active lifestyle and achieve more successful aging in late life in Asian countries.	[Chen, Ya-Mei; Chiang, Tung-Liang; Chang, Ray-E] Natl Taiwan Univ, Coll Publ Hlth, Inst Hlth Policy & Management, Taipei, Taiwan; [Tu, Yu-Kang] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Xu Zhou Rd, Taipei, Taiwan; [Yu, Hsiao-Wei] Chang Gung Univ Sci & Technol, Dept Gerontol Care & Management, Taoyuan, Taiwan; [Chiu, Tzu-Ying] Tzu Chi Univ Sci & Technol, Grad Inst Long Term Care, Hualien, Taiwan; [Chen, Duan-Rung] Natl Taiwan Univ, Coll Publ Hlth, Inst Hlth Behav & Community Sci, Taipei, Taiwan	National Taiwan University; National Taiwan University; Chang Gung University of Science & Technology; Tzu Chi University of Science & Technology; National Taiwan University	Chen, YM (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Hlth Policy & Management, Taipei, Taiwan.; Tu, YK (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Xu Zhou Rd, Taipei, Taiwan.	chenyamei@ntu.edu.tw; yukangtu@ntu.edu.tw		CHANG, RAY-E/0000-0003-3891-5313; CHIANG, TUNG-LIANG/0000-0002-7876-3943; Tu, Yu-Kang/0000-0002-2461-474X	Ministry of Science and Technology; National Science Council of Taiwan [NSC 101-2410-H-002-212-MY2, MOST 103-2410-H-002-146, MOST 106-2811-H-002-018]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study received funding support from the Ministry of Science and Technology and the National Science Council of Taiwan (NSC 101-2410-H-002-212-MY2, MOST 103-2410-H-002-146, MOST 106-2811-H-002-018) to YMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1979, ADV FACTOR ANAL STRU; Bengtsson S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173659; Bentler PM., 1999, STRUCTURAL EQUATION, V6; Bentler PM, 1990, PSYCHOL BULL, P107; Bishop J, 2015, PSYCHOL METHODS, V20, P43, DOI 10.1037/met0000018; BOLLEN KA, 1989, SOCIOL METHOD RES, V17, P303, DOI 10.1177/0049124189017003004; Chao SF, 2016, GERONTOLOGIST, V56, P397, DOI 10.1093/geront/gnu052; Chen CM, 2015, GERIATR GERONTOL INT, V15, P156, DOI 10.1111/ggi.12243; Chen CM, 2012, J GERONTOL A-BIOL, V67, P1059, DOI 10.1093/gerona/gls074; Chen YM, 2016, INT J BEHAV MED, V23, P697, DOI 10.1007/s12529-016-9554-y; Chen YM, 2015, ARCH GERONTOLOGY GER; Cheong J, 2003, STRUCT EQU MODELING, V10, P238, DOI 10.1207/S15328007SEM1002_5; Chiu YC, 2013, INT J NURS STUD, V50, P1314, DOI 10.1016/j.ijnurstu.2013.01.002; Chou KL, 2008, J AGING HEALTH, V20, P385, DOI 10.1177/0898264308315852; Duncan T, 2006, INTRO LATENT VARIABL; Everard KM, 2000, J GERONTOL B-PSYCHOL, V55, pS208, DOI 10.1093/geronb/55.4.S208; Feng Lei, 2011, J Aging Res, V2011, P960848, DOI 10.4061/2011/960848; Freedman VA, 2002, JAMA-J AM MED ASSOC, V288, P3137, DOI 10.1001/jama.288.24.3137; Gooloo S, 2009, IMPROVING MEASUREMEN; Hancock GR, 2001, STRUCT EQU MODELING, V8, P470, DOI 10.1207/S15328007SEM0803_7; Hung WW, 2012, MED CARE, V50, P501, DOI 10.1097/MLR.0b013e318245a0e0; Janke MC, 2008, INT J AGING HUM DEV, V67, P231, DOI 10.2190/AG.67.3.c; Kane RA, 1981, ASSESSING ELDERLY PR; KATZ S, 1976, MED CARE, V14, P116, DOI 10.1097/00005650-197605001-00018; Kline R.B., 2011, PRINCIPLES PRACTICE; Kmetic A, 2002, EPIDEMIOLOGY, V13, P437, DOI 10.1097/00001648-200207000-00012; Ku PW, 2012, AM J PREV MED, V42, P355, DOI 10.1016/j.amepre.2011.11.010; Liang J, 2010, SOC SCI MED, V71, P1208, DOI 10.1016/j.socscimed.2010.05.007; Lin YP, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-428; MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542; Martin LG, 2011, POP STUD-J DEMOG, V65, P289, DOI 10.1080/00324728.2011.604730; Moore SC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001335; Muthen B, 2011, APPL CAUSALLY DEFINE; Muthen L, GROWTH MODELING LATE, P1; Muthen L.K., 2009, MPLUS USERS GUIDE; NAGI SZ, 1976, MILBANK FUND Q, V54, P439, DOI 10.2307/3349677; Paganini-Hill A, 2011, J GERONTOL A-BIOL, V66, P559, DOI 10.1093/gerona/glq237; Palacios-Cena D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-799; Park I, 2005, RES Q EXERCISE SPORT, V76, P176, DOI 10.1080/02701367.2005.10599279; Preacher K.J., 2008, LATENT GROWTH CURVE; Puts MTE, 2008, AGE AGEING, V37, P187, DOI 10.1093/ageing/afm185; RADLOFF LS, 1991, J YOUTH ADOLESCENCE, V20, P149, DOI 10.1007/BF01537606; ROGOSA D, 1982, PSYCHOL BULL, V92, P726, DOI 10.1037/0033-2909.92.3.726; Rowe JW, 1997, GERONTOLOGIST, V37, P433, DOI 10.1093/geront/37.4.433; Schutte H YP, 1997, LEISURE BEHAV ASIA I; Sorman DE, 2014, J GERONTOL B-PSYCHOL, V69, P493, DOI 10.1093/geronb/gbt056; STEIGER JH, 1990, MULTIVAR BEHAV RES, V25, P173, DOI 10.1207/s15327906mbr2502_4; Stenholm S, 2015, J GERONTOL A-BIOL, V70, P330, DOI 10.1093/gerona/glu113; Strain LA, 2002, GERONTOLOGIST, V42, P217, DOI 10.1093/geront/42.2.217; Strobl R, 2014, PREV MED, V62, P8, DOI 10.1016/j.ypmed.2014.01.017; Sulander T, 2006, INT J EPIDEMIOL, V35, P1255, DOI 10.1093/ije/dyl183; Wang HX, 2012, BBA-MOL BASIS DIS, V1822, P482, DOI 10.1016/j.bbadis.2011.09.002; Yu HW, 2018, J APPL GERONTOL, V37, P706, DOI 10.1177/0733464816650800; Zimmer Z, 2014, J GERONTOL B-PSYCHOL, V69, P275, DOI 10.1093/geronb/gbt099	54	9	12	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0203757	10.1371/journal.pone.0203757	http://dx.doi.org/10.1371/journal.pone.0203757			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV7VQ	30281590	Green Published, Green Submitted, gold			2022-12-26	WOS:000446342400027
J	Norkaew, T; Brown, JL; Bansiddhi, P; Somgird, C; Thitaram, C; Punyapornwithaya, V; Punturee, K; Vongchan, P; Somboon, N; Khonmee, J				Norkaew, Treepradab; Brown, Janine L.; Bansiddhi, Pakkanut; Somgird, Chaleamchat; Thitaram, Chatchote; Punyapornwithaya, Veerasak; Punturee, Khanittha; Vongchan, Preeyanat; Somboon, Nopphamas; Khonmee, Jaruwan			Body condition and adrenal glucocorticoid activity affects metabolic marker and lipid profiles in captive female elephants in Thailand	PLOS ONE			English	Article							LIPOPROTEIN CONCENTRATIONS; INSULIN-RESISTANCE; CONDITION SCORE; MASS INDEX; DEXAMETHASONE; STRESS; FRUCTOSAMINE; CORTISOL; GLUCOSE; SECRETION	Studies in western zoo elephants have found relationships between body condition and physiological function, and identified mitigating management strategies to optimize health and welfare. A similar methodological approach was used in this study, which evaluated a body condition score (BCS; 1 = thinnest, 5 = fattest) every other month and fecal glucocorticoid metabolite (FGM) concentrations twice monthly in 33 tourist camp elephants in Thailand for a 1-year period to assess seasonal variations, and determine how lipid profiles [total cholesterol (TC), low density lipoproteins (LDL), high density lipoproteins (HDL), triglycerides (TG)] and metabolic parameters [insulin, glucose, fructosamine, glucose to insulin ratio (G:1)] related to measures of body condition and adrenal function. The most prevalent BCS was 3-3.5 (60.6%), with 27.3% at BCS = 4 (overweight) and 12.1% at BCS = 4.5-5 (very overweight); no elephants had a BCS <2. BCSs were higher in rainy and winter seasons compared to summer, with FGM, TG, HDL, LDL, and insulin also higher in the rainy and/or winter seasons (p<0.05). By contrast, TC and glucose were lowest in the rainy season. FGM measures were negatively associated with two environmental factors: temperature and rainfall, but not humidity. Positive correlations were found between BCS and TC, LDL, and HDL, and between FGM and TC, HDL, glucose, and insulin (p<0.05), whereas BCS and FGM were both negatively associated with the G:1 (p<0.05). However, there was no relationship between BCS and FGM among the camp elephants. Using BCS and FGM measures as outcome variables in separate regression models, this study found high BCS and elevated FGM concentrations were associated with altered lipid profiles and metabolic status in elephants. Furthermore, more work hours/day was associated with better body condition and health measures. Thus, being overweight and exposed to factors that increase adrenal activity could adversely affect health status, requiring alterations in management for some individuals, whereas exercise appears to have a protective effect.	[Norkaew, Treepradab] Chiang Mai Univ, Fac Vet Med, Grad Program Vet Sci, Chiang Mai, Thailand; [Norkaew, Treepradab; Bansiddhi, Pakkanut; Somgird, Chaleamchat; Thitaram, Chatchote; Khonmee, Jaruwan] Chiang Mai Univ, Fac Vet Med, Ctr Excellence Elephant & Wildlife Res, Chiang Mai, Thailand; [Brown, Janine L.] Smithsonian Conservat Biol Inst, Ctr Species Survival, Front Royal, VA USA; [Somgird, Chaleamchat; Thitaram, Chatchote] Chiang Mai Univ, Fac Vet Med, Dept Compan Anim & Wildlife Clin, Chiang Mai, Thailand; [Punyapornwithaya, Veerasak] Chiang Mai Univ, Fac Vet Med, Vet Publ Hlth Ctr Asia Pacific, Chiang Mai, Thailand; [Punturee, Khanittha; Vongchan, Preeyanat] Chiang Mai Univ, Fac Associated Med Sci, Dept Med Technol, Chiang Mai, Thailand; [Somboon, Nopphamas] Chiang Mai Univ, Fac Vet Med, Small Anim Teaching Hosp, Chiang Mai, Thailand; [Khonmee, Jaruwan] Chiang Mai Univ, Fac Vet Med, Dept Vet Biosci & Vet Publ Hlth, Chiang Mai, Thailand	Chiang Mai University; Chiang Mai University; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Chiang Mai University; Chiang Mai University; Chiang Mai University; Chiang Mai University; Chiang Mai University	Khonmee, J (corresponding author), Chiang Mai Univ, Fac Vet Med, Ctr Excellence Elephant & Wildlife Res, Chiang Mai, Thailand.; Khonmee, J (corresponding author), Chiang Mai Univ, Fac Vet Med, Dept Vet Biosci & Vet Publ Hlth, Chiang Mai, Thailand.	jaruwan.khonmee@cmu.ac.th	Punyapornwithaya, Veerasak/ABE-5119-2020; Punyapornwithaya, Verasak/V-9323-2019; Thitaram, Chatchote/AHD-1584-2022	Punyapornwithaya, Verasak/0000-0001-9870-7773; Punturee, Khanittha/0000-0003-2506-8530; Khonmee, Jaruwan/0000-0002-3806-9746; Bansiddhi, Pakkanut/0000-0001-6699-4819	Thailand Research Fund [MRG5980072]; Center of Excellence in Elephant and Wildlife Research, Chiang Mai University [002/2559]	Thailand Research Fund(Thailand Research Fund (TRF)); Center of Excellence in Elephant and Wildlife Research, Chiang Mai University	This work was supported by Thailand Research Fund (grant number MRG5980072) www.https://www.trf.or.th/, Center of Excellence in Elephant and Wildlife Research, Chiang Mai University (grant number 002/2559) www.asianelephantresearch.com.	Albon SD, 2017, GLOBAL CHANGE BIOL, V23, P1374, DOI 10.1111/gcb.13435; Asian Elephant Specialist Group, 2017, AS EL RANG STAT M FI; Bertin FR, 2017, EQUINE VET J, V49, P570, DOI 10.1111/evj.12703; Boden G, 2015, GLUCOSE INTAKE UTILI, P95; Brown JL, 2014, ADV EXP MED BIOL, V753, P135, DOI 10.1007/978-1-4939-0820-2_8; BROWN JL, 1994, BIOL REPROD, V51, P776, DOI 10.1095/biolreprod51.4.776; BUBENIK GA, 1989, COMP BIOCHEM PHYS A, V92, P499, DOI 10.1016/0300-9629(89)90356-3; Campos-Arceiz A, 2008, ECOL RES, V23, P1057, DOI 10.1007/s11284-008-0466-4; Chusyd DE, 2018, OBESITY, V26, P103, DOI 10.1002/oby.22046; Conde DA, 2011, SCIENCE, V331, P1390, DOI 10.1126/science.1200674; Coutinho AE, 2011, MOL CELL ENDOCRINOL, V335, P2, DOI 10.1016/j.mce.2010.04.005; Crone EE, 2001, EVOLUTION, V55, P2611; DANTZER R, 1983, J ANIM SCI, V57, P6, DOI 10.2527/jas1983.5716; de Laat MA, 2016, J VET INTERN MED, V30, P1732, DOI 10.1111/jvim.14577; DIVERTIE GD, 1991, DIABETES, V40, P1228, DOI 10.2337/diabetes.40.10.1228; Douhard M, 2018, ECOLOGY, V99, P724, DOI 10.1002/ecy.2141; Fowler M, 2008, BIOL MED SURG ELEPHA; Frank N, 2006, JAVMA-J AM VET MED A, V228, P1383, DOI 10.2460/javma.228.9.1383; FREEDMAN MR, 1986, AM J PHYSIOL, V250, pR595, DOI 10.1152/ajpregu.1986.250.4.R595; Gilor C, 2010, VET CLIN PATH, V39, P322, DOI 10.1111/j.1939-165X.2010.00227.x; GUILLAUMEGENTIL C, 1993, DIABETOLOGIA, V36, P899, DOI 10.1007/BF02374470; Harris DM, 2008, WELFARE HOUSING HUSB; Hasselgren P O, 1999, Curr Opin Clin Nutr Metab Care, V2, P201, DOI 10.1097/00075197-199905000-00002; Hayward GS, 2012, VET REC, V170, P202, DOI 10.1136/vr.e1212; HENNEKE DR, 1983, EQUINE VET J, V15, P371, DOI 10.1111/j.2042-3306.1983.tb01826.x; Heppell SS, 2000, ECOLOGY, V81, P654, DOI 10.1890/0012-9658(2000)081[0654:LHAEPP]2.0.CO;2; Herbut P, 2012, ANIM SCI PAP REP, V30, P363; HORNER HC, 1987, J BIOL CHEM, V262, P17696; IUCN, 2012, IUCN RED LIST CATEGO, VSecond edition; Jacobson TA, 2013, MAYO CLIN PROC, V88, P1294, DOI 10.1016/j.mayocp.2013.09.003; Jeusette IC, 2005, AM J VET RES, V66, P81, DOI 10.2460/ajvr.2005.66.81; Jung HS, 2014, OBESITY, V22, P1880, DOI 10.1002/oby.20751; Kosecki SM, 2005, ANN PHARMACOTHER, V39, P1557, DOI 10.1345/aph.1G010; Lambillotte C, 1997, J CLIN INVEST, V99, P414, DOI 10.1172/JCI119175; Lanktree MB, 2013, GENOMIC AND PERSONALIZED MEDICINE, VOL 1-2, 2ND EDITION, P1006, DOI 10.1016/B978-0-12-382227-7.00083-5; Lee L, 2012, PEDIATR REV, V33, P459, DOI 10.1542/pir.33-10-459; Legro RS, 1998, J CLIN ENDOCR METAB, V83, P2694, DOI 10.1210/jc.83.8.2694; LeMura LM, 2000, EUR J APPL PHYSIOL, V82, P451, DOI 10.1007/s004210000234; Lundberg U, 2002, WORK STRESS, V16, P356, DOI 10.1080/0267837021000064427; Malikhao P, 2017, COMMUN CULT CHANGE A, V3, P127, DOI 10.1007/978-981-10-4125-9_9; Manjrekar PA, 2012, J CLIN DIAGN RES, V6, P770; Manlik O, 2016, ECOL EVOL, V6, P3496, DOI 10.1002/ece3.2130; Mearns BM, 2011, NAT REV CARDIOL, V8, P179, DOI [10.1038/nrcardio.2011.55, 10.1038/nrcardio.2011.126, 10.1038/nrcardio.2011.42, 10.1038/nrcardio.2011.109, 10.1038/nrcardio.2011.93, 10.1038/nrcardio.2011.88, 10.1038/nrcardio.2011.52]; Marcilla AM, 2012, GEN COMP ENDOCR, V176, P259, DOI 10.1016/j.ygcen.2012.02.001; Miller MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155223; MODAN M, 1985, J CLIN INVEST, V75, P809, DOI 10.1172/JCI111776; Morfeld KA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188701; Morfeld KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155146; Morfeld KA, 2016, REPROD FERT DEVELOP, V28, P640, DOI 10.1071/RD14140; Mudron P, 2005, ACTA VET BRNO, V74, P37, DOI 10.2754/avb200574010037; Mumby HS, 2015, CONSERV PHYSIOL, V3, DOI 10.1093/conphys/cov030; Nelson RW, 2012, SMALL ANIMAL CLIN DI, P156; Oli MK, 2003, AM NAT, V161, P422, DOI 10.1086/367591; Orozco-Beltran D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186196; PHILLIPOU G, 1988, CLIN CHEM, V34, P1561; Proctor C, 2015, J ZOO AQUAR RES; Rabasa C, 2016, CURR OPIN BEHAV SCI, V9, P71, DOI 10.1016/j.cobeha.2016.01.011; Ratnasooriya WD, 2006, GAJAH, V24, P45; Rebuffe-Scrive M, 1988, Acta Med Scand Suppl, V723, P143; Rughetti M, 2012, J MAMMAL, V93, P1301, DOI 10.1644/11-MAMM-A-402.1; Sacks David B, 2011, Diabetes Care, V34, pe61, DOI 10.2337/dc11-9998; Sakoda H, 2000, DIABETES, V49, P1700, DOI 10.2337/diabetes.49.10.1700; SALTZ D, 1991, J WILDLIFE MANAGE, V55, P1, DOI 10.2307/3809235; Sanlier Nevin, 2007, J Pak Med Assoc, V57, P491; Strzelec K, 2011, ACTA VET BRNO, V80, P101, DOI 10.2754/avb201180010101; SUKUMAR R, 1988, ANIM BEHAV, V36, P1233, DOI 10.1016/S0003-3472(88)80084-8; Suter IC, 2014, ENDANGER SPECIES RES, V24, P1, DOI 10.3354/esr00578; Takada H, 1998, INT J OBESITY, V22, P470, DOI 10.1038/sj.ijo.0800610; Tamashiro KL, 2011, STRESS, V14, P468, DOI 10.3109/10253890.2011.606341; Thitaram C., 2012, Japanese Journal of Zoo and Wildlife Medicine, V17, P91; Tipprasert P, 2001, INT WORKSH DOM CAT A; Touma C, 2005, ANN NY ACAD SCI, V1046, P54, DOI 10.1196/annals.1343.006; Vegiopoulos A, 2007, MOL CELL ENDOCRINOL, V275, P43, DOI 10.1016/j.mce.2007.05.015; WANG CN, 1995, ARTERIOSCL THROM VAS, V15, P1481, DOI 10.1161/01.ATV.15.9.1481; Wang Minghan, 2005, Nutr Metab (Lond), V2, P3, DOI 10.1186/1743-7075-2-3; Wang YT, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0515-5; Watson R, 2013, GEN COMP ENDOCR, V186, P16, DOI 10.1016/j.ygcen.2013.02.001; WATSON TDG, 1990, VET REC, V127, P498; Weerakhun S, 2010, KKU VET J, V20, P208; Weinstein SP, 1998, METABOLISM, V47, P3, DOI 10.1016/S0026-0495(98)90184-6; Wemmer C, 2006, ZOO BIOL, V25, P187, DOI 10.1002/zoo.20099; WESTERN D, 1984, AFR J ECOL, V22, P229, DOI 10.1111/j.1365-2028.1984.tb00699.x; Wijeyamohan S, 2015, ZOO BIOL, V34, P53, DOI 10.1002/zoo.21181; WOO J, 1992, CLIN CHEM, V38, P2190; Young KE, 2011, J APPL SCI TECHOL, V1, P266; YOUSEF MK, 1971, COMP BIOCHEM PHYSIOL, V40, P789, DOI 10.1016/0300-9629(71)90264-7	86	19	19	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0204965	10.1371/journal.pone.0204965	http://dx.doi.org/10.1371/journal.pone.0204965			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3QJ	30278087	Green Submitted, Green Published, gold			2022-12-26	WOS:000446010200029
J	Zhang, QB; Yu, K; Liu, ZK; Wang, DW; Zhao, YY; Yin, SJ; Liu, ZX				Zhang, Qing-bin; Yu, Kai; Liu, Zekun; Wang, Dawei; Zhao, Yuanyuan; Yin, Sanjun; Liu, Zexian			Prediction of prkC-mediated protein serine/threonine phosphorylation sites for bacteria	PLOS ONE			English	Article							BACILLUS-SUBTILIS; ESCHERICHIA-COLI; KINASE; PHOSPHOPROTEOME; SER/THR/TYR; LOGO	As an abundant post-translational modification, reversible phosphorylation is critical for the dynamic regulation of various biological processes. prkC, a critical serine/threonine-protein kinase in bacteria, plays important roles in regulation of signaling transduction. Identification of prkC-specific phosphorylation sites is fundamental for understanding the molecular mechanism of phosphorylation-mediated signaling. However, experimental identification of substrates for prkC is time-consuming and labor-intensive, and computational methods for kinase-specific phosphorylation prediction in bacteria have yet to be developed. In this study, we manually curated the experimentally identified substrates and phosphorylation sites of prkC from the published literature. The analyses of the sequence preferences showed that the substrate recognition pattern for prkC might be miscellaneous, and a complex strategy should be employed to predict potential prkC-specific phosphorylation sites. To develop the predictor, the amino acid location feature extraction method and the support vector machine algorithm were employed, and the methods achieved promising performance. Through 10-fold cross validation, the predictor reached a sensitivity of 91.67% at the specificity of 95.12%. Then, we developed freely accessible software, which is provided at http://free.cancerbio.info/prkc/. Based on the predictor, hundreds of potential prkC-specific phosphorylation sites were annotated based on the known bacterial phosphorylation sites. prkC-PSP was the first predictor for prkC-specific phosphorylation sites, and its prediction performance was promising. We anticipated that these analyses and the predictor could be helpful for further studies of prkC-mediated phosphorylation.	[Zhang, Qing-bin] Guangzhou Med Univ, Key Lab Oral Med, Guangzhou Inst Oral Dis, Stomatol Hosp, Guangzhou, Guangdong, Peoples R China; [Yu, Kai; Liu, Zekun; Liu, Zexian] Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Canc Ctr, Guangzhou, Guangdong, Peoples R China; [Liu, Zekun] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Hepatobiliary Surg, Wuhan, Hubei, Peoples R China; [Wang, Dawei] China Meitan Gen Hosp, Dept Thorac Surg, Beijing, Peoples R China; [Zhao, Yuanyuan] Hefei Normal Univ, Sch Arts & Media, Hefei, Anhui, Peoples R China; [Yin, Sanjun] Healthtimegene Inst, Shenzhen, Peoples R China	Guangzhou Medical University; State Key Lab Oncology South China; Sun Yat Sen University; Huazhong University of Science & Technology; Hefei Normal University	Zhang, QB (corresponding author), Guangzhou Med Univ, Key Lab Oral Med, Guangzhou Inst Oral Dis, Stomatol Hosp, Guangzhou, Guangdong, Peoples R China.; Liu, ZX (corresponding author), Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Canc Ctr, Guangzhou, Guangdong, Peoples R China.	doctorqingbin@hotmail.com; liuzx@sysucc.org.cn	Liu, Zexian/D-1153-2011	Liu, Zexian/0000-0001-9698-0610; Yu, Kai/0000-0003-3343-2902; Qing-bin, Zhang/0000-0002-8523-9293	Natural Science Foundation of China [31501069]; Fundamental Research Funds for the Central Universities [SYSU:16ykzd06]; Science and Technology Planning Project of Guangdong Province [201511013, 2016ZC0147]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Science and Technology Planning Project of Guangdong Province	This work was supported by grants from the Natural Science Foundation of China (31501069), the Fundamental Research Funds for the Central Universities (SYSU:16ykzd06), and the Science and Technology Planning Project of Guangdong Province (201511013, 2016ZC0147). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akmal MA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181966; Butt AH, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8370132; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022913; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Cousin C, 2013, FEMS MICROBIOL LETT; COZZONE AJ, 1988, ANNU REV MICROBIOL, V42, P97, DOI 10.1146/annurev.mi.42.100188.000525; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Ehsan A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19491-y; Eymann C, 2007, PROTEOMICS, V7, P3509, DOI 10.1002/pmic.200700232; FERNLEY RT, 1981, BIOSCIENCE REP, V1, P497, DOI 10.1007/BF01121583; Fry B, 2000, APPL ENVIRON MICROB, V66, P4045, DOI 10.1128/AEM.66.9.4045-4049.2000; Hallier M, 2004, J BIOL CHEM, V279, P25978, DOI 10.1074/jbc.M314086200; He ZY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S22; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Johnson LN, 2009, BIOCHEM SOC T, V37, P627, DOI 10.1042/BST0370627; Khan YD, 2018, ANAL BIOCHEM, V550, P109, DOI 10.1016/j.ab.2018.04.021; Kristich CJ, 2007, P NATL ACAD SCI USA, V104, P3508, DOI 10.1073/pnas.0608742104; Lakshminarayan H, 2008, PROTEIN EXPRES PURIF, V58, P309, DOI 10.1016/j.pep.2007.12.012; LIPPMANN C, 1993, J BIOL CHEM, V268, P601; Macek B, 2008, MOL CELL PROTEOMICS, V7, P299, DOI 10.1074/mcp.M700311-MCP200; Macek B, 2007, MOL CELL PROTEOMICS, V6, P697, DOI 10.1074/mcp.M600464-MCP200; Madec E, 2002, MOL MICROBIOL, V46, P571, DOI 10.1046/j.1365-2958.2002.03178.x; Miller ML, 2009, PROTEOMICS, V9, P116, DOI 10.1002/pmic.200800285; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Ohlsen K, 2010, INT J MED MICROBIOL, V300, P137, DOI 10.1016/j.ijmm.2009.08.016; Page CA, 2013, J BACTERIOL, V195, P1750, DOI 10.1128/JB.02277-12; Pawson T, 2005, TRENDS BIOCHEM SCI, V30, P286, DOI 10.1016/j.tibs.2005.04.013; Pereira SFF, 2011, MICROBIOL MOL BIOL R, V75, P192, DOI 10.1128/MMBR.00042-10; Raju TNK, 2000, LANCET, V356, P81, DOI 10.1016/S0140-6736(05)73417-6; Ren J, 2009, CELL RES, V19, P271, DOI 10.1038/cr.2009.6; Schumacher MA, 2009, SCIENCE, V323, P396, DOI 10.1126/science.1163806; Squeglia F, 2011, J AM CHEM SOC, V133, P20676, DOI 10.1021/ja208080r; Vacic V, 2006, BIOINFORMATICS, V22, P1536, DOI 10.1093/bioinformatics/btl151; Xu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055844; Xue Y, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-163; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Zou L, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-247	40	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0203840	10.1371/journal.pone.0203840	http://dx.doi.org/10.1371/journal.pone.0203840			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3QJ	30278050	Green Published, gold, Green Submitted			2022-12-26	WOS:000446010200006
J	Lee, JK; Bloom, J; Zubeldia-Plazaola, A; Garbe, JC; Stampfer, MR; LaBarge, MA				Lee, Jonathan K.; Bloom, Jessica; Zubeldia-Plazaola, Arantzazu; Garbe, James C.; Stampfer, Martha R.; LaBarge, Mark A.			Different culture media modulate growth, heterogeneity, and senescence in human mammary epithelial cell cultures	PLOS ONE			English	Article							HUMAN BREAST-CANCER; CATALYTIC SUBUNIT; TRANSFORMATION; INACTIVATION; MYC; TUMORIGENESIS; METHYLATION; PROGENITORS; TELOMERASE; EXPRESSION	The ability to culture normal human mammary epithelial cells (HMEC) greatly facilitates experiments that seek to understand both normal mammary cell biology and the many differences between normal and abnormal human mammary epithelia. To maximize in vivo relevance, the primary cell culture conditions should maintain cells in states that resemble in vivo as much as possible. Towards this goal, we compared the properties of HMEC strains from two different reduction mammoplasty tissues that were grown in parallel using different media and culture conditions. Epithelial organoids were initiated into three different media: two commonly used serum-free-media, MCDB 170-type (e.g. MEGM) and WIT-P, and a low stress media, M87A. Growth, lineage heterogeneity, p16 protein expression, and population doublings to senescence were measured for each culture condition. MCDB 170 caused rapid senescence and loss of heterogeneity within 2 to 3 passages, but some cultures went through the 1 to 2 month process of selection to generate clonal finite post-selection post-stasis cells. WIT-P caused impressive expansion of luminal cells in 2nd passage followed by their near complete disappearance by passage 4 and senescence shortly thereafter. M87A supported as much as twice the number of population doublings compared to either serum-free medium, and luminal and myoepithelial cells were present for as many as 8 passages. Thus, of the three media compared, WIT-P and MCDB 170 imposed rapid senescence and loss of lineage heterogeneity, phenotypes consistent with cells maintained in high-stress conditions, while M87A supported cultures that maintained multiple lineages and robust growth for up to 60 population doublings. In conjunction with previous studies examining the molecular properties of cultures grown in these media, we conclude that M87A medium is most able to support long-term culture of multiple lineages similar to in vivo conditions, thereby facilitating investigations of normal HMEC biology relevant to the mammary gland in situ.	[Lee, Jonathan K.; Garbe, James C.; Stampfer, Martha R.; LaBarge, Mark A.] Lawrence Berkeley Natl Lab, Biol Syst & Engn Div, Berkeley, CA 94720 USA; [Bloom, Jessica; LaBarge, Mark A.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Populat Sci, Duarte, CA 91010 USA; [Zubeldia-Plazaola, Arantzazu] Univ Barcelona, Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; City of Hope; Beckman Research Institute of City of Hope; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Stampfer, MR; LaBarge, MA (corresponding author), Lawrence Berkeley Natl Lab, Biol Syst & Engn Div, Berkeley, CA 94720 USA.; LaBarge, MA (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Populat Sci, Duarte, CA 91010 USA.	mrstampfer@lbl.gov; mlabarge@coh.org		LaBarge, Mark/0000-0003-2405-4719	National Institutes of Aging [R01AG040081]; Era of Hope Scholar Award from the Congressionally Directed Medical Research Program's Breast Cancer Research Program [BC141351]; U.S. Department of Energy [DE-AC02-05CH11231]; NATIONAL INSTITUTE ON AGING [R01AG040081] Funding Source: NIH RePORTER	National Institutes of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Era of Hope Scholar Award from the Congressionally Directed Medical Research Program's Breast Cancer Research Program; U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Aging (R01AG040081), and the Era of Hope Scholar Award from the Congressionally Directed Medical Research Program's Breast Cancer Research Program (BC141351). MRS and JCG are supported by U.S. Department of Energy under Contract No. DE-AC02-05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brenner AJ, 1998, ONCOGENE, V17, P199, DOI 10.1038/sj.onc.1201919; Chanson L, 2011, P NATL ACAD SCI USA, V108, P3264, DOI 10.1073/pnas.1019556108; Crawford YG, 2004, CANCER CELL, V5, P263, DOI 10.1016/S1535-6108(04)00023-6; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Elster D, 2016, CELL CYCLE, V15, P2551, DOI 10.1080/15384101.2016.1207837; Feijoo P, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-015-0667-z; Garbe JC, 2007, CELL CYCLE, V6, P1927, DOI 10.4161/cc.6.15.4519; Garbe JC, 2014, CELL CYCLE, V13, P3423, DOI 10.4161/15384101.2014.954456; Garbe JC, 2012, CANCER RES, V72, P3687, DOI 10.1158/0008-5472.CAN-12-0157; Garbe JC, 2009, CANCER RES, V69, P7557, DOI 10.1158/0008-5472.CAN-09-0270; HAMMOND SL, 1984, P NATL ACAD SCI-BIOL, V81, P5435, DOI 10.1073/pnas.81.17.5435; HERMAN JG, 1995, CANCER RES, V55, P4525; Holst CR, 2003, CANCER RES, V63, P1596; Hsu TYT, 2015, NATURE, V525, P384, DOI 10.1038/nature14985; Ince TA, 2007, CANCER CELL, V12, P160, DOI 10.1016/j.ccr.2007.06.013; Keller PJ, 2012, P NATL ACAD SCI USA, V109, P2772, DOI 10.1073/pnas.1017626108; Keller PJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2755; Kessler JD, 2012, SCIENCE, V335, P348, DOI 10.1126/science.1212728; Kim H, 2002, BIOCHEM J, V365, P765, DOI 10.1042/BJ20011848; LaBarge MA, 2013, JOVE-J VIS EXP, DOI 10.3791/50011; LaBarge MA, 2009, INTEGR BIOL-UK, V1, P70, DOI 10.1039/b816472j; Lee JK, 2015, FRONTIERS CELL DEV B; Li YZ, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-7; Miyano M, 2017, AGING-US, V9, P2025, DOI 10.18632/aging.101298; Moumen M, 2011, INT J DEV BIOL, V55, P763, DOI 10.1387/ijdb.113385mm; Novak P, 2009, CANCER RES, V69, P5251, DOI 10.1158/0008-5472.CAN-08-4977; Pelissier FA, 2014, CELL REP, V7, P1926, DOI 10.1016/j.celrep.2014.05.021; Romanov SR, 2001, NATURE, V409, P633, DOI 10.1038/35054579; STAMPFER M, 1980, IN VITRO CELL DEV B, V16, P415; Stampfer M, 1985, J TISSUE CULTURE MET, V9, P107; STAMPFER MR, 1982, IN VITRO CELL DEV B, V18, P531; Stampfer MR, 2001, P NATL ACAD SCI USA, V98, P4498, DOI 10.1073/pnas.071483998; STAMPFER MR, 1985, P NATL ACAD SCI USA, V82, P2394, DOI 10.1073/pnas.82.8.2394; Stampfer MR, 2013, CELL MOL BIOL BREAST, P323, DOI [10.1007/978-1-62703-634-4_15, DOI 10.1007/978-1-62703-634-4_15]; TAYLORPAPADIMITRIOU J, 1989, J CELL SCI, V94, P403; Vatter FAP, 2018, CELL REP, V23, P1205, DOI 10.1016/j.celrep.2018.03.114; Wu M, 2009, P NATL ACAD SCI USA, V106, P7022, DOI 10.1073/pnas.0811785106	37	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204645	10.1371/journal.pone.0204645	http://dx.doi.org/10.1371/journal.pone.0204645			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273377	Green Published, gold			2022-12-26	WOS:000446124700029
J	Ugarte-Berzal, E; Berghmans, N; Boon, L; Martens, E; Vandooren, J; Cauwe, B; Thijs, G; Proost, P; Van Damme, J; Opdenakker, G				Ugarte-Berzal, Estefania; Berghmans, Nele; Boon, Lise; Martens, Erik; Vandooren, Jennifer; Cauwe, Benedicte; Thijs, Greet; Proost, Paul; Van Damme, Jo; Opdenakker, Ghislain			Gelatinase B/matrix metalloproteinase-9 is a phase-specific effector molecule, independent from Fas, in experimental autoimmune encephalomyelitis	PLOS ONE			English	Article							MYELIN BASIC-PROTEIN; MULTIPLE-SCLEROSIS; CEREBROSPINAL-FLUID; MATRIX METALLOPROTEINASES; DEFICIENT MICE; MMP-9; DISEASES; CLEAVAGE; BIOLOGY; BRAIN	Gelatinase B/matrix metalloproteinase-9 (MMP-9) triggers multiple sclerosis (MS) and the animal model of experimental autoimmune encephalomyelitis (EAE) by the breakdown of the blood-brain barrier. Interestingly, MMP-9 is beneficial in systemic autoimmunity caused by Fas-deficiency. Fas-deficient (fas(lpr)) and Fas-ligand-deficient mice are protected against EAE. We here investigated the interaction between Fas and MMP-9 in the setting of induction of EAE and compared short- and long-term effects. We provoked EAE with myelin oligodendrocyte glycoprotein (MOG) peptide and compared EAE development in four genotypes (wild-type (WT), single knockout mmp-9(-/-), fas(lpr), and mmp-9(-/-)/fas(lpr)) and monitored leukocytes, cytokines and chemokines as immunological parameters. As expected, fas(lpr) mice were resistant against EAE induction, whereas MMP-9 single knockout mice were not. In the double mmp-9(-/-)/fas(lpr) mice the effects on disease scores pointed to independent rather than interrelated disease mechanisms. On a short term, after EAE induction leukocytes infiltrated into the brain and cytokine and chemokine levels were significantly higher in all the four genotypes studied, even in the fas(lpr) and mmp-9(-/-)/fas(lpr), which did not develop clinical disease. The levels of MMP-9 but not of MMP-2 were increased in the brain and in the peripheral organs after EAE induction. After 40 days all the animals recovered and did not show signs of EAE. However, the absence of MMP-9 in the remission phase suggested a protective role of MMP-9 in the late phase of the disease, because single mmp-9(-/-) mice presented a delayed remission in comparison with WT animals suggesting a phase-dependent role of MMP-9 in the disease. Nevertheless, the levels of some cytokines and chemokines remained higher than in control animals even 100 days after EAE induction, attesting to a prolonged state of immune activation. We thus yielded new insights and useful markers to monitor this activated immune status. Furthermore, MMP-9 but not MMP-2 levels remained increased in the brains and, to a higher extend, in the spleens of the WT mice even during the remission phase, which is in line with the role of MMP-9 as a useful marker and a protective factor for EAE in the remission phase.	[Ugarte-Berzal, Estefania; Boon, Lise; Martens, Erik; Vandooren, Jennifer; Cauwe, Benedicte; Thijs, Greet; Opdenakker, Ghislain] Univ Leuven, KU Leuven, Lab Immunol, Dept Microbiol & Immunol,Rega Inst Med Res, Leuven, Belgium; [Berghmans, Nele; Proost, Paul; Van Damme, Jo] Univ Leuven, KU Leuven, Lab Mol Immunol, Dept Microbiol & Immunol,Rega Inst Med Res, Leuven, Belgium	KU Leuven; KU Leuven	Opdenakker, G (corresponding author), Univ Leuven, KU Leuven, Lab Immunol, Dept Microbiol & Immunol,Rega Inst Med Res, Leuven, Belgium.	Ghislain.opdenakker@kuleuvan.be	Vandooren, Jennifer/H-5318-2019; Vandooren, Jennifer/O-6424-2018; Martens, Erik/F-9214-2015; Proost, Paul/V-3052-2017; Opdenakker, Ghislain/Q-3130-2017; Opdenakker, Ghislain/V-8562-2019	Vandooren, Jennifer/0000-0002-7157-3370; Martens, Erik/0000-0002-7947-6567; Proost, Paul/0000-0002-0133-5545; Opdenakker, Ghislain/0000-0003-1714-2294; Opdenakker, Ghislain/0000-0003-1714-2294; Van Damme, Jo/0000-0002-6707-1167	Geconcerteerde OnderzoeksActies [GOA 2013/015, C16/17/010]; Foundation for Scientific Research of Flanders (FWO-Vlaanderen); Charcot Foundation (Belgium)	Geconcerteerde OnderzoeksActies; Foundation for Scientific Research of Flanders (FWO-Vlaanderen)(FWO); Charcot Foundation (Belgium)	The present study was possible thanks to funding by the Geconcerteerde OnderzoeksActies (GOA 2013/015) and (C16/17/010), the Foundation for Scientific Research of Flanders (FWO-Vlaanderen) and the Charcot Foundation (Belgium).	Agrawal S, 2006, J EXP MED, V203, P1007, DOI 10.1084/jem.20051342; Agrawal SM, 2007, INT REV NEUROBIOL, V79, P99, DOI 10.1016/S0074-7742(07)79005-0; Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554; Berghmans N, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-243; Brandle SM, 2016, P NATL ACAD SCI USA, V113, P7864, DOI 10.1073/pnas.1522730113; Cauwe B, 2011, J AUTOIMMUN, V36, P239, DOI 10.1016/j.jaut.2011.02.002; Cauwe B, 2010, CRIT REV BIOCHEM MOL, V45, P351, DOI 10.3109/10409238.2010.501783; Cauwe B, 2009, INTEGR BIOL-UK, V1, P404, DOI 10.1039/b904701h; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; de Bruyn M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15384; Descamps FJ, 2002, LAB INVEST, V82, P1607, DOI 10.1097/01.LAB.0000038556.54069.73; Dittel BN, 1999, J IMMUNOL, V162, P6392; Dowling P, 1996, J EXP MED, V184, P1513, DOI 10.1084/jem.184.4.1513; DSouza SD, 1996, J EXP MED, V184, P2361, DOI 10.1084/jem.184.6.2361; Dubois B, 1999, J CLIN INVEST, V104, P1507, DOI 10.1172/JCI6886; Dubois B, 2000, J CLIN INVEST, V106, P627, DOI 10.1172/JCI10910; Esparza J, 2004, FASEB J, V18, P1682, DOI 10.1096/fj.04-2445com; Ethell DW, 2003, J CLIN IMMUNOL, V23, P363, DOI 10.1023/A:1025317516396; Fainardi E, 2006, MULT SCLER J, V12, P294, DOI 10.1191/135248506ms1274oa; Garrido-Mesa N, 2013, BRIT J PHARMACOL, V169, P337, DOI 10.1111/bph.12139; Gerwien H, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf8020; GIJBELS K, 1993, J NEUROSCI RES, V36, P432, DOI 10.1002/jnr.490360409; GIJBELS K, 1992, J NEUROIMMUNOL, V41, P29, DOI 10.1016/0165-5728(92)90192-N; GRABAR P, 1974, LANCET, V1, P1320; Hu JL, 2007, NAT REV DRUG DISCOV, V6, P480, DOI 10.1038/nrd2308; Kallaur AP, 2013, MOL MED REP, V7, P1010, DOI 10.3892/mmr.2013.1256; Kim JH, 2006, NEUROBIOL DIS, V21, P626, DOI 10.1016/j.nbd.2005.09.009; Kruger A, 2010, BBA-MOL CELL RES, V1803, P95, DOI 10.1016/j.bbamcr.2009.09.016; Larsen PH, 2003, J NEUROSCI, V23, P11127, DOI 10.1523/jneurosci.23-35-11127.2003; Legroux L, 2015, J NEUROSCI METH, V247, P23, DOI 10.1016/j.jneumeth.2015.03.021; Loma I, 2011, CURR NEUROPHARMACOL, V9, P409, DOI 10.2174/157015911796557911; McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202; McQuibban GA, 2001, J BIOL CHEM, V276, P43503, DOI 10.1074/jbc.M107736200; Metz LM, 2017, NEW ENGL J MED, V376, P2122, DOI 10.1056/NEJMoa1608889; Opdenakker G, 2003, LANCET NEUROL, V2, P747, DOI 10.1016/S1474-4422(03)00587-8; OPDENAKKER G, 1994, IMMUNOL TODAY, V15, P103, DOI 10.1016/0167-5699(94)90151-1; Opdenakker G, 2016, TRENDS MOL MED, V22, P746, DOI 10.1016/j.molmed.2016.07.002; Overall CM, 2006, CANCER METAST REV, V25, P69, DOI 10.1007/s10555-006-7890-0; Paemen L, 1996, BIOCHEM PHARMACOL, V52, P105, DOI 10.1016/0006-2952(96)00168-2; PROOST P, 1993, BIOCHEM BIOPH RES CO, V192, P1175, DOI 10.1006/bbrc.1993.1540; Proost P, 2017, J AUTOIMMUN, V85, P45, DOI 10.1016/j.jaut.2017.06.009; Rosenberg GA, 2002, NEUROSCIENTIST, V8, P586, DOI 10.1177/1073858402238517; Sabelko-Downes KA, 1999, J EXP MED, V189, P1195, DOI 10.1084/jem.189.8.1195; Shiryaev SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004952; Song J, 2015, CELL REP, V10, P1040, DOI 10.1016/j.celrep.2015.01.037; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Van den Steen PE, 2000, BLOOD, V96, P2673, DOI 10.1182/blood.V96.8.2673.h8002673_2673_2681; Van den Steen PE, 2006, J BIOL CHEM, V281, P18626, DOI 10.1074/jbc.M512308200; Vanden Berghe T, 2015, IMMUNITY, V43, P200, DOI 10.1016/j.immuni.2015.06.011; Vandooren J, 2013, CRIT REV BIOCHEM MOL, V48, P222, DOI 10.3109/10409238.2013.770819; Vandooren J, 2013, NAT METHODS, V10, P211, DOI [10.1038/NMETH.2371, 10.1038/nmeth.2371]; Waldner H, 1997, J IMMUNOL, V159, P3100	52	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0197944	10.1371/journal.pone.0197944	http://dx.doi.org/10.1371/journal.pone.0197944			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273366	Green Submitted, Green Published, gold			2022-12-26	WOS:000446124700001
J	Aainaa, HN; Ahmed, OH; Ab Majid, NM				Aainaa, Hasbullah Nur; Ahmed, Osumanu Haruna; Ab Majid, Nik Muhamad			Effects of clinoptilolite zeolite on phosphorus dynamics and yield of Zea Mays L. cultivated on an acid soil	PLOS ONE			English	Article							ORGANIC-ACIDS; AMMONIA VOLATILIZATION; IRON REDUCTION; ROCK PHOSPHATE; USE EFFICIENCY; FRACTIONS; FERTILIZER; NITROGEN; UREA; AVAILABILITY	Efficient management of P fertilizers ensures good yield of crops and adequate food supply. In the acid soil of the tropics, soluble P is fixed by Al and Fe. Exploitation of the high CEC and pH of Clinoptilolite zeolite (CZ) could mitigate low soil pH and P fixation in acid soils. This study was undertaken to determine the effects of amending a weathered acid soil with CZ on: (i) soil P availability and other related soil chemical properties, and (ii) nutrient concentration, nutrient uptake, above-ground biomass, agronomic efficiency, and yield of Zea mays L. on a tropical acidic soil. Triple superphosphate (TSP), Egypt Rock phosphate (ERP), and Christmas Island Rock phosphate (CIRP) were used as P sources. The treatments evaluated were: (i) soil alone, (ii) 100% recommended fertilizer rate (NPK), and (iii) 75% fertilizer rate + Clinoptilolite zeolite. Selected soil chemical properties and P availability were determined before and after field trials. Zea mays L. above-ground biomass, nutrient concentration, nutrient uptake, agronomic efficiency, and fresh cob yield were also determined. Results revealed that the effects of treatments with and without CZ treatments on soil pH, P fractions, soil acidity, dry matter production, yield of maize, nutrient uptake, and agronomic efficiency were similar. Hence, suggesting CZ inclusion in the fertilization program of Zea mays L is beneficial in terms of reducing excessive or unbalanced use of chemical fertilizers due to reduction of fertilizers usage by 25%.	[Aainaa, Hasbullah Nur] Univ Malaysia Sabah, Fac Sustainable Agr, Sandakan Campus, Sandakan, Sabah, Malaysia; [Aainaa, Hasbullah Nur; Ahmed, Osumanu Haruna] Univ Putra Malaysia, Fac Agr & Food Sci, Dept Crop Sci, Bintulu Sarawak Campus, Bintulu, Sarawak, Malaysia; [Ahmed, Osumanu Haruna] Univ Putra Malaysia, Inst Trop Agr & Food Secur ITAFoS, Serdang, Selangor, Malaysia; [Ab Majid, Nik Muhamad] Univ Putra Malaysia, Inst Trop Forestry & Forest Prod INTROP, Serdang, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia	Aainaa, HN (corresponding author), Univ Malaysia Sabah, Fac Sustainable Agr, Sandakan Campus, Sandakan, Sabah, Malaysia.; Aainaa, HN (corresponding author), Univ Putra Malaysia, Fac Agr & Food Sci, Dept Crop Sci, Bintulu Sarawak Campus, Bintulu, Sarawak, Malaysia.	aainaa.hasbullah@ums.edu.my	Ahmed, Osumanu Haruna/ABH-1031-2021	NUR AAINAA, HASBULLAH/0000-0003-2496-5459	Ministry of Higher Education, Malaysia [5525019]; Universiti Putra Malaysia [5525019]; Universiti Putra Malaysia; (Fundamental Research Grant Scheme, FRGS) from the Ministry of Higher Education, Malaysia	Ministry of Higher Education, Malaysia(Ministry of Education, Malaysia); Universiti Putra Malaysia; Universiti Putra Malaysia; (Fundamental Research Grant Scheme, FRGS) from the Ministry of Higher Education, Malaysia	The authors gratefully acknowledge the financial support from the Ministry of Higher Education, Malaysia and Universiti Putra Malaysia for the collaborative research (ERGS grant number 5525019). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors gratefully acknowledge the financial support (Fundamental Research Grant Scheme, FRGS) from the Ministry of Higher Education, Malaysia and Universiti Putra Malaysia for the collaborative research.	Aainaa H. N., 2015, Sustainable Agriculture Research, V4, P56; Adhami E, 2013, J SOIL SCI PLANT NUT, V13, P11, DOI [10.4067/S0718-95162012005000002, 10.4067/S0718-95162013005000002]; Ahmed OH, 2010, INT J PHYS SCI, V5, P2393; Ahmed OH, 2017, ZEOLITES UNLOCK PHOS, P188; Akande M.O., 2008, NIG J SOIL SCI, V18, P167; Al-Busaidi A, 2008, J PLANT NUTR, V31, P1159, DOI 10.1080/01904160802134434; Allen E R, 1995, NATURAL ZEOLITES, P477; ALLEN ER, 1993, SOIL SCI SOC AM J, V57, P1368, DOI 10.2136/sssaj1993.03615995005700050034x; Basak BB, 2016, GEODERMA, V263, P104, DOI 10.1016/j.geoderma.2015.09.016; Beqiraj E, 2008, CARPATH J EARTH ENV, V3, P33; Bidin A., 1986, P 2 IMPHOS REG SEM S, P161; Bremner J. M., 1982, METHODS SOIL ANAL 2, P595; Bundy L. G., 2005, Phosphorus: agriculture and the environment, P685; Cassman KG, 2002, AMBIO, V31, P132, DOI 10.1639/0044-7447(2002)031[0132:ANUEAN]2.0.CO;2; Cerozi BD, 2016, BIORESOURCE TECHNOL, V219, P778, DOI 10.1016/j.biortech.2016.08.079; Chacon N, 2006, BIOGEOCHEMISTRY, V78, P67, DOI 10.1007/s10533-005-2343-3; Cordell D, 2009, GLOBAL ENVIRON CHANG, V19, P292, DOI 10.1016/j.gloenvcha.2008.10.009; Cottenie A., 1980, FAO SOILS B, V38, P70; CROSS AF, 1995, GEODERMA, V64, P197, DOI 10.1016/0016-7061(94)00023-4; Delve RJ, 2009, NUTR CYCL AGROECOSYS, V84, P293, DOI 10.1007/s10705-008-9243-6; Dobermann A., 2005, AGRON FAC PUBL, V316, P1; Duputel M, 2013, APPL GEOCHEM, V35, P120, DOI 10.1016/j.apgeochem.2013.03.018; FAN MX, 1993, SOIL SCI SOC AM J, V57, P839, DOI 10.2136/sssaj1993.03615995005700030034x; FENN LB, 1986, FERT RES, V9, P265, DOI 10.1007/BF01050352; FENN LB, 1990, FERT RES, V21, P125, DOI 10.1007/BF01087421; Fixen PE, 2009, THE BETTER CROPS, V93, P8; Gasparatos D, 2006, COMMUN SOIL SCI PLAN, V37, P2375, DOI 10.1080/00103620600819891; Gichangi EM, 2009, SOIL SCI PLANT NUTR, V55, P764, DOI 10.1111/j.1747-0765.2009.00415.x; Goto I, 1980, J AGR SCI TOKYO NOGY, V25, P164; Grant C, 2005, CAN J PLANT SCI, V85, P3, DOI 10.4141/P03-182; GRIERSON PF, 1992, PLANT SOIL, V144, P259, DOI 10.1007/BF00012883; GROSSL PR, 1991, SOIL SCI SOC AM J, V55, P670, DOI 10.2136/sssaj1991.03615995005500030006x; Gupta PK, 2009, SOIL PLANT WATER FER, P350; Hamon RE, 2002, AUST J SOIL RES, V40, P1383, DOI 10.1071/SR02045; Harter RD, 2012, 48 ECH, V48, P1; Hasbullah Nur Aainaa, 2014, International Journal of Agricultural Research, V9, P136; Hasbullah Nur Aainaa, 2014, International Journal of Soil Science, V9, P55; He ZL, 2002, PLANT SOIL, V247, P253, DOI 10.1023/A:1021584300322; HOFFLAND E, 1992, PLANT SOIL, V140, P279, DOI 10.1007/BF00010605; Iyamuremye F, 1996, ADV AGRON, V56, P139, DOI 10.1016/S0065-2113(08)60181-9; Jalali M, 2010, GEODERMA, V155, P101, DOI 10.1016/j.geoderma.2009.11.030; Kavoosi M, 2007, COMMUN SOIL SCI PLAN, V38, P69, DOI 10.1080/00103620601093652; KOCHIAN LV, 1995, ANNU REV PLANT PHYS, V46, P237, DOI 10.1146/annurev.pp.46.060195.001321; Kolahchi Z, 2012, POL J ENVIRON STUD, V21, P395; Kuo S., AGRONOMY, V9; Latifah O, 2017, GEODERMA, V306, P152, DOI 10.1016/j.geoderma.2017.07.012; Leinonen H, 2001, WASTE MANAGE RES, V19, P45, DOI 10.1177/0734242X0101900106; Lija M, 2014, EMIR J FOOD AGR, V26, P284, DOI 10.9755/ejfa.v26i3.16183; Liptzin D, 2009, SOIL BIOL BIOCHEM, V41, P1696, DOI 10.1016/j.soilbio.2009.05.013; Malaysian Agricultural Research and Development Institute (MARDI), 1990, NEW SWEET CORN MASMA, P3; Malaysian Meteorological Department, 2014, 10 DAY AGROMETEOROGI; Mehlich A, 1953, DETERMINATION P K CA; MELESE A, 2015, APPL ENVIRON SOIL SC, V2015, pNIL1, DOI DOI 10.1155/2015/748390; Mengel K, 1982, Principles of plant nutrition.; MING DW, 1986, SOIL SCI SOC AM J, V50, P1618, DOI 10.2136/sssaj1986.03615995005000060047x; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Nnadi L. A, 1998, COMM SOIL SCI PLANT, V19, P79; Oburger E, 2009, SOIL BIOL BIOCHEM, V41, P449, DOI 10.1016/j.soilbio.2008.10.034; Okalebo J. R., 2002, LAB METHODS SOIL PLA, DOI 10.1016/0038-0717(72)90064-8; Omar Latifah, 2017, Bulgarian Journal of Agricultural Science, V23, P418; Omar L, 2011, AFR J MICROBIOL RES, V5, P3462; Paramananthan S., 2000, SOIL MALAYSIA THEIR, V1, P11; Paulos D, 1996, SOIL RESOURCE BASE S, P119; Pavinato PS, 2009, SOIL TILL RES, V105, P149, DOI 10.1016/j.still.2009.07.001; Peech M, 1965, METHODS SOIL ANAL 2, DOI [10.2134/agronmonogr9.2.c9, DOI 10.2134/AGRONMONOGR9.2, DOI 10.2134/AGRONMONOGR9.2.C9]; Piccolo A., 1996, HUMIC SUBSTANCES TER, P225, DOI [DOI 10.1016/B978-044481516-3/50006-2, 10.1016/B978-044481516-3/50006-2]; Pickering HW, 2002, SCI HORTIC-AMSTERDAM, V94, P333, DOI 10.1016/S0304-4238(02)00006-7; Pitcher SK, 2004, SCI TOTAL ENVIRON, V334, P161, DOI 10.1016/j.scitotenv.2004.04.035; Polat Ersin, 2004, Journal of Fruit and Ornamental Plant Research, V12, P183; Rabai KA, 2013, EMIR J FOOD AGR, V25, P1; Rahmani A. R., 2004, International Journal of Environmental Science and Technology, V1, P125; Rowell D. L., 1994, SOIL SCI METHODS APP, P169; Sabri MA, 2009, IFA CROSSROADS ASIA, P40; Schachtman DP, 1998, PLANT PHYSIOL, V116, P447, DOI 10.1104/pp.116.2.447; Sharpley AN, 2003, ARS, V149; Singh CP, 1998, BIORESOURCE TECHNOL, V63, P13, DOI 10.1016/S0960-8524(97)00104-1; Smit AL, 2009, 282 PLANT RES INT; Snyder C.S., 2007, NUTRIENT USE EFFICIE; Vaananen R, 2008, BOREAL ENVIRON RES, V13, P553; Xavier FAD, 2011, NUTR CYCL AGROECOSYS, V89, P31, DOI 10.1007/s10705-010-9373-5; Yangyuoru M., 2009, J APPL ECOL, V9, DOI [10.4314/wajae.v9i1.45676, DOI 10.4314/WAJAE.V9I1.45676]; Zhang FC, 2004, SOIL SCI SOC AM J, V68, P1890, DOI 10.2136/sssaj2004.1890; Zhang FS, 1997, PLANT SOIL, V196, P261, DOI 10.1023/A:1004214410785; Zhang TQ, 1997, SOIL SCI SOC AM J, V61, P485, DOI 10.2136/sssaj1997.03615995006100020017x; Zhang TQ, 1997, PLANT SOIL, V192, P133, DOI 10.1023/A:1004232417658	85	24	24	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204401	10.1371/journal.pone.0204401	http://dx.doi.org/10.1371/journal.pone.0204401			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30261005	Green Published, Green Submitted, gold			2022-12-26	WOS:000445907400043
J	El-Abhar, H; Abd El Fattah, MA; Wadie, W; El-Tanbouly, DM				El-Abhar, Hanan; Abd El Fattah, Mai A.; Wadie, Walaa; El-Tanbouly, Dalia M.			Cilostazol disrupts TLR-4, Akt/GSK-3 beta/CREB, and IL-6/JAK-2/STAT-3/SOCS-3 crosstalk in a rat model of Huntington's disease	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; GLYCOGEN-SYNTHASE KINASE-3; TRAUMATIC BRAIN-INJURY; TUMOR-NECROSIS-FACTOR; WHITE-MATTER DAMAGE; 3-NITROPROPIONIC ACID; CHROMOSOME-10 PHOSPHORYLATION; NEURODEGENERATIVE DISEASES; PI3K/AKT/GSK3-BETA PATHWAY; CYTOKINE SIGNALING-3	Countless neurodegenerative diseases are associated with perverse multiple targets of cyclic nucleotide signalling, hastening neuronal death. Cilostazol, a phosphodiesterase-III inhibitor, exerts neuroprotective effects against sundry models of neurotoxicity, however, its role against Huntington's disease (HD) has not yet been tackled. Hence, its modulatory effect on several signalling pathways using the 3-nitropropionic acid (3-NP) model was conducted. Animals were injected with 3-NP (10 mg/kg/day, i.p) for two successive weeks with or without the administration of cilostazol (100 mg/kg/day, p.o.). Contrary to the 3-NP effects, cilostazol largely preserved striatal dopaminergic neurons, improved motor coordination, and enhanced the immunohistochemical reaction of tyrosine hydroxylase enzyme. The anti-inflammatory effect of cilostazol was documented by the pronounced reduction of the toll like receptor-4 (TLR-4) protein expression and the inflammatory cytokine IL-6, but with a marked elevation in IL-10 striatal contents. As a consequence, cilostazol reduced IL-6 downstream signal, where it promoted the level of suppressor of cytokine signalling 3 (SOCS3), while abated the phosphorylation of Janus Kinase 2 (JAK-2) and Signal transducers and activators of transcription 3 (STAT-3). Phosphorylation of the protein kinase B/glycogen synthase kinase-3 beta/cAMP response element binding protein (Akt/GSK-3 beta/CREB) cue is another signalling pathway that was modulated by cilostazol to further signify its anti-inflammatory and antiapoptotic capacities. The latter was associated with a reduction in the caspase-3 expression assessed by immunohistochemical assay. In conclusion the present study provided a new insight into the possible mechanisms by which cilostazol possesses neuroprotective properties. These intersecting mechanisms involve the interference between TLR-4, IL-6-IL-10/JAK-2/STAT-3/SOCS-3, and Akt/GSK-3 beta/CREB signalling pathways.	[El-Abhar, Hanan; Abd El Fattah, Mai A.; Wadie, Walaa; El-Tanbouly, Dalia M.] Cairo Univ, Dept Pharmacol & Toxicol, Fac Pharm, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Cairo University	El-Abhar, H (corresponding author), Cairo Univ, Dept Pharmacol & Toxicol, Fac Pharm, Cairo, Egypt.	Hanan.elabhar@pharma.cu.edu.eg	El-Abhar, Hanan/L-2289-2019	El-Abhar, Hanan/0000-0001-8819-9891				Alexander WS, 2002, NAT REV IMMUNOL, V2, P410, DOI 10.1038/nri818; Alexi T, 1998, NEUROREPORT, V9, pR57, DOI 10.1097/00001756-199808030-00001; Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Antoniv TT, 2011, IMMUNOLOGY, V132, P567, DOI 10.1111/j.1365-2567.2010.03402.x; Atkins CM, 2007, EXP NEUROL, V208, P145, DOI 10.1016/j.expneurol.2007.08.011; Berlato C, 2002, J IMMUNOL, V168, P6404, DOI 10.4049/jimmunol.168.12.6404; Beurel E, 2008, J BIOL CHEM, V283, P21934, DOI 10.1074/jbc.M802481200; Beurel E, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-9; Bollen E, 2012, IUBMB LIFE, V64, P965, DOI 10.1002/iub.1104; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cannon JR, 2009, NEUROSCI LETT, V464, P14, DOI 10.1016/j.neulet.2009.08.023; Cha B, 2015, YONSEI MED J, V56, P862, DOI 10.3349/ymj.2015.56.3.862; Choi JM, 2002, J PHARMACOL EXP THER, V300, P787, DOI 10.1124/jpet.300.3.787; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dong Q, 2009, PLACENTA, V30, P11, DOI 10.1016/j.placenta.2008.10.008; Fleming SM, 2004, EXP NEUROL, V187, P418, DOI 10.1016/j.expneurol.2004.01.023; Gaudy AM, 2010, J BIOL CHEM, V285, P41356, DOI 10.1074/jbc.M110.159111; Glajch KE, 2012, BEHAV BRAIN RES, V230, P309, DOI 10.1016/j.bbr.2011.12.007; Gopinath K, 2016, CAN J PHYSIOL PHARM, V94, P65, DOI 10.1139/cjpp-2015-0035; Gotoh F, 2000, J Stroke Cerebrovasc Dis, V9, P147, DOI 10.1053/jscd.2000.7216; Grimes CA, 2001, J NEUROCHEM, V78, P1219, DOI 10.1046/j.1471-4159.2001.00495.x; Hanna DMF, 2015, PROG NEURO-PSYCHOPH, V60, P36, DOI 10.1016/j.pnpbp.2015.02.005; Honda F, 2006, STROKE, V37, P223, DOI 10.1161/01.STR.0000196977.76702.6d; Hong KW, 2003, J PHARMACOL EXP THER, V306, P1182, DOI 10.1124/jpet.103.052365; Hu XY, 2006, IMMUNITY, V24, P563, DOI 10.1016/j.immuni.2006.02.014; Jang M, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/237207; Kaisho T, 2006, J ALLERGY CLIN IMMUN, V117, P979, DOI 10.1016/j.jaci.2006.02.023; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Keller JN, 1998, J NEUROSCI, V18, P4439; KIMURA Y, 1985, ARZNEIMITTEL-FORSCH, V35-2, P1144; Klein A, 2009, BEHAV BRAIN RES, V199, P317, DOI 10.1016/j.bbr.2008.12.007; Knott EP, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040696; Lee JH, 2006, BRAIN RES, V1082, P182, DOI 10.1016/j.brainres.2006.01.088; Lee JH, 2004, J PHARMACOL EXP THER, V308, P896, DOI 10.1124/jpet.103.061853; Lee JH, 2003, BRAIN RES, V994, P91, DOI 10.1016/j.brainres.2003.09.021; Leegwater-Kim Julie, 2004, NeuroRx, V1, P128, DOI 10.1602/neurorx.1.1.128; Lu P, 2004, J NEUROSCI, V24, P6402, DOI 10.1523/JNEUROSCI.1492-04.2004; Ma JW, 2016, SCI REP-UK, V6, DOI 10.1038/srep23817; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Okun E, 2009, BRAIN RES REV, V59, P278, DOI 10.1016/j.brainresrev.2008.09.001; Ozawa Y, 2008, J BIOL CHEM, V283, P24561, DOI 10.1074/jbc.M802238200; Park SY, 2013, BRIT J PHARMACOL, V168, P1401, DOI 10.1111/bph.12021; Park SY, 2006, J PHARMACOL EXP THER, V317, P1238, DOI 10.1124/jpet.105.098509; Park SY, 2016, PLOS ONE, V11, DOI [10.1371/journatpone.0168286, DOI 10.1371/JOURNATPONE.0168286]; Perry VH, 2007, NAT REV IMMUNOL, V7, P161, DOI 10.1038/nri2015; PORTERACAILLIAU C, 1995, J NEUROSCI, V15, P3775, DOI 10.1523/jneurosci.15-05-03775.1995; Qin HW, 2016, J NEUROSCI, V36, P5144, DOI 10.1523/JNEUROSCI.4658-15.2016; Ragab D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095313; Rangel-Barajas C, 2015, AGING DIS, V6, P349, DOI 10.14336/AD.2015.0330; Rauch F, 2010, BEHAV BRAIN RES, V210, P46, DOI 10.1016/j.bbr.2010.02.003; Rodriguez AI, 2003, NEUROTOX RES, V5, P443, DOI 10.1007/BF03033174; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Satriotomo I, 2006, J NEUROCHEM, V98, P1353, DOI 10.1111/j.1471-4159.2006.04051.x; Shin S, 2014, MOL METAB, V3, P803, DOI 10.1016/j.molmet.2014.08.001; Shyu KG, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-15; Soliman A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015044; Stefanova N, 2007, MOVEMENT DISORD, V22, P2196, DOI 10.1002/mds.21671; Tamandl D, 2003, SHOCK, V20, P224, DOI 10.1097/00024382-200309000-00005; Tang SC, 2008, EXP NEUROL, V213, P114, DOI 10.1016/j.expneurol.2008.05.014; Tunez I, 2010, MOLECULES, V15, P878, DOI 10.3390/molecules15020878; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Wadie W, 2017, EUR J PHARMACOL, V814, P187, DOI 10.1016/j.ejphar.2017.08.027; Watanabe T, 2006, STROKE, V37, P1539, DOI 10.1161/01.STR.0000221783.08037.a9; Yan ZQ, 2018, CLIN IMMUNOL, V189, P4, DOI 10.1016/j.clim.2016.09.014; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938; Ye YL, 2007, EUR J PHARMACOL, V557, P23, DOI 10.1016/j.ejphar.2006.11.003; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Yu-Taeger L, 2012, J NEUROSCI, V32, P15426, DOI 10.1523/JNEUROSCI.1148-12.2012; Zhang W, 2016, PARKINSONS DIS-US, V2016, DOI 10.1155/2016/9450137; Zhao SF, 2012, NEUROL RES, V34, P400, DOI 10.1179/1743132812Y.0000000025; Zipp F, 2006, TRENDS NEUROSCI, V29, P518, DOI 10.1016/j.tins.2006.07.006	72	27	27	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0203837	10.1371/journal.pone.0203837	http://dx.doi.org/10.1371/journal.pone.0203837			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30260985	Green Published, gold, Green Submitted			2022-12-26	WOS:000445907400017
J	Willer, K; Fingerle, AA; Gromann, LB; De Marco, F; Herzen, J; Achterhold, K; Gleich, B; Muenzel, D; Scherer, K; Renz, M; Renger, B; Kopp, F; Kriner, F; Fischer, F; Braun, C; Auweter, S; Hellbach, K; Reiser, MF; Schroeter, T; Mohr, J; Yaroshenko, A; Maack, HI; Pralow, T; van der Heijden, H; Proksa, R; Koehler, T; Wieberneit, N; Rindt, K; Rummeny, EJ; Pfeiffer, F; Noel, PB				Willer, Konstantin; Fingerle, Alexander A.; Gromann, Lukas B.; De Marco, Fabio; Herzen, Julia; Achterhold, Klaus; Gleich, Bernhard; Muenzel, Daniela; Scherer, Kai; Renz, Martin; Renger, Bernhard; Kopp, Felix; Kriner, Fabian; Fischer, Florian; Braun, Christian; Auweter, Sigrid; Hellbach, Katharina; Reiser, Maximilian F.; Schroeter, Tobias; Mohr, Juergen; Yaroshenko, Andre; Maack, Hanns-Ingo; Pralow, Thomas; van der Heijden, Hendrik; Proksa, Roland; Koehler, Thomas; Wieberneit, Nataly; Rindt, Karsten; Rummeny, Ernst J.; Pfeiffer, Franz; Noel, Peter B.			X-ray dark-field imaging of the human lung-A feasibility study on a deceased body	PLOS ONE			English	Article							CONTRAST; DIAGNOSIS; PREVALENCE; BURDEN; COPD	Disorders of the lungs such as chronic obstructive pulmonary disease (COPD) are a major cause of chronic morbidity and mortality and the third leading cause of death in the world. The absence of sensitive diagnostic tests for early disease stages of COPD results in under-diagnosis of this treatable disease in an estimated 60-85% of the patients. In recent years a grating-based approach to X-ray dark-field contrast imaging has shown to be very sensitive for the detection and quantification of pulmonary emphysema in small animal models. However, translation of this technique to imaging systems suitable for humans remains challenging and has not yet been reported. In this manuscript, we present the first X-ray dark-field images of in-situ human lungs in a deceased body, demonstrating the feasibility of X-ray dark-field chest radiography on a human scale. Results were correlated with findings of computed tomography imaging and autopsy. The performance of the experimental radiography setup allows acquisition of multi-contrast chest X-ray images within clinical boundary conditions, including radiation dose. Upcoming clinical studies will have to demonstrate that this technology has the potential to improve early diagnosis of COPD and pulmonary diseases in general.	[Willer, Konstantin; Fingerle, Alexander A.; Gromann, Lukas B.; De Marco, Fabio; Herzen, Julia; Achterhold, Klaus; Gleich, Bernhard; Muenzel, Daniela; Scherer, Kai; Pfeiffer, Franz; Noel, Peter B.] Tech Univ Munich, Dept Phys, Garching, Germany; [Willer, Konstantin; Fingerle, Alexander A.; Gromann, Lukas B.; De Marco, Fabio; Herzen, Julia; Achterhold, Klaus; Gleich, Bernhard; Muenzel, Daniela; Scherer, Kai; Pfeiffer, Franz; Noel, Peter B.] Tech Univ Munich, Munich Sch BioEngn, Garching, Germany; [Fingerle, Alexander A.; Muenzel, Daniela; Renz, Martin; Renger, Bernhard; Kopp, Felix; Rummeny, Ernst J.; Pfeiffer, Franz; Noel, Peter B.] Tech Univ Munich, Dept Diagnost & Intervent Radiol, Klinikum Rechts Isar, Munich, Germany; [Kriner, Fabian; Fischer, Florian; Braun, Christian] Ludwig Maximilians Univ Munchen, Inst Forens Med, Munich, Germany; [Auweter, Sigrid; Hellbach, Katharina; Reiser, Maximilian F.] Ludwig Maximilians Univ Munchen, Inst Clin Radiol, Munich, Germany; [Schroeter, Tobias; Mohr, Juergen] Karlsruhe Inst Technol, Inst Microstruct Technol, Eggenstein Leopoldshafen, Germany; [Yaroshenko, Andre; Maack, Hanns-Ingo; Pralow, Thomas; van der Heijden, Hendrik; Wieberneit, Nataly; Rindt, Karsten] Philips Med Syst DMC GmbH, Hamburg, Germany; [Proksa, Roland; Koehler, Thomas] Philips GmbH Innovat Technol, Res Labs, Hamburg, Germany; [Koehler, Thomas; Pfeiffer, Franz] Tech Univ Munich, Inst Adv Study, Garching, Germany	Technical University of Munich; Technical University of Munich; Technical University of Munich; University of Munich; University of Munich; Helmholtz Association; Karlsruhe Institute of Technology; Philips; Philips Healthcare; Philips; Philips Research; Technical University of Munich	Pfeiffer, F (corresponding author), Tech Univ Munich, Dept Phys, Garching, Germany.; Pfeiffer, F (corresponding author), Tech Univ Munich, Munich Sch BioEngn, Garching, Germany.; Pfeiffer, F (corresponding author), Tech Univ Munich, Dept Diagnost & Intervent Radiol, Klinikum Rechts Isar, Munich, Germany.; Pfeiffer, F (corresponding author), Tech Univ Munich, Inst Adv Study, Garching, Germany.	franz.pfeiffer@tum.de	Gleich, Bernhard/D-4803-2009; Herzen, Julia/B-2368-2015	Gleich, Bernhard/0000-0002-0574-7678; Herzen, Julia/0000-0002-9456-1591; Pfeiffer, Franz/0000-0001-6665-4363; Noel, Peter/0000-0002-9671-6171; Achterhold, Klaus/0000-0002-8724-1637; De Marco, Fabio/0000-0002-3561-7305	European Research Council (ERC, H2020) [AdG 695045]; DFG (German Research Foundation) Gottfried Wilhelm Leibniz program; German Center for Lung Research; Hans und Klementia Langmatz-Foundation; TUM (Technical University of Munich) Institute for Advanced Study - German Excellence Initiative; Karlsruhe Nano Micro Facility (KNMF), a Helmholtz Research Infrastructure at Karlsruhe Institute of Technology (KIT)	European Research Council (ERC, H2020)(European Research Council (ERC)); DFG (German Research Foundation) Gottfried Wilhelm Leibniz program(German Research Foundation (DFG)); German Center for Lung Research; Hans und Klementia Langmatz-Foundation; TUM (Technical University of Munich) Institute for Advanced Study - German Excellence Initiative; Karlsruhe Nano Micro Facility (KNMF), a Helmholtz Research Infrastructure at Karlsruhe Institute of Technology (KIT)	We acknowledge financial support through the European Research Council (ERC, H2020, AdG 695045), the DFG (German Research Foundation) Gottfried Wilhelm Leibniz program, the German Center for Lung Research, the Hans und Klementia Langmatz-Foundation and the support of the TUM (Technical University of Munich) Institute for Advanced Study, funded by the German Excellence Initiative. This work was carried out with the support of the Karlsruhe Nano Micro Facility (KNMF, www.kit.edu/knmf), a Helmholtz Research Infrastructure at Karlsruhe Institute of Technology (KIT). Philips Healthcare provided support in the form of salaries for authors A.Y., H-I.M., T.P., H.H., R.P., T.K., N.W., and K.R, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2007, Ann ICRP, V37, P1, DOI 10.1016/j.icrp.2008.08.001; Bech M, 2013, SCI REP-UK, V3, DOI 10.1038/srep03209; Bech M, 2010, PHYS MED BIOL, V55, P5529, DOI 10.1088/0031-9155/55/18/017; Chabior M, 2011, MED PHYS, V38, P1189, DOI 10.1118/1.3553408; Drexler G, 1993, BESTIMMUNG ORGANDOSE; Endrizzi M, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/50/505102; Gromann LB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05101-w; Halbert RJ, 2003, CHEST, V123, P1684, DOI 10.1378/chest.123.5.1684; Hellbach K, 2016, INVEST RADIOL, V51, P597, DOI 10.1097/RLI.0000000000000285; Hellbach K, 2015, INVEST RADIOL, V50, P430, DOI 10.1097/RLI.0000000000000147; Koehler T, 2015, MED PHYS, V42, P1959, DOI 10.1118/1.4914420; Kottler C, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2723064; Liberty Mutual Insurance, 2019, 2019 WORKPL SAF IND; Malecki A, 2012, EPL-EUROPHYS LETT, V99, DOI 10.1209/0295-5075/99/48001; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Meinel FG, 2014, INVEST RADIOL, V49, P653, DOI 10.1097/RLI.0000000000000067; Mohr J, 2012, AIP CONF PROC, V1466, P41, DOI 10.1063/1.4742267; Momose A, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2013.0023; Pfeiffer F, 2008, NAT MATER, V7, P134, DOI 10.1038/nmat2096; Pfeiffer F, 2006, NAT PHYS, V2, P258, DOI 10.1038/nphys265; Rigon L, 2003, J PHYS D APPL PHYS, V36, pA107, DOI 10.1088/0022-3727/36/10A/322; Scherer K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00489-x; Scherer K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130776; Schroter TJ, 2017, REV SCI INSTRUM, V88, DOI 10.1063/1.4973632; Wall BF., 2011, HPACRCE028; Wang HB, 2016, SCI REP-UK, V6, DOI 10.1038/srep39607; Willner M, 2014, PHYS MED BIOL, V59, P1557, DOI 10.1088/0031-9155/59/7/1557; Yang F, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4898783; Yaroshenko A, 2016, SCI REP-UK, V6, DOI 10.1038/srep24269; Yaroshenko A, 2015, SCI REP-UK, V5, DOI 10.1038/srep17492; Yaroshenko A, 2013, RADIOLOGY, V269, P426, DOI 10.1148/radiol.13122413; Yashiro W, 2010, OPT EXPRESS, V18, P16890, DOI 10.1364/OE.18.016890	32	51	52	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204565	10.1371/journal.pone.0204565	http://dx.doi.org/10.1371/journal.pone.0204565			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30261038	Green Published, gold, Green Submitted			2022-12-26	WOS:000445907400068
J	Balakrishnan, S; Mironov, SL				Balakrishnan, Saju; Mironov, Sergej L.			Regenerative glutamate release in the hippocampus of Rett syndrome model mice	PLOS ONE			English	Article							HCN1 CHANNELS; RESPIRATORY NETWORK; KAINATE RECEPTORS; CALCIUM INFLUX; CA2+ CHANNELS; I-H; SYNAPSES; DENDRITES; CONTRIBUTES; ACTIVATION	Excess glutamate during intense neuronal activity is not instantly cleared and may accumulate in the extracellular space. This has various long-term consequences such as ectopic signaling, modulation of synaptic efficacy and excitotoxicity; the latter implicated in various neurodevelopmental and neurodegenerative diseases. In this study, the quantitative imaging of glutamate homeostasis of hippocampal slices from methyl-CpG binding protein 2 knock-out (Mecp2(-/y)) mice, a model of Rett syndrome (RTT), revealed unusual repetitive glutamate transients. They appeared in phase with bursts of action potentials in the CA1 neurons. Both glutamate transients and bursting activity were suppressed by the blockade of sodium, AMPA and voltage-gated calcium channels (T- and R-type), and enhanced after the inhibition of HCN channels. HCN and calcium channels in RTT and wild-type (WT) CA1 neurons displayed different voltage-dependencies and kinetics. Both channels modulated postsynaptic integration and modified the pattern of glutamate spikes in the RTT hippocampus. Spontaneous glutamate transients were much less abundant in the WT preparations, and, when observed, had smaller amplitude and frequency. The basal ambient glutamate levels in RTT were higher and transient glutamate increases (spontaneous and evoked by stimulation of Schaffer collaterals) decayed slower. Both features indicate less efficient glutamate uptake in RTT. To explain the generation of repetitive glutamate spikes, we designed a novel model of glutamate-induced glutamate release. The simulations correctly predicted the patterns of spontaneous glutamate spikes observed under different experimental conditions. We propose that pervasive spontaneous glutamate release is a hallmark of Mecp2(-/y) hippocampus, stemming from and modulating the hyperexcitability of neurons.	[Balakrishnan, Saju; Mironov, Sergej L.] Georg August Univ, Inst Neuro & Sensory Physiol, CNMPB Ctr Nanoscale Microscopy & Mol Physiol Brai, DFG Res Ctr 103, Gottingen, Germany	University of Gottingen	Mironov, SL (corresponding author), Georg August Univ, Inst Neuro & Sensory Physiol, CNMPB Ctr Nanoscale Microscopy & Mol Physiol Brai, DFG Res Ctr 103, Gottingen, Germany.	smirono@gwdg.de			Cluster of Excellence; DFG Research Centre for Nanoscale Microscopy and Molecular Physiology of the Brain [EXC 171, FZT 103]	Cluster of Excellence; DFG Research Centre for Nanoscale Microscopy and Molecular Physiology of the Brain	This work was funded through the Cluster of Excellence and DFG Research Centre for Nanoscale Microscopy and Molecular Physiology of the Brain (EXC 171 and FZT 103).	Balakrishnan S, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00015; Bazargani N, 2016, NAT NEUROSCI, V19, P182, DOI 10.1038/nn.4201; Bedogni F, 2016, CEREB CORTEX, V26, P2517, DOI 10.1093/cercor/bhv078; Bender RA, 2007, J NEUROSCI, V27, P4697, DOI 10.1523/JNEUROSCI.4699-06.2007; Blasco H, 2014, CURR MED CHEM, V21, P3551, DOI 10.2174/0929867321666140916120118; Calfa G, 2015, HIPPOCAMPUS, V25, P159, DOI 10.1002/hipo.22360; Calfa G, 2011, J NEUROPHYSIOL, V105, P1768, DOI 10.1152/jn.00800.2010; Christie J, 2010, NAT NEUROSCI, V14, P63, DOI DOI 10.1038/NN.2718; DiNuzzo M, 2014, EPILEPSY RES, V108, P995, DOI 10.1016/j.eplepsyres.2014.04.001; Einspieler C, 2005, BRAIN DEV-JPN, V27, pS8, DOI 10.1016/j.braindev.2005.03.014; Einspieler C, 2005, PEDIATR RES, V57, P696, DOI 10.1203/01.PDR.0000155945.94249.0A; Ermolyuk YS, 2013, NAT NEUROSCI, V16, P1754, DOI 10.1038/nn.3563; FABIATO A, 1975, J PHYSIOL-LONDON, V249, P469, DOI 10.1113/jphysiol.1975.sp011026; Feldman D, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/6154080; Ferron L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4628; Gee KR, 2000, CELL CALCIUM, V27, P97, DOI 10.1054/ceca.1999.0095; Gigli CC, 2018, CEREB CORTEX, V28, P1846, DOI 10.1093/cercor/bhx360; Gundersen V, 2015, PHYSIOL REV, V95, P695, DOI 10.1152/physrev.00024.2014; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Hartelt N, 2008, MOL CELL NEUROSCI, V37, P425, DOI 10.1016/j.mcn.2007.10.011; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hoogland TM, 2004, J NEUROSCI, V24, P8416, DOI 10.1523/JNEUROSCI.1677-04.2004; Howes O, 2015, J PSYCHOPHARMACOL, V29, P97, DOI 10.1177/0269881114563634; Huang Z, 2011, NAT NEUROSCI, V14, P478, DOI 10.1038/nn.2757; Ip JPK, 2018, NAT REV NEUROSCI, V19, P368, DOI 10.1038/s41583-018-0006-3; Johnston MV, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00118; Jung S, 2007, J NEUROSCI, V27, P13012, DOI 10.1523/JNEUROSCI.3605-07.2007; Kalmbach BE, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0114-15.2015; KOSTYUK PG, 1982, J MEMBRANE BIOL, V70, P171, DOI 10.1007/BF01870560; Kron M, 2012, J NEUROSCI, V32, P13860, DOI 10.1523/JNEUROSCI.2159-12.2012; Kullmann DM, 2001, NEURON, V32, P561, DOI 10.1016/S0896-6273(01)00507-4; Lauri SE, 2007, NEUROPHARMACOLOGY, V52, P1, DOI 10.1016/j.neuropharm.2006.06.017; Lerma J, 2003, NAT REV NEUROSCI, V4, P481, DOI 10.1038/nrn1118; Lewis AS, 2011, MOL CELL NEUROSCI, V46, P357, DOI 10.1016/j.mcn.2010.11.007; Maezawa I, 2010, J NEUROSCI, V30, P5346, DOI 10.1523/JNEUROSCI.5966-09.2010; Marvin JS, 2013, NAT METHODS, V10, P162, DOI [10.1038/NMETH.2333, 10.1038/nmeth.2333]; Marx MC, 2015, J NEUROSCI RES, V93, P1031, DOI 10.1002/jnr.23561; Min MY, 1998, NEURON, V21, P561, DOI 10.1016/S0896-6273(00)80566-8; Mironov SL, 2011, NEUROPHARMACOLOGY, V60, P869, DOI 10.1016/j.neuropharm.2011.01.002; Mironov SL, 2009, J PHYSIOL-LONDON, V587, P2473, DOI 10.1113/jphysiol.2009.169805; Mironov SL, 2007, BRAIN RES, V1130, P73, DOI 10.1016/j.brainres.2006.09.114; MIRONOV SL, 1990, J THEOR BIOL, V146, P87, DOI 10.1016/S0022-5193(05)80045-1; Mironov SL, 2000, EUR J NEUROSCI, V12, P520, DOI 10.1046/j.1460-9568.2000.00928.x; MIRONOV SL, 1992, BRAIN RES, V580, P341, DOI 10.1016/0006-8993(92)90965-C; Mironov SL, 2005, NEUROPHARMACOLOGY, V48, P1056, DOI 10.1016/j.neuropharm.2005.01.021; Moretti P, 2006, CURR OPIN GENET DEV, V16, P276, DOI 10.1016/j.gde.2006.04.009; Nelson SB, 2015, NEURON, V87, P684, DOI 10.1016/j.neuron.2015.07.033; Noam Y, 2011, CURR OPIN NEUROBIOL, V21, P873, DOI 10.1016/j.conb.2011.06.013; Obrenovitch TP, 1997, J NEUROTRAUM, V14, P677, DOI 10.1089/neu.1997.14.677; Okabe Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035354; Otis TS, 1998, J NEUROSCI, V18, P7099; Park JY, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000534; Parsons MP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11251; Ribeiro FM, 2011, MOL NEUROBIOL, V43, P1, DOI 10.1007/s12035-010-8153-1; Rudolph S, 2015, J NEUROSCI, V35, P15492, DOI 10.1523/JNEUROSCI.3132-15.2015; Rusakov DA, 1999, TRENDS NEUROSCI, V22, P382, DOI 10.1016/S0166-2236(99)01425-3; Sochivko D, 2002, J PHYSIOL-LONDON, V542, P699, DOI 10.1113/jphysiol.2002.020677; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tang WN, 2015, J NEUROSCI, V35, P3016, DOI 10.1523/JNEUROSCI.3319-14.2015; Thanawala MS, 2013, J NEUROSCI, V33, P4625, DOI 10.1523/JNEUROSCI.4031-12.2013; Toloe J, 2014, MOL CELL NEUROSCI, V59, P47, DOI 10.1016/j.mcn.2013.12.008; Tsay D, 2007, NEURON, V56, P1076, DOI 10.1016/j.neuron.2007.11.015; Vaidya SP, 2013, NAT NEUROSCI, V16, P1812, DOI 10.1038/nn.3562; Yaari Y, 2007, J PHYSIOL-LONDON, V580, P435, DOI 10.1113/jphysiol.2007.127670; Yu X, 2004, P NATL ACAD SCI USA, V101, P1051, DOI 10.1073/pnas.0305167101; Zadori D, 2014, J ALZHEIMERS DIS, V42, pS177, DOI 10.3233/JAD-132621; Zhang L, 2008, HIPPOCAMPUS, V18, P294, DOI 10.1002/hipo.20389; Zhang Z, 2007, P NATL ACAD SCI USA, V104, P18025, DOI 10.1073/pnas.0704570104; Zhou N, 2013, J CEREBR BLOOD F MET, V33, P1582, DOI 10.1038/jcbfm.2013.113	69	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2018	13	9							e0202802	10.1371/journal.pone.0202802	http://dx.doi.org/10.1371/journal.pone.0202802			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3NB	30256804	Green Published, gold			2022-12-26	WOS:000446000200005
J	Frelinger, AL; Gerrits, AJ; Neculaes, VB; Gremmel, T; Torres, AS; Caiafa, A; Carmichael, SL; Michelson, AD				Frelinger, Andrew L., III; Gerrits, Anja J.; Neculaes, V. Bogdan; Gremmel, Thomas; Torres, Andrew S.; Caiafa, Anthony; Carmichael, Sabrina L.; Michelson, Alan D.			Tunable activation of therapeutic platelet-rich plasma by pulse electric field: Differential effects on clot formation, growth factor release, and platelet morphology	PLOS ONE			English	Article							TISSUE REGENERATION; GEL; THROMBIN; ELECTROPORATION; PROTHROMBIN; MECHANISMS; PROTEINS; SURGERY; ALPHA; CELLS	Background Activation of platelet-rich plasma (PRP) by pulse electric field (PEF) releases growth factors which promote wound healing (e.g., PDGF, VEGF for granulation, EGF for epithelialization). Aims To determine after PEF activation of therapeutic PRP: 1) platelet gel strength; 2) profile of released growth factors; 3) alpha- and T-granule release; 4) platelet morphology. Methods Concentrated normal donor PRP was activated by 5 mu sec (long) monopolar pulse, similar to 4000 V/cm (PEF A) or 150 nsec (short) bipolar pulse, similar to 3000 V/cm (PEF B) in the presence of 2.5 mM (low) or 20 mM (high) added CaCl2. Clot formation was evaluated by thromboelastography (TEG). Surface exposure of alpha granule (P-selectin) and T-granule (TLR9 and protein disulfide isomerase [PDI]) markers were assessed by flow cytometry. Factors in supernatants of activated PRP were measured by ELISA. Platelet morphology was evaluated by transmission electron microscopy (TEM). Results Time to initial clot formation was shorter with thrombin (<1 min) than with PEF A and B (4.4-8.7 min) but clot strength (elastic modulus, derived from TEG maximum amplitude) was greater with PEF B than with either thrombin or PEF A (p<0.05). Supernatants of PRP activated with PEF A had higher EGF levels than supernatants from all other conditions. In contrast, levels of PF4, PDGF, and VEGF in supernatants were not significantly different after PEF A, PEF B, and thrombin activation. T-granule markers (TLR9 and PDI) were higher after thrombin than after PEF A or B with low or high CaCl2. By TEM, platelets in PEF-treated samples retained a subset of granules suggesting regulated granule release. Conclusion Pulse length and polarity can be modulated to produce therapeutic platelet gels as strong or stronger than those produced by thrombin, and this is tunable to produce growth factor profiles enhanced in specific factors important for different stages of wound healing.	[Frelinger, Andrew L., III; Gerrits, Anja J.; Gremmel, Thomas; Carmichael, Sabrina L.; Michelson, Alan D.] Harvard Med Sch, Ctr Platelet Res Studies, Dana Farber Boston Childrens Canc & Blood Disorde, Boston, MA 02115 USA; [Neculaes, V. Bogdan; Torres, Andrew S.; Caiafa, Anthony] GE Global Res Ctr, Niskayuna, NY 12309 USA; [Gremmel, Thomas] Med Univ Vienna, Dept Internal Med 2, Vienna, Austria	Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; General Electric; Medical University of Vienna	Frelinger, AL (corresponding author), Harvard Med Sch, Ctr Platelet Res Studies, Dana Farber Boston Childrens Canc & Blood Disorde, Boston, MA 02115 USA.; Neculaes, VB (corresponding author), GE Global Res Ctr, Niskayuna, NY 12309 USA.	Andrew.Frelinger@childrens.harvard.edu; neculaes@research.ge.com	Michelson, Alan/ABE-8487-2021	Michelson, Alan/0000-0002-1746-4819; Frelinger, Andrew/0000-0002-6871-7441; Gremmel, Thomas/0000-0001-9554-7292	GE Healthcare	GE Healthcare(General ElectricGE Healthcare)	This work was funded by a research grant from GE Healthcare to Boston Children's Hospital, Principal Investigator, A.L. Frelinger. The funders participated in study design, data collection, and preparation of the manuscript, but had no role in data analysis or the decision to publish. Authors V.B. Neculaes, A.S. Torres, and A. Caiafa are employed by a commercial company: GE Global Research Center. V.B. Neculaes and A.S. Torres contributed to design of the studies and provided critical revisions to the manuscript. A. Caiafa contributed to design of the studies, performed experiments and provided critical revisions to the manuscript. Neither these authors nor the funders had a role in data analysis or the decision to publish.	Anitua E, 2004, THROMB HAEMOSTASIS, V91, P4, DOI 10.1160/TH03-07-0440; Berney-Lang MA, 2013, PLATELETS, P581; Bielecki TM, 2007, J BONE JOINT SURG BR, V89B, P417, DOI 10.1302/0301-620X.89B3.18491; Broughton G, 2006, PLAST RECONSTR SURG, V117, p6S, DOI 10.1097/01.prs.0000225429.76355.dd; D'asta F, 2018, PLATELETS, V29, P9, DOI 10.1080/09537104.2017.1317731; Davis VL, 2014, J ORAL IMPLANTOL, V40, P511, DOI 10.1563/AAID-JOI-D-12-00106; Dohan Ehrenfest David M, 2014, Muscles Ligaments Tendons J, V4, P3; Driver VR, 2006, OSTOMY WOUND MANAG, V52, P68; Esser AT, 2010, BIOPHYS J, V98, P2506, DOI 10.1016/j.bpj.2010.02.035; Everts Peter A M, 2006, J Extra Corpor Technol, V38, P174; Frelinger AL, 2016, PLATELETS, V27, P128, DOI 10.3109/09537104.2015.1048214; Frelinger AL, 2006, CIRCULATION, V113, P2888, DOI 10.1161/CIRCULATIONAHA.105.596627; Frelinger AL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160933; Garner AL, 2007, BIOCHEM BIOPH RES CO, V362, P139, DOI 10.1016/j.bbrc.2007.07.159; Garner AL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181214; Giusti I, 2018, EXP THER MED, V15, P4029, DOI 10.3892/etm.2018.5887; GREENBERG CS, 1994, CLIN CHEM, V40, P1962; GROTENDORST GR, 1989, J CELL PHYSIOL, V139, P617, DOI 10.1002/jcp.1041390323; Gunaydin S, 2008, PERFUSION-UK, V23, P179, DOI 10.1177/0267659108097783; Italiano JE, 2009, J THROMB HAEMOST, V7, P173, DOI 10.1111/j.1538-7836.2009.03387.x; Martinez-Zapata MJ, 2009, TRANSFUSION, V49, P44, DOI 10.1111/j.1537-2995.2008.01945.x; Keowmaneechai E, 2002, J AGR FOOD CHEM, V50, P7145, DOI 10.1021/jf020489a; Lacci Kathleen M., 2010, Yale Journal of Biology and Medicine, V83, P1; Lakka Klement G, 2013, PLATELETS, P487; LAWRENCE WT, 1994, CLIN DERMATOL, V12, P157, DOI 10.1016/0738-081X(94)90266-6; Lin Cai, 2007, Zhonghua Shao Shang Za Zhi, V23, P339; Man D, 2001, PLAST RECONSTR SURG, V107, P229, DOI 10.1097/00006534-200101000-00037; Mann KG, 2003, ARTERIOSCL THROM VAS, V23, P17, DOI 10.1161/01.ATV.0000046238.23903.FC; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; MCDUFFIE FC, 1979, THROMB RES, V16, P759, DOI 10.1016/0049-3848(79)90219-6; MICHELSON AD, 1994, BLOOD COAGUL FIBRIN, V5, P121, DOI 10.1097/00001721-199402000-00014; Mlynarek Ryan A, 2016, Am J Orthop (Belle Mead NJ), V45, P290; Nabzdyk LP, 2013, J VASC SURG, V58, P766, DOI 10.1016/j.jvs.2012.11.095; Neculaes V.B., 2015, EWMA J, V15, P15; Pakhomov AG, 2007, BIOELECTROMAGNETICS, V28, P655, DOI 10.1002/bem.20354; Samra DJ, 2015, BMJ OPEN SPORT EXERC, V1, DOI [10.1136/bmjsem-2015-000054, DOI 10.1136/BMJSEM-2015-000054]; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Thon JN, 2012, J CELL BIOL, V198, P561, DOI 10.1083/jcb.201111136; Torres AS, 2014, J TRAUMA ACUTE CARE, V77, pS94, DOI 10.1097/TA.0000000000000322; Weaver JC, 2012, BIOELECTROCHEMISTRY, V87, P236, DOI 10.1016/j.bioelechem.2012.02.007; Zhou YQ, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0172-4; Zhu Y, 2013, OSTEOARTHR CARTILAGE, V21, P1627, DOI 10.1016/j.joca.2013.07.017	42	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2018	13	9							e0203557	10.1371/journal.pone.0203557	http://dx.doi.org/10.1371/journal.pone.0203557			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3NB	30256831	gold, Green Submitted, Green Published			2022-12-26	WOS:000446000200019
J	Korpilo, S; Jalkanen, J; Virtanen, T; Lehvavirta, S				Korpilo, Silviya; Jalkanen, Joel; Virtanen, Tarmo; Lehvavirta, Susanna			Where are the hotspots and coldspots of landscape values, visitor use and biodiversity in an urban forest?	PLOS ONE			English	Article							PUBLIC-PARTICIPATION GIS; ECOSYSTEM SERVICES; SOCIAL VALUES; NATIONAL-PARK; GREEN SPACES; GROWTH; AREAS; SUSTAINABILITY; PREFERENCES; INDICATORS	Cities and urban green areas therein can be considered as complex social-ecological systems that provide various ecosystem services with different synergies and trade-offs among them. In this article, we show that multiple stakeholder perspectives and data sources should be used to capture key values for sustainable planning and management of urban green spaces. Using an urban forest in Helsinki, Finland as a case study, we incorporated data collected using public participation GIS, expert elicitation and forest inventories in order to investigate the guidance that the different types of data, and their integration, can provide for landscape planning. We examined the relationship and spatial concurrence between two social variables i.e. visitors' perceived landscape values and green space use, and two ecological variables i.e. forest habitat quality and urban biodiversity, using hot/coldspot analysis. We found weak correlations and low mean spatial coincidence between the social and ecological data, indicating great complementary importance to multi-criteria decision-making. In addition, there was a higher level of spatial agreement between the ecological datasets than between the social datasets. Forest habitat quality and urban biodiversity were positively correlated and spatially coincided moderately, while we found a negative correlation and very low overlap between visitor use and landscape values. This highlights the conceptual and spatial distinction between the general preferences and values citizens assign to public green spaces and the realized everyday use of these areas and their services. The resulting maps can inform planners on overall social and environmental quality of the landscape, and point out potential threats to areas of high ecological value due to intensive recreational use, which is crucial information for natural resource management. In the end, we discuss different strategies for managing overlaps and discrepancies between the social and ecological values.	[Korpilo, Silviya; Jalkanen, Joel; Virtanen, Tarmo; Lehvavirta, Susanna] Univ Helsinki, Fac Biol & Environm Sci, Ecosyst & Environm Res Programme, Helsinki, Finland; [Jalkanen, Joel] Univ Helsinki, Dept Geosci & Geog, Digital Geog Lab, Helsinki, Finland; [Lehvavirta, Susanna] Swedish Univ Agr Sci, Dept Landscape Architecture Planning & Management, Alnarp, Sweden	University of Helsinki; University of Helsinki; Swedish University of Agricultural Sciences	Korpilo, S (corresponding author), Univ Helsinki, Fac Biol & Environm Sci, Ecosyst & Environm Res Programme, Helsinki, Finland.	silviya.korpilo@helsinki.fi	BITOUN, RACHEL Elisabeth/AAC-9538-2021; Lehvavirta, Susanna/L-3948-2014	BITOUN, RACHEL Elisabeth/0000-0002-3614-9910; Korpilo, Silviya/0000-0002-6399-4239; Jalkanen, Joel/0000-0002-6170-9916; Lehvavirta, Susanna/0000-0002-8148-9981; Virtanen, Tarmo/0000-0001-8660-2464	Maj and Tor Nessling Foundation [201600532, 201700215, 201800174, 201600107]; Kone Foundation; Finnish National Agency for Education (CIMO) [TM-14-9143]; University of Helsinki, Faculty of Biological and Environmental Sciences	Maj and Tor Nessling Foundation; Kone Foundation; Finnish National Agency for Education (CIMO); University of Helsinki, Faculty of Biological and Environmental Sciences	This study was funded by Maj and Tor Nessling Foundation (grant numbers: 201600532/201700215/201800174) (SK); Maj and Tor Nessling Foundation (project number: 201600107) (JJ); Kone Foundation (JJ); Finnish National Agency for Education (CIMO) (grant number: TM-14-9143) (SK); University of Helsinki, Faculty of Biological and Environmental Sciences (SK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern J, 2014, LANDSCAPE URBAN PLAN, V125, P254, DOI 10.1016/j.landurbplan.2014.01.020; Alberti M, 2003, BIOSCIENCE, V53, P1169, DOI 10.1641/0006-3568(2003)053[1169:IHIEOA]2.0.CO;2; Alessa L, 2008, LANDSCAPE URBAN PLAN, V85, P27, DOI 10.1016/j.landurbplan.2007.09.007; Allen GR, 2015, ADAPTIVE MANAGEMENT; [Anonymous], 2005, NAT RECR SPORT HELS, P23; Arnberger Arne, 2005, Urban Forestry & Urban Greening, V3, P125, DOI 10.1016/j.ufug.2005.04.002; Arnberger A, 2012, SUSTAINABILITY-BASEL, V4, P703, DOI 10.3390/su4040703; Bagstad KJ, 2017, LANDSCAPE ECOL, V32, P77, DOI 10.1007/s10980-016-0430-6; Bagstad KJ, 2016, REG ENVIRON CHANGE, V16, P2005, DOI 10.1007/s10113-015-0756-7; Balvanera P, 2005, ECOL APPL, V15, P360, DOI 10.1890/03-5192; Bonchi F., 2011, SIGKDD EXPLOR NEWSL, V13, P30, DOI DOI 10.1145/2031331.2031336; Brown G, 2004, APPL GEOGR, V24, P161, DOI 10.1016/j.apgeog.2004.03.006; Brown G, 2005, INT J WILDERNESS, V11, P1; Brown G, 2017, APPL GEOGR, V79, P153, DOI 10.1016/j.apgeog.2016.12.015; Brown G, 2012, SOC NATUR RESOUR, V25, P633, DOI 10.1080/08941920.2011.621511; Brown G, 2011, LANDSCAPE URBAN PLAN, V102, P1, DOI 10.1016/j.landurbplan.2011.03.003; Brown GG, 2012, INT J GEOGR INF SCI, V26, P231, DOI 10.1080/13658816.2011.585139; Bryan BA, 2011, CONSERV BIOL, V25, P172, DOI 10.1111/j.1523-1739.2010.01560.x; Bunce RGH, 2013, ECOL INDIC, V33, P19, DOI 10.1016/j.ecolind.2012.07.014; Chirici G, 2012, FOREST SCI, V58, P257, DOI 10.5849/forsci.12-003; City of Helsinki, 2021, TOIMINTAA LAPSIPERHE; Corona P, 2011, FOREST ECOL MANAG, V262, P2061, DOI 10.1016/j.foreco.2011.08.044; Crossman ND, 2013, ECOSYST SERV, V4, P4, DOI 10.1016/j.ecoser.2013.02.001; Daniel TC, 2012, P NATL ACAD SCI USA, V109, P8812, DOI 10.1073/pnas.1114773109; De Vreesea R, 2016, ECOL INDIC, V66, P517, DOI 10.1016/j.ecolind.2016.01.048; Donovan SM, 2009, ECOL SOC, V14; Egoh B., 2012, VIA ENRICO FERMI 274, DOI [10.2788/41823, DOI 10.2788/41823]; Finnish Meterological Institue, 2018, LESS SNOW; Gao T, 2015, ECOL INDIC, V57, P420, DOI 10.1016/j.ecolind.2015.05.028; Gimona A, 2007, LANDSCAPE ECOL, V22, P1255, DOI 10.1007/s10980-007-9105-7; Grimm NB, 2000, BIOSCIENCE, V50, P571, DOI 10.1641/0006-3568(2000)050[0571:IATLTO]2.0.CO;2; Haase D, 2014, AMBIO, V43, P407, DOI 10.1007/s13280-014-0503-1; Hamberg L, 2010, J ENVIRON MANAGE, V91, P1811, DOI 10.1016/j.jenvman.2010.04.003; Harrison PA, 2014, ECOSYST SERV, V9, P191, DOI 10.1016/j.ecoser.2014.05.006; Herzele V., 2003, LANDSCAPE URBAN PLAN, V63, P109, DOI [10.1016/s0169-2046(02)00192-5, DOI 10.1016/S0169-2046(02)00192-5]; Ilvesniemi S., 2015, KESKUSPUISTON KAYTTA; Jalkenen J., 2016, THESIS; Kabisch N, 2015, ENVIRON IMPACT ASSES, V50, P25, DOI 10.1016/j.eiar.2014.08.007; Karimi A, 2017, CONSERV BIOL, V31, P1439, DOI 10.1111/cobi.12947; Karimi A, 2015, APPL GEOGR, V63, P9, DOI 10.1016/j.apgeog.2015.06.003; Korpilo S., 2017, P 20 AGILE C GEOGR I; Korpilo S, 2018, J ENVIRON MANAGE, V207, P124, DOI 10.1016/j.jenvman.2017.11.020; Korpilo S, 2017, LANDSCAPE URBAN PLAN, V157, P608, DOI 10.1016/j.landurbplan.2016.08.005; Kremen C, 2005, ECOL LETT, V8, P468, DOI 10.1111/j.1461-0248.2005.00751.x; Lehtomaki J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135926; Luck GW, 2003, TRENDS ECOL EVOL, V18, P331, DOI 10.1016/S0169-5347(03)00100-9; Lyon K, 2011, SCAND J HOSP TOUR, V11, P100, DOI 10.1080/15022250.2011.629909; MA (Millennium Ecosystem Assessment), 2005, ECOSYSTEMS HUMAN WEL, P1; Martikainen P, 2000, BIOL CONSERV, V94, P199, DOI 10.1016/S0006-3207(99)00175-5; Nielsen TS, 2007, HEALTH PLACE, V13, P839, DOI 10.1016/j.healthplace.2007.02.001; Oksanen J, 2015, J TRANSP GEOGR, V48, P135, DOI 10.1016/j.jtrangeo.2015.09.001; Ostrom E, 2009, SCIENCE, V325, P419, DOI 10.1126/science.1172133; Potschin M, 2006, LANDSCAPE URBAN PLAN, V75, P162, DOI 10.1016/j.landurbplan.2005.03.005; Raymond C., 2006, Journal of Environmental Planning and Management, V49, P797, DOI 10.1080/09640560600945331; Redman CL, 2004, ECOSYSTEMS, V7, P161, DOI 10.1007/s10021-003-0215-z; Schetke S, 2012, ENVIRON IMPACT ASSES, V32, P195, DOI 10.1016/j.eiar.2011.08.008; Schipperijn J, 2010, LANDSCAPE URBAN PLAN, V95, P130, DOI 10.1016/j.landurbplan.2009.12.010; Schroter M, 2016, LANDSCAPE ECOL, V31, P431, DOI 10.1007/s10980-015-0258-5; Schrotter M, 2017, AMBIO, V46, P756, DOI 10.1007/s13280-017-0922-x; Schwarz N, 1999, AM PSYCHOL, V54, P93, DOI 10.1037/0003-066X.54.2.93; Siitonen J, 2000, FOREST ECOL MANAG, V128, P211, DOI 10.1016/S0378-1127(99)00148-6; Spano M, 2017, ENVIRON SCI POLICY, V73, P52, DOI 10.1016/j.envsci.2017.04.008; Statistics Finland, 2012, REG POP DENS; Stokland JN, 2012, ECOL BIODIVERS CONS, P380; TEEB, 2011, TEEB MAN CIT EC SERV, P1; Tyrvainen L, 2007, LANDSCAPE URBAN PLAN, V79, P5, DOI 10.1016/j.landurbplan.2006.03.003; van Jaarsveld AS, 1998, SCIENCE, V279, P2106, DOI 10.1126/science.279.5359.2106; Whitehead AL, 2014, CONSERV BIOL, V28, P992, DOI 10.1111/cobi.12257; Wolff S, 2015, ECOL INDIC, V55, P159, DOI 10.1016/j.ecolind.2015.03.016	69	8	9	11	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2018	13	9							e0203611	10.1371/journal.pone.0203611	http://dx.doi.org/10.1371/journal.pone.0203611			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV3NB	30256807	Green Published, gold, Green Submitted			2022-12-26	WOS:000446000200020
J	Ramzi, NH; Yiorkas, AM; Sebert, S; Keinanen-Kiukaanniemi, S; Ala-Mursula, L; Svento, R; Jokelainen, J; Veijola, J; Auvinen, J; Miettunen, J; Dovey, TM; Jarvelin, MR; Blakemore, AIF				Ramzi, Nurul Hanis; Yiorkas, Andrianos M.; Sebert, Sylvain; Keinanen-Kiukaanniemi, Sirkka; Ala-Mursula, Leena; Svento, Rauli; Jokelainen, Jari; Veijola, Juha; Auvinen, Juha; Miettunen, Jouko; Dovey, Terence M.; Jarvelin, Marjo-Riitta; Blakemore, Alexandra I. F.			Relationship between BMI and emotion-handling capacity in an adult Finnish population: The Northern Finland Birth Cohort 1966	PLOS ONE			English	Article							TORONTO-ALEXITHYMIA-SCALE; BINGE-EATING DISORDER; SOCIODEMOGRAPHIC VARIABLES; GENERAL-POPULATION; ANOREXIA-NERVOSA; OBESITY; PERSONALITY; PREVALENCE; DEPRESSION; HEMISPHERE	Background Alexithymia, a difficulty in identifying and expressing emotions, has been associated with obesity and eating disorders in small-scale cross-sectional studies. Here, we assess the relationship between body mass index (BMI) and alexithymia in a large cohort of free-living Finnish adults over a 15-year period. Methods Participants were drawn from the Northern Finnish Birth Cohort 1966 (NFBC1966). The 20-Item Toronto Alexithymia Scale (TAS-20) was used as a measure of alexithymia and was completed at the age of 31 years (31y: n = 4841), and 46 years (46y: n = 5404). BMI was recorded at both time points. Where data at both time points were available (n = 3274), the relationship between changes in BMI and TAS-20 over this time period was also investigated. Results BMI was significantly and positively associated with TAS-20 score (p<0.0001, both at 31 years and at 46 years of ages). The association remained statistically significant after adjustment for potential confounders (sex, marital status and several socio-economic indicators). In individuals who experienced the greatest change in BMI (in either direction) over the 15-year period, there was a modest mean increase in TAS-20 score. Conclusions Our data revealed that TAS-20 score was correlated with and co-varied with body mass status. We suggest that future clinical research should consider the role of alexithymia in obesity. Further investigation of this relationship is warranted to ensure that the needs of obese subjects with undiagnosed alexithymia are considered in the design of weight management programmes.	[Ramzi, Nurul Hanis; Yiorkas, Andrianos M.; Blakemore, Alexandra I. F.] Imperial Coll London, Fac Med, Div Diabet Endocrinol & Metab, Sect Investigative Med, London, England; [Ramzi, Nurul Hanis; Yiorkas, Andrianos M.; Dovey, Terence M.; Jarvelin, Marjo-Riitta; Blakemore, Alexandra I. F.] Brunel Univ London, Coll Hlth & Life Sci, Dept Life Sci, London, England; [Sebert, Sylvain; Keinanen-Kiukaanniemi, Sirkka; Ala-Mursula, Leena; Svento, Rauli; Jokelainen, Jari; Auvinen, Juha; Miettunen, Jouko; Jarvelin, Marjo-Riitta] Univ Oulu, Fac Med, Ctr Life Course Hlth Res, Oulu, Finland; [Sebert, Sylvain; Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Keinanen-Kiukaanniemi, Sirkka; Svento, Rauli; Jokelainen, Jari; Auvinen, Juha; Jarvelin, Marjo-Riitta] Oulu Univ Hosp, Unit Primary Hlth Care, Oulu, Finland; [Keinanen-Kiukaanniemi, Sirkka; Svento, Rauli; Jokelainen, Jari; Auvinen, Juha; Jarvelin, Marjo-Riitta] Oulu Univ Hosp, Med Res Ctr, Oulu, Finland; [Veijola, Juha; Miettunen, Jouko] Oulu Univ Hosp, Med Res Ctr Oulu, Oulu, Finland; [Veijola, Juha; Miettunen, Jouko] Univ Oulu, Oulu, Finland; Oulu Univ Hosp, Res Unit Clin Neurosci, Dept Psychiat, Oulu, Finland; [Jarvelin, Marjo-Riitta] Imperial Coll London, Sch Publ Hlth, MRC PHE Ctr Environm & Hlth, Dept Epidemiol & Biostat, London, England	Imperial College London; Brunel University; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu; Imperial College London	Ramzi, NH (corresponding author), Imperial Coll London, Fac Med, Div Diabet Endocrinol & Metab, Sect Investigative Med, London, England.; Ramzi, NH (corresponding author), Brunel Univ London, Coll Hlth & Life Sci, Dept Life Sci, London, England.	hanisramzi@gmail.com	Ramzi, Nurul Hanis/GZL-4285-2022; Miettunen, Jouko/AAC-4334-2019; Ramzi, Nurul Hanis/T-7594-2019	Ramzi, Nurul Hanis/0000-0002-7622-7581; Miettunen, Jouko/0000-0003-0575-2669; Jokelainen, Jari/0000-0003-4629-0560; Dovey, Terence/0000-0001-6469-2438	Academy of Finland [104781, 120315, 129269, 1114194, 24300796]; University Hospital Oulu, Biocenter, University of Oulu, Finland [75617]; Medical Research Council, UK; DynaHEALTH action [H2020-633595]; academy of Finland EGEA-project [285547]; Medical Research Council; Biotechnology and Biological Sciences Research Council; National Institute for Health Research (NIHR); Integrative Mammalian Biology (IMB) Capacity Building Award; EuroCHIP grant [FP7-HEALTH-2009-241592]; NIHR Biomedical Research Centre Funding Scheme; MARA [Majlis Amanah Rakyat]; DynaHEALTH European Union's Horizon 2020 research and innovation programme [633595]	Academy of Finland(Academy of Finland); University Hospital Oulu, Biocenter, University of Oulu, Finland; Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); DynaHEALTH action; academy of Finland EGEA-project(Academy of Finland); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Integrative Mammalian Biology (IMB) Capacity Building Award; EuroCHIP grant; NIHR Biomedical Research Centre Funding Scheme(National Institute for Health Research (NIHR)); MARA [Majlis Amanah Rakyat]; DynaHEALTH European Union's Horizon 2020 research and innovation programme	NFBC1966 received financial support from the Academy of Finland [project grants 104781, 120315, 129269, 1114194, 24300796], University Hospital Oulu, Biocenter, University of Oulu, Finland [75617], and the Medical Research Council, UK. The program is currently being funded by the H2020-633595 DynaHEALTH action (to SS) and academy of Finland EGEA-project [285547]. The Section of Endocrinology and Investigative Medicine is funded by grants from the Medical Research Council, Biotechnology and Biological Sciences Research Council, National Institute for Health Research (NIHR), an Integrative Mammalian Biology (IMB) Capacity Building Award, an FP7-HEALTH-2009-241592 EuroCHIP grant and is supported by the NIHR Biomedical Research Centre Funding Scheme. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The first author, NHR, is also funded by MARA [Majlis Amanah Rakyat]. SS, LAM, SKK, JM and MRJ have received funding from the DynaHEALTH European Union's Horizon 2020 research and innovation programme under grant agreement [No 633595]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAGBY RM, 1994, J PSYCHOSOM RES, V38, P33, DOI 10.1016/0022-3999(94)90006-X; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Berger SS, 2014, COMPR PSYCHIAT, V55, P170, DOI 10.1016/j.comppsych.2013.08.005; Bird G, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.61; BULL RH, 1991, PSYCHOTHER PSYCHOSOM, V56, P146, DOI 10.1159/000288548; Cahill L, 2003, PROG NEURO-PSYCHOPH, V27, P1235, DOI 10.1016/j.pnpbp.2003.09.019; Canli T, 2002, P NATL ACAD SCI USA, V99, P10789, DOI 10.1073/pnas.162356599; Carano A, 2012, J PSYCHIATR PRACT, V18, P5, DOI 10.1097/01.pra.0000410982.08229.99; Courty A, 2015, COMPR PSYCHIAT, V56, P217, DOI 10.1016/j.comppsych.2014.09.011; de Haan H, 2012, PSYCHIAT RES, V198, P123, DOI 10.1016/j.psychres.2011.09.027; DEZWAAN M, 1995, INT J EAT DISORDER, V17, P135, DOI 10.1002/1098-108X(199503)17:2&lt;135::AID-EAT2260170205&gt;3.0.CO;2-7; Elfhag K, 2007, SCAND J PSYCHOL, V48, P391, DOI 10.1111/j.1467-9450.2007.00583.x; Gross J J, 1998, EMERGING FIELD EMOTI, P271; Gross JJ, 2002, PSYCHOPHYSIOLOGY, V39, P281, DOI 10.1017/S0048577201393198; Herva A, 2006, INT J OBESITY, V30, P520, DOI 10.1038/sj.ijo.0803174; Honkalampi K, 2004, PSYCHOSOMATICS, V45, P197, DOI 10.1176/appi.psy.45.3.197; Jaaskelainen A, 2015, J OCCUP ENVIRON MED, V57, P485, DOI 10.1097/JOM.0000000000000432; Joukamaa M, 2001, NORD J PSYCHIAT, V55, P123, DOI 10.1080/08039480151108561; Karukivi M, 2014, PSYCHIAT RES, V219, P386, DOI 10.1016/j.psychres.2014.05.058; Kokkonen P, 2001, COMPR PSYCHIAT, V42, P471, DOI 10.1053/comp.2001.27892; Levant RF, 2009, PSYCHOL MEN MASCULIN, V10, P190, DOI 10.1037/a0015652; Lumley M., 2008, EMOTION REGULATION C, P43; Lumley MA, 2000, COMPR PSYCHIAT, V41, P352, DOI 10.1053/comp.2000.9014; Mattila AK, 2006, J PSYCHOSOM RES, V61, P629, DOI 10.1016/j.jpsychores.2006.04.013; Nevanpera N, 2015, J OCCUP ENVIRON MED, V57, P1262, DOI 10.1097/JOM.0000000000000579; Noli G, 2010, J HUM NUTR DIET, V23, P616, DOI 10.1111/j.1365-277X.2010.01079.x; Nowakowski ME, 2013, J EAT DISORD, V1, DOI 10.1186/2050-2974-1-21; Pinna F, 2011, EAT WEIGHT DISORD-ST, V16, pE164, DOI 10.3275/7509; Rantakallio P, 1988, Paediatr Perinat Epidemiol, V2, P59, DOI 10.1111/j.1365-3016.1988.tb00180.x; Salminen JK, 1999, J PSYCHOSOM RES, V46, P75, DOI 10.1016/S0022-3999(98)00053-1; Schirmer A, 2006, TRENDS COGN SCI, V10, P24, DOI 10.1016/j.tics.2005.11.009; Strigo IA, 2013, INT J EAT DISORDER, V46, P23, DOI 10.1002/eat.22045; Swart M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005751; Tolmunen T, 2011, COMPR PSYCHIAT, V52, P536, DOI 10.1016/j.comppsych.2010.09.007; Westwood H, 2017, J PSYCHOSOM RES, V99, P66, DOI 10.1016/j.jpsychores.2017.06.007; Zak-Golab A, 2013, EUR J PSYCHIAT, V27, P149	36	3	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2018	13	9							e0203660	10.1371/journal.pone.0203660	http://dx.doi.org/10.1371/journal.pone.0203660			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV3NB	30256810	Green Submitted, Green Published, gold			2022-12-26	WOS:000446000200023
J	Brustio, PR; Moise, P; Marasso, D; Alossa, D; Miglio, F; Mulasso, A; Rabaglietti, E; Rainoldi, A; Boccia, G				Brustio, Paolo Riccardo; Moise, Paolo; Marasso, Danilo; Alossa, Davide; Miglio, Franco; Mulasso, Anna; Rabaglietti, Emanuela; Rainoldi, Alberto; Boccia, Gennaro			Participation in a school-based walking intervention changes the motivation to undertake physical activity in middle-school students	PLOS ONE			English	Article							SELF-DETERMINATION THEORY; ACCUMULATED BRISK WALKING; ACTIVITY PROMOTION; SHORT BOUTS; EDUCATION; CHILDREN; BEHAVIOR; ATTENTION; LESSONS; PROGRAM	The motivation to perform physical activity is a crucial factor in achieving a persistent active lifestyle. However, motivation decreases with increasing age from childhood to adolescence. The promotion of physical activity in educational settings might be an important tool to increase motivation and, consequently, to decrease sedentary behavior. The aim of this study was to explore the effect of a 4-month school-based walking intervention on motivation to participate in physical activity among Italian middle-school students. This study included 276 students (mean age 13 1 years, 41.3% female). A total of 138 students (intervention group) participated in a brief walking intervention that was added to their routine daily school activity, while a convenience sample of 138 students performed the routine daily school activity. The activity consisted of walking one kilometer outside of school buildings during the morning break. Motivation data were collected before and after the walking breaks using the Participation Motivation Questionnaire (PMQ). Controlling for age, significant interactions between group and time were observed in the "Social Status" [F(1,273) = 4.851; p = 0.028], "Team" [F(1,273) = 6.015; p = 0.015] and "Energy Release" components [F(1,273) = 8.527; p = 0.038]. Specifically, a significant decrease in the "Social Status" components of the PMQ and an increase in the "Team" and "Energy Release" components were observed in the intervention group. On the contrary. control group showed an increase in "Social Status" and a decrease in the "Team" and "Energy Release" components. Within this developmental context, incorporation of the walking activity helped to modify the motivational orientation towards physical activity to include more intrinsic factors, which were related to the possibility of remaining with classmates and peer groups and releasing a surplus of energy.	[Brustio, Paolo Riccardo; Mulasso, Anna; Rainoldi, Alberto; Boccia, Gennaro] Univ Turin, Sch Exercise & Sport Sci, Dept Med Sci, NeuroMuscularFunct Res Grp, Turin, Italy; [Moise, Paolo; Marasso, Danilo] Univ Turin, Sch Exercise & Sport Sci, SUISM, Turin, Italy; [Moise, Paolo; Miglio, Franco] Scuola Secondaria Primo Grad G Jaquerio, Ist Comprens Statale Buttigliera Alta Rosta, Turin, Italy; [Alossa, Davide] Scuola Secondaria Primo Grad G Falcone, Ist Comprens Santena, Turin, Italy; [Rabaglietti, Emanuela] Univ Turin, Dept Psychol, Turin, Italy	University of Turin; University of Turin; University of Turin	Rainoldi, A (corresponding author), Univ Turin, Sch Exercise & Sport Sci, Dept Med Sci, NeuroMuscularFunct Res Grp, Turin, Italy.	alberto.rainoldi@unito.it	Rabaglietti, Emanuela/ABI-2585-2020	Rabaglietti, Emanuela/0000-0002-5286-3743; MARASSO, DANILO/0000-0003-4640-4185; Boccia, Gennaro/0000-0001-8706-4098; BRUSTIO, PAOLO RICCARDO/0000-0001-8422-5132; Rainoldi, Alberto/0000-0003-4553-2898; Moise, Paolo/0000-0002-3067-3455	Department of Medical Sciences (University of Torino)	Department of Medical Sciences (University of Torino)	This publication was supported by the "progetti bando ricerca locale (ex-60%) 2016-2017" of the Department of Medical Sciences (University of Torino).1ww	Barr-Anderson DJ, 2011, AM J PREV MED, V40, P76, DOI 10.1016/j.amepre.2010.09.033; Breheny K, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-5019-8; Brustio PR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202091; Carlin A, 2018, TRIALS, V19, DOI 10.1186/s13063-017-2415-4; Carlin A, 2016, SPORTS MED, V46, P515, DOI 10.1007/s40279-015-0432-6; Centers for Disease Control and Prevention Services DoHaH, 2011, STRAT PREV OB OTH CH; Chesham RA, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1049-z; Coe DP, 2006, MED SCI SPORT EXER, V38, P1515, DOI 10.1249/01.mss.0000227537.13175.1b; Cox AE, 2008, J ADOLESCENT HEALTH, V43, P506, DOI 10.1016/j.jadohealth.2008.04.020; Dinkel D, 2017, TEACH TEACH EDUC, V63, P186, DOI 10.1016/j.tate.2016.12.020; Dishman RK, 2018, MED SCI SPORT EXER, V50, P1206, DOI 10.1249/MSS.0000000000001542; Drummy C, 2016, J PAEDIATR CHILD H, V52, P745, DOI 10.1111/jpc.13182; DWYER JJM, 1992, PSYCHOL REP, V70, P283, DOI 10.2466/PR0.70.1.283-290; Ford P, 2012, EUR J SPORT SCI, V12, P89, DOI 10.1080/17461391.2010.545436; Ford PA, 2013, J SPORT SCI, V31, P114, DOI 10.1080/02640414.2012.723816; Galle F, 2016, J PHYS ACT HEALTH, V13, P854, DOI 10.1123/jpah.2015-0452; Gill D, 2008, PSYCHOLOGICAL DYNAMI; GILL DL, 1983, INT J SPORT PSYCHOL, V14, P1; Gonzalez-Cutre D, 2018, J EDUC RES, V111, P320, DOI 10.1080/00220671.2016.1255871; Ha AS, 2017, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-4553-8; Hills AP, 2015, PROG CARDIOVASC DIS, V57, P368, DOI 10.1016/j.pcad.2014.09.010; Jones GW, 2006, J SPORT SCI MED, V5, P28; Koivula N., 1999, Journal of Sport Behavior, V22, P360; Kolt GS, 2004, J AGING PHYS ACTIV, V12, P185, DOI 10.1123/japa.12.2.185; Kondric M, 2013, J SPORT SCI MED, V12, P10; Lonsdale C, 2009, PREV MED, V48, P69, DOI 10.1016/j.ypmed.2008.09.013; Lonsdale C, 2013, PREV MED, V56, P152, DOI 10.1016/j.ypmed.2012.12.004; Ma JK, 2015, APPL PHYSIOL NUTR ME, V40, P238, DOI 10.1139/apnm-2014-0309; Mahar MT, 2011, PREV MED, V52, pS60, DOI 10.1016/j.ypmed.2011.01.026; Mahar MT, 2006, MED SCI SPORT EXER, V38, pS80, DOI 10.1249/00005768-200605001-00366; Metcalf BS, 2015, MED SCI SPORT EXER, V47, P2084, DOI 10.1249/MSS.0000000000000644; Ministero della Salute, ATT FIS RACC BAMB RA; Ministero della Salute, 2014, PIAN NAZ PREV 2014 2; MIUR, 2018, IND NAZ NUOV SCEN 20; Morton KL, 2016, OBES REV, V17, P142, DOI 10.1111/obr.12352; Murtagh E, 2013, PEDIATR EXERC SCI, V25, P300, DOI 10.1123/pes.25.2.300; Nader PR, 2008, JAMA-J AM MED ASSOC, V300, P295, DOI 10.1001/jama.300.3.295; Ng JYY, 2012, PERSPECT PSYCHOL SCI, V7, P325, DOI 10.1177/1745691612447309; Ntoumanis N, 2009, J EDUC PSYCHOL, V101, P717, DOI 10.1037/a0014696; Nunes HEG, 2016, PERCEPT MOTOR SKILL, V123, P526, DOI 10.1177/0031512516667694; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Owen KB, 2014, PREV MED, V67, P270, DOI 10.1016/j.ypmed.2014.07.033; Pannekoek L, 2013, HUM MOVEMENT SCI, V32, P1097, DOI 10.1016/j.humov.2013.08.004; Park S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174674; Pelletier LG, 2001, MOTIV EMOTION, V25, P279, DOI 10.1023/A:1014805132406; Roberts G.C., 2007, HDB SPORT PSYCHOL, P3, DOI DOI 10.1002/9781118270011.CH1; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Sallis JF, 2012, RES Q EXERCISE SPORT, V83, P125, DOI 10.1080/02701367.2012.10599842; Spinelli A, 2014, SUPERIORE SANITA  I; Teixeira PJ, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-78; Tomkinson Grant R, 2007, Med Sport Sci, V50, P46, DOI 10.1159/000101075; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Tsai PY, 2009, J SCH NURS, V25, P163, DOI 10.1177/1059840509331437; Vallerand R. J., 2012, HDB SPORT PSYCHOL, V3rd, P59, DOI [DOI 10.1002/9781118270011.CH3, 10.1002/9781118270011.ch3]; Weinberg RS, 2014, FDN SPORT EXERCISE P; Wilson AN, 2017, PEDIATR EXERC SCI, V29, P145, DOI 10.1123/pes.2016-0057; World Health Organization, 2010, Global recommendations on physical activity for health; World Health Organization, 2004, GLOB STRAT DIET PHYS; Zahariadis P. N, 2000, ATHLETIC INSIGHT, V2, P1; Zahariadis P, 2006, PERCEPT MOTOR SKILL, V102, P405, DOI 10.2466/PMS.102.2.405-420	60	12	12	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2018	13	9							e0204098	10.1371/journal.pone.0204098	http://dx.doi.org/10.1371/journal.pone.0204098			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GU9BO	30252867	gold, Green Submitted, Green Published			2022-12-26	WOS:000445639700028
J	Koukouvinis, P; Kyriazis, N; Gavaises, M				Koukouvinis, Phoevos; Kyriazis, Nikolaos; Gavaises, Manolis			Smoothed particle hydrodynamics simulation of a laser pulse impact onto a liquid metal droplet	PLOS ONE			English	Article							FREE-SURFACE FLOWS; SPH-ALE METHOD; INDUCED CAVITATION; SHOCK-WAVES; DYNAMICS; TIN; DEFORMATION; FRAGMENTATION; GENERATION; PICOSECOND	The impact of a laser pulse onto a liquid metal droplet is numerically investigated by utilising a weakly compressible single phase model; the thermodynamic closure is achieved by the Tait equation of state (EoS) for the liquid metal. The smoothed particle hydrodynamics (SPH) method, which has been employed in the arbitrary Lagrangian Eulerian (ALE) framework, offers numerical efficiency, compared to grid related discretization methods. The latter would require modelling not only of the liquid metal phase, but also of the vacuum, which would necessitate special numerical schemes, suitable for high density ratios. In addition, SPH-ALE allows for the easy deformation handling of the droplet, compared to interface tracking methods where strong mesh deformation and most likely degenerate cells occur. Then, the laser-induced deformation of the droplet is simulated and cavitation formation is predicted. The ablation pattern due to the emitted shock wave and the two low pressure lobes created in the middle of the droplet because of the rarefaction waves are demonstrated. The liquid metal droplet is subject to material rupture, when the shock wave, the rarefaction wave and the free surface interact. Similar patterns regarding the wave dynamics and the hollow structure have been also noticed in prior experimental studies.	[Koukouvinis, Phoevos; Kyriazis, Nikolaos; Gavaises, Manolis] City Univ London, Dept Mech Engn & Aeronaut, Sch Math Comp Sci & Engn, Northampton Sq, London, England	City University London	Koukouvinis, P (corresponding author), City Univ London, Dept Mech Engn & Aeronaut, Sch Math Comp Sci & Engn, Northampton Sq, London, England.	Foivos.Koukouvinis.1@city.ac.uk	Koukouvinis, Foivos/A-6938-2019	Koukouvinis, Foivos/0000-0002-3945-3707; Gavaises, Manolis/0000-0003-0874-8534	MSCA-IF-GF of the European Union's H2020 programme [748784]; MSCA-ITN-ETN of the European Union's H2020 programme [642536]	MSCA-IF-GF of the European Union's H2020 programme; MSCA-ITN-ETN of the European Union's H2020 programme	The research leading to these results has received funding from the MSCA-IF-GF of the European Union's H2020 programme, under REA grant agreement n. 748784 and from the MSCA-ITN-ETN of the European Union's H2020 programme, under REA grant agreement n. 642536. The authors would also like to acknowledge the contribution of The Lloyd's Register Foundation. Lloyd's Register Foundation helps to protect life and property by supporting engineering-related education, public engagement and the application of research.; The research leading to these results has received funding from the MSCA-ITN-ETN of the European Union's H2020 programme, under REA grant agreement n. 642536. The authors would also like to acknowledge the contribution of The Lloyd's Register Foundation. Lloyd's Register Foundation helps to protect life and property by supporting engineering-related education, public engagement and the application of research.	Akhatov I, 2002, EXP THERM FLUID SCI, V26, P731, DOI 10.1016/S0894-1777(02)00182-6; Antuono M, 2010, COMPUT PHYS COMMUN, V181, P532, DOI 10.1016/j.cpc.2009.11.002; Ashitkov SI, 2016, JETP LETT+, V103, P544, DOI 10.1134/S0021364016080038; Avila SRG, 2016, J FLUID MECH, V805, P551, DOI 10.1017/jfm.2016.583; Banine VY, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/25/253001; Basko MM, 2017, LASER PHYS LETT, V14, DOI 10.1088/1612-202X/aa539b; Batani D, 2016, EPL-EUROPHYS LETT, V114, DOI 10.1209/0295-5075/114/65001; Brennen C.E., 1995, CAVITATION BUBBLE DY; Colagrossi A, 2003, J COMPUT PHYS, V191, P448, DOI 10.1016/S0021-9991(03)00324-3; Crespo A, 2009, HIGH PERFORMANCE SPH; Dalrymple RA, 2006, COAST ENG, V53, P141, DOI 10.1016/j.coastaleng.2005.10.004; de Resseguier T, 2007, J APPL PHYS, V102, DOI 10.1063/1.2795436; Fujioka S, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2948874; FUKAI J, 1993, PHYS FLUIDS A-FLUID, V5, P2588, DOI 10.1063/1.858724; GATES DS, 1960, AICHE J, V6, P50, DOI 10.1002/aic.690060110; Gelderblom H, 2016, J FLUID MECH, V794, P676, DOI 10.1017/jfm.2016.182; GINGOLD RA, 1977, MON NOT R ASTRON SOC, V181, P375, DOI 10.1093/mnras/181.3.375; Grenier N, 2009, J COMPUT PHYS, V228, P8380, DOI 10.1016/j.jcp.2009.08.009; Haller KK, 2002, J APPL PHYS, V92, P2821, DOI 10.1063/1.1495533; Hirschfelder JO, 1964, MOLECULAR THEORY OF; HIRT CW, 1981, J COMPUT PHYS, V39, P201, DOI 10.1016/0021-9991(81)90145-5; Ivings MJ, 1998, INT J NUMER METH FL, V28, P395, DOI 10.1002/(SICI)1097-0363(19980915)28:3<395::AID-FLD718>3.0.CO;2-S; Kanel' GI, 2007, PHYS-USP+, V50, P771, DOI 10.1070/PU2007v050n08ABEH006327; Kanel GI, 2015, JETP LETT+, V102, P548, DOI 10.1134/S0021364015200059; Klein AL, 2015, PHYS REV APPL, V3, DOI 10.1103/PhysRevApplied.3.044018; Koukouvinis PK, 2013, INT J NUMER METH FL, V71, P1152, DOI 10.1002/fld.3706; Koukouvinis PK, 2012, DEV MESHFREE PARTICL; Krivokorytov MS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-19140-w; Krivokorytov MS, 2017, PHYS REV E, V95, DOI 10.1103/PhysRevE.95.031101; Kurilovich D, 2016, PHYS REV APPL, V6, DOI 10.1103/PhysRevApplied.6.014018; Li Z, 2014, COMPUT FLUIDS, V103, P6, DOI 10.1016/j.compfluid.2014.06.028; LUCY LB, 1977, ASTRON J, V82, P1013, DOI 10.1086/112164; Marongiu J., 2008, 3 SPHERIC WORKSH P L, V6; Marongiu JC, 2009, 4 SPHER WORKSH NANT; Marongiu JC, 2011, 6 INT SPHERIC WORKSH; Marongiu JC, 2010, 5 SPHER WORKSH; Marongiu JC, 2010, J HYDRAUL RES, V48, P40, DOI 10.1080/00221686.2010.9641244; Marrone S, 2011, COMPUT METHOD APPL M, V200, P1526, DOI 10.1016/j.cma.2010.12.016; Mizuta H, 2006, SILICON NANOELECTRONICS, P105; Mojarad N, 2015, SCI REP-UK, V5, DOI 10.1038/srep09235; MONAGHAN JJ, 1994, J COMPUT PHYS, V110, P399, DOI 10.1006/jcph.1994.1034; Moore G., 2006, IEEE J SOLID-ST CIRC, V20, P36, DOI [10.1109/N-SSC.2006.4804410, DOI 10.1109/N-SSC.2006.4804410]; Moshe E, 1999, J APPL PHYS, V86, P4242, DOI 10.1063/1.371352; Niu YY, 2016, COMPUT FLUIDS, V134, P196, DOI 10.1016/j.compfluid.2016.05.018; Omidvar P, 2012, INT J NUMER METH FL, V68, P686, DOI 10.1002/fld.2528; Pasandideh-Fard M, 2002, INT J HEAT MASS TRAN, V45, P2229, DOI 10.1016/S0017-9310(01)00336-2; Peel CS, 2011, APPL PHYS A-MATER, V103, P1131, DOI 10.1007/s00339-010-6056-7; Pirati A, 2017, PROC SPIE, V10143, DOI 10.1117/12.2261079; Reijers SA, 2016, J COMPUT SCI-NETH, V17, P309, DOI 10.1016/j.jocs.2016.05.012; Reijers SA, 2017, J FLUID MECH, V828, P374, DOI 10.1017/jfm.2017.518; SIGRIST MW, 1986, J APPL PHYS, V60, pR83, DOI 10.1063/1.337089; Stan CA, 2016, J PHYS CHEM LETT, V7, P2055, DOI 10.1021/acs.jpclett.6b00687; Tagawa Y, 2012, PHYS REV X, V2, DOI 10.1103/PhysRevX.2.031002; Ternovoi VY, 1998, AIP CONF PROC, V429, P87, DOI 10.1063/1.55607; Thoroddsen ST, 2009, PHYS FLUIDS, V21, DOI 10.1063/1.3253394; Toro E.F., 2009, RIEMANN SOLVERS NUME, Vthird, DOI DOI 10.1007/B79761; Totzeck M, 2007, NAT PHOTONICS, V1, P629, DOI 10.1038/nphoton.2007.218; Tran T, 2013, SOFT MATTER, V9, P3272, DOI 10.1039/c3sm27643k; Vila JP, 1999, MATH MOD METH APPL S, V9, P161, DOI 10.1142/S0218202599000117; Villermaux E, 2007, ANNU REV FLUID MECH, V39, P419, DOI 10.1146/annurev.fluid.39.050905.110214; Villermaux E, 2009, NAT PHYS, V5, P697, DOI 10.1038/NPHYS1340; Vinokhodov AY, 2016, QUANTUM ELECTRON+, V46, P23, DOI 10.1070/QE2016v046n01ABEH015867; Vogel A, 1996, J ACOUST SOC AM, V100, P148, DOI 10.1121/1.415878; Yarin AL, 2006, ANNU REV FLUID MECH, V38, P159, DOI 10.1146/annurev.fluid.38.050304.092144	64	5	5	8	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2018	13	9							e0204125	10.1371/journal.pone.0204125	http://dx.doi.org/10.1371/journal.pone.0204125			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU9BO	30252872	gold, Green Published, Green Accepted			2022-12-26	WOS:000445639700032
J	Yang, JK; Liang, JF; Xiao, LM; Yang, Y; Chao, QF				Yang, Jiang-Ke; Liang, Jian-Fang; Xiao, Lu-Mei; Yang, Yang; Chao, Qun-Fang			Vertical stratification of bacteria and the chemical compounds in crude oil-contaminated soil layers of the semi-deserted Dzungharian Basin	PLOS ONE			English	Article							ENVIRONMENTAL-FACTORS; DIVERSITY; CHINA; COMMUNITIES; SEDIMENTS; SPILL	The largely semi-deserted and deserted Dzungharian Basin sites in the northwest of China geologically represent an extension of the Paleozoic Kazakhstan Block and were once part of an independent continent. For reasons of overdevelopment and unreasonable operations during the process of exploitation and transportation, oil pollutants that were discharged into the soil environment caused serious pollution in this weak ecosystem. To explore the bacterial community composition in detail and their possible origination and potential during the natural attenuation of petroleum contaminants in this type of ecologic niche, GC-MS and high-throughput sequencing techniques were used to resolve the organic compounds and bacterial communities in vertical soil layers. The degradation of petroleum contaminants in semi-deserted and deserted soils mainly occurred in the layer at a depth of 45 +/- 55 cm. During this process, aromatic and heterocyclic compounds were significantly enriched in soils. The bacterial communities in this basin exhibited a distinct vertical stratification from the surface layer down to the bottom soil layer. Considering the interaction between the community composition and the geochemical properties, we speculate that the degradation of petroleum contaminants in this semi-deserted and deserted soil might represent a microorganism-mediated process and mainly occur in the deeper soil layer.	[Yang, Jiang-Ke] Wuhan Polytech Univ, Coll Biol & Pharmaceut Engn, Wuhan, Hubei, Peoples R China; [Liang, Jian-Fang; Xiao, Lu-Mei; Yang, Yang; Chao, Qun-Fang] Xinjiang Univ, Coll Life Sci & Technol, Urumqi, Xinjiang, Peoples R China	Wuhan Polytechnic University; Xinjiang University	Yang, JK (corresponding author), Wuhan Polytech Univ, Coll Biol & Pharmaceut Engn, Wuhan, Hubei, Peoples R China.	jiang.yang@gmail.com		Yang, Jiangke/0000-0001-6234-451X	National Natural and Science Foundation of China [31460027]	National Natural and Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Natural and Science Foundation of China (31460027).	Acosta-Gonzalez A, 2016, CURR OPIN BIOTECH, V38, P24, DOI 10.1016/j.copbio.2015.12.010; Adhikari PL, 2017, CHEMOSPHERE, V184, P939, DOI 10.1016/j.chemosphere.2017.06.077; Ainsworth CH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190840; Al-Awadhi H, 2012, ARCH MICROBIOL, V194, P689, DOI 10.1007/s00203-012-0800-7; Al-Mailem DM, 2015, EXTREMOPHILES, V19, P573, DOI 10.1007/s00792-015-0739-0; Al-Sayegh A, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0330-5; Barbato M, 2016, MAR POLLUT BULL, V104, P211, DOI 10.1016/j.marpolbul.2016.01.029; Bayat Z, 2016, MAR POLLUT BULL, V105, P120, DOI 10.1016/j.marpolbul.2016.02.042; Benyahia F, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13020219; Dauner ALL, 2015, SCI TOTAL ENVIRON, V536, P750, DOI 10.1016/j.scitotenv.2015.07.091; Gao PK, 2016, SCI REP-UK, V6, DOI 10.1038/srep20174; Jung J, 2015, APPL MICROBIOL BIOT, V99, P2533, DOI 10.1007/s00253-015-6439-y; Thi NCL, 2016, J ENVIRON SCI HEAL A, V51, P267, DOI 10.1080/10934529.2015.1094351; LI YP, 1991, J GEOPHYS RES-SOL EA, V96, P16047, DOI 10.1029/91JB01619; Liang Jianfang, 2016, Weishengwu Xuebao, V56, P1301, DOI 10.13343/j.cnki.wsxb.20150531; Liao JQ, 2015, MICROB ECOL, V70, P380, DOI 10.1007/s00248-015-0572-0; Long HZ, 2017, ENVIRON MONIT ASSESS, V189, DOI 10.1007/s10661-017-5798-5; O'Brien SL, 2016, ENVIRON MICROBIOL, V18, P2039, DOI 10.1111/1462-2920.13231; Obida CB, 2018, ENVIRON INT, V111, P32, DOI 10.1016/j.envint.2017.11.009; Omrani R, 2018, BIODEGRADATION, V29, P187, DOI 10.1007/s10532-018-9823-3; Peng M, 2015, INT J ENV RES PUB HE, V12, P12002, DOI 10.3390/ijerph121012002; Popov LE, 2017, ACTA GEOL POL, V67, P323, DOI 10.1515/agp-2017-0020; Saadoun I, 2008, BRAZ J MICROBIOL, V39, P453, DOI 10.1590/S1517-83822008000300008; Schumacher B., 2002, SOILS SEDIMENTS; Schwarz A, 2017, MICROB ECOL, P1; Seo JS, 2009, INT J ENV RES PUB HE, V6, P278, DOI 10.3390/ijerph6010278; Wang YZ, 2018, SCI TOTAL ENVIRON, V618, P419, DOI 10.1016/j.scitotenv.2017.11.066; Xue JL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08832-y; Yang JK, 2011, AQUAT MICROB ECOL, V62, P231, DOI 10.3354/ame01473; Zeng QL, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0343-x	30	3	3	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2018	13	9							e0203919	10.1371/journal.pone.0203919	http://dx.doi.org/10.1371/journal.pone.0203919			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU9BO	30252862	Green Submitted, gold, Green Published			2022-12-26	WOS:000445639700017
J	Arya, S; Kumar, SK; Nath, A; Kapoor, P; Aggarwal, A; Misra, R; Sinha, S				Arya, Suvrat; Kumar, Shashi Kant; Nath, Alok; Kapoor, Prerna; Aggarwal, Amita; Misra, Ramnath; Sinha, Sudhir			Synergy between tuberculin skin test and proliferative T cell responses to PPD or cell-membrane antigens of Mycobacterium tuberculosis for detection of latent TB infection in a high disease-burden setting	PLOS ONE			English	Article							ANTIBODY-RESPONSES; HIGH-PREVALENCE; BCG; RESPONSIVENESS; EXPOSURE; CONTACTS; CHILDREN; IMMUNITY; HEALTHY; HUMANS	Tuberculin skin test (TST) is used most widely for the detection of latent tuberculosis infection (LTBI), even though evidences suggest that it could be underreporting the prevalence of LTBI particularly in high disease-burden settings. We have explored whether in vivo (TST) and in vitro (cell-proliferative) T cell responses to PPD can serve as complementary measures. In addition, we also probed whether in vitro T cell response to cell-membrane antigens (Mem) of Mycobacterium tuberculosis (MTB) can serve as a biomarker for LTBI. Study subjects comprised 43 healthcare workers (HCWs), and 9 smear-positive TB patients served as `disease control'. To measure proliferative T cell responses, 0.1 ml blood (diluted 1:10) was incubated (5 days) with test or control antigen. Cells were stained with fluorescent antibodies to T cell (CD3+/CD4+/CD8+) surface markers and, after fixation and permeabilization, to nuclear proliferation marker Ki67. Data was acquired on a flow cytometer. HCWs who had an intimate exposure to MTB showed significantly higher TST positivity (85%) than the rest (43%), notwithstanding their BCG vaccination status. The proliferative responses of CD4+ and CD8+ subsets of T cells were comparable. Sixty seven and 100% TST-negative HCWs, respectively, were positive for proliferative T cell response to PPD and MTBMem. Cumulative positivity (TST or in vitro) was 86% with PPD and 100% with MTBMem indicating complementarity of the two responses. As standalone in vitro assay, MTBMem provided a significantly higher positivity (95%) than PPD (67%). T cell responses of TB patients were `generally' depressed, having implications for the development of immunological assays for `progressive' LTBI. Altogether, these results demonstrate that in vivo and in vitro T cell responses to PPD are complementary and in vitro response to MTBMem can be developed as a highly sensitive biomarker for LTBI.	[Arya, Suvrat; Kumar, Shashi Kant; Aggarwal, Amita; Misra, Ramnath; Sinha, Sudhir] Sanjay Gandhi Postgrad Inst Med Sci, Dept Clin Immunol, Lucknow, Uttar Pradesh, India; [Nath, Alok] Sanjay Gandhi Postgrad Inst Med Sci, Dept Pulm Med, Lucknow, Uttar Pradesh, India; [Kapoor, Prerna] Sanjay Gandhi Postgrad Inst Med Sci, DOT Ctr, Lucknow, Uttar Pradesh, India	Sanjay Gandhi Postgraduate Institute of Medical Sciences; Sanjay Gandhi Postgraduate Institute of Medical Sciences; Sanjay Gandhi Postgraduate Institute of Medical Sciences	Sinha, S (corresponding author), Sanjay Gandhi Postgrad Inst Med Sci, Dept Clin Immunol, Lucknow, Uttar Pradesh, India.	ssinha@sgpgi.ac.in	Sinha, Sudhir/C-7268-2009; Misra, Ramnath/N-9808-2019	Sinha, Sudhir/0000-0003-3149-1116; 				Adekambi T, 2015, J CLIN INVEST, V125, P1827, DOI 10.1172/JCI77990; Akbar AN, 2013, CLIN EXP IMMUNOL, V173, P163, DOI 10.1111/cei.12107; Arlehamn CSL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003130; Bernhagen J, 1996, J EXP MED, V183, P277, DOI 10.1084/jem.183.1.277; Black GF, 2001, INT J TUBERC LUNG D, V5, P664; Chadha VK, 2013, INT J TUBERC LUNG D, V17, P312, DOI 10.5588/ijtld.12.0330; Cho YS, 2012, PROTEOMICS, V12, P979, DOI 10.1002/pmic.201100544; Day CL, 2011, J IMMUNOL, V187, P2222, DOI 10.4049/jimmunol.1101122; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; Gallant CJ, 2010, CHEST, V137, P1071, DOI 10.1378/chest.09-1852; Hill PC, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000068; Hoff ST, 2007, CLIN INFECT DIS, V45, P575, DOI 10.1086/520662; Hussain Rabia, 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P764; Kelly A, 2017, ADV IMMUNOL, V134, P137, DOI 10.1016/bs.ai.2017.01.001; Khayyam Khalid Umer, 2010, Indian J Tuberc, V57, P192; Kumar SK, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150171; Kunnath-Velayudhan S, 2010, P NATL ACAD SCI USA, V107, P14703, DOI 10.1073/pnas.1009080107; Lagrange PH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073579; Lalvani A, 2001, J INFECT DIS, V183, P469, DOI 10.1086/318081; Lewinsohn DA, 2017, NPJ VACCINES, V2, DOI 10.1038/s41541-017-0008-6; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; McMullen SE, 2014, CLIN INFECT DIS, V58, P1260, DOI 10.1093/cid/ciu119; Narasimhan P, 2017, T ROY SOC TROP MED H, V111, P55, DOI 10.1093/trstmh/trx016; Narayanan PR, 2003, INT J TUBERC LUNG D, V7, P1083; Pai M, 2005, JAMA-J AM MED ASSOC, V293, P2746, DOI 10.1001/jama.293.22.2746; Rieder HL, 2011, INT J TUBERC LUNG D, V15, pS1; RIEDER HL, 1995, TUBERCLE LUNG DIS, V76, P114, DOI 10.1016/0962-8479(95)90552-9; SANCHEZ FO, 1994, INFECT IMMUN, V62, P5673; Schwander SK, 1998, J INFECT DIS, V178, P1434, DOI 10.1086/314454; Seddon JA, 2016, THORAX, V71, P932, DOI 10.1136/thoraxjnl-2015-207687; Sharma SK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169539; Single N, 2011, INT J TUBERC LUNG D, V15, P1326, DOI 10.5588/ijtld.10.0564; Sinha S, 2005, MICROBIOL-SGM, V151, P2411, DOI 10.1099/mic.0.27799-0; SMITH JA, 1972, AM REV RESPIR DIS, V106, P194, DOI 10.1164/arrd.1972.106.2.194; Soares A, 2010, J IMMUNOL METHODS, V362, P43, DOI 10.1016/j.jim.2010.08.007; Sutherland JS, 2009, EUR J IMMUNOL, V39, P723, DOI 10.1002/eji.200838693; Tebruegge M, 2016, INT J TUBERC LUNG D, V20, P1293, DOI 10.5588/ijtld.15.0975; The International Union against Tuberculosis and Lung disease, 2018, SIL EP CALL ACT CHIL; TOOSSI Z, 1995, INFECT IMMUN, V63, P224, DOI 10.1128/IAI.63.1.224-228.1995; WHO, 2017, WHOHTMTB201718; WHO, 2017, GLOB TUB REP; World Health Organization (WHO), 2015, GUIDELINES MANAGEMEN; World Medical Association, WMA DECL HELS ETH PR	43	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2018	13	9							e0204429	10.1371/journal.pone.0204429	http://dx.doi.org/10.1371/journal.pone.0204429			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3MI	30248144	gold, Green Published, Green Submitted			2022-12-26	WOS:000445998100039
J	Cruz-Benedetti, IC; Bublot, I; Ribas, T; Fourel, I; Vogl, C; Dubois, C; Milani, M; Ida, KK; Portier, K				Cruz-Benedetti, Inga-Catalina; Bublot, Isabelle; Ribas, Thibault; Fourel, Isabelle; Vogl, Claus; Dubois, Claire; Milani, Mathilde; Ida, Keila Kazue; Portier, Karine			Pharmacokinetics of intramuscular alfaxalone and its echocardiographic, cardiopulmonary and sedative effects in healthy dogs	PLOS ONE			English	Article							BEAGLE DOGS; BUTORPHANOL; INDUCTION; ANESTHESIA; ACEPROMAZINE; MEDETOMIDINE; COMBINATION; ALPHAXALONE; MEDICATION; ROUTE	The pharmacokinetics and the effects of a single intramuscular (IM) dose of alfaxalone on sedation and cardiopulmonary and echocardiographic variables was studied in dogs. Twelve healthy adult Beagles (3 females, 9 males) were used in this prospective controlled cross-over trial. Echocardiography was performed with and without 4 mg kg(-1) alfaxalone IM with a week wash-out interval. Sedation (19-point scale; 0 = no sedation), cardiopulmonary parameters, blood gas analysis and plasma concentration of alfaxalone were assessed every 5 minutes following the injection (T0). The influence of the alfaxalone plasma concentration and time on physiological variables was tested using a linear model whereas echocardiographic measurements were compared between conscious and alfaxalone-administered dogs using paired t-tests. Compared to baseline, alfaxalone administration was followed by an increase in heart rate (HR) from T5 to T30 and a decrease in mean arterial pressure (MAP) at T10, T25 and T30, in stroke volume (SV; 15 +/- 5 to 11 +/- 3 ml; P<0.0001), and end-diastolic volume (EDV; 24.7 +/- 5.7 to 19.4 +/- 4.9 ml). Cardiac output (CO) and blood gas analysis did not change significantly throughout. Mean plasma half-life was 29 +/- 8 minutes, volume of distribution was 1.94 +/- 0.63 L kg(-1), and plasma clearance was 47.7 +/- 14.1 ml kg(-1) minute(-1). Moderate to deep sedation was observed from T5 to T35. Ten dogs showed paddling, trembling, nystagmus and strong reaction to sound during the procedure. Although there were no significant changes in CO and oxygenation, the impact of HR, MAP, SV, EDV alterations requires further investigations in dogs with cardiac disease.	[Cruz-Benedetti, Inga-Catalina; Dubois, Claire; Ida, Keila Kazue; Portier, Karine] Univ Lyon, VetAgro Sup, GREAT, Marcy Ietoile, France; [Bublot, Isabelle; Milani, Mathilde] Univ Lyon, Unit Cardiol, VetAgro Sup, Marcy Ietoile, France; [Ribas, Thibault] Azurvet, Hippodrome, Cagnes Sur Mer, France; [Fourel, Isabelle] Univ Lyon, RS2GP, USC1233, INRA,VetAgro Sup, Marcy Ietoile, France; [Vogl, Claus] Vetmeduni, Sect Mol Biol, Dept Anim Husb & Genet, Vienna, Austria; [Ida, Keila Kazue] Univ Sao Paulo, Med Sch, Lab Med Invest Anaesthesiol 8, Sao Paulo, Brazil; [Portier, Karine] Univ Claude Bernard Lyon 1, Univ Lyon, INSERM,INSA Lyon, INRA,CarMeN Lab, Bron, France; [Cruz-Benedetti, Inga-Catalina] Vet Med Univ Wien, Dept Anaesthesiol & Perioperat Intens Care Med, Vienna, Austria; [Bublot, Isabelle] Clin Vet Cerisioz, Cardiol, St Priest, France; [Milani, Mathilde] Clin Vet Calvisson, Cardiol, Calvisson, France; [Ida, Keila Kazue] Univ Liege, Dept Compan Anim & Horses Clin, Anesthesiol & Vet Reanimat, Liege, Belgium	VetAgro Sup; VetAgro Sup; INRAE; VetAgro Sup; Universidade de Sao Paulo; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Veterinary Medicine Vienna; University of Liege	Portier, K (corresponding author), Univ Lyon, VetAgro Sup, GREAT, Marcy Ietoile, France.; Portier, K (corresponding author), Univ Claude Bernard Lyon 1, Univ Lyon, INSERM,INSA Lyon, INRA,CarMeN Lab, Bron, France.	karine.portier@vetagro-sup.fr	Fourel, Isabelle/AAI-1564-2020; Portier, Karine/CAA-7165-2022	Fourel, Isabelle/0000-0001-5470-612X; Ida, Keila/0000-0003-2200-4355	Dechra; Jurox; biochemistry department of Vetagro-Sup	Dechra; Jurox; biochemistry department of Vetagro-Sup	We would like to thank Dr. Mehdi Midoun and SCIL for lending us the echocardiograph and Dechra and Jurox for providing us with alfaxalone and for their financial support. We would like to thank Dr. Benoit Rannou from the biochemistry department of Vetagro-Sup for sponsoring the pre-operative blood work and Mr. Guillaume Noel from the Institut Claude Bourgelat for providing the dogs for our study. A very heartfelt thank you goes to the rest of the Anaesthesia Team of Vetagro-Sup.	Amengual M, 2013, VET ANAESTH ANALG, V40, P115, DOI 10.1111/j.1467-2995.2012.00747.x; Boon JA, 2011, VET ECHOCARDIOGRAPHY, P118; BREWSTER ME, 1989, J PARENT SCI TECHN, V43, P262; Chiu KW, 2016, J VET PHARMACOL THER, V39, P525, DOI 10.1111/jvp.12312; Clutton RE, 2007, BSAVA MANUAL CANINE, P200; Diehl KH, 2001, J APPL TOXICOL, V21, P15, DOI 10.1002/jat.727; Ferchichi S, 2013, VET ANAESTH ANALG, V40, P655, DOI 10.1111/vaa.12085; Ferre PJ, 2006, VET ANAESTH ANALG, V33, P229, DOI 10.1111/j.1467-2995.2005.00264.x; Gurney M, 2009, J SMALL ANIM PRACT, V50, P474, DOI 10.1111/j.1748-5827.2009.00786.x; Jin JF, 2015, PATIENT PREFER ADHER, V9, P923, DOI 10.2147/PPA.S87271; Kellum HB, 2007, J VET INTERN MED, V21, P1258, DOI 10.1892/07-006.1; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim YeWon, 2015, Korean Journal of Veterinary Research, V55, P221, DOI 10.14405/kjvr.2015.55.4.221; Lee J, 2015, J VET MED SCI, V77, P1677, DOI 10.1292/jvms.15-0065; Maney JK, 2013, VET ANAESTH ANALG, V40, P237, DOI 10.1111/vaa.12006; Rodriguez JM, 2012, VET ANAESTH ANALG, V39, P357, DOI 10.1111/j.1467-2995.2011.00695.x; Muir W, 2008, VET ANAESTH ANALG, V35, P451, DOI 10.1111/j.1467-2995.2008.00406.x; Pasloske K, 2009, J VET PHARMACOL THER, V32, P510, DOI 10.1111/j.1365-2885.2009.01070.x; Psatha E, 2011, VET ANAESTH ANALG, V38, P24, DOI 10.1111/j.1467-2995.2010.00577.x; Ribas T, 2015, J FELINE MED SURG, V17, P530, DOI 10.1177/1098612X14551187; Rishniw M, 2000, J VET INTERN MED, V14, P429, DOI 10.1892/0891-6640(2000)014&lt;0429:EOFEMO&gt;2.3.CO;2; Robinson R., 2016, BSAVA MANUAL CANINE, P283; Seo JI, 2015, VET ANAESTH ANALG, V42, P304, DOI 10.1111/vaa.12223; Smith LJ, 2001, J AM VET MED ASSOC, V218, P1101, DOI 10.2460/javma.2001.218.1101; Tamura J, 2016, J VET MED SCI, V78, P929, DOI 10.1292/jvms.15-0159; Tamura J, 2015, J VET MED SCI, V77, P289, DOI 10.1292/jvms.14-0368; THOMAS WP, 1993, J VET INTERN MED, V7, P247, DOI 10.1111/j.1939-1676.1993.tb01015.x; Visser SAG, 2000, J CHROMATOGR B, V745, P357, DOI 10.1016/S0378-4347(00)00296-6	28	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2018	13	9							e0204553	10.1371/journal.pone.0204553	http://dx.doi.org/10.1371/journal.pone.0204553			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3MI	30248146	Green Published, gold, Green Submitted			2022-12-26	WOS:000445998100050
J	Zhang, XS; Lo Iacono, G				Zhang, Xu-Sheng; Lo Iacono, Giovanni			Estimating human-to-human transmissibility of hepatitis A virus in an outbreak at an elementary school in China, 2011	PLOS ONE			English	Article							UNITED-STATES; DISEASE; MODEL	Hepatitis A is caused by hepatitis A virus and occurs worldwide. Estimating the transmissibility, which is usually characterized by the basic reproductive number R-0, the mean number of secondary infectious cases generated by a single primary infectious case introduced into a totally susceptible population, provides crucial information for the effort required to stop infection spreading. Hepatitis A virus is usually transmitted indirectly through contaminated food and environment. An outbreak from March to June 2011 was reported to have occurred at an elementary school of 698 pupils in China and it was found that the outbreak was due to direct transmission between school children. Based on the symptom onset date and the social contact network of the children, in this study we estimate the serial interval (i.e. the gap in symptom onset between an infectee and its infector) and use different statistical methods to estimate R-0. Combining with the positivity of IgG antibodies tests, we develop a compartmental transmission dynamics model which includes both asymptomatic and symptomatic infections to estimate the overall R-0. Our analysis suggests a serial interval of mean = 23.9 days and standard deviation = 20.9 days. The different statistical methods suggest estimates for R-0 in the outbreak varying from 2.1 to 2.8, and the estimates from the transmission dynamics model are consistent with this range. Our estimates are in agreement with that from one study in England but are higher than that from one study in the United States. Our transmission dynamics model suggests that the proportion of symptomatic infections is about 9%, implying that there were about 344 asymptomatic infections along with the 32 observed symptomatic cases. Furthermore, it is shown that the inclusion of asymptomatic infection in the epidemic process increases the estimate of R-0 but does not do so greatly provided that the proportion of symptomatic infections is constant over the outbreak and there is no difference in transmissibility between symptomatic and asymptomatic infections.	[Zhang, Xu-Sheng] Publ Hlth England, Ctr Infect Dis Surveillance & Control, Natl Infect Serv, London, England; [Zhang, Xu-Sheng] Imperial Coll Sch Publ Hlth, Med Res Council Ctr Outbreak Anal & Modelling, Dept Infect Dis Epidemiol, Norfolk Pl, London, England; [Lo Iacono, Giovanni] Publ Hlth England, Chem & Environm Effects Ctr Radiat, Chem & Environm Hazards, London, England; [Lo Iacono, Giovanni] Univ Surrey, Sch Vet Med, Guildford, Surrey, England	Public Health England; Imperial College London; Public Health England; University of Surrey	Zhang, XS (corresponding author), Publ Hlth England, Ctr Infect Dis Surveillance & Control, Natl Infect Serv, London, England.; Zhang, XS (corresponding author), Imperial Coll Sch Publ Hlth, Med Res Council Ctr Outbreak Anal & Modelling, Dept Infect Dis Epidemiol, Norfolk Pl, London, England.	xu-sheng.zhang@phe.gov.uk	Iacono, Giovanni Lo/J-7164-2019	Iacono, Giovanni Lo/0000-0002-6150-2843; Zhang, Xu-Sheng/0000-0002-6596-4500				ANDERSON R M, 1991; Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Armstrong GL, 2002, PEDIATRICS, V109, P839, DOI 10.1542/peds.109.5.839; Beebeejaun K, 2017, EUROSURVEILLANCE, V22, P7, DOI 10.2807/1560-7917.ES.2017.22.5.30454; Champredon D, 2018, EPIDEMICS-NETH, V22, P36, DOI 10.1016/j.epidem.2017.02.011; Chowell G, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0659; Connor BA, 2005, AM J MED, V118, P58, DOI 10.1016/j.amjmed.2005.07.018; Fraser C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000758; GAY NJ, 1994, EPIDEMIOL INFECT, V113, P113, DOI 10.1017/S0950268800051529; HAWKER J, 2001, COMMUNICABLE DIS CON; Hens N, 2012, AM J EPIDEMIOL, V176, P196, DOI 10.1093/aje/kws006; Hollinger F. B., 1996, FIELDS VIROLOGY, P735; KOFF RS, 1992, VACCINE, V10, pS15, DOI 10.1016/0264-410X(92)90533-P; Lim Hyun-Sul, 2013, J Prev Med Public Health, V46, P62, DOI 10.3961/jpmph.2013.46.2.62; Matheny SC, 2012, AM FAM PHYSICIAN, V86, P1027; Nishiura H, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009936; Omori R, 2015, SCI REP-UK, V5, DOI 10.1038/srep14473; Pell B, 2018, EPIDEMICS-NETH, V22, P62, DOI 10.1016/j.epidem.2016.11.002; Regan DG, 2016, EPIDEMIOL INFECT, V144, P1528, DOI 10.1017/S0950268815002605; Tuite AR, 2018, EPIDEMICS-NETH, V22, P71, DOI 10.1016/j.epidem.2016.09.001; Van Effelterre TP, 2006, CLIN INFECT DIS, V43, P158, DOI 10.1086/505115; Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754; Wallinga J, 2004, AM J EPIDEMIOL, V160, P509, DOI 10.1093/aje/kwh255; White LF, 2008, STAT MED, V27, P2999, DOI 10.1002/sim.3136; WHO Immunization Vaccines and Biologicals, 2009, WHO IMMUNIZATION VAC; Woolhouse M, 2001, NATURE, V411, P258, DOI 10.1038/35077149; Wu JB, 2014, EPIDEMIOL INFECT, V142, P1450, DOI 10.1017/S0950268813002331; Wu Jau-Shin, 1993, Journal of the Formosan Medical Association, V92, P812; Zhang XS, 2017, INFLUENZA OTHER RESP, V11, P434, DOI 10.1111/irv.12467	29	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2018	13	9							e0204201	10.1371/journal.pone.0204201	http://dx.doi.org/10.1371/journal.pone.0204201			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3MI	30248120	Green Submitted, Green Published, gold			2022-12-26	WOS:000445998100026
J	Chen, TL; Chen, JS; Zhu, YB; Li, Y; Wang, Y; Chen, HJ; Wang, JH; Li, X; Liu, Y; Li, BS; Sun, XL; Ke, YQ				Chen, Taoliang; Chen, Jiansheng; Zhu, Yubo; Li, Yan; Wang, Yun; Chen, Huajian; Wang, Jihui; Li, Xiao; Liu, Yang; Li, Baisheng; Sun, Xinlin; Ke, Yiquan			CsD163, a novel therapeutic target, regulates the proliferation and stemness of glioma cells via casein kinase 2	ONCOGENE			English	Article							MACROPHAGE SCAVENGER RECEPTOR; PROTEIN-KINASE; HUMAN GLIOBLASTOMA; CANCER; CD163; EXPRESSION; BRAIN; CK2; ANTIGEN; CD133	Glioma is a devastating cancer with a dismal prognosis and there is an urgent need to discover novel glioma-specific antigens for glioma therapy. Previous studies have identified CD163-positive tumour cells in certain solid tumours, but CD163 expression in glioma remains unknown. In this study, via an analysis of public datasets, we demonstrated that CD163 overexpression in glioma specimens correlated with an unfavourable patient prognosis. CD163 expression was increased in glioma cells, especially primary glioma cells. The loss of CD163 expression inhibited both cell cycle progression and the proliferation of glioblastoma multiforme (GBM) cell lines and primary glioma cells. CD163 interacted directly with casein kinase 2 (CK2) and CD163 silencing reduced AKT/GSK3 beta/beta-catenin/cyclin D1 pathway activity via CK2. Moreover, CD163 was upregulated in CD133-positive glioma stem cells (GSCs), and CD163 downregulation decreased the expression of GSC markers, including CD133, ALDH1A1, NANOG and OCT4. The knockdown of CD163 impaired GSC stemness by inhibiting the CK2/AKT/GSK3 beta/beta-catenin pathway. Finally, a CD163 antibody successfully induced complement-dependent cytotoxicity against glioma cells. Our findings indicate that CD163 contributes to gliomagenesis via CK2 and provides preclinical evidence that CD163 and the CD163 pathway might serve as a therapeutic target for glioma.	[Chen, Taoliang; Chen, Jiansheng; Zhu, Yubo; Li, Yan; Wang, Yun; Chen, Huajian; Wang, Jihui; Li, Xiao; Liu, Yang; Li, Baisheng; Sun, Xinlin; Ke, Yiquan] Southern Med Univ, Dept Neurosurg,Zhujiang Hosp,Minist China, Natl Key Clin Specialty,Engn Technol Res Ctr Educ, Guangdong Prov Key Lab Brain Funct Repair & Regen, Guangzhou 510282, Guangdong, Peoples R China; [Wang, Yun] Xinjiang Med Univ, Hosp 1, Dept Neurosurg, Urumqi 830054, Peoples R China; [Li, Baisheng] Huizhou Cent Peoples Hosp, Dept Neurosurg, Huizhou 516001, Peoples R China	Southern Medical University - China; Xinjiang Medical University	Sun, XL; Ke, YQ (corresponding author), Southern Med Univ, Dept Neurosurg,Zhujiang Hosp,Minist China, Natl Key Clin Specialty,Engn Technol Res Ctr Educ, Guangdong Prov Key Lab Brain Funct Repair & Regen, Guangzhou 510282, Guangdong, Peoples R China.	zjsunxinlin@163.com; kyquan@smu.edu.cn			Natural Science Foundation of China [81772651, 81772652]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of China (nos. 81772651 and 81772652).	Beatty GL, 2015, CLIN CANCER RES, V21, P687, DOI 10.1158/1078-0432.CCR-14-1860; BIGNER SH, 1985, NEUROL CLIN, V3, P769, DOI 10.1016/S0733-8619(18)31008-9; Binnemars-Postma K, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18050979; Boussiotis VA, 2018, ONCOGENE, V37, P1121, DOI 10.1038/s41388-017-0024-z; Brown CE, 2016, NEW ENGL J MED, V375, P2561, DOI 10.1056/NEJMoa1610497; Calvert JG, 2007, J VIROL, V81, P7371, DOI 10.1128/JVI.00513-07; Chang AL, 2016, CANCER RES, V76, P5671, DOI 10.1158/0008-5472.CAN-16-0144; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Condello S, 2015, ONCOGENE, V34, P2297, DOI 10.1038/onc.2014.178; Di Maira G, 2005, CELL DEATH DIFFER, V12, P668, DOI 10.1038/sj.cdd.4401604; Dixit D, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.10; Fabriek BO, 2009, BLOOD, V113, P887, DOI 10.1182/blood-2008-07-167064; He CJ, 2018, THERANOSTICS, V8, P237, DOI 10.7150/thno.21945; Ikushima H, 2011, J BIOL CHEM, V286, P41434, DOI 10.1074/jbc.M111.300863; Jensen TO, 2010, J CLIN ONCOL, V28; Kaminska B, 2009, INT J ONCOL, V35, P1091, DOI 10.3892/ijo_00000424; Kemper K, 2010, CANCER RES, V70, P719, DOI 10.1158/0008-5472.CAN-09-1820; Kim WK, 2006, AM J PATHOL, V168, P822, DOI 10.2353/ajpath.2006.050215; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Lai SS, 2016, J HEPATOL, V64, P352, DOI 10.1016/j.jhep.2015.09.025; LAW SKA, 1993, EUR J IMMUNOL, V23, P2320, DOI 10.1002/eji.1830230940; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lin KY, 2010, ANN SURG ONCOL, V17, P1695, DOI 10.1245/s10434-010-0911-9; Lisi L, 2017, NEUROSCI LETT, V645, P106, DOI 10.1016/j.neulet.2017.02.076; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Lu X, 2011, ADV EXP MED BIOL, V714, P129, DOI 10.1007/978-94-007-0782-5_6; Ma CY, 2018, MED MOL MORPHOL, V51, P13, DOI 10.1007/s00795-017-0165-8; Natsume A, 2008, DRUG DES DEV THER, V3, P7; Nitta RT, 2015, ONCOGENE, V34, P3688, DOI 10.1038/onc.2014.299; Noubissi FK, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091587; Olsen BB, 2010, ONCOGENE, V29, P6016, DOI 10.1038/onc.2010.337; Ostrom QT, 2017, NEURO-ONCOLOGY, V19, pV1, DOI 10.1093/neuonc/nox158; Ostuni R, 2015, TRENDS IMMUNOL, V36, P229, DOI 10.1016/j.it.2015.02.004; Pallares J, 2009, AM J PATHOL, V174, P287, DOI 10.2353/ajpath.2009.080552; Ponce DP, 2011, J CELL PHYSIOL, V226, P1953, DOI 10.1002/jcp.22527; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Prosniak M, 2013, CLIN CANCER RES, V19, P3776, DOI 10.1158/1078-0432.CCR-12-1940; Qi L, 2016, ONCOTARGET, V7, P71673, DOI 10.18632/oncotarget.12317; Quail DF, 2017, CANCER CELL, V31, P326, DOI 10.1016/j.ccell.2017.02.009; Rasper M, 2010, NEURO-ONCOLOGY, V12, P1024, DOI 10.1093/neuonc/noq070; Reardon DA, 2016, CANCER IMMUNOL RES, V4, P124, DOI 10.1158/2326-6066.CIR-15-0151; Reardona DA, 2017, NEURO-ONCOLOGY, V19, P21, DOI 10.1093/neuonc/nox036.071; Ritter M, 2001, EUR J IMMUNOL, V31, P999, DOI 10.1002/1521-4141(200104)31:4<999::AID-IMMU999>3.0.CO;2-R; Sanchez-Torres C, 2003, ARCH VIROL, V148, P2307, DOI 10.1007/s00705-003-0188-4; Shabo I, 2008, INT J CANCER, V123, P780, DOI 10.1002/ijc.23527; Shabo I, 2011, ADV EXP MED BIOL, V714, P141, DOI 10.1007/978-94-007-0782-5_7; Shabo I, 2009, INT J CANCER, V125, P1826, DOI 10.1002/ijc.24506; Shi Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15080; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Tang YY, 2018, CELL COMMUN SIGNAL, V16, DOI 10.1186/s12964-018-0222-5; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Xi G, 2016, ONCOGENE, V35, P241, DOI 10.1038/onc.2015.78; Ye XZ, 2012, J IMMUNOL, V189, P444, DOI 10.4049/jimmunol.1103248; Ying M, 2011, ONCOGENE, V30, P3454, DOI 10.1038/onc.2011.58; Zbinden M, 2010, EMBO J, V29, P2659, DOI 10.1038/emboj.2010.137; Zhang ZR, 2012, BRAIN RES, V1461, P102, DOI 10.1016/j.brainres.2012.04.038	57	27	28	2	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 21	2019	38	8					1183	1199		10.1038/s41388-018-0515-6	http://dx.doi.org/10.1038/s41388-018-0515-6			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HM1XR	30258108				2022-12-26	WOS:000459249800003
J	Cherezova, A; Tomilin, V; Buncha, V; Zaika, O; Ortiz, PA; Mei, F; Cheng, XD; Mamenko, M; Pochynyuk, O				Cherezova, Alena; Tomilin, Viktor; Buncha, Vadym; Zaika, Oleg; Ortiz, Pablo A.; Mei, Fang; Cheng, Xiaodong; Mamenko, Mykola; Pochynyuk, Oleh			Urinary concentrating defect in mice lacking Epac1 or Epac2	FASEB JOURNAL			English	Article						collecting duct; AQP2; NHE-3; urea; water deprivation	RENAL COLLECTING DUCT; THICK ASCENDING LIMB; UREA TRANSPORTER; COTRANSPORTER NKCC2; PARATHYROID-HORMONE; APICAL EXOCYTOSIS; CA2+ MOBILIZATION; DISTAL NEPHRON; NHE3 ACTIVITY; VASOPRESSIN	cAMP is a universal second messenger regulating a plethora of processes in the kidney. Two downstream effectors of cAMP are PKA and exchange protein directly activated by cAMP (Epac), which, unlike PKA, is often linked to elevation of [Ca2+](i). While both Epac isoforms (Epac1 and Epac2) are expressed along the nephron, their relevance in the kidney remains obscure. We combined ratiometric calcium imaging with quantitative immunoblotting, immunofluorescent confocal microscopy, and balance studies in mice lacking Epac1 or Epac2 to determine the role of Epac in renal water-solute handling. Epac1(-/-) and Epac2(-/-) mice developed polyuria despite elevated arginine vasopressin levels. We did not detect major deficiencies in arginine vasopressin [Ca2+](i) signaling in split-opened collecting ducts or decreases in aquaporin water channel type 2 levels. Instead, sodium-hydrogen exchanger type 3 levels in the proximal tubule were dramatically reduced in Epac1(-/-) and Epac2(-/-) mice. Water deprivation revealed persisting polyuria, impaired urinary concentration ability, and augmented urinary excretion of Na+ and urea in both mutant mice. In summary, we report a nonredundant contribution of Epac isoforms to renal function. Deletion of Epac1 and Epac2 decreases sodium-hydrogen exchanger type 3 expression in the proximal tubule, leading to polyuria and osmotic diuresis.Cherezova, A., Tomilin, V., Buncha, V., Zaika, O., Ortiz, P. A., Mei, F., Cheng, X., Mamenko, M., Pochynyuk, O. Urinary concentrating defect in mice lacking Epac1 or Epac2.	[Cherezova, Alena; Buncha, Vadym; Mamenko, Mykola] Augusta Univ, Med Coll Georgia, Dept Physiol, Augusta, GA USA; [Tomilin, Viktor; Zaika, Oleg; Mei, Fang; Cheng, Xiaodong; Pochynyuk, Oleh] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, 6431 Fannin St, Houston, TX 77030 USA; [Cheng, Xiaodong] Univ Texas Hlth Sci Ctr Houston, Texas Therapeut Inst, Houston, TX 77030 USA; [Ortiz, Pablo A.] Henry Ford Hosp, Dept Internal Med, Hypertens & Vasc Res Div, Detroit, MI 48202 USA	University System of Georgia; Augusta University; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Henry Ford Health System; Henry Ford Hospital	Pochynyuk, O (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, 6431 Fannin St, Houston, TX 77030 USA.	oleh.m.pochynyuk@uth.tmc.edu	Mamenko, Mykola/I-6061-2015; Cheng, Xiaodong/O-8176-2019	Mamenko, Mykola/0000-0001-8683-0715; Cheng, Xiaodong/0000-0002-3479-1694	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [DK095029, DK119170]; American Heart Association (AHA) [17GRNT33660488]; American Society of Nephrology Ben J. Lipps Research Fellowship [AHA-15SDG25550150]; NIH National Institute of General Medical Sciences [GM066170, GM122536]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK119170, R01DK095029, R01DK107263] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066170, R35GM122536] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Heart Association (AHA)(American Heart Association); American Society of Nephrology Ben J. Lipps Research Fellowship; NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Alicia McDonough (Keck School of Medicine, University of Southern California, Los Angeles, CA, USA) for the insights and advice on technical aspects of renal transporter detection; and Svetlana Cherezova for her invaluable help with schematic illustration of the nephron. This research was supported by U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Grants DK095029 and DK119170 (to O.P.), American Heart Association (AHA) Grant 17GRNT33660488 (to O.P.), American Society of Nephrology Ben J. Lipps Research Fellowship (to V.T.), AHA-15SDG25550150 (to M.M.), and NIH National Institute of General Medical Sciences Grants GM066170 and GM122536 (to X.C.). The authors declare no conflicts of interest.	Almahariq M, 2013, MOL PHARMACOL, V83, P122, DOI 10.1124/mol.112.080689; Balasubramanian L, 2008, PFLUG ARCH EUR J PHY, V456, P747, DOI 10.1007/s00424-007-0371-7; Banerjee U, 2015, GENE, V570, P157, DOI 10.1016/j.gene.2015.06.063; Berrout J, 2012, J BIOL CHEM, V287, P8782, DOI 10.1074/jbc.M111.308411; Bockenhauer D, 2015, NAT REV NEPHROL, V11, P576, DOI 10.1038/nrneph.2015.89; Bradford EM, 2009, AM J PHYSIOL-GASTR L, V296, pG886, DOI 10.1152/ajpgi.90520.2008; Broere N, 2009, PFLUG ARCH EUR J PHY, V457, P1079, DOI 10.1007/s00424-008-0579-1; Caceres PS, 2009, J BIOL CHEM, V284, P24965, DOI 10.1074/jbc.M109.037135; Chou CL, 2000, J BIOL CHEM, V275, P36839, DOI 10.1074/jbc.M005552200; Collazo R, 2000, J BIOL CHEM, V275, P31601, DOI 10.1074/jbc.M000600200; Cunninghan R, 2004, J BIOL CHEM, V279, P37815, DOI 10.1074/jbc.M405893200; Danziger J, 2015, CLIN J AM SOC NEPHRO, V10, P852, DOI 10.2215/CJN.10741013; de Bruijn PIA, 2015, AM J PHYSIOL-RENAL, V309, pF146, DOI 10.1152/ajprenal.00154.2015; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Donowitz M, 2009, J EXP BIOL, V212, P1638, DOI 10.1242/jeb.028605; Ecelbarger CA, 2001, EXP NEUROL, V171, P227, DOI 10.1006/exnr.2001.7775; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Fenton RA, 2017, KIDNEY INT, V92, P397, DOI 10.1016/j.kint.2017.02.001; Fushimi K, 1997, J BIOL CHEM, V272, P14800, DOI 10.1074/jbc.272.23.14800; Gimenez I, 2003, J BIOL CHEM, V278, P26946, DOI 10.1074/jbc.M303435200; Gloerich M, 2010, ANNU REV PHARMACOL, V50, P355, DOI 10.1146/annurev.pharmtox.010909.105714; Good DW, 1996, AM J PHYSIOL-RENAL, V270, pF691, DOI 10.1152/ajprenal.1996.270.4.F691; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Holz GG, 2006, J PHYSIOL-LONDON, V577, P5, DOI 10.1113/jphysiol.2006.119644; Honegger KJ, 2006, P NATL ACAD SCI USA, V103, P803, DOI 10.1073/pnas.0503562103; Kang GX, 2003, J BIOL CHEM, V278, P8279, DOI 10.1074/jbc.M211682200; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Klein JD, 2016, J AM SOC NEPHROL, V27, P1448, DOI 10.1681/ASN.2014121267; Klein JD, 2011, COMPR PHYSIOL, V1, P699, DOI 10.1002/cphy.c100030; Knepper MA, 2015, NEW ENGL J MED, V372, P1349, DOI 10.1056/NEJMra1404726; Kortenoeven MLA, 2012, AM J PHYSIOL-RENAL, V302, pF1395, DOI 10.1152/ajprenal.00376.2011; Lezoualc'h F, 2016, CIRC RES, V118, P881, DOI 10.1161/CIRCRESAHA.115.306529; Li SZ, 2007, AM J PHYSIOL-CELL PH, V292, pC1606, DOI 10.1152/ajpcell.00588.2005; Li Y, 2008, AM J PHYSIOL-RENAL, V295, pF525, DOI 10.1152/ajprenal.00448.2007; Lobo MJ, 2016, J CELL SCI, V129, P2599, DOI 10.1242/jcs.185629; Mamenko M, 2016, J AM SOC NEPHROL, V27, P2035, DOI 10.1681/ASN.2014121200; Mamenko M, 2013, J BIOL CHEM, V288, P20306, DOI 10.1074/jbc.M113.466797; Mamenko Mykola, 2013, Methods Mol Biol, V998, P371, DOI 10.1007/978-1-62703-351-0_29; Mamenko M, 2012, HYPERTENSION, V60, P1234, DOI 10.1161/HYPERTENSIONAHA.112.200469; Matsumura Y, 1997, J AM SOC NEPHROL, V8, P861; Morel E, 2005, CIRC RES, V97, P1296, DOI 10.1161/01.RES.0000194325.31359.86; Mount DB, 2014, CLIN J AM SOC NEPHRO, V9, P1974, DOI 10.2215/CJN.04480413; Palmer LG, 2015, CLIN J AM SOC NEPHRO, V10, P676, DOI 10.2215/CJN.12391213; Pedersen NB, 2010, KIDNEY INT, V78, P160, DOI 10.1038/ki.2010.130; Pereira L, 2013, CIRCULATION, V127, P913, DOI 10.1161/CIRCULATIONAHA.12.148619; Rinschen MM, 2010, P NATL ACAD SCI USA, V107, P3882, DOI 10.1073/pnas.0910646107; Robichaux WG, 2018, PHYSIOL REV, V98, P919, DOI 10.1152/physrev.00025.2017; Schmidt M, 2013, PHARMACOL REV, V65, P670, DOI 10.1124/pr.110.003707; Schultheis PJ, 1998, NAT GENET, V19, P282, DOI 10.1038/969; Tsalkova T, 2012, P NATL ACAD SCI USA, V109, P18613, DOI 10.1073/pnas.1210209109; Uchida S, 2005, MOL CELL BIOL, V25, P7357, DOI 10.1128/MCB.25.16.7357-7363.2005; Wade JB, 2000, AM J PHYSIOL-RENAL, V278, pF52, DOI 10.1152/ajprenal.2000.278.1.F52; Wang PY, 2017, BIOORG MED CHEM LETT, V27, P1633, DOI 10.1016/j.bmcl.2017.02.065; Wang YH, 2009, J AM SOC NEPHROL, V20, P2018, DOI 10.1681/ASN.2008121225; Wiederkehr MR, 2001, KIDNEY INT, V59, P197, DOI 10.1046/j.1523-1755.2001.00480.x; Wilson JLL, 2013, CLIN EXP NEPHROL, V17, P751, DOI 10.1007/s10157-013-0789-5; Yan JB, 2013, MOL CELL BIOL, V33, P918, DOI 10.1128/MCB.01227-12; Yang LE, 2008, AM J PHYSIOL-RENAL, V295, pF1003, DOI 10.1152/ajprenal.90235.2008; Yasui M, 1997, AM J PHYSIOL-RENAL, V272, pF443, DOI 10.1152/ajprenal.1997.272.4.F443; Yip KP, 2006, AM J PHYSIOL-RENAL, V291, pF882, DOI 10.1152/ajprenal.00411.2005; Yip KP, 2011, AM J PHYSIOL-RENAL, V300, pF540, DOI 10.1152/ajprenal.00544.2009; Yip KP, 2002, J PHYSIOL-LONDON, V538, P891, DOI 10.1113/jphysiol.2001.012606; Zaika O, 2013, J AM SOC NEPHROL, V24, P604, DOI 10.1681/ASN.2012050442; Zhu YM, 2015, SCI REP-UK, V5, DOI 10.1038/srep09344	64	6	6	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2156	2170		10.1096/fj.201800435R	http://dx.doi.org/10.1096/fj.201800435R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30252533	Green Published			2022-12-26	WOS:000457296600051
J	Coullon, H; Rifflet, A; Wheeler, R; Janoir, C; Boneca, IG; Candela, T				Coullon, Heloise; Rifflet, Aline; Wheeler, Richard; Janoir, Claire; Boneca, Ivo Gomperts; Candela, Thomas			N-Deacetylases required for muramic--lactam production are involved in Clostridium difficile sporulation, germination, and heat resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						sporulation; bacteria; bacterial pathogenesis; acetylation; Gram-positive bacteria; infectious disease; microbiology; peptidoglycan; Clostridium difficile; germination; muramic--lactams; N-deacetylase; spore cortex	BACILLUS-SUBTILIS; PEPTIDOGLYCAN STRUCTURE; SPORE CORTEX; GENE; INHIBITORS; INFECTION; RESIDUES; DYNAMICS; HOMOLOG; DISEASE	Spores are produced by many organisms as a survival mechanism activated in response to several environmental stresses. Bacterial spores are multilayered structures, one of which is a peptidoglycan layer called the cortex, containing muramic--lactams that are synthesized by at least two bacterial enzymes, the muramoyl-l-alanine amidase CwlD and the N-deacetylase PdaA. This study focused on the spore cortex of Clostridium difficile, a Gram-positive, toxin-producing anaerobic bacterial pathogen that can colonize the human intestinal tract and is a leading cause of antibiotic-associated diarrhea. Using ultra-HPLC coupled with high-resolution MS, here we found that the spore cortex of the C. difficile 630erm strain differs from that of Bacillus subtilis. Among these differences, the muramic--lactams represented only 24% in C. difficile, compared with 50% in B. subtilis. CD630_14300 and CD630_27190 were identified as genes encoding the C. difficile N-deacetylases PdaA1 and PdaA2, required for muramic--lactam synthesis. In a pdaA1 mutant, only 0.4% of all muropeptides carried a muramic--lactam modification, and muramic--lactams were absent in the cortex of a pdaA1-pdaA2 double mutant. Of note, the pdaA1 mutant exhibited decreased sporulation, altered germination, decreased heat resistance, and delayed virulence in a hamster infection model. These results suggest a much greater role for muramic--lactams in C. difficile than in other bacteria, including B. subtilis. In summary, the spore cortex of C. difficile contains lower levels of muramic--lactams than that of B. subtilis, and PdaA1 is the major N-deacetylase for muramic--lactam biosynthesis in C. difficile, contributing to sporulation, heat resistance, and virulence.	[Coullon, Heloise; Janoir, Claire; Candela, Thomas] Univ Paris Saclay, Univ Paris Sud, UBaPS, EA4043, F-92290 Chatenay Malabry, France; [Rifflet, Aline; Wheeler, Richard; Boneca, Ivo Gomperts] Inst Pasteur, Unite Biol & Genet Paroi Bacterienne, F-75724 Paris, France; [Rifflet, Aline; Wheeler, Richard; Boneca, Ivo Gomperts] INSERM, Equipe Avenir, F-75015 Paris, France	UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm)	Candela, T (corresponding author), Univ Paris Sud, Unite Bacteries Pathogenes & Sante, EA 4043, F-92296 Chatenay Malabry, France.	Thomas.candela@u-psud.fr	Boneca, Ivo G/H-1677-2014; Candela, Thomas/ABA-6367-2021; WHEELER, Richard/AAB-8262-2022; Candela, Thomas/AAC-9583-2021	Boneca, Ivo G/0000-0001-8122-509X; WHEELER, Richard/0000-0002-9249-2377; Candela, thomas/0000-0002-4686-2533	French Government's Investissement d'Avenir Program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" [ANR-10-LABX-62-IBEID]; Ministere de l'Enseignement Superieur, de la Recherche et de l'Innovation	French Government's Investissement d'Avenir Program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases"(French National Research Agency (ANR)); Ministere de l'Enseignement Superieur, de la Recherche et de l'Innovation	This work was supported in part by the French Government's Investissement d'Avenir Program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases," Grant ANR-10-LABX-62-IBEID. The authors declare that they have no conflicts of interest with the contents of this article.; Funded by Ministere de l'Enseignement Superieur, de la Recherche et de l'Innovation.	Ariyakumaran R, 2015, CHEMBIOCHEM, V16, P1350, DOI 10.1002/cbic.201500091; Atrih A, 1999, MICROBIOL-UK, V145, P1033, DOI 10.1099/13500872-145-5-1033; Atrih A, 2001, J APPL MICROBIOL, V91, P364, DOI 10.1046/j.1365-2672.2001.01394.x; BEAMAN TC, 1982, J BACTERIOL, V150, P870, DOI 10.1128/JB.150.2.870-877.1982; Carlson PE, 2015, ANAEROBE, V33, P64, DOI 10.1016/j.anaerobe.2015.02.003; Carlson PE, 2013, ANAEROBE, V24, P109, DOI 10.1016/j.anaerobe.2013.04.003; Cartman ST, 2012, APPL ENVIRON MICROB, V78, P4683, DOI 10.1128/AEM.00249-12; Cartman ST, 2010, APPL ENVIRON MICROB, V76, P1103, DOI 10.1128/AEM.02525-09; Chibba A, 2012, ORG BIOMOL CHEM, V10, P7103, DOI 10.1039/c2ob26105g; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Deakin LJ, 2012, INFECT IMMUN, V80, P2704, DOI 10.1128/IAI.00147-12; Debast SB, 2014, CLIN MICROBIOL INFEC, V20, P1, DOI 10.1111/1469-0691.12418; Dembek M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01793; Dembek M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064011; Diaz CR, 2018, ADV EXP MED BIOL, V1050, P227, DOI 10.1007/978-3-319-72799-8_13; Donnelly ML, 2016, J BACTERIOL, V198, P1694, DOI 10.1128/JB.00986-15; Fimlaid KA, 2015, CURR OPIN MICROBIOL, V24, P88, DOI 10.1016/j.mib.2015.01.006; Fukushima T, 2005, J BACTERIOL, V187, P1287, DOI 10.1128/JB.187.4.1287-1292.2005; Fukushima T, 2004, J BIOCHEM, V136, P283, DOI 10.1093/jb/mvh151; Fukushima T, 2002, J BACTERIOL, V184, P6007, DOI 10.1128/JB.184.21.6007-6015.2002; Ghosh S, 2008, J BACTERIOL, V190, P6741, DOI 10.1128/JB.00896-08; Gil F, 2017, ANAEROBE, V45, P3, DOI 10.1016/j.anaerobe.2017.02.018; Gilmore ME, 2004, J BACTERIOL, V186, P80, DOI 10.1128/JB.186.1.80-89.2004; Hall RS, 2007, BIOCHEMISTRY-US, V46, P7953, DOI 10.1021/bi700544c; Heap JT, 2009, J MICROBIOL METH, V78, P79, DOI 10.1016/j.mimet.2009.05.004; Heffron JD, 2011, J BACTERIOL, V193, P125, DOI 10.1128/JB.00869-10; Hong HA, 2017, J INFECT DIS, V216, P1452, DOI 10.1093/infdis/jix488; Hu K, 2006, CAN J MICROBIOL, V52, P935, DOI 10.1139/W06-045; Hussain HA, 2005, J MED MICROBIOL, V54, P137, DOI 10.1099/jmm.0.45790-0; Janoir C, 2013, INFECT IMMUN, V81, P3757, DOI 10.1128/IAI.00515-13; Jones AM, 2013, J INFECTION, V66, P115, DOI 10.1016/j.jinf.2012.10.019; Lawley TD, 2009, J BACTERIOL, V191, P5377, DOI 10.1128/JB.00597-09; Leggett MJ, 2012, J APPL MICROBIOL, V113, P485, DOI 10.1111/j.1365-2672.2012.05336.x; Lessa FC., 2015, NEW ENGL J MED, V372, P2369, DOI DOI 10.1056/NEJMC1505190; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; Loshon CA, 1999, J APPL MICROBIOL, V87, P8, DOI 10.1046/j.1365-2672.1999.00783.x; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Murphy-Benenato KE, 2014, ACS MED CHEM LETT, V5, P1213, DOI 10.1021/ml500210x; Orsburn B, 2008, APPL ENVIRON MICROB, V74, P3328, DOI 10.1128/AEM.02629-07; Paredes-Sabja D, 2014, TRENDS MICROBIOL, V22, P406, DOI 10.1016/j.tim.2014.04.003; Peltier J, 2011, J BIOL CHEM, V286, P29053, DOI 10.1074/jbc.M111.259150; Pereira FC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003782; Permpoonpattana P, 2013, J BACTERIOL, V195, P1492, DOI 10.1128/JB.02104-12; Permpoonpattana P, 2011, INFECT IMMUN, V79, P2295, DOI 10.1128/IAI.00130-11; Popham DL, 1996, J BACTERIOL, V178, P6451, DOI 10.1128/jb.178.22.6451-6458.1996; Popham DL, 1996, P NATL ACAD SCI USA, V93, P15405, DOI 10.1073/pnas.93.26.15405; Quan JY, 2014, METHODS MOL BIOL, V1116, P103, DOI 10.1007/978-1-62703-764-8_8; Quan JY, 2011, NAT PROTOC, V6, P242, DOI 10.1038/nprot.2010.181; Sadovskaya I, 2017, MBIO, V8, DOI 10.1128/mBio.01303-17; Saujet L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003756; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; SEKIGUCHI J, 1995, J BACTERIOL, V177, P5582, DOI 10.1128/jb.177.19.5582-5589.1995; Setlow P, 2006, J APPL MICROBIOL, V101, P514, DOI 10.1111/j.1365-2672.2005.02736.x; Setlow P., 2014, MICROBIOL SPECTR, P201, DOI [DOI 10.1128/MICROBIOLSPEC.TBS-0003-2012, DOI 10.1128/microbiolspec.TBS-0003-2012]; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Terrier MCZ, 2014, WORLD J GASTROENTERO, V20, P7416, DOI 10.3748/wjg.v20.i23.7416; WILSON KH, 1985, J INFECT DIS, V151, P355, DOI 10.1093/infdis/151.2.355; Wu X, 2015, BIOTECHNOL BIOENG, V112, P1365, DOI 10.1002/bit.25565; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249	60	12	14	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18040	18054		10.1074/jbc.RA118.004273	http://dx.doi.org/10.1074/jbc.RA118.004273			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30266804	Green Published, hybrid			2022-12-26	WOS:000451375200003
J	Ruocco, N; Mutalipassi, M; Pollio, A; Costantini, S; Costantini, M; Zupo, V				Ruocco, Nadia; Mutalipassi, Mirko; Pollio, Antonino; Costantini, Susan; Costantini, Maria; Zupo, Valerio			First evidence of Halomicronema metazoicum (Cyanobacteria) free-living on Posidonia oceanica leaves	PLOS ONE			English	Article							MARINE CYANOBACTERIA; PHYLOGENETIC-RELATIONSHIPS; HOT-SPRINGS; DIVERSITY	Cyanobacteria contribute to the ecology of various marine environments, also for their symbioses, since some of them are common hosts of sponges and ascidians. They are also emerging as an important source of novel bioactive secondary metabolites in pharmacological (as anticancer drugs) and biotechnological applications. In the present work we isolated a cyanobacteria in a free-living state from leaves of the seagrass Posidonia oceanica leaves. This newly collected strain was then cultivated under two laboratory conditions, and then characterized by combining morphological observation and molecular studies based on 16S rRNA gene sequences analysis. The strain showed 99% pairwise sequence identity with Halomicronema metazoicum ITAC101, never isolated before as a free-living organisms, but firstly described as an endosymbiont of the Mediterranean marine spongae Petrosia ficiformis, under the form of a filamentous strain. Further studies will investigate the actual role of this cyanobacterium in the leaf stratum of P. oceanica leaves, given its demonstrated ability to influence the vitality and the life cycle of other organisms. In fact, its newly demonstrated free-living stage, described in this study, indicate that Phormidium-like cyanobacteria could play important roles in the ecology of benthic and planktonic communities.	[Ruocco, Nadia; Costantini, Maria] Stn Zool Anton Dohrn, Dept Biol & Evolut Marine Organisms, Naples, Italy; [Ruocco, Nadia; Pollio, Antonino] Univ Naples Federico II, Dept Biol, Complesso Univ Monte St Angelo, Naples, Italy; [Ruocco, Nadia] CNR, Inst Biomol Chem, Bioorgan Chem Unit, Naples, Italy; [Mutalipassi, Mirko; Zupo, Valerio] Stn Zool Anton Dohrn, Dept Integrat Marine Ecol, Ctr Villa Dohrn Ischia Benth Ecol, Naples, Italy; [Costantini, Susan] Fdn G Pascale, IRCCS, Ist Nazl Tumori, Naples, Italy	Stazione Zoologica Anton Dohrn di Napoli; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Stazione Zoologica Anton Dohrn di Napoli; Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Fondazione Pascale	Costantini, M (corresponding author), Stn Zool Anton Dohrn, Dept Biol & Evolut Marine Organisms, Naples, Italy.; Zupo, V (corresponding author), Stn Zool Anton Dohrn, Dept Integrat Marine Ecol, Ctr Villa Dohrn Ischia Benth Ecol, Naples, Italy.	maria.costantini@szn.it; vzupo@szn.it	Ruocco, Nadia/HGA-2143-2022; Mutalipassi, Mirko/AAP-2473-2021; Costantini, Maria/AGH-4080-2022; Costantini, Susan/J-9914-2018; pollio, antonino/AAE-6006-2019; Zupo, Valerio/A-5887-2011	Mutalipassi, Mirko/0000-0002-5521-5303; Costantini, Susan/0000-0002-7538-4657; Zupo, Valerio/0000-0001-9766-8784	PhD in Biology, University of Naples Federico II; Stazione Zoologica Anton Dohrn and Bio-Organic Chemistry Unit of the Institute of Biomolecular Chemistry-CNR, Pozzuoli, Naples; Open University-SZN PhD fellowship	PhD in Biology, University of Naples Federico II; Stazione Zoologica Anton Dohrn and Bio-Organic Chemistry Unit of the Institute of Biomolecular Chemistry-CNR, Pozzuoli, Naples; Open University-SZN PhD fellowship	Nadia Ruocco was supported by a PhD (PhD in Biology, University of Naples Federico II) fellowship co-funded by the Stazione Zoologica Anton Dohrn and Bio-Organic Chemistry Unit of the Institute of Biomolecular Chemistry-CNR, Pozzuoli, Naples. Mirko Mutalipassi was supported by an Open University-SZN PhD fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed RMM, 2002, ARCH MICROBIOL, V177, P361, DOI 10.1007/s00203-001-0390-2; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANAGNOSTIDIS K, 1988, Archiv fuer Hydrobiologie Supplement, V80, P327; Caroppo C, 2012, FOTTEA, V12, P315, DOI 10.5507/fot.2012.022; Carr NG, 1982, BIOL BLUE GREEN ALGA; Castenholz R. W., 1996, NOVA HEDWIGIA, V112, P33; Costa M, 2012, MAR DRUGS, V10, P2181, DOI 10.3390/md10102181; Costantini Susan, 2007, Genomics Proteomics & Bioinformatics, V5, P253, DOI 10.1016/S1672-0229(08)60013-3; Deng MD, 1999, APPL ENVIRON MICROB, V65, P523; Diaz Maria Cristina, 2007, V28, P31; Dorador C, 2008, FEMS MICROBIOL ECOL, V64, P419, DOI 10.1111/j.1574-6941.2008.00483.x; Dutta D, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-36; Finsinger K, 2008, ENVIRON MICROBIOL, V10, P460, DOI 10.1111/j.1462-2920.2007.01467.x; Gademann K, 2008, CURR ORG CHEM, V12, P326, DOI 10.2174/138527208783743750; Gantar M, 2008, J PHYCOL, V44, P260, DOI 10.1111/j.1529-8817.2008.00469.x; Garcia-Pichel F, 1998, ARCH MICROBIOL, V169, P469, DOI 10.1007/s002030050599; Geitler L, 1932, KRYPTOGAMEN FLORA DE, P673; Govindjee, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00028; Hader DP, 2007, PHOTOCH PHOTOBIO SCI, V6, P267, DOI 10.1039/b700020k; Hoffmann L, 1999, EUR J PHYCOL, V34, P371; Ishida T, 1997, J GEN APPL MICROBIOL, V43, P237, DOI 10.2323/jgam.43.237; Komarek J., 2005, OCEANOLOGICAL HYDROB, V34, P5, DOI DOI 10.1080/09670262.2016.1163738; Lacap DC, 2005, CAN J MICROBIOL, V51, P583, DOI 10.1139/W05-038; Ma ZL, 2009, PLANTA, V230, P329, DOI 10.1007/s00425-009-0947-x; Madamwar D, 2015, EXCLI J, V14, P527, DOI 10.17179/excli2014-696; Marquardt J, 2007, ARCH MICROBIOL, V187, P397, DOI 10.1007/s00203-006-0204-7; Meeks JC, 2002, MICROBIOL MOL BIOL R, V66, P94, DOI 10.1128/MMBR.66.1.94-121.2002; Miller SR, 2005, P NATL ACAD SCI USA, V102, P850, DOI 10.1073/pnas.0405667102; Mugnai G, 2018, BIOL FERT SOILS, V54, P27, DOI 10.1007/s00374-017-1234-9; Mur L., 1999, TOXIC CYANOBACTERIA, P15; Nikam T. D., 2013, Bioremediation, Biodiversity and Bioavailability, V7, P70; Nowruzi B, 2018, J PHARM HEALTH SERV, V9, P5, DOI 10.1111/jphs.12202; Nubel U, 2000, ENVIRON MICROBIOL, V2, P217, DOI 10.1046/j.1462-2920.2000.00094.x; Nubel U, 1997, APPL ENVIRON MICROB, V63, P3327; Oren A, 2015, BIODIVERS CONSERV, V24, P781, DOI 10.1007/s10531-015-0882-z; Pagliara P., 2010, RAPP COMM INT MER ME, V39, P392; Pagliara P, 2011, TOXICON, V57, P889, DOI 10.1016/j.toxicon.2011.03.006; Perkerson RB, 2011, J PHYCOL, V47, P1397, DOI 10.1111/j.1529-8817.2011.01077.x; Rastogi RP, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/592980; Rastogi RP, 2009, BIOTECHNOL ADV, V27, P521, DOI 10.1016/j.biotechadv.2009.04.009; Rastogi RP, 2011, INT J PHARM BIOSCI, V2, pB271; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Singh SP, 2011, WORLD J MICROB BIOT, V27, P1225, DOI 10.1007/s11274-010-0571-8; Sompong U, 2005, FEMS MICROBIOL ECOL, V52, P365, DOI 10.1016/j.femsec.2004.12.007; Stancheva R, 2013, HYDROBIOLOGIA, V720, P111, DOI 10.1007/s10750-013-1630-6; STANIER RY, 1977, ANNU REV MICROBIOL, V31, P225, DOI 10.1146/annurev.mi.31.100177.001301; Stoyanov P, 2014, EVOL BIOINFORM, V10, P39, DOI 10.4137/EBO.S13748; Strunecky O, 2010, POLAR BIOL, V33, P1419, DOI 10.1007/s00300-010-0834-8; Subramanian G, 1996, J SCI IND RES INDIA, V55, P685; Sundararaman M, 1996, PHYTOTHER RES, V10, P9, DOI 10.1002/(SICI)1099-1573(199602)10:1&lt;9::AID-PTR762&gt;3.0.CO;2-0; Sundararaman M, 2001, ALGAL BIOTECHNOLOGY, P31; Tuo SH, 2017, J PLANKTON RES, V39, P404, DOI 10.1093/plankt/fbx023; Usher KM, 2004, MICROB ECOL, V48, P167, DOI 10.1007/s00248-003-1062-3; Vaishampayan A, 2001, BOT REV, V67, P453, DOI 10.1007/BF02857893; Wang LC, 2017, HARMFUL ALGAE, V61, P56, DOI 10.1016/j.hal.2016.11.010; West NJ, 1997, APPL ENVIRON MICROB, V63, P4479, DOI 10.1128/AEM.63.11.4479-4484.1997; Yamazaki SS, 2008, FT LAUD FLOR P 11 IN, P265; Zhu P, 2008, MICROB ECOL, V55, P406, DOI 10.1007/s00248-007-9285-3; Zi JM, 2018, AQUAT TOXICOL, V194, P78, DOI 10.1016/j.aquatox.2017.11.007	59	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204954	10.1371/journal.pone.0204954	http://dx.doi.org/10.1371/journal.pone.0204954			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273387	Green Published, gold, Green Submitted			2022-12-26	WOS:000446124700054
J	Allen, JD; Ray, S; Ross, TM				Allen, James D.; Ray, Satyajit; Ross, Ted M.			Split inactivated COBRA vaccine elicits protective antibodies against H1N1 and H3N2 influenza viruses	PLOS ONE			English	Article							COMPUTATIONALLY OPTIMIZED HEMAGGLUTININ; RESPONSES; IMMUNOGENICITY; INFECTION; CHILDREN; IMMUNITY; VIRION	Development of broadly reactive or universal influenza vaccines will be a paradigm shifting event for the influenza vaccine field. These next generation vaccines could replace the current standard of care with vaccines that elicit broadly cross-protective immune responses. However, a variety of in vitro and in vivo models are necessary to make the best assessments of these vaccine formulations to determine their mechanisms of action, and allow for downselection of candidates prior to human clinical trials. Our group has developed the computationally optimized broadly reactive antigen (COBRA) technology to develop HA head-based strategies to elicit antibodies against H1, H3, and H5 influenza strains. These vaccines elicit broadly reactive antibody responses that neutralize not only historical and contemporary vaccine strains, but also co-circulating variants in mice. In this study, we used H1 and H3 HA antigens in a split, inactivated vaccine (IIV) formulation in combination with the AF03 squalene-in-water emulsion adjuvant in ferrets immunologically naive to influenza virus. The H3 COBRA IIV vaccine T11 elicited antibodies with HAI activity against more H3N2 influenza strains compared to IIV expressing wild-type H3 HA antigens, except for IIV vaccines expressing the HA from A/Texas/50/2012 (Tx/12) virus. H1 COBRA IIV vaccines, P1 and X6, elicited antibodies that recognized a similar number of H1N1 viruses as those antibodies elicited by IIV expressing the A/California/07/2009 (CA/09) HA. Ferrets vaccinated with the P1 or X6 COBRA IIV were protected against CA/09 challege and cleared virus from the lungs of the ferrets, similar to ferrets vaccinated with the CA/09 IIV.	[Allen, James D.; Ross, Ted M.] Univ Georgia, Ctr Vaccines & Immunol, Athens, GA 30602 USA; [Ross, Ted M.] Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA; [Ray, Satyajit] Sanofi Pasteur Inc, Cambridge, MA USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Ross, TM (corresponding author), Univ Georgia, Ctr Vaccines & Immunol, Athens, GA 30602 USA.; Ross, TM (corresponding author), Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA.	tedross@uga.edu		Ross, Ted/0000-0003-1947-7469	University of Georgia (UGA) [UGA-001]; Sanofi Pasteur [CROA UGA 001]; Georgia Research Alliance	University of Georgia (UGA); Sanofi Pasteur; Georgia Research Alliance	This work, including the efforts of TMR, was funded by University of Georgia (UGA) (UGA-001). This work, including the efforts of TMR, was funded by Sanofi Pasteur (CROA UGA 001). In addition, TMR is supported by the Georgia Research Alliance as an Eminent Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Agency EM Use CfMPfH], 2014, EMACHMPVWP4572592014; Allen JD, 2017, VACCINE, V35, P5209, DOI 10.1016/j.vaccine.2017.07.107; Allen JD, 2018, J VIROL UNPUB; Barberis I, 2016, J Prev Med Hyg, V57, pE115; Carter DM, 2017, J VIROL, V91, DOI [10.1128/JVI.01283-17, 10.1128/jvi.01283-17]; Carter DM, 2016, J VIROL, V90, P4720, DOI 10.1128/JVI.03152-15; Crevar CJ, 2015, HUM VACC IMMUNOTHER, V11, P572, DOI 10.1080/21645515.2015.1012013; DAVENPORT FM, 1964, J LAB CLIN MED, V63, P5; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Ellebedy AH, 2009, VACCINE, V27, pD65, DOI 10.1016/j.vaccine.2009.08.038; ENNIS FA, 1977, J INFECT DIS, V136, pS397, DOI 10.1093/infdis/136.Supplement_3.S397; Erbelding EJ, 2018, J INFECT DIS, V218, P347, DOI 10.1093/infdis/jiy103; Geeraedts F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000138; Geeraedts F, 2008, INFLUENZA OTHER RESP, V2, P41, DOI 10.1111/j.1750-2659.2008.00038.x; Giles BM, 2012, J INFECT DIS, V205, P1562, DOI 10.1093/infdis/jis232; Giles BM, 2012, CLIN VACCINE IMMUNOL, V19, P128, DOI 10.1128/CVI.05533-11; Giles BM, 2011, VACCINE, V29, P3043, DOI 10.1016/j.vaccine.2011.01.100; Katz JM, 2011, EXPERT REV ANTI-INFE, V9, P669, DOI [10.1586/ERI.11.51, 10.1586/eri.11.51]; Kon TC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150700; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; Lina B, 2000, BIOLOGICALS, V28, P95, DOI 10.1006/biol.2000.0245; Lupulescu E, 1997, Bacteriol Virusol Parazitol Epidemiol, V42, P110; MCELHANEY JE, 1994, J GERONTOL, V49, pM37, DOI 10.1093/geronj/49.2.M37; Monto AS, 2010, VACCINE, V28, pD33, DOI 10.1016/j.vaccine.2010.08.027; Oh DY, 2008, J CLIN MICROBIOL, V46, P2189, DOI 10.1128/JCM.00398-08; Ross Ted M, 2011, PLoS Curr, V3, pRRN1265, DOI 10.1371/currents.RRN1265; Rowe T, 2010, VIROLOGY, V401, P257, DOI 10.1016/j.virol.2010.02.020; Song JS, 2011, J VIROL, V85, P2180, DOI 10.1128/JVI.01975-10; VERSLUIS DJ, 1988, NEPHRON, V49, P16, DOI 10.1159/000184979; Wong TM, 2017, J VIROL, V91, DOI 10.1128/JVI.01581-17; World Health Organization, 2011, MAN LAB DIAGN VIR SU; Wu JA, 2010, VACCINE, V28, P6221, DOI 10.1016/j.vaccine.2010.07.008	32	20	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204284	10.1371/journal.pone.0204284	http://dx.doi.org/10.1371/journal.pone.0204284			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265682	Green Published, gold, Green Submitted			2022-12-26	WOS:000446005500025
J	Bohm, BB; Fehrl, Y; Janczi, T; Schneider, N; Burkhardt, H				Boehm, Beate B.; Fehrl, Yuliya; Janczi, Tomasz; Schneider, Nadine; Burkhardt, Harald			Cell adhesion-induced transient interaction of ADAM15 with poly(A) binding protein at the cell membrane colocalizes with mRNA translation	PLOS ONE			English	Article							POLY(A)-BINDING PROTEIN; INITIATION-FACTOR; EUKARYOTIC TRANSLATION; INTEGRIN BINDING; FOCAL ADHESIONS; DISINTEGRIN; KINASE; DOMAIN; LOCALIZATION; CHONDROCYTES	The regulation of temporo-spatial compartmentalization of protein synthesis is of crucial importance for a variety of physiologic cellular functions. Here, we demonstrate that the cell membrane-anchored disintegrin metalloproteinase ADAM15, upregulated in a variety of aggressively growing tumor cells, in the hyperproliferative synovial membrane of inflamed joints as well as in osteoarthritic chondrocytes, transiently binds to poly(A) binding protein 1 (PABP) in cells undergoing adhesion. The cytoplasmic domain of ADAM15 was shown to selectively interact with the proline-rich linker of PABP. Immunostainings of adhesion-triggered cells demonstrate an ADAM15-dependent recruitment of PABP to cell membrane foci coinciding with ongoing mRNA translation as visualized by the detection of puromycin-terminated polypeptides. Moreover, the increase in cell membrane-associated neosynthesis of puromycylated proteins upon induction of cell adhesion was proven linked to ADAM15 expression in HeLa and ADAM15-transfected chondrocytic cells. Thus, down regulation of ADAM15 by siRNA and/or the use of a cell line transfected with a mutant ADAM15-construct lacking the cytoplasmic tail resulted in a considerable reduction in the amount of cell membrane-associated puromycylated proteins formed during induced cell adhesion. These results provide first direct evidence for a regulatory role of ADAM15 on mRNA translation at the cell membrane that transiently emerges in response to triggering cell adhesion and might have potential implications under pathologic conditions of matrix remodeling associated with ADAM15 upregulation.	[Boehm, Beate B.; Fehrl, Yuliya; Janczi, Tomasz; Burkhardt, Harald] Goethe Univ, Univ Hosp Frankfurt, Div Rheumatol, Frankfurt, Germany; [Schneider, Nadine; Burkhardt, Harald] Fraunhofer Inst Mol Biol & Appl Ecol IME, Project Grp Translat Med & Pharmacol TMP, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Fraunhofer Gesellschaft	Burkhardt, H (corresponding author), Goethe Univ, Univ Hosp Frankfurt, Div Rheumatol, Frankfurt, Germany.; Burkhardt, H (corresponding author), Fraunhofer Inst Mol Biol & Appl Ecol IME, Project Grp Translat Med & Pharmacol TMP, Frankfurt, Germany.	harald.burkhardt@kgu.de		Janczi, Tomasz/0000-0003-0228-0256	Deutsche Forschungsgemeinschaft DFG grant [DFG BU 584/5-1]	Deutsche Forschungsgemeinschaft DFG grant(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft DFG grant DFG BU 584/5-1.	Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Beck V, 2005, INT J BIOCHEM CELL B, V37, P590, DOI 10.1016/j.biocel.2004.08.005; Besse F, 2008, NAT REV MOL CELL BIO, V9, P971, DOI 10.1038/nrm2548; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Bohm B, 2010, ARTHRITIS RHEUM-US, V62, P1372, DOI 10.1002/art.27387; Bohm BB, 2013, ARTHRITIS RHEUM-US, V65, P2826, DOI 10.1002/art.38109; Bohm BB, 2009, J CELL MOL MED, V13, P2634, DOI 10.1111/j.1582-4934.2008.00490.x; Bohm BB, 2005, ARTHRITIS RHEUM-US, V52, P1100, DOI 10.1002/art.20974; Bohm BB, 2001, ARTHRITIS RHEUM-US, V44, P2046, DOI 10.1002/1529-0131(200109)44:9<2046::AID-ART354>3.0.CO;2-3; Brune C, 2005, RNA, V11, P517, DOI 10.1261/rna.7291205; Burdelski C, 2017, NEOPLASIA, V19, P279, DOI 10.1016/j.neo.2017.01.005; Burgess HM, 2011, J CELL SCI, V124, P3344, DOI 10.1242/jcs.087692; Charrier-Hisamuddin L, 2008, FASEB J, V22, P641, DOI 10.1096/fj.07-8876rev; Chicurel ME, 1998, NATURE, V392, P730, DOI 10.1038/33719; de Hoog CL, 2004, CELL, V117, P649, DOI 10.1016/S0092-8674(04)00456-8; Deo RC, 1999, CELL, V98, P835, DOI 10.1016/S0092-8674(00)81517-2; Duffy MJ, 2009, CLIN CANCER RES, V15, P1140, DOI 10.1158/1078-0432.CCR-08-1585; Eliseeva IA, 2013, BIOCHEMISTRY-MOSCOW+, V78, P1377, DOI 10.1134/S0006297913130014; Eto K, 2002, J BIOL CHEM, V277, P17804, DOI 10.1074/jbc.M200086200; Fried D, 2012, J BIOL CHEM, V287, P21214, DOI 10.1074/jbc.M112.347120; GOLDRING MB, 1994, J CLIN INVEST, V94, P2307, DOI 10.1172/JCI117595; Goss DJ, 2013, WIRES RNA, V4, P167, DOI 10.1002/wrna.1151; Gray NK, 2015, BIOCHEM SOC T, V43, P1277, DOI 10.1042/BST20150171; Hiles GL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150138; Horton ER, 2015, NAT CELL BIOL, V17, P1577, DOI 10.1038/ncb3257; Hu YL, 2014, SCI REP-UK, V4, DOI 10.1038/srep06024; Kahvejian A, 2005, GENE DEV, V19, P104, DOI 10.1101/gad.1262905; Karim MM, 2006, P NATL ACAD SCI USA, V103, P9494, DOI 10.1073/pnas.0603701103; Kleino I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121301; Kuhn U, 2004, BBA-GENE STRUCT EXPR, V1678, P67, DOI 10.1016/j.bbaexp.2004.03.008; Kuyumcu-Martinez NM, 2004, MOL CELL BIOL, V24, P1779, DOI 10.1128/MCB.24.4.1779-1790.2004; Lee JH, 2009, STRUCTURE, V17, P833, DOI 10.1016/j.str.2009.04.010; Lin JX, 2012, BIOPHYS J, V102, P1427, DOI 10.1016/j.bpj.2012.02.025; Lu D, 2006, THROMB HAEMOSTASIS, V96, P642, DOI 10.1160/TH06-07-0395; Mangus DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-223; Martineau Y, 2008, MOL CELL BIOL, V28, P6658, DOI 10.1128/MCB.00738-08; Melo EO, 2003, J BIOL CHEM, V278, P46357, DOI 10.1074/jbc.M307624200; Mochizuki S, 2007, CANCER SCI, V98, P621, DOI 10.1111/j.1349-7006.2007.00434.x; Najy AJ, 2008, CANCER RES, V68, P1092, DOI 10.1158/0008-5472.CAN-07-2432; Nath D, 1999, J CELL SCI, V112, P579; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Smith RWP, 2010, BIOCHEM J, V426, P1, DOI 10.1042/BJ20091571; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Willett M, 2006, EXP CELL RES, V312, P2942, DOI 10.1016/j.yexcr.2006.05.020; Woods AJ, 2002, J BIOL CHEM, V277, P6428, DOI 10.1074/jbc.M109446200; Woods AJ, 2005, MOL CELL BIOL, V25, P3763, DOI 10.1128/MCB.25.9.3763-3773.2005	47	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0203847	10.1371/journal.pone.0203847	http://dx.doi.org/10.1371/journal.pone.0203847			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265671	Green Submitted, gold, Green Published			2022-12-26	WOS:000446005500011
J	Koethe, S; Banysch, S; Alves-dos-Santos, I; Lunau, K				Koethe, Sebastian; Banysch, Sarah; Alves-dos-Santos, Isabel; Lunau, Klaus			Spectral purity, intensity and dominant wavelength: Disparate colour preferences of two Brazilian stingless bee species	PLOS ONE			English	Article							TETRAGONULA-CARBONARIA SM; RECRUITMENT BEHAVIOR; RAIN-FOREST; HONEYBEES; HUMMINGBIRDS; MELIPONINI; FLOWERS; VISION; APIDAE; RED	Bees use floral colour as a major long distance orientation cue. While it is known for bumblebees and honeybees that dominant wavelength ((sic) colour hue), colour contrast and spectral purity ((sic) saturation) are crucial for flower detection and discrimination, only little is known about colour preferences in stingless bees (Meliponini). In this experiment freely flying workers of two Brazilian species of stingless bees-Partamona helleri and Melipona bicolor-were tested for colour preferences concerning the colour parameters dominant wavelength, spectral purity and intensity ((sic) brightness). Each individual bee had to perform 57 tests, in which a definite series of dual choices between colour stimuli varying in intensity, spectral purity or dominant wavelength were presented. The results show that P. helleri chose colours of higher spectral purity and preferred bluish colours, while M. bicolor made generalized colour choices. Intensity did not influence the colour choice of any bee species. The results of P. helleri are consistent with findings for honeybees and bumblebees, while colour preferences in M. bicolor seem to be absent.	[Koethe, Sebastian; Banysch, Sarah; Lunau, Klaus] Heinrich Heine Univ Dusseldorf, Inst Sensory Ecol, Dusseldorf, Germany; [Alves-dos-Santos, Isabel] Univ Sao Paulo, Inst Biociencias, Dept Ecol, Lab Abelhas, Sao Paulo, SP, Brazil	Heinrich Heine University Dusseldorf; Universidade de Sao Paulo	Koethe, S (corresponding author), Heinrich Heine Univ Dusseldorf, Inst Sensory Ecol, Dusseldorf, Germany.	sebastian.koethe@hhu.de	Alves-dos-Santos, Isabel/C-7624-2012; Lunau, Klaus/AAL-2532-2021	Lunau, Klaus/0000-0001-5184-4201; Koethe, Sebastian/0000-0003-0489-9909; alves dos santos, isabel/0000-0003-2352-1290	Deutsche Forschungsgemeinschaft [F020511114]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (http://www.dfg.de/), Grant number: F020511114, Recipient: SK.	AUTRUM H, 1964, Z VERGL PHYSIOL, V48, P357, DOI 10.1007/BF00299270; Avargues-Weber A, 2014, J COMP PHYSIOL A, V200, P449, DOI 10.1007/s00359-014-0909-z; Barth FG, 2008, J COMP PHYSIOL A, V194, P313, DOI 10.1007/s00359-008-0321-7; BENE FRANK, 1941, CONDOR, V43, P237, DOI 10.2307/1364506; Bergamo PJ, 2016, FUNCT ECOL, V30, P710, DOI 10.1111/1365-2435.12537; Biesmeijer JC, 2004, APIDOLOGIE, V35, P143, DOI 10.1051/apido:2004003; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; Chittka L, 1997, ISRAEL J PLANT SCI, V45, P169, DOI 10.1080/07929978.1997.10676682; CHITTKA L, 1992, J COMP PHYSIOL A, V170, P533; Chittka L, 1996, J THEOR BIOL, V181, P179, DOI 10.1006/jtbi.1996.0124; De Ibarra NH, 2000, J EXP BIOL, V203, P3289; Del Sarto MCL, 2005, J ECON ENTOMOL, V98, P260, DOI 10.1603/0022-0493-98.2.260; Dyer AG, 2008, J COMP PHYSIOL A, V194, P617, DOI 10.1007/s00359-008-0335-1; Dyer AG, 2016, J COMP PHYSIOL A, V202, P603, DOI 10.1007/s00359-016-1101-4; Dyer AG, 2016, J COMP PHYSIOL A, V202, P629, DOI 10.1007/s00359-016-1107-y; FREITAS SW, 2006, MENS DOCE, V86, P1; GILL FB, 1982, IBIS, V124, P44, DOI 10.1111/j.1474-919X.1982.tb03739.x; Giurfa M, 1996, J COMP PHYSIOL A, V178, P699; GIURFA M, 1995, J COMP PHYSIOL A, V177, P247; Giurfa M, 1997, J COMP PHYSIOL A, V180, P235, DOI 10.1007/s003590050044; GIURFA M, 1994, J COMP PHYSIOL A, V175, P773, DOI 10.1007/BF00191849; GOLDSMITH TH, 1979, J COMP PHYSIOL, V130, P209, DOI 10.1007/BF00614607; GRANT KA, 1966, AM NAT, V100, P85, DOI 10.1086/282403; Heard TA, 1999, ANNU REV ENTOMOL, V44, P183, DOI 10.1146/annurev.ento.44.1.183; Jarau S, 2003, INSECT SOC, V50, P365, DOI 10.1007/s00040-003-0684-2; Jarau S, 2009, CONTEMP TOP ENTOMOL, P223; Kantsa A, 2017, NAT ECOL EVOL, V1, P1502, DOI 10.1038/s41559-017-0298-0; Koethe S, 2016, J COMP PHYSIOL A, V202, P615, DOI 10.1007/s00359-016-1115-y; LUNAU K, 1995, J COMP PHYSIOL A, V177, P1; Lunau K, 1996, J COMP PHYSIOL A, V178, P477, DOI 10.1007/BF00190178; Lunau K, 2011, J EXP BIOL, V214, P1607, DOI 10.1242/jeb.052688; MCDADE LA, 1983, CONDOR, V85, P360, DOI 10.2307/1367077; MelendezAckerman E, 1997, ECOLOGY, V78, P2532, DOI 10.1890/0012-9658(1997)078[2532:HBAMOS]2.0.CO;2; Michener, 2007, BEES WORLD, P953, DOI DOI 10.1080/00379271.2007.10697535; MICHENER C D, 1974, P404; Michener Charles D., 1946, JOUR NEW YORK ENT SOC, V54, P179; MILLER RS, 1971, CONDOR, V73, P309, DOI 10.2307/1365757; Morawetz L, 2013, J COMP PHYSIOL A, V199, P817, DOI 10.1007/s00359-013-0843-5; Murillo Martinez R.M., 1985, Biotica (Mexico), V9, P423; Nagamitsu T, 1997, OECOLOGIA, V110, P432, DOI 10.1007/s004420050178; Ng L, 2018, FACETS, V3, P800, DOI 10.1139/facets-2017-0116; Nieh JC, 2004, APIDOLOGIE, V35, P159, DOI 10.1051/apido:2004007; Papiorek S, 2013, NATURWISSENSCHAFTEN, V100, P633, DOI 10.1007/s00114-013-1060-3; PEITSCH D, 1992, J COMP PHYSIOL A, V170, P23, DOI 10.1007/BF00190398; Porsch O, 1931, BIOL GEN, V2, P647; R Core Team, 2018, R LANG ENV STAT COMP; RAVEN PH, 1972, EVOLUTION, V26, P674, DOI 10.1111/j.1558-5646.1972.tb01975.x; Rhode K, 2013, J COMP PHYSIOL A, V199, P197; Rodriguez-Girones MA, 2004, PLOS BIOL, V2, P1515, DOI 10.1371/journal.pbio.0020350; ROUBIK D W, 1986, Journal of Tropical Ecology, V2, P97, DOI 10.1017/S0266467400000699; Roubik D.W., 1989, ECOLOGY NATURAL HIST; ROUBIK DW, 1978, SCIENCE, V201, P1030, DOI 10.1126/science.201.4360.1030; Sanfiorenzo Andre, 2018, Journal of Pollination Ecology, V22, P1, DOI 10.26786/1920-7603(2018)one; Slaa EJ, 2003, ECOL ENTOMOL, V28, P369, DOI 10.1046/j.1365-2311.2003.00512.x; Slaa EJ, 2006, INSECT SOC, V53, P70, DOI 10.1007/s00040-005-0837-6; Slaa EJ, 2006, APIDOLOGIE, V37, P293, DOI 10.1051/apido:2006022; Spaethe J, 2014, J COMP PHYSIOL A, V200, P485, DOI 10.1007/s00359-014-0886-2; Spaethe J, 2001, P NATL ACAD SCI USA, V98, P3898, DOI 10.1073/pnas.071053098; STILES FG, 1976, CONDOR, V78, P10, DOI 10.2307/1366912; Streinzer M, 2016, J COMP PHYSIOL A, V202, P643, DOI 10.1007/s00359-016-1118-8; Valido A, 2011, J EVOLUTION BIOL, V24, P751, DOI 10.1111/j.1420-9101.2010.02206.x; Vorobyev M, 1997, ISRAEL J PLANT SCI, V45, P103, DOI 10.1080/07929978.1997.10676677	62	7	7	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204663	10.1371/journal.pone.0204663	http://dx.doi.org/10.1371/journal.pone.0204663			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265685	gold, Green Submitted, Green Published			2022-12-26	WOS:000446005500043
J	Best, N; Rodoni, B; Rawlin, G; Beddoe, T				Best, Nickala; Rodoni, Brendan; Rawlin, Grant; Beddoe, Travis			The development and deployment of a field-based loop mediated isothermal amplification assay for virulent Dichelobacter nodosus detection on Australian sheep	PLOS ONE			English	Article							OVINE FOOT-ROT; RAPID DETECTION; PATHOGENESIS; DIAGNOSIS; LAMP; PCR; EXTRACTION; ETIOLOGY; TESTS; LOAD	Dichelobacter nododus is the causative agent of footrot, a major disease of sheep that creates welfare concerns and large economic loss. The virulence of D. nododus depends on the presence of extracellular proteases, AprV2 and AprB2, which differ by one amino acid. Strains possessing AprV2 can cause clinically virulent disease, while AprB2 may cause clinically benign disease. Current methods for detecting D. nodosus are difficult, laborious and time consuming. New techniques capable of rapidly detecting and typing D. nodosus are needed to aid control programs. Molecular methods, like real-time polymerase chain reaction (rtPCR) can detect aprV2 and aprB2, however, this assay is not field-deployable and cannot support local decision-making during an outbreak. Here we present a field-based molecular assay for detecting aprV2, using loop mediated isothermal amplification (LAMP). The aprV2 LAMP (VDN LAMP) assay was optimised to reliably detect aprV2 from laboratory purified genomic (gDNA) of virulent D. nodosus down to 5x10(-3) ng mu L-1, with time to positive (Tp) <= 16 minutes, while aprB2 was unreliably detected at 5 ng mu L-1 from 16 - 20 minutes. The use of field collected samples that were rtPCR positive for aprB2 resulted in no amplification, while aprV2 positive field samples by VDN LAMP assay are defined as having Tps' of - 20 minutes and melting temperature between 88.0-88.9 degrees C. When compared to rtPCR, the VDN LAMP was shown to have a diagnostic specificity of 100% and sensitivity of 83.33%. As proof of concept, the VDN LAMP was taken on farm, with all processing occurring in-field. The on farm VDN LAMP successfully detected 91.67% aprV2 positive samples, no aprB2 positive samples (n = 9) or D. nodosus negative (n = 23) samples, with a kappa agreement of 'almost perfect' to rtPCR. This highlights the potential of the assay to inform local treatment decisions for management.	[Best, Nickala; Beddoe, Travis] La Trobe Univ, Dept Anim Plant & Soil Sci, Melbourne, Vic, Australia; [Best, Nickala; Beddoe, Travis] La Trobe Univ, Ctr AgriBiosci AgriBio, Melbourne, Vic, Australia; [Rodoni, Brendan; Rawlin, Grant] Victorian Govt, Dept Econ Dev Jobs Transport & Resources, Ctr AgriBiosci AgriBio, Melbourne, Vic, Australia	La Trobe University; La Trobe University	Beddoe, T (corresponding author), La Trobe Univ, Dept Anim Plant & Soil Sci, Melbourne, Vic, Australia.; Beddoe, T (corresponding author), La Trobe Univ, Ctr AgriBiosci AgriBio, Melbourne, Vic, Australia.	t.beddoe@latrobe.edu.au	Beddoe, Travis/F-3415-2014	Beddoe, Travis/0000-0003-4550-2277				Alhassan A, 2007, VET PARASITOL, V143, P155, DOI 10.1016/j.vetpar.2006.08.014; Allworth MB, 2014, SMALL RUMINANT RES, V118, P110, DOI 10.1016/j.smallrumres.2013.12.007; Armstrong E, 2013, MANAGING VIRULENT FO; Badolo A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-227; Best Nickala, 2018, BMC Res Notes, V11, P108, DOI 10.1186/s13104-018-3229-5; Chomczynski P, 2006, BIOTECHNIQUES, V40, P454, DOI 10.2144/000112149; CLAXTON PD, 1983, AUST VET J, V60, P331, DOI 10.1111/j.1751-0813.1983.tb02834.x; Claxton PD, 1982, AUSTR STANDARD DIAGN; Dukes JP, 2006, ARCH VIROL, V151, P1093, DOI 10.1007/s00705-005-0708-5; EGERTON JR, 1969, J COMP PATHOL, V79, P207, DOI 10.1016/0021-9975(69)90007-3; Fleiss JL, 2004, STAT METHODS RATES P, P598, DOI DOI 10.1002/0471445428.CH18; Francois P, 2011, FEMS IMMUNOL MED MIC, V62, P41, DOI 10.1111/j.1574-695X.2011.00785.x; GRAHAM NPH, 1968, AUST VET J, V44, P235, DOI 10.1111/j.1751-0813.1968.tb09092.x; Kaneko H, 2007, J BIOCHEM BIOPH METH, V70, P499, DOI 10.1016/j.jbbm.2006.08.008; Kennan RM, 2014, MBIO, V5, DOI 10.1128/mBio.01821-14; Kennan RM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001210; Kubota R, 2015, INT J MOL SCI, V16, P4786, DOI 10.3390/ijms16034786; Lin ZB, 2012, VET PARASITOL, V185, P296, DOI 10.1016/j.vetpar.2011.10.016; LIU D, 1994, VET MICROBIOL, V42, P373, DOI 10.1016/0378-1135(94)90068-X; Maboni G, 2016, VET REC, V179, DOI 10.1136/vr.103610; MacKenzie DJ, 1997, PLANT DIS, V81, P222, DOI 10.1094/PDIS.1997.81.2.222; Mansour SMG, 2015, ANIM HEALTH RES REV, V16, P89, DOI 10.1017/S1466252315000018; McPherson AS, 2017, J CLIN MICROBIOL, V55, P1313, DOI 10.1128/JCM.02403-16; Moore LJ, 2005, VET MICROBIOL, V108, P57, DOI 10.1016/j.vetmic.2005.01.029; Nagamine K, 2001, CLIN CHEM, V47, P1742; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Riffkin MC, 1995, GENE, V167, P279, DOI 10.1016/0378-1119(95)00664-8; ROBERTS DS, 1969, J COMP PATHOL, V79, P217, DOI 10.1016/0021-9975(69)90008-5; Sahoo PR, 2016, VET WORLD, V9, P465, DOI 10.14202/vetworld.2016.465-469; Stauble A, 2014, J CLIN MICROBIOL, V52, P1228, DOI 10.1128/JCM.03485-13; Stauble A, 2014, VET MICROBIOL, V168, P177, DOI 10.1016/j.vetmic.2013.11.013; Tanner NA, 2012, BIOTECHNIQUES, V53, P81, DOI 10.2144/0000113902; Thekisoe OMM, 2005, VET PARASITOL, V130, P327, DOI 10.1016/j.vetpar.2005.04.019; Tomlinson JA, 2010, PLANT PATHOL, V59, P465, DOI 10.1111/j.1365-3059.2009.02233.x; Witcomb LA, 2015, VET MICROBIOL, V176, P321, DOI 10.1016/j.vetmic.2015.01.022; Witcomb LA, 2014, PREV VET MED, V115, P48, DOI 10.1016/j.prevetmed.2014.03.004	36	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204310	10.1371/journal.pone.0204310	http://dx.doi.org/10.1371/journal.pone.0204310			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30260992	gold, Green Submitted, Green Published			2022-12-26	WOS:000445907400034
J	Kumari, N; Cher, J; Chua, E; Hamzah, H; Wong, TY; Cheung, CY				Kumari, Neelam; Cher, Joanna; Chua, Edwin; Hamzah, Haslina; Wong, Tien Yin; Cheung, Carol Y.			Association of serum lutein and zeaxanthin with quantitative measures of retinal vascular parameters	PLOS ONE			English	Article							LOS-ANGELES-ATHEROSCLEROSIS; LOW-DENSITY-LIPOPROTEIN; HUMAN MACULAR PIGMENT; VESSEL CALIBER; DIABETIC-RETINOPATHY; EPITHELIAL-CELLS; VEIN OCCLUSION; HEART-DISEASE; EYE DISEASE; DEGENERATION	To evaluate the association between serum carotenoids and quantitative measures of retinal vasculature in elderly Singapore Chinese subjects. The following details were collected in 128 healthy subjects: sociodemographics, lifestyle information, medical and drug history, and anthropometric measurements. Serum concentrations of carotenoids were estimated in fasting venous blood using high performance liquid chromatography. Retinal vascular parameters were quantitatively measured from retinal photographs using a computer-assisted program (Singapore I Vessel Assessment). The mean age of the population was 54.1 years (range 40 to 81 years). In multiple linear regression analysis, per SD decrease in retinal arteriolar caliber [beta = 0.045 (0.003 to 0.086), p = 0.036], per SD increase in retinal venular caliber [beta = -0.045 (-0.086 to -0.003), p = 0.036] and per SD increase in arteriolar branching angle [beta = -0.039 (-0.072 to -0.006), p = 0.021] were associated with decreased serum lutein. Per SD increase in retinal venular tortuosity [beta = -0.0075 (-0.0145 to -0.0004), p = 0.039] and per SD increase in arteriolar branching angle (beta = -0.0073 [-0.0142 to -0.0059], p = 0.041) were associated with decreased serum zeaxanthin. None of the other carotenoids demonstrated meaningful relationship with quantitative measures of retinal vasculature. Lower levels of lutein and zeaxanthin demonstrated significant relationship with adverse quantitative measures of retinal vasculature in elderly healthy subjects.	[Kumari, Neelam; Cher, Joanna] Khoo Teck Puat Hosp, Dept Ophthalmol & Visual Sci, Singapore, Singapore; [Kumari, Neelam; Chua, Edwin; Hamzah, Haslina; Wong, Tien Yin; Cheung, Carol Y.] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [Wong, Tien Yin] Natl Univ Singapore, Ophthalmol & Visual Sci Acad Clin Programme, Duke NUS Grad Med Sch, Singapore, Singapore; [Cheung, Carol Y.] Chinese Univ Hong Kong, Dept Ophthalmol & Visual Sci, Shatin, Hong Kong, Peoples R China	National University of Singapore; Singapore National Eye Center; National University of Singapore; Chinese University of Hong Kong	Kumari, N (corresponding author), Khoo Teck Puat Hosp, Dept Ophthalmol & Visual Sci, Singapore, Singapore.; Kumari, N (corresponding author), Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore.	kumari.neelam@ktph.com.sg	Cheung, Carol Y./G-7895-2016; Cheung, Carol/AAF-1101-2020; Wong, Tien Yin/AAC-9724-2020	Cheung, Carol/0000-0002-9672-1819; Wong, Tien Yin/0000-0002-8448-1264	Small Innovative grant I - Alexandra Health Private Limited	Small Innovative grant I - Alexandra Health Private Limited	This study was supported by Small Innovative grant I for the year 2012, awarded to NK by Alexandra Health Private Limited. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashino T, 2008, MOL IMMUNOL, V45, P2106, DOI 10.1016/j.molimm.2007.10.011; Bernstein PS, 2016, PROG RETIN EYE RES, V50, P34, DOI 10.1016/j.preteyeres.2015.10.003; Bian QN, 2012, FREE RADICAL BIO MED, V53, P1298, DOI 10.1016/j.freeradbiomed.2012.06.024; BONE RA, 1993, INVEST OPHTH VIS SCI, V34, P2033; Chapman N, 2009, CLI SCI LON, V99, P438; Cheung CYL, 2010, MICROCIRCULATION, V17, P495, DOI 10.1111/j.1549-8719.2010.00048.x; Chew EY, 2013, JAMA-J AM MED ASSOC, V309, P2005, DOI 10.1001/jama.2013.4997; Chew SKH, 2012, CURR HYPERTENS REP, V14, P144, DOI 10.1007/s11906-012-0252-0; Daien V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071089; DANIELS SR, 1993, J HUM HYPERTENS, V7, P223; Diaz MN, 1997, NEW ENGL J MED, V337, P408, DOI 10.1056/NEJM199708073370607; Dwyer JH, 2004, ARTERIOSCL THROM VAS, V24, P313, DOI 10.1161/01.ATV.0000109955.80818.8a; Dwyer JH, 2001, CIRCULATION, V103, P2922, DOI 10.1161/01.CIR.103.24.2922; Eperjesi F, 2005, NUTR EYE PRACTICAL A, P91; Ferrara DC, 2007, AM J OPHTHALMOL, V144, P864, DOI 10.1016/j.ajo.2007.07.038; Frank RN, 2004, NEW ENGL J MED, V350, P48, DOI 10.1056/NEJMra021678; Gabrielska J, 1996, BBA-BIOMEMBRANES, V1285, P167, DOI 10.1016/S0005-2736(96)00152-6; Gammone MA, 2015, FOOD NUTR RES, V59, DOI 10.3402/fnr.v59.26762; Gao SS, 2011, MOL VIS, V17, P3180; Giblin FJ, 2000, J OCUL PHARMACOL TH, V16, P121, DOI 10.1089/jop.2000.16.121; Gruszecki WI, 2005, BBA-MOL BASIS DIS, V1740, P108, DOI 10.1016/j.bbadis.2004.11.015; Hammond BR, 1997, INVEST OPHTH VIS SCI, V38, P1795; HANDELMAN GJ, 1992, METHOD ENZYMOL, V213, P220; Hubbard LD, 1999, OPHTHALMOLOGY, V106, P2269, DOI 10.1016/S0161-6420(99)90525-0; Ikram MK, 2013, OPHTHALMOLOGICA, V229, P125, DOI 10.1159/000342158; Jeganathan VSE, 2008, AM J OPHTHALMOL, V146, P954, DOI 10.1016/j.ajo.2008.07.006; Jin XH, 2006, INVEST OPHTH VIS SCI, V47, P2562, DOI 10.1167/iovs.05-1429; Johnson EJ, 2005, INVEST OPHTH VIS SCI, V46, P692, DOI 10.1167/iovs.02-1192; Kan H, 2007, AM J CLIN NUTR, V86, P1626; Khachik F, 1997, INVEST OPHTH VIS SCI, V38, P1802; Klein R, 2006, ARCH OPHTHALMOL-CHIC, V124, P87, DOI 10.1001/archopht.124.1.87; Klein R, 2004, ARCH OPHTHALMOL-CHIC, V122, P76, DOI 10.1001/archopht.122.1.76; Klipstein-Grobusch K, 2000, ATHEROSCLEROSIS, V148, P49, DOI 10.1016/S0021-9150(99)00221-X; Krishnaswamy R, 2010, FREE RADICAL BIO MED, V49, P50, DOI 10.1016/j.freeradbiomed.2010.03.016; Li BX, 2010, ARCH BIOCHEM BIOPHYS, V504, P56, DOI 10.1016/j.abb.2010.07.024; Liew G, 2007, INVEST OPHTH VIS SCI, V48, P52, DOI 10.1167/iovs.06-0672; Malek J, 2015, NEURAL COMPUT APPL, V26, P25, DOI 10.1007/s00521-014-1657-2; Mares-Perlman JA, 2001, AM J EPIDEMIOL, V153, P424, DOI 10.1093/aje/153.5.424; McGeechan K, 2009, AM J EPIDEMIOL, V170, P1323, DOI 10.1093/aje/kwp306; Moeller SM, 2006, ARCH OPHTHALMOL-CHIC, V124, P1151, DOI 10.1001/archopht.124.8.1151; Murray CD, 1926, P NATL ACAD SCI USA, V12, P207, DOI 10.1073/pnas.12.3.207; Navab M, 2004, J LIPID RES, V45, P993, DOI 10.1194/jlr.R400001-JLR200; Patton N, 2006, INVEST OPHTH VIS SCI, V47, P1329, DOI 10.1167/iovs.05-1248; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; Sun C, 2009, SURV OPHTHALMOL, V54, P74, DOI 10.1016/j.survophthal.2008.10.003; Tan JSL, 2008, OPHTHALMOLOGY, V115, P334, DOI 10.1016/j.ophtha.2007.03.083; Tserentsoodol N, 2006, MOL VIS, V12, P1306; Witt N, 2006, HYPERTENSION, V47, P975, DOI 10.1161/01.HYP.0000216717.72048.6c; Wu J, 2015, JAMA OPHTHALMOL, V133, P1415, DOI 10.1001/jamaophthalmol.2015.3590; Youm DJ, 2012, CURR EYE RES, V37, P334, DOI 10.3109/02713683.2011.629070; ZAMIR M, 1979, J GEN PHYSIOL, V74, P537, DOI 10.1085/jgp.74.4.537; Zhao RZ, 2005, ATHEROSCLEROSIS, V179, P277, DOI 10.1016/j.atherosclerosis.2004.11.013; Zou ZY, 2011, ATHEROSCLEROSIS, V219, P789, DOI 10.1016/j.atherosclerosis.2011.08.006	54	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0203868	10.1371/journal.pone.0203868	http://dx.doi.org/10.1371/journal.pone.0203868			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30260964	Green Published, gold, Green Submitted			2022-12-26	WOS:000445907400018
J	Rodondi, PY; Dubois, J; Bill, AS; Koutaissoff, D; Ros, J; Aveni, E; Pasquier, J; Herzig, L; Decosterd, I; Burnand, B				Rodondi, Pierre-Yves; Dubois, Julie; Bill, Anne-Sylvie; Koutaissoff, Daria; Ros, Jenny; Aveni, Eleonore; Pasquier, Jerome; Herzig, Lilli; Decosterd, Isabelle; Burnand, Bernard			Primary care physicians' attitude and reported prescribing behavior for chronic low back pain: An exploratory cross-sectional study	PLOS ONE			English	Article							GENERAL-PRACTITIONERS; ALTERNATIVE MEDICINE; MANAGEMENT; COMPLEMENTARY; GUIDELINES; BELIEFS; METAANALYSIS	Objective Recent guidelines for chronic or recurrent low back pain recommend non-pharmacologic treatments as first-line options. The objective of this study was thus to explore the perceived usefulness of several conventional and complementary medicine treatments for chronic or recurrent low back pain by primary care physicians and their reported prescribing behavior. Design An exploratory cross-sectional study. Setting and participants Primary care physicians of the French-speaking part of Switzerland. Main outcome measures Primary care physicians' perceived usefulness of each conventional and complementary medicine treatment and their reported recommendation behavior were considered dependent variables in multivariate logistic regression models. All correlations were computed between binary variables, and phi coefficients were calculated to estimate correlation strengths. Results 533 primary care physicians answered the questionnaire (response rate: 25.6%). The top 3 conventional treatments most often considered useful by primary care physicians for chronic or recurrent low back pain were physiotherapy (94.8%), nonsteroidal anti-inflammatory drugs (87.9%), and manual therapy (82.5%), whereas the most prescribed conventional treatments were physiotherapy (99.2%), nonsteroidal anti-inflammatory drugs (97.4%), and acetaminophen (94.4%). Osteopathic treatment (78.4%), yoga (69.3%), and therapeutic massage (63.9%) were the complementary medicine treatments most often considered useful by primary care physicians in managing chronic or recurrent low back pain. Being a female physician, younger than 56 years, trained in complementary medicine, or using complementary medicine were all associated with higher perceived usefulness of complementary medicine treatments in general. The most recommended complementary medicine treatments by primary care physicians were osteopathic treatment (87.3%), acupuncture (69.3%), and therapeutic massage (58.7%). Being a female physician, younger than 56, and using complementary medicine were all associated with more complementary medicine recommendation in general. Conclusion Our results highlight the importance of better understanding the prescribing patterns of primary care physicians for chronic or recurrent low back pain. Considering the frequency and burden of chronic or recurrent low back pain, programs focusing on the most (cost-) effective treatments should be implemented.	[Rodondi, Pierre-Yves; Dubois, Julie; Bill, Anne-Sylvie; Koutaissoff, Daria; Ros, Jenny; Aveni, Eleonore; Pasquier, Jerome; Burnand, Bernard] Univ Lausanne, Lausanne Univ Hosp, Inst Social & Prevent Med, Lausanne, Switzerland; [Rodondi, Pierre-Yves; Dubois, Julie; Bill, Anne-Sylvie; Koutaissoff, Daria; Ros, Jenny; Aveni, Eleonore; Pasquier, Jerome; Decosterd, Isabelle; Burnand, Bernard] Univ Lausanne, Fac Biol & Med, Lausanne, Switzerland; [Rodondi, Pierre-Yves; Dubois, Julie] Univ Fribourg, Inst Family Med, Fribourg, Switzerland; [Herzig, Lilli] Univ Lausanne, Inst Family Med, Lausanne, Switzerland; [Decosterd, Isabelle] Univ Lausanne, Lausanne Univ Hosp, Dept Anesthesiol, Pain Ctr, Lausanne, Switzerland; [Decosterd, Isabelle] Univ Lausanne, Lausanne Univ Hosp, Dept Anesthesiol, Ctr Integrat & Complementary Med, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Fribourg; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Dubois, J (corresponding author), Univ Lausanne, Lausanne Univ Hosp, Inst Social & Prevent Med, Lausanne, Switzerland.; Dubois, J (corresponding author), Univ Lausanne, Fac Biol & Med, Lausanne, Switzerland.; Dubois, J (corresponding author), Univ Fribourg, Inst Family Med, Fribourg, Switzerland.	Julie.dubois@unifr.ch	Rodondi, Pierre-Yves/AAU-3708-2020	Dubois, Julie/0000-0001-9241-0231; Ros, Jenny/0000-0001-8144-0312; Pasquier, Jerome/0000-0002-5554-2988; Rodondi, Pierre-Yves/0000-0003-2007-2995; Burnand, Bernard/0000-0002-5678-6044	Swiss Academy of Medical Science; Gottfried and Julia Bangerter-Rhyner Foundation	Swiss Academy of Medical Science; Gottfried and Julia Bangerter-Rhyner Foundation	This research was funded by the Swiss Academy of Medical Science and the Gottfried and Julia Bangerter-Rhyner Foundation (PYR). http:// www.bangerter-stiftung.ch/bangerter/de/stiftung/portrait.html The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorin-Woods Lyndon G, 2014, J Can Chiropr Assoc, V58, P220; Becker WC, 2017, BMC FAM PRACT, V18, DOI 10.1186/s12875-017-0608-2; Bishop A, 2008, PAIN, V135, P187, DOI 10.1016/j.pain.2007.11.010; Bishop FL, 2015, SPINE, V40, P1842, DOI 10.1097/BRS.0000000000001215; Bishop Paul B, 2003, Spine J, V3, P442, DOI 10.1016/S1529-9430(03)00152-9; Breen A, 2007, EUR J PAIN, V11, P21, DOI 10.1016/j.ejpain.2005.12.006; Carey TS, 2009, SPINE, V34, P718, DOI 10.1097/BRS.0b013e31819792b0; Carlsen B, 2007, BRIT J GEN PRACT, V57, P971, DOI 10.3399/096016407782604820; Chen L, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1284; Cherkin DC, 2016, JAMA-J AM MED ASSOC, V315, P1240, DOI 10.1001/jama.2016.2323; CHERKIN DC, 1995, SPINE, V20, P1, DOI 10.1097/00007632-199501000-00001; Chou R, 2007, ANN INTERN MED, V147, P478, DOI 10.7326/0003-4819-147-7-200710020-00006; Corbett M, 2009, FAM PRACT, V26, P359, DOI 10.1093/fampra/cmp042; Coudeyre E, 2006, PAIN, V124, P330, DOI 10.1016/j.pain.2006.05.003; Cramer H, 2013, CLIN J PAIN, V29, P450, DOI 10.1097/AJP.0b013e31825e1492; Dahan R, 2007, J EVAL CLIN PRACT, V13, P616, DOI 10.1111/j.1365-2753.2007.00855.x; Deyo RA, 2009, J AM BOARD FAM MED, V22, P62, DOI 10.3122/jabfm.2009.01.080102; Francke AL, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-38; Franke H, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-286; Freeman AC, 2001, BRIT MED J, V323, P1100, DOI 10.1136/bmj.323.7321.1100; Fullen BM, 2008, PAIN, V136, P388, DOI 10.1016/j.pain.2008.01.003; Giannitrapani KF, 2017, PAIN MED; Hall AM, 2011, ARTHRIT CARE RES, V63, P1576, DOI 10.1002/acr.20594; Hostettler S, 2018, B MED SUISSES, V99, P408; Hoy D, 2012, ARTHRITIS RHEUM-US, V64, P2028, DOI 10.1002/art.34347; Koes BW, 2010, EUR SPINE J, V19, P2075, DOI 10.1007/s00586-010-1502-y; Kuijpers T, 2011, EUR SPINE J, V20, P40, DOI 10.1007/s00586-010-1541-4; Little P, 2004, BMJ-BRIT MED J, V328, P444, DOI 10.1136/bmj.38013.644086.7C; Lugtenberg M, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-54; Machado GC, 2017, PHYS THER, V97, P889, DOI 10.1093/ptj/pzx067; Machado GC, 2017, ANN RHEUM DIS, V76, P1269, DOI 10.1136/annrheumdis-2016-210597; Machado GC, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1225; Matthias MS, 2010, PAIN MED, V11, P1688, DOI 10.1111/j.1526-4637.2010.00980.x; Nahin RL, 2016, MAYO CLIN PROC, V91, P1292, DOI 10.1016/j.mayocp.2016.06.007; National GCU, 2016, LOW BACK PAIN SCIAT; Phelan SM, 2009, PAIN MED, V10, P1270, DOI 10.1111/j.1526-4637.2009.00717.x; Qaseem A, 2017, ANN INTERN MED, V166, P514, DOI 10.7326/M16-2367; Rubinstein SM, 2010, EUR SPINE J, V19, P1213, DOI 10.1007/s00586-010-1356-3; Schers H, 2001, Spine (Phila Pa 1976), V26, pE348, DOI 10.1097/00007632-200108010-00013; Scott NA, 2010, PAIN RES MANAG, V15, P392, DOI 10.1155/2010/252695; Shaheed CA, 2016, JAMA INTERN MED, V176, P958, DOI 10.1001/jamainternmed.2016.1251; Sherman Karen J, 2004, BMC Complement Altern Med, V4, P9, DOI 10.1186/1472-6882-4-9; Tan G, 2015, EUR J PAIN, V19, P271, DOI 10.1002/ejp.545; Traeger A, 2017, CAN MED ASSOC J, V189, pE1386, DOI 10.1503/cmaj.170527; Treede RD, 2015, PAIN, V156, P1003, DOI 10.1097/j.pain.0000000000000160; van Buuren S, 2011, J STAT SOFTW, V45, P1; van Middelkoop M, 2011, EUR SPINE J, V20, P19, DOI 10.1007/s00586-010-1518-3; Vickers AJ, 2012, ARCH INTERN MED, V172, P1444, DOI 10.1001/archinternmed.2012.3654; Wahner-Roedler DL, 2014, COMPLEMENT THER CLIN, V20, P54, DOI 10.1016/j.ctcp.2013.09.003; Wieland LS, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010671.pub2; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Winslow LC, 2002, ARCH INTERN MED, V162, P1176	52	8	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204613	10.1371/journal.pone.0204613	http://dx.doi.org/10.1371/journal.pone.0204613			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30261029	Green Submitted, Green Published, gold			2022-12-26	WOS:000445907400076
J	Katajamaa, R; Larsson, LH; Lundberg, P; Sorensen, I; Jensen, P				Katajamaa, Rebecca; Larsson, Lovisa H.; Lundberg, Pauline; Sorensen, Ida; Jensen, Per			Activity, social and sexual behaviour in Red Junglefowl selected for divergent levels of fear of humans	PLOS ONE			English	Article							GALLUS-GALLUS; RESOURCE-ALLOCATION; DOMESTIC-FOWL; CHICKENS; REVEALS; EVOLUTION; TAMENESS; ANIMALS; GENOME; MODEL	The domesticated phenotype is a set of behavioural, morphological and physiological traits that is common for domesticated species. Previous research has found that selection for tameness only can give rise to correlated selection responses that resemble the domesticated phenotype. It has therefore been suggested that tameness may drive the domesticated phenotype as correlated traits. We selected Red Junglefowl for divergent levels of fear of human for eight generations and assessed possible correlated selection responses in other behaviours in semi-natural settings. Behavioural studies were carried out on birds from generations six to eight, and at different ages, in order to study possible effects on general activity, social behaviour and male courtship behaviour. We found that the differences between selection lines changed with age. Adult low fear birds were generally more active and high fear males showed a more intense courtship behaviour. Our study shows that several behaviours can be modified through correlated selection responses by selection on reduced fear of humans only, emphasising the putative role of tameness as a driver of domestication related phenotypes.	[Katajamaa, Rebecca; Larsson, Lovisa H.; Lundberg, Pauline; Sorensen, Ida; Jensen, Per] Linkoping Univ, IFM Biol, AVIAN Behav Genom & Physiol Grp, Linkoping, Sweden	Linkoping University	Jensen, P (corresponding author), Linkoping Univ, IFM Biol, AVIAN Behav Genom & Physiol Grp, Linkoping, Sweden.	per.jensen@liu.se		Sorensen, Ida/0000-0002-9571-2910; Katajamaa, Rebecca/0000-0002-1581-8548	Swedish Research Council [2015-05444]; European Research Council [322206]	Swedish Research Council(Swedish Research CouncilEuropean Commission); European Research Council(European Research Council (ERC)European Commission)	The work was funded by the Swedish Research Council (https://www.vr.se/), grant no. 2015-05444 (PJ), and the European Research Council Advanced Grant (https://erc.europa.eu/funding/advanced-grants), grant no. 322206 (PJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnvall B, 2014, ANIMAL, V8, P1498, DOI 10.1017/S1751731114001426; Agnvall B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03236-4; Agnvall B, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0509; Agnvall B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035162; Al-Nasser A, 2007, WORLD POULTRY SCI J, V63, P285, DOI 10.1017/S004393390700147X; Albert FW, 2008, HORM BEHAV, V53, P413, DOI 10.1016/j.yhbeh.2007.11.010; Albert FW, 2009, GENETICS, V182, P541, DOI 10.1534/genetics.109.102186; Anholt R. R., 2010, PRINCIPLES BEHAV GEN; Belteky J, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160033; BOITANI L, 1995, ETHOL ECOL EVOL, V7, P49, DOI 10.1080/08927014.1995.9522969; Carneiro M, 2014, SCIENCE, V345, P1074, DOI 10.1126/science.1253714; COLLIAS N, 1953, BEHAVIOUR, V5, P175, DOI 10.1163/156853953X00104; Collias NE, 1996, ANIM BEHAV, V51, P1337, DOI 10.1006/anbe.1996.0137; EVANS CS, 1993, ANIM BEHAV, V46, P1, DOI 10.1006/anbe.1993.1156; GYGER M, 1988, ANIM BEHAV, V36, P358, DOI 10.1016/S0003-3472(88)80006-X; Jensen P, 2014, GENETICS AND THE BEHAVIOR OF DOMESTIC ANIMALS, 2ND EDITION, P41, DOI 10.1016/B978-0-12-394586-0.00002-0; KEELING LJ, 1991, APPL ANIM BEHAV SCI, V32, P205, DOI 10.1016/S0168-1591(05)80044-9; Kokolakis A, 2010, ANIM BEHAV, V79, P1373, DOI 10.1016/j.anbehav.2010.03.013; LEONARD ML, 1995, ANIM BEHAV, V49, P1283, DOI 10.1006/anbe.1995.0160; Lindqvist CES, 2002, BEHAVIOUR, V139, P1195, DOI 10.1163/15685390260437335; Malmkvist J, 2002, ANIM BEHAV, V64, P487, DOI 10.1006/anbe.2002.3058; Nicol C. J., 2015, BEHAV BIOL CHICKENS; Price EO, 1999, APPL ANIM BEHAV SCI, V65, P245, DOI 10.1016/S0168-1591(99)00087-8; Rauw WM, 1998, LIVEST PROD SCI, V56, P15, DOI 10.1016/S0301-6226(98)00147-X; Rubin CJ, 2012, P NATL ACAD SCI USA, V109, P19529, DOI 10.1073/pnas.1217149109; Schutz K, 2002, BEHAV GENET, V32, P423, DOI 10.1023/A:1020880211144; Schutz KE, 2001, ETHOLOGY, V107, P753, DOI 10.1046/j.1439-0310.2001.00703.x; Singh N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175043; Smith CL, 2011, ANIM BEHAV, V82, P521, DOI 10.1016/j.anbehav.2011.06.002; SUAREZ SD, 1983, ANIM LEARN BEHAV, V11, P119, DOI 10.3758/BF03212318; Trut L, 2009, BIOESSAYS, V31, P349, DOI 10.1002/bies.200800070; VanKampen HS, 1997, BEHAVIOUR, V134, P775, DOI 10.1163/156853997X00061; WEST B, 1988, J ARCHAEOL SCI, V15, P515, DOI 10.1016/0305-4403(88)90080-5; Wilson DR, 2008, ANIM BEHAV, V76, P2029, DOI 10.1016/j.anbehav.2008.08.021	34	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2018	13	9							e0204303	10.1371/journal.pone.0204303	http://dx.doi.org/10.1371/journal.pone.0204303			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV3NB	30256834	Green Published, gold			2022-12-26	WOS:000446000200043
J	Kennedy, K; Graham, SM; Arora, N; Shuhart, MC; Kim, HN				Kennedy, Kaitlyn; Graham, Susan M.; Arora, Nayan; Shuhart, Margaret C.; Kim, H. Nina			Hepatocellular carcinoma among US and non US-born patients with chronic hepatitis B: Risk factors and age at diagnosis	PLOS ONE			English	Article							UNITED-STATES; LIVER-CANCER; VIRAL LOAD; CIRRHOSIS; EPIDEMIOLOGY; VIRUS; SURVEILLANCE; INCREASES; INFECTION; FIBROSIS	Background Risk factors for hepatocellular carcinoma (HCC) have not been well characterized among African immigrants with chronic hepatitis B virus (HBV) infection. We conducted a case-control study to identify demographic and clinical factors associated with HCC among a diverse cohort of patients with chronic HBV infection seen in a large academic health setting. Methods We identified a total of 278 patients with HCC and chronic HBV seen at two medical centers in a 14-year span from January 2002 to December 2015. These cases were age-and sex matched in a 1:3 ratio with 823 non-cancer control subjects with chronic HBV. Conditional logistic regression was used to estimate the odds of HCC by race, with black race stratified by African-born status, after adjusting for diabetes, HIV or HCV coinfection, alcohol misuse and cirrhosis. Results Of the 278 HCC cases, 67% were 60 years of age or older, 78% were male, 87% had cirrhosis and 72% were Asian. HIV infection was present in 6% of cases. Only 7% (19 of 278) of HCC cases were black, of whom 14 were African immigrants. The median age at HCC diagnosis was 44 years in Africans. Notably, nearly all (93%) of the African -born patients with HCC were diagnosed at an age younger than 60 years compared with 52% of Asian cases (P<0.001). The main factors independently associated with greater odds of HCC overall were Asian race (adjusted odds ratio [aOR] 3.3, 95% confidence interval [CI] 1.9-5.5) and cirrhosis (aOR 19.7, 95% CI 12.2-31.8). Conclusion African immigrants accounted for a small proportion of HBV-associated HCC cases overall compared with Asians but appeared to have greater likelihood of early-onset HCC. Optimal strategies for HCC prevention in these key subroups with chronic HBV warrant further study.	[Kennedy, Kaitlyn; Graham, Susan M.; Kim, H. Nina] Univ Washington, Sch Med, Dept Global Hlth, Seattle, WA 98195 USA; [Graham, Susan M.; Kim, H. Nina] Univ Washington, Div Allergy & Infect Dis, Dept Med, Seattle, WA 98195 USA; [Arora, Nayan] Univ Washington, Dept Med, Div Nephrol, Seattle, WA 98195 USA; [Shuhart, Margaret C.] Univ Washington, Div Gastroenterol, Dept Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Kim, HN (corresponding author), Univ Washington, Sch Med, Dept Global Hlth, Seattle, WA 98195 USA.; Kim, HN (corresponding author), Univ Washington, Div Allergy & Infect Dis, Dept Med, Seattle, WA 98195 USA.	hyangkim@uw.edu	Graham, Susan/W-6133-2019	Graham, Susan/0000-0001-7847-8686				Arzumanyan A, 2013, NAT REV CANCER, V13, P123, DOI 10.1038/nrc3449; Bandoh S, 2015, PARTICULARLY ASS CHR, V42, P1629, DOI [10.1038/ajg.2015.289, DOI 10.1038/AJG.2015.289]; Cao GW, 2009, WORLD J GASTROENTERO, V15, P5761, DOI 10.3748/wjg.15.5761; Chen Chien-Jen, 2007, Clin Liver Dis, V11, P797, DOI 10.1016/j.cld.2007.08.005; Coppola N, 2015, WORLD J HEPATOL, V7, P2955, DOI 10.4254/wjh.v7.i30.2955; Davila JA, 2005, GUT, V54, P533, DOI 10.1136/gut.2004.052167; Davila JA, 2011, ANN INTERN MED, V154, P85, DOI 10.7326/0003-4819-154-2-201101180-00006; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Evans AA, 1998, CANCER EPIDEM BIOMAR, V7, P559; Ezzikouri S, 2013, HEPATOL INT, V7, P820, DOI 10.1007/s12072-013-9463-y; Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014; Giannini EG, 2013, WORLD J GASTROENTERO, V19, P8808, DOI 10.3748/wjg.v19.i47.8808; Global Burden of Disease Cancer Collaboration, 2017, JAMA Oncol, V3, P524, DOI 10.1001/jamaoncol.2016.5688; Hearn B, 2015, CLIN INFECT DIS, V61, P1742, DOI 10.1093/cid/civ654; Howlader N, 2016, SEER CANC STAT REV; KEW MC, 1989, GASTROENTEROLOGY, V97, P136, DOI 10.1016/0016-5085(89)91426-1; Kew MC, 2013, ANN HEPATOL, V12, P173, DOI 10.1016/S1665-2681(19)31354-7; Kim BK, 2010, LIVER INT, V30, P546, DOI 10.1111/j.1478-3231.2009.02192.x; Kirk GD, 2004, HEPATOLOGY, V39, P211, DOI 10.1002/hep.20027; Kramvis A, 2007, HEPATOL RES, V37, pS9, DOI 10.1111/j.1872-034X.2007.00098.x; Ladep NG, 2014, WORLD J HEPATOL, V6, P783, DOI 10.4254/wjh.v6.i11.783; Lamarca A, 2016, CRIT REV ONCOL HEMAT, V105, P65, DOI 10.1016/j.critrevonc.2016.06.007; Li YG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111707; Mendy ME, 2010, J VIRAL HEPATITIS, V17, P115, DOI 10.1111/j.1365-2893.2009.01168.x; Mitchell AE, 2010, HEPATOLOGY, V51, P729, DOI 10.1002/hep.23561; Mitchell T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027717; Navasa M, 2010, HEPATOLOGY, V51, P12, DOI 10.1002/hep.23332; Organization WH, 2017, GLOB HEP REP D 2017; Papatheodoridis GV, 2017, HEPATOLOGY, V66, P1444, DOI 10.1002/hep.29320; Papatheodoridis GV, 2015, J HEPATOL, V62, P956, DOI 10.1016/j.jhep.2015.01.002; Park JW, 2015, LIVER INT, V35, P2155, DOI 10.1111/liv.12818; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Raffetti E, 2016, LIVER INT, V36, P1239, DOI 10.1111/liv.13142; Ryerson AB, 2016, CANCER-AM CANCER SOC, V122, P1312, DOI 10.1002/cncr.29936; Santi V, 2012, J HEPATOL, V56, P397, DOI 10.1016/j.jhep.2011.05.026; Sarkar M, 2012, J VIRAL HEPATITIS, V19, P594, DOI 10.1111/j.1365-2893.2011.01577.x; Shimakawa Y, 2016, GUT, V65, P2007, DOI 10.1136/gutjnl-2015-309892; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Venook AP, 2010, ONCOLOGIST, V15, P5, DOI 10.1634/theoncologist.2010-S4-05; Walker M, 2016, ALIMENT PHARM THER, V43, P621, DOI 10.1111/apt.13505; Walter SR, 2011, J GASTROEN HEPATOL, V26, P1757, DOI 10.1111/j.1440-1746.2011.06785.x; Welzel TM, 2011, HEPATOLOGY, V54, P463, DOI 10.1002/hep.24397; Yang JD, 2016, CANCER, P81; Yang JD, 2017, J CLIN GASTROENTEROL, V51, P742, DOI [10.1097/MCG.0000000000000810, 10.1097/mcg.0000000000000810]; Yang JD, 2015, AM J GASTROENTEROL, V110, P1629, DOI 10.1038/ajg.2015.289	45	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2018	13	9							e0204031	10.1371/journal.pone.0204031	http://dx.doi.org/10.1371/journal.pone.0204031			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU9BO	30252863	gold, Green Published, Green Submitted			2022-12-26	WOS:000445639700024
J	Maiti, AK; Sharba, S; Navabi, N; Linden, SK				Maiti, Arpan K.; Sharba, Sinan; Navabi, Nazanin; Linden, Sara K.			Colonic levels of vasoactive intestinal peptide decrease during infection and exogenous VIP protects epithelial mitochondria against the negative effects of IFN gamma and TNF alpha induced during Citrobacter rodentium infection	PLOS ONE			English	Article							ENTEROPATHOGENIC ESCHERICHIA-COLI; SUBSTANCE-P; IN-VIVO; POLYPEPTIDE; MICE; MODEL; PATHOGENESIS; DYSFUNCTION; VIRULENCE; NEURONS	Citrobacter rodentium infection is a model for infection with attaching and effacing pathogens, such as enteropathogenic Escherichia coli. The vasoactive intestinal peptide (VIP) has emerged as an anti-inflammatory agent, documented to inhibit Th1 immune responses and successfully treat animal models of inflammation. VIP is also a mucus secretagogue. Here, we found that colonic levels of VIP decrease during murine C. rodentium infection with a similar time dependency as measurements reflecting mitochondrial function and epithelial integrity. The decrease in VIP appears mainly driven by changes in the cytokine environment, as no changes in VIP levels were detected in infected mice lacking interferon gamma (IFN gamma). VIP supplementation alleviated the reduction of activity and levels of mitochondrial respiratory complexes I and IV, mitochondrial phosphorylation capacity, transmembrane potential and ATP generation caused by IFN gamma, TNF alpha and C. rodentium infection, in an in vitro mucosal surface. Similarly, VIP treatment regimens that included the day 5-10 post infection period alleviated decreases in enzyme complexes I and IV, phosphorylation capacity, mitochondrial transmembrane potential and ATP generation as well as increased apoptosis levels during murine infection with C. rodentium. However, VIP treatment failed to alleviate colitis, although there was a tendency to decreased pathogen density in contact with the epithelium and in the spleen. Both in vivo and in vitro, NO generation increased during C. rodentium infection, which was alleviated by VIP. Thus, therapeutic VIP administration to restore the decreased levels during infection had beneficial effects on epithelial cells and their mitochondria, but not on the overall infection outcome.	[Maiti, Arpan K.; Sharba, Sinan; Navabi, Nazanin; Linden, Sara K.] Univ Gothenburg, Sahlgrenska Acad, Dept Med Biochem & Cell Biol, Gothenburg, Sweden; [Maiti, Arpan K.] Dayananda Sagar Univ, Sch Basic & Appl Sci, Bangalore, Karnataka, India	University of Gothenburg	Linden, SK (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Med Biochem & Cell Biol, Gothenburg, Sweden.	sara.linden@biomedicine.gu.se	Maiti, Arpan Kumar/AAR-5647-2021	sharba, sinan/0000-0003-0531-2137; MAITI, ARPAN/0000-0003-3790-5666	Swedish research council [521-2011-2370]; Swedish Research Counsil Formas [221-2011-1036, 221-2013-590]; Novo Nordisk Foundation; Rickard Julin Foundation; Ake Wiberg Foundation; Wilhelm and Martina Lundgren's Foundation; Knut and Alice Wallenberg Foundation	Swedish research council(Swedish Research CouncilEuropean Commission); Swedish Research Counsil Formas(Swedish Research Council Formas); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Rickard Julin Foundation; Ake Wiberg Foundation; Wilhelm and Martina Lundgren's Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was supported by the Swedish research council [521-2011-2370], the Swedish Research Counsil Formas [221-2011-1036 and 221-2013-590] and the Novo Nordisk, Rickard Julin, Ake Wiberg, Wilhelm and Martina Lundgren's and Knut and Alice Wallenberg Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad C, 2003, GASTROENTEROLOGY, V124, P961, DOI 10.1053/gast.2003.50141; ADAMS RB, 1993, J IMMUNOL, V150, P2356; ALESSANDRINI F, 1993, TRANSPLANTATION, V56, P964, DOI 10.1097/00007890-199310000-00036; Ao XX, 2011, REGUL PEPTIDES, V168, P1, DOI 10.1016/j.regpep.2011.02.006; BARTHOLD SW, 1980, LAB ANIM SCI, V30, P167; Belai A, 1997, GUT, V40, P767, DOI 10.1136/gut.40.6.767; BISHOP AE, 1980, GASTROENTEROLOGY, V79, P853; BROWNING KN, 1994, NEUROSCIENCE, V62, P1257, DOI 10.1016/0306-4522(94)90357-3; Chandrasekharan B, 2013, AM J PHYSIOL-GASTR L, V304, pG949, DOI 10.1152/ajpgi.00493.2012; Clark JB, 1997, NEUROCHEMISTRY PRACT, P151; Conlin VS, 2009, AM J PHYSIOL-GASTR L, V297, pG735, DOI 10.1152/ajpgi.90551.2008; COOKE HJ, 1994, AM J PHYSIOL, V266, pG167, DOI 10.1152/ajpgi.1994.266.2.G167; Crane JK, 1999, INFECT IMMUN, V67, P2575, DOI 10.1128/IAI.67.5.2575-2584.1999; Delgado M, 1999, J IMMUNOL, V162, P1200; Delgado M, 2002, J MOL MED, V80, P16, DOI 10.1007/s00109-001-0291-5; Delgado M, 2004, PHARMACOL REV, V56, P249, DOI 10.1124/pr.56.2.7; Deng WY, 2004, P NATL ACAD SCI USA, V101, P3597, DOI 10.1073/pnas.0400326101; Deng WY, 2001, INFECT IMMUN, V69, P6323, DOI 10.1128/IAI.69.10.6323-6335.2001; Dijkstra Gerard, 2004, Curr Opin Investig Drugs, V5, P529; EKBLAD E, 1988, NEUROSCIENCE, V27, P655, DOI 10.1016/0306-4522(88)90296-5; Foster DB, 2000, INFECT IMMUN, V68, P3108, DOI 10.1128/IAI.68.6.3108-3115.2000; Frankel G, 1996, INFECT IMMUN, V64, P5315, DOI 10.1128/IAI.64.12.5315-5325.1996; Gomariz RP, 2001, CURR PHARM DESIGN, V7, P89, DOI 10.2174/1381612013398374; Goyal RK, 1996, NEW ENGL J MED, V334, P1106, DOI 10.1056/NEJM199604253341707; GRIFFIN PM, 1990, GASTROENTEROLOGY, V99, P142, DOI 10.1016/0016-5085(90)91241-W; Grimm MC, 2003, J IMMUNOL, V171, P4990, DOI 10.4049/jimmunol.171.10.4990; Gustafsson JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084430; Hatefi Y, 1978, Methods Enzymol, V53, P11; Hinkle PC, 1995, BIOENERGETICS PRACTI, P1; Hokari R, 2005, AM J PHYSIOL-GASTR L, V289, pG949, DOI 10.1152/ajpgi.00142.2005; JOHNSON E, 1979, AM J PATHOL, V97, P291; Johnson-Henry KC, 2005, J INFECT DIS, V191, P2106, DOI 10.1086/430318; KOCH TR, 1987, DIGEST DIS SCI, V32, P369, DOI 10.1007/BF01296290; Lelievre V, 2007, PEPTIDES, V28, P1688, DOI 10.1016/j.peptides.2007.05.006; Linden SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003952; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luperchio SA, 2001, MICROBES INFECT, V3, P333, DOI 10.1016/S1286-4579(01)01387-9; Ma CX, 2006, CELL MICROBIOL, V8, P1669, DOI 10.1111/j.1462-5822.2006.00741.x; Maiti AK, 2015, SCI REP-UK, V5, DOI 10.1038/srep15434; MARCHISMOUREN G, 1988, BIOCHIMIE, V70, P663, DOI 10.1016/0300-9084(88)90251-9; Miampamba M, 1998, NEUROGASTROENT MOTIL, V10, P315; MILLER MJS, 1993, AM J PHYSIOL, V265, pG321, DOI 10.1152/ajpgi.1993.265.2.G321; Mundy R, 2005, CELL MICROBIOL, V7, P1697, DOI 10.1111/j.1462-5822.2005.00625.x; Nagai T, 2005, J BIOL CHEM, V280, P2998, DOI 10.1074/jbc.M411550200; Navabi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068761; Neunlist M, 2003, GUT, V52, P84, DOI 10.1136/gut.52.1.84; Newman R, 2005, CLIN EXP IMMUNOL, V139, P411, DOI 10.1111/j.1365-2249.2005.02673.x; O'Hara JR, 2006, CELL MICROBIOL, V8, P646, DOI 10.1111/j.1462-5822.2005.00657.x; SAID SI, 1991, TRENDS ENDOCRIN MET, V2, P107, DOI 10.1016/S1043-2760(05)80006-2; Schulz S, 2004, CLIN CANCER RES, V10, P8235, DOI 10.1158/1078-0432.CCR-04-0939; Shiomi H, 2010, INFECT IMMUN, V78, P2653, DOI 10.1128/IAI.01343-09; SJOLUND K, 1983, GUT, V24, P724, DOI 10.1136/gut.24.8.724; Smirnova MG, 2001, EUR CYTOKINE NETW, V12, P119; SWAIN MG, 1992, GASTROENTEROLOGY, V102, P1913, DOI 10.1016/0016-5085(92)90313-N; Treede I, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-53; Vallance BA, 2003, INFECT IMMUN, V71, P3443, DOI 10.1128/IAI.71.6.3443-3453.2003; Wallace JL, 2000, GASTROENTEROLOGY, V119, P512, DOI 10.1053/gast.2000.9304; Wharton DC., 1967, METHOD ENZYMOL, P245; Williams RO, 2002, ARTHRITIS RHEUM, V46, P271, DOI 10.1002/1529-0131(200201)46:1<271::AID-ART10039>3.0.CO;2-C; Zund G, 1996, J BIOL CHEM, V271, P7460	60	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2018	13	9							e0204567	10.1371/journal.pone.0204567	http://dx.doi.org/10.1371/journal.pone.0204567			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU9BO	30252907	gold, Green Published, Green Submitted			2022-12-26	WOS:000445639700063
J	Shearer, K; Evans, D; Xhosa, B; Hirasen, K; Bracken, C; Mahomed, K; Long, L; Fox, MP				Shearer, Kate; Evans, Denise; Xhosa, Barbara; Hirasen, Kamban; Bracken, Craig; Mahomed, Kay; Long, Lawrence; Fox, Matthew P.			Low prevalence of depressive symptoms among stable patients on antiretroviral therapy in Johannesburg, South Africa	PLOS ONE			English	Article							MENTAL-HEALTH; HIV; ADHERENCE; HIV/AIDS; ANXIETY	Background Depression is a leading cause of disability and may be associated with decreased adherence to ART. We sought to describe the prevalence of depressive symptoms and outcomes one year after screening among patients receiving ART at a large HIV Clinic in Johannesburg, South Africa. Methods Adult (>= 18) patients who had been on first-line ART between 6-18 months who could communicate in English were eligible. Depressive symptoms were evaluated using the Patient Health Questionnaire (PHQ)-9 and a score >= 10 indicated depression. Results 97 patients enrolled. Patients had been on ART for a median (IQR) of 8 (7-10) months, 61% were female, the median (IQR) age at enrollment was 38 (33-42) years, and the median (IQR) CD4 count at ART initiation was 154.5 (65-263) cells/mm(3). 7 (7%) patients were found to have symptoms of depression; 4 (4%) had symptoms of moderate depression (PHQ score of 10-14) and 3 (3%) had symptoms of moderate/severe depression (PHQ score of 15-19). Women (10%) were more likely to have symptoms of depression than men (3%; prevalence difference [PD]: 7.5%; 95% confidence interval [CI]:-1.7%-16.8%); as were patients under the age of 30 (14%) compared to those 30-39 (4%; PD: -10.2; 95% CI: -29.4-9.0%) or >= 40 (9%; PD: -5.5%; -26.1%-15.2%), those with lower CD4 counts at ART initiation (<200 cells/mm(3) vs >= 200 cells/mm(3) : 8% vs 3%; PD: 4.8%; 95% CI: -4.5%-14.0%), and those with high viral loads (> 1000 copies/mL vs. <400 copies/mL: 40% vs. 5%; PD: 34.6%; 95% CI: -8.6%-77.6%). No relationship between depressive symptoms and retention in HIV care one year after screening was observed. Conclusions We found a lower prevalence of depressive symptoms compared to findings from other HIV-positive populations in South Africa but more than one-third of patients with an elevated viral load had evidence of depression. Further research on the relationship between depression, adherence, and viral failure is warranted as this may present an opportunity for early interventions to improve treatment outcomes and reduce the need for second-line treatment.	[Shearer, Kate; Evans, Denise; Xhosa, Barbara; Hirasen, Kamban; Long, Lawrence; Fox, Matthew P.] Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Hlth Econ & Epidemiol Res Off,Dept Internal Med, Johannesburg, South Africa; [Bracken, Craig] Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Dept Psychiat, Johannesburg, South Africa; [Mahomed, Kay] Right Care, Johannesburg, South Africa; [Fox, Matthew P.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Fox, Matthew P.] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA USA	University of Witwatersrand; University of Witwatersrand; Boston University; Boston University	Shearer, K (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Hlth Econ & Epidemiol Res Off,Dept Internal Med, Johannesburg, South Africa.	kshearer@heroza.org	Fox, Matthew/K-2004-2019	Long, Lawrence/0000-0003-4986-4988; Shearer, Kate/0000-0003-2049-4258	South African Mission of USAID [674-A-12-00029]; National Institutes of Health [T32AI102623]; American people through the United States Agency for International Development (USAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI102623] Funding Source: NIH RePORTER	South African Mission of USAID; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American people through the United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded through the South African Mission of USAID under the terms of Cooperative Agreement 674-A-12-00029 to the Health Economics and Epidemiology Research Office (HE2RO), a Division of the Wits Health Consortium (Pty) Ltd. Additional support to KS was provided by the National Institutes of Health (T32AI102623). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We express our gratitude to the directors, staff, and patients of the Themba Lethu Clinic for their support of this research. This study is made possible by the generous support of the American people through the United States Agency for International Development (USAID). The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government.	Brandt R, 2009, AJAR-AFR J AIDS RES, V8, P123, DOI 10.2989/AJAR.2009.8.2.1.853; Cholera R, 2017, AIDS BEHAV, V21, P1632, DOI 10.1007/s10461-016-1442-6; Fox MP, 2013, INT J EPIDEMIOL, V42, P430, DOI 10.1093/ije/dys029; Freeman M, 2007, AIDS CARE, V19, P1201, DOI 10.1080/09540120701426482; Furin J, 2013, MANAGEMENT MENTAL HL, V14, P155; Kagee A, 2010, AIDS CARE, V22, P159, DOI 10.1080/09540120903111445; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Myer L, 2008, AIDS PATIENT CARE ST, V22, P147, DOI 10.1089/apc.2007.0102; National Department of Health Republic of South Africa, 2016, IMPL UN TEST TREAT S; National Department of Health Republic of South Africa, 2013, S AFR ANT TREATM GUI; Nel A, 2013, AIDS CARE, V25, P948, DOI 10.1080/09540121.2012.748867; Nel A, 2011, AIDS CARE, V23, P1360, DOI 10.1080/09540121.2011.565025; Pappin M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-244; Peltzer K, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-111; Ramirez-Avila L, 2012, AIDS BEHAV, V16, P2226, DOI 10.1007/s10461-012-0160-y; Statistics South Africa, 2012, CENS 2011 CENS BRIEF; Tomlinson M, 2009, SAMJ S AFR MED J, V99, P368; Vos T, 2017, LANCET, V390, P1211, DOI 10.1016/S0140-6736(17)32154-2; who, DEPRESSION	19	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2018	13	9							e0203797	10.1371/journal.pone.0203797	http://dx.doi.org/10.1371/journal.pone.0203797			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GU9BO	30252844	gold, Green Submitted, Green Published			2022-12-26	WOS:000445639700012
J	Prasad, V; Wasser, Y; Hans, F; Goswami, A; Katona, I; Outeiro, TF; Kahle, PJ; Schulz, JB; Voigt, A				Prasad, Vibha; Wasser, Yasmine; Hans, Friederike; Goswami, Anand; Katona, Istvan; Outeiro, Tiago F.; Kahle, Philipp J.; Schulz, Joerg B.; Voigt, Aaron			Monitoring -synuclein multimerization in vivo	FASEB JOURNAL			English	Article						Parkinson's disease; synucleinopathy; protein aggregation; BiFC	ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; DROSOPHILA MODEL; PROTEIN; PHOSPHORYLATION; TOXICITY; AGGREGATION; MUTATION; NEURODEGENERATION; NEUROTOXICITY	The pathophysiology of Parkinson's disease is characterized by the abnormal accumulation of -synuclein (-Syn), eventually resulting in the formation of Lewy bodies and neurites in surviving neurons in the brain. Although -Syn aggregation has been extensively studied in vitro, there is limited in vivo knowledge on -Syn aggregation. Here, we used the powerful genetics of Drosophila melanogaster and developed an in vivo assay to monitor -Syn accumulation by using a bimolecular fluorescence complementation assay. We found that both genetic and pharmacologic manipulations affected -Syn accumulation. Interestingly, we also found that alterations in the cellular protein degradation mechanisms strongly influenced -Syn accumulation. Administration of compounds identified as risk factors for Parkinson's disease, such as rotenone or heavy metal ions, had only mild or even no impact on -Syn accumulation in vivo. Finally, we show that increasing phosphorylation of -Syn at serine 129 enhances the accumulation and toxicity of -Syn. Altogether, our study establishes a novel model to study -Syn accumulation and illustrates the complexity of manipulating proteostasis in vivo.Prasad, V., Wasser, Y., Hans, F., Goswami, A., Katona, I., Outeiro, T. F., Kahle, P. J., Schulz, J. B., Voigt, A. Monitoring -synuclein multimerization in vivo.	[Prasad, Vibha; Wasser, Yasmine; Schulz, Joerg B.; Voigt, Aaron] Rheinisch Westfaelische TH RWTH Aachen Univ, Univ Med Ctr, Dept Neurol, Aachen, Germany; [Goswami, Anand; Katona, Istvan] Rheinisch Westfaelische TH RWTH Aachen Univ, Univ Med Ctr, Inst Neuropathol, Aachen, Germany; [Hans, Friederike; Kahle, Philipp J.] German Ctr Neurodegenerat Dis, Hertie Inst Clin Brain Res, Dept Neurodegenerat, Lab Funct Neurogenet, Tubingen, Germany; [Outeiro, Tiago F.] Univ Med Ctr Gottingen, Ctr Biostruct Imaging Neurodegenerat, Ctr Mol Physiol Brain, Dept Expt Neurodegenerat, Gottingen, Germany; [Outeiro, Tiago F.] Max Planck Inst Expt Med, Gottingen, Germany; [Outeiro, Tiago F.] Newcastle Univ, Med Sch, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England; [Schulz, Joerg B.; Voigt, Aaron] Forschungszentrum Julich, Brain Inst Mol Neurosci & Neuroimaging, JARA, Aachen, Germany; [Schulz, Joerg B.; Voigt, Aaron] Rhein Westfal TH Aachen, Aachen, Germany	RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Gottingen; Max Planck Society; Newcastle University - UK; Helmholtz Association; Research Center Julich; RWTH Aachen University	Voigt, A (corresponding author), Rhein Westfal TH Aachen, Univ Med Ctr, Dept Neurol, Pauwelsstr 30, D-52074 Aachen, Germany.	avoigt@ukaachen.de	Katona, Istvan/AAD-4943-2022; Outeiro, Tiago/L-7351-2019; Schulz, Jorg B./D-9786-2012	Katona, Istvan/0000-0002-0955-8911; Outeiro, Tiago/0000-0003-1679-1727; Schulz, Jorg B./0000-0002-8903-0593; Wasser, Yasmine/0000-0002-7545-9508	Interdisciplinary Center for Clinical Research Aachen within the Faculty of Medicine at RWTH Aachen University [N7-3]; German Research Foundation (DFG) Center for Nanoscale Microscopy and Molecular Physiology of the Brain	Interdisciplinary Center for Clinical Research Aachen within the Faculty of Medicine at RWTH Aachen University; German Research Foundation (DFG) Center for Nanoscale Microscopy and Molecular Physiology of the Brain	The authors thank Claudia Krude and Hannelore Mader (Institute of Neuropathology, University Medical Center, RWTH Aachen University) for their excellent technical assistance with regard to electron microscopy. The authors also thank Sabine Hamm (Department of Neurology, University Medical Center, RWTH Aachen University) for excellent technical assistance. This work is supported by the Interdisciplinary Center for Clinical Research Aachen within the Faculty of Medicine at RWTH Aachen University (Clinical Neuroscience, Project N7-3). T.F.O. is supported by the German Research Foundation (DFG) Center for Nanoscale Microscopy and Molecular Physiology of the Brain. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare no conflicts of interest.	Alexopoulou Z, 2016, P NATL ACAD SCI USA, V113, pE4688, DOI 10.1073/pnas.1523597113; Ali YO, 2011, JOVE-J VIS EXP, DOI 10.3791/2504; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Balchin D, 2016, SCIENCE, V353, DOI 10.1126/science.aac4354; Bandopadhyay R., 2016, JOVE-J VIS EXP, V107, P53415; Bonini NM, 2002, P NATL ACAD SCI USA, V99, P16407, DOI 10.1073/pnas.152330499; Brady OA, 2011, J NEUROCHEM, V116, P248, DOI 10.1111/j.1471-4159.2010.07098.x; Butler EK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002488; Calap-Quintana P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132376; Chandrasekaran A, 2017, REDOX BIOL, V11, P91, DOI 10.1016/j.redox.2016.11.005; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Chen L, 2009, J CLIN INVEST, V119, P3257, DOI 10.1172/JCI39088; Cho J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050644; Ciechanover A, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2014.117; Collier TJ, 2017, MOVEMENT DISORD, V32, P983, DOI 10.1002/mds.27037; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Cookson MR, 2008, INT J CLIN EXP PATHO, V1, P217; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Coyne AN, 2014, J NEUROSCI, V34, P15962, DOI 10.1523/JNEUROSCI.2526-14.2014; Dinter E, 2016, J NEUROCHEM, V138, P758, DOI 10.1111/jnc.13712; Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Foo LC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07179-8; Fuchs J, 2008, FASEB J, V22, P1327, DOI 10.1096/fj.07-9348com; Goedert M, 2017, J PARKINSON DIS, V7, pS53, DOI 10.3233/JPD-179005; Gong WJ, 2006, GENETICS, V172, P275, DOI 10.1534/genetics.105.048793; Greenbaum EA, 2005, J BIOL CHEM, V280, P7800, DOI 10.1074/jbc.M411638200; Griciuc A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001075; Gupta R, 2011, NAT METHODS, V8, P879, DOI [10.1038/NMETH.1697, 10.1038/nmeth.1697]; Hosamani R, 2010, NEUROCHEM RES, V35, P1402, DOI 10.1007/s11064-010-0198-z; Iijima K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001703; Roberti MJ, 2012, BIOPHYS J, V102, P1598, DOI 10.1016/j.bpj.2012.03.010; Kahle PJ, 2001, AM J PATHOL, V159, P2215, DOI 10.1016/S0002-9440(10)63072-6; Karpinar DP, 2009, EMBO J, V28, P3256, DOI 10.1038/emboj.2009.257; Kivimae S, 2008, PLOS BIOL, V6, P1570, DOI 10.1371/journal.pbio.0060183; Krishna G, 2016, J SCI FOOD AGR, V96, P1745, DOI 10.1002/jsfa.7281; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Lazaro DF, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0402-8; Lazaro DF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004741; Ling DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004201; Lundgren J, 2005, MOL CELL BIOL, V25, P4662, DOI 10.1128/MCB.25.11.4662-4675.2005; Marmolino D, 2016, MOL CELL NEUROSCI, V71, P92, DOI 10.1016/j.mcn.2015.12.012; Melo TQ, 2017, EXP BRAIN RES, V235, P731, DOI 10.1007/s00221-016-4836-9; Meng H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15500; Muskus MJ, 2007, MOL CELL BIOL, V27, P8049, DOI 10.1128/MCB.00680-07; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Tue NT, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/252049; Okochi M, 2000, J BIOL CHEM, V275, P390, DOI 10.1074/jbc.275.1.390; Oueslati A, 2016, J PARKINSON DIS, V6, P39, DOI 10.3233/JPD-160779; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Outeiro TF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001867; Park Y, 2011, BIOCHEM BIOPH RES CO, V404, P638, DOI 10.1016/j.bbrc.2010.12.030; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; PRICE DJ, 1992, SCIENCE, V257, P973, DOI 10.1126/science.1380182; Sancenon V, 2012, HUM MOL GENET, V21, P2432, DOI 10.1093/hmg/dds058; Santner A, 2010, METALLOMICS, V2, P378, DOI 10.1039/b926659c; Sato H, 2011, J NEUROSCI, V31, P16884, DOI 10.1523/JNEUROSCI.3967-11.2011; Shin JH, 2013, SCI REP-UK, V3, DOI 10.1038/srep01561; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Sudati JH, 2013, NEUROTOXICOLOGY, V37, P118, DOI 10.1016/j.neuro.2013.04.006; Suzuki M, 2015, HUM MOL GENET, V24, P6675, DOI 10.1093/hmg/ddv372; Sweeney P, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0077-5; Tanner C. M., 2011, ENV HLTH PERSPECT, V119, P886; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; VanPelt J, 2017, BBA-PROTEINS PROTEOM, V1865, P133, DOI 10.1016/j.bbapap.2016.11.005; Varma S, 2007, BBA-GEN SUBJECTS, V1770, P71, DOI 10.1016/j.bbagen.2006.07.016; Visanji NP, 2016, TRENDS NEUROSCI, V39, P750, DOI 10.1016/j.tins.2016.09.003; Volles MJ, 2007, J MOL BIOL, V366, P1510, DOI 10.1016/j.jmb.2006.12.044; Voronin D, 2012, P NATL ACAD SCI USA, V109, pE1638, DOI 10.1073/pnas.1203519109; Wang LY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132638; Wanker EE, 1999, METHOD ENZYMOL, V309, P375; Waxman EA, 2008, J NEUROPATH EXP NEUR, V67, P402, DOI 10.1097/NEN.0b013e31816fc995; WENZEL T, 1995, NAT STRUCT BIOL, V2, P199, DOI 10.1038/nsb0395-199; Winslow AR, 2010, J CELL BIOL, V190, P1023, DOI 10.1083/jcb.201003122; Wolozin B, 2002, NEUROSCIENTIST, V8, P22, DOI 10.1177/107385840200800107; Yedlapudi D, 2016, SCI REP-UK, V6, DOI 10.1038/srep38510; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhang L, 2013, HUM MOL GENET, V22, P2829, DOI 10.1093/hmg/ddt132; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810	83	8	8	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2116	2131		10.1096/fj.201800148RRR	http://dx.doi.org/10.1096/fj.201800148RRR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30252534				2022-12-26	WOS:000457296600048
J	Wu, D; Kanda, A; Liu, Y; Kase, S; Noda, K; Ishida, S				Wu, Di; Kanda, Atsuhiro; Liu, Ye; Kase, Satoru; Noda, Kousuke; Ishida, Susumu			Galectin-1 promotes choroidal neovascularization and subretinal fibrosis mediated via epithelial-mesenchymal transition	FASEB JOURNAL			English	Article						AMD; RPE; SMAD family member 2; TGF-; VEGF	ENDOTHELIAL GROWTH-FACTOR; FACTOR-KAPPA-B; MACULAR DEGENERATION; EXPRESSION; HYPOXIA; CANCER; ICAM-1; CELLS; NONRESPONDERS; INFLAMMATION	VEGFA and TGF- are known major angiogenic and fibrogenic factors. Galectin-1, encoded by lectin, galactoside-binding, soluble (LGALS)1, has attracted growing attention for its facilitatory role in angiogenesis and fibrosis through its modification of VEGFA and TGF- receptor signaling pathways. We reveal galectin-1 involvement in the mouse model of laser-induced choroidal neovascularization (CNV) and subretinal fibrosis, both of which represent the pathogenesis of age-related macular degeneration (AMD). Neither deletion nor overexpression of Lgals1 affected physiologic retinal development or visual function. Galectin-1/Lgals1 was upregulated by CNV induction, whereas deletion of Lgals1 suppressed CNV together with downstream molecules of VEGF receptor (VEGFR)2. Loss of Lgals1 also attenuated subretinal fibrosis, expression of epithelial-mesenchymal transition (EMT) markers including Snai1, and phosphorylation of SMAD family member 2. Supporting these in vivo findings, silencing of LGALS1 in human retinal pigment epithelial (RPE) cells inhibited TGF-1-induced EMT-related molecules and cell motilities. Conversely, overexpression of Lgals1 enhanced CNV and subretinal fibrosis. Specimens from patients with AMD demonstrated colocalization of galectin-1 with VEGFR2 in neovascular endothelial cells and with phosphorylated SMAD2 in RPE cells. These results suggested a biologic significance of galectin-1 as a key promotor for both angiogenesis and fibrosis in eyes with AMD.Wu, D., Kanda, A., Liu, Y., Kase, S., Noda, K., Ishida, S. Galectin-1 promotes choroidal neovascularization and subretinal fibrosis mediated via epithelial-mesenchymal transition.	Hokkaido Univ, Lab Ocular Cell Biol & Visual Sci, Dept Ophthalmol, Fac Med, Sapporo, Hokkaido, Japan; Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Kanda, A (corresponding author), Hokkaido Univ, Lab Ocular Cell Biol & Visual Sci, Dept Ophthalmol, Fac Med,Kita Ku, N-15 W-7, Sapporo, Hokkaido 0608638, Japan.; Kanda, A (corresponding author), Hokkaido Univ, Grad Sch Med, Kita Ku, N-15 W-7, Sapporo, Hokkaido 0608638, Japan.	kanda@med.hokudai.ac.jp			Bayer Yakuhin Ltd.; Uehara Memorial Foundation; Eye Research Foundation for the Aged; Japan National Society for the Prevention of Blindness; Otsuka Toshimi Scholarship Foundation; China Scholarship Council	Bayer Yakuhin Ltd.; Uehara Memorial Foundation(Uehara Memorial Foundation); Eye Research Foundation for the Aged; Japan National Society for the Prevention of Blindness(Japan National Society for the Prevention of Blindness); Otsuka Toshimi Scholarship Foundation(Otsuka Pharmaceutical); China Scholarship Council(China Scholarship Council)	The authors thank Ikuyo Hirose, Shiho Yoshida, and Miyuki Murata (Hokkaido University) for skilled technical assistance. This work was supported, in part, by Bayer Yakuhin Ltd., the Uehara Memorial Foundation, the Eye Research Foundation for the Aged, and the Japan National Society for the Prevention of Blindness (to A.K.). D.W. and Y.L. are recipients of scholarships from the Otsuka Toshimi Scholarship Foundation and China Scholarship Council, respectively. The authors declare no conflicts of interest.	AMIN R, 1994, INVEST OPHTH VIS SCI, V35, P3178; Ashcroft GS, 1999, NAT CELL BIOL, V1, P260, DOI 10.1038/12971; Ashraf M, 2016, BRIT J OPHTHALMOL, V100, P1596, DOI 10.1136/bjophthalmol-2016-308388; Bloch SB, 2013, AM J OPHTHALMOL, V156, P116, DOI 10.1016/j.ajo.2013.02.012; Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025; Cao JT, 2010, INVEST OPHTH VIS SCI, V51, P6009, DOI 10.1167/iovs.09-4956; Chao HH, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0393-1; Chung LY, 2012, CLIN CANCER RES, V18, P4037, DOI 10.1158/1078-0432.CCR-11-3348; Croci DO, 2014, CELL, V156, P744, DOI 10.1016/j.cell.2014.01.043; Daniel E, 2014, OPHTHALMOLOGY, V121, P656, DOI 10.1016/j.ophtha.2013.10.019; Elad-Sfadia G, 2002, J BIOL CHEM, V277, P37169, DOI 10.1074/jbc.M205698200; Friedlander M, 2007, J CLIN INVEST, V117, P576, DOI 10.1172/JCI31030; Hirasawa M, 2011, MOL VIS, V17, P1222; Hsieh SH, 2008, ONCOGENE, V27, P3746, DOI 10.1038/sj.onc.1211029; Ishida S, 2003, J EXP MED, V198, P483, DOI 10.1084/jem.20022027; Ishikawa K, 2016, EXP EYE RES, V142, P19, DOI 10.1016/j.exer.2015.03.009; Iwanishi H, 2016, LAB INVEST, V96, P641, DOI 10.1038/labinvest.2016.30; Jiang SJ, 2013, MICROCIRCULATION, V20, P190, DOI 10.1111/micc.12024; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kanda A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16499-8; Kanda A, 2017, MOL THER-NUCL ACIDS, V7, P116, DOI 10.1016/j.omtn.2017.01.001; Kanda A, 2015, SCI REP-UK, V5, DOI 10.1038/srep17946; Kathiriya JJ, 2017, CELL DEATH DISCOV, V3, DOI 10.1038/cddiscovery.2017.10; Kim I, 2001, J BIOL CHEM, V276, P7614, DOI 10.1074/jbc.M009705200; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lim MJ, 2014, EXP CELL RES, V326, P125, DOI 10.1016/j.yexcr.2014.06.001; Lin MK, 2012, INVEST OPHTH VIS SCI, V53, P6197, DOI 10.1167/iovs.11-8936; Lux A, 2007, BRIT J OPHTHALMOL, V91, P1318, DOI 10.1136/bjo.2006.113902; Marumo T, 1999, DIABETES, V48, P1131, DOI 10.2337/diabetes.48.5.1131; Miller JW, 2013, OPHTHALMOLOGY, V120, P106, DOI 10.1016/j.ophtha.2012.07.038; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; O'Connor JW, 2014, CLIN TRANSL MED, V3, DOI 10.1186/2001-1326-3-23; Otsuji T, 2013, CLIN OPHTHALMOL, V7, P1487, DOI 10.2147/OPTH.S46317; Piek E, 2001, J BIOL CHEM, V276, P19945, DOI 10.1074/jbc.M102382200; Radisavljevic Z, 2000, J BIOL CHEM, V275, P20770, DOI 10.1074/jbc.M002448200; Ridano ME, 2017, ONCOTARGET, V8, P32505, DOI 10.18632/oncotarget.17129; Sakurai E, 2003, INVEST OPHTH VIS SCI, V44, P2743, DOI 10.1167/iovs.02-1246; Sakurai E, 2003, INVEST OPHTH VIS SCI, V44, P3578, DOI 10.1167/iovs.03-0097; Swaroop A, 2009, ANNU REV GENOM HUM G, V10, P19, DOI 10.1146/annurev.genom.9.081307.164350; Tang D, 2018, ONCOL REP, V39, P1347, DOI 10.3892/or.2018.6202; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thijssen VL, 2010, CANCER RES, V70, P6216, DOI 10.1158/0008-5472.CAN-09-4150; Thijssen VLJL, 2006, P NATL ACAD SCI USA, V103, P15975, DOI 10.1073/pnas.0603883103; Tsutsumi C, 2003, J LEUKOCYTE BIOL, V74, P25, DOI 10.1189/jlb.0902436; Uehara F, 2001, INVEST OPHTH VIS SCI, V42, P2164; Willoughby AS, 2015, OPHTHALMOLOGY, V122, P1846, DOI 10.1016/j.ophtha.2015.05.042; Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1; Xu FY, 2016, J HISTOCHEM CYTOCHEM, V64, P157, DOI 10.1369/0022155415627681; Yang N, 2017, J OPHTHALMOL, V2017, DOI 10.1155/2017/5053035; Yang N, 2017, EXP EYE RES, V159, P1, DOI 10.1016/j.exer.2017.02.015; Zhao XY, 2010, CARCINOGENESIS, V31, P1367, DOI 10.1093/carcin/bgq116; Zheng LY, 2016, AM J TRANSL RES, V8, P1641; Zhong X, 2012, BIOCHEM BIOPH RES CO, V425, P401, DOI 10.1016/j.bbrc.2012.07.110; Zudaire E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027385	54	34	35	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2498	2513		10.1096/fj.201801227R	http://dx.doi.org/10.1096/fj.201801227R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30277820				2022-12-26	WOS:000457296600077
J	Bart, AG; Scott, EE				Bart, Aaron G.; Scott, Emily E.			Structures of human cytochrome P450 1A1 with bergamottin and erlotinib reveal active-site modifications for binding of diverse ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytochrome P450; X-ray crystallography; enzyme structure; structure-function; protein structure; cancer; membrane protein; bergamottin; CYP1A1; detoxification; erlotinib; progdrug activation	POLYCYCLIC AROMATIC-HYDROCARBONS; RECEPTOR TYROSINE KINASE; INHIBITOR ERLOTINIB; LUNG-CANCER; P450 1A1; METABOLISM; CYP1A1; ACTIVATION; EXPRESSION; DRUG	Human cytochrome P450 1A1 (CYP1A1) is an extrahepatic enzyme involved in the monooxygenation of structurally diverse compounds ranging from natural products to drugs and protoxins. Because CYP1A1 has a role in human carcinogenesis, inhibiting its activity may potentially aid in cancer chemoprevention, whereas utilizing CYP1A1's oxidative activity could help selectively activate anticancer prodrugs. Such potential therapeutic purposes require detailed knowledge of CYP1A1's interactions with potential ligands. Known CYP1A1 ligands also vary substantially in size, and it has not been apparent from a single existing CYP1A1 structure how larger, structurally diverse ligands are accommodated within the enclosed active site. Here, two new X-ray structures with the natural product furanocoumarin bergamottin (at 2.85 angstrom resolution) and the lung cancer drug erlotinib (3.0 angstrom) revealed binding orientations consistent with the formation of innocuous metabolites and of toxic metabolites, respectively. They also disclosed local changes in the roof of the active site that enlarge the active site and ultimately form a channel to the protein exterior. Although further structural modifications would be required to accommodate the largest CYP1A1 ligands, knowing which components of the active site are malleable provides powerful information for those attempting to use computational approaches to predict compound binding and substrate metabolism by this clinically relevant monooxygenase.	[Bart, Aaron G.; Scott, Emily E.] Univ Michigan, Program Biophys, Ann Arbor, MI 48109 USA; [Scott, Emily E.] Univ Michigan, Dept Med Chem, 428 Church St, Ann Arbor, MI 48109 USA; [Scott, Emily E.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Scott, EE (corresponding author), Univ Michigan, Dept Med Chem, 428 Church St, Ann Arbor, MI 48109 USA.	scottee@umich.edu			National Institutes of Health [R37 GM076343, T32 GM008545]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393, R37GM076343, T32GM008545] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R37 GM076343 (to E. E. S.) and T32 GM008545. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Androutsopoulos VP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082487; Androutsopoulos VP, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-187; Bart AG, 2017, J BIOL CHEM, V292, P20818, DOI 10.1074/jbc.RA117.000220; Bruno RD, 2007, BIOORGAN MED CHEM, V15, P5047, DOI 10.1016/j.bmc.2007.05.046; Cai YN, 1996, CHEM RES TOXICOL, V9, P729, DOI 10.1021/tx950208b; Cappuzzo F, 2010, LANCET ONCOL, V11, P521, DOI 10.1016/S1470-2045(10)70112-1; Chun YJ, 2001, DRUG METAB DISPOS, V29, P389; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; DeVore NM, 2009, DRUG METAB DISPOS, V37, P1319, DOI 10.1124/dmd.109.026765; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fortin S, 2017, J MED CHEM, V60, P4963, DOI 10.1021/acs.jmedchem.7b00343; Hamilton M, 2006, CLIN CANCER RES, V12, P2166, DOI 10.1158/1078-0432.CCR-05-2235; He K, 1998, CHEM RES TOXICOL, V11, P252, DOI 10.1021/tx970192k; Hughes AN, 2009, J CLIN ONCOL, V27, P1220, DOI 10.1200/JCO.2008.19.3995; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kent UM, 2006, J PHARMACOL EXP THER, V318, P992, DOI 10.1124/jpet.105.099887; Kim JH, 2004, TOXICOL APPL PHARM, V199, P210, DOI 10.1016/j.taap.2003.11.015; Kiyohara Y, 2013, J AM ACAD DERMATOL, V69, P463, DOI 10.1016/j.jaad.2013.02.025; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Li J, 2007, CLIN CANCER RES, V13, P3731, DOI 10.1158/1078-0432.CCR-07-0088; Li XH, 2010, DRUG METAB DISPOS, V38, P1238, DOI 10.1124/dmd.109.030361; Lin D, 2017, J PHARMACOL EXP THER, V363, P12, DOI 10.1124/jpet.117.243246; Ling J, 2006, DRUG METAB DISPOS, V34, P420, DOI 10.1124/dmd.105.007765; Liu JW, 2013, MOLECULES, V18, P14470, DOI 10.3390/molecules181214470; Liu V, 2007, CHEST, V132, P1042, DOI 10.1378/chest.07-0050; Lu JF, 2006, CLIN PHARMACOL THER, V80, P136, DOI 10.1016/j.clpt.2006.04.007; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCLEMORE TL, 1990, J NATL CANCER I, V82, P1333, DOI 10.1093/jnci/82.16.1333; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Olguin-Reyes S, 2012, FOOD CHEM TOXICOL, V50, P3094, DOI 10.1016/j.fct.2012.05.058; OMURA T, 1964, J BIOL CHEM, V239, P2370; OPRIAN DD, 1982, J BIOL CHEM, V257, P8935; Rendic S, 2012, CHEM RES TOXICOL, V25, P1316, DOI 10.1021/tx300132k; Rochat B, 2008, BIOPHARM DRUG DISPOS, V29, P103, DOI 10.1002/bdd.598; Sansen S, 2007, J BIOL CHEM, V282, P14348, DOI 10.1074/jbc.M611692200; Schwarz D, 2004, BIOCHEM PHARMACOL, V67, P1445, DOI 10.1016/j.bcp.2003.12.023; Shimada T, 2004, CANCER SCI, V95, P1, DOI 10.1111/j.1349-7006.2004.tb03162.x; Stone EL, 2015, BIOORGAN MED CHEM, V23, P6891, DOI 10.1016/j.bmc.2015.09.052; Studier FW, 2014, METHODS MOL BIOL, V1091, P17, DOI 10.1007/978-1-62703-691-7_2; Sutherland M, 2013, MOL CANCER THER, V12, P27, DOI 10.1158/1535-7163.MCT-12-0405; Wacker B, 2007, CLIN CANCER RES, V13, P3913, DOI 10.1158/1078-0432.CCR-06-2610; Walsh AA, 2013, J BIOL CHEM, V288, P12932, DOI 10.1074/jbc.M113.452953; Wang A, 2011, J BIOL CHEM, V286, P5736, DOI 10.1074/jbc.M110.204420; Yakkundi A, 2006, CANCER GENE THER, V13, P598, DOI 10.1038/sj.cgt.7700933; Zhao HM, 2018, DRUG METAB DISPOS, V46, P442, DOI 10.1124/dmd.117.079327	47	27	27	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2018	293	50					19201	19210		10.1074/jbc.RA118.005588	http://dx.doi.org/10.1074/jbc.RA118.005588			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HE6RA	30254074	Green Published, hybrid			2022-12-26	WOS:000453537300004
J	Milano, SK; Wang, CY; Erickson, JW; Cerione, RA; Ramachandran, S				Milano, Shawn K.; Wang, Chenyue; Erickson, Jon W.; Cerione, Richard A.; Ramachandran, Sekar			Gain-of-function screen of alpha-transducin identifies an essential phenylalanine residue necessary for full effector activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adenylate cyclase (adenylyl cyclase); G protein; G protein-coupled receptor (GPCR); GTPase; rhodopsin; photoreceptor; phosphodiesterases; Gs; phototransduction; transducin; signal transduction	HETEROTRIMERIC G-PROTEIN; CRYSTAL-STRUCTURE; ADENYLYL-CYCLASE; CGMP PHOSPHODIESTERASE; GAMMA-SUBUNIT; STRUCTURAL DETERMINANTS; GUANINE-NUCLEOTIDES; BINDING-SITES; 2.0 ANGSTROM; GS-ALPHA	Two regions on the subunits of heterotrimeric GTP-binding proteins (G-proteins), the Switch II/2 helix (which changes conformation upon GDP-GTP exchange) and the 3 helix, have been shown to contain the binding sites for their effector proteins. However, how the binding of G subunits to their effector proteins is translated into the stimulation of effector activity is still poorly understood. Here, we took advantage of a reconstituted rhodopsin-coupled phototransduction system to address this question and identified a distinct surface and an essential residue on the subunit of the G-protein transducin ((T)) that is necessary to fully activate its effector enzyme, the cGMP phosphodiesterase (PDE). We started with a chimeric G-protein subunit ((T)*) comprising residues mainly from (T) and a short stretch of residues from the G(i1) subunit ((i1)), which only weakly stimulates PDE activity. We then reinstated the (T) residues by systematically replacing the corresponding (i1) residues within (T)* with the aim of fully restoring PDE stimulatory activity. These experiments revealed that the G/4 loop and a phenylalanine residue at position 283 are essential for conferring the (T)* subunit with full PDE stimulatory capability. We further demonstrated that this same region and amino acid within the subunit of the G(s) protein ((s)) are necessary for full adenylyl cyclase activation. These findings highlight the importance of the G/4 loop and of an essential phenylalanine residue within this region on G subunits (T) and (s) as being pivotal for their selective and optimal stimulation of effector activity.	[Milano, Shawn K.; Wang, Chenyue; Erickson, Jon W.; Cerione, Richard A.; Ramachandran, Sekar] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Cerione, Richard A.] Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA; [Wang, Chenyue] US Naval Res Lab, 4555 Overlook Ave SW, Washington, DC 20375 USA	Cornell University; Cornell University; United States Department of Defense; United States Navy; Naval Research Laboratory	Cerione, RA (corresponding author), Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA.; Cerione, RA (corresponding author), Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA.	rac1@cornell.edu	Ramachandran, Sekar/AAP-2287-2020; Cote, Rick H/G-3363-2013	Ramachandran, Sekar/0000-0002-2243-1368; Cote, Rick H/0000-0002-1573-6526	National Institutes of Health [GM122575]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM122575] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM122575. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Berger AL, 1997, J BIOL CHEM, V272, P2714, DOI 10.1074/jbc.272.5.2714; Berger AL, 1999, BIOCHEMISTRY-US, V38, P1293, DOI 10.1021/bi981683m; BERLOT CH, 1992, CELL, V68, P911, DOI 10.1016/0092-8674(92)90034-A; Coleman DE, 1998, BIOCHEMISTRY-US, V37, P14376, DOI 10.1021/bi9810306; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; FAHMY K, 1993, BIOCHEMISTRY-US, V32, P7229, DOI 10.1021/bi00079a020; FAWZI AB, 1990, BIOCHEMISTRY-US, V29, P3804, DOI 10.1021/bi00467a030; Gu C, 2002, EUR J BIOCHEM, V269, P413, DOI 10.1046/j.0014-2956.2001.02708.x; Harry A, 1997, J BIOL CHEM, V272, P19017, DOI 10.1074/jbc.272.30.19017; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P762; ITOH H, 1991, J BIOL CHEM, V266, P16226; LAMBRIGHT DG, 1994, NATURE, V369, P621, DOI 10.1038/369621a0; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Li QB, 1997, J BIOL CHEM, V272, P21673, DOI 10.1074/jbc.272.35.21673; LIEBMAN PA, 1982, METHOD ENZYMOL, V81, P532; Liu Y, 1996, J BIOL CHEM, V271, P26900, DOI 10.1074/jbc.271.43.26900; Majumdar S, 2006, J BIOL CHEM, V281, P9219, DOI 10.1074/jbc.M513837200; Majumdar S, 2004, J BIOL CHEM, V279, P40137, DOI 10.1074/jbc.M405420200; Min KC, 2000, PROTEIN EXPRES PURIF, V20, P514, DOI 10.1006/prep.2000.1326; Natochin M, 1998, J BIOL CHEM, V273, P21808, DOI 10.1074/jbc.273.34.21808; Natochin M, 1999, J BIOL CHEM, V274, P7865, DOI 10.1074/jbc.274.12.7865; Natochin M, 2000, J BIOL CHEM, V275, P2669, DOI 10.1074/jbc.275.4.2669; Nishimura A, 2010, P NATL ACAD SCI USA, V107, P13666, DOI 10.1073/pnas.1003553107; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; Palczewski K, 2012, J BIOL CHEM, V287, P1612, DOI 10.1074/jbc.R111.301150; Phillips W. J., 1991, BIOPHYSICAL BIOCH AS, P135, DOI 10.1007/978-1-4757-9513-4; Qureshi BM, 2018, OPEN BIOL, V8, DOI 10.1098/rsob.180075; Ramachandran S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.166538; RARICK HM, 1992, SCIENCE, V256, P1031, DOI 10.1126/science.1317058; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Sadana R, 2009, NEUROSIGNALS, V17, P5, DOI 10.1159/000166277; Singh G, 2012, BIOCHEMISTRY-US, V51, P3232, DOI 10.1021/bi3001984; Skiba NP, 1996, J BIOL CHEM, V271, P413, DOI 10.1074/jbc.271.1.413; Slep KC, 2001, NATURE, V409, P1071, DOI 10.1038/35059138; SPICKOFSKY N, 1994, NAT STRUCT BIOL, V1, P771, DOI 10.1038/nsb1194-771; Sunahara RK, 1997, SCIENCE, V278, P1943, DOI 10.1126/science.278.5345.1943; TANG WJ, 1995, BIOCHEMISTRY-US, V34, P14563, DOI 10.1021/bi00044a035; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1	40	3	3	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2018	293	46					17941	17952		10.1074/jbc.RA118.003746	http://dx.doi.org/10.1074/jbc.RA118.003746			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HA6SG	30266806	Green Published, hybrid			2022-12-26	WOS:000450409500023
J	Jakel, F; Worm, O; Lange, S; Mertelsmann, R				Jaekel, Frank; Worm, Oliver; Lange, Sascha; Mertelsmann, Roland			A stochastic model of myeloid cell lineages in hematopoiesis and pathway mutations in acute myeloid leukemia	PLOS ONE			English	Article							SELF-RENEWAL; STEM-CELLS; CANCER; CLASSIFICATION; DISEASE	A model for hematopoiesis is presented that explicitly includes the erythrocyte, granulocyte, and thrombocyte lineages and their common precursors. A small number of stem cells proliferate and differentiate through different compartments to produce the vast number of blood cells needed every day. Growth factors regulate the proliferation of cells dependent on the current demand. We provide a steady state analysis of the model and rough parameter estimates. Furthermore, we extend the model to include mutations that alter the replicative capacity of cells and introduce differentiation blocks. With these mutations the model develops signs of acute myeloid leukemia.	[Jaekel, Frank; Worm, Oliver; Lange, Sascha] Psiori GmbH, Freiburg, Germany; [Mertelsmann, Roland] Univ Klinikum Freiburg, Innere Med 1, Freiburg, Germany	University of Freiburg	Jakel, F (corresponding author), Psiori GmbH, Freiburg, Germany.	frank@psiori.com			Addison Fischer Institute for Research and Ethical Use of Artificial Intelligence	Addison Fischer Institute for Research and Ethical Use of Artificial Intelligence	Funding was partly provided by the private Addison Fischer Institute for Research and Ethical Use of Artificial Intelligence through a grant to PSIORI GmbH, Freiburg. FJ and OW were employees of PSIORI at the time the research was conducted. SL is the CEO of PSIORI. There was no additional external funding received for this study. The funders had no additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.; This research was partly funded by the Addison Fischer Institute for Research and Ethical Use of Artificial Intelligence. The authors would like to thank Theresa Go E bel for combing through clinical records.	Catlin SN, 2011, BLOOD, V117, P4460, DOI 10.1182/blood-2010-08-303537; Dingli D, 2009, CELL PROLIFERAT, V42, P330, DOI 10.1111/j.1365-2184.2009.00598.x; Dingli D, 2007, PLOS COMPUT BIOL, V3, P482, DOI 10.1371/journal.pcbi.0030053; Dingli D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000345; Dingli D, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000002; Dohner H, 2015, NEW ENGL J MED, V373, P1136, DOI 10.1056/NEJMra1406184; Foley C, 2009, J MATH BIOL, V58, P285, DOI 10.1007/s00285-008-0165-3; Garcia HG, 2007, 1 EXPOSURE STAT MECH; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Groten J, 2016, JOSHA, V3, P1; Hamey FK, 2017, NAT CELL BIOL, V19, P261, DOI 10.1038/ncb3494; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HARKER LA, 1969, J CLIN INVEST, V48, P963, DOI 10.1172/JCI106077; HJORT NL, 1990, ANN STAT, V18, P1259, DOI 10.1214/aos/1176347749; Krinner A, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-117; Luzzatto L, 2015, NEW ENGL J MED, V373, P84, DOI 10.1056/NEJMsb1502456; Papaemmanuil E, 2016, NEW ENGL J MED, V374, P2209, DOI 10.1056/NEJMoa1516192; Peixoto D, 2011, MATH COMPUT MODEL, V53, P1546, DOI 10.1016/j.mcm.2010.04.013; Pillay J, 2010, BLOOD, V116, P625, DOI 10.1182/blood-2010-01-259028; Pujo-Menjouet L, 2015, MATH MODEL NAT PHENO, V10, P182; Rapin N, 2014, BLOOD, V123, P894, DOI 10.1182/blood-2013-02-485771; Rufer N, 1999, J EXP MED, V190, P157, DOI 10.1084/jem.190.2.157; Seita J, 2010, WIRES SYST BIOL MED, V2, P640, DOI 10.1002/wsbm.86; Sidorov I, 2009, EXP HEMATOL, V37, P514, DOI 10.1016/j.exphem.2008.11.009; Stiehl T, 2012, MATH MODEL NAT PHENO, V7, P166, DOI 10.1051/mmnp/20127199; Stiehl T, 2015, CELL DIVISION PATTER; Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825; Traulsen A, 2010, CANCER LETT, V294, P43, DOI 10.1016/j.canlet.2010.01.020; VAZIRI H, 1994, P NATL ACAD SCI USA, V91, P9857, DOI 10.1073/pnas.91.21.9857; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Werner B, 2015, ELIFE, V4, DOI 10.7554/eLife.08687; Werner B, 2014, CANCER RES, V74, P5386, DOI 10.1158/0008-5472.CAN-14-1210; Werner B, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002290	34	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204393	10.1371/journal.pone.0204393	http://dx.doi.org/10.1371/journal.pone.0204393			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273383	gold, Green Submitted, Green Published			2022-12-26	WOS:000446124700020
J	Osei, M; Ansah, F; Matrevi, SA; Asante, KP; Awandare, GA; Quashie, NB; Duah, NO				Osei, Musah; Ansah, Felix; Matrevi, Sena A.; Asante, Kwaku P.; Awandare, Gordon A.; Quashie, Neils B.; Duah, Nancy O.			Amplification of GTP-cyclohydrolase 1 gene in Plasmodium falciparum isolates with the quadruple mutant of dihydrofolate reductase and dihydropteroate synthase genes in Ghana	PLOS ONE			English	Article							HUMAN MALARIA PARASITE; SULFADOXINE-PYRIMETHAMINE; ANTIFOLATE RESISTANCE; STEPWISE ACQUISITION; MOLECULAR MARKERS; MUTATIONS; SURVEILLANCE; SYNTHETASE; SUSCEPTIBILITY; CYCLOGUANIL	Sulfadoxine-pyrimethamine (SP) is used as malaria chemoprophylaxis for pregnant women and children in Ghana. Plasmodium falciparum resistance to SP is linked to mutations in the dihydropteroate synthase gene (pfdhps), dihydrofolate reductase gene (pfdhfr) and amplification of GTP cyclohydrolase 1 (pfgch1) gene. The pfgch1 duplication is associated with pfdhfr L164, a crucial mutant for high level pyrimethamine resistance which is rare in Ghana. The presence of amplified pfgch1 in Ghanaian isolates could be an indicator of the evolution of the L164 mutant. This study therefore determined the pfgch1 copy number variations and SP resistance mutations in clinical isolates from Ghana. One hundred and ninety-two (192) blood samples collected from children aged <= 14 years with uncomplicated malaria in 2013-14 and 2015-16 were used. Quantitative real-time polymerase chain reaction (qRT-PCR) was used to detect the pfgch1 copy number and nested PCR-Sanger sequencing used to detect mutations in pfdhps and pfdhfr genes. Twelve parasites (6.3%) harbored double copies of the pfgch1 gene out of the 192 samples. Of the 12, 75% had the pfdhfr I51-R59-N108, 92% had the pfdhps G437 mutant, 8% had the pfdhps E540 and 67% had the SP resistance haplotype IRNG. No L164 was detected in samples with amplified pfgch1. The rare T108 mutant associated with cycloguanil resistance showed predominance (60%) over N108 in the 2015-16 isolates. The observation of parasites with increased copy number of pfgch1 gene is indicative of the future evolution of the rare quadruple pfdhfr mutant, I51-R59-N108-L164, in Ghanaian parasites. Mutant pfdhps isolates also had increased gch1 copy number suggestive that it may also facilitate sulphadoxine resistance. The selection of parasites with pfgch1 gene amplification will enhance the sustenance and persistence of parasites with SP resistance in the country. Policy makers need to begin the search for a replacement chemoprophylaxis drug for malaria vulnerable groups in Ghana.	[Osei, Musah; Ansah, Felix; Matrevi, Sena A.; Awandare, Gordon A.] Univ Ghana, West African Ctr Cell Biol Infect Pathogens WACCB, Dept Biochem Cell & Mol Biol, Sch Biol Sci,Coll Basic & Appl Sci, Legon, Accra, Ghana; [Osei, Musah; Asante, Kwaku P.] Kintampo Hlth Res Ctr, Kintampo, Ghana; [Matrevi, Sena A.; Quashie, Neils B.; Duah, Nancy O.] Univ Ghana, Dept Epidemiol, Noguchi Mem Inst Med Res, Coll Hlth Sci, Legon, Accra, Ghana; [Quashie, Neils B.] Univ Ghana, Ctr Trop Clin Pharmacol & Therapeut, Sch Med & Dent, Coll Hlth Sci, Legon, Accra, Ghana	University of Ghana; Kintampo Health Research Centre; University of Ghana; University of Ghana	Duah, NO (corresponding author), Univ Ghana, Dept Epidemiol, Noguchi Mem Inst Med Res, Coll Hlth Sci, Legon, Accra, Ghana.	nduah@noguchi.ug.edu.gh		Ansah, Felix/0000-0002-6928-2363; Awandare, Gordon/0000-0002-8793-3641; Duah-Quashie, Nancy/0000-0001-8819-1793; QUASHIE, NEILS/0000-0002-2538-0324	World Bank African Centres of Excellence [ACE02-WACCBIP]; Global Fund for Tuberculosis, AIDS and Malaria/National Malaria Control Programme, Ghana	World Bank African Centres of Excellence; Global Fund for Tuberculosis, AIDS and Malaria/National Malaria Control Programme, Ghana	This work was supported by funds from Musah Osei Master's fellowship from a World Bank African Centres of Excellence Grant (ACE02-WACCBIP: Awandare). Field work for 2015-6 samples was supported by the Global Fund for Tuberculosis, AIDS and Malaria/National Malaria Control Programme, Ghana. The views expressed in this publication are those of the author(s) and not necessarily those of the funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abugri J, 2018, AAS OPEN RES, V1, P1, DOI DOI 10.12688/aasopenres.12825.1; Alam MT, 2011, J INFECT DIS, V203, P220, DOI 10.1093/infdis/jiq038; Andriantsoanirina V, 2010, ANTIMICROB AGENTS CH, V54, P2323, DOI 10.1128/AAC.01511-09; BROOKS DR, 1994, EUR J BIOCHEM, V224, P397, DOI 10.1111/j.1432-1033.1994.00397.x; Brown KM, 2010, MOL BIOL EVOL, V27, P2682, DOI 10.1093/molbev/msq160; Chookajorn T, 2011, VIRULENCE, V2, P244, DOI 10.4161/viru.2.3.16194; Cisse M, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1695-1; COWMAN AF, 1988, P NATL ACAD SCI USA, V85, P9109, DOI 10.1073/pnas.85.23.9109; Duah NO, 2012, AM J TROP MED HYG, V87, P996, DOI 10.4269/ajtmh.2012.12-0202; Duraisingh MT, 1998, EXP PARASITOL, V89, P1, DOI 10.1006/expr.1998.4274; FOOTE SJ, 1990, P NATL ACAD SCI USA, V87, P3014, DOI 10.1073/pnas.87.8.3014; Freeman Alexander, 2017, J Pharm Policy Pract, V10, P15, DOI 10.1186/s40545-017-0103-0; Gregson A, 2005, PHARMACOL REV, V57, P117, DOI 10.1124/pr.57.1.4; Hamour S, 2005, T ROY SOC TROP MED H, V99, P548, DOI 10.1016/j.trstmh.2004.10.003; Heinberg A, 2015, ANN NY ACAD SCI, V1342, P10, DOI 10.1111/nyas.12662; Heinberg A, 2013, MOL MICROBIOL, V88, P702, DOI 10.1111/mmi.12162; Hossain T, 2004, P NATL ACAD SCI USA, V101, P5158, DOI 10.1073/pnas.0401342101; Kateera F, 2016, ACTA TROP, V164, P329, DOI 10.1016/j.actatropica.2016.09.008; Kiara SM, 2009, ANTIMICROB AGENTS CH, V53, P3793, DOI 10.1128/AAC.00308-09; Kidgell C, 2006, PLOS PATHOG, V2, P562, DOI 10.1371/journal.ppat.0020057; Kublin JG, 2002, J INFECT DIS, V185, P380, DOI 10.1086/338566; Kumpornsin K, 2014, MOL BIOL EVOL, V31, P1649, DOI 10.1093/molbev/msu140; Kumpornsin K, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-150; Lozovsky ER, 2009, P NATL ACAD SCI USA, V106, P12025, DOI 10.1073/pnas.0905922106; Mbogo GW, 2014, AM J TROP MED HYG, V91, P54, DOI 10.4269/ajtmh.13-0647; Mockenhaupt FP, 2005, TROP MED INT HEALTH, V10, P901, DOI 10.1111/j.1365-3156.2005.01471.x; Muller IB, 2010, FUTURE MICROBIOL, V5, P1857, DOI 10.2217/FMB.10.136; Naidoo I, 2013, TRENDS PARASITOL, V29, P505, DOI 10.1016/j.pt.2013.08.002; Nair S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000243; PETERSON DS, 1990, P NATL ACAD SCI USA, V87, P3018, DOI 10.1073/pnas.87.8.3018; PLOWE CV, 1995, AM J TROP MED HYG, V52, P565, DOI 10.4269/ajtmh.1995.52.565; Ravenhall M, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1634-6; Tahita MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137440; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; TRIGLIA T, 1994, P NATL ACAD SCI USA, V91, P7149, DOI 10.1073/pnas.91.15.7149; Wang P, 1997, MOL MICROBIOL, V23, P979, DOI 10.1046/j.1365-2958.1997.2821646.x; Yuvaniyama J, 2003, NAT STRUCT BIOL, V10, P357, DOI 10.1038/nsb921	37	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204871	10.1371/journal.pone.0204871	http://dx.doi.org/10.1371/journal.pone.0204871			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265714	gold, Green Published, Green Submitted			2022-12-26	WOS:000446005500052
J	Montgomery, SA; Young, EF; Durham, PG; Zulauf, KE; Rank, L; Miller, BK; Hayden, JD; Lin, FC; Welch, JT; Hickey, AJ; Braunstein, M				Montgomery, Stephanie A.; Young, Ellen F.; Durham, Phillip G.; Zulauf, Katelyn E.; Rank, Laura; Miller, Brittany K.; Hayden, Jennifer D.; Lin, Feng-Chang; Welch, John T.; Hickey, Anthony J.; Braunstein, Miriam			Efficacy of pyrazinoic acid dry powder aerosols in resolving necrotic and non necrotic granulomas in a guinea pig model of tuberculosis	PLOS ONE			English	Article							RESISTANT MYCOBACTERIUM-TUBERCULOSIS; EXPERIMENTAL AIRBORNE TUBERCULOSIS; PYRAZINAMIDE RESISTANCE; IN-VITRO; ANTIMYCOBACTERIAL ACTIVITY; STERILIZING ACTIVITY; ANTITUBERCULOSIS AGENTS; DRUG DISCOVERY; MURINE MODEL; ESTERS	New therapeutic strategies are needed to treat drug resistant tuberculosis (TB) and to improve treatment for drug sensitive TB. Pyrazinamide (PZA) is a critical component of current first-line TB therapy. However, the rise in PZA-resistant TB cases jeopardizes the future utility of PZA. To address this problem, we used the guinea pig model of TB and tested the efficacy of an inhaled dry powder combination, referred to as Pyrazinoic acid/ester Dry Powder (PDP), which is comprised of pyrazinoic acid (POA), the active moiety of PZA, and pyrazinoic acid ester (PAE), which is a PZA analog. Both POA and PAE have the advantage of being able to act on PZA-resistant Mycobacterium tuberculosis. When used in combination with oral rifampicin (R), inhaled PDP had striking effects on tissue pathology. Effects were observed in lungs, the site of delivery, but also in the spleen and liver indicating both local and systemic effects of inhaled PDP. Tissue granulomas that harbor M. tuberculosis in a persistent state are a hallmark of TB and they pose a challenge for therapy. Compared to other treatments, which preferentially cleared non-necrotic granulomas, R+PDP reduced necrotic granulomas more effectively. The increased ability of R+PDP to act on more recalcitrant necrotic granulomas suggests a novel mechanism of action. The results presented in this report reveal the potential for developing therapies involving POA that are optimized to target necrotic as well as non-necrotic granulomas as a means of achieving more complete sterilization of M. tuberculosis bacilli and preventing disease relapse when therapy ends.	[Montgomery, Stephanie A.] Univ N Carolina, Sch Med, Dept Pathol & Lab Med, Chapel Hill, NC USA; [Montgomery, Stephanie A.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Sch Med, Chapel Hill, NC 27599 USA; [Young, Ellen F.; Zulauf, Katelyn E.; Rank, Laura; Miller, Brittany K.; Hayden, Jennifer D.; Braunstein, Miriam] Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Durham, Phillip G.; Hickey, Anthony J.] RTI Int, Res Triangle Pk, NC USA; [Lin, Feng-Chang] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Lin, Feng-Chang] Univ N Carolina, North Carolina Translat & Clin Sci Inst, Chapel Hill, NC USA; [Welch, John T.] SUNY Albany, Dept Chem, Albany, NY 12222 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Research Triangle Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Braunstein, M (corresponding author), Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.	miriam_braunstein@med.unc.edu	Lin, Feng-Chang/ABE-9659-2020; Durham, Phillip/GNH-6202-2022; , Pathology Services Core/CEZ-2246-2022; Durham, Phillip/AAB-7932-2020	Durham, Phillip/0000-0001-8102-4407	National Center for Advancing Translational Sciences, National Institutes of Health [1UL1TR001111, NC TraCS 4DR31502]; National Science Foundation [CHE-1337594]; NCI Center Core Support Grant [5P30CA016086-41]; National Center for Advancing Translational Sciences [UL1TR002489]	National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Science Foundation(National Science Foundation (NSF)); NCI Center Core Support Grant; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant Award 1UL1TR001111 and NC TraCS 4DR31502 awards to MB and AJH and through National Science Foundation grant award CHE-1337594 to JTW. Histopathology was performed by the Animal Histopathology & Laboratory Medicine Core at the University of North Carolina, UNC Lineberger Comprehensive Cancer Center, which is supported in part by an NCI Center Core Support Grant (5P30CA016086-41). National Center for Advancing Translational Sciences (UL1TR002489) to FCL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Z, 2011, ANTIMICROB AGENTS CH, V55, P1527, DOI 10.1128/AAC.01524-10; Chang KC, 2011, ANTIMICROB AGENTS CH, V55, P4499, DOI 10.1128/AAC.00630-11; CYNAMON MH, 1995, J MED CHEM, V38, P3902, DOI 10.1021/jm00020a003; CYNAMON MH, 1992, J MED CHEM, V35, P1212, DOI 10.1021/jm00085a007; Dartois V, 2014, NAT REV MICROBIOL, V12, P159, DOI 10.1038/nrmicro3200; Davenne T, 2016, EXPERT REV VACCINES, V15, P1009, DOI 10.1586/14760584.2016.1170599; Dharmadhikari AS, 2013, ANTIMICROB AGENTS CH, V57, P2613, DOI 10.1128/AAC.02346-12; Dhillon J, 1996, ANTIMICROB AGENTS CH, V40, P552, DOI 10.1128/AAC.40.3.552; Durham PG, 2016, INT J PHARM; Dutta NK, 2014, MICROBIOL MOL BIOL R, V78, P343, DOI 10.1128/MMBR.00010-14; Dutta NK, 2013, ANTIMICROB AGENTS CH, V57, P3910, DOI 10.1128/AAC.00761-13; Garcia-Contreras L, 2007, ANTIMICROB AGENTS CH, V51, P2830, DOI 10.1128/AAC.01164-06; Garcia-Contreras L, 2010, ANTIMICROB AGENTS CH, V54, P1436, DOI 10.1128/AAC.01471-09; Geller DE, 2011, J AEROSOL MED PULM D, V24, P175, DOI 10.1089/jamp.2010.0855; Gopal P, 2014, CURR OPIN MICROBIOL, V21, P7, DOI 10.1016/j.mib.2014.06.015; Grover A, 2009, INFECT IMMUN, V77, P4837, DOI 10.1128/IAI.00704-09; Guirado E, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00098; Gupta A, 2016, PHARM RES-DORDR, V33, P1899, DOI 10.1007/s11095-016-1926-0; HEIFETS L, 1992, AM REV RESPIR DIS, V145, P1223, DOI 10.1164/ajrccm/145.5.1223; HEIFETS LB, 1989, ANTIMICROB AGENTS CH, V33, P1252, DOI 10.1128/AAC.33.8.1252; Hickey AJ, 2016, J CONTROL RELEASE, V240, P127, DOI 10.1016/j.jconrel.2015.11.018; Hickey A.J., 2016, DELIVERY SYSTEMS TUB; Hickey AJ, 2013, J PHARM SCI-US, V102, P3900, DOI 10.1002/jps.23705; Hu Y, 2006, INT J TUBERC LUNG D, V10, P317; Hu Y, 2017, CLIN MICROBIOL INFEC, V23, P835, DOI 10.1016/j.cmi.2017.03.028; Kim JJ, 2012, CELL HOST MICROBE, V11, P457, DOI 10.1016/j.chom.2012.03.008; Lanoix JP, 2016, ANTIMICROB AGENTS CH, V60, P4197, DOI 10.1128/AAC.03085-15; Lee RE, 2014, NAT MED, V20, P152, DOI 10.1038/nm.3458; Lenaerts AJ, 2007, ANTIMICROB AGENTS CH, V51, P3338, DOI 10.1128/AAC.00276-07; Manca C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074082; McMurray DN, 2003, TUBERCULOSIS, V83, P131, DOI 10.1016/S1472-9792(02)00079-3; Mdluli K, 2015, COLD SPRING HARB PER, V5; Mendez S, 2009, ANTIMICROB AGENTS CH, V53, P5114, DOI 10.1128/AAC.01146-09; Mikusova K, 2017, DRUG DISCOV TODAY, V22, P534, DOI 10.1016/j.drudis.2016.09.025; MILLER JB, 1950, AM J DIS CHILD, V80, P207; Miotto P, 2014, MBIO, V5, DOI 10.1128/mBio.01819-14; Mitchison DA, 2010, TUBERCULOSIS, V90, P177, DOI 10.1016/j.tube.2010.03.005; Mphahlele M, 2008, J CLIN MICROBIOL, V46, P3459, DOI 10.1128/JCM.00973-08; Muttil P, 2009, PHARM RES-DORDR, V26, P2401, DOI 10.1007/s11095-009-9957-4; Ordway DJ, 2010, ANTIMICROB AGENTS CH, V54, P1820, DOI 10.1128/AAC.01521-09; Palanisamy GS, 2008, TUBERCULOSIS, V88, P295, DOI 10.1016/j.tube.2007.12.003; Pandey R, 2003, J ANTIMICROB CHEMOTH, V52, P981, DOI 10.1093/jac/dkg477; Pierre-Audigier C, 2012, INT J TUBERC LUNG D, V16, P221, DOI 10.5588/ijtld.11.0266; Pires D, 2015, ANTIMICROB AGENTS CH, V59, P7693, DOI 10.1128/AAC.00936-15; Prideaux B, 2015, NAT MED, V21, P1223, DOI 10.1038/nm.3937; Ramirez-Busby SM, 2015, ANTIMICROB AGENTS CH, V59, P5267, DOI 10.1128/AAC.00204-15; Roy CJ, 2012, ANTIMICROB AGENTS CH, V56, P883, DOI 10.1128/AAC.05633-11; Russell DG, 2010, SCIENCE, V328, P852, DOI 10.1126/science.1184784; Scorpio A, 1997, ANTIMICROB AGENTS CH, V41, P540, DOI 10.1128/AAC.41.3.540; Segretti ND, 2016, TUBERCULOSIS, V99, P11, DOI 10.1016/j.tube.2016.04.002; Shang SB, 2011, ANTIMICROB AGENTS CH, V55, P124, DOI 10.1128/AAC.00978-10; Sharma A, 2004, J ANTIMICROB CHEMOTH, V54, P761, DOI 10.1093/jac/dkh411; SMITH DW, 1991, TUBERCLE, V72, P223, DOI 10.1016/0041-3879(91)90013-I; SMITH DW, 1966, J BACTERIOL, V91, P718, DOI 10.1128/JB.91.2.718-724.1966; SPEIRS RJ, 1995, ANTIMICROB AGENTS CH, V39, P1269, DOI 10.1128/AAC.39.6.1269; STAHL WR, 1967, J APPL PHYSIOL, V22, P453, DOI 10.1152/jappl.1967.22.3.453; Suarez S, 2001, J ANTIMICROB CHEMOTH, V48, P431, DOI 10.1093/jac/48.3.431; Suarez S, 2001, PHARMACEUT RES, V18, P1315, DOI 10.1023/A:1013094112861; Tasneen R, 2011, ANTIMICROB AGENTS CH, V55, P5485, DOI 10.1128/AAC.05293-11; Turner OC, 2003, INFECT IMMUN, V71, P864, DOI 10.1128/IAI.71.2.864-871.2003; Via LE, 2015, ACS INFECT DIS, V1, P203, DOI 10.1021/id500028m; Wade MM, 2006, J ANTIMICROB CHEMOTH, V58, P936, DOI 10.1093/jac/dkl358; Whitfield MG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133869; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; Young EF, 2016, PHARM RES-DORDR, V33, P2495, DOI 10.1007/s11095-016-1974-5; Zhang Y, 2003, INT J TUBERC LUNG D, V7, P6; Zhang Y, 2002, J MED MICROBIOL, V51, P42, DOI 10.1099/0022-1317-51-1-42; Zhang Y, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MGM2-0023-2013; Zimhony O, 2007, ANTIMICROB AGENTS CH, V51, P752, DOI 10.1128/AAC.01369-06	69	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204495	10.1371/journal.pone.0204495	http://dx.doi.org/10.1371/journal.pone.0204495			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30261007	Green Published, Green Submitted, gold			2022-12-26	WOS:000445907400060
J	Vestergaard, AL; Bang-Berthelsen, CH; Floyel, T; Stahl, JL; Christen, L; Sotudeh, FT; Horskjaer, PD; Frederiksen, KS; Kofod, FG; Bruun, C; Berchtold, LA; Storling, J; Regazzi, R; Kaur, S; Pociot, F; Mandrup-Poulsen, T				Vestergaard, Anna Lindelov; Bang-Berthelsen, Claus Heiner; Floyel, Tina; Stahl, Jonathan Lucien; Christen, Lisa; Sotudeh, Farzaneh Taheri; Horskjaer, Peter de Hemmer; Frederiksen, Klaus Stensgaard; Kofod, Frida Greek; Bruun, Christine; Berchtold, Lukas Adrian; Storling, Joachim; Regazzi, Romano; Kaur, Simranjeet; Pociot, Flemming; Mandrup-Poulsen, Thomas			MicroRNAs and histone deacetylase inhibition-mediated protection against inflammatory beta-cell damage	PLOS ONE			English	Article							KAPPA-B ACTIVATION; PROINFLAMMATORY CYTOKINES; EXPRESSION CONTRIBUTE; INTERFERON-GAMMA; NITRIC-OXIDE; IN-VIVO; TYPE-1; MIR-146A; MIRNA; DYSFUNCTION	Inflammatory beta-cell failure contributes to type 1 and type 2 diabetes pathogenesis. Pro-inflammatory cytokines cause beta-cell dysfunction and apoptosis, and lysine deacetylase inhibitors (KDACi) prevent beta-cell failure in vitro and in vivo, in part by reducing NF-kappa B transcriptional activity. We investigated the hypothesis that the protective effect of KDACi involves transcriptional regulation of microRNAs (miRs), potential new targets in diabetes treatment. Insulin-producing INS1 cells were cultured with or without the broad-spectrum KDACi Givinostat, prior to exposure to the pro-inflammatory cytokines IL-1 beta and IFN-gamma for 6 h or 24 h, and miR expression was profiled with miR array. Thirteen miRs (miR-7a-2-3p, miR-29c-3p, miR-96-5p, miR-101a-3p, miR-140-5p, miR-146a-5p, miR-146b-5p, miR-340-5p, miR-384-5p, miR-455-5p, miR-466b-2-3p, miR-652-5p, and miR-3584-5p) were regulated by both cytokines and Givinostat, and nine were examined by qRT-PCR. miR-146a-5p was strongly regulated by cytokines and KDACi and was analyzed further. miR-146a-5p expression was induced by cytokines in rat and human islets. Cytokine-induced miR-146a5p expression was specific for INS1 and beta-TC3 cells, whereas alpha-TC1 cells exhibited a higher basal expression. Transfection of INS1 cells with miR-146a-5p reduced cytokine signaling, including the activity of NF-kappa B and iNOS promoters, as well as NO production and protein levels of iNOS and its own direct targets TNF receptor associated factor 6 (TRAF6) and interleukin-1 receptor-associated kinase 1 (IRAK1). miR-146a-5p was elevated in the pancreas of diabetes-prone BB-DP rats at diabetes onset, suggesting that miR-146a-5p could play a role in type 1 diabetes development. The miR array of cytokine-exposed INS1 cells rescued by KDACi revealed several other miRs potentially involved in cytokine-induced beta-cell apoptosis, demonstrating the strength of this approach.	[Vestergaard, Anna Lindelov; Stahl, Jonathan Lucien; Christen, Lisa; Sotudeh, Farzaneh Taheri; Horskjaer, Peter de Hemmer; Mandrup-Poulsen, Thomas] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark; [Bang-Berthelsen, Claus Heiner; Floyel, Tina; Frederiksen, Klaus Stensgaard; Storling, Joachim; Pociot, Flemming] Herlev & Gentofte Hosp, Dept Pediat, Ctr Noncoding RNA Technol & Hlth, Herlev, Denmark; [Floyel, Tina; Kofod, Frida Greek; Storling, Joachim; Kaur, Simranjeet; Pociot, Flemming] Steno Diabet Ctr Copenhagen, Gentofte, Denmark; [Frederiksen, Klaus Stensgaard] Novo Nordisk, Dept GLP 1 & T2D Biol, Malov, Denmark; [Bruun, Christine; Berchtold, Lukas Adrian] Hagedorn Res Inst, Gentofte, Denmark; [Berchtold, Lukas Adrian] Univ Hosp Herlev, Dept Pediat, Copenhagen Diabet Res Ctr, Herlev, Denmark; [Regazzi, Romano] Univ Lausanne, Dept Fundamental Neurosci, Lausanne, Switzerland	University of Copenhagen; Steno Diabetes Center; Novo Nordisk; Novo Nordisk; Hagedorn Research Institute; University of Lausanne	Mandrup-Poulsen, T (corresponding author), Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark.; Pociot, F (corresponding author), Herlev & Gentofte Hosp, Dept Pediat, Ctr Noncoding RNA Technol & Hlth, Herlev, Denmark.; Pociot, F (corresponding author), Steno Diabet Ctr Copenhagen, Gentofte, Denmark.	flemming.pociot@regionh.dk; tmpo@sund.ku.dk	Kaur, Simranjeet/K-2487-2019	Kaur, Simranjeet/0000-0003-0490-1028; Christen, Lisa/0000-0003-3664-2892; Storling, Joachim/0000-0002-7529-4264; Stahl-Meyer, Jonathan/0000-0002-9476-5455; Rose, Peter Horskjaer/0000-0002-8664-8662; Pociot, Flemming/0000-0003-3274-5448; Floyel, Tina/0000-0003-4746-2627	Independent Research Fund Denmark; Novo Nordisk Foundation; Danish Diabetes Association; DesireAe and Niels Yde Foundation; A.P. Moller Foundation; Poul and Erna Sehested Hansen Foundation; Sven Hansen and wife Ina Hansen Foundation; Danish Strategic Research Council, Center for non-coding RNA in Technology and Health; commercial company Novo Nordisk A/S; Novo Nordisk A/S	Independent Research Fund Denmark; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Diabetes Association; DesireAe and Niels Yde Foundation; A.P. Moller Foundation; Poul and Erna Sehested Hansen Foundation; Sven Hansen and wife Ina Hansen Foundation; Danish Strategic Research Council, Center for non-coding RNA in Technology and Health; commercial company Novo Nordisk A/S; Novo Nordisk A/S(Novo Nordisk)	This work was supported by the Independent Research Fund Denmark (ALV, TMP; https://ufm.dk/en/research-and-innovation/councils-and-commissions/independent-research-fund-Denmark), the Novo Nordisk Foundation (ALV, TMP; http://novonordiskfonden.dk/en), the Danish Diabetes Association (FP; https://diabetes.dk/diabetesforeningen/inenglish/the-danish-diabetes-association.aspx), the DesireAe and Niels Yde Foundation (ALV, TMP), the A.P. Moller Foundation (ALV, TMP, CHBB; https://www.apmollerfonde.dk/), Novo Nordisk A/S (KSF), the Poul and Erna Sehested Hansen Foundation (CHBB, ALV), the Sven Hansen and wife Ina Hansen Foundation (ALV), and the Danish Strategic Research Council (FP; https://ufm.dk/en/research-and-innovation/councils-and-commissions/the-danish-council-for-research-and-innovation-policy/the-danish-council-for-research-policy) by funding the Center for non-coding RNA in Technology and Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The commercial company Novo Nordisk A/S provided support in the form of salaries for authors [ALV, KSF], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Berchtold LA, 2016, ADV CLIN CHEM, V75, P99, DOI 10.1016/bs.acc.2016.02.001; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Cameron JE, 2008, J VIROL, V82, P1946, DOI 10.1128/JVI.02136-07; Chakraborty C, 2017, MOL THER-NUCL ACIDS, V8, P132, DOI 10.1016/j.omtn.2017.06.005; Choi SW, 2014, LANCET ONCOL, V15, P87, DOI 10.1016/S1470-2045(13)70512-6; Chou CH, 2016, NUCLEIC ACIDS RES, V44, pD239, DOI 10.1093/nar/gkv1258; Chou DHC, 2012, CHEM BIOL, V19, P669, DOI 10.1016/j.chembiol.2012.05.010; Christensen DP, 2014, P NATL ACAD SCI USA, V111, P1055, DOI 10.1073/pnas.1320850111; Dai RJ, 2008, BLOOD, V112, P4591, DOI 10.1182/blood-2008-04-152488; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Donath MY, 2003, J MOL MED-JMM, V81, P455, DOI 10.1007/s00109-003-0450-y; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; Fernandez-Valverde SL, 2011, DIABETES, V60, P1825, DOI 10.2337/db11-0171; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fred RG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010843; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Grunnet LG, 2009, DIABETES, V58, P1807, DOI 10.2337/db08-0178; Hansen JB, 2012, CELL METAB, V16, P449, DOI 10.1016/j.cmet.2012.09.001; Heimberg H, 2001, DIABETES, V50, P2219, DOI 10.2337/diabetes.50.10.2219; Hendgen-Cotta UB, 2017, FREE RADICAL RES, V51, P91, DOI 10.1080/10715762.2017.1282158; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jiang MH, 2012, AGING CELL, V11, P29, DOI 10.1111/j.1474-9726.2011.00757.x; Karlsen AE, 2001, P NATL ACAD SCI USA, V98, P12191, DOI 10.1073/pnas.211445998; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Kutmon M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082160; Larsen L, 2007, DIABETOLOGIA, V50, P779, DOI 10.1007/s00125-006-0562-3; Lewis EC, 2011, MOL MED, V17, P369, DOI 10.2119/molmed.2010.00152; Lindholm MW, 2012, MOL THER, V20, P376, DOI 10.1038/mt.2011.260; Liu Da Zhi, 2015, J Neuromuscul Dis, V2, P387; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lovis P, 2008, DIABETES, V57, P2728, DOI 10.2337/db07-1252; Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012; Lundh M, 2012, DIABETOLOGIA, V55, P2421, DOI 10.1007/s00125-012-2615-0; Lundh M, 2010, DIABETOLOGIA, V53, P2569, DOI 10.1007/s00125-010-1892-8; Mandrup-Poulsen T, 2010, NAT REV ENDOCRINOL, V6, P158, DOI 10.1038/nrendo.2009.271; MANDRUPPOULSEN T, 1987, J IMMUNOL, V139, P4077; MANDRUPPOULSEN T, 1986, DIABETOLOGIA, V29, P63, DOI 10.1007/BF02427283; Mokhtari D, 2008, DIABETES, V57, P1896, DOI 10.2337/db07-1670; Nesca V, 2013, DIABETOLOGIA, V56, P2203, DOI 10.1007/s00125-013-2993-y; Nielsen K, 1999, DIABETES, V48, P2324, DOI 10.2337/diabetes.48.12.2324; Olsen CA, 2014, CHEMMEDCHEM, V9, P434, DOI 10.1002/cmdc.201300421; Osmai M, 2016, DIABETES-METAB RES, V32, P334, DOI 10.1002/dmrr.2719; Perry MM, 2009, FEBS LETT, V583, P3349, DOI 10.1016/j.febslet.2009.09.038; Perske C, 2010, AM J PATHOL, V177, P2046, DOI 10.2353/ajpath.2010.091111; Roggli E, 2012, DIABETES, V61, P1742, DOI 10.2337/db11-1086; Roggli E, 2010, DIABETES, V59, P978, DOI 10.2337/db09-0881; Roos J, 2016, SCI REP-UK, V6, DOI 10.1038/srep38339; Saba R, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00578; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Sparre T, 2003, AUTOIMMUNITY, V36, P99, DOI 10.1080/0891693031000079248; Strandell E, 1995, IMMUNOL LETT, V48, P145, DOI 10.1016/0165-2478(95)02459-X; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Vojinovic J, 2011, MOL MED, V17, P397, DOI 10.2119/molmed.2011.00030; Wang HY, 2001, J BIOL CHEM, V276, P25279, DOI 10.1074/jbc.M101233200; Wang JH, 2013, OSTEOARTHR CARTILAGE, V21, P1987, DOI 10.1016/j.joca.2013.09.008; Yang ML, 2015, J DIABETES, V7, P158, DOI 10.1111/1753-0407.12163; Zhao EP, 2009, MAMM GENOME, V20, P476, DOI 10.1007/s00335-009-9217-2	60	15	15	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0203713	10.1371/journal.pone.0203713	http://dx.doi.org/10.1371/journal.pone.0203713			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30260972	Green Published, gold			2022-12-26	WOS:000445907400015
J	Wang, YN; Lv, SY; Wang, Q; Wang, C; Zhu, MX; Ma, ZB; Zhao, W				Wang, Yana; Lv, Shiyu; Wang, Qiang; Wang, Chan; Zhu, Mingxing; Ma, Zhanbing; Zhao, Wei			Mechanisms underlying immune tolerance caused by recombinant Echinococcus granulosus antigens Eg mMDH and Eg10 in dendritic cells	PLOS ONE			English	Article							INDOLEAMINE 2,3-DIOXYGENASE; MATURATION; PROLIFERATION; SUPPRESSION; INHIBITION; AUTOIMMUNE; INDUCTION	Mice immunized with recombinant Echinococcus granulosus antigens Eg10 and Eg mMDH do not show elevated resistance to E. granulosus infection but show aggravated infection instead. To gain a deeper insight in the immune tolerance mechanisms in mice immunized with Eg10 and Eg mMDH, this study simulated the immune tolerance process in vitro by culturing bone marrow-derived dendritic cells (BMDCs) in the presence of Eg10 or Eg mMDH. Scanning electron microscopy revealed that Eg10- and Eg mMDH-treated DCs exhibited immature cell morphology, while addition of LPS to the cells induced changes in cell morphology and an increase in the number of cell-surface protrusions. This observation was consistent with the increased expression of the cell-surface molecules MHCII and CD80 in Eg10- and Eg mMDH-treated DCs pretreated with LPS. DCs exposed to the two antigens had a very weak ability to induce T-cell proliferation, but could promote the formation of Treg cells. Introduction of the indoleamine 2,3-dioxygenase (IDO) inhibitor, 1-methyl tryptopha (1-MT) enhanced the ability of the antigens to induce T cells and inhibited the induction of Treg cells. Eg mMDH-treated DCs showed a strong response to 1-MT: the DCs had high mRNA levels of IDO, IL-6, and IL-10, while 1-MT decreased the expression. In contrast, DCs treated with Eg10 did not show significant changes after 1-MT treatment. Eg mMDH inhibited DC maturation and promoted IDO expression, which, on the one hand, decreased the ability of DCs to induce T-cell proliferation, resulting in T-cell anergy, and on the other hand, induced the formation of Tregs, resulting in an immunosuppressive effect. In contrast, the escape mechanisms induced by Eg10 did not primarily depend on the IDO pathway and might involve other mechanisms that need to be further explored.	[Wang, Yana; Wang, Chan; Ma, Zhanbing; Zhao, Wei] Ningxia Med Univ, Dept Cell Biol & Med Genet, Sch Basic Med Sci, Ningxia, Peoples R China; [Wang, Yana; Wang, Qiang; Zhu, Mingxing; Zhao, Wei] Ningxia Med Univ, Echinococcosis Lab, Ningxia, Peoples R China; [Lv, Shiyu] Qianfoshan Hosp Shandong Prov, Clin Lab, Jinan, Shandong, Peoples R China	Ningxia Medical University; Ningxia Medical University; Shandong First Medical University & Shandong Academy of Medical Sciences	Zhao, W (corresponding author), Ningxia Med Univ, Dept Cell Biol & Med Genet, Sch Basic Med Sci, Ningxia, Peoples R China.; Zhao, W (corresponding author), Ningxia Med Univ, Echinococcosis Lab, Ningxia, Peoples R China.	zw-6915@163.com			Nation Natural Science Foundation of China [81106230]; Special talent launch project of Ningxia Medical University [XT2015003]; project i West China first-class Diciplines Basic Medical Sciences at Ningxia Medical University [NXYLXK 2017B07]	Nation Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special talent launch project of Ningxia Medical University; project i West China first-class Diciplines Basic Medical Sciences at Ningxia Medical University	This work was supported by the Nation Natural Science Foundation of China (Number 81106230) and Special talent launch project of Ningxia Medical University (Number XT2015003) and the project i West China first-class Diciplines Basic Medical Sciences at Ningxia Medical University (Number NXYLXK 2017B07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baz A, 2008, EXP PARASITOL, V119, P460, DOI 10.1016/j.exppara.2008.04.024; Benitez L, 1998, PARASITOL RES, V84, P426, DOI 10.1007/s004360050423; Benvenuti F, 2004, SCIENCE, V305, P1150, DOI 10.1126/science.1099159; Broder A, 2013, CLIN IMMUNOL, V146, P197, DOI 10.1016/j.clim.2012.12.002; Casaravilla C, 2014, INFECT IMMUN, V82, P3164, DOI 10.1128/IAI.01959-14; Cools N, 2011, IMMUNOTHERAPY-UK, V3, P1203, DOI [10.2217/IMT.11.110, 10.2217/imt.11.110]; Diaz A, 2016, PARASITE IMMUNOL, V38, P193, DOI 10.1111/pim.12282; Du Juan, 2010, Chinese Journal of Parasitology and Parasitic Diseases, V28, P339; Ermann J, 2003, P NATL ACAD SCI USA, V100, P15292, DOI 10.1073/pnas.0307001100; Ferret-Bernard S, 2008, PROTEOMICS, V8, P980, DOI 10.1002/pmic.200700538; Goubier A, 2008, IMMUNITY, V29, P464, DOI 10.1016/j.immuni.2008.06.017; Higuita NIA, 2016, J CLIN MICROBIOL, V54, P518, DOI 10.1128/JCM.02420-15; Jurgens B, 2009, BLOOD, V114, P3235, DOI 10.1182/blood-2008-12-195073; KUCHROO VK, 1995, CELL, V80, P707, DOI 10.1016/0092-8674(95)90349-6; Liu Li-Hua, 2012, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V30, P206; Lutz MB, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00123; Makala LHC, 2011, J INFECT DIS, V203, P715, DOI 10.1093/infdis/jiq095; Munn DH, 1999, J EXP MED, V189, P1363, DOI 10.1084/jem.189.9.1363; Nuyts AH, 2013, MULT SCLER J, V19, P995, DOI 10.1177/1352458512473189; Rigano R, 2007, INFECT IMMUN, V75, P1667, DOI 10.1128/IAI.01156-06; Siracusano A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/639362; Smits HH, 2005, TRENDS IMMUNOL, V26, P123, DOI 10.1016/j.it.2005.01.002; Terness P, 2002, J EXP MED, V196, P447, DOI 10.1084/jem.20020052; Tetsutani K, 2007, PARASITOLOGY, V134, P923, DOI 10.1017/S0031182007002326; Tuxun T, 2012, PARASITE IMMUNOL, V34, P520, DOI 10.1111/j.1365-3024.2012.01383.x; Virginio VG, 2007, PARASITOL RES, V100, P935, DOI 10.1007/s00436-006-0366-x; [王强 Wang Qiang], 2014, [四川大学学报. 自然科学版, Journal of Sichuan University. Natural Science Edition], V51, P592; Wang YN, 2015, PARASITOLOGY, V142, P879, DOI 10.1017/S0031182014002005; Wang Y, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0110-3; Yeung AWS, 2015, CLIN SCI, V129, P601, DOI 10.1042/CS20140392; Zaitseva J, 2009, ACTA CRYSTALLOGR F, V65, P866, DOI 10.1107/S1744309109032217; Zhang J, 2006, J PATHOGEN BIOL, V1, P249	32	4	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204868	10.1371/journal.pone.0204868	http://dx.doi.org/10.1371/journal.pone.0204868			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30261049	Green Published, Green Submitted, gold			2022-12-26	WOS:000445907400110
J	Chen, XY; Liu, X; Du, YY; Wang, B; Zhao, N; Geng, ZY				Chen, Xingyong; Liu, Xue; Du, Yeye; Wang, Bin; Zhao, Ning; Geng, Zhaoyu			Green forage and fattening duration differentially modulate cecal microbiome of Wanxi white geese	PLOS ONE			English	Article							DIETARY FIBER; FATTY-ACID; BROILER; FERMENTATION; PREVOTELLA; BACTERIA; GROWTH	Gut microbial ecology is responsible for fatty acid metabolism in ruminants. The cecal micro-biota composition of geese and their adaptation to fiber inclusion and feeding times were investigated in this study. A total of 116 Wanxi white geese were randomly selected at 70 days old. Eight geese were subjected to cecal sampling at 70 d of age, and the remaining 108 geese were divided into four groups with three replicates each (9 geese in each replicate). The geese in the four groups were fed 0, 15, 30, and 45% green forage (relative to dry matter), respectively. Three birds from each replicate were selected for cecal sampling at 80, 90, and 100 days old. All samples were subjected to 16S rRNA gene sequencing using the Illumina Ion Personal Genome Machine platform. Bacterial abundance was analyzed using two-way ANOVA analysis, and the relationship between the relative abundance of bacteria (phylum level) and fatty acids was analyzed using acanonical correspondence analysis. Cecal microbiota in geese were mainly composed of Bacteroidetes (68.46%), Firmicutes (20.04%), and Proteobacteria (7.89%). Dietary treatments had no significant effect on the a-diversity indices of the cecal bacterial community (P > 0.05), but a numerical increase occurred with increased fattening duration and green forage inclusion. The Selenomonadales order (P = 0.024), Negativicutes class (P = 0.026), and Megamonas (P = 0.012) and Oscillospira (P = 0.042) genera were affected by green forageinclusion level, and microflora abundance was mainly influenced by the fattening duration. Bacteria phyla were mostly set along the line of linolenic acid and oleic acid. Finally, Bacteroidales might be an intestinal promoter that improves unsaturated fatty acid synthesis in geese.	[Chen, Xingyong; Liu, Xue; Du, Yeye; Wang, Bin; Zhao, Ning; Geng, Zhaoyu] Anhui Agr Univ, Coll Anim Sci & Technol, Hefei, Anhui, Peoples R China; [Chen, Xingyong; Geng, Zhaoyu] Anhui Agr Univ, Anhui Prov Key Lab Local Livestock & Poultry Gene, Hefei, Anhui, Peoples R China; [Wang, Bin] Tongcheng Teachers Coll, Dept Primary Educ, Tongcheng, Peoples R China	Anhui Agricultural University; Anhui Agricultural University	Geng, ZY (corresponding author), Anhui Agr Univ, Coll Anim Sci & Technol, Hefei, Anhui, Peoples R China.; Geng, ZY (corresponding author), Anhui Agr Univ, Anhui Prov Key Lab Local Livestock & Poultry Gene, Hefei, Anhui, Peoples R China.	gzy@ahau.edu.cn			Natural Science Foundation of Anhui Province [1508085MC53]	Natural Science Foundation of Anhui Province(Natural Science Foundation of Anhui Province)	This work was financially supported by the Natural Science Foundation from Anhui Province (1508085MC53) to ZG. The funder helps data collection and analysis.r This work was financially supported by the Natural Science Foundation of Anhui Province (1508085MC53). We thank Ms. Boni G. Funmilayo from the Anhui Province Key Laboratory of Local Livestock and Poultry Genetic Resource Conservation and Bio-breeding for her help with manuscript edits.	Adamski M, 2010, 22 INT POULTR S PB W, P214; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Ban-Tokuda T, 2017, ANAEROBE, V47, P188, DOI 10.1016/j.anaerobe.2017.06.006; Castro-Carrera T, 2014, J DAIRY SCI, V97, P1661, DOI 10.3168/jds.2013-7243; Chen XingYong, 2017, Acta Veterinaria et Zootechnica Sinica, V48, P1912; Dhiman TR, 2005, J DAIRY SCI, V88, P276; Ghaffarzadegan T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157427; Gimeno A, 2015, ANIM FEED SCI TECH, V199, P113, DOI 10.1016/j.anifeedsci.2014.11.008; Huws SA, 2011, ENVIRON MICROBIOL, V13, P1500, DOI 10.1111/j.1462-2920.2011.02452.x; Iji PA, 2001, ANIM FEED SCI TECH, V89, P175, DOI 10.1016/S0377-8401(00)00223-6; Inigo MA, 2011, WORLD RABBIT SCI, V19, P67, DOI 10.4995/wrs.2011.819; Jorgensen H, 1996, BRIT J NUTR, V75, P379, DOI 10.1079/BJN19960141; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Liu DC, 2013, J INTEGR AGR, V12, P319, DOI [10.1016/S2095-3119(13)60231-2, 10.1016/s2095-3119(13)60231-2]; Lou YJ, 2010, S AFR J ANIM SCI, V40, P70; Min BR, 2016, J ANIMAL NUTR, V1, P1, DOI DOI 10.21767/2572-5459.100006; Mohammadzadeh H, 2014, ANAEROBE, V29, P52, DOI 10.1016/j.anaerobe.2013.11.012; Mustafa AF, 2017, J APPL POULTRY RES; Pedersen R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056612; Pitta DW, 2010, MICROB ECOL, V59, P511, DOI 10.1007/s00248-009-9609-6; Pourabedin M, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0079-4; Roofchaei A, 2019, ANIM NUTR, V5, P63, DOI 10.1016/j.aninu.2017.12.001; Scupham AJ, 2008, MICROB ECOL, V56, P322, DOI 10.1007/s00248-007-9349-4; Simon K, 2016, POULTRY SCI, V95, P1543, DOI 10.3382/ps/pew088; Stevenson DM, 2007, APPL MICROBIOL BIOT, V75, P165, DOI 10.1007/s00253-006-0802-y; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vasai F, 2014, POULTRY SCI, V93, P916, DOI 10.3382/ps.2013-03497; Walugembe M, 2015, POULTRY SCI, V94, P2351, DOI 10.3382/ps/pev242; Wang W, 2016, MICROBIOL RES, V182, P59, DOI 10.1016/j.micres.2015.10.003; Wu FF, 2017, EXP THER MED, V14, P3122, DOI 10.3892/etm.2017.4878; Yin HC, 2016, J INTEGR AGR, V15, P2077, DOI 10.1016/S2095-3119(15)61198-4	31	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2018	13	9							e0204210	10.1371/journal.pone.0204210	http://dx.doi.org/10.1371/journal.pone.0204210			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU9BO	30252869	Green Published, gold, Green Submitted			2022-12-26	WOS:000445639700034
J	Minic, R; Papic, Z; Dordevic, B; Michalickova, D; Llic, V; Mathiesen, G; Zivkovic, I; Pantic, V; Dimitrijevic, L				Minic, Rajna; Papic, Zlatko; Dordevic, Brizita; Michalickova, Danica; Llic, Vesna; Mathiesen, Geir; Zivkovic, Irena; Pantic, Visnja; Dimitrijevic, Ljiljana			Profiling of microorganism-binding serum antibody specificities in professional athletes	PLOS ONE			English	Article							MICROBIOTA; IMMUNITY; MUCOSAL; ENDOTOXINS; GENERATION; ANTIGENS; EXERCISE; MICE; IGA	The goal of this work was to elucidate similarities between microorganisms from the perspective of the humoral immune system reactivity in professional athletes. The reactivity of serum IgG of 14 young, individuals was analyzed to 23 selected microorganisms as antigens by use of the in house ELISA. Serum IgM and IgA reactivity was also analyzed and a control group of sex and age matched individuals was used for comparison. The obtained absorbance levels were used as a string of values to correlate the reactivity to different microorganisms. IgM was found to be the most cross reactive antibody class, Pearson's r = 0.7 +/- 0.92, for very distant bacterial species such as Lactobacillus and E. coli. High correlation in IgG levels was found for Gammaproteobacteria and LPS (from E. coli) (r = 0.77 for LPS vs. P. aeruginosa to r = 0.98 for LPS vs. E. coli), whereas this correlation was lower in the control group (r = 0.49 for LPS vs. P. aeruginosa to r = 0.66 for LPS vs. E. coli). The correlation was also analyzed between total IgG and IgG subclasses specific for the same microorganism, and IgG2 was identified as the main subclass recognising different microorganisms, as well as recognising LPS. Upon correlation of IgG with IgA for the same microorganism absence of or negative correlation was found between bacteria-specific IgA and IgG in case of Lactobacillus and Staphylococcusgeni, whereas correlation was absent or positive for Candida albicans, Enterococcusfaecalis, Streptococcus species tested in professional athletes. Opposite results were obtained for the control group. Outlined here is a simple experimental procedure and data analysis which yields functional significance and which can be used for determining the similarities between microorganisms from the aspect of the humoral immune system, for determining the main IgG subclass involved in an immune response as well as for the analysis of different target populations.	[Minic, Rajna; Zivkovic, Irena; Pantic, Visnja; Dimitrijevic, Ljiljana] Inst Virol Vaccines & Sera, Dept Sci Res, Belgrade, Serbia; [Papic, Zlatko] Univ Leeds, Sch Phys & Astron, EC Stoner Bldg, Leeds, W Yorkshire, England; [Dordevic, Brizita] Univ Belgrade, Fac Pharm, Dept Bromatol, Belgrade, Serbia; [Michalickova, Danica] Charles Univ Prague, Fac Med 1, Inst Pharmacol, Prague, Czech Republic; [Llic, Vesna] Univ Belgrade, Inst Med Res, Belgrade, Serbia; [Mathiesen, Geir] Norwegian Univ Life Sci NMBU, Dept Chem Biotechnol & Food Sci, As, Norway	University of Leeds; University of Belgrade; Charles University Prague; University of Belgrade; Norwegian University of Life Sciences	Minic, R (corresponding author), Inst Virol Vaccines & Sera, Dept Sci Res, Belgrade, Serbia.	minicrajna@gmail.com	Michalickova, Danica/K-2824-2017	Michalickova, Danica/0000-0002-9690-9846; Minic, Rajna/0000-0003-2941-9246; Zivkovic, Irena/0000-0002-4074-590X; Ilic, Vesna/0000-0003-1119-1343				BROWN TA, 1985, INFECT IMMUN, V49, P459, DOI 10.1128/IAI.49.2.459-462.1985; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; DiGiandomenico A, 2015, CURR OPIN MICROBIOL, V27, P78, DOI 10.1016/j.mib.2015.07.014; Fransen F, 2015, IMMUNITY, V43, P527, DOI 10.1016/j.immuni.2015.08.011; FRENCH MAH, 1984, CLIN EXP IMMUNOL, V56, P473; Gill SK, 2015, INT J SPORTS MED, V36, P688, DOI 10.1055/s-0034-1398535; Gleeson M, 2013, EXERC SPORT SCI REV, V41, P148, DOI 10.1097/JES.0b013e3182956ead; Lin M, 2014, MUCOSAL IMMUNOL, V7, P511, DOI 10.1038/mi.2013.68; Michalickova DM, 2017, J STRENGTH COND RES, V31, P62, DOI 10.1519/JSC.0000000000001456; Morrison C, 2015, NAT REV DRUG DISCOV, V14, P737, DOI 10.1038/nrd4770; ORSKOV I, 1977, BACTERIOL REV, V41, P667, DOI 10.1128/MMBR.41.3.667-710.1977; Panda S, 2015, J IMMUNOL, V194, P13, DOI 10.4049/jimmunol.1400844; RAETZ CRH, 1990, ANNU REV BIOCHEM, V59, P129, DOI 10.1146/annurev.bi.59.070190.001021; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; SCOTT MG, 1988, DIAGN CLIN IMMUNOL, V5, P241; Shek PN, 1998, CAN J PHYSIOL PHARM, V76, P589, DOI 10.1139/cjpp-76-5-589; Spence L, 2007, MED SCI SPORT EXER, V39, P577, DOI 10.1249/mss.0b013e31802e851a; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Walsh NP, 2011, EXERC IMMUNOL REV, V17, P6; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Zapata HJ, 2015, J AM GERIATR SOC, V63, P776, DOI 10.1111/jgs.13310	24	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2018	13	9							e0203665	10.1371/journal.pone.0203665	http://dx.doi.org/10.1371/journal.pone.0203665			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU9BO	30252853	Green Published, gold, Green Submitted			2022-12-26	WOS:000445639700011
J	Huang, QF; Van Keer, J; Zhang, ZY; Trenson, S; Nkuipou-Kenfack, E; Van Aelst, LNL; Yang, WY; Thijs, L; Wei, FF; Ciarka, A; Vanhaecke, J; Janssens, S; Van Cleemput, J; Mischak, H; Staessen, JA				Huang, Qi-Fang; Van Keer, Jan; Zhang, Zhen-Yu; Trenson, Sander; Nkuipou-Kenfack, Esther; Van Aelst, Lucas N. L.; Yang, Wen-Yi; Thijs, Lutgarde; Wei, Fang-Fei; Ciarka, Agnieszka; Vanhaecke, Johan; Janssens, Stefan; Van Cleemput, Johan; Mischak, Harald; Staessen, Jan A.			Urinary proteomic signatures associated with beta-blockade and heart rate in heart transplant recipients	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; MYOCARDIAL-INFARCTION; BLOCKERS; DIAGNOSIS; OUTCOMES	Objectives Heart transplant (HTx) recipients have a high heart rate (HR), because of graft denervation and are frequently started on beta-blockade (BB). We assessed whether BB and HR post HTx are associated with a specific urinary proteomic signature. Methods In 336 HTx patients (mean age, 56.8 years; 22.3% women), we analyzed cross-sectional data obtained 7.3 years (median) after HTx. We recorded medication use, measured HR during right heart catheterization, and applied capillary electrophoresis coupled with mass spectrometry to determine the multidimensional urinary classifiers HF1 and HF2 (known to be associated with left ventricular dysfunction), ACSP75 (acute coronary syndrome) and CKD273 (renal dysfunction) and 48 sequenced urinary peptides revealing the parental proteins. Results In adjusted analyses, HF1, HF2 and CKD273 (p <= 0.024) were higher in BB users than nonusers with a similar trend for ACSP75 (p = 0.06). Patients started on BB within 1 year after HTx and non-users had similar HF1 and HF2 levels (p >= 0.098), whereas starting BB later was associated with higher HF1 and HF2 compared with non-users (p <= 0.014). There were no differences in the urinary biomarkers (p >= 0.27) according to HR. BB use was associated with higher urinary levels of collagen II and III fragments and non-use with higher levels of collagen I fragments. Conclusions BB use, but not HR, is associated with a urinary proteomic signature that is usually associated with worse outcome, because unhealthier conditions probably lead to initiation of BB. Starting BB early after HTx surgery might be beneficial.	[Huang, Qi-Fang; Zhang, Zhen-Yu; Yang, Wen-Yi; Thijs, Lutgarde; Wei, Fang-Fei; Staessen, Jan A.] Univ Leuven, Dept Cardiovasc Sci, KU Leuven, Res Unit Hypertens & Cardiovasc Epidemiol,Studies, Leuven, Belgium; [Huang, Qi-Fang] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp,Ctr Epidemiol Studies & Clin Trials &, Shanghai Key Lab Hypertens,Shanghai Inst Hyperten, Shanghai, Peoples R China; [Van Keer, Jan; Trenson, Sander; Van Aelst, Lucas N. L.; Ciarka, Agnieszka; Vanhaecke, Johan; Janssens, Stefan; Van Cleemput, Johan] Univ Hosp Leuven, Div Cardiol, Leuven, Belgium; [Zhang, Zhen-Yu; Yang, Wen-Yi] Shanghai Gen Hosp, Dept Cardiol, Shanghai, Peoples R China; [Nkuipou-Kenfack, Esther; Mischak, Harald] Mosa Diagnost GmbH, Hannover, Germany; [Mischak, Harald] Univ Glasgow, BHF Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Staessen, Jan A.] Maastricht Univ, Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands	KU Leuven; Shanghai Jiao Tong University; KU Leuven; University Hospital Leuven; Modular Open Systems Approach (MOSA) Solutions; University of Glasgow; Maastricht University	Staessen, JA (corresponding author), Univ Leuven, Dept Cardiovasc Sci, KU Leuven, Res Unit Hypertens & Cardiovasc Epidemiol,Studies, Leuven, Belgium.; Staessen, JA (corresponding author), Maastricht Univ, Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands.	jan.staessen@med.kuleuven.be	Zhang, Zhenyu/GZL-8479-2022; Yang, Wenyi/ABA-5526-2021; Van Aelst, Lucas/GNM-7867-2022; Ciarka, Agnieszka/AAI-4490-2020; Staessen, Jan A/A-1065-2011	Zhang, Zhenyu/0000-0002-3785-7417; Staessen, Jan A/0000-0002-3026-1637; Thijs, Lutgarde/0000-0002-8108-2356	European Union [HEALTH-F7-305507 HOMAGE]; European Research Council [2011-294713-EPLORE, 713601-uPROPHET]; European Research Area Net for Cardiovascular Diseases [JTC2017-046-PROACT]; Fonds voor Wetenschappelijk Onderzoek Vlaanderen, Ministry of the Flemish Community, Brussels, Belgium [G.0881.13]; European Commission [HEALTH FP7-603288]; Fonds voor Wetenschappelijk Onderzoek Vlaanderen [11B3618N]	European Union(European Commission); European Research Council(European Research Council (ERC)European Commission); European Research Area Net for Cardiovascular Diseases; Fonds voor Wetenschappelijk Onderzoek Vlaanderen, Ministry of the Flemish Community, Brussels, Belgium(FWO); European Commission(European CommissionEuropean Commission Joint Research Centre); Fonds voor Wetenschappelijk Onderzoek Vlaanderen(FWO)	The European Union (HEALTH-F7-305507 HOMAGE; URL: http://www.homage-hf.eu/) and the European Research Council (Advanced Researcher Grant 2011-294713-EPLORE and Proof-of-Concept Grant 713601-uPROPHET; URL: http://cordis.europa.eu/project/rcn/104182_en.html and http://cordis.europa.eu/project/rcn/205861_en.html), the European Research Area Net for Cardiovascular Diseases (JTC2017-046-PROACT; URL: http://www.eracvd.eu/), and the Fonds voor Wetenschappelijk Onderzoek Vlaanderen, Ministry of the Flemish Community, Brussels, Belgium (G.0881.13; URL: http://www.fwo.be/) currently support the Studies Coor-dinating Centre in Leuven. Dr. Harald Mischak and Esther Nkuipou-Kenfack received support from the European Commission via the SysVasc project (HEALTH FP7-603288; URL: https://cordis.europa.eu/project/rcn/111200_en.html). Dr. Jan Van Keer is the recipient of a PhD researcher scholarship granted by the Fonds voor Wetenschappelijk Onderzoek Vlaanderen (11B3618N; URL: http://www.fwo.be/en/). The funder provided support in the form of salaries for authors (QFH, JVK, ZYZ, ST, WYY, LT, FFW, JAS), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Castel MA, 2013, INT J CARDIOL, V168, P2003, DOI 10.1016/j.ijcard.2012.12.089; Bangalore S, 2012, JAMA-J AM MED ASSOC, V308, P1340, DOI 10.1001/jama.2012.12559; Barge-Caballero E, 2015, REV ESP CARDIOL, V68, P943, DOI 10.1016/j.rec.2014.09.028; Blom G., 1958, STAT ESTIMATES TRANS; Ciarka A, 2016, AM J CARDIOL, V118, P1916, DOI 10.1016/j.amjcard.2016.08.084; Delles C, 2010, J HYPERTENS, V28, P2316, DOI 10.1097/HJH.0b013e32833d81b7; Expert Committee, 2003, DIABETES CARE S1, V26, pS5, DOI DOI 10.2337/DIACARE.26.2007.S5; Fukui M, 2016, HEART VESSELS, V31, P173, DOI 10.1007/s00380-014-0597-1; Haddad H, 2009, CAN J CARDIOL, V25, P197, DOI 10.1016/S0828-282X(09)70061-3; Htun NM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172036; Huang QF, 2018, TRANSPLANT DIRECT, V4, DOI 10.1097/TXD.0000000000000783; Huang QF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184443; Jaffe M., 1886, J PHYS CHEM-US, V10, P391, DOI [DOI 10.1515/BCHM1.1886.10.5.391, 10.1515/bchm1.1886.10.5.391]; Jantos-Siwy J, 2009, J PROTEOME RES, V8, P268, DOI 10.1021/pr800401m; Jaradat M, 2016, INT J CARDIOL, V223, P976, DOI 10.1016/j.ijcard.2016.08.239; Klein J, 2014, ELECTROPHORESIS, V35, P1060, DOI 10.1002/elps.201300327; Kuznetsova T, 2012, EUR HEART J, V33, P2342, DOI 10.1093/eurheartj/ehs185; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lindsey ML, 2015, CIRCULATION, V132, P852, DOI 10.1161/CIR.0000000000000226; Mischak H, 2010, PROTEOM CLIN APPL, V4, P464, DOI 10.1002/prca.200900189; Myers GL, 2006, CLIN CHEM, V52, P5, DOI 10.1373/clinchem.2005.0525144; Pontillo C, 2017, KIDNEY INT REP, V2, P1066, DOI 10.1016/j.ekir.2017.06.004; Schanstra JP, 2015, J AM SOC NEPHROL, V26, P1999, DOI 10.1681/ASN.2014050423; Seviiri M, 2018, HEART, V104, P1076, DOI 10.1136/heartjnl-2017-312251; Shigeyama J, 2005, EUR HEART J, V26, P2698, DOI 10.1093/eurheartj/ehi492; STAESSEN J, 1982, AM HEART J, V104, P1395, DOI 10.1016/0002-8703(82)90184-3; Tobias R. D., 1997, INTRO PARTIAL LEAST, P1250; Wachter SB, 2015, CLIN TRANSPLANT, V29, P829, DOI 10.1111/ctr.12587; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Zhang Z, 2016, J HYPERTENS, V34, pE91, DOI 10.1097/01.hjh.0000491572.80267.23; Zhang ZY, 2017, KIDNEY INT REP, V2, P811, DOI 10.1016/j.ekir.2017.03.012; Zhang ZY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167582; Zhang ZY, 2015, HYPERTENSION, V66, P52, DOI 10.1161/HYPERTENSIONAHA.115.05296; Zhang ZY, 2014, INT J CARDIOL, V176, P158, DOI 10.1016/j.ijcard.2014.07.014	34	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2018	13	9							e0204439	10.1371/journal.pone.0204439	http://dx.doi.org/10.1371/journal.pone.0204439			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3MI	30248148	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000445998100041
J	Shrestha, S; Oh, DH; McKowen, JK; Dassanayake, M; Hart, CM				Shrestha, Shraddha; Oh, Dong-Ha; McKowen, J. Keller; Dassanayake, Maheshi; Hart, Craig M.			4C-seq characterization of Drosophila BEAF binding regions provides evidence for highly variable long-distance interactions between active chromatin	PLOS ONE			English	Article							CHROMOSOME CONFORMATION CAPTURE; BOUNDARY-ELEMENT; ARCHITECTURAL PROTEINS; RANGE INTERACTIONS; ASSOCIATING DOMAINS; GENOME ORGANIZATION; PHASE-SEPARATION; CTCF SITES; TRANSCRIPTION; REVEALS	Chromatin organization is crucial for nuclear functions such as gene regulation, DNA replication and DNA repair. Insulator binding proteins, such as the Drosophila Boundary Element-Associated Factor (BEAF), are involved in chromatin organization. To further understand the role of BEAF, we detected cis-and trans-interaction partners of four BEAF binding regions (viewpoints) using 4C (circular chromosome conformation capture) and analyzed their association with different genomic features. Previous genome-wide mapping found that BEAF usually binds near transcription start sites, often of housekeeping genes, so our viewpoints were selected to reflect this. Our 4C data show the interaction partners of our viewpoints are highly variable and generally enriched for active chromatin marks. The most consistent association was with housekeeping genes, a feature in common with our viewpoints. Fluorescence in situ hybridization indicated that the long-distance interactions occur even in the absence of BEAF. These data are most consistent with a model in which BEAF is redundant with other factors found at active promoters. Our results point to principles of long-distance interactions made by active chromatin, supporting a previously proposed model in which condensed chromatin is sticky and associates into topologically associating domains (TADs) separated by active chromatin. We propose that the highly variable long-distance interactions we detect are driven by redundant factors that open chromatin to promote transcription, combined with active chromatin filling spaces between TADs while packing of TADs relative to each other varies from cell to cell.	[Shrestha, Shraddha; Oh, Dong-Ha; McKowen, J. Keller; Dassanayake, Maheshi; Hart, Craig M.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Hart, CM (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	chart4@lsu.edu	Hart, Craig/B-4832-2016; Oh, Dong-Ha/O-7591-2019	Hart, Craig/0000-0002-9870-991X; Oh, Dong-Ha/0000-0003-1526-9814; McKowen, J. Keller/0000-0002-1630-6966	National Science Foundation [1244100, 1616827]; Louisiana Board of Regents [LEQSF-EPS(2012)-PFUND-274]; Rural Development Administration, Republic of Korea Next-Generation BioGreen21 Program [PJ01317301]	National Science Foundation(National Science Foundation (NSF)); Louisiana Board of Regents; Rural Development Administration, Republic of Korea Next-Generation BioGreen21 Program	This work was supported by the National Science Foundation [1244100 to CMH; 1616827 to DHO and MD]; Louisiana Board of Regents [LEQSF-EPS(2012)-PFUND-274 to CMH]; and Rural Development Administration, Republic of Korea Next-Generation BioGreen21 Program [PJ01317301 to DHO and MD]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali T, 2016, CURR OPIN GENET DEV, V37, P17, DOI 10.1016/j.gde.2015.11.009; Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P421, DOI 10.1016/S0968-0004(00)01620-0; Avva SVSP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162906; Bantignies F, 2014, METHODS MOL BIOL, V1196, P103, DOI 10.1007/978-1-4939-1242-1_7; Blanton J, 2003, GENE DEV, V17, P664, DOI 10.1101/gad.1052003; Bushey AM, 2009, GENE DEV, V23, P1338, DOI 10.1101/gad.1798209; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Chetverina D, 2014, BIOESSAYS, V36, P163, DOI 10.1002/bies.201300125; Cubenas-Potts C, 2017, NUCLEIC ACIDS RES, V45, P1714, DOI 10.1093/nar/gkw1114; Cuvier O, 1998, MOL CELL BIOL, V18, P7478, DOI 10.1128/MCB.18.12.7478; Cuvier O, 2002, CHROMOSOMA, V110, P519, DOI 10.1007/s00412-001-0181-1; Dekker J, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a019356; Delattre M, 2002, INT J DEV BIOL, V46, P167; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Eagen KP, 2015, CELL, V163, P934, DOI 10.1016/j.cell.2015.10.026; El-Sharnouby S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172725; Emberly E, 2008, PLOS BIOL, V6, P2896, DOI 10.1371/journal.pbio.0060327; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Franke M, 2016, NATURE, V538, P265, DOI 10.1038/nature19800; Fuda NJ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005108; GEYER PK, 1992, GENE DEV, V6, P1865, DOI 10.1101/gad.6.10.1865; Gheldof N, 2012, METHODS MOL BIOL, V786, P211, DOI 10.1007/978-1-61779-292-2_13; Gomez-Diaz E, 2014, TRENDS CELL BIOL, V24, P703, DOI 10.1016/j.tcb.2014.08.003; Gomez-Marin C, 2015, P NATL ACAD SCI USA, V112, P7542, DOI 10.1073/pnas.1505463112; Gondor A, 2008, NAT PROTOC, V3, P303, DOI 10.1038/nprot.2007.540; Gramates LS, 2017, NUCLEIC ACIDS RES, V45, pD663, DOI 10.1093/nar/gkw1016; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Guo Y, 2015, CELL, V162, P900, DOI 10.1016/j.cell.2015.07.038; Hart CM, 1997, MOL CELL BIOL, V17, P999, DOI 10.1128/MCB.17.2.999; Heger A, 2013, BIOINFORMATICS, V29, P2046, DOI 10.1093/bioinformatics/btt343; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Jiang N, 2009, MOL CELL BIOL, V29, P3556, DOI 10.1128/MCB.01748-08; Kalhor R, 2012, NAT BIOTECHNOL, V30, P90, DOI 10.1038/nbt.2057; Katrukha E., 2012, SPOTS COLOCALIZATION; KELLUM R, 1991, CELL, V64, P941, DOI 10.1016/0092-8674(91)90318-S; KELLUM R, 1992, MOL CELL BIOL, V12, P2424, DOI 10.1128/MCB.12.5.2424; Kong Y, 2011, GENOMICS, V98, P152, DOI 10.1016/j.ygeno.2011.05.009; Lam KC, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002736; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Larson AG, 2017, NATURE, V547, P236, DOI 10.1038/nature22822; Li J, 2013, EMBO J, V32, P1829, DOI 10.1038/emboj.2013.111; Liang J, 2014, MOL CELL, V53, P672, DOI 10.1016/j.molcel.2013.12.029; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lupianez DG, 2015, CELL, V161, P1012, DOI 10.1016/j.cell.2015.04.004; Mourad R, 2018, NUCLEIC ACIDS RES, V46, DOI 10.1093/nar/gkx1246; Negre N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000814; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramirez F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02525-w; Roy S, 2007, GENETICS, V176, P801, DOI 10.1534/genetics.106.068056; Rudan MV, 2015, CELL REP, V10, P1297, DOI 10.1016/j.celrep.2015.02.004; Salzberg AC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173723; Sati S, 2017, CHROMOSOMA, V126, P33, DOI 10.1007/s00412-016-0593-6; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schwartz YB, 2017, GENETICS, V205, P5, DOI 10.1534/genetics.115.185132; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Splinter E, 2012, METHODS, V58, P221, DOI 10.1016/j.ymeth.2012.04.009; Strom AR, 2017, NATURE, V547, P241, DOI 10.1038/nature22989; Szabo Q, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar8082; Tang ZH, 2015, CELL, V163, P1611, DOI 10.1016/j.cell.2015.11.024; UDVARDY A, 1985, J MOL BIOL, V185, P341, DOI 10.1016/0022-2836(85)90408-5; Ulianov SV, 2016, GENOME RES, V26, P70, DOI 10.1101/gr.196006.115; Van Bortle K, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-5-r82; Wang Q, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02526-9; Williams RL, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku156; ZHAO K, 1995, CELL, V81, P879, DOI 10.1016/0092-8674(95)90008-X; Zolotarev N, 2016, NUCLEIC ACIDS RES, V44, P7228, DOI 10.1093/nar/gkw371	66	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2018	13	9							e0203843	10.1371/journal.pone.0203843	http://dx.doi.org/10.1371/journal.pone.0203843			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3MI	30248133	Green Published, gold, Green Submitted			2022-12-26	WOS:000445998100013
J	Fuchs, T; Hahn, M; Ries, L; Giesler, S; Busch, S; Wang, CL; Han, J; Schulze, TJ; Puellmann, K; Beham, AW; Kaminski, WE; Neumaier, M				Fuchs, Tina; Hahn, Martin; Ries, Lukas; Giesler, Sophie; Busch, Svenja; Wang, Chunlin; Han, Jian; Schulze, Torsten J.; Puellmann, Kerstin; Beham, Alexander W.; Kaminski, Wolfgang E.; Neumaier, Michael			Expression of combinatorial immunoglobulins in macrophages in the tumor microenvironment	PLOS ONE			English	Article							FLEXIBLE IMMUNE RECOGNITION; CELL SUBPOPULATION; GENE TRANSCRIPTS; LIGHT-CHAIN; ALPHA-BETA; T-CELLS; B-CELLS; RECEPTOR; IDENTIFICATION; REARRANGEMENT	Recent evidence indicates the presence of macrophage subpopulations that express the TCR alpha beta in chronic inflammatory diseases such as tuberculosis and atherosclerosis and in the tumor microenvironment. Here, we demonstrate that a second subpopulation of macrophages expresses rearranged heavy and light chain immunoglobulins. We identify immunoglobulin expression in human and murine monocytes, in ex vivo differentiated macrophages and macrophages from the tumor microenvironment of five randomly selected distinct human tumor entities. The immunoglobulin heavy and light chains are expressed in a small macrophage subfraction (similar to 3-5%) as combinatorial and individual-specific immune receptors. Using Sanger sequencing and deep sequencing, we routinely find markedly restricted Ig repertoires in monocytes/macrophages compared to normal B cells. Furthermore, we report the complete Ig heavy and light chain sequences of a fully functional immunoglobulin from a single tumor-associated macrophage. These results demonstrate that Ig expression is a defining feature of monocytes and also macrophages in the tumor microenvironment and thus reveal an as yet unrecognized modus operandi of host defense in professional phagocytes.	[Fuchs, Tina; Hahn, Martin; Ries, Lukas; Giesler, Sophie; Busch, Svenja; Kaminski, Wolfgang E.; Neumaier, Michael] Heidelberg Univ, Med Fac Mannheim, Inst Clin Chem, Mannheim, Germany; [Wang, Chunlin; Han, Jian] iRepertoire Inc, Huntsville, AL USA; [Han, Jian] HudsonAlpha Inst Biotechnol, Huntsville, AL USA; [Schulze, Torsten J.] Heidelberg Univ, Med Fac Mannheim, Inst Transfus Med & Immunol, Mannheim, Germany; [Puellmann, Kerstin] Aesculab Hamburg, Hamburg, Germany; [Beham, Alexander W.] Univ Gottingen, Dept Surg, Gottingen, Germany; [Kaminski, Wolfgang E.] Bioscientia Inst Med Diagnost, Ingelheim, Germany	Ruprecht Karls University Heidelberg; HudsonAlpha Institute for Biotechnology; Ruprecht Karls University Heidelberg; University of Gottingen	Fuchs, T (corresponding author), Heidelberg Univ, Med Fac Mannheim, Inst Clin Chem, Mannheim, Germany.	Tina.fuchs@umm.de		Schulze, Torsten J/0000-0003-0204-2207; Fuchs, Tina/0000-0002-9622-4871	"Stiftung fur Pathobiochemie und Molekulare Diagnostik' der "Deutschen Vereinten Gesellschaft fOr Klinische Chemie und Labormedizin" [FUCHS 55015]; intramural funding program MEAMEDMA of the Medical Faculty Mannheim of Heidelberg University, Germany [81000186]; iRepertoire inc.; Aesculabor Hamburg and Bioscientia	"Stiftung fur Pathobiochemie und Molekulare Diagnostik' der "Deutschen Vereinten Gesellschaft fOr Klinische Chemie und Labormedizin"; intramural funding program MEAMEDMA of the Medical Faculty Mannheim of Heidelberg University, Germany; iRepertoire inc.; Aesculabor Hamburg and Bioscientia	WEK and TF were supported by a grant from "Stiftung fur Pathobiochemie und Molekulare Diagnostik' der "Deutschen Vereinten Gesellschaft fOr Klinische Chemie und Labormedizin" (FUCHS 55015) and the intramural funding program MEAMEDMA of the Medical Faculty Mannheim of Heidelberg University, Germany to TF (81000186). The companies iRepertoire inc., Aesculabor Hamburg and Bioscientia provided support in the form of salaries for authors [CW, JH, KP and WEK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Babbage G, 2006, CANCER RES, V66, P3996, DOI 10.1158/0008-5472.CAN-05-3704; Beham AW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002375; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Chavez-Galan L, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00263; Deng Yu-qing, 2006, Zhonghua Zhongliu Zazhi, V28, P88; Fuchs T, 2017, IMMUNOBIOLOGY, V222, P39, DOI 10.1016/j.imbio.2015.09.022; Fuchs T, 2015, BIOCHEM BIOPH RES CO, V456, P59, DOI 10.1016/j.bbrc.2014.11.034; Fuchs T, 2013, IMMUNOBIOLOGY, V218, P960, DOI 10.1016/j.imbio.2012.11.005; Fuchs T, 2012, LANCET, V379, P1364, DOI 10.1016/S0140-6736(11)61939-9; Fuchs T, 2012, BIOCHEM BIOPH RES CO, V419, P309, DOI 10.1016/j.bbrc.2012.02.017; Goetz CA, 2004, J IMMUNOL, V172, P4770, DOI 10.4049/jimmunol.172.8.4770; Griffin DO, 2011, J EXP MED, V208, P2591, DOI 10.1084/jem.20110978; Hagemann T, 2004, CARCINOGENESIS, V25, P1543, DOI 10.1093/carcin/bgh146; Han J, 2006, J CLIN MICROBIOL, V44, P4157, DOI 10.1128/JCM.01762-06; Hanada T, 2000, INT J UROL, V7, P263, DOI 10.1046/j.1442-2042.2000.00190.x; HAYAKAWA K, 1983, J EXP MED, V157, P202, DOI 10.1084/jem.157.1.202; Hirano M, 2011, ADV IMMUNOL, V109, P125, DOI 10.1016/B978-0-12-387664-5.00004-2; Huang J, 2008, INT J BIOCHEM CELL B, V40, P1604, DOI 10.1016/j.biocel.2007.12.004; Huang J, 2014, CELL MOL IMMUNOL, V11, P94, DOI 10.1038/cmi.2013.45; HUTCHESON K, 1970, J THEOR BIOL, V29, P151, DOI 10.1016/0022-5193(70)90124-4; Jackson KJL, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00263; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jiang DY, 2015, INT J MOL SCI, V16, P2574, DOI 10.3390/ijms16022574; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Kaminski WE, 2001, BLOOD, V97, P1990, DOI 10.1182/blood.V97.7.1990; Kaminski WE, 2013, IMMUNOBIOLOGY, V218, P418, DOI 10.1016/j.imbio.2012.05.024; Kaminski WE, 2012, AGING DIS, V3, P404; Kim S, 2012, PLOS ONE; Kimoto Y, 1998, GENE CHROMOSOME CANC, V22, P83, DOI 10.1002/(SICI)1098-2264(1998)22:1<83::AID-GCC12>3.0.CO;2-O; Lakschevitz FS, 2013, J PERIODONTOL, V84, P1493, DOI 10.1902/jop.2012.120477; Legrand F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005926; Liu HD, 2007, CELL SIGNAL, V19, P419, DOI 10.1016/j.cellsig.2006.07.012; Liu JF, 2016, GENE, V575, P108, DOI 10.1016/j.gene.2015.08.046; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mantovani A, 2006, CANCER METAST REV, V25, P315, DOI 10.1007/s10555-006-9001-7; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Patton DT, 2014, J IMMUNOL, V193, P3446, DOI 10.4049/jimmunol.1302925; Popi AF, 2015, ANN NY ACAD SCI, V1362, P86, DOI 10.1111/nyas.12814; Puellmann K, 2006, NEW ENGL J MED, V355, P2592; Puellmann K, 2006, P NATL ACAD SCI USA, V103, P14441, DOI 10.1073/pnas.0603406103; Qiu X, 2013, LEUKEMIA, V27, P92, DOI 10.1038/leu.2012.184; Retter I, 2005, NUCLEIC ACIDS RES, V33, pD671, DOI 10.1093/nar/gki088; Shao WW, 2016, SCI REP-UK, V6, DOI 10.1038/srep23669; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanaka Y, 2002, HUM PATHOL, V33, P1105, DOI 10.1053/hupa.2002.129203; Throsby M, 2006, J VIROL, V80, P6982, DOI 10.1128/JVI.00551-06; van der Bij GJ, 2005, CELL ONCOL, V27, P203; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Wang C, 2015, ONCOTARGET, V6, P39062, DOI 10.18632/oncotarget.5393; Wang CL, 2010, P NATL ACAD SCI USA, V107, P1518, DOI 10.1073/pnas.0913939107; Wang S, 2016, IMMUNITY, V45, P131, DOI 10.1016/j.immuni.2016.06.019; Yang Y, 2015, ELIFE, V4, DOI 10.7554/eLife.09083; Zhao YY, 2011, J HISTOCHEM CYTOCHEM, V59, P474, DOI 10.1369/0022155411400871; Zheng J, 2009, J BIOL CHEM, V284, P13610, DOI 10.1074/jbc.M809524200; Zhu DX, 2013, AM J HEMATOL, V88, P379, DOI 10.1002/ajh.23416	55	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2018	13	9							e0204108	10.1371/journal.pone.0204108	http://dx.doi.org/10.1371/journal.pone.0204108			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU5MM	30240437	Green Submitted, gold, Green Published			2022-12-26	WOS:000445329700026
J	Rubab, M; Chellia, R; Saravanakumar, K; Mandava, S; Khan, I; Tango, CN; Hussain, MS; Daliri, EBM; Kim, SH; Ramakrishnan, SR; Wang, MH; Lee, J; Kwon, JH; Chandrashekar, S; Oh, DH				Rubab, Momna; Chellia, Ramachandran; Saravanakumar, Kandasamy; Mandava, Suresh; Khan, Imran; Tango, Charles Nkufi; Hussain, Mohammad Shakhawat; Daliri, Eric Banan-Mwine; Kim, Se-Hun; Ramakrishnan, Sudha Rani; Wang, Myeong-Hyeon; Lee, Jongkook; Kwon, Joong-Ho; Chandrashekar, Sangeeta; Oh, Deog-Hwan			Preservative effect of Chinese cabbage (Brassica rapa subsp pekinensis) extract on their molecular docking, antioxidant and antimicrobial properties	PLOS ONE			English	Article							CHEMICAL-COMPOSITION; ANTIBACTERIAL ACTIVITY; CRYSTAL-STRUCTURE; VAR. CAPITATA; SOUTH-KOREA; IN-VIVO; BIOSYNTHESIS; AGENTS; PLANTS; LPXC	This study aimed at investigating the antimicrobial activity of different solvent extracts of Chinese cabbage Brassica rapa subsp. pekinensis (BRARP) and their antioxidant and cytotoxicity properties. Of the different solvents extracts, the chloroform extracts (CE) were significantly inhibited the bacterial pathogens at minimum inhibitory concentration (MIC) of 16.5 mg.mL(-1). Biochemical analysis revealed that total phenol (62.6 +/- 0.05 mg GAE.g(-1)) and flavonoids (27.6 +/- 0.04 mg QE.g(-1)) were higher in the extracts of BRARP, which resulted in enhanced antioxidant activity in CE. A total of eight dominant compounds were detected in the potent antimicrobial extract from BRARP based on GC-MS analysis. The molecular interactions study revealed that, among the screened compounds the 1,2-benzenedicarboxylic acid and 2,3-dicyanopropionamide interacted with the active site of pathogenicity and survival related protein with lipopolysaccharide (LpxC) with higer binding energy. This work concluded that the 1, 2-Benzenedicarboxylic acid and 2, 3-Dicyanopropionamide from BRARP was reported to be good non-cytotoxic and antioxidant antimicrobials against bacterial pathogens.	[Rubab, Momna; Chellia, Ramachandran; Khan, Imran; Tango, Charles Nkufi; Hussain, Mohammad Shakhawat; Daliri, Eric Banan-Mwine; Kim, Se-Hun; Oh, Deog-Hwan] Kangwon Natl Univ, Coll Agr & Life Sci, Dept Food Sci & Biotechnol, Chunchon, South Korea; [Saravanakumar, Kandasamy; Wang, Myeong-Hyeon] Kangwon Natl Univ, Coll Biomed Sci, Dept Med Biotechnol, Chunchon, South Korea; [Mandava, Suresh; Lee, Jongkook] Kangwon Natl Univ, Coll Pharm, Chunchon, South Korea; [Ramakrishnan, Sudha Rani; Kwon, Joong-Ho] Kyungpook Natl Univ, Sch Food Sci & Biotechnol, Daegu, South Korea; [Chandrashekar, Sangeeta] Sri Venkateshwara Dent Coll, Madras, Tamil Nadu, India	Kangwon National University; Kangwon National University; Kangwon National University; Kyungpook National University	Oh, DH (corresponding author), Kangwon Natl Univ, Coll Agr & Life Sci, Dept Food Sci & Biotechnol, Chunchon, South Korea.	deoghwa@kangwon.ac.kr	Saravanakumar, Kandasamy/P-6745-2018; Ramakrishnan, Sudha Rani/V-6342-2017; Khan, Imran/S-3149-2018	Saravanakumar, Kandasamy/0000-0002-4465-4378; Ramakrishnan, Sudha Rani/0000-0002-4460-416X; Khan, Imran/0000-0001-9802-0429; Lee, Jongkook/0000-0003-0739-7963; Kwon, Joong-Ho/0000-0002-3875-1438; Myeong-Hyeon, Wang/0000-0003-1760-1622	Brain Korea (BK) 21 Plus Project [22A20153713433]; National Research Foundation of Korea, Ministry of Science [2018007551]; National Research Foundation of Korea (NRF) [2017H1D3A1A01052610]; Brain Korea (BK) 21 Plus Project - Korean Government, Republic of Korea [22A20153713433]; National Research Foundation of Korea (NRF) - Ministry of Science, ICT [2017H1D3A1A01052610]; Young Researchers Program [2018007551]	Brain Korea (BK) 21 Plus Project; National Research Foundation of Korea, Ministry of Science; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Brain Korea (BK) 21 Plus Project - Korean Government, Republic of Korea; National Research Foundation of Korea (NRF) - Ministry of Science, ICT; Young Researchers Program	Funded by Brain Korea (BK) 21 Plus Project 22A20153713433 to Ms Momna Rubab. Korea Research Fellowship Program, National Research Foundation of Korea, Ministry of Science, Young Researchers Program for 2018007551 to Dr Ramachandran Chelliah. Korea Research Fellowship Program through the National Research Foundation of Korea (NRF) 2017H1D3A1A01052610 to Dr Kandasamy Saravanakumar.; We thank Mr. Park-Yong IK (Kangwon National University, Central laboratory) for technical support for GC-MS and CLSM analysis. This work was supported by a grant from the Brain Korea (BK) 21 Plus Project (Grant No. 22A20153713433) Funded by the Korean Government, Republic of Korea. The part of this work was supported by Korea Research Fellowship Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT (2017H1D3A1A01052610) and Young Researchers Program for (2018007551) (http://www.nrf.re.kr/eng/main).	Alam MN, 2013, SAUDI PHARM J, V21, P143, DOI 10.1016/j.jsps.2012.05.002; [Anonymous], 1994, HERBALGRAM; Arabshahi-D S, 2007, FOOD CHEM, V100, P1100, DOI 10.1016/j.foodchem.2005.11.014; Armesto J, 2019, INT J FOOD SCI NUTR, V70, P136, DOI 10.1080/09637486.2018.1482530; Arora S., 2018, J PHARMACOGNOSY PHYT, V7, P1445; Ashraf S, 2018, ENVIRON TOXICOL PHAR, V58, P54, DOI 10.1016/j.etap.2017.12.017; Balouiri M, 2016, J PHARM ANAL, V6, P71, DOI 10.1016/j.jpha.2015.11.005; Borges A, 2015, J FOOD SCI TECH MYS, V52, P4737, DOI 10.1007/s13197-014-1533-1; Brown MF, 2012, J MED CHEM, V55, P914, DOI 10.1021/jm2014748; Chalannavar RK, 2014, J ESSENT OIL BEAR PL, V17, P1293, DOI 10.1080/0972060X.2014.892840; Cho JI, 2014, FOOD SCI BIOTECHNOL, V23, P209, DOI 10.1007/s10068-014-0028-1; CLSI, 2012, PERF STAND ANT DISK; DICKERMAN JM, 1952, FOOD RES, V17, P438; Ding C, 2017, STUD NAT PROD CHEM, V54, P141, DOI 10.1016/B978-0-444-63929-5.00005-X; El-Hefny M, 2017, BIORESOURCES, V12, P1835, DOI 10.15376/biores.12.1.1835-1849; Elshouny WAF, 2017, J MICROB BIOTEC FOOD, V6, P1203, DOI 10.15414/jmbfs.2017.6.5.1203-1208; Gersnoviez A., 2018, 2018 13 TECHN APPL E, P1, DOI [10.1007/s00425-017-2798-1, DOI 10.1007/S00425-017-2798-1]; Gogo L. A., 2010, Journal of Applied Sciences Research, P1807; Gronow S, 2001, J ENDOTOXIN RES, V7, P3, DOI 10.1179/096805101101532468; Gyawali R, 2014, FOOD CONTROL, V46, P412, DOI 10.1016/j.foodcont.2014.05.047; Hanschen FS, 2018, FOOD CHEM, V263, P240, DOI 10.1016/j.foodchem.2018.04.069; HarborneJB, 1984, PHYTOCHEMICAL METHOD, P1, DOI [DOI 10.1007/978-94-009-5570-7_1, 10.1007/978-94-009-5570-7_1]; Hariharan B, 2013, MICROBIAL BIOCH TECH, V6; Hong Eunyoung, 2013, Prev Nutr Food Sci, V18, P218, DOI 10.3746/pnf.2013.18.3.218; Hu Shu-Hui, 2004, Kaohsiung Journal of Medical Sciences, V20, P591, DOI 10.1016/S1607-551X(09)70264-5; Igwe K.K., 2016, INT J SCI TECH RES E, V1, P9; Igwe KK, 2016, INT J ADV RES SCI EN, V3, P1765; Jackman JE, 2000, J BIOL CHEM, V275, P11002, DOI 10.1074/jbc.275.15.11002; Jaiswal AK, 2012, J FOOD BIOCHEM, V36, P344, DOI 10.1111/j.1745-4514.2011.00545.x; Jang Dai-Ja, 2015, Journal of Ethnic Foods, V2, P126; Kalinin DV, 2017, EXPERT OPIN THER PAT, V27, P1227, DOI 10.1080/13543776.2017.1360282; Kim GH, 2015, J FOOD SCI, V80, pM2257, DOI 10.1111/1750-3841.12996; Koncic MZ, 2010, FOOD CHEM TOXICOL, V48, P1537, DOI 10.1016/j.fct.2010.03.021; LIU J Y, 1986, Annals of the Phytopathological Society of Japan, V52, P669, DOI 10.3186/jjphytopath.52.669; Males E, 2004, JPC-J PLANAR CHROMAT, V17, P280, DOI 10.1556/JPC.17.2004.4.7; Mataragas M, 2015, MEAT SCI, V103, P39, DOI 10.1016/j.meatsci.2015.01.002; Matuschek E, 2014, CLIN MICROBIOL INFEC, V20, pO255, DOI 10.1111/1469-0691.12373; Mochalkin I, 2008, PROTEIN SCI, V17, P450, DOI 10.1110/ps.073324108; Mollica A, 2018, BIOMED PHARMACOTHER, V107, P129, DOI 10.1016/j.biopha.2018.07.169; Mudzengi CP, 2017, PHARM BIOL, V55, P1054, DOI 10.1080/13880209.2017.1287744; Nabavi SM, 2015, FOOD CHEM, V173, P339, DOI 10.1016/j.foodchem.2014.10.042; Oliveira DA, 2013, J BIOTECHNOL, V164, P423, DOI 10.1016/j.jbiotec.2012.09.014; Ortega-Ramirez Luis Alberto, 2014, J Food Sci, V79, pR129, DOI 10.1111/1750-3841.12341; Parashar S., 2014, J PHARMACOGN PHYTOCH, V3; Pederson CS, 1944, NEW YORK STATE AGR E, V237; Perez IA, 2015, ADV METEOROL, V2015, DOI 10.1155/2015/284213; Pirbalouti AG, 2014, J MED FOOD, V17, P1151, DOI 10.1089/jmf.2013.0057; Prasanna G, 2014, MED CHEM RES, V23, P2651, DOI 10.1007/s00044-013-0858-z; Puupponen-Pimia R, 2001, J APPL MICROBIOL, V90, P494, DOI 10.1046/j.1365-2672.2001.01271.x; Rokayya S, 2013, ASIAN PAC J CANCER P, V14, P6657, DOI 10.7314/APJCP.2013.14.11.6657; Shen XJ, 2017, IND CROP PROD, V96, P110, DOI 10.1016/j.indcrop.2016.11.053; Shen ZH, 2017, CURR ORG CHEM, V21, P1626, DOI 10.2174/1385272821666170410145554; Shenoy N, 2017, LAB INVEST, V97, P494, DOI 10.1038/labinvest.2017.18; Sherman J. M., 1936, J BACTERIOL, V31; Shin J, 2016, FOODBORNE PATHOG DIS, V13, P535, DOI 10.1089/fpd.2016.2147; Soengas P., 2018, J AGR FOOD CHEM; Soengas P, 2018, ACS OMEGA, V3, P5237, DOI 10.1021/acsomega.8b00242; Thangam R, 2013, PHYTOTHER RES, V27, P1664, DOI 10.1002/ptr.4908; Thielmann J, 2017, INT J FOOD MICROBIOL, V251, P48, DOI 10.1016/j.ijfoodmicro.2017.03.019; Thiruvengadam M, 2015, SCI HORTIC-AMSTERDAM, V193, P136, DOI 10.1016/j.scienta.2015.07.007; Tomaras AP, 2014, MBIO, V5, DOI 10.1128/mBio.01551-14; Varghese P., 2015, J STUDENT RES, V4, P87; Vijayan A., 2017, J NATURAL PRODUCTS R, V3, P125; Whittington DA, 2003, P NATL ACAD SCI USA, V100, P8146, DOI 10.1073/pnas.1432990100; Wu Q, 2013, ARCH PHARM RES, V36, P423, DOI 10.1007/s12272-013-0068-8; Yee LW, 2007, MALAYSIAN J NUTR, V13, P71; YILDIZ F, 1981, J FOOD SCI, V46, P962, DOI 10.1111/j.1365-2621.1981.tb15397.x; [周璐 Zhou Lu], 2017, [机械传动, Journal of Mechanical Transmission], V41, P1	68	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0203306	10.1371/journal.pone.0203306	http://dx.doi.org/10.1371/journal.pone.0203306			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281596	Green Submitted, Green Published, gold			2022-12-26	WOS:000446342400018
J	Gokmen-Polar, Y; True, JD; Vieth, E; Gu, Y; Gu, XP; Qi, GD; Mosley, AL; Badve, SS				Gokmen-Polar, Yesim; True, Jason D.; Vieth, Edyta; Gu, Yuan; Gu, Xiaoping; Qi, Guihong D.; Mosley, Amber L.; Badve, Sunil S.			Quantitative phosphoproteomic analysis identifies novel functional pathways of tumor suppressor DLC1 in estrogen receptor positive breast cancer	PLOS ONE			English	Article							PROMOTER HYPERMETHYLATION; METASTASIS SUPPRESSOR; GENE; PROTEIN; LIVER; EXPRESSION; METHYLATION; ECT2; PHOSPHORYLATION; GROWTH	Deleted in Liver Cancer-1 (DLC1), a member of the RhoGAP family of proteins, functions as a tumor suppressor in several cancers including breast cancer. However, its clinical relevance is unclear in breast cancer. In this study, expression of DLC1 was correlated with prognosis using publicly available breast cancer gene expression datasets and quantitative Reverse Transcription PCR in cohorts of Estrogen Receptor-positive (ER+) breast cancer. Low expression of DLC1 correlates with poor prognosis in patients with ER+ breast cancer with further decrease in metastatic lesions. The Cancer Genome Atlas (TCGA) data showed that down regulation of DLC1 is not due to methylation or mutations. To seek further insights in understanding the role of DLC1 in ER+ breast cancer, we stably overexpressed DLC1-full-length (DLC1-FL) in T-47D breast cancer cells; this inhibited cell colony formation significantly in vitro compared to its control counterpart. Label-free global proteomic and TiO2 phosphopeptide enrichment assays (ProteomeXchange identifier PXD008220) showed that 205 and 122 phosphopeptides were unique to DLC1-FL cells and T-47D-control cells, respectively, whereas 6,726 were quantified by phosphoproteomics analysis in both conditions. The top three significant clusters of differentially phosphopeptides identified by DAVID pathway analysis represent cell-cell adhesion, mRNA processing and splicing, and transcription regulation. Phosphoproteomics analysis documented an inverse relation between DLC1 expression and several phosphopeptides including epithelial cell transforming sequence 2 (ECT2). Decreased phosphorylation of ECT2 at the residue T359, critical for its active conformational change, was validated by western blot. In addition, the ECT2 T359-containing phosphopeptide was detected in both basal and luminal patient-derived breast cancers breast cancer phosphoproteomics data on the Clinical Proteomic Tumor Analysis Consortium (CPTAC) Assay portal. Together, for the first time, this implicates ECT2 phosphorylation in breast cancer, which has been proposed as a therapeutic target in lung cancer. In conclusion, this data suggests that low expression of DLC1 is associated with poor prognosis. Targeting ECT2 phosphopeptides could provide a promising mechanism for controlling poor prognosis seen in DLC1(low) ER+ breast cancer.	[Gokmen-Polar, Yesim; Vieth, Edyta; Gu, Yuan; Gu, Xiaoping; Badve, Sunil S.] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [True, Jason D.; Qi, Guihong D.; Mosley, Amber L.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Badve, Sunil S.] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Badve, Sunil S.] Indiana Univ, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46204 USA; [True, Jason D.] Ball State Univ, Dept Biol, Muncie, IN 47306 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis; Ball State University	Gokmen-Polar, Y (corresponding author), Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA.	ypolar@iu.edu	Gokmen-Polar, Yesim/AAX-4001-2021	Gokmen-Polar, Yesim/0000-0001-9927-4893; Vieth, Edyta/0000-0002-7413-9078; Badve, Sunil/0000-0001-8861-9980	Susan G. Komen for the Cure(R); Joshua Edwards Professor of Pathology & Laboratory Medicine Funds	Susan G. Komen for the Cure(R)(Susan G. Komen Breast Cancer Foundation); Joshua Edwards Professor of Pathology & Laboratory Medicine Funds	This work was partly supported by the Susan G. Komen for the Cure (R) and Joshua Edwards Professor of Pathology & Laboratory Medicine Funds to Sunil Badve.	Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen J, 2015, CARDIOVASC DIABETOL, V14, P1, DOI DOI 10.1016/J.JHEP.2015.01.014; Dai XF, 2015, G3-GENES GENOM GENET, V5, P81, DOI 10.1534/g3.114.014894; Deutsch EW, 2017, NUCLEIC ACIDS RES, V45, pD1100, DOI 10.1093/nar/gkw936; Durkin ME, 2007, J CELL MOL MED, V11, P1185, DOI 10.1111/j.1582-4934.2007.00098.x; Dydensborg AB, 2009, ONCOGENE, V28, P2634, DOI 10.1038/onc.2009.126; El-Sitt S, 2013, J RECEPT SIG TRANSD, V33, P10, DOI 10.3109/10799893.2012.752002; Fields AP, 2010, ADV ENZYME REGUL, V50, P190, DOI 10.1016/j.advenzreg.2009.10.010; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gokmen-Polar Y, 2015, MODERN PATHOL, V28, P677, DOI 10.1038/modpathol.2014.146; Gokmen-Polar Y, 2011, BREAST CANCER RES TR, V127, P375, DOI 10.1007/s10549-010-1004-y; Gokmen-Polar Y, 2010, BREAST CANCER RES TR, V124, P327, DOI 10.1007/s10549-010-0733-2; Goodison S, 2005, CANCER RES, V65, P6042, DOI 10.1158/0008-5472.CAN-04-3043; Guan M, 2006, CLIN CANCER RES, V12, P1412, DOI 10.1158/1078-0432.CCR-05-1906; Guo ZH, 2017, MED ONCOL, V34, DOI 10.1007/s12032-016-0872-3; Hara T, 2006, ONCOGENE, V25, P566, DOI 10.1038/sj.onc.1209078; Hebert AS, 2014, MOL CELL PROTEOMICS, V13, P339, DOI 10.1074/mcp.M113.034769; Huff Lauren P, 2013, Genes Cancer, V4, P460, DOI 10.1177/1947601913514851; Iyoda M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014082; Justilien Verline, 2019, Small GTPases, V10, P388, DOI 10.1080/21541248.2017.1335274; Justilien V, 2017, CANCER CELL, V31, P256, DOI 10.1016/j.ccell.2016.12.010; Justilien V, 2011, J BIOL CHEM, V286, P8149, DOI 10.1074/jbc.M110.196113; Kim TY, 2003, ONCOGENE, V22, P3943, DOI 10.1038/sj.onc.1206573; Ko FCF, 2014, INT J CANCER, V135, P264, DOI 10.1002/ijc.28505; Lahoz A, 2008, GENE DEV, V22, P1724, DOI 10.1101/gad.1691408; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200; Liao YC, 2008, INT J BIOCHEM CELL B, V40, P843, DOI 10.1016/j.biocel.2007.04.008; Lukasik D, 2011, ONCOL LETT, V2, P763, DOI 10.3892/ol.2011.345; Mansour M, 2016, CANCER RES, V76, P4236, DOI 10.1158/0008-5472.CAN-15-1553; Mertins P, 2014, MOL CELL PROTEOMICS, V13, P1690, DOI 10.1074/mcp.M113.036392; MIKI T, 1993, NATURE, V362, P462, DOI 10.1038/362462a0; Mosley AL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000687; Mosley AL, 2009, J PROTEOMICS, V72, P110, DOI 10.1016/j.jprot.2008.10.008; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Perez-Riverol Y, 2016, MOL CELL PROTEOMICS, V15, P305, DOI 10.1074/mcp.O115.050229; Plaumann M, 2003, J CANCER RES CLIN, V129, P349, DOI 10.1007/s00432-003-0440-z; Popescu NC, 2014, MOL DIAGN THER, V18, P293, DOI 10.1007/s40291-014-0086-3; Ringner M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017911; Seng TJ, 2007, ONCOGENE, V26, P934, DOI 10.1038/sj.onc.1209839; Smith-Kinnaman WR, 2014, MOL BIOSYST, V10, P1730, DOI 10.1039/c4mb00109e; Song YF, 2006, J CLIN PATHOL, V59, P947, DOI 10.1136/jcp.2005.031377; Sparano JA, 2015, NEW ENGL J MED, V373, P2005, DOI 10.1056/NEJMoa1510764; Taylor KH, 2007, CANCER RES, V67, P2617, DOI 10.1158/0008-5472.CAN-06-3993; Teramoto A, 2004, ONCOL REP, V12, P141; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wang HB, 2016, CLIN TRANSL ONCOL, V18, P735, DOI 10.1007/s12094-015-1428-2; Wang X, 2018, CANCER RES, V78; Wang YF, 2014, J CLIN INVEST, V124, P1646, DOI 10.1172/JCI71812; Xue W, 2008, GENE DEV, V22, P1439, DOI 10.1101/gad.1672608; Yuan BZ, 1998, CANCER RES, V58, P2196; Yuan BZ, 2004, ONCOGENE, V23, P1405, DOI 10.1038/sj.onc.1207291; Yuan BZ, 2003, ONCOGENE, V22, P445, DOI 10.1038/sj.onc.1206064; Zhang T, 2009, UROL INT, V82, P380, DOI 10.1159/000218524	53	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0204658	10.1371/journal.pone.0204658	http://dx.doi.org/10.1371/journal.pone.0204658			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3QJ	30278072	Green Published, Green Submitted, gold			2022-12-26	WOS:000446010200019
J	Egieyeh, S; Syce, J; Malan, SF; Christoffels, A				Egieyeh, Samuel; Syce, James; Malan, Sarel F.; Christoffels, Alan			Predictive classifier models built from natural products with antimalarial bioactivity using machine learning approach	PLOS ONE			English	Article							APPLICABILITY DOMAIN; DRUG DEVELOPMENT; ATTRITION; MALARIA; VIRULENCE	In view of the vast number of natural products with potential antiplasmodial bioactivity and cost of conducting antiplasmodial bioactivity assays, it may be judicious to learn from previous antiplasmodial bioassays and predict bioactivity of these natural products before experimental bioassays. This study set out to harness antimalarial bioactivity data of natural products to build accurate predictive models, utilizing classical machine learning approaches, which can find potential antimalarial hits from new sets of natural products. Classical machine learning approaches were used to build four classifier models (Naive Bayesian, Voted Perceptron, Random Forest and Sequence Minimization Optimization of Support Vector Machines) from bioactivity data of natural products with in-vitro antiplasmodial activity (NAA) using a combination of the molecular descriptors and two-dimensional molecular fingerprints of the compounds. Models were evaluated with an independent test dataset. Possible chemical features associated with reported antimalarial activities of the compounds were also extracted. From the results, Random Forest (accuracy 82.81%, Kappa statistics 0.65 and Area under Receiver Operating Characteristics curve 0.91) and Sequential Minimization Optimization (accuracy 85.93%, Kappa statistics 0.72 and Area under Receiver Operating Characteristics curve 0.86) showed good predictive performance for the NAA dataset. The amine chemical group (specifically alkyl amines and basic nitrogen) was confirmed to be essential for antimalarial activity in active NAA dataset. This study built and evaluated classifier models that were used to predict the antiplasmodial bioactivity class (active or inactive) of a set of natural products from interBioScreen chemical library.	[Egieyeh, Samuel; Christoffels, Alan] Univ Western Cape, South African Natl Bioinformat Inst, South African Med Res Council Bioinformat Unit, Cape Town, South Africa; [Egieyeh, Samuel; Syce, James; Malan, Sarel F.] Univ Western Cape, Sch Pharm, Cape Town, South Africa	University of the Western Cape; University of the Western Cape	Egieyeh, S (corresponding author), Univ Western Cape, South African Natl Bioinformat Inst, South African Med Res Council Bioinformat Unit, Cape Town, South Africa.; Egieyeh, S (corresponding author), Univ Western Cape, Sch Pharm, Cape Town, South Africa.	segieyeh@uwc.ac.za	Malan, Sarel/AAA-4189-2020	Malan, Sarel/0000-0002-1640-6457	South African Research Chairs Initiative of the Department of Science and Technology (DST); National Research Foundation (NRF) of South Africa [UID-64751]; National Research Foundation (NRF) of South Africa	South African Research Chairs Initiative of the Department of Science and Technology (DST); National Research Foundation (NRF) of South Africa(National Research Foundation - South Africa); National Research Foundation (NRF) of South Africa(National Research Foundation - South Africa)	This work was supported by South African Research Chairs Initiative of the Department of Science and Technology (DST) and the National Research Foundation (NRF) of South Africa http://www.nrf.ac.za. Grant number: UID-64751. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to acknowledge William Jose, Godinez Navarro and Azzaoui Kamal all of Novartis Institute for Biomedical Research (NIBR), Basel Switzerland for reading this paper and making valuable contributions. The South African Research Chairs Initiative of the Department of Science and Technology (DST) and the National Research Foundation (NRF) of South Africa supported this work.	[Anonymous], 2005, P 1 INT WORKSH OP SO; Barnes PJ, 2015, EUR RESPIR J, V45, P1197, DOI 10.1183/09031936.00007915; Bathurst I, 2006, TRENDS PARASITOL, V22, P301, DOI 10.1016/j.pt.2006.05.011; Batista R, 2009, MOLECULES, V14, P3037, DOI 10.3390/molecules14083037; Berthold M., 2009, ACM SIGKDD EXPLOR NE, V11, P26, DOI [10.1145/1656274.1656280, DOI 10.1145/1656274.1656280]; Berthold M. R., 2008, KNIME KONSTANZ INFOR; Bull PC, 2002, TRENDS MICROBIOL, V10, P55, DOI 10.1016/S0966-842X(01)02278-8; Burgess D., 2014, NAT REV GENET, V15, P147; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Christensen SB, 2001, BIOACTIVE COMPOUNDS FROM NATURAL SOURCES: ISOLATION CHARACTERISATION AND BIOLOGICAL PROPERTIES, P379; Chu W, 2007, NEURAL COMPUT, V19, P792, DOI 10.1162/neco.2007.19.3.792; Davis RA, 2012, J MED CHEM, V55, P5851, DOI 10.1021/jm3002795; Drummond C, 2006, COST CURVES IMPROVED; Fang, 2015, MESOZOIC CENOZOIC IN, P1, DOI DOI 10.1007/S11517-014-1207-1; Ferri N, 2013, PHARMACOL THERAPEUT, V138, P470, DOI 10.1016/j.pharmthera.2013.03.005; Frederich M, 2008, T ROY SOC TROP MED H, V102, P11, DOI 10.1016/j.trstmh.2007.10.002; GUPTA S, 1994, P NATL ACAD SCI USA, V91, P3715, DOI 10.1073/pnas.91.9.3715; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Hajian-Tilaki K, 2013, CASP J INTERN MED, V4, P627; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Jamal S, 2013, BMC BIOINFORMATICS, V14; Jamal S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-329; James G., 2014, INTRO STAT LEARNING; Jaworska J, 2005, ATLA-ALTERN LAB ANIM, V33, P445, DOI 10.1177/026119290503300508; Ji SH, 2007, PATTERN RECOGN, V40, P1474, DOI 10.1016/j.patcog.2006.11.008; Jimenez-Valverde A, 2012, GLOBAL ECOL BIOGEOGR, V21, P498, DOI 10.1111/j.1466-8238.2011.00683.x; Kaestli M, 2006, J INFECT DIS, V193, P1567, DOI 10.1086/503776; Kaur K, 2009, BIOORGAN MED CHEM, V17, P3229, DOI 10.1016/j.bmc.2009.02.050; Klein EY, 2013, INT J ANTIMICROB AG, V41, P311, DOI 10.1016/j.ijantimicag.2012.12.007; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Landrum G, 2014, OPEN SOURCE CHEMINFO; Landrum G., 2013, RELEASE, V1, P4; Loukeris N, 2015, INT J FINANCE EC; Martisius Ignas, 2013, International Journal of Artificial Intelligence, V10, P41; Mayer AMS, 2011, COMP BIOCHEM PHYS C, V153, P191, DOI 10.1016/j.cbpc.2010.08.008; Mazanetz MP, 2012, CURR TOP MED CHEM, V12, P1965; Meinl T, 2009, KONSTANZ INFORM MINE; Mojab F, 2012, AVICENNA J PHYTOMEDI, V2, P52; Nidhi, 2006, J CHEM INF MODEL, V46, P1124, DOI 10.1021/ci060003g; Nogueira CR, 2011, MOLECULES, V16, P2146, DOI 10.3390/molecules16032146; NUR EM, 1993, SOC SCI MED, V37, P1115, DOI 10.1016/0277-9536(93)90250-8; Periwal V, 2011, BMC RES NOTES, V4; Roberts RA, 2014, DRUG DISCOV TODAY, V19, P341, DOI 10.1016/j.drudis.2013.11.014; Russell S, 2004, AM J TROP MED HYG, V71, P147, DOI 10.4269/ajtmh.2004.71.147; Sahigara F, 2012, MOLECULES, V17, P4791, DOI 10.3390/molecules17054791; Severini C, 2015, J GLOBAL ANTIMICROBI; Sharma I, 2015, ANTIMICROB AGENTS CH; Sheridan RP, 2012, J CHEM INF MODEL, V52, P814, DOI 10.1021/ci300004n; Singh H, 2015, BIOL DIRECT, V10; Spangenberg T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062906; Wang YL, 2009, NUCLEIC ACIDS RES, V37, pW623, DOI 10.1093/nar/gkp456; Xu YJ, 2013, MINI-REV MED CHEM, V13, P1056, DOI 10.2174/1389557511313070009	52	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204644	10.1371/journal.pone.0204644	http://dx.doi.org/10.1371/journal.pone.0204644			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265702	Green Published, Green Submitted, gold			2022-12-26	WOS:000446005500042
J	Porter, MM; Niksiar, P				Porter, Michael M.; Niksiar, Pooya			Multidimensional mechanics: Performance mapping of natural biological systems using permutated radar charts	PLOS ONE			English	Article							DARWINS FINCHES; ECOSYSTEM MULTIFUNCTIONALITY; HIERARCHICAL STRUCTURE; CORTICAL BONE; DESIGN; TENDON; VISUALIZATION; BIODIVERSITY; ADAPTATION; TOUGHNESS	Comparing the functional performance of biological systems often requires comparing multiple mechanical properties. Such analyses, however, are commonly presented using orthogonal plots that compare N <= 3 properties. Here, we develop a multidimensional visualization strategy using permutated radar charts (radial, multi-axis plots) to compare the relative performance distributions of mechanical systems on a single graphic across N >= 3 properties. Leveraging the fact that radar charts plot data in the form of closed polygonal profiles, we use shape descriptors for quantitative comparisons. We identify mechanical property-function correlations distinctive to rigid, flexible, and damage-tolerant biological materials in the form of structural ties, beams, shells, and foams. We also show that the microstructures of dentin, bone, tendon, skin, and cartilage dictate their tensile performance, exhibiting a trade-off between stiffness and extensibility. Lastly, we compare the feeding versus singing performance of Darwin's finches to demonstrate the potential of radar charts for multidimensional comparisons beyond mechanics of materials.	[Porter, Michael M.; Niksiar, Pooya] Clemson Univ, Dept Mech Engn, Clemson, SC 29634 USA	Clemson University	Porter, MM (corresponding author), Clemson Univ, Dept Mech Engn, Clemson, SC 29634 USA.	mmporte@clemson.edu	Porter, Michael/A-4895-2016	Porter, Michael/0000-0002-1607-6531				Achrai B, 2017, J MECH BEHAV BIOMEDI; Albo Y, 2016, IEEE T VIS COMPUT GR, V22, P569, DOI 10.1109/TVCG.2015.2467322; Albuquerque G., 2010, 2010 Proceedings of IEEE Symposium on Visual Analytics Science and Technology (VAST 2010), P19, DOI 10.1109/VAST.2010.5652433; Ankerst M, 1998, IEEE SYMPOSIUM ON INFORMATION VISUALIZATION - PROCEEDINGS, P52, DOI 10.1109/INFVIS.1998.729559; Ashby M. F., 2017, MAT SELECTION MECH D; Ashby MF, 2000, ACTA MATER, V48, P359, DOI 10.1016/S1359-6454(99)00304-3; ASKEW MJ, 1978, J BIOMECH ENG-T ASME, V100, P105, DOI 10.1115/1.3426200; Barthelat F, 2007, J MECH PHYS SOLIDS, V55, P306, DOI 10.1016/j.jmps.2006.07.007; Barthelat F, 2011, J MECH PHYS SOLIDS, V59, P829, DOI 10.1016/j.jmps.2011.01.001; Bechthold M, 2017, NAT REV MATER, V2, DOI 10.1038/natrevmats.2017.82; Byrnes JEK, 2014, METHODS ECOL EVOL, V5, P111, DOI 10.1111/2041-210X.12143; Campas O, 2010, P NATL ACAD SCI USA, V107, P3356, DOI 10.1073/pnas.0911575107; CHAMBERLAIN JA, 1978, PALEOBIOLOGY, V4, P419, DOI 10.1017/S0094837300006163; Chandrasekaran P, 2017, J BIOMECH, V60, P134, DOI 10.1016/j.jbiomech.2017.06.031; Claessen JHT, 2011, IEEE T VIS COMPUT GR, V17, P2310, DOI 10.1109/TVCG.2011.201; Clemmer J, 2010, J BIOMECH, V43, P2785, DOI 10.1016/j.jbiomech.2010.06.009; Dickinson MH, 2000, SCIENCE, V288, P100, DOI 10.1126/science.288.5463.100; Draper GM, 2009, IEEE T VIS COMPUT GR, V15, P759, DOI 10.1109/TVCG.2009.23; EASTERLING KE, 1982, P ROY SOC LOND A MAT, V383, P31, DOI 10.1098/rspa.1982.0118; ELLIOTT DH, 1965, BIOL REV, V40, P392, DOI 10.1111/j.1469-185X.1965.tb00808.x; Feldman R, 2013, SOC INDIC RES, V111, P709, DOI 10.1007/s11205-012-0028-6; Floater MS, 2003, COMPUT AIDED GEOM D, V20, P19, DOI 10.1016/S0167-8396(03)00002-5; Flusser J., 2009, MOMENTS MOMENT INVAR; Fox AJS, 2009, SPORTS HEALTH, V1, P461, DOI 10.1177/1941738109350438; Fratzl P., 2008, COLLAGEN STRUCTURE M; Fratzl P, 2007, PROG MATER SCI, V52, P1263, DOI 10.1016/j.pmatsci.2007.06.001; George WT, 2005, J ORTHOP RES, V23, P1047, DOI 10.1016/j.orthres.2005.02.008; Goldberg Michel, 2011, Front Biosci (Elite Ed), V3, P711, DOI 10.2741/e281; Gosline JM, 1999, J EXP BIOL, V202, P3295; Hamed E, 2012, ACTA BIOMATER, V8, P1080, DOI 10.1016/j.actbio.2011.11.010; Harrington MJ, 2010, SCIENCE, V328, P216, DOI 10.1126/science.1181044; Herrel A, 2010, EMU, V110, P39, DOI 10.1071/MU09034; Herrel A, 2009, FUNCT ECOL, V23, P119, DOI 10.1111/j.1365-2435.2008.01494.x; Hoffman P., 1997, P VISUALIZATION, V97, P437; Huang W, 2017, ACTA BIOMATER, V64, P1, DOI 10.1016/j.actbio.2017.09.043; Jaccard P., 1902, B SOC VAUD SCI NAT, V38, P69, DOI [DOI 10.5169/SEALS-266762, 10.5169/seals-266762]; Kandogan E., 2000, P IEEE INF VIS S, V650, P22, DOI DOI 10.1145/502512.502530; Kinney JH, 2003, CRIT REV ORAL BIOL M, V14, P13, DOI 10.1177/154411130301400103; Kjaer M, 2004, PHYSIOL REV, V84, P649, DOI 10.1152/physrev.00031.2003; Krzywinski M, 2013, NAT METHODS, V10, P595, DOI 10.1038/nmeth.2531; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.1111/j.1558-5646.1983.tb00236.x; Lehmann DJ, 2016, COMPUT GRAPH FORUM, V35, P443, DOI 10.1111/cgf.12845; LEU JG, 1991, PATTERN RECOGN, V24, P949, DOI 10.1016/0031-3203(91)90092-J; Liu SS, 2017, IEEE T VIS COMPUT GR, V23, P1249, DOI 10.1109/TVCG.2016.2640960; Liu WY, 2008, PROCEEDINGS OF 2008 INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND CYBERNETICS, VOLS 1-7, P857, DOI 10.1109/ICMLC.2008.4620524; McKittrick J, 2010, MAT SCI ENG C-MATER, V30, P331, DOI 10.1016/j.msec.2010.01.011; Meyers MA, 2013, SCIENCE, V339, P773, DOI 10.1126/science.1220854; Miettinen K., 2014, OR SPECTRUM, P1; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; Montagna W., 2012, STRUCTURE FUNCTION S; Naleway SE, 2015, ADV MATER, V27, P5455, DOI 10.1002/adma.201502403; Olszta MJ, 2007, MAT SCI ENG R, V58, P77, DOI 10.1016/j.mser.2007.05.001; Pasari JR, 2013, P NATL ACAD SCI USA, V110, P10219, DOI 10.1073/pnas.1220333110; Peng W, 2004, IEEE SYMPOSIUM ON INFORMATION VISUALIZATION 2004, PROCEEDINGS, P89; Peura M., 1997, P 3 INT WORKSH VIS F, V443, P451; Podos J, 2001, NATURE, V409, P185, DOI 10.1038/35051570; Ritchie RO, 2011, NAT MATER, V10, P817, DOI [10.1038/NMAT3115, 10.1038/nmat3115]; Rosario GE, 2003, INFOVIS 2002: IEEE SYMPOSIUM ON INFORMATION VISUALIZATION 2003, PROCEEDINGS, P113, DOI 10.1109/INFVIS.2003.1249016; Sacha D, 2016, IEEE T VIS COMPUT GR, V22, P240, DOI 10.1109/TVCG.2015.2467591; Sedlmair M, 2014, IEEE T VIS COMPUT GR, V20, P2161, DOI 10.1109/TVCG.2014.2346321; Sherman VR, 2015, J MECH BEHAV BIOMED, V52, P22, DOI 10.1016/j.jmbbm.2015.05.023; Shoval O, 2012, SCIENCE, V336, P1157, DOI 10.1126/science.1217405; Smith BL, 1999, NATURE, V399, P761, DOI 10.1038/21607; Soons J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129479; Sullivan TN, 2017, MAT TODAY; Tan T, 2011, ACTA BIOMATER, V7, P3796, DOI 10.1016/j.actbio.2011.06.008; Tebbich S, 2002, ECOL LETT, V5, P656, DOI 10.1046/j.1461-0248.2002.00370.x; Long TV, 2015, PROC INT CONF ADV, P297, DOI 10.1109/ATC.2015.7388338; Wainwright PC, 2005, INTEGR COMP BIOL, V45, P256, DOI 10.1093/icb/45.2.256; Wegst UGK, 2004, PHILOS MAG, V84, P2167, DOI 10.1080/14786430410001680935; Wegst UGK, 2015, NAT MATER, V14, P23, DOI [10.1038/NMAT4089, 10.1038/nmat4089]; Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271; Wong B, 2012, NAT METHODS, V9, P1131, DOI 10.1038/nmeth.2258; Wong B, 2010, NAT METHODS, V7, P665, DOI 10.1038/nmeth0910-665; Yang W, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7649; Yaraghi NA, 2018, ANNU REV PHYS CHEM, V69, P23, DOI 10.1146/annurev-physchem-040215-112621; Zhang DS, 2004, PATTERN RECOGN, V37, P1, DOI 10.1016/j.patcog.2003.07.008	78	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204309	10.1371/journal.pone.0204309	http://dx.doi.org/10.1371/journal.pone.0204309			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265707	Green Published, gold, Green Submitted			2022-12-26	WOS:000446005500029
J	Carpinone, EM; Li, ZR; Mills, MK; Foltz, C; Brannon, ER; Carlow, CKS; Starai, VJ				Carpinone, Emily M.; Li, Zhiru; Mills, Michael K.; Foltz, Clemence; Brannon, Emma R.; Carlow, Clotilde K. S.; Starai, Vincent J.			Identification of putative effectors of the Type IV secretion system from the Wolbachia endosymbiont of Brugia malayi	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; ARP2/3 COMPLEX; BUDDING YEAST; ACTIN CYTOSKELETON; FAMILY PROTEINS; VACUOLE; BINDING; GENES; WASP; ENDOCYTOSIS	Wolbachia is an unculturable, intracellular bacterium that persists within an extremely broad range of arthropod and parasitic nematode hosts, where it is transmitted maternally to offspring via vertical transmission. In the filarial nematode Brugia malayi, a causative agent of human lymphatic filariasis, Wolbachia is an endosymbiont, and its presence is essential for proper nematode development, survival, and pathogenesis. While the elucidation of Wolbachia: nematode interactions that promote the bacterium's intracellular persistence is of great importance, research has been hampered due to the fact that Wolbachia cannot be cultured in the absence of host cells. The Wolbachia endosymbiont of B. malayi (wBm) has an active Type IV secretion system (T4SS). Here, we have screened 47 putative T4SS effector proteins of wBm for their ability to modulate growth or the cell biology of a typical eukaryotic cell, Saccharomyces cerevisiae. Five candidates strongly inhibited yeast growth upon expression, and 6 additional proteins showed toxicity in the presence of zinc and caffeine. Studies on the uptake of an endocytic vacuole-specific fluorescent marker, FM4-64, identified 4 proteins (wBm0076 wBm00114, wBm0447 and wBm0152) involved in vacuole membrane dynamics. The WAS(p)-family protein, wBm0076, was found to colocalize with yeast cortical actin patches and disrupted actin cytoskeleton dynamics upon expression. Deletion of the Arp2/3-activating protein, Abp1p, provided resistance to wBm0076 expression, suggesting a role for wBm0076 in regulating eukaryotic actin dynamics and cortical actin patch formation. Furthermore, wBm0152 was found to strongly disrupt endosome: vacuole cargo trafficking in yeast. This study provides molecular insight into the potential role of the T4SS in the Wolbachia endosymbiont: nematode relationship.	[Carpinone, Emily M.; Mills, Michael K.; Brannon, Emma R.; Starai, Vincent J.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [Li, Zhiru; Foltz, Clemence; Carlow, Clotilde K. S.] New England Biolabs Inc, Div Genome Biol, Ipswich, MA USA; [Starai, Vincent J.] Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA	University System of Georgia; University of Georgia; New England Biolabs; University System of Georgia; University of Georgia	Starai, VJ (corresponding author), Univ Georgia, Dept Microbiol, Athens, GA 30602 USA.; Starai, VJ (corresponding author), Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA.	vjstarai@uga.edu		Mills, Michael/0000-0002-9545-9564; Foltz, Clemence/0000-0001-7385-4152	National Institute of Allergy and Infectious Diseases [R01AI100913]; National Science Foundation; New England Biolabs, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100913] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Science Foundation(National Science Foundation (NSF)); New England Biolabs, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	V.J.S. was supported by the National Institute of Allergy and Infectious Diseases grant R01AI100913 (www.nih.gov). E.M.C. was supported by a Graduate Research Fellowship from the National Science Foundation (www.nsfgrfp.org). Z.L., C.F., and C.K.S.C. were financially supported by New England Biolabs, Inc. The funders had no role in study design data collection and analysis, or preparation of the manuscript. New England Biolabs approved the final submission of this manuscript. New England Biolabs provided support in the form of salaries for authors [ZL, CF and CKSC] but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aghamohammadzadeh S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103311; Aleman A, 2009, FEMS MICROBIOL LETT, V296, P167, DOI 10.1111/j.1574-6968.2009.01630.x; Babst M, 2011, CURR OPIN CELL BIOL, V23, P452, DOI 10.1016/j.ceb.2011.04.008; BANTA LM, 1988, J CELL BIOL, V107, P1369, DOI 10.1083/jcb.107.4.1369; Banuelos MG, 2010, CURR GENET, V56, P121, DOI 10.1007/s00294-009-0285-3; Bennett TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056798; Bennuru S, 2016, MBIO, V7, DOI 10.1128/mBio.02028-16; Bone N, 1998, CURR BIOL, V8, P135, DOI 10.1016/S0960-9822(98)00060-8; Cho KO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022703; Colwill K, 1999, GENETICS, V152, P881; D'Silva S, 2011, RNA, V17, P1100, DOI 10.1261/rna.2652611; de Felipe KS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000117; de Felipe KS, 2005, J BACTERIOL, V187, P7716, DOI 10.1128/JB.187.22.7716-7726.2005; Debrah AY, 2007, TROP MED INT HEALTH, V12, P1433, DOI 10.1111/j.1365-3156.2007.01949.x; Debrah Alexander Yaw, 2011, J Parasitol Res, V2011, P201617, DOI 10.1155/2011/201617; Du J, 2016, P NATL ACAD SCI USA, V113, P4794, DOI 10.1073/pnas.1520699113; Fernandez-Pinar P, 2012, MOL BIOL CELL, V23, P4430, DOI 10.1091/mbc.E12-03-0243; Fischer K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086383; Fischer K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001174; Foster J, 2005, PLOS BIOL, V3, P599, DOI 10.1371/journal.pbio.0030121; Gao CY, 2000, BIOTECHNIQUES, V29, P1226, DOI 10.2144/00296st02; Genty LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094577; Goode BL, 2001, J CELL BIOL, V153, P627, DOI 10.1083/jcb.153.3.627; Gouin E, 2004, NATURE, V427, P457, DOI 10.1038/nature02318; Gourlay CW, 2003, J CELL SCI, V116, P2551, DOI 10.1242/jcs.00454; HICKE L, 1990, BIOESSAYS, V12, P253, DOI 10.1002/bies.950120602; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Hoerauf A, 2001, LANCET, V357, P1415, DOI 10.1016/S0140-6736(00)04581-5; Huckaba TM, 2004, J CELL BIOL, V167, P519, DOI 10.1083/jcb.200404173; Ireton K, 1997, ANNU REV GENET, V31, P113, DOI 10.1146/annurev.genet.31.1.113; Kaksonen M, 2003, CELL, V115, P475, DOI 10.1016/S0092-8674(03)00883-3; Katzmann DJ, 2004, MOL BIOL CELL, V15, P468, DOI 10.1091/mbc.E03-07-0473; Kucharczyk R, 1999, YEAST, V15, P987, DOI 10.1002/(SICI)1097-0061(199907)15:10B<987::AID-YEA403>3.0.CO;2-5; Landmann F, 2012, BIOL OPEN, V1, P536, DOI 10.1242/bio.2012737; Landmann F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002351; Landmann F, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000758; Lee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067902; Lesser CF, 2001, EMBO J, V20, P1840, DOI 10.1093/emboj/20.8.1840; Li ZR, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035834, 10.1371/journal.pone.0051597]; Lloubes R, 2001, RES MICROBIOL, V152, P523, DOI 10.1016/S0923-2508(01)01226-8; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; MacDonald C, 2012, TRAFFIC, V13, P586, DOI 10.1111/j.1600-0854.2011.01326.x; Malek JA, 2004, NUCLEIC ACIDS RES, V32, P1059, DOI 10.1093/nar/gkh254; MATILE P, 1967, ARCH MIKROBIOL, V56, P148, DOI 10.1007/BF00408765; McNatt MW, 2007, MOL BIOL CELL, V18, P697, DOI 10.1091/mbc.E06-08-0663; Melnikow E, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002151; Melnikow E, 2011, INT J PARASITOL, V41, P1053, DOI 10.1016/j.ijpara.2011.05.008; Michel LV, 2015, MICROBIOL-SGM, V161, P1251, DOI 10.1099/mic.0.000084; Michelot A, 2013, DEV CELL, V24, P182, DOI 10.1016/j.devcel.2012.12.008; Molyneux DH, 2003, TRENDS PARASITOL, V19, P516, DOI 10.1016/j.pt.2003.09.004; MULHOLLAND J, 1994, J CELL BIOL, V125, P381, DOI 10.1083/jcb.125.2.381; Naqvi SN, 1998, CURR BIOL, V8, P959, DOI 10.1016/S0960-9822(98)70396-3; Newton ILG, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004798; Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9; Pan XX, 2008, SCIENCE, V320, P1651, DOI 10.1126/science.1158160; Pelham HRB, 2002, CURR OPIN CELL BIOL, V14, P454, DOI 10.1016/S0955-0674(02)00352-6; Peplowska K, 2007, DEV CELL, V12, P739, DOI 10.1016/j.devcel.2007.03.006; Peterson MR, 2001, TRAFFIC, V2, P476, DOI 10.1034/j.1600-0854.2001.20705.x; Pinyol R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000400; Rances E, 2008, J BACTERIOL, V190, P5020, DOI 10.1128/JB.00377-08; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; Reinke A, 2006, J BIOL CHEM, V281, P31616, DOI 10.1074/jbc.M603107200; Renvoise A, 2011, TRENDS MOL MED, V17, P573, DOI 10.1016/j.molmed.2011.05.009; Rice DW, 2017, GENOME BIOL EVOL, V9, P1925, DOI 10.1093/gbe/evx139; Rodal AA, 2003, CURR BIOL, V13, P1000, DOI 10.1016/S0960-9822(03)00383-X; ROTHMAN JH, 1986, CELL, V47, P1041, DOI 10.1016/0092-8674(86)90819-6; Sahin A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002556; Sato TK, 2000, MOL CELL, V6, P661, DOI 10.1016/S1097-2765(00)00064-2; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schulein R, 2005, P NATL ACAD SCI USA, V102, P856, DOI 10.1073/pnas.0406796102; Seals DF, 2000, P NATL ACAD SCI USA, V97, P9402, DOI 10.1073/pnas.97.17.9402; Seeley ES, 2002, MOL BIOL CELL, V13, P782, DOI 10.1091/mbc.01-10-0512; Sheehan KB, 2016, MBIO, V7, DOI 10.1128/mBio.00622-16; Shohdy N, 2005, P NATL ACAD SCI USA, V102, P4866, DOI 10.1073/pnas.0501315102; Sisko JL, 2006, MOL MICROBIOL, V60, P51, DOI 10.1111/j.1365-2958.2006.05074.x; Slagowski NL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040009; Sreelatha A, 2015, P NATL ACAD SCI USA, V112, P100, DOI 10.1073/pnas.1413764111; Stamnes M, 2002, CURR OPIN CELL BIOL, V14, P428, DOI 10.1016/S0955-0674(02)00349-6; Stolk WA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004560; Sun YD, 2006, DEV CELL, V11, P33, DOI 10.1016/j.devcel.2006.05.008; Takenawa T, 2001, J CELL SCI, V114, P1801; Taylor MJ, 2014, PARASITOLOGY, V141, P119, DOI 10.1017/S0031182013001108; Taylor MJ, 2010, LANCET, V376, P1175, DOI 10.1016/S0140-6736(10)60586-7; Taylor MJ, 2005, LANCET, V365, P2116, DOI 10.1016/S0140-6736(05)66591-9; Taylor MJ, 1999, EXP PARASITOL, V91, P356, DOI 10.1006/expr.1998.4383; Veltman DM, 2010, MOL BIOL CELL, V21, P2880, DOI 10.1091/mbc.E10-04-0372; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Voronin D, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0462-1; Voronin D, 2012, P NATL ACAD SCI USA, V109, pE1638, DOI 10.1073/pnas.1203519109; Voth DE, 2012, FUTURE MICROBIOL, V7, P241, DOI [10.2217/fmb.11.150, 10.2217/FMB.11.150]; Voth WP, 2003, YEAST, V20, P985, DOI 10.1002/yea.1018; WADA Y, 1992, J BIOL CHEM, V267, P18665; Webb GC, 1997, GENETICS, V147, P467; Welch MD, 1998, SCIENCE, V281, P105, DOI 10.1126/science.281.5373.105; Whitaker N, 2016, J BACTERIOL, V198, P2701, DOI 10.1128/JB.00378-16; Wickner W, 2010, ANNU REV CELL DEV BI, V26, P115, DOI 10.1146/annurev-cellbio-100109-104131; Wurmser AE, 2000, J CELL BIOL, V151, P551, DOI 10.1083/jcb.151.3.551; Zrieq R, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00081	99	10	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204736	10.1371/journal.pone.0204736	http://dx.doi.org/10.1371/journal.pone.0204736			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30261054	Green Submitted, Green Published, gold			2022-12-26	WOS:000445907400098
J	Siriboon, C; Li, TS; Yu, CW; Chern, JW; Ju, JC				Siriboon, Chawalit; Li, Tzai-Shiuan; Yu, Chao-Wu; Chern, Ji-Wang; Ju, Jyh-Cherng			Novel histone deacetylase inhibitors and embryo aggregation enhance cloned embryo development and ES cell derivation in pigs	PLOS ONE			English	Article							NUCLEAR TRANSFER EMBRYOS; IN-VITRO DEVELOPMENT; TRICHOSTATIN-A TREATMENT; PLURIPOTENT STEM-CELLS; BOVINE EMBRYOS; SIGNIFICANT IMPROVEMENT; CLONING EFFICIENCY; MOUSE CLONING; ACETYLATION; BLASTOCYSTS	The histone deacetylase inhibitor (HDACi) has been investigated for treating cancers and many other diseases as well as enhancing the reprogramming efficiency in cloned embryos for decades. In the present study, we investigated the effects of two novel HDAC inhibitors, i.e., HDACi-14 and -79, at the concentrations of 0, 1, 2, or 4 mu M on the development of embryos cloned by the oocyte bisection cloning technique (OBCT). Blastocyst rates for the reconstructed embryos reached 60% in the 2 mu M HDACi-14-treated groups, which was higher (P < 0.05) compared to the untreated group (36.9%). Similarly, HDACi-79 treatment at 2 and 4 mu M also conferred higher (P < 0.05) blastocyst rates than that of the untreated group (79.4, 74.2, and 50.0%, respectively). Both HDACi-14 and -79 treatments had no beneficial effect on total cell numbers and apoptotic indices of cloned embryos (P > 0.05). Histone acetylation profile by both HDACi-14 (2 mu M) and -79 (2 mu M) treatments demonstrated a drastic increase (P < 0.05) mainly in two-cell stage embryos when compared to the control group. After seeding on the feeder cells, the aggregated cloned blastocysts produced by the HDACi-79 treatment showed a significant increase of primary outgrowths compared to the control group (60.0% vs. 42.9%; P < 0.05). Finally, the cloned embryo-derived ES cell lines from aggregated cloned embryos produced from the HDACi-79-treated, HDACi-14-treated and control groups were established (5, 3, and 2 lines, respectively). In conclusion, the novel histone deacetylation inhibitors improve blastocyst formation and potentially increase the derivation efficiency of ES cell lines from the cloned porcine embryos produced in vitro. Depending on the purposes, some fine-tuning may be required to maximize its beneficial effects of these newly synthesized chemicals.	[Siriboon, Chawalit; Ju, Jyh-Cherng] China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan; [Siriboon, Chawalit] Ubon Ratchathani Univ, Dept Anim Sci, Fac Agr, Ubon Ratchathani, Thailand; [Li, Tzai-Shiuan; Ju, Jyh-Cherng] China Med Univ Hosp, Translat Med Res Ctr, Taichung, Taiwan; [Yu, Chao-Wu; Chern, Ji-Wang] Natl Taiwan Univ, Sch Pharm, Taipei, Taiwan; [Ju, Jyh-Cherng] Asia Univ, Dept Bioinformat & Med Engn, Taichung, Taiwan; [Ju, Jyh-Cherng] Natl Chung Hsing Univ, Dept Anim Sci, Taichung, Taiwan	China Medical University Taiwan; Ubon Ratchathani University; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Taiwan University; Asia University Taiwan; National Chung Hsing University	Ju, JC (corresponding author), China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan.; Ju, JC (corresponding author), China Med Univ Hosp, Translat Med Res Ctr, Taichung, Taiwan.; Ju, JC (corresponding author), Asia Univ, Dept Bioinformat & Med Engn, Taichung, Taiwan.; Ju, JC (corresponding author), Natl Chung Hsing Univ, Dept Anim Sci, Taichung, Taiwan.	jcju@dragon.nchu.edu.tw		Yu, Chao-Wu/0000-0002-5176-4225	Ministry of Science and Technology [104-2313-B-039-003, 105-2313-B-039-001, DMR-105-086]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	Ministry of Science and Technology, 104-2313-B-039-003 (https://www.most.gov.tw/?l=en) to J-CJ and MST# 105-2313-B-039-001 and DMR-105-086 (http://www.cmuh.cmu.edu.tw/en/index.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackwell L, 2008, LIFE SCI, V82, P1050, DOI 10.1016/j.lfs.2008.03.004; Boiani M, 2003, EMBO J, V22, P5304, DOI 10.1093/emboj/cdg507; Brevini TAL, 2010, STEM CELL REV REP, V6, P484, DOI 10.1007/s12015-010-9153-2; Byrne JA, 2007, NATURE, V450, P497, DOI 10.1038/nature06357; Carambula SF, 2009, BIOCHEM BIOPH RES CO, V388, P418, DOI 10.1016/j.bbrc.2009.08.029; Cervera RP, 2009, THERIOGENOLOGY, V72, P1097, DOI 10.1016/j.theriogenology.2009.06.030; Chawalit S, 2012, REPROD SCI, V19, P976, DOI 10.1177/1933719112440049; Chuang DM, 2009, TRENDS NEUROSCI, V32, P591, DOI 10.1016/j.tins.2009.06.002; Codd R, 2009, INT J BIOCHEM CELL B, V41, P736, DOI 10.1016/j.biocel.2008.05.026; Costa-Borges N, 2010, CELL REPROGRAM, V12, P437, DOI 10.1089/cell.2009.0108; Cui XS, 2011, CELL REPROGRAM, V13, P179, DOI 10.1089/cell.2010.0060; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Ding X, 2008, THERIOGENOLOGY, V70, P622, DOI 10.1016/j.theriogenology.2008.04.042; Fang ZF, 2006, EXP CELL RES, V312, P3669, DOI 10.1016/j.yexcr.2006.08.013; Hou LM, 2014, CELL REPROGRAM, V16, P253, DOI 10.1089/cell.2013.0058; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Iager AE, 2008, CLONING STEM CELLS, V10, P371, DOI 10.1089/clo.2007.0002; Kim JM, 2003, J CELL BIOL, V162, P37, DOI 10.1083/jcb.200303047; Kim S, 2010, ZYGOTE, V18, P93, DOI 10.1017/S0967199409990372; Kishigami S, 2006, BIOCHEM BIOPH RES CO, V340, P183, DOI 10.1016/j.bbrc.2005.11.164; Kishigami S, 2007, J REPROD DEVELOP, V53, P165, DOI 10.1262/jrd.18098; Kuhn AN, 2009, RNA, V15, P153, DOI 10.1261/rna.1332609; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Lanza RP, 1999, NAT BIOTECHNOL, V17, P1171, DOI 10.1038/70709; Lee SG, 2007, MOL REPROD DEV, V74, P1436, DOI 10.1002/mrd.20728; Li J, 2008, THERIOGENOLOGY, V70, P800, DOI 10.1016/j.theriogenology.2008.05.046; Li L, 2013, MOL ASPECTS MED, V34, P919, DOI 10.1016/j.mam.2013.01.003; Li L, 2010, DEVELOPMENT, V137, P859, DOI 10.1242/dev.039487; Liang S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134567; Mukhopadhyay NK, 2006, ANN THORAC SURG, V81, P1034, DOI 10.1016/j.athoracsur.2005.06.059; Nguyen NT, 2009, REPROD FERT DEVELOP, V21, P805, DOI 10.1071/RD08277; Ono T, 2010, BIOL REPROD, V83, P929, DOI 10.1095/biolreprod.110.085282; Panda SK, 2012, THERIOGENOLOGY, V77, P195, DOI 10.1016/j.theriogenology.2011.07.033; Pratt S L, 2006, Soc Reprod Fertil Suppl, V62, P303; Rybouchkin A, 2006, BIOL REPROD, V74, P1083, DOI 10.1095/biolreprod.105.047456; Shi LH, 2008, DEV DYNAM, V237, P640, DOI 10.1002/dvdy.21450; Siriboon C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118165; Siriboon C, 2014, REPROD FERT DEVELOP, V26, P395, DOI 10.1071/RD12243; Su JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018106; Tachibana M, 2013, CELL, V153, P1228, DOI 10.1016/j.cell.2013.05.006; Tang PC, 2000, ZYGOTE, V8, P235, DOI 10.1017/S0967199400001039; Terashita Y, 2011, REPROD DOMEST ANIM, V46, P189, DOI 10.1111/j.1439-0531.2010.01614.x; Vassiliev I, 2011, CELL REPROGRAM, V13, P205, DOI 10.1089/cell.2010.0102; Vogelauer M, 2002, MOL CELL, V10, P1223, DOI 10.1016/S1097-2765(02)00702-5; Wakayama T, 2001, SCIENCE, V292, P740, DOI 10.1126/science.1059399; Wang FC, 2007, BIOL REPROD, V77, P1007, DOI 10.1095/biolreprod.107.063149; Wang L, 2005, BIOL REPROD, V73, P149, DOI 10.1095/biolreprod.104.037150; Wee G, 2006, J BIOL CHEM, V281, P6048, DOI 10.1074/jbc.M511340200; Yang XZ, 2007, NAT GENET, V39, P295, DOI 10.1038/ng1973; Yu CW, 2013, J MED CHEM, V56, P6775, DOI 10.1021/jm400564j; Zhao JG, 2009, BIOL REPROD, V81, P525, DOI 10.1095/biolreprod.109.077016	51	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204588	10.1371/journal.pone.0204588	http://dx.doi.org/10.1371/journal.pone.0204588			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30261020	Green Submitted, gold, Green Published			2022-12-26	WOS:000445907400072
J	Ida, T; Kaku, M; Kitami, M; Terajima, M; Rocabado, JMR; Akiba, Y; Nagasawa, M; Yamauchi, M; Uoshima, K				Ida, Takako; Kaku, Masaru; Kitami, Megumi; Terajima, Masahiko; Rocabado, Juan Marcelo Rosales; Akiba, Yosuke; Nagasawa, Masako; Yamauchi, Mitsuo; Uoshima, Katsumi			Extracellular matrix with defective collagen cross-linking affects the differentiation of bone cells	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; I COLLAGEN; MECHANICAL-PROPERTIES; OSTEOGENIC DIFFERENTIATION; TUMOR STROMA; STRENGTH; LATHYRISM; QUALITY; PROLIFERATION; DETERMINANTS	Fibrillar type I collagen, the predominant organic component in bone, is stabilized by lysyl oxidase (LOX)-initiated covalent intermolecular cross-linking, an important determinant of bone quality. However, the impact of collagen cross-linking on the activity of bone cells and subsequent tissue remodeling is not well understood. In this study, we investigated the effect of collagen cross-linking on bone cellular activities employing a loss-of-function approach, using a potent LOX inhibitor, beta-aminopropionitrile (BAPN). Osteoblastic cells (MC3T3-E1) were cultured for 2 weeks in the presence of 0-2 mM BAPN to obtain low cross-linked collagen matrices. The addition of BAPN to the cultures diminished collagen cross-links in a dose-dependent manner and, at 1 mM level, none of the major cross-links were detected without affecting collagen production. After the removal of cellular components from these cultures, MC3T3-E1, osteoclasts (RAW264.7), or mouse primary bone marrow-derived stromal cells (BMSCs) were seeded. MC3T3-E1 cells grown on low cross-link matrices showed increased alkaline phosphatase (ALP) activity. The number of multinucleate tartrate-resistant acid phosphatase (TRAP)-positive cells increased in RAW264.7 cells. Initial adhesion, proliferation, and ALP activity of BMSCs also increased. In the animal experiments, 4-week-old C57BL/6 mice were fed with BAPN-containing diet for 8 weeks. At this point, biochemical analysis of bone demonstrated that collagen cross-links decreased without affecting collagen content. Then, the diet was changed to a control diet to minimize the direct effect of BAPN. At 2 and 4 weeks after the change, histological samples were prepared. Histological examination of femur samples at 4 weeks showed a significant increase in the number of bone surface osteoblasts, while the bone volume and surface osteoclast numbers were not significantly affected. These results clearly demonstrated that the extent of collagen cross-linking of bone matrix affected the differentiation of bone cells, underscoring the importance of collagen cross-linking in the regulation of cell behaviors and tissue remodeling in bone. Characterization of collagen cross-linking in bone may be beneficial to obtain insight into not only bone mechanical property, but also bone cellular activities.	[Ida, Takako; Kaku, Masaru; Kitami, Megumi; Rocabado, Juan Marcelo Rosales; Akiba, Yosuke; Nagasawa, Masako; Uoshima, Katsumi] Niigata Univ, Div Bioprosthodont, Grad Sch Med & Dent Sci, Niigata, Japan; [Terajima, Masahiko; Yamauchi, Mitsuo] Univ North Carolina Chapel Hill, North Carolina Oral Hlth Inst, Chapel Hill, NC USA	Niigata University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Kaku, M (corresponding author), Niigata Univ, Div Bioprosthodont, Grad Sch Med & Dent Sci, Niigata, Japan.	kakum@dent.niigata-u.ac.jp	Kaku, Masaru/K-5041-2019; Kaku, Masaru/S-7309-2017	Kaku, Masaru/0000-0002-7988-6435; Kaku, Masaru/0000-0002-7988-6435	Japan Society for the Promotion of Science (JSPS) [JP15J03831, JP26293407 JP15KK0337, JP15K15704]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS, JP15J03831 to TI, JP26293407 JP15KK0337, and JP15K15704 to MKa).	Ammann P, 2003, OSTEOPOROSIS INT, V14, pS13, DOI 10.1007/s00198-002-1345-4; Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731; Changoor A, 2011, OSTEOARTHR CARTILAGE, V19, P126, DOI 10.1016/j.joca.2010.10.010; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Chen YL, 2015, J CLIN INVEST, V125, P1147, DOI 10.1172/JCI74725; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Depalle B, 2015, J MECH BEHAV BIOMED, V52, P1, DOI 10.1016/j.jmbbm.2014.07.008; Dhand C, 2016, BIOMATERIALS, V104, P323, DOI 10.1016/j.biomaterials.2016.07.007; El Rouby DH, 2008, ARCH ORAL BIOL, V53, P916, DOI 10.1016/j.archoralbio.2008.04.008; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Farlay D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028736; Fassett J, 2006, MOL BIOL CELL, V17, P345, DOI 10.1091/mbc.E05-09-0871; Fernandes H, 2010, TISSUE ENG PT A, V16, P1693, DOI [10.1089/ten.tea.2009.0341, 10.1089/ten.TEA.2009.0341]; Fernandes H, 2009, TISSUE ENG PT A, V15, P3857, DOI 10.1089/ten.tea.2009.0011; Ferreira AM, 2012, ACTA BIOMATER, V8, P3191, DOI 10.1016/j.actbio.2012.06.014; Fonseca H, 2014, SPORTS MED, V44, P37, DOI 10.1007/s40279-013-0100-7; Francisco JI, 2011, J ORTHOP RES, V29, P189, DOI 10.1002/jor.21217; Gandavarapu NR, 2014, BIOMATER SCI-UK, V2, P352, DOI 10.1039/c3bm60149h; Hansen LK, 2006, CURR TOP DEV BIOL, V72, P205, DOI 10.1016/S0070-2153(05)72004-4; Henriet P, 2000, P NATL ACAD SCI USA, V97, P10026, DOI 10.1073/pnas.170290997; Huja SS, 2008, ANAT REC, V291, P1, DOI 10.1002/ar.20619; Kaku M, 2007, BIOCHEM BIOPH RES CO, V359, P463, DOI 10.1016/j.bbrc.2007.05.109; Kaku M, 2016, J CELL PHYSIOL, V231, P926, DOI 10.1002/jcp.25184; Khatiwala CB, 2007, J CELL PHYSIOL, V211, P661, DOI 10.1002/jcp.20974; Kitami M, 2016, J CELL PHYSIOL, V231, P1974, DOI 10.1002/jcp.25302; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; Knott L, 1998, BONE, V22, P181, DOI 10.1016/S8756-3282(97)00279-2; Koyama H, 1996, CELL, V87, P1069, DOI 10.1016/S0092-8674(00)81801-2; Kuroshima S, 2017, J PROSTHODONT RES, V61, P353, DOI 10.1016/j.jpor.2017.05.006; KWONGHING A, 1991, ANAT EMBRYOL, V184, P93, DOI 10.1007/BF01744265; Matsuura T, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/769414; Mauney J, 2009, MATRIX BIOL, V28, P239, DOI 10.1016/j.matbio.2009.04.003; McNerny EMB, 2015, J BONE MINER RES, V30, P446, DOI 10.1002/jbmr.2356; Mercier I, 1996, EXP CELL RES, V225, P245, DOI 10.1006/excr.1996.0174; OXLUND H, 1995, BONE, V17, pS365, DOI 10.1016/8756-3282(95)00328-B; Pankova D, 2016, MOL CANCER RES, V14, P287, DOI 10.1158/1541-7786.MCR-15-0307; Paschalis EP, 2011, BONE, V49, P1232, DOI 10.1016/j.bone.2011.08.027; Rosales-Rocabado JM, 2014, J ORAL MAXIL SURG, V72, DOI 10.1016/j.joms.2013.12.001; Saito M, 2015, CALCIFIED TISSUE INT, V97, P242, DOI 10.1007/s00223-015-9985-5; Schocklmann HO, 2000, KIDNEY INT, V58, P1108, DOI 10.1046/j.1523-1755.2000.00268.x; Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077; Shi ST, 1996, J BONE MINER RES, V11, P1139, DOI 10.1002/jbmr.5650110813; Shih YRV, 2011, J BONE MINER RES, V26, P730, DOI 10.1002/jbmr.278; Shiiba M, 2002, J BONE MINER RES, V17, P1639, DOI 10.1359/jbmr.2002.17.9.1639; Shiiba M, 2001, CONNECT TISSUE RES, V42, P303, DOI 10.3109/03008200109016844; Thaler R, 2010, BONE, V46, P703, DOI 10.1016/j.bone.2009.10.038; Turecek C, 2008, CALCIFIED TISSUE INT, V82, P392, DOI 10.1007/s00223-008-9136-3; Viguet-Carrin S, 2006, OSTEOPOROSIS INT, V17, P319, DOI 10.1007/s00198-005-2035-9; Yamauchi M, 1989, Connect Tissue Res, V21, P159, DOI 10.3109/03008208909050006; YAMAUCHI M, 1986, BIOCHEMISTRY-US, V25, P4907, DOI 10.1021/bi00365a027; Yamauchi M, 2018, METHOD CELL BIOL, V143, P115, DOI 10.1016/bs.mcb.2017.08.006; Yamauchi M, 2012, ESSAYS BIOCHEM, V52, P113, DOI [10.1042/BSE0520113, 10.1042/bse0520113]	52	15	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2018	13	9							e0204306	10.1371/journal.pone.0204306	http://dx.doi.org/10.1371/journal.pone.0204306			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU9BO	30252876	Green Published, Green Submitted, gold			2022-12-26	WOS:000445639700040
J	Ren, GM; Liu, L; Feng, MK; He, YJ				Ren, Guangming; Liu, Lan; Feng, Mingku; He, Yingji			Coevolution of public goods game and networks based on survival of the fittest	PLOS ONE			English	Article							PRISONERS-DILEMMA GAME; EVOLUTIONARY GAMES; COMPLEX NETWORKS; COOPERATION; SELECTION; STRATEGY; GRAPHS; RULE	We introduce a random strategy update rule for the evolutionary public goods game on networks based on survival of the fittest. A survival cost parameter is introduced to public goods game. Players whose payoffs are below the survival cost will be deleted from the network. The same number of new nodes are randomly connected to the network and randomly designated cooperation or defection. Numerical results show that cooperation can flourish if the multiplication factor of the public goods game is greater than the network degree. We present a simple analytical method to explain this result. The fraction of cooperators reaches the maximum for a suitable survival cost. Furthermore, the initial random network has evolved into a heterogeneous network which facilitates the emergence of the cooperation. Our work could be helpful to understand how natural selection favors cooperation. It suggests a new method to investigate the impact of the survival cost on the evolution of cooperation.	[Ren, Guangming; Feng, Mingku; He, Yingji] Guangdong Polytech Normal Univ, Sch Optoelect Engn, Guangzhou, Guangdong, Peoples R China; [Liu, Lan] Guangdong Polytech Normal Univ, Sch Elect & Informat, Guangzhou, Guangdong, Peoples R China	Guangdong Polytechnic Normal University; Guangdong Polytechnic Normal University	Ren, GM (corresponding author), Guangdong Polytech Normal Univ, Sch Optoelect Engn, Guangzhou, Guangdong, Peoples R China.	ren_guang-ming@163.com			Guangdong Province Education Department Foundation of China [2014KZDXM059]	Guangdong Province Education Department Foundation of China	This work was supported by the Guangdong Province Education Department Foundation of China (Grant No. 2014KZDXM059). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altrock PM, 2017, PHYS REV E, V95, DOI 10.1103/PhysRevE.95.022407; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Bandyopadhyay A, 2018, APPL MATH COMPUT, V320, P710, DOI 10.1016/j.amc.2017.09.048; Chen W, 2015, J STAT MECH-THEORY E, V01; Chen XJ, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.017103; GINTIS H, 2000, GAME THEORY EVOLUTIO; Hauert C, 2002, SCIENCE, V296, P1129, DOI 10.1126/science.1070582; Iyer S, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004779; Khoo T, 2016, SCI REP-UK, V6, DOI 10.1038/srep36293; Liu XS, 2016, PHYS REV E, V94, DOI 10.1103/PhysRevE.94.012124; Liu YK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030689; NOWAK M, 1993, NATURE, V364, P56, DOI 10.1038/364056a0; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Pacheco JM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.258103; Paulsson J, 2002, GENETICS, V161, P1373; Rainey PB, 2003, NATURE, V425, P72, DOI 10.1038/nature01906; Santos FC, 2008, NATURE, V454, P213, DOI 10.1038/nature06940; Shen C, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.180199; Szabo G, 1998, PHYS REV E, V58, P69, DOI 10.1103/PhysRevE.58.69; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; TAYLOR PD, 1978, MATH BIOSCI, V40, P145, DOI 10.1016/0025-5564(78)90077-9; Traulsen A, 2006, P NATL ACAD SCI USA, V103, P10952, DOI 10.1073/pnas.0602530103; Wang WX, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.035102; Wilson EO, 2005, P NATL ACAD SCI USA, V102, P13367, DOI 10.1073/pnas.0505858102; Yang HX, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.065101; Zhang JL, 2010, J THEOR BIOL, V267, P41, DOI 10.1016/j.jtbi.2010.08.011; Zimmermann MG, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.065102	29	1	1	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2018	13	9							e0204616	10.1371/journal.pone.0204616	http://dx.doi.org/10.1371/journal.pone.0204616			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU9BO	30252900	Green Published, gold, Green Submitted			2022-12-26	WOS:000445639700065
J	Makretskaya, N; Bezlepkina, O; Kolodkina, A; Kiyaev, A; Vasilyev, EV; Petrov, V; Kalinenkova, S; Malievsky, O; Dedov, II; Tiulpakov, A				Makretskaya, Nina; Bezlepkina, Olga; Kolodkina, Anna; Kiyaev, Alexey; Vasilyev, Evgeny V.; Petrov, Vasily; Kalinenkova, Svetlana; Malievsky, Oleg; Dedov, Ivan I.; Tiulpakov, Anatoly			High frequency of mutations in 'dyshormonogenesis genes' in severe congenital hypothyroidism	PLOS ONE			English	Article							IODIDE ORGANIFICATION DEFECTS; THYROID PEROXIDASE GENE; THYROTROPIN RECEPTOR; MONOALLELIC EXPRESSION; SEQUENCE VARIANTS; PENDRED-SYNDROME; CAUSATIVE GENES; DYSGENESIS; IDENTIFICATION; COHORT	Objective Results of the screening of disease causative mutations in congenital hypothyroidism (CH) vary significantly, depending on the sequence strategy, patients' inclusion criteria and bioinformatics. The objective was to study the molecular basis of severe congenital hypothyroidism, using the next generation sequencing (NGS) and the recent guidelines for assessment of sequence variants. Design 243 patients with CH (TSH levels at neonatal screening or retesting greater than 90 mU/I) and 56 control subjects were included in the study. Methods A custom NGS panel targeting 12 CH causative genes was used for sequencing. The sequence variants were rated according to American College of Medical Genetics and Genomics (ACMG) guidelines. Results In total, 48 pathogenic, 7 likely pathogenic and 57 variants of uncertain significance were identified in 92/243 patients (37.9%), while 4 variants of uncertain significance were found in 4/56 control subjects (7.1%). 13.1% (12/92) of the cases showed variants in 'thyroid dysgenesis' (TD) genes: TSHR, n = 6; NKX2-1, n = 2; NKX2-5, n = 1; PAX8, n = 3. The variants in tlyshormonogenesis' (DH) genes were found in 84.8% (78/92) of cases: TPO, n = 30; DUOX2, n = 24; TG, n = 8; SLC5A5, n = 3; SLC26A4, n = 6; IYD, n =1. 8 patients showed oligonenic variants. The majority of variants identified in DH genes were monoallelic. Conclusions In contrast to earlier studies demonstrating the predominance of TD in severe CH, the majority of variants identified in our study were in DH genes. A large proportion of monoallelic variants detected among DH genes suggests that non-mendelian mechanisms may play a role in the development of CH.	[Makretskaya, Nina; Bezlepkina, Olga; Kolodkina, Anna; Vasilyev, Evgeny V.; Petrov, Vasily; Dedov, Ivan I.; Tiulpakov, Anatoly] Endocrinol Res Ctr, Dept & Lab Inherited Endocrine Disorders, Moscow, Russia; [Kiyaev, Alexey] Ural State Med Univ, Dept Polyclin Pediat, Ekaterinburg, Russia; [Kalinenkova, Svetlana] Moscow Reg Res & Clin Inst, Genet Lab, Moscow, Russia; [Malievsky, Oleg] Republican Childrens Clin Hosp, Dept Hosp Pediat, Ufa, Russia	Russian Academy of Medical Sciences; Endocrinology Research Centre; Ural State Medical University	Makretskaya, N (corresponding author), Endocrinol Res Ctr, Dept & Lab Inherited Endocrine Disorders, Moscow, Russia.	makretskayan@gmail.com	Bezlepkina, Olga Borisovna/B-6627-2017; Makretskaya, Nina/AAH-7391-2021; Васильев, Евгений/S-1912-2019; Kolodkina, Anna/AAJ-7625-2021	Bezlepkina, Olga Borisovna/0000-0001-9621-5732; Makretskaya, Nina/0000-0003-0412-7140; Васильев, Евгений/0000-0003-1107-362X; Kalinenkova, Svetlana/0000-0003-3611-2365; Malievskiy, Oleg/0000-0003-2599-0867	Alfa-Endo Program of Charities Aid Foundation (CAF) Russia	Alfa-Endo Program of Charities Aid Foundation (CAF) Russia	This work was supported by Alfa-Endo Program of Charities Aid Foundation (CAF) Russia.	ABRAMOWICZ MJ, 1992, J CLIN INVEST, V90, P1200, DOI 10.1172/JCI115981; ACEBRON A, 1995, J CLIN INVEST, V96, P781, DOI 10.1172/JCI118123; Al Taji E, 2007, EUR J ENDOCRINOL, V156, P521, DOI 10.1530/EJE-06-0709; Albert S, 2006, EUR J HUM GENET, V14, P773, DOI 10.1038/sj.ejhg.5201611; Bakker B, 2000, J CLIN ENDOCR METAB, V85, P3708, DOI 10.1210/jc.85.10.3708; Bakker B, 2001, J CLIN ENDOCR METAB, V86, P1164, DOI 10.1210/jc.86.3.1164; Bubuteishvili L, 2003, J PEDIATR-US, V143, P759, DOI 10.1067/S0022-3476(03)00537-7; Clifton-Bligh RJ, 1998, NAT GENET, V19, P399, DOI 10.1038/1294; de Filippis T, 2017, HUM MOL GENET, V26, P2507, DOI 10.1093/hmg/ddx145; Delange F, 1997, B WORLD HEALTH ORGAN, V75, P95; den Dunnen JT, 2016, HUM MUTAT, V37, P564, DOI 10.1002/humu.22981; Dentice M, 2006, J CLIN ENDOCR METAB, V91, P1428, DOI 10.1210/jc.2005-1350; Devos H, 1999, J CLIN ENDOCR METAB, V84, P2502, DOI 10.1210/jc.84.7.2502; Everett LA, 1997, NAT GENET, V17, P411, DOI 10.1038/ng1297-411; Fan X, 2017, CLIN CHIM ACTA, V468, P76, DOI 10.1016/j.cca.2017.02.009; Fugazzola L, 2003, J CLIN ENDOCR METAB, V88, P3264, DOI 10.1210/jc.2002-021377; Fujiwara H, 1997, NAT GENET, V16, P124, DOI 10.1038/ng0697-124; IEIRI T, 1991, J CLIN INVEST, V88, P1901, DOI 10.1172/JCI115513; Jonard L, 2010, INT J PEDIATR OTORHI, V74, P1049, DOI 10.1016/j.ijporl.2010.06.002; Kosugi S, 1999, J CLIN ENDOCR METAB, V84, P3248, DOI 10.1210/jc.84.9.3248; Kotani T, 2001, MOL CELL ENDOCRINOL, V182, P61, DOI 10.1016/S0303-7207(01)00547-0; Kuhnen P, 2014, J CLIN ENDOCR METAB, V99, pE169, DOI 10.1210/jc.2013-2619; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lof C, 2016, THYROID, V26, P1215, DOI 10.1089/thy.2016.0016; Macchia PE, 1998, NAT GENET, V19, P83, DOI 10.1038/ng0598-83; Magne F, 2016, THYROID, V26, P852, DOI 10.1089/thy.2016.0009; Moreno JC, 2002, NEW ENGL J MED, V347, P95, DOI 10.1056/NEJMoa012752; Moreno JC, 2008, NEW ENGL J MED, V358, P1811, DOI 10.1056/NEJMoa0706819; Muzza M, 2014, J CLIN ENDOCR METAB, V99, pE544, DOI 10.1210/jc.2013-3618; Narumi S, 2013, HORMONE RES PEDIA S1, V80, P6; Narumi S, 2010, J CLIN ENDOCR METAB, V95, P1981, DOI 10.1210/jc.2009-2373; Narumi S, 2009, J CLIN ENDOCR METAB, V94, P1317, DOI 10.1210/jc.2008-1767; Nascimento AC, 2003, THYROID, V13, P1145, DOI 10.1089/10507250360731550; Nettore IC, 2013, J ENDOCRINOL INVEST, V36, P654, DOI 10.3275/8973; Nettore IC, 2013, THYROID, V23, P675, DOI 10.1089/thy.2012.0267; Nicholas AK, 2016, J CLIN ENDOCR METAB, V101, P4521, DOI 10.1210/jc.2016-1879; Park KJ, 2016, ANN LAB MED, V36, P145, DOI 10.3343/alm.2016.36.2.145; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Rodrigues C, 2005, EUR J ENDOCRINOL, V152, P193, DOI 10.1530/eje.1.01826; Sriphrapradang C, 2011, J CLIN ENDOCR METAB, V96, pE1001, DOI 10.1210/jc.2011-0127; Stenson PD, 2017, HUM GENET, V136, P665, DOI 10.1007/s00439-017-1779-6; SUNTHORNTHEPVARAKUL T, 1995, NEW ENGL J MED, V332, P155, DOI 10.1056/NEJM199501193320305; Szinnai G, 2014, ENDOCR DEV, V26, P60, DOI 10.1159/000363156; TOUBLANC JE, 1992, HORM RES, V38, P230, DOI 10.1159/000182549; Van Hauwe P, 1998, HUM MOL GENET, V7, P1099, DOI 10.1093/hmg/7.7.1099; VASSART G, 1991, TRENDS ENDOCRIN MET, V2, P151, DOI 10.1016/1043-2760(91)90006-9; Vigone Maria Cristina, 2005, Hum Mutat, V26, P395; Vockley J, 2008, J INHERIT METAB DIS, V31, P619, DOI 10.1007/s10545-008-1005-8; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Yapakci E, 2011, J PEDIATR ENDOCR MET, V23, P651, DOI [10.1515/JPEM.2010.23.7.651, DOI 10.1515/JPEM.2010.23.7.651]; Yuan ZF, 2008, ENDOCR J, V55, P415, DOI 10.1507/endocrj.K07E-064; Zamproni I, 2008, J CLIN ENDOCR METAB, V93, P605, DOI 10.1210/jc.2007-2020; Zimmermann MB, 2004, AM J CLIN NUTR, V79, P231	53	29	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2018	13	9							e0204323	10.1371/journal.pone.0204323	http://dx.doi.org/10.1371/journal.pone.0204323			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU5MM	30240412	gold, Green Submitted, Green Published			2022-12-26	WOS:000445329700040
J	Suleman, M; Yasmin, S; Rasul, M; Yahya, M; Atta, BM; Mirza, MS				Suleman, Muhammad; Yasmin, Sumera; Rasul, Maria; Yahya, Mahreen; Atta, Babar Manzoor; Mirza, Muhammad Sajjad			Phosphate solubilizing bacteria with glucose dehydrogenase gene for phosphorus uptake and beneficial effects on wheat	PLOS ONE			English	Article							GROWTH-PROMOTING RHIZOBACTERIA; SOIL ENZYME-ACTIVITIES; PLANT-GROWTH; ACC DEAMINASE; PYRROLOQUINOLINE QUINONE; RHIZOSPHERE; ZINC; PGPR; L.; ADAPTATIONS	The aim of this study was to isolate, characterize and use phosphate solubilizing bacteria to enhance the bioavailability of insoluble Ca-phosphate for wheat plants. For this purpose, 15 phosphorus solubilizing bacteria (PSB) were isolated from wheat rhizospheric soils of Peshawar and southern Punjab region, Pakistan. These isolates were identified using light microscopy and 16S rRNA gene. Among the isolated bacteria, two strains (Pseudomonas sp. MS16 and Enterobactersp. MS32) were the efficient P solubilizers based on their P solubilization activity determined qualitatively (solubilization index 3.2-5.8) as well as quantitatively (136280 mu g mL(-1)). These two strains produced indole-3-acetic acid (25.6-28.1 mu g mL(-1)), gibberellic acid (2.5-11.8), solubilized zinc compounds (SI 2.8-3.3) and showed nitrogenase and 1-Aminocyclopropane-1-carboxylic acid deaminase activity in vitro. Phosphate solubilization activity of Pseudomonas sp. MS16 was further validated by amplification, sequencing and phylogenetic analysis of glucose dehydrogenase (gcd) gene (LT908484) responsible for P solubilization. Response Surface Methodology for large-scale production was used to find optimal conditions (Temperature 22.5 degrees C, pH 7) for P solubilization. Glucose was found to support higher P solubilization in vitro. In an in vitro experiment, PSB treated wheat seedlings improved germination and seedling vigor (11% increases) as compared to un-inoculated control. Rhizoscanning of these seedlings showed an increase in various root growth parameters. Wheat inoculation with selected strain MS16 showed pronounced effect on grain yield in pot (38.5% increase) and field (17-18% increase) experiments compared to non-inoculated control. Root colonization by PSB through Florescent in situ Hybridization and Confocal Laser Scanning Microscopy confirmed their rhizosphere competence in soil. BOX-PCR confirmed the re-isolated colonies of Pseudomonas sp. MS16. The results indicated that gluconic acid producing Pseudomonas sp. MS16 from un-explored soils may be cost effective and environment friendly candidate to improve plant growth and phosphorous uptake by wheat plants.	[Suleman, Muhammad; Yasmin, Sumera; Rasul, Maria; Yahya, Mahreen; Mirza, Muhammad Sajjad] NIBGE, Soil & Environm Biotechnol Div, Faisalabad, Pakistan; [Atta, Babar Manzoor] NIFA, Plant Breeding & Genet Div, Peshawar, Pakistan; [Suleman, Muhammad] Lanzhou Univ, Sch Life Sci, Inst Microbiol, Lanzhou, Gansu, Peoples R China	Pakistan Institute of Engineering & Applied Science; Nuclear Institute for Food & Agriculture - Pakistan; Lanzhou University	Yasmin, S (corresponding author), NIBGE, Soil & Environm Biotechnol Div, Faisalabad, Pakistan.	sumeraimran2012@gmail.com	Atta, Babar Manzoor/AAC-2881-2022	Atta, Babar Manzoor/0000-0002-5166-2632; Yasmin, Sumera/0000-0002-9744-6257; , Muhammad Suleman/0000-0001-8462-2381	Higher Education Commission (HEC) [3813]	Higher Education Commission (HEC)(Higher Education Commission of Pakistan)	The research work was partially supported by the grant of Higher Education Commission (HEC) funded project No. 3813 but there is no allocation of HEC project funds for charges of manuscript publication. Our institute (National Institute for Biotechnology & Genetic Engineering) does not financially support the authors to pay manuscript publication and processing charges. Furthermore, the corresponding author does not have any other grant from which this article processing charges can be paid. There was no additional external funding received for this study.	Abbas MT, 2014, J ADV RES, V5, P41, DOI 10.1016/j.jare.2012.11.004; Abdelrahman M, 2016, PLANT SCI, V246, P128, DOI 10.1016/j.plantsci.2016.02.008; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; [Anonymous], 1993, SOIL SAMPLING METHOD, DOI DOI 10.1016/B978-0-12-415955-6.00001-3; [Anonymous], 2015, FRONTIERS MICROBIOLO, V6, DOI [10.3389/fmicb.2015.00006, DOI 10.3389/FMICB.2015.00006]; Basheer A, 2016, PAK J AGR SCI, V53, P135, DOI 10.21162/PAKJAS/16.2324; Bhattacharyya PN, 2012, WORLD J MICROB BIOT, V28, P1327, DOI 10.1007/s11274-011-0979-9; BOLTON H, 1985, SOIL BIOL BIOCHEM, V17, P297, DOI 10.1016/0038-0717(85)90064-1; Chauhan H, 2015, APPL SOIL ECOL, V95, P38, DOI 10.1016/j.apsoil.2015.05.011; Chen WM, 2016, GEOMICROBIOL J, V33, P870, DOI 10.1080/01490451.2015.1123329; Choi O, 2008, PLANT PHYSIOL, V146, P657, DOI 10.1104/pp.107.112748; Deppenmeier U, 2002, APPL MICROBIOL BIOT, V60, P233, DOI 10.1007/s00253-002-1114-5; Devi SNP, 2016, ARAB J SCI ENG, V41, P2117, DOI 10.1007/s13369-015-1907-3; DICK RP, 1994, SSSA SPEC PUBL, P107; EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843; Egamberdiyeva D, 2007, APPL SOIL ECOL, V36, P184, DOI 10.1016/j.apsoil.2007.02.005; Etesami H, 2015, METHODSX, V2, P72, DOI 10.1016/j.mex.2015.02.008; Fasim F, 2002, FEMS MICROBIOL LETT, V213, P1; Firdous S, 2020, PEDOSPHERE, V30, P618, DOI 10.1016/S1002-0160(17)60381-3; Gaind S, 1990, INDIAN J MICROBIOL, V30, P305; Gandhi A, 2016, EUR J SOIL BIOL, V76, P1, DOI 10.1016/j.ejsobi.2016.06.006; Glick BR, 2014, MICROBIOL RES, V169, P30, DOI 10.1016/j.micres.2013.09.009; Gontia-Mishra I, 2017, RHIZOSPHERE-NETH, V3, P185, DOI 10.1016/j.rhisph.2017.04.013; Gontia-Mishra I, 2017, PLANT SOIL, V414, P213, DOI 10.1007/s11104-016-3119-3; Gopala Krishnamurthy A, 1967, INDIAN J MICROBIOL, V7, P21; GUPTA R, 1994, J GEN APPL MICROBIOL, V40, P255, DOI 10.2323/jgam.40.255; Gyaneshwar P, 2002, PLANT SOIL, V245, P83, DOI 10.1023/A:1020663916259; Hafeez FY., 2009, P INT S MICR TECHN S, P279; Han SH, 2008, FEMS MICROBIOL LETT, V282, P140, DOI 10.1111/j.1574-6968.2008.01120.x; Hanif MK, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00583; HARDY RWF, 1968, PLANT PHYSIOL, V43, P1185, DOI 10.1104/pp.43.8.1185; Hegazi NA, 2001, ARCH AGRON SOIL SCI, V47, P103, DOI [10.1080/03650340109366202, DOI 10.1080/03650340109366202]; ILLMER P, 1992, SOIL BIOL BIOCHEM, V24, P389, DOI 10.1016/0038-0717(92)90199-8; Ipek M, 2014, J PLANT NUTR, V37, P990, DOI 10.1080/01904167.2014.881857; Islam E, 2007, J HAZARD MATER, V147, P806, DOI 10.1016/j.jhazmat.2007.01.117; Islam S, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01360; Jensen EC, 2013, ANAT REC, V296, P378, DOI 10.1002/ar.22641; Jogaiah S, 2018, MOL PLANT PATHOL, V19, P870, DOI 10.1111/mpp.12571; Khan Mohammad Saghir, 2010, Archives of Agronomy and Soil Science, V56, P73, DOI 10.1080/03650340902806469; Kim CH, 2003, CURR MICROBIOL, V47, P457, DOI 10.1007/s00284-003-4068-7; Kim YC, 2011, APPL ENVIRON MICROB, V77, P1548, DOI 10.1128/AEM.01867-10; Lamizadeh E., 2016, INT J CURRENT MICROB, V5, P1072; Liu ZG, 2015, APPL SOIL ECOL, V96, P217, DOI 10.1016/j.apsoil.2015.08.003; LOUWS FJ, 1994, APPL ENVIRON MICROB, V60, P2286, DOI 10.1128/AEM.60.7.2286-2295.1994; Majeed A, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00198; Mehnaz S, 2001, CAN J MICROBIOL, V47, P110, DOI 10.1139/cjm-47-2-110; Moutia JFY, 2010, PLANT SOIL, V337, P233, DOI 10.1007/s11104-010-0519-7; Muhammad Tahir, 2013, Australian Journal of Crop Science, V7, P1284; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Naik PR, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-230; Nannipieri P, 2011, SOIL BIOL, V26, P215, DOI 10.1007/978-3-642-15271-9_9; Nautiyal CS, 1999, FEMS MICROBIOL LETT, V170, P265, DOI 10.1111/j.1574-6968.1999.tb13383.x; OLSEN GJ, 1986, ANNU REV MICROBIOL, V40, P337, DOI 10.1146/annurev.mi.40.100186.002005; Olsen S. R., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P403; OLSEN STERLING R., 1954, U S DEPT AGRIC CIRC, V939, P1; Oteino N, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00745; Pallavi K.P., 2013, BIOSCAN, V8, P1299; Penrose DM, 2003, PHYSIOL PLANTARUM, V118, P10, DOI 10.1034/j.1399-3054.2003.00086.x; Perez E, 2007, SOIL BIOL BIOCHEM, V39, P2905, DOI 10.1016/j.soilbio.2007.06.017; Pii Y, 2015, BIOL FERT SOILS, V51, P403, DOI 10.1007/s00374-015-0996-1; PIKOVSKAIA R. I., 1948, Mikrobiologiya, V17, P362; Richardson AE, 2011, PLANT PHYSIOL, V156, P989, DOI 10.1104/pp.111.175448; Rodriguez D, 1999, PLANT SOIL, V209, P283, DOI 10.1023/A:1004690404870; Rodriguez H, 2006, PLANT SOIL, V287, P15, DOI 10.1007/s11104-006-9056-9; Rodriguez H, 1999, BIOTECHNOL ADV, V17, P319, DOI 10.1016/S0734-9750(99)00014-2; Russell FM, 2006, J CLIN MICROBIOL, V44, P3346, DOI 10.1128/JCM.02631-05; Saharan BC, 2011, LIFE SCI MED RES, V21, P1, DOI DOI 10.4172/2157-7471.1000266; Saharan BS, 2011, J ENV RES DEV, V5; Saravanan VS, 2007, CHEMOSPHERE, V66, P1794, DOI 10.1016/j.chemosphere.2006.07.067; Schachtman DP, 1998, PLANT PHYSIOL, V116, P447, DOI 10.1104/pp.116.2.447; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shahab S, 2009, AFR J AGR RES, V4, P1312; Sharma SB, 2013, SPRINGERPLUS, V2, DOI [10.1186/2193-1801-2-587, 10.1186/2193-1801-2-41]; Shen JB, 2011, PLANT PHYSIOL, V156, P997, DOI 10.1104/pp.111.175232; Singh AV, 2013, ARCH AGRON SOIL SCI, V59, P641, DOI 10.1080/03650340.2012.664767; Anzuay MS, 2015, APPL SOIL ECOL, V95, P31, DOI 10.1016/j.apsoil.2015.05.003; SOLTANPOUR PN, 1979, COMMUN SOIL SCI PLAN, V10, P1411, DOI 10.1080/00103627909366996; Somasegaran P., 1994, HDB RHIZOBIA, P47, DOI [DOI 10.1007/978-1-4613-8375-8_5, 10.1007/978-1-4613-8375-8_5]; Suri VK, 2011, COMMUN SOIL SCI PLAN, V42, P1177, DOI 10.1080/00103624.2011.566962; TABATABAI M. A., 1969, Soil Biology and Biochemistry, V1, P301, DOI 10.1016/0038-0717(69)90012-1; Tahir M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130030; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THEODOROU ME, 1993, PLANT PHYSIOL, V101, P339, DOI 10.1104/pp.101.2.339; TIEN TM, 1979, APPL ENVIRON MICROB, V37, P1016, DOI 10.1128/AEM.37.5.1016-1024.1979; Vance CP, 2003, NEW PHYTOL, V157, P423, DOI 10.1046/j.1469-8137.2003.00695.x; Vessey JK, 2003, PLANT SOIL, V255, P571, DOI 10.1023/A:1026037216893; VINCENT J. M., 1970, A Manual for the Practical Study of the Root- Bacteria.; Vyas P, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-174; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Yasmin S, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01895	90	88	95	6	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2018	13	9							e0204408	10.1371/journal.pone.0204408	http://dx.doi.org/10.1371/journal.pone.0204408			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU5MM	30240432	Green Published, Green Submitted, gold			2022-12-26	WOS:000445329700047
J	Balamurugan, K; Mendoza-Villanueva, D; Sharan, S; Summers, GH; Dobrolecki, LE; Lewis, MT; Sterneck, E				Balamurugan, Kuppusamy; Mendoza-Villanueva, Daniel; Sharan, Shikha; Summers, Glenn H.; Dobrolecki, Lacey E.; Lewis, Michael T.; Sterneck, Esta			C/EBP delta links IL-6 and HIF-1 signaling to promote breast cancer stem cell-associated phenotypes	ONCOGENE			English	Article						Hypoxia; IL-6; Breast cancer; Cancer stem cells; C/EBP; CEBPD; Inflammation; FBXW7; NOTCH; MYC	TUMOR-INITIATING CELLS; EXPRESSION; IDENTIFICATION; INFLAMMATION; METASTASIS; CARCINOMA; PATHWAY; MODELS; DRIVER	To improve cancer patient outcome significantly, we must understand the mechanisms regulating stem-like cancer cells, which have been implicated as a cause of metastasis and treatment resistance. The transcription factor C/EBP delta can exhibit pro- and anti-tumorigenic activities, but the mechanisms underlying the complexity of its functions are poorly understood. Here we identify a role for breast cancer cell intrinsic C/EBP delta in promoting phenotypes that have been associated with cancer stem cells (CSCs). While C/EBP delta expression is not abundant in most metastatic breast cancers, our data support a pro-tumorigenic role of C/EBP delta when expressed in subsets of tumor cells and/or through transient activation by the tumor microenvironment or loss of substrate adhesion. Using genetic mouse models and human breast cancer cell lines, we show that deletion or depletion of C/EBP delta reduced expression of stem cell factors and stemnness markers, sphere formation and self-renewal, along with growth of tumors and established experimental metastases in vivo. C/EBP delta is also known as a mediator of the innate immune response, which is enhanced by hypoxia and interleukin-6 (IL-6) signaling, two conditions that also play important roles in cancer progression. Our mechanistic data reveal C/EBP delta as a link that engages two positive feedback loops, in part by directly targeting the IL-6 receptor (IL6RA) gene, and, thus, amplifying IL-6 and HIF-1 signaling. This study provides a molecular mechanism for the synergism of tumor microenvironmental conditions in cancer progression with potential implications for the targeting of CSCs.	[Balamurugan, Kuppusamy; Mendoza-Villanueva, Daniel; Sharan, Shikha; Sterneck, Esta] NCI, Lab Cell & Dev Signaling, Ctr Canc Res, Frederick, MD 21702 USA; [Summers, Glenn H.] Leidos Biomed Res Inc, Lab Anim Sci Program, Frederick, MD 21702 USA; [Dobrolecki, Lacey E.; Lewis, Michael T.] Baylor Coll Med, Dept Mol & Cellular Biol, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA; [Dobrolecki, Lacey E.; Lewis, Michael T.] Baylor Coll Med, Dept Radiol, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA; [Mendoza-Villanueva, Daniel] Mission Bio, San Francisco, CA 94080 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Baylor College of Medicine; Baylor College of Medicine	Balamurugan, K; Sterneck, E (corresponding author), NCI, Lab Cell & Dev Signaling, Ctr Canc Res, Frederick, MD 21702 USA.	kuppusamyb@mail.nih.gov; sternecg@mail.nih.gov	Kuppusamy, Balamurugan/AAC-6020-2022; Lewis, Michael T/A-9572-2009	Sterneck, Esta/0000-0001-7716-8766	Intramural Research Program of the NIH, National Cancer Institute; Frederick Cancer Institute (NIH) [HHSN261200800001E]; BCRF Founders Fund Grant [CPRIT DP150069]; V-Foundation grant [T2014-010]; NATIONAL CANCER INSTITUTE [ZIABC010307] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Frederick Cancer Institute (NIH); BCRF Founders Fund Grant; V-Foundation grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are thankful for superb support through services provided by Leidos Biomedical Research, Inc., FNLCR (Laboratory Animal Sciences Program, Protein Expression Laboratory, Illustrations, and Graphical Support); and the NCI/CCR cores (Small Animal Imaging, Flow Cytometry, Optical Microscopy, and Analysis Laboratory); and Data Management Services, Inc. for assistance with Statistics. We thank Linda Miller, Suzanne Specht, Rena Mao, and the student interns for their valuable contributions; Heidi Dowst for providing clinical information related to the PDX models; and all the investigators who kindly shared their valuable reagents (see Methods) or provided critical comments on the manuscript. This research was supported by the Intramural Research Program of the NIH, National Cancer Institute, in part with Federal Funds from the Frederick Cancer Institute (NIH) under contract no. HHSN261200800001E. LED and MTL were supported by BCRF Founders Fund Grant CPRIT DP150069 and V-Foundation grant T2014-010. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Balamurugan K, 2016, INT J CANCER, V138, P1058, DOI 10.1002/ijc.29519; Balamurugan K, 2013, INT J BIOL SCI, V9, P917, DOI 10.7150/ijbs.7224; Balamurugan K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2677; Balamurugan K, 2010, EMBO J, V29, P4106, DOI 10.1038/emboj.2010.280; Brower V, 2016, JNCI-J NATL CANCER I, V108, P2; Chang Q, 2014, SEMIN IMMUNOL, V26, P48, DOI 10.1016/j.smim.2014.01.007; Chen JC, 2014, CELL, V159, P402, DOI 10.1016/j.cell.2014.09.021; Cojoc Monica, 2013, Onco Targets Ther, V6, P1347, DOI 10.2147/OTT.S36109; Davis RJ, 2014, CANCER CELL, V26, P455, DOI 10.1016/j.ccell.2014.09.013; Dobrolecki LE, 2016, CANCER METAST REV, V35, P547, DOI 10.1007/s10555-016-9653-x; Espinoza I, 2013, ONCOTARGETS THER, V6, P1249, DOI 10.2147/OTT.S36162; Fallah Y, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7030053; Friedmann-Morvinski D, 2014, EMBO REP, V15, P244, DOI 10.1002/embr.201338254; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Gwak JM, 2017, ONCOTARGET, V8, P36305, DOI 10.18632/oncotarget.16750; Harrison H, 2013, CANCER RES, V73, P1420, DOI 10.1158/0008-5472.CAN-12-2505; Kageyama Y, 2004, FASEB J, V18, P1028, DOI 10.1096/fj.03-1233fje; Korkaya H, 2011, CLIN CANCER RES, V17, P6125, DOI 10.1158/1078-0432.CCR-10-2743; Lagadec C, 2014, STEM CELLS, V32, P135, DOI 10.1002/stem.1537; Litvak V, 2009, NAT IMMUNOL, V10, P437, DOI 10.1038/ni.1721; Luo M, 2015, CURR PHARM DESIGN, V21, P1301, DOI 10.2174/1381612821666141211120604; Mamlouk S, 2013, INT J CANCER, V132, P2721, DOI 10.1002/ijc.27901; Marotta LLC, 2011, J CLIN INVEST, V121, P2723, DOI 10.1172/JCI44745; Mathieu J, 2011, CANCER RES, V71, P4640, DOI 10.1158/0008-5472.CAN-10-3320; Mendoza-Villanueva D, 2016, ONCOGENE, V35, P6166, DOI 10.1038/onc.2016.156; Mihara M, 2012, CLIN SCI, V122, P143, DOI 10.1042/CS20110340; Min Y, 2011, ONCOGENE, V30, P4901, DOI 10.1038/onc.2011.187; Min YF, 2017, ONCOTARGET, V8, P50582, DOI 10.18632/oncotarget.16410; Mitra A, 2015, ONCOTARGET, V6, P10697, DOI 10.18632/oncotarget.4037; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Rustighi A, 2014, EMBO MOL MED, V6, P99, DOI 10.1002/emmm.201302909; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Sarkar TR, 2012, MOL CELL BIOL, V32, P320, DOI 10.1128/MCB.05790-11; Seymour T, 2015, INT J MOL SCI, V16, P27288, DOI 10.3390/ijms161126024; Tabassum DP, 2015, NAT REV CANCER, V15, P473, DOI 10.1038/nrc3971; Taniguchi K, 2014, SEMIN IMMUNOL, V26, P54, DOI 10.1016/j.smim.2014.01.001; Valent P, 2012, NAT REV CANCER, V12, P767, DOI 10.1038/nrc3368; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Wang YH, 2015, ONCOTARGET, V6, P31069, DOI 10.18632/oncotarget.5209; Watanabe M, 2014, CYTOM PART A, V85, P206, DOI 10.1002/cyto.a.22422; Wei W, 2015, ENDOCR-RELAT CANCER, V22, pR135, DOI 10.1530/ERC-14-0447; Wei W, 2014, STEM CELLS, V32, P2571, DOI 10.1002/stem.1752; Yamaguchi J, 2015, KIDNEY INT, V88, P262, DOI 10.1038/ki.2015.21; Yan WX, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-62; Yang AM, 2017, CANCER RES, V77, P6641, DOI 10.1158/0008-5472.CAN-16-3452; Zhang XM, 2013, CANCER RES, V73, P4885, DOI 10.1158/0008-5472.CAN-12-4081; Zou J, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-3; 2012, ONCOGENE, V31, P2614, DOI DOI 10.1038/ONC.2011.439	49	27	28	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 16	2019	38	20					3765	3780		10.1038/s41388-018-0516-5	http://dx.doi.org/10.1038/s41388-018-0516-5			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HY3OI	30262865	Green Accepted			2022-12-26	WOS:000468035600001
J	Klug, LR; Bannon, AE; Javidi-Sharifi, N; Town, A; Fleming, WH; VanSlyke, JK; Musil, LS; Fletcher, JA; Tyner, JW; Heinrich, MC				Klug, Lillian R.; Bannon, Amber E.; Javidi-Sharifi, Nathalie; Town, Ajia; Fleming, William H.; VanSlyke, Judy K.; Musil, Linda S.; Fletcher, Jonathan A.; Tyner, Jeffrey W.; Heinrich, Michael C.			LMTK3 is essential for oncogenic KIT expression in KIT-mutant GIST and melanoma	ONCOGENE			English	Article							GASTROINTESTINAL STROMAL TUMORS; IMATINIB MESYLATE; TYROSINE KINASE; C-KIT; THERAPEUTIC TARGET; MOUSE MODEL; PHASE-II; PROTEIN PHOSPHATASE-1; GENE-MUTATIONS; DOSE IMATINIB	Certain cancers, including gastrointestinal stromal tumor (GIST) and subsets of melanoma, are caused by somatic KIT mutations that result in KIT receptor tyrosine kinase constitutive activity, which drives proliferation. The treatment of KIT-mutant GIST has been revolutionized with the advent of KIT-directed cancer therapies. KIT tyrosine kinase inhibitors (TKI) are superior to conventional chemotherapy in their ability to control advanced KIT-mutant disease. However, these therapies have a limited duration of activity due to drug-resistant secondary KIT mutations that arise (or that are selected for) during KIT TKI treatment. To overcome the problem of KIT TKI resistance, we sought to identify novel therapeutic targets in KIT-mutant GIST and melanoma cells using a human tyrosine kinome siRNA screen. From this screen, we identified lemur tyrosine kinase 3 (LMTK3) and herein describe its role as a novel KIT regulator in KIT-mutant GIST and melanoma cells. We find that LMTK3 regulated the translation rate of KIT, such that loss of LMTK3 reduced total KIT, and thus KIT downstream signaling in cancer cells. Silencing of LMTK3 decreased cell viability and increased cell death in KIT-dependent, but not KIT-independent GIST and melanoma cell lines. Notably, LMTK3 silencing reduced viability of all KIT-mutant cell lines tested, even those with drug-resistant KIT secondary mutations. Furthermore, targeting of LMTK3 with siRNA delayed KIT-dependent GIST growth in a xenograft model. Our data suggest the potential of LMTK3 as a target for treatment of patients with KIT-mutant cancer, particularly after failure of KIT TKIs.	[Klug, Lillian R.; Bannon, Amber E.; Town, Ajia; Heinrich, Michael C.] Portland VA Hlth Care Syst, Portland, OR 97239 USA; [Klug, Lillian R.; Bannon, Amber E.; Javidi-Sharifi, Nathalie; Town, Ajia; Fleming, William H.; Tyner, Jeffrey W.; Heinrich, Michael C.] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA; [Klug, Lillian R.; Bannon, Amber E.; Javidi-Sharifi, Nathalie; Town, Ajia; Fleming, William H.; Tyner, Jeffrey W.; Heinrich, Michael C.] Oregon Hlth & Sci Univ, Div Hematol & Med Oncol, Portland, OR 97201 USA; [Fleming, William H.] Oregon Hlth & Sci Univ, Dept Pediat, Oregon Stem Cell Ctr, 3181 Sw Sam Jackson Pk Rd, Portland, OR 97201 USA; [VanSlyke, Judy K.; Musil, Linda S.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA; [Fletcher, Jonathan A.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Fletcher, Jonathan A.] Brigham & Womens Hosp, Dept Pediat, 75 Francis St, Boston, MA 02115 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Klug, LR (corresponding author), Portland VA Hlth Care Syst, Portland, OR 97239 USA.; Klug, LR (corresponding author), Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA.; Klug, LR (corresponding author), Oregon Hlth & Sci Univ, Div Hematol & Med Oncol, Portland, OR 97201 USA.	klugl@ohsu.edu	Heinrich, Michael/AAC-6745-2019	Heinrich, Michael/0000-0003-3790-0478	VA Merit Review Grants [1I01BX000338-01, 2I01BX000338-05]; GIST Cancer Research Fund; Life Raft Group; V Foundation for Cancer Research; Leukemia & Lymphoma Society; Gabrielle's Angel Foundation for Cancer Research; National Cancer Institute [5R00CA151457-04, 1R01CA183947-01]; Oregon Clinical and Translational Research Institute (OCTRI) from the National Center for Advancing Translational Sciences (NCATS), a component of the NIH [TL1 RR024159]; NIH Roadmap for Medical Research; NATIONAL CANCER INSTITUTE [R00CA151457, R01CA183974] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024159] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000338] Funding Source: NIH RePORTER	VA Merit Review Grants(US Department of Veterans Affairs); GIST Cancer Research Fund; Life Raft Group; V Foundation for Cancer Research; Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Gabrielle's Angel Foundation for Cancer Research; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Oregon Clinical and Translational Research Institute (OCTRI) from the National Center for Advancing Translational Sciences (NCATS), a component of the NIH; NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Veterans Affairs(US Department of Veterans Affairs)	L.R. Klug, A. Town, A.E. Bannon, and M.C. Heinrich were supported by VA Merit Review Grants 1I01BX000338-01 and 2I01BX000338-05. M.C. Heinrich was also supported by the GIST Cancer Research Fund and the Life Raft Group. L.R. Klug, W.H. Fleming, J.W. Tyner, and M.C. Heinrich were supported by the V Foundation for Cancer Research. J.W. Tyner was supported by the Leukemia & Lymphoma Society, Gabrielle's Angel Foundation for Cancer Research, and the National Cancer Institute (5R00CA151457-04; 1R01CA183947-01). N. Javidi-Sharifi was supported by the Oregon Clinical and Translational Research Institute (OCTRI), grant number TL1 RR024159 from the National Center for Advancing Translational Sciences (NCATS), a component of the NIH, and NIH Roadmap for Medical Research.	Agarwal A, 2016, METHODS MOL BIOL, V1470, P85, DOI 10.1007/978-1-4939-6337-9_7; An NF, 2016, EXP HEMATOL ONCOL, V5, P1, DOI 10.1186/s40164-016-0060-3; Antonescu CR, 2005, CLIN CANCER RES, V11, P4182, DOI 10.1158/1078-0432.CCR-04-2245; Bannon AE, 2017, EXPERT REV MOL DIAGN, V17, P445, DOI 10.1080/14737159.2017.1308826; Beadling C, 2008, CLIN CANCER RES, V14, P6821, DOI 10.1158/1078-0432.CCR-08-0575; Blanke CD, 2008, J CLIN ONCOL, V26, P620, DOI 10.1200/JCO.2007.13.4403; Blanke CD, 2008, J CLIN ONCOL, V26, P626, DOI 10.1200/JCO.2007.13.4452; Carvajal RD, 2015, CLIN CANCER RES, V21, P2289, DOI 10.1158/1078-0432.CCR-14-1630; Corless CL, 2011, NAT REV CANCER, V11, P865, DOI 10.1038/nrc3143; DeMatteo RP, 2002, HUM PATHOL, V33, P466, DOI 10.1053/hupa.2002.124122; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Edmonson JH, 2002, CANCER INVEST, V20, P605, DOI 10.1081/CNV-120002485; Gagnon KBE, 2007, AM J PHYSIOL-CELL PH, V292, pC1809, DOI 10.1152/ajpcell.00580.2006; Garner AP, 2014, CLIN CANCER RES, V20, P5745, DOI 10.1158/1078-0432.CCR-14-1397; Giamas G, 2011, NAT MED, V17, P715, DOI 10.1038/nm.2351; Gramza AW, 2009, CLIN CANCER RES, V15, P7510, DOI 10.1158/1078-0432.CCR-09-0190; Grzmil M, 2012, CANCER RES, V72, P3891, DOI 10.1158/0008-5472.CAN-12-0026; Guo J, 2011, J CLIN ONCOL, V29, P2904, DOI 10.1200/JCO.2010.33.9275; Hodi FS, 2008, J CLIN ONCOL, V26, P2046, DOI 10.1200/JCO.2007.14.0707; Hodi FS, 2013, J CLIN ONCOL, V31, P3182, DOI 10.1200/JCO.2012.47.7836; Jacob J, 2016, CANCER LETT, V372, P137, DOI 10.1016/j.canlet.2015.12.026; Javidi-Sharifi N, 2015, CANCER RES, V75, P880, DOI 10.1158/0008-5472.CAN-14-0573; Kajimoto N, 2015, INT J CLIN EXP PATHO, V8, P11970; Kemmer K, 2004, AM J PATHOL, V164, P305, DOI 10.1016/S0002-9440(10)63120-3; Larizza L, 2005, LEUKEMIA LYMPHOMA, V46, P247, DOI 10.1080/10428190400007565; LEV S, 1992, J BIOL CHEM, V267, P15970; LEV S, 1991, EMBO J, V10, P647, DOI 10.1002/j.1460-2075.1991.tb07993.x; Liegl B, 2008, J PATHOL, V216, P64, DOI 10.1002/path.2382; NAGATA H, 1995, P NATL ACAD SCI USA, V92, P10560, DOI 10.1073/pnas.92.23.10560; Nakai N, 2008, J PATHOL, V214, P302, DOI 10.1002/path.2296; Roberts KG, 2007, MOL CANCER THER, V6, P1159, DOI 10.1158/1535-7163.MCT-06-0641; Rossi F, 2010, MOL CANCER RES, V8, P1271, DOI 10.1158/1541-7786.MCR-10-0065; Rubin BP, 2005, CANCER RES, V65, P6631, DOI 10.1158/0008-5472.CAN-05-0891; Sakurama K, 2009, MOL CANCER THER, V8, P127, DOI 10.1158/1535-7163.MCT-08-0884; Spencer KR, 2016, CANCER TREAT RES, V167, P295, DOI 10.1007/978-3-319-22539-5_13; Stebbing J, 2013, ONCOGENE, V32, P3371, DOI 10.1038/onc.2012.343; Taguchi T, 2002, LAB INVEST, V82, P663, DOI 10.1038/labinvest.3780461; Takahashi T, 2013, INT J CANCER, V133, P2737, DOI 10.1002/ijc.28282; Tian QS, 1999, AM J PATHOL, V154, P1643, DOI 10.1016/S0002-9440(10)65419-3; Tomomura M, 2007, NEUROSCIENCE, V148, P510, DOI 10.1016/j.neuroscience.2007.05.048; Tyner JW, 2008, BLOOD, V111, P2238, DOI 10.1182/blood-2007-06-097253; Tyner JW, 2009, P NATL ACAD SCI USA, V106, P8695, DOI 10.1073/pnas.0903233106; Verweij J, 2004, LANCET, V364, P1127, DOI 10.1016/S0140-6736(04)17098-0; Wang H, 2002, J BIOL CHEM, V277, P49605, DOI 10.1074/jbc.M209335200; Weisberg E, 2003, DRUG RESIST UPDATE, V6, P231, DOI 10.1016/S1368-7646(03)00062-1; WITTE ON, 1990, CELL, V63, P5, DOI 10.1016/0092-8674(90)90280-R; Xu YC, 2015, CELL REP, V12, P837, DOI 10.1016/j.celrep.2015.06.073; Xu YC, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005170	48	8	10	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 21	2019	38	8					1200	1210		10.1038/s41388-018-0508-5	http://dx.doi.org/10.1038/s41388-018-0508-5			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HM1XR	30242244	Green Accepted			2022-12-26	WOS:000459249800004
J	Sepuru, KM; Nagarajan, B; Desai, UR; Rajarathnam, K				Sepuru, Krishna Mohan; Nagarajan, Balaji; Desai, Umesh R.; Rajarathnam, Krishna			Structural basis, stoichiometry, and thermodynamics of binding of the chemokines KC and MIP2 to the glycosaminoglycan heparin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycosaminoglycan; nuclear magnetic resonance (NMR); isothermal titration calorimetry (ITC); molecular dynamics; heparin; chemokine	MACROPHAGE INFLAMMATORY PROTEIN-2; SOLUTION NMR CHARACTERIZATION; NEUTROPHIL RECRUITMENT; MOLECULAR-BASIS; GENERALIZED BORN; CXC-CHEMOKINES; DIMER BINDING; HOST-DEFENSE; RECEPTOR; LIGAND	Keratinocyte-derived chemokine (KC or mCXCL1) and macrophage inflammatory protein 2 (MIP2 or mCXCL2) play nonredundant roles in trafficking blood neutrophils to sites of infection and injury. The functional responses of KC and MIP2 are intimately coupled to their interactions with glycosaminoglycans (GAGs). GAG interactions orchestrate chemokine concentration gradients and modulate receptor activity, which together regulate neutrophil trafficking. Here, using NMR, molecular dynamics (MD) simulations, and isothermal titration calorimetry (ITC), we characterized the molecular basis of KC and MIP2 binding to the GAG heparin. Both chemokines reversibly exist as monomers and dimers, and the NMR analysis indicates that the dimer binds heparin with higher affinity. The ITC experiments indicate a stoichiometry of two GAGs per KC or MIP2 dimer and that the enthalpic and entropic contributions vary significantly between the two chemokine-heparin complexes. NMR-based structural models of heparin-KC and heparin-MIP2 complexes reveal that different combinations of residues from the N-loop, 40s turn, (3)-strand, and C-terminal helix form a binding surface within a monomer and that both conserved residues and residues unique to a particular chemokine mediate the binding interactions. MD simulations indicate significant residue-specific differences in their contribution to binding and affinity for a given chemokine and between chemokines. On the basis of our observations that KC and MIP2 bind to GAG via distinct molecular interactions, we propose that the differences in these GAG interactions lead to differences in neutrophil recruitment and play nonoverlapping roles in resolution of inflammation.	[Sepuru, Krishna Mohan; Rajarathnam, Krishna] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Rajarathnam, Krishna] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Sepuru, Krishna Mohan; Rajarathnam, Krishna] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA; [Nagarajan, Balaji; Desai, Umesh R.] Virginia Commonwealth Univ, Dept Med Chem, Richmond, VA 23219 USA; [Nagarajan, Balaji; Desai, Umesh R.] Virginia Commonwealth Univ, Inst Struct Biol & Drug Discovery & Dev, Richmond, VA 23219 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Virginia Commonwealth University; Virginia Commonwealth University	Rajarathnam, K (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.	krrajara@utmb.edu	Sepuru, Krishna Mohan/K-5321-2014	Sepuru, Krishna Mohan/0000-0002-3675-6294	Sealy and Smith Foundation; Sealy Center for Structural Biology and Molecular Biophysics at the University of Texas Medical Branch at Galveston; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI124681] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD023576] Funding Source: NIH RePORTER	Sealy and Smith Foundation; Sealy Center for Structural Biology and Molecular Biophysics at the University of Texas Medical Branch at Galveston; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Dr. Wang and Dr. Holthauzen for technical support, Emily Lowry and Brigith Penaranda for protein purification, and Dr. Heather Lander for editorial assistance. We also acknowledge the DSealy Center for Structural Biology and Molecular Biophysics at the University of Texas Medical Branch at Galveston for providing research resources. The Sealy Center for Structural Biology and Molecular Biophysics was supported by a Sealy and Smith Foundation grant.	Bonecchi R, 2009, FRONT BIOSCI-LANDMRK, V14, P540, DOI 10.2741/3261; Brown AJ, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01248; Call DR, 2001, SHOCK, V15, P278, DOI 10.1097/00024382-200115040-00005; Case DA, 2014, AMBER 14; Craciun FL, 2010, J IMMUNOL, V185, P6930, DOI 10.4049/jimmunol.1002300; De Filippo K, 2013, BLOOD, V121, P4930, DOI 10.1182/blood-2013-02-486217; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Dutta AK, 2015, METHODS MOL BIOL, V1229, P315, DOI 10.1007/978-1-4939-1714-3_25; Feig M, 2004, J COMPUT CHEM, V25, P265, DOI 10.1002/jcc.10378; Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838; Gandhi NS, 2009, GLYCOBIOLOGY, V19, P1103, DOI 10.1093/glycob/cwp101; Gangavarapu P, 2012, J LEUKOCYTE BIOL, V91, P259, DOI 10.1189/jlb.0511239; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Iozzo RV, 2005, NAT REV MOL CELL BIO, V6, P646, DOI 10.1038/nrm1702; Jin LL, 2014, J IMMUNOL, V193, P3549, DOI 10.4049/jimmunol.1401138; Johnson DJD, 2010, P NATL ACAD SCI USA, V107, P645, DOI 10.1073/pnas.0910144107; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Joseph PRB, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170168; Joseph PRB, 2015, BIOCHEM J, V472, P121, DOI 10.1042/BJ20150059; Joseph PRB, 2015, PROTEIN SCI, V24, P81, DOI 10.1002/pro.2590; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Kobayashi Y, 2008, FRONT BIOSCI-LANDMRK, V13, P2400, DOI 10.2741/2853; Ladbury JE, 2010, NAT REV DRUG DISCOV, V9, P23, DOI 10.1038/nrd3054; LEE J, 1995, J IMMUNOL, V155, P2158; Li LY, 2012, MOL BIOSYST, V8, P1613, DOI 10.1039/c2mb25021g; Luscinskas FW, 2013, BLOOD, V122, P3708, DOI 10.1182/blood-2013-10-531905; Marki A, 2015, J LEUKOCYTE BIOL, V98, P503, DOI 10.1189/jlb.3MR0115-011R; Massena S, 2010, BLOOD, V116, P1924, DOI 10.1182/blood-2010-01-266072; Meneghetti MCZ, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0589; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; Monneau Y, 2016, J LEUKOCYTE BIOL, V99, P935, DOI 10.1189/jlb.3MR0915-440R; Monneau YR, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170133; MULLOY B, 1993, BIOCHEM J, V293, P849, DOI 10.1042/bj2930849; Nourshargh S, 2014, IMMUNITY, V41, P694, DOI 10.1016/j.immuni.2014.10.008; Ojala WH, 1996, J AM CHEM SOC, V118, P2131, DOI 10.1021/ja951121f; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Panitz N, 2016, GLYCOBIOLOGY, V26, P1209, DOI 10.1093/glycob/cww059; Poluri KM, 2013, J BIOL CHEM, V288, P25143, DOI 10.1074/jbc.M113.492579; Rajagopalan L, 2006, BIOSCIENCE REP, V26, P325, DOI 10.1007/s10540-006-9025-9; Rajarathnam K, 2018, J HISTOCHEM CYTOCHEM, V66, P229, DOI 10.1369/0022155417739864; Rajasekaran D, 2012, BIOCHEMISTRY-US, V51, P5642, DOI 10.1021/bi3001566; Ravindran A, 2013, J BIOL CHEM, V288, P12244, DOI 10.1074/jbc.M112.443762; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Samsonov SA, 2011, J COMPUT AID MOL DES, V25, P477, DOI 10.1007/s10822-011-9433-1; Sankaranarayanan NV, 2018, CURR OPIN STRUC BIOL, V50, P91, DOI 10.1016/j.sbi.2017.12.004; Sarkar A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141127; Sawant KV, 2016, SCI REP-UK, V6, DOI 10.1038/srep33123; Schaefer L, 2010, CELL TISSUE RES, V339, P237, DOI 10.1007/s00441-009-0821-y; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sepuru KM, 2016, J BIOL CHEM, V291, P20539, DOI 10.1074/jbc.M116.745265; Sepuru KM, 2016, J BIOL CHEM, V291, P4247, DOI 10.1074/jbc.M115.697888; Sepuru KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093228; Severin IC, 2010, J BIOL CHEM, V285, P17713, DOI 10.1074/jbc.M109.082552; Shao WP, 1998, BIOCHEMISTRY-US, V37, P8303, DOI 10.1021/bi980112r; Shea-Donohue T, 2008, INNATE IMMUN-LONDON, V14, P117, DOI 10.1177/1753425908088724; Tanino Y, 2010, J IMMUNOL, V184, P2677, DOI 10.4049/jimmunol.0903274; Weinbaum S, 2007, ANNU REV BIOMED ENG, V9, P121, DOI 10.1146/annurev.bioeng.9.060906.151959; Wengner AM, 2008, BLOOD, V111, P42, DOI 10.1182/blood-2007-07-099648; Xu D, 2014, ANNU REV BIOCHEM, V83, P129, DOI 10.1146/annurev-biochem-060713-035314; Ziarek JJ, 2013, J BIOL CHEM, V288, P737, DOI 10.1074/jbc.M112.394064; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X; Zwijnenburg PJG, 2003, IMMUNOL LETT, V85, P1, DOI 10.1016/S0165-2478(02)00200-6	63	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2018	293	46					17817	17828		10.1074/jbc.RA118.004866	http://dx.doi.org/10.1074/jbc.RA118.004866			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HA6SG	30257866	Green Published, hybrid			2022-12-26	WOS:000450409500013
J	Amadori, M; Soares-Filipe, JF; Riva, F; Vitali, A; Ruggeri, J; Lacetera, N				Amadori, Massimo; Soares-Filipe, Joel Fernando; Riva, Federica; Vitali, Andrea; Ruggeri, Jessica; Lacetera, Nicola			Characterization of the blastogenic response to LPS of bovine peripheral blood mononuclear cells	PLOS ONE			English	Article							PERIPARTURIENT DAIRY-COWS; MONOCLONAL-ANTIBODIES; LIPOPOLYSACCHARIDE; RECEPTOR; EXPRESSION; IDENTIFICATION; STRESS; ALPHA	Mitogens are diverse compounds of plant and microbial origin, widely employed to test immunocompetence in animals. The blastogenic response of bovine Peripheral Blood Mononuclear Cells (PBMC) to lypopolysaccharides (LPS) has been investigated in our laboratories for a long time. In particular, a possible correlation between blastogenic response to LPS and disease resistance of periparturient dairy cows had been observed in previous studies. Most important, low responder cows presented a higher frequency of disease cases after calving, compared with high responder animals. Owing to the above, different aspects of the blastogenic response to LPS were investigated on PBMC of healthy Friesian cows, using a 72-hour Bromodeoxyuridin (BrDU) cell proliferation assay. Stimulation with LPS induced little if any replication of bovine PBMC over 72 hours despite consistent BrDU detection in all the PBMC samples under study. Poor replication of LPS-stimulated PBMC was confirmed by cell cycle and cell growth flow cytometry analyses. In particular, LPS stimulation gave rise to very low percentages of S phase cells, sometimes lower than in control, unstimulated cells, as opposed to Concanavalin A-stimulated PBMC. Magnetic separation and analysis of BrDU-treated bovine PBMC after exposure to LPS showed that both B and CD4 T cells are involved in the blastogenic response to LPS, in contrast with current data based on human and murine models. Finally, LPS caused an early, specific up-regulation of TNF-alpha and TLR4 genes in bovine PBMC, and significant correlations were shown between the expression of inflammatory cytokine and Indoleamine-pyrrole 2,3-dioxygenase (IDO1) genes. On the whole, our data indicate that differences in the blastogenic response to LPS could be partly accounted for by heterogenicity of responding cells (B and T lymphocytes), which might also have an impact on induction and regulation of inflammatory responses and endotoxin tolerance.	[Amadori, Massimo; Ruggeri, Jessica] IZSLER, Lab Cellular Immunol, Brescia, Italy; [Soares-Filipe, Joel Fernando; Riva, Federica] UNIMI, Dept Vet Med DIMEVET, Milan, Italy; [Vitali, Andrea; Lacetera, Nicola] Univ Tuscia, Dept Agr & Forestry Sci DAFNE, Viterbo, Italy	IZS Lombardia e Emilia; Tuscia University	Amadori, M (corresponding author), IZSLER, Lab Cellular Immunol, Brescia, Italy.	massimo.amadori@izsler.it	Lacetera, Nicola/GLV-1404-2022; Vitali, Andrea/AAA-6423-2020; Filipe, Joel/U-7718-2017; Amadori, Massimo/J-2511-2014	Vitali, Andrea/0000-0002-4739-9077; Filipe, Joel/0000-0001-8849-2051; Amadori, Massimo/0000-0002-7562-0322	MIUR (Ministry for Education, University and Research) [Law 232/216]	MIUR (Ministry for Education, University and Research)(Ministry of Education, Universities and Research (MIUR))	The research was partially supported by MIUR (Ministry for Education, University and Research), Law 232/216 (Department of excellence): Dr. Nicola Lacetera, and partially by internal resources (manpower and consumables) of our organizations. There was no additional external funding received for this study.	ABRAHAM C, 1977, EUR J IMMUNOL, V7, P301, DOI 10.1002/eji.1830070512; ADAMS JL, 1990, J LEUKOCYTE BIOL, V48, P549, DOI 10.1002/jlb.48.6.549; Amadori M., 2016, INNATE IMMUNE RESPON; BALDWIN CL, 1986, J IMMUNOL, V136, P4385; Bessede A, 2014, NATURE, V511, P184, DOI 10.1038/nature13323; CALDER PC, 1990, BIOCHEM SOC T, V18, P904, DOI 10.1042/bst0180904; Catalani E, 2013, J DAIRY SCI, V96, P7077, DOI 10.3168/jds.2013-6854; Darzynkiewicz Zbigniew, 2004, Curr Protoc Cytom, VChapter 7, DOI 10.1002/0471142956.cy0703s30; DAVIS WC, 1993, VET IMMUNOL IMMUNOP, V39, P85, DOI 10.1016/0165-2427(93)90167-3; Divanovic S, 2005, NAT IMMUNOL, V6, P571, DOI 10.1038/ni1198; Duvigneau JC, 2007, J IMMUNOL METHODS, V324, P38, DOI 10.1016/j.jim.2007.04.012; Duvigneau JC, 2003, J IMMUNOL METHODS, V272, P11, DOI 10.1016/S0022-1759(02)00372-1; HOWARD CJ, 1991, VET IMMUNOL IMMUNOP, V27, P21, DOI 10.1016/0165-2427(91)90072-K; Komai-Koma M, 2009, EUR J IMMUNOL, V39, P1564, DOI 10.1002/eji.200838866; Lacetera N, 2002, INT J BIOMETEOROL, V46, P33, DOI 10.1007/s00484-001-0115-x; Li FX, 2017, INT IMMUNOPHARMACOL, V47, P70, DOI 10.1016/j.intimp.2017.03.024; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Collazo E, 2013, CRIT CARE, V17, DOI 10.1186/cc13110; Muul L. M., 2011, CURRENT PROTOCOLS IM, DOI DOI 10.1002/0471142735.IM0710S94; NAESSENS J, 1988, IMMUNOLOGY, V63, P569; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Rath PC, 2001, J INTERF CYTOK RES, V21, P523, DOI 10.1089/10799900152434402; Riva F, 2010, VET IMMUNOL IMMUNOP, V136, P65, DOI 10.1016/j.vetimm.2010.02.009; Trevisi E, 2012, RES VET SCI, V93, P695, DOI 10.1016/j.rvsc.2011.11.008	24	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0204827	10.1371/journal.pone.0204827	http://dx.doi.org/10.1371/journal.pone.0204827			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3QJ	30278079	Green Published, gold, Green Submitted			2022-12-26	WOS:000446010200025
J	Brown, B; Marg, L; Leon, S; Chen, C; Siu, JNY; Calvo, G; Sanchez, H; Galea, JT				Brown, Brandon; Marg, Logan; Leon, Segundo; Chen, Cynthia; Siu, Junice Ng Yi; Calvo, Gino; Sanchez, Hugo; Galea, Jerome T.			The relationship between anogenital HPV types and incident HIV infection among men who have sex with men and transgender women in Lima, Peru: Findings from a prospective cohort study	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; HUMAN-PAPILLOMAVIRUS INFECTION; GENITAL WARTS; HIGH-RISK; IMMUNODEFICIENCY; PREVALENCE; ACQUISITION; PREVENTION; TRANSWOMEN	Although it is known that individuals living with HIV have a higher HPV prevalence, the impact of individual HPV types on HIV acquisition is less clear. In this prospective cohort study we investigated the relationship between HPV types and incident HIV infection among men who have sex with men (MSM) and transgender women (TW) in Lima, Peru. Six hundred HIV-negative Peruvian MSM and TW participated in a 2-year study with biannual visits. At baseline, participants completed a computerized, self-administered questionnaire on sexual behavior and HPV knowledge and underwent a physical exam including anogenital swabs for HPV DNA (37 genotypes via linear array testing) and HIV testing; follow-up visits included the questionnaire and HIV testing. Participant mean age was 25 years (range = 18-40), with 48.9% self-identifying as gay and 86.5% reporting having sex exclusively with men. At baseline, 530 participants had HPV DNA present (61.1% with high-risk HPV, 84.9% with low-risk HPV). Among 571 participants who returned for any study visit, 73 (12.8%) became infected with HIV during the 2-year follow-up (6% HIV incidence). Compared to those without HIV, more participants with HIV had any HPV type present (97.3% vs. 87.6%, respectively, p = .01), more than one HPV type (79.5% vs. 58.2%, p< .01), or high-risk HPV (72.6% vs. 51.4%, p< .01). Some participants lost to follow-up could have been HIV-positive, which would have affected the relationship of HPV and HIV infection. Our prospective study showed that participants with any HPV type, more than one HPV type, or high-risk HPV were more likely to test positive for HIV. Although most studies have shown HPV-HIV coinfection, our findings illustrate the strong relationship between individual HPV types and HIV infection. This further illustrates the potential utility of HPV vaccine for MSM and TW, not only for HPV prevention but also possibly for HIV prevention.	[Brown, Brandon; Marg, Logan] Univ Calif Riverside, Sch Med, Riverside, CA 92521 USA; [Leon, Segundo] Socios Salud, Lima, Peru; [Chen, Cynthia; Siu, Junice Ng Yi] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Calvo, Gino; Sanchez, Hugo; Galea, Jerome T.] Epictr Salud, Lima, Peru; [Galea, Jerome T.] Univ S Florida, Coll Behav & Community Sci, Sch Social Work, Tampa, FL USA	University of California System; University of California Riverside; National University of Singapore; State University System of Florida; University of South Florida	Brown, B (corresponding author), Univ Calif Riverside, Sch Med, Riverside, CA 92521 USA.	brandon.brown@medsch.ucr.edu	Galea, Jerome T/HGV-0203-2022; Galea, Jerome T./AAF-2172-2019; Leon, Segundo Ramos/J-3058-2019	Galea, Jerome T/0000-0001-8732-6959; Galea, Jerome T./0000-0001-8732-6959; Leon, Segundo Ramos/0000-0002-5630-5714; Brown, Brandon/0000-0002-6348-4108; Calvo Moreno, Gino Mauricio/0000-0002-4838-1960	Merck MISP [39619]; Foundation for the National Institutes of Health NIH [T32 MH080634]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH080634] Funding Source: NIH RePORTER	Merck MISP; Foundation for the National Institutes of Health NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by Merck MISP 39619: http://www.merck.com/index.html; and Foundation for the National Institutes of Health NIH T32 MH080634: https://grants.nih.gov/grants/guide/pa-files/PA-16-152.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartolini RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048017; Beyrer C, 2008, SEX TRANSM INFECT, V84, P410, DOI 10.1136/sti.2008.033290; Bingham A, 2009, ARCH PEDIAT ADOL MED, V163, P455, DOI 10.1001/archpediatrics.2009.50; Blas MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139524; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Brown B, 2015, CALIF J HLTH PROMOT, V13, pvi; Brown B, 2017, LGBT HEALTH, V4, P315, DOI 10.1089/lgbt.2016.0142; Brown Brandon, 2016, Transgend Health, V1, P94, DOI 10.1089/trgh.2016.0001; Brown B, 2015, SEX TRANSM DIS, V42, P198, DOI 10.1097/OLQ.0000000000000258; Brown B, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005687; Brown B, 2012, VIRUSES-BASEL, V4, P3851, DOI 10.3390/v4123851; Centers for Disease Control and Prevention, 2016, AN SEX HIV RISK; Chin-Hong PV, 2009, AIDS, V23, P1135, DOI 10.1097/QAD.0b013e32832b4449; Clark JL, 2010, SEX TRANSM INFECT, V86, P545, DOI 10.1136/sti.2010.042697; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Galea JT, 2015, SEX TRANSM DIS, V42, P202, DOI 10.1097/OLQ.0000000000000253; Giuliano AR, 2011, LANCET, V377, P932, DOI 10.1016/S0140-6736(10)62342-2; Goldstone S, 2011, J INFECT DIS, V203, P66, DOI 10.1093/infdis/jiq016; Jin FY, 2010, JAIDS-J ACQ IMM DEF, V53, P144, DOI 10.1097/QAI.0b013e3181b48f33; KENT C, 1987, JAMA-J AM MED ASSOC, V258, P3385, DOI 10.1001/jama.1987.03400230045017; Ministerio de Salud del Peru, 2013, NORM TECN SAL EST ES; Moscicki AB, 2011, J LOW GENIT TRACT DI, V15, P231, DOI 10.1097/LGT.0b013e318203ae61; Muller EE, 2010, SEX TRANSM INFECT, V86, P175, DOI 10.1136/sti.2009.037598; Palefsky J, 2006, Adv Dent Res, V19, P99; Quinn R, 2012, AIDS RES HUM RETROV, V28, P1734, DOI [10.1089/aid.2011.0307, 10.1089/AID.2011.0307]; Silva-Santisteban A, 2012, AIDS BEHAV, V16, P872, DOI 10.1007/s10461-011-0053-5; Silverberg MJ, 2002, SEX TRANSM DIS, V29, P427, DOI 10.1097/00007435-200208000-00001; Smits PHM, 2005, J CLIN MICROBIOL, V43, P5936, DOI 10.1128/JCM.43.12.5936-5939.2005; Solomon MM, 2014, CLIN INFECT DIS, V59, P1020, DOI 10.1093/cid/ciu450; Steen R, 2004, J CLIN VIROL, V29, P143, DOI 10.1016/j.jcv.2003.05.001; UNAIDS, 2015, PERU HIV AIDS EST; UNAIDS, 2010, GLOB REP UNAIDS REP; UNAIDS, 2008, REP GLOB AIDS EP; van Aar F, 2013, AIDS, V27, P2921, DOI 10.1097/01.aids.0000432541.67409.3c	34	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0204996	10.1371/journal.pone.0204996	http://dx.doi.org/10.1371/journal.pone.0204996			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3QJ	30278061	Green Published, Green Submitted, gold			2022-12-26	WOS:000446010200033
J	Mamach, M; Kessler, M; Bankstahl, JP; Wilke, F; Geworski, L; Bengel, FM; Kurt, S; Berding, G				Mamach, Martin; Kessler, Mariella; Bankstahl, Jens P.; Wilke, Florian; Geworski, Lilli; Bengel, Frank M.; Kurt, Simone; Berding, Georg			Visualization of the auditory pathway in rats with F-18-FDG PET activation studies based on different auditory stimuli and reference conditions including cochlea ablation	PLOS ONE			English	Article							BRAIN; NOISE; IMPLANTATION	Activation studies with positron emission tomography (PET) in auditory implant users explained some of the mechanisms underlying the variability of achieved speech comprehension. Since future developments of auditory implants will include studies in rodents, we aimed to inversely translate functional PET imaging to rats. In normal hearing rats, activity in auditory and non-auditory regions was studied using F-18-fluorodeoxyglucose (F-18-FDG) PET with 3 different acoustic conditions: sound attenuated laboratory background, continuous white noise and rippled noise. Additionally, bilateral cochlea ablated animals were scanned. 3D image data were transferred into a stereotaxic standard space and evaluated using volume of interest (VOI) analyses and statistical parametric mapping (SPM). In normal hearing rats alongside the auditory pathway consistent activations of the nucleus cochlearis (NC), olivary complex (OC) and inferior colliculus (IC) were seen comparing stimuli with background. In this respect, no increased activation could be detected in the auditory cortex (AC), which even showed deactivation with white noise stimulation. Nevertheless, higher activity in the AC in normal hearing rats was observed for all 3 auditory conditions against the cochlea ablated status. Vice versa, in ablated status activity in the olfactory nucleus (ON) was higher compared to all auditory conditions in normal hearing rats. Our results indicate that activations can be demonstrated in normal hearing animals based on F-18-FDG PET in nuclei along the central auditory pathway with different types of noise stimuli. However, in the AC missing activation with respect to the background advises the need for more rigorous background noise attenuation for non-invasive reference conditions. Finally, our data suggest cross-modal activation of the olfactory system following cochlea ablation-underlining, that F-18-FDG PET appears to be well suited to study plasticity in rat models for cochlear implantation.	[Mamach, Martin; Wilke, Florian; Geworski, Lilli] Hannover Med Sch, Dept Med Phys & Radiat Protect, Hannover, Germany; [Mamach, Martin; Kessler, Mariella; Kurt, Simone; Berding, Georg] Hannover Med Sch, Cluster Excellence Hearing4all, Hannover, Germany; [Kessler, Mariella; Bankstahl, Jens P.; Bengel, Frank M.; Berding, Georg] Hannover Med Sch, Dept Nucl Med, Hannover, Germany; [Kurt, Simone] Hannover Med Sch, Dept Otolaryngol, Hannover, Germany; [Kurt, Simone] Saarland Univ, CIPMM, Dept Biophys, Homburg, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School; Hannover Medical School; Universitatsklinikum des Saarlandes	Mamach, M (corresponding author), Hannover Med Sch, Dept Med Phys & Radiat Protect, Hannover, Germany.; Mamach, M (corresponding author), Hannover Med Sch, Cluster Excellence Hearing4all, Hannover, Germany.	mamach.martin@mh-hannover.de	Bengel, Frank/AAR-7353-2020	Mamach, Martin/0000-0002-3461-2668; Kurt, Simone/0000-0002-1820-2597; Bengel, Frank/0000-0003-4529-7963	public "Deutsche Forschungsgemeinschaft" (DFG) [EXC 1077]	public "Deutsche Forschungsgemeinschaft" (DFG)	This research was executed within the Cluster of Excellence EXC 1077 "Hearing for all: Models, technology and solutions for diagnostics, restoration and support of hearing", funded by the public "Deutsche Forschungsgemeinschaft" (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott SD, 1999, NEUROSCIENCE, V93, P1375, DOI 10.1016/S0306-4522(99)00300-0; Ahn SH, 2004, HEARING RES, V196, P33, DOI 10.1016/j.heares.2004.05.012; Arno P, 2001, NEUROIMAGE, V13, P632, DOI 10.1006/nimg.2000.0731; Berding G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128743; Blamey PJ, 2015, EAR HEARING, V36, P408, DOI 10.1097/AUD.0000000000000150; Chonde DB, 2013, INVEST RADIOL, V48, P302, DOI 10.1097/RLI.0b013e3182839fbc; CLARK WW, 1991, J ACOUST SOC AM, V90, P155, DOI 10.1121/1.401309; Constantinescu CC, 2009, PHYS MED BIOL, V54, P2885, DOI 10.1088/0031-9155/54/9/020; Dedeurwaerdere S, 2009, EUR J NUCL MED MOL I, V36, P958, DOI 10.1007/s00259-009-1066-4; Deutscher A, 2006, NEUROREPORT, V17, P853, DOI 10.1097/01.wnr.0000221837.20255.62; Giraud AL, 2001, AUDIOL NEURO-OTOL, V6, P381, DOI 10.1159/000046847; Hsu WC, 2009, ACTA OTO-LARYNGOL, V129, P423, DOI 10.1080/00016480802593497; Jang DP, 2012, NEUROREPORT, V23, P228, DOI 10.1097/WNR.0b013e32835022c7; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Knoop BO, 2002, PHYS MED BIOL, V47, P1237, DOI 10.1088/0031-9155/47/8/302; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Laudanski J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050539; Lazard DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048739; Lu W, 2005, HEARING RES, V205, P115, DOI 10.1016/j.heares.2005.03.010; Mamach M, 2018, EJNMMI RES, V8, DOI 10.1186/s13550-018-0362-z; Merabet LB, 2010, NAT REV NEUROSCI, V11, P44, DOI 10.1038/nrn2758; Niparko JK, 2010, JAMA-J AM MED ASSOC, V303, P1498, DOI 10.1001/jama.2010.451; Parellada E, 2008, NUCL MED COMMUN, V29, P894, DOI 10.1097/MNM.0b013e328302cd10; Paul AK, 2009, NEUROIMAGE, V44, P312, DOI 10.1016/j.neuroimage.2008.09.024; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pietrini P, 2000, J NUCL MED, V41, P575; Rao DB, 2000, HEARING RES, V150, P206, DOI 10.1016/S0378-5955(00)00202-1; Rausch I, 2015, EJNMMI PHYS, V2, DOI 10.1186/s40658-015-0132-1; Ruytjens L, 2006, ACTA OTO-LARYNGOL, V126, P1236, DOI 10.1080/00016480600801373; Schiffer WK, 2006, J NEUROSCI METH, V155, P272, DOI 10.1016/j.jneumeth.2006.01.027; Schwarz AJ, 2006, NEUROIMAGE, V32, P538, DOI 10.1016/j.neuroimage.2006.04.214; Smith JJ, 2009, NEURAL PLAST, V2009, DOI 10.1155/2009/754014; Soto-Montenegro M, 2009, MOL IMAGING BIOL, V11, P94, DOI 10.1007/s11307-008-0179-7; Wehr M, 2005, NEURON, V47, P437, DOI 10.1016/j.neuron.2005.06.009; Willmore BDB, 2009, CURR BIOL, V19, pR1123, DOI 10.1016/j.cub.2009.11.003; Wilson BS, 2008, HEARING RES, V242, P3, DOI 10.1016/j.heares.2008.06.005; Zhou Y, 2017, BIOCHEM BIOPH RES CO, V486, P833, DOI 10.1016/j.bbrc.2017.03.140; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	39	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0205044	10.1371/journal.pone.0205044	http://dx.doi.org/10.1371/journal.pone.0205044			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3QJ	30278068	Green Published, gold, Green Submitted			2022-12-26	WOS:000446010200036
J	De Wolfe, TJ; Eggers, S; Barker, AK; Kates, AE; Dill-McFarland, KA; Suen, G; Safdar, N				De Wolfe, T. J.; Eggers, S.; Barker, A. K.; Kates, A. E.; Dill-McFarland, K. A.; Suen, G.; Safdar, N.			Oral probiotic combination of Lactobacillus and Bifidobacterium alters the gastrointestinal microbiota during antibiotic treatment for Clostridium difficile infection	PLOS ONE			English	Article							FECAL MICROBIOTA; SEQUENCE DATA; RESISTANCE; KEGG	Perturbations in the gastrointestinal microbiome caused by antibiotics are a major risk factor for Clostridium difficile infection (CDI). Probiotics are often recommended to mitigate CDI symptoms; however, there exists only limited evidence showing probiotic efficacy for CDI. Here, we examined changes to the GI microbiota in a study population where probiotic treatment was associated with significantly reduced duration of CDI diarrhea. Subjects being treated with standard of care antibiotics for a primary episode of CDI were randomized to probiotic treatment or placebo for 4 weeks. Probiotic treatment consisted of a daily multi-strain capsule (Lactobacillus acidophilus NCFM, ATCC 700396; Lactobacillus paracasei Lpc-37, ATCC SD5275; Bifidobacterium lactis Bi-07, ATCC SC5220; Bifidobacterium lactis B1-04, ATCC SD5219) containing 1.7 x 10(10) CFUs. Stool was collected and analyzed using 16S rRNA sequencing. Microbiome analysis revealed apparent taxonomic differences between treatments and timepoints. Subjects administered probiotics had reduced Verrucomicrobiaceae at week 8 compared to controls. Bacteroides were significantly reduced between weeks 0 to 4 in probiotic treated subjects. Ruminococcus (family Lachnospiraceae), tended to be more abundant at week 8 than week 4 within the placebo group and at week 8 than week 0 within the probiotic group. Similar to these results, previous studies have associated these taxa with probiotic use and with mitigation of CDI symptoms. Compositional prediction of microbial community function revealed that subjects in the placebo group had microbiomes enriched with the iron complex transport system, while probiotic treated subjects had microbiomes enriched with the antibiotic transport system. Results indicate that probiotic use may impact the microbiome function in the face of a CDI; yet, more sensitive methods with higher resolution are warranted to better elucidate the roles associated with these changes. Continuing studies are needed understand probiotic effects on microbiome structure and function and the resulting impacts on CDI.	[De Wolfe, T. J.] Univ Pittsburgh, Dept Biomed Informat, Pittsburgh, PA 15260 USA; [De Wolfe, T. J.; Kates, A. E.; Safdar, N.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Div Infect Dis, Madison, WI 53706 USA; [Eggers, S.; Barker, A. K.] Univ Wisconsin, Madison Sch Med & Publ Hlth, Dept Populat Hlth Sci, Madison, WI USA; [Kates, A. E.; Safdar, N.] William S Middleton Mem Vet Adm Med Ctr, Madison, WI USA; [Dill-McFarland, K. A.; Suen, G.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital; University of Wisconsin System; University of Wisconsin Madison	De Wolfe, TJ (corresponding author), Univ Pittsburgh, Dept Biomed Informat, Pittsburgh, PA 15260 USA.; De Wolfe, TJ (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Div Infect Dis, Madison, WI 53706 USA.	tjdewolfe@gmail.com	De Wolfe, Travis J/C-6827-2013; Suen, Garret/AAF-2080-2019	De Wolfe, Travis J/0000-0001-6261-1235; Suen, Garret/0000-0002-6170-711X; Eggers, Shoshannah/0000-0002-4321-9219	National Institute of Food and Agriculture, United States Department of Agriculture [WIS01729]; National Institutes of Health [1R03AG040669-01A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008692] Funding Source: NIH RePORTER	National Institute of Food and Agriculture, United States Department of Agriculture(United States Department of Agriculture (USDA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of Food and Agriculture, United States Department of Agriculture, ID #WIS01729 to G.S. and by the National Institutes of Health, ID #1R03AG040669-01A1 to N.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubucker S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002358; Abujamel T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076269; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Antharam VC, 2013, J CLIN MICROBIOL, V51, P2884, DOI 10.1128/JCM.00845-13; Barker AK, 2017, J ANTIMICROB CHEMOTH, V72, P1; Bassis CM, 2014, ANTIMICROB AGENTS CH, V58, P2767, DOI 10.1128/AAC.02262-13; Britton RA, 2014, GASTROENTEROLOGY, V146, P1547, DOI 10.1053/j.gastro.2014.01.059; Brown JS, 2002, MICROBES INFECT, V4, P1149, DOI 10.1016/S1286-4579(02)01640-4; Butler M., 2016, EARLY DIAGNOSIS PREV; Cammarota G, 2014, INTERN EMERG MED, V9, P365, DOI 10.1007/s11739-014-1069-4; Centers for Disease Control and Prevention, 2013, ANTIBIOTIC RESISTANC, P1; Dabard J, 2001, APPL ENVIRON MICROB, V67, P4111, DOI 10.1128/AEM.67.9.4111-4118.2001; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Engelbrektson A, 2009, J MED MICROBIOL, V58, P663, DOI 10.1099/jmm.0.47615-0; Goldenberg JZ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006095.pub3; Grehan MJ, 2010, J CLIN GASTROENTEROL, V44, P551, DOI 10.1097/MCG.0b013e3181e5d06b; Jackson MA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05184-7; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M., 2000, KEGG KYOTO ENCY GENE; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Kristensen NB, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0300-5; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; Louie TJ, 2012, CLIN INFECT DIS, V55, pS132, DOI 10.1093/cid/cis338; Mathur H, 2014, GUT MICROBES, V5, P696, DOI 10.4161/19490976.2014.983768; McDonald LC, 2006, EMERG INFECT DIS, V12, P409, DOI 10.3201/eid1203.051064; McNulty NP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002701; Mendez C, 2001, RES MICROBIOL, V152, P341, DOI 10.1016/S0923-2508(01)01205-0; Miller BA, 2011, INFECT CONT HOSP EP, V32, P387, DOI 10.1086/659156; Miller M, 2009, ANAEROBE, V15, P281, DOI 10.1016/j.anaerobe.2009.08.005; Noguchi K, 2012, J STAT SOFTWARE; Oksanen J., 2017, VEGAN COMMUNITY ECOL, P1; OLSON MM, 1994, INFECT CONT HOSP EP, V15, P371; Petrof EO, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-3; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; ROLFE RD, 1981, J INFECT DIS, V143, P470, DOI 10.1093/infdis/143.3.470; Sanders ME, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0629-z; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schubert AM, 2015, MBIO, V6, DOI 10.1128/mBio.00974-15; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Tannock GW, 2000, APPL ENVIRON MICROB, V66, P2578, DOI 10.1128/AEM.66.6.2578-2588.2000; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weingarden AR, 2014, AM J PHYSIOL-GASTR L, V306, pG310, DOI 10.1152/ajpgi.00282.2013; Wilson DN, 2014, NAT REV MICROBIOL, V12, P35, DOI 10.1038/nrmicro3155	47	20	20	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204253	10.1371/journal.pone.0204253	http://dx.doi.org/10.1371/journal.pone.0204253			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265691	gold, Green Published, Green Submitted			2022-12-26	WOS:000446005500021
J	Romano, MR; Cennamo, G; Montorio, D; Del Prete, S; Ferrara, M; Cennamo, G				Romano, Mario R.; Cennamo, Gilda; Montorio, Daniela; Del Prete, Salvatore; Ferrara, Mariantonia; Cennamo, Giovanni			Correlation between various trace elements and ultramicroscopic structure of epiretinal macular membranes and glial cells	PLOS ONE			English	Article							RETINAL-PIGMENT EPITHELIUM; PROLIFERATIVE DIABETIC-RETINOPATHY; FIBRILLARY ACIDIC PROTEIN; PATHOPHYSIOLOGICAL CONDITIONS; VITREOMACULAR TRACTION; DNA-SYNTHESIS; VITREORETINOPATHY; FIBRONECTIN; EXPRESSION; DETACHMENT	Introduction Elements such as zinc, iron, copper, sulphur and phosphorus have been identified in retinal layers and implicated in vital retinal functions. Regarding mineral composition of epiretinal membranes (ERMs), literature is lacking. This study aimed to analyze both mineral composition and anatomical ultrastructure of ERMs to clarify the pathophysiology of this disease. Methods Twenty ERMs (10 diabetic ERMs and 10 idiopathic ERMs) from 20 patients were harvested during pars plana vitrectomy. Scanning Electron Microscopy (SEM) was used to investigate the anatomical ultrastructure of the peeled ERMs. Mineral composition was analyzed using energy-dispersive spectrometry (EDS). The most frequent elements were evaluated in relation to appearance of ERMs analyzed at SEM and at OCT images. Results Sulphur was the most frequent element found (in 80% of the samples), followed by sodium (50%) and phosphorus (45%). The presence of these elements was not significantly different between diabetic and idiopathic ERMs (P >0.05). Using SEM we found a folded tissue in all ERMs, except in 4 ERMs, where we observed only a smooth tissue. There was a trend of sodium to be more frequent in ERMs with folded layers at SEM examination. Conclusions Several elements were identified in ERMs, and sulphur, sodium and phosphorus were the most frequent ones. This finding may help to understand their role in the physiopatology of epiretinal proliferation and in glial activation.	[Romano, Mario R.] Humanitas Univ, Dept Biomed Sci, Pieve Emanuele Milan, Italy; [Cennamo, Gilda] Univ Federico II, Dept Publ Hlth, Naples, Italy; [Montorio, Daniela; Ferrara, Mariantonia; Cennamo, Giovanni] Univ Federico II, Dept Neurosci Reprod & Odontostomatol Sci, Naples, Italy; [Del Prete, Salvatore] Univ Federico II, Interdept Electron Microscope Ctr, Naples, Italy	Humanitas University; University of Naples Federico II; University of Naples Federico II; University of Naples Federico II	Romano, MR (corresponding author), Humanitas Univ, Dept Biomed Sci, Pieve Emanuele Milan, Italy.	mario.romano.md@gmail.com	Ferrara, Mariantonia/AEC-7557-2022; Del Prete, Salvatore/AAC-7867-2020; Montorio, Daniela/AAJ-8687-2020; Del Prete, Salvatore/AAW-7149-2021	Ferrara, Mariantonia/0000-0002-1191-4989; Del Prete, Salvatore/0000-0001-6004-7781; Romano, Mario R/0000-0003-0348-0532; Montorio, Daniela/0000-0003-1423-9621				Armstrong D, 1998, OPHTHALMOLOGICA, V212, P410, DOI 10.1159/000027378; Azzolini C, 2017, EUR J OPHTHALMOL, V19, DOI [10.5301/ejo, DOI 10.5301/EJO]; Boscia F, 2016, GLIA, V64, P1677, DOI 10.1002/glia.23030; Brosnan JT, 2006, J NUTR, V136, p1636S, DOI 10.1093/jn/136.6.1636S; Bu SC, 2014, RETINA-J RET VIT DIS, V34, P2317, DOI 10.1097/IAE.0000000000000349; Charteris DG, 2007, GRAEF ARCH CLIN EXP, V245, P93, DOI 10.1007/s00417-006-0323-5; ERICKSON PA, 1987, EXP EYE RES, V44, P37, DOI 10.1016/S0014-4835(87)80023-4; Erie JC, 2009, AM J OPHTHALMOL, V147, P276, DOI 10.1016/j.ajo.2008.08.014; Gandorfer A, 2005, AM J OPHTHALMOL, V139, P638, DOI 10.1016/j.ajo.2004.11.035; Gass JDM., 1997, DIAGNOSIS TREATMENT, V4th edition; GRIERSON I, 1994, EYE, V8, P255, DOI 10.1038/eye.1994.54; GRISANTI S, 1993, BRIT J OPHTHALMOL, V77, P238, DOI 10.1136/bjo.77.4.238; Heidenkummer H.-P., 1996, Ophthalmologe, V93, P675, DOI 10.1007/s003470050057; Higashimori H, 2007, GLIA, V55, P1668, DOI 10.1002/glia.20574; Hiscott P, 2002, EYE, V16, P393, DOI 10.1038/sj.eye.6700196; HISCOTT PS, 1983, T OPHTHAL SOC UK, V103, P89; HISCOTT PS, 1984, BRIT J OPHTHALMOL, V68, P698, DOI 10.1136/bjo.68.10.698; Joshi M, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/192582; KAMPIK A, 1981, ARCH OPHTHALMOL-CHIC, V99, P1445, DOI 10.1001/archopht.1981.03930020319025; Kenawy N, 2010, OPHTHALMOLOGY, V117, P320, DOI 10.1016/j.ophtha.2009.07.024; Kodal H, 2000, INVEST OPHTH VIS SCI, V41, P4262; LEWIS GP, 1994, AM J OPHTHALMOL, V118, P368, DOI 10.1016/S0002-9394(14)72962-9; Lewis GP, 2003, INT REV CYTOL, V230, P263, DOI 10.1016/S0074-7696(03)30005-1; MARANO RPC, 1994, INVEST OPHTH VIS SCI, V35, P2791; MAZURE A, 1992, INVEST OPHTH VIS SCI, V33, P3407; Moll V, 2002, INVEST OPHTH VIS SCI, V43, P766; Newbury DE, 2013, SCANNING, V35, P141, DOI 10.1002/sca.21041; NISHIMURA H, 1991, HISTOCHEMISTRY, V95, P535, DOI 10.1007/BF00266738; Rose CR, 2016, NEUROSCIENCE, V323, P121, DOI 10.1016/j.neuroscience.2015.03.002; Rose CR, 2016, GLIA, V64, P1611, DOI 10.1002/glia.22964; Rose CR, 2013, GLIA, V61, P1191, DOI 10.1002/glia.22492; Scavelli K, 2015, J OCUL PHARMACOL TH, V31, P396, DOI 10.1089/jop.2015.0057; Schumann RG, 2006, AM J OPHTHALMOL, V141, P1112, DOI 10.1016/j.ajo.2006.01.074; Schumann RG, 2011, INVEST OPHTH VIS SCI, V52, P7822, DOI 10.1167/iovs.11-7514; Ugarte M, 2013, SURV OPHTHALMOL, V58, P585, DOI 10.1016/j.survophthal.2012.12.002; Ugarte M, 2012, METALLOMICS, V4, P1245, DOI 10.1039/c2mt20157g; VINORES SA, 1990, INVEST OPHTH VIS SCI, V31, P2529; VINORES SA, 1990, INVEST OPHTH VIS SCI, V31, P14; Yoon HS, 1996, AM J OPHTHALMOL, V122, P67, DOI 10.1016/S0002-9394(14)71965-8; Zhao F, 2013, RETINA-J RET VIT DIS, V33, P77, DOI 10.1097/IAE.0b013e3182602087	40	2	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204497	10.1371/journal.pone.0204497	http://dx.doi.org/10.1371/journal.pone.0204497			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265684	Green Published, Green Submitted, gold			2022-12-26	WOS:000446005500035
J	Alahakoon, C; Dassanayake, TL; Gawarammana, IB; Sedgwick, EM; Weerasinghe, VS; Abdalla, A; Roberts, MS; Buckley, NA				Alahakoon, Chanika; Dassanayake, Tharaka L.; Gawarammana, Indika B.; Sedgwick, E. Michael; Weerasinghe, Vajira S.; Abdalla, Ahmed; Roberts, Michael S.; Buckley, Nicholas A.			Prediction of organophosphorus insecticide-induced intermediate syndrome with stimulated concentric needle single fibre electromyography	PLOS ONE			English	Article							ORBICULARIS-OCULI; JITTER; MUSCLE; ACETYLCHOLINESTERASE	Background Deliberate self-poisoning (DSP) using organophosphorus (OP) insecticides are a common clinical problem in Asia. OPs inhibit acetylcholine esterase (AChE), leading to over-activity of muscarinic and nicotinic cholinergic circuits. Intermediate syndrome (IMS) is mediated via prolonged nicotinic receptor stimulation at the neuromuscular junction and its onset is between 24-96 hours post ingestion. The aims of the present study were 1) to investigate whether neuromuscular junction dysfunction within the first 24 hours following exposure, quantified by jitter in single fibre electromyography (SfEMG), can predict IMS, and 2) to compare the changes in SfEMG jitter over the course of the illness among patients who developed IMS (IMS+) and those who did not (IMS-). Methods and findings We conducted a prospective cohort study in a tertiary care hospital in Sri Lanka on 120 patients admitted between September 2014 and August 2016 following DSP by OP insecticides viz., profenofos 53, phenthoate 17, diazinon 13, chlorpyrifos 5, others 12, unknown 20. SfEMG was performed every second day during hospitalization. Exposure was confirmed based on the history and red blood cell AChE assays. IMS was diagnosed in patients who demonstrated at least three out of four of the standard IMS criteria: proximal muscle weakness, bulbar muscle weakness, neck muscle weakness, respiratory paralysis between 24-96 hours post ingestion. Respiratory failure requiring intubation occurred in 73 out of 120 patients; 64 of these were clinically diagnosed with IMS. Of the 120 patients, 96 had repeated SfEMG testing, 67 of them being tested within the first 24 hours. Prolonged jitter (>33.4 mu s) within the first 24 hours was associated with greatly increased risk of IMS ( odds ratio = 8.9, 95% confidence intervals = 2.4-29.6, p = 0.0003; sensitivity 86%, specificity 58%). The differences in jitter between IMS+ and IMS- patients remained significant for 72 hours and increased jitter was observed in some patients for up to 216 hours. For intubated patients, the median time for jitter to normalize and median time to extubate were similar, and the two variables had a moderate positive correlation (r = 0.49, P = 0.001). Conclusions Prolonged jitter recorded with SfEMG <24 hours of ingestion of an OP strongly correlates with subsequent occurrence of IMS. The time course of electrophysiological recovery of the NMJ was similar to the time course of respiratory recovery in IMS patients.	[Alahakoon, Chanika; Dassanayake, Tharaka L.; Sedgwick, E. Michael; Weerasinghe, Vajira S.] Univ Peradeniya, Dept Physiol, Peradeniya, Sri Lanka; [Alahakoon, Chanika; Dassanayake, Tharaka L.; Gawarammana, Indika B.; Sedgwick, E. Michael; Weerasinghe, Vajira S.; Buckley, Nicholas A.] Univ Peradeniya, South Asian Clin Toxicol Res Collaborat, Peradeniya, Sri Lanka; [Dassanayake, Tharaka L.] Univ Newcastle, Sch Psychol, Newcastle, NSW, Australia; [Gawarammana, Indika B.] Univ Peradeniya, Dept Med, Peradeniya, Sri Lanka; [Abdalla, Ahmed; Roberts, Michael S.] Univ South Australia, Basil Hetzel Inst Translat Hlth Res, Sch Pharm & Med Sci, Adelaide, SA, Australia; [Abdalla, Ahmed] Helwan Univ, Dept Pharmaceut Chem, Cairo, Egypt; [Roberts, Michael S.] Univ Queensland, Diamantina Inst, Therapeut Res Ctr, Brisbane, Qld, Australia; [Roberts, Michael S.] Translat Res Inst, Brisbane, Qld, Australia; [Buckley, Nicholas A.] Univ Sydney, Sch Med Sci, Discipline Pharmacol, Sydney, NSW, Australia	University of Peradeniya; University of Peradeniya; University of Newcastle; University of Peradeniya; University of South Australia; Egyptian Knowledge Bank (EKB); Helwan University; University of Queensland; University of Sydney	Alahakoon, C (corresponding author), Univ Peradeniya, Dept Physiol, Peradeniya, Sri Lanka.; Alahakoon, C (corresponding author), Univ Peradeniya, South Asian Clin Toxicol Res Collaborat, Peradeniya, Sri Lanka.	alahakoonchanika@gmail.com	Mostafa, Ahmad/AAJ-9470-2020; Buckley, Nicholas A/D-4030-2012; Roberts, Michael/C-5247-2014	Buckley, Nicholas A/0000-0002-6326-4711; Abdalla, Ahmed/0000-0003-1924-3734; Roberts, Michael/0000-0003-3894-5301; Alahakoon, Chanika/0000-0001-9678-6420; Gawarammana, Indika/0000-0001-6795-0113	NHMRC Australia (NHMRC) through South Asian Clinical Research Collaboration [1030069, 1055176]	NHMRC Australia (NHMRC) through South Asian Clinical Research Collaboration	Funding for this research was provided by NHMRC Australia (NHMRC Grant IDs 1030069 and 1055176) through South Asian Clinical Research Collaboration.	Alahakoon C, 2018, NEUROTOXICOLOGY, V69, P209, DOI 10.1016/j.neuro.2017.12.002; [Anonymous], 2017, K D K ORGANOPHOSPHAT; Aygun D, 2002, J TOXICOL-CLIN TOXIC, V40, P903, DOI 10.1081/CLT-120016962; Aygun D, 2007, BASIC CLIN PHARMACOL, V100, P201, DOI 10.1111/j.1742-7843.2007.00042.x; Ba DJ, 1996, HUMAN EXPT TOXICOLOG; Blijham PJ, 2006, CLIN NEUROPHYSIOL, V117, P388, DOI 10.1016/j.clinph.2005.09.018; Buckley NA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005085.pub2; Colak S, 2014, TURK J MED SCI, V44, P279, DOI 10.3906/sag-1211-31; Dandapani M, 2003, INDIAN J MED RES, V117, P253; Dassanayake TL, 2012, CNS DRUGS, V26, P269, DOI 10.2165/11599790-000000000-00000; DEBLEECKER J, 1993, CRIT CARE MED, V21, P1706, DOI 10.1097/00003246-199311000-00020; DEBLEECKER J, 1992, J TOXICOL-CLIN TOXIC, V30, P321, DOI 10.3109/15563659209021546; DeBleecker J, 1992, J TOXICOL-CLIN TOXIC, V30, P31; DEWILDE V, 1991, KLIN WOCHENSCHR, V69, P177; Eddleston M, 2006, INJURY PREV, V12, P333, DOI 10.1136/ip.2006.012641; Eddleston M, 2006, B WORLD HEALTH ORGAN, V84, P276, DOI 10.2471/BLT.05.025379; Eddleston M, 2009, QJM-INT J MED, V102, P785, DOI 10.1093/qjmed/hcp119; Eddleston M, 2008, LANCET, V371, P597, DOI 10.1016/S0140-6736(07)61202-1; Eddleston M, 2016, BRIT J CLIN PHARMACO, V81, P462, DOI 10.1111/bcp.12784; He FS, 1998, HUM EXP TOXICOL, V17, P40, DOI 10.1191/096032798678907810; Indira M, 2013, CLIN TOXICOL, V51, P838, DOI 10.3109/15563650.2013.837915; Jalady AM, 2013, ANN FR ANESTH, V32, P856, DOI 10.1016/j.annfar.2013.08.018; Jayawardane P, 2008, PLOS MED, V5, P1143, DOI 10.1371/journal.pmed.0050147; Jayawardane P, 2012, CLIN TOXICOL, V50, P250, DOI 10.3109/15563650.2012.670875; Jayawardane P, 2009, CLIN TOXICOL, V47, P193, DOI 10.1080/15563650902832608; King AM, 2015, EMERG MED CLIN N AM, V33, P133, DOI 10.1016/j.emc.2014.09.010; Knipe DW, 2017, LANCET GLOB HEALTH, V5, pE651, DOI 10.1016/S2214-109X(17)30208-5; Knipe DW, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-839; Kouyoumdjian JA, 2011, CLIN NEUROPHYSIOL, V122, P617, DOI 10.1016/j.clinph.2010.07.012; MIHELIN M, 1991, MUSCLE NERVE, V14, P739, DOI 10.1002/mus.880140808; Moon J, 2014, RESP CARE, V59, P1360, DOI 10.4187/respcare.02916; Rajapakse BN, 2011, ANN EMERG MED, V58, P559, DOI 10.1016/j.annemergmed.2011.07.014; Rajapakse T, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0221-z; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Sedgwick EM, 1997, J NEUROL NEUROSUR PS, V62, P201, DOI 10.1136/jnnp.62.2.201; SENANAYAKE N, 1987, NEW ENGL J MED, V316, P761, DOI 10.1056/NEJM198703263161301; Stalberg E, 1997, J NEUROSCI METH, V74, P145, DOI 10.1016/S0165-0270(97)02245-0; Stalberg EV, 2009, MUSCLE NERVE, V40, P331, DOI 10.1002/mus.21424; Tanhehco Justina L, 2003, Phys Med Rehabil Clin N Am, V14, P207, DOI 10.1016/S1047-9651(02)00123-7; Tongpoo A, 2015, SE ASIAN J TROP MED, V46, P798; TRONTELJ JV, 1988, J NEUROL NEUROSUR PS, V51, P814, DOI 10.1136/jnnp.51.6.814; Weerasinghe V, 2014, CLIN NEUROPHYSIOL, pS138; Wickramasinghe K, 2009, B WORLD HEALTH ORGAN, V87, P180, DOI 10.2471/BLT.08.051920; Yang Chen-Chang, 2007, J Chin Med Assoc, V70, P467, DOI 10.1016/S1726-4901(08)70043-1	44	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0203596	10.1371/journal.pone.0203596	http://dx.doi.org/10.1371/journal.pone.0203596			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30261032	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000445907400013
J	Allen, JW; Tevatia, R; Demirel, Y; DiRusso, CC; Black, PN				Allen, James W.; Tevatia, Rahul; Demirel, Yasar; DiRusso, Concetta C.; Black, Paul N.			Induction of oil accumulation by heat stress is metabolically distinct from N stress in the green microalgae Coccomyxa subellipsoidea C169	PLOS ONE			English	Article							LIPID-ACCUMULATION; CHLAMYDOMONAS-REINHARDTII; CHLORELLA-VULGARIS; BIODIESEL PRODUCTION; ALGAL BIOFUELS; AMINO-ACIDS; GROWTH; TEMPERATURE; COMMERCIALIZATION; OLEOABUNDANS	Algae are often promoted as feedstock organisms to produce a sustainable petroleum fossil fuel alternative. However, to induce lipid accumulation most often requires a severe stress that is difficult to induce in large batch cultures. The objective of this study is to analyze and mathematically model heat stress on growth, chlorophyll content, triacylglyceride, and starch synthesis in algae. We initially screened 30 algal species for the most pronounced induction of lipid droplets from heat stress using confocal microscopy and mass spectroscopy techniques. One species, Coccomyxa subellipsoidea C169, was selected and subjected to further biochemical analyses using a jacketed bioreactor amended with 1% CO2 at 25 degrees C, 30 degrees C, 32 degrees C, 33 degrees C, 34 degrees C, 35 degrees C, and 36 degrees C. Lipid and starch accumulation was less extreme than N stress. Growth was reduced above 25 degrees C, but heat stress induced lipid droplet synthesis was negatively correlated with growth only past a demonstrated threshold temperature above 32 degrees C. The optimal temperature for lipid accumulation was 35 degrees C, which led to 6% of dry weight triglyceride content and a 72% reduction from optimal growth after 5 days. Fatty acid influx rates into triglycerides and N-15 labeling of amino acids and proteins indicate that heat stress is mechanistically distinct from N stress. Thus, this study lends support to a novel hypothesis that lipid droplet triglycerides result from a redistribution of carbon flux as fatty acids to neutral storage lipids over membrane or other lipids.	[Allen, James W.; DiRusso, Concetta C.; Black, Paul N.] Univ Nebraska, Dept Biochem, Beadle Ctr, Lincoln, NE 68583 USA; [Tevatia, Rahul; Demirel, Yasar] Univ Nebraska, Dept Chem & Biomol Engn, Othmer Hall, Lincoln, NE USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Allen, JW; Black, PN (corresponding author), Univ Nebraska, Dept Biochem, Beadle Ctr, Lincoln, NE 68583 USA.	jallen7@unl.edu; pblack2@unl.edu	Tevatia, Rahul/I-1549-2019; Allen, James/AAG-6465-2019	Tevatia, Rahul/0000-0002-6783-5649; 	Nebraska Center for Energy Sciences Research; Nebraska Department of Economic Development; Biochemical analysis of microalgae for enhanced oil synthesis and biomass in a wastewater system, Vestal W2O LLC	Nebraska Center for Energy Sciences Research; Nebraska Department of Economic Development; Biochemical analysis of microalgae for enhanced oil synthesis and biomass in a wastewater system, Vestal W2O LLC	The work was supported by the Nebraska Center for Energy Sciences Research under PN Black; Biochemical analysis of microalgae for enhanced oil synthesis and biomass in a wastewater system, Vestal W2O LLC and the Nebraska Department of Economic Development. The Vajra Instruments Inc. and Vestal W2O LLC provided support in the form of salaries for authors RT and JA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ajjawi I, 2017, NAT BIOTECHNOL, V35, P647, DOI 10.1038/nbt.3865; Allen JW, 2017, J BIOL CHEM, V292, P361, DOI 10.1074/jbc.M116.760843; Allen JW, 2015, ALGAL RES, V10, P110, DOI 10.1016/j.algal.2015.04.019; Andre C, 2012, P NATL ACAD SCI USA, V109, P10107, DOI 10.1073/pnas.1204604109; BENGTSSON G, 1979, ANAL BIOCHEM, V92, P426, DOI 10.1016/0003-2697(79)90681-X; Blanc G, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-5-r39; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Branyikova I, 2011, BIOTECHNOL BIOENG, V108, P766, DOI 10.1002/bit.23016; Chen M, 2011, BIORESOURCE TECHNOL, V102, P1649, DOI 10.1016/j.biortech.2010.09.062; Chisti Y, 2013, J BIOTECHNOL, V167, P201, DOI 10.1016/j.jbiotec.2013.07.020; Chisti Y, 2011, APPL ENERG, V88, P3277, DOI 10.1016/j.apenergy.2011.04.038; Converti A, 2009, CHEM ENG PROCESS, V48, P1146, DOI 10.1016/j.cep.2009.03.006; Fernandes TV, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01742; Foley PM, 2011, GREEN CHEM, V13, P1399, DOI 10.1039/c1gc00015b; Georgianna DR, 2012, NATURE, V488, P329, DOI 10.1038/nature11479; Haimovich-Dayan M, 2013, NEW PHYTOL, V197, P177, DOI 10.1111/j.1469-8137.2012.04375.x; HUPPE HC, 1994, PLANT PHYSIOL, V105, P1043, DOI 10.1104/pp.105.4.1043; Karpowicz SJ, 2011, J BIOL CHEM, V286, P21427, DOI 10.1074/jbc.M111.233734; Kobayashi Y, 2014, GENOME BIOL EVOL, V6, P2731, DOI 10.1093/gbe/evu216; Li YQ, 2008, APPL MICROBIOL BIOT, V81, P629, DOI 10.1007/s00253-008-1681-1; Liu HC, 2012, PLANT SIGNAL BEHAV, V7, P547, DOI 10.4161/psb.19803; Liu ZY, 2008, BIORESOURCE TECHNOL, V99, P4717, DOI 10.1016/j.biortech.2007.09.073; Madeira MS, 2017, LIVEST SCI, V205, P111, DOI 10.1016/j.livsci.2017.09.020; MORRISON WR, 1964, J LIPID RES, V5, P600; Sills DL, 2013, ENVIRON SCI TECHNOL, V47, P687, DOI 10.1021/es3029236; Su YJ, 2017, RENEW SUST ENERG REV, V74, P402, DOI 10.1016/j.rser.2016.12.078; Sullivan C. Y., 1977, Amir Muhammed; Aksel, R.; Borstel, R. V. von: Genetic diversity in plants. V. Prospects of breeding for physiological characters., P301; Surendhiran D, 2015, 3 BIOTECH, V5, P663, DOI 10.1007/s13205-014-0264-3; Sutherland DL, 2017, ALGAL RES, V25, P496, DOI 10.1016/j.algal.2017.05.023; Tevatia R, 2015, COMPUT CHEM ENG, V75, P28, DOI 10.1016/j.compchemeng.2015.01.011; Tevatia R, 2014, BIORESOURCE TECHNOL, V170, P152, DOI 10.1016/j.biortech.2014.07.043; Tevatia R, 2012, BIORESOURCE TECHNOL, V119, P419, DOI 10.1016/j.biortech.2012.05.124; Tibbetts SM, 2017, AQUACULTURE, V481, P25, DOI 10.1016/j.aquaculture.2017.08.018; Usher PK, 2014, BIOFUELS-UK, V5, P331, DOI 10.1080/17597269.2014.913925; Vasconcelos VM, 2001, WATER RES, V35, P1354, DOI 10.1016/S0043-1354(00)00512-1; Wang C, 2017, WORLD J MICROB BIOT, V33, DOI 10.1007/s11274-017-2324-4; Yang Y, 2013, APPL MICROBIOL BIOT, V97, P2263, DOI 10.1007/s00253-012-4671-2	37	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204505	10.1371/journal.pone.0204505	http://dx.doi.org/10.1371/journal.pone.0204505			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30261009	gold, Green Published, Green Submitted			2022-12-26	WOS:000445907400061
J	Guo, ZQ; Pfohl, K; Karlovsky, P; Dehne, HW; Altincicek, B				Guo, Zhiqing; Pfohl, Katharina; Karlovsky, Petr; Dehne, Heinz-Wilhelm; Altincicek, Boran			Dissemination of Fusarium proliferatum by mealworm beetle Tenebrio molitor	PLOS ONE			English	Article							YELLOW MEALWORM; F-PROLIFERATUM; FUMONISIN B-1; BLACK POINT; PCR ASSAY; WHEAT; IDENTIFICATION; PATHOGENICITY; TRANSMISSION; MYCOTOXINS	Background Plant pathogenic fungi of the genus Fusarium infect a wide array of crops and produce numerous health-threatening mycotoxins. Recently, we found that larvae of the common pest of stored products Tenebrio molitor preferably fed on grains colonized with Fusarium proliferatum. We draw the hypothesis that the increased attractiveness of infected grains for mealworms facilitates dispersal of the fungus. In this work we examined the dissemination of F. proliferatum and further Fusarium spp. by adults of T. molitor. Results Mealworm beetle Tenebrio molitor transmitted Fusarium species F. avenaceum, F. culmorum, F. poae, and F. proliferatum to wheat grains with varying efficiency. F. proliferatum was disseminated most efficiently: 20 days after feeding on Fusarium cultures, the beetles still transmitted F. proliferatum to most grains exposed to feeding. The transmission of F. culmorum gradually declined over time and the transmission of the other Fusarium spp. ceased completely 20 d after beetles feeding of fungal cultures. Propagules of F. proliferatum and F. culmorum were traceable in beetles' feces for 20 days while no colonies of F. poae and F. avenaceum were detectable after 5 days. Because F. proliferatum was transmitted by mealworms most efficiently, this species was further investigated. Mealworm beetles T. molitor preferred feeding on grains colonized with F. proliferatum as compared to uninfected grains. Male beetles infected with F. proliferatum transmitted the fungus by copulation. Conclusions Efficient dissemination of F. proliferatum by mealworm beetle together with the feeding preference of the beetle for grains colonized with F. proliferatum show that the chemical phenotype of the fungus responsible for the enhanced attractiveness of infected grains is subjected to positive selection. This indicates that adaptation of F. proliferatum to transmission by insects involved an alteration of insects' feeding preferences.	[Guo, Zhiqing] Chinese Acad Agr Sci, Tobacco Res Inst, Lab Qual & Safety Risk Assessment Tobacco, Qingdao, Peoples R China; [Guo, Zhiqing; Dehne, Heinz-Wilhelm; Altincicek, Boran] Rheinische Friedrich Wilhelms Univ Bonn, Inst Crop Sci & Resource Conservat INRES Phytomed, Bonn, Germany; [Pfohl, Katharina; Karlovsky, Petr] Univ Goettingen, Mol Phytopathol & Mycotoxin Res, Gottingen, Germany	Chinese Academy of Agricultural Sciences; Tobacco Research Institute, CAAS; University of Bonn; University of Gottingen	Altincicek, B (corresponding author), Rheinische Friedrich Wilhelms Univ Bonn, Inst Crop Sci & Resource Conservat INRES Phytomed, Bonn, Germany.	altincicek@hotmail.de		Karlovsky, Petr/0000-0002-6532-5856	German Research Foundation (DFG) [AL902/4-1]; PLANTFOODSEC project of the European Union (FP7/2007-2013) [261752]; China Postdoctoral Science Foundation [2017M622304]	German Research Foundation (DFG)(German Research Foundation (DFG)); PLANTFOODSEC project of the European Union (FP7/2007-2013); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This research was partly supported by German Research Foundation (DFG, AL902/4-1 to B.A. www.dfg.de), the PLANTFOODSEC project of the European Union (FP7/2007-2013, No. 261752, https://cordis.europa.eu/project/rcn/100052_en.html) and China Postdoctoral Science Foundation (No. 2017M622304 support to ZG, www.chinapostdoctor.org.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abado-Becognee K, 1998, ENTOMOL EXP APPL, V86, P135, DOI 10.1023/A:1003141712796; Abdalla MY, 2000, PLANT DIS, V84, P321, DOI 10.1094/PDIS.2000.84.3.321; ABILDGREN MP, 1987, LETT APPL MICROBIOL, V5, P83, DOI 10.1111/j.1472-765X.1987.tb01620.x; Adejumo TO, 2007, FOOD ADDIT CONTAM, V24, P993, DOI 10.1080/02652030701317285; Adejumo TO, 2007, INT J FOOD MICROBIOL, V116, P350, DOI 10.1016/j.ijfoodmicro.2007.02.009; Amato B, 2015, J APPL BOT FOOD QUAL, V88, P228, DOI 10.5073/JABFQ.2015.088.033; Brandfass C, 2008, INT J MOL SCI, V9, P2306, DOI 10.3390/ijms9112306; Chehri K, 2017, J INVERTEBR PATHOL, V144, P1, DOI 10.1016/j.jip.2017.01.003; CLEAR RM, 1990, CAN J PLANT SCI, V70, P1057, DOI 10.4141/cjps90-128; Conner RL, 1996, CAN J PLANT PATHOL, V18, P419, DOI 10.1080/07060669609500598; DAVIS GRF, 1975, J INVERTEBR PATHOL, V26, P299, DOI 10.1016/0022-2011(75)90225-6; Desjardins AE, 2007, FOOD ADDIT CONTAM, V24, P1131, DOI 10.1080/02652030701513834; Drakulic J, 2017, PLANT PATHOL, V66, P3, DOI 10.1111/ppa.12546; DUNKEL FV, 1988, INT J FOOD MICROBIOL, V7, P227, DOI [10.1016/0168-1605(88)90042-6, 10.1016/S0168-1605(01)00458-5]; Eigenbrode SD, 2018, ANNU REV ENTOMOL, V63, P169, DOI 10.1146/annurev-ento-020117-043119; FERMAUD M, 1992, PHYTOPATHOLOGY, V82, P1393, DOI 10.1094/Phyto-82-1393; Friedli J, 2001, OECOLOGIA, V129, P571, DOI 10.1007/s004420100763; GORDON W. L., 1959, CANADIAN JOUR BOT, V37, P257, DOI 10.1139/b59-021; Grau T, 2017, Z NATURFORSCH C, V72, P337, DOI 10.1515/znc-2017-0033; Guo ZV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101397; Guo ZQ, 2016, AGR FOOD SCI, V25, P138, DOI 10.23986/afsci.55539; Hyun Jae Wook, 2000, Mycobiology, V28, P158; JIMENEZ M, 1993, J PHYTOPATHOL, V137, P214, DOI 10.1111/j.1439-0434.1993.tb01341.x; Joint FAO/WHO Expert Committee on Food Additives, 2001, SAF EV CERT MYC FOOD; Jurado M, 2010, FOOD MICROBIOL, V27, P50, DOI 10.1016/j.fm.2009.08.001; Laith AA, ECOLOGY ENV CONSERVA; LESLIE JF, 2006, FUSARIUM LAB MANUAL, DOI [DOI 10.1002/9780470278376, 10.1002/9780470278376]; Li LY, 2013, ACTA ASTRONAUT, V92, P103, DOI 10.1016/j.actaastro.2012.03.012; Maniania NK, 2011, BIOL CONTROL, V58, P374, DOI 10.1016/j.biocontrol.2011.05.012; MARASAS WFO, 1986, MYCOLOGIA, V78, P242, DOI 10.2307/3793169; Miller JD, 1995, CAN J PLANT PATHOL, V17, P233; Moretti A, 1994, Mycotoxin Res, V10, P73, DOI 10.1007/BF03192255; Mule G, 2004, EUR J PLANT PATHOL, V110, P495, DOI 10.1023/B:EJPP.0000032389.84048.71; Nutz S, 2011, ANAL BIOANAL CHEM, V401, P717, DOI 10.1007/s00216-011-5089-x; Ocamb CM, 2002, NEW FOREST, V24, P67, DOI 10.1023/A:1020589121134; OSWEILER GD, 1992, J VET DIAGN INVEST, V4, P53, DOI 10.1177/104063879200400112; Paine TD, 1997, ANNU REV ENTOMOL, V42, P179, DOI 10.1146/annurev.ento.42.1.179; Parry DW, 1996, PLANT PATHOL, V45, P383, DOI 10.1046/j.1365-3059.1996.d01-133.x; Prom LK, 2003, J SUSTAIN AGR, V21, P49, DOI 10.1300/J064v21n04_05; R Core Team, 2013, R LANG ENV STAT COMP; Ritieni Alberto, 1995, Natural Toxins, V3, P17, DOI 10.1002/nt.2620030105; ROY BA, 1993, NATURE, V362, P56, DOI 10.1038/362056a0; Sambrock J, 1989, MOL CLONING LAB MANU, V1; TEETORBARSCH GH, 1983, MYCOPATHOLOGIA, V84, P3, DOI 10.1007/BF00436991; Thrane U, 1996, INT J FOOD MICROBIOL, V29, P149, DOI 10.1016/0168-1605(95)00040-2; Visentin I, 2012, EUKARYOT CELL, V11, P252, DOI 10.1128/EC.05159-11; Waalwijk C, 2004, EUR J PLANT PATHOL, V110, P481, DOI 10.1023/B:EJPP.0000032387.52385.13; Waskiewicz A, 2010, FOOD ADDIT CONTAM A, V27, P608, DOI 10.1080/19440040903551947; Wilson T M, 1990, J Vet Diagn Invest, V2, P213	49	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204602	10.1371/journal.pone.0204602	http://dx.doi.org/10.1371/journal.pone.0204602			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30261034	gold, Green Published, Green Submitted			2022-12-26	WOS:000445907400073
J	Aung, ZZ; Oo, MM; Tripathy, JP; Kyaw, NTT; Hone, S; Oo, HN; Majumdar, SS				Aung, Zaw Zaw; Oo, Myo Minn; Tripathy, Jaya Prasad; Nang Thu Thu Kyaw; Hone, San; Oo, Htun Nyunt; Majumdar, Suman S.			Are death and loss to follow-up still high in people living with HIV on ART after national scale-up and earlier treatment initiation? A large cohort study in government hospital-based setting, Myanmar: 2013-2016	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY PROGRAMS; INFECTED INDIVIDUALS; CLINIC ATTENDANCE; REMINDERS; SMOKING; AFRICA; APPOINTMENTS; METAANALYSIS; RETENTION; ADHERENCE	Setting Myanmar National AIDS Program has had significant scale-up of services and changes in CD4 eligibility criterion for ART initiation from 2013 to 2016. This study assessed early death within 6 months and attrition (death and loss to follow-up, LTFU) after ART initiation and their associated factors. Design A retrospective cohort study on people living with HIV (PLHIV > 15 year of age) enrolled at three specialist hospitals in Yangon from 1st June 2013 to 30th June 2016. Cox regression was used to calculate hazard ratios (HRs) of early death and attrition. Results Of 11,727 adults enrolled, 11,186 (95%) were initiated on ART, providing 15,964 person-years of follow-up. At baseline, median age was 36 years [IQR: 30-43], 58% were men and median CD4 count was 151 cells/mm3 (IQR: 54-310). There were 733(6%) early deaths, 961(9%) total deaths and 1371 (12%) LTFU during the study period. Independent risk factors for early death were older age (41-50 and >= 51 years) [aHR 1.38, 1.07-1.78 and 1.68, 1.21-2.34], male (1.84, 1.44-2.35), low weight (2.06, 1.64-2.59), bedridden, (3.81, 2.57-5.66) and CD4 count <= 50 cells/mm3 (6.83, 2.52-18.57). In addition to above factors, high attrition was associated with an abacavir-based regimen. Conclusion Although there was a low rate of early deaths, patients were being diagnosed late and there was a high attrition rate from specialist hospitals. Concerted effort is required to increase early diagnosis and ART initiation, and strengthen community systems for HIV care to achieve ambitious goal of ending AIDS epidemic by 2030.	[Aung, Zaw Zaw; Hone, San; Oo, Htun Nyunt] Minist Hlth & Sports, Dept Publ Hlth, Natl AIDS Programme, Nay Pyi Taw, Myanmar; [Oo, Myo Minn; Nang Thu Thu Kyaw] Int Union TB & Lung Dis, Mandalay, Myanmar; [Tripathy, Jaya Prasad] Int Union TB & Lung Dis, South East Asia Reg Off, New Delhi, India; [Majumdar, Suman S.] Burnet Inst, Melbourne, Vic, Australia	Burnet Institute	Aung, ZZ (corresponding author), Minist Hlth & Sports, Dept Publ Hlth, Natl AIDS Programme, Nay Pyi Taw, Myanmar.	aungzawzaw515@gmail.com	Aung, Zaw Zaw/AFC-4601-2022; Aung, Zaw Zaw/AAF-9560-2022; Majumdar, Suman/AAL-3070-2020; Oo, Myo Minn/P-3720-2018	Aung, Zaw Zaw/0000-0002-3995-9249; Aung, Zaw Zaw/0000-0002-3995-9249; Majumdar, Suman/0000-0002-9656-557X; Oo, Myo Minn/0000-0003-4089-016X	Department for International Development (DFID), UK	Department for International Development (DFID), UK	The training programme within which this paper was developed were funded by the Department for International Development (DFID), UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The author(s) received no specific funding for this work.	Alamo ST, 2012, AIDS BEHAV, V16, P368, DOI 10.1007/s10461-011-9996-9; Bonjour Maeva A, 2008, AIDS Res Ther, V5, P6, DOI 10.1186/1742-6405-5-6; Bonnet F, 2002, HIV Med, V3, P195, DOI 10.1046/j.1468-1293.2002.00117.x; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Crankshaw T, 2010, AIDS PATIENT CARE ST, V24, P729, DOI 10.1089/apc.2010.0146; Department of Population Ministry of Immigration and Population Republic of the Union of Myanmar, 2015, 2014 MYANM POP HOUS; Farahani M, 2017, INT J STD AIDS, V28, P636, DOI 10.1177/0956462416632428; Ford N, 2015, LANCET HIV, V2, pE438, DOI 10.1016/S2352-3018(15)00137-X; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Geng EH, 2010, JAIDS-J ACQ IMM DEF, V53, P405, DOI 10.1097/QAI.0b013e3181b843f0; Hachfeld A, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20317; Hasvold PE, 2011, J TELEMED TELECARE, V17, P358, DOI 10.1258/jtt.2011.110707; Helleberg M, 2015, AIDS, V29, P221, DOI 10.1097/QAD.0000000000000540; Helleberg M, 2013, CLIN INFECT DIS, V56, P727, DOI 10.1093/cid/cis933; Kumarasamy N, 2010, INT J INFECT DIS, V14, pE127, DOI 10.1016/j.ijid.2009.03.034; Kunutsor S, 2010, AIDS BEHAV, V14, P1347, DOI 10.1007/s10461-010-9780-2; National AIDS Programme Myanmar, 2011, GUID CLIN MAN HIV IN; National AIDS Programme Myanmar, 2014, GUID CLIN MAN HIV IN; National AIDS Programme Myanmar, 2010, UNGASS COUNTR PROGR; National AIDS Programme Myanmar, 2017, NAT STRAT PLAN HIV A; National AIDS Programme Myanmar, 2015, GLOB AIDS RESP PROGR; National AIDS Programme (NAP), 2015, GLOB AIDS RESP PROGR; Organization WH, 2015, HIV AIDS IN MYANM; Pustil R., 2016, AIDS S4, V17, pS3; Sabapathy K, 2012, JAIDS-J ACQ IMM DEF, V60, pE53, DOI 10.1097/QAI.0b013e31824d5689; Sawyer SM, 2002, J PAEDIATR CHILD H, V38, P79, DOI 10.1046/j.1440-1754.2002.00766.x; Shet A, 2010, AIDS BEHAV, V14, P716, DOI 10.1007/s10461-009-9658-3; Shirley DK, 2013, CLIN INFECT DIS, V57, P275, DOI 10.1093/cid/cit207; Thida A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108615; Tweya H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075761; VONELM EA, 2007, LANCET; Worthington C, 2003, QUAL HEAL RES, V13	32	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2018	13	9							e0204550	10.1371/journal.pone.0204550	http://dx.doi.org/10.1371/journal.pone.0204550			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GU9BO	30252904	Green Submitted, gold, Green Published			2022-12-26	WOS:000445639700061
J	Chaput, CD; Shar, A; Jupiter, D; Hubert, Z; Clough, B; Krause, U; Gregory, CA				Chaput, Christopher D.; Shar, Adam; Jupiter, Daniel; Hubert, Zach; Clough, Bret; Krause, Ulf; Gregory, Carl A.			How stem cell composition in bone marrow aspirate relates to clinical outcomes when used for cervical spine fusion	PLOS ONE			English	Article							ILIAC CREST; SMOKING; GENDER; PROGENITORS; ALLOGRAFT; CULTURE; IMPACT; AGE	Anterior cervical discectomy and fusion (ACDF) is performed to relieve pain caused by degenerative disk disease and nerve obstruction. As an alternative to bone graft, autologous concentrated bone marrow aspirate (CBMA) is used to achieve vertebral fusion with a satisfactory success rate. This has been attributed in part to bone marrow-resident mesenchymal stromal cells (MSCs) with the capacity to differentiate into osteoblasts and generate bone tissue. To date, there has been no study comparing cellular yields, MSC frequencies and their osteogenic potential with ACDF outcome. Patients (n = 24) received ACDF with CBMA and allograft bone matrix. Colony forming unit fibroblast (CFU-F) and CFU-osteoblasts (CFU-O) assays were performed on CBMA samples to enumerate MSCs (CFU-F) and osteogenic MSCs (CFU-O). CFUs were normalized to CBMA volume to define yield and also to mononuclear cells (MNC) to define frequency. After 1-year, fusion rates were good (86.7%) with pain and disability improved. There was a negative relationship between MNC and CFU-F measurements with age of patient and CFU-Os negatively correlated with age in females but not males. Tobacco use did not affect CBMA but was associated with poorer clinical outcome. Surprisingly, we found that while high-grade fusion was not associated with CFU-O, it correlated strongly (p<0.0067) with CBMA containing the lowest frequencies of CFU-F (3.0x10(-6)-5.83x10(-5)CFU-F/MNC). MNC levels alone were not responsible for the results. These observations suggest that osteogenesis by human bone marrow is controlled by homeostatic ratio of MSCs to other cellular bone marrow components rather than absolute level of osteogenic MSCs, and that a lower ratio of MSCs to other cellular components in marrow tends to predict effective osteogenesis during ACDF. The results presented herein challenge the current dogma surrounding the proposed mechanism of MSCs in bone healing.	[Chaput, Christopher D.; Shar, Adam] Univ Texas Hlth San Antonio, Dept Orthoped, San Antonio, TX 78229 USA; [Shar, Adam; Hubert, Zach] Texas A&M Hlth Sci Ctr, Med Educ Bldg,Temple Campus, Temple, TX USA; [Jupiter, Daniel] Univ Texas Med Branch, Dept Prevent Med & Community Hlth, Galveston, TX 77555 USA; [Clough, Bret; Gregory, Carl A.] Texas A&M Hlth Sci Ctr, Inst Regenerat Med, College Stn, TX 77843 USA; [Krause, Ulf] Univ Hosp Muenster, Inst Transfus Med & Transplant Immunol, Munster, Germany	University of Texas System; University of Texas Health San Antonio; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Medical Branch Galveston; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Munster	Chaput, CD (corresponding author), Univ Texas Hlth San Antonio, Dept Orthoped, San Antonio, TX 78229 USA.; Gregory, CA (corresponding author), Texas A&M Hlth Sci Ctr, Inst Regenerat Med, College Stn, TX 77843 USA.	chaput@uthscsa.edu; cgregory@medicine.tamhsc.edu		Gregory, Carl/0000-0001-6444-5541	Scott and White RGP Grant [100296]; Texas Engineering Experiment Station Strategic Initiative; NIH from NIAMS [R01 AR066033]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR066033] Funding Source: NIH RePORTER	Scott and White RGP Grant; Texas Engineering Experiment Station Strategic Initiative; NIH from NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was funded by Scott and White RGP Grant#100296 (CDC, CAG), The Texas Engineering Experiment Station Strategic Initiative (CAG), and NIH R01 AR066033 from NIAMS (CAG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert T J, 1999, J Am Acad Orthop Surg, V7, P368; Andersen T, 2001, SPINE, V26, P2623, DOI 10.1097/00007632-200112010-00018; Badrinath R, 2014, SPINE J, V14, P990, DOI 10.1016/j.spinee.2013.10.021; Bidula J, 2006, CLIN ORTHOP RELAT R, P252, DOI 10.1097/01.blo.0000183738.43245.c2; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; Christensen FB, 1999, EUR SPINE J, V8, P54, DOI 10.1007/s005860050127; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Einhorn TA, 1998, CLIN ORTHOP RELAT R, pS7; El-Badri NS, 2012, MED HYPOTHESES, V79, P481, DOI 10.1016/j.mehy.2012.06.029; Epstein Nancy E, 2012, Surg Neurol Int, V3, pS143, DOI 10.4103/2152-7806.98575; Fossett E, 2012, J ORTHOP RES, V30, P1013, DOI 10.1002/jor.22057; Gebler A, 2012, TRENDS MOL MED, V18, P128, DOI 10.1016/j.molmed.2011.10.004; Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435; Gregory C. A., 2007, CULTURE HUMAN STEM C, P208; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; Hadjiargyrou M, 2002, J BIOL CHEM, V277, P30177, DOI 10.1074/jbc.M203171200; Hadley MN, 1997, NEUROSURGERY, V41, P116, DOI 10.1097/00006123-199707000-00025; Harrell DB, 2015, ORTHOP REV, V7, P122, DOI 10.4081/or.2015.5691; Hernigou J, 2014, INT ORTHOP, V38, P2585, DOI 10.1007/s00264-014-2353-7; Hernigou P, 2005, J BONE JOINT SURG AM, V87A, P1430, DOI 10.2106/JBJS.D.02215; Hernigou P, 2014, INT ORTHOP, V38, P1855, DOI 10.1007/s00264-014-2318-x; Hernigou P, 2013, INT ORTHOP, V37, P2279, DOI 10.1007/s00264-013-2017-z; Hofmann TJ, 2013, MOL THER, V21, P1224, DOI 10.1038/mt.2013.36; Hostin R, 2016, CLIN SPINE SURG, V29, pE384, DOI 10.1097/BSD.0b013e318292468f; Hyer CF, 2013, J BONE JOINT SURG AM, V95A, P1312, DOI 10.2106/JBJS.L01529; Johnson RG, 2014, SPINE, V39, P695, DOI 10.1097/BRS.0000000000000254; Kfoury Y, 2015, CELL STEM CELL, V16, P239, DOI 10.1016/j.stem.2015.02.019; Khoueir P, 2007, NEUROSURGERY, V61, P963, DOI 10.1227/01.neu.0000303192.64802.c6; Kitchel Scott H, 2006, Spine J, V6, P405, DOI 10.1016/j.spinee.2005.09.013; Klyushnenkova E, 2005, J BIOMED SCI, V12, P47, DOI 10.1007/s11373-004-8183-7; LENKE LG, 1992, J SPINAL DISORD, V5, P433, DOI 10.1097/00002517-199212000-00008; Luszczyk M, 2013, J NEUROSURG-SPINE, V19, P527, DOI 10.3171/2013.7.SPINE13208; Motulsky HJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-123; Muschler GF, 1997, J BONE JOINT SURG AM, V79A, P1699, DOI 10.2106/00004623-199711000-00012; Muschler GF, 2001, J ORTHOP RES, V19, P117, DOI 10.1016/S0736-0266(00)00010-3; Neen D, 2006, SPINE, V31, pE636, DOI 10.1097/01.brs.0000232028.97590.12; OWEN M, 1988, CIBA F SYMP, V136, P42, DOI 10.1002/9780470513637.ch4; Park JJ, 2013, BULL HOSP JT DIS, V71, P39; Phinney DG, 1999, J CELL BIOCHEM, V75, P424, DOI 10.1002/(SICI)1097-4644(19991201)75:3<424::AID-JCB8>3.0.CO;2-8; Pierini M, 2013, J BONE JOINT SURG AM, V95A, P1101, DOI 10.2106/JBJS.L.00429; SMITH GW, 1958, J BONE JOINT SURG AM, V40, P607, DOI 10.2106/00004623-195840030-00009; Spees JL, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0363-7; Uccelli A, 2006, EUR J IMMUNOL, V36, P2566, DOI 10.1002/eji.200636416; VERNON H, 1991, J MANIP PHYSIOL THER, V14, P409; Yamada T, 2012, SPINE, V37, pE174, DOI 10.1097/BRS.0b013e3182269d64	45	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2018	13	9							e0203714	10.1371/journal.pone.0203714	http://dx.doi.org/10.1371/journal.pone.0203714			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3MI	30248138	Green Published, gold, Green Submitted			2022-12-26	WOS:000445998100011
J	Knezevic, A; Neblett, R; Gatchel, RJ; Jeremic-Knezevic, M; Bugarski-Ignjatovic, V; Tomasevic-Todorovic, S; Boskovic, K; Cuesta-Vargas, AI				Knezevic, Aleksandar; Neblett, Randy; Gatchel, Robert J.; Jeremic-Knezevic, Milica; Bugarski-Ignjatovic, Vojislava; Tomasevic-Todorovic, Snezana; Boskovic, Ksenija; Cuesta-Vargas, Antonio, I			Psychometric validation of the Serbian version of the Fear Avoidance Component Scale (FACS)	PLOS ONE			English	Article							LOW-BACK-PAIN; CHRONIC MUSCULOSKELETAL PAIN; ANXIETY SYMPTOMS SCALE; COEFFICIENT-ALPHA; POWER ANALYSIS; DISABILITY; QUESTIONNAIRE; MODEL; BELIEFS; PREDICTORS	Objective The Fear Avoidance Components Scale (FACS) is a new patient-reported outcome (PRO) questionnaire designed to comprehensively evaluate fear avoidance (FA) beliefs and attitudes in persons with painful medical conditions. The original English version has demonstrated acceptable psychometric properties, including concurrent and predictive validity. Two factors have been identified: 1. general fear avoidance; and 2. types of activities that are avoided. Methods The FACS was first translated into Serbian, and then psychometrically validated. A cohort of 322 chronic musculoskeletal pain subjects completed the FACS-Serb and additional FA-related patient-reported outcome (PRO) measures. Their FACS-Serb scores were then compared to a cohort of 68 acute pain subjects. Results Test-retest reliability (ICC2,1 = 0.928) and internal consistency for both Factors (Cronbach alpha 0.904 and 0,880 respectively) were very good. An acceptable fit was found with a confirmatory factor analysis of the 2-factor model found with the original English version of the FACS. Strong associations were found among FACS-Serb scores and other PRO measures of pain catastrophizing, depressive/anxiety symptoms, perceived disability, and pain intensity (p<0.001 for all analyses). FACS-Serb total scores, separate Factor scores, and subjective pain ratings were significantly higher in the chronic vs. acute pain cohorts (p<0.001 for all analyses). Conclusions The FACS-Serb demonstrated strong psychometric properties, including strong reliability and internal consistency, criterion validity (through associations with other FA-related PRO measures), and discriminant validity (through comparisons with a separate acute pain cohort). The FACS-Serb appears to be a potentially useful pain-related assessment tool.	[Knezevic, Aleksandar; Jeremic-Knezevic, Milica; Bugarski-Ignjatovic, Vojislava; Tomasevic-Todorovic, Snezana; Boskovic, Ksenija] Univ Novi Sad, Fac Med, Novi Sad, Serbia; [Knezevic, Aleksandar; Tomasevic-Todorovic, Snezana; Boskovic, Ksenija] Clin Ctr Vojvodina, Med Rehabil Clin, Novi Sad, Serbia; [Neblett, Randy] PRIDE Res Fdn, Dallas, TX USA; [Gatchel, Robert J.] Univ Texas Arlington, Ctr Excellence Study Hlth & Chron Illnesses, Dept Psychol, Coll Sci, Arlington, TX 76019 USA; [Cuesta-Vargas, Antonio, I] Univ Malaga, Fac Hlth Sci, Dept Physiotherapy, Malaga, Spain; [Cuesta-Vargas, Antonio, I] Queensland Univ Technol, Sch Clin Sci, Fac Hlth, Brisbane, Qld, Australia	University of Novi Sad; University of Texas System; University of Texas Arlington; Universidad de Malaga; Queensland University of Technology (QUT)	Knezevic, A (corresponding author), Univ Novi Sad, Fac Med, Novi Sad, Serbia.; Knezevic, A (corresponding author), Clin Ctr Vojvodina, Med Rehabil Clin, Novi Sad, Serbia.	aleksandar.knezevic@mf.uns.ac.rs		Cuesta-Vargas, Antonio I/0000-0002-8880-4315; Boskovic, Ksenija/0000-0002-6362-4895; Bugarski Ignjatovic, Vojislava/0000-0002-9742-6512; Neblett, Randy/0000-0002-8620-2468				Ang DC, 2010, PAIN MED, V11, P482, DOI 10.1111/j.1526-4637.2009.00759.x; Asmundson GJG, 1999, CLIN PSYCHOL REV, V19, P97, DOI 10.1016/S0272-7358(98)00034-8; Asmundson GJG, 2008, PAIN, V134, P51, DOI 10.1016/j.pain.2007.03.033; Baker DJ, 1989, BACK PAIN NEW APPROA, P174; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Boricic K, 2013, RESULTS NATL HLTH SU; Burns JW, 2000, PAIN, V84, P247, DOI 10.1016/S0304-3959(99)00218-3; Cohen J.E., 1988, STAT POWER ANAL BEHA; Crombez G, 2002, HEALTH PSYCHOL, V21, P573, DOI 10.1037//0278-6133.21.6.573; Crombez G, 1999, PAIN, V80, P329, DOI 10.1016/S0304-3959(98)00229-2; Crombez G, 2012, CLIN J PAIN, V28, P475, DOI 10.1097/AJP.0b013e3182385392; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Engel CC, 1996, PAIN, V65, P197, DOI 10.1016/0304-3959(95)00164-6; Esteve R, 2013, INT J BEHAV MED, V20, P59, DOI 10.1007/s12529-011-9216-z; Fairbank J C, 1980, Physiotherapy, V66, P271; Fairbank JCT, 2000, SPINE, V25, P2940, DOI 10.1097/00007632-200011150-00017; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Ferreira ML, 2010, EUR J PAIN, V14, DOI 10.1016/j.ejpain.2009.11.005; Gay CW, 2015, EUR J PAIN, V19, P48, DOI 10.1002/ejp.519; George SZ, 2009, PHYS THER, V89, P969, DOI 10.2522/ptj.20090032; George SZ, 2009, J PAIN, V10, P293, DOI 10.1016/j.jpain.2008.09.004; Gheldof ELM, 2010, EUR J PAIN, V14, DOI 10.1016/j.ejpain.2010.01.003; Hasenbring MI, 2009, EUR J PAIN, V13, P620, DOI 10.1016/j.ejpain.2008.11.001; Heymans MW, 2010, SPINE J, V10, P847, DOI 10.1016/j.spinee.2010.06.005; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Karoly P, 2008, COGNITIVE THER RES, V32, P418, DOI 10.1007/s10608-007-9136-z; Kori S, 1990, PAIN MANAG, V3, P35; Kroska EB, 2016, SCAND J PAIN, V13, P43, DOI 10.1016/j.sjpain.2016.06.011; Leeuw M, 2007, EUR J PAIN, V11, P256, DOI 10.1016/j.ejpain.2006.02.009; LETHEM J, 1983, BEHAV RES THER, V21, P401, DOI 10.1016/0005-7967(83)90009-8; Lopez-Martinez AE, 2014, EUR J PAIN, V18, P1129, DOI 10.1002/j.1532-2149.2014.00459.x; Lundberg M, 2011, PAIN RES TREAT, V2011, DOI 10.1155/2011/494196; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; MCCRACKEN LM, 1992, PAIN, V50, P67, DOI 10.1016/0304-3959(92)90113-P; McNeil DW, 1998, J BEHAV MED, V21, P389, DOI 10.1023/A:1018782831217; Nahin RL, 2015, J PAIN, V16, P769, DOI 10.1016/j.jpain.2015.05.002; Neblett R, 2017, CLIN J PAIN; Neblett R, 2016, PAIN PRACT, V16, P435, DOI 10.1111/papr.12333; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; PHILIPS HC, 1987, BEHAV RES THER, V25, P273, DOI 10.1016/0005-7967(87)90005-2; Pincus T, 2010, CLIN J PAIN, V26, P739, DOI 10.1097/AJP.0b013e3181f15d45; Rainville J, 2011, SPINE J, V11, P895, DOI 10.1016/j.spinee.2011.08.006; Spielberger C.D., 1983, MANUAL STATE TRAIT A, DOI DOI 10.1002/9780470479216.CORPSY0943; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Statistical Office of the Republic of Serbia, 2016, 2011 CNESUS POPULATI; Stratford P. W., 2004, PHYSIOTHER CAN, V56, P27, DOI [10.2310/6640.2004.15377, DOI 10.2310/6640.2004.15377]; Streiner DL, 2003, J PERS ASSESS, V80, P217, DOI 10.1207/S15327752JPA8003_01; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Trost Z, 2008, PAIN, V137, P26, DOI 10.1016/j.pain.2007.08.005; van Wijk AJ, 2003, EUR J ORAL SCI, V111, P12, DOI 10.1034/j.1600-0722.2003.00005.x; VLAEYEN JWS, 1995, PAIN, V62, P363, DOI 10.1016/0304-3959(94)00279-N; Vlaeyen JWS, 2000, PAIN, V85, P317, DOI 10.1016/S0304-3959(99)00242-0; WADDELL G, 1993, PAIN, V52, P157, DOI 10.1016/0304-3959(93)90127-B; Wertli MM, 2014, SPINE J, V14, P2658, DOI 10.1016/j.spinee.2014.02.033; Wicksell RK, 2008, EUR J PAIN, V12, P491, DOI 10.1016/j.ejpain.2007.08.003; Wild D, 2005, VALUE HEALTH, V8, P94, DOI 10.1111/j.1524-4733.2005.04054.x; Zale EL, 2015, CURR OPIN PSYCHOL, V5, P24, DOI 10.1016/j.copsyc.2015.03.014; Zale EL, 2013, J PAIN, V14, P1019, DOI 10.1016/j.jpain.2013.05.005	60	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2018	13	9							e0204311	10.1371/journal.pone.0204311	http://dx.doi.org/10.1371/journal.pone.0204311			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV3MI	30248127	Green Submitted, Green Published, gold			2022-12-26	WOS:000445998100031
J	Veneruso, PE; Bruzzese, D; Magli, A				Veneruso, Paolo Esposito; Bruzzese, Dario; Magli, Adriano			Long-term development of refractive error in refractive, nonrefractive and partially accommodative esotropia	PLOS ONE			English	Article							LONGITUDINAL CHANGES; CHILDREN; EYE; EMMETROPISATION; ANISOMETROPIA; HYPERMETROPIA; COMPENSATION; AMBLYOPIA; DEFOCUS; GROWTH	Accommodative esotropia (AE) is a convergent deviation due to an excess of the convergence linked to the innervational stimulus for accommodation and it is usually associated to the presence of hyperopia. The development of hyperopia over time has been widely described but the lack of comparative analysis among accommodative esotropia subtypes, does not allow to verify the existence of different developmental patterns. In this study we aimed to describe the long term changes of refractive error in patients affected by accommodative esotropia as a function of the strabismus type: refractive (RAE), non-refractive (NRAE) and partially accommodative esotropia (PAE). The medical records of 66 patients (24 RAE, 22 PAE, 20 NRAE), who wore the full correction of their cycloplegic refraction error during the entire follow up period, were retrospectively reviewed. Mean outcome was the analysis of the variations, among groups, of refractive error over time; differences between mild (<= 3.00D) and high (>= 5.00D) hyperopia, effects of amblyopia and relationship with AC/A ratio were also investigated. All patients were followed up from approximately 4 years of age to 20, with mean follow up of 16.06 +/- 0.29 years. Our results described similar non-linear trend of refractive error development among groups. The initial increase of hyperopia (up to 7-8 years) was followed by a decreasing trend persisting up to adulthood (approximately 20 years of age). During this period, spherical equivalent decreased at a lower mean annual rate in patients affected by RAE (-0.07D) compared to other groups (NRAE -0.11D, p = 0.003 and PAE 0.13D, p = 0.002). In all groups, however, significant amount of hyperopia was found at last examination; indeed the observed difference in SE values from baseline to the end of follow up, was not significant (RAE: +0.27D, 95% C.I. -0.49 to +1.04D, p = 0.472; PAE: -0.69D, 95% C.I. -1.67 to +0.28D, p = 0.154; NRAE: -0.39D, 95% C.I. -1.11 to +0.34D, p = 0.278). AC/A ratio, amblyopia and amount of initial hyperopia appeared to have no significant role in longitudinal change of the refractive error. In conclusion, this study provides a complete overview, from childhood to adulthood, of refractive error development in different form of accommodative esotropia.	[Veneruso, Paolo Esposito] GIMA Eyecare Ctr, Naples, Italy; [Bruzzese, Dario] Univ Naples Federico II, Dept Publ Hlth, Naples, Italy; [Magli, Adriano] Univ Salerno, Dept Pediat Ophthalmol, Salerno, Italy	University of Naples Federico II; University of Salerno	Magli, A (corresponding author), Univ Salerno, Dept Pediat Ophthalmol, Salerno, Italy.	amagli@unisa.it	Magli, Adriano/AAU-7380-2020; Veneruso, Paolo Esposito/AAU-7390-2020	Magli, Adriano/0000-0002-6490-2068; Veneruso, Paolo Esposito/0000-0002-9294-1881; Bruzzese, Dario/0000-0001-9911-4646				BAKER JD, 1980, AM J OPHTHALMOL, V90, P11, DOI 10.1016/S0002-9394(14)75070-6; Biler ED, 2010, J AAPOS, V14, P305, DOI 10.1016/j.jaapos.2010.01.017; Birch EE, 2010, EYE, V24, P1814, DOI 10.1038/eye.2010.129; Black Bradley Charles, 2006, Trans Am Ophthalmol Soc, V104, P303; Burtolo C, 2002, J PEDIAT OPHTH STRAB, V39, P209, DOI 10.3928/0191-3913-20020701-08; Flitcroft DI, 1998, VISION RES, V38, P2869, DOI 10.1016/S0042-6989(98)00087-X; INGRAM RM, 1991, BRIT J OPHTHALMOL, V75, P414, DOI 10.1136/bjo.75.7.414; Ingram RM, 2000, BRIT J OPHTHALMOL, V84, P324, DOI 10.1136/bjo.84.3.324; IRVING EL, 1992, OPHTHAL PHYSL OPT, V12, P448, DOI 10.1111/j.1475-1313.1992.tb00315.x; Lambert SR, 2006, BRIT J OPHTHALMOL, V90, P357, DOI 10.1136/bjo.2005.078105; Lin Z, 2017, BMC OPHTHALMOL, V17, DOI 10.1186/s12886-017-0598-9; Mezer E, 2015, GRAEF ARCH CLIN EXP, V253, P1013, DOI 10.1007/s00417-015-3033-z; Mulvihill A, 2000, BRIT J OPHTHALMOL, V84, P746, DOI 10.1136/bjo.84.7.746; NASTRI G, 1984, DOC OPHTHALMOL, V56, P265, DOI 10.1007/BF00159077; Nevin ST, 1998, CURR EYE RES, V17, P322, DOI 10.1076/ceyr.17.3.322.5220; Oh SY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166695; Paris V, 1995, Bull Soc Belge Ophtalmol, V259, P143; Park KA, 2010, OPHTHALMOLOGY, V117, P2196, DOI 10.1016/j.ophtha.2010.02.019; Raab E L, 1984, J Pediatr Ophthalmol Strabismus, V21, pP64; Raab E L, 1982, Trans Am Ophthalmol Soc, V80, P657; Repka MX, 1989, BINOC VIS, V4, P15; Smith EL, 1999, VISION RES, V39, P1415, DOI 10.1016/S0042-6989(98)00229-6; TROILO D, 1992, EYE, V6, P154, DOI 10.1038/eye.1992.31; Von Noorden G. K., 2002, BINOCULAR VISION OCU, V6th; Wang JY, 2016, INVEST OPHTH VIS SCI, V57, P2203, DOI 10.1167/iovs.15-18454; Weakley DR, 2001, J AAPOS, V5, P153, DOI 10.1067/mpa.2001.114662; WILDSOET C, 1995, VISION RES, V35, P1175, DOI 10.1016/0042-6989(94)00233-C; Yang HK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110663; You XF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154671	29	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2018	13	9							e0204396	10.1371/journal.pone.0204396	http://dx.doi.org/10.1371/journal.pone.0204396			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3MI	30248135	Green Submitted, gold, Green Published			2022-12-26	WOS:000445998100035
J	Pellowe, AS; Sauler, M; Hou, Y; Merola, J; Liu, R; Calderon, B; Lauridsen, HM; Harris, MR; Leng, L; Zhang, Y; Tilstam, PV; Pober, JS; Bucala, R; Lee, PJ; Gonzalez, AL				Pellowe, Amanda S.; Sauler, Maor; Hou, Yue; Merola, Jonathan; Liu, Rebecca; Calderon, Brenda; Lauridsen, Holly M.; Harris, Mariah R.; Leng, Lin; Zhang, Yi; Tilstam, Pathricia V.; Pober, Jordan S.; Bucala, Richard; Lee, Patty J.; Gonzalez, Anjelica L.			Endothelial cell-secreted MIF reduces pericyte contractility and enhances neutrophil extravasation	FASEB JOURNAL			English	Article						microvasculature; inflammation; cytokine; transmigration	MIGRATION-INHIBITORY FACTOR; LIGHT-CHAIN KINASE; VENULAR WALLS; FACTOR GENE; MECHANISMS; TRANSMIGRATION; FIBRONECTIN; CAPILLARY; MOTILITY; DRIVE	Dysregulated neutrophil extravasation contributes to the pathogenesis of many inflammatory disorders. Pericytes (PCs) have been implicated in the regulation of neutrophil transmigration, and previous work demonstrates that endothelial cell (EC)-derived signals reduce PC barrier function; however, the signaling mechanisms are unknown. Here, we demonstrate a novel role for EC-derived macrophage migration inhibitory factor (MIF) in inhibiting PC contractility and facilitating neutrophil transmigration. With the use of micro-ELISAs, RNA sequencing, quantitative PCR, and flow cytometry, we found that ECs secrete MIF, and PCs upregulate CD74 in response to TNF-. We demonstrate that EC-derived MIF decreases PC contractility on 2-dimensional silicone substrates via reduction of phosphorylated myosin light chain. With the use of an in vitro microvascular model of the human EC-PC barrier, we demonstrate that MIF decreases the PC barrier to human neutrophil transmigration by increasing intercellular PC gap formation. For the first time, an EC-specific MIF knockout mouse was used to investigate the effects of selective deletion of EC MIF. In a model of acute lung injury, selective deletion of EC MIF decreases neutrophil infiltration to the bronchoalveolar lavage and tissue and simultaneously decreases PC relaxation by increasing myosin light-chain phosphorylation. We conclude that paracrine signals from EC via MIF decrease PC contraction and enhance PC-regulated neutrophil transmigration.Pellowe, A. S., Sauler, M., Hou, Y., Merola, J., Liu, R., Calderon, B., Lauridsen, H. M., Harris, M. R., Leng, L., Zhang, Y., Tilstam, P. V., Pober, J. S., Bucala, R., Lee, P. J., Gonzalez, A. L. Endothelial cell-secreted MIF reduces pericyte contractility and enhances neutrophil extravasation.	[Pellowe, Amanda S.; Hou, Yue; Calderon, Brenda; Lauridsen, Holly M.; Harris, Mariah R.; Gonzalez, Anjelica L.] Yale Univ, Dept Biomed Engn, New Haven, CT USA; [Sauler, Maor; Leng, Lin; Zhang, Yi; Tilstam, Pathricia V.; Bucala, Richard; Lee, Patty J.] Yale Sch Med, Dept Internal Med, New Haven, CT USA; [Merola, Jonathan; Liu, Rebecca; Pober, Jordan S.] Yale Sch Med, Dept Immunobiol, New Haven, CT USA	Yale University; Yale University; Yale University	Gonzalez, AL (corresponding author), Yale Univ, 55 Prospect St,Room 301,MEC 314, New Haven, CT 06511 USA.	anjelica.gonzalez@yale.edu		Leng, Lin/0000-0002-0605-358X; Tilstam, Pathricia/0000-0003-3620-6775	U.S. National Institutes of Health/National Heart, Lung, and Blood Institute (NIH/NHLBI) [5R01HL051014-24]; Flight Attendant Medical Research-Young Clinical Scientist Award; Parker B. Francis Fellowship; NIH/NHLBI Grant [K08HL135402, 1R01HL130669]; Flight Attendant Medical Research-Clinical Innovator Award [R01HL138396]; DoD [PR150809]; VAORD [11858595]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL138396, R01HL130669, R01HL051014, K08HL135402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007276] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003265] Funding Source: NIH RePORTER	U.S. National Institutes of Health/National Heart, Lung, and Blood Institute (NIH/NHLBI); Flight Attendant Medical Research-Young Clinical Scientist Award; Parker B. Francis Fellowship; NIH/NHLBI Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Flight Attendant Medical Research-Clinical Innovator Award; DoD(United States Department of Defense); VAORD(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	The authors thank Endah Sulistijo and Kathryn Miller-Jensen for their assistance in fabricating and performing micro-ELISA assays, and Rong Fan for the use of the SpotBot personal array printer (all from Yale University). The authors also acknowledge the following funding sources: A.L.G. and J.S.P. are supported by U.S. National Institutes of Health/National Heart, Lung, and Blood Institute (NIH/NHLBI) Grant 5R01HL051014-24. M.S. is supported by the Flight Attendant Medical Research-Young Clinical Scientist Award, Parker B. Francis Fellowship, and NIH/NHLBI Grant K08HL135402. P.J.L. is supported by the Flight Attendant Medical Research-Clinical Innovator Award, R01HL138396, VAORD 11858595 and DoD PR150809. R.B. is supported by NIH/NHLBI Grant 1R01HL130669. The authors declare no conflicts of interest.	Alford PW, 2011, INTEGR BIOL-UK, V3, P1063, DOI 10.1039/c1ib00061f; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Ayres-Sander CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060025; Baker NL, 2007, ANN NEUROL, V62, P390, DOI 10.1002/ana.21213; Bhadriraju K, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-43; Boudaoud A, 2014, NAT PROTOC, V9, P457, DOI 10.1038/nprot.2014.024; Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; Brown LA, 2015, CELL MOL BIOENG, V8, P349, DOI 10.1007/s12195-015-0408-5; Donnelly SC, 1997, NAT MED, V3, P320, DOI 10.1038/nm0397-320; Dunn G A, 1983, Agents Actions Suppl, V12, P14; Esteban A, 2013, AM J RESP CRIT CARE, V188, P220, DOI 10.1164/rccm.201212-2169OC; Fernandez IE, 2012, LANCET, V380, P680, DOI 10.1016/S0140-6736(12)61144-1; Fingerle-Rowson G, 2003, P NATL ACAD SCI USA, V100, P9354, DOI 10.1073/pnas.1533295100; GIMBRONE MA, 1974, J CELL BIOL, V60, P673, DOI 10.1083/jcb.60.3.673; Guo Yubiao, 2002, Zhonghua Jiehe He Huxi Zazhi, V25, P337; Hare AA, 2010, BIOORG MED CHEM LETT, V20, P5811, DOI 10.1016/j.bmcl.2010.07.129; Hou Y, 2012, BMC BIOPHYS, V5, DOI 10.1186/2046-1682-5-8; Hung C, 2013, AM J RESP CRIT CARE, V188, P820, DOI 10.1164/rccm.201212-2297OC; KELLEY C, 1987, J CELL BIOL, V104, P483, DOI 10.1083/jcb.104.3.483; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; Lai KN, 2003, J PATHOL, V199, P496, DOI 10.1002/path.1291; Lauridsen HM, 2014, FASEB J, V28, P1166, DOI 10.1096/fj.13-240986; Lee S, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194115; Lehmann LE, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-100; Leng L, 2011, J IMMUNOL, V186, P527, DOI 10.4049/jimmunol.1001767; Liu R, 2016, J IMMUNOL, V197, P2400, DOI 10.4049/jimmunol.1600138; Maier CL, 2010, MICROCIRCULATION, V17, P367, DOI 10.1111/j.1549-8719.2010.00038.x; Mamdouh Z, 2009, J EXP MED, V206, P2795, DOI 10.1084/jem.20082745; MANDARINO LJ, 1993, EXP EYE RES, V57, P609, DOI 10.1006/exer.1993.1166; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Muller WA, 2015, CARDIOVASC RES, V107, P310, DOI 10.1093/cvr/cvv145; Muller WA, 2011, ANNU REV PATHOL-MECH, V6, P323, DOI 10.1146/annurev-pathol-011110-130224; Nourshargh S, 2010, NAT REV MOL CELL BIO, V11, P366, DOI 10.1038/nrm2889; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Pantouris G, 2015, CHEM BIOL, V22, P1197, DOI 10.1016/j.chembiol.2015.08.006; Pellowe AS, 2016, WIRES NANOMED NANOBI, V8, P5, DOI 10.1002/wnan.1349; Pober JS, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016345; Proebstl D, 2012, J EXP MED, V209, P1219, DOI 10.1084/jem.20111622; Romsey NR, 2014, CELL MOL BIOENG, V7, P122, DOI 10.1007/s12195-013-0299-2; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Sabatier L, 2009, MOL BIOL CELL, V20, P846, DOI 10.1091/mbc.E08-08-0830; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sauler M, 2015, AM J PHYSIOL-LUNG C, V309, pL1, DOI 10.1152/ajplung.00339.2014; Serini G, 1998, J CELL BIOL, V142, P873, DOI 10.1083/jcb.142.3.873; Sreih A, 2011, ARTHRITIS RHEUM-US, V63, P3942, DOI 10.1002/art.30624; Stark K, 2013, NAT IMMUNOL, V14, P41, DOI 10.1038/ni.2477; Stroka KM, 2012, J BIOMECH, V45, P1828, DOI 10.1016/j.jbiomech.2012.04.011; Stroka KM, 2011, BLOOD, V118, P1632, DOI 10.1182/blood-2010-11-321125; Taniguchi T, 1996, ONCOGENE, V12, P1357; Truong T, 2015, INTEGR BIOL-UK, V7, P1285, DOI 10.1039/c5ib00133a; Villar J, 2011, INTENS CARE MED, V37, P1932, DOI 10.1007/s00134-011-2380-4; Voisin MB, 2010, AM J PATHOL, V176, P482, DOI 10.2353/ajpath.2010.090510; Wadgaonkar R, 2005, J CELL BIOCHEM, V95, P849, DOI 10.1002/jcb.20472; Wang SJ, 2006, J EXP MED, V203, P1519, DOI 10.1084/jem.20051210; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Weiser JN, 2015, J INFECT DIS, V212, P1677, DOI 10.1093/infdis/jiv262; Xu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038701; Yoo SA, 2016, P NATL ACAD SCI USA, V113, pE7917, DOI 10.1073/pnas.1612717113	58	15	15	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2171	2186		10.1096/fj.201800480R	http://dx.doi.org/10.1096/fj.201800480R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30252532	Green Published			2022-12-26	WOS:000457296600052
J	Li, QY; Wang, F; Xiao, XZ; Kim, C; Bohon, J; Kiselar, J; Safar, JG; Ma, JY; Surewicz, WK				Li, Qiuye; Wang, Fei; Xiao, Xiangzhu; Kim, Chae; Bohon, Jen; Kiselar, Janna; Safar, Jiri G.; Ma, Jiyan; Surewicz, Witold K.			Structural attributes of mammalian prion infectivity: Insights from studies with synthetic prions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN AMYLOID FIBRILS; MASS-SPECTROMETRY; BETA; PARALLEL; CONVERSION; MOLECULES; COFACTOR; DISEASES; DOMAIN; CORE	Prion diseases are neurodegenerative disorders that affect many mammalian species. Mammalian prion proteins (PrPs) can misfold into many different aggregates. However, only a small subpopulation of these structures is infectious. One of the major unresolved questions in prion research is identifying which specific structural features of these misfolded protein aggregates are important for prion infectivity in vivo. Previously, two types of proteinase K-resistant, self-propagating aggregates were generated from the recombinant mouse prion protein in the presence of identical cofactors. Although these two aggregates appear biochemically very similar, they have dramatically different biological properties, with one of them being highly infectious and the other one lacking any infectivity. Here, we used several MS-based structural methods, including hydrogen-deuterium exchange and hydroxyl radical foot-printing, to gain insight into the nature of structural differences between these two PrP aggregate types. Our experiments revealed a number of specific differences in the structure of infectious and noninfectious aggregates, both at the level of the polypeptide backbone and quaternary packing arrangement. In particular, we observed that a high degree of order and stability of beta-sheet structure within the entire region between residues similar to 89 and 227 is a primary attribute of infectious PrP aggregates examined in this study. By contrast, noninfectious PrP aggregates are characterized by markedly less ordered structure up to residue similar to 167. The structural constraints reported here should facilitate development of experimentally based high-resolution structural models of infectiosus mammalian prions.	[Li, Qiuye; Xiao, Xiangzhu; Surewicz, Witold K.] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Kim, Chae; Safar, Jiri G.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Bohon, Jen] Case Western Reserve Univ, Ctr Synchrotron Biosci, Cleveland, OH 44106 USA; [Bohon, Jen; Kiselar, Janna] Case Western Reserve Univ, Ctr Prote & Bioinformat, Cleveland, OH 44106 USA; [Wang, Fei; Ma, Jiyan] Van Andel Res Inst, Ctr Neurodegenerat Sci, Grand Rapids, MI 49503 USA; [Wang, Fei] Univ Texas Hlth Sci Ctr Houston, Dept Neurol, Houston, TX 77030 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Van Andel Institute; University of Texas System; University of Texas Health Science Center Houston	Surewicz, WK (corresponding author), Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA.	witold.surewicz@case.edu		Ma, Jiyan/0000-0001-7150-1898; Li, Qiuye/0000-0001-7869-8814	National Institutes of Health [P01AI106705, R01NS060729, R01NS103848, R01NS083687, P30EB00998]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI106705] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060729, R01NS083687, R01NS103848] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants P01AI106705, R01NS060729, R01NS103848, R01NS083687, and P30EB00998. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguilar-Calvo P, 2017, SCI REP-UK, V7, DOI 10.1038/srep43295; Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Bohon J, 2016, AIP CONF PROC, V1741, DOI 10.1063/1.4952828; Burns-Hamuro LL, 2005, PROTEIN SCI, V14, P2982, DOI 10.1110/ps.051687305; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Caughey B, 2001, PHILOS T ROY SOC B, V356, P197, DOI 10.1098/rstb.2000.0765; CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P7672, DOI 10.1021/bi00245a003; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; Cobb NJ, 2014, J BIOL CHEM, V289, P2643, DOI 10.1074/jbc.M113.520718; Cobb NJ, 2009, BIOCHEMISTRY-US, V48, P2574, DOI 10.1021/bi900108v; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Deleault NR, 2012, P NATL ACAD SCI USA, V109, pE1938, DOI 10.1073/pnas.1206999109; Deleault NR, 2012, P NATL ACAD SCI USA, V109, P8546, DOI 10.1073/pnas.1204498109; Diaz-Espinoza R, 2012, NAT STRUCT MOL BIOL, V19, P370, DOI 10.1038/nsmb.2266; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; Espino JA, 2015, ANAL CHEM, V87, P7971, DOI 10.1021/acs.analchem.5b01888; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Groveman BR, 2014, J BIOL CHEM, V289, P24129, DOI 10.1074/jbc.M114.578344; Kim C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04584-z; Kim C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002242; Kiselar J, 2018, ANNU REV BIOPHYS, V47, P315, DOI 10.1146/annurev-biophys-070317-033123; Kiselar JG, 2002, INT J RADIAT BIOL, V78, P101, DOI 10.1080/09553000110094805; Klinger AL, 2014, BIOCHEMISTRY-US, V53, P7724, DOI 10.1021/bi5010409; Knaus KJ, 2001, NAT STRUCT BIOL, V8, P770, DOI 10.1038/nsb0901-770; Lu XJ, 2007, P NATL ACAD SCI USA, V104, P1510, DOI 10.1073/pnas.0608447104; Miyagi M, 2008, ANAL CHEM, V80, P6481, DOI 10.1021/ac8009643; Miyagi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017055; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Noble GP, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005017; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Ritter C, 2005, NATURE, V435, P844, DOI 10.1038/nature03793; Rodriguez JA, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a031336; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Safar JG, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004832; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Smirnovas V, 2011, NAT STRUCT MOL BIOL, V18, P504, DOI 10.1038/nsmb.2035; Smirnovas V, 2009, J BIOL CHEM, V284, P24233, DOI 10.1074/jbc.M109.036558; Surewicz WK, 2011, TOP CURR CHEM, V305, P135, DOI 10.1007/128_2011_165; Theint T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00794-z; Timmes AG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071081; Toyama BH, 2007, NATURE, V449, P233, DOI 10.1038/nature06108; Tycko R, 2010, BIOCHEMISTRY-US, V49, P9488, DOI 10.1021/bi1013134; Vazquez-Fernandez E, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005835; Wang F, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006491; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Wang LW, 2017, MOL CELL PROTEOMICS, V16, P706, DOI 10.1074/mcp.O116.064386; Wang LW, 2011, ANAL CHEM, V83, P7234, DOI 10.1021/ac200567u; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; Wille H, 2018, PATHOGENS, V7, DOI 10.3390/pathogens7010020; Xu GH, 2007, CHEM REV, V107, P3514, DOI 10.1021/cr0682047; Xu H, 2009, PROTEOMICS, V9, P1548, DOI 10.1002/pmic.200700322; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145	55	20	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2018	293	48					18494	18503		10.1074/jbc.RA118.005622	http://dx.doi.org/10.1074/jbc.RA118.005622			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL1NX	30275016	Green Published, hybrid			2022-12-26	WOS:000458467300007
J	Wang, N; Zou, QA; Xu, JX; Zhang, JC; Liu, JS				Wang, Na; Zou, Qingan; Xu, Jinxin; Zhang, Jiancun; Liu, Jinsong			Ligand binding and heterodimerization with retinoid X receptor alpha (RXR alpha) induce farnesoid X receptor (FXR) conformational changes affecting coactivator binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nuclear receptor; transcription factor; X-ray crystallography; allosteric regulation; signal transduction; metabolism; conformational change; allostery; Farnesoid X receptor; Retinoid X receptor	NUCLEAR RECEPTOR; CRYSTAL-STRUCTURE; STRUCTURAL DETERMINANTS; ACID; PATHWAYS; COMPLEX; LIVER; ACTIVATION; REVEALS; CAR	Nuclear receptor farnesoid X receptor (FXR) functions as the major bile acid sensor coordinating cholesterol metabolism, lipid homeostasis, and absorption of dietary fats and vitamins. Because of its central role in metabolism, FXR represents an important drug target to manage metabolic and other diseases, such as primary biliary cirrhosis and nonalcoholic steatohepatitis. FXR and nuclear receptor retinoid X receptor (RXR) form a heterodimer that controls the expression of numerous downstream genes. To date, the structural basis and functional consequences of the FXR/RXR heterodimer interaction have remained unclear. Herein, we present the crystal structures of the heterodimeric complex formed between the ligand-binding domains of human FXR and RXR. We show that both FXR and RXR bind to the transcriptional coregulator steroid receptor coactivator 1 with higher affinity when they are part of the heterodimer complex than when they are in their respective monomeric states. Furthermore, structural comparisons of the FXR/RXR heterodimers and the FXR monomers bound with different ligands indicated that both heterodimerization and ligand binding induce conformational changes in the C terminus of helix 11 in FXR that affect the stability of the coactivator binding surface and the coactivator binding in FXR. In summary, our findings shed light on the allosteric signal transduction in the FXR/RXR heterodimer, which may be utilized for future drug development targeting FXR.	[Wang, Na] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China; [Wang, Na; Xu, Jinxin; Zhang, Jiancun; Liu, Jinsong] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, State Key Lab Resp Dis, Guangzhou 510530, Guangdong, Peoples R China; [Wang, Na; Xu, Jinxin; Zhang, Jiancun; Liu, Jinsong] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangdong Prov Key Lab Biocomp, Guangzhou 510530, Guangdong, Peoples R China; [Zou, Qingan; Zhang, Jiancun] Guangzhou Henovcom Biosci Inc, Guangzhou 510530, Guangdong, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; State Key Laboratory of Respiratory Disease; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS	Liu, JS (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, State Key Lab Resp Dis, Guangzhou 510530, Guangdong, Peoples R China.; Liu, JS (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangdong Prov Key Lab Biocomp, Guangzhou 510530, Guangdong, Peoples R China.	liu_jinsong@gibh.ac.cn		Liu, Jinsong/0000-0003-2317-0558	National Key Research and Development Program [2017YFA0504104]; National Natural Science Foundation of China [31770817]; Guangdong Science and Technology Department [2015A030312017]; Guangdong Provincial Key Laboratory of Biocomputing [2016B030301007]; National R&D Infrastructure and Facility Development Program of China "Fundamental Science Data Sharing Platform" [DKA2017-12-02-22]	National Key Research and Development Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Science and Technology Department; Guangdong Provincial Key Laboratory of Biocomputing; National R&D Infrastructure and Facility Development Program of China "Fundamental Science Data Sharing Platform"	This work was supported by National Key Research and Development Program Grant 2017YFA0504104, National Natural Science Foundation of China Grant 31770817, Guangdong Science and Technology Department Grant 2015A030312017, Guangdong Provincial Key Laboratory of Biocomputing Grant 2016B030301007, and National R&D Infrastructure and Facility Development Program of China, "Fundamental Science Data Sharing Platform" Grant DKA2017-12-02-22. The authors declare that they have no conflicts of interest with the contents of this article.	Akwabi-Ameyaw A, 2008, BIOORG MED CHEM LETT, V18, P4339, DOI 10.1016/j.bmcl.2008.06.073; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bourguet W, 2000, MOL CELL, V5, P289, DOI 10.1016/S1097-2765(00)80424-4; Bruning JB, 2010, NAT CHEM BIOL, V6, P837, DOI 10.1038/NCHEMBIO.451; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; Downes M, 2003, MOL CELL, V11, P1079, DOI 10.1016/S1097-2765(03)00104-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Fernandez EJ, 2018, PHARMACOL THERAPEUT, V183, P152, DOI 10.1016/j.pharmthera.2017.10.014; Fiorucci S, 2011, MINI-REV MED CHEM, V11, P753, DOI 10.2174/138955711796355258; FORMAN BM, 1995, CELL, V81, P541, DOI 10.1016/0092-8674(95)90075-6; FORMAN BM, 1995, CELL, V81, P687, DOI 10.1016/0092-8674(95)90530-8; Gabler M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25158-5; Gampe RT, 2000, MOL CELL, V5, P545, DOI 10.1016/S1097-2765(00)80448-7; Joosten RP, 2014, IUCRJ, V1, P213, DOI 10.1107/S2052252514009324; Kim KH, 2017, DIGEST DIS, V35, P203, DOI 10.1159/000450912; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; Kojetin DJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9013; LEBLANC BP, 1995, GENE DEV, V9, P1811, DOI 10.1101/gad.9.15.1811; Lee FY, 2006, TRENDS BIOCHEM SCI, V31, P572, DOI 10.1016/j.tibs.2006.08.002; Li GD, 2015, ACTA PHARM SIN B, V5, P93, DOI 10.1016/j.apsb.2015.01.005; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nettles KW, 2005, ANNU REV PHYSIOL, V67, P309, DOI 10.1146/annurev.physiol.66.032802.154710; Peng L., 2017, NUCL RECEPTOR RES, V4; Pogenberg V, 2005, J BIOL CHEM, V280, P1625, DOI 10.1074/jbc.M409302200; Schuetz EG, 2001, J BIOL CHEM, V276, P39411, DOI 10.1074/jbc.M106340200; Shulman AI, 2004, CELL, V116, P417, DOI 10.1016/S0092-8674(04)00119-9; Suino K, 2004, MOL CELL, V16, P893, DOI 10.1016/j.molcel.2004.11.036; Svensson S, 2003, EMBO J, V22, P4625, DOI 10.1093/emboj/cdg456; Wallace BD, 2013, J MOL BIOL, V425, P2561, DOI 10.1016/j.jmb.2013.04.012; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Wang YD, 2008, CELL RES, V18, P1087, DOI 10.1038/cr.2008.289; Wright E, 2007, BIOCHEMISTRY-US, V46, P862, DOI 10.1021/bi061627i; Zheng W., 2018, J BIOL CHEM	38	23	24	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18180	18191		10.1074/jbc.RA118.004652	http://dx.doi.org/10.1074/jbc.RA118.004652			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30275017	Green Published, hybrid			2022-12-26	WOS:000451375200013
J	Chen, YQ; Song, QY; Pan, L; Jia, MQ; Li, CW; Hu, BB; Wu, GH				Chen, Yueqin; Song, Qiuyang; Pan, Ling; Jia, Meiqing; Li, Congwei; Hu, Beibei; Wu, Guanghong			Trace metals, organic carbon and nutrients in the Beidagang Wetland Nature Reserve, northern China	PLOS ONE			English	Article							FIRED POWER-PLANTS; ATMOSPHERIC PARTICULATE MERCURY; HEAVY-METALS; URBAN SOILS; MATTER; SEDIMENTS; MOBILITY; NITROGEN; TIANJIN; FRACTIONATION	This study aimed to determine sediment contamination in the Beidagang Wetland Nature Reserve to describe atmospheric deposition of trace metals. We analyzed Hg, Cd, Pb, TOC, TN, TP, delta C-13, and delta N-15, and studied their variations in surface sediments and in the vertical profiles of sediment cores collected from the reserve. Evaluation of environmental trace metal contamination using sediment quality guidelines and geochemical background values indicated that the risk of metal pollution in the reserve sediments was relatively low. Concentrations of Hg, Cd, and Pb in the sediments were much lower than concentrations in sediment samples from Bohai Bay and polluted rivers in Tianjin. Enrichment factors indicate that samples are moderately contaminated with Hg, Cd, and Pb; whereas the geo-accumulation index results classify the sediments as uncontaminated to moderately contaminated with Hg, Cd, and Pb. The distribution patterns of trace metal concentrations in the three core samples were uniform. delta C-13 and delta N-15 were used to track the sources of TOC and TN in sediments. Results show that TOC mainly originated from the residue and decaying matter of aquatic plants (e.g., algae, reeds, and Typha), while TN was derived from soil N and elevated atmospheric N deposition. Because domestic and industrial waste is not discharged into the Beidagang Wetland Nature Reserve, trace metals found in sediments mainly originate from atmospheric deposition. The results provide baseline data for analysis of trace metal accumulation in Beijing-Tianjin-Hebei, a region subject to atmospheric deposition in northern China.	[Chen, Yueqin; Song, Qiuyang; Pan, Ling; Jia, Meiqing; Wu, Guanghong] Tianjin Normal Univ, Tianjin Key Lab Water Resources & Environm, Tianjin, Peoples R China; [Li, Congwei; Hu, Beibei] Tianjin Normal Univ, Coll Urban & Environm Sci, Tianjin, Peoples R China	Tianjin Normal University; Tianjin Normal University	Wu, GH (corresponding author), Tianjin Normal Univ, Tianjin Key Lab Water Resources & Environm, Tianjin, Peoples R China.	wuguanghong@hotmail.com		wu, guanghong/0000-0003-2779-3306	Discipline Construction Projects from the Tianjin Municipal Commission of Education [ZX110GG019]; Open Research Fund of State Key Laboratory of Simulation and Regulation of Water Cycle in River Basin [IWHR-SKL-201418]	Discipline Construction Projects from the Tianjin Municipal Commission of Education; Open Research Fund of State Key Laboratory of Simulation and Regulation of Water Cycle in River Basin	This work was financially supported by the Discipline Construction Projects from the Tianjin Municipal Commission of Education (ZX110GG019) and the Open Research Fund of State Key Laboratory of Simulation and Regulation of Water Cycle in River Basin (IWHR-SKL-201418). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuduwaili J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120001; Acosta JA, 2011, CHEMOSPHERE, V85, P1318, DOI 10.1016/j.chemosphere.2011.07.046; Chen Qing, 2015, Chinese Journal of Plant Ecology, V39, P1044, DOI 10.17521/cjpe.2015.0101; Chen X, 2010, ENVIRON POLLUT, V158, P48, DOI 10.1016/j.envpol.2009.08.028; Cheng HX, 2013, J GEOCHEM EXPLOR, V124, P195, DOI 10.1016/j.gexplo.2012.09.007; Deng S, 2014, FUEL PROCESS TECHNOL, V126, P469, DOI 10.1016/j.fuproc.2014.06.009; Driscoll CT, 2013, ENVIRON SCI TECHNOL, V47, P4967, DOI 10.1021/es305071v; Du Laing G, 2008, ESTUAR COAST SHELF S, V77, P589, DOI 10.1016/j.ecss.2007.10.017; ElBishlawi H, 2015, CHEMOSPHERE, V127, P144, DOI 10.1016/j.chemosphere.2014.12.080; Emerson S, 1988, PALEOCEANOGRAPHY, V3, P621, DOI 10.1029/PA003i005p00621; Evans RD, 2001, TRENDS PLANT SCI, V6, P121, DOI 10.1016/S1360-1385(01)01889-1; Fellman JB, 2008, BIOGEOCHEMISTRY, V88, P169, DOI 10.1007/s10533-008-9203-x; Feng HA, 2011, J ENVIRON MANAGE, V92, P1185, DOI 10.1016/j.jenvman.2010.11.020; Guentzel JL, 2009, SCI TOTAL ENVIRON, V407, P1344, DOI 10.1016/j.scitotenv.2008.09.030; Hogberg P, 1999, NEW PHYTOL, V142, P569, DOI 10.1046/j.1469-8137.1999.00404.x; Hyun Sangmin, 2011, Ocean Science Journal, V46, P289, DOI 10.1007/s12601-011-0022-y; LEDGARD SF, 1985, AUST J PLANT PHYSIOL, V12, P631, DOI 10.1071/PP9850631; Liu JH, 2000, J ENVIRON SCI, V12, P77; Liu MD, 2016, ENVIRON SCI TECHNOL, V50, P6224, DOI 10.1021/acs.est.5b04999; [刘明 Liu Ming], 2016, [海洋学报, Acta Oceanologica Sinica], V38, P36; LONG ER, 1995, ENVIRON MANAGE, V19, P81, DOI 10.1007/BF02472006; MEYERS PA, 1994, CHEM GEOL, V114, P289, DOI 10.1016/0009-2541(94)90059-0; Middelburg JJ, 1998, MAR CHEM, V60, P217, DOI 10.1016/S0304-4203(97)00104-7; Okuda T, 2008, CHEMOSPHERE, V72, P917, DOI 10.1016/j.chemosphere.2008.03.033; Pacyna Jozef M., 1995, Environmental Reviews, V3, P145, DOI 10.1139/a95-006; Pavageau MP, 2002, ENVIRON SCI TECHNOL, V36, P1561, DOI 10.1021/es015595s; Qiao Jun, 2010, Research of Environmental Sciences, V23, P1343; Sanei H, 2006, APPL GEOCHEM, V21, P1900, DOI 10.1016/j.apgeochem.2006.08.015; Schleicher NJ, 2016, ATMOS ENVIRON, V124, P396, DOI 10.1016/j.atmosenv.2015.09.040; Schleicher NJ, 2015, ATMOS ENVIRON, V109, P251, DOI 10.1016/j.atmosenv.2015.03.018; Schleicher NJ, 2011, ATMOS ENVIRON, V45, P7248, DOI 10.1016/j.atmosenv.2011.08.067; SHI GT, 2010, ATMOS ENVIRON, V8, P39, DOI DOI 10.1016/j.atmosenv.2010.08.039; Shi GT, 2008, ENVIRON POLLUT, V156, P251, DOI 10.1016/j.envpol.2008.02.027; Shi JB, 2005, ENVIRON INT, V31, P357, DOI 10.1016/j.envint.2004.08.008; SMITH BN, 1971, PLANT PHYSIOL, V47, P380, DOI 10.1104/pp.47.3.380; Streets DG, 2005, ATMOS ENVIRON, V39, P7789, DOI 10.1016/j.atmosenv.2005.08.029; Sun CH, 2017, MAR POLLUT BULL, V115, P451, DOI 10.1016/j.marpolbul.2016.10.066; Tang RL, 2013, APPL GEOCHEM, V35, P88, DOI 10.1016/j.apgeochem.2013.03.016; Tang SL, 2016, FUEL, V180, P194, DOI 10.1016/j.fuel.2016.04.037; Tian HZ, 2011, SCI TOTAL ENVIRON, V409, P3078, DOI 10.1016/j.scitotenv.2011.04.039; Wang XL, 2005, SCI TOTAL ENVIRON, V350, P28, DOI 10.1016/j.scitotenv.2004.09.044; Wei Q, 2017, HYDROL RES, V48, P1058, DOI 10.2166/nh.2016.142; Wei X., 2015, ECOTOX ENVIRON SAFE, V112, P186, DOI [10. 1016/j. ecoenv. 2014. 11. 005 25463870, DOI 10.1016/J.EC0ENV.2014.11.005]; Wei Z, 2011, ENVIRON TOXICOL CHEM, V30, P1997, DOI 10.1002/etc.605; Wu GH, 2010, B ENVIRON CONTAM TOX, V84, P336, DOI 10.1007/s00128-010-9939-6; Wu GH, 2016, AIR QUAL ATMOS HLTH, V9, P687, DOI 10.1007/s11869-015-0375-y; Wu GH, 2014, MAR POLLUT BULL, V82, P194, DOI 10.1016/j.marpolbul.2014.02.033; Xing JW, 2017, CHEMOSPHERE, V174, P428, DOI 10.1016/j.chemosphere.2017.02.004; Xue DM, 2009, WATER RES, V43, P1159, DOI 10.1016/j.watres.2008.12.048; You Ping, 2006, Acta Ecologica Sinica, V26, P999, DOI 10.1016/S1872-2032(06)60018-8; Zhang L, 2015, ENVIRON SCI TECHNOL, V49, P3185, DOI 10.1021/es504840m; Zhang XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135182; Zhao L, 2014, SCI TOTAL ENVIRON, V468, P654, DOI 10.1016/j.scitotenv.2013.08.094	53	2	2	9	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0204812	10.1371/journal.pone.0204812	http://dx.doi.org/10.1371/journal.pone.0204812			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3QJ	30278089	gold, Green Submitted, Green Published			2022-12-26	WOS:000446010200023
J	Lee, SH; Hong, SH; Tang, CH; Ling, YS; Chen, KH; Liang, HJ; Lin, CY				Lee, Sheng-Han; Hong, Si-Han; Tang, Chuan-Ho; Ling, Yee Soon; Chen, Ke-Han; Liang, Hao-Jan; Lin, Ching-Yu			Mass spectrometry-based lipidomics to explore the biochemical effects of naphthalene toxicity or tolerance in a mouse model	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; DIALLYL TRISULFIDE; ORGANIC-COMPOUNDS; FATTY-ACIDS; CLARA CELLS; MICE; RAT; MEMBRANES; INJURY; DISCRIMINATION	Naphthalene causes mouse airway epithelial injury. However, repeated exposures of naphthalene result in mouse airway tolerance. Previous results showed that toxicity or tolerance was correlated with changes of phosphorylcholine-containing lipids. In this study, a mass spectrometry-based lipidomic approach was applied to examine the effects of naphthalene-induced injury or tolerance in the male ICR mice. The injury model was vehicle x 7 plus 300 mg/kg naphthalene while the tolerant one was 200 mg/kg daily x 7 followed by 300 mg/kg naphthalene on day 8. The lung, liver, kidney, and serum samples were collected for profiles of phosphorylcholine-containing lipids including phosphatidylcholines (PCs) and sphingomyelins (SMs). A partial least-square-discriminate analysis model showed different lung phosphorylcholine-containing lipid profiles from the injured, tolerant, and control groups. Perturbation of diacyl-PCs and plasmenylcholines may be associated with enhanced membrane flexibility and anti-oxidative mechanisms in the lungs of tolerant mice. Additionally, alterations of lyso-PCs and SMs may be responsible for pulmonary dysfunction and inflammation in the lungs of injured mice. Moreover, serum PC(16:0/18:1) has potential to reflect naphthalene-induced airway injuries. Few phosphorylcholine-containing lipid alterations were found in the mouse livers and kidneys across different treatments. This study revealed the changes in lipid profiles associated with the perturbations caused by naphthalene tolerance and toxicity; examination of lipids in serum may assist biomarker development with the potential for application in the human population.	[Lee, Sheng-Han; Hong, Si-Han; Ling, Yee Soon; Chen, Ke-Han; Liang, Hao-Jan; Lin, Ching-Yu] Natl Taiwan Univ, Inst Environm Hlth, Coll Publ Hlth, Taipei, Taiwan; [Tang, Chuan-Ho] Natl Museum Marine Biol & Aquarium, Pingtung, Taiwan; [Tang, Chuan-Ho] Natl Dong Hwa Univ, Inst Marine Biodivers & Evolutionary Biol, Pingtung, Taiwan; [Ling, Yee Soon] Natl Taiwan Univ, Grad Inst Toxicol, Coll Med, Taipei, Taiwan; [Ling, Yee Soon] Univ Malaysia Sabah, Biotechnol Res Inst, Jalan UMS, Kota Kinabalu, Sabah, Malaysia	National Taiwan University; National Museum of Marine Biology & Aquarium; National Dong Hwa University; National Taiwan University; Universiti Malaysia Sabah	Lin, CY (corresponding author), Natl Taiwan Univ, Inst Environm Hlth, Coll Publ Hlth, Taipei, Taiwan.	chingyulin@ntu.edu.tw	Ling, Yee_Soon/H-6815-2016	Ling, Yee_Soon/0000-0002-1042-7820; LIN, CHING-YU/0000-0002-7144-0383	Ministry of Science and Technology of Taiwan [MST 102-2628-B-002-048-MY3, MST 105-2628-B-002-026-MY3]; National Health Research Institutes of Taiwan [NHRI-EX102-9915EC]; National Taiwan University, Taiwan [NTU-CDP-107L7730]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institutes of Taiwan(National Health Research Institutes - Taiwan); National Taiwan University, Taiwan(National Taiwan University)	This study was funded by Ministry of Science and Technology of Taiwan, Grant/Award Numbers: MST 102-2628-B-002-048-MY3 and MST 105-2628-B-002-026-MY3), National Health Research Institutes of Taiwan, Grant/Award Numbers: NHRI-EX102-9915EC, and National Taiwan University, Taiwan, Grant/Award Numbers: NTU-CDP-107L7730.	ATSDR, 2005, TOX PROF NAPHTH 1 ME; Bagchi M, 1998, FREE RADICAL BIO MED, V25, P137, DOI 10.1016/S0891-5849(98)00063-X; Barker M, 2003, J CHEMOMETR, V17, P166, DOI 10.1002/cem.785; Bowler RP, 2015, AM J RESP CRIT CARE, V191, P275, DOI 10.1164/rccm.201410-1771OC; Chen WL, 2014, MOL BIOSYST, V10, P3163, DOI 10.1039/c4mb00435c; Dong J, 2010, METABOLOMICS, V6, P478, DOI 10.1007/s11306-010-0215-x; EISELE GR, 1985, B ENVIRON CONTAM TOX, V34, P549, DOI 10.1007/BF01609774; Evans CR, 2014, J PROTEOME RES, V13, P640, DOI 10.1021/pr4007624; Fahy E, 2005, J LIPID RES, V46, P839, DOI 10.1194/jlr.E400004-JLR200; Feller SE, 2002, J AM CHEM SOC, V124, P318, DOI 10.1021/ja0118340; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fuller N, 2001, BIOPHYS J, V81, P243, DOI 10.1016/S0006-3495(01)75695-0; Ghidoni R, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/487508; Gorgas K, 2006, BBA-MOL CELL RES, V1763, P1511, DOI 10.1016/j.bbamcr.2006.08.038; Guo S, 2014, SCI REP-UK, V4, DOI 10.1038/srep05959; Hong JH, 2014, J APPL TOXICOL, V34, P1379, DOI 10.1002/jat.2970; Hull MC, 2004, J PHYS CHEM B, V108, P15890, DOI 10.1021/jp049845d; Kang DH, 2012, ATMOS ENVIRON, V50, P79, DOI 10.1016/j.atmosenv.2011.12.060; Kang YP, 2014, J PROTEOME RES, V13, P3919, DOI 10.1021/pr5002059; Khaselev N, 2000, J LIPID RES, V41, P564; Kidd PM, 2005, ALTERN MED REV, V10, P268; Lessig J, 2009, CURR MED CHEM, V16, P2021; Li X, 2011, OMICS, V15, P655, DOI 10.1089/omi.2011.0027; Lin CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120429; Ling YS, 2014, MOL BIOSYST, V10, P1918, DOI 10.1039/c4mb00090k; Ma DWL, 2004, J NUTR BIOCHEM, V15, P700, DOI 10.1016/j.jnutbio.2004.08.002; Mander A, 2002, AM J RESP CELL MOL, V27, P714, DOI 10.1165/rcmb.4746; Miekisch W, 2004, CLIN CHIM ACTA, V347, P25, DOI 10.1016/j.cccn.2004.04.023; Miyamoto S, 2016, EBIOMEDICINE, V7, P121, DOI 10.1016/j.ebiom.2016.03.033; OBRIEN KAF, 1985, CHEM-BIOL INTERACT, V55, P109, DOI 10.1016/S0009-2797(85)80122-8; PELLIZZARI ED, 1982, B ENVIRON CONTAM TOX, V28, P322, DOI 10.1007/BF01608515; Pierson DJ, 2006, RESP CARE, V51, P413; PLOPPER CG, 1992, J PHARMACOL EXP THER, V261, P353; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; Preuss R, 2003, INT ARCH OCC ENV HEA, V76, P556, DOI 10.1007/s00420-003-0458-1; Ravipati S, 2015, METABOLOMICS, V11, P1600, DOI 10.1007/s11306-015-0811-x; Shoemaker SD, 2002, IND ENG CHEM RES, V41, P324, DOI 10.1021/ie010049t; Slupsky CM, 2007, ANAL CHEM, V79, P6995, DOI 10.1021/ac0708588; Smith HL, 2009, J AM CHEM SOC, V131, P3631, DOI 10.1021/ja807680m; Stanley JS, 1986, BROAD SCAN ANAL FY82, V1; STUBBS CD, 1984, BIOCHIM BIOPHYS ACTA, V779, P89, DOI 10.1016/0304-4157(84)90005-4; Tang C.-S., 2011, CHINA CIV ENG J, V44, P5, DOI [DOI 10.15951/J.TMGCXB.2011.S2.040, 10.1016/j.geotexmem.2006.11.002]; Tang CH, 2012, ANAL BIOANAL CHEM, V404, P2949, DOI 10.1007/s00216-012-6414-8; Taniguchi M, 2014, BBA-MOL CELL BIOL L, V1841, P692, DOI 10.1016/j.bbalip.2013.12.003; Teichgraber V, 2008, NAT MED, V14, P382, DOI 10.1038/nm1748; THIES F, 1992, J NEUROCHEM, V59, P1110, DOI 10.1111/j.1471-4159.1992.tb08353.x; TINGLE MD, 1993, BIOCHEM PHARMACOL, V46, P1529, DOI 10.1016/0006-2952(93)90319-R; Todd DA, 2010, PEDIATR CRIT CARE ME, V11, P82, DOI 10.1097/PCC.0b013e3181ae5a4c; Tokumura A, 2011, J HEALTH SCI, V57, P115, DOI 10.1248/jhs.57.115; Van Winkle LS, 1999, AM J RESP CELL MOL, V21, P44, DOI 10.1165/ajrcmb.21.1.3630; Vuchetich PJ, 1996, FREE RADICAL BIO MED, V21, P577, DOI 10.1016/0891-5849(96)00161-X; West JAA, 2000, J PHARMACOL EXP THER, V294, P516; West JAA, 2003, TOXICOL SCI, V75, P161, DOI 10.1093/toxsci/kfg156; West JAA, 2002, AM J PATHOL, V160, P1115, DOI 10.1016/S0002-9440(10)64932-2; Westerhuis JA, 2008, METABOLOMICS, V4, P81, DOI 10.1007/s11306-007-0099-6; Xu Yi, 2014, Biomed J, V37, P112, DOI 10.4103/2319-4170.131378; YOUNES M, 1980, RES COMMUN CHEM PATH, V27, P119; Zhang F, 2016, INT J IMMUNOPATH PH, V29, P205, DOI 10.1177/0394632015627160; Zhang F, 2015, INT IMMUNOPHARMACOL, V29, P326, DOI 10.1016/j.intimp.2015.10.033	59	8	9	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204829	10.1371/journal.pone.0204829	http://dx.doi.org/10.1371/journal.pone.0204829			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273358	Green Submitted, Green Published, gold			2022-12-26	WOS:000446124700038
J	Fundova, I; Funda, T; Wu, HX				Fundova, Irena; Funda, Tomas; Wu, Harry X.			Non-destructive wood density assessment of Scots pine (Pinus sylvestris L.) using Resistograph and Pilodyn	PLOS ONE			English	Article							GENETIC-VARIATION; DRILL RESISTANCE; MICROFIBRIL ANGLE; RAPID ASSESSMENT; QUALITY TRAITS; GROWTH TRAITS; PICEA-ABIES; SELECTION; SPRUCE; RADIATA	We tested two methods for non-destructive assessment of wood density of Scots pine standing trees: one based on penetration depth of a steel pin (Pilodyn) and the other on micro-drilling resistance (Resistograph). As a benchmark we used wood density data from x-ray analysis (SilviScan). We assessed in total 622 trees of 175 full-sib families growing in a single progeny test. Pilodyn was applied with bark (PIL) and without bark (PILB). Raw Resistograph drilling profiles (RES) were adjusted (RESTB) in order to eliminate increasing trend caused by needle friction. Individual narrow-sense heritability of benchmark SilviScan density (DEN; 0.46) was most closely approached by that of adjusted RESTB (0.43). Heritabilities were lower for unadjusted RES (0.35) as well as for PIL and PILB (both 0.32). Additive genetic correlations of the benchmark DEN with RES, RESTB, PIL and PILB were 0.89, 0.96, 0.59 and 0.71, respectively. Our results suggest that Resistograph is a more reliable tool than Pilodyn for wood density assessment of Scots pine; however, we highly recommend adjusting Resistograph drilling profiles prior to further analyses.	[Fundova, Irena; Funda, Tomas; Wu, Harry X.] Swedish Univ Agr Sci, Umea Plant Sci Ctr, Dept Forest Genet & Plant Physiol, Umea, Sweden; [Fundova, Irena] Skogforsk Forestry Res Inst Sweden, Savar, Sweden	Swedish University of Agricultural Sciences; Umea University; Skogforsk	Wu, HX (corresponding author), Swedish Univ Agr Sci, Umea Plant Sci Ctr, Dept Forest Genet & Plant Physiol, Umea, Sweden.	Harry.Wu@slu.se	Funda, Tomas/B-8314-2011	Funda, Tomas/0000-0003-1275-9906; Wu, Harry/0000-0002-7072-4704; Fundova, Irena/0000-0002-3817-1599	UPSC Berzelii Center for Forest Biotechnology; Foreningen Skogstradsforadling; Fonden for Skogsvetenskaplig Forskning (Swedish University of Agricultural Sciences)	UPSC Berzelii Center for Forest Biotechnology; Foreningen Skogstradsforadling; Fonden for Skogsvetenskaplig Forskning (Swedish University of Agricultural Sciences)	This work was supported by UPSC Berzelii Center for Forest Biotechnology to Harry X. Wu; Foreningen Skogstradsforadling to Harry X. Wu and Fonden for Skogsvetenskaplig Forskning (Swedish University of Agricultural Sciences) to Irena Fundova. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG JP, 1984, WOOD SCI TECHNOL, V18, P137; Baltunis BS, 2007, CAN J FOREST RES, V37, P2164, DOI 10.1139/X07-061; Bouffier L, 2008, ANN FOREST SCI, V65, DOI 10.1051/forest:2007078; Brandel G., 1990, VOLUME FUNCTIONS IND; Chen ZQ, 2015, ANN FOREST SCI, V72, P499, DOI 10.1007/s13595-015-0458-9; Core Team R, 2013, AL ENV STAT COMP; COWN DJ, 1978, NEW ZEAL J FOR SCI, V8, P384; Desponts M, 2017, ANN FOREST SCI, V74, DOI 10.1007/s13595-017-0646-x; Eckard JT, 2010, FOREST SCI, V56, P233; El-Kassaby YA, 2011, TREE GENET GENOMES, V7, P553, DOI 10.1007/s11295-010-0355-1; EVANS R, 1994, HOLZFORSCHUNG, V48, P168, DOI 10.1515/hfsg.1994.48.2.168; Fries A, 2006, SILVAE GENET, V55, P84, DOI 10.1515/sg-2006-0013; Fries A, 2012, ANN FOREST SCI, V69, P783, DOI 10.1007/s13595-012-0202-7; Fukatsu E, 2011, J FOREST RES-JPN, V16, P128, DOI 10.1007/s10310-010-0217-6; Gao S, 2017, ANN FOREST SCI, V74, DOI 10.1007/s13595-017-0623-4; Gilmour A. R., 2015, ASREML USER GUIDE RE; Glass SV, 2010, FPLGTR190 FOR PROD L; Grans D, 2009, SCAND J FOREST RES, V24, P494, DOI 10.1080/02827580903280061; Greaves BL, 1996, CAN J FOREST RES, V26, P1643, DOI 10.1139/x26-185; Gwaze D, 2008, SOUTH J APPL FOR, V32, P130, DOI 10.1093/sjaf/32.3.130; Haapanen Matti, 1997, Silva Fennica, V31, P3; Hallingback HR, 2014, TREE GENET GENOMES, V10, P605, DOI 10.1007/s11295-014-0707-3; Hallingback HR, 2010, CAN J FOREST RES, V40, P173, DOI 10.1139/X09-173; Hannrup B, 2000, SCAND J FOREST RES, V15, P161, DOI 10.1080/028275800750014966; Hayatgheibi H, 2017, CAN J FOREST RES, V47, P1303, DOI 10.1139/cjfr-2017-0152; Hernandez RE, 2001, FOREST PROD J, V51, P82; Hong Z, 2014, ANN FOREST SCI, V71, P463, DOI 10.1007/s13595-014-0359-3; Isik F, 2003, CAN J FOREST RES, V33, P2426, DOI [10.1139/x03-176, 10.1139/X03-176]; Isik F, 2011, ANN FOREST SCI, V68, P283, DOI 10.1007/s13595-011-0035-9; Ivkovic M, 2006, CAN J FOREST RES, V36, P2920, DOI 10.1139/X06-161; Krakau U-K, 2013, FOREST TREE BREEDING, V25, P267, DOI DOI 10.1007/978-94-007-6146-9_; Li L, 2005, CAN J FOREST RES, V35, P2019, DOI [10.1139/x05-134, 10.1139/X05-134]; Livingston AK, 2004, FORESTRY, V77, P325, DOI 10.1093/forestry/77.4.325; Pot D, 2002, ANN FOREST SCI, V59, P563, DOI 10.1051/forest:2002042; Rinn F, 1996, HOLZFORSCHUNG, V50, P303, DOI 10.1515/hfsg.1996.50.4.303; Rinn F., 2012, HOLZTECHNOLOGIE, V53, P24; SPRAGUE JR, 1983, FOREST SCI, V29, P696; Wilhelmsson L., 1993, CORRECTED REPRINT PR, P184; Wu HX, 2011, AUST FORESTRY, V74, P36, DOI 10.1080/00049158.2011.10676344; Wu HX., 2008, NZ J FORESTRY SCI, V38, P56; YANCHUK AD, 1993, SILVAE GENET, V42, P141; ZHANG SY, 1995, WOOD SCI TECHNOL, V30, P63, DOI 10.1007/BF00195269	42	31	32	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204518	10.1371/journal.pone.0204518	http://dx.doi.org/10.1371/journal.pone.0204518			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30261004	Green Submitted, Green Published, gold			2022-12-26	WOS:000445907400062
J	Petkov, S; Kahland, T; Shomroni, O; Lingner, T; Salinas, G; Fuchs, S; Debowski, K; Behr, R				Petkov, Stoyan; Kahland, Tobias; Shomroni, Orr; Lingner, Thomas; Salinas, Gabriela; Fuchs, Sigrid; Debowski, Katharina; Behr, Rudiger			Immortalization of common marmoset monkey fibroblasts by piggyBac transposition of hTERT	PLOS ONE			English	Article							MESENCHYMAL STEM-CELL; TELOMERASE ACTIVITY; CALLITHRIX-JACCHUS; NEOPLASTIC TRANSFORMATION; KARYOTYPIC VARIATIONS; HERPESVIRUS-SAIMIRI; GENE-EXPRESSION; SENESCENCE; TRANSFECTION; DIFFERENTIATION	Following a certain type-specific number of mitotic divisions, terminally differentiated cells undergo proliferative senescence, thwarting efforts to expand different cell populations in vitro for the needs of scientific research or medical therapies. The primary cause of this phenomenon is the progressive shortening of the telomeres and the subsequent activation of cell cycle control pathways leading to a block of cell proliferation. Restoration of telomere length by transgenic expression of telomerase reverse transcriptase (TERT) usually results in bypassing of the replicative senescence and ultimately in cell immortalization. To date, there have not been any reports regarding immortalization of cells from common marmoset (Callithrix jacchus), an important non-human primate model for various human diseases, with the use of exogenous human TERT (hTERT). In this study, marmoset fibroblasts were successfully immortalized with transposon-integrated transgenic hTERT and expanded in vitro for over 500 population doublings. Calculation of population doubling levels (PDL) showed that the derived hTERT-transgenic lines had significantly higher proliferation potential than the wild-type fibroblasts, which reached only a maximum of 46 doublings. However, the immortalized cells exhibited differences in the morphology compared with the control fibroblasts and transcriptome analysis also revealed changes in the gene expression patterns. Finally, the karyotypes of all hTERT-transgenic cell lines showed various aberrations such as presence of extra Chromosome 17, isochromosome 21q, or tetraploidy. By single-cell expansion of the least affected monoclonal immortalized line, one sub-clonal line with normal karyotype was established, suggesting the possibility to derive immortal marmoset cells with normal karyotypes. The results of this study are an important step towards the development and optimization of methods for the production of immortalized cells from common marmoset monkeys.	[Petkov, Stoyan; Kahland, Tobias; Debowski, Katharina; Behr, Rudiger] Leibniz Inst Primate Res, German Primate Ctr, Platform Degenerat Dis, Gottingen, Germany; [Petkov, Stoyan; Behr, Rudiger] DZHK German Ctr Cardiovasc Res, Partner Site Gottingen, Gottingen, Germany; [Shomroni, Orr; Lingner, Thomas; Salinas, Gabriela] Univ Med Ctr Gottingen UMG, Microarray & Deep Sequencing Core Facil, Gottingen, Germany; [Fuchs, Sigrid] Univ Med Ctr Hamburg Eppendorf, Dept Human Genet, Hamburg, Germany; [Kahland, Tobias] A Tune Software AG, Darmstadt, Germany; [Debowski, Katharina] STEMCELL Technol Germany GmbH, Cologne, Germany	Deutsches Primatenzentrum (DPZ); German Centre for Cardiovascular Research; University of Hamburg; University Medical Center Hamburg-Eppendorf	Behr, R (corresponding author), Leibniz Inst Primate Res, German Primate Ctr, Platform Degenerat Dis, Gottingen, Germany.; Behr, R (corresponding author), DZHK German Ctr Cardiovasc Res, Partner Site Gottingen, Gottingen, Germany.	rbehr@dpz.eu	Petkov, Stoyan/AAF-5417-2021	Petkov, Stoyan/0000-0001-7551-7862; Kahland, Tobias/0000-0003-3716-428X				ALLSOPP RC, 1995, EXP CELL RES, V219, P130, DOI 10.1006/excr.1995.1213; Belgiovine C, 2008, CYTOGENET GENOME RES, V122, P255, DOI 10.1159/000167811; Ben-David U, 2013, NAT PROTOC, V8, P989, DOI 10.1038/nprot.2013.051; Bischoff DS, 2012, BIORESEARCH OPEN ACC, V1, P273, DOI 10.1089/biores.2012.0252; Blagosklonny MV, 2006, J CELL PHYSIOL, V209, P592, DOI 10.1002/jcp.20750; Bocker W, 2008, J CELL MOL MED, V12, P1347, DOI [10.1111/j.1582-4934.2008.00299.x, 10.1111/j.1582-4934.2008.0299.x]; Condon J, 2002, BIOL REPROD, V67, P506, DOI 10.1095/biolreprod67.2.506; Cui W, 2002, J BIOL CHEM, V277, P38531, DOI 10.1074/jbc.M205981200; Darimont C, 2003, CELL DEATH DIFFER, V10, P1025, DOI 10.1038/sj.cdd.4401273; Debowski K, 2016, SCI REP-UK, V6, DOI 10.1038/srep29122; Debowski K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118424; Dolcetti R, 2014, INFECT AGENTS CANCER, V9, DOI 10.1186/1750-9378-9-8; Duesberg P, 2013, CELL CYCLE, V12, P783, DOI 10.4161/cc.23720; Gao K, 2008, TRANSPL P, V40, P634, DOI 10.1016/j.transproceed.2008.01.053; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Herbert BS, 2002, ONCOGENE, V21, P7897, DOI 10.1038/sj.onc.1205902; Husen B, 2002, ALTEX-ALTERN TIEREXP, V19, P64; Jagessar SA, 2013, EXP ANIM TOKYO, V62, P159, DOI 10.1538/expanim.62.159; Katakura Y, 1998, METHOD CELL BIOL, V57, P69; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kishi N, 2014, DEV GROWTH DIFFER, V56, P53, DOI 10.1111/dgd.12109; KIYOTAKI M, 1986, J EXP MED, V164, P926, DOI 10.1084/jem.164.3.926; Lee KM, 2003, BIOCHEM BIOPH RES CO, V301, P1038, DOI 10.1016/S0006-291X(03)00086-X; Masutomi K, 2003, CELL, V114, P241, DOI 10.1016/S0092-8674(03)00550-6; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; Mondello C, 2003, BIOCHEM BIOPH RES CO, V308, P914, DOI 10.1016/S0006-291X(03)01484-0; Mondello C, 2013, CELL CYCLE, V12, P1804, DOI 10.4161/cc.24940; Morales CP, 2003, GUT, V52, P327, DOI 10.1136/gut.52.3.327; Neusser M, 2001, CYTOGENET CELL GENET, V94, P206, DOI 10.1159/000048818; Oh HY, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-20; Ouellette MM, 2000, HUM MOL GENET, V9, P403, DOI 10.1093/hmg/9.3.403; Salmon P, 2000, MOL THER, V2, P404, DOI 10.1006/mthe.2000.0141; Shay JW, 2005, CARCINOGENESIS, V26, P867, DOI 10.1093/carcin/bgh296; SHAY JW, 1991, EXP CELL RES, V196, P33, DOI 10.1016/0014-4827(91)90453-2; Sherlock JK, 1996, GENOMICS, V33, P214, DOI 10.1006/geno.1996.0186; Sullivan CS, 2002, MICROBIOL MOL BIOL R, V66, P179, DOI 10.1128/MMBR.66.2.179-202.2002; SZOMOLANYI E, 1987, J VIROL, V61, P3485, DOI 10.1128/JVI.61.11.3485-3490.1987; Techangamsuwan S, 2009, J NEUROSCI METH, V176, P112, DOI 10.1016/j.jneumeth.2008.08.030; Vaziri H, 1996, EXP GERONTOL, V31, P295, DOI 10.1016/0531-5565(95)02025-X; Wei WY, 1999, EXP CELL RES, V253, P519, DOI 10.1006/excr.1999.4665; Wu YH, 2010, STEM CELL RES, V4, P180, DOI 10.1016/j.scr.2010.02.003; Yudoh K, 2001, J BONE MINER RES, V16, P1453, DOI 10.1359/jbmr.2001.16.8.1453; Zongaro S, 2005, CANCER RES, V65, P11411, DOI 10.1158/0008-5472.CAN-05-1140; Zuhlke U, 2003, Toxicol Pathol, V31 Suppl, P123, DOI 10.1080/01926230309767	45	6	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204580	10.1371/journal.pone.0204580	http://dx.doi.org/10.1371/journal.pone.0204580			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30261016	Green Submitted, Green Published, gold			2022-12-26	WOS:000445907400071
J	Reichenbach, T; Kalyani, D; Gandini, R; Svartstrom, O; Aspeborg, H; Divne, C				Reichenbach, Tom; Kalyani, Dayanand; Gandini, Rosaria; Svartstrom, Olov; Aspeborg, Henrik; Divne, Christina			Structural and biochemical characterization of the Cutibacterium acnes exo-beta-1,4-mannosidase that targets the N-glycan core of host glycoproteins	PLOS ONE			English	Article							PROPIONIBACTERIUM-ACNES; STREPTOCOCCUS-PNEUMONIAE; PROTEIN GLYCOSYLATION; SUBSTRATE-SPECIFICITY; CATALYTIC MECHANISM; BETA-GALACTOSIDASE; CRYSTAL-STRUCTURE; INSIGHTS; COMPLEX; GENOME	Commensal and pathogenic bacteria have evolved efficient enzymatic pathways to feed on host carbohydrates, including protein-linked glycans. Most proteins of the human innate and adaptive immune system are glycoproteins where the glycan is critical for structural and functional integrity. Besides enabling nutrition, the degradation of host N-glycans serves as a means for bacteria to modulate the host's immune system by for instance removing N-glycans on immunoglobulin G. The commensal bacterium Cutibacterium acnes is a gram-positive natural bacterial species of the human skin microbiota. Under certain circumstances, C. acnes can cause pathogenic conditions, acne vulgaris, which typically affects 80% of adolescents, and can become critical for immunosuppressed transplant patients. Others have shown that C. acnes can degrade certain host O-glycans, however, no degradation pathway for host N-glycans has been proposed. To investigate this, we scanned the C. acnes genome and were able to identify a set of gene candidates consistent with a cytoplasmic N-glycan-degradation pathway of the canonical eukaryotic N-glycan core. We also found additional gene sequences containing secretion signals that are possible candidates for initial trimming on the extracellular side. Furthermore, one of the identified gene products of the cytoplasmic pathway, AEE72695, was produced and characterized, and found to be a functional, dimeric exo-beta-1,4-mannosidase with activity on the beta-1,4 glycosidic bond between the second N-acetylglucosamine and the first mannose residue in the canonical eukaryotic N-glycan core. These findings corroborate our model of the cytoplasmic part of a C. acnes N-glycan degradation pathway.	[Reichenbach, Tom; Kalyani, Dayanand; Gandini, Rosaria; Svartstrom, Olov; Aspeborg, Henrik; Divne, Christina] KTH Royal Inst Technol, Dept Ind Biotechnol, Sch Engn Sci Chem Biotechnol & Hlth CBH, Stockholm, Sweden	Royal Institute of Technology	Divne, C (corresponding author), KTH Royal Inst Technol, Dept Ind Biotechnol, Sch Engn Sci Chem Biotechnol & Hlth CBH, Stockholm, Sweden.	divne@kth.se	Kalyani, Dayanand/AAF-3120-2020	Kalyani, Dayanand/0000-0001-5829-9357; Gandini, Rosaria/0000-0003-4171-0693; Reichenbach, Tom/0000-0001-5156-4592	Swedish Research Council VR (vr.se) [20135717]; Swedish Research Council Formas [20131741, 2012-1513, 2014-176]; European Community's Seventh Framework Programme (FP7/2007-2013) under BioStruct-X [283570, 20151194]; iNEXT [20151194, PID 1678]; European Community's Seventh Framework Programme (FP7/2007 +/- 2013) under BioStruct-X [283570]	Swedish Research Council VR (vr.se)(Swedish Research Council); Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); European Community's Seventh Framework Programme (FP7/2007-2013) under BioStruct-X; iNEXT; European Community's Seventh Framework Programme (FP7/2007 +/- 2013) under BioStruct-X	This work was funded by the Swedish Research Council VR (vr.se) grant numbers 20135717 to C.D., and by the Swedish Research Council Formas (www.formas.se) grant number 20131741 to C.D. and grant numbers 2012-1513 and 2014-176 to H.A. For synchrotron data collection, C.D. also received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under BioStruct-X (grant agreement no 283570), and iNEXT (PID 1678) for data collection at SOLEIL project No. 20151194 (France).; We thank the beamline staff scientists for support during data collection at PROXIMA 1 beamline at SOLEIL synchrotron (France). Part of this work was facilitated by the Protein Science Facility at Karolinska Institutet/SciLifeLab (http://psf. ki. se). The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007 +/- 2013) under BioStruct-X (grant agreement no 283570). Parts of this project received support from iNEXT (PID 1678) for data collection at SOLEIL project No. 20151194 (France).	Achermann Y, 2014, CLIN MICROBIOL REV, V27, P419, DOI 10.1128/CMR.00092-13; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aebi M, 2013, BBA-MOL CELL RES, V1833, P2430, DOI 10.1016/j.bbamcr.2013.04.001; Amaya MF, 2004, STRUCTURE, V12, P775, DOI 10.1016/j.str.2004.02.036; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186; Bek-Thomsen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107908; Bertipaglia C, 2016, EMBO REP, V17, P1044, DOI 10.15252/embr.201541960; Breitling J, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013359; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Bruggemann H, 2004, SCIENCE, V305, P671, DOI 10.1126/science.1100330; Brzuszkiewicz E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021581; Burnaugh AM, 2008, J BACTERIOL, V190, P221, DOI 10.1128/JB.01251-07; Byers HL, 1999, GLYCOBIOLOGY, V9, P469, DOI 10.1093/glycob/9.5.469; Cao YL, 2014, P NATL ACAD SCI USA, V111, P12901, DOI 10.1073/pnas.1407344111; Collin M, 2004, J BIOL CHEM, V279, P22558, DOI 10.1074/jbc.M402156200; Collin M, 2001, INFECT IMMUN, V69, P7187, DOI 10.1128/IAI.69.11.7187-7189.2001; Copley RR, 2001, PROTEIN SCI, V10, P285, DOI 10.1110/ps.31901; Dagnelie MA, 2018, ACTA DERM-VENEREOL, V98, P262, DOI 10.2340/00015555-2847; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dias FMV, 2004, J BIOL CHEM, V279, P25517, DOI 10.1074/jbc.M401647200; Dupoiron S, 2015, J BIOL CHEM, V290, P6022, DOI 10.1074/jbc.M114.624593; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Garbe J, 2012, J INNATE IMMUN, V4, P121, DOI 10.1159/000334775; GASKELL A, 1995, STRUCTURE, V3, P1197, DOI 10.1016/S0969-2126(01)00255-6; Gregg KJ, 2011, J BIOL CHEM, V286, P15586, DOI 10.1074/jbc.M111.223172; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HENRISSAT B, 1995, P NATL ACAD SCI USA, V92, P7090, DOI 10.1073/pnas.92.15.7090; HIRSCHBERG CB, 1987, ANNU REV BIOCHEM, V56, P63, DOI 10.1146/annurev.bi.56.070187.000431; Holland C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-230; Jeong JK, 2009, J BACTERIOL, V191, P3011, DOI 10.1128/JB.01601-08; Jung D, 2004, CELL, V116, P299, DOI 10.1016/S0092-8674(04)00039-X; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KOSHLAND DE, 1953, BIOL REV, V28, P416, DOI 10.1111/j.1469-185X.1953.tb01386.x; Koutsioulis D, 2008, GLYCOBIOLOGY, V18, P799, DOI 10.1093/glycob/cwn069; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Leaver-Fay A, 2016, STRUCTURE, V24, P641, DOI 10.1016/j.str.2016.02.013; Lichtenberger R, 2017, J EUR ACAD DERMATOL, V31, P1978, DOI 10.1111/jdv.14385; Litzinger S, 2010, J BIOL CHEM, V285, P35675, DOI 10.1074/jbc.M110.131037; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lomholt HB, 2017, ANAEROBE, V47, P57, DOI 10.1016/j.anaerobe.2017.04.006; Manfredi P, 2011, MOL MICROBIOL, V81, P1050, DOI 10.1111/j.1365-2958.2011.07750.x; Marcobal A, 2013, GLYCOBIOLOGY, V23, P1038, DOI 10.1093/glycob/cwt040; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Nakatsuji T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001551; Nakayama-Imaohji H, 2012, J MED INVESTIG, V59, P79, DOI 10.2152/jmi.59.79; Nielsen H, 2017, METHODS MOL BIOL, V1611, P59, DOI 10.1007/978-1-4939-7015-5_6; Price MN, 2005, NUCLEIC ACIDS RES, V33, P880, DOI 10.1093/nar/gki232; Renzi F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002118; Robb M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006090; Robb M, 2015, J BIOL CHEM, V290, P30888, DOI 10.1074/jbc.M115.688630; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rojas AL, 2004, J MOL BIOL, V343, P1281, DOI 10.1016/j.jmb.2004.09.012; Scholz CFP, 2016, SCI REP-UK, V6, DOI 10.1038/srep20662; Schroeder HW, 2010, J ALLERGY CLIN IMMUN, V125, pS41, DOI 10.1016/j.jaci.2009.09.046; Shi H, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-83; Sjogren J, 2015, GLYCOBIOLOGY, V25, P1053, DOI 10.1093/glycob/cwv047; Stals I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040854; Stanley P, 2015, ESSENTIALS GLYCOBIOL, P99, DOI DOI 10.1101/GLYCOBIOLOGY.3E.009; Struwe WB, 2012, GLYCOBIOLOGY, V22, P863, DOI 10.1093/glycob/cws053; Suits MDL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009006; Sulzenbacher G, 2004, J BIOL CHEM, V279, P13119, DOI 10.1074/jbc.M313783200; Tailford LE, 2007, J BIOL CHEM, V282, P11291, DOI 10.1074/jbc.M610964200; van Bueren AL, 2010, J AM CHEM SOC, V132, P1804, DOI 10.1021/ja908908q; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Walsh CT, 2005, ANGEW CHEM INT EDIT, V44, P7342, DOI 10.1002/anie.200501023; Wang P, 2017, SCI REP-UK, V7, DOI 10.1038/srep40301; Zhou P, 2014, ACTA CRYSTALLOGR D, V70, P2970, DOI 10.1107/S1399004714019762	71	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204703	10.1371/journal.pone.0204703	http://dx.doi.org/10.1371/journal.pone.0204703			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30261037	gold, Green Published, Green Submitted			2022-12-26	WOS:000445907400093
J	Velickovic, VM; Borisenko, O; Svensson, M; Spelman, T; Siebert, U				Velickovic, Vladica M.; Borisenko, Oleg; Svensson, Mikael; Spelman, Tim; Siebert, Uwe			Congenital heart defect repair with ADAPT tissue engineered pericardium scaffold: An early-stage health economic model	PLOS ONE			English	Article							AORTIC-VALVE-REPLACEMENT; COST-EFFECTIVENESS; BIOMATERIALS ADVANCES; BOVINE PERICARDIUM; DISEASE; PATCH; POPULATION; SURGERY; PREVALENCE; CARDIOCEL	Objective The objective of this study was to evaluate the cost effectiveness of tissue engineered bovine tissue pericardium scaffold (CardioCel) for the repair of congenital heart defects in comparison with surgery using xenogeneic, autologous, and synthetic patches over a 40-year time horizon from the perspective of the UK National Health Service. Methods A six-state Markov state-transition model to model natural history of disease and difference in the interventional effect of surgeries depending on patch type implanted. Patches differed regarding their probability of re-operation due to patch calcification, based on a systematic literature review. Transition probabilities were based on the published literature, other clinical inputs were based on UK registry data, and cost data were based on UK sources and the published literature. Incremental cost-effectiveness ratio (ICER) was determined as incremental costs per quality adjusted life years (QALY) gained. We used a 40-year analytic time-horizon and adopted the payer perspective. Comprehensive sensitivity analyses were performed. Results According to the model predictions, CardioCel was associated with reduced incidence of re-operation, increased QALY, and costs savings compared to all other patches. Cost savings were greatest compared to synthetic patches. Estimated cost savings associated with CardioCel were greatest within atrioventricular septal defect repair and lowest for ventricular septal defect repair. Based on our model, CardioCel relative risk for re-operations is 0.938, 0.956and 0.902 relative to xenogeneic, autologous, and synthetic patches, respectively. Conclusion CardioCel was estimated to increase health benefits and save cost when used during surgery for congenital heart defects instead of other patches.	[Velickovic, Vladica M.; Borisenko, Oleg; Spelman, Tim] Synergus AB, Hlth Econ & Evidence Synth Dept, Stockholm, Sweden; [Velickovic, Vladica M.; Siebert, Uwe] UMIT Univ Hlth Sci Med Informat & Technol, Inst Publ Hlth Med Decis Making & Hlth Technol As, Dept Publ Hlth Hlth Serv Reseaech & Hlth Technol, Hall In Tirol, Austria; [Svensson, Mikael] Univ Gothenburg, Sahlgrenska Acad, Hlth Metr, Gothenburg, Sweden; [Spelman, Tim] Burnet Inst, Ctr Populat Hlth, Melbourne, Australia; [Spelman, Tim] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Australia	UMIT - Private University for Health Sciences, Medical Informatics & Technology GmbH; University of Gothenburg; Burnet Institute; Monash University	Velickovic, VM (corresponding author), Synergus AB, Hlth Econ & Evidence Synth Dept, Stockholm, Sweden.; Velickovic, VM (corresponding author), UMIT Univ Hlth Sci Med Informat & Technol, Inst Publ Hlth Med Decis Making & Hlth Technol As, Dept Publ Hlth Hlth Serv Reseaech & Hlth Technol, Hall In Tirol, Austria.	vladica.velickovic@edu.umit.at	Velickovic, Vladica/AAA-4161-2020; Siebert, Uwe/M-5057-2019; Svensson, Mikael/P-2108-2014	Velickovic, Vladica/0000-0001-7146-1267; Siebert, Uwe/0000-0001-6425-7671; Svensson, Mikael/0000-0003-1113-7478	Admedus Ltd.	Admedus Ltd.	This research was funded by Admedus Ltd. The funders had no role in study design, data collection and analysis, or preparation of the manuscript. Vladica Velickovic, Oleg Borisenko, Mikael Svensson, and Tim Spelman are/were employees of Synergus AB. Synergus AB provided support in the form of salaries for authors VV, OB, MS and TS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alexiou C, 2001, EUR J CARDIO-THORAC, V20, P239, DOI 10.1016/S1010-7940(01)00813-2; [Anonymous], THE GREEN BOOK; [Anonymous], 2016, HRG 4 2015 16 REF CO; Brown KL, 2006, HEART, V92, P1298, DOI 10.1136/hrt.2005.078097; Caro JJ, 2012, MED DECIS MAKING, V32, P667, DOI 10.1177/0272989X12454577; Caviness AC, 2004, PEDIATRICS, V113, P1291, DOI 10.1542/peds.113.5.1291; Dean PN, 2011, PEDIATRICS, V128, pE1181, DOI 10.1542/peds.2010-3742; Fraser CD, 2011, J CARDIOVASC TRANSL, V4, P655, DOI 10.1007/s12265-011-9294-y; Ginde S, 2015, J THORAC CARDIOV SUR, V150, P369, DOI 10.1016/j.jtcvs.2015.05.011; Halpern DG, 2015, CONGENIT HEART DIS, V10, P396, DOI 10.1111/chd.12243; Hoffman JI, 2013, CARDIOVASC J AFR, V24, P141, DOI 10.5830/CVJA-2013-028; Husereau Don, 2013, Cost Eff Resour Alloc, V11, P6, DOI 10.1186/1478-7547-11-6; Kirsch J, 2000, HEALTH ECON, V9, P149, DOI 10.1002/(SICI)1099-1050(200003)9:2<149::AID-HEC501>3.0.CO;2-N; Knowles R, 2005, HEALTH TECHNOL ASSES, V9, P1; Lacour-Gayet F, 2004, EUR J CARDIO-THORAC, V25, P911, DOI 10.1016/j.ejcts.2004.03.027; Lakshmanan R, 2012, EXPERT OPIN BIOL TH, V12, P1623, DOI 10.1517/14712598.2012.721770; Latimer N, 2011, 14 U SCHARR U SHEFF; Majeed A, 2016, PEDIATR DEVEL PATHOL, V19, P383, DOI 10.2350/15-08-1696-OA.1; Mangham LJ, 2009, PEDIATRICS, V123, pE312, DOI 10.1542/peds.2008-1827; Marelli AJ, 2014, CIRCULATION, V130, P749, DOI 10.1161/CIRCULATIONAHA.113.008396; Mirensky TL, 2008, PEDIATR RES, V63, P559, DOI 10.1203/01.pdr.0000305938.92695.b9; Mistry H, 2013, J TELEMED TELECARE, V19, P190, DOI 10.1258/jtt.2012.120418; Monro JL, 2003, J THORAC CARDIOV SUR, V126, P511, DOI 10.1016/S0022-5223(03)00115-6; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Neethling WML, 2013, INTERACT CARDIOV TH, V17, P698, DOI 10.1093/icvts/ivt268; Nieminen HP, 2007, J AM COLL CARDIOL, V50, P1263, DOI 10.1016/j.jacc.2007.05.040; Nordmeyer S, 2015, 46 ANN M GERM SOC TH, DOI [10.1055/s-0035-1544410, DOI 10.1055/S-0035-1544410]; Odim J, 2005, ANN THORAC SURG, V80, P647, DOI 10.1016/j.athoracsur.2005.03.060; Orlando R, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17330; Pagel C, 2013, MORTALITY RISK MODEL; Peterson C, 2013, PEDIATRICS, V132, pE595, DOI 10.1542/peds.2013-0332; Pok S, 2011, J CARDIOVASC TRANSL, V4, P646, DOI 10.1007/s12265-011-9289-8; Prabhu S, 2017, SEMIN THORAC CARDIOV, V29, P356, DOI 10.1053/j.semtcvs.2017.05.017; Puvimanasinghe JPA, 2004, HEART, V90, P1172, DOI 10.1136/hrt.2003.013102; Roche SL, 2013, CAN J CARDIOL, V29, P841, DOI 10.1016/j.cjca.2013.03.021; Sakurai T, 2012, INTERACT CARDIOV TH, V15, P865, DOI 10.1093/icvts/ivs265; Schoof PH, 1998, J HEART VALVE DIS, V7, P407; Siebert U, 2003, J HLTH EC, V4, P143, DOI DOI 10.1007/S10198-003-0205-2]; Siebert U, 2012, MED DECIS MAKING, V32, P690, DOI 10.1177/0272989X12455463; Sobieraj M, 2016, KARDIOCHIR TORAKOCHI, V13, P210, DOI 10.5114/kitp.2016.62607; Statistics OfN, 2017, NAT LIF TABL UK; Strange G, 2015, EXPERT REV MED DEVIC, V12, P135, DOI 10.1586/17434440.2015.985651; Tutarel O, 2014, EUR HEART J, V35, P725, DOI 10.1093/eurheartj/eht257; Us MH, 2004, J INT MED RES, V32, P218, DOI 10.1177/147323000403200216; van der Linde D, 2011, J AM COLL CARDIOL, V58, P2241, DOI 10.1016/j.jacc.2011.08.025; van Geldorp MWA, 2007, J THORAC CARDIOV SUR, V134, P702, DOI 10.1016/j.jtcvs.2007.03.051; Walther T, 2003, EUR J CARDIO-THORAC, V23, P246, DOI 10.1016/S1010-7940(02)00748-0; Yount LE, 2004, PEDIATRICS, V114, P1606, DOI 10.1542/peds.2004-0224	48	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204643	10.1371/journal.pone.0204643	http://dx.doi.org/10.1371/journal.pone.0204643			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30261033	Green Published, gold, Green Submitted			2022-12-26	WOS:000445907400083
J	Carrillo-Campos, J; Riveros-Rosas, H; Rodriguez-Satres, R; Munoz-Clares, RA				Carrillo-Campos, Javier; Riveros-Rosas, Hector; Rodriguez-Satres, Rogelio; Munoz-Clares, Rosario A.			Bona fide choline monoxygenases evolved in Amaranthaceae plants from oxygenases of unknown function: Evidence from phylogenetics, homology modeling and docking studies	PLOS ONE			English	Article							GLYCINE BETAINE SYNTHESIS; HORIZONTAL GENE-TRANSFER; ALDEHYDE DEHYDROGENASE; PROTEIN EVOLUTION; MONOOXYGENASE; STRESS; BINDING; OSMOPROTECTANTS; DETERMINANTS; SPECIFICITY	Few land plants can synthesize and accumulate the osmoprotectant glycine betaine (GB) even though this metabolic trait has major adaptive importance given the prevalence of drought, hypersaline soils or cold. GB is synthesized from choline in two reactions catalyzed by choline monooxygenases (CMOs) and enzymes of the family 10 of aldehyde dehydrogenases (ALDH10s) that gained betaine aldehyde dehydrogenase activity (BADH). Homolog genes encoding CMO and ALDH10 enzymes are present in all known land plant genomes, but since GB-non-accumulators plants lack the BADH-type ALDH10 isozyme, they would be expected to also lack the CMO activity to avoid accumulation of the toxic betaine aldehyde. To explore CMOs substrate specificity, we performed amino acid sequence alignments, phylogenetic analysis, homology modeling and docking simulations. We found that plant CMOs form a monophyletic subfamily within the Rieske/mononuclear non-heme oxygenases family with two clades: CMO1 and CMO2, the latter diverging from CMO1 after gene duplication. CMO1 enzymes are present in all plants; CMO2s only in the Amaranthaceae high-GB-accumulators plants. CMO2s, and particularly their mononuclear non-heme iron domain where the active site is located, evolved at a faster rate than CMO1s, which suggests positive selection. The homology model and docking simulations of the spinach CMO2 enzyme showed at the active site three aromatic residues forming a box with which the trimethylammonium group of choline could interact through cation-pi interactions, and a glutamate, which also may interact with the trimethylammonium group through a charge-charge interaction. The aromatic box and the carboxylate have been shown to be critical for choline binding in other proteins. Interestingly, these residues are conserved in CMO2 proteins but not in CMO1 proteins, where two of these aromatic residues are leucine and the glutamate is asparagine. These findings reinforce our proposal that the CMO1s physiological substrate is not choline but a still unknown metabolite.	[Carrillo-Campos, Javier; Rodriguez-Satres, Rogelio; Munoz-Clares, Rosario A.] Univ Nacl Autonoma Mexico, Fac Quim, Dept Bioquim, Ciudad De Mexico, Mexico; [Riveros-Rosas, Hector] Univ Nacl Autonoma Mexico, Fac Med, Dept Bioquim, Ciudad De Mexico, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Munoz-Clares, RA (corresponding author), Univ Nacl Autonoma Mexico, Fac Quim, Dept Bioquim, Ciudad De Mexico, Mexico.	clares@unam.mx	Rodriguez-Sotres, Rogelio/A-3381-2008; Riveros-Rosas, Hector/B-6607-2008; Riveros-Rosas, Hector/ABD-6638-2020	Rodriguez-Sotres, Rogelio/0000-0002-9443-3207; Riveros-Rosas, Hector/0000-0003-0194-2537; Riveros-Rosas, Hector/0000-0003-0194-2537; Carrillo-Campos, Javier/0000-0001-7125-1948; Munoz-Clares, Rosario A./0000-0002-0115-3565	DGAPA-UNAM PAPIIT [IN217814, IN220317, IN225016]; CONACYT; PASPA-DGAPA, UNAM program;  [LANCAD-UNAM-DGTIC-215]	DGAPA-UNAM PAPIIT(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); PASPA-DGAPA, UNAM program; 	This work was supported by DGAPA-UNAM PAPIIT grants (IN217814 and IN220317 to RAMC, IN225016 to HRR) and LANCAD-UNAM-DGTIC-215 to RRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by DGAPA-UNAM PAPIIT grants (IN217814 and IN220317 to RAMC, IN225016 to HRR) and LANCAD-UNAM-DGTIC-215 to RRS. JCC is a student of the Biochemical Sciences Graduate Program at UNAM and a recipient of a CONACYT doctoral scholarship. HRR was supported by PASPA-DGAPA, UNAM program.	Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bock R, 2010, TRENDS PLANT SCI, V15, P11, DOI 10.1016/j.tplants.2009.10.001; Boratyn GM, 2013, NUCLEIC ACIDS RES, V41, pW29, DOI 10.1093/nar/gkt282; BOYER JS, 1982, SCIENCE, V218, P443, DOI 10.1126/science.218.4571.443; BROUQUISSE R, 1989, PLANT PHYSIOL, V90, P322, DOI 10.1104/pp.90.1.322; BURNET M, 1995, PLANT PHYSIOL, V108, P581, DOI 10.1104/pp.108.2.581; Case D. A., 2016, AMBER 2016; Castiglioni P, 2018, PLANT DIRECT, V2, DOI 10.1002/pld3.40; Chen THH, 2011, PLANT CELL ENVIRON, V34, P1, DOI 10.1111/j.1365-3040.2010.02232.x; Clares RA, 2014, BMC PLANT BIOL, V14, P1, DOI [10.1186/1471-2229-14-1, DOI 10.1186/1471-2229-14-1]; Clarke M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-r11; Courtenay ES, 2000, BIOCHEMISTRY-US, V39, P4455, DOI 10.1021/bi992887l; Craig SAS, 2004, AM J CLIN NUTR, V80, P539; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Diaz-Sanchez AG, 2012, PLANT PHYSIOL, V158, P1570, DOI 10.1104/pp.112.194514; Dosztanyi Z, 2018, PROTEIN SCI, V27, P331, DOI 10.1002/pro.3334; Edler E, 2014, EUR J INORG CHEM, P3587, DOI 10.1002/ejic.201402295; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Figueira Thais Rezende e Silva, 2012, BMC Res Notes, V5, P185, DOI 10.1186/1756-0500-5-185; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hibino T, 2002, J BIOL CHEM, V277, P41352, DOI 10.1074/jbc.M205965200; Hibino T, 2001, PLANT MOL BIOL, V45, P353, DOI 10.1023/A:1006497113323; Horn C, 2006, J MOL BIOL, V357, P592, DOI 10.1016/j.jmb.2005.12.085; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; James LC, 2003, TRENDS BIOCHEM SCI, V28, P361, DOI 10.1016/S0968-0004(03)00135-X; Joseph S, 2013, BIOLOGIA, V68, P879, DOI 10.2478/s11756-013-0229-8; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li Qiuli, 2007, Journal of Genetics and Genomics, V34, P355, DOI 10.1016/S1673-8527(07)60038-1; Linder T, 2014, MICROBIOL-SGM, V160, P929, DOI 10.1099/mic.0.073932-0; Luo D, 2007, NEW PHYTOL, V175, P439, DOI 10.1111/j.1469-8137.2007.02124.x; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; Martinez-Castilla LP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012483; McNeil SD, 1999, PLANT PHYSIOL, V120, P945, DOI 10.1104/pp.120.4.945; Mitra D, 2013, J AM CHEM SOC, V135, P2530, DOI 10.1021/ja307027n; Mitsuya S, 2011, PLANTA, V234, P1215, DOI 10.1007/s00425-011-1478-9; NAYLOR JF, 1968, J BIOL CHEM, V243, P341; Oswald C, 2008, J BIOL CHEM, V283, P32848, DOI 10.1074/jbc.M806021200; PAPAGEORGIOU GC, 1995, PHOTOSYNTH RES, V44, P243, DOI 10.1007/BF00048597; Parales RE, 1999, J BACTERIOL, V181, P1831, DOI 10.1128/JB.181.6.1831-1837.1999; Park J, 2009, PLANT SCI, V176, P616, DOI 10.1016/j.plantsci.2009.01.014; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rathinasabapathi B, 1997, P NATL ACAD SCI USA, V94, P3454, DOI 10.1073/pnas.94.7.3454; RATHINASABAPATHI B, 1994, PLANTA, V193, P155, DOI 10.1007/BF00192524; Ratriyanto A, 2009, ASIAN AUSTRAL J ANIM, V22, P1461, DOI 10.5713/ajas.2009.80659; RHODES D, 1993, ANNU REV PLANT PHYS, V44, P357, DOI 10.1146/annurev.pp.44.060193.002041; Richardson AO, 2007, J EXP BOT, V58, P1, DOI 10.1093/jxb/erl148; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Russell BL, 1998, PLANT PHYSIOL, V116, P859, DOI 10.1104/pp.116.2.859; Schiefner A, 2004, J BIOL CHEM, V279, P5588, DOI 10.1074/jbc.M309771200; Schmidt CL, 2001, J BIOENERG BIOMEMBR, V33, P9, DOI 10.1023/A:1005616505962; Solovyev V, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s10; Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529; Vasiliou V, 1999, PHARMACOGENETICS, V9, P421, DOI 10.1097/00008571-199910000-00004; Weinhold F., 1988, STRUCTURE SMALL MOL, P227, DOI DOI 10.1007/978-1-4684-7424-4_24; WERETILNYK EA, 1989, PLANTA, V178, P342, DOI 10.1007/BF00391862; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124	62	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2018	13	9							e0204711	10.1371/journal.pone.0204711	http://dx.doi.org/10.1371/journal.pone.0204711			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3NB	30256846	Green Published, gold, Green Submitted			2022-12-26	WOS:000446000200061
J	Faccin, TC; Cargnelutti, JF; Rodrigues, FD; de Menezes, FR; Piazer, JVM; de Melo, SMP; Lautert, BF; Flores, EF; Kommers, GD				Faccin, Tatiane Cargnin; Cargnelutti, Juliana Felipetto; Rodrigues, Fernando de Souza; de Menezes, Fernanda Rezer; Piazer, Jose Vitor Marcon; Pereira de Melo, Stella Maris; Lautert, Betina Fabis; Flores, Eduardo Furtado; Kommers, Glaucia Denise			Bovine upper alimentary squamous cell carcinoma associated with bracken fern poisoning: Clinical-pathological aspects and etiopathogenesis of 100 cases	PLOS ONE			English	Article							PAPILLOMAVIRUS TYPE-4; GROWTH-PATTERN; ORAL-CAVITY; CATTLE; CANCER; THICKNESS; PAPILLOMATOSIS; METASTASIS; MALIGNANCY; SHAPE	Upper digestive tract (UDT) cancer is rare in cattle, however in Southern Brazil, the UDT squamous cell carcinomas (SCCs) are relatively common and have been associated with bracken fern consumption and the presence of papillomas. Although a theory of pathogenesis considers bovine papillomavirus type 4 (BPV-4) as a cofactor in the development of these SCCs, some aspects of the etiopathogenesis of this disease need to be more investigated. In fact, detection of BPV-4 in UDT papillomas is scarce in other regions of the world and has not been performed in Brazil. Therefore, this study had two aims: 1) to analyze the epidemiological, clinical and pathological aspects of 100 natural cases of SCCs in the UDT of cattle grazing on bracken fern (Pteridium arachnoideum) highly contaminated areas, investigating the associations between these parameters; and 2) to investigate the presence of papillomavirus DNA by polymerase chain reaction (PCR) in the UDT papillomas (n = 47) from 30 cattle that also had UDT SCCs. There were statistically significant associations between clinical signs and tumor localization in the UDT; between histological grade of differentiation and tumor localization; and a trend towards significant association between histological grade of differentiation and presence of metastases. The average age of cattle with oropharyngeal SCCs was 7.39 years, with statistically significant difference comparing to cattle with esophageal SCCs (8.6 years). No statistical association was observed among other clinical-pathological parameters (growth pattern and primary site of the tumor) analyzed. No BPV DNA was detected in papillomas by PCR. Therefore, these results suggest the possibility that papillomas of the UDT are not necessarily associated with BPV infection.	[Faccin, Tatiane Cargnin; Pereira de Melo, Stella Maris; Lautert, Betina Fabis; Kommers, Glaucia Denise] Univ Fed Santa Maria, Dept Patol, Santa Maria, RS, Brazil; [Cargnelutti, Juliana Felipetto; Rodrigues, Fernando de Souza; Flores, Eduardo Furtado] Univ Fed Santa Maria, Dept Med Vet Prevent, Santa Maria, RS, Brazil; [de Menezes, Fernanda Rezer] Inst Fed Farroupilha, Sao Vicente Do Sul, RS, Brazil; [Piazer, Jose Vitor Marcon] Inspetoria Vet Jaguari, Jaguari, RS, Brazil	Universidade Federal de Santa Maria (UFSM); Universidade Federal de Santa Maria (UFSM); Instituto Federal Farroupilha	Kommers, GD (corresponding author), Univ Fed Santa Maria, Dept Patol, Santa Maria, RS, Brazil.	glaukommers@yahoo.com	Cargnelutti, Juliana Felipetto/L-5023-2015	Cargnelutti, Juliana Felipetto/0000-0002-3160-3643	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil [424768/ 2016-0]; CNPq [307963/2016-0]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); CNPq	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; Grant # 424768/ 2016-0), Brazil. G. D. Kommers (PQ-2 # 307963/2016-0) and E. F. Flores have a fellowship from CNPq, T. C. Faccin and J. F. Cargnelutti have a scholarship from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and S. M. P. Melo and B. F. Lautert have a scholarship from CNPq.	Borzacchiello G, 2003, J COMP PATHOL, V128, P203, DOI 10.1053/jcpa.2002.0626; CAMPO MS, 1994, CARCINOGENESIS, V15, P1597, DOI 10.1093/carcin/15.8.1597; CAMPO MS, 1985, EMBO J, V4, P1819, DOI 10.1002/j.1460-2075.1985.tb03856.x; CAMPO MS, 1980, NATURE, V286, P180, DOI 10.1038/286180a0; Canto MT, 2002, ORAL ONCOL, V38, P610, DOI 10.1016/S1368-8375(01)00109-9; DUNCAN JR, 1975, CORNELL VET, V65, P205; Eslami A, 2015, BRIT J CANCER, V112, P338, DOI 10.1038/bjc.2014.590; Faccin TC, 2017, J COMP PATHOL, V157, P174, DOI 10.1016/j.jcpa.2017.07.008; FENWICK GR, 1989, J SCI FOOD AGR, V46, P147, DOI 10.1002/jsfa.2740460204; Forslund O, 1999, J GEN VIROL, V80, P2437, DOI 10.1099/0022-1317-80-9-2437; Franceschi S, 2000, ORAL ONCOL, V36, P106, DOI 10.1016/S1368-8375(99)00070-6; Genden EM, 2003, ORAL ONCOL, V39, P207, DOI 10.1016/S1368-8375(02)00049-0; Goldschmidt M. H., 2017, Tumors in domestic animals, P88; Gonzalez-Moles MA, 2002, ORAL ONCOL, V38, P394, DOI 10.1016/S1368-8375(01)00081-1; HIRONO I, 1973, J NATL CANCER I, V50, P1367, DOI 10.1093/jnci/50.5.1367; JARRETT WFH, 1978, NATURE, V274, P215, DOI 10.1038/274215a0; Johnson N, 2005, PATHOLOGY GENETICS H, V1st, P168; KIRITA T, 1994, J ORAL MAXIL SURG, V52, P149, DOI 10.1016/0278-2391(94)90398-0; Lucena RB, 2011, J COMP PATHOL, V145, P20, DOI 10.1016/j.jcpa.2010.11.002; Martin CK, 2011, VET PATHOL, V48, P302, DOI 10.1177/0300985810384414; Masuda EK, 2011, J COMP PATHOL, V144, P48, DOI 10.1016/j.jcpa.2010.04.009; Masuda EK, 2011, PESQUISA VET BRASIL, V31, P383, DOI 10.1590/S0100-736X2011000500004; Masuda EK, 2010, THESIS; Munday J. S., 2017, Tumors in domestic animals, P499; Munday JS, 2014, VET PATHOL, V51, P1063, DOI 10.1177/0300985814537837; Nemec A, 2012, J COMP PATHOL, V147, P111, DOI 10.1016/j.jcpa.2011.11.198; O-charoenrat P, 2003, ORAL ONCOL, V39, P386, DOI 10.1016/S1368-8375(02)00142-2; Sato J, 2010, ODONTOLOGY, V98, P60, DOI 10.1007/s10266-009-0107-6; Shintani S, 1997, ONCOLOGY, V54, P463; Souto MAM, 2006, PESQUI VET BRASIL, V26, P112, DOI 10.1590/S0100-736X2006000200009; STEBBINS KE, 1989, VET PATHOL, V26, P121, DOI 10.1177/030098588902600204; Tokarnia C. H., 1969, Pesquisa Agropecuaria Brasileira, V4, P209; Tokarnia C.H., 2012, PLANTAS TOXICAS BRAS; Uzal F.A., 2016, JUBB KENNEDY PALMERS, V2, P6, DOI DOI 10.1016/B978-0-7020-5318-4.00007-3>; Yuen APW, 2002, HEAD NECK-J SCI SPEC, V24, P513, DOI 10.1002/hed.10094	35	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2018	13	9							e0204656	10.1371/journal.pone.0204656	http://dx.doi.org/10.1371/journal.pone.0204656			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3NB	30256853	Green Published, Green Submitted, gold			2022-12-26	WOS:000446000200058
J	Hayashi, M; Keyamura, K; Hishida, T				Hayashi, Masafumi; Keyamura, Kenji; Hishida, Takashi			Cyclin-dependent kinase modulates budding yeast Rad5 stability during cell cycle	PLOS ONE			English	Article							DNA-DAMAGE TOLERANCE; CHROMOSOME-REPLICATION; PHYSICAL INTERACTION; INDUCED MUTAGENESIS; GLOBAL ANALYSIS; UBIQUITIN; REPAIR; PHOSPHORYLATION; PCNA; BYPASS	The DNA damage tolerance (DDT) pathway facilitates the bypass of the fork-blocking lesions without removing them through either translesion DNA synthesis or error-free damage bypass mechanism. The Saccharomyces cerevisiae Rad5 is a multi-functional protein involved in the error-free branch of the DDT pathway, and its protein level periodically fluctuates through the cell cycle; however, the mechanistic basis and functional importance of the Rad5 level for the cell cycle regulation remain unclear. Here, we show that Rad5 is predominantly phosphorylated on serine 130 (S130) during S/G2 phase and that this modification depends on the cyclin-dependent kinase Cdc28/CDK1. We also show that the phosphorylated Rad5 species at S130 exhibit a relatively short half-life compared with non-phosphorylated Rad5 moiety, and that the Rad5 protein is partially stabilized in phosphorylation-defective rad5 S130A cells. Importantly, the elimination of this modification results in a defective cell-cycle dependent Rad5 oscillation pattern. Together, our results demonstrate that CDK1 modulates Rad5 stability by phosphorylation during the cell cycle, suggesting a crosstalk between the phosphorylation and degradation of Rad5.	[Hayashi, Masafumi; Keyamura, Kenji; Hishida, Takashi] Gakushuin Univ, Grad Sch Sci, Dept Life Sci, Tokyo, Japan	Gakushuin University	Hishida, T (corresponding author), Gakushuin Univ, Grad Sch Sci, Dept Life Sci, Tokyo, Japan.	takashi.hishida@gakushuin.ac.jp		Hishida, Takashi/0000-0002-9752-6599	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [23114007]	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was funded by grants-in-aid for Scientific Research (23114007) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan to TH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Amberg DC., 2005, METHODS YEAST GENETI; Ortiz-Bazan MA, 2014, CELL REP, V9, P460, DOI 10.1016/j.celrep.2014.09.005; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Blastyak A, 2007, MOL CELL, V28, P167, DOI 10.1016/j.molcel.2007.07.030; Boiteux S, 2013, GENETICS, V193, P1025, DOI 10.1534/genetics.112.145219; Bonner JN, 2016, GENES-BASEL, V7, DOI 10.3390/genes7080048; Branzei D, 2011, FEBS LETT, V585, P2810, DOI 10.1016/j.febslet.2011.04.053; Branzei D, 2008, NATURE, V456, P915, DOI 10.1038/nature07587; Choi KY, 2015, NUCLEIC ACIDS RES, V43, P2666, DOI 10.1093/nar/gkv004; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Hammet A, 2002, J BIOL CHEM, V277, P22469, DOI 10.1074/jbc.M202473200; Haruta N, 2012, NUCLEIC ACIDS RES, V40, P8406, DOI 10.1093/nar/gks580; Hishida T, 2002, EMBO J, V21, P2019, DOI 10.1093/emboj/21.8.2019; Hishida T, 2006, MOL CELL BIOL, V26, P5509, DOI 10.1128/MCB.00307-06; Hishida T, 2009, NATURE, V457, P612, DOI 10.1038/nature07580; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Masuda Y, 2012, NUCLEIC ACIDS RES, V40, P10394, DOI 10.1093/nar/gks763; Minca EC, 2010, MOL CELL, V38, P649, DOI 10.1016/j.molcel.2010.03.020; Parker JL, 2009, EMBO J, V28, P3657, DOI 10.1038/emboj.2009.303; Prado F., 2014, MOL CELLULAR ONCOLOG, P1; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Saugar I, 2014, EXP CELL RES, V329, P170, DOI 10.1016/j.yexcr.2014.07.009; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Swaney DL, 2013, NAT METHODS, V10, P676, DOI [10.1038/NMETH.2519, 10.1038/nmeth.2519]; Ulrich HD, 2011, FEBS LETT, V585, P2861, DOI 10.1016/j.febslet.2011.05.028; Unk I, 2010, DNA REPAIR, V9, P257, DOI 10.1016/j.dnarep.2009.12.013; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; Xu X, 2016, NUCLEIC ACIDS RES, V44, P5231, DOI 10.1093/nar/gkw183	33	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2018	13	9							e0204680	10.1371/journal.pone.0204680	http://dx.doi.org/10.1371/journal.pone.0204680			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3NB	30256854	Green Published, gold, Green Submitted			2022-12-26	WOS:000446000200060
J	Novak, P				Novak, Peter			Hypocapnic cerebral hypoperfusion: A biomarker of orthostatic intolerance	PLOS ONE			English	Article							POSTURAL TACHYCARDIA SYNDROME; HYPERVENTILATION SYNDROME; BLOOD-FLOW; NEUROPATHY; SYMPTOMS; SYNCOPE; TILT	The objective of the study was to identify markers of hypocapnic cerebral hypoperfusion (HYCH) in patients with orthostatic intolerance (OI) without tachycardia and without orthostatic hypotension. This single center, retrospective study included OI patients referred for autonomic evaluation with the 10 min tilt test. Heart rate, end-tidal CO2 (ET-CO2), blood pressure, and cerebral blood flow velocity (CBFv) from middle cerebral artery were monitored. HYCH was defined by: (1) Symptoms of OI; (2) Orthostatic hypocapnia (low ET-CO2); (3) Abnormal decline in orthostatic CBFv due to hypocapnia; 4) Absence of tachycardia, orthostatic hypotension, or other causes of low CBFv or hypocapnia. Sixteen subjects met HYCH criteria (15/1 women/men, age 38.5 +/- 8.0 years) and were matched by age and gender to postural tachycardia patients (POTS, n = 16) and healthy controls (n = 16). During the tilt, CBFv decreased more in HYCH (-22.4 +/- 7.7%, p<0.0001) and POTS (-19.0 +/- 10.3%, p<0.0001) compared to controls (-3.0 +/- 5.0%). Orthostatic ET-CO2 was lower in HYCH (26.4 +/- 4.2 (mmHg), p<0.0001) and POTS (28.6 +/- 4.3, p<0.0001) compared to controls (36.9 +/- 2.1 mmHg). Orthostatic heart rate was normal in HYCH (89.0 +/- 10.9 (BPM), p<0.08) and controls (80.8 +/- 11.2), but was higher in POTS (123.7 +/- 11.2, p<0.0001). Blood pressure was normal and similar in all groups. It is concluded that both HYCH and POTS patients have comparable decrease in CBFv which is due to vasoconstrictive effect of hypocapnia. Blood flow velocity monitoring can provide an objective biomarker for HYCH in OI patients without tachycardia.	[Novak, Peter] Brigham & Womens Faulkner Hosp, Dept Neurol, Boston, MA 02130 USA		Novak, P (corresponding author), Brigham & Womens Faulkner Hosp, Dept Neurol, Boston, MA 02130 USA.	pnovak2@bwh.harvard.edu			Department of Neurology, University of Massachusetts Medical School; Department of Neurology, Brigham and Women's Faulkner Hospital, Harvard Medical School	Department of Neurology, University of Massachusetts Medical School; Department of Neurology, Brigham and Women's Faulkner Hospital, Harvard Medical School	Study Funded by Department of Neurology, University of Massachusetts Medical School and Department of Neurology, Brigham and Women's Faulkner Hospital, Harvard Medical School.	Bastyr EJ, 2005, CLIN THER, V27, P1278, DOI 10.1016/j.clinthera.2005.08.002; Benarroch EE, 2012, MAYO CLIN PROC, V87, P1214, DOI 10.1016/j.mayocp.2012.08.013; Bhave G, 2011, AM J KIDNEY DIS, V58, P302, DOI 10.1053/j.ajkd.2011.02.395; Del Pozzi AT, 2014, HYPERTENSION, V63, P1302, DOI 10.1161/HYPERTENSIONAHA.113.02824; Garland EM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0583-8; Hornsveld H, 1997, NETH J MED, V50, P13, DOI 10.1016/S0300-2977(96)00080-0; Immink RV, 2014, J APPL PHYSIOL, V116, P844, DOI 10.1152/japplphysiol.00637.2013; Laffey JG, 2002, NEW ENGL J MED, V347, P43, DOI 10.1056/NEJMra012457; LOW PA, 1993, MAYO CLIN PROC, V68, P748, DOI 10.1016/S0025-6196(12)60631-4; Low PA, 2009, J CARDIOVASC ELECTR, V20, P352, DOI 10.1111/j.1540-8167.2008.01407.x; Malmberg LP, 2000, THORAX, V55, P295, DOI 10.1136/thorax.55.4.295; MATALON SV, 1979, J APPL PHYSIOL, V47, P503, DOI 10.1152/jappl.1979.47.3.503; Medow MS, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00234; Mehta JH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180187; Naschitz JE, 2006, AM J MED SCI, V331, P295, DOI 10.1097/00000441-200606000-00001; Natelson Benjamin H, 2007, Dyn Med, V6, P2, DOI 10.1186/1476-5918-6-2; Novak, 2015, J NEUROL DISORD, V3, P11; Novak P, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00022; Novak P, 2011, JOVE-J VIS EXP, DOI 10.3791/2502; Novak P, 2011, NEUROLOGY, V76, P2010, DOI 10.1212/WNL.0b013e31821e5563; Novak V, 1998, STROKE, V29, P1876, DOI 10.1161/01.STR.29.9.1876; Ocon AJ, 2009, AM J PHYSIOL-HEART C, V297, pH664, DOI 10.1152/ajpheart.00138.2009; Parsaik A, 2012, NEUROLOGY, V79, P1435, DOI 10.1212/WNL.0b013e31826d5f95; RABARY O, 1994, ANN FR ANESTH, V13, P111, DOI 10.1016/S0750-7658(94)80194-0; Schuchmann S, 2006, NAT MED, V12, P817, DOI 10.1038/nm1422; Serrador JM, 2000, STROKE, V31, P1672, DOI 10.1161/01.STR.31.7.1672; Stewart JM, 2013, PEDIATRICS, V131, P968, DOI 10.1542/peds.2012-2610; Zilliox L, 2011, NEUROLOGY, V76, P1099, DOI 10.1212/WNL.0b013e3182120147	28	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2018	13	9							e0204419	10.1371/journal.pone.0204419	http://dx.doi.org/10.1371/journal.pone.0204419			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3NB	30256820	Green Submitted, Green Published, gold			2022-12-26	WOS:000446000200045
J	Reiman, JM; Das, B; Sindberg, GM; Urban, MD; Hammerlund, MEM; Lee, HB; Spring, KM; Lyman-Gingerich, J; Generous, AR; Koep, TH; Ewing, K; Lilja, P; Enders, FT; Ekker, SC; Huskins, WC; Fadel, HJ; Pierret, C				Reiman, Jennifer M.; Das, Biswadeep; Sindberg, Gregory M.; Urban, Mark D.; Hammerlund, Madeleine E. M.; Lee, Han B.; Spring, Katie M.; Lyman-Gingerich, Jamie; Generous, Alex R.; Koep, Tyler H.; Ewing, Kevin; Lilja, Phil; Enders, Felicity T.; Ekker, Stephen C.; Huskins, W. Charles; Fadel, Hind J.; Pierret, Chris			Humidity as a non-pharmaceutical intervention for influenza A	PLOS ONE			English	Article							VIRUS; SURVIVAL; TRANSMISSION; SEASONALITY; INFECTIONS; SIZE	Influenza is a global problem infecting 5-10% of adults and 20-30% of children annually. Non-pharmaceutical interventions (NPIs) are attractive approaches to complement vaccination in the prevention and reduction of influenza. Strong cyclical reduction of absolute humidity has been associated with influenza outbreaks in temperate climates. This study tested the hypothesis that raising absolute humidity above seasonal lows would impact influenza virus survival and transmission in a key source of influenza virus distribution, a community school. Air samples and objects handled by students (e.g. blocks and markers) were collected from preschool classrooms. All samples were processed and PCR used to determine the presence of influenza virus and its amount. Additionally samples were tested for their ability to infect cells in cultures. We observed a significant reduction (p < 0.05) in the total number of influenza A virus positive samples (air and fomite) and viral genome copies upon humidification as compared to control rooms. This suggests the future potential of artificial humidification as a possible strategy to control influenza outbreaks in temperate climates. There were 2.3 times as many ILI cases in the control rooms compared to the humidified rooms, and whether there is a causal relationship, and its direction between the number of cases and levels of influenza virus in the rooms is not known. Additional research is required, but this is the first prospective study suggesting that exogenous humidification could serve as a scalable NPI for influenza or other viral outbreaks.	[Reiman, Jennifer M.; Das, Biswadeep; Sindberg, Gregory M.; Hammerlund, Madeleine E. M.; Ekker, Stephen C.; Huskins, W. Charles; Pierret, Chris] Mayo Clin, Ctr Clin & Translat Sci, Rochester, MN 55905 USA; [Das, Biswadeep] KIIT Univ, Sch Biotechnol, Bhubaneswar, India; [Urban, Mark D.; Ekker, Stephen C.; Pierret, Chris] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Lee, Han B.] Mayo Clin, Neurobiol Dis Grad Program, Rochester, MN USA; [Spring, Katie M.] Mayo Clin, Dept Mol Med, Rochester, MN USA; [Lyman-Gingerich, Jamie] Univ Wisconsin Eau Claire, Dept Biol, Eau Claire, WI USA; [Generous, Alex R.] Mayo Clin, Virol & Gene Therapy Grad Program, Rochester, MN USA; [Koep, Tyler H.] Univ Minnesota, Dept Biol Teaching & Learning, St Paul, MN 55108 USA; [Ewing, Kevin] Aldrich Mem Nursery Sch, Rochester, MN USA; [Lilja, Phil] DriSteem, Eden Prairie, MN USA; [Enders, Felicity T.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Huskins, W. Charles; Pierret, Chris] Mayo Clin, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA; [Fadel, Hind J.] Mayo Clin, Dept Infect Dis, Rochester, MN USA	Mayo Clinic; Kalinga Institute of Industrial Technology (KIIT); Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Wisconsin System; University of Wisconsin Eau Claire; Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities; Mayo Clinic; Mayo Clinic; Mayo Clinic	Pierret, C (corresponding author), Mayo Clin, Ctr Clin & Translat Sci, Rochester, MN 55905 USA.; Pierret, C (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.; Pierret, C (corresponding author), Mayo Clin, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA.	Pierret.Christopher@mayo.edu	Das, Biswadeep/AAX-5120-2020	Das, Biswadeep/0000-0001-8214-3600; Ekker, Stephen/0000-0003-0726-4212; Lee, Han/0000-0002-6633-966X; Reiman, Jennifer/0000-0002-3888-8135; Sindberg, Greg/0000-0002-4773-0305	Mayo Clinic; National Center for Advancing Translational Sciences [UL1 TR002377]; DriSteem; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002377] Funding Source: NIH RePORTER	Mayo Clinic; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); DriSteem; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the Mayo Clinic to WCH and HJF and the National Center for Advancing Translational Sciences grant no. UL1 TR002377 to CP. DriSteem provided the materials (two commercial humidifiers, DriSteem Model XTR), and covered their installation at Aldrich Memorial Preschool. The funder [DriSteem] provided support in the form of salaries for authors [PL], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2015, MINNESOTA DEP HLTH W; [Anonymous], 2016, MINNESOTA DEP HLTH W; BEAN B, 1982, J INFECT DIS, V146, P47, DOI 10.1093/infdis/146.1.47; Blachere FM, 2007, INFLUENZA OTHER RESP, V1, P113, DOI 10.1111/j.1750-2659.2007.00020.x; Brownstein JS, 2008, ANN EMERG MED, V52, P63, DOI 10.1016/j.annemergmed.2008.02.009; Campbell CE, 2007, BIOSENS BIOELECTRON, V23, P536, DOI 10.1016/j.bios.2007.06.015; COX CS, 1989, SCI PROG, V73, P469; Edward DGF, 1941, LANCET, V2, P664; Eisfeld AJ, 2014, NAT PROTOC, V9, P2663, DOI 10.1038/nprot.2014.180; Greatorex JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027932; Koep TH, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-71; Lafond KE, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001977; Lindsley WG, 2006, J ENVIRON MONITOR, V8, P1136, DOI 10.1039/b609083d; Lindsley WG, 2010, CLIN INFECT DIS, V50, P693, DOI 10.1086/650457; Lowen AC, 2014, J VIROL, V88, P7692, DOI 10.1128/JVI.03544-13; McCoy MH, 2005, J VIROL METHODS, V130, P157, DOI 10.1016/j.jviromet.2005.06.023; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Mukherjee DV, 2012, AM J INFECT CONTROL, V40, P590, DOI 10.1016/j.ajic.2011.09.006; Musher DM, 2003, NEW ENGL J MED, V348, P1256, DOI 10.1056/NEJMra021771; NOAA/NCEP/EMC, 2016, N AM LAND DAT ASS SY; Noti JD, 2012, CLIN INFECT DIS, V54, P1569, DOI 10.1093/cid/cis237; Ozawa S, 2016, HEALTH AFFAIR, V35, P2124, DOI 10.1377/hlthaff.2016.0462; Pennington MR, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00039-17; Shaman J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000316; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; Sterling E., 1985, ASHRAE T, V91, P611; Tang JW, 2009, J R SOC INTERFACE, V6, pS737, DOI 10.1098/rsif.2009.0227.focus; Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus; Thomas Y, 2008, APPL ENVIRON MICROB, V74, P3002, DOI 10.1128/AEM.00076-08; Tian D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031965; Weber TP, 2008, J INFECTION, V57, P361, DOI 10.1016/j.jinf.2008.08.013; Yang W, 2011, J R SOC INTERFACE, V8, P1176, DOI 10.1098/rsif.2010.0686; Yang WH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0045233, 10.1371/journal.pone.0046789, 10.1371/journal.pone.0053429]	33	21	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2018	13	9							e0204337	10.1371/journal.pone.0204337	http://dx.doi.org/10.1371/journal.pone.0204337			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU9BO	30252890	Green Published, Green Submitted, gold			2022-12-26	WOS:000445639700045
J	Tegern, M; Aasa, U; Ang, BO; Harms-Ringdahl, K; Larsson, H				Tegern, Matthias; Aasa, Ulrike; Ang, Bjorn O.; Harms-Ringdahl, Karin; Larsson, Helena			Inter-rater and test-retest reliability of movement control tests for the neck, shoulder, thoracic, lumbar, and hip regions in military personnel	PLOS ONE			English	Article							LOW-BACK-PAIN; HELICOPTER PILOTS; CERVICAL-SPINE; RISK-FACTORS; PREMATURE DISCHARGE; MOTOR VARIABILITY; SYSTEM; CLASSIFICATION; EPIDEMIOLOGY; DYSFUNCTION	Strategies are needed to mitigate the high rates and related risks of musculoskeletal complaints and injuries (MSCI) in the military aviator community. Previous work on Swedish Armed Forces (SwAF) soldiers have shown that proper screening methods have been successful in reducing early discharge from military training. Research has pointed at the importance of optimal spinal movement control in military aviators. The aim of this work was to investigate the inter-rater and test-retest reliability of a battery of clinical tests for evaluating movement control in the neck, shoulders, thoracic, lumbar, and hip regions in a population of SwAF military personnel. Inter-rater and test-retest reliability of 15 movement control tests were assessed by crude and prevalence-adjusted kappa coefficient. The study included 37 (inter-rater) and 45 (test-retest) SwAF personnel and was performed with two physiotherapists simultaneously observing and rating the movements on the first occasion and repeated with one physiotherapist on the second occasion. For inter-rater reliability, the kappa coefficient ranged from .19 to .95. Seven tests showed substantial to almost perfect agreement (kappa > .60). With the adjusted kappa, three more tests reached the level of substantial agreement. The corresponding values for test-retest reliability ranged from .26 to .65. Substantial agreement was attained for two tests, three with adjusted kappa. The following tests can reliably be used when screening for biomechanically less advantageous movement patters in military aviators: Shoulder flexion, and rotation, Neck flexion in sitting and supine, Neck extension and rotation in sitting, Pelvic tilt, Forward lean and Single and Double knee extension tests. Grading criteria for tests in supine and quadruped positions need to be further elaborated.	[Tegern, Matthias; Aasa, Ulrike] Umea Univ, Dept Community Community Med & Rehabil, Physiotherapy, Umea, Sweden; [Tegern, Matthias; Ang, Bjorn O.; Harms-Ringdahl, Karin; Larsson, Helena] Karolinska Inst, Div Physiotherapy, Dept Neurobiol Care Sci & Soc, Huddinge, Sweden; [Ang, Bjorn O.] Dalarna Univ, Sch Educ Hlth & Social Studies, Falun, Sweden; [Harms-Ringdahl, Karin] Karolinska Univ Hosp, Allied Hlth Profess Funct Funct Area Occupat Ther, Stockholm, Sweden; [Larsson, Helena] Swedish Armed Forces, HQ, Stockholm, Sweden	Umea University; Karolinska Institutet; Dalarna University; Karolinska Institutet; Karolinska University Hospital	Tegern, M (corresponding author), Umea Univ, Dept Community Community Med & Rehabil, Physiotherapy, Umea, Sweden.; Tegern, M (corresponding author), Karolinska Inst, Div Physiotherapy, Dept Neurobiol Care Sci & Soc, Huddinge, Sweden.	matthias.tegern@umu.se		Tegern, Matthias/0000-0001-6871-1341; Ang, Bjorn/0000-0001-7767-4589				Aasa B, 2014, EUR J PHYSIOTHER, V16, P173, DOI 10.3109/21679169.2014.917435; Ang B, 2006, AVIAT SPACE ENVIR MD, V77, P713; Ang BO, 2008, J ELECTROMYOGR KINES, V18, P538, DOI 10.1016/j.jelekin.2007.01.002; Caldwell C, 2007, J ORTHOP SPORT PHYS, V37, P551, DOI 10.2519/jospt.2007.2283; Comerford M., 2012, KINETIC CONTROL MANA; Davids K, 2003, SPORTS MED, V33, P245, DOI 10.2165/00007256-200333040-00001; De Loose V, 2009, AVIAT SPACE ENVIR MD, V80, P477, DOI 10.3357/ASEM.2408.2009; De Vet H.C.W., 2011, MEASUREMENT MED PRAC, P96; Dingenen B, 2018, ASSESSMENT MOVEMENT; Fersum KV, 2009, MANUAL THER, V14, P555, DOI 10.1016/j.math.2008.08.003; Hoy D, 2010, BEST PRACT RES CL RH, V24, P769, DOI 10.1016/j.berh.2010.10.002; Hoy DG, 2010, BEST PRACT RES CL RH, V24, P783, DOI 10.1016/j.berh.2011.01.019; Kelley AM, 2017, AEROSP MED HUM PERF, V88, P96, DOI 10.3357/AMHP.4740.2017; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lange B, 2013, CLIN J PAIN, V29, P50, DOI 10.1097/AJP.0b013e3182478678; Larsson H, 2008, MIL MED, V173, P259, DOI 10.7205/MILMED.173.3.259; Larsson H, 2012, WORK, V42, P241, DOI 10.3233/WOR-2012-1347; Larsson H, 2009, MIL MED, V174, P9, DOI 10.7205/MILMED-D-03-7407; Luomajoki H, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-90; Luomajoki H, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-170; Monnier A, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007943; Monnier A, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-263; Norman GR, 2008, BIOSTATISTICS BARE E, V3rd; O'Leary S, 2009, J ORTHOP SPORT PHYS, V39, P324, DOI 10.2519/jospt.2009.2872; Patroncini M, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-402; Rintala H, 2015, MIL MED, V180, P1233, DOI 10.7205/MILMED-D-14-00467; Roy TC, 2012, AVIAT SPACE ENVIR MD, V83, P1060, DOI 10.3357/ASEM.3341.2012; Sahrmann S, 2002, DIAGNOSIS TREATMENT; Sandlund J, 2017, HUM MOVEMENT SCI, V51, P17, DOI 10.1016/j.humov.2016.10.009; Segarra V, 2015, MANUAL THER, V20, P570, DOI 10.1016/j.math.2015.01.007; Spitznagel T, 2011, MOVEMENT SYSTEM IMPA, P103; Srinivasan D, 2012, CLIN BIOMECH, V27, P979, DOI 10.1016/j.clinbiomech.2012.08.007; van den Oord MHAH, 2010, MIL MED, V175, P55, DOI 10.7205/MILMED-D-09-00038; Van Dillen LR, 1998, PHYS THER, V78, P979, DOI 10.1093/ptj/78.9.979; Van Dillen LR, 2003, J ORTHOP SPORT PHYS, V33, P126, DOI 10.2519/jospt.2003.33.3.126; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31012-1, 10.1016/S0140-6736(16)31678-6]	37	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2018	13	9							e0204552	10.1371/journal.pone.0204552	http://dx.doi.org/10.1371/journal.pone.0204552			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU9BO	30252903	Green Submitted, Green Published, gold			2022-12-26	WOS:000445639700062
J	Einoder, LD; Southwell, DM; Lahoz-Monfort, JJ; Gillespie, GR; Fisher, A; Wintle, BA				Einoder, Luke D.; Southwell, Darren M.; Lahoz-Monfort, Jose J.; Gillespie, Graeme R.; Fisher, Alaric; Wintle, Brendan A.			Occupancy and detectability modelling of vertebrates in northern Australia using multiple sampling methods	PLOS ONE			English	Article							KAKADU-NATIONAL-PARK; SMALL MAMMALS; SPECIES DISTRIBUTION; TROPICAL SAVANNAS; DISTRIBUTION PATTERNS; DESIGNING OCCUPANCY; POWER ANALYSIS; SOIL TEXTURE; FIRE; TERRITORY	Understanding where species occur and how difficult they are to detect during surveys is crucial for designing and evaluating monitoring programs, and has broader applications for conservation planning and management. In this study, we modelled occupancy and the effectiveness of six sampling methods at detecting vertebrates across the Top End of northern Australia. We fitted occupancy-detection models to 136 species (83 birds, 33 reptiles, 20 mammals) of 242 recorded during surveys of 333 sites in eight conservation reserves between 2011 and 2016. For modelled species, mean occupancy was highly variable: birds and reptiles ranged from 0.01-0.81 and 0.01-0.49, respectively, whereas mammal occupancy was lower, ranging from 0.02-0.30. Of the 11 environmental covariates considered as potential predictors of occupancy, topographic ruggedness, elevation, maximum temperature, and fire frequency were retained more readily in the top models. Using these models, we predicted species occupancy across the Top End of northern Australia (293,017 km(2)) and generated species richness maps for each species group. For mammals and reptiles, high richness was associated with rugged terrain, while bird richness was highest in coastal lowland woodlands. On average, detectability of diurnal birds was higher per day of surveys (0.33 +/- 0.09) compared with nocturnal birds per night of spotlighting (0.13 +/- 0.06). Detectability of reptiles was similar per day/night of pit trapping (0.30 +/- 0.09) as per night of spotlighting (0.29 +/- 0.11). On average, mammals were highly detectable using motion-sensor cameras for a week (0.36 +/- 0.06), with exception of smaller-bodied species. One night of Elliott trapping (0.20 +/- 0.06) and spotlighting (0.19 +/- 0.06) was more effective at detecting mammals than cage (0.08 +/- 0.03) and pit trapping (0.05 +/- 0.04). Our estimates of species occupancy and detectability will help inform decisions about how best to redesign a long-running vertebrate monitoring program in the Top End of northern Australia.	[Einoder, Luke D.; Gillespie, Graeme R.; Fisher, Alaric] Dept Environm & Nat Resources, Flora & Fauna Div, Darwin, NT, Australia; [Southwell, Darren M.; Lahoz-Monfort, Jose J.; Wintle, Brendan A.] Univ Melbourne, Sch BioSci, Quantit & Appl Ecol Grp, Melbourne, Vic, Australia	University of Melbourne	Einoder, LD (corresponding author), Dept Environm & Nat Resources, Flora & Fauna Div, Darwin, NT, Australia.	Luke.Einoder@nt.gov.au		wintle, brendan/0000-0002-4234-5950; Einoder, Luke/0000-0002-9122-7053	Australian Government's National Environmental Science Programme through the Threatened Species Recovery Hub	Australian Government's National Environmental Science Programme through the Threatened Species Recovery Hub(Australian Government)	This study was supported by funding from the Australian Government's National Environmental Science Programme through the Threatened Species Recovery Hub.	Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Andersen AN, 2005, AUSTRAL ECOL, V30, P155, DOI 10.1111/j.1442-9993.2005.01441.x; [Anonymous], 2010, MAPPING SPECIES DIST; Austin MP, 2002, ECOL MODEL, V157, P101, DOI 10.1016/S0304-3800(02)00205-3; Balme GA, 2009, J WILDLIFE MANAGE, V73, P433, DOI 10.2193/2007-368; Barton K., MUMIN MULTIMODEL INF; Bowman DMJS, 2010, J BIOGEOGR, V37, P201, DOI 10.1111/j.1365-2699.2009.02210.x; BRADLEY AJ, 1987, AUST WILDLIFE RES, V14, P397; BRAITHWAITE RW, 1987, J TROP ECOL, V3, P265, DOI 10.1017/S0266467400002145; Brotons L, 2004, ECOGRAPHY, V27, P437, DOI 10.1111/j.0906-7590.2004.03764.x; Burnham K. P., 1998, MODEL SELECTION INFE; Calabrese JM, 2014, GLOBAL ECOL BIOGEOGR, V23, P99, DOI 10.1111/geb.12102; Davies HF, 2017, DIVERS DISTRIB, V23, P272, DOI 10.1111/ddi.12522; De Bondi N, 2010, WILDLIFE RES, V37, P456, DOI 10.1071/WR10046; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Einoder LD., 2018, MONITORING THREATENE, P165; Elith J, 2009, SPATIAL CONSERVATION; Firth RSC, 2006, J BIOGEOGR, V33, P1820, DOI 10.1111/j.1365-2699.2006.01543.x; Fisher DO, 2014, GLOBAL ECOL BIOGEOGR, V23, P181, DOI 10.1111/geb.12088; Fiske IJ, 2011, J STAT SOFTW, V43, P1; Gelman A., 2006, DATA ANAL USING REGR, DOI DOI 10.1017/CBO9780511790942.005; Gillespie G. R., 2015, GUIDE USE REMOTE CAM; Guerschman JP, 2009, REMOTE SENS ENVIRON, V113, P928, DOI 10.1016/j.rse.2009.01.006; Guillera-Arroita G, 2017, ECOGRAPHY, V40, DOI 10.1111/ecog.02445; Guillera-Arroita G, 2012, METHODS ECOL EVOL, V3, P860, DOI 10.1111/j.2041-210X.2012.00225.x; Guillera-Arroita G, 2010, METHODS ECOL EVOL, V1, P131, DOI 10.1111/j.2041-210X.2010.00017.x; Harrell FE, 2001, REGRESSION MODELING; Kellner KF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111436; Kery M, 2004, CONSERV BIOL, V18, P570, DOI 10.1111/j.1523-1739.2004.00105.x; Lahoz-Monfort JJ, 2014, GLOBAL ECOL BIOGEOGR, V23, P504, DOI 10.1111/geb.12138; Lawes MJ, 2015, INT J WILDLAND FIRE, V24, P712, DOI 10.1071/WF14163; Leahy L, 2015, WILDLIFE RES, V42, P705, DOI 10.1071/WR15011; Legge S, 2017, BIOL CONSERV, V206, P293, DOI 10.1016/j.biocon.2016.11.032; Legge S, 2011, AUSTRAL ECOL, V36, P791, DOI 10.1111/j.1442-9993.2010.02218.x; Lindenmayer DB, 2012, AUSTRAL ECOL, V37, P285, DOI 10.1111/j.1442-9993.2011.02314.x; Long RA, 2007, J WILDLIFE MANAGE, V71, P2018, DOI 10.2193/2006-292; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; MacKenzie DI, 2004, J AGR BIOL ENVIR ST, V9, P300, DOI 10.1198/108571104X3361; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; McDonald PJ, 2015, BIOL CONSERV, V191, P93, DOI 10.1016/j.biocon.2015.06.027; McGregor H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133915; Milne DJ, 2006, BIOL CONSERV, V130, P370, DOI 10.1016/j.biocon.2005.12.031; Morrison LW, 2007, NAT AREA J, V27, P83, DOI 10.3375/0885-8608(2007)27[83:ATROEM]2.0.CO;2; Price B, 2010, BIOL CONSERV, V143, P2504, DOI 10.1016/j.biocon.2010.06.017; R Development Core Team, 2014, R LANG ENV STAT COMP; Radford IJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130721; Reside AE, 2012, DIVERS DISTRIB, V18, P213, DOI 10.1111/j.1472-4642.2011.00818.x; Rota C, 2013, ECOGRAPHY, V34, P659; Russell-Smith J, 2014, BIODIVERSITY ENV CHA, P335; Sewell D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043387; Smith J., 2017, Pacific Conservation Biology, V23, P43, DOI 10.1071/PC16017; WHITEHEAD PJ, 1992, J BIOGEOGR, V19, P151, DOI 10.2307/2845501; Williams RJ, 1996, J BIOGEOGR, V23, P747, DOI 10.1111/j.1365-2699.1996.tb00036.x; Wintle BA, 2005, J WILDLIFE MANAGE, V69, P905, DOI 10.2193/0022-541X(2005)069[0905:EADWDI]2.0.CO;2; Wintle BA, 2012, DIVERS DISTRIB, V18, P417, DOI 10.1111/j.1472-4642.2011.00874.x; Woinarski JCZ, 2013, EMU, V113, P319, DOI 10.1071/MU12109; Woinarski JCZ, 2010, WILDLIFE RES, V37, P116, DOI 10.1071/WR09125; WOINARSKI JCZ, 1992, WILDLIFE RES, V19, P665, DOI 10.1071/WR9920665; Woinarski JCZ, 1999, J TROP ECOL, V15, P381, DOI 10.1017/S0266467499000905; WOINARSKI JCZ, 1992, WILDLIFE RES, V19, P105, DOI 10.1071/WR9920105; Woinarski JCZ, 2011, CONSERV LETT, V4, P192, DOI 10.1111/j.1755-263X.2011.00164.x; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4; Ziembicki Mark R., 2015, Therya, V6, P169, DOI 10.12933/therya-15-236	64	23	23	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2018	13	9							e0203304	10.1371/journal.pone.0203304	http://dx.doi.org/10.1371/journal.pone.0203304			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3MI	30248104	gold, Green Published			2022-12-26	WOS:000445998100008
J	Khalatbari-Soltani, S; Marques-Vidal, P				Khalatbari-Soltani, Saman; Marques-Vidal, Pedro			Adherence to hospital nutritional status monitoring and reporting guidelines	PLOS ONE			English	Article							CONSENSUS STATEMENT; CHARLSON INDEX; MALNUTRITION; CARE; NURSES; UNDERNUTRITION; DOCUMENTATION; DOCTORS; HEALTH; IDENTIFICATION	Aims of the study Despite the widespread existence of guidelines regarding undernutrition monitoring and reporting, there is scarce information whether they are followed. We aimed to evaluate the adherence to guidelines regarding undernutrition monitoring and reporting as well as their determinants in a university hospital. Methods Retrospective analysis of discharged patients with data on Nutritional Risk Screening score (NRS-2002) from the department of internal medicine of the Lausanne University Hospital for years 2013-14. Adherence to the hospital monitoring guidelines, i.e.: 1) discharged patients with NRS-2002 score >= 3 should have prealbumin levels measured, and 2) discharged patients with prealbumin levels<0.20 g/l should be rechecked 7 days afterwards, was assessed. Reporting of nutritionally 'at-risk' status in the discharge letter was also assessed. Multivariable logistic regression was used to examine potential determinants of adherence to guidelines. Results Of the 2,539 discharged patients with NRS-2002 data, 1,605 (63.0%) were nutritionally 'atrisk'. Complete adherence to the monitoring guideline was observed in 238 (14.8%) of 'atrisk' patients. After multivariable analysis, adherence to the first step of monitoring guideline was associated with older age (>= 80 years) [OR (95% CI): 2.03 (1.29-3.18)], high comorbidity index [1.36 (1.05-1.77)], and nutritional management [5.57 (4.38-7.07)]. Nutritional management was also associated with adherence to the second step of monitoring [3.98 (2.33-6.78)]. Adherence to the reporting guideline was observed in 343 (21.4%) of 'at-risk' patients. Multivariable analysis showed that adherence to the reporting guideline was associated with NRS-2002 score>4 [1.97 (1.47-2.64)], nutritional management [3.80 (2.85-5.07)], and adherence to the monitoring guideline [3.33 (2.35-4.71)]. Conclusions Our results show a poor adherence to guidelines regarding undernutrition monitoring and reporting, possibly due to lack of training, staff, and time.	[Khalatbari-Soltani, Saman] Inst Social & Prevent Med IUMSP, Lausanne, Switzerland; [Khalatbari-Soltani, Saman; Marques-Vidal, Pedro] Lausanne Univ Hosp CHUV, Dept Med, Internal Med, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Khalatbari-Soltani, S (corresponding author), Inst Social & Prevent Med IUMSP, Lausanne, Switzerland.; Khalatbari-Soltani, S (corresponding author), Lausanne Univ Hosp CHUV, Dept Med, Internal Med, Lausanne, Switzerland.	Saman.KhalatbariSoltani@unil.ch	Marques-Vidal, Pedro/C-9449-2009; Khalatbari Soltani, Saman/M-7161-2014	Marques-Vidal, Pedro/0000-0002-4548-8500; Khalatbari Soltani, Saman/0000-0001-8437-1906	Swiss Government Excellence PhD Scholarship [2014.0739]	Swiss Government Excellence PhD Scholarship	SK-S is a recipient of a Swiss Government Excellence PhD Scholarship [2014.0739]. This funding source had no contribution to the study design, analysis and interpretation, the writing of the report, or the decision to submit the article for publication.	Ahmed T, 2010, CLIN INTERV AGING, V5, P207; Attar A, 2012, NUTR CANCER, V64, P535, DOI 10.1080/01635581.2012.670743; Badia T, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0033-0; Barker LA, 2011, INT J ENV RES PUB HE, V8, P514, DOI 10.3390/ijerph8020514; Bavelaar JW, 2008, CLIN NUTR, V27, P431, DOI 10.1016/j.clnu.2008.01.016; Beck AM, 2002, CLIN NUTR, V21, P351, DOI 10.1054/clnu.2002.0555; Beck AM, 2001, CLIN NUTR, V20, P455, DOI 10.1054/clnu.2001.0494; Becker P, 2015, NUTR CLIN PRACT, V30, P147, DOI 10.1177/0884533614557642; Cederholm T, 2015, CLIN NUTR, V34, P335, DOI 10.1016/j.clnu.2015.03.001; Cereda E, 2010, EUR J CLIN NUTR, V64, P894, DOI 10.1038/ejcn.2010.85; Costa Sandra Patricia da, 2010, Rev. Gaúcha Enferm., V31, P62, DOI 10.1590/S1983-14472010000100009; Elia M, 2005, CLIN NUTR, V24, P867, DOI 10.1016/j.clnu.2005.03.004; Geurden B, 2014, INT J NURS KNOWL, V25, P43, DOI 10.1111/2047-3095.12011; Goldstein LB, 2004, STROKE, V35, P1941, DOI 10.1161/01.STR.0000135225.80898.1c; Guenter P, 2015, JT COMM J QUAL PATIE, V41, P469, DOI 10.1016/S1553-7250(15)41061-X; Imoberdorf R, 2010, CLIN NUTR, V29, P38, DOI 10.1016/j.clnu.2009.06.005; Khalatbari-Soltani S, 2016, CLIN NUTR, V35, P1340, DOI 10.1016/j.clnu.2016.02.012; Kondrup J, 2003, CLIN NUTR, V22, P415, DOI 10.1016/S0261-5614(03)00098-0; Kondrup J, 2003, CLIN NUTR, V22, P321, DOI 10.1016/S0261-5614(02)00214-5; Kyle UG, 2006, CLIN NUTR, V25, P409, DOI 10.1016/j.clnu.2005.11.001; Lindorff-Larsen K, 2007, CLIN NUTR, V26, P371, DOI 10.1016/j.clnu.2007.01.006; Meijers JMM, 2009, NUTRITION, V25, P512, DOI 10.1016/j.nut.2008.11.004; Mowe M, 2008, CLIN NUTR, V27, P196, DOI 10.1016/j.clnu.2007.10.014; Mowe M, 2006, CLIN NUTR, V25, P524, DOI 10.1016/j.clnu.2005.11.011; Mueller C, 2011, JPEN-PARENTER ENTER, V35, P16, DOI 10.1177/0148607110389335; Organisation for Economic Cooperation and Development; World Health Organization, 2011, OECD REV HLTH SYST, DOI [10.1787/9789264120914-en, DOI 10.1787/9789264120914-EN]; Persenius MW, 2008, J CLIN NURS, V17, P2125, DOI 10.1111/j.1365-2702.2007.02202.x; Porben SS, 2006, CLIN NUTR, V25, P1015, DOI 10.1016/j.clnu.2006.04.001; Rasmussen HH, 1999, CLIN NUTR, V18, P153, DOI 10.1016/S0261-5614(99)80005-3; Sauer AC, 2016, NURSINGPLUS OPEN, V2, P21, DOI [10.1016/j.npls.2016.05.001, DOI 10.1016/J.NPLS.2016.05.001]; Schindler K, 2010, CLIN NUTR, V29, P552, DOI 10.1016/j.clnu.2010.04.001; Soeters P, 2017, CLIN NUTR, V36, P896, DOI 10.1016/j.clnu.2016.09.032; Sukkar SG, 2012, MEDITERR J NUTR META, V5, P75, DOI 10.1007/s12349-012-0105-z; Sundararajan V, 2007, MED CARE, V45, P1210, DOI 10.1097/MLR.0b013e3181484347; Tappenden KA, 2013, JPEN-PARENTER ENTER, V37, P482, DOI 10.1177/0148607113484066; Vonzun N, 2014, THER UMSCH, V71, P185, DOI 10.1024/0040-5930/a000501	37	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2018	13	9							e0204000	10.1371/journal.pone.0204000	http://dx.doi.org/10.1371/journal.pone.0204000			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU5MM	30240436	Green Submitted, gold, Green Published			2022-12-26	WOS:000445329700019
J	Liu, Y; Ren, HZ; Wang, JL; Yang, FJ; Li, J; Zhou, Y; Yuan, XW; Zhu, W; Shi, XL				Liu, Yang; Ren, Haozhen; Wang, Jinglin; Yang, Faji; Li, Jun; Zhou, Yuan; Yuan, Xianwen; Zhu, Wei; Shi, Xiaolei			Prostaglandin E-2 secreted by mesenchymal stem cells protects against acute liver failure via enhancing hepatocyte proliferation	FASEB JOURNAL			English	Article						cell proliferation; YAP; mTOR	HIPPO PATHWAY; STROMAL CELLS; YAP; GROWTH; PHOSPHORYLATION; TUMORIGENESIS; REGENERATION; INFLAMMATION; INHIBITION; EXPRESSION	Bone marrow-derived mesenchymal stem cells (MSCs) have been recently used in clinical trials as treatment for liver diseases. However, the underlying mechanism of their effectiveness remains largely unexplored. In the present study, we confirmed that the protective effects of MSCs on mouse model of acute liver failure (ALF) were based on MSC-secreted prostaglandin (PG)E-2. Our data confirmed that MSC-secreted PGE(2) not only inhibited apoptosis but also enhanced hepatocyte proliferation, thus attenuating ALF. Moreover, Yes-associated protein (YAP) played a major role in PGE(2)-triggered hepatocyte proliferation. In vitro studies showed that PGE(2) increased the expression of PGE(4) and enhanced the phosphorylation of cAMP response element binding protein, resulting in YAP activation and increased expression of YAP-related genes. Furthermore, the mammalian target of rapamycin, another major regulator of cell proliferation, was activated by YAP via suppressing phosphatase and tensin homolog through miR-29a-3p. These pathways coordinated to control cell proliferation. Collectively, MSCs could promote the recovery of ALF through PGE(2)-induced hepatocyte proliferation.Liu, Y., Ren, H., Wang, J., Yang, F., Li, J., Zhou, Y., Yuan, X., Zhu, W., Shi, X. Prostaglandin E-2 secreted by mesenchymal stem cells protects against acute liver failure via enhancing hepatocyte proliferation.	[Liu, Yang; Ren, Haozhen; Wang, Jinglin; Yang, Faji; Li, Jun; Zhou, Yuan; Yuan, Xianwen; Shi, Xiaolei] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Hepatobiliary Surg, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China; [Zhu, Wei] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Anesthesiol, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing University	Shi, XL (corresponding author), Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Hepatobiliary Surg, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China.; Zhu, W (corresponding author), Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Anesthesiol, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China.	chzhuwei118@qq.com; njsxl2000@163.com			National Natural Science Foundation of China [81670566]; Jiangsu Provincial Medical Talent Grant [ZDRCA2016066]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial Medical Talent Grant	This work was supported by National Natural Science Foundation of China Grant 81670566, and by Jiangsu Provincial Medical Talent Grant ZDRCA2016066. The authors declare no conflicts of interest.	Alfaifi M, 2018, J HEPATOL, V68, P1272, DOI 10.1016/j.jhep.2018.01.030; Bernal W, 2015, J HEPATOL, V62, pS112, DOI 10.1016/j.jhep.2014.12.016; Blenis J, 2017, CELL, V171, P10, DOI 10.1016/j.cell.2017.08.019; Chaulk SG, 2014, J BIOL CHEM, V289, P1886, DOI 10.1074/jbc.C113.529362; Chung Raymond T, 2012, Gastroenterology, V143, pe1, DOI 10.1053/j.gastro.2012.07.011; Detry O, 2017, J HEPATOL, V67, P47, DOI 10.1016/j.jhep.2017.03.001; Fan FQ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf2304; Hansen CG, 2015, CELL RES, V25, P1299, DOI 10.1038/cr.2015.140; Hong AW, 2016, NAT REV GASTRO HEPAT, V13, P324, DOI 10.1038/nrgastro.2016.59; Hossain MA, 1999, BRIT J SURG, V86, P776, DOI 10.1046/j.1365-2168.1999.01098.x; Jiang JW, 2017, CELL PROLIFERAT, V50, DOI 10.1111/cpr.12351; Kachaylo E, 2017, HEPATOLOGY, V66, P908, DOI 10.1002/hep.29226; Kim HB, 2017, GASTROENTEROLOGY, V152, P616, DOI 10.1053/j.gastro.2016.11.005; Kim HS, 2013, GASTROENTEROLOGY, V145, P1392, DOI 10.1053/j.gastro.2013.08.033; Kogure T, 2012, J CELL MOL MED, V16, P2647, DOI 10.1111/j.1582-4934.2012.01578.x; Kong GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019518; Kota DJ, 2017, STEM CELLS, V35, P1416, DOI 10.1002/stem.2603; Kuzumoto Y, 2005, HEPATOLOGY, V42, P608, DOI 10.1002/hep.20827; Lin BL, 2017, HEPATOLOGY, V66, P209, DOI 10.1002/hep.29189; Loforese G, 2017, EMBO MOL MED, V9, P46, DOI 10.15252/emmm.201506089; Mao YX, 2015, STEM CELLS, V33, P2331, DOI 10.1002/stem.1996; Matsumoto Y, 2016, MOL THER, V24, P1848, DOI 10.1038/mt.2016.127; Miyamura N, 2017, NAT COMMUN, V8, P1, DOI 10.1038/ncomms16017; Nakanishi M, 2013, SEMIN IMMUNOPATHOL, V35, P123, DOI 10.1007/s00281-012-0342-8; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Nguyen HB, 2013, ONCOGENE, V32, P4100, DOI 10.1038/onc.2012.431; Patel SH, 2017, GASTROENTEROLOGY, V152, P533, DOI 10.1053/j.gastro.2016.10.047; Swiderska-Syn M, 2016, HEPATOLOGY, V64, P232, DOI 10.1002/hep.28542; Tiao MM, 2014, APOPTOSIS, V19, P30, DOI 10.1007/s10495-013-0909-4; Umemura A, 2014, CELL METAB, V20, P133, DOI 10.1016/j.cmet.2014.05.001; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Wang C, 2011, MOL CELL BIOCHEM, V352, P197, DOI 10.1007/s11010-011-0755-z; Wang JY, 2013, HEPATOLOGY, V58, P1011, DOI 10.1002/hep.26420; Yimlamai D, 2015, J HEPATOL, V63, P1491, DOI 10.1016/j.jhep.2015.07.008; Zhang YY, 2015, SCIENCE, V348, DOI 10.1126/science.aaa2340	35	16	16	2	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2514	2525		10.1096/fj.201801349RR	http://dx.doi.org/10.1096/fj.201801349RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30260707				2022-12-26	WOS:000457296600078
J	He, Q; Tang, QY; Sun, YF; Zhou, M; Gartner, W; Zhao, KH				He, Qi; Tang, Qi-Ying; Sun, Ya-Fang; Zhou, Ming; Gaertner, Wolfgang; Zhao, Kai-Hong			Chromophorylation of cyanobacteriochrome Slr1393 from Synechocystis sp PCC 6803 is regulated by protein Slr2111 through allosteric interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyanobacteria; protein-protein interaction; photosynthesis; photosynthetic pigment; photoreceptor; phototransduction; adenosine-binding protein; co-immunoprecipitation; cystathionine beta-synthase domain; phycocyanobilin; regulation	BETA-SYNTHASE DOMAIN; NUCLEOTIDE-BINDING; HISTIDINE KINASE; CBS DOMAINS; INOSINE 5-MONOPHOSPHATE; SIGNAL-TRANSDUCTION; SWISS-MODEL; GAF DOMAIN; FLUORESCENCE; PHYCOCYANOBILIN	Cyanobacteriochromes (CBCRs) are photochromic proteins in cyanobacteria that act as photosensors. CBCRs bind bilins as chromophores and sense nearly the entire visible spectrum of light, but the regulation of the chromophorylation of CBCRs is unknown. Slr1393 from Synechocystis sp. PCC 6803 is a CBCR containing three consecutive GAF (cGMP phosphodiesterase, adenylyl cyclase, and FhlA protein) domains, of which only the third one (Slr1393g3) can be phycocyanobilin-chromophorylated. The protein Slr2111 from Synechocystis sp. PCC 6803 includes a cystathionine -synthase (CBS) domain pair of an as yet unknown function at its N terminus. CBS domains are often characterized as sensors of cellular energy status by binding nucleotides. In this work, we demonstrate that Slr2111 strongly interacts with Slr1393 in vivo and in vitro, which generates a complex in a 1:1 molar ratio. This tight interaction inhibits the chromophorylation of Slr1393g3, even if the chromophore is present. Instead, the complex stability and thereby the chromophorylation of Slr1393 are regulated by the binding of nucleotides (ATP, ADP, AMP) to the CBS domains of Slr2111 with varying affinities. It is demonstrated that residues Asp-53 and Arg-97 of Slr2111 are involved in nucleotide binding. While ATP binds to Slr2111, the association between the two proteins gets weaker and chromophorylation of Slr1393 are enabled. In contrast, AMP binding to Slr2111 leads to a stronger association, thereby inhibiting the chromophorylation. It is concluded that Slr2111 acts as a sensor of the cellular energy status that regulates the chromophorylation of Slr1393 and thereby its function as a light-driven histidine kinase.	[He, Qi; Tang, Qi-Ying; Sun, Ya-Fang; Zhou, Ming; Zhao, Kai-Hong] Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan 430070, Hubei, Peoples R China; [Gaertner, Wolfgang] Univ Leipzig, Inst Analyt Chem, D-04103 Leipzig, Germany	Huazhong Agricultural University; Leipzig University	Zhao, KH (corresponding author), Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan 430070, Hubei, Peoples R China.	khzhao@163.com			National Natural Science Foundation of China [31370777, 21472055, 31770822]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grants 31370777 (to M. Z.) and 21472055 and 31770822 (to K. H. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bateman A, 1997, TRENDS BIOCHEM SCI, V22, P12, DOI 10.1016/S0968-0004(96)30046-7; Baugh L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053851; Baykov AA, 2011, ACS CHEM BIOL, V6, P1156, DOI 10.1021/cb200231c; BERKELMAN TR, 1986, ANAL BIOCHEM, V156, P194, DOI 10.1016/0003-2697(86)90173-9; Bilwes AM, 2001, NAT STRUCT BIOL, V8, P353, DOI 10.1038/86243; BIRDSALL B, 1983, ANAL BIOCHEM, V132, P353, DOI 10.1016/0003-2697(83)90020-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bussell AN, 2013, P NATL ACAD SCI USA, V110, P12834, DOI 10.1073/pnas.1303371110; Chen L, 2012, NAT STRUCT MOL BIOL, V19, P716, DOI 10.1038/nsmb.2319; Chen Y, 2012, FEBS J, V279, P40, DOI 10.1111/j.1742-4658.2011.08397.x; COLE WJ, 1968, BIOCHEMISTRY-US, V7, P2929, DOI 10.1021/bi00848a033; De Angeli A, 2009, J BIOL CHEM, V284, P26526, DOI 10.1074/jbc.M109.005132; Ereno-Orbea J, 2013, ARCH BIOCHEM BIOPHYS, V540, P70, DOI 10.1016/j.abb.2013.10.008; Fushimi K, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00588; Gomez-Garcia I, 2010, J MOL BIOL, V399, P53, DOI 10.1016/j.jmb.2010.03.045; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Ignoul S, 2005, AM J PHYSIOL-CELL PH, V289, pC1369, DOI 10.1152/ajpcell.00282.2005; Ikeuchi M, 2008, PHOTOCH PHOTOBIO SCI, V7, P1159, DOI 10.1039/b802660m; Jamsen J, 2007, BIOCHEM J, V408, P327, DOI 10.1042/BJ20071017; Jeong BC, 2013, J STRUCT BIOL, V183, P40, DOI 10.1016/j.jsb.2013.04.013; Kemp BE, 2004, J CLIN INVEST, V113, P182, DOI 10.1172/JCI200420846; Kushwaha HR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEHRER SS, 1971, BIOCHEMISTRY-US, V10, P3254, DOI 10.1021/bi00793a015; Lucas M, 2010, J MOL BIOL, V396, P800, DOI 10.1016/j.jmb.2009.12.012; Ma Q, 2012, FEBS J, V279, P4095, DOI 10.1111/febs.12003; Meyer S, 2007, NAT STRUCT MOL BIOL, V14, P60, DOI 10.1038/nsmb1188; Miller J. N., 1979, ANAL P, V16, P203; Narikawa R, 2008, J MOL BIOL, V380, P844, DOI 10.1016/j.jmb.2008.05.035; Nicholas K.B., 1997, EMBNETNEWS, V4, P1; Oakhill JS, 2011, SCIENCE, V332, P1433, DOI 10.1126/science.1200094; Paul BK, 2012, PHYS CHEM CHEM PHYS, V14, P15482, DOI 10.1039/c2cp42415k; Pimkin M, 2008, MOL MICROBIOL, V68, P342, DOI 10.1111/j.1365-2958.2008.06153.x; Rockwell NC, 2012, BIOCHEMISTRY-US, V51, P9667, DOI 10.1021/bi3013565; Rockwell NC, 2011, P NATL ACAD SCI USA, V108, P11854, DOI 10.1073/pnas.1107844108; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SAMWORTH CM, 1988, EUR J BIOCHEM, V171, P81, DOI 10.1111/j.1432-1033.1988.tb13761.x; Sato S, 2007, DNA RES, V14, P207, DOI 10.1093/dnares/dsm021; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Shrivastava R, 2007, FEBS LETT, V581, P1903, DOI 10.1016/j.febslet.2007.03.089; Stewart RC, 1998, BIOCHEMISTRY-US, V37, P12269, DOI 10.1021/bi980970n; Storf M, 2001, BIOCHEMISTRY-US, V40, P12444, DOI 10.1021/bi010776s; Surette MG, 1996, J BIOL CHEM, V271, P939, DOI 10.1074/jbc.271.2.939; TAWA P, 1994, BIOCHEMISTRY-US, V33, P7917, DOI 10.1021/bi00191a019; Townley R, 2007, SCIENCE, V315, P1726, DOI 10.1126/science.1137503; Huynh TN, 2016, MOL MICROBIOL, V102, P233, DOI 10.1111/mmi.13456; Ulijasz AT, 2009, J BIOL CHEM, V284, P29757, DOI 10.1074/jbc.M109.038513; Wang W, 1996, BIOCHEMISTRY-US, V35, P95, DOI 10.1021/bi951499q; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; Xu XL, 2014, CHEMBIOCHEM, V15, P1190, DOI 10.1002/cbic.201400053; Zhang JA, 2010, ANGEW CHEM INT EDIT, V49, P5456, DOI 10.1002/anie.201001094; Zhao KH, 2006, J BIOL CHEM, V281, P8573, DOI 10.1074/jbc.M513796200	53	2	2	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2018	293	46					17705	17715		10.1074/jbc.RA118.003830	http://dx.doi.org/10.1074/jbc.RA118.003830			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HA6SG	30242127	hybrid, Green Published			2022-12-26	WOS:000450409500004
J	Kakad, PP; Penserga, T; Davis, BP; Henry, B; Boerner, J; Riso, A; Pielage, J; Godenschwege, TA				Kakad, Priyanka P.; Penserga, Tyrone; Davis, Blake P.; Henry, Brittany; Boerner, Jana; Riso, Anna; Pielage, Jan; Godenschwege, Tanja A.			An ankyrin-binding motif regulates nuclear levels of L1-type neuroglian and expression of the oncogene Myc in Drosophila neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						transcription regulation; ankyrin; cancer; Drosophila; Myc (c-Myc); oxidative stress; L1-CAM; neuroglian; nuclear function; ankyrin-binding motif	ADHESION MOLECULE L1; CELL-ADHESION; C-MYC; PRESENILIN/GAMMA-SECRETASE; DNA-DAMAGE; CANCER; L1-CAM; RECEPTOR; TRANSLOCATION; MIGRATION	L1 cell adhesion molecule (L1CAM) is well-known for its importance in nervous system development and cancer progression. In addition to its role as a plasma membrane protein in cytoskeletal organization, recent in vitro studies have revealed that both transmembrane and cytosolic fragments of proteolytically cleaved vertebrate L1CAM translocate to the nucleus. In vitro studies indicate that nuclear L1CAM affects genes with functions in DNA post-replication repair, cell cycle control, and cell migration and differentiation, but its in vivo role and how its nuclear levels are regulated is less well-understood. Here, we report that mutations in the conserved ankyrin-binding domain affect nuclear levels of the sole Drosophila homolog neuroglian (Nrg) and that it also has a noncanonical role in regulating transcript levels of the oncogene Myc in the adult nervous system. We further show that altered nuclear levels of Nrg correlate with altered transcript levels of Myc in neurons, similar to what has been reported for human glioblastoma stem cells. However, whereas previous in vitro studies suggest that increased nuclear levels of L1CAM promote tumor cell survival, we found here that elevated levels of nuclear Nrg in neurons are associated with increased sensitivity to oxidative stress and reduced life span of adult animals. We therefore conclude that these findings are of potential relevance to the management of neurodegenerative diseases associated with oxidative stress and cancer.	[Kakad, Priyanka P.; Penserga, Tyrone; Davis, Blake P.; Henry, Brittany; Boerner, Jana; Godenschwege, Tanja A.] Florida Atlantic Univ, Dept Biol Sci, Jupiter, FL 33458 USA; [Riso, Anna] Florida Atlantic Univ, Harriet L Wilkes Honors Coll, Jupiter, FL 33458 USA; [Pielage, Jan] Univ Kaiserslautern, Div Zool Neurobiol, Dept Biol, D-67653 Kaiserslautern, Germany	State University System of Florida; Florida Atlantic University; State University System of Florida; Florida Atlantic University; University of Kaiserslautern	Godenschwege, TA (corresponding author), Florida Atlantic Univ, John D MacArthur Campus,5353 Parkside Dr, Jupiter, FL 33458 USA.	godensch@fau.edu	; Godenschwege, Tanja/A-2830-2010	Pielage, Jan/0000-0002-5115-5884; Godenschwege, Tanja/0000-0003-3322-4134	NINDS, National Institutes of Health [R15 NS090043]; Jupiter Life Sciences Initiative at Florida Atlantic University; SURF fellowship; Office of Undergraduate Research and Inquiry at Florida Atlantic University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS090043] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Jupiter Life Sciences Initiative at Florida Atlantic University; SURF fellowship; Office of Undergraduate Research and Inquiry at Florida Atlantic University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NINDS, National Institutes of Health, Grant R15 NS090043 (to T. A. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the Jupiter Life Sciences Initiative at Florida Atlantic University.; Supported by a SURF fellowship and an undergraduate research grant from the Office of Undergraduate Research and Inquiry at Florida Atlantic University.	Boerner J, 2011, JOVE-J VIS EXP, DOI 10.3791/3080; Boerner J, 2010, J NEUROGENET, V24, P158, DOI 10.3109/01677063.2010.489624; Bondong S, 2012, ANN ONCOL, V23, P1795, DOI 10.1093/annonc/mdr568; Brand TM, 2013, RADIOTHER ONCOL, V108, P370, DOI 10.1016/j.radonc.2013.06.010; Cai MS, 2011, J GEN VIROL, V92, P621, DOI 10.1099/vir.0.027029-0; Carpenter G, 2003, EXP CELL RES, V284, P66, DOI 10.1016/S0014-4827(02)00100-3; Carpenter G, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008979; Carpenter G, 2009, EXP CELL RES, V315, P1556, DOI 10.1016/j.yexcr.2008.09.027; Cassari M, 2015, HUM MOL GENET, V24, P197, DOI 10.1093/hmg/ddu430; Chen MM, 2009, BIOCHEM BIOPH RES CO, V389, P257, DOI 10.1016/j.bbrc.2009.08.143; Cheng L, 2005, J NEUROSCI, V25, P395, DOI 10.1523/JNEUROSCI.4097-04.2005; Cheng L, 2011, EMBO J, V30, P800, DOI 10.1038/emboj.2011.10; Costantini LM, 2012, TRAFFIC, V13, P643, DOI 10.1111/j.1600-0854.2012.01336.x; DAVIS JQ, 1993, J CELL BIOL, V121, P121, DOI 10.1083/jcb.121.1.121; de la Cova C, 2004, CELL, V117, P107, DOI 10.1016/S0092-8674(04)00214-4; Enneking EM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001537; Fogel M, 2003, LANCET, V362, P869, DOI 10.1016/S0140-6736(03)14342-5; Freitas N, 2009, CURR GENOMICS, V10, P550, DOI 10.2174/138920209789503941; Godenschwege TA, 2006, CURR BIOL, V16, P12, DOI 10.1016/j.cub.2005.11.062; Greer C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074641; Hoffman B, 2008, ONCOGENE, V27, P6462, DOI 10.1038/onc.2008.312; Hofmann JW, 2015, CELL, V160, P477, DOI 10.1016/j.cell.2014.12.016; Hortsch M, 2000, MOL CELL NEUROSCI, V15, P1, DOI 10.1006/mcne.1999.0809; Hosamani R, 2010, NEUROCHEM RES, V35, P1402, DOI 10.1007/s11064-010-0198-z; Jumbo-Lucioni PP, 2013, DIS MODEL MECH, V6, P84, DOI 10.1242/dmm.010207; Kalus I, 2003, J BIOL CHEM, V278, P10381, DOI 10.1074/jbc.M208351200; Kudumala S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076974; Kudumala SR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183605; Li S, 2009, CLIN CANCER RES, V15, P7345, DOI 10.1158/1078-0432.CCR-09-0959; Liberti MV, 2016, TRENDS BIOCHEM SCI, V41, P211, DOI 10.1016/j.tibs.2015.12.001; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Lutz D, 2014, J NEUROCHEM, V128, P713, DOI 10.1111/jnc.12473; Lutz D, 2012, J BIOL CHEM, V287, P17161, DOI 10.1074/jbc.M112.346759; Maretzky T, 2005, MOL CELL BIOL, V25, P9040, DOI 10.1128/MCB.25.20.9040-9053.2005; Mechtersheimer S, 2001, J CELL BIOL, V155, P661, DOI 10.1083/jcb.200101099; Minois N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.139; Montero L, 2008, GENESIS, V46, P104, DOI 10.1002/dvg.20373; Nardozzi JD, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-32; Nishimura K, 2003, J CELL BIOL, V163, P1077, DOI 10.1083/jcb.200303060; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Rached J, 2016, INT J ONCOL, V49, P1722, DOI 10.3892/ijo.2016.3625; Riedle S, 2009, BIOCHEM J, V420, P391, DOI 10.1042/BJ20081625; Schlessinger J, 2006, CELL, V127, P45, DOI 10.1016/j.cell.2006.09.013; Schwartz L, 2017, ANTI-CANCER AGENT ME, V17, P164, DOI 10.2174/1871520616666161031143301; Sedivy JM, 2015, MOL CANCER RES, V13, DOI 10.1158/1557-3125.MYC15-IA20; Siegenthaler D, 2015, J CELL BIOL, V208, P1003, DOI 10.1083/jcb.201407131; Tanaka H, 2002, MOL CELL, V9, P1017, DOI 10.1016/S1097-2765(02)00522-1; Tanaka K, 2002, EXP GERONTOL, V37, P1469, DOI 10.1016/S0531-5565(02)00167-5; Tuvia S, 1997, P NATL ACAD SCI USA, V94, P12957, DOI 10.1073/pnas.94.24.12957; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Wagstaff KM, 2009, TRAFFIC, V10, P1188, DOI 10.1111/j.1600-0854.2009.00937.x; Wang Qi-En, 2015, World J Biol Chem, V6, P57, DOI 10.4331/wjbc.v6.i3.57; Wang SC, 2009, CLIN CANCER RES, V15, P6484, DOI 10.1158/1078-0432.CCR-08-2813; Whittard JD, 2006, MOL BIOL CELL, V17, P2696, DOI 10.1091/mbc.E06-01-0090; Yu L, 2009, J ONCOL, V2009, DOI 10.1155/2009/780874	55	5	5	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2018	293	45					17442	17453		10.1074/jbc.RA118.004240	http://dx.doi.org/10.1074/jbc.RA118.004240			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ9EI	30257867	Green Published, hybrid			2022-12-26	WOS:000449799000011
J	Nie, M; Wang, YD; Guo, C; Li, XY; Wang, Y; Deng, YX; Yao, B; Gui, T; Ma, C; Liu, M; Wang, PX; Wang, RY; Tan, RX; Fang, M; Chen, B; He, YH; Huang, DCS; Ju, JY; Zhao, Q				Nie, Min; Wang, Yadong; Guo, Chan; Li, Xinyu; Wang, Ying; Deng, Yexuan; Yao, Bing; Gui, Tao; Ma, Chi; Liu, Ming; Wang, Panxue; Wang, Ruoyun; Tan, Renxiang; Fang, Ming; Chen, Bing; He, Yinghong; Huang, David C. S.; Ju, Junyi; Zhao, Quan			CARM1-mediated methylation of protein arginine methyltransferase 5 represses human -globin gene expression in erythroleukemia cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein arginine N-methyltransferase 5 (PRMT5); protein methylation; hemoglobin; histone methylation; gene expression; CARM1	FETAL-HEMOGLOBIN EXPRESSION; TERMINAL DOMAIN; HISTONE H3; CARM1; PRMT5; DISEASE; TRANSCRIPTION; INHIBITION; COMPLEX; DIMETHYLARGININE	Protein arginine methyltransferase 5 (PRMT5) is a member of the arginine methyltransferase protein family that critically mediates the symmetric dimethylation of Arg-3 at histone H4 (H4R3me2s) and is involved in many key cellular processes, including hematopoiesis. However, the post-translational modifications (PTMs) of PRMT5 that may affect its biological functions remain less well-understood. In this study, using MS analyses, we found that PRMT5 itself is methylated in human erythroleukemia Lys-562 cells. Biochemical assays revealed that coactivator-associated arginine methyltransferase 1 (CARM1) interacts directly with and methylates PRMT5 at Arg-505 both in vivo and in vitro. Substitutions at Arg-505 significantly reduced PRMT5's methyltransferase activity, decreased H4R3me2s enrichment at the -globin gene promoter, and increased the expression of the -globin gene in Lys-562 cells. Moreover, CARM1 knockdown consistently reduced PRMT5 activity and activated -globin gene expression. Importantly, we show that CARM1-mediated methylation of PRMT5 is essential for the intracellular homodimerization of PRMT5 to its active form. These results thus reveal a critical PTM of PRMT5 that represses human -globin gene expression. We conclude that CARM1-mediated asymmetric methylation of PRMT5 is critical for its dimerization and methyltransferase activity leading to the repression of -globin expression. Given PRMT5's crucial role in diverse cellular processes, these findings may inform strategies for manipulating its methyltransferase activity for managing hemoglobinopathy or cancer.	[Nie, Min; Wang, Yadong; Guo, Chan; Li, Xinyu; Wang, Ying; Deng, Yexuan; Yao, Bing; Gui, Tao; Ma, Chi; Liu, Ming; Wang, Panxue; Wang, Ruoyun; Tan, Renxiang; Chen, Bing; Ju, Junyi; Zhao, Quan] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Dept Hematol,Sch Life Sci, Affiliated Drum Tower Hosp,Med Sch,China Australi, Nanjing 210023, Jiangsu, Peoples R China; [Tan, Renxiang] Nanjing Univ Chinese Med, State Key Lab Cultivat Base TCM Qual & Efficacy, Nanjing 210046, Jiangsu, Peoples R China; [Fang, Ming] Southeast Univ, Inst Life Sci, Nanjing 210096, Jiangsu, Peoples R China; [He, Yinghong] Dali Univ, Sch Basic Med, Dali 671003, Yunnan, Peoples R China; [Huang, David C. S.] Univ Melbourne, Walter & Eliza Hall Inst Med Res, Dept Med Biol, Melbourne, Vic 3010, Australia	Nanjing University; Nanjing University of Chinese Medicine; Southeast University - China; Dali University; University of Melbourne	Ju, JY; Zhao, Q (corresponding author), 163 Xianlin Ave, Nanjing 210023, Jiangsu, Peoples R China.	jujunyi@nju.edu.cn; qzhao@nju.edu.cn	Zhao, Quan/E-9147-2011; Xinyu, Li/AAG-1655-2021; Huang, David C. S./C-7586-2013	Zhao, Quan/0000-0002-8533-1938; Xinyu, Li/0000-0003-3694-4188; Huang, David C. S./0000-0002-3101-4873; ju, junyi/0000-0002-9141-2363	National Natural Science Foundation of China [NSFC 31770809, 31470750, 81700108, 31701191]; China Postdoctoral Science Foundation [2017M621706, 2016M590442]; State Key Laboratory (SKL) fund [01KF-201703]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); State Key Laboratory (SKL) fund	This work was supported by National Natural Science Foundation of China NSFC 31770809 and 31470750 (to Q. Z.), 81700108 (to J. J.), and 31701191 (to M. L.), China Postdoctoral Science Foundation 2017M621706 (to J. J.) and 2016M590442 (to M. L.), and State Key Laboratory (SKL) fund 01KF-201703 (to M. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Allis CD, 2016, NAT REV GENET, V17, P487, DOI 10.1038/nrg.2016.59; Antonysamy S, 2012, P NATL ACAD SCI USA, V109, P17960, DOI 10.1073/pnas.1209814109; Bauer UM, 2002, EMBO REP, V3, P39, DOI 10.1093/embo-reports/kvf013; Blanc RS, 2017, MOL CELL, V65, P8, DOI 10.1016/j.molcel.2016.11.003; Bode-Boger SM, 2006, J AM SOC NEPHROL, V17, P1128, DOI 10.1681/ASN.2005101119; Branscombe TL, 2001, J BIOL CHEM, V276, P32971, DOI 10.1074/jbc.M105412200; Breveglieri G, 2017, BMC MED GENET, V18, DOI 10.1186/s12881-017-0450-3; Casadio F, 2013, P NATL ACAD SCI USA, V110, P14894, DOI 10.1073/pnas.1312925110; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Chen DY, 2017, AM J HUM GENET, V101, P130, DOI 10.1016/j.ajhg.2017.05.012; Cheng DH, 2007, MOL CELL, V25, P71, DOI 10.1016/j.molcel.2006.11.019; Covic M, 2005, EMBO J, V24, P85, DOI 10.1038/sj.emboj.7600500; Cui SY, 2015, BLOOD, V126, P386, DOI 10.1182/blood-2015-02-626259; Daujat S, 2002, CURR BIOL, V12, P2090, DOI 10.1016/S0960-9822(02)01387-8; El-Shafey A, 2006, PROTEIN SCI, V15, P429, DOI 10.1110/ps.051685706; Feng Q, 2006, MOL CELL BIOL, V26, P7846, DOI 10.1128/MCB.00568-06; Frankel A, 2002, J BIOL CHEM, V277, P3537, DOI 10.1074/jbc.M108786200; Fujiwara T, 2006, MOL CELL BIOL, V26, P2273, DOI 10.1128/MCB.26.6.2273-2285.2006; Geng PY, 2017, FASEB J, V31, P2287, DOI 10.1096/fj.201601196R; Gu ZP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044033; Ju JY, 2014, NUCLEIC ACIDS RES, V42, P9740, DOI 10.1093/nar/gku718; Karkhanis V, 2011, TRENDS BIOCHEM SCI, V36, P633, DOI 10.1016/j.tibs.2011.09.001; Kawabe YI, 2012, CELL STEM CELL, V11, P333, DOI 10.1016/j.stem.2012.07.001; Kim KY, 2015, MOL CELL BIOL, V35, P238, DOI 10.1128/MCB.00945-14; Krivega I, 2015, BLOOD, V126, P665, DOI 10.1182/blood-2015-02-629972; Kuhn P, 2011, NUCLEIC ACIDS RES, V39, P2717, DOI 10.1093/nar/gkq1246; Lee J, 2002, EMBO REP, V3, P268, DOI 10.1093/embo-reports/kvf052; Li J, 2013, J IMMUNOL, V190, P597, DOI 10.4049/jimmunol.1102513; Liu F, 2015, J CLIN INVEST, V125, P3532, DOI 10.1172/JCI81749; Liu F, 2011, CANCER CELL, V19, P283, DOI 10.1016/j.ccr.2010.12.020; Naeem H, 2007, MOL CELL BIOL, V27, P120, DOI 10.1128/MCB.00815-06; Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3; Pimentel H, 2014, NUCLEIC ACIDS RES, V42, P4031, DOI 10.1093/nar/gkt1388; Quan X, 2015, J NEUROCHEM, V134, P969, DOI 10.1111/jnc.13191; Rank G, 2010, BLOOD, V116, P1585, DOI 10.1182/blood-2009-10-251116; Ratovitski T, 2015, CELL CYCLE, V14, P1716, DOI 10.1080/15384101.2015.1033595; Renneville A, 2015, BLOOD, V126, P1930, DOI 10.1182/blood-2015-06-649087; Richters A, 2017, FUTURE MED CHEM, V9, P2081, DOI 10.4155/fmc-2017-0089; Sayegh J, 2007, J BIOL CHEM, V282, P36444, DOI 10.1074/jbc.M704650200; Sims RJ, 2011, SCIENCE, V332, P99, DOI 10.1126/science.1202663; Tee WW, 2010, GENE DEV, V24, P2772, DOI 10.1101/gad.606110; Van Allen EM, 2014, CANCER DISCOV, V4, P94, DOI 10.1158/2159-8290.CD-13-0617; Wang L, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500463; Wang L, 2014, CANCER CELL, V25, P21, DOI 10.1016/j.ccr.2013.12.007; Xu J, 2013, P NATL ACAD SCI USA, V110, P6518, DOI 10.1073/pnas.1303976110; Yang YZ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7428; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Zhang HT, 2016, BBA-MOL CELL RES, V1863, P335, DOI 10.1016/j.bbamcr.2015.12.001; Zhao HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027026; Zhao Q, 2009, NAT STRUCT MOL BIOL, V16, P304, DOI 10.1038/nsmb.1568	50	15	15	3	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2018	293	45					17454	17463		10.1074/jbc.RA118.004028	http://dx.doi.org/10.1074/jbc.RA118.004028			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ9EI	30257864	hybrid, Green Published			2022-12-26	WOS:000449799000012
J	Freeman, SE; Freeman, LA; Giorli, G; Haas, AF				Freeman, Simon E.; Freeman, Lauren A.; Giorli, Giacomo; Haas, Andreas F.			Photosynthesis by marine algae produces sound, contributing to the daytime soundscape on coral reefs	PLOS ONE			English	Article							SEA; EXTINCTION; ACOUSTICS; PATTERNS; BUBBLES	We have observed that marine macroalgae produce sound during photosynthesis. The resultant soundscapes correlate with benthic macroalgal cover across shallow Hawaiian coral reefs during the day, despite the presence of other biological noise. Likely ubiquitous but previously overlooked, this source of ambient biological noise in the coastal ocean is driven by local supersaturation of oxygen near the surface of macroalgal filaments, and the resultant formation and release of oxygen-containing bubbles into the water column. During release, relaxation of the bubble to a spherical shape creates a monopole sound source that 'rings' at the Minnaert frequency. Many such bubbles create a large, distributed sound source over the sea floor. Reef soundscapes contain vast quantities of biological information, making passive acoustic ecosystem evaluation a tantalizing prospect if the sources are known. Our observations introduce the possibility of a general, volumetrically integrative, noninvasive, rapid and remote technique for evaluating algal abundance and rates of primary productivity in littoral aquatic communities. Increased algal cover is one of the strongest indicators for coral reef ecosystem stress. Visually determining variations in algal abundance is a time-consuming and expensive process. This technique could therefore provide a valuable tool for ecosystem management but also for industrial monitoring of primary production, such as in algae-based biofuel synthesis.	[Freeman, Simon E.; Freeman, Lauren A.] Naval Undersea Warfare Ctr, Newport, RI 02841 USA; [Freeman, Simon E.] US Naval Res Lab, Underwater Acoust & Signal Proc Div, Washington, DC 20375 USA; [Giorli, Giacomo] Natl Inst Water & Atmospher Res, Wellington, New Zealand; [Haas, Andreas F.] NIOZ Royal Netherlands Inst Sea Res, Dept Marine Microbiol & Biogeochem, Texel, Netherlands; [Haas, Andreas F.] Univ Utrecht, Texel, Netherlands	United States Department of Defense; United States Navy; US Navy Naval Sea Systems Command; United States Department of Defense; United States Navy; Naval Research Laboratory; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Utrecht University	Freeman, SE (corresponding author), Naval Undersea Warfare Ctr, Newport, RI 02841 USA.; Freeman, SE (corresponding author), US Naval Res Lab, Underwater Acoust & Signal Proc Div, Washington, DC 20375 USA.	simon.freeman@navy.mil		Giorli, Giacomo/0000-0003-1230-4901	NSF IGERT [0903551]; U.S. Naval Research Laboratory section 219 program funds; National Research Council; American Society for Engineering Education; NASA [NASA-14HYSP14-0003]	NSF IGERT(National Science Foundation (NSF)); U.S. Naval Research Laboratory section 219 program funds; National Research Council(Consiglio Nazionale delle Ricerche (CNR)); American Society for Engineering Education; NASA(National Aeronautics & Space Administration (NASA))	Work was supported by NSF IGERT grant no. 0903551, U.S. Naval Research Laboratory section 219 program funds, National Research Council and American Society for Engineering Education postdoctoral fellowships and NASA grant no. NASA-14HYSP14-0003.	Ainslie MA, 2011, J ACOUST SOC AM, V130, P3184, DOI 10.1121/1.3628321; Akamatsu T, 2002, J ACOUST SOC AM, V112, P3073, DOI 10.1121/1.1515799; [Anonymous], 2017, SENSORS SONDES MONIT, V11, P20; Au WWL, 1998, J ACOUST SOC AM, V103, P41, DOI 10.1121/1.423234; Bohnenstiehl DR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0143691; Boyd JWR, 2001, CHEM ENG SCI, V56, P1749, DOI 10.1016/S0009-2509(00)00540-6; Chapman NR, 2011, J ACOUST SOC AM, V129, pE161, DOI 10.1121/1.3567084; Dahl P.H., 2007, ACOUST TODAY, V3, P23, DOI [10.1121/1.2961145, DOI 10.1121/1.2961145]; Deane GB, 2002, NATURE, V418, P839, DOI 10.1038/nature00967; Dunlop RA, 2010, P ROY SOC LOND B BIO; Freeman LA, 2016, MAR ECOL PROG SER, V561, P69, DOI 10.3354/meps11938; Freeman SE, 2015, J ACOUST SOC AM, V137, P30, DOI 10.1121/1.4904523; Freeman SE, 2014, J ACOUST SOC AM, V135, P1775, DOI 10.1121/1.4865922; Giorli G, 2016, DEEP-SEA RES PT I, V107, P1, DOI 10.1016/j.dsr.2015.10.002; Giorli G, 2015, J ACOUST SOC AM, V137, P2495, DOI 10.1121/1.4919291; Haas AF, 2015, PEERJ, V3, DOI 10.7717/peerj.1390; Jackson JBC, 2008, P NATL ACAD SCI USA, V105, P11458, DOI 10.1073/pnas.0802812105; KEELING RF, 1993, J MAR RES, V51, P237, DOI 10.1357/0022240933223800; Kennedy EV, 2010, J EXP MAR BIOL ECOL, V395, P85, DOI 10.1016/j.jembe.2010.08.017; Kraines S, 1996, LIMNOL OCEANOGR, V41, P1790, DOI 10.4319/lo.1996.41.8.1790; Leighton T.G., 1994, ACOUSTIC BUBBLE, DOI DOI 10.1121/1.410082; Lillis A, 2014, MAR ECOL PROG SER, V505, P1, DOI 10.3354/meps10805; Luczkovich JJ, 2008, T AM FISH SOC, V137, P533, DOI 10.1577/T06-258.1; McCauley RD, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0195; MEDWIN H, 1970, J GEOPHYS RES, V75, P599, DOI 10.1029/JC075i003p00599; Minnaert M, 1933, PHILOS MAG, V16, P235; Pandolfi JM, 2005, SCIENCE, V307, P1725, DOI 10.1126/science.1104258; Preskitt Linda B., 2004, Pacific Science, V58, P201, DOI 10.1353/psc.2004.0021; Radford C, 2008, MAR ECOL PROG SER, V362, P37, DOI 10.3354/meps07444; Radford CA, 2011, MAR ECOL PROG SER, V438, P167, DOI 10.3354/meps09312; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; Staaterman E, 2013, CORAL REEFS, V32, P553, DOI 10.1007/s00338-012-1007-8; Staaterman E, 2014, MAR ECOL PROG SER, V508, P17, DOI 10.3354/meps10911; Sueur J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004065; TYREE MT, 1989, ANNU REV PLANT PHYS, V40, P19, DOI 10.1146/annurev.pp.40.060189.000315; Vargas-Angel B, 2017, BASELINE ASSESSMENTS; Versluis M, 2000, SCIENCE, V289, P2114, DOI 10.1126/science.289.5487.2114; Wilson CJ, 2012, MAR BIOL, V159, P2311, DOI 10.1007/s00227-012-2016-4; Wilson PS, 2009, J ACOUST SOC AM, V125, P1951, DOI 10.1121/1.3086272; Yentsch CS, 2002, J EXP MAR BIOL ECOL, V268, P171, DOI 10.1016/S0022-0981(01)00379-3	41	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0201766	10.1371/journal.pone.0201766	http://dx.doi.org/10.1371/journal.pone.0201766			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281593	Green Published, gold, Green Submitted			2022-12-26	WOS:000446342400008
J	Bandason, T; Dauya, E; Dakshina, S; McHugh, G; Chonzi, P; Munyati, S; Weiss, HA; Simms, V; Kranzer, K; Ferrand, RA				Bandason, Tsitsi; Dauya, Ethel; Dakshina, Subathira; McHugh, Grace; Chonzi, Prosper; Munyati, Shungu; Weiss, Helen A.; Simms, Victoria; Kranzer, Katharina; Ferrand, Rashida Abbas			Screening tool to identify adolescents living with HIV in a community setting in Zimbabwe: A validation study	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; CARE; METAANALYSIS; CHILDREN	Introduction A simple cost-effective strategy to pre-screen for targeted HIV testing can have substantial benefit in high burden and resource limited settings. A 4-item (previous hospitalisation, orphanhood, poor health status, and recurring skin problems) screening tool to identify adolescents living with HIV has previously shown high sensitivity in healthcare facility settings. We validated this screening tool in a community setting, in Harare, Zimbabwe in a community-based HIV prevalence survey. Methods A community-based HIV prevalence survey was conducted among individuals aged 8-17 years with guardian consent and child assent and residing in 7 communities during the period February 2015 to December 2015. Participants without previously diagnosed HIV were evaluated for the probability of having HIV using the screening tool. HIV status was defined using an anonymous HIV test which was done using Oral Mucosal Transudate (OMT). A questionnaire was also administered to ascertain self-reported HIV status and screening tool items. The validity of a 4-item screening tool was tested. Sensitivity and specificity of the screening tool was assessed against the HIV status based on OMT result. Results Prevalence survey participants were 5386 children who had an HIV test result, aged 8-17 years. However, 5384, who did not report testing HIV positive and responded to all screening tool item questions were included in the validation. Their median age was 12 (IQR: 10-15) years, 2515 (46.7%) were male. HIV prevalence was 1.3% (95% CI:1.0-1.8%). The 4-item screening tool had poor accuracy with an area under the receiver operating curve of 0.65(95% CI: 0.60-0.72) at a cut-off score >= 1. Its sensitivity was 56.3% (95% CI:44.0-68.1) and specificity of 75.1% (95% CI:73.9-76.3%), PPV of 2.9% (95% CI:2.1-3.9%) and a NPV of 99.2% (95% CI:98.9-99.5%). The number needed to test to diagnose one child using the screening tool was 55% lower than universal testing for HIV. Conclusion Use of the 4-item screening tool could be a strategy that can be adopted to identify children living with HIV in a community setting in resource limited settings by reducing the number needed to test compared to universal testing since it is inexpensive, easy to administer and not harmful. However, screening items adapted to a community setting need to be explored to improve the performance of the screening tool.	[Bandason, Tsitsi; Dauya, Ethel; Dakshina, Subathira; McHugh, Grace; Munyati, Shungu; Ferrand, Rashida Abbas] Biomed Res & Training Inst, Harare, Zimbabwe; [Chonzi, Prosper] Harare City Hlth, Harare, Zimbabwe; [Weiss, Helen A.; Simms, Victoria] LSHTM, MRC Trop Epidemiol Grp, London, England; [Kranzer, Katharina; Ferrand, Rashida Abbas] London Sch Hyg & Trop Med, London, England; [Kranzer, Katharina] Res Ctr Borstel, Borstel, Germany	Biomedical Research Training Institute; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Forschungszentrum Borstel	Bandason, T (corresponding author), Biomed Res & Training Inst, Harare, Zimbabwe.	tbandason@brti.co.zw	weiss, helen/ABC-7823-2021; Simms, Victoria/AAU-4134-2021; Simms, Victoria/C-3278-2009; Kranzer, Katharina/O-8845-2014	weiss, helen/0000-0003-3547-7936; Simms, Victoria/0000-0002-4897-458X; Kranzer, Katharina/0000-0001-5691-7270; Bandason, Tsitsi/0000-0003-0066-8345	Wellcome Trust [095878/Z/11Z]; Medical Research Council [MR/K012126/1]	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funded by Wellcome Trust (grant number 095878/Z/11Z to Dr Rashida Abbas Ferrand), Medical Research Council (grant number MR/K012126/1 to Dr Helen A Weiss, Dr Victoria Simms).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, GLON UPD HLTH SECT R; Bandason T, 2016, AIDS, V30, P779, DOI 10.1097/QAD.0000000000000959; Bandason T, 2013, AIDS CARE, V25, P1520, DOI 10.1080/09540121.2013.780120; Dakshina S, 2016, 21 INT AIDS C DURB S; Ferrand RA, 2011, TROP MED INT HEALTH, V16, P349, DOI 10.1111/j.1365-3156.2010.02708.x; Ferrand RA, 2010, CLIN INFECT DIS, V51, P844, DOI 10.1086/656361; Ferrand RA, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000178; Govindasamy D, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20182; Kayigamba FR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095459; Kranzer K, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001649; Mwinga A., 2008, Morbidity and Mortality Weekly Report, V57, P285; Pai NP, 2012, LANCET INFECT DIS, V12, P373, DOI 10.1016/S1473-3099(11)70368-1; Pufall EL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113415; Sharma M, 2015, NATURE, V528, pS77, DOI 10.1038/nature16044; Suthar AB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001496; UNAIDS, 2014, 90 90 90 AMB TREATM; WHO UNAIDS, 2007, GUID PROV IN TEST CO; World Health Organization, 2015, GUID START ANT THER	18	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0204891	10.1371/journal.pone.0204891	http://dx.doi.org/10.1371/journal.pone.0204891			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3QJ	30278064	Green Accepted, gold, Green Submitted, Green Published			2022-12-26	WOS:000446010200026
J	Mubaiwa, J; Fogliano, V; Chidewe, C; Bakker, EJ; Linnemann, AR				Mubaiwa, Juliet; Fogliano, Vincenzo; Chidewe, Cathrine; Bakker, Evert Jan; Linnemann, Anita R.			Utilization of bambara groundnut (Vigna subterranea (L.) Verdc.) for sustainable food and nutrition security in semi-arid regions of Zimbabwe	PLOS ONE			English	Article							BEANS PHASEOLUS-VULGARIS; KANWA ALKALINE SALT; PHYSICAL-PROPERTIES; FUNCTIONAL-PROPERTIES; CHEMICAL-COMPOSITION; L THOUARS; UNGUICULATA; QUALITY; AFRICA; SEEDS	Bambara groundnut (Vigna subterranea (L.) Verdc.) is an indigenous legume crop, cultivated by subsistence farmers throughout sub-Saharan countries. Research findings indicate that the crop has great nutritional and agronomic potential, but it remains scientifically neglected. A baseline study was conducted in seven districts in semi-arid regions of rural Zimbabwe to gather knowledge on current production and utilization of bambara groundnut, assess its role in providing sustainable food and nutrition security for rural populations and determine priorities for follow-up research. Results revealed a variety of bambara groundnut processing techniques, which included boiling, soaking, roasting and milling across the surveyed districts. Reported constraints to processing and consumption included long cooking time, difficulties with milling and high firewood and water requirements. Fifty to eighty percent of respondents in all districts consumed bambara groundnut once or twice weekly from August to December. Preferred consumer attributes were taste, the satiating effect, nutritional benefits or a combination of these. Current, culturally acceptable processing techniques need improvement to support sustainable bambara groundnut processing while optimising nutrient bio-accessibility. Ultimately, community resilience to food and nutrition insecurity can be promoted by exchange of bambara groundnut processing knowledge amongst the production areas, involving the different stakeholders in the food supply chains.	[Mubaiwa, Juliet] Chinhoyi Univ Technol, Dept Food Sci & Technol, Chinhoyi, Zimbabwe; [Mubaiwa, Juliet; Fogliano, Vincenzo; Linnemann, Anita R.] Food Qual & Design, Wageningen, Netherlands; [Chidewe, Cathrine] Univ Zimbabwe, Dept Biochem, Harare, Zimbabwe; [Bakker, Evert Jan] Wageningen Univ, Math & Stat Methods, Wageningen, Netherlands	Wageningen University & Research; University of Zimbabwe; Wageningen University & Research	Linnemann, AR (corresponding author), Food Qual & Design, Wageningen, Netherlands.	anita.linnemann@wur.nl	fogliano, vincenzo/W-6885-2019; Fogliano, Vincenzo/M-8166-2019; fogliano, vincenzo/A-1419-2009; Mubaiwa, Juliet/K-8392-2019; Linnemann, Anita/O-7509-2014	fogliano, vincenzo/0000-0001-8786-9355; fogliano, vincenzo/0000-0001-8786-9355; Mubaiwa, Juliet/0000-0001-9553-5830; Linnemann, Anita/0000-0003-3201-3343	Netherlands Fellowship Programmes [CF9152/2013]	Netherlands Fellowship Programmes	This research was supported by the Netherlands Fellowship Programmes (grant award CF9152/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKPAPUNAM MA, 1994, PLANT FOOD HUM NUTR, V46, P147, DOI 10.1007/BF01088767; Amarteifio J. O., 1998, Journal of Food Composition and Analysis, V11, P329, DOI 10.1006/jfca.1998.0595; Amarteifio JO, 2006, AFR J BIOTECHNOL, V5, P2408; Amarteifio J. O., 2002, Tropical Science, V42, P188; Ani D, 2013, BAMBARA GROUNDNUT PA; Annan NT, 2003, DESSEMINATION IMPROV; Asiedu R, 2010, FOOD SECUR, V2, P305, DOI 10.1007/s12571-010-0085-0; Azam-Ali S., 2001, GLOBAL MAPPING SYSTE; Azam-Ali SN, 2001, EXP AGR, V37, P433, DOI 10.1017/S0014479701000412; Berchie J. N., 2010, Journal of Agronomy, V9, P111, DOI 10.3923/ja.2010.111.118; Bisnath S., 1996, GENDER POVERTY ANAL; Boyd H.K.R., 1981, MARKETING RES TEXT C; Boye J, 2010, FOOD RES INT, V43, P414, DOI 10.1016/j.foodres.2009.09.003; BRESSANI R, 1993, FOOD REV INT, V9, P237, DOI 10.1080/87559129309540960; Browne K., 2005, INT J SOC RES METHOD, V8, P47, DOI DOI 10.1080/1364557032000081663; Burchi F, 2011, INT J ENV RES PUB HE, V8, P358, DOI 10.3390/ijerph8020358; Cavendish W, 1999, 991 U OXF; Chazovachii B, 2013, BANGLADESH E J SOCIO, V10; Clover J., 2003, AFR SECUR REV, V12, P5, DOI [10.1080/10246029.2003.9627566, DOI 10.1080/10246029.2003.9627566]; CTDT, CONS IND FOODS ZIMB; De Kock C., 2013, BAMBARA GROUNDNUT; Drechsel P, 2001, ECOL ECON, V38, P251, DOI 10.1016/S0921-8009(01)00167-7; Enwere N, 1986, TROPICAL SCI; Enwere NJ, 1996, INT J FOOD SCI NUTR, V47, P469, DOI 10.3109/09637489609031875; Garcia E, 1998, J AGR FOOD CHEM, V46, P2110, DOI 10.1021/jf970848f; Garnett T, 2013, SCIENCE, V341, P33, DOI 10.1126/science.1234485; Gomez M.I., 1989, RESOURCE INVENTORY I; Gunjal K, 2009, SPECIAL REPORT, P22; Hill LD., 1990, GRAIN GRADES STANDAR; Hillocks R. J., 2012, African Crop Science Journal, V20, P1; Jideani VA, 2009, J FOOD ENG, V92, P182, DOI 10.1016/j.jfoodeng.2008.10.040; Johnston JL, 2014, ADV NUTR, V5, P418, DOI 10.3945/an.113.005553; Kaptso KG, 2008, J FOOD ENG, V86, P91, DOI 10.1016/j.jfoodeng.2007.09.014; Linnemann AR, 1987, BAMBARA GROUNDNUT VI, V12; Mabhena C, 2012, J CONTEMP AFR STUD, V30, P219, DOI 10.1080/02589001.2012.664416; Madebwe C, 2005, PAKISTAN J SOCIAL SC, V3, P868; Madode YE, 2011, ECOL FOOD NUTR, V50, P115, DOI 10.1080/03670244.2011.552371; Madode YE, 2013, LWT-FOOD SCI TECHNOL, V54, P186, DOI 10.1016/j.lwt.2013.04.010; Makanda I., 2008, African Crop Science Journal, V16, P175; Makate C, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2802-4; Manda J, 2010, AGR HUM VALUES, V27, P85, DOI 10.1007/s10460-008-9171-8; Massawe FJ, 2005, AFR J BIOTECHNOL, V4, P463; Mataruka D., 1985, ZIMBABWE AGR J; Matsa W, 2013, TRADITIONAL SCI SEED; Mbata T. I., 2009, African Journal of Food Science (ACFS), V3, P107; Minka SR, 1999, FOOD CHEM, V64, P145, DOI 10.1016/S0308-8146(98)00166-6; Mpotokwane SM, 2008, J FOOD ENG, V89, P93, DOI 10.1016/j.jfoodeng.2008.04.006; Mubaiwa J, 2017, FOOD REV INT, V33, P167, DOI 10.1080/87559129.2016.1149864; Muimba-Kankolongo A, 2018, FOOD CROP PRODUCTION BY SMALLHOLDER FARMERS IN SOUTHERN AFRICA: CHALLENGES AND OPPORTUNITIES FOR IMPROVEMENT, P173, DOI 10.1016/B978-0-12-814383-4.00010-4; Mupawaenda AC, 2009, TROP ANIM HEALTH PRO, V41, P1017, DOI 10.1007/s11250-008-9268-5; Murevanhema YY, 2013, CRIT REV FOOD SCI, V53, P954, DOI 10.1080/10408398.2011.574803; Mwangela A, BAMBARA GROUNDNUT SI; Mwaniki A., 2006, ACHIEVING FOOD SECUR; Nhamo N., 2003, GRAIN LEGUMES GREEN, P119; Nti CA, 2009, INT J FOOD SCI TECH, V44, P2234, DOI 10.1111/j.1365-2621.2009.02064.x; Oniang'o RK, 2004, J FOOD SCI, P69; Padulosi S., 2013, FIGHTING POVERTY HUN; Phillips JG, 1998, AGR FOREST METEOROL, V90, P39, DOI 10.1016/S0168-1923(97)00095-6; PLAHAR WA, 1996, EVALUATION SOYBEAN C; Plahar WA, 2002, CROP POSTHARVEST PRO; POULTER NH, 1980, J SCI FOOD AGR, V31, P1158, DOI 10.1002/jsfa.2740311106; POULTER NH, 1981, J SCI FOOD AGR, V32, P44, DOI 10.1002/jsfa.2740320108; Powell B, 2015, FOOD SECUR, V7, P535, DOI 10.1007/s12571-015-0466-5; Proctor S, 2000, FACILITATING EFFECTI; QGIS Development Team, QGIS GEOGR INF SYST; Quaye W, 2003, SOCIOECONOMIC SURVEY; Quaye W, 2004, BAMBARA MARKETING MA, V26; Schaafsma G, 2012, BRIT J NUTR, V108, pS333, DOI 10.1017/S0007114512002541; Shiferaw B, 2011, FOOD SECUR, V3, P475, DOI 10.1007/s12571-011-0153-0; Sreerama YN, 2009, J FOOD ENG, V92, P389, DOI 10.1016/j.jfoodeng.2008.12.008; Swanevelder CJ., 1998, BAMBARA FOOD AFRICA; UZOGARA SG, 1988, FOOD CHEM, V30, P1, DOI 10.1016/0308-8146(88)90019-2; Verbeke W, 2006, FOOD QUAL PREFER, V17, P126, DOI 10.1016/j.foodqual.2005.03.003; Vermeulen SJ, 1996, HUM ECOL, V24, P479, DOI 10.1007/BF02168863; Weiss W, 2015, TRAINING COURSE SCOP; Winniefridah M., 2013, International Journal of Humanities and Social Science, V3, P234; Yadav N, 2018, INT J FOOD PROP, V21, P437, DOI 10.1080/10942912.2018.1431659	77	30	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0204817	10.1371/journal.pone.0204817	http://dx.doi.org/10.1371/journal.pone.0204817			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3QJ	30278086	Green Published, gold, Green Submitted			2022-12-26	WOS:000446010200024
J	Ongun, N				Ongun, Nedim			Does nutritional status affect Parkinson's Disease features and quality of life?	PLOS ONE			English	Article							SUBJECTIVE GLOBAL ASSESSMENT; PHYSICAL FUNCTION; DEPRESSION SCALE; CHINESE PATIENTS; OLDER-ADULTS; SHORT-FORM; MALNUTRITION; PREVALENCE; RISK; IMPAIRMENT	Objectives The aim of this study was to determine the relationship between nutritional status and Parkinson's Disease (PD) features in association with depression, anxiety and quality of life in people with PD. Materials and methods This study was conducted on 96 patients with idiopathic PD to whom the following scales were applied: Unified Parkinson's Disease Rating Scale (UPDRS), 39-item PD questionnaire (PDQ-39), Hospital Anxiety and Depression Score (HADS), Mini Nutritional Assessment (MNA). The scales and measurements were applied to patients at their first assessment. Patients with malnutrition or at risk of malnutrition were assessed by the dietitian and nutrition nurse. These patients received nutritional support through personalized diet recommendations and appropriate enteral nutritional products, considering factors such as age, comorbidity, socioeconomic and cultural conditions. At the end of 6 weeks, the scales and measurements applied during the first visit were again applied to the patients. Results A significant and inverse correlation was determined between mental (Spearman r:-0.510, p<0.001), activities of daily living (Spearman r:-0.520, p<0.001), motor (Spearman r:-0.480, p<0.001), complications (Spearman r:-0.346, p<0.001) UPDRS subdivisions and total scores (Spearman r:-0.644, p<0.001) and total MNA score. A significant and inverse correlation was found between all PDQ-39 subdomains and total MNA score (p<0.05). The highest inverse correlations were found in mobility (Spearman r:-0.690, p<0.001) and stigma (Spearman r:-0.570, p<0.001). Both depression (Spearman r:-0.631, p<0.001) and anxiety (Spearman r:-0.333, p<0.001) scores were determined to be inversely correlated with total MNA score. At the 6-week control visit, significantly lower scores were found in all subdivisions and in the total UPDRS score, PDQ-39 score and in the patients' anxiety and depression scores (p<0.05). MNA scores were found to be significantly higher in the assessment performed after 6 weeks of support for patients who had abnormal nutritional status at inception (p<0.001). Conclusion PD motor and nonmotor functions, disease duration and severity are related to nutritional status. Quality of life was also shown to be affected by changes in the nutritional status. These results show that nutritional status assessment should be a standard approach in the PD treatment and follow-up processes.	[Ongun, Nedim] Burdur State Hosp, Dept Neurol, Burdur, Turkey	Burdur State Hospital	Ongun, N (corresponding author), Burdur State Hosp, Dept Neurol, Burdur, Turkey.	nedimongun@yahoo.com						Afsar B, 2006, J RENAL NUTR, V16, P277, DOI 10.1053/j.jrn.2006.01.012; Bannerman E, 2002, PUBLIC HEALTH NUTR, V5, P655, DOI 10.1079/PHN2002336; Barichella M, 2003, EUR J CLIN NUTR, V57, P543, DOI 10.1038/sj.ejcn.1601581; Barichella M, 2008, NUTR NEUROSCI, V11, P128, DOI 10.1179/147683008X301441; Bauer JM, 2006, DEUT MED WOCHENSCHR, V131, P223, DOI 10.1055/s-2006-924953; Burgos R, 2018, CLIN NUTR, V37, P354, DOI 10.1016/j.clnu.2017.09.003; Dereli EE, 2015, ARCH NEUROPSYCHIATR, V52, P128; Fereshtehnejad SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137081; Fereshtehnejad SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091153; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Goetz CG, 2003, MOVEMENT DISORD, V18, P738, DOI 10.1002/mds.10473; Grosset KA, 2005, MOVEMENT DISORD, V20, P616, DOI 10.1002/mds.20393; Guigoz Y, 1994, FACTS RES GERONTOL, V2, P15, DOI DOI 10.1016/S0899-9007(98)00171-3; Hickson M, 2004, CLIN NUTR, V23, P213, DOI 10.1016/S0261-5614(03)00127-4; Hinnell C, 2012, MOVEMENT DISORD, V27, P236, DOI 10.1002/mds.23961; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Jaafar A, 2010, MOVEMENT DISORD, V25, pS424; Keller HH, 2004, J GERONTOL A-BIOL, V59, P68; Li HJ, 2010, MOVEMENT DISORD, V25, P2740, DOI 10.1002/mds.23368; Lorefalt B, 2004, ACTA NEUROL SCAND, V110, P180, DOI 10.1111/j.1600-0404.2004.00307.x; Mackenzie AE, 2002, DISABIL REHABIL, V24, P259, DOI 10.1080/09638380110081805; MARKUS HS, 1993, J NEURAL TRANSM-PARK, V5, P117, DOI 10.1007/BF02251202; Martinez-Martin P, 2011, MOVEMENT DISORD, V26, P399, DOI 10.1002/mds.23462; Neumann SA, 2005, J HUM NUTR DIET, V18, P129, DOI 10.1111/j.1365-277X.2005.00596.x; Olin AO, 2005, EUR J CLIN NUTR, V59, P263, DOI 10.1038/sj.ejcn.1602067; Persson MD, 2002, J AM GERIATR SOC, V50, P1996, DOI 10.1046/j.1532-5415.2002.50611.x; Peto V, 1998, J NEUROL, V245, pS10, DOI 10.1007/PL00007730; Ramaker C, 2002, MOVEMENT DISORD, V17, P867, DOI 10.1002/mds.10248; Sarikaya D, 2015, ARCH GERONTOL GERIAT, V61, P56, DOI 10.1016/j.archger.2015.04.006; Serrano-Urrea R, 2013, GERONTOLOGY, V59, P490, DOI 10.1159/000351763; Sheard JM, 2014, BMC NEUROL, V14, DOI 10.1186/s12883-014-0212-1; Sheard JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057986; Sheard JM, 2011, NUTR REV, V69, P520, DOI 10.1111/j.1753-4887.2011.00413.x; Shearer J, 2012, J NEUROL, V259, P462, DOI 10.1007/s00415-011-6202-y; Starkstein SE, 2008, MOVEMENT DISORD, V23, P538, DOI 10.1002/mds.21866; Tsai AC, 2011, INT J NURS STUD, V48, P1429, DOI 10.1016/j.ijnurstu.2011.05.004; Tumas V, 2008, ARQ NEURO-PSIQUIAT, V66, P152, DOI 10.1590/S0004-282X2008000200002; Uc EY, 2006, MOVEMENT DISORD, V21, P930, DOI 10.1002/mds.20837; Vailas LI, 1998, J AM DIET ASSOC, V98, P548, DOI 10.1016/S0002-8223(98)00123-0; Visser M, 2008, J NEUROL, V255, P1580, DOI 10.1007/s00415-008-0994-4; Visvanathan R, 2003, J AM GERIATR SOC, V51, P1007, DOI 10.1046/j.1365-2389.2003.51317.x; Wang G, 2010, PARKINSONISM RELAT D, V16, P119, DOI 10.1016/j.parkreldis.2009.08.009; Winter Y, 2010, J NEUROL, V257, P638, DOI 10.1007/s00415-009-5389-7; Wu Y, 2014, J NEUROL SCI, V340, P144, DOI 10.1016/j.jns.2014.03.014; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	45	22	23	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0205100	10.1371/journal.pone.0205100	http://dx.doi.org/10.1371/journal.pone.0205100			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV3QJ	30278074	Green Published, Green Submitted, gold			2022-12-26	WOS:000446010200038
J	Jun, DY; Jang, WY; Kim, KY; Woo, MH; Kim, YH				Jun, Do Youn; Jang, Won Young; Kim, Ki Yun; Woo, Mi Hee; Kim, Young Ho			Cytoprotective effect of 2-carbomethoxy-2,3-epoxy-3-prenyl-1,4-naphthoquinone (CMEP-NQ) is mediated by the inhibition of BAK-dependent mitochondrial apoptosis pathway	PLOS ONE			English	Article							OXYGEN SPECIES ROS; PROMETAPHASE ARREST; OXIDATIVE STRESS; CANCER-CELLS; GLUCOCORTICOIDS ACTIVATE; DRUG-RESISTANCE; SUICIDE PROCESS; KEY ROLE; MCL-1; PHOSPHORYLATION	The inhibitory mechanism of 2-carbomethoxy-2,3-epoxy-3-prenyl-1,4-naphthoquinone (CMEP-NQ) against apoptosis induced by the microtubule-damaging agents (MDAs), noco-dazole (NOC) and 2-methoxyestradiol (2-MeO-E-2), or a DNA-damaging agent (DDA), camptothecin (CPT) were investigated in human Jurkat T cell clones (J/Neo and J/BCL-XL cells). Treatment of J/Neo cells with NOC, 2-MeO-E-2, or CPT caused cytotoxicity and apoptotic DNA fragmentation but these events were significantly attenuated in the presence of CMEP-NQ. Although not only MDA (NOC or 2-MeO-E-2)-induced mitotic arrest, CDK1 activation, and BCL-2, BCL-XL and BIM phosphorylation, but also DDA (CPT)-induced S-phase arrest and ATM-CHK1/CHK2-p53 pathway activation were not or were barely affected in the presence of CMEP-NQ, the levels of anti-apoptotic BAG3 and MCL-1, which were markedly downregulated after MDA- or DDA-treatment, were rather elevated by CMEP-NQ. Under the same conditions, MDA- or DDA-induced mitochondrial apoptotic events including BAK activation, mitochondrial membrane potential (Delta psi m) loss, caspase-9 activation, and PARP cleavage were significantly inhibited by CMEP-NQ. While MDA- or DDA-induced sub-G(1) peak and Delta psi m loss were abrogated in J/BCL-XL cells, MDA-induced mitotic arrest and DDA-induced S-arrest were more apparent in J/BCL-XL cells than in J/Neo cells. Simultaneously, the induced cell cycle arrest in J/BCL-XL cells was not significantly disturbed by CMEP-NQ. MDA- or DDA-treatment caused intracellular reactive oxygen species (ROS) production; however, MDA- or DDA-induced ROS production was almost completely abrogated in J/BCL-XL cells. MDA- or DDA-induced ROS production in J/Neo cells was significantly suppressed by CMEP-NQ, but the suppressive effect was hardly observed in J/BCL-XL cells. Together, these results show that CMEP-NQ efficiently protects Jurkat T cells from apoptotic cell death via the elevation of BAG3 and MCL-1 levels, which results in the inhibition of intrinsic BAK-dependent mitochondrial apoptosis pathway, as does the overexpression of BCL-XL.	[Jun, Do Youn; Jang, Won Young; Kim, Ki Yun; Kim, Young Ho] Kyungpook Natl Univ, Coll Nat Sci, Sch Life Sci & Biotechnol, Lab Immunobiol, Daegu, South Korea; [Woo, Mi Hee] Daegu Catholic Univ, Coll Pharmacol, Gyongsan, South Korea	Kyungpook National University; Catholic University of Daegu	Kim, YH (corresponding author), Kyungpook Natl Univ, Coll Nat Sci, Sch Life Sci & Biotechnol, Lab Immunobiol, Daegu, South Korea.	ykim@knu.ac.kr		Kim, Ki Yun/0000-0003-2909-7056	National Research Foundation of Korea - Korean government [NRF-2016R1A2B4016101]	National Research Foundation of Korea - Korean government(National Research Foundation of KoreaKorean Government)	This study was supported by a grant from the National Research Foundation of Korea funded by the Korean government (NRF-2016R1A2B4016101). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by a grant from the National Research Foundation of Korea funded by the Korean government (NRF-2016R1A2B4016101).	Arciuch VGA, 2012, ANTIOXID REDOX SIGN, V16, P1150, DOI 10.1089/ars.2011.4085; Boiani M, 2013, J BIOL CHEM, V288, P6980, DOI 10.1074/jbc.M112.414177; BUTTKE TM, 1994, IMMUNOL TODAY, V15, P7, DOI 10.1016/0167-5699(94)90018-3; Carra S, 2008, AUTOPHAGY, V4, P237, DOI 10.4161/auto.5407; Chu R, 2012, BIOCHEM PHARMACOL, V83, P199, DOI 10.1016/j.bcp.2011.10.008; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x; Festa M, 2011, AM J PATHOL, V178, P2504, DOI 10.1016/j.ajpath.2011.02.002; Fiers W, 1999, ONCOGENE, V18, P7719, DOI 10.1038/sj.onc.1203249; Habata S, 2016, INT J ONCOL, V49, P402, DOI 10.3892/ijo.2016.3494; Han CR, 2014, APOPTOSIS, V19, P224, DOI 10.1007/s10495-013-0928-1; Han CR, 2013, BBA-MOL CELL RES, V1833, P2220, DOI 10.1016/j.bbamcr.2013.05.016; Harley ME, 2010, EMBO J, V29, P2407, DOI 10.1038/emboj.2010.112; Herrant M, 2004, ONCOGENE, V23, P7863, DOI 10.1038/sj.onc.1208069; Herrera B, 2001, FASEB J, V15, P741, DOI 10.1096/fj.00-0267com; Hirota T, 2005, NATURE, V438, P1176, DOI 10.1038/nature04254; Hu QS, 2016, TRANSL NEURODEGENER, V5, DOI 10.1186/s40035-016-0060-6; Jacobs AT, 2009, J BIOL CHEM, V284, P9176, DOI 10.1074/jbc.M808656200; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Jun DY, 2007, CARCINOGENESIS, V28, P1303, DOI 10.1093/carcin/bgm028; Jun DY, 2011, J MED FOOD, V14, P454, DOI 10.1089/jmf.2010.1385; KROEMER G, 1995, FASEB J, V9, P1277, DOI 10.1096/fasebj.9.13.7557017; Kummer JL, 1997, J BIOL CHEM, V272, P20490, DOI 10.1074/jbc.272.33.20490; Lee ST, 2015, BIOCHEM PHARMACOL, V94, P257, DOI 10.1016/j.bcp.2015.02.011; Mao X, 2008, CELL RES, V18, P879, DOI 10.1038/cr.2008.86; Marchi Saverio, 2012, J Signal Transduct, V2012, P329635, DOI 10.1155/2012/329635; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; MCCONKEY DJ, 1989, ARCH BIOCHEM BIOPHYS, V269, P365, DOI 10.1016/0003-9861(89)90119-7; MIGLIORATI G, 1992, CELL IMMUNOL, V143, P348, DOI 10.1016/0008-8749(92)90031-J; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Park HS, 2011, BIOCHEM PHARMACOL, V82, P1110, DOI 10.1016/j.bcp.2011.07.085; Payne BAI, 2015, BBA-BIOENERGETICS, V1847, P1347, DOI 10.1016/j.bbabio.2015.05.022; Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; RIEBER MS, 1994, BIOCHEM BIOPH RES CO, V203, P1629, DOI 10.1006/bbrc.1994.2373; Rosati A, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.24; Rudolf E, 2011, APOPTOSIS, V16, P1165, DOI 10.1007/s10495-011-0635-8; Samraj AK, 2006, ONCOGENE, V25, P186, DOI 10.1038/sj.onc.1209034; Sastre J, 2000, IUBMB LIFE, V49, P427; Schulz JB, 1996, J NEUROSCI, V16, P4696; SCHWARTZMAN RA, 1993, ENDOCR REV, V14, P133, DOI 10.1210/er.14.2.133; Son JK, 2008, CHEM PHARM BULL, V56, P213, DOI 10.1248/cpb.56.213; Sugio A, 2014, GYNECOL ONCOL, V134, P615, DOI 10.1016/j.ygyno.2014.06.024; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; TENNANT JR, 1964, TRANSPLANTATION, V2, P685, DOI 10.1097/00007890-196411000-00001; Tewari M, 1997, CANCER RES, V57, P4063; Tse WP, 2007, INT J MOL MED, V20, P663; UCKER DS, 1987, NATURE, V327, P62, DOI 10.1038/327062a0; Van Horn RD, 2010, J BIOL CHEM, V285, P21849, DOI 10.1074/jbc.M110.141010; Virador VM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005136; Wallach D, 1997, FEBS LETT, V410, P96, DOI 10.1016/S0014-5793(97)00553-X; Wang HQ, 2010, J CELL PHYSIOL, V224, P94, DOI 10.1002/jcp.22097; Weng CJ, 2005, J BIOL CHEM, V280, P10491, DOI 10.1074/jbc.M412819200; Woo HJ, 2017, J ETHNOPHARMACOL, V205, P103, DOI 10.1016/j.jep.2017.04.029; Xu Y, 2015, BIOMOLECULES, V5, P1652, DOI 10.3390/biom5031652; ZAMZAMI N, 1995, J EXP MED, V181, P1661, DOI 10.1084/jem.181.5.1661; Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013	58	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204585	10.1371/journal.pone.0204585	http://dx.doi.org/10.1371/journal.pone.0204585			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273361	Green Published, gold, Green Submitted			2022-12-26	WOS:000446124700026
J	Kassa, A; Human, SP; Gemeda, H				Kassa, Andargachew; Human, Sarie Petronella; Gemeda, Hirut			Knowledge of preconception care among healthcare providers working in public health institutions in Hawassa, Ethiopia	PLOS ONE			English	Article							RECOMMENDATIONS; DETERMINANTS; WOMEN	Background Preconception care (PCC) is an evidence-based health promotion intervention to prevent adverse pregnancy outcomes. Nevertheless, it is one of the missing elements within the continuum of maternal and child healthcare. Despite the WHO's recommendation, most of the developing countries have not yet started implementing preconception care. Objective To determine the knowledge level of healthcare providers about PCC and to identify predictors of effective knowledge of preconception care. Method This is a cross-sectional study conducted among 634 healthcare providers (HCP) working in public health institutions of Hawassa. A pilot-tested and validated self-administered survey tool was used to collect data from individual healthcare providers who were selected randomly using a multistage sampling technique. The data entry and analysis were conducted using SPSS version 20 software. Frequency, proportions, means and standard deviations were used to describe the data. Bivariate and multivariate logistic regression models were implemented to determine the predictors of HCP's PCC knowledge. Results Only a few (31%) of the healthcare providers demonstrated a good level of knowledge on preconception care. The odds of having good PCC knowledge was high among HCPs working in hospitals (AOR = 1.8, 95% C.I. 1.3-2.6), HCPs using their smart phone to access clinical resources (AOR = 1.4, 95% C.I. 1.1-2.0), among those HCPs ever have read PCC guideline prepared by organization outside of Ethiopia (AOR = 1.9, 95% C.I. 1.4-2.7), among those who claimed practicing PCC (AOR = 3.4, 95% C.I. 2.0-5.9), and among those who earn salary of >= 146.0 $(AOR = 1.5, 95% C.I. 1.1-2.1). Conclusion There is an unacceptably low level of knowledge about PCC among most of the healthcare providers in public health facilities in Ethiopia. The predictors identified in this study can be used to enhance the knowledge of healthcare providers about preconception care.	[Kassa, Andargachew; Gemeda, Hirut] Hawassa Univ, Coll Med & Hlth Sci, Sch Nursing & Midwifery, Hawassa, Ethiopia; [Human, Sarie Petronella] Univ South Africa, Coll Human Sci, Dept Hlth Sci, UNISA, Pretoria, South Africa	Hawassa University; University of South Africa	Kassa, A (corresponding author), Hawassa Univ, Coll Med & Hlth Sci, Sch Nursing & Midwifery, Hawassa, Ethiopia.	akandkassa@gmail.com		Biratu, Andargachew Kassa/0000-0003-4696-2582				ACP-ACOG, 2007, GUID PER CAR; Ajayi GO, 2013, CLIN EXP OBSTET GYN, V40, P359; Al-Darzi W, 2014, E MEDITERR HEALTH J, V20, P561, DOI 10.26719/2014.20.9.561; Asemahagn MA, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-431; Ayalew Y, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0279-4; Bradley EH, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000987; Braspenningx S, 2013, FACTS VIEWS VIS OBGY, V5, P13; BSRC, 2009, PREC HLTH PHYS PRACT; Ebrahimipour Bayram, 2013, J RES HLTH, V3; Fleuren M, 2004, INT J QUAL HEALTH C, V16, P107, DOI 10.1093/intqhc/mzh030; Fleuren MAH, 2014, INT J QUAL HEALTH C, V26, P501, DOI 10.1093/intqhc/mzu060; FMOH, 2015, FED DEM REP ETH MIN; ICF CSACEa, 2016, ETH DEM HLTH SURV 20; Kassa A, 2017, ADDRESSING HIGH ADVE; Kitamura Kazuya, 2005, BMC Fam Pract, V6, P31, DOI 10.1186/1471-2296-6-31; McCluskey A., 2003, AUST OCCUP THER J, V50, P3, DOI [10.1046/j.1440-1630.2003.00303.x, DOI 10.1046/J.1440-1630.2003.00303.X]; MOH, 2015, GUIDL MAT CAR S AFR; Moos MK, 2008, AM J OBSTET GYNECOL, V199, pS280, DOI 10.1016/j.ajog.2008.08.060; Mosale F. A., 2012, EL MINIA MED B, V23, P14; National AIDS and STI Control Programme, 2014, GUIDELINES USE ANTIR; Sanders Lorraine B, 2009, Policy Polit Nurs Pract, V10, P129, DOI 10.1177/1527154409338494; Sardasht FG, 2013, J MIDWIFERY REPROD H, V1, P10; World Health Organisation, 2013, M DEV GLOB CONS PREC; World Health Organization, 2013, PREC HLTH MAX GAINS	24	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204415	10.1371/journal.pone.0204415	http://dx.doi.org/10.1371/journal.pone.0204415			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV5EV	30273381	Green Published, gold, Green Submitted			2022-12-26	WOS:000446124700021
J	Liu, LB; Guo, YD; Xu, AD; Zhong, JX; Zhuo, WY				Liu, Li-Bin; Guo, Ya-Dong; Xu, An-Ding; Zhong, Jie-Xi; Zhuo, Wen-Yan			Diagnostic value of STAF score in combination with D-dimer in cardioembolism	PLOS ONE			English	Article							LEFT ATRIAL SIZE; ISCHEMIC-STROKE; FIBRILLATION STAF; RISK; ECHOCARDIOGRAPHY; CLASSIFICATION; DILATATION; PREVENTION; PREDICTORS; SUBTYPE	The aim of this study was to evaluate the diagnostic value of the Score for the Targeting of Atrial Fibrillation (STAF) in combination with the serum D-dimer (DD) levels in cardioembolism(CE).This study was a retrospective case-onlystudy, consecutively including patients with acute ischemic stroke. All patients were evaluated following the STAF scoring criteria and were classified according to the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) etiology classification criteria. A total of 317 patients were enrolled, including 37 CE cases (11.67%). STAF >= 5 showed a sensitivity of 89% and a specificity of 91% for the diagnosis of CE, whereas DD >791.30 ng/mL had a sensitivity of 58% and a specificity of 78%. When the STAF was used in combination with the DD level, the sensitivity was 95%, and the specificity was 100%.STAF score is an excellent tool for the diagnosis of CE when combined with DD, and can facilitate the etiological classification of acute ischemic stroke.	[Liu, Li-Bin; Guo, Ya-Dong; Zhong, Jie-Xi; Zhuo, Wen-Yan] Jinan Univ, Zhuhai Hosp, Dept Neurol, Zhuhai, Peoples R China; [Guo, Ya-Dong; Xu, An-Ding] Jinan Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou, Guangdong, Peoples R China	Jinan University; Jinan University	Zhuo, WY (corresponding author), Jinan Univ, Zhuhai Hosp, Dept Neurol, Zhuhai, Peoples R China.	zhuhaizwy@163.com		Zhuo, Wen-Yan/0000-0001-9003-4041	Medical Scientific Research Fund of Zhuhai, China [20181117A010020]	Medical Scientific Research Fund of Zhuhai, China	This study was supported by the Medical Scientific Research Fund of Zhuhai, China (Project No. 20181117A010020).	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Ageno W, 2002, ARCH INTERN MED, V162, P2589, DOI 10.1001/archinte.162.22.2589; Allessie M, 2002, CARDIOVASC RES, V54, P230, DOI 10.1016/S0008-6363(02)00258-4; Ambrosy AP, 2014, J AM COLL CARDIOL, V63, P1123, DOI 10.1016/j.jacc.2013.11.053; Arauz A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166091; BENJAMIN EJ, 1995, CIRCULATION, V92, P835, DOI 10.1161/01.CIR.92.4.835; Castellano Jose Maria, 2014, Card Electrophysiol Clin, V6, P5, DOI 10.1016/j.ccep.2013.10.007; Di Tullio MR, 1999, STROKE, V30, P2019, DOI 10.1161/01.STR.30.10.2019; Ferro JM, 2003, J NEUROL, V250, P139, DOI 10.1007/s00415-003-1017-0; Gardin JM, 2002, J AM SOC ECHOCARDIOG, V15, P275, DOI 10.1067/mje.2002.121536; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Hoit BD, 2014, J AM COLL CARDIOL, V63, P493, DOI 10.1016/j.jacc.2013.10.055; Hong KS, 2013, J STROKE CEREBROVASC, V22, pE373, DOI 10.1016/j.jstrokecerebrovasdis.2013.04.008; Horstmann S, 2013, EUR J NEUROL, V20, P147, DOI 10.1111/j.1468-1331.2012.03816.x; Isenegger J, 2010, CEREBROVASC DIS, V29, P82, DOI 10.1159/000256652; Jaroch J, 2016, POL ARCH MED WEWN, V126, P25, DOI 10.20452/pamw.3261; Kim TW, 2015, J NEUROL SCI, V354, P97, DOI 10.1016/j.jns.2015.05.008; Lai CL, 2011, ECHOCARDIOGR-J CARD, V28, P1054, DOI 10.1111/j.1540-8175.2011.01489.x; Lee MJ, 2016, J STROKE, V18, P304, DOI 10.5853/jos.2016.00290; Lin SP, 2016, INT J NEUROSCI, V25, P1; Liu LB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118301; Liu XY, 2017, J STROKE CEREBROVASC, V26, P1280, DOI 10.1016/j.jstrokecerebrovasdis.2017.01.022; Montaner J, 2008, STROKE, V39, P2280, DOI 10.1161/STROKEAHA.107.505354; Nkomo VT, 2006, LANCET, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8; Pritchett AM, 2002, J AM COLL CARDIOL, V39, p276A; Shin Hye-Young, 2013, J Cerebrovasc Endovasc Neurosurg, V15, P131, DOI 10.7461/jcen.2013.15.3.131; Suissa L, 2011, CEREBROVASC DIS, V31, P442, DOI 10.1159/000323852; Suissa L, 2009, STROKE, V40, P2866, DOI 10.1161/STROKEAHA.109.552679; Takoglu A, 2013, TURK J MED SCI, V43, P957, DOI 10.3906/sag-1208-60; VAZIRI SM, 1994, CIRCULATION, V89, P724, DOI 10.1161/01.CIR.89.2.724; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Yaghi S, 2015, STROKE, V46, P1488, DOI 10.1161/STROKEAHA.115.008711	32	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204838	10.1371/journal.pone.0204838	http://dx.doi.org/10.1371/journal.pone.0204838			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273382	gold, Green Submitted, Green Published			2022-12-26	WOS:000446124700039
J	Asberg, AN; Hagen, K; Stovner, LJ; Heuch, I; Zwart, JA; Winsvold, BS				Asberg, Anders Nikolai; Hagen, Knut; Stovner, Lars Jacob; Heuch, Ingrid; Zwart, John-Anker; Winsvold, Bendik Slagsvold			Do incident musculoskeletal complaints influence mortality? The Nord-Trondelag Health study	PLOS ONE			English	Article							POPULATION-BASED COHORT; CHRONIC WIDESPREAD PAIN; FOLLOW-UP; GLOBAL BURDEN; OLDER-ADULTS; BACK-PAIN; BODY PAIN; HUNT; EPIDEMIOLOGY; PREVALENCE	Background Musculoskeletal complaints (MSC) are common in the general population, causing a major disease burden to the individual and society. The association between MSC and mortality is still unclear. To our knowledge, no study has hitherto evaluated the association between MSC onset within the last month (incident MSC) on the one hand, and all-cause and cause-specific mortality on the other. Methods This prospective population-based cohort study was done using data from the second Nord-Trondelag Health Study (HUNT2) linked with data from a comprehensive national registry of cause of death. A total of 25,931 participants at risk for incident MSC were included. Hazard ratios (HR) of mortality were estimated for participants with incident MSC using Cox regression based on a mean of 14.1 years of follow-up. Results Participants who reported incident MSC did not have an excess mortality compared to those with no MSC in the analyses of all-cause mortality (HR 0.99, 95% CI 0.89-1.10) and cause specific mortality. This was true also after adjustment for several potential confounding factors. No clear association between the number of MSC body sites and mortality was found. Conclusion Incident MSC were not associated with an increased mortality, neither for all-cause mortality, nor cause-specific mortality.	[Asberg, Anders Nikolai; Hagen, Knut; Stovner, Lars Jacob] NTNU Norwegian Univ Sci & Technol, Dept Neurosci, Trondheim, Norway; [Hagen, Knut; Stovner, Lars Jacob] St Olays Univ Hosp, Norwegian Advisory Unit Headache, Trondheim, Norway; [Heuch, Ingrid; Zwart, John-Anker] Oslo Univ Hosp, Div Clin Neurosci, Dept Res Innovat & Educ, Oslo, Norway; [Zwart, John-Anker; Winsvold, Bendik Slagsvold] Univ Oslo, Inst Clin Med, Oslo, Norway; [Winsvold, Bendik Slagsvold] Oslo Univ Hosp, Dept Neurol, Oslo, Norway; [Winsvold, Bendik Slagsvold] Oslo Univ Hosp, FORMI, Oslo, Norway	Norwegian University of Science & Technology (NTNU); University of Oslo; University of Oslo; University of Oslo; University of Oslo	Asberg, AN (corresponding author), NTNU Norwegian Univ Sci & Technol, Dept Neurosci, Trondheim, Norway.	anders.n.asberg@ntnu.no	Winsvold, Bendik/ABF-7839-2021	Winsvold, Bendik/0000-0003-4171-8919				Ahacic K, 2010, PAIN, V151, P206, DOI 10.1016/j.pain.2010.07.011; Alfsen G Cecilie, 2012, Tidsskr Nor Laegeforen, V132, P147, DOI 10.4045/tidsskr.11.0427; Andersson HI, 2009, DISABIL REHABIL, V31, P1980, DOI 10.3109/09638280902874154; Andorsen OF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181417; Andorsen OF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164341; Asberg AN, 2016, PAIN, V157, P1443, DOI 10.1097/j.pain.0000000000000537; Bergman S, 2005, DISABIL REHABIL, V27, P675, DOI 10.1080/09638280400009030; Bergman S, 2001, J RHEUMATOL, V28, P1369; Cimmino MA, 2011, BEST PRACT RES CL RH, V25, P173, DOI 10.1016/j.berh.2010.01.012; Docking RE, 2015, EUR J PAIN, V19, P466, DOI 10.1002/ejp.568; Ekholm O, 2014, PAIN, V155, P2486, DOI 10.1016/j.pain.2014.07.006; Fagerstrom K, 2002, DRUGS, V62, P1, DOI 10.2165/00003495-200262002-00001; Gustavsson A, 2012, EUR J PAIN, V16, P289, DOI 10.1016/j.ejpain.2011.07.006; Hagen K, 2006, SPINE, V31, P2146, DOI 10.1097/01.brs.0000231734.56161.6b; Hagen K, 2011, PAIN MED, V12, P1657, DOI 10.1111/j.1526-4637.2011.01240.x; Hartvigsen J, 2014, SCAND J PUBLIC HEALT, V42, P698, DOI 10.1177/1403494814542263; Holley AL, 2017, PAIN, V158, P794, DOI 10.1097/j.pain.0000000000000817; Holley AL, 2017, CLIN J PAIN, V33, P28, DOI 10.1097/AJP.0000000000000371; Holmen J, 2003, NORSK EPIDEMIOLOGI, V13, P19, DOI DOI 10.1093/eurheartj/eht019; Holth HS, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-159; Jimenez-Sanchez S, 2010, J PAIN, V11, P612, DOI 10.1016/j.jpain.2009.09.015; Kvalheim S, 2013, PAIN, V154, P1073, DOI 10.1016/j.pain.2013.03.015; Macfarlane GJ, 2007, RHEUMATOLOGY, V46, P805, DOI 10.1093/rheumatology/kel403; Macfarlane GJ, 2017, ANN RHEUM DIS, V76, P1815, DOI 10.1136/annrheumdis-2017-211476; Macfarlane GJ, 2001, BRIT MED J, V323, P662, DOI 10.1136/bmj.323.7314.662; McBeth J, 2009, RHEUMATOLOGY, V48, P74, DOI 10.1093/rheumatology/ken424; McBeth J, 2007, BEST PRACT RES CL RH, V21, P403, DOI 10.1016/j.berh.2007.03.003; MONTO AS, 1974, JAMA-J AM MED ASSOC, V227, P164, DOI 10.1001/jama.227.2.164; Moradi-Lakeh M, 2017, ANN RHEUM DIS, V76, P1365, DOI 10.1136/annrheumdis-2016-210146; Mykletun A, 2001, BRIT J PSYCHIAT, V179, P540, DOI 10.1192/bjp.179.6.540; Nitter AK, 2013, SCAND J PAIN, V4, P86, DOI 10.1016/j.sjpain.2012.12.002; Pedersen AG, 2015, TIDSSKR NORSKE LAEGE, V135, P768, DOI 10.4045/tidsskr.14.1065; Schisterman EF, 2009, EPIDEMIOLOGY, V20, P488, DOI 10.1097/EDE.0b013e3181a819a1; Scott WK, 1997, J CLIN EPIDEMIOL, V50, P291, DOI 10.1016/S0895-4356(96)00365-4; Smith BH, 2001, FAM PRACT, V18, P292, DOI 10.1093/fampra/18.3.292; Smith D, 2017, ARTHRITIS CARE RES, DOI 10.1002/acr.23268; Smith D, 2018, PAIN, V159, P1112, DOI 10.1097/j.pain.0000000000001193; Torrance N, 2010, EUR J PAIN, V14, P380, DOI 10.1016/j.ejpain.2009.07.006; Videm V, 2017, J RHEUMATOL, V44, P1134, DOI 10.3899/jrheum.161396; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Weiner DK, 2003, PAIN MED, V4, P311, DOI 10.1111/j.1526-4637.2003.03042.x; Wolfe F, 2011, ARTHRIT CARE RES, V63, P94, DOI 10.1002/acr.20301; Woolf AD, 2003, B WORLD HEALTH ORGAN, V81, P646	44	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0203925	10.1371/journal.pone.0203925	http://dx.doi.org/10.1371/journal.pone.0203925			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265708	Green Published, gold, Green Submitted			2022-12-26	WOS:000446005500013
J	Puzo, Q; Mehlum, L; Qin, P				Puzo, Quirino; Mehlum, Lars; Qin, Ping			Rates and characteristics of suicide by immigration background in Norway	PLOS ONE			English	Article							PSYCHOLOGICAL DISTRESS; MENTAL-HEALTH; OSLO HEALTH; SOCIAL INTEGRATION; INCOME COUNTRIES; AUSTRALIA; POPULATION; MORTALITY; SWEDEN; 1ST-GENERATION	Suicide mortality among immigrant groups is an important health issue, particularly in countries with growing segments of immigrant populations such as Norway. Through linkage of Norwegian national registers we wanted to estimate suicide rates (per 100,000 population) in immigrant groups and to profile characteristics of suicide by immigration background with respect to sex, age, method and seasonality of suicide as well as time since immigrating to Norway. Among all 11,409 suicides during 1992-2012, 1,139 (10%) were individuals with an immigration background. Suicide rate was lower in first-generation immigrants (foreign-born persons to two foreign-born parents) than native Norwegians (9.53 vs 12.22, P < 0.01), with a significant difference confined to male rates only. Foreign-born persons with at least one Norwegian-born parent had significantly higher suicide rates than natives in both sexes (22.42 vs 18.03 in males, 11.67 vs 6.54 in females, P < 0.01). The most frequently used suicide method in all the population groups was hanging; this method accounted for 44.0% of all suicides of first-generation immigrants, 45.2% of all suicides of foreign-born persons with at least one Norwegian-born parent, and 35.4% of all suicides of natives. Suicide by firearms accounted for a much smaller proportion of cases of first-generation immigrants (6.7%) and foreign-born persons with at least one Norwegian-born parent (6.8%) than cases of native Norwegians (20.7%). In terms of monthly distribution, suicides of first-generation immigrants displayed two peaks, in May and in November (P= 0.01). More than 25% of all first-generation immigrant suicides occurred in the first five years after immigration; but differences in time since immigration were observed by sex and country group of origin, in particular among those aged 35 years or less when moving to Norway. In conclusion, there are notable differences in characteristics of suicides by immigration background. Knowledge of immigrant mortality according to suicide method, seasonality of suicide, and time since immigration may be useful when planning suicide preventive measures.	[Puzo, Quirino; Mehlum, Lars; Qin, Ping] Univ Oslo, Natl Ctr Suicide Res & Prevent, Inst Clin Med, Oslo, Norway	University of Oslo	Puzo, Q (corresponding author), Univ Oslo, Natl Ctr Suicide Res & Prevent, Inst Clin Med, Oslo, Norway.	quirino.puzo@medisin.uio.no	Mehlum, Lars/AAV-9241-2021					Abebe DS, 2014, J IMMIGR MINOR HEALT, V16, P60, DOI 10.1007/s10903-012-9745-9; Alpers P, 2018, NORWAY GUN FACTS FIG; [Anonymous], 2006, SOCIAL EC DIMENSIONS; Ashwood JS, 2017, RAND HLTH Q, V6; Berkman LF, 2000, SOC SCI MED, V51, P843, DOI 10.1016/S0277-9536(00)00065-4; Bhugra D, 2004, ACTA PSYCHIAT SCAND, V109, P243, DOI 10.1046/j.0001-690X.2003.00246.x; Bhugra Dinesh, 2005, World Psychiatry, V4, P18; Bramness JG, 2015, AM J EPIDEMIOL, V182, P244, DOI 10.1093/aje/kwv064; Burvill PW, 1998, PSYCHOL MED, V28, P201, DOI 10.1017/S0033291797005850; Christodoulou C., 2012, ENCEPHALOS, V49, P9; Dalgard OS, 2006, SCAND J PSYCHOL, V47, P551, DOI 10.1111/j.1467-9450.2006.00546.x; Dalgard Odd Steffen, 2007, Clin Pract Epidemiol Ment Health, V3, P24, DOI 10.1186/1745-0179-3-24; De La Rica S., 2015, OXFORD EC INT MIGR B, V1B, P1303; De Leo D, 2003, SUICIDE LIFE-THREAT, V33, P151, DOI 10.1521/suli.33.2.151.22775; Ekblad S, 2013, TRANSCULT PSYCHIATRY, V50, P841, DOI 10.1177/1363461513511181; Erlangsen A, 2018, STUDIES SUICIDAL BEH; GABENNESCH H, 1988, SOC FORCES, V67, P129, DOI 10.2307/2579103; Gjertsen F, 2014, INT J ENV RES PUB HE, V11, P487, DOI 10.3390/ijerph110100487; Hakko H, 1998, ACTA PSYCHIAT SCAND, V98, P92, DOI 10.1111/j.1600-0447.1998.tb10048.x; Hanigan IC, 2012, P NATL ACAD SCI USA, V109, P13950, DOI 10.1073/pnas.1112965109; Henriksen K, 2011, IMMIGRATION IMMIGRAN; Hjern A, 2002, LANCET, V360, P443, DOI 10.1016/S0140-6736(02)09674-5; Hjern A, 2002, SOC PSYCH PSYCH EPID, V37, P423, DOI 10.1007/s00127-002-0564-5; Holopainen J, 2013, ENVIRON HEALTH PREV, V18, P494, DOI 10.1007/s12199-013-0348-4; Ide N, 2012, SOC PSYCH PSYCH EPID, V47, P1917, DOI 10.1007/s00127-012-0499-4; Johansson LM, 1997, SOC PSYCH PSYCH EPID, V32, P165; Johansson LM, 1997, SOC SCI MED, V44, P181, DOI 10.1016/S0277-9536(96)00142-6; Karasouli E, 2014, JMIR MENT HEALTH, V1, DOI 10.2196/mental.3708; Kliewer E, 1991, J Aust Popul Assoc, V8, P111; KLIEWER EV, 1988, AM J EPIDEMIOL, V127, P640, DOI 10.1093/oxfordjournals.aje.a114839; Kolves K, 2018, PSYCHIAT RES, V260, P67, DOI 10.1016/j.psychres.2017.11.035; Kposowa AJ, 2008, ARCH SUICIDE RES, V12, P82, DOI 10.1080/13811110701801044; Makinen I. H., 2003, ARCH SUICIDE RES, V7, P93, DOI DOI 10.1080/13811110301574; Marie N, 2010, INT J PUBLIC HEALTH, V55, P413, DOI [10.1007/s00038-010-0162-3, 10.1007/s00038-010-0190-z]; MARMOT MG, 1984, LANCET, V1, P1455, DOI 10.1016/S0140-6736(84)91943-3; Mirsky J, 2008, J CLIN PSYCHIAT, V69, P1715, DOI 10.4088/JCP.v69n1106; Mirsky J, 2011, SOC PSYCH PSYCH EPID, V46, P1133, DOI 10.1007/s00127-010-0280-5; NIPH, 2016, CAUS DEATH STAT; Nystadnes T., 2010, 100012010 KITH; Ostby L., 2013, CHANGE INTEGRATION; Park S, 2014, INT J MENT HEALTH SY, V8, DOI 10.1186/1752-4458-8-22; Patel K, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-017-0463-1; Pedersen AG, 2015, TIDSSKR NORSKE LAEGE, V135, P768, DOI 10.4045/tidsskr.14.1065; Pedersen CB, 2006, DAN MED BULL, V53, P441; Petridou E, 2002, EPIDEMIOLOGY, V13, P106, DOI 10.1097/00001648-200201000-00017; Population Statistics, 2022, IMM NORW BORN IMM PA; Postolache TT, 2010, J AFFECT DISORDERS, V121, P88, DOI 10.1016/j.jad.2009.05.015; Puzo Q, 2017, ACTA PSYCHIAT SCAND, V135, P584, DOI 10.1111/acps.12732; Puzo Q, 2018, J PSYCHIAT RES; Puzo Q, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2919-y; Qin P, 2003, ARCH GEN PSYCHIAT, V60, P797, DOI 10.1001/archpsyc.60.8.797; Ratkowska KA, 2013, OPEN J MED PSYCHOL, V2, P10; RCoreTeam, 2017, R LANG ENV STAT COMP; Reneflot A, 2018, SUICIDE SUICIDE ATTE; Sandnes Toril., 2017, INNVANDRERE NORGE 20; SSB, 2017, TABL 05182 PERS IMM; SSB, 2016, EMPL IMM STAT NORW; SSB, 2008, LIV COND IMM STAT NO; SSB, 2016, IMM REAS IMM STAT NO; SSB, 2011, IMM CAT 2008 STAT NO; SSB, 2018, REG UN IMM STAT NORW; SSB, 2017, TABL 05196 POP SEX A; Stack S., 2000, MEDIA IMPACTS SUICID, P957; Straiton M, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-341; Sumarokov YA, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0601-z; Syed HR, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-182; Thapa SB, 2005, SOC PSYCH PSYCH EPID, V40, P78, DOI 10.1007/s00127-005-0855-8; Thapa SB, 2007, NORD J PSYCHIAT, V61, P459, DOI 10.1080/08039480701773261; Tollefsen IM, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009120; UN, 2017, INT MIGR REP 2017 UN; WHO, 2014, SUIC RAT PER 100 000; Yamaguchi S, 2013, J NERV MENT DIS, V201, P490, DOI 10.1097/NMD.0b013e31829480df	72	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0205035	10.1371/journal.pone.0205035	http://dx.doi.org/10.1371/journal.pone.0205035			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV3OT	30265720	Green Published, Green Submitted, gold			2022-12-26	WOS:000446005500063
J	Cohen, Y; Rubin, AE; Galperin, M				Cohen, Yigal; Rubin, Avia Evgenia; Galperin, Mariana			Oxathiapiprolin-based fungicides provide enhanced control of tomato late blight induced by mefenoxam-insensitive Phytophthora infestans	PLOS ONE			English	Article							PHENYLAMIDE FUNGICIDES; ROOT-ROT; SENSITIVITY; RESISTANCE; NICOTIANAE; TOBACCO; CAPSICI; MILDEW	Oxathiapiprolin is a new fungicide with extremely high efficacy against oomycete plant pathogens. Solo components oxathiapiprolin (OXPT), chlorothalonil (CHT), azoxystrobin (AZ), mandipropamid (MPD), and mefenoxam (MFX) were compared with each other and with four oxathiapiprolin pre-packed fungicidal mixtures, OXPT+CHT 1+66.7, OXPT+AZ 1+10.3, OXPT+MPD 1+8.3, and OXPT+MFX 1+3 (weight active ingredient ratio), for control efficacy of late blight induced by MFX-insensitive Phytophthora infestans strains in tomato in growth chambers and the field. Mixtures performed better than all partner fungicides alone, except OXPT. Of the four mixtures, OXPT+MFX outperformed, with the highest preventive, curative, translaminar, and systemic efficacies. In the field, OXPT+MFX was superior to other fungicides in controlling late blight epidemics induced by MFX-insensitive isolates. Its deployment in the field will combat the dominating MFX-insensitive isolates, reduce the selection pressure imposed on P. infestans and delay the buildup of subpopulations resistant to oxathiapiprolin.	[Cohen, Yigal; Rubin, Avia Evgenia; Galperin, Mariana] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel	Bar Ilan University	Cohen, Y (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel.	ycohen@biu.ac.il		cohen, yigal/0000-0002-4443-1940				Andreassi I. I. J. L., 2013, International Patent, Patent No. [WO13/009971, 13009971]; Belisle RJ, 2017, PHYTOPATHOLOGY, V107, P182; Bittner R, 2016, PHYTOPATHOLOGY, V106, P76; Bittner RJ, 2017, CROP PROT, V93, P9, DOI 10.1016/j.cropro.2016.10.019; COHEN Y, 1990, PHYSIOL MOL PLANT P, V36, P191, DOI 10.1016/0885-5765(90)90025-S; Cohen Y, 2007, PLANT PATHOL, V56, P836, DOI 10.1111/j.1365-3059.2007.01625.x; Cohen Y, 2017, PHYTOPATHOLOGY, V107, P1149, DOI [10.1094/PHYTO-01-17-0017-FI, 10.1094/PHYTO-01-17-0017-F1]; Cohen Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140015; Gisi U, 1996, ANNU REV PHYTOPATHOL, V34, P549, DOI 10.1146/annurev.phyto.34.1.549; Gray MA, 2017, PHYTOPATHOLOGY, V107, P186; Ji P, 2015, ANN APPL BIOL, V166, P229, DOI 10.1111/aab.12176; Kosman E, 1996, PHYTOPATHOLOGY, V86, P1263; LEVY Y, 1986, Bulletin OEPP, V16, P651, DOI 10.1111/j.1365-2338.1986.tb00338.x; Miao J, 2018, PESTICIDE BIOCH PHYS; Miao JQ, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00615; Olaya G, 2016, PHYTOPATHOLOGY, V106, P76; Pasteris RJ, World Patent Appl, Patent No. [WO2,008,013,9252008, 2008013925]; Pasteris RJ, 2016, BIOORGAN MED CHEM, V24, P354, DOI 10.1016/j.bmc.2015.07.064; Qu TL, 2016, PLANT DIS, V100, P2119, DOI 10.1094/PDIS-04-16-0429-RE; Rubin AE, 2011, EUR J PLANT PATHOL, V129, P339, DOI 10.1007/s10658-010-9698-6; Rubin A, 2008, PLANT DIS, V92, P675, DOI 10.1094/PDIS-92-5-0675; Saheki Y, 2017, ANNU REV BIOCHEM, V86, P659, DOI 10.1146/annurev-biochem-061516-044932; Weber-Boyvat M, 2013, BIOCHEM PHARMACOL, V86, P89, DOI 10.1016/j.bcp.2013.02.016	23	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204523	10.1371/journal.pone.0204523	http://dx.doi.org/10.1371/journal.pone.0204523			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30260986	Green Published, Green Submitted, gold			2022-12-26	WOS:000445907400064
J	Hamidian, M; Hall, RM				Hamidian, Mohammad; Hall, Ruth M.			Genetic structure of four plasmids found in Acinetobacter baumannii isolate D36 belonging to lineage 2 of global clone 1	PLOS ONE			English	Article							GENOMIC RESISTANCE ISLANDS; AMINOGLYCOSIDE RESISTANCE; ANTIMICROBIAL RESISTANCE; CONJUGATIVE PLASMID; SUL2 SULFONAMIDE; CARBAPENEM; EVOLUTION; IDENTIFICATION; SEQUENCE; REGION	Four plasmids ranging in size from 4.7 to 44.7 kb found in the extensively antibiotic resistant Acinetobacter baumannii isolate D36 that belongs to lineage 2 of global clone 1 were examined. D36 includes two cryptic plasmids and two carrying antibiotic resistance genes. The smallest plasmid pD36-1 (4.7 kb) carries no resistance genes but includes mobA and mobC mobilisation genes related to those found in pRAY* (pD36-2, 6,078 bp) that also carries the aadB gentamicin, kanamycin and tobramycin resistance gene cassette. These two plasmids do not encode a Rep protein. Plasmid pRAY* was found to be mobilised at high frequency by the large conjugative plasmid pA297-3 but a pRAY* derivative lacking the mobA and mobC genes was not. The two larger plasmids, pD36-3 and pD36-4, encode Rep_3 family proteins (Pfam1051). The cryptic plasmid pD36-3 (6.2 kb) has RepAci1 and pD36-4 (44.7 kb) encodes two novel Rep_3 family proteins suggesting a co-integrate. Plasmid pD36-4 includes the sul2 sulfonamide resistance gene, the aphA1a kanamycin/neomycin resistance gene in Tn4352::ISAba1 and a mer module in a hybrid Tn501/Tn1696 transposon conferring resistance to mercuric ions. New examples of dif modules flanked by pdif sites (XerC-XerD binding sites) that are part of many A. baumannii plasmids were also identified in pD36-3 and pD36-4 which carry three and two dif modules, respectively. Homologs of three dif modules, the sup sulphate permease module in pD36-3, and of the abkAB toxin-antitoxin module and the orf module in pD36-4, were found in different contexts in diverse Acinetobacter plasmids, consistent with module mobility. A novel insertion sequence named ISAba32 found next to the pdif site in the abkAB dif module is related to members of the ISAjo2 group which also are associated with the pdif sites of dif modules. Plasmids found in D36 were also found in some other members of GC1 lineage 2.	[Hamidian, Mohammad] Univ Technol Sydney, Ithree Inst, Ultimo, NSW, Australia; [Hall, Ruth M.] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia	University of Technology Sydney; University of Sydney	Hamidian, M (corresponding author), Univ Technol Sydney, Ithree Inst, Ultimo, NSW, Australia.	Mohammad.Hamidian@uts.edu.au	Hamidian, Mehrad/Q-7839-2016	Hamidian, Mehrad/0000-0002-3614-7261	Chancellor's Postdoctoral Research Fellowship (CPDRF) from the University of Technology Sydney; National Health and Medical Research Council (NHMRC) [1079616]	Chancellor's Postdoctoral Research Fellowship (CPDRF) from the University of Technology Sydney; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	MH is supported by the Chancellor's Postdoctoral Research Fellowship (CPDRF) received from the University of Technology Sydney (https://www.uts.edu.au/). Funding for this study was received from National Health and Medical Research Council (NHMRC) grant 1079616 (https://www.nhmrc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2010, ANTIMICROB AGENTS CH, V54, P3569, DOI 10.1128/AAC.00057-10; Adams MD, 2008, J BACTERIOL, V190, P8053, DOI 10.1128/JB.00834-08; Bertini A, 2010, ANTIMICROB AGENTS CH, V54, P4168, DOI 10.1128/AAC.00542-10; Blackwell GA, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.00780-17; Blackwell GA, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00117-16; Brantl S, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.PLAS-0001-2013; Cameranesi MM, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00066; Cameranesi MM., 2017, J INFECT DIS EPIDEMI, V3, P046, DOI [10.23937/2474-3658/1510046, DOI 10.23937/2474-3658/1510046]; CAMERON FH, 1986, NUCLEIC ACIDS RES, V14, P8625, DOI 10.1093/nar/14.21.8625; D'Andrea MM, 2009, ANTIMICROB AGENTS CH, V53, P3528, DOI 10.1128/AAC.00178-09; Garcillan-Barcia MP, 2009, FEMS MICROBIOL REV, V33, P657, DOI 10.1111/j.1574-6976.2009.00168.x; Hamidian Mohammad, 2017, Genome Announc, V5, DOI 10.1128/genomeA.00836-17; Hamidian M, 2016, PLASMID, V87-88, P43, DOI 10.1016/j.plasmid.2016.09.001; Hamidian Mohammad, 2015, Genome Announc, V3, DOI 10.1128/genomeA.01478-15; Hamidian M, 2014, J ANTIMICROB CHEMOTH, V69, P2625, DOI 10.1093/jac/dku188; Hamidian M, 2014, J ANTIMICROB CHEMOTH, V69, P955, DOI 10.1093/jac/dkt454; Hamidian M, 2014, J ANTIMICROB CHEMOTH, V69, P77, DOI 10.1093/jac/dkt312; Hamidian M, 2012, J ANTIMICROB CHEMOTH, V67, P2833, DOI 10.1093/jac/dks318; Hamidian M, 2011, J ANTIMICROB CHEMOTH, V66, P2484, DOI 10.1093/jac/dkr356; Holt K, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000052; Holt KE, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00032-15; Jones LS, 2014, ANTIMICROB AGENTS CH, V58, P4211, DOI 10.1128/AAC.02500-14; Jurenaite M, 2013, J BACTERIOL, V195, P3165, DOI 10.1128/JB.00237-13; Kurakov A, 2016, PLASMID, V84-85, P36, DOI 10.1016/j.plasmid.2016.02.005; Merino M, 2010, ANTIMICROB AGENTS CH, V54, P2724, DOI 10.1128/AAC.01674-09; Mindlin S, 2018, FEMS MICROBIOL LETT, V365, DOI 10.1093/femsle/fny047; Nigro SJ, 2016, J ANTIMICROB CHEMOTH, V71, P2432, DOI 10.1093/jac/dkw176; Nigro SJ, 2015, J ANTIMICROB CHEMOTH, V70, P1259, DOI 10.1093/jac/dku486; Nigro SJ, 2011, J ANTIMICROB CHEMOTH, V66, P2175, DOI 10.1093/jac/dkr230; Post V, 2010, J ANTIMICROB CHEMOTH, V65, P1162, DOI 10.1093/jac/dkq095; Post V, 2009, ANTIMICROB AGENTS CH, V53, P2667, DOI 10.1128/AAC.01407-08; Rice LB, 2008, J INFECT DIS, V197, P1079, DOI 10.1086/533452; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; WRIGHTON CJ, 1987, PLASMID, V17, P37, DOI 10.1016/0147-619X(87)90006-0; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zarrilli R, 2013, INT J ANTIMICROB AG, V41, P11, DOI 10.1016/j.ijantimicag.2012.09.008	36	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204357	10.1371/journal.pone.0204357	http://dx.doi.org/10.1371/journal.pone.0204357			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30260997	Green Submitted, Green Published, gold			2022-12-26	WOS:000445907400040
J	McGlashan, EM; Burns, AC; Murray, JM; Sletten, TL; Magee, M; Rajaratnam, SMW; Cain, SW				McGlashan, Elise M.; Burns, Angus C.; Murray, Jade M.; Sletten, Tracey L.; Magee, Michelle; Rajaratnam, Shantha M. W.; Cain, Sean W.			The pupillary light reflex distinguishes between circadian and non-circadian delayed sleep phase disorder (DSPD) phenotypes in young adults	PLOS ONE			English	Article							EXOGENOUS MELATONIN; HEALTHY-YOUNG; MELANOPSIN; SENSITIVITY; DIAGNOSIS; CELLS	This study investigated the utility of the pupillary light reflex as a method of differentiating DSPD patients with delayed melatonin timing relative to desired/required sleep time (circadian type) and those with non-delayed melatonin timing (non-circadian type). All participants were young adults, with a total of 14 circadian DSPD patients (M = 28.14, SD = 5.26), 12 non-circadian DSPD patients (M = 29.42, SD = 11.51) and 51 healthy controls (M = 21.47 SD = 3.16) completing the protocol. All participants were free of central nervous system acting medications and abstained from caffeine and alcohol on the day of the assessment. Two pupillary light reflex measurements were completed by each participant, one with a 1s dim (similar to 10 lux) light exposure, and one with a 1s bright (similar to 1500 lux) light exposure. Circadian DSPD patients showed a significantly faster pupillary light reflex than both non-circadian DSPD patients and healthy controls. Non-circadian patients and healthy controls did not differ significantly. Receiver operating characteristic curves were generated to determine the utility of mean and maximum constriction velocity in differentiating the two DSPD phenotypes, and these demonstrated high levels of sensitivity (69.23 +/- -100%) and specificity (66.67 +/- 91.67%) at their optimal cut offs. The strongest predictor of DSPD phenotype was the mean constriction velocity to bright light (AUC = 0.87). These results support the potential for the pupillary light reflex to clinically differentiate between DSPD patients with normal vs. delayed circadian timing relative to desired bedtime, without the need for costly and time-consuming circadian assessments.	[Cain, Sean W.] Monash Univ, Monash Inst Cognit & Clin Neurosci, Melbourne, Vic, Australia; Monash Univ, Sch Psychol Sci, Melbourne, Vic, Australia	Monash University; Monash University	Cain, SW (corresponding author), Monash Univ, Monash Inst Cognit & Clin Neurosci, Melbourne, Vic, Australia.	sean.cain@monash.edu	Magee, Michelle/F-5888-2019; McGlashan, Elise/AAC-1190-2019	Magee, Michelle/0000-0001-6642-0882; McGlashan, Elise/0000-0002-3864-7198; Burns, Angus/0000-0001-6336-5531; Rajaratnam, Shantha/0000-0001-7527-8558; Sletten, Tracey/0000-0002-0005-7838; Cain, Sean/0000-0002-8385-1550	National Health and Medical Research Council [1031513, 1087665]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by the National Health and Medical Research Council, projects 1031513 awarded to SMW Rajaratnam, and 1087665 awarded to SWC, https://www.nhmrc.gov.au/.	Adhikari P, 2015, INVEST OPHTH VIS SCI, V56, P3838, DOI 10.1167/iovs.14-16233; Aickin M, 1996, AM J PUBLIC HEALTH, V86, P726, DOI 10.2105/AJPH.86.5.726; American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS; Aoki H, 2001, CHRONOBIOL INT, V18, P263, DOI 10.1081/CBI-100103190; Bitsios P, 1996, AGE AGEING, V25, P432, DOI 10.1093/ageing/25.6.432; Brzezinski A, 2005, SLEEP MED REV, V9, P41, DOI 10.1016/j.smrv.2004.06.004; Burgess Helen J, 2003, Behav Sleep Med, V1, P102, DOI 10.1207/S15402010BSM0102_3; Flynn-Evans EE, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx163; Gooley JJ, 2003, J NEUROSCI, V23, P7093, DOI 10.1523/JNEUROSCI.23-18-07093.2003; Gooley JJ, 2012, J NEUROSCI, V32, P14242, DOI 10.1523/JNEUROSCI.1321-12.2012; Gooley JJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000741; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Hallam KT, 2006, PSYCHONEUROENDOCRINO, V31, P867, DOI 10.1016/j.psyneuen.2006.04.004; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Khalsa SBS, 2003, J PHYSIOL-LONDON, V549, P945, DOI 10.1113/jphysiol.2003.040477; Lucas RJ, 2014, TRENDS NEUROSCI, V37, P1, DOI 10.1016/j.tins.2013.10.004; Magee M, 2016, SLEEP MED CLIN, V11, P389, DOI 10.1016/j.jsmc.2016.05.004; Maynard ML, 2017, INVEST OPHTH VIS SCI, V58, DOI 10.1167/iovs.16-20659; Moderie C, 2017, SLEEP MED, V34, P148, DOI 10.1016/j.sleep.2017.03.021; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; Murray JM, 2017, SLEEP, V40, DOI 10.1093/sleep/zsw002; PITTENDRIGH CS, 1964, AM NAT, V98, P261, DOI 10.1086/282327; Qaseem A, 2016, ANN INTERN MED, V165, P125, DOI 10.7326/M15-2175; Rajaratnam SMW, 2004, J PHYSIOL-LONDON, V561, P339, DOI 10.1113/jphysiol.2004.073742; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Ruopp MD, 2008, BIOMETRICAL J, V50, P419, DOI 10.1002/bimj.200710415; Stores G, 2007, J NEUROL NEUROSUR PS, V78, P1293, DOI 10.1136/jnnp.2006.111179; van der Meijden WP, 2016, SLEEP, V39, P1305, DOI 10.5665/sleep.5858; van Geijlswijk IM, 2010, SLEEP, V33, P1605, DOI 10.1093/sleep/33.12.1605; Wyatt JK, 2006, SLEEP, V29, P609, DOI 10.1093/sleep/29.5.609; Zele AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017860	31	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204621	10.1371/journal.pone.0204621	http://dx.doi.org/10.1371/journal.pone.0204621			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30261080	Green Published, gold			2022-12-26	WOS:000445907400080
J	Bomfim, VS; Jordao, AA; Alves, LG; Martinez, FE; Camelo, JS				Bomfim, Vanessa S.; Jordao Junior, Alceu A.; Alves, Larissa G.; Martinez, Francisco E.; Camelo, Joso Simon, Jr.			Human milk enriched with human milk lyophilisate for feeding very low birth weight preterm infants: A preclinical experimental study focusing on fatty acid profile	PLOS ONE			English	Article							HUMAN BREAST-MILK; ARACHIDONIC-ACID; NUTRITION; FORTIFICATION; WOMEN; PASTEURIZATION; NUTRIENT; CARE; 1ST; MACRONUTRIENTS	Background Human milk, with essential nutrients and long chain polyunsaturated fatty acids (LC-PUFAs) such as the omega 3 and 6 fatty acids is important for development of the central nervous system and the retina in very low birth weight infants (< 1,500 g). However, breast milk may not be sufficient to meet these needs. The possibility of supplementing breast milk with a lyophilisate of human milk was explored in this study. The objectives of this study were to determine the total lipid content and the lipid profile of the Human Milk on Baseline (HMB) and that of the Concentrates with the Human Milk + lyophilisate (with lyophilisate of milk in the immediate period (HMCI), at 3 months (HMC3m), and at 6 months (HMC6m) of storage). Methods Fifty donors from the Human Milk Bank of Children's Hospital provided consent, and donated milk samples. Macronutrient (including total lipids) quantification was performed using the MIRIS (R) Human Milk Analyzer, and the fatty acid profile was determined by gas chromatography (CG-FID, SHIMADZU (R)). Results There was a higher lipid concentration in HMCI relative to HMB. The concentrations of the main fatty acids (% of total) were as follows: palmitic acid (C16:0) HMB, 22.30%; HMCI, 21.46%; HMC3m, 21.54%; and HMC6m, 21.95% (p < 0.01); oleic acid (C18:1n-9) HMB, 30.41%; HMCI, 30.47%; HMC3m, 30.55%; and HMC6m, 29.79% (p = 0.46); linoleic acid (C18:2n-6) HMB, 19.62%; HMCI, 19.88%; HMC3m, 19.49%; and HMC6m, 19.45% (p = 0.58); arachidonic acid (C20:4n-6) HMB, 0.35%; HMCI, 0.16%; HMC3m, 0.13%; and HMC6m, 0.15% (p < 0.01); a-linolenic acid (C18:3n-3) HMB, 1.32%; HMCI, 1.37%; HMC3m, 1.34%; and 1.34% HMC6m (p = 0.14); docosahexaenoic acid (C22:6n-3) HMB, 0.10%; HMCI, 0.06%; HMC3m, 0.05%; and HMC6m, 0.06% (p < 0.01). There were no significant changes in the lipid profile when stored. There was no evidence of peroxidation during storage. Conclusions Freeze-dried human milk fortified with a human milk concentrate brings potential benefits to newborns, mainly by preserving the essential nutrients present only in breast milk; however, further clinical studies are required to evaluate the safety and efficacy of the concentrate as a standard nutritional food option for very low birth weight infants.	[Bomfim, Vanessa S.] Univ Sao Paulo, Ribeirao Preto Med Sch, Childrens Hosp, Dept Pediat, Ribeirao Preto, Brazil; [Jordao Junior, Alceu A.] Univ Sao Paulo, Dept Internal Med, Nutr Lab, Ribeirao Preto Med Sch, Ribeirao Preto, Brazil; [Alves, Larissa G.] Univ Sao Paulo, Human Milk Bank, Clin Hosp, Ribeirao Preto Med Sch, Ribeirao Preto, Brazil; [Martinez, Francisco E.; Camelo, Joso Simon, Jr.] Univ Sao Paulo, Childrens Hosp, Ribeirao Preto Med Sch, Dept Pediat,Neonatol, Ribeirao Preto, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Camelo, JS (corresponding author), Univ Sao Paulo, Childrens Hosp, Ribeirao Preto Med Sch, Dept Pediat,Neonatol, Ribeirao Preto, Brazil.	jscamelo@fmrp.usp.br	Martinez, Francisco E/H-1194-2014; Camelo, Jose S/G-3169-2012	Martinez, Francisco E/0000-0002-6269-9182; /0000-0003-1288-0802	Bill and Melinda Gates Foundation (Grand Challenges Brazil) [OPP1107597]; CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil [401612/2013-9]; Ministry of Health / Department of Science and Technology, Brazil	Bill and Melinda Gates Foundation (Grand Challenges Brazil); CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministry of Health / Department of Science and Technology, Brazil	The present study was supported by Bill and Melinda Gates Foundation (Grand Challenges Brazil), Grant # OPP1107597, Grant Recipient # Prof. Dr. JoseA Simon Camelo Jr., CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil, Grant # 401612/2013-9, Grant Recipient # Prof. Dr. JoseA Simon Camelo Jr., and Ministry of Health / Department of Science and Technology, Brazil.	Agostoni C, 2010, J PEDIATR GASTR NUTR, V50, P85, DOI 10.1097/MPG.0b013e3181adaee0; Andreas NJ, 2015, EARLY HUM DEV, V91, P629, DOI 10.1016/j.earlhumdev.2015.08.013; [Anonymous], 1976, PEDIATRICS, V57, P278; Bar-Yoseph F, 2013, PROSTAG LEUKOTR ESS, V89, P139, DOI 10.1016/j.plefa.2013.03.002; Barreiro R, 2018, J PHYSIOL BIOCHEM, V74, P127, DOI 10.1007/s13105-017-0580-2; Bertino E, 2013, EARLY HUM DEV, V89, pS3, DOI 10.1016/j.earlhumdev.2013.07.008; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Calder PC, 2016, ANN NUTR METAB, V69, P8, DOI 10.1159/000448262; Carlson SJ, 2013, JPEN-PARENTER ENTER, V37, P15, DOI 10.1177/0148607112467821; Cristofalo EA, 2013, J PEDIATR-US, V163, P1592, DOI 10.1016/j.jpeds.2013.07.011; Darios F, 2006, NATURE, V440, P813, DOI 10.1038/nature04598; de Halleux V, 2013, AM J CLIN NUTR, V98, p529S, DOI 10.3945/ajcn.112.042689; Delplanque B, 2015, J PEDIATR GASTR NUTR, V61, P8, DOI 10.1097/MPG.0000000000000818; Donovan R, 2017, J PERINATOL, V37, P42, DOI 10.1038/jp.2016.166; Elisia I, 2011, J CLIN BIOCHEM NUTR, V49, P147, DOI 10.3164/jcbn.10-142; Erick M, 2018, MED HYPOTHESES, V111, P82, DOI 10.1016/j.mehy.2017.12.020; Escuder-Vieco D, 2016, J HUM LACT, V32, P73; Fukaya T, 2007, NEUROBIOL AGING, V28, P1179, DOI 10.1016/j.neurobiolaging.2006.05.023; Fusch G, 2017, CLIN PERINATOL, V44, P209, DOI 10.1016/j.clp.2016.11.001; Fusch G, 2015, CLIN NUTR, V34, P465, DOI 10.1016/j.clnu.2014.05.005; Gallier S, 2015, COLLOID SURFACE B, V136, P329, DOI 10.1016/j.colsurfb.2015.09.024; Gibson RA, 2011, MATERN CHILD NUTR, V7, P17, DOI 10.1111/j.1740-8709.2011.00299.x; Giuffrida F, 2016, NUTRIENTS, V8, DOI 10.3390/nu8110715; Gonzalez HF, 2016, ARCH ARGENT PEDIATR, V114, P472, DOI [10.5546/aap.2016.eng.472, 10.5546/aap.2016.472]; Grance Thayana Regina de Souza, 2015, Rev. paul. pediatr., V33, P28, DOI 10.1016/j.rpped.2014.07.001; Grote V, 2016, EUR J CLIN NUTR, V70, P250, DOI 10.1038/ejcn.2015.162; Gubert JK, 2012, CIENC CUID SAUDE, V11, P146, DOI [10.4025/cienccuidsaude.v11i1.18871, DOI 10.4025/CIENCCUIDSAUDE.V11I1.18871]; Haggarty P, 2004, EUR J CLIN NUTR, V58, P1559, DOI 10.1038/sj.ejcn.1602016; Haiden N, 2016, ANN NUTR METAB, V69, P8, DOI 10.1159/000452821; Harding JE, 2017, LANCET, V389, P1660, DOI 10.1016/S0140-6736(17)30552-4; Havemose MS, 2004, INT DAIRY J, V14, P563, DOI 10.1016/j.idairyj.2003.11.005; Havlicekova Z, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0145-1; Hay WW, 1999, PEDIATRICS, V104, P1360, DOI 10.1542/peds.104.6.1360; Huang HL, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-27; Innis SM, 2016, CRIT REV FOOD SCI, V56, P1952, DOI 10.1080/10408398.2015.1018045; Innis SM, 2003, J PEDIATR-US, V143, pS1, DOI 10.1067/S0022-3476(03)00396-2; Jimenez EY, 2015, PROSTAG LEUKOTR ESS, V95, P71, DOI 10.1016/j.plefa.2014.12.002; Kanmaz HG, 2013, J HUM LACT, V29, P400, DOI 10.1177/0890334412459903; Kim H, 2017, BRIT J NUTR, V117, P556, DOI [10.1017/S0007114517000253, 10.1017/s0007114517000253]; Koletzko B, 2011, ACTA PAEDIATR, V100, P1405, DOI 10.1111/j.1651-2227.2011.02343.x; Kreissl A, 2013, J PEDIATR GASTR NUTR, V57, P432, DOI 10.1097/MPG.0b013e3182a208c7; Kuipers RS, 2005, PROSTAG LEUKOTR ESS, V72, P279, DOI 10.1016/j.plefa.2004.12.001; Kunz C, 1999, CLIN PERINATOL, V26, P307, DOI 10.1016/S0095-5108(18)30055-1; Lozano B, 2014, INT J FOOD SCI NUTR, V65, P703, DOI 10.3109/09637486.2014.917154; Maas C, 2017, EUR J NUTR, V56, P1733, DOI [10.1007/s00394-016-1220-2, 10.1007/s00]; McLeod G, 2016, BRIT J NUTR, V115, P431, DOI 10.1017/S0007114515004614; McNelis K, 2017, CLIN PERINATOL, V44, P395, DOI 10.1016/j.clp.2017.01.012; Meredith-Dennis L, 2018, J HUM LACT, V34, P120, DOI 10.1177/0890334417710635; Nishimura RY, 2013, J PEDIAT-BRAZIL, V89, P263, DOI 10.1016/j.jped.2012.11.007; Pamplona R, 1998, J LIPID RES, V39, P1989; Peila C, 2016, NUTRIENTS, V8, DOI 10.3390/nu8080477; Picaud JC, 2017, CLIN PERINATOL, V44, P95, DOI 10.1016/j.clp.2016.11.003; Raiten DJ, 2016, AM J CLIN NUTR, V103, p599S, DOI 10.3945/ajcn.115.124222; Ribeiro M, 2008, ANN NUTR METAB, V53, P50, DOI 10.1159/000156597; Rochow N, 2015, CURR OPIN CLIN NUTR, V18, P276, DOI 10.1097/MCO.0000000000000167; Rochow N, 2013, J PEDIATR-US, V163, P1001, DOI 10.1016/j.jpeds.2013.04.052; Romeu-Nadal M, 2008, FOOD CHEM, V107, P434, DOI 10.1016/j.foodchem.2007.06.060; da Costa RDS, 2016, LIPIDS, V51, P1363, DOI 10.1007/s11745-016-4206-1; Saphier O, 2013, INDIAN PEDIATR, V50, P1044, DOI 10.1007/s13312-013-0277-8; Schanler RJ, 2001, PEDIATR CLIN N AM, V48, P207, DOI 10.1016/S0031-3955(05)70295-9; Shofian NM, 2011, INT J MOL SCI, V12, P4678, DOI 10.3390/ijms12074678; Sousa SG, 2016, CRIT REV FOOD SCI, V56, P1043, DOI 10.1080/10408398.2012.753402; Sullivan S, 2010, J PEDIATR-US, V156, P562, DOI 10.1016/j.jpeds.2009.10.040; Szabo E, 2010, J PEDIATR GASTR NUTR, V50, P316, DOI 10.1097/MPG.0b013e3181a9f944; Thomaz DMC, 2012, J PEDIAT-BRAZIL, V88, P119, DOI 10.2223/JPED.2166; Tudehope DI, 2013, J PEDIATR-US, V162, pS17, DOI 10.1016/j.jpeds.2012.11.049; Uauy R, 2006, NUTR REV, V64, pS24, DOI 10.1301/nr.2006.may.S24-S33; Cortez MV, 2016, BREASTFEED MED, V11, P551, DOI 10.1089/bfm.2016.0102; van Elten TM, 2015, ALLERGY, V70, P1468, DOI 10.1111/all.12703; Vieira AA, 2011, EARLY HUM DEV, V87, P577, DOI 10.1016/j.earlhumdev.2011.04.016; Wang ZJ, 2006, CHEM-BIOL INTERACT, V163, P207, DOI 10.1016/j.cbi.2006.08.005; Wegman ME, 2001, J NUTR, V131, p401S, DOI 10.1093/jn/131.2.401S; Wight N E, 2001, J Perinatol, V21, P249, DOI 10.1038/sj.jp.7200533; Yuhas R, 2006, LIPIDS, V41, P851, DOI 10.1007/s11745-006-5040-7	74	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2018	13	9							e0202794	10.1371/journal.pone.0202794	http://dx.doi.org/10.1371/journal.pone.0202794			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU9BO	30252854	Green Published, Green Submitted, gold			2022-12-26	WOS:000445639700005
J	Pagan, HJT; Ferrer, T; O'Corry-Crowe, G				Pagan, Heidi J. T.; Ferrer, Tatiana; O'Corry-Crowe, Greg			Positive selection in coding regions and motif duplication in regulatory regions of bottlenose dolphin MHC class II genes	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; SEQUENCE VARIABILITY; BALANCING SELECTION; TURSIOPS-TRUNCATUS; INTERFERON-GAMMA; EXPRESSION; LOCI; DIVERSITY; PROMOTERS; EVOLUTION	The vertebrate immune response is mediated through highly adaptive, quickly evolving cell surface receptors, the major histocompatibility complex (MHC). MHC molecules bind and present a diverse array of pathogenic molecules and trigger a cascade of defenses. Use of MHC variation as a marker for population health has also evolved quickly following advances in sequencing methods. We applied a combination of traditional and next generation sequencing methodology to characterize coding (peptide binding region) and regulatory (proximal promoter) sequence variation in MHC Class II DQA and DQB genes between estuarine and coastal populations of the bottlenose dolphin, Tursiops truncatus, an apex predator whose health status is indicative of anthropogenic impacts on the ecosystem. The coding regions had 10 alleles each at DQA and DQB; the promoters had 6 and 7 alleles at DQA and DQB, respectively with variation within key regulatory motifs. Positive selection was observed for the coding regions of both genes while both coding and promoter regions exhibited geographic differences in allele composition that likely indicates diversifying selection across habitats. Most notable was the discovery of a complete duplication of a 14-bp T-box motif in the DQA promoter. Four class II promoter regions (DQA, DQB, DRA, DRB) were characterized in species from four cetacean families (Delphinidae, Monodontidae, Lipotidae, and Physeteridae) and revealed substantial promoter structural diversity across this order. Peptide binding regions may not be the only source of adaptive potential within cetacean MHC for responding to pathogenic threats. These findings are the first analysis of cetacean MHC regulatory motifs, which may divulge unique immunogenetic strategies among cetaceans and reveal how MHC transcriptional control continues to evolve. The combined MHC regulatory and coding data provide new genetic context for distinct vulnerability profiles between coastal and estuarine populations, which are key concerns for health and risk management.	[Pagan, Heidi J. T.; Ferrer, Tatiana; O'Corry-Crowe, Greg] Florida Atlantic Univ, Harbor Branch Oceanog Inst, Ft Pierce, FL USA	Harbor Branch Oceanographic Institute Foundation; State University System of Florida; Florida Atlantic University	Pagan, HJT (corresponding author), Florida Atlantic Univ, Harbor Branch Oceanog Inst, Ft Pierce, FL USA.	HeidiJTP@gmail.com			Florida Specialty License Plate Programs [PWD2015-2017, PFW2015-2017]	Florida Specialty License Plate Programs	Funding for this research was provided by grants from the Florida Specialty License Plate Programs: Protect Wild Dolphins and Protect Florida Whales, administered by the Harbor Branch Oceanographic Institute Foundation. http://www.hboifoundation.org/. Grant #:PWD2015-2017, PFW2015-2017. Grantees: HJTP GOC and TF.	Aguilar A, 2004, P NATL ACAD SCI USA, V101, P3490, DOI 10.1073/pnas.0306582101; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amills M, 2008, GENES IMMUN, V9, P651, DOI 10.1038/gene.2008.62; AMOS B, 1991, P99; Antunes SG, 1998, P NATL ACAD SCI USA, V95, P11745, DOI 10.1073/pnas.95.20.11745; Apanius V, 1997, CRIT REV IMMUNOL, V17, P179, DOI 10.1615/CritRevImmunol.v17.i2.40; Arbanasic H, 2014, MAR BIOL, V161, P2407, DOI 10.1007/s00227-014-2515-6; Archie EA, 2010, IMMUNOGENETICS, V62, P85, DOI 10.1007/s00251-009-0413-8; Baker CS, 2006, IMMUNOGENETICS, V58, P283, DOI 10.1007/s00251-006-0080-y; BASTA PV, 1988, P NATL ACAD SCI USA, V85, P8618, DOI 10.1073/pnas.85.22.8618; BENOIST C, 1990, ANNU REV IMMUNOL, V8, P681, DOI 10.1146/annurev.immunol.8.1.681; Berggren KT, 2008, J MOL EVOL, V67, P76, DOI 10.1007/s00239-008-9126-0; Berggren KT, 2005, IMMUNOGENETICS, V57, P267, DOI 10.1007/s00251-005-0776-4; Bondinas GP, 2007, IMMUNOGENETICS, V59, P539, DOI 10.1007/s00251-007-0224-8; Bossart G, 2006, HLTH ASSESSMENT BOTT, P36; Burge CB, 1998, CURR OPIN STRUC BIOL, V8, P346, DOI 10.1016/S0959-440X(98)80069-9; Caballero Susana, 2010, Latin American Journal of Aquatic Mammals, V8, P81; Cammen KM, 2015, IMMUNOGENETICS, V67, P125, DOI 10.1007/s00251-014-0818-x; Cowell LG, 1998, GENOME RES, V8, P124, DOI 10.1101/gr.8.2.124; Croze M, 2016, ZOOLOGY, V119, P322, DOI 10.1016/j.zool.2016.03.004; Dooley CT, 2018, BRIDGING IMMUNOGENET, V13; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eimes JA, 2015, PEERJ, V3, DOI 10.7717/peerj.853; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fayer R, 2004, TRENDS PARASITOL, V20, P531, DOI 10.1016/j.pt.2004.08.008; Fisheries N, 2008, MARINE MAMMAL STOCK; Fisheries N, 2014, MARINE MAMMAL STOCK; Fisheries N, 2013, FAQS MORBILLIVIRUS A; FREUND YR, 1990, J EXP MED, V171, P1283, DOI 10.1084/jem.171.4.1283; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hall T., 2005, BIOEDIT BIOL SEQUENC; Harton JA, 2000, MOL CELL BIOL, V20, P6185, DOI 10.1128/MCB.20.17.6185-6194.2000; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Hedrick PW, 2002, EVOLUTION, V56, P1902, DOI 10.1111/j.0014-3820.2002.tb00116.x; Heimeier D, 2009, MAR MAMMAL SCI, V25, P68, DOI 10.1111/j.1748-7692.2008.00244.x; Hughes AL, 1998, ANNU REV GENET, V32, P415, DOI 10.1146/annurev.genet.32.1.415; Hwang S, 2015, SCI REP-UK, V5, DOI 10.1038/srep17875; JabraneFerrat N, 1996, MOL CELL BIOL, V16, P4683; Janitz M, 1997, TISSUE ANTIGENS, V49, P99, DOI 10.1111/j.1399-0039.1997.tb02721.x; Jepson PD, 1999, SCI TOTAL ENVIRON, V243, P339, DOI 10.1016/S0048-9697(99)00417-9; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Kimura M., 1983, NEUTRAL THEORY MOL E; Klein J, 1993, HLA SYSTEM CLIN TRAN, P407; Knetsch J, 1994, STEPS INTRACOASTAL W; Koutsogiannouli EA, 2009, MOL ECOL, V18, P4631, DOI 10.1111/j.1365-294X.2009.04394.x; Krawczyk M, 2006, TISSUE ANTIGENS, V67, P183, DOI 10.1111/j.1399-0039.2006.00557.x; Kulski JK, 2002, IMMUNOL REV, V190, P95, DOI 10.1034/j.1600-065X.2002.19008.x; Kumanovics A, 2003, ANNU REV IMMUNOL, V21, P629, DOI 10.1146/annurev.immunol.21.090501.080116; Lenz TL, 2008, GENE, V427, P117, DOI 10.1016/j.gene.2008.09.013; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Mazzoil Marilyn, 2005, Florida Scientist, V68, P217; Mazzoil M, 2008, ECOHEALTH, V5, P278, DOI 10.1007/s10393-008-0194-9; McCallum HI, 2004, TRENDS ECOL EVOL, V19, P585, DOI 10.1016/j.tree.2004.08.009; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miller MA, 2008, INT J PARASITOL, V38, P1319, DOI 10.1016/j.ijpara.2008.02.005; Milne I, 2013, BRIEF BIOINFORM, V14, P193, DOI 10.1093/bib/bbs012; Mitchison NA, 2002, P NATL ACAD SCI USA, V99, P10561, DOI 10.1073/pnas.152329999; Montani V, 1998, ENDOCRINOLOGY, V139, P290, DOI 10.1210/en.139.1.290; Morris SE, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0676; MorzyckaWroblewska E, 1997, IMMUNOGENETICS, V45, P163, DOI 10.1007/s002510050185; Mos L, 2006, ENVIRON TOXICOL CHEM, V25, P3110, DOI 10.1897/06-027R.1; MuhlethalerMOttet A, 1997, EMBO J, V16, P2851, DOI 10.1093/emboj/16.10.2851; Murdoch ME, 2008, ECOHEALTH, V5, P289, DOI 10.1007/s10393-008-0187-8; Murray BW, 1999, MOL ECOL, V8, P1127, DOI 10.1046/j.1365-294x.1999.00670.x; Murray BW, 1998, IMMUNOGENETICS, V48, P242, DOI 10.1007/s002510050428; MURRAY BW, 1995, MOL BIOL EVOL, V12, P582; Odell DK, 1990, DISTRIBUTION MOVEMEN, P515; Paliakasis K, 1996, J STRUCT BIOL, V117, P145, DOI 10.1006/jsbi.1996.0079; Reche PA, 2003, J MOL BIOL, V331, P623, DOI 10.1016/S0022-2836(03)00750-2; REICHSTETTER S, 1994, IMMUNOGENETICS, V39, P207; Ripoli MV, 2005, TISSUE ANTIGENS, V66, P136, DOI 10.1111/j.1399-0039.2005.00433.x; Rodgers SE, 2013, POPULATION STRUCTURE; ROMANO TA, 1992, J EXP ZOOL, V263, P96, DOI 10.1002/jez.1402630110; Romano TA, 1999, IMMUNOGENETICS, V49, P376, DOI 10.1007/s002510050510; Sommer Simone, 2005, Frontiers in Zoology, V2, P1, DOI 10.1186/1742-9994-2-16; Spurgin LG, 2010, P ROY SOC B-BIOL SCI, V277, P979, DOI 10.1098/rspb.2009.2084; Stoltzfus A, 2016, MOL BIOL EVOL, V33, P595, DOI 10.1093/molbev/msv274; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Van Bressem MF, 2009, DIS AQUAT ORGAN, V86, P143, DOI 10.3354/dao02101; Van Bressem MF, 1999, DIS AQUAT ORGAN, V38, P53, DOI 10.3354/dao038053; van den Elsen PJ, 1998, IMMUNOL TODAY, V19, P308, DOI 10.1016/S0167-5699(98)01287-0; Vassilakos D, 2009, MOL BIOL EVOL, V26, P681, DOI 10.1093/molbev/msn296; Venn-Watson S, 2012, DIS AQUAT ORGAN, V99, P237, DOI 10.3354/dao02471; VIVILLE S, 1991, J IMMUNOL, V146, P3211; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wilson B, 1999, P ROY SOC B-BIOL SCI, V266, P1077, DOI 10.1098/rspb.1999.0746; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	92	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2018	13	9							e0203450	10.1371/journal.pone.0203450	http://dx.doi.org/10.1371/journal.pone.0203450			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU9BO	30252841	Green Submitted, Green Published, gold			2022-12-26	WOS:000445639700008
J	Wichmann, AB; Adang, EMM; Vissers, KCP; Szczerbinska, K; Kylanen, M; Payne, S; Gambassi, G; Onwuteaka-Philipsen, BD; Smets, T; Van den Block, L; Deliens, L; Vernooij-Dassen, MJFJ; Engels, Y				Wichmann, Anne B.; Adang, Eddy M. M.; Vissers, Kris C. P.; Szczerbinska, Katarzyna; Kylanen, Marika; Payne, Sheila; Gambassi, Giovanni; Onwuteaka-Philipsen, Bregje D.; Smets, Tinne; Van den Block, Lieve; Deliens, Luc; Vernooij-Dassen, Myrra J. F. J.; Engels, Yvonne		PACE Consortium	Technical-efficiency analysis of end-of-life care in long-term care facilities within Europe: A cross-sectional study of deceased residents in 6 EU countries (PACE)	PLOS ONE			English	Article							DATA ENVELOPMENT ANALYSIS; QUALITY	Background An ageing population in the EU leads to a higher need of long-term institutional care at the end of life. At the same time, healthcare costs rise while resources remain limited. Consequently, an urgency to extend our knowledge on factors affecting efficiency of long-term care facilities (LTCFs) arises. This study aims to investigate and explain variation in technical efficiency of end-of-life care within and between LTCFs of six EU countries: Belgium (Flanders), England, Finland, Italy, the Netherlands and Poland. In this study, technical efficiency reflects the LTCFs' ability to obtain maximal quality of life (QoL) and quality of dying (QoD) for residents from a given set of resource inputs (personnel and capacity). Methods Cross-sectional data were collected by means of questionnaires on deceased residents identified by LTCFs over a three-month period. An output-oriented data-envelopment analysis (DEA) was performed, producing efficiency scores, incorporating personnel and capacity as input and QoL and QoD as output. Scenario analysis was conducted. Regression analysis was performed on explanatory (country, LTCF type, ownership, availability of palliative care and opioids) and case mix (disease severity) variables. Results 133 LTCFs of only one type (onsite nurses and offsite GPs) were considered in order to reduce heterogeneity. Variation in LTCF efficiency was found across as well as within countries. This variation was not explained by country, ownership, availability of palliative care or opioids. However, in the 'hands-on care at the bedside' scenario, i.e. only taking into account nursing and care assistants as input, Poland (p = 0.00) and Finland (p = 0.04) seemed to be most efficient. Conclusions Efficiency of LTCFs differed extensively across as well as within countries, indicating room for considerable efficiency improvement. Our findings should be interpreted cautiously, as comprehensive comparative EU-wide research is challenging as it is influenced by many factors.	[Wichmann, Anne B.; Vernooij-Dassen, Myrra J. F. J.] Radboud Univ Nijmegen, Radboud Inst Hlth Sci, IQ Healthcare, Med Ctr, Nijmegen, Netherlands; [Adang, Eddy M. M.] Radboud Univ Nijmegen, Dept Hlth Evidence, Med Ctr, Nijmegen, Netherlands; [Vissers, Kris C. P.; Engels, Yvonne] Radboud Univ Nijmegen, Dept Anesthesiol Pain & Palliat Med, Med Ctr, Nijmegen, Netherlands; [Szczerbinska, Katarzyna] Jagiellonian Univ, Med Coll, Unit Res Aging Soc, Epidemiol & Prevent Med Chair, Krakow, Poland; [Kylanen, Marika] Natl Inst Hlth & Welf, Helsinki, Finland; [Payne, Sheila] Univ Lancaster, Div Hlth Res, Lancaster, England; [Gambassi, Giovanni] Univ Cattolica Sacro Cuore, Fac Med & Surg, Rome, Italy; [Onwuteaka-Philipsen, Bregje D.] Vrije Univ Amsterdam Med Ctr, Dept Publ & Occupat Hlth, Amsterdam Publ Hlth Res Inst, Amsterdam, Netherlands; [Onwuteaka-Philipsen, Bregje D.] Vrije Univ Brussel, End Life Care Res Grp, Brussels, Belgium; [Smets, Tinne; Van den Block, Lieve; Deliens, Luc] Univ Ghent, Brussels, Belgium	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Jagiellonian University; Collegium Medicum Jagiellonian University; Finland National Institute for Health & Welfare; Lancaster University; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Brussel; Ghent University	Wichmann, AB (corresponding author), Radboud Univ Nijmegen, Radboud Inst Hlth Sci, IQ Healthcare, Med Ctr, Nijmegen, Netherlands.	Anne.Wichmann@radboudumc.nl	Adang, E.M.M./L-4169-2015; Vissers, Kris/H-8110-2014; Engels, Yvonne/I-1814-2015; Szczerbinska, Katarzyna/AAG-9333-2020; Wichmann, Anne/F-3166-2016; Szczerbinska, Katarzyna/AGG-8995-2022; Van den Block, Lieve/D-1247-2011	Vissers, Kris/0000-0002-2919-6356; Engels, Yvonne/0000-0002-7669-1018; Szczerbinska, Katarzyna/0000-0002-0004-3858; Wichmann, Anne/0000-0003-0085-9782; Szczerbinska, Katarzyna/0000-0002-0004-3858; Smets, Tinne/0000-0003-1439-316X; Van den Block, Lieve/0000-0002-7770-348X; Onwuteaka-Philipsen, Bregje/0000-0002-9440-1248	EU 7th Framework Programme [6031111]	EU 7th Framework Programme	This study was supported by the EU 7th Framework Programme (https://ec.europa.eu/research/fp7), grant agreement 6031111. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adang EMM, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0434-2; [Anonymous], 2016, VALUING HLTH RELATED; Bjorkgren M A, 2001, Health Care Manag Sci, V4, P193; Coelli T. J., 2005, MEDICINE; Dowd B, 2014, HEALTH ECON, V23, P1465, DOI 10.1002/hec.3000; EuroQol, 2017, EQ 5D 5L VAL; EuroStat, 2017, HEALTHC EXP STAT; EUROSTAT, 2017, POPULATION STRUCTURE; EuroStat, 2017, LOOK LIV ELD EU TOD; Feng Zhanlian, 2005, J Am Med Dir Assoc, V6, P27, DOI 10.1016/j.jamda.2004.12.008; Froggatt K, 2010, PALLIATIVE CARE LONG; Garavaglia G, 2011, HEALTH CARE MANAG SC, V14, P22, DOI 10.1007/s10729-010-9139-2; Harrington C, 2012, J NURS SCHOLARSHIP, V44, P88, DOI 10.1111/j.1547-5069.2011.01430.x; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; Lee RH, 2009, HEALTH SERV RES, V44, P15, DOI 10.1111/j.1475-6773.2008.00895.x; Munn JC, 2007, J AM GERIATR SOC, V55, P1371, DOI 10.1111/j.1532-5415.2007.01293.x; Murray SA, 2005, BMJ-BRIT MED J, V330, P1007, DOI 10.1136/bmj.330.7498.1007; Norman R, 2009, VALUE HEALTH, V12, P1194, DOI 10.1111/j.1524-4733.2009.00581.x; Organisation for Economic Co-operation and Development, 2017, PUBL SPEND HLTH LONG; Reitlinger E, 2013, EUR J PALLIAT CARE, V20, P251; Rodrigues R., 2012, FACTS FIGURES HLTH A; Shimshak DG, 2009, OMEGA-INT J MANAGE S, V37, P672, DOI 10.1016/j.omega.2008.05.004; Simar L, 1998, MANAGE SCI, V44, P49, DOI 10.1287/mnsc.44.1.49; Van den Block L, 2016, J AM MED DIR ASSOC, V17, DOI 10.1016/j.jamda.2016.03.008; Wichmann AB, 2017, PALLIATIVE MED; World Health Organization, 2000, WORLD HLTH REP 2000	26	2	2	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2018	13	9							e0204120	10.1371/journal.pone.0204120	http://dx.doi.org/10.1371/journal.pone.0204120			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GU9BO	30252888	Green Published, gold, Green Submitted			2022-12-26	WOS:000445639700031
J	Neubauer, HA; Tea, MN; Zebol, JR; Gliddon, BL; Stefanidis, C; Moretti, PAB; Pitman, MR; Costabile, M; Kular, J; Stringer, BW; Day, BW; Samuel, MS; Bonder, CS; Powell, JA; Pitson, SM				Neubauer, Heidi A.; Tea, Melinda N.; Zebol, Julia R.; Gliddon, Briony L.; Stefanidis, Cassandra; Moretti, Paul A. B.; Pitman, Melissa R.; Costabile, Maurizio; Kular, Jasreen; Stringer, Brett W.; Day, Bryan W.; Samuel, Michael S.; Bonder, Claudine S.; Powell, Jason A.; Pitson, Stuart M.			Cytoplasmic dynein regulates the subcellular localization of sphingosine kinase 2 to elicit tumor-suppressive functions in glioblastoma	ONCOGENE			English	Article							INTERMEDIATE CHAIN; CELL-MIGRATION; SPHINGOSINE-1-PHOSPHATE; RECEPTORS; CANCER; EXPRESSION; GROWTH; ROLES; TRANSLOCATION; 1-PHOSPHATE	While the two mammalian sphingosine kinases, SK1 and SK2, both catalyze the generation of pro-survival sphingosine 1-phosphate (S1P), their roles vary dependent on their different subcellular localization. SK1 is generally found in the cytoplasm or at the plasma membrane where it can promote cell proliferation and survival. SK2 can be present at the plasma membrane where it appears to have a similar function to SK1, but can also be localized to the nucleus, endoplasmic reticulum or mitochondria where it mediates cell death. Although SK2 has been implicated in cancer initiation and progression, the mechanisms regulating SK2 subcellular localization are undefined. Here, we report that SK2 interacts with the intermediate chain subunits of the retrograde-directed transport motor complex, cytoplasmic dynein 1 (DYNC1I1 and -2), and we show that this interaction, particularly with DYNC1I1, facilitates the transport of SK2 away from the plasma membrane. DYNC1I1 is dramatically downregulated in patient samples of glioblastoma (GBM), where lower expression of DYNC1I1 correlates with poorer patient survival. Notably, low DYNC1I1 expression in GBM cells coincided with more SK2 localized to the plasma membrane, where it has been recently implicated in oncogenesis. Re-expression of DYNC1I1 reduced plasma membrane-localized SK2 and extracellular S1P formation, and decreased GBM tumor growth and tumor-associated angiogenesis in vivo. Consistent with this, chemical inhibition of SK2 reduced the viability of patient-derived GBM cells in vitro and decreased GBM tumor growth in vivo. Thus, these findings demonstrate a tumor-suppressive function of DYNC1I1, and uncover new mechanistic insights into SK2 regulation which may have implications in targeting this enzyme as a therapeutic strategy in GBM.	[Neubauer, Heidi A.; Tea, Melinda N.; Zebol, Julia R.; Gliddon, Briony L.; Stefanidis, Cassandra; Moretti, Paul A. B.; Pitman, Melissa R.; Costabile, Maurizio; Kular, Jasreen; Samuel, Michael S.; Bonder, Claudine S.; Powell, Jason A.; Pitson, Stuart M.] Univ South Australia, Ctr Canc Biol, Adelaide, SA, Australia; [Neubauer, Heidi A.; Tea, Melinda N.; Zebol, Julia R.; Gliddon, Briony L.; Stefanidis, Cassandra; Moretti, Paul A. B.; Pitman, Melissa R.; Costabile, Maurizio; Kular, Jasreen; Samuel, Michael S.; Bonder, Claudine S.; Powell, Jason A.; Pitson, Stuart M.] SA Pathol, Adelaide, SA, Australia; [Neubauer, Heidi A.; Pitson, Stuart M.] Univ Adelaide, Sch Biol Sci, Adelaide, SA, Australia; [Stefanidis, Cassandra; Costabile, Maurizio] Univ South Australia, Sch Pharm & Med Sci, Adelaide, SA, Australia; [Stringer, Brett W.; Day, Bryan W.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Samuel, Michael S.; Bonder, Claudine S.; Powell, Jason A.; Pitson, Stuart M.] Univ Adelaide, Adelaide Med Sch, Adelaide, SA, Australia	Centre for Cancer Biology; University of South Australia; SA Pathology; University of Adelaide; University of South Australia; QIMR Berghofer Medical Research Institute; University of Adelaide	Pitson, SM (corresponding author), Univ South Australia, Ctr Canc Biol, Adelaide, SA, Australia.; Pitson, SM (corresponding author), SA Pathol, Adelaide, SA, Australia.; Pitson, SM (corresponding author), Univ Adelaide, Sch Biol Sci, Adelaide, SA, Australia.; Pitson, SM (corresponding author), Univ Adelaide, Adelaide Med Sch, Adelaide, SA, Australia.	stuart.pitson@unisa.edu.au	Samuel, Michael/D-2706-2011; costabile, maurizio/AEN-4356-2022; Pitson, Stuart/B-9342-2009; Neubauer, Heidi A./AAD-8727-2019; Day, Bryan/AAV-6170-2020; Stringer, Brett/GZB-1390-2022	Samuel, Michael/0000-0001-7880-6379; costabile, maurizio/0000-0002-2162-6497; Pitson, Stuart/0000-0002-9527-2740; Pitman, Melissa/0000-0002-9587-3837; Stringer, Brett/0000-0003-4552-9736; Neubauer, Heidi/0000-0001-7372-7786; Day, Bryan/0000-0002-8948-9089; Dobbins, Julia/0000-0001-5833-2655; Gliddon, Briony/0000-0003-3928-7478; Bonder, Claudine S./0000-0001-9875-967X; Tea, Melinda/0000-0001-7045-1198; Powell, jason/0000-0001-8493-9178; Moretti, Paul/0000-0002-3523-1496	Neurosurgical Research Foundation; Fay Fuller Foundation; National Health and Medical Research Council of Australia (NHMRC) [GNT626936]; NHMRC [508098, 1042589]; Australian Postgraduate Award; Royal Adelaide Hospital (RAH) Dawes Scholarship; RAH Research Fund Early Career Fellowship	Neurosurgical Research Foundation; Fay Fuller Foundation; National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government); Royal Adelaide Hospital (RAH) Dawes Scholarship; RAH Research Fund Early Career Fellowship	This work was supported by the Neurosurgical Research Foundation, the Fay Fuller Foundation, a National Health and Medical Research Council of Australia (NHMRC) Project Grant (GNT626936), NHMRC Senior Research Fellowships (508098 and 1042589) to SMP, an Australian Postgraduate Award and a Royal Adelaide Hospital (RAH) Dawes Scholarship to HAN, and a RAH Research Fund Early Career Fellowship to MRP.	Abuhusain HJ, 2013, J BIOL CHEM, V288, P37355, DOI 10.1074/jbc.M113.494740; Bien-Moller S, 2016, ONCOTARGET, V7, P13031, DOI 10.18632/oncotarget.7366; Blondeau N, 2007, J NEUROCHEM, V103, P509, DOI 10.1111/j.1471-4159.2007.04755.x; Carpinteiro A, 2008, CANCER LETT, V264, P1, DOI 10.1016/j.canlet.2008.02.020; Chipuk JE, 2012, CELL, V148, P988, DOI 10.1016/j.cell.2012.01.038; French KJ, 2010, J PHARMACOL EXP THER, V333, P129, DOI 10.1124/jpet.109.163444; Ha JH, 2008, J CELL BIOL, V181, P1027, DOI 10.1083/jcb.200803150; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Horikawa I, 2001, J CELL BIOCHEM, V82, P415, DOI 10.1002/jcb.1169; Ibbetson SJ, 2013, AM J PATHOL, V183, P930, DOI 10.1016/j.ajpath.2013.05.014; Igarashi N, 2003, J BIOL CHEM, V278, P46832, DOI 10.1074/jbc.M306577200; Jarman KE, 2010, J BIOL CHEM, V285, P483, DOI 10.1074/jbc.M109.068395; Kapitonov D, 2009, CANCER RES, V69, P6915, DOI 10.1158/0008-5472.CAN-09-0664; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Kular J, 2015, DEV CELL, V35, P759, DOI 10.1016/j.devcel.2015.11.026; Kuta A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011682; Ligon LA, 2001, NAT CELL BIOL, V3, P913, DOI 10.1038/ncb1001-913; LIN SXH, 1992, J CELL SCI, V101, P125; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Liu K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056471; Maceyka M, 2005, J BIOL CHEM, V280, P37118, DOI 10.1074/jbc.M502207200; Neubauer HA, 2017, F1000 RES, V5, P2825; Neubauer HA, 2016, ONCOTARGET, V7, P64886, DOI 10.18632/oncotarget.11714; Neubauer HA, 2013, FEBS J, V280, P5317, DOI 10.1111/febs.12314; Newton J, 2015, EXP CELL RES, V333, P195, DOI 10.1016/j.yexcr.2015.02.025; Olivera A, 2006, J BIOL CHEM, V281, P2515, DOI 10.1074/jbc.M508931200; Palmer KJ, 2009, MOL BIOL CELL, V20, P2885, DOI 10.1091/mbc.E08-12-1160; Pitman MR, 2015, ONCOTARGET, V6, P7065, DOI 10.18632/oncotarget.3178; Pitson SM, 2003, EMBO J, V22, P5491, DOI 10.1093/emboj/cdg540; Pitson SM, 2005, J EXP MED, V201, P49, DOI 10.1084/jem.20040559; Pitson SM, 2011, TRENDS BIOCHEM SCI, V36, P97, DOI 10.1016/j.tibs.2010.08.001; Quint K, 2014, TUMOR BIOL, V35, P8979, DOI 10.1007/s13277-014-2172-x; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Roberts JL, 2004, ANAL BIOCHEM, V331, P122, DOI 10.1016/j.ab.2004.03.030; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Siow D, 2011, CRIT REV BIOCHEM MOL, V46, P365, DOI 10.3109/10409238.2011.580097; Sordillo LA, 2016, ANTICANCER RES, V36, P2085; Stringer BW, 2016, ONCOTARGET, V7, P29306, DOI 10.18632/oncotarget.8720; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sun WY, 2016, J IMMUNOL, V196, P3854, DOI 10.4049/jimmunol.1501510; Takabe K, 2014, J LIPID RES, V55, P1839, DOI 10.1194/jlr.R046656; Van Brocklyn JR, 2005, J NEUROPATH EXP NEUR, V64, P695, DOI 10.1097/01.jnen.0000175329.59092.2c; Van Brocklyn JR, 2003, CANCER LETT, V199, P53, DOI 10.1016/S0304-3835(03)00334-3; Van Brocklyn JR, 2002, CANCER LETT, V181, P195, DOI 10.1016/S0304-3835(02)00050-2; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang QH, 2017, CANCER CELL, V32, P42, DOI 10.1016/j.ccell.2017.06.003; Weigert A, 2009, INT J CANCER, V125, P2114, DOI 10.1002/ijc.24594; Young N, 2007, EXP CELL RES, V313, P1615, DOI 10.1016/j.yexcr.2007.02.009; Zebol JR, 2009, INT J BIOCHEM CELL B, V41, P822, DOI 10.1016/j.biocel.2008.08.012; Zhang J, 2002, MOL MICROBIOL, V44, P381, DOI 10.1046/j.1365-2958.2002.02900.x; Zhu W, 2017, ONCOGENE, V36, P2619, DOI 10.1038/onc.2016.428; Zhu WY, 2017, CANCER RES, V77, P4823, DOI 10.1158/0008-5472.CAN-17-0025	52	14	15	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 21	2019	38	8					1151	1165		10.1038/s41388-018-0504-9	http://dx.doi.org/10.1038/s41388-018-0504-9			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HM1XR	30250299	Green Published, hybrid			2022-12-26	WOS:000459249800001
J	Kinouchi, R; Ishiko, S; Hanada, K; Hayashi, H; Mikami, D; Tani, T; Zenimaru, T; Kawai, M; Nakabayashi, S; Kinouchi, M; Yoshida, A				Kinouchi, Reiko; Ishiko, Satoshi; Hanada, Kazuomi; Hayashi, Hiroki; Mikami, Daiki; Tani, Tomofumi; Zenimaru, Tatsuya; Kawai, Motofumi; Nakabayashi, Seigo; Kinouchi, Motoshi; Yoshida, Akitoshi			A low meat diet increases the risk of open-angle glaucoma in women-The results of population-based, cross-sectional study in Japan	PLOS ONE			English	Article							LIFE-STYLE; OCULAR HYPERTENSION; PREVALENCE; CONSUMPTION; DISEASE; ASSOCIATION; HEALTH	Background Studies identifying modifiable lifestyle risk factors related to open-angle glaucoma (OAG) are limited, especially from Asian countries. This study aimed to identify lifestyle risk factors for OAG in a Japanese population. Methods and findings This population-based, cross-sectional study recruited Japanese participants aged 40 years or older from January 2013 to March 2015. We took fundus photographs for OAG screening, determined lifestyle and health characteristics through a questionnaire and performed physical examinations. The participants who had suspect findings in the fundus photographs were sent for a detailed ophthalmic examination to diagnose OAG. Lifestyle and heath characteristics were statistically compared between the OAG and non-OAG participants. A total of 1583 participants were included in the study, of which 42 had OAG and 1541 did not have OAG. The number of days per week that the female participants consumed meat (mean +/- SD; OAG: 1.7 +/- 1.2 days, non-OAG: 2.7 +/- 1.5 days) was negatively associated with OAG (OR = 0.61; 95% CI: 0.43-0.88; p =0.007). Higher intraocular pressure was positively associated with OAG in men (OR = 1.20; 95% CI: 1.05-1.38, p = 0.009). No significant difference between participants with and without OAG was observed for a range of other lifestyle factors and health criteria including self-report of diabetes, number of family living together, body mass index, blood pressure, pulse rate, coffee drinking, tea drinking, alcohol drinking, number of fruits consumed per day and days of fish consumption per week. Conclusions A higher weekly consumption of meat appears to be negatively associated with OAG in Japanese women. Increasing the dietary intake of meat can contribute to reducing the risk of developing OAG.	[Kinouchi, Reiko; Ishiko, Satoshi; Hanada, Kazuomi; Hayashi, Hiroki; Mikami, Daiki] Asahikawa Med Univ, Med & Engn Combined Res Inst, Asahikawa, Hokkaido, Japan; [Kinouchi, Reiko; Ishiko, Satoshi; Hanada, Kazuomi; Kawai, Motofumi; Nakabayashi, Seigo; Yoshida, Akitoshi] Asahikawa Med Univ, Dept Ophthalmol, Asahikawa, Hokkaido, Japan; [Tani, Tomofumi] Rumoi Municipal Hosp, Dept Ophthalmol, Rumoi, Hokkaido, Japan; [Zenimaru, Tatsuya] Zenimaru Eye Clin, Rumoi, Hokkaido, Japan; [Kinouchi, Motoshi] Red Cross Asahikawa Hosp, Dept Dermatol, Asahikawa, Hokkaido, Japan; [Tani, Tomofumi] Ororon Line Eye Clin, Rumoi, Japan	Asahikawa Medical College; Asahikawa Medical College	Kinouchi, R (corresponding author), Asahikawa Med Univ, Med & Engn Combined Res Inst, Asahikawa, Hokkaido, Japan.; Kinouchi, R (corresponding author), Asahikawa Med Univ, Dept Ophthalmol, Asahikawa, Hokkaido, Japan.	rkino@asahikawa-med.ac.jp	Kinouchi, Reiko/R-6833-2019	kinouchi, reiko/0000-0003-1344-1641	Asahikawa Medical University; Rumoi city government	Asahikawa Medical University; Rumoi city government	This study was supported by research funding from the Asahikawa Medical University president.; We would like to thank the Rumoi city government, the staff members of NPO Rumoi Cohotopia for their support and cooperation and all the participants who took part in this study.	Araie Makoto, 2012, Nippon Ganka Gakkai Zasshi, V116; Bonomi L, 1998, OPHTHALMOLOGY, V105, P209, DOI 10.1016/S0161-6420(98)92665-3; Bourne RRA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162229; Chan EW, 2016, BRIT J OPHTHALMOL, V100, P78, DOI 10.1136/bjophthalmol-2014-306102; Coleman AL, 2008, AM J OPHTHALMOL, V145, P1081, DOI 10.1016/j.ajo.2008.01.022; Daly RM, 2015, TRIALS, V16, DOI [10.1186/s13063-015-0652-y, 10.1186/s13063-015-0884-x]; DIELEMANS I, 1994, OPHTHALMOLOGY, V101, P1851; Doi Y, 2010, STROKE, V41, P203, DOI 10.1161/STROKEAHA.109.564708; Doshi V, 2008, OPHTHALMOLOGY, V115, P639, DOI 10.1016/j.ophtha.2007.05.032; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Giaconi JA, 2012, AM J OPHTHALMOL, V154, P635, DOI 10.1016/j.ajo.2012.03.048; Iwase A, 2004, OPHTHALMOLOGY, V111, P1641, DOI 10.1016/j.ophtha.2004.03.029; Jonas JB, 2017, LANCET, DOI 10.1016/s0140-6736(17)31469-1; Kang JH, 2016, JAMA OPHTHALMOL, V134, P294, DOI 10.1001/jamaophthalmol.2015.5601; Kang JH, 2004, AM J CLIN NUTR, V79, P755; Keenan TDL, 2015, BRIT J OPHTHALMOL, V99, P524, DOI 10.1136/bjophthalmol-2014-305863; Kim KE, 2016, OPHTHALMOLOGY, V123, P532, DOI 10.1016/j.ophtha.2015.11.004; KLEIN BEK, 1992, OPHTHALMOLOGY, V99, P1499; Leske MC, 2008, OPHTHALMOLOGY, V115, P85, DOI 10.1016/j.ophtha.2007.03.017; Livingston G, 2017, LANCET, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6; Oliver JE, 2002, AM J OPHTHALMOL, V133, P764, DOI 10.1016/S0002-9394(02)01403-4; Podcasy JL, 2016, DIALOGUES CLIN NEURO, V18, P437; Ramdas WD, 2012, EUR J EPIDEMIOL, V27, P385, DOI 10.1007/s10654-012-9672-z; Ramdas WD, 2011, ARCH OPHTHALMOL-CHIC, V129, P767, DOI 10.1001/archophthalmol.2010.373; Renard JP, 2013, ACTA OPHTHALMOL, V91, P505, DOI 10.1111/j.1755-3768.2011.02356.x; Su CW, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002833; Suzuki Y, 2006, OPHTHALMOLOGY, V113, P1613, DOI 10.1016/j.ophtha.2006.03.059; Taniguchi Y, 2014, J GERONTOL A-BIOL, V69, P1276, DOI 10.1093/gerona/glt286; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Yamamoto T, 2005, OPHTHALMOLOGY, V112, P1661, DOI 10.1016/j.ophtha.2005.05.012	30	7	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0204955	10.1371/journal.pone.0204955	http://dx.doi.org/10.1371/journal.pone.0204955			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3QJ	30278082	gold, Green Submitted, Green Published			2022-12-26	WOS:000446010200028
J	Belay, E; Endrias, A; Alem, B; Endris, K				Belay, Ezra; Endrias, Asrat; Alem, Birhane; Endris, Kedir			Hematological responses to iron-folate supplementation and its determinants in pregnant women attending antenatal cares in Mekelle City, Ethiopia	PLOS ONE			English	Article							BIRTH-WEIGHT; ANEMIA; DEFICIENCY; INFLAMMATION; PREVALENCE; DISEASE	Objective To characterize anemia and evaluate hematological responses to universal iron-folic acid (IFA) supplementation in Ethiopian pregnant women. Method A hospital-based prospective follow up study was done between December 2016 and June 2017. Hematological profiles were measured in pregnant women before and after a minimum of one-month IFA supplementation. Mean values and abnormal proportions of hematological profiles were compared before and after supplementation using paired t-test and McNemar test, respectively. Univariate and multivariate analysis were used to analyze the association between independent variables and poor treatment responses. Result Lack of adequate hemoglobin response was found in 48.5%(95/196) of the participants. Prevalence of anemia and low hematocrit value were decreased significantly after IFA supplementation (p = 0.002, and p = 0.001, respectively). Normocytic hypochromic anemia was the commonest form of anemia found in this study followed by normocytic normochromic anemia. There was no statistically significant association between poor hemoglobin responses and all studied factors such as educational level, household size, parity, recent illness, stage of pregnancy, coffee consumption, and duration of iron treatment. Conclusion Our study revealed poor hemoglobin responses in nearly half of the study participants and a high proportion of anemias morphologically atypical of iron deficiency anemia. There is a need to consider anemia attributable to etiologies other than an iron deficiency in anemia intervention programs.	[Belay, Ezra; Endrias, Asrat] Mekelle Univ, Coll Hlth Sci, Dept Med Biochem, Mekelle, Ethiopia; [Alem, Birhane] Mekelle Univ, Coll Hlth Sci, Dept Anat, Mekelle, Ethiopia; [Endris, Kedir] Mekelle Univ, Coll Hlth Sci, Dept Nursing, Mekelle, Ethiopia	Mekelle University; Mekelle University; Mekelle University	Belay, E (corresponding author), Mekelle Univ, Coll Hlth Sci, Dept Med Biochem, Mekelle, Ethiopia.	aga.bely@gmail.com		belay, Ezra/0000-0001-6546-0591	Mekelle University [CRPO/CHS/Sm/003/09]	Mekelle University	The project was funded by Mekelle University under grant number:CRPO/CHS/Sm/003/09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LH, 2005, AM J CLIN NUTR, V81, p1206S; Allen LH, 2000, AM J CLIN NUTR, V71, P1485; Allen LH, 2002, J NUTR, V132, p813S, DOI 10.1093/jn/132.4.813S; Allen LH, 2009, AM J CLIN NUTR, V89, p693S, DOI 10.3945/ajcn.2008.26947A; [Anonymous], 2001, WHO TECHN REP SER; [Anonymous], 2012, GUID DAIL IR FOL AC; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Barker DJP, 1997, ACTA PAEDIATR, V86, P78; BEATON GH, 1999, EFFICACY INTERMITTEN; Beck KL, 2014, NUTRIENTS, V6, P3747, DOI 10.3390/nu6093747; Brugnara C, 1999, JAMA-J AM MED ASSOC, V281, P2225, DOI 10.1001/jama.281.23.2225; Cappellini MD, 2015, SEMIN HEMATOL, V52, P261, DOI 10.1053/j.seminhematol.2015.07.006; Cascio MJ, 2017, MED CLIN N AM, V101, P263, DOI 10.1016/j.mcna.2016.09.003; Cheesbrough M, 2006, DISTRICT LAB PRACTIC, V2nd; Ethiopian public health institute (EPHI), 2016, NAT MICR SURV REP; Federal Ministry of Health (FMOH) of Ethiopia, 2004, NAT GUID CONTR PREV; FERGUSON BJ, 1992, J LAB CLIN MED, V119, P385; Ganz T, 2018, INT J HEMATOL, V107, P7, DOI 10.1007/s12185-017-2366-2; Gebreegziabher T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184742; Gebreselassie SG, 2013, J HEALTH POPUL NUTR, V31, P185; Ghio AJ, 2012, ANN HEMATOL, V91, P957, DOI 10.1007/s00277-011-1335-8; Gutteridge John M. C., 1996, P239; Haidar J, 2010, J HEALTH POPUL NUTR, V28, P359; International Social Security Association, 2002, WHO RET WORK WHY EV, P1; Longo DL, 2012, HARRISONS PRINCIPLES; Lonnerdal B, 2004, NESTLE NUTR WORKS SE, V54, P67, DOI 10.1159/000080447; McIntire DD, 1999, NEW ENGL J MED, V340, P1234, DOI 10.1056/NEJM199904223401603; Micronutrient Initiative, 2009, INV FUT UN CALL ACT; Mori R, 2012, COCHRANE DATABASE SY, V7; Nasreen H, 2010, SERIES 32 RES MONOGR, V32; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Pathak Priyali, 2004, Indian Journal of Pediatrics, V71, P1007; Richards M, 2002, INT J EPIDEMIOL, V31, P342, DOI 10.1093/ije/31.2.342; Ross AC, 2017, AM J CLIN NUTR, V106, p1581S, DOI 10.3945/ajcn.117.155838; Short MW, 2013, AM FAM PHYSICIAN, V87, P98; Tahaineh L, 2017, J PHARM HEALTH SERV, V8, P45, DOI 10.1111/jphs.12149; Uche-Nwachi EO, 2010, AFR HEALTH SCI, V10, P66; Wirth JP, 2017, AM J CLIN NUTR, V106, p416S, DOI 10.3945/ajcn.116.143073	39	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204791	10.1371/journal.pone.0204791	http://dx.doi.org/10.1371/journal.pone.0204791			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273373	Green Submitted, Green Published, gold			2022-12-26	WOS:000446124700035
J	Wang, X; Elksnis, A; Wikstrom, P; Walum, E; Welsh, N; Carlsson, PO				Wang, Xuan; Elksnis, Andris; Wikstrom, Per; Walum, Erik; Welsh, Nils; Carlsson, Per-Ola			The novel NADPH oxidase 4 selective inhibitor GLX7013114 counteracts human islet cell death in vitro	PLOS ONE			English	Article							INSULIN-RESISTANCE; OXIDATIVE STRESS; MITOCHONDRIAL; NOX4; DYSFUNCTION; SECRETION; CYTOKINES; KINASE	It has been proposed that pancreatic beta-cell dysfunction in type 2 diabetes is promoted by oxidative stress caused by NADPH oxidase (Nox) over-activity. The aim of the present study was to evaluate the efficacy of novel Nox inhibitors as protective agents against cytokine- or high glucose + palmitate-induced human beta-cell death. The Nox2 protein was present mainly in the cytoplasm and was induced by cytokines. Nox4 protein immunoreactivity, with some nuclear accumulation, was observed in human islet cells, and was not affected by islet culture in the presence of cytokines or high glucose + palmitate. Nox inhibitors with partial or no isoform selectivity (DPI, dapsone, GLX351322, and GLX481372) all reduced ROS production of human islet cells exposed to high glucose + palmitate. This was paralleled by improved viability and reduced caspase 3 activation. The Nox1 selective inhibitor ML171 failed to reduce human islet cell death in response to both cytokines and high glucose + palmitate. The selective Nox2 inhibitor Phox-12 also failed to protect against cytokines, but protected partially against high glucose + palmitate-induced cellular death. The highly selective Nox4 inhibitor GLX7013114 protected islet cells against both cytokines and high glucose + palmitate. However, as no osmotic control for high glucose was used, we cannot exclude the possibility that the high glucose effect was due to osmosis. It is concluded that Nox4 may participate in stress-induced islet cell death in human islets in vitro. We propose that Nox4 mediates pro-apoptotic effects in intact islets under stressful conditions and that selective Nox4-inhibition may be a therapeutic strategy in type 2 diabetes.	[Wang, Xuan; Elksnis, Andris; Welsh, Nils; Carlsson, Per-Ola] Uppsala Univ, Dept Med Cell Biol, Sci Life Lab, Uppsala, Sweden; [Wikstrom, Per; Walum, Erik] Glucox Biotech AB, Stockholm, Sweden	Uppsala University	Wang, X (corresponding author), Uppsala Univ, Dept Med Cell Biol, Sci Life Lab, Uppsala, Sweden.	xuan.wang@mcb.uu.se		Welsh, Nils/0000-0001-5926-5407	Olle Engkvist Byggmastare; Swedish Research Council [2017-01343]; Swedish Diabetes Association; Novo Nordisk Foundation; family Ernfors Fund; Swedish Child Diabetes Fund; EXODIAB; Glucox Biotech AB	Olle Engkvist Byggmastare; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Diabetes Association; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); family Ernfors Fund; Swedish Child Diabetes Fund; EXODIAB; Glucox Biotech AB	The present study was supported in part by Olle Engkvist Byggmastare, the Swedish Research Council (2017-01343), the Swedish Diabetes Association, the Novo Nordisk Foundation, the family Ernfors Fund, the Swedish Child Diabetes Fund and EXODIAB. The funder Glucox Biotech AB provided support in the form of salaries for authors EW and PW. Glucox Biotech AB has supported this study by generating, characterizing and providing NOX inhibitors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenhofer S, 2015, ANTIOXID REDOX SIGN, V23, P406, DOI 10.1089/ars.2013.5814; Anvari E, 2015, FREE RADICAL RES, V49, P1308, DOI 10.3109/10715762.2015.1067697; Bergman RN, 2000, TRENDS ENDOCRIN MET, V11, P351, DOI 10.1016/S1043-2760(00)00323-4; Block K, 2008, J BIOL CHEM, V283, P24061, DOI 10.1074/jbc.M803964200; Bosco EE, 2012, CHEM BIOL, V19, P228, DOI 10.1016/j.chembiol.2011.12.017; Carlsson C, 1999, ENDOCRINOLOGY, V140, P3422, DOI 10.1210/en.140.8.3422; Chul S, 2011, Patent application EP, Patent No. [2364698A2, 2364698]; de Souza AH, 2017, MOL CELL ENDOCRINOL, V439, P354, DOI 10.1016/j.mce.2016.09.022; Derscheid RJ, 2014, AM J RESP CELL MOL, V50, P389, DOI 10.1165/rcmb.2012-0529OC; EIZIRIK DL, 1994, J CLIN INVEST, V93, P1968, DOI 10.1172/JCI117188; Evans JL, 2003, DIABETES, V52, P1, DOI 10.2337/diabetes.52.1.1; Fred RG, 2015, MOL CELL ENDOCRINOL, V414, P53, DOI 10.1016/j.mce.2015.07.015; Gianni D, 2010, ACS CHEM BIOL, V5, P981, DOI 10.1021/cb100219n; Guichard C, 2008, BIOCHEM SOC T, V36, P920, DOI 10.1042/BST0360920; Guo SH, 2015, J DRUG TARGET, V23, P888, DOI 10.3109/1061186X.2015.1036276; Han CY, 2016, DIABETES METAB J, V40, P272, DOI 10.4093/dmj.2016.40.4.272; Hirano K, 2015, ANTIOXID REDOX SIGN, V23, P358, DOI 10.1089/ars.2014.6202; Hubatsch I, 2007, NAT PROTOC, V2, P2111, DOI 10.1038/nprot.2007.303; Jaquet V, 2011, BRIT J PHARMACOL, V164, P507, DOI 10.1111/j.1476-5381.2011.01439.x; Kim YM, 2017, AM J PHYSIOL-CELL PH, V312, pC749, DOI 10.1152/ajpcell.00346.2016; Krizhanovskii C, 2017, ISLETS, V9, P43, DOI 10.1080/19382014.2017.1296995; Lacraz G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006963; Liang J, 2016, ANTIOXID REDOX SIGN, V24, P419, DOI 10.1089/ars.2014.6135; Moon JS, 2016, NAT MED, V22, P1002, DOI 10.1038/nm.4153; Newsholme P, 2007, J PHYSIOL-LONDON, V583, P9, DOI 10.1113/jphysiol.2007.135871; Oliveira HR, 2003, DIABETES, V52, P1457, DOI 10.2337/diabetes.52.6.1457; Przybylska D, 2016, ONCOTARGET, V7, P66429, DOI 10.18632/oncotarget.12079; Ravassard P, 2011, J CLIN INVEST, V121, P3589, DOI 10.1172/JCI58447; Rebelato E, 2012, LIFE SCI, V91, P244, DOI 10.1016/j.lfs.2012.07.004; Robertson RP, 2006, CURR OPIN PHARMACOL, V6, P615, DOI 10.1016/j.coph.2006.09.002; Sakai K, 2003, BIOCHEM BIOPH RES CO, V300, P216, DOI 10.1016/S0006-291X(02)02832-2; Sato Y, 2014, J DIABETES INVEST, V5, P19, DOI 10.1111/jdi.12124; Shanmugasundaram K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01106-1; Syed I, 2011, DIABETES, V60, P2843, DOI 10.2337/db11-0809; Type Mandrup-Poulsen T., 2013, DERMATOL CLIN, V31, P495, DOI [10.1016/j.det.2013.04.006, DOI 10.1016/J.DET.2013.04.006]; Uchizono Y, 2006, LIFE SCI, V80, P133, DOI 10.1016/j.lfs.2006.08.031; Wagner B, 2014, AM J PHYSIOL-RENAL, V306, pF85, DOI 10.1152/ajprenal.00371.2013; Wang LZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118553; Weaver JR, 2012, MOL CELL ENDOCRINOL, V358, P88, DOI 10.1016/j.mce.2012.03.004; Xiong QB, 1996, BIOL PHARM BULL, V19, P1580, DOI 10.1248/bpb.19.1580	40	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204271	10.1371/journal.pone.0204271	http://dx.doi.org/10.1371/journal.pone.0204271			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265686	Green Submitted, gold, Green Published			2022-12-26	WOS:000446005500024
J	Ding, YR; Li, B; Zhang, YJ; Mao, QM; Chen, B				Ding, Yi-Ran; Li, Bo; Zhang, Yu-Juan; Mao, Qi-Meng; Chen, Bin			Complete mitogenome of Anopheles sinensis and mitochondrial insertion segments in the nuclear genomes of 19 mosquito species	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; CULEX-QUINQUEFASCIATUS; DIPTERA-CULICIDAE; AEDES-AEGYPTI; DNA; NUMTS; PSEUDOGENES; EVOLUTION; PROGRAM; ORIGIN	Anopheles sinensis is a major malarial vector in China and Southeast Asia. The mitochondria is involved in many important biological functions. Nuclear mitochondrial DNA segments (NUMTs) are common in eukaryotic organisms, but their characteristics are poorly understood. We sequenced and analyzed the complete mitochondrial (mt) genome of An. sinensis. The mt genome is 15,418 bp long and contains 13 protein-coding genes (PCGs), two rRNAs, 22 tRNAs and a large non-coding region. Its gene arrangement is similar to previously published mosquito mt genomes. We identified and analyzed the NUMTs of 19 mosquito species with both nuclear genomes and mt genome sequences. The number, total length and density of NUMTs are significantly correlated with genome size. About half of NUMTs are short (< 200 bp), but larger genomes can house longer NUMTs. NUMTs may help explain genome size expansion in mosquitoes. The expansion due to mitochondrial insertion segments is variable in different insect groups. PCGs are transferred to nuclear genomes at a higher frequency in mosquitoes, but NUMT origination is more different than in mammals. Larger-sized nuclear genomes have longer mt genome sequences in both mosquitoes and mammals. The study provides a foundation for the functional research of mitochondrial genes in An. sinensis and helps us understand the characteristics and origin of NUMTs and the potential contribution to genome expansion.	[Ding, Yi-Ran; Li, Bo; Zhang, Yu-Juan; Mao, Qi-Meng; Chen, Bin] Chongqing Normal Univ, Chongqing Key Lab Vector Insects, Chongqing, Peoples R China; [Ding, Yi-Ran; Li, Bo; Zhang, Yu-Juan; Mao, Qi-Meng; Chen, Bin] Chongqing Normal Univ, Inst Entomol & Mol Biol, Chongqing, Peoples R China	Chongqing Normal University; Chongqing Normal University	Chen, B (corresponding author), Chongqing Normal Univ, Chongqing Key Lab Vector Insects, Chongqing, Peoples R China.; Chen, B (corresponding author), Chongqing Normal Univ, Inst Entomol & Mol Biol, Chongqing, Peoples R China.	bin.chen@cqnu.edu.cn			National Natural Science Foundation of China [31672363, 31372265]; National Key Program of Science and Technology Foundation Work of China [2015FY210300]; Science and Technology Major Special Project of Guangxi [GKAA17129002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Program of Science and Technology Foundation Work of China; Science and Technology Major Special Project of Guangxi	This research was supported by the followings: The National Natural Science Foundation of China (31672363, 31372265), National Key Program of Science and Technology Foundation Work of China (2015FY210300) and Science and Technology Major Special Project of Guangxi (GKAA17129002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Arensburger P, 2010, SCIENCE, V330, P86, DOI 10.1126/science.1191864; Beard C.B., 1993, Insect Molecular Biology, V2, P103, DOI 10.1111/j.1365-2583.1993.tb00131.x; Behura SK, 2011, INSECT BIOCHEM MOLEC, V41, P770, DOI 10.1016/j.ibmb.2011.05.006; Bensasson D, 2000, MOL BIOL EVOL, V17, P406, DOI 10.1093/oxfordjournals.molbev.a026320; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Beye M, 2006, GENOME RES, V16, P1339, DOI 10.1101/gr.5680406; Cameron SL, 2014, ANNU REV ENTOMOL, V59, P95, DOI 10.1146/annurev-ento-011613-162007; Cha SY, 2007, GENE, V392, P206, DOI 10.1016/j.gene.2006.12.031; Chen B, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-314; Chen K, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0362-7; Chen XG, 2015, P NATL ACAD SCI USA, V112, pE5907, DOI 10.1073/pnas.1516410112; Chen ZT, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18050996; David JP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-216; Demari-Silva B, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1951-0; Foster PG, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170758; Hao YJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07977-0; Hardy CM, 2016, MITOCHONDRIAL DNA A, V27, P2552, DOI 10.3109/19401736.2015.1038800; Hazkani-Covo E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000834; Hazkani-Covo E, 2009, MOL BIOL EVOL, V26, P2175, DOI 10.1093/molbev/msp131; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Hua YQ, 2016, INSECT SCI, V23, P353, DOI 10.1111/1744-7917.12326; Hua YQ, 2016, MITOCHONDRIAL DNA A, V27, P2909, DOI 10.3109/19401736.2015.1060434; Krzywinski J, 2006, MOL PHYLOGENET EVOL, V39, P417, DOI 10.1016/j.ympev.2006.01.006; Leister D, 2005, TRENDS GENET, V21, P655, DOI 10.1016/j.tig.2005.09.004; Li XJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1234-9; Logue K, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-64; LOPEZ JV, 1994, J MOL EVOL, V39, P174; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Martins J, 2007, INSECT MOL BIOL, V16, P777, DOI 10.1111/j.1365-2583.2007.00771.x; MITCHELL SE, 1993, GENOME, V36, P1058, DOI 10.1139/g93-141; Moreno M, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-127; Neafsey DE, 2015, SCIENCE, V347, DOI 10.1126/science.1258522; Negrisolo E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-221; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Pamilo P, 2007, MOL BIOL EVOL, V24, P1340, DOI 10.1093/molbev/msm055; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Qu HY, 2008, J GENET GENOMICS, V35, P485, DOI 10.1016/S1673-8527(08)60066-1; Richly E, 2004, MOL BIOL EVOL, V21, P1081, DOI 10.1093/molbev/msh110; Saito S, 2005, GENETICS, V171, P1695, DOI 10.1534/genetics.105.046243; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Sorenson MD, 1998, AUK, V115, P214, DOI 10.2307/4089130; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thorsness PE, 1996, INT REV CYTOL, V165, P207, DOI 10.1016/S0074-7696(08)62223-8; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Ullrich H, 1997, PLANT MOL BIOL, V33, P37, DOI 10.1023/A:1005720910028; VANDERKUYL AC, 1995, J MOL EVOL, V40, P652, DOI 10.1007/BF00160513; Wolstenholme DR, 1992, CURR OPIN GENET DEV, V2, P918, DOI 10.1016/S0959-437X(05)80116-9; Wu XM, 2018, PEST MANAG SCI, V74, P159, DOI 10.1002/ps.4672; Yan ZW, 2018, PEST MANAG SCI, V74, P1810, DOI 10.1002/ps.4879; Zhang DX, 2003, MOL ECOL, V12, P563, DOI 10.1046/j.1365-294X.2003.01773.x; Zhang DX, 1996, TRENDS ECOL EVOL, V11, P247, DOI 10.1016/0169-5347(96)10031-8; Zhang HD, 2016, MITOCHONDRIAL DNA A, V27, P2787, DOI 10.3109/19401736.2015.1053067; Zhang NX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139736; Zhang NaiXin, 2013, Acta Entomologica Sinica, V56, P398; Zou Yi-lin, 2015, Zhongguo Meijieshengwuxue Ji Kongzhi Zazhi, V26, P333	60	7	7	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204667	10.1371/journal.pone.0204667	http://dx.doi.org/10.1371/journal.pone.0204667			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30261042	gold, Green Published, Green Submitted			2022-12-26	WOS:000445907400085
J	Hamm, M; Ladd, TB; Levites, Y; Golde, TE; Giasson, BI; Lewis, J				Hamm, Matthew; Ladd, Thomas B.; Levites, Yona; Golde, Todd E.; Giasson, Benoit I.; Lewis, Jada			Designing antibodies against LRRK2-targeted tau epitopes	PLOS ONE			English	Article							REPEAT KINASE 2; ALZHEIMERS-DISEASE; MOUSE MODEL; PHOSPHORYLATION; AGGREGATION; IMPAIRMENT; TAUOPATHY	Phosphorylation of the microtubule associated protein tau is an important modulator of its normal physiological functioning; however, it may also contribute to tau mis-folding and aggregation in neurodegenerative diseases, which are collectively termed tauopathies. As such, the investigations of tau phosphorylation and kinases that modify tau are important in trying to elucidate tau function and the mechanisms involved in the development of tauopathies. We have recently demonstrated that the putative tau kinase leucine-rich repeat kinase 2 is capable of phosphorylating tau at threonines 169 and 175 in vitro, and it has been previously shown that hyperphosphorylation at threonine 175 occurs in filamentous tau species from Alzheimer's brain tissue. These prior findings suggest that further studies of phosphorylation of tau at these epitopes may shed light on the pathogenesis of tauopathies. There is, however, a lack of tools available to analyze phosphorylation of tau at these sites. This study aimed to bridge that resource gap by generating monoclonal antibodies against tau phosphorylated at either threonine 169 or 175. While we did not succeed in generating a phospho-specific antibody, we did generate an antibody, MHT2, which is specific for human tau encompassing the threonine 169/175 epitope region. Immunostaining of transgenic rTg4510 mouse tissue as well as human tauopathy cases with MHT2 indicates that this antibody selectively detects cytoplasmic tau in the form of neurofibrillary tangles, and that it may have a further specificity pertaining to severity of disease progression, either because of phosphorylation or conformational bias.	[Hamm, Matthew; Ladd, Thomas B.; Levites, Yona; Golde, Todd E.; Giasson, Benoit I.; Lewis, Jada] Univ Florida, Coll Med, Dept Neurosci, Gainesville, FL 32610 USA; [Hamm, Matthew; Ladd, Thomas B.; Levites, Yona; Golde, Todd E.; Giasson, Benoit I.; Lewis, Jada] Univ Florida, Coll Med, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32611 USA; [Levites, Yona; Golde, Todd E.; Giasson, Benoit I.; Lewis, Jada] Univ Florida, Coll Med, McKnight Brain Inst, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Giasson, BI (corresponding author), Univ Florida, Coll Med, Dept Neurosci, Gainesville, FL 32610 USA.; Giasson, BI (corresponding author), Univ Florida, Coll Med, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32611 USA.; Giasson, BI (corresponding author), Univ Florida, Coll Med, McKnight Brain Inst, Gainesville, FL 32611 USA.	bgiasson@ufl.edu			National Institute of Neurological Disorders and Stroke [NS082672]; National Institute on Aging [AG047266]; Barbara's Dream Fund for Frontotemporal Dementia Research and Education	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Barbara's Dream Fund for Frontotemporal Dementia Research and Education	This work was supported by grants from the National Institute of Neurological Disorders and Stroke (NS082672) and the National Institute on Aging (AG047266), as well as The Barbara's Dream Fund for Frontotemporal Dementia Research and Education. TEG is a cofounder of Lacerta Therapeutics Inc., but does not currently receive a salary or other income resulting from this affiliation. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This work was supported by grants from the National Institute of Neurological Disorders and Stroke (NS082672) and the National Institute on Aging (AG047266), as well as The Barbara's Dream Fund for Frontotemporal Dementia Research and Education.	Bailey RM, 2013, ACTA NEUROPATHOL, V126, P809, DOI 10.1007/s00401-013-1188-4; Dawson HN, 2001, J CELL SCI, V114, P1179; Gilliland LK, 1996, TISSUE ANTIGENS, V47, P1, DOI 10.1111/j.1399-0039.1996.tb02509.x; Gohar M, 2009, J NEUROCHEM, V108, P634, DOI 10.1111/j.1471-4159.2008.05791.x; Guerreiro PS, 2016, MOL NEUROBIOL, V53, P3124, DOI 10.1007/s12035-015-9209-z; Hamm M, 2015, J NEUROSCI RES, V93, P1567, DOI 10.1002/jnr.23614; Hanger DP, 1998, J NEUROCHEM, V71, P2465; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; IQBAL K, 1986, LANCET, V2, P421; Kawakami F, 2014, FEBS J, V281, P3, DOI 10.1111/febs.12579; Kawakami F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030834; Moszczynski AJ, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-016-0406-4; Ramsden M, 2005, J NEUROSCI, V25, P10637, DOI 10.1523/JNEUROSCI.3279-05.2005; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Shanley MR, 2015, BIOCHEMISTRY-US, V54, P5198, DOI 10.1021/acs.biochem.5b00326; Strang KH, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0458-0; Waxman EA, 2011, J NEUROSCI, V31, P7604, DOI 10.1523/JNEUROSCI.0297-11.2011	17	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204367	10.1371/journal.pone.0204367	http://dx.doi.org/10.1371/journal.pone.0204367			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30261006	Green Published, gold, Green Submitted			2022-12-26	WOS:000445907400041
J	Saurabh, S; Vanaphan, N; Wen, W; Dauwalder, B				Saurabh, Sumit; Vanaphan, Nancy; Wen, Walter; Dauwalder, Brigitte			High functional conservation of takeout family members in a courtship model system	PLOS ONE			English	Article							SEX-DETERMINATION PATHWAY; JUVENILE-HORMONE; EPIPHYAS-POSTVITTANA; FEEDING-BEHAVIOR; GENE FAMILY; DROSOPHILA; PROTEINS; MET; GCE	takeout (to) is one of the male-specific genes expressed in the fat body that regulate male courtship behavior, and has been shown to act as a secreted protein in conjunction with courtship circuits. There are 23 takeout family members in Drosophila melanogaster, and homologues of this family are distributed across insect species. Sequence conservation among family members is low. Here we test the functional conservation of takeout family members by examining whether they can rescue the takeout courtship defect. We find that despite their sequence divergence takeout members from Aedes aegypti and Epiphas post-vittana, as well as family members from D. melanogaster can substitute for takeout in courtship, demonstrating their functional conservation. Making use of the known E. postvittana Takeout structure, we used homology modeling and amphipathic helix analysis and found high overall structural conservation, including high conservation of the structure and amphipathic lining of an internal cavity that has been shown to accommodate hydrophobic ligands. Together these data suggest a high degree of structural conservation that likely underlies functional conservation in courtship. In addition, we have identified a role for a conserved exposed protein motif important for the protein's role in courtship.	[Saurabh, Sumit; Vanaphan, Nancy; Wen, Walter; Dauwalder, Brigitte] Univ Houston, Dept Biol & Biochem, Houston, TX 77004 USA	University of Houston System; University of Houston	Dauwalder, B (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77004 USA.	bdauwalder@uh.edu	Saurabh, Sumit/ABD-8993-2020	Sumit Saurabh, Sumit/0000-0001-7661-1914	National Science Foundation [IOS-0919697]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation (https://nsf.gov/) IOS-0919697 to BD. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer J, 2010, AGING-US, V2, P298, DOI 10.18632/aging.100146; Benito J, 2010, P NATL ACAD SCI USA, V107, P2544, DOI 10.1073/pnas.0906422107; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Bernardo TJ, 2012, J BIOL CHEM, V287, P7821, DOI 10.1074/jbc.M111.327254; Billeter JC, 2006, CURR BIOL, V16, pR766, DOI 10.1016/j.cub.2006.08.025; Bohbot J, 2005, INSECT BIOCHEM MOLEC, V35, P961, DOI 10.1016/j.ibmb.2005.03.010; Chamseddin KH, 2012, MECH AGEING DEV, V133, P637, DOI 10.1016/j.mad.2012.08.004; Corcoran JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128596; Dauwalder B, 2002, GENE DEV, V16, P2879, DOI 10.1101/gad.1010302; Dauwalder B, 2008, CURR GENOMICS, V9, P517, DOI 10.2174/138920208786847980; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Du JG, 2003, INSECT BIOCHEM MOLEC, V33, P803, DOI 10.1016/S0965-1748(03)00079-1; Fujikawa K, 2006, FEBS J, V273, P4311, DOI 10.1111/j.1742-4658.2006.05422.x; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; Hagai T, 2007, INSECT BIOCHEM MOLEC, V37, P689, DOI 10.1016/j.ibmb.2007.04.002; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; Hamiaux C, 2009, J BIOL CHEM, V284, P3496, DOI 10.1074/jbc.M807467200; Hamiaux C, 2013, J STRUCT BIOL, V182, P259, DOI 10.1016/j.jsb.2013.03.013; Harker BW, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-29; Jindra M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005394; Jordan MD, 2008, INSECT MOL BIOL, V17, P361, DOI 10.1111/j.1365-2583.2008.00812.x; Kopec KO, 2011, BIOCHEM SOC T, V39, P1033, DOI 10.1042/BST0391033; Lazareva AA, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030016; Liu Y, 2009, DEVELOPMENT, V136, P2015, DOI 10.1242/dev.033712; MCROBERT SP, 1985, GENETICS, V111, P89; Meunier N, 2007, J EXP BIOL, V210, P1424, DOI 10.1242/jeb.02755; Rund SSC, 2013, SCI REP-UK, V3, DOI 10.1038/srep02494; Saito K, 2006, INSECT MOL BIOL, V15, P245, DOI 10.1111/j.1365-2583.2006.00612.x; Sarov-Blat L, 2000, CELL, V101, P647, DOI 10.1016/S0092-8674(00)80876-4; So WV, 2000, MOL CELL BIOL, V20, P6935, DOI 10.1128/MCB.20.18.6935-6944.2000; TAYLOR BJ, 1994, DEV GENET, V15, P275, DOI 10.1002/dvg.1020150309; Vanaphan N, 2012, GENE, V491, P142, DOI 10.1016/j.gene.2011.10.003; Yamamoto D, 2007, ADV GENET, V59, P39, DOI 10.1016/S0065-2660(07)59002-4	34	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204615	10.1371/journal.pone.0204615	http://dx.doi.org/10.1371/journal.pone.0204615			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30261021	gold, Green Submitted, Green Published			2022-12-26	WOS:000445907400078
J	Shiba, M; Sugano, Y; Ikeda, Y; Okada, H; Nagai, T; Ishibashi-Ueda, H; Yasuda, S; Ogawa, H; Anzai, T				Shiba, Mikio; Sugano, Yasuo; Ikeda, Yoshihiko; Okada, Hideshi; Nagai, Toshiyuki; Ishibashi-Ueda, Hatsue; Yasuda, Satoshi; Ogawa, Hisao; Anzai, Toshihisa			Presence of increased inflammatory infiltrates accompanied by activated dendritic cells in the left atrium in rheumatic heart disease	PLOS ONE			English	Article							TENASCIN-C; DILATED CARDIOMYOPATHY; FIBRILLATION; FEVER; EXPRESSION; GUIDELINES; BIOPSIES	Aims Left atrial (LA) structural remodelling develops in rheumatic heart disease (RHD) according to the disease severity of the mitral valve and the presence of atrial fibrillation. Sustained active inflammation has been previously reported in the LA of patients with RHD, suggesting a direct role of cell-mediated immunity in the pathogenesis of LA remodelling. Dendritic cells (DCs) have a major antigen-presenting role, and are known as crucial modulators of innate and adaptive immunity. We investigated whether DCs are involved in the pathogenesis of LA remodelling in RHD. Methods and results Immunohistochemical analyses were performed using antibodies to CD11c, CD209 and CD80 as markers of myeloid DCs, migratory-active DCs, mature DCs and infiltrated inflammatory cells including T lymphocytes (CD3) and M1 (CD68; pro-inflammatory profile) and M2 (CD163; pro-resolution profile) macrophages. Furthermore, tenascin-C, an extracellular matrix (ECM) protein that appears during ECM remodelling and inflammatory response, was examined. Infiltrated myeloid DCs, migratory-active DCs, mature DCs and other inflammatory infiltrates including T lymphocytes and M1 and M2 macrophages, were significantly higher in the RHD group than the non-RHD group. The positive area fraction for tenascin-C was significantly higher in the RHD group than in the non-RHD group. Conclusion Our histological findings suggest that inflammation may persist long after a bout of rheumatic fever, ultimately leading to ECM remodelling. We identified and quantitatively assessed several subsets of DCs and other immunocompetent cells, and our results indicated that activation of DCs has some role in persistence of LA inflammation in patients with chronic RHD.	[Shiba, Mikio; Sugano, Yasuo; Nagai, Toshiyuki; Yasuda, Satoshi; Ogawa, Hisao; Anzai, Toshihisa] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Osaka, Japan; [Shiba, Mikio] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Osaka, Japan; [Sugano, Yasuo] Keiyu Hosp, Dept Cardiovasc Med, Yokohama, Kanagawa, Japan; [Ikeda, Yoshihiko; Ishibashi-Ueda, Hatsue] Natl Cerebral & Cardiovasc Ctr, Dept Pathol, Osaka, Japan; [Okada, Hideshi] Gifu Univ, Grad Sch Med, Dept Emergency & Disaster Med, Gifu, Japan; [Nagai, Toshiyuki; Anzai, Toshihisa] Hokkaido Univ, Grad Sch Med, Dept Cardiovasc Med, Sapporo, Hokkaido, Japan	National Cerebral & Cardiovascular Center - Japan; Osaka University; National Cerebral & Cardiovascular Center - Japan; Gifu University; Hokkaido University	Sugano, Y (corresponding author), Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Osaka, Japan.; Sugano, Y (corresponding author), Keiyu Hosp, Dept Cardiovasc Med, Yokohama, Kanagawa, Japan.	ysugano@ncvc.go.jp		Shiba, Mikio/0000-0003-4418-7834; Okada, Hideshi/0000-0002-7775-4308	Japan Society for the Promotion of Science [2646098]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Funded by Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science(2646098 to Y.S.). https://www.jsps.go.jp/english/e-grants/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu CAC, 2005, CIRCULATION, V112, pI20, DOI 10.1161/CIRCULATIONAHA.104.526301; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bhatnagar A, 1999, CLIN EXP IMMUNOL, V116, P100; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Carapetis JR, 2005, LANCET, V366, P155, DOI 10.1016/S0140-6736(05)66874-2; CARLSSON R, 1988, J IMMUNOL, V140, P2484; Chopra P, 1992, J Heart Valve Dis, V1, P92; Corradi D, 2008, NAT CLIN PRACT CARD, V5, P782, DOI 10.1038/ncpcardio1370; DAJANI AS, 1992, JAMA-J AM MED ASSOC, V268, P2069, DOI 10.1001/jama.1992.03490150121036; Frustaci A, 1997, CIRCULATION, V96, P1180, DOI 10.1161/01.CIR.96.4.1180; Imanaka-Yoshida K, 2012, CIRC J, V76, P2513, DOI 10.1253/circj.CJ-12-1033; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Marcus GM, 2010, HEART RHYTHM, V7, P149, DOI 10.1016/j.hrthm.2009.10.004; Marijon E, 2012, LANCET, V379, P953, DOI 10.1016/S0140-6736(11)61171-9; Midwood KS, 2016, J CELL SCI, V129, P4321, DOI 10.1242/jcs.190546; Nagai T, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000839; Nair M, 2001, CIRCULATION, V104, P802, DOI 10.1161/hc3201.094228; Nakayama T, 2017, EUR J HEART FAIL, V19, P490, DOI 10.1002/ejhf.767; PLASCHKES J, 1971, ANN SURG, V174, P194, DOI 10.1097/00000658-197108000-00004; SCHENK S, 1995, INT J CANCER, V61, P443, DOI 10.1002/ijc.2910610402; Sharma S, 2014, CARDIOVASC PATHOL, V23, P319, DOI 10.1016/j.carpath.2014.07.008; TEICHHOLZ LE, 1976, AM J CARDIOL, V37, P7, DOI 10.1016/0002-9149(76)90491-4; Thomas CV, 1998, CIRCULATION, V97, P1708, DOI 10.1161/01.CIR.97.17.1708; Udalova IA, 2011, CRIT REV IMMUNOL, V31, P115, DOI 10.1615/CritRevImmunol.v31.i2.30; Yokokawa T, 2016, EUR J HEART FAIL, V18, P375, DOI 10.1002/ejhf.464	26	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0203756	10.1371/journal.pone.0203756	http://dx.doi.org/10.1371/journal.pone.0203756			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30261069	Green Submitted, Green Published, gold			2022-12-26	WOS:000445907400016
J	Bohlenius, H; Asp, H; Hjelm, K				Bohlenius, Henrik; Asp, Hakan; Hjelm, Karin			Differences in Al sensitivity affect establishment of Populus genotypes on acidic forest land	PLOS ONE			English	Article							HYBRID POPLAR PLANTATIONS; ALUMINUM TOLERANCE LEVELS; ABANDONED FARMLAND; MINERAL-NUTRITION; PLANT-GROWTH; ROOT-GROWTH; BARLEY; TOXICITY; WHEAT; SOIL	Forest lands hold great potential for Populus plantations, but in native boreal forests, soils normally have low pH and thus higher levels of aluminum ions (Al3+ and hydroxides). Aluminum (Al) is one of the major factors limiting plant growth on these soils by inhibiting root growth, thus reducing water and nutrient uptake and slowing growth. There is a large variation in Al resistance both among and within species. In this study, growth responses of greenhouse-grown hybrid aspen (P. tremula x tremuloides) and poplar (P. trichocarpa hybrids) were monitored in relation to changes in Al concentrations. In quartz sand, hybrid aspen was more tolerant to exogenous application of Al than P. trichocarpa hybrids. This difference in Al-tolerance was further confirmed by hematoxylin staining of the roots, with hybrid aspen displaying less staining after Al treatment than poplar clones. When planted on forest land with low pH, hybrid aspen increased growth after planting and showed low mortality. This was not the case for poplar clones; plant height decreased after planting and mortality increased. Together, our results suggest that differences in initial growth and survival on forest land among hybrid aspen and the tested poplar clones may be connected to differences in Al tolerance. Our findings that staining with hematoxylin can identify Al-tolerant Populus genotypes may help identify Al-tolerant genotypes suitable for forest land.	[Bohlenius, Henrik] Swedish Univ Agr Sci, Dept Southern Swedish Forest Res Ctr, Alnarp, Sweden; [Asp, Hakan] Swedish Univ Agr Sci, Dept Biosyst & Technol, Alnarp, Sweden; [Hjelm, Karin] Forestry Res Inst Sweden Skogforsk, Ekebo 2250, Svalov, Sweden	Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; Skogforsk	Bohlenius, H (corresponding author), Swedish Univ Agr Sci, Dept Southern Swedish Forest Res Ctr, Alnarp, Sweden.	Henrik.Bohlenius@slu.se	Hjelm, Karin/AAD-1590-2022	Hjelm, Karin/0000-0002-6144-8250	Swedish research program; "Trees and Crops for the Future"(TC4F) a Vinnova project; Bio4energy, a Strategic Research Environment	Swedish research program; "Trees and Crops for the Future"(TC4F) a Vinnova project; Bio4energy, a Strategic Research Environment	This project was funded by the Swedish research program; "Trees and Crops for the Future"(TC4F) a Vinnova project, and Bio4energy, a Strategic Research Environment appointed by the Swedish government.	ALAM SM, 1981, COMMUN SOIL SCI PLAN, V12, P121, DOI 10.1080/00103628109367134; Anas, 2000, Plant Production Science, V3, P246, DOI 10.1626/pps.3.246; [Anonymous], [No title captured]; Barcelo J, 2002, ENVIRON EXP BOT, V48, P75, DOI 10.1016/S0098-8472(02)00013-8; Bergstedt AE, 1981, DYRKNING POPPEL GROW; Bilodeau-Gauthier S, 2011, FOREST ECOL MANAG, V261, P620, DOI 10.1016/j.foreco.2010.11.016; Bohlenius H, 2016, CAN J FOREST RES, V46, P1367, DOI 10.1139/cjfr-2016-0146; Bona KA, 2008, FOREST ECOL MANAG, V255, P2761, DOI 10.1016/j.foreco.2008.01.042; Bona L, 1998, CEREAL RES COMMUN, V26, P97; Brunner I, 2007, J FOREST RES-JPN, V12, P78, DOI 10.1007/s10310-006-0261-4; BURDETT AN, 1984, CAN J FOREST RES, V14, P644, DOI 10.1139/x84-116; CARVER BF, 1995, ADV AGRON, V54, P117, DOI 10.1016/S0065-2113(08)60899-8; Christersson L, 2008, BIOMASS BIOENERG, V32, P997, DOI 10.1016/j.biombioe.2007.12.018; Christersson L, 2010, BIOMASS BIOENERG, V34, P1289, DOI 10.1016/j.biombioe.2010.03.021; CLARKSON DT, 1966, PLANT PHYSIOL, V41, P165, DOI 10.1104/pp.41.1.165; Coll L, 2007, ANN FOREST SCI, V64, P275, DOI 10.1051/forest:2007005; Delhaize E, 2007, FEBS LETT, V581, P2255, DOI 10.1016/j.febslet.2007.03.057; Echart CL, 2002, EUPHYTICA, V126, P309, DOI 10.1023/A:1019964410057; Foy C.D., 1992, ADV SOIL SCI, P97, DOI DOI 10.1007/978-1-4612-2894-3_5; FOY CD, 1976, PLANT ADAPTATION MIN, P255; GORANSSON A, 1987, PHYSIOL PLANTARUM, V69, P193, DOI 10.1111/j.1399-3054.1987.tb04275.x; Grisel N, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-185; Grossnickle SC, 2005, NEW FOREST, V30, P273, DOI 10.1007/s11056-004-8303-2; Hiradate S, 2007, ADV AGRON, V96, P65, DOI 10.1016/S0065-2113(07)96004-6; Huang CF, 2009, PLANT CELL PHYSIOL, V50, P976, DOI 10.1093/pcp/pcp050; HUANG JWW, 1992, PLANT PHYSIOL, V98, P230, DOI 10.1104/pp.98.1.230; Kochian LV, 2005, PLANT SOIL, V274, P175, DOI 10.1007/s11104-004-1158-7; Kopittke PM, 2015, PLANT PHYSIOL, V167, P1402, DOI 10.1104/pp.114.253229; Kozlowski T.T., 1975, ARBORICULTURE; Lof M., 2010, ECOL BULL, V53, P165, DOI DOI 10.1016/J.FORECO.2016.02.020; Lu EY, 2001, CAN J FOREST RES, V31, P123, DOI 10.1139/cjfr-31-1-123; Ma JF, 1997, PLANT SOIL, V191, P133, DOI 10.1023/A:1004257711952; Ma JF, 1999, PLANT CELL PHYSIOL, V40, P549, DOI 10.1093/oxfordjournals.pcp.a029576; Magistad OC, 1925, SOIL SCI, V20, P181, DOI 10.1097/00010694-192509000-00001; MCCORMICK LH, 1978, FOREST SCI, V24, P565; Miyake K, 1916, J BIOL CHEM, V25, P23; MIYASAKA SC, 1989, PLANT PHYSIOL, V91, P1188, DOI 10.1104/pp.91.3.1188; Mossberg B, 2015, NORDISK FLORA SCANDI; Naik D, 2009, TREE PHYSIOL, V29, P423, DOI 10.1093/treephys/tpn035; Nguyen NT, 2003, TREE PHYSIOL, V23, P1041, DOI 10.1093/treephys/23.15.1041; Nilsson N.-E., 1990, FOREST NATL ATLAS SW; Pallardy SG, 2003, AGROFOREST SYST, V59, P21, DOI 10.1023/A:1026176702075; PARKER DR, 1995, PLANT SOIL, V171, P151, DOI 10.1007/BF00009579; POLLE E, 1978, CROP SCI, V18, P823, DOI 10.2135/cropsci1978.0011183X001800050035x; Purcino AAC, 2003, J PLANT NUTR, V26, P31, DOI 10.1081/PLN-120016496; Qin RJ, 2007, TREE PHYSIOL, V27, P313, DOI 10.1093/treephys/27.2.313; R Core TeamR, LANG ENV STAT COMP; Rangel AF, 2009, PHYSIOL PLANTARUM, V135, P162, DOI 10.1111/j.1399-3054.2008.01183.x; REID DA, 1969, AGRON J, V61, P218, DOI 10.2134/agronj1969.00021962006100020014x; REID DA, 1971, AGRON J, V63, P600, DOI 10.2134/agronj1971.00021962006300040026x; Rietveld W. J., 1989, Northern Journal of Applied Forestry, V6, P99; SCHAEDLE M, 1989, TREE PHYSIOL, V5, P337, DOI 10.1093/treephys/5.3.337; Sivaguru M, 1998, PLANT PHYSIOL, V116, P155, DOI 10.1104/pp.116.1.155; Smith E, 2011, ENVIRON EXP BOT, V72, P182, DOI 10.1016/j.envexpbot.2011.03.003; Stanturf JA, 2014, POPLARS AND WILLOWS: TREES FOR SOCIETY AND THE ENVIRONMENT, P200, DOI 10.1079/9781780641089.0200; STEINER KC, 1984, FOREST SCI, V30, P404; Stener LG, 2017, SILVA FENN, V51, DOI 10.14214/sf.5656; STONE EC, 1955, FOREST SCI, V1, P89; Truax B, 2014, FORESTS, V5, P3107, DOI 10.3390/f5123107; Truax B, 2012, FOREST ECOL MANAG, V267, P228, DOI 10.1016/j.foreco.2011.12.012; Tullus A, 2012, SCAND J FOREST RES, V27, P10, DOI 10.1080/02827581.2011.628949; Tullus H, 2005, 273 EST U LIF SCI TA; Veitch FP, 1904, J AM CHEM SOC, V26, P637, DOI 10.1021/ja01996a005; vergaard R, 2011, ODLING HYBRIDASP POP; Wakeley PC, 1954, USDA AGR MONOGRAPH; Wang Jun-ping, 2006, J Zhejiang Univ Sci B, V7, P769, DOI 10.1631/jzus.2006.B0769; Wehr JB, 2017, NEW FOREST, V48, P137, DOI 10.1007/s11056-016-9560-6; Wilander A, 2000, RECOVERY ACIDIFICATI	68	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2018	13	9							e0204461	10.1371/journal.pone.0204461	http://dx.doi.org/10.1371/journal.pone.0204461			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3NB	30256819	Green Submitted, Green Published, gold			2022-12-26	WOS:000446000200046
J	Martin-Morales, L; Rofes, P; Diaz-Rubio, E; Llovet, P; Lorca, V; Bando, I; Perez-Segura, P; de la Hoya, M; Garre, P; Garcia-Barberan, V; Caldes, T				Martin-Morales, Lorena; Rofes, Paula; Diaz-Rubio, Eduardo; Llovet, Patricia; Lorca, Victor; Bando, Inmaculada; Perez-Segura, Pedro; de la Hoya, Miguel; Garre, Pilar; Garcia-Barberan, Vanesa; Caldes, Trinidad			Novel genetic mutations detected by multigene panel are associated with hereditary colorectal cancer predisposition	PLOS ONE			English	Article							LYNCH-SYNDROME; MISMATCH REPAIR; BREAST-CANCER; MOLECULAR-GENETICS; OVARIAN-CANCER; RISK; SUSCEPTIBILITY; VARIANTS; HNPCC; MANAGEMENT	Half of the high-risk colorectal cancer families that fulfill the clinical criteria for Lynch syndrome lack germline mutations in the mismatch repair (MMR) genes and remain unexplained. Genetic testing for hereditary cancers is rapidly evolving due to the introduction of multigene panels, which may identify more mutations than the old screening methods. The aim of this study is the use of a Next Generation Sequencing panel in order to find the genes involved in the cancer predisposition of these families. For this study, 98 patients from these unexplained families were tested with a multigene panel targeting 94 genes involved in cancer predisposition. The mutations found were validated by Sanger sequencing and the segregation was studied when possible. We identified 19 likely pathogenic variants in 18 patients. Out of these, 8 were found in MMR genes (5 in MLH1, 1 in MSH6 and 2 in PMS2). In addition, 11 mutations were detected in other genes, including high penetrance genes (APC, SMAD4 and TP53) and moderate penetrance genes (BRIP1, CHEK2, MUTYH, HNF1A and XPC). Mutations c.1194G>A in SMAD4, c.714_720dup in PMS2, c.2050T>G in MLH1 and c.1635_1636de1 in MSH6 were novel. In conclusion, the detection of new pathogenic mutations in high and moderate penetrance genes could contribute to the explanation of the heritability of colorectal cancer, changing the individual clinical management. Multigene panel testing is a more effective method to identify germline variants in cancer patients compared to single-gene approaches and should be therefore included in clinical laboratories.	[Martin-Morales, Lorena; Rofes, Paula; Llovet, Patricia; Lorca, Victor; Bando, Inmaculada; de la Hoya, Miguel; Garre, Pilar; Garcia-Barberan, Vanesa; Caldes, Trinidad] Hosp Clin San Carlos, Mol Oncol Lab, IdISSC1, Madrid, Spain; [Martin-Morales, Lorena; Diaz-Rubio, Eduardo; Llovet, Patricia; Bando, Inmaculada; de la Hoya, Miguel; Garre, Pilar; Garcia-Barberan, Vanesa; Caldes, Trinidad] Carlos III Hlth Inst, CIBERONC Ctr Invest Biomed Red Canc, Madrid, Spain; [Diaz-Rubio, Eduardo; Perez-Segura, Pedro] Hosp Clin San Carlos, Med Oncol, Madrid, Spain	Hospital Clinico San Carlos; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Hospital Clinico San Carlos	Caldes, T (corresponding author), Hosp Clin San Carlos, Mol Oncol Lab, IdISSC1, Madrid, Spain.; Caldes, T (corresponding author), Carlos III Hlth Inst, CIBERONC Ctr Invest Biomed Red Canc, Madrid, Spain.	trinidad.caldes@salud.madrid.org	de la Hoya, MIguel/Z-2911-2019	Rofes, Paula/0000-0001-6045-7879; de la Hoya, Miguel/0000-0002-8113-1410; Martin-Morales, Lorena/0000-0002-1970-8872; Llovet, Patricia/0000-0003-0190-2105; Garre Rubio, Pilar/0000-0001-8285-4138; Garcia-Barberan, Vanesa/0000-0002-2531-0203; LORCA CASTELLANOS, VICTOR/0000-0002-3681-4319	ISCIII [PI16/01292]; European Regional Development FEDER funds	ISCIII(Instituto de Salud Carlos III); European Regional Development FEDER funds	This work has been supported by grant PI16/01292 from ISCIII, partially supported by the European Regional Development FEDER funds.	Beamer LC, 2012, J CLIN ONCOL, V30, P1058, DOI 10.1200/JCO.2011.38.4719; Caldes T, 2002, INT J CANCER, V98, P774, DOI 10.1002/ijc.10240; Desmond A, 2015, JAMA ONCOL, V1, P943, DOI 10.1001/jamaoncol.2015.2690; Easton D, 2004, AM J HUM GENET, V74, P1175, DOI 10.1086/421251; Espenschied CR, 2017, J CLIN ONCOL, V35, P2568, DOI 10.1200/JCO.2016.71.9260; Esteban-Jurado C, 2015, GENET MED, V17, P131, DOI 10.1038/gim.2014.89; Gallego CJ, 2015, J CLIN ONCOL, V33, P2084, DOI 10.1200/JCO.2014.59.3665; Garre P, 2015, CLIN GENET, V87, P582, DOI 10.1111/cge.12427; Garre P, 2014, FAM CANCER, V13, P109, DOI 10.1007/s10689-013-9683-2; Garre P, 2011, CLIN CANCER RES, V17, P1701, DOI 10.1158/1078-0432.CCR-10-2491; Godino J, 2001, Hum Mutat, V18, P549, DOI 10.1002/humu.1240; Goel A, 2010, GASTROENTEROLOGY, V138, P1854, DOI 10.1053/j.gastro.2010.01.035; Hampel H, 2006, CANCER RES, V66, P7810, DOI 10.1158/0008-5472.CAN-06-1114; Ingvarsson S, 2002, BREAST CANCER RES, V4, DOI 10.1186/bcr435; Lindor NM, 2005, JAMA-J AM MED ASSOC, V293, P1979, DOI 10.1001/jama.293.16.1979; Lindor NM, 2009, SURG ONCOL CLIN N AM, V18, P637, DOI 10.1016/j.soc.2009.07.003; Lorans M, 2018, CLIN COLORECTAL CANC, V17, pE293, DOI 10.1016/j.clcc.2018.01.001; Lynch HT, 2008, FAM CANCER, V7, P27, DOI 10.1007/s10689-007-9165-5; Lynch HT, 1999, J MED GENET, V36, P801; Lynch HT, 1996, INT J CANCER, V69, P38, DOI 10.1002/(SICI)1097-0215(19960220)69:1<38::AID-IJC9>3.0.CO;2-X; MacDonald JR, 2014, NUCLEIC ACIDS RES, V42, pD986, DOI 10.1093/nar/gkt958; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; Narod SA, 2010, CLIN GENET, V78, P1, DOI 10.1111/j.1399-0004.2010.01402.x; Palomaki GE, 2009, GENET MED, V11, P42, DOI 10.1097/GIM.0b013e31818fa2db; Peltomaki P, 2004, DIS MARKERS, V20, P269, DOI 10.1155/2004/305058; Plon SE, 2008, HUM MUTAT, V29, P1282, DOI 10.1002/humu.20880; Rafnar T, 2011, NAT GENET, V43, P1104, DOI 10.1038/ng.955; Ramus SJ, 2015, JNCI-J NATL CANCER I, P107; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rohlin A, 2017, FAM CANCER, V16, P195, DOI 10.1007/s10689-016-9934-0; Rosenthal ET, 2017, CANCER GENET-NY, V218, P58, DOI 10.1016/j.cancergen.2017.09.003; Sanchez-de-Abajo A, 2007, CLIN CANCER RES, V13, P5729, DOI 10.1158/1078-0432.CCR-06-2996; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Shirts BH, 2016, GENET MED, V18, P974, DOI 10.1038/gim.2015.212; Slavin TP, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00208; Sodha N, 2006, CANCER RES, V66, P8966, DOI 10.1158/0008-5472.CAN-06-1990; Susswein LR, 2016, GENET MED, V18, P823, DOI 10.1038/gim.2015.166; Vasen HFA, 1999, GASTROENTEROLOGY, V116, P1453, DOI 10.1016/S0016-5085(99)70510-X; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; WATSON P, 1993, CANCER, V71, P677, DOI 10.1002/1097-0142(19930201)71:3<677::AID-CNCR2820710305>3.0.CO;2-#; Yurgelun MB, 2015, GASTROENTEROLOGY, V149, P604, DOI 10.1053/j.gastro.2015.05.006	42	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2018	13	9							e0203885	10.1371/journal.pone.0203885	http://dx.doi.org/10.1371/journal.pone.0203885			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3NB	30256826	Green Published, gold, Green Submitted			2022-12-26	WOS:000446000200030
J	Labayru, G; Arenzana, I; Aliri, J; Zulaica, M; de Munain, AL; Sistiaga, A				Labayru, Garazi; Arenzana, Irati; Aliri, Jone; Zulaica, Miren; Lopez de Munain, Adolfo; Sistiaga A, Andone			Social cognition in myotonic dystrophy type 1: Specific or secondary impairment?	PLOS ONE			English	Article							FACIAL EMOTION RECOGNITION; QUALITY-OF-LIFE; FRONTOTEMPORAL DEMENTIA; DISEASE; PERSONALITY; PREVALENCE; EXPANSION; SPECTRUM; DEFICITS; PATTERN	Aims The cognitive profile of Myotonic Dystrophy type 1 (DM1) has been described in recent decades. Moreover, DM1 patients show lowered social engagement and difficulties in social-cognitive functions. The aim of the present study is to explore whether social cognition impairment is present in DM1 taking into account the overall cognitive condition. Method 38 patients and a control group paired in age and gender participated in the study. All the participants had an IQ within the normal range. Subjects were administered an abbreviated neuropsychological battery which comprised a facial emotion recognition test (POFA) and Faux Pas Test, as well as a self-report questionnaire on cognitive and affective empathy (TECA). Results Statistically significant differences were found only for facial emotion recognition (U = 464.0, p = .006) with a moderate effect size (.31), with the controls obtaining a higher score than the patients. Analyzing each emotion separately, DM1 patients scored significantly lower than controls on the recognition of anger and disgust items. Emotion recognition did not correlate with genetic load, but did correlate negatively with age. No differences were found between patients and controls in any of the other variables related to Theory of Mind (ToM) and empathy. Conclusion DM1 does not manifest specific impairments in ToM since difficulties in this area predominantly rely on the cognitive demand of the tasks employed. However, a more basic process such as emotion recognition appears as a core deficit. The role of this deficit as a marker of aging related decline is discussed.	[Labayru, Garazi; Zulaica, Miren; Lopez de Munain, Adolfo; Sistiaga A, Andone] Biodonostia Res Inst, Neurosci Area, Donostia San Sebastian, Gipuzkoa, Spain; [Labayru, Garazi; Sistiaga A, Andone] Univ Basque Country, Personal Assessment & Psychol Treatment Dept, UPV EHU, Psychol Fac, Donostia San Sebastian, Gipuzkoa, Spain; [Arenzana, Irati] Autonoma Univ Barcelona, Masters Child & Adult Neuropsychol, Barcelona, Spain; [Aliri, Jone] Univ Basque Country, Dept Social Psychol & Methodol Behav Sci, UPV EHU, Donostia San Sebastian, Gipuzkoa, Spain; [Lopez de Munain, Adolfo] Donostia Univ Hosp, Neurol Dept, Donostia San Sebastian, Gipuzkoa, Spain	University of Basque Country; Autonomous University of Barcelona; University of Basque Country; University Hospital Donostia	Sistiaga, A (corresponding author), Biodonostia Res Inst, Neurosci Area, Donostia San Sebastian, Gipuzkoa, Spain.; Sistiaga, A (corresponding author), Univ Basque Country, Personal Assessment & Psychol Treatment Dept, UPV EHU, Psychol Fac, Donostia San Sebastian, Gipuzkoa, Spain.	andone.sistiaga@ehu.es	Aliri, Jone/I-4257-2019; Sistiaga, Andone/ABA-8447-2021; DE MUNAIN, ADOLFO LOPEZ/AAB-1824-2020	Aliri, Jone/0000-0003-2292-2164; Sistiaga, Andone/0000-0003-2511-0911; /0000-0002-9509-4032; LABAYRU, GARAZI/0000-0002-7304-320X	Instituto de Salud Carlos III - Fondo Europeo de Desarrollo Regional - FEDER [PI17/01231]	Instituto de Salud Carlos III - Fondo Europeo de Desarrollo Regional - FEDER	The present study has been supported by grants of the Instituto de Salud Carlos III co-founded by Fondo Europeo de Desarrollo Regional - FEDER (Ref: PI17/01231).	Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; American Psychiatric Association [APA], 2014, MAN DIAGN EST TRAST; Angeard N, 2018, NEUROMUSCULAR DISORD, V28, P216, DOI 10.1016/j.nmd.2017.12.006; [Anonymous], 2008, NEW HDB METHODS NONV; Badoud D, 2017, J NEURODEV DISORD, V9, DOI 10.1186/s11689-017-9216-7; BIRD TD, 1983, J NEUROL NEUROSUR PS, V46, P971, DOI 10.1136/jnnp.46.11.971; Bora E, 2016, J GERIATR PSYCH NEUR, V29, P205, DOI 10.1177/0891988716640375; Brune M, 2005, PSYCHIAT RES, V133, P135, DOI 10.1016/j.psychres.2004.10.007; Cohen J., 1998, STAT POWER ANAL BEHA; De Antonio M, 2016, REV NEUROL-FRANCE, V172, P572, DOI 10.1016/j.neurol.2016.08.003; DEMUNAIN AL, 1993, NEUROLOGY, V43, P1573, DOI 10.1212/WNL.43.8.1573; Ekman P., 1976, PICTURES FACIAL AFFE; Ekstrom AB, 2008, AM J MED GENET B, V147B, P918, DOI 10.1002/ajmg.b.30698; Gagnon C, 2008, ARCH PHYS MED REHAB, V89, P1246, DOI 10.1016/j.apmr.2007.10.049; Gallais B, 2017, NEUROMUSCULAR DISORD, V27, P61, DOI 10.1016/j.nmd.2016.10.003; Gallais B, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0401-6; Goodkind MS, 2015, EMOTION, V15, P416, DOI 10.1037/a0039261; Harper P, 2009, MYOTONIC DYSTROPHY; Heavey L, 2000, J AUTISM DEV DISORD, V30, P225, DOI 10.1023/A:1005544518785; Kalkman JS, 2005, J NEUROL NEUROSUR PS, V76, P1406, DOI 10.1136/jnnp.2004.050005; Kaufman AS., 1997, K BIT TEST BREVE INT; Kleberg JL, 2014, ACTA NEUROL SCAND, V130, P312, DOI 10.1111/ane.12228; Kobayakawa Mutsutaka, 2016, Brain Nerve, V68, P137, DOI 10.11477/mf.1416200363; Kobayakawa M, 2012, NEUROSCI RES, V72, P341, DOI 10.1016/j.neures.2012.01.005; Kobayakawa M, 2010, J NEUROL SCI, V290, P48, DOI 10.1016/j.jns.2009.11.011; Konstantakopoulos G, 2014, SOC NEUROSCI-UK, V9, P590, DOI 10.1080/17470919.2014.934395; Laberge L, 2007, CLIN GENET, V71, P59, DOI 10.1111/j.1399-0004.2007.00732.x; Laberge L, 2013, EUR NEUROL, V70, P308, DOI 10.1159/000353991; Lopez-Perez B., 2008, TECA TEST EMPATIA CO; MALLOY P, 1990, J NEUROL NEUROSUR PS, V53, P1011, DOI 10.1136/jnnp.53.11.1011; Mathieu J, 2001, NEUROLOGY, V56, P336, DOI 10.1212/WNL.56.3.336; MEHRABIAN A, 1972, J PERS, V40, P525, DOI 10.1111/j.1467-6494.1972.tb00078.x; Modoni A, 2004, ARCH NEUROL-CHICAGO, V61, P1943, DOI 10.1001/archneur.61.12.1943; Modoni A, 2008, J NEUROL, V255, P1737, DOI 10.1007/s00415-008-0017-5; Natterlund B, 2001, J REHABIL MED, V33, P206; NOVELLI G, 1993, BIOCHEM MED METAB B, V50, P85, DOI 10.1006/bmmb.1993.1049; Okkersen K, 2017, CORTEX, V95, P143, DOI 10.1016/j.cortex.2017.08.008; Perez-Albeniz A, 2003, PSICOTHEMA, V15, P267; Perini GI, 1999, BIOL PSYCHIAT, V46, P425, DOI 10.1016/S0006-3223(99)00016-5; Rosenthal R, 1991, METAANALYTIC PROCEDU; Rubinsztein JS, 1997, J MED GENET, V34, P229, DOI 10.1136/jmg.34.3.229; Serra L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156901; Sistiaga A, 2010, PSYCHOL MED, V40, P487, DOI 10.1017/S0033291709990602; Spek AA, 2010, J AUTISM DEV DISORD, V40, P280, DOI 10.1007/s10803-009-0860-y; Takeda A, 2009, J NEUROL SCI, V280, P35, DOI 10.1016/j.jns.2009.01.014; Wechsler D., 1999, PUBLICACIONES PSICOL, P273; Winblad S, 2006, J NEUROL NEUROSUR PS, V77, P219, DOI 10.1136/jnnp.2005.070763; Winblad S, 2016, EUR J NEUROL, V23, P1471, DOI 10.1111/ene.13062; Winblad Stefan, 2006, Behav Brain Funct, V2, P16, DOI 10.1186/1744-9081-2-16; Yeh ZT, 2015, J CLIN EXP NEUROPSYC, V37, P128, DOI 10.1080/13803395.2014.992864; Zalla T, 2009, J AUTISM DEV DISORD, V39, P373, DOI 10.1007/s10803-008-0634-y	51	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2018	13	9							e0204227	10.1371/journal.pone.0204227	http://dx.doi.org/10.1371/journal.pone.0204227			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV3MI	30248121	gold, Green Published			2022-12-26	WOS:000445998100028
J	Luong, LMT; Phung, D; Dang, TN; Sly, PD; Morawska, L; Thai, PK				Luong, Ly M. T.; Phung, Dung; Tran Ngoc Dang; Sly, Peter D.; Morawska, Lidia; Thai, Phong K.			Seasonal association between ambient ozone and hospital admission for respiratory diseases in Hanoi, Vietnam	PLOS ONE			English	Article							OUTDOOR AIR-POLLUTION; NITROGEN-DIOXIDE; DISTRIBUTED LAG; DAILY MORTALITY; YOUNG-CHILDREN; EXPOSURE; ASTHMA; VISITS; INFECTIONS; HEALTH	Background Many studies have indicated the detrimental effect of ambient ozone to respiratory health in different countries. The levels of ozone in Hanoi, Vietnam are frequently above the WHO guideline but very few studies on the effects of ambient ozone on human health have been conducted in this location. This study aimed to examine the effects of ozone on hospital admission for respiratory diseases in Hanoi, by diseases, ages and seasons. Methods Hospital admissions, air pollutants and meteorological data were collected from January 2010 to June 2014. We used generalized linear models and distributed lag linear model to assess the association. In addition to full year analysis, we conducted restricted analysis of the data for two summer (from June-August) and winter (from December-February) seasons and grouped hospital admissions by diseases and ages (all ages, children 0 to 5 years and elderly >65 years). The delayed effect of ozone was assessed using lags of up to 5 days. Results Ozone has a stronger effect on the risk of hospital admission for respiratory diseases and wheeze-associated disorders in the winter. For respiratory diseases, children were affected by ozone more than other age groups in both winter and summer. Each increase of 10 mu g/m(3) of ozone is associated with an increase of 6.2% risk of admission for respiratory disease among children in the winter and 1.2% in the summer. For wheeze-associated disorders, the elderly group seemed to be more affected by ozone in full year and winter but no significant association was found between ozone and admission for wheeze-associated diseases in any age group. Conclusions Ozone is a risk factor for respiratory admission, especially amongst children under 5 years old in Hanoi, and ozone has a stronger effect in the winter than in the summer in this city.	[Luong, Ly M. T.; Sly, Peter D.] Univ Queensland, Fac Med, Brisbane, Qld, Australia; [Luong, Ly M. T.; Sly, Peter D.] Univ Queensland, Childrens Hlth & Environm Program, Brisbane, Qld, Australia; [Luong, Ly M. T.] VNU Univ Sci, Fac Environm Sci, Hanoi, Vietnam; [Phung, Dung] Griffith Univ, Ctr Environm & Populat Hlth, Brisbane, Qld, Australia; [Tran Ngoc Dang] Duy Tan Univ, Inst Res & Dev, Da Nang, Vietnam; [Tran Ngoc Dang] Univ Med & Pharm, Dept Environm Hlth, Ho Chi Minh City, Vietnam; [Morawska, Lidia; Thai, Phong K.] Queensland Univ Technol, Int Lab Air Qual & Hlth, Brisbane, Qld, Australia	University of Queensland; University of Queensland; Vietnam National University Hanoi; Griffith University; Duy Tan University; Hochiminh City University of Medicine & Pharmacy; Queensland University of Technology (QUT)	Phung, D (corresponding author), Griffith Univ, Ctr Environm & Populat Hlth, Brisbane, Qld, Australia.; Thai, PK (corresponding author), Queensland Univ Technol, Int Lab Air Qual & Hlth, Brisbane, Qld, Australia.	d.phung@griffith.edu.au; phong.thai@qut.edu.au	Luong, Thi Mai Ly/ABG-3188-2021; Luong, Thi Mai Ly/ABF-1148-2021; Sly, Peter D/F-1486-2010; Phung, Dung/ABC-9218-2021; Thai, Phong K/A-3998-2011; Morawska, Lidia/B-4140-2011	Luong, Thi Mai Ly/0000-0002-1980-686X; Luong, Thi Mai Ly/0000-0002-1980-686X; Sly, Peter D/0000-0001-6305-2201; Phung, Dung/0000-0002-1615-3234; Thai, Phong K/0000-0003-0042-3057; Morawska, Lidia/0000-0002-0594-9683	Australia Award Scholarship; Griffith Postdoctoral Research Fellowship; National Health and Medical Research Council; Queensland University of Technology	Australia Award Scholarship; Griffith Postdoctoral Research Fellowship; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Queensland University of Technology	LL is funded by an Australia Award Scholarship. DP is funded by a Griffith Postdoctoral Research Fellowship. PS is funded by a National Health and Medical Research Council Senior Principal Research Fellowship. PT is funded by a Queensland University of Technology Vice-Chancellor's Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	[Anonymous], 2020, STATE AIR POLLUTION, P31; Bae S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129423; Bell ML, 2014, AM J EPIDEMIOL, V180, P15, DOI 10.1093/aje/kwu115; Brunekreef B, 2002, LANCET, V360, P1233, DOI 10.1016/S0140-6736(02)11274-8; Burnett RT, 1997, ENVIRON RES, V72, P24, DOI 10.1006/enrs.1996.3685; Burnett RT, 2001, AM J EPIDEMIOL, V153, P444, DOI 10.1093/aje/153.5.444; CAI-Asia Center, 2010, AIR QUAL AS STAT TRE; Chen RJ, 2014, AM J EPIDEMIOL, V180, P729, DOI 10.1093/aje/kwu183; Cooper O. R., 2014, Elementa-Science of the Anthropocene, V2, P000029, DOI 10.12952/journal.elementa.000029; de Almeida SP, 2011, ENVIRON RES, V111, P406, DOI 10.1016/j.envres.2011.01.024; deLeon AP, 1996, J EPIDEMIOL COMMUN H, V50, pS63, DOI 10.1136/jech.50.Suppl_1.s63; Farhat SCL, 2005, BRAZ J MED BIOL RES, V38, P227, DOI 10.1590/S0100-879X2005000200011; Fusco D, 2001, EUR RESPIR J, V17, P1143, DOI 10.1183/09031936.01.00005501; Gasparrini A., DISTRIBUTED LAG LINE, P212; Gasparrini A, 2011, J STAT SOFTW, V43, P1, DOI 10.18637/jss.v043.i08; Ghaffari HR, 2017, ENVIRON SCI POLLUT R, V24, P27402, DOI 10.1007/s11356-017-0226-5; Glad JA, 2012, ARCH ENVIRON OCCUP H, V67, P103, DOI 10.1080/19338244.2011.598888; Gouveia N, 2000, OCCUP ENVIRON MED, V57, P477, DOI 10.1136/oem.57.7.477; Gryparis A, 2004, AM J RESP CRIT CARE, V170, P1080, DOI 10.1164/rccm.200403-333OC; Guerreiro CBB, 2014, ATMOS ENVIRON, V98, P376, DOI 10.1016/j.atmosenv.2014.09.017; Hanoi DPI, 2013, HAN DEP PLANN INV; Hwang JS, 2002, AM J EPIDEMIOL, V155, P1, DOI 10.1093/aje/155.1.1; Ji M, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/2/024006; Karr C, 2007, AM J EPIDEMIOL, V165, P553, DOI 10.1093/aje/kwk032; Kim BJ, 2011, ANN ALLERG ASTHMA IM, V107, P214, DOI 10.1016/j.anai.2011.05.025; Lin S, 2008, ENVIRON HEALTH PERSP, V116, P1725, DOI 10.1289/ehp.11184; Luong LMT, 2017, SCI TOTAL ENVIRON, V578, P249, DOI 10.1016/j.scitotenv.2016.08.012; Marchenko Y., 2010, STAT C BOST MA; Medina-Ramon M, 2008, EPIDEMIOLOGY, V19, P672, DOI 10.1097/EDE.0b013e3181773476; Mehta S, 2013, AIR QUAL ATMOS HLTH, V6, P167, DOI 10.1007/s11869-011-0158-z; MONRE, 2014, NAT STAT ENV REP 201; Nhung NTT, 2018, ENVIRON INT, V110, P139, DOI 10.1016/j.envint.2017.10.024; Norazian MN, 2008, SCIENCEASIA, V34, P341, DOI 10.2306/scienceasia1513-1874.2008.34.341; Paulu C, 2008, J PUBLIC HEALTH MAN, V14, P581, DOI 10.1097/01.PHH.0000338371.53242.0e; Peng RD, 2013, AIR QUAL ATMOS HLTH, V6, P445, DOI 10.1007/s11869-012-0180-9; Pershagen G, 1995, INT J EPIDEMIOL, V24, P1147, DOI 10.1093/ije/24.6.1147; Petroeschevsky A, 2001, ARCH ENVIRON HEALTH, V56, P37, DOI 10.1080/00039890109604053; Phung D, 2016, SCI TOTAL ENVIRON, V557, P322, DOI 10.1016/j.scitotenv.2016.03.070; Qin LJ, 2017, INT J BIOMETEOROL, V61, P1003, DOI 10.1007/s00484-016-1279-8; Rahman SRA, 2017, ANN TROP MED PUBLIC, V10, P44, DOI 10.4103/ATMPH.ATMPH_75_17; Roberts-Semple D, 2012, ATMOS POLLUT RES, V3, P247, DOI 10.5094/APR.2012.027; Sandstrom T., 2003, European Respiratory Journal, V21, p92s, DOI 10.1183/09031936.03.00403503; Schwartz J, 2000, EPIDEMIOLOGY, V11, P320, DOI 10.1097/00001648-200005000-00016; SCHWARTZ J, 1994, AM J RESP CRIT CARE, V150, P648, DOI 10.1164/ajrccm.150.3.8087333; Shannon MW, 2004, PEDIATRICS, V114, P1699, DOI 10.1542/peds.2004-2166; Tao YB, 2012, ENVIRON HEALTH PERSP, V120, P393, DOI 10.1289/ehp.1103715; The World Bank, 2013, UPD VIETN REC EC DEV; U.S. EPA, 2013, EPA600R20012; Vahedian M, 2017, J ENVIRON HEALTH SCI, V15, DOI 10.1186/s40201-017-0277-z; WHO, 2016, AMB AIR POLL GLOB AS; WHO, 2005, WHO AIR QUAL GUILD P; Wong TW, 1999, OCCUP ENVIRON MED, V56, P679, DOI 10.1136/oem.56.10.679; Yang CX, 2012, SCI TOTAL ENVIRON, V426, P83, DOI 10.1016/j.scitotenv.2012.03.036; Yang QY, 2003, INHAL TOXICOL, V15, P1297, DOI 10.1080/08958370390241768; Zemp E, 1999, AM J RESP CRIT CARE, V159, P1257, DOI 10.1164/ajrccm.159.4.9807052	55	25	26	5	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2018	13	9							e0203751	10.1371/journal.pone.0203751	http://dx.doi.org/10.1371/journal.pone.0203751			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3MI	30248114	Green Published, Green Submitted, gold			2022-12-26	WOS:000445998100012
J	Pilkerton, CS; Hobbs, GR; Lilly, C; Knox, SS				Pilkerton, Courtney S.; Hobbs, Gerald R.; Lilly, Christa; Knox, Sarah S.			Rubella immunity and serum perfluoroalkyl substances: Sex and analytic strategy	PLOS ONE			English	Article							MENSTRUATING WOMEN EVIDENCE; HUMORAL IMMUNITY; PERFLUOROOCTANOIC ACID; ENHANCED ELIMINATION; C8 HEALTH; VACCINE; EXPOSURE; POPULATION; RESPONSES; ANTIBODY	Background Perfluoroalkyl substances (PFASs) have been associated with decreased immunity to childhood tetanus and diphtheria immunizations. If these vaccinations are vulnerable to influence from PFASs, questions arise about associations with other common inoculations. Objective To examine whether serum PFASs were associated with reduced immunity to rubella immunization, and whether interactions with sex or ethnicity warranted analytic stratification. Usually, toxicology analyses are calculated controlling for race and sex. However, sex differences in immune function have been reported and a reduction of immunity to rubella in women could pose risks such miscarriage. Methods We analyzed a nationally representative sample of individuals >= 12 years from the National Health and Nutrition Examination Survey (NHANES) for years 1999-2000 and 2003-2004 for whom PFAS measures were available. Our analytic strategy was to start with separate analyses for youth and adults controlling for several covariates including ethnicity and sex, as well as the interaction of these terms with PFASs. If there was a main effect of PFASs and an interaction term, we would stratify analyses of effect size. The outcome variable was Rubella IgG titers by quartile of perfluoroalkyl substances. Results After exclusion for missing data, the analyzed sample contained 581 adult women, 621 adult men, and 1012 youth. There was no significant effect of PFASs on immunity in youths but a significant effect of both PFOA and PFOS in adults, as well as a significant interaction of PFOA x sex and a borderline significant interaction of PFOS x sex. When effect size analyses were stratified by sex, a significant association between rubella titres and PFOA was found in men but not women and PFOS was not significant in either sex. Conclusions These results support our earlier studies showing sex specific responses to PFASs and indicate the importance of thinking carefully about analytic strategies in population based toxicology research.	[Pilkerton, Courtney S.] West Virginia Univ, WVU Sch Med, Morgantown, WV USA; [Hobbs, Gerald R.] West Virginia Univ, Dept Stat, Morgantown, WV USA; [Lilly, Christa] West Virginia Univ, Dept Biostat, Sch Publ Hlth, Morgantown, WV USA; [Knox, Sarah S.] West Virginia Univ, Dept Epidemiol, Sch Publ Hlth, Morgantown, WV 26506 USA	West Virginia University; West Virginia University; West Virginia University; West Virginia University	Knox, SS (corresponding author), West Virginia Univ, Dept Epidemiol, Sch Publ Hlth, Morgantown, WV 26506 USA.	sknox@hsc.wvu.edu	Lilly, Christa L/R-6644-2017	Lilly, Christa L/0000-0002-0009-0638	WVU School of Public Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104942] Funding Source: NIH RePORTER	WVU School of Public Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by WVU School of Public Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brieger A, 2011, TOXICOL IN VITRO, V25, P960, DOI 10.1016/j.tiv.2011.03.005; BUCKLEY CE, 1971, ANN INTERN MED, V75, P673, DOI 10.7326/0003-4819-75-5-673; Calafat AM, 2007, ENVIRON HEALTH PERSP, V115, P1596, DOI 10.1289/ehp.10598; Centers for Disease Control and Prevention (CDC), 2014, NAT HLTH NUTR EX SUR; Chalubinski M, 2006, ALLERGY, V61, P1326, DOI 10.1111/j.1398-9995.2006.01135.x; Cook IF, 2008, VACCINE, V26, P3551, DOI 10.1016/j.vaccine.2008.04.054; Cooper GS, 2003, AUTOIMMUN REV, V2, P119, DOI 10.1016/S1568-9972(03)00006-5; Corsini E, 2011, TOXICOL APPL PHARM, V250, P108, DOI 10.1016/j.taap.2010.11.004; Cui L, 2009, ARCH ENVIRON CON TOX, V56, P338, DOI 10.1007/s00244-008-9194-6; DeWitt J, 2009, CRIT REV TOXICOL, V39, P76, DOI [10.1080/10408440802209804, 10.1080/10408440802209804 ]; Dhiman N, 2008, TISSUE ANTIGENS, V72, P211, DOI 10.1111/j.1399-0039.2008.01097.x; Dong GH, 2009, ARCH TOXICOL, V83, P805, DOI 10.1007/s00204-009-0424-0; Engler RJM, 2008, ARCH INTERN MED, V168, P2405, DOI 10.1001/archinternmed.2008.513; Fair PA, 2011, J IMMUNOTOXICOL, V8, P17, DOI 10.3109/1547691X.2010.527868; Frisbee SJ, 2010, ARCH PEDIAT ADOL MED, V164, P860, DOI 10.1001/archpediatrics.2010.163; Grandjean P, 2012, JAMA-J AM MED ASSOC, V307, P391, DOI 10.1001/jama.2011.2034; Granum B, 2013, J IMMUNOTOXICOL, V10, P373, DOI 10.3109/1547691X.2012.755580; Harda K, 2005, ENVIRON RES, V99, P253, DOI [10.1016/j.envres.2004.12.003, DOI 10.1016/J.ENVRES.2004.12.003]; Javins B, 2013, ENVIRON SCI TECHNOL, V47, P1606, DOI 10.1021/es3028082; Jin YX, 2010, FISH SHELLFISH IMMUN, V28, P854, DOI 10.1016/j.fsi.2010.02.009; Kennedy RB, 2009, VACCINE, V27, P3319, DOI 10.1016/j.vaccine.2009.01.086; Knox SS, 2011, J TOXICOL SCI, V36, P403; Knox SS, 2011, J CLIN ENDOCR METAB, V96, P1747, DOI 10.1210/jc.2010-2401; Lau C, 2007, TOXICOL SCI, V99, P366, DOI 10.1093/toxsci/kfm128; Li Y, 22017 GOT U SAHLGR A; Lin CY, 2009, DIABETES CARE, V32, P702, DOI 10.2337/dc08-1816; Looker C, 2014, TOXICOL SCI, V138, P76, DOI 10.1093/toxsci/kft269; Lorber M, 2015, CHEMOSPHERE, V118, P170, DOI 10.1016/j.chemosphere.2014.07.093; Melzer D, 2010, ENVIRON HEALTH PERSP, V118, P686, DOI 10.1289/ehp.0901584; Milla S, 2011, ECOTOXICOLOGY, V20, P305, DOI 10.1007/s10646-010-0588-7; MITCHELL LA, 1992, J INFECT DIS, V166, P1258, DOI 10.1093/infdis/166.6.1258; Needham LL, 2011, ENVIRON SCI TECHNOL, V45, P1121, DOI 10.1021/es1019614; Ovsyannikova IG, 2008, PEDIATRICS, V121, pE1091, DOI 10.1542/peds.2007-1575; Peden-Adams MM, 2008, TOXICOL SCI, V104, P144, DOI 10.1093/toxsci/kfn059; Peden-Adams MM, 2007, J TOXICOL ENV HEAL A, V70, P1130, DOI 10.1080/15287390701252733; Skendzel LP, 1996, AM J CLIN PATHOL, V106, P170; Stein CR, 2016, PEDIATR RES, V79, P348, DOI 10.1038/pr.2015.213; Verner MA, 2015, ENVIRON SCI TECHNOL, V49, P5836, DOI 10.1021/acs.est.5b00187; Vestergren R, 2009, ENVIRON SCI TECHNOL, V43, P5565, DOI 10.1021/es900228k; Watson JC, 1998, MMWR RECOMM REP, V47, P1; Wong F, 2014, ENVIRON SCI TECHNOL, V48, P8807, DOI 10.1021/es500796y	41	14	15	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2018	13	9							e0203330	10.1371/journal.pone.0203330	http://dx.doi.org/10.1371/journal.pone.0203330			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3MI	30248109	Green Published, gold, Green Submitted			2022-12-26	WOS:000445998100009
J	Faraci, C; Jin, J; Woods, DC				Faraci, Christine; Jin, Joyce; Woods, Dori C.			Calorie restriction does not influence oocyte quality in oocytes from POLG mitochondrial mutator mice	PLOS ONE			English	Article							OXIDATIVE STRESS; DIETARY RESTRICTION; DNA POLYMERASE; LIFE-SPAN; AGED RAT; MUTATIONS; EXERCISE; BRAIN	It has recently been demonstrated that moderate adult onset caloric restriction (e.g. calorie restriction; CR) has a positive impact on female fertility in aged mice, due in large to preventing the age-associated decline in the quality of oocytes available for fertilization. The impact of CR on oocyte quality has been attributed, at least in part, to mitochondrial functions. In mitochondrial DNA (mtDNA) mutator mice (polg(D257A)(/)(D257A)) which harbor a mutation in the proofreading mtDNA polymerase-gamma (POLG), mitochondrial mutations rapidly accumulate, resulting in a premature aging phenotype and female infertility. As CR has been shown to extend both lifespan and 'healthspan' as well as improve oocyte quality in aged mice, we investigated whether adult onset CR could improve oocyte quality in the POLG mouse. Female Polg(D)(257A/D257A) mice exhibited infertility based on an inability to produce litters through natural mating. Analysis of oocytes from 8-9-month-old Polg(D)(257A/D257A) mice on CR following hormone stimulation revealed no improvement in the number of oocytes ovulated. Furthermore, CR did not result in a greater percentage of metaphase II oocytes, with the majority of the oocytes prematurely arrested at the germinal vesicle stage. Finally, CR did not improve the abnormal mitochondrial distribution or pronounced defects in meiotic spindle assembly and chromosomal distribution observed in the ad libitum fed Polg(D)(257A/D257A). Taken together, these data suggest that although CR benefits oocyte quality and fertility outcomes in naturally aged female mice, it does not sufficiently improve oocyte quality in Polg(D)(257A/D257A).	[Faraci, Christine; Jin, Joyce; Woods, Dori C.] Northeastern Univ, Dept Biol, Lab Aging & Infertil Res, Boston, MA 02115 USA	Northeastern University	Woods, DC (corresponding author), Northeastern Univ, Dept Biol, Lab Aging & Infertil Res, Boston, MA 02115 USA.	d.woods@northeastern.edu			National Science Foundation [1750996]	National Science Foundation(National Science Foundation (NSF))	This material is based upon work supported by the National Science Foundation under grant number 1750996 to D.C.W. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspnes LE, 1997, FASEB J, V11, P573, DOI 10.1096/fasebj.11.7.9212081; Boudoures AL, 2016, REPRODUCTION, V151, P261, DOI 10.1530/REP-15-0419; Cassano P, 2004, ANN NY ACAD SCI, V1019, P269, DOI 10.1196/annals.1297.045; Faraci C, 2018, REPRODUCTION, V156, P185, DOI 10.1530/REP-18-0061; Hansen AB, 2006, DNA REPAIR, V5, P71, DOI 10.1016/j.dnarep.2005.07.009; Hauser DN, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0075-14.2015; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Lezza AMS, 2008, NEUROCHEM RES, V33, P2609, DOI 10.1007/s11064-008-9866-7; Logan A, 2014, AGING CELL, V13, P765, DOI 10.1111/acel.12212; Macao B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8303; NELSON JF, 1985, BIOL REPROD, V32, P515, DOI 10.1095/biolreprod32.3.515; Ni T, 2015, SCI REP-UK, V5, DOI 10.1038/srep12049; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Safdar A, 2016, CURR OPIN GENET DEV, V38, P127, DOI 10.1016/j.gde.2016.06.011; Safdar A, 2016, SKELET MUSCLE, V6, DOI 10.1186/s13395-016-0075-9; Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108; Safdar A, 2011, J BIOL CHEM, V286, P10605, DOI 10.1074/jbc.M110.211466; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Selesniemi K, 2011, P NATL ACAD SCI USA, V108, P12319, DOI 10.1073/pnas.1018793108; Sharov AA, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-24; Someya S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171159; Szklarczyk R, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0439; Tamura H, 2008, J PINEAL RES, V44, P280, DOI 10.1111/j.1600-079X.2007.00524.X; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Turturro A, 1999, J GERONTOL A-BIOL, V54, pB492, DOI 10.1093/gerona/54.11.B492; Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95; Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988; WEINDRUCH R, 1986, J NUTR, V116, P641, DOI 10.1093/jn/116.4.641; Woods DC, 2018, GENES-BASEL, V9, DOI 10.3390/genes9050265	29	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2018	13	9							e0204373	10.1371/journal.pone.0204373	http://dx.doi.org/10.1371/journal.pone.0204373			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU5MM	30240410	Green Submitted, Green Published, gold			2022-12-26	WOS:000445329700043
J	Strand, BH; Knapskog, AB; Persson, K; Edwin, TH; Amland, R; Mjorud, M; Bjertness, E; Engedal, K; Selbaek, G				Strand, Bjorn Heine; Knapskog, Anne-Brita; Persson, Karin; Edwin, Trine Holt; Amland, Rachel; Mjorud, Marit; Bjertness, Espen; Engedal, Knut; Selbaek, Geir			Survival and years of life lost in various aetiologies of dementia, mild cognitive impairment (MCI) and subjective cognitive decline (SCD) in Norway	PLOS ONE			English	Article							MORTALITY; INDIVIDUALS; DISEASE; DEATH; PEOPLE; COHORT; RISK	Introduction Alzheimer's disease patients are reported to have higher survival rate compared to patients with vascular dementia or dementia with Lewy bodies. There is a paucity of studies investigating survival including persons with cognitive decline and dementia of various aetiologies. Objectives We aimed to compare survival for patients with subjective cognitive decline, mild cognitive impairment, Alzheimer's disease, vascular dementia, mixed Alzheimer's/vascular dementia, dementia with Lewy bodies/Parkinson's disease, and other dementias compared to the general Norwegian population, taking into account the role of gender, cognitive function, function in everyday activities, comorbidity and education. Methods Patients (N = 4682), >= 65 years, in the The Norwegian register of persons assessed for cognitive symptoms (NorCog) during 2009-2017 were followed for mortality in the National Registry until January 2018. Flexible parametric survival models were applied to estimate relative survival, life expectancy and years of life lost for diagnostic groups compared with the general population. Results Patients with vascular dementia or dementia with Lewy bodies/Parkinson's had the shortest survival, followed by mixed dementia, Alzheimer's disease, unspecified dementia, mild cognitive impairment and subjective cognitive decline. At age 70 years, men with vascular dementia or dementia with Lewy bodies/Parkinson's had life expectancy of 4.7 years, which corresponded to 10.3 years of life lost compared to the general population. Years of life lost for other diagnoses were 10.0 years for mixed dementia, 9.2 years for Alzheimer's disease, 9.3 years for other dementias, 5.2 years for mild cognitive impairment and 2.2 years for subjective cognitive decline. Corresponding years of life lost in women were: 12.7 years, 10.5 years, 9.8 years, 10.6 years, 7.8 years, and 2.6 years. Poor relative survival among dementia patients was associated with male gender, comorbidity, low cognitive function, and low function in activities of daily living. Conclusions Compared with the general population, patients with subjective cognitive decline had no significant loss in life expectancy, while patients with mild cognitive impairment and all dementia subtypes had large losses, especially those with a diagnosis of vascular dementia or dementia with Lewy bodies/Parkinson's.	[Strand, Bjorn Heine; Persson, Karin; Edwin, Trine Holt; Amland, Rachel; Mjorud, Marit; Engedal, Knut; Selbaek, Geir] Vestfold Hosp Trust, Norwegian Natl Advisory Unit Aging & Hlth, Tonsberg, Norway; [Strand, Bjorn Heine; Knapskog, Anne-Brita; Persson, Karin; Edwin, Trine Holt; Amland, Rachel; Engedal, Knut; Selbaek, Geir] Oslo Univ Hosp, Dept Geriatr Med, Oslo, Norway; [Strand, Bjorn Heine] Norwegian Inst Publ Hlth, Oslo, Norway; [Strand, Bjorn Heine; Bjertness, Espen] Univ Oslo, Fac Med, Oslo, Norway; [Selbaek, Geir] Innlandet Hosp Trust, Ctr Old Age Psychiat Res, Ottestad, Norway	University of Oslo; Norwegian Institute of Public Health (NIPH); University of Oslo; Innlandet Hospital Trust	Strand, BH (corresponding author), Vestfold Hosp Trust, Norwegian Natl Advisory Unit Aging & Hlth, Tonsberg, Norway.; Strand, BH (corresponding author), Oslo Univ Hosp, Dept Geriatr Med, Oslo, Norway.; Strand, BH (corresponding author), Norwegian Inst Publ Hlth, Oslo, Norway.; Strand, BH (corresponding author), Univ Oslo, Fac Med, Oslo, Norway.	heine@fhi.no	Strand, Bjørn/AAV-7948-2021	Strand, Bjørn/0000-0003-4385-8886; Edwin, Trine Holt/0000-0002-0530-8771; Selbaek, Geir/0000-0001-6511-8219				Bermejo-Pareja F, 2016, J ALZHEIMERS DIS, V50, P719, DOI 10.3233/JAD-150625; Bower H, 2016, BLOOD CANCER J, V6, DOI 10.1038/bcj.2016.3; BRAEKHUS A, 2011, TIDSSKR NOR LAEGEFOR, V131, P2254, DOI DOI 10.4045/TIDSSKR.11.0786; Brodaty H, 2012, INT PSYCHOGERIATR, V24, P1034, DOI 10.1017/S1041610211002924; Dickman PW, 2006, J INTERN MED, V260, P103, DOI 10.1111/j.1365-2796.2006.01677.x; Engedal K, 2012, DEMENT GERIATR COGN, V34, P263, DOI 10.1159/000345435; Fereshtehnejad SM, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0065-2; Fitzpatrick AL, 2005, SURVIVAL FOLLOWING D; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Garcia-Ptacek S, 2016, J AM GERIATR SOC, V64, pE137, DOI 10.1111/jgs.14421; Garcia-Ptacek S, 2014, J ALZHEIMERS DIS, V41, P467, DOI 10.3233/JAD-131856; Guehne U, 2005, NEUROEPIDEMIOLOGY, V25, P153, DOI 10.1159/000086680; Guehne U, 2006, DEMENT GERIATR COGN, V21, P403, DOI 10.1159/000092846; Jellinger KA, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1016-8; Jessen F, 2014, ALZHEIMERS DEMENT, V10, P844, DOI 10.1016/j.jalz.2014.01.001; Lambert PC, 1999, STATA J, V9, P1; Larsson Victoria, 2018, PLoS One, V13, pe0202044, DOI 10.1371/journal.pone.0202044; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Levey A, 2006, CLIN THER, V28, P991, DOI 10.1016/j.clinthera.2006.07.006; Luck T, 2015, J ALZHEIMERS DIS, V48, pS33, DOI 10.3233/JAD-150090; Mueller C, 2017, LANCET NEUROL, V16, P390, DOI 10.1016/S1474-4422(17)30074-1; Naavik M, 2017, ANN REPORT 2016; Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9; Nelson CP, 2008, EUR HEART J, V29, P941, DOI 10.1093/eurheartj/ehn079; Nilsson K, 2011, DEMENT GERIATR COGN, V32, P342, DOI 10.1159/000335728; Persson K, 2015, DEMENT GERIATR COGN, V40, P256, DOI 10.1159/000437298; Price A, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017504; Roehr S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147050; Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203; Siersma V, 2013, SCAND J PRIM HEALTH, V31, P7, DOI 10.3109/02813432.2012.754092; Todd S, 2013, INT J GERIATR PSYCH, V28, P1109, DOI 10.1002/gps.3946; van de Vorst IE, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008897; Ward A, 2013, DEMENT GER COGN D EX, V3, P320, DOI 10.1159/000354370; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; Wolfson C, 2001, NEW ENGL J MED, V344, P1111, DOI 10.1056/NEJM200104123441501	35	29	29	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2018	13	9							e0204436	10.1371/journal.pone.0204436	http://dx.doi.org/10.1371/journal.pone.0204436			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GU5MM	30240425	Green Accepted, gold, Green Submitted, Green Published			2022-12-26	WOS:000445329700049
J	Xiang, SS; Wang, Z; Ye, YY; Zhang, F; Li, HF; Yang, Y; Miao, HJ; Liang, HB; Zhang, YJ; Jiang, L; Hu, YP; Zheng, L; Liu, XY; Liu, YB				Xiang, Shanshan; Wang, Zheng; Ye, Yuanyuan; Zhang, Fei; Li, Huaifeng; Yang, Yang; Miao, Huijie; Liang, Haibin; Zhang, Yijian; Jiang, Lin; Hu, Yunping; Zheng, Lei; Liu, Xiyong; Liu, Yingbin			E2F1 and E2F7 differentially regulate KPNA2 to promote the development of gallbladder cancer	ONCOGENE			English	Article							TRANSCRIPTION FACTOR; KARYOPHERIN ALPHA-2; CELL-PROLIFERATION; PROGNOSTIC MARKER; FAMILY-MEMBERS; DNA-DAMAGE; PROTEIN; DP-1; IDENTIFICATION; LOCALIZATION	Karyopherin alpha 2 (KPNA2) is a nuclear import factor that is elevated in multiple cancers. However, its molecular regulation at the transcriptional levels is poorly understood. Here we found that KPNA2 was significantly upregulated in gallbladder cancer (GBC), and the increased levels were correlated with short survival of patients. Gene knocking down of KPNA2 inhibited tumor cell proliferation and migration in vitro as well as xenografted tumor development in vivo. A typical transcription factor E2F1 associated with its DNA-binding partner DP1 bond to the promoter region of KPNA2 and induced KPNA2 expression. In contrast, an atypical transcription factor E2F7 competed against DP1 and blocked E2F1-induced KPNA2 gene activation. Mutation of the dimerization residues of E2F7 or DNA-binding domain of E2F1 abolished the suppressive effects of E2F7 on KPNA2 gene expression. In addition, KPNA2 mediated nuclear localization of E2F1 and E2F7, where they in turn controlled KPNA2 expression. Taken together, our data provided mechanistic insights into divergently transcriptional regulation of KPNA2, thus pointing to KPNA2 as a potential target for cancer therapy.	[Xiang, Shanshan; Wang, Zheng; Ye, Yuanyuan; Zhang, Fei; Li, Huaifeng; Yang, Yang; Miao, Huijie; Liang, Haibin; Zhang, Yijian; Jiang, Lin; Hu, Yunping; Liu, Yingbin] Shanghai Jiao Tong Univ, Dept Gen Surg, Xinhua Hosp, Sch Med, 1665 Kongjiang Rd, Shanghai 200092, Peoples R China; [Xiang, Shanshan; Wang, Zheng; Ye, Yuanyuan; Zhang, Fei; Li, Huaifeng; Yang, Yang; Miao, Huijie; Liang, Haibin; Zhang, Yijian; Jiang, Lin; Hu, Yunping; Liu, Yingbin] Shanghai Key Lab Biliary Tract Dis Res, 1665 Kongjiang Rd, Shanghai 200092, Peoples R China; [Xiang, Shanshan; Wang, Zheng; Ye, Yuanyuan; Zhang, Fei; Li, Huaifeng; Yang, Yang; Miao, Huijie; Liang, Haibin; Zhang, Yijian; Jiang, Lin; Hu, Yunping; Liu, Yingbin] Shanghai Res Ctr Biliary Tract Dis, 1665 Kongjiang Rd, Shanghai 200092, Peoples R China; [Zheng, Lei] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Liu, Xiyong] City Hope Comprehens Canc Ctr, Dept Mol Pharmacol, Duarte, CA USA	Shanghai Jiao Tong University; Johns Hopkins University; City of Hope	Liu, YB (corresponding author), Shanghai Jiao Tong Univ, Dept Gen Surg, Xinhua Hosp, Sch Med, 1665 Kongjiang Rd, Shanghai 200092, Peoples R China.; Liu, YB (corresponding author), Shanghai Key Lab Biliary Tract Dis Res, 1665 Kongjiang Rd, Shanghai 200092, Peoples R China.; Liu, YB (corresponding author), Shanghai Res Ctr Biliary Tract Dis, 1665 Kongjiang Rd, Shanghai 200092, Peoples R China.	liuyingbin@xinhuamed.com.cn	LIU, YING/GZL-7252-2022; Liu, Yingbin/AAI-1919-2020	Liu, Yingbin/0000-0001-6110-0185	Shanghai Key Laboratory of Biliary Tract Disease Research Foundation [17DZ2260200]; National Natural Science Foundation of China [91440203, 31620103910, 31601021, 81773043]; Precision Medicine Research Program of Shanghai Jiao Tong University School of Medicine [15ZH4003, DKY201507]; development fund for Shanghai talents [201608]	Shanghai Key Laboratory of Biliary Tract Disease Research Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Precision Medicine Research Program of Shanghai Jiao Tong University School of Medicine; development fund for Shanghai talents	This study was supported by Shanghai Key Laboratory of Biliary Tract Disease Research Foundation (17DZ2260200), the National Natural Science Foundation of China (No. 91440203, 31620103910, 31601021, 81773043), the development fund for Shanghai talents (No. 201608), and the Precision Medicine Research Program of Shanghai Jiao Tong University School of Medicine (No. 15ZH4003, DKY201507). We sincerely thank Professor Shao Rong from Shanghai Jiao Tong University School of Medicine for substantially editing the manuscript and offering constructive suggestions; and A.M. Sieuwerts from Erasmus MC, Dong Qiongzhu from Fudan University for the help.	Alshareeda AT, 2015, BRIT J CANCER, V112, P1929, DOI 10.1038/bjc.2015.165; Araki K, 2003, ONCOGENE, V22, P7632, DOI 10.1038/sj.onc.1206840; BANDARA LR, 1993, EMBO J, V12, P4317, DOI 10.1002/j.1460-2075.1993.tb06116.x; Chen CX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000912; Chong JL, 2009, NATURE, V462, P930, DOI 10.1038/nature08677; Christiansen A, 2013, CANCER LETT, V331, P18, DOI 10.1016/j.canlet.2012.12.013; Crosby ME, 2004, CANCER BIOL THER, V3, P1208, DOI 10.4161/cbt.3.12.1494; Dahl E, 2006, CLIN CANCER RES, V12, P3950, DOI 10.1158/1078-0432.CCR-05-2090; de Bruin A, 2003, J BIOL CHEM, V278, P42041, DOI 10.1074/jbc.M308105200; DeGregori J, 2006, CURR MOL MED, V6, P739; Di Stefano L, 2003, EMBO J, V22, P6289, DOI 10.1093/emboj/cdg613; Endo-Munoz L, 2009, CANCER RES, V69, P1800, DOI 10.1158/0008-5472.CAN-08-2725; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Gorlich D, 1998, EMBO J, V17, P2721, DOI 10.1093/emboj/17.10.2721; HELIN K, 1993, GENE DEV, V7, P1850, DOI 10.1101/gad.7.10.1850; Hu ZY, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/s13046-014-0061-1; Huang L, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.256; Ishida H, 2005, J BIOL CHEM, V280, P24642, DOI 10.1074/jbc.M500189200; Kanthan R, 2015, J ONCOL, V2015, DOI 10.1155/2015/967472; Korah J, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.146; Lammens T, 2009, TRENDS CELL BIOL, V19, P111, DOI 10.1016/j.tcb.2009.01.002; Lee BK, 2011, NUCLEIC ACIDS RES, V39, P3558, DOI 10.1093/nar/gkq1313; Lee EK, 2010, NAT STRUCT MOL BIOL, V17, P732, DOI 10.1038/nsmb.1815; Li J, 2008, DEV CELL, V14, P62, DOI 10.1016/j.devcel.2007.10.017; Li ML, 2017, CANCER LETT, V391, P20, DOI 10.1016/j.canlet.2016.12.027; Li ML, 2014, NAT GENET, V46, P872, DOI 10.1038/ng.3030; Liang HB, 2017, CELL PHYSIOL BIOCHEM, V41, P2117, DOI 10.1159/000475454; Lin WC, 2001, GENE DEV, V15, P1833; Liu BY, 2013, J BIOL CHEM, V288, P24581, DOI 10.1074/jbc.M113.467506; Logan N, 2004, ONCOGENE, V23, P5138, DOI 10.1038/sj.onc.1207649; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Moon NS, 2005, DEV CELL, V9, P463, DOI 10.1016/j.devcel.2005.08.015; Sakai M, 2010, ANTICANCER RES, V30, P851; Shu YJ, 2017, CELL DEATH DIFFER, V24, P445, DOI 10.1038/cdd.2016.146; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Tseng SF, 2005, J BIOL CHEM, V280, P39594, DOI 10.1074/jbc.M508425200; van der Watt PJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027723; Wang B, 2004, J BIOL CHEM, V279, P54140, DOI 10.1074/jbc.M410493200; Wang CI, 2012, MOL CELL PROTEOMICS, V11, P1105, DOI 10.1074/mcp.M111.016592; Winnepenninckx VR, 2006, JNCI-J NATL CANCER I, V98, P472, DOI 10.1093/jnci/djj103; Wu XS, 2017, EMBO REP, V18, P1837, DOI 10.15252/embr.201744147; Ye YY, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0444-x; Zannini L, 2003, J BIOL CHEM, V278, P42346, DOI 10.1074/jbc.M303304200; Zeng HM, 2018, LANCET GLOB HEALTH, V6, pE555, DOI 10.1016/S2214-109X(18)30127-X	44	31	33	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 21	2019	38	8					1269	1281		10.1038/s41388-018-0494-7	http://dx.doi.org/10.1038/s41388-018-0494-7			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HM1XR	30254209				2022-12-26	WOS:000459249800009
J	Zhou, CF; Ma, J; Huang, L; Yi, HY; Zhang, YM; Wu, XG; Yan, RM; Liang, L; Zhong, M; Yu, YH; Wu, S; Wang, W				Zhou, Chen-Fei; Ma, Jing; Huang, Lei; Yi, Hong-Yan; Zhang, Yan-Mei; Wu, Xiang-Guang; Yan, Rui-Ming; Liang, Li; Zhong, Mei; Yu, Yan-Hong; Wu, Sha; Wang, Wei			Cervical squamous cell carcinoma-secreted exosomal miR-221-3p promotes lymphangiogenesis and lymphatic metastasis by targeting VASH1	ONCOGENE			English	Article							TUMOR LYMPHANGIOGENESIS; MESENCHYMAL TRANSITION; CANCER METASTASIS; EXPRESSION; INVASION; PROLIFERATION; GROWTH; ANGIOGENESIS; ENDOTHELIUM; RECURRENCE	Cancer-secreted exosomal miRNAs are emerging mediators of cancer-stromal cross-talk in the tumor environment. Our previous miRNAs array of cervical squamous cell carcinoma (CSCC) clinical specimens identified upregulation of miR-221-3p. Here, we show that miR-221-3p is closely correlated with peritumoral lymphangiogenesis and lymph node (LN) metastasis in CSCC. More importantly, miR-221-3p is characteristically enriched in and transferred by CSCC-secreted exosomes into human lymphatic endothelial cells (HLECs) to promote HLECs migration and tube formation in vitro, and facilitate lymphangiogenesis and LN metastasis in vivo according to both gain-of-function and loss-of-function experiments. Furthermore, we identify vasohibin-1 (VASH1) as a novel direct target of miR-221-3p through bioinformatic target prediction and luciferase reporter assay. Re-expression and knockdown of VASH1 could respectively rescue and simulate the effects induced by exosomal miR-221-3p. Importantly, the miR-221-3p-VASH1 axis activates the ERK/AKT pathway in HLECs independent of VEGF-C. Finally, circulating exosomal miR-221-3p levels also have biological function in promoting HLECs sprouting in vitro and are closely associated with tumor miR-221-3p expression, lymphatic VASH1 expression, lymphangiogenesis, and LN metastasis in CSCC patients. In conclusion, CSCC-secreted exosomal miR-221-3p transfers into HLECs to promote lymphangiogenesis and lymphatic metastasis via downregulation of VASH1 and may represent a novel diagnostic biomarker and therapeutic target for metastatic CSCC patients in early stages.	[Zhou, Chen-Fei; Ma, Jing; Wu, Xiang-Guang; Wang, Wei] Guangzhou Med Univ, Dept Obstet & Gynecol, Affiliated Hosp 1, Guangzhou 510120, Guangdong, Peoples R China; [Zhou, Chen-Fei; Ma, Jing; Yi, Hong-Yan; Yan, Rui-Ming; Zhong, Mei; Yu, Yan-Hong; Wang, Wei] Southern Med Univ, Nanfang Hosp, Dept Obstet & Gynecol, Sch Clin Med 1, Guangzhou 510515, Guangdong, Peoples R China; [Huang, Lei] Newcastle Univ, Fac Med Sci, Inst Cellular Med, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Zhang, Yan-Mei; Wu, Sha] Southern Med Univ, Sch Basic Med Sci, Dept Immunol, Guangdong Prov Key Lab Prote, Guangzhou 510515, Guangdong, Peoples R China; [Liang, Li] Southern Med Univ, Sch Basic Med Sci, Dept Pathol, Guangzhou 510515, Guangdong, Peoples R China	Guangzhou Medical University; Southern Medical University - China; Newcastle University - UK; Southern Medical University - China; Southern Medical University - China	Wang, W (corresponding author), Guangzhou Med Univ, Dept Obstet & Gynecol, Affiliated Hosp 1, Guangzhou 510120, Guangdong, Peoples R China.; Wang, W (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Obstet & Gynecol, Sch Clin Med 1, Guangzhou 510515, Guangdong, Peoples R China.; Wu, S (corresponding author), Southern Med Univ, Sch Basic Med Sci, Dept Immunol, Guangdong Prov Key Lab Prote, Guangzhou 510515, Guangdong, Peoples R China.	shawu99@outlook.com; smugowwang@126.com	Yu, Yan/GYV-4514-2022; Wu, Xiang-Guang/AAC-1937-2020; liang, li/AAB-9126-2022; wu, xiangguang/AAC-6193-2020	wu, xiangguang/0000-0001-8276-4810; huang, lei/0000-0002-1996-944X	National Natural Science Foundation of China [81672589, 81372781]; National Natural Science foundation of Guangdong province [2017A030313872]; Shenzhen Science and Technology Program [JCYJ20160429161218745]; National Key Research and Development Program of China [2016YFC1302901]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science foundation of Guangdong province(National Natural Science Foundation of Guangdong Province); Shenzhen Science and Technology Program; National Key Research and Development Program of China	This work was supported by the National Natural Science Foundation of China (grant numbers: 81672589, 81372781), the National Natural Science foundation of Guangdong province (grant number: 2017A030313872), the Shenzhen Science and Technology Program (grant number: JCYJ20160429161218745), and the National Key Research and Development Program of China (grant number: 2016YFC1302901).	Achen MG, 2005, CANCER CELL, V7, P121, DOI 10.1016/j.ccr.2005.01.017; Alitalo K, 2005, NATURE, V438, P946, DOI 10.1038/nature04480; Bang C, 2014, J CLIN INVEST, V124, P2136, DOI 10.1172/JCI70577; Beavis AL, 2016, GYNECOL ONCOL, V143, P302, DOI 10.1016/j.ygyno.2016.08.236; Bono P, 2004, CLIN CANCER RES, V10, P7144, DOI 10.1158/1078-0432.CCR-03-0826; Cairns RA, 2004, CANCER RES, V64, P2054, DOI 10.1158/0008-5472.CAN-03-3196; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Dadras SS, 2005, MODERN PATHOL, V18, P1232, DOI 10.1038/modpathol.3800410; Felicetti F, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0811-2; Fu B, 2015, INT J ONCOL, V46, P1169, DOI 10.3892/ijo.2015.2837; Gombos Z, 2005, CLIN CANCER RES, V11, P8364, DOI 10.1158/1078-0432.CCR-05-1238; Hannafon BN, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0753-x; Hashimoto K, 2018, P NATL ACAD SCI USA, V115, P2204, DOI 10.1073/pnas.1717363115; Heishi T, 2010, AM J PATHOL, V176, P1950, DOI 10.2353/ajpath.2010.090829; Hosaka T, 2009, AM J PATHOL, V175, P430, DOI 10.2353/ajpath.2009.080788; Ito S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073931; Jafri MA, 2017, SEMIN CANCER BIOL, V44, P117, DOI 10.1016/j.semcancer.2017.02.004; Josson S, 2015, ONCOGENE, V34, P2690, DOI 10.1038/onc.2014.212; Keklikoglou I, 2015, ONCOGENE, V34, P4867, DOI 10.1038/onc.2014.408; Kim YJ, 2015, RADIAT ONCOL J, V33, P109, DOI 10.3857/roj.2015.33.2.109; Kneitz B, 2014, CANCER RES, V74, P2591, DOI 10.1158/0008-5472.CAN-13-1606; Kuehbacher A, 2007, CIRC RES, V101, P59, DOI 10.1161/CIRCRESAHA.107.153916; Lee YJ, 2017, GYNECOL ONCOL, V144, P536, DOI 10.1016/j.ygyno.2017.01.001; Lehuede C, 2016, CANCER RES, V76, P5201, DOI 10.1158/0008-5472.CAN-16-0266; Li L, 2016, CANCER RES, V76, P1770, DOI 10.1158/0008-5472.CAN-15-1625; Liu D, 2014, CANCER RES, V74, P5597, DOI 10.1158/0008-5472.CAN-13-3598; Liu D, 2014, INT J ONCOL, V45, P1232, DOI 10.3892/ijo.2014.2510; Liu LP, 2015, GUT, V64, P26, DOI 10.1136/gutjnl-2013-306388; Liu YQ, 2018, MOL CANCER, V17, DOI 10.1186/s12943-017-0751-3; Maeng YS, 2016, ONCOGENE, V35, P196, DOI 10.1038/onc.2015.73; Manier S, 2017, BLOOD, V129, P2429, DOI 10.1182/blood-2016-09-742296; Mao SY, 2016, J OBSTET GYNAECOL RE, V42, P1317, DOI 10.1111/jog.13058; Melo SA, 2015, NATURE, V523, P177, DOI 10.1038/nature14581; Nedaeinia R, 2017, CANCER GENE THER, V24, P48, DOI 10.1038/cgt.2016.77; Que T, 2015, ONCOGENE, V34, P4952, DOI 10.1038/onc.2014.419; Redis RS, 2012, PHARMACOL THERAPEUT, V136, P169, DOI 10.1016/j.pharmthera.2012.08.003; Sato Y, 2013, J BIOCHEM, V153, P5, DOI 10.1093/jb/mvs128; Shukla Girish C, 2011, Mol Cell Pharmacol, V3, P83; Stacker SA, 2014, NAT REV CANCER, V14, P159, DOI 10.1038/nrc3677; Takahashi RU, 2017, CLIN CHEM LAB MED, V55, P648, DOI 10.1515/cclm-2016-0708; Takanami I, 2006, ONCOL REP, V15, P437; Vaccarella S, 2013, EUR J CANCER, V49, P3262, DOI 10.1016/j.ejca.2013.04.024; Wang J, 2015, MOL CLIN ONCOL, V3, P363, DOI 10.3892/mco.2014.465; Wang T, 2014, HUM PATHOL, V45, P1839, DOI 10.1016/j.humpath.2014.05.001; Watanabe K, 2004, J CLIN INVEST, V114, P898, DOI 10.1172/JC1200421152; WEI WF, 2017, CELL DEATH DIS, V8, DOI DOI 10.1038/S41419-017-0077-5; Wu LF, 2017, FEBS J, V284, P3000, DOI 10.1111/febs.14162; Zhou WY, 2014, CANCER CELL, V25, P501, DOI 10.1016/j.ccr.2014.03.007; Zhuang GL, 2012, EMBO J, V31, P3513, DOI 10.1038/emboj.2012.183	49	106	115	1	46	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 21	2019	38	8					1256	1268		10.1038/s41388-018-0511-x	http://dx.doi.org/10.1038/s41388-018-0511-x			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HM1XR	30254211	Green Published, hybrid			2022-12-26	WOS:000459249800008
J	Boetefuer, EL; Lake, RJ; Dreval, K; Fan, HY				Boetefuer, Erica L.; Lake, Robert J.; Dreval, Kostiantyn; Fan, Hua-Ying			Poly(ADP-ribose) polymerase 1 (PARP1) promotes oxidative stress-induced association of Cockayne syndrome group B protein with chromatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						base-excision repair (BER); oxidative stress; DNA repair; reactive oxygen species (ROS); transcription regulation; chromatin; ATP-dependent chromatin remodeling; Cockayne syndrome protein; CSB; PARP1; single-strand DNA repair	BASE EXCISION-REPAIR; STRAND BREAK REPAIR; DNA-REPAIR; XERODERMA-PIGMENTOSUM; PRIMARY FIBROBLASTS; CELLULAR REPAIR; COUPLING FACTOR; GENE-PRODUCT; DHFR GENE; TRANSCRIPTION	Cockayne syndrome protein B (CSB) is an ATP-dependent chromatin remodeler that relieves oxidative stress by regulating DNA repair and transcription. CSB is proposed to participate in base-excision repair (BER), the primary pathway for repairing oxidative DNA damage, but exactly how CSB participates in this process is unknown. It is also unclear whether CSB contributes to other repair pathways during oxidative stress. Here, using a patient-derived CS1AN-sv cell line, we examined how CSB is targeted to chromatin in response to menadione-induced oxidative stress, both globally and locus-specifically. We found that menadione-induced, global CSB-chromatin association does not require CSB's ATPase activity and is, therefore, mechanistically distinct from UV-induced CSB-chromatin association. Importantly, poly(ADP-ribose) polymerase 1 (PARP1) enhanced the kinetics of global menadione-induced CSB-chromatin association. We found that the major BER enzymes, 8-oxoguanine DNA glycosylase (OGG1) and apurinic/apyrimidinic endodeoxyribonuclease 1 (APE1), do not influence this association. Additionally, the level of -H2A histone family member X (-H2AX), a marker for dsDNA breaks, was not increased in menadione-treated cells. Therefore, our results support a model whereby PARP1 localizes to ssDNA breaks and recruits CSB to participate in DNA repair. Furthermore, this global CSB-chromatin association occurred independently of RNA polymerase II-mediated transcription elongation. However, unlike global CSB-chromatin association, both PARP1 knockdown and inhibition of transcription elongation interfered with menadione-induced CSB recruitment to specific genomic regions. This observation supports the hypothesis that CSB is also targeted to specific genomic loci to participate in transcriptional regulation in response to oxidative stress.	[Boetefuer, Erica L.; Lake, Robert J.; Dreval, Kostiantyn; Fan, Hua-Ying] Univ New Mexico, Dept Internal Med, Div Mol Med, Program Canc Genet Epigenet & Genom,Comprehens Ca, Albuquerque, NM 87131 USA; [Boetefuer, Erica L.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	University of New Mexico; University of Pennsylvania	Fan, HY (corresponding author), Univ New Mexico, Hlth Sci Ctr, Dept Internal Med, Albuquerque, NM 87131 USA.	hufan@salud.unm.edu		Fan, Hua-Ying/0000-0003-1790-4041; Dreval, Kostiantyn/0000-0002-6214-2843	National Institutes of Health [GM115888, T32 GM-07229]; NATIONAL CANCER INSTITUTE [P30CA118100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115888, T32GM007229] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM115888 (to H. Y. F.) and T32 GM-07229 (to E. L. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abbotts R, 2017, FREE RADICAL BIO MED, V107, P228, DOI 10.1016/j.freeradbiomed.2016.11.039; Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Aherne SA, 2000, FREE RADICAL BIO MED, V29, P507, DOI 10.1016/S0891-5849(00)00360-9; Balajee AS, 1997, P NATL ACAD SCI USA, V94, P4306, DOI 10.1073/pnas.94.9.4306; Boetefuer EL, 2018, NUCLEIC ACIDS RES, V46, P7471, DOI 10.1093/nar/gky660; BOHR VA, 1985, CELL, V40, P359, DOI 10.1016/0092-8674(85)90150-3; BRYANT PE, 1984, MUTAT RES, V131, P19, DOI 10.1016/0167-8817(84)90043-9; Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380; Chaudhuri AR, 2017, NAT REV MOL CELL BIO, V18, P610, DOI 10.1038/nrm.2017.53; Cho I, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003407; Citterio E, 2000, MOL CELL BIOL, V20, P7643, DOI 10.1128/MCB.20.20.7643-7653.2000; Dianov G, 1999, NUCLEIC ACIDS RES, V27, P1365, DOI 10.1093/nar/27.5.1365; Dianov GL, 2013, NUCLEIC ACIDS RES, V41, P3483, DOI 10.1093/nar/gkt076; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; El-Khamisy SF, 2003, NUCLEIC ACIDS RES, V31, P5526, DOI 10.1093/nar/gkg761; Fisher AEO, 2007, MOL CELL BIOL, V27, P5597, DOI 10.1128/MCB.02248-06; Gibson BA, 2016, SCIENCE, V353, P45, DOI 10.1126/science.aaf7865; Gottschalk AJ, 2009, P NATL ACAD SCI USA, V106, P13770, DOI 10.1073/pnas.0906920106; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Hanzlikova H, 2017, NUCLEIC ACIDS RES, V45, P2546, DOI 10.1093/nar/gkw1246; Khobta A, 2013, MECH AGEING DEV, V134, P253, DOI 10.1016/j.mad.2013.03.001; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; Kyng KJ, 2003, ONCOGENE, V22, P1135, DOI 10.1038/sj.onc.1206187; Lake RJ, 2016, NUCLEIC ACIDS RES, V44, P2125, DOI 10.1093/nar/gkv1219; Lake RJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004284; Lake RJ, 2010, MOL CELL, V37, P235, DOI 10.1016/j.molcel.2009.10.027; LAUTIER D, 1993, MOL CELL BIOCHEM, V122, P171, DOI 10.1007/BF01076101; LEHMANN AR, 1982, MUTAT RES, V106, P347, DOI 10.1016/0027-5107(82)90115-4; Luijsterburg MS, 2016, MOL CELL, V61, P547, DOI 10.1016/j.molcel.2016.01.019; Ma WJ, 2012, P NATL ACAD SCI USA, V109, P6590, DOI 10.1073/pnas.1118078109; MAYNE LV, 1982, CANCER RES, V42, P1473; MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6; Menoni H, 2012, J CELL BIOL, V199, P1037, DOI 10.1083/jcb.201205149; Muftuoglu M, 2009, J BIOL CHEM, V284, P9270, DOI 10.1074/jbc.M807006200; NANCE MA, 1992, AM J MED GENET, V42, P68, DOI 10.1002/ajmg.1320420115; Newman JC, 2006, P NATL ACAD SCI USA, V103, P9613, DOI 10.1073/pnas.0510909103; Parsons JL, 2005, FEBS J, V272, P2012, DOI 10.1111/j.1742-4658.2005.04628.x; Pascucci B, 2012, AGING CELL, V11, P520, DOI 10.1111/j.1474-9726.2012.00815.x; SATOH MS, 1992, NATURE, V356, P356, DOI 10.1038/356356a0; Scheibye-Knudsen M, 2014, CELL METAB, V20, P840, DOI 10.1016/j.cmet.2014.10.005; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Selby CP, 1997, P NATL ACAD SCI USA, V94, P11205, DOI 10.1073/pnas.94.21.11205; Smeenk G, 2013, J CELL SCI, V126, P889, DOI 10.1242/jcs.109413; Tantin D, 1997, MOL CELL BIOL, V17, P6803, DOI 10.1128/MCB.17.12.6803; Thorslund T, 2005, MOL CELL BIOL, V25, P7625, DOI 10.1128/MCB.25.17.7625-7636.2005; TROELSTRA C, 1992, CELL, V71, P939, DOI 10.1016/0092-8674(92)90390-X; TROELSTRA C, 1990, MOL CELL BIOL, V10, P5806, DOI 10.1128/MCB.10.11.5806; Tuo J, 2001, J BIOL CHEM, V276, P45772, DOI 10.1074/jbc.M107888200; Tuo JS, 2003, FASEB J, V17, P668, DOI 10.1096/fj.02-0851com; Tuo JS, 2002, J BIOL CHEM, V277, P30832, DOI 10.1074/jbc.M204814200; Tuo JS, 2002, DNA REPAIR, V1, P913, DOI 10.1016/S1568-7864(02)00116-7; vanGool AJ, 1997, EMBO J, V16, P4155, DOI 10.1093/emboj/16.14.4155; VENEMA J, 1990, NUCLEIC ACIDS RES, V18, P443, DOI 10.1093/nar/18.3.443; Wong HK, 2007, NUCLEIC ACIDS RES, V35, P4103, DOI 10.1093/nar/gkm404; Wu PK, 2017, STEM CELL TRANSL MED, V6, P1504, DOI 10.1002/sctm.15-0394; Zhao HL, 2015, MOL CELL, V59, P984, DOI 10.1016/j.molcel.2015.07.019	56	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2018	293	46					17863	17874		10.1074/jbc.RA118.004548	http://dx.doi.org/10.1074/jbc.RA118.004548			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HA6SG	30266807	Green Published, hybrid			2022-12-26	WOS:000450409500017
J	Fu, JJ; Dang, YK; Counter, C; Liu, Y				Fu, Jingjing; Dang, Yunkun; Counter, Christopher; Liu, Yi			Codon usage regulates human KRAS expression at both transcriptional and translational levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						GTPase Kras (KRAS); transcription; translation; oncogene; chromatin regulation; C content; codon optimization; codon usage bias; oncogenesis; protein folding	MESSENGER-RNA STABILITY; GENE AMPLIFICATION; PROTEIN EXPRESSION; SYNONYMOUS CODONS; ADAPTATION INDEX; POLYMERASE-II; RAS; DROSOPHILA; ELONGATION; SELECTION	KRAS and HRAS are highly homologous oncogenic Ras GTPase family members that are mutated in a wide spectrum of human cancers. Despite having high amino acid identity, KRAS and HRAS have very different codon usage biases: the HRAS gene contains many common codons, and KRAS is enriched for rare codons. Rare codons in KRAS suppress its protein expression, which has been shown to affect both normal and cancer biology in mammals. Here, using HRAS or KRAS expression in different human cell lines and in vitro transcription and translation assays, we show that KRAS rare codons inhibit both translation efficiency and transcription and that the contribution of these two processes varies among different cell lines. We observed that codon usage regulates mRNA translation efficiency such that WT KRAS mRNA is poorly translated. On the other hand, common codons increased transcriptional rates by promoting activating histone modifications and recruitment of transcriptional coactivators. Finally, we found that codon usage also influences KRAS protein conformation, likely because of its effect on co-translational protein folding. Together, our results reveal that codon usage has multidimensional effects on protein expression, ranging from effects on transcription to protein folding in human cells.	[Fu, Jingjing; Liu, Yi] Univ Texas Southwestern Med Ctr Dallas, Dept Physiol, Dallas, TX 75235 USA; [Dang, Yunkun] Yunnan Univ, State Key Lab Conservat & Utilizat Bioresources, Sch Life Sci, Kunming 650500, Yunnan, Peoples R China; [Dang, Yunkun] Yunnan Univ, Ctr Life Sci, Sch Life Sci, Kunming 650500, Yunnan, Peoples R China; [Counter, Christopher] Duke Univ, Dept Pharmacol & Canc Biol, Sch Med, Durham, NC 27708 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Yunnan University; Yunnan University; Duke University	Liu, Y (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Yi.Liu@UTsouthwestern.edu		Liu, Yi/0000-0002-8801-9317; Fu, Jingjing/0000-0001-6502-321X; Counter, Christopher M/0000-0003-0748-3079	National Institutes of Health [1R35GM118118, R01CA94184, P01CA203657]; Cancer Prevention and Research Institute of Texas Grant [RP160268]; Welch Foundation [I-1560]; NATIONAL CANCER INSTITUTE [R01CA094184, P01CA203657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118118] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas Grant; Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant 1R35GM118118, Cancer Prevention and Research Institute of Texas Grant RP160268, Welch Foundation Grant I-1560 (to Y. L.), and National Institutes of Health Grants R01CA94184 and P01CA203657 (to C. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AKASHI H, 1994, GENETICS, V136, P927; Ali M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15617; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Bazzini AA, 2016, EMBO J, V35, P2087, DOI 10.15252/embj.201694699; Birkeland E, 2012, BRIT J CANCER, V107, P1997, DOI 10.1038/bjc.2012.477; Boel G, 2016, NATURE, V529, P358, DOI 10.1038/nature16509; Buhr F, 2016, MOL CELL, V61, P341, DOI 10.1016/j.molcel.2016.01.008; Carlini DB, 2003, GENETICS, V163, P239; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Comeron JM, 2004, GENETICS, V167, P1293, DOI 10.1534/genetics.104.026351; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Cox Adrienne D, 2010, Small GTPases, V1, P2; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Duret L, 1999, P NATL ACAD SCI USA, V96, P4482, DOI 10.1073/pnas.96.8.4482; FIORUCCI G, 1988, BIOCHIM BIOPHYS ACTA, V950, P81, DOI 10.1016/0167-4781(88)90076-0; Friberg M, 2004, YEAST, V21, P1083, DOI 10.1002/yea.1150; Fu JJ, 2016, GENE DEV, V30, P1761, DOI 10.1101/gad.281030.116; Gingold H, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.14; Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006; Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442; Hsin JP, 2012, GENE DEV, V26, P2119, DOI 10.1101/gad.200303.112; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; Jafari R, 2014, NAT PROTOC, V9, P2100, DOI 10.1038/nprot.2014.138; Kim SJ, 2015, SCIENCE, V348, P444, DOI 10.1126/science.aaa3974; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kirchner S, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2000779; Koera K, 1997, ONCOGENE, V15, P1151, DOI 10.1038/sj.onc.1201284; Komar AA, 1999, FEBS LETT, V462, P387, DOI 10.1016/S0014-5793(99)01566-5; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Krinner S, 2014, NUCLEIC ACIDS RES, V42, P3551, DOI 10.1093/nar/gkt1358; Kudla G, 2006, PLOS BIOL, V4, P933, DOI 10.1371/journal.pbio.0040180; Lampson BL, 2013, CURR BIOL, V23, P70, DOI 10.1016/j.cub.2012.11.031; Lazrak A, 2013, FASEB J, V27, P4630, DOI 10.1096/fj.13-227330; Liu R, 2001, CELL, V106, P309, DOI 10.1016/S0092-8674(01)00446-9; Mallon S, 2012, P NATL ACAD SCI USA, V109, pE3549, DOI 10.1073/pnas.1218783109; McCarthy C, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3609-6; Mishima Y, 2016, MOL CELL, V61, P874, DOI 10.1016/j.molcel.2016.02.027; Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606; Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292; Newman ZR, 2016, P NATL ACAD SCI USA, V113, pE1362, DOI 10.1073/pnas.1518976113; Pechmann S, 2014, NAT STRUCT MOL BIOL, V21, P1100, DOI 10.1038/nsmb.2919; Pershing NLK, 2015, J CLIN INVEST, V125, P222, DOI 10.1172/JCI77627; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Presnyak V, 2015, CELL, V160, P1111, DOI 10.1016/j.cell.2015.02.029; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Qian WF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002603; Radhakrishnan A, 2016, CELL, V167, P122, DOI 10.1016/j.cell.2016.08.053; Sander IM, 2014, J AM CHEM SOC, V136, P858, DOI 10.1021/ja411302m; Sasine J. P., 2018, J CLIN INVEST INSIGH, V3; Sauna ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/nrg3051; SHARP PM, 1986, NUCLEIC ACIDS RES, V14, P5125, DOI 10.1093/nar/14.13.5125; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Spencer PS, 2012, J MOL BIOL, V422, P328, DOI 10.1016/j.jmb.2012.06.010; Stergachis AB, 2013, SCIENCE, V342, P1367, DOI 10.1126/science.1243490; Valtorta E, 2013, INT J CANCER, V133, P1259, DOI 10.1002/ijc.28106; Weinberg DE, 2016, CELL REP, V14, P1787, DOI 10.1016/j.celrep.2016.01.043; Wu C, 2007, METHOD ENZYMOL, V429, P203, DOI 10.1016/S0076-6879(07)29010-X; Yu CH, 2015, MOL CELL, V59, P744, DOI 10.1016/j.molcel.2015.07.018; Zhao F, 2017, NUCLEIC ACIDS RES, V45, P8484, DOI 10.1093/nar/gkx501; Zhou M, 2015, MOL MICROBIOL, V97, P974, DOI 10.1111/mmi.13079; Zhou M, 2013, NATURE, V495, P111, DOI 10.1038/nature11833; Zhou ZP, 2018, ELIFE, V7, DOI [10.7554/eLife.33569.001, 10.7554/eLife.33569]; Zhou ZP, 2016, P NATL ACAD SCI USA, V113, pE6117, DOI 10.1073/pnas.1606724113	65	28	30	3	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2018	293	46					17929	17940		10.1074/jbc.RA118.004908	http://dx.doi.org/10.1074/jbc.RA118.004908			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HA6SG	30275015	Green Published, hybrid			2022-12-26	WOS:000450409500022
J	Sherer, LA; Zweifel, ME; Courtemanche, N				Sherer, Laura A.; Zweifel, Mark E.; Courtemanche, Naomi			Dissection of two parallel pathways for formin-mediated actin filament elongation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						formin; actin; profilin; fluorescence; cytoskeleton; actin polymerization; Bni1; Cdc12; formin homology domain; TIRF microscopy	FISSION YEAST; HOMOLOGY-2 DOMAIN; CELL-DIVISION; BETA-ACTIN; FH1 DOMAIN; ATP-ACTIN; ADP-ACTIN; PROFILIN; NUCLEATION; MECHANISM	Formins direct the elongation of unbranched actin filaments that are incorporated into a diverse set of cytoskeletal structures. Elongation of formin-bound filaments occurs along two parallel pathways. The formin homology 2 (FH2) pathway allows actin monomers to bind directly to barbed ends bound by dimeric FH2 domains. The formin homology 1 (FH1) pathway involves transfer of profilin-bound actin to the barbed end from polyproline tracts located in the disordered FH1 domains. Here, we used a total internal reflection fluorescence (TIRF) microscopy-based fluorescence approach to determine the fraction of actin subunits incorporated via the FH1 and FH2 pathways during filament elongation mediated by two formins. We found that the fraction of filament elongation that occurs via each pathway directly depends on the efficiency of the other pathway, indicating that these two pathways compete with each other for subunit addition by formins. We conclude that this competition allows formins to compensate for changes in the efficiency of one pathway by adjusting the frequency of subunit addition via the other, thus increasing the overall robustness of formin-mediated actin polymerization.	[Sherer, Laura A.; Zweifel, Mark E.; Courtemanche, Naomi] Univ Minnesota, Dept Genet Cell & Dev Biol, 6-130 MCB,420 Washington Ave SE, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Courtemanche, N (corresponding author), Univ Minnesota, Dept Genet Cell & Dev Biol, 6-130 MCB,420 Washington Ave SE, Minneapolis, MN 55455 USA.	ncourtem@umn.edu			National Institutes of Health [GM 122787]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM122787] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM 122787. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Boyer O, 2011, NEW ENGL J MED, V365, P2377, DOI 10.1056/NEJMoa1109122; Brown EJ, 2010, NAT GENET, V42, P72, DOI 10.1038/ng.505; Chang F, 1997, J CELL BIOL, V137, P169, DOI 10.1083/jcb.137.1.169; Chik JK, 1996, J MOL BIOL, V263, P607, DOI 10.1006/jmbi.1996.0602; Courtemanche N, 2012, J BIOL CHEM, V287, P7812, DOI 10.1074/jbc.M111.322958; DeWard AD, 2010, BBA-MOL CELL RES, V1803, P226, DOI 10.1016/j.bbamcr.2009.11.006; Eads JC, 1998, BIOCHEMISTRY-US, V37, P11171, DOI 10.1021/bi9720033; Ercan-Sencicek AG, 2015, EUR J HUM GENET, V23, P165, DOI 10.1038/ejhg.2014.82; Feierbach B, 2001, CURR BIOL, V11, P1656, DOI 10.1016/S0960-9822(01)00525-5; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; Kobielak A, 2004, NAT CELL BIOL, V6, P21, DOI 10.1038/ncb1075; Kovar DR, 2003, J CELL BIOL, V161, P875, DOI 10.1083/jcb.200211078; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; Lu J, 2001, MOL BIOL CELL, V12, P1161, DOI 10.1091/mbc.12.4.1161; Michelot A, 2005, PLANT CELL, V17, P2296, DOI 10.1105/tpc.105.030908; Moseley JB, 2004, MOL BIOL CELL, V15, P896, DOI 10.1091/mbc.E03-08-0621; Nakano K, 2002, J CELL SCI, V115, P4629, DOI 10.1242/jcs.00150; Neidt EM, 2009, J BIOL CHEM, V284, P673, DOI 10.1074/jbc.M804201200; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Paul A, 2008, CURR BIOL, V18, P9, DOI 10.1016/j.cub.2007.11.062; Paul AS, 2009, CELL MOTIL CYTOSKEL, V66, P606, DOI 10.1002/cm.20379; Pellegrin S, 2005, CURR BIOL, V15, P129, DOI 10.1016/j.cub.2005.01.011; Petersen J, 1998, J CELL BIOL, V141, P1217, DOI 10.1083/jcb.141.5.1217; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; Pring M, 2003, BIOCHEMISTRY-US, V42, P486, DOI 10.1021/bi026520j; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schonichen A, 2010, BBA-MOL CELL RES, V1803, P152, DOI 10.1016/j.bbamcr.2010.01.014; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Vavylonis D, 2006, MOL CELL, V21, P455, DOI 10.1016/j.molcel.2006.01.016; Vinson VK, 1998, BIOCHEMISTRY-US, V37, P10871, DOI 10.1021/bi980093l; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7	38	8	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2018	293	46					17917	17928		10.1074/jbc.RA118.004845	http://dx.doi.org/10.1074/jbc.RA118.004845			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HA6SG	30266808	hybrid, Green Published			2022-12-26	WOS:000450409500021
J	Simard, S; Shail, P; MacGregor, J; El Sayed, M; Duman, RS; Vaccarino, FM; Salmaso, N				Simard, Stephanie; Shail, Pragya; MacGregor, Jessica; El Sayed, Maha; Duman, Ronald S.; Vaccarino, Flora M.; Salmaso, Natalina			Fibroblast growth factor 2 is necessary for the antidepressant effects of fluoxetine	PLOS ONE			English	Article							FACTOR SYSTEM; RAT-BRAIN; MAJOR DEPRESSION; ANXIETY; FGF2; DISORDERS; RECEPTORS; BEHAVIOR; FIBROBLAST-GROWTH-FACTOR-2; PREVALENCE	Previous research has shown that fibroblast growth factor 2 protein (FGF2) can act as an anxiolytic and anti-depressive agent in rodents. Levels of hippocampal FGF2 and FGF2 receptors are decreased in post-mortem brains of individuals with mood disorders. No changes in FGF2 were noted in the post-mortem brains of individuals with mood disorders that were successfully treated with anti-depressant medication prior to death. Mutations in the FGF2 gene in humans have been shown to predict non-responsiveness to the therapeutic effects of selective serotonin reuptake inhibitors (SSRIs). These findings suggest that FGF2 may potentially be a target of and/or required for the therapeutic effects of antidepressant medications. To test this, we employed a rodent model of depressive behaviour, chronic variable stress (CVS) in conjunction with antidepressant treatment (fluoxetine) in wild-type (WT) and FGF2 knockout mice (FGF2KO) and examined depressive and anxiety behaviors. Results showed that fluoxetine reversed the effects of CVS on depressive and anxiety behaviours in wild-type mice only, suggesting that the FGF2 gene is indeed necessary for the therapeutic effects of fluoxetine. Interestingly, CVS decreased hippocampal FGF2 levels and fluoxetine partially reversed this effect. Because FGF2 has been previously shown to modify HPA activity through hippocampal glucocorticoid receptors (GR), we examined levels of glucocorticoid receptors and found a decrease in GR in response to CVS, with a further decrease in FGF2KO. No effect of fluoxetine on GR was observed in either WT or FGF2KO mice. This suggests that further changes in glucocorticoid receptors are not necessary for the anti-depressant effects of fluoxetine in WT mice, although decreased glucocorticoid receptors in response to FGF2 deletion may preclude the therapeutic actions of fluoxetine in FGF2KO. Whether astroglia, astroglial functions, or HPA changes are the downstream target of FGF2-mediated changes induced by fluoxetine remains to be determined, however, the current study reaffirms the potential of FGF2 as a novel therapeutic target in the treatment of depression and anxiety disorders.	[Simard, Stephanie; Shail, Pragya; MacGregor, Jessica; Salmaso, Natalina] Carleton Univ, Dept Neurosci, Ottawa, ON, Canada; [El Sayed, Maha; Duman, Ronald S.] Yale Univ, Dept Psychiat, New Haven, CT 06520 USA; [Vaccarino, Flora M.; Salmaso, Natalina] Yale Univ, Child Study Ctr, New Haven, CT 06520 USA	Carleton University; Yale University; Yale University	Salmaso, N (corresponding author), Carleton Univ, Dept Neurosci, Ottawa, ON, Canada.; Salmaso, N (corresponding author), Yale Univ, Child Study Ctr, New Haven, CT 06520 USA.	Natalina.salmaso@carleton.ca		Simard, Stephanie/0000-0001-7770-2295; Salmaso, Natalina/0000-0002-9661-5194	Canadian Institute of Health Research Canada Research Chair Award; Canadian Funds for Innovation; Ontario Small Infrastructure award; Carleton University iCUREUS award; iCUREUS award; Ontario Small Infrastructure Funds	Canadian Institute of Health Research Canada Research Chair Award; Canadian Funds for Innovation; Ontario Small Infrastructure award; Carleton University iCUREUS award; iCUREUS award; Ontario Small Infrastructure Funds	This work was supported by Canadian Institute of Health Research Canada Research Chair Award to N.S.; Canadian Funds for Innovation to N.S.; Ontario Small Infrastructure award to N.S.; Carleton University iCUREUS award to J.M.; We would like to thank Dr. Michael Schlossmacher and Dr. Julianna Tomlinson for allowing us to use their facilities at the University of Ottawa during the transitory period of our facilities relocation. This work was supported by and iCUREUS award to J.M. in addition to the Canadian Funds for Innovation, Ontario Small Infrastructure Funds and a Canadian Institute of Health Research Canada Research Chair award to N.S.	Akil H, 2008, Novartis Found Symp, V289, P94; Akil H, 2008, NOVART FDN SYMP, V289, P93; Akil H, 2008, NOVART FDN SYMP, V289, p[7, 93]; Audet MC, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00068; Bachis A, 2008, NEUROPHARMACOLOGY, V55, P1114, DOI 10.1016/j.neuropharm.2008.07.014; Banasr M, 2008, BIOL PSYCHIAT, V64, P863, DOI 10.1016/j.biopsych.2008.06.008; CADAY CG, 1990, DEV BRAIN RES, V52, P241, DOI 10.1016/0165-3806(90)90240-Y; Carola V, 2002, BEHAV BRAIN RES, V134, P49, DOI 10.1016/S0166-4328(01)00452-1; Di Liberto V, 2014, CURR PROTEIN PEPT SC, V15, P691, DOI 10.2174/1389203715666140901112245; Dulawa SC, 2004, NEUROPSYCHOPHARMACOL, V29, P1321, DOI 10.1038/sj.npp.1300433; Eren-Kocak E, 2011, BIOL PSYCHIAT, V69, P534, DOI 10.1016/j.biopsych.2010.11.020; Evans SJ, 2004, P NATL ACAD SCI USA, V101, P15506, DOI 10.1073/pnas.0406788101; Flores C, 2000, PSYCHOPHARMACOLOGY, V151, P152, DOI 10.1007/s002130000417; GONZALEZ AM, 1995, BRAIN RES, V701, P201, DOI 10.1016/0006-8993(95)01002-X; Guilloux JP, 2011, J NEUROSCI METH, V197, P21, DOI 10.1016/j.jneumeth.2011.01.019; Haj-Mirzaian A, 2016, CAN J PHYSIOL PHARM, V94, P599, DOI 10.1139/cjpp-2015-0429; Hercher C, 2009, J PSYCHIATR RES, V43, P947, DOI 10.1016/j.jpsychires.2009.01.006; Kato M, 2009, EUR NEUROPSYCHOPHARM, V19, P718, DOI 10.1016/j.euroneuro.2009.06.006; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Kessler RC, 2005, NEW ENGL J MED, V352, P2515, DOI 10.1056/NEJMsa043266; Mallei A, 2002, MOL PHARMACOL, V61, P1017, DOI 10.1124/mol.61.5.1017; Maragnoli ME, 2004, BIOL PSYCHIAT, V55, P1095, DOI 10.1016/j.biopsych.2004.02.003; Paradiso B, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00152; Peng L, 2015, EXPERT REV NEUROTHER, V15, P1299, DOI 10.1586/14737175.2015.1095094; Perez JA, 2009, J NEUROSCI, V29, P6379, DOI 10.1523/JNEUROSCI.4829-08.2009; Rajkowska G., 2007, CNS & Neurological Disorders-Drug Targets, V6, P219, DOI 10.2174/187152707780619326; Rial D, 2016, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00521; Salmaso N, 2016, BIOL PSYCHIAT, V80, P479, DOI 10.1016/j.biopsych.2016.02.026; SIMARD S, 2018, NEUROPSYCHOPHARMACOL; Smialowska M, 2013, PHARMACOL REP, V65, P1572; Torres-Platas SG, 2016, MOL PSYCHIATR, V21, P509, DOI 10.1038/mp.2015.65; Torres-Platas SG, 2011, NEUROPSYCHOPHARMACOL, V36, P2650, DOI 10.1038/npp.2011.154; Tumer C.A., 2015, SEMIN CELL DEV BIOL; Turner CA, 2008, BRAIN RES, V1224, P63, DOI 10.1016/j.brainres.2008.05.088; Turner CA, 2008, NEUROSCI LETT, V430, P147, DOI 10.1016/j.neulet.2007.10.041; Turner CA, 2006, BIOL PSYCHIAT, V59, P1128, DOI 10.1016/j.biopsych.2006.02.026; Turner CA, 2012, NEURON, V76, P160, DOI 10.1016/j.neuron.2012.08.037; Turner CA, 2011, P NATL ACAD SCI USA, V108, P8021, DOI 10.1073/pnas.1103732108; Vaccarino FM, 2007, NEUROSCIENTIST, V13, P173, DOI 10.1177/1073858406298336; Webster MJ, 2005, NEUROSCIENCE, V133, P453, DOI 10.1016/j.neuroscience.2005.02.037; Zechel S, 2010, NEUROSCIENTIST, V16, P357, DOI 10.1177/1073858410371513; Zheng W, 2004, DEV NEUROSCI-BASEL, V26, P181, DOI 10.1159/000082136	42	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204980	10.1371/journal.pone.0204980	http://dx.doi.org/10.1371/journal.pone.0204980			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273396	Green Published, gold			2022-12-26	WOS:000446124700056
J	Hoffman, LK; Tomalin, LE; Schultz, G; Howell, MD; Anandasabapathy, N; Alavi, A; Suarez-Farinas, M; Lowes, MA				Hoffman, Lauren K.; Tomalin, Lewis E.; Schultz, Gregory; Howell, Michael D.; Anandasabapathy, Niroshana; Alavi, Afsaneh; Suarez-Farinas, Mayte; Lowes, Michelle A.			Integrating the skin and blood transcriptomes and serum proteome in hidradenitis suppurativa reveals complement dysregulation and a plasma cell signature	PLOS ONE			English	Article							METABOLISM PATHWAYS; GENE-EXPRESSION; MICROBIOME; PSORIASIS; DISEASES; SUBSETS	Hidradenitis suppurativa (HS) is a chronic skin disease of the pilo-sebaceous apocrine unit characterized by significant inflammation and an impaired quality of life. The pathogenesis of HS remains unclear. To determine the HS skin and blood transcriptomes and HS blood proteome, patient data from previously published studies were analysed and integrated from a cohort of patients with moderate to severe HS (n = 17) compared to healthy volunteers (n = 10). The analysis utilized empirical Bayes methods to determine differentially expressed genes (DEGs) (fold change (FCH) >2.0 and false discovery rate (FDR) <0.05), and differentially expressed proteins (DEPs) (FCH>1.5, FDR<0.05). In the HS skin transcriptome (lesional skin compared to non-lesional skin), there was an abundance of immunoglobulins, antimicrobial peptides, and an interferon signature. Gene-sets related to Notch signalling and Interferon pathways were differentially activated in lesional compared to non-lesional skin. CIBERSORT analysis of the HS skin transcriptome revealed a significantly increased proportion of plasma cells in lesional skin. In the HS skin and blood transcriptomes and HS blood proteome, gene-sets related to the complement system changed significantly (FDR<0.05), with dysregulation of complement-specific DEGs and DEPs. These data point towards an exaggerated immune response in lesional skin that may be responding to commensal cutaneous bacterial presence and raise the possibility that this may be an important driver of HS disease progression.	[Hoffman, Lauren K.] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Tomalin, Lewis E.; Suarez-Farinas, Mayte] Icahn Sch Med Mt Sinai, Dept Populat Hlth & Sci Policy, Dept Genet & Genom, New York, NY 10029 USA; [Schultz, Gregory] Univ Florida, Dept Obstet & Gynecol, Miami, FL USA; [Howell, Michael D.] Incyte Corp, Wilmington, DE USA; [Anandasabapathy, Niroshana] Weill Cornell Med Coll, Dept Dermatol, New York, NY USA; [Alavi, Afsaneh] Univ Toronto, Womens Coll Hosp, Dept Med, Div Dermatol, Toronto, ON, Canada; [Lowes, Michelle A.] Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA	Yeshiva University; Albert Einstein College of Medicine; Icahn School of Medicine at Mount Sinai; State University System of Florida; University of Florida; Incyte; Cornell University; University of Toronto; University Toronto Affiliates; Womens College Hospital; Rockefeller University	Lowes, MA (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.	lowesm@rockefeller.edu	Lowes, Michelle A/G-9585-2016	Lowes, Michelle A/0000-0003-4256-478X; Anandasabapathy, Niroshana/0000-0002-0473-8358	NIAMS NIH HHS [R01 AR070234] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR070234] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Blok JL, 2016, BRIT J DERMATOL, V174, P1392, DOI 10.1111/bjd.14371; Blok JL, 2016, BRIT J DERMATOL, V174, P839, DOI 10.1111/bjd.14338; Chehoud C, 2013, P NATL ACAD SCI USA, V110, P15061, DOI 10.1073/pnas.1307855110; Chyou S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032828; Dany M, 2017, J AM ACAD DERMATOL, V77, P268, DOI 10.1016/j.jaad.2017.03.016; Ewald DA, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0133-x; Fuentes-Duculan J, 2010, J INVEST DERMATOL, V130, P2412, DOI 10.1038/jid.2010.165; Guet-Revillet H, 2017, CLIN INFECT DIS, V65, P282, DOI 10.1093/cid/cix285; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Hajishengallis G, 2017, NAT IMMUNOL, V18, P1288, DOI 10.1038/ni.3858; Hess C, 2016, IMMUNITY, V45, P240, DOI 10.1016/j.immuni.2016.08.003; Hoffman LK, 2018, BRIT J DERMATOL, V178, pE134, DOI 10.1111/bjd.15958; Hoffman LK, 2017, SEMIN CUTAN MED SURG, V36, P47, DOI 10.12788/j.sder.2017.017; Hotz C, 2016, J INVEST DERMATOL, V136, P1768, DOI 10.1016/j.jid.2016.04.036; Jimenez-Gallo D, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/2450401; Kanni T, 2018, BRIT J DERMATOL, V179, P413, DOI 10.1111/bjd.16428; Kim Soohyun, 2014, Immune Netw, V14, P123, DOI 10.4110/in.2014.14.3.123; Kuo KY, 2018, J INVEST DERMATOL, V138, P1209, DOI 10.1016/j.jid.2017.12.002; Lima AL, 2016, BRIT J DERMATOL, V174, P514, DOI 10.1111/bjd.14214; Lowes MA, 2014, ANNU REV IMMUNOL, V32, P227, DOI 10.1146/annurev-immunol-032713-120225; Matusiak L, 2017, J AM ACAD DERMATOL, V76, P670, DOI 10.1016/j.jaad.2016.10.042; Matusiak L, 2009, ACTA DERM-VENEREOL, V89, P601, DOI 10.2340/00015555-0749; Moran B, 2017, J INVEST DERMATOL, V137, P2389, DOI 10.1016/j.jid.2017.05.033; Netea MG, 2017, NAT IMMUNOL, V18, P826, DOI 10.1038/ni.3790; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/nmeth.3337, 10.1038/NMETH.3337]; Nirschl CJ, 2017, CELL, V170, P127, DOI 10.1016/j.cell.2017.06.016; Nograles KE, 2008, BRIT J DERMATOL, V159, P1092, DOI 10.1111/j.1365-2133.2008.08769.x; Olsen I, 2017, J ORAL MICROBIOL, V9, DOI 10.1080/20002297.2017.1340085; Ribeiro-Dias F, 2017, J LEUKOCYTE BIOL, V101, P39, DOI [10.1189/jlb.4ru0416-175rr, 10.1189/jlb.4RU0416-175RR]; Riis PT, 2018, EXPERT OPIN INV DRUG, V27, P43, DOI 10.1080/13543784.2018.1412430; Ring HC, 2017, JAMA DERMATOL, V153, P897, DOI 10.1001/jamadermatol.2017.0904; Takahashi K, 2018, J DERMATOL, V45, pE116, DOI 10.1111/1346-8138.14144; Tanaka T, 2011, FEBS LETT, V585, P3699, DOI 10.1016/j.febslet.2011.03.023; Thomi R, 2017, BRIT J DERMATOL, V177, P1358, DOI 10.1111/bjd.15458; van der Zee HH, 2012, BRIT J DERMATOL, V166, P98, DOI 10.1111/j.1365-2133.2011.10643.x; Wang J, 2017, CLIN EXP ALLERGY, V47, P1456, DOI 10.1111/cea.12979; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Xu HX, 2017, POSTEP DERM ALERGOL, V34, P82, DOI 10.5114/ada.2017.65626	38	45	46	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0203672	10.1371/journal.pone.0203672	http://dx.doi.org/10.1371/journal.pone.0203672			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265680	gold, Green Published, Green Submitted			2022-12-26	WOS:000446005500009
J	An, BC; Choi, YD; Oh, IJ; Kim, JH; Park, JI; Lee, SW				An, Byung Chull; Choi, Yoo-Duk; Oh, In-Jae; Kim, Ju Han; Park, Jae-Il; Lee, Seung-won			GPx3-mediated redox signaling arrests the cell cycle and acts as a tumor suppressor in lung cancer cell lines	PLOS ONE			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; PLASMA GLUTATHIONE-PEROXIDASE; OXIDATIVE STRESS; DNA-DAMAGE; GENE-EXPRESSION; PROSTATE-CANCER; B1 EXPRESSION; HELA-CELLS; G(2) DELAY; CATALASE	Glutathione peroxidase 3 (GPx3), a major scavenger of reactive oxygen species (ROS) in plasma, acts as a redox signal modulator. However, the mechanism underlying GPx3-mediated suppression of cancer cell growth is unclear. The aim of this study was to identify these mechanisms with respect to lung cancer. To enhance the redox modulating properties of GPx3, lung cancer cells were subjected to serum starvation for 12 h, resulting in ROS generation in the absence of oxidant treatment. We then investigated whether suppression of tumorigenesis under conditions of oxidative stress was dependent on GPx3. The results showed that GPx3 effectively suppressed proliferation, migration, and invasion of lung cancer cells under oxidative stress. In addition, GPx3 expression led to a significant reduction in ROS production by cancer cells and induced G2/M phase arrest. We also found that inactivation of cyclin B1 significantly suppressed by nuclear factor-kappa B(NF-kappa B) inactivation in lung cancer cells was dependent on GPx3 expression. To further elucidate the mechanism(s) underlying GPx3-medited suppression of tumor proliferation, we next examined the effect of GPx3-mediated redox signaling on the ROS-MKP3-extracellular signal-regulated kinase (Erk)-NF-kappa B-cyclin B1 pathway and found that GPx3 strongly suppressed activation of the Erk-NF-kappa B-cyclin B1 signaling cascade by protecting MKP3 (an Erk-specific phosphatase) from the effects of ROS. Thus, this study demonstrates for the first time that the GPx3 suppresses proliferation of lung cancer cells by modulating redox-mediated signals.	[An, Byung Chull; Lee, Seung-won] Chonnam Natl Univ, Sch Med, Dept Anat, Hwasun Gun, Jeollanam Do, South Korea; [Choi, Yoo-Duk] Chonnam Natl Univ Hosp, Dept Pathol, Gwangju, South Korea; [Oh, In-Jae] Chonnam Natl Univ, Hwasun Hosp, Dept Lung & Esophageal Canc Clin, Hwasun Gun, Jeollanam Do, South Korea; [Kim, Ju Han] Chonnam Natl Univ Hosp, Dept Internal Med, Gwangju, South Korea; [Park, Jae-Il] Korea Basic Sci Inst, Anim Facil Aging Sci, Gwangju, South Korea	Chonnam National University; Chonnam National University; Chonnam National University Hospital; Chonnam National University; Chonnam National University; Chonnam National University Hospital; Korea Basic Science Institute (KBSI)	Lee, SW (corresponding author), Chonnam Natl Univ, Sch Med, Dept Anat, Hwasun Gun, Jeollanam Do, South Korea.	seunglee@chonnam.ac.kr	Oh, In-Jae/AAG-5919-2020	Oh, In-Jae/0000-0003-4837-1321	Chonnam National University Hospital Biomedical Research Institute [CRI 17036-21]	Chonnam National University Hospital Biomedical Research Institute	This study was supported by a grant (CRI 17036-21) from Chonnam National University Hospital Biomedical Research Institute; This study was supported by a grant (CRI 17036-21) from the Chonnam National University Hospital Biomedical Research Institute.	An BC, 2016, MOL CELLS, V39, P631, DOI 10.14348/molcells.2016.0164; Androic I, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-391; Barrett CW, 2013, CANCER RES, V73, P1245, DOI 10.1158/0008-5472.CAN-12-3150; Bechtel W, 2009, ANTICANCER RES, V29, P4541; BJORNSTEDT M, 1994, J BIOL CHEM, V269, P29382; Bohm B, 2015, BIOL CHEM, V396, P1339, DOI 10.1515/hsz-2014-0234; Brigelius-Flohe R, 2006, BIOL CHEM, V387, P1329, DOI 10.1515/BC.2006.166; Brigelius-Flohe R, 2009, BBA-GEN SUBJECTS, V1790, P1555, DOI 10.1016/j.bbagen.2009.03.006; Cao JX, 2009, EMBO J, V28, P1505, DOI 10.1038/emboj.2009.101; Castaldo SA, 2015, TUMOR BIOL, V36, P909, DOI 10.1007/s13277-014-2714-2; Chan DW, 2008, CARCINOGENESIS, V29, P1742, DOI 10.1093/carcin/bgn167; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen BS, 2011, CANCER LETT, V309, P37, DOI 10.1016/j.canlet.2011.05.013; Chen MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028203; Chiu J, 2012, TRENDS CELL BIOL, V22, P592, DOI 10.1016/j.tcb.2012.08.002; Chung SS, 2009, MOL CELL BIOL, V29, P20, DOI 10.1128/MCB.00544-08; Cullen JJ, 2003, PANCREAS, V26, P23, DOI 10.1097/00006676-200301000-00005; Dayem Ahmed Abdal, 2010, Cancers (Basel), V2, P859, DOI 10.3390/cancers2020859; Donzelli M, 2003, EMBO REP, V4, P671, DOI 10.1038/sj.embor.embor887; Guo GZ, 2003, MOL CELL BIOL, V23, P2362, DOI 10.1128/MCB.23.7.2362-2378.2003; Hayano T, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-17; He Y, 2012, DIGEST DIS SCI, V56, P681; Heinzelmann S, 2010, BIOL CHEM, V391, P675, DOI 10.1515/BC.2010.068; Ho JCM, 2001, CANCER RES, V61, P8578; Janss AJ, 2001, NEURO-ONCOLOGY, V3, P11, DOI 10.1093/neuonc/3.1.11; Kang DH, 2011, MOL CELL, V44, P545, DOI 10.1016/j.molcel.2011.08.040; Kao GD, 1997, CANCER RES, V57, P753; Kawanishi S, 2006, BIOL CHEM, V387, P365, DOI 10.1515/BC.2006.049; Kayanoki Y, 1996, J BIOCHEM-TOKYO, V119, P817; Kunsch C, 1999, CIRC RES, V85, P753, DOI 10.1161/01.RES.85.8.753; Lee SB, 2010, APOPTOSIS, V15, P204, DOI 10.1007/s10495-009-0411-1; Li SM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12131-x; Liu RG, 1997, HUM GENE THER, V8, P585, DOI 10.1089/hum.1997.8.5-585; Liu SY, 2012, APOPTOSIS, V17, P1156, DOI 10.1007/s10495-012-0758-6; Maity A, 1996, ONCOGENE, V13, P1647; METTING NF, 1995, RADIAT RES, V143, P286, DOI 10.2307/3579215; Mohamed MM, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/787195; OBERLEY LW, 1979, CANCER RES, V39, P1141; Oberley TD, 1997, HISTOL HISTOPATHOL, V12, P525; Ozeki M, 2004, ANTICANCER RES, V24, P2657; Park J., 2014, INT J CELL BIOL, V2014, DOI DOI 10.1155/2014/715867; Peng DF, 2012, GUT, V61, P1250, DOI 10.1136/gutjnl-2011-301078; Qi X, 2014, ONCOTARGET, V5, P11103, DOI 10.18632/oncotarget.2549; Sarsour EH, 2008, AGING CELL, V7, P405, DOI 10.1111/j.1474-9726.2008.00384.x; Savitsky PA, 2002, J BIOL CHEM, V277, P20535, DOI 10.1074/jbc.M201589200; Saydam N, 1997, CANCER LETT, V119, P13, DOI 10.1016/S0304-3835(97)00245-0; Shin JS, 2008, INT J ONCOL, V32, P435; Shin J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183896; Sies H, 1997, J BIOL CHEM, V272, P27812, DOI 10.1074/jbc.272.44.27812; Steinbrenner H, 2009, BBA-GEN SUBJECTS, V1790, P1478, DOI 10.1016/j.bbagen.2009.02.014; Wang H, 2012, J BIOL CHEM, V287, P16890, DOI 10.1074/jbc.M111.322636; Whitaker HC, 2013, BRIT J CANCER, V109, P983, DOI 10.1038/bjc.2013.396; Yu YP, 2007, CANCER RES, V67, P8043, DOI 10.1158/0008-5472.CAN-07-0648	53	35	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204170	10.1371/journal.pone.0204170	http://dx.doi.org/10.1371/journal.pone.0204170			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30260967	Green Published, Green Submitted, gold			2022-12-26	WOS:000445907400028
J	Fujiwara, M; Ando, I; Satoh, K; Shishido, Y; Totsune, K; Sato, H; Imai, Y				Fujiwara, Masako; Ando, Itiro; Satoh, Keisuke; Shishido, You; Totsune, Kazuhito; Sato, Hiroshi; Imai, Yutaka			Biochemical evidence of cell starvation in diabetic hemodialysis patients	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; AMINO-ACID; INSULIN; QUANTIFICATION; METABOLISM; DIAGNOSIS; MELLITUS; MUSCLE	Recently, the ratio of patients with diabetes mellitus (DM) among hemodialysis (HD) patients has increased to become the largest sub-population. Their prognoses are significantly worse than those of patients without diabetes (non-DM). In the present study, 10 DM patients who did not take meals and 10 non-DM patients who took meals during HD sessions were investigated. The time courses of the change in plasma levels of metabolites during HD were determined. DM patients exhibited decreased plasma levels of lactate, pyruvate and alanine and dramatically increased levels of ketone bodies. At the end of HD, the plasma levels of lactate, pyruvate, alanine and ketone body were 0.46 +/- 0.07, 0.026 +/- 0.01, 0.12 +/- 0.04 and 0.26 +/- 0.04 mM (mean +/- standard error), respectively. The profile was 'hypolactatemia and hyperketonemia', indicating non-homeostasis. Glycolysis and tricarboxylic acid cycle were suppressed, and the oxidation of fatty acid was accelerated, indicating starvation, even though high amounts of glucose (150 mg/dl) in dialysate were supplied continuously to the bloodstream. In contrast, the plasma levels of lactate, pyruvate, and alanine in the non-DM patients were increased, with the levels of ketone body remaining low during HD to maintain homeostasis, indicating accelerated glycolysis. Furthermore, their plasma levels of insulin increased from 8.1 +/- 1.4 to 19.8 +/- 3.4 mu U/ml, which indicated endogenous secretion stimulated by glucose in dialysate and meal intake. In contrast, in the DM patients, the levels decreased from 19.2 +/- 3.4 to 5.5 +/- 1.1 mu U/ml. This value was the lower limit of the normal range. The depletion of the insulin through extracorporeal circulation may inhibit the transportation of glucose from the blood into the muscles, with the consequence of cell starvation. Such cell starvation along with lipolysis every two days may accelerate proteolysis and affect the prognosis of DM patients.	[Fujiwara, Masako; Ando, Itiro; Totsune, Kazuhito; Imai, Yutaka] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Planning Drug Dev & Clin Evaluat, Sendai, Miyagi, Japan; [Satoh, Keisuke] Koujikai Nagamachi Clin, Sendai, Miyagi, Japan; [Shishido, You] Midorinosato Clin, Iwanuma, Miyagi, Japan; [Sato, Hiroshi] Tohoku Univ, Grad Sch Pharmaceut Sci, Lab Clin Pharmacol & Therapeut, Sendai, Miyagi, Japan; [Imai, Yutaka] Tohoku Inst Management Blood Pressure, Sendai, Miyagi, Japan	Tohoku University; Tohoku University	Fujiwara, M (corresponding author), Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Planning Drug Dev & Clin Evaluat, Sendai, Miyagi, Japan.	fmasako@m.tohoku.ac.jp		Fujiwara, Masako/0000-0001-9468-1617	Ministry of Education, Culture, Sports, Science and Technology of Japan [15K15326]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Grants-in-Aids from the Ministry of Education, Culture, Sports, Science and Technology of Japan, 15K15326, H.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. * Foundation from the Japanese Association of Dialysis Physicians 2015-9 and 2017-12. M.F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Two of our authors [KS, YS], are employed by a commercial company: "Koujikai Nagamachi Clinic and Midorinosato Clinic", respectively. These funders provided support in the form of salaries for authors [KS, YS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2015, NAT REV NEPHROL, V11, P302, DOI 10.1038/nrneph.2015.38; Abe M, 2011, ARTIF ORGANS, V35, P398, DOI 10.1111/j.1525-1594.2010.01112.x; Ando I, 2013, MAGN RESON MED SCI, V12, P129, DOI 10.2463/mrms.2012-0076; Ando I, 2010, J TOXICOL SCI, V35, P253, DOI 10.2131/jts.35.253; BATES MW, 1968, BIOCHEM J, V110, P655, DOI 10.1042/bj1100655; Berg JM, 2012, BIOCHEMISTRY-US, P534; Bonanni A, 2011, INT J ENV RES PUB HE, V8, P1631, DOI 10.3390/ijerph8051631; Caglar K, 2002, KIDNEY INT, V62, P1408, DOI 10.1111/j.1523-1755.2002.kid556.x; Cahill GF, 2006, ANNU REV NUTR, V26, P1, DOI 10.1146/annurev.nutr.26.061505.111258; Couser WG, 2011, KIDNEY INT, V80, P1258, DOI 10.1038/ki.2011.368; DAUGIRDAS JT, 1993, J AM SOC NEPHROL, V4, P1205; FELIG P, 1977, ARCH INTERN MED, V137, P507, DOI 10.1001/archinte.137.4.507; Fujiwara M, 2015, J PHARMACEUT BIOMED, V111, P159, DOI 10.1016/j.jpba.2015.03.035; Geiyo F, 1986, KIDNEY INT, V30, P385; IKIZLER TA, 1994, KIDNEY INT, V46, P830, DOI 10.1038/ki.1994.339; Ikizler TA, 2002, AM J PHYSIOL-ENDOC M, V282, pE107, DOI 10.1152/ajpendo.2002.282.1.E107; Iwase H, 2001, FORENSIC SCI INT, V115, P123, DOI 10.1016/S0379-0738(00)00298-X; Kallen AJ, 2010, EXPERT REV ANTI-INFE, V8, P643, DOI [10.1586/eri.10.47, 10.1586/ERI.10.47]; Kobayashi S, 2017, ANN VASC DIS, V10, P1, DOI 10.3400/avd.ra.17-00006; Koppel JD, 1973, T AM SOC ARTIF ORG, V13, P309; Kraut JA, 2005, AM J KIDNEY DIS, V45, P978, DOI 10.1053/j.ajkd.2005.03.003; LAIDLAW SA, 1994, AM J KIDNEY DIS, V23, P504, DOI 10.1016/S0272-6386(12)80371-4; Lim VS, 2003, J AM SOC NEPHROL, V14, P2297, DOI 10.1097/01.ASN.0000085590.83005.A0; Mak R. H. K., 1994, DIABETES REV, V2, P19; Masakane I, 2015, THER APHER DIAL, V19, P540, DOI 10.1111/1744-9987.12378; MCGARRY JD, 1972, METABOLISM, V21, P471, DOI 10.1016/0026-0495(72)90059-5; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Schrauwen P, 2008, DIABETOLOGIA, V51, P1694, DOI 10.1007/s00125-008-1069-x; Wang XNH, 2014, NAT REV NEPHROL, V10, P504, DOI 10.1038/nrneph.2014.112	29	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204406	10.1371/journal.pone.0204406	http://dx.doi.org/10.1371/journal.pone.0204406			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30261059	Green Submitted, gold, Green Published			2022-12-26	WOS:000445907400045
J	Lu, IN; Kirsteina, A; Farinelle, S; Willieme, S; Tars, K; Muller, CP; Kazaks, A				Lu, I-Na; Kirsteina, Anna; Farinelle, Sophie; Willieme, Stephanie; Tars, Kaspars; Muller, Claude P.; Kazaks, Andris			Structure and applications of novel influenza HA tri-stalk protein for evaluation of HA stem-specific immunity	PLOS ONE			English	Article							HUMAN-DISEASE; VIRUS; HEMAGGLUTININ; ANTIBODIES; VACCINATION; INTERFACE; INFECTION; SUBTYPES; FUSION; PH	Long alpha helix (LAH) from influenza virus hemagglutinin (HA) stem or stalk domain is one of the most conserved influenza virus antigens. Expression of N-terminally extended LAH in E. coli leads to assembly of alpha-h elical homotrimer which is structurally nearly identical to the corresponding region of post-fusion form of native HA. This novel tri-stalk protein was able to differentiate between group 1 and 2 influenza in ELISA with virus-infected mice sera. It was also successfully applied for enzyme-linked immunospot assay to estimate the number of HA stem-reactive antibody (Ab)-secreting cells in mice. An in-house indirect ELISA was developed using a HA tri-stalk protein as a coating antigen for evaluation of HA stem-specific Ab levels in human sera collected in Luxembourg from 211 persons with occupational exposure to swine before the pandemic H1N1/09 virus had spread to Western Europe. Our results show that 70% of these pre-pandemic sera are positive for HA stem-specific Abs. In addition, levels of HA stem-specific Abs have positive correlation with the corresponding IgG titers and neutralizing activities against pandemic H1N1/09 virus.	[Lu, I-Na; Farinelle, Sophie; Willieme, Stephanie; Muller, Claude P.] Luxembourg Inst Hlth, Dept Infect & Immun, Esch Sur Alzette, Luxembourg; [Kirsteina, Anna; Tars, Kaspars; Kazaks, Andris] Latvian Biomed Res & Study Ctr, Riga, Latvia; [Tars, Kaspars] Fac Biol, Dept Mol Biol, Riga, Latvia; [Muller, Claude P.] Lab Natl Sante, Dudelange, Luxembourg	Luxembourg Institute of Health; Latvian Biomedical Research & Study Centre	Kazaks, A (corresponding author), Latvian Biomed Res & Study Ctr, Riga, Latvia.	andris@biomed.lu.lv	Lu, I-Na/AAA-2359-2020; Kazaks, Andris/AAI-2282-2021	Kirsteina, Anna/0000-0003-3742-7158; , Andris/0000-0003-4964-0984	European Union Seventh Framework Programme for research, technological development and demonstration [602437]; European Regional Development Fund [1.1.1.1/16/A/054]	European Union Seventh Framework Programme for research, technological development and demonstration; European Regional Development Fund(European Commission)	The research leading to these results has received funding from the European Union Seventh Framework Programme for research, technological development and demonstration under grant agreement 602437 (all authors) and from European Regional Development Fund project 1.1.1.1/16/A/054 (AKi, KT and AKa). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Chen J, 1995, P NATL ACAD SCI USA, V92, P12205, DOI 10.1073/pnas.92.26.12205; Chen SH, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/901817; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; de Vries RD, 2018, VACCINES-BASEL, V6, DOI 10.3390/vaccines6030046; Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908; Ellebedy AH, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00053; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Gerloff NA, 2011, EMERG INFECT DIS, V17, P403, DOI [10.3201/eid1703100581, 10.3201/eid1703.100851]; Harris AK, 2013, P NATL ACAD SCI USA, V110, P4592, DOI 10.1073/pnas.1214913110; Heaton NS, 2013, P NATL ACAD SCI USA, V110, P20248, DOI 10.1073/pnas.1320524110; Impagliazzo A, 2015, SCIENCE, V349, P1301, DOI 10.1126/science.aac7263; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Kallewaard NL, 2016, CELL, V166, P596, DOI 10.1016/j.cell.2016.05.073; Kazaks A, 2017, BMC BIOTECHNOL, V17, DOI 10.1186/s12896-017-0396-8; Krammer F, 2013, CURR OPIN VIROL, V3, P521, DOI 10.1016/j.coviro.2013.07.007; Margine I, 2013, J VIROL, V87, P4728, DOI 10.1128/JVI.03509-12; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Miller MS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006637; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Neu KE, 2016, CURR OPIN IMMUNOL, V42, P48, DOI 10.1016/j.coi.2016.05.012; Paules C, 2017, LANCET, V390, P697, DOI 10.1016/S0140-6736(17)30129-0; Pica N, 2012, P NATL ACAD SCI USA, V109, P2573, DOI 10.1073/pnas.1200039109; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Preaud E, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-813; Ramirez A, 2018, VACCINE, V36, P873, DOI 10.1016/j.vaccine.2017.12.053; Sasaki S, 2011, J CLIN INVEST, V121, P3109, DOI 10.1172/JCI57834; SHORTRIDGE KF, 1977, SCIENCE, V196, P1454, DOI 10.1126/science.867041; Valkenburg SA, 2016, SCI REP-UK, V6, DOI 10.1038/srep22666; Wang TT, 2010, P NATL ACAD SCI USA, V107, P18979, DOI 10.1073/pnas.1013387107; Wei SH, 2013, LANCET RESP MED, V1, P771, DOI 10.1016/S2213-2600(13)70221-2; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Xu R, 2011, J VIROL, V85, P5172, DOI 10.1128/JVI.02430-10; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9	37	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204776	10.1371/journal.pone.0204776	http://dx.doi.org/10.1371/journal.pone.0204776			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30261065	gold, Green Published, Green Submitted			2022-12-26	WOS:000445907400105
J	Grinyo, J; Viladrich, N; Diaz, D; Munoz, A; Mallol, S; Salazar, J; Castillo, R; Gili, JM; Gori, A				Grinyo, Jordi; Viladrich, Nuria; Diaz, David; Munoz, Anabel; Mallol, Sandra; Salazar, Janire; Castillo, Raquel; Gili, Josep-Maria; Gori, Andrea			Reproduction, energy storage and metabolic requirements in a mesophotic population of the gorgonian Paramuricea macrospina	PLOS ONE			English	Article							BENTHIC SUSPENSION FEEDERS; SEXUAL REPRODUCTION; GONADAL DEVELOPMENT; BIOCHEMICAL-COMPOSITION; SPATIAL VARIABILITY; DEVELOPMENT CYCLE; PRECIOUS CORALS; ORGANIC-MATTER; STABLE CARBON; FATTY-ACIDS	This study examined the sexual reproductive cycle, energy storage and metabolic requirements of a Mediterranean gorgonian in a mesophotic ecosystem (similar to 70 m depth). Paramuricea macrospina resulted to be a gonochoric internal brooding species with a 1:1 population sex ratio. Oogenesis lasted similar to 12-14 months, whereas spermatogenesis was significantly shorter, only lasting 6 months. Fertilization occurred during late summer (August) and larval release occurred during autumn (September-October). The organic matter and total lipid content showed a slight seasonal variability. Stable isotopic composition remained constant throughout the year, reflecting a general stability in gorgonian food sources. Conversely, the free fatty acid composition varied seasonally, reflecting changes in P. macrospina energetic demands probably related to gametogenesis and larval brooding. The reproductive ecology and biochemical composition of P. macrospina significantly differ from shallow coastal gorgonian species, reflecting the higher environmental stability of deeper environments.	[Grinyo, Jordi; Viladrich, Nuria; Salazar, Janire; Gili, Josep-Maria; Gori, Andrea] CSIC, Inst Ciencies Mar, Barcelona, Spain; [Viladrich, Nuria] Univ Autonoma Barcelona, Inst Ciencies & Tecnol Ambiental, Cerdanyola Del Valles, Spain; [Diaz, David; Munoz, Anabel; Mallol, Sandra] Ctr Oceanog Balears, Inst Espanol Oceanog, Palma De Mallorca, Spain; [Castillo, Raquel] Univ Autonoma Barcelona, Ctr Recerca Ecol & Aplicac Forestals, Cerdanyola Del Valles, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Autonomous University of Barcelona; Spanish Institute of Oceanography; Autonomous University of Barcelona; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF)	Grinyo, J (corresponding author), CSIC, Inst Ciencies Mar, Barcelona, Spain.	jordigrinyo85@icm.csic.es	Grinyó, Jordi/Q-8098-2018; DIAZ, DAVID/AAS-8722-2021; Castillo-Contreras, Raquel/AAI-1831-2019; Gori, Andrea/AAT-4501-2020; Contreras, Raquel Castillo/AAG-6050-2020; Viladrich Canudas, Nuria/GVS-1360-2022	Grinyó, Jordi/0000-0001-8425-1349; DIAZ, DAVID/0000-0003-0611-2516; Gori, Andrea/0000-0001-8442-8079; Contreras, Raquel Castillo/0000-0002-5770-7264; Viladrich Canudas, Nuria/0000-0001-8456-4812; Munoz, Anabel/0000-0002-4216-0315	European project LIFE+ INDEMARES "Inventario y designacion de la red Natura 2000 en areas marinas del estado espanol" [LIFE07/NAT/E/000732]	European project LIFE+ INDEMARES "Inventario y designacion de la red Natura 2000 en areas marinas del estado espanol"	This work was funded by the European project LIFE+ INDEMARES "Inventario y designacion de la red Natura 2000 en areas marinas del estado espanol" (LIFE07/NAT/E/000732).	ARAI T, 1993, CORAL REEFS, V12, P71; Baker E, 2016, MESOPHOTIC CORAL ECO, P11; BALLESTEROS E, 1994, PSZNI MAR ECOL, V15, P233; Ballesteros E, 2006, OCEANOGR MAR BIOL, V44, P123; BARNES H, 1973, Journal of Experimental Marine Biology and Ecology, V12, P103, DOI 10.1016/0022-0981(73)90040-3; Beazley LI, 2012, DEEP-SEA RES PT I, V68, P92, DOI 10.1016/j.dsr.2012.05.013; Beiring EA, 2000, MAR ECOL PROG SER, V196, P169, DOI 10.3354/meps196169; Ben-Yosef DZ, 1999, MAR BIOL, V135, P473, DOI 10.1007/s002270050647; BENAYAHU Y, 1989, ACTA ZOOL-STOCKHOLM, V70, P29, DOI 10.1111/j.1463-6395.1989.tb01049.x; Bo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049870; Bo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016357; Bongaerts P, 2010, CORAL REEFS, V29, P309, DOI 10.1007/s00338-009-0581-x; Brandtneris VW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151953; BRAZEAU DA, 1990, MAR BIOL, V104, P465, DOI 10.1007/BF01314351; BRAZEAU DA, 1989, BIOL BULL, V176, P1, DOI 10.2307/1541882; Brito T.A.S., 1997, P63; Carlier A, 2007, ESTUAR COAST SHELF S, V72, P1, DOI 10.1016/j.ecss.2006.10.001; CARPINE C, 1975, Bulletin de l'Institut Oceanographique (Monaco), V71, P1; Cau A, 2015, MAR BIOL, V162, P1865, DOI 10.1007/s00227-015-2718-5; Cerrano C, 2005, AQUAT CONSERV, V15, P147, DOI 10.1002/aqc.661; Chambers J., 1992, STAT MODELS S WADSWO, DOI 10.1201/9780203738535-4; Chang T. H., 2007, THESIS; Cocito S, 2013, MAR ECOL PROG SER, V473, P179, DOI 10.3354/meps10037; Coelho MAG, 2014, INVERTEBR BIOL, V133, P299, DOI 10.1111/ivb.12070; Coma R, 2000, TRENDS ECOL EVOL, V15, P448, DOI 10.1016/S0169-5347(00)01970-4; Coma R, 2003, OIKOS, V101, P205, DOI 10.1034/j.1600-0706.2003.12028.x; COMA R, 1995, MAR ECOL PROG SER, V117, P173, DOI 10.3354/meps117173; Dalsgaard J, 2003, ADV MAR BIOL, V46, P225, DOI 10.1016/S0065-2881(03)46005-7; Danovaro R, 2000, PROG OCEANOGR, V46, P259, DOI 10.1016/S0079-6611(00)00022-7; de Putron SJ, 2009, INVERTEBR BIOL, V128, P213, DOI 10.1111/j.1744-7410.2009.00170.x; Excoffon AC, 2004, J MAR BIOL ASSOC UK, V84, P695, DOI 10.1017/S0025315404009774h; Eyal-Shaham L, 2016, SCI REP-UK, V6, DOI 10.1038/srep20964; Fanelli E, 2009, J SEA RES, V61, P174, DOI 10.1016/j.seares.2008.10.005; Feehan KA, 2015, J MAR BIOL ASSOC UK, V95, P691, DOI 10.1017/S0025315415000053; Fine M, 2005, CORAL REEFS, V24, P161, DOI 10.1007/s00338-004-0462-2; Fiorillo I, 2013, MAR BIOL, V160, P719, DOI 10.1007/s00227-012-2126-z; Garrabou J, 2002, ESTUAR COAST SHELF S, V55, P493, DOI 10.1006/ecss.2001.0920; GILI J M, 1987, Vie et Milieu, V37, P85; Goni R, 2013, IEOCOBLANBAL131; Gori A, 2012, CORAL REEFS, V31, P823, DOI 10.1007/s00338-012-0904-1; Gori A, 2007, MAR BIOL, V151, P1571, DOI 10.1007/s00227-006-0595-7; Gori A, 2013, J EXP MAR BIOL ECOL, V444, P38, DOI 10.1016/j.jembe.2013.03.009; Gori A, 2011, MAR BIOL, V158, P1721, DOI 10.1007/s00227-011-1686-7; GRIGG RW, 1977, ECOLOGY, V58, P278, DOI 10.2307/1935603; Grigg RW, 1970, THESIS; Grinyo J, 2017, PROG OCEANOGR, V159, P323, DOI 10.1016/j.pocean.2017.11.005; Grinyo J, 2016, PROG OCEANOGR, V145, P42, DOI 10.1016/j.pocean.2016.05.001; Grottoli AG, 2004, MAR BIOL, V145, P621, DOI 10.1007/s00227-004-1337-3; Gurr M. I, 2002, LIPID BIOCH; Gutierrez-Rodrigueza C, 2004, INVERTEBR BIOL, V123, P54; Hinderstein LM, 2010, CORAL REEFS, V29, P247, DOI 10.1007/s00338-010-0614-5; Holstein DM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146068; Imbs AB, 2013, RUSS J MAR BIOL+, V39, P153, DOI 10.1134/S1063074013030061; Kahng SE, 2014, CURR OPIN ENV SUST, V7, P72, DOI 10.1016/j.cosust.2013.11.019; Kahng SE, 2010, CORAL REEFS, V29, P255, DOI 10.1007/s00338-010-0593-6; Kahng SE, 2011, MAR ECOL PROG SER, V443, P265, DOI 10.3354/meps09414; Kipson S, 2014, MAR ECOL, DOI [10.1111/maec.12195, DOI 10.1111/MAEC.12195]; Linares C, 2008, J APPL ECOL, V45, P688, DOI 10.1111/j.1365-2664.2007.01419.x; Loya Y, 2016, CORAL REEFS, V35, P1, DOI 10.1007/s00338-016-1410-7; de Puelles MLF, 2007, PROG OCEANOGR, V74, P329, DOI 10.1016/j.pocean.2007.04.009; Martin E, 1982, AN I CIENC MAR LIMNO, V1, P359; Mercier A, 2011, CORAL REEFS, V30, P337, DOI 10.1007/s00338-011-0724-8; Muller-Navarra DC, 2000, NATURE, V403, P74, DOI 10.1038/47469; Nonaka M, 2015, PAC SCI, V69, P15, DOI 10.2984/69.1.2; Oksanen J., 2006, VEGAN COMMUNITY ECOL; Oku H, 2002, FISHERIES SCI, V68, P517, DOI 10.1046/j.1444-2906.2002.00456.x; Orejas C, 2007, MAR BIOL, V150, P551, DOI 10.1007/s00227-006-0370-9; Pakes MJ, 2008, J EXP MAR BIOL ECOL, V357, P121, DOI 10.1016/j.jembe.2008.01.003; Palanques A, 2002, CONT SHELF RES, V22, P285, DOI 10.1016/S0278-4343(01)00058-9; Patefield W. M., 1981, APPL STAT, V30, P91, DOI DOI 10.2307/2346669; PECHENIK JA, 1990, OPHELIA, V32, P63, DOI 10.1080/00785236.1990.10422025; Pernet V, 2002, J COMP PHYSIOL B, V172, P455, DOI 10.1007/s00360-002-0268-x; Prasetia R, 2016, CORAL REEFS, V35, P53, DOI 10.1007/s00338-015-1348-1; Priori C, 2013, ESTUAR COAST SHELF S, V118, P43, DOI 10.1016/j.ecss.2012.12.011; Puig P, 2001, MAR GEOL, V178, P81, DOI 10.1016/S0025-3227(01)00186-4; R Development Core Team, 2014, R LANG ENV STAT COMP; Ribes M, 1999, MAR ECOL PROG SER, V183, P125, DOI 10.3354/meps183125; Ribes M, 2007, INVERTEBR BIOL, V126, P307, DOI 10.1111/j.1744-7410.2007.00101.x; RICHMOND RH, 1987, B MAR SCI, V41, P594; Riedl R., 1971, Marine Ecol, V1, P1123; Rossi S, 2003, ESTUAR COAST SHELF S, V58, P423, DOI 10.1016/S0272-7714(03)00108-2; Rossi S, 2006, MAR BIOL, V149, P643, DOI 10.1007/s00227-005-0229-5; Rossi S, 2009, INVERTEBR REPROD DEV, V53, P175, DOI 10.1080/07924259.2009.9652304; Sargent J, 1999, AQUACULTURE, V179, P217, DOI 10.1016/S0044-8486(99)00191-X; Sargent JR., 1988, MICROBES SEA, P119; Seo SY, 2008, ANIM CELLS SYST, V12, P231, DOI 10.1080/19768354.2008.9647177; SLATTERY M, 1995, MAR BIOL, V122, P461, DOI 10.1007/BF00350880; Southward AJ, 1996, J MAR BIOL ASSOC UK, V76, P265, DOI 10.1017/S002531540003054X; Stearns S.C., 1992, pi; Tchernov D, 2004, P NATL ACAD SCI USA, V101, P13531, DOI 10.1073/pnas.0402907101; THORSON G, 1950, BIOL REV, V25, P1, DOI 10.1111/j.1469-185X.1950.tb00585.x; Topcu NE, 2016, INVERTEBR BIOL, V135, P13, DOI 10.1111/ivb.12112; Tsounis G, 2006, MAR BIOL, V148, P513, DOI 10.1007/s00227-005-0100-8; Turner JA, 2017, ICES J MAR SCI, V74, P2309, DOI 10.1093/icesjms/fsx085; Viladrich N, 2017, MAR ECOL PROG SER, V573, P117, DOI 10.3354/meps12141; Viladrich N, 2013, 17 IB S MAR BIOL STU, P154; Viladrich N, 2016, CORAL REEFS, V35, P1033, DOI 10.1007/s00338-016-1440-1; Wacker A, 2001, ECOLOGY, V82, P2507, DOI 10.2307/2679932; Waller RG, 2007, B MAR SCI, V81, P533; Waller RG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090893; WARD S, 1995, CORAL REEFS, V14, P87, DOI 10.1007/BF00303428	101	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2018	13	9							e0203308	10.1371/journal.pone.0203308	http://dx.doi.org/10.1371/journal.pone.0203308			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3NB	30256802	Green Submitted, gold, Green Published			2022-12-26	WOS:000446000200016
J	Gebresenbet, F; Bauer, H; Vadjunec, JM; Papes, M				Gebresenbet, Fikirte; Bauer, Hans; Vadjunec, Jacqueline M.; Papes, Monica			Beyond the numbers: Human attitudes and conflict with lions (Panthera leo) in and around Gambella National Park, Ethiopia	PLOS ONE			English	Article							HUMAN-CARNIVORE COEXISTENCE; LIVESTOCK PREDATION; LAW-ENFORCEMENT; SOCIAL-FACTORS; CONSERVATION; REINTRODUCTION; PERCEPTIONS; DEPREDATION; MANAGEMENT; TOLERANCE	Human-lion conflict is one of the leading threats to lion populations and while livestock loss is a source of conflict, the degree to which livestock depredation is tolerated by people varies between regions and across cultures. Knowledge of local attitudes towards lions and identification of drivers of human-lion conflict can help formulate mitigation measures aimed at promoting coexistence of humans with lions. We assessed locals' attitudes towards lions in and around Gambella National Park and compared the findings with published data from Kafa Biosphere Reserve, both in western Ethiopia. We used household interviews to quantify livestock loss. We found that depredation was relatively low and that disease and theft were the top factors of livestock loss. Remarkably, however, tolerance of lions was lower around Gambella National Park than in Kafa Biosphere Reserve. Multivariate analysis revealed that education level, number of livestock per household, livestock loss due to depredation, and livestock loss due to theft were strong predictors of locals' attitude towards lion population growth and conservation. We show that the amount of livestock depredation alone is not sufficient to understand human-lion conflicts and we highlight the importance of accounting for cultural differences in lion conservation. The low cultural value of lions in the Gambella region corroborate the findings of our study. In combination with growing human population and land-use change pressures, low cultural value poses serious challenges to long-term lion conservation in the Gambella region. We recommend using Arnstein's ladder of participation in conservation education programs to move towards proactive involvement of locals in conservation.	[Gebresenbet, Fikirte] Oklahoma State Univ, Dept Integrat Biol, Stillwater, OK 74078 USA; [Bauer, Hans] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Oxford, England; [Vadjunec, Jacqueline M.] Oklahoma State Univ, Dept Geog, Stillwater, OK 74078 USA; [Papes, Monica] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN USA	Oklahoma State University System; Oklahoma State University - Stillwater; University of Oxford; Oklahoma State University System; Oklahoma State University - Stillwater; University of Tennessee System; University of Tennessee Knoxville	Gebresenbet, F (corresponding author), Oklahoma State Univ, Dept Integrat Biol, Stillwater, OK 74078 USA.	fikirte.erda@okstate.edu		Bauer, Hans/0000-0001-5031-5842	Schlumberger Foundation via their Faculty for the Future fellowship program	Schlumberger Foundation via their Faculty for the Future fellowship program(Schlumberger)	FG obtained funding for this study from the Schlumberger Foundation via their Faculty for the Future fellowship program (http://www.slb.com/news/inside_news/2017/2017_05-12_faculty_of_the_future.aspx). The Schlumberger Foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJZEN I, 1977, PSYCHOL BULL, V84, P888, DOI 10.1037/0033-2909.84.5.888; Amare A., 2015, NATURAL RESOURCES, V6, P405, DOI DOI 10.4236/NR.2015.66039; ARNSTEIN SR, 1969, J AM I PLANNERS, V35, P216, DOI 10.1080/01944366908977225; Baruch-Mordo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015681; Bauer H., 2022, PANTHERA LEO, DOI [10.2305/IUCN.UK.2016-3.RLTS.T15951A107265605.en, DOI 10.2305/IUCN.UK.2016-3.RLTS.T15951A107265605.EN]; Benjaminsen TA, 2010, FORUM DEV STUD, V37, P385, DOI 10.1080/08039410.2010.516406; Bjerke T, 1998, SOC NATUR RESOUR, V11, P169, DOI 10.1080/08941929809381070; Cascao AE, 2013, STATE SOC CHALLENGES, P143; CMS, 2014, INCL WHIT EAR KOB KO; CSA, 2007, CENS 2007 REP GAMB R; Curry CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143827; Dar NI, 2009, BIOL CONSERV, V142, P2076, DOI 10.1016/j.biocon.2009.04.003; Dickman A., 2013, KEY TOPICS CONSERVAT, V2; Dickman AJ, 2010, ANIM CONSERV, V13, P458, DOI 10.1111/j.1469-1795.2010.00368.x; Dickman AJ, 2016, PROBLEMATIC WILDLIFE, P339, DOI [10.1007/978-3-319-22246-2_16, DOI 10.1007/978-3-319-22246-2_16]; Dickman AJ, 2014, BIOL CONSERV, V178, P19, DOI 10.1016/j.biocon.2014.07.011; Dolrenry S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088081; Dorresteijn I, 2016, AMBIO, V45, P490, DOI 10.1007/s13280-015-0760-7; Duckworth F., 1973, WILDLIFE SITUATION G; EWCA, GAMB NAT PARK UND; Feyissa D, 2010, J EAST AFR STUD, V4, P314, DOI 10.1080/17531055.2010.487341; Gebeyehu T., 2013, E AFRICA SOCIAL SCI, V29, P97; Gebresenbet F, 2009, P NAT LION CONS WORK; Gebresenbet F, 2016, AFR SPECTR, V51, P5, DOI 10.1177/000203971605100102; Gebresenbet F, 2018, ORYX, V52, P751, DOI 10.1017/S0030605316001356; Goldman MJ, 2013, ORYX, V47, P490, DOI 10.1017/S0030605312000907; Gore ML, 2008, CONSERV LETT, V1, P136, DOI 10.1111/j.1755-263X.2008.00017.x; Gusset M, 2009, ORYX, V43, P67, DOI 10.1017/S0030605308990475; Gusset M, 2008, BIODIVERS CONSERV, V17, P83, DOI 10.1007/s10531-007-9232-0; Hayward MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023607; Hazzah L, 2014, CONSERV BIOL, V28, P851, DOI 10.1111/cobi.12244; Hazzah L, 2009, BIOL CONSERV, V142, P2428, DOI 10.1016/j.biocon.2009.06.006; Henschel P, 2015, PANTHERA LEO W AFRIC; HoARECN, 2013, LAUNCH BIOD MAN PROG; Holmes G., 2007, CONSERV SOC, V5, P184; IUCN, 2006, CONS STRAT LION E SO; Jachmann H, 2008, BIOL CONSERV, V141, P89, DOI 10.1016/j.biocon.2007.09.012; Keane A, 2008, ANIM CONSERV, V11, P75, DOI 10.1111/j.1469-1795.2008.00170.x; Kissui BM, 2008, ANIM CONSERV, V11, P422, DOI 10.1111/j.1469-1795.2008.00199.x; Kruuk H, 2002, HUNTER HNTED RELATIO; Lagendijk DDG, 2008, ENVIRON MANAGE, V42, P971, DOI 10.1007/s00267-008-9204-5; Land Feyissa D., 2005, COMPETEING JURISDICT, P203; Marchini S, 2012, BIOL CONSERV, V147, P213, DOI 10.1016/j.biocon.2012.01.002; Marker LL, 2003, CONSERV BIOL, V17, P1290, DOI 10.1046/j.1523-1739.2003.02077.x; Martin E, 2010, PACHYDERM, P24; McKnight PatrickE., 2010, CORSINI ENCY PSYCHOL; Moeliono M, 2007, HANDS HANDS COMMUNIT, P165; Nalepa RA, 2017, GEOFORUM, V82, P237, DOI 10.1016/j.geoforum.2016.10.008; Naughton-Treves L, 2005, CONSERV BIOL SER, V9, P252; Njuki J., 2011, ILRI ADD AB 2 MAY; Ogada MO, 2003, CONSERV BIOL, V17, P1521, DOI 10.1111/j.1523-1739.2003.00061.x; Patterson BD, 2004, BIOL CONSERV, V119, P507, DOI 10.1016/j.biocon.2004.01.013; Reed M.S., 2015, CONFLICTS CONSERVATI, P226; Riggio J, 2013, BIODIVERS CONSERV, V22, P17, DOI 10.1007/s10531-012-0381-4; Rode J, 2015, ECOL ECON, V117, P270, DOI 10.1016/j.ecolecon.2014.11.019; Romanach SS, 2007, ORYX, V41, P185, DOI 10.1017/S0030605307001779; Roskaft E, 2007, WILDLIFE BIOL, V13, P172, DOI 10.2981/0909-6396(2007)13[172:HATLCI]2.0.CO;2; Santos J.R.A., 1999, J EXT, V37, P1, DOI DOI 10.4135/9781483381411.N492; Schapira P, 2016, ORYX, V51, P19, DOI [10.1017/S0030605316000363, DOI 10.1017/S0030605316000363]; Schwartzman S, 2000, CONSERV BIOL, V14, P1351, DOI 10.1046/j.1523-1739.2000.99329.x; Scott J., 1989, EVERYDAY FORMS PEASA, V4, P33, DOI DOI 10.22439/CJAS.V4I1.1765; Sillero-Zubiri C, 2001, CONSERV BIOL SER, V5, P282; Sillero-Zubiri C, 2006, KEY TOPICS CONSERVAT, P255; Sogbohossou EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084674; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Tumenta PN, 2013, ORYX, V47, P237, DOI 10.1017/S0030605311001621; Twyman C, 2000, GEOGR J, V166, P323, DOI 10.1111/j.1475-4959.2000.tb00034.x; UNHCR, 2017, S SUD SIT 2017; Wals A. E. J., 2012, OXFORD HDB ENV CONSE, P628, DOI DOI 10.1093/OXFORDHB/9780199733026.013.0032; Waylen KA, 2010, CONSERV BIOL, V24, P1119, DOI 10.1111/j.1523-1739.2010.01446.x; White PA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153648; Williams CK, 2002, WILDLIFE SOC B, V30, P575; Woodroffe R, 2000, ANIM CONSERV, V3, P165, DOI 10.1111/j.1469-1795.2000.tb00241.x; Woodroffe R, 2005, ANIM CONSERV, V8, P91, DOI 10.1017/S1367943004001829; ZEWDE B, 1987, INT J AFR HIST STUD, V20, P75, DOI 10.2307/219279	76	8	8	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2018	13	9							e0204320	10.1371/journal.pone.0204320	http://dx.doi.org/10.1371/journal.pone.0204320			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GU9BO	30252886	Green Published, Green Submitted, gold			2022-12-26	WOS:000445639700043
J	Hu, TH; Wei, QZ; Wang, WH; Hu, HJ; Mao, WH; Zhu, QM; Bao, CL				Hu, Tianhua; Wei, Qingzhen; Wang, Wuhong; Hu, Haijiao; Mao, Weihai; Zhu, Qinmei; Bao, Chonglai			Genome-wide identification and characterization of CONSTANS-like gene family in radish (Raphanus sativus)	PLOS ONE			English	Article							CIRCADIAN CLOCK; ARABIDOPSIS; PROTEIN; EXPRESSION; TOOL; EVOLUTION; ONTOLOGY; REVEALS; ENCODES; DOMAINS	Floral induction that initiates bolting and flowering is crucial for reproductive fitness in radishes. CONSTANS-like (CO-like, COL) genes play an important role in the circadian clock, which ensures regular development through complicated time-keeping mechanisms. However, the specific biological and functional roles of each COL transcription factor gene in the radish remain unknown. In this study, we performed a genome-wide identification of COL genes in the radish genome of three cultivars including 'Aokubr, `kazusa' and WK10039', and we analyzed their exon-intron structure, gene phylogeny and synteny, and expression levels in different tissues. The bioinformatics analysis identified 20 COL transcription factors in the radish genome, which were divided into three subgroups (Group I to Group III). RsaCOL-09 and RsaCOL-12 might be tandem duplicated genes, whereas the others may have resulted from segmental duplication. The Ka/Ks ratio indicated that all the COL genes in radish, Arabidopsis, Brassica rapa, Brassica oleracea, Capsella rubella and rice were under purifying selection. We identified 6 orthologous and 19 co-orthologous COL gene pairs between the radish and Arabidopsis, and we constructed an interaction network among these gene pairs. The expression values for each COL gene during vegetable and flower development showed that the majority of Group I members had similar expression patterns. In general, the expression of radish COL genes in Groups I and III decreased during development, whereas the expression of radish COL genes in Group II first increased and then decreased. Substantial numbers of radish COL genes were differentially expressed after vernalization treatment. The expression levels of RsaCOL-02 and RsaCOL-04 were significantly increased during vernalization treatment, while the expression of RsaCOL-10 was significantly decreased. These outcomes provide insights for improving the genetic control of bolting and flowering in radish and other root vegetable crops, and they facilitate genetic improvements to radish yields and quality.	[Hu, Tianhua; Wei, Qingzhen; Wang, Wuhong; Hu, Haijiao; Mao, Weihai; Zhu, Qinmei; Bao, Chonglai] Zhejiang Acad Agr Sci, Inst Vegetable, Hangzhou, Zhejiang, Peoples R China	Zhejiang Academy of Agricultural Sciences	Bao, CL (corresponding author), Zhejiang Acad Agr Sci, Inst Vegetable, Hangzhou, Zhejiang, Peoples R China.	baocl@mail.zaas.ac.cn		Bao, Chonglai/0000-0003-1295-4381; Wei, QingZhen/0000-0002-7928-4741	National technology system of commodity vegetable industry-radish [CARS-23-A-14]; New variety breeding project of the Major Science and Technology Projects of Zhejiang [2016C02051-2-1]	National technology system of commodity vegetable industry-radish; New variety breeding project of the Major Science and Technology Projects of Zhejiang	This study was funded by the National technology system of commodity vegetable industry-radish (CARS-23-A-14), and New variety breeding project of the Major Science and Technology Projects of Zhejiang (2016C02051-2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amasino RM, 2010, PLANT PHYSIOL, V154, P516, DOI 10.1104/pp.110.161653; An HL, 2004, DEVELOPMENT, V131, P3615, DOI 10.1242/dev.01231; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Beilstein MA, 2010, P NATL ACAD SCI USA, V107, P18724, DOI 10.1073/pnas.0909766107; Blake JA, 2013, NUCLEIC ACIDS RES, V41, pD530, DOI 10.1093/nar/gks1050; Borden KLB, 2000, J MOL BIOL, V295, P1103, DOI 10.1006/jmbi.1999.3429; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Cheng XF, 2005, PLANT J, V43, P758, DOI 10.1111/j.1365-313X.2005.02491.x; Cockram J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045307; Couvreur TLP, 2010, MOL BIOL EVOL, V27, P55, DOI 10.1093/molbev/msp202; Curtis IS, 2003, TRENDS PLANT SCI, V8, P305, DOI 10.1016/S1360-1385(03)00127-4; Curtis IS, 2002, TRANSGENIC RES, V11, P249, DOI 10.1023/A:1015655606996; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; FITCH WM, 1970, SYST ZOOL, V19, P99, DOI 10.2307/2412448; Fornara Fabio, 2010, Cell, V141, DOI 10.1016/j.cell.2010.04.024; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Griffiths S, 2003, PLANT PHYSIOL, V131, P1855, DOI 10.1104/pp.102.016188; Hassidim M, 2009, PLANTA, V230, P481, DOI 10.1007/s00425-009-0958-7; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; Jeong YM, 2016, THEOR APPL GENET, V129, P1357, DOI 10.1007/s00122-016-2708-0; Jeong YM, 2014, THEOR APPL GENET, V127, P1975, DOI 10.1007/s00122-014-2354-3; Jin JP, 2014, NUCLEIC ACIDS RES, V42, pD1182, DOI 10.1093/nar/gkt1016; Karanja BK, 2017, PLANT CELL REP, V36, P1757, DOI 10.1007/s00299-017-2190-4; Khanna R, 2009, PLANT CELL, V21, P3416, DOI 10.1105/tpc.109.069088; Kitashiba H, 2014, DNA RES, V21, P481, DOI 10.1093/dnares/dsu014; Koch MA, 2000, MOL BIOL EVOL, V17, P1483, DOI 10.1093/oxfordjournals.molbev.a026248; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee J, 2010, J EXP BOT, V61, P2247, DOI 10.1093/jxb/erq098; Li C, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fols.2016.01390; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liu C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177594; Mei SY, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010042; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Mitsui Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep10835; Moghe GD, 2014, PLANT CELL, V26, P1925, DOI [1, 10.1105/tpc.114.124297]; Moon J, 2005, PLANT CELL PHYSIOL, V46, P292, DOI 10.1093/pcp/pci024; Nie SS, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00682; Nie SS, 2015, SCI REP-UK, V5, DOI 10.1038/srep14034; Nystedt B, 2013, NATURE, V497, P579, DOI 10.1038/nature12211; Parcy F, 2005, INT J DEV BIOL, V49, P585, DOI 10.1387/ijdb.041930fp; Preuss SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030717; PUTTERILL J, 1995, CELL, V80, P847, DOI 10.1016/0092-8674(95)90288-0; Robson F, 2001, PLANT J, V28, P619, DOI 10.1046/j.1365-313x.2001.01163.x; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Schultz TF, 2001, PLANT CELL, V13, P2659, DOI 10.1105/tpc.13.12.2659; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Song XM, 2015, SCI REP-UK, V5, DOI 10.1038/srep14631; Srikanth A, 2011, CELL MOL LIFE SCI, V68, P2013, DOI 10.1007/s00018-011-0673-y; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Town CD, 2006, PLANT CELL, V18, P1348, DOI 10.1105/tpc.106.041665; Tripathi P, 2017, P NATL ACAD SCI USA, V114, P172, DOI 10.1073/pnas.1616459114; Wang K, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav023; Wang SF, 2012, PLANT CELL REP, V31, P1437, DOI 10.1007/s00299-012-1259-3; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wang Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-836; Wang Y, 2013, ELECTROCHIM ACTA, V102, P1, DOI 10.1016/j.electacta.2013.03.178; Wu WX, 2017, PLANT SCI, V260, P60, DOI 10.1016/j.plantsci.2017.04.004; Xu L, 2015, PLANT SCI, V236, P313, DOI 10.1016/j.plantsci.2015.04.015; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang Z, 2012, BIOCHEM BIOPH RES CO, V419, P779, DOI 10.1016/j.bbrc.2012.02.101; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P173, DOI 10.1016/S1672-0229(06)60030-2; Zobell O, 2005, PLANT BIOLOGY, V7, P266, DOI 10.1055/s-2005-865621	67	13	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2018	13	9							e0204137	10.1371/journal.pone.0204137	http://dx.doi.org/10.1371/journal.pone.0204137			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3MI	30248137	Green Submitted, Green Published, gold			2022-12-26	WOS:000445998100024
J	Agrawal, A; Rathor, R; Kumar, R; Suryakumar, G; Ganju, L				Agrawal, Akanksha; Rathor, Richa; Kumar, Ravi; Suryakumar, Geetha; Ganju, Lilly			Role of altered proteostasis network in chronic hypobaric hypoxia induced skeletal muscle atrophy	PLOS ONE			English	Article							OXIDATIVELY MODIFIED PROTEINS; ER STRESS; PROTEASOME PATHWAY; CANCER CACHEXIA; SOLEUS MUSCLE; DISEASE; HYPERTROPHY; PROTEOLYSIS; ACTIVATION; STRATEGIES	Background High altitude associated hypobaric hypoxia is one of the cellular and environmental perturbation that alters proteostasis network and push the healthy cell towards loss of muscle mass. The present study has elucidated the robust proteostasis network and signaling mechanism for skeletal muscle atrophy under chronic hypobaric hypoxia (CHH). Methods Male Sprague Dawley rats were exposed to simulated hypoxia equivalent to a pressure of 282 torr for different durations (1, 3, 7 and 14 days). After CHH exposure, skeletal muscle tissue was excised from the hind limb of rats for biochemical analysis. Results Chronic hypobaric hypoxia caused a substantial increase in protein oxidation and exhibited a greater activation of ER chaperones, glucose-regulated protein-78 (GRP-78) and protein disulphide isomerase (PDI) till 14d of CHH. Presence of oxidized proteins triggered the proteolytic systems, 20S proteasome and calpain pathway which were accompanied by a marked increase in [Ca2+]. Upregulated Akt pathway was observed upto 07d of CHH which was also linked with enhanced glycogen synthase kinase-3 beta (GSk-3 beta) expression, a negative regulator of Akt. Muscle-derived cytokines, tumor necrosis factor-alpha (TNF-alpha), interferon-gamma (IFN-(C)) and interleukin-1 beta (IL-1 beta) levels significantly increased from 07d onwards. CHH exposure also upregulated the expression of nuclear factor kappa-B (NF-kappa B) and E3 ligase, muscle atrophy F-box-1 (Mafbx-1/Atrogin-1) and MuRF-1 (muscle ring finger-1) on 07d and 14d. Further, severe hypoxia also lead to increase expression of ER-associated degradation (ERAD) CHOP/ GADD153, Ub-proteasome and apoptosis pathway. Conclusions The disrupted proteostasis network was tightly coupled to degradative pathways, altered anabolic signaling, inflammation, and apoptosis under chronic hypoxia. Severe and prolonged hypoxia exposure affected the protein homeostasis which overwhelms the muscular system and tends towards skeletal muscle atrophy.	[Agrawal, Akanksha; Rathor, Richa; Kumar, Ravi; Suryakumar, Geetha; Ganju, Lilly] Def Inst Physiol & Allied Sci, Delhi, India	Defence Research & Development Organisation (DRDO); Defence Institute of Physiology & Allied Sciences (DIPAS)	Rathor, R (corresponding author), Def Inst Physiol & Allied Sci, Delhi, India.	richa110in@dipas.drdo.in	Agrawal, Akanksha/AAH-2871-2022; Suryakumar, Geetha/GRX-6469-2022; Agrawal, Akanksha/AFM-0501-2022	Agrawal, Akanksha/0000-0003-2564-4999	Defence Research and Development Organization (DRDO), Ministry of Defence, India; DRDO	Defence Research and Development Organization (DRDO), Ministry of Defence, India; DRDO(Defence Research & Development Organisation (DRDO))	The work was funded by the Defence Research and Development Organization (DRDO), Ministry of Defence, India.; The authors are thankful to Dr Bhuvnesh Kumar, Director, DIPAS for his constant support and encouragement. This study was fully funded by the Defence R&D Organization, Ministry of Defence, Govt of India. One of the authors, Ms. Akanksha Agrawal is thankful for obtaining Senior Research Fellowship from DRDO.	Agrawal A, 2017, CELL STRESS CHAPERON, V22, P429, DOI 10.1007/s12192-017-0795-8; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bharadwaj H, 2000, DEFENCE SCI J, V50, P167, DOI 10.14429/dsj.50.3421; Bohnert KR, 2016, FASEB J, V30, P3053, DOI 10.1096/fj.201600250RR; Bowen TS, 2015, J CACHEXIA SARCOPENI, V6, P197, DOI 10.1002/jcsm.12043; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruno A, 2016, BBA-MOL BASIS DIS, V1862, P2023, DOI [10.1016/j.bbadis.2016.08.005, DOI 10.1016/J.BBADIS.2016.08.005]; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Chaillou T, 2014, PFLUG ARCH EUR J PHY, V466, P587, DOI 10.1007/s00424-013-1336-7; Chaudhary P, 2012, MOL CELL BIOCHEM, V364, P101, DOI 10.1007/s11010-011-1210-x; Dodson S, 2011, ANNU REV MED, V62, P265, DOI 10.1146/annurev-med-061509-131248; Dudek EJ, 2005, FASEB J, V19, P1707, DOI 10.1096/fj.05-4049fje; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Fareed MU, 2006, AM J PHYSIOL-REG I, V290, pR1589, DOI 10.1152/ajpregu.00668.2005; Fedorova M, 2014, MASS SPECTROM REV, V33, P79, DOI 10.1002/mas.21381; Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018; Guo YT, 2013, AM J RESP CRIT CARE, V188, P1313, DOI 10.1164/rccm.201304-0732OC; Hepple RT, 2008, AM J PHYSIOL-REG I, V295, pR1231, DOI 10.1152/ajpregu.90478.2008; Hoppeler H, 2008, SCAND J MED SCI SPOR, V18, P38, DOI 10.1111/j.1600-0838.2008.00831.x; Hoppeler H, 2001, J EXP BIOL, V204, P3133; Hsu SW, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-016-1524-z; Jackman RW, 2004, AM J PHYSIOL-CELL PH, V287, pC834, DOI 10.1152/ajpcell.00579.2003; Jain K, 2013, INT J CARDIOL, V168, P4667, DOI 10.1016/j.ijcard.2013.07.180; Leeuwenburgh C, 2005, AM J PHYSIOL-REG I, V288, pR1288, DOI 10.1152/ajpregu.00576.2004; Leger B, 2006, J PHYSIOL-LONDON, V576, P923, DOI 10.1113/jphysiol.2006.116715; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; Levine RL, 2002, FREE RADICAL BIO MED, V32, P790, DOI 10.1016/S0891-5849(02)00765-7; Li SY, 2004, J BIOL CHEM, V279, P11244, DOI 10.1074/jbc.M308011200; Magalhaes J, 2004, AVIAT SPACE ENVIR MD, V75, P16; Mastrocola R, 2008, FREE RADICAL BIO MED, V44, P584, DOI 10.1016/j.freeradbiomed.2007.10.047; Mathieu-Costello O, 2001, HIGH ALT MED BIOL, V2, P413, DOI 10.1089/15270290152608598; Meder W, 1997, N-S ARCH PHARMACOL, V356, P797, DOI 10.1007/PL00005120; Menconi MJ, 2004, SURGERY, V136, P135, DOI 10.1016/j.surg.2004.03.014; Murton AJ, 2008, BBA-MOL BASIS DIS, V1782, P730, DOI 10.1016/j.bbadis.2008.10.011; Oishi Y, 2008, ACTA PHYSIOL, V192, P381, DOI 10.1111/j.1748-1716.2007.01747.x; Puig-Vilanova E, 2015, CLIN SCI, V128, P905, DOI 10.1042/CS20140428; Reid MB, 2014, J PHYSIOL-LONDON, V592, P5345, DOI 10.1113/jphysiol.2014.279406; Snel B, 2000, NUCLEIC ACIDS RES, V28, P3442, DOI 10.1093/nar/28.18.3442; Song TT, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0528-4; Stadtman ER, 1997, CHEM RES TOXICOL, V10, P485, DOI 10.1021/tx960133r; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Takano K, 2010, SCIENCE, V330, P1536, DOI 10.1126/science.1197767; Tutdibi O, 1999, J PHYSIOL-LONDON, V515, P859, DOI 10.1111/j.1469-7793.1999.859ab.x; Wang M, 2014, NAT REV CANCER, V14, P581, DOI 10.1038/nrc3800; WitkoSarsat V, 1996, KIDNEY INT, V49, P1304, DOI 10.1038/ki.1996.186; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840	47	19	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2018	13	9							e0204283	10.1371/journal.pone.0204283	http://dx.doi.org/10.1371/journal.pone.0204283			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU5MM	30240405	Green Submitted, gold, Green Published			2022-12-26	WOS:000445329700038
J	Elchinova, E; Teubel, I; Roura, S; Fernandez, MA; Lupon, J; Galvez-Monton, C; de Antonio, M; Moliner, P; Domingo, M; Zamora, E; Nunez, J; Cediel, G; Bayes-Genis, A				Elchinova, Elena; Teubel, Iris; Roura, Santiago; Fernandez, Marco A.; Lupon, Josep; Galvez-Monton, Carolina; de Antonio, Marta; Moliner, Pedro; Domingo, Mar; Zamora, Elisabet; Nunez, Julio; Cediel, German; Bayes-Genis, Antoni			Circulating monocyte subsets and heart failure prognosis	PLOS ONE			English	Article							CD14(++)CD16(+) MONOCYTES; CD14++CD16+ MONOCYTES; BIOMARKERS; MORTALITY	Monocytes are a heterogeneous population of effector cells with key roles in tissue integrity restoration and maintenance. Here, we explore the association of monocyte subsets and prognosis in patients with ambulatory heart failure (HF). Monocyte subsets were classified as classical (CD14(++)/CD16(-)), intermediate (CD14(++)/CD16(+)), or non-classical (CD14(+)/CD16(++)). Percentage distribution and absolute cell count were assessed in each subset, and multivariable Cox regression analyses were performed with all-cause death, HF-related hospitalization, and the composite end-point of both as dependent variables. 400 patients were consecutively included (72.8% male, age 69.4 +/- 12.2 years, 45.5% from ischemic aetiology, left ventricle ejection fraction (LVEF) 41.6% +/- 14.5, New York Heart Association (NYHA) class II 62.8% and III 30.8%). During a mean follow-up of 2.6 +/- 0.9 years, 107 patients died, 99 had a HF-related hospitalization and 160 suffered the composite end-point of all-cause death or HF-related hospitalization. Monocyte subsets assessed in percentages were not independently associated to any of the end-points. When considering number of cells/mu L, intermediate subset was independently associated with an increase of all-cause death (HR 1.25 [95% CI 1,02-1.52], p = 0.03), and the composite end-point HR 1.20 [95% CI 1,03-1.40], p = 0.02). The presented findings show that absolute cell count of monocyte subsets was preferred over monocyte percentage for prognosis stratification for outpatients with HF. The intermediate monocyte subset provides information on increased risk of allcause death and the composite end-point.	[Elchinova, Elena; Lupon, Josep; de Antonio, Marta; Moliner, Pedro; Domingo, Mar; Zamora, Elisabet; Cediel, German; Bayes-Genis, Antoni] Germans Trias & Pujol Univ Hosp, Heart Failure Unit, Badalona, Spain; [Elchinova, Elena; Lupon, Josep; de Antonio, Marta; Moliner, Pedro; Domingo, Mar; Zamora, Elisabet; Cediel, German; Bayes-Genis, Antoni] Germans Trias & Pujol Univ Hosp, Cardiol Serv, Badalona, Spain; [Elchinova, Elena; Lupon, Josep; Zamora, Elisabet; Bayes-Genis, Antoni] Univ Autonoma Barcelona, Dept Med, Barcelona, Spain; [Elchinova, Elena] Univ Hosp, Inselspital, Bern, Switzerland; [Teubel, Iris; Fernandez, Marco A.] Germans Trias & Pujol Hlth Sci Res Inst, Flow Cytometry Facil, Badalona, Spain; [Roura, Santiago; Lupon, Josep; Galvez-Monton, Carolina; de Antonio, Marta; Zamora, Elisabet; Nunez, Julio; Bayes-Genis, Antoni] Inst Salud Carlos III, CIBERCV, Madrid, Spain; [Roura, Santiago; Galvez-Monton, Carolina; Bayes-Genis, Antoni] Germans Trias & Pujol Hlth Sci Res Inst, ICREC Res Program, Badalona, Spain; [Nunez, Julio] Univ Valencia, Hosp Clin Univ, Cardiol Dept, INCLIVA, Valencia, Spain	Autonomous University of Barcelona; University of Bern; University Hospital of Bern; CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Instituto de Salud Carlos III; University of Valencia	Bayes-Genis, A (corresponding author), Germans Trias & Pujol Univ Hosp, Heart Failure Unit, Badalona, Spain.; Bayes-Genis, A (corresponding author), Germans Trias & Pujol Univ Hosp, Cardiol Serv, Badalona, Spain.; Bayes-Genis, A (corresponding author), Univ Autonoma Barcelona, Dept Med, Barcelona, Spain.; Bayes-Genis, A (corresponding author), Inst Salud Carlos III, CIBERCV, Madrid, Spain.; Bayes-Genis, A (corresponding author), Germans Trias & Pujol Hlth Sci Res Inst, ICREC Res Program, Badalona, Spain.	abayesgenis@gmail.com	de A F, Marta/AAL-3341-2020; Fernandez, Marco/R-3964-2019; Galvez-Monton, Carolina/K-4480-2014; Cediel, Germán/ABB-8722-2021; Bayes-Genis, Antonio/AAV-9422-2021	de A F, Marta/0000-0002-4319-797X; Fernandez, Marco/0000-0002-3921-2209; Galvez-Monton, Carolina/0000-0003-2254-9371; Bayes-Genis, Antonio/0000-0002-3044-197X; Domingo, Mar/0000-0002-2935-1272; Nunez, Julio/0000-0003-1672-7119; Roura, Santiago/0000-0003-4063-9661; Moliner Borja, Pedro/0000-0002-5511-8597; Lupon, Josep/0000-0002-5601-9611	Ministerio de Economia, lndustria y Com petitividad [SAF2017-84324-C2-1-R]; Fundacio La MARATO de TV3 [201502, 201516]; GIBER Cardiovascular [CB16/11/00403]; Red de Terapia Celular TerCel [RD16/ 0011/0006]; AdvanceCa of ACCIO [Catalonia Trade Investment; Generalitat de Catalunya] under the Catalonian ERDF [European Regional Development Fund] operational program (2014-2020); Fundacio Bancaria La Caixa, and Fondo de Investigacion Sanitaria, Institute de Salud Carlos III [FIS PI17/01487]; Plan Nacional de I+D+I	Ministerio de Economia, lndustria y Com petitividad; Fundacio La MARATO de TV3; GIBER Cardiovascular; Red de Terapia Celular TerCel; AdvanceCa of ACCIO [Catalonia Trade Investment; Generalitat de Catalunya] under the Catalonian ERDF [European Regional Development Fund] operational program (2014-2020); Fundacio Bancaria La Caixa, and Fondo de Investigacion Sanitaria, Institute de Salud Carlos III; Plan Nacional de I+D+I	This work was supported by grants from the Ministerio de Economia, lndustria y Com petitividad (SAF2017-84324-C2-1-R to ABG), Fundacio La MARATO de TV3 (201502 to ABG, 201516), GIBER Cardiovascular (CB16/11/00403 to ABG), Red de Terapia Celular TerCel (RD16/ 0011/0006 to ABG), AdvanceCat with the support of ACCIO [Catalonia Trade & Investment; Generalitat de Catalunya] under the Catalonian ERDF [European Regional Development Fund] operational program (2014-2020), the Fundacio Bancaria La Caixa, and Fondo de Investigacion Sanitaria, Institute de Salud Carlos III (FIS PI17/01487 to JL) as part of the Plan Nacional de I+D+I cofounded by ISCIII-Sudireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barisione C, 2010, DIS MARKERS, V28, P115, DOI [10.1155/2010/236405, 10.3233/DMA-2010-0691]; Barnett D, 1999, CLIN LAB HAEMATOL, V21, P301, DOI 10.1046/j.1365-2257.1999.00253.x; Bouvy ML, 2003, HEART, V89, P605, DOI 10.1136/heart.89.6.605; Brando B, 2000, CYTOMETRY, V42, P327, DOI 10.1002/1097-0320(20001215)42:6<327::AID-CYTO1000>3.0.CO;2-F; Braunwald E, 2008, NEW ENGL J MED, V358, P2148, DOI 10.1056/NEJMra0800239; Chow SL, 2017, CIRCULATION, V135, pE1054, DOI 10.1161/CIR.0000000000000490; Connaughton EP, 2018, IMMUNOL CELL BIOL, V96, P742, DOI 10.1111/imcb.12032; Correale M, 2018, HEART FAIL REV, V23, P237, DOI 10.1007/s10741-018-9683-2; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; Gainaru G, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-1977-1; Gastelurrutia P, 2012, MAYO CLIN PROC, V87, P555, DOI 10.1016/j.mayocp.2012.02.018; General Assembly of the World Medical Association, 2014, J Am Coll Dent, V81, P14; Gerszten RE, 2012, NEW ENGL J MED, V366, P1734, DOI 10.1056/NEJMcibr1200164; Levy WC, 2006, CIRCULATION, V113, P1424, DOI 10.1161/CIRCULATIONAHA.105.584102; Mandl M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112140; Neuser J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183670; Pocock SJ, 2006, EUR HEART J, V27, P65, DOI 10.1093/eurheartj/ehi555; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Rogacev KS, 2014, ARTERIOSCL THROM VAS, V34, P2120, DOI 10.1161/ATVBAHA.114.304172; Rogacev KS, 2012, J AM COLL CARDIOL, V60, P1512, DOI 10.1016/j.jacc.2012.07.019; Rogacev KS, 2011, EUR HEART J, V32, P84, DOI 10.1093/eurheartj/ehq371; Roura S, 2016, LAB INVEST, V96, P1223, DOI 10.1038/labinvest.2016.100; Tapp LD, 2012, J THROMB HAEMOST, V10, P1231, DOI 10.1111/j.1538-7836.2011.04603.x; Vanhems P, 1996, INT J STD AIDS, V7, P495, DOI 10.1258/0956462961918572; Wong KL, 2012, IMMUNOL RES, V53, P41, DOI 10.1007/s12026-012-8297-3; Wrigley BJ, 2013, EUR J CLIN INVEST, V43, P121, DOI 10.1111/eci.12023; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Yang MX, 2012, INFLAMMATION, V35, P388, DOI 10.1007/s10753-011-9374-9; Zamora E, 2012, J AM COLL CARDIOL, V59, P1709, DOI 10.1016/j.jacc.2011.11.066; Zawada AM, 2012, IMMUNOBIOLOGY, V217, P1273, DOI 10.1016/j.imbio.2012.07.001; Zawada AM, 2011, BLOOD, V118, pE50, DOI 10.1182/blood-2011-01-326827; Zeng S, 2018, J CARDIOVASC TRANSL, V11, P22, DOI 10.1007/s12265-017-9782-9; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	34	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2018	13	9							e0204074	10.1371/journal.pone.0204074	http://dx.doi.org/10.1371/journal.pone.0204074			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU5MM	30240448	Green Published, Green Submitted, gold			2022-12-26	WOS:000445329700023
J	Riang'a, RM; Nangulu, AK; Broerse, JEW				Riang'a, Roselyter Monchari; Nangulu, Anne Kisaka; Broerse, Jacqueline E. W.			"I should have started earlier, but I was not feeling ill!" Perceptions of Kalenjin women on antenatal care and its implications on initial access and differentials in patterns of antenatal care utilization in rural Uasin Gishu County Kenya	PLOS ONE			English	Article							DETERMINANTS; BOOKING	Aim The aim of this study was to explore how Kalenjin women in rural Uasing Gishu County in Kenya perceive antenatal care and how their perceptions impede or motivate earlier access and continuous use of antenatal care services. Methods A study was conducted among 188 pregnant and post-natal mothers seeking care in 23 rural public health facilities. Gestational age at the initial antenatal care booking was established from their medical cards. Further researcher-administered questionnaire with closed and open-ended questions was used. Key informant interviews with traditional birth attendants (n = 6) and maternal and child health nursing officers (n = 6) were also conducted for triangulation. Descriptive statistics were applied using SPSS programme. The interviews of women who gave consent to be audio recorded (n = 52) were transcribed and thematically analysed using MAXQDA program, based on Andersen and Newman's (1973) behavioural model of health services utilization. Results The mean gestational age at booking initial biomedical care was 23.36 weeks. Only 18 patients (10%) booked before 13 weeks and 45% made four or more visits. The main reasons given for early booking were: illness in index pregnancy (42%) checking the foetus position and monitoring foetus progress (7%). The main reasons given for late booking were: no reason (31%), was not feeling sick (16%), fear or shame due to unexpected pregnancy (13%). Almost half of the respondents (44%) used both biomedical and traditional antenatal care services. Main reasons for visiting traditional care were to: check foetus position and reposition it (63%), collect medicinal herbs (31%), relief discomforts through massage (18%). Conclusion Early antenatal care booking is meant for women with unpleasant physical signs and symptoms. Later ANC is meant to check foetus position and reposition it to cephalic presentation and monitor its progress and this is only possible if the foetus is large.	[Riang'a, Roselyter Monchari] Moi Univ, Sch Arts & Social Sci, Dept Sociol & Psychol, Eldoret, Kenya; [Riang'a, Roselyter Monchari; Broerse, Jacqueline E. W.] Vrije Univ Amsterdam, Fac Sci, Athena Inst, Amsterdam, Netherlands; [Nangulu, Anne Kisaka] Commiss Univ Educ, Nairobi, Kenya; [Nangulu, Anne Kisaka] Moi Univ, Sch Arts & Social Sci, Dept Hist, Eldoret, Kenya	Moi University; Vrije Universiteit Amsterdam; Moi University	Riang'a, RM (corresponding author), Moi Univ, Sch Arts & Social Sci, Dept Sociol & Psychol, Eldoret, Kenya.; Riang'a, RM (corresponding author), Vrije Univ Amsterdam, Fac Sci, Athena Inst, Amsterdam, Netherlands.	monchari2002@yahoo.com	Riang'a, Roselyter/AAW-7541-2021		A Sustainable Approach to Livelihood Improvement (ASALI) project	A Sustainable Approach to Livelihood Improvement (ASALI) project	The authors acknowledge the financial support by A Sustainable Approach to Livelihood Improvement (ASALI) project (https://acwfs.vu.nl/en/research/themes/inequality-in-food-security/projects/sustainable-livelihood/index.aspx). ASALI is a joint collaboration project of Moi University Kenya, South Eastern Kenya University (SEKU) and Vrije Universiteit Amsterdam (VU) that is being implemented in Kenya. The project is coordinated by: Prof. Ann Nangulu - Moi University, Prof. Mary Mburu - South Eastern Kenya University, Dr. Denyse Snelder - Vrije Universiteit Amsterdam. The funding was granted to RMR. This financial support proved fundamental to the design of the study, the collection and analysis of data, and the writing of this manuscript. Only one coordinator (Prof. Anne Nangulu) of ASALI project who participated in this study. Prof. Anne Nangulu contributed to design, analysis, supervision, methodology, prove-reading,review, and decision to publish.	Abu-Saad K, 2010, EPIDEMIOL REV, V32, P5, DOI 10.1093/epirev/mxq001; Adekanle DA, 2008, ONLINE J HLTH ALLIED, V7, P1; Amna A., 2015, ISRA MED J, V7, P38; ANDERSEN R, 1973, MILBANK FUND Q, V51, P95, DOI 10.2307/3349613; Banda I., 2012, MED J AUSTRALIA, V39, P29; Blomberg M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005840; Bourbonnais B., 2013, IMPLEMENTING FREE MA; Braun V., 2022, THEMATIC ANAL PRACTI; Brown CA, 2008, BMC PREGNANCY CHILDB, V8, P1, DOI [10.1186/1471-2393-8-1, DOI 10.1186/1471-2393-8-1]; Central Statistical Agency and ICF International, 2012, ETH DEM HLTH SURV, P452; Cheptum J., 2014, Developing Country Studies, V4, P48; Chorongo D, 2016, PAN AFR MED J, V25, DOI 10.11604/pamj.supp.2016.25.2.10520; County Government of Uasin Gishu Department of Health Services, 2013, COUNT HLTH STRAT INV; Ebeigbe P N, 2010, Ghana Med J, V44, P47; Essendi H, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0078-8; Fisher C, 2015, ASSESSING ENHANCING, DOI [10.1207/S1532480XADS0701, DOI 10.1207/S1532480XADS0701]; Floridia M, 2014, HIV CLIN TRIALS, V15, P104, DOI 10.1310/hct1503-104; Government of Uasin Gishu County, 2013, UAS GISH COUNT INT D; Grinnel RM, 2007, SOCIAL WORK RES EVAL; Gross J, 2015, AFR J MIDWIFERY WOME, V9; Gross K, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-16; Helman CG, 2007, CUTURE HLTH ILLINESS; Izugbara CO, 2009, PUBLIC HEALTH REP, V124, P585, DOI 10.1177/003335490912400416; Jebet CJ, 2013, FACTORS CONTRIBUTING; Jebet J, 2015, POOR PREGNANCY OUTCO, P4, DOI [10.12968/ajmw.2012.6.4.183, DOI 10.12968/AJMW.2012.6.4.183]; Kaingu CK, 2011, J ETHNOPHARMACOL, V137, P495, DOI 10.1016/j.jep.2011.05.044; Kanogo Tabitha, 2005, AFRICAN WOMANHOOD CO; Kenya M, 2013, MATERNAL INFANT YOUN; Kenya National Bureau of Statistics, 2014, KEN DEM HLTH SURV 20; Kenya national Bureau of statistics (KNBS) and ICF macro, 2010, KEN DEM HLTH SURV 20; Kisuule I, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-121; Kitui J, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-40; Lincetto O, ANTENATAL CARE, P51; Magadi M, 2000, SOC BIOL, V47, P164; Magadi MA, 2000, SOC SCI MED, V51, P551, DOI 10.1016/S0277-9536(99)00495-5; Mothupi MC, 2014, BMC COMPLEM ALTERN M, P1, DOI [10.1186/1472-6882-14-1, DOI 10.1186/1472-6882-14-1]; Ngom P, 2000, INTRA HOUSEHOLD DECI; Ochako R, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-1; Okunlola M A, 2006, J Obstet Gynaecol, V26, P195, DOI 10.1080/01443610500508220; Olungah CO, 2006, THESIS; Onoh RC, 2012, ANN MED HEALTH SCI R, V2, P169, DOI 10.4103/2141-9248.105666; Pell C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053747; Riang'a RM, 2017, J HEALTH POPUL NUTR, V36, DOI 10.1186/s41043-017-0130-0; Riang'a RM, 2017, J ETHNOBIOL ETHNOMED, V13, DOI 10.1186/s13002-017-0157-8; Rono AK., 2015, THESIS, DOI [10.1007/s13398-014-0173-7.2, DOI 10.1007/S13398-014-0173-7.2]; Ruiz-Canela M, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-2; Severinski NS, 2009, INT J GYNECOL OBSTET, V107, P63, DOI 10.1016/j.ijgo.2009.05.011; Shah AT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170415; van Eijk Anna M, 2006, Reprod Health, V3, P2, DOI 10.1186/1742-4755-3-2; Verschuren P., 2010, DESIGNING RES PROJEC, V2; Villar J, 2001, LANCET, V357, P1551, DOI 10.1016/S0140-6736(00)04722-X	51	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0202895	10.1371/journal.pone.0202895	http://dx.doi.org/10.1371/journal.pone.0202895			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281594	gold, Green Published, Green Submitted			2022-12-26	WOS:000446342400015
J	Oh, WS; Yoon, S; Noh, J; Sohn, J; Kim, C; Heo, J				Oh, Won Seob; Yoon, Sanghyun; Noh, Juhwan; Sohn, Jungwoo; Kim, Changsoo; Heo, Joon			Geographical variations and influential factors in prevalence of cardiometabolic diseases in South Korea	PLOS ONE			English	Article							ENVIRONMENTAL RISK-FACTORS; CANCER INCIDENCE; BLOOD-PRESSURE; LYME-DISEASE; STROKE; ASSOCIATION; POPULATION; MORTALITY	Geographical variations and influential factors of disease prevalence are crucial information enabling optimal allocation of limited medical resources and prioritization of appropriate treatments for each regional unit. The purpose of this study was to explore the geographical variations and influential factors of cardiometabolic disease prevalence with respect to 230 administrative districts in South Korea. Global Moran's I was calculated to determine whether the standardized prevalences of cardiometabolic diseases (hypertension, stroke, and diabetes mellitus) were spatially clustered. The CART algorithm was then applied to generate decision tree models that could extract the diseases' regional influential factors from among 101 demographic, economic, and public health data variables. Finally, the accuracies of the resulting model-hypertension (67.4%), stroke (62.2%), and diabetes mellitus (56.5%)-were assessed by ten-fold cross-validation. Marriage rate was the main determinant of geographic variation in hypertension and stroke prevalence, which has the possibility that married life could have positive effects in lowering disease risks. Additionally, stress-related variables were extracted as factors positively associated with hypertension and stroke. In the opposite way, the wealth status of a region was found to have an influence on the prevalences of stroke and diabetes mellitus. This study suggested a framework for provision of novel insights into the regional characteristics of diseases and the corresponding influential factors. The results of the study are anticipated to provide valuable information for public health practitioners' cost-effective disease management and to facilitate primary intervention and mitigation efforts in response to regional disease outbreaks.	[Oh, Won Seob; Yoon, Sanghyun; Heo, Joon] Yonsei Univ, Coll Engn, Sch Civil & Environm Engn, Seoul, South Korea; [Noh, Juhwan; Sohn, Jungwoo; Kim, Changsoo] Yonsei Univ, Coll Med, Dept Prevent Med, Seoul, South Korea	Yonsei University; Yonsei University; Yonsei University Health System	Heo, J (corresponding author), Yonsei Univ, Coll Engn, Sch Civil & Environm Engn, Seoul, South Korea.	jheo@yonsei.ac.kr	Noh, Juhwan/Q-9902-2019; Heo, Joon/J-8399-2012	Noh, Juhwan/0000-0003-0657-0082; a, gokul/0000-0003-2226-4691; Kim, Changsoo/0000-0002-5940-5649	MOLIT (The Ministry of Land, Infrastructure and Transport), Korea, under the national spatial information research program [18NSIP-B081011-05]; Fire Fighting Safety & 119 Rescue Technology Research and Development Program - National Fire Agency [MPSS-2015-80]	MOLIT (The Ministry of Land, Infrastructure and Transport), Korea, under the national spatial information research program; Fire Fighting Safety & 119 Rescue Technology Research and Development Program - National Fire Agency	This research, 'Geospatial Big Data Management, Analysis and Service Platform Technology Development', was supported by the MOLIT (The Ministry of Land, Infrastructure and Transport), Korea, under the national spatial information research program supervised by the KAIA (Korea Agency for Infrastructure Technology Advancement)"(18NSIP-B081011-05). Also, this research was supported by the Fire Fighting Safety & 119 Rescue Technology Research and Development Program funded by National Fire Agency (MPSS-2015-80).	Al-Ahmadi K, 2013, INT J ENV RES PUB HE, V10, P7207, DOI 10.3390/ijerph10127207; Attig A., 2011, T CASE BASED REASONI, V4, P3; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Chen ZY, 2012, AM J MED, V125, P568, DOI 10.1016/j.amjmed.2011.10.034; Darnaud C, 2015, AM J HYPERTENS, V28, P1257, DOI 10.1093/ajh/hpv025; Engstrom G, 2001, STROKE, V32, P1098, DOI 10.1161/01.STR.32.5.1098; ESRI (Environmental Systems Research Institute), 2016, SPATIAL AUTOCORRELAT; ESRI (Environmental Systems Research Institute), 2016, A Z SCOR; Fowkes FGR, 2013, LANCET, V382, P1329, DOI 10.1016/S0140-6736(13)61249-0; Gehlke CE, 1934, J AM STAT ASSOC, V29, P169, DOI 10.2307/2277827; GLASS GE, 1995, AM J PUBLIC HEALTH, V85, P944, DOI 10.2105/AJPH.85.7.944; Gottlieb DJ, 2005, ARCH INTERN MED, V165, P863, DOI 10.1001/archinte.165.8.863; Gou FX, 2017, INT J BIOMETEOROL, V61, P137, DOI 10.1007/s00484-016-1197-9; Griffith DA, 1987, A PRIMER; Hanchette CL, 2003, HLTH INFORMAT SER, P431; Hassarangsee S, 2015, INT J ENV RES PUB HE, V12, P16005, DOI 10.3390/ijerph121215040; Hay SI, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001413; Khalili H, 2012, GUT, V61, P1686, DOI 10.1136/gutjnl-2011-301574; Kitron U, 1997, AM J EPIDEMIOL, V145, P558, DOI 10.1093/oxfordjournals.aje.a009145; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; KOSIS (Korean Statistical Information Service), 2016, STAT ANN REP; Lee DS, 2009, CAN MED ASSOC J, V181, pE55, DOI 10.1503/cmaj.081629; Li P, 2015, EUR UROL, V67, P1134, DOI 10.1016/j.eururo.2014.11.001; Lipowicz A, 2005, EUR J EPIDEMIOL, V20, P421, DOI 10.1007/s10654-005-1752-x; Longley PA., 2005, GEOGRAPHIC INFORM SY; Madsen KA, 2015, AM J PREV MED, V48, P292, DOI 10.1016/j.amepre.2014.09.033; Ng SC, 2013, GUT, V62, P630, DOI 10.1136/gutjnl-2012-303661; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Pan A, 2011, JAMA-J AM MED ASSOC, V306, P1241, DOI 10.1001/jama.2011.1282; Parrish G B, 2000, PRINCIPLES PRACTICE, V2000, P76; SGIS (Statistical Geographic Information Service), 2016, KOR DISTR MAP; Suzumori N, 2014, PRENATAL DIAG, V34, P1055, DOI 10.1002/pd.4427; Timofeev R., 2004, CLASSIFICATION REGRE, P1; Tomines A, 2014, HEALTH INFORM SER, P329, DOI 10.1007/978-1-4471-4237-9_18; Wang A, 2012, MILBANK Q, V90, P592, DOI 10.1111/j.1468-0009.2012.00675.x; Wang C, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1560-9; Xu M, 2016, EPIDEMIOL INFECT, V144, P940, DOI 10.1017/S095026881500223X; Yun Jeong Mi, 2015, [journal of Korean Society for Geospatial Information Science, 대한공간정보학회지], V23, P77, DOI 10.7319/kogsis.2015.23.3.077; Zhou M, 2014, DIABETES CARE	39	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0205005	10.1371/journal.pone.0205005	http://dx.doi.org/10.1371/journal.pone.0205005			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3QJ	30278073	Green Published, Green Submitted, gold			2022-12-26	WOS:000446010200034
J	Nielsen, SH; Rasmussen, DGK; Brix, S; Fenton, A; Jesky, M; Ferro, CJ; Karsdal, M; Genovese, F; Cocicwell, P				Nielsen, Signe Holm; Rasmussen, Daniel Guldager Kring; Brix, Susanne; Fenton, Anthony; Jesky, Mark; Ferro, Charles J.; Karsdal, Morten; Genovese, Federica; Cocicwell, Paul			A novel biomarker of laminin turnover is associated with disease progression and mortality in chronic kidney disease	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; COLLABORATIVE METAANALYSIS; POPULATION COHORTS; BASEMENT-MEMBRANES; LIGHT-CHAINS; ALBUMINURIA; NEPHROPATHY; PROTEINS	Background Patients with chronic kidney disease (CKD) have increased risk of development of end-stage renal disease (ESRD) and early mortality. Fibrosis is the central pathogenic process in CKD and is caused by dysregulated extracellular matrix (ECM) remodeling. The laminin gamma 1 chain (LAMC1) is a core structural protein present in the basement membrane of several organs, including the kidneys. We hypothesized that dysregulation of LAMC1 remodeling could be associated with a higher risk of adverse clinical outcomes in patients with CKD. Methods A novel immunoassay targeting LG1M, a specific MMP-9-generated neo-epitope fragment of LAMC1, was developed and used to measure the levels of the fragment in urine and serum from 492 patients from the Renal Impairment in Secondary Care (RIISC) study, a prospective cohort of patients with high-risk CKD. Patients were monitored for a median followup time of 3.5 years. Associations between serum and urine LG1M levels and progression of CKD at 12 months were assessed by a multivariable logistic regression model. The association with ESRD or mortality was assessed by Kaplan-Meier survival curves and Cox proportional hazards regression. Results Forty-six (11%) of the 416 patients who reached 12-month follow-up had progression of CKD; during the study follow-up, 125 patients (25.4%) developed ESRD and 71 patients (14.4%) died. Serum and urine levels of LG1 M correlated with baseline eGFR (r = -0.43, p<0.0001 and r = -0.17, p = 0.0002, respectively). Serum levels of LG1M were higher in patients with one-year progression of CKD compared to those who did not progress (p<0.01). Baseline serum levels of LG1 M were associated with development of ESRD (HR 3.2, 95% CI 1.99-5.2 for patients in the highest LG1 M tertile compared to patient in the lowest tertile). Baseline urinary levels of LG1M (uLG1 M) were significantly associated with mortality (HR 5.0, 95% CI 2.8-8.9, p<0.0001 for patients in the highest LG1M tertile compared to patients in the lowest tertile). Urine LG1M was retained in the model for prediction of mortality (HR per standard deviation of uLG1 M: 1.01, 95% CI 1.00-1.02, p = 0.001). Conclusions LG1M, a marker of basement membrane remodeling, is increased in serum and urine of patients with CKD and levels are associated with one-year disease progression, development of ESRD, and mortality.	[Nielsen, Signe Holm; Rasmussen, Daniel Guldager Kring; Karsdal, Morten; Genovese, Federica] Nord Biosci Biomarkers & Res, Herlev, Denmark; [Nielsen, Signe Holm; Brix, Susanne] Tech Univ Denmark, Dept Biotechnol & Biomed, Lyngby, Denmark; [Rasmussen, Daniel Guldager Kring] Univ Southern Denmark, Inst Mol Med Cardiovasc & Renal Res, Inst Clin Res, Odense, Denmark; [Fenton, Anthony; Jesky, Mark; Ferro, Charles J.; Cocicwell, Paul] Queen Elizabeth Hosp, Dept Renal Med, Birmingham, W Midlands, England; [Fenton, Anthony; Ferro, Charles J.; Cocicwell, Paul] Univ Birmingham, Coll Med & Dent Sci, Birmingham, W Midlands, England	Nordic Bioscience; Technical University of Denmark; University of Southern Denmark; University of Birmingham; University of Birmingham	Nielsen, SH (corresponding author), Nord Biosci Biomarkers & Res, Herlev, Denmark.; Nielsen, SH (corresponding author), Tech Univ Denmark, Dept Biotechnol & Biomed, Lyngby, Denmark.	shn@nordicbio.com	ferro, charles/L-7250-2019; Ferro, Charles J./O-8912-2016; Holm, Signe/GLT-8793-2022; Pedersen, Susanne Brix/B-3484-2009	ferro, charles/0000-0003-0577-7081; Ferro, Charles J./0000-0003-0577-7081; Holm, Signe/0000-0002-4612-1014; Pedersen, Susanne Brix/0000-0001-8951-6705; Fenton, Anthony/0000-0003-2665-6924; Karsdal, Morten/0000-0001-5026-8740; Cockwell, Paul/0000-0003-1975-266X	Danish Research Fund (Den Danske Forskningsfond); Binding Site Ltd (Birmingham, UK)	Danish Research Fund (Den Danske Forskningsfond); Binding Site Ltd (Birmingham, UK)	This work was supported by the Danish Research Fund (Den Danske Forskningsfond) to SHN. The Binding Site Ltd (Birmingham, UK) is acknowledged for the funding of the research fellowship of AF. The funder Nordic Bioscience provided support in the form of salaries for authors SHN, DGKR, MK and FGE, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder Binding Site Ltd. provided support in the form of salaries for author AF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This work was supported by the Danish Research Fund (Den Danske Forskningsfond). The Binding Site Ltd (Birmingham, UK) is acknowledged for the funding of the research fellowship of AF.	ABRAHAMSON DR, 1993, KIDNEY INT, V43, P73, DOI 10.1038/ki.1993.13; Altemtam N, 2012, NEPHRON EXTRA, V2, P219, DOI 10.1159/000339645; BOHLE A, 1987, AM J NEPHROL, V7, P421, DOI 10.1159/000167514; Catania JM, 2007, AM J PHYSIOL-RENAL, V292, pF905, DOI 10.1152/ajprenal.00421.2006; Fogo AB, 2007, PEDIATR NEPHROL, V22, P2011, DOI 10.1007/s00467-007-0524-0; Gansevoort RT, 2011, KIDNEY INT, V80, P93, DOI 10.1038/ki.2010.531; Genovese F, 2014, FIBROGENESIS TISSUE, V7, DOI 10.1186/1755-1536-7-4; Gross ML, 2008, SEMIN DIALYSIS, V21, P308, DOI 10.1111/j.1525-139X.2008.00454.x; Henry MD, 1999, CURR OPIN CELL BIOL, V11, P602, DOI 10.1016/S0955-0674(99)00024-1; Herrera G A, 2000, Ann Diagn Pathol, V4, P174; Hutchison CA, 2008, CLIN J AM SOC NEPHRO, V3, P1684, DOI 10.2215/CJN.02290508; Kikkawa Y, 2000, J CELL SCI, V113, P869; Kohfeldt E, 1998, J MOL BIOL, V282, P99, DOI 10.1006/jmbi.1998.2004; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Macy EM, 1997, CLIN CHEM, V43, P52; Malinda KM, 1996, INT J BIOCHEM CELL B, V28, P957, DOI 10.1016/1357-2725(96)00042-8; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Miner JH, 2008, MICROSC RES TECHNIQ, V71, P349, DOI 10.1002/jemt.20563; Montseny JJ, 1998, NEPHROL DIAL TRANSPL, V13, P1438, DOI 10.1093/ndt/13.6.1438; National Institute for Health and Clinical Excellence, 2008, CHRON KIDN DIS EARL; Pote A, 2000, AM J KIDNEY DIS, V36, P735, DOI 10.1053/ajkd.2000.17620; RISDON RA, 1968, LANCET, V2, P363; SANDERS PW, 1992, J CLIN INVEST, V89, P630, DOI 10.1172/JCI115629; Schainuck L I, 1970, Hum Pathol, V1, P631, DOI 10.1016/S0046-8177(70)80061-2; Setty S, 2012, MODERN PATHOL, V25, P859, DOI 10.1038/modpathol.2011.216; Stringer S, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-95; Timpl R, 1996, CURR OPIN CELL BIOL, V8, P618, DOI 10.1016/S0955-0674(96)80102-5; TIMPL R, 1989, EUR J BIOCHEM, V180, P487, DOI 10.1111/j.1432-1033.1989.tb14673.x; Willem M, 2002, DEVELOPMENT, V129, P2711; Yabluchanskiy A, 2013, PHYSIOLOGY, V28, P391, DOI 10.1152/physiol.00029.2013; Zhao Hong, 2013, World J Nephrol, V2, P84, DOI 10.5527/wjn.v2.i3.84	32	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204239	10.1371/journal.pone.0204239	http://dx.doi.org/10.1371/journal.pone.0204239			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273365	Green Published, gold, Green Submitted			2022-12-26	WOS:000446124700016
J	Osorno, T; Arenas, O; Ramirez-Suarez, NJ; Echeverry, FA; Gomez, MD; Nasi, E				Osorno, Tomas; Arenas, Oscar; Ramirez-Suarez, Nelson J.; Echeverry, Fabio A.; del Pilar Gomez, Maria; Nasi, Enrico			Light control of G protein signaling pathways by a novel photopigment	PLOS ONE			English	Article							CILIARY INVERTEBRATE PHOTORECEPTORS; MUSCARINIC ACETYLCHOLINE-RECEPTOR; VISUAL PIGMENT; IN-VIVO; HYPERPOLARIZING PHOTORECEPTORS; COUPLED RECEPTORS; CALCIUM-CHANNELS; CHLORIDE CHANNEL; BOVINE RHODOPSIN; OPTICAL CONTROL	Channelopsins and photo-regulated ion channels make it possible to use light to control electrical activity of cells. This powerful approach has lead to a veritable explosion of applications, though it is limited to changing membrane voltage of the target cells. An enormous potential could be tapped if similar opto-genetic techniques could be extended to the control of chemical signaling pathways. Photopigments from invertebrate photoreceptors are an obvious choice-as they do not bleach upon illumination -however, their functional expression has been problematic. We exploited an unusual opsin, pScop2, recently identified in ciliary photoreceptors of scallop. Phylogenetically, it is closer to vertebrate opsins, and offers the advantage of being a bi-stable photopigment. We inserted its coding sequence and a fluorescent protein reporter into plasmid vectors and demonstrated heterologous expression in various mammalian cell lines. HEK 293 cells were selected as a heterologous system for functional analysis, because wild type cells displayed the largest currents in response to the G-protein activator, GTP-gamma-S. A line of HEK cells stably transfected with pScop2 was generated; after reconstitution of the photopigment with retinal, light responses were obtained in some cells, albeit of modest amplitude. In native photoreceptors pScop2 couples to G(center dot); HEK cells express poorly this G-protein, but have a prominent Gq/PLC pathway linked to internal Ca mobilization. To enhance pScop2 competence to tap into this pathway, we swapped its third intracellular loop-important to confer specificity of interaction between 7TMDRs and G-proteins-with that of a G(q)-linked opsin which we cloned from microvillar photoreceptors present in the same retina. The chimeric construct was evaluated by a Ca fluorescence assay, and was shown to mediate a robust mobilization of internal calcium in response to illumination. The results project pScop2 as a potentially powerful optogenetic tool to control signaling pathways.	[Osorno, Tomas; Arenas, Oscar; Ramirez-Suarez, Nelson J.; Echeverry, Fabio A.; del Pilar Gomez, Maria] Univ Nacl Colombia, Dept Biol, Bogota, Colombia; [del Pilar Gomez, Maria; Nasi, Enrico] Marine Biol Lab, Woods Hole, MA 02543 USA; [Nasi, Enrico] Univ Nacl Colombia, Inst Genet, Bogota, Colombia; [Osorno, Tomas] Harvard Med Sch, Dept Neurobiol, Boston, MA USA; [Arenas, Oscar] Northwestern Univ, Dept Neurosci, Chicago, IL 60611 USA; [Ramirez-Suarez, Nelson J.; Echeverry, Fabio A.] Albert Einstein Coll Med, Dept Neurosci, New York, NY USA	Universidad Nacional de Colombia; Marine Biological Laboratory - Woods Hole; Universidad Nacional de Colombia; Harvard University; Harvard Medical School; Northwestern University; Yeshiva University	Nasi, E (corresponding author), Marine Biol Lab, Woods Hole, MA 02543 USA.; Nasi, E (corresponding author), Univ Nacl Colombia, Inst Genet, Bogota, Colombia.	enasil@unal.edu.co	Echeverry, Fabio/AAS-2830-2021	Echeverry, Fabio/0000-0002-4200-4080; Ramirez, Nelson/0000-0001-7394-860X	Colciencias grant [FP44842-010-2015]; Connecticut Fund for Science	Colciencias grant(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Connecticut Fund for Science	This work was funded by Colciencias grant FP44842-010-2015 and Connecticut Fund for Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRADE R, 1994, METHOD ENZYMOL, V238, P348; Arenas O, 2018, J GEN PHYSIOL, V150, P401, DOI 10.1085/jgp.201711938; Atwood Brady K, 2011, BMC Genomics, V12, P14, DOI 10.1186/1471-2164-12-14; Berndt A, 2014, SCIENCE, V344, P420, DOI 10.1126/science.1252367; BLIN N, 1995, J BIOL CHEM, V270, P17741, DOI 10.1074/jbc.270.30.17741; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; BREITWIESER GE, 1988, J GEN PHYSIOL, V91, P469, DOI 10.1085/jgp.91.4.469; Brydon L, 1999, MOL ENDOCRINOL, V13, P2025, DOI 10.1210/me.13.12.2025; CHAN T, 1992, J BIOL CHEM, V267, P9478; Chen YM, 2003, VISION RES, V43, P3037, DOI 10.1016/j.visres.2003.08.001; Colecraft HM, 2001, J NEUROSCI, V21, P1137; CONE RA, 1967, SCIENCE, V155, P1128, DOI 10.1126/science.155.3766.1128; CORNWALL MC, 1983, J PHYSIOL-LONDON, V340, P307, DOI 10.1113/jphysiol.1983.sp014764; CORNWALL MC, 1983, CELL MOL NEUROBIOL, V3, P311, DOI 10.1007/BF00734713; COTECCHIA S, 1992, J BIOL CHEM, V267, P1633; Gomez MD, 2011, J NEUROSCI, V31, P1811, DOI 10.1523/JNEUROSCI.3320-10.2011; Gomez MD, 2009, J GEN PHYSIOL, V134, P177, DOI 10.1085/jgp.200910214; Erster O, 2010, METHODS MOL BIOL, V634, P157, DOI 10.1007/978-1-60761-652-8_12; FEILER R, 1992, J NEUROSCI, V12, P3862; Francken BJB, 2000, MOL PHARMACOL, V57, P1034; Giesbers ME, 2008, PHOTOCHEM PHOTOBIOL, V84, P990, DOI 10.1111/j.1751-1097.2008.00347.x; Gomez MD, 2005, J BIOL CHEM, V280, P16784, DOI 10.1074/jbc.M414538200; GOMEZ MD, 1995, NEURON, V15, P607, DOI 10.1016/0896-6273(95)90149-3; Gomez MD, 2000, J NEUROSCI, V20, P5254, DOI 10.1523/JNEUROSCI.20-14-05254.2000; Greasley PJ, 2001, J BIOL CHEM, V276, P46485, DOI 10.1074/jbc.M105791200; Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299; HILLMAN P, 1972, SCIENCE, V175, P1486, DOI 10.1126/science.175.4029.1486; HILLMAN P, 1983, PHYSIOL REV, V63, P668, DOI 10.1152/physrev.1983.63.2.668; Horn F, 2000, PROTEINS, V41, P448, DOI 10.1002/1097-0134(20001201)41:4<448::AID-PROT30>3.0.CO;2-C; Hsu SH, 2007, AM J PHYSIOL-ENDOC M, V293, pE1021, DOI 10.1152/ajpendo.00003.2007; Jansen V, 2017, CURR OPIN BIOTECH, V48, P15, DOI 10.1016/j.copbio.2017.02.014; Jiang MS, 2009, NEUROSIGNALS, V17, P23, DOI 10.1159/000186688; KHORANA HG, 1988, P NATL ACAD SCI USA, V85, P7917, DOI 10.1073/pnas.85.21.7917; Kim JM, 2005, BIOCHEMISTRY-US, V44, P2284, DOI 10.1021/bi048328i; Knox BE, 2003, J BIOL CHEM, V278, P40493, DOI 10.1074/jbc.M304567200; Kojima D, 1997, J BIOL CHEM, V272, P22979, DOI 10.1074/jbc.272.37.22979; Koyanagi M, 2002, FEBS LETT, V531, P525, DOI 10.1016/S0014-5793(02)03616-5; Koyanagi M, 2013, P NATL ACAD SCI USA, V110, P4998, DOI 10.1073/pnas.1219416110; Kramarenko II, 2009, BIOCHEM PHARMACOL, V77, P269, DOI 10.1016/j.bcp.2008.09.027; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Levitz J, 2013, NAT NEUROSCI, V16, P507, DOI 10.1038/nn.3346; Luo JS, 2008, MOL PHARMACOL, V74, P338, DOI 10.1124/mol.107.044750; Ma JX, 1999, FEBS LETT, V452, P199, DOI 10.1016/S0014-5793(99)00606-7; McDavid S, 2006, J NEUROSCI, V26, P13373, DOI 10.1523/JNEUROSCI.3332-06.2006; Melyan Z, 2005, NATURE, V433, P741, DOI 10.1038/nature03344; MINKE B, 1975, J COMP PHYSIOL, V98, P345, DOI 10.1007/BF00709805; Mundell SJ, 2000, J BIOL CHEM, V275, P12900, DOI 10.1074/jbc.275.17.12900; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; NOLTE J, 1972, J GEN PHYSIOL, V59, P186, DOI 10.1085/jgp.59.2.186; Oh E, 2010, J BIOL CHEM, V285, P30825, DOI 10.1074/jbc.M110.147298; Parry JWL, 2000, VISION RES, V40, P2241, DOI 10.1016/S0042-6989(00)00101-2; PEPPERBERG DR, 1978, J GEN PHYSIOL, V71, P369, DOI 10.1085/jgp.71.4.369; RASMUSSEN T, 1947, FED PROC, V6, P184; Reiner A, 2013, TRENDS NEUROSCI, V36, P557, DOI 10.1016/j.tins.2013.08.005; Schroder-Lang S, 2007, NAT METHODS, V4, P39, DOI 10.1038/NMETH975; Sexton TJ, 2012, J BIOL CHEM, V287, P20888, DOI 10.1074/jbc.M111.325969; Shcherbakova DM, 2015, ANNU REV BIOCHEM, V84, P519, DOI 10.1146/annurev-biochem-060614-034411; Shichida Y, 2003, PHOTOCH PHOTOBIO SCI, V2, P1237, DOI 10.1039/b300434a; Spoida K, 2016, CURR BIOL, V26, P1206, DOI 10.1016/j.cub.2016.03.007; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; Terakita A, 2002, J BIOL CHEM, V277, P40, DOI 10.1074/jbc.M104960200; Terakita A, 2008, J NEUROCHEM, V105, P883, DOI 10.1111/j.1471-4159.2007.05184.x; Tsukamoto H, 2005, P NATL ACAD SCI USA, V102, P6303, DOI 10.1073/pnas.0500378102; Wietek J, 2014, SCIENCE, V344, P409, DOI 10.1126/science.1249375; Zemelman BV, 2002, NEURON, V33, P15, DOI 10.1016/S0896-6273(01)00574-8; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zheng LL, 2010, J NEUROSCI, V30, P7187, DOI 10.1523/JNEUROSCI.0852-10.2010; ZUKER CS, 1988, CELL, V53, P475, DOI 10.1016/0092-8674(88)90167-5	69	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0205015	10.1371/journal.pone.0205015	http://dx.doi.org/10.1371/journal.pone.0205015			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273391	Green Published, gold, Green Submitted			2022-12-26	WOS:000446124700059
J	Perez, PA; DiPatrizio, NV				Perez, Pedro A.; DiPatrizio, Nicholas, V			Impact of maternal western diet-induced obesity on offspring mortality and peripheral endocannabinoid system in mice	PLOS ONE			English	Article							CANNABINOID RECEPTORS; INSULIN-SECRETION; UNITED-STATES; FOOD; HYPERPHAGIA; PREVALENCE; MECHANISMS; PREGNANCY; GUT; ANTAGONIST	Over two-thirds of adults in the United States are obese or overweight, which is largely due to chronic overconsumption of diets high in fats and sugars (i.e., Western diet). Recent studies reveal that maternal obesity may predispose offspring to development of obesity and other metabolic diseases; however, the molecular underpinnings of these outcomes are largely unknown. The endocannabinoid system is an important signaling pathway that controls feeding behavior and energy homeostasis, and its activity becomes upregulated in the upper small intestinal epithelium of Western diet-induced obese mice, which drives overeating. In the current investigation, we examined the impact of chronic maternal consumption of Western diet on the expression and function of the endocannabinoid system in several peripheral organs important for food intake and energy homeostasis in offspring. Female C57BU6Tac mice were fed a Western diet or low-fat/no-sucrose control chow for 10 weeks, then males were introduced for mating. Dams were maintained on their respective diets through weaning of pups, at which time pups were maintained on low-fat/nosucrose chow for 10 weeks. Neonates born from dams fed Western diet, when compared to those born from mice fed control chow, unexpectedly displayed increases in mortality that occurred exclusively within six days following birth (greater than 50% mortality). Males comprised a larger fraction of surviving offspring from obese dams. Furthermore, surviving offspring displayed transient increases in body mass for first two days post weaning, and no marked changes in feeding patterns and endocannabinoid levels in upper small intestinal epithelium, pancreas, and plasma, or in expression of key endocannabinoid system genes in the upper small intestinal epithelium and pancreas at 10 weeks post-weaning. Collectively, these results suggest that maternal diet composition greatly influences survival of neonate C57BL/6Tac mice, and that surviving offspring from dams chronically fed a Western diet do not display marked changes in body mass, eating patterns, or expression and function of the endocannabinoid system in several peripheral organs important for feeding behavior and energy homeostasis.	[Perez, Pedro A.; DiPatrizio, Nicholas, V] Univ Calif Riverside, Sch Med, Div Biomed Sci, Riverside, CA 92521 USA	University of California System; University of California Riverside	DiPatrizio, NV (corresponding author), Univ Calif Riverside, Sch Med, Div Biomed Sci, Riverside, CA 92521 USA.	ndipatri@ucr.edu	DiPatrizio, NIcholas/AAV-1865-2021	DiPatrizio, NIcholas/0000-0001-8423-0695; Perez, Pedro/0000-0002-2480-552X	National Institutes of Health [DA034009, DK114978]; NATIONAL INSTITUTE ON DRUG ABUSE [R00DA034009] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institutes of Health grants DA034009 and DK114978 to NVD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal P, 2018, CRIT REV CL LAB SCI, V55, P71, DOI 10.1080/10408363.2017.1422109; Almeida MM, 2017, BRIT J NUTR, V118, P788, DOI 10.1017/S0007114517002884; Angelini R, 2017, CANNABIS CANNABINOID, V2, P123, DOI 10.1089/can.2017.0019; Argueta DA, 2017, PHYSIOL BEHAV, V171, P32, DOI 10.1016/j.physbeh.2016.12.044; Arnone M, 1997, PSYCHOPHARMACOLOGY, V132, P104, DOI 10.1007/s002130050326; Bayol SA, 2007, BRIT J NUTR, V98, P843, DOI 10.1017/S0007114507812037; Bermudez-Silva FJ, 2008, DIABETOLOGIA, V51, P476, DOI 10.1007/s00125-007-0890-y; Buchanan TA, 2012, NAT REV ENDOCRINOL, V8, P639, DOI 10.1038/nrendo.2012.96; Cristino L, 2014, BIOFACTORS, V40, P389, DOI 10.1002/biof.1168; De Petrocellis L, 2007, EXP CELL RES, V313, P2993, DOI 10.1016/j.yexcr.2007.05.012; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Di Marzo V, 2005, NAT NEUROSCI, V8, P585, DOI 10.1038/nn1457; DiPatrizio NV, 2016, CANNABIS CANNABINOID, V1, P67, DOI 10.1089/can.2016.0001; DiPatrizio NV, 2015, AM J PHYSIOL-REG I, V309, pR805, DOI 10.1152/ajpregu.00239.2015; DiPatrizio NV, 2015, J CLIN INVEST, V125, P891, DOI 10.1172/JCI76302; DiPatrizio NV, 2013, FASEB J, V27, P2513, DOI 10.1096/fj.13-227587; DiPatrizio NV, 2012, TRENDS NEUROSCI, V35, P403, DOI 10.1016/j.tins.2012.04.006; DiPatrizio NV, 2011, P NATL ACAD SCI USA, V108, P12904, DOI 10.1073/pnas.1104675108; Dotsey E, 2017, SCI REP-UK, V7, DOI 10.1038/srep42584; Elahi MM, 2009, BRIT J NUTR, V102, P514, DOI 10.1017/S000711450820749X; Ferrara A, 2007, DIABETES CARE, V30, pS141, DOI 10.2337/dc07-s206; Fride E, 2001, EUR J PHARMACOL, V419, P207, DOI 10.1016/S0014-2999(01)00953-0; Fryar C.D., 2014, PREVALENCE OVERWEIGH; Hiramatsu L, 2017, PHYSIOL BEHAV, V179, P235, DOI 10.1016/j.physbeh.2017.06.008; Izzo AA, 2010, PHARMACOL THERAPEUT, V126, P21, DOI 10.1016/j.pharmthera.2009.12.005; Izzo AA, 2009, BRIT J PHARMACOL, V158, P451, DOI 10.1111/j.1476-5381.2009.00183.x; Jarbe TUC, 2005, BEHAV PHARMACOL, V16, P373; Juan-Pico P, 2006, CELL CALCIUM, V39, P155, DOI 10.1016/j.ceca.2005.10.005; Kim HY, 2018, MOL ASPECTS MED, DOI [10.1016/j.mam, DOI 10.1016/J.MAM]; Kim W, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002519; Kim W, 2011, DIABETES, V60, P1198, DOI 10.2337/db10-1550; Li C, 2010, ISLETS, V2, P293, DOI 10.4161/isl.2.5.12729; Maccarrone M, 2015, TRENDS PHARMACOL SCI, V36, P277, DOI 10.1016/j.tips.2015.02.008; Malenczyk K, 2015, P NATL ACAD SCI USA, V112, pE6185, DOI 10.1073/pnas.1519040112; Malenczyk K, 2013, J BIOL CHEM, V288, P32685, DOI 10.1074/jbc.M113.478354; Masuyama H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092805; Medina-Remon A, 2018, CRIT REV FOOD SCI, V58, P262, DOI 10.1080/10408398.2016.1158690; Nakata M, 2008, REGUL PEPTIDES, V145, P49, DOI 10.1016/j.regpep.2007.08.009; Nivoit P, 2009, DIABETOLOGIA, V52, P1133, DOI 10.1007/s00125-009-1316-9; Nivoit P, 2017, ESTABLISHED DIET IND, P1432, DOI [10.1017/S0007114517002884, DOI 10.1017/S0007114517002884]; Ogden CL, 2016, JAMA-J AM MED ASSOC, V315, P2292, DOI 10.1001/jama.2016.6361; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Park T, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0751-z; Pertwee RG, 2015, HANDB EXP PHARMACOL, V231, P1, DOI 10.1007/978-3-319-20825-1_1; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Pirkola J, 2010, DIABETES CARE, V33, P1115, DOI 10.2337/dc09-1871; Poti JM, 2014, AM J CLIN NUTR, V99, P162, DOI 10.3945/ajcn.113.071928; Ramirez-Lopez M. T., 2016, FRONT BEHAV NEUROSCI, V10, P1, DOI DOI 10.3389/; Shin H, 2018, J CELL MOL MED, V22, P2337, DOI 10.1111/jcmm.13523; Simon V, 2017, EUR J ENDOCRINOL, V176, pR309, DOI 10.1530/EJE-16-1044; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; Tam J, 2010, J CLIN INVEST, V120, P2953, DOI 10.1172/JCI42551; Ramirez-Lopez MT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165432; Ramirez-Lopez MT, 2016, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00339; Trillou CR, 2003, AM J PHYSIOL-REG I, V284, pR345, DOI 10.1152/ajpregu.00545.2002; Vahratian A, 2009, MATERN CHILD HLTH J, V13, P268, DOI 10.1007/s10995-008-0340-6	56	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0205021	10.1371/journal.pone.0205021	http://dx.doi.org/10.1371/journal.pone.0205021			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273406	Green Published, Green Submitted, gold			2022-12-26	WOS:000446124700061
J	Bartual, AM; Bocci, G; Marini, S; Moonen, AC				Bartual, Agustin M.; Bocci, Gionata; Marini, Simone; Moonen, Anna Camilla			Local and landscape factors affect sunflower pollination in a Mediterranean agroecosystem	PLOS ONE			English	Article							MASS-FLOWERING CROPS; HONEY-BEES; WILD BEES; CONFECTION SUNFLOWERS; INSECT POLLINATION; HELIANTHUS-ANNUUS; SEED YIELD; DIVERSITY; SERVICES; DECLINES	In Europe, the surface devoted to sunflower cultivation has expanded by similar to 26% from 2006 to 2016. Theoretically, this implies an increasing demand for pollinators, while at the same time, scientific reports claim that pollinator communities worldwide are threatened by multiple stressors such as agrochemicals, the loss of suitable habitats and habitat fragmentation. However, the question that arises is whether insect pollination is still relevant for modern sunflower varieties that are often highly self-fertile. Following recent studies which demonstrate that surrounding land use composition may affect ecosystem service provisioning in cropped fields, this study aims at re-examining the pollination status of sunflower while disentangling the effects of local and landscape variables on sunflower seed set and oil content in Central Italy. Commercial cultivars, regardless of their degree of self-fertility, showed increased seed set and oil content when receiving adequate amounts of cross-pollination; oil composition, though, was not affected by cross-pollination events. Honey bees accounted for the vast majority of pollinators ensuring an overall adequate pollination. Sunflower seed set was higher in fields surrounded by landscapes containing a greater abundance of beehives, early flowering crops, urban areas and woody linear elements; conversely, seed set was lower where herbaceous semi-natural habitats dominated the surrounding landscape. This information is necessary for a science-based planning of agricultural policies and shows that, despite the adoption of self-fertile cultivars, sunflower still benefits from insect pollination and land use planning may affect crop productivity.	[Bartual, Agustin M.; Bocci, Gionata; Marini, Simone; Moonen, Anna Camilla] Scuola Super Sant Anna, Inst Life Sci, Pisa, Italy	Scuola Superiore Sant'Anna	Bartual, AM; Marini, S (corresponding author), Scuola Super Sant Anna, Inst Life Sci, Pisa, Italy.	am.bartual@gmail.com; simone.marini@santannapisa.it		Bartual, Agustin M./0000-0002-8089-5822; Marini, Simone/0000-0002-9040-6850; MOONEN, Anna Camilla/0000-0002-4472-1665	European Union's Seventh Framework Programme for research, technological development and demonstration [311879]; International Doctoral Programme in Agrobiodiversity from the Scuola Superiore Sant'Anna, Pisa, Italy	European Union's Seventh Framework Programme for research, technological development and demonstration; International Doctoral Programme in Agrobiodiversity from the Scuola Superiore Sant'Anna, Pisa, Italy	This study was supported by the European Union's Seventh Framework Programme for research, technological development and demonstration [grant number 311879] assigned to ACM; AMB and SM received a PhD grant of the International Doctoral Programme in Agrobiodiversity from the Scuola Superiore Sant'Anna, Pisa, Italy.	Aizen MA, 2008, CURR BIOL, V18, P1572, DOI 10.1016/j.cub.2008.08.066; Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Alberio C, 2016, EUR J AGRON, V73, P25, DOI 10.1016/j.eja.2015.10.003; [Anonymous], 2016, REG TOSC SIST INF TE; Barton K., 2016, MUMIN MULTIMODEL INF; Bartual AM, 2016, THESIS; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Bommarco R, 2012, OECOLOGIA, V169, P1025, DOI 10.1007/s00442-012-2271-6; Breeze TD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082996; Burmistrov AN, 1965, 20 AP INT C AP BUCH, P342; Carvalheiro LG, 2011, ECOL LETT, V14, P251, DOI 10.1111/j.1461-0248.2010.01579.x; Cockerell T. D. A., 1914, Canadian Entomologist, V46; Cong RG, 2014, ECOL ECON, V99, P53, DOI 10.1016/j.ecolecon.2014.01.007; De Costa WAJM, 2005, AGROFOREST SYST, V63, P199, DOI 10.1007/s10457-005-1090-8; DeGrandi-Hoffman G, 2000, J APICULT RES, V39, P37, DOI 10.1080/00218839.2000.11101019; Degrandi-Hoffman G, 2006, ENVIRON ENTOMOL, V35, P1103, DOI 10.1603/0046-225X-35.4.1103; Delaplane K. S., 2000, Crop pollination by bees., DOI 10.1079/9780851994482.0000; Di Pasquale G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072016; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Ekroos J, 2013, LANDSCAPE ECOL, V28, P1283, DOI 10.1007/s10980-013-9864-2; Ellis JD, 2010, J APICULT RES, V49, P134, DOI 10.3896/IBRA.1.49.1.30; Farina WM, 2015, APIDOLOGIE, P161; Food and Agricultural Organization of the United Nations, 2016, FAOSTAT STAT DAT; Fournier DA, 2012, OPTIM METHOD SOFTW, V27, P233, DOI 10.1080/10556788.2011.597854; Frediani D., 1978, Apicoltore Moderno, V69, P109; Frediani D, 1972, S INT AP TOR; Garibaldi LA, 2011, ECOL LETT, V14, P1062, DOI 10.1111/j.1461-0248.2011.01669.x; Garibaldi LA, 2011, P NATL ACAD SCI USA, V108, P5909, DOI 10.1073/pnas.1012431108; Ghazoul J, 2005, TRENDS ECOL EVOL, V20, P367, DOI 10.1016/j.tree.2005.04.026; Goulson D, 2008, ANNU REV ENTOMOL, V53, P191, DOI 10.1146/annurev.ento.53.103106.093454; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; Greenleaf SS, 2006, P NATL ACAD SCI USA, V103, P13890, DOI 10.1073/pnas.0600929103; Hannon LE, 2009, BIOL CONSERV, V142, P2140, DOI 10.1016/j.biocon.2009.04.014; Holland JM, 2017, AGRON SUSTAIN DEV, V37, DOI 10.1007/s13593-017-0434-x; Hurd P.D. Jr, 1980, Smithsonian Contributions to Zoology, P1; Jeanneret P, 2013, REPORT METHODS ASSES; Kennedy CM, 2013, ECOL LETT, V16, P584, DOI 10.1111/ele.12082; King C, 2013, METHODS ECOL EVOL, V4, P811, DOI 10.1111/2041-210X.12074; Klatt BK, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2440; Koh I, 2016, P NATL ACAD SCI USA, V113, P140, DOI 10.1073/pnas.1517685113; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Macchia M, 1974, AGRICOLTURA ITALIANA, V74, P116; MacIvor JS, 2017, APIDOLOGIE, V48, P311, DOI 10.1007/s13592-016-0477-z; Mallinger R, 2017, CROP SCI, V57, P3264, DOI 10.2135/cropsci2017.03.0148; Marrero HJ, 2016, AGR ECOSYST ENVIRON, V218, P28, DOI 10.1016/j.agee.2015.10.024; McGregor S. E., 1976, INSECT POLLINATION C, V496; MILLER JF, 1987, CROP SCI, V27, P923, DOI 10.2135/cropsci1987.0011183X002700050019x; MINCKLEY RL, 1994, ECOLOGY, V75, P1406, DOI 10.2307/1937464; Morrison J, 2017, AGR ECOSYST ENVIRON, V247, P216, DOI 10.1016/j.agee.2017.06.047; National Research Council, 2007, STAT POLL N AM; Nderitu J, 2008, SPAN J AGRIC RES, V6, P271, DOI 10.5424/sjar/2008062-318; PARK MG, 2015, P ROYAL SOC LONDON B, V282, DOI DOI 10.1098/RSPB.2015.0299; PARKER FD, 1981, J APICULT RES, V20, P49, DOI 10.1080/00218839.1981.11100473; Pisanty G, 2014, APIDOLOGIE, V45, P235, DOI 10.1007/s13592-013-0242-5; Pollard E., 1993, MONITORING BUTTERFLI; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Potts SG, 2010, J APICULT RES, V49, P15, DOI 10.3896/IBRA.1.49.1.02; QGIS Development Team, 2016, QGIS GEOGR INF SYST; Quinet M, 2017, EUR J AGRON, V91, P84, DOI 10.1016/j.eja.2017.09.015; R Core Team, 2021, R LANGUAGE ENV STAT; Ricciardelli d'Albore G, 1982, REDIA GIORNALE ZOOLO; Ricciardelli D'albore G, 1976, APICOLTORE MODERNO, P109; Ricketts TH, 2008, ECOL LETT, V11, P499, DOI 10.1111/j.1461-0248.2008.01157.x; Riedinger V, 2014, LANDSCAPE ECOL, V29, P425, DOI 10.1007/s10980-013-9973-y; Rundlof M, 2008, BIOL CONSERV, V141, P417, DOI 10.1016/j.biocon.2007.10.011; Saez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030968; Samnegard U, 2011, BIOL CONSERV, V144, P2602, DOI 10.1016/j.biocon.2011.07.008; Sardinas HS, 2015, AGR ECOSYST ENVIRON, V207, P17, DOI 10.1016/j.agee.2015.03.020; Sarthou JP, 2014, AGR ECOSYST ENVIRON, V194, P17, DOI 10.1016/j.agee.2014.04.018; Scheper J, 2013, ECOL LETT, V16, P912, DOI 10.1111/ele.12128; Schirmel J, 2018, J APPL ECOL, V55, P1747, DOI 10.1111/1365-2664.13095; Skaug H., 2016, GEN LINEAR MIXED MOD; Steffan-Dewenter I, 2005, TRENDS ECOL EVOL, V20, P651, DOI 10.1016/j.tree.2005.09.004; Steffan-Dewenter I, 2003, P ROY SOC B-BIOL SCI, V270, P569, DOI 10.1098/rspb.2002.2292; Tasei JN, 2008, APIDOLOGIE, V39, P397, DOI 10.1051/apido:2008017; Tscharntke T, 2012, BIOL CONSERV, V151, P53, DOI 10.1016/j.biocon.2012.01.068; Vaissiere B.E, 2011, PROTOCOL DETECT ASSE; Westphal C, 2003, ECOL LETT, V6, P961, DOI 10.1046/j.1461-0248.2003.00523.x; Westphal C, 2008, ECOL MONOGR, V78, P653, DOI 10.1890/07-1292.1; Westphal C, 2006, OECOLOGIA, V149, P289, DOI 10.1007/s00442-006-0448-6; Zuur Alain F., 2009, P1	82	9	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0203990	10.1371/journal.pone.0203990	http://dx.doi.org/10.1371/journal.pone.0203990			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30260974	Green Published, gold, Green Submitted			2022-12-26	WOS:000445907400020
J	Bystrom, A; Egenvall, A; Roepstorff, L; Rhodin, M; Braganca, FS; Hernlund, E; van Weeren, R; Weishaupt, MA; Clayton, HM				Bystrom, Anna; Egenvall, Agneta; Roepstorff, Lars; Rhodin, Marie; Braganca, Filipe S.; Hernlund, Elin; van Weeren, Rene; Weishaupt, Michael A.; Clayton, Hilary M.			Biomechanical findings in horses showing asymmetrical vertical excursions of the withers at walk	PLOS ONE			English	Article							COMPENSATORY LOAD REDISTRIBUTION; GROUND REACTION FORCES; HORIZONTAL MOMENT; GAIT ANALYSIS; TREADMILL; LAMENESS; TIME; PREFERENCES; PARAMETERS; PRESSURE	The walk and trot are inherently symmetrical gaits, making them potentially suitable for the detection of left-right asymmetries. The aims of this study were to describe asymmetrical vertical excursions of the withers at walk in non-lame high-level dressage horses and to seek associations between these asymmetric movements and other kinematic variables and vertical ground reaction forces (vGRFs). Seven dressage horses, judged clinically as being sound, walked unridden and unrestrained on a treadmill with an integrated force measuring system (480 Hz), from which spatiotemporal and vGRF variables were extracted. Markers were tracked by 12 infrared cameras (240 Hz). The vertical position of the sixth thoracic vertebra (T6), limb protraction and retraction distances throughout stance, and global limb lengths were determined. Contralateral trial-mean differences were calculated, including difference in T6 minimum vertical position between contralateral steps (T6minDiff). Mixed models were used to study associations between symmetry parameters. Trial-mean T6minDiff ranged between 0.3-23 mm. Of the seven horses, five consistently dropped the withers more in early left forelimb stance, one was fairly symmetrical, and one dropped the withers more in early right forelimb stance. Comparisons between contralateral limbs showed the following associations. The forelimb that was retracted when T6min was lowest showed greater retraction at toe-off (1 mm increase predicted 0.17 mm T6minDiff increase) and shorter stance duration (1 ms decrease predicted 0.3 mm T6minDiff increase). The hind limb that was in midstance when T6min was lowest showed a greater range of motion during the stance phase (1 mm increase in protraction or retraction predicted 0.2 mm T6minDiff increase). The haunches were displaced away from the side of the forelimb that was protracted when T6min was lowest (1 mm lateral shift predicted 0.07 mm T6minDiff increase). Forelimb and hind limb vGRF parameters were non-significant. Asymmetry of vertical withers movement in horses assessed as being sound at trot was related to a complex pattern of asymmetries in spatiotemporal variables throughout the stride cycle rather than to vertical load redistribution between the forelimbs. This suggests that the asymmetry may be due to inherent laterality rather than weight-bearing lameness.	[Bystrom, Anna; Roepstorff, Lars; Rhodin, Marie; Hernlund, Elin] Swedish Univ Agr Sci, Fac Vet Med & Anim Sci, Dept Anat Physiol & Biochem, Uppsala, Sweden; [Egenvall, Agneta; Hernlund, Elin] Swedish Univ Agr Sci, Fac Vet Med & Anim Sci, Dept Clin Sci, Uppsala, Sweden; [Braganca, Filipe S.; van Weeren, Rene] Univ Utrecht, Dept Equine Sci, Fac Vet Med, Utrecht, Netherlands; [Weishaupt, Michael A.] Univ Zurich, Equine Dept, Zurich, Switzerland; [Clayton, Hilary M.] Dept Large Anim Clin Sci, E Lansing, MI USA	Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; Utrecht University; University of Zurich	Egenvall, A (corresponding author), Swedish Univ Agr Sci, Fac Vet Med & Anim Sci, Dept Clin Sci, Uppsala, Sweden.	agneta.egenvall@slu.se	Rhodin, Marie/AAD-7266-2020; Bystrom, Anna/H-1525-2017	Roepstorff, Lars/0000-0002-4109-9284; Clayton, Hilary/0000-0002-8759-0925; Weishaupt, Michael/0000-0001-7314-162X; Rhodin, Marie/0000-0003-0575-2765; Bystrom, Anna/0000-0002-2008-8244; Hernlund, Elin/0000-0002-5769-3958				Bergh A, 2014, COMP EXERC PHYSIOL, V10, P181, DOI 10.3920/CEP143003; Braganca PMS, 2018, VET J, V234, P11, DOI 10.1016/j.tvjl.2018.01.006; CLAYTON H. M., 2004, THE DYNAMIC HORSE; Colborne GR, 2016, NEW ZEAL VET J, V64, P76, DOI 10.1080/00480169.2015.1068138; Colborne GR, 2009, EQUINE VET J, V41, P242, DOI 10.2746/042516409X396993; DREVEMO S, 1987, EQUINE VET J, V19, P189, DOI 10.1111/j.2042-3306.1987.tb01373.x; Dyson S, 2016, J EQUINE VET SCI, V38, P1, DOI 10.1016/j.jevs.2015.12.012; Federation Equestre Internationale, 2018, FEI DRESS RUL; Grzimek B., 1949, Zeitschrift fuer Tierpsychologie Berlin, V6, P406; Heaps LA, 2011, EQUINE VET J, V43, P190, DOI 10.1111/j.2042-3306.2010.00146.x; Ishihara A, 2009, JAVMA-J AM VET MED A, V234, P644, DOI 10.2460/javma.234.5.644; Lucidi P, 2013, PHYSIOL BEHAV, V109, P8, DOI 10.1016/j.physbeh.2012.11.006; Moorman VJ, 2017, J EQUINE VET SCI, V58, P34, DOI 10.1016/j.jevs.2017.08.009; Podhajksy A., 1967, COMPLETE TRAINING HO; Rhodin M, 2018, EQUINE VET J, V50, P818, DOI 10.1111/evj.12844; Rhodin M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176253; Rogers LJ, 2009, PHILOS T R SOC B, V364, P943, DOI 10.1098/rstb.2008.0225; Scott D., TUKEYS LADDER POWERS; Starke SD, 2013, VET J, V197, P245, DOI 10.1016/j.tvjl.2013.03.006; van Heel MCV, 2006, EQUINE VET J, V38, P646, DOI 10.2746/042516406X159070; van Weeren P R, 1990, Equine Vet J Suppl, P101; van Weeren PR, 2017, EQUINE VET J, V49, P567, DOI 10.1111/evj.12715; Waldern NM, 2009, EQUINE VET J, V41, P268, DOI 10.2746/042516409X397389; Weishaupt MA, 2010, EQUINE VET J, V42, P530, DOI 10.1111/j.2042-3306.2010.00190.x; Weishaupt MA, 2006, VET J, V171, P135, DOI 10.1016/j.tvjl.2004.09.004; Weishaupt MA, 2004, EQUINE VET J, V36, P727, DOI 10.2746/0425164044848244; Weishaupt MA, 2004, VET J, V168, P304, DOI 10.1016/j.tvjl.2003.08.007; Weishaupt MA, 2002, AM J VET RES, V63, P520, DOI 10.2460/ajvr.2002.63.520; Wiggers N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114836; Williams DE, 2007, ANIM BEHAV, V74, P941, DOI 10.1016/j.anbehav.2007.01.014	30	17	17	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204548	10.1371/journal.pone.0204548	http://dx.doi.org/10.1371/journal.pone.0204548			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30261019	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000445907400065
J	Kawahara, T; Akiba, I; Sakou, M; Sakaguchi, T; Taniguchi, H				Kawahara, Takayoshi; Akiba, Isamu; Sakou, Megumi; Sakaguchi, Takemasa; Taniguchi, Hatsumi			Inactivation of human and avian influenza viruses by potassium oleate of natural soap component through exothermic interaction	PLOS ONE			English	Article							INFECTION	An influenza epidemic is still a problem despite the development of vaccines and anti-influenza drugs. Preventive measures such as handwashing are fundamental and important for counteracting influenza virus infection. In this study, we clarified the anti-influenza virus effects of surfactants, which are the main components of hand soaps for hand washing: potassium oleate (C18:1), sodium laureth sulfate (LES) and sodium lauryl sulfate (SDS). For a human influenza virus strain (H3N2), C18:1 reduced the infectivity by 4 logs or more, whereas LES and SDS reduced the infectivity by 1 log or less. Similar results were obtained when an avian influenza virus strain (H5N3) was used. The interaction between the surfactant and virus was then investigated by isothermal titration calorimetry. The LES-virus system showed a positive value of enthalpy changes (Delta H), meaning an exothermic interaction that indicated a hydrophobic interaction. In contrast, both the C18:1-virus system and the SDS-virus system showed negative values of Delta H, meaning an endothermic interaction that indicated an electrical interaction. The Delta H value of the C18:1-virus system was much higher than that of the SDS-virus system. A mixture of C18:1 and HA proteins similarly showed negative values of Delta H. These results indicate that influenza virus inactivation by a hydrophobic interaction of a surfactant with the viral envelope is insufficient to prevent infection, whereas inactivation by an electrical interaction of a surfactant with HA proteins is sufficient to prevent influenza virus infection.	[Kawahara, Takayoshi; Taniguchi, Hatsumi] Univ Occupat & Environm Hlth, Dept Microbiol, Kitakyushu, Fukuoka, Japan; [Kawahara, Takayoshi] Shabondama Soap Co Ltd, Res & Dev Dept, Kitakyushu, Fukuoka, Japan; [Akiba, Isamu; Sakou, Megumi] Univ Kitakyushu, Dept Chem & Biochem, Kitakyushu, Fukuoka, Japan; [Sakaguchi, Takemasa] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Virol, Hiroshima, Japan	University of Occupational & Environmental Health - Japan; University of Kitakyushu; Hiroshima University	Kawahara, T (corresponding author), Univ Occupat & Environm Hlth, Dept Microbiol, Kitakyushu, Fukuoka, Japan.; Kawahara, T (corresponding author), Shabondama Soap Co Ltd, Res & Dev Dept, Kitakyushu, Fukuoka, Japan.	kawahara@shabon.com	Sakaguchi, Takemasa/H-1488-2019	Sakaguchi, Takemasa/0000-0002-3754-1252	Shabondama Soap Co., Ltd.	Shabondama Soap Co., Ltd.	The funder (Shabondama Soap Co., Ltd.) provided support in the form of salaries for TK but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ampofo K, 2006, PEDIATRICS, V118, P2409, DOI 10.1542/peds.2006-1475; Arinaminpathy N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015674; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Charbonnier V, 2001, FOOD CHEM TOXICOL, V39, P279, DOI 10.1016/S0278-6915(00)00132-0; de Jonge J, 2006, BBA-BIOMEMBRANES, V1758, P527, DOI 10.1016/j.bbamem.2006.03.011; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Jonges M, 2010, J CLIN MICROBIOL, V48, P928, DOI 10.1128/JCM.02045-09; Kobayashi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040422; Lamb RA, 2001, FIELDS VIROL, V1, P1487; NEBEL S, 1995, BIOCHEMISTRY-US, V34, P5705, DOI 10.1021/bi00017a001; Noma K, 1998, ARCH VIROL, V143, P1893, DOI 10.1007/s007050050428; Ueda K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055343; Wright P.F., 2013, FIELDS VIROLOGY, P1186	13	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204908	10.1371/journal.pone.0204908	http://dx.doi.org/10.1371/journal.pone.0204908			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30261071	gold, Green Submitted, Green Published			2022-12-26	WOS:000445907400113
J	Lewicky, JD; Martel, AL; Fraleigh, NL; Boraman, A; Nguyen, TMD; Schiller, PW; Shiao, TC; Roy, R; Le, HT				Lewicky, Jordan D.; Martel, Alexandrine L.; Fraleigh, Nya L.; Boraman, Amanda; Nguyen, Thi M. -D.; Schiller, Peter W.; Shiao, Tze Chieh; Roy, Rene; Le, Hoang-Thanh			Strengthening peptide-based drug activity with novel glyconanoparticle	PLOS ONE			English	Article							KAPPA-OPIOID RECEPTOR; IN-VITRO; MANNOSYLATED LIPOSOMES; STABILITY; NANOPARTICLES; DELIVERY; ANTAGONISTS; ANALOGS; DESIGN; SYSTEM	The therapeutic application of peptide-based drugs is significantly limited by the rapid proteolytic degradation that occurs when in blood. Encapsulation of these peptide structures within a delivery system, such as liposomes, can greatly improve both stability and target delivery. As part of our work focused on novel ambiphilic mannosylated neoglycolipids as targeted drug delivery systems, we have developed a C14-alkyl-mannopyranoside that forms self-assembled monodisperse liposomes. Herein, these glycoliposomes are investigated as a potential method to improve the plasma stability of peptide-based drugs. Reversed phase high-performance liquid chromatography (RP-HPLC) and mass spectrometry (MS) methods were developed to assess the in vitro plasma stability of two structurally diverse peptides, including the kappa opioid receptor selective antagonist dynantin, and the NOD2 innate immune receptor ligand muramyl dipeptide (MDP). The RP-HPLC methods developed were able to resolve the peptides from background plasma contaminants and provided suitable response levels and linearity over an appropriate concentration range. Both compounds were found to be significantly degraded in rat plasma. Increasing degrees of both entrapment and stabilization were noted when dynantin was combined with the C14(-) alkyl-mannopyranoside in increasing peptide:glycoside ratios. The combination of MDP with the glycolipid also led to peptide entrapment, which greatly improved the plasma stability of the peptide. Overall, the results clearly indicate that the stability of peptide-based structures, which are subject to degradation in plasma, can be greatly improved via entrapment within C14-alkyl-mannopyranoside-bearing glycoliposomes.	[Lewicky, Jordan D.; Martel, Alexandrine L.; Fraleigh, Nya L.; Boraman, Amanda; Le, Hoang-Thanh] Hlth Sci North Res Inst, Sudbury, ON, Canada; [Nguyen, Thi M. -D.; Schiller, Peter W.] Clin Res Inst Montreal, Lab Chem Biol & Peptide Res, Montreal, PQ, Canada; [Schiller, Peter W.] Univ Montreal, Dept Pharmacol & Physiol, Montreal, PQ, Canada; [Shiao, Tze Chieh; Roy, Rene] Glycovax Pharma Inc, Montreal, PQ, Canada; [Le, Hoang-Thanh] Northern Ontario Sch Med, Med Sci Div, Sudbury, ON, Canada; [Le, Hoang-Thanh] Laurentian Univ, Dept Chem & Biochem, Sudbury, ON, Canada; [Le, Hoang-Thanh] Laurentian Univ, Dept Biol, Sudbury, ON, Canada	Health Sciences North; Northern Ontario School of Medicine; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; Northern Ontario School of Medicine; Laurentian University; Laurentian University	Le, HT (corresponding author), Hlth Sci North Res Inst, Sudbury, ON, Canada.; Le, HT (corresponding author), Northern Ontario Sch Med, Med Sci Div, Sudbury, ON, Canada.; Le, HT (corresponding author), Laurentian Univ, Dept Chem & Biochem, Sudbury, ON, Canada.; Le, HT (corresponding author), Laurentian Univ, Dept Biol, Sudbury, ON, Canada.	hle@hsnri.ca			Canadian Institutes of Health Research [PJT-148531]; Northern Cancer Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Northern Cancer Foundation	This work was supported by the Canadian Institutes of Health Research (Project Grant PJT-148531 to HTL) and the Northern Cancer Foundation (2017-2019 to HTL). The funders provided support in the form of salaries for authors [JDL, AM, NF, AB] but did not have any role in study design, data collection and interpretation, or the decision to submit the work for publication. The specific roles of these authors are articulated in the 'author contributions' section.	Ahmad N, 2016, EXPERT OPIN DRUG DEL, V13, P621, DOI 10.1517/17425247.2016.1160889; Albrechtsen NJW, 2015, ENDOCR CONNECT, V4, DOI 10.1530/EC-14-0126; Asthana GS, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/526391; Bottger R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178943; Boge L, 2018, J COLLOID INTERF SCI, V522, P126, DOI 10.1016/j.jcis.2018.03.062; Bruchas MR, 2007, J BIOL CHEM, V282, P29803, DOI 10.1074/jbc.M705540200; Brugos B, 2004, PHARMAZIE, V59, P339; Bruno BJ, 2013, THER DELIV, V4, P1443, DOI [10.4155/TDE.13.104, 10.4155/tde.13.104]; Butelman ER, 2012, TRENDS NEUROSCI, V35, P587, DOI 10.1016/j.tins.2012.05.005; Carrillo-Conde B, 2011, MOL PHARMACEUT, V8, P1877, DOI 10.1021/mp200213r; Carroll FI, 2013, J MED CHEM, V56, P2178, DOI 10.1021/jm301783x; Costa A, 2018, EUR J PHARM SCI, V114, P103, DOI 10.1016/j.ejps.2017.12.006; De Prins A, 2018, EUR J MED CHEM, V144, P887, DOI 10.1016/j.ejmech.2017.12.035; Diao L, 2013, CLIN PHARMACOKINET, V52, P855, DOI 10.1007/s40262-013-0079-0; Dissanayake S, 2017, J CONTROL RELEASE, V250, P62, DOI 10.1016/j.jconrel.2017.02.006; Domhan C, 2018, INT J ANTIMICROB AG, V52, P52, DOI 10.1016/j.ijantimicag.2018.03.023; Domi E, 2018, NEUROPSYCHOPHARMACOL, V43, P1805, DOI 10.1038/s41386-018-0015-y; Dong WB, 2018, EUR J MED CHEM, V150, P546, DOI 10.1016/j.ejmech.2018.03.025; Eley J., 2001, AAPS PHARMSCITECH, V2, P81, DOI DOI 10.1208/PT020319; Erak M, 2018, BIOORGAN MED CHEM, V26, P2759, DOI 10.1016/j.bmc.2018.01.012; Fredholt K, 2000, J CONTROL RELEASE, V63, P261, DOI 10.1016/S0168-3659(99)00196-0; Goyard D, 2016, J MATER CHEM B, V4, P4227, DOI 10.1039/c6tb00344c; Habibi N, 2016, NANO TODAY, V11, P41, DOI 10.1016/j.nantod.2016.02.004; Hamman JH, 2005, BIODRUGS, V19, P165, DOI 10.2165/00063030-200519030-00003; HARRISON J, 1985, INFECT IMMUN, V50, P320, DOI 10.1128/IAI.50.1.320-321.1985; Hayward AR, 2013, PLANT PHYSIOL BIOCH, V64, P84, DOI 10.1016/j.plaphy.2012.12.018; Helal MA, 2017, EUR J MED CHEM, V141, P632, DOI 10.1016/j.ejmech.2017.10.012; Karhu L, 2018, PEPTIDES, V102, P54, DOI 10.1016/j.peptides.2018.02.004; Lai CH, 2016, NANO LETT, V16, P807, DOI 10.1021/acs.nanolett.5b04984; Lalanne L, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00170; Lu YX, 2001, J MED CHEM, V44, P3048, DOI 10.1021/jm0101186; Mangal V, 2016, ANAL BIOANAL CHEM, V408, P1891, DOI 10.1007/s00216-015-9295-9; Mentlein R, 1997, BRAIN RES PROTOC, V1, P237, DOI 10.1016/S1385-299X(96)00035-9; Merhi G, 1996, J MED CHEM, V39, P4483, DOI 10.1021/jm960147u; MEYER JP, 1995, PEPTIDES, V16, P1215, DOI 10.1016/0196-9781(95)02005-H; Muller S, 1996, PHARMAZIE, V51, P581; Niu ZG, 2018, J CONTROL RELEASE, V276, P125, DOI 10.1016/j.jconrel.2018.03.004; Noto PB, 2008, PROTEIN SCI, V17, P1249, DOI 10.1110/ps.034330.108; Ogawa Chikako, 2011, Curr Bioact Compd, V7, P180; PARANT M, 1979, INT J IMMUNOPHARMACO, V1, P35, DOI 10.1016/0192-0561(79)90028-6; Perez-Ortiz M, 2017, COLLOID SURFACE B, V158, P25, DOI 10.1016/j.colsurfb.2017.06.015; POWELL MF, 1993, PHARMACEUT RES, V10, P1268, DOI 10.1023/A:1018953309913; Rader AFB, 2018, BIOORGAN MED CHEM, V26, P2766, DOI 10.1016/j.bmc.2017.08.031; RIVEAU G, 1980, J EXP MED, V152, P869, DOI 10.1084/jem.152.4.869; Ryu J, 2010, BIOTECHNOL BIOENG, V105, P221, DOI 10.1002/bit.22544; SCHWARTZMAN SM, 1980, PREP BIOCHEM, V10, P255, DOI 10.1080/10826068009412828; Stimac A, 2016, INT J PHARMACEUT, V511, P44, DOI 10.1016/j.ijpharm.2016.06.123; Tu ZG, 2007, BIOCHEM BIOPH RES CO, V361, P712, DOI 10.1016/j.bbrc.2007.06.178; Uhlig T., 2014, EUPA OPEN PROTEOMICS, V4, P58, DOI [10.1016/j.euprot.2014.05.003, DOI 10.1016/J.EUPROT.2014.05.003]; Vieira ACC, 2018, ARTIF CELL NANOMED B, V46, pS653, DOI 10.1080/21691401.2018.1434186; Vieira ACC, 2016, INT J NANOMED, V11, P2601, DOI 10.2147/IJN.S104908; Wijagkanalan W, 2008, J CONTROL RELEASE, V125, P121, DOI 10.1016/j.jconrel.2007.10.011; Witoonsaridsilp W, 2012, AAPS PHARMSCITECH, V13, P699, DOI 10.1208/s12249-012-9788-1; Ye Z, 2016, CHEM-EUR J, V22, P15216, DOI 10.1002/chem.201603294; Yi JZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134427; Yi JZ, 2011, METHODS MOL BIOL, V728, P161, DOI 10.1007/978-1-61779-068-3_10; Ying M, 2016, J CONTROL RELEASE, V243, P86, DOI 10.1016/j.jconrel.2016.09.035; Zhang MF, 2018, ACTA PHARM SIN B, V8, P106, DOI 10.1016/j.apsb.2017.11.004; Zhou L, 2015, NEUROPHARMACOLOGY, V99, P131, DOI 10.1016/j.neuropharm.2015.07.001; Zhou XR, 2017, INT J PHARMACEUT, V528, P723, DOI 10.1016/j.ijpharm.2017.06.051	60	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204472	10.1371/journal.pone.0204472	http://dx.doi.org/10.1371/journal.pone.0204472			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30260999	Green Published, gold, Green Submitted			2022-12-26	WOS:000445907400056
J	Zhou, SX; Xiang, YB; Tie, LH; Han, BH; Huang, CD				Zhou, Shixing; Xiang, Yuanbin; Tie, Liehua; Han, Bohan; Huang, Congde			Simulated nitrogen deposition significantly reduces soil respiration in an evergreen broadleaf forest in western China	PLOS ONE			English	Article							MICROBIAL RESPIRATION; LEAVED FOREST; WATER CONTENT; CARBON-CYCLE; RAINY AREA; CO2 EFFLUX; FINE ROOTS; TEMPERATURE; RESPONSES; HARDWOOD	Soil respiration is the second largest terrestrial carbon (C) flux; the responses of soil respiration to nitrogen (N) deposition have far-reaching influences on the global C cycle. N deposition has been documented to significantly affect soil respiration, but the results are conflicting. The response of soil respiration to N deposition gradients remains unclear, especially in ecosystems receiving increasing ambient N depositions. A field experiment was conducted in a natural evergreen broadleaf forest in western China from November 2013 to November 2015 to understand the effects of increasing N deposition on soil respiration. Four levels of N deposition were investigated: control (Ctr, without N added), low N (L, 50 kg N ha(-1).a(-1)), medium N (M, 150 kg N ha(-1).a(-1)), and high N (H, 300 kg N ha(-1).a(-1)). The results show that (1) the mean soil respiration rates in the L, M, and H treatments were 9.13%, 15.8% (P < 0.05) and 22.57% (P < 0.05) lower than that in the Ctr treatment (1.56 +/- 0.13 mu mol.m(-2).s(-1)), respectively; (2) soil respiration rates showed significant positive exponential and linear relationships with soil temperature and moisture (P < 0.01), respectively. Soil temperature is more important than soil moisture in controlling the soil respiration rate; (3) the Ctr, L, M, and H treatments yielded Q(10) values of 2.98, 2.78, 2.65, and 2.63, respectively. N deposition decreased the temperature sensitivity of soil respiration; (4) simulated N deposition also significantly decreased the microbial biomass C and N, fine root biomass, pH and extractable dissolved organic C (P < 0.05). Overall, the results suggest that soil respiration declines in response to N deposition. The decrease in soil respiration caused by simulated N deposition may occur through decreasing the microbial biomass C and N, fine root biomass, pH and extractable dissolved organic C. Ongoing N deposition may have significant impacts on C cycles and increase C sequestration with the increase in global temperature in evergreen broadleaf forests.	[Zhou, Shixing; Xiang, Yuanbin; Tie, Liehua; Han, Bohan; Huang, Congde] Sichuan Agr Univ, Coll Forestry, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University	Huang, CD (corresponding author), Sichuan Agr Univ, Coll Forestry, Chengdu, Sichuan, Peoples R China.	lyyxq100@aliyun.com	Huang, Congde/AAR-8821-2020; Zhou, Shixing/L-1829-2016	Huang, Congde/0000-0002-6379-7497; Zhou, Shixing/0000-0003-4228-4227; Tie, Liehua/0000-0003-4105-3945	Sci-tech Project of the "12th Five-year-plan" of China from the Ministry of Science and Technology of the People's Republic of China [2010BACO1A11]; Crop Breeding Research Project of the "12th Five-year-plan" of Sichuan Province form the Department of Science and Technology of Sichuan Province [2011NZ0098-10]; China Scholarship Council [201706910038]; Crop Breeding Research Project of the "12th Five-year-plan" of Sichuan Province [2011NZ0098-10]; Sci-tech Project of the "12th Five-year-plan" of China [2010BACO1A11]	Sci-tech Project of the "12th Five-year-plan" of China from the Ministry of Science and Technology of the People's Republic of China; Crop Breeding Research Project of the "12th Five-year-plan" of Sichuan Province form the Department of Science and Technology of Sichuan Province; China Scholarship Council(China Scholarship Council); Crop Breeding Research Project of the "12th Five-year-plan" of Sichuan Province; Sci-tech Project of the "12th Five-year-plan" of China	This work was supported by the Sci-tech Project of the "12th Five-year-plan" of China (2010BACO1A11) from the Ministry of Science and Technology of the People's Republic of China (http://www.most.gov.cn/) granted to Congde Huang., the Crop Breeding Research Project of the "12th Five-year-plan" of Sichuan Province (2011NZ0098-10) form the Department of Science and Technology of Sichuan Province (http://www.scst.gov.cn/) granted to Congde Huang, and the joint Ph.D. program grant (201706910038) from the China Scholarship Council (http://www.csc.edu.cn/) granted to Shixing Zhou. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to thank Yongxiang Xiao, Shiping Huang, Xiong Liu, Chao Luo, Junxi Hu, and Shengzhao Wei for their kind assistance in the field. Shixing Zhou acknowledges the financial support by the China Scholarship Council via a joint PhD program grant (201706910038). This work was supported by the Crop Breeding Research Project of the "12th Five-year-plan" of Sichuan Province (2011NZ0098-10) and the Sci-tech Project of the "12th Five-year-plan" of China (2010BACO1A11) granted to Congde Huang.	ABER JD, 1989, BIOSCIENCE, V39, P378, DOI 10.2307/1311067; Ambus P, 2006, BIOGEOCHEMISTRY, V79, P315, DOI 10.1007/s10533-005-5313-x; Bond-Lamberty B, 2010, NATURE, V464, P579, DOI 10.1038/nature08930; Bowden RD, 2004, FOREST ECOL MANAG, V196, P43, DOI 10.1016/j.foreco.2004.03.011; Burton AJ, 2003, TREE PHYSIOL, V23, P273, DOI 10.1093/treephys/23.4.273; Chang SX, 2016, BIOL FERT SOILS, V52, P629, DOI 10.1007/s00374-016-1104-x; CHAPIN FS, 1983, POLAR BIOL, V2, P47, DOI 10.1007/BF00258285; Chen J, 2017, GLOBAL CHANGE BIOL, V23, P1328, DOI 10.1111/gcb.13402; Cleveland CC, 2006, P NATL ACAD SCI USA, V103, P10316, DOI 10.1073/pnas.0600989103; Comeau LP, 2016, GEODERMA, V268, P41, DOI 10.1016/j.geoderma.2016.01.016; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Davidson EA, 1998, GLOBAL CHANGE BIOL, V4, P217, DOI 10.1046/j.1365-2486.1998.00128.x; Ding WX, 2010, GEODERMA, V155, P381, DOI 10.1016/j.geoderma.2009.12.023; Eissenstat DM, 1997, ADV ECOL RES, V27, P1, DOI 10.1016/S0065-2504(08)60005-7; Fang C, 2017, SCI TOTAL ENVIRON, V590, P729, DOI 10.1016/j.scitotenv.2017.03.034; Fisk MC, 2001, BIOGEOCHEMISTRY, V53, P201, DOI 10.1023/A:1010693614196; Frey SD, 2004, FOREST ECOL MANAG, V196, P159, DOI 10.1016/j.foreco.2004.03.018; Frey SD, 2013, NAT CLIM CHANGE, V3, P395, DOI [10.1038/NCLIMATE1796, 10.1038/nclimate1796]; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Hanson PJ, 2000, BIOGEOCHEMISTRY, V48, P115, DOI 10.1023/A:1006244819642; Hyvonen R, 2008, BIOGEOCHEMISTRY, V89, P121, DOI 10.1007/s10533-007-9121-3; Janssens IA, 2010, NAT GEOSCI, V3, P315, DOI [10.1038/ngeo844, 10.1038/NGEO844]; Janssens IA, 2003, GLOBAL CHANGE BIOL, V9, P911, DOI 10.1046/j.1365-2486.2003.00636.x; Kuzyakov Y, 2006, SOIL BIOL BIOCHEM, V38, P425, DOI 10.1016/j.soilbio.2005.08.020; Lei ZF, 2017, FORESTS, V8, DOI 10.3390/f8110452; Li H., 2016, SICHAUN FOR EXPLOR D, V4, P16; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Lu M, 2013, ECOLOGY, V94, P726, DOI 10.1890/12-0279.1; Magill AH, 2004, FOREST ECOL MANAG, V196, P7, DOI 10.1016/j.foreco.2004.03.033; Melillo JM, 2002, SCIENCE, V298, P2173, DOI 10.1126/science.1074153; Mo J, 2008, GLOBAL CHANGE BIOL, V14, P403, DOI 10.1111/j.1365-2486.2007.01503.x; Nannipieri P, 2018, BIOL FERT SOILS, V54, P11, DOI 10.1007/s00374-017-1245-6; Niu SL, 2016, ECOL LETT, V19, P697, DOI 10.1111/ele.12591; Peng SS, 2009, SOIL BIOL BIOCHEM, V41, P1008, DOI 10.1016/j.soilbio.2008.10.023; Peng Y, 2018, PLANT SOIL, V431, P449, DOI 10.1007/s11104-018-3751-1; Peng Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03044-w; Powers JS, 2005, NEW PHYTOL, V165, P913, DOI 10.1111/j.1469-8137.2004.01279.x; Pregitzer KS, 2000, NEW PHYTOL, V147, P105, DOI 10.1046/j.1469-8137.2000.00689.x; Rabalais NN, 2002, AMBIO, V31, P102, DOI 10.1579/0044-7447-31.2.102; Reynolds LL, 2015, GLOBAL CHANGE BIOL, V21, P487, DOI 10.1111/gcb.12732; Rodeghiero M, 2006, PLANT SOIL, V284, P7, DOI 10.1007/s11104-005-5109-8; Samuelson L, 2009, FOREST ECOL MANAG, V258, P2431, DOI 10.1016/j.foreco.2009.08.020; Savage KE, 2013, GLOBAL CHANGE BIOL, V19, P2389, DOI 10.1111/gcb.12224; Schlesinger WH, 2000, BIOGEOCHEMISTRY, V48, P7, DOI 10.1023/A:1006247623877; Sun ZZ, 2014, AGR FOREST METEOROL, V197, P103, DOI 10.1016/j.agrformet.2014.06.010; Tang XL, 2006, GLOBAL CHANGE BIOL, V12, P546, DOI 10.1111/j.1365-2486.2006.01109.x; Tateno R, 2004, FOREST ECOL MANAG, V193, P297, DOI 10.1016/j.foreco.2003.11.011; Tu LH, 2015, PLANT SOIL, V389, P273, DOI 10.1007/s11104-014-2353-9; Tu LH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088752; Tu LH, 2013, SOIL BIOL BIOCHEM, V58, P255, DOI 10.1016/j.soilbio.2012.12.005; Tu LH, 2011, PLANT SOIL, V340, P383, DOI 10.1007/s11104-010-0610-0; Wang CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031042; Wei D, 2014, GEODERMA, V232, P88, DOI 10.1016/j.geoderma.2014.05.002; Xu WH, 2008, SOIL BIOL BIOCHEM, V40, P679, DOI 10.1016/j.soilbio.2007.10.003; Xu ZF, 2013, ENVIRON POLLUT, V177, P201, DOI 10.1016/j.envpol.2012.12.031; Yoshitake S, 2007, EUR J SOIL BIOL, V43, P1, DOI 10.1016/j.ejsobi.2006.01.003; Yue K, 2017, GLOBAL CHANGE BIOL, V23, P2450, DOI 10.1111/gcb.13569; Zhang LH, 2010, J ARID ENVIRON, V74, P1200, DOI 10.1016/j.jaridenv.2010.05.031; Zhang L, 2018, SCI TOTAL ENVIRON, V642, P781, DOI 10.1016/j.scitotenv.2018.06.111; Zhou SX, 2017, PLANT SOIL, V420, P135, DOI 10.1007/s11104-017-3383-x; Zhou SX, 2018, FOREST ECOL MANAG, V430, P219, DOI 10.1016/j.foreco.2018.08.022; Zhou ShiXing, 2017, Acta Ecologica Sinica - International Journal, V37, P258, DOI 10.1016/j.chnaes.2017.02.013; [周世兴 Zhou Shixing], 2017, [生态学报, Acta Ecologica Sinica], V37, P1191; Zhuang Ping, 2002, Shengwu Duoyangxing, V10, P339	65	12	14	11	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204661	10.1371/journal.pone.0204661	http://dx.doi.org/10.1371/journal.pone.0204661			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30261036	Green Submitted, gold, Green Published			2022-12-26	WOS:000445907400084
J	Koehler-McNicholas, SR; Slater, BCS; Koester, K; Nickel, EA; Ferguson, JE; Hansen, AH				Koehler-McNicholas, Sara R.; Slater, Billie C. Savvas; Koester, Karl; Nickel, Eric A.; Ferguson, John E.; Hansen, Andrew H.			Bimodal ankle-foot prosthesis for enhanced standing stability	PLOS ONE			English	Article							LOWER-LIMB AMPUTEES; BALANCE CONFIDENCE; TRANSTIBIAL AMPUTATION; POSTURAL RESPONSES; SOCIAL ACTIVITY; USERS SURVEY; GO TEST; PLUS-M; MOBILITY; INDIVIDUALS	Previous work suggests that to restore postural stability for individuals with lower-limb amputation, ankle-foot prostheses should be designed with a flat effective rocker shape for standing. However, most commercially available ankle-foot prostheses are designed with a curved effective rocker shape for walking. To address the demands of both standing and walking, we designed a novel bimodal ankle-foot prosthesis that can accommodate both functional modes using a rigid foot plate and an ankle that can lock and unlock. The primary objective of this study was to determine if the bimodal ankle-foot system could improve various aspects of standing balance (static, dynamic, and functional) and mobility in a group of Veterans with lower-limb amputation (n = 18). Standing balance was assessed while subjects completed a series of tests on a NeuroCom Clinical Research System (NeuroCom, a Division of Natus, Clackamas, OR), including a Sensory Organization Test, a Limits of Stability Test, and a modified Motor Control Test. Few statistically significant differences were observed between the locked and unlocked ankle conditions while subjects completed these tests. However, in the absence of visual feedback, the locked bimodal ankle appeared to improve static balance in a group of experienced lower-limb prosthesis users whose PLUS-M mobility rating was higher than approximately 73% of the sample population used to develop the PLUS-M survey. Given the statistically significant increase in mean equilibrium scores between the unlocked and locked conditions (p = 0.004), future testing of this system should focus on new amputees and lower mobility users (e.g., Medicare Functional Classification Level K1 and K2 prosthesis users). Furthermore, commercial implementation of the bimodal ankle-foot system should include a robust control system that can automatically switch between modes based on the user's activity.	[Koehler-McNicholas, Sara R.; Slater, Billie C. Savvas; Koester, Karl; Nickel, Eric A.; Ferguson, John E.; Hansen, Andrew H.] Minneapolis Dept Vet Affairs Hlth Care Syst, Minneapolis, MN 55417 USA; [Ferguson, John E.; Hansen, Andrew H.] Univ Minnesota, Div Rehabil Sci, Dept Rehabil Med, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities	Koehler-McNicholas, SR (corresponding author), Minneapolis Dept Vet Affairs Hlth Care Syst, Minneapolis, MN 55417 USA.	sara.koehler@va.gov		Koester, Karl/0000-0002-2499-6813; Slater, Billie C.S./0000-0003-0738-5639; Koehler-McNicholas, Sara/0000-0002-7201-3607	United States Department of Veterans Affairs, Veterans Health Administration, Rehabilitation Research and Development Service [A1531-R]	United States Department of Veterans Affairs, Veterans Health Administration, Rehabilitation Research and Development Service	This work was supported by Merit Review Award #A1531-R (awarded to AHH) from the United States Department of Veterans Affairs, Veterans Health Administration, Rehabilitation Research and Development Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk P. G., 2008, THESIS; Amtmann D, 2015, ARCH PHYS MED REHAB, V96, P1474, DOI 10.1016/j.apmr.2015.03.024; Asano M, 2008, PROSTHET ORTHOT INT, V32, P231, DOI 10.1080/03093640802024955; Barnett CT, 2013, GAIT POSTURE, V37, P319, DOI 10.1016/j.gaitpost.2012.07.023; Brooks D, 2001, ARCH PHYS MED REHAB, V82, P1478, DOI 10.1053/apmr.2001.25153; CLARK LA, 1981, PROSTHET ORTHOT INT, V5, P11; Deathe AB, 2005, PHYS THER, V85, P626, DOI 10.1093/ptj/85.7.626; Fairhurst SR, 2017, DES MED DEV C AM SOC; Gailey RS, 2002, ARCH PHYS MED REHAB, V83, P613, DOI 10.1053/ampr.2002.32309; Hafner BJ, 2017, ARCH PHYS MED REHAB, V98, P277, DOI 10.1016/j.apmr.2016.07.026; Hafner BJ, 2016, PROSTHET ORTHOT INT, V40, P582, DOI 10.1177/0309364615579315; Hansen A.H., 2004, JPO, V16, P41; Hansen AH, 2010, DISABIL REHABIL, V32, P2201, DOI 10.3109/09638288.2010.502586; Hansen AH, 2010, GAIT POSTURE, V32, P181, DOI 10.1016/j.gaitpost.2010.04.014; Jayakaran P, 2011, PM&R, V3, P723, DOI 10.1016/j.pmrj.2011.01.005; Kaufman KR, 2007, GAIT POSTURE, V26, P489, DOI 10.1016/j.gaitpost.2007.07.011; Kolarova B, 2013, ARCH PHYS MED REHAB, V94, P2234, DOI 10.1016/j.apmr.2013.05.019; Lajoie Y, 2004, ARCH GERONTOL GERIAT, V38, P11, DOI 10.1016/S0167-4943(03)00082-7; Leung ECC, 1996, ARCH PHYS MED REHAB, V77, P605, DOI 10.1016/S0003-9993(96)90303-2; Miller WC, 2003, ARCH PHYS MED REHAB, V84, P656, DOI 10.1016/S0003-9993(03)04807-4; Miller WC, 2001, ARCH PHYS MED REHAB, V82, P1238, DOI 10.1053/apmr.2001.25079; Miller WC, 2011, PROSTHET ORTHOT INT, V35, P379, DOI 10.1177/0309364611418874; Mohieldin A. H. A., 2010, Macedonian Journal of Medical Sciences, V3, P138, DOI 10.3889/MJMS.1857-5773.2010.0095; Molero-Sanchez A, 2015, PM&R, V7, P123, DOI 10.1016/j.pmrj.2014.08.953; Morgan SJ, 2014, QUAL LIFE RES, V23, P1767, DOI 10.1007/s11136-013-0618-z; Nickel E, 2013, J MED DEVICES, V7, DOI 10.1115/1.4024325; Perera S, 2006, J AM GERIATR SOC, V54, P743, DOI 10.1111/j.1532-5415.2006.00701.x; Pickerill ML, 2011, J ATHL TRAINING, V46, P600; POWELL LE, 1995, J GERONTOL A-BIOL, V50, pM28, DOI 10.1093/gerona/50A.1.M28; Schoppen T, 1999, ARCH PHYS MED REHAB, V80, P825, DOI 10.1016/S0003-9993(99)90234-4; Shultz AH, 2016, IEEE T NEUR SYS REH, V24, P495, DOI 10.1109/TNSRE.2015.2428196; Vanicek N, 2009, ARCH PHYS MED REHAB, V90, P1018, DOI 10.1016/j.apmr.2008.12.024	32	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2018	13	9							e0204512	10.1371/journal.pone.0204512	http://dx.doi.org/10.1371/journal.pone.0204512			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV3NB	30256851	gold, Green Published, Green Submitted			2022-12-26	WOS:000446000200051
J	Pozzo, T; Higdon, SM; Pattathil, S; Hahn, MG; Bennett, AB				Pozzo, Tania; Higdon, Shawn M.; Pattathil, Sivakumar; Hahn, Michael G.; Bennett, Alan B.			Characterization of novel glycosyl hydrolases discovered by cell wall glycan directed monoclonal antibody screening and metagenome analysis of maize aerial root mucilage	PLOS ONE			English	Article							DATABASE; GENOMES	An indigenous maize landrace from the Sierra Mixe region of Oaxaca, Mexico exhibits extensive formation of aerial roots which exude large volumes of a polysaccharide-rich gel matrix or "mucilage" that harbors diazotrophic microbiota. We hypothesize that the mucilage associated microbial community carries out multiple functions, including disassembly of the mucilage polysaccharide. In situ, hydrolytic assay of the mucilage revealed endogenous arabinofuranosidase, galactosidase, fucosidase, mannosidase and xylanase activities. Screening the mucilage against plant cell wall glycan-specific monoclonal antibodies recognized the presence of carbohydrate epitopes of hemicellulosic polysaccharides like xyloglucan (both non-fucosylated and fucosylated), xylan (both substituted and unsubstituted xylan domains) and pecticarabinogalactans, all of which are potential carbon sources for mucilage microbial residents. Mucilage metagenome annotation using MG-RAST identified the members forming the microbial community, and gene fragments with predicted functions associated with carbohydrate disassembly. Data from the in situ hydrolytic activity and monoclonal antibody screening assays were used to guide the selection of five full length genes with predicted glycosyl hydrolase function from the GenBank database that were similar to gene fragments of high relative abundance in the mucilage metagenomes. These five genes were then synthesized for recombinant production in Escherichia coll. Here we report the characterization of an alpha-N-arabinofuranosidase (GH51) and an oligosaccharide reducing-end xylanase (GH8) from Flavobacterium johnsoniae; an alpha-L-fucosidase (GH29) and a xylan beta-1,4 xylosidase (GH39) from Spirosoma linguale, and a beta-mannosidase (GH2) from Agrobacterium fabrum. Biochemical characterization of these enzymes revealed a beta-Mannosidase that also exhibits a secondary activity towards the cleavage of galactosyl residues. We also describe two xylanases (GH8 and GH39) from underexplored glycosyl hydrolase families, one thermostable alpha-L-Fucosidase (GH29) and a thermostable alpha-N-Arabinofuranosidase (GH51).	[Pozzo, Tania; Higdon, Shawn M.; Bennett, Alan B.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Pattathil, Sivakumar] Mascoma LLC, Lallemand Inc, Lebanon, NH USA; [Pattathil, Sivakumar; Hahn, Michael G.] Oak Ridge Natl Lab, BioEnergy Sci Ctr BESC, Oak Ridge, TN USA; [Hahn, Michael G.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	University of California System; University of California Davis; Mascoma Corporation; United States Department of Energy (DOE); Oak Ridge National Laboratory; BioEnergy Science Center (BESC); University System of Georgia; University of Georgia	Pozzo, T; Bennett, AB (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.	tania.pozzo@gmail.com; abbennett@ucdavis.edu	Hahn, Michael/AHC-5847-2022; Bennett, Alan/D-8980-2011	Higdon, Shawn Miles/0000-0002-0033-7688; Bennett, Alan/0000-0002-3684-4307; Pozzo, Tania/0000-0002-3645-2303	Mars, Incorporated; National Science Foundation [DBI-0421683, IOS-0923992]; Department of Energy Office of Biological and Environmental Research in the Department of Energy (DOE) Office of Science through the BioEnergy Science Center (BESC) at Oak Ridge National Laboratory [DE-PS02-06ER64304]	Mars, Incorporated; National Science Foundation(National Science Foundation (NSF)); Department of Energy Office of Biological and Environmental Research in the Department of Energy (DOE) Office of Science through the BioEnergy Science Center (BESC) at Oak Ridge National Laboratory(United States Department of Energy (DOE))	This work was supported by Mars, Incorporated, http://www.mars.com/global. The research was primarily funded by an unrestricted gift and grant to ABB. The funder provided support in the form of salaries for authors SMH and TP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The generation of the CCRC series of plant cell wall glycan-directed monoclonal antibodies used in this work was supported by the National Science Foundation Plant Genome Program (DBI-0421683 and IOS-0923992). Antibody screening assays were supported by the Department of Energy Office of Biological and Environmental Research in the Department of Energy (DOE) Office of Science through the BioEnergy Science Center (BESC) at Oak Ridge National Laboratory (Contract DE-PS02-06ER64304).	A Linares-Pasten J, 2014, CURR BIOTECHNOL, V3; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Bai X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111622; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Berlemont R, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005300; Berlemont R, 2015, APPL ENVIRON MICROB, V81, P1513, DOI 10.1128/AEM.03718-14; Bouffaud ML, 2014, ENVIRON MICROBIOL, V16, P2804, DOI 10.1111/1462-2920.12442; Chistoserdova L, 2010, BIOTECHNOL LETT, V32, P1351, DOI 10.1007/s10529-010-0306-9; de MENESES CHSG, 2009, EMBRAPA AGROBIOLOGIA; Fernandez-Arrojo L, 2010, CURR OPIN BIOTECH, V21, P725, DOI 10.1016/j.copbio.2010.09.006; Ferrer M, 2016, MICROB BIOTECHNOL, V9, P22, DOI 10.1111/1751-7915.12309; Jackson CR, 2013, JOVE-J VIS EXP, DOI 10.3791/50399; Jimenez DJ, 2016, APPL MICROBIOL BIOT, P1; Kolton M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076704; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Levy A, 2018, NAT GENET, V50, P138, DOI 10.1038/s41588-017-0012-9; Lezyk M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147438; Linares-Pasten JA, 2018, CURR PROTEIN PEPT SC, V19, P48, DOI 10.2174/1389203717666160923155209; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Matsuo N, 2000, BIOCHEM J, V346, P9, DOI 10.1042/0264-6021:3460009; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Parages ML, 2016, MAR DRUGS, V14, DOI 10.3390/md14030062; Pattathil Sivakumar, 2012, Methods Mol Biol, V908, P61, DOI 10.1007/978-1-61779-956-3_6; Pattathil S, 2010, PLANT PHYSIOL, V153, P514, DOI 10.1104/pp.109.151985; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Pozzo T, 2018, ACS OMEGA, V3, P2628, DOI 10.1021/acsomega.7b02068; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Ruprecht C, 2017, PLANT PHYSIOL, V175, P1094, DOI 10.1104/pp.17.00737; Sasse J, 2018, TRENDS PLANT SCI, V23, P25, DOI 10.1016/j.tplants.2017.09.003; Serrato RV, 2013, CARBOHYD POLYM, V98, P1153, DOI 10.1016/j.carbpol.2013.07.025; Stewart RD, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03317-6; Tailford LE, 2007, J BIOL CHEM, V282, P11291, DOI 10.1074/jbc.M610964200; Tan L, 2013, PLANT CELL, V25, P270, DOI 10.1105/tpc.112.107334; Van Deynze A, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006352	34	20	20	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2018	13	9							e0204525	10.1371/journal.pone.0204525	http://dx.doi.org/10.1371/journal.pone.0204525			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3NB	30256843	Green Published, gold			2022-12-26	WOS:000446000200053
J	Baron, S; Peleg, Y; Grunwald, J; Morgenstern, D; Elad, N; Peretz, M; Albeck, S; Levin, Y; Welch, JT; DeWeerd, KA; Schwarz, A; Burstein, Y; Diskin, R; Shakked, Z; Zimhony, O				Baron, Szilvia; Peleg, Yoav; Grunwald, Jacob; Morgenstern, David; Elad, Nadav; Peretz, Moshe; Albeck, Shire; Levin, Yishai; Welch, John T.; DeWeerd, Kim A.; Schwarz, Alon; Burstein, Yigal; Diskin, Ron; Shakked, Zippora; Zimhony, Oren			Expression of a recombinant, 4 '-Phosphopantetheinylated, active M-tuberculosis fatty acid synthase I in E-coli	PLOS ONE			English	Article							ACYL CARRIER PROTEIN; CRYO-EM STRUCTURE; ELECTRON-MICROSCOPY; FAS; BIOSYNTHESIS; SYNTHETASE	Background Fatty acid synthase 1 (FAS I) from Mycobacterium tuberculosis (Mtb) is an essential protein and a promising drug target. FAS I is a multi-functional, multi-domain protein that is organized as a large (1.9 MDa) homohexameric complex. Acyl intermediates produced during fatty acid elongation are attached covalently to an acyl carrier protein (ACP) domain. This domain is activated by the transfer of a 4'-Phosphopantetheine (4'-PP, also termed P-pant) group from CoA to ACP catalyzed by a 4'-PP transferase, termed acyl carrier protein synthase (AcpS). Methods In order to obtain an activated FAS I in E. coli, we transformed E. coli with tagged Mtb fast and acpS genes encoded by a separate plasmid. We induced the expression of Mtb FAS I following induction of AcpS expression. FAS I was purified by Strep-Tactin affinity chromatography. Results Activation of Mtb FAS I was confirmed by the identification of a bound P-pant group on serine at position 1808 by mass spectrometry. The purified FAS I displayed biochemical activity shown by spectrophotometric analysis of NADPH oxidation and by CoA production, using the Ellman reaction. The purified Mtb FAS I forms a hexameric complex shown by negative staining and cryo-EM. Conclusion Purified hexameric and active Mtb FAS I is required for binding and drug inhibition studies and for structure-function analysis of this enzyme. This relatively simple and short procedure for Mtb FAS I production should facilitate studies of this enzyme.	[Baron, Szilvia; Peretz, Moshe; Schwarz, Alon; Diskin, Ron; Shakked, Zippora] Weizmann Inst Sci, Dept Struct Biol, Rehovot, Israel; [Peleg, Yoav; Grunwald, Jacob; Albeck, Shire] Weizmann Inst Sci, Life Sci Core Facil, SPU, Rehovot, Israel; [Morgenstern, David; Levin, Yishai] Weizmann Inst Sci, De Botton Inst Prot Profiling, Rehovot, Israel; [Elad, Nadav] Weizmann Inst Sci, Dept Chem Res Support, Rehovot, Israel; [Welch, John T.] SUNY Albany, Dept Chem, Coll Arts & Sci, Albany, NY 12222 USA; [DeWeerd, Kim A.] SUNY Albany, Mol Core Facil, Coll Arts & Sci, Albany, NY 12222 USA; [Burstein, Yigal] Weizmann Inst Sci, Dept Organ Chem, Rehovot, Israel; [Zimhony, Oren] Hebrew Univ & Hadassah, Sch Med, Kaplan Med Ctr, Jerusalem, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Weizmann Institute of Science; Hebrew University of Jerusalem; Hadassah University Medical Center; Kaplan Medical Center	Zimhony, O (corresponding author), Hebrew Univ & Hadassah, Sch Med, Kaplan Med Ctr, Jerusalem, Israel.	Oren_z@clalit.org.il		Elad, Nadav/0000-0001-6222-2280; Baron, Szilvia/0000-0002-0406-1359; Burstein, Yigal/0000-0003-0494-7739	Legacy Heritage Clinical Research Initiative of the Israel Science Foundation [1629/10]; Israeli Ministry of Health [6223]; Ministry of Aliyah and Immigrant Absorption [17733]; Kimmelman Center for Macromolecular Structure and Assembly at the Weizmann Institute of Science	Legacy Heritage Clinical Research Initiative of the Israel Science Foundation; Israeli Ministry of Health; Ministry of Aliyah and Immigrant Absorption; Kimmelman Center for Macromolecular Structure and Assembly at the Weizmann Institute of Science	The work was supported by the following: Legacy Heritage Clinical Research Initiative of the Israel Science Foundation, Grant No. 1629/10, and the Israeli Ministry of Health Chief Scientist award No. 6223 to OZ; and The Ministry of Aliyah and Immigrant Absorption grant no. 17733 to Dr Szilvia Baron. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the continuous support of the Kimmelman Center for Macromolecular Structure and Assembly at the Weizmann Institute of Science.	Bhatt A, 2007, MOL MICROBIOL, V64, P1442, DOI 10.1111/j.1365-2958.2007.05761.x; Boehringer D, 2013, J MOL BIOL, V425, P841, DOI 10.1016/j.jmb.2012.12.021; Chalut C, 2006, P NATL ACAD SCI USA, V103, P8511, DOI 10.1073/pnas.0511129103; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Dao DN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000081; Dym O, 2009, J MOL BIOL, V393, P937, DOI 10.1016/j.jmb.2009.08.065; ELLMAN GL, 1962, ANAL BIOCHEM, V3, P40, DOI 10.1016/0003-2697(62)90042-8; Enderle M, 2015, ACTA CRYSTALLOGR F, V71, P1401, DOI 10.1107/S2053230X15018336; Fichtlscherer F, 2000, EUR J BIOCHEM, V267, P2666, DOI 10.1046/j.1432-1327.2000.01282.x; Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6; Jenni S, 2007, SCIENCE, V316, P254, DOI 10.1126/science.1138248; Johansson P, 2009, STRUCTURE, V17, P1063, DOI 10.1016/j.str.2009.06.014; Leibundgut M, 2007, SCIENCE, V316, P288, DOI 10.1126/science.1138249; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Lomakin IB, 2007, CELL, V129, P319, DOI 10.1016/j.cell.2007.03.013; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Meier JL, 2011, J PROTEOME RES, V10, P320, DOI 10.1021/pr100953b; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Mondino S, 2013, MOL MICROBIOL, V89, P372, DOI 10.1111/mmi.12282; Ngo SC, 2007, ANTIMICROB AGENTS CH, V51, P2430, DOI 10.1128/AAC.01458-06; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Schweizer E, 2004, MICROBIOL MOL BIOL R, V68, P501, DOI 10.1128/MMBR.68.3.501-517.2004; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Zimhony O, 2000, NAT MED, V6, P1043, DOI 10.1038/79558; Zimhony O, 2007, ANTIMICROB AGENTS CH, V51, P752, DOI 10.1128/AAC.01369-06	27	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2018	13	9							e0204457	10.1371/journal.pone.0204457	http://dx.doi.org/10.1371/journal.pone.0204457			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3MI	30248156	gold, Green Submitted, Green Published			2022-12-26	WOS:000445998100042
J	Nuka, E; Ohnishi, K; Terao, J; Kawai, Y				Nuka, Erika; Ohnishi, Kohta; Terao, Junji; Kawai, Yoshichika			ATP/P2X7 receptor signaling as a potential anti-inflammatory target of natural polyphenols	PLOS ONE			English	Article							NF-KAPPA-B; NITRIC-OXIDE SYNTHASE; TOLL-LIKE RECEPTOR; P2X(7) RECEPTOR; P2X7 RECEPTOR; INFLAMMATORY RESPONSES; EXTRACELLULAR ATP; ADENOSINE-TRIPHOSPHATE; PHYSIOLOGICAL ROLES; CYTOKINE PRODUCTION	Innate immune cells, such as macrophages, respond to pathogen-associated molecular patterns, such as a lipopolysaccharide (LPS), to secrete various inflammatory mediators. Recent studies have suggested that damage-associated molecular patterns (DAMPs), released extracellularly from damaged or immune cells, also play a role in the activation of inflammatory responses. In this study, to prevent excess inflammation, we focused on DAMPs-mediated signaling that promotes LPS-stimulated inflammatory responses, especially adenosine 5'-triphosphate (ATP)-triggered signaling through the ionotropic purinergic receptor 7 (P2X7R), as a potential new anti-inflammatory target of natural polyphenols. We focused on the phenomenon that ATP accelerates the production of inflammatory mediators, such as nitric oxide, in LPS-stimulated J774.1 mouse macrophages. Using an siRNA-mediated knockdown and specific antagonist, it was found that the ATP-induced enhanced inflammatory responses were mediated through P2X7R. We then screened 42 polyphenols for inhibiting the ATP/P2X7R-induced calcium influx, and found that several polyphenols exhibited significant inhibitory effects. Especially, a flavonoid baicalein significantly inhibited ATP-induced inflammation, including interleukin-1 beta secretion, through inhibition of the ATP/P2X7R signaling. These findings suggest that ATP/P2X7R signaling plays an important role in excess inflammatory responses and could be a potential anti-inflammatory target of natural polyphenolic compounds.	[Nuka, Erika; Ohnishi, Kohta; Terao, Junji; Kawai, Yoshichika] Tokushima Univ, Grad Sch Biomed Sci, Dept Food Sci, Tokushima, Japan; [Terao, Junji] Konan Womens Univ, Fac Nursing & Rehabil, Kobe, Hyogo, Japan	Tokushima University	Kawai, Y (corresponding author), Tokushima Univ, Grad Sch Biomed Sci, Dept Food Sci, Tokushima, Japan.	kawai.yoshichika@tokushima-u.ac.jp			JSPS KAKENHI [26292069, 15K14730]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 26292069, 15K14730.	Alves LA, 2013, MOLECULES, V18, P10953, DOI 10.3390/molecules180910953; Antonioli L, 2013, TRENDS MOL MED, V19, P355, DOI 10.1016/j.molmed.2013.03.005; Bagyinszky E, 2017, J NEUROL SCI, V376, P242, DOI 10.1016/j.jns.2017.03.031; Bartlett R, 2014, PHARMACOL REV, V66, P638, DOI 10.1124/pr.113.008003; Bhullar KS, 2015, BBA-MOL BASIS DIS, V1852, P1209, DOI 10.1016/j.bbadis.2015.01.012; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Bours MJL, 2006, PHARMACOL THERAPEUT, V112, P358, DOI 10.1016/j.pharmthera.2005.04.013; Burnstock G, 2014, PURINERG SIGNAL, V10, P103, DOI 10.1007/s11302-013-9395-y; Cekic C, 2016, NAT REV IMMUNOL, V16, P177, DOI 10.1038/nri.2016.4; Chen CY, 2005, BIOCHEM BIOPH RES CO, V331, P993, DOI 10.1016/j.bbrc.2005.03.237; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Chuah YK, 2013, INT J INFLAMM, V2013, DOI 10.1155/2013/403460; Coddou C, 2011, PHARMACOL REV, V63, P641, DOI 10.1124/pr.110.003129; Colasanti M, 2000, TRENDS PHARMACOL SCI, V21, P249, DOI 10.1016/S0165-6147(00)01499-1; Costa HM, 2011, PURINERG SIGNAL, V7, P381, DOI 10.1007/s11302-011-9255-6; Costa HM, 2011, PURINERG SIGNAL, V7, P7, DOI 10.1007/s11302-011-9215-1; da Cruz CM, 2006, BRIT J PHARMACOL, V147, P324, DOI 10.1038/sj.bjp.0706559; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Eltzschig HK, 2012, NEW ENGL J MED, V367, P2322, DOI 10.1056/NEJMra1205750; Endale M, 2013, IMMUNOBIOLOGY, V218, P1452, DOI 10.1016/j.imbio.2013.04.019; Farlik M, 2010, IMMUNITY, V33, P25, DOI 10.1016/j.immuni.2010.07.001; Feske S, 2012, NAT REV IMMUNOL, V12, P532, DOI 10.1038/nri3233; Fujimoto Y, 2012, J VET MED SCI, V74, P27, DOI 10.1292/jvms.11-0228; Gasic-Milenkovic J, 2003, EUR J NEUROSCI, V17, P813, DOI 10.1046/j.1460-9568.2003.02506.x; Gavala ML, 2013, J LEUKOCYTE BIOL, V94, P759, DOI 10.1189/jlb.0712351; Gendron FP, 2003, AM J PHYSIOL-CELL PH, V284, pC571, DOI 10.1152/ajpcell.00286.2002; Giuliani AL, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00123; Golia E, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-014-0435-z; Gough DJ, 2012, IMMUNITY, V36, P166, DOI 10.1016/j.immuni.2012.01.011; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gupta SC, 2014, ARCH BIOCHEM BIOPHYS, V559, P91, DOI 10.1016/j.abb.2014.06.006; He XX, 2015, INT IMMUNOPHARMACOL, V28, P470, DOI 10.1016/j.intimp.2015.07.012; Idzko M, 2007, NAT MED, V13, P913, DOI 10.1038/nm1617; Ishisaka A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080843; Jacobson KA, 2016, NEUROPHARMACOLOGY, V104, P31, DOI 10.1016/j.neuropharm.2015.12.001; Jiang LH, 2000, MOL PHARMACOL, V58, P82, DOI 10.1124/mol.58.1.82; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim M, 2001, EMBO J, V20, P6347, DOI 10.1093/emboj/20.22.6347; Lee KW, 2008, CANCER RES, V68, P946, DOI 10.1158/0008-5472.CAN-07-3140; Lee YM, 2010, ARCH PHARM RES, V33, P231, DOI 10.1007/s12272-010-0207-4; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Leyva-Grado VH, 2017, MBIO, V8, DOI 10.1128/mBio.00229-17; Li-Weber M, 2009, CANCER TREAT REV, V35, P57, DOI 10.1016/j.ctrv.2008.09.005; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lin CW, 2010, J AGR FOOD CHEM, V58, P4477, DOI 10.1021/jf904061x; Lohman AW, 2014, FEBS LETT, V588, P1379, DOI 10.1016/j.febslet.2014.02.004; Lommatzsch M, 2010, AM J RESP CRIT CARE, V181, P928, DOI 10.1164/rccm.200910-1506OC; LOWENSTEIN CJ, 1993, P NATL ACAD SCI USA, V90, P9730, DOI 10.1073/pnas.90.20.9730; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Medzhitov R, 2010, CELL, V140, P771, DOI 10.1016/j.cell.2010.03.006; Mehta N, 2014, BIOORGAN MED CHEM, V22, P54, DOI 10.1016/j.bmc.2013.10.054; Moncada S, 1997, PHARMACOL REV, V49, P137; Na HK, 2008, ARCH BIOCHEM BIOPHYS, V476, P171, DOI 10.1016/j.abb.2008.04.003; Nicholas C, 2007, J IMMUNOL, V179, P7121, DOI 10.4049/jimmunol.179.10.7121; North RA, 2013, MOL PHARMACOL, V83, P759, DOI 10.1124/mol.112.083758; Pelegrin P, 2008, J IMMUNOL, V180, P7147, DOI 10.4049/jimmunol.180.11.7147; Piccinini AM, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/672395; Portales-Cervantes L, 2010, HUM IMMUNOL, V71, P818, DOI 10.1016/j.humimm.2010.05.008; Prasad S, 2010, PLANTA MED, V76, P1044, DOI 10.1055/s-0030-1250111; Rahimifard M, 2017, AGEING RES REV, V36, P11, DOI 10.1016/j.arr.2017.02.004; Ralevic V, 1998, PHARMACOL REV, V50, P413; Riteau N, 2010, AM J RESP CRIT CARE, V182, P774, DOI 10.1164/rccm.201003-0359OC; Ryu JK, 2011, J NEUROPATH EXP NEUR, V70, P13, DOI 10.1097/NEN.0b013e318201d4d4; Sakaguchi S, 2003, BIOCHEM BIOPH RES CO, V306, P860, DOI 10.1016/S0006-291X(03)01049-0; Santangelo Carmela, 2007, Ann Ist Super Sanita, V43, P394; Sato S, 2003, J IMMUNOL, V171, P4304, DOI 10.4049/jimmunol.171.8.4304; Soares-Bezerra RJ, 2013, PHARMACEUTICALS, V6, P650, DOI 10.3390/ph6050650; Tangney CC, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0324-x; Tsao HK, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.274; Vazquez-Torres A, 2000, J EXP MED, V192, P227, DOI 10.1084/jem.192.2.227; Venereau E, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00422; Wan P, 2016, SCI REP-UK, V6, DOI 10.1038/srep19108; Wang YD, 2013, AUTOPHAGY, V9, P1624, DOI 10.4161/auto.25873; Xagorari A, 2001, J PHARMACOL EXP THER, V296, P181; Yang H, 2015, J EXP MED, V212, P5, DOI 10.1084/jem.20141318; Youn HS, 2006, BIOCHEM PHARMACOL, V72, P850, DOI 10.1016/j.bcp.2006.06.021; Zanin RF, 2015, PURINERG SIGNAL, V11, P463, DOI 10.1007/s11302-015-9464-5; Zhao L, 2011, NUTR REV, V69, P310, DOI 10.1111/j.1753-4887.2011.00394.x; Zhao MY, 2015, INT IMMUNOPHARMACOL, V28, P938, DOI 10.1016/j.intimp.2015.04.032	83	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2018	13	9							e0204229	10.1371/journal.pone.0204229	http://dx.doi.org/10.1371/journal.pone.0204229			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3MI	30248132	Green Submitted, gold, Green Published			2022-12-26	WOS:000445998100029
J	Richards, E; Bouche, L; Panico, M; Arbeloa, A; Vinogradov, E; Morris, H; Wren, B; Logan, SM; Dell, A; Fairweather, NF				Richards, Emma; Bouche, Laura; Panico, Maria; Arbeloa, Ana; Vinogradov, Evgeny; Morris, Howard; Wren, Brendan; Logan, Susan M.; Dell, Anne; Fairweather, Neil F.			The S-layer protein of a Clostridium difficile SLCT-11 strain displays a complex glycan required for normal cell growth and morphology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mass spectrometry (MS); nuclear magnetic resonance (NMR); microbiology; glycoprotein structure; genetics; Clostridium difficile; surface layer; virulence; glycosylation; glycomics; glycoproteomics; cell wall	SURFACE-LAYER; MASS-SPECTROMETRY; ANTHRACIS; GENE; RECONSTRUCTION; GLYCOSYLATION; TRANSMISSION; FLAGELLIN; DOMAINS	Clostridium difficile is a bacterial pathogen that causes major health challenges worldwide. It has a well-characterized surface (S)-layer, a para-crystalline proteinaceous layer surrounding the cell wall. In many bacterial and archaeal species, the S-layer is glycosylated, but no such modifications have been demonstrated in C. difficile. Here, we show that a C. difficile strain of S-layer cassette type 11, Ox247, has a complex glycan attached via an O-linkage to Thr-38 of the S-layer low-molecular-weight subunit. Using MS and NMR, we fully characterized this glycan. We present evidence that it is composed of three domains: (i) a core peptide-linked tetrasaccharide with the sequence -4--Rha-3--Rha-3--Rha-3--Gal-peptide; (ii) a repeating pentasaccharide with the sequence -4--Rha-4--Glc-3--Rha-4-(-Rib-3-)-Rha-; and (iii) a nonreducing end-terminal 2,3 cyclophosphoryl-rhamnose attached to a ribose-branched sub-terminal rhamnose residue. The Ox247 genome contains a 24-kb locus containing genes for synthesis and protein attachment of this glycan. Mutations in genes within this locus altered or completely abrogated formation of this glycan, and their phenotypes suggested that this S-layer modification may affect sporulation, cell length, and biofilm formation of C. difficile. In summary, our findings indicate that the S-layer protein of SLCT-11 strains displays a complex glycan and suggest that this glycan is required for C. difficile sporulation and control of cell shape, a discovery with implications for the development of antimicrobials targeting the S-layer.	[Richards, Emma; Bouche, Laura; Panico, Maria; Arbeloa, Ana; Morris, Howard; Dell, Anne; Fairweather, Neil F.] Imperial Coll London, Dept Life Sci, London SW7 2AZ, England; [Vinogradov, Evgeny; Logan, Susan M.] CNR, Human Hlth Therapeut Res Ctr, Vaccine Program, Ottawa, ON K1A 0R6, Canada; [Morris, Howard] Lido Med Ctr, Biopharmaspec, Suite 3-1,St Saviours Rd, Jersey JE2 7LA, England; [Wren, Brendan] London Sch Hyg & Trop Med, London WC1E 7HT, England	Imperial College London; National Research Council Canada; University of London; London School of Hygiene & Tropical Medicine	Dell, A (corresponding author), Imperial Coll London, Dept Life Sci, Sir Ernst Chain Bldg, London SW7 2AZ, England.; Fairweather, NF (corresponding author), Imperial Coll London, Dept Life Sci, Flowers Bldg, London SW7 2AZ, England.	a.dell@imperial.ac.uk; n.fairweather@imperial.ac.uk		Dell, Anne/0000-0003-1380-2347; Fairweather, Neil/0000-0002-3224-0207	Medical Research Council [G1001721]; National Research Council of Canada; Wellcome Trust [102978/Z/13/Z]; MRC [MR/K000551/1, G1001721, G1000214] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Research Council of Canada; Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by a Medical Research Council Studentship.; Supported by Medical Research Council Grant G1001721 (to N.F.).; Supported by the National Research Council of Canada.; Recipient of funding from Wellcome Trust Award 102978/Z/13/Z.	Abt MC, 2016, NAT REV MICROBIOL, V14, P609, DOI 10.1038/nrmicro.2016.108; Abu-Qarn M, 2008, CURR OPIN STRUC BIOL, V18, P544, DOI 10.1016/j.sbi.2008.06.010; Anderson VJ, 2011, MOL MICROBIOL, V81, P192, DOI 10.1111/j.1365-2958.2011.07688.x; [Anonymous], 2016, Nat Rev Dis Primers, V2, P16021, DOI 10.1038/nrdp.2016.21; Arbing MA, 2012, P NATL ACAD SCI USA, V109, P11812, DOI 10.1073/pnas.1120595109; Baranova E, 2012, NATURE, V487, P119, DOI 10.1038/nature11155; Beveridge TJ, 1997, FEMS MICROBIOL REV, V20, P99, DOI 10.1016/S0168-6445(97)00043-0; Bharat TAM, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.59; Bouche L, 2016, J BIOL CHEM, V291, P25439, DOI 10.1074/jbc.M116.749481; Calabi E, 2002, INFECT IMMUN, V70, P5770, DOI 10.1128/IAI.70.10.5770-5778.2002; Calabi E, 2001, MOL MICROBIOL, V40, P1187, DOI 10.1046/j.1365-2958.2001.02461.x; Canis K, 2012, BIOCHEM J, V447, P217, DOI 10.1042/BJ20120810; Chang JY, 2008, J INFECT DIS, V197, P435, DOI 10.1086/525047; Clarke BR, 2011, J BIOL CHEM, V286, P41391, DOI 10.1074/jbc.M111.295857; Deakin LJ, 2012, INFECT IMMUN, V80, P2704, DOI 10.1128/IAI.00147-12; Dell A, 2001, SCIENCE, V291, P2351, DOI 10.1126/science.1058890; Dingle KE, 2013, J INFECT DIS, V207, P675, DOI 10.1093/infdis/jis734; Emerson JE, 2009, MOL MICROBIOL, V74, P541, DOI 10.1111/j.1365-2958.2009.06812.x; Fagan R, 2010, METHODS MOL BIOL, V646, P117, DOI 10.1007/978-1-60327-365-7_8; Fagan RP, 2014, NAT REV MICROBIOL, V12, P211, DOI 10.1038/nrmicro3213; Fagan RP, 2009, MOL MICROBIOL, V71, P1308, DOI 10.1111/j.1365-2958.2009.06603.x; Faulds-Pain A, 2014, MOL MICROBIOL, V94, P272, DOI 10.1111/mmi.12755; Ganeshapillai J, 2008, CARBOHYD RES, V343, P703, DOI 10.1016/j.carres.2008.01.002; Gebhart D, 2012, J BACTERIOL, V194, P6240, DOI 10.1128/JB.01272-12; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; Iavarone AT, 2002, INT J MASS SPECTROM, V219, P63, DOI 10.1016/S1387-3806(02)00587-0; Jang-Lee J, 2006, METHOD ENZYMOL, V415, P59, DOI 10.1016/S0076-6879(06)15005-3; Jank T, 2008, TRENDS MICROBIOL, V16, P222, DOI 10.1016/j.tim.2008.01.011; Jing H, 2002, STRUCTURE, V10, P1453, DOI 10.1016/S0969-2126(02)00840-7; Kern J, 2011, J BIOL CHEM, V286, P26042, DOI 10.1074/jbc.M111.248070; Kern J, 2010, MOL MICROBIOL, V75, P324, DOI 10.1111/j.1365-2958.2009.06958.x; Kirk JA, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah6813; Kirk JA, 2017, MICROB BIOTECHNOL, V10, P76, DOI 10.1111/1751-7915.12372; Lawley TD, 2009, INFECT IMMUN, V77, P3661, DOI 10.1128/IAI.00558-09; Merrigan MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078404; Mesnage S, 1999, J APPL MICROBIOL, V87, P256, DOI 10.1046/j.1365-2672.1999.00880.x; Moody AM, 2003, J BIOL CHEM, V278, P7240, DOI 10.1074/jbc.M210468200; Morris HR, 2007, INT J MASS SPECTROM, V259, P16, DOI 10.1016/j.ijms.2006.09.002; Morris HR, 1996, RAPID COMMUN MASS SP, V10, P889, DOI 10.1002/(SICI)1097-0231(19960610)10:8<889::AID-RCM615>3.0.CO;2-F; Morris HR, 1997, J PROTEIN CHEM, V16, P469, DOI 10.1023/A:1026309410737; Panico M, 2016, SCI REP-UK, V6, DOI 10.1038/srep32956; Qazi O, 2009, J MASS SPECTROM, V44, P368, DOI 10.1002/jms.1514; Ristl Robin, 2011, Int J Microbiol, V2011, DOI 10.1155/2011/127870; Ryan A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002076; Sara M, 2000, J BACTERIOL, V182, P859, DOI 10.1128/JB.182.4.859-868.2000; Schaffer C, 2017, FEMS MICROBIOL REV, V41, P49, DOI 10.1093/femsre/fuw036; Seekatz AM, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0298-8; Sernee MF, 2006, P NATL ACAD SCI USA, V103, P9458, DOI 10.1073/pnas.0603539103; SLEYTR UB, 1988, J BACTERIOL, V170, P2891, DOI 10.1128/jb.170.7.2891-2897.1988; Stewart A, 1998, CARBOHYD RES, V313, P193, DOI 10.1016/S0008-6215(98)00271-7; SWEET DP, 1974, BIOMED MASS SPECTROM, V1, P263, DOI 10.1002/bms.1200010410; Tarlovsky Y, 2010, J BACTERIOL, V192, P3503, DOI 10.1128/JB.00054-10; van der Wel H, 2001, J BIOL CHEM, V276, P33952, DOI 10.1074/jbc.M102555200; Willing SE, 2015, MOL MICROBIOL, V96, P596, DOI 10.1111/mmi.12958	54	10	10	1	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18123	18137		10.1074/jbc.RA118.004530	http://dx.doi.org/10.1074/jbc.RA118.004530			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30275012	Green Published, hybrid, Green Accepted, Green Submitted			2022-12-26	WOS:000451375200009
J	Leon, I; Tascon, L; Ortells-Pareja, JJ; Cimadevilla, JM				Leon, Irene; Tascon, Laura; Jose Ortells-Pareja, Juan; Manuel Cimadevilla, Jose			Virtual reality assessment of walking and non-walking space in men and women with virtual reality-based tasks	PLOS ONE			English	Article							SPATIAL MEMORY ALTERATIONS; TEMPORAL-LOBE EPILEPSY; GENDER-DIFFERENCES; SEX-DIFFERENCES; RECOGNITION; PLACE; ORIENTATION; HIPPOCAMPUS; STRATEGIES; CHILDREN	Far space and near space refer to different spatial features in which we unfold our behaviour. On the one hand, classical visuospatial neuropsychological tests assess spatial abilities in the near space; on the other, far space typically involves new spatial memory tasks in which participants display their behaviour in an environment, either interacting with objects or searching for targets. The Boxes Room Task is a virtual test that assesses spatial memory in the far space. Based upon this task, a new test was developed in which participants could not move about within the context, but they could actually perceive it from a specific viewpoint. In this work, both versions of the task were compared with one another. Furthermore, they were also compared with the results of 10/36 spatial recall test, a task assessing spatial memory in the near space. Two conditions were applied in all tasks, both in stable and rotated contexts. Our study included one hundred and twenty healthy young participants who were divided into two groups. The first group performed the Walking Space Boxes Room Task. A second group performed the Non-Walking Space Boxes Room Task as well as another traditional neuropsychological test for near space assessment, the 10/36 spatial recall test. Results proved that orientation in the non-walking space was more difficult than in the walking space. Additionally, our test also showed that men outperformed women in both virtual reality-based tasks, although they did not do it in the traditional 10/36 spatial recall test. In short, this work exposes that virtual-reality technologies provide tools to assess spatial memory, being more sensitive than traditional tests in the detection of small performance changes.	[Leon, Irene; Tascon, Laura; Jose Ortells-Pareja, Juan; Manuel Cimadevilla, Jose] Univ Almeria, Dept Psychol, Almeria, Spain	Universidad de Almeria	Cimadevilla, JM (corresponding author), Univ Almeria, Dept Psychol, Almeria, Spain.	cimadevilla@ual.es	leon, i/GZL-2093-2022; Leon, Irene/AAJ-6829-2020; Tascón, Laura/K-8748-2014; Cimadevilla, Jose Manuel/K-3249-2014	Leon, Irene/0000-0002-3558-8831; Tascón, Laura/0000-0003-3656-699X; Cimadevilla, Jose Manuel/0000-0002-0557-5546	MINECO [PSI2015-67442-P]; Ministry of Education, Culture and Sport of Spain [FPU2013/02655]	MINECO(Spanish Government); Ministry of Education, Culture and Sport of Spain(Spanish Government)	Authors declare no conflict of interest. This investigation was supported by MINECO (PSI2015-67442-P) and by the Ministry of Education, Culture and Sport of Spain [FPU2013/02655].	Amorim MA, 2003, VIS COGN, V10, P157, DOI 10.1080/13506280244000078; Astur RS, 2004, BEHAV BRAIN RES, V151, P103, DOI 10.1016/j.bbr.2003.08.024; Brain WR, 1941, BRAIN, V64, P244, DOI 10.1093/brain/64.4.244; Canovas R, 2008, BEHAV BRAIN RES, V190, P112, DOI 10.1016/j.bbr.2008.02.024; Canovas R, 2011, BEHAV BRAIN RES, V216, P116, DOI 10.1016/j.bbr.2010.07.026; Canovas R, 2009, RHEUMATOLOGY, V48, P1273, DOI 10.1093/rheumatology/kep218; Chua KP, 2003, PERCEPT PSYCHOPHYS, V65, P72, DOI 10.3758/BF03194784; Cimadevilla JM, 2001, BEHAV NEUROSCI, V115, P695, DOI 10.1037//0735-7044.115.3.695; Cimadevilla JM, 1999, BEHAV PROCESS, V46, P159, DOI 10.1016/S0376-6357(99)00034-0; Coluccia E, 2004, J ENVIRON PSYCHOL, V24, P329, DOI 10.1016/j.jenvp.2004.08.006; DOHLER KD, 1984, PROG BRAIN RES, V61, P99; Gerstenecker A, 2016, INT J GERIATR PSYCH, V31, P410, DOI 10.1002/gps.4346; Gorski R A, 1973, Prog Brain Res, V39, P149; Igloi K, 2009, HIPPOCAMPUS, V19, P1199, DOI 10.1002/hipo.20595; King JA, 2002, HIPPOCAMPUS, V12, P811, DOI 10.1002/hipo.10070; Leon I, 2016, BEHAV BRAIN RES, V306, P8, DOI 10.1016/j.bbr.2016.03.008; Leon I, 2014, NEUROPSYCHOLOGY, V28, P485, DOI 10.1037/neu0000054; Cimadevilla JM, 2014, EPILEPTIC DISORD, V16, P203, DOI 10.1684/epd.2014.0661; Nemmi F, 2013, NEUROPSYCHOLOGIA, V51, P1561, DOI 10.1016/j.neuropsychologia.2013.03.031; Nori R, 2015, COMPUT HUM BEHAV, V48, P72, DOI 10.1016/j.chb.2015.01.035; Packard MG, 1996, NEUROBIOL LEARN MEM, V65, P65, DOI 10.1006/nlme.1996.0007; Persson J, 2013, BEHAV BRAIN RES, V256, P219, DOI 10.1016/j.bbr.2013.07.050; Piccardi L, 2014, NEUROSCI LETT, V566, P226, DOI 10.1016/j.neulet.2014.03.005; Piccardi L, 2011, LEARN INDIVID DIFFER, V21, P114, DOI 10.1016/j.lindif.2010.11.003; Piccardi L, 2010, EXP BRAIN RES, V206, P171, DOI 10.1007/s00221-010-2234-2; Postma A, 1999, PSYCHONEUROENDOCRINO, V24, P175, DOI 10.1016/S0306-4530(98)00073-0; Canovas MR, 2011, PSICOTHEMA, V23, P752; Rosas K, 2013, EPILEPSY BEHAV, V28, P227, DOI 10.1016/j.yebeh.2013.05.010; Saucier DM, 2002, BEHAV NEUROSCI, V116, P403, DOI 10.1037//0735-7044.116.3.403; Tascon L, 2016, LEARN INDIVID DIFFER, V50, P270, DOI 10.1016/j.lindif.2016.08.007; Wolbers T, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00571	31	15	15	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0204995	10.1371/journal.pone.0204995	http://dx.doi.org/10.1371/journal.pone.0204995			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV3QJ	30278083	gold, Green Published, Green Submitted			2022-12-26	WOS:000446010200032
J	Biswal, MR; Justis, BD; Han, PY; Li, H; Gierhart, D; Dorey, CK; Lewin, AS				Biswal, Manas R.; Justis, Bradley D.; Han, Pingyang; Li, Hong; Gierhart, Dennis; Dorey, Cheryl K.; Lewin, Alfred S.			Daily zeaxanthin supplementation prevents atrophy of the retinal pigment epithelium (RPE) in a mouse model of mitochondrial oxidative stress	PLOS ONE			English	Article							MACULAR DEGENERATION; GEOGRAPHIC ATROPHY; CHOROIDAL NEOVASCULARIZATION; BETA-CAROTENE; RAT MODEL; HUMAN EYE; AGE; LUTEIN; CELLS; ACCUMULATION	Oxidative damage is implicated in the pathogenesis of age-related macular degeneration (AMD). The dry form of AMD (geographic atrophy) is characterized by loss of RPE, photoreceptors, and macular pigments. The cumulative effects of oxidative stress impact mitochondrial function in RPE. In Sod2(flox/flox)VMD2-cre mice, the RPE specific deletion of Sod2, the gene for mitochondrial manganese superoxide dismutase (MnSOD), leads to elevated oxidative stress in retina and RPE, and causes changes in the RPE and underlying Bruch's membrane that share some features of AMD. This study tested the hypothesis that zeaxanthin supplementation would reduce oxidative stress and preserve RPE structure and function in these mice. Zeaxanthin in retina/RPE/choroid and liver was quantified by LC/MS, retinal function and structure were evaluated by electroretinogram (ERG) and spectral domain optical coherence tomography (SD-OCT), and antioxidant gene expression was measured by RT-PCR. After one month of supplementation, zeaxanthin levels were 5-fold higher in the retina/RPE/choroid and 12-fold higher in liver than in unsupplemented control mice. After four months of supplementation, amplitudes of the ERG a-wave (function of rod photoreceptors) and b-wave (function of the inner retina) were not different in supplemented and control mice. In contrast, the c-wave amplitude (a measure of RPE function) was 28% higher in supplemented mice than in control mice. Higher RPE/choroid expression of antioxidant genes (Cat, Gstm1, Hmox1, Nqo1) and scaffolding protein Sqstm1 were found in supplemented mice than in unsupplemented controls. Reduced nitrotyrosine content in the RPE/choroid was demonstrated by ELISA. Preliminary assessment of retinal ultrastructure indicated that supplementation supported better preservation of RPE structure with more compact basal infoldings and intact mitochondria. We conclude that daily zeaxanthin supplementation protected RPE cells from mitochondrial oxidative stress associated with deficiency in the MnSOD and thereby improved RPE function early in the disease course.	[Biswal, Manas R.; Justis, Bradley D.; Han, Pingyang; Li, Hong; Lewin, Alfred S.] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32611 USA; [Biswal, Manas R.; Lewin, Alfred S.] Univ Florida, Ctr Vis Res, Gainesville, FL 32611 USA; [Biswal, Manas R.] Univ S Florida, Coll Pharm, Tampa, FL 33620 USA; [Gierhart, Dennis] ZeaVision, Chesterfield, MO USA; [Dorey, Cheryl K.] Virginia Tech Carilion Sch Med, Roanoke, VA USA; [Lewin, Alfred S.] Univ Florida, Coll Med, Dept Ophthalmol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of South Florida; State University System of Florida; University of Florida	Biswal, MR (corresponding author), Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32611 USA.; Biswal, MR (corresponding author), Univ Florida, Ctr Vis Res, Gainesville, FL 32611 USA.; Biswal, MR (corresponding author), Univ S Florida, Coll Pharm, Tampa, FL 33620 USA.	biswal@ufl.edu		Biswal, Manas/0000-0002-9685-2923; Lewin, Alfred/0000-0002-4192-9727	National Eye Institute (NEI) [R01EY020825, R01EY026268, 1K99EY027013]; NEI core grant [P30 EY02172]; ZeaVision LLC; Bright Focus Foundation; Shaler Richardson Professorship endowment; NATIONAL EYE INSTITUTE [R01EY026268] Funding Source: NIH RePORTER	National Eye Institute (NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI core grant; ZeaVision LLC; Bright Focus Foundation(BrightFocus Foundation); Shaler Richardson Professorship endowment; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by grants from the National Eye Institute (NEI) (R01EY020825 [ASL]; R01EY026268 [ASL]; 1K99EY027013 [MRB]), an NEI core grant to the University of Florida (P30 EY02172 [ASL]), a pilot grant from ZeaVision LLC (MRB), a grant from Bright Focus Foundation (ASL & MRB) and the Shaler Richardson Professorship endowment (ASL). None of the funding organization had any role in the design, data collection, analysis or preparation of the manuscript for publication. The funder provided support in the form of salaries for authors [MRB, ASL, HL, PH] and resources for research, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong D, 1998, Angiogenesis, V2, P93, DOI 10.1023/A:1009010628371; Baba T, 2010, AM J PATHOL, V176, P3085, DOI 10.2353/ajpath.2010.090989; Bernstein PS, 1998, INVEST OPHTH VIS SCI, V39, P2003; Bernstein PS, 2001, EXP EYE RES, V72, P215, DOI 10.1006/exer.2000.0954; Bhosale P, 2004, J BIOL CHEM, V279, P49447, DOI 10.1074/jbc.M405334200; Bian QN, 2012, FREE RADICAL BIO MED, V53, P1298, DOI 10.1016/j.freeradbiomed.2012.06.024; Biswal MR, 2017, INVEST OPHTH VIS SCI, V58, DOI 10.1167/iovs.16-21272; Biswal MR, 2015, EXP EYE RES, V140, P94, DOI 10.1016/j.exer.2015.07.022; Brightfocus Foundation, 2016, FACTS FIG; Chew EY, 2014, JAMA OPHTHALMOL, V132, P142, DOI 10.1001/jamaophthalmol.2013.7376; Chew EY, 2013, OPHTHALMOLOGY, V120, P1604, DOI 10.1016/j.ophtha.2013.01.021; Datta S, 2017, PROG RETIN EYE RES, V60, P201, DOI 10.1016/j.preteyeres.2017.03.002; Ding JD, 2015, AM J PATHOL, V185, P29, DOI 10.1016/j.ajpath.2014.08.026; Ebrahem Q, 2006, P NATL ACAD SCI USA, V103, P13480, DOI 10.1073/pnas.0601552103; Guo JH, 2016, CHEM RES TOXICOL, V29, P2125, DOI 10.1021/acs.chemrestox.6b00233; Indo HP, 2015, J CLIN BIOCHEM NUTR, V56, P1, DOI 10.3164/jcbn.14-42; Jarrett SG, 2012, MOL ASPECTS MED, V33, P399, DOI 10.1016/j.mam.2012.03.009; Khan JC, 2006, BRIT J OPHTHALMOL, V90, P75, DOI 10.1136/bjo.2005.073643; Landrum JT, 2001, ARCH BIOCHEM BIOPHYS, V385, P28, DOI 10.1006/abbi.2000.2171; Le YZ, 2008, INVEST OPHTH VIS SCI, V49, P1248, DOI 10.1167/iovs.07-1105; Leung IYF, 2004, INVEST OPHTH VIS SCI, V45, P3244, DOI 10.1167/iovs.02-1233; Li BX, 2017, EXP EYE RES, V159, P123, DOI 10.1016/j.exer.2017.02.016; Li BX, 2014, P NATL ACAD SCI USA, V111, P10173, DOI 10.1073/pnas.1402526111; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Mao HY, 2014, INVEST OPHTH VIS SCI, V55, P4613, DOI 10.1167/iovs.14-14633; Murdaugh LS, 2010, EXP EYE RES, V90, P564, DOI 10.1016/j.exer.2010.01.014; Olchawa MM, 2017, FREE RADICAL RES, V51, P799, DOI 10.1080/10715762.2017.1380307; Olk R Joseph, 2015, Int J Retina Vitreous, V1, P22, DOI 10.1186/s40942-015-0019-2; Orhan C, 2016, J OCUL PHARMACOL TH, V32, P631, DOI 10.1089/jop.2015.0154; Pinto LH, 2007, DOC OPHTHALMOL, V115, P127, DOI 10.1007/s10633-007-9064-y; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Rex TS, 2004, HUM GENE THER, V15, P960, DOI 10.1089/hum.2004.15.960; Rosen R, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/687386; Rudd LP, 2011, CHEM-BIOL INTERACT, V194, P113, DOI 10.1016/j.cbi.2011.08.012; SanGiovanni JP, 2008, ARCH OPHTHALMOL-CHIC, V126, P1274, DOI 10.1001/archopht.126.9.1274; SanGiovanni JP, 2007, ARCH OPHTHALMOL-CHIC, V125, P1225, DOI 10.1001/archopht.125.9.1225; Sanz MM, 2007, NEUROSCIENCE, V145, P1120, DOI 10.1016/j.neuroscience.2006.12.034; SARKS JP, 1988, EYE, V2, P552, DOI 10.1038/eye.1988.106; Schutt F, 2003, INVEST OPHTH VIS SCI, V44, P3663, DOI 10.1167/iovs.03-0172; SNODDERLY DM, 1995, AM J CLIN NUTR, V62, P1448; Sommerburg O, 1999, CURR EYE RES, V19, P491, DOI 10.1076/ceyr.19.6.491.5276; Sommerburg Olaf, 2000, Biofactors, V11, P3; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Tao RD, 2014, ANTIOXID REDOX SIGN, V20, P1646, DOI 10.1089/ars.2013.5482; Thomson LR, 2002, INVEST OPHTH VIS SCI, V43, P3538; Thomson LR, 2002, EXP EYE RES, V75, P529, DOI 10.1006/exer.2002.2050; Toyoda Y, 2002, INVEST OPHTH VIS SCI, V43, P1210; Veerappan M, 2016, OPHTHALMOLOGY, V123, P2554, DOI 10.1016/j.ophtha.2016.08.047; Weismann D, 2011, NATURE, V478, P76, DOI 10.1038/nature10449; Zhou JL, 2005, EXP EYE RES, V80, P567, DOI 10.1016/j.exer.2004.11.009; Zou X, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.190	51	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0203816	10.1371/journal.pone.0203816	http://dx.doi.org/10.1371/journal.pone.0203816			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265681	Green Submitted, Green Published, gold			2022-12-26	WOS:000446005500010
J	Caporali, JFD; Labanca, L; Florentino, KR; Souza, BO; Goncalves, DU				de Morais Caporali, Julia Fonseca; Labanca, Ludimila; Florentino, Kyonis Rodrigues; Souza, Barbara Oliveira; Goncalves, Denise Utsch			Intrarater and interrater agreement and reliability of vestibular evoked myogenic potential triggered by galvanic vestibular stimulation (galvanic-VEMP) for HTLV-1 associated myelopathy testing	PLOS ONE			English	Article							I-ASSOCIATED MYELOPATHY; TROPICAL SPASTIC PARAPARESIS; ELECTROMYOGRAPHIC RESPONSES; REFLEX RESPONSES; SHORT-LATENCY; DISEASE; STABILIZATION; CHEMOKINES; HAM/TSP; SYSTEM	Background The vestibular evoked myogenic potential triggered by galvanic vestibular stimulation (galvanic-VEMP) has been used to assess the function of the vestibulospinal motor tract and is a candidate biomarker to predict and monitor the human T-cell lymphotropic virus type 1 (HTLV-1) associated myelopathy (HAM). This study determined the agreement and reliability of this exam. Methods Galvanic-VEMP was performed in 96 participants, of which 24 patients presented HAM, 27 HTLV-1-asymptomatic carriers, and 45 HTLV-1-negative asymptomatic controls. Galvanic vestibular stimulation was achieved by passing a binaural and bipolar current at a 2 milliamperes (mA) intensity for 400 milliseconds (ms) between the mastoid processes. Galvanic-VEMP electromyographic wave responses of short latency (SL) and medium latency (ML) were recorded from the gastrocnemius muscle. Intrarater (test-retest) and interrater (two independent examiners) agreement and reliability were assessed by standard error of measurement (SEM), coefficient of repeatability (CR), intraclass correlation coefficient (ICC), and Kappa coefficient. Results In the total sample (n = 96), SL and ML medians were 56 ms (IQR 52 +/- 66) and 120 ms (IQR 107 +/- 130), respectively. The intrarater repeatability measures for SL and ML were, respectively: SEM of 6 and 8 ms; CR of 16 and 22 ms; ICC of 0.80 (p<0.001) and 0.91 (p<0.001); and a Kappa coefficient of 0.53 (p<0.001) and 0.82 (p<0.001). The interrater reproducibility measures for SL and ML were, respectively: SEM of 3 and 10 ms; CR of 8 and 27 ms; ICC of 0.95 (p<0.001) and 0.86 (p<0.001); and a Kappa coefficient of 0.77 (p<0.001) and 0.88 (p<0.001). Conclusion Galvanic-VEMP is a reliable and reproducible method to define the integrity of the vestibulospinal tract. Longitudinal studies will clarify its validity in the clinical context, aimed at achieving an early diagnosis and the monitoring of HAM.	[de Morais Caporali, Julia Fonseca; Labanca, Ludimila; Florentino, Kyonis Rodrigues; Souza, Barbara Oliveira; Goncalves, Denise Utsch] Univ Fed Minas Gerais, Fac Med, Programa Posgrad Infectol & Med Trop, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais	Caporali, JFD; Goncalves, DU (corresponding author), Univ Fed Minas Gerais, Fac Med, Programa Posgrad Infectol & Med Trop, Belo Horizonte, MG, Brazil.	juliacaporali@ufmg.br; denise@medicina.ufmg.br	Gonçalves, Denise Utsch/A-8203-2013	Gonçalves, Denise Utsch/0000-0002-9154-7436; Caporali, Julia/0000-0003-0544-309X	Pro-Reitoria de Pesquisa da Universidade Federal de Minas Gerais (PRPQ/UFMG); Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/COFECUB)	Pro-Reitoria de Pesquisa da Universidade Federal de Minas Gerais (PRPQ/UFMG); Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/COFECUB)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Pro-Reitoria de Pesquisa da Universidade Federal de Minas Gerais (PRPQ/UFMG) - https://www.ufmg.br/prpq/; Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG) - http://www.fapemig.br/en/; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) - http://cnpq.br/; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/COFECUB) - http://www.capes.gov.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLUM JHJ, 1985, EXP BRAIN RES, V58, P82; [Anonymous], 2012, INT VOC METR BAS GEN; Araujo AQC, 1998, J ACQ IMMUN DEF SYND, V19, P536, DOI 10.1097/00042560-199812150-00014; Bangham CRM, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.12; Bartlett JW, 2008, ULTRASOUND OBST GYN, V31, P466, DOI 10.1002/uog.5256; Starling ALB, 2015, BIOMARKERS, V20, P502, DOI 10.3109/1354750X.2015.1094141; BRITTON TC, 1993, EXP BRAIN RES, V94, P143; Bussel B, 1980, PROGR CLIN NEUROPHYS, V8, P310; Carneiro-Proietti Anna Bárbara F., 2002, Rev. Soc. Bras. Med. Trop., V35, P499, DOI 10.1590/S0037-86822002000500013; Castillo JL, 1999, EUR NEUROL, V42, P17, DOI 10.1159/000008063; Catalan-Soares Bernadette, 2005, Cad. Saúde Pública, V21, P926, DOI 10.1590/S0102-311X2005000300027; Cathers I, 2005, J PHYSIOL-LONDON, V563, P229, DOI 10.1113/jphysiol.2004.079525; Curthoys Ian S, 2012, Front Neurol, V3, P117, DOI 10.3389/fneur.2012.00117; Day BL, 2002, BRAIN, V125, P2081, DOI 10.1093/brain/awf212; De Castro-Costa CM, 2006, AIDS RES HUM RETROV, V22, P931, DOI 10.1089/aid.2006.22.931; Caporali JFD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004672; de Natale ER, 2015, NEUROL SCI, V36, P995, DOI 10.1007/s10072-014-2054-4; de Vet HCW, 2006, J CLIN EPIDEMIOL, V59, P1033, DOI 10.1016/j.jclinepi.2005.10.015; DETHE G, 1993, AIDS RES HUM RETROV, V9, P381, DOI 10.1089/aid.1993.9.381; Romanelli LCF, 2013, AIDS RES HUM RETROV, V29, P1199, DOI [10.1089/aid.2013.0086, 10.1089/AID.2013.0086]; FITZPATRICK R, 1994, J PHYSIOL-LONDON, V478, P363, DOI 10.1113/jphysiol.1994.sp020257; Fitzpatrick RC, 2004, J APPL PHYSIOL, V96, P2301, DOI 10.1152/japplphysiol.00008.2004; Franzoi AC, 2007, SPINAL CORD, V45, P64, DOI 10.1038/sj.sc.3101919; Franzoi AC, 2005, SPINAL CORD, V43, P236, DOI 10.1038/sj.sc.3101677; GESSAIN A, 1985, LANCET, V2, P407; Gessain A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00388; Goncalves DU, 2010, CLIN MICROBIOL REV, V23, P577, DOI 10.1128/CMR.00063-09; GRILLNER S, 1971, EXP BRAIN RES, V12, P457; Guerreiro JB, 2006, CLIN EXP IMMUNOL, V145, P296, DOI 10.1111/j.1365-2249.2006.03150.x; HORSTMANN GA, 1988, NEUROSCI LETT, V95, P179, DOI 10.1016/0304-3940(88)90653-2; Iles JF, 2004, BRAIN, V127, P1584, DOI 10.1093/brain/awh173; IWASAKI Y, 1992, AM J PATHOL, V140, P1003; JONES GM, 1971, J PHYSIOL-LONDON, V219, P729, DOI 10.1113/jphysiol.1971.sp009685; KAPLAN JE, 1990, J ACQ IMMUN DEF SYND, V3, P1096; Kim J, 2004, BRAIN RES BULL, V64, P265, DOI 10.1016/j.brainresbull.2004.07.008; Labanca L, 2015, AIDS RES HUM RETROV, V31, P649, DOI [10.1089/AID.2014.0153, 10.1089/aid.2014.0153]; Liechti M, 2008, CLIN NEUROPHYSIOL, V119, P2804, DOI 10.1016/j.clinph.2008.05.033; Maloney EM, 1998, J ACQ IMMUN DEF SYND, V17, P167, DOI 10.1097/00042560-199802010-00011; Martin F, 2010, J NEUROL NEUROSUR PS, V81, P1336, DOI 10.1136/jnnp.2009.191239; Cunha LCM, 2013, J CLIN NEUROL, V9, P252, DOI 10.3988/jcn.2013.9.4.252; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Muise SB, 2012, EXP BRAIN RES, V218, P63, DOI 10.1007/s00221-012-3002-2; Murphy EL, 1997, NEUROLOGY, V48, P315, DOI 10.1212/WNL.48.2.315; Narikawa K, 2005, J NEUROIMMUNOL, V159, P177, DOI 10.1016/j.jneuroim.2004.10.011; NASHNER LM, 1974, BRAIN RES, V67, P255, DOI 10.1016/0006-8993(74)90276-5; NASHNER LM, 1976, EXP BRAIN RES, V26, P59; Olindo S, 2006, ARCH NEUROL-CHICAGO, V63, P1560, DOI 10.1001/archneur.63.11.1560; Oliveira P, 2010, UROLOGY, V75, P1100, DOI 10.1016/j.urology.2009.11.041; Orland JR, 2003, NEUROLOGY, V61, P1588, DOI 10.1212/01.WNL.0000096011.92542.DA; OSAME M, 1986, LANCET, V1, P1031; OSAME M, 1990, HUMAN RETROVIROLOGY : HTLV, P191; Reiss DB, 2014, RETROVIROLOGY, V11, P51, DOI DOI 10.1186/1742-4690-11-S1-P51; ROMAN GC, 1988, LANCET, V1, P651; Sato T, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002479; SHIBASAKI H, 1988, J NEUROL SCI, V87, P15, DOI 10.1016/0022-510X(88)90050-0; Shoukri MM, 2004, STAT METHODS MED RES, V13, P251, DOI 10.1191/0962280204sm365ra; Vaz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073990; Watson SRD, 1998, EXP BRAIN RES, V119, P504, DOI 10.1007/s002210050366; [Anonymous], 2000, JAMA, V284, P3043, DOI 10.1001/jama.2013.281053	59	3	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204449	10.1371/journal.pone.0204449	http://dx.doi.org/10.1371/journal.pone.0204449			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30261002	Green Published, Green Submitted, gold			2022-12-26	WOS:000445907400051
J	Yang, KJ; Yang, YL; Xu, ZF; Wu, QG				Yang, Kaijun; Yang, Yulian; Xu, Zhenfeng; Wu, Qinggui			Soil respiration in a subtropical forest of southwestern China: Components, patterns and controls	PLOS ONE			English	Article							CUNNINGHAMIA-LANCEOLATA PLANTATIONS; DIFFERENT SUCCESSIONAL STAGES; MIXED HARDWOOD FOREST; BELOW-GROUND LITTER; CO2 EFFLUX; HETEROTROPHIC RESPIRATION; TEMPERATURE SENSITIVITY; CASTANOPSIS-CARLESII; AUTOTROPHIC COMPONENTS; ENVIRONMENTAL CONTROLS	Partitioning the components of soil respiration is crucial to understand and model carbon cycling in forest ecosystems. In this study, total soil respiration (R-S), autotrophic respiration (R-A), heterotrophic respiration (R-H), litter respiration (R-L), litterfall input and environmental factors were synchronously monitored for 2 years in a subtropical Michelia wilsonii forest of southwestern China. R-H rates were often higher than RA rates during the two years except for the middle growing season (from July to September). The mean rate of Rs, R-A, R-H and R-L was 1.94 mu mol m(-1) s(-1), 0.85 mu mol m(-1) s(-1), 1.09 mu mol m(-1) s(-1) and 0.65 mu mol m(-1) s(-1), respectively, during the 2-year experiment. Annual CO2 emission derived from R-A, R-H and R-L was 3.26 Mg C ha(-1) a(-1), 4.67 Mg C ha(-1) a(-1) and 2.61 Mg C ha(-1) a(-1), respectively, which accounted for 41.4%, 58.6% and 32.9% of R-S. Over the experimental period, the ratio of R-A/R-S increased with soil temperature but the opposite was true for R-H/R-S and R-L/R-S. The Q(10) value was 2.01, 4.01, 1.34 and 1.30, respectively, for R-S, R-A, R-H and R-L. Path analysis indicated that environmental variables and litterfall production together explained 82.0%, 86.8%, 42.9% and 34.7% variations of monthly fluxes of R-S, R-A, R-H and R-L, respectively. Taken together, our results highlight the differential responses of the components of R-S to environmental variables.	[Yang, Kaijun; Yang, Yulian; Wu, Qinggui] Mianyang Normal Univ, Ecol Secur & Protect Key Lab Sichuan Prov, Mianyang, Peoples R China; [Yang, Kaijun; Xu, Zhenfeng] Sichuan Agr Univ, Inst Ecol & Forest, Chengdu, Sichuan, Peoples R China	Mianyang Teachers' College; Sichuan Agricultural University	Wu, QG (corresponding author), Mianyang Normal Univ, Ecol Secur & Protect Key Lab Sichuan Prov, Mianyang, Peoples R China.	qgwu30@163.com	杨, 开军/AAQ-6563-2021	杨, 开军/0000-0003-0085-9395	National Natural Science Foundation of China [31570601]; open project of Ecological Security and Protection Key Laboratory of Sichuan Province [ESP1502]; National Key Research and Development Program of China [2016YFC0502505, 2017YFC0505003]; Key Program of Sichuan Education Department [17ZA0321]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); open project of Ecological Security and Protection Key Laboratory of Sichuan Province; National Key Research and Development Program of China; Key Program of Sichuan Education Department	This project was financially supported by National Natural Science Foundation of China (No. 31570601), the open project of Ecological Security and Protection Key Laboratory of Sichuan Province (ESP1502), the National Key Research and Development Program of China (2016YFC0502505 and 2017YFC0505003) and the Key Program of Sichuan Education Department (17ZA0321). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOWDEN RD, 1993, CAN J FOREST RES, V23, P1402, DOI 10.1139/x93-177; Butler A, 2012, PLANT SOIL, V352, P129, DOI 10.1007/s11104-011-0984-7; [陈光水 Chen Guangshui], 2005, [生态学报, Acta Ecologica Sinica], V25, P1941; Chen XL, 2018, GLOBAL CHANGE BIOL, V24, P3462, DOI 10.1111/gcb.14147; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Davidson EA, 1998, GLOBAL CHANGE BIOL, V4, P217, DOI 10.1046/j.1365-2486.1998.00128.x; Han Tian-Feng, 2011, Chinese Journal of Plant Ecology, V35, P946, DOI 10.3724/SP.J.1258.2011.00946; Huang WJ, 2016, FUNCT ECOL, V30, P1466, DOI 10.1111/1365-2435.12624; Huang ZQ, 2014, PLANT SOIL, V382, P75, DOI 10.1007/s11104-014-2141-6; [李伟 Li Wei], 2016, [林业科学, Scientia Silvae Sinicae], V52, P11; Li Xiao-Jie, 2016, Chinese Journal of Plant Ecology, V40, P447, DOI 10.17521/cjpe.2015.0404; Moinet GYK, 2016, GEODERMA, V274, P68, DOI 10.1016/j.geoderma.2016.03.027; RAICH JW, 1995, GLOBAL BIOGEOCHEM CY, V9, P23, DOI 10.1029/94GB02723; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; Rey A, 2002, GLOBAL CHANGE BIOL, V8, P851, DOI 10.1046/j.1365-2486.2002.00521.x; Schimel D, 2000, SCIENCE, V287, P2004, DOI 10.1126/science.287.5460.2004; Sheng H, 2010, GLOBAL CHANGE BIOL, V16, P1107, DOI 10.1111/j.1365-2486.2009.01988.x; Shi BK, 2015, EUR J SOIL BIOL, V66, P11, DOI 10.1016/j.ejsobi.2014.11.003; Subke JA, 2006, GLOBAL CHANGE BIOL, V12, P921, DOI 10.1111/j.1365-2486.2006.01117.x; Sulzman EW, 2005, BIOGEOCHEMISTRY, V73, P231, DOI 10.1007/s10533-004-7314-6; Tan ZH, 2013, J GEOPHYS RES-ATMOS, V118, P2981, DOI 10.1002/jgrd.50300; Tian DL, 2011, AUST J BOT, V59, P26, DOI 10.1071/BT10191; Tu LH, 2013, SOIL BIOL BIOCHEM, V58, P255, DOI 10.1016/j.soilbio.2012.12.005; Vargas R, 2008, NEW PHYTOL, V179, P460, DOI 10.1111/j.1469-8137.2008.02481.x; Wang CK, 2007, GLOBAL CHANGE BIOL, V13, P123, DOI 10.1111/j.1365-2486.2006.01291.x; Wang W, 2010, SOIL BIOL BIOCHEM, V42, P1236, DOI 10.1016/j.soilbio.2010.04.013; Wang YW, 2015, 2015 1ST IEEE INTERNATIONAL CONFERENCE ON MULTIMEDIA BIG DATA (BIGMM), P128, DOI 10.1109/BigMM.2015.74; Wangdi N, 2017, BIOGEOSCIENCES, V14, P99, DOI 10.5194/bg-14-99-2017; Wu Jun-Jun, 2014, Chinese Journal of Plant Ecology, V38, P45, DOI 10.3724/SP.J.1258.2014.00005; Xu ZF, 2015, J FORESTRY RES, V26, P679, DOI 10.1007/s11676-015-0120-2; Xu ZF, 2015, APPL SOIL ECOL, V93, P105, DOI 10.1016/j.apsoil.2015.04.008; Yang YS, 2007, PLANT ECOL, V193, P71, DOI 10.1007/s11258-006-9249-6; Yi ZG, 2007, FOREST ECOL MANAG, V243, P178, DOI 10.1016/j.foreco.2007.02.022; Yu L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117490; Yu SQ, 2017, SCI TOTAL ENVIRON, V607, P160, DOI 10.1016/j.scitotenv.2017.06.194; Yu ZaiPeng, 2014, Scientia Silvae Sinicae, V50, P7; Zhang Rui, 2015, Yingyong Shengtai Xuebao, V26, P2946	37	7	8	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204341	10.1371/journal.pone.0204341	http://dx.doi.org/10.1371/journal.pone.0204341			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30261012	Green Published, gold, Green Submitted			2022-12-26	WOS:000445907400038
J	Landschoff, J; Komai, T; du Plessis, A; Gouws, G; Griffiths, CL				Landschoff, Jannes; Komai, Tomoyuki; du Plessis, Anton; Gouws, Gavin; Griffiths, Charles L.			MicroCT imaging applied to description of a new species of Pagurus Fabricius, 1775 (Crustacea: Decapoda: Anomura: Paguridae), with selection of three-dimensional type data	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; CRABS CRUSTACEA; HERMIT-CRABS; KING CRABS; CT; DIOGENIDAE; PAGUROIDEA; BRACHYURA; INSIGHTS; SYSTEM	A new species of hermit crab, Pagurus fraserorum n. sp. (family Paguridae) is described from rocky subtidal reefs off KwaZulu-Natal, South Africa, and illustrated using both conventional drawings and colour photographs, and via three-dimensional (3D) X-ray micro-computed tomography (mu CT). Because of the limitation mu CT has in detecting very fine and soft structures, a novel approach of manually drawing setation and spinulation onto the two-dimensional images of the 3D visualizations was used to illustrate the pereopods. In addition, an interactive figure and rotation movie clips in the supplement section complement the species description, and the 3D raw data of the 3D type data are downloadable from the Gigascience Database repository. The new species is the sixth species of Pagurus Fabricius, 1775 reported from South Africa and is closely allied to the Indo-Pacific P. boriaustraliensis Morgen, 1990 and P. pitagsaleei McLaughlin, 2002, from which it differs by its shorter ocular peduncles, by the armature of the carpus of the right cheliped, and also in colouration. This study presents the first description of a hermit crab in which a majority of taxonomic details are illustrated through 3D volume-rendered illustrations. In addition, colour photographs and COI molecular barcodes are provided, and the latter compared to COI sequences of specimens from Western Australia previously identified as P. boriaustraliensis and of specimens of P. pitagsaleei from Taiwan, as well as to three additional South African members of the genus. The South African taxon was confirmed to be genetically distinct from all species tested.	[Landschoff, Jannes; Griffiths, Charles L.] Univ Cape Town, Dept Biol Sci, Rondebosch, Western Cape, South Africa; [Landschoff, Jannes; Griffiths, Charles L.] Univ Cape Town, Marine Res Inst, Rondebosch, Western Cape, South Africa; [Komai, Tomoyuki] Nat Hist Museum & Inst, Chuo Ku, Aoba Cho, Chiba, Japan; [du Plessis, Anton] Stellenbosch Univ, Cent Analyt Facil, CT Scanner, Stellenbosch, Western Cape, South Africa; [Gouws, Gavin] Natl Res Fdn, South African Inst Aquat Biodivers, Grahamstown, Eastern Cape, South Africa	University of Cape Town; University of Cape Town; Stellenbosch University; National Research Foundation - South Africa; South African Institute for Aquatic Biodiversity	Landschoff, J (corresponding author), Univ Cape Town, Dept Biol Sci, Rondebosch, Western Cape, South Africa.; Landschoff, J (corresponding author), Univ Cape Town, Marine Res Inst, Rondebosch, Western Cape, South Africa.	jannes@landschoff.net	Landschoff, Jannes/AAA-6012-2020; du Plessis, Anton/X-4206-2019	du Plessis, Anton/0000-0002-4370-8661	Foundational Biodiversity Information Programme's SeaKeys project; National Research Foundation (NRF); Doctoral Research Scholarship through the University of Cape Town (UCT)	Foundational Biodiversity Information Programme's SeaKeys project; National Research Foundation (NRF); Doctoral Research Scholarship through the University of Cape Town (UCT)	Funding for the senior author's PhD programme was provided through the Foundational Biodiversity Information Programme's SeaKeys project overseen by the South African National Biodiversity Institute (SANBI) and funded through the National Research Foundation (NRF), as well as by a Doctoral Research Scholarship through the University of Cape Town (UCT).	Akkari N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135243; Balss Heinrich, 1911, Zoologischer Anzeiger Leipzig, V38; BARNARD K. H., 1950, ANN S AFRICAN MUS, V38, P1; Barnard K. H., 1947, ANN S AFR MUS, V12, P361; Bell T., 1846, HIST BRIT STALK EYED; Brandt J.F., 1851, REISE AUSSERSTEN NOR, V2, P79; Carbayo F, 2016, ZOOL SCR, V45, P566, DOI 10.1111/zsc.12175; Chevreux E., 1892, B SOC ZOOL FR, V16, P252; Chu K.H., 2009, Crustacean Issues, V18, P89; Dinley J, 2010, J MICROSC-OXFORD, V238, P123, DOI 10.1111/j.1365-2818.2009.03335.x; du Plessis A, 2016, NUCL INSTRUM METH B, V384, P42, DOI 10.1016/j.nimb.2016.08.005; Fabricius JCH, 1775, RYNGOTA SYSTEMA ENTO, V1-32, P1; Faulwetter Sarah, 2014, Microscopy and Analysis, V11, pS9; Faulwetter Sarah, 2013, Microscopy and Analysis, V4, pS4; Faulwetter S, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.263.4261; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fernandez R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096617; Forest J., 1958, Bull Mus Hist nat Paris (2), V30, P184; FOREST J, 1978, Bulletin du Museum National d'Histoire Naturelle Zoologie, P525; Forest J, 1956, B RAFFLES MUS, P45; Forest J., 1955, RESULTATS SCI, V3, P23; Forest J, 1968, ANN I OCEANOGRAPHIQU, V45, P45; Forest J, 1966, SCI RES CALYPSO CAMP, V7, P125; Forest J, 1952, B MUS NATL HIST NAT, V2, P355; FOREST JACQUES, 1958, BULL MUS NATL HIST NAT, V30, P285; Forest Jacques, 1992, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V14, P217; Garcia FH, 2017, ZOOKEYS, P33, DOI 10.3897/zookeys.693.13012; Garcia FH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172641; Gardner C, 1998, J CRUSTACEAN BIOL, V18, P64, DOI 10.2307/1549521; Grant F. E., 1906, P LINN SOC N S W, V31, P1; Greco M, 2008, J APICULT RES, V47, P286, DOI 10.1080/00218839.2008.11101476; HAIG J, 1988, Records of the Australian Museum, V40, P151; Haug Carolin, 2011, International Journal of Zoology, V2011, P1; Hayer S, 2016, ZOOLOGY, V119, P455, DOI 10.1016/j.zool.2016.04.006; Holst S, 2016, J PLANKTON RES, V38, P1225, DOI 10.1093/plankt/fbw054; INGLE RW, 1985, J NAT HIST, V19, P745, DOI 10.1080/00222938500770461; Keiler J, 2016, CONTRIB ZOOL, V85, P361, DOI 10.1163/18759866-08504001; Keiler J, 2015, CONTRIB ZOOL, V84, P149, DOI 10.1163/18759866-08402004; Keiler J, 2013, J MORPHOL, V274, P759, DOI 10.1002/jmor.20133; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kohnk S, 2017, ZOOLOGY, V121, P1, DOI 10.1016/j.zool.2016.11.004; Komai T, 2004, RAFFLES B ZOOL, V52, P183; Komai T, 2001, ZOOL SCI, V18, P1291, DOI 10.2108/zsj.18.1291; Komai T, 2014, RAFFLES B ZOOL, V62, P620; Komai Tomoyuki, 1998, Zoosystema, V20, P265; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Landschoff J, 2015, AFR J MAR SCI, V37, P533, DOI 10.2989/1814232X.2015.1095801; Landschoff J., 2018, THESIS; Landschoff J, 2018, GIGASCIENCE DATABASE, DOI [10.5524/100364, DOI 10.5524/100364]; Landschoff J, 2018, GIGASCIENCE, V7, DOI 10.1093/gigascience/giy022; Landschoff J, 2018, ZOOTAXA, V4379, P268, DOI 10.11646/zootaxa.4379.2.7; Landschoff J, 2017, ZOOKEYS, P21, DOI 10.3897/zookeys.676.12987; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leach W.E, 1815, MALACOSTRACA PODOPHT; MacKinnon RB, 2017, INVERTEBR BIOL, V136, P146, DOI 10.1111/ivb.12164; Malay MCD, 2010, EVOLUTION, V64, P634, DOI 10.1111/j.1558-5646.2009.00848.x; McLaughlin P. A., 1974, ZOOL VERHANDEL LEIDE, V130, P1; McLaughlin PA, 2007, CATALOG HERMIT CRABS; McLaughlin PA, 2007, J CRUSTACEAN BIOL, V27, P97, DOI 10.1651/S-2675.1; McLaughlin PA, 2010, RAFFLES B ZOOL, P5; McLaughlin Patsy A., 2002, Phuket Marine Biological Center Special Publication, V23, P385; McLaughlin Patsy A., 1999, Annals of the South African Museum, V105, P297; Michalik P, 2013, ZOOKEYS, P117, DOI 10.3897/zookeys.352.6021; Morgan G.J, 1990, ZOOLOGISCHE VERHANDE, V265, P1; Noever C, 2016, J SEA RES, V113, P58, DOI 10.1016/j.seares.2015.08.002; Odhner T., 1923, Goteborgs Vetenskaps Handlingar (4), V27, P1; Olguin N, 2013, ZOOTAXA, V3666, P436, DOI 10.11646/zootaxa.3666.4.2; Paoli F, 2015, ARTHROPOD STRUCT DEV, V44, P622, DOI 10.1016/j.asd.2015.09.006; Paul'son O., 1875, STUDIES CRUSTACEA 1; Rahayu Dwi Listyo, 2000, Phuket Marine Biological Center Research Bulletin, V63, P21; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; RISSO A, 1827, HIST NATURELLE PRINC; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sankolli K.N, 1962, J ZOOLOGICAL SOC IND, V13, P136; Sarnat EM, 2016, PLOS ONE, V11, P1, DOI [10.5061/dryad.1j41m, DOI 10.1371/journal.pone.0156709]; Simonsen TJ, 2014, SYST ENTOMOL, V39, P606, DOI 10.1111/syen.12067; Stebbing T. R. R., 1924, Annals of the South African Museum, V19, P235; Stebbing T. R. R., 1920, ANN S AFR MUS, V17, P231, DOI DOI 10.5962/BHL.PART.22316; Stebbing T. R. R., 1910, ANN S AFR MUS, V6, P281, DOI DOI 10.5962/BHL.PART.15558; Stoev Pavel, 2013, Biodivers Data J, pe1013, DOI 10.3897/BDJ.1.e1013; Wipfler B, 2011, SYST ENTOMOL, V36, P241, DOI 10.1111/j.1365-3113.2010.00556.x; Ziegler A, 2012, ZOOSYMPOSIA, V7, P53, DOI 10.11646/zoosymposia.7.1.6	82	11	11	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2018	13	9							e0203107	10.1371/journal.pone.0203107	http://dx.doi.org/10.1371/journal.pone.0203107			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3NB	30256803	gold, Green Published, Green Submitted			2022-12-26	WOS:000446000200010
J	Tompkins, AM; Thomson, MC				Tompkins, Adrian M.; Thomson, Madeleine C.			Uncertainty in malaria simulations in the highlands of Kenya: Relative contributions of model parameter setting, driving climate and initial condition errors	PLOS ONE			English	Article							ANOPHELINE LARVAL HABITATS; LAND-USE; IMPROVED CALIBRATION; SENSITIVITY-ANALYSIS; MULTIMODEL ENSEMBLE; RAINFALL PRODUCTS; GENETIC ALGORITHM; HYDROLOGIC-MODELS; EPIDEMIC MALARIA; PART II	In this study, experiments are conducted to gauge the relative importance of model, initial condition, and driving climate uncertainty for simulations of malaria transmission at a highland plantation in Kericho, Kenya. A genetic algorithm calibrates each of these three factors within their assessed prior uncertainty in turn to see which allows the best fit to a timeseries of confirmed cases. It is shown that for high altitude locations close to the threshold for transmission, the spatial representativeness uncertainty for climate, in particular temperature, dominates the uncertainty due to model parameter settings. Initial condition uncertainty plays little role after the first two years, and is thus important in the early warning system context, but negligible for decadal and climate change investigations. Thus, while reducing uncertainty in the model parameters would improve the quality of the simulations, the uncertainty in the temperature driving data is critical. It is emphasized that this result is a function of the mean climate of the location itself, and it is shown that model uncertainty would be relatively more important at warmer, lower altitude locations.	[Tompkins, Adrian M.] Abdus Salam Int Ctr Theoret Phys ICTP, Earth Syst Phys, Str Costiera 11, Trieste, Italy; [Thomson, Madeleine C.] Columbia Univ, Lamont Doherty Earth Observ, Int Res Inst Climate & Soc, Palisades, NY USA	Abdus Salam International Centre for Theoretical Physics (ICTP); Columbia University	Tompkins, AM (corresponding author), Abdus Salam Int Ctr Theoret Phys ICTP, Earth Syst Phys, Str Costiera 11, Trieste, Italy.	tompkins@ictp.it	Tompkins, Adrian M/N-6472-2013	Tompkins, Adrian M/0000-0003-0975-6691	NIH	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project was initiated during two visits of the lead author to IRI which were financially supported by NIH. Bradfield Lyon and Israel Ukawuba are thanked for providing post-processed and quality controlled climate and health data and advice thereon. MCT Directs the IRI-WHO Collaborating Center (430) Malaria Early Warning Systems and Other Climate Sensitive Diseases and acknowledges the support of WHO in facilitating engagement with national policy makers and practitioners that generates questions for policy relevant research.	Adeyewa ZD, 2003, J APPL METEOROL, V42, P331, DOI 10.1175/1520-0450(2003)042<0331:VOTRRD>2.0.CO;2; Afrane YA, 2005, J MED ENTOMOL, V42, P974, DOI 10.1603/0022-2585(2005)042[0974:EOMCCB]2.0.CO;2; Afrane YA, 2006, AM J TROP MED HYG, V74, P772, DOI 10.4269/ajtmh.2006.74.772; Ali A, 2005, J APPL METEOROL, V44, P1707, DOI 10.1175/JAM2305.1; Alonso D, 2011, P ROY SOC B-BIOL SCI, V278, P1661, DOI 10.1098/rspb.2010.2020; Asare EO, 2016, PLOS ONE IN PRESS, DOI 10.1371/journal.pone.0150626; Asare EO, 2016, GEOSPATIAL HEALTH, V11, P56, DOI 10.4081/gh.2016.390; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; Bomblies A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-223; Boudin C, 2005, AM J TROP MED HYG, V73, P1090, DOI 10.4269/ajtmh.2005.73.1090; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Boyle DP, 2000, WATER RESOUR RES, V36, P3663, DOI 10.1029/2000WR900207; Brohan P, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006548; Buizza R, 1999, Q J ROY METEOR SOC, V125, P2887, DOI 10.1256/smsqj.56005; Caminade C, 2014, P NATL ACAD SCI USA, V111, P3286, DOI 10.1073/pnas.1302089111; Carter R, 2000, B WORLD HEALTH ORGAN, V78, P1401; Cazelles B, 2007, J R SOC INTERFACE, V4, P625, DOI 10.1098/rsif.2007.0212; Chaulagai CN, 2005, HEALTH POLICY PLANN, V20, P375, DOI 10.1093/heapol/czi044; Chitnis N, 2008, B MATH BIOL, V70, P1272, DOI 10.1007/s11538-008-9299-0; Chitnis N, 2010, AM J TROP MED HYG, V83, P230, DOI 10.4269/ajtmh.2010.09-0179; Chitnis Nakul, 2008, Journal of Biological Dynamics, V2, P259, DOI 10.1080/17513750701769857; Colon-Gonzalez FJ, 2016, GEOSPATIAL HEALTH, V11, P18, DOI 10.4081/gh.2016.379; COURTIER P, 1994, Q J ROY METEOR SOC, V120, P1367, DOI 10.1256/smsqj.51911; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; de Velde NV, 2007, AM J EPIDEMIOL, V165, P762, DOI 10.1093/aje/kwk059; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Dinku T, 2007, INT J REMOTE SENS, V28, P1503, DOI 10.1080/01431160600954688; Dinku T, 2015, ATMOS RES, V163, P48, DOI 10.1016/j.atmosres.2015.01.020; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; DUAN QY, 1992, WATER RESOUR RES, V28, P1015, DOI 10.1029/91WR02985; Ermert V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-35; Filipe JAN, 2007, PLOS COMPUT BIOL, V3, P2569, DOI 10.1371/journal.pcbi.0030255; Fillion L, 2003, MON WEATHER REV, V131, P2838, DOI 10.1175/1520-0493(2003)131<2838:JOAOPC>2.0.CO;2; Folland CK, 2001, GEOPHYS RES LETT, V28, P2621, DOI 10.1029/2001GL012877; Gouache D, 2013, AGR FOREST METEOROL, V170, P242, DOI 10.1016/j.agrformet.2012.04.019; Grover-Kopec E, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-6; Gubbins S, 2008, J R SOC INTERFACE, V5, P363, DOI 10.1098/rsif.2007.1110; Gupta HV, 1998, WATER RESOUR RES, V34, P751, DOI 10.1029/97WR03495; Hawkins E, 2009, B AM METEOROL SOC, V90, P1095, DOI 10.1175/2009BAMS2607.1; Hay SI, 2002, TRENDS PARASITOL, V18, P530, DOI 10.1016/S1471-4922(02)02374-7; Hay SI, 2003, LANCET, V361, P1705, DOI 10.1016/S0140-6736(03)13366-1; Hay SI, 2002, NATURE, V415, P905, DOI 10.1038/415905a; HOFFMAN FO, 1994, RISK ANAL, V14, P707, DOI 10.1111/j.1539-6924.1994.tb00281.x; Holm E, 2002, ASSIMILATION MODELLI, P55; Hoshen MB, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-32; Ihshaish H, 2012, PROCEDIA COMPUT SCI, V9, P276, DOI 10.1016/j.procs.2012.04.029; Ionides EL, 2006, P NATL ACAD SCI USA, V103, P18438, DOI 10.1073/pnas.0603181103; Karydis VA, 2012, ATMOS CHEM PHYS, V12, P9041, DOI 10.5194/acp-12-9041-2012; Katz RW, 2002, CLIM RES, V20, P167, DOI 10.3354/cr020167; Kay JE, 2015, B AM METEOROL SOC, V96, P1333, DOI 10.1175/BAMS-D-13-00255.1; Kienberger S, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-29; Kilian AHD, 1999, T ROY SOC TROP MED H, V93, P22, DOI 10.1016/S0035-9203(99)90165-7; Klein EY, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-67; Kleinschmidt I, 2001, AM J EPIDEMIOL, V153, P1213, DOI 10.1093/aje/153.12.1213; Knols BGJ, 1995, T ROY SOC TROP MED H, V89, P604, DOI 10.1016/0035-9203(95)90406-9; Knutti R, 2010, J CLIMATE, V23, P2739, DOI 10.1175/2009JCLI3361.1; Krishnamurti TN, 2000, J CLIMATE, V13, P4196, DOI 10.1175/1520-0442(2000)013<4196:MEFFWA>2.0.CO;2; Lacroix R, 2005, PLOS BIOL, V3, P1590, DOI 10.1371/journal.pbio.0030298; Laneri K, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000898; Larranaga P, 2013, INFORM SCIENCES, V233, P109, DOI 10.1016/j.ins.2012.12.051; Law KB, 2002, VERFICATION RAINFALL; Lazzus JA, 2016, PHYS LETT A, V380, P1164, DOI 10.1016/j.physleta.2016.01.040; Lee YH, 2006, ANN GEOPHYS-GERMANY, V24, P3185, DOI 10.5194/angeo-24-3185-2006; Leedale J, 2016, GEOSPATIAL HEALTH, V11, P102, DOI 10.4081/gh.2016.393; Li SL, 2017, P NATL ACAD SCI USA, V114, P5659, DOI 10.1073/pnas.1617482114; Lindblade KA, 2000, TROP MED INT HEALTH, V5, P263, DOI 10.1046/j.1365-3156.2000.00551.x; Lindblade KA, 1999, T ROY SOC TROP MED H, V93, P480, DOI 10.1016/S0035-9203(99)90344-9; LINDSAY SW, 1993, J MED ENTOMOL, V30, P368, DOI 10.1093/jmedent/30.2.368; Lindstrom T, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004187; LIONG SY, 1995, J HYDRAUL ENG-ASCE, V121, P613, DOI 10.1061/(ASCE)0733-9429(1995)121:8(613); Lowe R, 2016, ELIFE, V5, DOI 10.7554/eLife.11285; Lowe R, 2015, LANCET INFECT DIS, V15, P20, DOI 10.1016/S1473-3099(14)71031-X; Lowe R, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-416; Lowe R, 2013, STAT MED, V32, P864, DOI 10.1002/sim.5549; Lowe R, 2011, COMPUT GEOSCI-UK, V37, P371, DOI 10.1016/j.cageo.2010.01.008; Lu XJ, 2013, AGR FOREST METEOROL, V182, P292, DOI 10.1016/j.agrformet.2013.04.003; Lunde TM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-28; Lunde TM, 2013, PARASITE VECTOR, V6, P1, DOI 10.1186/1756-3305-6-20; Lwetoijera DW, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-57; McCollum JR, 2000, J APPL METEOROL, V39, P666, DOI 10.1175/1520-0450-39.5.666; Minakawa N, 2005, AM J TROP MED HYG, V73, P157, DOI 10.4269/ajtmh.2005.73.157; Molteni F, 1996, Q J ROY METEOR SOC, V122, P73, DOI 10.1002/qj.49712252905; Mordecai EA, 2013, ECOL LETT, V16, P22, DOI 10.1111/ele.12015; Morse AP, 2005, TELLUS A, V57, P464, DOI 10.1111/j.1600-0870.2005.00124.x; Mukabana Wolfgang R., 2002, Malaria Journal, V1, pUnpaginated, DOI 10.1186/1475-2875-1-17; Munga S, 2009, AM J TROP MED HYG, V81, P1079, DOI 10.4269/ajtmh.2009.09-0156; Nicholson SE, 2003, J APPL METEOROL, V42, P1355, DOI 10.1175/1520-0450(2003)042&lt;1355:VOTAOR&gt;2.0.CO;2; Omumbo JA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-12; Paaijmans KP, 2010, P NATL ACAD SCI USA, V107, P15135, DOI 10.1073/pnas.1006422107; Paaijmans KP, 2009, P NATL ACAD SCI USA, V106, P13844, DOI 10.1073/pnas.0903423106; Palmer TN, 2000, REP PROG PHYS, V63, P71, DOI 10.1088/0034-4885/63/2/201; Palmer TN, 2005, ANNU REV EARTH PL SC, V33, P163, DOI 10.1146/annurev.earth.33.092203.122552; Pascual M, 2006, P NATL ACAD SCI USA, V103, P5829, DOI 10.1073/pnas.0508929103; Piccolo C, 2016, MON WEATHER REV, V144, P213, DOI 10.1175/MWR-D-15-0270.1; Piontek F, 2014, P NATL ACAD SCI USA, V111, P3233, DOI 10.1073/pnas.1222471110; Reiner RC, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0849-2; Roesch A, 2014, R PACKAGE VERSION 1; Ruiz D, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-206; Shanks GD, 2005, EMERG INFECT DIS, V11, P1425, DOI 10.3201/eid1109.041131; Stainforth DA, 2005, NATURE, V433, P403, DOI 10.1038/nature03301; Stern DI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024524; Taylor CM, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030572; Taylor CM, 1998, MON WEATHER REV, V126, P1597, DOI 10.1175/1520-0493(1998)126<1597:OEOPCS>2.0.CO;2; Tebaldi C, 2007, PHILOS T R SOC A, V365, P2053, DOI 10.1098/rsta.2007.2076; Thomson MC, 2006, NATURE, V439, P576, DOI 10.1038/nature04503; Thorne V, 2001, INT J REMOTE SENS, V22, P1951, DOI 10.1080/01431160152043658; Tompkins A., 2018, GAP WEATHER CLIMATE; Tompkins A. M., 2016, CLIMATE SERVICES HLT, P130; Tompkins AM, 2016, GEOSPATIAL HEALTH, V11, P38, DOI 10.4081/gh.2016.407; Tompkins AM, 2016, GEOSPATIAL HEALTH, V11, P6, DOI 10.4081/gh.2016.380; Tompkins AM, 2015, J APPL METEOROL CLIM, V54, P521, DOI 10.1175/JAMC-D-14-0156.1; Tompkins AM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-65; Tompkins AM, 2012, J HYDROMETEOROL, V13, P1810, DOI 10.1175/JHM-D-12-039.1; Vie B, 2011, MON WEATHER REV, V139, P403, DOI 10.1175/2010MWR3487.1; Villarini G, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009214; Vrugt JA, 2003, WATER RESOUR RES, V39, DOI 10.1029/2002WR001642; Wallace DI, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-268; Wang L, 2015, THEOR APPL CLIMATOL, V119, P193, DOI 10.1007/s00704-014-1113-3; Wang QJ, 1997, ENVIRON MODELL SOFTW, V12, P27, DOI 10.1016/S1364-8152(96)00030-8; Wanjala CL, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-81; Warner TT, 1997, B AM METEOROL SOC, V78, P2599, DOI 10.1175/1520-0477(1997)078<2599:ATOLBC>2.0.CO;2; Wu WL, 2005, J CLIMATE, V18, P917, DOI 10.1175/JCLI-3293.1; Yamana TK, 2016, NAT CLIM CHANGE, V6, P1009, DOI [10.1038/NCLIMATE3085, 10.1038/nclimate3085]; Yin XD, 2015, J CLIMATE, V28, P1112, DOI 10.1175/JCLI-D-14-00244.1	125	11	11	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2018	13	9							e0200638	10.1371/journal.pone.0200638	http://dx.doi.org/10.1371/journal.pone.0200638			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3NB	30256799	gold, Green Submitted, Green Published			2022-12-26	WOS:000446000200002
J	Willis, EA; Shearer, JJ; Matthews, CE; Hofmann, JN				Willis, Erik A.; Shearer, Joseph J.; Matthews, Charles E.; Hofmann, Jonathan N.			Association of physical activity and sedentary time with blood cell counts: National Health and Nutrition Survey 2003-2006	PLOS ONE			English	Article							PLATELET ACTIVATION; PROSPECTIVE COHORT; CANCER INCIDENCE; UNITED-STATES; LUNG-CANCER; US ADULTS; RISK; INFLAMMATION; MORTALITY; MECHANISMS	Objective To assess the association of objectively measured levels of physical activity and sedentary time with major blood cell counts (e.g. white blood cells, red blood cells, platelets) among adults. Methods Data collected from the 2003-2004 and 2005-2006 cycles of the National Health and Nutrition Examination Survey (NHANES) was used to assess blood cell counts in relation to objectively measured physical activity and sedentary time (accelerometer). A series of linear regressions modes were used to assess these associations adjusting for a range of factors known to be associated with blood cell counts, including age, body mass index, dietary factors, and previous infections. Results Higher levels of moderate-vigorous physical activity (p(trend) < 0.001) and lower sedentary time (p(trend) = 0.040) were associated with lower white blood cell counts. Conclusion These results suggest that modifiable health behaviors, such as physical activity and sedentary time, may be associated with inflammatory status through white blood cell counts, which may be important for future disease risk.	[Willis, Erik A.; Matthews, Charles E.] NCI, Metab Epidemiol Branch, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Willis, Erik A.; Shearer, Joseph J.] NCI, Canc Prevent Fellowship Program, Div Canc Prevent, Bethesda, MD 20892 USA; [Shearer, Joseph J.; Hofmann, Jonathan N.] NCI, Occupat & Environm Epidemiol Branch, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Willis, EA (corresponding author), NCI, Metab Epidemiol Branch, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA.; Willis, EA; Shearer, JJ (corresponding author), NCI, Canc Prevent Fellowship Program, Div Canc Prevent, Bethesda, MD 20892 USA.; Shearer, JJ (corresponding author), NCI, Occupat & Environm Epidemiol Branch, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA.	erik.willis@nih.gov; joe.shearer@nih.gov	Willis, Erik/B-7055-2018; matthews, Charles e/E-8073-2015; Stefanadis, Christodoulos/ABH-2232-2020	Willis, Erik/0000-0002-0114-1660; matthews, Charles e/0000-0001-8037-3103; Stefanadis, Christodoulos/0000-0001-5974-6454	Intramural Research Program of the National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics	Intramural Research Program of the National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics)	This research was supported in part by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported in part by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics. The authors would like to acknowledge all the NHANES participants.	Adams RA, 2012, CLIN HEMORHEOL MICRO, V52, P57, DOI 10.3233/CH-2012-1566; American Cancer Society, LOW BLOOD COUNTS; Arinell K, 2013, PLATELETS, V24, P369, DOI 10.3109/09537104.2012.715215; Bailey SER, 2017, BRIT J GEN PRACT, V67, pE405, DOI 10.3399/bjgp17X691109; Biswas A, 2015, ANN INTERN MED, V162, P123, DOI 10.7326/M14-1651; Borsig L, 2008, EXPERT REV ANTICANC, V8, P1247, DOI 10.1586/14737140.8.8.1247; Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR; Chupel MU, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00377; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Erlinger TP, 2004, CANCER EPIDEM BIOMAR, V13, P1052; Franco AT, 2015, BLOOD, V126, P582, DOI 10.1182/blood-2014-08-531582; Healy GN, 2011, EUR HEART J, V32, P590, DOI 10.1093/eurheartj/ehq451; Hojman P, 2018, CELL METAB, V27, P10, DOI 10.1016/j.cmet.2017.09.015; Iida M, 2012, AM J EPIDEMIOL, V175, P504, DOI 10.1093/aje/kwr345; Johannsen NM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031319; Kabat GC, 2017, AM J EPIDEMIOL, V186, P63, DOI 10.1093/aje/kww226; KONSTAM MA, 1982, CIRCULATION, V66, P638, DOI 10.1161/01.CIR.66.3.638; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Lee YJ, 2006, YONSEI MED J, V47, P646, DOI 10.3349/ymj.2006.47.5.646; Madjid M, 2013, TEX HEART I J, V40, P17; Margolis KL, 2007, ARCH INTERN MED, V167, P1837, DOI 10.1001/archinte.167.17.1837; Matthews CE, 2005, MED SCI SPORT EXER, V37, pS512, DOI 10.1249/01.mss.0000185659.11982.3d; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; McTiernan A, 2008, NAT REV CANCER, V8, P205, DOI 10.1038/nrc2325; Montero D, 2017, AM J PHYSIOL-REG I, V312, pR894, DOI 10.1152/ajpregu.00012.2017; Moore SC, 2016, JAMA INTERN MED, V176, P816, DOI 10.1001/jamainternmed.2016.1548; National Cancer Institute, HLTH EAT IND POP RAT; Pitsavos C, 2005, EUR J CARDIOV PREV R, V12, P151, DOI 10.1097/00149831-200504000-00010; Sprague BL, 2008, CANCER EPIDEM BIOMAR, V17, P2714, DOI 10.1158/1055-9965.EPI-08-0042; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; US Department of Health and Human Services; US Department of Agriculture, 2015, 2015 2020 DIET GUID; Wannamethee SG, 2002, CIRCULATION, V105, P1785, DOI 10.1161/01.CIR.0000016346.14762.71; Zipf George, 2013, Vital Health Stat 1, P1	33	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2018	13	9							e0204277	10.1371/journal.pone.0204277	http://dx.doi.org/10.1371/journal.pone.0204277			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU9BO	30252884	Green Submitted, Green Published, gold			2022-12-26	WOS:000445639700039
J	Fouad, TM; Ueno, NT; Yu, RK; Ensor, JE; Alvarez, RH; Krishnamurthy, S; Lucci, A; Reuben, JM; Yang, W; Willey, JS; Valero, V; Bondy, ML; Cristofinalli, M; Shete, S; Woodward, WA; El-Zein, R				Fouad, Tamer M.; Ueno, Naoto T.; Yu, Robert K.; Ensor, Joe E.; Alvarez, Ricardo H.; Krishnamurthy, Savitri; Lucci, Anthony; Reuben, James M.; Yang, Wei; Willey, Jie S.; Valero, Vicente; Bondy, Melissa L.; Cristofinalli, Massimo; Shete, Sanjay; Woodward, Wendy A.; El-Zein, Randa			Distinct epidemiological profiles associated with inflammatory breast cancer (IBC): A comprehensive analysis of the IBC registry at The University of Texas MD Anderson Cancer Center	PLOS ONE			English	Article							END RESULTS PROGRAM; CARCINOMA INCIDENCE; SURVIVAL; SURVEILLANCE; RISK; DIAGNOSIS; INSTITUTE; FEATURES; WOMEN	Background To date, studies on inflammatory breast cancer (IBC) lack comprehensive epidemiological data. We analyzed detailed prospectively collected clinical and epidemiological data from the IBC Registry at The University of Texas MD Anderson Cancer Center. Methods Patients with IBC (n = 248) were consecutively diagnosed and prospectively enrolled between November 2006 and April 2013. All patients were newly diagnosed and at least 18 years old. Secondary IBC was excluded. Overall 160 variables were collected and evaluated including sociodemographics, anthropometrics, tobacco and alcohol consumption, reproductive variables, and family history data. Results Mean age at diagnosis was 51.6 (+/- 11.5 SD) years, and the majority of patients were White (77.8%). A mean BMI >= 25 kg/m(2), irrespective of menopausal status, was observed in 80.2% of all patients, with 82.6% of African Americans being obese. Approximately 42.2% of patients were ever smokers, and 91% reported ever being pregnant. A history of breastf-eeding was reported in 54% of patients, with significant differences between ethnic groups in favor of White women (P<0.0001). Other reproductive factors such as use of birth control pills & hormone replacement therapy were also more frequently associated with White women compare to other ethnic groups (P < 0.05). In the multivariate Cox proportional hazard analysis, African American or Hispanic ethnicity, not having breastfed, higher clinical stage, and TNBC subtype were associated with shorter survival. Conclusion Our data suggest that IBC is associated with distinct epidemiological profiles. This information could assist in targeting patients with specific preventive strategies based on their modifiable behavioral patterns.	[Fouad, Tamer M.; Ueno, Naoto T.; Alvarez, Ricardo H.; Willey, Jie S.; Valero, Vicente] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA; [Fouad, Tamer M.; Ueno, Naoto T.; Alvarez, Ricardo H.; Krishnamurthy, Savitri; Lucci, Anthony; Reuben, James M.; Yang, Wei; Willey, Jie S.; Valero, Vicente; Bondy, Melissa L.; Cristofinalli, Massimo; Woodward, Wendy A.; El-Zein, Randa] Univ Texas MD Anderson Canc Ctr, Morgan Welch Inflammatory Breast Canc Res Program, Houston, TX 77030 USA; [Yu, Robert K.; Ensor, Joe E.; Shete, Sanjay] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Krishnamurthy, Savitri] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Lucci, Anthony] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Reuben, James M.] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA; [Yang, Wei] Univ Texas MD Anderson Canc Ctr, Dept Diagnost Radiol, Houston, TX 77030 USA; [Woodward, Wendy A.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA; [El-Zein, Randa] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Woodward, WA; El-Zein, R (corresponding author), Univ Texas MD Anderson Canc Ctr, Morgan Welch Inflammatory Breast Canc Res Program, Houston, TX 77030 USA.; Woodward, WA (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA.; El-Zein, R (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA.	wwoodward@mdanderson.org; Rel-zein2@houstonmethodlist.org	Yang, Wei/HIA-0360-2022; Yang, Wei/GWV-4107-2022; Woodward, Wendy/AAX-6593-2020	Lucci, Anthony/0000-0003-4039-174X; Woodward, Wendy/0000-0002-7935-739X	State of Texas Rare and Aggressive Breast Cancer Research Program, the NIH [P30CA016672, R01CA180061]; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA180061] Funding Source: NIH RePORTER	State of Texas Rare and Aggressive Breast Cancer Research Program, the NIH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the State of Texas Rare and Aggressive Breast Cancer Research Program, the NIH (P30CA016672 to NTU and R01CA180061 to WAW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson William F, 2005, Breast Dis, V22, P9; Atkinson RL, 2016, CANCER CAUSE CONTROL, V27, P359, DOI 10.1007/s10552-015-0712-3; Aziz S A, 2001, Breast J, V7, P398, DOI 10.1046/j.1524-4741.2001.07604.x; Beral V, 2001, LANCET, V358, P1389, DOI 10.1016/S0140-6736(01)06524-2; Bonnier P, 1997, INT J CANCER, V72, P720, DOI 10.1002/(SICI)1097-0215(19970904)72:5<720::AID-IJC3>3.0.CO;2-U; Chang S, 1998, J CLIN ONCOL, V16, P3731, DOI 10.1200/JCO.1998.16.12.3731; Chang S, 1998, CANCER, V82, P2366; COLDITZ GA, 1995, CANCER EPIDEM BIOMAR, V4, P567; Cserni G, 2018, EJSO-EUR J SURG ONC, V44, P1128, DOI 10.1016/j.ejso.2018.04.001; Dawood S, 2011, ANN ONCOL, V22, P515, DOI 10.1093/annonc/mdq345; Edge S, 2010, AJCC CANC STAGING HD; Fouad TM, 2015, BREAST CANCER RES TR, V152, P407, DOI 10.1007/s10549-015-3436-x; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Hance KW, 2005, JNCI-J NATL CANCER I, V97, P966, DOI 10.1093/jnci/dji172; Kim T, 2006, CLIN BREAST CANCER, V7, P386, DOI 10.3816/CBC.2006.n.055; Le-Petross HT, 2011, AM J ROENTGENOL, V197, pW769, DOI 10.2214/AJR.10.6157; Levine PH, 2008, SEMIN ONCOL, V35, P11, DOI 10.1053/j.seminoncol.2007.11.018; LEVINE PH, 1985, JNCI-J NATL CANCER I, V74, P291; McCready J, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2578; MOURALI N, 1980, CANCER, V46, P2741, DOI 10.1002/1097-0142(19801215)46:12<2741::AID-CNCR2820461234>3.0.CO;2-W; Stecklein SR, 2017, J CANCER, V8, P1726, DOI 10.7150/jca.20095; van den Brandt PA, 2000, AM J EPIDEMIOL, V152, P514, DOI 10.1093/aje/152.6.514; Wingo PA, 2004, CANCER CAUSE CONTROL, V15, P321, DOI 10.1023/B:CACO.0000024222.61114.18; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Woodward WA, 2015, LANCET ONCOL, V16, pE568, DOI 10.1016/S1470-2045(15)00146-1; Yasuda MT, 2017, GENES ENVIRON, V39, DOI 10.1186/s41021-016-0071-7	26	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2018	13	9							e0204372	10.1371/journal.pone.0204372	http://dx.doi.org/10.1371/journal.pone.0204372			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3MI	30248155	Green Published, Green Submitted, gold			2022-12-26	WOS:000445998100034
J	la Cour, JM; Gojkovic, PW; Ambjorner, SEB; Bagge, J; Jensen, SM; Panina, S; Berchtold, MW				la Cour, Jonas M.; Gojkovic, Pernille Winding; Ambjorner, Sophie E. B.; Bagge, Jonas; Jensen, Simone M.; Panina, Svetlana; Berchtold, Martin W.			ALG-2 participates in recovery of cells after plasma membrane damage by electroporation and digitonin treatment	PLOS ONE			English	Article							APOPTOSIS-LINKED GENE-2; PROTEIN ALG-2; TARGET RECOGNITION; CALCIUM; MECHANISM; BINDING; ALIX; TRANSPORT; REPAIR; LINE	The calcium binding protein ALG-2 is upregulated in several types of cancerous tissues and cancer cell death may be a consequence of ALG-2 downregulation. Novel research suggests that ALG-2 is involved in membrane repair mechanisms, in line with several published studies linking ALG-2 to processes of membrane remodeling and transport, which may contribute to the fitness of cells or protect them from damage. To investigate the involvement of ALG-2 in cell recovery after membrane damage we disrupted the PDCD6 gene encoding the ALG-2 protein in DT-40 cells and exposed them to electroporation. ALG-2 knock-out cells were more sensitive to electroporation as compared to wild type cells. This phenotype could be reversed by reestablishing ALG-2 expression confirming that ALG-2 plays an important role in cell recovery after plasma membrane damage. We found that overexpression of wild type ALG-2 but not a mutated form unable to bind Ca2+ partially protected HeLa cells from digitonin-induced cell death. Further, we were able to inhibit the cell protective function of ALG-2 after digitonin treatment by adding a peptide with the ALG-2 binding sequence of ALIX, which has been proposed to serve as the ALG-2 downstream target in a number of processes including cell membrane repair. Our results suggest that ALG-2 may serve as a novel therapeutic target in combination with membrane damaging interventions.	[la Cour, Jonas M.; Gojkovic, Pernille Winding; Ambjorner, Sophie E. B.; Bagge, Jonas; Jensen, Simone M.; Panina, Svetlana; Berchtold, Martin W.] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Gojkovic, Pernille Winding] Hoiberg, Copenhagen, Denmark	University of Copenhagen	Berchtold, MW (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen, Denmark.	made@bio.ki.dk	Berchtold, Martin W./L-1695-2014; la Cour, Jonas/M-5088-2016	Berchtold, Martin W./0000-0001-8995-9047; la Cour, Jonas/0000-0002-1588-0608; Viswalingam Bagge, Jonas/0000-0002-0884-5337	Nilsson Foundation; Harboe Foundation; AP Moller Foundation; Dagmar Marshall Foundation; Willumsen Foundation; Danielsen Foundation; Wedell Wedellsborg Foundation; Fraenkels Foundation; Hansen Foundation	Nilsson Foundation; Harboe Foundation; AP Moller Foundation; Dagmar Marshall Foundation; Willumsen Foundation; Danielsen Foundation; Wedell Wedellsborg Foundation; Fraenkels Foundation; Hansen Foundation	The work was supported by the Nilsson, Harboe, AP Moller, Dagmar Marshall, Willumsen, Danielsen, Wedell Wedellsborg, Fraenkels, and Hansen Foundations. We thank Casper Hoelmkjaer for technical assistance.	Aviel-Ronen S, 2008, P NATL ACAD SCI USA, V105, P10155, DOI 10.1073/pnas.0709618105; Belete HA, 2010, CELL PHYSIOL BIOCHEM, V25, P71, DOI 10.1159/000272052; Chang H, 2004, CHROMOSOME RES, V12, P299, DOI 10.1023/B:CHRO.0000021947.17128.96; Helm JR, 2014, J BIOL CHEM, V289, P23609, DOI 10.1074/jbc.M114.561829; Henzl MT, 2018, BIOPHYS CHEM, V239, P16, DOI 10.1016/j.bpc.2018.05.001; Hoj BR, 2009, BIOCHEM BIOPH RES CO, V378, P145, DOI 10.1016/j.bbrc.2008.11.021; Hurley JH, 2015, EMBO J, V34, P2398, DOI 10.15252/embj.201592484; Jaiswal JK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4795; Jang IK, 2002, MOL CELL BIOL, V22, P4094, DOI 10.1128/MCB.22.12.4094-4100.2002; Jimenez AJ, 2014, SCIENCE, V343, P986, DOI 10.1126/science.1247136; Kitaura Y, 2001, J BIOL CHEM, V276, P14053, DOI 10.1074/jbc.M008649200; la Cour JM, 2003, AM J PATHOL, V163, P81, DOI 10.1016/S0002-9440(10)63632-2; la Cour JM, 2007, BIOCHEM BIOPH RES CO, V353, P1063, DOI 10.1016/j.bbrc.2006.12.143; la Cour JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075309; la Cour JM, 2008, MOL ONCOL, V1, P431, DOI 10.1016/j.molonc.2007.08.002; Li XR, 2016, NAT CELL BIOL, V18, P404, DOI 10.1038/ncb3324; Longo PA, 2013, METHOD ENZYMOL, V529, P227, DOI 10.1016/B978-0-12-418687-3.00018-5; Mahul-Mellier AL, 2006, J NEUROSCI, V26, P542, DOI 10.1523/JNEUROSCI.3069-05.2006; Maki M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091401; McGourty CA, 2016, CELL, V167, P525, DOI 10.1016/j.cell.2016.09.026; Missotten M, 1999, CELL DEATH DIFFER, V6, P124, DOI 10.1038/sj.cdd.4400456; Qin J, 2017, ONCOTARGET, V8, P2745, DOI 10.18632/oncotarget.13740; Rao RV, 2004, J BIOL CHEM, V279, P177, DOI 10.1074/jbc.M304490200; Scheffer LL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6646; Shibata H, 2004, J BIOCHEM, V135, P117, DOI 10.1093/jb/mvh014; Shibata H, 2008, J BIOL CHEM, V283, P9623, DOI 10.1074/jbc.M800717200; Su D, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-31; Subramanian L, 2004, BIOCHEM BIOPH RES CO, V322, P1153, DOI 10.1016/j.bbrc.2004.07.109; Takahashi T, 2015, INT J MOL SCI, V16, P3677, DOI 10.3390/ijms16023677; Tarabykina S, 2004, FRONT BIOSCI-LANDMRK, V9, P1817, DOI 10.2741/1358; Tarabykina S, 2000, J BIOL CHEM, V275, P10514, DOI 10.1074/jbc.275.14.10514; Vergarajauregui S, 2009, J BIOL CHEM, V284, P36357, DOI 10.1074/jbc.M109.047241; Vito P, 1999, J BIOL CHEM, V274, P1533, DOI 10.1074/jbc.274.3.1533; Vito P, 1996, SCIENCE, V271, P521, DOI 10.1126/science.271.5248.521; Winding P, 2001, J IMMUNOL METHODS, V249, P1, DOI 10.1016/S0022-1759(00)00333-1	35	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2018	13	9							e0204520	10.1371/journal.pone.0204520	http://dx.doi.org/10.1371/journal.pone.0204520			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU5MM	30240438	Green Submitted, Green Published, gold			2022-12-26	WOS:000445329700057
J	Sutherland, TD; Sriskantha, A; Rapson, TD; Kaehler, BD; Huttley, GA				Sutherland, Tara D.; Sriskantha, Alagacone; Rapson, Trevor D.; Kaehler, Benjamin D.; Huttley, Gavin A.			Did aculeate silk evolve as an antifouling material?	PLOS ONE			English	Article							SMALL-INTESTINAL SUBMUCOSA; COILED-COIL DOMAINS; ANTIMICROBIAL PEPTIDES; EXTRACELLULAR-MATRIX; HONEYBEE SILK; RECONSTRUCTION; RESISTANCE; INFECTION; PROTEINS; POLYTETRAFLUOROETHYLENE	Many of the challenges we currently face as an advanced society have been solved in unique ways by biological systems. One such challenge is developing strategies to avoid microbial infection. Social aculeates (wasps, bees and ants) mitigate the risk of infection to their colonies using a wide range of adaptations and mechanisms. These adaptations and mechanisms are reliant on intricate social structures and are energetically costly for the colony. It seems likely that these species must have had alternative and simpler mechanisms in place to ensure the maintenance of hygienic domicile conditions prior to the evolution of these complex behaviours. Features of the aculeate coiled-coil silk proteins are reminiscent of those of naturally occurring alpha-helical antimicrobial peptides (AMPs). In this study, we demonstrate that peptides derived from the aculeate silk proteins have antimicrobial activity. We reconstruct the predicted ancestral silk sequences of an aculeate ancestor that predates the evolution of sociality and demonstrate that these ancestral sequences also contained peptides with antimicrobial properties. It is possible that the silks evolved as an antifouling material and facilitated the evolution of sociality. These materials serve as model materials for consideration in future biomaterial development.	[Sutherland, Tara D.; Sriskantha, Alagacone; Rapson, Trevor D.] CSIRO, Hlth & Biosecur, Canberra, ACT, Australia; [Kaehler, Benjamin D.; Huttley, Gavin A.] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Australian National University	Sutherland, TD (corresponding author), CSIRO, Hlth & Biosecur, Canberra, ACT, Australia.	Tara.Sutherland@CSIRO.au	Sutherland, Tara/B-5635-2009; Huttley, Gavin/G-5169-2015; Rapson, Trevor/B-3510-2012	Sutherland, Tara/0000-0001-5211-4593; Huttley, Gavin/0000-0001-7224-2074; Rapson, Trevor/0000-0003-1289-0146; Kaehler, Benjamin/0000-0002-5318-9551	Australian Commonwealth Scientific and Industrial Research Organisation; Wellcome Trust (UK); University of Queensland (Australia)	Australian Commonwealth Scientific and Industrial Research Organisation; Wellcome Trust (UK)(Wellcome Trust); University of Queensland (Australia)(University of Queensland)	Funding provided by the Australian Commonwealth Scientific and Industrial Research Organisation. Antimicrobial screening was performed by CO-ADD (The Community for Antimicrobial Drug Discovery), funded by the Wellcome Trust (UK) and The University of Queensland (Australia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Antimicrobial screening was performed by CO-ADD (The Community for Antimicrobial Drug Discovery), funded by the Wellcome Trust (UK) and The University of Queensland (Australia). We thank Ella Cuthbert from Lyneham High school for conducting the initial study and identifying the KIKT peptide and Holly Trueman for the idea that the aculeate silks facilitated the evolution of sociality.	Anderson KE, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058425, 10.1371/journal.pone.0083125]; Badylak SF, 2003, J BIOMED MATER RES B, V67B, P648, DOI 10.1002/jbm.b.10062; BADYLAK SF, 1994, J VASC SURG, V19, P465, DOI 10.1016/S0741-5214(94)70073-7; Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013; BIS Research, 2017, GLOB BIOM MARK AN FO; Boomsma J.J., 2005, P139, DOI 10.1079/9780851998121.0139; Brady SG, 2006, P ROY SOC B-BIOL SCI, V273, P1643, DOI 10.1098/rspb.2006.3496; Brennan EP, 2006, TISSUE ENG, V12, P2949, DOI 10.1089/ten.2006.12.2949; Campbell PM, 2014, INSECT BIOCHEM MOLEC, V48, P40, DOI 10.1016/j.ibmb.2014.02.009; Carlson GA, 2004, BIOCHEM BIOPH RES CO, V321, P472, DOI 10.1016/j.bbrc.2004.06.165; Clare DA, 2003, CURR PHARM DESIGN, V9, P1239, DOI 10.2174/1381612033454874; Corby-Harris V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095056; Cremer S, 2007, CURR BIOL, V17, pR693, DOI 10.1016/j.cub.2007.06.008; Daghighi S, 2013, BIOMATERIALS, V34, P8013, DOI 10.1016/j.biomaterials.2013.07.044; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; ELEK SD, 1957, BRIT J EXP PATHOL, V38, P573; Fountain T, 2011, INSECT SOC, V58, P453, DOI 10.1007/s00040-011-0162-1; GILLIAM M, 1987, J INVERTEBR PATHOL, V49, P70, DOI 10.1016/0022-2011(87)90127-3; Grimaldi David, 2005, pi; Hartmann M, 2010, ANTIMICROB AGENTS CH, V54, P3132, DOI 10.1128/AAC.00124-10; HEPBURN HR, 1979, INSECT BIOCHEM, V9, P69, DOI 10.1016/0020-1790(79)90028-3; Hoge R., 2010, CURR RES TECHNOL ED, P383; Huang YB, 2010, PROTEIN CELL, V1, P143, DOI 10.1007/s13238-010-0004-3; Hughes WOH, 2008, SCIENCE, V320, P1213, DOI 10.1126/science.1156108; Ibrahim HR, 2011, J AGR FOOD CHEM, V59, P10336, DOI 10.1021/jf2020396; Jernigan TW, 2004, ANN SURG, V239, P733, DOI 10.1097/01.sla.0000124447.30808.c7; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kaur J, 2014, BIOPOLYMERS, V101, P237, DOI 10.1002/bip.22323; Knight R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r171; Lizzi AR, 2009, MINI-REV MED CHEM, V9, P687, DOI 10.2174/138955709788452757; Lok CN, 2007, J BIOL INORG CHEM, V12, P527, DOI 10.1007/s00775-007-0208-z; Lopez-Exposito I, 2006, J FOOD PROTECT, V69, P2992, DOI 10.4315/0362-028X-69.12.2992; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; Mak P, 2000, ANTON LEEUW INT J G, V77, P197, DOI 10.1023/A:1002081605784; Menon NG, 2003, ANN PLAS SURG, V50, P523, DOI 10.1097/01.SAP.0000044252.76804.6B; Moriarty TF, 2016, EFORT OPEN REV, V1, P89, DOI 10.1302/2058-5241.1.000037; Piccini C, 2004, J APICULT RES, V43, P101, DOI 10.1080/00218839.2004.11101118; Pie MR, 2005, ETHOL ECOL EVOL, V17, P41; Piterina AV, 2009, INT J MOL SCI, V10, P4375, DOI 10.3390/ijms10104375; Promnuan Y, 2009, WORLD J MICROB BIOT, V25, P1685, DOI 10.1007/s11274-009-0051-1; Pupko T, 2000, MOL BIOL EVOL, V17, P890, DOI 10.1093/oxfordjournals.molbev.a026369; Ramamoorthy A, 2006, BIOPHYS J, V91, P206, DOI 10.1529/biophysj.105.073890; Sarikaya A, 2002, TISSUE ENG, V8, P63, DOI 10.1089/107632702753503063; Sezutsu H, 2007, BIOSCI BIOTECH BIOCH, V71, P2725, DOI 10.1271/bbb.70326; Shell DH, 2005, ANN SURG, V241, P995, DOI 10.1097/01.sla.0000165186.79097.6c; Sutherland TD, 2007, MOL BIOL EVOL, V24, P2424, DOI 10.1093/molbev/msm171; Sutherland TD, 2006, GENOME RES, V16, P1414, DOI 10.1101/gr.5052606; Sutherland TD, 2018, J STRUCT BIOL, V201, P76, DOI 10.1016/j.jsb.2017.10.012; Sutherland TD, 2014, J STRUCT BIOL, V186, P402, DOI 10.1016/j.jsb.2014.01.002; Sutherland TD, 2010, ANNU REV ENTOMOL, V55, P171, DOI 10.1146/annurev-ento-112408-085401; Tranter C, 2015, BEHAV ECOL SOCIOBIOL, V69, P1687, DOI 10.1007/s00265-015-1980-3; Trueman HE, 2017, ACS OMEGA, V2, P4456, DOI 10.1021/acsomega.7b00694; Walker AA, 2013, J MATER CHEM B, V1, P3644, DOI 10.1039/c3tb20611d; Weisman S, 2010, BIOMATERIALS, V31, P2695, DOI 10.1016/j.biomaterials.2009.12.021; Woodhead AL, 2018, POLYMERS-BASEL, V10, DOI 10.3390/polym10070776; Wright Simon, 2012, BMC Res Notes, V5, P326, DOI 10.1186/1756-0500-5-326; Yap VB, 2010, MOL BIOL EVOL, V27, P726, DOI 10.1093/molbev/msp232	57	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2018	13	9							e0203948	10.1371/journal.pone.0203948	http://dx.doi.org/10.1371/journal.pone.0203948			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU5MM	30240428	Green Published, Green Submitted, gold			2022-12-26	WOS:000445329700016
J	Dou, CW; Zhou, ZY; Xu, QR; Liu, ZK; Zeng, YQ; Wang, YF; Li, Q; Wang, L; Yang, W; Liu, QG; Tu, KS				Dou, Changwei; Zhou, Zhenyu; Xu, Qiuran; Liu, Zhikui; Zeng, Yuqun; Wang, Yufeng; Li, Qing; Wang, Liang; Yang, Wei; Liu, Qingguang; Tu, Kangsheng			Hypoxia-induced TUFT1 promotes the growth and metastasis of hepatocellular carcinoma by activating the Ca2+/PI3K/AKT pathway	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR HYPOXIA; CANCER CELLS; EXPRESSION; TUFTELIN; INDUCTION; PROTEIN; GENE; RESISTANCE; HALLMARKS	Tuftelin1 (TUFT1), an acidic protein constituent of developing and mineralizing tooth tissues, is regulated by hypoxia and the Hedgehog signaling pathway. We investigated the role of TUFT1 in hepatocellular carcinoma (HCC). qRT-PCR, immunohistochemistry and western blot were employed to evaluate TUFT1 level in HCC. MTT, BrdU, 3D culture and Transwell assays were used to assess cell viability, proliferation, in vitro growth, migration, and invasion. Subcutaneous and tail vein injection models were established to investigate in vivo growth and metastasis. Chromatin immunoprecipitation was performed to assess binding of hypoxia-inducible factor 1 alpha (HIF-1 alpha) to TUFT1 promoter. A microRNA array was used to identify hypoxia-related microRNAs. TUFT1 was elevated in HCC, and correlated with unfavorable clinicopathologic characteristics and poor survival. TUFT1 promoted HCC cell growth, metastasis and epithelial-mesenchymal transition in vitro and in vivo via activation of Ca2+/PI3K/AKT pathway. Hypoxia induced TUFT1 expression in an HIF-1 alpha dependent manner, and TUFT1 expression was positively correlated with HIF-1a level in HCC tissues. Hypoxiaenhanced TUFT1 expression by downregulating miR-671-5p rather than by directly promoting the binding of HIF-1 alpha to TUFT1 promoter. MiR-671-5p interacted with the 3'-UTR of TUFT1 mRNA and subsequently inhibited TUFT1 expression. Consequently, knockdown of TUFT1 blocked the effects of hypoxia in promoting HCC progression. TUFT1 promoted the growth, metastasis and EMT of HCC cells through activating Ca2+/PI3K/AKT pathway. The hypoxic microenvironment increased the expression of TUFT1 via downregulation of miR-671-5p. TUFT1 may function as a potential therapeutic target for the intervention and treatment of HCC.	[Dou, Changwei; Liu, Zhikui; Wang, Yufeng; Li, Qing; Wang, Liang; Yang, Wei; Liu, Qingguang; Tu, Kangsheng] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Xian 710061, Shaanxi, Peoples R China; [Dou, Changwei] Hangzhou Med Coll, Peoples Hosp, Zhejiang Prov Peoples Hosp, Dept Hepatopancreatobiliary Surg & Minimally Inva, Hangzhou, Zhejiang, Peoples R China; [Zhou, Zhenyu] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Hepatobiliary Surg, Guangzhou 510120, Guangdong, Peoples R China; [Xu, Qiuran] Hangzhou Med Coll, Peoples Hosp, Zhejiang Prov Peoples Hosp, Key Lab Tumor Mol Diag & Individualized Med Zheji, Hangzhou 310014, Zhejiang, Peoples R China; [Zeng, Yuqun] Hangzhou Med Coll, Peoples Hosp, Zhejiang Prov Peoples Hosp, Dept Nephrol, Hangzhou 310014, Zhejiang, Peoples R China	Xi'an Jiaotong University; Hangzhou Medical College; Zhejiang Provincial People's Hospital; Sun Yat Sen University; Hangzhou Medical College; Zhejiang Provincial People's Hospital; Hangzhou Medical College; Zhejiang Provincial People's Hospital	Liu, QG; Tu, KS (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Xian 710061, Shaanxi, Peoples R China.	liuqingguang@vip.sina.com; tks0912@foxmail.com	dou, dou/ABB-4731-2020	Tu, Kangsheng/0000-0002-0032-1459; Zhou, Zhenyu/0000-0002-7934-4425; Xu, Qiuran/0000-0003-2171-9279	National Natural Science Foundation of China [81874049, 81773123, 81572847, 81502092]; Innovation Capacity Support Plan in Shaanxi Province of China [2018KJXX-045]; Fundamental Research Funds for the Central Universities [7N010011015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Capacity Support Plan in Shaanxi Province of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by grants from the National Natural Science Foundation of China (81874049, 81773123, 81572847, 81502092); Innovation Capacity Support Plan in Shaanxi Province of China (2018KJXX-045); the Fundamental Research Funds for the Central Universities (7N010011015).	Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bristow RG, 2008, NAT REV CANCER, V8, P180, DOI 10.1038/nrc2344; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Carnero A, 2016, BIOESSAYS, V38, pS65, DOI 10.1002/bies.201670911; Chang YN, 2016, GENE, V575, P1, DOI 10.1016/j.gene.2015.08.049; Choudhry H, 2016, MOL ASPECTS MED, V47-48, P35, DOI 10.1016/j.mam.2016.01.003; Davis FM, 2014, ONCOGENE, V33, P2307, DOI 10.1038/onc.2013.187; Deutsch D, 1998, EUR J ORAL SCI, V106, P315, DOI 10.1111/j.1600-0722.1998.tb02192.x; DEUTSCH D, 1995, INT J DEV BIOL, V39, P135; Dou CW, 2016, CANCER LETT, V381, P380, DOI 10.1016/j.canlet.2016.08.011; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Giatromanolaki A, 2001, ANTICANCER RES, V21, P4317; Gwak GY, 2005, J HEPATOL, V42, P358, DOI 10.1016/j.jhep.2004.11.020; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Jubb A, 2005, J CLIN PATHOL, V58, P1344; Kawasaki N, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-017-0001-2; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Lee Ji-Won, 2004, Experimental & Molecular Medicine, V36, P1; Leiser Y, 2007, ANAT REC, V290, P449, DOI 10.1002/ar.20512; Leiser Y, 2011, J CELL PHYSIOL, V226, P165, DOI 10.1002/jcp.22318; Li XH, 2012, ONCOL REP, V28, P77, DOI 10.3892/or.2012.1769; Maluccio M, 2012, CA-CANCER J CLIN, V62, P394, DOI 10.3322/caac.21161; Mao ZK, 2001, GENE, V279, P181, DOI 10.1016/S0378-1119(01)00749-1; Meng H, 2015, AM J CANCER RES, V5, P1062; Oliveira FS, 2012, J CELL BIOCHEM, V113, P204, DOI 10.1002/jcb.23345; Poon E, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001173; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Rankin EB, 2016, SCIENCE, V352, P175, DOI 10.1126/science.aaf4405; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Ruan K, 2009, J CELL BIOCHEM, V107, P1053, DOI 10.1002/jcb.22214; Sliz E, 2017, TUFT1 NOVEL CANDIDAT, V12; Sliz E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175474; Soni S, 2017, ACTA ONCOL, V56, P503, DOI 10.1080/0284186X.2017.1301680; Tan XH, 2016, ONCOTARGET, V7, P293, DOI 10.18632/oncotarget.6344; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wen L, 2016, SCI REP-UK, V6, DOI 10.1038/srep23269; Wu XZ, 2007, J GASTROEN HEPATOL, V22, P1178, DOI 10.1111/j.1440-1746.2007.04997.x; Xu S, 2016, CELL CYCLE, V15, P2920, DOI 10.1080/15384101.2016.1224043; Zhang YH, 2017, LAB INVEST, V97, P53, DOI 10.1038/labinvest.2016.127; Zheng X, 2013, ONCOL REP, V30, P2020, DOI 10.3892/or.2013.2690; Zheng X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049581; Zhou B, 2016, CANCER LETT, V382, P11, DOI 10.1016/j.canlet.2016.08.017	45	76	82	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 21	2019	38	8					1239	1255		10.1038/s41388-018-0505-8	http://dx.doi.org/10.1038/s41388-018-0505-8			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HM1XR	30250300				2022-12-26	WOS:000459249800007
J	Wang, YT; Li, Y; Zou, JJ; Polster, SP; Lightle, R; Moore, T; Dimaano, M; He, TC; Weber, CR; Awad, IA; Shen, L				Wang, Yitang; Li, Ye; Zou, Jinjing; Polster, Sean P.; Lightle, Rhonda; Moore, Thomas; Dimaano, Matthew; He, Tong-Chuan; Weber, Christopher R.; Awad, Issam A.; Shen, Le			The cerebral cavernous malformation disease causing gene KRIT1 participates in intestinal epithelial barrier maintenance and regulation	FASEB JOURNAL			English	Article						actin cytoskeleton; tight junction; tumor necrosis factor	TIGHT JUNCTION BARRIER; RHO-KINASE; VASCULAR-PERMEABILITY; MDCK CELLS; PROTEIN INTERACTIONS; BINDING-PROTEIN; E-CADHERIN; OCCLUDIN; EXPRESSION; MUTATIONS	Epithelial barrier maintenance and regulation requires an intact perijunctional actomyosin ring underneath the cell-cell junctions. By searching for known factors affecting the actin cytoskeleton, we identified Krev interaction trapped protein 1 (KRIT1) as a major regulator for epithelial barrier function through multiple mechanisms. KRIT1 is expressed in both small intestinal and colonic epithelium, and KRIT1 knockdown in differentiated Caco-2 intestinal epithelium decreases epithelial barrier function and increases cation selectivity. KRIT1 knockdown abolished Rho-associated protein kinase-induced and myosin II motor inhibitor-induced barrier loss by limiting both small and large molecule permeability but did not affect myosin light chain kinase-induced increases in epithelial barrier function. These data suggest that KRIT1 participates in Rho-associated protein kinase- and myosin II motor-dependent (but not myosin light chain kinase-dependent) epithelial barrier regulation. KRIT1 knockdown exacerbated low-dose TNF-induced barrier loss, along with increased cleaved caspase-3 production. Both events are blocked by pan-caspase inhibition, indicating that KRIT1 regulates TNF-induced barrier loss through limiting epithelial apoptosis. These data indicate that KRIT1 controls epithelial barrier maintenance and regulation through multiple pathways, suggesting that KRIT1 mutation in cerebral cavernous malformation disease may alter epithelial function and affect human health.Wang, Y., Li, Y., Zou, J., Polster, S. P., Lightle, R., Moore, T., Dimaano, M., He, T.-C., Weber, C. R., Awad, I. A., Shen, L. The cerebral cavernous malformation disease causing gene KRIT1 participates in intestinal epithelial barrier maintenance and regulation.	[Wang, Yitang; Li, Ye; Polster, Sean P.; Lightle, Rhonda; Moore, Thomas; Awad, Issam A.; Shen, Le] Univ Chicago, Dept Surg, Sect Neurosurg, 5841 S Maryland Ave,MC1089, Chicago, IL 60637 USA; [Wang, Yitang; Li, Ye; Zou, Jinjing; Weber, Christopher R.; Shen, Le] Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Dimaano, Matthew] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA; [He, Tong-Chuan] Univ Chicago, Dept Orthopaed Surg & Rehabil Med, Chicago, IL 60637 USA; [Zou, Jinjing] Wuhan Univ, Renmin Hosp, Dept Pulm & Crit Care Med, Wuhan, Hubei, Peoples R China	University of Chicago; University of Chicago; University of Chicago; University of Chicago; Wuhan University	Shen, L (corresponding author), Univ Chicago, Dept Surg, Sect Neurosurg, 5841 S Maryland Ave,MC1089, Chicago, IL 60637 USA.	leshen@uchicago.edu	Wang, Yin/HCI-9352-2022; wangwangwang, yuanyaun/HHN-6432-2022; Wang, Yanbo/HFZ-8018-2022; Wang, Yuan/HHC-1520-2022; wang, yi/GVT-8516-2022; wang, yan/GSE-6489-2022	Weber, Christopher/0000-0002-2117-3184; Polster, Sean/0000-0002-3229-5021	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [K01DK092381, P30DK042086]; U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (through The University of Chicago Digestive Disease Research Core Center Pilot and Feasibility Award Program); Safadi Program of Excellence in Clinical and Translational Neuroscience at The University of Chicago; National Natural Science Foundation of China [81400008]; American Association of Neurological Surgeons; Judy and Bill Davis Fund in Neurovascular Surgery Research at The University of Chicago Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK042086] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (through The University of Chicago Digestive Disease Research Core Center Pilot and Feasibility Award Program); Safadi Program of Excellence in Clinical and Translational Neuroscience at The University of Chicago; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); American Association of Neurological Surgeons; Judy and Bill Davis Fund in Neurovascular Surgery Research at The University of Chicago Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank The University of Chicago Integrated Light Microscopy Core for assistance with imaging; Candace Chan and The University of Chicago Digestive Research Core Center for enteroid culture; Douglas Marchuk (Duke University, Durham, NC, USA) for providing KRIT1 encoding plasmid; Wenli Dai, Pan Li, Yuehua Wei, and Qing Wu (all from The University of Chicago) for technical support and critical reading of the manuscript; and Ying Cao (The University of Chicago) for advice on biostatistical analyses. This research was supported, in part, by the U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Grants K01DK092381 (to L.S.) and P30DK042086 (to L.S., through The University of Chicago Digestive Disease Research Core Center Pilot and Feasibility Award Program); the Pilot Award from the Safadi Program of Excellence in Clinical and Translational Neuroscience at The University of Chicago (to L.S.); National Natural Science Foundation of China Grant 81400008 (to J.Z.); and the Dempsey Research Award from the American Association of Neurological Surgeons (to S.P.P.). L.S. also received partial support from the Judy and Bill Davis Fund in Neurovascular Surgery Research at The University of Chicago Medicine. The authors declare no conflicts of interest.	Akers A, 2017, NEUROSURGERY, V80, P665, DOI 10.1093/neuros/nyx091; Allingham JS, 2005, NAT STRUCT MOL BIOL, V12, P378, DOI 10.1038/nsmb908; Balda MS, 2016, CURR OPIN CELL BIOL, V42, P94, DOI 10.1016/j.ceb.2016.05.006; BENTZEL CJ, 1976, NATURE, V264, P666, DOI 10.1038/264666a0; Bergametti F, 2005, AM J HUM GENET, V76, P42, DOI 10.1086/426952; Borikova AL, 2010, J BIOL CHEM, V285, P11760, DOI 10.1074/jbc.C109.097220; Buckley A, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a029314; Buschmann MM, 2013, MOL BIOL CELL, V24, P3056, DOI 10.1091/mbc.E12-09-0688; Capaldo CT, 2007, MOL BIOL CELL, V18, P189, DOI 10.1091/mbc.E06-05-0471; Chow BW, 2015, TRENDS NEUROSCI, V38, P598, DOI 10.1016/j.tins.2015.08.003; Clayburgh DR, 2005, J CLIN INVEST, V115, P2702, DOI 10.1172/JCI24970; Corr M, 2012, ARTERIOSCL THROM VAS, V32, P2702, DOI 10.1161/ATVBAHA.112.300115; Deng F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113064; Denier C, 2004, AM J HUM GENET, V74, P326, DOI 10.1086/381718; DUFFEY ME, 1981, NATURE, V294, P451, DOI 10.1038/294451a0; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Girard R, 2017, J NEUROSURG, V127, P102, DOI 10.3171/2016.5.JNS16687; Gitter AH, 2001, GASTROENTEROLOGY, V121, P1320, DOI 10.1053/gast.2001.29694; Gitter AH, 2000, FASEB J, V14, P1749, DOI 10.1096/fj.99-0898com; Glading AJ, 2010, DIS MODEL MECH, V3, P73, DOI 10.1242/dmm.003293; Goitre L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08373-4; Guclu B, 2005, NEUROSURGERY, V57, P1008, DOI 10.1227/01.NEU.0000180811.56157.E1; Hecht G, 1996, AM J PHYSIOL-CELL PH, V271, pC1678, DOI 10.1152/ajpcell.1996.271.5.C1678; Imai M, 2015, SCI REP-UK, V5, DOI 10.1038/srep14208; Inai T, 1999, EUR J CELL BIOL, V78, P849, DOI 10.1016/S0171-9335(99)80086-7; Ivanov AI, 2004, MOL BIOL CELL, V15, P2639, DOI 10.1091/mbc.E04-02-0163; Komarova Y, 2010, ANNU REV PHYSIOL, V72, P463, DOI 10.1146/annurev-physiol-021909-135833; Laberge-le Couteulx S, 1999, NAT GENET, V23, P189, DOI 10.1038/13815; Liquori CL, 2003, AM J HUM GENET, V73, P1459, DOI 10.1086/380314; Marchiando AM, 2011, GASTROENTEROLOGY, V140, P1208, DOI 10.1053/j.gastro.2011.01.004; Marchiando AM, 2010, J CELL BIOL, V189, P111, DOI 10.1083/jcb.200902153; McCarthy KM, 2000, J CELL SCI, V113, P3387; McDonald DA, 2012, STROKE, V43, P571, DOI 10.1161/STROKEAHA.111.625467; MEZA I, 1982, J CELL BIOCHEM, V18, P407, DOI 10.1002/jcb.1982.240180403; Mikati AG, 2015, J CEREBR BLOOD F MET, V35, P1632, DOI 10.1038/jcbfm.2015.98; Raleigh DR, 2011, J CELL BIOL, V193, P565, DOI 10.1083/jcb.201010065; Sahoo T, 1999, HUM MOL GENET, V8, P2325, DOI 10.1093/hmg/8.12.2325; Samarin SN, 2007, MOL BIOL CELL, V18, P3429, DOI 10.1091/mbc.E07-04-0315; Schmitz H, 1999, J CELL SCI, V112, P137; Schulzke JD, 2006, ANN NY ACAD SCI, V1072, P288, DOI 10.1196/annals.1326.027; Schumann M, 2017, CELL MOL GASTROENTER, V3, P150, DOI 10.1016/j.jcmgh.2016.12.006; Shen L, 2005, MOL BIOL CELL, V16, P3919, DOI 10.1091/mbc.E04-12-1089; Shen L, 2008, J CELL BIOL, V181, P683, DOI 10.1083/jcb.200711165; Shen L, 2006, J CELL SCI, V119, P2095, DOI 10.1242/jcs.02915; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; Shenkar R, 2017, STROKE, V48, P187, DOI 10.1161/STROKEAHA.116.015013; Shewan AM, 2005, MOL BIOL CELL, V16, P4531, DOI 10.1091/mbc.E05-04-0330; Stockton RA, 2010, J EXP MED, V207, P881, DOI 10.1084/jem.20091258; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Sutton TA, 2001, AM J PHYSIOL-RENAL, V281, pF810, DOI 10.1152/ajprenal.2001.281.5.F810; Turner JR, 1997, AM J PHYSIOL-CELL PH, V273, pC1378, DOI 10.1152/ajpcell.1997.273.4.C1378; Van Itallie CM, 2008, J CELL SCI, V121, P298, DOI 10.1242/jcs.021485; Van Itallie CM, 2009, MOL BIOL CELL, V20, P3930, DOI 10.1091/mbc.E09-04-0320; Walsh SV, 2001, GASTROENTEROLOGY, V121, P566, DOI 10.1053/gast.2001.27060; Wang FJ, 2005, AM J PATHOL, V166, P409, DOI 10.1016/S0002-9440(10)62264-X; Weber CR, 2010, J BIOL CHEM, V285, P12037, DOI 10.1074/jbc.M109.064808; Whitehead KJ, 2009, NAT MED, V15, P177, DOI 10.1038/nm.1911; Williams JM, 2015, VET PATHOL, V52, P445, DOI 10.1177/0300985814559404; Wittchen ES, 1999, J BIOL CHEM, V274, P35179, DOI 10.1074/jbc.274.49.35179; Yu ASL, 2009, J GEN PHYSIOL, V133, P111, DOI 10.1085/jgp.200810154; Yu D, 2010, P NATL ACAD SCI USA, V107, P8237, DOI 10.1073/pnas.0908869107; Zawistowski JS, 2002, HUM MOL GENET, V11, P389, DOI 10.1093/hmg/11.4.389; Zolotarevsky Y, 2002, GASTROENTEROLOGY, V123, P163, DOI 10.1053/gast.2002.34235	65	10	10	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2132	2143		10.1096/fj.201800343R	http://dx.doi.org/10.1096/fj.201800343R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30252535	Green Published			2022-12-26	WOS:000457296600049
J	Lv, ZY; Williams, KM; Yuan, LM; Atkison, JH; Olsen, SK				Lv, Zongyang; Williams, Katelyn M.; Yuan, Lingmin; Atkison, James H.; Olsen, Shaun K.			Crystal structure of a human ubiquitin E1-ubiquitin complex reveals conserved functional elements essential for activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ubiquitin; enzyme mechanism; enzyme structure; structure-function; X-ray crystallography; conformational change; protein degradation; adenylation; E1; thioester	ACTIVATING ENZYME; PROTEIN-ACTIVATION; INSIGHTS; MECHANISM; E3; E2; E1; INHIBITORS; BINDING; SYSTEM	Ubiquitin (Ub) signaling plays a key regulatory role in nearly every aspect of eukaryotic biology and is initiated by E1 enzymes that activate and transfer Ub to E2 Ub-conjugating enzymes. Despite Ub E1's fundamental importance to the cell and its attractiveness as a target for therapeutic intervention in cancer and other diseases, its only available structural information is derived from yeast orthologs of human ubiquitin-like modifier-activating enzyme 1 (hUBA1). To illuminate structural differences between yeast and hUBA1 structures that might be exploited for the development of small-molecule therapeutics, we determined the first crystal structure of a hUBA1-Ub complex. Using structural analysis, molecular modeling, and biochemical analysis, we demonstrate that hUBA1 shares a conserved overall structure and mechanism with previously characterized yeast orthologs, but displays subtle structural differences, particularly within the active site. Computational analysis revealed four potential ligand-binding hot spots on the surface of hUBA1 that might serve as targets to inhibit hUBA1 at the level of Ub activation or E2 recruitment or that might potentially be used in approaches such as protein-targeting chimeric molecules. Taken together, our work enhances our understanding of the hUBA1 mechanism, provides an improved framework for the development of small-molecule inhibitors of UBA1, and serves as a stepping stone for structural studies that involve the enzymes of the human Ub system at the level of both E1 and E2.	Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; Med Univ South Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina	Olsen, SK (corresponding author), Dept Biochem & Mol Biol, 173 Ashley Ave,MSC 509,Rm 501, Charleston, SC 29425 USA.	olsensk@musc.edu		Olsen, Shaun/0000-0002-1265-7101	National Institutes of Health from NIGMS [P41 GM103403]; National Institutes of Health ORIP HEI [S10 RR029205]; DOE Office of Science [DE-AC02-06CH11357]; Office of the Vice President for Research at the Medical University of South Carolina; National Institutes of Health Shared Instrumentation Award [S10 RR027139-01]; NATIONAL CANCER INSTITUTE [T32CA193201, F30CA216921] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027139, S10RR029205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115568, P41GM103403] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health ORIP HEI; DOE Office of Science(United States Department of Energy (DOE)); Office of the Vice President for Research at the Medical University of South Carolina; National Institutes of Health Shared Instrumentation Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was based upon research conducted at the Northeastern Collaborative Access Team beamlines, which are funded by National Institutes of Health Grant P41 GM103403 from NIGMS. X-ray diffraction data were collected at SER-CAT 22-ID and NE-CAT 24-ID-E beamlines at the Advanced Photon Source, Argonne National Laboratory. The Pilatus 6M detector on 24-ID-C beam line is funded by National Institutes of Health ORIP HEI Grant S10 RR029205. This work used resources of the Advanced Photon Source, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No.DE-AC02-06CH11357. The X-ray crystallography facility used for this work was supported by the Office of the Vice President for Research at the Medical University of South Carolina. The liquid handling robot used was purchased via National Institutes of Health Shared Instrumentation Award S10 RR027139-01.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Berndsen CE, 2014, NAT STRUCT MOL BIOL, V21, P301, DOI 10.1038/nsmb.2780; Buetow L, 2016, NAT REV MOL CELL BIO, V17, P626, DOI 10.1038/nrm.2016.91; Cappadocia L, 2018, CHEM REV, V118, P889, DOI 10.1021/acs.chemrev.6b00737; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Deshaies RJ, 2015, NAT CHEM BIOL, V11, P634, DOI 10.1038/nchembio.1887; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; HAAS AL, 1982, J BIOL CHEM, V257, P2543; HAAS AL, 1982, J BIOL CHEM, V257, P329; HAAS AL, 1988, J BIOL CHEM, V263, P13268; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Hyer ML, 2018, NAT MED, V24, P186, DOI 10.1038/nm.4474; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kozakov D, 2015, NAT PROTOC, V10, P733, DOI 10.1038/nprot.2015.043; Lee I, 2008, CELL, V134, P268, DOI 10.1016/j.cell.2008.05.046; Lois LM, 2005, EMBO J, V24, P439, DOI 10.1038/sj.emboj.7600552; Lv ZY, 2017, J BIOL CHEM, V292, P12089, DOI 10.1074/jbc.M117.787622; Lv ZY, 2017, MOL CELL, V65, P699, DOI 10.1016/j.molcel.2017.01.008; Lyskov S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063906; Mattern MR, 2012, BBA-MOL CELL RES, V1823, P2014, DOI 10.1016/j.bbamcr.2012.05.005; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Misra M, 2017, STRUCTURE, V25, P1120, DOI 10.1016/j.str.2017.05.001; Olsen SK, 2013, MOL CELL, V49, P884, DOI 10.1016/j.molcel.2013.01.013; Olsen SK, 2010, NATURE, V463, P906, DOI 10.1038/nature08765; PICKART CM, 1985, J BIOL CHEM, V260, P1573; Popovic D, 2014, NAT MED, V20, P1242, DOI 10.1038/nm.3739; Schafer A, 2014, ACTA CRYSTALLOGR D, V70, P1311, DOI 10.1107/S1399004714002910; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Singh RK, 2017, ANAL CHEM, V89, P7852, DOI 10.1021/acs.analchem.6b04194; Spratt DE, 2014, BIOCHEM J, V458, P421, DOI 10.1042/BJ20140006; Streich FC, 2014, ANNU REV BIOPHYS, V43, P357, DOI 10.1146/annurev-biophys-051013-022958; Streich FC, 2010, SUBCELL BIOCHEM, V54, P1, DOI 10.1007/978-1-4419-6676-6_1; Tokgoz Z, 2012, J BIOL CHEM, V287, P311, DOI 10.1074/jbc.M111.294975; Tokgoz Z, 2006, J BIOL CHEM, V281, P14729, DOI 10.1074/jbc.M513562200; van der Veen AG, 2012, ANNU REV BIOCHEM, V81, P323, DOI 10.1146/annurev-biochem-093010-153308; Walden H, 2003, MOL CELL, V12, P1427, DOI 10.1016/S1097-2765(03)00452-0; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yau R, 2016, NAT CELL BIOL, V18, P579, DOI 10.1038/ncb3358; Yuan LM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00272-6	40	25	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18337	18352		10.1074/jbc.RA118.003975	http://dx.doi.org/10.1074/jbc.RA118.003975			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30279270	hybrid, Green Published			2022-12-26	WOS:000451375200025
J	Heidarieh, H; Alcami, A				Heidarieh, Haleh; Alcami, Antonio			Mechanism of action of the viral chemokine-binding protein E163 from ectromelia virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chemokine; glycosaminoglycan; virus; poxvirus; inflammation; cell migration; immune evasion; viral chemokine binding protein	GLYCOSAMINOGLYCAN BINDING; T1/35KDA FAMILY; CELL-SURFACE; RECEPTOR; INHIBITOR; EVASION; INTERLEUKIN-18; GLYCOPROTEIN; MODULATION; EXPRESSION	Chemokines interact with glycosaminoglycans (GAGs) at the cellular surface and to specific cell-surface receptors to activate signaling pathways. The GAG interaction allows the formation of a chemotactic gradient of chemokine required for cell haptotaxis and chemokine oligomerization. Poxviruses encode secreted chemokine-binding proteins with no sequence similarity to their cellular counterparts to modulate the host immune system. The E163 protein from ectromelia virus, the causative agent of mousepox, binds chemokines through their GAG-binding domain. In addition, E163 interacts with GAGs to be anchored at the cell surface, but its ability to interfere with chemokine-GAG interactions has not been demonstrated. We report the identification of the GAG-binding regions in E163 and the generation of mutant forms deficient of GAG binding. Chemokine binding assays show that some of the E163 GAG-binding sites are also involved in the interaction with chemokines. By using recombinant GAG-binding mutant forms we demonstrate that E163 prevents the interaction of chemokines with cell-surface GAGs, providing mechanisms for the immunomodulatory activity of the viral chemokine-binding protein E163.	CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain; Univ Autonoma Madrid, E-28049 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid	Alcami, A (corresponding author), Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Nicolas Cabrera 1, E-28049 Madrid, Spain.	aalcami@cbm.csic.es	Alcami, Antonio/F-8512-2015	Alcami, Antonio/0000-0002-3333-6016	Spanish Ministry of Economy and Competitiveness; European Union (European Regional Development's Funds) [SAF2012-38957, SAF2015-67485-R]; Formacion de Personal Investigador studentship	Spanish Ministry of Economy and Competitiveness(Spanish Government); European Union (European Regional Development's Funds); Formacion de Personal Investigador studentship	This work was supported Spanish Ministry of Economy and Competitiveness and European Union (European Regional Development's Funds, FEDER) Grants SAF2012-38957 and SAF2015-67485-R. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Formacion de Personal Investigador studentship.	Alcami A, 2003, NAT REV IMMUNOL, V3, P36, DOI 10.1038/nri980; Alcami A, 1998, J IMMUNOL, V160, P624; Alcami A, 2000, J VIROL, V74, P11230, DOI 10.1128/JVI.74.23.11230-11239.2000; Alejo A, 2006, P NATL ACAD SCI USA, V103, P5995, DOI 10.1073/pnas.0510462103; Alexander JM, 2002, CELL, V111, P343, DOI 10.1016/S0092-8674(02)01007-3; Alexander-Brett JM, 2007, J EXP MED, V204, P3157, DOI 10.1084/jem.20071677; Arnold PL, 2006, J VIROL, V80, P7439, DOI 10.1128/JVI.00576-06; Bahar MW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040005; Born TL, 2000, J IMMUNOL, V164, P3246, DOI 10.4049/jimmunol.164.6.3246; Born TL, 2000, J BIOL CHEM, V275, P29946, DOI 10.1074/jbc.M004077200; Bryant NA, 2003, EMBO J, V22, P833, DOI 10.1093/emboj/cdg092; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Carfi A, 1999, P NATL ACAD SCI USA, V96, P12379, DOI 10.1073/pnas.96.22.12379; Clark RH, 2006, J GEN VIROL, V87, P29, DOI 10.1099/vir.0.81417-0; de Marco MDF, 2010, FASEB J, V24, P1479, DOI 10.1096/fj.09-144733; Dyer DP, 2016, J BIOL CHEM, V291, P12627, DOI 10.1074/jbc.M116.720953; Dyer DP, 2014, J IMMUNOL, V192, P2177, DOI 10.4049/jimmunol.1300194; Epperson ML, 2012, IMMUNOL REV, V250, P199, DOI 10.1111/imr.12009; Esteban DJ, 2004, J GEN VIROL, V85, P1291, DOI 10.1099/vir.0.79902-0; Felix J, 2017, NAT REV IMMUNOL, V17, P112, DOI 10.1038/nri.2016.134; Finlay BB, 2006, CELL, V124, P767, DOI 10.1016/j.cell.2006.01.034; Gonzalez-Motos V, 2016, CYTOKINE GROWTH F R, V30, P71, DOI 10.1016/j.cytogfr.2016.02.007; Graham KA, 1997, VIROLOGY, V229, P12, DOI 10.1006/viro.1996.8423; Handel TM, 2005, ANNU REV BIOCHEM, V74, P385, DOI 10.1146/annurev.biochem.72.121801.161747; Heidarieh H, 2015, VIRUS RES, V209, P67, DOI 10.1016/j.virusres.2015.02.028; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; Laguri C, 2008, CARBOHYD RES, V343, P2018, DOI 10.1016/j.carres.2008.01.047; Lalani AS, 1998, VIROLOGY, V250, P173, DOI 10.1006/viro.1998.9340; Lau EK, 2004, ADV PROTEIN CHEM, V68, P351; Lubman OY, 2014, J VIROL, V88, P538, DOI 10.1128/JVI.02729-13; Martinez-Martin N, 2016, J GEN VIROL, V97, P3007, DOI 10.1099/jgv.0.000616; Martinez-Martin N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7163; Mavian C, 2014, VIROLOGY, V462, P218, DOI 10.1016/j.virol.2014.06.010; Mellado M, 2001, ANNU REV IMMUNOL, V19, P397, DOI 10.1146/annurev.immunol.19.1.397; Montanuy I, 2011, FASEB J, V25, P1960, DOI 10.1096/fj.10-177188; Nelson CA, 2015, VIRUSES-BASEL, V7, P4873, DOI 10.3390/v7092848; Ng A, 2001, J GEN VIROL, V82, P2095, DOI 10.1099/0022-1317-82-9-2095; Parry CM, 2000, J EXP MED, V191, P573, DOI 10.1084/jem.191.3.573; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Proudfoot AEI, 2017, PHARMACEUTICALS-BASE, V10, DOI 10.3390/ph10030070; Rueda P, 2012, CIRCULATION, V126, P1882, DOI 10.1161/CIRCULATIONAHA.112.113290; Ruiz-Arguello MB, 2008, J VIROL, V82, P917, DOI 10.1128/JVI.02111-07; Seet BT, 2003, ANNU REV IMMUNOL, V21, P377, DOI 10.1146/annurev.immunol.21.120601.141049; Seet BT, 2001, J BIOL CHEM, V276, P30504, DOI 10.1074/jbc.M011401200; Smith CA, 1997, VIROLOGY, V236, P316, DOI 10.1006/viro.1997.8730; Smith GL, 2013, J GEN VIROL, V94, P2367, DOI 10.1099/vir.0.055921-0; Smith VP, 2000, J VIROL, V74, P8460, DOI 10.1128/JVI.74.18.8460-8471.2000; SYMONS JA, 1995, CELL, V81, P551, DOI 10.1016/0092-8674(95)90076-4; Tsung KL, 1996, J VIROL, V70, P165, DOI 10.1128/JVI.70.1.165-171.1996; Viejo-Borbolla A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002497; Webb LMC, 2004, FASEB J, V18, P571, DOI 10.1096/fj.03-0485fje; Xiang Y, 2003, J VIROL, V77, P2623, DOI 10.1128/JVI.77.4.2623-2630.2003; Xue XG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002162; Zhang L, 2006, P NATL ACAD SCI USA, V103, P13985, DOI 10.1073/pnas.0602142103; Zhang LJ, 2006, METHOD ENZYMOL, V416, P205, DOI 10.1016/S0076-6879(06)16013-9; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X; Zlotnik A, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-243	57	3	3	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2018	293	45					17418	17429		10.1074/jbc.RA118.004432	http://dx.doi.org/10.1074/jbc.RA118.004432			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ9EI	30257868	hybrid, Green Published			2022-12-26	WOS:000449799000009
J	Lueschow, SR; Stumphy, J; Gong, HY; Kern, SL; Elgin, TG; Underwood, MA; Kalanetra, KM; Mills, DA; Wong, MH; Meyerholz, DK; Good, M; McElroy, SJ				Lueschow, Shiloh R.; Stumphy, Jessica; Gong, Huiyu; Kern, Stacy L.; Elgin, Timothy G.; Underwood, Mark A.; Kalanetra, Karen M.; Mills, David A.; Wong, Melissa H.; Meyerholz, David K.; Good, Misty; McElroy, Steven J.			Loss of murine Paneth cell function alters the immature intestinal microbiome and mimics changes seen in neonatal necrotizing enterocolitis	PLOS ONE			English	Article							KLEBSIELLA-PNEUMONIAE; BACTERIAL-INFECTION; SECRETORY AUTOPHAGY; INFANT GUT; LYSOZYME; MICE; PATHOGENESIS; ASSOCIATION; PREVENTION; SEQUENCES	Necrotizing enterocolitis (NEC) remains the leading cause of gastrointestinal morbidity and mortality in premature infants. Human and animal studies suggest a role for Paneth cells in NEC pathogenesis. Paneth cells play critical roles in host-microbial interactions and epithelial homeostasis. The ramifications of eliminating Paneth cell function on the immature hostmicrobial axis remains incomplete. Paneth cell function was depleted in the immature murine intestine using chemical and genetic models, which resulted in intestinal injury consistent with NEC. Paneth cell depletion was confirmed using histology, electron microscopy, flow cytometry, and real time RT-PCR. Cecal samples were analyzed at various time points to determine the effects of Paneth cell depletion with and without Klebsiella gavage on the microbiome. Deficient Paneth cell function induced significant compositional changes in the cecal microbiome with a significant increase in Enterobacteriacae species. Further, the bloom of Enterobacteriaceae species that occurs is phenotypically similar to what is seen in human NEC. This further strengthens our understanding of the importance of Paneth cells to intestinal homeostasis in the immature intestine.	[Lueschow, Shiloh R.; McElroy, Steven J.] Univ Iowa, Dept Microbiol & Immunol, Iowa City, IA 52242 USA; [Stumphy, Jessica; Gong, Huiyu; Kern, Stacy L.; Elgin, Timothy G.; McElroy, Steven J.] Univ Iowa, Stead Family Dept Pediat, Iowa City, IA 52242 USA; [Underwood, Mark A.; Kalanetra, Karen M.; Mills, David A.] Univ Calif Davis, Dept Pediat, Sacramento, CA 95817 USA; [Underwood, Mark A.; Kalanetra, Karen M.; Mills, David A.] Univ Calif Davis, Dept Food Sci & Technol, Sacramento, CA 95817 USA; [Wong, Melissa H.] Oregon Hlth & Sci Univ, Dept Cell Dev & Canc Biol, Portland, OR 97201 USA; [Meyerholz, David K.] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA; [Good, Misty] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA	University of Iowa; University of Iowa; University of California System; University of California Davis; University of California System; University of California Davis; Oregon Health & Science University; University of Iowa; Washington University (WUSTL)	McElroy, SJ (corresponding author), Univ Iowa, Dept Microbiol & Immunol, Iowa City, IA 52242 USA.; McElroy, SJ (corresponding author), Univ Iowa, Stead Family Dept Pediat, Iowa City, IA 52242 USA.	steven.mcelroy@uiowa.edu	McElroy, Steven/AGR-6835-2022; Mills, David Andrew/G-2282-2011; Good, Misty/AAI-6192-2020; Mills, David/GXF-1821-2022; McElroy, Steven/AAC-7204-2019; Kalanetra, Karen/AAP-3669-2021; Meyerholz, David/J-8131-2019	McElroy, Steven/0000-0002-4321-723X; Mills, David Andrew/0000-0003-1913-9865; Good, Misty/0000-0002-0264-5721; McElroy, Steven/0000-0002-4321-723X; Meyerholz, David/0000-0003-1552-3253; Elgin, Timothy/0000-0001-5936-0463; Lueschow, Shiloh/0000-0001-6185-7612	National Institutes of Health [DK083677, DK097335, DK101608, DK111473, DK085525, CA060533, AT007079, AT008759]; March of Dimes [MG: 5-FY17-79]; Children's Miracle Network; Stead Family Department of Pediatrics at the University of Iowa; Children's Discovery Institute of Washington University; St. Louis Children's Hospital; Genome Technology Access Center in the Department of Genetics at Washington University School of Medicine - NCI Cancer Center Support Grant [P30 CA91842]; National Center for Research Resources (NCRR) [UL1 TR000448]; National Institutes of Health (NIH); NIH Roadmap for Medical Research; Peter J. Shields Endowed Chair in Dairy Food Science; NATIONAL CANCER INSTITUTE [P30CA033572] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002345, UL1TR000448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK101608, U01DK085525, R03DK111473] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); Children's Miracle Network; Stead Family Department of Pediatrics at the University of Iowa; Children's Discovery Institute of Washington University; St. Louis Children's Hospital; Genome Technology Access Center in the Department of Genetics at Washington University School of Medicine - NCI Cancer Center Support Grant; National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Peter J. Shields Endowed Chair in Dairy Food Science; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Support for this work was provided from the National Institutes of Health (SJM: DK083677, SJM: DK097335, MG: DK101608, MG: DK111473, MHW: DK085525, and MHW: CA060533), The March of Dimes (MG: 5-FY17-79), the Children's Miracle Network, the Stead Family Department of Pediatrics at the University of Iowa, and the Children's Discovery Institute of Washington University and St. Louis Children's Hospital. RNA-seq data and analysis was supported by the Genome Technology Access Center in the Department of Genetics at Washington University School of Medicine which is partially supported by NCI Cancer Center Support Grant #P30 CA91842 to the Siteman Cancer Center and by ICTS/CTSA Grant# UL1 TR000448 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research. Microbial analysis supported through the Peter J. Shields Endowed Chair in Dairy Food Science and National Institutes of Health awards AT007079 and AT008759 (DAM). This publication is solely the responsibility of the authors and does not necessarily represent the official view of NCRR or NIH.	Bel S, 2018, AUTOPHAGY, V14, P719, DOI 10.1080/15548627.2018.1430462; Bel S, 2017, SCIENCE, V357, P1047, DOI 10.1126/science.aal4677; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Brown KS, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/852378; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Chelius MK, 2000, APPL ENVIRON MICROB, V66, P783, DOI 10.1128/AEM.66.2.783-787.2000; Chen AC, 2014, J PEDIATR GASTR NUTR, V58, P7, DOI 10.1097/MPG.0b013e3182a7dc74; Claud EC, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-20; Clevers HC, 2013, ANNU REV PHYSIOL, V75, P289, DOI 10.1146/annurev-physiol-030212-183744; Coggins SA, 2015, CLIN PERINATOL, V42, P133, DOI 10.1016/j.clp.2014.10.012; Coutinho HB, 1998, J CLIN PATHOL, V51, P512, DOI 10.1136/jcp.51.7.512; Delorme-Axford E, 2018, AUTOPHAGY, V14, P365, DOI 10.1080/15548627.2017.1401425; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Elgin TG, 2016, CLIN THER, V38, P706, DOI 10.1016/j.clinthera.2016.01.005; Fitzgibbons SC, 2009, J PEDIATR SURG, V44, P1072, DOI 10.1016/j.jpedsurg.2009.02.013; Fricke EM, 2017, AM J OBSTET GYNECOL, V216, pS225, DOI 10.1016/j.ajog.2016.11.631; Fung CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146542; Garabedian EM, 1997, J BIOL CHEM, V272, P23729, DOI 10.1074/jbc.272.38.23729; Gulati AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032403; Heida FH, 2016, PEDIATR RES, V80, P306, DOI 10.1038/pr.2016.67; Kinsella RL, 2018, VET PATHOL, V55, P366, DOI 10.1177/0300985818754967; La Rosa PS, 2014, P NATL ACAD SCI USA, V111, P12522, DOI 10.1073/pnas.1409497111; Lin PW, 2008, SEMIN PERINATOL, V32, P70, DOI 10.1053/j.semperi.2008.01.004; Liu TC, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86907; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; McElroy SJ, 2014, AM J PATHOLOGY; McElroy SJ, 2008, AM J PHYSIOL-GASTR L, V295, pG285, DOI 10.1152/ajpgi.00425.2007; McElroy SJ, 2011, AM J PHYSIOL-GASTR L, V301, pG656, DOI 10.1152/ajpgi.00550.2010; Morrow AL, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-13; Nino DF, 2016, NAT REV GASTRO HEPAT, V13, P590, DOI 10.1038/nrgastro.2016.119; Patel RM, 2015, NEW ENGL J MED, V372, P331, DOI 10.1056/NEJMoa1403489; Salzman NH, 2007, SEMIN IMMUNOL, V19, P70, DOI 10.1016/j.smim.2007.04.002; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; SAWADA M, 1993, LAB INVEST, V68, P338; SAWADA M, 1991, INT J EXP PATHOL, V72, P407; Sherman MP, 2005, INFECT IMMUN, V73, P6143, DOI 10.1128/IAI.73.9.6143-6146.2005; Sherman MP, 2005, MED HYPOTHESES, V65, P478, DOI 10.1016/j.mehy.2005.04.010; Timmerman HM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08268-4; Underwood MA, 2015, PEDIATR RES, V77, P229, DOI 10.1038/pr.2014.156; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Warner BB, 2016, LANCET, V387, P1928, DOI 10.1016/S0140-6736(16)00081-7; White JR, 2017, DIS MODEL MECH, V10, P727, DOI 10.1242/dmm.028589; Yee WH, 2012, PEDIATRICS, V129, pE298, DOI 10.1542/peds.2011-2022; Zhang CX, 2012, DIS MODEL MECH, V5, P522, DOI 10.1242/dmm.009001	46	30	30	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204967	10.1371/journal.pone.0204967	http://dx.doi.org/10.1371/journal.pone.0204967			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273395	gold, Green Published, Green Submitted			2022-12-26	WOS:000446124700055
J	Goncalves, GMR; da Silva, EN				Reis Goncalves, Gabriela Maria; da Silva, Everton Nunes			Cost of chronic kidney disease attributable to diabetes from the perspective of the Brazilian Unified Health System	PLOS ONE			English	Article							STAGE RENAL-DISEASE; UNITED-STATES; NATIONAL-HEALTH; MORTALITY; IMPACT; CARE; ASSOCIATION; PROGRESSION; POPULATION; DIALYSIS	Introduction Diabetes is the most common cause of chronic kidney disease, with a high economic impact on health systems. Objective To estimate the cost of chronic kidney disease (CKD) and end-stage kidney disease (ESKD) attributable to diabetes, stratified by sex, race/skin color, and age, from the perspective of the Brazilian public health system between 2010 and 2016. Methods Population attributable risk (PAR) was calculated from the Brazilian prevalence of diabetes and the relative risk (or odds ratio) of persons with diabetes developing CKD and ESKD as compared to non-diabetic subjects. The variables of interest were sex, race/skin color, and age. A top-down approach was used to measure the direct costs of the disease reimbursed by the Brazilian Ministry of Health, using data from outpatient and inpatient records. Results The cost of CKD and ESKD attributable to diabetes in the period 2010-2016 was US$1.2 billion (US$180 million per year) and trending upward. Female sex, age 65-75, and black race/skin color contributed substantially to the costs of CKD and ESKD (US$475 million, US $63 million, and US$25 million respectively). The clinical procedures accounting for the greatest share of disease-attributable costs are hemodialysis and peritoneal dialysis. Conclusion Diabetes accounted for 22% of the costs of CKD and ESKD. Female sex, age 65-75 years, and black race/skin color were the variables which contributed most to disease-related expenditure. The economic burden of CKD may increase gradually in the coming years, with serious implications for the financial sustainability of the Brazilian public health system.	[Reis Goncalves, Gabriela Maria; da Silva, Everton Nunes] Univ Brasilia, Brasilia, DF, Brazil; [da Silva, Everton Nunes] CNPq, Natl Inst Sci & Technol Hlth Technol Assessment I, Porto Alegre, RS, Brazil	Universidade de Brasilia	Goncalves, GMR (corresponding author), Univ Brasilia, Brasilia, DF, Brazil.	gabimaria.nut@gmail.com		Reis Goncalves, Gabriela Maria/0000-0003-0544-3831; Silva, Everton/0000-0001-8747-4185				Atkins Robert C., 2010, Arch. Cardiol. Méx., V80, P44; Barreto SM, 2016, J EPIDEMIOL COMMUN H, V70, P380, DOI 10.1136/jech-2015-205834; Barros MBDA, 2017, REV SAUDE PUBL, V51; Benzaquem DC, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0121160, 10.1371/journal.pone.0112217]; Brasil Ipea I de PEA, 2011, RETR DES GEN RAC, P39; Carrero JJ, 2011, NEPHROL DIAL TRANSPL, V26, P270, DOI 10.1093/ndt/gfq386; Carrero JJ, 2018, NAT REV NEPHROL, V14, P151, DOI 10.1038/nrneph.2017.181; Cherchiglia ML, 2010, CAD SAUDE PUBLICA, V26, P1627, DOI 10.1590/S0102-311X2010000800016; Collins AJ, 2015, KIDNEY INT SUPPL, V5, P2, DOI 10.1038/kisup.2015.2; Collins AJ, 2009, AM J KIDNEY DIS, V53, pS1, DOI 10.1053/j.ajkd.2008.10.005; Couser WG, 2011, KIDNEY INT, V80, P1258, DOI 10.1038/ki.2011.368; da BRASILM S, 2011, PLANO ACOES ESTRATEG; Danaei G, 2014, LANCET DIABETES ENDO, V2, P634, DOI 10.1016/S2213-8587(14)70102-0; De Cosmo S, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004007; de Moura L, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-111; de Oliveira ML, 2014, REV NUTR, V27, DOI 10.1590/1415-52732014000500007; Ene-Iordache B, 2016, LANCET GLOB HEALTH, V4, pE307, DOI 10.1016/S2214-109X(16)00071-1; Goes F, 2011, MULHERES NEGRAS BRAN, P571; Gregg EW, 2014, NEW ENGL J MED, V370, P1514, DOI 10.1056/NEJMoa1310799; Hemmelgarn BR, 2006, KIDNEY INT, V69, P2155, DOI 10.1038/sj.ki.5000270; Hemmelgarn BR, 2012, JAMA-J AM MED ASSOC, V307, P2507, DOI 10.1001/jama.2012.6455; Hill NR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158765; Hippisley-Cox J, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-49; Instituto Brasileiro de Geografia e Estatistica-IBGE, 2014, PESQ NAC SAUD; *INT ORG MIGR, 2017, WORLD MIGR REP 2018, P1, DOI DOI 10.1093/ESR/JCN046; Jha V, 2016, KIDNEY INT, V90, P1164, DOI 10.1016/j.kint.2016.09.009; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Levin Adeera, 2017, Lancet, V390, P1888, DOI 10.1016/S0140-6736(17)30788-2; Lewis EF, 2015, AM HEART J, V170, P322, DOI 10.1016/j.ahj.2015.05.008; Lipworth L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048407; Lorenzo V, 2010, NEPHROL DIAL TRANSPL, V25, P2283, DOI 10.1093/ndt/gfp761; Marinho Ana Wanda Guerra Barreto, 2017, Cad. saúde colet., V25, P379, DOI 10.1590/1414-462x201700030134; Martins D, 2006, AM J KIDNEY DIS, V47, P965, DOI 10.1053/j.ajkd.2006.02.179; Morton RL, 2016, NEPHROL DIAL TRANSPL, V31, P46, DOI 10.1093/ndt/gfu394; Moura L, 2013, REV BRAS EPIDEMIO S2, V18, P181; Muka T, 2015, EUR J EPIDEMIOL, V30, P251, DOI 10.1007/s10654-014-9984-2; Narres M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147329; Ng BL, 2011, INTERN MED J, V41, P761, DOI 10.1111/j.1445-5994.2011.02590.x; Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8; Pinheiro Rejane Sobrino, 2002, Ciênc. saúde coletiva, V7, P687; Schmidt MI, 2011, LANCET, V377, P1949, DOI 10.1016/S0140-6736(11)60135-9; Scialla JJ, 2012, KIDNEY INT, V82, P106, DOI 10.1038/ki.2012.82; Sesso Ricardo Cintra, 2017, Braz. J. Nephrol., V39, P261, DOI 10.5935/0101-2800.20170049; Seuring T, 2015, PHARMACOECONOMICS, V33, P811, DOI 10.1007/s40273-015-0268-9; Shen YJ, 2017, ENDOCRINE, V55, P75, DOI 10.1007/s12020-016-1014-6; Silva Junior Geraldo Bezerra da, 2017, Braz. J. Nephrol., V39, P65, DOI 10.5935/0101-2800.20170011; Tsai WC, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003013; van den Beukel TO, 2013, CLIN J AM SOC NEPHRO, V8, P1540, DOI 10.2215/CJN.10761012; Webster AC, 2017, LANCET, V389, P1238, DOI 10.1016/S0140-6736(16)32064-5; Wen CP, 2008, LANCET, V371, P2173, DOI 10.1016/S0140-6736(08)60952-6; Xavier DB, 2017, OBES SURG, V27, P641, DOI 10.1007/s11695-016-2327-5; Xue JL, 2007, J AM SOC NEPHROL, V18, P1299, DOI 10.1681/ASN.2006050524; Yu MK, 2015, NEPHROLOGY, V20, P451, DOI 10.1111/nep.12468; Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8	54	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0203992	10.1371/journal.pone.0203992	http://dx.doi.org/10.1371/journal.pone.0203992			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273345	Green Published, gold, Green Submitted			2022-12-26	WOS:000446124700011
J	Huertas-Delgado, FJ; Mertens, L; Chillon, P; Van Dyck, D				Javier Huertas-Delgado, Francisco; Mertens, Lieze; Chillon, Palma; Van Dyck, Delfien			Parents' and adolescents' perception of traffic- and crime-related safety as correlates of independent mobility among Belgian adolescents	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; NEIGHBORHOOD ENVIRONMENT; ACTIVE-TRANSPORT; SCHOOL; CHILDREN; WALKING; HEALTH; YOUTH; PLAY; FEAR	The independent mobility (IM), defined as the freedom of young people to travel without adult supervision, has been related to the physical activity time, the acquisition of personal autonomy, to less intense fear of crime, and to a stronger feeling of being part of their community and other health and social benefits. The aims of this study were to compare parents' and adolescents' traffic- and crime-related safety perceptions of their neighborhood and to analyze the associations of these perceptions with adolescents' IM. A total of 291 adolescents and their parents completed the Neighborhood Environment Walkability Scale (NEWS) questionnaire. Multilevel (two-level models: individual level-neighborhood level) regression analyses were conducted to examine whether the environmental perceptions differed between parents and adolescents and the association between the parental and adolescents' perception to the IM and the active independent mobility (AIM). Parents reported a more negative perception of traffic (except for amount and speed) and crime-related safety. Adolescents' environmental perceptions were not associated with their IM but parental perceptions of traffic- and crime-related safety were associated with IM and with active IM, although not all associations were in the expected direction. Future urban policy efforts should address environments where parents perceive sufficient levels of safety to increase the levels of IM in adolescents.	[Javier Huertas-Delgado, Francisco] Univ Granada, Teaching Ctr La Inmaculada, PA Help Phys Act Hlth Promot Res Grp, Granada, Spain; [Mertens, Lieze; Van Dyck, Delfien] Univ Ghent, Fac Med & Hlth Sci, Dept Movement & Sports Sci, Ghent, Belgium; [Mertens, Lieze; Van Dyck, Delfien] Res Fdn Flanders, Brussels, Belgium; [Chillon, Palma] Univ Granada, Fac Sport Sci, Dept Phys Educ & Sport, PROFITH Promoting FITness & Hlth Phys Act Res Grp, Granada, Spain	University of Granada; Ghent University; University of Granada	Huertas-Delgado, FJ (corresponding author), Univ Granada, Teaching Ctr La Inmaculada, PA Help Phys Act Hlth Promot Res Grp, Granada, Spain.	fjhuertas@ugr.es	Huertas-Delgado, Francisco Javier/AAT-7550-2020; Van Dyck, Delfien/AAO-8981-2020; Chillon, Palma/E-5634-2014; Huertas-Delgado, Francisco Javier/G-7664-2015; Mertens, Lieze/AAG-3340-2020	Huertas-Delgado, Francisco Javier/0000-0001-9957-4802; Chillon, Palma/0000-0003-0862-8989; Huertas-Delgado, Francisco Javier/0000-0001-9957-4802; 	Spanish Ministry of Education, Culture and Sport [CAST17/00072]; Research Foundation Flanders (FWO) [FWO12/PDO/158]; University of Granada, Plan Propio de Investigacion 2016, Excellence actions: Excellence Units, Scientific Excellence Unit on Exercise and Health (UCEES)	Spanish Ministry of Education, Culture and Sport; Research Foundation Flanders (FWO)(FWO); University of Granada, Plan Propio de Investigacion 2016, Excellence actions: Excellence Units, Scientific Excellence Unit on Exercise and Health (UCEES)	This study was supported by a grant from the Spanish Ministry of Education, Culture and Sport [CAST17/00072] and by a grant from the Research Foundation Flanders (FWO) [FWO12/PDO/158]. Additional support was obtained from the University of Granada, Plan Propio de Investigacion 2016, Excellence actions: Excellence Units, Scientific Excellence Unit on Exercise and Health (UCEES).	Ahern S., 2015, 11 ANN SCI M BIOL BE; Armstrong N, 2012, J SPORT HEALTH SCI, V1, P131, DOI 10.1016/j.jshs.2012.05.003; Bates B, 2015, J SCI MED SPORT, V18, P545, DOI 10.1016/j.jsams.2014.07.006; Biddle SJH, 2011, BRIT J SPORT MED, V45, P886, DOI 10.1136/bjsports-2011-090185; Brechwald WA, 2011, J RES ADOLESCENCE, V21, P166, DOI 10.1111/j.1532-7795.2010.00721.x; Carver A, 2005, AM J HEALTH PROMOT, V20, P139, DOI 10.4278/0890-1171-20.2.139; Carver A, 2008, HEALTH PLACE, V14, P217, DOI 10.1016/j.healthplace.2007.06.004; Carver A, 2014, J TRANSP HEALTH, V1, P25, DOI 10.1016/j.jth.2013.12.003; Carver A, 2014, J TRANSP HEALTH, V1, P267, DOI 10.1016/j.jth.2014.01.004; Carver A, 2012, J SCI MED SPORT, V15, P505, DOI 10.1016/j.jsams.2012.03.005; Carver A, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-126; Chillon P, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-61; Chillon P, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-10; D'Haese S, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0104-1; De Meester F, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-631; Defoe IN, 2015, PSYCHOL BULL, V141, P48, DOI 10.1037/a0038088; European Commision Staff, 2017, COMMUNICATION; Forman H, 2008, PREV MED, V46, P311, DOI 10.1016/j.ypmed.2007.12.006; Foster S, 2014, HEALTH PLACE, V26, P60, DOI 10.1016/j.healthplace.2013.11.006; Foster S, 2010, HEALTH PLACE, V16, P1156, DOI 10.1016/j.healthplace.2010.07.007; Fyhri A, 2011, TRANSPORT POLICY, V18, P703, DOI 10.1016/j.tranpol.2011.01.005; Garcia-Cervantes L, 2016, J PHYS ACT HEALTH, V13, P747, DOI 10.1123/jpah.2015-0415; Ghekiere A, 2017, J SCI MED SPORT, V20, P267, DOI 10.1016/j.jsams.2016.08.002; Ghekiere A, 2016, J SCI MED SPORT, V19, P149, DOI 10.1016/j.jsams.2015.01.003; Giles-Corti B, 2009, SPORTS MED, V39, P995, DOI 10.2165/11319620-000000000-00000; Hillman M., 1990, ONE FALSE MOVE STUDY; Hsieh PL, 2014, INT J ENV RES PUB HE, V11, P7275, DOI 10.3390/ijerph110707275; Janssen I, 2014, PREV MED, V66, P113, DOI 10.1016/j.ypmed.2014.06.016; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Huertas-Delgado FJ, 2017, EUR J PUBLIC HEALTH, V27, P416, DOI 10.1093/eurpub/ckw249; Kall LB, 2015, J SCHOOL HEALTH, V85, P704, DOI 10.1111/josh.12303; Larouche R, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-5005-1; Larouche R, 2013, CAN J PUBLIC HEALTH, V104, pE487, DOI 10.17269/cjph.104.4122; Lubans DR, 2011, RELATIONSHIP ACTIVE; Mackett R., 2005, BUILT ENV, V33, P454; Mammen G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-862; Mandic S, 2015, J SCI MED SPORT, V18, P432, DOI 10.1016/j.jsams.2014.06.012; Oluyomi AO, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-32; Pang B, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4648-2; Panter JR, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-34; Prezza M, 2007, J COMMUNITY PSYCHOL, V35, P151, DOI 10.1002/jcop.20140; PUTNAM RD, 1995, J DEMOCRACY, V0006; Rosenberg D, 2009, PREV MED, V49, P213, DOI 10.1016/j.ypmed.2009.07.011; Sallis JE, 2006, ANNU REV PUBL HEALTH, V27, P297, DOI 10.1146/annurev.publhealth.27.021405.102100; Schoeppe S, 2015, BMC PUBLIC HEALTH, P1; Schoeppe S, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-91; Seabrook JA, 2012, CAN REV SOCIOL, V49, P50, DOI 10.1111/j.1755-618X.2011.01280.x; Shaw B., 2013, CHILDRENS INDEPENDEN; Somerville LH, 2010, CURR OPIN NEUROBIOL, V20, P236, DOI 10.1016/j.conb.2010.01.006; Stone MR, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-5; Telama R, 2005, AM J PREV MED, V28, P267, DOI 10.1016/j.amepre.2004.12.003; Timperio A, 2004, PREV MED, V38, P39, DOI 10.1016/j.ypmed.2003.09.026; Tudor-Locke C, 2001, SPORTS MED, V31, P309, DOI 10.2165/00007256-200131050-00001; UNICEF, 2001, DEATHS INJ RICH NAT; Valentine G., 1997, GENDER PLACE CULT, V4, P37, DOI DOI 10.1080/09663699725495; Veitch J, 2006, HEALTH PLACE, V12, P383, DOI 10.1016/j.healthplace.2005.02.009; Villa-Gonzalez E, 2018, PREV MED, V111, P115, DOI 10.1016/j.ypmed.2018.02.010; Villa-Gonzalez E, 2016, EUR J PUBLIC HEALTH, V26, P272, DOI 10.1093/eurpub/ckv208; Whitzman C., 2009, VERTICAL LIVING KIDS; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Witten K, 2013, CHILD GEOGR, V11, P215, DOI 10.1080/14733285.2013.779839; Wolfe MK, 2016, J PHYS ACT HEALTH, V13, P970, DOI 10.1123/jpah.2015-0662	62	11	11	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204454	10.1371/journal.pone.0204454	http://dx.doi.org/10.1371/journal.pone.0204454			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV3OT	30265694	Green Submitted, Green Published, gold			2022-12-26	WOS:000446005500034
J	Kenagy, RD; Kikuchi, S; Evanko, SP; Ruiter, MS; Piola, M; Longchamp, A; Pesce, M; Soncini, M; Deglise, S; Fiore, GB; Haefliger, JA; Schmidt, TA; Majesky, MW; Sobel, M; Wight, TN				Kenagy, Richard D.; Kikuchi, Shinsuke; Evanko, Steve P.; Ruiter, Matthijs S.; Piola, Marco; Longchamp, Alban; Pesce, Maurizio; Soncini, Monica; Deglise, Sebastien; Fiore, Gianfranco B.; Haefliger, Jacques-Antoine; Schmidt, Tannin A.; Majesky, Mark W.; Sobel, Michael; Wight, Thomas N.			Versican is differentially regulated in the adventitial and medial layers of human vein grafts	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; HUMAN SAPHENOUS-VEIN; INTERNAL MAMMARY ARTERY; INTIMAL HYPERPLASIA; GROWTH-FACTOR; BYPASS GRAFT; IN-VITRO; OXIDATIVE STRESS; PROGENITOR CELLS; HYALURONAN	Changes in extracellular matrix proteins may contribute significantly to the adaptation of vein grafts to the arterial circulation. We examined the production and distribution of versican and hyaluronan in intact human vein rings cultured ex vivo, veins perfused ex vivo, and cultured venous adventitial and smooth muscle cells. Immunohistochemistry revealed higher levels of versican in the intima/media compared to the adventitia, and no differences in hyaluronan. In the vasa vasorum, versican and hyaluronan associated with CD34(+) pro-genitor cells. Culturing the vein rings for 14 days revealed increased versican immunostaining of 30-40% in all layers, with no changes in hyaluronan. Changes in versican accumulation appear to result from increased synthesis in the intima/media and decreased degradation in the adventitia as versican transcripts were increased in the intima/media, but unchanged in the adventitia, and versikine (the ADAMTS-mediated cleavage product of versican) was increased in the intima/media, but decreased in the adventitia. In perfused human veins, versican was specifically increased in the intima/media in the presence of venous pressure, but not with arterial pressure. Unexpectedly, cultured adventitial cells express and accumulate more versican and hyaluronan than smooth muscle cells. These data demonstrate a differential regulation of versican and hyaluronan in human venous adventitia vs. intima/media and suggest distinct functions for these extracellular matrix macromolecules in these venous wall compartments during the adaptive response of vein grafts to the arterial circulation.	[Kenagy, Richard D.] Univ Washington, Ctr Cardiovasc Biol, Inst Stem Cells & Regenerat Med, Seattle, WA 98195 USA; [Kenagy, Richard D.] Univ Washington, Dept Surg, Seattle, WA 98195 USA; [Kikuchi, Shinsuke] Asahikawa Med Univ, Dept Vasc Surg, Asahikawa, Hokkaido, Japan; [Evanko, Steve P.; Wight, Thomas N.] Benaroya Res Inst, Matrix Biol Program, Seattle, WA USA; [Ruiter, Matthijs S.; Pesce, Maurizio] IRCCS, Ctr Cardiol Monzino, Cardiovasc Tissue Engn Unit, Via Parea 4, Milan 4, Italy; [Piola, Marco; Soncini, Monica; Fiore, Gianfranco B.] Politecn Milan, Dipartimento Elettron Informaz & Bioingn, Milan, Italy; [Longchamp, Alban; Deglise, Sebastien; Haefliger, Jacques-Antoine] Lausanne Univ Hosp, CHUV, Dept Vasc Surg, Lausanne, Switzerland; [Schmidt, Tannin A.] Univ Connecticut, Hlth Ctr, Sch Dent Med, Biomed Engn Dept, Farmington, CT USA; [Majesky, Mark W.] Seattle Childrens Res Inst, Ctr Dev Biol & Regenerat Med, Seattle, WA USA; [Sobel, Michael] Univ Washington, VA Puget Sound Hlth Care Syst, Div Vasc Surg, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Asahikawa Medical College; Benaroya Research Institute; Polytechnic University of Milan; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Connecticut; Seattle Children's Hospital; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System	Kenagy, RD (corresponding author), Univ Washington, Ctr Cardiovasc Biol, Inst Stem Cells & Regenerat Med, Seattle, WA 98195 USA.; Kenagy, RD (corresponding author), Univ Washington, Dept Surg, Seattle, WA 98195 USA.	rkenagy@u.washington.edu	Pesce, Maurizio/AAA-4207-2019; Schmidt, Tannin/AAE-3830-2019; Pesce, Maurizio/B-4260-2010; Soncini, Monica/E-9609-2018; Ruiter, Matthijs/H-4287-2017	Pesce, Maurizio/0000-0002-3097-8961; Pesce, Maurizio/0000-0002-3097-8961; Soncini, Monica/0000-0001-8607-7196; Kikuchi, Shinsuke/0000-0002-5314-1603; Deglise, Sebastien/0000-0001-8244-952X; Kenagy, Richard/0000-0002-2021-5565; Ruiter, Matthijs/0000-0002-4834-4561	National Institutes of Health [R01 HL30946, RO01 EB012558, R43 HL10687]; American Heart Association; SNF [3100A_175452/1]; Muschamp Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL030946] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); SNF; Muschamp Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Institutes of Health grants R01 HL30946 (RDK, MS) and RO01 EB012558 and R43 HL10687 (TNW); an American Heart Association Grant-in-Aid (RDK); the SNF 3100A_175452/1 (JAH); and the Muschamp Foundation (SD).	Ackers-Johnson M, 2015, ARTERIOSCL THROM VAS, V35, P817, DOI 10.1161/ATVBAHA.114.305218; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Campagnolo P, 2010, CIRCULATION, V121, P1735, DOI 10.1161/CIRCULATIONAHA.109.899252; Castronuovo JJ, 2002, J VASC SURG, V35, P152, DOI 10.1067/mva.2002.119231; Chang YT, 2016, PULM CIRC, V6, P347, DOI 10.1086/686994; Chen YK, 2013, ARTERIOSCL THROM VAS, V33, P1844, DOI 10.1161/ATVBAHA.113.300902; Criqui MH, 2015, CIRC RES, V116, P1509, DOI 10.1161/CIRCRESAHA.116.303849; de Vries MR, 2016, NAT REV CARDIOL, V13, P451, DOI 10.1038/nrcardio.2016.76; Evanko SP, 2001, ARCH BIOCHEM BIOPHYS, V394, P29, DOI 10.1006/abbi.2001.2507; Fogelstrand P, 2005, CARDIOVASC RES, V67, P326, DOI 10.1016/j.cardiores.2005.03.027; Frischknecht K, 2006, J VASC RES, V43, P338, DOI 10.1159/000093606; Gentile AT, 1999, CARDIOVASC SURG, V7, P464, DOI 10.1016/S0967-2109(98)00093-3; George SJ, 1996, ATHEROSCLEROSIS, V120, P227, DOI 10.1016/0021-9150(95)05717-X; Goldman S, 2004, J AM COLL CARDIOL, V44, P2149, DOI 10.1016/j.jacc.2004.08.064; Grandoch M, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0340-6; Halpert I, 1996, P NATL ACAD SCI USA, V93, P9748, DOI 10.1073/pnas.93.18.9748; Harskamp RE, 2014, JAMA SURG, V149, P798, DOI 10.1001/jamasurg.2014.87; Heydarkhan-Hagvall S, 2006, TISSUE ENG, V12, P831, DOI 10.1089/ten.2006.12.831; Hofstra L, 1996, CIRCULATION, V94, P1283, DOI 10.1161/01.CIR.94.6.1283; Huang R, 2006, CIRC RES, V98, P370, DOI 10.1161/01.RES.0000202051.28319.c8; Jiang ZH, 2009, AM J PHYSIOL-HEART C, V297, pH1200, DOI 10.1152/ajpheart.00268.2009; Johansson B, 1999, HISTOCHEM J, V31, P723, DOI 10.1023/A:1003948515114; Kaplan-Albuquerque N, 2005, J BIOL CHEM, V280, P19966, DOI 10.1074/jbc.M500917200; Kenagy RD, 2002, ARTERIOSCL THROM VAS, V22, P400, DOI 10.1161/hq0302.105376; Kenagy RD, 2006, TRENDS CARDIOVAS MED, V16, P209, DOI 10.1016/j.tcm.2006.03.011; Kenagy RD, 2018, J VASC SURG, V67, P309, DOI 10.1016/j.jvs.2016.12.113; Kenagy RD, 2009, J VASC SURG, V49, P1282, DOI 10.1016/j.jvs.2008.12.020; Kiene LS, 2016, ARTERIOSCL THROM VAS, V36, pE9, DOI 10.1161/ATVBAHA.115.306607; Kikuchi S, 2018, J VASC SURG, V67, P1556, DOI 10.1016/j.jvs.2017.03.447; Kikuchi S, 2016, J VASC SURG, V63, P1044, DOI 10.1016/j.jvs.2014.10.017; Loesch A, 2009, CURR VASC PHARMACOL, V7, P58, DOI 10.2174/157016109787354150; Longchamp A, 2014, BIOMATERIALS, V35, P2588, DOI 10.1016/j.biomaterials.2013.12.041; Longpre JM, 2008, INT J BIOCHEM CELL B, P12480; Majesky MW, 2017, CIRC RES, V120, P296, DOI 10.1161/CIRCRESAHA.116.309322; Merrilees MJ, 2001, CORONARY ARTERY DIS, V12, P7, DOI 10.1097/00019501-200102000-00002; Mitra AK, 2006, IMMUNOL CELL BIOL, V84, P115, DOI 10.1111/j.1440-1711.2005.01407.x; Morton SU, 2008, P NATL ACAD SCI USA, V105, P17830, DOI 10.1073/pnas.0804673105; Nandadasa S, 2014, MATRIX BIOL, V35, P34, DOI 10.1016/j.matbio.2014.01.005; Nishimoto M, 2001, J THORAC CARDIOV SUR, V121, P729, DOI 10.1067/mtc.2001.112467; Osgood MJ, 2014, J VASC SURG, V60, P202, DOI 10.1016/j.jvs.2013.06.004; Owens CD, 2015, J VASC SURG, V61, P203, DOI 10.1016/j.jvs.2013.08.019; Passi A, 1999, FEBS LETT, V456, P93, DOI 10.1016/S0014-5793(99)00929-1; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; PERIDES G, 1995, BIOCHEM J, V312, P377, DOI 10.1042/bj3120377; Piola M, 2017, ANN BIOMED ENG, V45, P884, DOI 10.1007/s10439-016-1747-7; Piola M, 2016, ANN BIOMED ENG, V44, P1449, DOI 10.1007/s10439-015-1434-0; Piola M, 2016, J TISSUE ENG REGEN M, V10, pE204, DOI 10.1002/term.1798; Prandi F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117409; Raines EW, 2004, CYTOKINE GROWTH F R, V15, P237, DOI 10.1016/j.cytogfr.2004.03.004; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rutnam ZJ, 2013, MATRIX BIOL, V32, P74, DOI 10.1016/j.matbio.2012.11.003; Sandy JD, 2001, J BIOL CHEM, V276, P13372, DOI 10.1074/jbc.M009737200; Schmidt R, 1996, J HISTOTECHNOL, V19, P325; SCHONHERR E, 1991, J BIOL CHEM, V266, P17640; Shi Y, 2001, CIRCULATION, V103, P2408; Shi Y, 1997, CIRCULATION, V95, P2684, DOI 10.1161/01.CIR.95.12.2684; Siiskonen H, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00043; Sobel M, 2018, J VASC SURG, V68, p165S, DOI 10.1016/j.jvs.2018.03.436; Soneson C, 2015, F1000 RES, V4, P1521, DOI [10.12688/f1000research.7563.1, DOI 10.12688/F1000RESEARCH.7563.2]; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; THIENE G, 1980, THORAX, V35, P519, DOI 10.1136/thx.35.7.519; Tomas JJ, 2003, J VASC RES, V40, P266, DOI 10.1159/000071890; UNDERHILL CB, 1993, DEV BIOL, V155, P324, DOI 10.1006/dbio.1993.1032; van den Boom M, 2006, CIRC RES, V98, P36, DOI 10.1161/01.RES.0000199263.67107.c0; Vigetti D, 2014, J BIOL CHEM, V289, P28816, DOI 10.1074/jbc.M114.597401; WALLER BF, 1985, AM J CARDIOL, V55, P65, DOI 10.1016/0002-9149(85)90301-7; Wang XB, 2010, J BIOL CHEM, V285, P23239, DOI 10.1074/jbc.M109.084673; Weiss S, 2007, J VASC RES, V44, P149, DOI 10.1159/000099141; Wight TN, 2017, MATRIX BIOL, V60-61, P38, DOI 10.1016/j.matbio.2016.12.001; Wilkinson TS, 2004, AM J RESP CELL MOL, V31, P92, DOI 10.1165/rcmb.2003-0380OC; Yang ZH, 1998, CIRCULATION, V97, P181, DOI 10.1161/01.CIR.97.2.181	71	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204045	10.1371/journal.pone.0204045	http://dx.doi.org/10.1371/journal.pone.0204045			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265729	Green Submitted, gold, Green Published			2022-12-26	WOS:000446005500017
J	Veron, C; Pautex, S; Weber, C; Janssens, JP; Cedraschi, C				Veron, Claudia; Pautex, Sophie; Weber, Catherine; Janssens, Jean-Paul; Cedraschi, Christine			Recollection of participating in a trial: A qualitative study of patients with severe and very severe chronic obstructive pulmonary disease	PLOS ONE			English	Article							OF-LIFE CARE; END-STAGE COPD; PALLIATIVE CARE; HEALTH-CARE; LUNG-CANCER; COMMUNICATION; VIEWS	Background Despite having similar palliative needs to patients with lung cancer, advanced chronic obstructive pulmonary disease (COPD) patients are less likely to receive palliative care. To evaluate the effect of introducing specialized palliative care with severe to very severe COPD patients, a randomized controlled trial (RCT) was conducted in Switzerland. Aim To explore COPD patients' recollection of the trial, their needs and the usefulness of the palliative care interventions. Design and setting Qualitative study with advanced COPD patients who participated in a specialized palliative care intervention, conducted in a general hospital. Method Eighteen patients with severe to very severe COPD were interviewed about their experiences. Interviews were transcribed and thematic content analysis was performed. Results Patients had poor recollection of the trial and difficulties understanding the palliative care intervention. No major differences were observed between patients who received the specialized intervention and those who did not. Content analysis emphasized that although they experienced disabling symptoms, participants tended to attribute their limitations to problems other than COPD and some declared that they were not sick. Patients reported restrictions due to oxygen therapy, and the burden of becoming dependent on it. This dependence resulted in intense anxiety, leading participants to focus on the present only. A strong feeling of perceived helplessness emerged from the patients' interviews. Conclusions Our findings suggest that poor recollection and understanding of the palliative care intervention act as barriers to the conduct of clinical trials with severe and very severe COPD patients. Their cognitive difficulties, perception of COPD, functional limitations, overwhelming anxiety, focus on the present and perceived helplessness also seem to hinder the implementation of such care.	[Veron, Claudia; Pautex, Sophie; Weber, Catherine] Geneva Univ Hosp, Dept Community Med Primary Care & Emergency Med, Geneva, Switzerland; [Janssens, Jean-Paul] Geneva Univ Hosp, Div Pulm Dis, Geneva, Switzerland; [Cedraschi, Christine] Geneva Univ Hosp, Div Gen Med Rehabil, Geneva, Switzerland; [Cedraschi, Christine] Geneva Univ Hosp, Div Clin Pharmacol & Toxicol, Geneva, Switzerland; [Veron, Claudia] Univ Lausanne, Inst Psychol, Res Ctr Psychol Hlth Aging & Sport Examinat PHASE, Lausanne, Switzerland	University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Lausanne	Veron, C (corresponding author), Geneva Univ Hosp, Dept Community Med Primary Care & Emergency Med, Geneva, Switzerland.; Cedraschi, C (corresponding author), Geneva Univ Hosp, Div Gen Med Rehabil, Geneva, Switzerland.; Cedraschi, C (corresponding author), Geneva Univ Hosp, Div Clin Pharmacol & Toxicol, Geneva, Switzerland.; Veron, C (corresponding author), Univ Lausanne, Inst Psychol, Res Ctr Psychol Hlth Aging & Sport Examinat PHASE, Lausanne, Switzerland.	Claudia.Veron@unil.ch; Christine.Cedraschi@hcuge.ch	Janssens, Jean-Paul/AAV-8083-2020	Veron, Claudia/0000-0003-1357-2895; Pautex, Sophie/0000-0001-7248-3513	Geneva Lung Association	Geneva Lung Association	Funding was provided by the Geneva Lung Association to SP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro P, 2002, CHEST, V121, P1441, DOI 10.1378/chest.121.5.1441; Beernaert K, 2013, RESP MED, V107, P1731, DOI 10.1016/j.rmed.2013.06.003; Bove DG, 2017, J PSYCHOSOM RES, V98, P71, DOI 10.1016/j.jpsychores.2017.05.013; Bradley EH, 2007, HEALTH SERV RES, V42, P1758, DOI 10.1111/j.1475-6773.2006.00684.x; Claessens MT, 2000, J AM GERIATR SOC, V48, pS146, DOI 10.1111/j.1532-5415.2000.tb03124.x; Cooper C, 2014, CONTEMP CLIN TRIALS, V38, P338, DOI 10.1016/j.cct.2014.06.002; Curtis JR, 2008, EUR RESPIR J, V32, P796, DOI 10.1183/09031936.00126107; Curtis JR, 2004, EUR RESPIR J, V24, P200, DOI 10.1183/09031936.04.00010104; Dal Negro RW, 2015, MULTIDISCIP RESP MED, V10, DOI 10.1186/s40248-015-0013-4; Daly J, 2007, J CLIN EPIDEMIOL, V60, P43, DOI 10.1016/j.jclinepi.2006.03.014; Elkington H, 2004, RESP MED, V98, P439, DOI 10.1016/j.rmed.2003.11.006; Elkington H, 2001, FAM PRACT, V18, P440, DOI 10.1093/fampra/18.4.440; Elofsson LC, 2004, PALLIATIVE MED, V18, P611, DOI 10.1191/0269216304pm922oa; Gallay B, 1997, MED HYG, V55, P11; Giacomini M, 2012, Ont Health Technol Assess Ser, V12, P1; Giacomini MK, 2000, JAMA-J AM MED ASSOC, V284, P357, DOI 10.1001/jama.284.3.357; GOLD, 2017, GLOBAL STRATEGY DIAG; Gore JM, 2000, THORAX, V55, P1000, DOI 10.1136/thorax.55.12.1000; GRANT I, 1982, ARCH INTERN MED, V142, P1470, DOI 10.1001/archinte.142.8.1470; Habraken JM, 2007, PATIENT EDUC COUNS, V68, P121, DOI 10.1016/j.pec.2007.05.011; Habraken JM, 2008, BRIT J GEN PRACT, V58, P844, DOI 10.3399/bjgp08X376186; Hjalmarsen A, 1999, EUR NEUROL, V42, P27, DOI 10.1159/000008065; Knauft E, 2005, CHEST, V127, P2188, DOI 10.1378/chest.127.6.2188; Lewin S, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3496; MacPherson A, 2013, PALLIATIVE MED, V27, P265, DOI 10.1177/0269216312440606; Marx G, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011555; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; McNaughton A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012521; MCSWEENY AJ, 1982, ARCH INTERN MED, V142, P473, DOI 10.1001/archinte.142.3.473; Murray SA, 2005, BMJ-BRIT MED J, V330, P1007, DOI 10.1136/bmj.330.7498.1007; NICE, 2010, CHRON OBSTR PULM DIS; Pinnock Hilary, 2011, BMJ Support Palliat Care, V1, P174, DOI 10.1136/bmjspcare.d142rep; Pooler C, 2014, GLOB QUALIT NURS RES, V1, DOI 10.1177/2333393614548762; Seamark DA, 2007, J ROY SOC MED, V100, P225, DOI 10.1258/jrsm.100.5.225; Spathis Anna, 2008, Int J Chron Obstruct Pulmon Dis, V3, P11; Spence A, 2009, PALLIATIVE MED, V23, P126, DOI 10.1177/0269216308098804; Strang S, 2013, UPSALA J MED SCI, V118, P181, DOI 10.3109/03009734.2013.801059; Tavares N, 2017, EUR RESPIR J, V50, DOI 10.1183/1393003.congress-2017.PA3452; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Weber C, 2014, BMC PALLIAT CARE, V13, DOI 10.1186/1472-684X-13-47; World Health Organization, 2014, J Pain Palliat Care Pharmacother, V28, P130, DOI 10.3109/15360288.2014.911801	41	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204701	10.1371/journal.pone.0204701	http://dx.doi.org/10.1371/journal.pone.0204701			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV2HB	30261031	Green Published, Green Submitted, gold			2022-12-26	WOS:000445907400092
J	Nkoke, C; Luchuo, EB; Jingi, AM; Makoge, C; Hamadou, B; Dzudie, A				Nkoke, Clovis; Luchuo, Engelbert Bain; Jingi, Ahmadou Musa; Makoge, Christelle; Hamadou, Ba; Dzudie, Anastase			Rheumatic heart disease awareness in the South West region of Cameroon: A hospital based survey in a Sub-Saharan African setting	PLOS ONE			English	Article							FEVER; PREVENTION; PREVALENCE	Background Early diagnosis and adequate treatment of Group A streptococcal throat infection is an important initial stage in the primary prevention of acute rheumatic fever and rheumatic heart disease. This preventable condition associated with high mortality rates mandates a thorough understanding by the general public and the health. Objective The aim of the study was to assess the level of awareness about different aspects of rheumatic heart disease in patients coming to the outpatient department of the Buea regional Hospital, South West region of Cameroon. Methods This was a cross-sectional descriptive study carried in the outpatient department of the Buea Regional Hospital, Cameroon. The study population was adults and children aged 9 years and above. Data collection was done by using a self-administered questionnaire addressed to assess awareness on rheumatic heart disease. Results A total of 256 participants were interviewed, of which 70 (27.3%) were males. Their mean age was 34.4 +/- 11.9 years (males: 36.2 +/- 12.7 years versus females: 33.7 +/- 11.6 years, p = 0.129). Most of the participants were in the 20 to 29 year old group (37.9%). More than two thirds (71.1%) of the participants reported having had sore throat at least once. The disease was treated with antibiotics in only 45.4%, with the treatment prescribed by a health care professional in 35.8% of the cases. About 73% of the respondents did not know what causes sore throat, and most (71.1%) were unaware of any complications that could arise from poorly treated sore throat. More than 70% of the participants did not know that sore throat can be associated with heart disease. Rheumatic heart disease was unknown to 82% of the participants and 95% of them did not know what causes RHD. Only 5.1% percent of the participants had an adequate knowledge of RHD. Age <= 35 years, post-secondary level of education, and having heard of RHD were significantly associated with an adequate knowledge. After adjusting for age, post-secondary education (aOR: 9, [95% C: 1.2 +/- 67.5], p = 0.019), and having heard of RHD (aOR: 18.1, [95% CI: 4.7 +/- 70.3], p<0.001) were still associated with a fair knowledge. Conclusions Levels of knowledge and awareness on rheumatic heart disease is low. This study provides important insight into the perception and practices related to sore throat that can be used in the design of awareness activities aimed reducing the risk of RHD in Cameroon. The appropriateness of antibiotics prescribed, and the health care provider awareness and knowledge levels regarding RHD in Cameroon has not been reported yet in the literature. This grey area deserves more research.	[Nkoke, Clovis] Buea Reg Hosp, Buea, Cameroon; [Nkoke, Clovis; Jingi, Ahmadou Musa; Dzudie, Anastase] Clin Res Educ Networking & Consultancy, Douala, Cameroon; [Luchuo, Engelbert Bain] Vrije Univ, Athena Inst Res Innovat & Commun Hlth & Life Sci, Amsterdam, Netherlands; [Jingi, Ahmadou Musa; Makoge, Christelle; Hamadou, Ba; Dzudie, Anastase] Univ Yaounde1, Fac Med & Biomed Sci, Yaounde, Cameroon; [Dzudie, Anastase] Douala Gen Hosp, Douala, Cameroon	Vrije Universiteit Amsterdam; University of Yaounde I	Nkoke, C (corresponding author), Buea Reg Hosp, Buea, Cameroon.; Nkoke, C (corresponding author), Clin Res Educ Networking & Consultancy, Douala, Cameroon.	cnkoke@yahoo.com		Engelbert Bain, Luchuo/0000-0002-6006-2698; DZUDIE, Anastase/0000-0003-4038-4128				ARGUEDAS A, 1992, J PEDIATR-US, V121, P569, DOI 10.1016/S0022-3476(05)81146-1; Bach JF, 1996, LANCET, V347, P644, DOI 10.1016/S0140-6736(96)91202-7; Beaton A, 2012, CIRCULATION, V125, P3127, DOI 10.1161/CIRCULATIONAHA.112.092312; Bergmark R, 2010, PEDIATR INFECT DIS J, V29, P1135, DOI 10.1097/INF.0b013e3181edf475; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Carapetis JR, 2005, LANCET, V366, P155, DOI 10.1016/S0140-6736(05)66874-2; Damasceno A, 2012, ARCH INTERN MED, V172, P1386, DOI 10.1001/archinternmed.2012.3310; Engel ME, 2015, HEART, V101, P1389, DOI 10.1136/heartjnl-2015-307444; Essop MR, 2005, CIRCULATION, V112, P3584, DOI 10.1161/CIRCULATIONAHA.105.539775; Gerber MA, 2009, CIRCULATION, V119, P1541, DOI 10.1161/CIRCULATIONAHA.109.191959; Hamid Saeed M, 2016, JUMDC, V7; Marijon E, 2007, NEW ENGL J MED, V357, P470, DOI 10.1056/NEJMoa065085; Marijon E, 2012, LANCET, V379, P953, DOI 10.1016/S0140-6736(11)61171-9; Mayosi BM, 2010, SAMJ S AFR MED J, V100, P506, DOI 10.7196/SAMJ.3175; Mirabel M, 2015, CIRC-CARDIOVASC IMAG, V8, DOI 10.1161/CIRCIMAGING.114.002324; Musuku J, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2563-x; Ngaide AA, 2015, HEART ASIA, V7, P40, DOI 10.1136/heartasia-2015-010664; Nkoke C, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0584-z; Nordet P, 2008, CARDIOVASC J AFR, V19, P135; Osman Gehan M, 2015, Sudan J Paediatr, V15, P37; Regmi P, P HAVE HEART SAV HEA; Robertson KA, 2005, SAMJ S AFR MED J, V95, P52; Tantchou Tchoumi J C, 2009, Bull Soc Pathol Exot, V102, P155; Zuhlke L, 2013, HEART, V99, P1554, DOI 10.1136/heartjnl-2013-303896	24	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2018	13	9							e0203864	10.1371/journal.pone.0203864	http://dx.doi.org/10.1371/journal.pone.0203864			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU9BO	30252868	Green Published, Green Submitted, gold			2022-12-26	WOS:000445639700016
J	Ring, M; Landes, D; Hotho, A				Ring, Markus; Landes, Dieter; Hotho, Andreas			Detection of slow port scans in flow-based network traffic	PLOS ONE			English	Article								Frequently, port scans are early indicators of more serious attacks. Unfortunately, the detection of slow port scans in company networks is challenging due to the massive amount of network data. This paper proposes an innovative approach for preprocessing flow-based data which is specifically tailored to the detection of slow port scans. The preprocessing chain generates new objects based on flow-based data aggregated over time windows while taking domain knowledge as well as additional knowledge about the network structure into account. The computed objects are used as input for the further analysis. Based on these objects, we propose two different approaches for detection of slow port scans. One approach is unsupervised and uses sequential hypothesis testing whereas the other approach is supervised and uses classification algorithms. We compare both approaches with existing port scan detection algorithms on the flow-based CIDDS-001 data set. Experiments indicate that the proposed approaches achieve better detection rates and exhibit less false alarms than similar algorithms.	[Ring, Markus; Landes, Dieter] Coburg Univ Appl Sci & Arts, Fac Elect Engn & Informat, D-96450 Coburg, Germany; [Hotho, Andreas] Univ Wurzburg, Data Min & Informat Retrieval Grp, D-97074 Wurzburg, Germany	Klinikum Coburg; University of Wurzburg	Ring, M (corresponding author), Coburg Univ Appl Sci & Arts, Fac Elect Engn & Informat, D-96450 Coburg, Germany.	markus.ring@hs-coburg.de		Landes, Dieter/0000-0002-0741-3540	Bavarian Ministry for Economic affairs through the WISENT project [IUK 452/002]; BayWISS Consortium Digitization	Bavarian Ministry for Economic affairs through the WISENT project; BayWISS Consortium Digitization	This work is funded by the Bavarian Ministry for Economic affairs through the WISENT project (grant no. IUK 452/002) and the BayWISS Consortium Digitization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is funded by the Bavarian Ministry for Economic affairs through the WISENT project (grant no. IUK 452/002). M.R. was supported by the BayWISS Consortium Digitization.	AlEroud AF, 2018, IEEE T SYST MAN CY-S, V48, P207, DOI 10.1109/TSMC.2016.2600405; Avinash Sridharan, 2006, 25th IEEE International Performance, Computing, and Communications Conference (IEEE Cat. No.06CH37775C); Bhattacharyya D. K., 2013, NETWORK ANOMALY DETE; Bhuyan MH, 2014, IEEE COMMUN SURV TUT, V16, P303, DOI 10.1109/SURV.2013.052213.00046; Bhuyan MH, 2011, COMPUT J, V54, P1565, DOI 10.1093/comjnl/bxr035; Bou-Harb E, 2014, IEEE COMMUN SURV TUT, V16, P1496, DOI 10.1109/SURV.2013.102913.00020; Buczak AL, 2016, IEEE COMMUN SURV TUT, V18, P1153, DOI 10.1109/COMST.2015.2494502; Claise B., 2008, 5101 RFC; Claise B., 2004, CISCO SYSTEMS NETFLO; Dua S, 2016, DATA MINING MACHINE; Fontugne R, 2010, ACM CONEXT 10; Garcia S, 2014, COMPUT SECUR, V45, P100, DOI 10.1016/j.cose.2014.05.011; Gates C, 2006, P 11 IEEE S COMP COM, P402; Gordon Lyon, 2009, NMAP NETWORK SCANNIN; Han J, 2012, MOR KAUF D, P1; John W., 2010, P 6 IEEE INT WIR COM, P473, DOI DOI 10.1145/1815396.1815506; Jung J, 2004, P IEEE S SECUR PRIV, P211; Landes D., 2013, BUSINESS INTELLIGENC, P75; Nychis G, 2008, IMC'08: PROCEEDINGS OF THE 2008 ACM SIGCOMM INTERNET MEASUREMENT CONFERENCE, P151; Ring M., 2017, P 16 EUROPEAN C CYBE, P361; Ring M., 2017, J INF WARFARE, V16, P40; Ring M, 2017, DATA ANALYTIC, P3, DOI 10.1007/978-3-319-59439-2_1; Ring M, 2017, INT CONF DAT MIN WOR, P657, DOI 10.1109/ICDMW.2017.93; Shiravi A, 2012, COMPUT SECUR, V31, P357, DOI 10.1016/j.cose.2011.12.012; Skoudis E., 2006, PRENTICE HALL SERIES; Sommer R, 2010, P IEEE S SECUR PRIV, P305, DOI 10.1109/SP.2010.25; Staniford S., 2002, Journal of Computer Security, V10, P105; Webster A., 2015, SECURITY PRIVACY COM, V164, P385, DOI [10.1007/978-3-319-28865-9_21, DOI 10.1007/978-3-319-28865-9_21]; Weller-Fahy DJ, 2015, IEEE COMMUN SURV TUT, V17, P70, DOI 10.1109/COMST.2014.2336610; Zhang Y, 2009, PROCEEDINGS OF THE 2009 SIXTH INTERNATIONAL CONFERENCE ON INFORMATION TECHNOLOGY: NEW GENERATIONS, VOLS 1-3, P16, DOI 10.1109/ITNG.2009.16	30	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2018	13	9							e0204507	10.1371/journal.pone.0204507	http://dx.doi.org/10.1371/journal.pone.0204507			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU9BO	30252894	Green Submitted, Green Published, gold			2022-12-26	WOS:000445639700056
J	Liu, JG; Zhao, M; Song, W; Ma, LB; Li, X; Zhang, FY; Diao, L; Pi, Y; Jiang, KJ				Liu, Junguo; Zhao, Ming; Song, Wei; Ma, Lingbo; Li, Xiu; Zhang, Fengying; Diao, Le; Pi, Yan; Jiang, Keji			An amine oxidase gene from mud crab, Scylla paramamosain, regulates the neurotransmitters serotonin and dopamine in vitro	PLOS ONE			English	Article							HUMAN MONOAMINE-OXIDASE; HUMAN POLYAMINE OXIDASE; BEHAVIORAL-DISORDERS; SELECTIVE INHIBITORS; MESSENGER-RNA; ACTIVE-SITE; DRUG TARGET; AGGRESSION; QUERCETIN; RAT	Amine oxidase, which participates in the metabolic processing of biogenic amines, is widely found in organisms, including higher organisms and various microorganisms. In this study, the full-length cDNA of a novel amine oxidase gene was cloned from the mud crab, Scylla paramamosain, and termed SpAMO. The cDNA sequence was 2,599 bp in length, including an open reading frame of 1,521 bp encoding 506 amino acids. Two amino acid sequence motifs, a flavin adenine dinucleotide-binding domain and a flavin-containing amine oxidoreductase, were highly conserved in SpAMO. A quantitative real-time polymerase chain reaction analysis showed that the expression level of SpAMO after quercetin treatment was time- and concentration-dependent. The expression of SpAMO tended to decrease and then increase in the brain and haemolymph after treatment with 5 mg/kg/d quercetin; after treatment with 50 mg/kg/d quercetin, the expression of SpAMO declined rapidly and remained low in the brain and haemolymph. These results indicated that quercetin could inhibit the transcription of SpAMO, and the high dose (50 mg/kg/d) had a relatively significant inhibitory effect. SpAMO showed the highest catalytic activity on serotonin, followed by dopamine, beta-phenylethylamine, and spermine, suggesting that the specific substrates of SpAMO are serotonin and dopamine. A bioinformatics analysis of SpAMO showed that it has molecular characteristics of spermine oxidase, but a quercetin test and enzyme activity study indicated that it also functions like monoamine oxidase. It is speculated that SpAMO might be a novel amine oxidase in S. paramamosain that has the functions of both spermine oxidase and monoamine oxidase.	[Liu, Junguo; Zhao, Ming; Song, Wei; Ma, Lingbo; Li, Xiu; Zhang, Fengying; Diao, Le; Jiang, Keji] Chinese Acad Fishery Sci, East China Sea Fisheries Res Inst, Minist Agr & Rural Affairs, Key Lab Aquat Genom Ocean & Polar Fisheries, Shanghai, Peoples R China; [Liu, Junguo; Li, Xiu; Diao, Le] Shanghai Ocean Univ, Coll Fisheries & Life Sci, Shanghai, Peoples R China; [Pi, Yan] Fudan Univ, Sch Life Sci, Shanghai, Peoples R China	Chinese Academy of Fishery Sciences; East China Sea Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs; Shanghai Ocean University; Fudan University	Ma, LB; Jiang, KJ (corresponding author), Chinese Acad Fishery Sci, East China Sea Fisheries Res Inst, Minist Agr & Rural Affairs, Key Lab Aquat Genom Ocean & Polar Fisheries, Shanghai, Peoples R China.	malingbo@vip.sina.com; kjjiang@hotmail.com	Jiang, keji/F-1519-2010; Liu, Junguo/B-3021-2012	Liu, Junguo/0000-0002-5745-6311; Jiang, keji/0000-0003-2656-2119; Zhao, Ming/0000-0002-1221-9240	Central Public-interest Scientific Institution Basal Research Fund, CAFS [2018HY-ZD0203]; National Natural Science Foundation of China [31101890, 41506195]; Basic Research Fund for State-level Nonprofit Research Institute of ESCFRI [2014Z01-2]; Science and Technology Commission of Shanghai [15391900900]; China Agriculture Research System [48]	Central Public-interest Scientific Institution Basal Research Fund, CAFS; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic Research Fund for State-level Nonprofit Research Institute of ESCFRI; Science and Technology Commission of Shanghai(Science & Technology Commission of Shanghai Municipality (STCSM)); China Agriculture Research System	This study was funded by the Central Public-interest Scientific Institution Basal Research Fund, CAFS (grant no. 2018HY-ZD0203 to Fengying Zhang), the National Natural Science Foundation of China (grant no. 31101890 to Dr. Keji Jiang), the National Natural Science Foundation of China (grant no. 41506195 to Fengying Zhang), the Basic Research Fund for State-level Nonprofit Research Institute of ESCFRI (grant no. 2014Z01-2 to Fengying Zhang), Program of Science and Technology Commission of Shanghai (grant no. 15391900900 to Lingbo Ma), and the China Agriculture Research System-48 to Lingbo Ma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi MS, 2012, BIOCHEMISTRY-US, V51, P8690, DOI 10.1021/bi3011434; Alia-Klein N, 2008, J NEUROSCI, V28, P5099, DOI 10.1523/JNEUROSCI.0925-08.2008; APRISON MH, 1961, J NEUROCHEM, V6, P350, DOI 10.1111/j.1471-4159.1961.tb13486.x; BACH AWJ, 1988, P NATL ACAD SCI USA, V85, P4934, DOI 10.1073/pnas.85.13.4934; Bacque-Cazenave J, 2017, SCI REP-UK, V7, DOI 10.1038/srep39935; Bandaruk Y, 2014, TOXICOL REP, V1, P639, DOI 10.1016/j.toxrep.2014.08.016; Benedetti MS, 2001, FUND CLIN PHARMACOL, V15, P75, DOI 10.1046/j.1472-8206.2001.00011.x; BERRY MD, 1994, PROG NEUROBIOL, V42, P375, DOI 10.1016/0301-0082(94)90081-7; Binda C, 2002, J BIOL CHEM, V277, P23973, DOI 10.1074/jbc.R200005200; Binda C, 2002, NAT STRUCT BIOL, V9, P22, DOI 10.1038/nsb732; Binda C, 2004, FEBS LETT, V564, P225, DOI 10.1016/S0014-5793(04)00209-1; Bortolato M, 2013, NEUROSCIENCE, V236, P160, DOI 10.1016/j.neuroscience.2013.01.015; Brazeau BJ, 2004, ARCH BIOCHEM BIOPHYS, V428, P22, DOI 10.1016/j.abb.2004.03.034; BRUNNER HG, 1993, SCIENCE, V262, P578, DOI 10.1126/science.8211186; Butterweck V, 2000, PLANTA MED, V66, P3, DOI 10.1055/s-2000-11119; CASES O, 1995, SCIENCE, V268, P1763, DOI 10.1126/science.7792602; Cesura AM, 1998, J NEURAL TRANSM-SUPP, P189; Chakraborty J, 2014, CNS NEUROSCI THER, V20, P10, DOI 10.1111/cns.12189; CHEN K, 1994, MOL PHARMACOL, V46, P1226; Chen TJH, 2005, MED HYPOTHESES, V65, P703, DOI 10.1016/j.mehy.2005.04.037; Chimenti F, 2006, J NAT PROD, V69, P945, DOI 10.1021/np060015w; Comings DE, 2000, PROG BRAIN RES, V126, P325; Edmondson DE, 2004, NEUROTOXICOLOGY, V25, P63, DOI 10.1016/S0161-813X(03)00114-1; FOWLER CJ, 1984, MED RES REV, V4, P323, DOI 10.1002/med.2610040303; Franke R, 2013, AQUAC RES, V44, P451, DOI 10.1111/j.1365-2109.2011.03052.x; Geha RM, 2000, J NEUROCHEM, V75, P1304, DOI 10.1046/j.1471-4159.2000.751304.x; GRIMSBY J, 1990, J NEUROCHEM, V55, P1166, DOI 10.1111/j.1471-4159.1990.tb03121.x; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; HALL TR, 1983, COMP BIOCHEM PHYS B, V76, P393, DOI 10.1016/0305-0491(83)90265-1; HALL TR, 1982, COMP BIOCHEM PHYS C, V71, P141, DOI 10.1016/0306-4492(82)90027-2; Herraiz T, 2018, J CHROMATOGR B, V1073, P136, DOI 10.1016/j.jchromb.2017.12.004; Hu Fa-wen, 2007, Journal of Tropical Oceanography, V26, P64; Jeffs AG, 2010, J MAR BIOL ASSOC IND, V52, P320; Kong Q., 2006, PROGR MODERN BIOMEDI, V6, P55; KRAVITZ EA, 1988, SCIENCE, V241, P1775, DOI 10.1126/science.2902685; Landry J, 2003, BIOCHEM BIOPH RES CO, V303, P771, DOI 10.1016/S0006-291X(03)00416-9; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; Lesch KP, 2000, BEHAV SCI LAW, V18, P581, DOI 10.1002/1099-0798(200010)18:5<581::AID-BSL411>3.0.CO;2-L; Liu CH, 2016, J BIOMED SCI, V23, DOI 10.1186/s12929-016-0239-2; Liu ZhiYu, 2012, China Vegetables, P1; Ma JC, 2004, J MOL BIOL, V338, P103, DOI 10.1016/j.jmb.2004.02.032; Marshall S, 2005, APPL ANIM BEHAV SCI, V90, P65, DOI 10.1016/j.applanim.2004.07.007; Miczek KA, 2005, BIOL AGGRESSION, P114, DOI DOI 10.1093/ACPROF:OSO/9780195168761.003.0005; Mo JL, 1998, J CRUSTACEAN BIOL, V18, P442, DOI 10.2307/1549409; Moinard C, 2005, CLIN NUTR, V24, P184, DOI 10.1016/j.clnu.2004.11.001; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Pintar J E, 1983, Int J Dev Neurosci, V1, P49, DOI 10.1016/0736-5748(83)90010-2; Polticelli F, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-90; Reniers J, 2011, BIOORGAN MED CHEM, V19, P134, DOI 10.1016/j.bmc.2010.11.041; Reti IM, 2011, COMPR PSYCHIAT, V52, P188, DOI 10.1016/j.comppsych.2010.05.005; Romano N, 2017, REV FISH SCI AQUAC, V25, P42, DOI 10.1080/23308249.2016.1221379; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Sakakibara H, 2008, BIOSCI BIOTECH BIOCH, V72, P94, DOI 10.1271/bbb.70454; Samuels NM, 2005, BIOCHEMISTRY-US, V44, P14308, DOI 10.1021/bi051176m; SCHILLING B, 1995, BBA-GEN SUBJECTS, V1243, P529, DOI 10.1016/0304-4165(94)00183-X; Scott AL, 2008, NEUROREPORT, V19, P739, DOI 10.1097/WNR.0b013e3282fd6e88; SENATORI O, 1990, COMP BIOCHEM PHYS C, V96, P87, DOI 10.1016/0742-8413(90)90049-F; Setini A, 2005, COMP BIOCHEM PHYS B, V140, P153, DOI 10.1016/j.cbpc.2004.10.002; Shegokar R, 2011, PHARMAZIE, V66, P313, DOI 10.1691/ph.2011.0301; Shelley C., 2011, MUD CRAB AQUACULTURE; Son SY, 2008, P NATL ACAD SCI USA, V105, P5739, DOI 10.1073/pnas.0710626105; Sugawara A, 2015, J BIOSCI BIOENG, V119, P629, DOI 10.1016/j.jbiosc.2014.10.023; Sugimoto H, 2010, COMP BIOCHEM PHYS B, V155, P266, DOI 10.1016/j.cbpb.2009.11.010; SULLIVAN JP, 1986, BIOCHEM PHARMACOL, V35, P3255, DOI 10.1016/0006-2952(86)90421-1; [孙迪 Sun Di], 2011, [山东农业大学学报. 自然科学版, Journal of Shandong Agricultural University. Natural Science], V42, P223; Thomas T, 2001, CELL MOL LIFE SCI, V58, P244, DOI 10.1007/PL00000852; Veselovsky AV, 2004, NEUROTOXICOLOGY, V25, P37, DOI 10.1016/S0161-813X(03)00087-1; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wang D, 2019, CRIT REV FOOD SCI, V59, P2189, DOI 10.1080/10408398.2018.1441123; Wang GZ, 2005, AQUACULT INT, V13, P459, DOI 10.1007/s10499-005-1887-5; Wang HZ, 2010, BIOTECHNOL LETT, V32, P1719, DOI 10.1007/s10529-010-0354-1; Wang YL, 2001, CANCER RES, V61, P5370; Wang YL, 2003, BIOCHEM BIOPH RES CO, V304, P605, DOI 10.1016/S0006-291X(03)00636-3; Wei H. Q., 2015, FISHERY INFORM STRAT; WEYLER W, 1990, PHARMACOL THERAPEUT, V47, P391, DOI 10.1016/0163-7258(90)90064-9; Wouters J, 1998, CURR MED CHEM, V5, P137; WU HF, 1993, MOL PHARMACOL, V43, P888; Ye Hai-Hui, 2003, Oceanologia et Limnologia Sinica, V34, P329; Yoshino S, 2011, NUTRITION, V27, P847, DOI 10.1016/j.nut.2010.09.002; YOUDIM MBH, 1991, BIOCHEM PHARMACOL, V41, P155, DOI 10.1016/0006-2952(91)90471-G; Zhang Linjuan, 2007, Transactions of Oceanology and Limnology, V2, P114; Zhao DX, 2009, AQUACULTURE, V287, P297, DOI 10.1016/j.aquaculture.2008.10.050; Zhao YuChao, 2017, Oceanologia et Limnologia Sinica / Hai Yang Yu Hu Chao, V48, P628	83	0	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2018	13	9							e0204325	10.1371/journal.pone.0204325	http://dx.doi.org/10.1371/journal.pone.0204325			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3MI	30248122	Green Published, Green Submitted, gold			2022-12-26	WOS:000445998100033
J	Serganova, I; Cohen, IJ; Vemuri, K; Shindo, M; Maeda, M; Mane, M; Moroz, E; Khanin, R; Satagopan, J; Koutcher, JA; Blasberg, R				Serganova, Inna; Cohen, Ivan J.; Vemuri, Kiranmayi; Shindo, Masahiro; Maeda, Masatomo; Mane, Mayuresh; Moroz, Ekaterina; Khanin, Raya; Satagopan, Jaya; Koutcher, Jason A.; Blasberg, Ronald			LDH-A regulates the tumor microenvironment via HIF-signaling and modulates the immune response	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1; BREAST-CANCER METASTASIS; LACTATE DEHYDROGENASE-A; MOUSE MAMMARY-TUMOR; MACROPHAGE INFILTRATION; AEROBIC GLYCOLYSIS; COLORECTAL-CANCER; PATIENT SURVIVAL; PROGNOSTIC VALUE; PROSTATE-CANCER	Previous studies show that LDH-A knockdown reduces orthotopic 4T1 breast tumor lactate and delays tumor growth and the development of metastases in nude mice. Here, we report significant changes in the tumor microenvironment (TME) and a more robust anti-tumor response in immune competent BALB/c mice. 4T1 murine breast cancer cells were transfected with shRNA plasmids directed against LDH-A (KD) or a scrambled control plasmid (NC). Cells were also transduced with dual luciferase-based reporter systems to monitor HIF-1 activity and the development of metastases by bioluminescence imaging, using HRE-sensitive and constitutive promoters, respectively. The growth and metastatic profile of orthotopic 4T1 tumors developed from these cell lines were compared and a primary tumor resection model was studied to simulate the clinical management of breast cancer. Primary tumor growth, metastasis formation and TME phenotype were significantly different in LDH-A KD tumors compared with controls. In LDH-A KD cells, HIF-1 activity, hexokinase 1 and 2 expression and VEGF secretion were reduced. Differences in the TME included lower HIF-1 a expression that correlated with lower vascularity and pimonidazole staining, higher infiltration of CD3(+) and CD4(+) T cells and less infiltration of TAMs. These changes resulted in a greater delay in metastases formation and 40% long-term survivors (>20 weeks) in the LDH-A KD cohort following surgical resection of the primary tumor. We show for the first time that LDH-depletion inhibits the formation of metastases and prolongs survival of mice through changes in tumor microenvironment that modulate the immune response. We attribute these effects to diminished HIF-1 activity, vascularization, necrosis formation and immune suppression in immune competent animals. Gene-expression analyses from four human breast cancer datasets are consistent with these results, and further demonstrate the link between glycolysis and immune suppression in breast cancer.	[Serganova, Inna; Vemuri, Kiranmayi; Shindo, Masahiro; Maeda, Masatomo; Mane, Mayuresh; Moroz, Ekaterina; Blasberg, Ronald] Mem Sloan Kettering Canc Ctr, Dept Neurol, 1275 York Ave, New York, NY 10021 USA; [Cohen, Ivan J.] Mem Sloan Kettering Canc Ctr, Gerstner Sloan Kettering Grad Sch Biomed Sci, 1275 York Ave, New York, NY 10021 USA; [Khanin, Raya] Mem Sloan Kettering Canc Ctr, Bioinformat Core, 1275 York Ave, New York, NY 10021 USA; [Satagopan, Jaya] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Koutcher, Jason A.; Blasberg, Ronald] Mem Sloan Kettering Canc Ctr, Dept Radiol, 1275 York Ave, New York, NY 10021 USA; [Koutcher, Jason A.] Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10021 USA; [Koutcher, Jason A.] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Koutcher, Jason A.; Blasberg, Ronald] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, 1275 York Ave, New York, NY 10021 USA; [Shindo, Masahiro] Nozaki Tokushukai Hosp, Dept Neurosurg, Daito City, Osaka, Japan; [Moroz, Ekaterina] SageMedic Corp, MBC Biolabs, San Francisco, CA USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Blasberg, R (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Neurol, 1275 York Ave, New York, NY 10021 USA.; Blasberg, R (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Radiol, 1275 York Ave, New York, NY 10021 USA.; Blasberg, R (corresponding author), Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, 1275 York Ave, New York, NY 10021 USA.	blasberg@neuro1.mskcc.org		Vemuri, Kiranmayi/0000-0002-8564-773X	MSK Cancer Center [R01 CA163980, R01 CA172846, R01 CA204924, R01 CA215136, P30 CA008748]; DOD BCRP [BC161705]; Breast and Molecular Imaging Fund, Evelyn H. Lauder Breast Center; NATIONAL CANCER INSTITUTE [R01CA163980, R01CA204924, P30CA008748, R01CA215136, R01CA172846] Funding Source: NIH RePORTER	MSK Cancer Center; DOD BCRP(United States Department of Defense); Breast and Molecular Imaging Fund, Evelyn H. Lauder Breast Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by R01 CA163980; R01 CA172846; R01 CA204924; R01 CA215136; P30 CA008748 (MSK Cancer Center Support Grant/Core Grant); DOD BCRP BC161705 (J.A.K.); and Breast and Molecular Imaging Fund, Evelyn H. Lauder Breast Center (J.A.K.).	ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Assmann N, 2016, J CLIN INVEST, V126, P2031, DOI 10.1172/JCI83005; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Brader P, 2007, MOL CANCER THER, V6, P2900, DOI 10.1158/1535-7163.MCT-07-0432; Brand A, 2016, CELL METAB, V24, P657, DOI 10.1016/j.cmet.2016.08.011; Brizel DM, 2001, INT J RADIAT ONCOL, V51, P349, DOI 10.1016/S0360-3016(01)01630-3; Carlin S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010857; Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; Cohen I, 2017, BIOINFORMATIC CORREL; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; Crowther M, 2001, J LEUKOCYTE BIOL, V70, P478; de Kruijf EM, 2011, BREAST CANCER RES TR, V125, P687, DOI 10.1007/s10549-010-0855-6; De Saedeleer CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046571; Dobrenkov K, 2008, J NUCL MED, V49, P1162, DOI 10.2967/jnumed.107.047324; Eil R, 2016, NATURE, V537, P539, DOI 10.1038/nature19364; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Faubert B, 2017, CELL, V171, P358, DOI 10.1016/j.cell.2017.09.019; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gillies RJ, 2008, J NUCL MED, V49, p24S, DOI 10.2967/jnumed.107.047258; Goodwin Matthew L, 2014, Front Nutr, V1, P27, DOI 10.3389/fnut.2014.00027; Hatfield SM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1260; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Helmlinger G, 2002, CLIN CANCER RES, V8, P1284; Hirschhaeuser F, 2011, CANCER RES, V71, P6921, DOI 10.1158/0008-5472.CAN-11-1457; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Hunt TK, 2007, ANTIOXID REDOX SIGN, V9, P1115, DOI 10.1089/ars.2007.1674; Jacobo-Herrera NJ, 2015, INT J MOL MED, V36, pS41; Jiang FJ, 2016, BIOCHEM BIOPH RES CO, V469, P985, DOI 10.1016/j.bbrc.2015.12.078; Jin L, 2017, ONCOGENE, V36, P3797, DOI 10.1038/onc.2017.6; Koukourakis MI, 2006, CANCER RES, V66, P632, DOI 10.1158/0008-5472.CAN-05-3260; Koukourakis MI, 2003, BRIT J CANCER, V89, P877, DOI 10.1038/sj.bjc.6601205; Koukourakis MI, 2005, CLIN EXP METASTAS, V22, P25, DOI 10.1007/s10585-005-2343-7; Kumar VBS, 2007, J CELL PHYSIOL, V211, P477, DOI 10.1002/jcp.20955; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; Lechner MG, 2013, J IMMUNOTHER, V36, P477, DOI 10.1097/01.cji.0000436722.46675.4a; Lee YH, 2015, CLIN CANCER RES, V21, P1438, DOI 10.1158/1078-0432.CCR-14-1979; Leek RD, 1999, BRIT J CANCER, V79, P991, DOI 10.1038/sj.bjc.6690158; Leek RD, 1996, CANCER RES, V56, P4625; Lu HS, 2002, J BIOL CHEM, V277, P23111, DOI 10.1074/jbc.M202487200; Lu X, 2010, J BIOL CHEM, V285, P9317, DOI 10.1074/jbc.C110.104448; Matsuo Y, 2014, J HEPATO-BIL-PAN SCI, V21, P105, DOI 10.1002/jhbp.6; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Minn AJ, 2007, P NATL ACAD SCI USA, V104, P6740, DOI 10.1073/pnas.0701138104; Motz GT, 2014, NAT MED, V20, P607, DOI 10.1038/nm.3541; Palazon A, 2014, IMMUNITY, V41, P518, DOI 10.1016/j.immuni.2014.09.008; Rankin EB, 2016, SCIENCE, V352, P175, DOI 10.1126/science.aaf4405; Richards CH, 2012, BRIT J SURG, V99, P287, DOI 10.1002/bjs.7755; Richards CH, 2011, FUTURE ONCOL, V7, P1223, DOI [10.2217/fon.11.99, 10.2217/FON.11.99]; Rizwan A, 2013, CLIN CANCER RES, V19, P5158, DOI 10.1158/1078-0432.CCR-12-3300; Ryberg M, 2005, BREAST CANCER RES TR, V91, P217, DOI 10.1007/s10549-005-0323-x; Santos EB, 2009, NAT MED, V15, P338, DOI 10.1038/nm.1930; Semenza GL, 2007, BIOCHEM J, V405, P1, DOI 10.1042/BJ20070389; Serganova I, 2004, CANCER RES, V64, P6101, DOI 10.1158/0008-5472.CAN-04-0842; Serganova I, 2017, MOL THER-ONCOLYTICS, V4, P41, DOI 10.1016/j.omto.2016.11.005; Serganova I, 2011, CLIN CANCER RES, V17, P6250, DOI 10.1158/1078-0432.CCR-11-0397; Serganova I, 2009, FASEB J, V23, P2662, DOI 10.1096/fj.08-126920; Seth P, 2017, CANCER RES, V77, P3632, DOI 10.1158/0008-5472.CAN-16-2938; Seth P, 2011, NEOPLASIA, V13, P60, DOI 10.1593/neo.101020; Sheng SL, 2012, FEBS J, V279, P3898, DOI 10.1111/j.1742-4658.2012.08748.x; Simoes RV, 2015, NEOPLASIA, V17, P671, DOI 10.1016/j.neo.2015.08.005; Tao K, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-228; Tian L, 2017, NATURE, V544, P250, DOI 10.1038/nature21724; Vegran F, 2011, CANCER RES, V71, P2550, DOI 10.1158/0008-5472.CAN-10-2828; Walenta S, 2003, J CANCER RES CLIN, V129, P321, DOI 10.1007/s00432-003-0450-x; Walenta S, 2000, CANCER RES, V60, P916; Wang HX, 2014, GENET MOL RES, V13, P2817, DOI 10.4238/2014.January.22.6; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wang ZY, 2012, BREAST CANCER RES TR, V131, P791, DOI 10.1007/s10549-011-1466-6; Xian ZY, 2015, TUMOR BIOL, V36, P8093, DOI 10.1007/s13277-015-3540-x; Xie H, 2014, CELL METAB, V19, P795, DOI 10.1016/j.cmet.2014.03.003; Xie H, 2009, MOL CANCER THER, V8, P626, DOI 10.1158/1535-7163.MCT-08-1049; Zhang YJ, 2012, CANCER LETT, V321, P45, DOI 10.1016/j.canlet.2012.03.013	74	52	52	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2018	13	9							e0203965	10.1371/journal.pone.0203965	http://dx.doi.org/10.1371/journal.pone.0203965			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3MI	30248111	Green Published, gold, Green Submitted			2022-12-26	WOS:000445998100015
J	Bessell, PR; Lumbala, C; Lutumba, P; Baloji, S; Bieler, S; Ndung'u, JM				Bessell, Paul R.; Lumbala, Crispin; Lutumba, Pascal; Baloji, Sylvain; Bieler, Sylvain; Ndung'u, Joseph M.			Cost-effectiveness of using a rapid diagnostic test to screen for human African trypanosomiasis in the Democratic Republic of the Congo	PLOS ONE			English	Article							ECONOMIC-EVALUATION; SLEEPING SICKNESS; BRUCEI-GAMBIENSE; CONFIRMATION; ELIMINATION; STRATEGIES	New rapid diagnostic tests (RDTs) for screening human African trypanosomiasis (HAT) have been introduced as alternatives to the card agglutination test for trypanosomiasis (CATT). One brand of RDT, the SD BIOLINE HAT RDT has been shown to have lower specificity but higher sensitivity than CATT, so to make a rational choice between screening strategies, a cost-effectiveness analysis is a key element. In this paper we estimate the relative cost-effectiveness of CATT and the RDT when implemented in the Democratic Republic of the Congo (DRC). Data on the epidemiological parameters and costs were collected as part of a larger study. These data were used to model three different diagnostic algorithms in mobile teams and fixed health facilities, and the relative cost-effectiveness was measured as the average cost per case diagnosed. In both fixed facilities and mobile teams, screening of participants using the SD BIOLINE HAT RDT followed by parasitological confirmation had a lower cost-effectiveness ratio than in algorithms using CATT. Algorithms using the RDT were cheaper by 112.54 (33.2%) and 88.54 (32.92%) US dollars per case diagnosed in mobile teams and fixed health facilities respectively, when compared with algorithms using CATT. Sensitivity analysis demonstrated that these conclusions were robust to a number of assumptions, and that the results can be scaled to smaller or larger facilities, and a range of prevalences. The RDT was the most cost-effective screening test in all realistic scenarios and detected more cases than CATT. Thus, on this basis, the SD BIOLINE HAT RDT could be considered as the most cost-effective option for use in routine screening for HAT in the DRC.	[Bessell, Paul R.] Epi Intervent Ltd, Edinburgh, Midlothian, Scotland; [Lumbala, Crispin; Baloji, Sylvain] Programme Natl Lutte Trypanosomiase Humaine Afric, Kinshasa, DEM REP CONGO; [Lumbala, Crispin] Univ Antwerp, Global Hlth Inst, Antwerp, Belgium; [Lutumba, Pascal] Univ Kinshasa, Fac Med, Kinshasa, DEM REP CONGO; [Lutumba, Pascal] Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO; [Bieler, Sylvain; Ndung'u, Joseph M.] FIND, Campus Biotech,9 Chemin Mines, Geneva, Switzerland	University of Antwerp; Universite de Kinshasa; Institute Nacional de Recherche Biomedical; Foundation For Innovative New Diagnostics	Bessell, PR (corresponding author), Epi Intervent Ltd, Edinburgh, Midlothian, Scotland.	prbessell@gmail.com			Bill & Melinda Gates Foundation; UK aid from the UK government; Epi Interventions Ltd.	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); UK aid from the UK government(CGIAR); Epi Interventions Ltd.	This work was supported by the Bill & Melinda Gates Foundation and the UK aid from the UK government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Epi Interventions Ltd. provided support in the form of salaries for author PRB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	[Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Bisser S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004608; Chappuis F, 2005, CLIN MICROBIOL REV, V18, P133, DOI 10.1128/CMR.18.1.133-146.2005; Checchi F, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001233; FIND, 2016, US NOV STRAT ACC EL; FIND, 2016, DRIV EL HUM AFR TRYP; Franco JR, 2014, PARASITOLOGY, V141, P748, DOI 10.1017/S0031182013002102; Hasker E, 2011, TROP MED INT HEALTH, V16, P869, DOI 10.1111/j.1365-3156.2011.02772.x; Hasker E, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001950; Holmes P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003244; Husereau D, 2013, VALUE HEALTH, V16, P231, DOI 10.1016/j.jval.2013.02.002; Husereau D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1049; Jamonneau V, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003480; Lumbala C, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006386; Lumbala C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180555; Lutumba P, 2006, TROP MED INT HEALTH, V11, P470, DOI 10.1111/j.1365-3156.2006.01591.x; Lutumba P, 2005, EMERG INFECT DIS, V11, P1382; Lutumba P, 2005, TROP MED INT HEALTH, V10, P347, DOI 10.1111/j.1365-3156.2005.01391.x; Lutumba P, 2007, EMERG INFECT DIS, V13, P1484, DOI 10.3201/eid1310.060358; Mitashi P, 2015, TROP MED INT HEALTH, V20, P98, DOI 10.1111/tmi.12404; Mitashi P, 2015, MICROSC RES TECHNIQ, V03, P17, DOI [DOI 10.4236/MR.2015.32003, 10.4236/mr.2015.32003]; Mitashi P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001919; Mpanya A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001467; Mukadi P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146450; Priotto G, 2009, LANCET, V374, P56, DOI 10.1016/S0140-6736(09)61117-X; Robays J, 2004, TROP MED INT HEALTH, V9, P542, DOI 10.1111/j.1365-3156.2004.01240.x; Rock KS, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1131-8; Rushby JF, 2001, HEALTH POLICY PLANN, V16, P326, DOI 10.1093/heapol/16.3.326; Simarro PP, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-4; Sutherland CS, 2017, LANCET GLOB HEALTH, V5, pE69, DOI 10.1016/S2214-109X(16)30237-6; Sutherland CS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003397; Wamboga C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186429	32	12	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2018	13	9							e0204335	10.1371/journal.pone.0204335	http://dx.doi.org/10.1371/journal.pone.0204335			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU5MM	30240406	gold, Green Published, Green Submitted			2022-12-26	WOS:000445329700041
J	Emma, R; Bansal, AT; Kolmert, J; Wheelock, CE; Dahlen, SE; Loza, MJ; De Meulder, B; Lefaudeux, D; Auffray, C; Dahlen, B; Bakke, PS; Chanez, P; Fowler, SJ; Horvath, I; Montuschi, P; Krug, N; Sanak, M; Sandstrom, T; Shaw, DE; Fleming, LJ; Djukanovic, R; Howarth, PH; Singer, F; Sousa, AR; Sterk, PJ; Cortield, J; Pandis, I; Chung, KF; Adcock, IM; Lutter, R; Fabbella, L; Caruso, M				Emma, Rosalia; Bansal, Aruna T.; Kolmert, Johan; Wheelock, Craig E.; Dahlen, Swen-Erik; Loza, Matthew J.; De Meulder, Bertrand; Lefaudeux, Diane; Auffray, Charles; Dahlen, Barbro; Bakke, Per S.; Chanez, Pascal; Fowler, Stephen J.; Horvath, Ildiko; Montuschi, Paolo; Krug, Norbert; Sanak, Marek; Sandstrom, Thomas; Shaw, Dominick E.; Fleming, Louise J.; Djukanovic, Ratko; Howarth, Peter H.; Singer, Florian; Sousa, Ana R.; Sterk, Peter J.; Cortield, Julie; Pandis, Ioannis; Chung, Kian F.; Adcock, Ian M.; Lutter, Rene; Fabbella, Lorena; Caruso, Massimo		U-BIOPRED Study Grp	Enhanced oxidative stress in smoking and ex-smoking severe asthma in the U-BIOPRED cohort	PLOS ONE			English	Article							NF-KAPPA-B; NITRIC-OXIDE; SUPEROXIDE-DISMUTASE; LUNG INFLAMMATION; REDOX REGULATION; CIGARETTE-SMOKE; AIRWAY; MECHANISMS; EXPRESSION; BIOMARKERS	Oxidative stress is believed to be a major driver of inflammation in smoking asthmatics. The U-BIOPRED project recruited a cohort of Severe Asthma smokers/ex-smokers (SAs/ex) and non-smokers (SAn) with extensive clinical and biomarker information enabling characterization of these subjects. We investigated oxidative stress in severe asthma subjects by analysing urinary 8-iso-PGF(2 alpha) and the mRNA-expression of the main pro-oxidant (NOX2; NOSs) and anti-oxidant (SODs; CAT; GPX1) enzymes in the airways of SAs/ex and SAn. All the severe asthma U-BIOPRED subjects were further divided into current smokers with severe asthma (CSA), ex-smokers with severe asthma (ESA) and non-smokers with severe asthma (NSA) to deepen the effect of active smoking. Clinical data, urine and sputum were obtained from severe asthma subjects. A bronchoscopy to obtain bronchial biopsy and brushing was performed in a subset of subjects. The main clinical data were analysed for each subset of subjects (urine-8-iso-PGF(2 alpha); IS-transcriptomics; BB-transcriptomics; BBrtranscriptomics). Urinary 8-iso-PGF(2 alpha) was quantified using mass spectrometry. Sputum, bronchial biopsy and bronchial brushing were processed for mRNA expression microarray analysis. Urinary 8-iso-PGF(2 alpha) was increased in SAs/ex, median (IQR) = 31.7 (24.5 +/- 44.7) ng/mmol creatinine, compared to SAn, median (IQR) = 26.6 (19.6 +/- 36.6) ng/mmol creatinine (p< 0.001), and in CSA, median (IQR) = 34.25 (24.4 +/- 47.7), vs. ESA, median (IQR) = 29.4 (22.3 +/- 40.5), and NSA, median (IQR) = 26.5 (19.6 +/- 16.6) ng/mmol creatinine (p = 0.004). Sputum mRNA expression of NOX2 was increased in SAs/ex compared to SAn (probe sets 203922_PM_s_at fold-change = 1.05 p = 0.006; 203923_PM_s_at fold-change = 1.06, p = 0.003; 233538_PM_s_at fold-change = 1.06, p = 0.014). The mRNA expression of antioxidant enzymes were similar between the two severe asthma cohorts in all airway samples. NOS2 mRNA expression was decreased in bronchial brushing of SAs/ex compared to SAn (fold-change = -1.10; p = 0.029). NOS2 mRNA expression in bronchial brushing correlated with FeNO (Kendal's Tau = 0.535; p< 0.001). From clinical and inflammatory analysis, FeNO was lower in CSA than in ESA in all the analysed subject subsets (p< 0.01) indicating an effect of active smoking. Results about FeNO suggest its clinical limitation, as inflammation biomarker, in severe asthma active smokers. These data provide evidence of greater systemic oxidative stress in severe asthma smokers as reflected by a significant changes of NOX2 mRNA expression in the airways, together with elevated urinary 8-iso-PGF(2 alpha) in the smokers/ex-smokers group.	[Emma, Rosalia; Fabbella, Lorena; Caruso, Massimo] Univ Catania, Dept Clin & Expt Med, Catania, Italy; [Bansal, Aruna T.] Acclarogen Ltd, St Johns Innovat Ctr, Cambridge, England; [Kolmert, Johan; Wheelock, Craig E.] Karolinska Institutet, Dept Med Biochem & Biophys, Div Physiol Chem 2, Stockholm, Sweden; [Kolmert, Johan; Dahlen, Swen-Erik] Karolinska Inst, Inst Environm Med, Ctr Allergy Res, Stockholm, Sweden; [Loza, Matthew J.] Janssen Res & Dev LLC, Spring House, PA USA; [De Meulder, Bertrand; Lefaudeux, Diane; Auffray, Charles] CNRS ENS UCBL INSERM, European Inst Syst Biol & Med, CIRI UMR5308, Lyon, France; [Dahlen, Barbro] Karolinska Inst, Karolinska Univ Hosp, Stockholm, Sweden; [Dahlen, Barbro] Karolinska Inst, Ctr Allergy Res, Stockholm, Sweden; [Bakke, Per S.] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Chanez, Pascal] Aix Marseille Univ Marseille, CIC Nord, Dept Malad Resp, INSERM,U1067, Marseille, France; [Fowler, Stephen J.] Univ Manchester, Univ Hosp South Manchester NHS Fdn Trust, Lancashire Teaching Hosp NHS Fdn Trust, Ctr Resp Med & Allergy,Manchester Acad Hlth Sci C, Preston, Lancs, England; [Horvath, Ildiko] Semmelweis Univ, Dept Pulmonol, Budapest, Hungary; [Montuschi, Paolo] Univ Cattolica Sacro Cuore, Fac Med, Rome, Italy; [Krug, Norbert] Fraunhofer Inst Toxicol & Expt Med Hannover, Hannover, Germany; [Sanak, Marek] Jagiellonian Univ, Dept Med, Med Sch, Krakow, Poland; [Sandstrom, Thomas] Umea Univ, Dept Publ Hlth & Clin Med, Med, Umea, Sweden; [Shaw, Dominick E.] Univ Nottingham, Resp Res Unit, Nottingham, England; [Fleming, Louise J.; Chung, Kian F.; Adcock, Ian M.] Imperial Coll, Natl Heart & Lung Inst, London, England; [Djukanovic, Ratko; Howarth, Peter H.] Univ Southampton, NIHR Southampton Resp Biomed Res Unit, Clin & Expt Sci, Fac Med, Southampton, Hants, England; [Singer, Florian] Univ Childrens Hosp Bern, Bern, Switzerland; [Singer, Florian] Univ Childrens Hosp Zurich, Zurich, Switzerland; [Sousa, Ana R.] GlaxoSmithKline, Resp Therapy Unit, London, England; [Sterk, Peter J.; Lutter, Rene] Univ Amsterdam, Acad Med Ctr, Dept Resp Med, Amsterdam, Netherlands; [Cortield, Julie] AstraZeneca R&D, Molndal, Sweden; [Cortield, Julie] Areteva R&D, Nottingham, England; [Pandis, Ioannis] Imperial Coll London, Data Sci Inst, South Kensington Campus, London, England; [Caruso, Massimo] Univ Catania, Dept Biomed & Biotechnol Sci BIOMETEC, Catania, Italy	University of Catania; St Johns Innovation Centre - UK; Karolinska Institutet; Karolinska Institutet; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; University of Bergen; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Semmelweis University; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Fraunhofer Gesellschaft; Jagiellonian University; Umea University; University of Nottingham; Imperial College London; University of Southampton; University of Bern; University Hospital of Bern; University Children's Hospital Zurich; GlaxoSmithKline; University of Amsterdam; Academic Medical Center Amsterdam; AstraZeneca; Imperial College London; University of Catania	Caruso, M (corresponding author), Univ Catania, Dept Clin & Expt Med, Catania, Italy.; Caruso, M (corresponding author), Univ Catania, Dept Biomed & Biotechnol Sci BIOMETEC, Catania, Italy.	mascaru@unict.it	Sanak, Marek/AAV-1628-2021; Singer, Florian/AAO-1460-2021; Sterk, P.J./AAK-8175-2020; Caruso, Massimo/P-4161-2016; Emma, Rosalia/HDO-5255-2022; Horváth, Ildikó/GPP-6088-2022; Horvath, Ildiko/M-7874-2019; Chung, Kian Fan/B-1872-2012; Fleming, Louise/ABD-7452-2020; Adcock, Ian/L-3217-2019	Sanak, Marek/0000-0001-7635-8103; Singer, Florian/0000-0003-3471-5664; Caruso, Massimo/0000-0002-4412-2080; Chung, Kian Fan/0000-0001-7101-1426; Emma, Rosalia/0000-0002-2564-553X; Djukanovic, Ratko/0000-0001-6039-5612; Howarth, Peter/0000-0003-0619-7927; MONTUSCHI, Paolo/0000-0001-5589-1750; Adcock, Ian/0000-0003-2101-8843; Fleming, Louise/0000-0002-7268-7433; Fowler, Stephen/0000-0002-4524-1663; chanez, pascal/0000-0003-4059-0917	Innovative Medicines Initiative Joint Undertaking [115010]; European Union's Seventh Framework Programme (FP7/2007-2013); IMI [115446]; Acclarogen Ltd.; Janssen Research & Development, LLC.; GSK; Astra Zeneca RD; Areteva RD; EFPIA	Innovative Medicines Initiative Joint Undertaking; European Union's Seventh Framework Programme (FP7/2007-2013); IMI; Acclarogen Ltd.; Janssen Research & Development, LLC.; GSK(GlaxoSmithKline); Astra Zeneca RD(AstraZeneca); Areteva RD; EFPIA	U-BIOPRED is supported through an Innovative Medicines Initiative Joint Undertaking under grant agreement no. 115010, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies' in kind contribution (www.imi.europa.eu). We would also like to acknowledge help from the IMI funded eTRIKS project (EU Grant Code No.115446 to R.E.). Funding information for this article has been deposited with FundRef. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Acclarogen Ltd., Janssen Research & Development, LLC., GSK, Astra Zeneca R&D and Areteva R&D provided support in the form of salaries for authors ATB, MJL, ARS, AND JC but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Athey Brian D, 2013, AMIA Jt Summits Transl Sci Proc, V2013, P6; Balgoma D, 2013, ANAL CHEM, V85, P7866, DOI 10.1021/ac401461b; Batra J, 2007, INDIAN J BIOCHEM BIO, V44, P303; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Betsuyaku T, 2013, EUR RESPIR J, V42, P42, DOI 10.1183/09031936.00058912; Bogdan C, 2015, TRENDS IMMUNOL, V36, P161, DOI 10.1016/j.it.2015.01.003; Bousquet J, 2000, CLIN EXP ALLERGY, V30, P2; Bruijnzeel PLB, 2015, J LEUKOCYTE BIOL, V98, P549, DOI 10.1189/jlb.3VMR1214-600RR; Cheng SE, 2010, FREE RADICAL BIO MED, V48, P1410, DOI 10.1016/j.freeradbiomed.2010.02.026; Chung KF, 2014, DRUGS, V74, P719, DOI 10.1007/s40265-014-0213-9; Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; Comhair SAA, 2005, AM J RESP CRIT CARE, V172, P306, DOI 10.1164/rccm.200502-180OC; Comhair SAA, 2005, AM J PATHOL, V166, P663, DOI 10.1016/S0002-9440(10)62288-2; Gilks CB, 1998, AM J PATHOL, V152, P269; Hoffmann RF, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-97; Holgate ST, 2008, NAT REV IMMUNOL, V8, P218, DOI 10.1038/nri2262; Holguin Fernando, 2013, Ann Am Thorac Soc, V10 Suppl, pS150, DOI 10.1513/AnnalsATS.201305-116AW; Horvath I, 2004, RESPIRATION, V71, P463, DOI 10.1159/000080630; Jenifer Haziel Diana, 2015, J Tradit Complement Med, V5, P100, DOI 10.1016/j.jtcme.2014.11.003; Kelleher ZT, 2007, J BIOL CHEM, V282, P30667, DOI 10.1074/jbc.M705929200; Kelly FK, 1999, LANCET, V354, P482, DOI 10.1016/S0140-6736(99)01812-7; Kinnula VL, 2003, AM J RESP CRIT CARE, V167, P1600, DOI 10.1164/rccm.200212-1479SO; Lane C, 2004, THORAX, V59, P757, DOI 10.1136/thx.2003.014894; Lee IT, 2012, BIOCHEM PHARMACOL, V84, P581, DOI 10.1016/j.bcp.2012.05.005; Liu Hongfang, 2010, Front Biosci (Elite Ed), V2, P325; Mak Judith C W, 2013, ISRN Allergy, V2013, P561831, DOI 10.1155/2013/561831; MARKLUND SL, 1992, J BIOL CHEM, V267, P6696; Montuschi P, 1999, AM J RESP CRIT CARE, V160, P216, DOI 10.1164/ajrccm.160.1.9809140; Papaioannou AI, 2010, EUR J CLIN INVEST, V40, P103, DOI 10.1111/j.1365-2362.2009.02221.x; Polosa R, 2013, EUR RESPIR J, V41, P716, DOI 10.1183/09031936.00073312; Rahman I, 2006, EUR RESPIR J, V28, P219, DOI 10.1183/09031936.06.00053805; Rahman I, 2006, EUR J PHARMACOL, V533, P222, DOI 10.1016/j.ejphar.2005.12.087; Roos AB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090018; Shaw DE, 2015, EUR RESP J; Thomas AC, 2014, FRONT IMMUNOL, V5, DOI [10.3389/fimmu.2014.00479, 10.3389/fimmu.2014.00478]; Thomson NC, 2013, J ALLERGY CLIN IMMUN, V131, P1008, DOI 10.1016/j.jaci.2012.12.1574; Valavanidis A, 2009, INT J ENV RES PUB HE, V6, P445, DOI 10.3390/ijerph6020445; Voraphani N, 2014, MUCOSAL IMMUNOL, V7, P1175, DOI 10.1038/mi.2014.6; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Wood LG, 2003, EUR RESPIR J, V21, P177, DOI 10.1183/09031936.03.00017003a; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Yamamoto M, 2012, CLIN EXP ALLERGY, V42, P760, DOI 10.1111/j.1365-2222.2011.03860.x; Yao H, 2007, BIOCHEM SOC T, V35, P1151, DOI 10.1042/BST0351151; YORK GK, 1976, ARCH ENVIRON HEALTH, V31, P286, DOI 10.1080/00039896.1976.10667237; Zuo L, 2013, MOL IMMUNOL, V56, P57, DOI 10.1016/j.molimm.2013.04.002	45	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2018	13	9							e0203874	10.1371/journal.pone.0203874	http://dx.doi.org/10.1371/journal.pone.0203874			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU5MM	30240401	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000445329700010
J	Zhong, YC; Yang, S; Wang, W; Wei, PP; He, SW; Ma, HT; Yang, J; Wang, Q; Cao, LQ; Xiong, W; Zhou, M; Li, GY; Shuai, CJ; Peng, SP				Zhong, Yancheng; Yang, Sheng; Wang, Wei; Wei, Pingpin; He, Shiwei; Ma, Haotian; Yang, Juan; Wang, Qian; Cao, Lanqin; Xiong, Wei; Zhou, Ming; Li, Guiyuan; Shuai, Cijun; Peng, Shuping			The interaction of Lin28A/Rho associated coiled-coil containing protein kinase2 accelerates the malignancy of ovarian cancer	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; HEPATOCELLULAR-CARCINOMA; STEM-CELLS; RHO-KINASE; ROCK2; RNA; EXPRESSION; REGULATOR; PROMOTES; PROLIFERATION	Ovarian cancer (OC) is the leading cause of death among women with gynecologic malignant diseases, however, the molecular mechanism of ovarian cancer is not well defined. Previous studies have found that RNA binding protein Lin28A is a key factor of maintain the pluripotency of stem cells, and it is positively correlated with the degree of several cancers (breast, prostate, liver cancer, etc). Our previous study shows that Lin28A is highly expressed in OC tissues and is involved in the regulation of OC cell biological behavior. In this study, we confirmed that high expression of Lin28A promoted the survival, invasion, metastasis, and inhibited the apoptosis of OC cells. Lin28A interacts with Rho associated coiled-coil containing protein kinase2 (ROCK2) but not ROCK1 and upregulates the expression of ROCK2 in OC cells. The binding sites of each other were identified by truncated mutations and Immuno-precipitaion (IP) assay. After knock down of ROCK2 in cells with high expression of Lin28A, the survival, invasion, metastasis was significantly inhibited and early apoptosis was increased in OC cells and OC xenograft in nude mice. Our experimental data also showed that knock down of ROCK2 but not ROCK1 inhibited the invasion by decreasing the expression of N-cadherin, Slug, beta-catenin and increasing ZO-1 expression. Simultaneously, knock down of ROCK2 induced cell apoptosis by increasing cleaved Caspase-9, cleaved Caspase-7, and cleaved Caspase-3. Taken together, Lin28A regulated the biological behaviors in OC cells through ROCK2 and the interaction of Lin28A/ROCK2 may be a new target for diagnosis and gene therapy of OC.	[Zhong, Yancheng; Wei, Pingpin; He, Shiwei; Ma, Haotian; Yang, Juan; Xiong, Wei; Zhou, Ming; Li, Guiyuan; Peng, Shuping] Cent South Univ, Hunan Prov Tumor Hosp, Changsha, Hunan, Peoples R China; [Zhong, Yancheng; Wei, Pingpin; He, Shiwei; Ma, Haotian; Yang, Juan; Xiong, Wei; Zhou, Ming; Li, Guiyuan; Peng, Shuping] Cent South Univ, Affiliated Tumor Hosp, Xiangya Sch Med, Sch Basic Med Sci, Changsha, Hunan, Peoples R China; [Yang, Sheng] Hongkong Univ, Human Reprod Ctr, Shenzhen Hosp, Haiyuan 1 Rd, Shenzhen, Peoples R China; [Wang, Wei] Jining Med Univ, Pathol Dept, Jining, Shandong, Peoples R China; [Wang, Qian; Cao, Lanqin] Cent South Univ, Dept Gynecol, Xiangya Hosp, Changsha, Hunan, Peoples R China; [Shuai, Cijun] Jiangxi Univ Sci & Technol, Ganzhou 341000, Peoples R China	Central South University; Central South University; Jining Medical University; Central South University; Jiangxi University of Science & Technology	Peng, SP (corresponding author), Cent South Univ, Hunan Prov Tumor Hosp, Changsha, Hunan, Peoples R China.; Peng, SP (corresponding author), Cent South Univ, Affiliated Tumor Hosp, Xiangya Sch Med, Sch Basic Med Sci, Changsha, Hunan, Peoples R China.	shuping@csu.edu.cn	Shuai, Cijun/AAC-9740-2019	Shuai, Cijun/0000-0002-2029-5112	Natural Science Foundation of China [81572577]; Program of Introducing Talents of Discipline to Universities [111-2-12]; Project of Innovation-driven Plan of Central South University [2016CX023]; Hunan Province Natural Science Foundation of China [2016JJ1027]; Fundamental Research Funds for the Central Universities of Central South University [2017zzts371]; Open-End Fund for the Valuable and Precision Instruments of Central South University; High Resolution Mass Spectrometry Laboratory of Advanced Research Center in Central South University	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project); Project of Innovation-driven Plan of Central South University; Hunan Province Natural Science Foundation of China(Natural Science Foundation of Hunan Province); Fundamental Research Funds for the Central Universities of Central South University; Open-End Fund for the Valuable and Precision Instruments of Central South University; High Resolution Mass Spectrometry Laboratory of Advanced Research Center in Central South University	This work was supported by Natural Science Foundation of China (81572577), Program of Introducing Talents of Discipline to Universities (111-2-12), the Project of Innovation-driven Plan of Central South University (2016CX023), the Hunan Province Natural Science Foundation of China (2016JJ1027), the Fundamental Research Funds for the Central Universities of Central South University (2017zzts371), the Open-End Fund for the Valuable and Precision Instruments of Central South University. We thank the Professor Li zheng and Dr. Ge Xiaolu for their help in Mass Spectrometry identification. We also want to gratitude the High Resolution Mass Spectrometry Laboratory of Advanced Research Center in Central South University for the technological assistance in proteomic examinations.	Amano M, 2010, CYTOSKELETON, V67, P545, DOI 10.1002/cm.20472; Ben-Shmuel A, 2013, ONCOGENE, V32, P3220, DOI 10.1038/onc.2012.340; Bhuiyan MIH, 2013, NEUROSCIENCE, V248, P448, DOI 10.1016/j.neuroscience.2013.06.023; Boku S, 2013, BRAIN RES, V1492, P7, DOI 10.1016/j.brainres.2012.11.034; Cheng K, 2013, J CLIN ONCOL, V31; Grieco A, 2013, MOL CELL ENDOCRINOL, V365, P241, DOI 10.1016/j.mce.2012.10.025; Hsu KF, 2015, BRIT J CANCER, V113, P414, DOI 10.1038/bjc.2015.254; Huang YQ, 2012, WIRES RNA, V3, P483, DOI 10.1002/wrna.1112; Huelsken J, 2002, J CELL SCI, V115, P3977, DOI 10.1242/jcs.00089; Iizuka M, 2012, CELL STRUCT FUNCT, V37, P155, DOI 10.1247/csf.12018; Jimenez-Sanchez A, 2017, CELL, V170, P927, DOI 10.1016/j.cell.2017.07.025; Kalender ME, 2009, CANCER RES, V69, p658S; Kalender ME, 2010, ONCOL RES, V18, P583, DOI 10.3727/096504010X12767359113767; Liu TD, 2012, EXP CELL RES, V318, P1994, DOI 10.1016/j.yexcr.2012.04.017; Nakagawa O, 1996, FEBS LETT, V392, P189, DOI 10.1016/0014-5793(96)00811-3; Nam Y, 2011, CELL, V147, P1080, DOI 10.1016/j.cell.2011.10.020; Olson MF, 2008, CURR OPIN CELL BIOL, V20, P242, DOI 10.1016/j.ceb.2008.01.002; Pastushenko I, 2018, NATURE, V556, P463, DOI 10.1038/s41586-018-0040-3; Patel RA, 2012, CANCER RES, V72, P5025, DOI 10.1158/0008-5472.CAN-12-0954; Peng S, 2010, ONCOGENE, V29, P2153, DOI 10.1038/onc.2009.500; Piskounova E, 2008, J BIOL CHEM, V283, P21310, DOI 10.1074/jbc.C800108200; Pisu M, 2017, GYNECOL ONCOL, V147, P433, DOI 10.1016/j.ygyno.2017.08.028; Polesskaya A, 2007, GENE DEV, V21, P1125, DOI 10.1101/gad.415007; Rauh-Hain JA, 2013, GYNECOL ONCOL, V129, P63, DOI 10.1016/j.ygyno.2013.01.009; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Son H, 2010, TOX RESEARCH, V26, P245, DOI 10.5487/TR.2010.26.4.245; Song GL, 2016, INT J ONCOL, V49, P646, DOI 10.3892/ijo.2016.3539; Vigil D, 2012, CANCER RES, V72, P5338, DOI 10.1158/0008-5472.CAN-11-2373; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Wang QM, 2012, EXPERT OPIN THER TAR, V16, P1013, DOI 10.1517/14728222.2012.715149; Wertel Iwona, 2017, Wiad Lek, V70, P74; Wong CCL, 2011, GASTROENTEROLOGY, V140, P322, DOI 10.1053/j.gastro.2010.10.006; Wong CCL, 2009, HEPATOLOGY, V49, P1583, DOI 10.1002/hep.22836; Xue DB, 2011, HISTOPATHOLOGY, V59, P452, DOI 10.1111/j.1365-2559.2011.03949.x; Yap TA, 2012, CLIN CANCER RES, V18, P3912, DOI 10.1158/1078-0432.CCR-11-3313; Yuan RF, 2014, CANCER RES, V74, P5287, DOI 10.1158/0008-5472.CAN-14-0284; Yugaw T, 2013, MOL CELL BIOL, V33, P4434, DOI 10.1128/MCB.00577-13; Zhang H, 2016, CELL, V166, P755, DOI 10.1016/j.cell.2016.05.069; Zhong XM, 2010, J BIOL CHEM, V285, P41961, DOI 10.1074/jbc.M110.169607; Zhong YC, 2016, INT J GYNECOL CANCER, V26, P1564, DOI 10.1097/IGC.0000000000000828; Zlobec I, 2010, ONCOTARGET, V1, P651, DOI 10.18632/oncotarget.199	44	18	18	2	12	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 28	2019	38	9					1381	1397		10.1038/s41388-018-0512-9	http://dx.doi.org/10.1038/s41388-018-0512-9			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HN1KL	30266988	Green Published, hybrid			2022-12-26	WOS:000459945800002
J	Carrington, SJ; Hernandez, CC; Swale, DR; Aluko, OA; Denton, JS; Cone, RD				Carrington, Sheridan J.; Hernandez, Ciria C.; Swale, Daniel R.; Aluko, Oluwatosin A.; Denton, Jerod S.; Cone, Roger D.			G protein-coupled receptors differentially regulate glycosylation and activity of the inwardly rectifying potassium channel Kir7.1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ion channel; G protein-coupled receptor (GPCR); potassium channel; glycosylation; signal transduction	MULTIPLE-SCLEROSIS; GOLGI EXPORT; KCNJ13; INHIBITION; MUTATION; KIR4.1; EXCITABILITY; TRAFFICKING; ANTIBODIES; SUBUNITS	Kir7.1 is an inwardly rectifying potassium channel with important roles in the regulation of the membrane potential in retinal pigment epithelium, uterine smooth muscle, and hypothalamic neurons. Regulation of G protein-coupled inwardly rectifying potassium (GIRK) channels by G protein-coupled receptors (GPCRs) via the G protein subunits has been well characterized. However, how Kir channels are regulated is incompletely understood. We report here that Kir7.1 is also regulated by GPCRs, but through a different mechanism. Using Western blotting analysis, we observed that multiple GPCRs tested caused a striking reduction in the complex glycosylation of Kir7.1. Further, GPCR-mediated reduction of Kir7.1 glycosylation in HEK293T cells did not alter its expression at the cell surface but decreased channel activity. Of note, mutagenesis of the sole Kir7.1 glycosylation site reduced conductance and open probability, as indicated by single-channel recording. Additionally, we report that the L241P mutation of Kir7.1 associated with Lebers congenital amaurosis (LCA), an inherited retinal degenerative disease, has significantly reduced complex glycosylation. Collectively, these results suggest that Kir7.1 channel glycosylation is essential for function, and this activity within cells is suppressed by most GPCRs. The melanocortin-4 receptor (MC4R), a GPCR previously reported to induce ligand-regulated activity of this channel, is the only GPCR tested that does not have this effect on Kir7.1.	[Carrington, Sheridan J.; Cone, Roger D.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Carrington, Sheridan J.; Hernandez, Ciria C.; Aluko, Oluwatosin A.; Cone, Roger D.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Swale, Daniel R.] Louisiana State Univ, Dept Entomol, AgCtr, Baton Rouge, LA 70803 USA; [Denton, Jerod S.] Vanderbilt Univ, Dept Anesthesiol, Sch Med, Nashville, TN 37232 USA; [Denton, Jerod S.] Vanderbilt Univ, Dept Pharmacol, Sch Med, Nashville, TN 37232 USA; [Cone, Roger D.] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	Vanderbilt University; University of Michigan System; University of Michigan; Louisiana State University System; Louisiana State University; Vanderbilt University; Vanderbilt University; University of Michigan System; University of Michigan	Cone, RD (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.	rcone@umich.edu		Cone, Roger/0000-0003-3333-5651	National Institutes of Health [RO1 DK070332]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070332, P30DK020572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant RO1 DK070332 (to R. D. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aittoniemi J, 2009, PHILOS T R SOC B, V364, P257, DOI 10.1098/rstb.2008.0142; Cha SK, 2011, J BIOL CHEM, V286, P1828, DOI 10.1074/jbc.M110.160390; Chandrasekhar KD, 2006, J BIOL CHEM, V281, P40015, DOI 10.1074/jbc.M604398200; Cohen NA, 1996, J BIOL CHEM, V271, P32301, DOI 10.1074/jbc.271.50.32301; Cornejo I, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00428; Doring F, 1998, J NEUROSCI, V18, P8625; Ghamari-Langroudi M, 2015, NATURE, V520, P94, DOI 10.1038/nature14051; Hejtmancik JF, 2008, AM J HUM GENET, V82, P174, DOI 10.1016/j.ajhg.2007.08.002; Hibino H, 2004, J BIOL CHEM, V279, P44065, DOI 10.1074/jbc.M405985200; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Huang CF, 2007, AM J PHYSIOL-RENAL, V292, pF1073, DOI 10.1152/ajprenal.00269.2006; Iwashita M, 2006, PLOS GENET, V2, P1861, DOI 10.1371/journal.pgen.0020197; Khan AO, 2015, OPHTHALMIC GENET, V36, P79, DOI 10.3109/13816810.2014.985846; Kumar M, 2014, CHANNELS, V8, P488, DOI 10.4161/19336950.2014.959809; Lewis LM, 2009, MOL PHARMACOL, V76, P1094, DOI 10.1124/mol.109.059840; Li NN, 2017, CELL, V168, P101, DOI 10.1016/j.cell.2016.12.028; Li XM, 2016, J BIOL CHEM, V291, P14963, DOI 10.1074/jbc.M116.729822; Luscher C, 2010, NAT REV NEUROSCI, V11, P301, DOI 10.1038/nrn2834; Ma DH, 2011, CELL, V145, P1102, DOI 10.1016/j.cell.2011.06.007; Marnetto F, 2017, J IMMUNOL METHODS, V445, P53, DOI 10.1016/j.jim.2017.03.008; Martin GM, 2017, ELIFE, V6, DOI 10.7554/eLife.31054; McCloskey C, 2014, EMBO MOL MED, V6, P1161, DOI 10.15252/emmm.201403944; Nakamura N, 1999, BIOCHEM J, V342, P329, DOI 10.1042/0264-6021:3420329; Pabon A, 2000, J BIOL CHEM, V275, P30677, DOI 10.1074/jbc.M005338200; Pattnaik BR, 2015, HUM MUTAT, V36, P720, DOI 10.1002/humu.22807; Pattnaik BR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071744; Probstel AK, 2016, NEW ENGL J MED, V374, P1496, DOI 10.1056/NEJMc1507131; Rabouille C, 2011, COLD SPRING HARB PER, V3; Raphemot R, 2014, MOL PHARMACOL, V85, P858, DOI 10.1124/mol.114.091884; Raphemot R, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00075; SCHWALBE RA, 1995, J BIOL CHEM, V270, P15336, DOI 10.1074/jbc.270.25.15336; Sergouniotis PI, 2011, AM J HUM GENET, V89, P183, DOI 10.1016/j.ajhg.2011.06.002; Shealy RT, 2003, BIOPHYS J, V84, P2929, DOI 10.1016/S0006-3495(03)70020-4; Shen W, 2007, NAT NEUROSCI, V10, P1458, DOI 10.1038/nn1972; Stanley Pamela, 2011, Cold Spring Harb Perspect Biol, V3, DOI 10.1101/cshperspect.a005199; Yang DL, 2003, INVEST OPHTH VIS SCI, V44, P3178, DOI 10.1167/iovs.02-1189; Yin WG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05043-5; York N, 2017, CELL SIGNAL, V37, P93, DOI 10.1016/j.cellsig.2017.06.005; Zhang W, 2013, AM J PHYSIOL-CELL PH, V304, pC440, DOI 10.1152/ajpcell.00363.2012	39	9	9	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2018	293	46					17739	17753		10.1074/jbc.RA118.003238	http://dx.doi.org/10.1074/jbc.RA118.003238			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HA6SG	30257863	Green Published, hybrid			2022-12-26	WOS:000450409500007
J	Kaasboll, OJ; Gadicherla, AK; Wang, JH; Monsen, VT; Hagelin, EMV; Dong, MQ; Attramadal, H				Kaasboll, Ole Jorgen; Gadicherla, Ashish K.; Wang, Jian-Hua; Monsen, Vivi Talstad; Hagelin, Else Marie Valbjorn; Dong, Meng-Qiu; Attramadal, Havard			Connective tissue growth factor (CCN2) is a matricellular preproprotein controlled by proteolytic activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						connective tissue growth factor (CTGF); extracellular matrix protein; protein chemistry; protein processing; protein structure; recombinant protein expression; fibrosis; CCN protein; CCN2; Cyr61; matricellular protein; NOV	FACTOR CTGF; PULMONARY-FIBROSIS; LUNG FIBROBLASTS; CELL-ADHESION; FC-RECEPTOR; TGF-BETA; PROTEIN; EXPRESSION; BINDING; FAMILY	Connective tissue growth factor (CTGF; now often referred to as CCN2) is a secreted protein predominantly expressed during development, in various pathological conditions that involve enhanced fibrogenesis and tissue fibrosis, and in several cancers and is currently an emerging target in several early-phase clinical trials. Tissues containing high CCN2 activities often display smaller degradation products of full-length CCN2 (FL-CCN2). Interpretation of these observations is complicated by the fact that a uniform protein structure that defines biologically active CCN2 has not yet been resolved. Here, using DG44 CHO cells engineered to produce and secrete FL-CCN2 and cell signaling and cell physiological activity assays, we demonstrate that FL-CCN2 is itself an inactive precursor and that a proteolytic fragment comprising domains III (thrombospondin type 1 repeat) and IV (cystine knot) appears to convey all biologically relevant activities of CCN2. In congruence with these findings, purified FL-CCN2 could be cleaved and activated following incubation with matrix metalloproteinase activities. Furthermore, the C-terminal fragment of CCN2 (domains III and IV) also formed homodimers that were approximate to 20-fold more potent than the monomeric form in activating intracellular phosphokinase cascades. The homodimer elicited activation of fibroblast migration, stimulated assembly of focal adhesion complexes, enhanced RANKL-induced osteoclast differentiation of RAW264.7 cells, and promoted mammosphere formation of MCF-7 mammary cancer cells. In conclusion, CCN2 is synthesized and secreted as a preproprotein that is autoinhibited by its two N-terminal domains and requires proteolytic processing and homodimerization to become fully biologically active.	[Kaasboll, Ole Jorgen; Gadicherla, Ashish K.; Monsen, Vivi Talstad; Hagelin, Else Marie Valbjorn; Attramadal, Havard] Oslo Univ Hosp, Inst Surg Res, A3-1057,POB 4950 Nydalen, NO-0424 Oslo, Norway; [Kaasboll, Ole Jorgen; Gadicherla, Ashish K.; Monsen, Vivi Talstad; Hagelin, Else Marie Valbjorn; Attramadal, Havard] Univ Oslo, NO-0424 Oslo, Norway; [Kaasboll, Ole Jorgen; Gadicherla, Ashish K.; Monsen, Vivi Talstad; Hagelin, Else Marie Valbjorn; Attramadal, Havard] Univ Oslo, Ctr Heart Failure Res, NO-0316 Oslo, Norway; [Wang, Jian-Hua; Dong, Meng-Qiu] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Gadicherla, Ashish K.] Max Planck Inst Biophys, D-60438 Frankfurt, Germany	University of Oslo; University of Oslo; University of Oslo; National Institute of Biological Sciences, Beijing; Max Planck Society	Attramadal, H (corresponding author), Oslo Univ Hosp, Inst Surg Res, A3-1057,POB 4950 Nydalen, NO-0424 Oslo, Norway.; Attramadal, H (corresponding author), Univ Oslo, NO-0424 Oslo, Norway.	havard.attramadal@medisin.uio.no		Monsen, Vivi Talstad/0000-0003-2821-5145; Dong, Meng-Qiu/0000-0002-6094-1182; Attramadal, Havard/0000-0001-9506-0687	Norwegian Council for Cardiovascular Research; Scientia fellowship program, University of Oslo	Norwegian Council for Cardiovascular Research; Scientia fellowship program, University of Oslo	This work was supported by the Norwegian Council for Cardiovascular Research (to O. J. K.) and Scientia fellowship program, University of Oslo (to A. K. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Ahmed MS, 2011, AM J PHYSIOL-HEART C, V300, pH1291, DOI 10.1152/ajpheart.00604.2010; Ahmed MS, 2004, J MOL CELL CARDIOL, V36, P393, DOI 10.1016/j.yjmcc.2003.12.004; ALMENDRAL JM, 1988, MOL CELL BIOL, V8, P2140, DOI 10.1128/MCB.8.5.2140; Aoyama E, 2009, BIOCHEM J, V420, P413, DOI 10.1042/BJ20081991; Babic AM, 1999, MOL CELL BIOL, V19, P2958; Ball DK, 1998, BIOL REPROD, V59, P828, DOI 10.1095/biolreprod59.4.828; Ball DK, 2003, REPRODUCTION, V125, P271, DOI 10.1530/rep.0.1250271; Ball DK, 2003, J ENDOCRINOL, V176, pR1, DOI 10.1677/joe.0.176R001; Bickelhaupt S, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw339; Bohr W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0016000; BORK P, 1993, FEBS LETT, V327, P125, DOI 10.1016/0014-5793(93)80155-N; Brenner MC, 2016, PHARM RES-DORDR, V33, P1833, DOI 10.1007/s11095-016-1918-0; Brigstock DR, 1997, J BIOL CHEM, V272, P20275, DOI 10.1074/jbc.272.32.20275; Butler GS, 2017, MATRIX BIOL, V59, P23, DOI 10.1016/j.matbio.2016.07.006; Canalis E, 2010, ENDOCRINOLOGY, V151, P221, DOI 10.1210/en.2009-0574; CANFIELD SM, 1991, J EXP MED, V173, P1483, DOI 10.1084/jem.173.6.1483; Chen CC, 2001, J BIOL CHEM, V276, P10443, DOI 10.1074/jbc.M008087200; Chen NY, 2004, J BIOL CHEM, V279, P44166, DOI 10.1074/jbc.M406813200; Chien WW, 2011, INT J ONCOL, V38, P1741, DOI 10.3892/ijo.2011.985; Crean JKG, 2002, J BIOL CHEM, V277, P44187, DOI 10.1074/jbc.M203715200; CUNNINGHAM BC, 1991, SCIENCE, V253, P545, DOI 10.1126/science.1907025; Dean RA, 2007, MOL CELL BIOL, V27, P8454, DOI 10.1128/MCB.00821-07; Dixon AS, 2016, ACS CHEM BIOL, V11, P400, DOI 10.1021/acschembio.5b00753; Morales MG, 2013, HUM MOL GENET, V22, P4938, DOI 10.1093/hmg/ddt352; Galban S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066248; Gao E, 2010, CIRC RES, V107, P1445, DOI 10.1161/CIRCRESAHA.110.223925; Glaesner W, 2010, DIABETES-METAB RES, V26, P287, DOI 10.1002/dmrr.1080; GRAY AM, 1990, SCIENCE, V247, P1328, DOI 10.1126/science.2315700; Grotendorst GR, 2005, FASEB J, V19, P729, DOI 10.1096/fj.04-3217com; Guillon-Munos A, 2011, J BIOL CHEM, V286, P25505, DOI 10.1074/jbc.M110.213231; Hashimoto G, 2002, J BIOL CHEM, V277, P36288, DOI 10.1074/jbc.M201674200; Heath E, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-18; Hecht R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049345; Heng ECK, 2006, J CELL BIOCHEM, V98, P409, DOI 10.1002/jcb.20810; Hishikawa K, 1999, J BIOL CHEM, V274, P37461, DOI 10.1074/jbc.274.52.37461; Holbourn KP, 2011, J BIOL CHEM, V286, P22243, DOI 10.1074/jbc.M111.225755; Johnson BG, 2017, J AM SOC NEPHROL, V28, P1769, DOI 10.1681/ASN.2016080826; JOLIOT V, 1992, MOL CELL BIOL, V12, P10, DOI 10.1128/MCB.12.1.10; Jun JI, 2017, J CELL COMMUN SIGNAL, V11, P15, DOI 10.1007/s12079-016-0359-1; Jun JI, 2011, NAT REV DRUG DISCOV, V10, P945, DOI 10.1038/nrd3599; Kyurkchiev Stanimir, 2004, Cell Commun Signal, V2, P9, DOI 10.1186/1478-811X-2-9; Lau LF, 2016, J CELL COMMUN SIGNAL, V10, P121, DOI 10.1007/s12079-016-0324-z; Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270; Lee CH, 2015, J CLIN INVEST, V125, P2690, DOI [10.1172/JCI84508, 10.1172/JCI81589]; Lin CH, 2013, BBA-MOL CELL RES, V1833, P2823, DOI 10.1016/j.bbamcr.2013.07.016; Lu Shan, 2018, Biophys Rep, V4, P68, DOI 10.1007/s41048-018-0050-6; Lu S, 2015, NAT METHODS, V12, P329, DOI [10.1038/nmeth.3283, 10.1038/NMETH.3283]; Matsushita Y, 2013, J BIOL CHEM, V288, P19973, DOI 10.1074/jbc.M113.454652; Miura H, 2014, CELL STRUCT FUNCT, V39, P9, DOI 10.1247/csf.13018; Mochizuki S, 2010, BIOCHEM BIOPH RES CO, V402, P651, DOI 10.1016/j.bbrc.2010.10.077; Moe IT, 2013, J CELL COMMUN SIGNAL, V7, P31, DOI 10.1007/s12079-012-0183-1; Mokalled MH, 2016, SCIENCE, V354, P630, DOI 10.1126/science.aaf2679; Murphy-Ullrich JE, 2014, MATRIX BIOL, V37, P1, DOI 10.1016/j.matbio.2014.07.005; Neesse A, 2013, P NATL ACAD SCI USA, V110, P12325, DOI 10.1073/pnas.1300415110; Nishida T, 2011, J BONE MINER RES, V26, P351, DOI 10.1002/jbmr.222; Nishida Y, 2005, GENE, V344, P133, DOI 10.1016/j.gene.2004.09.007; Pi LY, 2015, AM J PATHOL, V185, P1552, DOI 10.1016/j.ajpath.2015.02.008; Rachfal AW, 2005, VITAM HORM, V70, P69, DOI 10.1016/S0083-6729(05)70003-0; Raghu G, 2016, EUR RESPIR J, V47, P1481, DOI 10.1183/13993003.01030-2015; Robertson IB, 2013, CYTOKINE GROWTH F R, V24, P355, DOI 10.1016/j.cytogfr.2013.06.003; Robinson PM, 2012, INVEST OPHTH VIS SCI, V53, P8093, DOI 10.1167/iovs.12-10419; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Sage EH, 2003, J BIOL CHEM, V278, P37849, DOI 10.1074/jbc.M302946200; Schafer S, 2017, NATURE, V552, P110, DOI 10.1038/nature24676; Schutze N, 2005, PROTEIN EXPRES PURIF, V42, P219, DOI 10.1016/j.pep.2005.03.031; Schutze N, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-45; Steffen CL, 1998, GROWTH FACTORS, V15, P199, DOI 10.3109/08977199809002117; Su BY, 2001, J CLIN PATHOL-MOL PA, V54, P184, DOI 10.1136/mp.54.3.184; Takafuji V, 2007, ONCOGENE, V26, P6361, DOI 10.1038/sj.onc.1210463; Tam EM, 2004, P NATL ACAD SCI USA, V101, P6917, DOI 10.1073/pnas.0305862101; Tan TK, 2013, LAB INVEST, V93, P434, DOI 10.1038/labinvest.2013.3; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Tong ZY, 2009, HEPATOLOGY, V50, P939, DOI 10.1002/hep.23102; Wang XC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12469; Weathington NM, 2006, NAT MED, V12, P317, DOI 10.1038/nm1361; Weng Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22456-w; Xu ER, 2017, J BIOL CHEM, V292, P12516, DOI 10.1074/jbc.M117.788992; Yang ZZ, 2015, MOL MED REP, V12, P1091, DOI 10.3892/mmr.2015.3537; Zhu XP, 2015, ONCOTARGET, V6, P25320, DOI 10.18632/oncotarget.4659	80	38	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2018	293	46					17953	17970		10.1074/jbc.RA118.004559	http://dx.doi.org/10.1074/jbc.RA118.004559			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HA6SG	30262666	hybrid, Green Published			2022-12-26	WOS:000450409500024
J	Gasior-Perczak, D; Palyga, I; Szymonek, M; Kowalik, A; Walczyk, A; Kopczynski, J; Lizis-Kolus, K; Trybek, T; Mikina, E; Szyska-Skrobot, D; Gadawska-Juszczyk, K; Hurej, S; Szczodry, A; Sluszniak, A; Sluszniak, J; Mezyk, R; Gozdz, S; Kowalska, A				Gasior-Perczak, Danuta; Palyga, Iwona; Szymonek, Monika; Kowalik, Artur; Walczyk, Agnieszka; Kopczynski, Janusz; Lizis-Kolus, Katarzyna; Trybek, Tomasz; Mikina, Estera; Szyska-Skrobot, Dorota; Gadawska-Juszczyk, Klaudia; Hurej, Stefan; Szczodry, Artur; Sluszniak, Anna; Sluszniak, Janusz; Mezyk, Ryszard; Gozdz, Stanislaw; Kowalska, Aldona			The impact of BMI on clinical progress, response to treatment, and disease course in patients with differentiated thyroid cancer	PLOS ONE			English	Article							BODY-MASS INDEX; INCREASING INCIDENCE; POOLED ANALYSIS; RISK; OBESITY; PREVALENCE; CARCINOMA; METAANALYSIS; ASSOCIATION; TRENDS	Introduction Obesity is a serious health problem worldwide, particularly in developed countries. It is a risk factor for many diseases, including thyroid cancer. The relationship between obesity and prognostic factors of thyroid cancer is unclear. Aims We sought to ascertain the relationship between body mass index (BMI) and clinicopathological features increasing the risk of poor clinical course, treatment response, and clinical outcome in patients with differentiated thyroid cancer (DTC). Subjects & methods The study included 1181 patients with DTC (88% women and 12% men) treated at a single center from 2000 to 2016. BMI before surgery and aggressive clinicopathological features, according to the American Thyroid Initial Risk stratification system, were analyzed. The relationship between BMI and initial risk, treatment response, and final status of the disease was evaluated, incorporating the revised 2015 American Thyroid Association guidelines and the 8th edition of the American Joint Committee on Cancer/Tumor-Node-Metastasis (AJCC/TNM) staging system. Patients were stratified according to the World Health Organization classification of BMI. Statistical analysis was performed using univariate and multivariate logistic regression analysis. Results Median follow-up was 7.7 years (1-16 years). There were no significant associations between BMI and extrathyroidal extension (microscopic and gross), cervical lymph node metastasis, or distant metastasis in univariate and multivariate analyses. BMI did not affect initial risk, treatment response or disease outcome. Obesity was more prevalent in men (p = 0.035) and in patients >= 55 years old (p = 0.001). There was no statistically significant relationship between BMI and more advanced TNM stage in patients <= 55 years old (stage I vs. stage II) (p = 0.266) or in patients >55 years old (stage I-II vs. III-IV) (p = 0.877). Conclusions Obesity is not associated with more aggressive clinicopathological features of thyroid cancer. Obesity is not a risk factor for progression to more advanced stages of disease, nor is it a prognostic factor for poorer treatment response and clinical outcome.	[Gasior-Perczak, Danuta; Palyga, Iwona; Szymonek, Monika; Walczyk, Agnieszka; Lizis-Kolus, Katarzyna; Trybek, Tomasz; Mikina, Estera; Szyska-Skrobot, Dorota; Gadawska-Juszczyk, Klaudia; Hurej, Stefan; Szczodry, Artur; Kowalska, Aldona] Holycross Canc Ctr, Endocrinol Clin, Kielce, Poland; [Kowalik, Artur] Holycross Canc Ctr, Dept Mol Diagnost, Kielce, Poland; [Kopczynski, Janusz] Holycross Canc Ctr, Dept Surg Pathol, Kielce, Poland; [Sluszniak, Anna] Holycross Canc Ctr, Lab Tumor Markers, Kielce, Poland; [Sluszniak, Janusz] Holycross Canc Ctr, Dept Surg Oncol, Kielce, Poland; [Mezyk, Ryszard] Holycross Canc Ctr, Canc Epidemiol, Kielce, Poland; [Gozdz, Stanislaw] Holycross Canc Ctr, Oncol Clin, Kielce, Poland; [Gozdz, Stanislaw; Kowalska, Aldona] Jan Kochanowski Univ Humanities & Sci, Fac Hlth Sci, Kielce, Poland	Jan Kochanowski University	Gasior-Perczak, D (corresponding author), Holycross Canc Ctr, Endocrinol Clin, Kielce, Poland.	danutagp@o2.pl	Kowalik, Artur/K-2111-2017; KOWALSKA, ALDONA/AAE-9040-2021; Kowalik, Artur/AAB-5690-2020; Walczyk, Agnieszka/ABC-3334-2020; Gąsior-Perczak, Danuta/AAM-2668-2020; Gozdz, Stanislaw/D-3300-2013	Kowalik, Artur/0000-0002-3718-999X; KOWALSKA, ALDONA/0000-0001-5647-5898; Kowalik, Artur/0000-0002-3718-999X; Gąsior-Perczak, Danuta/0000-0003-0936-4890; Walczyk, Agnieszka/0000-0002-5083-659X; Palyga, Iwona/0000-0001-5333-6112; Gozdz, Stanislaw/0000-0001-6902-3807				Agate L, 2012, J ENDOCRINOL INVEST, V35, P3; Al-Ammar Y, 2017, BRAZ J OTORHINOLARYN; Baskin ML, 2005, OBES REV, V6, P5, DOI 10.1111/j.1467-789X.2005.00165.x; Brito JP, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4706; Choi JS, 2015, ENDOCRINE, V48, P264, DOI 10.1007/s12020-014-0293-z; Chung YS, 2017, SURG TODAY, V47, P506, DOI 10.1007/s00595-016-1417-2; Davies L, 2015, ENDOCR PRACT, V21, P686, DOI 10.4158/EP14466.DSCR; Davies L, 2014, JAMA OTOLARYNGOL, V140, P317, DOI 10.1001/jamaoto.2014.1; Davies L, 2010, LARYNGOSCOPE, V120, P2446, DOI 10.1002/lary.21076; Dieringer P, 2015, J CANCER RES CLIN, V141, P93, DOI 10.1007/s00432-014-1792-2; Enewold L, 2009, CANCER EPIDEM BIOMAR, V18, P784, DOI 10.1158/1055-9965.EPI-08-0960; Farfel A, 2014, THYROID, V24, P987, DOI 10.1089/thy.2013.0173; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Gasior-Perczak D, 2017, ENDOCR CONNECT, V6, P522, DOI 10.1530/EC-17-0135; Grani G, 2019, J ENDOCRINOL INVEST, V42, P85, DOI 10.1007/s40618-018-0889-x; Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020; How J, 2007, CAN MED ASSOC J, V177, P1383, DOI 10.1503/cmaj.071464; Hughes DT, 2011, THYROID, V21, P231, DOI 10.1089/thy.2010.0137; Iribarren C, 2001, INT J CANCER, V93, P745, DOI 10.1002/ijc.1377; Jung KW, 2015, CANCER RES TREAT, V47, P127, DOI 10.4143/crt.2015.060; Kim HJ, 2013, CLIN ENDOCRINOL, V78, P134, DOI 10.1111/j.1365-2265.2012.04506.x; Kim JY, 2011, J KOREAN SURG SOC, V80, P241, DOI 10.4174/jkss.2011.80.4.241; Kim SH, 2015, SURG TODAY, V45, P723, DOI 10.1007/s00595-014-0984-3; Kitahara CM, 2016, THYROID, V26, P306, DOI 10.1089/thy.2015.0319; Kitahara CM, 2014, CANCER RES, V74, P235, DOI 10.1158/0008-5472.CAN-13-2228; Kowalska A, 2017, CLIN ENDOCRINOL; Kowalska A, 2013, THYROID RES, V6, pA30, DOI DOI 10.1186/1756-6614-6-S2-A30; Kowalska A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153242; Kowalska A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133852; Kwon H, 2015, ENDOCRINOL METAB, V30, P305, DOI 10.3803/EnM.2015.30.3.305; Liu ZM, 2015, INT J CLIN EXP MED, V8, P16472; Ljungvall A, 2012, SOC SCI MED, V75, P109, DOI 10.1016/j.socscimed.2012.03.003; Ma J, 2015, MED SCI MONITOR, V21, P283, DOI 10.12659/MSM.892035; Mangano JJ, 2009, INT J HEALTH SERV, V39, P643, DOI 10.2190/HS.39.4.c; Marcello MA, 2014, ENDOCR-RELAT CANCER, V21, pT255, DOI 10.1530/ERC-14-0070; Momesso DP, 2014, ENDOCRIN METAB CLIN, V43, P401, DOI 10.1016/j.ecl.2014.02.010; Paes JE, 2010, J CLIN ENDOCR METAB, V95, P4244, DOI 10.1210/jc.2010-0440; Pappa T, 2014, THYROID, V24, P190, DOI 10.1089/thy.2013.0232; Pazaitou-Panayiotou K, 2013, OBES REV, V14, P1006, DOI 10.1111/obr.12070; Pazaitou-Panayiotou K, 2013, EXP CLIN ENDOCR DIAB, V121, P397, DOI 10.1055/s-0033-1345125; Peterson E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029177; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Reynolds JV, 2011, IRISH J MED SCI, V180, P521, DOI 10.1007/s11845-010-0653-5; Rinaldi S, 2012, INT J CANCER, V131, pE1004, DOI 10.1002/ijc.27601; Roman BR, 2017, CURR OPIN ENDOCRINOL, V24, P332, DOI 10.1097/MED.0000000000000359; Rotondi M, 2016, EUR THYROID J, V5, P125, DOI 10.1159/000445054; Samanic C, 2006, CANCER CAUSE CONTROL, V17, P901, DOI 10.1007/s10552-006-0023-9; Segovia IG, 2004, THYROID, V14, P277, DOI 10.1089/105072504323030933; Simard EP, 2012, CA-CANCER J CLIN, V62, P118, DOI 10.3322/caac.20141; Stepaniak U, 2016, POL ARCH MED WEWN, V126, P662, DOI 10.20452/pamw.3499; Tresallet C, 2014, SURGERY, V156, P1145, DOI 10.1016/j.surg.2014.04.020; Tuttle M, 2017, AJCC CANC STAGING MA; Tuttle RM, 2017, THYROID, V27, P751, DOI 10.1089/thy.2017.0102; Tuttle RM, 2010, THYROID, V20, P1341, DOI 10.1089/thy.2010.0178; Vaccarella S, 2016, NEW ENGL J MED, V375, P614, DOI 10.1056/NEJMp1604412; Wu CH, 2017, MEDICINE, V96, DOI [10.1097/MD.0000000000006202, 10.1097/md.0000000000006202]; Xu L, 2014, THYROID, V24, P966, DOI 10.1089/thy.2013.0566; Yu ST, 2017, INT J ENDOCRINOL, V2017, DOI 10.1155/2017/5841942; Zhao ZG, 2012, J INT MED RES, V40, P2041, DOI 10.1177/030006051204000601	59	21	21	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204668	10.1371/journal.pone.0204668	http://dx.doi.org/10.1371/journal.pone.0204668			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273371	Green Submitted, gold, Green Published			2022-12-26	WOS:000446124700031
J	Komi, D; Kitani, T; Nakamura, A; Wakui, N; Mizutani, R; Ohue, M; Kametani, F; Akimitsu, N; Gojo, S				Komi, Daisuke; Kitani, Tomoya; Nakamura, Akihiro; Wakui, Naoki; Mizutani, Rena; Ohue, Masahito; Kametani, Fuyuki; Akimitsu, Nobuyoshi; Gojo, Satoshi			The DEAD-box RNA-binding protein DDX6 regulates parental RNA decay for cellular reprogramming to pluripotency	PLOS ONE			English	Article							TO-ZYGOTIC TRANSITION; MAGNETIC NANOPARTICLES; GENOME ACTIVATION; QUALITY-CONTROL; RO AUTOANTIGEN; MESSENGER-RNAS; Y RNAS; INSIGHTS; COMPLEX; LOCALIZATION	Cellular transitions and differentiation processes require mRNAs supporting the new phenotype but also the clearance of existing mRNAs for the parental phenotype. Cellular reprogramming from fibroblasts to induced pluripotent stem cells (iPSCs) occurs at the early stage of mesenchymal epithelial transition (MET) and involves drastic morphological changes. We examined the molecular mechanism for MET, focusing on RNA metabolism. DDX6, an RNA helicase, was indispensable for iPSC formation, in addition to RO60 and RNY1, a non-coding RNA, which form complexes involved in intracellular nucleotide sensing. RO60/RNY1/DDX6 complexes formed prior to processing body formation, which is central to RNA metabolism. The abrogation of DDX6 expression inhibited iPSC generation, which was mediated by RNA decay targeting parental mRNAs supporting mesenchymal phenotypes, along with microRNAs, such as miR-302b-3p. These results show that parental mRNA clearance is a prerequisite for cellular reprogramming and that DDX6 plays a central role in this process.	[Komi, Daisuke; Gojo, Satoshi] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Regenerat Med, Kyoto, Japan; [Kitani, Tomoya] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Cardiovasc Med, Kyoto, Japan; [Nakamura, Akihiro] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pediat Cardiol & Nephrol, Kyoto, Japan; [Wakui, Naoki; Ohue, Masahito] Tokyo Inst Technol, Sch Comp, Dept Comp Sci, Tokyo, Japan; [Mizutani, Rena; Akimitsu, Nobuyoshi] Univ Tokyo, Radioisotope Ctr, Tokyo, Japan; [Kametani, Fuyuki] Tokyo Metropolitan Inst Med Sci, Dept Dementia & Higher Brain Funct, Tokyo, Japan	Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; Tokyo Institute of Technology; University of Tokyo; Tokyo Metropolitan Institute of Medical Science	Gojo, S (corresponding author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Regenerat Med, Kyoto, Japan.	gojos@koto.kpu-m.ac.jp	Kametani, Fuyuki/G-4752-2011	Kametani, Fuyuki/0000-0001-9125-7001; Kami, Daisuke/0000-0002-9862-5513	Ministry of Education, Culture, Sports, Science and Technology of Japan [16K15260]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by a grant, Grant-in-Aid for challenging Exploratory Research 16K15260, from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to express our sincere thanks to Ms. Sayuri Shikata, Ms. Yoshie Koyama, and Mr. Takanori Hayashi for their technical assistance. This research was supported by a grant, Grant-in-Aid for challenging Exploratory Research 16K15260, from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Benoit B, 2009, DEVELOPMENT, V136, P923, DOI 10.1242/dev.031815; Buganim Y, 2013, NAT REV GENET, V14, P427, DOI 10.1038/nrg3473; Bushati N, 2008, CURR BIOL, V18, P501, DOI 10.1016/j.cub.2008.02.081; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen Y, 2014, MOL CELL, V54, P737, DOI 10.1016/j.molcel.2014.03.034; CLARK G, 1969, J IMMUNOL, V102, P117; Ernoult-Lange M, 2012, RNA, V18, P1702, DOI 10.1261/rna.034314.112; Giraldez AJ, 2010, CURR OPIN GENET DEV, V20, P369, DOI 10.1016/j.gde.2010.04.003; Hall Adam E, 2013, Biomol Concepts, V4, P103, DOI 10.1515/bmc-2012-0050; Han JW, 2011, ANTIOXID REDOX SIGN, V15, P1799, DOI 10.1089/ars.2010.3814; Hansson J, 2012, CELL REP, V2, P1579, DOI 10.1016/j.celrep.2012.10.014; Hogg JR, 2007, GENE DEV, V21, P3067, DOI 10.1101/gad.1603907; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang JH, 2017, SCI REP-UK, V7, DOI 10.1038/srep42853; Jonas S, 2015, NAT REV GENET, V16, P421, DOI 10.1038/nrg3965; Kami D, 2014, NANOMED-NANOTECHNOL, V10, P1165, DOI 10.1016/j.nano.2014.03.018; Kami D, 2011, J ARTIF ORGANS, V14, P215, DOI 10.1007/s10047-011-0568-6; Kami D, 2011, INT J MOL SCI, V12, P3705, DOI 10.3390/ijms12063705; Krude T, 2009, J CELL SCI, V122, P2836, DOI 10.1242/jcs.047563; Lee MT, 2014, ANNU REV CELL DEV BI, V30, P581, DOI 10.1146/annurev-cellbio-100913-013027; LERNER MR, 1981, SCIENCE, V211, P400, DOI 10.1126/science.6164096; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Liu X, 2018, CELL, V174, P187, DOI 10.1016/j.cell.2018.04.017; Maekawa S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1358-y; Mathys H, 2014, MOL CELL, V54, P751, DOI 10.1016/j.molcel.2014.03.036; MITSUI Y, 1980, EXP CELL RES, V126, P289, DOI 10.1016/0014-4827(80)90267-0; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; Moretti F, 2012, NAT STRUCT MOL BIOL, V19, P603, DOI 10.1038/nsmb.2309; MUHLRAD D, 1994, GENE DEV, V8, P855, DOI 10.1101/gad.8.7.855; Nishimura T, 2015, CELL REP, V11, P1425, DOI 10.1016/j.celrep.2015.04.065; Ohue M, 2014, BIOINFORMATICS, V30, P3281, DOI 10.1093/bioinformatics/btu532; Ohue M, 2014, PROTEIN PEPTIDE LETT, V21, P766; Ostareck DH, 2014, WIRES RNA, V5, P659, DOI 10.1002/wrna.1237; Ozgur S, 2015, CELL REP, V13, P703, DOI 10.1016/j.celrep.2015.09.033; Perreault J, 2007, MOL BIOL EVOL, V24, P1678, DOI 10.1093/molbev/msm084; Ramos SBV, 2004, DEVELOPMENT, V131, P4883, DOI 10.1242/dev.01336; Rosa A, 2009, DEV CELL, V16, P517, DOI 10.1016/j.devcel.2009.02.007; Rouya C, 2014, RNA, V20, P1398, DOI 10.1261/rna.045302.114; Rutjes SA, 2001, RNA, V7, P741, DOI 10.1017/S1355838201002503; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Sim S, 2009, MOL BIOL CELL, V20, P1555, DOI 10.1091/mbc.E08-11-1094; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Stein AJ, 2005, CELL, V121, P529, DOI 10.1016/j.cell.2005.03.009; Subramanyam D, 2011, NAT BIOTECHNOL, V29, P443, DOI 10.1038/nbt.1862; Sultana Azmiri, 2015, Curr Protoc Protein Sci, V79, DOI 10.1002/0471140864.ps1925s79; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tucker M, 2001, CELL, V104, P377, DOI 10.1016/S0092-8674(01)00225-2; VANVENROOIJ WJ, 1993, MOL BIOL REP, V18, P113, DOI 10.1007/BF00986765; Wang ZR, 2001, CELL, V107, P751, DOI 10.1016/S0092-8674(01)00592-X; Webb Benjamin, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi0506s47; Webb B, 2014, METHODS MOL BIOL, V1137, P1, DOI 10.1007/978-1-4939-0366-5_1; Wolin SL, 2013, RNA BIOL, V10, P1602, DOI 10.4161/rna.26166; Wong CC, 2010, NAT BIOTECHNOL, V28, P1115, DOI 10.1038/nbt.1686; Yartseva V, 2015, CURR TOP DEV BIOL, V113, P191, DOI 10.1016/bs.ctdb.2015.07.020	60	8	10	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0203708	10.1371/journal.pone.0203708	http://dx.doi.org/10.1371/journal.pone.0203708			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273347	gold, Green Published, Green Submitted			2022-12-26	WOS:000446124700008
J	Mahapatra, B; Bhattacharya, R; Atmavilas, Y; Saggurti, N				Mahapatra, Bidhubhusan; Bhattacharya, Ruchira; Atmavilas, Yamini; Saggurti, Niranjan			Measuring vulnerability among female sex workers in India using a multidimensional framework	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; HIV PREVENTION; ANDHRA-PRADESH; RISK-FACTORS; DETERMINANTS; INTERVENTIONS; PREVALENCE; SETTINGS; POVERTY	Measuring vulnerability and identifying determinants of vulnerability are key to designing interventions for marginalized groups like sex workers. The current study introduces a new approach of measuring vulnerability among female sex workers (FSWs) by adopting a multidimensional poverty measurement framework. A multidimensional vulnerability index was created from four dimensions and 16 indicators using a dual cut-off approach. The study found that 55% of FSWs were multidimensionally vulnerable with 48% of intensity in vulnerability. The overall value of multidimensional vulnerability index was 0.265. FSWs in Maharashtra were most vulnerable (82%). Lack of financial security contributed mostly to FSWs' vulnerability. Further, compared to less vulnerable FSWs, multidimensionally vulnerable ones were more to engage in behaviors that put them at risk such as inconsistent use of condoms with clients, alcohol consumption, engaging in anal sex with clients and experiencing sexually transmitted infections. Findings suggest that structural, social and financial vulnerabilities of FSWs need to be addressed concurrently.	[Mahapatra, Bidhubhusan; Bhattacharya, Ruchira; Saggurti, Niranjan] Populat Council, India Habitat Ctr, Zone 5A, New Delhi, India; [Bhattacharya, Ruchira] Natl Inst Rural Dev & Panchayati Raj, Hyderabad, India; [Atmavilas, Yamini] Bill & Melinda Gates Fdn, Capital Court, New Delhi, India		Mahapatra, B (corresponding author), Populat Council, India Habitat Ctr, Zone 5A, New Delhi, India.	bbmahapatra@popcouncil.org	Mahapatra, Bidhubhusan/M-1411-2019; Bhattacharya, Ruchira/AAG-9610-2021	Mahapatra, Bidhubhusan/0000-0003-0240-7026; Bhattacharya, Ruchira/0000-0002-7735-3301; Saggurti, Niranjan/0000-0002-5267-8425	Bill & Melinda Gates Foundation [OPP1110266]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This paper was written as part of an evaluation grant funded to the Population Council by the Bill & Melinda Gates Foundation (grant # OPP1110266). The donor had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript. YA who works with the Bill & Melinda Gates Foundation contributed to this paper on her individual capacity and opinion expressed in the paper does not necessarily reflect the official policy and position of the Bill & Melinda Gates Foundation.	Alkire S., 2007, COUNTING MULTIDIMENS; Alkire S, 2014, WORLD DEV, V59, P251, DOI 10.1016/j.worlddev.2014.01.026; Alkire S, 2011, J PUBLIC ECON, V95, P476, DOI 10.1016/j.jpubeco.2010.11.006; Avahan-3 Baseline Survey, 2018, HARV DAT, DOI [10.7910/DVN/SBN5PI, DOI 10.7910/DVN/SBN5PI]; Bharat S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068043; Blankenship KA, 2008, AIDS, V22, pS109, DOI 10.1097/01.aids.0000343769.92949.dd; Blankenship KM, 2006, J URBAN HEALTH, V83, P59, DOI 10.1007/s11524-005-9007-4; Chakravarthy JBR, 2012, J EPIDEMIOL COMMUN H, V66, pII78, DOI 10.1136/jech-2011-200487; Cornish F, 2014, AIDS BEHAV, V18, P2110, DOI 10.1007/s10461-014-0748-5; Dandona R, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-87; de Guzman A, 2001, AIDS CARE, V13, P663, DOI 10.1080/09540120120063287; Evans C, 2010, GLOB PUBLIC HEALTH, V5, P449, DOI 10.1080/17441690902942472; Foster J., 2009, COUNTING MULTIDIMENS; Gaikwad SS, 2012, J EPIDEMIOL COMMUN H, V66, pII69, DOI 10.1136/jech-2011-200514; Ganju D, 2016, BMC INT HEALTH HUM R, V16, DOI 10.1186/s12914-016-0102-2; Greener R, 2010, AIDS, V24, pS3, DOI 10.1097/01.aids.0000390084.37812.30; Greig FE, 2003, AIDS BEHAV, V7, P195, DOI 10.1023/A:1023954526639; Gupta GR, 2008, LANCET, V372, P764, DOI 10.1016/S0140-6736(08)60887-9; Gurnani V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-755; Jana S, 1995, Indian J Public Health, V39, P125; Moret W., 2014, EC STRENGTHENING FEM, P360; National AIDS Control Organization (NACO), 2015, NATIONAL INTEGRATED; Ntumbanzondo M, 2006, AIDS CARE, V18, P777, DOI 10.1080/09540120500412824; Parimi P, 2012, J EPIDEMIOL COMMUN H, V66, pII62, DOI 10.1136/jech-2011-200832; Patel KS, 2016, J FOOD SECURITY, V4, P104, DOI DOI 10.12691/JFS-4-5-1; Patel SK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156060; Pillai P., 2012, IMPACT 2 VULNERABILI; Punyam S, 2012, J EPIDEMIOLOGY COMMU; Ramesh BA, 2008, AIDS, V22, pS35, DOI 10.1097/01.aids.0000343762.54831.5c; Ramesh S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-764; Ranebennur V, 2014, HIV AIDS-RES PALLIAT, V6, P9, DOI 10.2147/HIV.S54062; Reed E, 2010, PUBLIC HEALTH REP, V125, P81, DOI 10.1177/00333549101250S412; Saggurti N, 2012, AIDS BEHAV, V16, P952, DOI 10.1007/s10461-011-9937-7; Saggurti N, 2011, J BIOSOC SCI, V43, P535, DOI 10.1017/S0021932011000277; Sarkar K, 2006, J INFECTION, V53, P255, DOI 10.1016/j.jinf.2005.11.009; Scorgie F, 2012, AIDS BEHAV, V16, P920, DOI 10.1007/s10461-011-9985-z; Shahmanesh M, 2009, SEX TRANSM INFECT, V85, P50, DOI 10.1136/sti.2008.030767; Shahmanesh M, 2008, TROP MED INT HEALTH, V13, P659, DOI 10.1111/j.1365-3156.2008.02040.x; Shannon K, 2014, CURR OPIN HIV AIDS, V9, P174, DOI 10.1097/COH.0000000000000042; Travasso SM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-248; Tsui KY, 2002, SOC CHOICE WELFARE, V19, P69, DOI 10.1007/s355-002-8326-3	41	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2018	13	9							e0204055	10.1371/journal.pone.0204055	http://dx.doi.org/10.1371/journal.pone.0204055			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GU9BO	30252879	Green Submitted, Green Published, gold			2022-12-26	WOS:000445639700027
J	Allavena, C; Hanf, M; Rey, D; Duvivier, C; BaniSadr, F; Poizot-Martin, I; Jacomet, C; Pugliese, P; Delobel, P; Katlama, C; Joly, V; Chidiac, C; Dournon, N; Merrien, D; May, T; Reynes, J; Gagneux-Brunon, A; Chirouze, C; Huleux, T; Cabie, A; Raffi, F				Allavena, Clotilde; Hanf, Matthieu; Rey, David; Duvivier, Claudine; BaniSadr, Firouze; Poizot-Martin, Isabelle; Jacomet, Christine; Pugliese, Pascal; Delobel, Pierre; Katlama, Christine; Joly, Veronique; Chidiac, Christian; Dournon, Nathalie; Merrien, Dominique; May, Thierry; Reynes, Jacques; Gagneux-Brunon, Amandine; Chirouze, Catherine; Huleux, Thomas; Cabie, Andre; Raffi, Francois		DatAIDS Study Grp	Antiretroviral exposure and comorbidities in an aging HIV-infected population: The challenge of geriatric patients	PLOS ONE			English	Article							AGE-RELATED COMORBIDITIES; THERAPY; COMBINATION; INFLAMMATION; INDIVIDUALS; PREVALENCE; MEDICATIONS; SUPPRESSION; MORTALITY; DIAGNOSIS	As HIV-infected adults on successful antiretroviral therapy (ART) are expected to have close to normal lifespans, they will increasingly develop age-related comorbidities. The objective of this cross-sectional study was to compare in the French Dat'AIDS cohort, the HIV geriatric population, aged 75 years and over, to the elderly one, aged from 50 to 74 years. As of Dec 2015, 16,436 subjects (43.8% of the French Dat'AIDS cohort) were aged from 50 to 74 (elderly group) and 572 subjects (1.5%) were aged 75 and over (geriatric group). Durations of HIV infection and of ART were slightly but significantly different, median at 19 and 18 years, and 15 and 16 years in the elderly and geriatric group, respectively. The geriatric group was more frequently at CDC stage C and had a lower nadir CD4. This group had been more exposed to first generation protease inhibitors and thymidine analogues. Despite similar virologic suppression, type of ART at the last visit significantly differed between the 2 groups: triple ART in 74% versus 68.2%, ART >= 4 drugs in 4.7% versus 2.7%; dual therapy in 11.6% versus 16.4% in the elderly group and the geriatric group, respectively. In the geriatric group all co-morbidities were significantly more frequent, except dyslipidemia, 4.3% of the elderly group had >= 4 co-morbidities versus18.4% in the geriatric group. Despite more co-morbidities and more advanced HIV infection the geriatric population achieve similar high rate of virologic suppression than the elderly population. A multidisciplinary approach should be developed to face the incoming challenge of aging HIV population.	[Allavena, Clotilde; Raffi, Francois] Univ Hosp Nantes, Infect Dis Dept, Nantes, France; [Allavena, Clotilde; Hanf, Matthieu; Raffi, Francois] Univ Hosp Nantes, INSERM CIC1413, Nantes, France; [Hanf, Matthieu] Versailles St Quentin Univ, Inst Pasteur, INSERM UMR B2PHI 1181, Villejuif, France; [Rey, David] Ctr HIV Infect Care, Strasbourg, France; [Duvivier, Claudine] Hop Necker Enfants Malad, AP HP, Infect Dis Dept, Necker Pasteur Infectiol Ctr, Paris, France; [Duvivier, Claudine] Pasteur Inst, Necker Pasteur Infectiol Ctr, Med Ctr, Paris, France; [Duvivier, Claudine] Paris Descartes Univ, Sorbonne Paris Cite, EA7327, Paris, France; [BaniSadr, Firouze] Univ Reims, Reims Teaching Hosp, Dept Internal Med Infect Dis & Clin Immunol, Reims, France; [BaniSadr, Firouze] Univ Reims, Fac Med, EA 4684, SFR CAP SANTE, Reims, France; [Poizot-Martin, Isabelle] Aix Marseille Univ, Hop St Marguerite, AP HM, Immunohematol Clin, Marseille, France; [Poizot-Martin, Isabelle] Inserm U912, SESSTIM, Marseille, France; [Jacomet, Christine] Univ Clermont Ferrand, Infect Dis Dept, Clermont Ferrand, France; [Pugliese, Pascal] Ctr Hosp Univ Archet, Dept Infect Dis, Nice, France; [Delobel, Pierre] INSERM, UMR1043, Toulouse, France; [Delobel, Pierre] Univ Toulouse III Paul Sabatier, Toulouse, France; [Delobel, Pierre] Toulouse Univ Hosp, Dept Infect Dis, Toulouse, France; [Katlama, Christine] Pitie Salpetriere Univ Hosp, AP HP, Dept Infect Dis, Paris, France; [Katlama, Christine] Sorbonne Univ, Univ Pierre & Marie Curie Paris 06, INSERM, Unite Mixte Rech Sante 1136, Paris, France; [Joly, Veronique] Hop Bichat Claude Bernard, AP HP, Infect Dis Dept, Paris, France; [Joly, Veronique] Paris Diderot Univ, Sorbonne Paris Cite, Natl Inst Hlth & Med Res INSERM IAME, UMR 1137, Paris, France; [Chidiac, Christian] Claude Bernard Lyon 1 Univ, Hosp Civils Lyon, Infect & Trop Dis Dept, Lyon, France; [Dournon, Nathalie] Univ Antilles, Fac Med Hyacinthe Bastaraud, Med Interne, Serv Malad Infect & Trop,Dermatol, Pointe a Pitre, Guadeloupe, France; [Dournon, Nathalie; Cabie, Andre] CHU Pointe a Pitre, Inserm CIC 1424, Pointe a Pitre, Guadeloupe, France; [Merrien, Dominique] CHD Vendee, Dept Infect Dis, La Roche Sur Yon, France; [May, Thierry] Univ Hosp Ctr, Dept Infect Dis, Nancy, France; [Reynes, Jacques] Montpellier Univ Hosp, Infect Dis Dept, Montpellier, France; [Reynes, Jacques] Montpellier Univ Hosp, INSERM UMI233 U1175, Montpellier, France; [Gagneux-Brunon, Amandine] Univ St Etienne, Infect Dis Dept, St Etienne, France; [Chirouze, Catherine] Univ Hosp Besancon, Infect Dis Dept, Besancon, France; [Chirouze, Catherine] Univ Bourgogne Franche Comte, UMR CNRS 6249, Besancon, France; [Huleux, Thomas] Univ Hosp Tourcoing, Infect Dis Dept, Tourcoing, France; [Cabie, Andre] Univ Hosp Martinique, Infect Dis Dept, Fort De France, Martinique, France; [Cabie, Andre] Univ Antilles, EA4537, Fort De France, Martinique, France	Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; CHU de Reims; Universite de Reims Champagne-Ardenne; Universite de Reims Champagne-Ardenne; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universite des Antilles; CHU Guadeloupe; Institut National de la Sante et de la Recherche Medicale (Inserm); CHD Vendee; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier; Universite Jean Monnet; Universite de Franche-Comte; CHU Besancon; Universite de Franche-Comte; CHU Martinique	Allavena, C (corresponding author), Univ Hosp Nantes, Infect Dis Dept, Nantes, France.; Allavena, C (corresponding author), Univ Hosp Nantes, INSERM CIC1413, Nantes, France.	clotilde.allavena@chu-nantes.fr	Gagneux-Brunon, Amandine/V-4269-2019; Delobel, Pierre/Q-6028-2019; Gagneux-Brunon, Amandine/ABA-1693-2021; Delobel, Pierre/K-3166-2014; Allavena, Clotilde/AAH-4310-2019	Delobel, Pierre/0000-0002-2874-3581; Gagneux-Brunon, Amandine/0000-0002-0892-2187; Delobel, Pierre/0000-0002-2874-3581; Allavena, Clotilde/0000-0003-1010-1270; Poizot-Martin, Isabelle/0000-0002-5676-5411; Cabie, Andre/0000-0003-0117-3061; Hanf, Matthieu/0000-0001-7133-1323				Althoff KN, 2015, CLIN INFECT DIS, V60, P627, DOI 10.1093/cid/ciu869; [Anonymous], 2017, GUIDELINES TREATMENT; Brown TT, 2006, AIDS, V20, P2165, DOI 10.1097/QAD.0b013e32801022eb; Brown TT, 2010, DIABETES CARE, V33, P2244, DOI 10.2337/dc10-0633; Burdo TH, 2013, AIDS, V27, P1387, DOI 10.1097/QAD.0b013e32836010bd; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Deeks SG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3172; Duprez DA, 2009, ATHEROSCLEROSIS, V207, P524, DOI 10.1016/j.atherosclerosis.2009.05.001; Gantner P, 2017, HIV MED, V18, P704, DOI 10.1111/hiv.12506; Greene M, 2014, J AM GERIATR SOC, V62, P447, DOI 10.1111/jgs.12695; Guaraldi G, 2017, CLIN INFECT DIS, V65, P507, DOI 10.1093/cid/cix316; Guaraldi G, 2011, CLIN INFECT DIS, V53, P1120, DOI 10.1093/cid/cir627; Hentzien M, 2016, J NUTR HEALTH AGING, V20, P408, DOI 10.1007/s12603-015-0608-7; Jacomet C, 2017, AIDS CARE, V29, P105, DOI 10.1080/09540121.2016.1200712; Joly V, 2017, C RETR OPP INF FEB 1; Katlama C, 2017, 9 IAS C HIV SCI IAS; Katlama C, 2014, J ANTIMICROB CHEMOTH, V69, P1648, DOI 10.1093/jac/dkt536; Legarth RA, 2016, JAIDS-J ACQ IMM DEF, V71, P213, DOI 10.1097/QAI.0000000000000825; Levy I, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012721; Mensforth S, 2014, J INT AIDS SOC, V17, P130, DOI 10.7448/IAS.17.4.19692; Pathai S, 2014, J GERONTOL A-BIOL, V69, P833, DOI 10.1093/gerona/glt168; Patterson S, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0969-x; Pugliese P, 2009, HIV MED, V10, P504, DOI 10.1111/j.1468-1293.2009.00719.x; Reliquet V, 2014, ANTIVIR THER, V19, P117, DOI 10.3851/IMP2691; Sabin CA, 2008, AIDS, V22, P1463; Samji H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081355; Schafer I, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-89; Schouten J, 2014, CLIN INFECT DIS, V59, P1787, DOI 10.1093/cid/ciu701; Serrano-Villar S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085798; Shiels MS, 2009, JAIDS-J ACQ IMM DEF, V52, P611, DOI 10.1097/QAI.0b013e3181b327ca; Singh HK, 2017, CLIN INFECT DIS, V65, P501, DOI 10.1093/cid/cix311; Smit M, 2015, LANCET INFECT DIS, V15, P810, DOI 10.1016/S1473-3099(15)00056-0; Steinman MA, 2010, JAMA-J AM MED ASSOC, V304, P1592, DOI 10.1001/jama.2010.1482; van Zoest RA, 2016, CLIN INFECT DIS, V63, P205, DOI 10.1093/cid/ciw285; Wada NI, 2015, AIDS, V29, P463, DOI 10.1097/QAD.0000000000000545	35	32	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2018	13	9							e0203895	10.1371/journal.pone.0203895	http://dx.doi.org/10.1371/journal.pone.0203895			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GU5MM	30240419	Green Submitted, Green Published, gold			2022-12-26	WOS:000445329700012
J	Turner, JA; Bemis, JGT; Bagby, SM; Capasso, A; Yacob, BW; Chimed, TS; Van Gulick, R; Lee, H; Tobin, R; Tentler, JJ; Pitts, T; McCarter, M; Robinson, WA; Couts, KL				Turner, Jacqueline A.; Bemis, Judson G. T.; Bagby, Stacey M.; Capasso, Anna; Yacob, Betelehem W.; Chimed, Tugs-Saikhan; Van Gulick, Robert; Lee, Hannah; Tobin, Richard; Tentler, John J.; Pitts, Todd; McCarter, Martin; Robinson, William A.; Couts, Kasey L.			BRAF fusions identified in melanomas have variable treatment responses and phenotypes	ONCOGENE			English	Article							RAF INHIBITOR RESISTANCE; TARGETED THERAPY; GENE FUSIONS; B-RAF; ACTIVATION; DIMERIZATION; MUTATIONS; PATHWAY; TUMORS	Oncogenic BRAF fusions have emerged as an alternate mechanism for BRAF activation in melanomas and other cancers. A number of BRAF fusions with different 5' gene partners and BRAF exon breakpoints have been described, but the effects of different partners and breakpoints on cancer phenotypes and treatment responses has not been well characterized. Targeted RNA sequencing was used to screen 60 melanoma patient-derived xenograft (PDX) models for BRAF fusions. We identified three unique BRAF fusions, including a novel SEPT3-BRAF fusion, occurring in four tumors (4/60, 6.7%), all of which were "pan-negative" (lacking other common mutations) (4/18, 22.2%). The BRAF fusion PDX models showed variable growth rates and responses to MAPK inhibitors in vivo. Overexpression of BRAF fusions identified in our study, as well as other BRAF fusions previously identified in melanomas, resulted in a high degree of variability in 2D proliferation and 3D invasion between the different fusions. While exogenously expressed BRAF fusions all responded to MAPK inhibition in vitro, we observed potential differences in signaling and feedback mechanisms. In summary, BRAF fusions are actionable therapeutic targets, however there are significant differences in phenotypes, treatment responses, and signaling which may be clinically relevant.	[Turner, Jacqueline A.; Bemis, Judson G. T.; Bagby, Stacey M.; Capasso, Anna; Yacob, Betelehem W.; Chimed, Tugs-Saikhan; Van Gulick, Robert; Lee, Hannah; Tentler, John J.; Pitts, Todd; Robinson, William A.; Couts, Kasey L.] Univ Colorado Denver, Dept Med, Div Med Oncol, Aurora, CO 80045 USA; [Lee, Hannah] Univ Colorado Denver, Dept Med, Internal Med Residency Training Program, Aurora, CO USA; [Tobin, Richard; McCarter, Martin] Univ Colorado Denver, Dept Surg, Div Surg Oncol, Aurora, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Couts, KL (corresponding author), Univ Colorado Denver, Dept Med, Div Med Oncol, Aurora, CO 80045 USA.	kasey.couts@ucdenver.edu		Turner, Jacqueline A./0000-0002-6638-1956; Robinson, William/0000-0003-1875-9691	Melanoma Scientific Advisory Board at the University of Colorado; Amy Davis Foundation; Moore Family Foundation; Heidi Horner Foundation; Genomic and Microarray Shared Resource of Colorado's NIH/NCI Cancer Center Support Grant [P30CA046934]; NIH/N CATS CCTSI Grant [UL1 TR001082]; Cancer League of Colorado	Melanoma Scientific Advisory Board at the University of Colorado; Amy Davis Foundation; Moore Family Foundation; Heidi Horner Foundation; Genomic and Microarray Shared Resource of Colorado's NIH/NCI Cancer Center Support Grant; NIH/N CATS CCTSI Grant; Cancer League of Colorado	We thank the patients and their families for donating tissue to the International Melanoma Biorepository and Research Laboratory at the University of Colorado Cancer Center. We thank the Melanoma Scientific Advisory Board at the University of Colorado for their support. The work presented here was supported in part by the Amy Davis Foundation, the Moore Family Foundation, and the Heidi Horner Foundation. Additionally, funding was also provided by the Genomic and Microarray Shared Resource of Colorado's NIH/NCI Cancer Center Support Grant P30CA046934, NIH/N CATS CCTSI Grant UL1 TR001082, and Cancer League of Colorado.	Alatrash G, 2013, EXPERT OPIN DRUG SAF, V12, P631, DOI 10.1517/14740338.2013.795944; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Bagby S, 2016, JOVE-J VIS EXP, V115, P54393; Baitei EY, 2009, J PATHOL, V217, P707, DOI 10.1002/path.2496; Baiter M, 2015, DERMATOLOGY, V231, P127, DOI 10.1159/000381849; Botton T, 2013, PIGM CELL MELANOMA R, V26, DOI 10.1111/pcmr.12148; Brummer T, 2006, ONCOGENE, V25, P6262, DOI 10.1038/sj.onc.1209640; Couts KL, 2013, ONCOGENE, V32, P1959, DOI 10.1038/onc.2012.209; Couts KL, 2018, MOL CANCER THER, V17, P222, DOI 10.1158/1535-7163.MCT-17-0472; Feitelson MA, 2015, SEMIN CANCER BIOL, V35, pS25, DOI 10.1016/j.semcancer.2015.02.006; Fischer A, 2009, J BIOL CHEM, V284, P3183, DOI 10.1074/jbc.M804795200; Fouad YA, 2017, AM J CANCER RES, V7, P1016; Gautschi O, 2015, J THORAC ONCOL, V10, P1451, DOI 10.1097/JTO.0000000000000625; Germann UA, 2017, MOL CANCER THER, V16, P2351, DOI 10.1158/1535-7163.MCT-17-0456; Hennig A, 2016, CELL COMMUN SIGNAL, V14, DOI 10.1186/s12964-016-0128-z; Hutchinson KE, 2013, CLIN CANCER RES, V19, P6696, DOI 10.1158/1078-0432.CCR-13-1746; Jain P, 2017, ONCOTARGET, V8, P84697, DOI 10.18632/oncotarget.20949; Jiang WG, 2015, SEMIN CANCER BIOL, V35, pS244, DOI 10.1016/j.semcancer.2015.03.008; Kim HS, 2017, ONCOGENE, V36, P3334, DOI 10.1038/onc.2016.486; Klempner SJ, 2016, CANCER DISCOV, V6, P594, DOI 10.1158/2159-8290.CD-15-1192; Lavoie H, 2018, NATURE, V554, P549, DOI 10.1038/nature25478; Li E, 2012, BBA-BIOMEMBRANES, V1818, P183, DOI 10.1016/j.bbamem.2011.08.031; Linnekamp JF, 2015, CANCER RES, V75, P245, DOI 10.1158/0008-5472.CAN-14-2240; Lu HY, 2017, CANCER RES, V77, P3502, DOI 10.1158/0008-5472.CAN-16-2745; Mar VJ, 2015, BRIT J DERMATOL, V173, P76, DOI 10.1111/bjd.13756; McGranahan N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1408; Menzies AM, 2015, PIGM CELL MELANOMA R, V28, P607, DOI 10.1111/pcmr.12388; Ortore MG, 2015, BIOPHYS J, V108, P2896, DOI 10.1016/j.bpj.2015.05.015; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Ross JS, 2016, INT J CANCER, V138, P881, DOI 10.1002/ijc.29825; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scolnick JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128916; Sievert AJ, 2013, P NATL ACAD SCI USA, V110, P5957, DOI 10.1073/pnas.1219232110; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Tentler JJ, 2012, NAT REV CLIN ONCOL, V9, P338, DOI 10.1038/nrclinonc.2012.61; Turner J, 2017, PIGM CELL MELANOMA R, V30, P53, DOI 10.1111/pcmr.12560; UEKI K, 1994, J BIOL CHEM, V269, P15756; Villanueva J, 2013, CELL REP, V4, P1090, DOI 10.1016/j.celrep.2013.08.023; Wang L, 2017, J MOL DIAGN, V19, P387, DOI 10.1016/j.jmoldx.2016.11.005; Weiss RH, 1998, AM J PHYSIOL-CELL PH, V274, pC1521, DOI 10.1152/ajpcell.1998.274.6.C1521	40	21	21	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 21	2019	38	8					1296	1308		10.1038/s41388-018-0514-7	http://dx.doi.org/10.1038/s41388-018-0514-7			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HM1XR	30254212				2022-12-26	WOS:000459249800011
J	Wu, LW; Chen, WL; Huang, SM; Chan, JYH				Wu, Li-Wei; Chen, Wei-Liang; Huang, Shih-Ming; Chan, James Yi-Hsin			Platelet-derived growth factor-AA is a substantial factor in the ability of adipose-derived stem cells and endothelial progenitor cells to enhance wound healing	FASEB JOURNAL			English	Article						mesenchymal stem cells; PDGF; growth factor; nitric oxide; angiogenesis	NITRIC-OXIDE; SYNTHASE GENE; PIVOTAL ROLE; TISSUE; ANGIOGENESIS; EXPRESSION; ISCHEMIA; PDGF	Nonhealing wounds with various forms of complications have been a major challenge for patients with different diseases, and few data are available regarding the clinical significance of platelet-derived growth factor-AA (PDGF-AA) in the enhanced wound healing with stem cells, and the precise molecular mechanism remains unclear. The study aims to investigate the role of PDGF-AA in adipose-derived stem cells (ASCs) and endothelial progenitor cells (EPCs) enhancing wound healing. In this study, ASCs and EPCs were applied to treat wounds in an animal wound model with a wound-healing assay. We knocked down PDGF-AA expression in ASCs using the PDGF-AA short hairpin RNA technique and investigated the related molecular mechanism. The wound model and wound-healing assay of the study showed that transplantation of ASCs could enhance wound healing. The results showed that the PDGF-AA knockdown ASC group had much less improvement of wound healing than other groups treated with wild-type ASCs in wound tissues. The regulation of PDGF-AA in ASCs may contribute to improve wound healing through the PI3K/Akt/eNOS signaling pathway. The data indicated that PDGF-AA might play a vital role in ASCs and EPCs enhancing wound healing, possibly by its effects on angiogenesis. It would be a potential approach using PDGF-AA for clinical treatment of chronic wounds.Wu, L.-W., Chen, W.-L., Huang, S.-M., Chan, J. Y.-H. Platelet-derived growth factor AA is a substantial factor in the ability of adipose-derived stem cells and endothelial progenitor cells to enhance wound healing.	[Wu, Li-Wei; Chen, Wei-Liang; Huang, Shih-Ming; Chan, James Yi-Hsin] Natl Def Med Ctr, Grad Inst Med Sci, Taipei 114, Taiwan; [Wu, Li-Wei; Chen, Wei-Liang] Natl Def Med Ctr, Sch Med, Taipei, Taiwan; [Huang, Shih-Ming] Natl Def Med Ctr, Dept Biochem, Taipei, Taiwan; [Huang, Shih-Ming] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Chan, James Yi-Hsin] Natl Def Med Ctr, Dept Microbiol & Immunol, Taipei, Taiwan; [Wu, Li-Wei] Triserv Gen Hosp, Penghu Branch, Div Family Med, Taipei, Taiwan; [Wu, Li-Wei; Chen, Wei-Liang] Triserv Gen Hosp, Natl Def Med Ctr, Div Family Med, Taipei, Taiwan; [Wu, Li-Wei; Chen, Wei-Liang] Triserv Gen Hosp, Natl Def Med Ctr, Div Geriatr Med, Dept Family & Community Med, Taipei, Taiwan; [Wu, Li-Wei; Chan, James Yi-Hsin] Triserv Gen Hosp, Natl Def Med Ctr, Dept Med Res, Taipei, Taiwan	National Defense Medical Center; National Defense Medical Center; National Defense Medical Center; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital	Chan, JYH (corresponding author), Natl Def Med Ctr, Grad Inst Med Sci, Taipei 114, Taiwan.	bigmouth0825@gmail.com			Tri-Service General Hospital, National Defense Medical Center [TSGH-C106-153, TSGH-PH-106-3, TSGH-PH-107-4, TSGH-PH-108-13, MAB-106-039, MAB-107-043, MAB-108-069]	Tri-Service General Hospital, National Defense Medical Center	This study was supported, in part, by the following grants from the Tri-Service General Hospital, National Defense Medical Center: TSGH-C106-153, TSGH-PH-106-3, TSGH-PH-107-4, TSGH-PH-108-13, MAB-106-039, MAB-107-043, and MAB-108-069. The authors declare no conflicts of interest.	Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Bader AG, 2005, NAT REV CANCER, V5, P921, DOI 10.1038/nrc1753; Basile DP, 2014, J CELL PHYSIOL, V229, P10, DOI 10.1002/jcp.24423; Bauer V, 2010, GEN PHYSIOL BIOPHYS, V29, P319, DOI 10.4149/gpb_2010_04_319; Beer HD, 1997, J INVEST DERMATOL, V109, P132, DOI 10.1111/1523-1747.ep12319188; Bouletreau PJ, 2002, PLAST RECONSTR SURG, V110, P139, DOI 10.1097/00006534-200207000-00025; Bueno-Beti C, 2013, J CELL MOL MED, V17, P1475, DOI 10.1111/jcmm.12133; Chen WL, 2017, ONCOTARGET, V8, P54115, DOI 10.18632/oncotarget.11132; Cherubino M, 2011, ANN PLAS SURG, V66, P210, DOI 10.1097/SAP.0b013e3181e6d06c; Dai NT, 2015, ANN PLAS SURG, V74, pS139, DOI 10.1097/SAP.0000000000000453; Guo XB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04153-2; Ha JM, 2016, KOREAN J PHYSIOL PHA, V20, P533, DOI 10.4196/kjpp.2016.20.5.533; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Hollinger JO, 2008, J BONE JOINT SURG AM, V90A, P48, DOI 10.2106/JBJS.G.01231; Hong SJ, 2011, ACTA OTO-LARYNGOL, V131, P1198, DOI 10.3109/00016489.2011.599816; Horikawa S, 2015, SCI REP-UK, V5, DOI 10.1038/srep17948; Huang AF, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-115; Huang SP, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-51; Huang SP, 2012, ANN PLAS SURG, V69, P656, DOI 10.1097/SAP.0b013e318273f909; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Ishida Y, 2012, J CLIN INVEST, V122, P711, DOI 10.1172/JCI43027; Iwami Y, 2004, J CELL MOL MED, V8, P488, DOI 10.1111/j.1582-4934.2004.tb00473.x; Karar J, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00051; Katusic ZS, 2002, ARTERIOSCL THROM VAS, V22, P1254, DOI 10.1161/01.ATV.0000026860.08501.0F; Kawamoto A, 2001, CIRCULATION, V103, P634; Kim WS, 2007, J DERMATOL SCI, V48, P15, DOI 10.1016/j.jdermsci.2007.05.018; Kim WS, 2015, HISTOL HISTOPATHOL, V30, P793, DOI 10.14670/HH-11-598; Lee SH, 2012, ANN DERMATOL, V24, P136, DOI 10.5021/ad.2012.24.2.136; Lee SH, 2011, ANN DERMATOL, V23, P150, DOI 10.5021/ad.2011.23.2.150; Liu ZJ, 2008, ANTIOXID REDOX SIGN, V10, P1869, DOI 10.1089/ars.2008.2121; MacLauchlan S, 2011, P NATL ACAD SCI USA, V108, pE1137, DOI 10.1073/pnas.1104357108; Maeng YS, 2009, BLOOD, V113, P233, DOI 10.1182/blood-2008-06-162891; Namba T, 2003, CIRCULATION, V108, P2250, DOI 10.1161/01.CIR.0000093190.53478.78; Nishimura Y, 2012, J INVEST DERMATOL, V132, P711, DOI 10.1038/jid.2011.356; Schaffler A, 2007, STEM CELLS, V25, P818, DOI 10.1634/stemcells.2006-0589; Song SH, 2012, J DERMATOL SCI, V66, P98, DOI 10.1016/j.jdermsci.2012.02.010; Wilson A, 2011, CELL PROLIFERAT, V44, P86, DOI 10.1111/j.1365-2184.2010.00736.x; Yoder MC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006692; Zhang ZG, 2002, CIRC RES, V90, P284, DOI 10.1161/hh0302.104460; Zhou KH, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002202; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	42	26	28	1	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2388	2395		10.1096/fj.201800658R	http://dx.doi.org/10.1096/fj.201800658R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30265575				2022-12-26	WOS:000457296600068
J	Byrd, AK; Bell, MR; Raney, KD				Byrd, Alicia K.; Bell, Matthew R.; Raney, Kevin D.			Pif1 helicase unfolding of G-quadruplex DNA is highly dependent on sequence and reaction conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA helicase; G-quadruplex; DNA-protein interaction; enzyme mechanism; enzyme kinetics; pre-steady-state kinetics; DNA unwinding; Pif1; secondary structure	C-MYC PROMOTER; SACCHAROMYCES-CEREVISIAE PIF1; ESCHERICHIA-COLI UVRD; SINGLE-STRANDED-DNA; HUMAN TELOMERIC DNA; TRANSFER-RNA GENES; DUPLEX DNA; STEP-SIZE; GENOME INSTABILITY; CRYSTAL-STRUCTURES	In addition to unwinding double-stranded nucleic acids, helicase activity can also unfold noncanonical structures such as G-quadruplexes. We previously characterized Pif1 helicase catalyzed unfolding of parallel G-quadruplex DNA. Here we characterized unfolding of the telomeric G-quadruplex, which can fold into antiparallel and mixed hybrid structures and found significant differences. Telomeric DNA sequences are unfolded more readily than the parallel quadruplex formed by the c-MYC promoter in K+. Furthermore, we found that under conditions in which the telomeric quadruplex is less stable, such as in Na+, Pif1 traps thermally melted quadruplexes in the absence of ATP, leading to the appearance of increased product formation under conditions in which the enzyme is preincubated with the substrate. Stable telomeric G-quadruplex structures were unfolded in a stepwise manner at a rate slower than that of duplex DNA unwinding; however, the slower dissociation from G-quadruplexes compared with duplexes allowed the helicase to traverse more nucleotides than on duplexes. Consistent with this, the rate of ATP hydrolysis on the telomeric quadruplex DNA was reduced relative to that on single-stranded DNA (ssDNA), but less quadruplex DNA was needed to saturate ATPase activity. Under single-cycle conditions, telomeric quadruplex was unfolded by Pif1, but for the c-MYC quadruplex, unfolding required multiple helicase molecules loaded onto the adjacent ssDNA. Our findings illustrate that Pif1-catalyzed unfolding of G-quadruplex DNA is highly dependent on the specific sequence and the conditions of the reaction, including both the monovalent cation and the order of addition.	[Byrd, Alicia K.; Bell, Matthew R.; Raney, Kevin D.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Raney, KD (corresponding author), Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA.	raneykevind@uams.edu		Bell, Matthew/0000-0003-4313-2989; Byrd, Alicia/0000-0001-5484-0759	National Institutes of Health, NIGMS [R35GM122601]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM122601] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Grant R35GM122601 (to K. D. R.) from the National Institutes of Health, NIGMS. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ail JA, 1999, J MOL BIOL, V293, P815, DOI 10.1006/jmbi.1999.3185; Ali JA, 1997, SCIENCE, V275, P377, DOI 10.1126/science.275.5298.377; Ambrus A, 2005, BIOCHEMISTRY-US, V44, P2048, DOI 10.1021/bi048242p; Ambrus A, 2006, NUCLEIC ACIDS RES, V34, P2723, DOI 10.1093/nar/gkl348; Barranco-Medina S, 2010, BIOCHEMISTRY-US, V49, P8445, DOI 10.1021/bi100984j; Bharti SK, 2014, J BIOL CHEM, V289, P29975, DOI 10.1074/jbc.M114.567073; Biffi G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102711; Biffi G, 2014, NAT CHEM, V6, P75, DOI [10.1038/NCHEM.1805, 10.1038/nchem.1805]; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Brazda V, 2014, INT J MOL SCI, V15, P17493, DOI 10.3390/ijms151017493; Budd ME, 2006, MOL CELL BIOL, V26, P2490, DOI 10.1128/MCB.26.7.2490-2500.2006; Byrd AK, 2005, BIOCHEMISTRY-US, V44, P12990, DOI 10.1021/bi050703z; Byrd AK, 2004, NAT STRUCT MOL BIOL, V11, P531, DOI 10.1038/nsmb774; Byrd AK, 2006, NUCLEIC ACIDS RES, V34, P3020, DOI 10.1093/nar/gkl369; Byrd AK, 2017, BIOCHEM SOC T, V45, P1159, DOI 10.1042/BST20170096; Byrd AK, 2015, J BIOL CHEM, V290, P6482, DOI 10.1074/jbc.M114.630749; Carroll SS, 1996, METHOD ENZYMOL, V275, P365; Chen MC, 2018, NATURE, V558, P465, DOI 10.1038/s41586-018-0209-9; Chen WF, 2016, NUCLEIC ACIDS RES, V44, P2949, DOI 10.1093/nar/gkw033; Chib S, 2016, J BIOL CHEM, V291, P5889, DOI 10.1074/jbc.M115.688648; Dewar JM, 2010, EMBO J, V29, P4020, DOI 10.1038/emboj.2010.267; Dillingham MS, 2000, BIOCHEMISTRY-US, V39, P205, DOI 10.1021/bi992105o; Dong DW, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-677; Duan XL, 2015, J BIOL CHEM, V290, P7722, DOI 10.1074/jbc.M114.628008; Eddy J, 2006, NUCLEIC ACIDS RES, V34, P3887, DOI 10.1093/nar/gkl529; Eoff RL, 2006, NAT STRUCT MOL BIOL, V13, P242, DOI 10.1038/nsmb1055; Eoff RL, 2010, BIOCHEMISTRY-US, V49, P4543, DOI 10.1021/bi100061v; FOURY F, 1985, EMBO J, V4, P3525, DOI 10.1002/j.1460-2075.1985.tb04112.x; Fry M, 1999, J BIOL CHEM, V274, P12797, DOI 10.1074/jbc.274.18.12797; Geronimo CL, 2016, DNA REPAIR, V44, P151, DOI 10.1016/j.dnarep.2016.05.021; Gray RD, 2014, J MOL BIOL, V426, P1629, DOI 10.1016/j.jmb.2014.01.009; Green JJ, 2003, J AM CHEM SOC, V125, P3763, DOI 10.1021/ja029149w; Guo MH, 2015, J BIOL CHEM, V290, P5174, DOI 10.1074/jbc.M114.634923; Hansel-Hertsch R, 2017, NAT REV MOL CELL BIO, V18, P279, DOI 10.1038/nrm.2017.3; Hatzakis E, 2010, BIOCHEMISTRY-US, V49, P9152, DOI 10.1021/bi100946g; Hou XM, 2015, BIOCHEM J, V466, P189, DOI 10.1042/BJ20140997; Huang WC, 2015, NUCLEIC ACIDS RES, V43, P10102, DOI 10.1093/nar/gkv1061; Jain A, 2010, BIOCHEMISTRY-US, V49, P6992, DOI 10.1021/bi100795m; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Kim BG, 2015, BIOCHEMISTRY-US, V54, P3420, DOI 10.1021/acs.biochem.5b00097; LAHAYE A, 1993, J BIOL CHEM, V268, P26155; Lam EYN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2792; Lemmens B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9909; Levin MK, 2004, J BIOL CHEM, V279, P26005, DOI 10.1074/jbc.M403257200; Li JR, 2016, BIOCHEM BIOPH RES CO, V473, P1235, DOI 10.1016/j.bbrc.2016.04.046; London TBC, 2008, J BIOL CHEM, V283, P36132, DOI 10.1074/jbc.M808152200; Long X, 2013, NUCLEIC ACIDS RES, V41, P2746, DOI 10.1093/nar/gks1341; Lu KY, 2018, NUCLEIC ACIDS RES, V46, P1486, DOI 10.1093/nar/gkx1217; Lucius AL, 2003, BIOPHYS J, V85, P2224, DOI 10.1016/S0006-3495(03)74648-7; Lucius AL, 2002, J MOL BIOL, V324, P409, DOI 10.1016/S0022-2836(02)01067-7; Maizels N, 2015, EMBO REP, V16, P910, DOI 10.15252/embr.201540607; Manosas M, 2010, NUCLEIC ACIDS RES, V38, P5518, DOI 10.1093/nar/gkq273; Marchand A, 2016, NUCLEIC ACIDS RES, V44, P10999, DOI 10.1093/nar/gkw970; Mendoza O, 2016, NUCLEIC ACIDS RES, V44, P1989, DOI 10.1093/nar/gkw079; Mendoza O, 2015, NUCLEIC ACIDS RES, V43, pE71, DOI 10.1093/nar/gkv193; Neidle S, 2016, J MED CHEM, V59, P5987, DOI 10.1021/acs.jmedchem.5b01835; Oliveira PH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059907; Osmundson JS, 2017, NAT STRUCT MOL BIOL, V24, P162, DOI 10.1038/nsmb.3342; Paeschke K, 2013, NATURE, V497, P458, DOI 10.1038/nature12149; Paeschke K, 2011, CELL, V145, P678, DOI 10.1016/j.cell.2011.04.015; Phan AT, 2006, NUCLEIC ACIDS RES, V34, P5715, DOI 10.1093/nar/gkl726; Tran PLT, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15025; Qureshi MH, 2012, J PHYS CHEM B, V116, P5588, DOI 10.1021/jp300546u; Rad B, 2015, P NATL ACAD SCI USA, V112, pE6852, DOI 10.1073/pnas.1518028112; Ramanagoudr-Bhojappa R, 2013, J BIOL CHEM, V288, P16185, DOI 10.1074/jbc.M113.470013; Rhodes D, 2015, NUCLEIC ACIDS RES, V43, P8627, DOI 10.1093/nar/gkv862; Ribeyre C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000475; Rodriguez R, 2012, NAT CHEM BIOL, V8, P301, DOI [10.1038/nchembio.780, 10.1038/NCHEMBIO.780]; Saini N, 2013, NATURE, V502, P389, DOI 10.1038/nature12584; Sarkies P, 2012, NUCLEIC ACIDS RES, V40, P1485, DOI 10.1093/nar/gkr868; Sarkies P, 2010, MOL CELL, V40, P703, DOI 10.1016/j.molcel.2010.11.009; Sauer M, 2017, BIOCHEM SOC T, V45, P1173, DOI 10.1042/BST20170097; SCHULZ VP, 1994, CELL, V76, P145, DOI 10.1016/0092-8674(94)90179-1; Seenisamy J, 2004, J AM CHEM SOC, V126, P8702, DOI 10.1021/ja040022b; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Singh SP, 2016, J MOL BIOL, V428, P1053, DOI 10.1016/j.jmb.2016.02.017; Sun H, 1998, J BIOL CHEM, V273, P27587, DOI 10.1074/jbc.273.42.27587; THIER SO, 1986, AM J MED, V80, P3, DOI 10.1016/0002-9343(86)90334-7; TSANEVA IR, 1993, P NATL ACAD SCI USA, V90, P1315, DOI 10.1073/pnas.90.4.1315; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Wanrooij PH, 2012, NUCLEIC ACIDS RES, V40, P10334, DOI 10.1093/nar/gks802; WHITBY MC, 1993, CELL, V75, P341, DOI 10.1016/0092-8674(93)80075-P; Wilson MA, 2013, NATURE, V502, P393, DOI 10.1038/nature12585; Wlodarczyk A, 2005, J PHYS CHEM B, V109, P3594, DOI 10.1021/jp045274d; Wu YL, 2008, MOL CELL BIOL, V28, P4116, DOI 10.1128/MCB.02210-07; Yangyuoru PM, 2018, J BIOL CHEM, V293, P1924, DOI 10.1074/jbc.M117.815076; Zhang B, 2016, NUCLEIC ACIDS RES, V44, P8385, DOI 10.1093/nar/gkw669; Zhou RB, 2014, ELIFE, V3, DOI 10.7554/eLife.02190	88	25	25	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2018	293	46					17792	17802		10.1074/jbc.RA118.004499	http://dx.doi.org/10.1074/jbc.RA118.004499			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HA6SG	30257865	Green Published, hybrid			2022-12-26	WOS:000450409500011
J	Xiao, YM; Li, MM; Larocque, R; Zhang, FM; Malhotra, A; Chen, JL; Linhardt, RJ; Konermann, L; Xu, D				Xiao, Yiming; Li, Miaomiao; Larocque, Rinzhi; Zhang, Fuming; Malhotra, Anju; Chen, Jianle; Linhardt, Robert J.; Konermann, Lars; Xu, Ding			Dimerization interface of osteoprotegerin revealed by hydrogen-deuterium exchange mass spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						heparin-binding protein; heparan sulfate; dimerization; hydrogen-deuterium exchange; hydrogen exchange mass spectrometry; bone loss; osteoclastogenesis; osteoporosis; osteoprotegerin; RANKL	HYDROGEN/DEUTERIUM EXCHANGE; HEPARAN-SULFATE; PROTEIN INTERACTIONS; CRYSTAL-STRUCTURE; DECOY RECEPTOR; OSTEOCLASTOGENESIS; DYNAMICS; REDUCTION; BINDING; MS	Previous structural studies of osteoprotegerin (OPG), a crucial negative regulator of bone remodeling and osteoclastogenesis, were mostly limited to the N-terminal ligand-binding domains. It is now known that the three C-terminal domains of OPG also play essential roles in its function by mediating OPG dimerization, OPG-heparan sulfate (HS) interactions, and formation of the OPG-HS-receptor activator of nuclear factor B ligand (RANKL) ternary complex. Employing hydrogen-deuterium exchange MS methods, here we investigated the structure of full-length OPG in complex with HS or RANKL in solution. Our data revealed two noteworthy aspects of the OPG structure. First, we found that the interconnection between the N- and C-terminal domains is much more rigid than previously thought, possibly because of hydrophobic interactions between the fourth cysteine-rich domain and the first death domain. Second, we observed that two hydrophobic clusters located in two separate C-terminal domains directly contribute to OPG dimerization, likely by forming a hydrophobic dimerization interface. Aided by site-directed mutagenesis, we further demonstrated that an intact dimerization interface is essential for the biological activity of OPG. Our study represents an important step toward deciphering the structure-function relationship of the full-length OPG protein.	[Xiao, Yiming; Konermann, Lars] Univ Western Ontario, Dept Chem, London, ON N6A 5B7, Canada; [Li, Miaomiao; Larocque, Rinzhi; Xu, Ding] SUNY Buffalo, Dept Oral Biol, Buffalo, NY 14214 USA; [Zhang, Fuming; Malhotra, Anju; Chen, Jianle; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Chem & Biol Engn, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA	Western University (University of Western Ontario); State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Rensselaer Polytechnic Institute	Konermann, L (corresponding author), Univ Western Ontario, Dept Chem, London, ON N6A 5B7, Canada.; Xu, D (corresponding author), SUNY Buffalo, Dept Oral Biol, Buffalo, NY 14214 USA.	konerman@uwo.ca; dingxu@buffalo.edu		Li, Miaomiao/0000-0003-4508-196X	National Institutes of Health NIAMS [AR070179]; National Institutes of Health NIDDK [DK111958]; National Institutes of Health NHLBI [HL125371, HL094463]; Canadian Network for Research and Innovation in Machining Technology, Natural Sciences and Engineering Research Council of Canada (CANRIMT, NSERC) [RGPIN-2018-04243]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125371, R01HL094463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR070179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK111958] Funding Source: NIH RePORTER	National Institutes of Health NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Canadian Network for Research and Innovation in Machining Technology, Natural Sciences and Engineering Research Council of Canada (CANRIMT, NSERC); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health NIAMS Grant AR070179, NIDDK Grant DK111958, and NHLBI Grants HL125371 and HL094463 and Canadian Network for Research and Innovation in Machining Technology, Natural Sciences and Engineering Research Council of Canada (CANRIMT, NSERC) Grant RGPIN-2018-04243. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson JS, 2008, BIOCHEMISTRY-US, V47, P6178, DOI 10.1021/bi800284y; Baud'huin M, 2011, EUR J CELL BIOL, V90, P49, DOI 10.1016/j.ejcb.2010.08.001; Bobst CE, 2009, J MOL BIOL, V388, P954, DOI 10.1016/j.jmb.2009.03.044; Burke JE, 2009, J AM CHEM SOC, V131, P8083, DOI 10.1021/ja900098y; Creighton T. E., 1993, PROTEINS STRUCTURES; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; Hernaiz M, 2000, BIOCHEM BIOPH RES CO, V276, P292, DOI 10.1006/bbrc.2000.3453; Hui X, 2005, PROTEIN SCI, V14, P543, DOI 10.1110/ps.0411001705; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Konermann L, 2011, CHEM SOC REV, V40, P1224, DOI 10.1039/c0cs00113a; Li MM, 2016, J BIOL CHEM, V291, P24160, DOI 10.1074/jbc.M116.751974; Luan XD, 2012, J IMMUNOL, V189, P245, DOI 10.4049/jimmunol.1103387; Maaty WS, 2016, J AM CHEM SOC, V138, P1335, DOI 10.1021/jacs.5b11742; Marciano DP, 2014, CURR OPIN STRUC BIOL, V28, P105, DOI 10.1016/j.sbi.2014.08.007; Nelson CA, 2012, STRUCTURE, V20, P1971, DOI 10.1016/j.str.2012.08.030; Nozawa S, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.89624; Pantazatos D, 2004, P NATL ACAD SCI USA, V101, P751, DOI 10.1073/pnas.0307204101; Percy AJ, 2012, ANAL CHIM ACTA, V721, P7, DOI 10.1016/j.aca.2012.01.037; Rand KD, 2014, ACCOUNTS CHEM RES, V47, P3018, DOI 10.1021/ar500194w; Schneeweis LA, 2005, J BIOL CHEM, V280, P41155, DOI 10.1074/jbc.M506366200; Shaw BF, 2010, J AM CHEM SOC, V132, P17411, DOI 10.1021/ja9067035; Shukla AK, 2014, NATURE, V512, P218, DOI 10.1038/nature13430; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Skinner JJ, 2012, PROTEIN SCI, V21, P996, DOI 10.1002/pro.2081; Sowole MA, 2013, J MOL BIOL, V425, P4508, DOI 10.1016/j.jmb.2013.08.005; Taylor Sarah E B, 2014, Bonekey Rep, V3, P585, DOI 10.1038/bonekey.2014.80; Trabjerg E, 2015, ANAL CHEM, V87, P8880, DOI 10.1021/acs.analchem.5b01996; Tsuda E, 1997, BIOCHEM BIOPH RES CO, V234, P137, DOI 10.1006/bbrc.1997.6603; Udagawa N, 2000, ENDOCRINOLOGY, V141, P3478, DOI 10.1210/en.141.9.3478; Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064; Wongkongkathep P, 2015, INT J MASS SPECTROM, V390, P137, DOI 10.1016/j.ijms.2015.07.008; Xu D, 2014, ANNU REV BIOCHEM, V83, P129, DOI 10.1146/annurev-biochem-060713-035314; Xu D, 2013, ACS CHEM BIOL, V8, P1611, DOI 10.1021/cb4001553; Xue Y, 2011, P NATL ACAD SCI USA, V108, P16229, DOI 10.1073/pnas.1103407108; Yamaguchi K, 1998, J BIOL CHEM, V273, P5117, DOI 10.1074/jbc.273.9.5117; Zhang HM, 2010, ANAL CHEM, V82, P1450, DOI 10.1021/ac902550n; Zhang J, 2015, INT J MASS SPECTROM, V377, P546, DOI 10.1016/j.ijms.2014.07.047; Zhao DS, 2013, PROTEOMICS, V13, P3256, DOI 10.1002/pmic.201300242	38	6	6	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2018	293	45					17523	17535		10.1074/jbc.RA118.004489	http://dx.doi.org/10.1074/jbc.RA118.004489			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ9EI	30254073	Green Published, hybrid			2022-12-26	WOS:000449799000017
J	Manzouri, A; Savic, I				Manzouri, Amirhossein; Savic, Ivanka			Multimodal MRI suggests that male homosexuality may be linked to cerebral midline structures	PLOS ONE			English	Article								The neurobiology of sexual preference is often discussed in terms of cerebral sex dimorphism. Yet, our knowledge about possible cerebral differences between homosexual men (HoM), heterosexual men (HeM) and heterosexual women (HeW) are extremely limited. In the present MRI study, we addressed this issue investigating measures of cerebral anatomy and function, which were previously reported to show sex difference. Specifically, we asked whether there were any signs of sex atypical cerebral dimorphism among HoM, if these were widely distributed (providing substrate for more general 'female' behavioral characteristics among HoM), or restricted to networks involved in self-referential sexual arousal. Cortical thickness (Cth), surface area (SA), subcortical structural volumes, and resting state functional connectivity were compared between 30 (HoM), 35 (HeM) and 38 (HeW). HoM displayed a significantly thicker anterior cingulate cortex (ACC), precuneus, and the left occipito-temporal cortex compared to both control groups. These differences seemed coordinated, since HoM also displayed stronger cortico-cortical covariations between these regions. Furthermore, functional connections within the default mode network, which mediates self- referential processing, and includes the ACC and precuneus were significantly weaker in HoM than HeM and HeW, whereas their functional connectivity between the thalamus and hypothalamus (important nodes for sexual behavior) was stronger. In addition to these singular features, HoM displayed 'female' characteristics, with a similar Cth in the left superior parietal and cuneus cortices as HeW, but different from HeM. These data suggest both singular and sex atypical features and motivate further investigations of cerebral midline structures in relation to male homosexuality.	[Manzouri, Amirhossein; Savic, Ivanka] Karolinska Inst & Hosp, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Manzouri, Amirhossein; Savic, Ivanka] Karolinska Inst & Hosp, Neurol Clin, Stockholm, Sweden; [Manzouri, Amirhossein] Stockholm Univ, Dept Psychol, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Stockholm University	Savic, I (corresponding author), Karolinska Inst & Hosp, Dept Womens & Childrens Hlth, Stockholm, Sweden.; Savic, I (corresponding author), Karolinska Inst & Hosp, Neurol Clin, Stockholm, Sweden.	ivanka.savic-berglund@ki.se		Savic, Ivanka/0000-0003-4275-0689	Swedish Science Council [2007-3107]; Stockholm Brain Institute; FORTE; AFA	Swedish Science Council; Stockholm Brain Institute; FORTE(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); AFA	This work was supported by the Swedish Science Council (I.S Dnr 2007-3107); Stockholm Brain Institute (I.S.); FORTE (I.S. and A.M.); AFA (I.S.); The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114721; ALLEN LS, 1991, J COMP NEUROL, V312, P97, DOI 10.1002/cne.903120108; Bellec P, 2006, NEUROIMAGE, V29, P1231, DOI 10.1016/j.neuroimage.2005.08.044; Berglund H, 2008, CEREB CORTEX, V18, P1900, DOI 10.1093/cercor/bhm216; Berglund H, 2006, P NATL ACAD SCI USA, V103, P8269, DOI 10.1073/pnas.0600331103; Bramen JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033850; Buckner RL, 2007, NEUROIMAGE, V37, P1091, DOI 10.1016/j.neuroimage.2007.01.010; Burrows CA, 2016, DEVELOPMENTAL SCI, V19, P564, DOI 10.1111/desc.12400; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Doyle-Thomas KAR, 2013, RES AUTISM SPECT DIS, V7, P141, DOI 10.1016/j.rasd.2012.08.004; Feusner JD, 2017, BRAIN IMAGING BEHAV, V11, P964, DOI 10.1007/s11682-016-9578-6; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Golkar A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104550; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Griffanti L, 2017, NEUROIMAGE, V154, P188, DOI 10.1016/j.neuroimage.2016.12.036; Habas C, 2009, J NEUROSCI, V29, P8586, DOI 10.1523/JNEUROSCI.1868-09.2009; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; Herting MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119774; Hu SH, 2008, AM J NEURORADIOL, V29, P1890, DOI 10.3174/ajnr.A1260; Hu SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059426; Jovanovic H, 2011, NEUROIMAGE, V55, P1178, DOI 10.1016/j.neuroimage.2010.12.060; Kelly RE, 2010, J NEUROSCI METH, V189, P233, DOI 10.1016/j.jneumeth.2010.03.028; Kim SW, 2006, INT J IMPOT RES, V18, P452, DOI 10.1038/sj.ijir.3901449; Kinsey AC, 1948, SEXUAL BEHAV HUMAN M, DOI [10.2105/AJPH.93.6.894, DOI 10.2105/AJPH.93.6.894]; Koolschijn PCMP, 2013, DEV COGN NEUROS-NETH, V5, P106, DOI 10.1016/j.dcn.2013.02.003; Lentini E, 2013, CEREB CORTEX, V23, P2322, DOI 10.1093/cercor/bhs222; LEVAY S, 1991, SCIENCE, V253, P1034, DOI 10.1126/science.1887219; Liem F, 2015, NEUROIMAGE, V108, P95, DOI 10.1016/j.neuroimage.2014.12.035; Luders E, 2006, HUM BRAIN MAPP, V27, P314, DOI 10.1002/hbm.20187; Lv B, 2010, NEUROIMAGE, V53, P373, DOI 10.1016/j.neuroimage.2010.05.020; Manzouri A, 2017, CEREB CORTEX, V27, P998, DOI 10.1093/cercor/bhv278; Metzler-Baddeley C, 2016, NEUROIMAGE, V130, P48, DOI 10.1016/j.neuroimage.2016.01.007; Motofei IG, 2014, BJU INT, V113, P296, DOI 10.1111/bju.12399; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Nopoulos P, 2000, PSYCHIAT RES-NEUROIM, V98, P1, DOI 10.1016/S0925-4927(99)00044-X; Northoff G, 2011, TRENDS COGN SCI, V15, P186, DOI 10.1016/j.tics.2011.03.001; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Panizzon MS, 2009, CEREB CORTEX, V19, P2728, DOI 10.1093/cercor/bhp026; Paul T, 2008, HUM BRAIN MAPP, V29, P726, DOI 10.1002/hbm.20435; Paus T, 2010, PROG BRAIN RES, V186, P13, DOI 10.1016/B978-0-444-53630-3.00002-6; Pletzer B, 2010, BRAIN RES, V1348, P55, DOI 10.1016/j.brainres.2010.06.019; Poeppl TB, 2016, FRONT NEUROENDOCRIN, V43, P28, DOI 10.1016/j.yfrne.2016.10.001; Ponseti J, 2006, NEUROIMAGE, V33, P825, DOI 10.1016/j.neuroimage.2006.08.002; Pruim RHR, 2015, NEUROIMAGE, V112, P267, DOI 10.1016/j.neuroimage.2015.02.064; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Raz N, 2004, NEUROBIOL AGING, V25, P377, DOI 10.1016/S0197-4580(03)00118-0; Raznahan A, 2010, P NATL ACAD SCI USA, V107, P16988, DOI 10.1073/pnas.1006025107; Safron A, 2007, BEHAV NEUROSCI, V121, P237, DOI 10.1037/0735-7044.121.2.237; Savic I, 2018, CEREB CORTEX, V28, P894, DOI 10.1093/cercor/bhw413; Savic I, 2014, CEREB CORTEX, V24, P3246, DOI 10.1093/cercor/bht180; Savic I, 2005, P NATL ACAD SCI USA, V102, P7356, DOI 10.1073/pnas.0407998102; Savic I, 2008, P NATL ACAD SCI USA, V105, P9403, DOI 10.1073/pnas.0801566105; Savic I, 2017, HUM BRAIN MAPP, V38, P1801, DOI 10.1002/hbm.23483; Savic I, 2015, CEREB CORTEX, V25, P1554, DOI 10.1093/cercor/bht348; Savic I, 2011, CEREB CORTEX, V21, P2525, DOI 10.1093/cercor/bhr032; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sowell ER, 2007, CEREB CORTEX, V17, P1550, DOI 10.1093/cercor/bhl066; Sylva D, 2013, HORM BEHAV, V64, P673, DOI 10.1016/j.yhbeh.2013.08.003; Nguyen TV, 2013, CEREB CORTEX, V23, P1424, DOI 10.1093/cercor/bhs125; Verhagen L., 2006, NEUROIMAGE, V31, pS45; Winkler AM, 2010, NEUROIMAGE, V53, P1135, DOI 10.1016/j.neuroimage.2009.12.028; Witelson SF, 2008, ARCH SEX BEHAV, V37, P857, DOI 10.1007/s10508-007-9276-y; Zhou W, 2014, CURR BIOL, V24, P1091, DOI 10.1016/j.cub.2014.03.035	67	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0203189	10.1371/journal.pone.0203189	http://dx.doi.org/10.1371/journal.pone.0203189			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV3QJ	30278046	Green Published, Green Submitted, gold			2022-12-26	WOS:000446010200004
J	Sasaki, N; Sato, S; Yamaguchi, S; Shimodaira, M; Kawakami, N				Sasaki, Natsuki; Sato, Sayaka; Yamaguchi, Sosei; Shimodaira, Michiyo; Kawakami, Norito			Development of a scale to assess motivation for competitive employment among persons with severe mental illness	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; NEGATIVE SYNDROME SCALE; SUPPORTED EMPLOYMENT; INDIVIDUAL PLACEMENT; INTRINSIC MOTIVATION; PEOPLE; SCHIZOPHRENIA; DISORDERS; EXPERIENCES; PREDICTORS	Background The employment rate among people with severe mental illness has recently increased, though it is still low. The motivation to work appears to be an important role as an intermediate outcome measure in vocational rehabilitation programs. In addition, measuring the work motivation for people with severe mental illness appears to be essential to identify candidates who are likely to benefit and monitor candidates' motivation in a supported employment program. This study aimed to develop a new measure for assessing both intrinsic and extrinsic motivation to work among people with severe mental illness, as there are currently no well-established instruments of this kind. Methods A focus group interview and review of previous qualitative research were used to identify possible items for inclusion in the new scale. A provisional scale was constructed and further refined for content and format based on feedback from a researcher and also three peer workers with severe mental illness. The resulting provisional 38-item version of the scale was completed by 136 respondents with severe mental illness, and we performed exploratory factor analysis to identify latent constructs within the new measure. The finalized scale was analyzed for test-retest reliability, internal consistency, and convergent validity. Result An exploratory factor analysis yielded a four-factor scale with 23 items. The finalized 23 items had high internal consistency (Cronbach's alpha = 0.91) and relatively high test-retest reliability (ICC = 0.83). The four subscales had fair internal consistency (Cronbach's alpha >= 0.69) and good test-retest reliability (ICC >= 0.61). Convergent validity was weakly supported by the significant positive correlations with the overall question on motivation to work (r >= 0.19, p < 0.01). Besides these correlations, only the "Pressure from others" subscale was negatively and significantly correlated with the negative symptoms evaluated using the Positive and Negative Syndrome Scale (r = -0.18, p = 0.04). Conclusions This study used factor analysis to develop a new multidimensional scale assessing motivation for competitive employment among persons with severe mental illness. The scale showed acceptable levels of reliability and factor-based and convergent validity. The new measure can be used for measuring the motivation for competitive employment among people with severe mental illness, and it would be useful to identify candidates who are likely to benefit from a certain supported employment program, and to monitor interim progress of the state of participants' motivation in a program.	[Sasaki, Natsuki; Sato, Sayaka; Yamaguchi, Sosei] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Community Mental Hlth & Law, Kodaira, Tokyo, Japan; [Shimodaira, Michiyo; Kawakami, Norito] Univ Tokyo, Grad Sch Med, Dept Mental Hlth, Tokyo, Japan	National Center for Neurology & Psychiatry - Japan; University of Tokyo	Sasaki, N (corresponding author), Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Community Mental Hlth & Law, Kodaira, Tokyo, Japan.	natsuki.sasaki2018@gmail.com	Yamaguchi, Sosei/T-9439-2019	Yamaguchi, Sosei/0000-0002-0579-4431; Sasaki, Natsuki/0000-0001-8813-1432	Ministry of Health, Labour and Welfare in Japan - Policy research for improving the quality of community life of people with mental disorders [H28-001, H26-002]; Japan Society for the Promotion of Science KAKENHI [25871175]	Ministry of Health, Labour and Welfare in Japan - Policy research for improving the quality of community life of people with mental disorders; Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by 1. Ministry of Health, Labour and Welfare in Japan - Policy research for improving the quality of community life of people with mental disorders [no. H28-001] (S.S received the funding); - A study on facilitating employment for people with mental illness [no. H26-002] (S.Y received the funding), URL: https://mhlw-grants.niph.go.jp/; 2. Japan Society for the Promotion of Science KAKENHI Grant-in-Aid for Young Scientists [B]: Development of assessment tools and collecting of fundamental data which would be helpful for vocational services to support people with severe mental illness in community settings [no. 25871175] (S.S received the funding), URL: https://kaken.nii.ac.jp/ja/grant/KAKENHI-PROJECT-25871175/.	[Anonymous], 2016, ZENK ZAIT SHOUG SHA; [Anonymous], 2017, SYOG NO SYUG JYOK TO; [Anonymous], 2013, LAB FORC SURV JAP; [Anonymous], 2016, COMPREHENSIVE SUPPOR; Areberg C, 2013, SCAND J OCCUP THER, V20, P420, DOI 10.3109/11038128.2013.765911; Asahi M, 2009, THOUGHTS USERS STAFF; Auerbach ES, 2005, PSYCHIATR REHABIL J, V28, P267, DOI 10.2975/28.2005.267.273; Bedell JR, 1998, PSYCHIATR REHABIL J, V21, P279, DOI 10.1037/h0095301; Bejerholm U, 2017, J AFFECT DISORDERS, V207, P212, DOI 10.1016/j.jad.2016.08.028; Bond GR, 2012, WORLD PSYCHIATRY, V11, P32, DOI 10.1016/j.wpsyc.2012.01.005; Braveman B, 2005, WORKER ROLE INTERVIE; Burns JK, 2008, SOC PSYCH PSYCH EPID, V43, P331, DOI 10.1007/s00127-008-0308-2; Choi J, 2010, SCHIZOPHRENIA BULL, V36, P966, DOI 10.1093/schbul/sbp030; Choi KH, 2013, J NERV MENT DIS, V201, P173, DOI 10.1097/NMD.0b013e3182848bd4; Corson TR, 2017, IMPACT PERCEIVED MEN; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Crowther R, 2001, Cochrane Database Syst Rev, pCD003080, DOI 10.1002/14651858.CD003080; Davidson M, 2016, SCHIZOPHRENIA BULL, V42, P443, DOI 10.1093/schbul/sbv023; Drake RE, 2008, PSYCHIATR REHABIL J, V31, P367, DOI 10.2975/31.4.2008.367.376; Dunn EC, 2008, PSYCHIATR REHABIL J, V32, P59, DOI 10.2975/32.1.2008.59.62; Dunn EC, 2010, AM J ORTHOPSYCHIAT, V80, P185, DOI 10.1111/j.1939-0025.2010.01022.x; Fukuhara S., 2004, MANUAL SF 8 JAPANESE; HEINRICHS DW, 1984, SCHIZOPHRENIA BULL, V10, P388, DOI 10.1093/schbul/10.3.388; Howard LM, 2010, BRIT J PSYCHIAT, V196, P404, DOI 10.1192/bjp.bp.108.061465; Igarashi Y, 1998, PSYCHIAT CLIN NEUROS, V52, P467, DOI 10.1046/j.1440-1819.1998.00425.x; Japanese Ministry of Health LaW, 2013, SURV EMPL STAT PERS; Kageyama M, 2016, ARCH PSYCHIAT NURS, V30, P614, DOI 10.1016/j.apnu.2016.02.003; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kinoshita Y, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008297.pub2; Knaeps J, 2015, J MENT HEALTH, V24, P196, DOI 10.3109/09638237.2015.1036972; McQuilken M., 2003, J VOCAT REHABIL, V18, P59; Metcalfe JD, 2018, SCHIZOPHRENIA BULL, V44, P22, DOI 10.1093/schbul/sbx132; Metcalfe JD, 2017, ADM POLICY MENT HLTH, V44, P345, DOI 10.1007/s10488-016-0774-x; Nakatogawa S, 2009, JAPAN ACAD PSYCHIAT, V18, P70; Oshima I, 2014, PSYCHIATR REHABIL J, V37, P137, DOI 10.1037/prj0000085; Reddy LF, 2016, SCHIZOPHR RES, V176, P462, DOI 10.1016/j.schres.2016.08.006; Salkever DS, 2007, PSYCHIAT SERV, V58, P315, DOI 10.1176/appi.ps.58.3.315; Saperstein AM, 2011, J NERV MENT DIS, V199, P672, DOI 10.1097/NMD.0b013e318229d0eb; Scupin R., 1997, HUM ORGAN, V56, P2; Suzuki Y, 2008, WORK, V30, P185; Tremblay MA, 2009, CAN J BEHAV SCI, V41, P213, DOI 10.1037/a0015167; Waghorn G, 2007, BIPOLAR DISORD, V9, P166, DOI 10.1111/j.1399-5618.2007.00417.x; Ware JE, 2001, GLAXOSMITHKLINE SC S; Yamaguchi S, 2017, PSYCHOL MED, V47, P53, DOI 10.1017/S0033291716002063	44	3	3	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2018	13	10							e0204809	10.1371/journal.pone.0204809	http://dx.doi.org/10.1371/journal.pone.0204809			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV3QJ	30278081	Green Submitted, Green Published, gold			2022-12-26	WOS:000446010200022
J	Dou, JL; Lu, XQ; Ali, A; Zhao, SJ; Zhang, L; He, N; Liu, WG				Dou, Junling; Lu, Xuqiang; Ali, Aslam; Zhao, Shengjie; Zhang, Lei; He, Nan; Liu, Wenge			Genetic mapping reveals a marker for yellow skin in watermelon (Citrullus lanatus L.)	PLOS ONE			English	Article							BULKED SEGREGANT ANALYSIS; GENOME-WIDE ASSOCIATION; FRUIT COLOR; LINKAGE MAP; RNA-SEQ; MODEL; DISCOVERY; CUCUMBER; LOCI; IDENTIFICATION	As a diverse species, watermelon [Citrullus lanatus (Thunb.) Matsum. &Nakai var. lanatus] has different kinds of fruit sizes, shapes, flesh colors and skin colors. Skin color is among the major objectives for breeding. Yellow skin is an important trait in watermelon, but the underlying genetic mechanism is unknown. In this study, we identified a locus for yellow skin through BSA-seq and GWAS. A segregation analysis in F-2 and BC1 populations derived from a cross of two inbred lines '94E1'(yellow skin) and 'Qingfeng'(green skin) suggested that skin color is a qualitative trait. BSA-seq mapping confirmed the locus in the F-2 population, which was detected on chromosome 4 by GWAS among 330 varieties. Several major markers, namely, 15 CAPS markers, 6 SSR markers and 2 SNP markers, were designed to delimit the region to 59.8 kb region on chromosome 4. Utilizing the two populations consisting of 10 yellow and 10 green skin watermelons, we found a tightly linked functional SNP marker for the yellow skin phenotype. The application of this marker as a selection tool in breeding programs will help to improve the breeder's ability to make selections at early stages of growth, thus accelerating the breeding program.	[Dou, Junling; Lu, Xuqiang; Ali, Aslam; Zhao, Shengjie; He, Nan; Liu, Wenge] Chinese Acad Agr Sci, Zhengzhou Fruit Res Inst, Zhengzhou, Henan, Peoples R China; [Dou, Junling; Zhang, Lei] Huazhong Agr Univ, Coll Hort & Forestry Sci, Wuhan, Hubei, Peoples R China	Chinese Academy of Agricultural Sciences; Zhengzhou Fruit Research Institute, CAAS; Huazhong Agricultural University	Liu, WG (corresponding author), Chinese Acad Agr Sci, Zhengzhou Fruit Res Inst, Zhengzhou, Henan, Peoples R China.	lwgwm@163.com	zhang, lei/ABE-2185-2020; Aslam, Ali/GRY-4159-2022	zhang, lei/0000-0002-0410-6553; Aslam, Ali/0000-0001-7984-4211	Agricultural Science and Technology Innovation Program (ASTIP) [CAAS-ASTIP-2017-ZFRI]; China Agriculture Research System [CARS-25-03]; National Natural Science Foundation of China [31471893, 31672178]; Central Public-interest Scientific Institution Basal Research Fund, China [1610192016301, 1610192016209]	Agricultural Science and Technology Innovation Program (ASTIP); China Agriculture Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Central Public-interest Scientific Institution Basal Research Fund, China	This work was supported by Agricultural Science and Technology Innovation Program (ASTIP) (CAAS-ASTIP-2017-ZFRI), China Agriculture Research System (CARS-25-03), National Natural Science Foundation of China (No. 31471893 and 31672178), and Central Public-interest Scientific Institution Basal Research Fund, China (1610192016301 and 1610192016209). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 2012, NAT BIOTECHNOL, V30, P174, DOI 10.1038/nbt.2095; Allan AC, 2008, TRENDS PLANT SCI, V13, P99, DOI 10.1016/j.tplants.2007.11.012; Andersen JR, 2003, TRENDS PLANT SCI, V8, P554, DOI 10.1016/j.tplants.2003.09.010; Ballester AR, 2010, PLANT PHYSIOL, V152, P71, DOI 10.1104/pp.109.147322; BARHAM WARREN S., 1956, PROC AMER SOC HORT SCI, V67, P487; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chandler K, 2013, CROP SCI, V53, P189, DOI 10.2135/cropsci2012.02.0129; Cheng Y, 2016, SCI HORTIC-AMSTERDAM, V202, P25, DOI 10.1016/j.scienta.2016.01.004; Chia JM, 2012, NAT GENET, V44, P803, DOI 10.1038/ng.2313; Dou JL, 2018, THEOR APPL GENET, V131, P947, DOI 10.1007/s00122-018-3050-5; Feder A, 2015, PLANT PHYSIOL, V169, P1714, DOI 10.1104/pp.15.01008; Gao ML, 2016, THEOR APPL GENET, V129, P1961, DOI 10.1007/s00122-016-2752-9; Garcia-Mas J, 2012, P NATL ACAD SCI USA, V109, P11872, DOI 10.1073/pnas.1205415109; Guner N, 2004, HORTSCIENCE, V39, P1175, DOI 10.21273/HORTSCI.39.6.1175; Guo SG, 2013, NAT GENET, V45, P51, DOI 10.1038/ng.2470; Harjes CE, 2008, SCIENCE, V319, P330, DOI 10.1126/science.1150255; Huang HY, 2017, HORTICULT J, V86, P238, DOI [10.2503/hortj.MI-159, 10.2503/hortj.mi-159]; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Inoue E, 2006, SCI HORTIC-AMSTERDAM, V107, P254, DOI 10.1016/j.scienta.2005.07.009; Kayesh E, 2013, ACTA PHYSIOL PLANT, V35, P2879, DOI 10.1007/s11738-013-1332-8; Kong QS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130865; Kumar R, 2011, J HERED, V102, P489, DOI 10.1093/jhered/esr025; Lado J, 2015, PHYSIOL PLANTARUM, V154, P469, DOI 10.1111/ppl.12332; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Lee YP, 2014, THEOR APPL GENET, V127, P2243, DOI 10.1007/s00122-014-2376-x; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin T, 2014, NAT GENET, V46, P1220, DOI 10.1038/ng.3117; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; Meng R, 2016, J PLANT GROWTH REGUL, V35, P449, DOI 10.1007/s00344-015-9552-3; Miao H, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101602; Poole Charles F., 1945, JOUR AGRIC RES, V71, P533; Porebski S, 1997, PLANT MOL BIOL REP, V15, P8, DOI 10.1007/BF02772108; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Qi JJ, 2013, NAT GENET, V45, P1510, DOI 10.1038/ng.2801; Ramirez-Gonzalez RH, 2015, PLANT BIOTECHNOL J, V13, P613, DOI 10.1111/pbi.12281; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shang JL, 2016, SCI HORTIC-AMSTERDAM, V203, P38, DOI 10.1016/j.scienta.2016.03.007; Sun G, 2010, HEREDITY, V105, P333, DOI 10.1038/hdy.2010.11; Takagi H, 2013, PLANT J, V74, P174, DOI 10.1111/tpj.12105; Weetman LM., 1937, IOWA AGR HOME EC EXP, V20, P1; Yang HB, 2015, KOREAN J HORTIC SCI, V33, P559, DOI 10.7235/hort.2015.14070; Yang ZM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068433; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang XD, 2011, PLANT MOL BIOL REP, V29, P305, DOI 10.1007/s11105-010-0231-z; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546	47	17	17	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0200617	10.1371/journal.pone.0200617	http://dx.doi.org/10.1371/journal.pone.0200617			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265662	gold, Green Submitted, Green Published			2022-12-26	WOS:000446005500003
J	Segura-Garcia, I; Tun, TY; Box, SJ				Segura-Garcia, Iris; Tun, Thu Yain; Box, Stephen J.			Genetic characterization of the artisanal mud crab fishery in Myanmar	PLOS ONE			English	Article							SPECIES GENUS SCYLLA; MITOCHONDRIAL-DNA; ANDAMAN SEA; BRACHYURA PORTUNIDAE; MANGROVE ECOSYSTEM; POPULATION SIZES; OLIVACEA; SPP.; BAY; CONFIRMATION	Fish are important for food supply, especially in developing countries. In Southeast Asia, including Myanmar, the mud crab fishery is an important livelihood that represents a valuable source of income and food to coastal communities. However, the increasing demand for mud crab in domestic and international markets and poor management has generated concern about the status of this fishery across Southeast Asia. In this region, at least four species of mud crab in the genus Scylla are recognised but their correct identification and occurrence remain to be fully explained. Relying on accurate taxonomic identification of mud crab species represents the cornerstone of the successful implementation of management plans as life history biology and relative exploitation rates may vary by species due to gear susceptibility. Toward this aim, tissue samples from mud crabs were collected from four fishing communities of the Mergui archipelago, in the Tanintharyi region of southern Myanmar. All crab samples were DNA barcoded for species identification through sequencing. This study is the first genetic characterization of the mud crab fishery in Myanmar and revealed that Scylla olivacea was the only species found in the sampled fisheries of the Tanintharyi region. The populations studied across the Mergui archipelago did not show evidence of genetic structure, but gene flow appeared to be limited among conspecifics from neighbouring countries.	[Segura-Garcia, Iris; Box, Stephen J.] Natl Museum Nat Hist, Smithsonian Marine Stn Ft Pierce, Ft Pierce, FL 34949 USA; [Tun, Thu Yain; Box, Stephen J.] Rare, Global Fisheries, Arlington, VA USA	Smithsonian Institution; Smithsonian National Museum of Natural History	Segura-Garcia, I (corresponding author), Natl Museum Nat Hist, Smithsonian Marine Stn Ft Pierce, Ft Pierce, FL 34949 USA.	SeguraGarciaI@si.edu		Segura-Garcia, Iris/0000-0003-3688-3557; Box, Stephen/0000-0001-5265-0556	Helmsley Charitable Trust [504604- 2017]	Helmsley Charitable Trust	This study was funded by the Helmsley Charitable Trust (grant number 504604- 2017) awarded to SB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bucklin A, 1998, J HERED, V89, P383, DOI 10.1093/jhered/89.5.383; Chatterjee A, 2017, J GEOPHYS RES-OCEANS, V122, P3200, DOI 10.1002/2016JC012300; ESTAMPADOR EULOGIO P., 1949, PHILIPPINE JOUR SCI, V78, P95; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FAO, 2003, MYANM AQ INL FISH MY; Fratini S, 2002, J EXP MAR BIOL ECOL, V272, P103, DOI 10.1016/S0022-0981(02)00052-7; FU YX, 1993, GENETICS, V133, P693; Fuseya R, 1996, FISHERIES SCI, V62, P705, DOI 10.2331/fishsci.62.705; Geller J, 2013, MOL ECOL RESOUR, V13, P851, DOI 10.1111/1755-0998.12138; Gopurenko D, 2003, MAR FRESHWATER RES, V54, P833, DOI 10.1071/MF03033; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; HILL BJ, 1994, MAR BIOL, V120, P379, DOI 10.1007/BF00680211; Imai H, 2004, AQUAT LIVING RESOUR, V17, P31, DOI 10.1051/alr:2004007; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Jirapunpipat Kanchana, 2008, Kasetsart Journal Natural Sciences, V42, P31; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Keenan CP, 1998, RAFFLES B ZOOL, V46, P217; Keenan CP, 2003, JOND C CTR BRIB ISL, P42; Koolkalya S, 2006, FISHERIES MANAG ECOL, V13, P391, DOI 10.1111/j.1365-2400.2006.00518.x; Lebata MJHL, 2007, B MAR SCI, V80, P891; Ma LB, 2006, AQUAC RES, V37, P1694, DOI 10.1111/j.1365-2109.2006.01603.x; MacIntosh DJ, 2002, J SHELLFISH RES, V21, P259; Macnae W., 1969, ADV MAR BIOL, V6; Mandal A, 2014, J SHELLFISH RES, V33, P503, DOI 10.2983/035.033.0219; Mandal A, 2014, BIOCHEM GENET, V52, P338, DOI 10.1007/s10528-014-9651-z; Moser S, 2005, FISH RES, V71, P27, DOI 10.1016/j.fishres.2004.07.008; Ng P., 1998, FAO SPECIES IDENTIFI, P1397; Ogawa CY, 2012, J CRUSTACEAN BIOL, V32, P762, DOI 10.1163/193724012X649787; Ong KS, 1964, IPFC P, P135; Overton JL, 2002, J CRUSTACEAN BIOL, V22, P790, DOI 10.1651/0278-0372(2002)022[0790:ESASMF]2.0.CO;2; Rizal Syamsul, 2012, American Journal of Environmental Sciences, V8, P479, DOI 10.3844/ajessp.2012.479.488; Roehrdanz R.L., 1993, Insect Molecular Biology, V2, P89, DOI 10.1111/j.1365-2583.1993.tb00129.x; Rosly HAAM, 2013, MOL BIOL REP, V40, P6407, DOI 10.1007/s11033-013-2755-4; Rozas J, 2017, MOL BIOL EVOL, V34, P3299, DOI 10.1093/molbev/msx248; Rumisha C., 2017, GENETIC DIVERSITY CO, V2017, P1; Sangthong Pradit, 2006, Kasetsart Journal Natural Sciences, V40, P958; Sarower MG, 2017, MITOCHONDRIAL DNA A, V28, P935, DOI 10.1080/24701394.2016.1214726; Serene R., 1952, INDO PACIFIC FISHERI, P132; Shukla M., 2013, RES J MAR SCI, V1, P2321; Slatkin M, 1999, GENETICS, V152, P775; Slatkin M, PAIRWISE COMPARISONS; Stamatis C, 2004, MOL ECOL, V13, P1377, DOI 10.1111/j.1365-294X.2004.02165.x; Stepien CA, 1999, MOL PHYLOGENET EVOL, V13, P31, DOI 10.1006/mpev.1999.0666; Supmee V, 2012, ZOOL STUD, V51, P1040; Wee AKS, 2014, J BIOGEOGR, V41, P954, DOI 10.1111/jbi.12263	48	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204905	10.1371/journal.pone.0204905	http://dx.doi.org/10.1371/journal.pone.0204905			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265718	Green Published, gold, Green Submitted			2022-12-26	WOS:000446005500053
J	Teng, F; Ye, H; Xue, TJ				Teng, Fei; Ye, Huan; Xue, Tianjiao			Predictive value of neutrophil to lymphocyte ratio in patients with acute exacerbation of chronic obstructive pulmonary disease	PLOS ONE			English	Article							COPD; DIAGNOSIS; MORTALITY; BURDEN	Objective This study aimed to determine the predictive value of the neutrophil to lymphocyte ratio (NLR) in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Methods A retrospective study was conducted from March 2012 to May 2016 in Fuxing Hospital, Capital University of Medical Science. We collected 906 cases (525 males, 381 females, mean age 81.86 +/- 9.75 years) diagnosed with AECOPD. The NLR was calculated from their white blood cell (WBC), neutrophil (NEU), and lymphocyte (LYM) counts, which were obtained at laboratory examination. Result After treatment, 698 patients with AECOPD improved. The NLR was higher at admission (6.89 +/- 6.82) than after treatment (4.19 +/- 5.11) (P = 0.000). The area under the receiver operating characteristic curve (AUC) of the NLR for predicting the 28-day mortality rate was 0.737. Using 8.130 as the critical NLR value, the sensitivity was 60.5%, and the specificity was 74.8%. The AUC of the NLR for predicting the frequency of the need for invasive mechanical ventilation was 0.732. Using 10.345 as the critical NLR value, the sensitivity was 54.3%, and the specificity was 84.8%. The AUC of WBC, NEU and LYM for predicting 28-day mortality and the need for invasive mechanical ventilation in these patients were all less than 0.7. An increased NLR was an independent risk factor for 28-day mortality (OR = 1.067, 95% CI = 1.039 to 1.095, P = 0.000), intensive care unit occupancy (OR = 1.046, 95% CI = 1.023 to 1.068, P = 0.000), and the need for invasive mechanical ventilation (OR = 1.042, 95% CI = 1.019 to 1.066, P = 0.000). Compared with those patients without comorbidities, patients with renal dysfunction or upper gastrointestinal bleeding had an increased risk of death within 28 days (OR = 3.102, 95% CI = 1.525 to 6.312; OR = 4.598, 95% CI = 1.825 to 11.583, respectively), ICU admission (OR = 2.228, 95% CI = 1.286 to 3.860; OR = 3.103, 95% CI = 1.402 to 6.866, respectively), and the need for invasive mechanical ventilation (OR = 3.572, 95% CI = 1.822 to 7.000; OR = 4.279, 95% CI = 1.823 to 10.045, respectively). Conclusion In patients with AECOPD, the accuracy of the NLR for predicting the 28-day mortality rate and frequency of the need for mechanical ventilation was significantly higher than the accuracy of WBC, NEU and LYM counts. AECOPD patients with an NLR >= 8.130 had higher 28-day mortality rate, while those with an NLR >= 10.345 were more likely to need invasive mechanical ventilation.	[Teng, Fei; Ye, Huan; Xue, Tianjiao] Capital Med Univ, Fuxing Hosp, Dept Infect Dis, Beijing, Peoples R China	Capital Medical University	Ye, H (corresponding author), Capital Med Univ, Fuxing Hosp, Dept Infect Dis, Beijing, Peoples R China.	yedahuan@yeah.net		Ye, Huan/0000-0001-9285-1504				[Anonymous], GLOB STRAT DIAFN MAN; Barnes PJ, 2016, J ALLERGY CLIN IMMUN, V138, P16, DOI 10.1016/j.jaci.2016.05.011; Bhat T, 2013, EXPERT REV CARDIOVAS, V11, P55, DOI [10.1586/erc.12.159, 10.1586/ERC.12.159]; Burge S, 2003, EUR RESPIR J, V21, p46S, DOI 10.1183/09031936.03.00078002; Celli BR, 2012, AM J RESP CRIT CARE, V185, P1065, DOI 10.1164/rccm.201110-1792OC; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; de Jager CPC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046561; de Jager CPC, 2010, CRIT CARE, V14, DOI 10.1186/cc9309; Hurst JR, 2007, THORAX, V62, P198, DOI 10.1136/thx.2007.077883; Lee H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156511; Liu CL, 2013, J SURG ONCOL, V107, P493, DOI 10.1002/jso.23270; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Papi Alberto, 2006, Proc Am Thorac Soc, V3, P245, DOI 10.1513/pats.200512-125SF; Perera PN, 2012, COPD, V9, P131, DOI 10.3109/15412555.2011.650239; Rahimirad S, 2017, TUBERK TORAK, V65, P25, DOI 10.5578/tt.27626; Seemungal TAR, 1998, AM J RESP CRIT CARE, V157, P1418, DOI 10.1164/ajrccm.157.5.9709032; Sethi S, 2008, NEW ENGL J MED, V359, P2355, DOI 10.1056/NEJMra0800353; Sorensen AK, 2015, J INFLAMM-LOND, V12, DOI 10.1186/s12950-015-0064-5; Stanescu D, 1996, THORAX, V51, P267, DOI 10.1136/thx.51.3.267; Stefan MS, 2015, CRIT CARE MED, V43, P1386, DOI 10.1097/CCM.0000000000000945; Taylan M, 2017, CLIN RESPIR J, V11, P311, DOI 10.1111/crj.12336; Templeton AJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju124; Terradas R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042860; Wedzicha JA, 2007, LANCET, V370, P786, DOI 10.1016/S0140-6736(07)61382-8; Wyllie DH, 2004, J CLIN PATHOL, V57, P950, DOI 10.1136/jcp.2004.017335; Yin P, 2016, CHEST, V150, P1269, DOI 10.1016/j.chest.2016.08.1474; Yoon NB, 2013, ANN LAB MED, V33, P105, DOI 10.3343/alm.2013.33.2.105; Zahorec R, 2001, Bratisl Lek Listy, V102, P5	28	14	18	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204377	10.1371/journal.pone.0204377	http://dx.doi.org/10.1371/journal.pone.0204377			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265703	Green Submitted, gold, Green Published			2022-12-26	WOS:000446005500031
J	Grun, TB; Nebelsick, JH				Grun, Tobias B.; Nebelsick, James H.			Structural design of the echinoid's trabecular system	PLOS ONE			English	Article							CLYPEASTEROID ECHINOIDS; ACCUMULATIONS; ARCHITECTURE; PREDATION; MIOCENE	The multi-plated skeleton of echinoids is made of the stereom, a light-weight construction which resembles a micro-beam framework. Although the two-dimensional design of the stereom has been studied, its spatial architecture is only little known. It is, however, imperative to understand the spatial architecture of the trabecular system in order to interpret its structural principles of this load-bearing construction. The echinoid's trabecular system is thus analyzed in-depth with respect to eight topological descriptors. The echinoid's plates are divided into two regions, the center of which consists of an unordered stereom, and the margin which consists of an ordered stereom. The eight trabecular descriptors indicate that the basal topology of the two plate regions are similar. The trabecular system predominantly consists of short and stocky trabeculae that show little tortuosity. The majority of trabeculae intersect in a 3N configuration, where three trabeculae intersect in one common node. Trabeculae in the 3N configuration intersect in an angle of around 120 degrees resulting in a planar and triangular motif. These planar elements, when arranged in an angular off-set, can resist multi-dimensional loads. Results also show that the trabecular orientation perpendicular to the plate's surface is at an angle of 60 degrees. The trabecular orientation in the plate's horizontal plane is directional. Both trabecular orientations reflect a construction which is capable of resisting applied loads and can distribute these loads over the entire skeleton. The spatial architecture of the echinoid's trabecular system is thus considered to be a performative light-weight and load-bearing system.	[Grun, Tobias B.; Nebelsick, James H.] Univ Tubingen, Dept Geosci, Tubingen, Germany	Eberhard Karls University of Tubingen	Grun, TB (corresponding author), Univ Tubingen, Dept Geosci, Tubingen, Germany.	tobias.grun@uni-tuebingen.de	Grun, Tobias B./K-6076-2015	Grun, Tobias B./0000-0002-1776-0212	German Research Foundation (Deutsche Forschungsgemeinschaft) within the Collaborative Research Centre : Biological Design and Integrative Structures [SFB/Transregio 141]; Deutsche Forschungsgemeinschaft; University of Tubingen	German Research Foundation (Deutsche Forschungsgemeinschaft) within the Collaborative Research Centre : Biological Design and Integrative Structures; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Tubingen	This work was funded by the German Research Foundation (Deutsche Forschungsgemeinschaft) within the Collaborative Research Centre SFB/Transregio 141: Biological Design and Integrative Structures. Open Access publication was supported by the Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of the University of Tubingen.	[Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Baddeley A, 2015, SPATIAL POINT PATTER; Belaustegui Z, 2013, PALAEONTOLOGY, V56, P783, DOI 10.1111/pala.12015; Belaustegui Z, 2012, LETHAIA, V45, P548, DOI 10.1111/j.1502-3931.2012.00314.x; Ben-Zvi Y, 2017, FRONT MATER, V4, DOI 10.3389/fmats.2017.00029; Donovan S.K., 1991, P241; Durham J. W., 1966, P450; Gordon J.E., 1978, STRUCTURES WHY THING; Gross D, 2007, TECHNISCHE MECHANIK; Grossmann JN, 2013, ZOOMORPHOLOGY, V132, P301, DOI 10.1007/s00435-013-0192-5; Grossmann N, 2013, ECHINODERMS IN A CHANGING WORLD, P97; Grun TB, 2018, DRYAD DIGITAL REPOSI, DOI [10.5061/dryad.rg54h, DOI 10.5061/DRYAD.RG54H]; Grun TB, J R SOC INTERFACE; Grun T, 2014, HIST BIOL, V26, P745, DOI 10.1080/08912963.2013.841683; Grun TB, 2018, NEUES JAHRB GEOL P-A, V289, P189, DOI 10.1127/njgpa/2018/0737; Grun TB, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.171323; Grun TB, 2016, BIOL INSPIR SYST, V9, P217, DOI 10.1007/978-3-319-46374-2_11; Grun TB, 2017, PALAIOS, V32, P448, DOI 10.2110/palo.2017.001; Lauer C, 2018, ZOOMORPHOLOGY, V137, P139, DOI 10.1007/s00435-017-0385-4; Lawrence J., 1987, FUNCTIONAL BIOL ECHI, DOI [10.1002/iroh.19890740316, DOI 10.1002/IROH.19890740316]; Mancosu A, 2017, ACTA PALAEONTOL POL, V62, P627, DOI 10.4202/app.00357.2017; Mancosu A, 2015, PALAIOS, V30, P373, DOI 10.2110/palo.2014.087; Mancosu A, 2013, PALAEOGEOGR PALAEOCL, V374, P173, DOI 10.1016/j.palaeo.2013.01.015; Mann W, 1986, VORLESUNG STAT FESTI; Nebelsick JH, 2015, BIOL INSPIR SYST, V6, P141, DOI 10.1007/978-94-017-9398-8_8; Nebelsick JH, 1999, PALAIOS, V14, P127, DOI 10.2307/3515369; Novomestky F, 2015, MOMENTS CUMULANTS SK; Presser V, 2010, J MATER SCI, V45, P2408, DOI 10.1007/s10853-010-4208-y; Reznikov N, 2016, ACTA BIOMATER, V44, P65, DOI 10.1016/j.actbio.2016.08.040; SEILACHER A, 1979, PALEOBIOLOGY, V5, P191, DOI 10.1017/S0094837300006527; Smith A.B., 1990, P413; Smith A.B., 1980, Special Papers in Palaeontology, P1; TELFORD M, 1985, ZOOMORPHOLOGY, V105, P114, DOI 10.1007/BF00312146; Telford M, 1995, ECHINODERMATA, P353; Tsafnat N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044140; Wainwright SA, 1973, MECH DESIGN ORGANISM	36	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204432	10.1371/journal.pone.0204432	http://dx.doi.org/10.1371/journal.pone.0204432			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30261078	Green Published, gold, Green Submitted			2022-12-26	WOS:000445907400048
J	Rhie, S; Chae, KY				Rhie, Seonkyeong; Chae, Kyu Young			Effects of school time on sleep duration and sleepiness in adolescents	PLOS ONE			English	Article							START TIMES; DELAYED PHASE; YOUNG-ADULTS; ASSOCIATION; PERFORMANCE; PREFERENCE; PATTERNS; BEHAVIOR; CHILDREN; HABITS	Delaying the time of start of school allows for longer sleep duration, better mood, and better school performance. In South Korea, a campaign was launched in 2014 to delay the school start time to 9 a.m. We analyzed the campaign's effects on adolescents' total sleep duration, sleepiness (presented as weekend catch-up sleep), emotions, and school performance. Based on data from 2013, changes of sleep patterns, emotions, and academic achievement in adolescents were evaluated using the 2012-2016 Korea Youth Risk Behavior Web-based survey from two educational districts: Gyeonggi (fully participated in the delayed school start time campaign; intervention group) and Daegu/Gyeongbuk/Ulsan (DGU, never participated; control group). The primary outcomes were sleep duration, time of sleep onset, and difference in sleep duration between weekdays and the weekend. Secondary outcomes were the proportional changes of mood, stress, and school performance. The sleep duration of students in the intervention group temporarily increased in 2015. However, because there was a simultaneous delay in time of sleep onset, sleep duration returned to pre-campaign levels in 2016. Although sleep duration did not increase, weekend catch-up sleep decreased by approximately 19 minutes for students in the intervention group. Meanwhile, in the control group sleep duration tended to decrease over the same period. The impact of the campaign on students' emotions and school performance could not be confirmed. This study demonstrated that delaying the school start time to 9 a.m. reduced duration of weekend catch-up sleep with a transient increase in sleep duration in adolescents.	[Rhie, Seonkyeong; Chae, Kyu Young] CHA Univ, CHA Bundang Med Ctr, Dept Pediat, Seongnam, South Korea	Pochon Cha University	Chae, KY (corresponding author), CHA Univ, CHA Bundang Med Ctr, Dept Pediat, Seongnam, South Korea.	danielchae21@gmail.com		Chae, Kyu Young/0000-0003-3243-5853; Rhie, Seonkyeong/0000-0003-3371-8310				Astill RG, 2012, PSYCHOL BULL, V138, P1109, DOI 10.1037/a0028204; Borlase BJ, 2013, SLEEP BIOL RHYTHMS, V11, P46, DOI 10.1111/sbr.12003; CARSKADON MA, 1993, SLEEP, V16, P258, DOI 10.1093/sleep/16.3.258; Carskadon MA, 1998, SLEEP, V21, P871, DOI 10.1093/sleep/21.8.871; Chung KF, 2008, SLEEP, V31, P185, DOI 10.1093/sleep/31.2.185; Crowley SJ, 2007, SLEEP MED, V8, P602, DOI 10.1016/j.sleep.2006.12.002; Drake C, 2003, SLEEP, V26, P455; Edwards F, 2012, ECON EDUC REV, V31, P970, DOI 10.1016/j.econedurev.2012.07.006; Giannotti F, 2002, J SLEEP RES, V11, P191, DOI 10.1046/j.1365-2869.2002.00302.x; Kim SJ, 2011, ARCH PEDIAT ADOL MED, V165, P806, DOI 10.1001/archpediatrics.2011.128; Klerman EB, 2005, SLEEP, V28, P1253, DOI 10.1093/sleep/28.10.1253; Lufi D, 2011, J CLIN SLEEP MED, V7, P137; Marx R, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009467.pub2; Millman RP, 2005, PEDIATRICS, V115, P1774, DOI 10.1542/peds.2005-0772; Minges KE, 2016, SLEEP MED REV, V28, P86, DOI 10.1016/j.smrv.2015.06.002; Owens JA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-1406; Owens JA, 2010, ARCH PEDIAT ADOL MED, V164, P608, DOI 10.1001/archpediatrics.2010.96; Paiva T, 2015, SLEEP MED, V16, P521, DOI 10.1016/j.sleep.2014.10.010; Rhie Seonkyeong, 2011, Korean J Pediatr, V54, P29, DOI 10.3345/kjp.2011.54.1.29; Wahlstrom K., 2002, NASSP BULL, V86, P3, DOI [10.1177/019263650208663302, DOI 10.1177/019263650208663302]; Wing YK, 2015, PEDIATRICS, V135, pE635, DOI 10.1542/peds.2014-2419; Wolfson Amy R, 2007, Behav Sleep Med, V5, P194; Wolfson AR, 2003, SLEEP, V26, P213, DOI 10.1093/sleep/26.2.213; Wolfson AR, 1998, CHILD DEV, V69, P875, DOI 10.2307/1132351	24	11	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2018	13	9							e0203318	10.1371/journal.pone.0203318	http://dx.doi.org/10.1371/journal.pone.0203318			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV3NB	30256800	Green Published, gold, Green Submitted			2022-12-26	WOS:000446000200017
J	Uli, N; Michelen-Gomez, E; Ramos, EI; Druley, TE				Uli, Nishanth; Michelen-Gomez, Eduardo; Ramos, Enrique, I; Druley, Todd E.			Age-specific changes in genome-wide methylation enrich for Foxa2 and estrogen receptor alpha binding sites	PLOS ONE			English	Article							DNA METHYLATION; GENE; HYPERMETHYLATION; EPIGENETICS; CANCER; CELLS	The role of DNA methylation patterns in complex phenotypes remains unclear. To explore this question, we adapted our methods for rare variant analysis to characterize genome-wide murine DNA hybridization array to investigate methylation at CpG islands, shores, and regulatory elements. We have applied this platform to compare age and tissue- specific methylation differences in the brain and spleen of young and aged mice. As expected from prior studies, there are clear global differences in organ-specific, but not age-specific, methylation due mostly to changes at repetitive elements. Surprisingly, out of 200,000 loci there were only 946 differentially methylated cytosines (DMCs) between young and old samples (529 hypermethylated, 417 hypomethylated in aged mice) compared to thousands of tissue-specific DMCs. Hypermethylated loci were clustered around the promoter region of Sfi1, exon 2 of Slc11a2, Drg1, Esr1 and Foxa2 transcription factor binding sites. In particular, there were 75 hypermethylated Foxa2 binding sites across a 2.7 Mb region of chromosome 11. Hypomethylated loci were clustered around Midi, Isoc2b and genome-wide loci with binding sites for Foxa2 and Esr1, which are known to play important roles in development and aging. These data suggest discreet tissue-independent methylation changes associated with aging processes such as cell division (Sfi1, Midi), energy production (Drg1, Isoc2b) and cell death (Foxa2, Esr1).	[Uli, Nishanth; Michelen-Gomez, Eduardo; Ramos, Enrique, I; Druley, Todd E.] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63110 USA; [Druley, Todd E.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Druley, Todd E.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Druley, Todd E.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Druley, TE (corresponding author), Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63110 USA.; Druley, TE (corresponding author), Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA.; Druley, TE (corresponding author), Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA.; Druley, TE (corresponding author), Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA.	druley_t@wustl.edu		Michelen, Eduardo/0000-0003-2355-7461; Ramos, Enrique/0000-0001-9921-7944	NIH/NHGRI [F31 HG6649]; Alex's Lemonade Stand Foundation Pediatric Oncology Student Training [POST] program; NIH/NCI Mentored Fellowship Training Award [K08 CA140720]	NIH/NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Alex's Lemonade Stand Foundation Pediatric Oncology Student Training [POST] program; NIH/NCI Mentored Fellowship Training Award	This work was supported by the NIH/NHGRI Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral Fellowships [F31 HG6649 to Ramos], Alex's Lemonade Stand Foundation Pediatric Oncology Student Training [POST] program [Uli], and the NIH/NCI Mentored Fellowship Training Award [K08 CA140720 to Druley]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A Quantitative Analysis, 2003, ENDOCRINOLOGY, V144, P4164, DOI [10.1210/en.2003-0052, DOI 10.1210/EN.2003-0052]; Ainger SA, 2014, EXP DERMATOL, V23, P916, DOI 10.1111/exd.12574; Bollati V, 2009, MECH AGEING DEV, V130, P234, DOI 10.1016/j.mad.2008.12.003; Boyd-Kirkup JD, 2013, EPIGENOMICS-UK, V5, P205, DOI [10.2217/EPI.13.5, 10.2217/epi.13.5]; Carrio E, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00019; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Desai M, 2015, INT J OBESITY, V39, P633, DOI 10.1038/ijo.2015.13; Dozmorov MG, 2015, EPIGENETICS-US, V10, P484, DOI 10.1080/15592294.2015.1040619; Druley TE, 2009, NAT METHODS, V6, P263, DOI [10.1038/NMETH.1307, 10.1038/nmeth.1307]; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; Friedman JR, 2006, CELL MOL LIFE SCI, V63, P2317, DOI 10.1007/s00018-006-6095-6; Goyama S, 2017, CANCER SCI, V108, P553, DOI 10.1111/cas.13168; Hing B, 2015, EPIGENETICS-US, V10, P581, DOI 10.1080/15592294.2015.1045179; Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; ISSA JPJ, 1994, NAT GENET, V7, P536, DOI 10.1038/ng0894-536; Issa JPJ, 1996, P NATL ACAD SCI USA, V93, P11757, DOI 10.1073/pnas.93.21.11757; Jiang M, 2004, EXP GERONTOL, V39, P1603, DOI 10.1016/j.exger.2004.06.017; Jones MJ, 2015, AGING CELL, V14, P924, DOI 10.1111/acel.12349; Kaestner KH, 2010, CURR OPIN GENET DEV, V20, P527, DOI 10.1016/j.gde.2010.06.005; Khalyfa A, 2003, EXP GERONTOL, V38, P1087, DOI 10.1016/S0531-5565(03)00210-9; Kile BT, 2003, NATURE, V425, P81, DOI 10.1038/nature01865; Klutstein M, 2016, CANCER RES, V76, P3446, DOI 10.1158/0008-5472.CAN-15-3278; Kwabi-Addo B, 2007, CLIN CANCER RES, V13, P3796, DOI 10.1158/1078-0432.CCR-07-0085; Ladd-Acosta C, 2014, MOL PSYCHIATR, V19, P862, DOI 10.1038/mp.2013.114; Levenson JM, 2006, CELL MOL LIFE SCI, V63, P1009, DOI 10.1007/s00018-006-6026-6; Levenson JM, 2006, J BIOL CHEM, V281, P15763, DOI 10.1074/jbc.M511767200; Li LC, 2004, BIOCHEM BIOPH RES CO, V321, P455, DOI 10.1016/j.bbrc.2004.06.164; Majumder A, 2017, J CELL BIOCHEM, V118, P2108, DOI 10.1002/jcb.25841; Martinez-Sanz J, 2006, FEBS J, V273, P4504, DOI 10.1111/j.1742-4658.2006.05456.x; Morris SA, 2016, DEVELOPMENT, V143, P2696, DOI 10.1242/dev.138263; Nikolich-Zugich J, 2018, NAT IMMUNOL, V19, P10, DOI 10.1038/s41590-017-0006-x; Oliveira AMM, 2012, NAT NEUROSCI, V15, P1111, DOI 10.1038/nn.3151; Pacchierotti F, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/123484; Perez-Arellano I, 2013, FEBS J, V280, P3647, DOI 10.1111/febs.12356; Petkovich DA, 2017, CELL METAB, V25, P954, DOI 10.1016/j.cmet.2017.03.016; Post WS, 1999, CARDIOVASC RES, V43, P985, DOI 10.1016/S0008-6363(99)00153-4; Rakyan VK, 2010, GENOME RES, V20, P434, DOI 10.1101/gr.103101.109; Sanchez-Mut JV, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2015.214; Schillebeeckx M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt230; Schweiger S, 1999, P NATL ACAD SCI USA, V96, P2794, DOI 10.1073/pnas.96.6.2794; Sharma P, 2014, GENE, V541, P31, DOI 10.1016/j.gene.2014.02.034; Shaw AC, 2010, CURR OPIN IMMUNOL, V22, P507, DOI 10.1016/j.coi.2010.05.003; Simell B, 2011, VACCINE, V29, P1929, DOI 10.1016/j.vaccine.2010.12.121; Sun D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128517; Taberlay PC, 2011, PROG DRUG RES, V67, P1, DOI 10.1007/978-3-7643-8989-5_1; Talens RP, 2012, AGING CELL, V11, P694, DOI 10.1111/j.1474-9726.2012.00835.x; Teschendorff AE, 2010, GENOME RES, V20, P440, DOI 10.1101/gr.103606.109; Udali S, 2013, MOL ASPECTS MED, V34, P883, DOI 10.1016/j.mam.2012.08.001; Watanabe Y, 2010, ADV CLIN CHEM, V52, P145, DOI 10.1016/S0065-2423(10)52006-7; Watson CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043840; Wilson AS, 2007, BBA-REV CANCER, V1775, P138, DOI 10.1016/j.bbcan.2006.08.007; WILSON VL, 1983, SCIENCE, V220, P1054; Xi YX, 2012, BIOINFORMATICS, V28, P430, DOI 10.1093/bioinformatics/btr668; Yara S, 2015, EPIGENOMICS-UK, V7, P283, DOI [10.2217/EPI.14.84, 10.2217/epi.14.84]; Yates D., 2013, NAT REV NEUROSCI, V15, P5, DOI [10.1038/nrn3664, DOI 10.1038/NRN3664]; Zhang W, 2013, FREE RADICAL RES, V47, P325, DOI 10.3109/10715762.2013.773589; Zovkic IB, 2013, LEARN MEMORY, V20, P61, DOI 10.1101/lm.026575.112	58	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2018	13	9							e0203147	10.1371/journal.pone.0203147	http://dx.doi.org/10.1371/journal.pone.0203147			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3NB	30256791	Green Published, gold, Green Submitted			2022-12-26	WOS:000446000200012
J	Wang, YC; Chen, YC; Ko, CY; Guo, YLL; Sung, FC				Wang, Yu-Chun; Chen, Yi-Chun; Ko, Chun-Yu; Guo, Yue-Liang Leon; Sung, Fung-Chang			Pre-existing comorbidity modify emergency room visit for out-of-hospital cardiac arrest in association with ambient environments	PLOS ONE			English	Article							CASE-CROSSOVER ANALYSIS; OUTDOOR AIR-POLLUTION; PARTICULATE MATTER; HEAT WAVES; TEMPERATURE; MORTALITY; CORONARY; DIAGNOSES; IMPACT; WOMEN	Background This study evaluated risks of emergency room visit (ERV) for out-of-hospital cardiac arrest (OHCA) in 2005-2011, among patients with cardiologic and metabolic syndromes (CMS), in association with ambient environments. Methods Pooled and area-specific weather related cumulative six-day (lags 0 to 5) relative risks (RRs) and confidence intervals (CIs) of ERV for OHCA were evaluated for CMS cases, using distributed lag nonlinear models and multivariate meta-analytical second-stage model in association with the daily average temperatures and daily concentrations of air pollutants. Results ERV risk increased as average temperature dropped to <27 degrees C. At the mean temperature of 14 degrees C, the cumulative six-day RRs of ERV were 1.73 (95% CI: 1.22, 2.46) for all OHCA patients, 1.74 (95% CI: 1.06, 2.84) for OHCA patients younger than 65 years old, and 1.99 (95% CI: 1.03, 3.81) for subjects with pre-existing hypertension. High temperature was also associated with elevated ERV of OHCA. Increased ERV risks in cases with pre-existing hypertension and diabetes mellitus were also associated with concentrations of air pollutants in northern Taiwan. Conclusions Our data provided evidences to clinicians, emerging medical services and public health that the ERV risk for OHCA patients is greater at low temperature than at high temperature. Patients with cardio and metabolic disorders need to pay greater attention to low temperature and avoid heat wave.	[Wang, Yu-Chun; Ko, Chun-Yu] Coll Engn, Dept Environm Engn, Zhongli, Taiwan; [Wang, Yu-Chun] Chung Yuan Christian Univ, Res Ctr Environm Risk Management, Zhongli, Taiwan; [Chen, Yi-Chun] I Shou Univ, Dept Hlth Management, Kaohsiung, Taiwan; [Guo, Yue-Liang Leon] Natl Taiwan Univ, Dept Environm & Occupat Med, Coll Med, Taipei, Taiwan; [Guo, Yue-Liang Leon] Natl Hlth Res Inst, Div Environm Hlth & Occupat Med, Zhunan, Miaoli County, Taiwan; [Sung, Fung-Chang] China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan; [Sung, Fung-Chang] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan	Chung Yuan Christian University; I Shou University; National Taiwan University; National Health Research Institutes - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Sung, FC (corresponding author), China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan.; Sung, FC (corresponding author), China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan.	fcsung1008@yahoo.com	王, 玉純/AAP-9936-2021; Guo, Yue-Liang Leon/ABF-2314-2020; Wang, Yu-Chun/AAP-8150-2021	王, 玉純/0000-0002-4797-7447; GUO, Yue Leon/0000-0002-8530-4809	Ministry of Science and Technology [MOST 104-2633-M-033-00, MOST 104-2621-M-006-002-]; National Health Research Institutes [NHRI-106A1-PDCO-3617191, MOHW105-TDU-M-212-113003]; Central Weather Bureau of Taiwan [MP10501-0125]; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW106-TDU-B-212-113004]; research laboratory of pediatrics, Children's Hospital of China Medical University [DMR-105-042]; China Medical University Hospital [DMR-106-025]; Academia Sinica Taiwan Biobank Stroke Biosignature Project [BM10501010037]; NRPB Stroke Clinical Trial Consortium [MOST 105-2325-B-039 -003]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Health Research Institutes(National Health Research Institutes, Japan); Central Weather Bureau of Taiwan; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; research laboratory of pediatrics, Children's Hospital of China Medical University; China Medical University Hospital; Academia Sinica Taiwan Biobank Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	This study was supported by grants from the Ministry of Science and Technology (MOST 104-2633-M-033-00 and MOST 104-2621-M-006-002-), National Health Research Institutes (NHRI-106A1-PDCO-3617191 and MOHW105-TDU-M-212-113003), and Central Weather Bureau (MP10501-0125) of Taiwan, Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW106-TDU-B-212-113004), the research laboratory of pediatrics, Children's Hospital of China Medical University (grant number DMR-105-042), China Medical University Hospital (DMR-106-025), Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037), NRPB Stroke Clinical Trial Consortium (MOST 105-2325-B-039 -003), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan.	Administration TEP, TAIW AIR QUAL MON NE; Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Andersson C, 2012, DIABETOLOGIA, V55, P2348, DOI 10.1007/s00125-012-2584-3; Bell ML, 2013, AM J EPIDEMIOL, V178, P865, DOI 10.1093/aje/kwt090; Coppler PJ, 2016, RESUSCITATION, V98, P9, DOI 10.1016/j.resuscitation.2015.09.399; Dahlquist M, 2016, INT J HYG ENVIR HEAL, V219, P389, DOI 10.1016/j.ijheh.2016.03.005; Dai JP, 2015, ENVIRON POLLUT, V203, P116, DOI 10.1016/j.envpol.2015.03.050; Dai XY, 2015, INT J CARDIOL, V192, P56, DOI 10.1016/j.ijcard.2015.05.016; De Bruin ML, 2005, J CLIN EPIDEMIOL, V58, P1325, DOI 10.1016/j.jclinepi.2005.04.009; Dennekamp M, 2010, EPIDEMIOLOGY, V21, P494, DOI 10.1097/EDE.0b013e3181e093db; Donahoe SM, 2007, JAMA-J AM MED ASSOC, V298, P765, DOI 10.1001/jama.298.7.765; Empana JP, 2009, CRIT CARE MED, V37, P3079, DOI 10.1097/CCM.0b013e3181b0868f; Ensor KB, 2013, CIRCULATION, V127, P1192, DOI 10.1161/CIRCULATIONAHA.113.000027; Fukuda T, 2014, J CRIT CARE, V29, P840, DOI 10.1016/j.jcrc.2014.03.034; Gasparrini A, 2010, STAT MED, V29, P2224, DOI 10.1002/sim.3940; Gasparrini A, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-1; Goraya TY, 2003, AM J EPIDEMIOL, V157, P763, DOI 10.1093/aje/kwg057; Kang SH, 2016, INT J CARDIOL, V221, P232, DOI 10.1016/j.ijcard.2016.07.071; Kang SH, 2016, INT J CARDIOL, V203, P1086, DOI 10.1016/j.ijcard.2015.11.100; KEATINGE WR, 1984, BMJ-BRIT MED J, V289, P1405, DOI 10.1136/bmj.289.6456.1405; Kenney WL, 2014, MED SCI SPORT EXER, V46, P1891, DOI 10.1249/MSS.0000000000000325; Larsson M, 2005, RESUSCITATION, V66, P303, DOI 10.1016/j.resuscitation.2005.03.012; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Murakami Y, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000533; Nishiyama C, 2011, RESUSCITATION, V82, P1008, DOI 10.1016/j.resuscitation.2011.03.035; Pradeau C, 2015, AM J EMERG MED, V33, P367, DOI 10.1016/j.ajem.2014.12.007; Raza A, 2014, EUR HEART J, V35, P861, DOI 10.1093/eurheartj/eht489; Ro YS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154245; Rosenthal FS, 2008, ENVIRON HEALTH PERSP, V116, P631, DOI 10.1289/ehp.10757; Rosenthal FS, 2013, J EXPO SCI ENV EPID, V23, P281, DOI 10.1038/jes.2012.121; Sacks JD, 2011, ENVIRON HEALTH PERSP, V119, P446, DOI 10.1289/ehp.1002255; Serinelli M, 2010, OCCUP ENVIRON MED, V67, P301, DOI 10.1136/oem.2009.046359; Smith BT, 2011, AM J EPIDEMIOL, V173, P438, DOI 10.1093/aje/kwq379; Straney L, 2014, J EPIDEMIOL COMMUN H, V68, P6, DOI 10.1136/jech-2013-202955; Tanigawa-Sugihara K, 2013, CIRC J, V77, P2073, DOI 10.1253/circj.CJ-13-0076; Teng THK, 2014, J EPIDEMIOL COMMUN H, V68, P37, DOI 10.1136/jech-2013-203116; van de Glind EMM, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-68; Wang CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122675; Wang YC, 2012, SCI TOTAL ENVIRON, V416, P97, DOI 10.1016/j.scitotenv.2011.11.073; Wells DM, 2016, ANN EPIDEMIOL, V26, P418, DOI 10.1016/j.annepidem.2016.04.001; Wichmann J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053684; Winther-Jensen M, 2015, RESUSCITATION, V96, P78, DOI 10.1016/j.resuscitation.2015.06.030; Yorifuji T, 2014, J OCCUP ENVIRON MED, V56, P1019, DOI 10.1097/JOM.0000000000000274; Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334	44	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2018	13	9							e0204593	10.1371/journal.pone.0204593	http://dx.doi.org/10.1371/journal.pone.0204593			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3NB	30256842	Green Published, gold, Green Submitted			2022-12-26	WOS:000446000200055
J	Boskovic, S; Marin-Juez, R; Jasnic, J; Reischauer, S; El Sammak, H; Kojic, A; Faulkner, G; Radojkovic, D; Stainier, DYR; Kojic, S				Boskovic, Srdjan; Marin-Juez, Ruben; Jasnic, Jovana; Reischauer, Sven; El Sammak, Hadil; Kojic, Ana; Faulkner, Georgine; Radojkovic, Dragica; Stainier, Didier Y. R.; Kojic, Snezana			Characterization of zebrafish (Danio rerio) muscle ankyrin repeat proteins reveals their conserved response to endurance exercise	PLOS ONE			English	Article							SKELETAL-MUSCLE; GENE-EXPRESSION; ECCENTRIC CONTRACTIONS; CONGENITAL MYOPATHY; MUSCULAR-DYSTROPHY; CARP; ANKRD2; HEART; IDENTIFICATION; REGULATOR	Muscle proteins with ankyrin repeats (MARPs) ANKRD1 and ANKRD2 are titin-associated proteins with a putative role as transcriptional co-regulators in striated muscle, involved in the cellular response to mechanical, oxidative and metabolic stress. Since many aspects of the biology of MARPs, particularly exact mechanisms of their action, in striated muscle are still elusive, research in this field will benefit from novel animal model system. Here we investigated the MARPs found in zebrafish for protein structure, evolutionary conservation, spatiotemporal expression profiles and response to increased muscle activity. Ankrd1 and Ankrd2 show overall moderate conservation at the protein level, more pronounced in the region of ankyrin repeats, motifs indispensable for their function. The two zebrafish genes, ankrd1a and ankrd1b, counterparts of mammalian ANKRD1/Ankrd1, have different expression profiles during first seven days of development. Mild increase of ankrd1a transcript levels was detected at 72 hpf (1.74 +/- 0.24 fold increase relative to 24 hpf time point), while ankrd1b expression was markedly upregulated from 24 hpf onward and peaked at 72 hpf (92.18 +/- 36.95 fold increase relative to 24 hpf time point). Spatially, they exhibited non-overlapping expression patterns during skeletal muscle development in trunk (ankrd1a) and tail (ankrd1b) somites. Expression of ankrd2 was barely detectable. Zebrafish MARPs, expressed at a relatively low level in adult striated muscle, were found to be responsive to endurance exercise training consisting of two bouts of 3 hours of forced swimming daily, for five consecutive days. Three hours after the last exercise bout, ankrd1a expression increased in cardiac muscle (6.19 +/- 5.05 fold change), while ankrd1b and ankrd2 were upregulated in skeletal muscle (1.97 +/- 1.05 and 1.84 +/- 0.58 fold change, respectively). This study provides the foundation to establish zebrafish as a novel in vivo model for further investigation of MARPs function in striated muscle.	[Boskovic, Srdjan; Jasnic, Jovana; Kojic, Ana; Radojkovic, Dragica; Kojic, Snezana] Univ Belgrade, Inst Mol Genet & Genet Engn, Lab Mol Biol, Belgrade, Serbia; [Marin-Juez, Ruben; Reischauer, Sven; El Sammak, Hadil; Stainier, Didier Y. R.] Max Planck Inst Heart & Lung Res, Dept Dev Genet, Bad Nauheim, Germany; [Faulkner, Georgine] Univ Padua, Dept Biol, Padua, Italy	University of Belgrade; Max Planck Society; University of Padua	Kojic, S (corresponding author), Univ Belgrade, Inst Mol Genet & Genet Engn, Lab Mol Biol, Belgrade, Serbia.	snezanakojic@imgge.bg.ac.rs	Reischauer, Sven/AAO-8900-2020; Kojic, Snezana/AAF-4873-2019; Marín-Juez, Rubén/AAN-7660-2021	Marín-Juez, Rubén/0000-0001-5903-7463; Stainier, Didier/0000-0002-0382-0026; Jasnic, Jovana/0000-0003-1118-0492; Reischauer, Sven/0000-0002-6955-9481; Kojic, Ana/0000-0002-1829-9990; El-Sammak, Hadil/0000-0002-0178-1457; Boskovic, Srdjan/0000-0002-8458-6066; Kojic, Snezana/0000-0001-5090-1278	Ministry of Education, Science and Technological Development of the Republic of Serbia [173008, 451-03-01766/2014-09/3, 57140778]; German Academic Exchange Service [451-03-01766/2014-09/3, 57140778]; Max Planck Society	Ministry of Education, Science and Technological Development of the Republic of Serbia; German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); Max Planck Society(Max Planck Society)	This study was supported by the Ministry of Education, Science and Technological Development of the Republic of Serbia (Project No. 173008 to DR), bilateral project funded by the German Academic Exchange Service and the Ministry of Education, Science and Technological Development of the Republic of Serbia (Project-ID 451-03-01766/2014-09/3 to SK and 57140778 to DYRS) and the Max Planck Society (DYRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angori S, 2017, CELL PHYSIOL BIOCHEM, V42, P169, DOI 10.1159/000477309; Arimura T, 2009, J AM COLL CARDIOL, V54, P334, DOI 10.1016/j.jacc.2008.12.082; Ba ANN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-202; Bang ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093638; Barash IA, 2004, AM J PHYSIOL-CELL PH, V286, pC355, DOI 10.1152/ajpcell.00211.2003; Barash IA, 2007, AM J PHYSIOL-CELL PH, V293, pC218, DOI 10.1152/ajpcell.00055.2007; Bean C, 2008, BBA-MOL CELL RES, V1783, P1023, DOI 10.1016/j.bbamcr.2008.01.027; Blazina AR, 2013, ZEBRAFISH, V10, P480, DOI 10.1089/zeb.2012.0860; Carson JA, 2001, FASEB J, V15, P207, DOI 10.1096/fj.01-0544fje; Cenni V, 2011, MOL BIOL CELL, V22, P2946, DOI 10.1091/mbc.E10-11-0928; Chen YW, 2002, J PHYSIOL-LONDON, V545, P27, DOI 10.1113/jphysiol.2002.021220; Crocini C, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0349-x; Duboscq-Bidot L, 2009, EUR HEART J, V30, P2128, DOI 10.1093/eurheartj/ehp225; Force A, 1999, GENETICS, V151, P1531; Goldman JA, 2017, DEV CELL, V40, P392, DOI 10.1016/j.devcel.2017.01.013; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gut P, 2017, PHYSIOL REV, V97, P889, DOI 10.1152/physrev.00038.2016; Hentzen ER, 2006, J PHYSIOL-LONDON, V570, P157, DOI 10.1113/jphysiol.2005.093005; IBANEZ J, 1990, EUR J APPL PHYSIOL, V60, P265, DOI 10.1007/BF00379394; Ikeda K, 2003, J BIOL CHEM, V278, P3514, DOI 10.1074/jbc.M204563200; Ishiguro N, 2002, AM J PATHOL, V160, P1767, DOI 10.1016/S0002-9440(10)61123-6; Jasnic-Savovic J, 2015, HISTOCHEM CELL BIOL, V143, P583, DOI 10.1007/s00418-015-1307-5; Jeyaseelan R, 1997, J BIOL CHEM, V272, P22800, DOI 10.1074/jbc.272.36.22800; Kanda K, 2014, EXERC IMMUNOL REV, V20, P39; Kemp TJ, 2000, GENOMICS, V66, P229, DOI 10.1006/geno.2000.6213; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kojic S, 2011, CRIT REV CL LAB SCI, V48, P269, DOI 10.3109/10408363.2011.643857; Koskinen SOA, 2017, HISTOCHEM CELL BIOL, V148, P545, DOI 10.1007/s00418-017-1595-z; Lai SL, 2017, ELIFE, V6, DOI 10.7554/eLife.25605; Lehti M, 2009, J APPL PHYSIOL, V106, P1419, DOI 10.1152/japplphysiol.90660.2008; Lehti TM, 2007, AM J PHYSIOL-ENDOC M, V292, pE533, DOI 10.1152/ajpendo.00229.2006; LeMoine CMR, 2010, J COMP PHYSIOL B, V180, P151, DOI 10.1007/s00360-009-0398-5; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Louis A, 2013, NUCLEIC ACIDS RES, V41, pD700, DOI 10.1093/nar/gks1156; Lun AS, 2014, ANAT REC, V297, P1615, DOI 10.1002/ar.22968; Ma GD, 2014, INT J BIOL SCI, V10, P309, DOI 10.7150/ijbs.7475; McClelland GB, 2006, J PHYSIOL-LONDON, V577, P739, DOI 10.1113/jphysiol.2006.119032; Mckoy G, 2005, J APPL PHYSIOL, V98, P2337, DOI 10.1152/japplphysiol.01046.2004; Mikhailov AT, 2008, INT J DEV BIOL, V52, P811, DOI 10.1387/ijdb.082655am; Miller MK, 2003, J MOL BIOL, V333, P951, DOI 10.1016/j.jmb.2003.09.012; Mohamed JS, 2010, FASEB J, V24, P3330, DOI 10.1096/fj.10-158386; Moriyama M, 2001, BIOCHEM BIOPH RES CO, V285, P715, DOI 10.1006/bbrc.2001.5216; Moulik M, 2009, J AM COLL CARDIOL, V54, P325, DOI 10.1016/j.jacc.2009.02.076; Nagueh SF, 2004, CIRCULATION, V110, P155, DOI 10.1161/01.CIR.0000135591.37759.AF; Nakada C, 2004, PATHOBIOLOGY, V71, P43, DOI 10.1159/000072961; Nakada C, 2003, PATHOL INT, V53, P653, DOI 10.1046/j.1440-1827.2003.01541.x; Nakada C, 2003, LAB INVEST, V83, P711, DOI 10.1097/01.LAB.0000067484.35298.1A; Nakamura K, 2002, PATHOBIOLOGY, V70, P197, DOI 10.1159/000069329; Nord H, 2014, MOL BIOL CELL, V25, P1384, DOI 10.1091/mbc.E13-08-0486; Ojima K, 2010, J CLIN INVEST, V120, P2672, DOI 10.1172/JCI40658; Pallavicini A, 2001, BIOCHEM BIOPH RES CO, V285, P378, DOI 10.1006/bbrc.2001.5131; Palstra AP, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1136; Petryszak R, 2016, NUCLEIC ACIDS RES, V44, pD746, DOI 10.1093/nar/gkv1045; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; Rovira M, 2016, THESIS; Rovira M, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.01063; Samaras SE, 2015, AM J PATHOL, V185, P96, DOI 10.1016/j.ajpath.2014.09.018; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shi Y, 2005, AM J PATHOL, V166, P303, DOI 10.1016/S0002-9440(10)62254-7; Shih YH, 2015, CIRC-CARDIOVASC GENE, V8, P261, DOI 10.1161/CIRCGENETICS.114.000702; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stuewe SR, 2000, J MOL CELL CARDIOL, V32, P903, DOI 10.1006/jmcc.2000.1131; Szeto DP, 2006, GENE DEV, V20, P1923, DOI 10.1101/gad.1435306; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tsukamoto Y, 2002, LAB INVEST, V82, P645, DOI 10.1038/labinvest.3780459; Tsukamoto Y, 2008, HISTOCHEM CELL BIOL, V129, P55, DOI 10.1007/s00418-007-0348-9; Usui T, 2018, PEERJ, V6, DOI 10.7717/peerj.4292; van der Meulen T, 2006, AM J PHYSIOL-REG I, V291, pR1040, DOI 10.1152/ajpregu.00116.2006; Wei YJ, 2009, EUR J HEART FAIL, V11, P559, DOI 10.1093/eurjhf/hfp049; Wette SG, 2017, AM J PHYSIOL-CELL PH, V313, pC327, DOI 10.1152/ajpcell.00077.2017; Witt SH, 2005, J MUSCLE RES CELL M, V26, P401, DOI 10.1007/s10974-005-9022-9; Wu CC, 2016, DEV CELL, V36, P36, DOI 10.1016/j.devcel.2015.12.010; Zolk O, 2002, BIOCHEM BIOPH RES CO, V293, P1377, DOI 10.1016/S0006-291X(02)00387-X; Zou YM, 1997, DEVELOPMENT, V124, P793	75	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2018	13	9							e0204312	10.1371/journal.pone.0204312	http://dx.doi.org/10.1371/journal.pone.0204312			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU9BO	30252882	Green Submitted, gold, Green Published			2022-12-26	WOS:000445639700041
J	Yi, HA; Won, KS; Chang, HW; Kim, HW				Yi, Hyon-Ah; Won, Kyoung Sook; Chang, Hyuk Won; Kim, Hae Won			Association between white matter lesions and cerebral A beta burden	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; VASCULAR RISK-FACTORS; BLOOD-BRAIN-BARRIER; ALZHEIMERS-DISEASE; HYPERINTENSITIES; THALAMUS; PLAQUES; ARTERY; NEURODEGENERATION; PATHOLOGY	Introduction White matter lesions (WMLs), detected as hyperintensities on T2-weighted MRI, represent small vessel disease in the brain and are considered a potential risk factor for memory and cognitive impairment in older adults. The purpose of this study was to evaluate the association between WMLs and cerebral amyloid-beta (A(beta) burden in patients with cognitive impairment. Methods A total of 83 patients with cognitive impairment, who underwent brain MRI and F-18 florbetaben PET, were included prospectively: 19 patients were cognitively unimpaired, 30 exhibited mild cognitive impairment (MCI), and 34 exhibited dementia. The Fazekas scale was used to quantify WMLs on T2-weighted brain MR images. Cerebral A beta burden was quantitatively estimated using volume-of-interest analysis. Differences in cerebral A beta burden were evaluated between low-WML (Fazekas scale <= 1) and high-WML (Fazekas scale >= 2) groups. The relationship between the Fazekas rating and cerebral A beta burden was evaluated using linear regression analysis after adjusting for age and sex. Results In the overall cohort, the high-WML group exhibited significantly higher A beta burden compared with the low-WML group (P=0.011) and cerebral A beta burden was positively correlated with Fazekas rating(beta= 0.299, P= 0.006). In patients with MCI, the high-WML group exhibited significantly higher A beta burden compared with the low-WML group (P= 0.019) and cerebral A beta burden was positively correlated with Fazekas rating (beta = 0.517, P= 0.003). Conclusion The presence of WMLs was associated with cerebral A beta burden in patients with MCI. Our findings suggest that small vessel disease in the brain is related to Alzheimer's disease pathology.	[Yi, Hyon-Ah] Keimyung Univ, Dept Neurol, Dongsan Med Ctr, Daegu, South Korea; [Won, Kyoung Sook; Kim, Hae Won] Keimyung Univ, Dept Nucl Med, Dongsan Med Ctr, Daegu, South Korea; [Chang, Hyuk Won] Semyung Radiol Clin, Dept Radiol, Gumi, South Korea	Keimyung University; Keimyung University	Kim, HW (corresponding author), Keimyung Univ, Dept Nucl Med, Dongsan Med Ctr, Daegu, South Korea.	hwkim.nm@gmail.com	Chang, Hyuk Won/AAJ-7586-2020	Chang, Hyuk Won/0000-0001-7863-0334	Keimyung University Dongsan Medical Center	Keimyung University Dongsan Medical Center	This work was supported by the research promoting grant from the Keimyung University Dongsan Medical Center in 2018.	Alosco ML, 2018, J ALZHEIMERS DIS, V63, P1347, DOI 10.3233/JAD-180017; Barthel H, 2011, LANCET NEUROL, V10, P424, DOI 10.1016/S1474-4422(11)70077-1; Basile AM, 2006, CEREBROVASC DIS, V21, P315, DOI 10.1159/000091536; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brickman AM, 2012, ARCH NEUROL-CHICAGO, V69, P1621, DOI 10.1001/archneurol.2012.1527; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Cho H, 2016, NEUROLOGY, V87, P375, DOI 10.1212/WNL.0000000000002892; de Bruijn RFAG, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0130-5; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Geppert AM, 2007, ALZHEIMERS DEMENT, V3, P54, DOI 10.1016/j.jalz.2006.10.007; Gorelick PB, 2004, STROKE, V35, P2620, DOI 10.1161/01.STR.0000143318.70292.47; Habes M, 2016, BRAIN, V139, P1164, DOI 10.1093/brain/aww008; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Iqbal K, 2005, BBA-MOL BASIS DIS, V1739, P198, DOI 10.1016/j.bbadis.2004.09.008; Jack CR, 2018, ALZHEIMERS DEMENT, V14, P535, DOI 10.1016/j.jalz.2018.02.018; Kalaria RN, 2000, NEUROBIOL AGING, V21, P321, DOI 10.1016/S0197-4580(00)00125-1; Kandel Benjamin M, 2016, Alzheimers Dement (Amst), V4, P18, DOI 10.1016/j.dadm.2016.03.001; Lindemer ER, 2015, NEUROBIOL AGING, V36, P2447, DOI 10.1016/j.neurobiolaging.2015.05.011; Lobanova Iryna, 2014, J Vasc Interv Neurol, V7, P52; Makinen S, 2008, J CEREBR BLOOD F MET, V28, P263, DOI 10.1038/sj.jcbfm.9600529; McAleese KE, 2017, ACTA NEUROPATHOL, V134, P459, DOI 10.1007/s00401-017-1738-2; Moghekar Abhay, 2012, Alzheimers Dement, V8, pS71, DOI 10.1016/j.jalz.2012.04.006; Morris JC, 2010, ANN NEUROL, V67, P122, DOI 10.1002/ana.21843; O'Brien JT, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0218-y; O'Brien JT, 2003, LANCET NEUROL, V2, P89, DOI 10.1016/S1474-4422(03)00305-3; Park JH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186976; Pluta R, 2007, CURR NEUROVASC RES, V4, P121, DOI 10.2174/156720207780637207; Pluta R, 2006, NEUROL RES, V28, P665, DOI 10.1179/016164106X130399; Pluta Ryszard, 2008, Neuropsychiatr Dis Treat, V4, P855; Ryan NS, 2013, BRAIN, V136, P1399, DOI 10.1093/brain/awt065; Sabri O, 2015, ALZHEIMERS DEMENT, V11, P964, DOI 10.1016/j.jalz.2015.02.004; Toledo JB, 2013, BRAIN, V136, P2697, DOI 10.1093/brain/awt188; Tosto G, 2015, ALZHEIMERS DEMENT, V11, P1510, DOI 10.1016/j.jalz.2015.05.014; van Groen T, 2005, STROKE, V36, P1551, DOI 10.1161/01.STR.0000169933.88903.cf; van Westen D, 2016, SCI REP-UK, V6, DOI 10.1038/srep20709; Villemagne VL, 2013, LANCET NEUROL, V12, P357, DOI 10.1016/S1474-4422(13)70044-9; Wagner M, 2015, NEURORADIOLOGY, V57, P1023, DOI 10.1007/s00234-015-1565-x; Wardlaw JM, 2004, J NEUROL, V251, P584, DOI 10.1007/s00415-004-0371-x; Wardlaw JM, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001140; Wardlaw JM, 2014, NEUROLOGY, V82, P1331, DOI 10.1212/WNL.0000000000000312; Zhou YX, 2015, J MAGN RESON IMAGING, V41, P102, DOI 10.1002/jmri.24550	42	10	10	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2018	13	9							e0204313	10.1371/journal.pone.0204313	http://dx.doi.org/10.1371/journal.pone.0204313			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3MI	30248123	Green Submitted, Green Published, gold			2022-12-26	WOS:000445998100032
J	Chuzel, L; Ganatra, MB; Rapp, E; Henrissat, B; Taron, CH				Chuzel, Lea; Ganatra, Mehul B.; Rapp, Erdmann; Henrissat, Bernard; Taron, Christopher H.			Functional metagenomics identifies an exosialidase with an inverting catalytic mechanism that defines a new glycoside hydrolase family (GH156)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						sialidase; glycoside hydrolase; high-throughput screening (HTS); neuraminidase; sialic acid; glycosylation; extremophile; functional metagenomics; inverting mechanism	CRYSTAL-STRUCTURE; SUBSTRATE-SPECIFICITY; VIRUS NEURAMINIDASE; TRANS-SIALIDASE; EXPRESSION; MUTAGENESIS; RETENTION; DIVERSITY; RESIDUES; COMPLEX	Exosialidases are glycoside hydrolases that remove a single terminal sialic acid residue from oligosaccharides. They are widely distributed in biology, having been found in prokaryotes, eukaryotes, and certain viruses. Most characterized prokaryotic sialidases are from organisms that are pathogenic or commensal with mammals. However, in this study, we used functional metagenomic screening to seek microbial sialidases encoded by environmental DNA isolated from an extreme ecological niche, a thermal spring. Using recombinant expression of potential exosialidase candidates and a fluorogenic sialidase substrate, we discovered an exosialidase having no homology to known sialidases. Phylogenetic analysis indicated that this protein is a member of a small family of bacterial proteins of previously unknown function. Proton NMR revealed that this enzyme functions via an inverting catalytic mechanism, a biochemical property that is distinct from those of known exosialidases. This unique inverting exosialidase defines a new CAZy glycoside hydrolase family we have designated GH156.	[Chuzel, Lea; Ganatra, Mehul B.; Taron, Christopher H.] New England Biolabs Inc, 240 Cty Rd, Ipswich, MA 01938 USA; [Chuzel, Lea; Rapp, Erdmann] Max Planck Inst Dynam Complex Tech Syst, D-39106 Magdeburg, Germany; [Rapp, Erdmann] GlyXera GmbH, D-39120 Magdeburg, Germany; [Henrissat, Bernard] Aix Marseille Univ, CNRS, Architecture & Fonct Macromol Biol, F-13288 Marseille, France; [Henrissat, Bernard] INRA, USC 1408, Architecture & Fonct Macromol Biol, F-13288 Marseille, France; [Henrissat, Bernard] King Abdulaziz Univ, Dept Biol Sci, Jeddah 21589, Saudi Arabia	New England Biolabs; Max Planck Society; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; INRAE; UDICE-French Research Universities; Aix-Marseille Universite; King Abdulaziz University	Taron, CH (corresponding author), New England Biolabs Inc, 240 Cty Rd, Ipswich, MA 01938 USA.	taron@neb.com	Henrissat, Bernard/J-2475-2012	Henrissat, Bernard/0000-0002-3434-8588; Taron, Christopher/0000-0001-8149-4556; Chuzel, Lea/0000-0001-7185-5872; Rapp, Erdmann/0000-0001-6618-2626	New England Biolabs; Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, U.S. Department of Energy [DE-SC0015662]	New England Biolabs; Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, U.S. Department of Energy(United States Department of Energy (DOE))	We thank Dr. Donald Comb for basic research funding at New England Biolabs. We thank Rick Morgan for kindly providing hot spring environmental DNA. We also thank Barbara Taron, Saulius Vainauskas, Bill Jack, and Tom Evans for comments and critical review of the manuscript prior to its submission. NMR analysis was performed by the Complex Carbohydrate Research Center supported by the Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, U.S. Department of Energy Grant DE-SC0015662.	BURMEISTER WP, 1993, STRUCTURE, V1, P19, DOI 10.1016/0969-2126(93)90005-2; Buschiazzo A, 2000, EMBO J, V19, P16, DOI 10.1093/emboj/19.1.16; Buschiazzo A, 2002, MOL CELL, V10, P757, DOI 10.1016/S1097-2765(02)00680-9; Chan J, 2011, ORG BIOMOL CHEM, V9, P4818, DOI 10.1039/c1ob05079f; Cheng JJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172545; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; CHONG AKJ, 1992, EUR J BIOCHEM, V207, P335, DOI 10.1111/j.1432-1033.1992.tb17055.x; Coughlan LM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00672; Crennell S, 2000, NAT STRUCT BIOL, V7, P1068; CRENNELL S, 1994, STRUCTURE, V2, P535, DOI 10.1016/S0969-2126(00)00053-8; CRENNELL SJ, 1993, P NATL ACAD SCI USA, V90, P9852, DOI 10.1073/pnas.90.21.9852; Czjzek M., INNOVATING GLYCOSIDE, DOI [10.1073/pnas.1704802114, 10. 1073/pnas. 1704802114, DOI 10.1073/PNAS.1704802114]; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; DeCastro ME, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01521; Foley MH, 2016, CELL MOL LIFE SCI, V73, P2603, DOI 10.1007/s00018-016-2242-x; FRIEBOLIN H, 1980, H-S Z PHYSIOL CHEM, V361, P697, DOI 10.1515/bchm2.1980.361.1.697; FRIEBOLIN H, 1981, H-S Z PHYSIOL CHEM, V362, P1455, DOI 10.1515/bchm2.1981.362.2.1455; FURSTE JP, 1986, GENE, V48, P119, DOI 10.1016/0378-1119(86)90358-6; Ghate AA, 1998, EUR J BIOCHEM, V258, P320, DOI 10.1046/j.1432-1327.1998.2580320.x; Gladden JM, 2012, BIOTECHNOL BIOENG, V109, P1140, DOI 10.1002/bit.24388; Guo J, 2015, PROCESS BIOCHEM, V50, P752, DOI 10.1016/j.procbio.2015.02.005; Jers C, 2015, PROTEIN ENG DES SEL, V28, P37, DOI 10.1093/protein/gzu054; Kao YH, 1997, GLYCOBIOLOGY, V7, P559, DOI 10.1093/glycob/7.4.559; Leis B, 2013, ADV APPL MICROBIOL, V83, P1, DOI 10.1016/B978-0-12-407678-5.00001-5; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Luo Y, 1998, STRUCTURE, V6, P521, DOI 10.1016/S0969-2126(98)00053-7; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; Maruthamuthu M, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2404-0; MCCARTER JD, 1994, CURR OPIN STRUC BIOL, V4, P885, DOI 10.1016/0959-440X(94)90271-2; Mewis K, 2013, J BIOTECHNOL, V167, P462, DOI 10.1016/j.jbiotec.2013.07.015; Minami A, 2013, FEBS OPEN BIO, V3, P231, DOI 10.1016/j.fob.2013.05.002; Mirete S, 2016, CURR OPIN BIOTECH, V38, P143, DOI 10.1016/j.copbio.2016.01.017; Morley TJ, 2009, J BIOL CHEM, V284, P17404, DOI 10.1074/jbc.M109.003970; Park KH, 2013, BBA-PROTEINS PROTEOM, V1834, P1510, DOI 10.1016/j.bbapap.2013.04.028; PETTER JG, 1993, J BACTERIOL, V175, P4354, DOI 10.1128/JB.175.14.4354-4363.1993; Rooks DJ, 2012, METHOD ENZYMOL, V510, P375, DOI 10.1016/B978-0-12-415931-0.00020-3; Sathya TA, 2014, J FOOD SCI, V79, pR2149, DOI 10.1111/1750-3841.12677; Sekiguchi Y, 2003, INT J SYST EVOL MICR, V53, P1843, DOI 10.1099/ijs.0.02699-0; Useh NA, 2006, CELL BIOCHEM FUNCT, V24, P347, DOI 10.1002/cbf.1240; VARGHESE JN, 1983, NATURE, V303, P35, DOI 10.1038/303035a0; Varki A, 1999, ESSENTIALS GLYCOBIOL, P195; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091; Vester JK, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-72; Vimr ER, 2004, MICROBIOL MOL BIOL R, V68, P132, DOI 10.1128/MMBR.68.1.132-153.2004; Vuong TV, 2010, BIOTECHNOL BIOENG, V107, P195, DOI 10.1002/bit.22838; Wang XD, 2017, BIOTECHNOL APPL BIOC, V64, P195, DOI 10.1002/bab.1475; Watson JN, 2003, BIOCHEMISTRY-US, V42, P12682, DOI 10.1021/bi035396g; WILSON JC, 1995, J AM CHEM SOC, V117, P4214, DOI 10.1021/ja00120a002; Wu DY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004207; Zhu WH, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq275	50	17	17	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18138	18150		10.1074/jbc.RA118.003302	http://dx.doi.org/10.1074/jbc.RA118.003302			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30249617	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000451375200010
J	Pedersen, TM; Boardman, NT; Hafstad, AD; Aasum, E				Pedersen, Tina M.; Boardman, Neoma T.; Hafstad, Anne D.; Aasum, Ellen			Isolated perfused working hearts provide valuable additional information during phenotypic assessment of the diabetic mouse heart	PLOS ONE			English	Article							CARDIOMYOCYTE-SPECIFIC EXCISION; INDUCED OBESE MICE; CARDIAC EFFICIENCY; DIASTOLIC DYSFUNCTION; CONTRACTILE DYSFUNCTION; INSULIN-RESISTANCE; DB/DB MICE; METABOLISM; GLUCOSE; HYPERTROPHY	Although murine models for studying the development of cardiac dysfunction in diabetes mellitus are well established, their reported cardiac phenotypes vary. These reported divergences may, in addition to the severity of different models, also be linked to the methods used for cardiac functional assessment. In the present study, we examined the functional changes using conventional transthoracic echocardiography (in vivo) and isolated heart perfusion techniques (ex vivo), in hearts from two mouse models; one with an overt type 2 diabetes (the db/db mouse) and one with a prediabetic state, where obesity was induced by a high-fat diet (HFD). Analysis of left ventricular function in the isolated working hearts from HFD-fed mice, suggested that these hearts develop diastolic dysfunction with preserved systolic function. Accordingly, in vivo examination demonstrated maintained systolic function, but we did not find parameters of diastolic function to be altered. In db/db mice, ex vivo working hearts showed both diastolic and systolic dysfunction. Although in vivo functional assessment revealed signs of diastolic dysfunction, the hearts did not display reduced systolic function. The contrasting results between ex vivo and in vivo function could be due to systemic changes that may sustain in vivo function, or a lack of sensitivity using conventional transthoracic echocardiography. Thus, this study demonstrates that the isolated perfused working heart preparation provides unique additional information related to the development of cardiomyopathy, which might otherwise go unnoticed when only using conventional echocardiographic assessment.	[Pedersen, Tina M.; Boardman, Neoma T.; Hafstad, Anne D.; Aasum, Ellen] UiT Arctic Univ Norway, Fac Hlth Sci, Dept Med Biol, Cardiovasc Res Grp, Tromso, Norway	UiT The Arctic University of Tromso	Aasum, E (corresponding author), UiT Arctic Univ Norway, Fac Hlth Sci, Dept Med Biol, Cardiovasc Res Grp, Tromso, Norway.	ellen.aasum@uit.no	Hafstad, Anne D/AAK-4269-2021	Pedersen, Tina Myhre/0000-0001-7950-4647; Aasum, Ellen/0000-0002-5731-3273; Hafstad, Anne/0000-0003-0711-9736	Norwegian Council on Cardiovascular Disease; UiT - The Arctic University of Norway	Norwegian Council on Cardiovascular Disease; UiT - The Arctic University of Norway	This work was supported by grants from The Norwegian Council on Cardiovascular Disease (TMP, ADH, NTB). This publication also arises from research funded by UiT - The Arctic University of Norway.	Aasum E, 2005, CAN J PHYSIOL PHARM, V83, P183, DOI 10.1139/Y04-139; Aasum E, 2003, DIABETES, V52, P434, DOI 10.2337/diabetes.52.2.434; Aasum E, 2002, AM J PHYSIOL-HEART C, V283, pH949, DOI 10.1152/ajpheart.00226.2001; Abdurrachim D, 2014, BBA-MOL CELL BIOL L, V1841, P1525, DOI 10.1016/j.bbalip.2014.07.016; Andersson KB, 2009, J MOL CELL CARDIOL, V47, P180, DOI 10.1016/j.yjmcc.2009.03.013; Barouch LA, 2003, CIRCULATION, V108, P754, DOI 10.1161/01.CIR.0000083716.82622.FD; Belke DD, 2000, AM J PHYSIOL-ENDOC M, V279, pE1104, DOI 10.1152/ajpendo.2000.279.5.E1104; Belke DD, 2004, DIABETES, V53, P3201, DOI 10.2337/diabetes.53.12.3201; Boardman NT, 2014, AM J PHYSIOL-HEART C, V306, pH1018, DOI 10.1152/ajpheart.00741.2013; Brainard RE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083174; Buchanan J, 2005, ENDOCRINOLOGY, V146, P5341, DOI 10.1210/en.2005-0938; Calligaris SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060931; COLEMAN DL, 1978, DIABETOLOGIA, V14, P141, DOI 10.1007/BF00429772; DANIELS A, 2010, DEV POLICY REV, V28, P11, DOI DOI 10.1111/J.1748-1716.2010.02102.X; Dludla PV, 2017, HEART VESSELS, V32, P1025, DOI 10.1007/s00380-017-0978-3; Dong F, 2006, J ENDOCRINOL, V188, P25, DOI 10.1677/joe.1.06241; FEIN FS, 1990, DIABETES CARE, V13, P1169, DOI 10.2337/diacare.13.11.1169; GALINANES M, 1990, CARDIOSCIENCE, V1, P127; GRUPP IL, 1993, AM J PHYSIOL, V265, pH1401, DOI 10.1152/ajpheart.1993.265.4.H1401; Hafstad AD, 2007, AM J PHYSIOL-ENDOC M, V292, pE1288, DOI 10.1152/ajpendo.00504.2006; Hafstad AD, 2013, DIABETES, V62, P2287, DOI 10.2337/db12-1580; Hamdani N, 2014, CARDIOVASC RES, V104, P423, DOI 10.1093/cvr/cvu223; How O. -J., 2007, Archives of Physiology and Biochemistry, V113, P211, DOI 10.1080/13813450701783281; How OJ, 2006, DIABETES, V55, P466, DOI 10.2337/diabetes.55.02.06.db05-1164; How OJ, 2005, AM J PHYSIOL-HEART C, V288, pH2979, DOI 10.1152/ajpheart.00084.2005; Jeong EM, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003046; Khalid AM, 2011, AM J PHYSIOL-HEART C, V300, pH2116, DOI 10.1152/ajpheart.00357.2010; Ko KY, 2017, ONCOTARGET, V8, P87795, DOI 10.18632/oncotarget.21202; Kuzmiak-Glancy S, 2018, AM J PHYSIOL-HEART C, V314, pH704, DOI 10.1152/ajpheart.00321.2017; Land S, 2013, BIOPHYS J, V104, P1349, DOI 10.1016/j.bpj.2013.01.042; Larsen TS, 1999, PFLUG ARCH EUR J PHY, V437, P979, DOI 10.1007/s004240050870; Li RJ, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-141; Lindsey ML, 2018, AM J PHYSIOL-HEART C, V314, pH733, DOI 10.1152/ajpheart.00339.2017; Lund J, 2015, AM J PHYSIOL-HEART C, V308, pH823, DOI 10.1152/ajpheart.00734.2014; Mori J, 2014, CIRC-HEART FAIL, V7, P327, DOI 10.1161/CIRCHEARTFAILURE.113.000672; Naresh NK, 2016, J CARDIOVASC MAGN R, V18, DOI 10.1186/s12968-016-0273-y; Nicholson A, 2010, OBESITY, V18, P1902, DOI 10.1038/oby.2009.477; Nilsson J, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0132-8; Panagia M, 2007, CAN J PHYSIOL PHARM, V85, P289, DOI 10.1139/Y07-028; Park SY, 2005, DIABETES, V54, P3530, DOI 10.2337/diabetes.54.12.3530; Pei XM, 2015, ACTA DIABETOL, V52, P293, DOI 10.1007/s00592-014-0637-4; Plante E, 2014, DIABETOLOGIA, V57, P1257, DOI 10.1007/s00125-014-3201-4; REGAN TJ, 1977, J CLIN INVEST, V60, P885, DOI 10.1172/JCI108843; Roberts NW, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0286-0; Russo SB, 2012, J CLIN INVEST, V122, P3919, DOI 10.1172/JCI63888; Schnelle M, 2018, J MOL CELL CARDIOL, V114, P20, DOI 10.1016/j.yjmcc.2017.10.006; Semeniuk LM, 2002, AM J PHYSIOL-HEART C, V283, pH976, DOI 10.1152/ajpheart.00088.2002; SHEHADEH A, 1995, CLIN CARDIOL, V18, P301, DOI 10.1002/clc.4960180604; Nguyen S, 2017, J NUTR BIOCHEM, V46, P137, DOI 10.1016/j.jnutbio.2017.05.009; Stolen TO, 2009, CIRC RES, V105, P527, DOI 10.1161/CIRCRESAHA.109.199810; Stuckey DJ, 2008, MAGN RESON MED, V60, P582, DOI 10.1002/mrm.21677; Ussher JR, 2009, DIABETES, V58, P1766, DOI 10.2337/db09-0011; van Bilsen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085078; Van den Bergh A, 2006, EUR J HEART FAIL, V8, P777, DOI 10.1016/j.ejheart.2006.03.001; Wang SD, 2016, TOXICOL LETT, V258, P134, DOI 10.1016/j.toxlet.2016.06.020; Yan J, 2009, CIRCULATION, V119, P2818, DOI 10.1161/CIRCULATIONAHA.108.832915; Yue P, 2007, AM J PHYSIOL-HEART C, V292, pH2106, DOI 10.1152/ajpheart.00856.2006; Zeng H, 2015, J CELL MOL MED, V19, P1847, DOI 10.1111/jcmm.12556; Zhang LY, 2011, CARDIOVASC RES, V89, P148, DOI 10.1093/cvr/cvq266	59	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204843	10.1371/journal.pone.0204843	http://dx.doi.org/10.1371/journal.pone.0204843			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273374	Green Published, Green Submitted, gold			2022-12-26	WOS:000446124700040
J	da Silva, RB; Machado, CR; Rodrigues, ARA; Pedrosa, AL				da Silva, Raissa Bernardes; Machado, Carlos Renato; Aquiles Rodrigues, Aldo Rogelis; Pedrosa, Andre Luiz			Selective human inhibitors of ATR and ATM render Leishmania major promastigotes sensitive to oxidative damage	PLOS ONE			English	Article							ATAXIA-TELANGIECTASIA FIBROBLASTS; MULTIPLE SEQUENCE ALIGNMENT; DNA-DAMAGE; CANCER-CELLS; TRYPANOSOMA-BRUCEI; STRUCTURE PREDICTION; TUMOR-CELLS; KINASE ATM; STRESS; CYCLE	All cellular processes, including those involved in normal cell metabolism to those responsible for cell proliferation or death, are finely controlled by cell signaling pathways, whose core proteins constitute the family of phosphatidylinositol 3-kinase-related kinases (PIKKs). Ataxia Telangiectasia Mutated (ATM) and Ataxia Telangiectasia and Rad3 related (ATR) are two important PIKK proteins that act in response to DNA damage, phosphorylating a large number of proteins to exert control over genomic integrity. The genus Leishmania belongs to a group of early divergent eukaryotes in evolution and has a highly plastic genome, probably owing to the existence of signaling pathways designed to maintain genomic integrity. The objective of this study was to evaluate the use of specific human inhibitors of ATR and ATM in Leishmania major. Bioinformatic analyses revealed the existence of the putative PIKK genes ATR and ATM, in addition to mTOR and DNA-PKcs in Leishmania spp. Moreover, it was possible to suggest that the inhibitors VE-821 and KU-55933 have binding affinity for the catalytic sites of putative L. major ATR and ATM, respectively. Promastigotes of L. major exposed to these inhibitors show slight growth impairment and minor changes in cell cycle and morphology. It is noteworthy that treatment of promastigotes with inhibitors VE-821 and KU-55933 enhanced the oxidative damage caused by hydrogen peroxide. These inhibitors could significantly reduce the number of surviving L. majorcells following H2O2 exposure whilst also decreasing their evaluated IC50 to H2O2 to less than half of that observed for non-treated cells. These results suggest that the use of specific inhibitors of ATR and ATM in Leishmania interferes in the signaling pathways of this parasite, which can impair its tolerance to DNA damage and affect its genome integrity. ATR and ATM could constitute novel targets for drug development and/or repositioning for treatment of leishmaniases.	[da Silva, Raissa Bernardes; Aquiles Rodrigues, Aldo Rogelis; Pedrosa, Andre Luiz] Univ Fed Triangulo Mineiro, Inst Ciencias Biol & Nat, Dept Bioquim Farmacol & Fisiol, Uberaba, MG, Brazil; [Machado, Carlos Renato] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil	Universidade Federal do Triangulo Mineiro; Universidade Federal de Minas Gerais	Pedrosa, AL (corresponding author), Univ Fed Triangulo Mineiro, Inst Ciencias Biol & Nat, Dept Bioquim Farmacol & Fisiol, Uberaba, MG, Brazil.	andre.pedrosa@uftm.edu.br	MACHADO, CARLOS/AAW-1492-2020; da Silva, Raíssa Bernardes/AAE-6357-2020; Pedrosa, Andre/C-1559-2014	da Silva, Raíssa Bernardes/0000-0002-2802-3808; Pedrosa, Andre/0000-0001-8682-813X	Fundacao de Amparo A Pesquisa do Estado de Minas Gerais [APQ-00644-16]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [408355/2016-6]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior	Fundacao de Amparo A Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Funded by Fundacao de Amparo A Pesquisa do Estado de Minas Gerais. Grant number APQ-00644-16 (www.fapemig.br) - ALP. Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. Grant number 408355/2016-6 (www.cnpq.br) - ALP. Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (www.capes.gov.br) - RBdaS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ambit A, 2011, EUKARYOT CELL, V10, P1429, DOI 10.1128/EC.05118-11; Aylett CHS, 2016, SCIENCE, V351, P48, DOI 10.1126/science.aaa3870; Bagley J, 2007, J IMMUNOL, V178, P4757, DOI 10.4049/jimmunol.178.8.4757; Ball HL, 2005, MOL BIOL CELL, V16, P2372, DOI 10.1091/mbc.e04-11-1006; Baretic D, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700933; Barzilai A, 2002, DNA REPAIR, V1, P3, DOI 10.1016/S1568-7864(01)00007-6; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Birben E, 2012, WORLD ALLERGY ORGAN, V5, P9, DOI 10.1097/WOX.0b013e3182439613; Biskup E, 2016, J DERMATOL SCI, V84, P239, DOI 10.1016/j.jdermsci.2016.09.010; Blackford AN, 2017, MOL CELL, V66, P801, DOI 10.1016/j.molcel.2017.05.015; Blasina A, 1999, CURR BIOL, V9, P1135, DOI 10.1016/S0960-9822(99)80486-2; Brown EJ, 2000, GENE DEV, V14, P397; Bruni N, 2017, INT J NANOMED, V12, P5289, DOI 10.2147/IJN.S140363; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Cavalier-Smith T, 2010, BIOL LETTERS, V6, P342, DOI 10.1098/rsbl.2009.0948; Charrier JD, 2011, J MED CHEM, V54, P2320, DOI 10.1021/jm101488z; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Choi M, 2016, MOL CANCER THER, V15, P1781, DOI 10.1158/1535-7163.MCT-15-0945; CODERRE JA, 1983, P NATL ACAD SCI-BIOL, V80, P2132, DOI 10.1073/pnas.80.8.2132; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Couch FB, 2013, GENE DEV, V27, P1610, DOI 10.1101/gad.214080.113; Damasceno JD, 2016, MOL MICROBIOL, V101, P1054, DOI 10.1111/mmi.13441; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Famulski KS, 2003, ONCOGENE, V22, P471, DOI 10.1038/sj.onc.1206167; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fujisawa H, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0464-y; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Hammarton TC, 2003, J BIOL CHEM, V278, P22877, DOI 10.1074/jbc.M300813200; Helaers R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-379; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Huntoon CJ, 2013, CANCER RES, V73, P3683, DOI 10.1158/0008-5472.CAN-13-0110; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Josse R, 2014, CANCER RES, V74, P6968, DOI 10.1158/0008-5472.CAN-13-3369; KAPLER GM, 1990, MOL CELL BIOL, V10, P1084, DOI 10.1128/MCB.10.3.1084; Kaye P, 2011, NAT REV MICROBIOL, V9, P604, DOI 10.1038/nrmicro2608; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kozlov SV, 2016, MOL CELL PROTEOMICS, V15, P1032, DOI 10.1074/mcp.M115.055723; LEBOWITZ JH, 1993, GENE DEV, V7, P996, DOI 10.1101/gad.7.6.996; Lempiainen H, 2009, EMBO J, V28, P3067, DOI 10.1038/emboj.2009.281; Leprohon P, 2009, NUCLEIC ACIDS RES, V37, P1387, DOI 10.1093/nar/gkn1069; Li Y, 2010, MOL CANCER THER, V9, P113, DOI 10.1158/1535-7163.MCT-08-1189; Li ZY, 2003, J BIOL CHEM, V278, P20652, DOI 10.1074/jbc.M301635200; Liu JH, 2017, INT J MED SCI, V14, P523, DOI 10.7150/ijms.19033; Luzwick JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099397; Manna PT, 2013, MOL PHYLOGENET EVOL, V67, P123, DOI 10.1016/j.ympev.2013.01.002; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McKinnon PJ, 2012, ANNU REV PATHOL-MECH, V7, P303, DOI 10.1146/annurev-pathol-011811-132509; Mishra A, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/4074357; Mittra B, 2013, TRENDS PARASITOL, V29, P489, DOI 10.1016/j.pt.2013.07.007; Moiseeva T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01401-x; Monte-Neto R, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003476; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Myler PJ, 1999, P NATL ACAD SCI USA, V96, P2902, DOI 10.1073/pnas.96.6.2902; Nadkarni A, 2012, J NEURO-ONCOL, V110, P349, DOI 10.1007/s11060-012-0979-0; Ng N, 2018, FEBS J, V285, P1563, DOI 10.1111/febs.14377; Nuhs A, 2014, INT J PARASITOL-DRUG, V4, P37, DOI 10.1016/j.ijpddr.2013.11.004; Palou R, 2017, CURR GENET, V63, P275, DOI 10.1007/s00294-016-0634-y; Perry J, 2003, CELL, V112, P151, DOI 10.1016/S0092-8674(03)00033-3; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pires IM, 2012, BRIT J CANCER, V107, P291, DOI 10.1038/bjc.2012.265; Prlic A, 2010, BIOINFORMATICS, V26, P2983, DOI 10.1093/bioinformatics/btq572; Rao QH, 2018, CELL RES, V28, P143, DOI 10.1038/cr.2017.158; Reaper PM, 2011, NAT CHEM BIOL, V7, P428, DOI [10.1038/NCHEMBIO.573, 10.1038/nchembio.573]; Requena JM, 2017, FRONTIERS PARASITOLO, P303; Rhodes N, 1998, GENE DEV, V12, P3686, DOI 10.1101/gad.12.23.3686; Rubinson EH, 2010, NATURE, V468, P406, DOI 10.1038/nature09428; Saini S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10041-6; Salovska B, 2014, INT J MOL SCI, V15, P12007, DOI 10.3390/ijms150712007; Sarkaria JN, 1999, CANCER RES, V59, P4375; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; Sibanda BL, 2010, NATURE, V463, P118, DOI 10.1038/nature08648; Smith J, 2010, ADV CANCER RES, V108, P73, DOI 10.1016/S0065.230X(10)08002.4; Teixeira DE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003594; Toulany M, 2014, RADIOTHER ONCOL, V111, P228, DOI 10.1016/j.radonc.2014.04.001; Tu XM, 2004, J BIOL CHEM, V279, P20519, DOI 10.1074/jbc.M312862200; Ubeda JM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001868; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weber AM, 2015, PHARMACOL THERAPEUT, V149, P124, DOI 10.1016/j.pharmthera.2014.12.001; Willis J, 2013, P NATL ACAD SCI USA, V110, P10592, DOI 10.1073/pnas.1301445110; Yamamoto K, 2016, ELIFE, V5, DOI 10.7554/eLife.14709; Yang CY, 2011, MOL CELL, V44, P597, DOI 10.1016/j.molcel.2011.09.016; Yang Y, 2013, NUCLEIC ACIDS RES, V41, P2296, DOI 10.1093/nar/gks1325; You ZS, 2005, MOL CELL BIOL, V25, P5363, DOI 10.1128/MCB.25.13.5363-5379.2005; Zhang TT, 2015, INT J RADIAT BIOL, V91, P368, DOI 10.3109/09553002.2015.1001531	90	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0205033	10.1371/journal.pone.0205033	http://dx.doi.org/10.1371/journal.pone.0205033			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265735	gold, Green Published, Green Submitted			2022-12-26	WOS:000446005500062
J	Bauters, K; Goetghebeur, P; Asselman, P; Meganck, K; Larridon, I				Bauters, Kenneth; Goetghebeur, Paul; Asselman, Pieter; Meganck, Kenny; Larridon, Isabel			Molecular phylogenetic study of Scleria subgenus Hypoporum (Sclerieae, Cyperoideae, Cyperaceae) reveals several species new to science	PLOS ONE			English	Article							MODELS; DNA; CLASSIFICATION; ALIGNMENT; MAFFT; TAXA	Scleria subgen. Hypoporum (Cyperaceae), with 68 species, is the second largest subgenus in Scleria. Species of this pantropically distributed subgenus generally occur in seasonally or permanently wet grasslands or on shallow soils over sandstone or lateritic outcrops, less often they can be found in (open) woodlands. Previous studies established the monophyly of the subgenus, but the relationships between the species remained uncertain. In this study, DNA sequence data of 61 taxa of Scleria subgen. Hypoporum, where possible represented by multiple accessions from across their distributional range, were obtained for four molecular markers: the coding chloroplast marker ndhF, the chloroplast intron rps16 and the nuclear ribosomal regions ETS and ITS. Phylogenetic trees were constructed using Bayesian inference and maximum likelihood approaches. A species tree was constructed to summarise the results. The results indicate the existence of three sections: the monotypic, pantropically occurring, Scleria sect. Lithospermae, a new section from central and south America containing two species, and Scleria sect. Hypoporum, also pantropically distributed, containing the remainder of the species of the subgenus. Relationships in the latter section are not fully resolved. However, three or four different clades can be distinguished supported by some morphological characters. Our results indicate at least six new species in Scleria sect. Hypoporum. The new section and species are described in a taxonomical treatment. Their morphology is compared with (morphologically) closely related species.	[Bauters, Kenneth; Asselman, Pieter] Bot Garden Meise, Meise, Belgium; [Bauters, Kenneth; Goetghebeur, Paul; Asselman, Pieter; Meganck, Kenny; Larridon, Isabel] Univ Ghent, Dept Biol, Res Grp Spermatophytes, Campus Ledeganck, Ghent, Belgium; [Meganck, Kenny] Royal Museum Cent Africa, Tervuren, Belgium; [Larridon, Isabel] Royal Bot Gardens, Richmond, Surrey, England	Ghent University; Royal Museum for Central Africa; Royal Botanic Gardens, Kew	Bauters, K (corresponding author), Bot Garden Meise, Meise, Belgium.; Bauters, K (corresponding author), Univ Ghent, Dept Biol, Res Grp Spermatophytes, Campus Ledeganck, Ghent, Belgium.	Kenneth.Bauters@botanicgardenmeise.be	Larridon, Isabel/ABH-5407-2020; Larridon, Isabel/J-8631-2013	Larridon, Isabel/0000-0003-0285-722X	Research Foundation - Flanders; FWO funding visit Missouri Botanical Garden [K211713N]; FWO [K206515N]; Leopold III fund	Research Foundation - Flanders(FWO); FWO funding visit Missouri Botanical Garden; FWO(FWO); Leopold III fund	This work was supported by: Research Foundation - Flanders (www.fwo.be), FWO funding visit Missouri Botanical Garden (2013): K211713N, FWO funding for field work in Mutinondo Wilderness Area, Zambia (2015): K206515N; Leopold III funding (http://www.naturalsciences.be/LIII), 2013: Funding for field work in Florida (USA), 2015: Funding for field work in Mutinondo Wilderness Area (Zambia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauters K, TAXONOMIC STUD UNPUB; Bauters K, 2016, TAXON, V65, P444, DOI 10.12705/653.2; Bauters K, 2015, PHYTOTAXA, V227, P45, DOI 10.11646/phytotaxa.227.1.5; Blattner FR, 1999, BIOTECHNIQUES, V27, P1180, DOI 10.2144/99276st04; Boeckeler O., 1874, LINNAEA, V38, P410; Mayedo WB, 2016, PHYTOTAXA, V268, P263, DOI 10.11646/phytotaxa.268.4.4; Camelbeke K., 2001, THESIS; Clarke C.B., 1908, KEW B ADDITIONAL SER, V8, P1; Clarke C. B, 1894, FLORA BRIT INDIA, V6, P685; CORE EARL L., 1936, BRITTONIA, V2, P1, DOI 10.2307/2804936; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Fenzl E, 1836, GENERA PLANTARUM, P109; Govaerts R, 2015, WORLD CHECKLIST SELE; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; HENNESSY E F F, 1985, Bothalia, V15, P505; Hinchliff CE, 2010, TAXON, V59, P709, DOI 10.1002/tax.593004; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kern JH, 1961, BLUMEA, V11, P150; Kunth CS, 1837, ENUMERATIO PLANTARUM, V2, P338; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Liden M, 1997, PLANT SYST EVOL, V206, P411, DOI 10.1007/BF00987960; Liebmann F. M., 1850, KONGELIGE DANSKE VID, V5, P189; Lock M, 2015, KEW B, V70, P46; Miller M.A., 2010, P GAT COMP ENV WORKS; Muller J, 2010, PHYDE PHYLOGENETIC D; Muller K., 2005, APPL BIOINF, V4, P6; Nees von Esenbeck C.G.D., 1834, LINNAEA, V9, P273; Nelmes E. L., 1955, KEW B, V10, P415; Ridley HN, 1884, T LINN SOC LOND, V2, P166; ROBINSON E. A., 1962, KIRKIA JOUR FED HERB SALISBURY RHODESIA AND NYASALAND, V3, P8; ROBINSON E. A., 1966, KEW BULL, V18, P487, DOI 10.2307/4115799; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Starr JR, 2003, INT J PLANT SCI, V164, P213, DOI 10.1086/346168; Steudel E.G., 1854, SYNOPSIS PLANTARUM G, V2; Steudel EG, 1841, NOMENCLATOR BOT, P542; Stover BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-7; SUN Y, 1994, THEOR APPL GENET, V89, P26, DOI 10.1007/BF00226978; Thiers B., INDEX HERBARIORUM GL; Torrey J, 1836, ANN LYCEUM NAT HIST, V3, P239, DOI DOI 10.1111/J.1749-6632.1828.TB00101.X; TropicosOrg, 2017, MISS BOT GARD; White TJ., 1990, PCR PROTOCOLS GUIDE, P315	45	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0203478	10.1371/journal.pone.0203478	http://dx.doi.org/10.1371/journal.pone.0203478			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30260979	gold, Green Submitted, Green Published			2022-12-26	WOS:000445907400011
J	Cozzoli, F; Ligetta, G; Vignes, F; Basset, A				Cozzoli, Francesco; Ligetta, Giovanna; Vignes, Fabio; Basset, Alberto			Revisiting GUD: An empirical test of the size-dependency of patch departure behaviour	PLOS ONE			English	Article							GIVING-UP DENSITIES; BODY-SIZE; FORAGING BEHAVIOR; ASSESSMENT ABILITIES; HABITAT SELECTION; METABOLIC THEORY; TEMPERATURE; COEXISTENCE; PREDATION; GROWTH	Behaviour related to patch resource exploitation is a major determinant of individual fitness. Assuming the size-dependency of patch departure behaviour, model-based approaches have shown size-mediated coexistence in systems of competing species. However, experimental evidence for the influence of body size on patch use behaviour is scarce. In this study, we explore whether allometric principles provide an underlying framework for interspecific patterns of resource use. To this end, we propose a meso-cosm approach using three species of gastropods differing in size as a model system and P-32 radio-isotopic techniques as a measure of resource use. Foragers of different size were placed in an artificial patch, provided with a limited amount of labelled resource and let them free to move as resources decrease and scarcity is sensed. We investigated the extent to which individual body size affects the exploitation of resources by examining Giving Up Density (GUD), Giving Up Time (GUT), resource absorption rate and exploitation efficiency as components of individual exploitation behaviour. To compare positive, constant and negative individual size scaling of population energy requirements, experimental trials with an equal numbers and equal biomass of differently sized foragers were carried out, and an experimental trial with equal metabolic requirements was simulated. We observed clear size dependency in the patch departure behaviour of the experimental organisms. Even under conditions of equivalent overall population energy requirements, larger foragers decided to leave the resource patch earlier and at a higher density of resources than smaller ones. Smaller foragers were able to prolong their presence and make more use of the resources, resulting in an inverse body-size scaling of resource exploitation efficiency.	[Cozzoli, Francesco; Ligetta, Giovanna; Vignes, Fabio; Basset, Alberto] Univ Salento, Dept Biol & Environm Sci & Technol, Lab Ecol, Lecce, Italy	University of Salento	Cozzoli, F; Basset, A (corresponding author), Univ Salento, Dept Biol & Environm Sci & Technol, Lab Ecol, Lecce, Italy.	francesco.cozzoli@unisalento.it; alberto.basset@unisalento.it	Cozzoli, Francesco/K-1273-2019; Vignes, Fabio/G-9998-2011	Cozzoli, Francesco/0000-0002-6413-0977; Vignes, Fabio/0000-0003-0579-6629	ECOPOTENTIAL project (H2020) [641762]; LifeWatch - Italy network	ECOPOTENTIAL project (H2020); LifeWatch - Italy network	This work was supported by a grant from the ECOPOTENTIAL project (H2020, grant agreement No 641762) to FC and by LifeWatch - Italy network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by a grant from the ECOPOTENTIAL project (H2020, grant agreement No 641762) and by the LifeWatch Italy network. We acknowledge WWF Italy for authorizing the access to Le Cesine - WWF Oasi during the preparatory phase of this study. The comments of H. Hagy, M. Bedoya-Perez and one anonymous referee greatly improved the manuscript. We thank George Metcalf for language editing.	Abu Baker MA, 2009, OIKOS, V118, P1721, DOI 10.1111/j.1600-0706.2008.17473.x; Allen AP, 2005, FUNCT ECOL, V19, P202, DOI 10.1111/j.1365-2435.2005.00952.x; BARLOCHER F, 1990, ARCH HYDROBIOL, V119, P249; Basset A, 1997, OIKOS, V78, P31, DOI 10.2307/3545797; BASSET A, 1995, ECOLOGY, V76, P1027, DOI 10.2307/1940913; BASSET A, 1990, FUNCT ECOL, V4, P685, DOI 10.2307/2389737; Basset A, 1992, REND SEMIN FS U CAGL, V62; Basset A., 1992, ATTI SOC ITAL ECOL, V15, P177; Basset A, 2007, OIKOS, V116, P1363, DOI 10.1111/j.2007.0030-1299.15702.x; Basset A, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00249.1; Baudron AR, 2014, GLOBAL CHANGE BIOL, V20, P1023, DOI 10.1111/gcb.12514; Bedoya-Perez MA, 2013, BEHAV ECOL SOCIOBIOL, V67, P1541, DOI 10.1007/s00265-013-1609-3; Bianchi FJJA, 2009, OIKOS, V118, P1363, DOI 10.1111/j.1600-0706.2009.17319.x; BIRD GA, 1992, HYDROBIOLOGIA, V234, P65, DOI 10.1007/BF00010862; Bird GA, 1996, HYDROBIOLOGIA, V333, P57, DOI 10.1007/BF00020964; BOWERS MA, 1993, OIKOS, V66, P229, DOI 10.2307/3544809; Bozinovic E, 1999, FUNCT ECOL, V13, P602, DOI 10.1046/j.1365-2435.1999.00355.x; Brendelberger H, 1997, ARCH HYDROBIOL, V140, P1; Brey T., 2001, A VIRTUAL HDB; Brey T, 2010, METHODS ECOL EVOL, V1, P92, DOI 10.1111/j.2041-210X.2009.00008.x; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; BROWN JS, 1988, OECOLOGIA, V76, P408, DOI 10.1007/BF00377036; Brown JS, 1999, EVOL ECOL RES, V1, P49; BROWN JS, 1994, ECOLOGY, V75, P2286, DOI 10.2307/1940884; CAMMEN LM, 1980, OECOLOGIA, V44, P303, DOI 10.1007/BF00545232; CARACO T, 1980, ANIM BEHAV, V28, P820, DOI 10.1016/S0003-3472(80)80142-4; Carthey AJR, 2016, OIKOS, V125, P918, DOI 10.1111/oik.02723; Casagranda C, 2005, ARCH HYDROBIOL, V164, P411, DOI 10.1127/0003-9136/2005/0164-0411; Cazzaniga NJ, 2006, J FRESHWATER ECOL, V21, P65, DOI 10.1080/02705060.2006.9664097; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Clark RM, 2016, FUNCT ECOL, V30, P922, DOI 10.1111/1365-2435.12574; Clarke A, 2006, FUNCT ECOL, V20, P405, DOI 10.1111/j.1365-2435.2006.01109.x; COSTANTINI ML, 1995, HYDROBIOLOGIA, V302, P81, DOI 10.1007/BF00006401; Cozzoli F, 2018, REVISITING GUD UNPUB; DAMUTH J, 1981, NATURE, V290, P699, DOI 10.1038/290699a0; Daufresne M, 2009, P NATL ACAD SCI USA, V106, P12788, DOI 10.1073/pnas.0902080106; DeLong JP, 2014, J ANIM ECOL, V83, P51, DOI 10.1111/1365-2656.12065; Englund G, 2011, ECOL LETT, V14, P914, DOI 10.1111/j.1461-0248.2011.01661.x; FENCHEL T, 1975, MAR BIOL, V30, P119, DOI 10.1007/BF00391586; Garb J, 2000, OIKOS, V88, P291, DOI 10.1034/j.1600-0706.2000.880207.x; Giuggioli L, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/43/434004; Gjoni V, 2018, E COAST; Gjoni V, 2017, ESTUAR COAST, V40, P1142, DOI 10.1007/s12237-016-0191-0; Gloer P, 2002, SUSSWASSERGASTROPODE, V73, P200; GOFAS S., 2009, MOLLUSCABASE; Gutman R, 2005, ECOLOGY, V86, P164, DOI 10.1890/03-0369; Hagy HM, 2017, J AVIAN BIOL, V48, P804, DOI 10.1111/jav.01275; Hagy HM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118349; Haskell JP, 2002, NATURE, V418, P527, DOI 10.1038/nature00840; Hoefnagel KN, 2015, J THERM BIOL, V54, P56, DOI 10.1016/j.jtherbio.2014.12.003; Holling C. S., 1959, Canadian Entomologist, V91, P385; HOLLING C. S., 1959, CANADIAN ENT, V91, P293; Hootsmans M, 2012, LAKE VELUWE MACROPHY; Jokinen E.H., 1992, FRESHWATER SNAILS MO; Jones M, 2001, ECOLOGY, V82, P2164, DOI 10.1890/0012-9658(2001)082[2164:COTPSM]2.0.CO;2; KAUSHIK NK, 1971, ARCH HYDROBIOL, V68, P465; Kazimierski LD, 2016, EUR PHYS J B, V89, DOI 10.1140/epjb/e2016-70241-1; KOFOED LH, 1975, J EXP MAR BIOL ECOL, V19, P233, DOI 10.1016/0022-0981(75)90060-X; KOTLER BP, 1993, J MAMMAL, V74, P614, DOI 10.2307/1382281; Kotler BP, 2002, EVOL ECOL RES, V4, P495; Lihoreau M, 2016, SCI REP-UK, V6, DOI 10.1038/srep30401; Lindmark M, 2018, ECOL LETT, V21, P181, DOI 10.1111/ele.12880; Lobo N, 2013, J MAMMAL, V94, P1449, DOI 10.1644/12-MAMM-A-295.1; Marquet PA, 2005, J EXP BIOL, V208, P1749, DOI 10.1242/jeb.01588; MCNAMARA J, 1982, THEOR POPUL BIOL, V21, P269, DOI 10.1016/0040-5809(82)90018-1; Messmer V, 2017, GLOBAL CHANGE BIOL, V23, P2230, DOI 10.1111/gcb.13552; Morris DW, 2016, EVOL ECOL RES, V17, P815; Morris DW, 2005, OIKOS, V109, P239, DOI 10.1111/j.0030-1299.2005.13789.x; Nadler LE, 2016, J EXP BIOL, V219, P2802, DOI 10.1242/jeb.139493; NAYLOR C, 1989, HYDROBIOLOGIA, V188, P517, DOI 10.1007/BF00027819; Nolet BA, 2006, OIKOS, V112, P342, DOI 10.1111/j.0030-1299.2006.13460.x; Nolet BA, 2006, OIKOS, V112, P353, DOI 10.1111/j.0030-1299.2006.13463.x; Nolet BA, 2009, OIKOS, V118, P431, DOI 10.1111/j.1600-0706.2008.16857.x; Olsson O, 2001, EVOL ECOL RES, V3, P285; Olsson O, 2010, OIKOS, V119, P292, DOI 10.1111/j.1600-0706.2009.17784.x; Owen-Smith N, 2010, PHILOS T R SOC B, V365, P2267, DOI 10.1098/rstb.2010.0095; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; PYKE GH, 1984, ANNU REV ECOL SYST, V15, P523, DOI 10.1146/annurev.es.15.110184.002515; RCoreTeam, 2017, R LANG ENV STAT COMP; REAL LA, 1980, AM NAT, V115, P623, DOI 10.1086/283588; Ritchie ME, 1999, NATURE, V400, P557, DOI 10.1038/23010; Ritchie ME, 1998, EVOL ECOL, V12, P309, DOI 10.1023/A:1006552200746; RONDELAUD D, 1974, Annales de Parasitologie Humaine et Comparee, V49, P427; Schmidt KA, 2000, ECOLOGY, V81, P2077, DOI 10.2307/177097; Schoener T. W., 1971, A Rev Ecol Syst, V2, P369, DOI 10.1146/annurev.es.02.110171.002101; Searle KR, 2005, OIKOS, V111, P417, DOI 10.1111/j.0030-1299.2005.13918.x; Stenberg M, 2006, OIKOS, V112, P332, DOI 10.1111/j.0030-1299.2006.13459.x; Stephens D.W., 1986, pi; STEPHENS DW, 1982, BEHAV ECOL SOCIOBIOL, V10, P251, DOI 10.1007/BF00302814; STRONG KW, 1980, CAN J ZOOL, V58, P1992, DOI 10.1139/z80-274; VALONE TJ, 1989, ECOLOGY, V70, P1800, DOI 10.2307/1938113; van Gils JA, 2003, AM NAT, V161, P777, DOI 10.1086/374205; van Gils JA, 2004, OIKOS, V104, P197, DOI 10.1111/j.0030-1299.2003.12214.x; van Gils JA, 2010, OIKOS, V119, P237, DOI 10.1111/j.1600-0706.2009.17497.x; Vasquez RA, 2006, OIKOS, V112, P298; Vickery WL, 2011, OIKOS, V120, P999, DOI 10.1111/j.1600-0706.2010.18448.x; WILSON DS, 1975, AM NAT, V109, P769, DOI 10.1086/283042	97	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204448	10.1371/journal.pone.0204448	http://dx.doi.org/10.1371/journal.pone.0204448			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30260989	Green Published, gold, Green Submitted			2022-12-26	WOS:000445907400050
J	Bogoni, JA; Pires, JSR; Graipel, ME; Peroni, N; Peres, CA				Bogoni, Juliano Andre; Rodrigues Pires, Jose Salatiel; Graipel, Mauricio Eduardo; Peroni, Nivaldo; Peres, Carlos A.			Wish you were here: How defaunated is the Atlantic Forest biome of its medium- to large-bodied mammal fauna?	PLOS ONE			English	Article							FUNCTIONAL DIVERSITY; AMAZONIAN FORESTS; TROPICAL FORESTS; CONSERVATION; EXTINCTION; DENSITY; COVER; COMMUNITIES; DISPERSAL; PATTERNS	Mammals represent the largest-bodied elements of the world's surviving megafauna and provide several key ecosystems services, yet their populations are often under steep decline throughout the tropics. Anthropogenic defaunation is one the most important contemporary threats to modern mammal faunas. Although the Atlantic Forest biome of South America shows several clear signs of defaunation, the extent to which this biome has lost its mammal fauna remains poorly understood. Here, we collate and analyze a comprehensive body of secondary data to quantitatively assess the spatial patterns of defaunation of all medium-to large-bodied Atlantic Forest mammals which were then classed by morpho-ecological traits. We used a Defaunation Index, which was scaled-up to the entire biome using kriging interpolation, to examine the integrity of site-specific mammal faunas. We further use environmental and socioeconomic predictors to explain the drivers of defaunation. Our results show high levels of defaunation (>0.5) for most of the Atlantic Forest. Apex predators, other carnivores, large-bodied mammals and large herbivores were among the most defaunated functional groups. Remaining native vegetation cover, forest fragment size, and the largest neighboring forest remnant were the main negative predictors of defaunation. We conclude that medium-to large-bodied Atlantic Forest mammals are under high levels of threat due to historical population losses that continue today. A conservation action plan thus becomes imperative to prevent this biome from becoming an even "emptier forest", severely compromising patterns of diversity, ecological processes and ecosystem functioning.	[Bogoni, Juliano Andre; Peroni, Nivaldo] Univ Fed Santa Catarina, Programa Posgrad Ecol, Florianopolis, SC, Brazil; [Bogoni, Juliano Andre] Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Lab Ecol Manejo & Conservac Fauna Silvestre LEMaC, Piracicaba, SP, Brazil; [Rodrigues Pires, Jose Salatiel; Graipel, Mauricio Eduardo] Univ Fed Santa Catarina, Ctr Ciencias Biol, Dept Ecol & Zool, Florianopolis, SC, Brazil; [Peres, Carlos A.] Univ East Anglia, Sch Environm Sci, Norwich, Norfolk, England; [Peres, Carlos A.] Univ Fed Paraiba, Dept Sistemat & Ecol, Joao Pessoa, Paraiba, Brazil	Universidade Federal de Santa Catarina (UFSC); Universidade de Sao Paulo; Universidade Federal de Santa Catarina (UFSC); University of East Anglia; Universidade Federal da Paraiba	Bogoni, JA (corresponding author), Univ Fed Santa Catarina, Programa Posgrad Ecol, Florianopolis, SC, Brazil.; Bogoni, JA (corresponding author), Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Lab Ecol Manejo & Conservac Fauna Silvestre LEMaC, Piracicaba, SP, Brazil.	bogoni.ja@gmail.com	Peroni, Nivaldo/AAU-4701-2020; Peres, Carlos A./ABE-8361-2020; Graipel, Maurício/T-3443-2019; Peres, Carlos A./B-1276-2013; Peroni, Nivaldo/ABA-2663-2021; Peres, Carlos Augusto/N-8275-2019	Peroni, Nivaldo/0000-0002-6770-5377; Peres, Carlos A./0000-0002-1588-8765; Peres, Carlos A./0000-0002-1588-8765; Peroni, Nivaldo/0000-0002-6770-5377; Bogoni, Juliano Andre/0000-0002-8541-0556; Pires, Jose Salatiel/0000-0002-7416-939X	Brazilian Program for Biodiversity Research (PPBio) Atlantic Forest Network (National Council for Scientific and Technological Development (CNPq) [457451/2012-9]; Sao Paulo Research Foundation (FAPESP) [2018-05970-1]	Brazilian Program for Biodiversity Research (PPBio) Atlantic Forest Network (National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was partly supported (unpublished data from JAB, MEG and NP) by the Brazilian Program for Biodiversity Research (PPBio) Atlantic Forest Network (National Council for Scientific and Technological Development (CNPq) 457451/2012-9), https://ppbio.inpa.gov.br, https://cnpq.br/. JAB is supported by a postdoctoral fellowship grant 2018-05970-1, Sao Paulo Research Foundation (FAPESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We sincerely thank all researchers who obtained and organized the datasets compiled in this study. This work was partly supported (unpublished data from JAB, MEG and NP) by the Brazilian Program for Biodiversity Research (PPBio) Atlantic Forest Network (National Council for Scientific and Technological Development (CNPq) 457451/2012-9). We sincerely thank two anonymous reviewers for their important contributions to this manuscript. JAB is supported by a postdoctoral fellowship grant 2018-05970-1, Sao Paulo Research Foundation (FAPESP).	Beca G, 2017, BIOL CONSERV, V210, P352, DOI 10.1016/j.biocon.2017.02.033; Bello C, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1501105; Biondi F., 2013, HYDROL EARTH SYST SC, V10, P4301, DOI [DOI 10.5194/HESSD-10-4301-2013, DOI 10.5194/hessd-10-4301-2013]; Bogoni JA, 2017, BIOL CONSERV, V211, P85, DOI 10.1016/j.biocon.2017.05.012; Bogoni JA, 2016, BIODIVERS CONSERV, V25, P1661, DOI 10.1007/s10531-016-1147-1; Bogoni JA, 2016, J MAMMAL, V97, P713, DOI 10.1093/jmammal/gyv215; Bornholdt R, 2013, ZOOL J LINN SOC-LOND, V167, P449, DOI 10.1111/j.1096-3642.2012.00859.x; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Canale GR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041671; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Cardillo M, 2008, P ROY SOC B-BIOL SCI, V275, P1441, DOI 10.1098/rspb.2008.0179; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Carvalho CS, 2016, SCI REP-UK, V6, DOI 10.1038/srep31957; Ceballos G, 2017, P NATL ACAD SCI USA, V114, pE6089, DOI 10.1073/pnas.1704949114; Chiarello AG, 2000, CONSERV BIOL, V14, P1649, DOI 10.1046/j.1523-1739.2000.99071.x; Cleveland W. S., 1992, STAT MODELS; Cressie N., 2011, STAT SPATIO TEMPORAL; Davidson AD, 2012, FRONT ECOL ENVIRON, V10, P477, DOI 10.1890/110054; Davidson AD, 2009, P NATL ACAD SCI USA, V106, P10702, DOI 10.1073/pnas.0901956106; Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817; Dobson A. J, 2002, INTRO GEN LINEAR MOD; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Earth Google, 2015, KML GALL EXPL EARTH; Galetti M, 2017, ANIM CONSERV, V20, P270, DOI DOI 10.1111/acv.12311; Galetti M, 2013, BIOL CONSERV, V163, P1, DOI 10.1016/j.biocon.2013.04.020; Galetti M, 2009, BIOL CONSERV, V142, P1229, DOI 10.1016/j.biocon.2009.01.023; Giacomini HC, 2013, BIOL CONSERV, V163, P33, DOI 10.1016/j.biocon.2013.04.007; Gitay H., 1997, PLANT FUNCTIONAL TYP, P3; Gonzalez Susana, 2010, P119; Gonzalez-Maya JF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175931; Grelle CE, 2000, THESIS; IBGE, 2015, EST POP MUN UN FED; Ingberman B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150906; IUCN, 2016, SPAT DAT DOWNL MAMM; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Joly CA, 2014, NEW PHYTOL, V204, P459, DOI 10.1111/nph.12989; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Jorge MLSP, 2013, BIOL CONSERV, V163, P49, DOI 10.1016/j.biocon.2013.04.018; Kurten EL, 2013, BIOL CONSERV, V163, P22, DOI 10.1016/j.biocon.2013.04.025; Lacerda AEB, 2016, BIOTROPICA, V48, P537, DOI 10.1111/btp.12317; Leal C. G., 2003, ATLANTIC FOREST S AM, V1; Legendre P, 2015, METHODS ECOL EVOL, V6, P1239, DOI 10.1111/2041-210X.12425; Lima Fernando, 2017, Ecology, V98, P2979, DOI 10.1002/ecy.1998; Lira PK, 2012, FOREST ECOL MANAG, V278, P80, DOI 10.1016/j.foreco.2012.05.008; Lopes PCA, 2004, MASTOZOOL NEOTROP, V11, P151; Maffei L, 2008, BIOTROPICA, V40, P71, DOI 10.1111/j.1744-7429.2007.00341.x; Magioli M, 2015, ANIM CONSERV, V18, P499, DOI 10.1111/acv.12201; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Martin P. S., 1995, QUATERNARY EXTINCTIO; McConkey KR, 2016, BIOL CONSERV, V201, P38, DOI 10.1016/j.biocon.2016.06.024; McNeill Alfred, 2003, COLUMBIAN EXCHANGE B, P13; Myers Norman, 2000, Nature (London), V403, P853, DOI 10.1038/35002501; Oliveira BF, 2016, GLOBAL ECOL BIOGEOGR, V25, P1119, DOI 10.1111/geb.12471; Oliveira U, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08707-2; Laureto LMO, 2015, NAT CONSERVACAO, V13, P112, DOI 10.1016/j.ncon.2015.11.001; Osuri AM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11351; Paglia A.P., 2012, OCCASIONAL PAPERS CO, V2nd; Paviolo A, 2016, SCI REP-UK, V6, DOI 10.1038/srep37147; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; PERES CA, 1990, BIOL CONSERV, V54, P47, DOI 10.1016/0006-3207(90)90041-M; Peres CA, 2001, CONSERV BIOL, V15, P1490, DOI 10.1046/j.1523-1739.2001.01089.x; Peres CA, 2000, OECOLOGIA, V122, P175, DOI 10.1007/PL00008845; Peres CA, 2007, BIOTROPICA, V39, P304, DOI 10.1111/j.1744-7429.2007.00272.x; Peres CA, 2016, P NATL ACAD SCI USA, V113, P892, DOI 10.1073/pnas.1516525113; Phillips OL, 1998, SCIENCE, V282, P439, DOI 10.1126/science.282.5388.439; Pitney Bowes Software Team, 2014, MAPINFO PRO DESKT GI; PNUD, 2010, BRAZ ATL HUM DEV RAN; R Development Core Team, 2017, R LANGUAGE ENV STAT; Raunkiaer C., 1934, LIFEFORMS PLANTS STA; REDFORD KH, 1987, AM ANTHROPOL, V89, P650, DOI 10.1525/aa.1987.89.3.02a00070; REDFORD KH, 1992, BIOSCIENCE, V42, P412, DOI 10.2307/1311860; Rees J, 1990, NATURAL RESOURCES AL; Regolin AL, 2017, J MAMMAL, V98, P1721, DOI 10.1093/jmammal/gyx103; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Ripple WJ, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160498; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Roemer GW, 2009, BIOSCIENCE, V59, P165, DOI 10.1525/bio.2009.59.2.9; Rondinini C, 2011, PHILOS T R SOC B, V366, P2633, DOI 10.1098/rstb.2011.0113; Seddon PJ, 2014, SCIENCE, V345, P406, DOI 10.1126/science.1251818; Silva WG., 2007, Braz. J. Biol., V67, P403, DOI 10.1590/S1519-69842007000300004; SOS Mata Atlantica, 2016, ATL REM 2016; Stoner KE, 2007, BIOTROPICA, V39, P316, DOI 10.1111/j.1744-7429.2007.00292.x; Tabarelli M, 2010, BIOL CONSERV, V143, P2328, DOI 10.1016/j.biocon.2010.02.005; TERBORGH J, 1988, CONSERV BIOL, V2, P402, DOI 10.1111/j.1523-1739.1988.tb00207.x; Tilman D, 2001, ENCY BIODIVERSITY, V3, P109, DOI [DOI 10.1016/B0-12-226865-2/00132-2, 10.1006/rwbd.1999.0154]; Tobler MW, 2008, ANIM CONSERV, V11, P169, DOI 10.1111/j.1469-1795.2008.00169.x; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; Wallach AD, 2015, OIKOS, P1; Wetzel R.M., 1985, P23; Wilman H., 2014, ECOLOGY, V95; [No title captured]; [No title captured]	93	49	51	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2018	13	9							e0204515	10.1371/journal.pone.0204515	http://dx.doi.org/10.1371/journal.pone.0204515			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU9BO	30252909	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000445639700057
J	Luo, B; Edge, AK; Tolg, C; Turley, EA; Dean, CB; Hill, KA; Kulperger, RJ				Luo, Bin; Edge, Alanna K.; Tolg, Cornelia; Turley, Eva A.; Dean, C. B.; Hill, Kathleen A.; Kulperger, R. J.			Spatial statistical tools for genome-wide mutation cluster detection under a microarray probe sampling system	PLOS ONE			English	Article							PRONE DNA-POLYMERASES; MULTIPLE MUTATIONS; ASSOCIATION; CANCERS; DISEASE; MOUSE	Mutation cluster analysis is critical for understanding certain mutational mechanisms relevant to genetic disease, diversity, and evolution. Yet, whole genome sequencing for detection of mutation clusters is prohibitive with high cost for most organisms and population surveys. Single nucleotide polymorphism (SNP) genotyping arrays, like the Mouse Diversity Genotyping Array, offer an alternative low-cost, screening for mutations at hundreds of thousands of loci across the genome using experimental designs that permit capture of de novo mutations in any tissue. Formal statistical tools for genome-wide detection of mutation clusters under a microarray probe sampling system are yet to be established. A challenge in the development of statistical methods is that microarray detection of mutation clusters is constrained to select SNP loci captured by probes on the array. This paper develops a Monte Carlo framework for cluster testing and assesses test statistics for capturing potential deviations from spatial randomness which are motivated by, and incorporate, the array design. While null distributions of the test statistics are established under spatial randomness via the homogeneous Poisson process, power performance of the test statistics is evaluated under postulated types of Neyman-Scott clustering processes through Monte Carlo simulation. A new statistic is developed and recommended as a screening tool for mutation cluster detection. The statistic is demonstrated to be excellent in terms of its robustness and power performance, and useful for cluster analysis in settings of missing data. The test statistic can also be generalized to any one dimensional system where every site is observed, such as DNA sequencing data. The paper illustrates how the informal graphical tools for detecting clusters may be misleading. The statistic is used for finding clusters of putative SNP differences in a mixture of different mouse genetic backgrounds and clusters of de novo SNP differences arising between tissues with development and carcinogenesis.	[Luo, Bin; Kulperger, R. J.] Western Univ, Dept Stat & Actuarial Sci, London, ON, Canada; [Edge, Alanna K.; Hill, Kathleen A.] Western Univ, Dept Biol, London, ON, Canada; [Tolg, Cornelia; Turley, Eva A.] Lawson Hlth Res Inst, London Reg Canc Program, London, ON, Canada; [Dean, C. B.] Univ Waterloo, Dept Stat & Actuarial Sci, Waterloo, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); University of Waterloo	Luo, B; Kulperger, RJ (corresponding author), Western Univ, Dept Stat & Actuarial Sci, London, ON, Canada.; Hill, KA (corresponding author), Western Univ, Dept Biol, London, ON, Canada.; Dean, CB (corresponding author), Univ Waterloo, Dept Stat & Actuarial Sci, Waterloo, ON, Canada.	bluo4@uwo.ca; cdean@uwaterloo.ca; khill22@uwo.ca; kulperger@stats.uwo.ca		Dean, Charmaine/0000-0002-1147-0636; Hill, Kathleen/0000-0002-7788-5105	Natural Sciences and Engineering Research Council of Canada; Natural Sciences and Engineering Research Council of Canada Discovery Grant [R3511A12, R4910A02, R1384A01]; Western Strategic Support for NSERC Success Accelerator Grant from Western University; Breast Cancer Society of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Natural Sciences and Engineering Research Council of Canada Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Western Strategic Support for NSERC Success Accelerator Grant from Western University; Breast Cancer Society of Canada	This research was funded by the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp), Natural Sciences and Engineering Research Council of Canada Discovery Grant no. R3511A12 to KAH, Grant no. R4910A02 to CBD, and Grant no. R1384A01 to RJK; a Western Strategic Support for NSERC Success Accelerator Grant from Western University to KAH; and a grant from Breast Cancer Society of Canada to EAT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chou WC, 2017, SCI REP-UK, V7, DOI 10.1038/srep44089; DARLING DA, 1957, ANN MATH STAT, V28, P823, DOI 10.1214/aoms/1177706788; Domanska D, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1679-8; Drake JW, 2007, CRIT REV BIOCHEM MOL, V42, P247, DOI 10.1080/10409230701495631; Friedberg EC, 2001, ENVIRON MOL MUTAGEN, V38, P105, DOI 10.1002/em.1059; Friedberg EC, 2001, CELL, V107, P9, DOI 10.1016/S0092-8674(01)00509-8; Goodman MF, 2002, ANNU REV BIOCHEM, V71, P17, DOI 10.1146/annurev.biochem.71.083101.124707; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hill KA, 2004, MUTAT RES-FUND MOL M, V554, P223, DOI 10.1016/j.mrfmmm.2004.05.005; Ionita-Laza I, 2012, AM J HUM GENET, V90, P1002, DOI 10.1016/j.ajhg.2012.04.010; Jia PL, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-11; KUNZ BA, 1991, ANNU REV GENET, V25, P339, DOI 10.1146/annurev.ge.25.120191.002011; Lada AG, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003736; Locke MEO, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1713-z; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Muino JM, 2014, COMPUT BIOL CHEM, V53, P79, DOI 10.1016/j.compbiolchem.2014.08.012; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; North BV, 2002, AM J HUM GENET, V71, P439, DOI 10.1086/341527; Roberts SA, 2012, MOL CELL, V46, P424, DOI 10.1016/j.molcel.2012.03.030; Wang JC, 2007, P NATL ACAD SCI USA, V104, P8403, DOI 10.1073/pnas.0610902104; Yang H, 2009, NAT METHODS, V6, P663, DOI [10.1038/NMETH.1359, 10.1038/nmeth.1359]; Ye JJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-11; Yip WK, 2014, GENET EPIDEMIOL, V38, P714, DOI 10.1002/gepi.21851	25	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2018	13	9							e0204156	10.1371/journal.pone.0204156	http://dx.doi.org/10.1371/journal.pone.0204156			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU9BO	30252889	Green Published, Green Submitted, gold			2022-12-26	WOS:000445639700033
J	Oliver, VL; Lambert, PA; Than, KK; Mohamed, Y; Luchters, S; Verma, S; Yadav, R; Kumar, V; Teklu, AM; Tolera, M; Minaye, A; McIntosh, MP				Oliver, Victoria L.; Lambert, Peter A.; Than, Kyu Kyu; Mohamed, Yasmin; Luchters, Stanley; Verma, Snigdha; Yadav, Ranjana; Kumar, Vishwajeet; Teklu, Alula M.; Tolera, Moti; Minaye, Abebaw; McIntosh, Michelle P.			Knowledge, perception and practice towards oxytocin stability and quality: A qualitative study of stakeholders in three resource-limited countries	PLOS ONE			English	Article							HEALTH FACILITIES; LABOR; INDUCTION; CRITERIA	Background Oxytocin is the gold standard drug for the prevention of postpartum haemorrhage, but limitations in cold chain systems in resource-constrained settings can severely compromise the quality of oxytocin product available in these environments. This study investigated the perspectives and practices of stakeholders in low and lower-middle income countries towards oxytocin, its storage requirements and associated barriers, and the quality of product available. Methods Qualitative inquiries were undertaken in Ethiopia, India and Myanmar, where data was collected through Focus Group Discussions (FGDs) and In-Depth Interviews (IDIs). A total of 12 FGDs and 106 IDIs were conducted with 158 healthcare providers (pharmacists, midwives, nurses, doctors and obstetricians) and 40 key informants (supply chain experts, program managers and policy-makers). Direct observations of oxytocin storage practices and cold chain resources were conducted at 51 healthcare facilities. Verbatim transcripts of FGDs and IDIs were translated to English and analysed according to a thematic content analysis framework. Findings Stakeholder awareness of oxytocin heat sensitivity and the requirement for cold storage of the drug was widespread in Ethiopia but more limited in Myanmar and India. A consistent finding across all study regions was the significant barriers to maintaining a consistent cold chain, with the lack of refrigeration facilities and unreliability of electricity cited as major challenges. Perceptions of compromised oxytocin quality were expressed by some stakeholders in each country. Conclusion Knowledge of the heat sensitivity of oxytocin and the potential impacts of inconsistent cold storage on product quality is not widespread amongst healthcare providers, policy makers and supply chain experts in Myanmar, Ethiopia and India. Targeted training and advocacy messages are warranted to emphasise the importance of cold storage to maintain oxytocin quality.	[Oliver, Victoria L.; Lambert, Peter A.; McIntosh, Michelle P.] Monash Univ, Monash Inst Pharmaceut Sci, Melbourne, Vic, Australia; [Than, Kyu Kyu; Mohamed, Yasmin; Luchters, Stanley] Burnet Inst, Melbourne, Vic, Australia; [Than, Kyu Kyu] Univ Melbourne, Dept Med, Melbourne, Vic, Australia; [Luchters, Stanley] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Luchters, Stanley] Univ Ghent, Int Ctr Reprod Hlth, Dept Obstet & Gynaecol, Ghent, Belgium; [Verma, Snigdha; Yadav, Ranjana; Kumar, Vishwajeet] Community Empowerment Lab, Lucknow, Uttar Pradesh, India; [Teklu, Alula M.] MERQ Consultancy PLC, Addis Ababa, Ethiopia; [Tolera, Moti] Haramaya Univ, Sch Publ Hlth, Harar, Ethiopia; [Minaye, Abebaw] Addis Ababa Univ, Sch Psychol, Addis Ababa, Ethiopia	Monash University; Burnet Institute; University of Melbourne; Monash University; Ghent University; Haramaya University; Addis Ababa University	McIntosh, MP (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Melbourne, Vic, Australia.	michelle.mcintosh@monash.edu	Tolera, Moti/ABC-6148-2021; Mohamed, Yasmin/AAH-3916-2020	Tolera, Moti/0000-0002-4739-1390; Mohamed, Yasmin/0000-0001-7406-8639; Luchters, Stanley/0000-0001-5235-5629; Oliver, Victoria/0000-0002-7023-5329; McIntosh, Michelle Paula/0000-0002-1605-7226	Saving Lives at Birth; United States Agency for International Development (USAID); Government of Norway; Bill and Melinda Gates Foundation; Grand Challenges Canada; UK Government [AIDOAA-F-14-00046]; McCall MacBain Foundation; Government of Canada [TTS 0609-05]; Australias National Health and Medical Research Council [GNT1090805]	Saving Lives at Birth(United States Agency for International Development (USAID)Bill & Melinda Gates Foundation); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); Government of Norway; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Grand Challenges Canada(CGIAR); UK Government; McCall MacBain Foundation; Government of Canada(CGIAR); Australias National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This study was made possible by the generous support of the Saving Lives at Birth partners: the United States Agency for International Development (USAID), the Government of Norway, the Bill and Melinda Gates Foundation, Grand Challenges Canada, and the UK Government https://savinglivesatbirth.net/; grant number: AIDOAA-F-14-00046). This funder provided support in the form of salary costs for author VO. The funder also provided support for research costs in all three countries, which included contributions to salary costs for KKT, SV, RY, AT, MT and AM. Funding support for the salary of PL was provided by the McCall MacBain Foundation (http://www.mccallmacbain.org/). Additional funding for non-salary research costs in Ethiopia was provided by Grand Challenges Canada and the Government of Canada (http://www.grandchallenges.ca/; grant number: TTS 0609-05). The authors gratefully acknowledge the contribution of the Victorian Operational Infrastructure Support Program (https://www2.health.vic.gov.au/about/clinical-trials-and-research/operational-infrastructure-support), which provided funding to the Burnet Institute to support research in Myanmar. Australias National Health and Medical Research Council (https://www.nhmrc.gov.au/; grant number: GNT1090805) provided funding in the form of a Career Development Fellowship for SL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of authors are articulated in the author contributions section. AT is the founder and CEO of a for-profit research organisation (MERQ consultancy). MT and AM were contracted by MERQ consultancy to provide services for the conduct of this study. MERQ consultancy undertook research in Ethiopia on a fee-for-service basis and provided no direct or in-kind financial support for the study. Beyond the roles of AT, MT and AM (articulated in the authors' contribution section) MERQ did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair-Rohani H, 2013, GLOB HEALTH-SCI PRAC, V1, P249, DOI 10.9745/GHSP-D-13-00037; [Anonymous], NAT FORM IND; ARULKUMARAN S, 1985, AUST NZ J OBSTET GYN, V25, P190, DOI 10.1111/j.1479-828X.1985.tb00641.x; Ateudjieu Jerome, 2013, BMC Res Notes, V6, P101, DOI 10.1186/1756-0500-6-101; Bangladesh Ministry of Health and Family Welfare, 2016, BANGL HLTH FAC SURV; Begley CM, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007412.pub3; Bergeson-Lockwood J., 2010, MATERNAL HLTH SUPPLI; Berhan Yifru, 2007, Ethiop Med J, V45, P235; Deepak NN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062801; Ehiopia Ministry of Health, 2010, MAN PROT SEL OBST TO; [Ethiopian Food Medicine and Healthcare Administration and Control Authority Ethiopian Food Medicine and Healthcare Administration and Control Authority], 2013, ETH MED FORM; Ethiopian Public Health Institute Federal Ministry of Health Columbia University, 2017, ETH EM OBST NEWB CAR; [Federal Ministry of Health of Nigeria National Drug Formulary and Essential Drug List Review Committee], 1989, NAT DRUG FORM ESS DR; Girma W, 2016, ETHIOP J HEALTH SCI, V26, P123, DOI 10.4314/ejhs.v26i2.6; Hogerzeil HV, 1993, STABILITY INJECTABLE; Joshi BS, 2014, CONSENSUS STATEMENT; Karikari-Boateng E, 2013, POSTMARKET QUALITY S; Lloyd J, 2017, VACCINE, V35, P2115, DOI 10.1016/j.vaccine.2016.11.097; Madsen E. L., 2010, MATERNAL HLTH SUPPLI; Malawi Ministry of Health, 2014, MAL SERV PROV ASS 20; Mfinanga Godfrey S, 2009, Health Res Policy Syst, V7, P6, DOI 10.1186/1478-4505-7-6; [Ministry of Health and Population Administration DoD], 2010, NEP NAT FORM; [Ministry of Health & Family Welfare Directorate General of Drug Administration], 2015, BANGL NAT FORM; Ministry of Medical Services, 2008, KEN NAT FORM PRIM CA; Myanmar Ministry of Health United Nations Population Fund (UNFPA), 2016, 2015 HLTH FAC ASS RE; Natarajan A, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0809-z; Poudyal A., 2014, J I MED, V36, P3; Pribluda VS, 2012, AS REG M INT IMP ESS; Reproductive Health Supplies Coalition, 2013, EML SEARCH DAT FAM P; Rouse DJ, 2000, OBSTET GYNECOL, V96, P671, DOI 10.1016/S0029-7844(00)01010-3; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Stanton C, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/s12884-014-0386-y; Stanton C, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000431; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Torloni MR, 2016, BJOG-INT J OBSTET GY, V123, P2076, DOI 10.1111/1471-0528.13998; United Nations Population Fund (UNFPA) WHO, 2009, JOINT UNFPA WHO MISS; WHO (World Health Organization), 2015, TRENDS MATERNAL MORT; World Health Organization, 2009, STAB TEST ACT PHARM; World Health Organization, 2015, UN B; World Health Organization United Nations Children's Fund, 2015, WHO UNICEF JOINT STA; World Health Organization WHO, 2012, RECOMMENDATIONS PREV; Zambia Ministry of Health, 2010, ZAMB SERV AV READ AS; [Zambia Ministry of Health Zambia National Formulary Committee], 2011, ZAMB NAT FORM	43	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2018	13	9							e0203810	10.1371/journal.pone.0203810	http://dx.doi.org/10.1371/journal.pone.0203810			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU9BO	30252860	Green Published, Green Submitted, gold			2022-12-26	WOS:000445639700013
J	Wang, WP; Yu, X; Luo, X; Wang, L; Li, LX; Kurths, J; Zhao, WB; Xiao, JH				Wang, Weiping; Yu, Xin; Luo, Xiong; Wang, Long; Li, Lixiang; Kurths, Juergen; Zhao, Wenbing; Xiao, Jiuhong			The stability of memristive multidirectional associative memory neural networks with time-varying delays in the leakage terms via sampled-data control	PLOS ONE			English	Article							EXPONENTIAL STABILITY; ANTI-SYNCHRONIZATION; DYNAMIC-BEHAVIORS; PERIODIC-SOLUTION; EXISTENCE; DISCRETE	In this paper, we propose a new model of memristive multidirectional associative memory neural networks, which concludes the time-varying delays in leakage terms via sampled-data control. We use the input delay method to turn the sampling system into a continuous time-delaying system. Then we analyze the exponential stability and asymptotic stability of the equilibrium points for this model. By constructing a suitable Lyapunov function, using the Lyapunov stability theorem and some inequality techniques, some sufficient criteria for ensuring the stability of equilibrium points are obtained. Finally, numerical examples are given to demonstrate the effectiveness of our results.	[Wang, Weiping; Yu, Xin; Luo, Xiong; Wang, Long] Univ Sci & Technol Beijing, Sch Comp & Commun Engn, Beijing, Peoples R China; [Wang, Weiping; Yu, Xin; Luo, Xiong; Wang, Long] Beijing Key Lab Knowledge Engn Mat Sci, Beijing, Peoples R China; [Wang, Weiping; Kurths, Juergen] Humboldt Univ, Inst Phys, Berlin, Germany; [Li, Lixiang] Beijing Univ Posts & Telecommun, Informat Secur Ctr, State Key Lab Networking & Switching Technol, Beijing, Peoples R China; [Kurths, Juergen] Potsdam Inst Climate Impact Res, Potsdam, Germany; [Zhao, Wenbing] Cleveland State Univ, Dept Elect Engn & Comp Sci, Cleveland, OH 44115 USA; [Xiao, Jiuhong] Univ Sci & Technol Beijing, Sch Automat & Elect Engn, Beijing, Peoples R China	University of Science & Technology Beijing; Humboldt University of Berlin; Beijing University of Posts & Telecommunications; Potsdam Institut fur Klimafolgenforschung; University System of Ohio; Cleveland State University; University of Science & Technology Beijing	Wang, WP; Luo, X (corresponding author), Univ Sci & Technol Beijing, Sch Comp & Commun Engn, Beijing, Peoples R China.; Wang, WP; Luo, X (corresponding author), Beijing Key Lab Knowledge Engn Mat Sci, Beijing, Peoples R China.; Wang, WP (corresponding author), Humboldt Univ, Inst Phys, Berlin, Germany.	weipingwangjt@ustb.edu.cn; xluo@ustb.edu.cn		Xiao, Jiuhong/0000-0002-7574-398X	National Key Research and Development Program of China [2017YFB0702300]; China Scholarship Council (CSC); National Natural Science Foundation of China [61603032, 61174103]; Fundamental Research Funds for the Central Universities [06500025]; University of Science and Technology Beijing-National Taipei University of Technology [TW201705]	National Key Research and Development Program of China; China Scholarship Council (CSC)(China Scholarship Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); University of Science and Technology Beijing-National Taipei University of Technology	This work was supported by the National Key Research and Development Program of China under Grants 2017YFB0702300, the State Scholarship Fund of China Scholarship Council (CSC), the National Natural Science Foundation of China under Grants 61603032 and 61174103, the Fundamental Research Funds for the Central Universities under Grant 06500025, and the University of Science and Technology Beijing-National Taipei University of Technology Joint Research Program under Grant TW201705.	Ali MS, 2016, NEUROCOMPUTING, V171, P1533, DOI 10.1016/j.neucom.2015.07.101; Arscott F. M., 1999, MATH ITS APPL SOVIET, V154, p[99, 128]; Cai ZW, 2014, COMMUN NONLINEAR SCI, V19, P1279, DOI 10.1016/j.cnsns.2013.09.004; Chai XL, 2017, SIGNAL PROCESS-IMAGE, V52, P6, DOI 10.1016/j.image.2016.12.007; Chandrasekar A, 2016, NEUROCOMPUTING, V202, P67, DOI 10.1016/j.neucom.2016.04.012; Chen JY, 2017, MOD PHYS LETT B, V31, DOI 10.1142/S0217984917500312; Chen LP, 2017, NEURAL NETWORKS, V94, P76, DOI 10.1016/j.neunet.2017.06.012; Chen Song-Can, 1998, Journal of Software, V9, P397; Duan L, 2016, NEUROCOMPUTING, V218, P259, DOI 10.1016/j.neucom.2016.08.049; FRIDMAN EM, 1992, AUTOMAT REM CONTR+, V53, P1523; Fridman E, 2010, AUTOMATICA, V46, P421, DOI 10.1016/j.automatica.2009.11.017; Gao J, 2017, NEURAL NETWORKS, V86, P1, DOI 10.1016/j.neunet.2016.10.008; Guo RN, 2017, APPL MATH COMPUT, V311, P100, DOI 10.1016/j.amc.2017.05.021; Hagiwara M., 1990, INT JOINT C NEUR NET, V1, P3; Itoh M, 2009, INT J BIFURCAT CHAOS, V19, P3605, DOI 10.1142/S0218127409025031; Jiang P, 2017, NEUROCOMPUTING, V219, P163, DOI 10.1016/j.neucom.2016.09.029; Jiang P, 2015, NEURAL NETWORKS, V68, P34, DOI 10.1016/j.neunet.2015.04.005; Li HF, 2016, NEURAL NETWORKS, V75, P97, DOI 10.1016/j.neunet.2015.12.006; Li N, 2015, NEURAL NETWORKS, V61, P1, DOI 10.1016/j.neunet.2014.08.015; Li XD, 2010, NONLINEAR ANAL-REAL, V11, P4092, DOI 10.1016/j.nonrwa.2010.03.014; Nie XB, 2016, NEURAL NETWORKS, V84, P172, DOI 10.1016/j.neunet.2016.08.006; Pershin YV, 2010, NEURAL NETWORKS, V23, P881, DOI 10.1016/j.neunet.2010.05.001; Sakthivel R, 2016, APPL MATH COMPUT, V275, P213, DOI 10.1016/j.amc.2015.11.060; Song YF, 2015, NEUROCOMPUTING, V156, P121, DOI 10.1016/j.neucom.2014.12.077; Wang B, 2018, OPTIK, V154, P538, DOI 10.1016/j.ijleo.2017.10.080; Wang LM, 2017, NEUROCOMPUTING, V245, P86, DOI 10.1016/j.neucom.2017.03.042; Wang M., 2012, ISRN DISCRETE MATH, V2012, P10, DOI [10.5402/2012/831715, DOI 10.5402/2012/831715]; Wang WP, 2018, MOD PHYS LETT B, V32, DOI 10.1142/S021798491850207X; Wang WP, 2017, CHAOS SOLITON FRACT, V104, P84, DOI 10.1016/j.chaos.2017.08.011; Wang WP, 2016, NONLINEAR DYNAM, V83, P2143, DOI 10.1007/s11071-015-2471-9; Wang X, 2017, NEUROCOMPUTING, V242, P131, DOI 10.1016/j.neucom.2017.02.059; Wu AL, 2012, NEURAL NETWORKS, V36, P1, DOI 10.1016/j.neunet.2012.08.009; Wu AL, 2011, PHYS LETT A, V375, P1661, DOI 10.1016/j.physleta.2011.02.068; Wu HQ, 2015, INT J MACH LEARN CYB, V6, P365, DOI 10.1007/s13042-014-0271-z; Xin YM, 2016, NEURAL NETWORKS, V80, P34, DOI 10.1016/j.neunet.2016.04.002; Yang DG, 2016, NEUROCOMPUTING, V171, P1021, DOI 10.1016/j.neucom.2015.07.040; Yang J, 2017, NEUROCOMPUTING, V227, P142, DOI 10.1016/j.neucom.2016.07.065; Yu M., 2017, WASTE BIOMASS VALORI, V2017, P1; Zhang GD, 2015, NEURAL NETWORKS, V61, P49, DOI 10.1016/j.neunet.2014.10.004; Zhang R, 2018, IEEE T NEURAL NETWOR, VPP, P1; Zhang RM, 2018, FUZZY SET SYST, V344, P108, DOI 10.1016/j.fss.2017.12.010; Zhang RM, 2017, J FRANKLIN I, V354, P4930, DOI 10.1016/j.jfranklin.2017.05.008; Zhang RM, 2017, APPL MATH COMPUT, V310, P57, DOI 10.1016/j.amc.2017.04.028; Zhou TJ, 2015, MATH COMPUT SIMULAT, V107, P52, DOI 10.1016/j.matcom.2014.06.004; Zhu S, 2017, NEUROCOMPUTING, V227, P149, DOI 10.1016/j.neucom.2016.07.068	45	0	0	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2018	13	9							e0204002	10.1371/journal.pone.0204002	http://dx.doi.org/10.1371/journal.pone.0204002			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3MI	30248118	Green Submitted, gold, Green Published			2022-12-26	WOS:000445998100017
J	Horn, R; Parker, M				Horn, Ruth; Parker, Michael			Health professionals' and researchers' perspectives on prenatal whole genome and exome sequencing: 'We can't shut the door now, the genie's out, we need to refine it'	PLOS ONE			English	Article							INCIDENTAL FINDINGS; ETHICAL-ISSUES; CHALLENGES; CLINICIAN; DIAGNOSIS; MEDICINE; FETUSES; DISEASE	The Prenatal Assessment of Genome and Exomes (PAGE) project is a UK-wide study aiming to gain a better understanding of genetic variants causing developmental problems during pregnancy. A further aim of the study is to provide an evidence-base for the introduction of prenatal whole genome and exome sequencing (PWGES) into prenatal diagnostics provided by the NHS, which is expected in 2018. This paper presents the findings of a qualitative interview study undertaken with 20 health professionals and researchers involved in the PAGE project, and explores their implications for understandings of 'good practice' in the uses of prenatal genomics clinically. A number of critical issues are identified that will need to be addressed in the development of a model of good ethical practice for prenatal genomics: consent, management of expectations, return of results, and professional duties in the context of PWGES. The analysis presented identifies and illustrates a great deal of complexity and qualitative richness in these issues as they arise in the day-to-day work of genomics professionals. Inclusive, critical discussion of these findings, together with the findings from other empirical studies, normative analysis and scientific discoveries resulting from PAGE, will be required to inform the development of appropriate guidelines of good ethical practice that address the needs and concerns to be encountered in daily clinical practice.	[Horn, Ruth] Univ Oxford, Ethox Ctr, Dept Populat Hlth, Oxford, England; Univ Oxford, Wellcome Trust Ctr Eth & Humanities, Oxford, England	University of Oxford; University of Oxford	Horn, R (corresponding author), Univ Oxford, Ethox Ctr, Dept Populat Hlth, Oxford, England.	ruth.horn@ethox.ox.ac.uk		Horn, Ruth/0000-0002-5714-3905; Parker, Michael/0000-0002-7054-4711	Department of Health; Wellcome Trust through the Health Innovation Challenge Fund; Health Innovation Challenge Fund [HICF-R7-396, 101177]; Department of Health and Wellcome Trust; Wellcome Centre Grant [203132/Z/16/Z]	Department of Health; Wellcome Trust through the Health Innovation Challenge Fund(Wellcome Trust); Health Innovation Challenge Fund; Department of Health and Wellcome Trust; Wellcome Centre Grant	The research reported in this paper has been conducted as part of the PAGE Ethics Programme with support from the Department of Health and Wellcome Trust through the Health Innovation Challenge Fund. The publication presents independent research commissioned by the Health Innovation Challenge Fund (HICF-R7-396; WT Ref: 101177), a parallel funding partnership between the Department of Health and Wellcome Trust. The views expressed in this publication are those of the author(s) and not necessarily those of the Department of Health or Wellcome Trust. Michael Parker's work on the ethics of genomics is supported by a Wellcome Centre Grant (203132/Z/16/Z). The funders approved the submission of this manuscript.	Allmark P, 2006, J MED ETHICS, V32, P439, DOI 10.1136/jme.2005.013722; Bernhardt BA, 2013, GENET MED, V15, P139, DOI 10.1038/gim.2012.113; Best S, 2017, PROMISES PITFALLS PR; Cacioppo CN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153597; Clarke AJ, 2014, BRIT MED BULL, V111, P17, DOI 10.1093/bmb/ldu017; Dressler LG, 2014, GENET TEST MOL BIOMA, V18, P131, DOI 10.1089/gtmb.2013.0366; Drury S, 2014, FET MAT MED REV, V25, P295; Gardiner C., 2015, RECOMMENDATIONS USE; General Medical Council, 2013, GOOD PRACT RES CONS; General Medical Council, 2013, GOOD MED PRACTICE; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Gupta Umesh Chandra, 2013, Perspect Clin Res, V4, P26, DOI 10.4103/2229-3485.106373; Hall A, 2013, MANAGING INCIDENTAL; Helmreich Rebecca J, 2007, Nurs Womens Health, V11, P576, DOI 10.1111/j.1751-486X.2007.00250.x; Hillman SC, 2015, ULTRASOUND OBST GYN, V45, P4, DOI 10.1002/uog.14653; Horn R, 2018, PRENATAL DIAG, V38, P20, DOI 10.1002/pd.5114; Kitzman JO, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004323; Klitzman RL, 2010, J GENET COUNS, V19, P430, DOI 10.1007/s10897-010-9307-z; Lucassen A, 2001, LANCET, V357, P1033, DOI 10.1016/S0140-6736(00)04240-9; Muir P, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0917-0; Nerlich B, 2002, HEALTH, V6, P445, DOI 10.1177/136345930200600403; Ormondroyd E, 2017, EUR J HUM GENET, V25, P680, DOI 10.1038/ejhg.2017.37; Pinxten W, 2014, BEST PRACT RES CL GA, V28, P269, DOI 10.1016/j.bpg.2014.02.004; Prainsack B, 2008, NATURE, V456, P34, DOI 10.1038/456034a; Quinlan-Jones E, 2017, PRENATAL DIAG, V37, P1225, DOI 10.1002/pd.5172; Quinlan-Jones E, 2016, PRENATAL DIAG, V36, P935, DOI 10.1002/pd.4916; Vetro A, 2012, HUM MUTAT, V33, P923, DOI 10.1002/humu.22050; Vora NL, 2017, GENET MED, V19, P1207, DOI 10.1038/gim.2017.33; Wellcome Sanger Institute, PAGE PREN ASS GEN EX; Westerfield L, 2014, J CLIN MED, V3, P1018, DOI 10.3390/jcm3031018; World Medical Association, 1964, DECL HELS; Yu JH, 2013, GENET MED, V15, P684, DOI 10.1038/gim.2013.35	32	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2018	13	9							e0204158	10.1371/journal.pone.0204158	http://dx.doi.org/10.1371/journal.pone.0204158			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU5MM	30240445	Green Published, gold, Green Submitted			2022-12-26	WOS:000445329700028
J	Tominaga, N; Fernandez, SJ; Mete, M; Shara, NM; Verbalis, JG				Tominaga, Naoto; Fernandez, Stephen J.; Mete, Mihriye; Shara, Nawar M.; Verbalis, Joseph G.			Hyponatremia and the risk of kidney stones: A matched case-control study in a large US health system	PLOS ONE			English	Article							BONE-MINERAL DENSITY; URINE CALCIUM EXCRETION; IDIOPATHIC HYPERCALCIURIA; UNITED-STATES; OSTEOPOROSIS; NEPHROLITHIASIS; POPULATION; UROLITHIASIS; DISEASE; PREVALENCE	Kidney stones impose a large and increasing public health burden. Previous studies showed that hyponatremia is associated with an increased risk of osteoporosis and bone fractures, which are also known to be associated with kidney stones. However, the relation between hyponatremia and kidney stones is not known. To assess the relation between hyponatremia and kidney stones, we designed a matched case-control study by using the electronic health records of the MedStar Health system with more than 3.4 million unique patient records as of March 2016. Data were extracted for clinical factors of patients with kidney stones (cases) and those without kidney stones (controls). Cases (n = 20,199) and controls (n = 20,199) were matched at a 1: 1 ratio for age, sex, race, and the duration of encounter window. Case and control exposures for each of the hyponatremia variables were defined by serum sodium laboratory measurements reported within the encounter windows, and divided into 3 categories: prior hyponatremia, recent hyponatremia, and persistent hyponatremia. In the final conditional logistic models adjusted for potential confounders, the risk of kidney stones significantly increased in both recent and persistent hyponatremia categories: prior hyponatremia odds ratio (OR) 0.93 (95% confidence interval [CI], 0.86 +/- 1.00); recent hyponatremia OR 2.02 (95% CI, 1.76 +/- 2.32); persistent hyponatremia OR 6.25 (95% CI, 3.27 +/- 11.96). In conclusion, chronic persistent hyponatremia is a significant and clinically important risk factor for kidney stones in patients in the U.S.	[Tominaga, Naoto; Verbalis, Joseph G.] Georgetown Univ, Med Ctr, Div Endocrinol & Metab, Washington, DC 20007 USA; [Fernandez, Stephen J.; Mete, Mihriye; Shara, Nawar M.] MedStar Hlth Res Inst, Dept Biostat & Biomed Informat, Hyattsville, MD USA	Georgetown University; MedStar Health Research Institute	Tominaga, N (corresponding author), Georgetown Univ, Med Ctr, Div Endocrinol & Metab, Washington, DC 20007 USA.	nt448@georgetown.edu			National Center for Advancing Translational Sciences (NCATS), National Institutes of Health [UL1TR001409]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001409] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences (NCATS), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This project was supported by grant funding from the National Center for Advancing Translational Sciences (NCATS, UL1TR001409), National Institutes of Health.	Adrogue HJ, 2000, NEW ENGL J MED, V342, P1581, DOI 10.1056/NEJM200005253422107; ALHAVA EM, 1976, SCAND J UROL NEPHROL, V10, P154, DOI 10.3109/00365597609179678; Santos LAA, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/1423462; ANDERSON RJ, 1985, ANN INTERN MED, V102, P164, DOI 10.7326/0003-4819-102-2-164; Arrabal-Polo MA, 2014, CURR OPIN UROL, V24, P633, DOI 10.1097/MOU.0000000000000111; Asplin JR, 2006, KIDNEY INT, V70, P1463, DOI 10.1038/sj.ki.5001778; Asplin JR, 2003, KIDNEY INT, V63, P662, DOI 10.1046/j.1523-1755.2003.00763.x; Barsony J, 2011, J BIOL CHEM, V286, P10864, DOI 10.1074/jbc.M110.155002; BERGSTROM WH, 1954, J CLIN INVEST, V33, P867, DOI 10.1172/JCI102959; Coe FL, 1988, NEPHROLITHIASIS PATH, P38; Coe FL, 2016, NAT REV NEPHROL, V12, P519, DOI 10.1038/nrneph.2016.101; Corona G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124105; Corona G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080451; DECAUX G, 1982, MINER ELECTROL METAB, V7, P192; Goldfarb DS, 2013, UROL CLIN N AM, V40, P13, DOI 10.1016/j.ucl.2012.09.007; Goldfarb DS, 1999, AM FAM PHYSICIAN, V60, P2269; Greenberg A, 2015, KIDNEY INT, V88, P167, DOI 10.1038/ki.2015.4; Hillier TA, 1999, AM J MED, V106, P399, DOI 10.1016/S0002-9343(99)00055-8; Hoorn EJ, 2011, J BONE MINER RES, V26, P1822, DOI 10.1002/jbmr.380; Jamal SA, 2015, J BONE MINER RES, V30, P970, DOI 10.1002/jbmr.2383; Kaelber DC, 2012, J AM MED INFORM ASSN, V19, P965, DOI 10.1136/amiajnl-2011-000782; Kaltreider NL, 1941, J EXP MED, V74, P569, DOI 10.1084/jem.74.6.569; Kinsella S, 2010, CLIN J AM SOC NEPHRO, V5, P275, DOI 10.2215/CJN.06120809; Kruse C, 2015, OSTEOPOROSIS INT, V26, P1005, DOI 10.1007/s00198-014-2973-1; Kruse C, 2016, BONE, V84, P9, DOI 10.1016/j.bone.2015.12.002; Litwin M., 2012, UROLOGIC DIS AM, V12-7865, P486; MANDEL NS, 1989, J UROLOGY, V142, P1516, DOI 10.1016/S0022-5347(17)39145-0; Melton LJ, 1998, KIDNEY INT, V53, P459, DOI 10.1046/j.1523-1755.1998.00779.x; Moe OW, 2011, KIDNEY INT, V79, P385, DOI 10.1038/ki.2010.389; PIETSCHMANN F, 1992, J BONE MINER RES, V7, P1383; Qiu SR, 2008, CHEM REV, V108, P4784, DOI 10.1021/cr800322u; SABTO J, 1984, MED J AUSTRALIA, V140, P354, DOI 10.5694/j.1326-5377.1984.tb104094.x; Sakhaee K, 2012, J CLIN ENDOCR METAB, V97, P1847, DOI 10.1210/jc.2011-3492; Sakhaee K, 2011, KIDNEY INT, V79, P393, DOI 10.1038/ki.2010.473; Sakhaee K, 2009, ADV CHRONIC KIDNEY D, V16, P30, DOI 10.1053/j.ackd.2008.10.004; Scales CD, 2016, CLIN J AM SOC NEPHRO, V11, P1305, DOI 10.2215/CJN.13251215; Scales CD, 2012, EUR UROL, V62, P160, DOI 10.1016/j.eururo.2012.03.052; Sejling AS, 2014, J CLIN ENDOCR METAB, V99, P3527, DOI 10.1210/jc.2014-1572; Sejling AS, 2012, J CLIN ENDOCR METAB, V97, P4306, DOI 10.1210/jc.2012-2031; SONNENBLICK M, 1993, CHEST, V103, P601, DOI 10.1378/chest.103.2.601; STERN TN, 1951, AM J PHYSIOL, V164, P437, DOI 10.1152/ajplegacy.1951.164.2.437; SUKI WN, 1979, AM J PHYSIOL, V237, pF1, DOI 10.1152/ajprenal.1979.237.1.F1; Thorleifsson G, 2009, NAT GENET, V41, P926, DOI 10.1038/ng.404; Upadhyay A, 2006, AM J MED, V119, pS30, DOI 10.1016/j.amjmed.2006.05.005; Usala RL, 2015, J CLIN ENDOCR METAB, V100, P3021, DOI 10.1210/jc.2015-1261; Verbalis JG, 2013, AM J MED, V126, pS5, DOI 10.1016/j.amjmed.2013.07.006; Verbalis JG, 2010, J BONE MINER RES, V25, P554, DOI 10.1359/jbmr.090827; Worcester EM, 2010, NEW ENGL J MED, V363, P954, DOI 10.1056/NEJMcp1001011; YENDT ER, 1978, KIDNEY INT, V13, P397, DOI 10.1038/ki.1978.58	49	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2018	13	9							e0203942	10.1371/journal.pone.0203942	http://dx.doi.org/10.1371/journal.pone.0203942			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU5MM	30240426	Green Published, gold, Green Submitted			2022-12-26	WOS:000445329700015
J	Terashima, M; Ishimura, A; Wanna-udom, S; Suzuki, T				Terashima, Minoru; Ishimura, Akihiko; Wanna-udom, Sasithorn; Suzuki, Takeshi			MEG8 long noncoding RNA contributes to epigenetic progression of the epithelial-mesenchymal transition of lung and pancreatic cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						transcription regulation; long noncoding RNA (long ncRNA; lncRNA); histone methylation; cancer biology; epithelial-mesenchymal transition (EMT); chromatin; epigenetics; metastasis; transforming growth factor	PRC2; CHROMATIN; SNAIL; RECRUITMENT; EXPRESSION; REPRESSION; PLASTICITY; JARID2; GENES; MARK	Long noncoding RNAs (lncRNAs) are important regulatory molecules in various biological and pathological processes, including cancer development. We have previously shown that the MEG3 lncRNA plays an essential role in transforming growth factor- (TGF-)-induced epithelial-mesenchymal transition (EMT) of human lung cancer cells. In this study, we investigated the function of another lncRNA, MEG8, which shares the DLK1-DIO3 locus with MEG3, in the regulation of EMT. MEG8 lncRNA expression was immediately induced during TGF--mediated EMT of A549 and LC2/ad lung cancer and Panc1 pancreatic cancer cell lines. MEG8 overexpression specifically suppressed the expression of microRNA-34a and microRNA-203 genes, resulting in up-regulation of SNAIL family transcriptional repressor 1 (SNAI1) and SNAI2 transcription factors, which repressed expression of cadherin 1 (CDH1)/E-cadherin. Mechanistic investigations revealed that MEG8 associates with enhancer of zeste 2 polycomb repressive complex 2 subunit (EZH2) protein and induces its recruitment to the regulatory regions of the two microRNA genes for histone H3 methylation and transcriptional repression. Interestingly, expression of both MEG8 and MEG3, but not each individually, could induce EMT-related cell morphological changes and increased cell motility in the absence of TGF- by activating the gene expression program required for EMT. MEG8 knockdown indicated that endogenous MEG8 lncRNA is indispensable for TGF--induced EMT in A549 lung cancer and Panc1 pancreatic cancer cells. Our findings indicate that MEG8 lncRNA significantly contributes to epigenetic EMT induction and increase our understanding of the lncRNA-mediated regulatory mechanisms involved in malignant progression of cancer.	[Terashima, Minoru; Ishimura, Akihiko; Wanna-udom, Sasithorn; Suzuki, Takeshi] Kanazawa Univ, Canc Res Inst, Div Funct Genom, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan	Kanazawa University	Suzuki, T (corresponding author), Kanazawa Univ, Canc Res Inst, Div Funct Genom, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	suzuki-t@staff.kanazawa-u.ac.jp	Terashima, Minoru/D-8462-2015	Suzuki, Takeshi/0000-0002-1737-0900	Ministry of Education, Culture, Sports, Science and Technology of Japan [15K08263, 16K19030]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-aid for Scientific Research C 15K08263 (to T. S.) and 16K19030 (to M. T.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Anastasiadou E, 2018, NAT REV CANCER, V18, P5, DOI 10.1038/nrc.2017.99; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Cao Q, 2008, ONCOGENE, V27, P7274, DOI 10.1038/onc.2008.333; Chase A, 2011, CLIN CANCER RES, V17, P2613, DOI 10.1158/1078-0432.CCR-10-2156; Comet I, 2016, NAT REV CANCER, V16, P803, DOI 10.1038/nrc.2016.83; da Rocha ST, 2014, MOL CELL, V53, P301, DOI 10.1016/j.molcel.2014.01.002; Davidovich C, 2015, RNA, V21, P2007, DOI 10.1261/rna.053918.115; Di Croce L, 2013, NAT STRUCT MOL BIOL, V20, P1147, DOI 10.1038/nsmb.2669; Dong PX, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0415-y; Enkhbaatar Z, 2013, CELL CYCLE, V12, P2100, DOI 10.4161/cc.25142; Fang SS, 2018, NUCLEIC ACIDS RES, V46, pD308, DOI 10.1093/nar/gkx1107; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; He YQ, 2017, ONCOTARGET, V8, P73282, DOI 10.18632/oncotarget.19931; Kaneko S, 2014, MOL CELL, V53, P290, DOI 10.1016/j.molcel.2013.11.012; Kimura H, 2008, CELL STRUCT FUNCT, V33, P61, DOI 10.1247/csf.07035; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Kopp F, 2018, CELL, V172, P393, DOI 10.1016/j.cell.2018.01.011; Liao HZ, 2015, ONCOTARGET, V6, P8914, DOI 10.18632/oncotarget.3563; Lin T, 2010, ONCOGENE, V29, P4896, DOI 10.1038/onc.2010.234; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Mitra R, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01781-0; Miyazono K, 2012, UPSALA J MED SCI, V117, P143, DOI 10.3109/03009734.2011.638729; Oktyabri D, 2014, BIOCHEM BIOPH RES CO, V453, P124, DOI 10.1016/j.bbrc.2014.09.082; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Qu Y, 2013, INT J CANCER, V133, P544, DOI 10.1002/ijc.28056; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Shen XH, 2009, CELL, V139, P1303, DOI 10.1016/j.cell.2009.12.003; Siemens H, 2011, CELL CYCLE, V10, P4256, DOI 10.4161/cc.10.24.18552; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Sun LD, 2016, CELL MOL LIFE SCI, V73, P4493, DOI 10.1007/s00018-016-2303-1; Suzuki T, 2002, NAT GENET, V32, P166, DOI 10.1038/ng949; Suzuki T, 2006, EMBO J, V25, P3422, DOI 10.1038/sj.emboj.7601215; Suzuki T, 2013, CANCER SCI, V104, P795, DOI 10.1111/cas.12169; Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336; Tange S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115684; Terashima M, 2017, BIOCHEM BIOPH RES CO, V490, P1407, DOI 10.1016/j.bbrc.2017.07.048; Terashima M, 2017, J BIOL CHEM, V292, P82, DOI 10.1074/jbc.M116.750950; Ye X, 2015, TRENDS CELL BIOL, V25, P675, DOI 10.1016/j.tcb.2015.07.012; Yoshida M, 2011, BIOCHEM J, V437, P555, DOI 10.1042/BJ20110343; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045; Zhou YL, 2012, J MOL ENDOCRINOL, V48, pR45, DOI 10.1530/JME-12-0008	43	72	72	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2018	293	47					18016	18030		10.1074/jbc.RA118.004006	http://dx.doi.org/10.1074/jbc.RA118.004006			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HB8XM	30262664	hybrid, Green Published			2022-12-26	WOS:000451375200001
J	Tsuchiya, K; Tabe, Y; Ai, T; Ohkawa, T; Usui, K; Yuri, M; Misawa, S; Morishita, S; Takaku, T; Kakimoto, A; Yang, H; Matsushita, H; Hanami, T; Yamanaka, Y; Okuzawa, A; Horii, T; Hayashizaki, Y; Ohsaka, A				Tsuchiya, Koji; Tabe, Yoko; Ai, Tomohiko; Ohkawa, Takahiro; Usui, Kengo; Yuri, Maiko; Misawa, Shigeki; Morishita, Soji; Takaku, Tomoiku; Kakimoto, Atsushi; Yang, Haeun; Matsushita, Hiromichi; Hanami, Takeshi; Yamanaka, Yasunari; Okuzawa, Atsushi; Horii, Takashi; Hayashizaki, Yoshihide; Ohsaka, Akimichi			Eprobe mediated RT-qPCR for the detection of leukemia-associated fusion genes	PLOS ONE			English	Article							MINIMAL-RESIDUAL-DISEASE; ACUTE MYELOID-LEUKEMIA; PCR; TIME; TRANSCRIPTS; BIOLOGY; SYSTEM	The detection and quantification of leukemia-associated fusion gene transcripts play important roles in the diagnosis and follow-up of leukemias. To establish a standardized method without interlaboratory discrepancies, we developed a novel one-step reverse transcription quantitative PCR (RT-qPCR) assay, called "the Eprobe leukemia assay," for major and minor BCR-ABL1, RUNX1-RUNX1T1, and various isoforms of PML-RARA. This assay is comprised of Eprobes that are exciton-controlled hybridization-sensitive fluorescent oligonucleotides. Melting curve analyses were performed on synthetic quantitative standard RNAs with strict quality control. Quantification capacity was evaluated by comparison with TaqMan RT-qPCR using 67 primary leukemia patient samples. The lower limit of detection and the limit of quantification of this assay were less than 31.3 copies/reaction and 62.5 copies/reaction, respectively. This assay correctly detected the fusion genes in samples with 100% sensitivity and specificity. The specificity of the reactions was confirmed by melting curve analyses. The assay detected low-level expression of minor BCR-ABL1 co-expressed with major BCR-ABL1. These results illustrate the feasibility and high accuracy of the Eprobe leukemia assay, even for minimal residual disease monitoring.	[Tsuchiya, Koji; Yuri, Maiko; Misawa, Shigeki; Horii, Takashi; Ohsaka, Akimichi] Juntendo Univ Hosp, Div Clin Lab, Tokyo, Japan; [Tsuchiya, Koji; Morishita, Soji; Kakimoto, Atsushi; Ohsaka, Akimichi] Juntendo Univ, Grad Sch Med, Dept Transfus Med & Stem Cell Regulat, Tokyo, Japan; [Tabe, Yoko; Ohsaka, Akimichi] Juntendo Univ, Grad Sch Med, Dept Next Generat Hematol Lab Med, Tokyo, Japan; [Tabe, Yoko; Ai, Tomohiko; Yang, Haeun] Juntendo Univ, Grad Sch Med, Dept Clin Lab Med, Tokyo, Japan; [Ohkawa, Takahiro; Usui, Kengo] RIKEN, Ctr Life Sci Technol, Div Genom Technol, Nucle Acid Diagnost Syst Dev Unit, Yokohama, Kanagawa, Japan; [Usui, Kengo; Hanami, Takeshi] RIKEN, Ctr Life Sci Technol, Div Genom Technol, Genet Diag Technol Unit, Yokohama, Kanagawa, Japan; [Takaku, Tomoiku] Juntendo Univ, Dept Hematol, Sch Med, Tokyo, Japan; [Matsushita, Hiromichi] Natl Canc Ctr, Div Pathol & Clin Labs, Tokyo, Japan; [Yamanaka, Yasunari; Hayashizaki, Yoshihide] RIKEN, Prevent Med & Diag Innovat Program, Wako, Saitama, Japan; [Okuzawa, Atsushi] Juntendo Univ, Innovat Med Technol Res & Dev Ctr, Sch Med, Tokyo, Japan	Juntendo University; Juntendo University; Juntendo University; Juntendo University; RIKEN; RIKEN; Juntendo University; National Cancer Center - Japan; RIKEN; Juntendo University	Tabe, Y (corresponding author), Juntendo Univ, Grad Sch Med, Dept Next Generat Hematol Lab Med, Tokyo, Japan.; Tabe, Y (corresponding author), Juntendo Univ, Grad Sch Med, Dept Clin Lab Med, Tokyo, Japan.	tabe@juntendo.ac.jp	松下, 弘道/AEX-6164-2022	松下, 弘道/0000-0002-1629-6630; Tabe, YOKO/0000-0002-3734-0346; Ai, Tomohiko/0000-0003-0376-0227	Foundation of Strategic Research Projects in Private Universities from the MEXT, Japan [S1311011];  [C15K08653];  [C16K08984]	Foundation of Strategic Research Projects in Private Universities from the MEXT, Japan; ; 	This work was supported in part by a Grant-in-Aid for Scientific Research (C15K08653, C16K08984), Japan, a Grant-in-Aid (S1311011) from the Foundation of Strategic Research Projects in Private Universities from the MEXT, Japan (to Y.T.).	Arber DA, 2017, ARCH PATHOL LAB MED, V141, P1342, DOI 10.5858/arpa.2016-0504-CP; Atsumi J, 2015, ONCOL REP, V33, P2719, DOI 10.3892/or.2015.3883; Beillard E, 2003, LEUKEMIA, V17, P2474, DOI 10.1038/sj.leu.2403136; Bibault JE, 2015, ONCOTARGET, V6, P22812, DOI 10.18632/oncotarget.4333; Cazzaniga Giovanni, 2003, Rev Clin Exp Hematol, V7, P292; Corradi B, 2008, LEUKEMIA, V22, P294, DOI 10.1038/sj.leu.2404987; de Reynies A, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-51; Goldman JM, 2003, NEW ENGL J MED, V349, P1451, DOI 10.1056/NEJMra020777; Goulden N, 2006, BRIT J HAEMATOL, V134, P273, DOI 10.1111/j.1365-2141.2006.06182.x; Hanami T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070942; Keen-Kim D, 2006, EXPERT REV MOL DIAGN, V6, P287, DOI 10.1586/14737159.6.3.287; Kern W, 2005, CRIT REV ONCOL HEMAT, V56, P283, DOI 10.1016/j.critrevonc.2004.06.004; Kern Wolfgang, 2005, Rev Clin Exp Hematol, V9, pE1; Kimura Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146950; Kimura Y, 2012, BIOCHEMISTRY-US, V51, P6056, DOI 10.1021/bi300293d; Mrozek Krzysztof, 2006, Hematology Am Soc Hematol Educ Program, P169; Pui Ching-Hon, 2004, Hematology Am Soc Hematol Educ Program, P118; Rodriguez-Lazaro D, 2005, APPL ENVIRON MICROB, V71, P9008, DOI 10.1128/AEM.71.12.9008-9012.2005; Ruiz MS, 2016, LEUKEMIA, V30, P2258, DOI 10.1038/leu.2016.197; van Dongen JJM, 1999, LEUKEMIA, V13, P1901, DOI 10.1038/sj.leu.2401592; vanRhee F, 1996, BLOOD, V87, P5213, DOI 10.1182/blood.V87.12.5213.bloodjournal87125213; Wu D, 2014, CLIN CANCER RES, V20, P4540, DOI 10.1158/1078-0432.CCR-13-3231; Yamada H, 2015, INT J LAB HEMATOL, V37, pe29, DOI 10.1111/ijlh.12274	23	2	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2018	13	10							e0202429	10.1371/journal.pone.0202429	http://dx.doi.org/10.1371/journal.pone.0202429			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV7VQ	30281597	gold, Green Submitted, Green Published			2022-12-26	WOS:000446342400011
J	Burkard, T; Trendelenburg, M; Daikeler, T; Hess, C; Bremerich, J; Haaf, P; Buser, P; Zellweger, MJ				Burkard, Thilo; Trendelenburg, Marten; Daikeler, Thomas; Hess, Christoph; Bremerich, Jens; Haaf, Philip; Buser, Peter; Zellweger, Michael J.			The heart in systemic lupus erythematosus - A comprehensive approach by cardiovascular magnetic resonance tomography	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; MYOCARDIAL-INFARCTION; REVISED CRITERIA; INVOLVEMENT; ENHANCEMENT; PERFUSION; CLASSIFICATION; PREVALENCE; PROGNOSIS; SYMPTOMS	Background In systemic lupus erythematosus (SLE), cardiac manifestations, e.g. coronary artery disease (CAD) and myocarditis are leading causes of morbidity and mortality. The prevalence of subclinical heart disease in SLE is unknown. We studied whether a comprehensive cardiovascular magnetic resonance (CMR) protocol may be useful for early diagnosis of heart disease in SLE patients without known CAD. Methods In this prospective, observational, cross-sectional study CMR including cine, late gadolinium enhancement (LGE) and stress perfusion sequences, ECG, and blood sampling were performed in 30 consecutive SLE patients without known CAD. All patients fulfilled at least 4/11 American College of Rheumatology (ACR) Criteria for the classification of SLE. Results 30 patients (83% female) were enrolled, mean age was 45 +/- 14 years and mean SLE disease duration was 10 +/- 8 years. 80% had low to moderate disease activity. All had a low SLE damage index. CMR was abnormal in 13/30 (43%), showing LGE in 9/13, stress perfusion deficits in 5/13 and pericardial effusion (PE) in 7/13. Patients with non-ischemic LGE had more often microalbuminuria while patients with stress perfusion deficits a history of hypertension, renal disorder as ACR criterion, repolarisation abnormalities on ECG and larger LV enddiastolic volume index. There was no correlation between clinical symptoms and CMR results. Conclusion Our study shows that cardiac involvement as observed by CMR is frequent in SLE and not necessarily associated with typical symptoms. CMR may thus help to detect subclinical cardiac involvement, which could lead to earlier treatment. Additionally we identify possible risk factors associated with cardiac involvement.	[Burkard, Thilo; Haaf, Philip; Buser, Peter; Zellweger, Michael J.] Univ Hosp Basel, Dept Cardiol, Basel, Switzerland; [Burkard, Thilo; Hess, Christoph] Univ Hosp Basel, Med Outpatient Dept, Basel, Switzerland; [Burkard, Thilo; Trendelenburg, Marten; Daikeler, Thomas; Hess, Christoph; Bremerich, Jens; Haaf, Philip; Buser, Peter; Zellweger, Michael J.] Univ Basel, Basel, Switzerland; [Trendelenburg, Marten] Univ Hosp Basel, Div Internal Med, Basel, Switzerland; [Daikeler, Thomas] Univ Hosp Basel, Dept Rheumatol, Basel, Switzerland; [Bremerich, Jens] Univ Hosp Basel, Dept Radiol, Basel, Switzerland	University of Basel; University of Basel; University of Basel; University of Basel; University of Basel; University of Basel	Burkard, T (corresponding author), Univ Hosp Basel, Dept Cardiol, Basel, Switzerland.; Burkard, T (corresponding author), Univ Hosp Basel, Med Outpatient Dept, Basel, Switzerland.; Burkard, T (corresponding author), Univ Basel, Basel, Switzerland.	thilo.burkard@usb.ch	Zellweger, Michael/AAB-4859-2022; Trendelenburg, Marten/AAM-1626-2020; Burkard, Thilo/N-7533-2014	Trendelenburg, Marten/0000-0001-7036-8386; Burkard, Thilo/0000-0001-6373-9820	Nycomed	Nycomed	This work was supported by a research grant from Nycomed, contributed to the Research Funds of the University Hospital Basel, Basel, Switzerland (TB). The funders had no role in study design, data collection and Analysis, decision to publish, or preparation of the manuscript.	Abdel-Aty H, 2008, LUPUS, V17, P561, DOI 10.1177/0961203308089401; BEEN M, 1988, EUR HEART J, V9, P1250, DOI 10.1093/oxfordjournals.eurheartj.a062437; BENCIVELLI W, 1992, CLIN EXP RHEUMATOL, V10, P549; Bjornadal L, 2004, J RHEUMATOL, V31, P713; CERVERA R, 1992, ANN RHEUM DIS, V51, P156, DOI 10.1136/ard.51.2.156; Chen JZ, 2016, CLIN RHEUMATOL, V35, P2437, DOI 10.1007/s10067-016-3373-z; Chizzolini Carlo, 2009, Rev Med Suisse, V5, P808; Coleman GC, 2017, JACC-CARDIOVASC IMAG, V10, P411, DOI 10.1016/j.jcmg.2016.05.009; de Cobelli F, 2006, J AM COLL CARDIOL, V47, P1649, DOI 10.1016/j.jacc.2005.11.067; DOHERTY NE, 1985, AM HEART J, V110, P1257, DOI 10.1016/0002-8703(85)90023-7; Edwards NC, 2007, RHEUMATOLOGY, V46, P1208, DOI 10.1093/rheumatology/kem077; Gladman D, 1996, ARTHRITIS RHEUM, V39, P363, DOI 10.1002/art.1780390303; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Ishimori ML, 2011, JACC-CARDIOVASC IMAG, V4, P27, DOI 10.1016/j.jcmg.2010.09.019; Klem I, 2006, J AM COLL CARDIOL, V47, P1630, DOI 10.1016/j.jacc.2005.10.074; Kouranos V, 2017, JACC-CARDIOVASC IMAG, V10, P1437, DOI 10.1016/j.jcmg.2016.11.019; Kwong RY, 2008, CIRCULATION, V118, P1011, DOI 10.1161/CIRCULATIONAHA.107.727826; Kwong RY, 2006, CIRCULATION, V113, P2733, DOI 10.1161/CIRCULATIONAHA.105.570648; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Mahrholdt H, 2004, CIRCULATION, V109, P1250, DOI 10.1161/01.CIR.0000118493.13323.81; Manzi S, 1997, AM J EPIDEMIOL, V145, P408; Mavrogeni S, 2018, LUPUS, V27, P564, DOI 10.1177/0961203317731533; Mavrogeni S, 2017, LUPUS, V26, P227, DOI 10.1177/0961203316671810; Mavrogeni S, 2016, LUPUS, V25, P289, DOI 10.1177/0961203315611496; Mavrogeni S, 2013, LUPUS, V22, P34, DOI 10.1177/0961203312462265; Mavrogeni S, 2012, LUPUS, V21, P821, DOI 10.1177/0961203312437437; Mavrogeni S, 2017, INT J CARDIOL, V236, P151, DOI 10.1016/j.ijcard.2017.01.104; Mavrogeni S, 2017, INT J CARDIOL, V228, P444, DOI 10.1016/j.ijcard.2016.11.242; Mavrogeni Sophie, 2015, Inflammation & Allergy Drug Targets, V14, P111, DOI 10.2174/1871528114666160105112758; Messroghli DR, 2017, J CARDIOVASC MAGN R, V19, DOI 10.1186/s12968-017-0389-8; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Nieves CEF, 2016, CURR RHEUMATOL REP, V18, DOI 10.1007/s11926-016-0571-2; Panchal L, 2006, J POSTGRAD MED, V52, P5; Seneviratne MG, 2016, LUPUS, V25, P573, DOI 10.1177/0961203315622275; Singh J. A., 2005, Lupus, V14, P137, DOI 10.1191/0961203305lu2050oa; Sun SS, 2001, RHEUMATOLOGY, V40, P1106, DOI 10.1093/rheumatology/40.10.1106; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Thiele H, 2006, J AM COLL CARDIOL, V47, P1641, DOI 10.1016/j.jacc.2005.11.065; VONFELDT JM, 1995, POSTGRAD MED, V97, P79, DOI 10.1080/00325481.1995.11945982; Weir-McCall JR, 2017, EUR HEART J-CARD IMG, V18, P657, DOI 10.1093/ehjci/jew155; Wijetunga M, 2002, AM J MED, V113, P419, DOI 10.1016/S0002-9343(02)01223-8; Wu KC, 2008, J AM COLL CARDIOL, V51, P2414, DOI 10.1016/j.jacc.2008.03.018	42	26	28	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0202105	10.1371/journal.pone.0202105	http://dx.doi.org/10.1371/journal.pone.0202105			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273933	Green Submitted, gold, Green Published			2022-12-26	WOS:000446124700002
J	Esteva, M; Ruiz-Diaz, M; Sanchez, MA; Pertega, S; Pita-Fernandez, S; Macia, F; Posso, M; Gonzalez-Lujan, L; Bosca-Wats, MM; Leiva, A; Ripoll, J				Esteva, Magdalena; Ruiz-Diaz, Mercedes; Antonia Sanchez, M.; Pertega, Sonia; Pita-Fernandez, Salvador; Macia, Francesc; Posso, Margarita; Gonzalez-Lujan, Luis; Bosca-Wats, Marta M.; Leiva, Alfonso; Ripoll, Joana		DECCIRE GRP	Emergency presentation of colorectal patients in Spain	PLOS ONE			English	Article							CANCER-DIAGNOSIS; COLON-CANCER; ADMISSION; MORTALITY; RESECTION; PATTERNS; SURVIVAL; FEATURES; SURGERY; ENGLAND	Background Colorectal cancer (CRC) is the leading cause of cancer deaths in Europe. Survival is poorer in patients admitted to hospitals through the emergency department than in electively admitted patients. Knowledge of factors associated with a cancer diagnosis through presentation at an emergency department may reduce the likelihood of an emergency diagnosis. This study evaluated factors influencing the diagnosis of CRC in the emergency department. Methods and findings This is a cross-sectional study in 5 Spanish regions; subjects were incident cases of CRC diagnosed in 9 public hospitals, between 2006 and 2008. Data were obtained from patient interviews and primary care and hospital clinical records. We found that approximately 40% of CRC patients first contacted a hospital for CRC through an emergency service. Women were more likely than men to be emergency presenters. The type of symptom associated with emergency presentation differed between patients with colon cancer and those with rectal cancer, in that the frequency of "alarm symptoms" was significantly lower in colon than in rectal cancer patients who initially presented to emergency services. Soon after symptom onset, some patients went to a hospital emergency service, whereas others contacted their GP. Lack of contact with a GP for CRC-related symptoms was consistently related to emergency presentation. Among patients who contacted a GP, a higher number of consultations for CRC symptoms and any referral to outpatient consultations reduced the likelihood of emergency presentation. All diagnostic time intervals were shorter in emergency presenters than in elective patients. Conclusions Emergency presenters are not a uniform category and can be divided into categories according to their symptoms, help seeking behavior trajectory and interaction with their GPs. Time constraints for testing and delays in obtaining outpatient appointments led patients to visit a hospital service either on their own or after referral by their GP.	[Esteva, Magdalena; Leiva, Alfonso; Ripoll, Joana] Balearic Isl Hlth Res Inst IdISBa, Baleares Hlth Serv IbSalut, Primary Care Res Unit, Majorca Dept Primary Care, Mallorca, Spain; [Ruiz-Diaz, Mercedes] Univ Zaragoza, Fac Hlth Sci, Zaragoza, Spain; [Antonia Sanchez, M.] Univ Zaragoza, Ctr Salud Fuentes Norte Zaragoza, Dept Med Psychiat & Dermatol, Zaragoza, Spain; [Pertega, Sonia; Pita-Fernandez, Salvador] Univ A Coruna, Clin Epidemiol & Biostat Res Grp, Inst Invest Biomed A Coruna INIBIC, CHUAC,SERGAS, La Coruna, Spain; [Macia, Francesc; Posso, Margarita] Hosp Mar, Epidemiol & Evaluat Dept, Barcelona, Spain; [Macia, Francesc; Posso, Margarita] IMIM Hosp Mar Med Res Inst, Barcelona, Spain; [Macia, Francesc; Posso, Margarita] REDISSEC Hlth Serv Res Chron Patients Network, Madrid, Spain; [Gonzalez-Lujan, Luis] Valencia Inst Hlth, Serreria Primary Care Ctr 2, Valencia, Spain; [Bosca-Wats, Marta M.] Hosp Clin Univ Valencia, Digest Med Unit, Valencia, Spain	Atencio Primaria de Mallorca; Institut Investigacio Sanitaria Illes Balears (IdISBa); University of Zaragoza; University of Zaragoza; Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC); Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut Hospital del Mar d'Investigacions Mediques (IMIM)	Esteva, M (corresponding author), Balearic Isl Hlth Res Inst IdISBa, Baleares Hlth Serv IbSalut, Primary Care Res Unit, Majorca Dept Primary Care, Mallorca, Spain.	mesteva@ibsalut.caib.es	Leiva, Alfonso/ABF-1361-2020; Pértega-Díaz, Sonia/E-4353-2013; Posso, Margarita/N-3824-2017; Peña, Mercedes Ruidíaz/AAB-5382-2019; Gonzalez Timoneda, Alba/C-8205-2019	Pértega-Díaz, Sonia/0000-0003-3891-3203; Posso, Margarita/0000-0002-5053-257X; Peña, Mercedes Ruidíaz/0000-0002-8153-1473; Esteva, Magdalena/0000-0001-8238-7891; Gonzalez Timoneda, Alba/0000-0003-1871-7758; Ripoll, Joana/0000-0002-5251-7234	Ministry of Health; Carlos III Institute [PI: 052273, PI050787, PI050700, PI052692, PI052141]; Health Promotion and Preventive Activities-Primary Health Care Network; Ministry of Health ISCIII-RETCI [G03/170, RD06/0018, RD12/0005/0011]; Instituto de Salud Carlos III	Ministry of Health; Carlos III Institute(Instituto de Salud Carlos III); Health Promotion and Preventive Activities-Primary Health Care Network; Ministry of Health ISCIII-RETCI; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This study was funded by the Ministry of Health. Carlos III Institute; grants PI: 052273, PI050787, PI050700, PI052692, PI052141. This study was also supported by the Health Promotion and Preventive Activities-Primary Health Care Network and by the Ministry of Health ISCIII-RETCI awards G03/170 and RD06/0018, RD12/0005/0011, http://www.isciii.es/. Instituto de Salud Carlos III is a public funder of investigation in health sciences depending of the Ministry of Economy. It has no role in design, data collection and analysis, decision to publish or preparation of the manuscript.; This study was funded by the Ministry of Health. Carlos III Institute; grants PI: 052273, PI050787, PI050700, PI052692, PI052141. This study was also supported by the Health Promotion and Preventive Activities-Primary Health Care Network and by the Ministry of Health ISCIII-RETCI awards G03/170 and RD06/0018, RD12/0005/0011. The authors would like to thank the surgeons, gastroenterologists and general practitioners who assisted with contacting their patients.	Abel GA, 2015, BRIT J CANCER, V112, pS129, DOI 10.1038/bjc.2015.52; Black G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135027; Bottle A, 2012, BRIT J CANCER, V107, P1213, DOI 10.1038/bjc.2012.320; Brenner H, 2012, INT J CANCER, V131, P1649, DOI 10.1002/ijc.26192; Brewster DH, 2011, BRIT J CANCER, V104, P60, DOI 10.1038/sj.bjc.6606036; Chiarugi M, 2007, SURG ONCOL, V16, pS73, DOI 10.1016/j.suronc.2007.10.019; Cleary J, 2007, FAM PRACT, V24, P3, DOI 10.1093/fampra/cml059; Diggs JC, 2007, AM J MANAG CARE, V13, P157; Downing A, 2013, BRIT J CANCER, V108, P681, DOI 10.1038/bjc.2012.585; Elliss-Brookes L, 2012, BRIT J CANCER, V107, P1220, DOI 10.1038/bjc.2012.408; Esteva M, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-87; Esteva M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-86; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Frattini M, 2004, CLIN CANCER RES, V10, P4015, DOI 10.1158/1078-0432.CCR-04-0031; Gunnarsson H, 2013, EJSO-EUR J SURG ONC, V39, P831, DOI 10.1016/j.ejso.2013.04.004; Hamilton W, 2012, BRIT J CANCER, V107, P1205, DOI 10.1038/bjc.2012.423; Iversen LH, 2008, BRIT J SURG, V95, P1012, DOI 10.1002/bjs.6114; Larsen MB, 2014, CANCER EPIDEMIOL, V38, P100, DOI 10.1016/j.canep.2013.10.006; Lyratzopoulos G, 2014, FUTURE ONCOL, V10, P1329, DOI [10.2217/fon.14.80, 10.2217/FON.14.80]; McArdle CS, 2004, BRIT J SURG, V91, P605, DOI 10.1002/bjs.4456; McPhail S, 2013, BRIT J CANCER, V109, P2027, DOI 10.1038/bjc.2013.569; Mitchell AD, 2007, ANN SURG ONCOL, V14, P1099, DOI 10.1245/s10434-006-9245-z; Mitchell ED, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006965; Murchie P, 2017, BRIT J CANCER, V116, P1148, DOI 10.1038/bjc.2017.71; National Institute for Health and Clinical Excellence, 2005, REF GUID SUSP CANC C; Neal RD, 2014, BRIT J CANCER, V110, P584, DOI 10.1038/bjc.2013.791; Polednak AP, 2000, CANCER DETECT PREV, V24, P283; Porta M, 1998, BRIT J CANCER, V77, P477, DOI 10.1038/bjc.1998.76; Rabeneck L, 2006, AM J GASTROENTEROL, V101, P1098, DOI 10.1111/j.1572-0241.2006.00488.x; Renzi C, 2016, BRIT J CANCER, V115, P866, DOI 10.1038/bjc.2016.250; Sheringham JR, 2014, BRIT J CANCER, V111, P1490, DOI 10.1038/bjc.2014.424; Sikka V, 2012, AM J EMERG MED, V30, P283, DOI 10.1016/j.ajem.2010.11.029; Singh H, 2009, AM J GASTROENTEROL, V104, P2543, DOI 10.1038/ajg.2009.324; Sjo OH, 2009, COLORECTAL DIS, V11, P733, DOI 10.1111/j.1463-1318.2008.01613.x; Torring ML, 2011, BRIT J CANCER, V104, P934, DOI 10.1038/bjc.2011.60; Tsang C, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-308; Wallace D, 2014, BRIT J CANCER, V111, P577, DOI 10.1038/bjc.2014.300; Weller D, 2012, BRIT J CANCER, V106, P1262, DOI 10.1038/bjc.2012.68; Zhou Y, 2017, NAT REV CLIN ONCOL, V14, P45, DOI 10.1038/nrclinonc.2016.155	39	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0203556	10.1371/journal.pone.0203556	http://dx.doi.org/10.1371/journal.pone.0203556			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273339	Green Submitted, gold, Green Published			2022-12-26	WOS:000446124700006
J	Niu, LN; Zhao, F; Chen, JL; Nong, JQ; Wang, CM; Wang, J; Gao, NS; Zhu, XX; Wu, L; Hu, SK				Niu, Lina; Zhao, Fan; Chen, Jinlong; Nong, Jinqing; Wang, Chunmei; Wang, Jing; Gao, Naishu; Zhu, Xiaoxue; Wu, Lei; Hu, Shoukui			Isothermal amplification and rapid detection of Klebsiella pneumoniae based on the multiple cross displacement amplification (MCDA) and gold nanoparticle lateral flow biosensor (LFB)	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; BETA-LACTAMASE; OUTBREAK; ASSAY; GENE; LAMP	Klebsiella pneumoniae (K. pneumoniae) is a frequent pathogen causing nosocomial infections and outbreaks. We developed a multiple cross displacement amplification (MCDA) assay for the detection of K. pneumoniae, which can get the positive results within 40 minutes' isothermal amplification. Gold-nanoparticle lateral flow biosensor (LFB) and colorimetric indicators were used for the rapid readouts of MCDA amplification. The detection limit of this assay was 100 fg per reaction at 65 degrees C, which was confirmed to be the optimal amplification temperature according to the real time turbidimeters. For specificity, all of the 30 clinical-source K. pneumoniae strains were positive for the MCDA, and all of the non-K. pneumoniae strains belonging to 31 different species were negative for this MCDA assay. To evaluate the practical applicability of this method, we assessed its detection limit for K. pneumoniae strains in sputum samples (24 CFU per reaction), and DNA templates of 100 sputum samples further underwent the MCDA-LFB tests. All of the sputum samples being positive for K. pneumoniae (30/100) with the culture method were successfully identified with the MCDA assay, the detection power of which was higher than that of polymerase chain reaction (PCR) (25/100). Thus, the MCDA test for K. pneumoniae combined with the gold nanoparticle LFB as the results readout scheme, are simple, specific, and sensitive methods for the rapid diagnosis of K. pneumoniae in clinical samples.	[Niu, Lina; Chen, Jinlong] Hainan Med Univ, Sch Basic Med & Lifesci, Dept Pathogen Biol, Haikou, Hainan, Peoples R China; [Niu, Lina; Zhao, Fan; Nong, Jinqing; Wang, Chunmei; Wang, Jing; Gao, Naishu; Zhu, Xiaoxue; Wu, Lei; Hu, Shoukui] Peking Univ, Dept Clin Lab, Shougang Hosp, Beijing, Peoples R China	Hainan Medical University; Peking University	Hu, SK (corresponding author), Peking Univ, Dept Clin Lab, Shougang Hosp, Beijing, Peoples R China.	shoukuihu@163.com	niu, lina/GWR-3585-2022	Hu, Shoukui/0000-0001-6339-3954; Nong, Jinqing/0000-0002-1955-9790; wu, lei/0000-0002-5619-8074; Zhu, Xiaoxue/0000-0001-9019-060X; Zhao, Fan/0000-0002-8164-5016	National Natural Science Foundation of China [81760376]; Beijing Natural Science Foundation [7162031]; Peking University Shougang Hospital [2017-Yuan-LC-08, SGYYZ201602]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Peking University Shougang Hospital	This work was supported by the National Natural Science Foundation of China [grant number 81760376] for LN, the Beijing Natural Science Foundation [grant number 7162031] for FZ, and the Peking University Shougang Hospital [grant numbers 2017-Yuan-LC-08, SGYYZ201602] for SH.	Ang GY, 2015, J MICROBIOL METH, V118, P99, DOI 10.1016/j.mimet.2015.08.024; Bialek-Davenet S, 2014, EMERG INFECT DIS, V20, P1812, DOI 10.3201/eid2011.140206; Chen YT, 2016, BIOSENS BIOELECTRON, V81, P317, DOI 10.1016/j.bios.2016.03.006; Dong DR, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00519; Kim HJ, 2016, ANN LAB MED, V36, P15, DOI 10.3343/alm.2016.36.1.15; Kola A, 2015, ANTIMICROB RESIST IN, V4, DOI 10.1186/s13756-015-0049-4; Kontopidou F, 2014, CLIN MICROBIOL INFEC, V20, pO117, DOI 10.1111/1469-0691.12341; Liu DX, 2018, J MICROBIOL METH, V145, P59, DOI 10.1016/j.mimet.2017.11.003; MCCALLUM KL, 1991, INFECT IMMUN, V59, P494, DOI 10.1128/IAI.59.2.494-502.1991; Misawa Yoshiki, 2007, Journal of Infection and Chemotherapy, V13, P134, DOI 10.1007/s10156-007-0508-9; Naas T, 2010, J ANTIMICROB CHEMOTH, V65, P1305, DOI 10.1093/jac/dkq117; Nakano R, 2015, J INFECT CHEMOTHER, V21, P202, DOI 10.1016/j.jiac.2014.11.010; Pandey BD, 2008, J MED MICROBIOL, V57, P439, DOI 10.1099/jmm.0.47499-0; Sanchez GV, 2013, EMERG INFECT DIS, V19, P133, DOI 10.3201/eid1901.120310; Snitkin ES, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004129; Soo PC, 2013, J MICROBIOL METH, V92, P197, DOI 10.1016/j.mimet.2012.11.020; Starlander G, 2012, J HOSP INFECT, V82, P122, DOI 10.1016/j.jhin.2012.07.004; Toubanaki DK, 2016, J MICROBIOL METH, V127, P51, DOI 10.1016/j.mimet.2016.05.027; Wang Y, 2018, NANO RES, V11, P2632, DOI 10.1007/s12274-017-1893-z; Wang Y, 2018, ARTIF CELL NANOMED B, V46, P1671, DOI 10.1080/21691401.2017.1389748; Wang Y, 2017, INT J NANOMED, V12, P473, DOI 10.2147/IJN.S123625; Wang Y, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02047; Wang Y, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01834; Wang Y, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00753; Wang Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep11902; Zweigner J, 2014, AM J INFECT CONTROL, V42, P936, DOI 10.1016/j.ajic.2014.04.022	26	13	13	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204332	10.1371/journal.pone.0204332	http://dx.doi.org/10.1371/journal.pone.0204332			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273362	Green Published, gold, Green Submitted			2022-12-26	WOS:000446124700019
J	Smogorzewska, J; Szumski, G; Grygiel, P				Smogorzewska, Joanna; Szumski, Grzegorz; Grygiel, Pawel			Same or different? Theory of mind among children with and without disabilities	PLOS ONE			English	Article							AUTISM SPECTRUM DISORDERS; TEST-RETEST RELIABILITY; HIGH-FUNCTIONING AUTISM; FALSE-BELIEF TASKS; MIDDLE CHILDHOOD; MEASUREMENT INVARIANCE; FACTORIAL INVARIANCE; MENTAL-RETARDATION; EXECUTIVE FUNCTION; SOCIAL COMPETENCE	Assessing theory of mind (ToM) with reliable and valid measures is important, as ToM plays a significant role in children's social and cognitive functioning. With this in mind, a thorough analysis of the Theory of Mind scale and the Faux Pas Recognition Test was conducted. Over 750 school-age (Mage = 7.7) children with disabilities (mild intellectual disability, hearing impairment) and without disabilities took part in our study. The psychometric properties of measures in these groups of children were checked, using confirmatory item factor analysis, reliability, and validity analyses. Thanks to groups' invariance it was possible to compare mean results of children in the groups. Both measures showed well-fitted models with acceptable goodness of fit as well as scalar and strict invariance. An IRT analysis showed significant differences in the difficulty of the tasks in all groups, but the same order of passing tasks in comparison to other studies, conducted in Western countries, has been observed. Our results showed that the tasks were the easiest for children without disabilities, and most difficult for children with mild intellectual disability. We obtained significant and positive correlations between ToM and social skills and language abilities. The findings are discussed in relation to results from other studies in the field.	[Smogorzewska, Joanna; Szumski, Grzegorz] Univ Warsaw, Dept Educ, Warsaw, Poland; [Grygiel, Pawel] Jagiellonian Univ, Fac Philosophy, Inst Pedag, Krakow, Poland	University of Warsaw; Jagiellonian University	Smogorzewska, J (corresponding author), Univ Warsaw, Dept Educ, Warsaw, Poland.	j.smogorzewska@gmail.com	Grygiel, Paweł/AAV-8389-2021; Smogorzewska, Joanna/K-7668-2019	Grygiel, Paweł/0000-0001-9790-3772; Smogorzewska, Joanna/0000-0002-4377-9136	National Science Centre (Narodowe Centrum Nauki) in Poland [2014/13/B/HS6/02663]; National Centre for Science, Poland [2014/13/B/HS6/02663]	National Science Centre (Narodowe Centrum Nauki) in Poland; National Centre for Science, Poland	The study was funded by the National Science Centre (Narodowe Centrum Nauki) in Poland. The grant number is 2014/13/B/HS6/02663. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study has been financed by National Centre for Science (no. 2014/13/B/HS6/02663), Poland	Baron-Cohen S, 1999, J AUTISM DEV DISORD, V29, P407, DOI 10.1023/A:1023035012436; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; BYRNE BM, 1989, PSYCHOL BULL, V105, P456, DOI 10.1037/0033-2909.105.3.456; Colle L, 2007, J AUTISM DEV DISORD, V37, P716, DOI 10.1007/s10803-006-0198-7; Devine RT, 2018, CHILD DEV, V89, P971, DOI 10.1111/cdev.12682; Devine RT, 2014, CHILD DEV, V85, P1777, DOI 10.1111/cdev.12237; DODGE KA, 1985, J CONSULT CLIN PSYCH, V53, P344, DOI 10.1037/0022-006X.53.3.344; Fink E, 2015, BRIT J DEV PSYCHOL, V33, P1, DOI 10.1111/bjdp.12060; Fink E, 2014, CHILD DEV, V85, P2389, DOI 10.1111/cdev.12302; Flavell JH, 1988, HDB CHILD PSYCHOL, V2, P851; GOPNIK A, 1991, CHILD DEV, V62, P98, DOI 10.2307/1130707; Greenfield PM, 2003, ANNU REV PSYCHOL, V54, P461, DOI 10.1146/annurev.psych.54.101601.145221; Haeberlin U, 1989, INTEGRATION SCHULKLA; Hayward EO, 2017, BRIT J DEV PSYCHOL, V35, P454, DOI 10.1111/bjdp.12186; Hofstede G, 2010, CULTURES ORG SOFTWAR, V3rd; HORN JL, 1992, EXP AGING RES, V18, P117, DOI 10.1080/03610739208253916; Hughes C, 2004, SOC DEV, V13, P590, DOI 10.1111/j.1467-9507.2004.00285.x; Hughes C, 2000, J CHILD PSYCHOL PSYC, V41, P483, DOI 10.1017/S0021963099005533; Hughes C, 2016, J EXP CHILD PSYCHOL, V149, P1, DOI 10.1016/j.jecp.2016.01.017; Ibanez A, 2013, PERS INDIV DIFFER, V54, P616, DOI 10.1016/j.paid.2012.11.022; Im-Bolter N, 2016, J EXP CHILD PSYCHOL, V149, P98, DOI 10.1016/j.jecp.2015.12.006; Joseph RM, 2004, DEV PSYCHOPATHOL, V16, P137, DOI 10.1017/S095457940404444X; Karwowski M., 2012, TEST UMIEJETNOSCI ST; Kimhi Y, 2014, TOP LANG DISORD, V34, P329, DOI 10.1097/TLD.0000000000000033; Kristen S, 2006, Z ENTWICKL PADAGOGIS, V38, P190, DOI 10.1026/0049-8637.38.4.186; Kuntoro IA, 2013, INT J BEHAV DEV, V37, P266, DOI 10.1177/0165025413478258; Lagattuta KH, 2016, J EXP CHILD PSYCHOL, V149, P116, DOI 10.1016/j.jecp.2016.01.013; Lam YG, 2012, RES AUTISM SPECT DIS, V6, P560, DOI 10.1016/j.rasd.2011.07.017; Leekam S, 1997, BRIT J DEV PSYCHOL, V15, P77, DOI 10.1111/j.2044-835X.1997.tb00726.x; Li AS, 2011, J AUTISM DEV DISORD, V41, P185, DOI 10.1007/s10803-010-1045-4; Little TD, 1997, MULTIVAR BEHAV RES, V32, P53, DOI 10.1207/s15327906mbr3201_3; Little TD, 2007, INT J BEHAV DEV, V31, P357, DOI 10.1177/0165025407077757; Lubke GH, 2003, BRIT J MATH STAT PSY, V56, P231, DOI 10.1348/000711003770480020; Mayes LC, 1996, J CHILD PSYCHOL PSYC, V37, P313, DOI 10.1111/j.1469-7610.1996.tb01408.x; McConnell SR, 1999, TOP EARLY CHILD SPEC, V19, P67, DOI 10.1177/027112149901900201; MEREDITH W, 1993, PSYCHOMETRIKA, V58, P525, DOI 10.1007/BF02294825; MEREDITH W, 1964, PSYCHOMETRIKA, V29, P177, DOI 10.1007/BF02289699; Meredith W, 2006, MED CARE, V44, pS69, DOI 10.1097/01.mlr.0000245438.73837.89; Milligan K, 2007, CHILD DEV, V78, P622, DOI 10.1111/j.1467-8624.2007.01018.x; Millsap RE, 2011, STAT APPROACHES MEAS; Moran JM, 2011, P NATL ACAD SCI USA, V108, P2688, DOI 10.1073/pnas.1011734108; Muthen L.K., 1998, MPLUS USERS GUIDE, V8th; Nilsson KK, 2016, CHILD DEV, V87, P143, DOI 10.1111/cdev.12462; Osterhaus C, 2016, CHILD DEV, V87, P1971, DOI 10.1111/cdev.12566; PERNER J, 1987, BRIT J DEV PSYCHOL, V5, P125, DOI 10.1111/j.2044-835X.1987.tb01048.x; Peskin J, 2003, SOC DEV, V12, P496, DOI 10.1111/1467-9507.00245; Peteron CC, 2016, J EXP CHILD PSYCHOL, V149, P146, DOI 10.1016/j.jecp.2015.11.008; Peterson CC, 2012, CHILD DEV, V83, P469, DOI 10.1111/j.1467-8624.2011.01728.x; Peterson CC, 2005, CHILD DEV, V76, P502, DOI 10.1111/j.1467-8624.2005.00859.x; Phillips W, 1998, BRIT J DEV PSYCHOL, V16, P337, DOI 10.1111/j.2044-835X.1998.tb00756.x; Rajkumar AP, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-51; Ronald A, 2005, SOC DEV, V14, P664, DOI 10.1111/j.1467-9507.2005.00323.x; Shahaeian A, 2014, J CROSS CULT PSYCHOL, V45, P1110, DOI 10.1177/0022022114534772; Slaughter V, 2015, CHILD DEV, V86, P1159, DOI 10.1111/cdev.12372; Smogorzewska J, 2018, INT J DISABIL DEV ED, V65, P318, DOI 10.1080/1034912X.2017.1368461; Szumski G, 2019, J AUTISM DEV DISORD, V49, P2822, DOI 10.1007/s10803-017-3377-9; Tager-Flusberg H, 2007, CURR DIR PSYCHOL SCI, V16, P311, DOI 10.1111/j.1467-8721.2007.00527.x; Tahiroglu D, 2014, DEV PSYCHOL, V50, P2485, DOI 10.1037/a0037914; Talwar V, 2012, FOCUS AUTISM DEV DIS, V27, P122, DOI 10.1177/1088357612441828; Thirion-Marissiaux AF, 2008, RES DEV DISABIL, V29, P414, DOI 10.1016/j.ridd.2007.07.001; Thirion-Marissiaux AF, 2008, RES DEV DISABIL, V29, P547, DOI 10.1016/j.ridd.2007.09.004; Wang ZL, 2016, J EXP CHILD PSYCHOL, V149, P6, DOI 10.1016/j.jecp.2015.09.028; Wellman H.M., 2002, HDB CHILDHOOD COGNIT, P167, DOI DOI 10.1002/9780470996652.CH8; Wellman HM, 2011, CHILD DEV, V82, P780, DOI 10.1111/j.1467-8624.2011.01583.x; Wellman HM, 2001, CHILD DEV, V72, P655, DOI 10.1111/1467-8624.00304; Wellman HM, 2004, CHILD DEV, V75, P523, DOI 10.1111/j.1467-8624.2004.00691.x; WHEELER VA, 1982, DEV PSYCHOL, V18, P795, DOI 10.1037/0012-1649.18.6.795; Yirmiya N, 1996, J CHILD PSYCHOL PSYC, V37, P1003, DOI 10.1111/j.1469-7610.1996.tb01497.x; Yirmiya N, 1998, PSYCHOL BULL, V124, P283, DOI 10.1037/0033-2909.124.3.283; Zhang T, 2016, RES AUTISM SPECT DIS, V23, P210, DOI 10.1016/j.rasd.2015.10.005; Zumbo BD, 2007, J MOD APPL STAT METH, V6, P21, DOI 10.22237/jmasm/1177992180	71	11	13	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0202553	10.1371/journal.pone.0202553	http://dx.doi.org/10.1371/journal.pone.0202553			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GV5EV	30273356	Green Published, Green Submitted, gold			2022-12-26	WOS:000446124700004
J	Wegermann, K; Henao, R; Diehl, AM; Murphy, SK; Abdelmalek, MF; Moylan, CA				Wegermann, Kara; Henao, Ricardo; Diehl, Anna Mae; Murphy, Susan K.; Abdelmalek, Manal F.; Moylan, Cynthia A.			Branched chain amino acid transaminase 1 (BCAT1) is overexpressed and hypomethylated in patients with non-alcoholic fatty liver disease who experience adverse clinical events: A pilot study	PLOS ONE			English	Article							GENE-EXPRESSION; FIBROSIS SCORE; NAFLD; STEATOHEPATITIS; EPIDEMIOLOGY; METABOLISM; PROFILES	Background and objectives Although the burden of non-alcoholic fatty liver disease (NAFLD) continues to increase worldwide, genetic factors predicting progression to cirrhosis and decompensation in NAFLD remain poorly understood. We sought to determine whether gene expression profiling was associated with clinical decompensation and death in patients with NAFLD, and to assess whether altered DNA methylation contributes to these changes in gene expression. Methods We performed a retrospective analysis of 86 patients in the Duke NAFLD Clinical Database and Biorepository with biopsy-proven NAFLD whose liver tissue was previously evaluated for gene expression and DNA methylation using array based technologies. We assessed the prospective development of liver and cardiovascular disease related outcomes, including hepatic decompensation as identified by the development of ascites, hepatic encephalopathy, hepatocellular carcinoma, or variceal bleeding as well as stroke and myocardial infarction via medical chart review. Results Of the 86 patients, 47 had F0-F1 fibrosis and 39 had F3-F4 fibrosis at index liver biopsy. Gene expression probe sets (n = 54,675) were analyzed; 42 genes showed significant differential expression (p<0.05) and a two-fold change in expression between patients with and without any outcome. Two expression probes of the branched chain amino-acid transaminase 1 (BCAT1) gene were upregulated (p = 0.02; fold change 2.1 and 2.2 respectively) in patients with a clinical outcome. Methylation of three of the 34 BCAT1 CpG methylation probes were significantly inversely correlated with BCAT1 expression specific to the probes predictive of clinical deterioration. Conclusion We found differential gene expression, correlated to changes in DNA methylation, at multiple BCAT1 loci in patients with cardiovascular outcomes and/or hepatic decompensation. BCAT1 catalyzes the transformation of alpha-ketoglutarate to glutamate and has been linked to the presence and severity of NAFLD, possibly through derangements in the balance between glutamate and alpha-ketoglutarate. Given the potential for BCAT1 to identify patients at risk for poor outcomes, and the potential therapeutic implications, these results should be validated in larger prospective studies.	[Wegermann, Kara; Diehl, Anna Mae; Abdelmalek, Manal F.; Moylan, Cynthia A.] Duke Univ Hlth Syst, Dept Med, Div Gastroenterol, Durham, NC 27710 USA; [Henao, Ricardo] Duke Univ, Biostat & Bioinformat, Durham, NC USA; [Murphy, Susan K.] Duke Univ Hlth Syst, Dept Obstet & Gynecol, Durham, NC USA; [Moylan, Cynthia A.] Durham Vet Affairs Hlth Syst, Dept Med, Durham, NC 27705 USA	Duke University; Duke University; Duke University	Moylan, CA (corresponding author), Duke Univ Hlth Syst, Dept Med, Div Gastroenterol, Durham, NC 27710 USA.; Moylan, CA (corresponding author), Durham Vet Affairs Hlth Syst, Dept Med, Durham, NC 27705 USA.	cynthia.moylan@duke.edu	Abdelmalek, Manal F/AAW-2203-2020; Murphy, Susan/R-3903-2019	Murphy, Susan/0000-0001-8298-7272; Henao, Ricardo/0000-0003-4980-845X; Abdelmalek, Manal/0000-0002-5001-8618; Moylan, Cynthia/0000-0001-8454-7086	Medicine Endowment Fund, National Institutes of Health [5RC2-AA019399]; American College of Gastroenterology Junior Faculty Development Award (2015)	Medicine Endowment Fund, National Institutes of Health; American College of Gastroenterology Junior Faculty Development Award (2015)	This work was supported by Florence McAlister Professor of Medicine Endowment Fund, National Institutes of Health 5RC2-AA019399 (PI: Diehl); American College of Gastroenterology Junior Faculty Development Award (2015; PI: Moylan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeva MM, 2012, AMINO ACIDS, V43, P171, DOI 10.1007/s00726-011-1088-7; Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496; Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Bellentani S, 2017, LIVER INT, V37, P81, DOI 10.1111/liv.13299; Estes C, 2018, HEPATOLOGY, V67, P123, DOI 10.1002/hep.29466; Francque S, 2015, J HEPATOL, V63, P164, DOI 10.1016/j.jhep.2015.02.019; Greco D, 2008, AM J PHYSIOL-GASTR L, V294, pG1281, DOI 10.1152/ajpgi.00074.2008; Guajardo-Salinas GE, 2010, OBES SURG, V20, P1647, DOI 10.1007/s11695-009-0027-0; Hattori A, 2017, NATURE, V545, P500, DOI 10.1038/nature22314; Honda T, 2017, METABOLISM, V69, P177, DOI 10.1016/j.metabol.2016.12.013; Kaikkonen JE, 2017, HEPATOLOGY, V65, P491, DOI 10.1002/hep.28899; Lake AD, 2015, AMINO ACIDS, V47, P603, DOI 10.1007/s00726-014-1894-9; Mardinoglu A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4083; Mitchell SM, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-54; Miyake T, 2012, INTERNAL MED, V51, P2151, DOI 10.2169/internalmedicine.51.7578; Moylan CA, 2014, HEPATOLOGY, V59, P471, DOI 10.1002/hep.26661; Murphy SK, 2013, GASTROENTEROLOGY, V145, P1076, DOI 10.1053/j.gastro.2013.07.047; Panosyan EH, 2016, J NEURO-ONCOL, V128, P57, DOI 10.1007/s11060-016-2073-5; Papathanassiu AE, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16040; Raszeja-Wyszomirska J, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-67; Ruffillo G, 2011, J HEPATOL, V54, P160, DOI 10.1016/j.jhep.2010.06.028; Sun WJ, 2016, HEPATOL RES, V46, P862, DOI 10.1111/hepr.12647; Suryawan A, 1998, AM J CLIN NUTR, V68, P72, DOI 10.1093/ajcn/68.1.72; Sweatt AJ, 2004, AM J PHYSIOL-ENDOC M, V286, pE64, DOI 10.1152/ajpendo.00276.2003; Tajiri K, 2013, WORLD J GASTROENTERO, V19, P7620, DOI 10.3748/wjg.v19.i43.7620; Thewes V, 2017, ONCOGENE, V36, P4124, DOI 10.1038/onc.2017.32; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Wang HG, 2016, CLIN RES HEPATOL GAS, V40, pE55, DOI 10.1016/j.clinre.2016.03.003; Xu M, 2016, ONCOL LETT, V12, P2648, DOI 10.3892/ol.2016.4969; Younossi Z, 2018, NAT REV GASTRO HEPAT, V15, P11, DOI 10.1038/nrgastro.2017.109; Zelber-Sagi S, 2017, WORLD J HEPATOL, V9, P91, DOI 10.4254/wjh.v9.i2.91; Zheng YH, 2016, LIVER INT, V36, P1836, DOI 10.1111/liv.13178	32	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204308	10.1371/journal.pone.0204308	http://dx.doi.org/10.1371/journal.pone.0204308			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265706	gold, Green Published, Green Submitted			2022-12-26	WOS:000446005500028
J	Klusch, A; Gorzelanny, C; Reeh, PW; Schmelz, M; Petersen, M; Sauer, SK				Klusch, Andreas; Gorzelanny, Christian; Reeh, Peter W.; Schmelz, Martin; Petersen, Marlen; Sauer, Susanne K.			Local NGF and GDNF levels modulate morphology and function of porcine DRG neurites, In Vitro	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; GENE-RELATED PEPTIDE; ROOT GANGLION NEURONS; PRIMARY SENSORY NEURONS; DORSAL-ROOT; NEUROTROPHIC FACTOR; CGRP-RELEASE; COMPARTMENTED CULTURES; NEUROPEPTIDE RELEASE; VANILLOID RECEPTOR	Nerve terminals of primary sensory neurons are influenced by their environment through target derived trophic factors, like nerve growth factor (NGF) or glial cell line-derived neurotrophic factor (GDNF). In mice, subpopulations of DRG neurons express receptors either for NGF or GDNF and therefore differentially respond to these neurotrophic factors. We probed neurite endings from porcine DRG neurons cultured in either NGF or GDNF and examined their shape, elongation and stimulus-evoked CGRP release. A compartmentalized culture system was employed allowing spatial separation of outgrown neurites from their somata and use of different growth factors in the compartments. We show that neurites of GDNF cultured somata extend into lateral compartments without added growth factor, unlike neurites of NGF cultured ones. Neurites of NGF cultured somata extend not only into NGF-but also into GDNF-containing compartments. GDNF at the site of terminals of NGF responsive somata led to a strong neurite arborization and formation of large growth cones, compared to neurites in medium with NGF. Functionally, we could detect evoked CGRP release from as few as 7 outgrown neurites per compartment and calculated release per mm neurite length. CGRP release was detected both in neurites from NGF and GDNF cultured somata, suggesting that also the latter ones are peptidergic in pig. When neurites of NGF cultured somata were grown in GDNF, capsaicin evoked a lower CGRP release than high potassium, compared to those grown in NGF. Our experiments demonstrate that the compartmented culture chamber can be a suitable model to assess neurite properties from trophic factor specific primary sensory neurons. With this model, insights into mechanisms of gain or loss of function of specific nociceptive neurites may be achieved.	[Klusch, Andreas; Schmelz, Martin; Petersen, Marlen] Heidelberg Univ, Med Fac Mannheim, Dept Expt Pain Res, Mannheim, Germany; [Gorzelanny, Christian] Univ Hosp Hamburg Eppendorf, Dept Dermatol & Venereol, Hamburg, Germany; [Reeh, Peter W.; Sauer, Susanne K.] Friedrich Alexander Univ Erlangen Nurnberg, Inst Physiol & Pathophysiol, Erlangen, Germany	Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Erlangen Nuremberg	Sauer, SK (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Inst Physiol & Pathophysiol, Erlangen, Germany.	Susanne.sauer@fau.de	Schmelz, Martin/A-9327-2013	Schmelz, Martin/0000-0002-9736-7241; Sauer, Susanne Katharina/0000-0002-9734-885X	Deutsche Forschungsgemeinschaft [SFB 1158]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (SFB 1158) to MS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Albers KM, 2007, NEUROSCIENTIST, V13, P371, DOI 10.1177/10738584070130040901; AMANN R, 1990, EUR J PHARMACOL, V186, P169, DOI 10.1016/0014-2999(90)90430-E; Amrutkar DV, 2011, NEUROSCIENCE, V172, P510, DOI 10.1016/j.neuroscience.2010.10.032; Anand P, 2004, PROG BRAIN RES, V146, P477; Averbeck B, 2003, INFLAMM RES, V52, P519, DOI 10.1007/s00011-003-1209-1; Babes A, 2010, METHODS MOL BIOL, V617, P237, DOI 10.1007/978-1-60327-323-7_19; Bennett DLH, 1996, EUR J NEUROSCI, V8, P2204; Bennett DLH, 2001, NEUROSCIENTIST, V7, P13, DOI 10.1177/107385840100700105; Bernardini N, 2004, NEUROSCIENCE, V126, P585, DOI 10.1016/j.neuroscience.2004.03.017; CAMPENOT RB, 1977, P NATL ACAD SCI USA, V74, P4516, DOI 10.1073/pnas.74.10.4516; Campenot RB, 2009, NAT PROTOC, V4, P1869, DOI 10.1038/nprot.2009.210; Castel D, 2017, J PAIN RES, V10, P2169, DOI 10.2147/JPR.S144949; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; COIMBRA A, 1974, J NEUROCYTOL, V3, P199, DOI 10.1007/BF01098389; DELBIANCO E, 1991, BRAIN RES, V566, P46, DOI 10.1016/0006-8993(91)91679-U; Eberhardt M, 2008, NEUROPEPTIDES, V42, P311, DOI 10.1016/j.npep.2008.01.002; Gee MD, 1999, NEUROSCIENCE, V90, P509, DOI 10.1016/S0306-4522(98)00454-0; Golden JP, 2010, J NEUROSCI, V30, P3983, DOI 10.1523/JNEUROSCI.5930-09.2010; Heerssen HM, 2002, TRENDS NEUROSCI, V25, P160, DOI 10.1016/S0166-2236(02)02144-6; Hirth M, 2013, PAIN, V154, P2500, DOI 10.1016/j.pain.2013.07.036; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Huang LYM, 1996, NEURON, V17, P135, DOI 10.1016/S0896-6273(00)80287-1; Jankowski M. P., 2010, TRANSLATIONAL PAIN R; Ji RR, 2002, NEURON, V36, P57, DOI 10.1016/S0896-6273(02)00908-X; Jonas R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139107; Jongen JLM, 2007, J COMP NEUROL, V500, P1136, DOI 10.1002/cne.21234; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; KALLNER G, 1995, ACTA PHYSIOL SCAND, V155, P251, DOI 10.1111/j.1748-1716.1995.tb09971.x; Kimpinski K, 1997, J NEUROBIOL, V33, P395, DOI 10.1002/(SICI)1097-4695(199710)33:4<395::AID-NEU5>3.0.CO;2-5; Klusch A, 2013, J INVEST DERMATOL, V133, P1387, DOI 10.1038/jid.2012.471; Kress M, 2001, NEUROREPORT, V12, P867, DOI 10.1097/00001756-200103260-00048; Lowery LA, 2009, NAT REV MOL CELL BIO, V10, P332, DOI 10.1038/nrm2679; Lynn B, 1996, J PHYSIOL-LONDON, V494, P587, DOI 10.1113/jphysiol.1996.sp021516; Malin SA, 2006, J NEUROSCI, V26, P8588, DOI 10.1523/JNEUROSCI.1726-06.2006; Markus A, 2002, CURR OPIN NEUROBIOL, V12, P523, DOI 10.1016/S0959-4388(02)00372-0; MATSUOKA I, 1991, J NEUROSCI, V11, P3165; Molliver DC, 1997, J COMP NEUROL, V381, P428, DOI 10.1002/(SICI)1096-9861(19970519)381:4<428::AID-CNE3>3.0.CO;2-4; Nemeth J, 2003, EUR J PHARMACOL, V458, P313, DOI 10.1016/S0014-2999(02)02794-2; Obreja O, 2008, EUR J PAIN, V12, P775, DOI 10.1016/j.ejpain.2007.11.010; Obreja O, 2010, PAIN, V148, P59, DOI 10.1016/j.pain.2009.10.006; Ohta T, 2005, BIOCHEM PHARMACOL, V71, P173, DOI 10.1016/j.bcp.2005.09.028; Paratcha G, 2003, CELL, V113, P867, DOI 10.1016/S0092-8674(03)00435-5; Paratcha G, 2008, TRENDS NEUROSCI, V31, P384, DOI 10.1016/j.tins.2008.05.003; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Price TJ, 2007, J PAIN, V8, P263, DOI 10.1016/j.jpain.2006.09.005; Quallo T, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.191; Ramer MS, 2003, EUR J NEUROSCI, V18, P2713, DOI 10.1111/j.1460-9568.2003.03012.x; REEH PW, 1986, NEUROSCI LETT, V66, P141, DOI 10.1016/0304-3940(86)90180-1; Roggenkamp D, 2013, J INVEST DERMATOL, V133, P1620, DOI 10.1038/jid.2012.464; Russo D, 2013, J COMP NEUROL, V521, P342, DOI 10.1002/cne.23177; Sah DWY, 2003, NAT REV DRUG DISCOV, V2, P460, DOI 10.1038/nrd1107; Sariola H, 2003, J CELL SCI, V116, P3855, DOI 10.1242/jcs.00786; Sauer SK, 2001, EUR J NEUROSCI, V14, P1203, DOI 10.1046/j.0953-816x.2001.01741.x; Schmelz M, 2000, BRAIN, V123, P560, DOI 10.1093/brain/123.3.560; Shu X, 2001, J NEUROPHYSIOL, V86, P2931, DOI 10.1152/jn.2001.86.6.2931; Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X; Spitzer MJS, 2008, NEUROSCIENCE, V151, P836, DOI 10.1016/j.neuroscience.2007.10.030; Todd AJ, 2010, NAT REV NEUROSCI, V11, P823, DOI 10.1038/nrn2947; Tokime K, 2008, ARCH DERMATOL RES, V300, P343, DOI 10.1007/s00403-008-0856-z; Touska F, 2017, MAR DRUGS, V15, DOI 10.3390/md15090269; Trupp M, 1999, J BIOL CHEM, V274, P20885, DOI 10.1074/jbc.274.30.20885; Tucker BA, 2005, BRAIN RES PROTOC, V16, P50, DOI 10.1016/j.brainresprot.2005.10.004; Turney SG, 2016, MOL BIOL CELL, V27, P500, DOI 10.1091/mbc.E15-09-0636; Vyklicky L, 1996, PHYSIOL RES, V45, P1; Weller K, 2011, NEUROPEPTIDES, V45, P391, DOI 10.1016/j.npep.2011.07.011; Zhang XM, 2005, EMBO J, V24, P4211, DOI 10.1038/sj.emboj.7600893; Zwick M, 2002, J NEUROSCI, V22, P4057, DOI 10.1523/JNEUROSCI.22-10-04057.2002; Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015	70	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0203215	10.1371/journal.pone.0203215	http://dx.doi.org/10.1371/journal.pone.0203215			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30260982	Green Published, gold, Green Submitted			2022-12-26	WOS:000445907400010
J	Vanmarsenille, C; Elseviers, J; Yvanoff, C; Hassanzadeh-Ghassabeh, G; Rodriguez, GG; Martens, E; Depicker, A; Martel, A; Haesebrouck, F; Pasmans, F; Hernalsteens, JP; De Greve, H				Vanmarsenille, Charlotte; Elseviers, Jelle; Yvanoff, Charlotte; Hassanzadeh-Ghassabeh, Gholamreza; Rodriguez, Gabriela Garcia; Martens, Edo; Depicker, Ann; Martel, An; Haesebrouck, Freddy; Pasmans, Frank; Hernalsteens, Jean-Pierre; De Greve, Henri			In planta expression of nanobody-based designer chicken antibodies targeting Campylobacter	PLOS ONE			English	Article							ESCHERICHIA-COLI INFECTION; OUTER-MEMBRANE PROTEIN; RECOMBINANT ANTIBODIES; TRANSIENT EXPRESSION; JEJUNI COLONIZATION; ARABIDOPSIS SEEDS; PASSIVE-IMMUNITY; AGROBACTERIUM; CHAIN; SYSTEMS	Campylobacteriosis is a widespread infectious disease, leading to a major health and economic burden. Chickens are considered as the most common infection source for humans. Campylobacter mainly multiplies in the mucus layer of their caeca. No effective control measures are currently available, but passive immunisation of chickens with pathogen-specific maternal IgY antibodies, present in egg yolk of immunised chickens, reduces Campylobacter colonisation. To explore this strategy further, anti-Campylobacter nanobodies, directed against the flagella and major outer membrane proteins, were fused to the constant domains of chicken IgA and IgY, combining the benefits of nanobodies and the effector functions of the Fc-domains. The designer chimeric antibodies were effectively produced in leaves of Nicotiana benthamiana and seeds of Arabidopsis thaliana. Stable expression of the chimeric antibodies in seeds resulted in production levels between 1% and 8% of the total soluble protein. These in planta produced antibodies do not only bind to their purified antigens but also to Campylobacter bacterial cells. In addition, the anti-flagellin chimeric antibodies are reducing the motility of Campylobacter bacteria. These antibody-containing Arabidopsis seeds can be tested for oral passive immunisation of chickens and, if effective, the chimeric antibodies can be produced in crop seeds.	[Vanmarsenille, Charlotte; Rodriguez, Gabriela Garcia; Martens, Edo; De Greve, Henri] VIB VUB Ctr Struct Biol, Brussels, Belgium; [Vanmarsenille, Charlotte; Rodriguez, Gabriela Garcia; Martens, Edo; De Greve, Henri] Vrije Univ Brussel, Struct Biol Brussels, Brussels, Belgium; [Vanmarsenille, Charlotte; Hernalsteens, Jean-Pierre] Vrije Univ Brussel, Viral Genet, Brussels, Belgium; [Vanmarsenille, Charlotte; Martel, An; Haesebrouck, Freddy; Pasmans, Frank] Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium; [Elseviers, Jelle; Hassanzadeh-Ghassabeh, Gholamreza] Vrije Univ Brussel, VIB Nanobody Core, Brussels, Belgium; [Yvanoff, Charlotte] Vrije Univ Brussel, Struct Biol Brussels, IJRG VUB EPFL BioNanotechnol & NanoMed, ARG VUB UGent NanoMicrobiol, Brussels, Belgium; [Depicker, Ann] Univ Ghent, Dept Plant Biotechnol & Bioinformat, Ghent, Belgium; [Depicker, Ann] VIB Ctr Plant Syst Biol, Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Vrije Universiteit Brussel; Ghent University; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Vrije Universiteit Brussel; Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University	De Greve, H (corresponding author), VIB VUB Ctr Struct Biol, Brussels, Belgium.; De Greve, H (corresponding author), Vrije Univ Brussel, Struct Biol Brussels, Brussels, Belgium.	hdegreve@vub.ac.be	Haesebrouck, Freddy/M-3857-2014; Pasmans, Frank/D-3667-2014	Haesebrouck, Freddy/0000-0002-1709-933X; YVANOFF, CHARLOTTE/0000-0002-3661-419X; Garcia-Rodriguez, Gabriela/0000-0002-7996-7622	Belgian Federal Public Service of Health, Food Chain Safety and Environment [RF 13/6272]	Belgian Federal Public Service of Health, Food Chain Safety and Environment	The research that yielded these results, was funded by the Belgian Federal Public Service of Health, Food Chain Safety and Environment (www.health.belgium.be) through the contract RF 13/6272 CampyNanoCure. The funding was received by HDG, JPH, FP, AM and FH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Adwani SR, 2013, FOODBORNE PATHOG DIS, V10, P624, DOI 10.1089/fpd.2012.1313; Baxter D, 2007, OCCUP MED-OXFORD, V57, P552, DOI 10.1093/occmed/kqm110; Blaser MJ, 1997, J INFECT DIS, V176, pS103, DOI 10.1086/513780; BOLLA JM, 1995, J BACTERIOL, V177, P4266, DOI 10.1128/jb.177.15.4266-4271.1995; Boothe J, 2010, PLANT BIOTECHNOL J, V8, P588, DOI 10.1111/j.1467-7652.2010.00511.x; Braun MB, 2016, SCI REP-UK, V6, DOI 10.1038/srep19211; Carlander D, 1999, UPSALA J MED SCI, V104, P179, DOI 10.3109/03009739909178961; Chen M, 2005, MED RES REV, V25, P343, DOI 10.1002/med.20022; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Conrath KE, 2001, ANTIMICROB AGENTS CH, V45, P2807, DOI 10.1128/AAC.45.10.2807-2812.2001; Corthesy B, 2002, TRENDS BIOTECHNOL, V20, P65, DOI 10.1016/S0167-7799(01)01874-1; DAGERT M, 1979, GENE, V6, P23, DOI 10.1016/0378-1119(79)90082-9; De Buck S, 2013, PLANT BIOTECHNOL J, V11, P1006, DOI 10.1111/pbi.12094; De Buck Sylvie, 2012, Methods Mol Biol, V911, P305, DOI 10.1007/978-1-61779-968-6_19; De Jaeger G, 2002, NAT BIOTECHNOL, V20, P1265, DOI 10.1038/nbt755; De Wilde K, 2013, PLANT PHYSIOL, V161, P1021, DOI 10.1104/pp.112.209718; de Zoete MR, 2007, VACCINE, V25, P5548, DOI 10.1016/j.vaccine.2006.12.002; European Food Safety Authority, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4329; European Food Safety Authority, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1503; Flanagan RC, 2009, INFECT IMMUN, V77, P2399, DOI 10.1128/IAI.01266-08; Gilbreath JJ, 2011, MICROBIOL MOL BIOL R, V75, P84, DOI 10.1128/MMBR.00035-10; Guerry P, 2007, TRENDS MICROBIOL, V15, P456, DOI 10.1016/j.tim.2007.09.006; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; Hassanzadeh-Ghassabeh G, 2013, NANOMEDICINE-UK, V8, P1013, DOI [10.2217/nnm.13.86, 10.2217/NNM.13.86]; Hermans D, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-27; Hermans D, 2011, VET MICROBIOL, V152, P219, DOI 10.1016/j.vetmic.2011.03.010; Hobb RI, 2009, MICROBIOL-SGM, V155, P979, DOI 10.1099/mic.0.024539-0; HOEKEMA A, 1983, NATURE, V303, P179, DOI 10.1038/303179a0; Hook H, 2005, VET MICROBIOL, V106, P109, DOI 10.1016/j.vetmic.2004.12.017; Hutt M, 2012, J BIOL CHEM, V287, P4462, DOI 10.1074/jbc.M111.311522; Huynh Kathy, 2015, Curr Protoc Protein Sci, V79, DOI 10.1002/0471140864.ps2809s79; Kaakoush NO, 2015, CLIN MICROBIOL REV, V28, P687, DOI 10.1128/CMR.00006-15; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; Konkel ME, 2004, J BACTERIOL, V186, P3296, DOI 10.1128/JB.186.11.3296-3303.2004; Kontermann RE, 2011, CURR OPIN BIOTECH, V22, P868, DOI 10.1016/j.copbio.2011.06.012; Kontermann RE, 2009, BIODRUGS, V23, P93, DOI 10.2165/00063030-200923020-00003; Kovacs-Nolan J, 2012, ANNU REV FOOD SCI T, V3, P163, DOI 10.1146/annurev-food-022811-101137; LEBACQVE.AM, 1974, IMMUNOLOGY, V27, P683; Lee MD, 2006, AVIAN DIS, V50, P1, DOI 10.1637/7474-111605R.1; Lin J, 2009, FOODBORNE PATHOG DIS, V6, P755, DOI 10.1089/fpd.2008.0247; LOGAN SM, 1983, INFECT IMMUN, V42, P675, DOI 10.1128/IAI.42.2.675-682.1983; MANSIKKA A, 1992, J IMMUNOL, V149, P855; McCormac AC, 1998, MOL BIOTECHNOL, V9, P155, DOI 10.1007/BF02760816; Messens W., 2007, P 18 EUR S QUAL POUL, P167; Moore JE, 2005, VET RES, V36, P351, DOI 10.1051/vetres:2005012; Moore JE, 2006, MICROBES INFECT, V8, P1955, DOI 10.1016/j.micinf.2005.12.030; Morandini F, 2011, PLANT BIOTECHNOL J, V9, P911, DOI 10.1111/j.1467-7652.2011.00605.x; Moser I, 1997, FEMS MICROBIOL LETT, V157, P233, DOI 10.1016/S0378-1097(97)00480-1; Muyldermans S, 2009, VET IMMUNOL IMMUNOP, V128, P178, DOI 10.1016/j.vetimm.2008.10.299; NACHAMKIN I, 1993, APPL ENVIRON MICROB, V59, P1269, DOI 10.1128/AEM.59.5.1269-1273.1993; Nather G, 2009, POULTRY SCI, V88, P1299, DOI 10.3382/ps.2008-00389; Newell DG, 2003, APPL ENVIRON MICROB, V69, P4343, DOI 10.1128/AEM.69.8.4343-4351.2003; Pardon E, 2014, NAT PROTOC, V9, P674, DOI 10.1038/nprot.2014.039; PARVARI R, 1988, EMBO J, V7, P739, DOI 10.1002/j.1460-2075.1988.tb02870.x; Pogue GP, 2010, PLANT BIOTECHNOL J, V8, P638, DOI 10.1111/j.1467-7652.2009.00495.x; Porro D, 2005, MOL BIOTECHNOL, V31, P245, DOI 10.1385/MB:31:3:245; Rademacher Thomas, 2009, V483, P69, DOI 10.1007/978-1-59745-407-0_5; Rahimi S., 2007, International Journal of Poultry Science, V6, P230; Riazi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083928; Roche AM, 2015, MUCOSAL IMMUNOL, V8, P176, DOI 10.1038/mi.2014.55; Rudolph MJ, 2014, J MOL BIOL, V426, P3057, DOI 10.1016/j.jmb.2014.05.026; Sahin O, 2003, APPL ENVIRON MICROB, V69, P5372, DOI 10.1128/AEM.69.9.5372-5379.2003; Sainsbury F, 2009, PLANT BIOTECHNOL J, V7, P682, DOI 10.1111/j.1467-7652.2009.00434.x; Schirrmann T, 2008, FRONT BIOSCI-LANDMRK, V13, P4576, DOI 10.2741/3024; Tufarelli V, 2015, CRIT REV FOOD SCI NU; Van Deun K, 2008, VET MICROBIOL, V130, P285, DOI 10.1016/j.vetmic.2007.11.027; Vanmarsenille C, 2017, VET RES, V48, DOI 10.1186/s13567-017-0491-9; Virdi V, 2013, P NATL ACAD SCI USA, V110, P11809, DOI 10.1073/pnas.1301975110; Wu ZW, 2016, P NATL ACAD SCI USA, V113, P10690, DOI 10.1073/pnas.1605869113; YOKOYAMA H, 1992, INFECT IMMUN, V60, P998, DOI 10.1128/IAI.60.3.998-1007.1992; Yusibov V, 2016, ANNU REV PLANT BIOL, V67, P669, DOI 10.1146/annurev-arplant-043015-111812; Zimmermann J, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-79	72	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204222	10.1371/journal.pone.0204222	http://dx.doi.org/10.1371/journal.pone.0204222			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30260981	Green Published, Green Submitted, gold			2022-12-26	WOS:000445907400029
J	Boehm, RE; Arbo, BD; Leal, D; Hansen, AW; Pulcinelli, RR; Thiesen, FV; Balsan, AM; Onsten, TGH; Gomez, R				Boehm, Renata E.; Arbo, Bruno D.; Leal, Denise; Hansen, Alana W.; Pulcinelli, Rianne R.; Thiesen, Flavia, V; Balsan, Almeri M.; Onsten, Tor G. H.; Gomez, Rosane			Smoking fewer than 20 cigarettes per day and remaining abstinent for more than 12 hours reduces carboxyhemoglobin levels in packed red blood cells for transfusion	PLOS ONE			English	Article							TOBACCO-SMOKE; LEAD LEVELS; DONORS; INFLAMMATION; MEMBRANES; EXPOSURE; US	Background The prevalence of smokers among blood donors and the effect of smoking on the quality of donated blood have not been extensively explored. In the present study, we determined the prevalence of smoker donors in a large blood bank in Southern Brazil and evaluated the quality of packed red blood cells (RBCs) from these donors through recommended quality control tests and measurement of carboxyhemoglobin (COHb) levels. We then assessed the influence of smoking habits and abstinence before donation on these parameters. Material and methods An observational study was conducted to determine the prevalence of smoking donors, while a prospective cohort study compared conventional hematological and serological parameters and COHb levels at 0, 15, and 30 days after donation in RBCs donated by smokers (N = 31) and nonsmokers (N = 31) and their association with smoking habits and abstinence before donation. Results Of 14,428 blood donations received in 1 year, 5.9% were provided by smokers. Storage over time slightly altered some quality parameters, such as hematocrit, hemoglobin, hemolysis, and COHb levels, in RBC packs. COHb levels were higher in RBC packs from smokers (8%) than from non-smokers (2%), and increased as a function of the number of cigarettes smoked daily and time elapsed since the last cigarette smoked before donation. Lower levels were found in RBC packs from donors who smoked fewer than 20 cigarettes per day or remained abstinent for more than 12h before giving blood. Conclusion Although cigarette smoke had no significant effect on blood quality parameters such as hematocrit, hemoglobin, or hemolysis, it quadrupled COHb levels in packed RBCs. Abstinence from smoking for more than 12h or smoking fewer than 20 cigarettes daily helped decrease COHb levels.	[Boehm, Renata E.; Gomez, Rosane] UFCSPA, Postgrad Program Hlth Sci, Porto Alegre, RS, Brazil; [Boehm, Renata E.; Balsan, Almeri M.; Onsten, Tor G. H.] HCPA, Hemoterapy Ctr, Porto Alegre, RS, Brazil; [Boehm, Renata E.; Arbo, Bruno D.; Hansen, Alana W.; Pulcinelli, Rianne R.; Gomez, Rosane] Univ Fed Rio Grande do Sul, Postgrad Program Pharmacol & Therapeut, Porto Alegre, RS, Brazil; [Leal, Denise; Thiesen, Flavia, V] Pontificia Univ Catolica Rio Grande do Sul PUCRS, Sch Pharm, Porto Alegre, RS, Brazil	Universidade Federal de Ciencias da Saude de Porto Alegre; Universidade Federal do Rio Grande do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul	Gomez, R (corresponding author), UFCSPA, Postgrad Program Hlth Sci, Porto Alegre, RS, Brazil.; Gomez, R (corresponding author), Univ Fed Rio Grande do Sul, Postgrad Program Pharmacol & Therapeut, Porto Alegre, RS, Brazil.	rosane.gomez@ufrgs.br	Gomez, Rosane/H-5615-2013; Arbo, Bruno D/T-2263-2017; Gomez, Rosane/K-8603-2019; thiesen, flavia/A-3470-2017; Onsten, Tor/W-5474-2019	Gomez, Rosane/0000-0002-0868-8394; thiesen, flavia/0000-0003-4907-6789; Arbo, Bruno/0000-0001-7929-1688; Boehm, Renata/0000-0001-7334-286X	Fundo de Incentivo a Pesquisa e Eventos (FIPE)/HCPA; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq	Fundo de Incentivo a Pesquisa e Eventos (FIPE)/HCPA; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by a grant from the Fundo de Incentivo a Pesquisa e Eventos (FIPE)/HCPA and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (RG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg AM, 2009, TRANSFUSION, V49, P347, DOI 10.1111/j.1537-2995.2008.01951.x; Abramson Joseph H, 2011, Epidemiol Perspect Innov, V8, P1, DOI 10.1186/1742-5573-8-1; ARONOW WS, 1984, CHEST, V85, P694, DOI 10.1378/chest.85.5.694; ARONOW WS, 1981, AM HEART J, V101, P154, DOI 10.1016/0002-8703(81)90658-X; Atsma F, 2011, TRANSFUSION, V51, P412, DOI 10.1111/j.1537-2995.2010.02867.x; Aubron C, 2014, J CRIT CARE, V29, DOI 10.1016/j.jcrc.2014.01.006; BEUTLER E, 1984, CLIN CHEM, V30, P871; Bolton-Maggs PHB, 2013, BRIT J HAEMATOL, V163, P303, DOI 10.1111/bjh.12547; Brand A, 2016, PRESSE MED, V45, pE313, DOI 10.1016/j.lpm.2016.06.024; BRASIL. Ministerio da Saude, 2016, RED REG TECN PROC HE, V25, P37; Brucker N, 2013, SCI TOTAL ENVIRON, V463, P884, DOI 10.1016/j.scitotenv.2013.06.098; Collard Keith James, 2014, World J Clin Pediatr, V3, P19, DOI 10.5409/wjcp.v3.i3.19; Cronenberger C, 2008, BRIT J CLIN PHARMACO, V65, P30, DOI 10.1111/j.1365-2125.2007.02974.x; Delage G, 2015, TRANSFUSION, V55, P2633, DOI 10.1111/trf.13199; EATOUGH DJ, 1989, ENVIRON SCI TECHNOL, V23, P679, DOI 10.1021/es00064a006; Ehlers M, 2009, J CARDIOTHOR VASC AN, V23, P336, DOI 10.1053/j.jvca.2008.12.006; El Kenz H, 2014, EUR J ANAESTH, V31, P345, DOI 10.1097/EJA.0000000000000015; Ernst E, 1995, J Cardiovasc Risk, V2, P435; FREEMAN R, 1990, ANAESTHESIA, V45, P581, DOI 10.1111/j.1365-2044.1990.tb14836.x; Fung MK, 2014, AM ASS BLOOD BANKS A; Gangopadhyay S, 2012, COPD, V9, P322, DOI 10.3109/15412555.2012.668581; Garraud O, 2016, PRESSE MED, V45, pE303, DOI 10.1016/j.lpm.2016.06.022; Geiss O., 2007, J EUR SCI TECH RES S; Goldstein M, 2008, J EMERG NURS, V34, P538, DOI 10.1016/j.jen.2007.11.014; Guimaraes LSP, 2012, REV HCPA, V32, P503; Hampson NB, 2008, AM J EMERG MED, V26, P191, DOI 10.1016/j.ajem.2007.04.028; Hughes J R, 1999, Nicotine Tob Res, V1 Suppl 2, pS149; HUGHES JR, 1999, NICOTINE TOB RES S2, V1, pS165; Koch CG, 2013, ANN THORAC SURG, V96, P1894, DOI 10.1016/j.athoracsur.2013.05.116; MADANY IM, 1992, SCI TOTAL ENVIRON, V116, P53, DOI 10.1016/0048-9697(92)90364-X; Mannino DM, 2005, NICOTINE TOB RES, V7, P557, DOI 10.1080/14622200500185264; Milnerowicz H, 2015, J TRACE ELEM MED BIO, V29, P1, DOI 10.1016/j.jtemb.2014.04.008; Pretorius E, 2014, TRANSFUSION, V54, P266, DOI 10.1111/trf.12338; Sakuma A, 2011, MANUAL CONTROLE QUAL; Spada Celso, 2006, Rev. Bras. Hematol. Hemoter., V28, P19, DOI 10.1590/S1516-84842006000100006; Strobel E, 2008, TRANSFUS MED HEMOTH, V35, P346, DOI 10.1159/000154811; Symvoulakis EK, 2010, XENOBIOTICA, V40, P613, DOI 10.3109/00498254.2010.500745; Talhout R, 2011, INT J ENV RES PUB HE, V8, P613, DOI 10.3390/ijerph8020613; UKBTS, 2013, GUID BLOOD TRANSF SE; Valieva OA, 2009, J PEDIATR-US, V155, P331, DOI 10.1016/j.jpeds.2009.02.026; WHO. World Health Organization, 2016, RAIS TAX TOB WHAT YO; World Health Organization, 2012, BLOOD DON SEL	42	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2018	13	9							e0204102	10.1371/journal.pone.0204102	http://dx.doi.org/10.1371/journal.pone.0204102			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3NB	30256832	Green Published, gold, Green Submitted			2022-12-26	WOS:000446000200035
J	Grosjean, F; Yubero-Serrano, EM; Zheng, F; Esposito, V; Swamy, S; Elliot, SJ; Cai, WJ; Vlassara, H; Salem, F; Striker, GE				Grosjean, Fabrizio; Yubero-Serrano, Elena M.; Zheng, Feng; Esposito, Vittoria; Swamy, Shobha; Elliot, Sharon J.; Cai, Weijing; Vlassara, Helen; Salem, Fadi; Striker, Gary E.			Pharmacologic control of oxidative stress and inflammation determines whether diabetic glomerulosclerosis progresses or decreases: A pilot study in sclerosis-prone mice	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; MESANGIAL CELL PROGENITORS; GROWTH-FACTOR-BETA; KIDNEY-DISEASE; OXIDANT STRESS; BONE-MARROW; GLOMERULAR HYPERTROPHY; SEVELAMER CARBONATE; PARADIGM SHIFT; C57B6 MICE	Diabetic kidney disease (DKD) is characterized by progressive glomerulosclerosis (GS). ROP mice have a sclerosis-prone phenotype. However, they develop severe, rapidly progressive GS when rendered diabetic. Since GS also develops in aged C57Bl6 mice, and can be reversed using bone marrow from young mice which have lower oxidative stress and inflammation (OS/Infl), we postulated that this might also apply to DKD. Therefore, this pilot study asked whether reducing OS/Infl in young adult sclerosis-prone (ROP) diabetic mice leads to resolution of existing GS in early DKD using safe, FDA-approved drugs. After 4 weeks of stable streptozotocin-induced hyperglycemia 8-12 week-old female mice were randomized and treated for 22 weeks as follows: 1) enalapril (EN) (n = 8); 2) pyridoxamine (PYR)+EN (n = 8); 3) pentosan polysulfate (PPS)+EN (n = 7) and 4) PPS+PYR+EN (n = 7). Controls were untreated (non-DB, n = 7) and hyperglycemic (DB, n = 8) littermates. PPS+PYR+EN reduced albuminuria and reversed GS in DB. Treatment effects: 1) Anti-OS/Infl defenses: a) PPS+PYR+EN increased the levels of SIRT1, Nrf2, estrogen receptor a (ER alpha) and advanced glycation endproduct-receptor1 (AGER1) levels; and b) PYR+EN increased ERa and AGER1 levels. 2) Pro-OS/Infl factors: a) PPS+PYR+EN reduced sTNFR1, b) all except EN reduced MCP1, c) RAGE was reduced by all treatments. In summary, PYR+PPS+EN modulated GS in sclerosis-prone hyperglycemic mice. PYR+PPS+EN also decreased albuminuria, OS/Infl and the sclerosis-prone phenotype. Thus, reducing OS/Infl may reverse GS in early diabetes in patients, and albuminuria may allow early detection of the sclerosis-prone phenotype.	[Grosjean, Fabrizio] Fdn IRCCS Policlin San Matteo, Div Nephrol Dialysis & Transplantat, Pavia, Italy; [Yubero-Serrano, Elena M.] Univ Cordoba, Reina Sofia Univ Hosp, Inst Maimonides Invest Biomed Cordoba IMIBIC, Lipids & Atherosclerosis Unit, Madrid, Spain; [Yubero-Serrano, Elena M.] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Madrid, Spain; [Zheng, Feng] Fujian Med Univ, Div Nephrol, Union Hosp, Fuzhou, Fujian, Peoples R China; [Zheng, Feng] Fujian Med Univ, Basic Sci Lab, Union Hosp, Fuzhou, Fujian, Peoples R China; [Esposito, Vittoria] Fdn IRCCS Salvatore Maugeri, Unit Nephrol & Dialysis, Pavia, Italy; [Swamy, Shobha] Univ Alabama Birmingham, Sch Med, Dept Med, Div Pulm Allergy & Crit Care, Birmingham, AL USA; [Elliot, Sharon J.] Univ Miami, Sch Med, Dept Surg, Miami, FL USA; [Cai, Weijing; Vlassara, Helen; Striker, Gary E.] Icahn Sch Med Mt Sinai, Dept Geriatr, Div Expt Diabet & Aging, New York, NY 10029 USA; [Salem, Fadi] Icahn Sch Med Mt Sinai, Dept Pathol, One Gustave Levy Pl,Annenberg 15-235, New York, NY 10029 USA; [Striker, Gary E.] Icahn Sch Med Mt Sinai, Dept Med, Div Nephrol, New York, NY 10029 USA	IRCCS Fondazione San Matteo; Universidad de Cordoba; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Fujian Medical University; Fujian Medical University; Istituti Clinici Scientifici Maugeri IRCCS; University of Alabama System; University of Alabama Birmingham; University of Miami; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Yubero-Serrano, EM (corresponding author), Univ Cordoba, Reina Sofia Univ Hosp, Inst Maimonides Invest Biomed Cordoba IMIBIC, Lipids & Atherosclerosis Unit, Madrid, Spain.; Yubero-Serrano, EM (corresponding author), Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Madrid, Spain.	helese35@hotmail.com	Salem, Fadi/AAP-9399-2020; Esposito, Vittoria/AAC-6610-2020	Salem, Fadi/0000-0002-2603-2778; Esposito, Vittoria/0000-0002-0411-7965; Yubero-Serrano, Elena M/0000-0002-2733-5359				Bobadilla NA, 2001, J AM SOC NEPHROL, V12, P2080, DOI 10.1681/ASN.V12102080; Brouwers O, 2014, DIABETOLOGIA, V57, P224, DOI 10.1007/s00125-013-3088-5; Cai WJ, 2008, AM J PATHOL, V173, P327, DOI 10.2353/ajpath.2008.080152; Cai WJ, 2007, AM J PATHOL, V170, P1893, DOI 10.2353/ajpath.2007.061281; Cai WJ, 2006, P NATL ACAD SCI USA, V103, P13801, DOI 10.1073/pnas.0600362103; Chen S, 2003, SEMIN NEPHROL, V23, P532, DOI 10.1053/S0270-9295(03)00132-3; Chow FY, 2006, KIDNEY INT, V69, P73, DOI 10.1038/sj.ki.5000014; Cornacchia F, 2001, J CLIN INVEST, V108, P1649; El-Meanawy A, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-61; Elliot SJ, 2007, KIDNEY INT, V72, P464, DOI 10.1038/sj.ki.5002328; Esposito C, 1999, AM J PATHOL, V154, P891, DOI 10.1016/S0002-9440(10)65336-9; Freedman BI, 2007, CLIN J AM SOC NEPHRO, V2, P1306, DOI 10.2215/CJN.02560607; HE CJ, 1995, AM J PHYSIOL-CELL PH, V269, pC554, DOI 10.1152/ajpcell.1995.269.3.C554; He CJ, 1996, J CLIN INVEST, V97, P1242, DOI 10.1172/JCI118539; HE CJ, 1995, AM J PHYSIOL-RENAL, V269, pF266, DOI 10.1152/ajprenal.1995.269.2.F266; Igo RP, 2011, AM J NEPHROL, V33, P381, DOI 10.1159/000326763; Illien-Junger S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064302; Jefferson JA, 2008, KIDNEY INT, V74, P22, DOI 10.1038/ki.2008.128; Kobayashi M, 2005, ANTIOXID REDOX SIGN, V7, P385, DOI 10.1089/ars.2005.7.385; Koschinsky T, 1997, P NATL ACAD SCI USA, V94, P6474, DOI 10.1073/pnas.94.12.6474; Kume S, 2007, J BIOL CHEM, V282, P151, DOI 10.1074/jbc.M605904200; Lee HB, 2003, J AM SOC NEPHROL, V14, pS241, DOI 10.1097/01.ASN.0000077410.66390.0F; Li JH, 2010, AM J PATHOL, V177, P1065, DOI 10.2353/ajpath.2010.090923; MACKAY K, 1990, KIDNEY INT, V37, P741, DOI 10.1038/ki.1990.41; Nagaraj RH, 2002, ARCH BIOCHEM BIOPHYS, V402, P110, DOI 10.1016/S0003-9861(02)00067-X; NAGLE RB, 1969, LAB INVEST, V21, P519; Navarro-Gonzalez JF, 2011, NAT REV NEPHROL, V7, P327, DOI 10.1038/nrneph.2011.51; Pereira-Simon S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159666; Ruggenenti P, 2010, NAT REV NEPHROL, V6, P319, DOI 10.1038/nrneph.2010.58; Schuchman EH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054459; Schwedler SB, 1999, TRANSPLANTATION, V68, P1583, DOI 10.1097/00007890-199911270-00025; Schwedler SB, 1999, KIDNEY INT, V56, P1683, DOI 10.1046/j.1523-1755.1999.00749.x; Singh DK, 2011, NAT REV ENDOCRINOL, V7, P176, DOI 10.1038/nrendo.2010.212; Skupien J, 2014, J AM SOC NEPHROL, V25, P2916, DOI 10.1681/ASN.2013091002; Stinghen AEM, 2016, J AM SOC NEPHROL, V27, P354, DOI 10.1681/ASN.2014101047; Striker GE, 1997, KIDNEY INT, pS120; Sun JK, 2011, DIABETES CARE, V34, P968, DOI 10.2337/dc10-1675; Tikoo K, 2007, FEBS LETT, V581, P1071, DOI 10.1016/j.febslet.2007.02.006; Vlassara H, 2012, J GERONTOL A-BIOL, V67, P1410, DOI 10.1093/gerona/gls195; Vlassara H, 2013, ENDOCRIN METAB CLIN, V42, P697, DOI 10.1016/j.ecl.2013.07.005; Vlassara H, 2012, CLIN J AM SOC NEPHRO, V7, P934, DOI 10.2215/CJN.12891211; Vlassara H, 2011, NAT REV ENDOCRINOL, V7, P526, DOI 10.1038/nrendo.2011.74; Vlassara H, 2009, KIDNEY INT, V76, pS3, DOI 10.1038/ki.2009.401; Voziyan PA, 2005, CELL MOL LIFE SCI, V62, P1671, DOI 10.1007/s00018-005-5082-7; Wu J, 2011, LAB INVEST, V91, P1459, DOI 10.1038/labinvest.2011.93; Wu J, 2010, AM J PATHOL, V176, P2163, DOI 10.2353/ajpath.2010.090386; Xu WH, 2008, LAB INVEST, V88, P1068, DOI 10.1038/labinvest.2008.75; YANG CW, 1994, P NATL ACAD SCI USA, V91, P9436, DOI 10.1073/pnas.91.20.9436; Yang HC, 2011, J AM SOC NEPHROL, V22, P2028, DOI 10.1681/ASN.2010090982; Yates D, 1999, PRACTICE STAT, V1st; Yubero-Serrano EM, 2015, CLIN J AM SOC NEPHRO, V10, P759, DOI 10.2215/CJN.07750814; Zheng F, 2006, KIDNEY INT, V70, P507, DOI 10.1038/sj.ki.5001578; Zheng F, 2004, DIABETES, V53, P2420, DOI 10.2337/diabetes.53.9.2420; Zheng F, 2003, AM J PATHOL, V162, P1339, DOI 10.1016/S0002-9440(10)63929-6; Zheng F, 1998, KIDNEY INT, V54, P1999, DOI 10.1046/j.1523-1755.1998.00219.x; Zheng F, 2002, DIABETES-METAB RES, V18, P224, DOI 10.1002/dmrr.283	56	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2018	13	9							e0204366	10.1371/journal.pone.0204366	http://dx.doi.org/10.1371/journal.pone.0204366			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU9BO	30252878	Green Published, Green Submitted, gold			2022-12-26	WOS:000445639700047
J	Hingorani, DV; Lippert, CN; Crisp, JL; Savariar, EN; Hasselmann, JPC; Kuo, C; Nguyen, QT; Tsien, RY; Whitney, MA; Ellies, LG				Hingorani, Dina, V; Lippert, Csilla N.; Crisp, Jessica L.; Savariar, Elamprakash N.; Hasselmann, Jonathan P. C.; Kuo, Christopher; Nguyen, Quyen T.; Tsien, Roger Y.; Whitney, Michael A.; Ellies, Lesley G.			Impact of MMP-2 and MMP-9 enzyme activity on wound healing, tumor growth and RACPP cleavage	PLOS ONE			English	Article							CELL-PENETRATING PEPTIDES; MATRIX METALLOPROTEINASES; IN-VIVO; CANCER PROGRESSION; DEFICIENT MICE; MOUSE MODELS; MURINE MODEL; DISEASE; INHIBITORS; EXPRESSION	Matrix metalloproteinases-2 and -9 (MMP-2/-9) are key tissue remodeling enzymes that have multiple overlapping activities critical for wound healing and tumor progression in vivo. To overcome issues of redundancy in studying their functions in vivo, we created MMP-2/-9 double knockout (DKO) mice in the C57BL/6 background to examine wound healing. We then bred the DKO mice into the polyomavirus middle T (PyVmT) model of breast cancer to analyze the role of these enzymes in tumorigenesis. Breeding analyses indicated that significantly fewer DKO mice were born than predicted by Mendelian genetics and weaned DKO mice were growth compromised compared with wild type (WT) cohorts. Epithelial wound healing was dramatically delayed in adult DKO mice and when the DKO was combined with the PyVmT oncogene, we found that the biologically related process of mammary tumorigenesis was inhibited in a site-specific manner. To further examine the role of MMP-2/-9 in tumor progression, tumor cells derived from WT or DKO PyVmT transgenic tumors were grown in WT or DKO mice. Ratiometric activatable cell penetrating peptides (RACPPs) previously used to image cancer based on MMP-2/-9 activity were used to understand differences in MMP activity in WT or knockout syngeneic tumors in WT and KO animals. Analysis of an MMP-2 selective RACPP in WT or DKO mice bearing WT and DKO PyVmT tumor cells indicated that the genotype of the tumor cells was more important than the host stromal genotype in promoting MMP-2/-9 activity in the tumors in this model system. Additional complexities were revealed as the recruitment of host macrophages by the tumor cells was found to be the source of the tumor MMP-2/-9 activity and it is evident that MMP-2/-9 from both host and tumor is required for maximum signal using RACPP imaging for detection. We conclude that in the PyVmT model, the majority of MMP-2/-9 activity in mammary tumors is associated with host macrophages recruited into the tumor rather than that produced by the tumor cells themselves. Thus therapies that target tumor-associated macrophage functions have the potential to slow tumor progression.	[Hingorani, Dina, V; Tsien, Roger Y.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA USA; [Lippert, Csilla N.; Crisp, Jessica L.; Savariar, Elamprakash N.; Tsien, Roger Y.; Whitney, Michael A.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA USA; [Hasselmann, Jonathan P. C.; Kuo, Christopher; Ellies, Lesley G.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Nguyen, Quyen T.; Tsien, Roger Y.; Ellies, Lesley G.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Nguyen, Quyen T.] Univ Calif San Diego, Dept Surg, La Jolla, CA USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Ellies, LG (corresponding author), Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA.; Ellies, LG (corresponding author), Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA.	lellies@ucsd.edu		Ellies, Lesley/0000-0002-9298-4419; Hasselmann, Jonathan/0000-0003-2630-9850; Kuo, Christopher/0000-0002-6222-147X	NIH [K22CA118182, R01CA158448, P30NS047101]; CALIT2 Scholarship; Doris A. Howell Research Scholarship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CALIT2 Scholarship; Doris A. Howell Research Scholarship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	TThis work was supported by NIH grants K22CA118182 (LGE), R01CA158448 (RYT), and P30NS047101 (UCSD Microscopy Core), CALIT2 Scholarship (JPCH) and Doris A. Howell Research Scholarship (CK).	Ardi VC, 2007, P NATL ACAD SCI USA, V104, P20262, DOI 10.1073/pnas.0706438104; Arpino V, 2015, MATRIX BIOL, V44-46, P247, DOI 10.1016/j.matbio.2015.03.005; Bao L, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0615-y; Biswas T, 2014, CANCER LETT, V346, P129, DOI 10.1016/j.canlet.2013.12.018; Buckell L, 2015, CANCER RES, V75, P1376, DOI 10.1158/0008-5472.CAN-14-1931; Chen P, 2009, J CELL BIOCHEM, V108, P1233, DOI 10.1002/jcb.22363; Chi CW, 2015, SCI REP-UK, V5, DOI 10.1038/srep14197; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Crisp JL, 2014, MOL CANCER THER, V13, P1514, DOI 10.1158/1535-7163.MCT-13-1067; Davie SA, 2007, TRANSGENIC RES, V16, P193, DOI 10.1007/s11248-006-9056-9; Dubois B, 1999, J CLIN INVEST, V104, P1507, DOI 10.1172/JCI6886; Dubois B, 2000, J CLIN INVEST, V106, P627, DOI 10.1172/JCI10910; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fanjul-Fernandez M, 2010, BBA-MOL CELL RES, V1803, P3, DOI 10.1016/j.bbamcr.2009.07.004; Felsen CN, 2014, AM J PHYSIOL-LUNG C, V306, pL764, DOI 10.1152/ajplung.00371.2013; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Hsu JYC, 2006, J NEUROSCI, V26, P9841, DOI 10.1523/JNEUROSCI.1993-06.2006; Itoh T, 1997, J BIOL CHEM, V272, P22389, DOI 10.1074/jbc.272.36.22389; Jodele S, 2006, CANCER METAST REV, V25, P35, DOI 10.1007/s10555-006-7887-8; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kyriakides TR, 2009, MATRIX BIOL, V28, P65, DOI 10.1016/j.matbio.2009.01.001; Lambert V, 2003, FASEB J, V17, P2290, DOI 10.1096/fj.03-0113fje; LEPPERT D, 1995, J IMMUNOL, V154, P4379; Li F, 2017, MOL CANCER THER, V16, P1347, DOI 10.1158/1535-7163.MCT-17-0019; Loffek S, 2011, EUR RESPIR J, V38, P191, DOI 10.1183/09031936.00146510; Lund LR, 1999, EMBO J, V18, P4645, DOI 10.1093/emboj/18.17.4645; Mc Donnell S, 1999, CLIN EXP METASTAS, V17, P341; McLennan SV, 2008, WOUND PRACT RES, V16, P116; Metildi CA, 2015, ANN SURG ONCOL, V22, P2082, DOI 10.1245/s10434-014-4144-1; Mosig RA, 2007, HUM MOL GENET, V16, P1113, DOI 10.1093/hmg/ddm060; Murphy G, 2002, ARTHRITIS RES THER, V4, DOI 10.1186/ar572; Nguyen QT, 2010, P NATL ACAD SCI USA, V107, P4317, DOI 10.1073/pnas.0910261107; Okada S, 1997, AM J RESP CELL MOL, V17, P519, DOI 10.1165/ajrcmb.17.4.2877; Olson ES, 2009, INTEGR BIOL-UK, V1, P382, DOI 10.1039/b904890a; Panni RZ, 2013, IMMUNOTHERAPY-UK, V5, P1075, DOI 10.2217/imt.13.102; Piperigkou Z, 2018, METHODS MOL BIOL, V1731, P325, DOI 10.1007/978-1-4939-7595-2_27; PYKE C, 1993, AM J PATHOL, V142, P359; Ra HJ, 2007, MATRIX BIOL, V26, P587, DOI 10.1016/j.matbio.2007.07.001; Rodriguez D, 2010, BBA-MOL CELL RES, V1803, P39, DOI 10.1016/j.bbamcr.2009.09.015; ROMER J, 1994, J INVEST DERMATOL, V102, P519, DOI 10.1111/1523-1747.ep12373187; Savariar EN, 2013, CANCER RES, V73, P855, DOI 10.1158/0008-5472.CAN-12-2969; Singer CF, 2002, BREAST CANCER RES TR, V72, P69, DOI 10.1023/A:1014918512569; Soo C, 2000, PLAST RECONSTR SURG, V105, P638, DOI 10.1097/00006534-200002000-00024; Spinale FG, 2014, BIOCHEM PHARMACOL, V90, P7, DOI 10.1016/j.bcp.2014.04.011; Tauro M, 2014, CANCER METAST REV, V33, P1043, DOI 10.1007/s10555-014-9530-4; Tester AM, 2001, CLIN EXP METASTAS, V18, P553, DOI 10.1023/A:1011953118186; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Wieczorek E, 2015, TUMOR BIOL, V36, P163, DOI 10.1007/s13277-014-2747-6	49	19	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2018	13	9							e0198464	10.1371/journal.pone.0198464	http://dx.doi.org/10.1371/journal.pone.0198464			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3MI	30248101	Green Published, Green Submitted, gold			2022-12-26	WOS:000445998100001
J	Kurobe, T; Lehman, PW; Hammock, BG; Bolotaolo, MB; Lesmeister, S; Teh, SJ				Kurobe, Tomofumi; Lehman, Peggy W.; Hammock, Bruce G.; Bolotaolo, Melissa B.; Lesmeister, Sarah; Teh, Swee J.			Biodiversity of cyanobacteria and other aquatic microorganisms across a freshwater to brackish water gradient determined by shotgun metagenomic sequencing analysis in the San Francisco Estuary, USA	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; MICROCYSTIS-AERUGINOSA; PHYLOGENETIC INFERENCE; GENETIC DIVERSITY; ORGANIC-CARBON; SEVERE DROUGHT; RIBOSOMAL-RNA; BLOOMS; RIVER; POPULATIONS	Blooms of Microcystis and other harmful cyanobacteria can degrade water quality by producing cyanotoxins or other toxic compounds. The goals of this study were (1) to facilitate understanding of community structure for various aquatic microorganisms in brackish water and freshwater regions with emphasis on cyanobacteria, and (2) to test a hypothesis that Microcystis genotypes that tolerate higher salinity were blooming in brackish water environments during the severe drought, 2014. Shotgun metagenomic analysis revealed that cyanobacteria dominated the brackish water region while bacteria dominated the freshwater region. A group of cyanobacteria (e.g., Aphanizomenon, Microcystis, Planktothrix, Pseudanabaena), bacteria (e.g., Bacillus, Porphyrobacter), and diatoms (Phaeodactylum and Thalassiosira) were abundant in the brackish water region. In contrast, Hassallia (cyanobacteria) and green algae (Nannochloropsis, Chlamydomonas, and Volvox) were abundant in the landward freshwater region. Station variation was also apparent. One landward sampling station located downstream of an urbanized area differed substantially from the other stations in terms of both water chemistry and community structure, with a higher percentage of arthropods, green algae, and eukaryotes. Screening of the Microcystis internal transcribed spacer region revealed six representative genotypes, and two of which were successfully quantified using qPCR (Genotypes I and VI). Both genotypes occurred predominantly in the freshwater region, so the data from this study did not support the hypothesis that salinity tolerant Microcystis genotypes bloomed in the brackish water region in 2014.	[Kurobe, Tomofumi; Hammock, Bruce G.; Bolotaolo, Melissa B.; Teh, Swee J.] Univ Calif Davis, Dept Anat Physiol & Cell Biol, Davis, CA 95616 USA; [Lehman, Peggy W.] Calif Dept Fish & Wildlife, Stockton, CA USA; [Lesmeister, Sarah] Calif Dept Water Resources, West Sacramento, CA USA	University of California System; University of California Davis	Kurobe, T (corresponding author), Univ Calif Davis, Dept Anat Physiol & Cell Biol, Davis, CA 95616 USA.	tkurobe@ucdavis.edu		Kurobe, Tomofumi/0000-0003-3906-1989; Lesmeister, Sarah/0000-0001-5492-1188	California Department of Water Resources and State Ops - Program 10 - General Fund Special Legislation, UC Davis [AB91/92, 0001S72015, 46000011155, 4600011638]; California Department of Fish and Wildlife Drought Response Program, UC Davis [E1183004]; California Department of Fish and Wildlife from the Water Quality, Supply, and Infrastructure Improvement Act of 2014 [CWC 79707[g], P1696041]; NIH [1S10OD010786-01]	California Department of Water Resources and State Ops - Program 10 - General Fund Special Legislation, UC Davis; California Department of Fish and Wildlife Drought Response Program, UC Davis; California Department of Fish and Wildlife from the Water Quality, Supply, and Infrastructure Improvement Act of 2014; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding for the study was provided by the California Department of Water Resources and State Ops - Program 10 - General Fund Special Legislation AB91/92 (Fund number 0001S72015), UC Davis contract# 46000011155 and 4600011638 (Program manager: Karen Gehrts) and by California Department of Fish and Wildlife Drought Response Program, UC Davis contract# E1183004 (Program manager: Chad Dibble), and the California Department of Fish and Wildlife from the Water Quality, Supply, and Infrastructure Improvement Act of 2014 (Proposition 1, CWC 79707[g], Agreement No.: P1696041) (Program manager: Adam Ballard). The sequencing reaction on the Illumina platform was carried out at the DNA Technologies and Expression Analysis Cores at the UC Davis Genome Center, supported by NIH Shared Instrumentation Grant 1S10OD010786-01.	Acuna S, 2012, AQUAT TOXICOL, V110, P1, DOI 10.1016/j.aquatox.2011.12.004; Alemzadeh E, 2014, IRAN J MICROBIOL, V6, P296; American Public Health Association A. W. W. A. Water Environment Federation APHA AWWA and WEF, 1998, STANDARD METHODS EXA; Andrews S., 2010, FASTQC QUALITY CONTR; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Backer L. C., 2016, Veterinary Sciences, V3, P8, DOI 10.3390/vetsci3020008; Bade DL, 2007, BIOGEOCHEMISTRY, V84, P115, DOI 10.1007/s10533-006-9013-y; Baxa DV, 2010, HARMFUL ALGAE, V9, P342, DOI 10.1016/j.hal.2010.01.001; Bennett W.A., 2005, SAN FRANCISCO ESTUAR, V3, P2, DOI [DOI 10.15447/SFEWS.2005V3ISS2ART1, 10.15447/sfews.2005v3iss2art1]; Boyer SL, 2001, MOL BIOL EVOL, V18, P1057, DOI 10.1093/oxfordjournals.molbev.a003877; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Chriki-Adeeb R, 2016, EVOL BIOINFORM, V12, P87, DOI 10.4137/EBO.S39070; CIEMINSKI KL, 1995, GREAT BASIN NAT, V55, P105; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Cohen A., 2000, INTRO SAN FRANCISCO; Conrads G, 2002, INT J SYST EVOL MICR, V52, P493, DOI 10.1099/00207713-52-2-493; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eiler A, 2003, APPL ENVIRON MICROB, V69, P3701, DOI 10.1128/AEM.69.7.3701-3709.2003; Fathalli A, 2011, SYST APPL MICROBIOL, V34, P303, DOI 10.1016/j.syapm.2010.12.003; Fishman M.J., 1985, METHODS DETERMINATIO, V5, P85; Galloway AWE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130053; Ger KA, 2010, FRESHWATER BIOL, V55, P1548, DOI 10.1111/j.1365-2427.2009.02367.x; Gorley C.K., 2006, GETTING STARTED PRIM; Hallett SL, 2006, DIS AQUAT ORGAN, V71, P109, DOI 10.3354/dao071109; Huson DH, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004957; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Ininbergs K, 2015, AMBIO, V44, pS439, DOI 10.1007/s13280-015-0663-7; Intergovernmental Oceanographic Commission Scientific Committee on Oceanic Research International Association for the Physical Sciences of the Ocean. The international thermodynamic equation of seawater, 2010, CAL US THERM PROP MA; Janda JM, 2010, CLIN MICROBIOL REV, V23, P35, DOI 10.1128/CMR.00039-09; Kahle D, 2013, R J, V5, P144; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kimmerer WJ, 2002, ESTUARIES, V25, P1275, DOI 10.1007/BF02692224; Kurobe T, 2018, SCI TOTAL ENVIRON, V610, P1029, DOI 10.1016/j.scitotenv.2017.07.267; Kurobe T, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-491; La Luz F., 2015, INTERAGENCY ECOLOGIC, V28, P3; Landsberg JH, 2002, REV FISH SCI, V10, P113, DOI 10.1080/20026491051695; Lehman PW, 2017, HARMFUL ALGAE, V63, P94, DOI 10.1016/j.hal.2017.01.011; Lehman PW, 2013, HYDROBIOLOGIA, V718, P141, DOI 10.1007/s10750-013-1612-8; Lehman PW, 2010, HYDROBIOLOGIA, V637, P229, DOI 10.1007/s10750-009-9999-y; Lehman PW, 2005, HYDROBIOLOGIA, V541, P87, DOI 10.1007/s10750-004-4670-0; Manikandan S, 2010, J PHARMACOL PHARMACO, V1, P126, DOI 10.4103/0976-500X.72373; Mioni CE, 2012, 10058150 SWAMP; Moisander PH, 2009, AQUAT MICROB ECOL, V57, P19, DOI 10.3354/ame01320; MOYLE PB, 1992, T AM FISH SOC, V121, P67, DOI 10.1577/1548-8659(1992)121<0067:LHASOD>2.3.CO;2; Moyle Peter B., 2016, San Francisco Estuary & Watershed Science, V14, P6; NICHOLS FH, 1986, SCIENCE, V231, P567, DOI 10.1126/science.231.4738.567; Oh KH, 2012, J MICROBIOL BIOTECHN, V22, P248, DOI 10.4014/jmb.1109.09051; Orr PT, 2004, MAR FRESHWATER RES, V55, P277, DOI 10.1071/MF03164; Orsi JJ, 1995, 41 IEP; Otten TG, 2017, ENVIRON MICROBIOL, V19, P3619, DOI 10.1111/1462-2920.13860; Otten TG, 2011, MICROB ECOL, V62, P907, DOI 10.1007/s00248-011-9884-x; Palinska KA, 1996, ARCH MICROBIOL, V166, P224, DOI 10.1007/s002030050378; Papke RT, 2003, ENVIRON MICROBIOL, V5, P650, DOI 10.1046/j.1462-2920.2003.00460.x; Parker AE, 2012, MAR POLLUT BULL, V64, P574, DOI 10.1016/j.marpolbul.2011.12.016; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sabart M, 2009, ENV MICROBIOL REP, V1, P263, DOI 10.1111/j.1758-2229.2009.00042.x; Sanders WE, 1997, CLIN MICROBIOL REV, V10, P220, DOI 10.1128/CMR.10.2.220; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Sommer T, 2007, FISHERIES, V32, P270, DOI 10.1577/1548-8446(2007)32[270:TCOPFI]2.0.CO;2; Song GF, 2015, J BASIC MICROB, V55, P1203, DOI 10.1002/jobm.201500080; Tonk L, 2007, AQUAT MICROB ECOL, V46, P117, DOI 10.3354/ame046117; U.S. Environmental Protection Agency, 2002, EPA600479020; United Stages Environmental Protection Agency, 2015, EPA832F15006 UN STAG; United States Geological Survey. United States Geological Survey, 2018, NO CAL HYDR MAP DAT, V1, P155; Verspagen JMH, 2006, ECOL APPL, V16, P313, DOI 10.1890/04-1953; Wang LC, 2017, HARMFUL ALGAE, V61, P56, DOI 10.1016/j.hal.2016.11.010; Warnes M.G.R., 2016, PACKAGE GPLOTS VARIO; White P., 2013, FAO FISHERIES AQUACU, V583, P553; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Work PA, 2017, 20171022 US GEOL SUR; Xiong M, 2017, IEP NEWSLETTER, V29, P52; Xu Y, 2011, MICROBIOL RES, V167, P20, DOI 10.1016/j.micres.2011.02.005; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593	76	13	13	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2018	13	9							e0203953	10.1371/journal.pone.0203953	http://dx.doi.org/10.1371/journal.pone.0203953			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3MI	30248115	Green Published, Green Submitted, gold			2022-12-26	WOS:000445998100014
J	Lee, J; Jung, SJ; Choi, JW; Shin, A; Lee, YJ				Lee, Joonki; Jung, Sun Jae; Choi, Jae-won; Shin, Aesun; Lee, Yu Jin			Use of sedative-hypnotics and the risk of Alzheimer's dementia: A retrospective cohort study	PLOS ONE			English	Article							NESTED CASE-CONTROL; BENZODIAZEPINE USE; COGNITIVE IMPAIRMENT; VASCULAR DEMENTIA; CLAIMS DATA; DISEASE; METAANALYSIS; ASSOCIATION; TRENDS; POPULATION	There has been a growing interest in the relationship between sedative-hypnotics use and the risk of Alzheimer's dementia (AD) risk. This study aimed to evaluate the risk of AD associated with the use of sedative-hypnotics. A retrospective cohort study was conducted with randomly selected 5% samples from >= 50 years old beneficiaries of National Health Insurance Service (NHIS) of Korea from January 2002 to December 2015. The exposure to sedative-hypnotics was defined when prescribed over 30 defined daily dose (DDD) after January 2004 and it was categorized by prescribed dosage, types and half-lives of benzodiazepines. Time-dependent Cox regression model with a lag period of 5-years was used to evaluate the association between use of sedative-hypnotics and the risk of subsequent AD. Sensitivity analysis was performed for restricting sedative-hypnotics only when prescribed with insomnia. A total of 268,170 subjects were identified and subjects exposed to sedative-hypnotics showed a higher risk of AD (HR: 1.79; 95% CI: 1.72-1.86) than those who were not. There was an increased risk of AD among subjects exposed to benzodiazepines or zolpidem (HR: 1.75; 95% CI: 1.67-1.82) and antidepressants or low-dose antipsychotics (HR: 1.63; 95% CI: 1.42-1.87). The risk of AD was increased regardless of dose of sedative-hypnotics and half-life among benzodiazepines, especially in exposure to more than 360 DDD of sedative-hypnotics (HR: 1.78; 95% CI: 1.60-1.99) and the long-acting benzodiazepine (HR:1.77; 95% CI: 1.65-1.89).	[Lee, Joonki; Shin, Aesun] Seoul Natl Univ, Dept Prevent Med, Coll Med, Seoul, South Korea; [Jung, Sun Jae] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Choi, Jae-won] Eulji Univ, Eulji Gen Hosp, Dept Neuropsychiat, Sch Med, Seoul, South Korea; [Lee, Yu Jin] Seoul Natl Univ, Dept Psychiat, Coll Med, Seoul, South Korea; [Lee, Yu Jin] Seoul Natl Univ, Ctr Sleep & Chronobiol, Coll Med, Seoul, South Korea	Seoul National University (SNU); Harvard University; Harvard T.H. Chan School of Public Health; Eulji University; Seoul National University (SNU); Seoul National University (SNU)	Shin, A (corresponding author), Seoul Natl Univ, Dept Prevent Med, Coll Med, Seoul, South Korea.; Lee, YJ (corresponding author), Seoul Natl Univ, Dept Psychiat, Coll Med, Seoul, South Korea.; Lee, YJ (corresponding author), Seoul Natl Univ, Ctr Sleep & Chronobiol, Coll Med, Seoul, South Korea.	shinaesun@snu.ac.kr; ewpsyche@snu.ac.kr	Jung, Sun Jae/ABC-7826-2020; Jung, Sun Jae/GVU-7200-2022; Jung, Sun Jae/O-5372-2019; Shin, Aesun/E-9145-2014	Jung, Sun Jae/0000-0002-5194-7339; Jung, Sun Jae/0000-0002-5194-7339; Shin, Aesun/0000-0002-6426-1969; Lee, Joonki/0000-0002-5643-3062	research fund of Mental Health Technology Development Project [HM15C1197]	research fund of Mental Health Technology Development Project	This work was supported by the research fund of Mental Health Technology Development Project (Project No. HM15C1197), (http://www.mhrnd.re.kr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amieva H, 2008, ANN NEUROL, V64, P492, DOI 10.1002/ana.21509; ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; [Anonymous], [No title captured]; Bae JB, 2015, DEMENT GERIATR COGN, V39, P105, DOI 10.1159/000366555; Barbui C, 2013, EPIDEMIOL PSYCH SCI, V22, P307, DOI 10.1017/S2045796013000358; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Buffett-Jerrott SE, 2002, CURR PHARM DESIGN, V8, P45, DOI 10.2174/1381612023396654; Buscemi N, 2007, J GEN INTERN MED, V22, P1335, DOI 10.1007/s11606-007-0251-z; Chen PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049113; Chung S, 2013, SLEEP MED RES, V4, P51, DOI DOI 10.17241/SMR.2013.4.2.51; de Gage SB, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5205; de Gage SB, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6231; Fastbom J, 1998, ALZ DIS ASSOC DIS, V12, P14, DOI 10.1097/00002093-199803000-00002; Fourrier A, 2001, EUR J CLIN PHARMACOL, V57, P419, DOI 10.1007/s002280100326; Gallacher J, 2012, J EPIDEMIOL COMMUN H, V66, P869, DOI 10.1136/jech-2011-200314; Gomm W, 2016, J ALZHEIMERS DIS, V54, P801, DOI 10.3233/JAD-151006; Gray SL, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i90; Imfeld P, 2015, DRUG SAFETY, V38, P909, DOI 10.1007/s40264-015-0319-3; Kalaria RN, 2008, LANCET NEUROL, V7, P812, DOI 10.1016/S1474-4422(08)70169-8; Kaufmann CN, 2016, PHARMACOEPIDEM DR S, V25, P637, DOI 10.1002/pds.3951; Kim YJ, 2014, J KOREAN MED SCI, V29, P903, DOI 10.3346/jkms.2014.29.7.903; Kripke D.F., 2006, SLEEP SLEEP DISORDER, P141, DOI DOI 10.1007/0-387-27682-3_15; Kripke DF, 2000, SLEEP MED REV, V4, P5, DOI 10.1053/smrv.1999.0076; Lagnaoui R, 2002, J CLIN EPIDEMIOL, V55, P314, DOI 10.1016/S0895-4356(01)00453-X; Lee J, 2017, INT J EPIDEMIOL, V46, DOI 10.1093/ije/dyv319; Luchsinger Jose A, 2004, Curr Atheroscler Rep, V6, P261, DOI 10.1007/s11883-004-0056-z; Sosa-Ortiz AL, 2012, ARCH MED RES, V43, P600, DOI 10.1016/j.arcmed.2012.11.003; Methodology WCCfDS, 2012, METH WCCIDS GUID ATC; Moraros J, 2017, DEPRESS ANXIETY, V34, P217, DOI 10.1002/da.22584; Oh SH, 2014, INT J CLIN PHARM TH, V52, P460, DOI 10.5414/CP202008; Pariente A, 2016, CNS DRUGS, V30, P1, DOI 10.1007/s40263-015-0305-4; Park JH, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-293; Prince M., 2016, WORLD ALZHEIMER REPO; Profenno LA, 2010, BIOL PSYCHIAT, V67, P505, DOI 10.1016/j.biopsych.2009.02.013; Shash D, 2016, ALZHEIMERS DEMENT, V12, P604, DOI 10.1016/j.jalz.2015.10.006; Suissa S, 2007, PHARMACOEPIDEM DR S, V16, P241, DOI 10.1002/pds.1357; Thiebaut ACM, 2004, STAT MED, V23, P3803, DOI 10.1002/sim.2098; Vermeeren A, 2011, PROG BRAIN RES, V190, P89, DOI 10.1016/B978-0-444-53817-8.00005-0; Wolkewitz M, 2012, J CLIN EPIDEMIOL, V65, P1171, DOI 10.1016/j.jclinepi.2012.04.008; Wu CS, 2011, AM J GERIAT PSYCHIAT, V19, P151, DOI 10.1097/JGP.0b013e3181e049ca; Wu CS, 2009, AM J GERIAT PSYCHIAT, V17, P614, DOI 10.1097/JGP.0b013e3181a65210; Zhong GC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127836; 양광익, 2010, Journal of sleep medicine, V7, P25	43	31	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2018	13	9							e0204413	10.1371/journal.pone.0204413	http://dx.doi.org/10.1371/journal.pone.0204413			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3MI	30248129	gold, Green Submitted, Green Published			2022-12-26	WOS:000445998100037
J	Friedman, MA; Szczepankiewicz, RP; Kohn, DH				Friedman, Michael A.; Szczepankiewicz, Robert P.; Kohn, David H.			Combined mineral-supplemented diet and exercise increases bone mass and strength after eight weeks and maintains increases after eight weeks detraining in adult mice	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; CORTICAL BONE; BIOMECHANICAL STRENGTH; PHYSICAL-ACTIVITY; IMPACT EXERCISE; CALCIUM; GROWTH; AGE; DECREASES; BENEFITS	Exercise has long-lasting benefits to bone mass and structural strength even after cessation. Combining exercise with a calcium- and phosphorus-supplemented diet increases cortical bone mineral content (BMC), area, and yield force more than exercise alone in adult mice. These increases could also be maintained after stopping exercise if the modified diet is maintained. It was hypothesized that combining exercise with a mineral-supplemented diet would lead to greater cortical BMC, area, and yield force immediately after a lengthy exercise program and after an equally long period of non-exercise (detraining) in adult mice. Male, 16-week old C57BI/6 mice were assigned to 9 weight-matched groups-a baseline group, exercise and non-exercise groups fed a control or mineral-supplemented diet for 8 weeks, exercise + detraining and non-exercise groups fed a control or mineral-supplemented diet for 16 weeks. Exercise + detraining consisted of 8 weeks of exercise followed by 8 weeks without exercise. The daily exercise program consisted of running on a treadmill at 12 m/min, 30 min/day. After 8 weeks, mice fed the supplemented diet had greater tibial cortical BMC and area, trabecular bone volume/tissue volume (BV/TV), bone mineral density (vBMD), yield force, and ultimate force than mice fed the control diet. Exercise increased cortical BMC and area only when coupled with the supplemented diet. After 16 weeks, both exercised and non-exercised mice fed the supplemented diet maintained greater tibial cortical BMC and area, trabecular BV/TV, vBMD, yield force, and ultimate force than mice fed the control diet. Combining exercise with a mineral-supplemented diet leads to greater bone mass and structural strength than exercise alone. These benefits remain after an equally long period of detraining. Long-term use of dietary mineral supplements may help increase and maintain bone mass with aging in adult mice.	[Friedman, Michael A.; Szczepankiewicz, Robert P.; Kohn, David H.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Kohn, David H.] Univ Michigan, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Kohn, DH (corresponding author), Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.; Kohn, DH (corresponding author), Univ Michigan, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA.	dhkohn@umich.edu	Friedman, Michael A/J-6414-2019; Kohn, David/AAJ-4131-2020	Friedman, Michael/0000-0001-8279-0306; Kohn, David/0000-0002-8833-0076	National Institutes of Health [R01-AR052010, S10RR026475-01]; National GEM Consortium Ph.D. Engineering Fellowship; NIH/NCRR [S10RR026475-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052010] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National GEM Consortium Ph.D. Engineering Fellowship; NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institutes of Health [R01-AR052010] (www.nih.gov) and the National GEM Consortium Ph.D. Engineering Fellowship (www.gemfellowship.org). Data collection was also done by the University of Michigan School of Dentistry MicroCT core, funded in part by the National Institutes of Health [S10RR026475-01]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Institutes of Health [R01-AR052010] and the National GEM Consortium Ph.D. Engineering Fellowship. Thank you to the University of Michigan School of Dentistry MicroCT core, funded in part by NIH/NCRR S10RR026475-01.	Bhatia V, 2008, INDIAN J MED RES, V127, P269; BLACKWELL BN, 1995, TOXICOL PATHOL, V23, P570, DOI 10.1177/019262339502300503; Bouxsein ML, 2005, BEST PRACT RES CL RH, V19, P897, DOI 10.1016/j.berh.2005.07.004; Cao JJ, 2009, BONE, V44, P1097, DOI 10.1016/j.bone.2009.02.017; Fonseca D, 2004, BONE, V35, P489, DOI 10.1016/j.bone.2004.03.031; Friedman MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151995; Fuchs RK, 2002, J PEDIATR-US, V141, P357, DOI 10.1067/mpd.2002.127275; Glatt V, 2007, J BONE MINER RES, V22, P1197, DOI 10.1359/JBMR.070507; Gunter K, 2008, J BONE MINER RES, V23, P986, DOI 10.1359/JBMR.071201; HALL DD, 1991, J ANIM SCI, V69, P646; Honda A, 2008, J APPL PHYSIOL, V105, P849, DOI 10.1152/japplphysiol.00902.2007; Hunt JR, 2008, J NUTR, V138, P1462, DOI 10.1093/jn/138.8.1462; Ionova-Martin SS, 2010, BONE, V46, P217, DOI 10.1016/j.bone.2009.10.015; KANNUS P, 1995, ANN INTERN MED, V123, P27, DOI 10.7326/0003-4819-123-1-199507010-00003; Kohn DH, 2009, CELLS TISSUES ORGANS, V189, P33, DOI 10.1159/000151452; Kohrt WM, 2004, MED SCI SPORT EXER, V36, P1985, DOI 10.1249/01.MSS.0000142662.21767.58; Masuyama R, 2003, J BONE MINER RES, V18, P1217, DOI 10.1359/jbmr.2003.18.7.1217; Nagy TR, 2002, OBES RES, V10, P412, DOI 10.1038/oby.2002.57; Ooi FK, 2011, J PHYSIOL SCI, V61, P487, DOI 10.1007/s12576-011-0169-4; Pikkarainen E, 2009, SCAND J MED SCI SPOR, V19, P166, DOI 10.1111/j.1600-0838.2008.00773.x; Riggs BL, 2004, J BONE MINER RES, V19, P1945, DOI 10.1359/JBMR.040916; Rizzoli R, 2010, BONE, V46, P294, DOI 10.1016/j.bone.2009.10.005; Russo CR, 2006, BONE, V38, P112, DOI 10.1016/j.bone.2005.07.025; Saxon LK, 2005, BONE, V36, P454, DOI 10.1016/j.bone.2004.12.001; Seeman E, 2003, NEW ENGL J MED, V349, P320, DOI 10.1056/NEJMp038101; Somerville JN, 2004, CALCIFIED TISSUE INT, V74, P469, DOI 10.1007/s00223-003-0101-x; Song QM, 2015, NUTR RES, V35, P146, DOI 10.1016/j.nutres.2014.11.003; TURNER CH, 1993, BONE, V14, P595, DOI 10.1016/8756-3282(93)90081-K; Umemura Y, 2008, J APPL PHYSIOL, V104, P1116, DOI 10.1152/japplphysiol.00937.2007; Wallace JM, 2009, CALCIFIED TISSUE INT, V84, P297, DOI 10.1007/s00223-009-9228-8; Warden SJ, 2007, J BONE MINER RES, V22, P251, DOI 10.1359/JBMR.061107; Welch JM, 2008, BONE, V42, P660, DOI 10.1016/j.bone.2007.12.220	32	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2018	13	9							e0204470	10.1371/journal.pone.0204470	http://dx.doi.org/10.1371/journal.pone.0204470			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU5MM	30240447	Green Submitted, Green Published, gold			2022-12-26	WOS:000445329700054
J	Kenne, E; Rasmuson, J; Renne, T; Vieira, ML; Muller-Esterl, W; Herwald, H; Lindbom, L				Kenne, Ellinor; Rasmuson, Joel; Renne, Thomas; Vieira, Monica L.; Mueller-Esterl, Werner; Herwald, Heiko; Lindbom, Lennart			Neutrophils engage the kallikrein-kinin system to open up the endothelial barrier in acute inflammation	FASEB JOURNAL			English	Article						vascular permeability; bradykinin; leukocyte; degranulation	HEPARIN-BINDING PROTEIN; VASCULAR-PERMEABILITY; HANTAVIRUS INFECTION; ACTIVATION; MECHANISMS; FIBRINOGEN; RELEASE; ACCUMULATION; COMPARTMENTS; INVOLVEMENT	Neutrophil recruitment and plasma exudation are key elements in the immune response to injury or infection. Activated neutrophils stimulate opening of the endothelial barrier; however, the underlying mechanisms have remained largely unknown. In this study, we identified a pivotal role of the proinflammatory kallikrein-kinin system and consequent formation of bradykinin in neutrophil-evoked vascular leak. In mouse and hamster models of acute inflammation, inhibitors of bradykinin generation, and signaling markedly reduced plasma exudation in response to chemoattractant activation of neutrophils. The neutrophil-driven leak was likewise suppressed in mice deficient in either the bradykinin B-2 receptor or factor XII (initiator of the kallikrein-kinin system). In human endothelial cell monolayers, material secreted from activated neutrophils induced cytoskeletal rearrangement, leading to paracellular gap formation in a bradykinin-dependent manner. As a mechanistic basis, we found that a neutrophil-derived heparin-binding protein (HBP/azurocidin) displaced the bradykinin precursor high-molecular-weight kininogen from endothelial cells, thereby enabling proteolytic processing of kininogen into bradykinin by neutrophil and plasma proteases. These data provide novel insight into the signaling pathway by which neutrophils open up the endothelial barrier and identify the kallikrein-kinin system as a target for therapeutic interventions in acute inflammatory reactions.Kenne, E., Rasmuson, J., Renne, T., Vieira, M. L., Muller-Esterl, W., Herwald, H., Lindbom, L. Neutrophils engage the kallikrein-kinin system to open up the endothelial barrier in acute inflammation.	[Kenne, Ellinor; Rasmuson, Joel; Lindbom, Lennart] Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden; [Renne, Thomas] Univ Med Ctr Hamburg Eppendorf, Inst Clin Chem & Lab Med, Hamburg, Germany; [Vieira, Monica L.; Herwald, Heiko] Lund Univ, Dept Clin Sci, Lund, Sweden; [Vieira, Monica L.] Butantan Inst, Biotechnol Ctr, Sao Paulo, Brazil; [Mueller-Esterl, Werner] Goethe Univ, Inst Biochem 2, Frankfurt, Germany	Karolinska Institutet; University of Hamburg; University Medical Center Hamburg-Eppendorf; Lund University; Instituto Butantan; Goethe University Frankfurt	Lindbom, L (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden.	lennart.lindbom@ki.se	Vieira, Mônica/AAE-9391-2021; Kenne, Ellinor/HCH-1218-2022; Herwald, Heiko/AAN-3708-2021	Vieira, Mônica/0000-0002-4162-8086; Herwald, Heiko/0000-0002-8111-2842; Renne, Thomas/0000-0003-4594-5975	Swedish Research Council; Swedish Heart-Lung Foundation; Torsten Soderberg Foundation; Swedish Foundation for Strategic Research; Lars Hierta Memorial Fund; Alfred Osterlund Foundation; German Research Society [SFB877]; European Research Council [ERC-StG-2012-311575]; Karolinska Institutet	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Torsten Soderberg Foundation; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Lars Hierta Memorial Fund; Alfred Osterlund Foundation; German Research Society(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); Karolinska Institutet(Karolinska Institutet)	The authors thank Dr. Hans Flodgaard (Novo Nordisk, Bagvaerd, Denmark) for valuable advice and gift of reagents. PK inhibitor VA999026 was a kind gift of Vantia Ltd. (Southampton, United Kingdom). This work was supported by grants from the Swedish Research Council, Swedish Heart-Lung Foundation, Torsten Soderberg Foundation, Swedish Foundation for Strategic Research, Lars Hierta Memorial Fund, Alfred Osterlund Foundation, German Research Society Grant SFB877 (to T.R.), European Research Council Grant ERC-StG-2012-311575 (to T.R.), and Karolinska Institutet. The authors declare no conflicts of interest.	Antonen J, 2013, SCAND J INFECT DIS, V45, P494, DOI 10.3109/00365548.2012.755268; ARFORS KE, 1987, BLOOD, V69, P338; Bjorkqvist J, 2013, BIOL CHEM, V394, P1195, DOI 10.1515/hsz-2013-0144; BORKOWSKI JA, 1995, J BIOL CHEM, V270, P13706, DOI 10.1074/jbc.270.23.13706; Breslin JW, 2004, AM J PHYSIOL-HEART C, V286, pH1057, DOI 10.1152/ajpheart.00841.2003; BRETT J, 1989, J EXP MED, V169, P1977, DOI 10.1084/jem.169.6.1977; CAMPANELLI D, 1990, J CLIN INVEST, V85, P904, DOI 10.1172/JCI114518; DelMaschio A, 1996, J CELL BIOL, V135, P497, DOI 10.1083/jcb.135.2.497; Di Gennaro A, 2009, FASEB J, V23, P1750, DOI 10.1096/fj.08-121277; DiStasi MR, 2009, TRENDS IMMUNOL, V30, P539, DOI 10.1016/j.it.2009.07.012; Finsterbusch M, 2014, J EXP MED, V211, P1306, DOI 10.1084/jem.20132413; Gautam N, 2001, NAT MED, V7, P1123, DOI 10.1038/nm1001-1123; Gautam N, 2000, J EXP MED, V191, P1829, DOI 10.1084/jem.191.11.1829; Griesbacher T, 2002, BRIT J PHARMACOL, V137, P692, DOI 10.1038/sj.bjp.0704910; Herwald H, 2004, CELL, V116, P367, DOI 10.1016/S0092-8674(04)00057-1; Imamura T, 2002, BIOCHEM BIOPH RES CO, V294, P423, DOI 10.1016/S0006-291X(02)00490-4; Iversen LF, 1997, NAT STRUCT BIOL, V4, P265, DOI 10.1038/nsb0497-265; Kahn R, 2009, J IMMUNOL, V182, P7906, DOI 10.4049/jimmunol.0803624; Kaplan AP, 2014, ADV IMMUNOL, V121, P41, DOI 10.1016/B978-0-12-800100-4.00002-7; Koma T, 2014, J VIROL, V88, P7178, DOI 10.1128/JVI.00254-14; Linder A, 2009, CLIN INFECT DIS, V49, P1044, DOI 10.1086/605563; LOIKE JD, 1992, ANN NY ACAD SCI, V667, P163, DOI 10.1111/j.1749-6632.1992.tb51608.x; Ma T, 2012, J NEURO-ONCOL, V106, P291, DOI 10.1007/s11060-011-0685-3; Macheboeuf P, 2011, NATURE, V472, P64, DOI 10.1038/nature09967; Mckenzie JAG, 2007, J CELL PHYSIOL, V213, P221, DOI 10.1002/jcp.21114; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Meini S, 1996, BRIT J PHARMACOL, V117, P1619, DOI 10.1111/j.1476-5381.1996.tb15331.x; MULLERESTERL W, 1988, METHOD ENZYMOL, V163, P240; Olofsson AM, 1999, J CLIN INVEST, V104, P885, DOI 10.1172/JCI6671; Orsenigo F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2199; Pauer HU, 2004, THROMB HAEMOSTASIS, V92, P503, DOI 10.1160/TH04-04-0250; RAUD J, 1994, HDB IMMUNOPHARMACOLO, P127; Renne T, 2000, J BIOL CHEM, V275, P33688, DOI 10.1074/jbc.M000313200; Renne T, 2005, J IMMUNOL, V175, P3377, DOI 10.4049/jimmunol.175.5.3377; ROSENGREN S, 1989, MICROVASC RES, V38, P243, DOI 10.1016/0026-2862(89)90003-4; Schmaier AH, 2016, J THROMB HAEMOST, V14, P28, DOI 10.1111/jth.13194; Soehnlein O, 2008, EUR RESPIR J, V32, P405, DOI 10.1183/09031936.00173207; Stuardo M, 2004, J LEUKOCYTE BIOL, V75, P631, DOI 10.1189/jlb.1103546; Tapper H, 2002, BLOOD, V99, P1785, DOI 10.1182/blood.V99.5.1785; Taylor SL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003470; Walzog B, 1999, AM J PHYSIOL-GASTR L, V276, pG1125, DOI 10.1152/ajpgi.1999.276.5.G1125; WEDMORE CV, 1981, NATURE, V289, P646, DOI 10.1038/289646a0; Wessel F, 2014, NAT IMMUNOL, V15, P223, DOI 10.1038/ni.2824; Williams A, 2003, TRANSFUS APHER SCI, V29, P255, DOI 10.1016/S1473-0502(03)00170-8; WIRTH K, 1991, BRIT J PHARMACOL, V102, P774, DOI 10.1111/j.1476-5381.1991.tb12249.x	45	20	20	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2599	2609		10.1096/fj.201801329R	http://dx.doi.org/10.1096/fj.201801329R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30281335				2022-12-26	WOS:000457296600085
J	Liu, B; Li, JR; Yan, HF; Tian, DP; Li, H; Zhang, YZ; Guo, TT; Wu, XZ; Luo, WH; Zhou, YB				Liu, Bin; Li, Jiarong; Yan, Hongfei; Tian, Dongping; Li, Hui; Zhang, Yingzhan; Guo, Tingting; Wu, Xiangzhong; Luo, Wenhong; Zhou, Yingbi			TP and/or EP3 receptors mediate the vasoconstrictor and pressor responses of prostaglandin F-2 in mice and/or humans	FASEB JOURNAL			English	Article						prostanoid; cyclooxygenase; blood pressure	ENDOTHELIUM-DEPENDENT CONTRACTIONS; PROSTACYCLIN SYNTHESIS; PROSTANOID RECEPTORS; FP-RECEPTORS; AORTA; RELAXATION; EXPRESSION; INCREASES	The vasoconstrictor and/or pressor effects of prostaglandin (PG)F-2 participate in the development of vascular pathologies and limit the clinical use of the agent. This study aimed to determine the receptor types responsible for the vasoconstrictor activity of PGF(2) and whether they mediate the pressor response evoked by the prostanoid under in vivo conditions. Experiments were performed on genetically altered mice and/or on vessels from these mice or humans. Here we show that deletion of the thromboxane-prostanoid receptor (TP-/-) abolished or drastically diminished the contraction to PGF(2) in isolated mouse vessels (some of which were resistance arteries) and reduced the elevation in blood pressure evoked by the prostanoid under in vivo conditions. In accordance, TP antagonism abolished the contraction in small arteries of human omentum. Further deletion of E prostanoid receptor type 3 (EP3(-/-)) removed the PGF(2)-evoked contraction that remained in some TP-/- arteries and added to the effect of TP-/- on the elevation in blood pressure evoked by the prostanoid under in vivo conditions. In contrast, the uterine contraction to PGF(2) mediated via the F prostanoid receptor (FP) was unaltered in TP-/-/EP3(-/-) mice. These results demonstrate that the non-FP receptors TP and/or EP3 mediate the vasoconstrictor and pressor effects of PGF(2), which are still of concern under clinical conditions.Liu, B., Li, J., Yan, H., Tian, D., Li, H., Zhang, Y., Guo, T., Wu, X., Luo, W., Zhou, Y. TP and/or EP3 receptors mediate the vasoconstrictor and pressor responses of prostaglandin F-2 in mice and/or humans.	[Liu, Bin; Li, Jiarong; Zhang, Yingzhan; Guo, Tingting; Wu, Xiangzhong; Zhou, Yingbi] Shantou Univ, Coll Med, Cardiovasc Res Ctr, 22 Xin Ling Rd, Shantou 515041, Peoples R China; [Tian, Dongping] Shantou Univ, Coll Med, Dept Pathol, Shantou, Peoples R China; [Li, Hui; Luo, Wenhong] Shantou Univ, Coll Med, Cent Lab, Shantou, Peoples R China; [Yan, Hongfei] Shantou Univ, Coll Med, Dept Pathol, Affiliated Canc Hosp, Shantou, Peoples R China	Shantou University; Shantou University; Shantou University; Shantou University	Liu, B; Zhou, YB (corresponding author), Shantou Univ, Coll Med, Cardiovasc Res Ctr, 22 Xin Ling Rd, Shantou 515041, Peoples R China.	bliu0210@yahoo.com; yz_sumc@163.com	li, jia/GVT-7587-2022		National Natural Science Foundation of China [81470572, 31771272, 81770678]; Department of Education under the Top-Tier University Development Scheme for Research and Control of Infectious Diseases [2016032]; Major Research Program for Universities of Guangdong Province [2017KZDXM037]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Education under the Top-Tier University Development Scheme for Research and Control of Infectious Diseases; Major Research Program for Universities of Guangdong Province	This work was supported by National Natural Science Foundation of China Grants 81470572 and 31771272 (to Y.Z.) and 81770678 (to B.L.); Department of Education under the Top-Tier University Development Scheme for Research and Control of Infectious Diseases Grant 2016032 (to B.L.); and Major Research Program for Universities of Guangdong Province Grant 2017KZDXM037 (to B.L.). The authors declare no conflicts of interest.	Alvarez Y, 2005, J HYPERTENS, V23, P767, DOI 10.1097/01.hjh.0000163145.12707.63; BJORO K, 1986, GYNECOL OBSTET INVES, V22, P1, DOI 10.1159/000298881; Chandraharan E, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3875; CHEN J, 1995, BRIT J PHARMACOL, V116, P3035, DOI 10.1111/j.1476-5381.1995.tb15960.x; Cirillo R, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.02.010; Dong YL, 2000, BIOL REPROD, V62, P533, DOI 10.1095/biolreprod62.3.533; FUCHS AR, 1987, J STEROID BIOCHEM, V27, P1073, DOI 10.1016/0022-4731(87)90192-0; GILES H, 1991, BRIT J PHARMACOL, V104, P541, DOI 10.1111/j.1476-5381.1991.tb12465.x; Gluais P, 2005, BRIT J PHARMACOL, V146, P834, DOI 10.1038/sj.bjp.0706390; Gross GA, 1998, P NATL ACAD SCI USA, V95, P11875, DOI 10.1073/pnas.95.20.11875; HAUGEN G, 1992, SCAND J CLIN LAB INV, V52, P141, DOI 10.3109/00365519209088778; HAYASHI S, 1985, J PHARMACOL EXP THER, V233, P628; Islam MZ, 2017, MICROVASC RES, V114, P52, DOI 10.1016/j.mvr.2017.06.001; JONES RL, 1982, BRIT J PHARMACOL, V76, P423, DOI 10.1111/j.1476-5381.1982.tb09236.x; Kawada N, 2004, AM J PHYSIOL-RENAL, V287, pF753, DOI 10.1152/ajprenal.00423.2003; KAWAI Y, 1991, AM J PHYSIOL, V260, pH1538, DOI 10.1152/ajpheart.1991.260.5.H1538; LAWRENCE RA, 1992, BRIT J PHARMACOL, V105, P817, DOI 10.1111/j.1476-5381.1992.tb09063.x; Li ZH, 2017, SCI REP-UK, V7, DOI 10.1038/srep42167; Liu B, 2017, EUR J PHARMACOL, V813, P140, DOI 10.1016/j.ejphar.2017.08.015; Liu B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09288-w; Liu B, 2012, AM J PHYSIOL-RENAL, V302, pF1133, DOI 10.1152/ajprenal.00604.2011; Liu B, 2012, EXP PHYSIOL, V97, P277, DOI 10.1113/expphysiol.2011.062034; Liu DL, 2015, AM J PHYSIOL-HEART C, V309, pH804, DOI 10.1152/ajpheart.00150.2015; Luo WH, 2016, EUR J PHARMACOL, V780, P148, DOI 10.1016/j.ejphar.2016.03.043; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Olson DM, 2003, BEST PRACT RES CL OB, V17, P717, DOI 10.1016/S1521-6934(03)00069-5; Saito O, 2003, AM J PHYSIOL-RENAL, V284, pF1164, DOI 10.1152/ajprenal.00441.2002; Sanchez T, 2006, EUR J PHARMACOL, V529, P16, DOI 10.1016/j.ejphar.2005.10.040; SENIOR J, 1992, BRIT J PHARMACOL, V107, P215, DOI 10.1111/j.1476-5381.1992.tb14489.x; Sugimoto Y, 1997, SCIENCE, V277, P681, DOI 10.1126/science.277.5326.681; Tang EHC, 2008, CARDIOVASC RES, V78, P130, DOI 10.1093/cvr/cvm112; Tian XY, 2012, ANTIOXID REDOX SIGN, V16, P363, DOI 10.1089/ars.2010.3874; TODA N, 1988, J CARDIOVASC PHARM, V11, P354, DOI 10.1097/00005344-198803000-00014; Vanhoutte PM, 2011, HYPERTENSION, V57, P526, DOI 10.1161/HYPERTENSIONAHA.110.165100; Vivancos M, 2002, NITRIC OXIDE-BIOL CH, V6, P255, DOI 10.1006/niox.2001.0410; Wong SL, 2009, CIRC RES, V104, P228, DOI 10.1161/CIRCRESAHA.108.179770; Yu Y, 2009, P NATL ACAD SCI USA, V106, P7985, DOI 10.1073/pnas.0811834106; Zhou YB, 2005, AM J PHYSIOL-HEART C, V289, pH1027, DOI 10.1152/ajpheart.00226.2005	38	11	12	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2019	33	2					2451	2459		10.1096/fj.201801064RR	http://dx.doi.org/10.1096/fj.201801064RR			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ6KJ	30277822				2022-12-26	WOS:000457296600073
J	Hone, AJ; Talley, TT; Bobango, J; Melo, CH; Hararah, F; Gajewiak, J; Christensen, S; Harvey, PJ; Craik, DJ; McIntosh, JM				Hone, Arik J.; Talley, Todd T.; Bobango, Janet; Melo, Cesar Huidobro; Hararah, Fuaad; Gajewiak, Joanna; Christensen, Sean; Harvey, Peta J.; Craik, David J.; McIntosh, J. Michael			Molecular determinants of alpha-conotoxin potency for inhibition of human and rat alpha 6 beta 4 nicotinic acetylcholine receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nicotinic acetylcholine receptors (nAChR); neuroinflammation; neuroscience; neurotransmitter receptor; neurotoxin; 1; -conotoxin; nicotinic subunit 6; nicotinic subunit 4; nuclear magnetic resonance spectroscopy; X-ray crystallography; small peptide; analgesic; neuropathic pain	DOPAMINE RELEASE; BINDING PROTEIN; CHOLINERGIC-RECEPTORS; SYNAPTIC TRANSMISSION; SUBUNIT COMPOSITION; CRYSTAL-STRUCTURE; DIFFERENT NACHR; MOUSE-BRAIN; SPINAL-CORD; SUBTYPES	Nicotinic acetylcholine receptors (nAChRs) containing 6 and 4 subunits are expressed by dorsal root ganglion neurons and have been implicated in neuropathic pain. Rodent models are often used to evaluate the efficacy of analgesic compounds, but species differences may affect the activity of some nAChR ligands. A previous candidate -conotoxin-based therapeutic yielded promising results in rodent models, but failed in human clinical trials, emphasizing the importance of understanding species differences in ligand activity. Here, we show that human and rat 6/34 nAChRs expressed in Xenopus laevis oocytes exhibit differential sensitivity to -conotoxins. Sequence homology comparisons of human and rat 64 nAChR subunits indicated that 6 residues forming the ligand-binding pocket are highly conserved between the two species, but several residues of 4 differed, including a Leu-Gln difference at position 119. X-ray crystallography of -conotoxin PeIA complexed with the Aplysia californica acetylcholine-binding protein (AChBP) revealed that binding of PeIA orients Pro(13) in close proximity to residue 119 of the AChBP complementary subunit. Site-directed mutagenesis studies revealed that Leu(119) of human 4 contributes to higher sensitivity of human 6/34 nAChRs to -conotoxins, and structure-activity studies indicated that PeIA Pro(13) is critical for high potency. Human and rat 6/34 nAChRs displayed differential sensitivities to perturbations of the interaction between PeIA Pro(13) and residue 119 of the 4 subunit. These results highlight the potential significance of species differences in 64 nAChR pharmacology that should be taken into consideration when evaluating the activity of candidate human therapeutics in rodent models.	[Hone, Arik J.; Melo, Cesar Huidobro; Hararah, Fuaad; Gajewiak, Joanna; Christensen, Sean; McIntosh, J. Michael] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [McIntosh, J. Michael] Univ Utah, Dept Psychiat, Salt Lake City, UT 84112 USA; [McIntosh, J. Michael] George E Whalen Vet Affairs Med Ctr, Salt Lake City, UT 84148 USA; [Talley, Todd T.] T3 Biosciences, Moses Lake, WA 98837 USA; [Bobango, Janet] Univ Montana, Dept Biomed & Pharmaceut Sci, Missoula, MT 59812 USA; [Harvey, Peta J.; Craik, David J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; University of Montana System; University of Montana; University of Queensland	Hone, AJ; McIntosh, JM (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.; McIntosh, JM (corresponding author), Univ Utah, Dept Psychiat, Salt Lake City, UT 84112 USA.	uuneurotox@yahoo.com; mcintosh.mike@gmail.com	Craik, David/B-1695-2010; harvey, peta/D-2048-2017	Craik, David/0000-0003-0007-6796; harvey, peta/0000-0003-4735-6242	NIGMS, NIH; Howard Hughes Medical Institute;  [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM103801, P01GM048677] Funding Source: NIH RePORTER	NIGMS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Quentin Kaas (University of Queensland, Brisbane, Australia) for critical reading of the manuscript. We acknowledge the contribution to the manuscript by the scientists and support staff of the Berkeley Center for Structural Biology (Berkeley Hills, CA) as well as those at the University of Utah DNA Sequencing and DNA/Peptide Synthesis Core Facilities (Salt Lake City, UT). The Berkeley Center for Structural Biology is supported in part by grants from NIGMS, NIH, and the Howard Hughes Medical Institute. The Advanced Light Source is a Department of Energy Office of Science User Facility under contract DE-AC02-05CH11231.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Bagdas D, 2018, CURR NEUROPHARMACOL, V16, P415, DOI 10.2174/1570159X15666170818102108; Bradaia A, 2002, J PHYSIOL-LONDON, V544, P727, DOI 10.1113/jphysiol.2002.028894; Cartier GE, 1996, J BIOL CHEM, V271, P7522, DOI 10.1074/jbc.271.13.7522; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Celie PHN, 2005, NAT STRUCT MOL BIOL, V12, P582, DOI 10.1038/nsmb951; Champtiaux N, 2002, J NEUROSCI, V22, P1208, DOI 10.1523/JNEUROSCI.22-04-01208.2002; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cierpicki T, 2001, J BIOMOL NMR, V21, P249, DOI 10.1023/A:1012911329730; Clarke PBS, 1996, BRIT J PHARMACOL, V117, P595, DOI 10.1111/j.1476-5381.1996.tb15232.x; Cordero-Erausquin M, 2004, PAIN, V109, P308, DOI 10.1016/j.pain.2004.01.034; Cox BC, 2008, J NEUROCHEM, V105, P1924, DOI 10.1111/j.1471-4159.2008.05282.x; Cuny H, 2018, BRIT J PHARMACOL, V175, P1855, DOI 10.1111/bph.13852; Daly NL, 2011, J BIOL CHEM, V286, P10233, DOI 10.1074/jbc.M110.196170; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; Delano W.L., 2017, PYMOL MOL GRAPHICS S; Dutertre S, 2005, J BIOL CHEM, V280, P30460, DOI 10.1074/jbc.M504229200; Dutertre S, 2007, EMBO J, V26, P3858, DOI 10.1038/sj.emboj.7601785; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Exley R, 2012, J NEUROSCI, V32, P2352, DOI 10.1523/JNEUROSCI.4985-11.2012; FAINZILBER M, 1994, BIOCHEMISTRY-US, V33, P9523, DOI 10.1021/bi00198a018; Giribaldi J, 2018, NEUROSCI LETT, V679, P24, DOI 10.1016/j.neulet.2017.11.063; Gotti C, 2010, J NEUROSCI, V30, P5311, DOI 10.1523/JNEUROSCI.5095-09.2010; Grady SR, 2001, J NEUROCHEM, V76, P258, DOI 10.1046/j.1471-4159.2001.00019.x; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hansen SB, 2006, J MOL NEUROSCI, V30, P101, DOI 10.1385/JMN:30:1:101; Hone AJ, 2018, FEBS LETT, V592, P1045, DOI 10.1002/1873-3468.12884; Hone AJ, 2015, MOL PHARMACOL, V88, P881, DOI 10.1124/mol.115.100982; Hone AJ, 2013, J BIOL CHEM, V288, P25428, DOI 10.1074/jbc.M113.482059; Hone AJ, 2012, MOL PHARMACOL, V82, P972, DOI 10.1124/mol.112.080853; Hone AJ, 2012, FASEB J, V26, P917, DOI 10.1096/fj.11-195883; Ikeya T, 2006, MAGN RESON CHEM, V44, pS152, DOI 10.1002/mrc.1815; Kaas Q, 2012, NUCLEIC ACIDS RES, V40, pD325, DOI 10.1093/nar/gkr886; Kaiser S, 2000, MOL PHARMACOL, V58, P312, DOI 10.1124/mol.58.2.312; Kuryatov A, 2000, NEUROPHARMACOLOGY, V39, P2570, DOI 10.1016/S0028-3908(00)00144-1; Lin B, 2016, MAR DRUGS, V14, DOI 10.3390/md14100173; Lu Y, 1998, J PHARMACOL EXP THER, V287, P648; Luo SQ, 1998, J NEUROSCI, V18, P8571; Luo SL, 2013, J BIOL CHEM, V288, P894, DOI 10.1074/jbc.M112.427898; Marritt AM, 2005, MOL PHARMACOL, V68, P1656, DOI 10.1124/mol.105.012380; McIntosh JM, 2005, J BIOL CHEM, V280, P30107, DOI 10.1074/jbc.M504102200; McIntosh JM, 2004, MOL PHARMACOL, V65, P944, DOI 10.1124/mol.65.4.944; McIntosh JM, 1999, ANNU REV BIOCHEM, V68, P59, DOI 10.1146/annurev.biochem.68.1.59; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Salminen O, 2004, MOL PHARMACOL, V65, P1526, DOI 10.1124/mol.65.6.1526; Sandall DW, 2003, BIOCHEMISTRY-US, V42, P6904, DOI 10.1021/bi034043e; Satkunanathan N, 2005, BRAIN RES, V1059, P149, DOI 10.1016/j.brainres.2005.08.009; Sharma G, 2003, NEURON, V38, P929, DOI 10.1016/S0896-6273(03)00322-2; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Smit AB, 2001, NATURE, V411, P261, DOI 10.1038/35077000; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Talley TT, 2006, J BIOL CHEM, V281, P24678, DOI 10.1074/jbc.M602969200; Talley TT, 2006, BIOCHEMISTRY-US, V45, P8894, DOI 10.1021/bi060534y; Thompson AJ, 2017, NEUROPHARMACOLOGY, V116, P421, DOI 10.1016/j.neuropharm.2017.01.008; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Whiteaker P, 2000, MOL PHARMACOL, V57, P913; Wieskopf JS, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3009986; Xu MY, 2017, PROTEIN CELL, V8, P675, DOI 10.1007/s13238-017-0426-2; Yang KC, 2011, J NEUROSCI, V31, P2537, DOI 10.1523/JNEUROSCI.3003-10.2011; Yu RL, 2013, J MED CHEM, V56, P3557, DOI 10.1021/jm400041h; Zhangsun DT, 2015, J BIOL CHEM, V290, P9855, DOI 10.1074/jbc.M114.632646	63	13	13	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2018	293	46					17838	17852		10.1074/jbc.RA118.005649	http://dx.doi.org/10.1074/jbc.RA118.005649			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HA6SG	30249616	Green Published, hybrid			2022-12-26	WOS:000450409500015
J	Liang, LH; Zhao, P; Zhang, ST; Ji, M; Song, JG; Yuan, J				Liang, Lihua; Zhao, Peng; Zhang, Songtao; Ji, Ming; Song, Jiguang; Yuan, Jia			Simulation and experimental study on control strategy of zero-speed fin stabilizer based on disturbance and compensation	PLOS ONE			English	Article							SHIP; DESIGN	Zero-speed fin stabilizer is applied to reduce the roll motion of ships at zero speed. This paper aims to explore the control strategy of zero-speed fin stabilizer through a composite method of theoretical analysis, simulations and tank tests. The hydrodynamic force model is established using analytical approach and a simplified model is obtained by fitting the CFD simulation data. The control strategy of zero-speed fin stabilizer is obtained based on disturbance and compensation by analyzing the phase matching relationship between the wave disturbance, the roll motion of the ship, the movement of the fin and the fin-induced hydrodynamic force. Simulations and water tank tests are performed to verify the effectiveness and feasibility of the obtained control strategies. The results of simulations and tank tests show that the obtained control strategies of zero-speed fin stabilizer based on disturbance and compensation are effective and practical. The proposed method provides theoretical and experimental support for engineering application, and can also be a reference for the controller design of zero-speed fin stabilizers.	[Liang, Lihua; Zhao, Peng; Zhang, Songtao; Ji, Ming; Song, Jiguang; Yuan, Jia] Harbin Engn Univ, Coll Automat, Harbin, Heilongjiang, Peoples R China	Harbin Engineering University	Zhao, P (corresponding author), Harbin Engn Univ, Coll Automat, Harbin, Heilongjiang, Peoples R China.	heu_zyy@hrbeu.edu.cn						Andrikov D, 2017, PROCEDIA COMPUT SCI, V103, P470, DOI 10.1016/j.procs.2017.01.027; Brunton SL, 2015, APPL MECH REV, V67, DOI 10.1115/1.4031175; Conolly J.E., 1969, T ROYAL I NAVAL ARCH, V111, P21; Crossland P, 2003, CONTROL ENG PRACT, V11, P423, DOI 10.1016/S0967-0661(01)00156-3; Dallinga R.P., 1999, ROLL STABILIZATION M; Dallinga R.P., 2002, ROLL STABILIZATION A; Fang MC, 2007, OCEAN ENG, V34, P479, DOI 10.1016/j.oceaneng.2006.03.004; Fossen T. I., 1994, GUIDANCE CONTROL OCE; Giannini M, 2005, GUIDELINES DESIGN AC; Ji M, 2014, CHINESE J SHIP RES, V9, p[8, 42]; Ji M, 2014, 2014 IEEE INTERNATIONAL CONFERENCE ON MECHATRONICS AND AUTOMATION (IEEE ICMA 2014), P1757, DOI 10.1109/ICMA.2014.6885966; Jin H., 2015, SHIP ANTIROLLING CON; Jin H. Z., 2013, SHIP CONTROL THEORY; Jin Hong-zhang, 2008, Journal of Harbin Engineering University, V29, P368; [金鸿章 Jin Hongzhang], 2012, [自动化学报, Acta Automatica Sinica], V38, P1059; [金鸿章 Jin Hongzhang], 2010, [中国造船, Shipbuilding of China], V51, P1; [金鸿章 JIN Hongzhang], 2007, [海洋工程, The Ocean Engineering], V25, P83; [金鸿章 JIN Hongzhang], 2008, [武汉理工大学学报, Journal of Wuhan University of Technology], V30, P136; [金鸿章 Jin Hongzhang], 2005, [中国造船, Shipbuilding of China], V46, P29; Lewis E.V., 1989, PRINCIPLES NAVAL ARC, VIII; Liang L., 2015, INT J SMART HOME, V9, P1, DOI DOI 10.HTTPS://D0I.0RG/10.14257/IJSH.2015.9.6.01; Liang LH., 2005, HYDRAULIC TRANSMISSI; Liang LH, 2018, OCEAN ENG, V164, P733, DOI 10.1016/j.oceaneng.2018.07.015; Liang LH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196107; Liang LH, 2017, OCEAN ENG, V142, P491, DOI 10.1016/j.oceaneng.2017.07.012; Liang LH, 2016, 2016 IEEE INTERNATIONAL CONFERENCE ON MECHATRONICS AND AUTOMATION, P2413, DOI 10.1109/ICMA.2016.7558944; Liu ZQ, 2013, OCEAN ENG, V72, P25, DOI 10.1016/j.oceaneng.2013.06.009; Mark A, 2006, QUANTUM MARINE ENG I; Ochi M.K., 1998, OCEAN WAVES STOCHAST; Oertel H., 2004, PRANDTLS ESSENTIALS; Ooms J., 2002, USE ROLL STABILIZER; Perez T., 2005, SHIP MOTION CONTROL; Perez T, 2012, ANNU REV CONTROL, V36, P129, DOI 10.1016/j.arcontrol.2012.03.010; Song Ji-guang, 2015, Control Theory & Applications, V32, P703, DOI 10.7641/CTA.2015.40499; Song Ji-guang, 2011, Control and Decision, V26, P1343; [宋吉广 Song Jiguang], 2013, [中国造船, Shipbuilding of China], V54, P1; Su XY, 2018, INT J FUZZY SYST, V20, P611, DOI 10.1007/s40815-017-0402-2; Talha M, 2017, INT J FUZZY LOG INTE, V17, P210, DOI 10.5391/IJFIS.2017.17.3.210; van Wieringen H.M., 2002, DESIGN CONSIDERATION; Wang Fan, 2009, OCEAN ENG, V36, P1425, DOI DOI 10.1016/J.OCEANENG.2009.07.013	40	5	5	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2018	13	10							e0204446	10.1371/journal.pone.0204446	http://dx.doi.org/10.1371/journal.pone.0204446			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV5EV	30273372	Green Submitted, Green Published, gold			2022-12-26	WOS:000446124700023
J	Lu, DCC; Boulay, C; Chan, ADC; Sachs, AJ				Lu, David Chao-Chia; Boulay, Chadwick; Chan, Adrian D. C.; Sachs, Adam J.			Realtime phase-amplitude coupling analysis of micro electrode recorded brain signals	PLOS ONE			English	Article							SUBTHALAMIC NUCLEUS; PARKINSONS-DISEASE; STIMULATION; OSCILLATIONS; SPIKING; POWER; DBS	Objective To demonstrate a method to calculate phase amplitude coupling (PAC) quickly and robustly for realtime applications. Methods We designed and implemented a multirate PAC algorithm with efficient filter bank processing and efficient computation of PAC for many frequency-pair combinations. We tested the developed algorithm for computing PAC on simulated data and on intraoperative neural recording data obtained during deep brain stimulation (DBS) electrode implantation surgery. Results A combination of parallelized frequency-domain filtering and modulation index for PAC estimation provided robust results that could be calculated in real time on modest computing hardware. Conclusion The standard methods for calculating PAC can be optimized for quick and robust performance. Significance These results demonstrated that PAC can be extracted in real time and is suitable for neuro-feedback applications.	[Lu, David Chao-Chia; Chan, Adrian D. C.; Sachs, Adam J.] Carleton Univ, Dept Syst & Comp Engn, Ottawa, ON, Canada; [Lu, David Chao-Chia; Boulay, Chadwick; Sachs, Adam J.] Ottawa Hosp Res Inst, Dept Neurosci, Ottawa, ON, Canada; [Boulay, Chadwick; Sachs, Adam J.] Univ Ottawa, Fac Med & Brian, Ottawa, ON, Canada; [Boulay, Chadwick; Sachs, Adam J.] Univ Ottawa, Mind Res Inst, Ottawa, ON, Canada	Carleton University; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa	Boulay, C (corresponding author), Ottawa Hosp Res Inst, Dept Neurosci, Ottawa, ON, Canada.; Boulay, C (corresponding author), Univ Ottawa, Fac Med & Brian, Ottawa, ON, Canada.; Boulay, C (corresponding author), Univ Ottawa, Mind Res Inst, Ottawa, ON, Canada.	chboulay@ohri.ca		Sachs, Adam/0000-0002-3630-4562; Boulay, Chadwick/0000-0003-1747-3931	2016 Larry Haffner Fellowship from the Parkinson Research Consortium Fellowship Award	2016 Larry Haffner Fellowship from the Parkinson Research Consortium Fellowship Award	This study is funded with 2016 Larry Haffner Fellowship from the Parkinson Research Consortium Fellowship Award (http://www.ohri.ca/prc/research.asp). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; de Hemptinne C, 2015, NAT NEUROSCI, V18, P779, DOI 10.1038/nn.3997; de Hemptinne C, 2013, P NATL ACAD SCI USA, V110, P4780, DOI 10.1073/pnas.1214546110; Dellavale D, 2013, C ICT RES NETH, V1, P68; Dupre la Tour T, 2017, BIORXIV, P1, DOI [10.1101/159731, DOI 10.1101/159731]; Hammond C, 2007, TRENDS NEUROSCI, V30, P357, DOI 10.1016/j.tins.2007.05.004; Khanna P, 2017, IEEE T NEUR SYS REH, V25, P1715, DOI 10.1109/TNSRE.2016.2597243; Kringelbach ML, 2007, NAT REV NEUROSCI, V8, P623, DOI 10.1038/nrn2196; Little S, 2013, ANN NEUROL, V74, P449, DOI 10.1002/ana.23951; Ozkurt TE, 2011, J NEUROSCI METH, V201, P438, DOI 10.1016/j.jneumeth.2011.08.014; Penny WD, 2008, J NEUROSCI METH, V174, P50, DOI 10.1016/j.jneumeth.2008.06.035; Pittman-Polletta B, 2014, J NEUROSCI METH, V226, P15, DOI 10.1016/j.jneumeth.2014.01.006; Rajpurohit V, 2015, CLIN NEUROPHYSIOL, V126, P975, DOI 10.1016/j.clinph.2014.05.039; Rosin B, 2011, NEURON, V72, P370, DOI 10.1016/j.neuron.2011.08.023; Telkes Ilknur, 2016, Front Neurosci, V10, P198, DOI 10.3389/fnins.2016.00198; Tort ABL, 2010, J NEUROPHYSIOL, V104, P1195, DOI 10.1152/jn.00106.2010; van Wijk BCM, 2015, J NEUROSCI METH, V243, P94, DOI 10.1016/j.jneumeth.2015.01.032; van Wijk BCM, 2016, CLIN NEUROPHYSIOL, V127, P2010, DOI 10.1016/j.clinph.2016.01.015; Verhagen R, 2015, J NEUROSCI METH, V253, P116, DOI 10.1016/j.jneumeth.2015.06.006; Voytek B, 2013, NEUROIMAGE, V64, P416, DOI 10.1016/j.neuroimage.2012.09.023; Wong S, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/2/026006; Wong S, 2012, STEREOT FUNCT NEUROS, V90, P51, DOI 10.1159/000334494; Yang AI, 2014, J NEUROSCI, V34, P12816, DOI 10.1523/JNEUROSCI.1895-14.2014	23	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2018	13	9							e0204260	10.1371/journal.pone.0204260	http://dx.doi.org/10.1371/journal.pone.0204260			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3OT	30265705	Green Submitted, gold, Green Published			2022-12-26	WOS:000446005500023
J	Casquero-Veiga, M; Garcia-Garcia, D; Pascau, J; Desco, M; Soto-Montenegro, ML				Casquero-Veiga, Marta; Garcia-Garcia, David; Pascau, Javier; Desco, Manuel; Soto-Montenegro, Maria Luisa			Stimulating the nucleus accumbens in obesity: A positron emission tomography study after deep brain stimulation in a rodent model	PLOS ONE			English	Article							MESOLIMBIC DOPAMINE SYSTEM; REWARD CIRCUITRY; NETWORK ACTIVITY; ZUCKER RATS; LEPTIN; COMPLICATIONS; ACTIVATION; SURGERY; DISEASE; CORTEX	Purpose The nucleus accumbens (NAcc) has been suggested as a possible target for deep brain stimulation (DBS) in the treatment of obesity. Our hypothesis was that NAcc-DBS would modulate brain regions related to reward and food intake regulation, consequently reducing the food intake and, finally, the weight gain. Therefore, we examined changes in brain glucose metabolism, weight gain and food intake after NAcc-DBS in a rat model of obesity. Procedures Electrodes were bilaterally implanted in 2 groups of obese Zucker rats targeting the NAcc. One group received stimulation one hour daily during 15 days, while the other remained as control. Weight and daily consumption of food and water were everyday registered the days of stimulation, and twice per week during the following month. Positron emission tomography (PET) studies with 2-deoxy-2-[F-18] fluoro-D-glucose (FDG) were performed 1 day after the end of DBS. PET data was assessed by statistical parametric mapping (SPM12) software and region of interest (ROI) analyses. Results NAcc-DBS lead to increased metabolism in the cingulate-retrosplenial-parietal association cortices, and decreased metabolism in the NAcc, thalamic and pretectal nuclei. Furthermore, ROIs analyses confirmed these results by showing a significant striatal and thalamic hypometabolism, and a cortical hypermetabolic region. However, NAcc-DBS did not induce a decrease in either weight gain or food intake. Conclusions NAcc-DBS led to changes in the metabolism of regions associated with cognitive and reward systems, whose impairment has been described in obesity.	[Casquero-Veiga, Marta; Pascau, Javier; Desco, Manuel; Soto-Montenegro, Maria Luisa] Inst Invest Sanitaria Gregorio Maranon IiSGM, Madrid, Spain; [Garcia-Garcia, David] Univ Isabel I, Fac Ciencia & Tecnol, Burgos, Spain; [Pascau, Javier; Desco, Manuel; Soto-Montenegro, Maria Luisa] CIBER Salud Mental CIBERSAM, Madrid, Spain; [Pascau, Javier; Desco, Manuel] Univ Carlos III Madrid, Dept Bioingn & Ingn Aeroespacial, Leganes, Spain; [Desco, Manuel] CNIC, Madrid, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Universidad Carlos III de Madrid; Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Desco, M (corresponding author), Inst Invest Sanitaria Gregorio Maranon IiSGM, Madrid, Spain.; Desco, M (corresponding author), CIBER Salud Mental CIBERSAM, Madrid, Spain.; Desco, M (corresponding author), Univ Carlos III Madrid, Dept Bioingn & Ingn Aeroespacial, Leganes, Spain.; Desco, M (corresponding author), CNIC, Madrid, Spain.	desco@hggm.es	Pascau, Javier/B-5734-2013; Casquero-Veiga, Marta/T-6576-2019; Casquero-Veiga, Marta/ABC-5114-2021; Garcia-Garcia, David/I-2105-2015; Soto-Montenegro, María Luisa/AFS-1781-2022; Desco, Manuel/AAD-7137-2019	Pascau, Javier/0000-0003-1484-731X; Casquero-Veiga, Marta/0000-0003-0859-9495; Casquero-Veiga, Marta/0000-0003-0859-9495; Garcia-Garcia, David/0000-0001-5224-3280; Desco, Manuel/0000-0003-0989-3231; Soto Montenegro, Maria Luisa/0000-0003-4350-4789	Ministry of Economy and Competitiveness ISCIII grants [PI14/00860, CPII14/00005]; Ministry of Economy, Industry and Competitiveness [PI17/01766]; ERDF (FEDER) Funds from the European Commission "A way of making Europe"; Fundacion Mapfre; Fundacion Alicia Koplowitz [FAK2016/01]; Delegacion de Gobierno para el Plan Nacional sobre Drogas [PNSD 2017/085]; Comunidad de Madrid [BRADE-CM S2013/ICE-2958]; Fundacion Tatiana Perez de Guzman el Bueno	Ministry of Economy and Competitiveness ISCIII grants; Ministry of Economy, Industry and Competitiveness; ERDF (FEDER) Funds from the European Commission "A way of making Europe"; Fundacion Mapfre; Fundacion Alicia Koplowitz; Delegacion de Gobierno para el Plan Nacional sobre Drogas; Comunidad de Madrid(Comunidad de Madrid); Fundacion Tatiana Perez de Guzman el Bueno	This research was supported by the Ministry of Economy and Competitiveness ISCIII grants (PI14/00860, CPII14/00005), Ministry of Economy, Industry and Competitiveness (PI17/01766), cofunded by ERDF (FEDER) Funds from the European Commission "A way of making Europe", Fundacion Mapfre, Fundacion Alicia Koplowitz (FAK2016/01), 'Delegacion de Gobierno para el Plan Nacional sobre Drogas' (PNSD 2017/085), Comunidad de Madrid (BRADE-CM S2013/ICE-2958) and Fundacion Tatiana Perez de Guzman el Bueno. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abella M, 2012, COMPUT METH PROG BIO, V107, P218, DOI 10.1016/j.cmpb.2011.06.008; Albasser MM, 2007, EUR J NEUROSCI, V26, P1254, DOI 10.1111/j.1460-9568.2007.05753.x; Albaugh DL, 2016, SCI REP-UK, V6, DOI 10.1038/srep31613; Arora S, 2006, NEUROPEPTIDES, V40, P375, DOI 10.1016/j.npep.2006.07.001; Bastien M, 2014, PROG CARDIOVASC DIS, V56, P369, DOI 10.1016/j.pcad.2013.10.016; Betry C, 2018, ASIA OCEANIA ASS STU, P2, DOI [10.1016/j.orcp.2018.02.004, DOI 10.1016/J.ORCP.2018.02.004]; Bewernick BH, 2010, BIOL PSYCHIAT, V67, P110, DOI 10.1016/j.biopsych.2009.09.013; Casquere-Veiga M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168689; Chiken S, 2016, NEUROSCIENTIST, V22, P313, DOI 10.1177/1073858415581986; Chiken S, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00033; Cumming P, 2015, MOL IMAGING BIOL, V17, P521, DOI 10.1007/s11307-014-0811-7; Dang LC, 2016, NEUROIMAGE, V138, P176, DOI 10.1016/j.neuroimage.2016.05.044; Doucette WT, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.197; Dougherty DD, 2018, PSYCHIAT CLIN N AM, V41, P385, DOI 10.1016/j.psc.2018.04.004; Favilla CG, 2012, BRAIN, V135, P1455, DOI 10.1093/brain/aws026; Fulton S, 2000, SCIENCE, V287, P125, DOI 10.1126/science.287.5450.125; Geiger BM, 2009, NEUROSCIENCE, V159, P1193, DOI 10.1016/j.neuroscience.2009.02.007; Green E, 2011, BRAIN RES, V1386, P109, DOI 10.1016/j.brainres.2011.02.071; Grillo CA, 2011, PHYSIOL BEHAV, V105, P138, DOI 10.1016/j.physbeh.2011.02.028; Hadar R, 2015, SCHIZOPHR RES, V166, P238, DOI 10.1016/j.schres.2015.05.010; Halpern CH, 2008, J NEUROSURG, V109, P625, DOI 10.3171/JNS/2008/109/10/0625; Halpern CH, 2013, J NEUROSCI, V33, P7122, DOI 10.1523/JNEUROSCI.3237-12.2013; Hamani C, 2008, ANN NEUROL, V63, P119, DOI 10.1002/ana.21295; Hamani C, 2014, NEUROBIOL DIS, V71, P205, DOI 10.1016/j.nbd.2014.08.007; Harat M, 2016, NEUROL NEUROCHIR POL, V50, P207, DOI 10.1016/j.pjnns.2016.01.014; Heldmann M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036572; Jebb S., 2004, WOMENS HLTH MED, V1, P38, DOI DOI 10.1383/WOHM.1.1.38.55418; Klein J, 2011, J PSYCHIATR RES, V45, P927, DOI 10.1016/j.jpsychires.2010.12.008; Knight EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056640; Kuhn J, 2009, EUR ARCH PSY CLIN N, V259, P135, DOI 10.1007/s00406-009-0055-8; Kushner RF, 2014, PROG CARDIOVASC DIS, V56, P465, DOI 10.1016/j.pcad.2013.09.005; Laxton Adrian W, 2013, Handb Clin Neurol, V116, P307, DOI 10.1016/B978-0-444-53497-2.00025-5; Leinninger GM, 2009, CELL METAB, V10, P89, DOI 10.1016/j.cmet.2009.06.011; Soto-Montenegro ML, 2014, MOL IMAGING BIOL, V16, P830, DOI 10.1007/s11307-014-0753-0; Mantione M, 2010, NEUROSURGERY, V66, P218, DOI 10.1227/01.NEU.0000360570.40339.64; McGovern RA, 2013, J NEUROSURG, V119, P1546, DOI 10.3171/2013.8.JNS13475; McIntyre CC, 2016, J NEUROCHEM, V139, P338, DOI 10.1111/jnc.13649; Mcnab F, 2008, NAT NEUROSCI, V11, P103, DOI 10.1038/nn2024; Miller AMP, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00586; Mtui E, 2011, CLIN NEUROANATOMY NE, P343; Mueller K, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.121; Neto S, 2016, J NEURAL TRANSM, V123, P1247, DOI 10.1007/s00702-016-1591-9; Pascau J, 2009, MOL IMAGING BIOL, V11, P107, DOI 10.1007/s11307-008-0166-z; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Perry ML, 2010, J NEUROCHEM, V114, P666, DOI 10.1111/j.1471-4159.2010.06757.x; Rada P, 2010, PHYSIOL BEHAV, V101, P394, DOI 10.1016/j.physbeh.2010.07.005; Cruz PMR, 2016, MOV DISORD CLIN PRAC, V3, P567, DOI 10.1002/mdc3.12337; Rummel J, 2016, J PSYCHIATR RES, V81, P36, DOI 10.1016/j.jpsychires.2016.06.016; Sankar Tejas, 2012, Surg Neurol Int, V3, pS26, DOI 10.4103/2152-7806.91607; Schlaepfer TE, 2008, NEUROPSYCHOPHARMACOL, V33, P368, DOI 10.1038/sj.npp.1301408; Shah RS, 2010, J CLIN NEUROL, V6, P167, DOI 10.3988/jcn.2010.6.4.167; Shinohara RT, 2014, NEUROIMAGE-CLIN, V6, P9, DOI 10.1016/j.nicl.2014.08.008; Stefater MA, 2013, MOL ASPECTS MED, V34, P84, DOI 10.1016/j.mam.2012.10.006; Stice E, 2011, J NEUROSCI, V31, P4360, DOI 10.1523/JNEUROSCI.6604-10.2011; Stoeckel LE, 2008, NEUROIMAGE, V41, P636, DOI 10.1016/j.neuroimage.2008.02.031; Taghva A, 2012, NEUROSURGERY, V71, P224, DOI 10.1227/NEU.0b013e31825972ab; Taylor JR, 2013, CLIN THER, V35, pA3, DOI 10.1016/j.clinthera.2012.12.012; Tomycz N, 2015, NEUROSURG FOCUS, V38, P1, DOI [10.3171/2015.3.FOCUS1542.Disclosure, DOI 10.3171/2015.3.FOCUS1542.DISCLOSURE]; van der Plasse G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033455; van Zessen R, 2012, P NUTR SOC, V71, P435, DOI 10.1017/S0029665112000614; Vann SD, 2009, NAT REV NEUROSCI, V10, P792, DOI 10.1038/nrn2733; Verger A, 2018, NEUROIMAGE-CLIN, V17, P491, DOI 10.1016/j.nicl.2017.11.005; Voges J, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.081232; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6; Winocur G, 2005, BEHAV NEUROSCI, V119, P1389, DOI 10.1037/0735-7044.119.5.1389; World Health Organization, 2018, OB OV; Zhang C, 2015, NEUROSCI LETT, V589, P1, DOI 10.1016/j.neulet.2015.01.019; Zhang HW, 2013, CLIN NUCL MED, V38, P943, DOI 10.1097/RLU.0000000000000261; Zrinzo L, 2012, J NEUROSURG, V116, P84, DOI 10.3171/2011.8.JNS101407	69	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204740	10.1371/journal.pone.0204740	http://dx.doi.org/10.1371/journal.pone.0204740			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30261068	Green Published, gold, Green Submitted			2022-12-26	WOS:000445907400100
J	Guo, L; Smith, JA; Abelson, M; Vlasova-St Louis, I; Schiff, LA; Bohjanen, PR				Guo, Liang; Smith, Jennifer A.; Abelson, Michelle; Vlasova-St Louis, Irina; Schiff, Leslie A.; Bohjanen, Paul R.			Reovirus infection induces stabilization and up-regulation of cellular transcripts that encode regulators of TGF-beta signaling	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; MESSENGER-RNA DECAY; KAPPA-B ACTIVATION; EPITHELIAL-CELLS; MAMMALIAN REOVIRUS; GENE-EXPRESSION; PROTEIN; TGF-BETA-1; VIRUS; APOPTOSIS	Reovirus infection induces dramatic changes in host mRNA expression. We utilized oligonucleotide microarrays to measure cellular mRNA decay rates in mock-or reovirus-infected murine L929 cells to determine if changes in host mRNA expression are a consequence of reovirus-induced alterations in cellular mRNA stability. Our analysis detected a subset of cellular transcripts that were coordinately induced and stabilized following infection with the reovirus isolates c87 and c8, strains that led to an inhibition of cellular translation, but not following infection with Dearing, a reovirus isolate that did not negatively impact cellular translation. The induced and stabilized transcripts encode multiple regulators of TGF-beta signaling, including components of the Smad signaling network and apoptosis/survival pathways. The coordinate induction, through mRNA stabilization, of multiple genes that encode components of TGF-beta signaling pathways represents a novel mechanism by which the host cell responds to reovirus infection.	[Guo, Liang; Vlasova-St Louis, Irina; Bohjanen, Paul R.] Univ Minnesota, Dept Med, Program Infect & Immun, Div Infect Dis & Int Med, Box 736 UMHC, Minneapolis, MN 55455 USA; [Guo, Liang; Bohjanen, Paul R.] Univ Minnesota, Inst Mol Virol, Training Program, Grad Program Comparat & Mol Biosci, Minneapolis, MN 55455 USA; [Smith, Jennifer A.; Abelson, Michelle; Vlasova-St Louis, Irina; Schiff, Leslie A.; Bohjanen, Paul R.] Univ Minnesota, Dept Microbiol & Immunol, Minneapolis, MN 55455 USA; [Smith, Jennifer A.] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA USA; [Smith, Jennifer A.] Harvard Med Sch, ICCB Longwood Screening Facil, Boston, MA USA; [Abelson, Michelle] LabCorp, Dept Immunoassay Allergy & Special Coagulat, Burlington, NC USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Bohjanen, PR (corresponding author), Univ Minnesota, Dept Med, Program Infect & Immun, Div Infect Dis & Int Med, Box 736 UMHC, Minneapolis, MN 55455 USA.; Bohjanen, PR (corresponding author), Univ Minnesota, Inst Mol Virol, Training Program, Grad Program Comparat & Mol Biosci, Minneapolis, MN 55455 USA.; Bohjanen, PR (corresponding author), Univ Minnesota, Dept Microbiol & Immunol, Minneapolis, MN 55455 USA.	Bohja001@umn.edu	Louis, Vlasova-St./ABC-1933-2020	Smith, Jennifer/0000-0002-8354-2272; Vlasova-St. Louis, Irina/0000-0003-0795-4723	NIH [AI057484, AI072068, AI045990, AI007421]; University of Minnesota Academic Health Center; University of Minnesota Medical School under the Research Resources Program of the Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI083196, R01AI072068, R56AI057484] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Minnesota Academic Health Center; University of Minnesota Medical School under the Research Resources Program of the Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants AI057484 (PRB), AI072068 (PRB), AI045990 (LAS), and AI007421 (MA), a seed grant from the University of Minnesota Academic Health Center, and an award to the University of Minnesota Medical School under the Research Resources Program of the Howard Hughes Medical Institute.	Abend JR, 2008, VIROLOGY, V378, P6, DOI 10.1016/j.virol.2008.05.009; Arnulf B, 2002, BLOOD, V100, P4129, DOI 10.1182/blood-2001-12-0372; Baresova P, 2013, J VIROL, V87, P9398, DOI 10.1128/JVI.03315-12; Beckham JD, 2009, J VIROL, V83, P5035, DOI 10.1128/JVI.02433-08; Bhuvanagiri M, 2014, EMBO MOL MED, V6, P1593, DOI 10.15252/emmm.201404461; Billen LP, 2008, ONCOGENE, V27, pS93, DOI 10.1038/onc.2009.47; Chang L, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0286-2; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; DeBiasi RL, 2003, J VIROL, V77, P8934, DOI 10.1128/JVI.77.16.8934-8947.2003; Denney L, 2017, MUCOSAL IMMUNOL; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dosanjh A, 2006, ACTA BIOCH BIOPH SIN, V38, P911, DOI 10.1111/j.1745-7270.2006.00234.x; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Ferrari G, 2006, P NATL ACAD SCI USA, V103, P17260, DOI 10.1073/pnas.0605556103; Ferrari G, 2012, MOL CANCER RES, V10, P605, DOI 10.1158/1541-7786.MCR-11-0507; Freudlsperger C, 2013, ONCOGENE, V32, P1549, DOI 10.1038/onc.2012.171; FURLONG DB, 1988, J VIROL, V62, P246, DOI 10.1128/JVI.62.1.246-256.1988; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Gibbs JD, 2009, J VIROL, V83, P12424, DOI 10.1128/JVI.00806-09; Gong Jun, 2016, World J Methodol, V6, P25, DOI 10.5662/wjm.v6.i1.25; Guo BC, 2007, J BIOL CHEM, V282, P11817, DOI 10.1074/jbc.M700017200; Guo L, 2018, FUTURE VIROL, V13, P211, DOI 10.2217/fvl-2017-0106; Guo L, 2018, NUCLEIC ACIDS RES, V46, P2537, DOI 10.1093/nar/gky061; Gupta A, 2006, NATURE, V442, P82, DOI 10.1038/nature04836; Heldin CH, 2012, CELL TISSUE RES, V347, P21, DOI 10.1007/s00441-011-1190-x; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Holm GH, 2010, J VIROL, V84, P6900, DOI 10.1128/JVI.01742-09; Ibarrola N, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-2; Inoue Y, 2008, CANCER SCI, V99, P2107, DOI 10.1111/j.1349-7006.2008.00925.x; Itoh S, 2000, EUR J BIOCHEM, V267, P6954, DOI 10.1046/j.1432-1327.2000.01828.x; JACOBS BL, 1991, J VIROL, V65, P5102, DOI 10.1128/JVI.65.9.5102-5104.1991; Jiang YJ, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2991-2; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; KEDL R, 1995, J VIROL, V69, P552, DOI 10.1128/JVI.69.1.552-559.1995; Kim M, 2007, J MICROBIOL, V45, P187; Knowlton JJ, 2012, J VIROL, V86, P1650, DOI 10.1128/JVI.05924-11; Kossmann T, 2003, J INFECT DIS, V187, P534, DOI 10.1086/373995; Kubiczkova L, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-183; Kucich U, 2002, AM J RESP CELL MOL, V26, P183, DOI 10.1165/ajrcmb.26.2.4666; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Li N, 2015, P NATL ACAD SCI USA, V112, P238, DOI 10.1073/pnas.1414422112; Liu F, 2006, CYTOKINE GROWTH F R, V17, P9, DOI 10.1016/j.cytogfr.2005.09.010; Lou CH, 2016, STEM CELL REP, V6, P844, DOI 10.1016/j.stemcr.2016.05.008; Malizia AP, 2008, AM J PHYSIOL-LUNG C, V295, pL451, DOI 10.1152/ajplung.00376.2007; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Mendez-Samperio P, 2000, J INTERF CYTOK RES, V20, P273, DOI 10.1089/107999000312405; Meyers JM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006171; Moser CV, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0319-3; Moustakas A, 2001, J CELL SCI, V114, P4359; Nelson JO, 2016, ELIFE, V5, DOI 10.7554/eLife.12876; Nie YH, 2008, MOL VIS, V14, P1631; O'Donnell SM, 2006, J VIROL, V80, P1077, DOI 10.1128/JVI.80.3.1077-1086.2006; Offermann MK, 2007, CURR TOP MICROBIOL, V312, P185; Presnyak V, 2015, CELL, V160, P1111, DOI 10.1016/j.cell.2015.02.029; Qin QS, 2009, J VIROL, V83, P11090, DOI 10.1128/JVI.01239-09; Raghavan A, 2002, NUCLEIC ACIDS RES, V30, P5529, DOI 10.1093/nar/gkf682; Rahimi RA, 2007, J CELL BIOCHEM, V102, P593, DOI 10.1002/jcb.21501; Rehwinkel A, 2005, RNA, V11, P1530, DOI 10.1261/rna.2160905; Roman A, 2013, VIROLOGY, V445, P138, DOI 10.1016/j.virol.2013.04.013; ROSEN L, 1960, AM J HYG, V71, P258, DOI 10.1093/oxfordjournals.aje.a120109; Rowan AG, 2008, J IMMUNOL, V181, P4485, DOI 10.4049/jimmunol.181.7.4485; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Sanchez-Capelo A, 2005, CYTOKINE GROWTH F R, V16, P15, DOI 10.1016/j.cytogfr.2004.11.002; Schiff LA, 2007, FIELDS VIROLOGY, P1854; Schmechel S, 1997, VIROLOGY, V232, P62, DOI 10.1006/viro.1997.8531; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Schuman J, 2009, BLOOD, V113, P4566, DOI 10.1182/blood-2008-08-176057; SHARPE AH, 1982, VIROLOGY, V122, P381, DOI 10.1016/0042-6822(82)90237-9; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Smith JA, 2006, J VIROL, V80, P2019, DOI 10.1128/JVI.80.4.2019-2033.2006; Smith JA, 2005, J VIROL, V79, P2240, DOI 10.1128/JVI.79.4.2240-2250.2005; Stanifer ML, 2016, CELL MICROBIOL, V18, P1831, DOI 10.1111/cmi.12626; Syed V, 2016, J CELL BIOCHEM, V117, P1279, DOI 10.1002/jcb.25496; Takeshita T, 1997, IMMUNITY, V6, P449, DOI 10.1016/S1074-7613(00)80288-5; Tyler KL, 2010, J NEUROVIROL, V16, P56, DOI 10.3109/13550280903586394; Umbach JL, 2008, NATURE, V454, P780, DOI 10.1038/nature07103; Varga J, 2008, CURR OPIN RHEUMATOL, V20, P720, DOI 10.1097/BOR.0b013e32830e48e8; Vlasova IA, 2005, GENOMICS, V86, P159, DOI 10.1016/j.ygeno.2005.04.013; Wang DH, 2007, P NATL ACAD SCI USA, V104, P145, DOI 10.1073/pnas.0601894104; Weng T, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.443; Wu XY, 2012, GENE, V500, P10, DOI 10.1016/j.gene.2012.03.021; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Yan XH, 2009, ACTA BIOCH BIOPH SIN, V41, P263, DOI 10.1093/abbs/gmp018; Zhang Y.E., 2017, COLD SPRING HARB PER, V9; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	88	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204622	10.1371/journal.pone.0204622	http://dx.doi.org/10.1371/journal.pone.0204622			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30261045	Green Published, Green Submitted, gold			2022-12-26	WOS:000445907400081
J	Guden, RM; Vafeiadou, AM; De Meester, N; Derycke, S; Moens, T				Mae Guden, Rodgee; Vafeiadou, Anna-Maria; De Meester, Nele; Derycke, Sofie; Moens, Tom			Living apart-together: Microhabitat differentiation of cryptic nematode species in a saltmarsh habitat	PLOS ONE			English	Article							MARINA COMPLEX NEMATODA; PELLIODITIS-MARINA; ESTUARINE ENVIRONMENT; COMMUNITY STRUCTURE; GENETIC-STRUCTURE; COEXISTENCE; DIVERSITY; SALINITY; ECOLOGY; TEMPERATURE	Coexistence of highly similar species is at odds with ecological theory of competition; coexistence, then, requires stabilizing mechanisms such as differences in ecological niche. In the bacterivore nematode Litoditis marina species complex, which occurs associated with macro-algae, four cryptic lineages (Pm I-IV) co-occur in the field along the south-western coast and estuaries of The Netherlands. Here we investigate the temporal and/or spatial niche differentiation in their natural environment using a qPCR-based detection and relative quantification method. We collected different algal species (i.e. two Fucus species and Ulva sp.) and separated algal structures (i.e. receptacula, thalli, non-fertile tips and bladders) at different sampling months and times (i.e. twice per sampling month), to examine differences in microhabitat use between coexisting L. marina species. Results demonstrate that the cryptic species composition varied among different algal species and algal structures, which was also subject to temporal shifts. Pm I dominated on Fucus spp., Pm II showed dominance on Ulva sp., while Pm III overall had the lowest frequencies. Microhabitat partitioning was most pronounced between the two cryptic species which had similar microbiomes (Pm I and Pm II), and less so between the two species which had significantly different microbiomes (Pm I and Pm III), suggesting that species which share the same microhabitats may avoid competition through resource partitioning. The interplay of microhabitat differentiation and temporal dynamics among the cryptic species of L. marina implies that there is a complex interaction between biotic components and abiotic factors which contributes to their coexistence in the field.	[Mae Guden, Rodgee; Vafeiadou, Anna-Maria; De Meester, Nele; Derycke, Sofie; Moens, Tom] Univ Ghent, Marine Biol Lab, Ghent, Belgium; [Mae Guden, Rodgee] Mindanao State Univ, Iligan Inst Technol, Iligan, Philippines; [Vafeiadou, Anna-Maria] Aristotle Univ Thessaloniki, Biol Dept, Thessaloniki, Greece; [Derycke, Sofie] Inst Agr & Fisheries Res, Aquat Environm & Qual, Oostende, Belgium	Ghent University; Mindanao State University System; Mindanao State University-IIT; Aristotle University of Thessaloniki; Institute For Agricultural & Fisheries Research	Guden, RM (corresponding author), Univ Ghent, Marine Biol Lab, Ghent, Belgium.; Guden, RM (corresponding author), Mindanao State Univ, Iligan Inst Technol, Iligan, Philippines.	rodgeemae.guden@ugent.be	Moens, Tom/AAB-8701-2019; Vafeiadou, Anna-Maria/F-4216-2017	Vafeiadou, Anna-Maria/0000-0003-1858-027X; Guden, Rodgee Mae/0000-0003-4526-5160; Moens, Tom/0000-0001-6544-9210	Flemish Interuniversity Council VLIR; EMBRC Belgium FWO project [GOH3817N]; Flemish Science Fund FWO [01GA1911W]	Flemish Interuniversity Council VLIR; EMBRC Belgium FWO project; Flemish Science Fund FWO	The first author acknowledged a scholarship from the Flemish Interuniversity Council VLIR during the period of this study. This publication benefitted from infrastructure and knowhow provided in the framework of EMBRC Belgium FWO project GOH3817N. Additional financial support was granted by the Flemish Science Fund FWO through project 01GA1911W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the abstract.; The first author acknowledged a scholarship from the Flemish Interuniversity Council VLIR during the period of this study. Annelien Rigaux is gratefully acknowledged for her help with the qPCR assay.	Amarasekare P, 2004, AM NAT, V164, P310, DOI 10.1086/422858; Andrassy I., 1983, TAXONOMIC REV SUBORD; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Bastian H. C., 1865, Transactions of the Linnean Society, Vvol. xxv, P73; Bell G, 2001, SCIENCE, V293, P2413, DOI 10.1126/science.293.5539.2413; Bhadury P, 2008, MAR BIOL, V154, P509, DOI 10.1007/s00227-008-0945-8; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bonaglia S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6133; Bongers T, 1999, TRENDS ECOL EVOL, V14, P224, DOI 10.1016/S0169-5347(98)01583-3; Boyd SE, 2000, ESTUAR COAST SHELF S, V51, P805, DOI 10.1006/ecss.2000.0722; Ceballos G, 2009, P NATL ACAD SCI USA, V106, P3841, DOI 10.1073/pnas.0812419106; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Ciros-Perez J, 2001, LIMNOL OCEANOGR, V46, P1511, DOI 10.4319/lo.2001.46.6.1511; Coppejans E, 1998, SCRIPTA BOT BELGICA, V17; Crummett LT, 2007, MAR BIOL, V152, P1, DOI 10.1007/s00227-007-0621-4; Darwin C, 1859, ORIGIN SPECIES MEANS; De Meester N, 2016, OECOLOGIA, V182, P559, DOI 10.1007/s00442-016-3677-3; De Meester N, 2015, J EXP MAR BIOL ECOL, V472, P54, DOI 10.1016/j.jembe.2015.07.002; De Meester N, 2011, MAR BIOL, V158, P2717, DOI 10.1007/s00227-011-1769-5; De Meester N, 2016, THESIS; De Meester N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131625; De Meester N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042674; De Mesel I, 2004, ENVIRON MICROBIOL, V6, P733, DOI 10.1111/j.1462-2920.2004.00610.x; De Oliveira DAS, 2012, ZOOL J LINN SOC-LOND, V164, P18, DOI 10.1111/j.1096-3642.2011.00758.x; Derycke S, 2008, MOL ECOL, V17, P3306, DOI 10.1111/j.1365-294X.2008.03846.x; Derycke S, 2007, LIMNOL OCEANOGR, V52, P992, DOI 10.4319/lo.2007.52.3.0992; Derycke S, 2006, GENETICA, V128, P307, DOI 10.1007/s10709-006-6944-0; Derycke S, 2005, MAR ECOL PROG SER, V300, P91, DOI 10.3354/meps300091; Derycke S, 2016, MOL ECOL, V25, P2093, DOI 10.1111/mec.13597; Derycke S, 2012, MOL ECOL RESOUR, V12, P607, DOI 10.1111/j.1755-0998.2012.03128.x; Fonseca G, 2008, BIOL J LINN SOC, V94, P737, DOI 10.1111/j.1095-8312.2008.01015.x; Friedrich M.W., 2012, SEAWEED BIOL, P189, DOI [10.1007/978-3-642-28451-9_10, DOI 10.1007/978-3-642-28451-9_10]; Gause F., 1934, YALE J BIOL MED, V7, P609; Goecke F, 2012, GAYANA BOT, V69, P376, DOI 10.4067/S0717-66432012000200016; Grosberg R, 2001, MARINE COMMUNITY ECOLOGY, P61; Hay ME, 2009, ANNU REV MAR SCI, V1, P193, DOI 10.1146/annurev.marine.010908.163708; Hubbell SP, 2006, ECOLOGY, V87, P1387, DOI 10.1890/0012-9658(2006)87[1387:NTATEO]2.0.CO;2; Kiirikki M, 1996, EUR J PHYCOL, V31, P61, DOI 10.1080/09670269600651201; Knowlton N, 2000, HYDROBIOLOGIA, V420, P73, DOI 10.1023/A:1003933603879; Lachnit T, 2011, ENVIRON MICROBIOL, V13, P655, DOI 10.1111/j.1462-2920.2010.02371.x; Lachnit T, 2009, AQUAT BIOL, V5, P181, DOI 10.3354/ab00149; Lambshead PJD, 2003, J BIOGEOGR, V30, P475, DOI 10.1046/j.1365-2699.2003.00843.x; Lapesa S, 2002, FRESHWATER BIOL, V47, P1685, DOI 10.1046/j.1365-2427.2002.00926.x; Leibold MA, 2006, ECOLOGY, V87, P1399, DOI 10.1890/0012-9658(2006)87[1399:COTNAN]2.0.CO;2; Linke-Gamenick I, 2000, MAR ECOL PROG SER, V203, P191, DOI 10.3354/meps203191; Liu M, 2011, WORLD J MICROB BIOT, V27, P1703, DOI 10.1007/s11274-010-0627-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marko PB, 1998, EVOLUTION, V52, P757, DOI 10.1111/j.1558-5646.1998.tb03700.x; McCairns RJS, 2008, MOL ECOL, V17, P3901, DOI 10.1111/j.1365-294X.2008.03884.x; McPeek MA, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P355; Michalska K, 2010, EXP APPL ACAROL, V51, P31, DOI 10.1007/s10493-009-9319-2; Moens T, 2000, J EXP MAR BIOL ECOL, V243, P137, DOI 10.1016/S0022-0981(99)00114-8; Moens T, 1997, J MAR BIOL ASSOC UK, V77, P211, DOI 10.1017/S0025315400033889; Moens T, 2000, J EXP MAR BIOL ECOL, V243, P115, DOI 10.1016/S0022-0981(99)00113-6; Monteiro LC, 2018, J EXP MAR BIOL ECOL, V502, P203, DOI 10.1016/j.jembe.2017.05.016; Neher DA, 2001, J NEMATOL, V33, P161; Nicholls B, 2006, BEHAV ECOL SOCIOBIOL, V61, P131, DOI 10.1007/s00265-006-0244-7; Oksanen J, 2022, COMMUNITY ECOLOGY PA; Pfenninger M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-121; Platt H.M., 1980, Systematics Association Special Volume Series, P729; Quist CW, 2016, APPL SOIL ECOL, V98, P254, DOI 10.1016/j.apsoil.2015.10.022; Rocha-Olivares A, 2001, MOL BIOL EVOL, V18, P1088, DOI 10.1093/oxfordjournals.molbev.a003880; Staufenberger T, 2008, FEMS MICROBIOL ECOL, V64, P65, DOI 10.1111/j.1574-6941.2008.00445.x; Sturzbecher C, 1998, P 4 INT CRUST C AMST, P287; Sudhaus W., 2011, Journal of Nematode Morphology and Systematics, V14, P113; Tujula NA, 2010, ISME J, V4, P301, DOI 10.1038/ismej.2009.107; Vervoort MTW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047555; Violle C, 2011, ECOL LETT, V14, P782, DOI 10.1111/j.1461-0248.2011.01644.x; Wellborn GA, 2004, FRESHWATER BIOL, V49, P1, DOI 10.1046/j.1365-2426.2003.01160.x; Wellborn GA, 2007, OECOLOGIA, V154, P175, DOI 10.1007/s00442-007-0816-x; Westram AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023879; Zhang DY, 2004, ECOL LETT, V7, P165, DOI 10.1111/j.1461-0248.2004.00569.x	72	8	8	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204750	10.1371/journal.pone.0204750	http://dx.doi.org/10.1371/journal.pone.0204750			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30261070	gold, Green Published, Green Submitted			2022-12-26	WOS:000445907400102
J	Martinez-Vernon, AS; Covington, JA; Arasaradnam, RP; Esfahani, S; O'Connell, N; Kyrou, I; Savage, RS				Martinez-Vernon, Andrea S.; Covington, James A.; Arasaradnam, Ramesh P.; Esfahani, Siavash; O'Connell, Nicola; Kyrou, Ioannis; Savage, Richard S.			An improved machine learning pipeline for urinary volatiles disease detection: Diagnosing diabetes	PLOS ONE			English	Article							ELECTRONIC-NOSE; TOOL	Motivation The measurement of disease biomarkers in easily-obtained bodily fluids has opened the door to a new type of non-invasive medical diagnostics. New technologies are being developed and fine-tuned in order to make this possibility a reality. One such technology is Field Asymmetric Ion Mobility Spectrometry (FAIMS), which allows the measurement of volatile organic compounds (VOCs) in biological samples such as urine. These VOCs are known to contain a range of information on the relevant person's metabolism and can in principle be used for disease diagnostic purposes. Key to the effective use of such data are well-developed data processing pipelines, which are necessary to extract the most useful data from the complex underlying biological structure. Results In this study, we present a new data analysis pipeline for FAIMS data, and demonstrate a number of improvements over previously used methods. We evaluate the effect of a series of candidate operational steps during data processing, such as the use of wavelet transforms, principal component analysis (PCA), and classifier ensembles. We also demonstrate the use of FAIMS data in our pipeline to diagnose diabetes on the basis of a simple urine sample using machine learning classifiers. We present results for data generated from a case-control study of 115 urine samples, collected from 72 type II diabetic patients, with 43 healthy volunteers as negative controls. The resulting pipeline combines the steps that resulted in the best classification model performance. These include the use of a two-dimensional discrete wavelet transform, and the Wilcoxon rank-sum test for feature selection. We are able to achieve a best ROC curve AUC of 0.825 (0.747-0.9, 95% CI) for classification of diabetes vs control. We also note that this result is robust to changes in the data pipeline and different analysis runs, with AUC > 0.80 achieved in a range of cases. This is a substantial improvement in performance over previously used data processing methods in this area. Our ability to make strong statements about FAIMS ability to diagnose diabetes is sadly limited, as we found confounding effects from the demographics when including these data in the pipeline. The demographics alone produced a best AUC of 0.87 (0.795-0.94, 95% CI). While the combination of the demographics and FAIMS data resulted in an improvement on the AUC (0.907; 0.848-0.97, 95% CI), it did not prove to be a significant difference. Nevertheless, the pipeline itself shows a significant improvement in performance over more basic methods which have been used with FAIMS data in the past.	[Martinez-Vernon, Andrea S.] Univ Warwick, Syst Biol Ctr, Coventry, W Midlands, England; [Covington, James A.; Esfahani, Siavash] Univ Warwick, Sch Engn, Coventry, W Midlands, England; [Arasaradnam, Ramesh P.; O'Connell, Nicola] Univ Hosp Coventry & Warwickshire, Dept Gastroenterol, Coventry, W Midlands, England; [Arasaradnam, Ramesh P.] Univ Coventry, Sch Appl Biol Sci, Coventry, W Midlands, England; [Arasaradnam, Ramesh P.; Savage, Richard S.] Univ Warwick, Clin Sci Res Inst, Coventry, W Midlands, England; [Kyrou, Ioannis] Univ Warwick, Warwick Med Sch, Coventry, W Midlands, England; [Kyrou, Ioannis] Aston Univ, Aston Med Sch, Aston Med Res Inst, Birmingham, W Midlands, England; [Kyrou, Ioannis] Univ Hosp Coventry & Warwickshire NHS Trust, WISDEM, Coventry, W Midlands, England; [Savage, Richard S.] Univ Warwick, Dept Stat, Coventry, W Midlands, England; [Martinez-Vernon, Andrea S.] Univ Warwick, Synthet Biol Ctr Doctoral Training, Coventry, W Midlands, England	University of Warwick; University of Warwick; University of Warwick; Coventry University; University of Warwick; University of Warwick; Aston University; University of Warwick; University of Warwick; University of Warwick	Savage, RS (corresponding author), Univ Warwick, Clin Sci Res Inst, Coventry, W Midlands, England.; Savage, RS (corresponding author), Univ Warwick, Dept Stat, Coventry, W Midlands, England.	r.s.savage@warwick.ac.uk	Covington, James A./Q-1934-2018	Covington, James A./0000-0003-1307-6488; Martinez-Vernon, Andrea Sofia/0000-0001-9432-6447; Esfahani, Siavash/0000-0003-3939-2286; Arasaradnam, Ramesh/0000-0002-2231-3062	Mexican Science and Technology Council (CONACyT); University of Warwick; MRC	Mexican Science and Technology Council (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); University of Warwick; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	ASMV was supported by Mexican Science and Technology Council (CONACyT) and The University of Warwick. RSS gives thanks for the Biostatistics Fellowship from MRC (https://mrc.ukri.org/).	Arasaradnam RP, 2014, ALIMENT PHARM THER, V39, P780, DOI 10.1111/apt.12657; Arasaradnam RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107312; Arasaradnam RP, 2013, INFLAMM BOWEL DIS, V19, P999, DOI 10.1097/MIB.0b013e3182802b26; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cichosz P, 2011, OPEN ENG, V1, P132, DOI 10.2478/s13531-011-0022-9; Covington JA, 2013, SENSORS-BASEL, V13, P11899, DOI 10.3390/s130911899; Covington JA, 2012, SENSORS-BASEL, V12, P13002, DOI 10.3390/s121013002; Flach P. A., 2011, P 28 INT C INT C MAC, P657; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Fritsch Stefan, 2012, NEURALNET TRAINING N; Hand DJ, 2009, MACH LEARN, V77, P103, DOI 10.1007/s10994-009-5119-5; Hastie T, 2009, ELEMENTS STAT LEARNI, DOI [10.1007/978-0-387-84858-7{_}1, DOI 10.1007/978-0-387-84858-7{}1]; Jolliffe I. T., 2010, PRINCIPAL COMPONENT; Karatzoglou A, 2004, J STAT SOFTW, V11, P1, DOI [10.18637/jss.v011.i09, DOI 10.18637/JSS.V011.I09]; Nason G, 2008, ANAL CHEM, DOI [10.1007/978-0-387-75961-6_2, DOI 10.1007/978-0-387-75961-6_2]; Nason G., 2013, WAVETHRESH WAVELETS; RIEDMILLER M, 1993, 1993 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS, VOLS 1-3, P586, DOI 10.1109/ICNN.1993.298623; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; RUSSELL S., 2013, ARTIFICIAL INTELLIGE; Shvartsburg AA, 2009, ANAL CHEM, V81, P6489, DOI 10.1021/ac900892u; Strauch M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03576; Venables WN, 2002, MODERN APPL STAT S S, DOI [10.1007/978-0-387-21706-2_1, DOI 10.1007/978-0-387-21706-2_1]; Wilson AD, 2011, SENSORS-BASEL, V11, P1105, DOI 10.3390/s110101105; Zhang ZH, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.03.35; ZLATKIS A, 1973, ANAL CHEM, V45, P763, DOI 10.1021/ac60326a036; ZLATKIS A, 1981, CLIN CHEM, V27, P789	26	17	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204425	10.1371/journal.pone.0204425	http://dx.doi.org/10.1371/journal.pone.0204425			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30261000	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000445907400047
J	Petersiel, N; Shresta, S; Tamrakar, R; Koju, R; Madhup, S; Shresta, A; Bedi, TRS; Zmora, N; Paran, Y; Schwartz, E; Neuberger, A				Petersiel, Neta; Shresta, Sudeep; Tamrakar, Rajendra; Koju, Rajendra; Madhup, Surendra; Shresta, Ashish; Bedi, T. R. S.; Zmora, Niv; Paran, Yael; Schwartz, Eli; Neuberger, Ami			The epidemiology of typhoid fever in the Dhulikhel area, Nepal: A prospective cohort study	PLOS ONE			English	Article							ENTERIC FEVER; ISRAELI TRAVELERS; KATHMANDU; RESISTANCE; INFECTION; PARATYPHI; ETIOLOGY; TRENDS	Introduction Typhoid fever (TF) continues to cause considerable morbidity and mortality in Nepal, but only limited epidemiologic data is available about TF outside Kathmandu. Methods As part of an interventional trial, we performed a prospective cohort study of bacteremic TF patients in Dhulikhel Hospital between October 2012 and October 2014. Demographic, epidemiological, clinical, and microbiologic data were recorded. Results 116 bacteremic typhoid patients were included in the study. Most were young, healthy, adults (mean age 27.9 +/- 12 years), 41.4% of whom were female. More than 70% of patients were employed in non-manual services or were university students. Salmonella Typhi accounted for 64/115 (55.7%) of all isolates, while Salmonella Paratyphi accounted for 51/115 (44.3%), of which 42 were Paratyphi A and 9 Paratyphi B. A significant proportion of TF cases occurred also during the dry season (48/116, 41.6%). The clinical presentation of Salmonella Typhi and Paratyphi infections was similar, except for a greater proportion of arthralgia in patients with Salmonella Typhi. Most Salmonella Typhi and Paratyphi isolates were resistant to nalidixic acid and susceptible to older antibiotics. One Salmonella Paratyphi isolate was resistant to ceftriaxone. Conclusions TF remains common in the Dhulikhel area, even among those with a high level of education. Public health measures aimed at reducing the incidence of TF in the Dhulikhel area are warranted. The relative burden of TF caused by Salmonella Paratyphi is rising; a vaccine with activity against Salmonella Paratyphi is needed. Since Salmonella Paratyphi B was more prevalent in this cohort than in large cohorts of patients from Kathmandu, it is likely that there are significant regional variations in the epidemiology of TF outside Kathmandu.	[Petersiel, Neta; Neuberger, Ami] Rambam Med Ctr, Unit Infect Dis Trop Dis & Travel Med, Internal Med B, Haifa, Israel; [Shresta, Sudeep; Tamrakar, Rajendra; Koju, Rajendra; Madhup, Surendra; Shresta, Ashish; Bedi, T. R. S.] Kathmandu Univ Hosp, Dhulikhel Hosp, Dhulikhel, Nepal; [Zmora, Niv; Paran, Yael] Tel Aviv Sourasky Med Ctr, Tel Aviv, Israel; [Zmora, Niv; Paran, Yael; Schwartz, Eli] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Schwartz, Eli] Chaim Sheba Med Ctr, Ctr Geog Med & Trop Dis, Tel Hashomer, Israel; [Neuberger, Ami] Technion, Bruce Rappaport Fac Med, Haifa, Israel	Rambam Health Care Campus; Technion Israel Institute of Technology; Kathmandu University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Petersiel, N (corresponding author), Rambam Med Ctr, Unit Infect Dis Trop Dis & Travel Med, Internal Med B, Haifa, Israel.	n_petersiel@rambam.health.gov.il		Paran, Yael/0000-0002-4825-6449; Petersiel, Neta/0000-0003-1981-3848				Johansen Ilesh Jani Kari, 2017, TYPH VACC SAGE M; Karkey A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002391; Karkey A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013988; Karki S, 2013, CLIN INFECT DIS, V57, pE167, DOI 10.1093/cid/cit563; Kleine CE, 2017, CLIN INFECT DIS, V65, P1754, DOI 10.1093/cid/cix652; Maskey AP, 2006, CLIN INFECT DIS, V42, P1247, DOI 10.1086/503033; Maskey AP, 2008, T ROY SOC TROP MED H, V102, P91, DOI 10.1016/j.trstmh.2007.10.003; Meltzer E, 2005, J TRAVEL MED, V12, P275, DOI 10.2310/7060.2005.12507; Meltzer E, 2014, CLIN INFECT DIS, V58, P359, DOI 10.1093/cid/cit723; Murdoch DR, 2004, AM J TROP MED HYG, V70, P670, DOI 10.4269/ajtmh.2004.70.670; Nepal G, 2018, CUREUS, V10, DOI 10.7759/cureus.2428; Pakkanen SH, 2015, VACCINE, V33, P451, DOI 10.1016/j.vaccine.2014.11.030; Pokhrel BM, 2009, ANN CLIN MICROB ANTI, V8, DOI 10.1186/1476-0711-8-1; Schwartz E, 2009, NEW ENGL J MED, V361, P2191; Sharma N, KATHMANDU U MED J KU, V2, P188; Sharma Nastu P., 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P351; Sherchan JB, 2017, AM J TROP MED HYG, V97, P1706, DOI 10.4269/ajtmh.17-0227; Shrestha S, JNMA J NEPAL MED ASS, V52, P692; Singh SD, 2013, J NEPAL PAEDIAT SOC, V32, P216, DOI [10.3126/jnps.v32i3.6682, DOI 10.3126/JNPS.V32I3.6682]; Thompson CN, 2017, CLIN INFECT DIS, V64, P1522, DOI 10.1093/cid/cix185; Thompson CN, 2015, AM J TROP MED HYG, V92, P875, DOI 10.4269/ajtmh.14-0709; Wain J, 2015, LANCET, V385, P1136, DOI 10.1016/S0140-6736(13)62708-7; Zellweger RM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006051; Zmora N, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006380	24	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204479	10.1371/journal.pone.0204479	http://dx.doi.org/10.1371/journal.pone.0204479			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30261024	Green Published, gold, Green Submitted			2022-12-26	WOS:000445907400057
J	Pornaro, C; Vincenzi, V; Furin, S; Fazzini, M; Minarelli, L; Macolino, S				Pornaro, Cristina; Vincenzi, Valentina; Furin, Stefano; Fazzini, Massimiliano; Minarelli, Luca; Macolino, Stefano			Seasonal changes in dry matter yield from Karst pastures as influenced by morphoclimatic features	PLOS ONE			English	Article							PLANT-SPECIES RICHNESS; GRASSLANDS; PRODUCTIVITY; FOREST	Pastures are strongly affected by local environmental variables in terms of their species richness, plant composition and herbage production. A multi-site monitoring study was conducted over three years to investigate the influence of morphoclimatic factors on the seasonal variations in dry matter (DM) yield from Karst pastures. Seven sites located on the Italian and Slovenian Karst regions were investigated that differed in terms of their geological and geomorphological features, as well as their soil types. At each site, the daily DM yield (kg ha(-1) d(-1)) was determined using Corral-Fenlon method which permits to simulate herbage utilization from grazing herds. The morphoclimatic features were also analysed, with the aim to evaluate the link between seasonal DM yield and geomorphological and environmental factors. Generalized non-linear mixed models were built to study the observed seasonal variations in DM yield, using day of the year (DOY), growing degree days (GDD), and cumulative rainfall. Furthermore, environmental descriptors were included in the model in order to evaluate their effects on DM yield. The seasonal variations in yield showed two growing periods (spring and late summer), which were described by Gaussian curves. For the spring growing period, the model improved when the interaction between soil granulometry and growing degree days corresponding to the curve peak was taken into account. This confirms the influence of soil type and air temperature on pasture yield. For the late summer growing period, the interaction between the sand classes and the number of rainy days from the beginning of the period to the peak of the curve improved the model. The curve parameters of our models are correlated with environmental descriptors depending on the lithology and particle size of soils. The results are essential for the optimization of pasture management and avoiding degradation due to over- or under-grazing.	[Pornaro, Cristina; Macolino, Stefano] Univ Padua, Dept Agron Food Nat Resources Anim & Environm, Padua, Italy; [Vincenzi, Valentina; Minarelli, Luca] Geotema Srl, Ferrara, Italy; [Furin, Stefano] Dolomiti Project Srl, Feltre, Belluno, Italy; [Fazzini, Massimiliano] Univ Ferrara, Dept Phys & Earth Sci, Ferrara, Italy	University of Padua; University of Ferrara	Pornaro, C (corresponding author), Univ Padua, Dept Agron Food Nat Resources Anim & Environm, Padua, Italy.	cristina.pornaro@unipd.it	Vincenzi, Valentina/AAJ-8498-2020	MACOLINO, STEFANO/0000-0002-5521-9929; Minarelli, Luca/0000-0003-3602-9975; Vincenzi, Valentina/0000-0002-5655-4147; Pornaro, Cristina/0000-0002-7513-747X	European Union; European programme of cross-border collaboration (Slovenia-Italy 2007-2013; project BioDiNet); European programme of cross-border collaboration (Slovenia-Italy 2007-2013); Geotema srl	European Union(European Commission); European programme of cross-border collaboration (Slovenia-Italy 2007-2013; project BioDiNet); European programme of cross-border collaboration (Slovenia-Italy 2007-2013); Geotema srl	The study has been conducted with European Union financial support. Funding was provided by the European programme of cross-border collaboration (Slovenia-Italy 2007-2013; project BioDiNet). Dolomiti Project provided support in the form of salaries for author Stefano Furin, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Geotema srl (company of the University of Ferrara) was partner of project BioDiNet funded by the European programme of cross-border collaboration (Slovenia-Italy 2007-2013). It was in charge of study and describe the hydro-geological characteristics of the area where the study presented in the manuscript was conducted. Geotema srl provided support in the form of salaries for author Valentina Vincenzi and Luca Minarelli.; The study has been conducted with European Union financial support. Funding was provided by the European programme of cross-border collaboration (Slovenia-Italy 2007-2013; project BioDiNet). We would like to thank Agriturismo Parco Rurale "Alture di Polazzo" and the municipality of Koper for access to land and for information on land management practices, Mike Richardson and Matthew Richardson for their help in field work. We are also grateful to the anonymous reviewer and the Academic Editor for comments on the manuscript.	Aguiar MR, 2005, GRASSLANDS: DEVELOPMENTS OPPORTUNTIES PERSPECTIVES, P261; Allen R. G., 1998, FAO Irrigation and Drainage Paper; Bensi S., 2007, REND SOC GEOL IT, V4, P145; Busetti M, 2010, B GEOFIS TEOR APPL, V51, P117; Cavallero A., 2002, COLTIVAZIONI ERBACEE, P239; Cohen KM, 2013, EPISODES, V36, P199, DOI 10.18814/epiiugs/2013/v36i3/002; CORRALL AJ, 1978, J AGR SCI, V91, P61, DOI 10.1017/S0021859600056628; Coxon C, 2011, KARST MANAGEMENT, P103, DOI 10.1007/978-94-007-1207-2_5; Cucchi F, 2007, MEMORIE I ITALIANO S, V19, P33; Epstein HE, 1997, ECOLOGY, V78, P2628, DOI 10.1890/0012-9658(1997)078[2628:EOTAST]2.0.CO;2; Epstein HE, 1996, J VEG SCI, V7, P777, DOI 10.2307/3236456; G. U. (Gazzetta Ufficiale dello Stato), 1999, G U GAZZETTA UF 1021, P248; GAUCH HG, 1972, ECOLOGY, V53, P446, DOI 10.2307/1934231; Hutchinson G. K., 2000, Proceedings of the New Zealand Grassland Association, V62, P81; KADMON R, 1995, ECOLOGY, V76, P458, DOI 10.2307/1941204; Klimek S, 2007, BIOL CONSERV, V134, P559, DOI 10.1016/j.biocon.2006.09.007; Lauenroth W. K., 1979, Perspectives in grassland ecology., P3; Li FY, 2011, NEW ZEAL J AGR RES, V54, P331, DOI 10.1080/00288233.2011.613403; Lieth H.F.H., 1978, PATTERNS PRIMARY PRO; Marini L, 2007, AGR ECOSYST ENVIRON, V119, P281, DOI 10.1016/j.agee.2006.07.015; Michaud A, 2012, GRASS FORAGE SCI, V67, P64, DOI 10.1111/j.1365-2494.2011.00821.x; Niqueux M., 1981, FOURRAGES, V88, P39; Noy-Meir I., 1973, Annual Review of Ecology and Systematics, V4, P25, DOI 10.1146/annurev.es.04.110173.000325; Noy-Meir I, 2001, J VEG SCI, V12, P749, DOI 10.2307/3236862; Oesterheld M, 2001, J VEG SCI, V12, P137, DOI 10.1111/j.1654-1103.2001.tb02624.x; Placer L., 1981, GEOLOGIJA, V24, P27; Pornaro C., 2014, BIODIVERS CONSERV, P195; Pornaro C, 2013, BIOL CONSERV, V161, P213, DOI 10.1016/j.biocon.2013.02.019; Risser PG., 1988, CONCEPTS ECOSYSTEM E, P115; SALA OE, 1988, ECOLOGY, V69, P40, DOI 10.2307/1943158; Schut AGT, 2010, CROP PASTURE SCI, V61, P32, DOI 10.1071/CP08438; Sharma M. L., 1985, Advances in Irrigation, V3, P213; Skornik S, 2010, PLANT BIOSYST, V144, P355, DOI 10.1080/11263501003750250; TILMAN D, 1988; WEBB W, 1978, ECOLOGY, V59, P1239, DOI 10.2307/1938237; WEBB WL, 1983, ECOLOGY, V64, P134, DOI 10.2307/1937336; Ziliotto U., 2004, TRATTI ESSENZIALI TI	37	2	2	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204092	10.1371/journal.pone.0204092	http://dx.doi.org/10.1371/journal.pone.0204092			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30261053	Green Published, gold, Green Submitted			2022-12-26	WOS:000445907400026
J	Saito, YF; Miyazaki, SH; Bartlem, DG; Nagamatsu, Y; Saito, T				Saito, Yumiko F.; Miyazaki, Saki H.; Bartlem, Derek G.; Nagamatsu, Yukiko; Saito, Tamao			Chemical compounds from Dictyostelium discoideum repel a plant-parasitic nematode and can protect roots	PLOS ONE			English	Article							CELLULAR SLIME-MOLDS; MELOIDOGYNE-INCOGNITA; SOCIAL AMEBA; SOIL	Slime mold species in the genus Dictyostelium are considered to have a close relationship with non-parasitic nematodes; they are sympatric in soils and can exhibit interspecific competition for food. We investigated whether this relationship extends to a plant-parasitic nematode that is active in the rhizosphere and has broad host specificity, damaging crops worldwide. Using a novel assay to examine the interaction between the cellular slime mold, Dictyostelium discoideum, and the plant-parasitic nematodes, Meloidogyne spp., we found that cellular slime molds can repel plant parasitic nematodes. Specifically, the repulsion activity was in response to chemical compounds released by cellular slime mold fruiting bodies. Under laboratory conditions, these soluble chemical extracts from fruiting bodies of D. discoideum showed repulsion activity strong enough to protect plant roots. The fruiting body cell extracts repelled but were not toxic to the plant-parasitic nematodes.	[Saito, Yumiko F.; Miyazaki, Saki H.] Sophia Univ, Grad Sch Sci & Technol, Tokyo, Japan; [Bartlem, Derek G.] Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido, Japan; [Nagamatsu, Yukiko] Panefri Ind Co, Inst Environm Sci, Okinawa, Japan; [Saito, Tamao] Sophia Univ, Fac Sci & Technol, Tokyo, Japan; [Bartlem, Derek G.] KWS Gateway Res Ctr, St Louis, MO USA	Sophia University; Hokkaido University; Sophia University	Saito, T (corresponding author), Sophia Univ, Fac Sci & Technol, Tokyo, Japan.	tasaito@sophia.ac.jp			Sumitomo Foundation; Grant for Environmental Research [103421]; JSPS KAKENHI [23651209]; Panefuri Industrial Co. Ltd	Sumitomo Foundation; Grant for Environmental Research; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Panefuri Industrial Co. Ltd	This research was supported by the Sumitomo Foundation, Grant for Environmental Research No. 103421 to TS, and JSPS KAKENHI No. 23651209 to DGB and TS. The above Grant Funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Panefuri Industrial Co. Ltd. contributed funds for consumables and support in the form of salaries to YN, but did not have additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin ANN, 2014, J BIOSCI BIOENG, V118, P205, DOI 10.1016/j.jbiosc.2014.01.006; Baidoo R, 2017, J NEMATOL, V49, P311, DOI 10.21307/jofnem-2017-077; Bonner JT, 2005, MYCOLOGIA, V97, P178, DOI 10.3852/mycologia.97.1.178; BONNER JT, 1982, AM NAT, V119, P530, DOI 10.1086/283930; Brock DA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3385; Brock DA, 2011, NATURE, V469, P393, DOI 10.1038/nature09668; BROUGHTON WJ, 1971, BIOCHEM J, V125, P1075, DOI 10.1042/bj1251075; BYBD DW, 1983, J NEMATOL, V15, P142; DiSalvo S, 2015, P NATL ACAD SCI USA, V112, pE5029, DOI 10.1073/pnas.1511878112; Dong LL, 2014, J EXP BOT, V65, P131, DOI 10.1093/jxb/ert356; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Elling AA, 2013, PHYTOPATHOLOGY, V103, P1092, DOI 10.1094/PHYTO-01-13-0019-RVW; Gotze S, 2017, ACS CHEM BIOL, V12, P2498, DOI 10.1021/acschembio.7b00589; HUSS MJ, 1989, MYCOLOGIA, V81, P677, DOI 10.2307/3759871; Kay RR, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001503; Kihika R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02379-8; Klapper M, 2018, SYNLETT, V29, P537, DOI 10.1055/s-0037-1609226; Klapper M, 2016, ANGEW CHEM INT EDIT, V55, P8944, DOI 10.1002/anie.201603312; Narita TB, 2011, FEMS MICROBIOL LETT, V319, P82, DOI 10.1111/j.1574-6968.2011.02273.x; R Core Team, 2018, R LANG ENV STAT COMP; ROSSIER C, 1979, J CELL SCI, V35, P321; Schaap P, 2006, SCIENCE, V314, P661, DOI 10.1126/science.1130670; Siddique S, 2015, ADV BOT RES, V73, P119, DOI 10.1016/bs.abr.2015.02.001; Smith J, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-105; Souza GM, 1998, DEVELOPMENT, V125, P2291; Sucgang R, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r20; Suthers HB, 1985, OECOLOGIA, V65, P526, DOI 10.1007/BF00379667; TERUYA R, 1984, JARQ-JPN AGR RES Q, V18, P142	29	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2018	13	9							e0204671	10.1371/journal.pone.0204671	http://dx.doi.org/10.1371/journal.pone.0204671			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV2HB	30261017	Green Published, Green Submitted, gold			2022-12-26	WOS:000445907400088
J	Costa, HTMD; Costa, TX; Martins, RR; Oliveira, AG				Matias de Lima Costa, Haline Tereza; Costa, Tatiana Xavier; Martins, Rand Randall; Oliveira, Antonio Gouveia			Use of off-label and unlicensed medicines in neonatal intensive care	PLOS ONE			English	Article							DRUG-USE; HOSPITALIZED CHILDREN; MEDICATION USE; UNIT; PATTERNS	Purpose To evaluate the use of off-label and unlicensed medicines in a neonatal intensive care unit (NICU) of a teaching maternity hospital specialized in high risk pregnancy. Methods A prospective cohort study was conducted between August 2015 and July 2016. All new-borns admitted to the NICU who had at least one medication prescribed and a hospital stay longer than 24 hours were included. The classification of off-label and unlicensed drugs for the neonatal population was done according to the information of Food and Drug Administration. Results A total of 17421 medication items were analyzed in 3935 prescriptions of 220 newborns. The proportion of newborns exposed to off-label drugs was 96.4%, and to unlicensed medicines was 66.8%. About one-half (49.3%) of the medication items were off-label and 24.6% were unlicensed. The main reason for off-label and unlicensed classification was, respectively, frequency of administration and the administration of adaptations of pharmaceutical forms. Conclusions Although there are actions to encourage the development of pharmacological studies with neonates, this study observed a high rate of prescription and exposure of newborns to off-label and unlicensed drugs in NICUs and pointed out areas of neonatal therapy that require scientific investment.	[Matias de Lima Costa, Haline Tereza] Univ Fed Rio Grande do Norte, Hlth Sci Ctr, Pharm Dept, Integrated Multiprofess Hlth Residency Program Ne, Natal, RN, Brazil; [Costa, Tatiana Xavier] Univ Fed Rio Grande do Norte, Hlth Sci Ctr, Sch Matern Januario Cicco, Natal, RN, Brazil; [Martins, Rand Randall; Oliveira, Antonio Gouveia] Univ Fed Rio Grande do Norte, Hlth Sci Ctr, Pharm Dept, Natal, RN, Brazil; [Matias de Lima Costa, Haline Tereza] Univ Fed Rio Grande do Norte, Fac Farm, Ctr Ciencias Saude, Natal, RN, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte	Costa, HTMD (corresponding author), Univ Fed Rio Grande do Norte, Hlth Sci Ctr, Pharm Dept, Integrated Multiprofess Hlth Residency Program Ne, Natal, RN, Brazil.; Costa, HTMD (corresponding author), Univ Fed Rio Grande do Norte, Fac Farm, Ctr Ciencias Saude, Natal, RN, Brazil.	halinetcosta@gmail.com	Costa, Maria Fernanda Furtado de Lima e/ABE-3779-2021; Martins, Rand Randall/X-8188-2019	Costa, Maria Fernanda Furtado de Lima e/0000-0002-3474-2980; Martins, Rand Randall/0000-0001-9668-0482; Xavier da Costa, Tatiana/0000-0003-4306-981X				Aamir M, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-1211-y; Allegaert K, 2014, NEONATOLOGY, V105, P344, DOI 10.1159/000360648; Anand KJS, 2007, PEDIATRICS, V119, P605, DOI 10.1542/peds.2006-2723; Aranda JV, 2005, CLIN THER, V27, P877, DOI 10.1016/j.clinthera.2005.06.019; Balain M, 2013, PAEDIAT CHILD HLTH, V24, P17; Blanco-Reina E, 2015, MED INTENSIVA, V40, P1; Camacho-Gonzalez A, 2013, PEDIATR CLIN N AM, V60, P367, DOI 10.1016/j.pcl.2012.12.003; Clark RH, 2006, PEDIATRICS, V117, P1979, DOI 10.1542/peds.2005-1707; Conroy S, 1999, ARCH DIS CHILD-FETAL, V80, pF142, DOI 10.1136/fn.80.2.F142; Conroy S, 2011, ARCH DIS CHILD, V96, P305, DOI 10.1136/adc.2010.191940; Cuzzolin L., 2014, J PEDIAT NEONAT INDI, V3, P1; de Souza AS, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0551-8; Dell'Aera M, 2007, PHARM WORLD SCI, V29, P361, DOI 10.1007/s11096-006-9081-z; Dessi A, 2010, PHARM WORLD SCI, V32, P120, DOI 10.1007/s11096-009-9356-2; Di Paolo Ermindo R, 2006, Swiss Med Wkly, V136, P218; Du W, 2006, AM J PERINAT, V23, P279, DOI 10.1055/s-2006-946719; Flint RB, 2018, BRIT J CLIN PHARMACO, V84, P1313, DOI 10.1111/bcp.13563; Flor-De-Lima F, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/643246; Food and Drug Administration, FOOD DRUG ADM MOD AC; Giacoia GP, 2012, CLIN PERINATOL, V39, P11, DOI 10.1016/j.clp.2011.12.016; Hsieh EM, 2014, AM J PERINAT, V31, P811, DOI 10.1055/s-0033-1361933; Hsien L, 2008, PHARM WORLD SCI, V30, P497, DOI 10.1007/s11096-008-9193-8; Institute for Safe Medication Practices, ISMP LIST HIGH AL ME; Kieran EA, 2014, ACTA PAEDIATR, V103, pE139, DOI 10.1111/apa.12541; Krzyzaniak N, 2016, J CLIN PHARM THER, V41, P612, DOI 10.1111/jcpt.12440; Krzyzaniak N, 2017, INT J PHARM PRACT, V25, P107, DOI 10.1111/ijpp.12284; Laforgia N, 2014, PEDIATR INT, V56, P57, DOI 10.1111/ped.12190; Lass J, 2011, EUR J CLIN PHARMACOL, V67, P1263, DOI 10.1007/s00228-011-1072-x; Lee JL, 2013, INT J CLIN PHARM-NET, V35, P1025, DOI 10.1007/s11096-013-9846-0; Neubert A, 2010, EUR J CLIN PHARMACOL, V66, P87, DOI 10.1007/s00228-009-0722-8; O'Donnell CPF, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.5.e52; Oguz SS, 2012, INT J CLIN PHARM-NET, V34, P136, DOI 10.1007/s11096-011-9604-0; Reuters T, 2016, THOMSON MICROMEDEX D; Santos DB, 2008, EUR J CLIN PHARMACOL, V64, P1111, DOI 10.1007/s00228-008-0543-1; Shah SS, 2007, ARCH PEDIAT ADOL MED, V161, P282, DOI 10.1001/archpedi.161.3.282; Stafford RS, 2008, NEW ENGL J MED, V358, P1427, DOI 10.1056/NEJMp0802107; Tayman Cuneyt, 2011, J Pediatr Pharmacol Ther, V16, P170, DOI 10.5863/1551-6776-16.3.170; Wiles JR, 2013, J PEDIATR-US, V162, P12, DOI 10.1016/j.jpeds.2012.08.034	38	25	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2018	13	9							e0204427	10.1371/journal.pone.0204427	http://dx.doi.org/10.1371/journal.pone.0204427			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU9BO	30252920	Green Submitted, Green Published, gold			2022-12-26	WOS:000445639700051
J	Wang, BX; Adachi, Y; Sugiyama, S				Wang, Boxi; Adachi, Yoichi; Sugiyama, Shuichi			Soil productivity and structure of bacterial and fungal communities in unfertilized arable soil	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; CONSISTENT RESPONSES; DIVERSITY; PH; BIOGEOGRAPHY; RHIZOSPHERE; GRASSLANDS; STRATEGIES; DRIVES; ALPHA	Soil productivity is strongly influenced by the activities of microbial communities. However, it is not well understood how community structure, including its richness, mass, and composition, influences soil functions. We investigated the relationships between soil productivity and microbial communities in unfertilized arable soils extending over 1000 km in eastern Japan. Soil properties, including C turnover rate, N mineralization rate, microbial C, and various soil chemical properties, were measured. Soil bacterial and fungal communities were analyzed by Illumina's MiSeq using 16S rRNA and ITS regions. In addition, root microbial communities from maize grown in each soil were also investigated. Soil bacterial communities shared many operational taxonomic units (OTUs) among farms. An ordination plot based on correspondence analysis revealed convergent distribution of soil bacterial communities across the farms, which seemed to be a result of similar agricultural management practices. Although fungal communities showed lower richness and a lower proportion of shared OTUs than bacterial communities, community structure between the farms tended to be convergent. On the other hand, root communities had lower richness and a higher abundance of specific taxa than the soil communities. Two soil functions, decomposition activity and soil productivity, were extracted by principal component analysis (PCA) based on eight soil properties. Soil productivity correlated with N mineralization rate, P2O5, and maize growth, but not with decomposition activity, which is characterized by C turnover rate, soil organic C, and microbial mass. Soil productivity showed a significant association with community composition, but not with richness and mass of soil microbial communities. Soil productivity also correlated with the abundance of several specific taxa, both in bacteria and fungi. Root communities did not show any clear correlations with soil productivity. These results demonstrate that community composition and abundance of soil microbial communities play important roles in determining soil productivity.	[Wang, Boxi; Adachi, Yoichi; Sugiyama, Shuichi] Hirosaki Univ, Fac Agr & Life Sci, Hirosaki, Aomori, Japan; [Wang, Boxi] Iwate Univ, United Grad Sch Agr Sci, Morioka, Iwate, Japan	Hirosaki University; Iwate University	Sugiyama, S (corresponding author), Hirosaki Univ, Fac Agr & Life Sci, Hirosaki, Aomori, Japan.	sugi@hirosaki-u.ac.jp			Japan Society for the Promotion of Science (KAKENHI) [JP25281059, JP26550092]	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by Japan Society for the Promotion of Science (KAKENHI Grant Number JP25281059 and JP26550092) to SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bulgarelli D, 2012, NATURE, V488, P91, DOI 10.1038/nature11336; Burns JH, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv030; Choudhary DK, 2011, BIOTECHNOL LETT, V33, P1905, DOI 10.1007/s10529-011-0662-0; Coleman-Derr D, 2016, NEW PHYTOL, V209, P798, DOI 10.1111/nph.13697; Coolon JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067884; Degrune F, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01127; Delgado-Baquerizo M, 2018, SCIENCE, V359, P320, DOI 10.1126/science.aap9516; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dong K, 2016, SCI REP-UK, V6, DOI 10.1038/srep26360; Dynarski KA, 2018, NEW PHYTOL, V217, P1050, DOI 10.1111/nph.14905; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2012, P NATL ACAD SCI USA, V109, P21390, DOI 10.1073/pnas.1215210110; Figuerola ELM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051075; Garcia-Orenes F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080522; Girvan MS, 2003, APPL ENVIRON MICROB, V69, P1800, DOI 10.1128/AEM.69.3.1800-1809.2003; Gottel NR, 2011, APPL ENVIRON MICROB, V77, P5934, DOI 10.1128/AEM.05255-11; Hargreaves SK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134345; Hartmann M, 2015, ISME J, V9, P1177, DOI 10.1038/ismej.2014.210; Hossain MZ, 2010, ECOL RES, V25, P255, DOI 10.1007/s11284-009-0648-8; Joa JH, 2014, J MICROBIOL, V52, P995, DOI 10.1007/s12275-014-4129-6; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Keeney D. R., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P643; Kim JM, 2016, J MICROBIOL, V54, P838, DOI 10.1007/s12275-016-6526-5; Knief C, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00216; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Lauber CL, 2008, SOIL BIOL BIOCHEM, V40, P2407, DOI 10.1016/j.soilbio.2008.05.021; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Laungani R, 2012, OIKOS, V121, P1840, DOI 10.1111/j.1600-0706.2011.20434.x; Leff JW, 2015, P NATL ACAD SCI USA, V112, P10967, DOI 10.1073/pnas.1508382112; Leppanen S, 2015, PLANT SOIL, V389, P185, DOI 10.1007/s11104-014-2356-6; Liu B, 2007, APPL SOIL ECOL, V37, P202, DOI 10.1016/j.apsoil.2007.06.007; Lundberg DS, 2013, NAT METHODS, V10, P999, DOI 10.1038/nmeth.2634; Ma JC, 2016, SCI TOTAL ENVIRON, V563, P199, DOI 10.1016/j.scitotenv.2016.04.122; Ma ZY, 2017, PLANT SOIL ENVIRON, V63, P574, DOI [10.17221/590/2017-PSE, 10.17221/590/2017-pse]; Macdonald C, 2014, BIOENGINEERED, V5, P5, DOI 10.4161/bioe.25320; Maestre FT, 2015, P NATL ACAD SCI USA, V112, P15684, DOI 10.1073/pnas.1516684112; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Masson-Boivin C, 2009, TRENDS MICROBIOL, V17, P458, DOI 10.1016/j.tim.2009.07.004; NM Yuko Takada-Hoshino, 2004, MICROBES ENVIRON, V19, P315; O'Donnell AG, 2001, PLANT SOIL, V232, P135, DOI 10.1023/A:1010394221729; Okubo A, 2009, ECOL RES, V24, P1399, DOI 10.1007/s11284-009-0602-9; Olsen S. R., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P403; Parkinson D., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P821; Peiffer JA, 2013, P NATL ACAD SCI USA, V110, P6548, DOI 10.1073/pnas.1302837110; Pimentel D., 2002, ENCY PEST MANAGEMENT, P525, DOI [10.1016/j.scitotenv.2017.09.265, DOI 10.1016/J.SCITOTENV.2017.09.265]; Pommier T, 2018, J APPL ECOL, V55, P49, DOI 10.1111/1365-2664.13010; Prober SM, 2015, ECOL LETT, V18, P85, DOI 10.1111/ele.12381; Samad MS, 2017, MOL ECOL, V26, P5500, DOI 10.1111/mec.14275; Schmidt SK, 2014, MOL ECOL, V23, P254, DOI 10.1111/mec.12589; Sellstedt A, 2013, FEMS MICROBIOL LETT, V342, P179, DOI 10.1111/1574-6968.12116; Shen CC, 2013, SOIL BIOL BIOCHEM, V57, P204, DOI 10.1016/j.soilbio.2012.07.013; Soman C, 2017, PLANT SOIL, V413, P145, DOI 10.1007/s11104-016-3083-y; Toju H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040863; Vanhala P, 2005, ENVIRON MONIT ASSESS, V101, P85, DOI 10.1007/s10661-005-9134-0; Wang WH, 2016, SCI REP-UK, V6, DOI 10.1038/srep35046; Wen CQ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176716; Xiong JB, 2012, ENVIRON MICROBIOL, V14, P2457, DOI 10.1111/j.1462-2920.2012.02799.x; Yang N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166536; Zhang Y, 2018, SCI TOTAL ENVIRON, V615, P517, DOI 10.1016/j.scitotenv.2017.09.265; Zhou JZ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12083	62	14	14	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2018	13	9							e0204085	10.1371/journal.pone.0204085	http://dx.doi.org/10.1371/journal.pone.0204085			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV3MI	30248134	Green Published, Green Submitted, gold			2022-12-26	WOS:000445998100023
J	Hsu, JC; Wu, HC; Feng, WC; Chou, CH; Lai, ECC; Lu, CY				Hsu, Jason C.; Wu, Huai-Chueh; Feng, Wen-Chia; Chou, Chih-Ho; Lai, Edward Chia-Cheng; Lu, Christine Y.			Disease and economic burden for rare diseases in Taiwan: A longitudinal study using Taiwan's National Health Insurance Research Database	PLOS ONE			English	Article							ORPHAN DRUGS; BUDGET IMPACT	Background High-cost orphan drugs are becoming increasingly available to treat rare diseases that affect a relatively small population. Little attention has been given to the prevalence of rare diseases and their health-related economic burden in Taiwan. Objectives This study examined the national trends in the prevalence of rare diseases and their health-related economic burden (including medication costs) in Taiwan. Methods Rare disease-related claims data from 2003-2014 (12 years) from the National Health Insurance Research Database were used in this study. We used a time series analysis to assess trends in the yearly rates of treated patients with rare diseases, overall healthcare use, and expenditures, including drugs. Results During the 12-year study period, the estimated prevalence of rare diseases increased from 10.57 to 33.21 per 100,000 population, an average rate of a 19.46% increase per year. Total health expenditures for treatment of rare diseases increased from US$18.65 million to US $137.44 million between 2003 and 2014, accounting for 0.68% of the total national health expenditures in 2014. Drug expenditures for treatment of rare diseases increased from US $13.24 million to US$121.98 million between 2003 and 2014, which accounted for 71.00% and 88.75% of the health expenditures for patients with rare diseases in 2003 and 2014, respectively. In 2014, we found a 20.43-fold difference in average health expenditures and a 69.46-fold difference in average drug expenditures between patients with rare diseases and the overall population. Conclusions The prevalence of rare diseases and the related economic burden have grown substantially in Taiwan over the past 12 years, and these trends are likely to continue. Drug expenditures accounted for almost 90% of health expenditures for rare diseases. Further analyses are underway to examine the economic burden of individual rare diseases.	[Hsu, Jason C.; Chou, Chih-Ho; Lai, Edward Chia-Cheng] Natl Cheng Kung Univ, Coll Med, Sch Pharm, Tainan, Taiwan; [Hsu, Jason C.; Chou, Chih-Ho; Lai, Edward Chia-Cheng] Natl Cheng Kung Univ, Coll Med, Inst Clin Pharm & Pharmaceut Sci, Tainan, Taiwan; [Wu, Huai-Chueh] Natl Cheng Kung Univ, Coll Med, Sch Med, Tainan, Taiwan; [Feng, Wen-Chia] Minist Hlth & Welf, Natl Hlth Insurance Adm, Taipei, Taiwan; [Chou, Chih-Ho] Chi Mei Hosp, Dept Neurol, Tainan, Taiwan; [Lu, Christine Y.] Harvard Med Sch, Dept Populat Med, Boston, MA USA; [Lu, Christine Y.] Harvard Pilgrim Hlth Care Inst, Boston, MA USA	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care	Hsu, JC (corresponding author), Natl Cheng Kung Univ, Coll Med, Sch Pharm, Tainan, Taiwan.; Hsu, JC (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Clin Pharm & Pharmaceut Sci, Tainan, Taiwan.	jasonhsu@mail.ncku.edu.tw		Wu, Huai-Chueh Gem/0000-0003-3475-4698; Chou, Chih-Ho/0000-0003-3491-6853	Taiwan Ministry of Science and Technology grant [MOST 105-2314-B-006-021]	Taiwan Ministry of Science and Technology grant	Dr. Hsu was supported by Taiwan Ministry of Science and Technology grant (Grant ID MOST 105-2314-B-006-021).	Alves R, 2016, PEERJ, V4, DOI 10.7717/peerj.2211; [Anonymous], 2010, TAIWAN REGULATION OR; [Anonymous], 2010, TAIWAN REGULATION RA; Arnold Renee J G, 2015, F1000Res, V4, P57, DOI 10.12688/f1000research.4268.1; Divino V, 2016, HEALTH AFFAIR, V35, P1588, DOI 10.1377/hlthaff.2016.0030; EvaluatePharma, 2013, ORPH DRUG REP 2013; Food and Drug Administration, LIST SPEC NUTR FOOD; Gammie T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140002; Gulbakan B, 2016, EPMA J, V7, DOI 10.1186/s13167-016-0074-2; Hayashi S, 2008, LANCET, V372, P889, DOI 10.1016/S0140-6736(08)61393-8; Health Promotion Administration MoHaW, MOHW PUBL LIST RAR D; Health Promotion Administration MoHaW, 2015, MOHW PUBL LIST RAR D; Hughes-Wilson W, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-74; Hutchings A, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-22; Natioanl Health Insurance Administration, LIST SPEC MED RAR DI; National Organization for Rare Disorders N, 2015, RAR DIS INF; Pastores GM, 2013, PEDIATR ENDOCR REV P, V11, P64; Paulden M, 2015, PHARMACOECONOMICS, V33, P255, DOI 10.1007/s40273-014-0235-x; Richter T, 2015, VALUE HEALTH, V18, P906, DOI 10.1016/j.jval.2015.05.008; Schey C, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-62; Schlander M, 2015, EXPERT REV PHARM OUT, V15, P171, DOI 10.1586/14737167.2015.965156; Song PP, 2012, INTRACTABLE RARE DIS, V1, P3, DOI 10.5582/irdr.2012.v1.1.3; Taiwan Ministry of Health and Welfare M, 2015, RAR DIS ORPH DRUG AC; Voelker R, 2017, JAMA-J AM MED ASSOC, V317, P1110, DOI 10.1001/jama.2017.1772	24	14	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2018	13	9							e0204206	10.1371/journal.pone.0204206	http://dx.doi.org/10.1371/journal.pone.0204206			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU5MM	30240449	Green Published, gold, Green Submitted			2022-12-26	WOS:000445329700030
J	Kim, SA; Kang, MK; Shim, CY; Lee, S; Chang, BC; Ha, JW				Kim, Sung-Ai; Kang, Min-Kyung; Shim, Chi Young; Lee, Sak; Chang, Byung-Chul; Ha, Jong-Won			Changes of body composition after valve surgery in patients with mitral valve disease	PLOS ONE			English	Article							CONGESTIVE-HEART-FAILURE; CARDIAC CACHEXIA; TRICUSPID REGURGITATION; ECHOCARDIOGRAPHIC-ASSESSMENT; PULMONARY-HYPERTENSION; EUROPEAN ASSOCIATION; ENERGY-EXPENDITURE; ADULTS; TRANSPLANTATION; RECOMMENDATIONS	Background Patients with chronic heart failure have alteration in body composition as a reduction in fat mass, lean body mass and bone mass. However, body wasting in valvular heart disease and the impact of corrective valvular surgery on body composition has not been investigated. Objectives We hypothesized that body wasting in severe mitral valve (MV) diseases is reversible through MV surgery. Methods Forty eight patients who were scheduled to undergo MV surgery were consecutively enrolled after excluding patients with combined valvular heart disease, ischemic heart disease, cardiomyopathies, and diseases or who were taking medications that could affect metabolism. All patients were subjected to simplified nutritional assessment questionnaire (SNAQ) for appetite, laboratory tests, echocardiography, and dual-energy X-ray absorptiometry (DXA) before and one year after MV surgery. Results One year after MV surgery, the patients showed increased appetite and improved laboratory data as well as hemodynamic improvement. When we classified the patients according to the primary MV lesion, no changes in body weight were observed in both patients with mitral regurgitation (MR) and mitral stenosis (MS). However, significant increase in bone mineral density and body fat percentage were observed in patients with MR and not in patients with MS. In patients with MR, patients with Delta fat >= 2% showed significantly higher pre-operative estimated right ventricular systolic pressure (eRVSP) level and greater decrease in eRVSP after surgery than those with Delta fat < 2% and both.SNAQ and.fat showed significant negative relationship with.eRVSP, respectively. Conclusions In patients with severe MV disease, corrective MV surgery led to favorable outcomes in wasting process as well as hemodynamic improvement. Particularly, right ventricular pressure overload showed a close association with the changes in appetite and body fat percentage in patients with MR.	[Kim, Sung-Ai; Kang, Min-Kyung] Hallym Univ, Hallym Sacred Heart Hosp, Div Cardiol, Coll Med, Anyang, South Korea; [Shim, Chi Young; Ha, Jong-Won] Yonsei Univ, Severance Cardiovasc Hosp, Div Cardiol, Coll Med, Seoul, South Korea; [Lee, Sak; Chang, Byung-Chul] Yonsei Univ, Coll Med, Div Cardiovasc Surg, Severance Cardiovasc Hosp,Dept Thorac & Cardiovas, Seoul, South Korea	Hallym University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Ha, JW (corresponding author), Yonsei Univ, Severance Cardiovasc Hosp, Div Cardiol, Coll Med, Seoul, South Korea.	jwha@yuhs.ac	Chang, Byung/AAP-9674-2020; Shim, Chi Young/AAK-1057-2021	Shim, Chi Young/0000-0002-6136-0136; Ha, Jong-Won/0000-0002-8260-2958; Lee, Sak/0000-0001-6130-2342	Korea Science and Engineering Foundation (KOSEF) - Korean government [M10642120001-06N4212-00110]	Korea Science and Engineering Foundation (KOSEF) - Korean government(Korea Science and Engineering FoundationKorean Government)	This work was supported by a Korea Science and Engineering Foundation (KOSEF) grant funded by the Korean government (M10642120001-06N4212-00110 to JWH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajayi AA, 1999, INT J CARDIOL, V71, P79, DOI 10.1016/S0167-5273(99)00117-5; Anker SD, 1999, EUR HEART J, V20, P683, DOI 10.1053/euhj.1998.1446; Anker SD, 2002, INT J CARDIOL, V85, P51, DOI 10.1016/S0167-5273(02)00233-4; Anker SD, 1997, LANCET, V349, P1050, DOI 10.1016/S0140-6736(96)07015-8; Baumgartner H, 2009, EUR J ECHOCARDIOGR, V10, P1, DOI 10.1093/ejechocard/jen303; BUCHANAN N, 1977, INTENS CARE MED, V3, P89, DOI 10.1007/BF01683067; CARR JG, 1989, AM J CARDIOL, V63, P709, DOI 10.1016/0002-9149(89)90256-7; Clark AL, 2007, EUR J HEART FAIL, V9, P839, DOI 10.1016/j.ejheart.2007.03.010; Florea VG, 2002, AM HEART J, V144, P45, DOI 10.1067/mhj.2002.123314; Fouladiun M, 2005, CANCER-AM CANCER SOC, V103, P2189, DOI 10.1002/cncr.21013; Giannakopoulos G, 2015, J AM GERIATR SOC, V63, P416, DOI 10.1111/jgs.13259; Habedank D, 2005, J HEART LUNG TRANSPL, V24, P1757, DOI 10.1016/j.healun.2005.02.003; Haddad F, 2008, CIRCULATION, V117, P1717, DOI 10.1161/CIRCULATIONAHA.107.653584; Lancellotti P, 2010, EUR J ECHOCARDIOGR, V11, P307, DOI 10.1093/ejechocard/jeq031; Magne J, 2015, JACC-CARDIOVASC IMAG, V8, P83, DOI 10.1016/j.jcmg.2014.12.003; Melenovsky V, 2013, J AM COLL CARDIOL, V62, P1660, DOI 10.1016/j.jacc.2013.06.046; Palmieri V, 2003, AM HEART J, V145, P1071, DOI 10.1016/S0002-8703(03)00099-1; PITTMAN JG, 1964, NEW ENGL J MED, V271, P403, DOI 10.1056/NEJM196408202710807; Polak J, 2011, J AM COLL CARDIOL, V58, P1119, DOI 10.1016/j.jacc.2011.05.042; Reichenbach A, 2013, INT J CARDIOL, V168, P60, DOI 10.1016/j.ijcard.2012.09.074; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; SEGAR WE, 1971, AM HEART J, V82, P371, DOI 10.1016/0002-8703(71)90303-6; Sekine S, 1998, SURG TODAY, V28, P1287, DOI 10.1007/BF02482817; STROBER W, 1968, AM J MED, V44, P842, DOI 10.1016/0002-9343(68)90084-3; Toth MJ, 1997, AM J PHYSIOL-ENDOC M, V272, pE469, DOI 10.1152/ajpendo.1997.272.3.E469; Wilson MMG, 2005, AM J CLIN NUTR, V82, P1074, DOI 10.1093/ajcn/82.5.1074	26	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2018	13	9							e0203798	10.1371/journal.pone.0203798	http://dx.doi.org/10.1371/journal.pone.0203798			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU5MM	30240396	gold, Green Submitted, Green Published			2022-12-26	WOS:000445329700009
